{"generated":"2026-10-03T15:50:28-07:00","rows":[{"id":"paper-w2158137297","cat":"papers","name":"Recent advances in the phencyclidine model of schizophrenia","year":"1991","cit":2927,"pfa":"Daniel C. Javitt","psa":"Stephen R. Zukin","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2158137297","eid":"W2158137297"},{"id":"paper-w2558412547","cat":"papers","name":"Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial","year":"2016","cit":2250,"pfa":"Roland R. Griffiths","psa":"Margaret A. Klinedinst","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2558412547","eid":"W2558412547"},{"id":"paper-w4211211437","cat":"papers","name":"Psychedelics","year":"2016","cit":1813,"pfa":"David E. Nichols","ptype":"article","src":"https://openalex.org/W4211211437","eid":"W4211211437"},{"id":"paper-w2559739670","cat":"papers","name":"Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial","year":"2016","cit":1748,"pfa":"Stephen Ross","psa":"Brian L. Schmidt","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2559739670","eid":"W2559739670"},{"id":"paper-w2121441663","cat":"papers","name":"Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance","year":"2006","cit":1718,"pfa":"Roland R. Griffiths","psa":"R. Jesse","ptype":"article","src":"https://openalex.org/W2121441663","eid":"W2121441663"},{"id":"paper-w2346390990","cat":"papers","name":"NMDAR inhibition-independent antidepressant actions of ketamine metabolites","year":"2016","cit":1639,"pfa":"Panos Zanos","psa":"Todd D. Gould","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2346390990","eid":"W2346390990"},{"id":"paper-w2396675581","cat":"papers","name":"Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study","year":"2016","cit":1582,"pfa":"Robin Lester Carhart-Harris","psa":"David Nutt","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2396675581","eid":"W2396675581"},{"id":"paper-w3156937150","cat":"papers","name":"Trial of Psilocybin versus Escitalopram for Depression","year":"2021","cit":1428,"pfa":"Robin Lester Carhart-Harris","psa":"David Nutt","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3156937150","eid":"W3156937150"},{"id":"paper-w2341140535","cat":"papers","name":"Multiple Serotonin Receptors: Differential Binding of [3H]5-Hydroxytryptamine, [3H]Lysergic Acid Diethylamide and [3H]Spiroperidol","year":"1979","cit":1362,"pfa":"Stephen J. Peroutka","psa":"Solomon H. Snyder","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2341140535","eid":"W2341140535"},{"id":"paper-w2109543774","cat":"papers","name":"The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs","year":"2014","cit":1329,"pfa":"Robin Lester Carhart-Harris","psa":"David Nutt","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2109543774","eid":"W2109543774"},{"id":"paper-w3096208965","cat":"papers","name":"Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder","year":"2020","cit":1322,"pfa":"Alan K. Davis","psa":"Roland R. Griffiths","topics":["Depression","Anxiety & end-of-life","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3096208965","eid":"W3096208965"},{"id":"paper-w2132011757","cat":"papers","name":"The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)","year":"2003","cit":1278,"pfa":"A. Richard Green","psa":"M. Isabel Colado","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2132011757","eid":"W2132011757"},{"id":"paper-w2949457836","cat":"papers","name":"REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics","year":"2019","cit":1242,"pfa":"Robin Lester Carhart-Harris","psa":"Karl John Friston","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2949457836","eid":"W2949457836"},{"id":"paper-w2161555895","cat":"papers","name":"Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer","year":"2010","cit":1238,"pfa":"Charles S. Grob","psa":"George R. Greer","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2161555895","eid":"W2161555895"},{"id":"paper-w2113099805","cat":"papers","name":"Human hallucinogen research: guidelines for safety","year":"2008","cit":1224,"pfa":"MW Johnson","psa":"R. R. Griffiths","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2113099805","eid":"W2113099805"},{"id":"paper-w2026832357","cat":"papers","name":"Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin","year":"2012","cit":1220,"pfa":"Robin Lester Carhart-Harris","psa":"David Nutt","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2026832357","eid":"W2026832357"},{"id":"paper-w2808301300","cat":"papers","name":"Psychedelics Promote Structural and Functional Neural Plasticity","year":"2018","cit":1220,"pfa":"Calvin Ly","psa":"David E. Olson","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2808301300","eid":"W2808301300"},{"id":"paper-w4211150788","cat":"papers","name":"Hallucinogens","year":"2004","cit":1202,"pfa":"David E. Nichols","ptype":"article","src":"https://openalex.org/W4211150788","eid":"W4211150788"},{"id":"paper-w2075238613","cat":"papers","name":"Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study","year":"2015","cit":1180,"pfa":"Michael P. Bogenschutz","psa":"Rick J. Strassman","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2075238613","eid":"W2075238613"},{"id":"paper-w4308146982","cat":"papers","name":"Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression","year":"2022","cit":1173,"pfa":"Guy M. Goodwin","psa":"David Printz","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4308146982","eid":"W4308146982"},{"id":"paper-w2790275773","cat":"papers","name":"Mechanisms of ketamine action as an antidepressant","year":"2018","cit":1144,"pfa":"Panos Zanos","psa":"Todd D. Gould","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2790275773","eid":"W2790275773"},{"id":"paper-w1997058647","cat":"papers","name":"Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action","year":"1998","cit":1045,"pfa":"Franz X. Vollenweider","psa":"Daniel Hell","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1997058647","eid":"W1997058647"},{"id":"paper-w1996278273","cat":"papers","name":"The Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for Psychosis","year":"2004","cit":1039,"pfa":"Deepak Cyril D’Souza","psa":"John Harrison Krystal","ptype":"article","src":"https://openalex.org/W1996278273","eid":"W1996278273"},{"id":"paper-w3160990818","cat":"papers","name":"MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study","year":"2021","cit":1001,"pfa":"Jennifer Mitchell","psa":"Rick Doblin","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W3160990818","eid":"W3160990818"},{"id":"paper-w2767530231","cat":"papers","name":"Psilocybin with psychological support for treatment-resistant depression: six-month follow-up","year":"2017","cit":996,"pfa":"Robin Lester Carhart-Harris","psa":"David Nutt","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2767530231","eid":"W2767530231"},{"id":"paper-w2001101493","cat":"papers","name":"Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects","year":"2011","cit":962,"pfa":"Roland R. Griffiths","psa":"Robert Jesse","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2001101493","eid":"W2001101493"},{"id":"paper-w1585016541","cat":"papers","name":"Medical Toxicology: Diagnosis and Treatment of Human Poisoning.","year":"1988","cit":949,"topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1585016541","eid":"W1585016541"},{"id":"paper-w2009134620","cat":"papers","name":"Hallucinogens Recruit Specific Cortical 5-HT2A Receptor-Mediated Signaling Pathways to Affect Behavior","year":"2007","cit":943,"pfa":"Javier González‐Maeso","psa":"Jay A. Gingrich","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2009134620","eid":"W2009134620"},{"id":"paper-w2122459973","cat":"papers","name":"Pilot study of the 5-HT 2A R agonist psilocybin in the treatment of tobacco addiction","year":"2014","cit":931,"pfa":"Matthew W. Johnson","psa":"Roland R. Griffiths","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2122459973","eid":"W2122459973"},{"id":"paper-w2118739111","cat":"papers","name":"Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness","year":"2011","cit":922,"pfa":"Katherine A. MacLean","psa":"Roland R. Griffiths","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2118739111","eid":"W2118739111"},{"id":"paper-w2138368199","cat":"papers","name":"Study of a New Schizophrenomimetic Drug—Sernyl","year":"1959","cit":922,"pfa":"Elliot D. Luby","ptype":"article","src":"https://openalex.org/W2138368199","eid":"W2138368199"},{"id":"paper-w2119738402","cat":"papers","name":"Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later","year":"2008","cit":916,"pfa":"R. R. Griffiths","psa":"R. Jesse","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2119738402","eid":"W2119738402"},{"id":"paper-w2077609442","cat":"papers","name":"Subanesthetic Doses of Ketamine Stimulate Psychosis in Schizophrenia","year":"1995","cit":905,"pfa":"Adrienne Carol Lahti","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2077609442","eid":"W2077609442"},{"id":"paper-w2336389811","cat":"papers","name":"Neural correlates of the LSD experience revealed by multimodal neuroimaging","year":"2016","cit":904,"pfa":"Robin Lester Carhart-Harris","psa":"David Nutt","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2336389811","eid":"W2336389811"},{"id":"paper-w2946661342","cat":"papers","name":"Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study","year":"2019","cit":901,"pfa":"Vanina Popova","psa":"Jaskaran B. Singh","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2946661342","eid":"W2946661342"},{"id":"paper-w2032643119","cat":"papers","name":"Psychotomimesis Mediated by κ Opiate Receptors","year":"1986","cit":866,"pfa":"Andreas F. H. Pfeiffer","psa":"H. M. Emrich","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2032643119","eid":"W2032643119"},{"id":"paper-w2952169207","cat":"papers","name":"Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial","year":"2018","cit":853,"pfa":"Fernanda Palhano-Fontes","psa":"Dráulio Barros de Araújo","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2952169207","eid":"W2952169207"},{"id":"paper-w1995909187","cat":"papers","name":"TWO KINDS OF TRYPTAMINE RECEPTOR","year":"1957","cit":850,"pfa":"John Henry Gaddum","psa":"Zuleika P. Picarelli","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1995909187","eid":"W1995909187"},{"id":"paper-w2021099633","cat":"papers","name":"NMDA Antagonist Neurotoxicity: Mechanism and Prevention","year":"1991","cit":850,"pfa":"John W. Olney","psa":"Michael A. Sesma","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2021099633","eid":"W2021099633"},{"id":"paper-w2142914211","cat":"papers","name":"Kaplan & Sadock's synopsis of psychiatry : behavioral sciences/clinical psychiatry","year":"2015","cit":844,"pfa":"Benjamin J. Sadock","psa":"Norman Sussman","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"book","src":"https://openalex.org/W2142914211","eid":"W2142914211"},{"id":"paper-w2792444257","cat":"papers","name":"Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression","year":"2018","cit":833,"pfa":"Leor Roseman","psa":"Robin Lester Carhart-Harris","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2792444257","eid":"W2792444257"},{"id":"paper-w4386765496","cat":"papers","name":"Treatment‐resistant depression: definition, prevalence, detection, management, and investigational interventions","year":"2023","cit":812,"pfa":"Roger S. McIntyre","psa":"Mario Maj","topics":["Depression","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4386765496","eid":"W4386765496"},{"id":"paper-w2043197532","cat":"papers","name":"Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder","year":"2006","cit":807,"pfa":"Francisco Moreno","psa":"Pedro L. Delgado","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2043197532","eid":"W2043197532"},{"id":"paper-w2948816951","cat":"papers","name":"Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression","year":"2019","cit":790,"pfa":"Ella Daly","psa":"Jaskaran B. Singh","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2948816951","eid":"W2948816951"},{"id":"paper-w2005643237","cat":"papers","name":"Salvinorin A: A potent naturally occurring nonnitrogenous κ opioid selective agonist","year":"2002","cit":785,"pfa":"Bryan L. Roth","psa":"Richard B. Rothman","topics":["Addiction","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2005643237","eid":"W2005643237"},{"id":"paper-w2753654430","cat":"papers","name":"Serotonin and brain function: a tale of two receptors","year":"2017","cit":767,"pfa":"Robin Lester Carhart-Harris","psa":"David Nutt","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2753654430","eid":"W2753654430"},{"id":"paper-w2078821747","cat":"papers","name":"Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases","year":"2014","cit":765,"pfa":"Peter Gasser","psa":"Rudolf Brenneisen","topics":["Anxiety & end-of-life","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2078821747","eid":"W2078821747"},{"id":"paper-w2068751924","cat":"papers","name":"The neurobiology of psychedelic drugs: implications for the treatment of mood disorders","year":"2010","cit":749,"pfa":"Franz X. Vollenweider","psa":"Michael Kometer","ptype":"review","src":"https://openalex.org/W2068751924","eid":"W2068751924"},{"id":"paper-w2069057651","cat":"papers","name":"Taking a Spiritual History Allows Clinicians to Understand Patients More Fully","year":"2000","cit":749,"pfa":"Christina M. Puchalski","psa":"Anna L. Romer","topics":["PTSD & trauma","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2069057651","eid":"W2069057651"},{"id":"paper-w2082669257","cat":"papers","name":"Toxicity and deaths from 3,4-methylenedioxymethamphetamine (\"ecstasy\")","year":"1992","cit":732,"pfa":"J.A. Henry","psa":"S. Dawling","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2082669257","eid":"W2082669257"},{"id":"paper-w2779386549","cat":"papers","name":"Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression","year":"2017","cit":726,"pfa":"Ella Daly","psa":"Wayne Curtis Drevets","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2779386549","eid":"W2779386549"},{"id":"paper-w3137976016","cat":"papers","name":"Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation","year":"2021","cit":726,"pfa":"Roger S. McIntyre","psa":"Stephen M. Stahl","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3137976016","eid":"W3137976016"},{"id":"paper-w4292937262","cat":"papers","name":"Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder","year":"2022","cit":719,"pfa":"Michael P. Bogenschutz","psa":"Lindsay Worth","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4292937262","eid":"W4292937262"},{"id":"paper-w2506717582","cat":"papers","name":"Long-term follow-up of psilocybin-facilitated smoking cessation","year":"2016","cit":715,"pfa":"Matthew W. Johnson","psa":"Roland R. Griffiths","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2506717582","eid":"W2506717582"},{"id":"paper-w2610144880","cat":"papers","name":"The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future","year":"2017","cit":713,"pfa":"Robin Lester Carhart-Harris","psa":"Guy M. Goodwin","ptype":"article","src":"https://openalex.org/W2610144880","eid":"W2610144880"},{"id":"paper-w2124484771","cat":"papers","name":"Specificity of Genetic and Environmental Risk Factors for Use and Abuse/Dependence of Cannabis, Cocaine, Hallucinogens, Sedatives, Stimulants, and Opiates in Male Twins","year":"2003","cit":708,"pfa":"Kenneth S. Kendler","psa":"Michael C. Neale","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2124484771","eid":"W2124484771"},{"id":"paper-w2133402952","cat":"papers","name":"Structural Features for Functional Selectivity at Serotonin Receptors","year":"2013","cit":703,"pfa":"Daniel Wacker","psa":"Raymond C. Stevens","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2133402952","eid":"W2133402952"},{"id":"paper-w2123488676","cat":"papers","name":"Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression","year":"2009","cit":697,"pfa":"Marije aan het Rot","psa":"Sanjay J. Mathew","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2123488676","eid":"W2123488676"},{"id":"paper-w1978751446","cat":"papers","name":"Complex visual hallucinations. Clinical and neurobiological insights","year":"1998","cit":685,"pfa":"Mark Manford","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1978751446","eid":"W1978751446"},{"id":"paper-w2089149909","cat":"papers","name":"The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study","year":"2010","cit":681,"pfa":"Michael C. Mithoefer","psa":"Rick Doblin","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2089149909","eid":"W2089149909"},{"id":"paper-w2322548405","cat":"papers","name":"Ketamine: A Review of Clinical Pharmacokinetics and Pharmacodynamics in Anesthesia and Pain Therapy","year":"2016","cit":681,"pfa":"Marko A. Peltoniemi","psa":"Teijo I. Saari","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2322548405","eid":"W2322548405"},{"id":"paper-w1572907996","cat":"papers","name":"Pharmacological characterization of designer cathinonesin vitro","year":"2012","cit":678,"pfa":"Linda D. Simmler","psa":"Matthias E. Liechti","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1572907996","eid":"W1572907996"},{"id":"paper-w2796940952","cat":"papers","name":"Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study","year":"2018","cit":678,"pfa":"Carla M. Canuso","psa":"Wayne Curtis Drevets","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2796940952","eid":"W2796940952"},{"id":"paper-w2788854095","cat":"papers","name":"Psychedelics and the essential importance of context","year":"2018","cit":670,"pfa":"Robin Lester Carhart-Harris","psa":"Mendel Kaelen","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2788854095","eid":"W2788854095"},{"id":"paper-w2340085151","cat":"papers","name":"Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin","year":"2015","cit":662,"pfa":"Frederick Streeter Barrett","psa":"Roland R. Griffiths","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2340085151","eid":"W2340085151"},{"id":"paper-w2171847604","cat":"papers","name":"Positron emission tomographic evidence of toxic effect of MDMA (“Ecstasy”) on brain serotonin neurons in human beings","year":"1998","cit":661,"pfa":"UD McCann","psa":"G.A. Ricaurte","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2171847604","eid":"W2171847604"},{"id":"paper-w2343195587","cat":"papers","name":"Amphetamine, 3,4-Methylenedioxymethamphetamine, Lysergic Acid Diethylamide, and Metabolites of the Catecholamine Neurotransmitters Are Agonists of a Rat Trace Amine Receptor","year":"2001","cit":655,"pfa":"James R. Bunzow","psa":"David K. Grandy","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2343195587","eid":"W2343195587"},{"id":"paper-w3006905788","cat":"papers","name":"Psychedelics and Psychedelic-Assisted Psychotherapy","year":"2020","cit":654,"pfa":"Collin M. Reiff","psa":"William Maffitt McDonald","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W3006905788","eid":"W3006905788"},{"id":"paper-w3179469168","cat":"papers","name":"Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo","year":"2021","cit":624,"pfa":"Ling-Xiao Shao","psa":"Alex C. Kwan","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3179469168","eid":"W3179469168"},{"id":"paper-w2040903359","cat":"papers","name":"Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation.","year":"1993","cit":623,"pfa":"Martial Ruat","psa":"Schwartz Jc","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2040903359","eid":"W2040903359"},{"id":"paper-w2122935241","cat":"papers","name":"The pharmacology and toxicology of \"ecstasy\" (MDMA) and related drugs.","year":"2001","cit":618,"pfa":"H. Kalant","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2122935241","eid":"W2122935241"},{"id":"paper-w1746596066","cat":"papers","name":"R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects","year":"2015","cit":609,"pfa":"Chun Yang","psa":"Kenji Hashimoto","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1746596066","eid":"W1746596066"},{"id":"paper-w2083947597","cat":"papers","name":"Ketamine","year":"1998","cit":608,"pfa":"Rainer Kohrs","psa":"Marcel E. Durieux","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2083947597","eid":"W2083947597"},{"id":"paper-w2762746674","cat":"papers","name":"Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms","year":"2017","cit":607,"pfa":"Robin Lester Carhart-Harris","psa":"David Nutt","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2762746674","eid":"W2762746674"},{"id":"paper-w2111728433","cat":"papers","name":"Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression","year":"2015","cit":605,"pfa":"D. Jeffrey Newport","psa":"Charles B. Nemeroff","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2111728433","eid":"W2111728433"},{"id":"paper-w2961020354","cat":"papers","name":"Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1)","year":"2019","cit":603,"pfa":"Maggie M Fedgchin","psa":"Jaskaran B. Singh","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2961020354","eid":"W2961020354"},{"id":"paper-w2644260506","cat":"papers","name":"Patients’ Accounts of Increased “Connectedness” and “Acceptance” After Psilocybin for Treatment-Resistant Depression","year":"2017","cit":600,"pfa":"Rosalind Watts","psa":"Robin Lester Carhart-Harris","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2644260506","eid":"W2644260506"},{"id":"paper-w3085641834","cat":"papers","name":"Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders","year":"2020","cit":600,"pfa":"Franz X. Vollenweider","psa":"Katrin H. Preller","ptype":"review","src":"https://openalex.org/W3085641834","eid":"W3085641834"},{"id":"paper-w2155867087","cat":"papers","name":"Prevalence of Substance Abuse in Schizophrenia: Demographic and Clinical Correlates","year":"1990","cit":595,"pfa":"K. T. Mueser","psa":"KASHINATH G. YADALAM","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2155867087","eid":"W2155867087"},{"id":"paper-w1973613743","cat":"papers","name":"Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials","year":"2012","cit":590,"pfa":"Teri Suzanne Krebs","psa":"Pål-Ørjan Johansen","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W1973613743","eid":"W1973613743"},{"id":"paper-w2069656785","cat":"papers","name":"The Glutamatergic Dysfunction Hypothesis for Schizophrenia","year":"1996","cit":573,"pfa":"Joseph T. Coyle","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2069656785","eid":"W2069656785"},{"id":"paper-w2741959390","cat":"papers","name":"Side-effects associated with ketamine use in depression: a systematic review","year":"2017","cit":568,"pfa":"Brooke L Short","psa":"Colleen K A Loo","topics":["Depression","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W2741959390","eid":"W2741959390"},{"id":"paper-w2513336695","cat":"papers","name":"Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences","year":"2016","cit":565,"pfa":"Theresa M. Carbonaro","psa":"Roland R. Griffiths","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2513336695","eid":"W2513336695"},{"id":"paper-w2090826913","cat":"papers","name":"Differences Between the Mechanism of Action of MDMA, MBDB, and the Classic Hallucinogens. Identification of a New Therapeutic Class: Entactogens","year":"1986","cit":565,"pfa":"David E. Nichols","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2090826913","eid":"W2090826913"},{"id":"paper-w3113263685","cat":"papers","name":"The Subjective Effects of Psychedelics Are Necessary for Their Enduring Therapeutic Effects","year":"2020","cit":556,"pfa":"David B. Yaden","psa":"Roland R. Griffiths","topics":["Mechanism & neuroscience"],"ptype":"editorial","src":"https://openalex.org/W3113263685","eid":"W3113263685"},{"id":"paper-w4386305655","cat":"papers","name":"Single-Dose Psilocybin Treatment for Major Depressive Disorder","year":"2023","cit":544,"pfa":"Charles L. Raison","psa":"Roland R. Griffiths","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4386305655","eid":"W4386305655"},{"id":"paper-w1693348571","cat":"papers","name":"Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity","year":"1988","cit":544,"pfa":"Elizabeth O’Hearn","psa":"Molliver Me","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1693348571","eid":"W1693348571"},{"id":"paper-w2762822955","cat":"papers","name":"Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and","year":"2017","cit":541,"pfa":"Roland R. Griffiths","psa":"Maggie A Klinedinst","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2762822955","eid":"W2762822955"},{"id":"paper-w2341558148","cat":"papers","name":"Increased Global Functional Connectivity Correlates with LSD-Induced Ego Dissolution","year":"2016","cit":540,"pfa":"Enzo Tagliazucchi","psa":"Robin Lester Carhart-Harris","ptype":"article","src":"https://openalex.org/W2341558148","eid":"W2341558148"},{"id":"paper-w2016532705","cat":"papers","name":"The molecular mechanism of \"ecstasy\" [3,4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release.","year":"1992","cit":538,"pfa":"Gary Rudnick","psa":"Stephen C. Wall","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2016532705","eid":"W2016532705"},{"id":"paper-w1981740630","cat":"papers","name":"Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies","year":"2010","cit":538,"pfa":"Erich Studerus","psa":"Franz X. Vollenweider","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1981740630","eid":"W1981740630"},{"id":"paper-w2004172377","cat":"papers","name":"5-Hydroxytryptamine 2A serotonin receptors in the primate cerebral cortex: Possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites","year":"1998","cit":538,"pfa":"Robert L. Jakab","psa":"Patricia S. Goldman‐Rakic","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2004172377","eid":"W2004172377"},{"id":"paper-w2125368083","cat":"papers","name":"The Hallucinogen N,N -Dimethyltryptamine (DMT) Is an Endogenous Sigma-1 Receptor Regulator","year":"2009","cit":537,"pfa":"Dominique Fontanilla","psa":"Arnold E. Ruoho","topics":["Addiction","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2125368083","eid":"W2125368083"},{"id":"paper-w2914255920","cat":"papers","name":"Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels","year":"2019","cit":529,"pfa":"Martin Korsbak Madsen","psa":"Gitte M. Knudsen","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2914255920","eid":"W2914255920"},{"id":"paper-w1949070403","cat":"papers","name":"Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine.","year":"1987","cit":529,"pfa":"C J Schmidt","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1949070403","eid":"W1949070403"},{"id":"paper-w2903001666","cat":"papers","name":"Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function","year":"2018","cit":528,"pfa":"Matthew W. Johnson","psa":"Roland R. Griffiths","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2903001666","eid":"W2903001666"},{"id":"paper-w2127884280","cat":"papers","name":"Illicit Psychoactive Substance Use, Heavy Use, Abuse, and Dependence in a US Population-Based Sample of Male Twins","year":"2000","cit":517,"pfa":"Kenneth S. Kendler","psa":"Carol Arlene Prescott","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2127884280","eid":"W2127884280"},{"id":"paper-w2039232630","cat":"papers","name":"Prevalence and Correlates of Drug Use and Dependence in the United States","year":"1995","cit":514,"pfa":"Lynn A. Warner","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2039232630","eid":"W2039232630"},{"id":"paper-w2033134445","cat":"papers","name":"Broadband Cortical Desynchronization Underlies the Human Psychedelic State","year":"2013","cit":513,"pfa":"Suresh D Muthukumaraswamy","psa":"David Nutt","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2033134445","eid":"W2033134445"},{"id":"paper-w1953082779","cat":"papers","name":"Ketamine for chronic pain: risks and benefits","year":"2013","cit":513,"pfa":"Marieke Niesters","psa":"Albert Dahan","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1953082779","eid":"W1953082779"},{"id":"paper-w1565257873","cat":"papers","name":"Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype.","year":"1993","cit":511,"pfa":"Yiping Shen","psa":"David R. Sibley","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1565257873","eid":"W1565257873"},{"id":"paper-w2335809166","cat":"papers","name":"Serotonin and Lysergic Acid Diethylamide Binding in Rat Brain Membranes: Relationship to Postsynaptic Serotonin Receptors","year":"1976","cit":509,"pfa":"James P. Bennett","psa":"Solomon H. Snyder","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2335809166","eid":"W2335809166"},{"id":"paper-w3086773311","cat":"papers","name":"Structure of a Hallucinogen-Activated Gq-Coupled 5-HT2A Serotonin Receptor","year":"2020","cit":508,"pfa":"Kuglae Kim","psa":"Bryan L. Roth","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3086773311","eid":"W3086773311"},{"id":"paper-w4321033185","cat":"papers","name":"Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors","year":"2023","cit":505,"pfa":"Maxemiliano V. Vargas","psa":"David E. Olson","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4321033185","eid":"W4321033185"},{"id":"paper-w2137983723","cat":"papers","name":"Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report","year":"2015","cit":494,"pfa":"Flávia de Lima Osório","psa":"Jaime E. C. Hallak","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2137983723","eid":"W2137983723"},{"id":"paper-w2439685582","cat":"papers","name":"Ego-Dissolution and Psychedelics: Validation of the Ego-Dissolution Inventory (EDI)","year":"2016","cit":491,"pfa":"Matthew M. Nour","psa":"Robin Lester Carhart-Harris","topics":["Addiction","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2439685582","eid":"W2439685582"},{"id":"paper-w1996780673","cat":"papers","name":"A Randomized Controlled Trial of Intranasal Ketamine in Major Depressive Disorder","year":"2014","cit":489,"pfa":"Kyle A. B. Lapidus","psa":"James W. Murrough","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W1996780673","eid":"W1996780673"},{"id":"paper-w2140013897","cat":"papers","name":"Psilocybin-Occasioned Mystical Experiences in the Treatment of Tobacco Addiction","year":"2015","cit":488,"pfa":"Albert Garcia‐Romeu","psa":"Matthew W. Johnson","topics":["Addiction","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2140013897","eid":"W2140013897"},{"id":"paper-w2552814605","cat":"papers","name":"Set and setting, psychedelics and the placebo response: An extra-pharmacological perspective on psychopharmacology","year":"2016","cit":488,"pfa":"Ido Hartogsohn","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2552814605","eid":"W2552814605"},{"id":"paper-w4379469019","cat":"papers","name":"Psychedelics promote plasticity by directly binding to BDNF receptor TrkB","year":"2023","cit":487,"pfa":"Rafael Moliner","psa":"Eero Ċastrén","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4379469019","eid":"W4379469019"},{"id":"paper-w3112535936","cat":"papers","name":"A non-hallucinogenic psychedelic analogue with therapeutic potential","year":"2020","cit":486,"pfa":"Lindsay P. Cameron","psa":"David E. Olson","ptype":"article","src":"https://openalex.org/W3112535936","eid":"W3112535936"},{"id":"paper-w2108265345","cat":"papers","name":"Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders","year":"2012","cit":483,"pfa":"Alline Cristina Campos","psa":"Francisco Silveira Guimarães","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2108265345","eid":"W2108265345"},{"id":"paper-w2896249550","cat":"papers","name":"Dose translation between laboratory animals and human in preclinical and clinical phases of drug development","year":"2018","cit":481,"pfa":"Anroop Balachandran Nair","psa":"Shery Jacob","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2896249550","eid":"W2896249550"},{"id":"paper-w3210183659","cat":"papers","name":"Stahl's Essential Psychopharmacology","year":"2021","cit":479,"pfa":"Stephen M. Stahl","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"book","src":"https://openalex.org/W3210183659","eid":"W3210183659"},{"id":"paper-w2981272605","cat":"papers","name":"Efficacy and Safety of Esketamine Nasal Spray Plus an Oral Antidepressant in Elderly Patients With Treatment-Resistant Depression—TRANSFORM-3","year":"2019","cit":478,"pfa":"Rachel Ochs-Ross","psa":"Jaskaran B. Singh","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2981272605","eid":"W2981272605"},{"id":"paper-w2581696375","cat":"papers","name":"Crystal Structure of an LSD-Bound Human Serotonin Receptor","year":"2017","cit":477,"pfa":"Daniel Wacker","psa":"Bryan L. Roth","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2581696375","eid":"W2581696375"},{"id":"paper-w2419844652","cat":"papers","name":"Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression","year":"2015","cit":475,"pfa":"Rafael Faria Sanches","psa":"Jaime E. C. Hallak","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2419844652","eid":"W2419844652"},{"id":"paper-w2154105276","cat":"papers","name":"The pharmacology of psilocybin","year":"2002","cit":472,"pfa":"Torsten Passie","psa":"H. M. Emrich","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2154105276","eid":"W2154105276"},{"id":"paper-w1948877773","cat":"papers","name":"Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study","year":"2015","cit":472,"pfa":"Jaskaran B. Singh","psa":"Luc Van Nueten","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1948877773","eid":"W1948877773"},{"id":"paper-w2093477837","cat":"papers","name":"The Psychedelic State Induced by Ayahuasca Modulates the Activity and Connectivity of the Default Mode Network","year":"2015","cit":469,"pfa":"Fernanda Palhano-Fontes","psa":"Dráulio Barros de Araújo","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2093477837","eid":"W2093477837"},{"id":"paper-w2164276826","cat":"papers","name":"LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: A qualitative study of acute and sustained subjective effects","year":"2014","cit":467,"pfa":"Peter Gasser","psa":"Torsten Passie","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2164276826","eid":"W2164276826"},{"id":"paper-w2096626991","cat":"papers","name":"Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose?effect study","year":"2004","cit":466,"pfa":"Felix Hasler","psa":"Franz X. Vollenweider","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2096626991","eid":"W2096626991"},{"id":"paper-w2145095988","cat":"papers","name":"The Pharmacology of Lysergic Acid Diethylamide: A Review","year":"2008","cit":465,"pfa":"Torsten Passie","psa":"Annelie K. Hintzen","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2145095988","eid":"W2145095988"},{"id":"paper-w2605399484","cat":"papers","name":"Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin","year":"2017","cit":462,"pfa":"Michael M. Schartner","psa":"Suresh D Muthukumaraswamy","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2605399484","eid":"W2605399484"},{"id":"paper-w2010322651","cat":"papers","name":"Dose-Response Study of N,N-Dimethyltryptamine in Humans","year":"1994","cit":461,"pfa":"Rick J. Strassman","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2010322651","eid":"W2010322651"},{"id":"paper-w2101367564","cat":"papers","name":"3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites.","year":"1987","cit":458,"pfa":"Giuseppe Battaglia","psa":"E B De Souza","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2101367564","eid":"W2101367564"},{"id":"paper-w2020749289","cat":"papers","name":"An N-methylaspartate receptor-mediated synapse in rat cerebral cortex: a site of action of ketamine?","year":"1985","cit":457,"pfa":"Alex M. Thomson","psa":"David Lodge","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2020749289","eid":"W2020749289"},{"id":"paper-w2048509938","cat":"papers","name":"Positron Emission Tomography and Fluorodeoxyglucose Studies of Metabolic Hyperfrontality and Psychopathology in the Psilocybin Model of Psychosis","year":"1997","cit":455,"pfa":"Franz X. Vollenweider","ptype":"article","src":"https://openalex.org/W2048509938","eid":"W2048509938"},{"id":"paper-w2253242458","cat":"papers","name":"Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain.","year":"1987","cit":452,"pfa":"Deborah Commins","psa":"Lewis S. Seiden","ptype":"article","src":"https://openalex.org/W2253242458","eid":"W2253242458"},{"id":"paper-w4223491164","cat":"papers","name":"Increased global integration in the brain after psilocybin therapy for depression","year":"2022","cit":451,"pfa":"Richard E. Daws","psa":"Robin Lester Carhart-Harris","topics":["Depression","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4223491164","eid":"W4223491164"},{"id":"paper-w2011428797","cat":"papers","name":"Human Pharmacology of MDMA","year":"2004","cit":447,"pfa":"Rafael de la Torre","psa":"Jordi Camı́","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2011428797","eid":"W2011428797"},{"id":"paper-w2799742551","cat":"papers","name":"3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical tria","year":"2018","cit":447,"pfa":"Michael C. Mithoefer","psa":"Rick Doblin","topics":["PTSD & trauma","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2799742551","eid":"W2799742551"},{"id":"paper-w3000386776","cat":"papers","name":"Management of Treatment-Resistant Depression: Challenges and Strategies","year":"2020","cit":444,"pfa":"Daphne Voineskos","psa":"Daniel M. Blumberger","topics":["Depression","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3000386776","eid":"W3000386776"},{"id":"paper-w4386740988","cat":"papers","name":"MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial","year":"2023","cit":442,"pfa":"Jennifer Mitchell","psa":"Amy Emerson","topics":["PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4386740988","eid":"W4386740988"},{"id":"paper-w2093795230","cat":"papers","name":"Ketamine activates psychosis and alters limbic blood flow in schizophrenia","year":"1995","cit":440,"pfa":"Adrienne Carol Lahti","psa":"Carol A. Tamminga","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2093795230","eid":"W2093795230"},{"id":"paper-w4212903385","cat":"papers","name":"Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up","year":"2022","cit":437,"pfa":"Natalie Gukasyan","psa":"Roland R. Griffiths","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4212903385","eid":"W4212903385"},{"id":"paper-w2894846833","cat":"papers","name":"Predicting Responses to Psychedelics: A Prospective Study","year":"2018","cit":436,"pfa":"Eline C. H. M. Haijen","psa":"Robin Lester Carhart-Harris","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2894846833","eid":"W2894846833"},{"id":"paper-w2962285119","cat":"papers","name":"Emotional breakthrough and psychedelics: Validation of the Emotional Breakthrough Inventory","year":"2019","cit":433,"pfa":"Leor Roseman","psa":"Robin Lester Carhart-Harris","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2962285119","eid":"W2962285119"},{"id":"paper-w2080123927","cat":"papers","name":"Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens","year":"2011","cit":430,"pfa":"Adam L. Halberstadt","psa":"Mark A. Geyer","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2080123927","eid":"W2080123927"},{"id":"paper-w2020179652","cat":"papers","name":"Ketamine for Perioperative Pain Management","year":"2004","cit":430,"pfa":"Sabine Himmelseher","psa":"Richard B. Weiskopf","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2020179652","eid":"W2020179652"},{"id":"paper-w2109884356","cat":"papers","name":"Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects","year":"2014","cit":429,"pfa":"Yasmin Schmid","psa":"Matthias E. Liechti","ptype":"article","src":"https://openalex.org/W2109884356","eid":"W2109884356"},{"id":"paper-w2151662898","cat":"papers","name":"Modification of 5‐HT neuron properties by sustained administration of the 5‐HT1A agonist gepirone: Electrophysiological studies in the rat brain","year":"1987","cit":428,"pfa":"Pierre Ulrich Blier","psa":"Claude de Montigny","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2151662898","eid":"W2151662898"},{"id":"paper-w2170596036","cat":"papers","name":"Enhanced repertoire of brain dynamical states during the psychedelic experience","year":"2014","cit":427,"pfa":"Enzo Tagliazucchi","psa":"Dante R. Chialvo","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2170596036","eid":"W2170596036"},{"id":"paper-w2950564037","cat":"papers","name":"Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor","year":"2018","cit":426,"pfa":"Katrin H. Preller","psa":"Alan Anticevic","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2950564037","eid":"W2950564037"},{"id":"paper-w2024490100","cat":"papers","name":"Factor Analysis of the Mystical Experience Questionnaire: A Study of Experiences Occasioned by the Hallucinogen Psilocybin","year":"2012","cit":423,"pfa":"Katherine A. MacLean","psa":"Roland R. Griffiths","ptype":"article","src":"https://openalex.org/W2024490100","eid":"W2024490100"},{"id":"paper-w3082490768","cat":"papers","name":"Esketamine Nasal Spray for Rapid Reduction of Depressive Symptoms in Patients With Major Depressive Disorder Who Have Active Suicide Ideation With Intent: Results of a Phase 3, Double-Blind, Randomized Study (ASPIRE II)","year":"2020","cit":423,"pfa":"Dawn Flosnik Ionescu","psa":"Carla M. Canuso","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3082490768","eid":"W3082490768"},{"id":"paper-w1973234849","cat":"papers","name":"Subjective Reports of the Effects of MDMA in a Clinical Setting","year":"1986","cit":419,"pfa":"George R. Greer","psa":"Requa Tolbert","ptype":"article","src":"https://openalex.org/W1973234849","eid":"W1973234849"},{"id":"paper-w2126853995","cat":"papers","name":"Startle Habituation and Sensorimotor Gating in Schizophrenia and Related Animal Models","year":"1987","cit":419,"pfa":"Mark A. Geyer","psa":"DAVID L. BRAFF","topics":["Mechanism & neuroscience","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2126853995","eid":"W2126853995"},{"id":"paper-w2095188030","cat":"papers","name":"Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or “Ecstasy”)","year":"1995","cit":417,"pfa":"A. Richard Green","psa":"Guy M. Goodwin","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2095188030","eid":"W2095188030"},{"id":"paper-w2045951745","cat":"papers","name":"Recreational MDMA use in Sydney: a profile of ‘Ecstasy’ users and their experiences with the drug","year":"1992","cit":416,"pfa":"Nadia Solowij","psa":"Nicole Lee","ptype":"article","src":"https://openalex.org/W2045951745","eid":"W2045951745"},{"id":"paper-w2892061340","cat":"papers","name":"Psychedelics, Meditation, and Self-Consciousness","year":"2018","cit":416,"pfa":"Raphaël Millière","psa":"Aviva Berkovich‐Ohana","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2892061340","eid":"W2892061340"},{"id":"paper-w1991333985","cat":"papers","name":"Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET)","year":"1997","cit":416,"pfa":"Franz X. Vollenweider","psa":"Jules Angst","ptype":"article","src":"https://openalex.org/W1991333985","eid":"W1991333985"},{"id":"paper-w2582692487","cat":"papers","name":"The Fabric of Meaning and Subjective Effects in LSD-Induced States Depend on Serotonin 2A Receptor Activation","year":"2017","cit":415,"pfa":"Katrin H. Preller","psa":"Franz X. Vollenweider","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2582692487","eid":"W2582692487"},{"id":"paper-w2942772596","cat":"papers","name":"Drug Overdose Deaths Involving Cocaine and Psychostimulants with Abuse Potential — United States, 2003–2017","year":"2019","cit":413,"pfa":"Mbabazi Kariisa","psa":"Brooke Hoots","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2942772596","eid":"W2942772596"},{"id":"paper-w2137981069","cat":"papers","name":"A randomized, controlled pilot study of MDMA (±3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD)","year":"2012","cit":409,"pfa":"Peter Oehen","psa":"Ulrich Schnyder","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2137981069","eid":"W2137981069"},{"id":"paper-w3088001093","cat":"papers","name":"Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis","year":"2020","cit":408,"pfa":"Anees Bahji","psa":"Carlos A. Zarate","topics":["Depression","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W3088001093","eid":"W3088001093"},{"id":"paper-w1972160704","cat":"papers","name":"Lysergic Acid Diethylamide: Sensitive Neuronal Units in the Midbrain Raphe","year":"1968","cit":406,"pfa":"George K. Aghajanian","psa":"Michael H. Sheard","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1972160704","eid":"W1972160704"},{"id":"paper-w2164164342","cat":"papers","name":"Non‐linear pharmacokinetics of MDMA (‘ecstasy’) in humans","year":"2000","cit":404,"pfa":"Rafael de la Torre","psa":"Jordi Camı́","topics":["Safety & adverse events","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2164164342","eid":"W2164164342"},{"id":"paper-w653808948","cat":"papers","name":"Hallucinogens and shamanism","year":"1973","cit":403,"pfa":"Michael J. Harner","ptype":"book","src":"https://openalex.org/W653808948","eid":"W653808948"},{"id":"paper-w3155245221","cat":"papers","name":"Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice","year":"2021","cit":402,"pfa":"Natalie Hesselgrave","psa":"Scott M. Thompson","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3155245221","eid":"W3155245221"},{"id":"paper-w2101808966","cat":"papers","name":"Monoamine oxidase inhibitors in South American hallucinogenic plants: Tryptamine and β-carboline constituents of Ayahuasca","year":"1984","cit":402,"pfa":"Dennis J. McKenna","psa":"F. S. Abbott","ptype":"article","src":"https://openalex.org/W2101808966","eid":"W2101808966"},{"id":"paper-w1882482010","cat":"papers","name":"The role of serotonin 5-HT2A receptors in memory and cognition","year":"2015","cit":398,"pfa":"Gongliang Zhang","psa":"Robert W. Stackman","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1882482010","eid":"W1882482010"},{"id":"paper-w230887154","cat":"papers","name":"Psychedelic White: Goa Trance and the Viscosity of Race","year":"2007","cit":396,"pfa":"Arun Saldanha","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W230887154","eid":"W230887154"},{"id":"paper-w2131489415","cat":"papers","name":"Psychological and Cardiovascular Effects and Short-Term Sequelae of MDMA (“Ecstasy”) in MDMA-Naïve Healthy Volunteers","year":"1998","cit":395,"pfa":"Franz X. Vollenweider","psa":"Theo Huber","ptype":"article","src":"https://openalex.org/W2131489415","eid":"W2131489415"},{"id":"paper-w2065540111","cat":"papers","name":"From drugs to deprivation: a Bayesian framework for understanding models of psychosis","year":"2009","cit":394,"pfa":"Philip Robert Corlett","psa":"Paul Charles Fletcher","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2065540111","eid":"W2065540111"},{"id":"paper-w1623883571","cat":"papers","name":"Autoradiographic localization of sigma receptor binding sites in guinea pig and rat central nervous system with (+)3H-3-(3-hydroxyphenyl)-N-(1- propyl)piperidine","year":"1986","cit":393,"pfa":"AL Gundlach","psa":"Solomon H. Snyder","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1623883571","eid":"W1623883571"},{"id":"paper-w2004109806","cat":"papers","name":"Depressive-Like Effects of the κ-Opioid Receptor Agonist Salvinorin A on Behavior and Neurochemistry in Rats","year":"2005","cit":391,"pfa":"William A. Carlezon","psa":"Bruce M. Cohen","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2004109806","eid":"W2004109806"},{"id":"paper-w2124026487","cat":"papers","name":"Human Pharmacology of Ayahuasca: Subjective and Cardiovascular Effects, Monoamine Metabolite Excretion, and Pharmacokinetics","year":"2003","cit":390,"pfa":"Jordi Riba","psa":"Manel J. Barbanoj","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2124026487","eid":"W2124026487"},{"id":"paper-w3005441929","cat":"papers","name":"Emotions and brain function are altered up to one month after a single high dose of psilocybin","year":"2020","cit":389,"pfa":"Frederick Streeter Barrett","psa":"Roland R. Griffiths","topics":["Addiction","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3005441929","eid":"W3005441929"},{"id":"paper-w2038754388","cat":"papers","name":"Schizophrenia and Glutamatergic Transmission","year":"1998","cit":386,"pfa":"Carol A. Tamminga","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2038754388","eid":"W2038754388"},{"id":"paper-w2003424951","cat":"papers","name":"Prediction of Psilocybin Response in Healthy Volunteers","year":"2012","cit":384,"pfa":"Erich Studerus","psa":"Franz X. Vollenweider","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2003424951","eid":"W2003424951"},{"id":"paper-w1997161439","cat":"papers","name":"Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population","year":"2015","cit":384,"pfa":"Peter S. Hendricks","psa":"Matthew W. Johnson","topics":["Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1997161439","eid":"W1997161439"},{"id":"paper-w2066663898","cat":"papers","name":"A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5‐HT1 and 5‐HT2 receptors","year":"1985","cit":383,"pfa":"Guy M. Goodwin","psa":"A. Richard Green","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2066663898","eid":"W2066663898"},{"id":"paper-w2064120012","cat":"papers","name":"Drug Treatment Outcomes for Adolescents with Comorbid Mental and Substance Use Disorders","year":"2001","cit":381,"pfa":"Christine E. Grella","psa":"Jennifer L. Rounds‐Bryant","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2064120012","eid":"W2064120012"},{"id":"paper-w2164537538","cat":"papers","name":"Ecstasy (MDMA): a review of its possible persistent psychological effects","year":"2000","cit":380,"pfa":"Michael John Morgan","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2164537538","eid":"W2164537538"},{"id":"paper-w2127654449","cat":"papers","name":"Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up stu","year":"2012","cit":379,"pfa":"Michael C. Mithoefer","psa":"Rick Doblin","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2127654449","eid":"W2127654449"},{"id":"paper-w2547918114","cat":"papers","name":"Psychedelics as Medicines: An Emerging New Paradigm","year":"2016","cit":379,"pfa":"DE Nichols","psa":"CD Nichols","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2547918114","eid":"W2547918114"},{"id":"paper-w2987203272","cat":"papers","name":"Psychological flexibility mediates the relations between acute psychedelic effects and subjective decreases in depression and anxiety","year":"2019","cit":379,"pfa":"Alan K. Davis","psa":"Roland R. Griffiths","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2987203272","eid":"W2987203272"},{"id":"paper-w2117269242","cat":"papers","name":"A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes","year":"2014","cit":379,"pfa":"Alexander McGirr","psa":"Raymond Wing Moon Lam","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W2117269242","eid":"W2117269242"},{"id":"paper-w2061633232","cat":"papers","name":"1,3-Di(2-[5-3H]tolyl)guanidine: a selective ligand that labels sigma-type receptors for psychotomimetic opiates and antipsychotic drugs.","year":"1986","cit":378,"pfa":"E Weber","psa":"John F. W. Keana","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2061633232","eid":"W2061633232"},{"id":"paper-w93539026","cat":"papers","name":"Substance abuse and psychosis. The strange case of opioids.","year":"2014","cit":377,"pfa":"Angelo Giovanni Icro Maremmani","psa":"Icro Maremmani","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W93539026","eid":"W93539026"},{"id":"paper-w3025905746","cat":"papers","name":"Esketamine Nasal Spray for Rapid Reduction of Major Depressive Disorder Symptoms in Patients Who Have Active Suicidal Ideation With Intent","year":"2020","cit":377,"pfa":"Dong‐Jing Fu","psa":"Carla M. Canuso","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3025905746","eid":"W3025905746"},{"id":"paper-w2549202270","cat":"papers","name":"The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms","year":"2016","cit":376,"pfa":"Frederick Streeter Barrett","psa":"Roland R. Griffiths","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2549202270","eid":"W2549202270"},{"id":"paper-w2135385264","cat":"papers","name":"Memory impairment in abstinent MDMA (\"Ecstasy\") users","year":"1998","cit":375,"pfa":"Karen I. Bolla","psa":"George A. Ricaurte","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2135385264","eid":"W2135385264"},{"id":"paper-w2113307128","cat":"papers","name":"Psychedelic Effects of Ketamine in Healthy Volunteers","year":"1998","cit":375,"pfa":"Andrew T. Bowdle","psa":"Peter Roy‐Byrne","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2113307128","eid":"W2113307128"},{"id":"paper-w2020974659","cat":"papers","name":"Activation of Serotonin 2A Receptors Underlies the Psilocybin-Induced Effects on Oscillations, N170 Visual-Evoked Potentials, and Visual Hallucinations","year":"2013","cit":369,"pfa":"Michael Kometer","psa":"Franz X. Vollenweider","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2020974659","eid":"W2020974659"},{"id":"paper-w2944263526","cat":"papers","name":"RETRACTED ARTICLE: MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials","year":"2019","cit":368,"pfa":"Michael C. Mithoefer","psa":"Rick Doblin","topics":["Depression","PTSD & trauma","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2944263526","eid":"W2944263526"},{"id":"paper-w2110701839","cat":"papers","name":"A REVIEW OF THE CLINICAL EFFECTS OF PSYCHOTOMIMETIC AGENTS","year":"1957","cit":368,"pfa":"Humphry Osmond","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2110701839","eid":"W2110701839"},{"id":"paper-w1497893548","cat":"papers","name":"Antidepressant‐like effects of cannabidiol in mice: possible involvement of 5‐HT1Areceptors","year":"2009","cit":368,"pfa":"TV Zanelati","psa":"Sâmia R.L. Joca","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1497893548","eid":"W1497893548"},{"id":"paper-w2075352853","cat":"papers","name":"Serotonin and Hallucinogens","year":"1999","cit":366,"pfa":"George K. Aghajanian","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2075352853","eid":"W2075352853"},{"id":"paper-w3000636165","cat":"papers","name":"Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer","year":"2020","cit":364,"pfa":"Gabrielle Agin-Liebes","psa":"Stephen Ross","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3000636165","eid":"W3000636165"},{"id":"paper-w4380684709","cat":"papers","name":"Psychedelics reopen the social reward learning critical period","year":"2023","cit":364,"pfa":"Romain Nardou","psa":"Gül Dölen","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4380684709","eid":"W4380684709"},{"id":"paper-w2165032621","cat":"papers","name":"MDMA enhances emotional empathy and prosocial behavior","year":"2013","cit":363,"pfa":"Cédric M. Hysek","psa":"Matthias E. Liechti","topics":["PTSD & trauma","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2165032621","eid":"W2165032621"},{"id":"paper-w1905675815","cat":"papers","name":"Cardiovascular and Neuroendocrine Effects and Pharmacokinetics of 3,4-Methylenedioxymethamphetamine in Humans","year":"1999","cit":362,"pfa":"Marta Más","psa":"Jordi Camı́","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1905675815","eid":"W1905675815"},{"id":"paper-w3096897894","cat":"papers","name":"Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern‐era clinical studies","year":"2020","cit":362,"pfa":"Kristoffer Andreas Aamodt Andersen","psa":"David Erritzøe","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"review","src":"https://openalex.org/W3096897894","eid":"W3096897894"},{"id":"paper-w2100182643","cat":"papers","name":"Finding the self by losing the self: Neural correlates of ego-dissolution under psilocybin","year":"2015","cit":361,"pfa":"Alexander V. Lebedev","psa":"Robin Lester Carhart-Harris","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2100182643","eid":"W2100182643"},{"id":"paper-w3213458191","cat":"papers","name":"Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder","year":"2021","cit":361,"pfa":"Manoj K. Doss","psa":"Frederick Streeter Barrett","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3213458191","eid":"W3213458191"},{"id":"paper-w4313530670","cat":"papers","name":"Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial","year":"2022","cit":361,"pfa":"Robin von Rotz","psa":"Franz X. Vollenweider","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4313530670","eid":"W4313530670"},{"id":"paper-w2806419184","cat":"papers","name":"The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act","year":"2018","cit":359,"pfa":"Matthew W. Johnson","psa":"Jack E. Henningfield","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2806419184","eid":"W2806419184"},{"id":"paper-w2122453635","cat":"papers","name":"Gender differences in the subjective effects of MDMA","year":"2001","cit":358,"pfa":"Matthias E. Liechti","psa":"Franz X. Vollenweider","ptype":"article","src":"https://openalex.org/W2122453635","eid":"W2122453635"},{"id":"paper-w2079825367","cat":"papers","name":"Functional characterization of agonists at recombinant human 5‐HT2A, 5‐HT2B and 5‐HT2C receptors in CHO‐K1 cells","year":"1999","cit":357,"pfa":"R H P Porter","psa":"Malcolm J. Sheardown","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2079825367","eid":"W2079825367"},{"id":"paper-w2121189426","cat":"papers","name":"Here Today, Gone Tomorrow…and Back Again? A Review of Herbal Marijuana Alternatives (K2, Spice), Synthetic Cathinones (Bath Salts), Kratom, Salvia divinorum, Methoxetamine, and Piperazines","year":"2012","cit":356,"pfa":"Christopher D. Rosenbaum","psa":"Kavita M. Babu","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2121189426","eid":"W2121189426"},{"id":"paper-w1244863148","cat":"papers","name":"Amelioration of negative symptoms in schizophrenia by glycine","year":"1994","cit":355,"pfa":"Daniel C. Javitt","psa":"Jean‐Pierre Lindenmayer","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1244863148","eid":"W1244863148"},{"id":"paper-w2011804248","cat":"papers","name":"R (−)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamine","year":"2013","cit":355,"pfa":"Ji‐chun Zhang","psa":"Kenji Hashimoto","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2011804248","eid":"W2011804248"},{"id":"paper-w2931582381","cat":"papers","name":"Oxytocin-dependent reopening of a social reward learning critical period with MDMA","year":"2019","cit":354,"pfa":"Romain Nardou","psa":"Gül Dölen","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2931582381","eid":"W2931582381"},{"id":"paper-w2005952891","cat":"papers","name":"Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3, 4-methylenedioxymethamphetamine","year":"1992","cit":354,"pfa":"J. Frank Nash","psa":"Bryan K. Yamamoto","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2005952891","eid":"W2005952891"},{"id":"paper-w2781316183","cat":"papers","name":"Psychiatry & the psychedelic drugs. Past, present & future","year":"2017","cit":350,"pfa":"James Rucker","psa":"David Nutt","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2781316183","eid":"W2781316183"},{"id":"paper-w2051226001","cat":"papers","name":"Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research","year":"2001","cit":347,"pfa":"Andrew C. Parrott","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2051226001","eid":"W2051226001"},{"id":"paper-w2043750066","cat":"papers","name":"Pharmacological Differentiation and Characterization of 5‐HT1A, 5‐HT1B, and 5‐HT1CBinding Sites in Rat Frontal Cortex","year":"1986","cit":347,"pfa":"Stephen J. Peroutka","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2043750066","eid":"W2043750066"},{"id":"paper-w2014761647","cat":"papers","name":"Psychedelics and Mental Health: A Population Study","year":"2013","cit":346,"pfa":"Teri Suzanne Krebs","psa":"Pål-Ørjan Johansen","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W2014761647","eid":"W2014761647"},{"id":"paper-w2021041549","cat":"papers","name":"The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain","year":"1986","cit":345,"pfa":"Donna M. Stone","psa":"James W. Gibb","ptype":"article","src":"https://openalex.org/W2021041549","eid":"W2021041549"},{"id":"paper-w1960526592","cat":"papers","name":"Small Changes in Ambient Temperature Cause Large Changes in 3,4-Methylenedioxymethamphetamine (MDMA)-Induced Serotonin Neurotoxicity and Core Body Temperature in the Rat","year":"1998","cit":345,"pfa":"Jessica E. Malberg","psa":"Lewis S. Seiden","topics":["Safety & adverse events","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1960526592","eid":"W1960526592"},{"id":"paper-w2087542866","cat":"papers","name":"Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens","year":"1988","cit":343,"pfa":"Milt Titeler","psa":"Richard A. Glennon","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2087542866","eid":"W2087542866"},{"id":"paper-w2117003509","cat":"papers","name":"Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance","year":"1998","cit":342,"pfa":"Andrew C. Parrott","psa":"J. Lasky","ptype":"article","src":"https://openalex.org/W2117003509","eid":"W2117003509"},{"id":"paper-w3112904824","cat":"papers","name":"The Subjective Effects of Psychedelics May Not Be Necessary for Their Enduring Therapeutic Effects","year":"2020","cit":341,"pfa":"David E. Olson","topics":["Mechanism & neuroscience"],"ptype":"editorial","src":"https://openalex.org/W3112904824","eid":"W3112904824"},{"id":"paper-w2946133992","cat":"papers","name":"Esketamine for Treatment-Resistant Depression — First FDA-Approved Antidepressant in a New Class","year":"2019","cit":341,"pfa":"Jean Kim","psa":"Robert Temple","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2946133992","eid":"W2946133992"},{"id":"paper-w2991342487","cat":"papers","name":"Neural correlates of the DMT experience assessed with multivariate EEG","year":"2019","cit":340,"pfa":"Christopher B. Timmermann","psa":"Robin Lester Carhart-Harris","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2991342487","eid":"W2991342487"},{"id":"paper-w2115290225","cat":"papers","name":"Altered Serotonin Innervation Patterns in the Forebrain of Monkeys Treated with (±)3,4-Methylenedioxymethamphetamine Seven Years Previously: Factors Influencing Abnormal Recovery","year":"1999","cit":339,"pfa":"George Hatzidimitriou","psa":"George A. Ricaurte","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2115290225","eid":"W2115290225"},{"id":"paper-w3015140823","cat":"papers","name":"Psychedelic Psychiatry’s Brave New World","year":"2020","cit":338,"pfa":"David Nutt","psa":"Robin Lester Carhart-Harris","ptype":"article","src":"https://openalex.org/W3015140823","eid":"W3015140823"},{"id":"paper-w2346262441","cat":"papers","name":"LSD‐induced entropic brain activity predicts subsequent personality change","year":"2016","cit":337,"pfa":"Alexander V. Lebedev","psa":"Robin Lester Carhart-Harris","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2346262441","eid":"W2346262441"},{"id":"paper-w2161617741","cat":"papers","name":"Human Psychopharmacology of Hoasca, A Plant Hallucinogen Used in Ritual Context in Brazil","year":"1996","cit":337,"pfa":"Charles S. Grob","psa":"Kyle Brauer Boone","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2161617741","eid":"W2161617741"},{"id":"paper-w2123354702","cat":"papers","name":"Control of Serotonergic Function in Medial Prefrontal Cortex by Serotonin-2A Receptors through a Glutamate-Dependent Mechanism","year":"2001","cit":335,"pfa":"Raúl Martín‐Ruiz","psa":"Francesc Artigas","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2123354702","eid":"W2123354702"},{"id":"paper-w2111920357","cat":"papers","name":"Ayahuasca-Assisted Therapy for Addiction: Results from a Preliminary Observational Study in Canada","year":"2013","cit":334,"pfa":"GERALD W. THOMAS","psa":"Gina Martin","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2111920357","eid":"W2111920357"},{"id":"paper-w2012979366","cat":"papers","name":"Serotonin Neurotoxicity after (±)3,4-Methylenedioxymethamphetamine (MDMA; “Ecstasy”): A Controlled Study in Humans","year":"1994","cit":334,"pfa":"Una D. McCann","psa":"George A. Ricaurte","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2012979366","eid":"W2012979366"},{"id":"paper-w2950701273","cat":"papers","name":"Rapid‐acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective","year":"2019","cit":333,"pfa":"Kenji Hashimoto","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2950701273","eid":"W2950701273"},{"id":"paper-w4210376981","cat":"papers","name":"Adverse effects of psychedelics: From anecdotes and misinformation to systematic science","year":"2022","cit":331,"pfa":"Anne Katrin Schlag","psa":"David Nutt","topics":["Safety & adverse events","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4210376981","eid":"W4210376981"},{"id":"paper-w2093203605","cat":"papers","name":"Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers","year":"2014","cit":330,"pfa":"Rainer Krähenmann","psa":"Franz X. Vollenweider","ptype":"article","src":"https://openalex.org/W2093203605","eid":"W2093203605"},{"id":"paper-w2037317432","cat":"papers","name":"LSD enhances suggestibility in healthy volunteers","year":"2014","cit":330,"pfa":"Robin Lester Carhart-Harris","psa":"David Nutt","ptype":"article","src":"https://openalex.org/W2037317432","eid":"W2037317432"},{"id":"paper-w4296373810","cat":"papers","name":"Towards an understanding of psychedelic-induced neuroplasticity","year":"2022","cit":328,"pfa":"Abigail E. Calder","psa":"Gregor Hasler","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4296373810","eid":"W4296373810"},{"id":"paper-w3164618783","cat":"papers","name":"Blinding and expectancy confounds in psychedelic randomized controlled trials","year":"2021","cit":327,"pfa":"Suresh D Muthukumaraswamy","psa":"Thomas Lumley","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3164618783","eid":"W3164618783"},{"id":"paper-w2055240237","cat":"papers","name":"A Review of Psychoactive Substance Use and Abuse in Schizophrenia","year":"1987","cit":325,"pfa":"Franklin R. Schneier","psa":"Samuel G. Siris","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2055240237","eid":"W2055240237"},{"id":"paper-w2045988021","cat":"papers","name":"Comparison of acute lethal toxicity of commonly abused psychoactive substances","year":"2004","cit":324,"pfa":"Robert S. Gable","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2045988021","eid":"W2045988021"},{"id":"paper-w2124688972","cat":"papers","name":"Recreational Ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity","year":"2002","cit":323,"pfa":"Andrew C. Parrott","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2124688972","eid":"W2124688972"},{"id":"paper-w2105964659","cat":"papers","name":"Novel psychoactive substances of interest for psychiatry","year":"2015","cit":323,"pfa":"Fabrizio Schifano","psa":"John Corkery","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2105964659","eid":"W2105964659"},{"id":"paper-w4210474529","cat":"papers","name":"Structure-based discovery of nonhallucinogenic psychedelic analogs","year":"2022","cit":322,"pfa":"Dongmei Cao","psa":"Sheng Wang","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4210474529","eid":"W4210474529"},{"id":"paper-w2271221126","cat":"papers","name":"LYSERGIC ACID DIETHYLAMIDE AND SEROTONIN: A COMPARISON OF EFFECTS ON SEROTONERGIC NEURONS AND NEURONS RECEIVING A SEROTONERGIC INPUT","year":"1974","cit":320,"pfa":"Henry James Haigler","psa":"George K. Aghajanian","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2271221126","eid":"W2271221126"},{"id":"paper-w4307167512","cat":"papers","name":"The neural basis of psychedelic action","year":"2022","cit":320,"pfa":"Alex C. Kwan","psa":"Bryan L. Roth","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4307167512","eid":"W4307167512"},{"id":"paper-w2100834566","cat":"papers","name":"Personality, Psychopathology, Life Attitudes and Neuropsychological Performance among Ritual Users of Ayahuasca: A Longitudinal Study","year":"2012","cit":317,"pfa":"José Carlos Bouso","psa":"Jordi Riba","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2100834566","eid":"W2100834566"},{"id":"paper-w4294631080","cat":"papers","name":"Lysergic Acid Diethylamide–Assisted Therapy in Patients With Anxiety With and Without a Life-Threatening Illness: A Randomized, Double-Blind, Placebo-Controlled Phase II Study","year":"2022","cit":316,"pfa":"Friederike Holze","psa":"Matthias E. Liechti","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4294631080","eid":"W4294631080"},{"id":"paper-w2052466574","cat":"papers","name":"Recent advances in the neuropsychopharmacology of serotonergic hallucinogens","year":"2014","cit":316,"pfa":"Adam L. Halberstadt","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2052466574","eid":"W2052466574"},{"id":"paper-w2091746900","cat":"papers","name":"ADVERSE REACTIONS TO PSYCHEDELIC DRUGS. A REVIEW OF THE LITERATURE","year":"1984","cit":316,"pfa":"Rick J. Strassman","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2091746900","eid":"W2091746900"},{"id":"paper-w2608897054","cat":"papers","name":"Patient Experiences of Psilocybin-Assisted Psychotherapy: An Interpretative Phenomenological Analysis","year":"2017","cit":315,"pfa":"Alexander Belser","psa":"Stephen Ross","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2608897054","eid":"W2608897054"},{"id":"paper-w1990635104","cat":"papers","name":"MDMA-induced neurotoxicity: Parameters of degeneration and recovery of brain serotonin neurons","year":"1988","cit":313,"pfa":"George Battaglia","psa":"Errol B. De Souza","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1990635104","eid":"W1990635104"},{"id":"paper-w2165489174","cat":"papers","name":"Mephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5-HT levels in nucleus accumbens of awake rats","year":"2011","cit":313,"pfa":"Ján Kehr","psa":"Takashi Yoshitake","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2165489174","eid":"W2165489174"},{"id":"paper-w2725596576","cat":"papers","name":"Hallucinogens and Serotonin 5-HT2A Receptor-Mediated Signaling Pathways","year":"2017","cit":313,"pfa":"Juan F. López‐Giménez","psa":"Javier González‐Maeso","topics":["Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W2725596576","eid":"W2725596576"},{"id":"paper-w4285091545","cat":"papers","name":"Psychedelics, Mystical Experience, and Therapeutic Efficacy: A Systematic Review","year":"2022","cit":313,"pfa":"Kwonmok Ko","psa":"Anthony James Cleare","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"review","src":"https://openalex.org/W4285091545","eid":"W4285091545"},{"id":"paper-w2159084784","cat":"papers","name":"Subjective effects of 3,4-methylenedioxymethamphetamine in recreational users.","year":"1988","cit":313,"pfa":"Stephen J. Peroutka","psa":"H Harris","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2159084784","eid":"W2159084784"},{"id":"paper-w2366411924","cat":"papers","name":"Positron emission tomography microdosing: a new concept with application in tracer and early clinical drug development","year":"2003","cit":313,"pfa":"Mats Bergstr�m","psa":"Bengt L�ngstr�m","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2366411924","eid":"W2366411924"},{"id":"paper-w2086048722","cat":"papers","name":"Diverse Psychotomimetics Act Through a Common Signaling Pathway","year":"2003","cit":313,"pfa":"Per Svenningsson","psa":"Paul Greengard","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2086048722","eid":"W2086048722"},{"id":"paper-w2040750242","cat":"papers","name":"Gone to Pot – A Review of the Association between Cannabis and Psychosis","year":"2014","cit":313,"pfa":"Rajiv Radhakrishnan","psa":"Deepak Cyril Dâ€TMSouza","topics":["PTSD & trauma","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2040750242","eid":"W2040750242"},{"id":"paper-w2325558246","cat":"papers","name":"Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years","year":"2016","cit":311,"pfa":"RAFAEL GUIMARÃES DOS SANTOS","psa":"Jaime E. C. Hallak","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"review","src":"https://openalex.org/W2325558246","eid":"W2325558246"},{"id":"paper-w2911514809","cat":"papers","name":"Effective connectivity changes in LSD-induced altered states of consciousness in humans","year":"2019","cit":311,"pfa":"Katrin H. Preller","psa":"Franz X. Vollenweider","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2911514809","eid":"W2911514809"},{"id":"paper-w1986425243","cat":"papers","name":"5-HT Modulation of Dopamine Release in Basal Ganglia in Psilocybin-Induced Psychosis in Man—A PET Study with [11C]raclopride","year":"1999","cit":310,"pfa":"F.X. Vollenweider","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1986425243","eid":"W1986425243"},{"id":"paper-w2166756269","cat":"papers","name":"Impaired cognitive performance in drug free users of recreational ecstasy (MDMA)","year":"2000","cit":309,"pfa":"Euphrosyne Gouzoulis‐Mayfrank","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2166756269","eid":"W2166756269"},{"id":"paper-w2166952073","cat":"papers","name":"Psychedelics and the Human Receptorome","year":"2010","cit":309,"pfa":"Thomas S. Ray","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2166952073","eid":"W2166952073"},{"id":"paper-w2015441565","cat":"papers","name":"Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study","year":"2010","cit":308,"pfa":"Celia J. A. Morgan","psa":"Helen Valerie Curran","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2015441565","eid":"W2015441565"},{"id":"paper-w1538056388","cat":"papers","name":"Principles of medical pharmacology","year":"1989","cit":308,"pfa":"H. Kalant","psa":"Walter H. E. Roschlau","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"book","src":"https://openalex.org/W1538056388","eid":"W1538056388"},{"id":"paper-w2622982732","cat":"papers","name":"Potential Therapeutic Effects of Psilocybin","year":"2017","cit":307,"pfa":"Matthew W. Johnson","psa":"Roland R. Griffiths","ptype":"article","src":"https://openalex.org/W2622982732","eid":"W2622982732"},{"id":"paper-w2940516695","cat":"papers","name":"Serotonin transporter–ibogaine complexes illuminate mechanisms of inhibition and transport","year":"2019","cit":306,"pfa":"Jonathan A. Coleman","psa":"Eric Gouaux","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2940516695","eid":"W2940516695"},{"id":"paper-w2025984201","cat":"papers","name":"Effects of enantiomers of MDA, MDMA and related analogues on [3H]serotonin and [3H]dopamine release from superfused rat brain slices","year":"1986","cit":306,"pfa":"Michael P. Johnson","psa":"David E. Nichols","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2025984201","eid":"W2025984201"},{"id":"paper-w1537216698","cat":"papers","name":"The Psychedelic Experience: A Manual Based on the Tibetan Book of the Dead","year":"1965","cit":306,"ptype":"article","src":"https://openalex.org/W1537216698","eid":"W1537216698"},{"id":"paper-w2097999899","cat":"papers","name":"Psychedelics not linked to mental health problems or suicidal behavior: A population study","year":"2015","cit":305,"pfa":"Pål-Ørjan Johansen","psa":"Teri Suzanne Krebs","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2097999899","eid":"W2097999899"},{"id":"paper-w2266766602","cat":"papers","name":"The paradoxical psychological effects of lysergic acid diethylamide (LSD)","year":"2016","cit":304,"pfa":"Robin Lester Carhart-Harris","psa":"David Nutt","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2266766602","eid":"W2266766602"},{"id":"paper-w1974074998","cat":"papers","name":"Psilocybin Biases Facial Recognition, Goal-Directed Behavior, and Mood State Toward Positive Relative to Negative Emotions Through Different Serotonergic Subreceptors","year":"2012","cit":304,"pfa":"Michael Kometer","psa":"Franz X. Vollenweider","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1974074998","eid":"W1974074998"},{"id":"paper-w2067354763","cat":"papers","name":"The NMDA-receptor antagonist CPP abolishes neurogenic ‘wind-up pain’ after intrathecal administration in humans","year":"1992","cit":304,"pfa":"Jens D. Kristensen","psa":"Torsten Gordh","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2067354763","eid":"W2067354763"},{"id":"paper-w2036881116","cat":"papers","name":"Subjective effects and tolerability of the South American psychoactive beverage Ayahuasca in healthy volunteers","year":"2001","cit":302,"pfa":"Jordi Riba","psa":"Manel J. Barbanoj","ptype":"article","src":"https://openalex.org/W2036881116","eid":"W2036881116"},{"id":"paper-w2127538073","cat":"papers","name":"Cognitive performance in (±) 3,4-methylenedioxymethamphetamine (MDMA, \"ecstasy\") users: a controlled study","year":"1999","cit":302,"pfa":"U. McCann","psa":"George A. Ricaurte","ptype":"article","src":"https://openalex.org/W2127538073","eid":"W2127538073"},{"id":"paper-w2124057487","cat":"papers","name":"3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”) Induces Fenfluramine-Like Proliferative Actions on Human Cardiac Valvular Interstitial Cells in Vitro","year":"2003","cit":302,"pfa":"Vincent Setola","psa":"Bryan L. Roth","ptype":"article","src":"https://openalex.org/W2124057487","eid":"W2124057487"},{"id":"paper-w2171104921","cat":"papers","name":"Transcriptome Fingerprints Distinguish Hallucinogenic and Nonhallucinogenic 5-Hydroxytryptamine 2A Receptor Agonist Effects in Mouse Somatosensory Cortex","year":"2003","cit":302,"pfa":"Javier González‐Maeso","psa":"Stuart C. Sealfon","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2171104921","eid":"W2171104921"},{"id":"paper-w2151439032","cat":"papers","name":"Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis","year":"2008","cit":301,"pfa":"Celia J. A. Morgan","psa":"Helen Valerie Curran","ptype":"article","src":"https://openalex.org/W2151439032","eid":"W2151439032"},{"id":"paper-w2161026846","cat":"papers","name":"Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges","year":"2004","cit":300,"pfa":"Dennis J. McKenna","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2161026846","eid":"W2161026846"},{"id":"paper-w2020344558","cat":"papers","name":"'Eve' and 'Ecstasy'. A report of five deaths associated with the use of MDEA and MDMA","year":"1987","cit":300,"pfa":"G Dowling","topics":["Safety & adverse events","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2020344558","eid":"W2020344558"},{"id":"paper-w2073377994","cat":"papers","name":"Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at various brain recognition sites","year":"1988","cit":300,"pfa":"George Battaglia","psa":"Errol B. De Souza","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2073377994","eid":"W2073377994"},{"id":"paper-w2022054381","cat":"papers","name":"Schizophrenia: A New Approach. II. Result of a Year's Research","year":"1954","cit":300,"pfa":"Abram Hoffer","psa":"John Smythies","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2022054381","eid":"W2022054381"},{"id":"paper-w3016794806","cat":"papers","name":"A growing need for youth mental health services in Canada: examining trends in youth mental health from 2011 to 2018","year":"2020","cit":299,"pfa":"Kathryn Wiens","psa":"Scott Burton Patten","topics":["Addiction","Anxiety & end-of-life","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3016794806","eid":"W3016794806"},{"id":"paper-w3017383621","cat":"papers","name":"Esketamine Nasal Spray Plus Oral Antidepressant in Patients With Treatment-Resistant Depression","year":"2020","cit":299,"pfa":"Ewa Wajs","psa":"Jaskaran B. Singh","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3017383621","eid":"W3017383621"},{"id":"paper-w1963722081","cat":"papers","name":"The effects of psilocybin and MDMA on between-network resting state functional connectivity in healthy volunteers","year":"2014","cit":297,"pfa":"Leor Roseman","psa":"Robin Lester Carhart-Harris","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1963722081","eid":"W1963722081"},{"id":"paper-w2044523676","cat":"papers","name":"Imaging of Lymph Flow in Breast Cancer Patients after Microdose Administration of a Near-Infrared Fluorophore: Feasibility Study","year":"2008","cit":296,"pfa":"Eva Marie Sevick-Muraca","psa":"Michel E. Mawad","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2044523676","eid":"W2044523676"},{"id":"paper-w2061414707","cat":"papers","name":"In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain","year":"1987","cit":296,"pfa":"Christopher J. Schmidt","psa":"Walter M. Lovenberg","ptype":"article","src":"https://openalex.org/W2061414707","eid":"W2061414707"},{"id":"paper-w2107849028","cat":"papers","name":"Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial","year":"2009","cit":296,"pfa":"Sanjay J. Mathew","psa":"Dennis S. Charney","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2107849028","eid":"W2107849028"},{"id":"paper-w2035325069","cat":"papers","name":"3,4‐Methylenedioxymethamphetamine (MDMA, “Ecstasy”): pharmacology and toxicology in animals and humans","year":"1994","cit":295,"pfa":"Thomas Steele","psa":"George A. Ricaurte","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2035325069","eid":"W2035325069"},{"id":"paper-w2107790349","cat":"papers","name":"Acute toxic effects of ‘Ecstasy’ (MDMA) and related compounds: overview of pathophysiology and clinical management","year":"2006","cit":294,"pfa":"Andrew P. Hall","psa":"John Aaron Henry","ptype":"article","src":"https://openalex.org/W2107790349","eid":"W2107790349"},{"id":"paper-w2018957682","cat":"papers","name":"The hallucinogenic world of tryptamines: an updated review","year":"2015","cit":294,"pfa":"Ana Margarida Araújo","psa":"Márcia C. Carvalho","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2018957682","eid":"W2018957682"},{"id":"paper-w2000909913","cat":"papers","name":"Dose-Response Study of N,N-Dimethyltryptamine in Humans","year":"1994","cit":293,"pfa":"Rick J. Strassman","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2000909913","eid":"W2000909913"},{"id":"paper-w2059491341","cat":"papers","name":"(±3,4-Methylenedioxymethamphetamine Selectively Damages Central Serotonergic Neurons in Nonhuman Primates","year":"1988","cit":293,"pfa":"George A. Ricaurte","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2059491341","eid":"W2059491341"},{"id":"paper-w2999364864","cat":"papers","name":"Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species","year":"2020","cit":292,"pfa":"Adam L. Halberstadt","psa":"Simon D. Brandt","ptype":"article","src":"https://openalex.org/W2999364864","eid":"W2999364864"},{"id":"paper-w2109698385","cat":"papers","name":"(±)3,4-Methylenedioxymethamphetamine (‘Ecstasy’)-Induced Serotonin Neurotoxicity: Studies in Animals","year":"2000","cit":292,"pfa":"George A. Ricaurte","psa":"Una D. McCann","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2109698385","eid":"W2109698385"},{"id":"paper-w2809850625","cat":"papers","name":"Psychedelic therapy for smoking cessation: Qualitative analysis of participant accounts","year":"2018","cit":292,"pfa":"Tehseen N. Noorani","psa":"Matthew W. Johnson","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2809850625","eid":"W2809850625"},{"id":"paper-w2726898022","cat":"papers","name":"Self unbound: ego dissolution in psychedelic experience","year":"2017","cit":292,"pfa":"Chris Letheby","psa":"Philip Gerrans","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2726898022","eid":"W2726898022"},{"id":"paper-w2140244867","cat":"papers","name":"Recreational Use of “Ecstasy” (MDMA) Is Associated with Elevated Impulsivity","year":"1998","cit":291,"pfa":"Michael J Morgan","ptype":"article","src":"https://openalex.org/W2140244867","eid":"W2140244867"},{"id":"paper-w2141767084","cat":"papers","name":"Clinical toxicology of newer recreational drugs","year":"2011","cit":291,"pfa":"Simon L. Hill","psa":"Simon H. L. Thomas","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2141767084","eid":"W2141767084"},{"id":"paper-w63013890","cat":"papers","name":"Amantadine and memantine are NMDA receptor antagonists with neuroprotective properties.","year":"1994","cit":291,"pfa":"Johannes Kornhuber","psa":"P. Riederer","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W63013890","eid":"W63013890"},{"id":"paper-w2945506353","cat":"papers","name":"Cessation and reduction in alcohol consumption and misuse after psychedelic use","year":"2019","cit":290,"pfa":"Albert Garcia‐Romeu","psa":"Matthew W. Johnson","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2945506353","eid":"W2945506353"},{"id":"paper-w2561419573","cat":"papers","name":"Phenomenology, Structure, and Dynamic of Psychedelic States","year":"2016","cit":290,"pfa":"Katrin H. Preller","psa":"Franz X. Vollenweider","ptype":"book-chapter","src":"https://openalex.org/W2561419573","eid":"W2561419573"},{"id":"paper-w2892030583","cat":"papers","name":"Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study","year":"2018","cit":289,"pfa":"Alicia L. Danforth","psa":"Amy Emerson","topics":["Anxiety & end-of-life","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2892030583","eid":"W2892030583"},{"id":"paper-w2554295594","cat":"papers","name":"Tumor-Specific Uptake of Fluorescent Bevacizumab–IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feasibility Study","year":"2016","cit":289,"pfa":"Laetitia E. Lamberts","psa":"Gooitzen M. van Dam","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2554295594","eid":"W2554295594"},{"id":"paper-w2141217193","cat":"papers","name":"Do the dissociative side effects of ketamine mediate its antidepressant effects?","year":"2014","cit":287,"pfa":"David A. Luckenbaugh","psa":"Carlos A. Zarate","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2141217193","eid":"W2141217193"},{"id":"paper-w2052665050","cat":"papers","name":"Relationship of Ketamine's Plasma Metabolites with Response, Diagnosis, and Side Effects in Major Depression","year":"2012","cit":287,"pfa":"Carlos A. Zarate","psa":"Irving W. Wainer","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2052665050","eid":"W2052665050"},{"id":"paper-w2398867243","cat":"papers","name":"Psilocybin, ein psychotroper Wirkstoff aus dem mexikanischen RauschpilzPsilocybe mexicana Heim","year":"1958","cit":286,"pfa":"Alfred André Hofmann","psa":"H. Kobel","ptype":"article","src":"https://openalex.org/W2398867243","eid":"W2398867243"},{"id":"paper-w3087859780","cat":"papers","name":"Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study","year":"2020","cit":286,"pfa":"Brian T. Anderson","psa":"Joshua D. Woolley","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3087859780","eid":"W3087859780"},{"id":"paper-w2312475727","cat":"papers","name":"LYSERGIC ACID DIETHYLAMIDE","year":"1960","cit":285,"pfa":"Sidney Cohen","ptype":"article","src":"https://openalex.org/W2312475727","eid":"W2312475727"},{"id":"paper-w2084770788","cat":"papers","name":"5‐HT1Areceptors are involved in the cannabidiol‐induced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats","year":"2008","cit":285,"pfa":"Leonardo B.M. Resstel","psa":"Francisco Silveira Guimarães","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2084770788","eid":"W2084770788"},{"id":"paper-w2083114671","cat":"papers","name":"Memory deficits associated with recreational use of \"ecstasy\" (MDMA)","year":"1999","cit":284,"pfa":"Michael John Morgan","ptype":"article","src":"https://openalex.org/W2083114671","eid":"W2083114671"},{"id":"paper-w1912050742","cat":"papers","name":"Noncompetitive Functional Inhibition at Diverse, Human Nicotinic Acetylcholine Receptor Subtypes by Bupropion, Phencyclidine, and Ibogaine","year":"1999","cit":282,"pfa":"John Denis Fryer","psa":"Ronald J. Lukas","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1912050742","eid":"W1912050742"},{"id":"paper-w2160059442","cat":"papers","name":"Mood and cognitive effects of ± 3,4‐methylenedioxymethamphetamine (MDMA, ‘ecstasy’): week‐end ‘high’ followed by mid‐week low","year":"1997","cit":282,"pfa":"Helen Valerie Curran","psa":"Ross A. Travill","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2160059442","eid":"W2160059442"},{"id":"paper-w2030252531","cat":"papers","name":"Salvia divinorum and salvinorin A: new pharmacologic findings","year":"1994","cit":281,"pfa":"Daniel J. Siebert","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2030252531","eid":"W2030252531"},{"id":"paper-w2048020456","cat":"papers","name":"Amphetamine toxicities","year":"2010","cit":280,"pfa":"Bryan K. Yamamoto","psa":"Gary A. Gudelsky","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2048020456","eid":"W2048020456"},{"id":"paper-w2800815779","cat":"papers","name":"Antidepressant Efficacy and Tolerability of Ketamine and Esketamine: A Critical Review","year":"2018","cit":280,"pfa":"Patricio Molero","psa":"J. Javier Meana","topics":["Depression","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2800815779","eid":"W2800815779"},{"id":"paper-w2092517056","cat":"papers","name":"Psilocybin – Summary of knowledge and new perspectives","year":"2013","cit":279,"pfa":"Filip Tylš","psa":"Jiřı́ Horáček","ptype":"article","src":"https://openalex.org/W2092517056","eid":"W2092517056"},{"id":"paper-w2036111662","cat":"papers","name":"Reducedin vivobinding to the serotonin transporter in the cerebral cortex of MDMA (‘ecstasy’) users","year":"1999","cit":279,"pfa":"David Michael Semple","psa":"Eve C. Johnstone","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2036111662","eid":"W2036111662"},{"id":"paper-w2603506674","cat":"papers","name":"Classic Hallucinogens and Mystical Experiences: Phenomenology and Neural Correlates","year":"2017","cit":278,"pfa":"Frederick Streeter Barrett","psa":"Roland R. Griffiths","topics":["Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W2603506674","eid":"W2603506674"},{"id":"paper-w3203928800","cat":"papers","name":"Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics","year":"2021","cit":276,"pfa":"Lily R. Aleksandrova","psa":"Anthony G. Phillips","topics":["Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W3203928800","eid":"W3203928800"},{"id":"paper-w1997714022","cat":"papers","name":"Evidence for a central 5‐hydroxytryptamine receptor stimulation by lysergic acid diethylamide","year":"1968","cit":274,"pfa":"N.‐E. Andén","psa":"Tomas G. M. Hökfelt","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1997714022","eid":"W1997714022"},{"id":"paper-w2807534705","cat":"papers","name":"Effects of psilocybin therapy on personality structure","year":"2018","cit":274,"pfa":"David Erritzøe","psa":"Robin Lester Carhart-Harris","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2807534705","eid":"W2807534705"},{"id":"paper-w3027590463","cat":"papers","name":"Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin","year":"2020","cit":274,"pfa":"Natasha Leigh Mason","psa":"Johannes Gerardus Ramaekers","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3027590463","eid":"W3027590463"},{"id":"paper-w2996321268","cat":"papers","name":"The use of the psychological flexibility model to support psychedelic assisted therapy","year":"2019","cit":274,"pfa":"Rosalind Watts","psa":"Jason B. Luoma","ptype":"article","src":"https://openalex.org/W2996321268","eid":"W2996321268"},{"id":"paper-w87529271","cat":"papers","name":"Decreased Serotonergic Receptor Binding in Rhombic Lip-Derived Regions of the Medulla Oblongata in the Sudden Infant Death Syndrome","year":"2000","cit":274,"pfa":"Ashok Panigrahy","psa":"Hannah C. Kinney","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W87529271","eid":"W87529271"},{"id":"paper-w3200757480","cat":"papers","name":"Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics","year":"2021","cit":273,"pfa":"Cato M. H. de Vos","psa":"Kim P. C. Kuypers","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W3200757480","eid":"W3200757480"},{"id":"paper-w2051271111","cat":"papers","name":"Effects of psilocybin on hippocampal neurogenesis and extinction of trace fear conditioning","year":"2013","cit":272,"pfa":"Briony J. Catlow","psa":"Juan Sanchez‐Ramos","ptype":"article","src":"https://openalex.org/W2051271111","eid":"W2051271111"},{"id":"paper-w2140018908","cat":"papers","name":"Peak experiences and the afterglow phenomenon: When and how do therapeutic effects of hallucinogens depend on psychedelic experiences?","year":"2015","cit":272,"pfa":"Tomislav Majić","psa":"Jürgen Gallinat","topics":["Addiction","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2140018908","eid":"W2140018908"},{"id":"paper-w2886249511","cat":"papers","name":"Psychedelics as anti-inflammatory agents","year":"2018","cit":271,"pfa":"Thomas Wayne Flanagan","psa":"Charles David Nichols","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2886249511","eid":"W2886249511"},{"id":"paper-w2744933359","cat":"papers","name":"Psychedelics and connectedness","year":"2017","cit":271,"pfa":"Robin Lester Carhart-Harris","psa":"R. Watts","ptype":"article","src":"https://openalex.org/W2744933359","eid":"W2744933359"},{"id":"paper-w4400729513","cat":"papers","name":"Psilocybin desynchronizes the human brain","year":"2024","cit":270,"pfa":"Joshua S. Siegel","psa":"Nico U.F. Dosenbach","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4400729513","eid":"W4400729513"},{"id":"paper-w1917890358","cat":"papers","name":"Lasting effects of (+-)-3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: neurochemical observations.","year":"1992","cit":269,"pfa":"G.A. Ricaurte","psa":"Mary Martello","ptype":"article","src":"https://openalex.org/W1917890358","eid":"W1917890358"},{"id":"paper-w1840994181","cat":"papers","name":"MODEL PSYCHOSES AND SCHIZOPHRENIA","year":"1962","cit":269,"pfa":"Elliot D. Luby","psa":"Edward F. Domino","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W1840994181","eid":"W1840994181"},{"id":"paper-w2344956345","cat":"papers","name":"Neuropharmacology of N,N-dimethyltryptamine","year":"2016","cit":268,"pfa":"Theresa M. Carbonaro","psa":"Michael B. Gatch","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2344956345","eid":"W2344956345"},{"id":"paper-w2964775179","cat":"papers","name":"Classical psychedelics for the treatment of depression and anxiety: A systematic review","year":"2019","cit":268,"pfa":"Silvia Muttoni","psa":"Christopher D. John","topics":["Depression","Anxiety & end-of-life","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W2964775179","eid":"W2964775179"},{"id":"paper-w2064576666","cat":"papers","name":"3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings","year":"2006","cit":267,"pfa":"Michael H. Baumann","psa":"Richard B. Rothman","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2064576666","eid":"W2064576666"},{"id":"paper-w1917168084","cat":"papers","name":"Reorganization of ascending 5-HT axon projections in animals previously exposed to the recreational drug (+/-)3,4-methylenedioxymethamphetamine (MDMA, \"ecstasy\")","year":"1995","cit":267,"pfa":"C Fischer","psa":"G.A. Ricaurte","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1917168084","eid":"W1917168084"},{"id":"paper-w3011668650","cat":"papers","name":"Reviewing the Potential of Psychedelics for the Treatment of PTSD","year":"2020","cit":267,"pfa":"Erwin Krediet","psa":"Eric H. G. J. M. Vermetten","topics":["PTSD & trauma","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3011668650","eid":"W3011668650"},{"id":"paper-w3012354707","cat":"papers","name":"Long-term effects of psychedelic drugs: A systematic review","year":"2020","cit":267,"pfa":"Jacob S. Aday","psa":"Alan K. Davis","topics":["Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W3012354707","eid":"W3012354707"},{"id":"paper-w3014121938","cat":"papers","name":"Designer drugs: mechanism of action and adverse effects","year":"2020","cit":267,"pfa":"Dino Luethi","psa":"Matthias E. Liechti","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3014121938","eid":"W3014121938"},{"id":"paper-w2069780576","cat":"papers","name":"Psychobiological problems in heavy 'ecstasy' (MDMA) polydrug users","year":"2000","cit":266,"pfa":"Andrew C. Parrott","ptype":"article","src":"https://openalex.org/W2069780576","eid":"W2069780576"},{"id":"paper-w2926998013","cat":"papers","name":"Psilocybin-assisted mindfulness training modulates self-consciousness and brain default mode network connectivity with lasting effects","year":"2019","cit":266,"pfa":"Lukasz Smigielski","psa":"Franz X. Vollenweider","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2926998013","eid":"W2926998013"},{"id":"paper-w2128437336","cat":"papers","name":"Human psychopharmacology of N,N-dimethyltryptamine","year":"1995","cit":265,"pfa":"Rick J. Strassman","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2128437336","eid":"W2128437336"},{"id":"paper-w1607931045","cat":"papers","name":"JWH018, a common constituent of ‘Spice’ herbal blends, is a potent and efficacious cannabinoid CB1receptor agonist","year":"2010","cit":263,"pfa":"Brady K. Atwood","psa":"Ken Mackie","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1607931045","eid":"W1607931045"},{"id":"paper-w2124203952","cat":"papers","name":"Synaptic Mechanisms Underlying Rapid Antidepressant Action of Ketamine","year":"2012","cit":263,"pfa":"Ege T. Kavalali","psa":"Lisa M. Monteggia","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2124203952","eid":"W2124203952"},{"id":"paper-w2887938296","cat":"papers","name":"Inclusion of people of color in psychedelic-assisted psychotherapy: a review of the literature","year":"2018","cit":262,"pfa":"Timothy I. Michaels","psa":"Monnica T. Williams","topics":["Safety & adverse events","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2887938296","eid":"W2887938296"},{"id":"paper-w1976511549","cat":"papers","name":"Blunted Psychotomimetic and Amnestic Effects of Δ-9-Tetrahydrocannabinol in Frequent Users of Cannabis","year":"2008","cit":262,"pfa":"Deepak Cyril D’Souza","psa":"John Harrison Krystal","ptype":"article","src":"https://openalex.org/W1976511549","eid":"W1976511549"},{"id":"paper-w3109908198","cat":"papers","name":"Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine","year":"2020","cit":261,"pfa":"Danilo De Gregorio","psa":"Gabriella Gobbi","topics":["Depression","PTSD & trauma","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3109908198","eid":"W3109908198"},{"id":"paper-w2150280237","cat":"papers","name":"Response of cluster headache to psilocybin and LSD","year":"2006","cit":260,"pfa":"Richard Andrew Sewell","psa":"Harrison Graham Pope","topics":["Anxiety & end-of-life","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2150280237","eid":"W2150280237"},{"id":"paper-w2801279915","cat":"papers","name":"Psychedelic Drugs Reconsidered","year":"1980","cit":260,"pfa":"Edward E. Seelye","ptype":"article","src":"https://openalex.org/W2801279915","eid":"W2801279915"},{"id":"paper-w2091711716","cat":"papers","name":"Big physics, small doses: the use of AMS and PET in human microdosing of development drugs","year":"2003","cit":260,"pfa":"Graham Lappin","psa":"R. Colin Garner","topics":["Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W2091711716","eid":"W2091711716"},{"id":"paper-w2328324756","cat":"papers","name":"Placebo‐controlled pilot trial testing dose titration and intravenous, intramuscular and subcutaneous routes for ketamine in depression","year":"2016","cit":259,"pfa":"Colleen K A Loo","psa":"Paul Glue","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2328324756","eid":"W2328324756"},{"id":"paper-w3007923795","cat":"papers","name":"Intravenous arketamine for treatment-resistant depression: open-label pilot study","year":"2020","cit":259,"pfa":"Gustavo Carneiro-Gomes Leal","psa":"Lucas C. Quarantini","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W3007923795","eid":"W3007923795"},{"id":"paper-w1599064892","cat":"papers","name":"Flesh of the Gods : The Ritual Use of Hallucinogens","year":"1972","cit":258,"pfa":"Peter T. Furst","ptype":"article","src":"https://openalex.org/W1599064892","eid":"W1599064892"},{"id":"paper-w4307093712","cat":"papers","name":"Default Mode Network Modulation by Psychedelics: A Systematic Review","year":"2022","cit":255,"pfa":"James J Gattuso","psa":"Jerome J. Sarris","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"review","src":"https://openalex.org/W4307093712","eid":"W4307093712"},{"id":"paper-w2332105174","cat":"papers","name":"The Botany and Chemistry of Hallucinogens","year":"1974","cit":255,"pfa":"Tom Reynolds","psa":"Alfred André Hofmann","ptype":"article","src":"https://openalex.org/W2332105174","eid":"W2332105174"},{"id":"paper-w2072526170","cat":"papers","name":"Phencyclidine (angel dust)/sigma \"opiate\" receptor: visualization by tritium-sensitive film.","year":"1981","cit":255,"pfa":"Rémi Quirion","psa":"Candace B. Pert","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2072526170","eid":"W2072526170"},{"id":"paper-w2983486486","cat":"papers","name":"Distinct acute effects of LSD, MDMA, and d-amphetamine in healthy subjects","year":"2019","cit":254,"pfa":"Friederike Holze","psa":"Matthias E. Liechti","topics":["Addiction","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2983486486","eid":"W2983486486"},{"id":"paper-w177540263","cat":"papers","name":"Childhood Maltreatment and Substance Use Disorders among Men and Women in a Nationally Representative Sample","year":"2012","cit":254,"pfa":"Tracie O. Afifi","psa":"Jitender Sareen","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W177540263","eid":"W177540263"},{"id":"paper-w2940999002","cat":"papers","name":"Survey of subjective \"God encounter experiences\": Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT","year":"2019","cit":253,"pfa":"Roland R. Griffiths","psa":"Robert Jesse","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2940999002","eid":"W2940999002"},{"id":"paper-w2171245354","cat":"papers","name":"Interaction of the Chiral Forms of Ketamine with Opioid, Phencyclidine, σ and Muscarinic Receptors","year":"1995","cit":253,"pfa":"Olav Hustveit","psa":"Ivar Øye","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2171245354","eid":"W2171245354"},{"id":"paper-w2945514479","cat":"papers","name":"Dynamical exploration of the repertoire of brain networks at rest is modulated by psilocybin","year":"2019","cit":252,"pfa":"Louis-David Lord","psa":"Joana Cabral","ptype":"article","src":"https://openalex.org/W2945514479","eid":"W2945514479"},{"id":"paper-w2413573456","cat":"papers","name":"LSD Acutely Impairs Fear Recognition and Enhances Emotional Empathy and Sociality","year":"2016","cit":252,"pfa":"Patrick C. Dolder","psa":"Matthias E. Liechti","topics":["Anxiety & end-of-life","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2413573456","eid":"W2413573456"},{"id":"paper-w1994271186","cat":"papers","name":"Is Ecstasy an “Empathogen”? Effects of ±3,4-Methylenedioxymethamphetamine on Prosocial Feelings and Identification of Emotional States in Others","year":"2010","cit":252,"pfa":"Gillinder Bedi","psa":"Harriet de Wit","ptype":"article","src":"https://openalex.org/W1994271186","eid":"W1994271186"},{"id":"paper-w2159815442","cat":"papers","name":"Neurotoxicity of MDMA and Related Compounds: Anatomic Studiesa","year":"1990","cit":251,"pfa":"Mark E. Molliver","psa":"Mary Ann Wilson","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2159815442","eid":"W2159815442"},{"id":"paper-w2139273914","cat":"papers","name":"Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons","year":"2001","cit":251,"pfa":"Liesbeth Reneman","psa":"Wim van den Brink","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2139273914","eid":"W2139273914"},{"id":"paper-w2162700737","cat":"papers","name":"Characterization of behavioral and endocrine effects of LSD on zebrafish","year":"2010","cit":250,"pfa":"Leah Grossman","psa":"Allan V. Kalueff","ptype":"article","src":"https://openalex.org/W2162700737","eid":"W2162700737"},{"id":"paper-w2073494415","cat":"papers","name":"Carrier‐Mediated Release of Serotonin by 3,4‐Methylenedioxymethamphetamine: Implications for Serotonin‐Dopamine Interactions","year":"1996","cit":250,"pfa":"Gary A. Gudelsky","psa":"J. Frank Nash","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2073494415","eid":"W2073494415"},{"id":"paper-w2145998697","cat":"papers","name":"Effects of psilocybin on time perception and temporal control of behaviour in humans","year":"2006","cit":249,"pfa":"Marc Wittmann","psa":"Franz X. Vollenweider","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2145998697","eid":"W2145998697"},{"id":"paper-w2120113858","cat":"papers","name":"Acute Psychological Effects of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”) are Attenuated by the Serotonin Uptake Inhibitor Citalopram","year":"2000","cit":249,"pfa":"Matthias E. Liechti","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2120113858","eid":"W2120113858"},{"id":"paper-w1993521516","cat":"papers","name":"N-Substituted Piperazines Abused by Humans Mimic the Molecular Mechanism of 3,4-Methylenedioxymethamphetamine (MDMA, or ‘Ecstasy’)","year":"2004","cit":249,"pfa":"Michael H. Baumann","psa":"Richard B. Rothman","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1993521516","eid":"W1993521516"},{"id":"paper-w2061657842","cat":"papers","name":"QUANTITATIVE STUDIES OF ANTAGONISTS FOR 5‐HYDROXYTRYPTAMINE","year":"1955","cit":249,"pfa":"John Henry Gaddum","psa":"F. F. Stephens","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2061657842","eid":"W2061657842"},{"id":"paper-w2893373014","cat":"papers","name":"Whole-Brain Multimodal Neuroimaging Model Using Serotonin Receptor Maps Explains Non-linear Functional Effects of LSD","year":"2018","cit":249,"pfa":"Gustavo Deco","psa":"Morten L. Kringelbach","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2893373014","eid":"W2893373014"},{"id":"paper-w3158143766","cat":"papers","name":"Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor","year":"2021","cit":249,"pfa":"Yan Wei","psa":"Kenji Hashimoto","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3158143766","eid":"W3158143766"},{"id":"paper-w3093375227","cat":"papers","name":"Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects","year":"2020","cit":248,"pfa":"Friederike Holze","psa":"Matthias E. Liechti","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3093375227","eid":"W3093375227"},{"id":"paper-w2137229007","cat":"papers","name":"Psychological and Physiological Effects of MDMA (“Ecstasy”) after Pretreatment with the 5-HT2 Antagonist Ketanserin in Healthy Humans","year":"2000","cit":248,"pfa":"Matthias E. Liechti","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2137229007","eid":"W2137229007"},{"id":"paper-w2154766235","cat":"papers","name":"Ketamine psychotherapy for heroin addiction: immediate effects and two-year follow-up","year":"2002","cit":248,"pfa":"Evgeny M. Krupitsky","psa":"A. Y. Grinenko","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2154766235","eid":"W2154766235"},{"id":"paper-w2098957364","cat":"papers","name":"Ceiling effect for respiratory depression by nalbuphine","year":"1980","cit":248,"pfa":"Alexander Romagnoli","psa":"Arthur S. Keats","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2098957364","eid":"W2098957364"},{"id":"paper-w587840252","cat":"papers","name":"Addiction as an attachment disorder","year":"2023","cit":247,"pfa":"Philip J. Flores","psa":"Barney Straus","topics":["Addiction","Therapy practice","Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W587840252","eid":"W587840252"},{"id":"paper-w3161556967","cat":"papers","name":"The Therapeutic Potential of Psilocybin","year":"2021","cit":246,"pfa":"Henry I. C. Lowe","psa":"Lorenzo Gordon","topics":["Anxiety & end-of-life","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3161556967","eid":"W3161556967"},{"id":"paper-w2035391615","cat":"papers","name":"Seeing with the eyes shut: Neural basis of enhanced imagery following ayahuasca ingestion","year":"2011","cit":246,"pfa":"Dráulio Barros de Araújo","psa":"Antonio Cardozo dos Santos","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2035391615","eid":"W2035391615"},{"id":"paper-w2140302582","cat":"papers","name":"Increasing MDMA use among college students: results of a national survey","year":"2002","cit":246,"pfa":"Jared N. Strote","psa":"Henry Wechsler","ptype":"article","src":"https://openalex.org/W2140302582","eid":"W2140302582"},{"id":"paper-w2001298144","cat":"papers","name":"Ketamine Psychedelic Therapy (KPT): A Review of the Results of Ten Years of Research","year":"1997","cit":246,"pfa":"Evgeny M. Krupitsky","psa":"A. Y. Grinenko","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2001298144","eid":"W2001298144"},{"id":"paper-w2001051801","cat":"papers","name":"Clinical and Endocrine Effects of a Microdose GnRH Agonist Flare Regimen Administered to Poor Responders Who Are Undergoing In Vitro Fertilization","year":"1998","cit":246,"pfa":"Eric S. Surrey","psa":"M. Surrey","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2001051801","eid":"W2001051801"},{"id":"paper-w2103583518","cat":"papers","name":"Increased frontal and paralimbic activation following ayahuasca, the pan-amazonian inebriant","year":"2006","cit":245,"pfa":"Jordi Riba","psa":"Manel J. Barbanoj","ptype":"article","src":"https://openalex.org/W2103583518","eid":"W2103583518"},{"id":"paper-w2063393199","cat":"papers","name":"Psilocybin-Induced Deficits in Automatic and Controlled Inhibition are Attenuated by Ketanserin in Healthy Human Volunteers","year":"2011","cit":245,"pfa":"Boris B. Quednow","psa":"Franz X. Vollenweider","ptype":"article","src":"https://openalex.org/W2063393199","eid":"W2063393199"},{"id":"paper-w4221001769","cat":"papers","name":"Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression","year":"2022","cit":245,"pfa":"Roberta Murphy","psa":"Robin Lester Carhart-Harris","topics":["Depression","PTSD & trauma","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4221001769","eid":"W4221001769"},{"id":"paper-w2080043971","cat":"papers","name":"Toxic effects of MDMA on central serotonergic neurons in the primate: importance of route and frequency of drug administration","year":"1988","cit":245,"pfa":"G.A. Ricaurte","psa":"J. William Langston","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2080043971","eid":"W2080043971"},{"id":"paper-w3089720030","cat":"papers","name":"Perioperative intravenous S-ketamine for acute postoperative pain in adults: A systematic review and meta-analysis","year":"2020","cit":245,"pfa":"Xuemei Wang","psa":"Jingchen Liu","topics":["Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W3089720030","eid":"W3089720030"},{"id":"paper-w4251474114","cat":"papers","name":"Psychological and Cardiovascular Effects and Short-Term Sequelae of MDMA (“Ecstasy”) in MDMA-Naïve Healthy Volunteers","year":"1998","cit":244,"pfa":"Franz X. Vollenweider","psa":"Theo Huber","ptype":"article","src":"https://openalex.org/W4251474114","eid":"W4251474114"},{"id":"paper-w2292804940","cat":"papers","name":"The Therapeutic Potentials of Ayahuasca: Possible Effects against Various Diseases of Civilization","year":"2016","cit":244,"pfa":"Ede Frecska","psa":"Michael Winkelman","topics":["Addiction","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2292804940","eid":"W2292804940"},{"id":"paper-w2831064708","cat":"papers","name":"Psychedelic-Assisted Psychotherapy: A Paradigm Shift in Psychiatric Research and Development","year":"2018","cit":244,"pfa":"Eduardo Ekman Schenberg","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2831064708","eid":"W2831064708"},{"id":"paper-w2017103866","cat":"papers","name":"Structure–Activity Relationships of One-Ring Psychotomimetics","year":"1969","cit":244,"pfa":"Alexander T. Shulgin","psa":"Claudio A. Naranjo","ptype":"article","src":"https://openalex.org/W2017103866","eid":"W2017103866"},{"id":"paper-w2094804227","cat":"papers","name":"Competitive Inhibition at the Glycine Site of the N -Methyl-d-aspartate Receptor by the Anesthetics Xenon and Isoflurane","year":"2007","cit":244,"pfa":"Robert Dickinson","psa":"Nicholas P. Franks","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2094804227","eid":"W2094804227"},{"id":"paper-w2781340150","cat":"papers","name":"Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression","year":"2017","cit":243,"pfa":"Leor Roseman","psa":"Robin Lester Carhart-Harris","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2781340150","eid":"W2781340150"},{"id":"paper-w2970453706","cat":"papers","name":"Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders","year":"2019","cit":243,"pfa":"Simone B. Sartori","psa":"Nicolas Singewald","topics":["PTSD & trauma","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2970453706","eid":"W2970453706"},{"id":"paper-w2896857564","cat":"papers","name":"Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test","year":"2018","cit":243,"pfa":"Ila Marques Porto Linares","psa":"José Alexandre S. Crippa","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2896857564","eid":"W2896857564"},{"id":"paper-w2156120803","cat":"papers","name":"Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids","year":"2006","cit":242,"pfa":"Robert S. Gable","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2156120803","eid":"W2156120803"},{"id":"paper-w2119134849","cat":"papers","name":"Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin","year":"2012","cit":242,"pfa":"Robin Lester Carhart-Harris","psa":"David Nutt","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2119134849","eid":"W2119134849"},{"id":"paper-w2895986834","cat":"papers","name":"A systematic study of microdosing psychedelics","year":"2019","cit":242,"pfa":"Vince Polito","psa":"Richard J. Stevenson","topics":["Depression","Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2895986834","eid":"W2895986834"},{"id":"paper-w2095031720","cat":"papers","name":"Which neuroreceptors mediate the subjective effects of MDMA in humans? A summary of mechanistic studies","year":"2001","cit":241,"pfa":"Matthias E. Liechti","psa":"Franz X. Vollenweider","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2095031720","eid":"W2095031720"},{"id":"paper-w1971746914","cat":"papers","name":"The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA (`ecstasy')","year":"1998","cit":241,"pfa":"Esther O’Shea","psa":"A.R Green","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1971746914","eid":"W1971746914"},{"id":"paper-w2127349182","cat":"papers","name":"Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration","year":"2009","cit":241,"pfa":"Glenn Dumont","psa":"Robbert Jan Verkes","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2127349182","eid":"W2127349182"},{"id":"paper-w2012712901","cat":"papers","name":"Use of microdosing to predict pharmacokinetics at the therapeutic dose: Experience with 5 drugs","year":"2006","cit":241,"pfa":"Graham Lappin","psa":"R GARNER","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2012712901","eid":"W2012712901"},{"id":"paper-w2985001984","cat":"papers","name":"Prescription opioid use and misuse among adolescents and young adults in the United States: A national survey study","year":"2019","cit":241,"pfa":"Joel D. Hudgins","psa":"Florence T. Bourgeois","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2985001984","eid":"W2985001984"},{"id":"paper-w2756069429","cat":"papers","name":"Long-lasting subjective effects of LSD in normal subjects","year":"2017","cit":240,"pfa":"Yasmin Schmid","psa":"Matthias E. Liechti","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2756069429","eid":"W2756069429"},{"id":"paper-w1995127336","cat":"papers","name":"Lysergic acid diethylamide and serotonin: Direct actions on serotonin-containing neurons in rat brain","year":"1972","cit":239,"pfa":"George K. Aghajanian","psa":"Floyd E. Bloom","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1995127336","eid":"W1995127336"},{"id":"paper-w2109384015","cat":"papers","name":"A role for oxytocin and 5-HT1A receptors in the prosocial effects of 3,4 methylenedioxymethamphetamine (“ecstasy”)","year":"2007","cit":239,"pfa":"Murray R. Thompson","psa":"Iain S. McGregor","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2109384015","eid":"W2109384015"},{"id":"paper-w3046100757","cat":"papers","name":"The Current Status of Psychedelics in Psychiatry","year":"2020","cit":239,"pfa":"David Nutt","psa":"Robin Lester Carhart-Harris","ptype":"article","src":"https://openalex.org/W3046100757","eid":"W3046100757"},{"id":"paper-w2099360322","cat":"papers","name":"NMDA Receptor Hypofunction Leads to Generalized and Persistent Aberrant γ Oscillations Independent of Hyperlocomotion and the State of Consciousness","year":"2009","cit":239,"pfa":"Tahir M. Hakami","psa":"Didier Pinault","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2099360322","eid":"W2099360322"},{"id":"paper-w2093527826","cat":"papers","name":"Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy","year":"2005","cit":238,"pfa":"Andrew C. Parrott","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2093527826","eid":"W2093527826"},{"id":"paper-w3112525124","cat":"papers","name":"Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms","year":"2020","cit":238,"pfa":"Antonio Inserra","psa":"Gabriella Gobbi","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3112525124","eid":"W3112525124"},{"id":"paper-w2022994360","cat":"papers","name":"Lanicemine: a low-trapping NMDA channel blocker produces sustained antidepressant efficacy with minimal psychotomimetic adverse effects","year":"2013","cit":238,"pfa":"Gerard Sanacora","psa":"Michael C. Quirk","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2022994360","eid":"W2022994360"},{"id":"paper-w2057804290","cat":"papers","name":"The Role of Ketamine in Treatment-Resistant Depression: A Systematic Review","year":"2014","cit":238,"pfa":"Gianluca Serafini","psa":"Mario Amore","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W2057804290","eid":"W2057804290"},{"id":"paper-w3013948476","cat":"papers","name":"Molecular mechanisms of the rapid-acting and long-lasting antidepressant actions of (R)-ketamine","year":"2020","cit":238,"pfa":"Kenji Hashimoto","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3013948476","eid":"W3013948476"},{"id":"paper-w2059976461","cat":"papers","name":"Determination of psilocin and 4-hydroxyindole-3-acetic acid in plasma by HPLC-ECD and pharmacokinetic profiles of oral and intravenous psilocybin in man","year":"1997","cit":237,"pfa":"Felix Hasler","psa":"F.X. Vollenweider","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2059976461","eid":"W2059976461"},{"id":"paper-w2996870046","cat":"papers","name":"The experimental effects of psilocybin on symptoms of anxiety and depression: A meta-analysis","year":"2020","cit":237,"pfa":"Simon Benjamin Goldberg","psa":"Paul R. Hutson","topics":["Depression","Anxiety & end-of-life","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W2996870046","eid":"W2996870046"},{"id":"paper-w2042593075","cat":"papers","name":"Using Psilocybin to Investigate the Relationship between Attention, Working Memory, and the Serotonin 1A and 2A Receptors","year":"2005","cit":237,"pfa":"Olivia L. Carter","psa":"Franz X. Vollenweider","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2042593075","eid":"W2042593075"},{"id":"paper-w2018057120","cat":"papers","name":"Human Pharmacology of 3,4-Methylenedioxymeth-amphetamine (\"Ecstasy\"): Psychomotor Performance and Subjective Effects","year":"2000","cit":237,"pfa":"Jordi Camı́","psa":"Rafael de la Torre","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2018057120","eid":"W2018057120"},{"id":"paper-w4214649547","cat":"papers","name":"Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects","year":"2022","cit":236,"pfa":"Friederike Holze","psa":"Matthias E. Liechti","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4214649547","eid":"W4214649547"},{"id":"paper-w2607844825","cat":"papers","name":"Modern Clinical Research on LSD","year":"2017","cit":236,"pfa":"Matthias E. Liechti","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2607844825","eid":"W2607844825"},{"id":"paper-w2008877918","cat":"papers","name":"The demethylenation of methylenedioxymethamphetamine (“ecstasy”) by debrisoquine hydroxylase (CYP2D6)","year":"1994","cit":236,"pfa":"Geoffrey T. Tucker","psa":"T.Y.Y. Chu","ptype":"article","src":"https://openalex.org/W2008877918","eid":"W2008877918"},{"id":"paper-w2089436854","cat":"papers","name":"Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists","year":"2011","cit":235,"pfa":"José L. Moreno","psa":"Javier González‐Maeso","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2089436854","eid":"W2089436854"},{"id":"paper-w1994263633","cat":"papers","name":"The epidemiology and patterns of acute and chronic toxicity associated with recreational ketamine use","year":"2011","cit":235,"pfa":"Kalsi SS","psa":"Paul Ivor Dargan","topics":["PTSD & trauma","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1994263633","eid":"W1994263633"},{"id":"paper-w2166092131","cat":"papers","name":"Glutamatergic theories of schizophrenia.","year":"2010","cit":235,"pfa":"Daniel C. Javitt","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2166092131","eid":"W2166092131"},{"id":"paper-w2033919519","cat":"papers","name":"Mechanisms underlying differential effectiveness of memantine and ketamine in rapid antidepressant responses","year":"2014","cit":235,"pfa":"Erinn S. Gideons","psa":"Lisa M. Monteggia","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2033919519","eid":"W2033919519"},{"id":"paper-w2116808683","cat":"papers","name":"The Background and Chemistry of MDMA","year":"1986","cit":234,"pfa":"Alexander T. Shulgin","ptype":"article","src":"https://openalex.org/W2116808683","eid":"W2116808683"},{"id":"paper-w2899027265","cat":"papers","name":"3,4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: A randomized phase 2 controlled trial","year":"2018","cit":234,"pfa":"Marcela Ot’alora G.","psa":"Rick Doblin","topics":["PTSD & trauma","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2899027265","eid":"W2899027265"},{"id":"paper-w2790381919","cat":"papers","name":"The Meaning-Enhancing Properties of Psychedelics and Their Mediator Role in Psychedelic Therapy, Spirituality, and Creativity","year":"2018","cit":234,"pfa":"Ido Hartogsohn","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2790381919","eid":"W2790381919"},{"id":"paper-w2811499691","cat":"papers","name":"The effects of ketamine on prefrontal glutamate neurotransmission in healthy and depressed subjects","year":"2018","cit":234,"pfa":"Chadi G. Abdallah","psa":"Graeme F. Mason","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2811499691","eid":"W2811499691"},{"id":"paper-w2887140173","cat":"papers","name":"Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews","year":"2018","cit":233,"pfa":"RAFAEL GUIMARÃES DOS SANTOS","psa":"Jaime E. C. Hallak","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"review","src":"https://openalex.org/W2887140173","eid":"W2887140173"},{"id":"paper-w4327914778","cat":"papers","name":"Human brain effects of DMT assessed via EEG-fMRI","year":"2023","cit":233,"pfa":"Christopher B. Timmermann","psa":"Robin Lester Carhart-Harris","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4327914778","eid":"W4327914778"},{"id":"paper-w2628731659","cat":"papers","name":"Antidepressant effects of ketamine and the roles of AMPA glutamate receptors and other mechanisms beyond NMDA receptor antagonism","year":"2017","cit":233,"pfa":"Lily R. Aleksandrova","psa":"Yu Tian Wang","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2628731659","eid":"W2628731659"},{"id":"paper-w2120918936","cat":"papers","name":"Mechanism of the 5-hydroxytryptamine 2A receptor-mediated facilitation of synaptic activity in prefrontal cortex","year":"2007","cit":232,"pfa":"Jean-Claude Béïque","psa":"Rodrigo Andrade","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2120918936","eid":"W2120918936"},{"id":"paper-w2608583841","cat":"papers","name":"Psychedelics, Personality and Political Perspectives","year":"2017","cit":232,"pfa":"Matthew M. Nour","psa":"Robin Lester Carhart-Harris","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2608583841","eid":"W2608583841"},{"id":"paper-w2954690399","cat":"papers","name":"The psychedelic renaissance and the limitations of a White-dominant medical framework: A call for indigenous and ethnic minority inclusion","year":"2019","cit":232,"pfa":"Jamilah R. George","psa":"Monnica T. Williams","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W2954690399","eid":"W2954690399"},{"id":"paper-w3134897339","cat":"papers","name":"Predicting Reactions to Psychedelic Drugs: A Systematic Review of States and Traits Related to Acute Drug Effects","year":"2021","cit":232,"pfa":"Jacob S. Aday","psa":"Christopher C. Davoli","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W3134897339","eid":"W3134897339"},{"id":"paper-w2059761623","cat":"papers","name":"Ketamine Safety and Tolerability in Clinical Trials for Treatment-Resistant Depression","year":"2014","cit":232,"pfa":"Le-Ben Wan","psa":"James W. Murrough","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2059761623","eid":"W2059761623"},{"id":"paper-w2001003931","cat":"papers","name":"Hyperpolarization of serotonergic neurons by serotonin and LSD: Studies in brain slices showing increased K+ conductance","year":"1984","cit":232,"pfa":"George K. Aghajanian","psa":"Joan M. Lakoski","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2001003931","eid":"W2001003931"},{"id":"paper-w2572835720","cat":"papers","name":"Metabolism of psilocybin and psilocin: clinical and forensic toxicological relevance","year":"2017","cit":231,"pfa":"Ricardo Jorge Dinis‐Oliveira","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2572835720","eid":"W2572835720"},{"id":"paper-w2116852450","cat":"papers","name":"Assessment of addiction severity among ritual users of ayahuasca","year":"2010","cit":231,"pfa":"Josep María Fábregas","psa":"José Carlos Bouso","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2116852450","eid":"W2116852450"},{"id":"paper-w2167729602","cat":"papers","name":"Is ecstasy MDMA? A review of the proportion of ecstasy tablets containing MDMA, their dosage levels, and the changing perceptions of purity","year":"2004","cit":231,"pfa":"Andrew C. Parrott","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2167729602","eid":"W2167729602"},{"id":"paper-w2085124531","cat":"papers","name":"Subjective and hormonal effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans","year":"2002","cit":231,"pfa":"Debra S. Harris","psa":"Reese T. Jones","ptype":"article","src":"https://openalex.org/W2085124531","eid":"W2085124531"},{"id":"paper-w1990140024","cat":"papers","name":"Classic hallucinogens in the treatment of addictions","year":"2015","cit":231,"pfa":"Michael P. Bogenschutz","psa":"Matthew W. Johnson","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1990140024","eid":"W1990140024"},{"id":"paper-w4226207502","cat":"papers","name":"Great Expectations: recommendations for improving the methodological rigor of psychedelic clinical trials","year":"2022","cit":231,"pfa":"Jacob S. Aday","psa":"Joshua D. Woolley","ptype":"article","src":"https://openalex.org/W4226207502","eid":"W4226207502"},{"id":"paper-w3205085416","cat":"papers","name":"Prolonged epigenomic and synaptic plasticity alterations following single exposure to a psychedelic in mice","year":"2021","cit":231,"pfa":"Mario de la Fuente Revenga","psa":"Javier González‐Maeso","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3205085416","eid":"W3205085416"},{"id":"paper-w2301686735","cat":"papers","name":"Ayahuasca: Pharmacology, neuroscience and therapeutic potential","year":"2016","cit":230,"pfa":"Elisabet Domínguez‐Clavé","psa":"Jordi Riba","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2301686735","eid":"W2301686735"},{"id":"paper-w2949283084","cat":"papers","name":"Connectome-harmonic decomposition of human brain activity reveals dynamical repertoire re-organization under LSD","year":"2017","cit":230,"pfa":"Selen Atasoy","psa":"Robin Lester Carhart-Harris","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2949283084","eid":"W2949283084"},{"id":"paper-w2887016029","cat":"papers","name":"DMT Models the Near-Death Experience","year":"2018","cit":230,"pfa":"Christopher B. Timmermann","psa":"Robin Lester Carhart-Harris","ptype":"article","src":"https://openalex.org/W2887016029","eid":"W2887016029"},{"id":"paper-w2028589914","cat":"papers","name":"PHARMACOLOGICAL CHARACTERIZATION OF THE PRESYNAPTIC α‐ADRENOCEPTORS REGULATING CHOLINERGIC ACTIVITY IN THE GUINEA‐PIG ILEUM","year":"1978","cit":229,"pfa":"Geoffrey M. Drew","topics":["Depression","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2028589914","eid":"W2028589914"},{"id":"paper-w2016371428","cat":"papers","name":"Hallucinogens of Plant Origin","year":"1969","cit":229,"pfa":"Richard Evans Schultes","ptype":"article","src":"https://openalex.org/W2016371428","eid":"W2016371428"},{"id":"paper-w1973149246","cat":"papers","name":"A Review of the Nonmedical Use of Ketamine: Use, Users and Consequences","year":"2000","cit":229,"pfa":"Karl L.R. Jansen","topics":["Safety & adverse events","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W1973149246","eid":"W1973149246"},{"id":"paper-w2123844596","cat":"papers","name":"Diagnostic and demographic correlates of substance abuse in schizophrenia and major affective disorder","year":"1992","cit":229,"pfa":"Kim T. Mueser","psa":"Alan S. Bellack","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W2123844596","eid":"W2123844596"},{"id":"paper-w2119804742","cat":"papers","name":"Asymmetrical reductions of hippocampal NMDAR1 glutamate receptor mRNA in the psychoses","year":"2001","cit":229,"pfa":"Amanda J. Law","psa":"J.F.W. Deakin","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2119804742","eid":"W2119804742"},{"id":"paper-w2167091782","cat":"papers","name":"Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence?","year":"2001","cit":228,"pfa":"Michael K. Morgan","psa":"Jennifer L. Robinson","ptype":"article","src":"https://openalex.org/W2167091782","eid":"W2167091782"},{"id":"paper-w1897852281","cat":"papers","name":"Head‐twitch response in rodents induced by the hallucinogen 2,5‐dimethoxy‐4‐iodoamphetamine: a comprehensive history, a re‐evaluation of mechanisms, and its utility as a model","year":"2012","cit":228,"pfa":"Clint E. Canal","psa":"Drake Morgan","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1897852281","eid":"W1897852281"},{"id":"paper-w2102963347","cat":"papers","name":"Neurometabolic Effects of Psilocybin, 3,4-Methylenedioxyethylamphetamine (MDE) and d-Methamphetamine in Healthy Volunteers A Double-Blind, Placebo-Controlled PET Study with [18F]FDG","year":"1999","cit":227,"pfa":"Euphrosyne Gouzoulis‐Mayfrank","ptype":"article","src":"https://openalex.org/W2102963347","eid":"W2102963347"},{"id":"paper-w1972616052","cat":"papers","name":"Long-term use of psychedelic drugs is associated with differences in brain structure and personality in humans","year":"2015","cit":227,"pfa":"José Carlos Bouso","psa":"Jordi Riba","ptype":"article","src":"https://openalex.org/W1972616052","eid":"W1972616052"},{"id":"paper-w2067481209","cat":"papers","name":"Characterization of the head-twitch response induced by hallucinogens in mice","year":"2013","cit":227,"pfa":"Adam L. Halberstadt","psa":"Mark A. Geyer","ptype":"article","src":"https://openalex.org/W2067481209","eid":"W2067481209"},{"id":"paper-w2057174717","cat":"papers","name":"Psilocybin und Psilocin, zwei psychotrope Wirkstoffe aus mexikanischen Rauschpilzen","year":"1959","cit":226,"pfa":"Alfred André Hofmann","psa":"F. Troxler","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2057174717","eid":"W2057174717"},{"id":"paper-w2083661078","cat":"papers","name":"Salvinorin, a new trans-neoclerodane diterpene from Salvia divinorum(Labiatae)","year":"1982","cit":226,"pfa":"Alfredo Ortega","psa":"Percy S. Manchand","ptype":"article","src":"https://openalex.org/W2083661078","eid":"W2083661078"},{"id":"paper-w1974766709","cat":"papers","name":"The Psychological and Physiological Effects of MDMA on Normal Volunteers","year":"1986","cit":226,"pfa":"Joseph Downing","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1974766709","eid":"W1974766709"},{"id":"paper-w2056541959","cat":"papers","name":"Cognitive performance in recreational users of MDMA or 'ecstasy': evidence for memory deficits","year":"1998","cit":226,"pfa":"Andrew C. Parrott","psa":"Keith Andrew Wesnes","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2056541959","eid":"W2056541959"},{"id":"paper-w3198351924","cat":"papers","name":"Philosophy of Psychedelics","year":"2021","cit":226,"pfa":"Chris Letheby","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"book","src":"https://openalex.org/W3198351924","eid":"W3198351924"},{"id":"paper-w2129576675","cat":"papers","name":"The behavioral pharmacology of hallucinogens","year":"2007","cit":226,"pfa":"William E. Fantegrossi","psa":"Chad J. Reissig","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2129576675","eid":"W2129576675"},{"id":"paper-w2899405464","cat":"papers","name":"How to Change Your Mind: What the New Science of Psychedelics Teaches Us about Consciousness, Dying, Addiction, Depression, and Transcendence,","year":"2018","cit":226,"pfa":"John Rhead","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W2899405464","eid":"W2899405464"},{"id":"paper-w2057997299","cat":"papers","name":"Respondent-driven sampling to recruit MDMA users: a methodological assessment","year":"2004","cit":225,"pfa":"Jichuan Wang","psa":"Linna Li","ptype":"article","src":"https://openalex.org/W2057997299","eid":"W2057997299"},{"id":"paper-w3049156731","cat":"papers","name":"Psychedelic Treatments for Psychiatric Disorders: A Systematic Review and Thematic Synthesis of Patient Experiences in Qualitative Studies","year":"2020","cit":225,"pfa":"Joost J. Breeksema","psa":"Robert A. Schoevers","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"review","src":"https://openalex.org/W3049156731","eid":"W3049156731"},{"id":"paper-w2155362097","cat":"papers","name":"Club drugs: methylenedioxymethamphetamine, flunitrazepam, ketamine hydrochloride, and gamma-hydroxybutyrate","year":"2002","cit":225,"pfa":"Kelly M. Smith","psa":"Frank Romanelli","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2155362097","eid":"W2155362097"},{"id":"paper-w4286449579","cat":"papers","name":"Pharmacological, neural, and psychological mechanisms underlying psychedelics: A critical review","year":"2022","cit":225,"pfa":"Michiel van Elk","psa":"David B. Yaden","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4286449579","eid":"W4286449579"},{"id":"paper-w2111990860","cat":"papers","name":"In Vivo Modulation of the Activity of Pyramidal Neurons in the Rat Medial Prefrontal Cortex by 5-HT2A Receptors: Relationship to Thalamocortical Afferents","year":"2003","cit":225,"pfa":"Maria Victoria Puig","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2111990860","eid":"W2111990860"},{"id":"paper-w2129721670","cat":"papers","name":"Effects of (S)-ketamine on striatal dopamine: a [11C]raclopride PET study of a model psychosis in humans","year":"2000","cit":225,"pfa":"Franz X. Vollenweider","psa":"Klaus Leonhard Leenders","ptype":"article","src":"https://openalex.org/W2129721670","eid":"W2129721670"},{"id":"paper-w2958413903","cat":"papers","name":"Microdosing psychedelics: More questions than answers? An overview and suggestions for future research","year":"2019","cit":224,"pfa":"Kim P. C. Kuypers","psa":"David Nutt","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"editorial","src":"https://openalex.org/W2958413903","eid":"W2958413903"},{"id":"paper-w1983960180","cat":"papers","name":"Clinical review: Major consequences of illicit drug consumption","year":"2008","cit":223,"pfa":"Robert J Devlin","psa":"John Aaron Henry","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1983960180","eid":"W1983960180"},{"id":"paper-w2143648030","cat":"papers","name":"Rapid modulation of spine morphology by the 5-HT 2A serotonin receptor through kalirin-7 signaling","year":"2009","cit":223,"pfa":"Kelly A. Jones","psa":"Peter Penzes","topics":["Depression","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2143648030","eid":"W2143648030"},{"id":"paper-w2051994523","cat":"papers","name":"Degeneration of purkinje cells in parasagittal zones of the cerebellar vermis after treatment with ibogaine or harmaline","year":"1993","cit":222,"pfa":"Elizabeth O’Hearn","psa":"M.E. Molliver","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2051994523","eid":"W2051994523"},{"id":"paper-w2726613221","cat":"papers","name":"Developing Guidelines and Competencies for the Training of Psychedelic Therapists","year":"2017","cit":222,"pfa":"Janis Phelps","topics":["Reviews & meta-analyses","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2726613221","eid":"W2726613221"},{"id":"paper-w2116697656","cat":"papers","name":"Opioid receptors and legal highs:Salvia divinorumand Kratom","year":"2008","cit":222,"pfa":"Kavita M. Babu","psa":"Edward W. Boyer","topics":["Addiction","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2116697656","eid":"W2116697656"},{"id":"paper-w2107441654","cat":"papers","name":"Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice","year":"2010","cit":221,"pfa":"Adam L. Halberstadt","psa":"Mark A. Geyer","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2107441654","eid":"W2107441654"},{"id":"paper-w3173955184","cat":"papers","name":"Psychedelics alter metaphysical beliefs","year":"2021","cit":221,"pfa":"Christopher B. Timmermann","psa":"Robin Lester Carhart-Harris","ptype":"article","src":"https://openalex.org/W3173955184","eid":"W3173955184"},{"id":"paper-w2148562084","cat":"papers","name":"The pharmacology of the acute hyperthermic response that follows administration of 3,4‐methylenedioxymethamphetamine (MDMA, ‘ecstasy’) to rats","year":"2002","cit":220,"pfa":"Annis O. Mechan","psa":"A. Richard Green","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2148562084","eid":"W2148562084"},{"id":"paper-w1965925823","cat":"papers","name":"Recreational Use, Analysis and Toxicity of Tryptamines","year":"2014","cit":220,"pfa":"Roberta Tittarelli","psa":"Francesco Saverio Romolo","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1965925823","eid":"W1965925823"},{"id":"paper-w2044165548","cat":"papers","name":"Effects of 3,4-methylenedioxymethamphetamine on autonomic thermoregulatory responses of the rat","year":"1991","cit":220,"pfa":"Christopher James Gordon","psa":"Diane Bemis Miller","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2044165548","eid":"W2044165548"},{"id":"paper-w2095159395","cat":"papers","name":"A Randomized, Placebo-Controlled, Crossover Pilot Trial of the Oral Selective NR2B Antagonist MK-0657 in Patients With Treatment-Resistant Major Depressive Disorder","year":"2012","cit":220,"pfa":"Lobna A. Ibrahim","psa":"Carlos A. Zarate","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2095159395","eid":"W2095159395"},{"id":"paper-w4387324672","cat":"papers","name":"Esketamine Nasal Spray versus Quetiapine for Treatment-Resistant Depression","year":"2023","cit":220,"pfa":"Andreas Reif","psa":"Yordan Godinov","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4387324672","eid":"W4387324672"},{"id":"paper-w2150903999","cat":"papers","name":"Hallucinogen persisting perception disorder: what do we know after 50 years?","year":"2003","cit":219,"pfa":"John H. Halpern","ptype":"article","src":"https://openalex.org/W2150903999","eid":"W2150903999"},{"id":"paper-w3000549374","cat":"papers","name":"Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression","year":"2020","cit":218,"pfa":"Lea Julia Mertens","psa":"Robin Lester Carhart-Harris","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3000549374","eid":"W3000549374"},{"id":"paper-w2792164490","cat":"papers","name":"MDMA-assisted psychotherapy for PTSD: Are memory reconsolidation and fear extinction underlying mechanisms?","year":"2018","cit":218,"pfa":"Allison A. Feduccia","psa":"Michael C. Mithoefer","topics":["PTSD & trauma","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2792164490","eid":"W2792164490"},{"id":"paper-w2006587749","cat":"papers","name":"The Experimental Use of Psychedelic (LSD) Psychotherapy","year":"1970","cit":218,"pfa":"Walter N. Pahnke","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2006587749","eid":"W2006587749"},{"id":"paper-w2068181946","cat":"papers","name":"Stimulatory Drugs of Abuse in Surface Waters and Their Removal in a Conventional Drinking Water Treatment Plant","year":"2008","cit":218,"pfa":"Maria Huerta‐Fontela","psa":"Francesc Ventura","ptype":"article","src":"https://openalex.org/W2068181946","eid":"W2068181946"},{"id":"paper-w2496516606","cat":"papers","name":"Use of microdoses for induction of buprenorphine treatment with overlapping full opioid agonist use: the “Bernese method”","year":"2016","cit":218,"pfa":"Marc Vogel","psa":"Kenneth M. Dürsteler","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2496516606","eid":"W2496516606"},{"id":"paper-w2148418924","cat":"papers","name":"Naloxone-inaccessible sigma receptor in rat central nervous system.","year":"1983","cit":218,"pfa":"S. William Tam","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2148418924","eid":"W2148418924"},{"id":"paper-w2114778692","cat":"papers","name":"MDMA (`ecstasy') consumption in the context of polydrug abuse: a report on 150 patients","year":"1998","cit":217,"pfa":"Fabrizio Schifano","psa":"R Bricolo","ptype":"article","src":"https://openalex.org/W2114778692","eid":"W2114778692"},{"id":"paper-w2098984053","cat":"papers","name":"Drug-Induced Psychosis: How to Avoid Star Gazing in Schizophrenia Research by Looking at More Obvious Sources of Light","year":"2011","cit":217,"pfa":"Alessandra Paparelli","psa":"Robin M. Murray","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2098984053","eid":"W2098984053"},{"id":"paper-w2097791185","cat":"papers","name":"Case series of individuals with analytically confirmed acute mephedrone toxicity","year":"2010","cit":217,"pfa":"David Michael Wood","psa":"Paul Ivor Dargan","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2097791185","eid":"W2097791185"},{"id":"paper-w2932518772","cat":"papers","name":"Ketamine Assisted Psychotherapy (KAP): Patient Demographics, Clinical Data and Outcomes in Three Large Practices Administering Ketamine with Psychotherapy","year":"2019","cit":217,"pfa":"Jennifer Dore","psa":"Phil Wolfson","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2932518772","eid":"W2932518772"},{"id":"paper-w2125337025","cat":"papers","name":"Effects of a MATE Protein Inhibitor, Pyrimethamine, on the Renal Elimination of Metformin at Oral Microdose and at Therapeutic Dose in Healthy Subjects","year":"2011","cit":217,"pfa":"Hiroyuki Kusuhara","psa":"Yuichi Sugiyama","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2125337025","eid":"W2125337025"},{"id":"paper-w169302724","cat":"papers","name":"Psychotomimetic drugs","year":"1971","cit":217,"pfa":"David J. Boullin","ptype":"article","src":"https://openalex.org/W169302724","eid":"W169302724"},{"id":"paper-w2518058704","cat":"papers","name":"Resting-state Network-specific Breakdown of Functional Connectivity during Ketamine Alteration of Consciousness in Volunteers","year":"2016","cit":217,"pfa":"Vincent Luce Bonhomme","psa":"Steven Laureys","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2518058704","eid":"W2518058704"},{"id":"paper-w2004193318","cat":"papers","name":"The acute effects of methylenedioxymethamphetamine on dopamine release in the awake-behaving rat","year":"1988","cit":216,"pfa":"Bryan K. Yamamoto","psa":"Linda J. Spanos","ptype":"article","src":"https://openalex.org/W2004193318","eid":"W2004193318"},{"id":"paper-w580067020","cat":"papers","name":"Serotonin receptor subtypes : basic and clinical aspects","year":"1991","cit":216,"pfa":"Stephen J. Peroutka","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"book","src":"https://openalex.org/W580067020","eid":"W580067020"},{"id":"paper-w3157088173","cat":"papers","name":"Psychedelic-inspired drug discovery using an engineered biosensor","year":"2021","cit":216,"pfa":"Chunyang Dong","psa":"Lin Tian","ptype":"article","src":"https://openalex.org/W3157088173","eid":"W3157088173"},{"id":"paper-w3152417644","cat":"papers","name":"Psychedelic Communitas: Intersubjective Experience During Psychedelic Group Sessions Predicts Enduring Changes in Psychological Wellbeing and Social Connectedness","year":"2021","cit":216,"pfa":"Hannes Kettner","psa":"Leor Roseman","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3152417644","eid":"W3152417644"},{"id":"paper-w2156177514","cat":"papers","name":"Ketamine abusers presenting to the Emergency Department: A case series","year":"2000","cit":216,"pfa":"Alan L Weiner","psa":"Marc J. Bayer","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2156177514","eid":"W2156177514"},{"id":"paper-w1966610837","cat":"papers","name":"Atypical antipsychotics in the treatment of drug-induced psychosis in Parkinson's disease","year":"2000","cit":216,"pfa":"Joseph H. Friedman","psa":"Stewart Alan Factor","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1966610837","eid":"W1966610837"},{"id":"paper-w2992709942","cat":"papers","name":"Pharmacokinetics and Safety of Esketamine in Chinese Patients Undergoing Painless Gastroscopy in Comparison with Ketamine: A Randomized, Open-Label Clinical Study","year":"2019","cit":216,"pfa":"Jing Wang","psa":"Qi Pei","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2992709942","eid":"W2992709942"},{"id":"paper-w2885455509","cat":"papers","name":"Sub-acute and long-term effects of ayahuasca on affect and cognitive thinking style and their association with ego dissolution","year":"2018","cit":214,"pfa":"Malin Vedøy Uthaug","psa":"Johannes Gerardus Ramaekers","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2885455509","eid":"W2885455509"},{"id":"paper-w3010499243","cat":"papers","name":"Psychedelics, but Not Ketamine, Produce Persistent Antidepressant-like Effects in a Rodent Experimental System for the Study of Depression","year":"2020","cit":214,"pfa":"Meghan Hibicke","psa":"Charles David Nichols","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3010499243","eid":"W3010499243"},{"id":"paper-w173089895","cat":"papers","name":"LSD-Assisted Psychotherapy in Patients with Terminal Cancer","year":"2017","cit":214,"pfa":"S Grof","psa":"A. A. Kurland","topics":["Depression","Anxiety & end-of-life","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W173089895","eid":"W173089895"},{"id":"paper-w2026781905","cat":"papers","name":"A review of the acute subjective effects of MDMA/ecstasy","year":"2006","cit":213,"pfa":"Chelsea A. Baylen","psa":"Harold Rosenberg","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2026781905","eid":"W2026781905"},{"id":"paper-w2173679640","cat":"papers","name":"Exploring the therapeutic potential of Ayahuasca: acute intake increases mindfulness-related capacities","year":"2015","cit":212,"pfa":"Joaquim Soler","psa":"Jordi Riba","ptype":"article","src":"https://openalex.org/W2173679640","eid":"W2173679640"},{"id":"paper-w3035643259","cat":"papers","name":"A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted Therapy","year":"2020","cit":212,"pfa":"Jason B. Luoma","psa":"Rafael Lancelotta","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"review","src":"https://openalex.org/W3035643259","eid":"W3035643259"},{"id":"paper-w4280624097","cat":"papers","name":"Stahl's Essential Psychopharmacology","year":"2022","cit":212,"pfa":"Stephen M. Stahl","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"book","src":"https://openalex.org/W4280624097","eid":"W4280624097"},{"id":"paper-w2741562499","cat":"papers","name":"Enzymatic Synthesis of Psilocybin","year":"2017","cit":211,"pfa":"Janis Fricke","psa":"Dirk Hoffmeister","ptype":"article","src":"https://openalex.org/W2741562499","eid":"W2741562499"},{"id":"paper-w2034818162","cat":"papers","name":"Effects of MDMA on sociability and neural response to social threat and social reward","year":"2009","cit":211,"pfa":"Gillinder Bedi","psa":"Harriet de Wit","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2034818162","eid":"W2034818162"},{"id":"paper-w2066423907","cat":"papers","name":"Salvinorin A, an Active Component of the Hallucinogenic Sage Salvia divinorum Is a Highly Efficacious κ-Opioid Receptor Agonist: Structural and Functional Considerations","year":"2004","cit":211,"pfa":"Charles Chavkin","psa":"Bryan L. Roth","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2066423907","eid":"W2066423907"},{"id":"paper-w2125082738","cat":"papers","name":"Recreational ecstasy/MDMA and other drug users from the UK and Italy: psychiatric symptoms and psychobiological problems","year":"2001","cit":211,"pfa":"Andy C. Parrott","psa":"John J. Turner","ptype":"article","src":"https://openalex.org/W2125082738","eid":"W2125082738"},{"id":"paper-w606574989","cat":"papers","name":"Principles of addiction medicine","year":"2009","cit":211,"pfa":"Richard R. Ries","psa":"Richard Saitz","topics":["Addiction","Dosing & pharmacology","Policy & ethics"],"ptype":"other","src":"https://openalex.org/W606574989","eid":"W606574989"},{"id":"paper-w2147495553","cat":"papers","name":"The globalization of ayahuasca: Harm reduction or benefit maximization?","year":"2006","cit":210,"pfa":"Kenneth W. Tupper","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2147495553","eid":"W2147495553"},{"id":"paper-w1984518599","cat":"papers","name":"Differential effects of MDMA, cocaine, and cannabis use severity on distinctive components of the executive functions in polysubstance users: A multiple regression analysis","year":"2004","cit":210,"pfa":"Antonio Verdejo‐García","psa":"Miguel Pérez-Garcı́a","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1984518599","eid":"W1984518599"},{"id":"paper-w1990508321","cat":"papers","name":"The substituted amphetamines 3,4-methylenedioxymethamphetamine, methamphetamine, p-chloroamphetamine and fenfluramine induce 5-hydroxytryptamine release via a common mechanism blocked by fluoxetine and cocaine","year":"1992","cit":210,"pfa":"Urs V. Berger","psa":"Efrain C. Azmitia","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1990508321","eid":"W1990508321"},{"id":"paper-w1973810935","cat":"papers","name":"Identification of the Rate-Determining Process in the Hepatic Clearance of Atorvastatin in a Clinical Cassette Microdosing Study","year":"2011","cit":210,"pfa":"Kazuya Maeda","psa":"Yuichi Sugiyama","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1973810935","eid":"W1973810935"},{"id":"paper-w4367835241","cat":"papers","name":"Treatment of Posttraumatic Stress Disorder: A State-of-the-art Review","year":"2023","cit":210,"pfa":"Lisa Burback","psa":"Eric H. G. J. M. Vermetten","topics":["PTSD & trauma","Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4367835241","eid":"W4367835241"},{"id":"paper-w2093943230","cat":"papers","name":"MDMA-Assisted Psychotherapy Using Low Doses in a Small Sample of Women with Chronic Posttraumatic Stress Disorder","year":"2008","cit":209,"pfa":"José Carlos Bouso","psa":"Gregorio Gómez-Jarabo","topics":["PTSD & trauma","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2093943230","eid":"W2093943230"},{"id":"paper-w4200471428","cat":"papers","name":"Models of psychedelic drug action: modulation of cortical-subcortical circuits","year":"2021","cit":209,"pfa":"Manoj K. Doss","psa":"Frederick Streeter Barrett","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4200471428","eid":"W4200471428"},{"id":"paper-w2163858520","cat":"papers","name":"Effects of ayahuasca on psychometric measures of anxiety, panic-like and hopelessness in Santo Daime members","year":"2007","cit":208,"pfa":"RAFAEL GUIMARÃES DOS SANTOS","psa":"Antônio Pedro de Mello Cruz","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2163858520","eid":"W2163858520"},{"id":"paper-w2058889376","cat":"papers","name":"Sub-chronic psychotomimetic phencyclidine induces deficits in reversal learning and alterations in parvalbumin-immunoreactive expression in the rat","year":"2007","cit":208,"pfa":"Z. Abdul-Monim","psa":"Gavin P. Reynolds","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2058889376","eid":"W2058889376"},{"id":"paper-w2166045982","cat":"papers","name":"Htr2a gene and 5-HT2A receptor expression in the cerebral cortex studied using genetically modified mice","year":"2010","cit":208,"pfa":"Weber","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2166045982","eid":"W2166045982"},{"id":"paper-w2616273018","cat":"papers","name":"Assessing the Psychedelic “After-Glow” in Ayahuasca Users: Post-Acute Neurometabolic and Functional Connectivity Changes Are Associated with Enhanced Mindfulness Capacities","year":"2017","cit":206,"pfa":"Frederic Sampedro","psa":"Jordi Riba","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2616273018","eid":"W2616273018"},{"id":"paper-w4220950644","cat":"papers","name":"The promises and perils of psychedelic pharmacology for psychiatry","year":"2022","cit":206,"pfa":"Tristan D. McClure‐Begley","psa":"Bryan L. Roth","topics":["Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W4220950644","eid":"W4220950644"},{"id":"paper-w2624901555","cat":"papers","name":"Effect of Psilocybin on Empathy and Moral Decision-Making","year":"2017","cit":205,"pfa":"Thomas Pokorny","psa":"Franz X. Vollenweider","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2624901555","eid":"W2624901555"},{"id":"paper-w2492489237","cat":"papers","name":"Ayahuasca enhances creative divergent thinking while decreasing conventional convergent thinking","year":"2016","cit":205,"pfa":"Kim P. C. Kuypers","psa":"Johannes Gerardus Ramaekers","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2492489237","eid":"W2492489237"},{"id":"paper-w2528752100","cat":"papers","name":"Alterations of consciousness and mystical-type experiences after acute LSD in humans","year":"2016","cit":205,"pfa":"Matthias E. Liechti","psa":"Yasmin Schmid","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2528752100","eid":"W2528752100"},{"id":"paper-w1998021006","cat":"papers","name":"Cannabidiol inhibits the hyperlocomotion induced by psychotomimetic drugs in mice","year":"2005","cit":205,"pfa":"Fabrício A. Moreira","psa":"Francisco Silveira Guimarães","ptype":"article","src":"https://openalex.org/W1998021006","eid":"W1998021006"},{"id":"paper-w2111247524","cat":"papers","name":"The NMDA Receptor as a Therapeutic Target in Major Depressive Disorder","year":"2007","cit":205,"pfa":"Christopher Pittenger","psa":"John Harrison Krystal","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2111247524","eid":"W2111247524"},{"id":"paper-w2979686202","cat":"papers","name":"Ketamine for suicidal ideation in adults with psychiatric disorders: A systematic review and meta-analysis of treatment trials","year":"2019","cit":205,"pfa":"Katrina Witt","psa":"Keith E Hawton","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W2979686202","eid":"W2979686202"},{"id":"paper-w2021489201","cat":"papers","name":"Dysfunctional brain dopamine systems induced by psychotomimetic NMDA-receptor antagonists and the effects of antipsychotic drugs","year":"2000","cit":204,"pfa":"T Svensson","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2021489201","eid":"W2021489201"},{"id":"paper-w2055661286","cat":"papers","name":"Ketamine and other N-methyl-D-aspartate receptor antagonists in the treatment of depression: a perspective review","year":"2015","cit":204,"pfa":"Nicolas D. Iadarola","psa":"Carlos A. Zarate","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2055661286","eid":"W2055661286"},{"id":"paper-w2156723449","cat":"papers","name":"Quantitative PET Studies of the Serotonin Transporter in MDMA Users and Controls Using [11C]McN5652 and [11C]DASB","year":"2005","cit":203,"pfa":"Una D. McCann","psa":"George A. Ricaurte","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2156723449","eid":"W2156723449"},{"id":"paper-w3134377893","cat":"papers","name":"Self-blinding citizen science to explore psychedelic microdosing","year":"2021","cit":203,"pfa":"Balázs Szigeti","psa":"David Erritzøe","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3134377893","eid":"W3134377893"},{"id":"paper-w2104374332","cat":"papers","name":"Drug metabolism and pharmacokinetics","year":"2009","cit":203,"pfa":"Margherita Strolin Benedetti","psa":"Jean‐Baptiste Watelet","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2104374332","eid":"W2104374332"},{"id":"paper-w2999679415","cat":"papers","name":"Ketamine disinhibits dendrites and enhances calcium signals in prefrontal dendritic spines","year":"2020","cit":203,"pfa":"Farhan Ali","psa":"Alex C. Kwan","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2999679415","eid":"W2999679415"},{"id":"paper-w2938570586","cat":"papers","name":"A single inhalation of vapor from dried toad secretion containing 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting is related to sustained enhancement of satisfaction with life, mindfulness-related","year":"2019","cit":202,"pfa":"Malin Vedøy Uthaug","psa":"Johannes Gerardus Ramaekers","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2938570586","eid":"W2938570586"},{"id":"paper-w2098185806","cat":"papers","name":"Treatment of Acute Opioid Withdrawal with Ibogaine","year":"1999","cit":202,"pfa":"Kenneth Alper","psa":"Jan Bastiaans","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2098185806","eid":"W2098185806"},{"id":"paper-w2999279320","cat":"papers","name":"Psilocybin Induces Time-Dependent Changes in Global Functional Connectivity","year":"2020","cit":202,"pfa":"Katrin H. Preller","psa":"Franz X. Vollenweider","ptype":"article","src":"https://openalex.org/W2999279320","eid":"W2999279320"},{"id":"paper-w2065194005","cat":"papers","name":"Methylenedioxymethamphetamine: A potentially neurotoxic amphetamine analogue","year":"1986","cit":202,"pfa":"Christopher J. Schmidt","psa":"Walter M. Lovenberg","ptype":"article","src":"https://openalex.org/W2065194005","eid":"W2065194005"},{"id":"paper-w2024217117","cat":"papers","name":"Dopamine receptor contribution to the action of PCP, LSD and ketamine psychotomimetics","year":"2005","cit":202,"pfa":"Philip M. Seeman","psa":"Teresa Tallerico","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2024217117","eid":"W2024217117"},{"id":"paper-w3133913092","cat":"papers","name":"Assessment of Annual Cost of Substance Use Disorder in US Hospitals","year":"2021","cit":202,"pfa":"Cora Peterson","psa":"Feijun Luo","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3133913092","eid":"W3133913092"},{"id":"paper-w2007549333","cat":"papers","name":"MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment","year":"2005","cit":201,"pfa":"Christopher D. Verrico","psa":"Bertha Kalifon Madras","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2007549333","eid":"W2007549333"},{"id":"paper-w3108222140","cat":"papers","name":"A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT2A Receptor Density in the Pig Brain","year":"2021","cit":201,"pfa":"Nakul Ravi Raval","psa":"Gitte M. Knudsen","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3108222140","eid":"W3108222140"},{"id":"paper-w3007835064","cat":"papers","name":"Learning to Let Go: A Cognitive-Behavioral Model of How Psychedelic Therapy Promotes Acceptance","year":"2020","cit":201,"pfa":"Max Wolff","psa":"Henrik Jungaberle","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3007835064","eid":"W3007835064"},{"id":"paper-w2490107109","cat":"papers","name":"Clinical applications of hallucinogens: A review.","year":"2016","cit":201,"pfa":"Albert Garcia‐Romeu","psa":"Peter H. Addy","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2490107109","eid":"W2490107109"},{"id":"paper-w2055100089","cat":"papers","name":"Animal models for the negative symptoms of schizophrenia","year":"2000","cit":201,"pfa":"Bart A. Ellenbroek","psa":"Alexander R. Cools","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2055100089","eid":"W2055100089"},{"id":"paper-w2044783071","cat":"papers","name":"Psychological Effects of (S)-Ketamine and N,N-Dimethyltryptamine (DMT): A Double-Blind, Cross-Over Study in Healthy Volunteers","year":"2005","cit":200,"pfa":"Euphrosyne Gouzoulis‐Mayfrank","psa":"K.‐A. Kovar","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2044783071","eid":"W2044783071"},{"id":"paper-w2169132085","cat":"papers","name":"The origin of MDMA (ecstasy) revisited: the true story reconstructed from the original documents*","year":"2006","cit":200,"pfa":"Roland W. Freudenmann","psa":"Sabine Bernschneider‐Reif","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2169132085","eid":"W2169132085"},{"id":"paper-w2061489773","cat":"papers","name":"Acute and subchronic effects of methylenedioxymethamphetamine [(±)MDMA] on locomotion and serotonin syndrome behavior in the rat","year":"1989","cit":200,"pfa":"Linda J. Spanos","psa":"Bryan K. Yamamoto","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2061489773","eid":"W2061489773"},{"id":"paper-w3027721867","cat":"papers","name":"Psilocybin acutely alters the functional connectivity of the claustrum with brain networks that support perception, memory, and attention","year":"2020","cit":200,"pfa":"Frederick Streeter Barrett","psa":"Brian N. Mathur","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3027721867","eid":"W3027721867"},{"id":"paper-w1601726925","cat":"papers","name":"Drugs and Behavior: An Introduction to Behavioral Pharmacology","year":"1986","cit":200,"pfa":"William A. McKim","topics":["Depression","Addiction","Dosing & pharmacology"],"ptype":"book","src":"https://openalex.org/W1601726925","eid":"W1601726925"},{"id":"paper-w2046133517","cat":"papers","name":"Scientific Basis of Drug Dependence","year":"1970","cit":200,"pfa":"Donald W. Goodwin","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2046133517","eid":"W2046133517"},{"id":"paper-w2026246966","cat":"papers","name":"Serotonin 5-HT2 receptors activate local GABA inhibitory inputs to serotonergic neurons of the dorsal raphe nucleus","year":"2000","cit":200,"pfa":"Rongjian Liu","psa":"George K. Aghajanian","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2026246966","eid":"W2026246966"},{"id":"paper-w2007798588","cat":"papers","name":"Unconventional ligands and modulators of nicotinic receptors","year":"2002","cit":200,"pfa":"Edna F. R. Pereira","psa":"Edson Xavier Albuquerque","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2007798588","eid":"W2007798588"},{"id":"paper-w2008361014","cat":"papers","name":"Methylenedioxymethamphetamine (MDMA, Ecstasy) neurotoxicity: cellular and molecular mechanisms","year":"2003","cit":199,"pfa":"Johnalyn Lyles","psa":"Jean Lud Cadet","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2008361014","eid":"W2008361014"},{"id":"paper-w4245707768","cat":"papers","name":"Serotonin and Hallucinogens","year":"1999","cit":199,"pfa":"George K. Aghajanian","psa":"GJ Marek","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4245707768","eid":"W4245707768"},{"id":"paper-w592732404","cat":"papers","name":"Psychedelic Drugs Reconsidered","year":"1979","cit":199,"pfa":"Lester Grinspoon","psa":"James B. Bakalar","ptype":"book","src":"https://openalex.org/W592732404","eid":"W592732404"},{"id":"paper-w2069939535","cat":"papers","name":"Chromosomal Damage in Human Leukocytes Induced by Lysergic Acid Diethylamide","year":"1967","cit":198,"pfa":"Maimon M. Cohen","psa":"Nathan Back","ptype":"article","src":"https://openalex.org/W2069939535","eid":"W2069939535"},{"id":"paper-w2336860660","cat":"papers","name":"Neuropharmacology of New Psychoactive Substances (NPS): Focus on the Rewarding and Reinforcing Properties of Cannabimimetics and Amphetamine-Like Stimulants","year":"2016","cit":198,"pfa":"Cristina Miliano","psa":"Maria Antonietta De Luca","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2336860660","eid":"W2336860660"},{"id":"paper-w2047276596","cat":"papers","name":"Ketamine","year":"2006","cit":198,"pfa":"Kim Wolff","psa":"ADAM R. WINSTOCK","ptype":"article","src":"https://openalex.org/W2047276596","eid":"W2047276596"},{"id":"paper-w2600624779","cat":"papers","name":"Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults","year":"2017","cit":197,"pfa":"Randall Brown","psa":"Paul R. Hutson","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2600624779","eid":"W2600624779"},{"id":"paper-w2055277208","cat":"papers","name":"Role of the Serotonin 5-HT2AReceptor in Learning","year":"2003","cit":197,"pfa":"John A. Harvey","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W2055277208","eid":"W2055277208"},{"id":"paper-w1996014444","cat":"papers","name":"Black Cohosh Acts as a Mixed Competitive Ligand and Partial Agonist of the Serotonin Receptor","year":"2003","cit":197,"pfa":"Joanna E. Burdette","psa":"Judy L. Bolton","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1996014444","eid":"W1996014444"},{"id":"paper-w1837126245","cat":"papers","name":"Metabolism of methylenedioxymethamphetamine: formation of dihydroxymethamphetamine and a quinone identified as its glutathione adduct.","year":"1990","cit":197,"pfa":"Masayuki Hiramatsu","psa":"A K Cho","ptype":"article","src":"https://openalex.org/W1837126245","eid":"W1837126245"},{"id":"paper-w1852587300","cat":"papers","name":"Comparative neuropharmacology of three psychostimulant cathinone derivatives: butylone, mephedrone and methylone","year":"2012","cit":197,"pfa":"Raúl López‐Arnau","psa":"Jorge Camarasa","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1852587300","eid":"W1852587300"},{"id":"paper-w2211459448","cat":"papers","name":"Predicting the Abuse Liability of Drugs with Animal Drug Self-Administration Procedures: Psychomotor Stimulants and Hallucinogens","year":"1979","cit":197,"pfa":"Roland R. Griffiths","psa":"L. DiAnne Bradford","ptype":"book-chapter","src":"https://openalex.org/W2211459448","eid":"W2211459448"},{"id":"paper-w2008670721","cat":"papers","name":"Psychotomimetic opiate receptors labeled and visualized with (+)-[3H]3-(3-hydroxyphenyl)-N-(1-propyl)piperidine.","year":"1984","cit":197,"pfa":"Brian L. Largent","psa":"S H Snyder","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2008670721","eid":"W2008670721"},{"id":"paper-w2075552167","cat":"papers","name":"The Therapeutic Value of Lysergic Acid Diethylamide in Mental Illness","year":"1954","cit":196,"pfa":"R. A. Sandison","psa":"J. D. A. Whitelaw","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2075552167","eid":"W2075552167"},{"id":"paper-w2437289999","cat":"papers","name":"Incidence of Recreational Use of 3,4-Methylenedimethoxymethamphetamine (MDMA, Ecstasy) on an Undergraduate Campus","year":"1987","cit":196,"pfa":"Stephen J. Peroutka","ptype":"article","src":"https://openalex.org/W2437289999","eid":"W2437289999"},{"id":"paper-w2115308878","cat":"papers","name":"The Effects of the Preferential 5-HT2A Agonist Psilocybin on Prepulse Inhibition of Startle in Healthy Human Volunteers Depend on Interstimulus Interval","year":"2007","cit":196,"pfa":"Franz X. Vollenweider","psa":"Boris B. Quednow","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2115308878","eid":"W2115308878"},{"id":"paper-w1972726499","cat":"papers","name":"Course, Severity, and Treatment of Substance Abuse Among Women Versus Men","year":"2000","cit":196,"pfa":"Joseph John Westermeyer","psa":"Amy B. Mullens","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1972726499","eid":"W1972726499"},{"id":"paper-w2097570857","cat":"papers","name":"HIV-Associated Distal Sensory Polyneuropathy in the Era of Highly Active Antiretroviral Therapy","year":"2004","cit":196,"pfa":"Susan Morgello","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2097570857","eid":"W2097570857"},{"id":"paper-w2169268349","cat":"papers","name":"Effects of the plant-derived hallucinogen salvinorin A on basal dopamine levels in the caudate putamen and in a conditioned place aversion assay in mice: agonist actions at kappa opioid receptors","year":"2005","cit":195,"pfa":"Yong Zhang","psa":"Mary Jeanne Kreek","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2169268349","eid":"W2169268349"},{"id":"paper-w2131218306","cat":"papers","name":"Anorexia induced by activation of serotonin 5-HT 4 receptors is mediated by increases in CART in the nucleus accumbens","year":"2007","cit":195,"pfa":"Alexandra Jean","psa":"Valérie Compan","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2131218306","eid":"W2131218306"},{"id":"paper-w2075782291","cat":"papers","name":"Neurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamine","year":"2013","cit":195,"pfa":"Laura E. Halpin","psa":"Bryan K. Yamamoto","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2075782291","eid":"W2075782291"},{"id":"paper-w1969549633","cat":"papers","name":"Differential interactions of indolealkylamines with 5-hydroxytryptamine receptor subtypes","year":"1990","cit":195,"pfa":"Dennis J. McKenna","psa":"Stephen J. Peroutka","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1969549633","eid":"W1969549633"},{"id":"paper-w2085670677","cat":"papers","name":"Psychedelic N,N-Dimethyltryptamine and 5-Methoxy-N,N-Dimethyltryptamine Modulate Innate and Adaptive Inflammatory Responses through the Sigma-1 Receptor of Human Monocyte-Derived Dendritic Cells","year":"2014","cit":194,"pfa":"Attila Szabó","psa":"Éva Rajnavölgyi","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2085670677","eid":"W2085670677"},{"id":"paper-w2146563642","cat":"papers","name":"Effects and aftereffects of ibogaine on morphine self-administration in rats","year":"1991","cit":194,"pfa":"S.D. Glick","psa":"Jeffrey N. Carlson","ptype":"article","src":"https://openalex.org/W2146563642","eid":"W2146563642"},{"id":"paper-w2022056885","cat":"papers","name":"Neurotoxicity of MDMA (ecstasy): the limitations of scaling from animals to humans","year":"2004","cit":194,"pfa":"Rafael de la Torre","psa":"Magı́ Farré","topics":["Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W2022056885","eid":"W2022056885"},{"id":"paper-w2626493232","cat":"papers","name":"Cancer at the Dinner Table: Experiences of Psilocybin-Assisted Psychotherapy for the Treatment of Cancer-Related Distress","year":"2017","cit":194,"pfa":"Thomas Cody Swift","psa":"Stephen Ross","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2626493232","eid":"W2626493232"},{"id":"paper-w2022144436","cat":"papers","name":"3,4-Methylenedioxymethamphetamine (Ecstasy) and Alcohol Interactions in Humans: Psychomotor Performance, Subjective Effects, and Pharmacokinetics","year":"2002","cit":194,"pfa":"Cándido Hernández-López","psa":"Rafael de la Torre","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2022144436","eid":"W2022144436"},{"id":"paper-w2138494388","cat":"papers","name":"Relationship of ketamine's antidepressant and psychotomimetic effects in unipolar depression.","year":"2013","cit":194,"pfa":"P. Šóš","psa":"Tomáš Páleníček","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2138494388","eid":"W2138494388"},{"id":"paper-w2903713826","cat":"papers","name":"Activity-dependent brain-derived neurotrophic factor signaling is required for the antidepressant actions of (2 R ,6 R )-hydroxynorketamine","year":"2018","cit":194,"pfa":"Kenichi Fukumoto","psa":"Ronald S. Duman","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2903713826","eid":"W2903713826"},{"id":"paper-w2986296475","cat":"papers","name":"Efficacy and safety of adjunctive therapy using esketamine or racemic ketamine for adult treatment-resistant depression: A randomized, double-blind, non-inferiority study","year":"2019","cit":194,"pfa":"Fernanda S. Correia‐Melo","psa":"Lucas C. Quarantini","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2986296475","eid":"W2986296475"},{"id":"paper-w2158513208","cat":"papers","name":"Comparison of Pharmacological Activities of Three Distinct κ Ligands (Salvinorin A, TRK-820 and 3FLB) on κ Opioid Receptors in Vitro and Their Antipruritic and Antinociceptive Activities in Vivo","year":"2004","cit":193,"pfa":"Yu‐Lin Wang","psa":"Lee‐Yuan Liu‐Chen","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2158513208","eid":"W2158513208"},{"id":"paper-w2077218907","cat":"papers","name":"The Botany and Chemistry of Hallucinogens.","year":"1981","cit":193,"pfa":"Frank J. Lipp","psa":"Albert Hofmann","ptype":"article","src":"https://openalex.org/W2077218907","eid":"W2077218907"},{"id":"paper-w2163104737","cat":"papers","name":"Comorbidity of substance abuse and schizophrenia: the role of pre-morbid adjustment","year":"1992","cit":193,"pfa":"Stephan V. Arndt","psa":"Nancy C. Andreasen","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2163104737","eid":"W2163104737"},{"id":"paper-w2060150052","cat":"papers","name":"Randomized Proof of Concept Trial of GLYX-13, an N-Methyl-D-Aspartate Receptor Glycine Site Partial Agonist, in Major Depressive Disorder Nonresponsive to a Previous Antidepressant Agent","year":"2015","cit":193,"pfa":"Sheldon Preskorn","psa":"Ronald M. Burch","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2060150052","eid":"W2060150052"},{"id":"paper-w4383998917","cat":"papers","name":"Must Psilocybin Always “Assist Psychotherapy”?","year":"2023","cit":192,"pfa":"Guy M. Goodwin","psa":"Charles B. Nemeroff","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4383998917","eid":"W4383998917"},{"id":"paper-w2155890773","cat":"papers","name":"Cortical Serotonin Transporter Density and Verbal Memory in Individuals Who Stopped Using 3,4-Methylenedioxymethamphetamine (MDMA or \"Ecstasy\")","year":"2001","cit":192,"pfa":"Liesbeth Reneman","psa":"Jan Booij","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2155890773","eid":"W2155890773"},{"id":"paper-w3110820786","cat":"papers","name":"LSD alters dynamic integration and segregation in the human brain","year":"2020","cit":192,"pfa":"Andrea I. Luppi","psa":"Emmanuel Andreas Stamatakis","topics":["Addiction","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3110820786","eid":"W3110820786"},{"id":"paper-w2792211781","cat":"papers","name":"Altered network hub connectivity after acute LSD administration","year":"2018","cit":192,"pfa":"Felix Müller","psa":"Stefan Borgwardt","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2792211781","eid":"W2792211781"},{"id":"paper-w1493936182","cat":"papers","name":"Suicide attempts in major affective disorder patients with comorbid substance use disorders.","year":"1999","cit":192,"pfa":"Leonardo Tondo","psa":"Piero Mannu","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1493936182","eid":"W1493936182"},{"id":"paper-w4310708835","cat":"papers","name":"Effect of Intraoperative Esketamine Infusion on Postoperative Sleep Disturbance After Gynecological Laparoscopy","year":"2022","cit":192,"pfa":"Di Qiu","psa":"Jianjun Yang","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4310708835","eid":"W4310708835"},{"id":"paper-w2071614008","cat":"papers","name":"Correspondence between 5-HT2 receptors and serotonergic axons in rat neocortex","year":"1988","cit":192,"pfa":"Mary E. Blue","psa":"Mark E. Molliver","topics":["Mechanism & neuroscience"],"ptype":"letter","src":"https://openalex.org/W2071614008","eid":"W2071614008"},{"id":"paper-w3009076589","cat":"papers","name":"A single psilocybin dose is associated with long-term increased mindfulness, preceded by a proportional change in neocortical 5-HT2A receptor binding","year":"2020","cit":191,"pfa":"Martin Korsbak Madsen","psa":"Gitte M. Knudsen","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3009076589","eid":"W3009076589"},{"id":"paper-w2047427656","cat":"papers","name":"Effects of the 5-HT2A Agonist Psilocybin on Mismatch Negativity Generation and AX-Continuous Performance Task: Implications for the Neuropharmacology of Cognitive Deficits in Schizophrenia","year":"2003","cit":191,"pfa":"Daniel Umbricht","psa":"R. Koller","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2047427656","eid":"W2047427656"},{"id":"paper-w3001118513","cat":"papers","name":"Transformative experience and social connectedness mediate the mood-enhancing effects of psychedelic use in naturalistic settings","year":"2020","cit":191,"pfa":"Matthias Forstmann","psa":"Molly J. Crockett","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W3001118513","eid":"W3001118513"},{"id":"paper-w2793403693","cat":"papers","name":"Unifying Theories of Psychedelic Drug Effects","year":"2018","cit":191,"pfa":"Link Ray Swanson","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2793403693","eid":"W2793403693"},{"id":"paper-w1984596649","cat":"papers","name":"Effects of iboga alkaloids on morphine and cocaine self-administration in rats: relationship to tremorigenic effects and to effects on dopamine release in nucleus accumbens and striatum","year":"1994","cit":190,"pfa":"S.D. Glick","psa":"Jeffrey N. Carlson","ptype":"article","src":"https://openalex.org/W1984596649","eid":"W1984596649"},{"id":"paper-w1580711543","cat":"papers","name":"Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users","year":"2003","cit":190,"pfa":"Rainer Thomasius","psa":"Achim Schmoldt","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1580711543","eid":"W1580711543"},{"id":"paper-w2110876011","cat":"papers","name":"Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?","year":"2006","cit":190,"pfa":"Euphrosyne Gouzoulis‐Mayfrank","psa":"Jörg Daumann","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2110876011","eid":"W2110876011"},{"id":"paper-w2272492541","cat":"papers","name":"Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats.","year":"1990","cit":190,"pfa":"Clifton W. Callaway","psa":"Mark A. Geyer","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2272492541","eid":"W2272492541"},{"id":"paper-w2170871632","cat":"papers","name":"Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signalling","year":"2015","cit":190,"pfa":"Matthias E. Liechti","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2170871632","eid":"W2170871632"},{"id":"paper-w2900604419","cat":"papers","name":"Current perspectives on psychedelic therapy: use of serotonergic hallucinogens in clinical interventions","year":"2018","cit":190,"pfa":"Albert Garcia‐Romeu","psa":"William A. Richards","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2900604419","eid":"W2900604419"},{"id":"paper-w2551626080","cat":"papers","name":"Psychedelics in the treatment of unipolar mood disorders: a systematic review","year":"2016","cit":189,"pfa":"James Rucker","psa":"Allan Hunter Young","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W2551626080","eid":"W2551626080"},{"id":"paper-w1983135802","cat":"papers","name":"Antagonism of the effects of the hallucinogen dom and the purported 5-HT agonist quipazine by 5-HT2 antagonists","year":"1983","cit":189,"pfa":"Richard A. Glennon","psa":"John A. Rosecrans","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1983135802","eid":"W1983135802"},{"id":"paper-w2056429846","cat":"papers","name":"(±)3,4-Methylenedioxymethamphetamine (‘Ecstasy’)-Induced Serotonin Neurotoxicity: Clinical Studies","year":"2000","cit":189,"pfa":"Una D. McCann","psa":"George A. Ricaurte","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2056429846","eid":"W2056429846"},{"id":"paper-w2793644042","cat":"papers","name":"Psychedelics: Where we are now, why we got here, what we must do","year":"2018","cit":189,"pfa":"Sean J. Belouin","psa":"Jack E. Henningfield","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W2793644042","eid":"W2793644042"},{"id":"paper-w2181040265","cat":"papers","name":"Psychedelic medicine: a re-emerging therapeutic paradigm","year":"2015","cit":189,"pfa":"Kenneth W. Tupper","psa":"Matthew W. Johnson","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W2181040265","eid":"W2181040265"},{"id":"paper-w2139192721","cat":"papers","name":"Psychological and Cognitive Effects of Long-Term Peyote Use Among Native Americans","year":"2005","cit":188,"pfa":"John H. Halpern","psa":"Harrison Graham Pope","ptype":"article","src":"https://openalex.org/W2139192721","eid":"W2139192721"},{"id":"paper-w2068360712","cat":"papers","name":"Working memory deficits in current and previous users of MDMA (‘ecstasy’)","year":"2000","cit":188,"pfa":"Michelle Wareing","psa":"Philip N. Murphy","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2068360712","eid":"W2068360712"},{"id":"paper-w2133416128","cat":"papers","name":"Can Drugs Be Used to Enhance the Psychotherapeutic Process?","year":"1986","cit":188,"pfa":"Lester Grinspoon","psa":"James B. Bakalar","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2133416128","eid":"W2133416128"},{"id":"paper-w4387902564","cat":"papers","name":"Extended difficulties following the use of psychedelic drugs: A mixed methods study","year":"2023","cit":188,"pfa":"Jules Evans","psa":"Ed Prideaux","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4387902564","eid":"W4387902564"},{"id":"paper-w2063001012","cat":"papers","name":"Phencyclidine and psychotomimetic sigma opiates: recent insights into their biochemical and physiological sites of action","year":"1988","cit":188,"pfa":"Mark S. Sonders","psa":"Eckard Weber","ptype":"review","src":"https://openalex.org/W2063001012","eid":"W2063001012"},{"id":"paper-w3045249492","cat":"papers","name":"The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis","year":"2020","cit":188,"pfa":"Roger S. McIntyre","psa":"Joshua Daniel Rosenblat","topics":["Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W3045249492","eid":"W3045249492"},{"id":"paper-w3025824861","cat":"papers","name":"Psilocybin: from ancient magic to modern medicine","year":"2020","cit":187,"pfa":"David E. Nichols","ptype":"article","src":"https://openalex.org/W3025824861","eid":"W3025824861"},{"id":"paper-w1992085755","cat":"papers","name":"Causes and consequences of methamphetamine and MDMA toxicity","year":"2006","cit":187,"pfa":"Maria S. Quinton","psa":"Bryan K. Yamamoto","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1992085755","eid":"W1992085755"},{"id":"paper-w2058609816","cat":"papers","name":"A Method of Conducting Therapeutic Sessions with MDMA","year":"1998","cit":187,"pfa":"George R. Greer","psa":"Requa Tolbert","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2058609816","eid":"W2058609816"},{"id":"paper-w1514792206","cat":"papers","name":"Human psychobiology of MDMA or ‘Ecstasy’: an overview of 25 years of empirical research","year":"2013","cit":187,"pfa":"Andrew C. Parrott","topics":["Addiction","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1514792206","eid":"W1514792206"},{"id":"paper-w3213378850","cat":"papers","name":"Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double‐Blind, Placebo‐Controlled, Crossover Study in Healthy Subjects","year":"2021","cit":187,"pfa":"A. Becker","psa":"Matthias E. Liechti","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3213378850","eid":"W3213378850"},{"id":"paper-w2095225260","cat":"papers","name":"Psychotomimetic N -Methylated Tryptamines: Formation in Brain in vivo and in vitro","year":"1972","cit":187,"pfa":"Juan M. Saavedra","psa":"Julius Axelrod","ptype":"article","src":"https://openalex.org/W2095225260","eid":"W2095225260"},{"id":"paper-w2014460982","cat":"papers","name":"Diversity of Psychopathology Associated with use of 3,4-Methylenedioxymethamphetamine (‘Ecstasy’)","year":"1994","cit":187,"pfa":"Philip K. McGuire","psa":"Thomas A. Fahy","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W2014460982","eid":"W2014460982"},{"id":"paper-w2086037111","cat":"papers","name":"Long-Lasting Psychotomimetic Consequences of Repeated Low-Dose Amphetamine Exposure in Rhesus Monkeys","year":"1999","cit":186,"pfa":"Stacy A. Castner","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2086037111","eid":"W2086037111"},{"id":"paper-w2049804872","cat":"papers","name":"Depression of rat brain tryptophan hydroxylase activity following the acute administration of methylenedioxymethamphetamine","year":"1987","cit":186,"pfa":"Christopher J. Schmidt","psa":"Vicki L. Taylor","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2049804872","eid":"W2049804872"},{"id":"paper-w3026344230","cat":"papers","name":"Association of Ketamine With Psychiatric Symptoms and Implications for Its Therapeutic Use and for Understanding Schizophrenia","year":"2020","cit":186,"pfa":"Katherine Beck","psa":"Oliver Howes","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3026344230","eid":"W3026344230"},{"id":"paper-w1977688928","cat":"papers","name":"The ibogaine medical subculture","year":"2007","cit":185,"pfa":"Kenneth Alper","psa":"Charles D. Kaplan","ptype":"article","src":"https://openalex.org/W1977688928","eid":"W1977688928"},{"id":"paper-w1996737495","cat":"papers","name":"Biosynthesis of Indole Alkaloids. The Aspidosperma and Iboga Bases","year":"1962","cit":185,"pfa":"Ernest Wenkert","ptype":"article","src":"https://openalex.org/W1996737495","eid":"W1996737495"},{"id":"paper-w2043768758","cat":"papers","name":"Mescaline-induced psychopathological, neuropsychological, and neurometabolic effects in normal subjects: Experimental psychosis as a tool for psychiatric research","year":"1992","cit":185,"pfa":"Leo Hermle","psa":"Manfred Spitzer","ptype":"article","src":"https://openalex.org/W2043768758","eid":"W2043768758"},{"id":"paper-w2604795661","cat":"papers","name":"Dreamlike effects of LSD on waking imagery in humans depend on serotonin 2A receptor activation","year":"2017","cit":185,"pfa":"Rainer Krähenmann","psa":"Franz X. Vollenweider","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2604795661","eid":"W2604795661"},{"id":"paper-w2131411880","cat":"papers","name":"A Clinical and Metabolic Study of Acute Intoxication with Cannabis Sativa and its Role in the Model Psychoses","year":"1958","cit":185,"pfa":"Frances R. Ames","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2131411880","eid":"W2131411880"},{"id":"paper-w2894541203","cat":"papers","name":"Awe: a putative mechanism underlying the effects of classic psychedelic-assisted psychotherapy","year":"2018","cit":185,"pfa":"Peter S. Hendricks","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2894541203","eid":"W2894541203"},{"id":"paper-w2018267671","cat":"papers","name":"Single Versus Repeated Sessions of Ketamine-Assisted Psychotherapy for People with Heroin Dependence","year":"2007","cit":185,"pfa":"Evgeny M. Krupitsky","psa":"A. Y. Grinenko","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2018267671","eid":"W2018267671"},{"id":"paper-w1982300225","cat":"papers","name":"Supplementing Desflurane-Remifentanil Anesthesia with Small-Dose Ketamine Reduces Perioperative Opioid Analgesic Requirements","year":"2002","cit":185,"pfa":"B. Guignard","psa":"MARCEL CHAUVIN","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1982300225","eid":"W1982300225"},{"id":"paper-w2117600795","cat":"papers","name":"Frontal Responses During Learning Predict Vulnerability to the Psychotogenic Effects of Ketamine","year":"2006","cit":185,"pfa":"Philip Robert Corlett","psa":"Paul Charles Fletcher","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2117600795","eid":"W2117600795"},{"id":"paper-w2126551481","cat":"papers","name":"Family-Based Analysis of Genetic Variation Underlying Psychosis-Inducing Effects of Cannabis Sibling Analysis and Proband Follow-up Genetic Variation Underlying Cannabis Effects","year":"2010","cit":185,"pfa":"Ruud van Winkel","topics":["Safety & adverse events","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2126551481","eid":"W2126551481"},{"id":"paper-w1766588580","cat":"papers","name":"100 years of ibogaine: neurochemical and pharmacological actions of a putative anti-addictive drug.","year":"1995","cit":184,"pfa":"Piotr Popik","psa":"Phil Skolnick","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1766588580","eid":"W1766588580"},{"id":"paper-w2010261402","cat":"papers","name":"Enzymatic Formation of Psychotomimetic Metabolites from Normally Occurring Compounds","year":"1961","cit":184,"pfa":"Julius Axelrod","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2010261402","eid":"W2010261402"},{"id":"paper-w2117805673","cat":"papers","name":"Two members of a distinct subfamily of 5-hydroxytryptamine receptors differentially expressed in rat brain.","year":"1993","cit":184,"pfa":"MG Erlander","psa":"Kurt S. Cannon","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2117805673","eid":"W2117805673"},{"id":"paper-w2097563002","cat":"papers","name":"The Effects of Acutely Administered 3,4-Methylenedioxymethamphetamine on Spontaneous Brain Function in Healthy Volunteers Measured with Arterial Spin Labeling and Blood Oxygen Level–Dependent Resting State Functional Con","year":"2014","cit":184,"pfa":"Robin Lester Carhart-Harris","psa":"David Nutt","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2097563002","eid":"W2097563002"},{"id":"paper-w2090037933","cat":"papers","name":"Glial Cell Line-Derived Neurotrophic Factor Mediates the Desirable Actions of the Anti-Addiction Drug Ibogaine against Alcohol Consumption","year":"2005","cit":183,"pfa":"Dao‐Yao He","psa":"Dorit Ron","topics":["Addiction","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2090037933","eid":"W2090037933"},{"id":"paper-w4310940483","cat":"papers","name":"Psychedelic Drug Legislative Reform and Legalization in the US","year":"2022","cit":183,"pfa":"Joshua S. Siegel","psa":"Ginger E. Nicol","topics":["Reviews & meta-analyses","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4310940483","eid":"W4310940483"},{"id":"paper-w2105625596","cat":"papers","name":"Role of endogenous dopamine in the central serotonergic deficits induced by 3,4-methylenedioxymethamphetamine.","year":"1988","cit":183,"pfa":"Donna M. Stone","psa":"James W. Gibb","ptype":"article","src":"https://openalex.org/W2105625596","eid":"W2105625596"},{"id":"paper-w2045165986","cat":"papers","name":"Effects of 5‐HT uptake inhibitors, agonists and antagonists on the burying of harmless objects by mice; a putative test for anxiolytic agents","year":"1991","cit":183,"pfa":"K. Njung'e","psa":"Sheila L. Handley","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2045165986","eid":"W2045165986"},{"id":"paper-w2951080359","cat":"papers","name":"Exploring the effect of microdosing psychedelics on creativity in an open-label natural setting","year":"2018","cit":183,"pfa":"Luisa Prochazkova","psa":"Bernhard Hommel","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2951080359","eid":"W2951080359"},{"id":"paper-w2074225517","cat":"papers","name":"\"Psychedelic\" Experiences in Acute Psychoses","year":"1966","cit":183,"pfa":"Malcolm B. Bowers","ptype":"article","src":"https://openalex.org/W2074225517","eid":"W2074225517"},{"id":"paper-w2136433757","cat":"papers","name":"Microdose Lithium Treatment Stabilized Cognitive Impairment in Patients with Alzheimer’s Disease","year":"2013","cit":183,"pfa":"Marielza Andrade Nunes","psa":"Hudson Sousa Buck","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2136433757","eid":"W2136433757"},{"id":"paper-w2154948759","cat":"papers","name":"Substance Dependence and Other Psychiatric Disorders Among Drug Dependent Subjects: Race and Gender Correlates","year":"2000","cit":183,"pfa":"Wilson M. Compton","psa":"Joseph C. Horton","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2154948759","eid":"W2154948759"},{"id":"paper-w2110735681","cat":"papers","name":"Ketamine and phencyclidine: the good, the bad and the unexpected","year":"2015","cit":183,"pfa":"David Lodge","psa":"M S Mercier","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2110735681","eid":"W2110735681"},{"id":"paper-w2785254539","cat":"papers","name":"Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness","year":"2018","cit":182,"pfa":"Jonathan Hamill","psa":"Glen B. Baker","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2785254539","eid":"W2785254539"},{"id":"paper-w2014352799","cat":"papers","name":"Neurochemistry and Neurotoxicity of 3,4‐Methylenedioxymethamphetamine (MDMA, “Ecstasy”)","year":"1990","cit":182,"pfa":"Dennis J. McKenna","psa":"Stephen J. Peroutka","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2014352799","eid":"W2014352799"},{"id":"paper-w2116910569","cat":"papers","name":"Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA (\"ecstasy\") polydrug users","year":"2002","cit":182,"pfa":"Helen C Fox","psa":"Barbara Jacquelyn Sahakian","ptype":"article","src":"https://openalex.org/W2116910569","eid":"W2116910569"},{"id":"paper-w1993036354","cat":"papers","name":"3,4-Methylenedioxymethamphetamine induces monoamine release, but not toxicity, when administered centrally at a concentration occurring following a peripherally injected neurotoxic dose","year":"2001","cit":182,"pfa":"B. Moreno Esteban","psa":"M. Isabel Colado","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1993036354","eid":"W1993036354"},{"id":"paper-w1981095245","cat":"papers","name":"Immediate and long-term effects of 3,4-methylenedioxymethamphetamine on serotonin pathways in brain of rat","year":"1987","cit":182,"pfa":"Donna M. Stone","psa":"James W. Gibb","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1981095245","eid":"W1981095245"},{"id":"paper-w1524042458","cat":"papers","name":"Comprehensive handbook of drug and alcohol addiction","year":"1991","cit":182,"pfa":"Norman Stanley Miller","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1524042458","eid":"W1524042458"},{"id":"paper-w2631673659","cat":"papers","name":"Effects of a ketamine metabolite on synaptic NMDAR function","year":"2017","cit":182,"pfa":"Kanzo Suzuki","psa":"Lisa M. Monteggia","ptype":"article","src":"https://openalex.org/W2631673659","eid":"W2631673659"},{"id":"paper-w2146866952","cat":"papers","name":"The subjective effects of MDMA and mCPP in moderate MDMA users","year":"2001","cit":181,"pfa":"Manuel E. Tancer","psa":"Chris‐Ellyn Johanson","ptype":"article","src":"https://openalex.org/W2146866952","eid":"W2146866952"},{"id":"paper-w4293194637","cat":"papers","name":"Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review","year":"2022","cit":181,"pfa":"Joost J. Breeksema","psa":"Robert A. Schoevers","topics":["Anxiety & end-of-life","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4293194637","eid":"W4293194637"},{"id":"paper-w2026552798","cat":"papers","name":"A bitter pill. Overview of ecstasy (MDMA, MDA) related fatalities","year":"2004","cit":181,"pfa":"Fabrizio Schifano","ptype":"article","src":"https://openalex.org/W2026552798","eid":"W2026552798"},{"id":"paper-w2124305193","cat":"papers","name":"THE EFFECTS OF METHYLENEDIOXYMETHAMPHETAMINE (MDMA, “ECSTASY”) ON MONOAMINERGIC NEUROTRANSMISSION IN THE CENTRAL NERVOUS SYSTEM","year":"1996","cit":181,"pfa":"S.R. White","ptype":"article","src":"https://openalex.org/W2124305193","eid":"W2124305193"},{"id":"paper-w2981695213","cat":"papers","name":"Characterization and prediction of acute and sustained response to psychedelic psilocybin in a mindfulness group retreat","year":"2019","cit":181,"pfa":"Lukasz Smigielski","psa":"Franz X. Vollenweider","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2981695213","eid":"W2981695213"},{"id":"paper-w2990240756","cat":"papers","name":"Therapeutic Use of LSD in Psychiatry: A Systematic Review of Randomized-Controlled Clinical Trials","year":"2020","cit":181,"pfa":"Juan José Fuentes","psa":"Marta Torrens","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"review","src":"https://openalex.org/W2990240756","eid":"W2990240756"},{"id":"paper-w1211550181","cat":"papers","name":"An integrated hypothesis for the serotonergic axonal loss induced by 3,4-methylenedioxymethamphetamine.","year":"1998","cit":181,"pfa":"Jon E. Sprague","psa":"David E. Nichols","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1211550181","eid":"W1211550181"},{"id":"paper-w625244993","cat":"papers","name":"Hallucinogens and culture","year":"1976","cit":181,"pfa":"Peter T. Furst","ptype":"book","src":"https://openalex.org/W625244993","eid":"W625244993"},{"id":"paper-w2074485067","cat":"papers","name":"A latent class analysis of illicit drug abuse/dependence: results from the National Epidemiological Survey on Alcohol and Related Conditions","year":"2006","cit":181,"pfa":"Arpana Agrawal","psa":"Andrew C. Heath","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2074485067","eid":"W2074485067"},{"id":"paper-w2119123878","cat":"papers","name":"Fatty acids and oxidative stress in psychiatric disorders","year":"2008","cit":181,"pfa":"Sofia Tsaluchidu","psa":"Basant K. Puri","topics":["Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2119123878","eid":"W2119123878"},{"id":"paper-w2945335566","cat":"papers","name":"Acute Subjective and Behavioral Effects of Microdoses of Lysergic Acid Diethylamide in Healthy Human Volunteers","year":"2019","cit":180,"pfa":"Anya K. Bershad","psa":"Harriet de Wit","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2945335566","eid":"W2945335566"},{"id":"paper-w2066213523","cat":"papers","name":"A review of the mechanisms involved in the acute MDMA (ecstasy)-induced hyperthermic response","year":"2004","cit":180,"pfa":"A. Richard Green","psa":"M. Isabel Colado","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2066213523","eid":"W2066213523"},{"id":"paper-w1993455459","cat":"papers","name":"The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview","year":"2006","cit":180,"pfa":"Euphrosyne Gouzoulis‐Mayfrank","psa":"Jörg Daumann","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1993455459","eid":"W1993455459"},{"id":"paper-w2784860341","cat":"papers","name":"Increased nature relatedness and decreased authoritarian political views after psilocybin for treatment-resistant depression","year":"2018","cit":180,"pfa":"Taylor Lyons","psa":"Robin Lester Carhart-Harris","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2784860341","eid":"W2784860341"},{"id":"paper-w2093897431","cat":"papers","name":"Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain","year":"1987","cit":180,"pfa":"Thomas Steele","psa":"George K. W. Yim","ptype":"article","src":"https://openalex.org/W2093897431","eid":"W2093897431"},{"id":"paper-w2024845040","cat":"papers","name":"Pharmacology of MDMA in Humans","year":"2000","cit":179,"pfa":"Rafael de la Torre","psa":"Jordi Camı́","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2024845040","eid":"W2024845040"},{"id":"paper-w2885412565","cat":"papers","name":"N, N-Dimethyltryptamine (DMT), an Endogenous Hallucinogen: Past, Present, and Future Research to Determine Its Role and Function","year":"2018","cit":179,"pfa":"Steven A. Barker","ptype":"article","src":"https://openalex.org/W2885412565","eid":"W2885412565"},{"id":"paper-w2044307156","cat":"papers","name":"RETRACTED: Severe Dopaminergic Neurotoxicity in Primates After a Common Recreational Dose Regimen of MDMA (\"Ecstasy\")","year":"2002","cit":179,"pfa":"George A. Ricaurte","psa":"Una D. McCann","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2044307156","eid":"W2044307156"},{"id":"paper-w2075886166","cat":"papers","name":"Inhibitory effect of chlorpromazine on the syndrome of hyperactivity produced by l ‐tryptophan or 5‐methoxy‐N,N‐dimethyltryptamine in rats treated with a monoamine oxidase inhibitor","year":"1971","cit":179,"pfa":"A. David Smith","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2075886166","eid":"W2075886166"},{"id":"paper-w4319067008","cat":"papers","name":"Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life","year":"2023","cit":179,"pfa":"Guy M. Goodwin","psa":"Ekaterina Malievskaia","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4319067008","eid":"W4319067008"},{"id":"paper-w1885853127","cat":"papers","name":"Elevation of serum prolactin and corticosterone concentrations in the rat after the administration of 3,4-methylenedioxymethamphetamine.","year":"1988","cit":179,"pfa":"J. Frank Nash","psa":"Gary A. Gudelsky","ptype":"article","src":"https://openalex.org/W1885853127","eid":"W1885853127"},{"id":"paper-w2030724156","cat":"papers","name":"Improved controlled ovarian hyperstimulation in poor responder in vitro fertilization patients with a microdose follicle-stimulating hormone flare, growth hormone protocol","year":"1997","cit":179,"pfa":"William B. Schoolcraft","psa":"Lyla Wagley","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2030724156","eid":"W2030724156"},{"id":"paper-w2164606563","cat":"papers","name":"A Direct Interaction of PSD-95 with 5-HT2A Serotonin Receptors Regulates Receptor Trafficking and Signal Transduction","year":"2003","cit":179,"pfa":"Zongqi Xia","psa":"Bryan L. Roth","topics":["Depression","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2164606563","eid":"W2164606563"},{"id":"paper-w2306810735","cat":"papers","name":"Inhibition of alpha oscillations through serotonin-2A receptor activation underlies the visual effects of ayahuasca in humans","year":"2016","cit":178,"pfa":"Marta Valle","psa":"Jordi Riba","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2306810735","eid":"W2306810735"},{"id":"paper-w2917218353","cat":"papers","name":"Sub-Acute Effects of Psilocybin on Empathy, Creative Thinking, and Subjective Well-Being","year":"2019","cit":178,"pfa":"Natasha Leigh Mason","psa":"Kim P. C. Kuypers","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2917218353","eid":"W2917218353"},{"id":"paper-w2948924404","cat":"papers","name":"Modulation of Serum Brain-Derived Neurotrophic Factor by a Single Dose of Ayahuasca: Observation From a Randomized Controlled Trial","year":"2019","cit":178,"pfa":"Raíssa Nóbrega de Almeida","psa":"Nicole Leite Galvão Coelho","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2948924404","eid":"W2948924404"},{"id":"paper-w2048412304","cat":"papers","name":"Effects of certain hallucinogenic amphetamine analogs on the release of [3H]-serotonin from rat brain synaptosomes","year":"1982","cit":178,"pfa":"David E. Nichols","psa":"George K. W. Yim","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2048412304","eid":"W2048412304"},{"id":"paper-w2980779999","cat":"papers","name":"Transition of Substance-Induced, Brief, and Atypical Psychoses to Schizophrenia: A Systematic Review and Meta-analysis","year":"2019","cit":178,"pfa":"Benjamin Murrie","psa":"Grant E. Sara","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W2980779999","eid":"W2980779999"},{"id":"paper-w2146645762","cat":"papers","name":"A randomized add-on trial of high-dose d-cycloserine for treatment-resistant depression","year":"2012","cit":178,"pfa":"Uriel Heresco‐Levy","psa":"Ilana Kremer","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2146645762","eid":"W2146645762"},{"id":"paper-w2068032560","cat":"papers","name":"Sub-anesthetic concentrations of (R,S)-ketamine metabolites inhibit acetylcholine-evoked currents in α7 nicotinic acetylcholine receptors","year":"2012","cit":178,"pfa":"Ruin Moaddel","psa":"Irving W. Wainer","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2068032560","eid":"W2068032560"},{"id":"paper-w2058472215","cat":"papers","name":"Increased serotonin2 (5-HT2) receptor binding as measured by 3H-lysergic acid diethylamide (3H-LSD) in the blood platelets of depressed patients","year":"1989","cit":176,"pfa":"Ramesh Arora","psa":"Herbert Y. Meltzer","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2058472215","eid":"W2058472215"},{"id":"paper-w2045711013","cat":"papers","name":"Inhibitory effects of ibogaine on cocaine self-administration in rats","year":"1993","cit":176,"pfa":"Susanne L.T. Cappendijk","psa":"Michailo R. Dzoljic","ptype":"article","src":"https://openalex.org/W2045711013","eid":"W2045711013"},{"id":"paper-w4384130479","cat":"papers","name":"Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication","year":"2023","cit":176,"pfa":"Guy M. Goodwin","psa":"Ekaterina Malievskaia","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4384130479","eid":"W4384130479"},{"id":"paper-w2066189612","cat":"papers","name":"Localization of MDMA‐induced brain activity in healthy volunteers using low resolution brain electromagnetic tomography (LORETA)","year":"2001","cit":176,"pfa":"Edi Frei","psa":"Franz X. Vollenweider","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2066189612","eid":"W2066189612"},{"id":"paper-w2079883338","cat":"papers","name":"Psychobiologic effects of 3,4-methylenedioxymethamphetamine in humans: methodological considerations and preliminary observations","year":"1995","cit":176,"pfa":"Charles S. Grob","psa":"Thomas Ernst","ptype":"article","src":"https://openalex.org/W2079883338","eid":"W2079883338"},{"id":"paper-w2336591896","cat":"papers","name":"Effects of serotonin 2A/1A receptor stimulation on social exclusion processing","year":"2016","cit":176,"pfa":"Katrin H. Preller","psa":"Franz X. Vollenweider","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2336591896","eid":"W2336591896"},{"id":"paper-w3093676138","cat":"papers","name":"Making “bad trips” good: How users of psychedelics narratively transform challenging trips into valuable experiences","year":"2020","cit":176,"pfa":"Liridona Gashi","psa":"Willy Pedersen","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3093676138","eid":"W3093676138"},{"id":"paper-w42904912","cat":"papers","name":"Platelet serotonin-2A receptors: a potential biological marker for suicidal behavior","year":"1995","cit":176,"pfa":"G.N. Pandey","psa":"John M. Davis","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W42904912","eid":"W42904912"},{"id":"paper-w2126900649","cat":"papers","name":"Psychedelic 5-Methoxy-N,N-Dimethyltryptamine: Metabolism, Pharmacokinetics, Drug Interactions, and Pharmacological Actions","year":"2010","cit":175,"pfa":"Hong-Wu Shen","psa":"Ai‐Ming Yu","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2126900649","eid":"W2126900649"},{"id":"paper-w2801418002","cat":"papers","name":"Effects of N,N-Dimethyltryptamine on Rat Behaviors Relevant to Anxiety and Depression","year":"2018","cit":175,"pfa":"Lindsay P. Cameron","psa":"David E. Olson","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2801418002","eid":"W2801418002"},{"id":"paper-w2728001011","cat":"papers","name":"The alkaloids of Banisteriopsis caapi, the plant source of the Amazonian hallucinogen Ayahuasca, stimulate adult neurogenesis in vitro","year":"2017","cit":175,"pfa":"Jose Angel Morales-Garcia","psa":"Jordi Riba","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2728001011","eid":"W2728001011"},{"id":"paper-w2027863825","cat":"papers","name":"A study of the neurotoxic effect of MDMA (‘ecstasy’) on 5‐HT neurones in the brains of mothers and neonates following administration of the drug during pregnancy","year":"1997","cit":175,"pfa":"M. Isabel Colado","psa":"A.R. Green","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2027863825","eid":"W2027863825"},{"id":"paper-w2016574995","cat":"papers","name":"“Ayahuasca,” the South American hallucinogenic drink: An ethnobotanical and chemical investigation","year":"1972","cit":174,"pfa":"Laurent Rivier","psa":"Jan‐Erik Lindgren","ptype":"article","src":"https://openalex.org/W2016574995","eid":"W2016574995"},{"id":"paper-w2984820573","cat":"papers","name":"Psilocybin-assisted therapy of major depressive disorder using Acceptance and Commitment Therapy as a therapeutic frame","year":"2019","cit":174,"pfa":"Jordan Sloshower","psa":"Matthew D. Skinta","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2984820573","eid":"W2984820573"},{"id":"paper-w3118498264","cat":"papers","name":"Development of the Psychological Insight Questionnaire among a sample of people who have consumed psilocybin or LSD","year":"2021","cit":174,"pfa":"Alan K. Davis","psa":"Roland R. Griffiths","ptype":"article","src":"https://openalex.org/W3118498264","eid":"W3118498264"},{"id":"paper-w2081349320","cat":"papers","name":"In vivo evidence for free radical involvement in the degeneration of rat brain 5‐HT following administration of MDMA (‘ecstasy’) and p‐chloroamphetamine but not the degeneration following fenfluramine","year":"1997","cit":174,"pfa":"María Isabel Colado","psa":"A R Green","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2081349320","eid":"W2081349320"},{"id":"paper-w2903300049","cat":"papers","name":"The effects of microdose LSD on time perception: a randomised, double-blind, placebo-controlled trial","year":"2018","cit":174,"pfa":"Steliana Yanakieva","psa":"Devin Blair Terhune","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2903300049","eid":"W2903300049"},{"id":"paper-w1480251240","cat":"papers","name":"From ultrasocial to antisocial: a role for oxytocin in the acute reinforcing effects and long‐term adverse consequences of drug use?","year":"2008","cit":174,"pfa":"Iain S. McGregor","psa":"Glenn E. Hunt","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W1480251240","eid":"W1480251240"},{"id":"paper-w2790481213","cat":"papers","name":"Hallucinogen Persisting Perception Disorder: Etiology, Clinical Features, and Therapeutic Perspectives","year":"2018","cit":174,"pfa":"Giovanni Martinotti","psa":"Arturo Lerner","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2790481213","eid":"W2790481213"},{"id":"paper-w1994495174","cat":"papers","name":"Serotonin, But Not N -Methyltryptamines, Activates the Serotonin 2A Receptor Via a β-Arrestin2/Src/Akt Signaling Complex In Vivo","year":"2010","cit":174,"pfa":"Cullen L. Schmid","psa":"Laura Bohn","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1994495174","eid":"W1994495174"},{"id":"paper-w4385556714","cat":"papers","name":"Ketamine for the treatment of major depression: a systematic review and meta-analysis","year":"2023","cit":174,"pfa":"Stevan Nikolin","psa":"Colleen K A Loo","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W4385556714","eid":"W4385556714"},{"id":"paper-w1973082508","cat":"papers","name":"Intracellular recordings from serotonergic dorsal raphe neurons: pacemaker potentials and the effects of LSD","year":"1982","cit":174,"pfa":"George K. Aghajanian","psa":"Cam P. VanderMaelen","ptype":"article","src":"https://openalex.org/W1973082508","eid":"W1973082508"},{"id":"paper-w2968540378","cat":"papers","name":"Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-Assisted Psychotherapy Compared to Paroxetine and Sertraline","year":"2019","cit":173,"pfa":"Allison A. Feduccia","psa":"Rick Doblin","topics":["PTSD & trauma","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2968540378","eid":"W2968540378"},{"id":"paper-w2907379922","cat":"papers","name":"Microdosing psychedelics: personality, mental health, and creativity differences in microdosers","year":"2019","cit":173,"pfa":"Thomas Anderson","psa":"Norman A. S. Farb","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2907379922","eid":"W2907379922"},{"id":"paper-w1980171233","cat":"papers","name":"Low-dose MDMA (“ecstasy”) induces vasopressin secretion","year":"1998","cit":172,"pfa":"John Aaron Henry","psa":"Mary L. Forsling","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1980171233","eid":"W1980171233"},{"id":"paper-w3107917596","cat":"papers","name":"MDMA-assisted psychotherapy for treatment of anxiety and other psychological distress related to life-threatening illnesses: a randomized pilot study","year":"2020","cit":172,"pfa":"Philip E. Wolfson","psa":"Rick Doblin","topics":["Depression","Anxiety & end-of-life","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3107917596","eid":"W3107917596"},{"id":"paper-w2003954063","cat":"papers","name":"Preferential action of 5-methoxytryptamine and 5-methoxydimethyltryptamine on presynaptic serotonin receptors: A comparative iontophoretic study with LSD and serotonin","year":"1977","cit":172,"pfa":"Claude de Montigny","psa":"George K. Aghajanian","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2003954063","eid":"W2003954063"},{"id":"paper-w4281891940","cat":"papers","name":"Psychedelic-Assisted Psychotherapy—A Systematic Review of Associated Psychological Interventions","year":"2022","cit":172,"pfa":"Mauro Cavarra","psa":"Carmela Mento","topics":["Reviews & meta-analyses","Therapy practice"],"ptype":"review","src":"https://openalex.org/W4281891940","eid":"W4281891940"},{"id":"paper-w2995530735","cat":"papers","name":"The effectiveness of a low-dose esketamine versus an alfentanil adjunct to propofol sedation during endoscopic retrograde cholangiopancreatography","year":"2019","cit":172,"pfa":"Susanne Eberl","psa":"Benedikt Preckel","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2995530735","eid":"W2995530735"},{"id":"paper-w2031549189","cat":"papers","name":"Chronic 3,4-Methylenedioxymethamphetamine (MDMA) Use: Effects on Mood and Neuropsychological Function?","year":"1992","cit":171,"pfa":"John Harrison Krystal","psa":"George R. Heninger","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2031549189","eid":"W2031549189"},{"id":"paper-w2002062361","cat":"papers","name":"Acute, sub‐acute and long‐term subjective consequences of ‘ecstasy’ (MDMA) consumption in 430 regular users","year":"2003","cit":171,"pfa":"Suzanne L. Verheyden","psa":"Helen Valerie Curran","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W2002062361","eid":"W2002062361"},{"id":"paper-w1545991786","cat":"papers","name":"Hallucinogens, cross-cultural perspectives","year":"1984","cit":171,"pfa":"Marlene Dobkin de Ríos","ptype":"book","src":"https://openalex.org/W1545991786","eid":"W1545991786"},{"id":"paper-w4389793820","cat":"papers","name":"Identification of 5-HT2A receptor signaling pathways associated with psychedelic potential","year":"2023","cit":171,"pfa":"Jason V. Wallach","psa":"John D. McCorvy","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4389793820","eid":"W4389793820"},{"id":"paper-w2416665044","cat":"papers","name":"Pimavanserin: An Inverse Agonist Antipsychotic Drug","year":"2016","cit":171,"pfa":"Robert H. Howland","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2416665044","eid":"W2416665044"},{"id":"paper-w2589381868","cat":"papers","name":"Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies","year":"2017","cit":170,"pfa":"RAFAEL GUIMARÃES DOS SANTOS","psa":"Jaime E. C. Hallak","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W2589381868","eid":"W2589381868"},{"id":"paper-w2167295928","cat":"papers","name":"Depressive-like effects of the kappa opioid receptor agonist salvinorin A are associated with decreased phasic dopamine release in the nucleus accumbens","year":"2010","cit":170,"pfa":"Stephanie R. Ebner","psa":"Elena H. Chartoff","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2167295928","eid":"W2167295928"},{"id":"paper-w2919894573","cat":"papers","name":"Chronic, Intermittent Microdoses of the Psychedelic N , N -Dimethyltryptamine (DMT) Produce Positive Effects on Mood and Anxiety in Rodents","year":"2019","cit":170,"pfa":"Lindsay P. Cameron","psa":"David E. Olson","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2919894573","eid":"W2919894573"},{"id":"paper-w4295136939","cat":"papers","name":"Signaling snapshots of a serotonin receptor activated by the prototypical psychedelic LSD","year":"2022","cit":170,"pfa":"Can Cao","psa":"Bryan L. Roth","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4295136939","eid":"W4295136939"},{"id":"paper-w2335147441","cat":"papers","name":"Sigma Receptors Inhibit High-Voltage–Activated Calcium Channels in Rat Sympathetic and Parasympathetic Neurons","year":"2002","cit":170,"pfa":"Hongling Zhang","psa":"Javier Cuevas","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2335147441","eid":"W2335147441"},{"id":"paper-w4361301344","cat":"papers","name":"Studying Harms Is Key to Improving Psychedelic-Assisted Therapy—Participants Call for Changes to Research Landscape","year":"2023","cit":170,"pfa":"Sarah McNamee","psa":"Meaghan Buisson","topics":["Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4361301344","eid":"W4361301344"},{"id":"paper-w4289745468","cat":"papers","name":"Psychedelic integration: An analysis of the concept and its practice","year":"2022","cit":170,"pfa":"Geoff J. Bathje","psa":"Mesphina Kudowor","topics":["Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4289745468","eid":"W4289745468"},{"id":"paper-w1774425324","cat":"papers","name":"Multiple Limbic Regions Mediate the Disruption of Prepulse Inhibition Produced in Rats by the Noncompetitive NMDA Antagonist Dizocilpine","year":"1998","cit":170,"pfa":"Vaishali P. Bakshi","psa":"Mark A. Geyer","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1774425324","eid":"W1774425324"},{"id":"paper-w1962432588","cat":"papers","name":"Ayahuasca Shamanism in the Amazon and Beyond","year":"2014","cit":169,"topics":["Safety & adverse events","Policy & ethics"],"ptype":"book","src":"https://openalex.org/W1962432588","eid":"W1962432588"},{"id":"paper-w1973743872","cat":"papers","name":"Repeated doses administration of MDMA in humans: pharmacological effects and pharmacokinetics","year":"2004","cit":169,"pfa":"Magı́ Farré","psa":"Jordi Camı́","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1973743872","eid":"W1973743872"},{"id":"paper-w2789706157","cat":"papers","name":"Solution of the multistep pathway for assembly of corynanthean, strychnos, iboga, and aspidosperma monoterpenoid indole alkaloids from 19 E -geissoschizine","year":"2018","cit":169,"pfa":"Yang Qu","psa":"Vincenzo De Luca","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2789706157","eid":"W2789706157"},{"id":"paper-w2110669693","cat":"papers","name":"The Acute and Chronic Effects of MDMA (“Ecstasy”) on Cortical 5-HT2A Receptors in Rat and Human Brain","year":"2002","cit":169,"pfa":"Liesbeth Reneman","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2110669693","eid":"W2110669693"},{"id":"paper-w2151222373","cat":"papers","name":"Oxidation of methamphetamine and methylenedioxymethamphetamine by CYP2D6.","year":"1997","cit":169,"pfa":"L.Y. Lin","psa":"Arthur K. Cho","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2151222373","eid":"W2151222373"},{"id":"paper-w1971547182","cat":"papers","name":"Effects of phencyclidine, SKF 10,047 and related psychotomimetic agents on N‐methyl‐ d ‐aspartate receptor mediated synaptic responses in rat hippocampal slices","year":"1987","cit":169,"pfa":"E.J. Coan","psa":"Graham L. Collingridge","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1971547182","eid":"W1971547182"},{"id":"paper-w4200437000","cat":"papers","name":"Mechanisms of ketamine and its metabolites as antidepressants","year":"2021","cit":169,"pfa":"Evan M. Hess","psa":"Todd D. Gould","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4200437000","eid":"W4200437000"},{"id":"paper-w4244069365","cat":"papers","name":"Chromosomal damage in human leukocytes induced by lysergic acid diethylamide","year":"1967","cit":168,"pfa":"Maimon M. Cohen","psa":"Nathan Back","ptype":"dataset","src":"https://openalex.org/W4244069365","eid":"W4244069365"},{"id":"paper-w2309497242","cat":"papers","name":"A drug discrimination analysis of lysergic acid diethylamide (LSD): in vivo agonist and antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenperone, a LSD-antagonist.","year":"1982","cit":168,"pfa":"F. C. Colpaert","psa":"P.A.J. Janssen","ptype":"article","src":"https://openalex.org/W2309497242","eid":"W2309497242"},{"id":"paper-w2086621170","cat":"papers","name":"Pursuit of Ecstasy: The MDMA Experience","year":"1995","cit":168,"pfa":"Patricia A. Adler","psa":"Marsha Rosenbaum","ptype":"article","src":"https://openalex.org/W2086621170","eid":"W2086621170"},{"id":"paper-w2024256764","cat":"papers","name":"Chronic MDMA (ecstasy) use, cognition and mood","year":"2004","cit":168,"pfa":"Ken McCardle","psa":"Con K. K. Stough","ptype":"article","src":"https://openalex.org/W2024256764","eid":"W2024256764"},{"id":"paper-w2066108155","cat":"papers","name":"Multiple Severe Complications From Recreational Ingestion of MDMA ('Ecstasy')","year":"1987","cit":168,"pfa":"Christopher R. Brown","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2066108155","eid":"W2066108155"},{"id":"paper-w1810864195","cat":"papers","name":"The prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA): Controlled studies in humans and laboratory animals","year":"2015","cit":168,"pfa":"Philip Kamilar-Britt","psa":"Gillinder Bedi","ptype":"article","src":"https://openalex.org/W1810864195","eid":"W1810864195"},{"id":"paper-w3204230901","cat":"papers","name":"Psychedelics and Other Psychoplastogens for Treating Mental Illness","year":"2021","cit":168,"pfa":"Maxemiliano V. Vargas","psa":"David E. Olson","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W3204230901","eid":"W3204230901"},{"id":"paper-w2147962956","cat":"papers","name":"Stereospecific binding ofd-lysergic acid diethylamide (LSD) to brain membranes: Relationship to serotonin receptors","year":"1975","cit":167,"pfa":"James P. Bennett","psa":"Solomon H. Snyder","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2147962956","eid":"W2147962956"},{"id":"paper-w2153960249","cat":"papers","name":"A Single Dose of Lysergic Acid Diethylamide Influences Gene Expression Patterns within the Mammalian Brain","year":"2002","cit":167,"pfa":"Charles David Nichols","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2153960249","eid":"W2153960249"},{"id":"paper-w2030985511","cat":"papers","name":"Indole alkaloids from cell suspension cultures of Tabernaemontana divaricata and Tabernanthe iboga","year":"1983","cit":167,"pfa":"Karl‐Heinz Pawelka","psa":"Joachim St�ckigt","ptype":"article","src":"https://openalex.org/W2030985511","eid":"W2030985511"},{"id":"paper-w1037524820","cat":"papers","name":"Psilocybin-induced spiritual experiences and insightfulness are associated with synchronization of neuronal oscillations","year":"2015","cit":167,"pfa":"Michael Kometer","psa":"Franz X. Volleinweider","ptype":"article","src":"https://openalex.org/W1037524820","eid":"W1037524820"},{"id":"paper-w2170588940","cat":"papers","name":"Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: A WWW study","year":"2004","cit":167,"pfa":"Andrew B Scholey","psa":"Jacqui Rodgers","ptype":"article","src":"https://openalex.org/W2170588940","eid":"W2170588940"},{"id":"paper-w2087200563","cat":"papers","name":"Psychedelics and schizophrenia","year":"2009","cit":167,"pfa":"Javier González‐Maeso","psa":"Stuart C. Sealfon","ptype":"review","src":"https://openalex.org/W2087200563","eid":"W2087200563"},{"id":"paper-w2036802268","cat":"papers","name":"Disruption of Prefrontal Cortex Large Scale Neuronal Activity by Different Classes of Psychotomimetic Drugs","year":"2012","cit":167,"pfa":"Jesse T. Wood","psa":"Bita Moghaddam","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2036802268","eid":"W2036802268"},{"id":"paper-w2608262290","cat":"papers","name":"Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2013–2016: A Review","year":"2017","cit":167,"pfa":"Barry Kerr Logan","psa":"Marilyn Ann Huestis","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2608262290","eid":"W2608262290"},{"id":"paper-w2716623847","cat":"papers","name":"Therapeutic effect of increased openness: Investigating mechanism of action in MDMA-assisted psychotherapy","year":"2017","cit":166,"pfa":"Mark T. Wagner","psa":"Rick Doblin","topics":["Depression","PTSD & trauma","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2716623847","eid":"W2716623847"},{"id":"paper-w2029197384","cat":"papers","name":"Ethnopharmacology of ska María Pastora (Salvia divinorum, Epling AND Játiva-M.)","year":"1983","cit":166,"pfa":"Leander J. Valdés","psa":"Ara G. Paul","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2029197384","eid":"W2029197384"},{"id":"paper-w4299306996","cat":"papers","name":"Methamphetamine and Methylenedioxymethamphetamine Neurotoxicity: Possible Mechanisms of Cell Destruction","year":"1996","cit":166,"pfa":"Lewis S. Seiden","psa":"Karen E. Sabol","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dataset","src":"https://openalex.org/W4299306996","eid":"W4299306996"},{"id":"paper-w1583934186","cat":"papers","name":"5HT4Receptors Couple Positively to Tetrodotoxin-Insensitive Sodium Channels in a Subpopulation of Capsaicin-Sensitive Rat Sensory Neurons","year":"1997","cit":166,"pfa":"Carla G. Cardenas","psa":"Reese S. Scroggs","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1583934186","eid":"W1583934186"},{"id":"paper-w1570699532","cat":"papers","name":"Psychopharmacology: Drugs, the Brain, and Behavior","year":"2004","cit":166,"pfa":"Jerrold S. Meyer","psa":"Linda F. Quenzer","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W1570699532","eid":"W1570699532"},{"id":"paper-w2566965256","cat":"papers","name":"( R )-Ketamine Shows Greater Potency and Longer Lasting Antidepressant Effects Than Its Metabolite (2 R ,6 R )-Hydroxynorketamine","year":"2016","cit":166,"pfa":"Chun Yang","psa":"Kenji Hashimoto","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2566965256","eid":"W2566965256"},{"id":"paper-w2084390511","cat":"papers","name":"Concurrent use of methamphetamine, MDMA, LSD, ketamine, GHB, and flunitrazepam among American youths","year":"2006","cit":165,"pfa":"Li-Tzy T. Wu","psa":"Deborah M. Galvin","ptype":"article","src":"https://openalex.org/W2084390511","eid":"W2084390511"},{"id":"paper-w1997306238","cat":"papers","name":"The hyperthermic and neurotoxic effects of ‘Ecstasy’ (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype","year":"1995","cit":165,"pfa":"M. Isabel Colado","psa":"A.R. Green","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1997306238","eid":"W1997306238"},{"id":"paper-w3033913667","cat":"papers","name":"RETRACTED ARTICLE: Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials","year":"2020","cit":165,"pfa":"Lisa Jerome","psa":"Rick Doblin","topics":["PTSD & trauma","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3033913667","eid":"W3033913667"},{"id":"paper-w2018025061","cat":"papers","name":"Illicit Drug Use and Treatment in South Africa: A Review","year":"2010","cit":165,"pfa":"Karl Peltzer","psa":"Nancy Refilwe Phaswana-Mafuya","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2018025061","eid":"W2018025061"},{"id":"paper-w2064705585","cat":"papers","name":"Exon‐Intron Structure, Analysis of Promoter Region, and Chromosomal Localization of the Human Type 1 σ Receptor Gene","year":"1998","cit":165,"pfa":"Puttur Devi Prasad","psa":"Vadivel Ganapathy","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2064705585","eid":"W2064705585"},{"id":"paper-w2886819021","cat":"papers","name":"Ketamine for pain management","year":"2018","cit":165,"pfa":"Rae Frances Bell","psa":"Eija Anneli Kalso","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2886819021","eid":"W2886819021"},{"id":"paper-w1983625634","cat":"papers","name":"Antagonism of 5‐hydroxytryptamine by LSD 25 in the central nervous system: a possible neuronal basis for the actions of LSD 25","year":"1970","cit":164,"pfa":"R.J. Boakes","psa":"A. Dray","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1983625634","eid":"W1983625634"},{"id":"paper-w2784340661","cat":"papers","name":"Taking Psychedelics Seriously","year":"2018","cit":164,"pfa":"Ira Robert Byock","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2784340661","eid":"W2784340661"},{"id":"paper-w2168830964","cat":"papers","name":"Pattern of use and subjective effects of Salvia divinorum among recreational users","year":"2006","cit":164,"pfa":"Débora González","psa":"Manel J. Barbanoj","ptype":"article","src":"https://openalex.org/W2168830964","eid":"W2168830964"},{"id":"paper-w2784219766","cat":"papers","name":"Ketamine for the treatment of addiction: Evidence and potential mechanisms","year":"2018","cit":164,"pfa":"Ivan Ezquerra-Romano","psa":"Celia J. A. Morgan","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2784219766","eid":"W2784219766"},{"id":"paper-w2917916000","cat":"papers","name":"Antidepressant-relevant concentrations of the ketamine metabolite (2 R ,6 R )-hydroxynorketamine do not block NMDA receptor function","year":"2019","cit":164,"pfa":"Eric W. Lumsden","psa":"Todd D. Gould","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2917916000","eid":"W2917916000"},{"id":"paper-w2040381320","cat":"papers","name":"Effects of lysergic acid diethylamide on the metabolism of brain 5-hydroxytryptamine","year":"1967","cit":163,"pfa":"John A. Rosecrans","psa":"Daniel X. Freedman","ptype":"article","src":"https://openalex.org/W2040381320","eid":"W2040381320"},{"id":"paper-w2797682963","cat":"papers","name":"The Peyote Religion Among the Navaho","year":"1967","cit":163,"pfa":"M. Douglas","psa":"David F. Aberle","ptype":"article","src":"https://openalex.org/W2797682963","eid":"W2797682963"},{"id":"paper-w2059321731","cat":"papers","name":"Asymmetric Synthesis of Salvinorin A, A Potent κ Opioid Receptor Agonist","year":"2007","cit":163,"pfa":"Jonathan R. Scheerer","psa":"David Albert Evans","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2059321731","eid":"W2059321731"},{"id":"paper-w4300960088","cat":"papers","name":"Receptor-informed network control theory links LSD and psilocybin to a flattening of the brain’s control energy landscape","year":"2022","cit":163,"pfa":"S. Parker Singleton","psa":"Amy F. Kuceyeski","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4300960088","eid":"W4300960088"},{"id":"paper-w1911708624","cat":"papers","name":"3,4-Methylenedioxymethamphetamine (\"ecstasy\") selectively destroys brain serotonin terminals in rhesus monkeys.","year":"1989","cit":163,"pfa":"Thomas R. Insel","psa":"E B De Souza","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1911708624","eid":"W1911708624"},{"id":"paper-w2022769542","cat":"papers","name":"Characterisation of Inhibitory 5‐Hydroxytryptamine Receptors That Modulate Dopamine Release in the Striatum","year":"1981","cit":163,"pfa":"Christine Ennis","psa":"Barry Cox","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2022769542","eid":"W2022769542"},{"id":"paper-w2025534288","cat":"papers","name":"Behavioral Evidence for Interactions between a Hallucinogenic Drug and Group II Metabotropic Glutamate Receptors","year":"2000","cit":163,"pfa":"Jamie Gewirtz","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2025534288","eid":"W2025534288"},{"id":"paper-w2618371434","cat":"papers","name":"Treatment of opioid use disorder with ibogaine: detoxification and drug use outcomes","year":"2017","cit":162,"pfa":"Thomas Kingsley Brown","psa":"Kenneth Alper","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2618371434","eid":"W2618371434"},{"id":"paper-w2020337411","cat":"papers","name":"MDMA induced dopamine release in vivo: role of endogenous serotonin","year":"1997","cit":162,"pfa":"Sebastian Koch","psa":"Matthew P. Galloway","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2020337411","eid":"W2020337411"},{"id":"paper-w2134647442","cat":"papers","name":"Ecstasy/MDMA attributed problems reported by novice, moderate and heavy recreational users","year":"2002","cit":162,"pfa":"Andrew C. Parrott","psa":"Jacqui Rodgers","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2134647442","eid":"W2134647442"},{"id":"paper-w2159609846","cat":"papers","name":"The spatial epidemiology of cocaine, methamphetamine and 3,4‐methylenedioxymethamphetamine (MDMA) use: a demonstration using a population measure of community drug load derived from municipal wastewater","year":"2009","cit":162,"pfa":"Caleb J. Banta‐Green","psa":"Luc de Montigny","ptype":"article","src":"https://openalex.org/W2159609846","eid":"W2159609846"},{"id":"paper-w3216164364","cat":"papers","name":"Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review","year":"2021","cit":162,"pfa":"Nina Schimmers","psa":"Robert A. Schoevers","topics":["Depression","Anxiety & end-of-life","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W3216164364","eid":"W3216164364"},{"id":"paper-w2488390441","cat":"papers","name":"The Democratic Surround: Multimedia and American Liberalism from World War II to the Psychedelic Sixties","year":"2016","cit":162,"pfa":"Craig J. Peariso","ptype":"article","src":"https://openalex.org/W2488390441","eid":"W2488390441"},{"id":"paper-w2996233343","cat":"papers","name":"From Egoism to Ecoism: Psychedelics Increase Nature Relatedness in a State-Mediated and Context-Dependent Manner","year":"2019","cit":162,"pfa":"Hannes Kettner","psa":"Robin Lester Carhart-Harris","ptype":"article","src":"https://openalex.org/W2996233343","eid":"W2996233343"},{"id":"paper-w2481976439","cat":"papers","name":"CHARACTERIZATION OF THREE NEW PSYCHOTOMIMETICS","year":"1978","cit":162,"pfa":"T. Alexander","psa":"David E. Nichols","ptype":"book-chapter","src":"https://openalex.org/W2481976439","eid":"W2481976439"},{"id":"paper-w1972745961","cat":"papers","name":"Drug and Alcohol Abuse Among Psychiatric Admissions","year":"1974","cit":162,"pfa":"Thomas J. Crowley","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1972745961","eid":"W1972745961"},{"id":"paper-w2768304164","cat":"papers","name":"Ketamine enhances structural plasticity in mouse mesencephalic and human iPSC-derived dopaminergic neurons via AMPAR-driven BDNF and mTOR signaling","year":"2017","cit":162,"pfa":"Laura Cavalleri","psa":"Ginetta Collo","ptype":"article","src":"https://openalex.org/W2768304164","eid":"W2768304164"},{"id":"paper-w2168575143","cat":"papers","name":"A preliminary investigation of ibogaine: Case reports and recommendations for further study","year":"1994","cit":161,"pfa":"Simon G. Sheppard","ptype":"article","src":"https://openalex.org/W2168575143","eid":"W2168575143"},{"id":"paper-w2082609266","cat":"papers","name":"MDMA (Ecstasy) Inhibition of MAO Type A and Type B: Comparisons with Fenfluramine and Fluoxetine (Prozac)","year":"1994","cit":161,"pfa":"Efthimia T. Kokotos Leonardi","psa":"Efrain C. Azmitia","ptype":"article","src":"https://openalex.org/W2082609266","eid":"W2082609266"},{"id":"paper-w4327895864","cat":"papers","name":"Psilocybin-assisted therapy for major depressive disorder: An exploratory placebo-controlled, fixed-order trial","year":"2023","cit":161,"pfa":"Jordan Sloshower","psa":"Deepak Cyril D’Souza","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4327895864","eid":"W4327895864"},{"id":"paper-w1967791661","cat":"papers","name":"3,4-Methylenedioxymethamphetamine (MDMA) Modulates Cortical and Limbic Brain Activity as Measured by [H215O]-PET in Healthy Humans","year":"2000","cit":161,"pfa":"Alex Gamma","ptype":"article","src":"https://openalex.org/W1967791661","eid":"W1967791661"},{"id":"paper-w2014776578","cat":"papers","name":"5-HT2 receptors exert a state-dependent regulation of dopaminergic function: studies with MDL 100,907 and the amphetamine analogue, 3,4-methylenedioxymethamphetamine","year":"1992","cit":161,"pfa":"Christopher J. Schmidt","psa":"Vicki L. Taylor","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2014776578","eid":"W2014776578"},{"id":"paper-w2093419170","cat":"papers","name":"Different glial response to methamphetamine- and methylenedioxymethamphetamine-induced neurotoxicity","year":"2003","cit":161,"pfa":"David Pubill","psa":"Elena Escubedo","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2093419170","eid":"W2093419170"},{"id":"paper-w3012020852","cat":"papers","name":"Hydrogel-forming microneedle arrays as a therapeutic option for transdermal esketamine delivery","year":"2020","cit":161,"pfa":"Aaron J. Courtenay","psa":"Ryan F. Donnelly","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3012020852","eid":"W3012020852"},{"id":"paper-w2300458685","cat":"papers","name":"Antidepressive and anxiolytic effects of ayahuasca: a systematic literature review of animal and human studies","year":"2016","cit":160,"pfa":"RAFAEL GUIMARÃES DOS SANTOS","psa":"Jaime E. C. Hallak","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W2300458685","eid":"W2300458685"},{"id":"paper-w1981281259","cat":"papers","name":"Therapeutic Effects of Ritual Ayahuasca Use in the Treatment of Substance Dependence—Qualitative Results","year":"2014","cit":160,"pfa":"Anja Loizaga-Velder","psa":"Rolf Verres","topics":["Addiction","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W1981281259","eid":"W1981281259"},{"id":"paper-w4281703399","cat":"papers","name":"Exploratory study of the dose-related safety, tolerability, and efficacy of dimethyltryptamine (DMT) in healthy volunteers and major depressive disorder","year":"2022","cit":160,"pfa":"Deepak Cyril D’Souza","psa":"Mohini Ranganathan","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4281703399","eid":"W4281703399"},{"id":"paper-w3001327571","cat":"papers","name":"Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey","year":"2020","cit":160,"pfa":"Albert Garcia‐Romeu","psa":"Matthew W. Johnson","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3001327571","eid":"W3001327571"},{"id":"paper-w1972468585","cat":"papers","name":"Comparative epidemiology of initial drug opportunities and transitions to first use: marijuana, cocaine, hallucinogens and heroin","year":"1999","cit":160,"pfa":"Michelle L. Van Etten","psa":"James Christopher Anthony","ptype":"article","src":"https://openalex.org/W1972468585","eid":"W1972468585"},{"id":"paper-w4312140284","cat":"papers","name":"A neurophenomenological approach to non-ordinary states of consciousness: hypnosis, meditation, and psychedelics","year":"2022","cit":160,"pfa":"Christopher B. Timmermann","psa":"Antoine Lutz","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"review","src":"https://openalex.org/W4312140284","eid":"W4312140284"},{"id":"paper-w1588638439","cat":"papers","name":"Gabbard’s Treatments of Psychiatric Disorders","year":"2014","cit":160,"pfa":"Glen O. Gabbard","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"book","src":"https://openalex.org/W1588638439","eid":"W1588638439"},{"id":"paper-w4224044203","cat":"papers","name":"Ketamine treatment for depression: a review","year":"2022","cit":160,"pfa":"Mani Yavi","psa":"Carlos A. Zarate","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4224044203","eid":"W4224044203"},{"id":"paper-w126579187","cat":"papers","name":"Chapter 1 Ibogaine: A review","year":"2001","cit":159,"pfa":"Kenneth Alper","topics":["Reviews & meta-analyses"],"ptype":"book-chapter","src":"https://openalex.org/W126579187","eid":"W126579187"},{"id":"paper-w2109355085","cat":"papers","name":"Analysis of 3,4-Methylenedioxymethamphetamine (MDMA) and its Metabolites in Plasma and Urine by HPLC-DAD and GC-MS","year":"1996","cit":159,"pfa":"H. J. Helmlin","psa":"J. Styk","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2109355085","eid":"W2109355085"},{"id":"paper-w2154896179","cat":"papers","name":"MDMA (‘ecstasy’) use, and its association with high risk behaviors, mental health, and other factors among gay/bisexual men in New York City","year":"2002","cit":159,"pfa":"Robert Klitzman","psa":"Curtis L. Dolezal","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2154896179","eid":"W2154896179"},{"id":"paper-w2757917284","cat":"papers","name":"Psychedelic Drugs in Biomedicine","year":"2017","cit":159,"pfa":"Evan J. Kyzar","psa":"Allan V. Kalueff","ptype":"review","src":"https://openalex.org/W2757917284","eid":"W2757917284"},{"id":"paper-w2657342869","cat":"papers","name":"Lifetime experience with (classic) psychedelics predicts pro-environmental behavior through an increase in nature relatedness","year":"2017","cit":159,"pfa":"Matthias Forstmann","psa":"Christina Sagioglou","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2657342869","eid":"W2657342869"},{"id":"paper-w2004098041","cat":"papers","name":"Biochemical and Behavioral Evidence for Antidepressant-Like Effects of 5-HT6Receptor Stimulation","year":"2007","cit":159,"pfa":"Per Svenningsson","psa":"Paul Greengard","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2004098041","eid":"W2004098041"},{"id":"paper-w2050336058","cat":"papers","name":"Observations on the psychotomimetic effects of sernyl","year":"1961","cit":159,"pfa":"Cornelis B. Bakker","psa":"Fari B. Amini","ptype":"article","src":"https://openalex.org/W2050336058","eid":"W2050336058"},{"id":"paper-w2055312975","cat":"papers","name":"Chronic Administration of Serotonergic Antidepressants Attenuates the Subjective Effects of LSD in Humans","year":"1996","cit":159,"pfa":"Katherine R. Bonson","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2055312975","eid":"W2055312975"},{"id":"paper-w1978230214","cat":"papers","name":"Sequential Regional Cerebral Blood Flow Brain Scans Using PET with H215O Demonstrate Ketamine Actions in CNS Dynamically","year":"2001","cit":159,"pfa":"Henry H. Holcomb","ptype":"article","src":"https://openalex.org/W1978230214","eid":"W1978230214"},{"id":"paper-w2145629098","cat":"papers","name":"Quantitation of N,N-Dimethyltryptamine and Harmala Alkaloids in Human Plasma after Oral Dosing with Ayahuasca","year":"1996","cit":158,"pfa":"J. C. Callaway","psa":"Deborah C. Mash","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2145629098","eid":"W2145629098"},{"id":"paper-w2145045322","cat":"papers","name":"Hyperpyrexia and rhabdomyolysis after MDMA (\"ecstasy\") abuse","year":"1992","cit":158,"pfa":"Gavin Robert Screaton","psa":"Simon L Cohen","ptype":"article","src":"https://openalex.org/W2145045322","eid":"W2145045322"},{"id":"paper-w2139686548","cat":"papers","name":"The Olivocerebellar Projection Mediates Ibogaine-Induced Degeneration of Purkinje Cells: A Model of Indirect, Trans-Synaptic Excitotoxicity","year":"1997","cit":158,"pfa":"Elizabeth O’Hearn","psa":"Mark E. Molliver","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2139686548","eid":"W2139686548"},{"id":"paper-w4385197359","cat":"papers","name":"Psilocybin therapy for females with anorexia nervosa: a phase 1, open-label feasibility study","year":"2023","cit":158,"pfa":"Stephanie Knatz Peck","psa":"Walter H. Kaye","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4385197359","eid":"W4385197359"},{"id":"paper-w2043934883","cat":"papers","name":"Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective","year":"2006","cit":158,"pfa":"Rainer Thomasius","psa":"Achim Schmoldt","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2043934883","eid":"W2043934883"},{"id":"paper-w2048184801","cat":"papers","name":"Animal Models of Serotonergic Psychedelics","year":"2012","cit":158,"pfa":"James B. Hanks","psa":"Javier González‐Maeso","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2048184801","eid":"W2048184801"},{"id":"paper-w2037891934","cat":"papers","name":"Mismatch negativity generation in the human 5HT2A agonist and NMDA antagonist model of psychosis","year":"2008","cit":158,"pfa":"Karsten Heekeren","psa":"Euphrosyne Gouzoulis‐Mayfrank","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2037891934","eid":"W2037891934"},{"id":"paper-w2032445862","cat":"papers","name":"A major role for thalamocortical afferents in serotonergic hallucinogen receptor function in the rat neocortex","year":"2001","cit":158,"pfa":"Gerard J. Marek","psa":"Darryle D. Schoepp","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2032445862","eid":"W2032445862"},{"id":"paper-w2904966234","cat":"papers","name":"Cannabidiol in the Treatment of Post-Traumatic Stress Disorder: A Case Series","year":"2018","cit":158,"pfa":"Lucas Elms","psa":"Nicole Lewis","topics":["PTSD & trauma","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2904966234","eid":"W2904966234"},{"id":"paper-w2795355519","cat":"papers","name":"Esketamine counters opioid-induced respiratory depression","year":"2018","cit":158,"pfa":"Kelly Jonkman","psa":"Albert Dahan","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W2795355519","eid":"W2795355519"},{"id":"paper-w2982569821","cat":"papers","name":"Esketamine for treatment-resistant depression: seven concerns about efficacy and FDA approval","year":"2019","cit":158,"pfa":"Erick H. Turner","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2982569821","eid":"W2982569821"},{"id":"paper-w2004089242","cat":"papers","name":"Peyote Hunt: The Sacred Journey of the Huichol Indians","year":"1975","cit":157,"pfa":"David F. Aberle","psa":"Barbara G. Myerhoff","ptype":"article","src":"https://openalex.org/W2004089242","eid":"W2004089242"},{"id":"paper-w2126656764","cat":"papers","name":"Drug Tourism or Spiritual Healing? Ayahuasca Seekers in Amazonia","year":"2005","cit":157,"pfa":"Michael Winkelman","ptype":"article","src":"https://openalex.org/W2126656764","eid":"W2126656764"},{"id":"paper-w1979653155","cat":"papers","name":"MDMA Elicits Behavioral and Neurochemical Sensitization in Rats","year":"1998","cit":157,"pfa":"Peter W. Kalivas","ptype":"article","src":"https://openalex.org/W1979653155","eid":"W1979653155"},{"id":"paper-w2548043919","cat":"papers","name":"Shannon entropy of brain functional complex networks under the influence of the psychedelic Ayahuasca","year":"2017","cit":157,"pfa":"Aline Viol","psa":"G. M. Viswanathan","topics":["Mechanism & neuroscience","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2548043919","eid":"W2548043919"},{"id":"paper-w2089306255","cat":"papers","name":"Duloxetine Inhibits Effects of MDMA (“Ecstasy\") In Vitro and in Humans in a Randomized Placebo-Controlled Laboratory Study","year":"2012","cit":157,"pfa":"Cédric M. Hysek","psa":"Matthias E. Liechti","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2089306255","eid":"W2089306255"},{"id":"paper-w2889959197","cat":"papers","name":"Dimensions of consciousness and the psychedelic state","year":"2018","cit":157,"pfa":"Tim Bayne","psa":"Olivia L. Carter","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2889959197","eid":"W2889959197"},{"id":"paper-w1829354874","cat":"papers","name":"EFFECTS OF LSD-25 ON BRAIN SEROTONIN","year":"1961","cit":157,"pfa":"Daniel X. Freedman","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1829354874","eid":"W1829354874"},{"id":"paper-w4293801859","cat":"papers","name":"Preparing for the Bursting of the Psychedelic Hype Bubble","year":"2022","cit":157,"pfa":"David B. Yaden","psa":"Roland R. Griffiths","ptype":"article","src":"https://openalex.org/W4293801859","eid":"W4293801859"},{"id":"paper-w2153645092","cat":"papers","name":"A Selective Positive Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 2 Blocks a Hallucinogenic Drug Model of Psychosis","year":"2007","cit":157,"pfa":"Michael A. Benneyworth","psa":"Elaine Sanders‐Bush","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2153645092","eid":"W2153645092"},{"id":"paper-w2303387325","cat":"papers","name":"Antidepressant-like effect of cannabidiol injection into the ventral medial prefrontal cortex—Possible involvement of 5-HT1A and CB1 receptors","year":"2016","cit":157,"pfa":"Ariandra Guerini Sartim","psa":"Sâmia R.L. Joca","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2303387325","eid":"W2303387325"},{"id":"paper-w1985835953","cat":"papers","name":"MDMA (Ecstasy) and the Rave: A Review","year":"1997","cit":156,"pfa":"Richard H. Schwartz","psa":"Norman Stanley Miller","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W1985835953","eid":"W1985835953"},{"id":"paper-w2073612520","cat":"papers","name":"Differential effects of MDMA and methylphenidate on social cognition","year":"2014","cit":156,"pfa":"Yasmin Schmid","psa":"Matthias E. Liechti","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2073612520","eid":"W2073612520"},{"id":"paper-w200566278","cat":"papers","name":"Enhancement of ovarian responsiveness with microdoses of gonadotropin-releasing hormone agonist during ovulation induction for in vitro fertilization","year":"1994","cit":156,"pfa":"Richard Thomas Scott","psa":"Daniel Navot","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W200566278","eid":"W200566278"},{"id":"paper-w1974907074","cat":"papers","name":"THE DISTRIBUTION AND METABOLISM OF LYSERGIC ACID DIETHYLAMIDE","year":"1957","cit":155,"pfa":"Julius Axelrod","psa":"Edward V. Evarts","ptype":"article","src":"https://openalex.org/W1974907074","eid":"W1974907074"},{"id":"paper-w2416727632","cat":"papers","name":"Antagonism between lysergic acid diethylamide and 5-hydroxytryptamine.","year":"1953","cit":155,"pfa":"Gaddum Jh","ptype":"article","src":"https://openalex.org/W2416727632","eid":"W2416727632"},{"id":"paper-w1933205484","cat":"papers","name":"Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis.","year":"1988","cit":155,"pfa":"Elaine Sanders‐Bush","psa":"Karen M. Knoth","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1933205484","eid":"W1933205484"},{"id":"paper-w2116536917","cat":"papers","name":"The pre-clinical behavioural pharmacology of 3,4-methylenedioxymethamphetamine (MDMA)","year":"2003","cit":155,"pfa":"Jon C. Cole","psa":"Harry R. Sumnall","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2116536917","eid":"W2116536917"},{"id":"paper-w2325989594","cat":"papers","name":"Pharmacological analysis of 5-hydroxytryptamine receptors in isolated intracranial and extracranial vessels of cat and man.","year":"1978","cit":155,"pfa":"Lars IH Edvinsson","psa":"Christer Owman","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2325989594","eid":"W2325989594"},{"id":"paper-w3122801192","cat":"papers","name":"Positive expectations predict improved mental-health outcomes linked to psychedelic microdosing","year":"2021","cit":155,"pfa":"Laura Kaertner","psa":"Robin Lester Carhart-Harris","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3122801192","eid":"W3122801192"},{"id":"paper-w2067384745","cat":"papers","name":"The Psychopharmacology of Hallucinogens","year":"1996","cit":155,"pfa":"Helayna Abraham","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2067384745","eid":"W2067384745"},{"id":"paper-w2074624810","cat":"papers","name":"Reinforcements from the first drug experience can predict later drug habits and/or addiction: Results with coffee, cigarettes, alcohol, barbiturates, minor and major tranquilizers, stimulants, marijuana, hallucinogens, h","year":"1983","cit":155,"pfa":"Charles A. Haertzen","psa":"Katsumasa Miyasato","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2074624810","eid":"W2074624810"},{"id":"paper-w2163830705","cat":"papers","name":"DOI-Induced Activation of the Cortex: Dependence on 5-HT 2A Heteroceptors on Thalamocortical Glutamatergic Neurons","year":"2000","cit":155,"pfa":"Jennifer L. Scruggs","psa":"Ariel Y. Deutch","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2163830705","eid":"W2163830705"},{"id":"paper-w2151052284","cat":"papers","name":"Antidepressant-Like and Anxiolytic-Like Effects of Cannabidiol: A Chemical Compound of Cannabis sativa","year":"2014","cit":155,"pfa":"Alexandre Rafael de Mello Schier","psa":"Adriana Ribeiro Silva","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2151052284","eid":"W2151052284"},{"id":"paper-w2030152904","cat":"papers","name":"The Ketamine Analogue Methoxetamine and 3- and 4-Methoxy Analogues of Phencyclidine Are High Affinity and Selective Ligands for the Glutamate NMDA Receptor","year":"2013","cit":155,"pfa":"Bryan L. Roth","psa":"Les Iversen","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2030152904","eid":"W2030152904"},{"id":"paper-w2922048335","cat":"papers","name":"( 2R,6R )-hydroxynorketamine exerts mGlu 2 receptor-dependent antidepressant actions","year":"2019","cit":155,"pfa":"Panos Zanos","psa":"Todd D. Gould","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2922048335","eid":"W2922048335"},{"id":"paper-w2104493382","cat":"papers","name":"Psilocybin links binocular rivalry switch rate to attention and subjective arousal levels in humans","year":"2007","cit":154,"pfa":"Olivia L. Carter","psa":"Franz X. Vollenweider","ptype":"article","src":"https://openalex.org/W2104493382","eid":"W2104493382"},{"id":"paper-w4251480506","cat":"papers","name":"Ketamine","year":"1998","cit":154,"pfa":"Rainer Kohrs","psa":"Marcel E. Durieux","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4251480506","eid":"W4251480506"},{"id":"paper-w2009737470","cat":"papers","name":"Salvinorin A: the ‘magic mint’ hallucinogen finds a molecular target in the kappa opioid receptor","year":"2003","cit":153,"pfa":"Douglas J. Sheffler","psa":"Bryan L. Roth","topics":["Addiction","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W2009737470","eid":"W2009737470"},{"id":"paper-w2140774335","cat":"papers","name":"LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex.","year":"1996","cit":153,"pfa":"Gerard J. Marek","psa":"George K. Aghajanian","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2140774335","eid":"W2140774335"},{"id":"paper-w3010491167","cat":"papers","name":"Tripping on nothing: placebo psychedelics and contextual factors","year":"2020","cit":153,"pfa":"Jay A. Olson","psa":"Samuel P. L. Veissière","ptype":"article","src":"https://openalex.org/W3010491167","eid":"W3010491167"},{"id":"paper-w2128196377","cat":"papers","name":"THE EFFECTS OF PUTATIVE 5‐HYDROXYTRYPTAMINE ANTAGONISTS ON THE BEHAVIOUR PRODUCED BY ADMINISTRATION OF TRANYLCYPROMINE AND L‐TRYPTOPHAN OR TRANYLCYPROMINE AND L‐DOPA TO RATS","year":"1978","cit":153,"pfa":"J.F.W. Deakin","psa":"A.R. Green","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2128196377","eid":"W2128196377"},{"id":"paper-w3122951191","cat":"papers","name":"Psychedelics, placebo effects, and set and setting: Insights from common factors theory of psychotherapy","year":"2021","cit":153,"pfa":"Natalie Gukasyan","psa":"Sandeep Manel Nayak","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W3122951191","eid":"W3122951191"},{"id":"paper-w2088785539","cat":"papers","name":"Residential Psychedelic (LSD) Therapy for the Narcotic Addict","year":"1973","cit":153,"pfa":"Charles Savage","topics":["Addiction","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2088785539","eid":"W2088785539"},{"id":"paper-w2402631960","cat":"papers","name":"Human Pharmacology of Mephedrone in Comparison with MDMA","year":"2016","cit":152,"pfa":"Esther Papaseit","psa":"Magı́ Farré","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2402631960","eid":"W2402631960"},{"id":"paper-w2127854642","cat":"papers","name":"Reinforcing, subjective, and physiological effects of MDMA in humans: a comparison with d-amphetamine and mCPP","year":"2003","cit":152,"pfa":"Manuel E. Tancer","psa":"Chris‐Ellyn Johanson","ptype":"article","src":"https://openalex.org/W2127854642","eid":"W2127854642"},{"id":"paper-w2118909127","cat":"papers","name":"Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function","year":"2004","cit":152,"pfa":"María Isabel Colado","psa":"A. Richard Green","ptype":"article","src":"https://openalex.org/W2118909127","eid":"W2118909127"},{"id":"paper-w2605994583","cat":"papers","name":"Ibogaine treatment outcomes for opioid dependence from a twelve-month follow-up observational study","year":"2017","cit":152,"pfa":"Geoff Noller","psa":"Berra Yazar‐Klosinski","topics":["Depression","Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2605994583","eid":"W2605994583"},{"id":"paper-w2115752255","cat":"papers","name":"MDMA (3,4-Methylenedioxymethamphetamine) or Ecstasy: The Neuropsychobiological Implications of Taking It at Dances and Raves","year":"2004","cit":152,"pfa":"Andrew C. Parrott","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2115752255","eid":"W2115752255"},{"id":"paper-w2013923425","cat":"papers","name":"The Norepinephrine Transporter Inhibitor Reboxetine Reduces Stimulant Effects of MDMA (“Ecstasy”) in Humans","year":"2011","cit":152,"pfa":"C.M. Hysek","psa":"Matthias E. Liechti","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2013923425","eid":"W2013923425"},{"id":"paper-w2148961584","cat":"papers","name":"Human Research on MDMA (3,4-Methylene- dioxymethamphetamine) Neurotoxicity: Cognitive and Behavioural Indices of Change","year":"2000","cit":152,"pfa":"Andrew C. Parrott","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2148961584","eid":"W2148961584"},{"id":"paper-w2034894507","cat":"papers","name":"Hallucinogenic drug interactions with neurotransmitter receptor binding sites in human cortex","year":"1989","cit":152,"pfa":"Pamela A. Pierce","psa":"Stephen J. Peroutka","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2034894507","eid":"W2034894507"},{"id":"paper-w2082651629","cat":"papers","name":"Characterization of a Dopamine D1 Receptor from Apis mellifera: Cloning, Functional Expression, Pharmacology, and mRNA Localization in the Brain","year":"1998","cit":152,"pfa":"Wolfgang Blenau","psa":"Arnd Baumann","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2082651629","eid":"W2082651629"},{"id":"paper-w2798667567","cat":"papers","name":"DMT: The Spirit Molecule: A Doctor's Revolutionary Research into the Biology of Near-Death and Mystical Experiences","year":"2000","cit":152,"pfa":"Rick J. Strassman","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2798667567","eid":"W2798667567"},{"id":"paper-w2951273177","cat":"papers","name":"Improved Fischer Indole Reaction for the Preparation of N,N-Dimethyltryptamines: Synthesis of L-695,894, a Potent 5-HT1D Receptor Agonist","year":"1994","cit":151,"pfa":"Cheng‐yi Chen","psa":"Paul J. Reider","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2951273177","eid":"W2951273177"},{"id":"paper-w2284048615","cat":"papers","name":"Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A/2A agonist ergotamine on psilocybin-induced psychedelic experience","year":"2016","cit":151,"pfa":"Thomas Pokorny","psa":"Franz X. Vollenweider","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2284048615","eid":"W2284048615"},{"id":"paper-w2098749471","cat":"papers","name":"Crystal Methamphetamine, Its Analogues, and HIV Infection: Medical and Psychiatric Aspects of a New Epidemic","year":"2004","cit":151,"pfa":"Antonio Urbina","psa":"Kristina Jones","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2098749471","eid":"W2098749471"},{"id":"paper-w2033215199","cat":"papers","name":"Early Activation of STAT3 Regulates Reactive Astrogliosis Induced by Diverse Forms of Neurotoxicity","year":"2014","cit":151,"pfa":"James Patrick O'Callaghan","psa":"Diane Bemis Miller","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2033215199","eid":"W2033215199"},{"id":"paper-w2345771415","cat":"papers","name":"Prediction error, ketamine and psychosis: An updated model","year":"2016","cit":151,"pfa":"Philip Robert Corlett","psa":"Paul Charles Fletcher","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2345771415","eid":"W2345771415"},{"id":"paper-w2416508815","cat":"papers","name":"Demonstration of [3H]cyclazocine binding to multiple opiate receptor sites.","year":"1981","cit":151,"pfa":"R. Suzanne Zukin","psa":"Stephen R. Zukin","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2416508815","eid":"W2416508815"},{"id":"paper-w2011580261","cat":"papers","name":"Impulsivity, risk taking and recreational ‘ecstasy’ (MDMA) use","year":"2004","cit":150,"pfa":"Georgia Butler","psa":"Anthony M. J. Montgomery","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2011580261","eid":"W2011580261"},{"id":"paper-w1900109421","cat":"papers","name":"Age-dependent sensitivity of rats to the long-term effects of the serotonergic neurotoxicant (+/-)-3,4-methylenedioxymethamphetamine (MDMA) correlates with the magnitude of the MDMA-induced thermal response.","year":"1995","cit":150,"pfa":"Harry W. Broening","psa":"William Slikker","ptype":"article","src":"https://openalex.org/W1900109421","eid":"W1900109421"},{"id":"paper-w2131302772","cat":"papers","name":"Neoclerodane Diterpenes as a Novel Scaffold for μ Opioid Receptor Ligands","year":"2005","cit":150,"pfa":"Wayne Wesley Harding","psa":"Thomas Edward Prisinzano","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2131302772","eid":"W2131302772"},{"id":"paper-w2147873829","cat":"papers","name":"2-Substituted Tryptamines: Agents with Selectivity for 5-HT6Serotonin Receptors","year":"2000","cit":150,"pfa":"Richard A. Glennon","psa":"David K.H. Lee","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2147873829","eid":"W2147873829"},{"id":"paper-w2474274656","cat":"papers","name":"LSD-assisted psychotherapy with terminal cancer patients.","year":"1969","cit":150,"pfa":"Pahnke Wn","psa":"Richards Wa","topics":["Anxiety & end-of-life","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2474274656","eid":"W2474274656"},{"id":"paper-w4301430340","cat":"papers","name":"The Varieties of Psychedelic Experience","year":"1967","cit":150,"pfa":"Richard Blum","psa":"Jean Houston","ptype":"article","src":"https://openalex.org/W4301430340","eid":"W4301430340"},{"id":"paper-w2959816154","cat":"papers","name":"Esketamine for treatment resistant depression","year":"2019","cit":150,"pfa":"Jennifer Swainson","psa":"Michael L Demas","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2959816154","eid":"W2959816154"},{"id":"paper-w1982462017","cat":"papers","name":"Ibogaine, a Noncompetitive Inhibitor of Serotonin Transport, Acts by Stabilizing the Cytoplasm-facing State of the Transporter","year":"2007","cit":149,"pfa":"Miriam T. Jacobs","psa":"Gary Rudnick","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1982462017","eid":"W1982462017"},{"id":"paper-w3018943978","cat":"papers","name":"Survey of entity encounter experiences occasioned by inhaled N,N -dimethyltryptamine: Phenomenology, interpretation, and enduring effects","year":"2020","cit":149,"pfa":"Alan K. Davis","psa":"Roland R. Griffiths","ptype":"article","src":"https://openalex.org/W3018943978","eid":"W3018943978"},{"id":"paper-w1533710606","cat":"papers","name":"3,4-Methylenedioxymethamphetamine (MDMA) as a Unique Model of Serotonin Receptor Function and Serotonin-Dopamine Interactions","year":"2001","cit":149,"pfa":"Michael G. Bankson","psa":"Kathryn A. Cunningham","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1533710606","eid":"W1533710606"},{"id":"paper-w2067112633","cat":"papers","name":"Role of 5-Hydroxytryptamine in Mental Diseases and its Antagonism to Lysergic Acid Derivatives","year":"1955","cit":149,"pfa":"A Cerletti","psa":"E Rothlin","ptype":"article","src":"https://openalex.org/W2067112633","eid":"W2067112633"},{"id":"paper-w4302773366","cat":"papers","name":"Psychedelic therapy for depressive symptoms: A systematic review and meta-analysis","year":"2022","cit":149,"pfa":"Kwonmok Ko","psa":"James Rucker","topics":["Depression","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4302773366","eid":"W4302773366"},{"id":"paper-w1986219496","cat":"papers","name":"Positron emission tomographic studies of brain dopamine and serotonin transporters in abstinent (±)3,4-methylenedioxymethamphetamine (“ecstasy”) users: relationship to cognitive performance","year":"2008","cit":149,"pfa":"Una D. McCann","psa":"George A. Ricaurte","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1986219496","eid":"W1986219496"},{"id":"paper-w2151818435","cat":"papers","name":"Disposition of methylenedioxymethamphetamine and three metabolites in the brains of different rat strains and their possible roles in acute serotonin depletion","year":"1996","cit":149,"pfa":"Teresa Chu","psa":"Arthur K. Cho","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2151818435","eid":"W2151818435"},{"id":"paper-w2118539399","cat":"papers","name":"A review of acute effects of 3,4-methylenedioxymethamphetamine in healthy volunteers","year":"2006","cit":149,"pfa":"Glenn Dumont","psa":"Robbert Jan Verkes","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2118539399","eid":"W2118539399"},{"id":"paper-w3139397908","cat":"papers","name":"Psychedelic Harm Reduction and Integration: A Transtheoretical Model for Clinical Practice","year":"2021","cit":149,"pfa":"Ingmar Gorman","psa":"Jonathan J. Sabbagh","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3139397908","eid":"W3139397908"},{"id":"paper-w2166934228","cat":"papers","name":"The Psychedelic Mystical Experience in the Human Encounter with Death","year":"1969","cit":149,"pfa":"Walter N. Pahnke","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2166934228","eid":"W2166934228"},{"id":"paper-w2014176100","cat":"papers","name":"To use or not to use: an update on licit and illicit ketamine use","year":"2011","cit":149,"pfa":"Jih‐Heng Li","psa":"Richard S. Schottenfeld","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2014176100","eid":"W2014176100"},{"id":"paper-w2057019330","cat":"papers","name":"Ketamine Disrupts Theta Modulation of Gamma in a Computer Model of Hippocampus","year":"2011","cit":149,"pfa":"Samuel A. Neymotin","psa":"William W. Lytton","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2057019330","eid":"W2057019330"},{"id":"paper-w3033447508","cat":"papers","name":"Pharmacological Treatments for Patients with Treatment-Resistant Depression","year":"2020","cit":149,"pfa":"Valerie L. Ruberto","psa":"James W. Murrough","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3033447508","eid":"W3033447508"},{"id":"paper-w4402221705","cat":"papers","name":"Adverse Events in Studies of Classic Psychedelics","year":"2024","cit":148,"pfa":"Jared T. Hinkle","psa":"David B. Yaden","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4402221705","eid":"W4402221705"},{"id":"paper-w2342266152","cat":"papers","name":"In Vivo and in Vitro Chromosomal Damage Induced by LSD-25","year":"1967","cit":148,"pfa":"Maimon M. Cohen","psa":"William A. Frosch","ptype":"article","src":"https://openalex.org/W2342266152","eid":"W2342266152"},{"id":"paper-w2040704650","cat":"papers","name":"Epidemic of illicit drug use, mechanisms of action/addiction and stroke as a health hazard","year":"2011","cit":148,"pfa":"Katherine Esse","psa":"Sheryl Martin‐Schild","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2040704650","eid":"W2040704650"},{"id":"paper-w2005997645","cat":"papers","name":"Mapping the Binding Site Pocket of the Serotonin 5-Hydroxytryptamine2A Receptor","year":"1996","cit":148,"pfa":"Niva Almaula","psa":"Stuart C. Sealfon","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2005997645","eid":"W2005997645"},{"id":"paper-w560776378","cat":"papers","name":"The Forensic Pharmacology of Drugs of Abuse","year":"2001","cit":148,"pfa":"Olaf H. Drummer","psa":"Morris S. Odell","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"book","src":"https://openalex.org/W560776378","eid":"W560776378"},{"id":"paper-w2170369188","cat":"papers","name":"Period, age, and cohort effects on substance use among American youth, 1976-82.","year":"1984","cit":148,"pfa":"Patrick M. O’Malley","psa":"Lloyd D. Johnston","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2170369188","eid":"W2170369188"},{"id":"paper-w2056836466","cat":"papers","name":"Effect of Subanesthetic Ketamine on Intrinsic Functional Brain Connectivity","year":"2012","cit":148,"pfa":"Marieke Niesters","psa":"Serge A.R.B. Rombouts","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2056836466","eid":"W2056836466"},{"id":"paper-w2625860417","cat":"papers","name":"Pilot Randomized Controlled Trial of Titrated Subcutaneous Ketamine in Older Patients with Treatment-Resistant Depression","year":"2017","cit":148,"pfa":"Duncan George","psa":"Colleen K A Loo","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2625860417","eid":"W2625860417"},{"id":"paper-w2996366481","cat":"papers","name":"Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide (LSD) in healthy older volunteers","year":"2019","cit":147,"pfa":"Neiloufar Family","psa":"Shlomi Raz","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2996366481","eid":"W2996366481"},{"id":"paper-w428411035","cat":"papers","name":"The Antipodes of the Mind: Charting the Phenomenology of the Ayahuasca Experience","year":"2003","cit":147,"pfa":"Benny Shanon","ptype":"article","src":"https://openalex.org/W428411035","eid":"W428411035"},{"id":"paper-w2133439321","cat":"papers","name":"Co-administration of MDMA with drugs that protect against MDMA neurotoxicity produces different effects on body temperature in the rat.","year":"1996","cit":147,"pfa":"Jessica E. Malberg","psa":"Lewis S. Seiden","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2133439321","eid":"W2133439321"},{"id":"paper-w2082832315","cat":"papers","name":"Relationship of the structure of mescaline and seven analogs to toxicity and behavior in five species of laboratory animals","year":"1973","cit":147,"pfa":"Harold F. Hardman","psa":"Maurice H. Seevers","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2082832315","eid":"W2082832315"},{"id":"paper-w2041614065","cat":"papers","name":"Development, maintenance and temporal pattern of self-administration maintained by ecstasy (MDMA) in rats","year":"2003","cit":147,"pfa":"Susan Schenk","psa":"Evangeline Daniela","ptype":"article","src":"https://openalex.org/W2041614065","eid":"W2041614065"},{"id":"paper-w1998129912","cat":"papers","name":"Acute psychological and physiological effects of MDMA (“Ecstasy”) after haloperidol pretreatment in healthy humans","year":"2000","cit":147,"pfa":"Matthias E. Liechti","psa":"Franz X. Vollenweider","ptype":"article","src":"https://openalex.org/W1998129912","eid":"W1998129912"},{"id":"paper-w2090472441","cat":"papers","name":"Construct Validity of the Balloon Analogue Risk Task (BART): Relationship with MDMA Use by Inner-City Drug Users in Residential Treatment","year":"2006","cit":147,"pfa":"Derek Richard Hopko","psa":"David R. Strong","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2090472441","eid":"W2090472441"},{"id":"paper-w2081874031","cat":"papers","name":"5‐Hydroxytryptamine receptors of visceral primary afferent neurones on rabbit nodose ganglia","year":"1982","cit":147,"pfa":"Hideho Higashi","psa":"S. Nishi","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2081874031","eid":"W2081874031"},{"id":"paper-w2157382250","cat":"papers","name":"Chemistry, Pharmacology, Toxicology, and Hepatic Metabolism of Designer Drugs of the Amphetamine (Ecstasy), Piperazine, and Pyrrolidinophenone Types","year":"2004","cit":147,"pfa":"Hans H. Maurer","psa":"Roland F. Staack","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2157382250","eid":"W2157382250"},{"id":"paper-w2082270913","cat":"papers","name":"Discoveries in Biological Psychiatry","year":"1971","cit":147,"pfa":"Charles Savage","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2082270913","eid":"W2082270913"},{"id":"paper-w3111481291","cat":"papers","name":"Antidepressant actions of ketamine engage cell-specific translation via eIF4E","year":"2020","cit":147,"pfa":"Argel Aguilar‐Valles","psa":"Nahum Sonenberg","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W3111481291","eid":"W3111481291"},{"id":"paper-w2025565008","cat":"papers","name":"Ibogaine: Complex Pharmacokinetics, Concerns for Safety, and Preliminary Efficacy Measures","year":"2000","cit":146,"pfa":"Deborah C. Mash","psa":"MANNY MAYOR","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2025565008","eid":"W2025565008"},{"id":"paper-w2002330441","cat":"papers","name":"Salvia divinorumand the Unique Diterpene Hallucinogen, Salvinorin (Divinorin) A","year":"1994","cit":146,"pfa":"Leander J. Valdés","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2002330441","eid":"W2002330441"},{"id":"paper-w2051579023","cat":"papers","name":"Ayahuasca and the process of regulation in Brazil and internationally: Implications and challenges","year":"2011","cit":146,"pfa":"Beatriz Caiuby Labate","psa":"Kevin Feeney","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2051579023","eid":"W2051579023"},{"id":"paper-w2590375860","cat":"papers","name":"Safety pharmacology of acute MDMA administration in healthy subjects","year":"2017","cit":146,"pfa":"Patrick Vizeli","psa":"Matthias E. Liechti","topics":["Safety & adverse events","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2590375860","eid":"W2590375860"},{"id":"paper-w1510556999","cat":"papers","name":"Agonist Properties of N,N-Dimethyltryptamine at Serotonin 5-HT2A and 5-HT2C Receptors","year":"1998","cit":146,"pfa":"Roger F. Smith","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1510556999","eid":"W1510556999"},{"id":"paper-w1822863173","cat":"papers","name":"A critical review of reports of endogenous psychedelic N, N‐dimethyltryptamines in humans: 1955–2010","year":"2012","cit":146,"pfa":"Steven A. Barker","psa":"Rick J. Strassman","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1822863173","eid":"W1822863173"},{"id":"paper-w2110422029","cat":"papers","name":"Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter","year":"2009","cit":146,"pfa":"Nicholas V. Cozzi","psa":"Arnold E. Ruoho","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2110422029","eid":"W2110422029"},{"id":"paper-w70805046","cat":"papers","name":"Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d -methamphetamine in healthy volunteers","year":"1999","cit":146,"pfa":"Euphrosyne Gouzoulis‐Mayfrank","psa":"H. Sass","ptype":"article","src":"https://openalex.org/W70805046","eid":"W70805046"},{"id":"paper-w2055598723","cat":"papers","name":"2,5-Dimethoxy-4-methyl-amphetamine (STP): A New Hallucinogenic Drug","year":"1967","cit":146,"pfa":"Solomon H. Snyder","psa":"Leo E. Hollister","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2055598723","eid":"W2055598723"},{"id":"paper-w2079767249","cat":"papers","name":"Hallucinogen-like actions of 5-methoxy-N,N-diisopropyltryptamine in mice and rats","year":"2006","cit":146,"pfa":"William E. Fantegrossi","psa":"J H Woods","ptype":"article","src":"https://openalex.org/W2079767249","eid":"W2079767249"},{"id":"paper-w2218120369","cat":"papers","name":"Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and gamma-aminobutyric acid in the substantia nigra.","year":"1995","cit":146,"pfa":"Bryan K. Yamamoto","psa":"Gary A. Gudelsky","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2218120369","eid":"W2218120369"},{"id":"paper-w2126218492","cat":"papers","name":"Serotonin 5-HT2BReceptors Are Required for 3,4-Methylenedioxymethamphetamine-Induced Hyperlocomotion and 5-HT ReleaseIn VivoandIn Vitro","year":"2008","cit":146,"pfa":"Stéphane Doly","psa":"Luc Maroteaux","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2126218492","eid":"W2126218492"},{"id":"paper-w2326523421","cat":"papers","name":"LSD: My Problem Child","year":"1981","cit":146,"pfa":"Barbara Kohn","psa":"Albert Hofmann","ptype":"article","src":"https://openalex.org/W2326523421","eid":"W2326523421"},{"id":"paper-w1565032507","cat":"papers","name":"THE MORPHINE ABSTINENCE SYNDROME, ITS NATURE AND TREATMENT","year":"1941","cit":146,"pfa":"C. K. Himmelsbach","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1565032507","eid":"W1565032507"},{"id":"paper-w2919995896","cat":"papers","name":"5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) used in a naturalistic group setting is associated with unintended improvements in depression and anxiety","year":"2019","cit":145,"pfa":"Alan K. Davis","psa":"Roland R. Griffiths","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2919995896","eid":"W2919995896"},{"id":"paper-w2999261467","cat":"papers","name":"Ayahuasca’s ‘afterglow’: improved mindfulness and cognitive flexibility in ayahuasca drinkers","year":"2020","cit":145,"pfa":"Ashleigh Murphy-Beiner","psa":"Kirstie Soar","ptype":"article","src":"https://openalex.org/W2999261467","eid":"W2999261467"},{"id":"paper-w2015778368","cat":"papers","name":"Potential anxiolytic‐ and antidepressant‐like effects of salvinorin A, the main active ingredient of Salvia divinorum , in rodents","year":"2009","cit":145,"pfa":"Daniela Braida","psa":"Mariaelvina Sala","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2015778368","eid":"W2015778368"},{"id":"paper-w2060970768","cat":"papers","name":"“Partying” Hard: Party Style, Motives for and Effects of MDMA Use at Rave Parties","year":"2005","cit":145,"pfa":"Tom ter Bogt","psa":"Rutger C. M. E. Engels","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2060970768","eid":"W2060970768"},{"id":"paper-w2000881947","cat":"papers","name":"MDMA enhances “mind reading” of positive emotions and impairs “mind reading” of negative emotions","year":"2012","cit":145,"pfa":"Cédric M. Hysek","psa":"Matthias E. Liechti","ptype":"article","src":"https://openalex.org/W2000881947","eid":"W2000881947"},{"id":"paper-w2060188319","cat":"papers","name":"Potentiation of 3,4-methylenedioxymethamphetamine-induced dopamine release and serotonin neurotoxicity by 5-HT2 receptor agonists","year":"1994","cit":145,"pfa":"Gary A. Gudelsky","psa":"J. Frank Nash","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2060188319","eid":"W2060188319"},{"id":"paper-w4230167918","cat":"papers","name":"Entheogens","year":"1979","cit":145,"pfa":"Carl A. P. Ruck","psa":"R. Gordon Wasson","ptype":"article","src":"https://openalex.org/W4230167918","eid":"W4230167918"},{"id":"paper-w2560564128","cat":"papers","name":"Validation of a microdose probe drug cocktail for clinical drug interaction assessments for drug transporters and CYP3A","year":"2016","cit":145,"pfa":"Thomayant Prueksaritanont","psa":"SA Stoch","topics":["Anxiety & end-of-life","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2560564128","eid":"W2560564128"},{"id":"paper-w4206700491","cat":"papers","name":"Validation of the Psychological Insight Scale: A new scale to assess psychological insight following a psychedelic experience","year":"2022","cit":145,"pfa":"Joseph M. Peill","psa":"Robin Lester Carhart-Harris","ptype":"article","src":"https://openalex.org/W4206700491","eid":"W4206700491"},{"id":"paper-w3121381676","cat":"papers","name":"Lysergic acid diethylamide (LSD) promotes social behavior through mTORC1 in the excitatory neurotransmission","year":"2021","cit":144,"pfa":"Danilo De Gregorio","psa":"Gabriella Gobbi","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3121381676","eid":"W3121381676"},{"id":"paper-w2159917347","cat":"papers","name":"A Fatal Intoxication Following the Ingestion of 5-Methoxy-N,N-Dimethyltryptamine in an Ayahuasca Preparation*","year":"2005","cit":144,"pfa":"J. H. Sklerov","psa":"David R. Fowler","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2159917347","eid":"W2159917347"},{"id":"paper-w3090852378","cat":"papers","name":"N,N-dimethyltryptamine compound found in the hallucinogenic tea ayahuasca, regulates adult neurogenesis in vitro and in vivo","year":"2020","cit":144,"pfa":"Jose Angel Morales-Garcia","psa":"Ana Pérez‐Castillo","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3090852378","eid":"W3090852378"},{"id":"paper-w2053392800","cat":"papers","name":"Ibogaine possesses a selective affinity for σ2 receptors","year":"1995","cit":144,"pfa":"Robert H. Mach","psa":"Steven R. Childers","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2053392800","eid":"W2053392800"},{"id":"paper-w3029961383","cat":"papers","name":"Ethics and ego dissolution: the case of psilocybin","year":"2020","cit":144,"pfa":"William Smith","psa":"Dominic A. Sisti","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3029961383","eid":"W3029961383"},{"id":"paper-w2146745496","cat":"papers","name":"In vivo detection of short- and long-term MDMA neurotoxicity?a positron emission tomography study in the living baboon brain","year":"1998","cit":144,"pfa":"Ursula Scheffel","psa":"George A. Ricaurte","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2146745496","eid":"W2146745496"},{"id":"paper-w3120778817","cat":"papers","name":"Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants","year":"2021","cit":144,"pfa":"Nicole Leite Galvão Coelho","psa":"Jerome J. Sarris","topics":["Depression","Reviews & meta-analyses","Therapy practice"],"ptype":"review","src":"https://openalex.org/W3120778817","eid":"W3120778817"},{"id":"paper-w2121872553","cat":"papers","name":"The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3, 4-methylenedioxymethamphetamine (‘Ecstasy’) in healthy volunteers","year":"2000","cit":144,"pfa":"Matthias E. Liechti","psa":"Franz X. Vollenweider","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2121872553","eid":"W2121872553"},{"id":"paper-w2087693218","cat":"papers","name":"Rapid and transient inhibition of mitochondrial function following methamphetamine or 3,4-methylenedioxymethamphetamine administration","year":"2000","cit":144,"pfa":"Kristan B. Burrows","psa":"Bryan K. Yamamoto","ptype":"article","src":"https://openalex.org/W2087693218","eid":"W2087693218"},{"id":"paper-w2890337129","cat":"papers","name":"Individual and combined effects of acute delta-9-tetrahydrocannabinol and cannabidiol on psychotomimetic symptoms and memory function","year":"2018","cit":144,"pfa":"Celia J. A. Morgan","psa":"Helen Valerie Curran","ptype":"article","src":"https://openalex.org/W2890337129","eid":"W2890337129"},{"id":"paper-w1601512098","cat":"papers","name":"Pharmacokinetic interaction study of sulphasalazine in healthy subjects and the impact of curcumin as anin vivoinhibitor of BCRP","year":"2012","cit":144,"pfa":"Hiroyuki Kusuhara","psa":"Yuichi Sugiyama","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1601512098","eid":"W1601512098"},{"id":"paper-w2802902398","cat":"papers","name":"The epidemiology of 5-methoxy- N, N -dimethyltryptamine (5-MeO-DMT) use: Benefits, consequences, patterns of use, subjective effects, and reasons for consumption","year":"2018","cit":143,"pfa":"Alan K. Davis","psa":"Elise Renn","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W2802902398","eid":"W2802902398"},{"id":"paper-w2810710828","cat":"papers","name":"DARK Classics in Chemical Neuroscience: Psilocybin","year":"2018","cit":143,"pfa":"Haden A. Geiger","psa":"R. Nathan Daniels","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2810710828","eid":"W2810710828"},{"id":"paper-w2025649131","cat":"papers","name":"Fatal interaction between ritonavir and MDMA","year":"1998","cit":143,"pfa":"JA Henry","psa":"I R Hill","ptype":"article","src":"https://openalex.org/W2025649131","eid":"W2025649131"},{"id":"paper-w2045231516","cat":"papers","name":"Effects of MDMA and Intranasal Oxytocin on Social and Emotional Processing","year":"2014","cit":143,"pfa":"Matthew G. Kirkpatrick","psa":"Harriet de Wit","ptype":"article","src":"https://openalex.org/W2045231516","eid":"W2045231516"},{"id":"paper-w2218174899","cat":"papers","name":"3,4-Methylenedioxymethamphetamine facilitates fear extinction learning","year":"2015","cit":143,"pfa":"M B Young","psa":"Leonard Lee Howell","topics":["PTSD & trauma","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2218174899","eid":"W2218174899"},{"id":"paper-w2012162755","cat":"papers","name":"On the Use and Abuse of LSD","year":"1968","cit":143,"pfa":"Daniel X. Freedman","ptype":"article","src":"https://openalex.org/W2012162755","eid":"W2012162755"},{"id":"paper-w1979642301","cat":"papers","name":"Cannabidiol inhibitory effect on marble-burying behaviour: involvement of CB1 receptors","year":"2010","cit":143,"pfa":"Plinio Cabrera Casarotto","psa":"Francisco Silveira Guimarães","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W1979642301","eid":"W1979642301"},{"id":"paper-w2592938514","cat":"papers","name":"Cannabidiol regulation of emotion and emotional memory processing: relevance for treating anxiety‐related and substance abuse disorders","year":"2017","cit":143,"pfa":"Jonathan L. C. Lee","psa":"Carl W. Stevenson","topics":["PTSD & trauma","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2592938514","eid":"W2592938514"},{"id":"paper-w4296935166","cat":"papers","name":"Real-world experience of esketamine use to manage treatment-resistant depression: A multicentric study on safety and effectiveness (REAL-ESK study)","year":"2022","cit":143,"pfa":"Giovanni Martinotti","psa":"Massimo Di Giannantonio","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4296935166","eid":"W4296935166"},{"id":"paper-w2086963232","cat":"papers","name":"Study of Lysergic Acid Diethylamide as an Analgesic Agent","year":"1964","cit":142,"pfa":"Eric C. Kast","psa":"Vincent J. Collins","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2086963232","eid":"W2086963232"},{"id":"paper-w3179473685","cat":"papers","name":"Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experience","year":"2021","cit":142,"pfa":"Martin Korsbak Madsen","psa":"Patrick M. Fisher","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3179473685","eid":"W3179473685"},{"id":"paper-w2062339243","cat":"papers","name":"Pharmacology of ayahuasca administered in two repeated doses","year":"2011","cit":142,"pfa":"RAFAEL GUIMARÃES DOS SANTOS","psa":"Jordi Riba","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2062339243","eid":"W2062339243"},{"id":"paper-w2061993323","cat":"papers","name":"Drug discrimination studies with MDMA and amphetamine","year":"1988","cit":142,"pfa":"Robert A. Oberlender","psa":"DavidE. Nichols","ptype":"article","src":"https://openalex.org/W2061993323","eid":"W2061993323"},{"id":"paper-w2923355729","cat":"papers","name":"A Review of 3,4-methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy","year":"2019","cit":142,"pfa":"Ben Sessa","psa":"David Nutt","topics":["PTSD & trauma","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2923355729","eid":"W2923355729"},{"id":"paper-w2014596337","cat":"papers","name":"Hallucinatory and rewarding effect of salvinorin A in zebrafish: κ-opioid and CB1-cannabinoid receptor involvement","year":"2007","cit":142,"pfa":"Daniela Braida","psa":"Mariaelvina Sala","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2014596337","eid":"W2014596337"},{"id":"paper-w2138700431","cat":"papers","name":"Ecstasy, 3–4 Methylenedioxymethamphetamine (MDMA), a Fatality Associated with Coagulopathy and Hyperthermia","year":"1991","cit":142,"pfa":"I. S. Chadwick","psa":"B. R. H. Doran","ptype":"article","src":"https://openalex.org/W2138700431","eid":"W2138700431"},{"id":"paper-w2104270720","cat":"papers","name":"Is MDMA (‘Ecstasy’) Neurotoxic in Humans? An Overview of Evidence and of Methodological Problems in Research","year":"2000","cit":142,"pfa":"Helen Valerie Curran","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2104270720","eid":"W2104270720"},{"id":"paper-w3210733143","cat":"papers","name":"MDMA‐Assisted Psychotherapy for Treatment of Posttraumatic Stress Disorder: A Systematic Review With Meta‐Analysis","year":"2021","cit":142,"pfa":"Kimberly W. Smith","psa":"Charles Michael White","topics":["PTSD & trauma","Anxiety & end-of-life","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W3210733143","eid":"W3210733143"},{"id":"paper-w2767725891","cat":"papers","name":"Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: similarities and differences in subjective experiences","year":"2017","cit":142,"pfa":"Theresa M. Carbonaro","psa":"Roland R. Griffiths","ptype":"article","src":"https://openalex.org/W2767725891","eid":"W2767725891"},{"id":"paper-w1982709634","cat":"papers","name":"Serotonin receptor cDNA cloned from Lymnaea stagnalis.","year":"1993","cit":142,"pfa":"Kim S. Sugamori","psa":"Hubert H.M. Van Tol","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1982709634","eid":"W1982709634"},{"id":"paper-w2146353697","cat":"papers","name":"3,4-Methylenedioxymethamphetamine (Ecstasy)-Induced Learning and Memory Impairments Depend on the Age of Exposure during Early Development","year":"2001","cit":142,"pfa":"Harry W. Broening","psa":"Charles V. Vorhees","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2146353697","eid":"W2146353697"},{"id":"paper-w2143350277","cat":"papers","name":"Hallucinogenic Drugs and Plants in Psychotherapy and Shamanism","year":"1998","cit":142,"pfa":"Ralph Metzner","topics":["Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2143350277","eid":"W2143350277"},{"id":"paper-w1576456598","cat":"papers","name":"The Varieties of Psychedelic Experience","year":"1968","cit":142,"ptype":"article","src":"https://openalex.org/W1576456598","eid":"W1576456598"},{"id":"paper-w1534748687","cat":"papers","name":"Psychotomimetics as anticholinergic agents—I","year":"1974","cit":142,"pfa":"Saul Maayani","psa":"Mordechai Sokolovsky","ptype":"article","src":"https://openalex.org/W1534748687","eid":"W1534748687"},{"id":"paper-w2925936518","cat":"papers","name":"How to Change Your Mind: What the New Science of Psychedelics Teaches Us About Consciousness, Dying, Addiction, Depression, and Transcendence","year":"2019","cit":142,"pfa":"Lindsay Haines","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W2925936518","eid":"W2925936518"},{"id":"paper-w2007529900","cat":"papers","name":"Pathological Gambling Among Youthful Multiple Substance Abusers in a Therapeutic Community","year":"1988","cit":142,"pfa":"Henry R. Lesieur","psa":"Mary Heineman","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2007529900","eid":"W2007529900"},{"id":"paper-w97709551","cat":"papers","name":"The Therapeutic Use of Ayahuasca","year":"2013","cit":141,"pfa":"Beatriz Caiuby Labate","psa":"Clancy Cavnar","ptype":"book","src":"https://openalex.org/W97709551","eid":"W97709551"},{"id":"paper-w1974109667","cat":"papers","name":"Konstitutionsaufklärung und Synthese von Psilocybin","year":"1958","cit":141,"pfa":"Alfred André Hofmann","psa":"F. Troxler","ptype":"article","src":"https://openalex.org/W1974109667","eid":"W1974109667"},{"id":"paper-w2008812687","cat":"papers","name":"Self-administration of methylenedioxymethamphetamine (MDMA) by rhesus monkeys","year":"1986","cit":141,"pfa":"Patrick M. Beardsley","psa":"Louis S. Harris","ptype":"article","src":"https://openalex.org/W2008812687","eid":"W2008812687"},{"id":"paper-w2041742732","cat":"papers","name":"Mechanisms of action of ibogaine and harmaline congeners based on radioligand binding studies","year":"1992","cit":141,"pfa":"Darlene C. Deecher","psa":"Stanley D. Glick","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2041742732","eid":"W2041742732"},{"id":"paper-w3105240299","cat":"papers","name":"Exploratory Controlled Study of the Migraine-Suppressing Effects of Psilocybin","year":"2020","cit":141,"pfa":"Emmanuelle A. D. Schindler","psa":"Deepak Cyril D’Souza","ptype":"article","src":"https://openalex.org/W3105240299","eid":"W3105240299"},{"id":"paper-w2087940450","cat":"papers","name":"Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on monoamines in rat caudate","year":"1991","cit":141,"pfa":"B. Gough","psa":"R.Robert Holson","ptype":"article","src":"https://openalex.org/W2087940450","eid":"W2087940450"},{"id":"paper-w2015485611","cat":"papers","name":"Actions of 3,4-methylenedioxymethamphetamine (MDMA) on cerebral dopaminergic, serotonergic and cholinergic neurons","year":"2007","cit":141,"pfa":"Gary A. Gudelsky","psa":"Bryan K. Yamamoto","ptype":"article","src":"https://openalex.org/W2015485611","eid":"W2015485611"},{"id":"paper-w2046209054","cat":"papers","name":"Subtypes of the 5-HT receptor mediating the behavioural responses to 5-methoxy-N,N-dimethyltryptamine in the rat","year":"1985","cit":141,"pfa":"Mark David Tricklebank","psa":"John R. Fozard","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2046209054","eid":"W2046209054"},{"id":"paper-w1992116349","cat":"papers","name":"Elevated impulsivity and impaired decision-making cognition in heavy users of MDMA (“Ecstasy”)","year":"2006","cit":141,"pfa":"Boris B. Quednow","psa":"Michael Wagner","ptype":"article","src":"https://openalex.org/W1992116349","eid":"W1992116349"},{"id":"paper-w2025131082","cat":"papers","name":"Cardiovascular Effects of 3,4-Methylenedioxymethamphetamine: A Double-Blind, Placebo-Controlled Trial","year":"2000","cit":141,"pfa":"Steven J. Lester","psa":"John E. Mendelson","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2025131082","eid":"W2025131082"},{"id":"paper-w2412432222","cat":"papers","name":"Psychedelic Agents in Creative Problem-Solving: A Pilot Study","year":"1966","cit":141,"pfa":"Willis W. Harman","psa":"Myron J. Stolaroff","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2412432222","eid":"W2412432222"},{"id":"paper-w3149986569","cat":"papers","name":"Ethical and legal issues in psychedelic harm reduction and integration therapy","year":"2021","cit":141,"pfa":"Brian C. Pilecki","psa":"Vilmarie Fraguada Narloch","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3149986569","eid":"W3149986569"},{"id":"paper-w62922542","cat":"papers","name":"Psychedelic drugs and mystical experience.","year":"1969","cit":141,"pfa":"Pahnke Wn","ptype":"article","src":"https://openalex.org/W62922542","eid":"W62922542"},{"id":"paper-w3010363778","cat":"papers","name":"Updating the dynamic framework of thought: Creativity and psychedelics","year":"2020","cit":141,"pfa":"Manesh Girn","psa":"Kalina Christoff","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3010363778","eid":"W3010363778"},{"id":"paper-w2897080393","cat":"papers","name":"The Psychedelic Explorer's Guide: Safe, Therapeutic, and Sacred Journeys","year":"2011","cit":141,"pfa":"James Fadiman","ptype":"book","src":"https://openalex.org/W2897080393","eid":"W2897080393"},{"id":"paper-w2054448912","cat":"papers","name":"A controlled trial of natural cycle versus microdose gonadotropin-releasing hormone analog flare cycles in poor responders undergoing in vitro fertilization","year":"2004","cit":141,"pfa":"Francesco Morgia","psa":"Cesare Aragona","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2054448912","eid":"W2054448912"},{"id":"paper-w2047622645","cat":"papers","name":"Analgesic effectiveness of the narcotic agonist‐antagonists.","year":"1979","cit":141,"pfa":"Houde Rw","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2047622645","eid":"W2047622645"},{"id":"paper-w4293582084","cat":"papers","name":"Experimenters’ sex modulates mouse behaviors and neural responses to ketamine via corticotropin releasing factor","year":"2022","cit":141,"pfa":"Polymnia Georgiou","psa":"Todd D. Gould","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4293582084","eid":"W4293582084"},{"id":"paper-w2152569564","cat":"papers","name":"Adverse consequences of lysergic acid diethylamide","year":"1993","cit":140,"pfa":"Henry David Abraham","psa":"Andrew M. Aldridge","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2152569564","eid":"W2152569564"},{"id":"paper-w1992914052","cat":"papers","name":"Autonomic, Neuroendocrine, and Immunological Effects of Ayahuasca","year":"2011","cit":140,"pfa":"RAFAEL GUIMARÃES DOS SANTOS","psa":"Jordi Riba","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1992914052","eid":"W1992914052"},{"id":"paper-w4289518537","cat":"papers","name":"Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study","year":"2022","cit":140,"pfa":"Federico Cavanna","psa":"Enzo Tagliazucchi","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4289518537","eid":"W4289518537"},{"id":"paper-w2118107039","cat":"papers","name":"3,4-Methylenedioxymethamphetamine (MDMA, \"ecstasy\") and its stereoisomers as reinforcers in rhesus monkeys: serotonergic involvement","year":"2002","cit":140,"pfa":"William E. Fantegrossi","psa":"Gail D. Winger","ptype":"article","src":"https://openalex.org/W2118107039","eid":"W2118107039"},{"id":"paper-w4393253405","cat":"papers","name":"Efficacy and safety of psychedelics for the treatment of mental disorders: A systematic review and meta-analysis","year":"2024","cit":140,"pfa":"Yuan Yao","psa":"Ying Han","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4393253405","eid":"W4393253405"},{"id":"paper-w1988432402","cat":"papers","name":"Pharmahuasca: Human Pharmacology of Oral DMT Plus Harmine","year":"1999","cit":140,"pfa":"Jonathan Ott","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1988432402","eid":"W1988432402"},{"id":"paper-w2898717395","cat":"papers","name":"How do psychedelics work?","year":"2018","cit":140,"pfa":"Robin Lester Carhart-Harris","topics":["Mechanism & neuroscience","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2898717395","eid":"W2898717395"},{"id":"paper-w4239734876","cat":"papers","name":"Psychedelic Psychiatry","year":"2008","cit":140,"pfa":"Erika Dyck","ptype":"book","src":"https://openalex.org/W4239734876","eid":"W4239734876"},{"id":"paper-w2075851250","cat":"papers","name":"Polydrug Use in Adolescent Drinkers with and without DSM‐IV Alcohol Abuse and Dependence","year":"1996","cit":140,"pfa":"Christopher S. Martin","psa":"Ralph E. Tarter","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2075851250","eid":"W2075851250"},{"id":"paper-w2415104265","cat":"papers","name":"Receptor mechanisms in antipsychotic drug action: focus on sigma receptors","year":"1989","cit":140,"pfa":"S H Snyder","psa":"Brian L. Largent","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2415104265","eid":"W2415104265"},{"id":"paper-w2761558601","cat":"papers","name":"Short term changes in the proteome of human cerebral organoids induced by 5-MeO-DMT","year":"2017","cit":139,"pfa":"Vanja Dakic","psa":"Stevens Kastrup Rehen","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2761558601","eid":"W2761558601"},{"id":"paper-w2040034137","cat":"papers","name":"Comparison of the reactions induced by psilocybin and LSD-25 in man","year":"1959","cit":139,"pfa":"Harris Isbell","ptype":"article","src":"https://openalex.org/W2040034137","eid":"W2040034137"},{"id":"paper-w2135061845","cat":"papers","name":"Chronic exposure to MDMA (Ecstasy) elicits behavioral sensitization in rats but fails to induce cross-sensitization to other psychostimulants","year":"2006","cit":139,"pfa":"Gunjan M Modi","psa":"Nachum Dafny","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2135061845","eid":"W2135061845"},{"id":"paper-w2002412029","cat":"papers","name":"MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress","year":"2006","cit":139,"pfa":"Andy C. Parrott","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2002412029","eid":"W2002412029"},{"id":"paper-w3138429576","cat":"papers","name":"Acute and Sustained Reductions in Loss of Meaning and Suicidal Ideation Following Psilocybin-Assisted Psychotherapy for Psychiatric and Existential Distress in Life-Threatening Cancer","year":"2021","cit":139,"pfa":"Stephen Ross","psa":"Sarah E. Mennenga","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3138429576","eid":"W3138429576"},{"id":"paper-w1979307345","cat":"papers","name":"5‐HYDROXYTRYPTAMINE. PHARMACOLOGICAL ACTION AND DESTRUCTION IN PERFUSED LUNGS","year":"1953","cit":139,"pfa":"John Henry Gaddum","psa":"A. A. B. Swan","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1979307345","eid":"W1979307345"},{"id":"paper-w2043356853","cat":"papers","name":"Pharmacological profile of ritanserin: A very specific central serotonin S2‐antagonist","year":"1988","cit":139,"pfa":"Frans H. L. Awouters","psa":"Paul A. J. Janssen","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2043356853","eid":"W2043356853"},{"id":"paper-w3182695044","cat":"papers","name":"Serotonin toxicity of serotonergic psychedelics","year":"2021","cit":139,"pfa":"Benjamin Malcolm","psa":"Kelan L. H. Thomas","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3182695044","eid":"W3182695044"},{"id":"paper-w2108046512","cat":"papers","name":"Hallucinogens: Neurochemical, Behavioral, and Clinical Perspectives","year":"1985","cit":139,"pfa":"Peter Jenner","ptype":"article","src":"https://openalex.org/W2108046512","eid":"W2108046512"},{"id":"paper-w2765759410","cat":"papers","name":"Common Neurotransmission Recruited in (R,S)-Ketamine and (2R,6R)-Hydroxynorketamine–Induced Sustained Antidepressant-like Effects","year":"2017","cit":139,"pfa":"Thu Ha Pham","psa":"Alain Michel Gardier","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2765759410","eid":"W2765759410"},{"id":"paper-w2158336114","cat":"papers","name":"Simultaneous population pharmacokinetic modelling of ketamine and three major metabolites in patients with treatment‐resistant bipolar depression","year":"2012","cit":139,"pfa":"Xiaochen Zhao","psa":"Irving W. Wainer","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2158336114","eid":"W2158336114"},{"id":"paper-w2019004642","cat":"papers","name":"Cross tolerance between LSD and psilocybin","year":"1961","cit":138,"pfa":"Harris Isbell","psa":"Edward J. Miner","ptype":"article","src":"https://openalex.org/W2019004642","eid":"W2019004642"},{"id":"paper-w2055682898","cat":"papers","name":"Antinociceptive profile of salvinorin A, a structurally unique kappa opioid receptor agonist","year":"2006","cit":138,"pfa":"Christopher R. McCurdy","psa":"Marcelo J. Nieto","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2055682898","eid":"W2055682898"},{"id":"paper-w1969572685","cat":"papers","name":"Attenuation of alcohol intake by Ibogaine in three strains of alcohol-preferring rats","year":"1995","cit":138,"pfa":"Amir H. Rezvani","psa":"Yue-Wei Leef","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1969572685","eid":"W1969572685"},{"id":"paper-w2166891211","cat":"papers","name":"Club drugs: MDMA, gamma-hydroxybutyrate (GHB), Rohypnol, and ketamine.","year":"2004","cit":138,"pfa":"Paul M. Gahlinger","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2166891211","eid":"W2166891211"},{"id":"paper-w2065859973","cat":"papers","name":"Recreational use of 3,4-methylenedioxymethamphetamine (MDMA) or ‘ecstasy’: evidence for cognitive impairment","year":"2001","cit":138,"pfa":"SARAJANE BHATTACHARY","psa":"Jane H. Powell","ptype":"article","src":"https://openalex.org/W2065859973","eid":"W2065859973"},{"id":"paper-w2121524779","cat":"papers","name":"Residual neuropsychological effects of illicit 3,4-methylenedioxymethamphetamine (MDMA) in individuals with minimal exposure to other drugs","year":"2004","cit":138,"pfa":"John H. Halpern","psa":"Deborah A Yurgelun-Todd","ptype":"article","src":"https://openalex.org/W2121524779","eid":"W2121524779"},{"id":"paper-w1976410688","cat":"papers","name":"Voice of the Psychonauts: Coping, Life Purpose, and Spirituality in Psychedelic Drug Users","year":"2011","cit":138,"pfa":"Levente Móró","psa":"József Rácz","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W1976410688","eid":"W1976410688"},{"id":"paper-w2119283923","cat":"papers","name":"Stereospecific Analysis and Enantiomeric Disposition of 3,4-Methylenedioxymethamphetamine (Ecstasy) in Humans","year":"1999","cit":138,"pfa":"John K. Fallon","psa":"Andrew J. Hutt","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2119283923","eid":"W2119283923"},{"id":"paper-w2165533815","cat":"papers","name":"Norbin Is an Endogenous Regulator of Metabotropic Glutamate Receptor 5 Signaling","year":"2009","cit":138,"pfa":"Hong Wang","psa":"Paul Greengard","topics":["Depression","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2165533815","eid":"W2165533815"},{"id":"paper-w2046037125","cat":"papers","name":"Activation of Metabotropic Glutamate 2/3 Receptors Reverses the Effects of NMDA Receptor Hypofunction on Prefrontal Cortex Unit Activity in Awake Rats","year":"2005","cit":138,"pfa":"Houman Homayoun","psa":"Bita Moghaddam","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2046037125","eid":"W2046037125"},{"id":"paper-w4280521929","cat":"papers","name":"Effect of AXS-05 (Dextromethorphan-Bupropion) in Major Depressive Disorder: A Randomized Double-Blind Controlled Trial","year":"2022","cit":138,"pfa":"Herriot Tabuteau","psa":"Dan Vlad Iosifescu","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4280521929","eid":"W4280521929"},{"id":"paper-w2328159225","cat":"papers","name":"PSYCHOTHERAPY WITH LYSERGIC ACID DIETHYLAMIDE","year":"1958","cit":137,"pfa":"Betty Grover Eisner","psa":"Sidney Cohen","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2328159225","eid":"W2328159225"},{"id":"paper-w1898795278","cat":"papers","name":"LYSERGIC ACID DIETHYLAMIDE (LSD-25)","year":"1952","cit":137,"pfa":"Charles Savage","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1898795278","eid":"W1898795278"},{"id":"paper-w2014982335","cat":"papers","name":"MDMA use and neurocognition: a meta-analytic review","year":"2006","cit":137,"pfa":"Ari D. Kalechstein","psa":"Thomas F. Newton","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2014982335","eid":"W2014982335"},{"id":"paper-w3143890706","cat":"papers","name":"Spontaneous and deliberate creative cognition during and after psilocybin exposure","year":"2021","cit":137,"pfa":"Natasha Leigh Mason","psa":"Johannes Gerardus Ramaekers","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3143890706","eid":"W3143890706"},{"id":"paper-w2147271251","cat":"papers","name":"Human psychopharmacology and dose-effects of salvinorin A, a kappa opioid agonist hallucinogen present in the plant Salvia divinorum","year":"2010","cit":137,"pfa":"Matthew W. Johnson","psa":"Roland R. Griffiths","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2147271251","eid":"W2147271251"},{"id":"paper-w4315620578","cat":"papers","name":"Shared and Distinct Brain Regions Targeted for Immediate Early Gene Expression by Ketamine and Psilocybin","year":"2023","cit":137,"pfa":"Pasha A. Davoudian","psa":"Alex C. Kwan","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4315620578","eid":"W4315620578"},{"id":"paper-w3112173414","cat":"papers","name":"The History of Psychedelics in Psychiatry","year":"2020","cit":137,"pfa":"David E. Nichols","psa":"Hannes Walter","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W3112173414","eid":"W3112173414"},{"id":"paper-w1893475387","cat":"papers","name":"Pharmacological Studies of the Acute and Chronic Effects of (+)-3,4-Methylenedioxymethamphetamine on Locomotor Activity: Role of 5-Hydroxytryptamine1A and 5-Hydroxytryptamine1B/1D Receptors","year":"1999","cit":137,"pfa":"Andrew C. McCreary","psa":"Kathryn A. Cunningham","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1893475387","eid":"W1893475387"},{"id":"paper-w2019924561","cat":"papers","name":"Increased anxiety and impaired memory in rats 3 months after administration of 3,4-methylenedioxymethamphetamine (“Ecstasy”)","year":"2001","cit":137,"pfa":"Kirsten C. Morley","psa":"Iain S. McGregor","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2019924561","eid":"W2019924561"},{"id":"paper-w2790959730","cat":"papers","name":"Serotonergic psychedelics and personality: A systematic review of contemporary research","year":"2018","cit":137,"pfa":"José Carlos Bouso","psa":"Jaime E. C. Hallak","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W2790959730","eid":"W2790959730"},{"id":"paper-w4318754695","cat":"papers","name":"Prevalence and associations of challenging, difficult or distressing experiences using classic psychedelics","year":"2023","cit":137,"pfa":"Otto Simonsson","psa":"Simon Benjamin Goldberg","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4318754695","eid":"W4318754695"},{"id":"paper-w4313201591","cat":"papers","name":"Ethical principles of traditional Indigenous medicine to guide western psychedelic research and practice","year":"2022","cit":137,"pfa":"Yuria Celidwen","psa":"Angelina Sacbajá","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4313201591","eid":"W4313201591"},{"id":"paper-w1996517694","cat":"papers","name":"The Psychotomimetic States Inventory (PSI): Measuring psychotic-type experiences from ketamine and cannabis","year":"2008","cit":137,"pfa":"Oliver John Mason","psa":"Helen Valerie Curran","ptype":"article","src":"https://openalex.org/W1996517694","eid":"W1996517694"},{"id":"paper-w2148291000","cat":"papers","name":"The Nonmedical Use of Ketamlne, Part Two: A Review of Problent Use and Dependence","year":"2001","cit":137,"pfa":"Karl L.R. Jansen","psa":"Rachael Darracot-Cankovic","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2148291000","eid":"W2148291000"},{"id":"paper-w2019379291","cat":"papers","name":"Developments in harmine pharmacology — Implications for ayahuasca use and drug-dependence treatment","year":"2012","cit":136,"pfa":"Daniel I. Brierley","psa":"Colin Davidson","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2019379291","eid":"W2019379291"},{"id":"paper-w2124133878","cat":"papers","name":"Ecstasy (MDMA) in Recreational Users: Self-Reported Psychological and Physiological Effects","year":"1997","cit":136,"pfa":"D. DAVISON","psa":"Andrew C. Parrott","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W2124133878","eid":"W2124133878"},{"id":"paper-w1997210023","cat":"papers","name":"Causes and consequences of the loss of serotonergic presynapses elicited by the consumption of 3,4-methylenedioxymethamphetamine (MDMA, ?ecstasy?) and its congeners","year":"1997","cit":136,"pfa":"Gerald Huether","psa":"Eckart R�ther","ptype":"article","src":"https://openalex.org/W1997210023","eid":"W1997210023"},{"id":"paper-w2093994427","cat":"papers","name":"Hallucinogenic drugs in pre-Columbian Mesoamerican cultures","year":"2014","cit":136,"pfa":"Francisco Javier Carod-Artal","ptype":"article","src":"https://openalex.org/W2093994427","eid":"W2093994427"},{"id":"paper-w2058217612","cat":"papers","name":"ANALGESIC ANTIPYRETIC DRUGS AS ANTAGONISTS OF BRADYKININ","year":"1960","cit":136,"pfa":"HARRY O. J. COLLIER","psa":"PATRICIA G. SHORLEY","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2058217612","eid":"W2058217612"},{"id":"paper-w2004671995","cat":"papers","name":"Lasting Neuropsychiatric Sequelae of (??)Methylenedioxymethamphetamine (???Ecstasy???) in Recreational Users","year":"1991","cit":136,"pfa":"Una D. McCann","psa":"Domenic A. Ciraulo","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2004671995","eid":"W2004671995"},{"id":"paper-w1972426098","cat":"papers","name":"Effect of Ring Fluorination on the Pharmacology of Hallucinogenic Tryptamines","year":"2000","cit":136,"pfa":"Joseph B. Blair","psa":"David E. Nichols","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1972426098","eid":"W1972426098"},{"id":"paper-w2040690369","cat":"papers","name":"Amphetamine Neurotoxicity: Cause and Consequence of Oxidative Stress","year":"2005","cit":136,"pfa":"Bryan K. Yamamoto","psa":"Michael G. Bankson","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2040690369","eid":"W2040690369"},{"id":"paper-w2400995186","cat":"papers","name":"Do classical hallucinogens act as 5-HT2 agonists or antagonists?","year":"1991","cit":136,"pfa":"Richard A. Glennon","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2400995186","eid":"W2400995186"},{"id":"paper-w2121744559","cat":"papers","name":"Comparisons of hallucinogenic phenylisopropylamine binding affinities at cloned human 5-HT2A, 5-HT2B and 5-HT2C receptors","year":"1999","cit":136,"pfa":"David L. Nelson","psa":"Richard A. Glennon","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2121744559","eid":"W2121744559"},{"id":"paper-w3082850425","cat":"papers","name":"Low Doses of LSD Acutely Increase BDNF Blood Plasma Levels in Healthy Volunteers","year":"2020","cit":136,"pfa":"Nadia R. P. W. Hutten","psa":"Kim P. C. Kuypers","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3082850425","eid":"W3082850425"},{"id":"paper-w2036492577","cat":"papers","name":"Regional Variations in the Pharmacology of NMDA Receptor Channel Blockers: Implications for Therapeutic Potential","year":"1995","cit":136,"pfa":"Richard H. P. Porter","psa":"J. Timothy Greenamyre","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2036492577","eid":"W2036492577"},{"id":"paper-w2038393570","cat":"papers","name":"The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs I: Antagonist correlation analysis","year":"1995","cit":136,"pfa":"David J. Fiorella","psa":"Jerrold C. Winter","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2038393570","eid":"W2038393570"},{"id":"paper-w2040542735","cat":"papers","name":"Conditioned aversion to saccharin by single administrations of mescaline and d-amphetamine","year":"1971","cit":135,"pfa":"Howard Cappell","psa":"A. Eugene LeBlanc","ptype":"article","src":"https://openalex.org/W2040542735","eid":"W2040542735"},{"id":"paper-w2081452182","cat":"papers","name":"Dose-related effects of salvinorin A in humans: dissociative, hallucinogenic, and memory effects","year":"2012","cit":135,"pfa":"Katherine A. MacLean","psa":"Roland R. Griffiths","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2081452182","eid":"W2081452182"},{"id":"paper-w2047887813","cat":"papers","name":"Subjective reports on the effects of the MDMA (‘ecstasy’) experience in humans","year":"1995","cit":135,"pfa":"Richard S. Cohen","ptype":"article","src":"https://openalex.org/W2047887813","eid":"W2047887813"},{"id":"paper-w2142285082","cat":"papers","name":"Ayahuasca Preparations and Serotonin Reuptake Inhibitors: A Potential Combination for Severe Adverse Interactions","year":"1998","cit":135,"pfa":"J. C. Callaway","psa":"Charles S. Grob","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2142285082","eid":"W2142285082"},{"id":"paper-w2162745202","cat":"papers","name":"Usefulness of Saliva for Measurement of 3,4-Methylenedioxymethamphetamine and Its Metabolites: Correlation with Plasma Drug Concentrations and Effect of Salivary pH","year":"2001","cit":135,"pfa":"Mèonica Navarro","psa":"Rafael de la Torre","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2162745202","eid":"W2162745202"},{"id":"paper-w2741751536","cat":"papers","name":"Multiple DSM‐5 substance use disorders: A national study of US adults","year":"2017","cit":135,"pfa":"Sean Esteban McCabe","psa":"Carol J. Boyd","topics":["PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W2741751536","eid":"W2741751536"},{"id":"paper-w2023187443","cat":"papers","name":"Comparative pharmacology in the rat of ketamine and its two principal metabolites, norketamine and (Z)-6-hydroxynorketamine","year":"1986","cit":135,"pfa":"Louis Y. Leung","psa":"Thomas A. Baillie","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2023187443","eid":"W2023187443"},{"id":"paper-w2589071607","cat":"papers","name":"Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide in Healthy Subjects","year":"2017","cit":134,"pfa":"Patrick C. Dolder","psa":"Matthias E. Liechti","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2589071607","eid":"W2589071607"},{"id":"paper-w2036570302","cat":"papers","name":"Thermoregulatory effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans","year":"2005","cit":134,"pfa":"Robert R. Freedman","psa":"Manuel E. Tancer","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2036570302","eid":"W2036570302"},{"id":"paper-w2069090513","cat":"papers","name":"Review article: mechanisms and management of hepatotoxicity in ecstasy (MDMA) and amphetamine intoxications","year":"1999","cit":134,"pfa":"Jones","psa":"Simpson","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2069090513","eid":"W2069090513"},{"id":"paper-w2054897664","cat":"papers","name":"Locomotor stimulation produced by 3,4-methylenedioxymethamphetamine (MDMA) is correlated with dialysate levels of serotonin and dopamine in rat brain","year":"2008","cit":134,"pfa":"Michael H. Baumann","psa":"Richard B. Rothman","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2054897664","eid":"W2054897664"},{"id":"paper-w2985843276","cat":"papers","name":"Psychedelic drugs—a new era in psychiatry?","year":"2019","cit":134,"pfa":"David Nutt","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W2985843276","eid":"W2985843276"},{"id":"paper-w2946918750","cat":"papers","name":"Motives and Side-Effects of Microdosing With Psychedelics Among Users","year":"2019","cit":134,"pfa":"Nadia R. P. W. Hutten","psa":"Kim P. C. Kuypers","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2946918750","eid":"W2946918750"},{"id":"paper-w2133147215","cat":"papers","name":"Triptans, Serotonin Agonists, and Serotonin Syndrome (Serotonin Toxicity): A Review","year":"2009","cit":134,"pfa":"Peter Kenneth Gillman","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2133147215","eid":"W2133147215"},{"id":"paper-w2051764111","cat":"papers","name":"2-[125I]Iodomelatonin Binding Sites in Hamster Brain Membranes: Pharmacological Characteristics and Regional Distribution*","year":"1988","cit":134,"pfa":"Marilyn J. Duncan","psa":"Margarita L. Dubocovich","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2051764111","eid":"W2051764111"},{"id":"paper-w2119220314","cat":"papers","name":"PSD-95 Is Essential for Hallucinogen and Atypical Antipsychotic Drug Actions at Serotonin Receptors","year":"2009","cit":134,"pfa":"Atheir I. Abbas","psa":"Bryan L. Roth","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2119220314","eid":"W2119220314"},{"id":"paper-w2033034887","cat":"papers","name":"The Hallucinogen DOI Reduces Low-Frequency Oscillations in Rat Prefrontal Cortex: Reversal by Antipsychotic Drugs","year":"2008","cit":134,"pfa":"Pau Celada","psa":"Francesc Artigas","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2033034887","eid":"W2033034887"},{"id":"paper-w2051166675","cat":"papers","name":"Direct and Indirect Modulation of the N-Methyl D-Aspartate Receptor: Potential for the Development of Novel Antipsychotic Therapies","year":"2002","cit":134,"pfa":"Michael J. Marino","psa":"P. Jeffrey Conn","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2051166675","eid":"W2051166675"},{"id":"paper-w2144602786","cat":"papers","name":"Cannabidiol inhibits the reward‐facilitating effect of morphine: involvement of 5‐HT1A receptors in the dorsal raphe nucleus","year":"2012","cit":134,"pfa":"Vicky Katsidoni","psa":"George Panagis","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2144602786","eid":"W2144602786"},{"id":"paper-w2897395578","cat":"papers","name":"Molecular Pharmacology and Neurobiology of Rapid-Acting Antidepressants","year":"2018","cit":134,"pfa":"Todd D. Gould","psa":"Scott M. Thompson","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W2897395578","eid":"W2897395578"},{"id":"paper-w2588408561","cat":"papers","name":"Ketamine and Beyond: Investigations into the Potential of Glutamatergic Agents to Treat Depression","year":"2017","cit":134,"pfa":"Marc S. Lener","psa":"Carlos A. Zarate","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2588408561","eid":"W2588408561"},{"id":"paper-w2087295746","cat":"papers","name":"Effects of the Selective 5-HT2A Receptor Antagonist MDL 100,907 on MDMA-Induced Locomotor Stimulation in Rats","year":"1996","cit":133,"pfa":"John H. Kehne","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2087295746","eid":"W2087295746"},{"id":"paper-w2065524454","cat":"papers","name":"Reduced cortical gray matter density in human MDMA (Ecstasy) users: a voxel-based morphometry study","year":"2003","cit":133,"pfa":"Ronald L. Cowan","psa":"Perry Franklin Renshaw","ptype":"article","src":"https://openalex.org/W2065524454","eid":"W2065524454"},{"id":"paper-w2033282483","cat":"papers","name":"Acute Prosocial Effects of Oxytocin and Vasopressin When Given Alone or in Combination with 3,4-Methylenedioxymethamphetamine in Rats: Involvement of the V1A Receptor","year":"2013","cit":133,"pfa":"Linnet Ramos","psa":"Iain S. McGregor","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2033282483","eid":"W2033282483"},{"id":"paper-w3126615622","cat":"papers","name":"Prevention and treatment of PTSD: the current evidence base","year":"2021","cit":133,"pfa":"Jonathan I. Bisson","psa":"Miranda Olff","topics":["PTSD & trauma","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"editorial","src":"https://openalex.org/W3126615622","eid":"W3126615622"},{"id":"paper-w2067937090","cat":"papers","name":"GLYX-13, an NMDA receptor glycine site functional partial agonist enhances cognition and produces antidepressant effects without the psychotomimetic side effects of NMDA receptor antagonists","year":"2013","cit":133,"pfa":"Joseph R. Moskal","psa":"J. David Leander","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2067937090","eid":"W2067937090"},{"id":"paper-w4240049843","cat":"papers","name":"Subanesthetic Doses of Ketamine Stimulate Psychosis in Schizophrenia","year":"1995","cit":133,"pfa":"Adrienne Carol Lahti","psa":"Carol A. Tamminga","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4240049843","eid":"W4240049843"},{"id":"paper-w2330498227","cat":"papers","name":"Preventive effects of minocycline in a neurodevelopmental two-hit model with relevance to schizophrenia","year":"2016","cit":133,"pfa":"Sandra Giovanoli","psa":"Urs Meyer","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2330498227","eid":"W2330498227"},{"id":"paper-w4281570368","cat":"papers","name":"Efficacy and Safety of AXS-05 (Dextromethorphan-Bupropion) in Patients With Major Depressive Disorder","year":"2022","cit":133,"pfa":"Dan Vlad Iosifescu","psa":"Herriot Tabuteau","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4281570368","eid":"W4281570368"},{"id":"paper-w4378174725","cat":"papers","name":"Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants","year":"2023","cit":132,"pfa":"Laura Ley","psa":"Matthias E. Liechti","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4378174725","eid":"W4378174725"},{"id":"paper-w2115359142","cat":"papers","name":"Differential tolerance to biological and subjective effects of four closely spaced doses of N,N-dimethyltryptamine in humans","year":"1996","cit":132,"pfa":"Rick J. Strassman","psa":"Laura M. Berg","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2115359142","eid":"W2115359142"},{"id":"paper-w2046054359","cat":"papers","name":"MDMA (“Ecstasy”) Abuse and High-Risk Sexual Behaviors Among 169 Gay and Bisexual Men","year":"2000","cit":132,"pfa":"Robert Klitzman","psa":"James I. Hudson","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2046054359","eid":"W2046054359"},{"id":"paper-w1980721637","cat":"papers","name":"Effects of the South American Psychoactive Beverage Ayahuasca on Regional Brain Electrical Activity in Humans: A Functional Neuroimaging Study Using Low-Resolution Electromagnetic Tomography","year":"2004","cit":132,"pfa":"Jordi Riba","psa":"Manel J. Barbanoj","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1980721637","eid":"W1980721637"},{"id":"paper-w2006073621","cat":"papers","name":"5‐HT loss in rat brain following 3, 4‐methylenedioxymethamphetamine (MDMA), p‐chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine","year":"1993","cit":132,"pfa":"María Isabel Colado","psa":"A.R. Green","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2006073621","eid":"W2006073621"},{"id":"paper-w4387019277","cat":"papers","name":"History repeating: guidelines to address common problems in psychedelic science","year":"2023","cit":132,"pfa":"Michiel van Elk","psa":"Eiko I. Fried","topics":["Safety & adverse events","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4387019277","eid":"W4387019277"},{"id":"paper-w2552761136","cat":"papers","name":"A Review of Hallucinogen Persisting Perception Disorder (HPPD) and an Exploratory Study of Subjects Claiming Symptoms of HPPD","year":"2016","cit":132,"pfa":"John H. Halpern","psa":"Torsten Passie","topics":["Reviews & meta-analyses"],"ptype":"book-chapter","src":"https://openalex.org/W2552761136","eid":"W2552761136"},{"id":"paper-w2518262606","cat":"papers","name":"Alcohol, Cannabis, and Opioid Use Disorders, and Disease Burden in an Integrated Health Care System","year":"2016","cit":132,"pfa":"Amber L. Bahorik","psa":"Cynthia I. Campbell","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2518262606","eid":"W2518262606"},{"id":"paper-w3082360571","cat":"papers","name":"Post-Marketing Safety Concerns with Esketamine: A Disproportionality Analysis of Spontaneous Reports Submitted to the FDA Adverse Event Reporting System","year":"2020","cit":132,"pfa":"Chiara Gastaldon","psa":"Georgios Schoretsanitis","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3082360571","eid":"W3082360571"},{"id":"paper-w2072570134","cat":"papers","name":"D-LSD binding to brain homogenates: Possible relationship to serotonin receptors","year":"1974","cit":132,"pfa":"James Leroy Bennett","psa":"George K. Aghajanian","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2072570134","eid":"W2072570134"},{"id":"paper-w2317441402","cat":"papers","name":"The Alkaloids of Tabernanthe iboga. Part IV.1 The Structures of Ibogamine, Ibogaine, Tabernanthine and Voacangine","year":"1958","cit":131,"pfa":"M. Fred Bartlett","psa":"W. I. Taylor","ptype":"article","src":"https://openalex.org/W2317441402","eid":"W2317441402"},{"id":"paper-w4387521434","cat":"papers","name":"Psilocybin-assisted therapy for depression: A systematic review and meta-analysis","year":"2023","cit":131,"pfa":"Sipan Haikazian","psa":"Joshua Daniel Rosenblat","topics":["Depression","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4387521434","eid":"W4387521434"},{"id":"paper-w2796179442","cat":"papers","name":"Individual Experiences in Four Cancer Patients Following Psilocybin-Assisted Psychotherapy","year":"2018","cit":131,"pfa":"Tara C. Malone","psa":"Stephen Ross","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2796179442","eid":"W2796179442"},{"id":"paper-w2957955970","cat":"papers","name":"Psychedelic microdosing benefits and challenges: an empirical codebook","year":"2019","cit":131,"pfa":"Thomas Anderson","psa":"Emma Hapke","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2957955970","eid":"W2957955970"},{"id":"paper-w22529605","cat":"papers","name":"Brain mechanisms of hallucinogens and entactogens","year":"2001","cit":131,"pfa":"Franz X. Vollenweider","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W22529605","eid":"W22529605"},{"id":"paper-w2028308920","cat":"papers","name":"Hallucinogenic drug interactions at human brain 5-HT2 receptors: implications for treating LSD-induced hallucinogenesis","year":"1989","cit":131,"pfa":"Bernard Sadzot","psa":"Milt Titeler","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2028308920","eid":"W2028308920"},{"id":"paper-w2057528351","cat":"papers","name":"Methylenedioxymethamphetamine-induced hyperthermia and neurotoxicity are independently mediated by 5-HT2 receptors","year":"1990","cit":131,"pfa":"Christopher J. Schmidt","psa":"Vicki L. Taylor","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2057528351","eid":"W2057528351"},{"id":"paper-w2096058212","cat":"papers","name":"Evidence of health and safety in American members of a religion who use a hallucinogenic sacrament.","year":"2008","cit":131,"pfa":"John H. Halpern","psa":"A. James Ruttenber","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2096058212","eid":"W2096058212"},{"id":"paper-w2078297889","cat":"papers","name":"Advances and Pathophysiological Models of Hallucinogenic Drug Actions in Humans: A Preamble to Schizophrenia Research","year":"1998","cit":131,"pfa":"F.X. Vollenweider","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2078297889","eid":"W2078297889"},{"id":"paper-w4206759226","cat":"papers","name":"Biochemical Mechanisms Underlying Psychedelic-Induced Neuroplasticity","year":"2022","cit":131,"pfa":"David E. Olson","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4206759226","eid":"W4206759226"},{"id":"paper-w2158383236","cat":"papers","name":"Impact of Substance Abuse on the Course and Outcome of Schizophrenia","year":"1990","cit":131,"pfa":"Winston M. Turner","psa":"Ming T. Tsuang","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2158383236","eid":"W2158383236"},{"id":"paper-w4376274076","cat":"papers","name":"Long-Term Safety and Maintenance of Response With Esketamine Nasal Spray in Participants With Treatment-Resistant Depression: Interim Results of the SUSTAIN-3 Study","year":"2023","cit":131,"pfa":"Naim Zaki","psa":"Dong‐Jing Fu","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4376274076","eid":"W4376274076"},{"id":"paper-w2617653209","cat":"papers","name":"The Role of Sigma-1 Receptor, an Intracellular Chaperone in Neurodegenerative Diseases","year":"2017","cit":131,"pfa":"Botond Penke","psa":"Ede Frecska","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2617653209","eid":"W2617653209"},{"id":"paper-w2335184277","cat":"papers","name":"Acute Effects of Lysergic Acid Diethylamide on Circulating Steroid Levels in Healthy Subjects","year":"2016","cit":130,"pfa":"Petra Strajhar","psa":"Matthias E. Liechti","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2335184277","eid":"W2335184277"},{"id":"paper-w2039265593","cat":"papers","name":"Differences in the central serotonergic effects of Methylenedioxymethamphetamine (MDMA) in mice and rats","year":"1987","cit":130,"pfa":"D STONE","psa":"James W. Gibb","ptype":"article","src":"https://openalex.org/W2039265593","eid":"W2039265593"},{"id":"paper-w3094714065","cat":"papers","name":"Transcriptional regulation in the rat prefrontal cortex and hippocampus after a single administration of psilocybin","year":"2020","cit":130,"pfa":"Oskar Hougaard Jefsen","psa":"Heidi Kaastrup Müller","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3094714065","eid":"W3094714065"},{"id":"paper-w1977822847","cat":"papers","name":"Acute Effects of 3,4-Methylenedioxymethamphetamine (MDMA) on Behavioral Measures of Impulsivity: Alone and in Combination with Alcohol","year":"2005","cit":130,"pfa":"Johannes Gerardus Ramaekers","psa":"Kim P. C. Kuypers","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1977822847","eid":"W1977822847"},{"id":"paper-w2008260361","cat":"papers","name":"Blockade of Striatal 5‐Hydroxytryptmine2Receptors Reduces the Increase in Extracellullar Concentrations of Dopamine Produced by the Amphhetamine analogue 3,4‐Methylenedioxymethamphetamine","year":"1994","cit":130,"pfa":"Christopher J. Schmidt","psa":"G. M. Fedayal","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2008260361","eid":"W2008260361"},{"id":"paper-w2926011243","cat":"papers","name":"Might Microdosing Psychedelics Be Safe and Beneficial? An Initial Exploration","year":"2019","cit":130,"pfa":"James Fadiman","psa":"Sophia Korb","topics":["Depression","PTSD & trauma","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2926011243","eid":"W2926011243"},{"id":"paper-w1556832695","cat":"papers","name":"Tomorrow Never Knows: Rock and Psychedelics in the 1960s","year":"2000","cit":130,"pfa":"Nicholas Knowles Bromell","ptype":"book","src":"https://openalex.org/W1556832695","eid":"W1556832695"},{"id":"paper-w2891256775","cat":"papers","name":"Epidemiology of hallucinogen use in the U.S. results from the National epidemiologic survey on alcohol and related conditions III","year":"2018","cit":130,"pfa":"Nadav Shalit","psa":"Shaul Lev‐Ran","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2891256775","eid":"W2891256775"},{"id":"paper-w2154488525","cat":"papers","name":"The use of pharmacokinetic and pharmacodynamic data in the assessment of drug safety in early drug development","year":"2004","cit":130,"pfa":"Don K. Walker","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2154488525","eid":"W2154488525"},{"id":"paper-w2027437909","cat":"papers","name":"Non-NMDA excitatory amino acid receptors in the ventral tegmental area mediate systemic dizocilpine (MK-801) induced hyperlocomotion and dopamine release in the nucleus accumbens","year":"1998","cit":130,"pfa":"J. M. Math�","psa":"Torgny H. Svensson","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2027437909","eid":"W2027437909"},{"id":"paper-w1992059353","cat":"papers","name":"Psychedelics as Medicines for Substance Abuse Rehabilitation: Evaluating Treatments with LSD, Peyote, Ibogaine and Ayahuasca","year":"2015","cit":129,"pfa":"Michael Winkelman","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1992059353","eid":"W1992059353"},{"id":"paper-w1957998952","cat":"papers","name":"Peyote in the Treatment of Alcoholism Among American Indians","year":"1974","cit":129,"pfa":"Bernard Albaugh","psa":"Philip O. Anderson","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W1957998952","eid":"W1957998952"},{"id":"paper-w4319765908","cat":"papers","name":"Therapeutic effect of psilocybin in addiction: A systematic review","year":"2023","cit":129,"pfa":"Pim B. van der Meer","psa":"Albert Batalla","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4319765908","eid":"W4319765908"},{"id":"paper-w3013100262","cat":"papers","name":"Metabolic engineering of Saccharomyces cerevisiae for the de novo production of psilocybin and related tryptamine derivatives","year":"2020","cit":129,"pfa":"N. Milne","psa":"Irina Borodina","ptype":"article","src":"https://openalex.org/W3013100262","eid":"W3013100262"},{"id":"paper-w2753989225","cat":"papers","name":"Nourishing the Spirit: Exploratory Research on Ayahuasca Experiences along the Continuum of Recovery from Eating Disorders","year":"2017","cit":129,"pfa":"Adèle Lafrance","psa":"Kenneth W. Tupper","ptype":"article","src":"https://openalex.org/W2753989225","eid":"W2753989225"},{"id":"paper-w2069477744","cat":"papers","name":"Hyperthermia following MDMA administration in rats: Effects of ambient temperature, water consumption, and chronic dosing","year":"1995","cit":129,"pfa":"Richard Ian Dafters","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2069477744","eid":"W2069477744"},{"id":"paper-w2573408014","cat":"papers","name":"An online survey of tobacco smoking cessation associated with naturalistic psychedelic use","year":"2017","cit":129,"pfa":"Matthew W. Johnson","psa":"Roland R. Griffiths","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2573408014","eid":"W2573408014"},{"id":"paper-w2095037755","cat":"papers","name":"Phenomenology and Sequelae of 3,4-Methylenedioxymethamphetamine Use","year":"1992","cit":129,"pfa":"Mitchell B. Liester","psa":"ROGER N. WALSH","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2095037755","eid":"W2095037755"},{"id":"paper-w3132728164","cat":"papers","name":"First study of safety and tolerability of 3,4-methylenedioxymethamphetamine-assisted psychotherapy in patients with alcohol use disorder","year":"2021","cit":129,"pfa":"Ben Sessa","psa":"David Nutt","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3132728164","eid":"W3132728164"},{"id":"paper-w1971460793","cat":"papers","name":"1H-[13C]-Nuclear Magnetic Resonance Spectroscopy Measures of Ketamine's Effect on Amino Acid Neurotransmitter Metabolism","year":"2011","cit":129,"pfa":"Golam M. I. Chowdhury","psa":"Gerard Sanacora","ptype":"article","src":"https://openalex.org/W1971460793","eid":"W1971460793"},{"id":"paper-w3213007658","cat":"papers","name":"Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression","year":"2021","cit":128,"pfa":"Susan Ling","psa":"Roger S. McIntyre","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3213007658","eid":"W3213007658"},{"id":"paper-w3023636576","cat":"papers","name":"Changes in inflammatory biomarkers are related to the antidepressant effects of Ayahuasca","year":"2020","cit":128,"pfa":"Nicole Leite Galvão Coelho","psa":"Dráulio Barros de Araújo","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3023636576","eid":"W3023636576"},{"id":"paper-w2065351116","cat":"papers","name":"Chronic paranoid psychosis after misuse of MDMA (\"ecstasy\")","year":"1991","cit":128,"pfa":"Philip K. McGuire","psa":"Thomas A. Fahy","ptype":"article","src":"https://openalex.org/W2065351116","eid":"W2065351116"},{"id":"paper-w2162501988","cat":"papers","name":"Topographic pharmaco‐EEG mapping of the effects of the South American psychoactive beverage ayahuasca in healthy volunteers","year":"2002","cit":128,"pfa":"Jordi Riba","psa":"Manel J. Barbanoj","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2162501988","eid":"W2162501988"},{"id":"paper-w2788524689","cat":"papers","name":"Clinical Interpretations of Patient Experience in a Trial of Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder","year":"2018","cit":128,"pfa":"Michael P. Bogenschutz","psa":"Sarah E. Mennenga","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2788524689","eid":"W2788524689"},{"id":"paper-w2005701415","cat":"papers","name":"LSD as an agonist of dopamine receptors in the striatum","year":"1974","cit":128,"pfa":"L. Pieri","psa":"Willy E. Haefely","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2005701415","eid":"W2005701415"},{"id":"paper-w1994102540","cat":"papers","name":"Plasma Pharmacokinetics of 3,4-Methylenedioxymethamphetamine After Controlled Oral Administration to Young Adults","year":"2008","cit":128,"pfa":"Erin A Kolbrich","psa":"Marilyn Ann Huestis","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1994102540","eid":"W1994102540"},{"id":"paper-w1989324273","cat":"papers","name":"Mismatch Negativity Encoding of Prediction Errors Predicts S-ketamine-Induced Cognitive Impairments","year":"2011","cit":128,"pfa":"André Schmidt","psa":"Franz X. Vollenweider","ptype":"article","src":"https://openalex.org/W1989324273","eid":"W1989324273"},{"id":"paper-w2537027964","cat":"papers","name":"Of Roots and Fruits: A Comparison of Psychedelic and Nonpsychedelic Mystical Experiences","year":"2016","cit":128,"pfa":"David B. Yaden","psa":"Andrew B. Newberg","topics":["Addiction","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2537027964","eid":"W2537027964"},{"id":"paper-w1985800994","cat":"papers","name":"Adverse Reactions to Marihuana","year":"1970","cit":128,"pfa":"Andrew Weil","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1985800994","eid":"W1985800994"},{"id":"paper-w2091155334","cat":"papers","name":"Ketamine Inhibits Monoamine Transporters Expressed in Human Embryonic Kidney 293 Cells","year":"1998","cit":128,"pfa":"Mitsuhiro Nishimura","psa":"Masaya Tohyama","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2091155334","eid":"W2091155334"},{"id":"paper-w2550530158","cat":"papers","name":"d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology","year":"2016","cit":127,"pfa":"Danilo De Gregorio","psa":"Gabriella Gobbi","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2550530158","eid":"W2550530158"},{"id":"paper-w2020659752","cat":"papers","name":"The Anti-Addiction Drug Ibogaine and the Heart: A Delicate Relation","year":"2015","cit":127,"pfa":"Xaver Koenig","psa":"Karlheinz Hilber","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2020659752","eid":"W2020659752"},{"id":"paper-w2048943442","cat":"papers","name":"Self-injection of d,1-3,4-methylenedioxymethamphetamine (MDMA) in the baboon","year":"1987","cit":127,"pfa":"Richard J Lamb","psa":"Roland R. Griffiths","ptype":"article","src":"https://openalex.org/W2048943442","eid":"W2048943442"},{"id":"paper-w2022443784","cat":"papers","name":"Psilocybin dose-dependently causes delayed, transient headaches in healthy volunteers","year":"2011","cit":127,"pfa":"Matthew W. Johnson","psa":"Roland R. Griffiths","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2022443784","eid":"W2022443784"},{"id":"paper-w2604586582","cat":"papers","name":"Acute effects of LSD on amygdala activity during processing of fearful stimuli in healthy subjects","year":"2017","cit":127,"pfa":"Felix Mueller","psa":"Stefan Borgwardt","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2604586582","eid":"W2604586582"},{"id":"paper-w2101693074","cat":"papers","name":"Psychopharmacology of the hallucinogenic sage Salvia divinorum","year":"2005","cit":127,"pfa":"Thomas Edward Prisinzano","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2101693074","eid":"W2101693074"},{"id":"paper-w2035247917","cat":"papers","name":"Relationship of Hallucinogens to Adrenergic Cerebral Neurohumors","year":"1955","cit":127,"pfa":"Amedeo S. Marrazzi","psa":"E. Ross Hart","ptype":"article","src":"https://openalex.org/W2035247917","eid":"W2035247917"},{"id":"paper-w1940682915","cat":"papers","name":"Therapeutic mechanisms of classic hallucinogens in the treatment of addictions: from indirect evidence to testable hypotheses","year":"2012","cit":127,"pfa":"Michael P. Bogenschutz","psa":"Jessica M. Pommy","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1940682915","eid":"W1940682915"},{"id":"paper-w2085598752","cat":"papers","name":"The hallucinogen 1-[2,5-dimethoxy-4-iodophenyl]-2-aminopropane (DOI) increases cortical extracellular glutamate levels in rats","year":"2003","cit":127,"pfa":"Jennifer L. Scruggs","psa":"Ariel Y. Deutch","ptype":"article","src":"https://openalex.org/W2085598752","eid":"W2085598752"},{"id":"paper-w3093109301","cat":"papers","name":"Mood and cognition after administration of low LSD doses in healthy volunteers: A placebo controlled dose-effect finding study","year":"2020","cit":127,"pfa":"Nadia R. P. W. Hutten","psa":"Kim P. C. Kuypers","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3093109301","eid":"W3093109301"},{"id":"paper-w2063194215","cat":"papers","name":"Agonist activity of LSD and lisuride at cloned 5HT 2A and 5HT 2C receptors","year":"1998","cit":127,"pfa":"Christina T. Egan","psa":"Milt Teitler","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2063194215","eid":"W2063194215"},{"id":"paper-w1980439126","cat":"papers","name":"Synthesis and Structure–Activity Relationships of N -Benzyl Phenethylamines as 5-HT 2A/2C Agonists","year":"2014","cit":127,"pfa":"Martin Asser Hansen","psa":"Jesper Langgaard Kristensen","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1980439126","eid":"W1980439126"},{"id":"paper-w2151677188","cat":"papers","name":"A meta-analysis of negative symptoms in dual diagnosis schizophrenia","year":"2005","cit":127,"pfa":"Stéphane Potvin","psa":"Émmanuel Stip","topics":["Addiction","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W2151677188","eid":"W2151677188"},{"id":"paper-w2890976209","cat":"papers","name":"Cannabidiol enhances morphine antinociception, diminishes NMDA-mediated seizures and reduces stroke damage via the sigma 1 receptor","year":"2018","cit":127,"pfa":"María Rodríguez-Muñoz","psa":"Pilar Sánchez‐Blázquez","topics":["Addiction","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2890976209","eid":"W2890976209"},{"id":"paper-w2807846829","cat":"papers","name":"NMDAR-independent, cAMP-dependent antidepressant actions of ketamine","year":"2018","cit":127,"pfa":"Nathan H. Wray","psa":"Mark M. Rasenick","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2807846829","eid":"W2807846829"},{"id":"paper-w2059690043","cat":"papers","name":"Lysergic Acid Diethylamide (LSD-25): I. Physiological and Perceptual Responses","year":"1955","cit":126,"pfa":"Harold A. Abramson","psa":"M. Wagner","ptype":"article","src":"https://openalex.org/W2059690043","eid":"W2059690043"},{"id":"paper-w2053798341","cat":"papers","name":"Studies on lysergic acid diethylamide (LSD-25). I. Effects in former morphine addicts and development of tolerance during chronic intoxication.","year":"1956","cit":126,"pfa":"Richard E. Belleville","psa":"A WIKLER","topics":["Addiction","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2053798341","eid":"W2053798341"},{"id":"paper-w2101409056","cat":"papers","name":"Ecstasy (MDMA) dependence","year":"1999","cit":126,"pfa":"K Jansen","ptype":"article","src":"https://openalex.org/W2101409056","eid":"W2101409056"},{"id":"paper-w2045056309","cat":"papers","name":"The Mechanistic Basis for Noncompetitive Ibogaine Inhibition of Serotonin and Dopamine Transporters","year":"2012","cit":126,"pfa":"Simon Bulling","psa":"Walter Sandtner","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2045056309","eid":"W2045056309"},{"id":"paper-w2005327856","cat":"papers","name":"Interactions between ibogaine, a potential anti-addictive agent, and morphine: an in vivo microdialysis study","year":"1991","cit":126,"pfa":"I.M. Maisonneuve","psa":"S.D. Glick","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2005327856","eid":"W2005327856"},{"id":"paper-w2007520100","cat":"papers","name":"Pharmacokinetic and pharmacodynamic effects of methylphenidate and MDMA administered alone or in combination","year":"2013","cit":126,"pfa":"Cédric M. Hysek","psa":"Matthias E. Liechti","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2007520100","eid":"W2007520100"},{"id":"paper-w2413873059","cat":"papers","name":"The current state of research on ayahuasca: A systematic review of human studies assessing psychiatric symptoms, neuropsychological functioning, and neuroimaging","year":"2016","cit":126,"pfa":"RAFAEL GUIMARÃES DOS SANTOS","psa":"Jaime E. C. Hallak","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W2413873059","eid":"W2413873059"},{"id":"paper-w2019125590","cat":"papers","name":"Elevated Impulsivity and Impaired Decision-Making in Abstinent Ecstasy (MDMA) Users Compared to Polydrug and Drug-Naïve Controls","year":"2005","cit":126,"pfa":"Michael John Morgan","psa":"Robert David Rogers","ptype":"article","src":"https://openalex.org/W2019125590","eid":"W2019125590"},{"id":"paper-w2117522474","cat":"papers","name":"Over 30 million psychedelic users in the United States","year":"2013","cit":126,"pfa":"Teri Suzanne Krebs","psa":"Pål-Ørjan Johansen","ptype":"article","src":"https://openalex.org/W2117522474","eid":"W2117522474"},{"id":"paper-w2757295924","cat":"papers","name":"Serotonergic hallucinogens in the treatment of anxiety and depression in patients suffering from a life-threatening disease: A systematic review","year":"2017","cit":126,"pfa":"Simon Reiche","psa":"Tomislav Majić","topics":["Depression","Anxiety & end-of-life","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W2757295924","eid":"W2757295924"},{"id":"paper-w1969432156","cat":"papers","name":"Bufo alvarius: a potent hallucinogen of animal origin","year":"1994","cit":126,"pfa":"Andrew Weil","psa":"Wade Davis","ptype":"article","src":"https://openalex.org/W1969432156","eid":"W1969432156"},{"id":"paper-w2990036135","cat":"papers","name":"Microdosing psychedelics: Motivations, subjective effects and harm reduction","year":"2019","cit":126,"pfa":"Toby Lea","psa":"Michael Klein","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2990036135","eid":"W2990036135"},{"id":"paper-w2066863828","cat":"papers","name":"Comparative Psychotomimetic Effects of Stereoisomers of Amphetamine","year":"1971","cit":126,"pfa":"BURTON M. ANGRIST","psa":"S Gershon","ptype":"article","src":"https://openalex.org/W2066863828","eid":"W2066863828"},{"id":"paper-w2094224042","cat":"papers","name":"The NBOMe hallucinogenic drug series: Patterns of use, characteristics of users and self-reported effects in a large international sample","year":"2014","cit":126,"pfa":"Will Lawn","psa":"ADAM R. WINSTOCK","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2094224042","eid":"W2094224042"},{"id":"paper-w2337679024","cat":"papers","name":"Reduction of dopamine D2/3 receptor binding in the striatum after a single administration of esketamine, but not R-ketamine: a PET study in conscious monkeys","year":"2016","cit":126,"pfa":"Kenji Hashimoto","psa":"Hideo Tsukada","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2337679024","eid":"W2337679024"},{"id":"paper-w2048256430","cat":"papers","name":"Effects of lisuride and LSD on cerebral monoamine systems and hallucinosis","year":"1978","cit":126,"pfa":"L. Pieri","psa":"M. Da Prada","ptype":"article","src":"https://openalex.org/W2048256430","eid":"W2048256430"},{"id":"paper-w2087000109","cat":"papers","name":"The Internationalization of Ayahuasca","year":"2012","cit":125,"pfa":"Edward MacRae","ptype":"book-review","src":"https://openalex.org/W2087000109","eid":"W2087000109"},{"id":"paper-w2066481312","cat":"papers","name":"Dose-Related Behavioral, Subjective, Endocrine, and Psychophysiological Effects of the κ Opioid Agonist Salvinorin A in Humans","year":"2012","cit":125,"pfa":"Mohini Ranganathan","psa":"Deepak Cyril D’Souza","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2066481312","eid":"W2066481312"},{"id":"paper-w1968643679","cat":"papers","name":"Reward-related decision-making deficits and elevated impulsivity among MDMA and other drug users","year":"2008","cit":125,"pfa":"Karen L. Hanson","psa":"Kristin Sullwold","ptype":"article","src":"https://openalex.org/W1968643679","eid":"W1968643679"},{"id":"paper-w2518801653","cat":"papers","name":"The Endogenous Hallucinogen and Trace Amine N,N-Dimethyltryptamine (DMT) Displays Potent Protective Effects against Hypoxia via Sigma-1 Receptor Activation in Human Primary iPSC-Derived Cortical Neurons and Microglia-Lik","year":"2016","cit":125,"pfa":"Attila Szabó","psa":"Ede Frecska","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2518801653","eid":"W2518801653"},{"id":"paper-w2115154626","cat":"papers","name":"Flashbacks: Recurrent Intrusive Images After the Use of LSD","year":"1969","cit":125,"pfa":"Mardi J. Horowitz","topics":["PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2115154626","eid":"W2115154626"},{"id":"paper-w2080319756","cat":"papers","name":"MK‐801, phencyclidine (PCP), and PCP‐like drugs increase burst firing in rat A10 dopamine neurons: Comparison to competitive NMDA antagonists","year":"1993","cit":125,"pfa":"Edward D. French","psa":"Ting Wang","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2080319756","eid":"W2080319756"},{"id":"paper-w3110803972","cat":"papers","name":"The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysis","year":"2020","cit":125,"pfa":"Jiaqi Xiong","psa":"Roger S. McIntyre","topics":["Depression","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W3110803972","eid":"W3110803972"},{"id":"paper-w1965146355","cat":"papers","name":"Comparison of psilocin with psilocybin, mescaline and LSD-25","year":"1962","cit":124,"pfa":"Albert B. Wolbach","psa":"Harris Isbell","ptype":"article","src":"https://openalex.org/W1965146355","eid":"W1965146355"},{"id":"paper-w2006269280","cat":"papers","name":"Adverse Reactions with 3,4-Methylenedioxymethamphetamine (MDMA; ???Ecstasy???)","year":"1996","cit":124,"pfa":"Una D. McCann","psa":"George A. Ricaurte","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2006269280","eid":"W2006269280"},{"id":"paper-w2092490886","cat":"papers","name":"Differences between rats and mice in MDMA (methylenedioxymethylamphetamine) neurotoxicity","year":"1988","cit":124,"pfa":"Barbara J. Logan","psa":"Yet Ben Yee","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2092490886","eid":"W2092490886"},{"id":"paper-w2164261722","cat":"papers","name":"Life-Threatening Interactions Between HIV-1 Protease Inhibitors and the Illicit Drugs MDMA and γ-Hydroxybutyrate","year":"1999","cit":124,"pfa":"Robert D. Harrington","psa":"John R. Horn","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2164261722","eid":"W2164261722"},{"id":"paper-w1830776808","cat":"papers","name":"Microdialysis studies on 3,4-methylenedioxymethamphetamine-induced dopamine release: effect of dopamine uptake inhibitors.","year":"1991","cit":124,"pfa":"J. Frank Nash","psa":"Jesse D Brodkin","ptype":"article","src":"https://openalex.org/W1830776808","eid":"W1830776808"},{"id":"paper-w2021015465","cat":"papers","name":"The Role of Metabolism in 3,4-(±)-Methylenedioxyamphetamine and 3,4-(±)-Methylenedioxymethamphetamine (Ecstasy) toxicity","year":"2004","cit":124,"pfa":"Terrence J. Monks","psa":"Serrine S. Lau","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2021015465","eid":"W2021015465"},{"id":"paper-w1999190513","cat":"papers","name":"Interaction of drugs of abuse and maintenance treatments with human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2)","year":"2009","cit":124,"pfa":"Nicolas Tournier","psa":"Xavier Declèves","topics":["Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W1999190513","eid":"W1999190513"},{"id":"paper-w4207016700","cat":"papers","name":"Psychedelics","year":"2022","cit":124,"pfa":"Benjamin Kelmendi","psa":"Alex C. Kwan","ptype":"article","src":"https://openalex.org/W4207016700","eid":"W4207016700"},{"id":"paper-w2104320372","cat":"papers","name":"Classical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical roles","year":"2014","cit":124,"pfa":"David Baumeister","psa":"Derek Kenneth Tracy","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2104320372","eid":"W2104320372"},{"id":"paper-w2483369152","cat":"papers","name":"Evidence That Familial Liability for Psychosis Is Expressed as Differential Sensitivity to Cannabis","year":"2010","cit":124,"topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2483369152","eid":"W2483369152"},{"id":"paper-w1581912111","cat":"papers","name":"The Peyote Cult","year":"1938","cit":123,"pfa":"Weston La Barre","ptype":"book","src":"https://openalex.org/W1581912111","eid":"W1581912111"},{"id":"paper-w2339594835","cat":"papers","name":"The psychedelic model of schizophrenia: the case of N,N- dimethyltryptamine","year":"1976","cit":123,"pfa":"J. Christian Gillin","psa":"Richard Jed Wyatt","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2339594835","eid":"W2339594835"},{"id":"paper-w4311205265","cat":"papers","name":"Pharmacokinetics and Pharmacodynamics of Oral Psilocybin Administration in Healthy Participants","year":"2022","cit":123,"pfa":"Friederike Holze","psa":"Matthias E. Liechti","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4311205265","eid":"W4311205265"},{"id":"paper-w2124858522","cat":"papers","name":"Modulating the Rate and Rhythmicity of Perceptual Rivalry Alternations with the Mixed 5-HT2A and 5-HT1A Agonist Psilocybin","year":"2005","cit":123,"pfa":"Olivia L. Carter","psa":"Franz X. Vollenweider","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2124858522","eid":"W2124858522"},{"id":"paper-w2126940530","cat":"papers","name":"Effects of Acute MDMA Intoxication on Mood and Impulsivity: Role of the 5-HT2 and 5-HT1 Receptors","year":"2012","cit":123,"pfa":"Janelle H. P. van Wel","psa":"Johannes Gerardus Ramaekers","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2126940530","eid":"W2126940530"},{"id":"paper-w2981686921","cat":"papers","name":"Psychedelic Microdosing: A Subreddit Analysis","year":"2019","cit":123,"pfa":"Toby Lea","psa":"Henrik Jungaberle","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2981686921","eid":"W2981686921"},{"id":"paper-w4210842328","cat":"papers","name":"The Psychopharmacology of Hallucinogens","year":"1978","cit":123,"topics":["Dosing & pharmacology"],"ptype":"book","src":"https://openalex.org/W4210842328","eid":"W4210842328"},{"id":"paper-w1968409185","cat":"papers","name":"Acute and Chronic Toxicity of Marijuana","year":"1968","cit":123,"pfa":"David Eugene Smith","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1968409185","eid":"W1968409185"},{"id":"paper-w137805992","cat":"papers","name":"Substance use and cognition in early psychosis","year":"2003","cit":123,"pfa":"Alissa H. Pencer","psa":"Jean Addington","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W137805992","eid":"W137805992"},{"id":"paper-w2769941606","cat":"papers","name":"Ketamine and its metabolite (2R,6R)-hydroxynorketamine induce lasting alterations in glutamatergic synaptic plasticity in the mesolimbic circuit","year":"2017","cit":123,"pfa":"Ning Yao","psa":"Karima Chergui","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2769941606","eid":"W2769941606"},{"id":"paper-w2168659851","cat":"papers","name":"A neurotoxic regimen of MDMA suppresses behavioral, thermal and neurochemical responses to subsequent MDMA administration","year":"1999","cit":122,"pfa":"Mahalakshmi Shankaran","psa":"Gary A. Gudelsky","ptype":"article","src":"https://openalex.org/W2168659851","eid":"W2168659851"},{"id":"paper-w1975258598","cat":"papers","name":"MDMA and Human Sexual Function","year":"1986","cit":122,"pfa":"John C. Buffum","psa":"Charles A. Moser","ptype":"article","src":"https://openalex.org/W1975258598","eid":"W1975258598"},{"id":"paper-w2168821442","cat":"papers","name":"Effects of hallucinogenic agents mescaline and phencyclidine on zebrafish behavior and physiology","year":"2012","cit":122,"pfa":"Evan J. Kyzar","psa":"Allan V. Kalueff","ptype":"article","src":"https://openalex.org/W2168821442","eid":"W2168821442"},{"id":"paper-w3137839889","cat":"papers","name":"Naturalistic Use of Mescaline Is Associated with Self-Reported Psychiatric Improvements and Enduring Positive Life Changes","year":"2021","cit":122,"pfa":"Gabrielle Agin-Liebes","psa":"Alan K. Davis","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W3137839889","eid":"W3137839889"},{"id":"paper-w2097021306","cat":"papers","name":"Memory impairment in abstinent MDMA (“Ecstasy”) users: A longitudinal investigation","year":"2001","cit":122,"pfa":"Konstantine K. Zakzanis","psa":"Donald A. Young","ptype":"article","src":"https://openalex.org/W2097021306","eid":"W2097021306"},{"id":"paper-w2012159028","cat":"papers","name":"Report on Psychoactive Drug Use Among Adolescents Using Ayahuasca Within a Religious Context","year":"2005","cit":122,"pfa":"Evelyn Doering-Silveira","psa":"Dartiu Xavier da Silveira","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2012159028","eid":"W2012159028"},{"id":"paper-w3083216124","cat":"papers","name":"Psilocybin as a New Approach to Treat Depression and Anxiety in the Context of Life-Threatening Diseases—A Systematic Review and Meta-Analysis of Clinical Trials","year":"2020","cit":122,"pfa":"Ana Sofia Vargas","psa":"Luísa Calais Pereira","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W3083216124","eid":"W3083216124"},{"id":"paper-w2072898255","cat":"papers","name":"Maternal Influenza Viral Infection Causes Schizophrenia-Like Alterations of 5-HT 2A and mGlu 2 Receptors in the Adult Offspring","year":"2011","cit":122,"pfa":"José L. Moreno","psa":"Javier González‐Maeso","topics":["Safety & adverse events","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2072898255","eid":"W2072898255"},{"id":"paper-w3196802696","cat":"papers","name":"Treatment-Resistant Depression: Approaches to Treatment","year":"2021","cit":122,"pfa":"Karan S. Kverno","psa":"Emma Mangano","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3196802696","eid":"W3196802696"},{"id":"paper-w4315620747","cat":"papers","name":"5-HT2ARs Mediate Therapeutic Behavioral Effects of Psychedelic Tryptamines","year":"2023","cit":122,"pfa":"Lindsay P. Cameron","psa":"David E. Olson","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4315620747","eid":"W4315620747"},{"id":"paper-w2167331557","cat":"papers","name":"A prospective cohort study challenging the effectiveness of population-based medical intervention for smoking cessation","year":"2012","cit":122,"pfa":"Hillel R. Alpert","psa":"Lois Biener","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2167331557","eid":"W2167331557"},{"id":"paper-w1663708161","cat":"papers","name":"Pharmacology for Nursing Care","year":"1990","cit":122,"pfa":"Richard Lehne","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"book","src":"https://openalex.org/W1663708161","eid":"W1663708161"},{"id":"paper-w1773987357","cat":"papers","name":"The Antipodes of the Mind: Charting the Phenomenology of the Ayahuasca Experience","year":"2003","cit":121,"pfa":"Thomas B. Roberts","ptype":"article","src":"https://openalex.org/W1773987357","eid":"W1773987357"},{"id":"paper-w1994910530","cat":"papers","name":"Effects of ibogaine on acute signs of morphine withdrawal in rats: Independence from tremor","year":"1992","cit":121,"pfa":"S.D. Glick","psa":"Jeffrey N. Carlson","ptype":"article","src":"https://openalex.org/W1994910530","eid":"W1994910530"},{"id":"paper-w2994786945","cat":"papers","name":"Distinct neural mechanisms for the prosocial and rewarding properties of MDMA","year":"2019","cit":121,"pfa":"Boris Dov Heifets","psa":"Robert C. Malenka","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2994786945","eid":"W2994786945"},{"id":"paper-w2103245338","cat":"papers","name":"Toxicodynamics and long-term toxicity of the recreational drug, 3,4-methylenedioxymethamphetamine (MDMA, ‘Ecstasy’)","year":"2000","cit":121,"pfa":"G.A. Ricaurte","psa":"Ursula Scheffel","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2103245338","eid":"W2103245338"},{"id":"paper-w2001854690","cat":"papers","name":"3,4-Methylenedioxymethamphetamine (MDMA): Stereoselective interactions at brain 5-HT1 and 5-HT2 receptors","year":"1986","cit":121,"pfa":"Robert A. Lyon","psa":"Milt Titeler","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2001854690","eid":"W2001854690"},{"id":"paper-w1990277146","cat":"papers","name":"A study of the mechanisms involved in the neurotoxic action of 3,4‐methylenedioxymethamphetamine (MDMA, ‘ecstasy’) on dopamine neurones in mouse brain","year":"2001","cit":121,"pfa":"M. Isabel Colado","psa":"A. Richard Green","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1990277146","eid":"W1990277146"},{"id":"paper-w1988522979","cat":"papers","name":"Effect of ecstasy [3,4-methylenedioxymethamphetamine (MDMA)] on cerebral blood flow: a co-registered SPECT and MRI study","year":"2000","cit":121,"pfa":"Linda Chang","psa":"Russell E. Poland","ptype":"article","src":"https://openalex.org/W1988522979","eid":"W1988522979"},{"id":"paper-w2022115750","cat":"papers","name":"Altered States of Consciousness and Short-Term Psychological After-Effects Induced by the First Time Ritual Use of Ayahuasca in an Urban Context in Brazil","year":"2005","cit":121,"pfa":"Paulo César Ribeiro Barbosa","psa":"Paulo Dalgalarrondo","ptype":"article","src":"https://openalex.org/W2022115750","eid":"W2022115750"},{"id":"paper-w1970073509","cat":"papers","name":"Increased Anxiety 3 Months after Brief Exposure to MDMA (‘Ecstasy’) in Rats: Association with Altered 5-HT Transporter and Receptor Density","year":"2003","cit":121,"pfa":"Iain S. McGregor","psa":"Andrew John Lawrence","topics":["Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1970073509","eid":"W1970073509"},{"id":"paper-w2558430488","cat":"papers","name":"Serotonergic Hallucinogen-Induced Visual Perceptual Alterations","year":"2016","cit":121,"pfa":"Michael Kometer","psa":"Franz X. Vollenweider","ptype":"book-chapter","src":"https://openalex.org/W2558430488","eid":"W2558430488"},{"id":"paper-w2016354938","cat":"papers","name":"EOS microdose protocol for the radiological follow-up of adolescent idiopathic scoliosis","year":"2015","cit":121,"pfa":"Brice Ilharreborde","psa":"Keyvan Mazda","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2016354938","eid":"W2016354938"},{"id":"paper-w3023228010","cat":"papers","name":"Chronic pain and psychedelics: a review and proposed mechanism of action","year":"2020","cit":121,"pfa":"Joel P Castellanos","psa":"Timothy J. Furnish","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3023228010","eid":"W3023228010"},{"id":"paper-w2952017800","cat":"papers","name":"Asymmetric synthesis of psychotomimetic phenylisopropylamines","year":"1973","cit":121,"pfa":"David E. Nichols","psa":"Richard D. Morin","ptype":"article","src":"https://openalex.org/W2952017800","eid":"W2952017800"},{"id":"paper-w2137939559","cat":"papers","name":"Central nervous system effects of subdissociative doses of (S)-ketamine are related to plasma and brain concentrations measured with positron emission tomography in healthy volunteers*","year":"1995","cit":121,"pfa":"Per Hartvig","psa":"Bengt Långström","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2137939559","eid":"W2137939559"},{"id":"paper-w1695543549","cat":"papers","name":"Excitatory amino acid antagonists for acute stroke","year":"2003","cit":121,"pfa":"Keith W. Muir","psa":"Kennedy R. Lees","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1695543549","eid":"W1695543549"},{"id":"paper-w4223474449","cat":"papers","name":"Long-term safety of ketamine and esketamine in treatment of depression","year":"2022","cit":121,"pfa":"Sina Nikayin","psa":"Samuel T. Wilkinson","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4223474449","eid":"W4223474449"},{"id":"paper-w2297557715","cat":"papers","name":"Decreased mental time travel to the past correlates with default-mode network disintegration under lysergic acid diethylamide","year":"2016","cit":120,"pfa":"Jana Speth","psa":"Robin Lester Carhart-Harris","topics":["Depression","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2297557715","eid":"W2297557715"},{"id":"paper-w2049460723","cat":"papers","name":"Effects of 5-methoxy-N,N-dimethyltryptamine on central monoamine neurons","year":"1972","cit":120,"pfa":"Kjell Fuxé","psa":"GÖSTA JONSSON","ptype":"article","src":"https://openalex.org/W2049460723","eid":"W2049460723"},{"id":"paper-w2035784753","cat":"papers","name":"MDMA: Nonmedical Use and Intoxication","year":"1986","cit":120,"pfa":"Ronald K. Siegel","ptype":"article","src":"https://openalex.org/W2035784753","eid":"W2035784753"},{"id":"paper-w2043857108","cat":"papers","name":"18-Methoxycoronaridine, a non-toxic iboga alkaloid congener: effects on morphine and cocaine self-administration and on mesolimbic dopamine release in rats","year":"1996","cit":120,"pfa":"S.D. Glick","psa":"Helen H. Molinari","ptype":"article","src":"https://openalex.org/W2043857108","eid":"W2043857108"},{"id":"paper-w2009336408","cat":"papers","name":"Hyponatraemic states following 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') ingestion","year":"2002","cit":120,"pfa":"T. K. Hartung","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2009336408","eid":"W2009336408"},{"id":"paper-w2051016570","cat":"papers","name":"Importance of ERK activation in behavioral and biochemical effects induced by MDMA in mice","year":"2003","cit":120,"pfa":"Julie Salzmann","psa":"Florence Noble","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2051016570","eid":"W2051016570"},{"id":"paper-w2050392483","cat":"papers","name":"A direct comparison of the behavioral and physiological effects of methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) in humans","year":"2011","cit":120,"pfa":"Matthew G. Kirkpatrick","psa":"Carl L. Hart","ptype":"article","src":"https://openalex.org/W2050392483","eid":"W2050392483"},{"id":"paper-w2137899752","cat":"papers","name":"Former chronic methylenedioxymethamphetamine (MDMA or ecstasy) users report mild depressive symptoms","year":"2001","cit":120,"pfa":"Nicholas MacInnes","psa":"Graham F. A. Harding","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W2137899752","eid":"W2137899752"},{"id":"paper-w2316559650","cat":"papers","name":"Prepulse Inhibition and Habituation of Acoustic Startle Response in Male MDMA (‘Ecstasy’) Users, Cannabis Users, and Healthy Controls","year":"2004","cit":120,"pfa":"Boris B. Quednow","psa":"Michael Wagner","ptype":"article","src":"https://openalex.org/W2316559650","eid":"W2316559650"},{"id":"paper-w2996702784","cat":"papers","name":"Prospective examination of synthetic 5-methoxy-N,N-dimethyltryptamine inhalation: effects on salivary IL-6, cortisol levels, affect, and non-judgment","year":"2019","cit":120,"pfa":"Malin Vedøy Uthaug","psa":"Johannes Gerardus Ramaekers","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2996702784","eid":"W2996702784"},{"id":"paper-w2105455639","cat":"papers","name":"Cutaneous Vasoconstriction Contributes to Hyperthermia Induced by 3,4-Methylenedioxymethamphetamine (Ecstasy) in Conscious Rabbits","year":"2001","cit":120,"pfa":"Nigel P. Pedersen","psa":"William Walter Blessing","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2105455639","eid":"W2105455639"},{"id":"paper-w1988209406","cat":"papers","name":"Oxytocin modulates psychotomimetic-induced deficits in sensorimotor gating","year":"1999","cit":120,"pfa":"David Feifel","psa":"Tammi L. Reza","ptype":"article","src":"https://openalex.org/W1988209406","eid":"W1988209406"},{"id":"paper-w2227510260","cat":"papers","name":"Stimulant and hallucinogenic behavioral profiles of 3,4-methylenedioxymethamphetamine and N-ethyl-3,4-methylenedioxyamphetamine in rats.","year":"1988","cit":120,"pfa":"Lisa H. Gold","psa":"Mark A. Geyer","ptype":"article","src":"https://openalex.org/W2227510260","eid":"W2227510260"},{"id":"paper-w2049939637","cat":"papers","name":"Quantifying the Attenuation of the Ketamine Pharmacological Magnetic Resonance Imaging Response in Humans: A Validation Using Antipsychotic and Glutamatergic Agents","year":"2013","cit":120,"pfa":"Orla Doyle","psa":"Mitul Ashok Mehta","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2049939637","eid":"W2049939637"},{"id":"paper-w3205776411","cat":"papers","name":"Lysergic Acid Diethylamide- and Mescaline-Induced Attenuation of the Effect of Punishment in the Rat","year":"1976","cit":119,"pfa":"Ronald I. Schoenfeld","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3205776411","eid":"W3205776411"},{"id":"paper-w2415257805","cat":"papers","name":"High-Affinity Binding of [3H]5-Hydroxytryptamine to Brain Synaptosomal Membranes: Comparison with [3H]Lysergic Acid Diethylamide Binding","year":"1978","cit":119,"pfa":"G. Fillion","psa":"Joseph Jacob","ptype":"article","src":"https://openalex.org/W2415257805","eid":"W2415257805"},{"id":"paper-w2154818640","cat":"papers","name":"Endogenous psychoactive tryptamines reconsidered: an anxiolytic role for dimethyltryptamine","year":"2005","cit":119,"pfa":"Michael Jacob","psa":"David E. Presti","ptype":"article","src":"https://openalex.org/W2154818640","eid":"W2154818640"},{"id":"paper-w1989460749","cat":"papers","name":"Striatal serotonin is depleted in brain of a human MDMA (Ecstasy) user","year":"2000","cit":119,"pfa":"Stephen J. Kish","psa":"Kathryn S. Kalasinsky","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1989460749","eid":"W1989460749"},{"id":"paper-w1998999302","cat":"papers","name":"MDMA, serotonergic neurotoxicity, and the diverse functional deficits of recreational ‘Ecstasy’ users","year":"2013","cit":119,"pfa":"Andrew C. Parrott","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1998999302","eid":"W1998999302"},{"id":"paper-w2620385377","cat":"papers","name":"Direct comparison of the acute subjective, emotional, autonomic, and endocrine effects of MDMA, methylphenidate, and modafinil in healthy subjects","year":"2017","cit":119,"pfa":"Patrick C. Dolder","psa":"Matthias E. Liechti","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2620385377","eid":"W2620385377"},{"id":"paper-w2799231894","cat":"papers","name":"The psychedelic renaissance: reassessing the role of psychedelic drugs in 21st century psychiatry and society","year":"2013","cit":119,"ptype":"book-review","src":"https://openalex.org/W2799231894","eid":"W2799231894"},{"id":"paper-w2036273649","cat":"papers","name":"Cognitive-disruptive effects of the psychotomimetic phencyclidine and attenuation by atypical antipsychotic medications in rats","year":"2007","cit":119,"pfa":"Nurith Amitai","psa":"Athina Markou","ptype":"article","src":"https://openalex.org/W2036273649","eid":"W2036273649"},{"id":"paper-w1553790444","cat":"papers","name":"Persistence of lysergic acid diethylamide in the plasma of human subjects","year":"1964","cit":118,"pfa":"George K. Aghajanian","psa":"Oscar H.L. Bing","ptype":"article","src":"https://openalex.org/W1553790444","eid":"W1553790444"},{"id":"paper-w2012077435","cat":"papers","name":"Lysergic acid diethylamide and [−]-2,5-dimethoxy-4-methylamphetamine increase extracellular glutamate in rat prefrontal cortex","year":"2004","cit":118,"pfa":"John W. Muschamp","psa":"Richard A. Rabin","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2012077435","eid":"W2012077435"},{"id":"paper-w4309139242","cat":"papers","name":"Adverse effects of ayahuasca: Results from the Global Ayahuasca Survey","year":"2022","cit":118,"pfa":"José Carlos Bouso","psa":"Daniel Perkins","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4309139242","eid":"W4309139242"},{"id":"paper-w2033434501","cat":"papers","name":"Efficient Access to the Core of the Strychnos, Aspidosperma and Iboga Alkaloids. A Short Synthesis of Norfluorocurarine","year":"2009","cit":118,"pfa":"David B. C. Martin","psa":"Christopher D. Vanderwal","ptype":"article","src":"https://openalex.org/W2033434501","eid":"W2033434501"},{"id":"paper-w2086961054","cat":"papers","name":"Studies toward the Pharmacophore of Salvinorin A, a Potent κ Opioid Receptor Agonist","year":"2004","cit":118,"pfa":"Thomas Anthony Munro","psa":"Feng Yan","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2086961054","eid":"W2086961054"},{"id":"paper-w1990943633","cat":"papers","name":"Sub-acute effects of MDMA (±3,4-methylenedioxymethamphetamine, \"ecstasy\") on mood: evidence of gender differences","year":"2002","cit":118,"pfa":"Suzanne L. Verheyden","psa":"Valerie H. Curran","ptype":"article","src":"https://openalex.org/W1990943633","eid":"W1990943633"},{"id":"paper-w2056704543","cat":"papers","name":"Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA","year":"2011","cit":118,"pfa":"Noelia Granado","psa":"Rosario Moratalla","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2056704543","eid":"W2056704543"},{"id":"paper-w2167711402","cat":"papers","name":"Behavioral and Neurochemical Consequences of Long-Term Intravenous Self-Administration of MDMA and Its Enantiomers by Rhesus Monkeys","year":"2004","cit":118,"pfa":"William E. Fantegrossi","psa":"Gail D. Winger","ptype":"article","src":"https://openalex.org/W2167711402","eid":"W2167711402"},{"id":"paper-w1555375083","cat":"papers","name":"Pharmacological characterization of the effects of 3,4-methylenedioxymethamphetamine (\"ecstasy\") and its enantiomers on lethality, core temperature, and locomotor activity in singly housed and crowded mice","year":"2003","cit":118,"pfa":"William E. Fantegrossi","psa":"James Henry Woods","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1555375083","eid":"W1555375083"},{"id":"paper-w2117864279","cat":"papers","name":"Traditional Medicine in the Treatment of Drug Addiction","year":"2009","cit":118,"pfa":"Lin Lü","psa":"Thomas R. Kosten","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2117864279","eid":"W2117864279"},{"id":"paper-w4281253144","cat":"papers","name":"The emerging science of microdosing: A systematic review of research on low dose psychedelics (1955–2021) and recommendations for the field","year":"2022","cit":118,"pfa":"Vince Polito","psa":"Paul Liknaitzky","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W4281253144","eid":"W4281253144"},{"id":"paper-w2083152069","cat":"papers","name":"Long Lasting Effects of LSD on Normals","year":"1967","cit":118,"pfa":"William H. McGlothlin","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2083152069","eid":"W2083152069"},{"id":"paper-w2054802990","cat":"papers","name":"Thinking Glutamatergically: Changing Concepts of Schizophrenia Based Upon Changing Neurochemical Models","year":"2010","cit":118,"pfa":"Joshua T. Kantrowitz","psa":"Daniel C. Javitt","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2054802990","eid":"W2054802990"},{"id":"paper-w2883970814","cat":"papers","name":"Dark Classics in Chemical Neuroscience:N,N-Dimethyltryptamine (DMT)","year":"2018","cit":117,"pfa":"Lindsay P. Cameron","psa":"David E. Olson","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2883970814","eid":"W2883970814"},{"id":"paper-w3133906491","cat":"papers","name":"A placebo-controlled study of the effects of ayahuasca, set and setting on mental health of participants in ayahuasca group retreats","year":"2021","cit":117,"pfa":"Malin Vedøy Uthaug","psa":"Johannes Gerardus Ramaekers","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3133906491","eid":"W3133906491"},{"id":"paper-w1981056570","cat":"papers","name":"Serotonergic-dopaminergic mediation of 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”)","year":"1988","cit":117,"pfa":"Martin D. Schechter","ptype":"article","src":"https://openalex.org/W1981056570","eid":"W1981056570"},{"id":"paper-w4226057129","cat":"papers","name":"Serotonergic psychedelic drugs LSD and psilocybin reduce the hierarchical differentiation of unimodal and transmodal cortex","year":"2022","cit":117,"pfa":"Manesh Girn","psa":"R. Nathan Spreng","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4226057129","eid":"W4226057129"},{"id":"paper-w2992322507","cat":"papers","name":"Therapeutic use of serotoninergic hallucinogens: A review of the evidence and of the biological and psychological mechanisms","year":"2019","cit":117,"pfa":"RAFAEL GUIMARÃES DOS SANTOS","psa":"Jaime E. C. Hallak","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2992322507","eid":"W2992322507"},{"id":"paper-w2008525776","cat":"papers","name":"LSD Revisited","year":"1971","cit":117,"pfa":"William H. McGlothlin","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2008525776","eid":"W2008525776"},{"id":"paper-w1969123793","cat":"papers","name":"Pharmacology of Potent and Selective S2-Serotonergic Antagonists","year":"1985","cit":117,"pfa":"Paul A. J. Janssen","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1969123793","eid":"W1969123793"},{"id":"paper-w2768082096","cat":"papers","name":"LSD Increases Primary Process Thinking via Serotonin 2A Receptor Activation","year":"2017","cit":117,"pfa":"Rainer Krähenmann","psa":"Franz X. Vollenweider","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2768082096","eid":"W2768082096"},{"id":"paper-w4322719045","cat":"papers","name":"Pharmacotherapies for Treatment-Resistant Depression: How Antipsychotics Fit in the Rapidly Evolving Therapeutic Landscape","year":"2023","cit":117,"pfa":"Manish K. Jha","psa":"Sanjay J. Mathew","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4322719045","eid":"W4322719045"},{"id":"paper-w2007646254","cat":"papers","name":"An evaluation of a brief motivational intervention among young ecstasy and cocaine users: no effect on substance and alcohol use outcomes","year":"2006","cit":117,"pfa":"John Marsden","psa":"Michael Farrell","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2007646254","eid":"W2007646254"},{"id":"paper-w2105588659","cat":"papers","name":"Sweat Testing in Opioid Users with a Sweat Patch","year":"1996","cit":117,"pfa":"Pascal Kintz","psa":"Yves Edel","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2105588659","eid":"W2105588659"},{"id":"paper-w2804532410","cat":"papers","name":"A Survey of American Psychiatrists' Attitudes Toward Classic Hallucinogens","year":"2018","cit":117,"pfa":"Brian Scott Barnett","psa":"Harrison Graham Pope","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2804532410","eid":"W2804532410"},{"id":"paper-w2170811861","cat":"papers","name":"Is it time to revisit the role of psychedelic drugs in enhancing human creativity?","year":"2008","cit":117,"pfa":"Ben Sessa","ptype":"article","src":"https://openalex.org/W2170811861","eid":"W2170811861"},{"id":"paper-w2161047862","cat":"papers","name":"The serotonin 2C receptor potently modulates the head-twitch response in mice induced by a phenethylamine hallucinogen","year":"2010","cit":117,"pfa":"Clinton Ernest Canal","psa":"David C. Airey","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2161047862","eid":"W2161047862"},{"id":"paper-w2015607927","cat":"papers","name":"In vivo Models of Cerebral Ischemia: Effects of Parenterally Administered NMDA Receptor Glycine Site Antagonists","year":"1995","cit":117,"pfa":"David S. Warner","psa":"Eckard Weber","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2015607927","eid":"W2015607927"},{"id":"paper-w2027590847","cat":"papers","name":"(R,S)-Ketamine Metabolites (R,S)-norketamine and (2S,6S)-hydroxynorketamine Increase the Mammalian Target of Rapamycin Function","year":"2014","cit":117,"pfa":"Rajib Kumar Paul","psa":"Irving W. Wainer","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2027590847","eid":"W2027590847"},{"id":"paper-w2484912492","cat":"papers","name":"Effects of Ketamine and Ketamine Metabolites on Evoked Striatal Dopamine Release, Dopamine Receptors, and Monoamine Transporters","year":"2016","cit":117,"pfa":"Adem Can","psa":"Todd D. Gould","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2484912492","eid":"W2484912492"},{"id":"paper-w4313460828","cat":"papers","name":"NMDA Receptor Activation-Dependent Antidepressant-Relevant Behavioral and Synaptic Actions of Ketamine","year":"2023","cit":117,"pfa":"Panos Zanos","psa":"Todd D. Gould","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4313460828","eid":"W4313460828"},{"id":"paper-w2334528135","cat":"papers","name":"Untoward Reactions to Lysergic Acid Diethylamide (LSD) Resulting in Hospitalization","year":"1965","cit":116,"pfa":"William A. Frosch","psa":"Marvin Stern","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2334528135","eid":"W2334528135"},{"id":"paper-w3094461574","cat":"papers","name":"Toxicokinetics and Toxicodynamics of Ayahuasca Alkaloids N,N-Dimethyltryptamine (DMT), Harmine, Harmaline and Tetrahydroharmine: Clinical and Forensic Impact","year":"2020","cit":116,"pfa":"Andreia Machado Brito-da-Costa","psa":"Áurea Madureira-Carvalho","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3094461574","eid":"W3094461574"},{"id":"paper-w2038460090","cat":"papers","name":"Medication development of ibogaine as a pharmacotherapy for drug dependence.","year":"1998","cit":116,"pfa":"Deborah C. Mash","psa":"Juan Sanchez‐Ramos","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2038460090","eid":"W2038460090"},{"id":"paper-w1914275515","cat":"papers","name":"Acute Biphasic Effects of Ayahuasca","year":"2015","cit":116,"pfa":"Eduardo Ekman Schenberg","psa":"Dartiu Xavier da Silveira","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1914275515","eid":"W1914275515"},{"id":"paper-w2017358382","cat":"papers","name":"EFFECTS OF MESCALINE AND LYSERGIC ACID (d-LSD-25)","year":"1952","cit":116,"pfa":"Paul H. Hoch","psa":"Harry H. Pennes","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2017358382","eid":"W2017358382"},{"id":"paper-w2797335301","cat":"papers","name":"The early use of MDMA (‘Ecstasy’) in psychotherapy (1977–1985)","year":"2018","cit":116,"pfa":"Torsten Passie","topics":["Reviews & meta-analyses","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2797335301","eid":"W2797335301"},{"id":"paper-w2077420576","cat":"papers","name":"Preliminary evidence of hippocampal dysfunction in adolescent MDMA (?ecstasy?) users: possible relationship to neurotoxic effects","year":"2004","cit":116,"pfa":"Leslie K. Jacobsen","psa":"John Harrison Krystal","ptype":"article","src":"https://openalex.org/W2077420576","eid":"W2077420576"},{"id":"paper-w1842708150","cat":"papers","name":"Pharmacological profile of novel psychoactive benzofurans","year":"2015","cit":116,"pfa":"Anna Rickli","psa":"Matthias E. Liechti","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1842708150","eid":"W1842708150"},{"id":"paper-w4282941940","cat":"papers","name":"Ketamine Assisted Psychotherapy: A Systematic Narrative Review of the Literature","year":"2022","cit":116,"pfa":"Sandra J Drozdz","psa":"Karim Shiraz Ladha","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"review","src":"https://openalex.org/W4282941940","eid":"W4282941940"},{"id":"paper-w4251765303","cat":"papers","name":"Making psychedelics into medicines: The politics and paradoxes of medicalization","year":"2019","cit":116,"pfa":"Tehseen N. Noorani","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4251765303","eid":"W4251765303"},{"id":"paper-w4389606379","cat":"papers","name":"Treatment with psychedelics is psychotherapy: beyond reductionism","year":"2023","cit":116,"pfa":"Gerhard Gründer","psa":"Max Wolff","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4389606379","eid":"W4389606379"},{"id":"paper-w3027835371","cat":"papers","name":"Efficacy of psychedelic treatments on depressive symptoms: A meta-analysis","year":"2020","cit":116,"pfa":"Bruno Roméo","psa":"Amine Benyamina","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W3027835371","eid":"W3027835371"},{"id":"paper-w2034505327","cat":"papers","name":"Contribution of Cystine–Glutamate Antiporters to the Psychotomimetic Effects of Phencyclidine","year":"2007","cit":116,"pfa":"David L. Baker","psa":"Ilangovan Raju","ptype":"article","src":"https://openalex.org/W2034505327","eid":"W2034505327"},{"id":"paper-w2121610933","cat":"papers","name":"1-Aminomethylbenzocycloalkanes: Conformationally Restricted Hallucinogenic Phenethylamine Analogues as Functionally Selective 5-HT2AReceptor Agonists","year":"2006","cit":116,"pfa":"Thomas H. McLean","psa":"David E. Nichols","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2121610933","eid":"W2121610933"},{"id":"paper-w3175732576","cat":"papers","name":"Therapeutic Potentials of Ketamine and Esketamine in Obsessive–Compulsive Disorder (OCD), Substance Use Disorders (SUD) and Eating Disorders (ED): A Review of the Current Literature","year":"2021","cit":116,"pfa":"Giovanni Martinotti","psa":"Massimo Di Giannantonio","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W3175732576","eid":"W3175732576"},{"id":"paper-w1982170313","cat":"papers","name":"Increased activation of indirect semantic associations under psilocybin","year":"1996","cit":115,"pfa":"Manfred Spitzer","psa":"Frank W. Schneider","ptype":"article","src":"https://openalex.org/W1982170313","eid":"W1982170313"},{"id":"paper-w1486304586","cat":"papers","name":"Neurotoxicity of drugs of abuse - the case of methylenedioxy amphetamines (MDMA, ecstasy ), and amphetamines","year":"2009","cit":115,"pfa":"Euphrosyne Gouzoulis‐Mayfrank","psa":"Jörg Daumann","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1486304586","eid":"W1486304586"},{"id":"paper-w2928737933","cat":"papers","name":"Psychedelic-Assisted Group Therapy: A Systematic Review","year":"2019","cit":115,"pfa":"Alexander Trope","psa":"Joshua D. Woolley","topics":["Addiction","Reviews & meta-analyses","Therapy practice"],"ptype":"review","src":"https://openalex.org/W2928737933","eid":"W2928737933"},{"id":"paper-w2949965849","cat":"papers","name":"Horizontal gene cluster transfer increased hallucinogenic mushroom diversity","year":"2018","cit":115,"pfa":"Hannah T. Reynolds","psa":"Jason C. Slot","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2949965849","eid":"W2949965849"},{"id":"paper-w2031993713","cat":"papers","name":"A Naturally Occurring Amino Acid Substitution of the Human Serotonin 5‐HT2A Receptor Influences Amplitude and Timing of Intracellular Calcium Mobilization","year":"1997","cit":115,"pfa":"Norio Ozaki","psa":"David A Goldman","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2031993713","eid":"W2031993713"},{"id":"paper-w2786230868","cat":"papers","name":"The Experience Elicited by Hallucinogens Presents the Highest Similarity to Dreaming within a Large Database of Psychoactive Substance Reports","year":"2018","cit":115,"pfa":"Camila Sanz","psa":"Enzo Tagliazucchi","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W2786230868","eid":"W2786230868"},{"id":"paper-w1894300836","cat":"papers","name":"The monoamine oxidase-B inhibitor L-deprenyl protects against 3,4-methylenedioxymethamphetamine-induced lipid peroxidation and long-term serotonergic deficits.","year":"1995","cit":115,"pfa":"Jon E. Sprague","psa":"David E. Nichols","ptype":"article","src":"https://openalex.org/W1894300836","eid":"W1894300836"},{"id":"paper-w2330718890","cat":"papers","name":"The sigma-1 receptors are present in monomeric and oligomeric forms in living cells in the presence and absence of ligands","year":"2014","cit":115,"pfa":"Ashish Kumar Mishra","psa":"Valerică Raicu","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2330718890","eid":"W2330718890"},{"id":"paper-w4220956513","cat":"papers","name":"Towards psychedelic apprenticeship: Developing a gentle touch for the mediation and validation of psychedelic-induced insights and revelations","year":"2022","cit":115,"pfa":"Christopher B. Timmermann","psa":"David Dupuis","topics":["Safety & adverse events","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4220956513","eid":"W4220956513"},{"id":"paper-w4210625095","cat":"papers","name":"Classic Psychedelic Drugs: Update on Biological Mechanisms","year":"2022","cit":115,"pfa":"Franz X. Vollenweider","psa":"John W Smallridge","topics":["Addiction","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4210625095","eid":"W4210625095"},{"id":"paper-w1996357107","cat":"papers","name":"Stereoselective and regiospecific hydroxylation of ketamine and norketamine","year":"2012","cit":115,"pfa":"Zeruesenay Desta","psa":"Irving W. Wainer","ptype":"article","src":"https://openalex.org/W1996357107","eid":"W1996357107"},{"id":"paper-w4391810199","cat":"papers","name":"Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybin","year":"2024","cit":114,"pfa":"Joshua Daniel Rosenblat","psa":"Roger S. McIntyre","topics":["Depression","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4391810199","eid":"W4391810199"},{"id":"paper-w2954656383","cat":"papers","name":"Biosynthesis and Extracellular Concentrations of N,N-dimethyltryptamine (DMT) in Mammalian Brain","year":"2019","cit":114,"pfa":"Jon G. Dean","psa":"Jimo Borjigin","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2954656383","eid":"W2954656383"},{"id":"paper-w2327230999","cat":"papers","name":"Synthesis and κ-Opioid Receptor Activity of Furan-Substituted Salvinorin A Analogues","year":"2014","cit":114,"pfa":"Andrew P. Riley","psa":"Thomas Edward Prisinzano","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2327230999","eid":"W2327230999"},{"id":"paper-w4283011889","cat":"papers","name":"Effect of Psilocybin and Ketamine on Brain Neurotransmitters, Glutamate Receptors, DNA and Rat Behavior","year":"2022","cit":114,"pfa":"Adam Wojtas","psa":"Krystyna Gołembiowska","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4283011889","eid":"W4283011889"},{"id":"paper-w1970902020","cat":"papers","name":"Ketanserin pretreatment attenuates MDMA-induced dopamine release in the striatum as measured by microdialysis","year":"1990","cit":114,"pfa":"J. Frank Nash","ptype":"article","src":"https://openalex.org/W1970902020","eid":"W1970902020"},{"id":"paper-w4293729162","cat":"papers","name":"Serotonin 5-HT2A, 5-HT2c and 5-HT1A receptor involvement in the acute effects of psilocybin in mice. In vitro pharmacological profile and modulation of thermoregulation and head-twich response","year":"2022","cit":114,"pfa":"Ines Erkizia-Santamaría","psa":"Jorge Emilio Ortega","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4293729162","eid":"W4293729162"},{"id":"paper-w2032849276","cat":"papers","name":"Adenylate cyclase and acetylcholine release regulated by separate serotonin receptors of somatic cell hybrids.","year":"1979","cit":114,"pfa":"John MacDermot","psa":"Marshall W. Nirenberg","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2032849276","eid":"W2032849276"},{"id":"paper-w2171463615","cat":"papers","name":"Effect of SCH 23390 on (±)-3,4-methylenedioxymethamphetamine hyperactivity and self-administration in rats","year":"2004","cit":114,"pfa":"Evangelene Joy Kia Daniela","psa":"Susan Schenk","ptype":"article","src":"https://openalex.org/W2171463615","eid":"W2171463615"},{"id":"paper-w2940073658","cat":"papers","name":"A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists","year":"2019","cit":114,"pfa":"Kendall L. Mores","psa":"Richard M. van Rijn","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2940073658","eid":"W2940073658"},{"id":"paper-w2793096639","cat":"papers","name":"The Psychedelic Debriefing in Alcohol Dependence Treatment: Illustrating Key Change Phenomena through Qualitative Content Analysis of Clinical Sessions","year":"2018","cit":114,"pfa":"Elizabeth M. Nielson","psa":"Michael P. Bogenschutz","topics":["Addiction","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2793096639","eid":"W2793096639"},{"id":"paper-w2165924165","cat":"papers","name":"‘Ecstasy’ Psychosis and Flashbacks","year":"1991","cit":114,"pfa":"F. J. Creighton","psa":"Clive E. Hyde","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2165924165","eid":"W2165924165"},{"id":"paper-w3002125030","cat":"papers","name":"Psychedelic Microdosing: Prevalence and Subjective Effects","year":"2020","cit":114,"pfa":"Lindsay P. Cameron","psa":"David E. Olson","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3002125030","eid":"W3002125030"},{"id":"paper-w2603746317","cat":"papers","name":"Chemistry and Structure–Activity Relationships of Psychedelics","year":"2017","cit":114,"pfa":"David E. Nichols","ptype":"book-chapter","src":"https://openalex.org/W2603746317","eid":"W2603746317"},{"id":"paper-w2502147470","cat":"papers","name":"Sacred Knowledge: Psychedelics and Religious Experiences","year":"2015","cit":114,"pfa":"William A. Richards","ptype":"article","src":"https://openalex.org/W2502147470","eid":"W2502147470"},{"id":"paper-w1999159677","cat":"papers","name":"Treatment of Alcoholism Using Psychedelic Drugs: A Review of the Program of Research","year":"1998","cit":114,"pfa":"Mariavittoria Mangini","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1999159677","eid":"W1999159677"},{"id":"paper-w3112909063","cat":"papers","name":"Consciousness, Religion, and Gurus: Pitfalls of Psychedelic Medicine","year":"2020","cit":114,"pfa":"Matthew W. Johnson","topics":["Policy & ethics"],"ptype":"editorial","src":"https://openalex.org/W3112909063","eid":"W3112909063"},{"id":"paper-w2014120139","cat":"papers","name":"Effects of the hallucinogen 2,5-dimethoxy-4-iodophenethylamine (2C-I) and superpotent N-benzyl derivatives on the head twitch response","year":"2013","cit":114,"pfa":"Adam L. Halberstadt","psa":"Mark A. Geyer","ptype":"article","src":"https://openalex.org/W2014120139","eid":"W2014120139"},{"id":"paper-w2516564083","cat":"papers","name":"The hallucinogen d -lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT 1A , D 2 and TAAR 1 receptors","year":"2016","cit":114,"pfa":"Danilo De Gregorio","psa":"Gabriella Gobbi","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2516564083","eid":"W2516564083"},{"id":"paper-w2360318451","cat":"papers","name":"An intervention study to prevent gastric cancer by micro-selenium and large dose of allitridum.","year":"2004","cit":114,"pfa":"Hao Li","psa":"Xiaoyan Xie","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2360318451","eid":"W2360318451"},{"id":"paper-w1508658735","cat":"papers","name":"Substance Abuse: Information for School Counselors, Social Workers, Therapists, and Counselors","year":"1996","cit":114,"pfa":"Gary L.Fisher","psa":"Thomas C. Harrison","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"book","src":"https://openalex.org/W1508658735","eid":"W1508658735"},{"id":"paper-w2373469551","cat":"papers","name":"The Prodrug 4-Chlorokynurenine Causes Ketamine-Like Antidepressant Effects, but Not Side Effects, by NMDA/GlycineB-Site Inhibition","year":"2015","cit":114,"pfa":"Panos Zanos","psa":"Todd D. Gould","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2373469551","eid":"W2373469551"},{"id":"paper-w2070871237","cat":"papers","name":"Hippocampal Complexin Proteins and Cognitive Dysfunction in Schizophrenia","year":"2005","cit":114,"pfa":"Ken Sawada","psa":"William G. Honer","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2070871237","eid":"W2070871237"},{"id":"paper-w2769297297","cat":"papers","name":"Lack of Antidepressant Effects of (2R,6R)-Hydroxynorketamine in a Rat Learned Helplessness Model: Comparison with (R)-Ketamine","year":"2017","cit":114,"pfa":"Yukihiko Shirayama","psa":"Kenji Hashimoto","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2769297297","eid":"W2769297297"},{"id":"paper-w79668366","cat":"papers","name":"Serotonergic markers in platelets of patients with major depression: upregulation of 5-HT2 receptors.","year":"1995","cit":114,"pfa":"Pavel D. Hrdina","psa":"Y.D. Lapierre","topics":["Depression","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W79668366","eid":"W79668366"},{"id":"paper-w4211131282","cat":"papers","name":"The clinical pharmacology and potential therapeutic applications of 5‐methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT)","year":"2022","cit":113,"pfa":"Johannes T. Reckweg","psa":"Johannes Gerardus Ramaekers","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4211131282","eid":"W4211131282"},{"id":"paper-w1797327965","cat":"papers","name":"Health status of ayahuasca users","year":"2012","cit":113,"pfa":"Paulo César Ribeiro Barbosa","psa":"Rick J. Strassman","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1797327965","eid":"W1797327965"},{"id":"paper-w201702608","cat":"papers","name":"N,N-Dimethyltryptamine: An Endogenous Hallucinogen","year":"1981","cit":113,"pfa":"Steven A. Barker","psa":"Samuel T. Christian","ptype":"book-chapter","src":"https://openalex.org/W201702608","eid":"W201702608"},{"id":"paper-w2084035469","cat":"papers","name":"Death following ingestion of MDMA (ecstasy) and moclobemide","year":"2003","cit":113,"pfa":"Erkki Vuori","psa":"Matti Jäntti","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2084035469","eid":"W2084035469"},{"id":"paper-w2150534429","cat":"papers","name":"Localization of Salvinorin A and Related Compounds in Glandular Trichomes of the Psychoactive Sage, Salvia divinorum","year":"2004","cit":113,"pfa":"Daniel J. Siebert","ptype":"article","src":"https://openalex.org/W2150534429","eid":"W2150534429"},{"id":"paper-w576219240","cat":"papers","name":"Ecstasy: The Clinical, Pharmacological and Neurotoxicological Effects of the Drug MDMA","year":"1990","cit":113,"topics":["Dosing & pharmacology"],"ptype":"book","src":"https://openalex.org/W576219240","eid":"W576219240"},{"id":"paper-w2064289961","cat":"papers","name":"A Comprehensive Review of MDMA and GHB: Two Common Club Drugs","year":"2001","cit":113,"pfa":"Christian J. Teter","psa":"Sally K. Guthrie","topics":["Depression","Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2064289961","eid":"W2064289961"},{"id":"paper-w2411612641","cat":"papers","name":"Persistent Effects of (±)3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”) on Human Sleep","year":"1993","cit":113,"pfa":"Richard P. Allen","psa":"George A. Ricaurte","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2411612641","eid":"W2411612641"},{"id":"paper-w2886435130","cat":"papers","name":"Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognition","year":"2018","cit":113,"pfa":"Frederick Streeter Barrett","psa":"Roland R. Griffiths","ptype":"article","src":"https://openalex.org/W2886435130","eid":"W2886435130"},{"id":"paper-w2091385849","cat":"papers","name":"The effects of fluoxetine on the subjective and physiological effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans","year":"2006","cit":113,"pfa":"Manuel E. Tancer","psa":"Chris‐Ellyn Johanson","ptype":"article","src":"https://openalex.org/W2091385849","eid":"W2091385849"},{"id":"paper-w3009608926","cat":"papers","name":"Effects of ayahuasca on mental health and quality of life in naïve users: A longitudinal and cross-sectional study combination","year":"2020","cit":113,"pfa":"Daniel F. Jiménez-Garrido","psa":"José Carlos Bouso","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3009608926","eid":"W3009608926"},{"id":"paper-w2060762300","cat":"papers","name":"A Six-Month Prospective Evaluation of Personality Traits, Psychiatric Symptoms and Quality of Life in Ayahuasca-Naïve Subjects","year":"2009","cit":113,"pfa":"Paulo César Ribeiro Barbosa","psa":"Rick J. Strassman","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2060762300","eid":"W2060762300"},{"id":"paper-w2124413615","cat":"papers","name":"The effect of acutely administered MDMA on subjective and BOLD-fMRI responses to favourite and worst autobiographical memories","year":"2013","cit":113,"pfa":"Robin Lester Carhart-Harris","psa":"David Nutt","topics":["PTSD & trauma","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2124413615","eid":"W2124413615"},{"id":"paper-w2101563375","cat":"papers","name":"Cognitive function and mood in MDMA/THC users, THC users and non-drug using controls","year":"2006","cit":113,"pfa":"C. T. J. Lamers","psa":"Johannes Gerardus Ramaekers","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2101563375","eid":"W2101563375"},{"id":"paper-w2136857979","cat":"papers","name":"Determination of MDMA and its Metabolites in Blood and Urine by Gas Chromatography-Mass Spectrometry and Analysis of Enantiomers by Capillary Electrophoresis","year":"2002","cit":113,"pfa":"Nieves Pizarro","psa":"Rafael de la Torre","ptype":"article","src":"https://openalex.org/W2136857979","eid":"W2136857979"},{"id":"paper-w2033236480","cat":"papers","name":"Neuroanatomic specificity and time course of alterations in rat brain serotonergic pathways induced by MDMA (3,4‐methylenedioxymethamphetamine): Assessment using quantitative autoradiography","year":"1991","cit":113,"pfa":"George Battaglia","psa":"Errol B. De Souza","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2033236480","eid":"W2033236480"},{"id":"paper-w2170848267","cat":"papers","name":"Pharmacokinetics and Concentration-Effect Relationship of Oral LSD in Humans","year":"2015","cit":113,"pfa":"Patrick C. Dolder","psa":"Matthias E. Liechti","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2170848267","eid":"W2170848267"},{"id":"paper-w1999585620","cat":"papers","name":"5-Year Trends in Use of Hallucinogens and Other Adjunct Drugs among UK Dance Drug Users","year":"2006","cit":113,"pfa":"Jim McCambridge","psa":"Luke Mitcheson","ptype":"article","src":"https://openalex.org/W1999585620","eid":"W1999585620"},{"id":"paper-w3113989724","cat":"papers","name":"A Dendrite-Focused Framework for Understanding the Actions of Ketamine and Psychedelics","year":"2020","cit":113,"pfa":"Neil K. Savalia","psa":"Alex C. Kwan","ptype":"review","src":"https://openalex.org/W3113989724","eid":"W3113989724"},{"id":"paper-w4387007980","cat":"papers","name":"Case analysis of long-term negative psychological responses to psychedelics","year":"2023","cit":113,"pfa":"Rebecka Bremler","psa":"Robin Lester Carhart-Harris","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4387007980","eid":"W4387007980"},{"id":"paper-w2037772699","cat":"papers","name":"Pharmacokinetics of fexofenadine: Evaluation of a microdose and assessment of absolute oral bioavailability","year":"2010","cit":113,"pfa":"Graham Lappin","psa":"Colin R. Garner","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2037772699","eid":"W2037772699"},{"id":"paper-w2076077022","cat":"papers","name":"How does ketamine elicit a rapid antidepressant response?","year":"2014","cit":113,"pfa":"Ege T. Kavalali","psa":"Lisa M. Monteggia","topics":["Depression"],"ptype":"review","src":"https://openalex.org/W2076077022","eid":"W2076077022"},{"id":"paper-w2986913805","cat":"papers","name":"Comprehensive assessment of side effects associated with a single dose of ketamine in treatment-resistant depression","year":"2019","cit":113,"pfa":"Elia E. Acevedo-Diaz","psa":"Lawrence T. Park","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2986913805","eid":"W2986913805"},{"id":"paper-w4297723523","cat":"papers","name":"Studies on Lysergic Acid Diethylamide (LSD-25)","year":"1956","cit":112,"pfa":"Harris Isbell","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4297723523","eid":"W4297723523"},{"id":"paper-w4320800338","cat":"papers","name":"Medication Development of Ibogaine as a Pharmacotherapy for Drug Dependencea","year":"1998","cit":112,"pfa":"Deborah C. Mash","psa":"Juan Sanchez‐Ramos","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4320800338","eid":"W4320800338"},{"id":"paper-w2106410954","cat":"papers","name":"Ayahuasca in Adolescence: A Preliminary Psychiatric Assessment","year":"2005","cit":112,"pfa":"Dartiu Xavier da Silveira","psa":"Evelyn Doering-Silveira","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2106410954","eid":"W2106410954"},{"id":"paper-w1995859810","cat":"papers","name":"Persistent MDMA‐induced dopaminergic neurotoxicity in the striatum and substantia nigra of mice","year":"2008","cit":112,"pfa":"Noelia Granado","psa":"Rosario Moratalla","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1995859810","eid":"W1995859810"},{"id":"paper-w2800419754","cat":"papers","name":"Ibogaine Detoxification Transitions Opioid and Cocaine Abusers Between Dependence and Abstinence: Clinical Observations and Treatment Outcomes","year":"2018","cit":112,"pfa":"Deborah C. Mash","psa":"Kathleen Allen-Ferdinand","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2800419754","eid":"W2800419754"},{"id":"paper-w1990530091","cat":"papers","name":"The ugly side of amphetamines: short- and long-term toxicity of 3,4-methylenedioxymethamphetamine (MDMA, ‘Ecstasy’), methamphetamine and d-amphetamine","year":"2011","cit":112,"pfa":"Thomas Steinkellner","psa":"Therese Montgomery","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1990530091","eid":"W1990530091"},{"id":"paper-w2158208927","cat":"papers","name":"Pharmacological Interaction between 3,4-Methylenedioxymethamphetamine (Ecstasy) and Paroxetine: Pharmacological Effects and Pharmacokinetics","year":"2007","cit":112,"pfa":"Magı́ Farré","psa":"Rafael de la Torre","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2158208927","eid":"W2158208927"},{"id":"paper-w2155854964","cat":"papers","name":"Acute Adverse Reactions to Lsd in Clinical and Experimental use in the United Kingdom","year":"1971","cit":112,"pfa":"Nicolas Malleson","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2155854964","eid":"W2155854964"},{"id":"paper-w2186598879","cat":"papers","name":"The Pharmacology of Hallucinogens","year":"1972","cit":112,"pfa":"Peter Brawley","psa":"James C. Duffield","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2186598879","eid":"W2186598879"},{"id":"paper-w2028724567","cat":"papers","name":"Factor and item‐response analysis DSM‐IV criteria for abuse of and dependence on cannabis, cocaine, hallucinogens, sedatives, stimulants and opioids","year":"2007","cit":112,"pfa":"Nathan A. Gillespie","psa":"Kenneth S. Kendler","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2028724567","eid":"W2028724567"},{"id":"paper-w2011158169","cat":"papers","name":"Acute Toxic and Withdrawal Reactions Associated with Drug Use and Abuse","year":"1979","cit":112,"pfa":"Edward J. Khantzian","psa":"G. J. McKENNA","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2011158169","eid":"W2011158169"},{"id":"paper-w646109958","cat":"papers","name":"Textbook of transpersonal psychiatry and psychology","year":"1996","cit":112,"pfa":"Bruce W. Scotton","psa":"John R. Battista","topics":["Safety & adverse events","Dosing & pharmacology","Therapy practice"],"ptype":"book","src":"https://openalex.org/W646109958","eid":"W646109958"},{"id":"paper-w4226063380","cat":"papers","name":"Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trial","year":"2022","cit":112,"pfa":"Chadi G. Abdallah","psa":"John Harrison Krystal","topics":["Depression","PTSD & trauma","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4226063380","eid":"W4226063380"},{"id":"paper-w2297304494","cat":"papers","name":"Use of d-Lysergic Acid Diethylamide in the Treatment of Alcoholism","year":"1959","cit":111,"pfa":"N. Chwelos","psa":"Abram Hoffer","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2297304494","eid":"W2297304494"},{"id":"paper-w2025546081","cat":"papers","name":"(±)-3,4-Methylenedioxymethamphetamine (MDMA, ‘Ecstasy’) increases social interaction in rats","year":"2000","cit":111,"pfa":"Kirsten C. Morley","psa":"Iain S. McGregor","ptype":"article","src":"https://openalex.org/W2025546081","eid":"W2025546081"},{"id":"paper-w2895740693","cat":"papers","name":"The influence of therapists’ first-hand experience with psychedelics on psychedelic-assisted psychotherapy research and therapist training","year":"2018","cit":111,"pfa":"Elizabeth M. Nielson","psa":"Jeffrey R. Guss","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2895740693","eid":"W2895740693"},{"id":"paper-w3047886920","cat":"papers","name":"Post-Psychedelic Reductions in Experiential Avoidance Are Associated With Decreases in Depression Severity and Suicidal Ideation","year":"2020","cit":111,"pfa":"Richard J. Zeifman","psa":"Robin Lester Carhart-Harris","topics":["Depression","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3047886920","eid":"W3047886920"},{"id":"paper-w1927768602","cat":"papers","name":"Gender Differences in Prevalence of Substance Use Disorders among Individuals with Lifetime Exposure to Substances: Results from a Large Representative Sample","year":"2013","cit":111,"pfa":"Shaul Lev‐Ran","psa":"Bernard Le Foll","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1927768602","eid":"W1927768602"},{"id":"paper-w2139643566","cat":"papers","name":"Period, age, and cohort effects on substance use among young Americans: a decade of change, 1976-86.","year":"1988","cit":111,"pfa":"Patrick M. O’Malley","psa":"Lloyd D. Johnston","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2139643566","eid":"W2139643566"},{"id":"paper-w2557969481","cat":"papers","name":"Are adolescents more vulnerable to the harmful effects of cannabis than adults? A placebo-controlled study in human males","year":"2016","cit":111,"pfa":"Claire Mokrysz","psa":"H. Valerie Curran","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2557969481","eid":"W2557969481"},{"id":"paper-w2130119797","cat":"papers","name":"Psilocybin, psychological distress, and suicidality","year":"2015","cit":110,"pfa":"Peter S. Hendricks","psa":"Roland R. Griffiths","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2130119797","eid":"W2130119797"},{"id":"paper-w2057370050","cat":"papers","name":"Salvinorin A Analogs as Probes in Opioid Pharmacology","year":"2008","cit":110,"pfa":"Thomas Edward Prisinzano","psa":"Richard B. Rothman","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W2057370050","eid":"W2057370050"},{"id":"paper-w2077534208","cat":"papers","name":"Treating drug dependence with the aid of ibogaine: A retrospective study","year":"2014","cit":110,"pfa":"Eduardo Ekman Schenberg","psa":"Dartiu Xavier da Silveira","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2077534208","eid":"W2077534208"},{"id":"paper-w2125885488","cat":"papers","name":"MDMA, methamphetamine, and CYP2D6 pharmacogenetics: what is clinically relevant?","year":"2012","cit":110,"pfa":"Rafael de la Torre","psa":"Magı́ Farré","topics":["Addiction","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2125885488","eid":"W2125885488"},{"id":"paper-w2074731904","cat":"papers","name":"When the Endogenous Hallucinogenic Trace AmineN,N-Dimethyltryptamine Meets the Sigma-1 Receptor","year":"2009","cit":110,"pfa":"Tsung‐Ping Su","psa":"D. Bruce Vaupel","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2074731904","eid":"W2074731904"},{"id":"paper-w2158268739","cat":"papers","name":"A possibly sigma-1 receptor mediated role of dimethyltryptamine in tissue protection, regeneration, and immunity","year":"2013","cit":110,"pfa":"Ede Frecska","psa":"Dennis J. McKenna","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2158268739","eid":"W2158268739"},{"id":"paper-w2163161496","cat":"papers","name":"MDMA-assisted therapy: A new treatment model for social anxiety in autistic adults","year":"2015","cit":110,"pfa":"Alicia L. Danforth","psa":"Charles S. Grob","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2163161496","eid":"W2163161496"},{"id":"paper-w4389397550","cat":"papers","name":"Single-Dose Synthetic Psilocybin With Psychotherapy for Treatment-Resistant Bipolar Type II Major Depressive Episodes","year":"2023","cit":110,"pfa":"Scott T. Aaronson","psa":"Trisha Suppes","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4389397550","eid":"W4389397550"},{"id":"paper-w2064147241","cat":"papers","name":"Long-term changes in social interaction and reward following repeated MDMA administration to adolescent rats without accompanying serotonergic neurotoxicity","year":"2002","cit":110,"pfa":"Kevin C.F. Fone","psa":"Laura Maddocks","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2064147241","eid":"W2064147241"},{"id":"paper-w2011221060","cat":"papers","name":"User perceptions of the benefits and harms of hallucinogenic drug use: A web-based questionnaire study","year":"2010","cit":110,"pfa":"Robin Lester Carhart-Harris","psa":"David Nutt","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2011221060","eid":"W2011221060"},{"id":"paper-w2275207943","cat":"papers","name":"Role of hypothermia in the mechanism of protection against serotonergic toxicity. I. Experiments using 3,4-methylenedioxymethamphetamine, dizocilpine, CGS 19755 and NBQX.","year":"1995","cit":110,"pfa":"Gail M. Farfel","psa":"Lewis S. Seiden","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2275207943","eid":"W2275207943"},{"id":"paper-w4281397183","cat":"papers","name":"Psychedelics and Psychotherapy: Cognitive-Behavioral Approaches as Default","year":"2022","cit":110,"pfa":"David B. Yaden","psa":"Matthew W. Johnson","topics":["Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4281397183","eid":"W4281397183"},{"id":"paper-w3083797211","cat":"papers","name":"Positive effects of psychedelics on depression and wellbeing scores in individuals reporting an eating disorder","year":"2020","cit":110,"pfa":"Meg J. Spriggs","psa":"Robin Lester Carhart-Harris","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W3083797211","eid":"W3083797211"},{"id":"paper-w2080389460","cat":"papers","name":"Approaches using molecular imaging technology — use of PET in clinical microdose studies","year":"2010","cit":110,"pfa":"Claudia Christina Wagner","psa":"Oliver Langer","topics":["Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W2080389460","eid":"W2080389460"},{"id":"paper-w1991205166","cat":"papers","name":"Pilot dose–response trial of i.v. ketamine in treatment-resistant depression","year":"2014","cit":110,"pfa":"Rosalyn Lai","psa":"Colleen K A Loo","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1991205166","eid":"W1991205166"},{"id":"paper-w2810586523","cat":"papers","name":"(2R,6R)-hydroxynorketamine rescues chronic stress-induced depression-like behavior through its actions in the midbrain periaqueductal gray","year":"2018","cit":110,"pfa":"Dylan Chou","psa":"Yu‐Cheng Ho","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2810586523","eid":"W2810586523"},{"id":"paper-w2103721605","cat":"papers","name":"Neuropharmacology of the Naturally Occurring κ-Opioid Hallucinogen Salvinorin A","year":"2011","cit":109,"pfa":"Christopher W. Cunningham","psa":"Thomas Edward Prisinzano","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2103721605","eid":"W2103721605"},{"id":"paper-w2129354754","cat":"papers","name":"Agony and ecstasy: a review of MDMA effects and toxicity","year":"2000","cit":109,"pfa":"C. Burgess","psa":"Michael Gill","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2129354754","eid":"W2129354754"},{"id":"paper-w2034106456","cat":"papers","name":"Ayahuasca healing beyond the Amazon: the globalization of a traditional indigenous entheogenic practice","year":"2008","cit":109,"pfa":"Kenneth W. Tupper","ptype":"article","src":"https://openalex.org/W2034106456","eid":"W2034106456"},{"id":"paper-w2150803086","cat":"papers","name":"Ayahuasca Tourism: Participants in Shamanic Rituals and their Personality Styles, Motivation, Benefits and Risks","year":"2015","cit":109,"pfa":"Veronika Kavenská","psa":"Hana Šimonová","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2150803086","eid":"W2150803086"},{"id":"paper-w2122215269","cat":"papers","name":"Cerebral1H MRS alterations in recreational 3,4-methylenedioxymethamphetamine (MDMA, ?ecstasy?) users","year":"1999","cit":109,"pfa":"L. Chang","psa":"Russell E. Poland","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2122215269","eid":"W2122215269"},{"id":"paper-w1986449836","cat":"papers","name":"Neurochemical and neurohistological alterations in the rat and monkey produced by orally administered methylenedioxymethamphetamine (MDMA)","year":"1988","cit":109,"pfa":"William Slikker","psa":"J. Bailey","ptype":"article","src":"https://openalex.org/W1986449836","eid":"W1986449836"},{"id":"paper-w2082986500","cat":"papers","name":"Effect of ambient temperature on hyperthermia and hyperkinesis induced by 3,4-methylenedioxymethamphetamine (MDMA or “ecstasy”) in rats","year":"1994","cit":109,"pfa":"Richard Ian Dafters","ptype":"article","src":"https://openalex.org/W2082986500","eid":"W2082986500"},{"id":"paper-w1479855792","cat":"papers","name":"MDMA self‐administration in rats: acquisition, progressive ratio responding and serotonin transporter binding","year":"2007","cit":109,"pfa":"Susan Schenk","psa":"Deborah C. Mash","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1479855792","eid":"W1479855792"},{"id":"paper-w2106566412","cat":"papers","name":"Glutathione and N-Acetylcysteine Conjugates of α-Methyldopamine Produce Serotonergic Neurotoxicity: Possible Role in Methylenedioxyamphetamine-Mediated Neurotoxicity","year":"1999","cit":109,"pfa":"Fengju Bai","psa":"Terrence J. Monks","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2106566412","eid":"W2106566412"},{"id":"paper-w2038786381","cat":"papers","name":"Toward a Comparative Overview of Dependence Potential and Acute Toxicity of Psychoactive Substances Used Nonmedically","year":"1993","cit":109,"pfa":"Robert S. Gable","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2038786381","eid":"W2038786381"},{"id":"paper-w2590821743","cat":"papers","name":"Effect of Hallucinogens on Unconditioned Behavior","year":"2016","cit":109,"pfa":"Adam L. Halberstadt","psa":"Mark A. Geyer","ptype":"book-chapter","src":"https://openalex.org/W2590821743","eid":"W2590821743"},{"id":"paper-w2163394473","cat":"papers","name":"Current markers of the Athlete Blood Passport do not flag microdose EPO doping","year":"2011","cit":109,"pfa":"Michael J. Ashenden","psa":"Ken Sharpe","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2163394473","eid":"W2163394473"},{"id":"paper-w2760068487","cat":"papers","name":"The Mechanisms of Psychedelic Visionary Experiences: Hypotheses from Evolutionary Psychology","year":"2017","cit":109,"pfa":"Michael Winkelman","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2760068487","eid":"W2760068487"},{"id":"paper-w3107835125","cat":"papers","name":"Psychedelics in Psychiatry—Keeping the Renaissance From Going Off the Rails","year":"2020","cit":109,"pfa":"David B. Yaden","psa":"Roland R. Griffiths","ptype":"article","src":"https://openalex.org/W3107835125","eid":"W3107835125"},{"id":"paper-w2068852619","cat":"papers","name":"How LSD Originated","year":"1979","cit":109,"pfa":"Albert Hofmann","ptype":"article","src":"https://openalex.org/W2068852619","eid":"W2068852619"},{"id":"paper-w562019813","cat":"papers","name":"Opioid Dependence: Mechanisms and Treatment","year":"1980","cit":109,"pfa":"Abraham Wikler","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"book","src":"https://openalex.org/W562019813","eid":"W562019813"},{"id":"paper-w1999600703","cat":"papers","name":"Ketamine: synaptogenesis, immunomodulation and glycogen synthase kinase-3 as underlying mechanisms of its antidepressant properties","year":"2013","cit":109,"pfa":"Patricia A. Zunszain","psa":"Carmine Maria Pariante","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1999600703","eid":"W1999600703"},{"id":"paper-w1980628262","cat":"papers","name":"Twenty-five Years of Glutamate in Schizophrenia: Are We There Yet?","year":"2012","cit":109,"pfa":"Daniel C. Javitt","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1980628262","eid":"W1980628262"},{"id":"paper-w2336055336","cat":"papers","name":"Binding Interactions of Lysergic Acid Diethylamide and Related Agents with Dopamine Receptors in the Brain","year":"1976","cit":108,"pfa":"David R. Burt","psa":"Solomon H. Snyder","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2336055336","eid":"W2336055336"},{"id":"paper-w4205906672","cat":"papers","name":"The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration and preparation","year":"2022","cit":108,"pfa":"James Rucker","psa":"Allan Hunter Young","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4205906672","eid":"W4205906672"},{"id":"paper-w2108609891","cat":"papers","name":"Pharmacokinetics of the potent hallucinogen, salvinorin A in primates parallels the rapid onset and short duration of effects in humans","year":"2008","cit":108,"pfa":"Jacob M. Hooker","psa":"Joanna S. Fowler","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2108609891","eid":"W2108609891"},{"id":"paper-w2739337936","cat":"papers","name":"Inhibition of serotonin transporters disrupts the enhancement of fear memory extinction by 3,4-methylenedioxymethamphetamine (MDMA)","year":"2017","cit":108,"pfa":"Matthew B. Young","psa":"Leonard Lee Howell","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2739337936","eid":"W2739337936"},{"id":"paper-w1978208122","cat":"papers","name":"Receptor binding profile suggests multiple mechanisms of action are responsible for ibogaine's putative anti-addictive activity","year":"1995","cit":108,"pfa":"Paul M. Sweetnam","psa":"John W. Ferkany","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1978208122","eid":"W1978208122"},{"id":"paper-w2972959563","cat":"papers","name":"LSD acutely impairs working memory, executive functions, and cognitive flexibility, but not risk-based decision-making","year":"2019","cit":108,"pfa":"Thomas Pokorny","psa":"Katrin H. Preller","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2972959563","eid":"W2972959563"},{"id":"paper-w2171299210","cat":"papers","name":"The Oligomeric States of the Purified Sigma-1 Receptor Are Stabilized by Ligands","year":"2014","cit":108,"pfa":"Katarzyna A. Gromek","psa":"Brian G. Fox","topics":["Addiction","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2171299210","eid":"W2171299210"},{"id":"paper-w2546678366","cat":"papers","name":"Classical hallucinogens and neuroimaging: A systematic review of human studies","year":"2016","cit":108,"pfa":"RAFAEL GUIMARÃES DOS SANTOS","psa":"Jaime E. C. Hallak","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W2546678366","eid":"W2546678366"},{"id":"paper-w4323049021","cat":"papers","name":"Association between mystical-type experiences under psychedelics and improvements in well-being or mental health – A comprehensive review of the evidence","year":"2023","cit":108,"pfa":"Samuli Kangaslampi","topics":["Depression","Anxiety & end-of-life","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4323049021","eid":"W4323049021"},{"id":"paper-w1848226399","cat":"papers","name":"Psychotomimetic Drugs: Structure-Activity Relationships","year":"1978","cit":108,"pfa":"Alexander T. Shulgin","ptype":"book-chapter","src":"https://openalex.org/W1848226399","eid":"W1848226399"},{"id":"paper-w2792879091","cat":"papers","name":"Substance Use, Anxiety, and Depressive Symptoms Among College Students","year":"2018","cit":108,"pfa":"Kenneth S. Walters","psa":"Rebecca Bonhomme","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2792879091","eid":"W2792879091"},{"id":"paper-w1984416965","cat":"papers","name":"How Do Prescription Opioid Users Differ From Users of Heroin or Other Drugs in Psychopathology: Results From the National Epidemiologic Survey on Alcohol and Related Conditions","year":"2010","cit":108,"pfa":"Li-Tzy T. Wu","psa":"Dan German Blazer","topics":["Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W1984416965","eid":"W1984416965"},{"id":"paper-w2011025664","cat":"papers","name":"Ketamine increases the striatal N-[11C]methylspiperone binding in vivo: positron emission tomography study using conscious rhesus monkey","year":"1994","cit":108,"pfa":"Hirotaka Onoe","psa":"Yasuyoshi Watanabe","ptype":"article","src":"https://openalex.org/W2011025664","eid":"W2011025664"},{"id":"paper-w2116244038","cat":"papers","name":"PTSD-Like Memory Generated Through Enhanced Noradrenergic Activity is Mitigated by a Dual Step Pharmacological Intervention Targeting its Reconsolidation","year":"2014","cit":108,"pfa":"Lucas Gazarini","psa":"Leandro Jose Bertoglio","topics":["PTSD & trauma","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2116244038","eid":"W2116244038"},{"id":"paper-w2800551343","cat":"papers","name":"(2R,6R)-Hydroxynorketamine is not essential for the antidepressant actions of (R)-ketamine in mice","year":"2018","cit":108,"pfa":"Jun-ichi Yamaguchi","psa":"Shigeyuki Chaki","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2800551343","eid":"W2800551343"},{"id":"paper-w3029166129","cat":"papers","name":"Efficacy of Esketamine Augmentation in Major Depressive Disorder","year":"2020","cit":108,"pfa":"George I. Papakostas","psa":"Maurizio Fava","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3029166129","eid":"W3029166129"},{"id":"paper-w2037018768","cat":"papers","name":"A parallel chiral–achiral liquid chromatographic method for the determination of the stereoisomers of ketamine and ketamine metabolites in the plasma and urine of patients with complex regional pain syndrome","year":"2010","cit":108,"pfa":"Ruin Moaddel","psa":"Irving W. Wainer","ptype":"article","src":"https://openalex.org/W2037018768","eid":"W2037018768"},{"id":"paper-w3110733646","cat":"papers","name":"Investigation of the Structure–Activity Relationships of Psilocybin Analogues","year":"2020","cit":107,"pfa":"Adam K. Klein","psa":"Adam L. Halberstadt","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3110733646","eid":"W3110733646"},{"id":"paper-w2007855506","cat":"papers","name":"Mescaline and LSD: Direct and indirect effects on serotonin-containing neurons in brain","year":"1973","cit":107,"pfa":"Henry James Haigler","psa":"George K. Aghajanian","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2007855506","eid":"W2007855506"},{"id":"paper-w2507165056","cat":"papers","name":"The effects of MDMA on socio-emotional processing: Does MDMA differ from other stimulants?","year":"2016","cit":107,"pfa":"Anya K. Bershad","psa":"Harriet de Wit","topics":["Mechanism & neuroscience","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2507165056","eid":"W2507165056"},{"id":"paper-w2071464244","cat":"papers","name":"Involvement of κ-Opioid and Endocannabinoid System on Salvinorin A-Induced Reward","year":"2007","cit":107,"pfa":"Daniela Braida","psa":"Mariaelvina Sala","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2071464244","eid":"W2071464244"},{"id":"paper-w2019031442","cat":"papers","name":"Identification of a primary metabolite of ibogaine that targets serotonin transporters and elevates serotonin","year":"1995","cit":107,"pfa":"Deborah C. Mash","psa":"William Lee Hearn","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2019031442","eid":"W2019031442"},{"id":"paper-w1191653087","cat":"papers","name":"The mixed serotonin receptor agonist psilocybin reduces threat-induced modulation of amygdala connectivity","year":"2015","cit":107,"pfa":"Rainer Krähenmann","psa":"Franz X. Vollenweider","topics":["Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1191653087","eid":"W1191653087"},{"id":"paper-w2010729444","cat":"papers","name":"MDMA and alcohol effects, combined and alone, on objective and subjective measures of actual driving performance and psychomotor function","year":"2006","cit":107,"pfa":"Kim P. C. Kuypers","psa":"Johannes Gerardus Ramaekers","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2010729444","eid":"W2010729444"},{"id":"paper-w1980997765","cat":"papers","name":"Psychotomimetic drugs and brain 5-hydroxytryptamine metabolism","year":"1970","cit":107,"pfa":"Daniel X. Freedman","psa":"Richard A. Lovell","ptype":"article","src":"https://openalex.org/W1980997765","eid":"W1980997765"},{"id":"paper-w4308372082","cat":"papers","name":"Ketanserin Reverses the Acute Response to LSD in a Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Participants","year":"2022","cit":107,"pfa":"A. Becker","psa":"Matthias E. Liechti","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4308372082","eid":"W4308372082"},{"id":"paper-w1985253324","cat":"papers","name":"5-Hydroxytryptamine uptake blockers attenuate the 5-hydroxytryptamine-releasing effect of 3,4-methylenedioxymethamphetamine and related agents","year":"1990","cit":107,"pfa":"Cameron R. Hekmatpanah","psa":"Stephen J. Peroutka","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1985253324","eid":"W1985253324"},{"id":"paper-w2100799471","cat":"papers","name":"Forensic investigation of K2, Spice, and “bath salt” commercial preparations: A three-year study of new designer drug products containing synthetic cannabinoid, stimulant, and hallucinogenic compounds","year":"2013","cit":107,"pfa":"Kathryn A. Seely","psa":"Jeffery H. Moran","ptype":"article","src":"https://openalex.org/W2100799471","eid":"W2100799471"},{"id":"paper-w1991362566","cat":"papers","name":"Sub-Anesthetic Ketamine Modulates Intrinsic BOLD Connectivity Within the Hippocampal-Prefrontal Circuit in the Rat","year":"2013","cit":107,"pfa":"Natalia Gass","psa":"Wolfgang Weber‐Fahr","ptype":"article","src":"https://openalex.org/W1991362566","eid":"W1991362566"},{"id":"paper-w2518780615","cat":"papers","name":"GLYX-13 Produces Rapid Antidepressant Responses with Key Synaptic and Behavioral Effects Distinct from Ketamine","year":"2016","cit":107,"pfa":"Rong-Jian Liu","psa":"Ronald S. Duman","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2518780615","eid":"W2518780615"},{"id":"paper-w1973814761","cat":"papers","name":"A Controlled Comparison of Lysergic Acid Diethylamide (LSD) and Dextroamphetamine in Alcoholics","year":"1969","cit":106,"pfa":"Leo E. Hollister","psa":"George Krieger","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W1973814761","eid":"W1973814761"},{"id":"paper-w2409554261","cat":"papers","name":"Some Effects of Lysergic Acid Diethylamide and Bufotenine on Electrical Activity in the Cat's Visual System","year":"1955","cit":106,"pfa":"Edward V. Evarts","psa":"Wade H. Marshall","ptype":"article","src":"https://openalex.org/W2409554261","eid":"W2409554261"},{"id":"paper-w2151828427","cat":"papers","name":"The non-hallucinogen 2-bromo-lysergic acid diethylamide as preventative treatment for cluster headache: An open, non-randomized case series","year":"2010","cit":106,"pfa":"Matthias Karst","psa":"Torsten Passie","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2151828427","eid":"W2151828427"},{"id":"paper-w2026484120","cat":"papers","name":"Ibogaine in the Treatment of Substance Dependence","year":"2013","cit":106,"pfa":"Thomas Brown","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2026484120","eid":"W2026484120"},{"id":"paper-w2025333158","cat":"papers","name":"Role of kappa-opioid receptors in the effects of salvinorin A and ketamine on attention in rats","year":"2010","cit":106,"pfa":"Christina L. Nemeth","psa":"William A. Carlezon","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2025333158","eid":"W2025333158"},{"id":"paper-w2099601730","cat":"papers","name":"Plasma oxytocin concentrations following MDMA or intranasal oxytocin in humans","year":"2014","cit":106,"pfa":"Matthew G. Kirkpatrick","psa":"Suma Jacob","ptype":"article","src":"https://openalex.org/W2099601730","eid":"W2099601730"},{"id":"paper-w2075802882","cat":"papers","name":"Memory deficits in abstinent MDMA (ecstasy) users: neuropsychological evidence of frontal dysfunction","year":"2006","cit":106,"pfa":"Boris B. Quednow","psa":"Michael Wagner","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2075802882","eid":"W2075802882"},{"id":"paper-w2171120634","cat":"papers","name":"Self-reported psychopathological symptoms in recreational ecstasy (MDMA) users are mainly associated with regular cannabis use: further evidence from a combined cross-sectional/longitudinal investigation","year":"2004","cit":106,"pfa":"Jörg Daumann","psa":"Euphrosyne Gouzoulis‐Mayfrank","ptype":"article","src":"https://openalex.org/W2171120634","eid":"W2171120634"},{"id":"paper-w2867834500","cat":"papers","name":"Dark Classics in Chemical Neuroscience: 3,4-Methylenedioxymethamphetamine","year":"2018","cit":106,"pfa":"Lee E. Dunlap","psa":"David E. Olson","topics":["Safety & adverse events","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2867834500","eid":"W2867834500"},{"id":"paper-w2140560102","cat":"papers","name":"Pharmepéna-Psychonautics: Human Intranasal, Sublingual and Oral Pharmacology of 5-Methoxy-N, N-Dimethyl-Tryptamine","year":"2001","cit":106,"pfa":"Jonathan Ott","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2140560102","eid":"W2140560102"},{"id":"paper-w1643991689","cat":"papers","name":"3,4-Methylenedioxymethamphetamine (Ecstasy) Inhibits Dyskinesia Expression and Normalizes Motor Activity in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Treated Primates","year":"2003","cit":106,"pfa":"Mahmoud M. Iravani","psa":"Peter G. Jenner","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1643991689","eid":"W1643991689"},{"id":"paper-w2058842534","cat":"papers","name":"Increased anxiety in rats after 3,4-methylenedioxymethamphetamine: association with serotonin depletion","year":"2002","cit":106,"pfa":"Clint G. Gurtman","psa":"Iain S. McGregor","topics":["Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2058842534","eid":"W2058842534"},{"id":"paper-w2107376791","cat":"papers","name":"Serotonergic Psychedelics Temporarily Modify Information Transfer in Humans","year":"2015","cit":106,"pfa":"Joan Francesc Alonso","psa":"Jordi Riba","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2107376791","eid":"W2107376791"},{"id":"paper-w2056899163","cat":"papers","name":"Repeated intermittent administration of psychomotor stimulant drugs alters the acquisition of Pavlovian approach behavior in rats: differential effects of cocaine, d-amphetamine and 3,4-methylenedioxymethamphetamine (“ec","year":"2001","cit":106,"pfa":"Jane R. Taylor","psa":"James David Jentsch","ptype":"article","src":"https://openalex.org/W2056899163","eid":"W2056899163"},{"id":"paper-w3197311089","cat":"papers","name":"Attitudes and Beliefs about the Therapeutic Use of Psychedelic Drugs among Psychologists in the United States","year":"2021","cit":106,"pfa":"Alan K. Davis","psa":"Jason B. Luoma","topics":["Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3197311089","eid":"W3197311089"},{"id":"paper-w2047362131","cat":"papers","name":"Microdosing Clinical Study: Pharmacokinetic, Pharmacogenomic (SLCO2B1), and Interaction (Grapefruit Juice) Profiles of Celiprolol Following the Oral Microdose and Therapeutic Dose","year":"2011","cit":106,"pfa":"Ichiro Ieiri","psa":"Yuichi Sugiyama","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2047362131","eid":"W2047362131"},{"id":"paper-w2931837427","cat":"papers","name":"Cortical dynamics during psychedelic and anesthetized states induced by ketamine","year":"2019","cit":106,"pfa":"Duan Li","psa":"George A. Mashour","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2931837427","eid":"W2931837427"},{"id":"paper-w2153141793","cat":"papers","name":"Dihydrobenzofuran Analogues of Hallucinogens. 3. Models of 4-Substituted (2,5-Dimethoxyphenyl)alkylamine Derivatives with Rigidified Methoxy Groups","year":"1996","cit":106,"pfa":"Aaron P. Monte","psa":"David E. Nichols","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2153141793","eid":"W2153141793"},{"id":"paper-w1984304181","cat":"papers","name":"Effect of LSD on Prepulse Inhibition and Spontaneous Behavior in the Rat A Pharmacological Analysis and Comparison between Two Rat Strains","year":"2001","cit":106,"pfa":"Abdel‐Mouttalib Ouagazzal","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1984304181","eid":"W1984304181"},{"id":"paper-w2160471925","cat":"papers","name":"Substance Use and Abuse in First-Episode Psychosis: Prevalence Before and After Early Intervention","year":"2006","cit":106,"pfa":"Suzanne Archie","psa":"Robert B. Zipursky","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2160471925","eid":"W2160471925"},{"id":"paper-w2006782584","cat":"papers","name":"Sleep Deprivation Disrupts Prepulse Inhibition and Induces Psychosis-Like Symptoms in Healthy Humans","year":"2014","cit":106,"pfa":"Nadine Petrovsky","psa":"Veena Kumari","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2006782584","eid":"W2006782584"},{"id":"paper-w4391420550","cat":"papers","name":"Esketamine: Less Drowsiness, More Analgesia","year":"2024","cit":106,"pfa":"Georges Mion","psa":"Sabine Himmelseher","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4391420550","eid":"W4391420550"},{"id":"paper-w1967653523","cat":"papers","name":"Mescaline and lysergic acid diethylamide (LSD) as discriminative stimuli","year":"1971","cit":105,"pfa":"Ira D. Hirschhorn","psa":"Jerrold C. Winter","ptype":"article","src":"https://openalex.org/W1967653523","eid":"W1967653523"},{"id":"paper-w2095483365","cat":"papers","name":"Prolonged Adverse Reactions to Lysergic Acid Diethylamide","year":"1963","cit":105,"pfa":"Sidney Cohen","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2095483365","eid":"W2095483365"},{"id":"paper-w2013576699","cat":"papers","name":"Mescaline use for 5700 years","year":"2002","cit":105,"pfa":"Jan G. Bruhn","psa":"Olof Beck","ptype":"article","src":"https://openalex.org/W2013576699","eid":"W2013576699"},{"id":"paper-w1983736209","cat":"papers","name":"Cross tolerance between mescaline and LSD-25 with a comparison of the mescaline and LSD reactions","year":"1962","cit":105,"pfa":"Albert B. Wolbach","psa":"Edward J. Miner","ptype":"article","src":"https://openalex.org/W1983736209","eid":"W1983736209"},{"id":"paper-w3014803974","cat":"papers","name":"Subacute effects of the psychedelic ayahuasca on the salience and default mode networks","year":"2020","cit":105,"pfa":"Lorenzo Pasquini","psa":"Dráulio Barros de Araújo","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3014803974","eid":"W3014803974"},{"id":"paper-w2035759859","cat":"papers","name":"Brain hyperthermia induced by MDMA (‘ecstasy’): modulation by environmental conditions","year":"2004","cit":105,"pfa":"Paul Leon Brown","psa":"Eugene A. Kiyatkin","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2035759859","eid":"W2035759859"},{"id":"paper-w2017509011","cat":"papers","name":"3,4-Dihydroxymethamphetamine (HHMA). A Major in Vivo 3,4-methylenedioxymethamphetamine (MDMA) Metabolite in Humans","year":"2001","cit":105,"pfa":"Mireia Segura","psa":"Rafael de la Torre","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2017509011","eid":"W2017509011"},{"id":"paper-w2138968721","cat":"papers","name":"Dissociable Effects of a Single Dose of Ecstasy (MDMA) on Psychomotor Skills and Attentional Performance","year":"2003","cit":105,"pfa":"C. T. J. Lamers","psa":"Karel Brookhuis","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2138968721","eid":"W2138968721"},{"id":"paper-w2735984207","cat":"papers","name":"Two dose investigation of the 5-HT-agonist psilocybin on relative and global cerebral blood flow","year":"2017","cit":105,"pfa":"Candace R. Lewis","psa":"Franz X. Vollenweider","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2735984207","eid":"W2735984207"},{"id":"paper-w2058799830","cat":"papers","name":"Effect of hallucinogens on spontaneous and sensory-evoked locus coeruleus unit activity in the rat: reversal by selective 5-HT2antagonists","year":"1986","cit":105,"pfa":"Kurt Rasmussen","psa":"George K. Aghajanian","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2058799830","eid":"W2058799830"},{"id":"paper-w2192859497","cat":"papers","name":"Indoleamine Hallucinogens in Cluster Headache: Results of the Clusterbusters Medication Use Survey","year":"2015","cit":105,"pfa":"Emmanuelle A. D. Schindler","psa":"Richard Andrew Sewell","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2192859497","eid":"W2192859497"},{"id":"paper-w1998906057","cat":"papers","name":"Possible Association Between 3,4-Methylenedioxymethamphetamine Abuse and Valvular Heart Disease","year":"2007","cit":105,"pfa":"Steven Droogmans","psa":"Guy Van Camp","ptype":"article","src":"https://openalex.org/W1998906057","eid":"W1998906057"},{"id":"paper-w2141206715","cat":"papers","name":"Methylenedioxymethamphetamine-induced serotonin deficits are followed by partial recovery over a 52-week period. Part I: Synaptosomal uptake and tissue concentrations.","year":"1996","cit":105,"pfa":"Karen E. Sabol","psa":"Lewis S. Seiden","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2141206715","eid":"W2141206715"},{"id":"paper-w2150654093","cat":"papers","name":"Hallucinogens on the Internet: A Vast New Source of Underground Drug Information","year":"2001","cit":105,"pfa":"John H. Halpern","psa":"Harrison Graham Pope","ptype":"article","src":"https://openalex.org/W2150654093","eid":"W2150654093"},{"id":"paper-w2028640606","cat":"papers","name":"Individual Differences in Psychotic Effects of Ketamine Are Predicted by Brain Function Measured under Placebo","year":"2008","cit":105,"pfa":"Garry D. Honey","psa":"Paul Charles Fletcher","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2028640606","eid":"W2028640606"},{"id":"paper-w4381334012","cat":"papers","name":"Ketamine in neuropsychiatric disorders: an update","year":"2023","cit":105,"pfa":"Jenessa N. Johnston","psa":"Carlos A. Zarate","ptype":"article","src":"https://openalex.org/W4381334012","eid":"W4381334012"},{"id":"paper-w1540340052","cat":"papers","name":"SER‐7b, a constitutively active Gαs coupled 5‐HT7‐like receptor expressed in the Caenorhabditis elegans M4 pharyngeal motorneuron","year":"2003","cit":105,"pfa":"Robert J. Hobson","psa":"Richard W. Komuniecki","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1540340052","eid":"W1540340052"},{"id":"paper-w1792210707","cat":"papers","name":"Fatalities Temporally Associated with the Ingestion of Ibogaine","year":"2012","cit":104,"pfa":"Kenneth Alper","psa":"James R. Gill","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1792210707","eid":"W1792210707"},{"id":"paper-w1983799144","cat":"papers","name":"Ibogaine, an anti-addictive drug: pharmacology and time to go further in development. A narrative review","year":"2008","cit":104,"pfa":"Romaldas Mačiulaitis","psa":"Vitalis Briedis","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W1983799144","eid":"W1983799144"},{"id":"paper-w2006293429","cat":"papers","name":"Dimethyltryptamine (DMT): Prevalence, user characteristics and abuse liability in a large global sample","year":"2013","cit":104,"pfa":"ADAM R. WINSTOCK","psa":"Rohan Borschmann","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2006293429","eid":"W2006293429"},{"id":"paper-w2801130428","cat":"papers","name":"Cortisol Modulation by Ayahuasca in Patients With Treatment Resistant Depression and Healthy Controls","year":"2018","cit":104,"pfa":"Ana Cecília de Menezes Galvão","psa":"Nicole Leite Galvão Coelho","topics":["Depression","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2801130428","eid":"W2801130428"},{"id":"paper-w2117093911","cat":"papers","name":"Differential Contributions of Dopamine D1, D2, and D3 Receptors to MDMA-Induced Effects on Locomotor Behavior Patterns in Mice","year":"2006","cit":104,"pfa":"Victoria B. Risbrough","psa":"Mark A. Geyer","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2117093911","eid":"W2117093911"},{"id":"paper-w2009328760","cat":"papers","name":"Involvement of the serotonin transporter in the formation of hydroxyl radicals induced by 3,4-methylenedioxymethamphetamine","year":"1999","cit":104,"pfa":"Mahalakshmi Shankaran","psa":"Gary A. Gudelsky","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2009328760","eid":"W2009328760"},{"id":"paper-w2886232664","cat":"papers","name":"Therapeutic use of classic psychedelics to treat cancer-related psychiatric distress","year":"2018","cit":104,"pfa":"Stephen Ross","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2886232664","eid":"W2886232664"},{"id":"paper-w1986349835","cat":"papers","name":"Novel Molecular Targets of Dezocine and Their Clinical Implications","year":"2013","cit":104,"pfa":"Renyu Liu","psa":"Bryan L. Roth","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1986349835","eid":"W1986349835"},{"id":"paper-w2211192072","cat":"papers","name":"Determination of cathinones and other stimulant, psychedelic, and dissociative designer drugs in real hair samples","year":"2015","cit":104,"pfa":"Alberto Salomone","psa":"Marco Vincenti","ptype":"article","src":"https://openalex.org/W2211192072","eid":"W2211192072"},{"id":"paper-w4247582466","cat":"papers","name":"Behavioral Neurobiology of Psychedelic Drugs","year":"2018","cit":104,"ptype":"book","src":"https://openalex.org/W4247582466","eid":"W4247582466"},{"id":"paper-w3084144945","cat":"papers","name":"Phase 0/microdosing approaches: time for mainstream application in drug development?","year":"2020","cit":104,"pfa":"Tal Burt","psa":"Yuichi Sugiyama","topics":["Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W3084144945","eid":"W3084144945"},{"id":"paper-w3108229983","cat":"papers","name":"Ketamine and Serotonergic Psychedelics: Common Mechanisms Underlying the Effects of Rapid-Acting Antidepressants","year":"2020","cit":104,"pfa":"Bashkim Kadriu","psa":"Carlos A. Zarate","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3108229983","eid":"W3108229983"},{"id":"paper-w2617057724","cat":"papers","name":"Acute memory and psychotomimetic effects of cannabis and tobacco both ‘joint’ and individually: a placebo-controlled trial","year":"2017","cit":104,"pfa":"Chandni N Hindocha","psa":"Helen Valerie Curran","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2617057724","eid":"W2617057724"},{"id":"paper-w1981952228","cat":"papers","name":"Safety Assessment and Dose Selection for First-in-Human Clinical Trials With Immunomodulatory Monoclonal Antibodies","year":"2009","cit":104,"pfa":"PY Muller","psa":"Frank R. Brennan","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1981952228","eid":"W1981952228"},{"id":"paper-w3107674131","cat":"papers","name":"Clinically meaningful changes on depressive symptom measures and patient‐reported outcomes in patients with treatment‐resistant depression","year":"2020","cit":104,"pfa":"Ibrahim Turkoz","psa":"Augustus John Rush","topics":["Depression","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3107674131","eid":"W3107674131"},{"id":"paper-w4311043198","cat":"papers","name":"Therapeutic use of psilocybin: Practical considerations for dosing and administration","year":"2022","cit":103,"pfa":"Caroline A. MacCallum","psa":"Jagpaul Kaur Deol","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4311043198","eid":"W4311043198"},{"id":"paper-w1260236800","cat":"papers","name":"Dantrolene in the treatment of MDMA-related hyperpyrexia: a systematic review","year":"2010","cit":103,"pfa":"Brian E. Grunau","psa":"Jeffrey Reynold Brubacher","topics":["Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W1260236800","eid":"W1260236800"},{"id":"paper-w2162840518","cat":"papers","name":"MDMA (\"Ecstasy\") and its association with cerebrovascular accidents: preliminary findings.","year":"2000","cit":103,"pfa":"Liesbeth Reneman","psa":"den G.J. Heeten","topics":["Safety & adverse events","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2162840518","eid":"W2162840518"},{"id":"paper-w597915230","cat":"papers","name":"Behavioural and neurotoxic effects of ayahuasca infusion (Banisteriopsis caapi and Psychotria viridis) in female Wistar rat","year":"2015","cit":103,"pfa":"Aline Pic‐Taylor","psa":"Eloísa Dutra Caldas","ptype":"article","src":"https://openalex.org/W597915230","eid":"W597915230"},{"id":"paper-w2044412002","cat":"papers","name":"Salvinorin A regulates dopamine transporter function via a kappa opioid receptor and ERK1/2-dependent mechanism","year":"2014","cit":103,"pfa":"Bronwyn Maree Kivell","psa":"Toni Shaun Shippenberg","topics":["Addiction","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2044412002","eid":"W2044412002"},{"id":"paper-w1992635678","cat":"papers","name":"MDMA and Sexual Behavior: Ecstasy Users' Perceptions About Sexuality and Sexual Risk","year":"2005","cit":103,"pfa":"Karen McElrath","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1992635678","eid":"W1992635678"},{"id":"paper-w3160765419","cat":"papers","name":"Registered clinical studies investigating psychedelic drugs for psychiatric disorders","year":"2021","cit":103,"pfa":"Ashley N. Siegel","psa":"Joshua Daniel Rosenblat","ptype":"article","src":"https://openalex.org/W3160765419","eid":"W3160765419"},{"id":"paper-w2791765313","cat":"papers","name":"Four Weekly Ayahuasca Sessions Lead to Increases in “Acceptance” Capacities: A Comparison Study With a Standard 8-Week Mindfulness Training Program","year":"2018","cit":103,"pfa":"Joaquim Soler","psa":"Jordi Riba","topics":["Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2791765313","eid":"W2791765313"},{"id":"paper-w2005066393","cat":"papers","name":"Near-fatal hyponatraemic coma due to vasopressin over-secretion after \"ecstasy\" (3,4-MDMA)","year":"1996","cit":103,"pfa":"Roger Holden","psa":"MauriceA. Jackson","ptype":"article","src":"https://openalex.org/W2005066393","eid":"W2005066393"},{"id":"paper-w2148004440","cat":"papers","name":"Rapid Analysis of Amphetamine, Methamphetamine, MDA, and MDMA in Urine Using Solid-Phase Microextraction, Direct On-Fiber Derivatization, and Analysis by GC-MS","year":"2000","cit":103,"pfa":"Carmen Jurado","psa":"Manuel Repetto","ptype":"article","src":"https://openalex.org/W2148004440","eid":"W2148004440"},{"id":"paper-w1844018320","cat":"papers","name":"Hallucinogenic indoleamines: Preferential action upon presynaptic serotonin receptors.","year":"1975","cit":103,"pfa":"George K. Aghajanian","psa":"H J Hailgler","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1844018320","eid":"W1844018320"},{"id":"paper-w3112172827","cat":"papers","name":"People of color in North America report improvements in racial trauma and mental health symptoms following psychedelic experiences","year":"2020","cit":103,"pfa":"Monnica T. Williams","psa":"Angela M. Haeny","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3112172827","eid":"W3112172827"},{"id":"paper-w2419147524","cat":"papers","name":"Modification of serotonergic neuron properties by long-term treatment with serotonin reuptake blockers.","year":"1990","cit":103,"pfa":"Claude de Montigny","psa":"Pierre Ulrich Blier","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2419147524","eid":"W2419147524"},{"id":"paper-w2157764621","cat":"papers","name":"Sigma Receptors in Oncology: Therapeutic and Diagnostic Applications of Sigma Ligands","year":"2010","cit":103,"pfa":"Aren van Waarde","psa":"Rudi Dierckx","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2157764621","eid":"W2157764621"},{"id":"paper-w2020623223","cat":"papers","name":"The Psychotomimetic Effects of Short-Term Sensory Deprivation","year":"2009","cit":103,"pfa":"Oliver John Mason","psa":"Francesca Brady","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2020623223","eid":"W2020623223"},{"id":"paper-w2274449219","cat":"papers","name":"AKT1 genotype moderates the acute psychotomimetic effects of naturalistically smoked cannabis in young cannabis smokers","year":"2016","cit":103,"pfa":"Celia J. A. Morgan","psa":"Helen Valerie Curran","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2274449219","eid":"W2274449219"},{"id":"paper-w4318339510","cat":"papers","name":"Distributed harmonic patterns of structure-function dependence orchestrate human consciousness","year":"2023","cit":103,"pfa":"Andrea I. Luppi","psa":"Emmanuel Andreas Stamatakis","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4318339510","eid":"W4318339510"},{"id":"paper-w2895828174","cat":"papers","name":"Pharmacokinetic and Pharmacodynamic Aspects of Peyote and Mescaline: Clinical and Forensic Repercussions","year":"2018","cit":102,"pfa":"Ricardo Jorge Dinis‐Oliveira","psa":"Diana Dias da Silva","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2895828174","eid":"W2895828174"},{"id":"paper-w2069005047","cat":"papers","name":"A Dimethyltryptamine-Forming Enzyme in Human Blood","year":"1973","cit":102,"pfa":"Richard Jed Wyatt","psa":"Julius Axelrod","ptype":"article","src":"https://openalex.org/W2069005047","eid":"W2069005047"},{"id":"paper-w2499216663","cat":"papers","name":"Psilocybin for treating substance use disorders?","year":"2016","cit":102,"pfa":"Bas T.H. de Veen","psa":"Judith Regina Homberg","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2499216663","eid":"W2499216663"},{"id":"paper-w2054487957","cat":"papers","name":"Long-Term Neuropsychiatric Consequences of \"Ecstasy\" (MDMA): A Review","year":"2002","cit":102,"pfa":"Alonso G. Montoya","psa":"Bruce Heimburger Price","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2054487957","eid":"W2054487957"},{"id":"paper-w2113448465","cat":"papers","name":"The plant-derived hallucinogen, salvinorin A, produces ?-opioid agonist-like discriminative effects in rhesus monkeys","year":"2004","cit":102,"pfa":"Eduardo R. Butelman","psa":"Mary Jeanne Kreek","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2113448465","eid":"W2113448465"},{"id":"paper-w3129221857","cat":"papers","name":"Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches","year":"2021","cit":102,"pfa":"Albert Garcia‐Romeu","psa":"Roland R. Griffiths","topics":["Depression","Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3129221857","eid":"W3129221857"},{"id":"paper-w2767171514","cat":"papers","name":"Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression","year":"2017","cit":102,"pfa":"Jack Stroud","psa":"Robin Lester Carhart-Harris","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2767171514","eid":"W2767171514"},{"id":"paper-w2971496197","cat":"papers","name":"Exploring ayahuasca‐assisted therapy for addiction: A qualitative analysis of preliminary findings among an Indigenous community in Canada","year":"2019","cit":102,"pfa":"Elena Argento","psa":"Kenneth W. Tupper","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2971496197","eid":"W2971496197"},{"id":"paper-w2038593489","cat":"papers","name":"The 5-HT2A/1A Agonist Psilocybin Disrupts Modal Object Completion Associated with Visual Hallucinations","year":"2010","cit":102,"pfa":"Michael Kometer","psa":"Franz X. Vollenweider","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2038593489","eid":"W2038593489"},{"id":"paper-w2107876659","cat":"papers","name":"Effects of MDMA (Ecstasy) on Prepulse Inhibition and Habituation of Startle in Humans after Pretreatment with Citalopram, Haloperidol, or Ketanserin","year":"2001","cit":102,"pfa":"Matthias E. Liechti","ptype":"article","src":"https://openalex.org/W2107876659","eid":"W2107876659"},{"id":"paper-w2118438870","cat":"papers","name":"The mechanisms involved in the long‐lasting neuroprotective effect of fluoxetine against MDMA (‘ecstasy’)‐induced degeneration of 5‐HT nerve endings in rat brain","year":"2001","cit":102,"pfa":"V Sanchez","psa":"M. Isabel Colado","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2118438870","eid":"W2118438870"},{"id":"paper-w2079258526","cat":"papers","name":"Transient reinforcing effects of phenylisopropylamine and indolealkylamine hallucinogens in rhesus monkeys","year":"2004","cit":102,"pfa":"William E. Fantegrossi","psa":"Gail D. Winger","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2079258526","eid":"W2079258526"},{"id":"paper-w2514441779","cat":"papers","name":"Psychosis associated with acute recreational drug toxicity: a European case series","year":"2016","cit":102,"pfa":"Odd Martin Vallersnes","psa":"Paul Ivor Dargan","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2514441779","eid":"W2514441779"},{"id":"paper-w2005023389","cat":"papers","name":"Pharmacological Studies of the Acute Effects of (+)-3,4-Methylenedioxymethamphetamine on Locomotor Activity, Role of 5-HT1B/1D and 5-HT2 Receptors","year":"2002","cit":102,"pfa":"Michael G. Bankson","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2005023389","eid":"W2005023389"},{"id":"paper-w4380371967","cat":"papers","name":"Psychedelic therapy in the treatment of addiction: the past, present and future","year":"2023","cit":102,"pfa":"Rayyan R. Zafar","psa":"David Erritzøe","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4380371967","eid":"W4380371967"},{"id":"paper-w1489572149","cat":"papers","name":"The serotonin receptors : from molecular pharmacology to human therapeutics","year":"2006","cit":102,"pfa":"Bryan L. Roth","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1489572149","eid":"W1489572149"},{"id":"paper-w2165689487","cat":"papers","name":"Plasma and Oral Fluid Pharmacokinetics and Pharmacodynamics after Oral Codeine Administration","year":"2002","cit":102,"pfa":"Insook Kim","psa":"Marilyn Ann Huestis","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2165689487","eid":"W2165689487"},{"id":"paper-w2074371541","cat":"papers","name":"Renal excretion profiles of psilocin following oral administration of psilocybin: a controlled study in man","year":"2002","cit":101,"pfa":"Felix Hasler","psa":"Franz X. Vollenweider","ptype":"article","src":"https://openalex.org/W2074371541","eid":"W2074371541"},{"id":"paper-w1984907750","cat":"papers","name":"Cerebral Pharmacokinetics of Tremor-Producing Harmala and Iboga Alkaloids","year":"2008","cit":101,"pfa":"GERHARD ZETLER","psa":"Lucie Schlosser","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1984907750","eid":"W1984907750"},{"id":"paper-w1995013188","cat":"papers","name":"The enzymic dephosphorylation and oxidation of psilocybin and pscilocin by mammalian tissue homogenates","year":"1961","cit":101,"pfa":"A. Horita","psa":"L. J. Weber","ptype":"article","src":"https://openalex.org/W1995013188","eid":"W1995013188"},{"id":"paper-w2021014311","cat":"papers","name":"Methylenedioxymethamphetamine (MDMA, ‘Ecstasy’): a stressor on the immune system","year":"2004","cit":101,"pfa":"Thomas J. Connor","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2021014311","eid":"W2021014311"},{"id":"paper-w2076211114","cat":"papers","name":"Behavioural analysis of the acute and chronic effects of MDMA treatment in the rat","year":"1999","cit":101,"pfa":"Hugh M. Marston","psa":"Steven P. Butcher","ptype":"article","src":"https://openalex.org/W2076211114","eid":"W2076211114"},{"id":"paper-w2006772874","cat":"papers","name":"Aminergic Metabolites in Cerebrospinal Fluid of Humans Previously Exposed to MDMA: Preliminary Observationsa","year":"1990","cit":101,"pfa":"G.A. Ricaurte","psa":"J. William Langston","ptype":"article","src":"https://openalex.org/W2006772874","eid":"W2006772874"},{"id":"paper-w2100352065","cat":"papers","name":"Effect of GBR 12909 and fluoxetine on the acute and long term changes induced by MDMA (‘ecstasy’) on the 5-HT and dopamine concentrations in mouse brain","year":"2001","cit":101,"pfa":"Esther O’Shea","psa":"M. Isabel Colado","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2100352065","eid":"W2100352065"},{"id":"paper-w2297061370","cat":"papers","name":"HALLUCINOGENIC DRUGS OF THE INDOLEALKYLAMINE TYPE AND CENTRAL MONOAMINE NEURONS","year":"1971","cit":101,"pfa":"Nils‐Erik Andén","psa":"Kjell Fuxé","ptype":"article","src":"https://openalex.org/W2297061370","eid":"W2297061370"},{"id":"paper-w2171603114","cat":"papers","name":"Efficacy and Enlightenment: LSD Psychotherapy and the Drug Amendments of 1962","year":"2012","cit":101,"pfa":"Matthew Oram","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2171603114","eid":"W2171603114"},{"id":"paper-w2025655040","cat":"papers","name":"A comparison of the physiological, behavioral, neurochemical and microglial effects of methamphetamine and 3,4-methylenedioxymethamphetamine in the mouse","year":"2007","cit":101,"pfa":"William E. Fantegrossi","psa":"J H Woods","ptype":"article","src":"https://openalex.org/W2025655040","eid":"W2025655040"},{"id":"paper-w1980453588","cat":"papers","name":"LSD and structural analogs: pharmacological evaluation at D1 dopamine receptors","year":"1995","cit":101,"pfa":"Val J. Watts","psa":"David E. Nichols","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1980453588","eid":"W1980453588"},{"id":"paper-w2148608081","cat":"papers","name":"Behavioural evidence for a functional interaction between central 5‐HT2 and 5‐HT1A receptors","year":"1990","cit":101,"pfa":"Lisa I. Backus","psa":"David G. Grahame‐Smith","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2148608081","eid":"W2148608081"},{"id":"paper-w3185477803","cat":"papers","name":"Does Psychedelic Therapy Have a Transdiagnostic Action and Prophylactic Potential?","year":"2021","cit":101,"pfa":"Rita Kočárová","psa":"Robin Lester Carhart-Harris","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W3185477803","eid":"W3185477803"},{"id":"paper-w3085274948","cat":"papers","name":"Psychedelic medicine: safety and ethical concerns","year":"2020","cit":101,"pfa":"Brian T. Anderson","psa":"Charles S. Grob","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3085274948","eid":"W3085274948"},{"id":"paper-w2576763726","cat":"papers","name":"Pharmacology and Toxicology of N-Benzylphenethylamine (“NBOMe”) Hallucinogens","year":"2017","cit":101,"pfa":"Adam L. Halberstadt","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W2576763726","eid":"W2576763726"},{"id":"paper-w3193503966","cat":"papers","name":"The socialization of hallucinations: Cultural priors, social interactions, and contextual factors in the use of psychedelics","year":"2021","cit":101,"pfa":"David Dupuis","topics":["Addiction","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3193503966","eid":"W3193503966"},{"id":"paper-w2064453282","cat":"papers","name":"Loss of Glial Glutamate and Aspartate Transporter (Excitatory Amino Acid Transporter 1) Causes Locomotor Hyperactivity and Exaggerated Responses to Psychotomimetics: Rescue by Haloperidol and Metabotropic Glutamate 2/3 A","year":"2008","cit":101,"pfa":"Rose‐Marie Karlsson","psa":"Andrew J. Holmes","ptype":"article","src":"https://openalex.org/W2064453282","eid":"W2064453282"},{"id":"paper-w1487250777","cat":"papers","name":"Addiction: from biology to drug policy","year":"1994","cit":101,"pfa":"Avram Goldstein","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1487250777","eid":"W1487250777"},{"id":"paper-w2089410048","cat":"papers","name":"Characteristics of Drug Abusers Admitted to a Psychiatric Hospital","year":"1968","cit":101,"pfa":"LEON J. HEKIMIAN","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2089410048","eid":"W2089410048"},{"id":"paper-w4385441778","cat":"papers","name":"Overview of Alcohol Use Disorder","year":"2023","cit":101,"pfa":"Henry R. Kranzler","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4385441778","eid":"W4385441778"},{"id":"paper-w2079643673","cat":"papers","name":"Psychotic Exacerbations and Enhanced Vasopressin Secretion in Schizophrenic Patients With Hyponatremia and Polydipsia","year":"1997","cit":101,"pfa":"Morris B. Goldman","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2079643673","eid":"W2079643673"},{"id":"paper-w2994886340","cat":"papers","name":"Intranasal Esketamine (SpravatoTM) for Use in Treatment-Resistant Depression In Conjunction With an Oral Antidepressant.","year":"2019","cit":101,"pfa":"Rebecca Bahr","psa":"Jose A Rey","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2994886340","eid":"W2994886340"},{"id":"paper-w4205850062","cat":"papers","name":"Clinical effects of low‐dose esketamine for anaesthesia induction in the elderly: A randomized controlled trial","year":"2022","cit":101,"pfa":"Juan Li","psa":"Zhaoyang Wang","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4205850062","eid":"W4205850062"},{"id":"paper-w2181738553","cat":"papers","name":"Citalopram antagonizes the stimulation by lysergic acid diethylamide of presynaptic inhibitory serotonin autoreceptors in the rat hypothalamus.","year":"1982","cit":100,"pfa":"Salomón Z. Langer","psa":"Chantal Moret","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2181738553","eid":"W2181738553"},{"id":"paper-w4306169038","cat":"papers","name":"Mescaline: The forgotten psychedelic","year":"2022","cit":100,"pfa":"Ioanna A. Vamvakopoulou","psa":"David Nutt","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4306169038","eid":"W4306169038"},{"id":"paper-w1927957122","cat":"papers","name":"NMDA antagonist properties of the putative antiaddictive drug, ibogaine.","year":"1995","cit":100,"pfa":"Piotr Popik","psa":"Phil Skolnick","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1927957122","eid":"W1927957122"},{"id":"paper-w2155043582","cat":"papers","name":"Electrophysiological Evidence of Serotonergic Impairment in Long-Term MDMA (“Ecstasy”) Users","year":"2001","cit":100,"pfa":"Rodney J. Croft","psa":"John H Gruzelier","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2155043582","eid":"W2155043582"},{"id":"paper-w2040494232","cat":"papers","name":"Demonstration and localization of neuronal degeneration in the rat forebrain following a single exposure to MDMA","year":"2003","cit":100,"pfa":"Larry C. Schmued","ptype":"article","src":"https://openalex.org/W2040494232","eid":"W2040494232"},{"id":"paper-w4220686675","cat":"papers","name":"Psilocybin-Induced Mystical-Type Experiences are Related to Persisting Positive Effects: A Quantitative and Qualitative Report","year":"2022","cit":100,"pfa":"Drummond E-Wen McCulloch","psa":"Dea Siggaard Stenbæk","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4220686675","eid":"W4220686675"},{"id":"paper-w4383186683","cat":"papers","name":"MDMA-Assisted Therapy for Severe PTSD: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study","year":"2023","cit":100,"pfa":"Jennifer Mitchell","psa":"Rick Doblin","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4383186683","eid":"W4383186683"},{"id":"paper-w2122464153","cat":"papers","name":"3,4‐methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein","year":"2004","cit":100,"pfa":"Xiaoying Wang","psa":"Richard B. Rothman","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2122464153","eid":"W2122464153"},{"id":"paper-w1974519338","cat":"papers","name":"Mortality among individuals with cannabis, cocaine, amphetamine, MDMA, and opioid use disorders: A nationwide follow-up study of Danish substance users in treatment","year":"2010","cit":100,"pfa":"Mikkel Christoffer Berg B. Arendt","psa":"S. O. W. Jensen","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1974519338","eid":"W1974519338"},{"id":"paper-w2069102021","cat":"papers","name":"Preclinical Pharmacology of mGlu2 / 3 Receptor Agonists: Novel Agents for Schizophrenia?","year":"2002","cit":100,"pfa":"Darryle D. Schoepp","psa":"Gerard J. Marek","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2069102021","eid":"W2069102021"},{"id":"paper-w2149928573","cat":"papers","name":"The NMDA receptor ion channel: a site for binding of huperzine A","year":"2001","cit":100,"pfa":"Richard Keith Gordon","psa":"Haresh S. Ved","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2149928573","eid":"W2149928573"},{"id":"paper-w2997141132","cat":"papers","name":"Adjunctive intranasal esketamine for major depressive disorder: A systematic review of randomized double-blind controlled-placebo studies","year":"2020","cit":100,"pfa":"Wei Zheng","psa":"Yu-Tao Xiang","topics":["Depression","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W2997141132","eid":"W2997141132"},{"id":"paper-w2522599389","cat":"papers","name":"Metabolomic signatures of drug response phenotypes for ketamine and esketamine in subjects with refractory major depressive disorder: new mechanistic insights for rapid acting antidepressants","year":"2016","cit":100,"pfa":"Daniel Miller Rotroff","psa":"Rima F Kaddurah-Daouk","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2522599389","eid":"W2522599389"},{"id":"paper-w2465993615","cat":"papers","name":"MDMA and PTSD treatment","year":"2016","cit":99,"pfa":"Ben Sessa","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W2465993615","eid":"W2465993615"},{"id":"paper-w571926712","cat":"papers","name":"Ayahuasca Visions: The Religious Iconography of a Peruvian Shaman","year":"1991","cit":99,"pfa":"Luís Eduardo Luna","psa":"Pablo Amaringo","ptype":"book","src":"https://openalex.org/W571926712","eid":"W571926712"},{"id":"paper-w2043147672","cat":"papers","name":"Synthesis of a Tricyclic Mescaline Analogue by Catalytic C−H Bond Activation","year":"2003","cit":99,"pfa":"Kateri A. Ahrendt","psa":"Jonathan A. Ellman","ptype":"article","src":"https://openalex.org/W2043147672","eid":"W2043147672"},{"id":"paper-w2036982675","cat":"papers","name":"MDMA induced hyperthermia: Report of a fatality and review of current therapy","year":"1996","cit":99,"pfa":"Khavar J. Dar","psa":"M. E. McBrien","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2036982675","eid":"W2036982675"},{"id":"paper-w3039116382","cat":"papers","name":"Serotonergic psychedelics LSD & psilocybin increase the fractal dimension of cortical brain activity in spatial and temporal domains","year":"2020","cit":99,"pfa":"Thomas F. Varley","psa":"Emmanuel Andreas Stamatakis","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3039116382","eid":"W3039116382"},{"id":"paper-w2771056291","cat":"papers","name":"The “Endless Trip” among the NPS Users: Psychopathology and Psychopharmacology in the Hallucinogen-Persisting Perception Disorder. A Systematic Review","year":"2017","cit":99,"pfa":"Laura Orsolini","psa":"Fabrizio Schifano","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W2771056291","eid":"W2771056291"},{"id":"paper-w2087314914","cat":"papers","name":"LSD: Injection Early in Pregnancy Produces Abnormalities in Offspring of Rats","year":"1967","cit":99,"pfa":"George J. Alexander","psa":"Rita B. Alexander","ptype":"article","src":"https://openalex.org/W2087314914","eid":"W2087314914"},{"id":"paper-w2074270863","cat":"papers","name":"5HT-2 mediation of acute behavioral effects of hallucinogens in rats","year":"1990","cit":99,"pfa":"Lauren L. Wing","psa":"Mark A. Geyer","ptype":"article","src":"https://openalex.org/W2074270863","eid":"W2074270863"},{"id":"paper-w3194401058","cat":"papers","name":"Pharmacology of Drugs Used as Stimulants","year":"2021","cit":99,"pfa":"James R. Docherty","psa":"Hadeel A. Alsufyani","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3194401058","eid":"W3194401058"},{"id":"paper-w1935081419","cat":"papers","name":"Complementary medicines in psychiatry","year":"2006","cit":99,"pfa":"Ursula Werneke","psa":"Stefan Priebe","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1935081419","eid":"W1935081419"},{"id":"paper-w2081793457","cat":"papers","name":"Values and Beliefs of Psychedelic Drug Users: A Cross-Cultural Study","year":"2006","cit":99,"pfa":"Michael Lerner","psa":"Michael Lyvers","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2081793457","eid":"W2081793457"},{"id":"paper-w4206147469","cat":"papers","name":"The Psychedelic Renaissance in Clinical Research: A Bibliometric Analysis of Three Decades of Human Studies with Psychedelics","year":"2022","cit":99,"pfa":"Aviad A. Hadar","psa":"Shaul Lev‐Ran","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4206147469","eid":"W4206147469"},{"id":"paper-w4294667223","cat":"papers","name":"Expectancy in placebo-controlled trials of psychedelics: if so, so what?","year":"2022","cit":99,"pfa":"Matthew Butler","psa":"James Rucker","ptype":"article","src":"https://openalex.org/W4294667223","eid":"W4294667223"},{"id":"paper-w2042538224","cat":"papers","name":"Antipsychotic drugs prevent the motor hyperactivity induced by psychotomimetic MK-801 in zebrafish (Danio rerio)","year":"2010","cit":99,"pfa":"Kelly Juliana Seibt","psa":"Carla Denise Bonan","ptype":"article","src":"https://openalex.org/W2042538224","eid":"W2042538224"},{"id":"paper-w2044136878","cat":"papers","name":"Sigma binding states in the brain; An emerging concept for multiple sites and their relevance for psychiatric disorders","year":"1990","cit":99,"pfa":"Yossef Itzhak","psa":"Ira D. Stein","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2044136878","eid":"W2044136878"},{"id":"paper-w2133373104","cat":"papers","name":"Ketamine and other glutamate receptor modulators for depression in bipolar disorder in adults","year":"2015","cit":99,"pfa":"Tayla L McCloud","psa":"Andrea Cipriani","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2133373104","eid":"W2133373104"},{"id":"paper-w2983463140","cat":"papers","name":"US Food and Drug Administration approval of esketamine and brexanolone","year":"2019","cit":99,"pfa":"Ioana A. Cristea","psa":"Florian Naudet","ptype":"article","src":"https://openalex.org/W2983463140","eid":"W2983463140"},{"id":"paper-w2083016249","cat":"papers","name":"Heat shock protein in mammalian brain and other organs after a physiologically relevant increase in body temperature induced by D-lysergic acid diethylamide.","year":"1983","cit":98,"pfa":"James W. Cosgrove","psa":"I. R. Brown","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2083016249","eid":"W2083016249"},{"id":"paper-w2135643379","cat":"papers","name":"Illicit Use of LSD or Psilocybin, but not MDMA or Nonpsychedelic Drugs, is Associated with Mystical Experiences in a Dose-Dependent Manner","year":"2012","cit":98,"pfa":"Michael Lyvers","psa":"Molly Meester","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2135643379","eid":"W2135643379"},{"id":"paper-w4241660517","cat":"papers","name":"Causes and Consequences of Methamphetamine and MDMA Toxicity","year":"2006","cit":98,"pfa":"MS Quinton","psa":"BK Yamamoto","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4241660517","eid":"W4241660517"},{"id":"paper-w2623228771","cat":"papers","name":"Neuroticism is associated with challenging experiences with psilocybin mushrooms","year":"2017","cit":98,"pfa":"Frederick Streeter Barrett","psa":"Roland R. Griffiths","ptype":"article","src":"https://openalex.org/W2623228771","eid":"W2623228771"},{"id":"paper-w2090188780","cat":"papers","name":"Acute effects of ayahuasca on neuropsychological performance: differences in executive function between experienced and occasional users","year":"2013","cit":98,"pfa":"José Carlos Bouso","psa":"Jordi Riba","ptype":"article","src":"https://openalex.org/W2090188780","eid":"W2090188780"},{"id":"paper-w2460738534","cat":"papers","name":"Behavioral and neurochemical effects of orally administered MDMA in the rodent and nonhuman primate.","year":"1989","cit":98,"pfa":"William Slikker","psa":"Scalzo Fm","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2460738534","eid":"W2460738534"},{"id":"paper-w2105541798","cat":"papers","name":"How could MDMA (ecstasy) help anxiety disorders? A neurobiological rationale","year":"2009","cit":98,"pfa":"P.-Ø. JOHANSEN","psa":"TS Krebs","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"editorial","src":"https://openalex.org/W2105541798","eid":"W2105541798"},{"id":"paper-w2028998494","cat":"papers","name":"A Clinical Plan for MDMA (Ecstasy) in the Treatment of Posttraumatic Stress Disorder (PTSD): Partnering with the FDA","year":"2002","cit":98,"pfa":"Rick Doblin","topics":["PTSD & trauma","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2028998494","eid":"W2028998494"},{"id":"paper-w2080967337","cat":"papers","name":"Effects of MDMA (ecstasy), and multiple drugs use on (simulated) driving performance and traffic safety","year":"2004","cit":98,"pfa":"Karel Brookhuis","psa":"Nele Samyn","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2080967337","eid":"W2080967337"},{"id":"paper-w2077688688","cat":"papers","name":"Inter-relations of the effects of psilocybin on subjective sensation, photopic critical frequency of fusion, and circulating non-esterified fatty acids","year":"1963","cit":98,"pfa":"MARTIN H. KEELER","ptype":"article","src":"https://openalex.org/W2077688688","eid":"W2077688688"},{"id":"paper-w2134763275","cat":"papers","name":"Can psychedelics have a role in psychiatry once again?","year":"2005","cit":98,"pfa":"Ben Sessa","ptype":"article","src":"https://openalex.org/W2134763275","eid":"W2134763275"},{"id":"paper-w2092230190","cat":"papers","name":"A Brief Overview of the Clinical Pharmacology of “Club Drugs”","year":"2005","cit":98,"pfa":"Gena Covell Britt","psa":"Elinore F. McCance‐Katz","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2092230190","eid":"W2092230190"},{"id":"paper-w3013565570","cat":"papers","name":"Implementation of emergency department–initiated buprenorphine for opioid use disorder in a rural southern state","year":"2020","cit":98,"pfa":"Carolyn Bogan","psa":"Kathleen T. Brady","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3013565570","eid":"W3013565570"},{"id":"paper-w3158455932","cat":"papers","name":"Moving Past Mysticism in Psychedelic Science","year":"2021","cit":98,"pfa":"James W. Sanders","psa":"Josjan Zijlmans","topics":["Safety & adverse events"],"ptype":"editorial","src":"https://openalex.org/W3158455932","eid":"W3158455932"},{"id":"paper-w2099918113","cat":"papers","name":"Microdosing and drug development: past, present and future","year":"2013","cit":98,"pfa":"Graham Lappin","psa":"Tal Burt","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2099918113","eid":"W2099918113"},{"id":"paper-w2157874700","cat":"papers","name":"Ketamine associated psychedelic effects and dependence.","year":"2003","cit":98,"pfa":"Lim Dk","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2157874700","eid":"W2157874700"},{"id":"paper-w2066323805","cat":"papers","name":"Evidence for a common biological basis of the absorption trait, hallucinogen effects, and positive symptoms: Epistasis between 5-HT2a and COMT polymorphisms","year":"2005","cit":98,"pfa":"Ulrich Ott","psa":"Dieter Vaitl","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2066323805","eid":"W2066323805"},{"id":"paper-w2320687740","cat":"papers","name":"Therapeutic Modulation of Glutamate Receptors in Major Depressive Disorder","year":"2016","cit":98,"pfa":"Brittany A. Jaso","psa":"Carlos A. Zarate","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2320687740","eid":"W2320687740"},{"id":"paper-w4292436051","cat":"papers","name":"Efficacy and safety of subanesthetic doses of esketamine combined with propofol in painless gastrointestinal endoscopy: a prospective, double-blind, randomized controlled trial","year":"2022","cit":98,"pfa":"Yongtong Zhan","psa":"Yalan Li","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4292436051","eid":"W4292436051"},{"id":"paper-w3188896843","cat":"papers","name":"Prevention and Management of Common Adverse Effects of Ketamine and Esketamine in Patients with Mood Disorders","year":"2021","cit":98,"pfa":"Felicia Ceban","psa":"Roger S. McIntyre","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3188896843","eid":"W3188896843"},{"id":"paper-w3201351307","cat":"papers","name":"Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder","year":"2021","cit":98,"pfa":"Rebecca L. Dean","psa":"Andrea Cipriani","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3201351307","eid":"W3201351307"},{"id":"paper-w3081126678","cat":"papers","name":"A low dose of lysergic acid diethylamide decreases pain perception in healthy volunteers","year":"2020","cit":97,"pfa":"Johannes Gerardus Ramaekers","psa":"Kim P. C. Kuypers","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3081126678","eid":"W3081126678"},{"id":"paper-w2329269363","cat":"papers","name":"The Total Synthesis of Iboga Alkaloids1","year":"1966","cit":97,"pfa":"G. Büchi","psa":"Frederick E. Ziegler","ptype":"article","src":"https://openalex.org/W2329269363","eid":"W2329269363"},{"id":"paper-w2010516245","cat":"papers","name":"Experiences of Encounters with Ayahuasca—“the Vine of the Soul”","year":"2009","cit":97,"pfa":"Anette Kjellgren","psa":"Torsten Norlander","ptype":"article","src":"https://openalex.org/W2010516245","eid":"W2010516245"},{"id":"paper-w2801728504","cat":"papers","name":"Assessment of Alcohol and Tobacco Use Disorders Among Religious Users of Ayahuasca","year":"2018","cit":97,"pfa":"Paulo César Ribeiro Barbosa","psa":"Michael Winkelman","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2801728504","eid":"W2801728504"},{"id":"paper-w2537388000","cat":"papers","name":"Development of a Psychotherapeutic Model for Psilocybin-Assisted Treatment of Alcoholism","year":"2016","cit":97,"pfa":"Michael P. Bogenschutz","psa":"Alyssa A. Forcehimes","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2537388000","eid":"W2537388000"},{"id":"paper-w1649318184","cat":"papers","name":"Metabolism and urinary disposition of N,N‐dimethyltryptamine after oral and smoked administration: a comparative study","year":"2014","cit":97,"pfa":"Jordi Riba","psa":"Steven A. Barker","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1649318184","eid":"W1649318184"},{"id":"paper-w2042586252","cat":"papers","name":"Intravenous self-administration of mephedrone, methylone and MDMA in female rats","year":"2015","cit":97,"pfa":"Kevin M. Creehan","psa":"Michael A. Taffe","ptype":"article","src":"https://openalex.org/W2042586252","eid":"W2042586252"},{"id":"paper-w2034187022","cat":"papers","name":"MDMA alters emotional processing and facilitates positive social interaction","year":"2014","cit":97,"pfa":"Margaret C. Wardle","psa":"Harriet de Wit","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2034187022","eid":"W2034187022"},{"id":"paper-w2144455058","cat":"papers","name":"Effects of varied doses of psilocybin on time interval reproduction in human subjects","year":"2008","cit":97,"pfa":"Jiřı́ Wackermann","psa":"Franz X. Vollenweider","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2144455058","eid":"W2144455058"},{"id":"paper-w2735648966","cat":"papers","name":"Who is ‘Molly’? MDMA adulterants by product name and the impact of harm-reduction services at raves","year":"2017","cit":97,"pfa":"Sarah Saleemi","psa":"Matthew W. Johnson","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2735648966","eid":"W2735648966"},{"id":"paper-w3021847224","cat":"papers","name":"Opposite effects of 3,4-methylenedioxymethamphetamine (MDMA) on sensorimotor gating in rats versus healthy humans","year":"1999","cit":97,"pfa":"Franz X. Vollenweider","psa":"Mark A. Geyer","ptype":"article","src":"https://openalex.org/W3021847224","eid":"W3021847224"},{"id":"paper-w3006005031","cat":"papers","name":"N,N-dimethyltryptamine reduces infarct size and improves functional recovery following transient focal brain ischemia in rats","year":"2020","cit":97,"pfa":"Sándor Nardai","psa":"Zsolt Nagy","ptype":"article","src":"https://openalex.org/W3006005031","eid":"W3006005031"},{"id":"paper-w2105566727","cat":"papers","name":"Genetic Deletion of Trace Amine 1 Receptors Reveals Their Role in Auto-Inhibiting the Actions of Ecstasy (MDMA)","year":"2011","cit":97,"pfa":"Benjamin Di Cara","psa":"Mark J. Millan","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2105566727","eid":"W2105566727"},{"id":"paper-w2037164190","cat":"papers","name":"Memory deficit and reduced anxiety in young adult rats given repeated intermittent MDMA treatment during the periadolescent period","year":"2004","cit":97,"pfa":"Brian J. Piper","psa":"Jerrold S. Meyer","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2037164190","eid":"W2037164190"},{"id":"paper-w2108989220","cat":"papers","name":"High Intensity Dependence of Auditory Evoked Dipole Source Activity Indicates Decreased Serotonergic Activity in Abstinent Ecstasy (MDMA) Users","year":"2000","cit":97,"pfa":"Frank Tuchtenhagen","ptype":"article","src":"https://openalex.org/W2108989220","eid":"W2108989220"},{"id":"paper-w3003581149","cat":"papers","name":"A review of emerging therapeutic potential of psychedelic drugs in the treatment of psychiatric illnesses","year":"2020","cit":97,"pfa":"Tingying Chi","psa":"Jessica A. Gold","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3003581149","eid":"W3003581149"},{"id":"paper-w1593351428","cat":"papers","name":"Neuropharmacology of 5‐hydroxytryptamine","year":"2006","cit":97,"pfa":"A. Richard Green","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1593351428","eid":"W1593351428"},{"id":"paper-w2996549067","cat":"papers","name":"Preliminary Report on the Effects of a Low Dose of LSD on Resting-State Amygdala Functional Connectivity","year":"2019","cit":97,"pfa":"Anya K. Bershad","psa":"Harriet de Wit","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2996549067","eid":"W2996549067"},{"id":"paper-w2078704741","cat":"papers","name":"Hypothalamic-Pituitary-Thyroid Axis and Sympathetic Nervous System Involvement in Hyperthermia Induced by 3,4-Methylenedioxymethamphetamine (Ecstasy)","year":"2003","cit":97,"pfa":"Jon E. Sprague","psa":"Edward Mills","ptype":"article","src":"https://openalex.org/W2078704741","eid":"W2078704741"},{"id":"paper-w2995178539","cat":"papers","name":"The relationship between subjective effects induced by a single dose of ketamine and treatment response in patients with major depressive disorder: A systematic review","year":"2019","cit":97,"pfa":"David S. Mathai","psa":"Thomas R. Kosten","topics":["Depression","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W2995178539","eid":"W2995178539"},{"id":"paper-w3118672806","cat":"papers","name":"The acute effects of classic psychedelics on memory in humans","year":"2021","cit":97,"pfa":"C. J. Healy","ptype":"article","src":"https://openalex.org/W3118672806","eid":"W3118672806"},{"id":"paper-w1966544510","cat":"papers","name":"Enduring Deficits in Sustained Visual Attention during Withdrawal of Intravenous Methylenedioxymethamphetamine Self-Administration in Rats: Results from a Comparative Study with d-Amphetamine and Methamphetamine","year":"2006","cit":97,"pfa":"Jeffrey W. Dalley","psa":"Trevor William Robbins","ptype":"article","src":"https://openalex.org/W1966544510","eid":"W1966544510"},{"id":"paper-w2133377406","cat":"papers","name":"MECHANISM-BASED INACTIVATION OF CYP2D6 BY METHYLENEDIOXYMETHAMPHETAMINE","year":"2004","cit":97,"pfa":"Amir Heydari","psa":"Amin Rostami‐Hodjegan","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2133377406","eid":"W2133377406"},{"id":"paper-w2920559226","cat":"papers","name":"Recreational use of psychedelics is associated with elevated personality trait openness: Exploration of associations with brain serotonin markers","year":"2019","cit":97,"pfa":"David Erritzøe","psa":"Gitte M. Knudsen","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2920559226","eid":"W2920559226"},{"id":"paper-w2155528285","cat":"papers","name":"Behavioral effects of LSD in the cat: Proposal of an animal behavior model for studying the actions of hallucinogenic drugs","year":"1977","cit":97,"pfa":"Barry L. Jacobs","psa":"Warren C. Stern","ptype":"article","src":"https://openalex.org/W2155528285","eid":"W2155528285"},{"id":"paper-w2021698268","cat":"papers","name":"Simultaneous quantification of amphetamines, caffeine and ketamine in urine by hollow fiber liquid phase microextraction combined with gas chromatography-flame ionization detector","year":"2010","cit":97,"pfa":"Jun Xiong","psa":"Bin Hu","ptype":"article","src":"https://openalex.org/W2021698268","eid":"W2021698268"},{"id":"paper-w2019494366","cat":"papers","name":"Patterns and predictors of simultaneous and concurrent use of alcohol, tobacco, marijuana, and hallucinogens in first-year college students","year":"1992","cit":97,"pfa":"Christopher S. Martin","psa":"Rock L. Clapper","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2019494366","eid":"W2019494366"},{"id":"paper-w2109814284","cat":"papers","name":"Pharmacology of Hallucinations: Several Mechanisms for One Single Symptom?","year":"2014","cit":97,"pfa":"Benjamin Rolland","psa":"Régis Bordet","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2109814284","eid":"W2109814284"},{"id":"paper-w39820996","cat":"papers","name":"Indian Adolescent Drug and Alcohol Use: Recent Patterns and Consequences","year":"1992","cit":97,"pfa":"Beauvais","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W39820996","eid":"W39820996"},{"id":"paper-w2923100148","cat":"papers","name":"A Hallucinogenic Serotonin-2A Receptor Agonist Reduces Visual Response Gain and Alters Temporal Dynamics in Mouse V1","year":"2019","cit":97,"pfa":"Angie M. Michaiel","psa":"Cristopher M. Niell","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2923100148","eid":"W2923100148"},{"id":"paper-w4309933714","cat":"papers","name":"Ketamine triggers a switch in excitatory neuronal activity across neocortex","year":"2022","cit":97,"pfa":"Joseph Cichon","psa":"Alex Proekt","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4309933714","eid":"W4309933714"},{"id":"paper-w3111975240","cat":"papers","name":"Mystical-type experiences occasioned by ketamine mediate its impact on at-risk drinking: Results from a randomized, controlled trial","year":"2020","cit":97,"pfa":"Rebecca L. Rothberg","psa":"Elias Dakwar","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3111975240","eid":"W3111975240"},{"id":"paper-w2031343230","cat":"papers","name":"Attenuation of anticipation: A therapeutic use of lysergic acid diethylamide","year":"1967","cit":96,"pfa":"Eric C. Kast","ptype":"article","src":"https://openalex.org/W2031343230","eid":"W2031343230"},{"id":"paper-w1998786450","cat":"papers","name":"The roles of 5-HT1A and 5-HT2 receptors in the effects of 5-MeO-DMT on locomotor activity and prepulse inhibition in rats","year":"2006","cit":96,"pfa":"Kirsten Krebs-Thomson","psa":"Mark A. Geyer","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1998786450","eid":"W1998786450"},{"id":"paper-w2125639418","cat":"papers","name":"Reinforcing Effects of MDMA (‘Ecstasy’) in Drug-Naive and Cocaine-Trained Rats","year":"2001","cit":96,"pfa":"Elisabeth Ratzenboeck","psa":"Gerald Zernig","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2125639418","eid":"W2125639418"},{"id":"paper-w4211114943","cat":"papers","name":"Diversity, biology, and history of psilocybin-containing fungi: Suggestions for research and technological development","year":"2022","cit":96,"pfa":"Ray C. Van Court","psa":"Jessie Uehling","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4211114943","eid":"W4211114943"},{"id":"paper-w2137627975","cat":"papers","name":"Level of use of 3,4-methylenedioxymethamphetamine (MDMA or Ecstasy) in humans correlates with EEG power and coherence","year":"1999","cit":96,"pfa":"Richard Ian Dafters","psa":"Caroline Bouquet","ptype":"article","src":"https://openalex.org/W2137627975","eid":"W2137627975"},{"id":"paper-w2085243884","cat":"papers","name":"Ecstasy (MDMA, MDA, MDEA, MBDB) consumption, seizures, related offences, prices, dosage levels and deaths in the UK (1994–2003)","year":"2006","cit":96,"pfa":"Fabrizio Schifano","psa":"Abdol Hamid Ghodse","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2085243884","eid":"W2085243884"},{"id":"paper-w2005277645","cat":"papers","name":"Ascorbic acid prevents 3,4-methylenedioxymethamphetamine (MDMA)-induced hydroxyl radical formation and the behavioral and neurochemical consequences of the depletion of brain 5-HT","year":"2001","cit":96,"pfa":"Mahalakshmi Shankaran","psa":"Gary A. Gudelsky","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2005277645","eid":"W2005277645"},{"id":"paper-w2007316404","cat":"papers","name":"Tolerance and cross-tolerance among psychotomimetic drugs","year":"1968","cit":96,"pfa":"J. B. Appel","psa":"Daniel X. Freedman","ptype":"article","src":"https://openalex.org/W2007316404","eid":"W2007316404"},{"id":"paper-w2749043159","cat":"papers","name":"The 21st century psychedelic renaissance: heroic steps forward on the back of an elephant","year":"2017","cit":96,"pfa":"Ben Sessa","ptype":"article","src":"https://openalex.org/W2749043159","eid":"W2749043159"},{"id":"paper-w1924308766","cat":"papers","name":"Cloning and characterization of a Caenorhabditis elegans D2‐like dopamine receptor","year":"2003","cit":96,"pfa":"Satoshi Suo","psa":"Shoichi Ishiura","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1924308766","eid":"W1924308766"},{"id":"paper-w2129530315","cat":"papers","name":"Receptor autoradiography in thoracic spinal cord: correlation of neurotransmitter binding sites with sympathoadrenal neurons","year":"1984","cit":96,"pfa":"VS Seybold","psa":"RP Elde","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2129530315","eid":"W2129530315"},{"id":"paper-w3196573181","cat":"papers","name":"LSD-stimulated behaviors in mice require β-arrestin 2 but not β-arrestin 1","year":"2021","cit":96,"pfa":"Ramona M. Rodriguiz","psa":"William C. Wetsel","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3196573181","eid":"W3196573181"},{"id":"paper-w2047997746","cat":"papers","name":"A demonstration of the use of ultra-performance liquid chromatography–mass spectrometry [UPLC/MS] in the determination of amphetamine-type substances and ketamine for forensic and toxicological analysis","year":"2006","cit":96,"pfa":"Luigino G. Apollonio","psa":"Jennelle M. Kyd","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2047997746","eid":"W2047997746"},{"id":"paper-w3216083737","cat":"papers","name":"Psychedelics as Tools for Belief Transmission. Set, Setting, Suggestibility, and Persuasion in the Ritual Use of Hallucinogens","year":"2021","cit":96,"pfa":"David Dupuis","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3216083737","eid":"W3216083737"},{"id":"paper-w2135002912","cat":"papers","name":"Is the Use of Ecstasy and Hallucinogens Increasing?","year":"1998","cit":96,"pfa":"Peter Moritz Schuster","psa":"Hans‐Ulrich Wïttchen","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2135002912","eid":"W2135002912"},{"id":"paper-w1976294695","cat":"papers","name":"Absence of long‐term analgesic effect from a short‐term S‐ketamine infusion on fibromyalgia pain: A randomized, prospective, double blind, active placebo‐controlled trial","year":"2011","cit":96,"pfa":"Ingeborg M. Noppers","psa":"Elise Y. Sarton","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1976294695","eid":"W1976294695"},{"id":"paper-w2081824154","cat":"papers","name":"Clozapine Plus Lamotrigine in Treatment-Resistant Schizophrenia","year":"1999","cit":96,"pfa":"Serdar Murat Dursun","psa":"Heather Milliken","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2081824154","eid":"W2081824154"},{"id":"paper-w3135759469","cat":"papers","name":"Hydroxynorketamines: Pharmacology and Potential Therapeutic Applications","year":"2021","cit":96,"pfa":"Jaclyn N. Highland","psa":"Todd D. Gould","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3135759469","eid":"W3135759469"},{"id":"paper-w2007729331","cat":"papers","name":"Lysergic Acid Diethylamide: Effect on Embryos","year":"1967","cit":95,"pfa":"Robert Auerbach","psa":"James A. Rugowski","ptype":"article","src":"https://openalex.org/W2007729331","eid":"W2007729331"},{"id":"paper-w2889525702","cat":"papers","name":"d-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: Mechanism of action and potential therapeutic applications in mood disorders","year":"2018","cit":95,"pfa":"Danilo De Gregorio","psa":"Gabriella Gobbi","topics":["Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W2889525702","eid":"W2889525702"},{"id":"paper-w4308486832","cat":"papers","name":"Structure–Activity Relationships for Psilocybin, Baeocystin, Aeruginascin, and Related Analogues to Produce Pharmacological Effects in Mice","year":"2022","cit":95,"pfa":"Grant C. Glatfelter","psa":"Michael H. Baumann","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4308486832","eid":"W4308486832"},{"id":"paper-w2012431780","cat":"papers","name":"MDMA (Ecstasy) neurotoxicity: assessing and communicating the risks","year":"2000","cit":95,"pfa":"Brandon P Boot","psa":"Wayne Hall","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2012431780","eid":"W2012431780"},{"id":"paper-w4381433809","cat":"papers","name":"A phase 1/2 trial to assess safety and efficacy of a vaporized 5-methoxy-N,N-dimethyltryptamine formulation (GH001) in patients with treatment-resistant depression","year":"2023","cit":95,"pfa":"Johannes T. Reckweg","psa":"Johannes Gerardus Ramaekers","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4381433809","eid":"W4381433809"},{"id":"paper-w1967894823","cat":"papers","name":"Molecular cloning and functional expression of 5-HT1E-like rat and human 5-hydroxytryptamine receptor genes.","year":"1993","cit":95,"pfa":"Timothy W. Lovenberg","psa":"J G Sutcliffe","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1967894823","eid":"W1967894823"},{"id":"paper-w4292410066","cat":"papers","name":"Adolescent and adult time trends in US hallucinogen use, 2002–19: any use, and use of ecstasy, LSD and PCP","year":"2022","cit":95,"pfa":"Ofir Livne","psa":"Deborah S. Hasin","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4292410066","eid":"W4292410066"},{"id":"paper-w2054754029","cat":"papers","name":"The Peak Experience Variable in DPT-Assisted Psychotherapy with Cancer Patients","year":"1977","cit":95,"pfa":"William A. Richards","psa":"Albert A. Kurland","topics":["Anxiety & end-of-life","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2054754029","eid":"W2054754029"},{"id":"paper-w2161795125","cat":"papers","name":"Psychiatric and Substance Use Disorders as Risk Factors for Attempted Suicide Among Adolescents: A Case Control Study","year":"2002","cit":95,"pfa":"Thomas M. Kelly","psa":"Kevin G. Lynch","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2161795125","eid":"W2161795125"},{"id":"paper-w2587622596","cat":"papers","name":"Association between alcohol, cannabis, and other illicit substance abuse and risk of developing schizophrenia: a nationwide population based register study","year":"2017","cit":95,"pfa":"S. M. Nielsen","psa":"Carsten Rygaard Hjorthøj","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2587622596","eid":"W2587622596"},{"id":"paper-w2946621262","cat":"papers","name":"A Word to the Wise About Intranasal Esketamine","year":"2019","cit":95,"pfa":"Alan F. Schatzberg","ptype":"article","src":"https://openalex.org/W2946621262","eid":"W2946621262"},{"id":"paper-w2793376319","cat":"papers","name":"Glutamatergic Modulators in Depression","year":"2018","cit":95,"pfa":"Ioline D. Henter","psa":"Carlos A. Zarate","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2793376319","eid":"W2793376319"},{"id":"paper-w2131028419","cat":"papers","name":"Metabolism and disposition of N,N‐dimethyltryptamine and harmala alkaloids after oral administration of ayahuasca","year":"2012","cit":94,"pfa":"Jordi Riba","psa":"Steven A. Barker","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2131028419","eid":"W2131028419"},{"id":"paper-w2008724430","cat":"papers","name":"Serotonin-Sensitive Adenylate Cyclase in Neural Tissue and Its Similarity to the Serotonin Receptor: A Possible Site of Action of Lysergic Acid Diethylamide","year":"1974","cit":94,"pfa":"James A. Nathanson","psa":"Paul Greengard","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2008724430","eid":"W2008724430"},{"id":"paper-w1995263930","cat":"papers","name":"3,4-methylenedioxymethamphetamine (MDMA): current perspectives","year":"2013","cit":94,"pfa":"Jerry Meyer","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W1995263930","eid":"W1995263930"},{"id":"paper-w4394693583","cat":"papers","name":"Acute Adverse Effects of Therapeutic Doses of Psilocybin","year":"2024","cit":94,"pfa":"Akhila Yerubandi","psa":"Joshua Caballero","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4394693583","eid":"W4394693583"},{"id":"paper-w1970393223","cat":"papers","name":"An Exploration of the History and Controversies Surrounding MDMA and MDA","year":"2001","cit":94,"pfa":"Alana Rae. Pentney","topics":["Addiction","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1970393223","eid":"W1970393223"},{"id":"paper-w1978147326","cat":"papers","name":"Ibogaine and its congeners are σ2 receptor-selective ligands with moderate affinity","year":"1995","cit":94,"pfa":"Wayne D. Bowen","psa":"Arthur E. Jacobson","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1978147326","eid":"W1978147326"},{"id":"paper-w3183684219","cat":"papers","name":"Systematized Review of Psychotherapeutic Components of Psilocybin-Assisted Psychotherapy","year":"2021","cit":94,"pfa":"David M. Horton","psa":"Judy A. Schmidt","topics":["Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3183684219","eid":"W3183684219"},{"id":"paper-w3135335789","cat":"papers","name":"Dose–response relationships of psilocybin-induced subjective experiences in humans","year":"2021","cit":94,"pfa":"Tim Hirschfeld","psa":"Timo Torsten Schmidt","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3135335789","eid":"W3135335789"},{"id":"paper-w2801092899","cat":"papers","name":"Psilocybin modulates functional connectivity of the amygdala during emotional face discrimination","year":"2018","cit":94,"pfa":"Oliver R. Grimm","psa":"Franz X. Vollenweider","ptype":"article","src":"https://openalex.org/W2801092899","eid":"W2801092899"},{"id":"paper-w2398037874","cat":"papers","name":"Effects of Ayahuasca and its Alkaloids on Drug Dependence: A Systematic Literature Review of Quantitative Studies in Animals and Humans","year":"2016","cit":94,"pfa":"Amanda Amorin Nunes","psa":"Jaime E. C. Hallak","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W2398037874","eid":"W2398037874"},{"id":"paper-w1978787522","cat":"papers","name":"Hippocampal serotonergic damage induced by MDMA (ecstasy): effects on spatial learning","year":"2003","cit":94,"pfa":"Jon E. Sprague","psa":"Brian L. Woodside","ptype":"article","src":"https://openalex.org/W1978787522","eid":"W1978787522"},{"id":"paper-w2794934757","cat":"papers","name":"Hypothesis: The Psychedelic Ayahuasca Heals Traumatic Memories via a Sigma 1 Receptor-Mediated Epigenetic-Mnemonic Process","year":"2018","cit":94,"pfa":"Antonio Inserra","topics":["PTSD & trauma","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2794934757","eid":"W2794934757"},{"id":"paper-w1979802714","cat":"papers","name":"Enantiomer profiling of high loads of amphetamine and MDMA in communal sewage: A Dutch perspective","year":"2013","cit":94,"pfa":"Erik Emke","psa":"Pim de Voogt","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1979802714","eid":"W1979802714"},{"id":"paper-w2053750947","cat":"papers","name":"The NMDA antagonist ketamine and the 5-HT agonist psilocybin produce dissociable effects on structural encoding of emotional face expressions","year":"2012","cit":94,"pfa":"André Schmidt","psa":"Franz X. Vollenweider","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2053750947","eid":"W2053750947"},{"id":"paper-w2156537898","cat":"papers","name":"A study of the effect of a single neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA; \"ecstasy\") on the subsequent long-term behaviour of rats in the plus maze and open field","year":"2001","cit":94,"pfa":"Annis O. Mechan","psa":"Richard A. Green","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2156537898","eid":"W2156537898"},{"id":"paper-w4313635392","cat":"papers","name":"Mechanisms of Antiaddictive Actions of Ibogainea","year":"1998","cit":94,"pfa":"Stanley D. Glick","psa":"Isabelle M. Maisonneuve","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4313635392","eid":"W4313635392"},{"id":"paper-w4409147414","cat":"papers","name":"Psilocybin’s lasting action requires pyramidal cell types and 5-HT2A receptors","year":"2025","cit":94,"pfa":"Ling-Xiao Shao","psa":"Alex C. Kwan","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4409147414","eid":"W4409147414"},{"id":"paper-w2766270028","cat":"papers","name":"The relationships of classic psychedelic use with criminal behavior in the United States adult population","year":"2017","cit":94,"pfa":"Peter S. Hendricks","psa":"Gregory Pavela","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2766270028","eid":"W2766270028"},{"id":"paper-w3002940062","cat":"papers","name":"Identification of Psychoplastogenic N , N -Dimethylaminoisotryptamine (isoDMT) Analogues through Structure–Activity Relationship Studies","year":"2020","cit":94,"pfa":"Lee E. Dunlap","psa":"David E. Olson","ptype":"article","src":"https://openalex.org/W3002940062","eid":"W3002940062"},{"id":"paper-w4388486766","cat":"papers","name":"Beyond the 5-HT2AReceptor: Classic and Nonclassic Targets in Psychedelic Drug Action","year":"2023","cit":94,"pfa":"Lindsay P. Cameron","psa":"Argel Aguilar‐Valles","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4388486766","eid":"W4388486766"},{"id":"paper-w4406381627","cat":"papers","name":"Post‐traumatic stress disorder: evolving conceptualization and evidence, and future research directions","year":"2025","cit":94,"pfa":"Chris R. Brewin","psa":"Roberto Lewis‐Fernández","topics":["PTSD & trauma","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4406381627","eid":"W4406381627"},{"id":"paper-w1969596417","cat":"papers","name":"Repeated administration of phencyclidine, amphetamine and MK-801 selectively impairs spatial learning in mice: a possible model of psychotomimetic drug-induced cognitive deficits","year":"2003","cit":94,"pfa":"Silvia Mandillo","psa":"Andrea Mele","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1969596417","eid":"W1969596417"},{"id":"paper-w2055186048","cat":"papers","name":"Do NMDA receptor antagonist models of schizophrenia predict the clinical efficacy of antipsychotic drugs?","year":"2007","cit":94,"pfa":"Charles H. Large","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2055186048","eid":"W2055186048"},{"id":"paper-w2608784747","cat":"papers","name":"Ketamine for Depression, 1: Clinical Summary of Issues Related to Efficacy, Adverse Effects, and Mechanism of Action","year":"2017","cit":94,"pfa":"Chittaranjan Andrade","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2608784747","eid":"W2608784747"},{"id":"paper-w3182403469","cat":"papers","name":"Efficacy and Tolerability of Combination Treatments for Major Depression: Antidepressants plus Second-Generation Antipsychotics vs. Esketamine vs. Lithium","year":"2021","cit":94,"pfa":"Gustavo Héctor Vázquez","psa":"Ross J. Baldessarini","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3182403469","eid":"W3182403469"},{"id":"paper-w2001310902","cat":"papers","name":"Localization of serotonin 5‐HT2 receptors in living human brain by positron emission tomography using N1‐([11C]‐methyl)‐2‐BR‐LSD","year":"1987","cit":94,"pfa":"Dean Foster Wong","psa":"Henry N. Wagner","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2001310902","eid":"W2001310902"},{"id":"paper-w2162527619","cat":"papers","name":"People of the Peyote: Huichol Indian History, Religion, and Survival","year":"1997","cit":93,"pfa":"Maury Hutcheson","ptype":"article","src":"https://openalex.org/W2162527619","eid":"W2162527619"},{"id":"paper-w3213463597","cat":"papers","name":"Psilocybin targets a common molecular mechanism for cognitive impairment and increased craving in alcoholism","year":"2021","cit":93,"pfa":"Marcus W. Meinhardt","psa":"Wolfgang H. Sommer","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3213463597","eid":"W3213463597"},{"id":"paper-w2013374926","cat":"papers","name":"Quantitation of psilocin in human plasma by high-performance liquid chromatography and electrochemical detection: comparison of liquid–liquid extraction with automated on-line solid-phase extraction","year":"1998","cit":93,"pfa":"Hiltrud Lindenblatt","psa":"Karl‐Artur Kovar","ptype":"article","src":"https://openalex.org/W2013374926","eid":"W2013374926"},{"id":"paper-w2112264361","cat":"papers","name":"Locomotor response to MDMA is attenuated in knockout mice lacking the 5-HT 1B receptor","year":"1999","cit":93,"pfa":"Kimberly A. Scearce-Levie","psa":"René Hen","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2112264361","eid":"W2112264361"},{"id":"paper-w2013932747","cat":"papers","name":"Death rates from ecstasy (MDMA, MDA) and polydrug use in England and Wales 1996–2002","year":"2003","cit":93,"pfa":"Fabrizio Schifano","psa":"Abdol Hamid Ghodse","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2013932747","eid":"W2013932747"},{"id":"paper-w2058459083","cat":"papers","name":"Increased anxiety and \"depressive\" symptoms months after MDMA (\"ecstasy\") in rats: drug-induced hyperthermia does not predict long-term outcomes","year":"2003","cit":93,"pfa":"Iain S. McGregor","psa":"Glenn E. Hunt","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2058459083","eid":"W2058459083"},{"id":"paper-w1995108501","cat":"papers","name":"LSD as an agonist and antagonist at central dopamine receptors","year":"1974","cit":93,"pfa":"Kern von Hungen","psa":"Diane F. Hill","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1995108501","eid":"W1995108501"},{"id":"paper-w2751240458","cat":"papers","name":"Psychoactive substances as a last resort—a qualitative study of self-treatment of migraine and cluster headaches","year":"2017","cit":93,"pfa":"Martin Andersson","psa":"Anette Kjellgren","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2751240458","eid":"W2751240458"},{"id":"paper-w2166423316","cat":"papers","name":"Abnormal visual experiences in individuals with histories of hallucinogen use: A web-based questionnaire","year":"2010","cit":93,"pfa":"Matthew J. Baggott","psa":"Lynn C. Robertson","ptype":"article","src":"https://openalex.org/W2166423316","eid":"W2166423316"},{"id":"paper-w2087265397","cat":"papers","name":"Psychometric assessment of the Hallucinogen Rating Scale☆","year":"2001","cit":93,"pfa":"Jordi Riba","psa":"Manel J. Barbanoj","ptype":"article","src":"https://openalex.org/W2087265397","eid":"W2087265397"},{"id":"paper-w1997220161","cat":"papers","name":"The role of temperature, stress, and other factors in the neurotoxicity of the substituted amphetamines 3,4-methylenedioxymethamphetamine and fenfluramine","year":"1995","cit":93,"pfa":"Diane Bemis Miller","psa":"James Patrick O'Callaghan","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1997220161","eid":"W1997220161"},{"id":"paper-w2133037699","cat":"papers","name":"Decreased platelet serotonin transporter sites and increased platelet inositol triphosphate levels in patients with unipolar depression: Effects of clomipramine and fluoxetine","year":"1999","cit":93,"pfa":"Jean‐Claude Alvarez","psa":"Odile Spreux‐Varoquaux","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2133037699","eid":"W2133037699"},{"id":"paper-w2025059824","cat":"papers","name":"Analysis of illicit ecstasy tablets: implications for clinical management in the accident and emergency department.","year":"1999","cit":93,"pfa":"Kellie Sherlock","psa":"Mark T. Conner","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2025059824","eid":"W2025059824"},{"id":"paper-w2028382512","cat":"papers","name":"Phytochemical Analyses ofBanisteriopsis CaapiandPsychotria Viridis","year":"2005","cit":93,"pfa":"J. C. Callaway","psa":"Edison S. Neves","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2028382512","eid":"W2028382512"},{"id":"paper-w1755040026","cat":"papers","name":"CYP2D6 genetic polymorphisms and their relevance for poisoning due to amfetamines, opioid analgesics and antidepressants","year":"2015","cit":93,"pfa":"Vincent Haufroid","psa":"Philippe E. Hantson","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1755040026","eid":"W1755040026"},{"id":"paper-w3031742716","cat":"papers","name":"Integrating psychotherapy and psychopharmacology: psychedelic-assisted psychotherapy and other combined treatments","year":"2020","cit":93,"pfa":"Kyle T. Greenway","psa":"Allison A. Feduccia","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3031742716","eid":"W3031742716"},{"id":"paper-w2078195269","cat":"papers","name":"GHB and synthetic cathinones: clinical effects and potential consequences","year":"2010","cit":93,"pfa":"Laurent Karila","psa":"Michel Reynaud","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2078195269","eid":"W2078195269"},{"id":"paper-w4210932781","cat":"papers","name":"Effects of Setting on Psychedelic Experiences, Therapies, and Outcomes: A Rapid Scoping Review of the Literature","year":"2022","cit":93,"pfa":"Tasha L. Golden","psa":"Frederick Streeter Barrett","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"book-chapter","src":"https://openalex.org/W4210932781","eid":"W4210932781"},{"id":"paper-w2592111319","cat":"papers","name":"Psychedelics and the science of self-experience","year":"2017","cit":93,"pfa":"Matthew M. Nour","psa":"Robin Lester Carhart-Harris","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2592111319","eid":"W2592111319"},{"id":"paper-w2287804084","cat":"papers","name":"Microdosing and Other Phase 0 Clinical Trials: Facilitating Translation in Drug Development","year":"2016","cit":93,"pfa":"Tal Burt","psa":"Malcolm Rowland","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2287804084","eid":"W2287804084"},{"id":"paper-w2057824358","cat":"papers","name":"What is the optimum maximal gonadotropin dosage used in microdose flare-up cycles in poor responders?","year":"2009","cit":93,"pfa":"Murat Berkkanoğlu","psa":"Kemal Özgür","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2057824358","eid":"W2057824358"},{"id":"paper-w2086730902","cat":"papers","name":"Pharmacological characterization of psychosis‐like behavior in the MPTP‐lesioned nonhuman primate model of Parkinson's disease","year":"2006","cit":93,"pfa":"Naomi P. Visanji","psa":"Susan Helen Fox","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2086730902","eid":"W2086730902"},{"id":"paper-w3169287921","cat":"papers","name":"The median effective concentration of propofol with different doses of esketamine during gastrointestinal endoscopy in elderly patients: A randomized controlled trial","year":"2021","cit":93,"pfa":"Hua Yang","psa":"Jin‐Chao Song","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3169287921","eid":"W3169287921"},{"id":"paper-w2088424683","cat":"papers","name":"IS LYSERGIC-ACID DIETHYLAMIDE A TERATOGEN ?","year":"1967","cit":92,"pfa":"Hans Zellweger","psa":"G Abbo","ptype":"article","src":"https://openalex.org/W2088424683","eid":"W2088424683"},{"id":"paper-w1975585335","cat":"papers","name":"Leukocytes of Humans Exposed to Lysergic Acid Diethylamide: Lack of Chromosomal Damage","year":"1967","cit":92,"pfa":"William D. Loughman","psa":"David M. Israelstam","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1975585335","eid":"W1975585335"},{"id":"paper-w1525003375","cat":"papers","name":"Chapter 8 Ibogaine in the treatment of heroin withdrawal","year":"2001","cit":92,"pfa":"Deborah C. Mash","psa":"William Lee Hearn","ptype":"book-chapter","src":"https://openalex.org/W1525003375","eid":"W1525003375"},{"id":"paper-w2011248808","cat":"papers","name":"Acute Psychological and Neurophysiological Effects of MDMA in Humans","year":"2002","cit":92,"pfa":"Franz X. Vollenweider","psa":"Mark A. Geyer","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2011248808","eid":"W2011248808"},{"id":"paper-w2101848978","cat":"papers","name":"8-epi-Salvinorin B: crystal structure and affinity at the κ opioid receptor","year":"2007","cit":92,"pfa":"Thomas Anthony Munro","psa":"Bruce M. Cohen","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2101848978","eid":"W2101848978"},{"id":"paper-w2166153441","cat":"papers","name":"Identification of the Molecular Mechanisms by Which the Diterpenoid Salvinorin A Binds to κ-Opioid Receptors","year":"2005","cit":92,"pfa":"Feng Yan","psa":"Bryan L. Roth","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2166153441","eid":"W2166153441"},{"id":"paper-w2128758691","cat":"papers","name":"Neuroendocrine and Mood Responses to Intravenous L-Tryptophan in 3,4-Methylenedioxymethamphetamine (MDMA) Users","year":"1989","cit":92,"pfa":"Lawrence H. Price","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2128758691","eid":"W2128758691"},{"id":"paper-w2086022256","cat":"papers","name":"Effects of ayahuasca on the development of ethanol-induced behavioral sensitization and on a post-sensitization treatment in mice","year":"2015","cit":92,"pfa":"A.J. Oliveira-Lima","psa":"E.A.V. Marinho","ptype":"article","src":"https://openalex.org/W2086022256","eid":"W2086022256"},{"id":"paper-w1977439880","cat":"papers","name":"The putative anti-addictive drug ibogaine is a competitive inhibitor of [3H]MK-801 binding to the NMDA receptor complex","year":"1994","cit":92,"pfa":"Piotr Popik","psa":"Phil Skolnick","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1977439880","eid":"W1977439880"},{"id":"paper-w2924129936","cat":"papers","name":"Combining Cognitive-Behavioral Conjoint Therapy for PTSD with 3,4-Methylenedioxymethamphetamine (MDMA): A Case Example","year":"2019","cit":92,"pfa":"Anne C. Wagner","psa":"Candice M. Monson","topics":["PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2924129936","eid":"W2924129936"},{"id":"paper-w4386861633","cat":"papers","name":"Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal survey","year":"2023","cit":92,"pfa":"Sandeep Manel Nayak","psa":"Albert Garcia‐Romeu","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4386861633","eid":"W4386861633"},{"id":"paper-w1989118896","cat":"papers","name":"CuZn-superoxide dismutase (CuZnSOD) transgenic mice show resistance to the lethal effects of methylenedioxyamphetamine (MDA) and of methylenedioxymethamphetamine (MDMA)","year":"1994","cit":92,"pfa":"Jean Lud Cadet","psa":"Charles B. Epstein","ptype":"article","src":"https://openalex.org/W1989118896","eid":"W1989118896"},{"id":"paper-w2704181554","cat":"papers","name":"Dreams and Psychedelics: Neurophenomenological Comparison and Therapeutic Implications","year":"2017","cit":92,"pfa":"Rainer Krähenmann","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2704181554","eid":"W2704181554"},{"id":"paper-w2121654107","cat":"papers","name":"Psychological Aspects of the Lsd Treatment of the Neuroses","year":"1954","cit":92,"pfa":"R. A. Sandison","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2121654107","eid":"W2121654107"},{"id":"paper-w1964116811","cat":"papers","name":"‘Hitting Highs at Rock Bottom’: LSD Treatment for Alcoholism, 1950–1970","year":"2006","cit":92,"pfa":"Erika Dyck","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1964116811","eid":"W1964116811"},{"id":"paper-w2411909579","cat":"papers","name":"Serotonin 5-HT1-like receptors mediate hyperactivity in rats induced by 3,4-methylenedioxymethamphetamine.","year":"1992","cit":92,"pfa":"Clifton W. Callaway","psa":"M A Geyer","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2411909579","eid":"W2411909579"},{"id":"paper-w1998317438","cat":"papers","name":"Functional Reconstitution of 5-Hydroxytryptamine2c (5HT2c) Receptors with αq and Inverse Agonism of 5HT2c Receptor Antagonists","year":"1996","cit":92,"pfa":"John L. Hartman","psa":"John K. Northup","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1998317438","eid":"W1998317438"},{"id":"paper-w2246550343","cat":"papers","name":"Methylenedioxymethamphetamine-induced serotonin deficits are followed by partial recovery over a 52-week period. Part II: Radioligand binding and autoradiography studies.","year":"1996","cit":92,"pfa":"Robert Lew","psa":"Lewis S. Seiden","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2246550343","eid":"W2246550343"},{"id":"paper-w2108454195","cat":"papers","name":"A Single Amino Acid Difference Accounts for the Pharmacological Distinctions Between the Rat and Human 5‐Hydroxytryptamine1B Receptors","year":"1993","cit":92,"pfa":"Eric M. Parker","psa":"Robert A. Shapiro","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2108454195","eid":"W2108454195"},{"id":"paper-w2130780046","cat":"papers","name":"N-Arylsulfonylindole Derivatives as Serotonin 5-HT6Receptor Ligands","year":"2001","cit":92,"pfa":"Michael G. N. Russell","psa":"José L. Castro","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2130780046","eid":"W2130780046"},{"id":"paper-w657356610","cat":"papers","name":"Handbook of Mushroom Poisoning: Diagnosis and Treatment","year":"1994","cit":92,"pfa":"Barry H. Rumack","psa":"David G. Spoerke","ptype":"book","src":"https://openalex.org/W657356610","eid":"W657356610"},{"id":"paper-w4307838483","cat":"papers","name":"Belief changes associated with psychedelic use","year":"2022","cit":92,"pfa":"Sandeep Manel Nayak","psa":"Roland R. Griffiths","ptype":"article","src":"https://openalex.org/W4307838483","eid":"W4307838483"},{"id":"paper-w2276639067","cat":"papers","name":"Effects Of Microdose Norgestrel On Endogenous Gonadotropic And Steroid Hormones, Cervical Mucus Properties, Vaginal Cytology, And Endometrium ,","year":"1971","cit":92,"pfa":"Kamran S. Moghissi","psa":"Carmelita Marks","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2276639067","eid":"W2276639067"},{"id":"paper-w2135112754","cat":"papers","name":"STRUCTURE ACTIVITY RELATIONS FOR THE INHIBITION OF 5‐HT UPTAKE INTO RAT HYPOTHALAMIC HOMOGENATES BY SEROTONIN AND TRYPTAMINE ANALOGUES","year":"1973","cit":92,"pfa":"A. S. Horn","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2135112754","eid":"W2135112754"},{"id":"paper-w2021360005","cat":"papers","name":"Dissimilar patterns of degeneration in brain following four different addictive stimulants","year":"1993","cit":92,"pfa":"Gaylord D. Ellison","psa":"Robert C. Switzer","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2021360005","eid":"W2021360005"},{"id":"paper-w2014413253","cat":"papers","name":"Increased phasic activity of dopaminergic neurones in the rat ventral tegmental area following pharmacologically elevated levels of endogenous kynurenic acid","year":"2002","cit":92,"pfa":"Sophie Erhardt","psa":"Göran Engberg","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2014413253","eid":"W2014413253"},{"id":"paper-w2966617845","cat":"papers","name":"(R)-Ketamine Induces a Greater Increase in Prefrontal 5-HT Release Than (S)-Ketamine and Ketamine Metabolites via an AMPA Receptor-Independent Mechanism","year":"2019","cit":92,"pfa":"Yukio Ago","psa":"Hitoshi Hashimoto","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2966617845","eid":"W2966617845"},{"id":"paper-w2079002943","cat":"papers","name":"Antagonism of histamine-activated adenylate cyclase in brain by D-lysergic acid diethylamide.","year":"1977","cit":91,"pfa":"J P Green","psa":"Saul Maayani","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2079002943","eid":"W2079002943"},{"id":"paper-w2018420238","cat":"papers","name":"Concise Large-Scale Synthesis of Psilocin and Psilocybin, Principal Hallucinogenic Constituents of “Magic Mushroom”","year":"2003","cit":91,"pfa":"Osamu Shirota","psa":"Yukihiro Goda","ptype":"article","src":"https://openalex.org/W2018420238","eid":"W2018420238"},{"id":"paper-w4220686515","cat":"papers","name":"Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review","year":"2022","cit":91,"pfa":"Aryan Sarparast","psa":"Christopher S. Stauffer","topics":["Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4220686515","eid":"W4220686515"},{"id":"paper-w1979102100","cat":"papers","name":"The Complications of 'Ecstasy' (MDMA)","year":"1988","cit":91,"pfa":"Jamyl Alrazi","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1979102100","eid":"W1979102100"},{"id":"paper-w2081759052","cat":"papers","name":"Salvinorin A: From Natural Product to Human Therapeutics","year":"2006","cit":91,"pfa":"Timothy A. Vortherms","psa":"B. L. Roth","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2081759052","eid":"W2081759052"},{"id":"paper-w2012142575","cat":"papers","name":"Baeocystin and Norbaeocystin: New Analogs of Psilocybin from Psilocybe baeocystis","year":"1968","cit":91,"pfa":"A.Y. Leung","psa":"Ara G. Paul","ptype":"article","src":"https://openalex.org/W2012142575","eid":"W2012142575"},{"id":"paper-w2151797682","cat":"papers","name":"Sex Differences in the Effects of MDMA (Ecstasy) on Plasma Copeptin in Healthy Subjects","year":"2011","cit":91,"pfa":"Linda D. Simmler","psa":"Matthias E. Liechti","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2151797682","eid":"W2151797682"},{"id":"paper-w3111512601","cat":"papers","name":"MDMA-facilitated cognitive-behavioural conjoint therapy for posttraumatic stress disorder: an uncontrolled trial","year":"2020","cit":91,"pfa":"Candice M. Monson","psa":"Michael C. Mithoefer","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3111512601","eid":"W3111512601"},{"id":"paper-w3127909847","cat":"papers","name":"Development and Evaluation of a Therapist Training Program for Psilocybin Therapy for Treatment-Resistant Depression in Clinical Research","year":"2021","cit":91,"pfa":"Sara Jane Tai","psa":"Ekaterina Malievskaia","topics":["Depression","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3127909847","eid":"W3127909847"},{"id":"paper-w2343567633","cat":"papers","name":"Treating posttraumatic stress disorder with MDMA-assisted psychotherapy: A preliminary meta-analysis and comparison to prolonged exposure therapy","year":"2016","cit":91,"pfa":"Timothy Amoroso","psa":"Michael Workman","topics":["PTSD & trauma","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2343567633","eid":"W2343567633"},{"id":"paper-w2045681706","cat":"papers","name":"MDMA polydrug users show processspecific central executive impairments coupled with impaired social and emotional judgement processes","year":"2006","cit":91,"pfa":"Jonathon Lee Reay","psa":"Andrew B Scholey","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2045681706","eid":"W2045681706"},{"id":"paper-w2147625857","cat":"papers","name":"Multiple 5-HT receptors are involved in the effects of acute MDMA treatment: studies on locomotor activity and responding for conditioned reinforcement","year":"2002","cit":91,"pfa":"Paul Fletcher","psa":"Glen B. Baker","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2147625857","eid":"W2147625857"},{"id":"paper-w2090183075","cat":"papers","name":"Direct central effects of acute methylenedioxymethamphetamine on serotonergic neurons","year":"1988","cit":91,"pfa":"Christopher J. Schmidt","psa":"Vicki L. Taylor","ptype":"article","src":"https://openalex.org/W2090183075","eid":"W2090183075"},{"id":"paper-w3117921577","cat":"papers","name":"Set and Setting: A Randomized Study of Different Musical Genres in Supporting Psychedelic Therapy","year":"2020","cit":91,"pfa":"Justin C. Strickland","psa":"Matthew W. Johnson","topics":["Addiction","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3117921577","eid":"W3117921577"},{"id":"paper-w69838075","cat":"papers","name":"Psychopharmacology of prepulse inhibition in mice.","year":"1996","cit":91,"pfa":"Stephanie C. Dulawa","psa":"Mark A. Geyer","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W69838075","eid":"W69838075"},{"id":"paper-w3004628662","cat":"papers","name":"City checking: Piloting the UK's first community‐based drug safety testing (drug checking) service in 2 city centres","year":"2020","cit":91,"pfa":"Fiona Catherine Measham","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3004628662","eid":"W3004628662"},{"id":"paper-w2082698879","cat":"papers","name":"Normal thermoregulatory responses to 3‐iodothyronamine, trace amines and amphetamine‐like psychostimulants in trace amine associated receptor 1 knockout mice","year":"2010","cit":91,"pfa":"Helen N. Panas","psa":"Gregory M. Miller","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2082698879","eid":"W2082698879"},{"id":"paper-w4281666404","cat":"papers","name":"Models of Psychedelic-Assisted Psychotherapy: A Contemporary Assessment and an Introduction to EMBARK, a Transdiagnostic, Trans-Drug Model","year":"2022","cit":91,"pfa":"Bill Brennan","psa":"Alexander Belser","topics":["Reviews & meta-analyses","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4281666404","eid":"W4281666404"},{"id":"paper-w2515280853","cat":"papers","name":"Psychedelics Recruit Multiple Cellular Types and Produce Complex Transcriptional Responses Within the Brain","year":"2016","cit":91,"pfa":"David Alexander Martin","psa":"Charles David Nichols","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2515280853","eid":"W2515280853"},{"id":"paper-w2047932245","cat":"papers","name":"Psychiatric Sequelae of Phencyclidine Abuse","year":"1976","cit":91,"pfa":"Beverly J. Fauman","psa":"Peter L. Rosen","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2047932245","eid":"W2047932245"},{"id":"paper-w2137578444","cat":"papers","name":"Synthesis and Evaluation of11C-LY2795050 as a κ-Opioid Receptor Antagonist Radiotracer for PET Imaging","year":"2013","cit":91,"pfa":"Ming‐Qiang Zheng","psa":"Yiyun Henry Huang","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2137578444","eid":"W2137578444"},{"id":"paper-w2321735995","cat":"papers","name":"Loss of parvalbumin-immunoreactivity in mouse brain regions after repeated intermittent administration of esketamine, but not R-ketamine","year":"2016","cit":91,"pfa":"Chun Yang","psa":"Kenji Hashimoto","ptype":"article","src":"https://openalex.org/W2321735995","eid":"W2321735995"},{"id":"paper-w1598136695","cat":"papers","name":"Differential regulation of σ and PCP receptors after chronic administration of haloperidol and phencyclidine in mice","year":"1989","cit":91,"pfa":"Yossef Itzhak","psa":"Sara Alerhand","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1598136695","eid":"W1598136695"},{"id":"paper-w1963570017","cat":"papers","name":"Ketamine for Intravenous Regional Anesthesia","year":"1989","cit":91,"pfa":"Zia Durrani","psa":"M L Burnett","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1963570017","eid":"W1963570017"},{"id":"paper-w2023368022","cat":"papers","name":"Effect of 5-HT3 receptor antagonist MDL 72222 on behaviors induced by ketamine in rats and mice","year":"2005","cit":91,"pfa":"Tomasz Kos","psa":"Anton Bespalov","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2023368022","eid":"W2023368022"},{"id":"paper-w2102686440","cat":"papers","name":"Memantine binding to a superficial site on NMDA receptors contributes to partial trapping","year":"2009","cit":91,"pfa":"Shawn E. Kotermanski","psa":"Jon W. Johnson","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2102686440","eid":"W2102686440"},{"id":"paper-w2070025517","cat":"papers","name":"Coexpression of N-methyl-D-aspartate and phencyclidine receptors in Xenopus oocytes injected with rat brain mRNA.","year":"1988","cit":91,"pfa":"Leslie Kushner","psa":"Michael V. L. Bennett","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2070025517","eid":"W2070025517"},{"id":"paper-w2788130744","cat":"papers","name":"Dark Classics in Chemical Neuroscience: Lysergic Acid Diethylamide (LSD)","year":"2018","cit":90,"pfa":"David E. Nichols","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2788130744","eid":"W2788130744"},{"id":"paper-w1973229407","cat":"papers","name":"Characterisation of [3H]lysergic acid diethylamide binding to a 5-hydroxytryptamine receptor on human platelet membranes","year":"1984","cit":90,"pfa":"David P. Geaney","psa":"David G. Grahame‐Smith","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1973229407","eid":"W1973229407"},{"id":"paper-w2596955093","cat":"papers","name":"Peyote religion among the Navajo","year":"1983","cit":90,"pfa":"David F. Aberle","ptype":"article","src":"https://openalex.org/W2596955093","eid":"W2596955093"},{"id":"paper-w2140542891","cat":"papers","name":"Dihydrobenzofuran Analogues of Hallucinogens. 4. Mescaline Derivatives","year":"1997","cit":90,"pfa":"Aaron P. Monte","psa":"David E. Nichols","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2140542891","eid":"W2140542891"},{"id":"paper-w2113298805","cat":"papers","name":"MDMA: The Dark Side of Ecstasy","year":"1986","cit":90,"pfa":"Gregory N. Hayner","psa":"Howard E. McKinney","ptype":"article","src":"https://openalex.org/W2113298805","eid":"W2113298805"},{"id":"paper-w1993479048","cat":"papers","name":"Synthesis of analogs of Iboga alkaloids. Investigation of electrophilic, palladium-catalyzed and radical cyclizations for preparation of 5,6-homoiboga derivatives","year":"1990","cit":90,"pfa":"Richard J. Sundberg","psa":"Robert J. Cherney","ptype":"article","src":"https://openalex.org/W1993479048","eid":"W1993479048"},{"id":"paper-w2065850862","cat":"papers","name":"α-Lipoic acid prevents 3,4-methylenedioxy-methamphetamine (MDMA)-induced neurotoxicity","year":"1999","cit":90,"pfa":"Norberto Aguirre","psa":"Berta Lasheras","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2065850862","eid":"W2065850862"},{"id":"paper-w1964918564","cat":"papers","name":"Repeated Exposure to the κ-Opioid Receptor Agonist Salvinorin A Modulates Extracellular Signal-Regulated Kinase and Reward Sensitivity","year":"2011","cit":90,"pfa":"David N. Potter","psa":"Elena H. Chartoff","topics":["Addiction","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1964918564","eid":"W1964918564"},{"id":"paper-w4386504040","cat":"papers","name":"Psilocybin induces acute and persisting alterations in immune status in healthy volunteers: An experimental, placebo-controlled study","year":"2023","cit":90,"pfa":"Natasha Leigh Mason","psa":"Johannes Gerardus Ramaekers","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4386504040","eid":"W4386504040"},{"id":"paper-w2104651539","cat":"papers","name":"Stimulant effects of 3,4‐methylenedioxymethamphetamine (MDMA) 75 mg and methylphenidate 20 mg on actual driving during intoxication and withdrawal","year":"2006","cit":90,"pfa":"Johannes Gerardus Ramaekers","psa":"Nele Samyn","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2104651539","eid":"W2104651539"},{"id":"paper-w4206268123","cat":"papers","name":"Assessing the risk–benefit profile of classical psychedelics: a clinical review of second-wave psychedelic research","year":"2022","cit":90,"pfa":"David A. Bender","psa":"David J. Hellerstein","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4206268123","eid":"W4206268123"},{"id":"paper-w1998631480","cat":"papers","name":"Hallucinogenic Drugs in Psychiatric Research and Treatment Perspectives and Prospects","year":"1995","cit":90,"pfa":"Rick J. Strassman","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1998631480","eid":"W1998631480"},{"id":"paper-w2107788476","cat":"papers","name":"Flashback: Psychiatric Experimentation with LSD in Historical Perspective","year":"2005","cit":90,"pfa":"Erika Dyck","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2107788476","eid":"W2107788476"},{"id":"paper-w1968241182","cat":"papers","name":"3,4-Methylenedioxymethamphetamine Self-Administration is Abolished in Serotonin Transporter Knockout Mice","year":"2007","cit":90,"pfa":"José Manuel Trigo","psa":"Rafaël Maldonado","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1968241182","eid":"W1968241182"},{"id":"paper-w1838890896","cat":"papers","name":"Comparative biochemical and pharmacological characterization of the mouse 5HT5A 5-hydroxytryptamine receptor and the human β2-adrenergic receptor produced in the methylotrophic yeast Pichia pastoris","year":"1998","cit":90,"pfa":"H. Weiss","psa":"Helmut Reiländer","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1838890896","eid":"W1838890896"},{"id":"paper-w2560424711","cat":"papers","name":"Harmine stimulates proliferation of human neural progenitors","year":"2016","cit":90,"pfa":"Vanja Dakic","psa":"Stevens Kastrup Rehen","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2560424711","eid":"W2560424711"},{"id":"paper-w2043678991","cat":"papers","name":"High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens","year":"2012","cit":90,"pfa":"Chad J. Reissig","psa":"Roland R. Griffiths","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2043678991","eid":"W2043678991"},{"id":"paper-w3092035884","cat":"papers","name":"DMT alters cortical travelling waves","year":"2020","cit":90,"pfa":"Andrea Alamia","psa":"Robin Lester Carhart-Harris","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3092035884","eid":"W3092035884"},{"id":"paper-w2618895617","cat":"papers","name":"Harmine is an inflammatory inhibitor through the suppression of NF-κB signaling","year":"2017","cit":90,"pfa":"Xin Liu","psa":"Cheng Huang","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2618895617","eid":"W2618895617"},{"id":"paper-w2010442380","cat":"papers","name":"Identification of narcotics, barbiturates, amphetamines, tranquilizers and psychotomimetics in human urine","year":"1969","cit":90,"pfa":"S.J. Mulé","ptype":"article","src":"https://openalex.org/W2010442380","eid":"W2010442380"},{"id":"paper-w2167566619","cat":"papers","name":"Microdose intravaginal levonorgestrel contraception: A multicentre clinical trial","year":"1990","cit":90,"pfa":"Suporn Koetsawang","psa":"Philip John Rowe","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2167566619","eid":"W2167566619"},{"id":"paper-w3087190666","cat":"papers","name":"Hallucinations Under Psychedelics and in the Schizophrenia Spectrum: An Interdisciplinary and Multiscale Comparison","year":"2020","cit":90,"pfa":"Pantelis Leptourgos","psa":"Renaud Jardri","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3087190666","eid":"W3087190666"},{"id":"paper-w1982307137","cat":"papers","name":"Ketamine as an Analgesic","year":"2002","cit":90,"pfa":"Robert Kronenberg","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1982307137","eid":"W1982307137"},{"id":"paper-w2055007705","cat":"papers","name":"A Comparison of Rural and Urban Nonmedical Prescription Opioid Users’ Lifetime and Recent Drug Use","year":"2012","cit":90,"pfa":"April M. Young","psa":"Carl G. Leukefeld","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2055007705","eid":"W2055007705"},{"id":"paper-w2151594144","cat":"papers","name":"Correlation of Saliva Cocaine Levels with Plasma Levels and with Pharmacologic Effects after Intravenous Cocaine Administration in Human Subjects","year":"1988","cit":90,"pfa":"Edward J. Cone","psa":"Michael A. Sherer","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2151594144","eid":"W2151594144"},{"id":"paper-w4291335291","cat":"papers","name":"Arketamine, a new rapid-acting antidepressant: A historical review and future directions","year":"2022","cit":90,"pfa":"Ji-chun Zhang","psa":"Kenji Hashimoto","topics":["Depression","PTSD & trauma","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4291335291","eid":"W4291335291"},{"id":"paper-w2233987578","cat":"papers","name":"Glutamate receptor ligands as anxiolytics.","year":"2001","cit":90,"pfa":"Ewa Chojnacka-Wójcik","psa":"Andrzej Pilc","topics":["Addiction","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2233987578","eid":"W2233987578"},{"id":"paper-w1964658450","cat":"papers","name":"Recent advances in understanding the actions and toxicity of nitrous oxide","year":"2000","cit":90,"pfa":"Mervyn Maze","psa":"Masahiko Fujinaga","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1964658450","eid":"W1964658450"},{"id":"paper-w2028690808","cat":"papers","name":"Some Serotoninlike Activities of Lysergic Acid Diethylamide","year":"1956","cit":89,"pfa":"E Shaw","psa":"D. W. Woolley","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2028690808","eid":"W2028690808"},{"id":"paper-w3205688202","cat":"papers","name":"A narrative synthesis of research with 5-MeO-DMT","year":"2021","cit":89,"pfa":"Anna O. Ermakova","psa":"Matthew W Johnson","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3205688202","eid":"W3205688202"},{"id":"paper-w4220653200","cat":"papers","name":"Repeated lysergic acid diethylamide (LSD) reverses stress-induced anxiety-like behavior, cortical synaptogenesis deficits and serotonergic neurotransmission decline","year":"2022","cit":89,"pfa":"Danilo De Gregorio","psa":"Gabriella Gobbi","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4220653200","eid":"W4220653200"},{"id":"paper-w2017510719","cat":"papers","name":"Mechanisms of antiaddictive actions of ibogaine.","year":"1998","cit":89,"pfa":"Stanley D. Glick","psa":"Isabelle M. Maisonneuve","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2017510719","eid":"W2017510719"},{"id":"paper-w2318447563","cat":"papers","name":"Sex differences and serotonergic mechanisms in the behavioural effects of psilocin","year":"2015","cit":89,"pfa":"Filip Tylš","psa":"Jiřı́ Horáček","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2318447563","eid":"W2318447563"},{"id":"paper-w2970757804","cat":"papers","name":"Purging and the body in the therapeutic use of ayahuasca","year":"2019","cit":89,"pfa":"Evgenia Fotiou","psa":"Alex K. Gearin","ptype":"article","src":"https://openalex.org/W2970757804","eid":"W2970757804"},{"id":"paper-w2070332167","cat":"papers","name":"A role for the mesolimbic dopamine system in the psychostimulant actions of MDMA","year":"1989","cit":89,"pfa":"Lisa H. Gold","psa":"George F. Koob","ptype":"article","src":"https://openalex.org/W2070332167","eid":"W2070332167"},{"id":"paper-w2077294441","cat":"papers","name":"18‐Methoxycoronaridine (18‐MC) and Ibogaine: Comparison of Antiaddictive Efficacy, Toxicity, and Mechanisms of Action","year":"2000","cit":89,"pfa":"Stanley D. Glick","psa":"Karen Kathleen Szumlinski","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2077294441","eid":"W2077294441"},{"id":"paper-w2072624253","cat":"papers","name":"Neuroimaging research in human MDMA users: a review","year":"2006","cit":89,"pfa":"Ronald L. Cowan","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2072624253","eid":"W2072624253"},{"id":"paper-w2101277151","cat":"papers","name":"MDMA and temperature: A review of the thermal effects of ‘Ecstasy’ in humans","year":"2011","cit":89,"pfa":"Andrew C. Parrott","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2101277151","eid":"W2101277151"},{"id":"paper-w2154835582","cat":"papers","name":"Fatalities Caused by the MDMA-Related Drug Paramethoxyamphetamine (PMA)","year":"2001","cit":89,"pfa":"James C. Kraner","psa":"Brenda J. Sweeney","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2154835582","eid":"W2154835582"},{"id":"paper-w1987686922","cat":"papers","name":"Long term psychiatric and cognitive effects of MDMA use","year":"2000","cit":89,"pfa":"Philip K. McGuire","ptype":"article","src":"https://openalex.org/W1987686922","eid":"W1987686922"},{"id":"paper-w2137597447","cat":"papers","name":"Enhancement of Creative Expression and Entoptic Phenomena as After-Effects of Repeated Ayahuasca Ceremonies","year":"2012","cit":89,"pfa":"Ede Frecska","psa":"Luís Eduardo Luna","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2137597447","eid":"W2137597447"},{"id":"paper-w3174951899","cat":"papers","name":"Ayahuasca Improves Self-perception of Speech Performance in Subjects With Social Anxiety Disorder","year":"2021","cit":89,"pfa":"RAFAEL GUIMARÃES DOS SANTOS","psa":"Jaime E. C. Hallak","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3174951899","eid":"W3174951899"},{"id":"paper-w1884253425","cat":"papers","name":"The abused drug MDMA (Ecstasy) induces programmed death of human serotonergic cells","year":"1997","cit":89,"pfa":"Rabi Simantov","psa":"M TAUBER","ptype":"article","src":"https://openalex.org/W1884253425","eid":"W1884253425"},{"id":"paper-w2889566085","cat":"papers","name":"Does getting high hurt? Characterization of cases of LSD and psilocybin-containing mushroom exposures to national poison centers between 2000 and 2016","year":"2018","cit":89,"pfa":"James B. Leonard","psa":"Wendy Klein‐Schwartz","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2889566085","eid":"W2889566085"},{"id":"paper-w4385628167","cat":"papers","name":"Psilocybin-assisted therapy for depression: A systematic review and dose-response meta-analysis of human studies","year":"2023","cit":89,"pfa":"Natacha Perez","psa":"Michel Sabé","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W4385628167","eid":"W4385628167"},{"id":"paper-w2604124685","cat":"papers","name":"Multifaceted empathy of healthy volunteers after single doses of MDMA: A pooled sample of placebo-controlled studies","year":"2017","cit":89,"pfa":"Kim P. C. Kuypers","psa":"Matthias E. Liechti","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2604124685","eid":"W2604124685"},{"id":"paper-w2127572868","cat":"papers","name":"No Evidence that MDMA-Induced Enhancement of Emotional Empathy Is Related to Peripheral Oxytocin Levels or 5-HT1a Receptor Activation","year":"2014","cit":89,"pfa":"Kim P. C. Kuypers","psa":"Johannes Gerardus Ramaekers","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2127572868","eid":"W2127572868"},{"id":"paper-w2947995541","cat":"papers","name":"The Past and Future of Psychedelic Science: An Introduction to This Issue","year":"2019","cit":89,"pfa":"Rick Doblin","psa":"Brad Burge","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W2947995541","eid":"W2947995541"},{"id":"paper-w2092775753","cat":"papers","name":"Characteristics of pregnant women who use Ecstasy (3, 4-methylenedioxymethamphetamine)","year":"2001","cit":89,"pfa":"Elaine Qiao Ying Ho","psa":"Gideon Koren","ptype":"article","src":"https://openalex.org/W2092775753","eid":"W2092775753"},{"id":"paper-w2793066401","cat":"papers","name":"Is LSD toxic?","year":"2018","cit":89,"pfa":"David E. Nichols","psa":"Charles S. Grob","ptype":"article","src":"https://openalex.org/W2793066401","eid":"W2793066401"},{"id":"paper-w1994940054","cat":"papers","name":"PSYCHOTOMIMETICS, CLINICAL AND THEORETICAL CONSIDERATIONS: HARMINE, WIN-2299 AND NALLINE","year":"1957","cit":89,"pfa":"Harry H. Pennes","psa":"Paul H. Hoch","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1994940054","eid":"W1994940054"},{"id":"paper-w2083993428","cat":"papers","name":"Multiple toxicity from 3,4-methylenedioxymethamphetamine (“ecstasy”)","year":"2003","cit":89,"pfa":"Shaun L. Greene","psa":"Mary Kerins","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2083993428","eid":"W2083993428"},{"id":"paper-w2036279988","cat":"papers","name":"Effect of D1-like and D2-like receptor antagonists on methamphetamine and 3,4-methylenedioxymethamphetamine self-administration in rats","year":"2009","cit":89,"pfa":"Katharine Alexandra Brennan","psa":"Susan Schenk","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2036279988","eid":"W2036279988"},{"id":"paper-w2057894499","cat":"papers","name":"The effects of some hallucinogenic drugs upon the metabolism of noradrenaline","year":"1969","cit":89,"pfa":"B.E. Leonard","psa":"Sally R. Tonge","ptype":"article","src":"https://openalex.org/W2057894499","eid":"W2057894499"},{"id":"paper-w3164067847","cat":"papers","name":"Psychedelics and health behaviour change","year":"2021","cit":89,"pfa":"Pedro J. Teixeira","psa":"Robin Lester Carhart-Harris","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3164067847","eid":"W3164067847"},{"id":"paper-w2995495462","cat":"papers","name":"Decreased directed functional connectivity in the psychedelic state","year":"2019","cit":89,"pfa":"Lionel Barnett","psa":"Anil K. Seth","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2995495462","eid":"W2995495462"},{"id":"paper-w4378782231","cat":"papers","name":"Importance of Integrating Spiritual, Existential, Religious, and Theological Components in Psychedelic-Assisted Therapies","year":"2023","cit":89,"pfa":"Roman Palitsky","psa":"Charles L. Raison","topics":["Anxiety & end-of-life","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4378782231","eid":"W4378782231"},{"id":"paper-w2129463334","cat":"papers","name":"The utility of microdosing over the past 5 years","year":"2008","cit":89,"pfa":"Graham Lappin","psa":"R. Colin Garner","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2129463334","eid":"W2129463334"},{"id":"paper-w3164900028","cat":"papers","name":"An analog of psychedelics restores functional neural circuits disrupted by unpredictable stress","year":"2021","cit":89,"pfa":"Ju Ming Lu","psa":"Yi Zuo","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3164900028","eid":"W3164900028"},{"id":"paper-w2219584703","cat":"papers","name":"Microdosed Lipid-Coated67Ga-Magnetite Enhances Antigen-Specific Immunity by Image Tracked Delivery of Antigen and CpG to Lymph Nodes","year":"2015","cit":89,"pfa":"Ane Ruiz‐de‐Angulo","psa":"Juan C. Mareque Rivas","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2219584703","eid":"W2219584703"},{"id":"paper-w2075703456","cat":"papers","name":"Investigation of hallucinogenic and related β-carbolines","year":"1998","cit":89,"pfa":"Brian S. Grella","psa":"Richard A. Glennon","ptype":"article","src":"https://openalex.org/W2075703456","eid":"W2075703456"},{"id":"paper-w2165640020","cat":"papers","name":"Cannabidiol Attenuates Sensorimotor Gating Disruption and Molecular Changes Induced by Chronic Antagonism of NMDA receptors in Mice","year":"2015","cit":89,"pfa":"Felipe V. Gomes","psa":"Francisco Silveira Guimarães","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2165640020","eid":"W2165640020"},{"id":"paper-w4233365829","cat":"papers","name":"Ketamine as an adjuvant to opioids for cancer pain","year":"2012","cit":89,"pfa":"Rae Frances Bell","psa":"Eija Anneli Kalso","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"reference-entry","src":"https://openalex.org/W4233365829","eid":"W4233365829"},{"id":"paper-w3194585947","cat":"papers","name":"Esketamine Nasal Spray for the Rapid Reduction of Depressive Symptoms in Major Depressive Disorder With Acute Suicidal Ideation or Behavior","year":"2021","cit":89,"pfa":"Carla M. Canuso","psa":"Dong‐Jing Fu","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3194585947","eid":"W3194585947"},{"id":"paper-w3154557415","cat":"papers","name":"Influence of anesthetic induction of propofol combined with esketamine on perioperative stress and inflammatory responses and postoperative cognition of elderly surgical patients.","year":"2021","cit":89,"pfa":"Wencai Tu","psa":"Jianhua Li","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3154557415","eid":"W3154557415"},{"id":"paper-w2015888858","cat":"papers","name":"LYSERGIC-ACID-DIETHYLAMIDE AND CANNABIS AS POSSIBLE TERATOGENS IN MAN","year":"1968","cit":88,"pfa":"Frederick M. Hecht","psa":"Patricia A. Roberts","ptype":"article","src":"https://openalex.org/W2015888858","eid":"W2015888858"},{"id":"paper-w2890770786","cat":"papers","name":"A Single Dose of 5-MeO-DMT Stimulates Cell Proliferation, Neuronal Survivability, Morphological and Functional Changes in Adult Mice Ventral Dentate Gyrus","year":"2018","cit":88,"pfa":"Rafael Vitor Lima da Cruz","psa":"Richardson Naves Leão","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2890770786","eid":"W2890770786"},{"id":"paper-w2056232804","cat":"papers","name":"Metabolic fate of mescaline in man","year":"1966","cit":88,"pfa":"Kyriakos Charalampous","psa":"John Kinross-Wright","ptype":"article","src":"https://openalex.org/W2056232804","eid":"W2056232804"},{"id":"paper-w2518856943","cat":"papers","name":"The Globalization of Ayahuasca Shamanism and the Erasure of Indigenous Shamanism","year":"2016","cit":88,"pfa":"Evgenia Fotiou","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2518856943","eid":"W2518856943"},{"id":"paper-w1968436488","cat":"papers","name":"Implications of mechanism-based inhibition of CYP2D6 for the pharmacokinetics and toxicity of MDMA","year":"2006","cit":88,"pfa":"Jiansong Yang","psa":"Amin Rostami‐Hodjegan","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1968436488","eid":"W1968436488"},{"id":"paper-w2810374266","cat":"papers","name":"High dose psilocybin is associated with positive subjective effects in healthy volunteers","year":"2018","cit":88,"pfa":"Christopher R. N. Nicholas","psa":"Paul R. Hutson","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2810374266","eid":"W2810374266"},{"id":"paper-w4396588878","cat":"papers","name":"Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis","year":"2024","cit":88,"pfa":"Athina-Marina Metaxa","psa":"Mike J Clarke","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W4396588878","eid":"W4396588878"},{"id":"paper-w2116485956","cat":"papers","name":"Effect of kappa-opioid receptor agonists U69593, U50488H, spiradoline and salvinorin A on cocaine-induced drug-seeking in rats","year":"2009","cit":88,"pfa":"Aashish S. Morani","psa":"Susan Schenk","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2116485956","eid":"W2116485956"},{"id":"paper-w2030932324","cat":"papers","name":"Tryptamine, N,N-Dimethyltryptamine, N,N-Dimethyl-5-hydroxytryptamine and 5-Methoxytryptamine in Human Blood and Urine","year":"1965","cit":88,"pfa":"Fr. Franzen","psa":"H Gross","ptype":"article","src":"https://openalex.org/W2030932324","eid":"W2030932324"},{"id":"paper-w1886032183","cat":"papers","name":"The role of monoamines in the changes in body temperature induced by 3,4‐methylenedioxymethamphetamine (MDMA, ecstasy) and its derivatives","year":"2010","cit":88,"pfa":"James R. Docherty","psa":"AR Green","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1886032183","eid":"W1886032183"},{"id":"paper-w2965468106","cat":"papers","name":"Culturally informed research design issues in a study for MDMA-assisted psychotherapy for posttraumatic stress disorder","year":"2019","cit":88,"pfa":"Monnica T. Williams","psa":"Ritika Aggarwal","topics":["PTSD & trauma","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2965468106","eid":"W2965468106"},{"id":"paper-w2969964941","cat":"papers","name":"Efficacy of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for posttraumatic stress disorder: A systematic review and meta-analysis","year":"2019","cit":88,"pfa":"Anees Bahji","psa":"Emily R. Hawken","topics":["PTSD & trauma","Reviews & meta-analyses","Therapy practice"],"ptype":"review","src":"https://openalex.org/W2969964941","eid":"W2969964941"},{"id":"paper-w2059551625","cat":"papers","name":"Elevation of Ambient Room Temperature has Differential Effects on MDMA-Induced 5-HT and Dopamine Release in Striatum and Nucleus Accumbens of Rats","year":"2005","cit":88,"pfa":"Esther O’Shea","psa":"M. Isabel Colado","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2059551625","eid":"W2059551625"},{"id":"paper-w4210511938","cat":"papers","name":"Repeated low doses of LSD in healthy adults: A placebo‐controlled, dose–response study","year":"2022","cit":88,"pfa":"Harriet de Wit","psa":"Royce Lee","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4210511938","eid":"W4210511938"},{"id":"paper-w2073293352","cat":"papers","name":"Transient memory impairment after acute dose of 75mg 3.4-Methylene-dioxymethamphetamine","year":"2005","cit":88,"pfa":"Kim P. C. Kuypers","psa":"Jan G. Ramaekers","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2073293352","eid":"W2073293352"},{"id":"paper-w2091399926","cat":"papers","name":"5-Hydroxyindoleacetic acid in cerebrospinal fluid reflects serotonergic damage induced by 3,4-methylenedioxymethamphetamine in CNS of non-human primates","year":"1988","cit":88,"pfa":"G.A. Ricaurte","psa":"J. William Langston","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2091399926","eid":"W2091399926"},{"id":"paper-w4377940122","cat":"papers","name":"Acute effects of intravenous DMT in a randomized placebo-controlled study in healthy participants","year":"2023","cit":88,"pfa":"Severin B. Vogt","psa":"Matthias E. Liechti","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4377940122","eid":"W4377940122"},{"id":"paper-w3009908805","cat":"papers","name":"Sexual, addiction and mental health care needs among men who have sex with men practicing chemsex – a cross-sectional study in the Netherlands","year":"2020","cit":88,"pfa":"Ymke Joline Evers","psa":"Geneviève A. F. S. van Liere","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3009908805","eid":"W3009908805"},{"id":"paper-w1985214811","cat":"papers","name":"A BEHAVIOURAL AND BIOCHEMICAL STUDY IN RATS OF 5‐HYDROXYTRYPTAMINE RECEPTOR AGONISTS AND ANTAGONISTS, WITH OBSERVATIONS ON STRUCTURE‐ACTIVITY REQUIREMENTS FOR THE AGONISTS","year":"1981","cit":88,"pfa":"A.R. GREEN","psa":"Anthony R. Rees","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1985214811","eid":"W1985214811"},{"id":"paper-w624665717","cat":"papers","name":"Journal of psychedelic drugs","year":"1967","cit":88,"pfa":"Haight-Ashbury Medical Clinic","psa":"Haight-Ashbury Free Medical Clinic","ptype":"book","src":"https://openalex.org/W624665717","eid":"W624665717"},{"id":"paper-w3134109999","cat":"papers","name":"How to Change Your Mind : The New Science of Psychedelics","year":"2018","cit":88,"pfa":"Michael Pollan","ptype":"book","src":"https://openalex.org/W3134109999","eid":"W3134109999"},{"id":"paper-w1996143523","cat":"papers","name":"Hallucinogen use predicts reduced recidivism among substance-involved offenders under community corrections supervision","year":"2014","cit":88,"pfa":"Peter S. Hendricks","psa":"Karen L. Cropsey","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1996143523","eid":"W1996143523"},{"id":"paper-w2263624231","cat":"papers","name":"STUDIES OF ANALGESIC DRUGS. VIII. A NARCOTIC ANTAGONIST ANALGESIC WITHOUT PSYCHOTOMIMETIC EFFECTS","year":"1964","cit":88,"pfa":"Arthur S. Keats","psa":"Jane Telford","ptype":"article","src":"https://openalex.org/W2263624231","eid":"W2263624231"},{"id":"paper-w2744624838","cat":"papers","name":"Isoflurane produces antidepressant effects and induces TrkB signaling in rodents","year":"2017","cit":88,"pfa":"Hanna Antila","psa":"Tomi Rantamäki","topics":["Depression","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2744624838","eid":"W2744624838"},{"id":"paper-w2109160909","cat":"papers","name":"Effects of subchronic phencyclidine (PCP) treatment on social behaviors and operant discrimination and reversal learning in C57BL/6J mice","year":"2009","cit":88,"pfa":"Jonathan L. Brigman","ptype":"article","src":"https://openalex.org/W2109160909","eid":"W2109160909"},{"id":"paper-w4406934817","cat":"papers","name":"Esketamine Treatment for Depression in Adults: A PRISMA Systematic Review and Meta-Analysis","year":"2025","cit":88,"pfa":"Konstantinos Ν. Fountoulakis","psa":"Alan F. Schatzberg","topics":["Depression","Reviews & meta-analyses","Policy & ethics"],"ptype":"review","src":"https://openalex.org/W4406934817","eid":"W4406934817"},{"id":"paper-w4389992631","cat":"papers","name":"Effect of Esketamine Added to Propofol Sedation on Desaturation and Hypotension in Bidirectional Endoscopy","year":"2023","cit":88,"pfa":"Nan Song","psa":"Fuhai Ji","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4389992631","eid":"W4389992631"},{"id":"paper-w4328111580","cat":"papers","name":"Effect of Subanesthetic Dose of Esketamine on Perioperative Neurocognitive Disorders in Elderly Undergoing Gastrointestinal Surgery: A Randomized Controlled Trial","year":"2023","cit":88,"pfa":"Chao Han","psa":"Tieliang Ma","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4328111580","eid":"W4328111580"},{"id":"paper-w1990266442","cat":"papers","name":"MDMA: A Review of Epidemiological Data","year":"2002","cit":87,"pfa":"Mim J. Landry","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1990266442","eid":"W1990266442"},{"id":"paper-w3092027192","cat":"papers","name":"Acute subjective effects in LSD- and MDMA-assisted psychotherapy","year":"2020","cit":87,"pfa":"Yasmin Schmid","psa":"Matthias E. Liechti","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W3092027192","eid":"W3092027192"},{"id":"paper-w2000906264","cat":"papers","name":"The neuropsychology of ecstasy (MDMA) use: a quantitative review","year":"2007","cit":87,"pfa":"Konstantine K. Zakzanis","psa":"Diana Jovanovski","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2000906264","eid":"W2000906264"},{"id":"paper-w2981779913","cat":"papers","name":"The Impact of Ayahuasca on Suicidality: Results From a Randomized Controlled Trial","year":"2019","cit":87,"pfa":"Richard J. Zeifman","psa":"Dráulio Barros de Araújo","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2981779913","eid":"W2981779913"},{"id":"paper-w2024880450","cat":"papers","name":"Safety and Side Effects of Ayahuasca in Humans—An Overview Focusing on Developmental Toxicology","year":"2013","cit":87,"pfa":"RAFAEL GUIMARÃES DOS SANTOS","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2024880450","eid":"W2024880450"},{"id":"paper-w3202537739","cat":"papers","name":"Persisting Effects of Ayahuasca on Empathy, Creative Thinking, Decentering, Personality, and Well-Being","year":"2021","cit":87,"pfa":"Maggie Kiraga","psa":"Kim P. C. Kuypers","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3202537739","eid":"W3202537739"},{"id":"paper-w1980067374","cat":"papers","name":"Unmasking of a neonatal somatovesical reflex in adult cats by the serotonin autoreceptor agonist 5-methoxy-N,N-dimethyltryptamine","year":"1990","cit":87,"pfa":"Karl B. Thor","psa":"William Chet de Groat","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1980067374","eid":"W1980067374"},{"id":"paper-w2038752911","cat":"papers","name":"Behavioural and neurochemical comparison of chronic intermittent cathinone, mephedrone and MDMA administration to the rat","year":"2012","cit":87,"pfa":"Sinead E. Shortall","psa":"Madeleine V. King","ptype":"article","src":"https://openalex.org/W2038752911","eid":"W2038752911"},{"id":"paper-w2040911489","cat":"papers","name":"Role of Serotonin via 5-HT2B Receptors in the Reinforcing Effects of MDMA in Mice","year":"2009","cit":87,"pfa":"Stéphane Doly","psa":"Luc Maroteaux","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2040911489","eid":"W2040911489"},{"id":"paper-w3159976828","cat":"papers","name":"The Yale Manual for Psilocybin-Assisted Therapy of Depression (using Acceptance and Commitment Therapy as a Therapeutic Frame)","year":"2020","cit":87,"pfa":"Jeffrey R. Guss","psa":"Jordan Sloshower","topics":["Depression","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W3159976828","eid":"W3159976828"},{"id":"paper-w2039244923","cat":"papers","name":"The Anxiogenic-Like and Anxiolytic-Like Effects of MDMA on Mice in the Elevated Plus-Maze A Comparison With Amphetamine","year":"1999","cit":87,"pfa":"Huangbin Lin","ptype":"article","src":"https://openalex.org/W2039244923","eid":"W2039244923"},{"id":"paper-w1983308889","cat":"papers","name":"Methylphenidate and MDMA adolescent exposure in mice: long-lasting consequences on cocaine-induced reward and psychomotor stimulation in adulthood","year":"2003","cit":87,"pfa":"Cindy Achat‐Mendes","ptype":"article","src":"https://openalex.org/W1983308889","eid":"W1983308889"},{"id":"paper-w2097113529","cat":"papers","name":"Fast LC–MS/MS method for the determination of amphetamine, methamphetamine, MDA, MDMA, MDEA, MBDB and PMA in urine","year":"2006","cit":87,"pfa":"Marta Concheiro","psa":"Manuel López‐Rivadulla","ptype":"article","src":"https://openalex.org/W2097113529","eid":"W2097113529"},{"id":"paper-w3204171992","cat":"papers","name":"Psychedelics, Sociality, and Human Evolution","year":"2021","cit":87,"pfa":"José Manuel Rodríguez Arce","psa":"Michael Winkelman","topics":["Mechanism & neuroscience","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3204171992","eid":"W3204171992"},{"id":"paper-w2040808064","cat":"papers","name":"The effects of some hallucinogenic drugs upon the metabolism of 5-hydroxy-tryptamine in the brain","year":"1969","cit":87,"pfa":"Sally R. Tonge","psa":"B.E. Leonard","ptype":"article","src":"https://openalex.org/W2040808064","eid":"W2040808064"},{"id":"paper-w2081112645","cat":"papers","name":"Acute carbon monoxide poisoning and delayed neurological sequelae: a potential neuroprotection bundle therapy","year":"2015","cit":87,"pfa":"Sangchun Choi","psa":"Sungho Oh","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W2081112645","eid":"W2081112645"},{"id":"paper-w3008107779","cat":"papers","name":"The role of Indigenous knowledges in psychedelic science","year":"2019","cit":87,"pfa":"Evgenia Fotiou","ptype":"article","src":"https://openalex.org/W3008107779","eid":"W3008107779"},{"id":"paper-w4295048117","cat":"papers","name":"Neural Mechanisms and Psychology of Psychedelic Ego Dissolution","year":"2022","cit":87,"pfa":"Devon Stoliker","psa":"Adeel Razi","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4295048117","eid":"W4295048117"},{"id":"paper-w2588071311","cat":"papers","name":"The association of psychedelic use and opioid use disorders among illicit users in the United States","year":"2017","cit":87,"pfa":"Vincent D. Pisano","psa":"Selma C. Holden","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2588071311","eid":"W2588071311"},{"id":"paper-w2003127631","cat":"papers","name":"Antagonist/letrozole protocol in poor ovarian responders for intracytoplasmic sperm injection: a comparative study with the microdose flare-up protocol","year":"2008","cit":87,"pfa":"Hakan Yaralı́","psa":"Bülent Tıraş","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2003127631","eid":"W2003127631"},{"id":"paper-w2001419062","cat":"papers","name":"High performance liquid chromatography–high resolution mass spectrometry and micropulverized extraction for the quantification of amphetamines, cocaine, opioids, benzodiazepines, antidepressants and hallucinogens in 2.5m","year":"2011","cit":87,"pfa":"Donata Favretto","psa":"Santo Davide Ferrara","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W2001419062","eid":"W2001419062"},{"id":"paper-w2415226826","cat":"papers","name":"The Involvement of Serotonin in Psychiatric Disorders and Behaviour","year":"1988","cit":87,"pfa":"Juan J López-Ibor","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2415226826","eid":"W2415226826"},{"id":"paper-w2036777101","cat":"papers","name":"A comparison of LSD-25 with (?)-?9-trans-tetrahydrocannabinol (THC) and attempted cross tolerance between LSD and THC","year":"1969","cit":87,"pfa":"Harris Isbell","psa":"Donald R. Jasinski","ptype":"article","src":"https://openalex.org/W2036777101","eid":"W2036777101"},{"id":"paper-w2328103612","cat":"papers","name":"The effect of five day dosing with THCV on THC-induced cognitive, psychological and physiological effects in healthy male human volunteers: A placebo-controlled, double-blind, crossover pilot trial","year":"2015","cit":87,"pfa":"Amir Englund","psa":"Paul A. Morrison","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2328103612","eid":"W2328103612"},{"id":"paper-w2792882327","cat":"papers","name":"Repeated intranasal ketamine for treatment-resistant depression – the way to go? Results from a pilot randomised controlled trial","year":"2018","cit":87,"pfa":"Verònica Gálvez","psa":"Colleen K A Loo","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2792882327","eid":"W2792882327"},{"id":"paper-w1989411584","cat":"papers","name":"Congenital Malformations Induced by Mescaline, Lysergic Acid Diethylamide, and Bromolysergic Acid in the Hamster","year":"1967","cit":86,"pfa":"William F. Geber","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1989411584","eid":"W1989411584"},{"id":"paper-w2093658818","cat":"papers","name":"Detection of psilocin in body fluids","year":"2000","cit":86,"pfa":"Guido Sticht","psa":"Herbert Käferstein","ptype":"article","src":"https://openalex.org/W2093658818","eid":"W2093658818"},{"id":"paper-w3014277121","cat":"papers","name":"Depression, Mindfulness, and Psilocybin: Possible Complementary Effects of Mindfulness Meditation and Psilocybin in the Treatment of Depression. A Review","year":"2020","cit":86,"pfa":"Kristin Heuschkel","psa":"Kim P. C. Kuypers","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3014277121","eid":"W3014277121"},{"id":"paper-w2079092936","cat":"papers","name":"Effect of Psilocin on Extracellular Dopamine and Serotonin Levels in the Mesoaccumbens and Mesocortical Pathway in Awake Rats","year":"2014","cit":86,"pfa":"Yuichi Sakashita","psa":"Kyoji Taguchi","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2079092936","eid":"W2079092936"},{"id":"paper-w2152721333","cat":"papers","name":"Prosocial effects of MDMA: A measure of generosity","year":"2015","cit":86,"pfa":"Matthew G. Kirkpatrick","psa":"Harriet de Wit","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2152721333","eid":"W2152721333"},{"id":"paper-w2040140561","cat":"papers","name":"MDMA decreases the effects of simulated social rejection","year":"2013","cit":86,"pfa":"Charles G. Frye","psa":"Harriet de Wit","ptype":"article","src":"https://openalex.org/W2040140561","eid":"W2040140561"},{"id":"paper-w2037169118","cat":"papers","name":"Impaired executive function in male MDMA (?ecstasy?) users","year":"2004","cit":86,"pfa":"Niels J. Alting von Geusau","psa":"K. Richard Ridderinkhof","ptype":"article","src":"https://openalex.org/W2037169118","eid":"W2037169118"},{"id":"paper-w2147606470","cat":"papers","name":"The psychotherapeutic potential of MDMA (3,4-methylenedioxymethamphetamine): an evidence-based review","year":"2007","cit":86,"pfa":"Andrew C. Parrott","topics":["Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2147606470","eid":"W2147606470"},{"id":"paper-w2019474799","cat":"papers","name":"Loss of Serotonin Transporter Protein after MDMA and Other Ring-Substituted Amphetamines","year":"2006","cit":86,"pfa":"Tao Xie","psa":"George A. Ricaurte","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2019474799","eid":"W2019474799"},{"id":"paper-w2060895955","cat":"papers","name":"In Vivo Imaging of Cerebral Serotonin Transporter and Serotonin2A Receptor Binding in 3,4-Methylenedioxymethamphetamine (MDMA or “Ecstasy”) and Hallucinogen Users","year":"2011","cit":86,"pfa":"David Erritzøe","psa":"Gitte M. Knudsen","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2060895955","eid":"W2060895955"},{"id":"paper-w2304049002","cat":"papers","name":"Acute Effects of 3,4-Methylenedioxymethamphetamine Alone and in Combination with Ethanol on the Immune System in Humans","year":"2001","cit":86,"pfa":"Roberta Pacifici","psa":"Rafael de la Torre","ptype":"article","src":"https://openalex.org/W2304049002","eid":"W2304049002"},{"id":"paper-w2073723494","cat":"papers","name":"The 5‐HT1 receptor agonist RU‐24969 decreases 5‐hydroxytryptamine (5‐HT) release and metabolism in the rat frontal cortex in vitro and in vivo","year":"1985","cit":86,"pfa":"Michael P. Brazell","psa":"Carol A. Routledge","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2073723494","eid":"W2073723494"},{"id":"paper-w4367857025","cat":"papers","name":"Ligand and G-protein selectivity in the κ-opioid receptor","year":"2023","cit":86,"pfa":"Jianming Han","psa":"Tao Che","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4367857025","eid":"W4367857025"},{"id":"paper-w4308768859","cat":"papers","name":"Psychedelics and Neural Plasticity: Therapeutic Implications","year":"2022","cit":86,"pfa":"Steven F. Grieco","psa":"Xiangmin Xu","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4308768859","eid":"W4308768859"},{"id":"paper-w2018680292","cat":"papers","name":"Chronic treatment with (W)DOI, a psychotomimetic 5-HT2 agonist, downregulates 5-HT2 receptors in rat brain","year":"1989","cit":86,"pfa":"D MCKENNA","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2018680292","eid":"W2018680292"},{"id":"paper-w2730594126","cat":"papers","name":"Discovery of Clinical Candidate 4-[2-(5-Amino-1H-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-1,3-thiazol-4-ylbenzenesulfonamide (PF-05089771): Design and Optimization of Diaryl Ether Aryl Sulfonamides as Selective","year":"2017","cit":86,"pfa":"Nigel A. Swain","psa":"Christopher W. West","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2730594126","eid":"W2730594126"},{"id":"paper-w2045435084","cat":"papers","name":"Anesthetic management of the illicit-substance-using patient","year":"2005","cit":86,"pfa":"Marcelle Hernandez","psa":"André A.J. van Zundert","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2045435084","eid":"W2045435084"},{"id":"paper-w1982029442","cat":"papers","name":"A systematic review of the effects of NMDA receptor antagonists on oscillatory activity recorded in vivo","year":"2013","cit":86,"pfa":"Mark Jeremy Hunt","psa":"Stefan Kasicki","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W1982029442","eid":"W1982029442"},{"id":"paper-w1978346382","cat":"papers","name":"Dose Escalation Study of the NMDA Glycine-Site Antagonist Licostinel in Acute Ischemic Stroke","year":"1999","cit":86,"pfa":"Gregory W. Albers","psa":"M.J. Whitehouse","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1978346382","eid":"W1978346382"},{"id":"paper-w3097506887","cat":"papers","name":"Practical recommendations for the management of treatment-resistant depression with esketamine nasal spray therapy: Basic science, evidence-based knowledge and expert guidance","year":"2020","cit":86,"pfa":"Siegfried F. Kasper","psa":"Allan Hunter Young","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3097506887","eid":"W3097506887"},{"id":"paper-w1988279571","cat":"papers","name":"Lysergic Acid Diethylamide: Its Effects on a Male Asiatic Elephant","year":"1962","cit":85,"pfa":"Louis Jolyon West","psa":"Warren D. Thomas","ptype":"article","src":"https://openalex.org/W1988279571","eid":"W1988279571"},{"id":"paper-w2071910089","cat":"papers","name":"Determination of N,N-dimethyltryptamine and β-carboline alkaloids in human plasma following oral administration of Ayahuasca","year":"2002","cit":85,"pfa":"Mercedes Yritia","psa":"Manel J. Barbanoj","ptype":"article","src":"https://openalex.org/W2071910089","eid":"W2071910089"},{"id":"paper-w2973895336","cat":"papers","name":"In vivo production of psilocybin in E. coli","year":"2019","cit":85,"pfa":"Alexandra M. Adams","psa":"J. Andrew Jones","ptype":"article","src":"https://openalex.org/W2973895336","eid":"W2973895336"},{"id":"paper-w2126987827","cat":"papers","name":"Pharmacokinetics of the plant-derived κ-opioid hallucinogen salvinorin A in nonhuman primates","year":"2005","cit":85,"pfa":"Matthew D. Schmidt","psa":"Thomas Edward Prisinzano","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2126987827","eid":"W2126987827"},{"id":"paper-w4391109410","cat":"papers","name":"Assessing expectancy and suggestibility in a trial of escitalopram v. psilocybin for depression","year":"2024","cit":85,"pfa":"Balázs Szigeti","psa":"Robin Lester Carhart-Harris","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4391109410","eid":"W4391109410"},{"id":"paper-w2096610047","cat":"papers","name":"Psilocybin impairs high-level but not low-level motion perception","year":"2004","cit":85,"pfa":"Olivia L. Carter","psa":"Franz X. Vollenweider","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2096610047","eid":"W2096610047"},{"id":"paper-w2172080717","cat":"papers","name":"Acute and prolonged effects of ibogaine on brain dopamine metabolism and morphine-induced locomotor activity in rats","year":"1992","cit":85,"pfa":"I.M. Maisonneuve","psa":"S.D. Glick","ptype":"article","src":"https://openalex.org/W2172080717","eid":"W2172080717"},{"id":"paper-w2121108165","cat":"papers","name":"Neuroimaging findings with MDMA/ecstasy: technical aspects, conceptual issues and future prospects","year":"2006","cit":85,"pfa":"Liesbeth Reneman","psa":"Gerard J. den Heeten","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2121108165","eid":"W2121108165"},{"id":"paper-w2051757993","cat":"papers","name":"Altered neuroendocrine and behavioral responses to m -chlorophenylpiperazine in 3,4-methylenedioxymethamphetamine (MDMA) users","year":"1999","cit":85,"pfa":"U. McCann","psa":"George A. Ricaurte","ptype":"article","src":"https://openalex.org/W2051757993","eid":"W2051757993"},{"id":"paper-w3091936754","cat":"papers","name":"Brain serotonin 2A receptor binding predicts subjective temporal and mystical effects of psilocybin in healthy humans","year":"2020","cit":85,"pfa":"Dea Siggaard Stenbæk","psa":"Patrick M. Fisher","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3091936754","eid":"W3091936754"},{"id":"paper-w2057566553","cat":"papers","name":"Chronic Fluoxetine Treatment Partly Attenuates the Long-Term Anxiety and Depressive Symptoms Induced by MDMA (‘Ecstasy’) in Rats","year":"2003","cit":85,"pfa":"Murray R. Thompson","psa":"Iain S. McGregor","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2057566553","eid":"W2057566553"},{"id":"paper-w4220695431","cat":"papers","name":"MDMA-assisted therapy significantly reduces eating disorder symptoms in a randomized placebo-controlled trial of adults with severe PTSD","year":"2022","cit":85,"pfa":"Timothy D. Brewerton","psa":"Rick Doblin","topics":["PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4220695431","eid":"W4220695431"},{"id":"paper-w2418413848","cat":"papers","name":"Quantitative electroencephalographic analysis of naturally occurring (schizophrenic) and drug‐induced psychotic states in human males","year":"1963","cit":85,"pfa":"Leonide Goldstein","psa":"Elizabeth H. Jenney","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2418413848","eid":"W2418413848"},{"id":"paper-w3082721315","cat":"papers","name":"The therapeutic potential of microdosing psychedelics in depression","year":"2020","cit":85,"pfa":"Kim P. C. Kuypers","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3082721315","eid":"W3082721315"},{"id":"paper-w2770636944","cat":"papers","name":"LSD modulates effective connectivity and neural adaptation mechanisms in an auditory oddball paradigm","year":"2017","cit":85,"pfa":"Christopher B. Timmermann","psa":"Suresh D Muthukumaraswamy","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2770636944","eid":"W2770636944"},{"id":"paper-w3041518543","cat":"papers","name":"Psychedelic Treatment for Trauma-Related Psychological and Cognitive Impairment Among US Special Operations Forces Veterans","year":"2020","cit":85,"pfa":"Alan K. Davis","psa":"Timothy Amoroso","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3041518543","eid":"W3041518543"},{"id":"paper-w2070018013","cat":"papers","name":"Screening hallucinogenic drugs: Systematic study of three behavioral tests","year":"1975","cit":85,"pfa":"M. Teresa A. Silva","psa":"Helena Maria Calil","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2070018013","eid":"W2070018013"},{"id":"paper-w618495272","cat":"papers","name":"Persephone's Quest: Entheogens and the Origins of Religion","year":"1988","cit":85,"pfa":"R. Gordon Wasson","psa":"Carl A. P. Ruck","ptype":"other","src":"https://openalex.org/W618495272","eid":"W618495272"},{"id":"paper-w3207479206","cat":"papers","name":"Why was early therapeutic research on psychedelic drugs abandoned?","year":"2021","cit":85,"pfa":"Wayne Hall","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3207479206","eid":"W3207479206"},{"id":"paper-w2904143914","cat":"papers","name":"DARK Classics in Chemical Neuroscience: Atropine, Scopolamine, and Other Anticholinergic Deliriant Hallucinogens","year":"2018","cit":85,"pfa":"Anton M. Lakstygal","psa":"Allan V. Kalueff","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2904143914","eid":"W2904143914"},{"id":"paper-w2078968281","cat":"papers","name":"Bufo Toads and Bufotenine: Fact and Fiction Surrounding an Alleged Psychedelic","year":"1996","cit":85,"pfa":"Thomas Lyttle","psa":"Jochen Gartz","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2078968281","eid":"W2078968281"},{"id":"paper-w2147379823","cat":"papers","name":"Effects of Hallucinogens on Locomotor and Investigatory Activity and Patterns: Influence of 5-HT2A and 5-HT2C Receptors","year":"1998","cit":85,"pfa":"Kirsten Krebs-Thomson","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2147379823","eid":"W2147379823"},{"id":"paper-w3109958928","cat":"papers","name":"Increased signal diversity/complexity of spontaneous EEG, but not evoked EEG responses, in ketamine-induced psychedelic state in humans","year":"2020","cit":85,"pfa":"Nadine Farnes","psa":"Johan Frederik Storm","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3109958928","eid":"W3109958928"},{"id":"paper-w2146564511","cat":"papers","name":"Salvia divinorum: Effects and use among YouTube users","year":"2009","cit":85,"pfa":"James E. Lange","psa":"John D. Clapp","ptype":"article","src":"https://openalex.org/W2146564511","eid":"W2146564511"},{"id":"paper-w3015053440","cat":"papers","name":"Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depression","year":"2020","cit":85,"pfa":"Cristan Farmer","psa":"Carlos A. Zarate","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W3015053440","eid":"W3015053440"},{"id":"paper-w2043776914","cat":"papers","name":"Losing Control Under Ketamine: Suppressed Cortico-Hippocampal Drive Following Acute Ketamine in Rats","year":"2014","cit":85,"pfa":"Rosalyn Moran","psa":"Karl John Friston","ptype":"article","src":"https://openalex.org/W2043776914","eid":"W2043776914"},{"id":"paper-w2749684885","cat":"papers","name":"Synthesis and N-Methyl- d -aspartate (NMDA) Receptor Activity of Ketamine Metabolites","year":"2017","cit":85,"pfa":"Patrick J. Morris","psa":"Craig J. Thomas","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2749684885","eid":"W2749684885"},{"id":"paper-w2014849557","cat":"papers","name":"Neuropharmacological reassessment of the discriminative stimulus properties ofd-lysergic acid diethylamide (LSD)","year":"1987","cit":84,"pfa":"Kathryn A. Cunningham","psa":"J. B. Appel","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2014849557","eid":"W2014849557"},{"id":"paper-w2806747726","cat":"papers","name":"Dark Classics in Chemical Neuroscience: Mescaline","year":"2018","cit":84,"pfa":"Bruce K. Cassels","psa":"Patricio Sáez‐Briones","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2806747726","eid":"W2806747726"},{"id":"paper-w2018806235","cat":"papers","name":"Rewarding Effects and Reinstatement of MDMA-Induced CPP in Adolescent Mice","year":"2007","cit":84,"pfa":"Manuel Daza‐Losada","psa":"José Miñarro","ptype":"article","src":"https://openalex.org/W2018806235","eid":"W2018806235"},{"id":"paper-w1972349079","cat":"papers","name":"Increased sensitivity to the acute effects of MDMA (“ecstasy”) in female rats","year":"2005","cit":84,"pfa":"Tomáš Páleníček","psa":"Jiřı́ Horáček","ptype":"article","src":"https://openalex.org/W1972349079","eid":"W1972349079"},{"id":"paper-w4389900078","cat":"papers","name":"Psilocybin‐assisted group therapy in patients with cancer diagnosed with a major depressive disorder","year":"2023","cit":84,"pfa":"Manish Agrawal","psa":"Paul M. Thambi","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4389900078","eid":"W4389900078"},{"id":"paper-w2983552824","cat":"papers","name":"Simultaneous Production of Psilocybin and a Cocktail of β‐Carboline Monoamine Oxidase Inhibitors in “Magic” Mushrooms","year":"2019","cit":84,"pfa":"Felix Blei","psa":"Dirk Hoffmeister","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2983552824","eid":"W2983552824"},{"id":"paper-w2895344032","cat":"papers","name":"Response dynamics of midbrain dopamine neurons and serotonin neurons to heroin, nicotine, cocaine, and MDMA","year":"2018","cit":84,"pfa":"Chao Kun Wei","psa":"Minmin Luo","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2895344032","eid":"W2895344032"},{"id":"paper-w2135538008","cat":"papers","name":"Pill content, dose and resulting plasma concentrations of 3,4‐methylendioxymethamphetamine (MDMA) in recreational ‘ecstasy’ users","year":"2011","cit":84,"pfa":"Kate Morefield","psa":"Rodney James Irvine","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2135538008","eid":"W2135538008"},{"id":"paper-w3095307948","cat":"papers","name":"Rapid and sustained decreases in suicidality following a single dose of ayahuasca among individuals with recurrent major depressive disorder: results from an open-label trial","year":"2020","cit":84,"pfa":"Richard J. Zeifman","psa":"Cory R. Weissman","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3095307948","eid":"W3095307948"},{"id":"paper-w2055369650","cat":"papers","name":"Heat increases 3,4-methylenedioxymethamphetamine self-administration and social effects in rats","year":"2003","cit":84,"pfa":"Jennifer L. Cornish","psa":"Iain S. McGregor","ptype":"article","src":"https://openalex.org/W2055369650","eid":"W2055369650"},{"id":"paper-w2616187260","cat":"papers","name":"Therapeutic Applications of Classic Hallucinogens","year":"2016","cit":84,"pfa":"Michael P. Bogenschutz","psa":"Stephen Ross","ptype":"book-chapter","src":"https://openalex.org/W2616187260","eid":"W2616187260"},{"id":"paper-w2334301455","cat":"papers","name":"No Difference in Brain Activation During Cognitive Performance Between Ecstasy (3,4-Methylenedioxymethamphetamine) Users and Control Subjects: A [H215O]-Positron Emission Tomography Study","year":"2001","cit":84,"pfa":"Alex Gamma","psa":"Franz X. Vollenweider","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2334301455","eid":"W2334301455"},{"id":"paper-w4297373842","cat":"papers","name":"Psychedelics therapeutics: What we know, what we think, and what we need to research","year":"2022","cit":84,"pfa":"David Nutt","psa":"David Erritzøe","ptype":"article","src":"https://openalex.org/W4297373842","eid":"W4297373842"},{"id":"paper-w1962566690","cat":"papers","name":"Simultaneous oral therapeutic and intravenous 14C‐microdoses to determine the absolute oral bioavailability of saxagliptin and dapagliflozin","year":"2012","cit":84,"pfa":"David W. Boulton","psa":"Frank P. LaCreta","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1962566690","eid":"W1962566690"},{"id":"paper-w2804613528","cat":"papers","name":"A study of the focal adhesion kinase inhibitor GSK2256098 in patients with recurrent glioblastoma with evaluation of tumor penetration of [11C]GSK2256098","year":"2018","cit":84,"pfa":"Nicholas Fraser Brown","psa":"Paul James Mulholland","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2804613528","eid":"W2804613528"},{"id":"paper-w2782003333","cat":"papers","name":"A sub-set of psychoactive effects may be critical to the behavioral impact of ketamine on cocaine use disorder: Results from a randomized, controlled laboratory study","year":"2018","cit":84,"pfa":"Elias Dakwar","psa":"FRANCES RUDNICK LEVIN","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2782003333","eid":"W2782003333"},{"id":"paper-w2395195328","cat":"papers","name":"Ketamine for analgosedation in critically ill patients","year":"2016","cit":84,"pfa":"Brian L. Erstad","psa":"Asad E. Patanwala","ptype":"article","src":"https://openalex.org/W2395195328","eid":"W2395195328"},{"id":"paper-w4317937589","cat":"papers","name":"Esketamine for treatment‑resistant depression: A review of clinical evidence (Review)","year":"2023","cit":84,"pfa":"Octavian Vasiliu","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4317937589","eid":"W4317937589"},{"id":"paper-w2161084744","cat":"papers","name":"Dopamine D2Highreceptors stimulated by phencyclidines, lysergic acid diethylamide, salvinorin A, and modafinil","year":"2009","cit":83,"pfa":"Philip M. Seeman","psa":"Hélène Hirbec","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2161084744","eid":"W2161084744"},{"id":"paper-w2904505693","cat":"papers","name":"Intensity of Mystical Experiences Occasioned by 5-MeO-DMT and Comparison With a Prior Psilocybin Study","year":"2018","cit":83,"pfa":"Joseph P. Barsuglia","psa":"Roland R. Griffiths","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2904505693","eid":"W2904505693"},{"id":"paper-w2342076491","cat":"papers","name":"D‐Lysergic acid diethylamide (LSD): A review of its present status","year":"1965","cit":83,"pfa":"Abram Hoffer","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2342076491","eid":"W2342076491"},{"id":"paper-w2408288035","cat":"papers","name":"Variations in ego feeling induced by D-lysergic acid diethylamide (LSD-25).","year":"1955","cit":83,"pfa":"Charles Savage","ptype":"article","src":"https://openalex.org/W2408288035","eid":"W2408288035"},{"id":"paper-w1991128922","cat":"papers","name":"Dynamic changes in prefrontal cortex gene expression following lysergic acid diethylamide administration","year":"2003","cit":83,"pfa":"Charles David Nichols","psa":"Elaine Sanders‐Bush","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1991128922","eid":"W1991128922"},{"id":"paper-w634526638","cat":"papers","name":"Effects of chlorimipramine and lysergic acid diethylamide on efflux of precursor-formed 3-H-serotonin: correlations with serotonergic impulse flow.","year":"1975","cit":83,"pfa":"Dorothy W. Gallager","psa":"George K. Aghajanian","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W634526638","eid":"W634526638"},{"id":"paper-w2088721778","cat":"papers","name":"Salvinorins D−F, New Neoclerodane Diterpenoids from Salvia divinorum, and an Improved Method for the Isolation of Salvinorin A","year":"2003","cit":83,"pfa":"Thomas Anthony Munro","psa":"Mark A. Rizzacasa","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2088721778","eid":"W2088721778"},{"id":"paper-w200847362","cat":"papers","name":"Relief of obsessive-compulsive symptoms by LSD and psilocin","year":"1987","cit":83,"pfa":"Henrietta L. Leonard","psa":"JUDITH L. RAPOPORT","ptype":"article","src":"https://openalex.org/W200847362","eid":"W200847362"},{"id":"paper-w2052169891","cat":"papers","name":"Neurotoxicity of MDMA: Neurochemical Effects","year":"1990","cit":83,"pfa":"CHRISTOPHER J. SCHMID","psa":"John H. Kehne","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2052169891","eid":"W2052169891"},{"id":"paper-w2152250507","cat":"papers","name":"Characterization of 3,4-Methylenedioxymethamphetamine (MDMA) EnantiomersIn Vitroand in the MPTP-Lesioned Primate:R-MDMA Reduces Severity of Dyskinesia, WhereasS-MDMA Extends Duration of ON-Time","year":"2011","cit":83,"pfa":"Philippe Huot","psa":"Jonathan M. Brotchie","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2152250507","eid":"W2152250507"},{"id":"paper-w2002549690","cat":"papers","name":"Salvia divinorum and Salvinorin A: An Update on Pharmacology and Analytical Methodology","year":"2007","cit":83,"pfa":"Oliver Grundmann","psa":"Veronika Butterweck","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2002549690","eid":"W2002549690"},{"id":"paper-w2064851543","cat":"papers","name":"Serotonin–GABA interactions modulate MDMA‐induced mesolimbic dopamine release","year":"2004","cit":83,"pfa":"Michael G. Bankson","psa":"Bryan K. Yamamoto","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2064851543","eid":"W2064851543"},{"id":"paper-w2128495617","cat":"papers","name":"Potential Human Neurotoxicity of MDMA (‘Ecstasy’): Subjective Self-Reports, Evidence from an Italian Drug Addiction Centre and Clinical Case Studies","year":"2000","cit":83,"pfa":"Fabrizio Schifano","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2128495617","eid":"W2128495617"},{"id":"paper-w3191550608","cat":"papers","name":"Anti-Inflammatory Effects of Four Psilocybin-Containing Magic Mushroom Water Extracts in vitro on 15-Lipoxygenase Activity and on Lipopolysaccharide-Induced Cyclooxygenase-2 and Inflammatory Cytokines in Human U937 Macro","year":"2021","cit":83,"pfa":"Sanah Malomile Nkadimeng","psa":"Jacobus Nicolaas Eloff","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3191550608","eid":"W3191550608"},{"id":"paper-w2073065955","cat":"papers","name":"Effects of methylenedioxymethamphetamine on the release of monoamines from rat brain slices","year":"1990","cit":83,"pfa":"John FitzGerald","psa":"Julianne J. Reid","ptype":"article","src":"https://openalex.org/W2073065955","eid":"W2073065955"},{"id":"paper-w2007345302","cat":"papers","name":"Some behavioural and neurochemical aspects of subacute (±)3,4-methylenedioxymethamphetamine administration in rats","year":"1995","cit":83,"pfa":"Mairead Geraldine McNamara","psa":"B.E. Leonard","ptype":"article","src":"https://openalex.org/W2007345302","eid":"W2007345302"},{"id":"paper-w1985558029","cat":"papers","name":"A randomized prospective study of microdose leuprolide versus ganirelix in in vitro fertilization cycles for poor responders","year":"2005","cit":83,"pfa":"David W. Schmidt","psa":"JOHN C. NULSEN","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1985558029","eid":"W1985558029"},{"id":"paper-w2173415260","cat":"papers","name":"Chronic Microdose Lithium Treatment Prevented Memory Loss and Neurohistopathological Changes in a Transgenic Mouse Model of Alzheimer's Disease","year":"2015","cit":83,"pfa":"Marielza Andrade Nunes","psa":"Hudson Sousa Buck","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2173415260","eid":"W2173415260"},{"id":"paper-w1989675489","cat":"papers","name":"Low Dose Propofol as a Supplement to Ketamine-Based Anesthesia During Intraoperative Monitoring of Motor-Evoked Potentials","year":"2000","cit":83,"pfa":"Masahiko Kawaguchi","psa":"Toshisuke Sakaki","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1989675489","eid":"W1989675489"},{"id":"paper-w1546799762","cat":"papers","name":"Harwood-Nuss' Clinical Practice of Emergency Medicine","year":"2020","cit":83,"pfa":"Allan B. Wolfson","psa":"Ann L. Harwood-Nuss","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"other","src":"https://openalex.org/W1546799762","eid":"W1546799762"},{"id":"paper-w4200195182","cat":"papers","name":"REL-1017 (Esmethadone) as Adjunctive Treatment in Patients With Major Depressive Disorder: A Phase 2a Randomized Double-Blind Trial","year":"2021","cit":83,"pfa":"Maurizio Fava","psa":"Paolo L. Manfredi","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4200195182","eid":"W4200195182"},{"id":"paper-w2294681374","cat":"papers","name":"Neuropeptides and Electroconvulsive Treatment","year":"1999","cit":83,"pfa":"Aleksander A. Math�","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2294681374","eid":"W2294681374"},{"id":"paper-w20807347","cat":"papers","name":"Low Dose Ketamine as an Analgesic Adjuvant in Difficult Pain Syndromes","year":"2002","cit":83,"pfa":"Edward Fitzgibbon","psa":"Raymond Viola","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W20807347","eid":"W20807347"},{"id":"paper-w4379137386","cat":"papers","name":"Opioid-Free Versus Opioid-Based Anesthesia on Postoperative Pain After Thoracoscopic Surgery: The Use of Intravenous and Epidural Esketamine","year":"2023","cit":83,"pfa":"Huan Yan","psa":"Hao Wang","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4379137386","eid":"W4379137386"},{"id":"paper-w3169261903","cat":"papers","name":"Psilocybin and MDMA for the treatment of trauma-related psychopathology","year":"2021","cit":82,"pfa":"Catherine Bird","psa":"James Rucker","topics":["Depression","PTSD & trauma","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3169261903","eid":"W3169261903"},{"id":"paper-w3165049600","cat":"papers","name":"Return of the lysergamides. Part I: Analytical and behavioural characterization of 1‐propionyl‐d‐lysergic acid diethylamide (1P‐LSD)","year":"2015","cit":82,"pfa":"Simon D. Brandt","psa":"Adam L. Halberstadt","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3165049600","eid":"W3165049600"},{"id":"paper-w2025791640","cat":"papers","name":"Increasing Use of “Ecstasy“ (MDMA) and other Hallucinogens on a College Campus","year":"1994","cit":82,"pfa":"Michael J. Cuomo","psa":"Victoria M. Gammino","ptype":"article","src":"https://openalex.org/W2025791640","eid":"W2025791640"},{"id":"paper-w3107630502","cat":"papers","name":"Examining changes in personality following shamanic ceremonial use of ayahuasca","year":"2021","cit":82,"pfa":"Brandon Weiss","psa":"William Keith Campbell","ptype":"article","src":"https://openalex.org/W3107630502","eid":"W3107630502"},{"id":"paper-w2138520379","cat":"papers","name":"Multiple MDMA (Ecstasy) Overdoses at a Rave Event","year":"2012","cit":82,"pfa":"Patil Armenian","psa":"Kent R. Olson","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2138520379","eid":"W2138520379"},{"id":"paper-w1581024190","cat":"papers","name":"Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans","year":"2012","cit":82,"pfa":"C.M. Hysek","psa":"Matthias E. Liechti","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1581024190","eid":"W1581024190"},{"id":"paper-w2040452225","cat":"papers","name":"MDMA (“Ecstasy”) and panic disorder: Induction by a single dose","year":"1992","cit":82,"pfa":"Una D. McCann","psa":"George A. Ricaurte","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2040452225","eid":"W2040452225"},{"id":"paper-w4362457938","cat":"papers","name":"Psilocybin facilitates fear extinction in mice by promoting hippocampal neuroplasticity","year":"2023","cit":82,"pfa":"Yingjie Du","psa":"Guyan Wang","topics":["Depression","PTSD & trauma","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4362457938","eid":"W4362457938"},{"id":"paper-w2039278365","cat":"papers","name":"Evolution of the Toxins Muscarine and Psilocybin in a Family of Mushroom-Forming Fungi","year":"2013","cit":82,"pfa":"Pawel Z. Kosentka","psa":"P. Brandon Matheny","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2039278365","eid":"W2039278365"},{"id":"paper-w3007379062","cat":"papers","name":"Self-reported negative outcomes of psilocybin users: A quantitative textual analysis","year":"2020","cit":82,"pfa":"Bheatrix Bienemann","psa":"Daniel C. Mograbi","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3007379062","eid":"W3007379062"},{"id":"paper-w3171384877","cat":"papers","name":"Psychedelic perceptions: mental health service user attitudes to psilocybin therapy","year":"2021","cit":82,"pfa":"Kate Corrigan","psa":"John Richard Kelly","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3171384877","eid":"W3171384877"},{"id":"paper-w2155111399","cat":"papers","name":"Contribution of cannabis and MDMA (\"ecstasy\") to cognitive changes in long-term polydrug users","year":"2004","cit":82,"pfa":"Richard Ian Dafters","psa":"Annie Claire Talbot","ptype":"article","src":"https://openalex.org/W2155111399","eid":"W2155111399"},{"id":"paper-w2145617693","cat":"papers","name":"Inhibitory effect of salvinorin A, fromSalvia divinorum, on ileitis‐induced hypermotility: cross‐talk between κ‐opioid and cannabinoid CB1receptors","year":"2008","cit":82,"pfa":"Raffaele Capasso","psa":"Angelo Antonio Izzo","topics":["Addiction","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2145617693","eid":"W2145617693"},{"id":"paper-w2103077274","cat":"papers","name":"Reserpine attenuates d-amphetamine and MDMA-induced transmitter release in vivo: a consideration of dose, core temperature and dopamine synthesis","year":"1998","cit":82,"pfa":"Karen E. Sabol","psa":"Lewis S. Seiden","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2103077274","eid":"W2103077274"},{"id":"paper-w1984757417","cat":"papers","name":"Studies on the role of dopamine in the degeneration of 5‐HT nerve endings in the brain of Dark Agouti rats following 3,4‐methylenedioxymethamphetamine (MDMA or ‘ecstasy’) administration","year":"1999","cit":82,"pfa":"María Isabel Colado","psa":"A R Green","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1984757417","eid":"W1984757417"},{"id":"paper-w2038439189","cat":"papers","name":"Chiral separation and quantification of R/S-amphetamine, R/S-methamphetamine, R/S-MDA, R/S-MDMA, and R/S-MDEA in whole blood by GC-EI-MS","year":"2006","cit":82,"pfa":"Louise Nygaard Rasmussen","psa":"Sys Stybe Johansen","ptype":"article","src":"https://openalex.org/W2038439189","eid":"W2038439189"},{"id":"paper-w4311093363","cat":"papers","name":"Lower-dose psycholytic therapy – A neglected approach","year":"2022","cit":82,"pfa":"Torsten Passie","psa":"Rainer Krähenmann","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4311093363","eid":"W4311093363"},{"id":"paper-w1966305781","cat":"papers","name":"Antagonism of the neurotoxicity due to a single administration of methylenedioxymethamphetamine","year":"1990","cit":82,"pfa":"Christopher J. Schmidt","psa":"Vicki L. Taylor","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1966305781","eid":"W1966305781"},{"id":"paper-w4390755783","cat":"papers","name":"Antidepressant-like effects of psychedelics in a chronic despair mouse model: is the 5-HT2A receptor the unique player?","year":"2024","cit":82,"pfa":"Mehdi Sekssaoui","psa":"Carine Bécamel","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4390755783","eid":"W4390755783"},{"id":"paper-w3211842562","cat":"papers","name":"Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers","year":"2021","cit":82,"pfa":"Joseph M. Rootman","psa":"Zach Walsh","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3211842562","eid":"W3211842562"},{"id":"paper-w3008629222","cat":"papers","name":"Synthesis and Biological Evaluation of Tryptamines Found in Hallucinogenic Mushrooms: Norbaeocystin, Baeocystin, Norpsilocin, and Aeruginascin","year":"2020","cit":82,"pfa":"Alexander M. Sherwood","psa":"Poncho L. Meisenheimer","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3008629222","eid":"W3008629222"},{"id":"paper-w3201526264","cat":"papers","name":"From psychiatry to neurology: Psychedelics as prospective therapeutics for neurodegenerative disorders","year":"2021","cit":82,"pfa":"Urszula Kozłowska","psa":"Maciej Figiel","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3201526264","eid":"W3201526264"},{"id":"paper-w2107790890","cat":"papers","name":"Neurochemical neutralization of methamphetamine with high-affinity nonselective inhibitors of biogenic amine transporters: a pharmacological strategy for treating stimulant abuse","year":"2000","cit":82,"pfa":"Richard B. Rothman","psa":"Kenner C. Rice","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2107790890","eid":"W2107790890"},{"id":"paper-w2994899318","cat":"papers","name":"Chemsex drugs on the rise: a longitudinal analysis of the Swiss HIV Cohort Study from 2007 to 2017","year":"2019","cit":82,"pfa":"Benjamin Hampel","psa":"for the Swiss HIV Cohort Study group","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2994899318","eid":"W2994899318"},{"id":"paper-w2769208625","cat":"papers","name":"Pharmacokinetic, Ambulatory, and Hyperthermic Effects of 3,4-Methylenedioxy-N-Methylcathinone (Methylone) in Rats","year":"2017","cit":82,"pfa":"Kristýna Štefková","psa":"Tomáš Páleníček","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2769208625","eid":"W2769208625"},{"id":"paper-w2020550842","cat":"papers","name":"Development of sampling methods for Raman analysis of solid dosage forms of therapeutic and illicit drugs","year":"2004","cit":82,"pfa":"Steven E. J. Bell","psa":"S. James Speers","ptype":"article","src":"https://openalex.org/W2020550842","eid":"W2020550842"},{"id":"paper-w4319079931","cat":"papers","name":"A complex systems perspective on psychedelic brain action","year":"2023","cit":82,"pfa":"Manesh Girn","psa":"Robin Lester Carhart-Harris","ptype":"review","src":"https://openalex.org/W4319079931","eid":"W4319079931"},{"id":"paper-w3004910645","cat":"papers","name":"Perceived outcomes of psychedelic microdosing as self-managed therapies for mental and substance use disorders","year":"2020","cit":82,"pfa":"Toby Lea","psa":"Michael Klein","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3004910645","eid":"W3004910645"},{"id":"paper-w2969627127","cat":"papers","name":"Self-Rated Effectiveness of Microdosing With Psychedelics for Mental and Physical Health Problems Among Microdosers","year":"2019","cit":82,"pfa":"Nadia R. P. W. Hutten","psa":"Kim P. C. Kuypers","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2969627127","eid":"W2969627127"},{"id":"paper-w2413090853","cat":"papers","name":"NBOMe: new potent hallucinogens--pharmacology, analytical methods, toxicities, fatalities: a review.","year":"2015","cit":82,"pfa":"Chrystalla Kyriakou","psa":"Francesco Paolo Busardò","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2413090853","eid":"W2413090853"},{"id":"paper-w3136469907","cat":"papers","name":"Combining Psychedelic and Mindfulness Interventions: Synergies to Inform Clinical Practice","year":"2021","cit":82,"pfa":"Jake Payne","psa":"Paul Liknaitzky","ptype":"article","src":"https://openalex.org/W3136469907","eid":"W3136469907"},{"id":"paper-w2003987133","cat":"papers","name":"Hallucinogen, opiate, sedative and stimulant use and abuse in a population‐based sample of female twins","year":"1999","cit":82,"pfa":"Kenneth S. Kendler","psa":"Carol Arlene Prescott","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2003987133","eid":"W2003987133"},{"id":"paper-w4220656556","cat":"papers","name":"Effects of Naturalistic Psychedelic Use on Depression, Anxiety, and Well-Being: Associations With Patterns of Use, Reported Harms, and Transformative Mental States","year":"2022","cit":82,"pfa":"Charles L. Raison","psa":"Saundra Jain","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4220656556","eid":"W4220656556"},{"id":"paper-w2167487535","cat":"papers","name":"PSYCHOTOMIMETIC DRUGS AND BRAIN BIOGENIC AMINES","year":"1963","cit":82,"pfa":"Daniel X. Freedman","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2167487535","eid":"W2167487535"},{"id":"paper-w2104897662","cat":"papers","name":"Online drug user-led harm reduction in Hungary: a review of “Daath”","year":"2013","cit":82,"pfa":"Levente Móró","psa":"József Rácz","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2104897662","eid":"W2104897662"},{"id":"paper-w2038768143","cat":"papers","name":"Effects of chlorpromazine and phencyclidine on mouse C2 acetylcholine receptor kinetics.","year":"1986","cit":82,"pfa":"Jean Pierre Changeux","psa":"Angeles B. Ribera","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2038768143","eid":"W2038768143"},{"id":"paper-w2401986986","cat":"papers","name":"[Ketamine--dreams and realities].","year":"2002","cit":82,"pfa":"J Arditti","psa":"Marcelo Valli","topics":["Addiction","Safety & adverse events"],"ptype":"other","src":"https://openalex.org/W2401986986","eid":"W2401986986"},{"id":"paper-w4308540849","cat":"papers","name":"Pharmacological Aspects and Biological Effects of Cannabigerol and Its Synthetic Derivatives","year":"2022","cit":82,"pfa":"Fabrizio Calapai","psa":"Carmen Mannucci","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4308540849","eid":"W4308540849"},{"id":"paper-w2137228851","cat":"papers","name":"The tyrosine phosphatase STEP: implications in schizophrenia and the molecular mechanism underlying antipsychotic medications","year":"2012","cit":82,"pfa":"Nikisha Carty","psa":"Paul J. Lombroso","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2137228851","eid":"W2137228851"},{"id":"paper-w3095851663","cat":"papers","name":"Population Pharmacokinetics of Esketamine Nasal Spray and its Metabolite Noresketamine in Healthy Subjects and Patients with Treatment-Resistant Depression","year":"2020","cit":82,"pfa":"Carlos Pérez‐Ruixo","psa":"Juan José Pérez Ruixo","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3095851663","eid":"W3095851663"},{"id":"paper-w3106099120","cat":"papers","name":"Meaningful Change in Depression Symptoms Assessed with the Patient Health Questionnaire (PHQ-9) and Montgomery-Åsberg Depression Rating Scale (MADRS) Among Patients with Treatment Resistant Depression in Two, Randomized,","year":"2020","cit":82,"pfa":"Stacie A. Hudgens","psa":"Jaskaran B. Singh","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3106099120","eid":"W3106099120"},{"id":"paper-w2075347895","cat":"papers","name":"Phencyclidine, Lysergic Acid Diethylamide, and Mescaline: Cerebral Artery Spasms and Hallucinogenic Activity","year":"1981","cit":81,"pfa":"Bella T. Altura","psa":"Burton M. Altura","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2075347895","eid":"W2075347895"},{"id":"paper-w2101786356","cat":"papers","name":"LYSERGIC ACID DIETHYLAMIDE AND RELATED SUBSTANCES","year":"1957","cit":81,"pfa":"E Rothlin","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2101786356","eid":"W2101786356"},{"id":"paper-w2068199765","cat":"papers","name":"Further Studies in the Therapeutic Value of Lysergic Acid Diethylamide in Mental Illness","year":"1957","cit":81,"pfa":"R. A. Sandison","psa":"J. D. A. Whitelaw","ptype":"article","src":"https://openalex.org/W2068199765","eid":"W2068199765"},{"id":"paper-w3049002780","cat":"papers","name":"The iboga enigma: the chemistry and neuropharmacology of iboga alkaloids and related analogs","year":"2020","cit":81,"pfa":"Rishab N. Iyer","psa":"David E. Olson","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3049002780","eid":"W3049002780"},{"id":"paper-w1977009773","cat":"papers","name":"Peyote Constituents: Chemistry, Biogenesis, and Biological Effects","year":"1970","cit":81,"pfa":"Govind J. Kapadia","psa":"M. Fayez","ptype":"article","src":"https://openalex.org/W1977009773","eid":"W1977009773"},{"id":"paper-w2550626767","cat":"papers","name":"Potential Psychiatric Uses for MDMA","year":"2016","cit":81,"pfa":"BB Yazar‐Klosinski","psa":"MC Mithoefer","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2550626767","eid":"W2550626767"},{"id":"paper-w2012633810","cat":"papers","name":"MDMA (Ecstasy) precipitation of panic disorder","year":"1992","cit":81,"pfa":"Stefano Pallanti","psa":"Donatella Mazzi","ptype":"article","src":"https://openalex.org/W2012633810","eid":"W2012633810"},{"id":"paper-w1994144122","cat":"papers","name":"Toxicity of methylenedioxymethamphetamine (MDMA) in the dog and the rat","year":"1987","cit":81,"pfa":"Chris Frith","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1994144122","eid":"W1994144122"},{"id":"paper-w1982395591","cat":"papers","name":"Prospective memory impairment in “ecstasy” (MDMA) users","year":"2007","cit":81,"pfa":"Peter G. Rendell","psa":"Georgina Anne Tolan","ptype":"article","src":"https://openalex.org/W1982395591","eid":"W1982395591"},{"id":"paper-w2170263071","cat":"papers","name":"Pharmacological screen for activities of 12-hydroxyibogamine: a primary metabolite of the indole alkaloid ibogaine","year":"1996","cit":81,"pfa":"Julie K. Staley","psa":"Deborah C. Mash","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2170263071","eid":"W2170263071"},{"id":"paper-w2044704612","cat":"papers","name":"Effects of the hallucinogen psilocybin on habituation and prepulse inhibition of the startle reflex in humans","year":"1998","cit":81,"pfa":"Euphrosyne Gouzoulis‐Mayfrank","psa":"M.A. Geyer","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2044704612","eid":"W2044704612"},{"id":"paper-w2952887070","cat":"papers","name":"Salvinorin C, a New Neoclerodane Diterpene from a Bioactive Fraction of the Hallucinogenic Mexican Mint Salvia divinorum","year":"2001","cit":81,"pfa":"Leander J. Valdés","psa":"Masato Koreeda","ptype":"article","src":"https://openalex.org/W2952887070","eid":"W2952887070"},{"id":"paper-w2899976521","cat":"papers","name":"Ayahuasca improves emotion dysregulation in a community sample and in individuals with borderline-like traits","year":"2018","cit":81,"pfa":"Elisabet Domínguez‐Clavé","psa":"Jordi Riba","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2899976521","eid":"W2899976521"},{"id":"paper-w1994849988","cat":"papers","name":"Properties of ibogaine and its principal metabolite (12-hydroxyibogamine) at the MK-801 binding site of the NMDA receptor complex","year":"1995","cit":81,"pfa":"Deborah C. Mash","psa":"Robert A. Davidoff","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1994849988","eid":"W1994849988"},{"id":"paper-w2066750823","cat":"papers","name":"MDMA (“ecstasy”), methamphetamine and their combination: long-term changes in social interaction and neurochemistry in the rat","year":"2004","cit":81,"pfa":"Kelly J. Clemens","psa":"Iain S. McGregor","ptype":"article","src":"https://openalex.org/W2066750823","eid":"W2066750823"},{"id":"paper-w2031048604","cat":"papers","name":"Profiles of urine samples from participants at rave party in Taiwan: prevalence of ketamine and MDMA abuse","year":"2003","cit":81,"pfa":"Ahai Chang Lua","psa":"Pei Chi Yeh","ptype":"article","src":"https://openalex.org/W2031048604","eid":"W2031048604"},{"id":"paper-w2005311286","cat":"papers","name":"Chlormethiazole, dizocilpine and haloperidol prevent the degeneration of serotonergic nerve terminals induced by administration of MDMA ('Ecstasy') to rats","year":"1994","cit":81,"pfa":"K Hewitt","ptype":"article","src":"https://openalex.org/W2005311286","eid":"W2005311286"},{"id":"paper-w2041828918","cat":"papers","name":"Superoxide radicals mediate the biochemical effects of methylenedioxymethamphetamine (MDMA): Evidence from using CuZn‐superoxide dismutase transgenic mice","year":"1995","cit":81,"pfa":"Jean Lud Cadet","psa":"Timothy H. Moran","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2041828918","eid":"W2041828918"},{"id":"paper-w2032639288","cat":"papers","name":"Role of metabolites in MDMA (ecstasy)-induced nephrotoxicity: an in vitro study using rat and human renal proximal tubular cells","year":"2002","cit":81,"pfa":"M x E rcia Carvalho","psa":"Maria de Lourdes Bastos","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2032639288","eid":"W2032639288"},{"id":"paper-w3204478846","cat":"papers","name":"Novel antidepressant drugs: Beyond monoamine targets","year":"2021","cit":81,"pfa":"Xénia Gonda","psa":"Frank I. Tarazi","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3204478846","eid":"W3204478846"},{"id":"paper-w2005405042","cat":"papers","name":"Structure–activity relationships of serotonin 5‐HT2Aagonists","year":"2012","cit":81,"pfa":"David E. Nichols","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2005405042","eid":"W2005405042"},{"id":"paper-w2077264035","cat":"papers","name":"Enantiomeric differences in the effects of 3,4-methylenedioxymethamphetamine on extracellular monoamines and metabolites in the striatum of freely-moving rats: An in vivo microdialysis study","year":"1990","cit":81,"pfa":"Masayuki Hiramatsu","psa":"A.K. Cho","ptype":"article","src":"https://openalex.org/W2077264035","eid":"W2077264035"},{"id":"paper-w122113993","cat":"papers","name":"Hallucinogen-induced relief of obsessions and compulsions","year":"1997","cit":81,"pfa":"Francisco Moreno","psa":"Pedro L. Delgado","ptype":"article","src":"https://openalex.org/W122113993","eid":"W122113993"},{"id":"paper-w2112884745","cat":"papers","name":"Do hallucinogens cause residual neuropsychological toxicity?","year":"1999","cit":81,"pfa":"John H. Halpern","psa":"Harrison Graham Pope","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2112884745","eid":"W2112884745"},{"id":"paper-w2911748025","cat":"papers","name":"Delta-9-tetrahydrocannabinol increases striatal glutamate levels in healthy individuals: implications for psychosis","year":"2019","cit":81,"pfa":"Marco Colizzi","psa":"Sagnik Bhattacharyya","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2911748025","eid":"W2911748025"},{"id":"paper-w3007555931","cat":"papers","name":"NBOMes–Highly Potent and Toxic Alternatives of LSD","year":"2020","cit":81,"pfa":"Jolanta Barbara Zawilska","psa":"Piotr Adamowicz","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3007555931","eid":"W3007555931"},{"id":"paper-w2328465604","cat":"papers","name":"[18F]-Organotrifluoroborates as Radioprosthetic Groups for PET Imaging: From Design Principles to Preclinical Applications","year":"2016","cit":81,"pfa":"David M. Perrin","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2328465604","eid":"W2328465604"},{"id":"paper-w1976691026","cat":"papers","name":"Interaction of serotonin and lysergic acid diethylamide (LSD) in the central nervous system","year":"1955","cit":80,"pfa":"Parkhurst A. Shore","psa":"B.B. Brodie","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1976691026","eid":"W1976691026"},{"id":"paper-w159676469","cat":"papers","name":"Lysergic acid diethylamide (LSD) administration selectively downregulates serotonin2 receptors in rat brain.","year":"1990","cit":80,"pfa":"Neil S. Buckholtz","psa":"W Z Potter","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W159676469","eid":"W159676469"},{"id":"paper-w2043324949","cat":"papers","name":"Lysergic Acid Diethylamide (LSD 25): II. Psychobiological Effects on the Siamese Fighting Fish","year":"1954","cit":80,"pfa":"Harold A. Abramson","psa":"Llewellyn Thomas Evans","ptype":"article","src":"https://openalex.org/W2043324949","eid":"W2043324949"},{"id":"paper-w2325546109","cat":"papers","name":"Effects of LSD‐25, psilocybin, and psilocin on temporal lobe EEG patterns and learned behavior in the cat","year":"1962","cit":80,"pfa":"W. ROSS ADEY","psa":"Barbara J. Dennis","ptype":"article","src":"https://openalex.org/W2325546109","eid":"W2325546109"},{"id":"paper-w2127165654","cat":"papers","name":"The Paradox of 5-Methoxy-N,N-Dimethyltryptamine","year":"2000","cit":80,"pfa":"Jerrold C. Winter","psa":"R.A. Rabin","ptype":"article","src":"https://openalex.org/W2127165654","eid":"W2127165654"},{"id":"paper-w244488234","cat":"papers","name":"Ayahuasca, Ritual and Religion in Brazil","year":"2016","cit":80,"pfa":"Beatriz Caiuby Labate","psa":"Edward MacRae","topics":["Addiction","Dosing & pharmacology"],"ptype":"book","src":"https://openalex.org/W244488234","eid":"W244488234"},{"id":"paper-w2173531201","cat":"papers","name":"SAR of psilocybin analogs: Discovery of a selective 5-HT2C agonist","year":"2005","cit":80,"pfa":"Howard Sard","psa":"Louis Shuster","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2173531201","eid":"W2173531201"},{"id":"paper-w2567379065","cat":"papers","name":"Clinical potential of psilocybin as a treatment for mental health conditions","year":"2017","cit":80,"pfa":"Jeremy Daniel","psa":"Margaret Haberman","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2567379065","eid":"W2567379065"},{"id":"paper-w3175441262","cat":"papers","name":"Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals","year":"2021","cit":80,"pfa":"Drummond E-Wen McCulloch","psa":"Patrick M. Fisher","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3175441262","eid":"W3175441262"},{"id":"paper-w2889504249","cat":"papers","name":"More Realistic Forecasting of Future Life Events After Psilocybin for Treatment-Resistant Depression","year":"2018","cit":80,"pfa":"Taylor Lyons","psa":"Robin Lester Carhart-Harris","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2889504249","eid":"W2889504249"},{"id":"paper-w4361279088","cat":"papers","name":"Pilot study of single-dose psilocybin for serotonin reuptake inhibitor-resistant body dysmorphic disorder","year":"2023","cit":80,"pfa":"Franklin R. Schneier","psa":"David J. Hellerstein","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4361279088","eid":"W4361279088"},{"id":"paper-w2048124537","cat":"papers","name":"Psychiatric disorders in Ecstasy (MDMA) users: a literature review focusing on personal predisposition and drug history","year":"2001","cit":80,"pfa":"Kirstie Soar","psa":"Andrew C. Parrott","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2048124537","eid":"W2048124537"},{"id":"paper-w1973287358","cat":"papers","name":"Serotonin (1A) receptor involvement in acute 3,4-methylenedioxymethamphetamine (MDMA) facilitation of social interaction in the rat","year":"2005","cit":80,"pfa":"Kirsten C. Morley","psa":"Iain S. McGregor","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W1973287358","eid":"W1973287358"},{"id":"paper-w2090053829","cat":"papers","name":"Development of the sigma-1 receptor in C-terminals of motoneurons and colocalization with the N,N′-dimethyltryptamine forming enzyme, indole-N-methyl transferase","year":"2012","cit":80,"pfa":"Timur A. Mavlyutov","psa":"Arnold E. Ruoho","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2090053829","eid":"W2090053829"},{"id":"paper-w2162552498","cat":"papers","name":"An electrophysiological study of 5‐hydroxytryptamine receptors of neurones in the molluscan nervous system","year":"1966","cit":80,"pfa":"H. M. Gerschenfeld","psa":"E. Stefani","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2162552498","eid":"W2162552498"},{"id":"paper-w1999522127","cat":"papers","name":"Physiological and Subjective Responses to Controlled Oral 3,4-Methylenedioxymethamphetamine Administration","year":"2008","cit":80,"pfa":"Erin A Kolbrich","psa":"Marilyn Ann Huestis","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1999522127","eid":"W1999522127"},{"id":"paper-w2071397075","cat":"papers","name":"Simultaneous determination of amphetamine, methamphetamine, 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine in human hair by gas chromatography-mass spectrometry","year":"1995","cit":80,"pfa":"Pascal Kintz","psa":"Patrice J. Mangin","ptype":"article","src":"https://openalex.org/W2071397075","eid":"W2071397075"},{"id":"paper-w2024558546","cat":"papers","name":"Secondary Metabolites from Three Florida Sponges with Antidepressant Activity","year":"2008","cit":80,"pfa":"Anna J. Kochanowska","psa":"Mark T. Hamann","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2024558546","eid":"W2024558546"},{"id":"paper-w2998403265","cat":"papers","name":"Diversity, equity, and access in psychedelic medicine","year":"2019","cit":80,"pfa":"Monnica T. Williams","psa":"Beatriz Caiuby Labate","topics":["Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2998403265","eid":"W2998403265"},{"id":"paper-w2412997344","cat":"papers","name":"Absolute configuration and psychotomimetic activity.","year":"1978","cit":80,"pfa":"Gary Anderson","psa":"A T Shulgin","ptype":"article","src":"https://openalex.org/W2412997344","eid":"W2412997344"},{"id":"paper-w2140313848","cat":"papers","name":"Impairment of inhibitory control processing related to acute psychotomimetic effects of cannabis","year":"2014","cit":80,"pfa":"Sagnik Bhattacharyya","psa":"Philip K. McGuire","ptype":"article","src":"https://openalex.org/W2140313848","eid":"W2140313848"},{"id":"paper-w1981219005","cat":"papers","name":"Aripiprazole, an atypical antipsychotic, prevents the motor hyperactivity induced by psychotomimetics and psychostimulants in mice","year":"2007","cit":80,"pfa":"Juliana V. Leite","psa":"Fabrício A. Moreira","ptype":"article","src":"https://openalex.org/W1981219005","eid":"W1981219005"},{"id":"paper-w2065086912","cat":"papers","name":"Behavioral Studies of Hallucinogenic Drugs in Animals: Implications for Schizophrenia Research","year":"1998","cit":80,"pfa":"Mark A. Geyer","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2065086912","eid":"W2065086912"},{"id":"paper-w2279757001","cat":"papers","name":"Ketamine administration reduces amygdalo‐hippocampal reactivity to emotional stimulation","year":"2016","cit":80,"pfa":"Milan Scheidegger","psa":"Simone Grimm","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2279757001","eid":"W2279757001"},{"id":"paper-w2730146128","cat":"papers","name":"Ketamine for Depression, 3: Does Chirality Matter?","year":"2017","cit":80,"pfa":"Chittaranjan Andrade","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2730146128","eid":"W2730146128"},{"id":"paper-w2554276897","cat":"papers","name":"Risks Associated with Misuse of Ketamine as a Rapid-Acting Antidepressant","year":"2016","cit":80,"pfa":"Weili Zhu","psa":"Lin Lü","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2554276897","eid":"W2554276897"},{"id":"paper-w104163714","cat":"papers","name":"[Glutaminergic hypothesis of schizophrenia: clinical research studies with ketamine].","year":"2001","cit":80,"pfa":"Anwar Mechri","psa":"Lotfi Gaha","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W104163714","eid":"W104163714"},{"id":"paper-w2966435311","cat":"papers","name":"The influence of ketamine on drug discovery in depression","year":"2019","cit":80,"pfa":"Christoph Kraus","psa":"Carlos A. Zarate","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2966435311","eid":"W2966435311"},{"id":"paper-w2095577612","cat":"papers","name":"Effect of mescaline, lysergic acid diethylamide and psilocybin on color perception","year":"1963","cit":79,"pfa":"Alan M. Hartman","psa":"Leo E. Hollister","ptype":"article","src":"https://openalex.org/W2095577612","eid":"W2095577612"},{"id":"paper-w2000493240","cat":"papers","name":"Patterns of Tolerance to Lysergic Acid Diethylamide and Mescaline in Rats","year":"1958","cit":79,"pfa":"Daniel X. Freedman","psa":"Burton S. Rosner","ptype":"article","src":"https://openalex.org/W2000493240","eid":"W2000493240"},{"id":"paper-w2018604380","cat":"papers","name":"Lysergic Acid Diethylamide (LSD-25) as a Facilitating Agent in Psychotherapy","year":"1960","cit":79,"pfa":"ARTHUR L. CHANDLER","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2018604380","eid":"W2018604380"},{"id":"paper-w2221104206","cat":"papers","name":"Deconstructing Ecstasy: The Politics Of Mdma Research","year":"2000","cit":79,"pfa":"Charles S. Grob","ptype":"article","src":"https://openalex.org/W2221104206","eid":"W2221104206"},{"id":"paper-w2065337799","cat":"papers","name":"Ibogaine fails to reduce naloxone-precipitated withdrawal in the morphine-dependent rat","year":"1990","cit":79,"pfa":"Lawrence G. Sharpe","psa":"Jerome H. Jaffe","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2065337799","eid":"W2065337799"},{"id":"paper-w3205506305","cat":"papers","name":"Study Protocol for “Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study”","year":"2021","cit":79,"pfa":"Meg J. Spriggs","psa":"Robin Lester Carhart-Harris","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3205506305","eid":"W3205506305"},{"id":"paper-w2766061290","cat":"papers","name":"Well-being, problematic alcohol consumption and acute subjective drug effects in past-year ayahuasca users: a large, international, self-selecting online survey","year":"2017","cit":79,"pfa":"Will Lawn","psa":"Celia J. A. Morgan","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2766061290","eid":"W2766061290"},{"id":"paper-w1990342021","cat":"papers","name":"Diels-Alder adducts of 1-benzenesulfonylindole-2-acrylates and 1-(alkoxycarbonyl)-1,2-dihydropyridines. Intermediates for synthesis of iboga alkaloid analogs","year":"1981","cit":79,"pfa":"Richard J. Sundberg","psa":"Jonathan D. Bloom","ptype":"article","src":"https://openalex.org/W1990342021","eid":"W1990342021"},{"id":"paper-w3204735568","cat":"papers","name":"Low doses of LSD reduce broadband oscillatory power and modulate event-related potentials in healthy adults","year":"2021","cit":79,"pfa":"Conor H. Murray","psa":"Harriet de Wit","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3204735568","eid":"W3204735568"},{"id":"paper-w1562529961","cat":"papers","name":"3,4‐Methylenedioxymethamphetamine increases interleukin‐1β levels and activates microglia in rat brain: studies on the relationship with acute hyperthermia and 5‐HT depletion","year":"2004","cit":79,"pfa":"Laura Orío","psa":"M. Isabel Colado","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1562529961","eid":"W1562529961"},{"id":"paper-w2107985334","cat":"papers","name":"Serotonergic/glutamatergic interactions: the effects of mGlu 2/3 receptor ligands in rats trained with LSD and PCP as discriminative stimuli","year":"2004","cit":79,"pfa":"Jerrold C. Winter","psa":"R.A. Rabin","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2107985334","eid":"W2107985334"},{"id":"paper-w1973126788","cat":"papers","name":"The role of the sympathetic nervous system and uncoupling proteins in the thermogenesis induced by 3,4-methylenedioxymethamphetamine","year":"2004","cit":79,"pfa":"Edward Mills","psa":"Jon E. Sprague","ptype":"article","src":"https://openalex.org/W1973126788","eid":"W1973126788"},{"id":"paper-w2059793998","cat":"papers","name":"Platelet serotonin uptake sites increased in drinkers ofayahuasca","year":"1994","cit":79,"pfa":"J. C. Callaway","psa":"Charles S. Grob","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2059793998","eid":"W2059793998"},{"id":"paper-w1987657728","cat":"papers","name":"3,4-Methylenedioxymethamphetamine in Adult Rats Produces Deficits in Path Integration and Spatial Reference Memory","year":"2005","cit":79,"pfa":"Jessica A. Able","psa":"Michael T. Williams","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W1987657728","eid":"W1987657728"},{"id":"paper-w2094785538","cat":"papers","name":"Effects of 5-HT receptor agonists and antagonists on a reflex response to radiant heat in normal and spinally transected rats","year":"1982","cit":79,"pfa":"Odd‐Geir Berge","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2094785538","eid":"W2094785538"},{"id":"paper-w2054171656","cat":"papers","name":"A Review of the Usefulness of the Standard EEG in Psychiatry","year":"1996","cit":79,"pfa":"John Russell Hughes","topics":["Addiction","Anxiety & end-of-life","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2054171656","eid":"W2054171656"},{"id":"paper-w2991390907","cat":"papers","name":"Embedding existential psychology within psychedelic science: reduced death anxiety as a mediator of the therapeutic effects of psychedelics","year":"2019","cit":79,"pfa":"Sam G. Moreton","psa":"Andrew F. A. Arena","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2991390907","eid":"W2991390907"},{"id":"paper-w2116046167","cat":"papers","name":"Interindividual and interspecies variation in the metabolism of the hallucinogen 4-methoxyamphetamine","year":"1979","cit":79,"pfa":"Ian Kitchen","psa":"R. Tecwyn Williams","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2116046167","eid":"W2116046167"},{"id":"paper-w2900445331","cat":"papers","name":"The Varieties of the Psychedelic Experience: A Preliminary Study of the Association Between the Reported Subjective Effects and the Binding Affinity Profiles of Substituted Phenethylamines and Tryptamines","year":"2018","cit":79,"pfa":"Federico Zamberlán","psa":"Enzo Tagliazucchi","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2900445331","eid":"W2900445331"},{"id":"paper-w2086263362","cat":"papers","name":"Microdose gonadotropin-releasing hormone agonist flare-up protocol versus multiple dose gonadotropin-releasing hormone antagonist protocol in poor responders undergoing intracytoplasmic sperm injection–embryo transfer cy","year":"2008","cit":79,"pfa":"Korhan Kahraman","psa":"Hakan Şatıroğlu","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2086263362","eid":"W2086263362"},{"id":"paper-w2129986289","cat":"papers","name":"Differential Drug Use Patterns Among Sexually Abused Adolescent Girls in Treatment for Chemical Dependency","year":"1989","cit":79,"pfa":"Patricia Ann Harrison","psa":"Glenace E. Ed wall","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2129986289","eid":"W2129986289"},{"id":"paper-w2074999964","cat":"papers","name":"College student use of Salvia divinorum","year":"2008","cit":79,"pfa":"James E. Lange","psa":"John D. Clapp","ptype":"article","src":"https://openalex.org/W2074999964","eid":"W2074999964"},{"id":"paper-w2044659508","cat":"papers","name":"Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands","year":"2014","cit":79,"pfa":"Mellar P. Davis","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2044659508","eid":"W2044659508"},{"id":"paper-w2112559593","cat":"papers","name":"Rapid-acting antidepressant strategies: mechanisms of action","year":"2011","cit":79,"pfa":"Blynn G. Bunney","psa":"William Edward Bunney","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2112559593","eid":"W2112559593"},{"id":"paper-w2982430136","cat":"papers","name":"Efficacy and safety of intranasal esketamine for the treatment of major depressive disorder","year":"2019","cit":79,"pfa":"Joanna Kryst","psa":"Andrzej Pilc","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2982430136","eid":"W2982430136"},{"id":"paper-w4223540845","cat":"papers","name":"Esketamine alleviates postoperative depression-like behavior through anti-inflammatory actions in mouse prefrontal cortex","year":"2022","cit":79,"pfa":"Tianyuan Wang","psa":"Yalan Li","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4223540845","eid":"W4223540845"},{"id":"paper-w2573419808","cat":"papers","name":"Investigational drugs in recent clinical trials for treatment-resistant depression","year":"2017","cit":79,"pfa":"Ricardo Pablo Garay","psa":"Pierre‐Michel Llorca","topics":["Depression","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2573419808","eid":"W2573419808"},{"id":"paper-w2089084925","cat":"papers","name":"Radioligand-binding study of noribogaine, a likely metabolite of ibogaine","year":"1995","cit":78,"pfa":"Sandra M. Pearl","psa":"Stanley D. Glick","ptype":"article","src":"https://openalex.org/W2089084925","eid":"W2089084925"},{"id":"paper-w2016210950","cat":"papers","name":"Relationships of psychotomimetic to anti-serotonin potencies of congeners of lysergic acid diethylamide (LSD-25)","year":"1959","cit":78,"pfa":"Harris Isbell","psa":"C. R. Logan","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2016210950","eid":"W2016210950"},{"id":"paper-w2118033121","cat":"papers","name":"Hypotheses Regarding the Mechanisms of Ayahuasca in the Treatment of Addictions","year":"2012","cit":78,"pfa":"Mitchell B. Liester","psa":"James I. Prickett","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2118033121","eid":"W2118033121"},{"id":"paper-w359263171","cat":"papers","name":"Psilocybin mushrooms of the world: an identification guide","year":"1997","cit":78,"ptype":"book-review","src":"https://openalex.org/W359263171","eid":"W359263171"},{"id":"paper-w2005483474","cat":"papers","name":"MDMA effects consistent across laboratories","year":"2014","cit":78,"pfa":"Matthew G. Kirkpatrick","psa":"Harriet de Wit","ptype":"article","src":"https://openalex.org/W2005483474","eid":"W2005483474"},{"id":"paper-w2950747661","cat":"papers","name":"Replication and extension of a model predicting response to psilocybin","year":"2019","cit":78,"pfa":"Suzanne L. Russ","psa":"Melody S. Elliott","ptype":"article","src":"https://openalex.org/W2950747661","eid":"W2950747661"},{"id":"paper-w2769818061","cat":"papers","name":"Progress and promise for the MDMA drug development program","year":"2017","cit":78,"pfa":"Allison A. Feduccia","psa":"Michael C. Mithoefer","ptype":"article","src":"https://openalex.org/W2769818061","eid":"W2769818061"},{"id":"paper-w3127352965","cat":"papers","name":"Neural and subjective effects of inhaled N,N-dimethyltryptamine in natural settings","year":"2021","cit":78,"pfa":"Carla Pallavicini","psa":"Enzo Tagliazucchi","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3127352965","eid":"W3127352965"},{"id":"paper-w2001289498","cat":"papers","name":"Chronic atypical psychosis associated with MDMA (\"ecstasy\") abuse","year":"1991","cit":78,"pfa":"Fabrizio Schifano","ptype":"article","src":"https://openalex.org/W2001289498","eid":"W2001289498"},{"id":"paper-w2553852565","cat":"papers","name":"Biosynthesis of the psychotropic plant diterpene salvinorin A: Discovery and characterization of the Salvia divinorum clerodienyl diphosphate synthase","year":"2016","cit":78,"pfa":"Kyle A. Pelot","psa":"Philipp Zerbe","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2553852565","eid":"W2553852565"},{"id":"paper-w2075919620","cat":"papers","name":"Kappa-opioid receptor-mediated effects of the plant-derived hallucinogen, salvinorin A, on inverted screen performance in the mouse","year":"2005","cit":78,"pfa":"William E. Fantegrossi","psa":"James Henry Woods","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2075919620","eid":"W2075919620"},{"id":"paper-w2901877120","cat":"papers","name":"An exploratory study of experiences with conventional eating disorder treatment and ceremonial ayahuasca for the healing of eating disorders","year":"2018","cit":78,"pfa":"Marika Renelli","psa":"Adèle Lafrance","ptype":"article","src":"https://openalex.org/W2901877120","eid":"W2901877120"},{"id":"paper-w1991339455","cat":"papers","name":"MDMA (`Ecstasy') enhances 5-HT1A receptor density and 8-OH-DPAT-induced hypothermia: blockade by drugs preventing 5-hydroxytryptamine depletion","year":"1998","cit":78,"pfa":"Norberto Aguirre","psa":"Joaquı́n Del Rı́o","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1991339455","eid":"W1991339455"},{"id":"paper-w4309832620","cat":"papers","name":"Exploratory investigation of a patient‐informed low‐dose psilocybin pulse regimen in the suppression of cluster headache: Results from a randomized, double‐blind, placebo‐controlled trial","year":"2022","cit":78,"pfa":"Emmanuelle A. D. Schindler","psa":"Deepak Cyril D’Souza","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4309832620","eid":"W4309832620"},{"id":"paper-w2150839665","cat":"papers","name":"The effects of psychotomimetic drugs on primary suggestibility","year":"1965","cit":78,"pfa":"Bernard M. Sjoberg","psa":"Leo E. Hollister","ptype":"article","src":"https://openalex.org/W2150839665","eid":"W2150839665"},{"id":"paper-w1981905546","cat":"papers","name":"Coma, Hyperthermia, and Bleeding Associated with Massive LSD Overdose a Report of Eight Cases","year":"1975","cit":78,"pfa":"John Klock","psa":"Charles E. Becker","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1981905546","eid":"W1981905546"},{"id":"paper-w2074491668","cat":"papers","name":"Role of Gq protein in behavioral effects of the hallucinogenic drug 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane","year":"2007","cit":78,"pfa":"Efrain E. Garcia","psa":"Elaine Sanders‐Bush","ptype":"article","src":"https://openalex.org/W2074491668","eid":"W2074491668"},{"id":"paper-w1934698545","cat":"papers","name":"3,4-Methylenedioxymethamphetamine, serotonin and memory.","year":"1993","cit":78,"pfa":"G.A. Ricaurte","psa":"D.S. Olton","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1934698545","eid":"W1934698545"},{"id":"paper-w3157608139","cat":"papers","name":"Whitewashing psychedelics: racial equity in the emerging field of psychedelic-assisted mental health research and treatment","year":"2021","cit":78,"pfa":"Johannes Thrul","psa":"Albert Garcia‐Romeu","ptype":"editorial","src":"https://openalex.org/W3157608139","eid":"W3157608139"},{"id":"paper-w3007315114","cat":"papers","name":"Microdosing psychedelics: Demographics, practices, and psychiatric comorbidities","year":"2020","cit":78,"pfa":"Daniel Rosenbaum","psa":"Emma Hapke","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3007315114","eid":"W3007315114"},{"id":"paper-w2031832463","cat":"papers","name":"Effects ofPsilocybe argentipeson Marble-Burying Behavior in Mice","year":"2009","cit":78,"pfa":"Yoshihiro Matsushima","psa":"Fumio Eguchi","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2031832463","eid":"W2031832463"},{"id":"paper-w2018132456","cat":"papers","name":"Various Alkaloid Profiles in Decoctions of Banisteriopsis Caapi","year":"2005","cit":78,"pfa":"J. C. Callaway","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2018132456","eid":"W2018132456"},{"id":"paper-w1966130297","cat":"papers","name":"The neurotoxicity of amphetamines during the adolescent period","year":"2014","cit":78,"pfa":"A. Gomes","psa":"João Paulo Capela","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1966130297","eid":"W1966130297"},{"id":"paper-w1987051299","cat":"papers","name":"A PSYCHO-PHARMACOLOGICAL ANALYSIS OF BEHAVIOUR IN RATS","year":"1971","cit":78,"pfa":"B.D. Gupta","psa":"M.L. GUPTA","topics":["Depression","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W1987051299","eid":"W1987051299"},{"id":"paper-w1539046970","cat":"papers","name":"Species‐scanning mutagenesis of the serotonin transporter reveals residues essential in selective, high‐affinity recognition of antidepressants","year":"2001","cit":78,"pfa":"Ole Valente Mortensen","psa":"Ove Wiborg","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1539046970","eid":"W1539046970"},{"id":"paper-w635741393","cat":"papers","name":"Visionary vine : psychedelic healing in the Peruvian Amazon","year":"1972","cit":78,"pfa":"Marlene Dobkin de Ríos","ptype":"book","src":"https://openalex.org/W635741393","eid":"W635741393"},{"id":"paper-w4220776312","cat":"papers","name":"A Single Belief-Changing Psychedelic Experience Is Associated With Increased Attribution of Consciousness to Living and Non-living Entities","year":"2022","cit":78,"pfa":"Sandeep Manel Nayak","psa":"Roland R. Griffiths","ptype":"article","src":"https://openalex.org/W4220776312","eid":"W4220776312"},{"id":"paper-w2112854905","cat":"papers","name":"The generalizability of the dependence syndrome across substances: an examination of some properties of the proposed DSM‐IV dependence criteria","year":"1994","cit":78,"pfa":"Jon Morgenstern","psa":"Erich W. Labouvie","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2112854905","eid":"W2112854905"},{"id":"paper-w2010879984","cat":"papers","name":"Use patterns and self-reported effects of Salvia divinorum: An internet-based survey","year":"2010","cit":78,"pfa":"Matthew J. Baggott","psa":"John E. Mendelson","ptype":"article","src":"https://openalex.org/W2010879984","eid":"W2010879984"},{"id":"paper-w2025404618","cat":"papers","name":"Illicit Drug use and Dependence in a New Zealand Birth Cohort","year":"2006","cit":78,"pfa":"Joseph M. Boden","psa":"L. John Horwood","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2025404618","eid":"W2025404618"},{"id":"paper-w2022064606","cat":"papers","name":"Measures of Substance Consumption Among Substance Users, DSM-IV Abusers, and Those With DSM-IV Dependence Disorders in a Nationally Representative Sample","year":"2012","cit":78,"pfa":"Howard B. Moss","psa":"Hsiao‐ye Yi","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2022064606","eid":"W2022064606"},{"id":"paper-w1918174127","cat":"papers","name":"Novel Δ9‐tetrahydrocannabinol formulation Namisol® has beneficial pharmacokinetics and promising pharmacodynamic effects","year":"2012","cit":78,"pfa":"Linda E. Klumpers","psa":"Joop van Gerven","topics":["Anxiety & end-of-life","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1918174127","eid":"W1918174127"},{"id":"paper-w1988987102","cat":"papers","name":"A behavioral and molecular analysis of ketamine in zebrafish","year":"2010","cit":78,"pfa":"Sherry M. Zakhary","psa":"German Torres","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1988987102","eid":"W1988987102"},{"id":"paper-w3080908622","cat":"papers","name":"Pharmacokinetics of ketamine and its major metabolites norketamine, hydroxynorketamine, and dehydronorketamine: a model-based analysis","year":"2020","cit":78,"pfa":"Jasper Kamp","psa":"Erik Olofsen","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3080908622","eid":"W3080908622"},{"id":"paper-w4384153740","cat":"papers","name":"Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial","year":"2023","cit":78,"pfa":"Colleen K A Loo","psa":"Anthony J. Rodgers","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4384153740","eid":"W4384153740"},{"id":"paper-w1991480577","cat":"papers","name":"Gas chromatographic analysis of dimethyltryptamine and β‐carboline alkaloids in ayahuasca, an amazonian psychoactive plant beverage","year":"2009","cit":77,"pfa":"Ana Paula Salum Pires","psa":"Maurı́cio Yonamine","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1991480577","eid":"W1991480577"},{"id":"paper-w135677869","cat":"papers","name":"The Detection of Psilocin in Human Urine","year":"2001","cit":77,"pfa":"Alison Grieshaber","psa":"BARRY S. LEVINE","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W135677869","eid":"W135677869"},{"id":"paper-w2110642016","cat":"papers","name":"ECSTACY: A Review of MDMA and MDA","year":"1987","cit":77,"pfa":"Robert P. Climko","psa":"Jamil Al-Razi","topics":["Addiction","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2110642016","eid":"W2110642016"},{"id":"paper-w2794077792","cat":"papers","name":"A review of salvinorin analogs and their kappa-opioid receptor activity","year":"2018","cit":77,"pfa":"Jeremy J. Roach","psa":"Ryan A. Shenvi","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2794077792","eid":"W2794077792"},{"id":"paper-w2162013081","cat":"papers","name":"Dance Clubbing on MDMA and during Abstinence from Ecstasy/MDMA: Prospective Neuroendocrine and Psychobiological Changes","year":"2008","cit":77,"pfa":"Andrew C. Parrott","psa":"Johannes Thome","ptype":"article","src":"https://openalex.org/W2162013081","eid":"W2162013081"},{"id":"paper-w4321377299","cat":"papers","name":"Acute psilocybin enhances cognitive flexibility in rats","year":"2023","cit":77,"pfa":"Alejandro Torrado Pacheco","psa":"Bita Moghaddam","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4321377299","eid":"W4321377299"},{"id":"paper-w2139748231","cat":"papers","name":"Psilocybin Mushroom ( Psilocybe semilanceata ) Intoxication with Myocardial Infarction","year":"1998","cit":77,"pfa":"Krzysztof S. Borowiak","psa":"Piotr Waloszczyk","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2139748231","eid":"W2139748231"},{"id":"paper-w2086420493","cat":"papers","name":"Excitotoxic insult due to ibogaine leads to delayed induction of neuronal NOS in Purkinje cells","year":"1995","cit":77,"pfa":"Elizabeth O’Hearn","psa":"M.E. Molliver","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2086420493","eid":"W2086420493"},{"id":"paper-w3111293057","cat":"papers","name":"Influence of Context and Setting on the Mental Health and Wellbeing Outcomes of Ayahuasca Drinkers: Results of a Large International Survey","year":"2021","cit":77,"pfa":"Daniel Perkins","psa":"Jerome J. Sarris","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3111293057","eid":"W3111293057"},{"id":"paper-w2021632386","cat":"papers","name":"Effects of repeated doses of MDMA (“Ecstasy”) on cell-mediated immune response in humans","year":"2001","cit":77,"pfa":"Roberta Pacifici","psa":"Rafael de la Torre","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2021632386","eid":"W2021632386"},{"id":"paper-w2122117464","cat":"papers","name":"Symptoms of anxiety and depression in childhood and use of MDMA: prospective, population based study","year":"2006","cit":77,"pfa":"Anja C. Huizink","psa":"Frank C. Verhulst","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2122117464","eid":"W2122117464"},{"id":"paper-w34984478","cat":"papers","name":"Ecstasy (MDMA) Deaths in New York City: A Case Series and Review of the Literature","year":"2002","cit":77,"pfa":"James R. Gill","psa":"Marina Stajić","topics":["PTSD & trauma","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W34984478","eid":"W34984478"},{"id":"paper-w2152580730","cat":"papers","name":"Neurobehavioral outcomes of infants exposed to MDMA (Ecstasy) and other recreational drugs during pregnancy","year":"2012","cit":77,"pfa":"Lynn T. Singer","psa":"Andrew C. Parrott","ptype":"article","src":"https://openalex.org/W2152580730","eid":"W2152580730"},{"id":"paper-w2098659673","cat":"papers","name":"Psychological profile of abstinent recreational Ecstasy (MDMA) users and significance of concomitant cannabis use","year":"2001","cit":77,"pfa":"Jörg Daumann","psa":"Euphrosyne Gouzoulis‐Mayfrank","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2098659673","eid":"W2098659673"},{"id":"paper-w2045749418","cat":"papers","name":"Qualitative Review of Serotonin Syndrome, Ecstasy (MDMA) and the use of Other Serotonergic Substances: Hierarchy of Risk","year":"2007","cit":77,"pfa":"Edmund Silins","psa":"Paul Dillon","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2045749418","eid":"W2045749418"},{"id":"paper-w2137292290","cat":"papers","name":"The effect of 3,4‐methylenedioxymethamphetamine (MDMA, ?ecstasy?) and its metabolites on neurohypophysial hormone release from the isolated rat hypothalamus","year":"2002","cit":77,"pfa":"Mary L. Forsling","psa":"Andrew J. Hutt","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2137292290","eid":"W2137292290"},{"id":"paper-w2018597152","cat":"papers","name":"Headspace sampling and detection of cocaine, MDMA, and marijuana via volatile markers in the presence of potential interferences by solid phase microextraction–ion mobility spectrometry (SPME-IMS)","year":"2008","cit":77,"pfa":"Hanh Lai","psa":"José R. Almirall","ptype":"article","src":"https://openalex.org/W2018597152","eid":"W2018597152"},{"id":"paper-w4390628394","cat":"papers","name":"The Psychedelic Future of Post-Traumatic Stress Disorder Treatment","year":"2024","cit":77,"pfa":"Tamar Glatman Zaretsky","psa":"Rachel Yehuda","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4390628394","eid":"W4390628394"},{"id":"paper-w2135562277","cat":"papers","name":"Hallucinogenic mushrooms on the German market — simple instructions for examination and identification","year":"2000","cit":77,"pfa":"Frank Mußhoff","psa":"J. Beike","ptype":"article","src":"https://openalex.org/W2135562277","eid":"W2135562277"},{"id":"paper-w2059689375","cat":"papers","name":"Cueing effects of amphetamine and LSD: Elicitation by direct microinjection of the drugs into the nucleus accumbens","year":"1986","cit":77,"pfa":"Erik B. Nielsen","psa":"Jørgen Scheel‐Krüger","ptype":"article","src":"https://openalex.org/W2059689375","eid":"W2059689375"},{"id":"paper-w2049141885","cat":"papers","name":"Pathological Findings in 2 Cases of Fatal 25I-NBOMe Toxicity","year":"2014","cit":77,"pfa":"Jeffrey P. Walterscheid","psa":"Luis A. Sanchez","topics":["Safety & adverse events","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2049141885","eid":"W2049141885"},{"id":"paper-w2028853329","cat":"papers","name":"Tolerance to 3,4-methylenedioxymethamphetamine in rats exposed to single high-dose binges","year":"2008","cit":77,"pfa":"Michael H. Baumann","psa":"RB Rothman","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2028853329","eid":"W2028853329"},{"id":"paper-w2158719307","cat":"papers","name":"Studies, using in vivo microdialysis, on the effect of the dopamine uptake inhibitor GBR 12909 on 3,4‐methylenedioxymethamphetamine (‘ecstasy’)‐induced dopamine release and free radical formation in the mouse striatum","year":"2002","cit":77,"pfa":"Jorge Camarero","psa":"María Isabel Colado","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2158719307","eid":"W2158719307"},{"id":"paper-w2065619339","cat":"papers","name":"Effect of acute monoamine depletion on 3,4-methylenedioxymethamphetamine-induced neurotoxicity","year":"1993","cit":77,"pfa":"Jesse D Brodkin","psa":"J. Frank Nash","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2065619339","eid":"W2065619339"},{"id":"paper-w1984540221","cat":"papers","name":"Methylenedioxymethamphetamine depresses glutamate-evoked neuronal firing and increases extracellular levels of dopamine and serotonin in the nucleus accumbens in vivo","year":"1994","cit":77,"pfa":"S.R. White","psa":"Peter W. Kalivas","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1984540221","eid":"W1984540221"},{"id":"paper-w2009584249","cat":"papers","name":"Metabolism Is Required for the Expression of Ecstasy-Induced Cardiotoxicity in Vitro","year":"2004","cit":77,"pfa":"Márcia C. Carvalho","psa":"Maria de Lourdes Bastos","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2009584249","eid":"W2009584249"},{"id":"paper-w2138930549","cat":"papers","name":"DOM (STP), a New Hallucinogenic Drug, and DOET: Effects in Normal Subjects","year":"1968","cit":77,"pfa":"Solomon H. Snyder","psa":"Herbert Weingartner","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2138930549","eid":"W2138930549"},{"id":"paper-w2163648720","cat":"papers","name":"Foxy, a Designer Tryptamine Hallucinogen*","year":"2003","cit":77,"pfa":"Robert C. Meatherall","psa":"Pankaj Kumar Sharma","ptype":"article","src":"https://openalex.org/W2163648720","eid":"W2163648720"},{"id":"paper-w2003030192","cat":"papers","name":"Millet response to microdose fertilization in south–western Niger: Effect of antecedent fertility management and environmental factors","year":"2014","cit":77,"pfa":"Charles Louis Bielders","psa":"Bruno G. Gerard","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2003030192","eid":"W2003030192"},{"id":"paper-w3134098691","cat":"papers","name":"Clinical and biological predictors of psychedelic response in the treatment of psychiatric and addictive disorders: A systematic review","year":"2021","cit":77,"pfa":"Bruno Roméo","psa":"Amine Benyamina","topics":["Addiction","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W3134098691","eid":"W3134098691"},{"id":"paper-w2964957485","cat":"papers","name":"Transitioning Hospitalized Patients with Opioid Use Disorder from Methadone to Buprenorphine without a Period of Opioid Abstinence Using a Microdosing Protocol","year":"2019","cit":77,"pfa":"Dale Terasaki","psa":"Susan L. Calcaterra","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2964957485","eid":"W2964957485"},{"id":"paper-w4220945184","cat":"papers","name":"Buprenorphine initiation strategies for opioid use disorder and pain management: A systematic review","year":"2022","cit":77,"pfa":"Lauren A. Spreen","psa":"Michael Anthony Smith","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W4220945184","eid":"W4220945184"},{"id":"paper-w2484882115","cat":"papers","name":"Narcotic Antagonists as Analgesics","year":"1964","cit":77,"pfa":"Arthur S. Keats","psa":"Jane Telford","topics":["Depression","Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W2484882115","eid":"W2484882115"},{"id":"paper-w2626989920","cat":"papers","name":"Harmine produces antidepressant-like effects via restoration of astrocytic functions","year":"2017","cit":77,"pfa":"Fengguo Liu","psa":"Chao Huang","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2626989920","eid":"W2626989920"},{"id":"paper-w2000946580","cat":"papers","name":"Response of central monoaminergic neurons to lisuride: Comparison with LSD","year":"1979","cit":77,"pfa":"Michael A. Rogawski","psa":"George K. Aghajanian","ptype":"article","src":"https://openalex.org/W2000946580","eid":"W2000946580"},{"id":"paper-w2160011621","cat":"papers","name":"Pharmacological Properties of Glutamatergic Drugs Targeting NMDA Receptors and their Application in Major Depression","year":"2013","cit":77,"pfa":"Gianluca Serafini","psa":"Paolo Girardi","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2160011621","eid":"W2160011621"},{"id":"paper-w4315928736","cat":"papers","name":"Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine in bipolar versus unipolar treatment‐resistant depression","year":"2023","cit":77,"pfa":"Giovanni Martinotti","psa":"the REAL‐ESK Study Group","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4315928736","eid":"W4315928736"},{"id":"paper-w2161119575","cat":"papers","name":"The natural hallucinogen 5-MeO-DMT, component of Ayahuasca, disrupts cortical function in rats: reversal by antipsychotic drugs","year":"2014","cit":76,"pfa":"Maurizio S. Riga","psa":"Pau Celada","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2161119575","eid":"W2161119575"},{"id":"paper-w1990666634","cat":"papers","name":"Mental changes experimentally produced by L. S. D. (d-Lysergic acid diethylamide tartrate)","year":"1952","cit":76,"pfa":"H. Jackson Deshon","psa":"Harry C. Solomon","ptype":"article","src":"https://openalex.org/W1990666634","eid":"W1990666634"},{"id":"paper-w2251369525","cat":"papers","name":"How toxic is ibogaine?","year":"2016","cit":76,"pfa":"Ruud P. W. Litjens","psa":"Tibor M. Brunt","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2251369525","eid":"W2251369525"},{"id":"paper-w2128356296","cat":"papers","name":"Acquired and Crossed Tolerance to Mescaline, LSD-25, and BOL-148","year":"1959","cit":76,"pfa":"Antonio Balestrieri","ptype":"article","src":"https://openalex.org/W2128356296","eid":"W2128356296"},{"id":"paper-w2044222328","cat":"papers","name":"In vivo metabolism of 5-methoxy-N, N-dimethyltryptamine and N,N-dimethyltryptamine in the rat","year":"1987","cit":76,"pfa":"Balvant R. Sitaram","psa":"W. R. McLeod","ptype":"article","src":"https://openalex.org/W2044222328","eid":"W2044222328"},{"id":"paper-w1965689912","cat":"papers","name":"Evaluation of the transport, in vitro metabolism and pharmacokinetics of Salvinorin A, a potent hallucinogen","year":"2009","cit":76,"pfa":"Zeynep Şafak Teksin","psa":"Natalie D. Eddington","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1965689912","eid":"W1965689912"},{"id":"paper-w2120122043","cat":"papers","name":"Salvinorin A: Allosteric Interactions at the μ-Opioid Receptor","year":"2006","cit":76,"pfa":"Richard B. Rothman","psa":"Thomas Edward Prisinzano","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2120122043","eid":"W2120122043"},{"id":"paper-w2736157036","cat":"papers","name":"Pursuit of Ecstasy: The MDMA Experience","year":"1994","cit":76,"pfa":"Clark R. McCauley","ptype":"book-review","src":"https://openalex.org/W2736157036","eid":"W2736157036"},{"id":"paper-w2071107645","cat":"papers","name":"Relevance of rodent models of intravenous MDMA self-administration to human MDMA consumption patterns","year":"2006","cit":76,"pfa":"Richard De La Garza","psa":"Amita Jain Gupta","ptype":"article","src":"https://openalex.org/W2071107645","eid":"W2071107645"},{"id":"paper-w4390615514","cat":"papers","name":"Magnesium–ibogaine therapy in veterans with traumatic brain injuries","year":"2024","cit":76,"pfa":"Kirsten N. Cherian","psa":"Nolan Williams","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4390615514","eid":"W4390615514"},{"id":"paper-w4214511680","cat":"papers","name":"The therapeutic potential of psilocybin: a systematic review","year":"2022","cit":76,"pfa":"Jan van Amsterdam","psa":"Wim van den Brink","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W4214511680","eid":"W4214511680"},{"id":"paper-w2115241864","cat":"papers","name":"MDMA: Interactions with other psychoactive drugs","year":"2011","cit":76,"pfa":"Wael M.Y. Mohamed","psa":"Byron C. Jones","ptype":"article","src":"https://openalex.org/W2115241864","eid":"W2115241864"},{"id":"paper-w2914190175","cat":"papers","name":"Ayahuasca and Public Health: Health Status, Psychosocial Well-Being, Lifestyle, and Coping Strategies in a Large Sample of Ritual Ayahuasca Users","year":"2019","cit":76,"pfa":"Genís Oña","psa":"José Carlos Bouso","ptype":"article","src":"https://openalex.org/W2914190175","eid":"W2914190175"},{"id":"paper-w2122806567","cat":"papers","name":"Daytime Ayahuasca administration modulates REM and slow-wave sleep in healthy volunteers","year":"2007","cit":76,"pfa":"Manel J. Barbanoj","psa":"Sergio Romero","ptype":"article","src":"https://openalex.org/W2122806567","eid":"W2122806567"},{"id":"paper-w2082682583","cat":"papers","name":"Verbal working memory deficits in current and previous users of MDMA","year":"2004","cit":76,"pfa":"Michelle Wareing","psa":"Catharine Montgomery","ptype":"article","src":"https://openalex.org/W2082682583","eid":"W2082682583"},{"id":"paper-w1872197089","cat":"papers","name":"Salvinorin-A Induces Intense Dissociative Effects, Blocking External Sensory Perception and Modulating Interoception and Sense of Body Ownership in Humans","year":"2015","cit":76,"pfa":"Ana Elda Maqueda","psa":"Jordi Riba","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1872197089","eid":"W1872197089"},{"id":"paper-w2101748932","cat":"papers","name":"Structure‐Activity Relationships of MDMA and Related Compounds: A New Class of Psychoactive Drugs?a","year":"1990","cit":76,"pfa":"David E. Nichols","psa":"Robert A. Oberlender","ptype":"article","src":"https://openalex.org/W2101748932","eid":"W2101748932"},{"id":"paper-w2025725402","cat":"papers","name":"Drug use practices among MDMA/ecstasy users in Ohio: a latent class analysis","year":"2005","cit":76,"pfa":"Robert Gideon Carlson","psa":"Harvey Alan Siegal","ptype":"article","src":"https://openalex.org/W2025725402","eid":"W2025725402"},{"id":"paper-w2000083255","cat":"papers","name":"Hallucinogen persisting perception disorder and the serotonergic system: A comprehensive review including new MDMA-related clinical cases","year":"2014","cit":76,"pfa":"Ruud P. W. Litjens","psa":"Remco H.S. Westerink","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2000083255","eid":"W2000083255"},{"id":"paper-w4311477082","cat":"papers","name":"Risks and benefits of psilocybin use in people with bipolar disorder: An international web-based survey on experiences of ‘magic mushroom’ consumption","year":"2022","cit":76,"pfa":"Emma E. Morton","psa":"Josh D. Woolley","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4311477082","eid":"W4311477082"},{"id":"paper-w2010757875","cat":"papers","name":"Exposure to 3,4‐methylenedioxymethamphetamine (MDMA) on postnatal days 11–20 induces reference but not working memory deficits in the Morris water maze in rats: implications of prior learning","year":"2004","cit":76,"pfa":"Charles V. Vorhees","psa":"Michael T. Williams","ptype":"article","src":"https://openalex.org/W2010757875","eid":"W2010757875"},{"id":"paper-w2013032759","cat":"papers","name":"Analyzing mechanism(s) of hallucinogenic drug action with drug discrimination procedures","year":"1982","cit":76,"pfa":"J. B. Appel","psa":"Alice M. Holohean","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2013032759","eid":"W2013032759"},{"id":"paper-w2002554882","cat":"papers","name":"Alterations in responses to LSD in humans associated with chronic administration of tricyclic antidepressants, monoamine oxidase inhibitors or lithium","year":"1995","cit":76,"pfa":"Katherine R. Bonson","psa":"Dennis L. Murphy","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2002554882","eid":"W2002554882"},{"id":"paper-w2001972521","cat":"papers","name":"LSD but not lisuride disrupts prepulse inhibition in rats by activating the 5-HT2A receptor","year":"2009","cit":76,"pfa":"Adam L. Halberstadt","psa":"Mark A. Geyer","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2001972521","eid":"W2001972521"},{"id":"paper-w2292536823","cat":"papers","name":"Serotonergic modulation of rat pup ultrasonic vocal development: studies with 3,4-methylenedioxymethamphetamine.","year":"1990","cit":76,"pfa":"J. T. Winslow","psa":"T R Insel","ptype":"article","src":"https://openalex.org/W2292536823","eid":"W2292536823"},{"id":"paper-w1867008676","cat":"papers","name":"5-HT2 antagonists stereoselectively prevent the neurotoxicity of 3,4-methylenedioxymethamphetamine by blocking the acute stimulation of dopamine synthesis: reversal by L-dopa.","year":"1990","cit":76,"pfa":"C J Schmidt","psa":"Thaddeus R. Nieduzak","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1867008676","eid":"W1867008676"},{"id":"paper-w2139607193","cat":"papers","name":"Memory-related hippocampal dysfunction in poly-drug ecstasy (3,4-methylenedioxymethamphetamine) users","year":"2004","cit":76,"pfa":"Jörg Daumann","psa":"Euphrosyne Gouzoulis‐Mayfrank","ptype":"article","src":"https://openalex.org/W2139607193","eid":"W2139607193"},{"id":"paper-w2938595859","cat":"papers","name":"Psychedelics as a treatment for disorders of consciousness","year":"2019","cit":76,"pfa":"Gregory Scott","psa":"Robin Lester Carhart-Harris","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2938595859","eid":"W2938595859"},{"id":"paper-w2075487573","cat":"papers","name":"Synthesis and Serotonergic Activity of N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethylamine and Analogs: Potent Agonists for 5-HT1D Receptors","year":"1995","cit":76,"pfa":"Leslie J. Street","psa":"Alan P. Watt","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2075487573","eid":"W2075487573"},{"id":"paper-w2944038128","cat":"papers","name":"Narrative identity, rationality, and microdosing classic psychedelics","year":"2019","cit":76,"pfa":"Megan E. Webb","psa":"Peter S. Hendricks","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2944038128","eid":"W2944038128"},{"id":"paper-w1816695864","cat":"papers","name":"Cognitive-behavioural treatment for amphetamine-type stimulants (ATS)-use disorders","year":"2018","cit":76,"pfa":"Takayuki Harada","psa":"David B. Wilson","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1816695864","eid":"W1816695864"},{"id":"paper-w4288758418","cat":"papers","name":"Indigenous Philosophies and the \"Psychedelic Renaissance\"","year":"2022","cit":76,"pfa":"Keith J. Williams","psa":"Suzanne Brant","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4288758418","eid":"W4288758418"},{"id":"paper-w2070274847","cat":"papers","name":"Behavioral and serotonin receptor properties of 4-substituted derivatives of the hallucinogen 1-(2,5-dimethoxyphenyl)-2-aminopropane","year":"1982","cit":76,"pfa":"Richard A. Glennon","psa":"Richard D. Morin","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2070274847","eid":"W2070274847"},{"id":"paper-w2030125274","cat":"papers","name":"Early microdose drug studies in human volunteers can minimise animal testing: Proceedings of a workshop organised by Volunteers in Research and Testing","year":"2003","cit":76,"pfa":"Robert D. Combes","psa":"P Wilcox","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2030125274","eid":"W2030125274"},{"id":"paper-w2135354406","cat":"papers","name":"WAY 100135, an Antagonist of 5-HT1A Serotonin Receptors, Attenuates Psychotomimetic Effects of MK-801","year":"2000","cit":76,"pfa":"K Wedzony","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2135354406","eid":"W2135354406"},{"id":"paper-w1995807677","cat":"papers","name":"Potency of antipsychotics in reversing the effects of a hallucinogenic drug on locus coeruleus neurons correlates with 5-HT2 binding affinity","year":"1988","cit":76,"pfa":"K. Rasmussen","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1995807677","eid":"W1995807677"},{"id":"paper-w2063105674","cat":"papers","name":"The association between cannabis abuse and subsequent schizophrenia: a Swedish national co-relative control study","year":"2014","cit":76,"pfa":"Giuseppe Nicola Giordano","psa":"Kenneth S. Kendler","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2063105674","eid":"W2063105674"},{"id":"paper-w1906452053","cat":"papers","name":"Sigma receptors regulate contractions of the guinea pig ileum longitudinal muscle/myenteric plexus preparation elicited by both electrical stimulation and exogenous serotonin","year":"1989","cit":76,"pfa":"BG Campbell","psa":"E Weber","topics":["Addiction","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1906452053","eid":"W1906452053"},{"id":"paper-w3016220354","cat":"papers","name":"New‐generation, non‐SSRI antidepressants: Drug‐drug interactions and therapeutic drug monitoring. Part 2: NaSSAs, NRIs, SNDRIs, MASSAs, NDRIs, and others","year":"2020","cit":76,"pfa":"Michele Protti","psa":"Laura Mercolini","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3016220354","eid":"W3016220354"},{"id":"paper-w2790184875","cat":"papers","name":"Role of the 5-HT2AReceptor in Self- and Other-Initiated Social Interaction in Lysergic Acid Diethylamide-Induced States: A Pharmacological fMRI Study","year":"2018","cit":75,"pfa":"Katrin H. Preller","psa":"Franz X. Vollenweider","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2790184875","eid":"W2790184875"},{"id":"paper-w1990245488","cat":"papers","name":"Psilocybin-induced stimulus control in the rat","year":"2007","cit":75,"pfa":"Jerrold C. Winter","psa":"R.A. Rabin","ptype":"article","src":"https://openalex.org/W1990245488","eid":"W1990245488"},{"id":"paper-w2092674780","cat":"papers","name":"The fate of psilocin in the rat","year":"1962","cit":75,"pfa":"F. Kalberer","psa":"J. Rutschmann","ptype":"article","src":"https://openalex.org/W2092674780","eid":"W2092674780"},{"id":"paper-w2089965431","cat":"papers","name":"MDMA: Its History and Pharmacology","year":"1994","cit":75,"pfa":"David M. McDowell","psa":"Herbert D. Kleber","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2089965431","eid":"W2089965431"},{"id":"paper-w1985177369","cat":"papers","name":"Ibogaine reduces preference for cocaine consumption in C57BL/6By mice","year":"1994","cit":75,"pfa":"Henry W. Sershen","psa":"Ábel Lajtha","ptype":"article","src":"https://openalex.org/W1985177369","eid":"W1985177369"},{"id":"paper-w2087247225","cat":"papers","name":"Synthesis and in vitro pharmacological evaluation of salvinorin A analogues modified at C(2)","year":"2005","cit":75,"pfa":"Cécile Béguin","psa":"Bruce M. Cohen","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2087247225","eid":"W2087247225"},{"id":"paper-w100614747","cat":"papers","name":"Drug intelligence based on MDMA tablets data","year":"2007","cit":75,"pfa":"Céline Weyermann","psa":"Frantisek Zrcek","ptype":"article","src":"https://openalex.org/W100614747","eid":"W100614747"},{"id":"paper-w2170673134","cat":"papers","name":"Ecstasy (MDMA) and memory function: a meta‐analytic update","year":"2007","cit":75,"pfa":"Keith R. Laws","psa":"Joy Kokkalis","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2170673134","eid":"W2170673134"},{"id":"paper-w2011798603","cat":"papers","name":"Effects of 5-methoxy-N,N-dimethyltryptamine on behavior and raphe unit acitivity in freely moving cats","year":"1979","cit":75,"pfa":"Michael E. Trulson","psa":"Barry L. Jacobs","ptype":"article","src":"https://openalex.org/W2011798603","eid":"W2011798603"},{"id":"paper-w3166424032","cat":"papers","name":"Ceremonial Ayahuasca in Amazonian Retreats—Mental Health and Epigenetic Outcomes From a Six-Month Naturalistic Study","year":"2021","cit":75,"pfa":"Simon Ruffell","psa":"Celia J. A. Morgan","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3166424032","eid":"W3166424032"},{"id":"paper-w2045897942","cat":"papers","name":"Carvedilol reverses hyperthermia and attenuates rhabdomyolysis induced by 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) in an animal model*","year":"2005","cit":75,"pfa":"Jon E. Sprague","psa":"Edward Mills","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2045897942","eid":"W2045897942"},{"id":"paper-w2085511565","cat":"papers","name":"Decreased social behaviour following 3,4-methylenedioxymethamphetamine (MDMA) is accompanied by changes in 5-HT2A receptor responsivity","year":"2003","cit":75,"pfa":"E Bull","psa":"Kevin C.F. Fone","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2085511565","eid":"W2085511565"},{"id":"paper-w2031099959","cat":"papers","name":"Effect of the R(−) and S(+) isomers of MDA and MDMA on phosphotidyl inositol turnover in cultured cells expressing 5-HT2A or 5-HT2C receptors","year":"1994","cit":75,"pfa":"J. Frank Nash","psa":"Gary A. Gudelsky","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2031099959","eid":"W2031099959"},{"id":"paper-w4392797453","cat":"papers","name":"The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorder","year":"2024","cit":75,"pfa":"Adam W. Levin","psa":"Alan K. Davis","topics":["Depression","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4392797453","eid":"W4392797453"},{"id":"paper-w2132090177","cat":"papers","name":"Simultaneous chiral separation of 3,4‐methylenedioxymethamphetamine (MDMA), 3‐4‐methylenedioxyamphetamine (MDA), 3,4‐methylenedioxyethylamphetamine (MDE), ephedrine, amphetamine and methamphetamine by capillary electroph","year":"1998","cit":75,"pfa":"Franco Tagliaro","psa":"M. Marigo","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2132090177","eid":"W2132090177"},{"id":"paper-w2003369004","cat":"papers","name":"Effects of Serotonin Antagonists in Normal Subjects and Patients with Carcinoid Tumors","year":"1957","cit":75,"pfa":"Roland E. Schneckloth","psa":"A. C. Corcoran","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2003369004","eid":"W2003369004"},{"id":"paper-w140271714","cat":"papers","name":"Entheogens and Existential Intelligence: The Use of Plant Teachers as Cognitive Tools","year":"2002","cit":75,"pfa":"Kenneth W. Tupper","topics":["Anxiety & end-of-life","Therapy practice"],"ptype":"article","src":"https://openalex.org/W140271714","eid":"W140271714"},{"id":"paper-w1487335348","cat":"papers","name":"Lost in translation: preclinical studies on 3,4‐methylenedioxymethamphetamine provide information on mechanisms of action, but do not allow accurate prediction of adverse events in humans","year":"2011","cit":75,"pfa":"Andrew R. Green","psa":"Kevin C.F. Fone","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1487335348","eid":"W1487335348"},{"id":"paper-w2104506785","cat":"papers","name":"Methylenedioxymethamphetamine Decreases Plasmalemmal and Vesicular Dopamine Transport: Mechanisms and Implications for Neurotoxicity","year":"2002","cit":75,"pfa":"JL Hansen","psa":"Annette E. Fleckenstein","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2104506785","eid":"W2104506785"},{"id":"paper-w2110725190","cat":"papers","name":"Composition, standardization and chemical profiling of Banisteriopsis caapi, a plant for the treatment of neurodegenerative disorders relevant to Parkinson's disease","year":"2010","cit":75,"pfa":"Yanhong Wang","psa":"Ilias Muhammad","ptype":"article","src":"https://openalex.org/W2110725190","eid":"W2110725190"},{"id":"paper-w3135005144","cat":"papers","name":"Associations between lifetime classic psychedelic use and markers of physical health","year":"2021","cit":75,"pfa":"Otto Simonsson","psa":"Peter S. Hendricks","topics":["Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3135005144","eid":"W3135005144"},{"id":"paper-w2021868318","cat":"papers","name":"Microdose clinical trial: Quantitative determination of fexofenadine in human plasma using liquid chromatography/electrospray ionization tandem mass spectrometry","year":"2007","cit":75,"pfa":"Naoe Yamane","psa":"Yuji Kumagai","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2021868318","eid":"W2021868318"},{"id":"paper-w1982089118","cat":"papers","name":"Plant Toxins That Affect Nicotinic Acetylcholine Receptors: A Review","year":"2013","cit":75,"pfa":"Benedict T. Green","psa":"Stephen Tomas Lee","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1982089118","eid":"W1982089118"},{"id":"paper-w2136160870","cat":"papers","name":"Psychometric properties of DSM assessments of illicit drug abuse and dependence: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)","year":"2007","cit":75,"pfa":"Michael T. Lynskey","psa":"Arpana Agrawal","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2136160870","eid":"W2136160870"},{"id":"paper-w2025853788","cat":"papers","name":"Harmaline: A competitive inhibitor of Na Ion in the (Na++K+)-ATPase system","year":"1973","cit":75,"pfa":"MITZY L. CANESSA","psa":"Milton de la Fuente","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2025853788","eid":"W2025853788"},{"id":"paper-w2999453539","cat":"papers","name":"Electrophysiological biomarkers of antidepressant response to ketamine in treatment-resistant depression: Gamma power and long-term potentiation","year":"2020","cit":75,"pfa":"Jessica R. Gilbert","psa":"Carlos A. Zarate","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2999453539","eid":"W2999453539"},{"id":"paper-w2043329362","cat":"papers","name":"Chronic ketamine use increases serum levels of brain-derived neurotrophic factor","year":"2010","cit":75,"pfa":"Valerio Ricci","psa":"Francesco Angelucci","ptype":"article","src":"https://openalex.org/W2043329362","eid":"W2043329362"},{"id":"paper-w2000104590","cat":"papers","name":"Subchronic ketamine treatment leads to permanent changes in EEG, cognition and the astrocytic glutamate transporter EAAT2 in mice","year":"2012","cit":75,"pfa":"Robert E. Featherstone","psa":"Steven J. Siegel","ptype":"article","src":"https://openalex.org/W2000104590","eid":"W2000104590"},{"id":"paper-w4224297291","cat":"papers","name":"Global Trends and Hotspots in Esketamine Research: A Bibliometric Analysis of Past and Estimation of Future Trends","year":"2022","cit":75,"pfa":"Xiang Li","psa":"Jingyi Du","topics":["Depression","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4224297291","eid":"W4224297291"},{"id":"paper-w4382369675","cat":"papers","name":"The Effect of Low-Dose Esketamine on Postoperative Neurocognitive Dysfunction in Elderly Patients Undergoing General Anesthesia for Gastrointestinal Tumors: A Randomized Controlled Trial","year":"2023","cit":75,"pfa":"Jia-Min Ma","psa":"Yun Lin","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4382369675","eid":"W4382369675"},{"id":"paper-w3012495265","cat":"papers","name":"Ketamine and nitrous oxide: The evolution of NMDA receptor antagonists as antidepressant agents","year":"2020","cit":75,"pfa":"Molly C. Kalmoe","psa":"Charles R. Conway","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3012495265","eid":"W3012495265"},{"id":"paper-w4318316266","cat":"papers","name":"Application of opioid-free general anesthesia for gynecological laparoscopic surgery under ERAS protocol: a non-inferiority randomized controlled trial","year":"2023","cit":75,"pfa":"Liang Chen","psa":"Yuanhai Li","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4318316266","eid":"W4318316266"},{"id":"paper-w2061607209","cat":"papers","name":"Mescaline, lysergic acid diethylamide and psilocybin: Comparison of clinical syndromes, effects on color perception and biochemical measures","year":"1962","cit":74,"pfa":"Leo E. Hollister","psa":"Alan M. Hartman","ptype":"article","src":"https://openalex.org/W2061607209","eid":"W2061607209"},{"id":"paper-w2462370446","cat":"papers","name":"Stimulus properties of phenethylamine hallucinogens and lysergic acid diethylamide: the role of 5-hydroxytryptamine.","year":"1978","cit":74,"pfa":"Jerrold C. Winter","ptype":"article","src":"https://openalex.org/W2462370446","eid":"W2462370446"},{"id":"paper-w1983731006","cat":"papers","name":"Peyote Religion: A History","year":"1989","cit":74,"pfa":"L. G. Moses","psa":"Omer C. Stewart","ptype":"article","src":"https://openalex.org/W1983731006","eid":"W1983731006"},{"id":"paper-w2124184748","cat":"papers","name":"The antinociceptive effect of Salvinorin A in mice","year":"2006","cit":74,"pfa":"Trentini F. John","psa":"Joseph S. Erlichman","ptype":"article","src":"https://openalex.org/W2124184748","eid":"W2124184748"},{"id":"paper-w2003384135","cat":"papers","name":"Tabernanthe iboga: an African narcotic plant of social importance","year":"1969","cit":74,"pfa":"Harrison Graham Pope","ptype":"article","src":"https://openalex.org/W2003384135","eid":"W2003384135"},{"id":"paper-w2316721389","cat":"papers","name":"Fungal Hallucinogens Psilocin, Ibotenic Acid, and Muscimol","year":"2013","cit":74,"pfa":"Katarzyna Stebelska","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2316721389","eid":"W2316721389"},{"id":"paper-w2774349944","cat":"papers","name":"Psilocybin mushrooms of the world","year":"1996","cit":74,"pfa":"Paul E. Stamets","ptype":"book","src":"https://openalex.org/W2774349944","eid":"W2774349944"},{"id":"paper-w2070075142","cat":"papers","name":"Hydroxylation and N-demethylation of N,N-dimethyltryptamine","year":"1959","cit":74,"pfa":"Stephen Szára","psa":"Joshua L. Axelrod","ptype":"article","src":"https://openalex.org/W2070075142","eid":"W2070075142"},{"id":"paper-w2160850152","cat":"papers","name":"Dimethyltryptamine (DMT): Subjective effects and patterns of use among Australian recreational users","year":"2010","cit":74,"pfa":"Vince Cakic","psa":"Alex Marshall","ptype":"article","src":"https://openalex.org/W2160850152","eid":"W2160850152"},{"id":"paper-w2999489633","cat":"papers","name":"Therapeutic potential of ayahuasca in grief: a prospective, observational study","year":"2020","cit":74,"pfa":"Débora González","psa":"José Carlos Bouso","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2999489633","eid":"W2999489633"},{"id":"paper-w2142519612","cat":"papers","name":"Effects of acute and repeated administration of salvinorin A on dopamine function in the rat dorsal striatum","year":"2008","cit":74,"pfa":"Brenda J. Gehrke","psa":"Toni Shaun Shippenberg","ptype":"article","src":"https://openalex.org/W2142519612","eid":"W2142519612"},{"id":"paper-w4207069915","cat":"papers","name":"Therapeutic effect of an ayahuasca analogue in clinically depressed patients: a longitudinal observational study","year":"2022","cit":74,"pfa":"Kim I. M. van Oorsouw","psa":"Johannes Gerardus Ramaekers","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4207069915","eid":"W4207069915"},{"id":"paper-w2943600109","cat":"papers","name":"Effects of MDMA on attention to positive social cues and pleasantness of affective touch","year":"2019","cit":74,"pfa":"Anya K. Bershad","psa":"Harriet de Wit","ptype":"article","src":"https://openalex.org/W2943600109","eid":"W2943600109"},{"id":"paper-w2060519440","cat":"papers","name":"Lack of serotonin neurotoxicity after intraraphe microinjection of (+)-3,4-methylenedioxymethamphetamine (MDMA)","year":"1992","cit":74,"pfa":"Joseph M. Paris","psa":"Kathryn A. Cunningham","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2060519440","eid":"W2060519440"},{"id":"paper-w2121654640","cat":"papers","name":"Determination of Salvinorin A in body fluids by high performance liquid chromatography–atmospheric pressure chemical ionization","year":"2005","cit":74,"pfa":"Mark S. Schmidt","psa":"Daryl J. Murry","ptype":"article","src":"https://openalex.org/W2121654640","eid":"W2121654640"},{"id":"paper-w2917658072","cat":"papers","name":"Ibogaine Administration Modifies GDNF and BDNF Expression in Brain Regions Involved in Mesocorticolimbic and Nigral Dopaminergic Circuits","year":"2019","cit":74,"pfa":"Soledad Marton","psa":"Ignacio Carrera","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2917658072","eid":"W2917658072"},{"id":"paper-w2154778496","cat":"papers","name":"Tissue concentrations of MDMA and its metabolite MDA in three fatal cases of overdose","year":"2003","cit":74,"pfa":"Rosario García-Repetto","psa":"Manuel Menéndez‐González","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2154778496","eid":"W2154778496"},{"id":"paper-w2034875280","cat":"papers","name":"Hyponeophagia and arousal in rats: Effects of diazepam, 5-methoxy-N,N-dimethyltryptamine, d-amphetamine and food deprivation","year":"1982","cit":74,"pfa":"R.A. Shephard","psa":"P. L. Broadhurst","ptype":"article","src":"https://openalex.org/W2034875280","eid":"W2034875280"},{"id":"paper-w1976268530","cat":"papers","name":"Memory function and serotonin transporter promoter gene polymorphism in ecstasy (MDMA) users","year":"2006","cit":74,"pfa":"Liesbeth Reneman","psa":"Onno Bakker","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1976268530","eid":"W1976268530"},{"id":"paper-w3127961940","cat":"papers","name":"Ayahuasca use and reported effects on depression and anxiety symptoms: An international cross-sectional study of 11,912 consumers","year":"2021","cit":74,"pfa":"Jerome J. Sarris","psa":"Luís Fernando Tófoli","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3127961940","eid":"W3127961940"},{"id":"paper-w2135367985","cat":"papers","name":"Acute and long-term consequences of single MDMA administration in relation to individual anxiety levels in the rat","year":"2003","cit":74,"pfa":"Ying‐Jui Ho","psa":"Rainer K.W. Schwarting","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2135367985","eid":"W2135367985"},{"id":"paper-w2432569781","cat":"papers","name":"Cocaine, MDMA and methamphetamine residues in wastewater: Consumption trends (2009–2015) in South East Queensland, Australia","year":"2016","cit":74,"pfa":"Foon Yin Lai","psa":"Jochen F. Mueller","ptype":"article","src":"https://openalex.org/W2432569781","eid":"W2432569781"},{"id":"paper-w2034253843","cat":"papers","name":"Administration of SCH 23390 into the Medial Prefrontal Cortex Blocks the Expression of MDMA-Induced Behavioral Sensitization in Rats: An Effect Mediated by 5-HT2C Receptor Stimulation and not by D1 Receptor Blockade","year":"2005","cit":74,"pfa":"María Ramos","psa":"Norberto Aguirre","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2034253843","eid":"W2034253843"},{"id":"paper-w2037606383","cat":"papers","name":"Agonist-Trafficking and Hallucinogens","year":"2009","cit":74,"pfa":"Javier González‐Maeso","psa":"Stuart C. Sealfon","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2037606383","eid":"W2037606383"},{"id":"paper-w2410613263","cat":"papers","name":"Contribution of a helix 5 locus to selectivity of hallucinogenic and nonhallucinogenic ligands for the human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors: direct and indirect effects on ligand affinity media","year":"1996","cit":74,"pfa":"Niva Almaula","psa":"Stuart C. Sealfon","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2410613263","eid":"W2410613263"},{"id":"paper-w4409723793","cat":"papers","name":"5-HT2A receptors: Pharmacology and functional selectivity","year":"2025","cit":74,"pfa":"Benjamin R. Cummins","psa":"Charles David Nichols","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4409723793","eid":"W4409723793"},{"id":"paper-w2011982178","cat":"papers","name":"An Animal Behavior Model for Studying the Actions of LSD and Related Hallucinogens","year":"1976","cit":74,"pfa":"Barry L. Jacobs","psa":"Warren C. Stern","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2011982178","eid":"W2011982178"},{"id":"paper-w2010875415","cat":"papers","name":"Effects of Dose and Route of Administration on Pharmacokinetics of (±)-3,4-Methylenedioxymethamphetamine in the Rat","year":"2009","cit":74,"pfa":"Michael H. Baumann","psa":"Marilyn Ann Huestis","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2010875415","eid":"W2010875415"},{"id":"paper-w2165450714","cat":"papers","name":"Hallucinogen-like actions of 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) in mice and rats","year":"2005","cit":74,"pfa":"William E. Fantegrossi","psa":"James H. Woods","ptype":"article","src":"https://openalex.org/W2165450714","eid":"W2165450714"},{"id":"paper-w2026446530","cat":"papers","name":"Contrasting effects of d-methamphetamine, 3,4-methylenedioxymethamphetamine, 3,4-methylenedioxypyrovalerone, and 4-methylmethcathinone on wheel activity in rats","year":"2012","cit":74,"pfa":"Pai-Kai Huang","psa":"Michael A. Taffe","ptype":"article","src":"https://openalex.org/W2026446530","eid":"W2026446530"},{"id":"paper-w75914508","cat":"papers","name":"Neuropsychedelia: the revival of hallucinogen research since the decade of the brain","year":"2013","cit":74,"topics":["Dosing & pharmacology"],"ptype":"book-review","src":"https://openalex.org/W75914508","eid":"W75914508"},{"id":"paper-w2084515342","cat":"papers","name":"β‐ADRENOCEPTOR ANTAGONISTS INHIBIT THE BEHAVIOURAL RESPONSES OF RATS TO INCREASED BRAIN 5‐HYDROXYTRYPTAMINE","year":"1978","cit":74,"pfa":"David W. Costain","psa":"A.R. Green","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2084515342","eid":"W2084515342"},{"id":"paper-w2273743412","cat":"papers","name":"Effectiveness of a universal internet‐based prevention program for ecstasy and new psychoactive substances: a cluster randomized controlled trial","year":"2016","cit":74,"pfa":"Katrina Elizabeth Champion","psa":"Maree Teesson","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2273743412","eid":"W2273743412"},{"id":"paper-w4289841582","cat":"papers","name":"Antidepressant effects of a psychedelic experience in a large prospective naturalistic sample","year":"2022","cit":74,"pfa":"Victoria Amalie Nygart","psa":"David Erritzøe","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4289841582","eid":"W4289841582"},{"id":"paper-w2993940948","cat":"papers","name":"Modulation of Social Cognition via Hallucinogens and “Entactogens”","year":"2019","cit":74,"pfa":"Katrin H. Preller","psa":"Franz X. Vollenweider","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2993940948","eid":"W2993940948"},{"id":"paper-w2276439990","cat":"papers","name":"Microdose 14C-urea breath test offers diagnosis of Helicobacter pylori in 10 minutes.","year":"1996","cit":74,"pfa":"David A. Peura","psa":"Barry James Marshall","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2276439990","eid":"W2276439990"},{"id":"paper-w1970161990","cat":"papers","name":"Hallucinogen-Induced UP States in the Brain Slice of Rat Prefrontal Cortex: Role of Glutamate Spillover and NR2B-NMDA Receptors","year":"2005","cit":74,"pfa":"Evelyn K. Lambe","psa":"George K. Aghajanian","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1970161990","eid":"W1970161990"},{"id":"paper-w3179536112","cat":"papers","name":"Research abuses against people of colour and other vulnerable groups in early psychedelic research","year":"2021","cit":74,"pfa":"Dana Strauss","psa":"Monnica T. Williams","topics":["Addiction","Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3179536112","eid":"W3179536112"},{"id":"paper-w2070852308","cat":"papers","name":"Toward Prediction of Efficacy of Chemotherapy: A Proof of Concept Study in Lung Cancer Patients Using [11C]docetaxel and Positron Emission Tomography","year":"2013","cit":74,"pfa":"Astrid A.M. van der Veldt","psa":"Adriaan A. Lammertsma","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2070852308","eid":"W2070852308"},{"id":"paper-w2063601228","cat":"papers","name":"Schizophrenia‐related endophenotypes in heterozygous neuregulin‐1 ‘knockout’ mice","year":"2010","cit":74,"pfa":"Colm M. P. O’Tuathaigh","psa":"John L. Waddington","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2063601228","eid":"W2063601228"},{"id":"paper-w2776494598","cat":"papers","name":"Cigarette use is increasing among people with illicit substance use disorders in the United States, 2002–14: emerging disparities in vulnerable populations","year":"2017","cit":74,"pfa":"Andrea H. Weinberger","psa":"Renée D. Goodwin","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2776494598","eid":"W2776494598"},{"id":"paper-w4214898817","cat":"papers","name":"Efficacy and safety of racemic ketamine and esketamine for depression: a systematic review and meta-analysis","year":"2022","cit":74,"pfa":"Anees Bahji","psa":"Gustavo Héctor Vázquez","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4214898817","eid":"W4214898817"},{"id":"paper-w4283711009","cat":"papers","name":"Blood-based biomarkers of antidepressant response to ketamine and esketamine: A systematic review and meta-analysis","year":"2022","cit":74,"pfa":"Gustavo C. Medeiros","psa":"Fernando S. Goes","topics":["Depression","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4283711009","eid":"W4283711009"},{"id":"paper-w4380203898","cat":"papers","name":"Mini-dose esketamine–dexmedetomidine combination to supplement analgesia for patients after scoliosis correction surgery: a double-blind randomised trial","year":"2023","cit":74,"pfa":"Ying Zhang","psa":"Dong‐Xin Wang","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4380203898","eid":"W4380203898"},{"id":"paper-w2015051316","cat":"papers","name":"A re-evaluation of the mode of action of 5-hydroxytryptamine on lateral geniculate neurones: Comparison with catecholamines and LSD","year":"1972","cit":74,"pfa":"A. K. Tebēcis","psa":"A. Di Maria","ptype":"article","src":"https://openalex.org/W2015051316","eid":"W2015051316"},{"id":"paper-w2110879932","cat":"papers","name":"Simultaneous determination of nineteen hallucinogenic tryptamines/β-calbolines and phenethylamines using gas chromatography–mass spectrometry and liquid chromatography–electrospray ionisation-mass spectrometry","year":"2005","cit":74,"pfa":"Ruri Kikura‐Hanajiri","psa":"Yukihiro Goda","ptype":"article","src":"https://openalex.org/W2110879932","eid":"W2110879932"},{"id":"paper-w2083808333","cat":"papers","name":"Lysergic Acid Diethylamide (LSD-25): XVII. Tolerance Development and its Relationship to a Theory of Psychosis","year":"1956","cit":73,"pfa":"Harold A. Abramson","psa":"M. W. Hirsch","ptype":"article","src":"https://openalex.org/W2083808333","eid":"W2083808333"},{"id":"paper-w2030775210","cat":"papers","name":"Actions of d -Lysergic Acid Diethylamide and Its 2-Bromo Derivative on Heart of Venus mercenaria","year":"1957","cit":73,"pfa":"John H. Welsh","psa":"Anne C. McCoy","ptype":"article","src":"https://openalex.org/W2030775210","eid":"W2030775210"},{"id":"paper-w4200405004","cat":"papers","name":"A systematic literature review of clinical trials and therapeutic applications of ibogaine","year":"2021","cit":73,"pfa":"Patrick Köck","psa":"Kenneth M. Dürsteler","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"review","src":"https://openalex.org/W4200405004","eid":"W4200405004"},{"id":"paper-w2019466002","cat":"papers","name":"MDMA (‘ecstasy’) and other ‘club drugs’","year":"2002","cit":73,"pfa":"Stephen C Koesters","psa":"Christiana R. Rajasingham","ptype":"article","src":"https://openalex.org/W2019466002","eid":"W2019466002"},{"id":"paper-w2059059769","cat":"papers","name":"Differential interactions of dimethyltryptamine (DMT) with 5-HT1A and 5-HT2 receptors","year":"1991","cit":73,"pfa":"Anna V. Deliganis","psa":"Stephen J. Peroutka","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2059059769","eid":"W2059059769"},{"id":"paper-w2052783348","cat":"papers","name":"Changes in Spirituality Among Ayahuasca Ceremony Novice Participants","year":"2009","cit":73,"pfa":"Stephen Trichter","psa":"Stanley Krippner","ptype":"article","src":"https://openalex.org/W2052783348","eid":"W2052783348"},{"id":"paper-w2749659487","cat":"papers","name":"MDMA Impairs Both the Encoding and Retrieval of Emotional Recollections","year":"2017","cit":73,"pfa":"Manoj K. Doss","psa":"Harriet de Wit","ptype":"article","src":"https://openalex.org/W2749659487","eid":"W2749659487"},{"id":"paper-w2042201688","cat":"papers","name":"Distribution of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) stereoisomers in a fatal poisoning","year":"1996","cit":73,"pfa":"Karla A. Moore","psa":"Alphonse Poklis","ptype":"article","src":"https://openalex.org/W2042201688","eid":"W2042201688"},{"id":"paper-w1999779609","cat":"papers","name":"Mechanisms of MDMA (Ecstasy)-Induced Oxidative Stress, Mitochondrial Dysfunction, and Organ Damage","year":"2010","cit":73,"pfa":"Byoung‐Joon Song","psa":"Insong James Lee","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1999779609","eid":"W1999779609"},{"id":"paper-w2120522320","cat":"papers","name":"LC/MS/MS analysis of the endogenous dimethyltryptamine hallucinogens, their precursors, and major metabolites in rat pineal gland microdialysate","year":"2013","cit":73,"pfa":"Steven A. Barker","psa":"Rick J. Strassman","ptype":"article","src":"https://openalex.org/W2120522320","eid":"W2120522320"},{"id":"paper-w4200583144","cat":"papers","name":"Psilocybin microdosing does not affect emotion-related symptoms and processing: A preregistered field and lab-based study","year":"2021","cit":73,"pfa":"Josephine Marschall","psa":"Michiel van Elk","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4200583144","eid":"W4200583144"},{"id":"paper-w2150506554","cat":"papers","name":"Estimating the relative reinforcing strength of (±)-3,4-methylenedioxymethamphetamine (MDMA) and its isomers in rhesus monkeys: comparison to (+)-methamphetamine","year":"2006","cit":73,"pfa":"Zhixia Wang","psa":"William L. Woolverton","ptype":"article","src":"https://openalex.org/W2150506554","eid":"W2150506554"},{"id":"paper-w2002861559","cat":"papers","name":"Fatal multi-organ failure after suicidal overdose with MDMA, `Ecstasy': case report and review of the literature","year":"1999","cit":73,"pfa":"Andrew Walubo","psa":"Donna Seger","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2002861559","eid":"W2002861559"},{"id":"paper-w4224443490","cat":"papers","name":"Using a MDMA- and LSD-Group Therapy Model in Clinical Practice in Switzerland and Highlighting the Treatment of Trauma-Related Disorders","year":"2022","cit":73,"pfa":"Peter Oehen","psa":"Peter Gasser","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4224443490","eid":"W4224443490"},{"id":"paper-w1969156270","cat":"papers","name":"Stability study of the designer drugs “MDA, MDMA and MDEA” in water, serum, whole blood, and urine under various storage temperatures","year":"2001","cit":73,"pfa":"Karine M. Clauwaert","psa":"André P. De Leenheer","ptype":"article","src":"https://openalex.org/W1969156270","eid":"W1969156270"},{"id":"paper-w2054001837","cat":"papers","name":"Gender differences in self-reported anxiety, depression, and somatization among ecstasy/MDMA polydrug users, alcohol/tobacco users, and nondrug users","year":"2004","cit":73,"pfa":"Raffaella Margherita Milani","psa":"Helen C Fox","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2054001837","eid":"W2054001837"},{"id":"paper-w2770565632","cat":"papers","name":"Regulation of human research with LSD in the United States (1949-1987)","year":"2017","cit":73,"pfa":"Katherine R. Bonson","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2770565632","eid":"W2770565632"},{"id":"paper-w2075473657","cat":"papers","name":"Role of reactive oxygen species, glutathione and NF-κB in apoptosis induced by 3,4-methylenedioxymethamphetamine (“Ecstasy”) on hepatic stellate cells","year":"2003","cit":73,"pfa":"Cristina Montiel‐Duarte","psa":"María J. Iraburu","ptype":"article","src":"https://openalex.org/W2075473657","eid":"W2075473657"},{"id":"paper-w2135847541","cat":"papers","name":"STEREOCHEMICAL ANALYSIS OF 3,4-METHYLENEDIOXYMETHAMPHETAMINE AND ITS MAIN METABOLITES IN HUMAN SAMPLES INCLUDING THE CATECHOL-TYPE METABOLITE (3,4-DIHYDROXYMETHAMPHETAMINE)","year":"2004","cit":73,"pfa":"Nieves Pizarro","psa":"Rafael de la Torre","ptype":"article","src":"https://openalex.org/W2135847541","eid":"W2135847541"},{"id":"paper-w1965043593","cat":"papers","name":"3-Methoxy-4 5-methylenedioxy Amphetamine, a New Psychotomimetic Agent","year":"1964","cit":73,"pfa":"Alexander T. Shulgin","ptype":"article","src":"https://openalex.org/W1965043593","eid":"W1965043593"},{"id":"paper-w2116715079","cat":"papers","name":"Quantitative Phosphoproteomics Unravels Biased Phosphorylation of Serotonin 2A Receptor at Ser280 by Hallucinogenic versus Nonhallucinogenic Agonists","year":"2014","cit":73,"pfa":"Samah Karaki","psa":"Franck Vandermoere","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2116715079","eid":"W2116715079"},{"id":"paper-w2406629148","cat":"papers","name":"Neurochemical basis of neurotoxicity.","year":"1990","cit":73,"pfa":"Gibb Jw","psa":"Hanson Gr","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2406629148","eid":"W2406629148"},{"id":"paper-w4306913343","cat":"papers","name":"Culture, context, and ethics in the therapeutic use of hallucinogens: Psychedelics as active super-placebos?","year":"2022","cit":73,"pfa":"David Dupuis","psa":"Samuel P. L. Veissière","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"editorial","src":"https://openalex.org/W4306913343","eid":"W4306913343"},{"id":"paper-w3033052133","cat":"papers","name":"A systematic review of psychedelic-assisted psychotherapy for mental health: An evaluation of the current wave of research and suggestions for the future.","year":"2020","cit":73,"pfa":"Spencer W. Wheeler","psa":"Natalie L. Dyer","topics":["Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3033052133","eid":"W3033052133"},{"id":"paper-w657183938","cat":"papers","name":"Psychedelics: The uses and implications of hallucinogenic drugs;","year":"1971","cit":73,"pfa":"Bernard S. Aaronson","psa":"Humphry Osmond","ptype":"book","src":"https://openalex.org/W657183938","eid":"W657183938"},{"id":"paper-w2094387287","cat":"papers","name":"Structure-activity relations in psychotomimetic phenylalkylamines","year":"1974","cit":73,"pfa":"F.A.B. Aldous","psa":"K. J. Tutt","ptype":"article","src":"https://openalex.org/W2094387287","eid":"W2094387287"},{"id":"paper-w2078385555","cat":"papers","name":"Acute Psychosis Induced by Psychotomimetic Drug Abuse","year":"1972","cit":73,"pfa":"Malcolm B. Bowers","ptype":"article","src":"https://openalex.org/W2078385555","eid":"W2078385555"},{"id":"paper-w652017239","cat":"papers","name":"Handbook of substance abuse : neurobehavioral pharmacology","year":"1998","cit":73,"pfa":"Ralph E. Tarter","psa":"Peggy J. Ott","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W652017239","eid":"W652017239"},{"id":"paper-w2091608595","cat":"papers","name":"Role of 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs II: reassessment of LSD false positives","year":"1995","cit":73,"pfa":"David J. Fiorella","psa":"Jerrold C. Winter","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2091608595","eid":"W2091608595"},{"id":"paper-w2769944013","cat":"papers","name":"Ketamine for chronic non‐cancer pain: A meta‐analysis and trial sequential analysis of randomized controlled trials","year":"2017","cit":73,"pfa":"D. Michelet","psa":"Souhayl Dahmani","topics":["Anxiety & end-of-life","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2769944013","eid":"W2769944013"},{"id":"paper-w2034511256","cat":"papers","name":"Role of training dose in drug discrimination","year":"2011","cit":73,"pfa":"Ian P. Stolerman","psa":"Kathleen A. Grant","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2034511256","eid":"W2034511256"},{"id":"paper-w2158691492","cat":"papers","name":"Urinary Excretion Rates of Ketamine and Norketamine Following Therapeutic Ketamine Administration: Method and Detection Window Considerations","year":"2005","cit":73,"pfa":"Piotr Adamowicz","psa":"Maria Kała","ptype":"article","src":"https://openalex.org/W2158691492","eid":"W2158691492"},{"id":"paper-w2989523661","cat":"papers","name":"The clinical challenges of synthetic cathinones","year":"2019","cit":73,"pfa":"Fabrizio Schifano","psa":"Alessandro Emiliano Vento","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2989523661","eid":"W2989523661"},{"id":"paper-w2187337315","cat":"papers","name":"Acceptability and utility of an electronic psychosocial assessment (myAssessment) to increase self-disclosure in youth mental healthcare: a quasi-experimental study","year":"2015","cit":73,"pfa":"Sally Bradford","psa":"Debra Rickwood","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2187337315","eid":"W2187337315"},{"id":"paper-w1989188733","cat":"papers","name":"Effects of norketamine enantiomers in rodent models of persistent pain","year":"2008","cit":73,"pfa":"J HOLTMANJR","psa":"Elzbieta P. Wala","ptype":"article","src":"https://openalex.org/W1989188733","eid":"W1989188733"},{"id":"paper-w1974696185","cat":"papers","name":"Glutamate pharmacology and the treatment of schizophrenia: current status and future directions","year":"1995","cit":73,"pfa":"Carol A. Tamminga","psa":"Adrienne Carol Lahti","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1974696185","eid":"W1974696185"},{"id":"paper-w1997781923","cat":"papers","name":"Stereoselective effects of ketamine on dopamine, serotonin and noradrenaline release and uptake in rat brain slices","year":"2003","cit":73,"pfa":"M Tso","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1997781923","eid":"W1997781923"},{"id":"paper-w4394770673","cat":"papers","name":"The impact of perioperative ketamine or esketamine on the subjective quality of recovery after surgery: a meta-analysis of randomised controlled trials","year":"2024","cit":73,"pfa":"Kuo‐Chuan Hung","psa":"I‐Wen Chen","topics":["Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4394770673","eid":"W4394770673"},{"id":"paper-w2979131874","cat":"papers","name":"Dextromethorphan/Bupropion: A Novel Oral NMDA (N-methyl-d-aspartate) Receptor Antagonist with Multimodal Activity","year":"2019","cit":73,"pfa":"Stephen M. Stahl","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2979131874","eid":"W2979131874"},{"id":"paper-w2312675623","cat":"papers","name":"INTOXICANT DRUGS (MESCALINE AND LYSERGIC ACID DIETHYLAMIDE) IN PSYCHOTHERAPY","year":"1955","cit":72,"pfa":"Walter Frederking","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2312675623","eid":"W2312675623"},{"id":"paper-w2155222763","cat":"papers","name":"Lysergic acid diethylamide: evidence for stimulation of cerebral dopamine receptors","year":"1975","cit":72,"pfa":"M. Da Prada","psa":"A. Pletscher","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2155222763","eid":"W2155222763"},{"id":"paper-w2146585068","cat":"papers","name":"Return of the lysergamides. Part V: Analytical and behavioural characterization of 1‐butanoyl‐d‐lysergic acid diethylamide (1B‐LSD)","year":"2019","cit":72,"pfa":"Simon D. Brandt","psa":"Adam L. Halberstadt","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2146585068","eid":"W2146585068"},{"id":"paper-w4361213071","cat":"papers","name":"Acute Mood-Elevating Properties of Microdosed Lysergic Acid Diethylamide in Healthy Volunteers: A Home-Administered Randomized Controlled Trial","year":"2023","cit":72,"pfa":"Robin J. Murphy","psa":"Suresh D Muthukumaraswamy","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4361213071","eid":"W4361213071"},{"id":"paper-w2157384069","cat":"papers","name":"Repeated lysergic acid diethylamide in an animal model of depression: Normalisation of learning behaviour and hippocampal serotonin 5-HT 2 signalling","year":"2014","cit":72,"pfa":"Tobias Buchborn","psa":"Gisela Grecksch","topics":["Depression","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2157384069","eid":"W2157384069"},{"id":"paper-w1972188670","cat":"papers","name":"Ayahuasca in Adolescence: A Neuropsychological Assessment","year":"2005","cit":72,"pfa":"Evelyn Doering-Silveira","psa":"Dartiu Xavier da Silveira","ptype":"article","src":"https://openalex.org/W1972188670","eid":"W1972188670"},{"id":"paper-w4285007883","cat":"papers","name":"Psilocybin in neuropsychiatry: a review of its pharmacology, safety, and efficacy","year":"2022","cit":72,"pfa":"Seetal Dodd","psa":"Michael Berk","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4285007883","eid":"W4285007883"},{"id":"paper-w2092160482","cat":"papers","name":"Tissue distribution of ibogaine after intraperitoneal and subcutaneous administration","year":"1996","cit":72,"pfa":"Lindsay B. Hough","psa":"Stanley D. Glick","ptype":"article","src":"https://openalex.org/W2092160482","eid":"W2092160482"},{"id":"paper-w2020941806","cat":"papers","name":"Metabolism of the hallucinogen N,N-dimethyltryptamine in rat brain homogenates","year":"1980","cit":72,"pfa":"Steven A. Barker","psa":"Samuel T. Christian","ptype":"article","src":"https://openalex.org/W2020941806","eid":"W2020941806"},{"id":"paper-w2005595186","cat":"papers","name":"Subarachnoid haemorrhage associated with MDMA abuse.","year":"1993","cit":72,"pfa":"J. Gledhill","psa":"John Aaron Henry","ptype":"article","src":"https://openalex.org/W2005595186","eid":"W2005595186"},{"id":"paper-w2125869037","cat":"papers","name":"Ecstasy (MDMA) mimics the post-orgasmic state: Impairment of sexual drive and function during acute MDMA-effects may be due to increased prolactin secretion","year":"2005","cit":72,"pfa":"Torsten Passie","psa":"Tillmann H. C. Krüger","ptype":"article","src":"https://openalex.org/W2125869037","eid":"W2125869037"},{"id":"paper-w2134755979","cat":"papers","name":"Synthesis and in vitro evaluation of salvinorin A analogues: Effect of configuration at C(2) and substitution at C(18)","year":"2006","cit":72,"pfa":"Cécile Béguin","psa":"Bruce M. Cohen","ptype":"article","src":"https://openalex.org/W2134755979","eid":"W2134755979"},{"id":"paper-w2161282151","cat":"papers","name":"Exposure to the Selective κ-Opioid Receptor Agonist Salvinorin A Modulates the Behavioral and Molecular Effects of Cocaine in Rats","year":"2008","cit":72,"pfa":"Elena H. Chartoff","psa":"William A. Carlezon","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2161282151","eid":"W2161282151"},{"id":"paper-w2132722030","cat":"papers","name":"Salvinorin A inhibits colonic transit and neurogenic ion transport in mice by activating κ‐opioid and cannabinoid receptors","year":"2009","cit":72,"pfa":"Jakub Fichna","psa":"Martin Storr","topics":["Addiction","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2132722030","eid":"W2132722030"},{"id":"paper-w3201625402","cat":"papers","name":"Dose effect of psilocybin on primary and secondary depression: a preliminary systematic review and meta-analysis","year":"2021","cit":72,"pfa":"Nan‐Xi Li","psa":"Bin Zhang","topics":["Depression","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W3201625402","eid":"W3201625402"},{"id":"paper-w3164491540","cat":"papers","name":"N,N-Dimethyltryptamine attenuates spreading depolarization and restrains neurodegeneration by sigma-1 receptor activation in the ischemic rat brain","year":"2021","cit":72,"pfa":"Írisz Szabó","psa":"Eszter Farkas","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3164491540","eid":"W3164491540"},{"id":"paper-w2087971225","cat":"papers","name":"Mephedrone does not damage dopamine nerve endings of the striatum, but enhances the neurotoxicity of methamphetamine, amphetamine, and MDMA","year":"2012","cit":72,"pfa":"Mariana Angoa‐Pérez","psa":"Donald M. Kuhn","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2087971225","eid":"W2087971225"},{"id":"paper-w2057818249","cat":"papers","name":"Psychomotor stimulant effects ofd-amphetamine, MDMA and PCP: aggressive and schedule-controlled behavior in mice","year":"1994","cit":72,"pfa":"Klaus A. Miczek","psa":"Margaret Haney","ptype":"article","src":"https://openalex.org/W2057818249","eid":"W2057818249"},{"id":"paper-w2060635458","cat":"papers","name":"Neural Correlates of the Severity of Cocaine, Heroin, Alcohol, MDMA and Cannabis Use in Polysubstance Abusers: A Resting-PET Brain Metabolism Study","year":"2012","cit":72,"pfa":"Laura Moreno-López","psa":"Antonio Verdejo‐García","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2060635458","eid":"W2060635458"},{"id":"paper-w2166403556","cat":"papers","name":"Dancing hot on Ecstasy: physical activity and thermal comfort ratings are associated with the memory and other psychobiological problems reported by recreational MDMA users","year":"2006","cit":72,"pfa":"Andrew C. Parrott","psa":"Andrew B Scholey","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2166403556","eid":"W2166403556"},{"id":"paper-w2069414657","cat":"papers","name":"Quantitative and qualitative analysis of MDMA, MDEA, MA and amphetamine in urine by head-space/solid phase micro-extraction (SPME) and GC/MS","year":"1996","cit":72,"pfa":"Fabio Centini","psa":"Ida Barni Comparini","ptype":"article","src":"https://openalex.org/W2069414657","eid":"W2069414657"},{"id":"paper-w1979963125","cat":"papers","name":"Hallucinogen-like effects of N,N-dipropyltryptamine (DPT): Possible mediation by serotonin 5-HT1A and 5-HT2A receptors in rodents","year":"2007","cit":72,"pfa":"William E. Fantegrossi","psa":"J WINTER","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1979963125","eid":"W1979963125"},{"id":"paper-w2129290879","cat":"papers","name":"Hallucinogen-persisting perception disorder","year":"2012","cit":72,"pfa":"Leo Hermle","psa":"Martin Geppert","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2129290879","eid":"W2129290879"},{"id":"paper-w2057298190","cat":"papers","name":"Hallucinogens as discriminative stimuli in animals: LSD, phenethylamines, and tryptamines","year":"2008","cit":72,"pfa":"Jerrold C. Winter","ptype":"article","src":"https://openalex.org/W2057298190","eid":"W2057298190"},{"id":"paper-w61153387","cat":"papers","name":"The biochemical pharmacology of abused drugs","year":"1974","cit":72,"pfa":"John Caldwell","psa":"Peter S. Sever","topics":["Dosing & pharmacology","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W61153387","eid":"W61153387"},{"id":"paper-w2256156657","cat":"papers","name":"COMPARATIVE STUDY ON THE SEROTONIN ANTAGONISM OF AMIDE DERIVATIVES OF LYSERGIC ACID AND OF ERGOT ALKALOIDS","year":"1958","cit":72,"pfa":"A Cerletti","psa":"Wolfgang Doepfner","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2256156657","eid":"W2256156657"},{"id":"paper-w1905166601","cat":"papers","name":"Clozapine Reverses Hyperthermia and Sympathetically Mediated Cutaneous Vasoconstriction Induced by 3,4-Methylenedioxymethamphetamine (Ecstasy) in Rabbits and Rats","year":"2003","cit":72,"pfa":"William Walter Blessing","psa":"Youichirou Ootsuka","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1905166601","eid":"W1905166601"},{"id":"paper-w2525190545","cat":"papers","name":"Psychedelic Psychotherapy: Insights From 25 Years of Research","year":"2016","cit":72,"pfa":"William A. Richards","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2525190545","eid":"W2525190545"},{"id":"paper-w1977996110","cat":"papers","name":"Urine Analysis of 3,4-Methylenedioxypyrovalerone in Opioid-Dependent Patients by Gas Chromatography–Mass Spectrometry","year":"2011","cit":72,"pfa":"Ilkka Antero Ojanperä","psa":"Ilpo Rasanen","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1977996110","eid":"W1977996110"},{"id":"paper-w2615479147","cat":"papers","name":"Ethnopharmacology of Medicinal Plants: Asia and the Pacific","year":"2007","cit":72,"pfa":"Peter John Houghton","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2615479147","eid":"W2615479147"},{"id":"paper-w3198980648","cat":"papers","name":"Critical Period Plasticity as a Framework for Psychedelic-Assisted Psychotherapy","year":"2021","cit":72,"pfa":"Lauren Lepow","psa":"Rachel Yehuda","topics":["PTSD & trauma","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3198980648","eid":"W3198980648"},{"id":"paper-w3182096564","cat":"papers","name":"Containment Matters: Set and Setting in Contemporary Psychedelic Psychiatry","year":"2021","cit":72,"pfa":"Tehseen N. Noorani","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W3182096564","eid":"W3182096564"},{"id":"paper-w4255869843","cat":"papers","name":"Microdose Lithium Treatment Stabilized Cognitive Impairment in Patients with Alzheimer's Disease","year":"2013","cit":72,"pfa":"Marielza Andrade Nunes","psa":"Hudson Sousa Buck","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4255869843","eid":"W4255869843"},{"id":"paper-w2809718318","cat":"papers","name":"Positive psychology in the investigation of psychedelics and entactogens: A critical review","year":"2018","cit":72,"pfa":"Henrik Jungaberle","psa":"Milan Scheidegger","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2809718318","eid":"W2809718318"},{"id":"paper-w1690318541","cat":"papers","name":"Stable isotope‐labelled intravenous microdose for absolute bioavailability and effect of grapefruit juice on ibrutinib in healthy adults","year":"2015","cit":72,"pfa":"Ronald de Vries","psa":"Jan L. de Jong","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1690318541","eid":"W1690318541"},{"id":"paper-w2123298321","cat":"papers","name":"Acute cannabis use causes increased psychotomimetic experiences in individuals prone to psychosis","year":"2008","cit":72,"pfa":"Oliver John Mason","psa":"Helen Valerie Curran","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2123298321","eid":"W2123298321"},{"id":"paper-w3140816870","cat":"papers","name":"A qualitative and quantitative account of patient’s experiences of ketamine and its antidepressant properties","year":"2021","cit":72,"pfa":"Rachael L. Sumner","psa":"Frederick Sundram","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W3140816870","eid":"W3140816870"},{"id":"paper-w1975083768","cat":"papers","name":"Implantable MicroPump for Drug Delivery in Patients with Diabetic Macular Edema","year":"2014","cit":72,"pfa":"Mark S. Humayun","psa":"Sean Caffey","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1975083768","eid":"W1975083768"},{"id":"paper-w2142523997","cat":"papers","name":"Opposite effects of ketamine and deep brain stimulation on rat thalamocortical information processing","year":"2012","cit":72,"pfa":"Sofya P. Kulikova","psa":"Didier Pinault","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2142523997","eid":"W2142523997"},{"id":"paper-w4381149534","cat":"papers","name":"How Oxidative Stress Induces Depression?","year":"2023","cit":72,"pfa":"Na Ji","psa":"Bo Zhang","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4381149534","eid":"W4381149534"},{"id":"paper-w2962807939","cat":"papers","name":"Surgical Technique for Subretinal Gene Therapy in Humans with Inherited Retinal Degeneration","year":"2019","cit":72,"pfa":"Janet L. Davis","psa":"Byron L. Lam","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2962807939","eid":"W2962807939"},{"id":"paper-w3025572281","cat":"papers","name":"Sex-specific neurobiological actions of prophylactic (R,S)-ketamine, (2R,6R)-hydroxynorketamine, and (2S,6S)-hydroxynorketamine","year":"2020","cit":72,"pfa":"Briana K. Chen","psa":"Christine Ann Denny","ptype":"article","src":"https://openalex.org/W3025572281","eid":"W3025572281"},{"id":"paper-w3044729970","cat":"papers","name":"Esketamine: new hope for the treatment of treatment-resistant depression? A narrative review","year":"2020","cit":72,"pfa":"Mohammed Saji Salahudeen","psa":"Gregory Mark Peterson","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W3044729970","eid":"W3044729970"},{"id":"paper-w2793977798","cat":"papers","name":"Effect of intranasal esketamine on cognitive functioning in healthy participants: a randomized, double-blind, placebo-controlled study","year":"2018","cit":72,"pfa":"Randall L. Morrison","psa":"Wayne Curtis Drevets","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2793977798","eid":"W2793977798"},{"id":"paper-w4362471767","cat":"papers","name":"Antidepressants for the treatment of depression in people with cancer","year":"2023","cit":72,"pfa":"Giovanni Vita","psa":"Giovanni Ostuzzi","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4362471767","eid":"W4362471767"},{"id":"paper-w1999354767","cat":"papers","name":"Photoelectron spectra of psychotropic drugs. 1. Phenethylamines, tryptamines, and LSD","year":"1977","cit":72,"pfa":"Linda N. Domelsmith","psa":"K. N. Houk","ptype":"article","src":"https://openalex.org/W1999354767","eid":"W1999354767"},{"id":"paper-w1993949623","cat":"papers","name":"Interactions between lysergic acid diethylamide and dopamine-sensitive adenylate cyclase systems in rat brain","year":"1975","cit":71,"pfa":"Kern von Hungen","psa":"Diane F. Hill","ptype":"article","src":"https://openalex.org/W1993949623","eid":"W1993949623"},{"id":"paper-w2016744112","cat":"papers","name":"Navajo Peyote Use: Its Apparent Safety","year":"1971","cit":71,"pfa":"Robert Bergman","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2016744112","eid":"W2016744112"},{"id":"paper-w2066049912","cat":"papers","name":"Acute and post-acute behavioral and psychological effects of salvinorin A in humans","year":"2011","cit":71,"pfa":"Peter H. Addy","ptype":"article","src":"https://openalex.org/W2066049912","eid":"W2066049912"},{"id":"paper-w2132624405","cat":"papers","name":"Glucuronidation of Psilocin and 4-Hydroxyindole by the Human UDP-Glucuronosyltransferases","year":"2009","cit":71,"pfa":"Nenad Manevski","psa":"Moshe Finel","ptype":"article","src":"https://openalex.org/W2132624405","eid":"W2132624405"},{"id":"paper-w2027481157","cat":"papers","name":"A Study of Ayahuasca Use in North America","year":"2012","cit":71,"pfa":"Rachel Harris","psa":"Lee Gurel","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2027481157","eid":"W2027481157"},{"id":"paper-w1982432310","cat":"papers","name":"Ibogaine induces glial activation in parasagittal zones of the cerebellum","year":"1993","cit":71,"pfa":"Elizabeth O’Hearn","psa":"Mark E. Molliver","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1982432310","eid":"W1982432310"},{"id":"paper-w3087313941","cat":"papers","name":"Natural Products for the Treatment of Pain: Chemistry and Pharmacology of Salvinorin A, Mitragynine, and Collybolide","year":"2020","cit":71,"pfa":"Soumen Chakraborty","psa":"Susruta Majumdar","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3087313941","eid":"W3087313941"},{"id":"paper-w104059927","cat":"papers","name":"Salvinorin A Analogs and Other Kappa-Opioid Receptor Compounds as Treatments for Cocaine Abuse","year":"2014","cit":71,"pfa":"Bronwyn Maree Kivell","psa":"Thomas Edward Prisinzano","topics":["Addiction","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W104059927","eid":"W104059927"},{"id":"paper-w2144193551","cat":"papers","name":"Effect of 3,4-Methylenedioxymethamphetamine (MDMA) on Hippocampal Dopamine and Serotonin","year":"1998","cit":71,"pfa":"Mahalakshmi Shankaran","psa":"Gary A. Gudelsky","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2144193551","eid":"W2144193551"},{"id":"paper-w2129582923","cat":"papers","name":"Effects of ayahuasca on sensory and sensorimotor gating in humans as measured by P50 suppression and prepulse inhibition of the startle reflex, respectively","year":"2002","cit":71,"pfa":"Jordi Riba","psa":"Manel J. Barbanoj","ptype":"article","src":"https://openalex.org/W2129582923","eid":"W2129582923"},{"id":"paper-w2047511029","cat":"papers","name":"Blood and urine levels of N,N-dimethyltryptamine following administration of psychoactive dosages to human subjects","year":"1974","cit":71,"pfa":"J. Kaplan","psa":"Richard Jed Wyatt","ptype":"article","src":"https://openalex.org/W2047511029","eid":"W2047511029"},{"id":"paper-w2162010222","cat":"papers","name":"Cannabis and Ecstasy/MDMA (3,4-methylenedioxymethamphetamine): an analysis of their neuropsychobiological interactions in recreational users","year":"2007","cit":71,"pfa":"Andrew C. Parrott","psa":"Jörg Daumann","ptype":"article","src":"https://openalex.org/W2162010222","eid":"W2162010222"},{"id":"paper-w2178675538","cat":"papers","name":"Forensic electrochemistry: simultaneous voltammetric detection of MDMA and its fatal counterpart “Dr Death” (PMA)","year":"2015","cit":71,"pfa":"Loanda Raquel Cumba","psa":"Craig Edward Banks","ptype":"article","src":"https://openalex.org/W2178675538","eid":"W2178675538"},{"id":"paper-w2077950523","cat":"papers","name":"Repeated MDMA (“Ecstasy”) exposure in adolescent male rats alters temperature regulation, spontaneous motor activity, attention, and serotonin transporter binding","year":"2005","cit":71,"pfa":"Brian J. Piper","psa":"Jerrold S. Meyer","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2077950523","eid":"W2077950523"},{"id":"paper-w2088157398","cat":"papers","name":"Integration of GC/EI-MS and GC/NCI-MS for simultaneous quantitative determination of opiates, amphetamines, MDMA, ketamine, and metabolites in human hair","year":"2008","cit":71,"pfa":"Ya‐Hsueh Wu","psa":"Yan‐Zin Chang","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2088157398","eid":"W2088157398"},{"id":"paper-w2135335578","cat":"papers","name":"Use of amphetamine by recreational users of ecstasy (MDMA) is associated with reduced striatal dopamine transporter densities: a [123I]β-CIT SPECT study – preliminary report","year":"2001","cit":71,"pfa":"Liesbeth Reneman","psa":"Wim van den Brink","ptype":"article","src":"https://openalex.org/W2135335578","eid":"W2135335578"},{"id":"paper-w1572042930","cat":"papers","name":"Alternative Headache Treatments: Nutraceuticals, Behavioral and Physical Treatments","year":"2011","cit":71,"pfa":"Christina Sun‐Edelstein","psa":"Alexander Mauskop","topics":["Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W1572042930","eid":"W1572042930"},{"id":"paper-w2104894566","cat":"papers","name":"Elucidation of LSD In Vitro Metabolism by Liquid Chromatography and Capillary Electrophoresis Coupled with Tandem Mass Spectrometry*","year":"1996","cit":71,"pfa":"Jianyi Cai","psa":"Jack D. Henion","ptype":"article","src":"https://openalex.org/W2104894566","eid":"W2104894566"},{"id":"paper-w2402694995","cat":"papers","name":"Stereochemical differences in the metabolism of 3,4-methylenedioxymethamphetamine in vivo and in vitro: a pharmacokinetic analysis.","year":"1990","cit":71,"pfa":"A K Cho","psa":"D J Jenden","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2402694995","eid":"W2402694995"},{"id":"paper-w2050476288","cat":"papers","name":"Protective effects of minocycline on 3,4-methylenedioxymethamphetamine-induced neurotoxicity in serotonergic and dopaminergic neurons of mouse brain","year":"2006","cit":71,"pfa":"Lin Zhang","psa":"Kenji Hashimoto","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2050476288","eid":"W2050476288"},{"id":"paper-w4205701940","cat":"papers","name":"The Need for Psychedelic-Assisted Therapy in the Black Community and the Burdens of Its Provision","year":"2022","cit":71,"pfa":"Darron T. Smith","psa":"Lilith Green","topics":["PTSD & trauma","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4205701940","eid":"W4205701940"},{"id":"paper-w4226060882","cat":"papers","name":"Adverse experiences resulting in emergency medical treatment seeking following the use of magic mushrooms","year":"2022","cit":71,"pfa":"Emma I Kopra","psa":"James Rucker","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4226060882","eid":"W4226060882"},{"id":"paper-w1998305432","cat":"papers","name":"Chemotype-selective Modes of Action of κ-Opioid Receptor Agonists","year":"2013","cit":71,"pfa":"Eyal Vardy","psa":"Bryan L. Roth","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1998305432","eid":"W1998305432"},{"id":"paper-w4389164252","cat":"papers","name":"Serotonin 2A Receptor (5-HT 2A R) Agonists: Psychedelics and Non-Hallucinogenic Analogues as Emerging Antidepressants","year":"2023","cit":71,"pfa":"Wenwen Duan","psa":"Jianjun Cheng","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W4389164252","eid":"W4389164252"},{"id":"paper-w1977963047","cat":"papers","name":"Validity of Self-Reports and Drug Use Among Young People Seeking Treatment for Substance Abuse or Dependence","year":"2004","cit":71,"pfa":"Elisabeth Jona Solbergsdottir","psa":"Jakob Kristinsson","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1977963047","eid":"W1977963047"},{"id":"paper-w4283584241","cat":"papers","name":"Psychedelic-assisted psychotherapy to treat psychiatric and existential distress in life-threatening medical illnesses and palliative care","year":"2022","cit":71,"pfa":"Stephen Ross","psa":"Jack E. Henningfield","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4283584241","eid":"W4283584241"},{"id":"paper-w4385196978","cat":"papers","name":"Therapeutic mechanisms of psychedelics and entactogens","year":"2023","cit":71,"pfa":"Boris Dov Heifets","psa":"David E. Olson","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4385196978","eid":"W4385196978"},{"id":"paper-w3186397158","cat":"papers","name":"Working with Weirdness: A Response to “Moving Past Mysticism in Psychedelic Science”","year":"2021","cit":71,"pfa":"Joost J. Breeksema","psa":"Michiel van Elk","ptype":"editorial","src":"https://openalex.org/W3186397158","eid":"W3186397158"},{"id":"paper-w2982002445","cat":"papers","name":"Buprenorphine–naloxone “microdosing”: an alternative induction approach for the treatment of opioid use disorder in the wake of North America’s increasingly potent illicit drug market","year":"2020","cit":71,"pfa":"Privia A. Randhawa","psa":"Seonaid Nolan","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2982002445","eid":"W2982002445"},{"id":"paper-w2132796129","cat":"papers","name":"Microdose Pharmacokinetics of IDX899 and IDX989, Candidate HIV‐1 Non‐Nucleoside Reverse Transcriptase Inhibitors, Following Oral and Intravenous Administration in Healthy Male Subjects","year":"2009","cit":71,"pfa":"Xiao‐Jian Zhou","psa":"Douglas L. Mayers","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2132796129","eid":"W2132796129"},{"id":"paper-w1991572990","cat":"papers","name":"Youth Drug Abuse: Problems, Issues, and Treatment","year":"1979","cit":71,"pfa":"Herbert J. Freudenberger","ptype":"article","src":"https://openalex.org/W1991572990","eid":"W1991572990"},{"id":"paper-w2597685695","cat":"papers","name":"β-Arrestin2 Couples Metabotropic Glutamate Receptor 5 to Neuronal Protein Synthesis and Is a Potential Target to Treat Fragile X","year":"2017","cit":71,"pfa":"Laura J. Stoppel","psa":"Mark F. Bear","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2597685695","eid":"W2597685695"},{"id":"paper-w2091250062","cat":"papers","name":"Ketamine Dependence in Anesthesia Providers","year":"1999","cit":71,"pfa":"Nicole N. Moore","psa":"John Michael Bostwick","ptype":"article","src":"https://openalex.org/W2091250062","eid":"W2091250062"},{"id":"paper-w2990917747","cat":"papers","name":"Esketamine: a glimmer of hope in treatment-resistant depression","year":"2019","cit":71,"pfa":"Upinder Kaur","psa":"Sankha Shubhra Chakrabarti","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2990917747","eid":"W2990917747"},{"id":"paper-w4366602076","cat":"papers","name":"RETRACTED: Efficacy and Safety of Esketamine for Supplemental Analgesia During Elective Cesarean Delivery","year":"2023","cit":71,"pfa":"Lili Xu","psa":"Xinzhong Chen","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4366602076","eid":"W4366602076"},{"id":"paper-w4393125481","cat":"papers","name":"Effects of esketamine on postoperative negative emotions and early cognitive disorders in patients undergoing non-cardiac thoracic surgery: A randomized controlled trial","year":"2024","cit":71,"pfa":"Tianyuan Luo","psa":"Haiying Wang","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4393125481","eid":"W4393125481"},{"id":"paper-w2318552418","cat":"papers","name":"LYSERGIC ACID DIETHYLAMIDE AS A VARIABLE IN THE HOSPITAL TREATMENT OF ALCOHOLISM","year":"1970","cit":70,"pfa":"William Talbot Bowen","psa":"John W. Chotlos","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2318552418","eid":"W2318552418"},{"id":"paper-w2040443703","cat":"papers","name":"Lack of cross-tolerance in rats among (?) ?9-trans-tetrahydrocannabinol (?9-THC), cannabis extract, mescaline and lysergic acid diethylamide (LSD-25)","year":"1968","cit":70,"pfa":"M. Teresa A. Silva","psa":"Friedhelm KORTE","ptype":"article","src":"https://openalex.org/W2040443703","eid":"W2040443703"},{"id":"paper-w2016388239","cat":"papers","name":"Improvements to the Synthesis of Psilocybin and a Facile Method for Preparing the O-Acetyl Prodrug of Psilocin","year":"1999","cit":70,"pfa":"David E. Nichols","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2016388239","eid":"W2016388239"},{"id":"paper-w2063553290","cat":"papers","name":"Lysergic acid diethylamide-induced Fos expression in rat brain: role of serotonin-2A receptors","year":"2002","cit":70,"pfa":"Paul J. Gresch","psa":"Elaine Sanders‐Bush","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2063553290","eid":"W2063553290"},{"id":"paper-w1928293948","cat":"papers","name":"In Vivo Neurobiological Effects of Ibogaine and Its O-Desmethyl Metabolite, 12-Hydroxyibogamine (Noribogaine), in Rats","year":"2001","cit":70,"pfa":"Michael H. Baumann","psa":"Deborah C. Mash","ptype":"article","src":"https://openalex.org/W1928293948","eid":"W1928293948"},{"id":"paper-w2064468738","cat":"papers","name":"Abwandlungsprodukte von Psilocybin und Psilocin. 2. Mitteilung über synthetische Indolverbindungen","year":"1959","cit":70,"pfa":"F. Troxler","psa":"Alfred André Hofmann","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2064468738","eid":"W2064468738"},{"id":"paper-w3094690508","cat":"papers","name":"Stability of psilocybin and its four analogs in the biomass of the psychotropic mushroom Psilocybe cubensis","year":"2020","cit":70,"pfa":"Klára Gotvaldová","psa":"Martin Kuchař","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3094690508","eid":"W3094690508"},{"id":"paper-w2092498135","cat":"papers","name":"Subjective effects of MDMA (‘Ecstasy’) on human sexual function","year":"2001","cit":70,"pfa":"Zvi Zemishlany","psa":"Abraham Weizman","ptype":"article","src":"https://openalex.org/W2092498135","eid":"W2092498135"},{"id":"paper-w2118962074","cat":"papers","name":"A contribution to the chemical profiling of 3,4-methylenedioxymethamphetamine (MDMA) tablets","year":"2002","cit":70,"pfa":"Pascal Gimeno","psa":"ALAIN LAMOTTE","ptype":"article","src":"https://openalex.org/W2118962074","eid":"W2118962074"},{"id":"paper-w4281386811","cat":"papers","name":"Phenomenology and content of the inhaled N, N-dimethyltryptamine (N, N-DMT) experience","year":"2022","cit":70,"pfa":"David Wyndham Lawrence","psa":"Christopher B. Timmermann","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4281386811","eid":"W4281386811"},{"id":"paper-w2143162373","cat":"papers","name":"Neurocognitive function in users of MDMA: the importance of clinically significant patterns of use","year":"2004","cit":70,"pfa":"Karen L. Hanson","psa":"Monica M. Luciana","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2143162373","eid":"W2143162373"},{"id":"paper-w1588615075","cat":"papers","name":"Rediscovering MDMA (ecstasy): the role of the American chemist Alexander T. Shulgin","year":"2010","cit":70,"pfa":"Udo Benzenhöfer","psa":"Torsten Passie","topics":["Dosing & pharmacology","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W1588615075","eid":"W1588615075"},{"id":"paper-w1982063200","cat":"papers","name":"Salvinorin A has antiinflammatory and antinociceptive effects in experimental models of colitis in mice mediated by KOR and CB1 receptors*","year":"2011","cit":70,"pfa":"Jakub Fichna","psa":"Martin Storr","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1982063200","eid":"W1982063200"},{"id":"paper-w3134320342","cat":"papers","name":"Low Doses of Psilocybin and Ketamine Enhance Motivation and Attention in Poor Performing Rats: Evidence for an Antidepressant Property","year":"2021","cit":70,"pfa":"Guy A. Higgins","psa":"Edward M. Sellers","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3134320342","eid":"W3134320342"},{"id":"paper-w2084808900","cat":"papers","name":"Intimate insight: MDMA changes how people talk about significant others","year":"2015","cit":70,"pfa":"Matthew J. Baggott","psa":"Harriet de Wit","ptype":"article","src":"https://openalex.org/W2084808900","eid":"W2084808900"},{"id":"paper-w1932356664","cat":"papers","name":"Studies on the effect of MDMA (‘ecstasy’) on the body temperature of rats housed at different ambient room temperatures","year":"2005","cit":70,"pfa":"A. Richard Green","psa":"M. Isabel Colado","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1932356664","eid":"W1932356664"},{"id":"paper-w2021230191","cat":"papers","name":"Ultrapotent effects of salvinorin A, a hallucinogenic compound from Salvia divinorum, on LPS-stimulated murine macrophages and its anti-inflammatory action in vivo","year":"2011","cit":70,"pfa":"Gabriella Aviello","psa":"Raffaele Capasso","ptype":"article","src":"https://openalex.org/W2021230191","eid":"W2021230191"},{"id":"paper-w2122051049","cat":"papers","name":"Simultaneous Determination of Amphetamine, Methamphetamine, Methylenedioxyamphetamine (MDA), Methylenedioxymethamphetamine (MDMA), and Methylenedioxyethylamphetamine (MDEA) Enantiomers by GC-MS","year":"1999","cit":70,"pfa":"D. Hensley","psa":"John T. Cody","ptype":"article","src":"https://openalex.org/W2122051049","eid":"W2122051049"},{"id":"paper-w2018651056","cat":"papers","name":"Cannabinoid-induced alterations in brain disposition of drugs of abuse 11Abbreviations: THC, tetrahydrocannabinol; CBD, cannabidiol; PCP, phencyclidine; MDMA, 3,4-methylenedioxyphenyl-methamphetamine HCl.","year":"2001","cit":70,"pfa":"Michael J. A. Reid","psa":"Lester M. Bornheim","ptype":"article","src":"https://openalex.org/W2018651056","eid":"W2018651056"},{"id":"paper-w2029125340","cat":"papers","name":"Serotonin Release from Brain Slices by Electrical Stimulation: Regional Differences and Effect of LSD","year":"1967","cit":70,"pfa":"Thomas N. Chase","psa":"Irwin J. Kopin","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2029125340","eid":"W2029125340"},{"id":"paper-w4391953134","cat":"papers","name":"Expectancy Effects in Psychedelic Trials","year":"2024","cit":70,"pfa":"Balázs Szigeti","psa":"Boris Dov Heifets","ptype":"article","src":"https://openalex.org/W4391953134","eid":"W4391953134"},{"id":"paper-w1997763487","cat":"papers","name":"A Review of Chemical Agents in the Pharmacotherapy of Addiction","year":"2002","cit":70,"pfa":"Mark S. Levi","psa":"Ronald F. Borne","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1997763487","eid":"W1997763487"},{"id":"paper-w2074861223","cat":"papers","name":"The discriminative stimulus properties of LSD: Mechanisms of action☆","year":"1978","cit":70,"pfa":"D KUHN","psa":"J APPEL","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2074861223","eid":"W2074861223"},{"id":"paper-w2172114662","cat":"papers","name":"Evidence for Chronically Altered Serotonin Function in the Cerebral Cortex of Female 3,4-Methylenedioxymethamphetamine Polydrug Users","year":"2011","cit":70,"pfa":"Tristan J. Watkins","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2172114662","eid":"W2172114662"},{"id":"paper-w2318227660","cat":"papers","name":"Differential Effect of Gepirone on Presynaptic and Postsynaptic Serotonin Receptors","year":"1990","cit":70,"pfa":"Pierre Ulrich Blier","psa":"Claude de Montigny","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2318227660","eid":"W2318227660"},{"id":"paper-w2143437320","cat":"papers","name":"(±)-3,4-Methylenedioxymethamphetamine Administration to Rats Does Not Decrease Levels of the Serotonin Transporter Protein or Alter Its Distribution between Endosomes and the Plasma Membrane","year":"2005","cit":70,"pfa":"Xiaoying Wang","psa":"Richard B. Rothman","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2143437320","eid":"W2143437320"},{"id":"paper-w3160183306","cat":"papers","name":"Classic Psychedelic Coadministration with Lithium, but Not Lamotrigine, is Associated with Seizures: An Analysis of Online Psychedelic Experience Reports","year":"2021","cit":70,"pfa":"Sandeep Manel Nayak","psa":"Roland R. Griffiths","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3160183306","eid":"W3160183306"},{"id":"paper-w1976480594","cat":"papers","name":"Salvia divinorum: an hallucinogenic mint which might become a new recreational drug in Switzerland","year":"2000","cit":70,"pfa":"C. Giroud","psa":"Patrice J. Mangin","ptype":"article","src":"https://openalex.org/W1976480594","eid":"W1976480594"},{"id":"paper-w2048326205","cat":"papers","name":"Simultaneous quantitative determination of amphetamines, ketamine, opiates and metabolites in human hair by gas chromatography/mass spectrometry","year":"2008","cit":70,"pfa":"Ya‐Hsueh Wu","psa":"Yan‐Zin Chang","ptype":"article","src":"https://openalex.org/W2048326205","eid":"W2048326205"},{"id":"paper-w2039160653","cat":"papers","name":"Choroid plexus epithelial cells in primary culture: a model of 5HT1C receptor activation by hallucinoginic drugs","year":"1991","cit":70,"pfa":"Elaine Sanders‐Bush","psa":"Marsha Breeding","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2039160653","eid":"W2039160653"},{"id":"paper-w616260190","cat":"papers","name":"Human Sleep: Research and Clinical Care","year":"1987","cit":70,"pfa":"Wallace B. Mendelson","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"book","src":"https://openalex.org/W616260190","eid":"W616260190"},{"id":"paper-w4200408156","cat":"papers","name":"Psychedelic Therapy's Transdiagnostic Effects: A Research Domain Criteria (RDoC) Perspective","year":"2021","cit":70,"pfa":"John Richard Kelly","psa":"Veronica O’Keane","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4200408156","eid":"W4200408156"},{"id":"paper-w2191898742","cat":"papers","name":"The epistemic innocence of psychedelic states","year":"2015","cit":70,"pfa":"Chris Letheby","ptype":"article","src":"https://openalex.org/W2191898742","eid":"W2191898742"},{"id":"paper-w3112208811","cat":"papers","name":"Psychedelics and Psychotherapy","year":"2020","cit":70,"pfa":"Sandeep Manel Nayak","psa":"Matthew W. Johnson","topics":["Reviews & meta-analyses","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3112208811","eid":"W3112208811"},{"id":"paper-w2009231298","cat":"papers","name":"Common receptors for hallucinogens in rat brain: a comparative autoradiographic study using [125I]LSD and [125I]DOI, a new psychotomimetic radioligand","year":"1989","cit":70,"pfa":"Dennis J. McKenna","psa":"Juan M. Saavedra","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2009231298","eid":"W2009231298"},{"id":"paper-w2551733333","cat":"papers","name":"The serotonin 5-HT 2C receptor and the non-addictive nature of classic hallucinogens","year":"2016","cit":70,"pfa":"Clinton Ernest Canal","psa":"Kevin Sean Murnane","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2551733333","eid":"W2551733333"},{"id":"paper-w2077664164","cat":"papers","name":"LSD before Leary: Sidney Cohen's Critique of 1950s Psychedelic Drug Research","year":"1997","cit":70,"pfa":"Steven J. Novak","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2077664164","eid":"W2077664164"},{"id":"paper-w2080117430","cat":"papers","name":"Comparison of microdose flare-up and antagonist multiple-dose protocols for poor-responder patients: a randomized study","year":"2008","cit":70,"pfa":"Aygül Demi̇rol","psa":"Timur Gürgan","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2080117430","eid":"W2080117430"},{"id":"paper-w1991884459","cat":"papers","name":"Characterization of Oxaliplatin−DNA Adduct Formation in DNA and Differentiation of Cancer Cell Drug Sensitivity at Microdose Concentrations","year":"2007","cit":70,"pfa":"Sang Soo Hah","psa":"Paul T. Henderson","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1991884459","eid":"W1991884459"},{"id":"paper-w2984882636","cat":"papers","name":"Exploring the case for research on incorporating psychedelics within interventions for borderline personality disorder","year":"2019","cit":70,"pfa":"Richard J. Zeifman","psa":"Anne C. Wagner","ptype":"article","src":"https://openalex.org/W2984882636","eid":"W2984882636"},{"id":"paper-w1823419985","cat":"papers","name":"Microdose follicular phase gonadotropin-releasing hormone agonists (GnRH-a) compared with luteal phase GnRH-a for ovarian stimulation at in vitro fertilization","year":"1999","cit":70,"pfa":"Mark P. Leondires","psa":"Brad T. Miller","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1823419985","eid":"W1823419985"},{"id":"paper-w2808867953","cat":"papers","name":"Sustained Activation of Postsynaptic 5-HT2A Receptors Gates Plasticity at Prefrontal Cortex Synapses","year":"2018","cit":70,"pfa":"Coralie Berthoux","psa":"Carine Bécamel","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2808867953","eid":"W2808867953"},{"id":"paper-w2398072928","cat":"papers","name":"Comparative Effects and Analgesic Efficacy of the Agonist-Antagonist Opioids","year":"1983","cit":70,"pfa":"Elizabeth M. Zola","psa":"Donald C. McLeod","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2398072928","eid":"W2398072928"},{"id":"paper-w2095811378","cat":"papers","name":"Do cannabis and urbanicity co-participate in causing psychosis? Evidence from a 10-year follow-up cohort study","year":"2011","cit":70,"pfa":"Rebecca Kuepper","psa":"Cécile Henquet","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2095811378","eid":"W2095811378"},{"id":"paper-w2996380708","cat":"papers","name":"Esketamine is approved in Europe for treating resistant major depressive disorder","year":"2019","cit":70,"pfa":"Elisabeth Mahase","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2996380708","eid":"W2996380708"},{"id":"paper-w3136383360","cat":"papers","name":"Antisuicidal and antidepressant effects of ketamine and esketamine in patients with baseline suicidality: A systematic review","year":"2021","cit":70,"pfa":"Ashley N. Siegel","psa":"Joshua Daniel Rosenblat","topics":["Depression","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W3136383360","eid":"W3136383360"},{"id":"paper-w4379141148","cat":"papers","name":"The clinical toxicology of ketamine","year":"2023","cit":70,"pfa":"Leo J. Schep","psa":"Paul Gee","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4379141148","eid":"W4379141148"},{"id":"paper-w1581274611","cat":"papers","name":"Cochlear NMDA Receptors as a Therapeutic Target of Noise-Induced Tinnitus","year":"2015","cit":70,"pfa":"Dan Bing","psa":"Wibke Singer","topics":["PTSD & trauma","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1581274611","eid":"W1581274611"},{"id":"paper-w2345020592","cat":"papers","name":"The effects of lysergic acid diethylamide and mescaline-derived hallucinogens on sensory-integrative function: tactile startle.","year":"1978","cit":69,"pfa":"Mark A. Geyer","psa":"Arnold J. Mandell","ptype":"article","src":"https://openalex.org/W2345020592","eid":"W2345020592"},{"id":"paper-w2031285037","cat":"papers","name":"Lysergic Acid Diethylamide: Role in Conversion of Plasma Tryptophan to Brain Serotonin (5-Hydroxytryptamine)","year":"1969","cit":69,"pfa":"ROBERT CHUN YU LIN","psa":"E. Costa","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2031285037","eid":"W2031285037"},{"id":"paper-w2767373236","cat":"papers","name":"Peyote Religion: A History","year":"1988","cit":69,"pfa":"Carol M. Hampton","psa":"Omer C. Stewart","ptype":"article","src":"https://openalex.org/W2767373236","eid":"W2767373236"},{"id":"paper-w185824688","cat":"papers","name":"New World Tryptamine Hallucinogens and the Neuroscience of Ayahuasca","year":"2016","cit":69,"pfa":"Dennis J. McKenna","psa":"Jordi Riba","ptype":"book-chapter","src":"https://openalex.org/W185824688","eid":"W185824688"},{"id":"paper-w2412319325","cat":"papers","name":"Ibogaine and addiction in the animal model, a systematic review and meta-analysis","year":"2016","cit":69,"pfa":"Maarten Belgers","psa":"Carlijn R. Hooijmans","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W2412319325","eid":"W2412319325"},{"id":"paper-w2204642832","cat":"papers","name":"Neuroimaging in moderate MDMA use: A systematic review","year":"2015","cit":69,"pfa":"Felix Mueller","psa":"Stefan Borgwardt","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W2204642832","eid":"W2204642832"},{"id":"paper-w2427363607","cat":"papers","name":"Effect of ibogaine on naloxone-precipitated withdrawal syndrome in chronic morphine-dependent rats.","year":"1989","cit":69,"pfa":"Dzoljic Ed","psa":"Dzoljic Mr","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2427363607","eid":"W2427363607"},{"id":"paper-w1975006228","cat":"papers","name":"Serotonin receptor subtype mediation of the interoceptive discriminative stimuli induced by 5-methoxy-N,N-dimethyltryptamine","year":"1987","cit":69,"pfa":"David G. Spencer","psa":"J. Traber","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1975006228","eid":"W1975006228"},{"id":"paper-w4205300093","cat":"papers","name":"Psychobiological problems in heavy ‘ecstasy’ (MDMA) polydrug users","year":"2000","cit":69,"pfa":"Andrew C. Parrott","psa":"John J. Turner","ptype":"article","src":"https://openalex.org/W4205300093","eid":"W4205300093"},{"id":"paper-w1664551018","cat":"papers","name":"The preclinical pharmacology of mephedrone; not just MDMA by another name","year":"2014","cit":69,"pfa":"Andrew R. Green","psa":"Kevin C.F. Fone","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1664551018","eid":"W1664551018"},{"id":"paper-w1972524714","cat":"papers","name":"Effects of the Hallucinogen Psilocybin on Covert Orienting of Visual Attention in Humans","year":"2002","cit":69,"pfa":"Euphrosyne Gouzoulis‐Mayfrank","psa":"Manfred Spitzer","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1972524714","eid":"W1972524714"},{"id":"paper-w2091295077","cat":"papers","name":"Cognitive Performance of MDMA-Treated Rhesus Monkeys, Sensitivity to Serotonergic Challenge","year":"2002","cit":69,"pfa":"Michael A. Taffe","ptype":"article","src":"https://openalex.org/W2091295077","eid":"W2091295077"},{"id":"paper-w2417725867","cat":"papers","name":"The effects of MDMA and other methylenedioxy-substituted phenylalkylamines on the structure of rat locomotor activity.","year":"1992","cit":69,"pfa":"Martin P. Paulus","psa":"Mark A. Geyer","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2417725867","eid":"W2417725867"},{"id":"paper-w3094915720","cat":"papers","name":"Post-acute psychological effects of classical serotonergic psychedelics: a systematic review and meta-analysis","year":"2020","cit":69,"pfa":"Simon Benjamin Goldberg","psa":"Charles L. Raison","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W3094915720","eid":"W3094915720"},{"id":"paper-w2081808118","cat":"papers","name":"Current Psychiatric Therapies","year":"1967","cit":69,"pfa":"Marjorie C. Meehan","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2081808118","eid":"W2081808118"},{"id":"paper-w2016453581","cat":"papers","name":"New neoclerodane diterpenoids isolated from the leaves of Salvia divinorum and their binding affinities for human κ opioid receptors","year":"2005","cit":69,"pfa":"David Y.W. Lee","psa":"Bruce M. Cohen","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2016453581","eid":"W2016453581"},{"id":"paper-w2118100568","cat":"papers","name":"Further evidence that the delayed temporal dopaminergic effects of LSD are mediated by a mechanism different than the first temporal phase of action","year":"2007","cit":69,"pfa":"Danuta Marona‐Lewicka","psa":"David E. Nichols","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2118100568","eid":"W2118100568"},{"id":"paper-w3180562559","cat":"papers","name":"Role of the 5-HT2A Receptor in Acute Effects of LSD on Empathy and Circulating Oxytocin","year":"2021","cit":69,"pfa":"Friederike Holze","psa":"Matthias E. Liechti","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3180562559","eid":"W3180562559"},{"id":"paper-w2090085463","cat":"papers","name":"Mazindol Attenuates the 3,4‐Methylenedioxymethamphetamine‐Induced Formation of Hydroxyl Radicals and Long‐Term Depletion of Serotonin in the Striatum","year":"1999","cit":69,"pfa":"Mahalakshmi Shankaran","psa":"Gary A. Gudelsky","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2090085463","eid":"W2090085463"},{"id":"paper-w2095195769","cat":"papers","name":"The Consequences of 3,4-Methylenedioxymethamphetamine Induced CYP2D6 Inhibition in Humans","year":"2008","cit":69,"pfa":"Brian O’Mathúna","psa":"Rafael de la Torre","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2095195769","eid":"W2095195769"},{"id":"paper-w2161950360","cat":"papers","name":"Effects of the α2-Adrenergic Agonist Clonidine on the Pharmacodynamics and Pharmacokinetics of 3,4-Methylenedioxymethamphetamine in Healthy Volunteers","year":"2011","cit":69,"pfa":"Cédric M. Hysek","psa":"Matthias E. Liechti","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2161950360","eid":"W2161950360"},{"id":"paper-w2000574341","cat":"papers","name":"Role of the serotonin 5-HT2A receptor in the hyperlocomotive and hyperthermic effects of (+)-3,4-methylenedioxymethamphetamine","year":"2004","cit":69,"pfa":"David V. Herin","psa":"Kathryn A. Cunningham","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2000574341","eid":"W2000574341"},{"id":"paper-w1539150888","cat":"papers","name":"Tyramine receptor (SER‐2) isoforms are involved in the regulation of pharyngeal pumping and foraging behavior in Caenorhabditis elegans","year":"2004","cit":69,"pfa":"Elizabeth Rex","psa":"Richard W. Komuniecki","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1539150888","eid":"W1539150888"},{"id":"paper-w2100884839","cat":"papers","name":"Effect of 3,4-methylenedioxymethamphetamine (\"ecstasy\") on body temperature and liver antioxidant status in mice: influence of ambient temperature","year":"2002","cit":69,"pfa":"Márcia C. Carvalho","psa":"Maria de Lourdes Bastos","ptype":"article","src":"https://openalex.org/W2100884839","eid":"W2100884839"},{"id":"paper-w2068223666","cat":"papers","name":"Determination of amphetamine-type stimulants, ketamine and metabolites in fingernails by gas chromatography–mass spectrometry","year":"2009","cit":69,"pfa":"Jin Young Kim","psa":"Moon Kyo In","ptype":"article","src":"https://openalex.org/W2068223666","eid":"W2068223666"},{"id":"paper-w2898334035","cat":"papers","name":"Common neural signatures of psychedelics: Frequency-specific energy changes and repertoire expansion revealed using connectome-harmonic decomposition","year":"2018","cit":69,"pfa":"Selen Atasoy","psa":"Morten L. Kringelbach","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W2898334035","eid":"W2898334035"},{"id":"paper-w2056647650","cat":"papers","name":"Pharmacological enhancement of exposure-based treatment in PTSD: a qualitative review","year":"2013","cit":69,"pfa":"Rianne A. de Kleine","psa":"Agnes van Minnen","topics":["PTSD & trauma","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2056647650","eid":"W2056647650"},{"id":"paper-w1919102068","cat":"papers","name":"Brain iron and dopamine receptor function.","year":"1983","cit":69,"pfa":"M.B.H. Youdim","psa":"Shlomo Yehuda","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1919102068","eid":"W1919102068"},{"id":"paper-w2245706386","cat":"papers","name":"The Psychotomimetic Agents","year":"1971","cit":69,"pfa":"Sidney Cohen","topics":["Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W2245706386","eid":"W2245706386"},{"id":"paper-w4316036302","cat":"papers","name":"Ketamine and serotonergic psychedelics: An update on the mechanisms and biosignatures underlying rapid-acting antidepressant treatment","year":"2023","cit":69,"pfa":"Jenessa N. Johnston","psa":"Carlos A. Zarate","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4316036302","eid":"W4316036302"},{"id":"paper-w2282046889","cat":"papers","name":"Drug-Induced Attenuation of Alcohol Consumption; A Review and Evaluation of Claimed, Potential or Current Therapies","year":"1973","cit":69,"pfa":"James Mottin","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2282046889","eid":"W2282046889"},{"id":"paper-w4225272835","cat":"papers","name":"Reddit discussions about buprenorphine associated precipitated withdrawal in the era of fentanyl","year":"2022","cit":69,"pfa":"Anthony Spadaro","psa":"Jeanmarie Perrone","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4225272835","eid":"W4225272835"},{"id":"paper-w2130712379","cat":"papers","name":"The efficacy of interviewing young drug users through online chat","year":"2011","cit":69,"pfa":"Monica Jane Barratt","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2130712379","eid":"W2130712379"},{"id":"paper-w2236921590","cat":"papers","name":"Is Off-label repeat prescription of ketamine as a rapid antidepressant safe? Controversies, ethical concerns, and legal implications","year":"2016","cit":69,"pfa":"Melvyn W. Zhang","psa":"Roger Ho","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2236921590","eid":"W2236921590"},{"id":"paper-w2605471194","cat":"papers","name":"Rapid Acting Antidepressants in Chronic Stress Models: Molecular and Cellular Mechanisms","year":"2017","cit":69,"pfa":"Brendan D. Hare","psa":"Ronald S. Duman","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2605471194","eid":"W2605471194"},{"id":"paper-w2047342648","cat":"papers","name":"Interaction of [3H]MK-801 with multiple states of the N-methyl-D-aspartate receptor complex of rat brain.","year":"1989","cit":69,"pfa":"Daniel C. Javitt","psa":"Stephen R. Zukin","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2047342648","eid":"W2047342648"},{"id":"paper-w2804722348","cat":"papers","name":"Blood pressure safety of subanesthetic ketamine for depression: A report on 684 infusions","year":"2018","cit":69,"pfa":"Patricio Riva‐Posse","psa":"William Maffitt McDonald","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2804722348","eid":"W2804722348"},{"id":"paper-w2108576626","cat":"papers","name":"Improvement of Pain Treatment After Major Abdominal Surgery by Intravenous S(+)-Ketamine","year":"2004","cit":69,"pfa":"Helena Argiriadou","psa":"Eberhard Friedrich Kochs","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2108576626","eid":"W2108576626"},{"id":"paper-w1630772525","cat":"papers","name":"Family history of alcohol dependence and antidepressant response to an N‐methyl‐D‐aspartate antagonist in bipolar depression","year":"2012","cit":69,"pfa":"David A. Luckenbaugh","psa":"Carlos A. Zarate","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1630772525","eid":"W1630772525"},{"id":"paper-w2953365016","cat":"papers","name":"(2R,6R)-hydroxynorketamine rapidly potentiates hippocampal glutamatergic transmission through a synapse-specific presynaptic mechanism","year":"2019","cit":69,"pfa":"Lace Marie Riggs","psa":"Todd D. Gould","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2953365016","eid":"W2953365016"},{"id":"paper-w4323365183","cat":"papers","name":"Sustained-Release Esketamine Based Nanoparticle-Hydrogel Delivery System for Neuropathic Pain Management","year":"2023","cit":69,"pfa":"Hao Zhang","psa":"Yuan Zhou","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4323365183","eid":"W4323365183"},{"id":"paper-w4394912930","cat":"papers","name":"Efficacy of a single low dose of esketamine after childbirth for mothers with symptoms of prenatal depression: randomised clinical trial","year":"2024","cit":69,"pfa":"Shuo Wang","psa":"Dong‐Xin Wang","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4394912930","eid":"W4394912930"},{"id":"paper-w4313588441","cat":"papers","name":"The effect of low-dose esketamine on pain and post-partum depression after cesarean section: A prospective, randomized, double-blind clinical trial","year":"2023","cit":69,"pfa":"Jiahong Shen","psa":"Jianliang Sun","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4313588441","eid":"W4313588441"},{"id":"paper-w3214988221","cat":"papers","name":"Augmentative Pharmacological Strategies in Treatment-Resistant Major Depression: A Comprehensive Review","year":"2021","cit":69,"pfa":"Alice Caldiroli","psa":"Antonios Dakanalis","topics":["Depression","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3214988221","eid":"W3214988221"},{"id":"paper-w1984420194","cat":"papers","name":"Lysergic Acid Diethylamide","year":"1968","cit":68,"pfa":"Donald B. Louria","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1984420194","eid":"W1984420194"},{"id":"paper-w2965523037","cat":"papers","name":"Biosynthesis of an Anti-Addiction Agent from the Iboga Plant","year":"2019","cit":68,"pfa":"Scott C. Farrow","psa":"Sarah Ellen O'Connor","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2965523037","eid":"W2965523037"},{"id":"paper-w2014505180","cat":"papers","name":"Artificial Psychoses Produced by Mescaline","year":"1936","cit":68,"pfa":"E. Guttmann","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2014505180","eid":"W2014505180"},{"id":"paper-w2135117833","cat":"papers","name":"2-Methoxymethyl-Salvinorin B Is a Potent κ Opioid Receptor Agonist with Longer Lasting Action in Vivo Than Salvinorin A","year":"2007","cit":68,"pfa":"Yu‐Lin Wang","psa":"Lee‐Yuan Liu‐Chen","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2135117833","eid":"W2135117833"},{"id":"paper-w2094840610","cat":"papers","name":"NEUROPHARMACOLOGICAL STUDIES ON IBOGAINE, AN INDOLE ALKALOID WITH CENTRAL‐STIMULANT PROPERTIES","year":"1957","cit":68,"pfa":"Jurg A. Schneider","psa":"E.B. Sigg","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2094840610","eid":"W2094840610"},{"id":"paper-w2308970470","cat":"papers","name":"Ascending Single‐Dose, Double‐Blind, Placebo‐Controlled Safety Study of Noribogaine in Opioid‐Dependent Patients","year":"2016","cit":68,"pfa":"Paul Glue","psa":"Lawrence T. Friedhoff","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2308970470","eid":"W2308970470"},{"id":"paper-w2128808302","cat":"papers","name":"Cytochrome P4502D6 catalyzes the O-demethylation of the psychoactive alkaloid ibogaine to 12-hydroxyibogamine.","year":"1998","cit":68,"pfa":"Ronald Scott Obach","psa":"Deborah C. Mash","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2128808302","eid":"W2128808302"},{"id":"paper-w2030035223","cat":"papers","name":"Cerebral oedema after ingestion of MDMA (“ecstasy”) and unrestricted intake of water","year":"1996","cit":68,"pfa":"S M Matthai","psa":"Dionysios Alexandrou","ptype":"article","src":"https://openalex.org/W2030035223","eid":"W2030035223"},{"id":"paper-w2161210432","cat":"papers","name":"A comparison of the reinforcing efficacy of 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) with cocaine in rhesus monkeys","year":"2004","cit":68,"pfa":"Joshua A. Lile","psa":"Michael A. Nader","ptype":"article","src":"https://openalex.org/W2161210432","eid":"W2161210432"},{"id":"paper-w4312196530","cat":"papers","name":"Psilocybin-assisted therapy improves psycho-social-spiritual well-being in cancer patients","year":"2022","cit":68,"pfa":"Sarah Shnayder","psa":"Manish Agrawal","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4312196530","eid":"W4312196530"},{"id":"paper-w1983482772","cat":"papers","name":"Acute 3,4-methylenedioxymethamphetamine (MDMA) administration produces a rapid and sustained suppression of immune function in the rat","year":"1998","cit":68,"pfa":"Thomas J. Connor","psa":"Brian E. Leonard","ptype":"article","src":"https://openalex.org/W1983482772","eid":"W1983482772"},{"id":"paper-w2003168266","cat":"papers","name":"Repeated weekly exposure to MDMA, methamphetamine or their combination: Long-term behavioural and neurochemical effects in rats","year":"2006","cit":68,"pfa":"Kelly J. Clemens","psa":"Iain S. McGregor","ptype":"article","src":"https://openalex.org/W2003168266","eid":"W2003168266"},{"id":"paper-w4211151055","cat":"papers","name":"The effects of MDMA-assisted therapy on alcohol and substance use in a phase 3 trial for treatment of severe PTSD","year":"2022","cit":68,"pfa":"Christopher R. N. Nicholas","psa":"Rick Doblin","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4211151055","eid":"W4211151055"},{"id":"paper-w1581194755","cat":"papers","name":"A comparative study on the acute and long‐term effects of MDMA and 3,4‐dihydroxymethamphetamine (HHMA) on brain monoamine levels after i.p. or striatal administration in mice","year":"2005","cit":68,"pfa":"Isabel Escobedo","psa":"María Isabel Colado","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1581194755","eid":"W1581194755"},{"id":"paper-w4380605918","cat":"papers","name":"In vivo mapping of pharmacologically induced functional reorganization onto the human brain’s neurotransmitter landscape","year":"2023","cit":68,"pfa":"Andrea I. Luppi","psa":"Emmanuel Andreas Stamatakis","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4380605918","eid":"W4380605918"},{"id":"paper-w2042335851","cat":"papers","name":"Comparison of Effects of LSD and Amphetamine on Midbrain Raphe Units","year":"1969","cit":68,"pfa":"Warren E. Foote","psa":"George K. Aghajanian","ptype":"article","src":"https://openalex.org/W2042335851","eid":"W2042335851"},{"id":"paper-w2009077897","cat":"papers","name":"Clinical Features and Management of Intoxication Due to Hallucinogenic Drugs","year":"1989","cit":68,"pfa":"Jerrold Blair Leikin","psa":"Daniel O. Hryhorczuk","ptype":"article","src":"https://openalex.org/W2009077897","eid":"W2009077897"},{"id":"paper-w2069098438","cat":"papers","name":"Neo-clerodane Diterpenes from the Hallucinogenic Sage Salvia divinorum","year":"2006","cit":68,"pfa":"Osamu Shirota","psa":"Setsuko Sekita","ptype":"article","src":"https://openalex.org/W2069098438","eid":"W2069098438"},{"id":"paper-w2138939084","cat":"papers","name":"Acute Administration of 3,4‐Methylenedioxymethamphetamine Induces Profound Hyperthermia, Blood–Brain Barrier Disruption, Brain Edema Formation, and Cell Injury","year":"2008","cit":68,"pfa":"Hari Shanker Sharma","psa":"Syed F. Ali","topics":["Safety & adverse events","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2138939084","eid":"W2138939084"},{"id":"paper-w2154365468","cat":"papers","name":"Determination of the Designer Drugs 3,4-Methylenedioxymethamphetamine, 3,4-Methylenedioxyethylamphetamine, and 3,4-Methylenedioxyamphetamine with HPLC and Fluorescence Detection in Whole Blood, Serum, Vitreous Humor, and","year":"2000","cit":68,"pfa":"Karine M. Clauwaert","psa":"André P. De Leenheer","ptype":"article","src":"https://openalex.org/W2154365468","eid":"W2154365468"},{"id":"paper-w3081977832","cat":"papers","name":"Phytochemical, Cytotoxicity, Antioxidant and Anti-Inflammatory Effects of Psilocybe Natalensis Magic Mushroom","year":"2020","cit":68,"pfa":"Sanah Malomile Nkadimeng","psa":"Jacobus Nicolaas Eloff","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3081977832","eid":"W3081977832"},{"id":"paper-w2059924500","cat":"papers","name":"Clonidine Transport at the Mouse Blood—Brain Barrier by a New H + Antiporter that Interacts with Addictive Drugs","year":"2009","cit":68,"pfa":"Pascal André","psa":"Salvatore Cisternino","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2059924500","eid":"W2059924500"},{"id":"paper-w2002515362","cat":"papers","name":"Characterization of the 5‐HT receptor subtypes involved in the motor behaviours produced by intrathecal administration of 5‐HT agonists in rats","year":"1991","cit":68,"pfa":"Kevin C.F. Fone","psa":"Charles Alexander Marsden","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2002515362","eid":"W2002515362"},{"id":"paper-w3198659533","cat":"papers","name":"Ancient Roots of Today’s Emerging Renaissance in Psychedelic Medicine","year":"2021","cit":68,"pfa":"Daniel R. George","psa":"Albert Garcia‐Romeu","ptype":"article","src":"https://openalex.org/W3198659533","eid":"W3198659533"},{"id":"paper-w4206615080","cat":"papers","name":"The Rapid Rise in Investment in Psychedelics—Cart Before the Horse","year":"2022","cit":68,"pfa":"Joshua Phelps","psa":"Jeffrey Alan Lieberman","ptype":"article","src":"https://openalex.org/W4206615080","eid":"W4206615080"},{"id":"paper-w2095636457","cat":"papers","name":"Midazolam microdose to determine systemic and pre‐systemic metabolic CYP3A activity in humans","year":"2014","cit":68,"pfa":"Nicolas Hohmann","psa":"Gerd Mikus","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2095636457","eid":"W2095636457"},{"id":"paper-w3041972496","cat":"papers","name":"Psychedelic Research and the Need for Transparency: Polishing Alice’s Looking Glass","year":"2020","cit":68,"pfa":"Rotem Petranker","psa":"Norman A. S. Farb","ptype":"article","src":"https://openalex.org/W3041972496","eid":"W3041972496"},{"id":"paper-w4200167589","cat":"papers","name":"Right-Wing Psychedelia: Case Studies in Cultural Plasticity and Political Pluripotency","year":"2021","cit":68,"pfa":"Brian A. Pace","psa":"Neşe Devenot","ptype":"article","src":"https://openalex.org/W4200167589","eid":"W4200167589"},{"id":"paper-w2004656027","cat":"papers","name":"DOM-stimulus generalization to LSD and other hallucinogenic indolealkylamines","year":"1983","cit":68,"pfa":"Richard A. Glennon","psa":"John A. Rosecrans","ptype":"article","src":"https://openalex.org/W2004656027","eid":"W2004656027"},{"id":"paper-w2259189213","cat":"papers","name":"Angel's Trumpet psychosis: a central nervous system anticholinergic syndrome","year":"1977","cit":68,"pfa":"Richard C.W. Hall","psa":"L E Mchenry","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2259189213","eid":"W2259189213"},{"id":"paper-w4311564573","cat":"papers","name":"Pharmacological Mechanism of the Non-hallucinogenic 5-HT2A Agonist Ariadne and Analogs","year":"2022","cit":68,"pfa":"Michael J. M. Cunningham","psa":"Dalibor Sameš","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4311564573","eid":"W4311564573"},{"id":"paper-w4225774171","cat":"papers","name":"Trips and neurotransmitters: Discovering principled patterns across 6850 hallucinogenic experiences","year":"2022","cit":68,"pfa":"Galen Ballentine","psa":"Danilo Bzdok","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4225774171","eid":"W4225774171"},{"id":"paper-w2002178209","cat":"papers","name":"EEG coherence in post-LSD visual hallucinations","year":"2001","cit":68,"pfa":"Henry David Abraham","psa":"Frank Hopkins Duffy","ptype":"article","src":"https://openalex.org/W2002178209","eid":"W2002178209"},{"id":"paper-w1906159628","cat":"papers","name":"Commonalities and Differences Across Substance Use Disorders: Phenomenological and Epidemiological Aspects","year":"2015","cit":68,"pfa":"Dvora Shmulewitz","psa":"Deborah S. Hasin","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1906159628","eid":"W1906159628"},{"id":"paper-w2187503248","cat":"papers","name":"Case series: toxicity from 25B-NBOMe – a cluster of N-bomb cases","year":"2015","cit":68,"pfa":"Paul Gee","psa":"Stuart Barrington","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2187503248","eid":"W2187503248"},{"id":"paper-w4225666514","cat":"papers","name":"Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2017–2020: A Review","year":"2022","cit":68,"pfa":"Amanda L A Mohr","psa":"Jeri D. Ropero‐Miller","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4225666514","eid":"W4225666514"},{"id":"paper-w2066791439","cat":"papers","name":"Parenteral Ketamine as an Analgesic Adjuvant for Severe Pain: Development and Retrospective Audit of a Protocol for a Palliative Care Unit","year":"2005","cit":68,"pfa":"Edward Fitzgibbon","psa":"Raymond Viola","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2066791439","eid":"W2066791439"},{"id":"paper-w3116555165","cat":"papers","name":"THERAPEUTIC MECHANISMS OF KETAMINE","year":"2020","cit":68,"pfa":"Slobodan Mihaljević","psa":"Marko Čačić","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3116555165","eid":"W3116555165"},{"id":"paper-w2080548934","cat":"papers","name":"The Mood Stabilizer Lithium Potentiates the Antidepressant-Like Effects and Ameliorates Oxidative Stress Induced by Acute Ketamine in a Mouse Model of Stress","year":"2015","cit":68,"pfa":"Chi‐Tso Chiu","psa":"De‐Maw Chuang","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2080548934","eid":"W2080548934"},{"id":"paper-w3007355462","cat":"papers","name":"(S)-norketamine and (2S,6S)-hydroxynorketamine exert potent antidepressant-like effects in a chronic corticosterone-induced mouse model of depression","year":"2020","cit":68,"pfa":"Rei Yokoyama","psa":"Yukio Ago","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W3007355462","eid":"W3007355462"},{"id":"paper-w3004365315","cat":"papers","name":"Cardiac Safety of Esketamine Nasal Spray in Treatment-Resistant Depression: Results from the Clinical Development Program","year":"2020","cit":68,"pfa":"Teodora Doherty","psa":"Michael A. Weber","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3004365315","eid":"W3004365315"},{"id":"paper-w2521511395","cat":"papers","name":"Ketamine’s antidepressant action: beyond NMDA receptor inhibition","year":"2016","cit":68,"pfa":"Kenji Hashimoto","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2521511395","eid":"W2521511395"},{"id":"paper-w2075390507","cat":"papers","name":"Lysergic Acid Diethylamide (LSD) and Lisuride: Differentiation of Their Neuropharmacological Actions","year":"1982","cit":67,"pfa":"Francis J. White","psa":"James B. Appel","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2075390507","eid":"W2075390507"},{"id":"paper-w2009846105","cat":"papers","name":"Iontophoretic release of acetylcholine, noradrenaline, 5‐hydroxytryptamine and d ‐lysergic acid diethylamide from micropipettes","year":"1970","cit":67,"pfa":"Philip B. Bradley","psa":"J.M. Candy","ptype":"article","src":"https://openalex.org/W2009846105","eid":"W2009846105"},{"id":"paper-w2160011379","cat":"papers","name":"A facile method for the preparation of deuterium labeled salvinorin A: synthesis of [2,2,2-2H3]-salvinorin A","year":"2004","cit":67,"pfa":"Kevin Joseph Tidgewell","psa":"Thomas Edward Prisinzano","ptype":"article","src":"https://openalex.org/W2160011379","eid":"W2160011379"},{"id":"paper-w3207752026","cat":"papers","name":"Neurotoxicity of MDMA: Main effects and mechanisms","year":"2021","cit":67,"pfa":"Giulia Costa","psa":"Krystyna Gołembiowska","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3207752026","eid":"W3207752026"},{"id":"paper-w2024868516","cat":"papers","name":"Behavioral effects of MDMA (‘ecstasy’) on adult zebrafish","year":"2011","cit":67,"pfa":"Adam Stewart","psa":"Allan V. Kalueff","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2024868516","eid":"W2024868516"},{"id":"paper-w1998516418","cat":"papers","name":"Drug intelligence based on MDMA tablets data","year":"2008","cit":67,"pfa":"Raymond Marquis","psa":"Frantisek Zrcek","ptype":"article","src":"https://openalex.org/W1998516418","eid":"W1998516418"},{"id":"paper-w2028940007","cat":"papers","name":"Vobasinyl-iboga bisindole alkaloids, potent acetylcholinesterase inhibitors from Tabernaemontana divaricata root","year":"2006","cit":67,"pfa":"Kornkanok Ingkaninan","psa":"Khanit Suwanborirux","ptype":"article","src":"https://openalex.org/W2028940007","eid":"W2028940007"},{"id":"paper-w2089361994","cat":"papers","name":"Standard protecting groups create potent and selective κ opioids: Salvinorin B alkoxymethyl ethers","year":"2007","cit":67,"pfa":"Thomas Anthony Munro","psa":"Cécile Béguin","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2089361994","eid":"W2089361994"},{"id":"paper-w3020950088","cat":"papers","name":"Psilocybin and LSD have no long-lasting effects in an animal model of alcohol relapse","year":"2020","cit":67,"pfa":"Marcus W. Meinhardt","psa":"Rainer Spanagel","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W3020950088","eid":"W3020950088"},{"id":"paper-w2104289848","cat":"papers","name":"Acute effects of nocturnal doses of MDMA on measures of impulsivity and psychomotor performance throughout the night","year":"2007","cit":67,"pfa":"Kim P. C. Kuypers","psa":"Johannes Gerardus Ramaekers","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2104289848","eid":"W2104289848"},{"id":"paper-w2151300113","cat":"papers","name":"Autoregulation of glial cell line‐derived neurotrophic factor expression: implications for the long‐lasting actions of the anti‐addiction drug, Ibogaine","year":"2006","cit":67,"pfa":"Dao‐Yao He","psa":"Dorit Ron","topics":["Addiction","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2151300113","eid":"W2151300113"},{"id":"paper-w2026451284","cat":"papers","name":"MDMA (ecstasy) effects on cultured serotonergic neurons: evidence for Ca2+-dependent toxicity linked to release","year":"1990","cit":67,"pfa":"Efrain C. Azmitia","psa":"Patricia M. Whitaker‐Azmitia","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2026451284","eid":"W2026451284"},{"id":"paper-w3180355975","cat":"papers","name":"Psilocybin Induces Aberrant Prediction Error Processing of Tactile Mismatch Responses—A Simultaneous EEG–FMRI Study","year":"2021","cit":67,"pfa":"Patricia Duerler","psa":"Katrin H. Preller","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3180355975","eid":"W3180355975"},{"id":"paper-w2025216803","cat":"papers","name":"Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”): The Influence of Gender and Genetics (CYP2D6, COMT, 5-HTT)","year":"2012","cit":67,"pfa":"Ricardo Pardo‐Lozano","psa":"Rafael de la Torre","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2025216803","eid":"W2025216803"},{"id":"paper-w2047050449","cat":"papers","name":"The role of 5-HT2A, 5-HT2C and mGlu2 receptors in the behavioral effects of tryptamine hallucinogens N,N-dimethyltryptamine and N,N-diisopropyltryptamine in rats and mice","year":"2014","cit":67,"pfa":"Theresa M. Carbonaro","psa":"Michael B. Gatch","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2047050449","eid":"W2047050449"},{"id":"paper-w2165440826","cat":"papers","name":"Pharmacokinetic Profile of Single and Repeated Oral Doses of MDMA in Squirrel Monkeys: Relationship to Lasting Effects on Brain Serotonin Neurons","year":"2005","cit":67,"pfa":"Annis O. Mechan","psa":"George A. Ricaurte","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2165440826","eid":"W2165440826"},{"id":"paper-w2616295682","cat":"papers","name":"Pooled human liver preparations, HepaRG, or HepG2 cell lines for metabolism studies of new psychoactive substances? A study using MDMA, MDBD, butylone, MDPPP, MDPV, MDPB, 5-MAPB, and 5-API as examples","year":"2017","cit":67,"pfa":"Lilian H.J. Richter","psa":"Markus R. Meyer","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2616295682","eid":"W2616295682"},{"id":"paper-w2083534769","cat":"papers","name":"Chronic LSD alters gene expression profiles in the mPFC relevant to schizophrenia","year":"2014","cit":67,"pfa":"David Alexander Martin","psa":"Charles David Nichols","ptype":"article","src":"https://openalex.org/W2083534769","eid":"W2083534769"},{"id":"paper-w2128418339","cat":"papers","name":"Cortisol and 3,4-Methylenedioxymethamphetamine: Neurohormonal Aspects of Bioenergetic Stress in Ecstasy Users","year":"2009","cit":67,"pfa":"Andrew C. Parrott","topics":["Depression","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2128418339","eid":"W2128418339"},{"id":"paper-w2024698714","cat":"papers","name":"A Pharmacologic Analysis of the Functions of the Spontaneous Electrical Activity of the Cerebral Cortex","year":"1954","cit":67,"pfa":"Abraham Wikler","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2024698714","eid":"W2024698714"},{"id":"paper-w127482867","cat":"papers","name":"Clinical pharmacology of phencyclidine toxicity","year":"1977","cit":67,"pfa":"Craig V. Showalter","psa":"W E Thornton","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W127482867","eid":"W127482867"},{"id":"paper-w2568924325","cat":"papers","name":"Neurotoxicity of β-Keto Amphetamines: Deathly Mechanisms Elicited by Methylone and MDPV in Human Dopaminergic SH-SY5Y Cells","year":"2017","cit":67,"pfa":"Maria João Valente","psa":"Márcia C. Carvalho","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2568924325","eid":"W2568924325"},{"id":"paper-w3129584613","cat":"papers","name":"The Evolved Psychology of Psychedelic Set and Setting: Inferences Regarding the Roles of Shamanism and Entheogenic Ecopsychology","year":"2021","cit":67,"pfa":"Michael Winkelman","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3129584613","eid":"W3129584613"},{"id":"paper-w3193146023","cat":"papers","name":"Increases in Psychological Flexibility Mediate Relationship Between Acute Psychedelic Effects and Decreases in Racial Trauma Symptoms Among People of Color","year":"2021","cit":67,"pfa":"Alan K. Davis","psa":"Monnica T. Williams","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W3193146023","eid":"W3193146023"},{"id":"paper-w2170437441","cat":"papers","name":"The Application of Accelerator Mass Spectrometry to Absolute Bioavailability Studies in Humans: Simultaneous Administration of an Intravenous Microdose of 14C‐Nelfinavir Mesylate Solution and Oral Nelfinavir to Healthy V","year":"2005","cit":67,"pfa":"Nenad Sarapa","psa":"R. Colin Garner","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2170437441","eid":"W2170437441"},{"id":"paper-w2087592711","cat":"papers","name":"Pharmacological blockade of GluN2B-containing NMDA receptors induces antidepressant-like effects lacking psychotomimetic action and neurotoxicity in the perinatal and adult rodent brain","year":"2013","cit":67,"pfa":"Juan M. Lima‐Ojeda","psa":"Dragoš Inta","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2087592711","eid":"W2087592711"},{"id":"paper-w2168165074","cat":"papers","name":"Substance abuse and psychiatric co-morbidity as predictors of premature mortality in Swedish drug abusers a prospective longitudinal study 1970 - 2006","year":"2011","cit":67,"pfa":"Anna Nyhlén","psa":"Peter Krantz","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2168165074","eid":"W2168165074"},{"id":"paper-w2944845898","cat":"papers","name":"The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence","year":"2019","cit":67,"pfa":"Samuel David Clark","psa":"Anissa Abi‐Dargham","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2944845898","eid":"W2944845898"},{"id":"paper-w2214021430","cat":"papers","name":"GluN2D N-Methyl-d-Aspartate Receptor Subunit Contribution to the Stimulation of Brain Activity and Gamma Oscillations by Ketamine: Implications for Schizophrenia","year":"2015","cit":67,"pfa":"Kiran Sapkota","psa":"Daniel T. Monaghan","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2214021430","eid":"W2214021430"},{"id":"paper-w2943410736","cat":"papers","name":"Cannabidiol attenuates aggressive behavior induced by social isolation in mice: Involvement of 5-HT1A and CB1 receptors","year":"2019","cit":67,"pfa":"Alice Hartmann dos Santos","psa":"Francisco Silveira Guimarães","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2943410736","eid":"W2943410736"},{"id":"paper-w4318753825","cat":"papers","name":"Comparative Effectiveness of Intravenous Ketamine and Intranasal Esketamine in Clinical Practice Among Patients With Treatment-Refractory Depression","year":"2023","cit":67,"pfa":"Balwinder Singh","psa":"Jennifer L. Vande Voort","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4318753825","eid":"W4318753825"},{"id":"paper-w4311288647","cat":"papers","name":"Effects of esketamine on analgesia and postpartum depression after cesarean section: A randomized, double-blinded controlled trial","year":"2022","cit":67,"pfa":"Wei Wang","psa":"Wanyou Yu","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4311288647","eid":"W4311288647"},{"id":"paper-w2027585755","cat":"papers","name":"Complications Associated with Lysergic Acid Diethylamide (LSD-25)","year":"1962","cit":66,"pfa":"Sidney Cohen","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2027585755","eid":"W2027585755"},{"id":"paper-w2169304350","cat":"papers","name":"EXPERIMENTAL PHYSIOLOGICAL STUDIES WITH LYSERGIC ACID DIETHYLAMIDE (LSD-25)","year":"1951","cit":66,"pfa":"Gordon R. Forrer","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2169304350","eid":"W2169304350"},{"id":"paper-w3088200196","cat":"papers","name":"Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide Microdoses in Healthy Participants","year":"2020","cit":66,"pfa":"Friederike Holze","psa":"Kim P. C. Kuypers","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3088200196","eid":"W3088200196"},{"id":"paper-w1984431812","cat":"papers","name":"Research on Acute Toxicity and the Behavioral Effects of Methanolic Extract from Psilocybin Mushrooms and Psilocin in Mice","year":"2015","cit":66,"pfa":"Olga V. Zhuk","psa":"Piotr Paweł Wieczorek","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1984431812","eid":"W1984431812"},{"id":"paper-w1966583126","cat":"papers","name":"Second-generation synthesis of salvinorin A","year":"2009","cit":66,"pfa":"Hisahiro Hagiwara","psa":"Toshio Suzuki","ptype":"article","src":"https://openalex.org/W1966583126","eid":"W1966583126"},{"id":"paper-w3126260393","cat":"papers","name":"Use of psilocybin (“mushrooms”) among US adults: 2015–2018","year":"2021","cit":66,"pfa":"R. Andrew Yockey","psa":"Keith A. King","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3126260393","eid":"W3126260393"},{"id":"paper-w3112557491","cat":"papers","name":"Psilocybin-Assisted Group Therapy and Attachment: Observed Reduction in Attachment Anxiety and Influences of Attachment Insecurity on the Psilocybin Experience","year":"2020","cit":66,"pfa":"Christopher S. Stauffer","psa":"Joshua D. Woolley","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3112557491","eid":"W3112557491"},{"id":"paper-w2005338085","cat":"papers","name":"Functional MRI study of working memory in MDMA users","year":"2004","cit":66,"pfa":"Frederick Gerard Moeller","psa":"Perry Franklin Renshaw","ptype":"article","src":"https://openalex.org/W2005338085","eid":"W2005338085"},{"id":"paper-w2028312987","cat":"papers","name":"Impurity profiling of seized MDMA tablets by capillary gas chromatography","year":"2002","cit":66,"pfa":"Fabien Palhol","psa":"Martine Chabrillat","ptype":"article","src":"https://openalex.org/W2028312987","eid":"W2028312987"},{"id":"paper-w2159738140","cat":"papers","name":"A reliable model of intravenous MDMA self-administration in naïve mice","year":"2005","cit":66,"pfa":"José Manuel Trigo","psa":"Patricia Robledo","ptype":"article","src":"https://openalex.org/W2159738140","eid":"W2159738140"},{"id":"paper-w4380151127","cat":"papers","name":"HOPE: A Pilot Study of Psilocybin Enhanced Group Psychotherapy in Patients With Cancer","year":"2023","cit":66,"pfa":"Benjamin R. Lewis","psa":"Paul D. Thielking","topics":["Anxiety & end-of-life","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4380151127","eid":"W4380151127"},{"id":"paper-w3159875688","cat":"papers","name":"The epidemiology of mescaline use: Pattern of use, motivations for consumption, and perceived consequences, benefits, and acute and enduring subjective effects","year":"2021","cit":66,"pfa":"Malin Vedøy Uthaug","psa":"Johannes Gerardus Ramaekers","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3159875688","eid":"W3159875688"},{"id":"paper-w2114905492","cat":"papers","name":"Usefulness of Sweat Testing for the Detection of MDMA after a Single-Dose Administration*","year":"2003","cit":66,"pfa":"Simona Pichini","psa":"Rafael de la Torre","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2114905492","eid":"W2114905492"},{"id":"paper-w1998774572","cat":"papers","name":"Ibogan, Tacaman, and Cytotoxic Bisindole Alkaloids from Tabernaemontana. Cononusine, an Iboga Alkaloid with Unusual Incorporation of a Pyrrolidone Moiety","year":"2015","cit":66,"pfa":"Kuan‐Hon Lim","psa":"Toh‐Seok Kam","ptype":"article","src":"https://openalex.org/W1998774572","eid":"W1998774572"},{"id":"paper-w4379967727","cat":"papers","name":"Attenuation of psilocybin mushroom effects during and after SSRI/SNRI antidepressant use","year":"2023","cit":66,"pfa":"Natalie Gukasyan","psa":"Sandeep Manel Nayak","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4379967727","eid":"W4379967727"},{"id":"paper-w2050166569","cat":"papers","name":"Unconditioned Behavioral Effects of the Powerful κ-Opioid Hallucinogen Salvinorin A in Nonhuman Primates: Fast Onset and Entry into Cerebrospinal Fluid","year":"2008","cit":66,"pfa":"Eduardo R. Butelman","psa":"Mary Jeanne Kreek","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2050166569","eid":"W2050166569"},{"id":"paper-w2560644411","cat":"papers","name":"Effects of the Naturalβ-Carboline Alkaloid Harmine, a Main Constituent of Ayahuasca, in Memory and in the Hippocampus: A Systematic Literature Review of Preclinical Studies","year":"2016","cit":66,"pfa":"RAFAEL GUIMARÃES DOS SANTOS","psa":"Jaime E. C. Hallak","topics":["Safety & adverse events","Reviews & meta-analyses","Policy & ethics"],"ptype":"review","src":"https://openalex.org/W2560644411","eid":"W2560644411"},{"id":"paper-w1977693639","cat":"papers","name":"Effects of dopamine D 1 - or D 2 -like receptor antagonists on the hypermotive and discriminative stimulus effects of (+)-MDMA","year":"2004","cit":66,"pfa":"Marcy J. Bubar","psa":"Kathryn A. Cunningham","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1977693639","eid":"W1977693639"},{"id":"paper-w2013501709","cat":"papers","name":"Developmental 3,4-methylenedioxymethamphetamine (MDMA) impairs sequential and spatial but not cued learning independent of growth, litter effects or injection stress","year":"2003","cit":66,"pfa":"Michael T. Williams","psa":"Charles V. Vorhees","ptype":"article","src":"https://openalex.org/W2013501709","eid":"W2013501709"},{"id":"paper-w2021806579","cat":"papers","name":"Acute dose of MDMA (75 mg) impairs spatial memory for location but leaves contextual processing of visuospatial information unaffected","year":"2006","cit":66,"pfa":"Kim P. C. Kuypers","psa":"Johannes Gerardus Ramaekers","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2021806579","eid":"W2021806579"},{"id":"paper-w2035179454","cat":"papers","name":"Effect of Repeated (‘Binge’) Dosing of MDMA to Rats Housed at Normal and High Temperature on Neurotoxicdamage to Cerebral 5-Ht and Dopamine Neurones","year":"2004","cit":66,"pfa":"Verónica Sánchez","psa":"A. Richard Green","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2035179454","eid":"W2035179454"},{"id":"paper-w2027739664","cat":"papers","name":"Cerebral activation in abstinent ecstasy (MDMA) users during a working memory task: a functional magnetic resonance imaging (fMRI) study","year":"2003","cit":66,"pfa":"Jörg Daumann","psa":"Euphrosyne Gouzoulis‐Mayfrank","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2027739664","eid":"W2027739664"},{"id":"paper-w2105780952","cat":"papers","name":"Concentrations and Ratios of Amphetamine, Methamphetamine, MDA, MDMA, and MDEA Enantiomers Determined in Plasma Samples from Clinical Toxicology and Driving Under the Influence of Drugs Cases by GC-NICI-MS*","year":"2003","cit":66,"pfa":"Frank T. Peters","psa":"Hans H. Maurer","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2105780952","eid":"W2105780952"},{"id":"paper-w2167955809","cat":"papers","name":"Serotonergic hallucinogens as translational models relevant to schizophrenia","year":"2013","cit":66,"pfa":"Adam L. Halberstadt","psa":"Mark A. Geyer","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2167955809","eid":"W2167955809"},{"id":"paper-w4293101934","cat":"papers","name":"Comparison of psychedelic and near-death or other non-ordinary experiences in changing attitudes about death and dying","year":"2022","cit":66,"pfa":"Mary Margaret Sweeney","psa":"Roland R. Griffiths","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4293101934","eid":"W4293101934"},{"id":"paper-w3124059976","cat":"papers","name":"Classical Psychedelics as Therapeutics in Psychiatry – Current Clinical Evidence and Potential Therapeutic Mechanisms in Substance Use and Mood Disorders","year":"2021","cit":66,"pfa":"Lea Julia Mertens","psa":"Katrin H. Preller","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3124059976","eid":"W3124059976"},{"id":"paper-w2949577636","cat":"papers","name":"Spectral signatures of serotonergic psychedelics and glutamatergic dissociatives","year":"2019","cit":66,"pfa":"Carla Pallavicini","psa":"Enzo Tagliazucchi","ptype":"article","src":"https://openalex.org/W2949577636","eid":"W2949577636"},{"id":"paper-w1881742754","cat":"papers","name":"Cloning and Functional Expression of anAplysia5-HT Receptor Negatively Coupled to Adenylate Cyclase","year":"1998","cit":66,"pfa":"Annie Angers","psa":"Luc DesGroseillers","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1881742754","eid":"W1881742754"},{"id":"paper-w2052694988","cat":"papers","name":"Reduced (±)-3,4-methylenedioxymethamphetamine (“Ecstasy”) metabolism with cytochrome P450 2D6 inhibitors and pharmacogenetic variants in vitro","year":"2002","cit":66,"pfa":"Yamini Ramamoorthy","psa":"Edward M. Sellers","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2052694988","eid":"W2052694988"},{"id":"paper-w2035707040","cat":"papers","name":"Alterations in hippocampal function following repeated exposure to the amphetamine derivative methylenedioxymethamphetamine (“Ecstasy”)","year":"1991","cit":66,"pfa":"John Sharkey","psa":"Paul A. Kelly","ptype":"article","src":"https://openalex.org/W2035707040","eid":"W2035707040"},{"id":"paper-w1585258539","cat":"papers","name":"Pharmacological recruitment of the GABAergic tail of the ventral tegmental area by acute drug exposure","year":"2010","cit":66,"pfa":"Jennifer Kaufling","psa":"Michel Barrot","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1585258539","eid":"W1585258539"},{"id":"paper-w3174895070","cat":"papers","name":"Sustained, Multifaceted Improvements in Mental Well-Being Following Psychedelic Experiences in a Prospective Opportunity Sample","year":"2021","cit":66,"pfa":"Keri Mans","psa":"Robin Lester Carhart-Harris","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3174895070","eid":"W3174895070"},{"id":"paper-w3086689250","cat":"papers","name":"Culture and psychedelic psychotherapy: Ethnic and racial themes from three Black women therapists","year":"2020","cit":66,"pfa":"Monnica T. Williams","psa":"Jamilah R. George","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W3086689250","eid":"W3086689250"},{"id":"paper-w4378472815","cat":"papers","name":"Transformative experience and informed consent to psychedelic-assisted psychotherapy","year":"2023","cit":66,"pfa":"Edward Jacobs","topics":["Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4378472815","eid":"W4378472815"},{"id":"paper-w2892664712","cat":"papers","name":"Psychedelics and the new behaviourism: considering the integration of third-wave behaviour therapies with psychedelic-assisted therapy","year":"2018","cit":66,"pfa":"Zach Walsh","psa":"Michelle S. Thiessen","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2892664712","eid":"W2892664712"},{"id":"paper-w3195045424","cat":"papers","name":"Psychedelic Knowledge and Opinions in Psychiatrists at Two Professional Conferences: An Exploratory Survey","year":"2021","cit":66,"pfa":"Brian Scott Barnett","psa":"Rick Doblin","topics":["Addiction","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3195045424","eid":"W3195045424"},{"id":"paper-w4311825681","cat":"papers","name":"A unified model of ketamine’s dissociative and psychedelic properties","year":"2022","cit":66,"pfa":"M. Marguilho","psa":"Pedro Castro-Rodrigues","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4311825681","eid":"W4311825681"},{"id":"paper-w2051521144","cat":"papers","name":"Shaping the renaissance of psychedelic research","year":"2012","cit":66,"pfa":"Ben Sessa","ptype":"article","src":"https://openalex.org/W2051521144","eid":"W2051521144"},{"id":"paper-w4406845122","cat":"papers","name":"Psychedelic-Induced Neural Plasticity: A Comprehensive Review and a Discussion of Clinical Implications","year":"2025","cit":66,"pfa":"Francesco Weiss","psa":"Donatella Marazziti","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4406845122","eid":"W4406845122"},{"id":"paper-w4323921607","cat":"papers","name":"Restructuring insight: An integrative review of insight in problem-solving, meditation, psychotherapy, delusions and psychedelics","year":"2023","cit":66,"pfa":"Kadi Tulver","psa":"Jaan Aru","topics":["Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4323921607","eid":"W4323921607"},{"id":"paper-w2076767938","cat":"papers","name":"Glycine Transporter Inhibitor Attenuates the Psychotomimetic Effects of Ketamine in Healthy Males: Preliminary Evidence","year":"2011","cit":66,"pfa":"Deepak Cyril D’Souza","psa":"Jacques Schipper","ptype":"article","src":"https://openalex.org/W2076767938","eid":"W2076767938"},{"id":"paper-w2793195254","cat":"papers","name":"Acute Pharmacological Effects of 2C-B in Humans: An Observational Study","year":"2018","cit":66,"pfa":"Esther Papaseit","psa":"Débora González","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2793195254","eid":"W2793195254"},{"id":"paper-w2000982876","cat":"papers","name":"The dextromethorphan analog dimemorfan attenuates kainate‐induced seizures via σ1 receptor activation: comparison with the effects of dextromethorphan","year":"2005","cit":66,"pfa":"Eun‐Joo Shin","psa":"Hyoung‐Chun Kim","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2000982876","eid":"W2000982876"},{"id":"paper-w2026146917","cat":"papers","name":"The Additive Antinociceptive Interaction Between WIN 55,212-2, a Cannabinoid Agonist, and Ketorolac","year":"2006","cit":66,"pfa":"Ahmet Ulugöl","psa":"Ahmet Bulent Dogrul","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2026146917","eid":"W2026146917"},{"id":"paper-w2057346921","cat":"papers","name":"Intrathecal anesthesia with ketamine*1","year":"1998","cit":66,"pfa":"C HAWKSWORTH","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2057346921","eid":"W2057346921"},{"id":"paper-w2604415576","cat":"papers","name":"Subanesthetic ketamine for pain management in hospitalized children, adolescents, and young adults: a single-center cohort study","year":"2017","cit":66,"pfa":"Kathy Ann Sheehy","psa":"Zenaide Quezado","topics":["Addiction","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2604415576","eid":"W2604415576"},{"id":"paper-w4392505460","cat":"papers","name":"Perioperative Adjunctive Esketamine for Postpartum Depression Among Women Undergoing Elective Cesarean Delivery","year":"2024","cit":66,"pfa":"Yu Chen","psa":"Xiaodan Wu","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4392505460","eid":"W4392505460"},{"id":"paper-w4317207262","cat":"papers","name":"Oral ketamine for depression: An updated systematic review","year":"2023","cit":66,"pfa":"Shakila Meshkat","psa":"Joshua Daniel Rosenblat","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W4317207262","eid":"W4317207262"},{"id":"paper-w4401654837","cat":"papers","name":"Glutamatergic Modulators for Major Depression from Theory to Clinical Use","year":"2024","cit":66,"pfa":"Roger S. McIntyre","psa":"Rakesh Jain","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4401654837","eid":"W4401654837"},{"id":"paper-w3186388954","cat":"papers","name":"High sedation needs of critically ill COVID-19 ARDS patients—A monocentric observational study","year":"2021","cit":66,"pfa":"Armin Niklas Flinspach","psa":"Elisabeth Adam","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3186388954","eid":"W3186388954"},{"id":"paper-w1971646691","cat":"papers","name":"Head twitches induced by LSD and quipazine: Similarities and differences","year":"1980","cit":66,"pfa":"J Vetulani","psa":"Anna Rokosz","ptype":"article","src":"https://openalex.org/W1971646691","eid":"W1971646691"},{"id":"paper-w1988081311","cat":"papers","name":"What can we learn about schizophrenia from studying the human model, drug‐induced psychosis?","year":"2013","cit":66,"pfa":"Robin M. Murray","psa":"Marta Di Forti","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1988081311","eid":"W1988081311"},{"id":"paper-w1589735237","cat":"papers","name":"Chapter 2 Mechanisms of action of ibogaine: Relevance to putative therapeutic effects and development of a safer iboga alkaloid congener","year":"2001","cit":65,"pfa":"Stanley D. Glick","psa":"Karen Kathleen Szumlinski","topics":["Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W1589735237","eid":"W1589735237"},{"id":"paper-w1970807094","cat":"papers","name":"Psilocybin and psilocin levels in twenty species from seven genera of wild mushrooms in the Pacific Northwest, U.S.A.","year":"1982","cit":65,"pfa":"Michael W. Beug","psa":"Jeremy Bigwood","ptype":"article","src":"https://openalex.org/W1970807094","eid":"W1970807094"},{"id":"paper-w2891949993","cat":"papers","name":"DARK Classics in Chemical Neuroscience: Ibogaine","year":"2018","cit":65,"pfa":"Michael J. Wasko","psa":"Christopher K. Surratt","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2891949993","eid":"W2891949993"},{"id":"paper-w1993294559","cat":"papers","name":"Effects of MDMA on body temperature in humans","year":"2014","cit":65,"pfa":"Matthias E. Liechti","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1993294559","eid":"W1993294559"},{"id":"paper-w1973316871","cat":"papers","name":"Optimized glucuronide hydrolysis for the detection of psilocin in human urine samples","year":"2003","cit":65,"pfa":"Tooru Kamata","psa":"Hitoshi Tsuchihashi","ptype":"article","src":"https://openalex.org/W1973316871","eid":"W1973316871"},{"id":"paper-w2945318261","cat":"papers","name":"Psilocybin lacks antidepressant-like effect in the Flinders Sensitive Line rat","year":"2019","cit":65,"pfa":"Oskar Hougaard Jefsen","psa":"Heidi Kaastrup Müller","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2945318261","eid":"W2945318261"},{"id":"paper-w2943015453","cat":"papers","name":"Ecstasy: the complete guide: a comprehensive look at the risks and benefits of MDMA","year":"2002","cit":65,"topics":["Safety & adverse events"],"ptype":"book-review","src":"https://openalex.org/W2943015453","eid":"W2943015453"},{"id":"paper-w333491296","cat":"papers","name":"Tracing the “Event” of Drug Use: “Context” and the Coproduction of a Night Out on MDMA","year":"2014","cit":65,"pfa":"Ella Dilkes‐Frayne","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W333491296","eid":"W333491296"},{"id":"paper-w2142271301","cat":"papers","name":"A Clinical Study of the Mescaline Psychosis, with Special Reference to the Mechanism of the Genesis of Schizophrenic and Other Psychotic States","year":"1940","cit":65,"pfa":"G. Tayleur Stockings","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2142271301","eid":"W2142271301"},{"id":"paper-w2903547094","cat":"papers","name":"3,4-methylenedioxymethamphetamine (MDMA) impairs the extinction and reconsolidation of fear memory in rats","year":"2018","cit":65,"pfa":"Holly Sue Hake","psa":"Benjamin N. Greenwood","ptype":"article","src":"https://openalex.org/W2903547094","eid":"W2903547094"},{"id":"paper-w2329445637","cat":"papers","name":"Persistent loss of thermoregulation in the rat induced by 3,4-methylenedioxymethamphetamine (MDMA or \"Ecstasy\") but not by fenfluramine","year":"1998","cit":65,"pfa":"Richard Ian Dafters","psa":"Emily Lynch","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2329445637","eid":"W2329445637"},{"id":"paper-w2804789712","cat":"papers","name":"Relief from intractable phantom pain by combining psilocybin and mirror visual-feedback (MVF)","year":"2018","cit":65,"pfa":"Vilayanur Subramanian Ramachandran","psa":"Albert Lin","ptype":"article","src":"https://openalex.org/W2804789712","eid":"W2804789712"},{"id":"paper-w2045762415","cat":"papers","name":"Effects of MPEP on expression of food‐, MDMA‐ or amphetamine‐conditioned place preference in rats","year":"2005","cit":65,"pfa":"Volker Herzig","psa":"Werner Schmidt","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2045762415","eid":"W2045762415"},{"id":"paper-w2055434589","cat":"papers","name":"Effect of MDMA (ecstasy) on activity and cocaine conditioned place preference in adult and adolescent rats","year":"2006","cit":65,"pfa":"Maria Åberg","psa":"Sari Izenwasser","ptype":"article","src":"https://openalex.org/W2055434589","eid":"W2055434589"},{"id":"paper-w2021048027","cat":"papers","name":"Effects of MDMA on Extracellular Dopamine and Serotonin Levels in Mice Lacking Dopamine and/or Serotonin Transporters","year":"2011","cit":65,"pfa":"Yoko Hagino","psa":"Kazutaka Ikeda","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2021048027","eid":"W2021048027"},{"id":"paper-w2068414924","cat":"papers","name":"Problematic versus non-problematic ecstasy/MDMA use: the influence of drug usage patterns and pre-existing psychiatric factors","year":"2006","cit":65,"pfa":"Kirstie Soar","psa":"Andrew C. Parrott","topics":["Depression","Anxiety & end-of-life","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2068414924","eid":"W2068414924"},{"id":"paper-w4309269582","cat":"papers","name":"Role of 5-HT2A, 5-HT2C, 5-HT1A and TAAR1 Receptors in the Head Twitch Response Induced by 5-Hydroxytryptophan and Psilocybin: Translational Implications","year":"2022","cit":65,"pfa":"Orr Shahar","psa":"Tzuri Lifschytz","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4309269582","eid":"W4309269582"},{"id":"paper-w4376619894","cat":"papers","name":"Oxytocin in response to MDMA provocation test in patients with arginine vasopressin deficiency (central diabetes insipidus): a single-centre, case-control study with nested, randomised, double-blind, placebo-controlled c","year":"2023","cit":65,"pfa":"Cihan Atila","psa":"Mirjam Christ‐Crain","ptype":"article","src":"https://openalex.org/W4376619894","eid":"W4376619894"},{"id":"paper-w1990958891","cat":"papers","name":"History and Future of the Multidisciplinary Association for Psychedelic Studies (MAPS)","year":"2014","cit":65,"pfa":"Amy Emerson","psa":"Rick Doblin","topics":["PTSD & trauma","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W1990958891","eid":"W1990958891"},{"id":"paper-w2314057280","cat":"papers","name":"Effects of Hallucinogenic and Tranquilizing Drugs on Serotonin Evoked Uterine Contractions.","year":"1956","cit":65,"pfa":"E. Costa","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2314057280","eid":"W2314057280"},{"id":"paper-w2002184176","cat":"papers","name":"Developmental effects of 3,4-methylenedioxymethamphetamine: a review","year":"2008","cit":65,"pfa":"Matthew R. Skelton","psa":"Charles V. Vorhees","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2002184176","eid":"W2002184176"},{"id":"paper-w2002956985","cat":"papers","name":"Contribution ???of ???Cytochrome??? P450??2D6??to??3,4-Methylenedioxymethamphetamine Disposition in Humans","year":"2005","cit":65,"pfa":"Mireia Segura","psa":"Rafael de la Torre","ptype":"article","src":"https://openalex.org/W2002956985","eid":"W2002956985"},{"id":"paper-w2019450022","cat":"papers","name":"Is hyperthermia the triggering factor for hepatotoxicity induced by 3,4-methylenedioxymethamphetamine (ecstasy)? An in vitro study using freshly isolated mouse hepatocytes","year":"2001","cit":65,"pfa":"M x E rcia Carvalho","psa":"Maria de Lourdes Bastos","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2019450022","eid":"W2019450022"},{"id":"paper-w2050865511","cat":"papers","name":"LSD and DOB: interaction with 5‐HT2A receptors to inhibit NMDA receptor‐mediated transmission in the rat prefrontal cortex","year":"1999","cit":65,"pfa":"Viktor L. Arvanov","psa":"Rex Y. Wang","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2050865511","eid":"W2050865511"},{"id":"paper-w2972809261","cat":"papers","name":"Introduction: Evidence for entheogen use in prehistory and world religions","year":"2019","cit":65,"pfa":"Michael Winkelman","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2972809261","eid":"W2972809261"},{"id":"paper-w3112064661","cat":"papers","name":"The potential synergistic effects between psychedelic administration and nature contact for the improvement of mental health","year":"2020","cit":65,"pfa":"Sam Gandy","psa":"Rosalind Watts","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3112064661","eid":"W3112064661"},{"id":"paper-w2793119328","cat":"papers","name":"Spiritual Emergency: The Understanding and Treatment of Transpersonal Crises","year":"2017","cit":65,"pfa":"Christina Grof","psa":"Stanislav Grof","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2793119328","eid":"W2793119328"},{"id":"paper-w2111682379","cat":"papers","name":"EVALUATION OF MICRODOSING STRATEGIES FOR STUDIES IN PRECLINICAL DRUG DEVELOPMENT: DEMONSTRATION OF LINEAR PHARMACOKINETICS IN DOGS OF A NUCLEOSIDE ANALOG OVER A 50-FOLD DOSE RANGE","year":"2004","cit":65,"pfa":"Punam Sandhu","psa":"Thomas A. Baillie","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2111682379","eid":"W2111682379"},{"id":"paper-w1984708862","cat":"papers","name":"Psychotomimetic amphetamines: Methoxy 3,4-dialkoxyamphetamines","year":"1964","cit":65,"pfa":"Alexander T. Shulgin","ptype":"article","src":"https://openalex.org/W1984708862","eid":"W1984708862"},{"id":"paper-w1986090648","cat":"papers","name":"Perspectives on Zebrafish Models of Hallucinogenic Drugs and Related Psychotropic Compounds","year":"2013","cit":65,"pfa":"Nikhil Neelkantan","psa":"Allan V. Kalueff","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1986090648","eid":"W1986090648"},{"id":"paper-w1964060986","cat":"papers","name":"Inhibitory effect of propofol on ketamine‐induced c‐Fos expression in the rat posterior cingulate and retrosplenial cortices is mediated by GABAA receptor activation","year":"2003","cit":65,"pfa":"Shinichi Nakao","psa":"Koh Shingu","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1964060986","eid":"W1964060986"},{"id":"paper-w2329340405","cat":"papers","name":"Long-Term Treatment With Ketamine in a 12-Year-Old Girl With Severe Neuropathic Pain Caused by a Cervical Spinal Tumor","year":"2001","cit":65,"pfa":"Pål Klepstad","psa":"Stein Kaasa","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2329340405","eid":"W2329340405"},{"id":"paper-w2083362331","cat":"papers","name":"Possible Pharmacotherapy of the Opioid κ Receptor Agonist for Drug Dependence","year":"2004","cit":65,"pfa":"Ko Hasebe","psa":"Tsutomu Suzuki","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2083362331","eid":"W2083362331"},{"id":"paper-w2030343452","cat":"papers","name":"Biotransformation of ketamine, (Z)-6-hydroxyketamine, and (E)-6-hydroxyketamine by rat, rabbit, and human liver microsomal preparations","year":"1987","cit":65,"pfa":"Thomas F. Woolf","psa":"James David Adams Jr.","ptype":"article","src":"https://openalex.org/W2030343452","eid":"W2030343452"},{"id":"paper-w4323294129","cat":"papers","name":"Investigation of self-treatment with lysergic acid diethylamide and psilocybin mushrooms: Findings from the Global Drug Survey 2020","year":"2023","cit":64,"pfa":"Emma I Kopra","psa":"James Rucker","topics":["PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4323294129","eid":"W4323294129"},{"id":"paper-w2075619963","cat":"papers","name":"Ibogaine-like effects of noribogaine in rats","year":"1996","cit":64,"pfa":"S.D. Glick","psa":"I.M. Maisonneuve","ptype":"article","src":"https://openalex.org/W2075619963","eid":"W2075619963"},{"id":"paper-w2052414519","cat":"papers","name":"Pharmacology of Lysergic Acid Diethylamide and Some of Its Related CompoundS","year":"1957","cit":64,"pfa":"E Rothlin","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2052414519","eid":"W2052414519"},{"id":"paper-w2006898400","cat":"papers","name":"Persistent Palinopsia Following Ingestion of Lysergic Acid Diethylamide (LSD)","year":"1996","cit":64,"pfa":"Aki Kawasaki","topics":["Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2006898400","eid":"W2006898400"},{"id":"paper-w4206486089","cat":"papers","name":"MDMA/ecstasy use and psilocybin use are associated with lowered odds of psychological distress and suicidal thoughts in a sample of US adults","year":"2022","cit":64,"pfa":"Grant M. Jones","psa":"Matthew K. Nock","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4206486089","eid":"W4206486089"},{"id":"paper-w2365917497","cat":"papers","name":"Bioinspired Collective Syntheses of Iboga-Type Indole Alkaloids","year":"2016","cit":64,"pfa":"Gaoyuan Zhao","psa":"Xuegong She","ptype":"article","src":"https://openalex.org/W2365917497","eid":"W2365917497"},{"id":"paper-w2019181379","cat":"papers","name":"In vitrostability and metabolism of salvinorin A in rat plasma","year":"2009","cit":64,"pfa":"Kenji Tsujikawa","psa":"Hiroyuki Inoue","ptype":"article","src":"https://openalex.org/W2019181379","eid":"W2019181379"},{"id":"paper-w1979641096","cat":"papers","name":"Ibogaine antagonizes cocaine-induced locomotor stimulation in mice","year":"1992","cit":64,"pfa":"Henry W. Sershen","psa":"Ábel Lajtha","ptype":"article","src":"https://openalex.org/W1979641096","eid":"W1979641096"},{"id":"paper-w1969779696","cat":"papers","name":"Neurotoxicity of Ecstasy (MDMA): An Overview","year":"2010","cit":64,"pfa":"Sumit Sarkar","psa":"Larry C. Schmued","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1969779696","eid":"W1969779696"},{"id":"paper-w2795942031","cat":"papers","name":"Changes in Withdrawal and Craving Scores in Participants Undergoing Opioid Detoxification Utilizing Ibogaine","year":"2018","cit":64,"pfa":"Benjamin Malcolm","psa":"Joseph P. Barsuglia","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2795942031","eid":"W2795942031"},{"id":"paper-w2915085314","cat":"papers","name":"Synthesis and in vitro pharmacological studies of new C(2) modified salvinorin A analogues","year":"2005","cit":64,"pfa":"David Y.W. Lee","psa":"Bruce M. Cohen","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2915085314","eid":"W2915085314"},{"id":"paper-w1968214284","cat":"papers","name":"Psychosocial profiles of older adolescent MDMA users","year":"2004","cit":64,"pfa":"Lynn T. Singer","psa":"Sonia Minnes","ptype":"article","src":"https://openalex.org/W1968214284","eid":"W1968214284"},{"id":"paper-w2340878256","cat":"papers","name":"Behavioral effects of 5-methoxy-N:N-dimethyltryptamine, other tryptamines, and LSD","year":"1962","cit":64,"pfa":"Peter K. Gessner","psa":"Irvine H. Page","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2340878256","eid":"W2340878256"},{"id":"paper-w1998750128","cat":"papers","name":"Fatal poisoning by MDMA (ecstasy) and MDEA: A case report","year":"1996","cit":64,"pfa":"Vittorio Fineschi","psa":"Alessandra Masti","ptype":"article","src":"https://openalex.org/W1998750128","eid":"W1998750128"},{"id":"paper-w4206965048","cat":"papers","name":"Flashback phenomena after administration of LSD and psilocybin in controlled studies with healthy participants","year":"2022","cit":64,"pfa":"Felix Müller","psa":"Stefan Borgwardt","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4206965048","eid":"W4206965048"},{"id":"paper-w2036990896","cat":"papers","name":"Thieno[3,2-b]- and Thieno[2,3-b]pyrrole Bioisosteric Analogues of the Hallucinogen and Serotonin Agonist N,N-Dimethyltryptamine","year":"1999","cit":64,"pfa":"Joseph B. Blair","psa":"David E. Nichols","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2036990896","eid":"W2036990896"},{"id":"paper-w2112422249","cat":"papers","name":"A neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) to rats results in a long term defect in thermoregulation","year":"2001","cit":64,"pfa":"Annis O. Mechan","psa":"Richard A. Green","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2112422249","eid":"W2112422249"},{"id":"paper-w2169957979","cat":"papers","name":"Spatiotemporal Brain Dynamics of Emotional Face Processing Modulations Induced by the Serotonin 1A/2A Receptor Agonist Psilocybin","year":"2013","cit":64,"pfa":"Fosco Bernasconi","psa":"Franz X. Vollenweider","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2169957979","eid":"W2169957979"},{"id":"paper-w3116827302","cat":"papers","name":"Investigating the role of 5-HT2A and 5-HT2C receptor activation in the effects of psilocybin, DOI, and citalopram on marble burying in mice","year":"2020","cit":64,"pfa":"Anna U. Odland","psa":"Jesper Tobias Andreasen","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3116827302","eid":"W3116827302"},{"id":"paper-w2018123394","cat":"papers","name":"Antinociceptive effects of herkinorin, a MOP receptor agonist derived from salvinorin A in the formalin test in rats: New concepts in mu opioid receptor pharmacology: From a symposium on new concepts in mu-opioid pharmac","year":"2011","cit":64,"pfa":"Kenneth R. Lamb","psa":"Thomas Edward Prisinzano","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2018123394","eid":"W2018123394"},{"id":"paper-w3135650175","cat":"papers","name":"On the Relationship between Classic Psychedelics and Suicidality: A Systematic Review","year":"2021","cit":64,"pfa":"Richard J. Zeifman","psa":"Cory R. Weissman","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W3135650175","eid":"W3135650175"},{"id":"paper-w2056168734","cat":"papers","name":"Steric and Electronic Relationships among Some Hallucinogenic Compounds","year":"1970","cit":64,"pfa":"Sungzong Kang","psa":"Jack Peter Green","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2056168734","eid":"W2056168734"},{"id":"paper-w1975552694","cat":"papers","name":"The Use of Hallucinogens in the Treatment of Addiction","year":"1996","cit":64,"pfa":"John H. Halpern","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1975552694","eid":"W1975552694"},{"id":"paper-w29522181","cat":"papers","name":"Platelet serotonin 2A (5-HT2A) receptor characteristics and parenting factors for boys at risk for delinquency: a preliminary report","year":"1996","cit":64,"pfa":"Daniel S Pine","psa":"Bruce Parsons","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W29522181","eid":"W29522181"},{"id":"paper-w4390794773","cat":"papers","name":"Effects of External Stimulation on Psychedelic State Neurodynamics","year":"2024","cit":64,"pfa":"Pedro A. M. Mediano","psa":"Robin Lester Carhart-Harris","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4390794773","eid":"W4390794773"},{"id":"paper-w2342939947","cat":"papers","name":"LSD alters eyes‐closed functional connectivity within the early visual cortex in a retinotopic fashion","year":"2016","cit":64,"pfa":"Leor Roseman","psa":"Robin Lester Carhart-Harris","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2342939947","eid":"W2342939947"},{"id":"paper-w1753881157","cat":"papers","name":"Tolerance and cross-tolerance to the activating effects of 3,4-methylenedioxymethamphetamine and a 5-hydroxytryptamine1B agonist.","year":"1992","cit":64,"pfa":"Clifton W. Callaway","psa":"Mark A. Geyer","ptype":"article","src":"https://openalex.org/W1753881157","eid":"W1753881157"},{"id":"paper-w2761856500","cat":"papers","name":"Acute LSD effects on response inhibition neural networks","year":"2017","cit":64,"pfa":"André Schmidt","psa":"Stefan Borgwardt","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2761856500","eid":"W2761856500"},{"id":"paper-w3033348802","cat":"papers","name":"Electrochemical detection of 3,4-methylenedioxymethamphetamine (ecstasy) using a boron-doped diamond electrode with differential pulse voltammetry: Simple and fast screening method for application in forensic analysis","year":"2020","cit":64,"pfa":"Karine Rocha Teófilo","psa":"Wallans Torres Pio dos Santos","ptype":"article","src":"https://openalex.org/W3033348802","eid":"W3033348802"},{"id":"paper-w2078194303","cat":"papers","name":"Structure-activity studies on hallucinogenic amphetamines using molecular connectivity","year":"1977","cit":64,"pfa":"Lemont B. Kier","psa":"Lowell H. Hall","ptype":"article","src":"https://openalex.org/W2078194303","eid":"W2078194303"},{"id":"paper-w4283269225","cat":"papers","name":"The gut metagenomics and metabolomics signature in patients with inflammatory bowel disease","year":"2022","cit":64,"pfa":"Xinwei Xu","psa":"Fei Mao","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4283269225","eid":"W4283269225"},{"id":"paper-w4361292040","cat":"papers","name":"Ethical and Practical Considerations for the Use of Psychedelics in Psychiatry","year":"2023","cit":64,"pfa":"Gregory Barber","psa":"Charles C. Dike","topics":["Reviews & meta-analyses","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4361292040","eid":"W4361292040"},{"id":"paper-w4385858302","cat":"papers","name":"Psychedelic Commercialization: A Wide-Spanning Overview of the Emerging Psychedelic Industry","year":"2023","cit":64,"pfa":"Jacob S. Aday","psa":"Peter S. Hendricks","topics":["Safety & adverse events","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4385858302","eid":"W4385858302"},{"id":"paper-w2612686287","cat":"papers","name":"The Botanical and Chemical Distribution of Hallucinogens","year":"1970","cit":64,"pfa":"Richard Evans Schultes","ptype":"article","src":"https://openalex.org/W2612686287","eid":"W2612686287"},{"id":"paper-w2054759608","cat":"papers","name":"Hallucinogens, Serotonin and Obsessive-Compulsive Disorder","year":"1998","cit":64,"pfa":"Pedro L. Delgado","psa":"Francisco Moreno","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2054759608","eid":"W2054759608"},{"id":"paper-w2117719880","cat":"papers","name":"Serotonergic Receptor Subtypes and Hallucinogen-Induced Stimulus Control","year":"1999","cit":64,"pfa":"Jerrold C. Winter","psa":"R.A. Rabin","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2117719880","eid":"W2117719880"},{"id":"paper-w2254502929","cat":"papers","name":"The effects of microdose recombinant human erythropoietin regimens in athletes.","year":"2006","cit":64,"pfa":"Michael J. Ashenden","psa":"Michel Audran","topics":["Dosing & pharmacology"],"ptype":"letter","src":"https://openalex.org/W2254502929","eid":"W2254502929"},{"id":"paper-w4402191865","cat":"papers","name":"Clinically relevant acute subjective effects of psychedelics beyond mystical experience","year":"2024","cit":64,"pfa":"David B. Yaden","psa":"Roland R. Griffiths","ptype":"review","src":"https://openalex.org/W4402191865","eid":"W4402191865"},{"id":"paper-w2337075201","cat":"papers","name":"Hallucinogen use and intimate partner violence: Prospective evidence consistent with protective effects among men with histories of problematic substance use","year":"2016","cit":64,"pfa":"Zach Walsh","psa":"Marc T. Swogger","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2337075201","eid":"W2337075201"},{"id":"paper-w2901800473","cat":"papers","name":"Burst SCS Microdosing Is as Efficacious as Standard Burst SCS in Treating Chronic Back and Leg Pain: Results From a Randomized Controlled Trial","year":"2018","cit":64,"pfa":"Jan Vesper","psa":"Tony Van Havenbergh","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2901800473","eid":"W2901800473"},{"id":"paper-w4376630644","cat":"papers","name":"Pharmacological Treatment of Generalised Anxiety Disorder: Current Practice and Future Directions","year":"2023","cit":64,"pfa":"Harry A. Fagan","psa":"David S. Baldwin","topics":["Anxiety & end-of-life","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4376630644","eid":"W4376630644"},{"id":"paper-w4394610842","cat":"papers","name":"A Multi-Level Analysis of Biological, Social, and Psychological Determinants of Substance Use Disorder and Co-Occurring Mental Health Outcomes","year":"2024","cit":64,"pfa":"Cecilia Ilaria Belfiore","psa":"Mirko Casu","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4394610842","eid":"W4394610842"},{"id":"paper-w2413713893","cat":"papers","name":"Return of the lysergamides. Part II: Analytical and behavioural characterization of N6‐allyl‐6‐norlysergic acid diethylamide (AL‐LAD) and (2’S,4’S)‐lysergic acid 2,4‐dimethylazetidide (LSZ)","year":"2016","cit":64,"pfa":"Simon D. Brandt","psa":"Adam L. Halberstadt","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2413713893","eid":"W2413713893"},{"id":"paper-w2020785500","cat":"papers","name":"Metaplastic effects of subanesthetic ketamine on CA1 hippocampal function","year":"2014","cit":64,"pfa":"Yukitoshi Izumi","psa":"Charles F. Zorumski","ptype":"article","src":"https://openalex.org/W2020785500","eid":"W2020785500"},{"id":"paper-w2963643921","cat":"papers","name":"An update on NMDA antagonists in depression","year":"2019","cit":64,"pfa":"Bartłomiej Pochwat","psa":"Bernadeta Szewczyk","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2963643921","eid":"W2963643921"},{"id":"paper-w1998985298","cat":"papers","name":"Pharmacodynamic effects and pharmacokinetic profile of a long‐term continuous rate infusion of racemic ketamine in healthy conscious horses","year":"2006","cit":64,"pfa":"D. P. K. Lankveld","psa":"Ludo J. Hellebrekers","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1998985298","eid":"W1998985298"},{"id":"paper-w2121208444","cat":"papers","name":"Ketamine for depression: evidence, challenges and promise","year":"2015","cit":64,"pfa":"Carlos A. Zarate","psa":"Mark J. Niciu","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W2121208444","eid":"W2121208444"},{"id":"paper-w1973752676","cat":"papers","name":"Determination of lysergic acid diethylamide (LSD), iso-LSD, and N-demethyl-LSD in body fluids by gas chromatography/tandem mass spectrometry","year":"1992","cit":63,"pfa":"Chad C. Nelson","psa":"Rodger L. Foltz","ptype":"article","src":"https://openalex.org/W1973752676","eid":"W1973752676"},{"id":"paper-w2044778613","cat":"papers","name":"Total Synthesis of the Hallucinogenic Neoclerodane Diterpenoid Salvinorin A","year":"2008","cit":63,"pfa":"Masato Nozawa","psa":"Hisahiro Hagiwara","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2044778613","eid":"W2044778613"},{"id":"paper-w2897360754","cat":"papers","name":"Ibogaine as a treatment for substance misuse: Potential benefits and practical dangers","year":"2018","cit":63,"pfa":"John Corkery","topics":["Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W2897360754","eid":"W2897360754"},{"id":"paper-w2768000814","cat":"papers","name":"Why MDMA therapy for alcohol use disorder? And why now?","year":"2017","cit":63,"pfa":"Ben Sessa","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2768000814","eid":"W2768000814"},{"id":"paper-w3012509924","cat":"papers","name":"Neuroprotective potential of Ayahuasca and untargeted metabolomics analyses: applicability to Parkinson's disease","year":"2020","cit":63,"pfa":"Albert Katchborian Neto","psa":"Ana Claudia Chagas de Paula","ptype":"article","src":"https://openalex.org/W3012509924","eid":"W3012509924"},{"id":"paper-w2335134869","cat":"papers","name":"Noncompetitive Inhibition of Indolethylamine- N -methyltransferase by N , N -Dimethyltryptamine and N , N -Dimethylaminopropyltryptamine","year":"2014","cit":63,"pfa":"Uyen Bao Chu","psa":"Arnold E. Ruoho","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2335134869","eid":"W2335134869"},{"id":"paper-w2025075297","cat":"papers","name":"Role of the endocannabinoid system in MDMA intracerebral self‐administration in rats","year":"2002","cit":63,"pfa":"Daniela Braida","psa":"Mariaelvina Sala","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2025075297","eid":"W2025075297"},{"id":"paper-w2010199734","cat":"papers","name":"Effects of Cocaine and MDMA Self-Administration on Serotonin Transporter Availability in Monkeys","year":"2007","cit":63,"pfa":"Matthew L. Banks","psa":"Michael A. Nader","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2010199734","eid":"W2010199734"},{"id":"paper-w1517185267","cat":"papers","name":"Effects of MDMA exposure on the conditioned place preference produced by other drugs of abuse","year":"2003","cit":63,"pfa":"Jon C. Cole","psa":"Charles Alexander Marsden","ptype":"article","src":"https://openalex.org/W1517185267","eid":"W1517185267"},{"id":"paper-w2118617956","cat":"papers","name":"Effects of Salvinorin A, a κ-Opioid Hallucinogen, on a Neuroendocrine Biomarker Assay in Nonhuman Primates with High κ-Receptor Homology to Humans","year":"2006","cit":63,"pfa":"Eduardo R. Butelman","psa":"Mary Jeanne Kreek","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2118617956","eid":"W2118617956"},{"id":"paper-w4310598708","cat":"papers","name":"A Case of Prolonged Mania, Psychosis, and Severe Depression After Psilocybin Use: Implications of Increased Psychedelic Drug Availability","year":"2022","cit":63,"pfa":"Gregory Barber","psa":"Steven Siegel","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4310598708","eid":"W4310598708"},{"id":"paper-w2006241298","cat":"papers","name":"MDMA and fenfluramine reduce L‐DOPA‐induced dyskinesia via indirect 5‐HT1A receptor stimulation","year":"2006","cit":63,"pfa":"Christopher Bishop","psa":"Paul D. Walker","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2006241298","eid":"W2006241298"},{"id":"paper-w2083146318","cat":"papers","name":"Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA (“Ecstasy”) and MDA (“Love”)","year":"2005","cit":63,"pfa":"Ruth McNamara","psa":"Andrew Harkin","ptype":"article","src":"https://openalex.org/W2083146318","eid":"W2083146318"},{"id":"paper-w2921718279","cat":"papers","name":"Perceived Benefits of MDMA-Assisted Psychotherapy beyond Symptom Reduction: Qualitative Follow-Up Study of a Clinical Trial for Individuals with Treatment-Resistant PTSD","year":"2019","cit":63,"pfa":"William P. Barone","psa":"Phillip Perl","topics":["Depression","PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2921718279","eid":"W2921718279"},{"id":"paper-w2079181656","cat":"papers","name":"Neural mechanisms of working memory in ecstasy (MDMA) users who continue or discontinue ecstasy and amphetamine use: Evidence from an 18-month longitudinal functional magnetic resonance imaging study","year":"2004","cit":63,"pfa":"Jörg Daumann","psa":"Euphrosyne Gouzoulis‐Mayfrank","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2079181656","eid":"W2079181656"},{"id":"paper-w3213217218","cat":"papers","name":"Molecular insights into psychedelic drug action","year":"2021","cit":63,"pfa":"Samuel T. Slocum","psa":"Bryan L. Roth","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3213217218","eid":"W3213217218"},{"id":"paper-w2119275464","cat":"papers","name":"Development of Novel Medications for Drug Addiction: The Legacy of an African Shrub","year":"2000","cit":63,"pfa":"Stanley D. Glick","psa":"Isabelle M. Maisonneuve","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2119275464","eid":"W2119275464"},{"id":"paper-w3080361799","cat":"papers","name":"Psychedelics as a Treatment for Alzheimer’s Disease Dementia","year":"2020","cit":63,"pfa":"Simon Vann Jones","psa":"Allison O’Kelly","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3080361799","eid":"W3080361799"},{"id":"paper-w2034861313","cat":"papers","name":"The 5-HT1A receptor and the stimulus effects of LSD in the rat","year":"2005","cit":63,"pfa":"Chad J. Reissig","psa":"Jerrold C. Winter","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2034861313","eid":"W2034861313"},{"id":"paper-w2070726342","cat":"papers","name":"Prenatal 3,4-methylenedioxymethamphetamine (ecstasy) alters exploratory behavior, reduces monoamine metabolism, and increases forebrain tyrosine hydroxylase fiber density of juvenile rats","year":"2003","cit":63,"pfa":"James B. Koprich","psa":"Jack W. Lipton","ptype":"article","src":"https://openalex.org/W2070726342","eid":"W2070726342"},{"id":"paper-w2175311495","cat":"papers","name":"Salvinicins A and B, New Neoclerodane Diterpenes from Salvia divinorum","year":"2005","cit":63,"pfa":"Wayne Wesley Harding","psa":"Thomas Edward Prisinzano","ptype":"article","src":"https://openalex.org/W2175311495","eid":"W2175311495"},{"id":"paper-w2010441475","cat":"papers","name":"Use of Nonprohibited Hallucinogenic Plants: Increasing Relevance for Public health?","year":"2005","cit":63,"pfa":"Reinhild Bücheler","psa":"I. Gaertner","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2010441475","eid":"W2010441475"},{"id":"paper-w4312058527","cat":"papers","name":"The varieties of psychedelic law","year":"2022","cit":63,"pfa":"Mason Marks","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4312058527","eid":"W4312058527"},{"id":"paper-w2745340904","cat":"papers","name":"Novel Psychoactive Substances—Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs","year":"2017","cit":63,"pfa":"Zurina Hassan","psa":"Christian P. Müller","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2745340904","eid":"W2745340904"},{"id":"paper-w2018810216","cat":"papers","name":"Training dose as a factor in LSD-saline discrimination","year":"1982","cit":63,"pfa":"Francis J. White","psa":"James B. Appel","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2018810216","eid":"W2018810216"},{"id":"paper-w2090729149","cat":"papers","name":"Antagonist action of progesterone at σ-receptors in the modulation of voltage-gated sodium channels","year":"2010","cit":63,"pfa":"Molly Johannessen","psa":"Meyer B. Jackson","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2090729149","eid":"W2090729149"},{"id":"paper-w3168039611","cat":"papers","name":"Spontaneous Spiritual Awakenings: Phenomenology, Altered States, Individual Differences, and Well-Being","year":"2021","cit":63,"pfa":"Jessica Sophie Corneille","psa":"David P. Luke","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W3168039611","eid":"W3168039611"},{"id":"paper-w2065411516","cat":"papers","name":"Involvement of 5‐HT2receptors in the behaviours produced by intrathecal administration of selected 5‐HT agonists and the TRH analogue (CG 3509) to rats","year":"1989","cit":63,"pfa":"Kevin C.F. Fone","psa":"Charles Alexander Marsden","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2065411516","eid":"W2065411516"},{"id":"paper-w3217718387","cat":"papers","name":"Psychedelic‐inspired approaches for treating neurodegenerative disorders","year":"2021","cit":63,"pfa":"Hannah N. Saeger","psa":"David E. Olson","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W3217718387","eid":"W3217718387"},{"id":"paper-w2163453478","cat":"papers","name":"Comparative pharmacokinetics between a microdose and therapeutic dose for clarithromycin, sumatriptan, propafenone, paracetamol (acetaminophen), and phenobarbital in human volunteers","year":"2011","cit":63,"pfa":"Graham Lappin","psa":"Colin R. Garner","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2163453478","eid":"W2163453478"},{"id":"paper-w2747515092","cat":"papers","name":"Fertilizer microdosing enhances maize yields but may exacerbate nutrient mining in maize cropping systems in northern Benin","year":"2017","cit":63,"pfa":"Pierre Gbènoukpo Tovihoudji","psa":"Charles Louis Bielders","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2747515092","eid":"W2747515092"},{"id":"paper-w2007052520","cat":"papers","name":"The anesthetics nitrous oxide and ketamine are more neurotoxic to old than to young rat brain","year":"2004","cit":63,"pfa":"Vesna Jevtović‐Todorović","psa":"Lisa B. Carter","ptype":"article","src":"https://openalex.org/W2007052520","eid":"W2007052520"},{"id":"paper-w2154665575","cat":"papers","name":"M4 muscarinic receptor knockout mice display abnormal social behavior and decreased prepulse inhibition","year":"2012","cit":63,"pfa":"Hisatsugu Koshimizu","psa":"Tsuyoshi Miyakawa","topics":["Depression","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2154665575","eid":"W2154665575"},{"id":"paper-w2044828322","cat":"papers","name":"Chromosomal Effect in vivo of Exposure to Lysergic Acid Diethylamide","year":"1968","cit":62,"pfa":"Robert S. Sparkes","psa":"Louis P. Bozzetti","ptype":"article","src":"https://openalex.org/W2044828322","eid":"W2044828322"},{"id":"paper-w2141244106","cat":"papers","name":"(+)Lysergic acid diethylamide, but not its nonhallucinogenic congeners, is a potent serotonin 5HT1C receptor agonist.","year":"1991","cit":62,"pfa":"Kevin D. Burris","psa":"Elaine Sanders‐Bush","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2141244106","eid":"W2141244106"},{"id":"paper-w2409471825","cat":"papers","name":"Correlation of performance test scores with “tissue concentration” of lysergic acid diethylamide in human subiects","year":"1968","cit":62,"pfa":"John G. Wagner","psa":"Oscar H.L. Bing","ptype":"article","src":"https://openalex.org/W2409471825","eid":"W2409471825"},{"id":"paper-w2407460961","cat":"papers","name":"Effects of lysergic acid diethylamide, and differences between normals and schizophrenics on the Stroop Color-Word Test.","year":"1998","cit":62,"pfa":"Seymour Wapner","psa":"Donald M. Krus","ptype":"article","src":"https://openalex.org/W2407460961","eid":"W2407460961"},{"id":"paper-w3087462486","cat":"papers","name":"The emerging role of psilocybin and MDMA in the treatment of mental illness","year":"2020","cit":62,"pfa":"Hartej Gill","psa":"Roger S. McIntyre","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3087462486","eid":"W3087462486"},{"id":"paper-w2012834083","cat":"papers","name":"Behavioral Tolerance to Lysergic Acid Diethylamide is Associated with Reduced Serotonin-2A Receptor Signaling in Rat Cortex","year":"2005","cit":62,"pfa":"Paul J. Gresch","psa":"Elaine Sanders‐Bush","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2012834083","eid":"W2012834083"},{"id":"paper-w2037449495","cat":"papers","name":"Mescaline and LSD facilitate the activation of locus coeruleus neurons by peripheral stimuli","year":"1980","cit":62,"pfa":"George K. Aghajanian","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2037449495","eid":"W2037449495"},{"id":"paper-w3027294800","cat":"papers","name":"\"Ecstasy\" (MDMA)-induced panic","year":"1989","cit":62,"pfa":"Patricia M. Whitaker‐Azmitia","psa":"T A Aronson","ptype":"article","src":"https://openalex.org/W3027294800","eid":"W3027294800"},{"id":"paper-w2013501854","cat":"papers","name":"Assessment of the kappa opioid agonist, salvinorin A, as a punisher of drug self-administration in monkeys","year":"2014","cit":62,"pfa":"Kevin B. Freeman","psa":"William L. Woolverton","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2013501854","eid":"W2013501854"},{"id":"paper-w1936638240","cat":"papers","name":"3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy) and Driving Impairment","year":"2001","cit":62,"pfa":"Barry Kerr Logan","psa":"Fiona J. Couper","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1936638240","eid":"W1936638240"},{"id":"paper-w1970428433","cat":"papers","name":"Brain Serotonin Function in MDMA (Ecstasy) Users: Evidence for Persisting Neurotoxicity","year":"2012","cit":62,"pfa":"Margaret M. Benningfield","psa":"Ronald L. Cowan","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1970428433","eid":"W1970428433"},{"id":"paper-w2088737294","cat":"papers","name":"Acute Toxicity of 3,4-Methylenedioxymethamphetamine (MDMA) in Sprague–Dawley and Dark Agouti Rats","year":"1999","cit":62,"pfa":"A Malpass","psa":"Felix Bochner","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2088737294","eid":"W2088737294"},{"id":"paper-w2033243193","cat":"papers","name":"Mechanism of 3,4‐methylenedioxymethamphetamine (MDMA, ecstasy)‐mediated mitochondrial dysfunction in rat liver","year":"2008","cit":62,"pfa":"Kwan–Hoon Moon","psa":"Byoung‐Joon Song","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2033243193","eid":"W2033243193"},{"id":"paper-w4367840575","cat":"papers","name":"How does psilocybin therapy work? An exploration of experiential avoidance as a putative mechanism of change","year":"2023","cit":62,"pfa":"Richard J. Zeifman","psa":"Robin Lester Carhart-Harris","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4367840575","eid":"W4367840575"},{"id":"paper-w2150536952","cat":"papers","name":"Direct analysis of Salvia divinorum leaves for salvinorin A by thin layer chromatography and desorption electrospray ionization multi‐stage tandem mass spectrometry","year":"2010","cit":62,"pfa":"Joseph H. Kennedy","psa":"Justin M. Wiseman","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2150536952","eid":"W2150536952"},{"id":"paper-w4394886406","cat":"papers","name":"Psychological flexibility as a mechanism of change in psilocybin-assisted therapy for major depression: results from an exploratory placebo-controlled trial","year":"2024","cit":62,"pfa":"Jordan Sloshower","psa":"Deepak Cyril D’Souza","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4394886406","eid":"W4394886406"},{"id":"paper-w1992055761","cat":"papers","name":"Effects of MDMA, MDA and MDEA on blood pressure, heart rate, locomotor activity and body temperature in the rat involveα‐adrenoceptors","year":"2006","cit":62,"pfa":"Sotiria Bexis","psa":"James R. Docherty","ptype":"article","src":"https://openalex.org/W1992055761","eid":"W1992055761"},{"id":"paper-w1982396189","cat":"papers","name":"A study of the mechanism of MDMA (‘Ecstasy’)‐induced neurotoxicity of 5‐HT neurones using chlormethiazole, dizocilpine and other protective compounds","year":"1994","cit":62,"pfa":"María Isabel Colado","psa":"A.R. Green","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1982396189","eid":"W1982396189"},{"id":"paper-w1984582808","cat":"papers","name":"The Neurotoxic Effects of 3,4-Methylenedioxymethamphetamine (MDMA) and Methamphetamine on Serotonin, Dopamine, and GABA-ergic Terminals: An In-Vitro Autoradiographic Study In Rats","year":"2004","cit":62,"pfa":"Brian D. Armstrong","psa":"Kazuma Noguchi","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1984582808","eid":"W1984582808"},{"id":"paper-w2021685218","cat":"papers","name":"Characterization of the Discriminative Stimulus Properties Induced by 5‐HT1and 5‐HT2Agonists in Rats","year":"1989","cit":62,"pfa":"Jørn Arnt","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2021685218","eid":"W2021685218"},{"id":"paper-w2026643634","cat":"papers","name":"Alterations in the behavioral effects of LSD by pretreatment with p-chlorophenylalanine and ?-methyl-p-tyrosine","year":"1970","cit":62,"pfa":"James B. Appel","psa":"Daniel X. Freedman","ptype":"article","src":"https://openalex.org/W2026643634","eid":"W2026643634"},{"id":"paper-w4292262959","cat":"papers","name":"The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder","year":"2022","cit":62,"pfa":"Joshua Daniel Rosenblat","psa":"Valerie H. Taylor","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4292262959","eid":"W4292262959"},{"id":"paper-w2010257486","cat":"papers","name":"Monoamine oxidase inhibitors in South American hallucinogenic plants part 2: Constituents of orally-active Myristicaceous hallucinogens","year":"1984","cit":62,"pfa":"Dennis J. McKenna","psa":"F. S. Abbott","ptype":"article","src":"https://openalex.org/W2010257486","eid":"W2010257486"},{"id":"paper-w2005247351","cat":"papers","name":"Quitting Ecstasy: An Investigation of Why People Stop Taking the Drug and Their Subsequent Mental Health","year":"2003","cit":62,"pfa":"Suzanne L. Verheyden","psa":"Helen Valerie Curran","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2005247351","eid":"W2005247351"},{"id":"paper-w1994836350","cat":"papers","name":"Abuse of Ketamine","year":"1980","cit":62,"pfa":"S. Nizam Ahmed","psa":"Leon Petchkovsky","ptype":"article","src":"https://openalex.org/W1994836350","eid":"W1994836350"},{"id":"paper-w1975788629","cat":"papers","name":"3,4 Methylenedioxymethamphetamine-induced conditioned place preference (CPP) is mediated by endocannabinoid system","year":"2004","cit":62,"pfa":"Daniela Braida","psa":"Mariaelvina Sala","ptype":"article","src":"https://openalex.org/W1975788629","eid":"W1975788629"},{"id":"paper-w1910240357","cat":"papers","name":"Substance Abuse and Other Adverse Outcomes for Military-Connected Youth in California","year":"2015","cit":62,"pfa":"Kathrine  S. Sullivan","psa":"Ron Avi Astor","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1910240357","eid":"W1910240357"},{"id":"paper-w2135616701","cat":"papers","name":"Neuronal correlates of visual and auditory alertness in the DMT and ketamine model of psychosis","year":"2009","cit":62,"pfa":"Jörg Daumann","psa":"Euphrosyne Gouzoulis‐Mayfrank","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2135616701","eid":"W2135616701"},{"id":"paper-w4282931386","cat":"papers","name":"Neural mechanisms underlying psilocybin’s therapeutic potential – the need for preclinical in vivo electrophysiology","year":"2022","cit":62,"pfa":"Rebecca Smausz","psa":"John Gigg","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4282931386","eid":"W4282931386"},{"id":"paper-w2013854283","cat":"papers","name":"Structural and Functional Evolution of the Trace Amine-Associated Receptors TAAR3, TAAR4 and TAAR5 in Primates","year":"2010","cit":62,"pfa":"Claudia Stäubert","psa":"Torsten Schöneberg","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2013854283","eid":"W2013854283"},{"id":"paper-w2112619564","cat":"papers","name":"Prevalence and Disposition of Drugs of Abuse and Opioid Treatment Drugs in Oral Fluid","year":"2007","cit":62,"pfa":"Edward J. Cone","psa":"Lolita Tsanaclis","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2112619564","eid":"W2112619564"},{"id":"paper-w4383334773","cat":"papers","name":"Pattern breaking: a complex systems approach to psychedelic medicine","year":"2023","cit":62,"pfa":"Inês Hipólito","psa":"Robin Lester Carhart-Harris","topics":["Safety & adverse events","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4383334773","eid":"W4383334773"},{"id":"paper-w2757390367","cat":"papers","name":"Does psychedelic drug use reduce risk of suicidality? Evidence from a longitudinal community-based cohort of marginalised women in a Canadian setting","year":"2017","cit":62,"pfa":"Elena Argento","psa":"Kate Shannon","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2757390367","eid":"W2757390367"},{"id":"paper-w2994058197","cat":"papers","name":"Neuropharmacological modulation of the aberrant bodily self through psychedelics","year":"2019","cit":62,"pfa":"Jasmine T. Ho","psa":"Bigna Lenggenhager","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2994058197","eid":"W2994058197"},{"id":"paper-w561860986","cat":"papers","name":"Uses and abuses of plant-derived smoke: its ethnobotany as hallucinogen, perfume, incense, and medicine","year":"2011","cit":62,"topics":["Addiction"],"ptype":"book-review","src":"https://openalex.org/W561860986","eid":"W561860986"},{"id":"paper-w2973627003","cat":"papers","name":"Race as a component of set and setting: How experiences of race can influence psychedelic experiences","year":"2019","cit":62,"pfa":"Logan Neitzke‐Spruill","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2973627003","eid":"W2973627003"},{"id":"paper-w3029260735","cat":"papers","name":"Broadening Your Mind to Include Others: The relationship between serotonergic psychedelic experiences and maladaptive narcissism","year":"2020","cit":62,"pfa":"Valerie van Mulukom","psa":"Michiel van Elk","ptype":"article","src":"https://openalex.org/W3029260735","eid":"W3029260735"},{"id":"paper-w2003430572","cat":"papers","name":"Hallucinogenic drug induced states resemble acute endogenous psychoses: results of an empirical study","year":"1998","cit":62,"pfa":"Euphrosyne Gouzoulis‐Mayfrank","psa":"H Sass","ptype":"article","src":"https://openalex.org/W2003430572","eid":"W2003430572"},{"id":"paper-w4402327722","cat":"papers","name":"Antidepressant and anxiolytic effects of activating 5HT2A receptors in the anterior cingulate cortex and the theoretical mechanisms underlying them – A scoping review of available literature","year":"2024","cit":62,"pfa":"Leonor Miranda","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4402327722","eid":"W4402327722"},{"id":"paper-w1775977861","cat":"papers","name":"Exploring the Association between Lifetime Prevalence of Mental Illness and Transition from Substance Use to Substance Use Disorders: Results from the National Epidemiologic Survey of Alcohol and Related Conditions (NESA","year":"2013","cit":62,"pfa":"Shaul Lev‐Ran","psa":"Bernard Le Foll","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1775977861","eid":"W1775977861"},{"id":"paper-w2116207690","cat":"papers","name":"Prevalence of Use, Abuse and Dependence of Illicit Drugs among Adolescents and Young Adults in a Community Sample","year":"1998","cit":62,"pfa":"Axel Perkonigg","psa":"Hans‐Ulrich Wïttchen","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2116207690","eid":"W2116207690"},{"id":"paper-w3014355680","cat":"papers","name":"A Randomized Trial of the N-Methyl-d-Aspartate Receptor Glycine Site Antagonist Prodrug 4-Chlorokynurenine in Treatment-Resistant Depression","year":"2020","cit":62,"pfa":"Lawrence T. Park","psa":"Carlos A. Zarate","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3014355680","eid":"W3014355680"},{"id":"paper-w2883574984","cat":"papers","name":"Expression of heat shock protein HSP-70 in the retrosplenial cortex of rat brain after administration of (R,S)-ketamine and (S)-ketamine, but not (R)-ketamine","year":"2018","cit":62,"pfa":"Z. Ryan Tian","psa":"Kenji Hashimoto","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2883574984","eid":"W2883574984"},{"id":"paper-w4323031002","cat":"papers","name":"Arketamine as adjunctive therapy for treatment-resistant depression: A placebo-controlled pilot study","year":"2023","cit":62,"pfa":"Gustavo Carneiro-Gomes Leal","psa":"Lucas C. Quarantini","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4323031002","eid":"W4323031002"},{"id":"paper-w2903075408","cat":"papers","name":"Mouse, rat, and dog bioavailability and mouse oral antidepressant efficacy of ( 2R,6R )-hydroxynorketamine","year":"2018","cit":62,"pfa":"Jaclyn N. Highland","psa":"Todd D. Gould","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2903075408","eid":"W2903075408"},{"id":"paper-w4390877045","cat":"papers","name":"Esketamine Prevents Postoperative Emotional and Cognitive Dysfunction by Suppressing Microglial M1 Polarization and Regulating the BDNF-TrkB Pathway in Ageing Rats with Preoperative Sleep Disturbance","year":"2024","cit":62,"pfa":"Yuxin Wen","psa":"Jianliang Sun","topics":["Depression","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4390877045","eid":"W4390877045"},{"id":"paper-w2164158534","cat":"papers","name":"The effect of N,N-dimethyltryptamine in human subjects tolerant to lysergic acid diethylamide","year":"1964","cit":61,"pfa":"D. E. Rosenberg","psa":"C. R. Logan","ptype":"article","src":"https://openalex.org/W2164158534","eid":"W2164158534"},{"id":"paper-w1184321860","cat":"papers","name":"Noribogaine is a G-protein biased κ-opioid receptor agonist","year":"2015","cit":61,"pfa":"Émeline L. Maillet","psa":"Deborah C. Mash","topics":["Addiction","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1184321860","eid":"W1184321860"},{"id":"paper-w2144085872","cat":"papers","name":"Ibogaine neurotoxicity: a re-evaluation","year":"1996","cit":61,"pfa":"Helen H. Molinari","psa":"S.D. Glick","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2144085872","eid":"W2144085872"},{"id":"paper-w2132500168","cat":"papers","name":"Ascending-dose study of noribogaine in healthy volunteers: Pharmacokinetics, pharmacodynamics, safety, and tolerability","year":"2014","cit":61,"pfa":"Paul Glue","psa":"Lawrence T. Friedhoff","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2132500168","eid":"W2132500168"},{"id":"paper-w4207030820","cat":"papers","name":"Administration of N,N-dimethyltryptamine (DMT) in psychedelic therapeutics and research and the study of endogenous DMT","year":"2022","cit":61,"pfa":"Steven A. Barker","ptype":"article","src":"https://openalex.org/W4207030820","eid":"W4207030820"},{"id":"paper-w2040089228","cat":"papers","name":"The threshold lowering effects of MDMA (ecstasy) on brain-stimulation reward","year":"1988","cit":61,"pfa":"Carol B. Hubner","psa":"Conan H. Kornetsky","ptype":"article","src":"https://openalex.org/W2040089228","eid":"W2040089228"},{"id":"paper-w2106188235","cat":"papers","name":"Hallucinogen persisting perception disorder after psilocybin consumption: a case study","year":"2005","cit":61,"pfa":"Marie-Laure Espiard","psa":"Sonia Dollfus","ptype":"article","src":"https://openalex.org/W2106188235","eid":"W2106188235"},{"id":"paper-w2091944060","cat":"papers","name":"Functional Consequences of Repeated (±)3,4-Methylenedioxymethamphetamine (MDMA) Treatment in Rhesus Monkeys","year":"2001","cit":61,"pfa":"Michael A. Taffe","ptype":"article","src":"https://openalex.org/W2091944060","eid":"W2091944060"},{"id":"paper-w2142240281","cat":"papers","name":"Early loss of dopaminergic terminals in striosomes after MDMA administration to mice","year":"2007","cit":61,"pfa":"Noelia Granado","psa":"Rosario Moratalla","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2142240281","eid":"W2142240281"},{"id":"paper-w2765698196","cat":"papers","name":"Subjective effectiveness of ibogaine treatment for problematic opioid consumption: Short- and long-term outcomes and current psychological functioning","year":"2017","cit":61,"pfa":"Alan K. Davis","psa":"Martín Polanco","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W2765698196","eid":"W2765698196"},{"id":"paper-w1986543617","cat":"papers","name":"Mescaline effects on rat behavior and its time profile in serum and brain tissue after a single subcutaneous dose","year":"2007","cit":61,"pfa":"Tomáš Páleníček","psa":"Jiřı́ Horáček","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1986543617","eid":"W1986543617"},{"id":"paper-w2064232494","cat":"papers","name":"Screening for and validated quantification of phenethylamine‐type designer drugs and mescaline in human blood plasma by gas chromatography/mass spectrometry","year":"2005","cit":61,"pfa":"Vilma Habrdová","psa":"Hans H. Maurer","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2064232494","eid":"W2064232494"},{"id":"paper-w2000671143","cat":"papers","name":"Confirmation of amphetamine, methamphetamine, MDA and MDMA in urine samples using disk solid-phase extraction and gas chromatography–mass spectrometry after immunoassay screening","year":"2003","cit":61,"pfa":"Zengping Huang","psa":"Shaoyu Zhang","ptype":"article","src":"https://openalex.org/W2000671143","eid":"W2000671143"},{"id":"paper-w3092151265","cat":"papers","name":"Microdosing psychedelics: Subjective benefits and challenges, substance testing behavior, and the relevance of intention","year":"2020","cit":61,"pfa":"Rotem Petranker","psa":"ADAM R. WINSTOCK","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3092151265","eid":"W3092151265"},{"id":"paper-w3092548915","cat":"papers","name":"Potential safety, benefits, and influence of the placebo effect in microdosing psychedelic drugs: A systematic review","year":"2020","cit":61,"pfa":"Genís Oña","psa":"José Carlos Bouso","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W3092548915","eid":"W3092548915"},{"id":"paper-w2129945845","cat":"papers","name":"The dangers of LSD. Analysis of seven months' experience in a university hospital's psychiatric service","year":"1966","cit":61,"pfa":"J. Thomas Ungerleider","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2129945845","eid":"W2129945845"},{"id":"paper-w2464973388","cat":"papers","name":"Flashback and Hallucinogen Persisting Perception Disorder: clinical aspects and pharmacological treatment approach.","year":"2002","cit":61,"pfa":"Arturo G. Lerner","psa":"Abraham Weizman","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2464973388","eid":"W2464973388"},{"id":"paper-w4283211919","cat":"papers","name":"Sustained effects of single doses of classical psychedelics in humans","year":"2022","cit":61,"pfa":"Gitte M. Knudsen","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4283211919","eid":"W4283211919"},{"id":"paper-w2507802242","cat":"papers","name":"Pharmacological Chaperones of the Dopamine Transporter Rescue Dopamine Transporter Deficiency Syndrome Mutations in Heterologous Cells","year":"2016","cit":61,"pfa":"Pieter Beerepoot","psa":"Ali Salahpour","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2507802242","eid":"W2507802242"},{"id":"paper-w2086331548","cat":"papers","name":"Long-term compulsive exercise reduces the rewarding efficacy of 3,4-methylenedioxymethamphetamine","year":"2007","cit":61,"pfa":"Hsiun Ing Chen","psa":"Lung Yu","ptype":"article","src":"https://openalex.org/W2086331548","eid":"W2086331548"},{"id":"paper-w2142771875","cat":"papers","name":"Ecstasy (3,4-Methylenedioxymethamphetamine): History, Neurochemistry, and Toxicology","year":"1999","cit":61,"pfa":"J. A. Rochester","psa":"Jeffrey T. Kirchner","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2142771875","eid":"W2142771875"},{"id":"paper-w2026436713","cat":"papers","name":"Methylenedioxymethamphetamine's capacity to establish place preferences and modify intake of an alcoholic beverage","year":"1990","cit":61,"pfa":"Edward J. Bilsky","psa":"Larry D. Reid","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2026436713","eid":"W2026436713"},{"id":"paper-w2117219351","cat":"papers","name":"Endogenous hallucinogens as ligands of the trace amine receptors: A possible role in sensory perception","year":"2008","cit":61,"pfa":"Jason V. Wallach","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2117219351","eid":"W2117219351"},{"id":"paper-w2079702200","cat":"papers","name":"New electrochemical method for the determination of β-carboline alkaloids, harmalol and harmine, in human urine samples and in Banisteriopsis caapi","year":"2014","cit":61,"pfa":"Dalibor M. Stanković","psa":"Kurt Kalcher","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2079702200","eid":"W2079702200"},{"id":"paper-w1986248725","cat":"papers","name":"Micro-solid phase extraction coupled with high-performance liquid chromatography–tandem mass spectrometry for the determination of stimulants, hallucinogens, ketamine and phencyclidine in oral fluids","year":"2010","cit":61,"pfa":"Manuel Sergi","psa":"Roberta Risoluti","ptype":"article","src":"https://openalex.org/W1986248725","eid":"W1986248725"},{"id":"paper-w2020948394","cat":"papers","name":"Metabolic pathways of the psychotropic-carboline alkaloids, harmaline and harmine, by liquid chromatography/mass spectrometry and NMR spectroscopy","year":"2012","cit":61,"pfa":"Ting Zhao","psa":"Zhengtao Wang","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2020948394","eid":"W2020948394"},{"id":"paper-w1888940232","cat":"papers","name":"BIOCHEMICAL ASPECTS OF THE ACTIONS OF PSYCHOTOMIMETIC DRUGS","year":"1965","cit":61,"pfa":"Nicholas J. Giarman","psa":"Daniel X. Freedman","ptype":"article","src":"https://openalex.org/W1888940232","eid":"W1888940232"},{"id":"paper-w3161861567","cat":"papers","name":"Psychedelics and Consciousness: Distinctions, Demarcations, and Opportunities","year":"2021","cit":61,"pfa":"David B. Yaden","psa":"Frederick Streeter Barrett","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3161861567","eid":"W3161861567"},{"id":"paper-w3108632668","cat":"papers","name":"2019: A year of expansion in psychedelic research, industry, and deregulation","year":"2020","cit":61,"pfa":"Jacob S. Aday","psa":"Christopher C. Davoli","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3108632668","eid":"W3108632668"},{"id":"paper-w4412520959","cat":"papers","name":"The polypharmacology of psychedelics reveals multiple targets for potential therapeutics","year":"2025","cit":61,"pfa":"Manish Kumar Jain","psa":"Bryan L. Roth","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4412520959","eid":"W4412520959"},{"id":"paper-w1911522785","cat":"papers","name":"EVALUATION OF MICRODOSING TO ASSESS PHARMACOKINETIC LINEARITY IN RATS USING LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY","year":"2005","cit":61,"pfa":"Suresh K. Balani","psa":"Gerald T. Miwa","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1911522785","eid":"W1911522785"},{"id":"paper-w2749408017","cat":"papers","name":"Interactions of Hallucinogens with the Glutamatergic System: Permissive Network Effects Mediated Through Cortical Layer V Pyramidal Neurons","year":"2017","cit":61,"pfa":"Gerard J. Marek","ptype":"book-chapter","src":"https://openalex.org/W2749408017","eid":"W2749408017"},{"id":"paper-w2234371484","cat":"papers","name":"Antichounergic Psychotomimetic Agents","year":"1962","cit":61,"pfa":"Leo G. Abood","psa":"John H. Biel","ptype":"book-chapter","src":"https://openalex.org/W2234371484","eid":"W2234371484"},{"id":"paper-w2409938610","cat":"papers","name":"Psychotomimetic drugs as anticholinergic agents. II. Quantum-mechanical study of molecular interaction potentials of 1-cyclohexylpiperidine derivatives with the cholinergic receptor.","year":"1973","cit":61,"pfa":"Harel Weinstein","psa":"Mordechai Sokolovsky","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2409938610","eid":"W2409938610"},{"id":"paper-w2979144408","cat":"papers","name":"Fully automated head-twitch detection system for the study of 5-HT2A receptor pharmacology in vivo","year":"2019","cit":61,"pfa":"Mario de la Fuente Revenga","psa":"Javier González-Maeso","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2979144408","eid":"W2979144408"},{"id":"paper-w2073516247","cat":"papers","name":"Phase 0 Clinical Trials: An Answer to Drug Development Stagnation?","year":"2009","cit":61,"pfa":"Patricia Mucci LoRusso","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2073516247","eid":"W2073516247"},{"id":"paper-w3005582604","cat":"papers","name":"Overlap in the neural circuitry and molecular mechanisms underlying ketamine abuse and its use as an antidepressant","year":"2020","cit":61,"pfa":"Saurabh S. Kokane","psa":"Linda I. Perrotti","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3005582604","eid":"W3005582604"},{"id":"paper-w2551378537","cat":"papers","name":"Cannabidiol Regulation of Learned Fear: Implications for Treating Anxiety-Related Disorders","year":"2016","cit":61,"pfa":"Regimantas Jurkus","psa":"Carl W. Stevenson","topics":["PTSD & trauma","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2551378537","eid":"W2551378537"},{"id":"paper-w2895770075","cat":"papers","name":"Cortical Excitability and Activation of TrkB Signaling During Rebound Slow Oscillations Are Critical for Rapid Antidepressant Responses","year":"2018","cit":61,"pfa":"Samuel Kohtala","psa":"Tomi Rantamäki","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2895770075","eid":"W2895770075"},{"id":"paper-w2895589451","cat":"papers","name":"Comparative study of esketamine and racemic ketamine in treatment-resistant depression","year":"2018","cit":61,"pfa":"Fernanda S. Correia‐Melo","psa":"Lucas C. Quarantini","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2895589451","eid":"W2895589451"},{"id":"paper-w4205972859","cat":"papers","name":"Effect of low-dose esketamine on pain control and postpartum depression after cesarean section: a retrospective cohort study","year":"2021","cit":61,"pfa":"Ye Wang","psa":"Haiming Luo","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4205972859","eid":"W4205972859"},{"id":"paper-w4376505825","cat":"papers","name":"Esketamine is neuroprotective against traumatic brain injury through its modulation of autophagy and oxidative stress via AMPK/mTOR-dependent TFEB nuclear translocation","year":"2023","cit":61,"pfa":"Tang Yanbin","psa":"Xingzhi Liao","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4376505825","eid":"W4376505825"},{"id":"paper-w1981113766","cat":"papers","name":"Lysergic Acid Diethylamide (LSD-25) and Ego Functions","year":"1963","cit":60,"pfa":"Gerald D. Klee","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1981113766","eid":"W1981113766"},{"id":"paper-w2184493925","cat":"papers","name":"Mescaline, LSD, Psilocybin, and Personality Change a Review†","year":"1963","cit":60,"pfa":"Sanford M. Unger","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2184493925","eid":"W2184493925"},{"id":"paper-w4362596352","cat":"papers","name":"5-MeO-DMT modifies innate behaviors and promotes structural neural plasticity in mice","year":"2023","cit":60,"pfa":"Sarah J. Jefferson","psa":"Alex C. Kwan","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4362596352","eid":"W4362596352"},{"id":"paper-w4396224564","cat":"papers","name":"In vitro and in vivo metabolism of psilocybin’s active metabolite psilocin","year":"2024","cit":60,"pfa":"Jan Thomann","psa":"Urs Duthaler","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4396224564","eid":"W4396224564"},{"id":"paper-w1997029623","cat":"papers","name":"Discriminative profile of MDMA","year":"1986","cit":60,"pfa":"Martin Schechter","ptype":"article","src":"https://openalex.org/W1997029623","eid":"W1997029623"},{"id":"paper-w2100578874","cat":"papers","name":"Suppressive Effect of Mitragynine on the 5-Methoxy-N,N-dimethyltryptamine-Induced Head-Twitch Response in Mice","year":"1997","cit":60,"pfa":"Kinzo Matsumoto","psa":"Hiroshi Watanabe","ptype":"article","src":"https://openalex.org/W2100578874","eid":"W2100578874"},{"id":"paper-w2108846054","cat":"papers","name":"The Potential Dangers of Using MDMA for Psychotherapy","year":"2014","cit":60,"pfa":"Andrew C. Parrott","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2108846054","eid":"W2108846054"},{"id":"paper-w2398840382","cat":"papers","name":"Enantioselective synthesis of Iboga alkaloids and vinblastine via rearrangements of quaternary ammoniums","year":"2016","cit":60,"pfa":"Yun Zhang","psa":"Tuoping Luo","ptype":"article","src":"https://openalex.org/W2398840382","eid":"W2398840382"},{"id":"paper-w1487746450","cat":"papers","name":"Tryptamine and dimethyltryptamine inhibit indoleamine 2,3 dioxygenase and increase the tumor‐reactive effect of peripheral blood mononuclear cells","year":"2013","cit":60,"pfa":"Melissa Cavalheiro Tourino","psa":"Ana Čampa","topics":["Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1487746450","eid":"W1487746450"},{"id":"paper-w4316511384","cat":"papers","name":"Psychedelic integration challenges: Participant experiences after a psilocybin truffle retreat in the Netherlands","year":"2023","cit":60,"pfa":"Anna Lutkajtis","psa":"Jules Evans","topics":["Safety & adverse events","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4316511384","eid":"W4316511384"},{"id":"paper-w2751840258","cat":"papers","name":"From ecstasy to MDMA: Recreational drug use, symbolic boundaries, and drug trends","year":"2017","cit":60,"pfa":"Marit Edland-Gryt","psa":"Willy Pedersen","ptype":"article","src":"https://openalex.org/W2751840258","eid":"W2751840258"},{"id":"paper-w1593226667","cat":"papers","name":"Caffeine provokes adverse interactions with 3,4‐methylenedioxymethamphetamine (MDMA, ‘ecstasy’) and related psychostimulants: mechanisms and mediators","year":"2012","cit":60,"pfa":"Natacha Vanattou‐Saïfoudine","psa":"Andrew Harkin","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1593226667","eid":"W1593226667"},{"id":"paper-w2017646919","cat":"papers","name":"Effects of Cortical Serotonin Depletion Induced by 3,4-Methylenedioxymethamphetamine (MDMA) on Behavior, Before and After Additional Cholinergic Blockade","year":"1993","cit":60,"pfa":"Terry E. Robinson","psa":"Ian Q. Whishaw","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2017646919","eid":"W2017646919"},{"id":"paper-w1992095498","cat":"papers","name":"Changes in serotonin, dopamine and noradrenaline levels in striatum and nucleus accumbens after repeated administration of the abused drug MDMA in rats","year":"2001","cit":60,"pfa":"Andreas Mayerhofer","psa":"Werner Schmidt","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1992095498","eid":"W1992095498"},{"id":"paper-w2006009021","cat":"papers","name":"LSD in Mice: Abnormalities in Meiotic Chromosomes","year":"1968","cit":60,"pfa":"Niels  Erik Skakkebæk","psa":"Ole J. Rafaelsen","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2006009021","eid":"W2006009021"},{"id":"paper-w3133542189","cat":"papers","name":"The Use of Classic Hallucinogens/Psychedelics in a Therapeutic Context: Healthcare Policy Opportunities and Challenges","year":"2021","cit":60,"pfa":"RAFAEL GUIMARÃES DOS SANTOS","psa":"Jaime E. C. Hallak","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3133542189","eid":"W3133542189"},{"id":"paper-w4211011432","cat":"papers","name":"The Therapeutic Potential of Psychedelic-assisted Therapies for Symptom Control in Patients Diagnosed With Serious Illness: A Systematic Review","year":"2022","cit":60,"pfa":"Lucas Oliveira Maia","psa":"Ana Cláudia Mesquita Garcia","topics":["Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4211011432","eid":"W4211011432"},{"id":"paper-w4240261099","cat":"papers","name":"LSD and chromosomes. A controlled experiment","year":"1969","cit":60,"pfa":"JOE HIN TJIO","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4240261099","eid":"W4240261099"},{"id":"paper-w2258968192","cat":"papers","name":"Effects of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine isomers on central serotonergic, dopaminergic and nigral neurotensin systems of the rat.","year":"1988","cit":60,"pfa":"M Johnson","psa":"James W. Gibb","ptype":"article","src":"https://openalex.org/W2258968192","eid":"W2258968192"},{"id":"paper-w1969054340","cat":"papers","name":"Solar retinopathy from sun-gazing under the influence of LSD.","year":"1973","cit":60,"pfa":"H. Schatz","psa":"Frank I. Mendelblatt","ptype":"article","src":"https://openalex.org/W1969054340","eid":"W1969054340"},{"id":"paper-w1991998611","cat":"papers","name":"Hallucinogenic phenylethylamines: Interactions with serotonin turnover and receptors","year":"1974","cit":60,"pfa":"Nils‐Erik Andén","psa":"James L. Meek","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1991998611","eid":"W1991998611"},{"id":"paper-w2090730172","cat":"papers","name":"Long‐term impairment of anterograde axonal transport along fiber projections originating in the rostral raphe nuclei after treatment with fenfluramine or methylenedioxymethamphetamine","year":"2001","cit":60,"pfa":"Brian T. Callahan","psa":"George A. Ricaurte","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2090730172","eid":"W2090730172"},{"id":"paper-w2003884779","cat":"papers","name":"Pharmañopo—Psychonautics: Human Intranasal, Sublingual, Intrarectal, Pulmonary and Oral Pharmacology of Bufotenine","year":"2001","cit":60,"pfa":"Jonathan Ott","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2003884779","eid":"W2003884779"},{"id":"paper-w2973110642","cat":"papers","name":"Cardiotoxicity screening of illicit drugs and new psychoactive substances (NPS) in human iPSC-derived cardiomyocytes using microelectrode array (MEA) recordings","year":"2019","cit":60,"pfa":"Anne Zwartsen","psa":"Laura Hondebrink","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2973110642","eid":"W2973110642"},{"id":"paper-w2032907021","cat":"papers","name":"London audit of drug‐related overdose deaths: characteristics and typology, and implications for prevention and monitoring","year":"2006","cit":60,"pfa":"Matthew Hickman","psa":"John Aaron Henry","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2032907021","eid":"W2032907021"},{"id":"paper-w4308117869","cat":"papers","name":"Clinically Relevant Drug Interactions with Monoamine Oxidase Inhibitors","year":"2022","cit":60,"pfa":"Amber N. Edinoff","psa":"Alan D. Kaye","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4308117869","eid":"W4308117869"},{"id":"paper-w2168312632","cat":"papers","name":"Liquid chromatography–atmospheric pressure ionization electrospray mass spectrometry determination of “hallucinogenic designer drugs” in urine of consumers","year":"2008","cit":60,"pfa":"Simona Pichini","psa":"Rafael de la Torre","ptype":"article","src":"https://openalex.org/W2168312632","eid":"W2168312632"},{"id":"paper-w2975384869","cat":"papers","name":"Removal of Selected Pharmaceuticals and Personal Care Products in Wastewater Treatment Plant in Jordan","year":"2019","cit":60,"pfa":"Othman Al‐Mashaqbeh","psa":"Daniel D. Snow","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2975384869","eid":"W2975384869"},{"id":"paper-w3203095924","cat":"papers","name":"Psychedelic therapy: a roadmap for wider acceptance and utilization","year":"2021","cit":60,"pfa":"Mason Marks","psa":"Ivan Glenn Cohen","ptype":"article","src":"https://openalex.org/W3203095924","eid":"W3203095924"},{"id":"paper-w4214914300","cat":"papers","name":"The challenges ahead for psychedelic ‘medicine’","year":"2022","cit":60,"pfa":"Suresh D Muthukumaraswamy","psa":"Rachael L. Sumner","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4214914300","eid":"W4214914300"},{"id":"paper-w4311688634","cat":"papers","name":"Treatment-Resistant Bipolar Depression: Therapeutic Trends, Challenges and Future Directions","year":"2022","cit":60,"pfa":"Omar H. Elsayed","psa":"Balwinder Singh","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4311688634","eid":"W4311688634"},{"id":"paper-w4284896320","cat":"papers","name":"At-home, sublingual ketamine telehealth is a safe and effective treatment for moderate to severe anxiety and depression: Findings from a large, prospective, open-label effectiveness trial","year":"2022","cit":60,"pfa":"Thomas D. Hull","psa":"Casey Paleos","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4284896320","eid":"W4284896320"},{"id":"paper-w3187215861","cat":"papers","name":"Two Models of Legalization of Psychedelic Substances","year":"2021","cit":60,"pfa":"William Smith","psa":"Paul S. Appelbaum","topics":["Addiction","Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3187215861","eid":"W3187215861"},{"id":"paper-w2034045987","cat":"papers","name":"Impact of microdosing clinical study — Why necessary and how useful?","year":"2010","cit":60,"pfa":"Yuichi Sugiyama","psa":"Shinji Yamashita","topics":["Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W2034045987","eid":"W2034045987"},{"id":"paper-w2161404275","cat":"papers","name":"Microdose and N and P fertilizer application rates for pearl millet in West Africa","year":"2011","cit":60,"pfa":"M. Bagayoko","psa":"Burkina Faso","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2161404275","eid":"W2161404275"},{"id":"paper-w4308294035","cat":"papers","name":"More than meets the eye: The role of sensory dimensions in psychedelic brain dynamics, experience, and therapeutics","year":"2022","cit":60,"pfa":"Marco Aqil","psa":"Leor Roseman","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4308294035","eid":"W4308294035"},{"id":"paper-w1990381119","cat":"papers","name":"Chronic Psychosis Associated With Long-Term Psychotomimetic Drug Abuse","year":"1970","cit":60,"pfa":"George S. Glass","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1990381119","eid":"W1990381119"},{"id":"paper-w2146788977","cat":"papers","name":"“My Friend Said it was Good LSD”: A Suicide Attempt Following Analytically Confirmed 25I-NBOMe Ingestion","year":"2014","cit":60,"pfa":"Joji Suzuki","psa":"Alphonse Poklis","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2146788977","eid":"W2146788977"},{"id":"paper-w2003236216","cat":"papers","name":"History and Pharmacology of PCP and PCP-Related Analogs","year":"1980","cit":60,"pfa":"Edward F. Domino","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2003236216","eid":"W2003236216"},{"id":"paper-w4313641892","cat":"papers","name":"Alleviating anxiety and taming trauma: Novel pharmacotherapeutics for anxiety disorders and posttraumatic stress disorder","year":"2023","cit":60,"pfa":"Nicolas Singewald","psa":"Andrew Holmes","topics":["PTSD & trauma","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4313641892","eid":"W4313641892"},{"id":"paper-w2028533082","cat":"papers","name":"Acute NMDA Receptor Antagonism Disrupts Synchronization of Action Potential Firing in Rat Prefrontal Cortex","year":"2014","cit":60,"pfa":"Leonardo A. Molina","psa":"Aaron J. Gruber","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2028533082","eid":"W2028533082"},{"id":"paper-w2007187948","cat":"papers","name":"The Investigation of Tramadol Dependence with No History of Substance Abuse: A Cross-Sectional Survey of Spontaneously Reported Cases in Guangzhou City, China","year":"2013","cit":60,"pfa":"Haoran Zhang","psa":"Zhimin Liu","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2007187948","eid":"W2007187948"},{"id":"paper-w4206152634","cat":"papers","name":"Relationship Between Dissociation and Antidepressant Effects of Esketamine Nasal Spray in Patients With Treatment-Resistant Depression","year":"2022","cit":60,"pfa":"Guang Chen","psa":"Wayne C Drevets","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4206152634","eid":"W4206152634"},{"id":"paper-w4220849487","cat":"papers","name":"ED 50 and ED 95 of propofol combined with different doses of esketamine for children undergoing upper gastrointestinal endoscopy: A prospective dose‐finding study using up‐and‐down sequential allocation method","year":"2022","cit":60,"pfa":"Xiaosu Zheng","psa":"Ying Sun","topics":["Safety & adverse events","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4220849487","eid":"W4220849487"},{"id":"paper-w4226172056","cat":"papers","name":"Toward Synergies of Ketamine and Psychotherapy","year":"2022","cit":60,"pfa":"David S. Mathai","psa":"Albert Garcia‐Romeu","topics":["Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4226172056","eid":"W4226172056"},{"id":"paper-w4405977949","cat":"papers","name":"MDMA and MDMA-Assisted Therapy","year":"2025","cit":59,"pfa":"Aaron S. Wolfgang","psa":"Charles B. Nemeroff","topics":["PTSD & trauma","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4405977949","eid":"W4405977949"},{"id":"paper-w3084012977","cat":"papers","name":"Chemical Composition of Traditional and Analog Ayahuasca","year":"2020","cit":59,"pfa":"Helle Kaasik","psa":"Alessandra Sussulini","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3084012977","eid":"W3084012977"},{"id":"paper-w2062548806","cat":"papers","name":"Iboga-Type Alkaloids from Ervatamia officinalis","year":"2014","cit":59,"pfa":"Ben-Qin Tang","psa":"Wen‐Cai Ye","ptype":"article","src":"https://openalex.org/W2062548806","eid":"W2062548806"},{"id":"paper-w2079286631","cat":"papers","name":"Synthesis of Salvinorin A Analogues as Opioid Receptor Probes","year":"2006","cit":59,"pfa":"Kevin Joseph Tidgewell","psa":"Thomas Edward Prisinzano","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2079286631","eid":"W2079286631"},{"id":"paper-w1993675273","cat":"papers","name":"Studies on the Mechanism of Action of Monoamine Oxidase: Metabolism of N,N-Dimethyltryptamine and N,N-Dimethyltryptamine-N-Oxide","year":"1962","cit":59,"pfa":"Thomas Edward Smith","psa":"Sidney Udenfriend","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1993675273","eid":"W1993675273"},{"id":"paper-w1900980019","cat":"papers","name":"Acquisition of MDMA self‐administration: pharmacokinetic factors and MDMA ‐induced serotonin release","year":"2013","cit":59,"pfa":"Sarah Bradbury","psa":"Susan Schenk","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1900980019","eid":"W1900980019"},{"id":"paper-w2796436652","cat":"papers","name":"Peyote Hunt: The Sacred Journey of the Huichol Indians","year":"1973","cit":59,"pfa":"Lee Drummond","psa":"Barbara G. Myerhoff","ptype":"article","src":"https://openalex.org/W2796436652","eid":"W2796436652"},{"id":"paper-w1969221628","cat":"papers","name":"Sociopsychotherapeutic Functions of Ayahuasca Healing in Amazonia","year":"1989","cit":59,"pfa":"Walter Andritzky","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W1969221628","eid":"W1969221628"},{"id":"paper-w1981560069","cat":"papers","name":"Interactions between ibogaine and cocaine in rats: in vivo microdialysis and motor behavior","year":"1992","cit":59,"pfa":"I.M. Maisonneuve","psa":"S.D. Glick","ptype":"article","src":"https://openalex.org/W1981560069","eid":"W1981560069"},{"id":"paper-w2043158710","cat":"papers","name":"Methamphetamine and MDMA (Ecstasy) Neurotoxicity: 'of Mice and Men'","year":"2004","cit":59,"pfa":"Yossef Itzhak","psa":"Cindy Achat‐Mendes","topics":["Safety & adverse events","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2043158710","eid":"W2043158710"},{"id":"paper-w1985795350","cat":"papers","name":"MDMA: On the translation from rodent to human dosing","year":"2009","cit":59,"pfa":"A. Richard Green","psa":"Kevin C.F. Fone","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1985795350","eid":"W1985795350"},{"id":"paper-w1997195617","cat":"papers","name":"Visuospatial memory impairments in users of MDMA (?ecstasy?)","year":"2004","cit":59,"pfa":"Michelle Wareing","psa":"John E. Fisk","ptype":"article","src":"https://openalex.org/W1997195617","eid":"W1997195617"},{"id":"paper-w3215098003","cat":"papers","name":"A Phase 1, Dose-Ranging Study to Assess Safety and Psychoactive Effects of a Vaporized 5-Methoxy-N, N-Dimethyltryptamine Formulation (GH001) in Healthy Volunteers","year":"2021","cit":59,"pfa":"Johannes T. Reckweg","psa":"Johannes Gerardus Ramaekers","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3215098003","eid":"W3215098003"},{"id":"paper-w2031745460","cat":"papers","name":"MDMA (“ecstasy”) abuse: Psychopathological features and craving for chocolate: A case series","year":"1994","cit":59,"pfa":"Fabrizio Schifano","psa":"Guido Magni","ptype":"article","src":"https://openalex.org/W2031745460","eid":"W2031745460"},{"id":"paper-w1541356587","cat":"papers","name":"Dopaminergic mechanisms of reinstatement of MDMA‐seeking behaviour in rats","year":"2010","cit":59,"pfa":"Susan Schenk","psa":"Joyce Colussi‐Mas","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1541356587","eid":"W1541356587"},{"id":"paper-w4294808278","cat":"papers","name":"Effects of psilocybin versus escitalopram on rumination and thought suppression in depression","year":"2022","cit":59,"pfa":"Tommaso Barba","psa":"Robin Lester Carhart-Harris","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4294808278","eid":"W4294808278"},{"id":"paper-w2066440126","cat":"papers","name":"Behavioral and neurochemical effects of prenatal methylenedioxymethamphetamine (MDMA) exposure in rats","year":"1991","cit":59,"pfa":"Vincent E. V. St. Omer","psa":"William Slikker","ptype":"article","src":"https://openalex.org/W2066440126","eid":"W2066440126"},{"id":"paper-w2782326064","cat":"papers","name":"Current Perspective on MDMA-Assisted Psychotherapy for Posttraumatic Stress Disorder","year":"2018","cit":59,"pfa":"Sascha B. Thal","psa":"Miriam J.J. Lommen","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2782326064","eid":"W2782326064"},{"id":"paper-w2079537717","cat":"papers","name":"Brain serotonin transporter binding in former users of MDMA (‘ecstasy’)","year":"2009","cit":59,"pfa":"Sudhakar Selvaraj","psa":"Paul M. Grasby","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2079537717","eid":"W2079537717"},{"id":"paper-w2039286002","cat":"papers","name":"The in vitro identification of dimethyltryptamine (DMT) in mammalian brain and its characterization as a possible endogenous neuroregulatory agent","year":"1977","cit":59,"pfa":"Samuel T. Christian","psa":"John A. Monti","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2039286002","eid":"W2039286002"},{"id":"paper-w4396229906","cat":"papers","name":"Psilocybin promotes neuroplasticity and induces rapid and sustained antidepressant-like effects in mice","year":"2024","cit":59,"pfa":"Xiangting Zhao","psa":"Liming Zhang","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4396229906","eid":"W4396229906"},{"id":"paper-w2166120388","cat":"papers","name":"MDMA induced hyperthermia: a survivor with an initial body temperature of 42.9 degrees C.","year":"1997","cit":59,"pfa":"Abhiram Mallick","psa":"Andrew R Bodenham","ptype":"article","src":"https://openalex.org/W2166120388","eid":"W2166120388"},{"id":"paper-w1995940903","cat":"papers","name":"Synthetic Studies of Neoclerodane Diterpenes from Salvia divinorum: Semisynthesis of Salvinicins A and B and Other Chemical Transformations of Salvinorin A","year":"2005","cit":59,"pfa":"Wayne Wesley Harding","psa":"Thomas Edward Prisinzano","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1995940903","eid":"W1995940903"},{"id":"paper-w2091600915","cat":"papers","name":"Effects of alcohol (BAC 0.5‰) and ecstasy (MDMA 100 mg) on simulated driving performance and traffic safety","year":"2011","cit":59,"pfa":"Janet L. Veldstra","psa":"Ricarda Jantos","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2091600915","eid":"W2091600915"},{"id":"paper-w2065820941","cat":"papers","name":"Cannabinoids prevent the acute hyperthermia and partially protect against the 5-HT depleting effects of MDMA (“Ecstasy”) in rats","year":"2004","cit":59,"pfa":"Kirsten C. Morley","psa":"Iain S. McGregor","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2065820941","eid":"W2065820941"},{"id":"paper-w2125487307","cat":"papers","name":"Determination of MDMA, MDA, MDEA and MBDB in oral fluid using high performance liquid chromatography with native fluorescence detection","year":"2005","cit":59,"pfa":"Marta Concheiro","psa":"Angelines Cruz","ptype":"article","src":"https://openalex.org/W2125487307","eid":"W2125487307"},{"id":"paper-w2061733755","cat":"papers","name":"p-Chloroamphetamine (PCA), 3,4-methylenedioxymethamphetamine (MDMA) andd-fenfluramine pretreatment attenuatesd-fenfluramine-evoked release of 5-HT in vivo","year":"1994","cit":59,"pfa":"Hugh G. Series","psa":"Trevor Sharp","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2061733755","eid":"W2061733755"},{"id":"paper-w2061257044","cat":"papers","name":"Behavioural Effects of some Morphine Antagonists and Hallucinogens in the Rat","year":"1968","cit":59,"pfa":"C Schneider","ptype":"article","src":"https://openalex.org/W2061257044","eid":"W2061257044"},{"id":"paper-w4387893679","cat":"papers","name":"Cardiovascular safety of psychedelic medicine: current status and future directions","year":"2023","cit":59,"pfa":"Agnieszka Wsół","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4387893679","eid":"W4387893679"},{"id":"paper-w2038437906","cat":"papers","name":"5-HT2A receptor-stimulated phosphoinositide hydrolysis in the stimulus effects of hallucinogens","year":"2002","cit":59,"pfa":"Richard A. Rabin","psa":"Jerrold C. Winter","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2038437906","eid":"W2038437906"},{"id":"paper-w3196761093","cat":"papers","name":"The psychedelic experience--a new concept in psychotherapy.","year":"1998","cit":59,"pfa":"Janet Sherwood","psa":"Harman Ww","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3196761093","eid":"W3196761093"},{"id":"paper-w4221108429","cat":"papers","name":"The Acceptance/Avoidance-Promoting Experiences Questionnaire (APEQ): A theory-based approach to psychedelic drugs’ effects on psychological flexibility","year":"2022","cit":59,"pfa":"Max Wolff","psa":"Ricarda Evens","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4221108429","eid":"W4221108429"},{"id":"paper-w2807286797","cat":"papers","name":"Psychedelic use and intimate partner violence: The role of emotion regulation","year":"2018","cit":59,"pfa":"Michelle S. Thiessen","psa":"Adèle Lafrance","topics":["Addiction","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2807286797","eid":"W2807286797"},{"id":"paper-w2004486666","cat":"papers","name":"The claustrum’s proposed role in consciousness is supported by the effect and target localization of Salvia divinorum","year":"2014","cit":59,"pfa":"Klaus  Maximilian Stiefel","psa":"Alex O. Holcombe","topics":["Addiction","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2004486666","eid":"W2004486666"},{"id":"paper-w2094933578","cat":"papers","name":"Hallucinogens and Redemption","year":"2002","cit":59,"pfa":"Marlene Dobkin de Ríos","psa":"John R. Baker","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2094933578","eid":"W2094933578"},{"id":"paper-w3093680025","cat":"papers","name":"RETRACTED ARTICLE: A mechanistic model of the neural entropy increase elicited by psychedelic drugs","year":"2020","cit":59,"pfa":"Ruben A Herzog","psa":"Rodrigo Cofré","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3093680025","eid":"W3093680025"},{"id":"paper-w3123680632","cat":"papers","name":"Use and abuse of dissociative and psychedelic drugs in adolescence","year":"2021","cit":59,"pfa":"M.L. Shawn Bates","psa":"Keith A. Trujillo","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3123680632","eid":"W3123680632"},{"id":"paper-w1907118202","cat":"papers","name":"The Role of Dopaminergic Systems in the Perinatal Sensitivity to 3,4-Methylenedioxymethamphetamine-Induced Neurotoxicity in Rats","year":"1998","cit":59,"pfa":"Norberto Aguirre","psa":"Joaquı́n Del Rı́o","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1907118202","eid":"W1907118202"},{"id":"paper-w2295203871","cat":"papers","name":"Selective 5-hydroxytryptamine2 receptor antagonists protect against the neurotoxicity of methylenedioxymethamphetamine in rats.","year":"1990","cit":59,"pfa":"C J Schmidt","psa":"Vicki L. Taylor","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2295203871","eid":"W2295203871"},{"id":"paper-w2277097137","cat":"papers","name":"Effects of 3,4-methylenedioxymethamphetamine on socioemotional feelings, authenticity, and autobiographical disclosure in healthy volunteers in a controlled setting","year":"2016","cit":59,"pfa":"Matthew J. Baggott","psa":"John E. Mendelson","topics":["Anxiety & end-of-life","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2277097137","eid":"W2277097137"},{"id":"paper-w2051496860","cat":"papers","name":"Interactions of metergoline with diazepam, quipazine, and hallucinogenic drugs on a conflict behavior in the rat","year":"1982","cit":59,"pfa":"Randall L. Commissaris","psa":"Richard H. Rech","ptype":"article","src":"https://openalex.org/W2051496860","eid":"W2051496860"},{"id":"paper-w3200846882","cat":"papers","name":"Safety pharmacology of acute LSD administration in healthy subjects","year":"2021","cit":59,"pfa":"Friederike Holze","psa":"Matthias E. Liechti","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3200846882","eid":"W3200846882"},{"id":"paper-w2023448476","cat":"papers","name":"β‐ADRENOCEPTOR AGONISTS ENHANCE 5‐HYDROXYTRYPTAMINE‐MEDIATED BEHAVIOURAL RESPONSES","year":"1982","cit":59,"pfa":"Philip J. Cowen","psa":"David J. Heal","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2023448476","eid":"W2023448476"},{"id":"paper-w4392369508","cat":"papers","name":"Psychiatric risks for worsened mental health after psychedelic use","year":"2024","cit":59,"pfa":"Alessia Marrocu","psa":"Robin Lester Carhart-Harris","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4392369508","eid":"W4392369508"},{"id":"paper-w4312965454","cat":"papers","name":"A Psychoanalytic Perspective on Psychedelic Experience","year":"2022","cit":59,"pfa":"Jeffrey R. Guss","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4312965454","eid":"W4312965454"},{"id":"paper-w570263944","cat":"papers","name":"Hallucinogens, neurochemical, behavioral, and clinical perspectives","year":"1984","cit":59,"pfa":"Barry L. Jacobs","ptype":"book","src":"https://openalex.org/W570263944","eid":"W570263944"},{"id":"paper-w4401228042","cat":"papers","name":"An Integrated theory of false insights and beliefs under psychedelics","year":"2024","cit":59,"pfa":"Hugh T. McGovern","psa":"Ruben Laukkonen","topics":["Safety & adverse events","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4401228042","eid":"W4401228042"},{"id":"paper-w2794166569","cat":"papers","name":"Comparative neuropharmacology of N-(2-methoxybenzyl)-2,5-dimethoxyphenethylamine (NBOMe) hallucinogens and their 2C counterparts in male rats","year":"2018","cit":59,"pfa":"Joshua S. Elmore","psa":"Michael H. Baumann","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2794166569","eid":"W2794166569"},{"id":"paper-w3166553838","cat":"papers","name":"Day trip to hell: A mixed methods study of challenging psychedelic experiences","year":"2021","cit":59,"pfa":"Petter Grahl Johnstad","ptype":"article","src":"https://openalex.org/W3166553838","eid":"W3166553838"},{"id":"paper-w2076912230","cat":"papers","name":"Effects of 5HT-1A agonists on locomotor and investigatory behaviors in rats differ from those of hallucinogens","year":"1989","cit":59,"pfa":"Susan M. Mittman","psa":"Mark A. Geyer","ptype":"article","src":"https://openalex.org/W2076912230","eid":"W2076912230"},{"id":"paper-w2739110661","cat":"papers","name":"Psychedelic drug use in healthy individuals: A review of benefits, costs, and implications for drug policy","year":"2017","cit":59,"pfa":"James W. B. Elsey","topics":["Safety & adverse events","Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2739110661","eid":"W2739110661"},{"id":"paper-w2042141246","cat":"papers","name":"Minimal stimulation protocol using letrozole versus microdose flare up GnRH agonist protocol in women with poor ovarian response undergoing ICSI","year":"2012","cit":59,"pfa":"Iman Abdel Mohsen","psa":"Rasha Ezz El Din","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2042141246","eid":"W2042141246"},{"id":"paper-w2018774087","cat":"papers","name":"The PCP Psychosis: Prolonged Intoxication or Drug-Precipitated Functional Illness?","year":"1980","cit":59,"pfa":"Robert E. Erard","psa":"Roger Peele","ptype":"article","src":"https://openalex.org/W2018774087","eid":"W2018774087"},{"id":"paper-w1999072976","cat":"papers","name":"Manganese-enhanced magnetic resonance imaging reveals increased DOI-induced brain activity in a mouse model of schizophrenia","year":"2014","cit":59,"pfa":"Natalia V. Malkova","psa":"Paul H. Patterson","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1999072976","eid":"W1999072976"},{"id":"paper-w2138964638","cat":"papers","name":"Use of Non-Occupational Post-Exposure Prophylaxis does not Lead to an Increase in High Risk Sex Behaviors in Men Who have Sex with Men Participating in the EXPLORE Trial","year":"2010","cit":59,"pfa":"Deborah J Donnell","psa":"Thomas J. Coates","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2138964638","eid":"W2138964638"},{"id":"paper-w4408345055","cat":"papers","name":"Expectancy Effects, Failure of Blinding Integrity, and Placebo Response in Trials of Treatments for Psychiatric Disorders","year":"2025","cit":59,"pfa":"Nathan T. M. Huneke","psa":"Samuele Cortese","topics":["Anxiety & end-of-life","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4408345055","eid":"W4408345055"},{"id":"paper-w1966533161","cat":"papers","name":"NMDA antagonist effects on striatal dopamine release: Microdialysis studies in awake monkeys","year":"2001","cit":59,"pfa":"Barbara W. Adams","psa":"Bita Moghaddam","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1966533161","eid":"W1966533161"},{"id":"paper-w4389828495","cat":"papers","name":"The correlation of Esketamine with specific adverse events: a deep dive into the FAERS database","year":"2023","cit":59,"pfa":"Ying Jiang","psa":"Haohao Zhu","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4389828495","eid":"W4389828495"},{"id":"paper-w4385335906","cat":"papers","name":"Predicting outcome with Intranasal Esketamine treatment: A machine-learning, three-month study in Treatment-Resistant Depression (ESK-LEARNING)","year":"2023","cit":59,"pfa":"Mauro Pettorruso","psa":"Giovanni Martinotti","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4385335906","eid":"W4385335906"},{"id":"paper-w4388942032","cat":"papers","name":"Nationwide consensus on the clinical management of treatment-resistant depression in Italy: a Delphi panel","year":"2023","cit":59,"pfa":"Giuseppe Maina","psa":"Enrico Pessina","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4388942032","eid":"W4388942032"},{"id":"paper-w1996279456","cat":"papers","name":"Behavioral effects of α,α,β,β-tetradeutero-5-MeO-DMT in rats: comparison with 5-MeO-DMT administered in combination with a monoamine oxidase inhibitor","year":"2012","cit":58,"pfa":"Adam L. Halberstadt","psa":"Mark A. Geyer","ptype":"article","src":"https://openalex.org/W1996279456","eid":"W1996279456"},{"id":"paper-w2001093441","cat":"papers","name":"THE EFFECTS OF D‐LYSERGIC ACID DIETHYLAMIDE ON CEREBRAL CIRCULATION AND OVER‐ALL METABOLISM","year":"1957","cit":58,"pfa":"Louis Sokoloff","psa":"Seymour S. Kety","ptype":"article","src":"https://openalex.org/W2001093441","eid":"W2001093441"},{"id":"paper-w4307201625","cat":"papers","name":"Low doses of lysergic acid diethylamide (LSD) increase reward-related brain activity","year":"2022","cit":58,"pfa":"James E. Glazer","psa":"Harriet de Wit","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4307201625","eid":"W4307201625"},{"id":"paper-w4382515410","cat":"papers","name":"Australia to prescribe MDMA and psilocybin for PTSD and depression in world first","year":"2023","cit":58,"pfa":"Rich Haridy","topics":["Depression","PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4382515410","eid":"W4382515410"},{"id":"paper-w3087672006","cat":"papers","name":"Efficacy of Psychoactive Drugs for the Treatment of Posttraumatic Stress Disorder: A Systematic Review of MDMA, Ketamine, LSD and Psilocybin","year":"2020","cit":58,"pfa":"Tracey Varker","psa":"Meaghan Louise O'Donnell","topics":["Depression","PTSD & trauma","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W3087672006","eid":"W3087672006"},{"id":"paper-w2773072410","cat":"papers","name":"The serotonin hallucinogen 5-MeO-DMT alters cortico-thalamic activity in freely moving mice: Regionally-selective involvement of 5-HT1A and 5-HT2A receptors","year":"2017","cit":58,"pfa":"Maurizio S. Riga","psa":"Pau Celada","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2773072410","eid":"W2773072410"},{"id":"paper-w2134103301","cat":"papers","name":"Sex Differences in Ibogaine Antagonism of Morphine-induced Locomotor Activity and in Ibogaine Brain Levels and Metabolism","year":"1997","cit":58,"pfa":"Sandra M. Pearl","psa":"S.D. Glick","ptype":"article","src":"https://openalex.org/W2134103301","eid":"W2134103301"},{"id":"paper-w2038839611","cat":"papers","name":"Dephosphorylation of psilocybin in the intact mouse","year":"1962","cit":58,"pfa":"A. Horita","psa":"L. J. Weber","ptype":"article","src":"https://openalex.org/W2038839611","eid":"W2038839611"},{"id":"paper-w2948000230","cat":"papers","name":"Ayahuasca: Uses, Phytochemical and Biological Activities","year":"2019","cit":58,"pfa":"Edgar Antonio Estrella-Parra","psa":"Francisco Javier Alarcón-Aguilar","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2948000230","eid":"W2948000230"},{"id":"paper-w4366742769","cat":"papers","name":"Pharmacokinetics of N,N-dimethyltryptamine in Humans","year":"2023","cit":58,"pfa":"Meghan Good","psa":"Ellen James","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4366742769","eid":"W4366742769"},{"id":"paper-w3044516305","cat":"papers","name":"Modulatory effects of ayahuasca on personality structure in a traditional framework","year":"2020","cit":58,"pfa":"Nige Netzband","psa":"Tom John Wolff","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W3044516305","eid":"W3044516305"},{"id":"paper-w2079634033","cat":"papers","name":"Bringing Ayahuasca to the Clinical Research Laboratory","year":"2005","cit":58,"pfa":"Jordi Riba","psa":"Manel J. Barbanoj","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2079634033","eid":"W2079634033"},{"id":"paper-w2118428004","cat":"papers","name":"Urinary MDMA, MDA, HMMA, and HMA Excretion Following Controlled MDMA Administration to Humans","year":"2009","cit":58,"pfa":"T. T. Abraham","psa":"Marilyn Ann Huestis","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2118428004","eid":"W2118428004"},{"id":"paper-w3125143320","cat":"papers","name":"How ecstasy and psilocybin are shaking up psychiatry","year":"2021","cit":58,"pfa":"Paul Tullis","ptype":"article","src":"https://openalex.org/W3125143320","eid":"W3125143320"},{"id":"paper-w2397724830","cat":"papers","name":"Ayahuasca, caapi, yage. Psychotropic properties of the harmala alkaloids.","year":"1967","cit":58,"pfa":"Bo R. Holmstedt","psa":"J.‐E. Lindgren","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2397724830","eid":"W2397724830"},{"id":"paper-w2953280092","cat":"papers","name":"Ayahuasca, an ancient substance with traditional and contemporary use in neuropsychiatry and neuroscience","year":"2019","cit":58,"pfa":"RAFAEL GUIMARÃES DOS SANTOS","psa":"Jaime E. C. Hallak","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2953280092","eid":"W2953280092"},{"id":"paper-w2796377954","cat":"papers","name":"Psychological variables implied in the therapeutic effect of ayahuasca: A contextual approach","year":"2018","cit":58,"pfa":"Alba Franquesa","psa":"José Carlos Bouso","ptype":"article","src":"https://openalex.org/W2796377954","eid":"W2796377954"},{"id":"paper-w2022199444","cat":"papers","name":"Mescaline‐induced head‐twitches in the rat: An in vivo method to evaluate serotonin S2 antagonists","year":"1983","cit":58,"pfa":"Carlos J. E. Niemegeers","psa":"P.A.J. Janseen","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2022199444","eid":"W2022199444"},{"id":"paper-w3204019137","cat":"papers","name":"Psilocybin for End-of-Life Anxiety Symptoms: A Systematic Review and Meta-Analysis","year":"2021","cit":58,"pfa":"Chia‐Ling Yu","psa":"Chih‐Sung Liang","topics":["Anxiety & end-of-life","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W3204019137","eid":"W3204019137"},{"id":"paper-w2078046027","cat":"papers","name":"Risperidone attenuates and reverses hyperthermia induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats","year":"2008","cit":58,"pfa":"Katsutoshi Shioda","psa":"Satoshi Kato","ptype":"article","src":"https://openalex.org/W2078046027","eid":"W2078046027"},{"id":"paper-w4391540455","cat":"papers","name":"Patient perspectives and experiences with psilocybin treatment for treatment-resistant depression: a qualitative study","year":"2024","cit":58,"pfa":"Joost J. Breeksema","psa":"Robert A. Schoevers","topics":["Depression","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4391540455","eid":"W4391540455"},{"id":"paper-w1519857898","cat":"papers","name":"Cell‐Mediated Immune Response in MDMA Users After Repeated Dose Administration","year":"2002","cit":58,"pfa":"Roberta Pacifici","psa":"Rafael de la Torre","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1519857898","eid":"W1519857898"},{"id":"paper-w2071075833","cat":"papers","name":"Quantification of the plant‐derived hallucinogen Salvinorin A in conventional and non‐conventional biological fluids by gas chromatography/mass spectrometry after Salvia divinorum smoking","year":"2005","cit":58,"pfa":"Simona Pichini","psa":"Piergiorgio Zuccaro","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2071075833","eid":"W2071075833"},{"id":"paper-w2064527612","cat":"papers","name":"Effects of MDMA alone and after pretreatment with reboxetine, duloxetine, clonidine, carvedilol, and doxazosin on pupillary light reflex","year":"2012","cit":58,"pfa":"Cédric M. Hysek","psa":"Matthias E. Liechti","ptype":"article","src":"https://openalex.org/W2064527612","eid":"W2064527612"},{"id":"paper-w2027331991","cat":"papers","name":"MDMA produces a conditioned place preference and elicits ejaculation in male rats: A modulatory role for the endogenous opioids","year":"1991","cit":58,"pfa":"Edward J. Bilsky","psa":"Larry D. Reid","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2027331991","eid":"W2027331991"},{"id":"paper-w4205947596","cat":"papers","name":"Toxicity of ayahuasca after 28 days daily exposure and effects on monoamines and brain-derived neurotrophic factor (BDNF) in brain of Wistar rats","year":"2020","cit":58,"pfa":"Camila Schoueri Colaço","psa":"Eloísa Dutra Caldas","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4205947596","eid":"W4205947596"},{"id":"paper-w1976834001","cat":"papers","name":"Discriminative stimulus effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans trained to discriminate among d-amphetamine, meta-chlorophenylpiperazine and placebo","year":"2005","cit":58,"pfa":"Chris‐Ellyn Johanson","psa":"Manuel E. Tancer","ptype":"article","src":"https://openalex.org/W1976834001","eid":"W1976834001"},{"id":"paper-w2122020940","cat":"papers","name":"Direct analysis of psychoactive tryptamine and harmala alkaloids in the Amazonian botanical medicine ayahuasca by liquid chromatography–electrospray ionization-tandem mass spectrometry","year":"2009","cit":58,"pfa":"Ethan H. McIlhenny","psa":"Steven A. Barker","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2122020940","eid":"W2122020940"},{"id":"paper-w2790056169","cat":"papers","name":"Natural speech algorithm applied to baseline interview data can predict which patients will respond to psilocybin for treatment-resistant depression","year":"2018","cit":58,"pfa":"Facundo Carrillo","psa":"Robin Lester Carhart-Harris","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2790056169","eid":"W2790056169"},{"id":"paper-w2150827861","cat":"papers","name":"Differential long-term effects of MDMA on the serotoninergic system and hippocampal cell proliferation in 5-HTT knock-out vs. wild-type mice","year":"2008","cit":58,"pfa":"Thibault Renoir","psa":"Laurence Lanfumey","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2150827861","eid":"W2150827861"},{"id":"paper-w3203419443","cat":"papers","name":"United States National Institutes of Health grant funding for psychedelic-assisted therapy clinical trials from 2006–2020","year":"2021","cit":58,"pfa":"Brian Scott Barnett","psa":"Jeremy Weleff","ptype":"article","src":"https://openalex.org/W3203419443","eid":"W3203419443"},{"id":"paper-w2009632756","cat":"papers","name":"A characteristic effect of hallucinogens on investigatory responding in rats","year":"1979","cit":58,"pfa":"Mark A. Geyer","psa":"Richard L. Hawkins","ptype":"article","src":"https://openalex.org/W2009632756","eid":"W2009632756"},{"id":"paper-w2020765068","cat":"papers","name":"Can psychedelic compounds play a part in drug dependence therapy?","year":"2015","cit":58,"pfa":"Ben Sessa","psa":"Matthew W. Johnson","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2020765068","eid":"W2020765068"},{"id":"paper-w2053343116","cat":"papers","name":"Alterations in Monoamine Receptors in the Brain of Suicide Victims","year":"1992","cit":58,"pfa":"Victoria Arango","psa":"Joseph John Mann","topics":["Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W2053343116","eid":"W2053343116"},{"id":"paper-w1741784106","cat":"papers","name":"How MDMA's Pharmacology and Pharmacokinetics Drive Desired Effects and Harms","year":"2014","cit":58,"pfa":"Charles Michael White","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1741784106","eid":"W1741784106"},{"id":"paper-w2621905925","cat":"papers","name":"Return of the lysergamides. Part IV: Analytical and pharmacological characterization of lysergic acid morpholide (LSM‐775)","year":"2017","cit":58,"pfa":"Simon D. Brandt","psa":"Adam L. Halberstadt","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2621905925","eid":"W2621905925"},{"id":"paper-w2150693637","cat":"papers","name":"Caffeine Enhances Astroglia and Microglia Reactivity Induced by 3,4-Methylenedioxymethamphetamine (‘Ecstasy’) in Mouse Brain","year":"2009","cit":58,"pfa":"Amit Khairnar","psa":"Micaela Morelli","ptype":"article","src":"https://openalex.org/W2150693637","eid":"W2150693637"},{"id":"paper-w2166148255","cat":"papers","name":"Age modulates the long-term but not the acute effects of the serotonergic neurotoxicant 3,4-methylenedioxymethamphetamine.","year":"1994","cit":58,"pfa":"Harry W. Broening","psa":"William Slikker","ptype":"article","src":"https://openalex.org/W2166148255","eid":"W2166148255"},{"id":"paper-w2111452082","cat":"papers","name":"Presence of Phenylethylamine in Hallucinogenic Psilocybe Mushroom: Possible Role in Adverse Reactions","year":"1998","cit":58,"pfa":"Olof Beck","psa":"Nikolai Stephansson","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2111452082","eid":"W2111452082"},{"id":"paper-w2042267445","cat":"papers","name":"MDL72222, a serotonin 5-HT3 receptor antagonist, blocks MDMA's ability to establish a conditioned place preference","year":"1991","cit":58,"pfa":"Edward J. Bilsky","psa":"Larry D. Reid","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2042267445","eid":"W2042267445"},{"id":"paper-w1964251139","cat":"papers","name":"The Secondary Conditioned Response of Rats and the Effects of Some Psychopharmacological Agents","year":"1959","cit":58,"pfa":"Giulio Maffii","topics":["Depression","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1964251139","eid":"W1964251139"},{"id":"paper-w1981133869","cat":"papers","name":"Massively Parallel Screening of the Receptorome","year":"2008","cit":58,"pfa":"Niels Jensen","psa":"Bryan L. Roth","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1981133869","eid":"W1981133869"},{"id":"paper-w2120561725","cat":"papers","name":"Three Cases of Fatal Paramethoxyamphetamine Overdose","year":"2001","cit":58,"pfa":"Teri L. Martin","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2120561725","eid":"W2120561725"},{"id":"paper-w2166672984","cat":"papers","name":"GC-MS Identification of Sympathomimetic Amine Drugs in Urine: Rapid Methodology Applicable for Emergency Clinical Toxicology","year":"2000","cit":58,"pfa":"J. L. Valentine","psa":"Roy Middleton","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2166672984","eid":"W2166672984"},{"id":"paper-w4362473033","cat":"papers","name":"On the need for metaphysics in psychedelic therapy and research","year":"2023","cit":58,"pfa":"Peter Sjöstedt-Hughes","topics":["Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4362473033","eid":"W4362473033"},{"id":"paper-w2158474067","cat":"papers","name":"Correction: Psychedelics and the Human Receptorome","year":"2010","cit":58,"pfa":"Thomas S. Ray","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"erratum","src":"https://openalex.org/W2158474067","eid":"W2158474067"},{"id":"paper-w4362623650","cat":"papers","name":"Psychedelic-induced mystical experiences: An interdisciplinary discussion and critique","year":"2023","cit":58,"pfa":"Sharday Catherine Mosurinjohn","psa":"Manesh Girn","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4362623650","eid":"W4362623650"},{"id":"paper-w4400449392","cat":"papers","name":"Potential Differences in Psychedelic Actions Based on Biological Sex","year":"2024","cit":58,"pfa":"Sheida Shadani","psa":"Claire J. Foldi","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4400449392","eid":"W4400449392"},{"id":"paper-w2903884088","cat":"papers","name":"States and traits related to the quality and consequences of psychedelic experiences.","year":"2018","cit":58,"pfa":"Suzanne L. Russ","psa":"Melody S. Elliott","ptype":"article","src":"https://openalex.org/W2903884088","eid":"W2903884088"},{"id":"paper-w2106140911","cat":"papers","name":"Ameliorating effect of microdoses of a potentized homeopathic drug, Arsenicum Album, on arsenic-induced toxicity in mice","year":"2003","cit":58,"pfa":"Pragayapriyadarshini Mallick","psa":"A.R. Khuda-Bukhsh","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2106140911","eid":"W2106140911"},{"id":"paper-w2038513611","cat":"papers","name":"Drug Abuse and Dependence","year":"1994","cit":58,"pfa":"James M. Russell","psa":"Roger C Bland","ptype":"article","src":"https://openalex.org/W2038513611","eid":"W2038513611"},{"id":"paper-w4292457905","cat":"papers","name":"Therapeutic Drug Monitoring and Dosage Adjustments of Immunosuppressive Drugs When Combined With Nirmatrelvir/Ritonavir in Patients With COVID-19","year":"2022","cit":58,"pfa":"Florian Lemaitre","psa":"Loralie J. Langman","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4292457905","eid":"W4292457905"},{"id":"paper-w2112864260","cat":"papers","name":"Validation of cerebral blood perfusion imaging as a modality for quantitative pharmacological MRI in rats","year":"2009","cit":58,"pfa":"Andreas Bruns","psa":"Markus von Kienlin","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2112864260","eid":"W2112864260"},{"id":"paper-w2883891109","cat":"papers","name":"Cytochrome P450 and O-methyltransferase catalyze the final steps in the biosynthesis of the anti-addictive alkaloid ibogaine from Tabernanthe iboga","year":"2018","cit":57,"pfa":"Scott C. Farrow","psa":"Sarah Ellen O'Connor","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2883891109","eid":"W2883891109"},{"id":"paper-w4240189847","cat":"papers","name":"The complications of 'ecstasy' (MDMA)","year":"1988","cit":57,"pfa":"Karl Verebey","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4240189847","eid":"W4240189847"},{"id":"paper-w636841827","cat":"papers","name":"The Peyote Religion: A Study in Indian-White Relations","year":"1957","cit":57,"pfa":"Lawrence R. Sullivan","psa":"J. S. Slotkin","ptype":"article","src":"https://openalex.org/W636841827","eid":"W636841827"},{"id":"paper-w1538452095","cat":"papers","name":"Methodology for determining major constituents of ayahuasca and their metabolites in blood","year":"2011","cit":57,"pfa":"Ethan H. McIlhenny","psa":"Steven A. Barker","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1538452095","eid":"W1538452095"},{"id":"paper-w2034878484","cat":"papers","name":"Designer Drug Confusion: A Focus on MDMA","year":"1986","cit":57,"pfa":"Jerome Beck","psa":"Patricia Morgan","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2034878484","eid":"W2034878484"},{"id":"paper-w2116951272","cat":"papers","name":"The inhibitory effect of norharman on morphine withdrawal syndrome in rats: Comparison with ibogaine","year":"1994","cit":57,"pfa":"Susanne L.T. Cappendijk","psa":"Michailo R. Dzoljic","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2116951272","eid":"W2116951272"},{"id":"paper-w4294804950","cat":"papers","name":"Microdosing psilocybin for chronic pain: a case series","year":"2022","cit":57,"pfa":"Matthew Lyes","psa":"Timothy J. Furnish","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4294804950","eid":"W4294804950"},{"id":"paper-w1912613430","cat":"papers","name":"Biogenesis of 5‐methoxy‐N,N‐dimethyltryptamine in human pineal gland","year":"1976","cit":57,"pfa":"Ras Bihari Guchhait","ptype":"article","src":"https://openalex.org/W1912613430","eid":"W1912613430"},{"id":"paper-w2798025613","cat":"papers","name":"Pharmacology of MDMA- and Amphetamine-Like New Psychoactive Substances","year":"2018","cit":57,"pfa":"Linda D. Simmler","psa":"Matthias E. Liechti","topics":["Addiction","Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W2798025613","eid":"W2798025613"},{"id":"paper-w2290816644","cat":"papers","name":"The History of MDMA as an Underground Drug in the United States, 1960–1979","year":"2016","cit":57,"pfa":"Torsten Passie","psa":"Udo Benzenhöfer","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2290816644","eid":"W2290816644"},{"id":"paper-w2053650416","cat":"papers","name":"Subjective ratings of prospective memory deficits in MDMA (‘ecstasy’) users","year":"2001","cit":57,"pfa":"Thomas Heffernan","psa":"Andrew B Scholey","ptype":"article","src":"https://openalex.org/W2053650416","eid":"W2053650416"},{"id":"paper-w2065603322","cat":"papers","name":"Neuropsychological Effects of 3,4-Methylenedioxymethamphetamine (MDMA or Ecstasy) in Recreational Users","year":"2003","cit":57,"pfa":"Carla Back‐Madruga","psa":"Russell E. Poland","ptype":"article","src":"https://openalex.org/W2065603322","eid":"W2065603322"},{"id":"paper-w3113337956","cat":"papers","name":"Development and validation of an LC-MS/MS method for the bioanalysis of psilocybin’s main metabolites, psilocin and 4-hydroxyindole-3-acetic acid, in human plasma","year":"2020","cit":57,"pfa":"Karolina E. Kolaczynska","psa":"Urs Duthaler","topics":["Addiction","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3113337956","eid":"W3113337956"},{"id":"paper-w2167224314","cat":"papers","name":"Adam (MDMA) and Eve (MDEA) misuse: an immunohistochemical study on three fatal cases","year":"1999","cit":57,"pfa":"Vittorio Fineschi","psa":"Emanuela Turillazzi","ptype":"article","src":"https://openalex.org/W2167224314","eid":"W2167224314"},{"id":"paper-w3047621140","cat":"papers","name":"Pilot Evaluation of a Residential Drug Addiction Treatment Combining Traditional Amazonian Medicine, Ayahuasca and Psychotherapy on Depression and Anxiety","year":"2020","cit":57,"pfa":"Cecile Giovannetti","psa":"Fernando M. Mendive","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3047621140","eid":"W3047621140"},{"id":"paper-w1574496069","cat":"papers","name":"MDMA‐induced neurotoxicity: long‐term effects on 5‐HT biosynthesis and the influence of ambient temperature","year":"2006","cit":57,"pfa":"Esther O’Shea","psa":"María Isabel Colado","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1574496069","eid":"W1574496069"},{"id":"paper-w2075841049","cat":"papers","name":"Electrochemical and spectroscopic characterisation of amphetamine-like drugs: Application to the screening of 3,4-methylenedioxymethamphetamine (MDMA) and its synthetic precursors","year":"2007","cit":57,"pfa":"Nuno Milhazes","psa":"Fernanda Borges","ptype":"article","src":"https://openalex.org/W2075841049","eid":"W2075841049"},{"id":"paper-w4376113773","cat":"papers","name":"Effect of psilocybin on marble burying in ICR mice: role of 5-HT1A receptors and implications for the treatment of obsessive-compulsive disorder","year":"2023","cit":57,"pfa":"Sandeep Singh","psa":"Tzuri Lifschytz","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4376113773","eid":"W4376113773"},{"id":"paper-w3200818806","cat":"papers","name":"Assessing the effects of methodological differences on outcomes in the use of psychedelics in the treatment of anxiety and depressive disorders: A systematic review and meta-analysis","year":"2021","cit":57,"pfa":"Robert F Leger","psa":"Ellen M. Unterwald","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W3200818806","eid":"W3200818806"},{"id":"paper-w2043279036","cat":"papers","name":"Daily LSD administration selectively decreases serotonin2 receptor binding in rat brain","year":"1985","cit":57,"pfa":"Neil S. Buckholtz","psa":"Lawrence D. Middaugh","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2043279036","eid":"W2043279036"},{"id":"paper-w2067074477","cat":"papers","name":"Forensic analysis of hallucinogenic mushrooms and khat (Catha edulisForsk) using cation-exchange liquid chromatography","year":"2010","cit":57,"pfa":"Tim Laußmann","psa":"Sigrid Meier‐Giebing","ptype":"article","src":"https://openalex.org/W2067074477","eid":"W2067074477"},{"id":"paper-w4296613147","cat":"papers","name":"The Emerging Field of Psychedelic Psychotherapy","year":"2022","cit":57,"pfa":"Gregory Barber","psa":"Scott T. Aaronson","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4296613147","eid":"W4296613147"},{"id":"paper-w2012172845","cat":"papers","name":"Effect of ascorbate and cysteine on the 3,4-methylenedioxymethamphetamine-induced depletion of brain serotonin","year":"1996","cit":57,"pfa":"Gary A. Gudelsky","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2012172845","eid":"W2012172845"},{"id":"paper-w2321994137","cat":"papers","name":"α1-Adrenergic Receptors Contribute to the Acute Effects of 3,4-Methylenedioxymethamphetamine in Humans","year":"2013","cit":57,"pfa":"Cédric M. Hysek","psa":"Matthias E. Liechti","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2321994137","eid":"W2321994137"},{"id":"paper-w1044341709","cat":"papers","name":"Pharmacological properties of mechanical responses of the rat oesophageal muscularis mucosae to vagal and field stimulation.","year":"1985","cit":57,"pfa":"Detlef Bieger","psa":"Chris R. Triggle","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1044341709","eid":"W1044341709"},{"id":"paper-w2092723934","cat":"papers","name":"3,4-Methylenedioxymethamphetamine induces Fos-like proteins in rat basal ganglia: reversal with MK 801","year":"1991","cit":57,"pfa":"Michael Dragunow","psa":"Richard Laverty","ptype":"article","src":"https://openalex.org/W2092723934","eid":"W2092723934"},{"id":"paper-w2039498667","cat":"papers","name":"Synthesis and Cytotoxic Profile of 3,4-Methylenedioxymethamphetamine (“Ecstasy”) and Its Metabolites on Undifferentiated PC12 Cells: A Putative Structure−Toxicity Relationship","year":"2006","cit":57,"pfa":"Nuno Milhazes","psa":"Fernanda Borges","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2039498667","eid":"W2039498667"},{"id":"paper-w2056535910","cat":"papers","name":"An assessment of the acute effects of the serotonin releasers methylenedioxymethamphetamine, methylenedioxyamphetamine and fenfluramine on immunity in rats","year":"2000","cit":57,"pfa":"Thomas J. Connor","psa":"B.E. Leonard","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2056535910","eid":"W2056535910"},{"id":"paper-w2507750198","cat":"papers","name":"Editor’s Highlight: Characterization of Hepatotoxicity Mechanisms Triggered by Designer Cathinone Drugs (β-Keto Amphetamines)","year":"2016","cit":57,"pfa":"Maria João Valente","psa":"Márcia C. Carvalho","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2507750198","eid":"W2507750198"},{"id":"paper-w2024790117","cat":"papers","name":"Pharmacotherapy of Addictive Disorders","year":"2009","cit":57,"pfa":"Stephen Ross","psa":"Eric D. Peselow","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2024790117","eid":"W2024790117"},{"id":"paper-w2014719102","cat":"papers","name":"Cathinone Neurotoxicity (“The “3Ms”)","year":"2014","cit":57,"pfa":"Steven B. Karch","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2014719102","eid":"W2014719102"},{"id":"paper-w2256741572","cat":"papers","name":"Effects of 3,4-dihydroxymethamphetamine and 2,4,5-trihydroxymethamphetamine, two metabolites of 3,4-methylenedioxymethamphetamine, on central serotonergic and dopaminergic systems.","year":"1992","cit":57,"pfa":"Michel Johnson","psa":"Hyun Kyoon Lim","ptype":"article","src":"https://openalex.org/W2256741572","eid":"W2256741572"},{"id":"paper-w3160423288","cat":"papers","name":"Microdosing for drug delivery application—A review","year":"2021","cit":57,"pfa":"Agnes Beate Bußmann","psa":"Martin Richter","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3160423288","eid":"W3160423288"},{"id":"paper-w3045176167","cat":"papers","name":"A Microdose Cocktail to Evaluate Drug Interactions in Patients with Renal Impairment","year":"2020","cit":57,"pfa":"Daniel A. Tatosian","psa":"Selwyn Aubrey Stoch","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3045176167","eid":"W3045176167"},{"id":"paper-w2331828106","cat":"papers","name":"Disease Detection by Ultrasensitive Quantification of Microdosed Synthetic Urinary Biomarkers","year":"2014","cit":57,"pfa":"Andrew Warren","psa":"David R. Walt","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2331828106","eid":"W2331828106"},{"id":"paper-w2063115509","cat":"papers","name":"A proposed animal model for hallucinogens based on LSD's effects on patterns of exploration in rats.","year":"1985","cit":57,"pfa":"Lynne M. Adams","psa":"Mark A. Geyer","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2063115509","eid":"W2063115509"},{"id":"paper-w4251541038","cat":"papers","name":"A proposed animal model for hallucinogens based on LSD's effects on patterns of exploration in rats.","year":"1985","cit":57,"pfa":"Lynne M. Adams","psa":"Mark A. Geyer","ptype":"article","src":"https://openalex.org/W4251541038","eid":"W4251541038"},{"id":"paper-w3127399862","cat":"papers","name":"Psychedelic drugs and perception: a narrative review of the first era of research","year":"2021","cit":57,"pfa":"Jacob S. Aday","psa":"Christopher C. Davoli","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W3127399862","eid":"W3127399862"},{"id":"paper-w1982274699","cat":"papers","name":"Habituation of acoustic startle is disrupted by psychotomimetic drugs: differential dependence on dopaminergic and nitric oxide modulatory mechanisms","year":"2004","cit":57,"pfa":"Daniel Klamer","psa":"Lennart Svensson","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1982274699","eid":"W1982274699"},{"id":"paper-w2983389719","cat":"papers","name":"Psychotomimetic opiate receptors labelled and visualized with (+)[^3H]3-(3-hydroxyphenyl)-N-(1-propyl)piperidine","year":"1984","cit":57,"pfa":"Brian L. Largent","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2983389719","eid":"W2983389719"},{"id":"paper-w2151799076","cat":"papers","name":"METABOLISM OF THE PSYCHOTOMIMETIC TRYPTAMINE DERIVATIVE 5-METHOXY-N,N-DIISOPROPYLTRYPTAMINE IN HUMANS: IDENTIFICATION AND QUANTIFICATION OF ITS URINARY METABOLITES","year":"2005","cit":57,"pfa":"Tooru Kamata","psa":"Hitoshi Tsuchihashi","ptype":"article","src":"https://openalex.org/W2151799076","eid":"W2151799076"},{"id":"paper-w2167666531","cat":"papers","name":"Alcohol, tobacco and cannabis use among Nova Scotia adolescents: implications for prevention and harm reduction.","year":"1997","cit":57,"pfa":"C. Poulin","psa":"Delbert Elliott","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2167666531","eid":"W2167666531"},{"id":"paper-w2403092971","cat":"papers","name":"[Schizophrenia and addiction: An evaluation of the self-medication hypothesis].","year":"2003","cit":57,"pfa":"Stéphane Potvin","psa":"J-Y Roy","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"other","src":"https://openalex.org/W2403092971","eid":"W2403092971"},{"id":"paper-w2206305343","cat":"papers","name":"Treatment-Resistant Major Depression: Rationale for NMDA Receptors as Targets and Nitrous Oxide as Therapy","year":"2015","cit":57,"pfa":"Charles F. Zorumski","psa":"Charles R. Conway","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2206305343","eid":"W2206305343"},{"id":"paper-w2114176302","cat":"papers","name":"Animal models for predicting the efficacy and side effects of antipsychotic drugs","year":"2013","cit":57,"pfa":"Pedro Henrique Gobira","psa":"Fabrício A. Moreira","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2114176302","eid":"W2114176302"},{"id":"paper-w4403249137","cat":"papers","name":"Ketamine, Esketamine, and Arketamine: Their Mechanisms of Action and Applications in the Treatment of Depression and Alleviation of Depressive Symptoms","year":"2024","cit":57,"pfa":"Piotr Kawczak","psa":"Tomasz Bączek","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4403249137","eid":"W4403249137"},{"id":"paper-w4384945458","cat":"papers","name":"Effects of perioperative use of esketamine on postpartum depression risk in patients undergoing cesarean section: A randomized controlled trial","year":"2023","cit":57,"pfa":"Qing-Ren Liu","psa":"Jianjun Yang","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4384945458","eid":"W4384945458"},{"id":"paper-w4383912273","cat":"papers","name":"Effects of different doses of esketamine intervention on postpartum depressive symptoms in cesarean section women: A randomized, double-blind, controlled clinical study","year":"2023","cit":57,"pfa":"Si Qi Yang","psa":"Kai‐Ming Duan","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4383912273","eid":"W4383912273"},{"id":"paper-w3208279447","cat":"papers","name":"Efficacy and safety of fixed doses of intranasal Esketamine as an add-on therapy to Oral antidepressants in Japanese patients with treatment-resistant depression: a phase 2b randomized clinical study","year":"2021","cit":57,"pfa":"Nagahide Takahashi","psa":"Yushin Tominaga","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3208279447","eid":"W3208279447"},{"id":"paper-w2981874813","cat":"papers","name":"Pharmacologically diverse antidepressants facilitate TRKB receptor activation by disrupting its interaction with the endocytic adaptor complex AP-2","year":"2019","cit":57,"pfa":"Senem Merve Fred","psa":"Eero Ċastrén","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2981874813","eid":"W2981874813"},{"id":"paper-w3003956960","cat":"papers","name":"A rapid positive influence of S-ketamine on the anxiety of patients in palliative care: a retrospective pilot study","year":"2020","cit":57,"pfa":"Eduard Falk","psa":"Martin Neukirchen","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3003956960","eid":"W3003956960"},{"id":"paper-w1995899818","cat":"papers","name":"Psychophysiological Investigations in Experimental Psychoses: Results of the Exhibition of D-Lysergic Acid Diethylamide to Psychiatric Patients","year":"1954","cit":56,"pfa":"Bruce C. Sloane","psa":"John W. Lovett Doust","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1995899818","eid":"W1995899818"},{"id":"paper-w1983083273","cat":"papers","name":"The Effect of Psilocin on Memory Acquisition, Retrieval, and Consolidation in the Rat","year":"2014","cit":56,"pfa":"Lukáš Rambousek","psa":"Aleš Stuchlı́k","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W1983083273","eid":"W1983083273"},{"id":"paper-w4353017554","cat":"papers","name":"Antidepressant Effects of Psilocybin in the Absence of Psychedelic Effects","year":"2023","cit":56,"pfa":"Joshua Daniel Rosenblat","psa":"Roger S. McIntyre","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4353017554","eid":"W4353017554"},{"id":"paper-w3090010637","cat":"papers","name":"The Acute Effects of the Atypical Dissociative Hallucinogen Salvinorin A on Functional Connectivity in the Human Brain","year":"2020","cit":56,"pfa":"Manoj K. Doss","psa":"Frederick Streeter Barrett","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3090010637","eid":"W3090010637"},{"id":"paper-w4390693439","cat":"papers","name":"Effects of MDMA-assisted therapy for PTSD on self-experience","year":"2024","cit":56,"pfa":"Bessel A. van der Kolk","psa":"Rick Doblin","topics":["PTSD & trauma","Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4390693439","eid":"W4390693439"},{"id":"paper-w1999999921","cat":"papers","name":"Preparation of the 4-Hydroxytryptamine Scaffold via Palladium-Catalyzed Cyclization: A Practical and Versatile Synthesis of Psilocin","year":"2003","cit":56,"pfa":"Nicholas Gathergood","psa":"Peter J. Scammells","ptype":"article","src":"https://openalex.org/W1999999921","eid":"W1999999921"},{"id":"paper-w2042096580","cat":"papers","name":"Acute Physiologic and Chronic Histologic Changes in Rats and Mice Exposed to the Unique Hallucinogen Salvinorin A","year":"2003","cit":56,"pfa":"Mark Mowry","psa":"Wayne Briner","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2042096580","eid":"W2042096580"},{"id":"paper-w2162485038","cat":"papers","name":"Cardiovascular and sympathetic responses and reflex changes elicited by MDMA","year":"2000","cit":56,"pfa":"Peggy O'Cain","psa":"Kurt James Varner","ptype":"article","src":"https://openalex.org/W2162485038","eid":"W2162485038"},{"id":"paper-w2018061252","cat":"papers","name":"Aeruginascin, a Trimethylammonium Analogue of Psilocybin from the Hallucinogenic MushroomInocybe aeruginascens","year":"2006","cit":56,"pfa":"Niels Jensen","psa":"Hartmut Laatsch","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2018061252","eid":"W2018061252"},{"id":"paper-w2132079250","cat":"papers","name":"Salvinorin A Reduces Mechanical Allodynia and Spinal Neuronal Hyperexcitability Induced by Peripheral Formalin Injection","year":"2012","cit":56,"pfa":"Francesca Guida","psa":"Sabatino Maione","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2132079250","eid":"W2132079250"},{"id":"paper-w2057694418","cat":"papers","name":"Study of the behavioural responses related to the potential addictive properties of MDMA in mice","year":"2004","cit":56,"pfa":"Patricia Robledo","psa":"Rafaël Maldonado","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2057694418","eid":"W2057694418"},{"id":"paper-w2118338972","cat":"papers","name":"Different likelihood ratio approaches to evaluate the strength of evidence of MDMA tablet comparisons","year":"2009","cit":56,"pfa":"Annabel Bolck","psa":"Jorrit van den Berg","ptype":"article","src":"https://openalex.org/W2118338972","eid":"W2118338972"},{"id":"paper-w3093269897","cat":"papers","name":"The cost-effectiveness of MDMA-assisted psychotherapy for the treatment of chronic, treatment-resistant PTSD","year":"2020","cit":56,"pfa":"Elliot A. Marseille","psa":"Rick Doblin","topics":["Depression","PTSD & trauma","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3093269897","eid":"W3093269897"},{"id":"paper-w2130593619","cat":"papers","name":"The hallucinogenic herb Salvia divinorum and its active ingredient salvinorin A inhibit enteric cholinergic transmission in the guinea‐pig ileum","year":"2005","cit":56,"pfa":"Raffaele Capasso","psa":"Angelo Antonio Izzo","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2130593619","eid":"W2130593619"},{"id":"paper-w3093454394","cat":"papers","name":"Psilocybin exerts distinct effects on resting state networks associated with serotonin and dopamine in mice","year":"2020","cit":56,"pfa":"Joanes Grandjean","psa":"Markus Rudin","topics":["Depression","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3093454394","eid":"W3093454394"},{"id":"paper-w4213037454","cat":"papers","name":"A randomized controlled trial of 3,4-methylenedioxymethamphetamine (MDMA) and fear extinction retention in healthy adults","year":"2022","cit":56,"pfa":"Jessica L. Maples‐Keller","psa":"BARBARA OLASOV ROTHBAUM","topics":["PTSD & trauma","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4213037454","eid":"W4213037454"},{"id":"paper-w2014863607","cat":"papers","name":"Oral administration of 3,4-methylenedioxymethamphetamine (MDMA) produces selective serotonergic depletion in the nonhuman primate","year":"1993","cit":56,"pfa":"Syed F. Ali","psa":"W SLIKKERJR","ptype":"article","src":"https://openalex.org/W2014863607","eid":"W2014863607"},{"id":"paper-w2017467139","cat":"papers","name":"Developing electrodes chemically modified with cucurbit[6]uril to detect 3,4-methylenedioxymethamphetamine (MDMA) by voltammetry","year":"2014","cit":56,"pfa":"Maraine Catarina Tadini","psa":"Marcelo Firmino de Oliveira","ptype":"article","src":"https://openalex.org/W2017467139","eid":"W2017467139"},{"id":"paper-w4283719838","cat":"papers","name":"Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls","year":"2022","cit":56,"pfa":"Joseph M. Rootman","psa":"Zach Walsh","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4283719838","eid":"W4283719838"},{"id":"paper-w1990336299","cat":"papers","name":"Sources of information about MDMA (3,4-methylenedioxymethamphetamine): perceived accuracy, importance, and implications for prevention among young adult users","year":"2004","cit":56,"pfa":"Rüssel S. Falck","psa":"Harvey Alan Siegal","ptype":"article","src":"https://openalex.org/W1990336299","eid":"W1990336299"},{"id":"paper-w2163955226","cat":"papers","name":"Test–re‐test reliability of DSM‐IV adopted criteria for 3,4‐methylenedioxymethamphetamine (MDMA) abuse and dependence: a cross‐national study","year":"2009","cit":56,"pfa":"Linda Bauer Cottler","psa":"Arbi Ben Abdallah","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2163955226","eid":"W2163955226"},{"id":"paper-w2011218949","cat":"papers","name":"Effects of a single dose of 3,4-methylenedioxymethamphetamine on circadian patterns, motor activity and sleep in drug-naive rats and rats previously exposed to MDMA","year":"2004","cit":56,"pfa":"Brigitta Balogh","psa":"György Bagdy","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2011218949","eid":"W2011218949"},{"id":"paper-w4283324512","cat":"papers","name":"Classic and non‐classic psychedelics for substance use disorder: A review of their historic, past and current research","year":"2022","cit":56,"pfa":"Fúlvio Rieli Mendes","psa":"Renato Filev","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4283324512","eid":"W4283324512"},{"id":"paper-w4223525754","cat":"papers","name":"Associations between classic psychedelics and opioid use disorder in a nationally-representative U.S. adult sample","year":"2022","cit":56,"pfa":"Grant M. Jones","psa":"Matthew K. Nock","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4223525754","eid":"W4223525754"},{"id":"paper-w4383187032","cat":"papers","name":"Risk of bias in randomized clinical trials on psychedelic medicine: A systematic review","year":"2023","cit":56,"pfa":"Oliver Rumle Hovmand","psa":"Ole Jakob Storebø","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"review","src":"https://openalex.org/W4383187032","eid":"W4383187032"},{"id":"paper-w2988070888","cat":"papers","name":"Injury‐Triggered Blueing Reactions of Psilocybe “Magic” Mushrooms","year":"2019","cit":56,"pfa":"Claudius Lenz","psa":"Dirk Hoffmeister","ptype":"article","src":"https://openalex.org/W2988070888","eid":"W2988070888"},{"id":"paper-w2053802427","cat":"papers","name":"An hallucinogenic amphetamine analog (DOM) in man","year":"1969","cit":56,"pfa":"Leo E. Hollister","psa":"H. K. Gillespie","ptype":"article","src":"https://openalex.org/W2053802427","eid":"W2053802427"},{"id":"paper-w3165686539","cat":"papers","name":"Genetic influence of CYP2D6 on pharmacokinetics and acute subjective effects of LSD in a pooled analysis","year":"2021","cit":56,"pfa":"Patrick Vizeli","psa":"Matthias E. Liechti","topics":["Addiction","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3165686539","eid":"W3165686539"},{"id":"paper-w2142723577","cat":"papers","name":"Enhancement of 3,4‐methylenedioxymethamphetamine neurotoxicity by the energy inhibitor malonate","year":"2001","cit":56,"pfa":"Wendy L. Nixdorf","psa":"Bryan K. Yamamoto","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2142723577","eid":"W2142723577"},{"id":"paper-w2168076399","cat":"papers","name":"Effect of 3,4‐Methylenedioxymethamphetamine on 3,4‐Dihydroxyphenylalanine Accumulation in the Striatum and Nucleus Accumbens","year":"1990","cit":56,"pfa":"J. Frank Nash","psa":"Gary A. Gudelsky","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2168076399","eid":"W2168076399"},{"id":"paper-w1994647182","cat":"papers","name":"Altered forebrain neurotransmitter responses to immobilization stress following 3,4-methylenedioxymethamphetamine","year":"2002","cit":56,"pfa":"Leslie Matuszewich","psa":"Bryan K. Yamamoto","ptype":"article","src":"https://openalex.org/W1994647182","eid":"W1994647182"},{"id":"paper-w2029675439","cat":"papers","name":"Differential Regulation by Methylenedioxymethamphetamine of 5‐Hydroxytryptamine1A Receptor Density and mRNA Expression in Rat Hippocampus, Frontal Cortex, and Brainstem: The Role of Corticosteroids","year":"1997","cit":56,"pfa":"Norberto Aguirre","psa":"Joaquı́n Del Rı́o","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2029675439","eid":"W2029675439"},{"id":"paper-w2162849842","cat":"papers","name":"Serotonergic Neurotoxicity of 3,4-(±)-Methylenedioxyamphetamine and 3,4-(±)-Methylendioxymethamphetamine (Ecstasy) Is Potentiated by Inhibition of γ-Glutamyl Transpeptidase","year":"2001","cit":56,"pfa":"Fengju Bai","psa":"Terrence J. Monks","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2162849842","eid":"W2162849842"},{"id":"paper-w2059393926","cat":"papers","name":"Computational approaches to design a molecular imprinted polymer for high selective extraction of 3,4-methylenedioxymethamphetamine from plasma","year":"2011","cit":56,"pfa":"Farhad Ahmadi","psa":"Mehdi Rahimi‐Nasrabadi","ptype":"article","src":"https://openalex.org/W2059393926","eid":"W2059393926"},{"id":"paper-w1998322518","cat":"papers","name":"Acute injection of drugs with low addictive potential (Δ9-tetrahydrocannabinol, 3,4-methylenedioxymethamphetamine, lysergic acid diamide) causes a much higher c-fos expression in limbic brain areas than highly addicting","year":"1999","cit":56,"pfa":"Martina Erdtmann-Vourliotis","psa":"Volker Höllt","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1998322518","eid":"W1998322518"},{"id":"paper-w2158582141","cat":"papers","name":"CONCURRENT OBSERVATIONS OF BEHAVIOR CHANGES AND OF ADRENOCORTICAL VARIATIONS IN A CYCLOTHYMIC PATIENT DURING A PERIOD OF 12 MONTHS","year":"1954","cit":56,"pfa":"NICHOLAS D. RIZZO","psa":"George W. Thorn","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2158582141","eid":"W2158582141"},{"id":"paper-w4298055464","cat":"papers","name":"A century of research on psychedelics: A scientometric analysis on trends and knowledge maps of hallucinogens, entactogens, entheogens and dissociative drugs","year":"2022","cit":56,"pfa":"Marco Solmi","psa":"Michel Sabé","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4298055464","eid":"W4298055464"},{"id":"paper-w2010689607","cat":"papers","name":"Roadside detection of impairment under the influence of ketamine—Evaluation of ketamine impairment symptoms with reference to its concentration in oral fluid and urine","year":"2007","cit":56,"pfa":"Wing‐Chi Cheng","psa":"Ben Kin Leung Cheung","ptype":"article","src":"https://openalex.org/W2010689607","eid":"W2010689607"},{"id":"paper-w2921776842","cat":"papers","name":"Illicit substance use after release from prison among formerly incarcerated primary care patients: a cross-sectional study","year":"2019","cit":56,"pfa":"Adam Chamberlain","psa":"Aaron D. Fox","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2921776842","eid":"W2921776842"},{"id":"paper-w2150894903","cat":"papers","name":"Psychedelic Therapy Utilizing LSD in the Treatment of the Alcoholic Patient: A Preliminary Report","year":"1967","cit":56,"pfa":"Albert A. Kurland","psa":"Charles Savage","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2150894903","eid":"W2150894903"},{"id":"paper-w2985188679","cat":"papers","name":"Toward a contextual psychedelic-assisted therapy: Perspectives from Acceptance and Commitment Therapy and contextual behavioral science","year":"2019","cit":56,"pfa":"Jason B. Luoma","psa":"Brian C. Pilecki","ptype":"article","src":"https://openalex.org/W2985188679","eid":"W2985188679"},{"id":"paper-w4387105778","cat":"papers","name":"Mechanisms and molecular targets surrounding the potential therapeutic effects of psychedelics","year":"2023","cit":56,"pfa":"Alaina M. Jaster","psa":"Javier González‐Maeso","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4387105778","eid":"W4387105778"},{"id":"paper-w2755417367","cat":"papers","name":"Psychedelic pleasures: An affective understanding of the joys of tripping","year":"2017","cit":56,"pfa":"Frederik Bøhling","ptype":"article","src":"https://openalex.org/W2755417367","eid":"W2755417367"},{"id":"paper-w4307429083","cat":"papers","name":"Psychosis and psychedelics: Historical entanglements and contemporary contrasts","year":"2022","cit":56,"pfa":"Phoebe Friesen","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4307429083","eid":"W4307429083"},{"id":"paper-w2038604736","cat":"papers","name":"Psychotomimetic σ-opiates and PCP","year":"1986","cit":56,"pfa":"David T. Manallack","psa":"Andrew L. Gundlach","ptype":"review","src":"https://openalex.org/W2038604736","eid":"W2038604736"},{"id":"paper-w3090497377","cat":"papers","name":"Identification of psychedelic new psychoactive substances (NPS) showing biased agonism at the 5-HT2AR through simultaneous use of β-arrestin 2 and miniGαq bioassays","year":"2020","cit":56,"pfa":"Eline Pottie","psa":"Christophe Pol Stove","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3090497377","eid":"W3090497377"},{"id":"paper-w3158333653","cat":"papers","name":"Stereoselective ketamine effect on cardiac output: a population pharmacokinetic/pharmacodynamic modelling study in healthy volunteers","year":"2021","cit":56,"pfa":"Jasper Kamp","psa":"Erik Olofsen","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3158333653","eid":"W3158333653"},{"id":"paper-w2061535895","cat":"papers","name":"Nonselective and NR2B-selective N -methyl-d-aspartic Acid Receptor Antagonists Produce Antinociception and Long-term Relief of Allodynia in Acute and Neuropathic Pain","year":"2011","cit":56,"pfa":"Maarten Swartjes","psa":"Albert Dahan","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2061535895","eid":"W2061535895"},{"id":"paper-w2415888642","cat":"papers","name":"Biochemical, behavioral, and electrophysiologic actions of the selective sigma receptor ligand (+)-pentazocine.","year":"1988","cit":56,"pfa":"Steinfels Gf","psa":"L Cook","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2415888642","eid":"W2415888642"},{"id":"paper-w2059327782","cat":"papers","name":"A role for D-aspartate oxidase in schizophrenia and in schizophrenia-related symptoms induced by phencyclidine in mice","year":"2015","cit":56,"pfa":"Francesco Errico","psa":"Alessandro Usiello","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2059327782","eid":"W2059327782"},{"id":"paper-w2742147198","cat":"papers","name":"Pharmacokinetics and Bioavailability of Inhaled Esketamine in Healthy Volunteers","year":"2017","cit":56,"pfa":"Kelly Jonkman","psa":"Albert Dahan","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2742147198","eid":"W2742147198"},{"id":"paper-w3029786173","cat":"papers","name":"Ketamine as a mental health treatment: Are acute psychoactive effects associated with outcomes? A systematic review","year":"2020","cit":56,"pfa":"Meryem Grabski","psa":"Helen Valerie Curran","topics":["Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W3029786173","eid":"W3029786173"},{"id":"paper-w2115506061","cat":"papers","name":"Agonist-Directed Signaling of Serotonin 5-HT2C Receptors Differences Between Serotonin and Lysergic Acid Diethylamide (LSD)","year":"1999","cit":55,"pfa":"J Backstrom","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2115506061","eid":"W2115506061"},{"id":"paper-w1973707671","cat":"papers","name":"Prevention of Psychological Effects of d-Lysergic Acid Diethylamide (LSD 25) by its 2-Brom Derivative (BOL 148)","year":"1956","cit":55,"pfa":"K. H. Ginzel","psa":"W. Mayer-Groß","ptype":"article","src":"https://openalex.org/W1973707671","eid":"W1973707671"},{"id":"paper-w2007799290","cat":"papers","name":"Fatal MDMA intoxication","year":"1999","cit":55,"pfa":"Rafael de la Torre","psa":"Jordi Segura","ptype":"article","src":"https://openalex.org/W2007799290","eid":"W2007799290"},{"id":"paper-w80104796","cat":"papers","name":"The Therapeutic Use of MDMA","year":"1990","cit":55,"pfa":"George R. Greer","psa":"Requa Tolbert","ptype":"book-chapter","src":"https://openalex.org/W80104796","eid":"W80104796"},{"id":"paper-w4283070601","cat":"papers","name":"Psilocybin for Trauma-Related Disorders","year":"2022","cit":55,"pfa":"Amanda J. Khan","psa":"Joshua D. Woolley","topics":["PTSD & trauma"],"ptype":"book-chapter","src":"https://openalex.org/W4283070601","eid":"W4283070601"},{"id":"paper-w2129340715","cat":"papers","name":"Psilocybin and Obsessive Compulsive Disorder","year":"2014","cit":55,"pfa":"JAMES ALLEN WILCOX","topics":["Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2129340715","eid":"W2129340715"},{"id":"paper-w2015468513","cat":"papers","name":"Ibogaine block of the NMDA receptor: In vitro and in vivo studies","year":"1996","cit":55,"pfa":"Kang Chen","psa":"Michael A. Rogawski","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2015468513","eid":"W2015468513"},{"id":"paper-w2071926809","cat":"papers","name":"Determination of psilocin, bufotenine, LSD and its metabolites in serum, plasma and urine by SPE-LC-MS/MS","year":"2012","cit":55,"pfa":"Rafaela Martin","psa":"Helga Köhler","ptype":"article","src":"https://openalex.org/W2071926809","eid":"W2071926809"},{"id":"paper-w2168545748","cat":"papers","name":"THC Prevents MDMA Neurotoxicity in Mice","year":"2010","cit":55,"pfa":"Clara Touriño","psa":"Olga Valverde","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2168545748","eid":"W2168545748"},{"id":"paper-w3114414169","cat":"papers","name":"Ethical Concerns about Psilocybin Intellectual Property","year":"2021","cit":55,"pfa":"Konstantin Gerber","psa":"Eduardo Ekman Schenberg","topics":["Depression","Policy & ethics"],"ptype":"editorial","src":"https://openalex.org/W3114414169","eid":"W3114414169"},{"id":"paper-w2159889085","cat":"papers","name":"Comparison of the discriminative stimulus effects of salvinorin A and its derivatives to U69,593 and U50,488 in rats","year":"2009","cit":55,"pfa":"Lisa E. Baker","psa":"Sheryl L. Walker","ptype":"article","src":"https://openalex.org/W2159889085","eid":"W2159889085"},{"id":"paper-w2020043643","cat":"papers","name":"Effects of MDMA on Complex Brain Function in Laboratory Animals","year":"1997","cit":55,"pfa":"David Frederick","psa":"Merle G. Paule","ptype":"article","src":"https://openalex.org/W2020043643","eid":"W2020043643"},{"id":"paper-w1966733439","cat":"papers","name":"Are there sex differences associated with the effects of ecstasy/3,4-methylenedioxymethamphetamine (MDMA)?","year":"2006","cit":55,"pfa":"Kelly Allott","psa":"Jennifer R. Redman","ptype":"article","src":"https://openalex.org/W1966733439","eid":"W1966733439"},{"id":"paper-w1966277101","cat":"papers","name":"Orally administered MDMA causes a long-term depletion of serotonin in rat brain","year":"1988","cit":55,"pfa":"Kevin T. Finnegan","psa":"J. William Langston","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1966277101","eid":"W1966277101"},{"id":"paper-w2082687578","cat":"papers","name":"A genetic deletion of the serotonin transporter greatly enhances the reinforcing properties of MDMA in rats","year":"2013","cit":55,"pfa":"Alana Oakly","psa":"Bart A. Ellenbroek","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2082687578","eid":"W2082687578"},{"id":"paper-w4307554429","cat":"papers","name":"Changes in mental health, wellbeing and personality following ayahuasca consumption: Results of a naturalistic longitudinal study","year":"2022","cit":55,"pfa":"Daniel Perkins","psa":"Richard Dean Chenhall","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4307554429","eid":"W4307554429"},{"id":"paper-w2082633159","cat":"papers","name":"Effect of 3,4-methylendioxymethamphetamine (MDMA, “ecstasy”) on dopamine transmission in the nucleus accumbens shell and core","year":"2005","cit":55,"pfa":"Cristina Cadoni","psa":"G. Di Chiara","ptype":"article","src":"https://openalex.org/W2082633159","eid":"W2082633159"},{"id":"paper-w2133409052","cat":"papers","name":"The effects of ‘ecstasy’ (MDMA) on visuospatial memory performance: findings from a systematic review with meta‐analyses","year":"2012","cit":55,"pfa":"Philip N. Murphy","psa":"Joanne Hilton","topics":["Reviews & meta-analyses","Therapy practice"],"ptype":"review","src":"https://openalex.org/W2133409052","eid":"W2133409052"},{"id":"paper-w2113285179","cat":"papers","name":"MDMA, methamphetamine and their combination: possible lessons for party drug users from recent preclinical research","year":"2007","cit":55,"pfa":"Kelly J. Clemens","psa":"Jennifer L. Cornish","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2113285179","eid":"W2113285179"},{"id":"paper-w2034680014","cat":"papers","name":"Interpretation of a 3,4-methylenedioxymethamphetamine (MDMA) blood level: discussion by means of a distribution study in two fatalities","year":"2004","cit":55,"pfa":"Els A. De Letter","psa":"Michel H A Piette","ptype":"article","src":"https://openalex.org/W2034680014","eid":"W2034680014"},{"id":"paper-w4408424120","cat":"papers","name":"Psilocybin-assisted therapy for relapse prevention in alcohol use disorder: a phase 2 randomized clinical trial","year":"2025","cit":55,"pfa":"Nathalie M. Rieser","psa":"Katrin H. Preller","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4408424120","eid":"W4408424120"},{"id":"paper-w3184561973","cat":"papers","name":"Associations between ayahuasca consumption in naturalistic settings and current alcohol and drug use: Results of a large international cross‐sectional survey","year":"2021","cit":55,"pfa":"Daniel Perkins","psa":"Jerome J. Sarris","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3184561973","eid":"W3184561973"},{"id":"paper-w4210661996","cat":"papers","name":"Mood and cognitive effects of 6 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy'): week-end 'high' followed by mid-week low","year":"1997","cit":55,"pfa":"Helen Valerie Curran","psa":"Ross A. Travill","ptype":"article","src":"https://openalex.org/W4210661996","eid":"W4210661996"},{"id":"paper-w2042631922","cat":"papers","name":"Altered response to tryptophan supplementation after long-term abstention from MDMA (ecstasy) is highly correlated with human memory function","year":"2003","cit":55,"pfa":"Helen Valerie Curran","psa":"Suzanne L. Verheyden","ptype":"article","src":"https://openalex.org/W2042631922","eid":"W2042631922"},{"id":"paper-w2960049453","cat":"papers","name":"First study of safety and tolerability of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy in patients with alcohol use disorder: preliminary data on the first four participants","year":"2019","cit":55,"pfa":"Ben Sessa","psa":"David Nutt","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2960049453","eid":"W2960049453"},{"id":"paper-w1994991954","cat":"papers","name":"Patterns of Hallucinogenic Drug Abuse","year":"1965","cit":55,"pfa":"Arnold M. Ludwig","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1994991954","eid":"W1994991954"},{"id":"paper-w2097227947","cat":"papers","name":"Direct effects of 3,4‐methylenedioxymethamphetamine (MDMA) on serotonin or dopamine release and uptake in the caudate putamen, nucleus accumbens, substantia nigra pars reticulata, and the dorsal raphé nucleus slices","year":"2000","cit":55,"pfa":"Mahmoud M. Iravani","psa":"Zygmunt L. Kruk","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2097227947","eid":"W2097227947"},{"id":"paper-w3134642859","cat":"papers","name":"Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigm","year":"2021","cit":55,"pfa":"Daniel Perkins","psa":"David Jonathan Castle","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3134642859","eid":"W3134642859"},{"id":"paper-w4379598244","cat":"papers","name":"The psychedelic afterglow phenomenon: a systematic review of subacute effects of classic serotonergic psychedelics","year":"2023","cit":55,"pfa":"Ricarda Evens","psa":"Timo Torsten Schmidt","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4379598244","eid":"W4379598244"},{"id":"paper-w1990371615","cat":"papers","name":"The role of central serotonergic mechanisms on head-twitch and backward locomotion induced by hallucinogenic drugs","year":"1981","cit":55,"pfa":"Tsuneyuki Yamamoto","psa":"Showa Ueki","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1990371615","eid":"W1990371615"},{"id":"paper-w4224106670","cat":"papers","name":"Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders","year":"2022","cit":55,"pfa":"Henry I. C. Lowe","psa":"Wilfred F. Ngwa","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4224106670","eid":"W4224106670"},{"id":"paper-w2089426354","cat":"papers","name":"LSD and 2-Bromo-Lsd: Comparison of effects on serotonergic neurones and on neurones in two serotonergic projection areas, the ventral lateral geniculate and amygdala","year":"1976","cit":55,"pfa":"George K. Aghajanian","ptype":"article","src":"https://openalex.org/W2089426354","eid":"W2089426354"},{"id":"paper-w4362722045","cat":"papers","name":"Sex-specific effects of psychedelic drug exposure on central amygdala reactivity and behavioral responding","year":"2023","cit":55,"pfa":"Devin P. Effinger","psa":"Melissa A. Herman","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4362722045","eid":"W4362722045"},{"id":"paper-w2326343158","cat":"papers","name":"High-affinity 3H-serotonin binding to caudate: Inhibition by hallucinogens and serotoninergic drugs","year":"1978","cit":55,"pfa":"Patricia M. Whitaker","psa":"Philip M. Seeman","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2326343158","eid":"W2326343158"},{"id":"paper-w2098781199","cat":"papers","name":"Determination of LSD in Urine by Capillary Column Gas Chromatography and Electron Impact Mass Spectrometry","year":"1988","cit":55,"pfa":"Paula Francom","psa":"R. T. Jones","ptype":"article","src":"https://openalex.org/W2098781199","eid":"W2098781199"},{"id":"paper-w2133869788","cat":"papers","name":"From local to global—Fifty years of research on Salvia divinorum","year":"2013","cit":55,"pfa":"Ivan Casselman","psa":"Michael Heinrich","ptype":"article","src":"https://openalex.org/W2133869788","eid":"W2133869788"},{"id":"paper-w2174034699","cat":"papers","name":"A New Hallucinogen: 3,4,5-Trimethoxyphenyl-β-Aminopropane","year":"1955","cit":55,"pfa":"Dwight I. Peretz","psa":"William C. Gibson","ptype":"article","src":"https://openalex.org/W2174034699","eid":"W2174034699"},{"id":"paper-w2043389085","cat":"papers","name":"Reinforcing Subjective Effects of (??) 3,4-Methylenedioxymethamphetamine (???Ecstasy???) May Be Separable from its Neurotoxic Actions","year":"1993","cit":55,"pfa":"Una D. McCann","psa":"George A. Ricaurte","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2043389085","eid":"W2043389085"},{"id":"paper-w2099469449","cat":"papers","name":"Reduced social interaction following 3,4-methylenedioxymethamphetamine is not associated with enhanced 5-HT2C receptor responsivity","year":"2003","cit":55,"pfa":"E Bull","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2099469449","eid":"W2099469449"},{"id":"paper-w2171986671","cat":"papers","name":"Synthetic studies of neoclerodane diterpenes from Salvia divinorum: Selective modification of the furan ring","year":"2006","cit":55,"pfa":"Wayne Wesley Harding","psa":"Thomas Edward Prisinzano","ptype":"article","src":"https://openalex.org/W2171986671","eid":"W2171986671"},{"id":"paper-w1973976795","cat":"papers","name":"Emerging Use of Isotope Ratio Mass Spectrometry as a Tool for Discrimination of 3,4-Methylenedioxymethamphetamine by Synthetic Route","year":"2008","cit":55,"pfa":"Hilary A. S. Buchanan","psa":"Michael Middleditch","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1973976795","eid":"W1973976795"},{"id":"paper-w4384823500","cat":"papers","name":"Application of Paper-Based Microfluidic Analytical Devices (µPAD) in Forensic and Clinical Toxicology: A Review","year":"2023","cit":55,"pfa":"Giacomo Musile","psa":"Federica Bortolotti","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4384823500","eid":"W4384823500"},{"id":"paper-w2139755095","cat":"papers","name":"The Netherlands XTC Toxicity (NeXT) study: objectives and methods of a study investigating causality, course, and clinical relevance","year":"2005","cit":55,"pfa":"Maartje M. L. de Win","psa":"Wim van den Brink","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2139755095","eid":"W2139755095"},{"id":"paper-w2605897253","cat":"papers","name":"Underestimated impact of novel psychoactive substances: laboratory confirmation of recreational drug toxicity in Oslo, Norway","year":"2017","cit":55,"pfa":"Odd Martin Vallersnes","psa":"Knut Erik Hovda","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2605897253","eid":"W2605897253"},{"id":"paper-w3067910638","cat":"papers","name":"Acceptance of Non-Abstinence as an Outcome Goal for Individuals Diagnosed With Substance Use Disorders: A Narrative Review of Published Research","year":"2020","cit":55,"pfa":"Harold Rosenberg","psa":"Alan K. Davis","topics":["Addiction","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W3067910638","eid":"W3067910638"},{"id":"paper-w4311508922","cat":"papers","name":"The economics of psychedelic-assisted therapies: A research agenda","year":"2022","cit":55,"pfa":"Elliot A. Marseille","psa":"James G. Kahn","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4311508922","eid":"W4311508922"},{"id":"paper-w4367553374","cat":"papers","name":"Psychedelics as Transformative Therapeutics","year":"2023","cit":55,"pfa":"Bryan L. Roth","psa":"Ryan H. Gumpper","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4367553374","eid":"W4367553374"},{"id":"paper-w2132639067","cat":"papers","name":"Some ethnopharmacological notes on African hallucinogens","year":"1996","cit":55,"pfa":"Peter A. G. M. De Smet","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2132639067","eid":"W2132639067"},{"id":"paper-w2896390000","cat":"papers","name":"Psychedelic Moral Enhancement","year":"2018","cit":55,"pfa":"Brian David Earp","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2896390000","eid":"W2896390000"},{"id":"paper-w3180018060","cat":"papers","name":"Associations between lifetime classic psychedelic use and cardiometabolic diseases","year":"2021","cit":55,"pfa":"Otto Simonsson","psa":"Peter S. Hendricks","ptype":"article","src":"https://openalex.org/W3180018060","eid":"W3180018060"},{"id":"paper-w2395560869","cat":"papers","name":"A common mechanism for lysergic acid, indolealkylamine and phenethylamine hallucinogens: serotonergic medication of behavioral effects in rats.","year":"1980","cit":55,"pfa":"Robert S. Sloviter","psa":"John D. Connor","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2395560869","eid":"W2395560869"},{"id":"paper-w2408517738","cat":"papers","name":"Ketamine Psychedelic Psychotherapy: Focus on its Pharmacology, Phenomenology, and Clinical Applications","year":"2014","cit":55,"pfa":"Eli Kolp","psa":"Anna Kolp","topics":["Depression","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2408517738","eid":"W2408517738"},{"id":"paper-w2739769016","cat":"papers","name":"BACE1 inhibition by microdose lithium formulation NP03 rescues memory loss and early stage amyloid neuropathology","year":"2017","cit":55,"pfa":"Edward Norman Wilson","psa":"A. Claudio Cuello","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2739769016","eid":"W2739769016"},{"id":"paper-w1974331201","cat":"papers","name":"GnRH Antagonist/Letrozole Versus Microdose GnRH Agonist Flare Protocol in Poor Responders Undergoing In Vitro Fertilization","year":"2010","cit":55,"pfa":"Robab Davar","psa":"Razieh Dehghani Firouzabadi","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1974331201","eid":"W1974331201"},{"id":"paper-w3042974916","cat":"papers","name":"A Microdosing Study with 99mTc-PHC-102 for the SPECT/CT Imaging of Primary and Metastatic Lesions in Renal Cell Carcinoma Patients","year":"2020","cit":55,"pfa":"Oana Cristina Kulterer","psa":"Alexander Robert Haug","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3042974916","eid":"W3042974916"},{"id":"paper-w1986400361","cat":"papers","name":"Psychoses Precipitated by Psychotomimetic Drugs","year":"1977","cit":55,"pfa":"Malcolm B. Bowers","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W1986400361","eid":"W1986400361"},{"id":"paper-w2009980062","cat":"papers","name":"Maize Response to Fertilizer Dosing at Three Sites in the Central Rift Valley of Ethiopia","year":"2014","cit":55,"pfa":"Getachew Sime","psa":"Jens B. Aune","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2009980062","eid":"W2009980062"},{"id":"paper-w2074667024","cat":"papers","name":"5-HT2 receptor immunoreactivity on cholinergic neurons of the pontomesencephalic tegmentum shown by double immunofluorescence","year":"1993","cit":55,"pfa":"David A. Morilak","psa":"Roland D. Ciaranello","topics":["Mechanism & neuroscience","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2074667024","eid":"W2074667024"},{"id":"paper-w1510543046","cat":"papers","name":"The American psychiatric press textbook of substance abuse treatment","year":"1994","cit":55,"pfa":"Marc S. Galanter","psa":"Herbert D. Kleber","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W1510543046","eid":"W1510543046"},{"id":"paper-w2044941602","cat":"papers","name":"Maternal Depressive Symptoms During Childhood and Risky Adolescent Health Behaviors","year":"2014","cit":55,"pfa":"Maeve E. Wickham","psa":"Ian Colman","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2044941602","eid":"W2044941602"},{"id":"paper-w2046080919","cat":"papers","name":"Mechanisms underlying ketamine-induced synaptic depression in rat hippocampus-medial prefrontal cortex pathway","year":"2010","cit":55,"pfa":"Hidekazu Kamiyama","psa":"Hiroko Togashi","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2046080919","eid":"W2046080919"},{"id":"paper-w2114603393","cat":"papers","name":"Illicit psychoactive substance use, abuse and dependence in a population-based sample of Norwegian twins","year":"2006","cit":55,"pfa":"Kenneth S. Kendler","psa":"Ted Reichborn‐Kjennerud","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2114603393","eid":"W2114603393"},{"id":"paper-w2916245206","cat":"papers","name":"Targeting metabotropic glutamate receptors in the treatment of epilepsy: rationale and current status","year":"2019","cit":55,"pfa":"Roberta Celli","psa":"Ferdinando Nicoletti","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2916245206","eid":"W2916245206"},{"id":"paper-w3087368824","cat":"papers","name":"Comparative effectiveness of esketamine in the treatment of anhedonia in bipolar and unipolar depression","year":"2020","cit":55,"pfa":"Rodrigo Simonini Delfino","psa":"Acioly L.T. Lacerda","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W3087368824","eid":"W3087368824"},{"id":"paper-w4382930062","cat":"papers","name":"Effect of Repeated Intravenous Esketamine on Adolescents With Major Depressive Disorder and Suicidal Ideation: A Randomized Active-Placebo-Controlled Trial","year":"2023","cit":55,"pfa":"Yanling Zhou","psa":"Yuping Ning","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4382930062","eid":"W4382930062"},{"id":"paper-w4213247170","cat":"papers","name":"Esketamine nasal spray in patients with treatment-resistant depression: the real-world experience in the French cohort early-access programme","year":"2022","cit":55,"pfa":"Ludovic Samalin","psa":"Anne Sauvaget","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4213247170","eid":"W4213247170"},{"id":"paper-w2594417342","cat":"papers","name":"Quantitative chiral and achiral determination of ketamine and its metabolites by LC–MS/MS in human serum, urine and fecal samples","year":"2017","cit":55,"pfa":"Mahmoud Hasan","psa":"Stefan Oswald","ptype":"article","src":"https://openalex.org/W2594417342","eid":"W2594417342"},{"id":"paper-w4304806525","cat":"papers","name":"The use of antidepressants is linked to bone loss: A systematic review and metanalysis","year":"2022","cit":55,"pfa":"Michele Mercurio","psa":"Giorgio Gasparini","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W4304806525","eid":"W4304806525"},{"id":"paper-w3200110356","cat":"papers","name":"The rapid anti-suicidal ideation effect of ketamine: A systematic review","year":"2021","cit":55,"pfa":"Annabella Hochschild","psa":"J. John Mann","topics":["Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W3200110356","eid":"W3200110356"},{"id":"paper-w2258636534","cat":"papers","name":"TOLERANCE TO A BEHAVIORAL EFFECT OF LYSERGIC ACID DIETHYLAMIDE AND CROSS-TOLERANCE TO MESCALINE IN THE RAT: ABSENCE OF A METABOLIC COMPONENT","year":"1971","cit":54,"pfa":"Jerrold C. Winter","ptype":"article","src":"https://openalex.org/W2258636534","eid":"W2258636534"},{"id":"paper-w2091196135","cat":"papers","name":"Lysergic Acid Diethylamide (LSD): No Teratogenicity in Rats","year":"1968","cit":54,"pfa":"Josef Warkany","psa":"Eva Takacs","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2091196135","eid":"W2091196135"},{"id":"paper-w2014168324","cat":"papers","name":"A REVIEW OF THE NEUROPHYSIOLOGICAL EFFECTS OF LYSERGIC ACID DIETHYLAMIDE (LSD) AND OTHER PSYCHOTOMIMETIC AGENTS","year":"1957","cit":54,"pfa":"Edward V. Evarts","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2014168324","eid":"W2014168324"},{"id":"paper-w2075641420","cat":"papers","name":"Evidence of catecholamine mediation in the ‘Aberrant’ behaviour induced by lysergic acid diethylamide (LSD) in the rat","year":"1968","cit":54,"pfa":"Arnold Keith Dixon","ptype":"article","src":"https://openalex.org/W2075641420","eid":"W2075641420"},{"id":"paper-w2059400961","cat":"papers","name":"Reduction of stimulation-produced analgesia by lysergic acid diethylamide, a depressor of serotonergic neural activity","year":"1977","cit":54,"pfa":"Ronald L. Hayes","psa":"David J. Mayer","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2059400961","eid":"W2059400961"},{"id":"paper-w2047890237","cat":"papers","name":"Gas chromatographic-electron-impact mass fragmentometric determination of lysergic acid diethylamide in urine","year":"1990","cit":54,"pfa":"Buddha Dev Paul","psa":"Robert Sroka","ptype":"article","src":"https://openalex.org/W2047890237","eid":"W2047890237"},{"id":"paper-w2409309885","cat":"papers","name":"Stereospecific Receptor Sites for d-Lysergic Acid Diethylamide in Rat Brain: Effects of Neurotransmitters, Amine Antagonists, and Other Psychotropic Drugs","year":"1976","cit":54,"pfa":"RICHARD A. LOVELL","psa":"Daniel X. Freedman","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2409309885","eid":"W2409309885"},{"id":"paper-w2148931748","cat":"papers","name":"Ecstasy (MDMA) and oral health","year":"2008","cit":54,"pfa":"Henk Simon Brand","psa":"A. van Nieuw Amerongen","ptype":"article","src":"https://openalex.org/W2148931748","eid":"W2148931748"},{"id":"paper-w3193511309","cat":"papers","name":"Ayahuasca reader: encounters with the Amazon's sacred vine","year":"2000","cit":54,"pfa":"Luís Eduardo Luna","ptype":"article","src":"https://openalex.org/W3193511309","eid":"W3193511309"},{"id":"paper-w1971674711","cat":"papers","name":"Interaction of ibogaine and d-amphetamine: in vivo microdialysis and motor behavior in rats","year":"1992","cit":54,"pfa":"I.M. Maisonneuve","psa":"S.D. Glick","ptype":"article","src":"https://openalex.org/W1971674711","eid":"W1971674711"},{"id":"paper-w1980700146","cat":"papers","name":"MDMA (“ecstasy”) abuse as an example of dopamine neuroplasticity","year":"2010","cit":54,"pfa":"Susan Schenk","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1980700146","eid":"W1980700146"},{"id":"paper-w2069605484","cat":"papers","name":"A developmental comparison of the neurobehavioral effects of ecstasy (MDMA)","year":"2006","cit":54,"pfa":"Brian J. Piper","ptype":"article","src":"https://openalex.org/W2069605484","eid":"W2069605484"},{"id":"paper-w1986704380","cat":"papers","name":"A Case of Mao Inhibitor/MDMA Interaction: Agony After Ecstasy","year":"1987","cit":54,"pfa":"Martin J. Smilkstein","psa":"Barry H. Rumack","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1986704380","eid":"W1986704380"},{"id":"paper-w1980443637","cat":"papers","name":"Mental disorders in current and former heavy ecstasy (MDMA) users","year":"2005","cit":54,"pfa":"Rainer Thomasius","psa":"Achim Schmoldt","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W1980443637","eid":"W1980443637"},{"id":"paper-w2045291968","cat":"papers","name":"Effect of ambient temperature and a prior neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA) on the hyperthermic response of rats to a single or repeated (‘binge’ ingestion) low dose of MDMA","year":"2004","cit":54,"pfa":"A. Richard Green","psa":"María Isabel Colado","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2045291968","eid":"W2045291968"},{"id":"paper-w2105510525","cat":"papers","name":"Action of MDMA (Ecstasy) and Its Metabolites on Arginine Vasopressin Release","year":"2002","cit":54,"pfa":"John K. Fallon","psa":"Mary L. Forsling","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2105510525","eid":"W2105510525"},{"id":"paper-w4385479997","cat":"papers","name":"Transient Elevation of Plasma Glucocorticoids Supports Psilocybin-Induced Anxiolysis in Mice","year":"2023","cit":54,"pfa":"N. Jones","psa":"Cody J. Wenthur","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4385479997","eid":"W4385479997"},{"id":"paper-w2011365853","cat":"papers","name":"Morbidity associated with MDMA (ecstasy) abuse: A survey of emergency department admissions","year":"2010","cit":54,"pfa":"Pinchas Halpern","psa":"Kobi Peleg","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2011365853","eid":"W2011365853"},{"id":"paper-w1586166128","cat":"papers","name":"A prospective study of learning, memory, and executive function in new MDMA users","year":"2012","cit":54,"pfa":"Daniel R. Wagner","psa":"Jörg Daumann","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1586166128","eid":"W1586166128"},{"id":"paper-w1978354677","cat":"papers","name":"Effect of MDMA neurotoxicity upon its conditioned place preference and discrimination","year":"1991","cit":54,"pfa":"Martin Schechter","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1978354677","eid":"W1978354677"},{"id":"paper-w2135650587","cat":"papers","name":"Fatality Due To Combined Use of the Designer Drugs MDMA and PMA: A Distribution Study","year":"2003","cit":54,"pfa":"Richard Dams","psa":"André P. De Leenheer","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2135650587","eid":"W2135650587"},{"id":"paper-w2075101325","cat":"papers","name":"Memory impairment in now abstinent MDMA users and continued users: A longitudinal follow-up","year":"2006","cit":54,"pfa":"Konstantine K. Zakzanis","psa":"Zachariah Campbell","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2075101325","eid":"W2075101325"},{"id":"paper-w2037782731","cat":"papers","name":"Investigation of the prejunctional α2‐adrenoceptor mediated actions of MDMA in rat atrium and vas deferens","year":"1999","cit":54,"pfa":"Aisling Lavelle","psa":"James R. Docherty","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2037782731","eid":"W2037782731"},{"id":"paper-w638595190","cat":"papers","name":"Long-term effects of repeated social stress on the conditioned place preference induced by MDMA in mice","year":"2015","cit":54,"pfa":"María Pilar García-Pardo","psa":"M.A. Aguilar","ptype":"article","src":"https://openalex.org/W638595190","eid":"W638595190"},{"id":"paper-w2154971988","cat":"papers","name":"DNA damage and ubiquitinated neuronal inclusions in the substantia nigra and striatum of mice following MDMA (ecstasy)","year":"2004","cit":54,"pfa":"Francesco Fornai","psa":"Antonio Paparelli","ptype":"article","src":"https://openalex.org/W2154971988","eid":"W2154971988"},{"id":"paper-w2065693314","cat":"papers","name":"New mescaline concentrations from 14 taxa/cultivars of Echinopsis spp. (Cactaceae) (“San Pedro”) and their relevance to shamanic practice","year":"2010","cit":54,"pfa":"Olabode Ogunbodede","psa":"Martin Terry","ptype":"article","src":"https://openalex.org/W2065693314","eid":"W2065693314"},{"id":"paper-w4391451404","cat":"papers","name":"Serotonergic Psychedelics: A Comparative Review of Efficacy, Safety, Pharmacokinetics, and Binding Profile","year":"2024","cit":54,"pfa":"Friederike Holze","psa":"Deepak Cyril D’Souza","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4391451404","eid":"W4391451404"},{"id":"paper-w2000732101","cat":"papers","name":"Short- and long-term effects of MDMA (“ecstasy”) on synaptosomal and vesicular uptake of neurotransmitters in vitro and ex vivo","year":"2003","cit":54,"pfa":"Inger Lise Bogen","psa":"Frode Fonnum","ptype":"article","src":"https://openalex.org/W2000732101","eid":"W2000732101"},{"id":"paper-w2092967249","cat":"papers","name":"Biochemical effects of the monoamine neurotoxins DSP-4 and MDMA in specific brain regions of MAO-B-deficient mice","year":"2001","cit":54,"pfa":"Francesco Fornai","psa":"Jean Chen Shih","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2092967249","eid":"W2092967249"},{"id":"paper-w2106141951","cat":"papers","name":"Self-reported prevalence of dependence of MDMA compared to cocaine, mephedrone and ketamine among a sample of recreational poly-drug users","year":"2014","cit":54,"pfa":"Hanna E. Tervonen","psa":"ADAM R. WINSTOCK","ptype":"article","src":"https://openalex.org/W2106141951","eid":"W2106141951"},{"id":"paper-w1517836179","cat":"papers","name":"Simultaneous Analysis of Amphetamine, Methamphetamine, and 3,4-Methylenedioxymethamphetamine (MDMA) in Urine Samples by Solid-Phase Extraction, Derivatization, and Gas Chromatography/Mass Spectrometry","year":"1991","cit":54,"pfa":"Ber K. Gan","psa":"AS Walia","ptype":"article","src":"https://openalex.org/W1517836179","eid":"W1517836179"},{"id":"paper-w3040046088","cat":"papers","name":"3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for victims of sexual abuse with severe post-traumatic stress disorder: an open label pilot study in Brazil","year":"2020","cit":54,"pfa":"Alvaro V. Jardim","psa":"Eduardo Ekman Schenberg","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3040046088","eid":"W3040046088"},{"id":"paper-w4402747955","cat":"papers","name":"Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled tr","year":"2024","cit":54,"pfa":"David Erritzøe","psa":"Robin Lester Carhart-Harris","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4402747955","eid":"W4402747955"},{"id":"paper-w2507811178","cat":"papers","name":"Semantic activation in LSD: evidence from picture naming","year":"2016","cit":54,"pfa":"Neiloufar Family","psa":"Robin Lester Carhart-Harris","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2507811178","eid":"W2507811178"},{"id":"paper-w3171546624","cat":"papers","name":"Ethnoracial health disparities and the ethnopsychopharmacology of psychedelic-assisted psychotherapies.","year":"2021","cit":54,"pfa":"Colleen Fogg","psa":"Monnica T. Williams","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W3171546624","eid":"W3171546624"},{"id":"paper-w2037065160","cat":"papers","name":"FURTHER STUDIES ON THE MODE OF ACTION OF PSYCHOTOMIMETIC DRUGS: ANTAGONISM OF THE EXCITATORY ACTIONS OF 5‐HYDROXYTRYPTAMINE BY METHYLATED DERIVATIVES OF TRYPTAMINE","year":"1974","cit":54,"pfa":"Philip B. Bradley","psa":"Ian Briggs","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2037065160","eid":"W2037065160"},{"id":"paper-w115832866","cat":"papers","name":"Club Drug Use and Dependence among Young Adults Recruited through Time-Space Sampling","year":"2009","cit":54,"pfa":"Jeffrey T. Parsons","psa":"Brian C. Kelly","ptype":"article","src":"https://openalex.org/W115832866","eid":"W115832866"},{"id":"paper-w2105119330","cat":"papers","name":"From trans-methylation to cytosine methylation: Evolution of the methylation hypothesis of schizophrenia","year":"2009","cit":54,"pfa":"Dennis R. Grayson","psa":"Alessandro Guidotti","topics":["Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2105119330","eid":"W2105119330"},{"id":"paper-w1983710102","cat":"papers","name":"Characterization and radioautography of [3H] LSD binding by rat brain slices in vitro: The effect of 5-hydroxytryptamine","year":"1980","cit":54,"pfa":"Richard C. Meibach","psa":"Jack Green","ptype":"article","src":"https://openalex.org/W1983710102","eid":"W1983710102"},{"id":"paper-w4366087911","cat":"papers","name":"A whole-brain model of the neural entropy increase elicited by psychedelic drugs","year":"2023","cit":54,"pfa":"Ruben A Herzog","psa":"Rodrigo Cofré","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4366087911","eid":"W4366087911"},{"id":"paper-w3178773473","cat":"papers","name":"LSD, madness and healing: Mystical experiences as possible link between psychosis model and therapy model","year":"2021","cit":54,"pfa":"Isabel Wießner","psa":"Luís Fernando Tófoli","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3178773473","eid":"W3178773473"},{"id":"paper-w2120534405","cat":"papers","name":"Evidence for the Involvement of Nitric Oxide in 3,4-Methylenedioxymethamphetamine-Induced Serotonin Depletion in the Rat Brain","year":"2005","cit":54,"pfa":"Altaf S. Darvesh","psa":"Gary A. Gudelsky","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2120534405","eid":"W2120534405"},{"id":"paper-w3199302798","cat":"papers","name":"A Qualitative Exploration of Relational Ethical Challenges and Practices in Psychedelic Healing","year":"2021","cit":54,"pfa":"Bill Brennan","psa":"Joseph G. Ponterotto","topics":["Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3199302798","eid":"W3199302798"},{"id":"paper-w2072724656","cat":"papers","name":"Induction of Malignant Hyperthermia in Susceptible Swine by 3,4-Methylenedioxymethamphetamine (“Ecstasy”)","year":"2003","cit":54,"pfa":"Marko Fiege","psa":"Jochen Schulte am Esch","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2072724656","eid":"W2072724656"},{"id":"paper-w2908746584","cat":"papers","name":"In vitro metabolic fate of nine LSD-based new psychoactive substances and their analytical detectability in different urinary screening procedures","year":"2019","cit":54,"pfa":"Lea Wagmann","psa":"Markus R. Meyer","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2908746584","eid":"W2908746584"},{"id":"paper-w2081419341","cat":"papers","name":"Synthetic Studies of Neoclerodane Diterpenes from Salvia divinorum: Preparation and Opioid Receptor Activity of Salvinicin Analogues","year":"2007","cit":54,"pfa":"Denise S. Simpson","psa":"Thomas Edward Prisinzano","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2081419341","eid":"W2081419341"},{"id":"paper-w4320305315","cat":"papers","name":"Psychedelic Identity Shift: A Critical Approach to Set And Setting","year":"2022","cit":54,"pfa":"Neşe Devenot","psa":"Matthew W. Johnson","topics":["Addiction","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4320305315","eid":"W4320305315"},{"id":"paper-w2062845417","cat":"papers","name":"Methylenedioxyamphetamine. Clinical description of overdose, death, and review of pharmacology","year":"1981","cit":54,"pfa":"DAVID L. SIMPSON","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2062845417","eid":"W2062845417"},{"id":"paper-w1984936010","cat":"papers","name":"Indolealkylamine analogs share 5-HT2 binding characteristics with phenylalkylamine hallucinogens","year":"1988","cit":54,"pfa":"Robert A. Lyon","psa":"Richard A. Glennon","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1984936010","eid":"W1984936010"},{"id":"paper-w3003871080","cat":"papers","name":"Isness: Using Multi-Person VR to Design Peak Mystical Type Experiences Comparable to Psychedelics","year":"2020","cit":54,"pfa":"David R. Glowacki","psa":"Oussama Metatla","topics":["Safety & adverse events","Dosing & pharmacology","Therapy practice"],"ptype":"conference-paper","src":"https://openalex.org/W3003871080","eid":"W3003871080"},{"id":"paper-w2014837790","cat":"papers","name":"5-HT depletion with 5,7-DHT, PCA and PCPA in mice: differential effects on the sensitivity to 5-MeODMT, 8-OH-DPAT and 5-HTP as measured by two nociceptive tests","year":"1988","cit":54,"pfa":"Per Kristian Eide","psa":"OLE JACOB BROCH","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2014837790","eid":"W2014837790"},{"id":"paper-w2069823906","cat":"papers","name":"Oral Fluid Drug Testing of Chronic Pain Patients. I. Positive Prevalence Rates of Licit and Illicit Drugs","year":"2011","cit":54,"pfa":"Rebecca M. Heltsley","psa":"Edward J. Cone","ptype":"article","src":"https://openalex.org/W2069823906","eid":"W2069823906"},{"id":"paper-w3154528253","cat":"papers","name":"Can pragmatic research, real-world data and digital technologies aid the development of psychedelic medicine?","year":"2021","cit":54,"pfa":"Robin Lester Carhart-Harris","psa":"David Erritzøe","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3154528253","eid":"W3154528253"},{"id":"paper-w2052341973","cat":"papers","name":"Serotonergic Hallucinogens and Emerging Targets for Addiction Pharmacotherapies","year":"2012","cit":54,"pfa":"Stephen Ross","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2052341973","eid":"W2052341973"},{"id":"paper-w2280157549","cat":"papers","name":"Notes on the Present Status of Ololiuhqui and the Other Hallucinogens of Mexico","year":"1963","cit":54,"pfa":"R. Gordon Wasson","ptype":"article","src":"https://openalex.org/W2280157549","eid":"W2280157549"},{"id":"paper-w4393359395","cat":"papers","name":"Safety and risk assessment of psychedelic psychotherapy: A meta-analysis and systematic review","year":"2024","cit":54,"pfa":"Bruno Roméo","psa":"Amine Benyamina","topics":["Safety & adverse events","Reviews & meta-analyses","Therapy practice"],"ptype":"review","src":"https://openalex.org/W4393359395","eid":"W4393359395"},{"id":"paper-w1953634463","cat":"papers","name":"The psychotomimetic drug phencyclidine labels two high affinity binding sites in guinea pig brain: evidence for N-methyl-D-aspartate-coupled and dopamine reuptake carrier-associated phencyclidine binding sites.","year":"1989","cit":54,"pfa":"Richard B. Rothman","psa":"Kenner C. Rice","ptype":"article","src":"https://openalex.org/W1953634463","eid":"W1953634463"},{"id":"paper-w2041335953","cat":"papers","name":"Hallucinogenic Plants of the Shuar and Related Indigenous Groups in Amazonian Ecuador and Peru","year":"1992","cit":54,"pfa":"Bradley C. Bennett","ptype":"article","src":"https://openalex.org/W2041335953","eid":"W2041335953"},{"id":"paper-w2332369176","cat":"papers","name":"Substance Use Among Homeless Individuals With Schizophrenia and Bipolar Disorder","year":"2016","cit":54,"pfa":"Angelo Giovanni Icro Maremmani","psa":"Michael Reinhardt Krausz","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2332369176","eid":"W2332369176"},{"id":"paper-w2118042425","cat":"papers","name":"Motivation for Marihuana Use: A Correlate of Adverse Reaction","year":"1968","cit":54,"pfa":"MARTIN H. KEELER","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2118042425","eid":"W2118042425"},{"id":"paper-w2313016104","cat":"papers","name":"Repeated ketamine administration alters N -methyl- d -aspartic acid receptor subunit gene expression: Implication of genetic vulnerability for ketamine abuse and ketamine psychosis in humans","year":"2014","cit":54,"pfa":"Ke Xu","psa":"Robert H. Lipsky","topics":["Addiction","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2313016104","eid":"W2313016104"},{"id":"paper-w4391228258","cat":"papers","name":"Opioid use disorder: current trends and potential treatments","year":"2024","cit":54,"pfa":"Yu Kyung Lee","psa":"Brian Fuehrlein","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4391228258","eid":"W4391228258"},{"id":"paper-w3030344574","cat":"papers","name":"Are we repeating mistakes of the past? A review of the evidence for esketamine","year":"2020","cit":54,"pfa":"Mark Abie Horowitz","psa":"Joanna Moncrieff","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3030344574","eid":"W3030344574"},{"id":"paper-w4391445497","cat":"papers","name":"Effect of esketamine on postoperative analgesia and postoperative delirium in elderly patients undergoing gastrointestinal surgery","year":"2024","cit":54,"pfa":"Jing Liu","psa":"Li Cao","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4391445497","eid":"W4391445497"},{"id":"paper-w4225154573","cat":"papers","name":"The effectiveness of esketamine and propofol versus dezocine and propofol sedation during gastroscopy: A randomized controlled study","year":"2022","cit":54,"pfa":"Yafei Xu","psa":"Zhongqi Zhang","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4225154573","eid":"W4225154573"},{"id":"paper-w4390145744","cat":"papers","name":"The rapid antidepressant effectiveness of repeated dose of intravenous ketamine and intranasal esketamine: A post-hoc analysis of pooled real-world data","year":"2023","cit":54,"pfa":"Giacomo d’Andrea","psa":"Roger S. McIntyre","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4390145744","eid":"W4390145744"},{"id":"paper-w2953498115","cat":"papers","name":"Metabolism of lysergic acid diethylamide (LSD): an update","year":"2019","cit":53,"pfa":"Rui Filipe Libânio Osório Marta","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2953498115","eid":"W2953498115"},{"id":"paper-w2399291187","cat":"papers","name":"ACTION OF D-LYSERGIC ACID DIETHYLAMIDE ON LATERAL GENICULATE SYNAPSES","year":"1958","cit":53,"pfa":"Peter Orlebar Bishop","psa":"Joseph R. Smith","ptype":"article","src":"https://openalex.org/W2399291187","eid":"W2399291187"},{"id":"paper-w2015609431","cat":"papers","name":"Identification of N,N‐dimethyltryptamine and β‐carbolines in psychotropic ayahuasca beverage","year":"2008","cit":53,"pfa":"Cristiana Gambelunghe","psa":"Mauro Bacci","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2015609431","eid":"W2015609431"},{"id":"paper-w2077147279","cat":"papers","name":"Comparison of a placebo, N-dimethyltryptamine, and 6-hydroxy-N-dimethyltryptamine in man","year":"1963","cit":53,"pfa":"D. E. Rosenberg","psa":"Edward J. Miner","ptype":"article","src":"https://openalex.org/W2077147279","eid":"W2077147279"},{"id":"paper-w3215379260","cat":"papers","name":"Using MDMA in psychotherapy.","year":"1985","cit":53,"pfa":"Esalen Greer","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W3215379260","eid":"W3215379260"},{"id":"paper-w2118483924","cat":"papers","name":"In Vitro Activities of Iboga Alkaloid Congeners Coronaridine and 18-Methoxycoronaridine againstLeishmania amazonensis","year":"2002","cit":53,"pfa":"Jan Carlo Morais Oliveira Bertassoni Delorenzi","psa":"Elvira M. Saraiva","ptype":"article","src":"https://openalex.org/W2118483924","eid":"W2118483924"},{"id":"paper-w2901826670","cat":"papers","name":"Neuroimaging of chronic MDMA (“ecstasy”) effects: A meta-analysis","year":"2018","cit":53,"pfa":"Felix Müller","psa":"Stefan Borgwardt","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W2901826670","eid":"W2901826670"},{"id":"paper-w2083758530","cat":"papers","name":"Salvinorin A and derivatives: Protection from metabolism does not prolong short-term, whole-brain residence","year":"2009","cit":53,"pfa":"Jacob M. Hooker","psa":"Bruce M. Cohen","ptype":"article","src":"https://openalex.org/W2083758530","eid":"W2083758530"},{"id":"paper-w2152092268","cat":"papers","name":"Salvinorin A exerts opposite presynaptic controls on neurotransmitter exocytosis from mouse brain nerve terminals","year":"2009","cit":53,"pfa":"Massimo Grilli","psa":"Anna Pittaluga","ptype":"article","src":"https://openalex.org/W2152092268","eid":"W2152092268"},{"id":"paper-w2044667945","cat":"papers","name":"Investigation of serotonin-1A receptor function in the human psychopharmacology of MDMA","year":"2008","cit":53,"pfa":"Felix Hasler","psa":"F.X. Vollenweider","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2044667945","eid":"W2044667945"},{"id":"paper-w1968883863","cat":"papers","name":"MDMA-like behavioral effects of N-substituted piperazines in the mouse","year":"2007","cit":53,"pfa":"Haley L. Yarosh","psa":"William E. Fantegrossi","ptype":"article","src":"https://openalex.org/W1968883863","eid":"W1968883863"},{"id":"paper-w2793853595","cat":"papers","name":"Psilocin and ketamine microdosing: effects of subchronic intermittent microdoses in the elevated plus-maze in male Wistar rats","year":"2018","cit":53,"pfa":"Rachel R. Horsley","psa":"Karel Valeš","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2793853595","eid":"W2793853595"},{"id":"paper-w2032674938","cat":"papers","name":"Acute behavioural and neurotoxic effects of MDMA plus cocaine in adolescent mice","year":"2008","cit":53,"pfa":"Manuel Daza‐Losada","psa":"José Miñarro","ptype":"article","src":"https://openalex.org/W2032674938","eid":"W2032674938"},{"id":"paper-w2030134429","cat":"papers","name":"Behavioral and neurochemical effects of chronic methylenedioxymethamphetamine (MDMA) treatment in rhesus monkeys","year":"1995","cit":53,"pfa":"David Frederick","psa":"Merle G. Paule","ptype":"article","src":"https://openalex.org/W2030134429","eid":"W2030134429"},{"id":"paper-w3141124634","cat":"papers","name":"Prediction of MDMA response in healthy humans: a pooled analysis of placebo-controlled studies","year":"2021","cit":53,"pfa":"Erich Studerus","psa":"Matthias E. Liechti","topics":["Addiction","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3141124634","eid":"W3141124634"},{"id":"paper-w2028163847","cat":"papers","name":"MDMA (ecstasy) pharmacokinetics in a CYP2D6 poor metaboliser and in nine CYP2D6 extensive metabolisers","year":"2005","cit":53,"pfa":"Rafael de la Torre","psa":"Jordi Camı́","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2028163847","eid":"W2028163847"},{"id":"paper-w2110233917","cat":"papers","name":"‘Ecstasy’ as a social drug: MDMA preferentially affects responses to emotional stimuli with social content","year":"2014","cit":53,"pfa":"Margaret C. Wardle","psa":"Harriet de Wit","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2110233917","eid":"W2110233917"},{"id":"paper-w2114461993","cat":"papers","name":"Blockade of 5-HT2 Receptor Selectively Prevents MDMA-Induced Verbal Memory Impairment","year":"2011","cit":53,"pfa":"Janelle H. P. van Wel","psa":"Johannes Gerardus Ramaekers","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2114461993","eid":"W2114461993"},{"id":"paper-w2039997415","cat":"papers","name":"Attenuation of 3,4‐methylenedioxymethamphetamine (MDMA, Ecstasy)‐induced rhabdomyolysis with α1‐ plus β3‐adrenoreceptor antagonists","year":"2004","cit":53,"pfa":"Jon E. Sprague","psa":"Daniel E. Rusyniak","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2039997415","eid":"W2039997415"},{"id":"paper-w2000675874","cat":"papers","name":"Validation of an ELISA-based screening assay for the detection of amphetamine, MDMA and MDA in blood and oral fluid","year":"2005","cit":53,"pfa":"Marleen Laloup","psa":"Nele Samyn","ptype":"article","src":"https://openalex.org/W2000675874","eid":"W2000675874"},{"id":"paper-w1999266594","cat":"papers","name":"Neurotoxic Effects of MDMA on Brain Serotonin Neurons: Evidence from Neurochemical and Radioligand Binding Studiesa","year":"1990","cit":53,"pfa":"Errol B. De Souza","psa":"Thomas R. Insel","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1999266594","eid":"W1999266594"},{"id":"paper-w2003730063","cat":"papers","name":"Chronic exposure to MDMA (ecstasy) increases DNA damage in sperm and alters testes histopathology in male rats","year":"2009","cit":53,"pfa":"Marta Barenys","psa":"Juan M. Llobet","ptype":"article","src":"https://openalex.org/W2003730063","eid":"W2003730063"},{"id":"paper-w2119268093","cat":"papers","name":"MDMA (3,4-methylenedioxymethamphetamine) inhibits the firing of dorsal raphe neurons in brain slices via release of serotonin","year":"1989","cit":53,"pfa":"Jeffrey S. Sprouse","psa":"George K. Aghajanian","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2119268093","eid":"W2119268093"},{"id":"paper-w3125520373","cat":"papers","name":"Highly sensitive electrochemical sensor based on Pt nanoparticles/carbon nanohorns for simultaneous determination of morphine and MDMA in biological samples","year":"2021","cit":53,"pfa":"Ruilin Zhang","psa":"Qingju Liu","ptype":"article","src":"https://openalex.org/W3125520373","eid":"W3125520373"},{"id":"paper-w2051426845","cat":"papers","name":"The administration of psilocybin to healthy, hallucinogen-experienced volunteers in a mock-functional magnetic resonance imaging environment: a preliminary investigation of tolerability","year":"2010","cit":53,"pfa":"Robin Lester Carhart-Harris","psa":"David Nutt","ptype":"article","src":"https://openalex.org/W2051426845","eid":"W2051426845"},{"id":"paper-w1983592473","cat":"papers","name":"Study on the neuroprotective effect of fluoxetine against MDMA-induced neurotoxicity on the serotonin transporter in rat brain using micro-PET","year":"2009","cit":53,"pfa":"I‐Hsun Li","psa":"Kuo‐Hsing Ma","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1983592473","eid":"W1983592473"},{"id":"paper-w2950212301","cat":"papers","name":"Synthesis and pharmacological examination of 1-(3-methoxy-4-methylphenyl)-2-aminopropane and 5-methoxy-6-methyl-2-aminoindan: similarities to 3,4-(methylenedioxy)methamphetamine (MDMA)","year":"1991","cit":53,"pfa":"Michael P. Johnson","psa":"David E. Nichols","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2950212301","eid":"W2950212301"},{"id":"paper-w2024784013","cat":"papers","name":"Hallucinogens potentiate responses to serotonin and norepinephrine in the facial motor nucleus","year":"1980","cit":53,"pfa":"Robert B. McCall","psa":"George K. Aghajanian","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2024784013","eid":"W2024784013"},{"id":"paper-w2128973960","cat":"papers","name":"Neuropsychological Assessment of Undergraduate Marihuana and LSD Users","year":"1974","cit":53,"pfa":"Charles M. Culver","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2128973960","eid":"W2128973960"},{"id":"paper-w4404731501","cat":"papers","name":"Reconsidering evidence for psychedelic-induced psychosis: an overview of reviews, a systematic review, and meta-analysis of human studies","year":"2024","cit":53,"pfa":"Michel Sabé","psa":"Matthias Kirschner","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4404731501","eid":"W4404731501"},{"id":"paper-w4378549583","cat":"papers","name":"Psychedelics: Threshold of a Therapeutic Revolution","year":"2023","cit":53,"pfa":"David J. Heal","psa":"Jack E. Henningfield","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4378549583","eid":"W4378549583"},{"id":"paper-w2477333650","cat":"papers","name":"Functional Rescue of a Misfolded Drosophila melanogaster Dopamine Transporter Mutant Associated with a Sleepless Phenotype by Pharmacological Chaperones","year":"2016","cit":53,"pfa":"Ameya Sanjay Kasture","psa":"Sonja Sučić","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2477333650","eid":"W2477333650"},{"id":"paper-w2073979670","cat":"papers","name":"Acute effects of 3,4-methylenedioxymethamphetamine on striatal single-unit activity and behavior in freely moving rats: differential involvement of dopamine D1 and D2 receptors","year":"2003","cit":53,"pfa":"Kevin T. Ball","psa":"George V. Rebec","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2073979670","eid":"W2073979670"},{"id":"paper-w2158476385","cat":"papers","name":"Reduced N-acetylaspartate levels in the frontal cortex of 3,4-methylenedioxymethamphetamine (Ecstasy) users: preliminary results.","year":"2002","cit":53,"pfa":"Liesbeth Reneman","psa":"Gerard J. den Heeten","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2158476385","eid":"W2158476385"},{"id":"paper-w1968135120","cat":"papers","name":"Further Studies on the Role of Metabolites in (±)-3,4-Methylenedioxymethamphetamine-Induced Serotonergic Neurotoxicity","year":"2009","cit":53,"pfa":"Melanie Mueller","psa":"George A. Ricaurte","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1968135120","eid":"W1968135120"},{"id":"paper-w2410411229","cat":"papers","name":"CYP2D6 function moderates the pharmacokinetics and pharmacodynamics of 3,4-methylene-dioxymethamphetamine in a controlled study in healthy individuals","year":"2016","cit":53,"pfa":"Yasmin Schmid","psa":"Matthias E. Liechti","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2410411229","eid":"W2410411229"},{"id":"paper-w1998049195","cat":"papers","name":"Development of selective tolerance to the serotonin behavioral syndrome and suppression of locomotor activity after repeated administration of either 5-MeODMT or mCPP","year":"1985","cit":53,"pfa":"Matthew A. Sills","psa":"Alan Frazer","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1998049195","eid":"W1998049195"},{"id":"paper-w2059224991","cat":"papers","name":"PRECLINICAL STUDY: Age‐dependent differences in sensitivity and sensitization to cannabinoids and ‘club drugs’ in male adolescent and adult rats","year":"2007","cit":53,"pfa":"Jenny L. Wiley","psa":"Katherine L. Nicholson","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2059224991","eid":"W2059224991"},{"id":"paper-w2008841166","cat":"papers","name":"Recent EEG and ERP Findings in Substance Abusers","year":"2009","cit":53,"pfa":"Natalie A. Ceballos","psa":"Rebecca J. Houston","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2008841166","eid":"W2008841166"},{"id":"paper-w2097196401","cat":"papers","name":"Dependence and psychosis with 4-methylmethcathinone (mephedrone) use","year":"2010","cit":53,"pfa":"Neeraj Bajaj","psa":"S Wylie","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2097196401","eid":"W2097196401"},{"id":"paper-w2959579307","cat":"papers","name":"Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses","year":"2019","cit":53,"pfa":"Amelia D. Dunn","psa":"Mary Jeanne Kreek","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2959579307","eid":"W2959579307"},{"id":"paper-w4392193120","cat":"papers","name":"Are “mystical experiences” essential for antidepressant actions of ketamine and the classic psychedelics?","year":"2024","cit":53,"pfa":"Kenji Hashimoto","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4392193120","eid":"W4392193120"},{"id":"paper-w1517951919","cat":"papers","name":"Restructuring consciousness –the psychedelic state in light of integrated information theory","year":"2015","cit":53,"pfa":"Andrew R. Gallimore","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1517951919","eid":"W1517951919"},{"id":"paper-w2733751315","cat":"papers","name":"The Effects of Hallucinogens on Gene Expression","year":"2017","cit":53,"pfa":"David Alexander Martin","psa":"Charles David Nichols","ptype":"book-chapter","src":"https://openalex.org/W2733751315","eid":"W2733751315"},{"id":"paper-w2160451094","cat":"papers","name":"Transcranial Magnetic Stimulation to Understand the Pathophysiology and Treatment of Substance Use Disorders","year":"2008","cit":53,"pfa":"Mera S. Barr","psa":"Zafiris Daskalakis","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2160451094","eid":"W2160451094"},{"id":"paper-w4384665053","cat":"papers","name":"Dark loops: contagion effects, consistency and chemosocial matrices in psychedelic-assisted therapy trials","year":"2023","cit":53,"pfa":"Tehseen N. Noorani","psa":"Suresh D Muthukumaraswamy","ptype":"article","src":"https://openalex.org/W4384665053","eid":"W4384665053"},{"id":"paper-w2901185945","cat":"papers","name":"An introduction to psychedelic neuroscience","year":"2018","cit":53,"pfa":"Tanya Calvey","psa":"Fleur Margaret Howells","ptype":"book-chapter","src":"https://openalex.org/W2901185945","eid":"W2901185945"},{"id":"paper-w2618263941","cat":"papers","name":"Psychedelic Psychiatry: LSD from Clinic to Campus","year":"2008","cit":53,"pfa":"Erika Dyck","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2618263941","eid":"W2618263941"},{"id":"paper-w2769643547","cat":"papers","name":"Validation of whole-blood transcriptome signature during microdose recombinant human erythropoietin (rHuEpo) administration","year":"2017","cit":53,"pfa":"Guan Wang","psa":"Yannis Paul Pitsiladis","topics":["Dosing & pharmacology","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2769643547","eid":"W2769643547"},{"id":"paper-w2019442101","cat":"papers","name":"A positron emission tomography microdosing study with a potential antiamyloid drug in healthy volunteers and patients with Alzheimer’s disease","year":"2006","cit":53,"pfa":"Martin Bauer","psa":"Paolo Carminati","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2019442101","eid":"W2019442101"},{"id":"paper-w2073997074","cat":"papers","name":"Behavioral, neurochemical and pharmaco-EEG profiles of the psychedelic drug 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in rats","year":"2012","cit":53,"pfa":"Tomáš Páleníček","psa":"Cyril Höschl","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2073997074","eid":"W2073997074"},{"id":"paper-w3216191508","cat":"papers","name":"An Integrative Approach to Ketamine Therapy May Enhance Multiple Dimensions of Efficacy: Improving Therapeutic Outcomes With Treatment Resistant Depression","year":"2021","cit":53,"pfa":"Sherry-Anne Muscat","psa":"Kevin W. Morin","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3216191508","eid":"W3216191508"},{"id":"paper-w3122632999","cat":"papers","name":"Prolonged ketamine infusion modulates limbic connectivity and induces sustained remission of treatment-resistant depression","year":"2021","cit":53,"pfa":"Joshua S. Siegel","psa":"Nuri B. Farber","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3122632999","eid":"W3122632999"},{"id":"paper-w1577969467","cat":"papers","name":"Pharmacokinetic–pharmacodynamic relationships of central nervous system effects of scopolamine in healthy subjects","year":"2011","cit":53,"pfa":"M Liem-Moolenaar","psa":"Joop van Gerven","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1577969467","eid":"W1577969467"},{"id":"paper-w2509738709","cat":"papers","name":"Differential regulation of GluA1 expression by ketamine and memantine","year":"2016","cit":53,"pfa":"Ke Zhang","psa":"Xiang Cai","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2509738709","eid":"W2509738709"},{"id":"paper-w3024654900","cat":"papers","name":"Unraveling the Intoxicating and Therapeutic Effects of Cannabis Ingredients on Psychosis and Cognition","year":"2020","cit":53,"pfa":"Marco Colizzi","psa":"Sagnik Bhattacharyya","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3024654900","eid":"W3024654900"},{"id":"paper-w2916638763","cat":"papers","name":"Investigation of medical effect of multiple ketamine infusions on patients with major depressive disorder","year":"2019","cit":53,"pfa":"Wei Zheng","psa":"Yuping Ning","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2916638763","eid":"W2916638763"},{"id":"paper-w4319349727","cat":"papers","name":"Ketamine and esketamine in suicidal thoughts and behaviors: a systematic review","year":"2023","cit":53,"pfa":"Fabrice Jollant","psa":"Gerd Wagner","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4319349727","eid":"W4319349727"},{"id":"paper-w3040446518","cat":"papers","name":"Cost-Effectiveness of Esketamine Nasal Spray for Patients With Treatment-Resistant Depression in the United States","year":"2020","cit":53,"pfa":"Eric L. Ross","psa":"Djøra I. Soeteman","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3040446518","eid":"W3040446518"},{"id":"paper-w4311798431","cat":"papers","name":"Effects of the Different Doses of Esketamine on Postoperative Quality of Recovery in Patients Undergoing Modified Radical Mastectomy: A Randomized, Double-Blind, Controlled Trial","year":"2022","cit":53,"pfa":"Min Zhu","psa":"Xitong Yu","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4311798431","eid":"W4311798431"},{"id":"paper-w2794118706","cat":"papers","name":"Lysergic Acid Diethylamide and Psilocybin for the Management of Patients with Persistent Pain: a Potential Role?","year":"2018","cit":52,"pfa":"Andy Whelan","psa":"Mark I. Johnson","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2794118706","eid":"W2794118706"},{"id":"paper-w2308102728","cat":"papers","name":"Lysergic acid diethylamide: a drug of ‘use’?","year":"2016","cit":52,"pfa":"Saibal Das","psa":"Somnath Mondal","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2308102728","eid":"W2308102728"},{"id":"paper-w1997866120","cat":"papers","name":"Some Effects of Bufotenine and Lysergic Acid Diethylamide on the Monkey","year":"1956","cit":52,"pfa":"Edward V. Evarts","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1997866120","eid":"W1997866120"},{"id":"paper-w1986364262","cat":"papers","name":"PRODUCTION OF ABNORMAL (PSYCHOTIC?) BEHAVIOR IN MICE WITH LYSERGIC ACID DIETHYLAMIDE, AND ITS PARTIAL PREVENTION WITH CHOLINERGIC DRUGS AND SEROTONIN","year":"1955","cit":52,"pfa":"D. W. Woolley","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1986364262","eid":"W1986364262"},{"id":"paper-w1976604434","cat":"papers","name":"Lysergic acid diethylamide (LSD) is a partial agonist of D2 dopaminergic receptors and it potentiates dopamine-mediated prolactin secretion in lactotrophs in vitro","year":"1998","cit":52,"pfa":"Sabrina Giacomelli","psa":"Bruno Silvestrini","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1976604434","eid":"W1976604434"},{"id":"paper-w2130590956","cat":"papers","name":"Quantitative analysis of psilocybin and psilocin and psilocybe baecystis (singer and smith) by high-performance liquid chromatography and by thin-layer chromatography","year":"1981","cit":52,"pfa":"Michael W. Beug","psa":"Jeremy Bigwood","ptype":"article","src":"https://openalex.org/W2130590956","eid":"W2130590956"},{"id":"paper-w2020446587","cat":"papers","name":"The epistemics of ayahuasca visions","year":"2010","cit":52,"pfa":"Benny Shanon","ptype":"article","src":"https://openalex.org/W2020446587","eid":"W2020446587"},{"id":"paper-w2884828036","cat":"papers","name":"Production Options for Psilocybin: Making of the Magic","year":"2018","cit":52,"pfa":"Janis Fricke","psa":"Dirk Hoffmeister","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2884828036","eid":"W2884828036"},{"id":"paper-w1979476863","cat":"papers","name":"Five New Iboga Alkaloids from Tabernaemontana corymbosa","year":"2002","cit":52,"pfa":"Toh‐Seok Kam","psa":"Kooi‐Mow Sim","ptype":"article","src":"https://openalex.org/W1979476863","eid":"W1979476863"},{"id":"paper-w2897760082","cat":"papers","name":"Methylenedioxymethamphetamine (MDMA) in Psychiatry","year":"2018","cit":52,"pfa":"Susan Schenk","psa":"David A. L. Newcombe","topics":["PTSD & trauma","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2897760082","eid":"W2897760082"},{"id":"paper-w2072556144","cat":"papers","name":"Memory performance in polyvalent MDMA (ecstasy) users who continue or discontinue MDMA use","year":"2005","cit":52,"pfa":"Euphrosyne Gouzoulis‐Mayfrank","psa":"Jörg Daumann","ptype":"article","src":"https://openalex.org/W2072556144","eid":"W2072556144"},{"id":"paper-w1988743423","cat":"papers","name":"Pharmacological activity of Salvinorin A, the major component of Salvia divinorum","year":"2011","cit":52,"pfa":"Joanna Listos","psa":"Sylwia Fidecka","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1988743423","eid":"W1988743423"},{"id":"paper-w2092586569","cat":"papers","name":"Serotonin, Psilocybin, and Body Dysmorphic Disorder","year":"1996","cit":52,"pfa":"Karl R. Hanes","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2092586569","eid":"W2092586569"},{"id":"paper-w2469172311","cat":"papers","name":"Ibogaine: A Potent Noncompetitive Blocker of Ganglionic/Neuronal Nicotinic Receptors","year":"1997","cit":52,"pfa":"Barbara Badio","psa":"John W. Daly","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2469172311","eid":"W2469172311"},{"id":"paper-w2802656036","cat":"papers","name":"Biocatalytic Production of Psilocybin and Derivatives in Tryptophan Synthase‐Enhanced Reactions","year":"2018","cit":52,"pfa":"Felix Blei","psa":"Dirk Hoffmeister","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2802656036","eid":"W2802656036"},{"id":"paper-w1995291999","cat":"papers","name":"Auditory stimuli enhance MDMA-conditioned reward and MDMA-induced nucleus accumbens dopamine, serotonin and locomotor responses","year":"2008","cit":52,"pfa":"Allison A. Feduccia","psa":"Christine L. Duvauchelle","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1995291999","eid":"W1995291999"},{"id":"paper-w1974654063","cat":"papers","name":"Nantenine: an antagonist of the behavioral and physiological effects of MDMA in mice","year":"2004","cit":52,"pfa":"William E. Fantegrossi","psa":"James Henry Woods","ptype":"article","src":"https://openalex.org/W1974654063","eid":"W1974654063"},{"id":"paper-w1988591059","cat":"papers","name":"Effects of (±) 3,4-Methylenedioxymethamphetamine (MDMA) on Sleep and Circadian Rhythms","year":"2007","cit":52,"pfa":"Una D. McCann","psa":"George A. Ricaurte","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1988591059","eid":"W1988591059"},{"id":"paper-w4253597476","cat":"papers","name":"Long-Term Neuropsychiatric Consequences of \"Ecstasy\" (MDMA): A Review","year":"2002","cit":52,"pfa":"Alonso G. Montoya","psa":"Bruce Heimburger Price","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4253597476","eid":"W4253597476"},{"id":"paper-w2034690984","cat":"papers","name":"Repeated administration of MDMA causes transient down-regulation of serotonin 5-HT2 receptors","year":"1992","cit":52,"pfa":"Ursula Scheffel","psa":"G.A. Ricaurte","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2034690984","eid":"W2034690984"},{"id":"paper-w2068910071","cat":"papers","name":"Effects of phencyclidine, ketamine and MDMA on complex operant behavior in monkeys","year":"1987","cit":52,"pfa":"Donald M. Thompson","psa":"John P. Mastropaolo","ptype":"article","src":"https://openalex.org/W2068910071","eid":"W2068910071"},{"id":"paper-w4240336364","cat":"papers","name":"Multiple severe complications from recreational ingestion of MDMA ('Ecstasy')","year":"1987","cit":52,"pfa":"C. Brown","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4240336364","eid":"W4240336364"},{"id":"paper-w99126694","cat":"papers","name":"Use of the Classic Hallucinogen Psilocybin for Treatment of Existential Distress Associated with Cancer","year":"2012","cit":52,"pfa":"Charles S. Grob","psa":"Roland R. Griffiths","topics":["Anxiety & end-of-life"],"ptype":"book-chapter","src":"https://openalex.org/W99126694","eid":"W99126694"},{"id":"paper-w2409042762","cat":"papers","name":"Influence of inducers and inhibitors on the metabolism in vitro and neurochemical effects in vivo of MDMA.","year":"1989","cit":52,"pfa":"Ram Gollamudi","psa":"William Slikker","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2409042762","eid":"W2409042762"},{"id":"paper-w1586595642","cat":"papers","name":"Ritualistic Use of Ayahuasca versus Street Use of Similar Substances Seized by the Police: A Key Factor Involved in the Potential for Intoxications and Overdose?","year":"2015","cit":52,"pfa":"Rafael Lanaro","psa":"Alessandra Linardi","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1586595642","eid":"W1586595642"},{"id":"paper-w1899272159","cat":"papers","name":"MDMA (‘ecstasy’) enhances basal acetylcholine release in brain slices of the rat striatum","year":"2000","cit":52,"pfa":"Hanspeter S. Fischer","psa":"Alois Saria","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1899272159","eid":"W1899272159"},{"id":"paper-w4220790925","cat":"papers","name":"Prospective examination of the therapeutic role of psychological flexibility and cognitive reappraisal in the ceremonial use of ayahuasca","year":"2022","cit":52,"pfa":"Gabrielle Agin-Liebes","psa":"Brandon Weiss","topics":["Mechanism & neuroscience","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4220790925","eid":"W4220790925"},{"id":"paper-w2159185808","cat":"papers","name":"MDMA and MDA Concentrations in Antemortem and Postmortem Specimens in Fatalities Following Hospital Admission","year":"2005","cit":52,"pfa":"Simon P Elliott","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2159185808","eid":"W2159185808"},{"id":"paper-w4378647709","cat":"papers","name":"UNRAVELing the synergistic effects of psilocybin and environment on brain-wide immediate early gene expression in mice","year":"2023","cit":52,"pfa":"Daniel Ryskamp Rijsketic","psa":"Boris Dov Heifets","ptype":"article","src":"https://openalex.org/W4378647709","eid":"W4378647709"},{"id":"paper-w1827337539","cat":"papers","name":"MPTP‐induced dopamine neuron degeneration and glia activation is potentiated in MDMA‐pretreated mice","year":"2013","cit":52,"pfa":"Giulia Costa","psa":"Micaela Morelli","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1827337539","eid":"W1827337539"},{"id":"paper-w1971933385","cat":"papers","name":"Studies on the role of dopamine D1 receptors in the development and expression of MDMA-induced behavioral sensitization in rats","year":"2004","cit":52,"pfa":"Mar�a Ramos","psa":"Norberto Aguirre","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1971933385","eid":"W1971933385"},{"id":"paper-w2782190599","cat":"papers","name":"Psilocybin disrupts sensory and higher order cognitive processing but not pre-attentive cognitive processing—study on P300 and mismatch negativity in healthy volunteers","year":"2018","cit":52,"pfa":"Anna Bravermanová","psa":"Tomáš Páleníček","ptype":"article","src":"https://openalex.org/W2782190599","eid":"W2782190599"},{"id":"paper-w2122564987","cat":"papers","name":"Pre-Exposure to (±)3,4-methylenedioxy-methamphetamine (MDMA) Facilitates Acquisition of Intravenous Cocaine Self-Administration in Rats","year":"2001","cit":52,"pfa":"Paul Fletcher","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2122564987","eid":"W2122564987"},{"id":"paper-w1972690561","cat":"papers","name":"MDMA Increases Glutamate Release and Reduces Parvalbumin-Positive GABAergic Cells in the Dorsal Hippocampus of the Rat: Role of Cyclooxygenase","year":"2012","cit":52,"pfa":"John H. Anneken","psa":"Gary A. Gudelsky","ptype":"article","src":"https://openalex.org/W1972690561","eid":"W1972690561"},{"id":"paper-w2801672416","cat":"papers","name":"Ayahuasca and Its DMT- and β-carbolines – Containing Ingredients Block the Expression of Ethanol-Induced Conditioned Place Preference in Mice: Role of the Treatment Environment","year":"2018","cit":52,"pfa":"Elisangela Gouveia Cata-Preta","psa":"E.A.V. Marinho","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2801672416","eid":"W2801672416"},{"id":"paper-w1496677669","cat":"papers","name":"Sex‐dependent long‐term effects of adolescent exposure to THC and/or MDMA on neuroinflammation and serotoninergic and cannabinoid systems in rats","year":"2013","cit":52,"pfa":"Ana Belén López-Rodríguez","psa":"María‐Paz Viveros","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1496677669","eid":"W1496677669"},{"id":"paper-w2237057236","cat":"papers","name":"Evaluating score- and feature-based likelihood ratio models for multivariate continuous data: applied to forensic MDMA comparison","year":"2015","cit":52,"pfa":"Annabel Bolck","psa":"Martin Lopatka","ptype":"article","src":"https://openalex.org/W2237057236","eid":"W2237057236"},{"id":"paper-w4387259638","cat":"papers","name":"Repeated low doses of psilocybin increase resilience to stress, lower compulsive actions, and strengthen cortical connections to the paraventricular thalamic nucleus in rats","year":"2023","cit":52,"pfa":"Kat F. Kiilerich","psa":"Mikael Palner","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4387259638","eid":"W4387259638"},{"id":"paper-w4395688958","cat":"papers","name":"Psilocybin restrains activity-based anorexia in female rats by enhancing cognitive flexibility: contributions from 5-HT1A and 5-HT2A receptor mechanisms","year":"2024","cit":52,"pfa":"Kyna‐Anne Conn","psa":"Claire J. Foldi","topics":["Depression","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4395688958","eid":"W4395688958"},{"id":"paper-w2019136896","cat":"papers","name":"Differential effects of intravenous R,S‐(±)‐3,4‐methylenedioxymethamphetamine (MDMA, Ecstasy) and its S(+)‐ and R(−)‐enantiomers on dopamine transmission and extracellular signal regulated kinase phosphorylation (pERK) i","year":"2007","cit":52,"pfa":"Elio Acquas","psa":"G. Di Chiara","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2019136896","eid":"W2019136896"},{"id":"paper-w3137933781","cat":"papers","name":"Hallucinogenic/psychedelic 5HT2A receptor agonists as rapid antidepressant therapeutics: Evidence and mechanisms of action","year":"2021","cit":52,"pfa":"RAFAEL GUIMARÃES DOS SANTOS","psa":"Serdar Murat Dursun","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3137933781","eid":"W3137933781"},{"id":"paper-w1988574431","cat":"papers","name":"A survey of hallucinogenic mushroom use, factors related to usage, and perceptions of use among college students","year":"2012","cit":52,"pfa":"Robert M. Hallock","psa":"Elise C. Taverna","ptype":"article","src":"https://openalex.org/W1988574431","eid":"W1988574431"},{"id":"paper-w1824548881","cat":"papers","name":"Serotonin autoreceptors on dorsal raphe neurons: structure-activity relationships of tryptamine analogs","year":"1981","cit":52,"pfa":"MA Rogawaski","psa":"George K. Aghajanian","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1824548881","eid":"W1824548881"},{"id":"paper-w1821271830","cat":"papers","name":"Further pharmacological characterization of 5‐HT2Creceptor agonist‐induced inhibition of 5‐HT neuronal activity in the dorsal raphe nucleusin vivo","year":"2009","cit":52,"pfa":"Philip Quérée","psa":"Trevor Sharp","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1821271830","eid":"W1821271830"},{"id":"paper-w2105500940","cat":"papers","name":"The action of tryptamine on the dog spinal cord and its relationship to the agonistic actions of LSD-like psychotogens","year":"1970","cit":52,"pfa":"William R. Martin","psa":"C. G. Eades","ptype":"article","src":"https://openalex.org/W2105500940","eid":"W2105500940"},{"id":"paper-w4291227674","cat":"papers","name":"Policy considerations that support equitable access to responsible, accountable, safe, and ethical uses of psychedelic medicines","year":"2022","cit":52,"pfa":"Sean J. Belouin","psa":"Brian T. Anderson","topics":["Safety & adverse events","Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4291227674","eid":"W4291227674"},{"id":"paper-w4362696780","cat":"papers","name":"Classical and non-classical psychedelic drugs induce common network changes in human cortex","year":"2023","cit":52,"pfa":"Rui Dai","psa":"George A. Mashour","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4362696780","eid":"W4362696780"},{"id":"paper-w2044109258","cat":"papers","name":"Possible Reproductive Detriment in LSD Users","year":"1972","cit":52,"pfa":"Cecil B. Jacobson","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2044109258","eid":"W2044109258"},{"id":"paper-w4288447327","cat":"papers","name":"Tolerance and Cross-Tolerance among Psychedelic and Nonpsychedelic 5-HT2A Receptor Agonists in Mice","year":"2022","cit":52,"pfa":"Mario de la Fuente Revenga","psa":"Javier González‐Maeso","topics":["Addiction","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4288447327","eid":"W4288447327"},{"id":"paper-w2146846049","cat":"papers","name":"[3H]1‐[2‐(4‐Aminophenyl)Ethyl]‐4‐(3‐Trifluoromethylphenyl)Piperazine: A Selective Radioligand for 5‐HT1A Receptors in Rat Brain","year":"1986","cit":52,"pfa":"Richard W. Ransom","psa":"Jean Chen Shih","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2146846049","eid":"W2146846049"},{"id":"paper-w2003158576","cat":"papers","name":"Acute Effects of 3,4-Methylenedioxymethamphetamine and Methylphenidate on Circulating Steroid Levels in Healthy Subjects","year":"2014","cit":52,"pfa":"Julia Seibert","psa":"Alex Odermatt","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2003158576","eid":"W2003158576"},{"id":"paper-w2100507133","cat":"papers","name":"Thioether Metabolites of 3,4-Methylenedioxyamphetamine and 3,4-Methylenedioxymethamphetamine Inhibit Human Serotonin Transporter (hSERT) Function and Simultaneously Stimulate Dopamine Uptake into hSERT-Expressing SK-N-MC","year":"2004","cit":52,"pfa":"Douglas C. Jones","psa":"Terrence J. Monks","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2100507133","eid":"W2100507133"},{"id":"paper-w3207135103","cat":"papers","name":"Caution at psychiatry’s psychedelic frontier","year":"2021","cit":52,"pfa":"Matthew J. Burke","psa":"Daniel M. Blumberger","ptype":"article","src":"https://openalex.org/W3207135103","eid":"W3207135103"},{"id":"paper-w2100465500","cat":"papers","name":"Behavioural, hyperthermic and neurotoxic effects of 3,4-methylenedioxymethamphetamine analogues in the wistar rat","year":"2001","cit":52,"pfa":"Eamond D. O'Loinsigh","psa":"Kathy M. O’Boyle","ptype":"article","src":"https://openalex.org/W2100465500","eid":"W2100465500"},{"id":"paper-w2034109798","cat":"papers","name":"Activation of glycogen phosphorylase by serotonin and 3,4-methylenedioxymethamphetamine in astroglial-rich primary cultures: involvement of the 5-HT2A receptor","year":"1995","cit":52,"pfa":"Jose C Poblete","psa":"Efrain C. Azmitia","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2034109798","eid":"W2034109798"},{"id":"paper-w1997127782","cat":"papers","name":"The effect of Salvia divinorum and Mitragyna speciosa extracts, fraction and major constituents on place aversion and place preference in rats","year":"2013","cit":52,"pfa":"Kenneth J. Sufka","psa":"Ikhlas Ahmed Khan","ptype":"article","src":"https://openalex.org/W1997127782","eid":"W1997127782"},{"id":"paper-w1988810162","cat":"papers","name":"Role of the 5-HT2A receptor in the locomotor hyperactivity produced by phenylalkylamine hallucinogens in mice","year":"2013","cit":52,"pfa":"Adam L. Halberstadt","psa":"Mark A. Geyer","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1988810162","eid":"W1988810162"},{"id":"paper-w3005218696","cat":"papers","name":"Rethinking Therapeutic Strategies for Anorexia Nervosa: Insights From Psychedelic Medicine and Animal Models","year":"2020","cit":52,"pfa":"Claire J. Foldi","psa":"Brian J. Oldfield","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3005218696","eid":"W3005218696"},{"id":"paper-w2399824717","cat":"papers","name":"Neuropathological evaluation by combined immunohistochemistry and degeneration-specific methods: application to methylenedioxymethamphetamine.","year":"1988","cit":52,"pfa":"A C Scallet","psa":"William Slikker","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2399824717","eid":"W2399824717"},{"id":"paper-w1989863309","cat":"papers","name":"Gender differences in abusers of amphetamine-type stimulants and ketamine in southwestern China","year":"2012","cit":52,"pfa":"Yangyang Zhang","psa":"Lin Kang","ptype":"article","src":"https://openalex.org/W1989863309","eid":"W1989863309"},{"id":"paper-w4382133350","cat":"papers","name":"Molecular mechanisms of rapid-acting antidepressants: New perspectives for developing antidepressants","year":"2023","cit":52,"pfa":"Tao Chen","psa":"Ling Zhao","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4382133350","eid":"W4382133350"},{"id":"paper-w2474588055","cat":"papers","name":"A Model for the Application of Target-Controlled Intravenous Infusion for a Prolonged Immersive DMT Psychedelic Experience","year":"2016","cit":52,"pfa":"Andrew R. Gallimore","psa":"Rick J. Strassman","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2474588055","eid":"W2474588055"},{"id":"paper-w4294308393","cat":"papers","name":"Classic psychedelics and alcohol use disorders: A systematic review of human and animal studies","year":"2022","cit":52,"pfa":"Javier Calleja‐Conde","psa":"Jose Antonio López‐Moreno","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W4294308393","eid":"W4294308393"},{"id":"paper-w1843378687","cat":"papers","name":"MDAI (5,6‐methylenedioxy‐2‐aminoindane; 6,7‐dihydro‐5H‐cyclopenta[f][1,3]benzodioxol‐6‐amine; ‘sparkle’; ‘mindy’) toxicity: a brief overview and update","year":"2013","cit":52,"pfa":"John Corkery","psa":"Abdol Hamid Ghodse","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1843378687","eid":"W1843378687"},{"id":"paper-w4225336626","cat":"papers","name":"Integration in Psychedelic-Assisted Treatments: Recurring Themes in Current Providers’ Definitions, Challenges, and Concerns","year":"2022","cit":52,"pfa":"Mitch Earleywine","psa":"Joseph Anthony De Leo","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4225336626","eid":"W4225336626"},{"id":"paper-w2013621465","cat":"papers","name":"Cannabinoids and Hallucinogens for Headache","year":"2012","cit":52,"pfa":"Brian E. McGeeney","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2013621465","eid":"W2013621465"},{"id":"paper-w1932312016","cat":"papers","name":"Microdosing Studies in Humans","year":"2008","cit":52,"pfa":"Martin Bauer","psa":"Oliver Langer","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1932312016","eid":"W1932312016"},{"id":"paper-w3049149550","cat":"papers","name":"Psychedelics and virtual reality: parallels and applications","year":"2020","cit":52,"pfa":"Jacob S. Aday","psa":"Emily K. Bloesch","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3049149550","eid":"W3049149550"},{"id":"paper-w4394693273","cat":"papers","name":"Essentials of Informed Consent to Psychedelic Medicine","year":"2024","cit":52,"pfa":"Mason Marks","psa":"Ivan Glenn Cohen","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4394693273","eid":"W4394693273"},{"id":"paper-w1965308157","cat":"papers","name":"Quantification of the Glycemic Response to Microdoses of Subcutaneous Glucagon at Varying Insulin Levels","year":"2014","cit":52,"pfa":"Joseph El Youssef","psa":"W. Kenneth Ward","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1965308157","eid":"W1965308157"},{"id":"paper-w2110971639","cat":"papers","name":"A pharmacokinetic evaluation of five H1 antagonists after an oral and intravenous microdose to human subjects","year":"2009","cit":52,"pfa":"Ajay Madan","psa":"Haig P. Bozigian","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2110971639","eid":"W2110971639"},{"id":"paper-w4319984222","cat":"papers","name":"Serotonergic psychedelics for depression: What do we know about neurobiological mechanisms of action?","year":"2023","cit":52,"pfa":"Muhammad Ishrat Husain","psa":"David Jonathan Castle","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4319984222","eid":"W4319984222"},{"id":"paper-w2999812626","cat":"papers","name":"Psychedelics and psychological flexibility – Results of a prospective web-survey using the Acceptance and Action Questionnaire II","year":"2020","cit":52,"pfa":"James B. Close","psa":"Robin Lester Carhart-Harris","ptype":"article","src":"https://openalex.org/W2999812626","eid":"W2999812626"},{"id":"paper-w4308387600","cat":"papers","name":"Neuroinflammation and neuroprogression in depression: Effects of alternative drug treatments","year":"2022","cit":52,"pfa":"Brandon Richardson","psa":"Francis Rodriguez Bambico","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4308387600","eid":"W4308387600"},{"id":"paper-w2947727383","cat":"papers","name":"A phase 0 first-in-human study using NU-0129: A gold base spherical nucleic acid (SNA) nanoconjugate targeting BCL2L12 in recurrent glioblastoma patients.","year":"2019","cit":52,"pfa":"Priya Kumthekar","psa":"Alexander H. Stegh","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W2947727383","eid":"W2947727383"},{"id":"paper-w4242630960","cat":"papers","name":"Treatment Episode Data Set -- Discharges (TEDS-D) -- Concatenated, 2006 to 2009","year":"2011","cit":52,"pfa":"United States Department Of Health And Human Services. Substance Abuse And…","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W4242630960","eid":"W4242630960"},{"id":"paper-w2078793785","cat":"papers","name":"Barriers to the Treatment of Obesity","year":"1991","cit":52,"pfa":"George A. Bray","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2078793785","eid":"W2078793785"},{"id":"paper-w2948106049","cat":"papers","name":"Efficacy and Safety of a Rapid Intravenous Injection of Ketamine 0.5 mg/kg in Treatment-Resistant Major Depression","year":"2018","cit":52,"pfa":"Sonia I. Vidal","psa":"Markus Kosel","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2948106049","eid":"W2948106049"},{"id":"paper-w4411932553","cat":"papers","name":"Esketamine Monotherapy in Adults With Treatment-Resistant Depression","year":"2025","cit":52,"pfa":"Adam Janik","psa":"Dong‐Jing Fu","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4411932553","eid":"W4411932553"},{"id":"paper-w2995768649","cat":"papers","name":"Esketamine for treatment resistant depression: a trick of smoke and mirrors?","year":"2019","cit":52,"pfa":"Chiara Gastaldon","psa":"Corrado Barbui","topics":["Depression","Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2995768649","eid":"W2995768649"},{"id":"paper-w4403617216","cat":"papers","name":"Ketamine and Esketamine in Clinical Trials: FDA‐ Approved and Emerging Indications, Trial Trends With Putative Mechanistic Explanations","year":"2024","cit":52,"pfa":"K. A. Vekhova","psa":"Helgi B. Schiöth","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4403617216","eid":"W4403617216"},{"id":"paper-w4393198452","cat":"papers","name":"Efficacy of intravenous ketamine and intranasal esketamine with dose escalation for Major depression: A systematic review and meta-analysis","year":"2024","cit":52,"pfa":"Ashok Seshadri","psa":"Balwinder Singh","topics":["Depression","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4393198452","eid":"W4393198452"},{"id":"paper-w3156926718","cat":"papers","name":"Rapid Onset of Intranasal Esketamine in Patients with Treatment Resistant Depression and Major Depression with Suicide Ideation: A Meta-Analysis","year":"2021","cit":52,"pfa":"Sheng‐Min Wang","psa":"Won‐Myong Bahk","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W3156926718","eid":"W3156926718"},{"id":"paper-w1976849880","cat":"papers","name":"THE EFFECTS OF METHEDRINE AND OF LYSERGIC ACID DIETHYLAMIDE ON MENTAL PROCESSES AND ON THE BLOOD ANDRENALINE LEVEL","year":"1953","cit":51,"pfa":"D. W. Liddell","psa":"H. Weil‐Malherbe","ptype":"article","src":"https://openalex.org/W1976849880","eid":"W1976849880"},{"id":"paper-w2078583994","cat":"papers","name":"Clonazepam treatment of lysergic acid diethylamide-induced hallucinogen persisting perception disorder with anxiety features","year":"2003","cit":51,"pfa":"Arturo G. Lerner","psa":"Avi Bleich","topics":["Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2078583994","eid":"W2078583994"},{"id":"paper-w2469256318","cat":"papers","name":"The internationalization of Ayahuasca","year":"2011","cit":51,"pfa":"Henrik Jungaberle","psa":"Beatriz Caiuby Labate","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2469256318","eid":"W2469256318"},{"id":"paper-w3008753848","cat":"papers","name":"The World Ayahuasca Diaspora","year":"2016","cit":51,"pfa":"St John, Graham","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"book","src":"https://openalex.org/W3008753848","eid":"W3008753848"},{"id":"paper-w1977783792","cat":"papers","name":"Role of serotonin in the discriminative stimulus properties of mescaline","year":"1975","cit":51,"pfa":"Ronald G. Browne","psa":"Beng T. Ho","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1977783792","eid":"W1977783792"},{"id":"paper-w2063339016","cat":"papers","name":"Assessment of the discriminative stimulus effects of the optical isomers of ecstasy (3,4-methylenedioxymethamphetamine; MDMA)","year":"1995","cit":51,"pfa":"Lisa E. Baker","psa":"J. B. Appel","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2063339016","eid":"W2063339016"},{"id":"paper-w1607733577","cat":"papers","name":"Anti‐addiction drug ibogaine inhibits hERG channels: a cardiac arrhythmia risk","year":"2012","cit":51,"pfa":"Xaver Koenig","psa":"Karlheinz Hilber","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1607733577","eid":"W1607733577"},{"id":"paper-w3033752070","cat":"papers","name":"Subjective features of the psilocybin experience that may account for its self-administration by humans: a double-blind comparison of psilocybin and dextromethorphan","year":"2020","cit":51,"pfa":"Theresa M. Carbonaro","psa":"Roland R. Griffiths","ptype":"article","src":"https://openalex.org/W3033752070","eid":"W3033752070"},{"id":"paper-w2042999049","cat":"papers","name":"Behavioral profile of constituents in ayahuasca, an Amazonian psychoactive plant mixture","year":"1999","cit":51,"pfa":"Cory S. Freedland","psa":"Robert S. Mansbach","ptype":"article","src":"https://openalex.org/W2042999049","eid":"W2042999049"},{"id":"paper-w2160167761","cat":"papers","name":"Effects of a -blocker on the cardiovascular response to MDMA (Ecstasy)","year":"2010","cit":51,"pfa":"C.M. Hysek","psa":"Matthias E. Liechti","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2160167761","eid":"W2160167761"},{"id":"paper-w2086103344","cat":"papers","name":"Aortic Dissection After Ingestion of \"Ecstasy\" (MDMA)","year":"2000","cit":51,"pfa":"Johan A Duflou","psa":"Adam Mark","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2086103344","eid":"W2086103344"},{"id":"paper-w2151633169","cat":"papers","name":"Drug seeking in response to a priming injection of MDMA in rats: relationship to initial sensitivity to self-administered MDMA and dorsal striatal dopamine","year":"2010","cit":51,"pfa":"Joyce Colussi‐Mas","psa":"Susan Schenk","ptype":"article","src":"https://openalex.org/W2151633169","eid":"W2151633169"},{"id":"paper-w2410698629","cat":"papers","name":"Ecstasy: towards an understanding of the biochemical basis of the actions of MDMA.","year":"1991","cit":51,"pfa":"Marcus Rattray","ptype":"article","src":"https://openalex.org/W2410698629","eid":"W2410698629"},{"id":"paper-w2087579542","cat":"papers","name":"Methodology for and the determination of the major constituents and metabolites of the Amazonian botanical medicine ayahuasca in human urine","year":"2010","cit":51,"pfa":"Ethan H. McIlhenny","psa":"Steven A. Barker","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2087579542","eid":"W2087579542"},{"id":"paper-w2081470393","cat":"papers","name":"Brain concentrations of d-MDMA are increased after stress","year":"2004","cit":51,"pfa":"Elizabeth Anne Johnson","psa":"Diane Bemis Miller","ptype":"article","src":"https://openalex.org/W2081470393","eid":"W2081470393"},{"id":"paper-w78622669","cat":"papers","name":"Changes in aminoacidergic and monoaminergic neurotransmission in the hippocampus and amygdala of rats after ayahuasca ingestion","year":"2013","cit":51,"pfa":"Eduardo Ferreira de Castro-Neto","psa":"Maria da Graça Naffah‐Mazzacoratti","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W78622669","eid":"W78622669"},{"id":"paper-w1968829652","cat":"papers","name":"Immunomodulating properties of MDMA alone and in combination with alcohol: A pilot study","year":"1999","cit":51,"pfa":"Roberta Pacifici","psa":"Rafael de la Torre","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1968829652","eid":"W1968829652"},{"id":"paper-w2159703995","cat":"papers","name":"Acute neuropsychological effects of MDMA and ethanol (co-)administration in healthy volunteers","year":"2008","cit":51,"pfa":"Glenn Dumont","psa":"Robbert Jan Verkes","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W2159703995","eid":"W2159703995"},{"id":"paper-w1983048332","cat":"papers","name":"Sex differences in the neurochemical and functional effects of MDMA in Sprague–Dawley rats","year":"2006","cit":51,"pfa":"Q. David Walker","psa":"Cynthia M. Kuhn","ptype":"article","src":"https://openalex.org/W1983048332","eid":"W1983048332"},{"id":"paper-w3130074420","cat":"papers","name":"Safety of ibogaine administration in detoxification of opioid‐dependent individuals: a descriptive open‐label observational study","year":"2021","cit":51,"pfa":"Thomas Knuijver","psa":"Robbert Jan Verkes","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3130074420","eid":"W3130074420"},{"id":"paper-w2122150204","cat":"papers","name":"N-Methylacetamide Analog of Salvinorin A: A Highly Potent and Selective κ-Opioid Receptor Agonist with Oral Efficacy","year":"2007","cit":51,"pfa":"Cécile Béguin","psa":"Bruce M. Cohen","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2122150204","eid":"W2122150204"},{"id":"paper-w2771971758","cat":"papers","name":"Dynamic Strategic Bond Analysis Yields a Ten-Step Synthesis of 20-nor-Salvinorin A, a Potent κ-OR Agonist","year":"2017","cit":51,"pfa":"Jeremy J. Roach","psa":"Ryan A. Shenvi","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2771971758","eid":"W2771971758"},{"id":"paper-w4382776629","cat":"papers","name":"Sub-acute effects of psilocybin on EEG correlates of neural plasticity in major depression: Relationship to symptoms","year":"2023","cit":51,"pfa":"Patrick D. Skosnik","psa":"Deepak Cyril D’Souza","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4382776629","eid":"W4382776629"},{"id":"paper-w2150159755","cat":"papers","name":"Pharmacokinetics and pharmacodynamics of 3,4-methylenedioxymethamphetamine (MDMA): interindividual differences due to polymorphisms and drug–drug interactions","year":"2012","cit":51,"pfa":"Saskia J. Rietjens","psa":"Jan Meulenbelt","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2150159755","eid":"W2150159755"},{"id":"paper-w1576909217","cat":"papers","name":"MDMA and 5‐HT neurotoxicity: the empirical evidence for its adverse effects in humans – no need for translation","year":"2012","cit":51,"pfa":"Andrew C. Parrott","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1576909217","eid":"W1576909217"},{"id":"paper-w2019509594","cat":"papers","name":"The Nature of 3, 4-Methylenedioxymethamphetamine (MDMA)-Induced Serotonergic Dysfunction: Evidence for and Against the Neurodegeneration Hypothesis","year":"2011","cit":51,"pfa":"Dominik K. Biezonski","psa":"Jerrold S. Meyer","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2019509594","eid":"W2019509594"},{"id":"paper-w2100410699","cat":"papers","name":"Cardiac oxidative stress determination and myocardial morphology after a single ecstasy (MDMA) administration in a rat model","year":"2008","cit":51,"pfa":"Daniela Cerretani","psa":"Vittorio Fineschi","ptype":"article","src":"https://openalex.org/W2100410699","eid":"W2100410699"},{"id":"paper-w4379383539","cat":"papers","name":"Reports of self-compassion and affect regulation in psilocybin-assisted therapy for alcohol use disorder: An interpretive phenomenological analysis.","year":"2023","cit":51,"pfa":"Gabrielle Agin-Liebes","psa":"Michael P. Bogenschutz","topics":["Addiction","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4379383539","eid":"W4379383539"},{"id":"paper-w1505064846","cat":"papers","name":"Differential effects of cathinone compounds and MDMA on body temperature in the rat, and pharmacological characterization of mephedrone‐induced hypothermia","year":"2012","cit":51,"pfa":"S.E. Shortall","psa":"Madeleine V. King","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1505064846","eid":"W1505064846"},{"id":"paper-w3166459008","cat":"papers","name":"Participant Reports of Mindfulness, Posttraumatic Growth, and Social Connectedness in Psilocybin-Assisted Group Therapy: An Interpretive Phenomenological Analysis","year":"2021","cit":51,"pfa":"Gabrielle Agin-Liebes","psa":"Josh D. Woolley","topics":["PTSD & trauma","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3166459008","eid":"W3166459008"},{"id":"paper-w2098469044","cat":"papers","name":"A combined ligand-based and target-based drug design approach for G-protein coupled receptors: application to salvinorin A, a selective kappa opioid receptor agonist","year":"2006","cit":51,"pfa":"Nidhi Singh","psa":"Christopher R. McCurdy","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2098469044","eid":"W2098469044"},{"id":"paper-w4388827052","cat":"papers","name":"Drug–drug interactions involving classic psychedelics: A systematic review","year":"2023","cit":51,"pfa":"Andreas Halman","psa":"Daniel Perkins","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W4388827052","eid":"W4388827052"},{"id":"paper-w3116749687","cat":"papers","name":"A comparison of MDMA-assisted psychotherapy to non-assisted psychotherapy in treatment-resistant PTSD: A systematic review and meta-analysis","year":"2020","cit":51,"pfa":"Benjamin J. G. Illingworth","psa":"James Rucker","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W3116749687","eid":"W3116749687"},{"id":"paper-w2080312372","cat":"papers","name":"MDMA-induced c-Fos expression in oxytocin-containing neurons is blocked by pretreatment with the 5-HT-1A receptor antagonist WAY 100635","year":"2011","cit":51,"pfa":"Glenn E. Hunt","psa":"Paul D. Callaghan","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2080312372","eid":"W2080312372"},{"id":"paper-w1976355699","cat":"papers","name":"Damage of serotonergic axons and immunolocalization of Hsp27, Hsp72, and Hsp90 molecular chaperones after a single dose of MDMA administration in Dark Agouti rat: Temporal, spatial, and cellular patterns","year":"2006","cit":51,"pfa":"Csaba Ádori","psa":"György Bagdy","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1976355699","eid":"W1976355699"},{"id":"paper-w2045867515","cat":"papers","name":"Does LSD induce chromosomal damage and malformations? A review of the literature","year":"1972","cit":51,"pfa":"Sally Y. Long","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2045867515","eid":"W2045867515"},{"id":"paper-w2018548741","cat":"papers","name":"Organicity Measures Following Repeated LSD Ingestion","year":"1969","cit":51,"pfa":"William H. McGlothlin","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2018548741","eid":"W2018548741"},{"id":"paper-w2005939041","cat":"papers","name":"Effects of 5-hydroxytryptamine, LSD and related compounds on electrical activities evokedin vitro in thin sections from the superior colliculus","year":"1969","cit":51,"pfa":"Nobufumi Kawai","psa":"C. Yamamoto","ptype":"article","src":"https://openalex.org/W2005939041","eid":"W2005939041"},{"id":"paper-w2072729119","cat":"papers","name":"A behavioral and pharmacological analysis of some discriminable properties of d-LSD in rats","year":"1973","cit":51,"pfa":"Oliver G. Cameron","psa":"James B. Appel","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2072729119","eid":"W2072729119"},{"id":"paper-w2024078219","cat":"papers","name":"Electrophysiological assessment of putative antagonists of 5-hydroxytryptamine receptors: a single-cell study in the rat dorsal raphe nucleus","year":"1989","cit":51,"pfa":"Pierre Ulrich Blier","psa":"Claude de Montigny","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2024078219","eid":"W2024078219"},{"id":"paper-w2086852262","cat":"papers","name":"Interactions between Bupropion and 3,4-Methylenedioxymethamphetamine in Healthy Subjects","year":"2015","cit":51,"pfa":"Yasmin Schmid","psa":"Matthias E. Liechti","ptype":"article","src":"https://openalex.org/W2086852262","eid":"W2086852262"},{"id":"paper-w2762169497","cat":"papers","name":"Separating the agony from ecstasy: R(–)-3,4-methylenedioxymethamphetamine has prosocial and therapeutic-like effects without signs of neurotoxicity in mice","year":"2017","cit":51,"pfa":"Daniel W. Curry","psa":"Leonard Lee Howell","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2762169497","eid":"W2762169497"},{"id":"paper-w2060222606","cat":"papers","name":"Neonatal 3,4-methylenedioxymethamphetamine (ecstasy) alters dopamine and serotonin neurochemistry and increases brain-derived neurotrophic factor in the forebrain and brainstem of the rat","year":"2003","cit":51,"pfa":"James B. Koprich","psa":"Jack W. Lipton","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2060222606","eid":"W2060222606"},{"id":"paper-w2106713530","cat":"papers","name":"Inhibitory metabolite complex formation of methylenedioxymethamphetamine with rat and human cytochrome P450. Particular involvement of CYP 2D","year":"1999","cit":51,"pfa":"Marcel Delaforge","psa":"Geneviève Bouillé","ptype":"article","src":"https://openalex.org/W2106713530","eid":"W2106713530"},{"id":"paper-w2091314128","cat":"papers","name":"Clozapine reverses increased brown adipose tissue thermogenesis induced by 3,4-methylenedioxymethamphetamine and by cold exposure in conscious rats","year":"2006","cit":51,"pfa":"William Walter Blessing","psa":"Youichirou Ootsuka","ptype":"article","src":"https://openalex.org/W2091314128","eid":"W2091314128"},{"id":"paper-w2145946906","cat":"papers","name":"Effect of depleting vesicular and cytoplasmic dopamine on methylenedioxymethamphetamine neurotoxicity","year":"2002","cit":51,"pfa":"Jie Yuan","psa":"George A. Ricaurte","topics":["Safety & adverse events","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2145946906","eid":"W2145946906"},{"id":"paper-w2329928444","cat":"papers","name":"Chromatographic and Mass Spectral Studies on Methoxymethcathinones Related to 3,4-Methylenedioxymethamphetamine","year":"2006","cit":51,"pfa":"T. Awad","psa":"Jack DeRuiter","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2329928444","eid":"W2329928444"},{"id":"paper-w4252245481","cat":"papers","name":"Hallucinogenic Mushrooms","year":"1988","cit":51,"pfa":"Richard H. Schwartz","psa":"Deborah E. Smith","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4252245481","eid":"W4252245481"},{"id":"paper-w1963730782","cat":"papers","name":"Methylenedioxymethamphetamine induces opposite changes in central pre- and postsynaptic 5-HT1A receptors in rats","year":"1995","cit":51,"pfa":"Norberto Aguirre","psa":"Joaquı́n Del Rı́o","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1963730782","eid":"W1963730782"},{"id":"paper-w2133384878","cat":"papers","name":"Analysis of hallucinogenic constituents in Amanita mushrooms circulated in Japan","year":"2006","cit":51,"pfa":"Kenji Tsujikawa","psa":"Tohru Kishi","ptype":"article","src":"https://openalex.org/W2133384878","eid":"W2133384878"},{"id":"paper-w2122335800","cat":"papers","name":"Methylone and Monoamine Transporters: Correlation with Toxicity","year":"2011","cit":51,"pfa":"Chiharu Aoki Sogawa","psa":"Shigeo Kitayama","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2122335800","eid":"W2122335800"},{"id":"paper-w3186114733","cat":"papers","name":"Classic psychedelics in the treatment of substance use disorder: Potential synergies with twelve-step programs","year":"2021","cit":51,"pfa":"David B. Yaden","psa":"Peter S. Hendricks","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W3186114733","eid":"W3186114733"},{"id":"paper-w4385063925","cat":"papers","name":"Psychedelic therapies reconsidered: compounds, clinical indications, and cautious optimism","year":"2023","cit":51,"pfa":"Jennifer Mitchell","psa":"Brian T. Anderson","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4385063925","eid":"W4385063925"},{"id":"paper-w4399323719","cat":"papers","name":"Developing an Ethics and Policy Framework for Psychedelic Clinical Care: A Consensus Statement","year":"2024","cit":51,"pfa":"Amy L. McGuire","psa":"David B. Yaden","topics":["Reviews & meta-analyses","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4399323719","eid":"W4399323719"},{"id":"paper-w2047907996","cat":"papers","name":"QSAR studies on hallucinogens","year":"1983","cit":51,"pfa":"Satya P. Gupta","psa":"Mahesh C. Bindal","ptype":"article","src":"https://openalex.org/W2047907996","eid":"W2047907996"},{"id":"paper-w2138741330","cat":"papers","name":"Microdosing: A Critical Assessment of Human Data","year":"2012","cit":51,"pfa":"Malcolm Rowland","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2138741330","eid":"W2138741330"},{"id":"paper-w2073608296","cat":"papers","name":"Pharmacokinetic and pharmacogenomic profiles of telmisartan after the oral microdose and therapeutic dose","year":"2011","cit":51,"pfa":"Ichiro Ieiri","psa":"Yuichi Sugiyama","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2073608296","eid":"W2073608296"},{"id":"paper-w1974019314","cat":"papers","name":"Field Tripping: Psychedelic communitas and Ritual in the Australian Bush","year":"2000","cit":51,"pfa":"Des Tramacchi","ptype":"article","src":"https://openalex.org/W1974019314","eid":"W1974019314"},{"id":"paper-w2005252389","cat":"papers","name":"Psychedelic drugs: steric factors that predict psychotropic activity.","year":"1968","cit":51,"pfa":"Solomon H. Snyder","psa":"Elliott Richelson","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2005252389","eid":"W2005252389"},{"id":"paper-w1978381452","cat":"papers","name":"American College of Clinical Pharmacology Position Statement on the Use of Microdosing in the Drug Development Process","year":"2007","cit":51,"pfa":"Joseph Bertino","psa":"Michael D. Reed","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1978381452","eid":"W1978381452"},{"id":"paper-w1984054906","cat":"papers","name":"A randomized trial of microdose leuprolide acetate protocol versus luteal phase ganirelix protocol in predicted poor responders","year":"2011","cit":51,"pfa":"Andrea J. DiLuigi","psa":"JOHN C. NULSEN","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1984054906","eid":"W1984054906"},{"id":"paper-w3049065734","cat":"papers","name":"Structure–Activity Relationship Analysis of Psychedelics in a Rat Model of Asthma Reveals the Anti-Inflammatory Pharmacophore","year":"2020","cit":51,"pfa":"Thomas Wayne Flanagan","psa":"Charles David Nichols","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3049065734","eid":"W3049065734"},{"id":"paper-w4400415795","cat":"papers","name":"New and emerging treatments for major depressive disorder","year":"2024","cit":51,"pfa":"Cecilia Njenga","psa":"Harold Alan Pincus","topics":["Depression","Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4400415795","eid":"W4400415795"},{"id":"paper-w2274676463","cat":"papers","name":"Ninety-six hour ketamine infusion with co-administered clonidine for treatment-resistant depression: A pilot randomised controlled trial","year":"2016","cit":51,"pfa":"Eric J. Lenze","psa":"John W. Newcomer","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2274676463","eid":"W2274676463"},{"id":"paper-w2581631145","cat":"papers","name":"Effects of early or late prenatal immune activation in mice on behavioral and neuroanatomical abnormalities relevant to schizophrenia in the adulthood","year":"2017","cit":51,"pfa":"Vívian T. da Silveira","psa":"Antônio Carlos Pinheiro de Oliveira","topics":["Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2581631145","eid":"W2581631145"},{"id":"paper-w4210669115","cat":"papers","name":"A Comparison of Intranasal Dexmedetomidine, Esketamine or a Dexmedetomidine-Esketamine Combination for Induction of Anaesthesia in Children: A Randomized Controlled Double-Blind Trial","year":"2022","cit":51,"pfa":"Xinlei Lu","psa":"Han Lin","topics":["Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4210669115","eid":"W4210669115"},{"id":"paper-w4367054142","cat":"papers","name":"Reporting of harms in clinical trials of esketamine in depression: a systematic review","year":"2023","cit":51,"pfa":"Tanguy Taillefer de Laportalière","psa":"François Montastruc","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4367054142","eid":"W4367054142"},{"id":"paper-w4285500081","cat":"papers","name":"Esketamine alleviates postoperative cognitive decline via stimulator of interferon genes/ TANK‐binding kinase 1 signaling pathway in aged rats","year":"2022","cit":51,"pfa":"Yan Li","psa":"Jingui Gao","ptype":"article","src":"https://openalex.org/W4285500081","eid":"W4285500081"},{"id":"paper-w4375855463","cat":"papers","name":"Esketamine in treatment-resistant depression patients comorbid with substance-use disorder: A viewpoint on its safety and effectiveness in a subsample of patients from the REAL-ESK study","year":"2023","cit":51,"pfa":"Stefania Chiappini","psa":"Giovanni Martinotti","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4375855463","eid":"W4375855463"},{"id":"paper-w2984808385","cat":"papers","name":"Ketamine and Active Ketamine Metabolites Regulate STAT3 and the Type I Interferon Pathway in Human Microglia: Molecular Mechanisms Linked to the Antidepressant Effects of Ketamine","year":"2019","cit":51,"pfa":"Ming‐Fen Ho","psa":"Richard M. Weinshilboum","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2984808385","eid":"W2984808385"},{"id":"paper-w4303021941","cat":"papers","name":"The treatment of depression — searching for new ideas","year":"2022","cit":51,"pfa":"Katarzyna Stachowicz","psa":"Magdalena Sowa-Kućma","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4303021941","eid":"W4303021941"},{"id":"paper-w2017272755","cat":"papers","name":"Bromocriptine, dihydroergotoxine, methysergide, d-LSD, CF 25-397, and 29-712: Effects on the metabolism of the biogenic amines in the brain of the rat","year":"1978","cit":51,"pfa":"Hans R. B�rki","psa":"P. E. Z�ger","ptype":"article","src":"https://openalex.org/W2017272755","eid":"W2017272755"},{"id":"paper-w2072140880","cat":"papers","name":"Lysergic Acid Diethylamide: Radioimmunoassay","year":"1973","cit":50,"pfa":"Alison Taunton-Rigby","psa":"Paul R. Kelley","ptype":"article","src":"https://openalex.org/W2072140880","eid":"W2072140880"},{"id":"paper-w2148237691","cat":"papers","name":"Use of Lysergic Acid Diethylamide in a Psychotherapeutic Setting","year":"1959","cit":50,"pfa":"Sidney Cohen","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2148237691","eid":"W2148237691"},{"id":"paper-w2325404307","cat":"papers","name":"Effects of Lysergic Acid Diethylamide upon Performance of Trained Rats","year":"1956","cit":50,"pfa":"C. A. Winter","psa":"Lars Flataker","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2325404307","eid":"W2325404307"},{"id":"paper-w2084792932","cat":"papers","name":"Severe Solar Maculopathy Associated with the use of Lysergic Acid Diethylamide (LSD)","year":"1976","cit":50,"pfa":"Dwain G. Fuller","ptype":"article","src":"https://openalex.org/W2084792932","eid":"W2084792932"},{"id":"paper-w2327221240","cat":"papers","name":"Dephosphorylation of Psilocybin to Psilocin by Alkaline Phosphatase","year":"1961","cit":50,"pfa":"A. Horita","psa":"L. J. Weber","ptype":"article","src":"https://openalex.org/W2327221240","eid":"W2327221240"},{"id":"paper-w4292791729","cat":"papers","name":"Effective Connectivity of Functionally Anticorrelated Networks Under Lysergic Acid Diethylamide","year":"2022","cit":50,"pfa":"Devon Stoliker","psa":"Adeel Razi","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4292791729","eid":"W4292791729"},{"id":"paper-w2042102728","cat":"papers","name":"Lysergic Acid Diethylamide (LSD-25): VI. Effect upon Recall and Recognition of Various Stimuli","year":"1955","cit":50,"pfa":"Murray E. Jarvik","psa":"M. W. Hirsch","ptype":"article","src":"https://openalex.org/W2042102728","eid":"W2042102728"},{"id":"paper-w2026428180","cat":"papers","name":"THE EFFECT OF LYSERGIC ACID DIETHYLAMIDE, 5‐HYDROXYTRYPTAMINE, AND RELATED COMPOUNDS ON THE LIVER FLUKE, FASCIOLA HEPATICA","year":"1957","cit":50,"pfa":"Tag E. Mansour","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2026428180","eid":"W2026428180"},{"id":"paper-w1978388644","cat":"papers","name":"Detection of metabolites of lysergic acid diethylamide (LSD) in human urine specimens: 2-oxo-3-hydroxy-LSD, a prevalent metabolite of LSD","year":"1999","cit":50,"pfa":"Gregory K. Poch","psa":"Cynthia J. Anderson","ptype":"article","src":"https://openalex.org/W1978388644","eid":"W1978388644"},{"id":"paper-w2165984877","cat":"papers","name":"Analysis of psilocybin and psilocin in Psilocybe subcubensis GUZMÁN by ion mobility spectrometry and gas chromatography–mass spectrometry","year":"1999","cit":50,"pfa":"Thomas Keller","psa":"Wolfgang Kisser","ptype":"article","src":"https://openalex.org/W2165984877","eid":"W2165984877"},{"id":"paper-w2322952716","cat":"papers","name":"Methylenedioxymethamphetamine (MDMA, “Ecstasy”)","year":"2000","cit":50,"pfa":"Michael Shannon","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2322952716","eid":"W2322952716"},{"id":"paper-w2588080892","cat":"papers","name":"Altered Insula Connectivity under MDMA","year":"2017","cit":50,"pfa":"Ishan C. Walpola","psa":"Robin Lester Carhart-Harris","ptype":"article","src":"https://openalex.org/W2588080892","eid":"W2588080892"},{"id":"paper-w1987165679","cat":"papers","name":"Neurotoxic effects of MDMA (“ecstasy”) administration to neonatal rats","year":"2004","cit":50,"pfa":"Jerrold S. Meyer","psa":"Syed F. Ali","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1987165679","eid":"W1987165679"},{"id":"paper-w1970340385","cat":"papers","name":"A Hallucinogenic Tea, Laced With Controversy. Ayahuasca in the Amazon and the United States","year":"2009","cit":50,"pfa":"Marlene Dobkin de Ríos","psa":"Róger Rumrrill","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1970340385","eid":"W1970340385"},{"id":"paper-w1604599271","cat":"papers","name":"Neural and Cardiac Toxicities Associated With 3,4-Methylenedioxymethamphetamine (MDMA)","year":"2009","cit":50,"pfa":"Michael H. Baumann","psa":"Richard B. Rothman","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W1604599271","eid":"W1604599271"},{"id":"paper-w2112814241","cat":"papers","name":"Investigating the potential neurotoxicity of Ecstasy (MDMA): an imaging approach","year":"2001","cit":50,"pfa":"Liesbeth Reneman","psa":"Gerard J. den Heeten","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2112814241","eid":"W2112814241"},{"id":"paper-w2126399456","cat":"papers","name":"Potentially hallucinogenic 5‐hydroxytryptamine receptor ligands bufotenine and dimethyltryptamine in blood and tissues","year":"2005","cit":50,"pfa":"Jorma Kärkkäinen","psa":"Antti Hesso","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2126399456","eid":"W2126399456"},{"id":"paper-w2071257918","cat":"papers","name":"Untersuchungen zur synthese des schwefelisosteren psilocins und einiger 4-hydroxybenzo(b)thiophenderivate","year":"1977","cit":50,"pfa":"Richard Neidlein","psa":"C. Gehringer","ptype":"article","src":"https://openalex.org/W2071257918","eid":"W2071257918"},{"id":"paper-w4291170424","cat":"papers","name":"Acute and long-term effects of psilocybin on energy balance and feeding behavior in mice","year":"2022","cit":50,"pfa":"Nicole Fadahunsi","psa":"Christoffer Clemmensen","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4291170424","eid":"W4291170424"},{"id":"paper-w4324147331","cat":"papers","name":"The Effect of Combined Treatment of Psilocybin and Eugenol on Lipopolysaccharide-Induced Brain Inflammation in Mice","year":"2023","cit":50,"pfa":"Timur Zanikov","psa":"Igor Kovalchuk","topics":["Depression","PTSD & trauma","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4324147331","eid":"W4324147331"},{"id":"paper-w2168069444","cat":"papers","name":"MDMA (‘ecstasy’) exhibits an anxiogenic-like activity in social encounters between male mice","year":"2001","cit":50,"pfa":"E. Maldonado","psa":"José Francisco Navarro","ptype":"article","src":"https://openalex.org/W2168069444","eid":"W2168069444"},{"id":"paper-w2011927990","cat":"papers","name":"Ecstasy (MDMA), Methamphetamine, and Date Rape (Drug-Facilitated Sexual Assault): A Consideration of the Issues","year":"2006","cit":50,"pfa":"Karl L. R. Jansen","psa":"Lynn Theron","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2011927990","eid":"W2011927990"},{"id":"paper-w2113041885","cat":"papers","name":"Sweat Testing of MDMA with the Drugwipe(R) Analytical Device: A Controlled Study with Two Volunteers","year":"2001","cit":50,"pfa":"Roberta Pacifici","psa":"Rafael de la Torre","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2113041885","eid":"W2113041885"},{"id":"paper-w2573513868","cat":"papers","name":"Pharmacogenetics of ecstasy: CYP1A2, CYP2C19, and CYP2B6 polymorphisms moderate pharmacokinetics of MDMA in healthy subjects","year":"2017","cit":50,"pfa":"Patrick Vizeli","psa":"Matthias E. Liechti","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2573513868","eid":"W2573513868"},{"id":"paper-w2393284343","cat":"papers","name":"Enantioselective degradation of amphetamine-like environmental micropollutants (amphetamine, methamphetamine, MDMA and MDA) in urban water","year":"2016","cit":50,"pfa":"Siân E. Evans","psa":"Barbara Kasprzyk‐Hordern","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2393284343","eid":"W2393284343"},{"id":"paper-w2163470826","cat":"papers","name":"Differential toxic effects of methamphetamine (METH) and methylenedioxymethamphetamine (MDMA) in multidrug-resistant (mdr1a) knockout mice","year":"1997","cit":50,"pfa":"Hema Mann","psa":"Jean Lud Cadet","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2163470826","eid":"W2163470826"},{"id":"paper-w2073562547","cat":"papers","name":"Cytotoxic effects of 3,4-methylenedioxy-N-alkylamphetamines, MDMA and its analogues, on isolated rat hepatocytes","year":"2008","cit":50,"pfa":"Yoshio Nakagawa","psa":"Akio Ogata","ptype":"article","src":"https://openalex.org/W2073562547","eid":"W2073562547"},{"id":"paper-w2000779397","cat":"papers","name":"Differential effects of MDMA and scopolamine on working versus reference memory in the radial arm maze task","year":"2009","cit":50,"pfa":"C. Kay","psa":"Maree J. Hunt","ptype":"article","src":"https://openalex.org/W2000779397","eid":"W2000779397"},{"id":"paper-w2100981342","cat":"papers","name":"Effects of Ecstasy (MDMA) on the Brain in Abstinent Users: Initial Observations with Diffusion and Perfusion MR Imaging","year":"2001","cit":50,"pfa":"Liesbeth Reneman","psa":"Gerard J. den Heeten","ptype":"article","src":"https://openalex.org/W2100981342","eid":"W2100981342"},{"id":"paper-w4292411376","cat":"papers","name":"Cyclic square-wave voltammetric discrimination of the amphetamine-type stimulants MDA and MDMA in real-world forensic samples by 3D-printed carbon electrodes","year":"2022","cit":50,"pfa":"Lucas V. de Faria","psa":"Rodrigo A.A. Muñoz","ptype":"article","src":"https://openalex.org/W4292411376","eid":"W4292411376"},{"id":"paper-w2044965435","cat":"papers","name":"Role of the Dopaminergic System in the Acquisition, Expression and Reinstatement of MDMA-Induced Conditioned Place Preference in Adolescent Mice","year":"2012","cit":50,"pfa":"Antonio Vidal‐Infer","psa":"Marta Rodríguez‐Arias","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2044965435","eid":"W2044965435"},{"id":"paper-w1968942318","cat":"papers","name":"Enhancement of conditioned place preference response to cocaine in rats following subchronic administration of 3,4-methylenedioxymethamphetamine (MDMA)","year":"2000","cit":50,"pfa":"Bryan Horan","psa":"Charles R. Ashby","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1968942318","eid":"W1968942318"},{"id":"paper-w2010710157","cat":"papers","name":"Calpain and caspase proteolytic markers co-localize with rat cortical neurons after exposure to methamphetamine and MDMA","year":"2007","cit":50,"pfa":"Matthew W. Warren","psa":"Kevin Wang","ptype":"article","src":"https://openalex.org/W2010710157","eid":"W2010710157"},{"id":"paper-w2024394065","cat":"papers","name":"Intracranial self-administration of MDMA into the ventral striatum of the rat: differential roles of the nucleus accumbens shell, core, and olfactory tubercle","year":"2008","cit":50,"pfa":"Rick S. Shin","psa":"Satoshi Ikemoto","ptype":"article","src":"https://openalex.org/W2024394065","eid":"W2024394065"},{"id":"paper-w4214531716","cat":"papers","name":"Updated cost-effectiveness of MDMA-assisted therapy for the treatment of posttraumatic stress disorder in the United States: Findings from a phase 3 trial","year":"2022","cit":50,"pfa":"Elliot A. Marseille","psa":"James G. Kahn","topics":["PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4214531716","eid":"W4214531716"},{"id":"paper-w2039465457","cat":"papers","name":"Release of serotonin induced by 3,4-methylenedioxymethamphetamine (MDMA) and other substituted amphetamines in cultured fetal raphe neurons: further evidence for calcium-independent mechanisms of release","year":"1995","cit":50,"pfa":"Christine H. Wichems","psa":"Barbara A. Bennett","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2039465457","eid":"W2039465457"},{"id":"paper-w2789541163","cat":"papers","name":"Serotonergic Psychedelics: Experimental Approaches for Assessing Mechanisms of Action","year":"2018","cit":50,"pfa":"Clinton Ernest Canal","topics":["Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W2789541163","eid":"W2789541163"},{"id":"paper-w2039087930","cat":"papers","name":"LSD-Like Panic From Risperidone in Post-LSD Visual Disorder","year":"1996","cit":50,"pfa":"Henry David Abraham","psa":"Anitra Mamen","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2039087930","eid":"W2039087930"},{"id":"paper-w1993845390","cat":"papers","name":"Methylenedioxymethamphetamine (ecstasy)-related hyperthermia","year":"2005","cit":50,"pfa":"Manish M. Patel","psa":"Michael A. Miller","ptype":"article","src":"https://openalex.org/W1993845390","eid":"W1993845390"},{"id":"paper-w957509594","cat":"papers","name":"Acute health problems due to recreational drug use in patients presenting to an urban emergency department in Switzerland","year":"2015","cit":50,"pfa":"Evangelia Liakoni","psa":"Matthias E. Liechti","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W957509594","eid":"W957509594"},{"id":"paper-w3182085149","cat":"papers","name":"Transcriptomics-informed large-scale cortical model captures topography of pharmacological neuroimaging effects of LSD","year":"2021","cit":50,"pfa":"Joshua B. Burt","psa":"John D. Murray","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3182085149","eid":"W3182085149"},{"id":"paper-w2147977831","cat":"papers","name":"Arginine vasopressin release in response to the administration of 3,4-methylenedioxymethamphetamine (“ecstasy”): is metabolism a contributory factor?","year":"2001","cit":50,"pfa":"Mary L. Forsling","psa":"John Aaron Henry","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2147977831","eid":"W2147977831"},{"id":"paper-w2010403615","cat":"papers","name":"3,4-Methylenedioxymethamphetamine (“Ecstasy”) induces apoptosis of cultured rat liver cells","year":"2002","cit":50,"pfa":"Cristina Montiel‐Duarte","psa":"María J. Iraburu","ptype":"article","src":"https://openalex.org/W2010403615","eid":"W2010403615"},{"id":"paper-w2020059513","cat":"papers","name":"Enhanced Tau Phosphorylation in the Hippocampus of Mice Treated with 3,4-Methylenedioxymethamphetamine (“Ecstasy”)","year":"2008","cit":50,"pfa":"Carla Letizia Busceti","psa":"Francesco Fornai","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2020059513","eid":"W2020059513"},{"id":"paper-w3122123232","cat":"papers","name":"Pharmacological-assisted Psychotherapy for Post Traumatic Stress Disorder: a systematic review and meta-analysis","year":"2021","cit":50,"pfa":"Mathew D. Hoskins","psa":"Liam Clarke","topics":["PTSD & trauma","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W3122123232","eid":"W3122123232"},{"id":"paper-w4406559947","cat":"papers","name":"Exploring DMT: Endogenous role and therapeutic potential","year":"2025","cit":50,"pfa":"Jakub Schimmelpfennig","psa":"Kamila Jankowiak-Siuda","topics":["Mechanism & neuroscience","Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4406559947","eid":"W4406559947"},{"id":"paper-w3165684389","cat":"papers","name":"Improving cognitive functioning in major depressive disorder with psychedelics: A dimensional approach","year":"2021","cit":50,"pfa":"Igor Magaraggia","psa":"Rudy Schreiber","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3165684389","eid":"W3165684389"},{"id":"paper-w2971371418","cat":"papers","name":"LSD-assisted psychotherapy and the human encounter with death.","year":"1972","cit":50,"pfa":"William A. Richards","psa":"Albert A. Kurland","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2971371418","eid":"W2971371418"},{"id":"paper-w4302584464","cat":"papers","name":"The Botany and Chemistry of Hallucinogens","year":"1973","cit":50,"topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4302584464","eid":"W4302584464"},{"id":"paper-w2009566670","cat":"papers","name":"Notes on the use of plant hallucinogens in Amazonian Brazil","year":"1970","cit":50,"pfa":"Ghillean Tolmie Prance","ptype":"article","src":"https://openalex.org/W2009566670","eid":"W2009566670"},{"id":"paper-w1208947668","cat":"papers","name":"Psychedelics and creativity: a review of the quantitative literature","year":"2015","cit":50,"pfa":"Matthew J. Baggott","topics":["Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W1208947668","eid":"W1208947668"},{"id":"paper-w2158640184","cat":"papers","name":"Nonlinear Pharmacokinetics of Oral Quinidine and Verapamil in Healthy Subjects: A Clinical Microdosing Study","year":"2011","cit":50,"pfa":"Kazuya Maeda","psa":"Yuichi Sugiyama","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2158640184","eid":"W2158640184"},{"id":"paper-w4307134464","cat":"papers","name":"Could psychedelic drugs have a role in the treatment of schizophrenia? Rationale and strategy for safe implementation","year":"2022","cit":50,"pfa":"Gilly Wolf","psa":"Bernard Lerer","ptype":"article","src":"https://openalex.org/W4307134464","eid":"W4307134464"},{"id":"paper-w1982691685","cat":"papers","name":"Phenethylamine hallucinogens in the locus coeruleus: potency of action correlates with rank order of 5-HT2 binding affinity","year":"1986","cit":50,"pfa":"Kurt Rasmussen","psa":"George K. Aghajanian","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1982691685","eid":"W1982691685"},{"id":"paper-w2325193637","cat":"papers","name":"Precision and Accuracy in the Quantitative Analysis of Biological Samples by Accelerator Mass Spectrometry: Application in Microdose Absolute Bioavailability Studies","year":"2011","cit":50,"pfa":"Lan Gao","psa":"Swapan K. Chowdhury","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2325193637","eid":"W2325193637"},{"id":"paper-w2329195628","cat":"papers","name":"Relative implications of protective responses versus damage induction at low dose and low-dose-rate exposures, using the microdose approach","year":"2003","cit":50,"pfa":"L. E. Feinendegen","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2329195628","eid":"W2329195628"},{"id":"paper-w2996066598","cat":"papers","name":"NP03, a Microdose Lithium Formulation, Blunts Early Amyloid Post-Plaque Neuropathology in McGill-R-Thy1-APP Alzheimer-Like Transgenic Rats","year":"2019","cit":50,"pfa":"Edward Norman Wilson","psa":"A. Claudio Cuello","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2996066598","eid":"W2996066598"},{"id":"paper-w2078380306","cat":"papers","name":"Sigma receptors mediate the psychotomimetic effects of N-allylnormetazocine (SKF-10,047), but not its opioid agonistic-antagonistic properties","year":"1984","cit":50,"pfa":"Naim Khazan","psa":"David O. Calligaro","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2078380306","eid":"W2078380306"},{"id":"paper-w568696044","cat":"papers","name":"The chemistry of mind-altering drugs: history, pharmacology, and cultural context","year":"1997","cit":50,"topics":["Depression","Addiction","Dosing & pharmacology"],"ptype":"book-review","src":"https://openalex.org/W568696044","eid":"W568696044"},{"id":"paper-w1043354236","cat":"papers","name":"Lymphatic transport in patients with chronic venous insufficiency and venous leg ulcers following sequential pneumatic compression","year":"2015","cit":50,"pfa":"John C. Rasmussen","psa":"Eva Marie Sevick-Muraca","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1043354236","eid":"W1043354236"},{"id":"paper-w2342092395","cat":"papers","name":"Subanesthetic ketamine: how it alters physiology and behavior in humans.","year":"2005","cit":50,"pfa":"Laura M. Rowland","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2342092395","eid":"W2342092395"},{"id":"paper-w2039264644","cat":"papers","name":"Meta-Analysis of Depressive Symptoms in Dual-Diagnosis Schizophrenia","year":"2007","cit":50,"pfa":"Stéphane Potvin","psa":"Émmanuel Stip","topics":["Depression","Addiction","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W2039264644","eid":"W2039264644"},{"id":"paper-w4210488365","cat":"papers","name":"Polysubstance Use in Early Adulthood: Patterns and Developmental Precursors in an Urban Cohort","year":"2022","cit":50,"pfa":"Annekatrin Steinhoff","psa":"Lilly Shanahan","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4210488365","eid":"W4210488365"},{"id":"paper-w2766190330","cat":"papers","name":"Ketamine and pharmacological imaging: use of functional magnetic resonance imaging to evaluate mechanisms of action","year":"2017","cit":50,"pfa":"Eric A. Maltbie","psa":"Leonard Lee Howell","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2766190330","eid":"W2766190330"},{"id":"paper-w2909908508","cat":"papers","name":"Efficacy of the ketamine metabolite (2R,6R)-hydroxynorketamine in mice models of pain","year":"2019","cit":50,"pfa":"Jeffrey S. Kroin","psa":"Asokumar Buvanendran","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2909908508","eid":"W2909908508"},{"id":"paper-w4322730794","cat":"papers","name":"Rethinking ketamine and esketamine action: Are they antidepressants with mood-stabilizing properties?","year":"2023","cit":50,"pfa":"Giacomo d’Andrea","psa":"Giovanni Martinotti","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4322730794","eid":"W4322730794"},{"id":"paper-w4391288716","cat":"papers","name":"Effects of ketamine and esketamine on preventing postpartum depression after cesarean delivery: A meta-analysis","year":"2024","cit":50,"pfa":"Shuying Li","psa":"Rongqian Lin","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4391288716","eid":"W4391288716"},{"id":"paper-w2755137735","cat":"papers","name":"Effects of esketamine sedation compared to morphine analgesia on hydrostatic reduction of intussusception: A case‐cohort comparison study","year":"2017","cit":50,"pfa":"Jascha A. van de Bunt","psa":"Maud Y.A. Lindeboom","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2755137735","eid":"W2755137735"},{"id":"paper-w2068666473","cat":"papers","name":"Lisuride and LSD: Dopaminergic and serotonergic interactions in the ?serotonin syndrome?","year":"1979","cit":50,"pfa":"Ellen Kovner Silbergeld","psa":"Robert E. Hruska","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2068666473","eid":"W2068666473"},{"id":"paper-w2080515992","cat":"papers","name":"Lysergic acid diethylamide (LSD) as a discriminative cue: Drugs with similar stimulus properties","year":"1972","cit":49,"pfa":"Martin Schechter","psa":"John A. Rosecrans","ptype":"article","src":"https://openalex.org/W2080515992","eid":"W2080515992"},{"id":"paper-w1602373301","cat":"papers","name":"Noribogaine, but not 18‐MC, exhibits similar actions as ibogaine on GDNF expression and ethanol self‐administration","year":"2010","cit":49,"pfa":"Sébastien Carnicella","psa":"Dorit Ron","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1602373301","eid":"W1602373301"},{"id":"paper-w2901151882","cat":"papers","name":"Biosynthetically Inspired Transformation of Iboga to Monomeric Post-iboga Alkaloids","year":"2018","cit":49,"pfa":"Sikwang Seong","psa":"Sunkyu Han","ptype":"article","src":"https://openalex.org/W2901151882","eid":"W2901151882"},{"id":"paper-w2584329988","cat":"papers","name":"The analgesic and anti‐inflammatory effects of Salvinorin A analogue β‐tetrahydropyran Salvinorin B in mice","year":"2017","cit":49,"pfa":"Kelly F. Paton","psa":"Bronwyn Maree Kivell","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2584329988","eid":"W2584329988"},{"id":"paper-w2021981153","cat":"papers","name":"Effects of Mescaline, LSD-25, and Adrenochrome on Depth Electrograms in Man","year":"1956","cit":49,"pfa":"Bert E. Schwarz","ptype":"article","src":"https://openalex.org/W2021981153","eid":"W2021981153"},{"id":"paper-w2023343652","cat":"papers","name":"Effects of priming injections of MDMA and cocaine on reinstatement of MDMA- and cocaine-seeking in rats","year":"2008","cit":49,"pfa":"Susan Schenk","psa":"Evangeline Daniela","ptype":"article","src":"https://openalex.org/W2023343652","eid":"W2023343652"},{"id":"paper-w2937257193","cat":"papers","name":"Ibogaine and Subjective Experience: Transformative States and Psychopharmacotherapy in the Treatment of Opioid Use Disorder","year":"2019","cit":49,"pfa":"Thomas Kingsley Brown","psa":"Julie O. Denenberg","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2937257193","eid":"W2937257193"},{"id":"paper-w3009264042","cat":"papers","name":"Psilocybin Therapeutic Research: The Present and Future Paradigm","year":"2020","cit":49,"pfa":"Robert B. Kargbo","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"editorial","src":"https://openalex.org/W3009264042","eid":"W3009264042"},{"id":"paper-w1993994434","cat":"papers","name":"Effects of ibogaine on responding maintained by food, cocaine and heroin reinforcement in rats","year":"1995","cit":49,"pfa":"Steven I. Dworkin","psa":"Thomas Jeff Martin","ptype":"article","src":"https://openalex.org/W1993994434","eid":"W1993994434"},{"id":"paper-w2091820270","cat":"papers","name":"Chronic paranoid psychosis after misuse of MDMA.","year":"1991","cit":49,"pfa":"ADAM R. WINSTOCK","ptype":"article","src":"https://openalex.org/W2091820270","eid":"W2091820270"},{"id":"paper-w2005206874","cat":"papers","name":"Assessment of the MDA and MDMA Optical Isomers in a Stimulant-Hallucinogen Discrimination","year":"1997","cit":49,"pfa":"Lisa E. Baker","psa":"Michele Taylor","ptype":"article","src":"https://openalex.org/W2005206874","eid":"W2005206874"},{"id":"paper-w4365444032","cat":"papers","name":"Assessment of Psilocybin Therapy for Patients With Cancer and Major Depression Disorder","year":"2023","cit":49,"pfa":"Manish Agrawal","psa":"Paul M. Thambi","topics":["Depression","Anxiety & end-of-life","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4365444032","eid":"W4365444032"},{"id":"paper-w2083438374","cat":"papers","name":"Sleep apnea in young abstinent recreational MDMA (“ecstasy”) consumers","year":"2009","cit":49,"pfa":"Una D. McCann","psa":"George A. Ricaurte","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2083438374","eid":"W2083438374"},{"id":"paper-w3096108931","cat":"papers","name":"Risk assessment of ayahuasca use in a religious context: self-reported risk factors and adverse effects","year":"2020","cit":49,"pfa":"Ícaro Durante","psa":"Jaime E. C. Hallak","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3096108931","eid":"W3096108931"},{"id":"paper-w2131536379","cat":"papers","name":"A Qualitative Report on the Subjective Experience of Intravenous Psilocybin Administered in an fMRI Environment","year":"2015","cit":49,"pfa":"Samuel Turton","psa":"Robin Lester Carhart-Harris","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2131536379","eid":"W2131536379"},{"id":"paper-w2100631896","cat":"papers","name":"Ibogaine attenuation of morphine withdrawal in mice: role of glutamate N-methyl-d-aspartate receptors","year":"2003","cit":49,"pfa":"Mirna Bainy Leal","psa":"Elaine Elisabetsky","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2100631896","eid":"W2100631896"},{"id":"paper-w2115347300","cat":"papers","name":"One-Year Outcomes of Prenatal Exposure to MDMA and Other Recreational Drugs","year":"2012","cit":49,"pfa":"Lynn T. Singer","psa":"Andrew C. Parrott","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2115347300","eid":"W2115347300"},{"id":"paper-w2075044404","cat":"papers","name":"Gas chromatographic-mass spectrometric isotope dilution determination of N,N-dimethyltryptamine concentrations in normals and psychiatric patients","year":"1973","cit":49,"pfa":"Richard Jed Wyatt","psa":"William J. A. Vanden Heuvel","ptype":"article","src":"https://openalex.org/W2075044404","eid":"W2075044404"},{"id":"paper-w2153034665","cat":"papers","name":"The hallucinogen derived from Salvia divinorum, salvinorin A, has κ-opioid agonist discriminative stimulus effects in rats","year":"2007","cit":49,"pfa":"Catherine B. Willmore-Fordham","psa":"David H. Kinder","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2153034665","eid":"W2153034665"},{"id":"paper-w1995158463","cat":"papers","name":"Constructing Iboga Alkaloids via C–H Bond Functionalization: Examination of the Direct and Catalytic Union of Heteroarenes and Isoquinuclidine Alkenes","year":"2015","cit":49,"pfa":"Andrew C. Kruegel","psa":"Dalibor Sameš","ptype":"article","src":"https://openalex.org/W1995158463","eid":"W1995158463"},{"id":"paper-w1970670051","cat":"papers","name":"Executive Working Memory Deficits in Abstinent Ecstasy/MDMA Users: A Critical Review","year":"2009","cit":49,"pfa":"Philip N. Murphy","psa":"Catharine Montgomery","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1970670051","eid":"W1970670051"},{"id":"paper-w2613178023","cat":"papers","name":"“Ecstasy” to addiction: Mechanisms and reinforcing effects of three synthetic cathinone analogs of MDMA","year":"2018","cit":49,"pfa":"Sean B. Dolan","psa":"Michael B. Gatch","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2613178023","eid":"W2613178023"},{"id":"paper-w2006900274","cat":"papers","name":"Prepulse inhibition of the startle reflex and its attentional modulation in the human S-ketamine and N,N-dimethyltryptamine (DMT) models of psychosis","year":"2007","cit":49,"pfa":"Karsten Heekeren","psa":"Euphrosyne Gouzoulis‐Mayfrank","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2006900274","eid":"W2006900274"},{"id":"paper-w2006275171","cat":"papers","name":"MDMA/Ecstasy Use Among Young People in Ohio: Perceived Risk and Barriers to Intervention","year":"2004","cit":49,"pfa":"Robert Gideon Carlson","psa":"Harvey Alan Siegal","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2006275171","eid":"W2006275171"},{"id":"paper-w2118703840","cat":"papers","name":"Behavioral profile of 3,4-methylenedioxy-methamphetamine (MDMA) in agonistic encounters between male mice","year":"1999","cit":49,"pfa":"José Francisco Navarro","psa":"E. Maldonado","ptype":"article","src":"https://openalex.org/W2118703840","eid":"W2118703840"},{"id":"paper-w2095889524","cat":"papers","name":"Drug Testing in Blood: Validated Negative-Ion Chemical Ionization Gas Chromatographic–Mass Spectrometric Assay for Enantioselective Measurement of the Designer Drugs MDEA, MDMA, and MDA and Its Application to Samples fro","year":"2005","cit":49,"pfa":"Frank T. Peters","psa":"Hans H. Maurer","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2095889524","eid":"W2095889524"},{"id":"paper-w1517515257","cat":"papers","name":"A reconsideration and response to Parrott AC (2013) “Human psychobiology of MDMA or ‘Ecstasy’: an overview of 25 years of empirical research”","year":"2014","cit":49,"pfa":"Rick Doblin","psa":"Ben Sessa","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1517515257","eid":"W1517515257"},{"id":"paper-w1978580602","cat":"papers","name":"A validated gas chromatographic–electron impact ionization mass spectrometric method for methylenedioxymethamphetamine (MDMA), methamphetamine and metabolites in oral fluid","year":"2006","cit":49,"pfa":"Karl B. Scheidweiler","psa":"Marilyn Ann Huestis","ptype":"article","src":"https://openalex.org/W1978580602","eid":"W1978580602"},{"id":"paper-w2141169361","cat":"papers","name":"Involvement of Inferior Parietal Lobules in Prospective Memory Impairment during Acute MDMA (Ecstasy) Intoxication: An Event-Related fMRI Study","year":"2008","cit":49,"pfa":"Johannes Gerardus Ramaekers","psa":"Elia Formisano","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2141169361","eid":"W2141169361"},{"id":"paper-w2050529774","cat":"papers","name":"Behavioral and Electroencephalographic Effects of Hallucinogenic Drugs","year":"1956","cit":49,"pfa":"Bert E. Schwarz","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2050529774","eid":"W2050529774"},{"id":"paper-w3129763680","cat":"papers","name":"How to Change Your Mind: What the New Science of Psychedelics Teaches Us About Consciousness, Dying, Addiction, Depression, and Transcendence","year":"2021","cit":49,"pfa":"Peter George Brindley","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3129763680","eid":"W3129763680"},{"id":"paper-w2493928838","cat":"papers","name":"Measuring the subjective: revisiting the psychometric properties of three rating scales that assess the acute effects of hallucinogens","year":"2016","cit":49,"pfa":"José Carlos Bouso","psa":"Miguel Ángel Alcázar‐Córcoles","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2493928838","eid":"W2493928838"},{"id":"paper-w1985612870","cat":"papers","name":"Stereoselective pharmacokinetics of 3,4‐methylenedioxymethamphetamine in the rat","year":"1990","cit":49,"pfa":"Robert L. Fitzgerald","psa":"Alphonse Poklis","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1985612870","eid":"W1985612870"},{"id":"paper-w2003186360","cat":"papers","name":"Dissociation of multiple effects of acute LSD on exploratory behavior in rats by ritanserin and propranolol","year":"1991","cit":49,"pfa":"Susan M. Mittman","psa":"Mark A. Geyer","ptype":"article","src":"https://openalex.org/W2003186360","eid":"W2003186360"},{"id":"paper-w2230319546","cat":"papers","name":"A Metabolomics Study of Retrospective Forensic Data from Whole Blood Samples of Humans Exposed to 3,4-Methylenedioxymethamphetamine: A New Approach for Identifying Drug Metabolites and Changes in Metabolism Related to Dr","year":"2015","cit":49,"pfa":"Kirstine Lykke Nielsen","psa":"Mogens Johannsen","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2230319546","eid":"W2230319546"},{"id":"paper-w4362699944","cat":"papers","name":"TMS-EEG and resting-state EEG applied to altered states of consciousness: oscillations, complexity, and phenomenology","year":"2023","cit":49,"pfa":"Andres Ort","psa":"Franz X. Vollenweider","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4362699944","eid":"W4362699944"},{"id":"paper-w1968555522","cat":"papers","name":"Hallucinogenic N-Methylated Indolealkylamines in the Cerebrospinal Fluid of Psychiatric and Control Populations","year":"1978","cit":49,"pfa":"Lionel Corbett","psa":"John Smythies","ptype":"article","src":"https://openalex.org/W1968555522","eid":"W1968555522"},{"id":"paper-w2321416759","cat":"papers","name":"Rapid Simultaneous Determination of Amphetamine, Methamphetamine, 3,4-Methylenedioxyamphetamine, 3,4-Methylenedioxymethamphetamine, and 3,4-Methylenedioxyethylamphetamine in Urine by Solid-Phase Extraction and GC-MS: A M","year":"2002","cit":49,"pfa":"Peter R. Stout","psa":"Kevin L. Klette","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2321416759","eid":"W2321416759"},{"id":"paper-w191918832","cat":"papers","name":"The N-methyl-d-aspartate antagonist MK-801 protects against serotonin depletions induced by methamphetamine 3,4-methylenedioxymethamphetamine and p-chloroamphetamine","year":"1992","cit":49,"pfa":"Gail M. Farfel","psa":"Lewis S. Seiden","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W191918832","eid":"W191918832"},{"id":"paper-w4321016287","cat":"papers","name":"Personal Psychedelic Use Is Common Among a Sample of Psychedelic Therapists: Implications for Research and Practice","year":"2023","cit":49,"pfa":"Jacob S. Aday","psa":"Joshua D. Woolley","topics":["Depression","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4321016287","eid":"W4321016287"},{"id":"paper-w4292056146","cat":"papers","name":"Molecular insights into the regulation of constitutive activity by RNA editing of 5HT2C serotonin receptors","year":"2022","cit":49,"pfa":"Ryan H. Gumpper","psa":"Bryan L. Roth","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4292056146","eid":"W4292056146"},{"id":"paper-w2891343109","cat":"papers","name":"Serotonin, psychedelics and psychiatry","year":"2018","cit":49,"pfa":"Robin Lester Carhart-Harris","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2891343109","eid":"W2891343109"},{"id":"paper-w2009956447","cat":"papers","name":"Activation of 5‐HT2 receptors enhances the release of acetylcholine in the prefrontal cortex and hippocampus of the rat","year":"2004","cit":49,"pfa":"Sunila G Nair","psa":"Gary A. Gudelsky","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2009956447","eid":"W2009956447"},{"id":"paper-w2790698047","cat":"papers","name":"Evaluating the abuse potential of psychedelic drugs as part of the safety pharmacology assessment for medical use in humans","year":"2018","cit":49,"pfa":"David J. Heal","psa":"Sharon L. Smith","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2790698047","eid":"W2790698047"},{"id":"paper-w4366352039","cat":"papers","name":"Emerging Challenges for Psychedelic Therapy","year":"2023","cit":49,"pfa":"Jacob S. Aday","psa":"Joshua D. Woolley","ptype":"article","src":"https://openalex.org/W4366352039","eid":"W4366352039"},{"id":"paper-w4220907466","cat":"papers","name":"Top Ten Tips Palliative Care Clinicians Should Know About Psychedelic-Assisted Therapy in the Context of Serious Illness","year":"2022","cit":49,"pfa":"William E. Rosa","psa":"Yvan Beaussant","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4220907466","eid":"W4220907466"},{"id":"paper-w4224254727","cat":"papers","name":"Effects of a psychedelic 5-HT2A receptor agonist on anxiety-related behavior and fear processing in mice","year":"2022","cit":49,"pfa":"Błażej D. Pędzich","psa":"Dimitri De Bundel","topics":["Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4224254727","eid":"W4224254727"},{"id":"paper-w2320275590","cat":"papers","name":"The Combination of Psychedelic and Aversive Approaches in Alcoholism Treatment","year":"1992","cit":49,"pfa":"Evgeny M. Krupitsky","psa":"Yu S. Borodikin","topics":["Addiction","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2320275590","eid":"W2320275590"},{"id":"paper-w4281879023","cat":"papers","name":"Group VR experiences can produce ego attenuation and connectedness comparable to psychedelics","year":"2022","cit":49,"pfa":"David R. Glowacki","psa":"Mike Chatziapostolou","ptype":"article","src":"https://openalex.org/W4281879023","eid":"W4281879023"},{"id":"paper-w2529166905","cat":"papers","name":"The Associations of Naturalistic Classic Psychedelic Use, Mystical Experience, and Creative Problem Solving","year":"2016","cit":49,"pfa":"Noah Wiles Sweat","psa":"Peter S. Hendricks","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2529166905","eid":"W2529166905"},{"id":"paper-w2007823565","cat":"papers","name":"Nontraditional approaches to first-in-human studies to increase efficiency of drug development: will microdose studies make a significant impact?","year":"2007","cit":49,"pfa":"Rebecca A. Boyd","psa":"Richard L. Lalonde","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2007823565","eid":"W2007823565"},{"id":"paper-w4244987475","cat":"papers","name":"Psychotomimetic Agents","year":"1967","cit":49,"pfa":"S S COHEN","ptype":"article","src":"https://openalex.org/W4244987475","eid":"W4244987475"},{"id":"paper-w2087109579","cat":"papers","name":"Phase 0 Microdosing PET Study Using the Human Mini Antibody F16SIP in Head and Neck Cancer Patients","year":"2013","cit":49,"pfa":"Derrek A. Heuveling","psa":"Guus A.M.S. van Dongen","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2087109579","eid":"W2087109579"},{"id":"paper-w3216348943","cat":"papers","name":"Examining Psychedelic-Induced Changes in Social Functioning and Connectedness in a Naturalistic Online Sample Using the Five-Factor Model of Personality","year":"2021","cit":49,"pfa":"Brandon Weiss","psa":"David Erritzøe","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3216348943","eid":"W3216348943"},{"id":"paper-w2160271718","cat":"papers","name":"Detection of Psychotomimetic N,N-Dimethylated Indoleamines in the Urine of Four Schizophrenic Patients","year":"1970","cit":49,"pfa":"Hiroshi Tanimukai","psa":"Harold E. Himwich","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2160271718","eid":"W2160271718"},{"id":"paper-w2077239925","cat":"papers","name":"History, Rationale and Potential of Human Experimental Hallucinogenic Drug Research in Psychiatry","year":"1998","cit":49,"pfa":"Euphrosyne Gouzoulis‐Mayfrank","psa":"H. Sass","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2077239925","eid":"W2077239925"},{"id":"paper-w2157156079","cat":"papers","name":"Concomitant oral and intravenous pharmacokinetics of trametinib, a MEK inhibitor, in subjects with solid tumours","year":"2014","cit":49,"pfa":"Cathrine Leonowens","psa":"Danièle Ouellet","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2157156079","eid":"W2157156079"},{"id":"paper-w2070367660","cat":"papers","name":"Antipsychotic Profile of Cannabidiol and Rimonabant in an Animal Model of Emotional Context Processing in Schizophrenia","year":"2012","cit":49,"pfa":"Raquel R. Levin","psa":"Vanessa Costhek Abílio","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2070367660","eid":"W2070367660"},{"id":"paper-w3045854214","cat":"papers","name":"Genome-wide association study and polygenic risk score analysis of esketamine treatment response","year":"2020","cit":49,"pfa":"Qingqin S. Li","psa":"Wayne Curtis Drevets","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3045854214","eid":"W3045854214"},{"id":"paper-w2939370832","cat":"papers","name":"Beneficial effects of (R)-ketamine, but not its metabolite (2R,6R)-hydroxynorketamine, in the depression-like phenotype, inflammatory bone markers, and bone mineral density in a chronic social defeat stress model","year":"2019","cit":49,"pfa":"Zhongwei Xiong","psa":"Kenji Hashimoto","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2939370832","eid":"W2939370832"},{"id":"paper-w2789562560","cat":"papers","name":"Lack of metabolism in (R)-ketamine’s antidepressant actions in a chronic social defeat stress model","year":"2018","cit":49,"pfa":"Kai Zhang","psa":"Kenji Hashimoto","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2789562560","eid":"W2789562560"},{"id":"paper-w4403100006","cat":"papers","name":"Efficacy of nonopioid analgesics and adjuvants in multimodal analgesia for reducing postoperative opioid consumption and complications in obesity: a systematic review and network meta-analysis","year":"2024","cit":49,"pfa":"Michele Carron","psa":"Paolo Navalesi","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4403100006","eid":"W4403100006"},{"id":"paper-w1982917705","cat":"papers","name":"CLINICAL REACTIONS OF SCHIZOPHRENICS TO SODIUM AMYTAL, PERVITIN HYDROCHLORIDE, MESCALINE SULFATE, AND D-LYSERGIC ACID DIETHYLAMIDE (LSD25)","year":"1954","cit":48,"pfa":"Harry H. Pennes","ptype":"article","src":"https://openalex.org/W1982917705","eid":"W1982917705"},{"id":"paper-w2007124928","cat":"papers","name":"The identification and determination of lysergic acid diethylamide in narcotic seizures","year":"1964","cit":48,"pfa":"KLAUS GENEST","psa":"Charles G. Farmilo","ptype":"article","src":"https://openalex.org/W2007124928","eid":"W2007124928"},{"id":"paper-w2134332736","cat":"papers","name":"Peyote and mescaline exposures: a 12-year review of a statewide poison center database","year":"2010","cit":48,"pfa":"Shaun D. Carstairs","psa":"Frank Lee Cantrell","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2134332736","eid":"W2134332736"},{"id":"paper-w4304118763","cat":"papers","name":"Race and ethnicity moderate the associations between lifetime psychedelic use (MDMA and psilocybin) and psychological distress and suicidality","year":"2022","cit":48,"pfa":"Grant M. Jones","psa":"Matthew K. Nock","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4304118763","eid":"W4304118763"},{"id":"paper-w2012260803","cat":"papers","name":"13C‐NMR. Spectroscopy of Naturally Occurring Substances. XLV. Iboga Alkaloids","year":"1976","cit":48,"pfa":"Ernest Wenkert","psa":"Maria Iracema Lacerda Machado Madruga","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2012260803","eid":"W2012260803"},{"id":"paper-w2016101020","cat":"papers","name":"Acute iboga alkaloid effects on extracellular serotonin (5-HT) levels in nucleus accumbens and striatum in rats","year":"1998","cit":48,"pfa":"D. Wei","psa":"S.D. Glick","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2016101020","eid":"W2016101020"},{"id":"paper-w3007311584","cat":"papers","name":"Scalable Hybrid Synthetic/Biocatalytic Route to Psilocybin","year":"2020","cit":48,"pfa":"Janis Fricke","psa":"Dirk Hoffmeister","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W3007311584","eid":"W3007311584"},{"id":"paper-w1969580202","cat":"papers","name":"Long-QT Syndrome Induced by the Antiaddiction Drug Ibogaine","year":"2009","cit":48,"pfa":"Dianne W. M. Hoelen","psa":"Gerlof Dirk Valk","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1969580202","eid":"W1969580202"},{"id":"paper-w2951809594","cat":"papers","name":"Palladium-catalyzed synthesis of tryptamines and tryptamine homologues: synthesis of psilocin","year":"2009","cit":48,"pfa":"Chunmei Hu","psa":"Yanxing Jia","ptype":"article","src":"https://openalex.org/W2951809594","eid":"W2951809594"},{"id":"paper-w2115580549","cat":"papers","name":"MDA-MDMA Concentrations in Urine Specimens*","year":"1996","cit":48,"pfa":"Gary W. Kunsman","psa":"Michael L. Smith","ptype":"article","src":"https://openalex.org/W2115580549","eid":"W2115580549"},{"id":"paper-w2329570187","cat":"papers","name":"The Alkaloids of Tabernanthe iboga. Part III.1 Isolation Studies","year":"1958","cit":48,"pfa":"D. F. Dickel","psa":"W. I. Taylor","ptype":"article","src":"https://openalex.org/W2329570187","eid":"W2329570187"},{"id":"paper-w2117146973","cat":"papers","name":"Structurally modified ibogaine analogs exhibit differing affinities for NMDA receptors","year":"1996","cit":48,"pfa":"Richard Thomas Layer","psa":"Piotr Popik","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2117146973","eid":"W2117146973"},{"id":"paper-w1981073133","cat":"papers","name":"Kappa opioid mediation of cannabinoid effects of the potent hallucinogen, salvinorin A, in rodents","year":"2010","cit":48,"pfa":"D. Matthew Walentiny","psa":"Jenny L. Wiley","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1981073133","eid":"W1981073133"},{"id":"paper-w2411886650","cat":"papers","name":"Structure-Activity Relationships of MDMA-Like Substances","year":"1989","cit":48,"pfa":"David E. Nichols","psa":"Robert A. Oberlender","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W2411886650","eid":"W2411886650"},{"id":"paper-w2150363216","cat":"papers","name":"In Vivo Long-Term Kinetics of Radiolabeled N,N-Dimethyltryptamine and Tryptamine","year":"2011","cit":48,"pfa":"Arturo Alberto Vitale","psa":"Jorge Ciprian‐Ollivier","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2150363216","eid":"W2150363216"},{"id":"paper-w2007717827","cat":"papers","name":"Long-term behavioral consequences of prenatal MDMA exposure","year":"2009","cit":48,"pfa":"Valerie B. Thompson","psa":"Jack W. Lipton","ptype":"article","src":"https://openalex.org/W2007717827","eid":"W2007717827"},{"id":"paper-w2064631169","cat":"papers","name":"Neural correlates of MDMA (“Ecstasy”)-induced social interaction in rats","year":"2008","cit":48,"pfa":"Murray R. Thompson","psa":"Iain S. McGregor","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2064631169","eid":"W2064631169"},{"id":"paper-w4214488648","cat":"papers","name":"The Use of Psilocybin in the Treatment of Psychiatric Disorders with Attention to Relative Safety Profile: A Systematic Review","year":"2022","cit":48,"pfa":"Andrew Troy Hodge","psa":"Robert C. Strayhan","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"review","src":"https://openalex.org/W4214488648","eid":"W4214488648"},{"id":"paper-w2969399656","cat":"papers","name":"Through the gateway of the heart : accounts of experiences with MDMA and other empathogenic substances","year":"1985","cit":48,"pfa":"S.C. Adamson","psa":"Ralph Metzner","topics":["Addiction"],"ptype":"book","src":"https://openalex.org/W2969399656","eid":"W2969399656"},{"id":"paper-w3135595060","cat":"papers","name":"Methylenedioxymethamphetamine (MDMA): Serotonergic and dopaminergic mechanisms related to its use and misuse","year":"2021","cit":48,"pfa":"Susan Schenk","psa":"Quenten Highgate","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3135595060","eid":"W3135595060"},{"id":"paper-w2317963375","cat":"papers","name":"Ayahuasca, Psychedelic Studies and Health Sciences: The Politics of Knowledge and Inquiry into an Amazonian Plant Brew","year":"2015","cit":48,"pfa":"Kenneth W. Tupper","psa":"Beatriz Caiuby Labate","ptype":"article","src":"https://openalex.org/W2317963375","eid":"W2317963375"},{"id":"paper-w2094043383","cat":"papers","name":"On the anxiogenic and anxiolytic nature of long-term cerebral 5-HT depletion following MDMA","year":"2002","cit":48,"pfa":"A. Richard Green","psa":"Iain S. McGregor","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2094043383","eid":"W2094043383"},{"id":"paper-w2084126795","cat":"papers","name":"The use of organic and inorganic impurities found in MDMA police seizures in a drug intelligence perspective","year":"2013","cit":48,"pfa":"Marie Morelato","psa":"Claude Patrick Roux","ptype":"article","src":"https://openalex.org/W2084126795","eid":"W2084126795"},{"id":"paper-w2003616879","cat":"papers","name":"Human pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) after repeated doses taken 2 h apart","year":"2012","cit":48,"pfa":"Ana María Peiró","psa":"Rafael de la Torre","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2003616879","eid":"W2003616879"},{"id":"paper-w3158614341","cat":"papers","name":"Effects of ayahuasca and its alkaloids on substance use disorders: an updated (2016–2020) systematic review of preclinical and human studies","year":"2021","cit":48,"pfa":"Lucas Silva Rodrigues","psa":"RAFAEL GUIMARÃES DOS SANTOS","topics":["Addiction","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W3158614341","eid":"W3158614341"},{"id":"paper-w2082109742","cat":"papers","name":"NMDA receptor subunit and CaMKII changes in rat hippocampus induced by acute MDMA treatment: a mechanism for learning impairment","year":"2004","cit":48,"pfa":"Sonia Moyano","psa":"J. Del R�o","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2082109742","eid":"W2082109742"},{"id":"paper-w2015023942","cat":"papers","name":"Development and validation of a disk solid phase extraction and gas chromatography–mass spectrometry method for MDMA, MDA, HMMA, HMA, MDEA, methamphetamine and amphetamine in sweat","year":"2007","cit":48,"pfa":"Bruno Spinosa De Martinis","psa":"Marilyn Ann Huestis","ptype":"article","src":"https://openalex.org/W2015023942","eid":"W2015023942"},{"id":"paper-w2046771826","cat":"papers","name":"Spinal 5-HT2A receptors regulate cutaneous sympathetic vasomotor outflow in rabbits and rats; relevance for cutaneous vasoconstriction elicited by MDMA (3,4-methylenedioxymethamphetamine, “Ecstasy”) and its reversal by c","year":"2004","cit":48,"pfa":"Youichirou Ootsuka","psa":"William Walter Blessing","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2046771826","eid":"W2046771826"},{"id":"paper-w2562621409","cat":"papers","name":"Identification and analytical characterization of nine synthetic cathinone derivatives N‐ethylhexedrone, 4‐Cl‐pentedrone, 4‐Cl‐α‐EAPP, propylone, N‐ethylnorpentylone, 6‐MeO‐bk‐MDMA, α‐PiHP, 4‐Cl‐α‐PHP, and 4‐F‐α‐PHP","year":"2016","cit":48,"pfa":"Cuimei Liu","psa":"Zhenhua Qian","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2562621409","eid":"W2562621409"},{"id":"paper-w2148265102","cat":"papers","name":"Extraction Studies ofTabernanthe IbogaandVoacanga Africana","year":"2002","cit":48,"pfa":"Christopher Jenks","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2148265102","eid":"W2148265102"},{"id":"paper-w2045710119","cat":"papers","name":"LSD as an agonist at mesolimbic dopamine receptors","year":"1975","cit":48,"pfa":"Peter H. Kelly","psa":"Leslie Lars Iversen","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2045710119","eid":"W2045710119"},{"id":"paper-w1984363223","cat":"papers","name":"The effects of (±)-methylenedioxymethamphetamine and (±)-methylenedioxyamphetamine in monkeys trained to discriminate (+)-amphetamine from saline","year":"1986","cit":48,"pfa":"Jonathan B. Kamien","psa":"William L. Woolverton","ptype":"article","src":"https://openalex.org/W1984363223","eid":"W1984363223"},{"id":"paper-w4381548553","cat":"papers","name":"Psychedelics in the treatment of eating disorders: Rationale and potential mechanisms","year":"2023","cit":48,"pfa":"Abigail E. Calder","psa":"Gregor Hasler","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4381548553","eid":"W4381548553"},{"id":"paper-w4388730617","cat":"papers","name":"Psychedelic Integration: Psychotherapy for non-ordinary states of consciousness","year":"2023","cit":48,"pfa":"Danelle Jones","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4388730617","eid":"W4388730617"},{"id":"paper-w156847057","cat":"papers","name":"Influence of some agents that affect 5-hydroxytryptamine metabolism and receptors on nitrazepam-induced sleep in mice.","year":"1985","cit":48,"pfa":"Charles O. Wambebe","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W156847057","eid":"W156847057"},{"id":"paper-w2161821412","cat":"papers","name":"Hyperthermia induced by 3,4-methylenedioxymethamphetamine in unrestrained rhesus monkeys","year":"2005","cit":48,"pfa":"Michael A. Taffe","psa":"Simon N. Katner","ptype":"article","src":"https://openalex.org/W2161821412","eid":"W2161821412"},{"id":"paper-w2047820731","cat":"papers","name":"Differential behavioural and neurochemical effects of para-methoxyamphetamine and 3,4-methylenedioxymethamphetamine in the rat","year":"2000","cit":48,"pfa":"Lynette C. Daws","psa":"Felix Bochner","ptype":"article","src":"https://openalex.org/W2047820731","eid":"W2047820731"},{"id":"paper-w2087326566","cat":"papers","name":"Binge administration of 3,4-methylenedioxymethamphetamine (“ecstasy”) impairs the survival of neural precursors in adult rat dentate gyrus","year":"2006","cit":48,"pfa":"Vicente Hernández‐Rabaza","psa":"Juan J. Canales","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2087326566","eid":"W2087326566"},{"id":"paper-w2004955095","cat":"papers","name":"Selective modulation of immune function resulting from in vitro exposure to methylenedioxymethamphetamine (Ecstasy)","year":"1995","cit":48,"pfa":"Robert V. House","psa":"Hemendra N. Bhargava","ptype":"article","src":"https://openalex.org/W2004955095","eid":"W2004955095"},{"id":"paper-w2144919948","cat":"papers","name":"Accumulation of Neurotoxic Thioether Metabolites of 3,4-(±)-Methylenedioxymethamphetamine in Rat Brain","year":"2007","cit":48,"pfa":"Gladys V. Erives","psa":"Terrence J. Monks","ptype":"article","src":"https://openalex.org/W2144919948","eid":"W2144919948"},{"id":"paper-w2936948587","cat":"papers","name":"Cytochrome P450 enzymes contribute to the metabolism of LSD to nor-LSD and 2-oxo-3-hydroxy-LSD: Implications for clinical LSD use","year":"2019","cit":48,"pfa":"Dino Luethi","psa":"Urs Duthaler","ptype":"article","src":"https://openalex.org/W2936948587","eid":"W2936948587"},{"id":"paper-w3118432627","cat":"papers","name":"Tracing consumption patterns of stimulants, opioids, and ketamine in China by wastewater-based epidemiology","year":"2021","cit":48,"pfa":"Siyu Liu","psa":"Degao Wang","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W3118432627","eid":"W3118432627"},{"id":"paper-w2124108531","cat":"papers","name":"Screening the receptorome reveals molecular targets responsible for drug-induced side effects: focus on ‘fen–phen’","year":"2005","cit":48,"pfa":"Vincent Setola","psa":"Bryan L. Roth","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2124108531","eid":"W2124108531"},{"id":"paper-w2079552625","cat":"papers","name":"Pharmacological characterization of RP 62203, a novel 5‐hydroxytryptamine 5‐HT2 receptor antagonist","year":"1992","cit":48,"pfa":"Adam Doble","psa":"J.C. Blanchard","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2079552625","eid":"W2079552625"},{"id":"paper-w4288045936","cat":"papers","name":"Active mechanisms of ketamine-assisted psychotherapy: A systematic review","year":"2022","cit":48,"pfa":"Isak Joneborg","psa":"Roger S. McIntyre","topics":["Mechanism & neuroscience","Reviews & meta-analyses","Therapy practice"],"ptype":"review","src":"https://openalex.org/W4288045936","eid":"W4288045936"},{"id":"paper-w2297940936","cat":"papers","name":"Contraceptive mechanism of microdose norethindrone.","year":"1973","cit":48,"pfa":"Kamran S. Moghissi","psa":"McBride Lc","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2297940936","eid":"W2297940936"},{"id":"paper-w2502502188","cat":"papers","name":"Microdose intravaginal levonorgestrel contraception: A multicentre clinical trial","year":"1990","cit":48,"pfa":"Suporn Koetsawang","psa":"Philip John Rowe","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2502502188","eid":"W2502502188"},{"id":"paper-w3170563218","cat":"papers","name":"Molecular and clinical aspects of potential neurotoxicity induced by new psychoactive stimulants and psychedelics","year":"2021","cit":48,"pfa":"Deborah Rudin","psa":"Dino Luethi","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3170563218","eid":"W3170563218"},{"id":"paper-w2056794896","cat":"papers","name":"Clinical effects of ovulation induction with recombinant follicle-stimulating hormone supplemented with recombinant luteinizing hormone or low-dose recombinant human chorionic gonadotropin in the midfollicular phase in m","year":"2007","cit":48,"pfa":"Murat Berkkanoğlu","psa":"Kemal Özgür","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2056794896","eid":"W2056794896"},{"id":"paper-w2076000543","cat":"papers","name":"Analysis of the LSD Flashback","year":"1970","cit":48,"pfa":"J. Fred E. Shick","psa":"David Eugene Smith","ptype":"article","src":"https://openalex.org/W2076000543","eid":"W2076000543"},{"id":"paper-w2794014176","cat":"papers","name":"Tolerance and Tachyphylaxis to Head Twitches Induced by the 5-HT2A Agonist 25CN-NBOH in Mice","year":"2018","cit":48,"pfa":"Tobias Buchborn","psa":"Thomas Knöpfel","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2794014176","eid":"W2794014176"},{"id":"paper-w4200055187","cat":"papers","name":"The Hallucinogenic Serotonin2A Receptor Agonist, 2,5-Dimethoxy-4-Iodoamphetamine, Promotes cAMP Response Element Binding Protein-Dependent Gene Expression of Specific Plasticity-Associated Genes in the Rodent Neocortex","year":"2021","cit":48,"pfa":"Lynette A. Desouza","psa":"Vidita A. Vaidya","topics":["Depression","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4200055187","eid":"W4200055187"},{"id":"paper-w94877239","cat":"papers","name":"Childhood stimulant treatment and risk for later substance abuse.","year":"2003","cit":48,"pfa":"Mariellen Fischer","psa":"Russell A. Barkley","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W94877239","eid":"W94877239"},{"id":"paper-w2159324210","cat":"papers","name":"The Neuropsychology of Cannabis and other Substance use in Schizophrenia: Review of the Literature and Critical Evaluation of Methodological Issues","year":"2007","cit":48,"pfa":"Carissa M. Coulston","psa":"Christopher C Tennant","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2159324210","eid":"W2159324210"},{"id":"paper-w1776912243","cat":"papers","name":"Determination of [ 11 C]Rifampin Pharmacokinetics within Mycobacterium tuberculosis-Infected Mice by Using Dynamic Positron Emission Tomography Bioimaging","year":"2015","cit":48,"pfa":"Vincent P. DeMarco","psa":"Sanjay Kumar Jain","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1776912243","eid":"W1776912243"},{"id":"paper-w4220855401","cat":"papers","name":"Differential contributions of serotonergic and dopaminergic functional connectivity to the phenomenology of LSD","year":"2022","cit":48,"pfa":"Timothy Lawn","psa":"Matthew A. Howard","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4220855401","eid":"W4220855401"},{"id":"paper-w2965715822","cat":"papers","name":"Demographic, socioeconomic, and health correlates of unmet need for mental health treatment in the United States, 2002–16: evidence from the national surveys on drug use and health","year":"2019","cit":48,"pfa":"Justin Yang","psa":"Carol Brayne","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2965715822","eid":"W2965715822"},{"id":"paper-w2411069100","cat":"papers","name":"Elevated urine levels of bufotenine in patients with autistic spectrum disorders and schizophrenia.","year":"2010","cit":48,"pfa":"Enzo Emanuele","psa":"Pierluigi Politi","ptype":"article","src":"https://openalex.org/W2411069100","eid":"W2411069100"},{"id":"paper-w3096972875","cat":"papers","name":"Ketamine activated glutamatergic neurotransmission by GABAergic disinhibition in the medial prefrontal cortex","year":"2020","cit":48,"pfa":"Bing Zhang","psa":"Zhiqiang Liu","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3096972875","eid":"W3096972875"},{"id":"paper-w4214926607","cat":"papers","name":"Cannabidiol and Other Phytocannabinoids as Cancer Therapeutics","year":"2022","cit":48,"pfa":"Gerhard Nahler","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4214926607","eid":"W4214926607"},{"id":"paper-w4388453068","cat":"papers","name":"Pharmacotherapies Targeting GABA-Glutamate Neurotransmission for Treatment-Resistant Depression","year":"2023","cit":48,"pfa":"Courtney M. Vecera","psa":"Rodrigo Machado‐Vieira","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4388453068","eid":"W4388453068"},{"id":"paper-w3134298422","cat":"papers","name":"Efficacy of dextromethorphan for the treatment of depression: a systematic review of preclinical and clinical trials","year":"2021","cit":48,"pfa":"Amna Majeed","psa":"Roger S. McIntyre","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W3134298422","eid":"W3134298422"},{"id":"paper-w2398204531","cat":"papers","name":"Psilocybin, Lysergic Acid Diethylamide, Mescaline, and Drug-Induced Synesthesia","year":"2016","cit":47,"pfa":"Berit “Brit” Brogaard","psa":"Dimitria Electra Gatzia","ptype":"book-chapter","src":"https://openalex.org/W2398204531","eid":"W2398204531"},{"id":"paper-w2340831700","cat":"papers","name":"Bizarre Deformities in Offspring of User of Lysergic Acid Diethylamide","year":"1970","cit":47,"pfa":"Jimmie L. Eller","psa":"J. M. Morton","ptype":"article","src":"https://openalex.org/W2340831700","eid":"W2340831700"},{"id":"paper-w2411998515","cat":"papers","name":"SOME BIOCHEMICAL STUDIES ON PSILOCYBIN AND PSILOCIN","year":"1962","cit":47,"pfa":"A. Horita","ptype":"report","src":"https://openalex.org/W2411998515","eid":"W2411998515"},{"id":"paper-w2020642629","cat":"papers","name":"Identification and estimation of lysergic acid diethylamide by thin-layer chromatography and fluorometry","year":"1966","cit":47,"pfa":"Leo A. Dal Cortivo","psa":"Bernard. Newman","ptype":"article","src":"https://openalex.org/W2020642629","eid":"W2020642629"},{"id":"paper-w4308485018","cat":"papers","name":"Psilocybin modulation of time-varying functional connectivity is associated with plasma psilocin and subjective effects","year":"2022","cit":47,"pfa":"Anders S. Olsen","psa":"Patrick M. Fisher","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4308485018","eid":"W4308485018"},{"id":"paper-w2129808204","cat":"papers","name":"THE APPEAL OF PEYOTE (LOPHOPHORA WILLIAMSII) AS A MEDICINE1","year":"1938","cit":47,"pfa":"Richard Evans Schultes","ptype":"article","src":"https://openalex.org/W2129808204","eid":"W2129808204"},{"id":"paper-w1964253779","cat":"papers","name":"The Problem of Psilocybin Mushroom Abuse","year":"1982","cit":47,"pfa":"Norman R. Peden","psa":"James E. Crooks","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1964253779","eid":"W1964253779"},{"id":"paper-w2142547960","cat":"papers","name":"MDMA as a discriminative stimulus: Isomeric comparisons","year":"1987","cit":47,"pfa":"Martin Schechter","ptype":"article","src":"https://openalex.org/W2142547960","eid":"W2142547960"},{"id":"paper-w2086002951","cat":"papers","name":"Effects of ibogaine on naloxone‐precipitated withdrawal in morphine‐dependent mice","year":"1992","cit":47,"pfa":"Bernard Francès","psa":"J.‐M. Zajac","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2086002951","eid":"W2086002951"},{"id":"paper-w2111738864","cat":"papers","name":"Toward a Structure-Based Model of Salvinorin A Recognition of the κ-Opioid Receptor","year":"2008","cit":47,"pfa":"Brian E. Kane","psa":"David M. Ferguson","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2111738864","eid":"W2111738864"},{"id":"paper-w1996607457","cat":"papers","name":"Studying the Effects of Classic Hallucinogens in the Treatment of Alcoholism: Rationale, Methodology, and Current Research with Psilocybin","year":"2013","cit":47,"pfa":"Michael P. Bogenschutz","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1996607457","eid":"W1996607457"},{"id":"paper-w1979459240","cat":"papers","name":"Chronic exposure to ethanol exacerbates MDMA-induced hyperthermia and exposes liver to severe MDMA-induced toxicity in CD1 mice","year":"2008","cit":47,"pfa":"Helena Pontes","psa":"Maria de Lourdes Bastos","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1979459240","eid":"W1979459240"},{"id":"paper-w2130864701","cat":"papers","name":"Enzymatic–nonenzymatic cellular antioxidant defense systems response and immunohistochemical detection of MDMA, VMAT2, HSP70, and apoptosis as biomarkers for MDMA (Ecstasy) neurotoxicity","year":"2009","cit":47,"pfa":"Irene Riezzo","psa":"Vittorio Fineschi","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2130864701","eid":"W2130864701"},{"id":"paper-w2168293844","cat":"papers","name":"A unique binding epitope for salvinorin A, a non‐nitrogenous kappa opioid receptor agonist","year":"2006","cit":47,"pfa":"Brian E. Kane","psa":"David M. Ferguson","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2168293844","eid":"W2168293844"},{"id":"paper-w2018910518","cat":"papers","name":"Potential drug abuse therapeutics derived from the hallucinogenic natural product salvinorin A","year":"2011","cit":47,"pfa":"Katherine M. Prevatt‐Smith","psa":"Thomas Edward Prisinzano","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2018910518","eid":"W2018910518"},{"id":"paper-w2159633740","cat":"papers","name":"Effects of 3,4‐methylenedioxymethamphetamine (MDMA) on serotonin transporter and vesicular monoamine transporter 2 protein and gene expression in rats: implications for MDMA neurotoxicity","year":"2009","cit":47,"pfa":"Dominik K. Biezonski","psa":"Jerrold S. Meyer","topics":["Safety & adverse events","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2159633740","eid":"W2159633740"},{"id":"paper-w2030104617","cat":"papers","name":"MDMA produces stimulant-like conditioned locomotor activity","year":"1989","cit":47,"pfa":"Lisa H. Gold","psa":"George F. Koob","ptype":"article","src":"https://openalex.org/W2030104617","eid":"W2030104617"},{"id":"paper-w1493562026","cat":"papers","name":"“Dancestasy”: Dance and MDMA Use in Dutch Youth Culture","year":"2002","cit":47,"pfa":"Tom ter Bogt","psa":"Stun Verhagen","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1493562026","eid":"W1493562026"},{"id":"paper-w1995256288","cat":"papers","name":"Abuse of Indigenous Psilocybin Mushrooms: A New Fashion and Some Psychiatric Complications","year":"1978","cit":47,"pfa":"Clive E. Hyde","psa":"Gary Taylor","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1995256288","eid":"W1995256288"},{"id":"paper-w2142007613","cat":"papers","name":"A Critical Evaluation of Reports Associating Ayahuasca with Life-Threatening Adverse Reactions","year":"2013","cit":47,"pfa":"RAFAEL GUIMARÃES DOS SANTOS","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2142007613","eid":"W2142007613"},{"id":"paper-w2557970431","cat":"papers","name":"Ayahuasca Exposure: Descriptive Analysis of Calls to US Poison Control Centers from 2005 to 2015","year":"2016","cit":47,"pfa":"Craig William Heise","psa":"Daniel E. Brooks","ptype":"article","src":"https://openalex.org/W2557970431","eid":"W2557970431"},{"id":"paper-w2043143222","cat":"papers","name":"The Influence of Genetic and Environmental Factors among MDMA Users in Cognitive Performance","year":"2011","cit":47,"pfa":"Elisabet Cuyàs","psa":"Rafael de la Torre","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2043143222","eid":"W2043143222"},{"id":"paper-w2301359231","cat":"papers","name":"Death from hyponatraemia-induced cerebral oedema associated with MDMA (\"Ecstasy\") use.","year":"1999","cit":47,"pfa":"A O'Connor","psa":"Beth J. L. Synek","ptype":"article","src":"https://openalex.org/W2301359231","eid":"W2301359231"},{"id":"paper-w3112700248","cat":"papers","name":"Effects of a single dose of psilocybin on behaviour, brain 5-HT2A receptor occupancy and gene expression in the pig","year":"2020","cit":47,"pfa":"Lene Lundgaard Donovan","psa":"Gitte M. Knudsen","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3112700248","eid":"W3112700248"},{"id":"paper-w1979961774","cat":"papers","name":"A study of impurities in intermediates and 3,4-methylenedioxymethamphetamine (MDMA) samples produced via reductive amination routes","year":"2005","cit":47,"pfa":"Pascal Gimeno","psa":"Huguette Chaudron-Thozet","ptype":"article","src":"https://openalex.org/W1979961774","eid":"W1979961774"},{"id":"paper-w2062163331","cat":"papers","name":"Acute and subchronic effects of MDMA (“ecstasy”) on anxiety in male mice tested in the elevated plus-maze","year":"2002","cit":47,"pfa":"José Francisco Navarro","psa":"E. Maldonado","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2062163331","eid":"W2062163331"},{"id":"paper-w2006629782","cat":"papers","name":"Sub-chronic nandrolone treatment modifies neurochemical and behavioral effects of amphetamine and 3,4-methylenedioxymethamphetamine (MDMA) in rats","year":"2008","cit":47,"pfa":"Sanna Kurling","psa":"Timo Seppαlä","ptype":"article","src":"https://openalex.org/W2006629782","eid":"W2006629782"},{"id":"paper-w2049781678","cat":"papers","name":"Differential effects of 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) on BDNF mRNA expression in rat frontal cortex and hippocampus","year":"2006","cit":47,"pfa":"Rebeca Martínez-Turrillas","psa":"Diana Frechilla","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2049781678","eid":"W2049781678"},{"id":"paper-w4287981303","cat":"papers","name":"Psilocybin reduces low frequency oscillatory power and neuronal phase-locking in the anterior cingulate cortex of awake rodents","year":"2022","cit":47,"pfa":"Caroline T. Golden","psa":"Paul T. Chadderton","topics":["Depression","PTSD & trauma","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4287981303","eid":"W4287981303"},{"id":"paper-w2055627955","cat":"papers","name":"The role of 5-HT in the impairment of thermoregulation observed in rats administered MDMA (‘ecstasy’) when housed at high ambient temperature","year":"2005","cit":47,"pfa":"Kathryn S. Saadat","psa":"A. Richard Green","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2055627955","eid":"W2055627955"},{"id":"paper-w1556899430","cat":"papers","name":"PRECLINICAL STUDY: Changes in leptin, ghrelin, growth hormone and neuropeptide‐Y after an acute model of MDMA and methamphetamine exposure in rats","year":"2007","cit":47,"pfa":"Firas Kobeissy","psa":"Mark S. Gold","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1556899430","eid":"W1556899430"},{"id":"paper-w1969475346","cat":"papers","name":"Critical Role of Peripheral Vasoconstriction in Fatal Brain Hyperthermia Induced by MDMA (Ecstasy) under Conditions That Mimic Human Drug Use","year":"2014","cit":47,"pfa":"Eugene A. Kiyatkin","psa":"Yavin Shaham","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1969475346","eid":"W1969475346"},{"id":"paper-w2050585684","cat":"papers","name":"Quantitative mapping shows that serotonin rather than dopamine receptor mRNA expressions are affected after repeated intermittent administration of MDMA in rat brain","year":"2006","cit":47,"pfa":"Anna M. S. Kindlundh-Högberg","psa":"H. B. Schiöth","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2050585684","eid":"W2050585684"},{"id":"paper-w4214897436","cat":"papers","name":"Effects of the 5-HT2A receptor antagonist volinanserin on head-twitch response and intracranial self-stimulation depression induced by different structural classes of psychedelics in rodents","year":"2022","cit":47,"pfa":"Alaina M. Jaster","psa":"Javier González‐Maeso","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4214897436","eid":"W4214897436"},{"id":"paper-w2367699339","cat":"papers","name":"On the Origin of the Genus Psilocybe and Its Potential Ritual Use in Ancient Africa and Europe1","year":"2016","cit":47,"pfa":"Tom Froese","psa":"Laura Guzmán‐Dávalos","ptype":"article","src":"https://openalex.org/W2367699339","eid":"W2367699339"},{"id":"paper-w2015032945","cat":"papers","name":"Psychopathology and Psychophysiology of Minimal LSD-25 Dosage","year":"1958","cit":47,"pfa":"THEODORE H. GREINER","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2015032945","eid":"W2015032945"},{"id":"paper-w2333108901","cat":"papers","name":"A placebo-controlled investigation of synaesthesia-like experiences under LSD","year":"2016","cit":47,"pfa":"Devin Blair Terhune","psa":"Jamie Ward","ptype":"article","src":"https://openalex.org/W2333108901","eid":"W2333108901"},{"id":"paper-w2003204916","cat":"papers","name":"Determination of LSD in blood by capillary electrophoresis with laser-induced fluorescence detection","year":"1997","cit":47,"pfa":"M Frost","psa":"Gottfried Blaschke","ptype":"article","src":"https://openalex.org/W2003204916","eid":"W2003204916"},{"id":"paper-w4387737676","cat":"papers","name":"A Systematic Review of Reporting Practices in Psychedelic Clinical Trials: Psychological Support, Therapy, and Psychosocial Interventions","year":"2023","cit":47,"pfa":"Bill Brennan","psa":"Alexander Belser","topics":["Safety & adverse events","Reviews & meta-analyses","Therapy practice"],"ptype":"review","src":"https://openalex.org/W4387737676","eid":"W4387737676"},{"id":"paper-w4221070625","cat":"papers","name":"Counselors’ attitudes toward psychedelics and their use in therapy","year":"2022","cit":47,"pfa":"Benjamin Hearn","psa":"George Burr Richardson","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4221070625","eid":"W4221070625"},{"id":"paper-w2117029937","cat":"papers","name":"Behavioral, thermal and neurochemical effects of acute and chronic 3,4-methylenedioxymethamphetamine (“Ecstasy”) self-administration","year":"2009","cit":47,"pfa":"Maria Elena Reveron","psa":"Christine L. Duvauchelle","ptype":"article","src":"https://openalex.org/W2117029937","eid":"W2117029937"},{"id":"paper-w1978569191","cat":"papers","name":"Serotonergic hallucinogens differentially modify gamma and high frequency oscillations in the rat nucleus accumbens","year":"2013","cit":47,"pfa":"Sailaja A. Goda","psa":"Mark Jeremy Hunt","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1978569191","eid":"W1978569191"},{"id":"paper-w2164680276","cat":"papers","name":"Liquid Chromatography-Tandem Mass Spectrometry Method for the Simultaneous Analysis of Multiple Hallucinogens, Chlorpheniramine, Ketamine, Ritalinic Acid, and Metabolites, in Urine","year":"2007","cit":47,"pfa":"María del Mar Ramírez Fernández","psa":"Nele Samyn","ptype":"article","src":"https://openalex.org/W2164680276","eid":"W2164680276"},{"id":"paper-w1973633427","cat":"papers","name":"Acute and sensitized response to 3,4‐methylenedioxymethamphetamine in rats: different behavioral profiles reflected in different patterns of Fos expression","year":"2008","cit":47,"pfa":"Joyce Colussi‐Mas","psa":"Susan Schenk","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1973633427","eid":"W1973633427"},{"id":"paper-w2050119023","cat":"papers","name":"CB1Cannabinoid Receptor Modulates 3,4-Methylenedioxymethamphetamine Acute Responses and Reinforcement","year":"2007","cit":47,"pfa":"Clara Touriño","psa":"Olga Valverde","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2050119023","eid":"W2050119023"},{"id":"paper-w4308570400","cat":"papers","name":"Ayahuasca's therapeutic potential: What we know – and what not","year":"2022","cit":47,"pfa":"Lucas Oliveira Maia","psa":"Luís Fernando Tófoli","ptype":"article","src":"https://openalex.org/W4308570400","eid":"W4308570400"},{"id":"paper-w2012950802","cat":"papers","name":"Ecstasy‐induced toxicity in rat liver","year":"2000","cit":47,"pfa":"Guadalupe Beitia","psa":"Edurne Cenarruzabeitia","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2012950802","eid":"W2012950802"},{"id":"paper-w2111190722","cat":"papers","name":"The profile of mephedrone on human monoamine transporters differs from 3,4-methylenedioxymethamphetamine primarily by lower potency at the vesicular monoamine transporter","year":"2015","cit":47,"pfa":"Christian Pifl","psa":"Oleh Hornykiewicz","ptype":"article","src":"https://openalex.org/W2111190722","eid":"W2111190722"},{"id":"paper-w1983947475","cat":"papers","name":"Acute methylenedioxymethamphetamine administration: effects on local cerebral blood flow and glucose utilisation in the dark agouti rat","year":"2004","cit":47,"pfa":"Linda Quate","psa":"Paul A. Kelly","ptype":"article","src":"https://openalex.org/W1983947475","eid":"W1983947475"},{"id":"paper-w2109738518","cat":"papers","name":"Distribution Study of 3,4-Methylenedioxymethamphetamine and 3,4-Methylenedioxyamphetamine in a Fatal Overdose","year":"2002","cit":47,"pfa":"Els A. De Letter","psa":"Michel H A Piette","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2109738518","eid":"W2109738518"},{"id":"paper-w1630233733","cat":"papers","name":"Short‐ and long‐term effects of (+)‐methamphetamine and (±)‐3,4‐methylenedioxymethamphetamine on monoamine and corticosterone levels in the neonatal rat following multiple days of treatment","year":"2007","cit":47,"pfa":"Tori L. Schaefer","psa":"Michael T. Williams","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W1630233733","eid":"W1630233733"},{"id":"paper-w2978988552","cat":"papers","name":"Ayahuasca’s Antidepressant Effects Covary with Behavioral Activation as Well as Mindfulness","year":"2019","cit":47,"pfa":"Maha N. Mian","psa":"Mitch Earleywine","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2978988552","eid":"W2978988552"},{"id":"paper-w1984696579","cat":"papers","name":"Determination of tryptamine derivatives in hallucinogenic mushrooms using high-performance liquid chromatography with photodiode array detection","year":"1987","cit":47,"pfa":"Stefan Borner","psa":"Rudolf Brenneisen","ptype":"article","src":"https://openalex.org/W1984696579","eid":"W1984696579"},{"id":"paper-w4238484479","cat":"papers","name":"Amphetamine Toxicity","year":"2002","cit":47,"pfa":"Suzanne R. White","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4238484479","eid":"W4238484479"},{"id":"paper-w2061908982","cat":"papers","name":"Phosphodiesterase 5 inhibitors prevent 3,4‐methylenedioxymethamphetamine‐induced 5‐HT deficits in the rat","year":"2008","cit":47,"pfa":"Elena Puerta","psa":"Norberto Aguirre","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2061908982","eid":"W2061908982"},{"id":"paper-w2111797563","cat":"papers","name":"A Fatal Trip with Ecstasy: A Case of 3,4-Methylene-Dioxymethamphetamine/ 3,4-Methylenedioxy-Amphetamine Toxicity","year":"1996","cit":47,"pfa":"Julie Coore","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2111797563","eid":"W2111797563"},{"id":"paper-w2114523420","cat":"papers","name":"Rapid Simultaneous Determination of Amphetamine, Methamphetamine, 3,4-Methylenedioxyamphetamine, 3,4-Methylenedioxymethamphetamine, and 3,4-Methylenedioxyethylamphetamine in Urine by Fast Gas chromatography-mass Spectrom","year":"2005","cit":47,"pfa":"Kevin L. Klette","psa":"J. J. Snyder","ptype":"article","src":"https://openalex.org/W2114523420","eid":"W2114523420"},{"id":"paper-w2002188432","cat":"papers","name":"Five-year trends in self-reported recreational drugs associated with presentation to a UK emergency department with suspected drug-related toxicity","year":"2012","cit":47,"pfa":"David Michael Wood","psa":"Paul Ivor Dargan","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2002188432","eid":"W2002188432"},{"id":"paper-w1966807589","cat":"papers","name":"Serotonin Receptors Expressed in Drosophila Mushroom Bodies Differentially Modulate Larval Locomotion","year":"2014","cit":47,"pfa":"Bryon Silva","psa":"Jorge M. Campusano","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1966807589","eid":"W1966807589"},{"id":"paper-w2792120884","cat":"papers","name":"Neuroendocrine Associations Underlying the Persistent Therapeutic Effects of Classic Serotonergic Psychedelics","year":"2018","cit":47,"pfa":"Emmanuelle A. D. Schindler","psa":"Deepak Cyril D’Souza","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2792120884","eid":"W2792120884"},{"id":"paper-w4250575659","cat":"papers","name":"Hallucinogens: a forensic drug handbook","year":"2003","cit":47,"ptype":"book-review","src":"https://openalex.org/W4250575659","eid":"W4250575659"},{"id":"paper-w2095297313","cat":"papers","name":"Structure-Activity Relationships of Phenethylamine Hallucinogens","year":"1981","cit":47,"pfa":"David E. Nichols","ptype":"article","src":"https://openalex.org/W2095297313","eid":"W2095297313"},{"id":"paper-w1995041454","cat":"papers","name":"Hallucinogen actions on human brain revealed","year":"2012","cit":47,"pfa":"Hyeong-Min Lee","psa":"Bryan L. Roth","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1995041454","eid":"W1995041454"},{"id":"paper-w1988550393","cat":"papers","name":"Neuropsychedelia: The revival of Hallucinogen research since the decade of the brain","year":"2013","cit":47,"pfa":"Natasha Dow Schüll","ptype":"article","src":"https://openalex.org/W1988550393","eid":"W1988550393"},{"id":"paper-w2996270584","cat":"papers","name":"Psychedelics and potential benefits in “healthy normals”: A review of the literature","year":"2019","cit":47,"pfa":"Sam Gandy","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2996270584","eid":"W2996270584"},{"id":"paper-w1993536435","cat":"papers","name":"Sixties Rock: Garage, Psychedelic, and Other Satisfactions","year":"1999","cit":47,"pfa":"Harris M. Berger","psa":"Michael Hicks","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1993536435","eid":"W1993536435"},{"id":"paper-w2895822196","cat":"papers","name":"Acute behavioral effects of deliriant hallucinogens atropine and scopolamine in adult zebrafish","year":"2018","cit":47,"pfa":"Andrey D. Volgin","psa":"Allan V. Kalueff","ptype":"article","src":"https://openalex.org/W2895822196","eid":"W2895822196"},{"id":"paper-w4366220780","cat":"papers","name":"Mini-review: The neurobiology of treating substance use disorders with classical psychedelics","year":"2023","cit":47,"pfa":"Marvin M. Urban","psa":"Marcus W. Meinhardt","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4366220780","eid":"W4366220780"},{"id":"paper-w3207723116","cat":"papers","name":"Bridging the Gap? Altered Thalamocortical Connectivity in Psychotic and Psychedelic States","year":"2021","cit":47,"pfa":"Mihai Avram","psa":"Stefan Borgwardt","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3207723116","eid":"W3207723116"},{"id":"paper-w4389684661","cat":"papers","name":"The central role of the Thalamus in psychosis, lessons from neurodegenerative diseases and psychedelics","year":"2023","cit":47,"pfa":"MARCO C. ONOFRJ","psa":"Stefano Luca Sensi","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4389684661","eid":"W4389684661"},{"id":"paper-w3005687344","cat":"papers","name":"Case report: Successful induction of buprenorphine/naloxone using a microdosing schedule and assertive outreach","year":"2020","cit":47,"pfa":"Jennifer Rozylo","psa":"Pouya Azar","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3005687344","eid":"W3005687344"},{"id":"paper-w2122148359","cat":"papers","name":"Induction of the plasticity-associated immediate early gene Arc by stress and hallucinogens: role of brain-derived neurotrophic factor","year":"2012","cit":47,"pfa":"Madhurima Benekareddy","psa":"Vidita A. Vaidya","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2122148359","eid":"W2122148359"},{"id":"paper-w2404009231","cat":"papers","name":"The psychotomimetic effects of opiates and the sigma receptor.","year":"1990","cit":47,"pfa":"José M. Musacchio","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2404009231","eid":"W2404009231"},{"id":"paper-w2129429509","cat":"papers","name":"Inhibition of glycogen synthase kinase-3 attenuates psychotomimetic effects of ketamine","year":"2012","cit":47,"pfa":"Ming‐Huan Chan","psa":"Hwei‐Hsien Chen","ptype":"article","src":"https://openalex.org/W2129429509","eid":"W2129429509"},{"id":"paper-w4239110771","cat":"papers","name":"Neuropsychedelia","year":"2012","cit":47,"pfa":"Nicolas Langlitz","topics":["Dosing & pharmacology"],"ptype":"book","src":"https://openalex.org/W4239110771","eid":"W4239110771"},{"id":"paper-w2164927851","cat":"papers","name":"Affinity for risky behaviors following prenatal and early childhood exposure to tetrachloroethylene (PCE)-contaminated drinking water: a retrospective cohort study","year":"2011","cit":47,"pfa":"Ann Aschengrau","psa":"David M. Ozonoff","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2164927851","eid":"W2164927851"},{"id":"paper-w2023978247","cat":"papers","name":"Studies of the interaction of the fluorophores harmine and harmaline with calf thymus DNA","year":"1975","cit":47,"pfa":"Guy Duportail","psa":"Hans Lami","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2023978247","eid":"W2023978247"},{"id":"paper-w1994059964","cat":"papers","name":"The Drug Dependence Syndrome and Related Disabilities","year":"1988","cit":47,"pfa":"Deborah S. Hasin","psa":"Jean Endicott","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1994059964","eid":"W1994059964"},{"id":"paper-w2165263537","cat":"papers","name":"Substance Use, Abuse and Dependence in Germany","year":"1998","cit":47,"pfa":"Axel Perkonigg","psa":"Hans‐Ulrich Wïttchen","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2165263537","eid":"W2165263537"},{"id":"paper-w2917330809","cat":"papers","name":"Serotonin and Glutamate Interactions in Preclinical Schizophrenia Models","year":"2019","cit":47,"pfa":"Urjita H. Shah","psa":"Javier González‐Maeso","topics":["Mechanism & neuroscience","Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2917330809","eid":"W2917330809"},{"id":"paper-w2325782912","cat":"papers","name":"Illicit drug use in cluster headache patients and in the general population: A comparative cross-sectional survey","year":"2012","cit":47,"pfa":"Paolo Dionigi Rossi","psa":"Giuseppe Nappi","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2325782912","eid":"W2325782912"},{"id":"paper-w1963519950","cat":"papers","name":"Usefulness of an animal behavioral model in studying the duration of action of LSD and the onset and duration of tolerance to LSD in the cat","year":"1977","cit":47,"pfa":"Michael E. Trulson","psa":"Barry L. Jacobs","ptype":"article","src":"https://openalex.org/W1963519950","eid":"W1963519950"},{"id":"paper-w2162448402","cat":"papers","name":"Acute neurotoxicity after yohimbine ingestion by a body builder","year":"2009","cit":47,"pfa":"Andrea Giampreti","psa":"Maria Teresa Campailla","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2162448402","eid":"W2162448402"},{"id":"paper-w2019191372","cat":"papers","name":"Pentobarbital Inhibits Ketamine-Induced Dopamine Release in the Rat Nucleus Accumbens: A Microdialysis Study","year":"2003","cit":47,"pfa":"Munehiro Masuzawa","psa":"Koh Shingu","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2019191372","eid":"W2019191372"},{"id":"paper-w583774625","cat":"papers","name":"Models of mental disorders : a new comparative psychiatry","year":"1988","cit":47,"pfa":"William T. McKinney","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"book","src":"https://openalex.org/W583774625","eid":"W583774625"},{"id":"paper-w2037595197","cat":"papers","name":"NMDA antagonists under investigation for the treatment of major depressive disorder","year":"2014","cit":47,"pfa":"Bartłomiej Pochwat","psa":"Gabriel Nowak","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2037595197","eid":"W2037595197"},{"id":"paper-w1993659014","cat":"papers","name":"Bremazocine: A κ‐Opioid Agonist with Potent Analgesic and Other Pharmacologic Properties","year":"2005","cit":47,"pfa":"Juanita Dortch‐Carnes","psa":"David E. Potter","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1993659014","eid":"W1993659014"},{"id":"paper-w4283750731","cat":"papers","name":"The CannTeen Study: Cannabis use disorder, depression, anxiety, and psychotic-like symptoms in adolescent and adult cannabis users and age-matched controls","year":"2022","cit":47,"pfa":"Will Lawn","psa":"Helen Valerie Curran","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4283750731","eid":"W4283750731"},{"id":"paper-w3008566999","cat":"papers","name":"Approval of esketamine for treatment-resistant depression","year":"2020","cit":47,"pfa":"Jaskaran B. Singh","psa":"Wayne Curtis Drevets","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W3008566999","eid":"W3008566999"},{"id":"paper-w4283692276","cat":"papers","name":"Target deconvolution studies of (2R,6R)-hydroxynorketamine: an elusive search","year":"2022","cit":47,"pfa":"Jordi Bonaventura","psa":"Michael Michaelides","ptype":"article","src":"https://openalex.org/W4283692276","eid":"W4283692276"},{"id":"paper-w4405031952","cat":"papers","name":"Variations in BDNF and Their Role in the Neurotrophic Antidepressant Mechanisms of Ketamine and Esketamine: A Review","year":"2024","cit":47,"pfa":"Simone Pardossi","psa":"Alessandro Cuomo","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4405031952","eid":"W4405031952"},{"id":"paper-w4389274581","cat":"papers","name":"Esketamine accelerates emergence from isoflurane general anaesthesia by activating the paraventricular thalamus glutamatergic neurones in mice","year":"2023","cit":47,"pfa":"Wenying Duan","psa":"Qingxiu Wang","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4389274581","eid":"W4389274581"},{"id":"paper-w3197828046","cat":"papers","name":"Effects of Esketamine on Acute and Chronic Pain After Thoracoscopy Pulmonary Surgery Under General Anesthesia: A Multicenter-Prospective, Randomized, Double-Blind, and Controlled Trial","year":"2021","cit":47,"pfa":"Yishan Lei","psa":"Fuhai Ji","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3197828046","eid":"W3197828046"},{"id":"paper-w3168086953","cat":"papers","name":"Intranasal Ketamine for Depression in Adults: A Systematic Review and Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled Trials","year":"2021","cit":47,"pfa":"Dongjiao An","psa":"Anshi Wu","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W3168086953","eid":"W3168086953"},{"id":"paper-w4309662022","cat":"papers","name":"Effect of lysergic acid diethylamide (LSD) on reinforcement learning in humans","year":"2022","cit":46,"pfa":"Jonathan W. Kanen","psa":"Hanneke E.M. den Ouden","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4309662022","eid":"W4309662022"},{"id":"paper-w2329465698","cat":"papers","name":"A Review of Lysergic Acid Diethylamide (LSD) in the Treatment of Addictions: Historical Perspectives and Future Prospects","year":"2015","cit":46,"pfa":"Mitchell B. Liester","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2329465698","eid":"W2329465698"},{"id":"paper-w2008614732","cat":"papers","name":"Distribution and fate of14C-labeled lysergic acid diethylamide (LSD 25) in the animal body","year":"1955","cit":46,"pfa":"A. Stoll","psa":"Wolfgang Schalch","ptype":"article","src":"https://openalex.org/W2008614732","eid":"W2008614732"},{"id":"paper-w2074108488","cat":"papers","name":"Lysergic Acid Diethylamide (LSD-25): III. As an Adjunct to Psychotherapy with Elimination of Fear of Homosexuality","year":"1955","cit":46,"pfa":"Harold A. Abramson","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2074108488","eid":"W2074108488"},{"id":"paper-w3014341075","cat":"papers","name":"Exposure‐Response Analysis to Assess the Concentration‐QTc Relationship of Psilocybin/Psilocin","year":"2020","cit":46,"pfa":"Elyes Dahmane","psa":"Jogarao V. S. Gobburu","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3014341075","eid":"W3014341075"},{"id":"paper-w4281793365","cat":"papers","name":"Adverse experiences resulting in emergency medical treatment seeking following the use of lysergic acid diethylamide (LSD)","year":"2022","cit":46,"pfa":"Emma I Kopra","psa":"ADAM R. WINSTOCK","topics":["Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4281793365","eid":"W4281793365"},{"id":"paper-w2324611257","cat":"papers","name":"Enterohepatic recycling of phenolphthalein, morphine, lysergic acid diethylamide (LSD) and diphenylacetic acid in the rat Hydrolysis of glucuronic acid conjugates in the gut lumen","year":"1980","cit":46,"pfa":"Robert Parker","psa":"Peter Millburn","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2324611257","eid":"W2324611257"},{"id":"paper-w2000261029","cat":"papers","name":"The Peyote Religion among the Navaho","year":"1993","cit":46,"pfa":"Will Roscoe","psa":"David F. Aberle","ptype":"article","src":"https://openalex.org/W2000261029","eid":"W2000261029"},{"id":"paper-w2045557633","cat":"papers","name":"Psychotomimetic agents related to mescaline","year":"1963","cit":46,"pfa":"Alexander T. Shulgin","ptype":"article","src":"https://openalex.org/W2045557633","eid":"W2045557633"},{"id":"paper-w2109392617","cat":"papers","name":"Modification of the effects of 5-methoxy-N,N-dimethyltryptamine on exploratory behavior in rats by monoamine oxidase inhibitors","year":"2008","cit":46,"pfa":"Adam L. Halberstadt","psa":"Mark A. Geyer","ptype":"article","src":"https://openalex.org/W2109392617","eid":"W2109392617"},{"id":"paper-w3154361912","cat":"papers","name":"Effects of Ayahuasca on the Recognition of Facial Expressions of Emotions in Naive Healthy Volunteers","year":"2021","cit":46,"pfa":"Juliana Mendes Rocha","psa":"RAFAEL GUIMARÃES DOS SANTOS","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3154361912","eid":"W3154361912"},{"id":"paper-w3039787540","cat":"papers","name":"The pharmacological interaction of compounds in ayahuasca: a systematic review","year":"2020","cit":46,"pfa":"Simon Ruffell","psa":"Mário F. Juruena","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W3039787540","eid":"W3039787540"},{"id":"paper-w2118867827","cat":"papers","name":"Biosynthesis of salvinorin A proceeds via the deoxyxylulose phosphate pathway","year":"2007","cit":46,"pfa":"Lukasz M. Kutrzeba","psa":"Jordan Kordian Zjawiony","ptype":"article","src":"https://openalex.org/W2118867827","eid":"W2118867827"},{"id":"paper-w878533373","cat":"papers","name":"Neurovascular and neuroimaging effects of the hallucinogenic serotonin receptor agonist psilocin in the rat brain","year":"2015","cit":46,"pfa":"Aisling Spain","psa":"Chris J. Martin","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W878533373","eid":"W878533373"},{"id":"paper-w1624667867","cat":"papers","name":"3,4-Methylenedioxymethamphetamine (MDMA) and Other Amphetamine Derivatives","year":"1988","cit":46,"pfa":"Robert O. Bost","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1624667867","eid":"W1624667867"},{"id":"paper-w2995890924","cat":"papers","name":"MDMA-related deaths in Australia 2000 to 2018","year":"2019","cit":46,"pfa":"Amanda Roxburgh","psa":"Julia Lappin","ptype":"article","src":"https://openalex.org/W2995890924","eid":"W2995890924"},{"id":"paper-w2038293302","cat":"papers","name":"Multiple molecular and neuropharmacological effects of MDMA (Ecstasy)","year":"2003","cit":46,"pfa":"Rabi Simantov","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2038293302","eid":"W2038293302"},{"id":"paper-w2588285636","cat":"papers","name":"A (–)-kolavenyl diphosphate synthase catalyzes the first step of salvinorin A biosynthesis in Salvia divinorum","year":"2017","cit":46,"pfa":"Xiaoyue Chen","psa":"David Roger Gang","ptype":"article","src":"https://openalex.org/W2588285636","eid":"W2588285636"},{"id":"paper-w1969046478","cat":"papers","name":"Proton magnetic resonance spectroscopy in ecstasy (MDMA) users","year":"2004","cit":46,"pfa":"Jörg Daumann","psa":"Euphrosyne Gouzoulis‐Mayfrank","ptype":"article","src":"https://openalex.org/W1969046478","eid":"W1969046478"},{"id":"paper-w2900791190","cat":"papers","name":"Acute effects of ayahuasca in a juvenile non-human primate model of depression","year":"2018","cit":46,"pfa":"Flávia S. da Silva","psa":"Nicole Leite Galvão Coelho","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2900791190","eid":"W2900791190"},{"id":"paper-w2165253899","cat":"papers","name":"Working with “ L a M edicina”: Elements of Healing in Contemporary Ayahuasca Rituals","year":"2012","cit":46,"pfa":"Evgenia Fotiou","ptype":"article","src":"https://openalex.org/W2165253899","eid":"W2165253899"},{"id":"paper-w2061996774","cat":"papers","name":"Partial lesion of the serotonergic system by a single dose of MDMA results in behavioural disinhibition and enhances acute MDMA-induced social behaviour on the social interaction test","year":"2006","cit":46,"pfa":"Rómeó D. Andó","psa":"György Bagdy","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2061996774","eid":"W2061996774"},{"id":"paper-w2152723462","cat":"papers","name":"Switch to mania after ayahuasca consumption in a man with bipolar disorder: a case report","year":"2015","cit":46,"pfa":"Alejandro Szmulewicz","psa":"José M. Smith","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2152723462","eid":"W2152723462"},{"id":"paper-w2510845042","cat":"papers","name":"Urinary and plasma oxytocin changes in response to MDMA or intranasal oxytocin administration","year":"2016","cit":46,"pfa":"Sunday M. Francis","psa":"Suma Jacob","ptype":"article","src":"https://openalex.org/W2510845042","eid":"W2510845042"},{"id":"paper-w2341333628","cat":"papers","name":"Ibogan, Aspidosperman, Vincamine, and Bisindole Alkaloids from a Malayan Tabernaemontana corymbosa: Iboga Alkaloids with C-20α Substitution","year":"2016","cit":46,"pfa":"Choy‐Eng Nge","psa":"Toh‐Seok Kam","ptype":"article","src":"https://openalex.org/W2341333628","eid":"W2341333628"},{"id":"paper-w2080507858","cat":"papers","name":"Isolation of Psilocybin From Psilocybe argentipes and Its Determination in Specimens of Some Mushrooms","year":"1981","cit":46,"pfa":"Yutaka Koike","psa":"Kazumasa Yokoyama","ptype":"article","src":"https://openalex.org/W2080507858","eid":"W2080507858"},{"id":"paper-w1925106232","cat":"papers","name":"Comparative Effects of Substituted Amphetamines (PMA, MDMA, and METH) on Monoamines in Rat Caudate","year":"2002","cit":46,"pfa":"B. Gough","psa":"Syed F. Ali","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1925106232","eid":"W1925106232"},{"id":"paper-w1554876839","cat":"papers","name":"Relevance of MDMA (\"ecstasy\")-induced neurotoxicity to long-lasting psychomotor stimulation in mice","year":"2003","cit":46,"pfa":"Yossef Itzhak","psa":"Karen L. Anderson","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1554876839","eid":"W1554876839"},{"id":"paper-w2093986323","cat":"papers","name":"Anti-addiction drug ibogaine inhibits voltage-gated ionic currents: A study to assess the drug's cardiac ion channel profile","year":"2013","cit":46,"pfa":"Xaver Koenig","psa":"Walter Sandtner","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2093986323","eid":"W2093986323"},{"id":"paper-w2427521123","cat":"papers","name":"Studies of MDMA-Induced Neurotoxicity in Nonhuman Primates: A Basis for Evaluating Long-Term Effects in Humans","year":"1989","cit":46,"pfa":"G.A. Ricaurte","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dataset","src":"https://openalex.org/W2427521123","eid":"W2427521123"},{"id":"paper-w2050061485","cat":"papers","name":"Involvement of D1 dopamine receptor in MDMA-induced locomotor activity and striatal gene expression in mice","year":"2008","cit":46,"pfa":"Nadia Benturquia","psa":"Cynthia Marie‐Claire","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2050061485","eid":"W2050061485"},{"id":"paper-w2031615001","cat":"papers","name":"High ambient temperature increases 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”)-induced Fos expression in a region-specific manner","year":"2007","cit":46,"pfa":"Garth A. Hargreaves","psa":"Iain S. McGregor","ptype":"article","src":"https://openalex.org/W2031615001","eid":"W2031615001"},{"id":"paper-w4396568315","cat":"papers","name":"N, N-Dimethyltryptamine, a natural hallucinogen, ameliorates Alzheimer’s disease by restoring neuronal Sigma-1 receptor-mediated endoplasmic reticulum-mitochondria crosstalk","year":"2024","cit":46,"pfa":"Dan Cheng","psa":"Zhang-Jin Zhang","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4396568315","eid":"W4396568315"},{"id":"paper-w4315649535","cat":"papers","name":"The Bright Side of Psychedelics: Latest Advances and Challenges in Neuropharmacology","year":"2023","cit":46,"pfa":"Andrea Mastinu","psa":"Maurizio Memo","topics":["Depression","PTSD & trauma","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4315649535","eid":"W4315649535"},{"id":"paper-w2000930207","cat":"papers","name":"MDMA (‘Ecstasy’) and methamphetamine combined: Order of administration influences hyperthermic and long-term adverse effects in female rats","year":"2005","cit":46,"pfa":"Kelly J. Clemens","psa":"Iain S. McGregor","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2000930207","eid":"W2000930207"},{"id":"paper-w2016102436","cat":"papers","name":"Hair MDMA Samples Are Consistent with Reported Ecstasy Use: Findings from a Study Investigating Effects of Ecstasy on Mood and Memory","year":"2010","cit":46,"pfa":"Andrew B Scholey","psa":"Andrew C. Parrott","ptype":"article","src":"https://openalex.org/W2016102436","eid":"W2016102436"},{"id":"paper-w2061175699","cat":"papers","name":"Microglial and astroglial activation by 3,4‐methylenedioxymethamphetamine ( MDMA ) in mice depends on S(+) enantiomer and is associated with an increase in body temperature and motility","year":"2012","cit":46,"pfa":"Lucia Frau","psa":"Micaela Morelli","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2061175699","eid":"W2061175699"},{"id":"paper-w2096122189","cat":"papers","name":"Enantiomeric Separation and Quantitation of ( )-Amphetamine, ( )-Methamphetamine, ( )-MDA, ( )-MDMA, and ( )-MDEA in Urine Specimens by GC-EI-MS after Derivatization with (R)-(-)- or (S)-(+)- -Methoxy- -(trifluoromethy)p","year":"2004","cit":46,"pfa":"B. D. Paul","psa":"DA Searles","ptype":"article","src":"https://openalex.org/W2096122189","eid":"W2096122189"},{"id":"paper-w2071508479","cat":"papers","name":"Characterisation of Human 5‐Hydroxytryptamine2A and 5‐Hydroxytryptamine2C Receptors Expressed in the Human Neuroblastoma Cell Line SH‐SY5Y: Comparative Stimulation by Hallucinogenic Drugs","year":"1996","cit":46,"pfa":"Rebecca A Newton","psa":"J. Martin Elliott","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2071508479","eid":"W2071508479"},{"id":"paper-w2312282932","cat":"papers","name":"Liquid Chromatographic Analysis of LSD","year":"1973","cit":46,"pfa":"John D. Wittwer","psa":"J. H. Kluckhohn","ptype":"article","src":"https://openalex.org/W2312282932","eid":"W2312282932"},{"id":"paper-w4389392873","cat":"papers","name":"Group psychedelic therapy: empirical estimates of cost-savings and improved access","year":"2023","cit":46,"pfa":"Elliot A. Marseille","psa":"James G. Kahn","topics":["Depression","PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4389392873","eid":"W4389392873"},{"id":"paper-w2042469037","cat":"papers","name":"LSD Produces Conditioned Place Preference in Male But Not Female Fawn Hooded Rats","year":"1998","cit":46,"pfa":"Shane A. Meehan","ptype":"article","src":"https://openalex.org/W2042469037","eid":"W2042469037"},{"id":"paper-w2037248020","cat":"papers","name":"LSD has high efficacy relative to serotonin in enhancing the cationic current Ih: Intracellular studies in rat facial motoneurons","year":"1993","cit":46,"pfa":"Jennifer C. Garratt","psa":"George K. Aghajanian","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2037248020","eid":"W2037248020"},{"id":"paper-w1972491768","cat":"papers","name":"The relationship between core body temperature and 3,4-methylenedioxymethamphetamine metabolism in rats: implications for neurotoxicity","year":"2007","cit":46,"pfa":"Beatriz Goñi‐Allo","psa":"Norberto Aguirre","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1972491768","eid":"W1972491768"},{"id":"paper-w4210962567","cat":"papers","name":"LSD, afterglow and hangover: Increased episodic memory and verbal fluency, decreased cognitive flexibility","year":"2022","cit":46,"pfa":"Isabel Wießner","psa":"Luís Fernando Tófoli","ptype":"article","src":"https://openalex.org/W4210962567","eid":"W4210962567"},{"id":"paper-w1982104252","cat":"papers","name":"Ethanol, 3,4-Methylenedioxymethamphetamine (Ecstasy) and Their Combination: Long-Term Behavioral, Neurochemical and Neuropharmacological Effects in the Rat","year":"2005","cit":46,"pfa":"Jean‐Christophe Cassel","psa":"Rolf Jackisch","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1982104252","eid":"W1982104252"},{"id":"paper-w4285087910","cat":"papers","name":"Effects of 3,4-Methylenedioxymethamphetamine on Conditioned Fear Extinction and Retention in a Crossover Study in Healthy Subjects","year":"2022","cit":46,"pfa":"Patrick Vizeli","psa":"Matthias E. Liechti","topics":["PTSD & trauma","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4285087910","eid":"W4285087910"},{"id":"paper-w2061320396","cat":"papers","name":"Pimavanserin for the treatment of Parkinson's disease psychosis","year":"2013","cit":46,"pfa":"Joseph H. Friedman","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2061320396","eid":"W2061320396"},{"id":"paper-w2093210784","cat":"papers","name":"Dopamine D4 receptor involvement in the discriminative stimulus effects in rats of LSD, but not the phenethylamine hallucinogen DOI","year":"2008","cit":46,"pfa":"Danuta Marona‐Lewicka","psa":"David E. Nichols","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2093210784","eid":"W2093210784"},{"id":"paper-w2078031000","cat":"papers","name":"In Vitro Reactivation of Rat Cortical Tryptophan Hydroxylase Following In Vivo Inactivation by Methylenedioxymethamphetamine","year":"1989","cit":46,"pfa":"Donna M. Stone","psa":"James W. Gibb","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2078031000","eid":"W2078031000"},{"id":"paper-w2026288932","cat":"papers","name":"Hallucinogenic agents as discriminative stimuli: A correlation with serotonin receptor affinities","year":"1980","cit":46,"pfa":"Richard A. Glennon","psa":"Mary Jeanne Kallman","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2026288932","eid":"W2026288932"},{"id":"paper-w4255544620","cat":"papers","name":"Liver transplantation for the treatment of fulminant hepatic failure induced by the ingestion of ecstasy","year":"1997","cit":46,"pfa":"Robert Brauer","psa":"U. Schweigart","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4255544620","eid":"W4255544620"},{"id":"paper-w2950598133","cat":"papers","name":"Benzofuran bioisosteres of hallucinogenic tryptamines","year":"1992","cit":46,"pfa":"Zbigniew Tomaszewski","psa":"David E. Nichols","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2950598133","eid":"W2950598133"},{"id":"paper-w4256328419","cat":"papers","name":"A PSYCHO-PHARMACOLOGICAL ANALYSIS OF BEHAVIOUR IN RATS","year":"1971","cit":46,"pfa":"B.D. Gupta","psa":"M.L. Gupta","topics":["Depression","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4256328419","eid":"W4256328419"},{"id":"paper-w2270165648","cat":"papers","name":"Safer ‘chemsex’: GPs’ role in harm reduction for emerging forms of recreational drug use","year":"2015","cit":46,"pfa":"Richard Ma","psa":"Seán Perera","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2270165648","eid":"W2270165648"},{"id":"paper-w4309093706","cat":"papers","name":"Should we be leery of being Leary? Concerns about psychedelic use by psychedelic researchers","year":"2022","cit":46,"pfa":"Brent Michael Kious","psa":"Benjamin R. Lewis","topics":["PTSD & trauma","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4309093706","eid":"W4309093706"},{"id":"paper-w1455919563","cat":"papers","name":"Guidance on the clinical management of acute and chronic harms of club drugs and novel psychoactive substances.","year":"2015","cit":46,"pfa":"Dima Abdulrahim","psa":"Owen Bowden‐Jones","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1455919563","eid":"W1455919563"},{"id":"paper-w4398774731","cat":"papers","name":"Psychedelic-assisted psychotherapy: where is the psychotherapy research?","year":"2024","cit":46,"pfa":"Jacob S. Aday","psa":"Joshua D. Woolley","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4398774731","eid":"W4398774731"},{"id":"paper-w1996402068","cat":"papers","name":"Psychedelic Therapy (Utilizing LSD) with Cancer Patients","year":"1970","cit":46,"pfa":"Walter N. Pahnke","psa":"Louis E. Goodman","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W1996402068","eid":"W1996402068"},{"id":"paper-w4408072192","cat":"papers","name":"The intensity of the psychedelic experience is reliably associated with clinical improvements: A systematic review and meta-analysis","year":"2025","cit":46,"pfa":"Bruno Roméo","psa":"Amine Benyamina","topics":["Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4408072192","eid":"W4408072192"},{"id":"paper-w2064822410","cat":"papers","name":"Hallucinogens as Medicine","year":"2010","cit":46,"pfa":"Roland R. Griffiths","psa":"Charles S. Grob","ptype":"article","src":"https://openalex.org/W2064822410","eid":"W2064822410"},{"id":"paper-w1530247448","cat":"papers","name":"Indolealkylamine and phenalkylamine hallucinogens","year":"1983","cit":46,"pfa":"Richard A. Glennon","psa":"John M. Jacyno","ptype":"article","src":"https://openalex.org/W1530247448","eid":"W1530247448"},{"id":"paper-w2147679442","cat":"papers","name":"Continuous 'microdose' isotretinoin in adult recalcitrant rosacea","year":"2004","cit":46,"pfa":"Thomas Franz Hofer","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2147679442","eid":"W2147679442"},{"id":"paper-w3169923559","cat":"papers","name":"Psychedelic medicalization, public discourse, and the morality of ego dissolution","year":"2021","cit":46,"pfa":"Alex K. Gearin","psa":"Neşe Devenot","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3169923559","eid":"W3169923559"},{"id":"paper-w4221018864","cat":"papers","name":"Psychedelic Mushrooms in the USA: Knowledge, Patterns of Use, and Association With Health Outcomes","year":"2022","cit":46,"pfa":"Richard Matzopoulos","psa":"Leonard B. Lerer","topics":["Depression","Anxiety & end-of-life","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4221018864","eid":"W4221018864"},{"id":"paper-w2058250518","cat":"papers","name":"The chemistry of the psychotomimetic substances","year":"1962","cit":46,"pfa":"D. F. Downing","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2058250518","eid":"W2058250518"},{"id":"paper-w2021000817","cat":"papers","name":"Temperament and character traits associated with the use of alcohol, cannabis, cocaine, benzodiazepines, and hallucinogens: evidence from a large Brazilian web survey","year":"2015","cit":46,"pfa":"Ricardo Schneider","psa":"Diogo Rizzato Lara","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2021000817","eid":"W2021000817"},{"id":"paper-w4388065041","cat":"papers","name":"Addiction","year":"2001","cit":46,"pfa":"Avram Goldstein","topics":["Addiction","Dosing & pharmacology"],"ptype":"book","src":"https://openalex.org/W4388065041","eid":"W4388065041"},{"id":"paper-w3021119031","cat":"papers","name":"Psychosis-Relevant Effects of Intravenous Delta-9-Tetrahydrocannabinol: A Mega Analysis of Individual Participant-Data from Human Laboratory Studies","year":"2020","cit":46,"pfa":"Suhas Ganesh","psa":"Deepak Cyril D’Souza","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3021119031","eid":"W3021119031"},{"id":"paper-w3085802627","cat":"papers","name":"Pharmacology and legal status of cannabidiol.","year":"2021","cit":46,"pfa":"Pietro Brunetti","psa":"Francesco Paolo Busardò","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3085802627","eid":"W3085802627"},{"id":"paper-w2592845471","cat":"papers","name":"Attenuation of ketamine-induced impairment in verbal learning and memory in healthy volunteers by the AMPA receptor potentiator PF-04958242","year":"2017","cit":46,"pfa":"Mohini Ranganathan","psa":"Deepak Cyril D’Souza","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2592845471","eid":"W2592845471"},{"id":"paper-w2013581906","cat":"papers","name":"RIM1α and Interacting Proteins Involved in Presynaptic Plasticity Mediate Prepulse Inhibition and Additional Behaviors Linked to Schizophrenia","year":"2010","cit":46,"pfa":"Jacqueline J. Blundell","psa":"Craig M. Powell","ptype":"article","src":"https://openalex.org/W2013581906","eid":"W2013581906"},{"id":"paper-w4235687336","cat":"papers","name":"Cannabis Psychosis","year":"1986","cit":46,"pfa":"Abdol Hamid Ghodse","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4235687336","eid":"W4235687336"},{"id":"paper-w2029868562","cat":"papers","name":"Molecular design of the N-methyl-D-aspartate receptor binding site for phencyclidine and dizolcipine.","year":"1995","cit":46,"pfa":"Antonio Vicente Ferrer-Montiel","psa":"Mauricio Montal","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2029868562","eid":"W2029868562"},{"id":"paper-w3030801398","cat":"papers","name":"Astrocytes in rapid ketamine antidepressant action","year":"2020","cit":46,"pfa":"Matjaž Stenovec","psa":"Robert Zorec","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3030801398","eid":"W3030801398"},{"id":"paper-w3175532567","cat":"papers","name":"Pharmacodynamic Interactions Between Ketamine and Psychiatric Medications Used in the Treatment of Depression: A Systematic Review","year":"2021","cit":46,"pfa":"Jolien K. E. Veraart","psa":"Daan Johannes Touw","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W3175532567","eid":"W3175532567"},{"id":"paper-w4312501419","cat":"papers","name":"The Behavioral and Pharmacological Actions of NMDA Receptor Antagonism are Conserved in Zebrafish Larvae","year":"2010","cit":46,"pfa":"John Li Chen","psa":"Kevin S. Jones","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4312501419","eid":"W4312501419"},{"id":"paper-w2157411761","cat":"papers","name":"Does adding ketamine to morphine patient-controlled analgesia safely improve post-thoracotomy pain?","year":"2011","cit":46,"pfa":"T. J. Mathews","psa":"Joel Dunning","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2157411761","eid":"W2157411761"},{"id":"paper-w4220798783","cat":"papers","name":"Research advances in the clinical application of esketamine","year":"2022","cit":46,"pfa":"Xiaoxi Zhang","psa":"Zhao‐Qiong Zhu","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4220798783","eid":"W4220798783"},{"id":"paper-w3183211470","cat":"papers","name":"The effect of esketamine in patients with treatment‐resistant depression with and without comorbid anxiety symptoms or disorder","year":"2021","cit":46,"pfa":"Ella Daly","psa":"Jaskaran B. Singh","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3183211470","eid":"W3183211470"},{"id":"paper-w2518100111","cat":"papers","name":"Ketamine-dependent neuronal activation in healthy volunteers","year":"2016","cit":46,"pfa":"Anna S. Höflich","psa":"Rupert R. Lanzenberger","ptype":"article","src":"https://openalex.org/W2518100111","eid":"W2518100111"},{"id":"paper-w2067422684","cat":"papers","name":"Pyretogenic Effect of Lysergic Acid Diethylamide","year":"1954","cit":45,"pfa":"Akira Horita","psa":"James M. Dille","ptype":"article","src":"https://openalex.org/W2067422684","eid":"W2067422684"},{"id":"paper-w2017899999","cat":"papers","name":"Immunological Consequences of In Vitro Exposure to Lysergic Acid Diethylamide (LSD)","year":"1994","cit":45,"pfa":"Robert V. House","psa":"Hemendra N. Bhargava","ptype":"article","src":"https://openalex.org/W2017899999","eid":"W2017899999"},{"id":"paper-w2071182556","cat":"papers","name":"Chromatographic and mass spectrometric methods for determination of lysergic acid diethylamide (LSD) and metabolites in body fluids","year":"1992","cit":45,"pfa":"Chad C. Nelson","psa":"Rodger L. Foltz","ptype":"article","src":"https://openalex.org/W2071182556","eid":"W2071182556"},{"id":"paper-w1985178027","cat":"papers","name":"Measurement of Lysergic Acid Diethylamide (LSD) in Human Plasma by Gas Chromatography/Negative Ion Chemical Ionization Mass Spectrometry*","year":"1990","cit":45,"pfa":"Damon I. Papac","psa":"Rodger L. Foltz","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1985178027","eid":"W1985178027"},{"id":"paper-w2094407119","cat":"papers","name":"Effects of Methiothepin and Lysergic Acid Diethylamide on Serotonin Release In Vitro and Serotonin Synthesis In Vivo: Possible Relation to Serotonin Autoreceptor Function","year":"1984","cit":45,"pfa":"Douglas J. Pettibone","psa":"A. Barbara Pflueger","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2094407119","eid":"W2094407119"},{"id":"paper-w2414349356","cat":"papers","name":"Identifizierung von Psilocin","year":"1959","cit":45,"pfa":"Alfred André Hofmann","psa":"F. Troxler","ptype":"article","src":"https://openalex.org/W2414349356","eid":"W2414349356"},{"id":"paper-w2481296943","cat":"papers","name":"Pharmacology of Ibogaine and Ibogaine-Related Alkaloids","year":"1999","cit":45,"pfa":"Piotr Popik","psa":"Phil Skolnick","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W2481296943","eid":"W2481296943"},{"id":"paper-w2115282999","cat":"papers","name":"Progress in the Synthesis of Iboga-alkaloids and their Congeners","year":"2011","cit":45,"pfa":"Goutam Kumar Jana","psa":"Surajit Sinha","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2115282999","eid":"W2115282999"},{"id":"paper-w2887389091","cat":"papers","name":"Structure-activity relationship studies on mescaline","year":"1967","cit":45,"pfa":"John Smythies","psa":"L. C. Clark","ptype":"article","src":"https://openalex.org/W2887389091","eid":"W2887389091"},{"id":"paper-w2165514293","cat":"papers","name":"Maternal and developmental toxicity of ayahuasca in Wistar rats","year":"2010","cit":45,"pfa":"Carolina Dizioli Rodrigues de Oliveira","psa":"Maurı́cio Yonamine","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2165514293","eid":"W2165514293"},{"id":"paper-w2410962965","cat":"papers","name":"Executive function in abstinent MDMA ('ecstasy') users.","year":"2002","cit":45,"pfa":"Zakzanis Kk","psa":"Young Da","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2410962965","eid":"W2410962965"},{"id":"paper-w2012509720","cat":"papers","name":"LSD, mescaline and serotonin injected into medial raphe nucleus potentiate apomorphine hypermotility","year":"1981","cit":45,"pfa":"Heidrun Fink","psa":"Wolfgang Oelssner","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2012509720","eid":"W2012509720"},{"id":"paper-w2783289116","cat":"papers","name":"Taburnaemines A–I, Cytotoxic Vobasinyl-Iboga-Type Bisindole Alkaloids from Tabernaemontana corymbosa","year":"2018","cit":45,"pfa":"Yu Zhang","psa":"Xiao‐Jiang Hao","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2783289116","eid":"W2783289116"},{"id":"paper-w2036966965","cat":"papers","name":"Forbidden Therapies: Santo Daime, Ayahuasca, and the Prohibition of Entheogens in Western Society","year":"2014","cit":45,"pfa":"Marc G. Blainey","ptype":"article","src":"https://openalex.org/W2036966965","eid":"W2036966965"},{"id":"paper-w4405528804","cat":"papers","name":"The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression","year":"2024","cit":45,"pfa":"Guy M. Goodwin","psa":"Ekaterina Malievskaia","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4405528804","eid":"W4405528804"},{"id":"paper-w2005055265","cat":"papers","name":"Identification and Quantitation of Ibogaine and an o-Demethylated Metabolite in Brain and Biological Fluids Using Gas Chromatography-Mass Spectrometry","year":"1995","cit":45,"pfa":"William Lee Hearn","psa":"Deborah C. Mash","ptype":"article","src":"https://openalex.org/W2005055265","eid":"W2005055265"},{"id":"paper-w2081637659","cat":"papers","name":"Hair analysis for Drug Abuse XV. Disposition of 3,4-methylenedioxymethamphetamine (MDMA) and its related compounds into rat hair and application to hair analysis for MDMA abuse","year":"1997","cit":45,"pfa":"Ruri Kikura","psa":"Franco Tagliaro","ptype":"article","src":"https://openalex.org/W2081637659","eid":"W2081637659"},{"id":"paper-w2167890374","cat":"papers","name":"Depressive symptomatology in young adults with a history of MDMA use: a longitudinal analysis","year":"2007","cit":45,"pfa":"Rüssel S. Falck","psa":"Robert Gideon Carlson","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2167890374","eid":"W2167890374"},{"id":"paper-w1999543481","cat":"papers","name":"Neural correlates of working memory in pure and polyvalent ecstasy (MDMA) users","year":"2003","cit":45,"pfa":"Jörg Daumann","psa":"Euphrosyne Gouzoulis‐Mayfrank","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1999543481","eid":"W1999543481"},{"id":"paper-w2069800617","cat":"papers","name":"Vascular actions of MDMA involve α1 and α2‐adrenoceptors in the anaesthetized rat","year":"2001","cit":45,"pfa":"John McDaid","psa":"James R. Docherty","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2069800617","eid":"W2069800617"},{"id":"paper-w2086448707","cat":"papers","name":"Ibogaine modulates cocaine responses which are altered due to environmental habituation: In vivo microvoltammetric and behavioral studies","year":"1994","cit":45,"pfa":"Patricia Ann Broderick","psa":"Robert T. Wechsler","ptype":"article","src":"https://openalex.org/W2086448707","eid":"W2086448707"},{"id":"paper-w1992552266","cat":"papers","name":"The effect of selective 5‐hydroxytryptamine uptake inhibitors on 5‐methoxy‐N,N‐dimethyltryptamine‐induced ejaculation in the rat","year":"1986","cit":45,"pfa":"Lucy Rényi","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1992552266","eid":"W1992552266"},{"id":"paper-w2791736883","cat":"papers","name":"Deaths related to MDMA (ecstasy/molly): Prevalence, root causes, and harm reduction interventions","year":"2018","cit":45,"pfa":"Khary K. Rigg","psa":"Amanda Sharp","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2791736883","eid":"W2791736883"},{"id":"paper-w1998116984","cat":"papers","name":"3,4-Methylenedioxymethamphetamine (MDMA) Abuse may Cause Oxidative Stress and Potential Free Radical Damage","year":"2003","cit":45,"pfa":"Jun F. Zhou","psa":"Huai H. Chen","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1998116984","eid":"W1998116984"},{"id":"paper-w2102803302","cat":"papers","name":"Dose-related effects of MDMA on psychomotor function and mood before, during, and after a night of sleep loss","year":"2010","cit":45,"pfa":"Wendy M. Bosker","psa":"Johannes Gerardus Ramaekers","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2102803302","eid":"W2102803302"},{"id":"paper-w2118819225","cat":"papers","name":"Methylenedioxymethamphetamine (MDMA; Ecstasy) suppresses IL-1β and TNF-α secretion following an in vivo lipopolysaccharide challenge","year":"2000","cit":45,"pfa":"Thomas J. Connor","psa":"Brian E. Leonard","ptype":"article","src":"https://openalex.org/W2118819225","eid":"W2118819225"},{"id":"paper-w2028455253","cat":"papers","name":"Ultra-high-pressure liquid chromatography tandem mass spectrometry determination of hallucinogenic drugs in hair of psychedelic plants and mushrooms consumers","year":"2014","cit":45,"pfa":"Simona Pichini","psa":"Roberta Pacifici","ptype":"article","src":"https://openalex.org/W2028455253","eid":"W2028455253"},{"id":"paper-w1982825786","cat":"papers","name":"Differential involvement of prelimbic and infralimbic medial prefrontal cortex in discrete cue-induced reinstatement of 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) seeking in rats","year":"2012","cit":45,"pfa":"Kevin T. Ball","psa":"Mylissa M. Slane","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1982825786","eid":"W1982825786"},{"id":"paper-w2059360851","cat":"papers","name":"Role of 5-HT2A and 5-HT2C/B receptors in the acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on striatal single-unit activity and locomotion in freely moving rats","year":"2005","cit":45,"pfa":"Kevin T. Ball","psa":"George V. Rebec","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2059360851","eid":"W2059360851"},{"id":"paper-w2941855003","cat":"papers","name":"Serotonergic hallucinogens and recognition of facial emotion expressions: a systematic review of the literature","year":"2019","cit":45,"pfa":"Juliana Mendes Rocha","psa":"RAFAEL GUIMARÃES DOS SANTOS","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W2941855003","eid":"W2941855003"},{"id":"paper-w3167904654","cat":"papers","name":"Cross-Sectional Associations Between Lifetime Use of Psychedelic Drugs and Psychometric Measures During the COVID-19 Confinement: A Transcultural Study","year":"2021","cit":45,"pfa":"Dóra Révész","psa":"José Carlos Bouso","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W3167904654","eid":"W3167904654"},{"id":"paper-w4210379385","cat":"papers","name":"Evaluating the Potential Use of Serotonergic Psychedelics in Autism Spectrum Disorder","year":"2022","cit":45,"pfa":"Athanasios Markopoulos","psa":"Gabriella Gobbi","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4210379385","eid":"W4210379385"},{"id":"paper-w4213251631","cat":"papers","name":"Exploring protective associations between the use of classic psychedelics and cocaine use disorder: a population-based survey study","year":"2022","cit":45,"pfa":"Grant M. Jones","psa":"Matthew K. Nock","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4213251631","eid":"W4213251631"},{"id":"paper-w2001290709","cat":"papers","name":"SHAPE CHANGE OF BLOOD PLATELETS—A MODEL FOR CEREBRAL 5‐HYDROXYTRYPTAMINE RECEPTORS?","year":"1979","cit":45,"pfa":"Martin R. Graf","psa":"A. Pletscher","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2001290709","eid":"W2001290709"},{"id":"paper-w3153638782","cat":"papers","name":"Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans","year":"2021","cit":45,"pfa":"Paul D. Cumming","psa":"Chantal Martin-Söelch","topics":["Mechanism & neuroscience","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3153638782","eid":"W3153638782"},{"id":"paper-w2065513651","cat":"papers","name":"Meiotic Chromosome Damage induced by LSD-25","year":"1968","cit":45,"pfa":"Maimon M. Cohen","psa":"Anil B. Mukherjee","ptype":"article","src":"https://openalex.org/W2065513651","eid":"W2065513651"},{"id":"paper-w2894631918","cat":"papers","name":"The neuropharmacology of sleep paralysis hallucinations: serotonin 2A activation and a novel therapeutic drug","year":"2018","cit":45,"pfa":"Baland Jalal","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2894631918","eid":"W2894631918"},{"id":"paper-w1972822274","cat":"papers","name":"Dissociations between the effects of hallucinogenic drugs on behavior and raphe unit activity in freely moving cats","year":"1981","cit":45,"pfa":"Michael E. Trulson","psa":"Barry L. Jacobs","ptype":"article","src":"https://openalex.org/W1972822274","eid":"W1972822274"},{"id":"paper-w2037932042","cat":"papers","name":"LC-ESI-MS/MS on an ion trap for the determination of LSD, iso-LSD, nor-LSD and 2-oxo-3-hydroxy-LSD in blood, urine and vitreous humor","year":"2006","cit":45,"pfa":"Donata Favretto","psa":"Santo Davide Ferrara","ptype":"article","src":"https://openalex.org/W2037932042","eid":"W2037932042"},{"id":"paper-w4210403083","cat":"papers","name":"LSD and creativity: Increased novelty and symbolic thinking, decreased utility and convergent thinking","year":"2022","cit":45,"pfa":"Isabel Wießner","psa":"Luís Fernando Tófoli","ptype":"article","src":"https://openalex.org/W4210403083","eid":"W4210403083"},{"id":"paper-w2037829582","cat":"papers","name":"Effect of Ethanol Administration and Withdrawal on Serotonin Receptor Subtypes and Receptor‐Mediated Phosphoinositide Hydrolysis in Rat Brain","year":"1992","cit":45,"pfa":"Subhash C. Pandey","psa":"Ghanshyam N. Pandey","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2037829582","eid":"W2037829582"},{"id":"paper-w1522391071","cat":"papers","name":"The Dark Side of Ecstasy: Neuropsychiatric Symptoms after Exposure to 3,4‐Methylenedioxymethamphetamine","year":"2007","cit":45,"pfa":"Sunniva Nyberg Karlsen","psa":"Lars Slørdal","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1522391071","eid":"W1522391071"},{"id":"paper-w2603180085","cat":"papers","name":"Return of the lysergamides. Part III: Analytical characterization of N6‐ethyl‐6‐norlysergic acid diethylamide (ETH‐LAD) and 1‐propionyl ETH‐LAD (1P–ETH‐LAD)","year":"2017","cit":45,"pfa":"Simon D. Brandt","psa":"Adam L. Halberstadt","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2603180085","eid":"W2603180085"},{"id":"paper-w2114644022","cat":"papers","name":"The neurotoxicity of hallucinogenic amphetamines in primary cultures of hippocampal neurons","year":"2012","cit":45,"pfa":"João Paulo Capela","psa":"Félix Dias Carvalho","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2114644022","eid":"W2114644022"},{"id":"paper-w4361248485","cat":"papers","name":"The need for establishing best practices and gold standards in psychedelic medicine","year":"2023","cit":45,"pfa":"Allison A. Feduccia","psa":"David M. Rabin","ptype":"article","src":"https://openalex.org/W4361248485","eid":"W4361248485"},{"id":"paper-w1531892057","cat":"papers","name":"Methylenedioxymethamphetamine inhibits mitochondrial complex I activity in mice: a possible mechanism underlying neurotoxicity","year":"2010","cit":45,"pfa":"Elena Puerta","psa":"Norberto Aguirre","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1531892057","eid":"W1531892057"},{"id":"paper-w2999306893","cat":"papers","name":"A qualitative descriptive analysis of effects of psychedelic phenethylamines and tryptamines","year":"2020","cit":45,"pfa":"Joseph J. Palamar","psa":"Patricia Acosta","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2999306893","eid":"W2999306893"},{"id":"paper-w1979858655","cat":"papers","name":"Functional consequences of perinatal exposure to3,4‐methylenedioxymethamphetamine in rat brain","year":"2002","cit":45,"pfa":"Paul A. Kelly","psa":"Henry J. Olverman","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1979858655","eid":"W1979858655"},{"id":"paper-w2099702453","cat":"papers","name":"SENSORY DEPRIVATION AND SCHIZOPHRENIA: SOME CLINICAL AND THEORETICAL SIMILARITIES","year":"1959","cit":45,"pfa":"Norman Rosenzweig","ptype":"article","src":"https://openalex.org/W2099702453","eid":"W2099702453"},{"id":"paper-w3006627293","cat":"papers","name":"Cannabidiol treatment in an adolescent with multiple substance abuse, social anxiety and depression","year":"2020","cit":45,"pfa":"Clarissa Laczkovics","psa":"Claudia M. Klier","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3006627293","eid":"W3006627293"},{"id":"paper-w4388007338","cat":"papers","name":"Psychological and physiological effects of extended DMT","year":"2023","cit":45,"pfa":"Lisa Xiaolu Luan","psa":"Christopher B. Timmermann","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4388007338","eid":"W4388007338"},{"id":"paper-w4382863178","cat":"papers","name":"E-cigarettes may serve as a gateway to conventional cigarettes and other addictive drugs","year":"2023","cit":45,"pfa":"Grace L. Chen","psa":"Kabirullah Lutfy","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4382863178","eid":"W4382863178"},{"id":"paper-w2097178480","cat":"papers","name":"Mefloquine and psychotomimetics share neurotransmitter receptor and transporter interactions in vitro","year":"2014","cit":45,"pfa":"Aaron J. Janowsky","psa":"Michael K. Riscoe","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2097178480","eid":"W2097178480"},{"id":"paper-w4210709241","cat":"papers","name":"A qualitative investigation exploring why dance festivals are risky environments for drug use and potential adverse outcomes","year":"2022","cit":45,"pfa":"Joseph J. Palamar","psa":"İbrahim Sönmez","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4210709241","eid":"W4210709241"},{"id":"paper-w1967189169","cat":"papers","name":"The pharmacology of ketanserin, the first selective serotonin S2‐antagonist","year":"1985","cit":45,"pfa":"Frans H. L. Awouters","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1967189169","eid":"W1967189169"},{"id":"paper-w3210645845","cat":"papers","name":"Structure–Activity Relationship of Novel Second-Generation Synthetic Cathinones: Mechanism of Action, Locomotion, Reward, and Immediate-Early Genes","year":"2021","cit":45,"pfa":"Núria Nadal‐Gratacós","psa":"Raúl López‐Arnau","topics":["Addiction","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3210645845","eid":"W3210645845"},{"id":"paper-w4400279567","cat":"papers","name":"Ethnoracial inclusion in clinical trials of psychedelics: a systematic review","year":"2024","cit":45,"pfa":"Marcus E. Hughes","psa":"Albert Garcia‐Romeu","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4400279567","eid":"W4400279567"},{"id":"paper-w2982759837","cat":"papers","name":"Seeing without self: Discovering new meaning with psychedelic-assisted psychotherapy","year":"2019","cit":45,"pfa":"Lawrence G. Fischman","topics":["Mechanism & neuroscience","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2982759837","eid":"W2982759837"},{"id":"paper-w3213721934","cat":"papers","name":"Self-Medication for Chronic Pain Using Classic Psychedelics: A Qualitative Investigation to Inform Future Research","year":"2021","cit":45,"pfa":"Julia Bornemann","psa":"Leor Roseman","topics":["Depression","Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3213721934","eid":"W3213721934"},{"id":"paper-w3091880200","cat":"papers","name":"“Tobacco Is the Chief Medicinal Plant in My Work”: Therapeutic Uses of Tobacco in Peruvian Amazonian Medicine Exemplified by the Work of a Maestro Tabaquero","year":"2020","cit":45,"pfa":"Ilana Berlowitz","psa":"Chantal Martin-Söelch","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3091880200","eid":"W3091880200"},{"id":"paper-w4392762192","cat":"papers","name":"Adolescent Psychedelic Use and Psychotic or Manic Symptoms","year":"2024","cit":45,"pfa":"Otto Simonsson","psa":"Laura W. Wesseldijk","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4392762192","eid":"W4392762192"},{"id":"paper-w4380442223","cat":"papers","name":"Psychedelic unselfing: self-transcendence and change of values in psychedelic experiences","year":"2023","cit":45,"pfa":"Juuso Kähönen","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4380442223","eid":"W4380442223"},{"id":"paper-w2108277662","cat":"papers","name":"Microdose Induced Data Loss on Floating Gate Memories","year":"2006","cit":45,"pfa":"Steven M. Guertin","psa":"J. D. Patterson","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2108277662","eid":"W2108277662"},{"id":"paper-w4317545575","cat":"papers","name":"The costs and benefits of psychedelics on cognition and mood","year":"2023","cit":45,"pfa":"Ceyda Sayalı","psa":"Frederick Streeter Barrett","ptype":"article","src":"https://openalex.org/W4317545575","eid":"W4317545575"},{"id":"paper-w2104584562","cat":"papers","name":"Beneficial synergistic effects of microdose lithium with pyrroloquinoline quinone in an Alzheimer's disease mouse model","year":"2014","cit":45,"pfa":"Lei Zhao","psa":"Tian‐Le Xu","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2104584562","eid":"W2104584562"},{"id":"paper-w4290805404","cat":"papers","name":"Naturalistic Psychedelic Use: A World Apart from Clinical Care","year":"2022","cit":45,"pfa":"Nicolas G. Glynos","psa":"Kevin F. Boehnke","topics":["Addiction","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4290805404","eid":"W4290805404"},{"id":"paper-w2911858244","cat":"papers","name":"Using the DSSAT Model to Support Decision Making Regarding Fertilizer Microdosing for Maize Production in the Sub-humid Region of Benin","year":"2019","cit":45,"pfa":"Pierre Gbènoukpo Tovihoudji","psa":"Charles Louis Bielders","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2911858244","eid":"W2911858244"},{"id":"paper-w2394898777","cat":"papers","name":"Psychotomimetic drugs; chemical and pharmacological aspects.","year":"1959","cit":45,"pfa":"Alfred André Hofmann","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2394898777","eid":"W2394898777"},{"id":"paper-w1971913921","cat":"papers","name":"Effects of asenapine, olanzapine, and risperidone on psychotomimetic-induced reversal-learning deficits in the rat","year":"2010","cit":45,"pfa":"Samantha Louise McLean","psa":"Mohammed Shahid","ptype":"article","src":"https://openalex.org/W1971913921","eid":"W1971913921"},{"id":"paper-w2036211371","cat":"papers","name":"Psychotomimetic opioid binding: specific binding of [3H]SKF-10047 to etorphine-inaccessible sites in guinea-pig brain","year":"1981","cit":45,"pfa":"Tsung‐Ping Su","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2036211371","eid":"W2036211371"},{"id":"paper-w2014915514","cat":"papers","name":"Changes in body temperature after administration of antipyretics, LSD, Δ9-THC, CNS depressants and stimulants, hormones, inorganic ions, gases, 2,4-DNP and miscellaneous agents","year":"1981","cit":45,"pfa":"Wesley G. Clark","psa":"Yvonne L. Clark","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2014915514","eid":"W2014915514"},{"id":"paper-w4392350911","cat":"papers","name":"TrkB transmembrane domain: bridging structural understanding with therapeutic strategy","year":"2024","cit":45,"pfa":"Giray Enkavi","psa":"Eero Ċastrén","topics":["Depression","Mechanism & neuroscience","Policy & ethics"],"ptype":"review","src":"https://openalex.org/W4392350911","eid":"W4392350911"},{"id":"paper-w2025762311","cat":"papers","name":"Religiosity and Drug Abuse among Psychiatric Inpatients","year":"1993","cit":45,"pfa":"David A. Brizer","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2025762311","eid":"W2025762311"},{"id":"paper-w2137665771","cat":"papers","name":"Salvia Divinorum: Exposures Reported to a Statewide Poison Control System Over 10 Years","year":"2009","cit":45,"pfa":"Rais B. Vohra","psa":"Richard F. Clark","ptype":"article","src":"https://openalex.org/W2137665771","eid":"W2137665771"},{"id":"paper-w11491783","cat":"papers","name":"Current hypotheses on sigma receptors and their physiological role: possible implications in psychiatry.","year":"1993","cit":45,"pfa":"Guy Debonnel","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W11491783","eid":"W11491783"},{"id":"paper-w3013453277","cat":"papers","name":"Ketamine in Major Depressive Disorder: Mechanisms and Future Perspectives","year":"2020","cit":45,"pfa":"Cheolmin Shin","psa":"Yong‐Ku Kim","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3013453277","eid":"W3013453277"},{"id":"paper-w3175061289","cat":"papers","name":"Efficacy of ketamine and esketamine on functional outcomes in treatment-resistant depression: A systematic review","year":"2021","cit":45,"pfa":"Jason Ng","psa":"Roger S. McIntyre","topics":["Depression","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W3175061289","eid":"W3175061289"},{"id":"paper-w3194412838","cat":"papers","name":"Efficacy and Safety of Intranasal Esketamine in Treatment-Resistant Depression in Adults: A Systematic Review","year":"2021","cit":45,"pfa":"Alisha Sapkota","psa":"Michael Alfonso","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W3194412838","eid":"W3194412838"},{"id":"paper-w4362523418","cat":"papers","name":"Effect of subanesthetic dose of esketamine on postoperative rehabilitation in elderly patients undergoing hip arthroplasty","year":"2023","cit":45,"pfa":"Menghang Min","psa":"Wenqi Xin","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4362523418","eid":"W4362523418"},{"id":"paper-w4392503807","cat":"papers","name":"Effect of Esketamine on Postoperative Delirium in Patients Undergoing Cardiac Valve Replacement with Cardiopulmonary Bypass: A Randomized Controlled Trial","year":"2024","cit":45,"pfa":"Xinglong Xiong","psa":"Jing Shi","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4392503807","eid":"W4392503807"},{"id":"paper-w4322763983","cat":"papers","name":"Effect of pre-administration of esketamine intraoperatively on postpartum depression after cesarean section: A randomized, double-blinded controlled trial","year":"2023","cit":45,"pfa":"Wei Ting Wang","psa":"Wanyou Yu","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4322763983","eid":"W4322763983"},{"id":"paper-w24534940","cat":"papers","name":"LYSERGIC ACID DIETHYLAMIDE (LSD-25) AND SCHIZOPHRENIC REACTIONS","year":"1968","cit":44,"pfa":"ROBERT J. LANGS","psa":"Harriet L. Barr","ptype":"article","src":"https://openalex.org/W24534940","eid":"W24534940"},{"id":"paper-w4366998343","cat":"papers","name":"The effect of lysergic acid diethylamide (LSD) on whole-brain functional and effective connectivity","year":"2023","cit":44,"pfa":"Peter Bedford","psa":"Andreea Oliviana Diaconescu","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4366998343","eid":"W4366998343"},{"id":"paper-w3019696286","cat":"papers","name":"A Single Administration of the Atypical Psychedelic Ibogaine or Its Metabolite Noribogaine Induces an Antidepressant-Like Effect in Rats","year":"2020","cit":44,"pfa":"Paola María Rodríguez","psa":"Ignacio Carrera","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3019696286","eid":"W3019696286"},{"id":"paper-w2753745784","cat":"papers","name":"MDA, MDMA, and other “mescaline‐like” substances in the US military's search for a truth drug (1940s to 1960s)","year":"2017","cit":44,"pfa":"Torsten Passie","psa":"Udo Benzenhöfer","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2753745784","eid":"W2753745784"},{"id":"paper-w2160625945","cat":"papers","name":"The Determination of Psilocin and Psilocybin in Hallucinogenic Mushrooms by HPLC Utilizing a Dual Reagent Acidic Potassium Permanganate and Tris(2,2′‐bipyridyl)ruthenium(II) Chemiluminescence Detection System","year":"2006","cit":44,"pfa":"Nicole Anastos","psa":"D. Noel Sims","ptype":"article","src":"https://openalex.org/W2160625945","eid":"W2160625945"},{"id":"paper-w3195762377","cat":"papers","name":"The adverse events of ibogaine in humans: an updated systematic review of the literature (2015–2020)","year":"2021","cit":44,"pfa":"Genís Oña","psa":"RAFAEL GUIMARÃES DOS SANTOS","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W3195762377","eid":"W3195762377"},{"id":"paper-w2154220771","cat":"papers","name":"Immunomodulating Activity of MDMA","year":"2000","cit":44,"pfa":"Roberta Pacifici","psa":"Rafael de la Torre","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2154220771","eid":"W2154220771"},{"id":"paper-w2397405373","cat":"papers","name":"Kappa Opioids, Salvinorin A and Major Depressive Disorder","year":"2016","cit":44,"pfa":"George T. Taylor","psa":"Francesca M. Manzella","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2397405373","eid":"W2397405373"},{"id":"paper-w4387264560","cat":"papers","name":"Ayahuasca: A review of historical, pharmacological, and therapeutic aspects","year":"2023","cit":44,"pfa":"Simon Ruffell","psa":"Jerome J. Sarris","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4387264560","eid":"W4387264560"},{"id":"paper-w2169164551","cat":"papers","name":"Lower Pecos and Coahuila peyote: new radiocarbon dates","year":"2006","cit":44,"pfa":"Martin Terry","psa":"Marvin W Rowe","ptype":"article","src":"https://openalex.org/W2169164551","eid":"W2169164551"},{"id":"paper-w1591491155","cat":"papers","name":"The Peyote road: religious freedom and the Native American Church","year":"2011","cit":44,"topics":["Policy & ethics"],"ptype":"book-review","src":"https://openalex.org/W1591491155","eid":"W1591491155"},{"id":"paper-w1963636752","cat":"papers","name":"Blood Flow and Cerebral Laterality in the Mescaline Model of Psychosis","year":"1998","cit":44,"pfa":"Leo Hermle","psa":"M. Spitzer","ptype":"article","src":"https://openalex.org/W1963636752","eid":"W1963636752"},{"id":"paper-w2070435252","cat":"papers","name":"Is there a case for MDMA-assisted psychotherapy in the UK?","year":"2007","cit":44,"pfa":"Ben Sessa","topics":["Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2070435252","eid":"W2070435252"},{"id":"paper-w2334993616","cat":"papers","name":"Dimethyltryptamine (DMT): a biochemical Swiss Army knife in neuroinflammation and neuroprotection?","year":"2016","cit":44,"pfa":"Attila Szabó","psa":"Ede Frecska","topics":["Depression","PTSD & trauma","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2334993616","eid":"W2334993616"},{"id":"paper-w1999517542","cat":"papers","name":"Serotonin toxicity involving MDMA (ecstasy) and moclobemide","year":"2011","cit":44,"pfa":"J. L. Pilgrim","psa":"Olaf H. Drummer","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1999517542","eid":"W1999517542"},{"id":"paper-w2087536428","cat":"papers","name":"The discriminative effects of the κ-opioid hallucinogen salvinorin A in nonhuman primates: dissociation from classic hallucinogen effects","year":"2010","cit":44,"pfa":"Eduardo R. Butelman","psa":"Mary Jeanne Kreek","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2087536428","eid":"W2087536428"},{"id":"paper-w4409638088","cat":"papers","name":"Rapid and sustained antidepressant effects of vaporized N,N-dimethyltryptamine: a phase 2a clinical trial in treatment-resistant depression","year":"2025","cit":44,"pfa":"Marcelo Falchi-Carvalho","psa":"Dráulio Barros de Araújo","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4409638088","eid":"W4409638088"},{"id":"paper-w2074715304","cat":"papers","name":"Biosynthesis of Psilocybin. Part II. Incorporation of Labelled Tryptamine Derivatives.","year":"1968","cit":44,"pfa":"Stig Agurell","psa":"Jaakko Paasiv́irta","ptype":"article","src":"https://openalex.org/W2074715304","eid":"W2074715304"},{"id":"paper-w2586126893","cat":"papers","name":"A unique natural selective kappa -opioid receptor agonist, salvinorin A, and its roles in human therapeutics","year":"2017","cit":44,"pfa":"André Cruz","psa":"Ana Martinho","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2586126893","eid":"W2586126893"},{"id":"paper-w2033836124","cat":"papers","name":"Behavioural and neurochemical effects of combined MDMA and THC administration in mice","year":"2007","cit":44,"pfa":"Patricia Robledo","psa":"Rafaël Maldonado","ptype":"article","src":"https://openalex.org/W2033836124","eid":"W2033836124"},{"id":"paper-w4378903602","cat":"papers","name":"Acute effects of MDMA and LSD co-administration in a double-blind placebo-controlled study in healthy participants","year":"2023","cit":44,"pfa":"Isabelle Straumann","psa":"Matthias E. Liechti","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4378903602","eid":"W4378903602"},{"id":"paper-w3008349045","cat":"papers","name":"Posttraumatic Growth After MDMA‐Assisted Psychotherapy for Posttraumatic Stress Disorder","year":"2020","cit":44,"pfa":"Ingmar Gorman","psa":"Allison A. Feduccia","topics":["PTSD & trauma","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3008349045","eid":"W3008349045"},{"id":"paper-w4390629750","cat":"papers","name":"Neural Mechanisms of Resting-State Networks and the Amygdala Underlying the Cognitive and Emotional Effects of Psilocybin","year":"2024","cit":44,"pfa":"Devon Stoliker","psa":"Adeel Razi","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4390629750","eid":"W4390629750"},{"id":"paper-w78410971","cat":"papers","name":"Toxicity of MDA (3,4-methylenedioxyamphetamine) considered for relevance to hazards of MDMA (Ecstasy) abuse.","year":"1987","cit":44,"pfa":"W. Marvin Davis","psa":"I. W. Waters","topics":["Safety & adverse events","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W78410971","eid":"W78410971"},{"id":"paper-w2059618143","cat":"papers","name":"Sex-Dependent Psychoneuroendocrine Effects of THC and MDMA in an Animal Model of Adolescent Drug Consumption","year":"2013","cit":44,"pfa":"Alvaro Llorente‐Berzal","psa":"María‐Paz Viveros","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2059618143","eid":"W2059618143"},{"id":"paper-w1977753287","cat":"papers","name":"Methylenedioxymethamphetamine (MDMA)-related fatalities in Australia: Demographics, circumstances, toxicology and major organ pathology","year":"2009","cit":44,"pfa":"Sharlene S. Kaye","psa":"Johan A Duflou","ptype":"article","src":"https://openalex.org/W1977753287","eid":"W1977753287"},{"id":"paper-w2050055314","cat":"papers","name":"Effects of 3,4-methylenedioxy-methamphetamine (MDMA) on anxiety in mice tested in the light-dark box","year":"2000","cit":44,"pfa":"E. Maldonado","psa":"José Francisco Navarro","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2050055314","eid":"W2050055314"},{"id":"paper-w2050757130","cat":"papers","name":"A three-choice discrimination procedure dissociates the discriminative stimulus effects of d-amphetamine and (±)-MDMA in rats.","year":"2000","cit":44,"pfa":"Amy Goodwin","psa":"Lisa E. Baker","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2050757130","eid":"W2050757130"},{"id":"paper-w4246046242","cat":"papers","name":"A three-choice discrimination procedure dissociates the discriminative stimulus effects of d-amphetamine and (±)-MDMA in rats.","year":"2000","cit":44,"pfa":"Amy Goodwin","psa":"Lisa E. Baker","ptype":"article","src":"https://openalex.org/W4246046242","eid":"W4246046242"},{"id":"paper-w2897437455","cat":"papers","name":"Kappa Opioid Receptor Agonist Mesyl Sal B Attenuates Behavioral Sensitization to Cocaine with Fewer Aversive Side-Effects than Salvinorin A in Rodents","year":"2018","cit":44,"pfa":"Bronwyn Maree Kivell","psa":"Thomas Edward Prisinzano","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2897437455","eid":"W2897437455"},{"id":"paper-w2045336176","cat":"papers","name":"Acute administration of 3,4-methylenedioxymethamphetamine (MDMA) induces oxidative stress, lipoperoxidation and TNFα-mediated apoptosis in rat liver","year":"2011","cit":44,"pfa":"Daniela Cerretani","psa":"Vittorio Fineschi","ptype":"article","src":"https://openalex.org/W2045336176","eid":"W2045336176"},{"id":"paper-w2148189513","cat":"papers","name":"Prospective associations between meth/amphetamine (speed) and MDMA (ecstasy) use and depressive symptoms in secondary school students","year":"2012","cit":44,"pfa":"Frédéric N. Brière","psa":"Linda S. Pagani","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2148189513","eid":"W2148189513"},{"id":"paper-w1965434217","cat":"papers","name":"Modification of Ag nanoparticles with mixed thiols for improved SERS detection of poorly adsorbing target molecules: detection of MDMA","year":"2011","cit":44,"pfa":"Alan Stewart","psa":"Steven E. J. Bell","ptype":"article","src":"https://openalex.org/W1965434217","eid":"W1965434217"},{"id":"paper-w2074629565","cat":"papers","name":"Evidence that MDMA (‘ecstasy’) increases cannabinoid CB2 receptor expression in microglial cells: role in the neuroinflammatory response in rat brain","year":"2010","cit":44,"pfa":"Elisa Torres","psa":"María Isabel Colado","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2074629565","eid":"W2074629565"},{"id":"paper-w1990193279","cat":"papers","name":"Treatment with MDMA from P11–20 disrupts spatial learning and path integration learning in adolescent rats but only spatial learning in older rats","year":"2006","cit":44,"pfa":"Matthew R. Skelton","psa":"Charles V. Vorhees","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W1990193279","eid":"W1990193279"},{"id":"paper-w4389900041","cat":"papers","name":"Set and setting predict psychopathology, wellbeing and meaningfulness of psychedelic experiences: a correlational study","year":"2023","cit":44,"pfa":"Lucas F. Borkel","psa":"Domingo Jesús Quintana Hernández","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4389900041","eid":"W4389900041"},{"id":"paper-w2084123852","cat":"papers","name":"Chronic treatment with LY341495 decreases 5-HT2A receptor binding and hallucinogenic effects of LSD in mice","year":"2013","cit":44,"pfa":"José L. Moreno","psa":"Javier González‐Maeso","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2084123852","eid":"W2084123852"},{"id":"paper-w2054762481","cat":"papers","name":"ON THE CONFORMATIONS OF HALLUCINOGENIC MOLECULES AND THEIR CORRELATION","year":"1969","cit":44,"pfa":"Cyrus Chothia","psa":"Peter Jeffress Pauling","ptype":"article","src":"https://openalex.org/W2054762481","eid":"W2054762481"},{"id":"paper-w1996835897","cat":"papers","name":"Dissociations Between the Effects of LSD on Behavior and Raphe Unit Activity in Freely Moving Cats","year":"1979","cit":44,"pfa":"Michael E. Trulson","psa":"Barry L. Jacobs","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1996835897","eid":"W1996835897"},{"id":"paper-w2034572287","cat":"papers","name":"In vitro Interaction of LSD with Purified Calf Thymus DNA","year":"1969","cit":44,"pfa":"Thomas E. Wagner","ptype":"article","src":"https://openalex.org/W2034572287","eid":"W2034572287"},{"id":"paper-w1974432965","cat":"papers","name":"Non-opioid psychotomimetic-like discriminative stimulus properties of N-allylnormetazocine (SKF 10,047) in the rat","year":"1982","cit":44,"pfa":"Gary T. Shearman","psa":"Albert Herz","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1974432965","eid":"W1974432965"},{"id":"paper-w2909121609","cat":"papers","name":"Effects of acute and repeated treatment with serotonin 5-HT2A receptor agonist hallucinogens on intracranial self-stimulation in rats.","year":"2019","cit":44,"pfa":"Farhana Sakloth","psa":"Sidney Stevens Negus","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2909121609","eid":"W2909121609"},{"id":"paper-w4280616839","cat":"papers","name":"Genetic Survey of Psilocybe Natural Products","year":"2022","cit":44,"pfa":"Sebastian Dörner","psa":"Dirk Hoffmeister","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4280616839","eid":"W4280616839"},{"id":"paper-w2131155943","cat":"papers","name":"Impact of Ambient Temperature on Hyperthermia Induced by (±)3,4-Methylenedioxymethamphetamine in Rhesus Macaques","year":"2006","cit":44,"pfa":"Stefani N. Von Huben","psa":"Michael A. Taffe","ptype":"article","src":"https://openalex.org/W2131155943","eid":"W2131155943"},{"id":"paper-w1984214570","cat":"papers","name":"Development and validation of a rapid turboflow LC-MS/MS method for the quantification of LSD and 2-oxo-3-hydroxy LSD in serum and urine samples of emergency toxicological cases","year":"2014","cit":44,"pfa":"Patrick C. Dolder","psa":"KATHARINA M. RENTSCH","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1984214570","eid":"W1984214570"},{"id":"paper-w2011833485","cat":"papers","name":"Methamphetamine and 3,4-methylenedioxymethamphetamine interact with central nicotinic receptors and induce their up-regulation","year":"2007","cit":44,"pfa":"Sara Garcia‐Ratés","psa":"David Pubill","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2011833485","eid":"W2011833485"},{"id":"paper-w1970215476","cat":"papers","name":"Discriminative stimulus properties of (±)-3,4-methylenedioxymethamphetamine and (±)-3,4-methylenedioxyamphetamine in pigeons","year":"1986","cit":44,"pfa":"Suzette M. Evans","psa":"Chris Ellyn Johanson","ptype":"article","src":"https://openalex.org/W1970215476","eid":"W1970215476"},{"id":"paper-w2059348149","cat":"papers","name":"The 5-HT2 receptor antagonist, MDL 28,133A, disrupts the serotonergic-dopaminergic interaction mediating the neurochemical effects of 3,4-methylenedioxymethamphetamine","year":"1992","cit":44,"pfa":"Christopher J. Schmidt","psa":"Stephen M. Sorensen","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2059348149","eid":"W2059348149"},{"id":"paper-w2790248870","cat":"papers","name":"An ontology of psychedelic entity experiences in evolutionary psychology and neurophenomenology","year":"2018","cit":44,"pfa":"Michael Winkelman","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2790248870","eid":"W2790248870"},{"id":"paper-w4409174511","cat":"papers","name":"Neuroplasticity and psychedelics: A comprehensive examination of classic and non-classic compounds in pre and clinical models","year":"2025","cit":44,"pfa":"Claudio Agnorelli","psa":"David Erritzøe","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4409174511","eid":"W4409174511"},{"id":"paper-w2026668920","cat":"papers","name":"Harmine augments electrically evoked dopamine efflux in the nucleus accumbens shell","year":"2012","cit":44,"pfa":"Daniel I. Brierley","psa":"Colin Davidson","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2026668920","eid":"W2026668920"},{"id":"paper-w2093011654","cat":"papers","name":"Biblical Entheogens: a Speculative Hypothesis","year":"2008","cit":44,"pfa":"Benny Shanon","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2093011654","eid":"W2093011654"},{"id":"paper-w2094594303","cat":"papers","name":"Neuropsychotoxicity of Abused Drugs: Molecular and Neural Mechanisms of Neuropsychotoxicity Induced by Methamphetamine, 3,4-Methylenedioxymethamphetamine (Ecstasy), and 5-Methoxy-N,N-diisopropyltryptamine (Foxy)","year":"2008","cit":44,"pfa":"Takayuki Nakagawa","psa":"Shuji Kaneko","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2094594303","eid":"W2094594303"},{"id":"paper-w2890893449","cat":"papers","name":"Rapid-Acting Antidepressants","year":"2018","cit":44,"pfa":"Jeffrey M. Witkin","psa":"Samuel Xiang-Yu Shi","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2890893449","eid":"W2890893449"},{"id":"paper-w4200392082","cat":"papers","name":"An Encounter With the Other: A Thematic and Content Analysis of DMT Experiences From a Naturalistic Field Study","year":"2021","cit":44,"pfa":"Pascal Michael","psa":"Oliver C. Robinson","topics":["Mechanism & neuroscience","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4200392082","eid":"W4200392082"},{"id":"paper-w4296082062","cat":"papers","name":"Being no one, being One: The role of ego-dissolution and connectedness in the therapeutic effects of psychedelic experience","year":"2022","cit":44,"pfa":"Ada Kałużna","psa":"James Cooke","topics":["Mechanism & neuroscience","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4296082062","eid":"W4296082062"},{"id":"paper-w3164868732","cat":"papers","name":"On the Varieties of Conscious Experiences: Altered Beliefs Under Psychedelics (ALBUS)","year":"2020","cit":44,"pfa":"Adam Safron","psa":"Matthew W. Johnson","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W3164868732","eid":"W3164868732"},{"id":"paper-w3094556688","cat":"papers","name":"Who is the typical psychedelics user? Methodological challenges for research in psychedelics use and its consequences","year":"2020","cit":44,"pfa":"Petter Grahl Johnstad","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3094556688","eid":"W3094556688"},{"id":"paper-w3177516331","cat":"papers","name":"Who is blind in psychedelic research? Letter to the editor regarding: blinding and expectancy confounds in psychedelic randomized controlled trials","year":"2021","cit":44,"pfa":"Eduardo Ekman Schenberg","topics":["Dosing & pharmacology"],"ptype":"letter","src":"https://openalex.org/W3177516331","eid":"W3177516331"},{"id":"paper-w2052728185","cat":"papers","name":"A Test of the Psychedelic Model of Altered States of Consciousness","year":"1976","cit":44,"pfa":"Harry T. Hunt","ptype":"article","src":"https://openalex.org/W2052728185","eid":"W2052728185"},{"id":"paper-w371993644","cat":"papers","name":"Hunting and hallucinogens: The use psychoactive and other plants to improve the hunting ability of dogs","year":"2015","cit":44,"pfa":"Bradley C. Bennett","psa":"Rocío Alarcón","ptype":"article","src":"https://openalex.org/W371993644","eid":"W371993644"},{"id":"paper-w4230522085","cat":"papers","name":"Psychedelic medicine: new evidence for hallucinogenic substances as treatments","year":"2008","cit":44,"topics":["Addiction"],"ptype":"book-review","src":"https://openalex.org/W4230522085","eid":"W4230522085"},{"id":"paper-w4310813805","cat":"papers","name":"Toward Mapping Neurobehavioral Heterogeneity of Psychedelic Neurobiology in Humans","year":"2022","cit":44,"pfa":"Flora Moujaes","psa":"Alan Anticevic","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4310813805","eid":"W4310813805"},{"id":"paper-w3114028558","cat":"papers","name":"How psychedelic researchers’ self-admitted substance use and their association with psychedelic culture affect people’s perceptions of their scientific integrity and the quality of their research","year":"2020","cit":44,"pfa":"Matthias Forstmann","psa":"Christina Sagioglou","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W3114028558","eid":"W3114028558"},{"id":"paper-w2987906134","cat":"papers","name":"The centrality of sense of self in psychological flexibility processes: What the neurobiological and psychological correlates of psychedelics suggest","year":"2019","cit":44,"pfa":"Steven C. Hayes","psa":"Xiaoyu Bai","ptype":"article","src":"https://openalex.org/W2987906134","eid":"W2987906134"},{"id":"paper-w1979813938","cat":"papers","name":"Posthallucinogen-Like Visual Illusions (Palinopsia) with Risperidone in a Patient without Previous Hallucinogen Exposure: Possible Relation to Serotonin 5HT2a Receptor Blockade","year":"2000","cit":44,"pfa":"Erik Lauterbach","psa":"J. Annandale","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1979813938","eid":"W1979813938"},{"id":"paper-w3014334735","cat":"papers","name":"Switching From High-Dose, Long-Term Opioids to Buprenorphine: A Case Series","year":"2020","cit":44,"pfa":"William C. Becker","psa":"Ellen Lockard Edens","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3014334735","eid":"W3014334735"},{"id":"paper-w2071442274","cat":"papers","name":"2C‐T‐4 intoxication: Acute psychosis caused by a designer drug","year":"2008","cit":44,"pfa":"Miho Miyajima","psa":"Shigeo Ito","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2071442274","eid":"W2071442274"},{"id":"paper-w2735958773","cat":"papers","name":"The Prevalence of Psychiatric Distress and Associated Risk Factors among College Students Using GHQ-28 Questionnaire.","year":"2017","cit":44,"pfa":"Jalal Poorolajal","psa":"Soheila Panahi","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2735958773","eid":"W2735958773"},{"id":"paper-w2526048283","cat":"papers","name":"Opioid-Sparing Effect of Ketamine in Children: A Meta-Analysis and Trial Sequential Analysis of Published Studies","year":"2016","cit":44,"pfa":"D. Michelet","psa":"Souhayl Dahmani","topics":["Addiction","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W2526048283","eid":"W2526048283"},{"id":"paper-w2470113918","cat":"papers","name":"A clinical comparison of the effects of oral and intramuscular administration of analgesics: Pentazocine and phenazocine","year":"1968","cit":44,"pfa":"W. T. Beaver","psa":"Ada G. Rogers","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2470113918","eid":"W2470113918"},{"id":"paper-w3037572205","cat":"papers","name":"A preliminary study of adjunctive ketamine for treatment-resistant bipolar depression","year":"2020","cit":44,"pfa":"Wei Zheng","psa":"Yuping Ning","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W3037572205","eid":"W3037572205"},{"id":"paper-w3003830815","cat":"papers","name":"An Update on Glutamatergic System in Suicidal Depression and on the Role of Esketamine","year":"2020","cit":44,"pfa":"Domenico De Berardis","psa":"Laura Orsolini","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3003830815","eid":"W3003830815"},{"id":"paper-w2706920074","cat":"papers","name":"Rapid infusion of esketamine for unipolar and bipolar depression: a retrospective chart review","year":"2017","cit":44,"pfa":"Fernanda S. Correia‐Melo","psa":"Lucas C. Quarantini","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2706920074","eid":"W2706920074"},{"id":"paper-w4212826549","cat":"papers","name":"Non-parenteral Ketamine for Depression: A Practical Discussion on Addiction Potential and Recommendations for Judicious Prescribing","year":"2022","cit":44,"pfa":"Jennifer Swainson","psa":"Atul Khullar","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4212826549","eid":"W4212826549"},{"id":"paper-w3180183782","cat":"papers","name":"Ketamine in the Past, Present, and Future: Mechanisms, Metabolites, and Toxicity","year":"2021","cit":44,"pfa":"Eric S. Schwenk","psa":"Eugene R. Viscusi","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3180183782","eid":"W3180183782"},{"id":"paper-w2053542641","cat":"papers","name":"Effects of lysergic acid diethylamide (LSD) on habituation and sensitization of the startle response in the rat","year":"1974","cit":43,"pfa":"Michael Davis","psa":"Michael H. Sheard","ptype":"article","src":"https://openalex.org/W2053542641","eid":"W2053542641"},{"id":"paper-w2087290332","cat":"papers","name":"[ 3 H]Lysergic Acid Diethylamide: Cellular Autoradiographic Localization in Rat Brain","year":"1971","cit":43,"pfa":"Ihsan M. Diab","psa":"Lloyd J. Roth","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2087290332","eid":"W2087290332"},{"id":"paper-w1533636181","cat":"papers","name":"d-[3H]Lysergic acid diethylamide binding to serotonin receptors in the molluscan nervous system.","year":"1980","cit":43,"pfa":"Alan H. Drummond","psa":"I. B. Levitan","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1533636181","eid":"W1533636181"},{"id":"paper-w3134702649","cat":"papers","name":"Lysergic acid diethylamide differentially modulates the reticular thalamus, mediodorsal thalamus, and infralimbic prefrontal cortex: An in vivo electrophysiology study in male mice","year":"2021","cit":43,"pfa":"Antonio Inserra","psa":"Gabriella Gobbi","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3134702649","eid":"W3134702649"},{"id":"paper-w3203708166","cat":"papers","name":"Psilocin, LSD, mescaline, and DOB all induce broadband desynchronization of EEG and disconnection in rats with robust translational validity","year":"2021","cit":43,"pfa":"Čestmír Vejmola","psa":"Tomáš Páleníček","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3203708166","eid":"W3203708166"},{"id":"paper-w2081883085","cat":"papers","name":"A Mescaline Associated Fatality","year":"1985","cit":43,"pfa":"Philip C. Reynolds","psa":"EJ Jindrich","ptype":"article","src":"https://openalex.org/W2081883085","eid":"W2081883085"},{"id":"paper-w2163808408","cat":"papers","name":"`Candyflipping': Synergistic discriminative effect of LSD and MDMA","year":"1998","cit":43,"pfa":"Martin Schechter","ptype":"article","src":"https://openalex.org/W2163808408","eid":"W2163808408"},{"id":"paper-w2407634776","cat":"papers","name":"Failure of N,N-dimethyltryptamine to evoke tolerance in cats.","year":"1973","cit":43,"pfa":"John Christian Gillin","psa":"Richard Jed Wyatt","ptype":"article","src":"https://openalex.org/W2407634776","eid":"W2407634776"},{"id":"paper-w2619396520","cat":"papers","name":"Potential Use of Ayahuasca in Grief Therapy","year":"2017","cit":43,"pfa":"Débora González","psa":"Magı́ Farré","ptype":"article","src":"https://openalex.org/W2619396520","eid":"W2619396520"},{"id":"paper-w2026568953","cat":"papers","name":"Dimethyltryptamine levels in blood of schizophrenic patients and control subjects","year":"1976","cit":43,"pfa":"Burt Angrist","psa":"William J. A. VandenHeuvel","ptype":"article","src":"https://openalex.org/W2026568953","eid":"W2026568953"},{"id":"paper-w2032969560","cat":"papers","name":"MDMA: a social drug in a social context","year":"2014","cit":43,"pfa":"Matthew G. Kirkpatrick","psa":"Harriet de Wit","ptype":"article","src":"https://openalex.org/W2032969560","eid":"W2032969560"},{"id":"paper-w2050577168","cat":"papers","name":"Occurrence of Psilocybin in Various Higher Fungi from Several European Countries","year":"1985","cit":43,"pfa":"T. Stijve","psa":"Th.W. Kuyper","ptype":"article","src":"https://openalex.org/W2050577168","eid":"W2050577168"},{"id":"paper-w4401339608","cat":"papers","name":"Different hierarchical reconfigurations in the brain by psilocybin and escitalopram for depression","year":"2024","cit":43,"pfa":"Gustavo Deco","psa":"Morten L. Kringelbach","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4401339608","eid":"W4401339608"},{"id":"paper-w2005228316","cat":"papers","name":"Voatinggine and Tabertinggine, Pentacyclic Indole Alkaloids Derived from an Iboga Precursor via a Common Cleavamine-Type Intermediate","year":"2013","cit":43,"pfa":"Choy‐Eng Nge","psa":"Toh‐Seok Kam","ptype":"article","src":"https://openalex.org/W2005228316","eid":"W2005228316"},{"id":"paper-w2430632207","cat":"papers","name":"Involvement of free radicals in MDMA-induced neurotoxicity in mice.","year":"2001","cit":43,"pfa":"Jean Lud Cadet","psa":"Subramaniam Jayanthi","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2430632207","eid":"W2430632207"},{"id":"paper-w3101729008","cat":"papers","name":"MDMA-induced changes in within-network connectivity contradict the specificity of these alterations for the effects of serotonergic hallucinogens","year":"2020","cit":43,"pfa":"Felix Müller","psa":"Stefan Borgwardt","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3101729008","eid":"W3101729008"},{"id":"paper-w4313585689","cat":"papers","name":"Psilocybin sex-dependently reduces alcohol consumption in C57BL/6J mice","year":"2023","cit":43,"pfa":"Kenneth Alper","psa":"K. Yaragudri Vinod","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4313585689","eid":"W4313585689"},{"id":"paper-w2049241646","cat":"papers","name":"EEG Gamma Coherence and Other Correlates of Subjective Reports During Ayahuasca Experiences","year":"2005","cit":43,"pfa":"David E. Stuckey","psa":"Luís Eduardo Luna","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2049241646","eid":"W2049241646"},{"id":"paper-w1967679048","cat":"papers","name":"Influence of (?) ?9-trans-tetrahydrocannabinol and mescaline on the behavior of rats submitted to food competition situations","year":"1971","cit":43,"pfa":"Jandira Masur","psa":"Friedhelm KORTE","ptype":"article","src":"https://openalex.org/W1967679048","eid":"W1967679048"},{"id":"paper-w2075121055","cat":"papers","name":"Users' perceptions of the risks and effects of taking ecstasy (MDMA): a questionnaire study","year":"2006","cit":43,"pfa":"Philip N. Murphy","psa":"John E. Fisk","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2075121055","eid":"W2075121055"},{"id":"paper-w258107681","cat":"papers","name":"Identification of dimethyltryptamine and O-methylbufotenin in human cerebrospinal fluid by combined gas chromatography/mass spectrometry.","year":"1979","cit":43,"pfa":"Smythies","psa":"G B Brown","ptype":"article","src":"https://openalex.org/W258107681","eid":"W258107681"},{"id":"paper-w2063138810","cat":"papers","name":"Evidence for a role of energy dysregulation in the MDMA-induced depletion of brain 5-HT","year":"2005","cit":43,"pfa":"Altaf S. Darvesh","psa":"Gary A. Gudelsky","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2063138810","eid":"W2063138810"},{"id":"paper-w4225144612","cat":"papers","name":"Characterizing Thalamocortical (Dys)connectivity Following D-Amphetamine, LSD, and MDMA Administration","year":"2022","cit":43,"pfa":"Mihai Avram","psa":"Stefan Borgwardt","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4225144612","eid":"W4225144612"},{"id":"paper-w2099365218","cat":"papers","name":"Direct Screening of Urine for MDMA and MDA by Liquid Chromatography-Tandem Mass Spectrometry*","year":"2003","cit":43,"pfa":"Helena K. Nordgren","psa":"Olof Beck","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2099365218","eid":"W2099365218"},{"id":"paper-w2136019384","cat":"papers","name":"MDMA ?ecstasy? alters hyperactive and perseverative behaviors in dopamine transporter knockout mice","year":"2004","cit":43,"pfa":"Susan B. Powell","psa":"Mark A. Geyer","ptype":"article","src":"https://openalex.org/W2136019384","eid":"W2136019384"},{"id":"paper-w2058428132","cat":"papers","name":"MDMA Toxicity and Pathological Consequences: A Review About Experimental Data and Autopsy Findings","year":"2010","cit":43,"pfa":"Emanuela Turillazzi","psa":"Vittorio Fineschi","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2058428132","eid":"W2058428132"},{"id":"paper-w2395256718","cat":"papers","name":"Mutagenicity testing of 3 hallucinogens: LSD, psilocybin and‡ 9-THC using the micronucleus test","year":"1978","cit":43,"pfa":"Greg Went","ptype":"article","src":"https://openalex.org/W2395256718","eid":"W2395256718"},{"id":"paper-w3171671394","cat":"papers","name":"Sleep Quality Improvements After MDMA‐Assisted Psychotherapy for the Treatment of Posttraumatic Stress Disorder","year":"2021","cit":43,"pfa":"Linnae Ponté","psa":"Allison A. Feduccia","topics":["PTSD & trauma","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3171671394","eid":"W3171671394"},{"id":"paper-w2143839580","cat":"papers","name":"Effects of the endogenous PPAR‐α agonist, oleoylethanolamide on MDMA‐induced cognitive deficits in mice","year":"2009","cit":43,"pfa":"Ainhoa Plaza‐Zabala","psa":"Patricia Robledo","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2143839580","eid":"W2143839580"},{"id":"paper-w4304143646","cat":"papers","name":"MDMA-assisted psychotherapy; Inclusion of transgender and gender diverse people in the frontiers of PTSD treatment trials","year":"2022","cit":43,"pfa":"Christopher S. Stauffer","psa":"Jae M. Sevelius","topics":["PTSD & trauma","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4304143646","eid":"W4304143646"},{"id":"paper-w2135085529","cat":"papers","name":"The Variety of Ecstasy/MDMA Users: Results from the National Epidemiologic Survey on Alcohol and Related Conditions","year":"2009","cit":43,"pfa":"Li-Tzy T. Wu","psa":"Dan German Blazer","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2135085529","eid":"W2135085529"},{"id":"paper-w2042654110","cat":"papers","name":"MDMA administration during adolescence exacerbates MPTP-induced cognitive impairment and neuroinflammation in the hippocampus and prefrontal cortex","year":"2014","cit":43,"pfa":"Giulia Costa","psa":"Micaela Morelli","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2042654110","eid":"W2042654110"},{"id":"paper-w2028683364","cat":"papers","name":"50-kHz calls in rats: Effects of MDMA and the 5-HT1A receptor agonist 8-OH-DPAT","year":"2012","cit":43,"pfa":"Monika Sadananda","psa":"Rainer K.W. Schwarting","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2028683364","eid":"W2028683364"},{"id":"paper-w2077260228","cat":"papers","name":"Binge ethanol administration enhances the MDMA-induced long-term 5-HT neurotoxicity in rat brain","year":"2006","cit":43,"pfa":"María Izco","psa":"M. Isabel Colado","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2077260228","eid":"W2077260228"},{"id":"paper-w1941813847","cat":"papers","name":"Effects of the serotonin releasers 3,4-methylenedioxymethamphetamine (MDMA), 4-chloroamphetamine (PCA) and fenfluramine on acoustic and tactile startle reflexes in rats.","year":"1992","cit":43,"pfa":"John H. Kehne","psa":"C J Schmidt","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1941813847","eid":"W1941813847"},{"id":"paper-w4220708535","cat":"papers","name":"Methodological challenges in psychedelic drug trials: Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) – Rationale and study design","year":"2022","cit":43,"pfa":"Lea Julia Mertens","psa":"Gerhard Gründer","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4220708535","eid":"W4220708535"},{"id":"paper-w4385230722","cat":"papers","name":"Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trial","year":"2023","cit":43,"pfa":"Muhammad Ishrat Husain","psa":"Benoit H. Mulsant","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4385230722","eid":"W4385230722"},{"id":"paper-w1667002192","cat":"papers","name":"Recreational 3,4-methylenedioxy-N-methylamphetamine (MDMA) or ‘ecstasy’ and self-focused compassion: Preliminary steps in the development of a therapeutic psychopharmacology of contemplative practices","year":"2015","cit":43,"pfa":"Sunjeev K. Kamboj","psa":"Tom P. Freeman","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W1667002192","eid":"W1667002192"},{"id":"paper-w2135841101","cat":"papers","name":"VASOCONSTRICTION PRODUCED BY HALLUCINOGENS ON ISOLATED HUMAN AND SHEEP UMBILICAL VASCULATURE","year":"1973","cit":43,"pfa":"D. C. Dyer","psa":"D.W. Gant","ptype":"article","src":"https://openalex.org/W2135841101","eid":"W2135841101"},{"id":"paper-w2134939065","cat":"papers","name":"Endogenous 5‐HT, released by MDMA through serotonin transporter‐ and secretory vesicle‐dependent mechanisms, reduces hippocampal excitatory synaptic transmission by preferential activation of 5‐HT1B receptors located on","year":"2003","cit":43,"pfa":"Boris Mlinar","psa":"Renato Corradetti","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2134939065","eid":"W2134939065"},{"id":"paper-w1994721957","cat":"papers","name":"Fluorescence enhancement of several hallucinogenic drugs in cyclodextrin media","year":"1985","cit":43,"pfa":"Oswald Jules","psa":"L. J. Cline. Love","ptype":"article","src":"https://openalex.org/W1994721957","eid":"W1994721957"},{"id":"paper-w4379769663","cat":"papers","name":"Hallucinogen use among young adults ages 19–30 in the United States: Changes from 2018 to 2021","year":"2023","cit":43,"pfa":"Katherine M. Keyes","psa":"Megan E. Patrick","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4379769663","eid":"W4379769663"},{"id":"paper-w1992714783","cat":"papers","name":"Hallucinogens and Drosophila: linking serotonin receptor activation to behavior","year":"2002","cit":43,"pfa":"Charles David Nichols","psa":"Elaine Sanders‐Bush","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1992714783","eid":"W1992714783"},{"id":"paper-w4237255258","cat":"papers","name":"The Dangers of LSD","year":"1966","cit":43,"pfa":"J. Thomas Ungerleider","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4237255258","eid":"W4237255258"},{"id":"paper-w2168303875","cat":"papers","name":"Flashback to the 1960s: LSD in the treatment of autism","year":"2007","cit":43,"pfa":"Jeff Sigafoos","psa":"Giulio E. Lancioni","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2168303875","eid":"W2168303875"},{"id":"paper-w2128667819","cat":"papers","name":"Intrahippocampal LSD accelerates learning and desensitizes the 5-HT2A receptor in the rabbit, Romano et al.","year":"2010","cit":43,"pfa":"Anthony G. Romano","psa":"John A. Harvey","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2128667819","eid":"W2128667819"},{"id":"paper-w2119114660","cat":"papers","name":"Identification of Residues in Transmembrane Regions III and VI that Contribute to the Ligand Binding Site of the Serotonin 5‐HT6 Receptor","year":"1998","cit":43,"pfa":"Frank Boess","psa":"Andrew J. Sleight","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2119114660","eid":"W2119114660"},{"id":"paper-w2156305343","cat":"papers","name":"Endocrine and Neurochemical Effects of 3,4-Methylenedioxymethamphetamine and Its Stereoisomers in Rhesus Monkeys","year":"2010","cit":43,"pfa":"Kevin Sean Murnane","psa":"Leonard Lee Howell","ptype":"article","src":"https://openalex.org/W2156305343","eid":"W2156305343"},{"id":"paper-w2110364687","cat":"papers","name":"Sympathomimetic Actions of Methylenedioxymethamphetamine in Rat and Rabbit Isolated Cardiovascular Tissues","year":"1994","cit":43,"pfa":"John FitzGerald","psa":"Julianne J. Reid","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2110364687","eid":"W2110364687"},{"id":"paper-w2060449158","cat":"papers","name":"The \"Ecstasy\" Hangover: Hyponatremia Due to 3,4-Methylenedioxymethamphetamine","year":"2002","cit":43,"pfa":"Stephen J. Traub","ptype":"article","src":"https://openalex.org/W2060449158","eid":"W2060449158"},{"id":"paper-w2025684297","cat":"papers","name":"Khat and mushrooms associated with psychosis","year":"2004","cit":43,"pfa":"Roman J Nielen","psa":"Willem M. A. Verhoeven","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2025684297","eid":"W2025684297"},{"id":"paper-w2020249036","cat":"papers","name":"Sensitizing regimens of (±)3, 4-methylenedioxymethamphetamine (ecstasy) elicit enduring and differential structural alterations in the brain motive circuit of the rat","year":"2009","cit":43,"pfa":"Kevin T. Ball","psa":"George V. Rebec","ptype":"article","src":"https://openalex.org/W2020249036","eid":"W2020249036"},{"id":"paper-w1968239400","cat":"papers","name":"Human Hallucinogenic Drug Research in the United States: A Present-day Case History and Review of the Process","year":"1991","cit":43,"pfa":"Rick J. Strassman","topics":["Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1968239400","eid":"W1968239400"},{"id":"paper-w1982429022","cat":"papers","name":"Psychiatry’s next top model: cause for a re-think on drug models of psychosis and other psychiatric disorders","year":"2013","cit":43,"pfa":"Robin Lester Carhart-Harris","psa":"James M. Stone","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W1982429022","eid":"W1982429022"},{"id":"paper-w2089032617","cat":"papers","name":"Determination of amphetamine, methamphetamine, 3,4‐methylenedioxyamphetamine, 3,4‐methylenedioxyethylamphetamine, and 3,4‐methylenedioxymethamphetamine in urine by online solid‐phase extraction and ion‐pairing liquid chr","year":"2005","cit":43,"pfa":"Ti‐Yu Wu","psa":"Ming‐Ren Fuh","ptype":"article","src":"https://openalex.org/W2089032617","eid":"W2089032617"},{"id":"paper-w2006747873","cat":"papers","name":"Paroxetine as an in vivo indicator of 3,4-methylenedioxymethamphetamine neurotoxicity: a presynaptic serotonergic positron emission tomography ligand?","year":"1990","cit":43,"pfa":"Ursula Scheffel","psa":"George A. Ricaurte","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2006747873","eid":"W2006747873"},{"id":"paper-w2736426002","cat":"papers","name":"Simultaneous Quantitation of Methamphetamine, Ketamine, Opiates and their Metabolites in Urine by SPE and LC–MS-MS","year":"2017","cit":43,"pfa":"Chu-An Yang","psa":"Shu‐Pao Wu","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2736426002","eid":"W2736426002"},{"id":"paper-w4323047575","cat":"papers","name":"Discovering the Potential Mechanisms of Medicinal Mushrooms Antidepressant Activity: A Review","year":"2023","cit":43,"pfa":"Jan Lazur","psa":"Bożena Muszyńska","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4323047575","eid":"W4323047575"},{"id":"paper-w2725589257","cat":"papers","name":"Patterns of use and toxicity of new para‐halogenated substituted cathinones: 4‐ CMC (clephedrone), 4‐ CEC (4‐chloroethcatinone) and 4‐ BMC (brephedrone)","year":"2017","cit":43,"pfa":"Marc Grifell","psa":"Marta Torrens","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2725589257","eid":"W2725589257"},{"id":"paper-w3156295774","cat":"papers","name":"Synthetic Cannabinoids and Cathinones Cardiotoxicity: Facts and Perspectives","year":"2021","cit":43,"pfa":"Davide Radaelli","psa":"Stefano D’Errico","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3156295774","eid":"W3156295774"},{"id":"paper-w1968531334","cat":"papers","name":"Synthesis and Serotonergic Activity of Substituted 2,N-Benzylcarboxamido-5-(2-ethyl-1-dioxoimidazolidinyl)-N,N-dimethyltrypt- amine Derivatives: Novel Antagonists for the Vascular 5-HT1B-like Receptor","year":"1999","cit":43,"pfa":"Gerard P. Moloney","psa":"Robert Charles Glen","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1968531334","eid":"W1968531334"},{"id":"paper-w1996634843","cat":"papers","name":"Characterization of the 5‐HT4 receptor mediating tachycardia in piglet isolated right atrium","year":"1993","cit":43,"pfa":"Andrew D. Medhurst","psa":"Alberto J. Kaumann","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1996634843","eid":"W1996634843"},{"id":"paper-w2728797029","cat":"papers","name":"Impact of Novel Psychoactive Substances on Clinical and Forensic Toxicology and Global Public Health","year":"2017","cit":43,"pfa":"Marilyn Ann Huestis","psa":"Michael H. Baumann","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2728797029","eid":"W2728797029"},{"id":"paper-w4254002436","cat":"papers","name":"The Trials of Psychedelic Therapy","year":"2018","cit":43,"pfa":"Matthew Oram","ptype":"book","src":"https://openalex.org/W4254002436","eid":"W4254002436"},{"id":"paper-w4388418934","cat":"papers","name":"Mindfulness meditation and psychedelics: potential synergies and commonalities","year":"2023","cit":43,"pfa":"Paweł Holas","psa":"Justyna Kamińska","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4388418934","eid":"W4388418934"},{"id":"paper-w4285041046","cat":"papers","name":"Modalities of the psychedelic experience: Microclimates of set and setting in hallucinogen research and culture","year":"2022","cit":43,"pfa":"Ido Hartogsohn","topics":["Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4285041046","eid":"W4285041046"},{"id":"paper-w4281762597","cat":"papers","name":"Motives for the use of serotonergic psychedelics: A systematic review","year":"2022","cit":43,"pfa":"Lukas Andreas Basedow","psa":"Sören Kuitunen‐Paul","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W4281762597","eid":"W4281762597"},{"id":"paper-w2059216747","cat":"papers","name":"Exposure opportunity as a mechanism linking youth marijuana use to hallucinogen use","year":"2002","cit":43,"pfa":"Holly C. Wilcox","psa":"James Christopher Anthony","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2059216747","eid":"W2059216747"},{"id":"paper-w4404349949","cat":"papers","name":"Isolation of psychedelic-responsive neurons underlying anxiolytic behavioral states","year":"2024","cit":43,"pfa":"Jessie Muir","psa":"Christina K. Kim","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4404349949","eid":"W4404349949"},{"id":"paper-w3048330057","cat":"papers","name":"Psychedelic substance use in the Reddit psychonaut community. A qualitative study on motives and modalities","year":"2020","cit":43,"pfa":"Jani Pestana","psa":"Enrico Petrilli","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3048330057","eid":"W3048330057"},{"id":"paper-w2085404501","cat":"papers","name":"Microdosing Assessment to Evaluate Pharmacokinetics and Drug Metabolism in Rats Using Liquid Chromatography-Tandem Mass Spectrometry","year":"2008","cit":43,"pfa":"Jinsong Ni","psa":"Andrew Acheampong","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2085404501","eid":"W2085404501"},{"id":"paper-w4391264477","cat":"papers","name":"Longitudinal associations between psychedelic use and psychotic symptoms in the United States and the United Kingdom","year":"2024","cit":43,"pfa":"Ludwig Honk","psa":"Otto Simonsson","ptype":"article","src":"https://openalex.org/W4391264477","eid":"W4391264477"},{"id":"paper-w4225107707","cat":"papers","name":"Ketamine: anesthetic, psychotomimetic, antidepressant, or anthelmintic?","year":"2022","cit":43,"pfa":"Kenji Hashimoto","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4225107707","eid":"W4225107707"},{"id":"paper-w3023746918","cat":"papers","name":"Psychotomimetic N-methyl-N-isopropyltryptamines. Effects of variation of aromatic oxygen substituents","year":"1985","cit":43,"pfa":"David B. Repke","psa":"Alexander T. Shulgin","ptype":"article","src":"https://openalex.org/W3023746918","eid":"W3023746918"},{"id":"paper-w1235712407","cat":"papers","name":"Partial mGlu5 Negative Allosteric Modulators Attenuate Cocaine-Mediated Behaviors and Lack Psychotomimetic-Like Effects","year":"2015","cit":43,"pfa":"Robert W. Gould","psa":"Carrie K. Jones","ptype":"article","src":"https://openalex.org/W1235712407","eid":"W1235712407"},{"id":"paper-w1988110304","cat":"papers","name":"Implications Of LSD and Experimental Mysticism","year":"1970","cit":43,"pfa":"Walter N. Pahnke","psa":"William A. Richards","ptype":"article","src":"https://openalex.org/W1988110304","eid":"W1988110304"},{"id":"paper-w2152030369","cat":"papers","name":"5-Meo-DALT-induced Cyclic Myoclonus (P3.013)","year":"2015","cit":43,"pfa":"Thananan Thammongkolchai","psa":"Bashar Katirji","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2152030369","eid":"W2152030369"},{"id":"paper-w2210848389","cat":"papers","name":"Metabolic Fate of Hallucinogenic NBOMes","year":"2015","cit":43,"pfa":"Sebastian Leth‐Petersen","psa":"Jesper Langgaard Kristensen","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2210848389","eid":"W2210848389"},{"id":"paper-w132561475","cat":"papers","name":"On-line preconcentration and determination of ketamine and norketamine by micellar electrokinetic chromatography","year":"2005","cit":43,"pfa":"Hsiu-Ping Jen","psa":"You‐Zung Hsieh","ptype":"article","src":"https://openalex.org/W132561475","eid":"W132561475"},{"id":"paper-w1980326622","cat":"papers","name":"The effect of ketamine isomers on both mice behavioral responses and c-Fos expression in the posterior cingulate and retrosplenial cortices","year":"2000","cit":43,"pfa":"Nobuyasu Nishizawa","psa":"Koh Shingu","ptype":"article","src":"https://openalex.org/W1980326622","eid":"W1980326622"},{"id":"paper-w1966339742","cat":"papers","name":"A Twin Study of Personality and Illicit Drug Use and Abuse/Dependence","year":"2004","cit":43,"pfa":"Arpana Agrawal","psa":"Kenneth S. Kendler","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1966339742","eid":"W1966339742"},{"id":"paper-w2319207837","cat":"papers","name":"Role of the NMDA receptor NR2B subunit in the discriminative stimulus effects of ketamine","year":"2003","cit":43,"pfa":"Jean De Vry","psa":"Klaus Rüdiger Jentzsch","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2319207837","eid":"W2319207837"},{"id":"paper-w2127040027","cat":"papers","name":"5-HT Receptor-Associated Protein Networks: New Targets for Drug Discovery in Psychiatric Disorders?","year":"2011","cit":43,"pfa":"Philippe Marin","psa":"Joël Bockaert","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2127040027","eid":"W2127040027"},{"id":"paper-w2158596530","cat":"papers","name":"Clinical Uses of Low – Dose Ketamine in Patients Undergoing Surgery","year":"2009","cit":43,"pfa":"Marco Berti","psa":"Gregory C. Fanelli","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2158596530","eid":"W2158596530"},{"id":"paper-w1964959168","cat":"papers","name":"Autistic Schizophrenic Children","year":"1962","cit":43,"pfa":"Alfred M. Freedman","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W1964959168","eid":"W1964959168"},{"id":"paper-w338086727","cat":"papers","name":"Ketamine and suicidal ideation in depression: Jumping the gun?","year":"2015","cit":43,"pfa":"Ramamoorthy Rajkumar","psa":"Gavin Stewart Dawe","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W338086727","eid":"W338086727"},{"id":"paper-w2089627897","cat":"papers","name":"Selective increases in the cytokine, TNFα, in the prefrontal cortex of PCP-treated rats and human schizophrenic subjects: influence of antipsychotic drugs","year":"2006","cit":43,"pfa":"Gavin Paterson","psa":"BRIAN J. MORRIS","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2089627897","eid":"W2089627897"},{"id":"paper-w2407277813","cat":"papers","name":"Molecular profile of dissociative drug ketamine in relation to its rapid antidepressant action","year":"2016","cit":43,"pfa":"Joanna Ficek","psa":"Michał Korostyński","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2407277813","eid":"W2407277813"},{"id":"paper-w2527654830","cat":"papers","name":"Antidepressant Actions of Ketamine Versus Hydroxynorketamine","year":"2016","cit":43,"pfa":"Graham L. Collingridge","psa":"David Lodge","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2527654830","eid":"W2527654830"},{"id":"paper-w4280561266","cat":"papers","name":"Evaluation of the Trajectory of Depression Severity With Ketamine and Esketamine Treatment in a Clinical Setting","year":"2022","cit":43,"pfa":"Sina Nikayin","psa":"Samuel T. Wilkinson","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4280561266","eid":"W4280561266"},{"id":"paper-w4310044456","cat":"papers","name":"Holding on or letting go? Patient experiences of control, context, and care in oral esketamine treatment for treatment-resistant depression: A qualitative study","year":"2022","cit":43,"pfa":"Joost J. Breeksema","psa":"Robert A. Schoevers","topics":["Depression","Anxiety & end-of-life","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4310044456","eid":"W4310044456"},{"id":"paper-w3021118503","cat":"papers","name":"Effects of Mu-Opiate Receptor Gene Polymorphism rs1799971 (A118G) on the Antidepressant and Dissociation Responses in Esketamine Nasal Spray Clinical Trials","year":"2020","cit":43,"pfa":"Ziad S. Saad","psa":"Guang Chen","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3021118503","eid":"W3021118503"},{"id":"paper-w4376225381","cat":"papers","name":"Efficacy and Safety of a Subanesthetic Dose of Esketamine Combined with Propofol in Patients with Obesity Undergoing Painless Gastroscopy: A Prospective, Double-Blind, Randomized Controlled Trial","year":"2023","cit":43,"pfa":"Longbin Zheng","psa":"Ning Yin","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4376225381","eid":"W4376225381"},{"id":"paper-w3205836206","cat":"papers","name":"Comparison of Long-Term Efficacy and Safety of Esketamine Nasal Spray Plus Oral Antidepressant in Younger Versus Older Patients With Treatment-Resistant Depression: Post-Hoc Analysis of SUSTAIN-2, a Long-Term Open-Label","year":"2021","cit":43,"pfa":"Rachel Ochs-Ross","psa":"Jaskaran B. Singh","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3205836206","eid":"W3205836206"},{"id":"paper-w3171701327","cat":"papers","name":"Subcutaneous Ketamine in Depression: A Systematic Review","year":"2021","cit":43,"pfa":"Vitor Breseghello Cavenaghi","psa":"Renério Fráguas","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W3171701327","eid":"W3171701327"},{"id":"paper-w3159176128","cat":"papers","name":"Strategies to Prolong Ketamine’s Efficacy in Adults with Treatment-Resistant Depression","year":"2021","cit":43,"pfa":"Eric P. McMullen","psa":"Roger S. McIntyre","topics":["Depression","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3159176128","eid":"W3159176128"},{"id":"paper-w1703845858","cat":"papers","name":"Lysergic Acid Diethylamide and Mescaline in Experimental Psychiatry","year":"1957","cit":42,"pfa":"Daniel X. Freedman","ptype":"article","src":"https://openalex.org/W1703845858","eid":"W1703845858"},{"id":"paper-w2050207278","cat":"papers","name":"EXPERIMENTAL ANALYSIS OF THE INHIBITORY ACTION OF LYSERGIC ACID DIETHYLAMIDE ON CORTICAL DENDRITIC ACTIVITY","year":"1957","cit":42,"pfa":"Dominick P. Purpura","ptype":"article","src":"https://openalex.org/W2050207278","eid":"W2050207278"},{"id":"paper-w4212894755","cat":"papers","name":"N,N‐dimethyltryptamine and Amazonian ayahuasca plant medicine","year":"2022","cit":42,"pfa":"Edward James","psa":"Ben Sessa","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4212894755","eid":"W4212894755"},{"id":"paper-w2163220726","cat":"papers","name":"DISAGGREGATION OF BRAIN POLYSOMES AFTER ADMINISTRATION OF d‐LYSERGIC ACID DIETHYLAMIDE (LSD) IN VIVO","year":"1976","cit":42,"pfa":"L. Holbrook","psa":"Ian R. Brown","ptype":"article","src":"https://openalex.org/W2163220726","eid":"W2163220726"},{"id":"paper-w4307747683","cat":"papers","name":"Effects of repeated lysergic acid diethylamide (LSD) on the mouse brain endocannabinoidome and gut microbiome","year":"2022","cit":42,"pfa":"Antonio Inserra","psa":"Vincenzo Di Marzo","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4307747683","eid":"W4307747683"},{"id":"paper-w3039457381","cat":"papers","name":"Direct Phosphorylation of Psilocin Enables Optimized cGMP Kilogram-Scale Manufacture of Psilocybin","year":"2020","cit":42,"pfa":"Robert B. Kargbo","psa":"Poncho L. Meisenheimer","ptype":"article","src":"https://openalex.org/W3039457381","eid":"W3039457381"},{"id":"paper-w2588053910","cat":"papers","name":"The Iboga Alkaloids","year":"2017","cit":42,"pfa":"Catherine Lavaud","psa":"Georges Massiot","ptype":"book-chapter","src":"https://openalex.org/W2588053910","eid":"W2588053910"},{"id":"paper-w2015086459","cat":"papers","name":"Variation of psilocybin and psilocin levels with repeated flushes (harvests) of mature sporocarps of Psilocybe cubensis (earle) singer","year":"1982","cit":42,"pfa":"Jeremy Bigwood","psa":"Michael W. Beug","ptype":"article","src":"https://openalex.org/W2015086459","eid":"W2015086459"},{"id":"paper-w2774218904","cat":"papers","name":"(±)-MDMA and its enantiomers: potential therapeutic advantages of R(−)-MDMA","year":"2017","cit":42,"pfa":"Elizabeth G. Pitts","psa":"Leonard Lee Howell","ptype":"article","src":"https://openalex.org/W2774218904","eid":"W2774218904"},{"id":"paper-w3006309218","cat":"papers","name":"Structural basis of cycloaddition in biosynthesis of iboga and aspidosperma alkaloids","year":"2020","cit":42,"pfa":"Lorenzo Caputi","psa":"Sarah Ellen O'Connor","ptype":"article","src":"https://openalex.org/W3006309218","eid":"W3006309218"},{"id":"paper-w2948341932","cat":"papers","name":"Validation of an analytical method for the determination of the main ayahuasca active compounds and application to real ayahuasca samples from Brazil","year":"2019","cit":42,"pfa":"Rita C. Z. Souza","psa":"Alessandra Sussulini","ptype":"article","src":"https://openalex.org/W2948341932","eid":"W2948341932"},{"id":"paper-w2099103834","cat":"papers","name":"Occurrence and use of hallucinogenic mushrooms containing psilocybin alkaloids","year":"2009","cit":42,"pfa":"Christer Andersson","psa":"Jakob Kristinsson","topics":["Safety & adverse events","Policy & ethics"],"ptype":"book","src":"https://openalex.org/W2099103834","eid":"W2099103834"},{"id":"paper-w3128937289","cat":"papers","name":"Pharmacokinetics and Pharmacodynamics of Salvinorin A and Salvia divinorum: Clinical and Forensic Aspects","year":"2021","cit":42,"pfa":"Andreia Machado Brito-da-Costa","psa":"Áurea Madureira-Carvalho","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3128937289","eid":"W3128937289"},{"id":"paper-w2472912283","cat":"papers","name":"MDMA as a Probe and Treatment for Social Behaviors","year":"2016","cit":42,"pfa":"Boris Dov Heifets","psa":"Robert C. Malenka","ptype":"article","src":"https://openalex.org/W2472912283","eid":"W2472912283"},{"id":"paper-w4214570845","cat":"papers","name":"Psilocin acutely alters sleep-wake architecture and cortical brain activity in laboratory mice","year":"2022","cit":42,"pfa":"Christopher W. Thomas","psa":"Vladyslav V. Vyazovskiy","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4214570845","eid":"W4214570845"},{"id":"paper-w2030147381","cat":"papers","name":"Memantine prevents MDMA-induced neurotoxicity","year":"2007","cit":42,"pfa":"Carlos Chipana","psa":"Elena Escubedo","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2030147381","eid":"W2030147381"},{"id":"paper-w2288440615","cat":"papers","name":"THE ESTIMATION OF AMINES IN BIOLOGICAL MATERIALS WITH CRITICAL DATA FOR COCAINE AND MESCALINE","year":"1951","cit":42,"pfa":"L.A. Woods","psa":"Maurice H. Seevers","ptype":"article","src":"https://openalex.org/W2288440615","eid":"W2288440615"},{"id":"paper-w1994758971","cat":"papers","name":"Hallucinogens as a discriminative stimuli: Generalization of DOM to a 5-methoxy-N, N-dimethyltryptamine stimulus","year":"1979","cit":42,"pfa":"Richard A. Glennon","psa":"Judith Gaines","ptype":"article","src":"https://openalex.org/W1994758971","eid":"W1994758971"},{"id":"paper-w2063227124","cat":"papers","name":"Methysergide potentiates the hyperactivity produced by MDMA in rats","year":"1988","cit":42,"pfa":"Lisa H. Gold","psa":"George F. Koob","ptype":"article","src":"https://openalex.org/W2063227124","eid":"W2063227124"},{"id":"paper-w2059889162","cat":"papers","name":"Ecstasy/MDMA and cannabis: the complexities of their interactive neuropsychobiological effects","year":"2004","cit":42,"pfa":"Andrew C. Parrott","psa":"Nadia Solowij","ptype":"article","src":"https://openalex.org/W2059889162","eid":"W2059889162"},{"id":"paper-w3159497666","cat":"papers","name":"The Shipibo Ceremonial Use of Ayahuasca to Promote Well-Being: An Observational Study","year":"2021","cit":42,"pfa":"Débora González","psa":"José Carlos Bouso","ptype":"article","src":"https://openalex.org/W3159497666","eid":"W3159497666"},{"id":"paper-w3177336864","cat":"papers","name":"Relational and Growth Outcomes Following Couples Therapy With MDMA for PTSD","year":"2021","cit":42,"pfa":"Anne C. Wagner","psa":"Candice M. Monson","topics":["PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3177336864","eid":"W3177336864"},{"id":"paper-w2105538880","cat":"papers","name":"Fatalities after taking ibogaine in addiction treatment could be related to sudden cardiac death caused by autonomic dysfunction","year":"2006","cit":42,"pfa":"Uwe Maas","psa":"S. Strubelt","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2105538880","eid":"W2105538880"},{"id":"paper-w2085062315","cat":"papers","name":"Role of α2A‐adrenoceptors in the effects of MDMA on body temperature in the mouse","year":"2005","cit":42,"pfa":"Sotiria Bexis","psa":"James R. Docherty","ptype":"article","src":"https://openalex.org/W2085062315","eid":"W2085062315"},{"id":"paper-w2076779802","cat":"papers","name":"Is vitreous humour useful for the interpretation of 3,4-methylenedioxymethamphetamine (MDMA) blood levels?","year":"2000","cit":42,"pfa":"Els A. De Letter","psa":"Michel H A Piette","ptype":"article","src":"https://openalex.org/W2076779802","eid":"W2076779802"},{"id":"paper-w1985979598","cat":"papers","name":"Imaging brain activity in conscious monkeys following oral MDMA (“ecstasy”)","year":"2006","cit":42,"pfa":"Mathew E. Brevard","psa":"Craig F. Ferris","ptype":"article","src":"https://openalex.org/W1985979598","eid":"W1985979598"},{"id":"paper-w2928852232","cat":"papers","name":"A phenomenology of subjectively relevant experiences induced by ayahuasca in Upper Amazon vegetalismo tourism","year":"2019","cit":42,"pfa":"Tom John Wolff","psa":"Torsten Passie","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2928852232","eid":"W2928852232"},{"id":"paper-w2135019658","cat":"papers","name":"The sub-acute effects of recreational ecstasy (MDMA) use: a controlled study in humans","year":"2006","cit":42,"pfa":"Joanna K. Huxster","psa":"Michael John Morgan","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2135019658","eid":"W2135019658"},{"id":"paper-w2077009331","cat":"papers","name":"Use of MDA (The \"Love Drug\") and Methamphetamine in Toronto by Unsuspecting Users of Ecstasy (MDMA)","year":"2004","cit":42,"pfa":"Kathryn S. Kalasinsky","psa":"SJ Kish","ptype":"article","src":"https://openalex.org/W2077009331","eid":"W2077009331"},{"id":"paper-w1976842105","cat":"papers","name":"Protection against MDMA-induced dopaminergic neurotoxicity in mice by methyllycaconitine: Involvement of nicotinic receptors","year":"2006","cit":42,"pfa":"Carlos Chipana","psa":"Elena Escubedo","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1976842105","eid":"W1976842105"},{"id":"paper-w2086577902","cat":"papers","name":"Current preclinical studies on neuroinflammation and changes in blood–brain barrier integrity by MDMA and methamphetamine","year":"2014","cit":42,"pfa":"Esther O’Shea","psa":"M. Isabel Colado","ptype":"article","src":"https://openalex.org/W2086577902","eid":"W2086577902"},{"id":"paper-w4405031949","cat":"papers","name":"Psilocybin Therapy for Clinicians With Symptoms of Depression From Frontline Care During the COVID-19 Pandemic","year":"2024","cit":42,"pfa":"Anthony L. Back","psa":"Ted Alan Gooley","topics":["Depression","PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4405031949","eid":"W4405031949"},{"id":"paper-w2089172972","cat":"papers","name":"Behavioral sensitization and cross-sensitization between methylphenidate amphetamine, and 3,4-methylenedioxymethamphetamine (MDMA) in female SD rats","year":"2011","cit":42,"pfa":"Pamela B. Yang","psa":"Nachum Dafny","ptype":"article","src":"https://openalex.org/W2089172972","eid":"W2089172972"},{"id":"paper-w2014873507","cat":"papers","name":"15N isotopic analyses: a powerful tool to establish links between seized 3,4-methylenedioxymethamphetamine (MDMA) tablets","year":"2003","cit":42,"pfa":"Norbert Naulet","psa":"Catherine Lamoureux","ptype":"article","src":"https://openalex.org/W2014873507","eid":"W2014873507"},{"id":"paper-w4239873389","cat":"papers","name":"Fatal multi-organ failure after suicidal overdose with MDMA, ‘Ecstasy’: case report and review of the literature","year":"1999","cit":42,"pfa":"A. Walubo","psa":"D. Seger","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4239873389","eid":"W4239873389"},{"id":"paper-w2091075456","cat":"papers","name":"A Study on the Mechanisms by Which Minocycline Protects Against MDMA (‘Ecstasy’)-Induced Neurotoxicity of 5-HT Cortical Neurons","year":"2009","cit":42,"pfa":"Laura Orío","psa":"María Isabel Colado","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2091075456","eid":"W2091075456"},{"id":"paper-w3080679302","cat":"papers","name":"P300 ‐mediated modulations in self–other processing under psychedelic psilocybin are related to connectedness and changed meaning: A window into the self–other overlap","year":"2020","cit":42,"pfa":"Lukasz Smigielski","psa":"Franz X. Vollenweider","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3080679302","eid":"W3080679302"},{"id":"paper-w2019578492","cat":"papers","name":"Hallucinogenic and stimulatory amphetamine derivatives: fingerprinting DOM, DOI, DOB, MDMA, and MBDB by spectral analysis of brain field potentials in the freely moving rat (Tele-Stereo-EEG)","year":"1989","cit":42,"pfa":"Wilfried Dimpfel","psa":"David E. Nichols","ptype":"article","src":"https://openalex.org/W2019578492","eid":"W2019578492"},{"id":"paper-w2145904740","cat":"papers","name":"Stimulus effects of N-monoethyl-1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDE) and N-hydroxy-1-(3,4-methylenedioxyphenyl)-2-aminopropane (N-OH MDA) in rats trained to discriminate MDMA from saline","year":"1989","cit":42,"pfa":"Richard A. Glennon","psa":"Bryan R. Misenheimer","ptype":"article","src":"https://openalex.org/W2145904740","eid":"W2145904740"},{"id":"paper-w1948675593","cat":"papers","name":"Simultaneous polysubstance use among Danish 3,4‐methylenedioxymethamphetamine and hallucinogen users: combination patterns and proposed biological bases","year":"2012","cit":42,"pfa":"Cecilie Löe Licht","psa":"David Erritzøe","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1948675593","eid":"W1948675593"},{"id":"paper-w2089176384","cat":"papers","name":"Zentrale vegetative LSD-Effekte","year":"1956","cit":42,"pfa":"E Rothlin","psa":"Max Taeschler","ptype":"article","src":"https://openalex.org/W2089176384","eid":"W2089176384"},{"id":"paper-w2072359636","cat":"papers","name":"The distribution of serotonin receptors in the human brain: high density of [3H]LSD binding sites in the raphe nuclei of the brainstem","year":"1983","cit":42,"pfa":"JOSE M. PALACIOS","psa":"Roser Cortés","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2072359636","eid":"W2072359636"},{"id":"paper-w2073988877","cat":"papers","name":"Pharmacological Receptors of the Cerebral Arteries of the Goat","year":"2008","cit":42,"pfa":"Pedro R. Urquilla","psa":"Salvador Lluch","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2073988877","eid":"W2073988877"},{"id":"paper-w2068446910","cat":"papers","name":"Monoamine replacement after reserpine: catecholaminergic agonists restore motor activity but phenylethylamine restores atropine-resistant neocortical low voltage fast activity.","year":"1980","cit":42,"pfa":"C.H. Vanderwolf","psa":"Bruce A. Pappas","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2068446910","eid":"W2068446910"},{"id":"paper-w2128698693","cat":"papers","name":"Ambient Temperature Effects on 3,4-Methylenedioxymethamphetamine-Induced Thermodysregulation and Pharmacokinetics in Male Monkeys","year":"2007","cit":42,"pfa":"Matthew L. Banks","psa":"Michael A. Nader","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2128698693","eid":"W2128698693"},{"id":"paper-w1520072533","cat":"papers","name":"Methylenedioxymethamphetamine (‘Ecstasy’)‐induced immunosuppression: a cause for concern?","year":"2010","cit":42,"pfa":"Noreen T. Boyle","psa":"Thomas J. Connor","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1520072533","eid":"W1520072533"},{"id":"paper-w3084922089","cat":"papers","name":"Beyond ecstasy: Alternative entactogens to 3,4-methylenedioxymethamphetamine with potential applications in psychotherapy","year":"2020","cit":42,"pfa":"Hans Emanuel Oeri","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3084922089","eid":"W3084922089"},{"id":"paper-w1967258094","cat":"papers","name":"Memantine prevents the cognitive impairment induced by 3,4-methylenedioxymethamphetamine in rats","year":"2008","cit":42,"pfa":"Jorge Camarasa","psa":"David Pubill","ptype":"article","src":"https://openalex.org/W1967258094","eid":"W1967258094"},{"id":"paper-w2088677530","cat":"papers","name":"The acute effects of 3,4-methylenedioxymethamphetamine and methamphetamine on driving: A simulator study","year":"2011","cit":42,"pfa":"Con K. K. Stough","psa":"Edward Ogden","ptype":"article","src":"https://openalex.org/W2088677530","eid":"W2088677530"},{"id":"paper-w1973256378","cat":"papers","name":"Interactions of methylenedioxymethamphetamine with monoamine transmitter release mechanisms in rat brain slices","year":"1993","cit":42,"pfa":"John FitzGerald","psa":"Julianne J. Reid","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1973256378","eid":"W1973256378"},{"id":"paper-w1993599005","cat":"papers","name":"Synthetic studies of neoclerodane diterpenes from Salvia divinorum: Exploration of the 1-position","year":"2007","cit":42,"pfa":"Kenneth G. Holden","psa":"Thomas Edward Prisinzano","ptype":"article","src":"https://openalex.org/W1993599005","eid":"W1993599005"},{"id":"paper-w2397862430","cat":"papers","name":"Human hallucinogen interactions with drugs affecting serotonergic neurotransmission.","year":"1992","cit":42,"pfa":"Rick J. Strassman","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2397862430","eid":"W2397862430"},{"id":"paper-w2769124319","cat":"papers","name":"Studies with psychedelic drugs in human volunteers","year":"2017","cit":42,"pfa":"Edward M. Sellers","psa":"Deborah B. Leiderman","ptype":"article","src":"https://openalex.org/W2769124319","eid":"W2769124319"},{"id":"paper-w2117393923","cat":"papers","name":"Treatment of drug dependence with Brazilian herbal medicines","year":"2006","cit":42,"pfa":"E.A. Carlini","psa":"Bruno Gianfratti","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2117393923","eid":"W2117393923"},{"id":"paper-w2037072019","cat":"papers","name":"The study of metabolite-to-parent drug ratios of methamphetamine and methylenedioxymethamphetamine in hair","year":"2006","cit":42,"pfa":"Eunyoung Han","psa":"Heesun Chung","ptype":"article","src":"https://openalex.org/W2037072019","eid":"W2037072019"},{"id":"paper-w3215496863","cat":"papers","name":"The Readiness of Psychiatrists to Implement Psychedelic-Assisted Psychotherapy","year":"2021","cit":42,"pfa":"Lisa Page","psa":"Graham Campbell","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3215496863","eid":"W3215496863"},{"id":"paper-w4365141030","cat":"papers","name":"With great power comes great vulnerability: an ethical analysis of psychedelics’ therapeutic mechanisms proposed by the REBUS hypothesis","year":"2023","cit":42,"pfa":"Daniel Villiger","psa":"Manuel Trachsel","topics":["Mechanism & neuroscience","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4365141030","eid":"W4365141030"},{"id":"paper-w1967681543","cat":"papers","name":"Hallucinogens: An update","year":"2003","cit":42,"pfa":"John H. Halpern","ptype":"article","src":"https://openalex.org/W1967681543","eid":"W1967681543"},{"id":"paper-w2079504951","cat":"papers","name":"The beta-carboline Hallucinogens of South America","year":"1982","cit":42,"pfa":"Richard Evans Schultes","ptype":"article","src":"https://openalex.org/W2079504951","eid":"W2079504951"},{"id":"paper-w2319975253","cat":"papers","name":"Psychedelic Drugs Reconsidered","year":"1999","cit":42,"pfa":"D. M. W.","psa":"Robert Forte","ptype":"article","src":"https://openalex.org/W2319975253","eid":"W2319975253"},{"id":"paper-w2308963264","cat":"papers","name":"Psychedelic effects of a subanesthetic concentration of nitrous oxide.","year":"1991","cit":42,"pfa":"Robert I. Block","psa":"Dhirendra Pathak","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2308963264","eid":"W2308963264"},{"id":"paper-w4311982880","cat":"papers","name":"Rapid antidepressant-like effect of non-hallucinogenic psychedelic analog lisuride, but not hallucinogenic psychedelic DOI, in lipopolysaccharide-treated mice","year":"2022","cit":42,"pfa":"Youge Qu","psa":"Kenji Hashimoto","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4311982880","eid":"W4311982880"},{"id":"paper-w2083634919","cat":"papers","name":"Predicting Drug Candidate Victims of Drug-Drug Interactions, using Microdosing","year":"2012","cit":42,"pfa":"Marie Croft","psa":"Graham Lappin","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2083634919","eid":"W2083634919"},{"id":"paper-w4410974136","cat":"papers","name":"An international Delphi consensus for reporting of setting in psychedelic clinical trials","year":"2025","cit":42,"pfa":"Chloé Pronovost-Morgan","psa":"Olivia Marcus","topics":["Addiction","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4410974136","eid":"W4410974136"},{"id":"paper-w4310945775","cat":"papers","name":"Journeying to Ixtlan: Ethics of Psychedelic Medicine and Research for Alzheimer’s Disease and Related Dementias","year":"2022","cit":42,"pfa":"Andrew H. Peterson","psa":"Dominic A. Sisti","topics":["Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4310945775","eid":"W4310945775"},{"id":"paper-w2470859535","cat":"papers","name":"Fluorescent Affibody Molecule Administered In Vivo at a Microdose Level Labels EGFR Expressing Glioma Tumor Regions","year":"2016","cit":42,"pfa":"Ana Luiza Ribeiro de Souza","psa":"Brian W. Pogue","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2470859535","eid":"W2470859535"},{"id":"paper-w2054412455","cat":"papers","name":"Correlation of psychotomimetic activity of phenethylamines and amphetamines with 1-octanol-water partition coefficients","year":"1975","cit":42,"pfa":"Charles F. Barfknecht","psa":"William J. Dunn","ptype":"article","src":"https://openalex.org/W2054412455","eid":"W2054412455"},{"id":"paper-w2158905380","cat":"papers","name":"Differential effects of antipsychotic and psychotomimetic drugs on neurotensin systems of discrete extrapyramidal and limbic regions.","year":"1994","cit":42,"pfa":"Steven P. Gygi","psa":"Glen R. Hanson","ptype":"article","src":"https://openalex.org/W2158905380","eid":"W2158905380"},{"id":"paper-w153680473","cat":"papers","name":"Treatment of acne scars with hyaluronic acid: an improved approach.","year":"2013","cit":42,"pfa":"Shlomit Halachmi","psa":"Moshe Lapidoth","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W153680473","eid":"W153680473"},{"id":"paper-w4226270886","cat":"papers","name":"Efficacy and Safety of Ketamine in the Treatment of Neuropathic Pain: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","year":"2022","cit":42,"pfa":"José Eduardo Guimarães Pereira","psa":"Hazem Adel Ashmawi","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4226270886","eid":"W4226270886"},{"id":"paper-w2887303718","cat":"papers","name":"Ketamine modulates aggressive behavior in adult zebrafish","year":"2018","cit":42,"pfa":"Paula Michelotti","psa":"Denis Broock Rosemberg","ptype":"article","src":"https://openalex.org/W2887303718","eid":"W2887303718"},{"id":"paper-w1835907458","cat":"papers","name":"Associations between Attention Deficit Hyperactivity Disorder Symptom Domains and DSM‐IV Lifetime Substance Dependence","year":"2013","cit":42,"pfa":"Katherine J. Ameringer","psa":"Adam Matthew Leventhal","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1835907458","eid":"W1835907458"},{"id":"paper-w2039541786","cat":"papers","name":"Identification of Two Serine Residues Essential for Agonist-Induced 5-HT2AReceptor Desensitization","year":"2003","cit":42,"pfa":"John Archibald Browne Gray","psa":"Bryan L. Roth","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2039541786","eid":"W2039541786"},{"id":"paper-w2844939796","cat":"papers","name":"Relationships between substance abuse/dependence and psychiatric disorders based on polygenic scores","year":"2018","cit":42,"pfa":"Xaquín Gurriarán","psa":"the GenPol Study Group","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2844939796","eid":"W2844939796"},{"id":"paper-w2415049614","cat":"papers","name":"Assessment of the Abuse Potential of the Orexin Receptor Antagonist, Suvorexant, Compared With Zolpidem in a Randomized Crossover Study","year":"2016","cit":42,"pfa":"Kerri A. Schoedel","psa":"John A. Wagner","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2415049614","eid":"W2415049614"},{"id":"paper-w1975979767","cat":"papers","name":"Psychomotor and cognitive effects of a single oral dose of talnetant (SB223412) in healthy volunteers compared with placebo or haloperidol","year":"2008","cit":42,"pfa":"M Liem-Moolenaar","psa":"JMA van Gerven","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1975979767","eid":"W1975979767"},{"id":"paper-w3121560609","cat":"papers","name":"Comparative effects of (S)-ketamine and racemic (R/S)-ketamine on psychopathology, state of consciousness and neurocognitive performance in healthy volunteers","year":"2021","cit":42,"pfa":"Torsten Passie","psa":"Matthias Karst","ptype":"article","src":"https://openalex.org/W3121560609","eid":"W3121560609"},{"id":"paper-w2977794982","cat":"papers","name":"Oral Cannabidiol Does Not Convert to Δ 8 -THC or Δ 9 -THC in Humans: A Pharmacokinetic Study in Healthy Subjects","year":"2019","cit":42,"pfa":"José Alexandre S. Crippa","psa":"Liberato Brum","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2977794982","eid":"W2977794982"},{"id":"paper-w2092499925","cat":"papers","name":"Review of NMDA antagonist-induced neurotoxicity and implications for clinical development","year":"2004","cit":42,"pfa":"S.J. Low","psa":"Carl L. Roland","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2092499925","eid":"W2092499925"},{"id":"paper-w2031330276","cat":"papers","name":"Identification of the binding subunit of the sigma-type opiate receptor by photoaffinity labeling with 1-(4-azido-2-methyl[6-3H]phenyl)-3-(2-methyl[4,6-3H]phenyl)guanidine.","year":"1988","cit":42,"pfa":"Michael P. Kavanaugh","psa":"E Weber","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2031330276","eid":"W2031330276"},{"id":"paper-w3204246306","cat":"papers","name":"Ketamine and other glutamate receptor modulators for depression in adults with bipolar disorder","year":"2021","cit":42,"pfa":"Rebecca L. Dean","psa":"Andrea Cipriani","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3204246306","eid":"W3204246306"},{"id":"paper-w4308182016","cat":"papers","name":"Safety and effectiveness of intranasal esketamine for treatment-resistant depression: a real-world retrospective study","year":"2022","cit":42,"pfa":"Madeline Brendle","psa":"Reid J. Robison","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4308182016","eid":"W4308182016"},{"id":"paper-w3205750883","cat":"papers","name":"Ketamine for Treatment of Mood Disorders and Suicidality: A Narrative Review of Recent Progress","year":"2021","cit":42,"pfa":"Michael D. Kritzer","psa":"Sanjay J. Mathew","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"review","src":"https://openalex.org/W3205750883","eid":"W3205750883"},{"id":"paper-w4281671491","cat":"papers","name":"Safety and effectiveness of NMDA receptor antagonists for depression: A multidisciplinary review","year":"2022","cit":42,"pfa":"Thomas J. Moore","psa":"Donald R. Mattison","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4281671491","eid":"W4281671491"},{"id":"paper-w2751936814","cat":"papers","name":"Ketamine metabolites with antidepressant effects: Fast, economical, and eco-friendly enantioselective separation based on supercritical-fluid chromatography (SFC) and single quadrupole MS detection","year":"2017","cit":42,"pfa":"Georg M. Fassauer","psa":"Andreas Link","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2751936814","eid":"W2751936814"},{"id":"paper-w2031400634","cat":"papers","name":"Behaviorally induced sensitivity to the discriminable properties of LSD","year":"1975","cit":42,"pfa":"Isaac Greenberg","psa":"J. B. Appel","ptype":"article","src":"https://openalex.org/W2031400634","eid":"W2031400634"},{"id":"paper-w2161083324","cat":"papers","name":"Distribution of Ibogaine and Noribogaine in a Man Following a Poisoning Involving Root Bark of the Tabernanthe iboga Shrub","year":"2006","cit":41,"pfa":"V. Kontrimaviciute","psa":"Françoise Bressolle","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2161083324","eid":"W2161083324"},{"id":"paper-w2074400292","cat":"papers","name":"Subjective Reactions to Lysergic Acid Diethylamide (LSD-25)","year":"1962","cit":41,"pfa":"Harriet B. Linton","ptype":"article","src":"https://openalex.org/W2074400292","eid":"W2074400292"},{"id":"paper-w2093159894","cat":"papers","name":"The hallucinogen d-lysergic acid diethylamide (d-LSD) induces the immediate-early gene c-Fos in rat forebrain","year":"2002","cit":41,"pfa":"Paul S. Frankel","psa":"Kathryn A. Cunningham","ptype":"article","src":"https://openalex.org/W2093159894","eid":"W2093159894"},{"id":"paper-w4283700520","cat":"papers","name":"Modulation of DNA methylation and protein expression in the prefrontal cortex by repeated administration of D-lysergic acid diethylamide (LSD): Impact on neurotropic, neurotrophic, and neuroplasticity signaling","year":"2022","cit":41,"pfa":"Antonio Inserra","psa":"Gabriella Gobbi","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4283700520","eid":"W4283700520"},{"id":"paper-w2532357142","cat":"papers","name":"Total Synthesis of (−)‐Salvinorin A","year":"2016","cit":41,"pfa":"Nathan J. Line","psa":"Craig J. Forsyth","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2532357142","eid":"W2532357142"},{"id":"paper-w4308146113","cat":"papers","name":"Psilocybin in Treatment-Resistant Depression","year":"2022","cit":41,"pfa":"Bertha Kalifon Madras","topics":["Depression","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4308146113","eid":"W4308146113"},{"id":"paper-w2307731583","cat":"papers","name":"DEGRADATION OF MESCALINE BY AMINE OXIDASES","year":"1958","cit":41,"pfa":"E. A. Zeller","psa":"James R. Fouts","ptype":"article","src":"https://openalex.org/W2307731583","eid":"W2307731583"},{"id":"paper-w4385783116","cat":"papers","name":"The risk of chronic psychedelic and MDMA microdosing for valvular heart disease","year":"2023","cit":41,"pfa":"Michael Tagen","psa":"Richard Knowles","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4385783116","eid":"W4385783116"},{"id":"paper-w2751749587","cat":"papers","name":"A phenomenological analysis of the subjective experience elicited by ibogaine in the context of a drug dependence treatment","year":"2017","cit":41,"pfa":"Eduardo Ekman Schenberg","psa":"Dartiu Xavier da Silveira","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2751749587","eid":"W2751749587"},{"id":"paper-w2114442416","cat":"papers","name":"Psilocin, Bufotenine and Serotonin: Historical and Biosynthetic Observations","year":"1979","cit":41,"pfa":"William Scott Chilton","psa":"Robert E. Jensen","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2114442416","eid":"W2114442416"},{"id":"paper-w201613717","cat":"papers","name":"Discarnate entities and dimethyltryptamine (DMT): Psychopharmacology, phenomenology and ontology","year":"2011","cit":41,"pfa":"David P. Luke","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W201613717","eid":"W201613717"},{"id":"paper-w4362471804","cat":"papers","name":"Psychotherapy with Psilocybin for Depression: Systematic Review","year":"2023","cit":41,"pfa":"Jonathan Joseph Dawood-Hristova","psa":"Virtudes Pérez‐Jover","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W4362471804","eid":"W4362471804"},{"id":"paper-w2076298662","cat":"papers","name":"The effect of mescaline upon the conditioned avoidance response in the rat","year":"1964","cit":41,"pfa":"John Smythies","psa":"Elizabeth A. Sykes","ptype":"article","src":"https://openalex.org/W2076298662","eid":"W2076298662"},{"id":"paper-w2412554478","cat":"papers","name":"Clinical, biochemical and psychologic effects of psilocybin.","year":"1961","cit":41,"pfa":"L E Hollister","ptype":"article","src":"https://openalex.org/W2412554478","eid":"W2412554478"},{"id":"paper-w4243473845","cat":"papers","name":"Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges","year":"2004","cit":41,"pfa":"David H. McKenna","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4243473845","eid":"W4243473845"},{"id":"paper-w2084382331","cat":"papers","name":"Determination and physiological disposition of dimethyltryptamine and diethyltryptamine in rat brain, liver and plasma","year":"1972","cit":41,"pfa":"Irving M. Cohen","psa":"Wolfgang H Vogel","ptype":"article","src":"https://openalex.org/W2084382331","eid":"W2084382331"},{"id":"paper-w2315678513","cat":"papers","name":"Frenquel, a Blocking Agent Against Experimental LSD‐25 and Mescaline Psychosis","year":"1955","cit":41,"pfa":"Howard D. Fabing","topics":["Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2315678513","eid":"W2315678513"},{"id":"paper-w1971381195","cat":"papers","name":"Mechanism of hERG Channel Block by the Psychoactive Indole Alkaloid Ibogaine","year":"2013","cit":41,"pfa":"Patrick Thurner","psa":"Xaver Koenig","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1971381195","eid":"W1971381195"},{"id":"paper-w2009833672","cat":"papers","name":"Modification of the furan ring of salvinorin A: Identification of a selective partial agonist at the kappa opioid receptor","year":"2008","cit":41,"pfa":"Cécile Béguin","psa":"Bruce M. Cohen","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2009833672","eid":"W2009833672"},{"id":"paper-w2138138743","cat":"papers","name":"Cannabis and Ecstasy/MDMA: Empirical Measures of Creativity in Recreational Users","year":"2009","cit":41,"pfa":"Katy A. Jones","psa":"Andrew C. Parrott","ptype":"article","src":"https://openalex.org/W2138138743","eid":"W2138138743"},{"id":"paper-w2052323109","cat":"papers","name":"Reinstatement of MDMA (ecstasy) seeking by exposure to discrete drug-conditioned cues","year":"2007","cit":41,"pfa":"Kevin T. Ball","psa":"George V. Rebec","ptype":"article","src":"https://openalex.org/W2052323109","eid":"W2052323109"},{"id":"paper-w1971561005","cat":"papers","name":"Neuropsychiatric manifestations following the use of 3, 4-methylenedioxymethamphetamine (MDMA; “Ecstasy”)","year":"1997","cit":41,"pfa":"Richard S. Cohen","psa":"James A. Cocores","ptype":"article","src":"https://openalex.org/W1971561005","eid":"W1971561005"},{"id":"paper-w2151385468","cat":"papers","name":"Recreational ecstasy use and the neurotoxic potential of MDMA: current status of the controversy and methodological issues","year":"2006","cit":41,"pfa":"Michael Lyvers","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2151385468","eid":"W2151385468"},{"id":"paper-w4391970820","cat":"papers","name":"Effect of chemically synthesized psilocybin and psychedelic mushroom extract on molecular and metabolic profiles in mouse brain","year":"2024","cit":41,"pfa":"Orr Shahar","psa":"Tzuri Lifschytz","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4391970820","eid":"W4391970820"},{"id":"paper-w2616851118","cat":"papers","name":"Comparative Effects of Methylphenidate, Modafinil, and MDMA on Response Inhibition Neural Networks in Healthy Subjects","year":"2017","cit":41,"pfa":"André Schmidt","psa":"Stefan Borgwardt","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2616851118","eid":"W2616851118"},{"id":"paper-w3091826712","cat":"papers","name":"MDMA Electrochemical Determination and Behavior at Carbon Screen‐printed Electrodes: Cheap Tools for Forensic Applications","year":"2020","cit":41,"pfa":"Gustavo Murilo Alves","psa":"Marcelo Firmino de Oliveira","ptype":"article","src":"https://openalex.org/W3091826712","eid":"W3091826712"},{"id":"paper-w2320132655","cat":"papers","name":"Identification of Indole Alkaloid Structural Units Important for Stimulus-Selective TRPM8 Inhibition: SAR Study of Naturally Occurring Iboga Derivatives","year":"2014","cit":41,"pfa":"Yuko Terada","psa":"Tatsuo Watanabe","ptype":"article","src":"https://openalex.org/W2320132655","eid":"W2320132655"},{"id":"paper-w3107283988","cat":"papers","name":"RETRACTED ARTICLE: Discontinuation of medications classified as reuptake inhibitors affects treatment response of MDMA-assisted psychotherapy","year":"2020","cit":41,"pfa":"Allison A. Feduccia","psa":"Julie A. Holland","topics":["Depression","PTSD & trauma","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3107283988","eid":"W3107283988"},{"id":"paper-w2055551716","cat":"papers","name":"Evidence that both intragastric and subcutaneous administration of methylenedioxymethylamphetamine (MDMA) produce serotonin neurotoxicity in rhesus monkeys","year":"1989","cit":41,"pfa":"Mark S. Kleven","psa":"Lewis S. Seiden","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2055551716","eid":"W2055551716"},{"id":"paper-w2157456383","cat":"papers","name":"Underground MDMA-, LSD- and 2-CB-assisted individual and group psychotherapy in Zurich: Outcomes, implications and commentary","year":"2015","cit":41,"pfa":"Ben Sessa","psa":"Friederike Meckel Fischer","topics":["Addiction","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2157456383","eid":"W2157456383"},{"id":"paper-w1872981930","cat":"papers","name":"Evaluation of drug incorporation into hair segments and nails by enantiomeric analysis following controlled single MDMA intakes","year":"2015","cit":41,"pfa":"Milena M. Madry","psa":"Thomas Kræmer","ptype":"article","src":"https://openalex.org/W1872981930","eid":"W1872981930"},{"id":"paper-w2901139539","cat":"papers","name":"MDMA Increases Cooperation and Recruitment of Social Brain Areas When Playing Trustworthy Players in an Iterated Prisoner's Dilemma","year":"2018","cit":41,"pfa":"Anthony S. Gabay","psa":"Mitul Ashok Mehta","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2901139539","eid":"W2901139539"},{"id":"paper-w2128322193","cat":"papers","name":"Neural Effects of MDMA as Determined by Functional Magnetic Resonance Imaging and Magnetic Resonance Spectroscopy in Awake Marmoset Monkeys","year":"2006","cit":41,"pfa":"Jerrold S. Meyer","psa":"Craig F. Ferris","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2128322193","eid":"W2128322193"},{"id":"paper-w2026843075","cat":"papers","name":"Chronic treatment with supraphysiological levels of corticosterone enhances d-MDMA-induced dopaminergic neurotoxicity in the C57BL/6J female mouse","year":"2002","cit":41,"pfa":"Elizabeth Anne Johnson","psa":"Diane Bemis Miller","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2026843075","eid":"W2026843075"},{"id":"paper-w4390790998","cat":"papers","name":"Microdosing psychedelics and the risk of cardiac fibrosis and valvulopathy: Comparison to known cardiotoxins","year":"2024","cit":41,"pfa":"Antonin Rouaud","psa":"Gregor Hasler","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4390790998","eid":"W4390790998"},{"id":"paper-w1969484211","cat":"papers","name":"Central 5-hydroxytryptamine and the effects of hallucinogens and phenobarbital on operant responding in rats","year":"1981","cit":41,"pfa":"Randall L. Commissaris","psa":"Richard H. Rech","ptype":"article","src":"https://openalex.org/W1969484211","eid":"W1969484211"},{"id":"paper-w2028456442","cat":"papers","name":"LSD flashback syndrome exacerbated by selective serotonin reuptake inhibitor antidepressants in adolescents","year":"1994","cit":41,"pfa":"Howard Markel","psa":"Edward F. Domino","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2028456442","eid":"W2028456442"},{"id":"paper-w1999427970","cat":"papers","name":"The use of illicit drugs as self-medication in the treatment of cluster headache: Results from an Italian online survey","year":"2015","cit":41,"pfa":"Cherubino Di Lorenzo","psa":"Francesco Pierelli","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1999427970","eid":"W1999427970"},{"id":"paper-w2091319148","cat":"papers","name":"LSD produces place preference and flavor avoidance but does not produce flavor aversion in rats.","year":"1996","cit":41,"pfa":"Linda A. Parker","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2091319148","eid":"W2091319148"},{"id":"paper-w4300670882","cat":"papers","name":"The experimental use of psychedelic (LSD) psychotherapy","year":"1970","cit":41,"pfa":"Pahnke Wn","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4300670882","eid":"W4300670882"},{"id":"paper-w2557014604","cat":"papers","name":"Tripping up addiction: the use of psychedelic drugs in the treatment of problematic drug and alcohol use","year":"2016","cit":41,"pfa":"Celia J. A. Morgan","psa":"Will Lawn","topics":["Addiction"],"ptype":"review","src":"https://openalex.org/W2557014604","eid":"W2557014604"},{"id":"paper-w2093052387","cat":"papers","name":"An analysis of some perceptual effects of morphine, chlorpromazine, and LSD","year":"1979","cit":41,"pfa":"Linda L. Hernández","psa":"James B. Appel","ptype":"article","src":"https://openalex.org/W2093052387","eid":"W2093052387"},{"id":"paper-w1996881474","cat":"papers","name":"Demonstration of an Autoreceptor Modulating the Release of [3H]5‐Hydroxytryptamine from a Synaptosomal‐Rich Spinal Cord Tissue Preparation","year":"1985","cit":41,"pfa":"Philip J. Monroe","psa":"David J. Smith","topics":["Depression","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1996881474","eid":"W1996881474"},{"id":"paper-w2143108928","cat":"papers","name":"The Role of Mitochondrial Uncoupling in 3,4-Methylenedioxymethamphetamine-Mediated Skeletal Muscle Hyperthermia and Rhabdomyolysis","year":"2005","cit":41,"pfa":"Daniel E. Rusyniak","psa":"Jon E. Sprague","ptype":"article","src":"https://openalex.org/W2143108928","eid":"W2143108928"},{"id":"paper-w2058110328","cat":"papers","name":"Serotonergic–dopaminergic mediation of MDMA's discriminative stimulus effects in a three-choice discrimination","year":"2003","cit":41,"pfa":"Amy Goodwin","psa":"Lisa E. Baker","ptype":"article","src":"https://openalex.org/W2058110328","eid":"W2058110328"},{"id":"paper-w2517871020","cat":"papers","name":"Development and validation of an ultra‐fast and sensitive microflow liquid chromatography‐tandem mass spectrometry (MFLC‐MS/MS) method for quantification of LSD and its metabolites in plasma and application to a controll","year":"2016","cit":41,"pfa":"Andrea Eva Steuer","psa":"Thomas Kræmer","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2517871020","eid":"W2517871020"},{"id":"paper-w2134907178","cat":"papers","name":"Paroxetine Inhibits Acute Effects of 3,4-Methylenedioxymethamphetamine on the Immune System in Humans","year":"2004","cit":41,"pfa":"Roberta Pacifici","psa":"Rafael de la Torre","ptype":"article","src":"https://openalex.org/W2134907178","eid":"W2134907178"},{"id":"paper-w2068257734","cat":"papers","name":"DNA fragmentation and oxidative stress in the hippocampal formation: a bridge between 3,4-methylenedioxymethamphetamine (ecstasy) intake and long-lasting behavioral alterations","year":"2007","cit":41,"pfa":"Giada Frenzilli","psa":"Francesco Fornai","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2068257734","eid":"W2068257734"},{"id":"paper-w2027880186","cat":"papers","name":"Effects of combined treatment with mephedrone and methamphetamine or 3,4-methylenedioxymethamphetamine on serotonin nerve endings of the hippocampus","year":"2013","cit":41,"pfa":"Mariana Angoa‐Pérez","psa":"Donald M. Kuhn","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2027880186","eid":"W2027880186"},{"id":"paper-w1987574409","cat":"papers","name":"Shedding New Light on the “Safe” Club Drug: Methylenedioxymethamphetamine (Ecstasy)‐related Fatalities","year":"2004","cit":41,"pfa":"Manish M Patel","psa":"Michael A. Miller","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1987574409","eid":"W1987574409"},{"id":"paper-w1965314215","cat":"papers","name":"Stereochemical analysis of 3,4‐methylenedioxymethamphetamine and its main metabolites by gas chromatography/mass spectrometry","year":"2003","cit":41,"pfa":"Nieves Pizarro","psa":"Rafael de la Torre","ptype":"article","src":"https://openalex.org/W1965314215","eid":"W1965314215"},{"id":"paper-w3090675239","cat":"papers","name":"Taking Different Roads: l ‐Tryptophan as the Origin of Psilocybe Natural Products","year":"2020","cit":41,"pfa":"Claudius Lenz","psa":"Dirk Hoffmeister","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3090675239","eid":"W3090675239"},{"id":"paper-w2109295270","cat":"papers","name":"Nitric Oxide and the Neurotoxic Effects of Methamphetamine and 3,4-Methylenedioxymethamphetamine","year":"1997","cit":41,"pfa":"Terri Taraska","psa":"Kevin T. Finnegan","ptype":"article","src":"https://openalex.org/W2109295270","eid":"W2109295270"},{"id":"paper-w2168434759","cat":"papers","name":"Determination of potentially hallucinogenic N-dimethylated indoleamines in human urine by HPLC/ESI-MS-MS","year":"2001","cit":41,"pfa":"T. Forsström, J. Tuominen, J. Kärkkäin","ptype":"article","src":"https://openalex.org/W2168434759","eid":"W2168434759"},{"id":"paper-w1988670123","cat":"papers","name":"The Neuropsychopharmacology and Toxicology of 3,4‐methylenedioxy‐N‐ethyl‐amphetamine (MDEA)","year":"2004","cit":41,"pfa":"Roland W. Freudenmann","psa":"Manfred Spitzer","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1988670123","eid":"W1988670123"},{"id":"paper-w2106903834","cat":"papers","name":"Hallucinogenic plant use and related indigenous belief systems in the ecuadorian amazon","year":"1979","cit":41,"pfa":"Plutarco Naranjo","ptype":"article","src":"https://openalex.org/W2106903834","eid":"W2106903834"},{"id":"paper-w2952525950","cat":"papers","name":"Naphthosultam derivatives: a new class of potent and selective 5-HT2 antagonists","year":"1991","cit":41,"pfa":"Jean-Luc Malleron","psa":"Jean‐Luc Zundel","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2952525950","eid":"W2952525950"},{"id":"paper-w3159796563","cat":"papers","name":"Psychedelic-Assisted Psychotherapy Practices and Human Caring Science: Toward a Care-Informed Model of Treatment","year":"2021","cit":41,"pfa":"Andrew  D. Penn","psa":"Jean Watson","topics":["Depression","PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3159796563","eid":"W3159796563"},{"id":"paper-w4382502499","cat":"papers","name":"Clinical specificity profile for novel rapid acting antidepressant drugs","year":"2023","cit":41,"pfa":"Mauro Scala","psa":"Chiara Fabbri","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4382502499","eid":"W4382502499"},{"id":"paper-w2150189337","cat":"papers","name":"Simultaneous quantification of amphetamine, opiates, ketamine and relative metabolites in urine for confirmatory analysis by liquid chromatography tandem mass spectrometry","year":"2013","cit":41,"pfa":"Huei‐Ru Lin","psa":"Anren Hu","ptype":"article","src":"https://openalex.org/W2150189337","eid":"W2150189337"},{"id":"paper-w2988260994","cat":"papers","name":"Neurochemical and Behavioral Profiling in Male and Female Rats of the Psychedelic Agent 25I-NBOMe","year":"2019","cit":41,"pfa":"Cristina Miliano","psa":"Maria Antonietta De Luca","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2988260994","eid":"W2988260994"},{"id":"paper-w2567036024","cat":"papers","name":"A Prospective Analysis of Patients Presenting for Medical Attention at a Large Electronic Dance Music Festival","year":"2016","cit":41,"pfa":"Matt S. Friedman","psa":"Benjamin Wolkin Friedman","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2567036024","eid":"W2567036024"},{"id":"paper-w3160306775","cat":"papers","name":"CE: Psychedelic-Assisted Therapy","year":"2021","cit":41,"pfa":"Andrew  D. Penn","psa":"William E. Rosa","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W3160306775","eid":"W3160306775"},{"id":"paper-w4210791300","cat":"papers","name":"The frontiers of new psychedelic therapies: A survey of sociological themes and issues","year":"2022","cit":41,"pfa":"Timothy Andrews","psa":"Katie Wright","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4210791300","eid":"W4210791300"},{"id":"paper-w3195587140","cat":"papers","name":"Examining the Potential Synergistic Effects Between Mindfulness Training and Psychedelic-Assisted Therapy","year":"2021","cit":41,"pfa":"Maria Eleni Eleftheriou","psa":"Emily M Thomas","topics":["Depression","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3195587140","eid":"W3195587140"},{"id":"paper-w4200517619","cat":"papers","name":"Palliative care provider attitudes toward existential distress and treatment with psychedelic-assisted therapies","year":"2021","cit":41,"pfa":"Halsey F. Niles","psa":"Mark Lazenby","topics":["Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4200517619","eid":"W4200517619"},{"id":"paper-w2803321455","cat":"papers","name":"Cannabis and hallucinogens","year":"2019","cit":41,"pfa":"United Nations Office on Drugs and Crime","ptype":"book-chapter","src":"https://openalex.org/W2803321455","eid":"W2803321455"},{"id":"paper-w3182623456","cat":"papers","name":"Psychoactive sacramentals: Essays on entheogens and religion.","year":"2001","cit":41,"pfa":"Thomas B. Roberts","ptype":"article","src":"https://openalex.org/W3182623456","eid":"W3182623456"},{"id":"paper-w2799034873","cat":"papers","name":"The Psychedelic 'Experience'","year":"1967","cit":41,"pfa":"Committee on Mental Health Student","ptype":"book-chapter","src":"https://openalex.org/W2799034873","eid":"W2799034873"},{"id":"paper-w2086553370","cat":"papers","name":"Plant Hallucinogens and the religion of the Mochica—an ancient Peruvian people","year":"1977","cit":41,"pfa":"Marlene Dobkin de Ríos","ptype":"article","src":"https://openalex.org/W2086553370","eid":"W2086553370"},{"id":"paper-w4307481525","cat":"papers","name":"Proposed Consensus Statement on Defining Psychedelic Drugs","year":"2022","cit":41,"pfa":"David E. Nichols","psa":"Peter S. Hendricks","ptype":"article","src":"https://openalex.org/W4307481525","eid":"W4307481525"},{"id":"paper-w3038388367","cat":"papers","name":"Historic psychedelic drug trials and the treatment of anxiety disorders","year":"2020","cit":41,"pfa":"N. Weston","psa":"James Rucker","topics":["Anxiety & end-of-life","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3038388367","eid":"W3038388367"},{"id":"paper-w2057721458","cat":"papers","name":"Psychedelic drug flashbacks: Subjective reports and biographical data","year":"1978","cit":41,"pfa":"Robert E. Matefy","psa":"Jerrold Hirsch","ptype":"article","src":"https://openalex.org/W2057721458","eid":"W2057721458"},{"id":"paper-w3208662682","cat":"papers","name":"Psychedelic experience dose-dependently modulated by cannabis: results of a prospective online survey","year":"2021","cit":41,"pfa":"Joanna Kuc","psa":"Robin Lester Carhart-Harris","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3208662682","eid":"W3208662682"},{"id":"paper-w2205353139","cat":"papers","name":"Licit and Illicit Drugs. The Consumers Union Report on Narcotics, Stimulants, Depressants, Inhalants, Hallucinogens, and Marijuana—Including Caffeine, Nicotine, and Alcohol.","year":"1973","cit":41,"pfa":"Becker, Charles E.","topics":["Depression","Addiction"],"ptype":"book-review","src":"https://openalex.org/W2205353139","eid":"W2205353139"},{"id":"paper-w4224998755","cat":"papers","name":"Naturalistic use of psychedelics is related to emotional reactivity and self-consciousness: The mediating role of ego-dissolution and mystical experiences","year":"2022","cit":41,"pfa":"Paweł Orlowski","psa":"Michał Bola","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4224998755","eid":"W4224998755"},{"id":"paper-w1988441264","cat":"papers","name":"Psychotomimetic‐induction of tissue plasminogen activator mRNA in corticostriatal neurons in rat brain","year":"1998","cit":41,"pfa":"Takanori Hashimoto","psa":"Toru Nishikawa","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1988441264","eid":"W1988441264"},{"id":"paper-w1973886362","cat":"papers","name":"Lack of amnestic, psychotomimetic or impairing effect on psychomotor performance of eliprodil, a new NMDA antagonist","year":"1994","cit":41,"pfa":"Alain A. Patat","psa":"Alain J. Puech","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1973886362","eid":"W1973886362"},{"id":"paper-w2293305691","cat":"papers","name":"Strategies to mitigate dissociative and psychotomimetic effects of ketamine in the treatment of major depressive episodes: a narrative review","year":"2016","cit":41,"pfa":"Matthew D. Cooper","psa":"Roger S. McIntyre","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W2293305691","eid":"W2293305691"},{"id":"paper-w2080016103","cat":"papers","name":"Posttraumatic Stress Symptom Clusters, Trauma History, and Substance Use among College Students","year":"2011","cit":41,"pfa":"Elizabeth M. Avant","psa":"Christopher C. Cranston","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W2080016103","eid":"W2080016103"},{"id":"paper-w2155307417","cat":"papers","name":"Ethnopharmacology and Taxonomy of Mexican Psychodysleptic Plants","year":"1979","cit":41,"pfa":"José Luis Díaz","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2155307417","eid":"W2155307417"},{"id":"paper-w2925297114","cat":"papers","name":"Perpetrator effects of ciclosporin (P‐glycoprotein inhibitor) and its combination with fluconazole (CYP3A inhibitor) on the pharmacokinetics of rivaroxaban in healthy volunteers","year":"2019","cit":41,"pfa":"Antonia Brings","psa":"David Czock","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2925297114","eid":"W2925297114"},{"id":"paper-w2068630770","cat":"papers","name":"Substance-Induced Dissociative Disorders and Psychiatric Nosology","year":"1989","cit":41,"pfa":"Michael I. Good","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2068630770","eid":"W2068630770"},{"id":"paper-w2740671766","cat":"papers","name":"Investigating the Short-Term Effects of Manual Lymphatic Drainage and Compression Garment Therapies on Lymphatic Function Using Near-Infrared Imaging","year":"2017","cit":41,"pfa":"Catalina Lopera Muñetón","psa":"Deborah Fenlon","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2740671766","eid":"W2740671766"},{"id":"paper-w3028928378","cat":"papers","name":"Effects of 5‐HT2A receptor stimulation on economic demand for fentanyl after intermittent and continuous access self‐administration in male rats","year":"2020","cit":41,"pfa":"David Alexander Martin","psa":"Donna J. Calu","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3028928378","eid":"W3028928378"},{"id":"paper-w4239256952","cat":"papers","name":"Bhang Psychosis","year":"1973","cit":41,"pfa":"Vinod Rai Thacore","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4239256952","eid":"W4239256952"},{"id":"paper-w2315636846","cat":"papers","name":"A comparison of drug effects in latent inhibition and the forced swim test differentiates between the typical antipsychotic haloperidol, the atypical antipsychotics clozapine and olanzapine, and the antidepressants imipr","year":"2003","cit":41,"pfa":"I. Weiner","psa":"Daphna Joel","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2315636846","eid":"W2315636846"},{"id":"paper-w2763165865","cat":"papers","name":"Sedation with propofol during ERCP: is the combination with esketamine more effective and safer than with alfentanil? Study protocol for a randomized controlled trial","year":"2017","cit":41,"pfa":"Susanne Eberl","psa":"Benedikt Preckel","topics":["Depression","Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2763165865","eid":"W2763165865"},{"id":"paper-w3097995107","cat":"papers","name":"Effects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Emotion, Cognition, and Attention: A Double-Blind, Placebo-Controlled, Randomized Experimental Trial in Healthy Volunteers","year":"2020","cit":41,"pfa":"Timo Woelfl","psa":"F. Markus Leweke","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3097995107","eid":"W3097995107"},{"id":"paper-w4320709462","cat":"papers","name":"Arketamine for cognitive impairment in psychiatric disorders","year":"2023","cit":41,"pfa":"Kenji Hashimoto","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4320709462","eid":"W4320709462"},{"id":"paper-w1511213533","cat":"papers","name":"The distribution and clearance of (2S,6S)‐hydroxynorketamine, an active ketamine metabolite, in Wistar rats","year":"2015","cit":41,"pfa":"Ruin Moaddel","psa":"Irving W. Wainer","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1511213533","eid":"W1511213533"},{"id":"paper-w3171328440","cat":"papers","name":"Neurocognitive aspects of ketamine and esketamine on subjects with treatment-resistant depression: A comparative, randomized and double-blind study","year":"2021","cit":41,"pfa":"Lucas Araújo-de-Freitas","psa":"Lucas C. Quarantini","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W3171328440","eid":"W3171328440"},{"id":"paper-w3004131643","cat":"papers","name":"Ketamine: The final frontier or another depressing end?","year":"2020","cit":41,"pfa":"Omar K. Sial","psa":"Carlos A. Bolaños‐Guzmán","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W3004131643","eid":"W3004131643"},{"id":"paper-w2967193400","cat":"papers","name":"Ketamine metabolite pilot study in a suicidal depression trial","year":"2019","cit":41,"pfa":"Michael F. Grunebaum","psa":"J. John Mann","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2967193400","eid":"W2967193400"},{"id":"paper-w2994314773","cat":"papers","name":"Suicide Has Many Faces, So Does Ketamine: a Narrative Review on Ketamine’s Antisuicidal Actions","year":"2019","cit":41,"pfa":"Aistė Lengvenytė","psa":"Philippe Courtet","topics":["Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W2994314773","eid":"W2994314773"},{"id":"paper-w3018943821","cat":"papers","name":"Antidepressant mechanisms of ketamine: Focus on GABAergic inhibition","year":"2020","cit":41,"pfa":"Bernhard Lüscher","psa":"Sarah J. Jefferson","topics":["Depression","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W3018943821","eid":"W3018943821"},{"id":"paper-w4224839098","cat":"papers","name":"The Possible Application of Ketamine in the Treatment of Depression in Alzheimer’s Disease","year":"2022","cit":41,"pfa":"Islam Mohammad Shehata","psa":"Alan D. Kaye","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4224839098","eid":"W4224839098"},{"id":"paper-w2017316864","cat":"papers","name":"Clinical Studies of Lysergic Acid Diethylamide","year":"2008","cit":40,"pfa":"E.W. Anderson","psa":"K Rawnsley","ptype":"article","src":"https://openalex.org/W2017316864","eid":"W2017316864"},{"id":"paper-w1484794648","cat":"papers","name":"Chapter 5 Comparative neuropharmacology of ibogaine and its O-desmethyl metabolite, noribogaine","year":"2001","cit":40,"pfa":"Michael H. Baumann","psa":"Deborah C. Mash","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W1484794648","eid":"W1484794648"},{"id":"paper-w2083313877","cat":"papers","name":"Lysergic acid diethylamide antagonizes shaking induced in rats by five chemically different compounds","year":"1978","cit":40,"pfa":"Alan Cowan","psa":"Trevor Watson","ptype":"article","src":"https://openalex.org/W2083313877","eid":"W2083313877"},{"id":"paper-w4205618858","cat":"papers","name":"Lifetime use of MDMA/ecstasy and psilocybin is associated with reduced odds of major depressive episodes","year":"2022","cit":40,"pfa":"Grant M. Jones","psa":"Matthew K. Nock","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4205618858","eid":"W4205618858"},{"id":"paper-w4229529225","cat":"papers","name":"Return of the lysergamides. Part VI: Analytical and behavioural characterization of 1‐cyclopropanoyl‐d‐lysergic acid diethylamide (1CP‐LSD)","year":"2020","cit":40,"pfa":"Simon D. Brandt","psa":"Adam L. Halberstadt","ptype":"article","src":"https://openalex.org/W4229529225","eid":"W4229529225"},{"id":"paper-w1975014719","cat":"papers","name":"Total synthesis of ibogaine, epiibogaine and their analogues","year":"2012","cit":40,"pfa":"Goutam Kumar Jana","psa":"Surajit Sinha","ptype":"article","src":"https://openalex.org/W1975014719","eid":"W1975014719"},{"id":"paper-w574241","cat":"papers","name":"Ayahuasca and the Treatment of Drug Addiction","year":"2013","cit":40,"pfa":"José Carlos Bouso","psa":"Jordi Riba","topics":["Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W574241","eid":"W574241"},{"id":"paper-w2537197074","cat":"papers","name":"Medicine, religion and ayahuasca in Catalonia. Considering ayahuasca networks from a medical anthropology perspective","year":"2016","cit":40,"pfa":"Ismael Apud","psa":"Oriol Romaní","ptype":"article","src":"https://openalex.org/W2537197074","eid":"W2537197074"},{"id":"paper-w568151244","cat":"papers","name":"Sacred Vine of Spirits: Ayahuasca","year":"2005","cit":40,"pfa":"Ralph Metzner","topics":["Addiction"],"ptype":"book","src":"https://openalex.org/W568151244","eid":"W568151244"},{"id":"paper-w3154999065","cat":"papers","name":"Psilocybin: From Serendipity to Credibility?","year":"2021","cit":40,"pfa":"James Rucker","psa":"Allan Hunter Young","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3154999065","eid":"W3154999065"},{"id":"paper-w2089833366","cat":"papers","name":"Neurochemical and behavioural interactions between ibogaine and nicotine in the rat","year":"1996","cit":40,"pfa":"Maureen E.M. Benwell","psa":"David J.K. Balfour","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2089833366","eid":"W2089833366"},{"id":"paper-w2031855620","cat":"papers","name":"Effects of monoamine oxidase inhibitor and cytochrome P450 2D6 status on 5-methoxy-N,N-dimethyltryptamine metabolism and pharmacokinetics","year":"2010","cit":40,"pfa":"Hong-Wu Shen","psa":"Ai‐Ming Yu","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2031855620","eid":"W2031855620"},{"id":"paper-w3156830775","cat":"papers","name":"Relational Processes in Ayahuasca Groups of Palestinians and Israelis","year":"2021","cit":40,"pfa":"Leor Roseman","psa":"Robin Lester Carhart-Harris","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W3156830775","eid":"W3156830775"},{"id":"paper-w1966429313","cat":"papers","name":"Mass fragmentographic quantification of urinary N,N-dimethyltryptamine and bufotenine","year":"1979","cit":40,"pfa":"Martti Räisänen","psa":"Jorma Kärkkäinen","ptype":"article","src":"https://openalex.org/W1966429313","eid":"W1966429313"},{"id":"paper-w2086029018","cat":"papers","name":"MDMA (3,4-Methylenedioxymethamphetamine) Analogues as Tools to Characterize MDMA-Like Effects: An Approach to Understand Entactogen Pharmacology","year":"2013","cit":40,"pfa":"Patricio Sáez‐Briones","psa":"Alejandro Hernández","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2086029018","eid":"W2086029018"},{"id":"paper-w4323928978","cat":"papers","name":"IUPHAR – invited review - Ibogaine – A legacy within the current renaissance of psychedelic therapy","year":"2023","cit":40,"pfa":"Deborah C. Mash","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4323928978","eid":"W4323928978"},{"id":"paper-w2108030643","cat":"papers","name":"Ayahuasca and Spiritual Crisis: Liminality as Space for Personal Growth","year":"2008","cit":40,"pfa":"SARA E. LEWIS","topics":["Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2108030643","eid":"W2108030643"},{"id":"paper-w2082182980","cat":"papers","name":"A validated method for quantitation of psilocin in plasma by LC–MS/MS and study of stability","year":"2011","cit":40,"pfa":"Rafaela Martin","psa":"Helga Köhler","ptype":"article","src":"https://openalex.org/W2082182980","eid":"W2082182980"},{"id":"paper-w1967959731","cat":"papers","name":"Determination of psilocybin in Psilocybe semilanceata using high-performance liquid chromatography on a silica column","year":"1981","cit":40,"pfa":"A.L. Christiansen","psa":"Finn Tønnesen","ptype":"article","src":"https://openalex.org/W1967959731","eid":"W1967959731"},{"id":"paper-w2152645438","cat":"papers","name":"Repeated Adolescent 3,4-Methylenedioxymethamphetamine (MDMA) Exposure in Rats Attenuates the Effects of a Subsequent Challenge with MDMA or a 5-Hydroxytryptamine1A Receptor Agonist","year":"2006","cit":40,"pfa":"Brian J. Piper","psa":"Jerrold S. Meyer","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2152645438","eid":"W2152645438"},{"id":"paper-w2056738425","cat":"papers","name":"MDMA, cannabis, and cocaine produce acute dissociative symptoms","year":"2015","cit":40,"pfa":"Dalena van Heugten–van der Kloet","psa":"Johannes Gerardus Ramaekers","ptype":"article","src":"https://openalex.org/W2056738425","eid":"W2056738425"},{"id":"paper-w2049360930","cat":"papers","name":"Evidence for executive deficits among users of MDMA (Ecstasy)","year":"2004","cit":40,"pfa":"John E. Fisk","psa":"Michelle Wareing","ptype":"article","src":"https://openalex.org/W2049360930","eid":"W2049360930"},{"id":"paper-w2028636162","cat":"papers","name":"Excitatory and depressant neuronal responses to noradrenaline, 5-hydroxytryptamine and mescaline: the role of the baseline firing rate","year":"1977","cit":40,"pfa":"E. Szabadi","psa":"Paul Bevan","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2028636162","eid":"W2028636162"},{"id":"paper-w4283768889","cat":"papers","name":"Psilocybin induces spatially constrained alterations in thalamic functional organizaton and connectivity","year":"2022","cit":40,"pfa":"Andrew Gaddis","psa":"Frederick Streeter Barrett","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4283768889","eid":"W4283768889"},{"id":"paper-w2795755164","cat":"papers","name":"Indolethylamine-N-methyltransferase Polymorphisms: Genetic and Biochemical Approaches for Study of Endogenous N,N,-dimethyltryptamine","year":"2018","cit":40,"pfa":"Jon G. Dean","ptype":"article","src":"https://openalex.org/W2795755164","eid":"W2795755164"},{"id":"paper-w4379093876","cat":"papers","name":"Personality change in a trial of psilocybin therapy v. escitalopram treatment for depression","year":"2023","cit":40,"pfa":"Brandon Weiss","psa":"David Erritzøe","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4379093876","eid":"W4379093876"},{"id":"paper-w2103378801","cat":"papers","name":"Influence of PCPA and MDMA (ecstasy) on physiology, development and behavior in Drosophila melanogaster","year":"2007","cit":40,"pfa":"Sameera Dasari","psa":"Robin Lewis Cooper","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2103378801","eid":"W2103378801"},{"id":"paper-w2969417347","cat":"papers","name":"Salvinorin A moderates postischemic brain injury by preserving endothelial mitochondrial function via AMPK/Mfn2 activation","year":"2019","cit":40,"pfa":"Haiping Dong","psa":"Zhenhong Wang","ptype":"article","src":"https://openalex.org/W2969417347","eid":"W2969417347"},{"id":"paper-w4395034174","cat":"papers","name":"Side-effects of mdma-assisted psychotherapy: a systematic review and meta-analysis","year":"2024","cit":40,"pfa":"Julia Colcott","psa":"Gillinder Bedi","topics":["Safety & adverse events","Reviews & meta-analyses","Therapy practice"],"ptype":"review","src":"https://openalex.org/W4395034174","eid":"W4395034174"},{"id":"paper-w2022519073","cat":"papers","name":"The rewarding properties of MDMA are preserved in mice lacking µ‐opioid receptors","year":"2004","cit":40,"pfa":"Patricia Robledo","psa":"Rafaël Maldonado","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2022519073","eid":"W2022519073"},{"id":"paper-w2327340604","cat":"papers","name":"COMPARISON OF THREE PSYCHOTROPIC DRUGS (PSILOCYBIN, JB-329, AND IT-290) IN VOLUNTEER SUBJECTS","year":"1960","cit":40,"pfa":"Leo E. Hollister","psa":"NORMA ROSENQUIST","ptype":"article","src":"https://openalex.org/W2327340604","eid":"W2327340604"},{"id":"paper-w1966417379","cat":"papers","name":"Context‐dependent behavioural and neuronal sensitization in striatum to MDMA (ecstasy) administration in rats","year":"2006","cit":40,"pfa":"Kevin T. Ball","psa":"George V. Rebec","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1966417379","eid":"W1966417379"},{"id":"paper-w2149007768","cat":"papers","name":"Determination of MDMA, MDEA and MDA in urine by high performance liquid chromatography with fluorescence detection","year":"2004","cit":40,"pfa":"J DACOSTA","psa":"Alice Aparecida da Matta Chasin","ptype":"article","src":"https://openalex.org/W2149007768","eid":"W2149007768"},{"id":"paper-w1990419571","cat":"papers","name":"Differential effect of dietary selenium on the long-term neurotoxicity induced by MDMA in mice and rats","year":"2003","cit":40,"pfa":"V Sanchez","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1990419571","eid":"W1990419571"},{"id":"paper-w2903438963","cat":"papers","name":"Monoamine Biosynthesis via a Noncanonical Calcium-Activatable Aromatic Amino Acid Decarboxylase in Psilocybin Mushroom","year":"2018","cit":40,"pfa":"Michael Patrick Torrens-Spence","psa":"Jing‐Ke Weng","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2903438963","eid":"W2903438963"},{"id":"paper-w1606160582","cat":"papers","name":"Neurotoxicity and persistent cognitive deficits induced by combined MDMA and alcohol exposure in adolescent rats","year":"2010","cit":40,"pfa":"Vicente Hernández‐Rabaza","psa":"Juan J. Canales","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1606160582","eid":"W1606160582"},{"id":"paper-w2042362523","cat":"papers","name":"Depression, impulsiveness, sleep, and memory in past and present polydrug users of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)","year":"2013","cit":40,"pfa":"Lynn Taurah","psa":"Geoff Sanders","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2042362523","eid":"W2042362523"},{"id":"paper-w2129301470","cat":"papers","name":"MDMA and methamphetamine: some paradoxical negative and positive mood changes in an acute dose laboratory study","year":"2011","cit":40,"pfa":"Andrew C. Parrott","psa":"Con K. K. Stough","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2129301470","eid":"W2129301470"},{"id":"paper-w4379095570","cat":"papers","name":"Cost-effectiveness of psilocybin-assisted therapy for severe depression: exploratory findings from a decision analytic model","year":"2023","cit":40,"pfa":"Paul McCrone","psa":"Joanna Caroline Neill","topics":["Depression","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4379095570","eid":"W4379095570"},{"id":"paper-w2900519507","cat":"papers","name":"Combining attenuated total reflectance- infrared spectroscopy and chemometrics for the identification and the dosage estimation of MDMA tablets","year":"2018","cit":40,"pfa":"Eric Deconinck","psa":"Patricia Courselle","ptype":"article","src":"https://openalex.org/W2900519507","eid":"W2900519507"},{"id":"paper-w2281991370","cat":"papers","name":"Inappropriate antidiuretic hormone secretion and extreme rises in serum creatinine kinase following MDMA ingestion.","year":"1994","cit":40,"pfa":"Simon C. Satchell","psa":"Martin A. Connaughton","ptype":"article","src":"https://openalex.org/W2281991370","eid":"W2281991370"},{"id":"paper-w2140518859","cat":"papers","name":"Extensive neuroadaptive changes in cortical gene-transcript expressions of the glutamate system in response to repeated intermittent MDMA administration in adolescent rats","year":"2008","cit":40,"pfa":"Anna M. S. Kindlundh-Högberg","psa":"Helgi B. Schiöth","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2140518859","eid":"W2140518859"},{"id":"paper-w3200677515","cat":"papers","name":"Spiritual experiences in psychedelic-assisted psychotherapy: Case reports of communion with the divine, the departed, and saints in research using psilocybin for the treatment of alcohol dependence.","year":"2021","cit":40,"pfa":"Samantha K. Podrebarac","psa":"Michael P. Bogenschutz","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3200677515","eid":"W3200677515"},{"id":"paper-w2953241597","cat":"papers","name":"Abbreviated Ibogaine Congeners. Synthesis and Reactions of Tropan-3-yl-2- and -3-indoles. Investigation of an Unusual Isomerization of 2-Substituted Indoles Using Computational and Spectroscopic Techniques","year":"1994","cit":40,"pfa":"David B. Repke","psa":"Erik H.F. Wong","ptype":"article","src":"https://openalex.org/W2953241597","eid":"W2953241597"},{"id":"paper-w2066833388","cat":"papers","name":"Development and validation of a liquid chromatography–atmospheric pressure chemical ionization-tandem mass spectrometry method for simultaneous analysis of 10 amphetamine-, methamphetamine- and 3,4-methylenedioxymethamph","year":"2008","cit":40,"pfa":"Tamsin Lisa Kelly","psa":"Marilyn Ann Huestis","ptype":"article","src":"https://openalex.org/W2066833388","eid":"W2066833388"},{"id":"paper-w4387105816","cat":"papers","name":"Neuroimaging in psychedelic drug development: past, present, and future","year":"2023","cit":40,"pfa":"Matthew B. Wall","psa":"David Erritzøe","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4387105816","eid":"W4387105816"},{"id":"paper-w4313488167","cat":"papers","name":"Are psychedelics the answer to chronic pain: A review of current literature","year":"2023","cit":40,"pfa":"Nina I. Kooijman","psa":"Selina E. I. van der Wal","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4313488167","eid":"W4313488167"},{"id":"paper-w2058119419","cat":"papers","name":"Local Cerebral Glucose Utilisation Following Indoleamine‐ and Piperazine‐Containing 5‐Hydroxytryptamine Agonists","year":"1986","cit":40,"pfa":"John J. Grome","psa":"Alice M Harper","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2058119419","eid":"W2058119419"},{"id":"paper-w2013734228","cat":"papers","name":"A Chronic Impairment of Colour Vision in Users of LSD","year":"1982","cit":40,"pfa":"Henry David Abraham","ptype":"article","src":"https://openalex.org/W2013734228","eid":"W2013734228"},{"id":"paper-w1971942122","cat":"papers","name":"Effect of LSD on Human Pregnancy","year":"1970","cit":40,"pfa":"William H. McGlothlin","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1971942122","eid":"W1971942122"},{"id":"paper-w2795495768","cat":"papers","name":"“Hallucinations” Following Acute Cannabis Dosing: A Case Report and Comparison to Other Hallucinogenic Drugs","year":"2018","cit":40,"pfa":"Frederick Streeter Barrett","psa":"Ryan G. Vandrey","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2795495768","eid":"W2795495768"},{"id":"paper-w2055266564","cat":"papers","name":"Acute Psychosis Induced by Psychotomimetic Drug Abuse","year":"1972","cit":40,"pfa":"Malcolm B. Bowers","ptype":"article","src":"https://openalex.org/W2055266564","eid":"W2055266564"},{"id":"paper-w2018477449","cat":"papers","name":"PHARMACOLOGICALLY ACTIVE PEPTIDES IN THE BLOOD AND URINE OF ANIMALS INFECTED WITH BABESIA RODHAINI AND OTHER PATHOGENIC ORGANISMS","year":"1960","cit":40,"pfa":"L. G. Goodwin","psa":"W. H. G. Richards","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2018477449","eid":"W2018477449"},{"id":"paper-w3025954068","cat":"papers","name":"Psychedelic treatment of functional neurological disorder: a systematic review","year":"2020","cit":40,"pfa":"Matthew Butler","psa":"James Rucker","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W3025954068","eid":"W3025954068"},{"id":"paper-w2053052987","cat":"papers","name":"Prolonged Adverse Reactions to LSD in Psychotic Subjects","year":"1966","cit":40,"pfa":"Max Fink","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2053052987","eid":"W2053052987"},{"id":"paper-w4396894158","cat":"papers","name":"Alterations in brain network connectivity and subjective experience induced by psychedelics: a scoping review","year":"2024","cit":40,"pfa":"Zijia Yu","psa":"Allen W. Chan","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4396894158","eid":"W4396894158"},{"id":"paper-w2075159439","cat":"papers","name":"Differential Helical Orientations among Related G Protein-coupled Receptors Provide a Novel Mechanism for Selectivity","year":"2006","cit":40,"pfa":"Timothy A. Vortherms","psa":"Bryan L. Roth","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2075159439","eid":"W2075159439"},{"id":"paper-w2159632402","cat":"papers","name":"Confirmation of LSD Intoxication by Analysis of Serum and Urine","year":"1990","cit":40,"pfa":"Margaret M. McCarron","psa":"Randall C. Baselt","ptype":"article","src":"https://openalex.org/W2159632402","eid":"W2159632402"},{"id":"paper-w3133726098","cat":"papers","name":"Psychoactive Substances of Natural Origin: Toxicological Aspects, Therapeutic Properties and Analysis in Biological Samples","year":"2021","cit":40,"pfa":"Joana Gonçalves","psa":"Ana Paula Duarte","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3133726098","eid":"W3133726098"},{"id":"paper-w2109427788","cat":"papers","name":"LC-MS Analysis of Human Urine Specimens for 2-Oxo-3-Hydroxy LSD: Method Validation for Potential Interferants and Stability Study of 2-Oxo-3-Hydroxy LSD Under Various Storage Conditions","year":"2002","cit":40,"pfa":"Kevin L. Klette","psa":"Carolyn J. Anderson","ptype":"article","src":"https://openalex.org/W2109427788","eid":"W2109427788"},{"id":"paper-w2082967389","cat":"papers","name":"Indoleamine and the phenethylamine hallucinogens: mechanisms of psychotomimetic action","year":"1998","cit":40,"pfa":"Gerard J. Marek","psa":"George K. Aghajanian","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2082967389","eid":"W2082967389"},{"id":"paper-w4400043767","cat":"papers","name":"The Global Psychedelic Survey: Consumer characteristics, patterns of use, and access in primarily anglophone regions around the world","year":"2024","cit":40,"pfa":"Stephanie Lake","psa":"Philippe Lucas","ptype":"article","src":"https://openalex.org/W4400043767","eid":"W4400043767"},{"id":"paper-w2090260786","cat":"papers","name":"Novel 5-HT5A receptor antagonists ameliorate scopolamine-induced working memory deficit in mice and reference memory impairment in aged rats","year":"2015","cit":40,"pfa":"Mayako Yamazaki","psa":"Katsuya Harada","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2090260786","eid":"W2090260786"},{"id":"paper-w1969017941","cat":"papers","name":"Variability in the 3,4-methylenedioxymethamphetamine content of 'ecstasy' tablets in the UK","year":"2010","cit":40,"pfa":"David Michael Wood","psa":"J. Ramsey","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1969017941","eid":"W1969017941"},{"id":"paper-w2049629389","cat":"papers","name":"Autophagy Activation Is Involved in 3,4-Methylenedioxymethamphetamine (‘Ecstasy’)—Induced Neurotoxicity in Cultured Cortical Neurons","year":"2014","cit":40,"pfa":"I‐Hsun Li","psa":"Yuahn‐Sieh Huang","topics":["PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2049629389","eid":"W2049629389"},{"id":"paper-w2001070086","cat":"papers","name":"Interactions between 3,4-methylenedioxymethamphetamine and σ1 receptors","year":"2006","cit":40,"pfa":"Matthew K. Brammer","psa":"Rae R. Matsumoto","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2001070086","eid":"W2001070086"},{"id":"paper-w2045198740","cat":"papers","name":"L-Tyrosine Contributes to (+)-3,4-Methylenedioxymethamphetamine-Induced Serotonin Depletions","year":"2006","cit":40,"pfa":"Joseph M. Breier","psa":"Bryan K. Yamamoto","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2045198740","eid":"W2045198740"},{"id":"paper-w1984280476","cat":"papers","name":"PRECLINICAL STUDY: Ecstasy‐induced oxidative stress to adolescent rat brain mitochondriain vivo: influence of monoamine oxidase type A","year":"2008","cit":40,"pfa":"Ema Alves","psa":"Félix Dias Carvalho","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1984280476","eid":"W1984280476"},{"id":"paper-w2145503328","cat":"papers","name":"Learning and memory after neonatal exposure to 3,4‐methylenedioxymethamphetamine (ecstasy) in rats: Interaction with exposure in adulthood","year":"2005","cit":40,"pfa":"Martha A. Cohen","psa":"Michael T. Williams","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2145503328","eid":"W2145503328"},{"id":"paper-w2022626595","cat":"papers","name":"A study of the role of noradrenaline in behavioural changes produced in the rat by psychotomimetic drugs","year":"1969","cit":40,"pfa":"Michael F. Sugrue","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2022626595","eid":"W2022626595"},{"id":"paper-w2047254589","cat":"papers","name":"Aplastic anaemia following exposure to 3,4‐methylenedioxymethamphetamine (‘Ecstasy’)","year":"1994","cit":40,"pfa":"Judith C. W. Marsh","psa":"E. C. Gordon‐Smith","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2047254589","eid":"W2047254589"},{"id":"paper-w2037554838","cat":"papers","name":"Recent national trends in Salvia divinorum use and substance-use disorders among recent and former Salvia divinorum users compared with nonusers","year":"2011","cit":40,"pfa":"Li-Tzy T. Wu","psa":"Blazer","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2037554838","eid":"W2037554838"},{"id":"paper-w2171834438","cat":"papers","name":"Gas chromatographic/mass spectrometric assay for profiling the enantiomers of 3,4-methylenedioxymethamphetamine and its chiral metabolites using positive chemical ionization ion trap mass spectrometry","year":"1997","cit":40,"pfa":"Douwe de Boer","psa":"R. A. A. Maes","ptype":"article","src":"https://openalex.org/W2171834438","eid":"W2171834438"},{"id":"paper-w1964047921","cat":"papers","name":"3,4-Methylenedioxymethamphetamine-induced acute changes in dopamine transporter function","year":"1998","cit":40,"pfa":"Ryan R. Metzger","psa":"Annette E. Fleckenstein","ptype":"article","src":"https://openalex.org/W1964047921","eid":"W1964047921"},{"id":"paper-w2399478936","cat":"papers","name":"Pharmacologic profile of amphetamine derivatives at various brain recognition sites: Selective effects on serotonergic systems.","year":"1989","cit":40,"pfa":"George Battaglia","psa":"Errol B. de Souza","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"dataset","src":"https://openalex.org/W2399478936","eid":"W2399478936"},{"id":"paper-w2150338880","cat":"papers","name":"Chromatographic and Mass Spectral Methods of Identification for the Side-Chain and Ring Regioisomers of Methylenedioxymethamphetamine","year":"2000","cit":40,"pfa":"Laura Aalberg","psa":"C. R. Clark","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2150338880","eid":"W2150338880"},{"id":"paper-w2048308779","cat":"papers","name":"Determination of amphetamine-type stimulants, cocaine and ketamine in human hair by liquid chromatography/linear ion trap–Orbitrap hybrid mass spectrometry","year":"2011","cit":40,"pfa":"Hajime Miyaguchi","psa":"Hiroyuki Inoue","ptype":"article","src":"https://openalex.org/W2048308779","eid":"W2048308779"},{"id":"paper-w2097809104","cat":"papers","name":"Decreased Platelet Monoamine Oxidase Activity in Chronic Schizophrenia, Shown With Novel Substrates","year":"1978","cit":40,"pfa":"Wade H. Berrettini","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2097809104","eid":"W2097809104"},{"id":"paper-w2031544765","cat":"papers","name":"Interactions between serotonergic agonists and antagonists in rats trained with LSD as a discriminative stimulus","year":"1988","cit":40,"pfa":"Jerrold C. Winter","psa":"R.A. Rabin","ptype":"article","src":"https://openalex.org/W2031544765","eid":"W2031544765"},{"id":"paper-w2378818514","cat":"papers","name":"Collybolide is a novel biased agonist of κ-opioid receptors with potent antipruritic activity","year":"2016","cit":40,"pfa":"Achla Gupta","psa":"Lakshmi A. Devi","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2378818514","eid":"W2378818514"},{"id":"paper-w2580771571","cat":"papers","name":"The fibrinolytic system: A new target for treatment of depression with psychedelics","year":"2017","cit":40,"pfa":"Richard D. Idell","psa":"Steven Idell","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2580771571","eid":"W2580771571"},{"id":"paper-w2129051227","cat":"papers","name":"Survival After Massive Ecstasy Overdose","year":"1998","cit":40,"pfa":"S Ramcharan","psa":"J. H. Beijnen","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2129051227","eid":"W2129051227"},{"id":"paper-w3048487171","cat":"papers","name":"The Biochemistry, Toxicology, and Uses of the Pharmacologically Active Phytochemicals: Alkaloids, Terpenes, Polyphenols, and Glycosides","year":"2019","cit":40,"pfa":"Chinaza Godswill Awuchi","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3048487171","eid":"W3048487171"},{"id":"paper-w3015163151","cat":"papers","name":"Defining the Roles and Research Priorities for Psychedelic-Assisted Therapies in Patients with Serious Illness: Expert Clinicians' and Investigators' Perspectives","year":"2020","cit":40,"pfa":"Yvan Beaussant","psa":"Ira Robert Byock","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3015163151","eid":"W3015163151"},{"id":"paper-w4220996705","cat":"papers","name":"A Cohort-Based Case Report: The Impact of Ketamine-Assisted Therapy Embedded in a Community of Practice Framework for Healthcare Providers With PTSD and Depression","year":"2022","cit":40,"pfa":"Shannon Dames","psa":"Crosbie Watler","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4220996705","eid":"W4220996705"},{"id":"paper-w2139867988","cat":"papers","name":"Less is more: the human microdosing concept","year":"2005","cit":40,"pfa":"R. C. Garner","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2139867988","eid":"W2139867988"},{"id":"paper-w2416183456","cat":"papers","name":"Structure-Activity Relationships of the Classic Hallucinogens and Their Analogs","year":"1994","cit":40,"pfa":"Peyton Jacob","psa":"Alexander T. Shulgin","ptype":"dataset","src":"https://openalex.org/W2416183456","eid":"W2416183456"},{"id":"paper-w4376223664","cat":"papers","name":"Control Conditions in Randomized Trials of Psychedelics","year":"2023","cit":40,"pfa":"Sandeep Manel Nayak","psa":"Matthew W. Johnson","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4376223664","eid":"W4376223664"},{"id":"paper-w3087516483","cat":"papers","name":"Elimination profiles of microdosed ostarine mimicking contaminated products ingestion","year":"2020","cit":40,"pfa":"Katja Walpurgis","psa":"Mario Thevis","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3087516483","eid":"W3087516483"},{"id":"paper-w2072792872","cat":"papers","name":"Improved early clinical development through human microdosing studies","year":"2005","cit":40,"pfa":"Ian R. Wilding","psa":"J. Angus Bell","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2072792872","eid":"W2072792872"},{"id":"paper-w4281738922","cat":"papers","name":"Systematic Review of Psychometric Instruments Used in Research with Psychedelics","year":"2022","cit":40,"pfa":"Alexandre Augusto de Deus Pontual","psa":"Dimitri Daldegan‐Bueno","topics":["Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4281738922","eid":"W4281738922"},{"id":"paper-w2049411989","cat":"papers","name":"Structural correlation between apomorphine and LSD: Involvement of dopamine as well as serotonin in the actions of hallucinogens","year":"1976","cit":40,"pfa":"David E. Nichols","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2049411989","eid":"W2049411989"},{"id":"paper-w2989568489","cat":"papers","name":"Rapid Induction of Buprenorphine/Naloxone for Chronic Pain Using a Microdosing Regimen: A Case Report","year":"2019","cit":40,"pfa":"Danny S. Lee","psa":"Pouya Rezazadeh-Azar","topics":["Addiction","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2989568489","eid":"W2989568489"},{"id":"paper-w4205711742","cat":"papers","name":"Linkages between Psychedelics and Meditation in a Population-Based Sample in the United States","year":"2022","cit":40,"pfa":"Otto Simonsson","psa":"Simon Benjamin Goldberg","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4205711742","eid":"W4205711742"},{"id":"paper-w4396893361","cat":"papers","name":"Measuring psychotherapeutic processes in the context of psychedelic experiences: Validation of the General Change Mechanisms Questionnaire (GCMQ)","year":"2024","cit":40,"pfa":"Max Wolff","psa":"Henrik Jungaberle","topics":["Safety & adverse events","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4396893361","eid":"W4396893361"},{"id":"paper-w3196481983","cat":"papers","name":"Consciousness in active inference: Deep self-models, other minds, and the challenge of psychedelic-induced ego-dissolution","year":"2021","cit":40,"pfa":"George E. Deane","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3196481983","eid":"W3196481983"},{"id":"paper-w3177513265","cat":"papers","name":"Using Psychedelics With Therapeutic Intent Is Associated With Lower Shame and Complex Trauma Symptoms in Adults With Histories of Child Maltreatment","year":"2021","cit":40,"pfa":"C. J. Healy","psa":"Wendy M. D'Andrea","topics":["PTSD & trauma","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3177513265","eid":"W3177513265"},{"id":"paper-w2034711387","cat":"papers","name":"Practical and Efficient Strategy for Evaluating Oral Absolute Bioavailability with an Intravenous Microdose of a Stable Isotopically-Labeled Drug Using a Selected Reaction Monitoring Mass Spectrometry Assay","year":"2012","cit":40,"pfa":"Hao Jiang","psa":"Mark E. Arnold","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2034711387","eid":"W2034711387"},{"id":"paper-w3205826958","cat":"papers","name":"Classic Psychedelic Use and Mechanisms of Mental Health: Exploring the Mediating Roles of Spirituality and Emotion Processing on Symptoms of Anxiety, Depressed Mood, and Disordered Eating in a Community Sample","year":"2021","cit":40,"pfa":"Adèle Lafrance","psa":"Zach Walsh","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3205826958","eid":"W3205826958"},{"id":"paper-w1972030149","cat":"papers","name":"Hallucinogenic Effects of Marijuana as Currently Used","year":"1971","cit":40,"pfa":"MARTIN H. KEELER","psa":"Beatrice A. Rouse","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1972030149","eid":"W1972030149"},{"id":"paper-w1998363435","cat":"papers","name":"Use of the Round Window Microcatheter in the Treatment of Meniere's Disease","year":"2001","cit":40,"pfa":"Michael E. Hoffer","psa":"Carey D. Balaban","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1998363435","eid":"W1998363435"},{"id":"paper-w4389269192","cat":"papers","name":"Greater subjective effects of a low dose of LSD in participants with depressed mood","year":"2023","cit":40,"pfa":"Hanna M. Molla","psa":"Harriet de Wit","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4389269192","eid":"W4389269192"},{"id":"paper-w2796404916","cat":"papers","name":"Global Scientific Production on Illicit Drug Addiction: A Two-Decade Analysis","year":"2018","cit":40,"pfa":"Malahat Khalili","psa":"Masoumeh Amin‐Esmaeili","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2796404916","eid":"W2796404916"},{"id":"paper-w3167760747","cat":"papers","name":"Initiating buprenorphine to treat opioid use disorder without prerequisite withdrawal: a systematic review","year":"2021","cit":40,"pfa":"Kathleen K. Adams","psa":"Diana M Sobieraj","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W3167760747","eid":"W3167760747"},{"id":"paper-w1993799344","cat":"papers","name":"Differential phospholipase C activation by phenylalkylamine serotonin 5‐HT2Areceptor agonists","year":"2005","cit":40,"pfa":"Jason C. Parrish","psa":"David E. Nichols","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1993799344","eid":"W1993799344"},{"id":"paper-w2020322439","cat":"papers","name":"Xenon Inhibits but N2O Enhances Ketamine-Induced c-Fos Expression in the Rat Posterior Cingulate and Retrosplenial Cortices","year":"2001","cit":40,"pfa":"Atsushi Nagata","psa":"Koh Shingu","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2020322439","eid":"W2020322439"},{"id":"paper-w2123123844","cat":"papers","name":"?-noradrenergic receptor modulation of the phencyclidine- and ?9-tetrahydrocannabinol-induced increases in dopamine utilization in rat prefrontal cortex","year":"1998","cit":40,"pfa":"David Jentsch","psa":"Robert Howard Roth","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2123123844","eid":"W2123123844"},{"id":"paper-w59884315","cat":"papers","name":"Memantine as an Example of a Fast, Voltage-Dependent, Open Channel N-Methyl-d-Aspartate Receptor Blocker","year":"2007","cit":40,"pfa":"Chris G. Parsons","psa":"Kate E. Gilling","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W59884315","eid":"W59884315"},{"id":"paper-w2507495628","cat":"papers","name":"Ketamine-induced changes in connectivity of functional brain networks in awake female nonhuman primates: a translational functional imaging model","year":"2016","cit":40,"pfa":"Kaundinya Gopinath","psa":"Leonard Lee Howell","ptype":"article","src":"https://openalex.org/W2507495628","eid":"W2507495628"},{"id":"paper-w618617582","cat":"papers","name":"Kynurenine Aminotransferases and the Prospects of Inhibitors for the Treatment of Schizophrenia","year":"2015","cit":40,"pfa":"Gayan S. Jayawickrama","psa":"William Bret Church","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W618617582","eid":"W618617582"},{"id":"paper-w280067339","cat":"papers","name":"Psychopharmacology : from theory to practice","year":"1977","cit":40,"pfa":"Jack D. Barchas","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W280067339","eid":"W280067339"},{"id":"paper-w2589198547","cat":"papers","name":"Beyond Ketamine: New Approaches to the Development of Safer Antidepressants","year":"2017","cit":40,"pfa":"Shigeyuki Chaki","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2589198547","eid":"W2589198547"},{"id":"paper-w2991384921","cat":"papers","name":"Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial","year":"2019","cit":40,"pfa":"Sanne Y. Smith-Apeldoorn","psa":"Robert A. Schoevers","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2991384921","eid":"W2991384921"},{"id":"paper-w2895043322","cat":"papers","name":"(2R,6R)-Hydroxynorketamine promotes dendrite outgrowth in human inducible pluripotent stem cell-derived neurons through AMPA receptor with timing and exposure compatible with ketamine infusion pharmacokinetics in humans","year":"2018","cit":40,"pfa":"Ginetta Collo","psa":"Emilio Merlo Pich","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2895043322","eid":"W2895043322"},{"id":"paper-w4383619110","cat":"papers","name":"Investigating the Effectiveness and Tolerability of Intranasal Esketamine Among Older Adults With Treatment-Resistant Depression (TRD): A Post-hoc Analysis from the REAL-ESK Study Group","year":"2023","cit":40,"pfa":"Giacomo d’Andrea","psa":"Giovanni Martinotti","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4383619110","eid":"W4383619110"},{"id":"paper-w4400884994","cat":"papers","name":"Comparison of opioid‐free and opioid‐inclusive propofol anaesthesia for thyroid and parathyroid surgery: a randomised controlled trial","year":"2024","cit":40,"pfa":"Dan Wang","psa":"Ke Peng","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4400884994","eid":"W4400884994"},{"id":"paper-w3107533476","cat":"papers","name":"Synthesis and Characterization of 5-MeO-DMT Succinate for Clinical Use","year":"2020","cit":39,"pfa":"Alexander M. Sherwood","psa":"Kelsey Lenoch","ptype":"article","src":"https://openalex.org/W3107533476","eid":"W3107533476"},{"id":"paper-w2011204842","cat":"papers","name":"Complex discriminative stimulus properties of (+)lysergic acid diethylamide (LSD) in C57Bl/6J mice","year":"2005","cit":39,"pfa":"Michael A. Benneyworth","psa":"Elaine Sanders‐Bush","ptype":"article","src":"https://openalex.org/W2011204842","eid":"W2011204842"},{"id":"paper-w1899595943","cat":"papers","name":"CHANGES IN SPIDER WEBS BROUGHT ABOUT BY MESCALINE, PSILOCYBIN AND AN INCREASE IN BODY WEIGHT","year":"1962","cit":39,"pfa":"A.L. Christiansen","psa":"Peter N. Witt","ptype":"article","src":"https://openalex.org/W1899595943","eid":"W1899595943"},{"id":"paper-w2136443367","cat":"papers","name":"Metabolism of Lysergic Acid Diethylamide (LSD) to 2-Oxo-3-Hydroxy LSD (O-H-LSD)in Human Liver Microsomes and Cryopreserved Human Hepatocytes","year":"2000","cit":39,"pfa":"Kevin L. Klette","psa":"Mahmoud A. ElSohly","ptype":"article","src":"https://openalex.org/W2136443367","eid":"W2136443367"},{"id":"paper-w1575957378","cat":"papers","name":"Peyote: The Divine Cactus","year":"1980","cit":39,"pfa":"Edward F. Anderson","topics":["Addiction","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1575957378","eid":"W1575957378"},{"id":"paper-w2130025885","cat":"papers","name":"Dimethyltryptamine Experiments with Psychotics","year":"1958","cit":39,"pfa":"Zoltán Böszörményi","psa":"St. Szára","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2130025885","eid":"W2130025885"},{"id":"paper-w2464677659","cat":"papers","name":"Blood dimethyltryptamine concentrations in psychotic disorders.","year":"1974","cit":39,"pfa":"J F Lipinski","psa":"Walker Rw","ptype":"article","src":"https://openalex.org/W2464677659","eid":"W2464677659"},{"id":"paper-w2162949965","cat":"papers","name":"Phenomenology of N,N-Dimethyltryptamine use : a thematic analysis","year":"2008","cit":39,"pfa":"Christopher Cott","psa":"Adam J. Rock","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2162949965","eid":"W2162949965"},{"id":"paper-w3007508147","cat":"papers","name":"Mephedrone and MDMA: A comparative review","year":"2020","cit":39,"pfa":"Jessica Mead","psa":"Andrew Parrott","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3007508147","eid":"W3007508147"},{"id":"paper-w2039324177","cat":"papers","name":"METHYLATION AND DEMETHYLATION IN RELATION TO THE IN VITRO METABOLISM OF MESCALINE","year":"1962","cit":39,"pfa":"John W. Daly","psa":"Bernhard Witkop","ptype":"article","src":"https://openalex.org/W2039324177","eid":"W2039324177"},{"id":"paper-w1949568430","cat":"papers","name":"Influence of CYP2D6 activity on the pharmacokinetics and pharmacodynamics of a single 20 mg dose of ibogaine in healthy volunteers","year":"2015","cit":39,"pfa":"Paul Glue","psa":"Cheung‐Tak Hung","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1949568430","eid":"W1949568430"},{"id":"paper-w2739758689","cat":"papers","name":"Behavioral Changes Over Time Following Ayahuasca Exposure in Zebrafish","year":"2017","cit":39,"pfa":"Robson Savoldi","psa":"Ana Carolina Luchiari","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2739758689","eid":"W2739758689"},{"id":"paper-w2120411943","cat":"papers","name":"THE EFFECT OF THE HALLUCINOGENIC DRUGS LSD‐25 AND MESCALINE ON THE ELECTRORETINOGRAM","year":"1957","cit":39,"pfa":"Julia T. Apter","psa":"Carl C. Pfeiffer","ptype":"article","src":"https://openalex.org/W2120411943","eid":"W2120411943"},{"id":"paper-w2099643170","cat":"papers","name":"Reasoning deficits in ecstasy (MDMA) polydrug users","year":"2005","cit":39,"pfa":"John E. Fisk","psa":"Philip N. Murphy","ptype":"article","src":"https://openalex.org/W2099643170","eid":"W2099643170"},{"id":"paper-w1992909065","cat":"papers","name":"Salvinorin A fails to substitute for the discriminative stimulus effects of LSD or ketamine in Sprague–Dawley rats","year":"2010","cit":39,"pfa":"Bryan A. Killinger","psa":"Lisa E. Baker","ptype":"article","src":"https://openalex.org/W1992909065","eid":"W1992909065"},{"id":"paper-w2066536621","cat":"papers","name":"Oxytocin and MDMA (‘Ecstasy’) enhance social reward in rats","year":"2015","cit":39,"pfa":"Linnet Ramos","psa":"Iain S. McGregor","ptype":"article","src":"https://openalex.org/W2066536621","eid":"W2066536621"},{"id":"paper-w4401212791","cat":"papers","name":"Psilocybin Facilitates Fear Extinction: Importance of Dose, Context, and Serotonin Receptors","year":"2024","cit":39,"pfa":"Samuel C. Woodburn","psa":"Alex C. Kwan","topics":["PTSD & trauma","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4401212791","eid":"W4401212791"},{"id":"paper-w3107150606","cat":"papers","name":"The Effects of Daytime Psilocybin Administration on Sleep: Implications for Antidepressant Action","year":"2020","cit":39,"pfa":"Daniela Dudysová","psa":"Jiřı́ Horáček","topics":["Depression","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3107150606","eid":"W3107150606"},{"id":"paper-w1992272125","cat":"papers","name":"Combined immunomodulating properties of 3,4‐methylenedioxymethamphetamine (MDMA) and cannabis in humans","year":"2007","cit":39,"pfa":"Roberta Pacifici","psa":"Rafael de la Torre","ptype":"article","src":"https://openalex.org/W1992272125","eid":"W1992272125"},{"id":"paper-w2015905030","cat":"papers","name":"Effects of methylphenidate and MDMA on appraisal of erotic stimuli and intimate relationships","year":"2014","cit":39,"pfa":"Yasmin Schmid","psa":"Matthias E. Liechti","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2015905030","eid":"W2015905030"},{"id":"paper-w2126659868","cat":"papers","name":"The hallucinogenic herbSalvia divinorumand its active ingredient salvinorin A reduce inflammation‐induced hypermotility in mice","year":"2007","cit":39,"pfa":"Raffaele Capasso","psa":"Angelo Antonio Izzo","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2126659868","eid":"W2126659868"},{"id":"paper-w2055317220","cat":"papers","name":"Long-term central 5-HT depletions resulting from repeated administration of MDMA enhances the effects of single administration of MDMA on schedule-controlled behavior of rats","year":"1989","cit":39,"pfa":"Abby A. Li","psa":"Lewis S. Seiden","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2055317220","eid":"W2055317220"},{"id":"paper-w2062403804","cat":"papers","name":"3,4-Methylenedioxymethamphetamine (MDMA) Intoxication in an Infant Chronically Exposed to Cocaine","year":"2005","cit":39,"pfa":"Óscar García‐Algar","psa":"Simona Pichini","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2062403804","eid":"W2062403804"},{"id":"paper-w1967620403","cat":"papers","name":"Lack of effect of sublingual salvinorin A, a naturally occurring kappa opioid, in humans: a placebo-controlled trial","year":"2010","cit":39,"pfa":"John E. Mendelson","psa":"Bruce M. Cohen","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1967620403","eid":"W1967620403"},{"id":"paper-w1995539451","cat":"papers","name":"Diffusion Tensor Imaging in MDMA Users and Controls: Association with Decision Making","year":"2007","cit":39,"pfa":"Frederick Gerard Moeller","psa":"Ponnada A. Narayana","ptype":"article","src":"https://openalex.org/W1995539451","eid":"W1995539451"},{"id":"paper-w1959492970","cat":"papers","name":"Contribution of impulsivity and novelty-seeking to the acquisition and maintenance of MDMA self-administration","year":"2012","cit":39,"pfa":"Judith Bird","psa":"Susan Schenk","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1959492970","eid":"W1959492970"},{"id":"paper-w1584069397","cat":"papers","name":"Mechanisms mediating the ability of caffeine to influence MDMA (‘Ecstasy’)‐induced hyperthermia in rats","year":"2010","cit":39,"pfa":"Natacha Vanattou‐Saïfoudine","psa":"Andrew Harkin","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1584069397","eid":"W1584069397"},{"id":"paper-w1974518872","cat":"papers","name":"MDMA produces a delayed and sustained increase in the extracellular concentration of glutamate in the rat hippocampus","year":"2012","cit":39,"pfa":"John H. Anneken","psa":"Gary A. Gudelsky","ptype":"article","src":"https://openalex.org/W1974518872","eid":"W1974518872"},{"id":"paper-w4394797601","cat":"papers","name":"Phase 1, placebo-controlled, single ascending dose trial to evaluate the safety, pharmacokinetics and effect on altered states of consciousness of intranasal BPL-003 (5-methoxy- N,N -dimethyltryptamine benzoate) in healt","year":"2024","cit":39,"pfa":"James Rucker","psa":"Frank Wiegand","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4394797601","eid":"W4394797601"},{"id":"paper-w1987678595","cat":"papers","name":"Total synthesis of indole and dihydroindole alkaloids. III. Transannular cyclization of carbomethoxydihydrocleavamine and carbomethoxycleavamine derivatives. Approach to vinca and iboga alkaloids","year":"1970","cit":39,"pfa":"James Peter Kutney","psa":"John R. Hadfield","ptype":"article","src":"https://openalex.org/W1987678595","eid":"W1987678595"},{"id":"paper-w2061081626","cat":"papers","name":"MDMA, politics and medical research: Have we thrown the baby out with the bathwater?","year":"2007","cit":39,"pfa":"Ben Sessa","psa":"David Nutt","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"editorial","src":"https://openalex.org/W2061081626","eid":"W2061081626"},{"id":"paper-w2054484454","cat":"papers","name":"Role of brain nitric oxide in (±)3,4-methylenedioxymethamphetamine (MDMA)-induced neurotoxicity in rats","year":"1998","cit":39,"pfa":"Yiwen Zheng","psa":"Richard Laverty","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2054484454","eid":"W2054484454"},{"id":"paper-w2003560125","cat":"papers","name":"5-Methoxy-N,N-dimethyltryptamine: Spinal cord and brainstem mediation of excitatory effects on acoustic startle","year":"1980","cit":39,"pfa":"Michael T. Davis","psa":"David S. Gendelman","ptype":"article","src":"https://openalex.org/W2003560125","eid":"W2003560125"},{"id":"paper-w2092912434","cat":"papers","name":"Cardiac effects of MDMA on the metabolic profile determined with 1H‐magnetic resonance spectroscopy in the rat","year":"2008","cit":39,"pfa":"Shane Alan Perrine","psa":"Matthew P. Galloway","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2092912434","eid":"W2092912434"},{"id":"paper-w2036010949","cat":"papers","name":"MDMA‐evoked changes in [11C]raclopride and [11C]NMSP binding in living pig brain","year":"2004","cit":39,"pfa":"Pedro Rosa‐Neto","psa":"Paul D. Cumming","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2036010949","eid":"W2036010949"},{"id":"paper-w2056616817","cat":"papers","name":"MDMA administration to pregnant Sprague–Dawley rats results in its passage to the fetal compartment","year":"2006","cit":39,"pfa":"Nicholas G. Campbell","psa":"Jack W. Lipton","ptype":"article","src":"https://openalex.org/W2056616817","eid":"W2056616817"},{"id":"paper-w1971769956","cat":"papers","name":"One day access to a running wheel reduces self-administration of d-methamphetamine, MDMA and methylone","year":"2015","cit":39,"pfa":"Shawn M. Aarde","psa":"Michael A. Taffe","ptype":"article","src":"https://openalex.org/W1971769956","eid":"W1971769956"},{"id":"paper-w2943605891","cat":"papers","name":"Metabolites of the ring-substituted stimulants MDMA, methylone and MDPV differentially affect human monoaminergic systems","year":"2019","cit":39,"pfa":"Dino Luethi","psa":"Matthias E. Liechti","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2943605891","eid":"W2943605891"},{"id":"paper-w2085759125","cat":"papers","name":"α1-Adrenergic receptors mediate the locomotor response to systemic administration of (±)-3,4-methylenedioxymethamphetamine (MDMA) in rats","year":"2007","cit":39,"pfa":"Jennifer Selken","psa":"David E. Nichols","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2085759125","eid":"W2085759125"},{"id":"paper-w2424255509","cat":"papers","name":"Methamphetamine, 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxypyrovalerone (MDPV) induce differential cytotoxic effects in bovine brain microvessel endothelial cells","year":"2016","cit":39,"pfa":"Héctor Rosas-Hernández","psa":"Syed F. Ali","ptype":"article","src":"https://openalex.org/W2424255509","eid":"W2424255509"},{"id":"paper-w2059405899","cat":"papers","name":"A qualitative/quantitative approach for the detection of 37 tryptamine-derived designer drugs, 5 β-carbolines, ibogaine, and yohimbine in human urine and plasma using standard urine screening and multi-analyte approaches","year":"2013","cit":39,"pfa":"Markus R. Meyer","psa":"Hans H. Maurer","ptype":"article","src":"https://openalex.org/W2059405899","eid":"W2059405899"},{"id":"paper-w2537035919","cat":"papers","name":"A Hexacyclic, Iboga-Derived Monoterpenoid Indole with a Contracted Tetrahydroazepine C-Ring and Incorporation of an Isoxazolidine Moiety, a Seco-Corynanthean, an Aspidosperma-Aspidosperma Bisindole with Anticancer Proper","year":"2016","cit":39,"pfa":"Choy‐Eng Nge","psa":"Toh‐Seok Kam","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2537035919","eid":"W2537035919"},{"id":"paper-w2023401401","cat":"papers","name":"(+/–)3,4-Methylenedioxymethamphetamine (MDMA) Dose-Dependently Impairs Spatial Learning in the Morris Water Maze after Exposure of Rats to Different Five-Day Intervals from Birth to Postnatal Day Twenty","year":"2009","cit":39,"pfa":"Charles V. Vorhees","psa":"Michael T. Williams","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2023401401","eid":"W2023401401"},{"id":"paper-w4205164075","cat":"papers","name":"Knowledge, Perceptions, and Use of Psychedelics among Individuals with Fibromyalgia","year":"2022","cit":39,"pfa":"Nicolas G. Glynos","psa":"Kevin F. Boehnke","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4205164075","eid":"W4205164075"},{"id":"paper-w2081185462","cat":"papers","name":"Homicide During a Psychosis Induced by LSD","year":"1972","cit":39,"pfa":"Peter Reich","ptype":"article","src":"https://openalex.org/W2081185462","eid":"W2081185462"},{"id":"paper-w2081244857","cat":"papers","name":"Analysis of psychotropic compounds in fungi of the genus psilocybe by reversed-phase high-performance liquid chromatography","year":"1984","cit":39,"pfa":"Milan Wurst","psa":"Jindřich Vokoun","ptype":"article","src":"https://openalex.org/W2081244857","eid":"W2081244857"},{"id":"paper-w4402500386","cat":"papers","name":"Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseases","year":"2024","cit":39,"pfa":"Sivan Schipper","psa":"Christopher S. Boehlke","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4402500386","eid":"W4402500386"},{"id":"paper-w2033195077","cat":"papers","name":"The relative potencies of psychotomimetic drugs","year":"1965","cit":39,"pfa":"J. B. Appel","psa":"Daniel X. Freedman","ptype":"article","src":"https://openalex.org/W2033195077","eid":"W2033195077"},{"id":"paper-w2011049990","cat":"papers","name":"Comparative effects of hallucinogenic drugs on rotational behavior in rats with unilateral 6-hydroxydopamine lesions","year":"1977","cit":39,"pfa":"Michael E. Trulson","psa":"Barry L. Jacobs","ptype":"article","src":"https://openalex.org/W2011049990","eid":"W2011049990"},{"id":"paper-w2163855981","cat":"papers","name":"Quantitative Determination of LSD and a Major Metabolite, 2-Oxo-3-Hydroxy-LSD, in Human Urine by Solid-Phase Extraction and Gas Chromatography-Tandem Mass Spectrometry","year":"1999","cit":39,"pfa":"Scott Reuschel","psa":"R. L. Foltz","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2163855981","eid":"W2163855981"},{"id":"paper-w2134310318","cat":"papers","name":"Forensic analysis of hallucinogenic fungi: a DNA-based approach","year":"2004","cit":39,"pfa":"Kimberly G. Nugent","psa":"Barry J. Saville","ptype":"article","src":"https://openalex.org/W2134310318","eid":"W2134310318"},{"id":"paper-w2419040698","cat":"papers","name":"Neuropharmacology and Neurotoxicity of 3,4-Methylenedioxymethamphetamine","year":"2003","cit":39,"pfa":"Gary A. Gudelsky","psa":"Bryan K. Yamamoto","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W2419040698","eid":"W2419040698"},{"id":"paper-w2155591011","cat":"papers","name":"Effects of (±)3,4-methylenedioxymethamphetamine, (±)3,4-methylenedioxyamphetamine and methamphetamine on temperature and activity in rhesus macaques","year":"2006","cit":39,"pfa":"Rebecca D. Crean","psa":"Michael A. Taffe","ptype":"article","src":"https://openalex.org/W2155591011","eid":"W2155591011"},{"id":"paper-w4391610480","cat":"papers","name":"Effects of DMT on mental health outcomes in healthy volunteers","year":"2024","cit":39,"pfa":"Christopher B. Timmermann","psa":"Robin Lester Carhart-Harris","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4391610480","eid":"W4391610480"},{"id":"paper-w4365786929","cat":"papers","name":"ALKALOIDS OFMUCUNA PRURIENSCHEMISTRY AND PHARMACOLOGY","year":"1971","cit":39,"pfa":"S. Ghosal","psa":"S. Bhattacharya","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4365786929","eid":"W4365786929"},{"id":"paper-w2103521072","cat":"papers","name":"Liver transplantation for the treatment of fulminant hepatic failure induced by the ingestion of ecstasy","year":"1997","cit":39,"pfa":"Robert Brauer","psa":"Jörg Rüdiger Siewert","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2103521072","eid":"W2103521072"},{"id":"paper-w1994297046","cat":"papers","name":"Monoaminergic involvement in the pharmacological actions of buspirone","year":"1985","cit":39,"pfa":"Phil Skolnick","psa":"Moussa B. H. Youdim","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1994297046","eid":"W1994297046"},{"id":"paper-w2786473897","cat":"papers","name":"Acute recreational drug toxicity","year":"2018","cit":39,"pfa":"Evangelia Liakoni","psa":"Matthias E. Liechti","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2786473897","eid":"W2786473897"},{"id":"paper-w4385828698","cat":"papers","name":"Prevalence and impact of recreational drug use in patients with acute cardiovascular events","year":"2023","cit":39,"pfa":"Théo Pezel","psa":"Patrick Henry","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4385828698","eid":"W4385828698"},{"id":"paper-w2050472078","cat":"papers","name":"Psychedelic and Entactogenic Drugs in the Treatment of Depression","year":"1994","cit":39,"pfa":"Thomas J. Riedlinger","psa":"June E. Riedlinger","topics":["Depression","PTSD & trauma","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2050472078","eid":"W2050472078"},{"id":"paper-w2560952055","cat":"papers","name":"Clinical Pharmacology of the Synthetic Cathinone Mephedrone","year":"2016","cit":39,"pfa":"Esther Papaseit","psa":"Magı́ Farré","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W2560952055","eid":"W2560952055"},{"id":"paper-w4225266953","cat":"papers","name":"Socio-psychedelic imaginaries: envisioning and building legal psychedelic worlds in the United States","year":"2022","cit":39,"pfa":"Claudia G. Schwarz-Plaschg","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4225266953","eid":"W4225266953"},{"id":"paper-w2991503240","cat":"papers","name":"Twenty percent better with 20 micrograms? A qualitative study of psychedelic microdosing self-rapports and discussions on YouTube","year":"2019","cit":39,"pfa":"Martin Andersson","psa":"Anette Kjellgren","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2991503240","eid":"W2991503240"},{"id":"paper-w4391527378","cat":"papers","name":"Perceptions and attitudes towards psychedelic-assisted psychotherapy among health professionals, patients, and the public: A systematic review","year":"2024","cit":39,"pfa":"Alesha Wells","psa":"Lisa Reynolds","topics":["Safety & adverse events","Reviews & meta-analyses","Therapy practice"],"ptype":"review","src":"https://openalex.org/W4391527378","eid":"W4391527378"},{"id":"paper-w3097501343","cat":"papers","name":"Effects of external stimulation on psychedelic state neurodynamics","year":"2020","cit":39,"pfa":"Pedro A. M. Mediano","psa":"Robin Lester Carhart-Harris","topics":["Addiction","Mechanism & neuroscience","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W3097501343","eid":"W3097501343"},{"id":"paper-w4396813127","cat":"papers","name":"Modulating self‐referential processing through meditation and psychedelics: is scientific investigation of self‐transcendence clinically relevant?","year":"2024","cit":39,"pfa":"Matthew D. Sacchet","psa":"Eric L. Garland","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4396813127","eid":"W4396813127"},{"id":"paper-w2411055364","cat":"papers","name":"Microdose paradox--a new concept.","year":"1965","cit":39,"pfa":"G O Barnard","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2411055364","eid":"W2411055364"},{"id":"paper-w2010451559","cat":"papers","name":"Psychedelic Drugs and Creativity","year":"1985","cit":39,"pfa":"Stanley Krippner","ptype":"article","src":"https://openalex.org/W2010451559","eid":"W2010451559"},{"id":"paper-w2094560790","cat":"papers","name":"Systemic Delivery of Atropine Sulfate by the MicroDose Dry-Powder Inhaler","year":"2012","cit":39,"pfa":"Timothy E. Corcoran","psa":"Michael P. Donahoe","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2094560790","eid":"W2094560790"},{"id":"paper-w101967749","cat":"papers","name":"Discriminative Stimulus Properties of Hallucinogens and Related Designer Drugs","year":"1991","cit":39,"pfa":"Richard A. Glennon","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"dataset","src":"https://openalex.org/W101967749","eid":"W101967749"},{"id":"paper-w3131378247","cat":"papers","name":"Buprenorphine Microdose Induction for the Management of Prescription Opioid Dependence","year":"2021","cit":39,"pfa":"Jonathan Leserman Robbins","psa":"Jessica L. Gregg","topics":["Addiction","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3131378247","eid":"W3131378247"},{"id":"paper-w3186232511","cat":"papers","name":"Engineering Safer Psychedelics for Treating Addiction","year":"2021","cit":39,"pfa":"Jamie Peters","psa":"David E. Olson","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"editorial","src":"https://openalex.org/W3186232511","eid":"W3186232511"},{"id":"paper-w428135944","cat":"papers","name":"Tripping: An Anthology of True-Life Psychedelic Adventures","year":"2000","cit":39,"pfa":"Charles Hayes","ptype":"book","src":"https://openalex.org/W428135944","eid":"W428135944"},{"id":"paper-w4408608578","cat":"papers","name":"The structural diversity of psychedelic drug actions revealed","year":"2025","cit":39,"pfa":"Ryan H. Gumpper","psa":"Bryan L. Roth","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4408608578","eid":"W4408608578"},{"id":"paper-w119064961","cat":"papers","name":"Efficacy Determinants of Subcutaneous Microdose Glucagon during Closed-Loop Control","year":"2010","cit":39,"pfa":"Steven J. Russell","psa":"Edward R. Damiano","topics":["Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W119064961","eid":"W119064961"},{"id":"paper-w1996296427","cat":"papers","name":"The Renewal of Psychedelic Research: Implications for Humanistic and Transpersonal Psychology.","year":"2006","cit":39,"pfa":"Harris L. Friedman","topics":["Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1996296427","eid":"W1996296427"},{"id":"paper-w2227171113","cat":"papers","name":"LSD-induced hallucinogen persisting perception disorder treatment with clonidine: an open pilot study","year":"2000","cit":39,"pfa":"A Lerner","psa":"Abraham Weizman","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2227171113","eid":"W2227171113"},{"id":"paper-w4390589662","cat":"papers","name":"Psychedelics for acquired brain injury: a review of molecular mechanisms and therapeutic potential","year":"2024","cit":39,"pfa":"Josh Allen","psa":"Sandy R. Shultz","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4390589662","eid":"W4390589662"},{"id":"paper-w2415510869","cat":"papers","name":"Social and Political Sources of Drug Effects: The Case of Bad Trips on Psychedelics","year":"1979","cit":39,"pfa":"Richard Bunce","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2415510869","eid":"W2415510869"},{"id":"paper-w2097662572","cat":"papers","name":"Practical Experience of Using Human Microdosing with AMS Analysis to Obtain Early Human Drug Metabolism and PK Data","year":"2010","cit":39,"pfa":"R. Colin Garner","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2097662572","eid":"W2097662572"},{"id":"paper-w2084049556","cat":"papers","name":"Calculation and Mitigation of Isotopic Interferences in Liquid Chromatography–Mass Spectrometry/Mass Spectrometry Assays and Its Application in Supporting Microdose Absolute Bioavailability Studies","year":"2012","cit":39,"pfa":"Huidong Gu","psa":"Mark E. Arnold","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2084049556","eid":"W2084049556"},{"id":"paper-w2098286404","cat":"papers","name":"Tailored Breast Cancer Screening Program with Microdose Mammography, US, and MR Imaging: Short-term Results of a Pilot Study in 40–49-Year-Old Women","year":"2013","cit":39,"pfa":"Elena Venturini","psa":"Alessandro Del Maschio","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2098286404","eid":"W2098286404"},{"id":"paper-w1984753350","cat":"papers","name":"Directional lipophilic character in a series of psychotomimetic phenethylamine derivatives","year":"1977","cit":39,"pfa":"David E. Nichols","psa":"Donald C. Dyer","ptype":"article","src":"https://openalex.org/W1984753350","eid":"W1984753350"},{"id":"paper-w2465255523","cat":"papers","name":"Betaine enhances antidepressant-like, but blocks psychotomimetic effects of ketamine in mice","year":"2016","cit":39,"pfa":"Jen-Cheng Lin","psa":"Hwei‐Hsien Chen","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2465255523","eid":"W2465255523"},{"id":"paper-w2062249187","cat":"papers","name":"The subjective experience of acute, experimentally-induced Salvia divinorum inebriation","year":"2015","cit":39,"pfa":"Peter H. Addy","psa":"Jenny Wade","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2062249187","eid":"W2062249187"},{"id":"paper-w274166914","cat":"papers","name":"Psychopathology and psychopharmacology","year":"1973","cit":39,"pfa":"Jonathan O Cole","psa":"Arnold J. Friedhoff","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W274166914","eid":"W274166914"},{"id":"paper-w2404165333","cat":"papers","name":"Flashbacks and HPPD: A Clinical-oriented Concise Review.","year":"2014","cit":39,"pfa":"Arturo G. Lerner","psa":"Craig Goodman","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2404165333","eid":"W2404165333"},{"id":"paper-w2100105805","cat":"papers","name":"Concomitant Oral and Intravenous Pharmacokinetics of Dabrafenib, a BRAF Inhibitor, in Patients with BRAF V600 Mutation‐Positive Solid Tumors","year":"2013","cit":39,"pfa":"Cathrine L. Denton","psa":"Danièle Ouellet","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2100105805","eid":"W2100105805"},{"id":"paper-w3021167577","cat":"papers","name":"Hallucinogenic agents","year":"1976","cit":39,"pfa":"Robin M. Murray","ptype":"article","src":"https://openalex.org/W3021167577","eid":"W3021167577"},{"id":"paper-w3213991078","cat":"papers","name":"Synergistic Effect of Ketamine and Buprenorphine Observed in the Treatment of Buprenorphine Precipitated Opioid Withdrawal in a Patient With Fentanyl Use","year":"2021","cit":39,"pfa":"Christian Hailozian","psa":"Andrew A. Herring","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3213991078","eid":"W3213991078"},{"id":"paper-w2079017722","cat":"papers","name":"Serotonin receptor binding affinities of tryptamine analogs","year":"1979","cit":39,"pfa":"Richard A. Glennon","psa":"Peter K. Gessner","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2079017722","eid":"W2079017722"},{"id":"paper-w2148979960","cat":"papers","name":"The Role of Rodent Models in The Discovery of New Treatments for Schizophrenia: Updating Our Strategy","year":"2010","cit":39,"pfa":"Holly M Moore","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2148979960","eid":"W2148979960"},{"id":"paper-w3182611925","cat":"papers","name":"Cannabidiol has therapeutic potential for myofascial pain in female and male parkinsonian rats","year":"2021","cit":39,"pfa":"Airam Nicole Vivanco-Estela","psa":"Glauce Crivelaro Nascimento","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3182611925","eid":"W3182611925"},{"id":"paper-w4286382981","cat":"papers","name":"Pharmacogenetic and drug interaction aspects on ketamine safety in its use as antidepressant ‐ implications for precision dosing in a global perspective","year":"2022","cit":39,"pfa":"Immaculate Mbongo Langmia","psa":"Julia Stingl","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4286382981","eid":"W4286382981"},{"id":"paper-w2974916455","cat":"papers","name":"Esketamine for treatment resistant depression","year":"2019","cit":39,"pfa":"Sameer Jauhar","psa":"Paul Morrison","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2974916455","eid":"W2974916455"},{"id":"paper-w4404858665","cat":"papers","name":"Personalized use of ketamine and esketamine for treatment-resistant depression","year":"2024","cit":39,"pfa":"Gustavo C. Medeiros","psa":"Todd D. Gould","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4404858665","eid":"W4404858665"},{"id":"paper-w3211285041","cat":"papers","name":"Use of ketamine and esketamine for depression: an overview of systematic reviews with meta-analyses","year":"2021","cit":39,"pfa":"Tácio de Mendonça Lima","psa":"Patrícia Melo Aguiar","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W3211285041","eid":"W3211285041"},{"id":"paper-w4306867604","cat":"papers","name":"The median effective concentration of propofol in combination with different doses of esketamine during gastrointestinal endoscopy in adults","year":"2022","cit":39,"pfa":"Miaomiao Feng","psa":"Weiwei Zhang","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4306867604","eid":"W4306867604"},{"id":"paper-w4213037518","cat":"papers","name":"Clinical predictors of depressive symptom remission and response after racemic ketamine and esketamine infusion in treatment‐resistant depression","year":"2022","cit":39,"pfa":"Ana Paula Jesus‐Nunes","psa":"Lucas C. Quarantini","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4213037518","eid":"W4213037518"},{"id":"paper-w4313647732","cat":"papers","name":"Esketamine-based opioid-free anaesthesia alleviates postoperative nausea and vomiting in patients who underwent laparoscopic surgery: study protocol for a randomized, double-blinded, multicentre trial","year":"2023","cit":39,"pfa":"Haiyan Chen","psa":"Jin‐Chao Song","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4313647732","eid":"W4313647732"},{"id":"paper-w2413902042","cat":"papers","name":"Serotoninergic receptors in brain tissue: properties and identification of various 3H-ligand binding sites in vitro.","year":"1981","cit":39,"pfa":"Jos�e E. Leysen","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2413902042","eid":"W2413902042"},{"id":"paper-w2070417729","cat":"papers","name":"Biochemical effects of lysergic acid diethylamide on the liver fluke Fasciola hepatica","year":"1970","cit":38,"pfa":"Tag E. Mansour","psa":"Deborah Bennett Stone","ptype":"article","src":"https://openalex.org/W2070417729","eid":"W2070417729"},{"id":"paper-w1968991011","cat":"papers","name":"Selective labeling of serotonin receptors by d-[3H]lysergic acid diethylamide in calf caudate.","year":"1978","cit":38,"pfa":"Patricia M. Whitaker","psa":"Phillip Seeman","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1968991011","eid":"W1968991011"},{"id":"paper-w1961691639","cat":"papers","name":"Radioimmunoassay of lysergic acid diethylamide (LSD) in serum and urine by using antisera of different specificities.","year":"1977","cit":38,"pfa":"WENDY A. RATCLIFFE","psa":"T E Levitt","ptype":"article","src":"https://openalex.org/W1961691639","eid":"W1961691639"},{"id":"paper-w2991486694","cat":"papers","name":"Pharmacological and biotransformation studies of 1-acyl-substituted derivatives of -lysergic acid diethylamide (LSD)","year":"2019","cit":38,"pfa":"Adam L. Halberstadt","psa":"Simon D. Brandt","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2991486694","eid":"W2991486694"},{"id":"paper-w1974603320","cat":"papers","name":"Noribogaine (12‐Hydroxyibogamine): A Biologically Active Metabolite of the Antiaddictive Drug Ibogaine","year":"2000","cit":38,"pfa":"Michael H. Baumann","psa":"Deborah C. Mash","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1974603320","eid":"W1974603320"},{"id":"paper-w2121291806","cat":"papers","name":"L.S.D. (Lysergic Acid Diethylamide) Treatment of Chronic Psychoneurotic Patients Under Day-Hospital Conditions","year":"1957","cit":38,"pfa":"A. Joyce Martin","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2121291806","eid":"W2121291806"},{"id":"paper-w2095643440","cat":"papers","name":"REVERSAL LEARNING ENHANCED BY LYSERGIC ACID DIETHYLAMIDE (LSD): CONCOMITANT RISE IN BRAIN 5‐HYDROXYTRYPTAMINE LEVELS","year":"1974","cit":38,"pfa":"A.R. KING","psa":"K. ARABELLA MELVILLE","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2095643440","eid":"W2095643440"},{"id":"paper-w2806513910","cat":"papers","name":"Psilocybin and MDMA reduce costly punishment in the Ultimatum Game","year":"2018","cit":38,"pfa":"Anthony S. Gabay","psa":"Mitul Ashok Mehta","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2806513910","eid":"W2806513910"},{"id":"paper-w2066408797","cat":"papers","name":"Screening for Drugs of Abuse (II): Cannabinoids, Lysergic Acid Diethylamide, Buprenorphine, Methadone, Barbiturates, Benzodiazepines and other Drugs","year":"1997","cit":38,"pfa":"Danny Simpson","psa":"Brian Widdop","topics":["Addiction","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2066408797","eid":"W2066408797"},{"id":"paper-w2019656624","cat":"papers","name":"5-Hydroxytryptamine (Serotonin)2A Receptors in Rat Anterior Cingulate Cortex Mediate the Discriminative Stimulus Properties of d-Lysergic Acid Diethylamide","year":"2006","cit":38,"pfa":"Paul J. Gresch","psa":"Randy L. Smith","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2019656624","eid":"W2019656624"},{"id":"paper-w2096155592","cat":"papers","name":"Enhanced effects of amphetamine but reduced effects of the hallucinogen, 5-MeO-DMT, on locomotor activity in 5-HT1A receptor knockout mice: Implications for schizophrenia","year":"2011","cit":38,"pfa":"Maarten van den Buuse","psa":"Adam L. Halberstadt","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2096155592","eid":"W2096155592"},{"id":"paper-w2064434554","cat":"papers","name":"Dispersive liquid–liquid microextraction prior to field-amplified sample injection for the sensitive analysis of 3,4-methylenedioxymethamphetamine, phencyclidine and lysergic acid diethylamide by capillary electrophoresi","year":"2012","cit":38,"pfa":"Diego Airado‐Rodríguez","psa":"Ana María García-Campaña","ptype":"article","src":"https://openalex.org/W2064434554","eid":"W2064434554"},{"id":"paper-w2001965040","cat":"papers","name":"Serotonin 5-HT2A Receptor Binding in Platelets from Healthy Subjects as Studied by [3H]-Lysergic Acid Diethylamide ([3H]-LSD): Intra- and Interindividual Variability","year":"1997","cit":38,"pfa":"Olav Spigset","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2001965040","eid":"W2001965040"},{"id":"paper-w2044593996","cat":"papers","name":"Ibogaine and the dopaminergic response to nicotine","year":"1997","cit":38,"pfa":"I.M. Maisonneuve","psa":"C. R. Deibel","ptype":"article","src":"https://openalex.org/W2044593996","eid":"W2044593996"},{"id":"paper-w2542493272","cat":"papers","name":"Role of psilocybin in the treatment of depression","year":"2016","cit":38,"pfa":"Ananya Mahapatra","psa":"Rishi G. Gupta","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2542493272","eid":"W2542493272"},{"id":"paper-w2040497662","cat":"papers","name":"Comparison of the discriminative stimulus effects of dimethyltryptamine with different classes of psychoactive compounds in rats","year":"2009","cit":38,"pfa":"Michael B. Gatch","psa":"Michael J. Forster","ptype":"article","src":"https://openalex.org/W2040497662","eid":"W2040497662"},{"id":"paper-w1583756083","cat":"papers","name":"Ibogaine Therapy: A 'Vast, Uncontrolled Experiment'","year":"2005","cit":38,"pfa":"Brian Vastag","ptype":"article","src":"https://openalex.org/W1583756083","eid":"W1583756083"},{"id":"paper-w4254497335","cat":"papers","name":"Fatal MDMA intoxication","year":"1999","cit":38,"pfa":"Matthias Georg Schwab","psa":"Ernst‐Ulrich Griese","ptype":"article","src":"https://openalex.org/W4254497335","eid":"W4254497335"},{"id":"paper-w2160440040","cat":"papers","name":"Disposition of MDMA and Metabolites in Human Sweat Following Controlled MDMA Administration","year":"2009","cit":38,"pfa":"Allan J. Barnes","psa":"Marilyn Ann Huestis","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2160440040","eid":"W2160440040"},{"id":"paper-w2298217188","cat":"papers","name":"The occurrence of psilocybin in Gymnopilus species.","year":"1978","cit":38,"pfa":"George M. Hatfield","psa":"Leander J. Valdés","ptype":"article","src":"https://openalex.org/W2298217188","eid":"W2298217188"},{"id":"paper-w1977713727","cat":"papers","name":"Alkaloids and ethnobotany of Mexican peyote cacti and related species","year":"1973","cit":38,"pfa":"Jan G. Bruhn","psa":"Catarina Bruhn","ptype":"article","src":"https://openalex.org/W1977713727","eid":"W1977713727"},{"id":"paper-w2033818561","cat":"papers","name":"BEHAVIOURAL CHANGES INDUCED BY N,N‐DIMETHYLTRYPTAMINE IN RODENTS","year":"1980","cit":38,"pfa":"Peter Jenner","psa":"C. M. Thanki","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2033818561","eid":"W2033818561"},{"id":"paper-w2313851828","cat":"papers","name":"MESCALINE ANALOGS. II. TETRA- AND PENTA-METHOXY-β-PHENETHYLAMINES","year":"1955","cit":38,"pfa":"Frederick Benington","psa":"Leland C. Clark","ptype":"article","src":"https://openalex.org/W2313851828","eid":"W2313851828"},{"id":"paper-w3021930083","cat":"papers","name":"Stability Evaluation of DMT and Harmala Alkaloids in Ayahuasca Tea Samples","year":"2020","cit":38,"pfa":"Gabriela de Oliveira Silveira","psa":"Maurı́cio Yonamine","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3021930083","eid":"W3021930083"},{"id":"paper-w2980930708","cat":"papers","name":"Toxicological Aspects and Determination of the Main Components of Ayahuasca: A Critical Review","year":"2019","cit":38,"pfa":"Ana Y. Simão","psa":"Eugénia Gallardo","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2980930708","eid":"W2980930708"},{"id":"paper-w2035815817","cat":"papers","name":"Trichocereus pachanoi—A mescaline cactus used in folk healing in Peru","year":"1968","cit":38,"pfa":"Marlene Dobkin","ptype":"article","src":"https://openalex.org/W2035815817","eid":"W2035815817"},{"id":"paper-w2037236090","cat":"papers","name":"Toxic effect of MDMA on brain serotonin neurons","year":"1999","cit":38,"pfa":"Anthony Klugman","psa":"John H Gruzelier","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2037236090","eid":"W2037236090"},{"id":"paper-w194590858","cat":"papers","name":"Experience of Treatment with Ayahuasca for Drug Addiction in the Brazilian Amazon","year":"2013","cit":38,"pfa":"Xavier Fernández","psa":"Josep María Fábregas","topics":["Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W194590858","eid":"W194590858"},{"id":"paper-w2096216064","cat":"papers","name":"Evidence for roles of κ-opioid and NMDA receptors in the mechanism of action of ibogaine","year":"1997","cit":38,"pfa":"Stanley D. Glick","psa":"Sandra M. Pearl","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2096216064","eid":"W2096216064"},{"id":"paper-w2011354665","cat":"papers","name":"Factors affecting the urinary excretion of endogenously formed dimethyltryptamine in normal human subjects","year":"1977","cit":38,"pfa":"M.C.H. Oon","psa":"J. L. T. Birley","ptype":"article","src":"https://openalex.org/W2011354665","eid":"W2011354665"},{"id":"paper-w2948005519","cat":"papers","name":"Enzymatic Route toward 6‐Methylated Baeocystin and Psilocybin","year":"2019","cit":38,"pfa":"Janis Fricke","psa":"Dirk Hoffmeister","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2948005519","eid":"W2948005519"},{"id":"paper-w2033580394","cat":"papers","name":"MDMA research: preliminary investigations with human subjects","year":"1998","cit":38,"pfa":"Charles S. Grob","ptype":"article","src":"https://openalex.org/W2033580394","eid":"W2033580394"},{"id":"paper-w2078750432","cat":"papers","name":"Opioid Receptor Probes Derived from Cycloaddition of the Hallucinogen Natural Product Salvinorin A","year":"2011","cit":38,"pfa":"Anthony Lozama","psa":"Thomas Edward Prisinzano","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2078750432","eid":"W2078750432"},{"id":"paper-w2008622429","cat":"papers","name":"The Meixner test in the detection of α-amanitin and false-positive reactions caused by psilocin and 5-substituted tryptamines","year":"2004","cit":38,"pfa":"Michael C. Beuhler","psa":"Richard D. Gerkin","ptype":"article","src":"https://openalex.org/W2008622429","eid":"W2008622429"},{"id":"paper-w2753158834","cat":"papers","name":"Discrete memory impairments in largely pure chronic users of MDMA","year":"2017","cit":38,"pfa":"Michael D. Wunderli","psa":"Boris B. Quednow","ptype":"article","src":"https://openalex.org/W2753158834","eid":"W2753158834"},{"id":"paper-w4409632414","cat":"papers","name":"The Rise of Psilocybin Use in the United States: A Multisource Observational Study","year":"2025","cit":38,"pfa":"Karilynn M. Rockhill","psa":"Andrew A. Monte","ptype":"article","src":"https://openalex.org/W4409632414","eid":"W4409632414"},{"id":"paper-w1976048240","cat":"papers","name":"A Review of Recent Advances in Impurity Profiling of Illicit MDMA Samples","year":"2007","cit":38,"pfa":"Ruth Smith","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1976048240","eid":"W1976048240"},{"id":"paper-w3133450788","cat":"papers","name":"What is the clinical evidence on psilocybin for the treatment of psychiatric disorders? A systematic review","year":"2021","cit":38,"pfa":"Henrique Castro Santos","psa":"João Gama Marques","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W3133450788","eid":"W3133450788"},{"id":"paper-w2322337041","cat":"papers","name":"The Alkaloids of Tabernanthe iboga. Part VI.1 The Synthesis of the Selenium Dehydrogenation Products from Ibogamine","year":"1958","cit":38,"pfa":"H. B. MacPhillamy","psa":"M. E. Kuehne","ptype":"article","src":"https://openalex.org/W2322337041","eid":"W2322337041"},{"id":"paper-w2396173371","cat":"papers","name":"[Incorporation of physiologically-active substances into a colloidal blood plasma substitute. I. Incorporation of mescaline peptide into polyvinylpyrrolidone].","year":"1954","cit":38,"pfa":"Horst Jatzkewitz","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2396173371","eid":"W2396173371"},{"id":"paper-w2043078944","cat":"papers","name":"The effect of optical isomers of 3,4-methylenedioxymethamphetamine (MDMA) on stereotyped behavior in rats","year":"1989","cit":38,"pfa":"Masayuki Hiramatsu","psa":"Arthur K. Cho","ptype":"article","src":"https://openalex.org/W2043078944","eid":"W2043078944"},{"id":"paper-w6228469","cat":"papers","name":"Chemical Profiling of 3,4 Methylenedioxymethamphetamine (MDMA) Tablets Seized in Hong Kong","year":"2003","cit":38,"pfa":"W-C Cheng","psa":"M-F Chan","ptype":"article","src":"https://openalex.org/W6228469","eid":"W6228469"},{"id":"paper-w1988357658","cat":"papers","name":"Interactions between ethanol and cocaine, amphetamine, or MDMA in the rat: thermoregulatory and locomotor effects","year":"2007","cit":38,"pfa":"Sami Ben Hamida","psa":"Jean‐Christophe Cassel","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1988357658","eid":"W1988357658"},{"id":"paper-w1976047443","cat":"papers","name":"Local effects of ibogaine on extracellular levels of dopamine and its metabolites in nucleus accumbens and striatum: interactions withd-amphetamine","year":"1993","cit":38,"pfa":"S.D. Glick","psa":"Richard W. Keller","ptype":"article","src":"https://openalex.org/W1976047443","eid":"W1976047443"},{"id":"paper-w2066000439","cat":"papers","name":"Visuo-spatial working memory deficits in current and former users of MDMA (?ecstasy?)","year":"2005","cit":38,"pfa":"Michelle Wareing","psa":"Catharine Montgomery","ptype":"article","src":"https://openalex.org/W2066000439","eid":"W2066000439"},{"id":"paper-w4297478109","cat":"papers","name":"Esketamine and Psilocybin—The Comparison of Two Mind-Altering Agents in Depression Treatment: Systematic Review","year":"2022","cit":38,"pfa":"Dominika Psiuk","psa":"Marzena Samardakiewicz","topics":["Depression","Addiction","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4297478109","eid":"W4297478109"},{"id":"paper-w1974396339","cat":"papers","name":"MDMA exposure alters cognitive and electrophysiological sensitivity to rapid tryptophan depletion in rhesus monkeys","year":"2003","cit":38,"pfa":"Michael A. Taffe","ptype":"article","src":"https://openalex.org/W1974396339","eid":"W1974396339"},{"id":"paper-w2058661501","cat":"papers","name":"The acute and sub-acute effects of ‘ecstasy’ (MDMA) on processing of facial expressions: preliminary findings","year":"2004","cit":38,"pfa":"Rosa Hoshi","psa":"Helen Valerie Curran","ptype":"article","src":"https://openalex.org/W2058661501","eid":"W2058661501"},{"id":"paper-w2012805447","cat":"papers","name":"Event-related potentials (ERPs) in ecstasy (MDMA) users during a visual oddball task","year":"2005","cit":38,"pfa":"Sandrine Mejias","psa":"Salvatore Campanella","ptype":"article","src":"https://openalex.org/W2012805447","eid":"W2012805447"},{"id":"paper-w2166469175","cat":"papers","name":"An antisense oligonucleotide targeted at MAO-B attenuates rat striatal serotonergic neurotoxicity induced by MDMA","year":"2002","cit":38,"pfa":"Erin M. Falk","psa":"Jon E. Sprague","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2166469175","eid":"W2166469175"},{"id":"paper-w2893652576","cat":"papers","name":"Characterizing Complex Networks Using Entropy-Degree Diagrams: Unveiling Changes in Functional Brain Connectivity Induced by Ayahuasca","year":"2019","cit":38,"pfa":"Aline Viol","psa":"G. M. Viswanathan","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2893652576","eid":"W2893652576"},{"id":"paper-w4395069371","cat":"papers","name":"MDMA enhances empathy-like behaviors in mice via 5-HT release in the nucleus accumbens","year":"2024","cit":38,"pfa":"Benjamin A. Rein","psa":"Robert C. Malenka","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4395069371","eid":"W4395069371"},{"id":"paper-w2021958736","cat":"papers","name":"Relation of sex and estrous phase to deficits in prepulse inhibition of the startle response induced by ecstasy (MDMA)","year":"2005","cit":38,"pfa":"V. Buben kov","psa":"T. P len ek","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2021958736","eid":"W2021958736"},{"id":"paper-w4213145592","cat":"papers","name":"Trajectory of Antidepressant Effects after Single- or Two-Dose Administration of Psilocybin: A Systematic Review and Multivariate Meta-Analysis","year":"2022","cit":38,"pfa":"Chia‐Ling Yu","psa":"Kuan‐Pin Su","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W4213145592","eid":"W4213145592"},{"id":"paper-w1996548848","cat":"papers","name":"Acute psychomotor, memory and subjective effects of MDMA and THC co-administration over time in healthy volunteers","year":"2010","cit":38,"pfa":"Glenn Dumont","psa":"RJ Verkes","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1996548848","eid":"W1996548848"},{"id":"paper-w1903518157","cat":"papers","name":"Examining the role of oxytocin in the interoceptive effects of 3,4‐methylenedioxymethamphetamine (MDMA, ‘ecstasy’) using a drug discrimination paradigm in the rat","year":"2010","cit":38,"pfa":"Jillian Helen Broadbear","psa":"Katherine Beringer","topics":["Depression","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W1903518157","eid":"W1903518157"},{"id":"paper-w4393489617","cat":"papers","name":"Psilocybin pulse regimen reduces cluster headache attack frequency in the blinded extension phase of a randomized controlled trial","year":"2024","cit":38,"pfa":"Emmanuelle A. D. Schindler","psa":"Deepak Cyril D’Souza","ptype":"article","src":"https://openalex.org/W4393489617","eid":"W4393489617"},{"id":"paper-w2043125836","cat":"papers","name":"A sensitive semi-micro column HPLC method with peroxyoxalate chemiluminescence detection and column switching for determination of MDMA-related compounds in hair","year":"2006","cit":38,"pfa":"Shinichi Nakamura","psa":"Kenichiro Nakashima","ptype":"article","src":"https://openalex.org/W2043125836","eid":"W2043125836"},{"id":"paper-w1968969588","cat":"papers","name":"Altered energy production, lowered antioxidant potential, and inflammatory processes mediate CNS damage associated with abuse of the psychostimulants MDMA and methamphetamine","year":"2014","cit":38,"pfa":"Luke A. Downey","psa":"Jennifer M. Loftis","ptype":"article","src":"https://openalex.org/W1968969588","eid":"W1968969588"},{"id":"paper-w2094939014","cat":"papers","name":"Plasma Levels of Parent Compound and Metabolites after Doses of Either d-Fenfluramine or d-3,4-Methylenedioxymethamphetamine (MDMA) that Produce Long-Term Serotonergic Alterations","year":"2003","cit":38,"pfa":"John F. Bowyer","psa":"Merle G. Paule","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2094939014","eid":"W2094939014"},{"id":"paper-w2143555651","cat":"papers","name":"Negative-Ion Chemical Ionization Gas Chromatography–Mass Spectrometry Assay for Enantioselective Measurement of Amphetamines in Oral Fluid: Application to a Controlled Study with MDMA and Driving Under the Influence Case","year":"2007","cit":38,"pfa":"Frank T. Peters","psa":"Hans H. Maurer","ptype":"article","src":"https://openalex.org/W2143555651","eid":"W2143555651"},{"id":"paper-w4294796248","cat":"papers","name":"Use of plant-based hallucinogens and dissociative agents: U.S. Time Trends, 2002–2019","year":"2022","cit":38,"pfa":"Claire A. Walsh","psa":"Deborah S. Hasin","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4294796248","eid":"W4294796248"},{"id":"paper-w199370843","cat":"papers","name":"Baeocystin in psilocybe, conocybe and panaeolus.","year":"1978","cit":38,"pfa":"Repke Db","psa":"Gastón Guzmán","ptype":"article","src":"https://openalex.org/W199370843","eid":"W199370843"},{"id":"paper-w2187905600","cat":"papers","name":"Behavioral evidence for the stimulation of CNS serotonin receptors by high doses of LSD.","year":"1976","cit":38,"pfa":"M E Trulson","psa":"Jacobs Bl","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2187905600","eid":"W2187905600"},{"id":"paper-w266681429","cat":"papers","name":"Coma, hyperthermia and bleeding associated with massive LSD overdose. A report of eight cases.","year":"1974","cit":38,"pfa":"John Klock","psa":"Charles E. Becker","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W266681429","eid":"W266681429"},{"id":"paper-w561083445","cat":"papers","name":"Bioactive Alkaloids of Hallucinogenic Mushrooms","year":"2015","cit":38,"pfa":"Piotr Paweł Wieczorek","psa":"Katarzyna Zielińska","ptype":"book-chapter","src":"https://openalex.org/W561083445","eid":"W561083445"},{"id":"paper-w2083806710","cat":"papers","name":"Cytogenetic Effects of LSD 25 Therapy in Man","year":"1968","cit":38,"pfa":"David A. Hungerford","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2083806710","eid":"W2083806710"},{"id":"paper-w4283123029","cat":"papers","name":"Nootropic effects of LSD: Behavioral, molecular and computational evidence","year":"2022","cit":38,"pfa":"Isis Moraes Ornelas","psa":"Sidarta Tollendal Gomes Ribeiro","ptype":"article","src":"https://openalex.org/W4283123029","eid":"W4283123029"},{"id":"paper-w1981542299","cat":"papers","name":"Effect of lisuride and LSD on monoamine synthesis after axotomy or reserpine treatment in rat brain","year":"1978","cit":38,"pfa":"W. Kehr","psa":"Wolfgang Speckenbach","ptype":"article","src":"https://openalex.org/W1981542299","eid":"W1981542299"},{"id":"paper-w2127825881","cat":"papers","name":"Modeling “psychosis” in vitro by inducing disordered neuronal network activity in cortical brain slices","year":"2009","cit":38,"pfa":"George K. Aghajanian","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2127825881","eid":"W2127825881"},{"id":"paper-w3044345421","cat":"papers","name":"LSD-induced increases in social adaptation to opinions similar to one’s own are associated with stimulation of serotonin receptors","year":"2020","cit":38,"pfa":"Patricia Duerler","psa":"Katrin H. Preller","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3044345421","eid":"W3044345421"},{"id":"paper-w2888119399","cat":"papers","name":"LSD Administered as a Single Dose Reduces Alcohol Consumption in C57BL/6J Mice","year":"2018","cit":38,"pfa":"Kenneth Alper","psa":"K. Yaragudri Vinod","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2888119399","eid":"W2888119399"},{"id":"paper-w2142154698","cat":"papers","name":"Salvia divinorum use and phenomenology: results from an online survey","year":"2010","cit":38,"pfa":"Harry R. Sumnall","psa":"Jon C. Cole","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2142154698","eid":"W2142154698"},{"id":"paper-w3127201130","cat":"papers","name":"Increased sensitivity to strong perturbations in a whole-brain model of LSD","year":"2021","cit":38,"pfa":"Beatrice Jobst","psa":"Gustavo Deco","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3127201130","eid":"W3127201130"},{"id":"paper-w1997943226","cat":"papers","name":"Psychotomimetic phenylisopropylamines. 5. 4-Alkyl-2,5-dimethoxyphenylisopropylamines","year":"1975","cit":38,"pfa":"Alexander T. Shulgin","psa":"Donald C. Dyer","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1997943226","eid":"W1997943226"},{"id":"paper-w4293203309","cat":"papers","name":"Set, Setting, and Clinical Trials: Colonial Technologies and Psychedelics","year":"2022","cit":38,"pfa":"Joseph Dumit","psa":"Emilia Sanabria","ptype":"book-chapter","src":"https://openalex.org/W4293203309","eid":"W4293203309"},{"id":"paper-w1982993626","cat":"papers","name":"Differential interactions of \"prosexual\" drugs with 5-hydroxytryptamine-sub(1A ) and alpha-sub-2-adrenergic receptors.","year":"1986","cit":38,"pfa":"Lenelle L. Kwong","psa":"Stephen J. Peroutka","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W1982993626","eid":"W1982993626"},{"id":"paper-w3204333168","cat":"papers","name":"Targeting INMT and interrupting its methylation pathway for the treatment of castration resistant prostate cancer","year":"2021","cit":38,"pfa":"Shangwei Zhong","psa":"Jun‐Li Luo","topics":["Anxiety & end-of-life","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3204333168","eid":"W3204333168"},{"id":"paper-w2064335517","cat":"papers","name":"Neuroimaging in Drug and Substance Abuse Part I","year":"2005","cit":38,"pfa":"Rafael Rojas","psa":"Jessica Borne","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2064335517","eid":"W2064335517"},{"id":"paper-w2789431474","cat":"papers","name":"Evaluation of three rapid oral fluid test devices on the screening of multiple drugs of abuse including ketamine","year":"2018","cit":38,"pfa":"Magdalene H.Y. Tang","psa":"Tony W.L. Mak","ptype":"article","src":"https://openalex.org/W2789431474","eid":"W2789431474"},{"id":"paper-w2297323134","cat":"papers","name":"Molecular Signaling Pathways Behind the Biological Effects ofSalviaSpecies Diterpenes in Neuropharmacology and Cardiology","year":"2016","cit":38,"pfa":"Maryam Akaberi","psa":"Soghra Mehri","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2297323134","eid":"W2297323134"},{"id":"paper-w4387563197","cat":"papers","name":"Novel treatments for anorexia nervosa: Insights from neuroplasticity research","year":"2023","cit":38,"pfa":"Johanna Louise Keeler","psa":"Hubertus Himmerich","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4387563197","eid":"W4387563197"},{"id":"paper-w1984271729","cat":"papers","name":"Evidence for a hallucinogen dependence syndrome developing soon after onset of hallucinogen use during adolescence","year":"2006","cit":38,"pfa":"Andrea L. Stone","psa":"J. C. Anthony","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1984271729","eid":"W1984271729"},{"id":"paper-w4200066447","cat":"papers","name":"Long-Acting Injectable Antipsychotic Treatment in Schizophrenia and Co-occurring Substance Use Disorders: A Systematic Review","year":"2021","cit":38,"pfa":"Alexandria S. Coles","psa":"David Jonathan Castle","topics":["Addiction","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4200066447","eid":"W4200066447"},{"id":"paper-w3126536249","cat":"papers","name":"Ketamine-Assisted Psychotherapy for PTSD Related to Racial Discrimination","year":"2021","cit":38,"pfa":"Mailae Halstead","psa":"Monnica T. Williams","topics":["Depression","PTSD & trauma","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3126536249","eid":"W3126536249"},{"id":"paper-w4396793804","cat":"papers","name":"A Psychedelic Renaissance","year":"2022","cit":38,"pfa":"Danielle Schlosser","psa":"Thomas R. Insel","ptype":"conference-abstract","src":"https://openalex.org/W4396793804","eid":"W4396793804"},{"id":"paper-w4225410099","cat":"papers","name":"Do psychedelics change beliefs?","year":"2022","cit":38,"pfa":"Hugh T. McGovern","psa":"Philip Robert Corlett","ptype":"article","src":"https://openalex.org/W4225410099","eid":"W4225410099"},{"id":"paper-w3165796092","cat":"papers","name":"Catalysts for change: the cellular neurobiology of psychedelics","year":"2021","cit":38,"pfa":"Matthew I. Banks","psa":"Cody J. Wenthur","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3165796092","eid":"W3165796092"},{"id":"paper-w4406326366","cat":"papers","name":"Distinctive But Not Exceptional: The Risks of Psychedelic Ethical Exceptionalism","year":"2025","cit":38,"pfa":"Katherine Cheung","psa":"David B. Yaden","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4406326366","eid":"W4406326366"},{"id":"paper-w1986401321","cat":"papers","name":"A microdosing approach for characterizing formation and repair of carboplatin–DNA monoadducts and chemoresistance","year":"2010","cit":38,"pfa":"Paul T. Henderson","psa":"Chong-xian Pan","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1986401321","eid":"W1986401321"},{"id":"paper-w4233034280","cat":"papers","name":"Dissolving the self:Active inference, psychedelics, and ego-dissolution","year":"2020","cit":38,"pfa":"Deane, George","topics":["Reviews & meta-analyses"],"ptype":"paratext","src":"https://openalex.org/W4233034280","eid":"W4233034280"},{"id":"paper-w597315667","cat":"papers","name":"The ecstatic imagination: psychedelic experiences and the psychoanalysis of self-actualization","year":"1998","cit":38,"ptype":"book-review","src":"https://openalex.org/W597315667","eid":"W597315667"},{"id":"paper-w2936870174","cat":"papers","name":"Moksha: Aldous Huxley's Classic Writings on Psychedelics and the Visionary Experience","year":"1977","cit":38,"pfa":"Aldous Huxley","psa":"Cynthia L. Palmer","ptype":"book","src":"https://openalex.org/W2936870174","eid":"W2936870174"},{"id":"paper-w2278944819","cat":"papers","name":"Higher Wisdom: Eminent Elders Explore the Continuing Impact of Psychedelics","year":"2005","cit":38,"pfa":"ROGER N. WALSH","psa":"Charles S. Grob","ptype":"book","src":"https://openalex.org/W2278944819","eid":"W2278944819"},{"id":"paper-w621567176","cat":"papers","name":"The Varieties of Psychedelic Experience: The Classic Guide to the Effects of LSD on the Human Psyche","year":"2000","cit":38,"pfa":"Robert Masters","psa":"Jean Houston","topics":["Addiction","Policy & ethics"],"ptype":"book","src":"https://openalex.org/W621567176","eid":"W621567176"},{"id":"paper-w2027511141","cat":"papers","name":"Lung Nodule Detection by Microdose CT Versus Chest Radiography (Standard and Dual-Energy Subtracted)","year":"2015","cit":38,"pfa":"Lukas Ebner","psa":"Andreas Christe","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2027511141","eid":"W2027511141"},{"id":"paper-w1966857191","cat":"papers","name":"Microdose Study of 14C-Acetaminophen With Accelerator Mass Spectrometry to Examine Pharmacokinetics of Parent Drug and Metabolites in Healthy Subjects","year":"2010","cit":38,"pfa":"Zenzaburo Tozuka","psa":"Yuichi Sugiyama","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1966857191","eid":"W1966857191"},{"id":"paper-w4296163279","cat":"papers","name":"Self-Entropic Broadening Theory: Toward a New Understanding of Self and Behavior Change Informed by Psychedelics and Psychosis","year":"2022","cit":38,"pfa":"Haley Maria Dourron","psa":"Peter S. Hendricks","ptype":"article","src":"https://openalex.org/W4296163279","eid":"W4296163279"},{"id":"paper-w2029629517","cat":"papers","name":"Licit and Illicit Drugs: The Consumers' Union Report on Narcotics, Stimulants, Depressants, Inhalants, Hallucinogens, and Marijuana—Including Caffeine, Nicotine, and Alcohol","year":"1973","cit":38,"pfa":"Barry I. Liskow","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2029629517","eid":"W2029629517"},{"id":"paper-w2530388172","cat":"papers","name":"Lack of Exposure in a First-in-Man Study Due to Aldehyde Oxidase Metabolism: Investigated by Use of 14C-microdose, Humanized Mice, Monkey Pharmacokinetics, and In Vitro Methods","year":"2016","cit":38,"pfa":"Klaus Gjervig Jensen","psa":"Martin Jørgensen","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2530388172","eid":"W2530388172"},{"id":"paper-w2074739793","cat":"papers","name":"Shamans, Sacraments, and Psychiatrists","year":"1989","cit":38,"pfa":"GARY L. BRAVO","psa":"Charles S. Grob","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2074739793","eid":"W2074739793"},{"id":"paper-w2089272286","cat":"papers","name":"The Use of LSD in Psychotherapy","year":"1970","cit":38,"pfa":"Stanislav Grof","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2089272286","eid":"W2089272286"},{"id":"paper-w2893556097","cat":"papers","name":"Understanding Central Nervous System Effects of Deliriant Hallucinogenic Drugs through Experimental Animal Models","year":"2018","cit":38,"pfa":"Andrey D. Volgin","psa":"Allan V. Kalueff","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2893556097","eid":"W2893556097"},{"id":"paper-w1982358973","cat":"papers","name":"Ketamine Enhanced Psychotherapy: Preliminary Clinical Observations on Its Effectiveness in Treating Alcoholism.","year":"2006","cit":38,"pfa":"Eli Kolp","psa":"Evgeny M. Krupitsky","topics":["Addiction","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1982358973","eid":"W1982358973"},{"id":"paper-w2019278705","cat":"papers","name":"Interrater reliability of the Psychiatric Research Interview for Substance and Mental Disorders in an HIV‐infected cohort: experience of the National NeuroAIDS Tissue Consortium","year":"2006","cit":38,"pfa":"Susan Morgello","psa":"Elyse J. Singer","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W2019278705","eid":"W2019278705"},{"id":"paper-w2141764226","cat":"papers","name":"Use of Salvia divinorum in a Nationally Representative Sample","year":"2011","cit":38,"pfa":"Brian Edward Perron","psa":"Li-Tzy T. Wu","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2141764226","eid":"W2141764226"},{"id":"paper-w1986866761","cat":"papers","name":"Early development of PAT-SM6 for the treatment of melanoma","year":"2013","cit":38,"pfa":"Frank Hensel","psa":"Stephanie Brändlein","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1986866761","eid":"W1986866761"},{"id":"paper-w1977701240","cat":"papers","name":"Drug and Alcohol Use by Canadian University Athletes: A National Survey","year":"1996","cit":38,"pfa":"John C. Spence","psa":"Lise I. Gauvin","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1977701240","eid":"W1977701240"},{"id":"paper-w2020015498","cat":"papers","name":"Tolerance and Dependence on Pentazocine","year":"1969","cit":38,"pfa":"Raynaldo G. Sandoval","psa":"Richard I. H. Wang","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2020015498","eid":"W2020015498"},{"id":"paper-w2005278069","cat":"papers","name":"Rectal ketamine for induction of anaesthesia in children","year":"1983","cit":38,"pfa":"Jan Idvall","psa":"Värnamo Pål Stenberg","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2005278069","eid":"W2005278069"},{"id":"paper-w2903001051","cat":"papers","name":"The Effects of Substance Abuse on Blood Glucose Parameters in Patients with Diabetes: A Systematic Review and Meta-Analysis","year":"2018","cit":38,"pfa":"Omorogieva Ojo","psa":"Jude Ibe","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W2903001051","eid":"W2903001051"},{"id":"paper-w66332573","cat":"papers","name":"Therapeutic N-methyl-D-aspartate receptor antagonists: will reality meet expectation?","year":"2003","cit":38,"pfa":"Paul F. Smith","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W66332573","eid":"W66332573"},{"id":"paper-w4253242404","cat":"papers","name":"Pentobarbital Inhibits Ketamine-Induced Dopamine Release in the Rat Nucleus Accumbens: A Microdialysis Study","year":"2003","cit":38,"pfa":"Munehiro Masuzawa","psa":"Koh Shingu","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4253242404","eid":"W4253242404"},{"id":"paper-w2800749866","cat":"papers","name":"Cognitive profile of ketamine-dependent patients compared with methamphetamine-dependent patients and healthy controls","year":"2018","cit":38,"pfa":"Liang‐Jen Wang","psa":"Ming‐Chyi Huang","ptype":"article","src":"https://openalex.org/W2800749866","eid":"W2800749866"},{"id":"paper-w2990152285","cat":"papers","name":"Short-term ketamine administration in treatment-resistant depression: focus on cardiovascular safety.","year":"2019","cit":38,"pfa":"Joanna Szarmach","psa":"Mariusz Stanisław Wiglusz","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2990152285","eid":"W2990152285"},{"id":"paper-w2041828151","cat":"papers","name":"What is hydroxynorketamine and what can it bring to neurotherapeutics?","year":"2014","cit":38,"pfa":"N. Singh","psa":"Irving W. Wainer","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2041828151","eid":"W2041828151"},{"id":"paper-w4410062466","cat":"papers","name":"Safety and efficacy with esketamine in treatment-resistant depression: long-term extension study","year":"2025","cit":38,"pfa":"Naim Zaki","psa":"Dong‐Jing Fu","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4410062466","eid":"W4410062466"},{"id":"paper-w2999514415","cat":"papers","name":"mGlu2/3 receptor antagonism: A mechanism to induce rapid antidepressant effects without ketamine-associated side-effects","year":"2020","cit":38,"pfa":"Jeffrey M. Witkin","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2999514415","eid":"W2999514415"},{"id":"paper-w4307705064","cat":"papers","name":"Inpatient suicide in psychiatric settings: Evaluation of current prevention measures","year":"2022","cit":38,"pfa":"Francesca Chammas","psa":"Noomane Bouaziz","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4307705064","eid":"W4307705064"},{"id":"paper-w2323848014","cat":"papers","name":"The Metabolites of Ergometrine and Lysergic Acid Diethylamide in Rat Bile","year":"1962","cit":37,"pfa":"M. Slaytor","psa":"Stephen E. Wright","ptype":"article","src":"https://openalex.org/W2323848014","eid":"W2323848014"},{"id":"paper-w2898270213","cat":"papers","name":"A case report SPECT study and theoretical rationale for the sequential administration of ibogaine and 5-MeO-DMT in the treatment of alcohol use disorder","year":"2018","cit":37,"pfa":"Joseph P. Barsuglia","psa":"Tanya Calvey","topics":["Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W2898270213","eid":"W2898270213"},{"id":"paper-w2316059351","cat":"papers","name":"Antagonism of 5-hydroxytryptamine2 receptor-mediated phosphatidylinositol turnover by d-lysergic acid diethylamide.","year":"1988","cit":37,"pfa":"P A Pierce","psa":"Stephen J. Peroutka","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2316059351","eid":"W2316059351"},{"id":"paper-w1973988066","cat":"papers","name":"Characteristics of d-lysergic acid diethylamide binding to subcellular fractions derived from rat brain","year":"1973","cit":37,"pfa":"John T. Farrow","psa":"Helen Van Vunakis","ptype":"article","src":"https://openalex.org/W1973988066","eid":"W1973988066"},{"id":"paper-w3210796807","cat":"papers","name":"Dosing Psychedelics and MDMA","year":"2021","cit":37,"pfa":"Matthias E. Liechti","psa":"Friederike Holze","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W3210796807","eid":"W3210796807"},{"id":"paper-w2123695441","cat":"papers","name":"Short-Term Stability of Lysergic Acid Diethylamide (LSD), N-Desmethyl-LSD, and 2-Oxo-3-hydroxy-LSD in Urine, Assessed by Liquid Chromatography–Tandem Mass Spectrometry","year":"2002","cit":37,"pfa":"Gisela Skopp","psa":"Rolf Aderjan","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2123695441","eid":"W2123695441"},{"id":"paper-w2044961305","cat":"papers","name":"Early peyote research an interdisciplinary study","year":"1973","cit":37,"pfa":"Jan G. Bruhn","psa":"Bo R. Holmstedt","ptype":"article","src":"https://openalex.org/W2044961305","eid":"W2044961305"},{"id":"paper-w2110096690","cat":"papers","name":"MDMA and Learning","year":"2000","cit":37,"pfa":"Tom Byrne","psa":"Alan D. Poling","ptype":"article","src":"https://openalex.org/W2110096690","eid":"W2110096690"},{"id":"paper-w1973330027","cat":"papers","name":"Effect of Iboga Alkaloids on µ-Opioid Receptor-Coupled G Protein Activation","year":"2013","cit":37,"pfa":"Tamara Antonio","psa":"Kenneth Alper","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1973330027","eid":"W1973330027"},{"id":"paper-w1501031773","cat":"papers","name":"THE OXIDATION OF MESCALINE AND CERTAIN OTHER AMINES","year":"1938","cit":37,"pfa":"Frederick Bernheim","psa":"Mary L.C. Bernheim","ptype":"article","src":"https://openalex.org/W1501031773","eid":"W1501031773"},{"id":"paper-w2077309758","cat":"papers","name":"Increased Excretion of Dimethyltryptamine and Certain Features of Psychosis","year":"1979","cit":37,"pfa":"Robin M. Murray","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2077309758","eid":"W2077309758"},{"id":"paper-w2065345227","cat":"papers","name":"The effect of microelectrophoretically applied mescaline on cortical neurones","year":"1974","cit":37,"pfa":"Paul Bevan","psa":"E. Szabadi","ptype":"article","src":"https://openalex.org/W2065345227","eid":"W2065345227"},{"id":"paper-w133762166","cat":"papers","name":"Recreational Use of MDMA","year":"1990","cit":37,"pfa":"Stephen J. Peroutka","ptype":"book-chapter","src":"https://openalex.org/W133762166","eid":"W133762166"},{"id":"paper-w1974645848","cat":"papers","name":"Investigation of MDMA-related agents in rats trained to discriminate MDMA from saline","year":"1992","cit":37,"pfa":"Richard A. Glennon","psa":"Rodney Higgs","ptype":"article","src":"https://openalex.org/W1974645848","eid":"W1974645848"},{"id":"paper-w167841785","cat":"papers","name":"Ayahuasca as a Candidate Therapy for PTSD","year":"2013","cit":37,"pfa":"Jessica L. Nielson","psa":"Julie D. Megler","topics":["PTSD & trauma"],"ptype":"book-chapter","src":"https://openalex.org/W167841785","eid":"W167841785"},{"id":"paper-w1970402589","cat":"papers","name":"Blockade and reversal of 5-Methoxy-N, N-Dimethyltryptamine-induced analgesia following noradrenaline depletion","year":"1985","cit":37,"pfa":"Trevor Archer","psa":"Claes Post","ptype":"article","src":"https://openalex.org/W1970402589","eid":"W1970402589"},{"id":"paper-w1903260451","cat":"papers","name":"Production of Psilocybin in Psilocybe baeocystis Saprophytic Culture","year":"1965","cit":37,"pfa":"Albert Leung","psa":"Ara G. Paul","ptype":"article","src":"https://openalex.org/W1903260451","eid":"W1903260451"},{"id":"paper-w2071066362","cat":"papers","name":"Making a medicine out of MDMA","year":"2015","cit":37,"pfa":"Ben Sessa","psa":"David Nutt","topics":["Depression","PTSD & trauma","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2071066362","eid":"W2071066362"},{"id":"paper-w2125738925","cat":"papers","name":"A Dose-Response Study of Ibogaine-Induced Neuropathology in the Rat Cerebellum","year":"2000","cit":37,"pfa":"Z. Xu","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2125738925","eid":"W2125738925"},{"id":"paper-w2796428584","cat":"papers","name":"Is Ayahuasca an Option for the Treatment of Crack Cocaine Dependence?","year":"2018","cit":37,"pfa":"Joselaine Ida da Cruz","psa":"Solange Aparecida Nappo","topics":["PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W2796428584","eid":"W2796428584"},{"id":"paper-w2121090314","cat":"papers","name":"Involvement of 5-HT2A receptors in MDMA reinforcement and cue-induced reinstatement of MDMA-seeking behaviour","year":"2010","cit":37,"pfa":"María Juliana Orejarena","psa":"Patricia Robledo","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2121090314","eid":"W2121090314"},{"id":"paper-w3182390788","cat":"papers","name":"Psilocybin for Depression: The ACE Model Manual","year":"2021","cit":37,"pfa":"Rosalind Watts","topics":["Depression"],"ptype":"preprint","src":"https://openalex.org/W3182390788","eid":"W3182390788"},{"id":"paper-w1966592369","cat":"papers","name":"Some observations on psilocybin, a new hallucinogen, in volunteer subjects","year":"1960","cit":37,"pfa":"Sidney Malitz","psa":"Paul H. Hoch","ptype":"article","src":"https://openalex.org/W1966592369","eid":"W1966592369"},{"id":"paper-w3082638431","cat":"papers","name":"Tropane-Based Ibogaine Analog Rescues Folding-Deficient Serotonin and Dopamine Transporters","year":"2020","cit":37,"pfa":"Shreyas Bhat","psa":"Amy Hauck Newman","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3082638431","eid":"W3082638431"},{"id":"paper-w1987937095","cat":"papers","name":"MDMA on the Street: Analysis Anonymous®","year":"1986","cit":37,"pfa":"Renfroe Cl","ptype":"article","src":"https://openalex.org/W1987937095","eid":"W1987937095"},{"id":"paper-w2101327441","cat":"papers","name":"Profile of MDMA Self-Administration from a Large Cohort of Rats: MDMA Develops a Profile of Dependence with Extended Testing","year":"2012","cit":37,"pfa":"Susan Schenk","psa":"Judith Bird","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2101327441","eid":"W2101327441"},{"id":"paper-w1483615162","cat":"papers","name":"PRECLINICAL STUDY: Acquisition and reinstatement of MDMA‐induced conditioned place preference in mice pre‐treated with MDMA or cocaine during adolescence","year":"2009","cit":37,"pfa":"Manuel Daza‐Losada","psa":"José Miñarro","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1483615162","eid":"W1483615162"},{"id":"paper-w2313225109","cat":"papers","name":"Antidepressive effects of the κ-opioid receptor agonist salvinorin A in a rat model of anhedonia","year":"2012","cit":37,"pfa":"Mitchell T. Harden","psa":"George T. Taylor","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2313225109","eid":"W2313225109"},{"id":"paper-w2144353982","cat":"papers","name":"Analysis of the Psychoactive Terpenoid Salvinorin A Content in Five Salvia divinorum Herbal Products","year":"2006","cit":37,"pfa":"William R. Wolowich","psa":"John J. Cienki","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2144353982","eid":"W2144353982"},{"id":"paper-w2121685154","cat":"papers","name":"Pharmacogenetic studies of change in cortisol on ecstasy (MDMA) consumption","year":"2011","cit":37,"pfa":"Kim Wolff","psa":"Katherine Jean Aitchison","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2121685154","eid":"W2121685154"},{"id":"paper-w2002241454","cat":"papers","name":"Studies on the neuroprotective effect of pentobarbitone on MDMA-induced neurodegeneration","year":"1999","cit":37,"pfa":"M. Isabel Colado","psa":"A. R. Green","ptype":"article","src":"https://openalex.org/W2002241454","eid":"W2002241454"},{"id":"paper-w2138612704","cat":"papers","name":"Cocaine, metamfetamine, and MDMA abuse: the role and clinical importance of neuroadaptation","year":"2010","cit":37,"pfa":"Donna Seger","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2138612704","eid":"W2138612704"},{"id":"paper-w2150966446","cat":"papers","name":"What is the evidence that Ecstasy (MDMA) can cause Parkinson's disease?","year":"2003","cit":37,"pfa":"Stephen J. Kish","ptype":"article","src":"https://openalex.org/W2150966446","eid":"W2150966446"},{"id":"paper-w2042166241","cat":"papers","name":"Party people: Personality and MDMA use of house party visitors","year":"2005","cit":37,"pfa":"Tom ter Bogt","psa":"Judith Semon Dubas","ptype":"article","src":"https://openalex.org/W2042166241","eid":"W2042166241"},{"id":"paper-w3191241244","cat":"papers","name":"Effects of Ayahuasca on Personality: Results of Two Randomized, Placebo-Controlled Trials in Healthy Volunteers","year":"2021","cit":37,"pfa":"Juliana Mendes Rocha","psa":"RAFAEL GUIMARÃES DOS SANTOS","ptype":"article","src":"https://openalex.org/W3191241244","eid":"W3191241244"},{"id":"paper-w1563242167","cat":"papers","name":"Assessment of the Psychotherapeutic Effects of Ritual Ayahuasca Use on Drug Dependency: A Pilot Study","year":"2013","cit":37,"pfa":"Xavier Fernández","psa":"Josep María Fábregas","topics":["Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W1563242167","eid":"W1563242167"},{"id":"paper-w4378783751","cat":"papers","name":"Assessment of the Acute Effects of 2C‐B vs. Psilocybin on Subjective Experience, Mood, and Cognition","year":"2023","cit":37,"pfa":"Pablo Mallaroni","psa":"Johannes Gerardus Ramaekers","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4378783751","eid":"W4378783751"},{"id":"paper-w2792430928","cat":"papers","name":"Long-term effects of ayahuasca in patients with recurrent depression: a 5-year qualitative follow-up","year":"2018","cit":37,"pfa":"RAFAEL GUIMARÃES DOS SANTOS","psa":"Jaime E. C. Hallak","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2792430928","eid":"W2792430928"},{"id":"paper-w2314016336","cat":"papers","name":"Asymmetric Total Synthesis of an Iboga-Type Indole Alkaloid, Voacangalactone, Newly Isolated from Voacanga africana","year":"2012","cit":37,"pfa":"Masaya Harada","psa":"Hiromitsu Takayama","ptype":"article","src":"https://openalex.org/W2314016336","eid":"W2314016336"},{"id":"paper-w2071921031","cat":"papers","name":"Ayahuasca from Peru to Uruguay: Ritual Design and Redesign through a Distributed Cognition Approach","year":"2015","cit":37,"pfa":"Ismael Apud","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2071921031","eid":"W2071921031"},{"id":"paper-w2026280390","cat":"papers","name":"Organic impurity profiling of 3,4-methylenedioxymethamphetamine (MDMA) tablets seized in the Netherlands","year":"2006","cit":37,"pfa":"M.M. van Deursen","psa":"A.J. Poortman-van der Meer","ptype":"article","src":"https://openalex.org/W2026280390","eid":"W2026280390"},{"id":"paper-w2017461205","cat":"papers","name":"d-MDMA during vitamin E deficiency: effects on dopaminergic neurotoxicity and hepatotoxicity","year":"2002","cit":37,"pfa":"Elizabeth Anne Johnson","psa":"Diane Bemis Miller","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2017461205","eid":"W2017461205"},{"id":"paper-w3215766429","cat":"papers","name":"Psilocybin, a Naturally Occurring Indoleamine Compound, Could Be Useful to Prevent Suicidal Behaviors","year":"2021","cit":37,"pfa":"Robertas Strumila","psa":"Philippe Courtet","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3215766429","eid":"W3215766429"},{"id":"paper-w4220928043","cat":"papers","name":"A systematic literature review and meta-analysis of the effect of psilocybin and methylenedioxymethamphetamine on mental, behavioural or developmental disorders","year":"2022","cit":37,"pfa":"Steve R Kisely","psa":"Dan J. Siskind","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"review","src":"https://openalex.org/W4220928043","eid":"W4220928043"},{"id":"paper-w4390586775","cat":"papers","name":"Preliminary evidence for the importance of therapeutic alliance in MDMA-assisted psychotherapy for posttraumatic stress disorder","year":"2024","cit":37,"pfa":"Richard J. Zeifman","psa":"Anne C. Wagner","topics":["PTSD & trauma","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4390586775","eid":"W4390586775"},{"id":"paper-w2005077795","cat":"papers","name":"Acute psychomotor effects of MDMA and ethanol (co-) administration over time in healthy volunteers","year":"2009","cit":37,"pfa":"Glenn Dumont","psa":"RJ Verkes","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2005077795","eid":"W2005077795"},{"id":"paper-w2029608095","cat":"papers","name":"Role of α1‐ and β3‐adrenoceptors in the modulation by SR59230A of the effects of MDMA on body temperature in the mouse","year":"2009","cit":37,"pfa":"Sotiria Bexis","psa":"James R. Docherty","ptype":"article","src":"https://openalex.org/W2029608095","eid":"W2029608095"},{"id":"paper-w1880731034","cat":"papers","name":"Self‐administered MDMA produces dose‐ and time‐dependent serotonin deficits in the rat brain","year":"2011","cit":37,"pfa":"Jennifer Do","psa":"Susan Schenk","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1880731034","eid":"W1880731034"},{"id":"paper-w1973431248","cat":"papers","name":"The excitability and rhythm of medullary respiratory neurons in the cat are altered by the serotonin receptor agonist 5-methoxy-N,N, dimethyltryptamine","year":"1994","cit":37,"pfa":"Peter M. Lalley","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1973431248","eid":"W1973431248"},{"id":"paper-w3034423620","cat":"papers","name":"Acute effects of MDMA on trust, cooperative behaviour and empathy: A double-blind, placebo-controlled experiment","year":"2020","cit":37,"pfa":"Anna Borissova","psa":"Will Lawn","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W3034423620","eid":"W3034423620"},{"id":"paper-w2074347997","cat":"papers","name":"Repeated exposure to MDMA and amphetamine: sensitization, cross-sensitization, and response to dopamine D1- and D2-like agonists","year":"2012","cit":37,"pfa":"Sarah Bradbury","psa":"Susan Schenk","ptype":"article","src":"https://openalex.org/W2074347997","eid":"W2074347997"},{"id":"paper-w2078923718","cat":"papers","name":"Behavioral and neurochemical consequences of multiple MDMA administrations in the rat: Role of individual differences in anxiety-related behavior","year":"2007","cit":37,"pfa":"V. Ludwig","psa":"Rainer K.W. Schwarting","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2078923718","eid":"W2078923718"},{"id":"paper-w2809565885","cat":"papers","name":"Oxytocin receptor gene variations and socio-emotional effects of MDMA: A pooled analysis of controlled studies in healthy subjects","year":"2018","cit":37,"pfa":"Patrick Vizeli","psa":"Matthias E. Liechti","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2809565885","eid":"W2809565885"},{"id":"paper-w2156833690","cat":"papers","name":"GENETIC STUDY: 5‐HTTLPR polymorphism, mood disorders and MDMA use in a 3‐year follow‐up study","year":"2009","cit":37,"pfa":"Rocío Martín‐Santos","psa":"Rafael de la Torre","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2156833690","eid":"W2156833690"},{"id":"paper-w2006571572","cat":"papers","name":"The Role of Adenosine A1 and A2A Receptors in the Caffeine Effect on MDMA-Induced DA and 5-HT Release in the Mouse Striatum","year":"2014","cit":37,"pfa":"Anna Maria Górska","psa":"Krystyna Gołembiowska","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2006571572","eid":"W2006571572"},{"id":"paper-w3135169733","cat":"papers","name":"Association Between Lifetime Classic Psychedelic Use and Hypertension in the Past Year","year":"2021","cit":37,"pfa":"Otto Simonsson","psa":"Walter Osika","ptype":"article","src":"https://openalex.org/W3135169733","eid":"W3135169733"},{"id":"paper-w2113363590","cat":"papers","name":"In vivo evidence against clomethiazole being neuroprotective against MDMA (‘ecstasy’)-induced degeneration of rat brain 5-HT nerve terminals by a free radical scavenging mechanism","year":"1999","cit":37,"pfa":"María Isabel Colado","psa":"A.R Green","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2113363590","eid":"W2113363590"},{"id":"paper-w4392660340","cat":"papers","name":"Scoping Review: The Role of Psychedelics in the Management of Chronic Pain","year":"2024","cit":37,"pfa":"Christopher Louis Robinson","psa":"Trent D. Emerick","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4392660340","eid":"W4392660340"},{"id":"paper-w3162909048","cat":"papers","name":"The Potential Role of Psychedelic Drugs in Mental Health Care of the Future","year":"2021","cit":37,"pfa":"Gerhard Gründer","psa":"Henrik Jungaberle","topics":["Safety & adverse events","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3162909048","eid":"W3162909048"},{"id":"paper-w1977152489","cat":"papers","name":"ACTIONS OF DERIVATIVES OF LYSERGIC ACID ON THE HEART OF VENUS MERCENARIA","year":"1962","cit":37,"pfa":"ANNE McCOY WRIGHT","psa":"John H. Welsh","ptype":"article","src":"https://openalex.org/W1977152489","eid":"W1977152489"},{"id":"paper-w2022770178","cat":"papers","name":"The determination of LSD in human plasma following oral administration","year":"1972","cit":37,"pfa":"David G. Upshall","psa":"D. G. Wailling","ptype":"article","src":"https://openalex.org/W2022770178","eid":"W2022770178"},{"id":"paper-w2106658282","cat":"papers","name":"\"MODEL PSYCHOSIS\" PRODUCED BY INHALATION OF GASOLINE FUMES","year":"1964","cit":37,"pfa":"ELIERE J. TOLAN","psa":"F. A. LINGL","ptype":"article","src":"https://openalex.org/W2106658282","eid":"W2106658282"},{"id":"paper-w3127644232","cat":"papers","name":"Trends in the Top-Cited Articles on Classic Psychedelics","year":"2021","cit":37,"pfa":"David Wyndham Lawrence","psa":"Robin Lester Carhart-Harris","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3127644232","eid":"W3127644232"},{"id":"paper-w2034506918","cat":"papers","name":"Analysis of LSD in human body fluids and hair samples applying ImmunElute columns","year":"2000","cit":37,"pfa":"J. Röhrich","psa":"Jürgen Reiner Becker","ptype":"article","src":"https://openalex.org/W2034506918","eid":"W2034506918"},{"id":"paper-w3111336391","cat":"papers","name":"The entropic tongue: Disorganization of natural language under LSD","year":"2020","cit":37,"pfa":"Camila Sanz","psa":"Enzo Tagliazucchi","ptype":"article","src":"https://openalex.org/W3111336391","eid":"W3111336391"},{"id":"paper-w1985379163","cat":"papers","name":"Carotid Artery Obstruction Following LSD Capsule Ingestion","year":"1971","cit":37,"pfa":"Jack D. Sobel","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W1985379163","eid":"W1985379163"},{"id":"paper-w4205605194","cat":"papers","name":"Novel Antidepressants in the Pipeline (Phase II and III): A Systematic Review of the US Clinical Trials Registry","year":"2022","cit":37,"pfa":"Hitoshi Sakurai","psa":"Hiroyuki Uchida","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4205605194","eid":"W4205605194"},{"id":"paper-w1268863279","cat":"papers","name":"Effects of LSD on grooming behavior in serotonin transporter heterozygous (Sert) mice","year":"2015","cit":37,"pfa":"Evan J. Kyzar","psa":"Allan V. Kalueff","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1268863279","eid":"W1268863279"},{"id":"paper-w2152521595","cat":"papers","name":"Detection of LSD and Metabolite in Rat Hair and Human Hair","year":"1996","cit":37,"pfa":"Y. Nakahara","psa":"Tammy A. Mieczkowski","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2152521595","eid":"W2152521595"},{"id":"paper-w2083687710","cat":"papers","name":"3,4-Methylenedioxymethamphetamine Produces Glycogenolysis and Increases the Extracellular Concentration of Glucose in the Rat Brain","year":"2002","cit":37,"pfa":"Altaf S. Darvesh","psa":"Gary A. Gudelsky","ptype":"article","src":"https://openalex.org/W2083687710","eid":"W2083687710"},{"id":"paper-w1966478406","cat":"papers","name":"Developmental effects of ±3,4‐methylenedioxymethamphetamine on spatial versus path integration learning: Effects of dose distribution","year":"2007","cit":37,"pfa":"Charles V. Vorhees","psa":"Michael T. Williams","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W1966478406","eid":"W1966478406"},{"id":"paper-w4401123563","cat":"papers","name":"LSD-assisted therapy in patients with anxiety: open-label prospective 12-month follow-up","year":"2024","cit":37,"pfa":"Friederike Holze","psa":"Matthias E. Liechti","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4401123563","eid":"W4401123563"},{"id":"paper-w2142790779","cat":"papers","name":"Tissue Distribution of Methylenedioxymethamphetamine","year":"1992","cit":37,"pfa":"Timothy P. Rohrig","psa":"Richard W. Prouty","ptype":"article","src":"https://openalex.org/W2142790779","eid":"W2142790779"},{"id":"paper-w2166183746","cat":"papers","name":"Chromatographic and Mass Spectral Studies on Methoxy Methyl Methamphetamines Related to 3,4-Methylenedioxymethamphetamine","year":"2007","cit":37,"pfa":"T. Awad","psa":"Charles R. Clark","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2166183746","eid":"W2166183746"},{"id":"paper-w2314466819","cat":"papers","name":"Trazodone, meta-Chlorophenylpiperazine (an Hallucinogenic Drug and Trazodone Metabolite), and the Hallucinogen Trifluoromethylphenylpiperazine Cross-React with the EMIT®II Ecstasy Immunoassay in Urine","year":"2010","cit":37,"pfa":"Barry Kerr Logan","psa":"David J. Sanders","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2314466819","eid":"W2314466819"},{"id":"paper-w2129695646","cat":"papers","name":"Neurotoxic Thioether Adducts of 3,4-Methylenedioxymethamphetamine Identified in Human Urine After Ecstasy Ingestion","year":"2009","cit":37,"pfa":"Ximena Perfetti","psa":"Rafael de la Torre","ptype":"article","src":"https://openalex.org/W2129695646","eid":"W2129695646"},{"id":"paper-w1983588884","cat":"papers","name":"Nutmeg as a Narcotic. A Contribution to the Chemistry and Pharmacology of Nutmeg (Myristica fragrans)","year":"1971","cit":37,"pfa":"D.A. Kalbhen","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1983588884","eid":"W1983588884"},{"id":"paper-w2004018026","cat":"papers","name":"The classification of peripheral 5‐HT2‐like receptors using tryptamine agonist and antagonist analogues","year":"1986","cit":37,"pfa":"P. Leff","psa":"J.M. Morse","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2004018026","eid":"W2004018026"},{"id":"paper-w4404236211","cat":"papers","name":"Transformative Therapies for Depression: Postpartum Depression, Major Depressive Disorder, and Treatment-Resistant Depression","year":"2024","cit":37,"pfa":"Elizabeth Richardson","psa":"Amanda C. Tow","topics":["Depression","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4404236211","eid":"W4404236211"},{"id":"paper-w3131502434","cat":"papers","name":"Drug Checking as Strategy for Harm Reduction in Recreational Contests: Evaluation of Two Different Drug Analysis Methodologies","year":"2021","cit":37,"pfa":"Martina Fregonese","psa":"Cristiana Gambelunghe","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3131502434","eid":"W3131502434"},{"id":"paper-w2025872598","cat":"papers","name":"Voltammetric determination of harmaline in natural food products using boron-doped diamond electrode","year":"2015","cit":37,"pfa":"Ĺubomíŕ́ Švorc","psa":"Kurt Kalcher","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2025872598","eid":"W2025872598"},{"id":"paper-w4310945038","cat":"papers","name":"Update on treatments for anxiety-related disorders","year":"2022","cit":37,"pfa":"Hyun Jeong Lee","psa":"Murray B. Stein","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4310945038","eid":"W4310945038"},{"id":"paper-w2418238179","cat":"papers","name":"Drug addiction. Part I. Psychoactive substances in the past and presence.","year":"2002","cit":37,"pfa":"J Vetulani","topics":["Addiction","Reviews & meta-analyses","Policy & ethics"],"ptype":"other","src":"https://openalex.org/W2418238179","eid":"W2418238179"},{"id":"paper-w2059076739","cat":"papers","name":"Effects of DOM and DMT in a proposed animal model of hallucinogenic activity","year":"1985","cit":37,"pfa":"Lynne M. Adams","psa":"Mark A. Geyer","ptype":"article","src":"https://openalex.org/W2059076739","eid":"W2059076739"},{"id":"paper-w4200162407","cat":"papers","name":"Psychedelic-Assisted Therapy for Substance Use Disorders and Potential Mechanisms of Action","year":"2021","cit":37,"pfa":"Nathalie M. Rieser","psa":"Katrin H. Preller","topics":["Addiction","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W4200162407","eid":"W4200162407"},{"id":"paper-w4311448180","cat":"papers","name":"Seeking the Psilocybiome: Psychedelics meet the microbiota-gut-brain axis","year":"2022","cit":37,"pfa":"John Richard Kelly","psa":"Timothy G. Dinan","topics":["Mechanism & neuroscience","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4311448180","eid":"W4311448180"},{"id":"paper-w2403267016","cat":"papers","name":"Classical Hallucinogens: An Introductory Overview","year":"1994","cit":37,"pfa":"Richard A. Glennon","ptype":"dataset","src":"https://openalex.org/W2403267016","eid":"W2403267016"},{"id":"paper-w2043892534","cat":"papers","name":"Personality correlates of hallucinogen use.","year":"1977","cit":37,"pfa":"Khalil Akhtar Khavari","psa":"Mae Humes","ptype":"article","src":"https://openalex.org/W2043892534","eid":"W2043892534"},{"id":"paper-w2413445853","cat":"papers","name":"Ketamine — “Dissociative Agent” or Hallucinogen?","year":"1971","cit":37,"pfa":"Charles E. Reier","ptype":"article","src":"https://openalex.org/W2413445853","eid":"W2413445853"},{"id":"paper-w1496251699","cat":"papers","name":"The psychedelic drug therapies.","year":"1981","cit":37,"pfa":"Lester Grinspoon","psa":"James B. Bakalar","ptype":"article","src":"https://openalex.org/W1496251699","eid":"W1496251699"},{"id":"paper-w2063550900","cat":"papers","name":"Vulnerability to psychosis associated with hallucinogen use","year":"1983","cit":37,"pfa":"Malcolm B. Bowers","psa":"Mary E. Swigar","ptype":"article","src":"https://openalex.org/W2063550900","eid":"W2063550900"},{"id":"paper-w1985486328","cat":"papers","name":"Innovative Early Development Regulatory Approaches: expIND, expCTA, Microdosing","year":"2007","cit":37,"pfa":"W. T. Robinson","topics":["Dosing & pharmacology","Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1985486328","eid":"W1985486328"},{"id":"paper-w3191704139","cat":"papers","name":"Moral Psychopharmacology Needs Moral Inquiry: The Case of Psychedelics","year":"2021","cit":37,"pfa":"Nicolas Langlitz","psa":"Dimitris Repantis","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3191704139","eid":"W3191704139"},{"id":"paper-w3185700361","cat":"papers","name":"Racial/ethnic differences in prevalence of hallucinogen use by age cohort: Findings from the 2018 National Survey on Drug Use and Health","year":"2021","cit":37,"pfa":"Zoe W. Jahn","psa":"Monnica T. Williams","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W3185700361","eid":"W3185700361"},{"id":"paper-w2020266843","cat":"papers","name":"Self-Experimentations with Psychedelics Among Mental Health Professionals: LSD in the Former Czechoslovakia","year":"2014","cit":37,"pfa":"Petr Winkler","psa":"Ladislav Csémy","topics":["Addiction","Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2020266843","eid":"W2020266843"},{"id":"paper-w2234681180","cat":"papers","name":"Psychedelics and cognitive liberty: Reimagining drug policy through the prism of human rights","year":"2016","cit":37,"pfa":"Charlotte Walsh","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2234681180","eid":"W2234681180"},{"id":"paper-w2894431596","cat":"papers","name":"The moderating effect of psychedelics on the prospective relationship between prescription opioid use and suicide risk among marginalized women","year":"2018","cit":37,"pfa":"Elena Argento","psa":"Kate Shannon","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W2894431596","eid":"W2894431596"},{"id":"paper-w4223562941","cat":"papers","name":"Validation of a French Version of the Mystical Experience Questionnaire with Retrospective Reports of the Most Significant Psychedelic Experience among French Users","year":"2022","cit":37,"pfa":"Baptiste Fauvel","psa":"Pascale Piolino","ptype":"article","src":"https://openalex.org/W4223562941","eid":"W4223562941"},{"id":"paper-w1992113586","cat":"papers","name":"Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol for patients with a","year":"2008","cit":37,"pfa":"Vanessa N. Weitzman","psa":"Claudio A Benadiva","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1992113586","eid":"W1992113586"},{"id":"paper-w1993324335","cat":"papers","name":"The Beyond Within: The LSD Story","year":"1965","cit":37,"pfa":"Donald E. Widmann","topics":["Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W1993324335","eid":"W1993324335"},{"id":"paper-w2079933491","cat":"papers","name":"Mushroom chemical defense: Food aversion learning induced by hallucinogenic toxin, muscimol","year":"1983","cit":37,"pfa":"Scott M. Camazine","ptype":"article","src":"https://openalex.org/W2079933491","eid":"W2079933491"},{"id":"paper-w2008071452","cat":"papers","name":"Stable quantitative EEG difference in post-LSD visual disorder by split-half analysis: evidence for disinhibition","year":"1996","cit":37,"pfa":"Henry David Abraham","psa":"Frank Hopkins Duffy","ptype":"article","src":"https://openalex.org/W2008071452","eid":"W2008071452"},{"id":"paper-w2317388891","cat":"papers","name":"Coma in the course of severe poisoning after consumption of red fly agaric (Amanita muscaria).","year":"2016","cit":37,"pfa":"Małgorzata Mikaszewska-Sokolewicz","psa":"Krzysztof Jankowski","ptype":"article","src":"https://openalex.org/W2317388891","eid":"W2317388891"},{"id":"paper-w4319335998","cat":"papers","name":"The acute effects of cannabis with and without cannabidiol in adults and adolescents: A randomised, double‐blind, placebo‐controlled, crossover experiment","year":"2023","cit":37,"pfa":"Will Lawn","psa":"Helen Valerie Curran","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4319335998","eid":"W4319335998"},{"id":"paper-w2413609378","cat":"papers","name":"Drug dependence and abuse potential of tramadol.","year":"1999","cit":37,"pfa":"Z M Liu","psa":"Z J Cai","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2413609378","eid":"W2413609378"},{"id":"paper-w2063136461","cat":"papers","name":"Comparison of the Analgesic Effects of Intravenous Nalbuphine and Pentazocine in Patients with Postoperative Pain","year":"1977","cit":37,"pfa":"T. Tammisto","psa":"Irma Tigerstedt","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2063136461","eid":"W2063136461"},{"id":"paper-w2807724431","cat":"papers","name":"Cannabidiol did not induce teratogenicity or neurotoxicity in exposed zebrafish embryos","year":"2018","cit":37,"pfa":"Tamires Amabile Valim Brigante","psa":"Danielle Palma de Oliveira","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2807724431","eid":"W2807724431"},{"id":"paper-w2094447888","cat":"papers","name":"Schizophrenia risk gene CAV1 is both pro-psychotic and required for atypical antipsychotic drug actions in vivo","year":"2011","cit":37,"pfa":"J A Allen","psa":"Bryan L. Roth","topics":["Safety & adverse events","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2094447888","eid":"W2094447888"},{"id":"paper-w2324251075","cat":"papers","name":"A Targeted Multiplexed Proteomic Investigation Identifies Ketamine-Induced Changes in Immune Markers in Rat Serum and Expression Changes in Protein Kinases/Phosphatases in Rat Brain","year":"2014","cit":37,"pfa":"Hendrik Wesseling","psa":"Sabine Bahn","topics":["Depression","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2324251075","eid":"W2324251075"},{"id":"paper-w2925451033","cat":"papers","name":"Characterization of the Safety and Pharmacokinetic Profile of d-Methadone, a Novel N-Methyl-d-Aspartate Receptor Antagonist in Healthy, Opioid-Naive Subjects","year":"2019","cit":37,"pfa":"Galina Bernstein","psa":"Ottavio V. Vitolo","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2925451033","eid":"W2925451033"},{"id":"paper-w2884332078","cat":"papers","name":"Is (S)-norketamine an alternative antidepressant for esketamine?","year":"2018","cit":37,"pfa":"Kenji Hashimoto","psa":"Chun Yang","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2884332078","eid":"W2884332078"},{"id":"paper-w4280637500","cat":"papers","name":"Autophagy: A New Mechanism for Esketamine as a Depression Therapeutic","year":"2022","cit":37,"pfa":"Guanghao Jiang","psa":"Lidong Zhang","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4280637500","eid":"W4280637500"},{"id":"paper-w4318912123","cat":"papers","name":"Reconsidering “dissociation” as a predictor of antidepressant efficacy for esketamine","year":"2023","cit":37,"pfa":"David S. Mathai","psa":"Albert Garcia‐Romeu","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4318912123","eid":"W4318912123"},{"id":"paper-w4401037015","cat":"papers","name":"A Phase 1 Assessment of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of (2 R ,6 R )‐Hydroxynorketamine in Healthy Volunteers","year":"2024","cit":37,"pfa":"Shruti M. Raja","psa":"Craig J. Thomas","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4401037015","eid":"W4401037015"},{"id":"paper-w4386030218","cat":"papers","name":"Investigational Drugs for the Treatment of Postherpetic Neuralgia: Systematic Review of Randomized Controlled Trials","year":"2023","cit":37,"pfa":"Miguel Á. Huerta","psa":"Nancy Paniagua","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W4386030218","eid":"W4386030218"},{"id":"paper-w2043556771","cat":"papers","name":"Clinical syndromes and biochemical alterations following mescaline, lysergic acid diethylamide, psilocybin and a combination of the three psychotomimetic drugs","year":"1964","cit":36,"pfa":"Leo E. Hollister","psa":"Bernard M. Sjoberg","ptype":"article","src":"https://openalex.org/W2043556771","eid":"W2043556771"},{"id":"paper-w4231467291","cat":"papers","name":"Interaction of Reserpine, Serotonin, and Lysergic Acid Diethylamide in Brain","year":"1955","cit":36,"pfa":"Parkhurst A. Shore","psa":"Bernard B. Brodie","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4231467291","eid":"W4231467291"},{"id":"paper-w1997788694","cat":"papers","name":"Effect of lysergic acid diethylamide (LSD-25) on the absolute visual threshold.","year":"1958","cit":36,"pfa":"Virgil R. Carlson","ptype":"article","src":"https://openalex.org/W1997788694","eid":"W1997788694"},{"id":"paper-w1975445052","cat":"papers","name":"Electrochemistry and analytical determination of lysergic acid diethylamide (LSD) via adsorptive stripping voltammetry","year":"2014","cit":36,"pfa":"Daniele Merli","psa":"Antonella Profumo","ptype":"article","src":"https://openalex.org/W1975445052","eid":"W1975445052"},{"id":"paper-w1984704959","cat":"papers","name":"Actions of d-Lysergic Acid Diethylamide and Its 2-Bromo Derivative on Heart of Venus mercenaria","year":"1957","cit":36,"pfa":"John H. Welsh","psa":"Anne C. McCoy","ptype":"article","src":"https://openalex.org/W1984704959","eid":"W1984704959"},{"id":"paper-w4402403273","cat":"papers","name":"Neurobiological research on N,N-dimethyltryptamine (DMT) and its potentiation by monoamine oxidase (MAO) inhibition: from ayahuasca to synthetic combinations of DMT and MAO inhibitors","year":"2024","cit":36,"pfa":"Klemens Egger","psa":"Milan Scheidegger","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4402403273","eid":"W4402403273"},{"id":"paper-w2109793009","cat":"papers","name":"Ayahuasca—The Healing Vine","year":"1971","cit":36,"pfa":"Marlene Dobkin de Ríos","ptype":"article","src":"https://openalex.org/W2109793009","eid":"W2109793009"},{"id":"paper-w2588307423","cat":"papers","name":"The antiaddictive effects of ibogaine: A systematic literature review of human studies","year":"2017","cit":36,"pfa":"RAFAEL GUIMARÃES DOS SANTOS","psa":"Jaime E. C. Hallak","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W2588307423","eid":"W2588307423"},{"id":"paper-w55169691","cat":"papers","name":"The Therapeutic Potentials of Ayahuasca in the Treatment of Depression","year":"2013","cit":36,"pfa":"Fernanda Palhano-Fontes","psa":"Dráulio Barros de Araújo","topics":["Depression"],"ptype":"book-chapter","src":"https://openalex.org/W55169691","eid":"W55169691"},{"id":"paper-w2025464258","cat":"papers","name":"MDMA (\"Ecstasy\") and Neurotoxicity","year":"2003","cit":36,"pfa":"Michael C. Mithoefer","psa":"George A. Ricaurte","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2025464258","eid":"W2025464258"},{"id":"paper-w2389537203","cat":"papers","name":"Effects of low dose ibogaine on subjective mood state and psychological performance","year":"2016","cit":36,"pfa":"Bridget Forsyth","psa":"Paul Glue","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2389537203","eid":"W2389537203"},{"id":"paper-w4304784508","cat":"papers","name":"A proposed mechanism for the MDMA-mediated extinction of traumatic memories in PTSD patients treated with MDMA-assisted therapy","year":"2022","cit":36,"pfa":"Robert Sottile","psa":"Thomas Vida","topics":["PTSD & trauma","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4304784508","eid":"W4304784508"},{"id":"paper-w3040045458","cat":"papers","name":"A Divergent Enantioselective Total Synthesis of Post‐Iboga Indole Alkaloids","year":"2020","cit":36,"pfa":"Jie Zhou","psa":"Fu‐She Han","ptype":"article","src":"https://openalex.org/W3040045458","eid":"W3040045458"},{"id":"paper-w2063314459","cat":"papers","name":"Biogenesis of Strychnos, Aspidosperma, and Iboga alkaloids. Structure and reactions of preakuammicine","year":"1969","cit":36,"pfa":"Alastair Ian Scott","psa":"Asaf A. Qureshi","ptype":"article","src":"https://openalex.org/W2063314459","eid":"W2063314459"},{"id":"paper-w2078656533","cat":"papers","name":"Conditioning following repeated exposure to MDMA in rats: Role in the maintenance of MDMA self-administration.","year":"2006","cit":36,"pfa":"Evangeline Daniela","psa":"Susan Schenk","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2078656533","eid":"W2078656533"},{"id":"paper-w3013387849","cat":"papers","name":"MDMA interactions with pharmaceuticals and drugs of abuse","year":"2020","cit":36,"pfa":"Esther Papaseit","psa":"Magı́ Farré","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3013387849","eid":"W3013387849"},{"id":"paper-w2414362583","cat":"papers","name":"The effects of psilocybin on primary process content in language.","year":"1977","cit":36,"pfa":"Colin Martindale","psa":"R Fischer","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2414362583","eid":"W2414362583"},{"id":"paper-w2102284364","cat":"papers","name":"Tryptophan als biogenetische Vorstufe des Psilocybins","year":"1961","cit":36,"pfa":"André Brack","psa":"J. Rutschmann","ptype":"article","src":"https://openalex.org/W2102284364","eid":"W2102284364"},{"id":"paper-w2055241614","cat":"papers","name":"Direct detection of serum psilocin glucuronide by LC/MS and LC/MS/MS: time-courses of total and free (unconjugated) psilocin concentrations in serum specimens of a “magic mushroom” user","year":"2006","cit":36,"pfa":"Tooru Kamata","psa":"Hitoshi Tsuchihashi","ptype":"article","src":"https://openalex.org/W2055241614","eid":"W2055241614"},{"id":"paper-w2046759010","cat":"papers","name":"Can MDMA Play a Role in the Treatment of Substance Abuse?","year":"2013","cit":36,"pfa":"Lisa Jerome","psa":"B. Yazar-Klosinski","topics":["PTSD & trauma","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2046759010","eid":"W2046759010"},{"id":"paper-w4225279504","cat":"papers","name":"Monoamine Oxidase Inhibition by Plant-Derived β-Carbolines; Implications for the Psychopharmacology of Tobacco and Ayahuasca","year":"2022","cit":36,"pfa":"Ilana Berlowitz","psa":"Paul D. Cumming","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4225279504","eid":"W4225279504"},{"id":"paper-w2014027615","cat":"papers","name":"Adverse symptomatology and suicide associated with the use of methylenedioxymethamphetamine (MDMA; “Ecstasy”)","year":"1996","cit":36,"pfa":"Richard S. Cohen","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2014027615","eid":"W2014027615"},{"id":"paper-w2053306153","cat":"papers","name":"Serotonin receptor binding affinities of several hallucinogenic phenylalkylamine and N,N-dimethyltryptamine analogs","year":"1978","cit":36,"pfa":"Richard A. Glennon","psa":"Elizabeth C. Mack","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2053306153","eid":"W2053306153"},{"id":"paper-w2070395917","cat":"papers","name":"Neuroendocrine abnormalities in recreational ecstasy (MDMA) users: is it ecstasy or cannabis?","year":"2002","cit":36,"pfa":"Euphrosyne Gouzoulis‐Mayfrank","psa":"Jörg Daumann","ptype":"article","src":"https://openalex.org/W2070395917","eid":"W2070395917"},{"id":"paper-w2080147024","cat":"papers","name":"Biscarpamontamines A and B, an Aspidosperma−Iboga Bisindole Alkaloid and an Aspidosperma−Aspidosperma Bisindole Alkaloid, from Tabernaemontana sphaerocarpa","year":"2009","cit":36,"pfa":"Kazumasa Zaima","psa":"Hiroshi Morita","topics":["Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2080147024","eid":"W2080147024"},{"id":"paper-w2283502508","cat":"papers","name":"THE RELATIONSHIP BETWEEN THE METABOLIC FATE AND PHARMACOLOGICAL ACTIONS OF SEROTONIN, BUFOTENINE AND PSILOCYBIN","year":"1960","cit":36,"pfa":"Peter K. Gessner","psa":"Irvine H. Page","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2283502508","eid":"W2283502508"},{"id":"paper-w2025350929","cat":"papers","name":"Ecstasy (MDMA): effects and patterns of use reported by users in São Paulo","year":"2003","cit":36,"pfa":"Stella Pereira de Almeida","psa":"Maria Teresa Araújo Silva","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2025350929","eid":"W2025350929"},{"id":"paper-w2114937850","cat":"papers","name":"Synthesis and Cyclic Voltammetry Studies of 3,4-Methylenedioxymethamphetamine (MDMA) Human Metabolites","year":"2007","cit":36,"pfa":"Carla Macedo","psa":"Félix Dias Carvalho","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2114937850","eid":"W2114937850"},{"id":"paper-w2053048573","cat":"papers","name":"Acute toxicity and gross behavioral effects of amphetamine, four methoxyamphetamines, and mescaline in rodents, dogs, and monkeys","year":"1978","cit":36,"pfa":"W. Marvin Davis","psa":"Monique C. Braude","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2053048573","eid":"W2053048573"},{"id":"paper-w4405955624","cat":"papers","name":"Single-Dose Psilocybin for Depression With Severe Treatment Resistance: An Open-Label Trial","year":"2025","cit":36,"pfa":"Scott T. Aaronson","psa":"Harold A. Sackeïm","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4405955624","eid":"W4405955624"},{"id":"paper-w2027191929","cat":"papers","name":"Determination of psilocybin in hallucinogenic mushrooms by reversed-phase liquid chromatography with fluorescence detection","year":"2005","cit":36,"pfa":"Kimie Saito","psa":"Yukihiro Goda","ptype":"article","src":"https://openalex.org/W2027191929","eid":"W2027191929"},{"id":"paper-w4390951308","cat":"papers","name":"High-resolution tracking of unconfined zebrafish behavior reveals stimulatory and anxiolytic effects of psilocybin","year":"2024","cit":36,"pfa":"Dotan Braun","psa":"Takashi Kawashima","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4390951308","eid":"W4390951308"},{"id":"paper-w2089143133","cat":"papers","name":"(±)3,4-Methylenedioxymethamphetamine (MDMA) produces long-term reductions in brain 5-hydroxytryptamine in rats","year":"1987","cit":36,"pfa":"David J. Mokler","psa":"John A. Rosecrans","ptype":"article","src":"https://openalex.org/W2089143133","eid":"W2089143133"},{"id":"paper-w4302007737","cat":"papers","name":"Lasting increases in trait mindfulness after psilocybin correlate positively with the mystical-type experience in healthy individuals","year":"2022","cit":36,"pfa":"Anna Søndergaard","psa":"Dea Siggaard Stenbæk","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4302007737","eid":"W4302007737"},{"id":"paper-w2099831292","cat":"papers","name":"The intriguing effects of ecstasy (MDMA) on cognitive function in mice subjected to a minimal traumatic brain injury (mTBI)","year":"2010","cit":36,"pfa":"Shahaf Edut","psa":"Chaim G. Pick","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W2099831292","eid":"W2099831292"},{"id":"paper-w4315796633","cat":"papers","name":"Altered brain activity and functional connectivity after MDMA-assisted therapy for post-traumatic stress disorder","year":"2023","cit":36,"pfa":"S. Parker Singleton","psa":"Amy F. Kuceyeski","topics":["PTSD & trauma","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4315796633","eid":"W4315796633"},{"id":"paper-w2940827144","cat":"papers","name":"Variability in content and dissolution profiles of MDMA tablets collected in the UK between 2001 and 2018 – A potential risk to users?","year":"2019","cit":36,"pfa":"Lewis Couchman","psa":"A. E. Johnston","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2940827144","eid":"W2940827144"},{"id":"paper-w4299698801","cat":"papers","name":"Acute Effects of Dexfenfluramine (d‐FEN) and Methylenedioxymethamphetamine (MDMA) before and after Short‐Course, High‐Dose Treatment","year":"1998","cit":36,"pfa":"David Frederick","psa":"Merle G. Paule","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4299698801","eid":"W4299698801"},{"id":"paper-w2106180565","cat":"papers","name":"Effect of the CB1 cannabinoid agonist WIN 55212-2 on the acquisition and reinstatement of MDMA-induced conditioned place preference in mice","year":"2010","cit":36,"pfa":"Carmen Manzanedo","psa":"José Miñarro","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2106180565","eid":"W2106180565"},{"id":"paper-w1980870639","cat":"papers","name":"High-pressure liquid chromatography/electrochemical detection method for monitoring MDA and MDMA in whole blood and other biological tissues","year":"1993","cit":36,"pfa":"Robert E. Michel","psa":"William J. George","ptype":"article","src":"https://openalex.org/W1980870639","eid":"W1980870639"},{"id":"paper-w1985406002","cat":"papers","name":"MDMA (“Ecstasy”) suppresses the innate IFN-γ response in vivo: A critical role for the anti-inflammatory cytokine IL-10","year":"2007","cit":36,"pfa":"Noreen T. Boyle","psa":"Thomas J. Connor","ptype":"article","src":"https://openalex.org/W1985406002","eid":"W1985406002"},{"id":"paper-w2059433762","cat":"papers","name":"Urinary excretion of the main metabolites of 3,4-methylenedioxymethamphetamine (MDMA), including the sulfate and glucuronide of 4-hydroxy-3-methoxymethamphetamine (HMMA), in humans and rats","year":"2008","cit":36,"pfa":"Noriaki Shima","psa":"Nobuo Nemoto","ptype":"article","src":"https://openalex.org/W2059433762","eid":"W2059433762"},{"id":"paper-w2017525927","cat":"papers","name":"3,4-Methylenedioxymethamphetamine (MDMA, ecstasy)-mediated production of hydrogen peroxide in an in vitro model: the role of dopamine, the serotonin-reuptake transporter, and monoamine oxidase-B","year":"2004","cit":36,"pfa":"Sandra L. Hrometz","psa":"Jon E. Sprague","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2017525927","eid":"W2017525927"},{"id":"paper-w2038276801","cat":"papers","name":"Two-Dimensional Gas Chromatography/Electron-Impact Mass Spectrometry with Cryofocusing for Simultaneous Quantification of MDMA, MDA, HMMA, HMA, and MDEA in Human Plasma","year":"2007","cit":36,"pfa":"Erin A Kolbrich","psa":"Marilyn Ann Huestis","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2038276801","eid":"W2038276801"},{"id":"paper-w2078510258","cat":"papers","name":"Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on 5-HT cell firing and release: Comparison between dorsal and median raphe 5-HT systems","year":"1997","cit":36,"pfa":"Sarah E. Gartside","psa":"Trevor Sharp","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2078510258","eid":"W2078510258"},{"id":"paper-w2279719644","cat":"papers","name":"Differences in the stimulus properties of 3,4-methylenedioxyamphetamine and 3,4- methylenedioxymethamphetamine in animals trained to discriminate hallucinogens from saline.","year":"1988","cit":36,"pfa":"Patrick M. Callahan","psa":"J. B. Appel","ptype":"article","src":"https://openalex.org/W2279719644","eid":"W2279719644"},{"id":"paper-w2135357132","cat":"papers","name":"Serotonin Agonists Reduce Dopamine Synthesis in the Striatum Only when the Impulse Flow of Nigro‐Striatal Neurons Is Intact","year":"1985","cit":36,"pfa":"Umberto Spampinato","psa":"ROSARIO SAMANIN","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2135357132","eid":"W2135357132"},{"id":"paper-w1982344849","cat":"papers","name":"Drosophila melanogaster Treated with LSD: Absence of Mutation and Chromosome Breakage","year":"1968","cit":36,"pfa":"Dale Grace","psa":"Philip C. Goodman","ptype":"article","src":"https://openalex.org/W1982344849","eid":"W1982344849"},{"id":"paper-w1972261890","cat":"papers","name":"Extreme Hyperthermia After LSD Ingestion","year":"1971","cit":36,"pfa":"Steven Arthur Friedman","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1972261890","eid":"W1972261890"},{"id":"paper-w2089835620","cat":"papers","name":"Blood Platelet 5-Hydroxytryptamine Levels in Psychiatric Patients","year":"1960","cit":36,"pfa":"Archibald Todrick","psa":"Elizabeth F. Marshall","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2089835620","eid":"W2089835620"},{"id":"paper-w37633322","cat":"papers","name":"Rave drugs: pharmacological considerations.","year":"2004","cit":36,"pfa":"Mary Klein","psa":"Frances Kramer","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W37633322","eid":"W37633322"},{"id":"paper-w4409415903","cat":"papers","name":"Molecular design of a therapeutic LSD analogue with reduced hallucinogenic potential","year":"2025","cit":36,"pfa":"Jeremy R. Tuck","psa":"David E. Olson","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4409415903","eid":"W4409415903"},{"id":"paper-w2056709622","cat":"papers","name":"A characterization of LSD-antagonist effects of pirenperone in the rat","year":"1983","cit":36,"pfa":"Françis C. Colpaert","psa":"Paul A. J. Janssen","ptype":"article","src":"https://openalex.org/W2056709622","eid":"W2056709622"},{"id":"paper-w2749086259","cat":"papers","name":"Development of a quantitative approach in blood plasma for low-dosed hallucinogens and opioids using LC-high resolution mass spectrometry","year":"2017","cit":36,"pfa":"Achim T. Caspar","psa":"Markus R. Meyer","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2749086259","eid":"W2749086259"},{"id":"paper-w2405452591","cat":"papers","name":"Adenylate cyclase from Fasciola hepatica. 1. Ligand specificity of adenylate cyclase-coupled serotonin receptors.","year":"1978","cit":36,"pfa":"John K. Northup","psa":"Tag E. Mansour","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2405452591","eid":"W2405452591"},{"id":"paper-w2050415436","cat":"papers","name":"3,4-Methylenedioxymethamphetamine enhances the release of acetylcholine in the prefrontal cortex and dorsal hippocampus of the rat","year":"2005","cit":36,"pfa":"Sunila G Nair","psa":"Gary A. Gudelsky","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2050415436","eid":"W2050415436"},{"id":"paper-w2064363561","cat":"papers","name":"Enhanced prefrontal serotonin 2A receptor signaling in the subchronic phencyclidine mouse model of schizophrenia","year":"2013","cit":36,"pfa":"Martin A. Santini","psa":"Jens Damsgaard Mikkelsen","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2064363561","eid":"W2064363561"},{"id":"paper-w1975096749","cat":"papers","name":"Prenatal stress affects 3,4-methylenedioxymethamphetamine pharmacokinetics and drug-induced motor alterations in adolescent female rats","year":"2004","cit":36,"pfa":"Sara Morley‐Fletcher","psa":"Giovanni Laviola","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1975096749","eid":"W1975096749"},{"id":"paper-w2331368560","cat":"papers","name":"Laboratory Measures of Methylphenidate Effects in Cocaine-Dependent Patients Receiving Treatment","year":"2000","cit":36,"pfa":"John D. Roache","psa":"Howard M. Rhoades","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2331368560","eid":"W2331368560"},{"id":"paper-w4406959828","cat":"papers","name":"From relaxed beliefs under psychedelics (REBUS) to revised beliefs after psychedelics (REBAS)","year":"2025","cit":36,"pfa":"Richard J. Zeifman","psa":"Robin Lester Carhart-Harris","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4406959828","eid":"W4406959828"},{"id":"paper-w2161933077","cat":"papers","name":"Rnd family genes are differentially regulated by 3,4-methylenedioxymethamphetamine and cocaine acute treatment in mice brain","year":"2006","cit":36,"pfa":"Cynthia Marie‐Claire","psa":"Florence Noble","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2161933077","eid":"W2161933077"},{"id":"paper-w1940121045","cat":"papers","name":"Oscillatory serotonin function in depression","year":"2013","cit":36,"pfa":"Ronald M. Salomon","psa":"Ronald L. Cowan","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1940121045","eid":"W1940121045"},{"id":"paper-w2045856913","cat":"papers","name":"Pharmacological Characterization of a Serotonin Receptor (5-HT7) Stimulating cAMP Production in Human Corneal Epithelial Cells","year":"2003","cit":36,"pfa":"Julie Y. Crider","psa":"Najam A. Sharif","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2045856913","eid":"W2045856913"},{"id":"paper-w2097337046","cat":"papers","name":"Molecular Docking of Opiates and Opioid Peptides, a Tool for the Design of Selective Agonists and Antagonists, and for the Investigation of Atypical Ligand-Receptor Interactions","year":"2012","cit":36,"pfa":"Luca Gentilucci","psa":"Roberto Artali","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2097337046","eid":"W2097337046"},{"id":"paper-w1983818533","cat":"papers","name":"The Psychotomimetic Properties of 3,4,5-Trimethoxyamphetamine","year":"1961","cit":36,"pfa":"Alexander T. Shulgin","psa":"Thornton Sargent","ptype":"article","src":"https://openalex.org/W1983818533","eid":"W1983818533"},{"id":"paper-w2893642694","cat":"papers","name":"Trends in DMT and other tryptamine use among young adults in the United States","year":"2018","cit":36,"pfa":"Joseph J. Palamar","psa":"Austin Le","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2893642694","eid":"W2893642694"},{"id":"paper-w2099374738","cat":"papers","name":"Brave New Spain: An Irishman's Independence Plot in Seventeenth-Century Mexico","year":"2010","cit":36,"pfa":"Ryan Dominic Crewe","ptype":"article","src":"https://openalex.org/W2099374738","eid":"W2099374738"},{"id":"paper-w4206661393","cat":"papers","name":"Decreases in Suicidality Following Psychedelic Therapy","year":"2022","cit":36,"pfa":"Richard J. Zeifman","psa":"Cory R. Weissman","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4206661393","eid":"W4206661393"},{"id":"paper-w4386305685","cat":"papers","name":"Psychedelic Therapy—A New Paradigm of Care for Mental Health","year":"2023","cit":36,"pfa":"Rachel Yehuda","psa":"Amy Lehrner","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4386305685","eid":"W4386305685"},{"id":"paper-w4229078353","cat":"papers","name":"A case series of group-based ketamine-assisted psychotherapy for patients in residential treatment for eating disorders with comorbid depression and anxiety disorders","year":"2022","cit":36,"pfa":"Reid J. Robison","psa":"Erin J. Strahan","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4229078353","eid":"W4229078353"},{"id":"paper-w4385271945","cat":"papers","name":"The difference between ‘placebo group’ and ‘placebo control’: a case study in psychedelic microdosing","year":"2023","cit":36,"pfa":"Balázs Szigeti","psa":"David Erritzøe","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4385271945","eid":"W4385271945"},{"id":"paper-w2605832123","cat":"papers","name":"Entheogens: True or False?","year":"2003","cit":36,"pfa":"ROGER N. WALSH","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2605832123","eid":"W2605832123"},{"id":"paper-w2059295576","cat":"papers","name":"Prefrontal cortical network activity: Opposite effects of psychedelic hallucinogens and D1/D5 dopamine receptor activation","year":"2007","cit":36,"pfa":"Evelyn K. Lambe","psa":"George K. Aghajanian","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2059295576","eid":"W2059295576"},{"id":"paper-w1988861809","cat":"papers","name":"Microdosing: Current and The Future","year":"2010","cit":36,"pfa":"Graham Lappin","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1988861809","eid":"W1988861809"},{"id":"paper-w2911871414","cat":"papers","name":"Psychedelic medicine: The biology underlying the persisting psychedelic effects","year":"2019","cit":36,"pfa":"Kim P. C. Kuypers","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2911871414","eid":"W2911871414"},{"id":"paper-w4212849374","cat":"papers","name":"Ketamine Psychedelic and Antinociceptive Effects Are Connected","year":"2022","cit":36,"pfa":"Erik Olofsen","psa":"Albert Dahan","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4212849374","eid":"W4212849374"},{"id":"paper-w1484799892","cat":"papers","name":"Psychedelics as catalysts of insight-oriented psychotherapy","year":"2001","cit":36,"pfa":"Lester Grinspoon","psa":"Rick Doblin","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W1484799892","eid":"W1484799892"},{"id":"paper-w4295789857","cat":"papers","name":"The Use of Psychedelics in the Treatment of Medical Conditions: An Analysis of Currently Registered Psychedelics Studies in the American Drug Trial Registry","year":"2022","cit":36,"pfa":"Joshua S. Kurtz","psa":"Mickey Ellis Abraham","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4295789857","eid":"W4295789857"},{"id":"paper-w2023596965","cat":"papers","name":"Psychedelic Medicine: New evidence for hallucinogenic substances as treatments","year":"2008","cit":36,"pfa":"David P. Luke","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2023596965","eid":"W2023596965"},{"id":"paper-w2137208333","cat":"papers","name":"Impacts Of Inventory Credit, Input Supply Shops, and Fertilizer Microdosing in the Drylands of Niger","year":"2006","cit":36,"pfa":"John Pender","psa":"Edward, Kato","topics":["Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W2137208333","eid":"W2137208333"},{"id":"paper-w2143176701","cat":"papers","name":"Comparison of mild and microdose GnRH agonist flare protocols on IVF outcome in poor responders","year":"2011","cit":36,"pfa":"Mohammad Karimzadeh","psa":"Fatemeh Mansoori Moghaddam","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2143176701","eid":"W2143176701"},{"id":"paper-w4387674199","cat":"papers","name":"A Systematic Review of Study Design and Placebo Controls in Psychedelic Research","year":"2023","cit":36,"pfa":"Alexander Q. Wen","psa":"Cory R. Weissman","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4387674199","eid":"W4387674199"},{"id":"paper-w2108679234","cat":"papers","name":"The Psychedelic Genes of Maize Redundantly Promote Carbohydrate Export From Leaves","year":"2010","cit":36,"pfa":"Thomas L. Slewinski","psa":"David M. Braun","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2108679234","eid":"W2108679234"},{"id":"paper-w2054188228","cat":"papers","name":"Microdosing of scopolamine as a “cognitive stress test”: Rationale and test of a very low dose in an at‐risk cohort of older adults","year":"2014","cit":36,"pfa":"Peter Jeffrey Snyder","psa":"Paul T. Maruff","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2054188228","eid":"W2054188228"},{"id":"paper-w2317128191","cat":"papers","name":"A New Group of Psychotomimetic Agents.","year":"1958","cit":36,"pfa":"Leo G. Abood","psa":"John H. Biel","ptype":"article","src":"https://openalex.org/W2317128191","eid":"W2317128191"},{"id":"paper-w4385272503","cat":"papers","name":"5-HT2AR and NMDAR psychedelics induce similar hyper-synchronous states in the rat cognitive-limbic cortex-basal ganglia system","year":"2023","cit":36,"pfa":"Ivani Brys","psa":"Pär Halje","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4385272503","eid":"W4385272503"},{"id":"paper-w3040590429","cat":"papers","name":"In vitro structure–activity relationship determination of 30 psychedelic new psychoactive substances by means of β-arrestin 2 recruitment to the serotonin 2A receptor","year":"2020","cit":36,"pfa":"Eline Pottie","psa":"Christophe Pol Stove","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3040590429","eid":"W3040590429"},{"id":"paper-w642459522","cat":"papers","name":"The Harvard Psychedelic Club: How Timothy Leary, Ram Dass, Huston Smith, and Andrew Weil Killed the Fifties and Ushered in a New Age for America","year":"2009","cit":36,"pfa":"Don Lattin","ptype":"article","src":"https://openalex.org/W642459522","eid":"W642459522"},{"id":"paper-w2032320073","cat":"papers","name":"Functional dissociation between serotonergic pathways in dorsal and ventral hippocampus in psychotomimetic drug‐induced locomotor hyperactivity and prepulse inhibition in rats","year":"2004","cit":36,"pfa":"Snezana Kusljic","psa":"Maarten van den Buuse","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2032320073","eid":"W2032320073"},{"id":"paper-w261907579","cat":"papers","name":"The war on drugs III: the continuing saga of the mysteries and miseries of intoxification, addiction, crime, and public policy.","year":"2002","cit":36,"pfa":"James A. Inciardi","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W261907579","eid":"W261907579"},{"id":"paper-w3041112046","cat":"papers","name":"Depression and Anxiety Subgroups Across Alcohol Use Disorder and Substance Use in a National Epidemiologic Study","year":"2020","cit":36,"pfa":"Sasha Rudenstine","psa":"Anusha M. Kumar","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3041112046","eid":"W3041112046"},{"id":"paper-w4200159834","cat":"papers","name":"High Prevalence and Early Onsets: Legal and Illegal Substance Use in an Urban Cohort of Young Adults in Switzerland","year":"2021","cit":36,"pfa":"Boris B. Quednow","psa":"Lilly Shanahan","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4200159834","eid":"W4200159834"},{"id":"paper-w2072159859","cat":"papers","name":"Effects of the phenethylamine derivatives, BL-3912, fenfluramine, and Sch-12679, in rats trained with LSD as a discriminative stimulus","year":"1980","cit":36,"pfa":"Jerrold C. Winter","ptype":"article","src":"https://openalex.org/W2072159859","eid":"W2072159859"},{"id":"paper-w2122167862","cat":"papers","name":"Comparing Three Cohorts of MSM Sampled Via Sex Parties, Bars/Clubs, and Craigslist.org: Implications for Researchers and Providers","year":"2014","cit":36,"pfa":"Christian Grov","psa":"Jeffrey T. Parsons","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2122167862","eid":"W2122167862"},{"id":"paper-w2164768170","cat":"papers","name":"The effects of pentazocine, a kappa agonist, in patients with mania","year":"2007","cit":36,"pfa":"Bruce M. Cohen","psa":"Beth L. Murphy","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2164768170","eid":"W2164768170"},{"id":"paper-w2166819069","cat":"papers","name":"Mexican-American Heroin Addicts","year":"1984","cit":36,"pfa":"David P. Desmond","psa":"James F. Maddux","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2166819069","eid":"W2166819069"},{"id":"paper-w2015820007","cat":"papers","name":"What kind of hallucinogenic snuff was used at Chavín de Huántar? An iconographic identification","year":"2011","cit":36,"pfa":"Richard L. Burger","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2015820007","eid":"W2015820007"},{"id":"paper-w2002033628","cat":"papers","name":"Nicotine and smoker status moderate brain electric and mood activation induced by ketamine, an N-methyl-d-aspartate (NMDA) receptor antagonist","year":"2006","cit":36,"pfa":"Verner Knott","psa":"Edward Horn","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2002033628","eid":"W2002033628"},{"id":"paper-w4361010400","cat":"papers","name":"Effect of esketamine on opioid consumption and postoperative pain in thyroidectomy: A randomized controlled trial","year":"2023","cit":36,"pfa":"Penglei Wang","psa":"Yun Lin WU","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4361010400","eid":"W4361010400"},{"id":"paper-w2010580662","cat":"papers","name":"Photoelectron spectra of psychotropic drugs. 6. Relationships between physical properties and pharmacological actions of amphetamine analogs","year":"1981","cit":36,"pfa":"Linda N. Domelsmith","psa":"Peter A. Kollman","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2010580662","eid":"W2010580662"},{"id":"paper-w4381893311","cat":"papers","name":"Arketamine for bipolar depression: Open-label, dose-escalation, pilot study","year":"2023","cit":36,"pfa":"Igor Dórea Bandeira","psa":"Lucas C. Quarantini","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4381893311","eid":"W4381893311"},{"id":"paper-w3129649658","cat":"papers","name":"Intranasal esketamine: From origins to future implications in treatment-resistant depression","year":"2021","cit":36,"pfa":"Benjamin J Sanders","psa":"Abdul Qadir Brula","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W3129649658","eid":"W3129649658"},{"id":"paper-w3192551573","cat":"papers","name":"Neurocognitive Effects of Ketamine and Esketamine for Treatment-Resistant Major Depressive Disorder: A Systematic Review","year":"2021","cit":36,"pfa":"Breno Souza‐Marques","psa":"Aline S. Sampaio","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W3192551573","eid":"W3192551573"},{"id":"paper-w3082976951","cat":"papers","name":"Benefit–Risk Assessment of Esketamine Nasal Spray vs. Placebo in Treatment‐Resistant Depression","year":"2020","cit":36,"pfa":"Eva G. Katz","psa":"Bennett S. Levitan","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3082976951","eid":"W3082976951"},{"id":"paper-w3120269913","cat":"papers","name":"Repeated subcutaneous esketamine for treatment-resistant depression: Impact of the degree of treatment resistance and anxiety comorbidity","year":"2021","cit":36,"pfa":"Ana Cecília Lucchese","psa":"Sérgio Baxter Andreoli","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3120269913","eid":"W3120269913"},{"id":"paper-w4362519238","cat":"papers","name":"Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Plus a Newly Initiated Oral Antidepressant in Adult Patients with Treatment-Resistant Depression: A Randomized, Double-Blind, Multicenter, Active-Controlled St","year":"2023","cit":36,"pfa":"Xu Chen","psa":"Dong‐Jing Fu","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4362519238","eid":"W4362519238"},{"id":"paper-w4400555819","cat":"papers","name":"Ketamine and its two enantiomers in anesthesiology and psychiatry: A historical review and future directions","year":"2024","cit":36,"pfa":"Kenji Hashimoto","psa":"Jianjun Yang","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4400555819","eid":"W4400555819"},{"id":"paper-w2189600143","cat":"papers","name":"Microassay for ketamine and metabolites in plasma and serum based on enantioselective capillary electrophoresis with highly sulfated γ-cyclodextrin and electrokinetic analyte injection","year":"2015","cit":36,"pfa":"Regula Theurillat","psa":"Wolfgang Thormann","ptype":"article","src":"https://openalex.org/W2189600143","eid":"W2189600143"},{"id":"paper-w4410301491","cat":"papers","name":"Demyelination in psychiatric and neurological disorders: Mechanisms, clinical impact, and novel therapeutic strategies","year":"2025","cit":36,"pfa":"Rumi Murayama","psa":"Kenji Hashimoto","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4410301491","eid":"W4410301491"},{"id":"paper-w2007623062","cat":"papers","name":"Molecular modeling and docking studies of human 5-hydroxytryptamine 2A (5-HT2A) receptor for the identification of hotspots for ligand binding","year":"2009","cit":36,"pfa":"Karuppiah Kanagarajadurai","psa":"Ramanathan Sowdhamini","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2007623062","eid":"W2007623062"},{"id":"paper-w2029762085","cat":"papers","name":"A comparison of the stimulus effects of morphine and lysergic acid diethylamide (LSD)","year":"1974","cit":35,"pfa":"Ira D. Hirschhorn","psa":"John A. Rosecrans","ptype":"article","src":"https://openalex.org/W2029762085","eid":"W2029762085"},{"id":"paper-w2129472758","cat":"papers","name":"The subjective experience of time during lysergic acid diethylamide (LSD-25) intoxication","year":"1964","cit":35,"pfa":"J. C. Kenna","psa":"Garry L. Sedman","ptype":"article","src":"https://openalex.org/W2129472758","eid":"W2129472758"},{"id":"paper-w1824213812","cat":"papers","name":"Blockade of the behavioral effects of lysergic acid diethylamide, 2,5-dimethoxy-4-methylamphetamine, quipazine and lisuride by 5-hydroxytryptamine antagonists.","year":"1983","cit":35,"pfa":"David J. Mokler","psa":"Richard H. Rech","ptype":"article","src":"https://openalex.org/W1824213812","eid":"W1824213812"},{"id":"paper-w1996442587","cat":"papers","name":"hERG Blockade by Iboga Alkaloids","year":"2015","cit":35,"pfa":"Kenneth Alper","psa":"Yanfei Ruan","ptype":"article","src":"https://openalex.org/W1996442587","eid":"W1996442587"},{"id":"paper-w4389912710","cat":"papers","name":"Determination of psilocybin and psilocin content in multiple Psilocybe cubensis mushroom strains using liquid chromatography – tandem mass spectrometry","year":"2023","cit":35,"pfa":"Roman Goff","psa":"Kevin A. Schug","ptype":"article","src":"https://openalex.org/W4389912710","eid":"W4389912710"},{"id":"paper-w2324298988","cat":"papers","name":"Chemical Transformations of Ibogaine","year":"1966","cit":35,"pfa":"G. Büchi","psa":"R. E. Manning","ptype":"article","src":"https://openalex.org/W2324298988","eid":"W2324298988"},{"id":"paper-w2023306187","cat":"papers","name":"Twenty Years of Peyote Studies","year":"1960","cit":35,"pfa":"Weston La Barre","ptype":"article","src":"https://openalex.org/W2023306187","eid":"W2023306187"},{"id":"paper-w2093056695","cat":"papers","name":"Urinary excretion of 5-methoxy-N,N-dimethyltryptamine, N,N-dimethyltryptamine and their N-oxides in the rat","year":"1987","cit":35,"pfa":"Balvant R. Sitaram","psa":"W. R. McLeod","ptype":"article","src":"https://openalex.org/W2093056695","eid":"W2093056695"},{"id":"paper-w196124280","cat":"papers","name":"History of MDMA","year":"1990","cit":35,"pfa":"Alexander T. Shulgin","ptype":"book-chapter","src":"https://openalex.org/W196124280","eid":"W196124280"},{"id":"paper-w2943533317","cat":"papers","name":"Mescaline: A Global History of the First Psychedelic","year":"2019","cit":35,"pfa":"Mike Jay","ptype":"book","src":"https://openalex.org/W2943533317","eid":"W2943533317"},{"id":"paper-w2242604812","cat":"papers","name":"Behavioral and pharmacokinetic interactions between monoamine oxidase inhibitors and the hallucinogen 5-methoxy-N,N-dimethyltryptamine","year":"2016","cit":35,"pfa":"Adam L. Halberstadt","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2242604812","eid":"W2242604812"},{"id":"paper-w1877800070","cat":"papers","name":"A COMPARISON OF THE STIMULUS PROPERTIES OF MESCALINE AND 2, 3, 4-TRIMETHOXYPHENYLETHYLAMINE","year":"1973","cit":35,"pfa":"Jerrold C. Winter","ptype":"article","src":"https://openalex.org/W1877800070","eid":"W1877800070"},{"id":"paper-w2023082261","cat":"papers","name":"Behavioral and Biochemical Evidence for a Nonessential 5-HT2A Component of the Ibogaine-Induced Discriminative Stimulus","year":"1998","cit":35,"pfa":"Scott Helsley","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2023082261","eid":"W2023082261"},{"id":"paper-w1965503653","cat":"papers","name":"Toxic effect of MDMA on brain serotonin neurons","year":"1999","cit":35,"pfa":"JOHN FARNILL MORGAN","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1965503653","eid":"W1965503653"},{"id":"paper-w4282579732","cat":"papers","name":"Significance of mammalian N, N-dimethyltryptamine (DMT): A 60-year-old debate","year":"2022","cit":35,"pfa":"Javier Hidalgo Jiménez","psa":"José Carlos Bouso","topics":["Mechanism & neuroscience","Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4282579732","eid":"W4282579732"},{"id":"paper-w2077350985","cat":"papers","name":"A pure amnestic syndrome after MDMA (\"ecstasy\") ingestion.","year":"1997","cit":35,"pfa":"J. Spatt","psa":"B. Mamoli","ptype":"article","src":"https://openalex.org/W2077350985","eid":"W2077350985"},{"id":"paper-w4386305913","cat":"papers","name":"Psilocybin history, action and reaction: A narrative clinical review","year":"2023","cit":35,"pfa":"Pravesh Sharma","psa":"Christopher Joseph Hammond","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4386305913","eid":"W4386305913"},{"id":"paper-w2136021259","cat":"papers","name":"Determination of salvinorins and divinatorins in Salvia divinorum leaves by liquid chromatography/multistage mass spectrometry","year":"2005","cit":35,"pfa":"Claudio Medana","psa":"Claudio Baiocchi","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2136021259","eid":"W2136021259"},{"id":"paper-w2519712963","cat":"papers","name":"Examination of the Phenomenology of the Ibogaine Treatment Experience: Role of Altered States of Consciousness and Psychedelic Experiences","year":"2017","cit":35,"pfa":"Annamarie Heink","psa":"Tiffany M. Lange","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2519712963","eid":"W2519712963"},{"id":"paper-w4212981695","cat":"papers","name":"MDMA and memory, addiction, and depression: dose-effect analysis","year":"2022","cit":35,"pfa":"Madeline M. Pantoni","psa":"Stephan Anagnostaras","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4212981695","eid":"W4212981695"},{"id":"paper-w2884955837","cat":"papers","name":"A Mixed-Method Analysis of Persisting Effects Associated with Positive Outcomes Following Ibogaine Detoxification","year":"2018","cit":35,"pfa":"Alan K. Davis","psa":"Joseph P. Barsuglia","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2884955837","eid":"W2884955837"},{"id":"paper-w2108906130","cat":"papers","name":"Deaths Involving MDMA and the Concomitant Use of Pharmaceutical Drugs","year":"2011","cit":35,"pfa":"Jennifer L. Pilgrim","psa":"Olaf H. Drummer","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2108906130","eid":"W2108906130"},{"id":"paper-w1994466741","cat":"papers","name":"Increased cortisol levels in hair of recent Ecstasy/MDMA users","year":"2013","cit":35,"pfa":"Andrew C. Parrott","psa":"Tobias Stalder","ptype":"article","src":"https://openalex.org/W1994466741","eid":"W1994466741"},{"id":"paper-w3041774426","cat":"papers","name":"Biodiversity of β-Carboline Profile of Banisteriopsis caapi and Ayahuasca, a Plant and a Brew with Neuropharmacological Potential","year":"2020","cit":35,"pfa":"Beatriz Werneck Lopes Santos","psa":"Eloísa Dutra Caldas","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3041774426","eid":"W3041774426"},{"id":"paper-w2008409216","cat":"papers","name":"Initial deficit and recovery of function after MDMA preexposure in rats","year":"2005","cit":35,"pfa":"Katharine Alexandra Brennan","psa":"Susan Schenk","ptype":"article","src":"https://openalex.org/W2008409216","eid":"W2008409216"},{"id":"paper-w1995535685","cat":"papers","name":"Effects of (±)3,4-methylenedioxymethamphetamine (MDMA) on brain dopaminergic activity in rats","year":"1989","cit":35,"pfa":"Robert T. Matthews","psa":"Gerald D. Frye","ptype":"article","src":"https://openalex.org/W1995535685","eid":"W1995535685"},{"id":"paper-w2272843035","cat":"papers","name":"Oxytocin receptor gene variation predicts subjective responses to MDMA","year":"2016","cit":35,"pfa":"Anya K. Bershad","psa":"Harriet de Wit","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2272843035","eid":"W2272843035"},{"id":"paper-w2083386625","cat":"papers","name":"Major depression: the relative contribution of gender, MDMA, and cannabis use","year":"2007","cit":35,"pfa":"Heather Durdle","psa":"Manuel E. Tancer","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2083386625","eid":"W2083386625"},{"id":"paper-w2484035117","cat":"papers","name":"Protective effects of physical exercise on MDMA-induced cognitive and mitochondrial impairment","year":"2016","cit":35,"pfa":"Ghorban Taghizadeh","psa":"Mohammad Sharifzadeh","ptype":"article","src":"https://openalex.org/W2484035117","eid":"W2484035117"},{"id":"paper-w4206807456","cat":"papers","name":"In Silico Studies on Psilocybin Drug Derivatives Against SARS-CoV-2 and Cytokine Storm of Human Interleukin-6 Receptor","year":"2022","cit":35,"pfa":"Faez Iqbal Khan","psa":"Dakun Lai","topics":["Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4206807456","eid":"W4206807456"},{"id":"paper-w4390825728","cat":"papers","name":"Potential therapeutic effects of an ayahuasca-inspired N,N-DMT and harmine formulation: a controlled trial in healthy subjects","year":"2024","cit":35,"pfa":"Helena Aicher","psa":"Milan Scheidegger","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4390825728","eid":"W4390825728"},{"id":"paper-w3110345791","cat":"papers","name":"Long-term Amelioration of OCD Symptoms in a Patient with Chronic Consumption of Psilocybin-containing Mushrooms","year":"2020","cit":35,"pfa":"Agustín Lugo-Radillo","psa":"Jorge Luis Cortés-López","ptype":"article","src":"https://openalex.org/W3110345791","eid":"W3110345791"},{"id":"paper-w1600370546","cat":"papers","name":"Effects of 3,4‐methylenedioxymethamphetamine ( MDMA ) and its main metabolites on cardiovascular function in conscious rats","year":"2013","cit":35,"pfa":"Charles W. Schindler","psa":"Michael H. Baumann","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1600370546","eid":"W1600370546"},{"id":"paper-w2107526208","cat":"papers","name":"Verbal Memory Deficits Are Correlated with Prefrontal Hypometabolism in 18FDG PET of Recreational MDMA Users","year":"2013","cit":35,"pfa":"Oliver Gero Bosch","psa":"Boris B. Quednow","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2107526208","eid":"W2107526208"},{"id":"paper-w1983711520","cat":"papers","name":"Mediating MDMA-Related Harm: Preloading and Post-loading Among Ecstasy-Using Youth","year":"2009","cit":35,"pfa":"Brian C. Kelly","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1983711520","eid":"W1983711520"},{"id":"paper-w2002234218","cat":"papers","name":"3 cases of primary intracranial hemorrhage associated with “Molly”, a purified form of 3,4-methylenedioxymethamphetamine (MDMA)","year":"2012","cit":35,"pfa":"D. Ethan Kahn","psa":"Ronald Jay Benveniste","ptype":"article","src":"https://openalex.org/W2002234218","eid":"W2002234218"},{"id":"paper-w2091602135","cat":"papers","name":"Memory impairment and hippocampus specific protein oxidation induced by ethanol intake and 3, 4‐Methylenedioxymethamphetamine ( MDMA ) in mice","year":"2013","cit":35,"pfa":"Clara Ros‐Simó","psa":"Olga Valverde","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2091602135","eid":"W2091602135"},{"id":"paper-w1988877053","cat":"papers","name":"Pharmacological aspects of the combined use of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and gamma-hydroxybutyric acid (GHB): a review of the literature","year":"2005","cit":35,"pfa":"Joachim D. K. Uys","psa":"Raymond J.M. Niesink","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1988877053","eid":"W1988877053"},{"id":"paper-w1479662652","cat":"papers","name":"Activation of Protein Kinase C (PKC) by 3,4-Methylenedioxymethamphetamine (MDMA) Occurs Through the Stimulation of Serotonin Receptors and Transporter","year":"1997","cit":35,"pfa":"H Kenneth Kramer","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1479662652","eid":"W1479662652"},{"id":"paper-w2115613596","cat":"papers","name":"Serotonin neurotoxicity in rats after combined treatment with a dopaminergic agent followed by a nonneurotoxic 3,4-methylenedioxymethamphetamine (MDMA) analogue","year":"1991","cit":35,"pfa":"Michael P. Johnson","psa":"David E. Nichols","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2115613596","eid":"W2115613596"},{"id":"paper-w3158216155","cat":"papers","name":"An episode of mania following self‐reported ingestion of psilocybin mushrooms in a woman previously not diagnosed with bipolar disorder: A case report","year":"2021","cit":35,"pfa":"Holly M. Hendin","psa":"Andrew  D. Penn","ptype":"article","src":"https://openalex.org/W3158216155","eid":"W3158216155"},{"id":"paper-w2069972539","cat":"papers","name":"THE PREVENTION BY INHIBITORS OF BRAIN PROTEIN SYNTHESIS OF THE HYPERACTIVITY AND HYPERPYREXIA PRODUCED IN RATS BY MONOAMINE OXIDASE INHIBITION AND THE ADMINISTRATION OF L‐TRYPTOPHAN OR 5‐METHOXY‐N,N‐DIMETHYLTRYPTAMINE","year":"1972","cit":35,"pfa":"D. G. Grahame‐Smitha","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2069972539","eid":"W2069972539"},{"id":"paper-w2056484198","cat":"papers","name":"Inhibitory effects of dopamine and methylenedioxymethamphetamine (MDMA) on glutamate-evoked firing of nucleus accumbens and caudate/putamen cells are enchanced following cocaine self-administration","year":"1995","cit":35,"pfa":"S.R. White","psa":"Michael J. Wheaton","ptype":"article","src":"https://openalex.org/W2056484198","eid":"W2056484198"},{"id":"paper-w2749020239","cat":"papers","name":"IMAGERY AND “HALLUCINATIONS”: EFFECTS OF LSD CONTRASTED WITH THE EFFECTS OF “HYPNOTIC” SUGGESTIONS11Work on this paper was supported by a research grant (MH-11521) from the National Institute of Mental Health, U.S. Publi","year":"1971","cit":35,"pfa":"Theodore Xenophon Barber","ptype":"book-chapter","src":"https://openalex.org/W2749020239","eid":"W2749020239"},{"id":"paper-w4283813871","cat":"papers","name":"Psychedelics in the treatment of unipolar and bipolar depression","year":"2022","cit":35,"pfa":"Oliver Gero Bosch","psa":"Erich Seifritz","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4283813871","eid":"W4283813871"},{"id":"paper-w48775267","cat":"papers","name":"Chloroquine psychosis: a chemical psychosis?","year":"1981","cit":35,"pfa":"Deepa Mohan","psa":"Ray Rajat","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W48775267","eid":"W48775267"},{"id":"paper-w2011559307","cat":"papers","name":"Effects of 18-methoxycoronaridine on acute signs of morphine withdrawal in rats","year":"1998","cit":35,"pfa":"Brian Rho","psa":"Stanley D. Glick","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2011559307","eid":"W2011559307"},{"id":"paper-w2160775146","cat":"papers","name":"Bioanalytical and clinical evaluation of 103 suspected cases of intoxications with psychoactive plant materials","year":"2009","cit":35,"pfa":"Kristian Björnstad","psa":"Anders Helander","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2160775146","eid":"W2160775146"},{"id":"paper-w2029745372","cat":"papers","name":"10-Methoxyharmalan, a Potent Serotonin Antagonist Which Affects Conditioned Behavior","year":"1961","cit":35,"pfa":"William M. McIsaac","psa":"Irvine H. Page","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2029745372","eid":"W2029745372"},{"id":"paper-w2076110327","cat":"papers","name":"Use of hallucinogenic drugs on campus.","year":"1968","cit":35,"pfa":"Lillian L. Imperi","psa":"James S. Davie","ptype":"article","src":"https://openalex.org/W2076110327","eid":"W2076110327"},{"id":"paper-w1984904752","cat":"papers","name":"Block by LSD of the Increase in Brain Serotonin Turnover induced by Elevated Ambient Temperature","year":"1968","cit":35,"pfa":"George K. Aghajanian","psa":"B. L. WEISS","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1984904752","eid":"W1984904752"},{"id":"paper-w2144726121","cat":"papers","name":"Effects of LSD, Ritanserin, 8-OH-DPAT, and Lisuride on Classical Conditioning in the Rabbit","year":"1998","cit":35,"pfa":"Scott Welsh","ptype":"article","src":"https://openalex.org/W2144726121","eid":"W2144726121"},{"id":"paper-w3047563555","cat":"papers","name":"Neuropsychiatric Effects of Antiviral Drugs","year":"2020","cit":35,"pfa":"Nicholas Zareifopoulos","psa":"Dimitrios Velissaris","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3047563555","eid":"W3047563555"},{"id":"paper-w4391313086","cat":"papers","name":"Neural complexity is increased after low doses of LSD, but not moderate to high doses of oral THC or methamphetamine","year":"2024","cit":35,"pfa":"Conor H. Murray","psa":"Harriet de Wit","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4391313086","eid":"W4391313086"},{"id":"paper-w2057196189","cat":"papers","name":"LSD and dopamine-sensitive adenylate-cyclase in various rat brain areas","year":"1975","cit":35,"pfa":"PierFranco Spano","psa":"Marco Trabucchi","ptype":"article","src":"https://openalex.org/W2057196189","eid":"W2057196189"},{"id":"paper-w2065167691","cat":"papers","name":"(±)-3,4-Methylenedioxymethamphetamine treatment in adult rats impairs path integration learning: A comparison of single vs once per week treatment for 5 weeks","year":"2008","cit":35,"pfa":"Matthew R. Skelton","psa":"Michael T. Williams","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2065167691","eid":"W2065167691"},{"id":"paper-w2156499781","cat":"papers","name":"3,4-Methylenedioxymethamphetamine- and 8-Hydroxy-2-di-n-propylamino-tetralin-Induced Hypothermia: Role and Location of 5-Hydroxytryptamine 1A Receptors","year":"2007","cit":35,"pfa":"Daniel E. Rusyniak","psa":"Joseph A. DiMicco","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2156499781","eid":"W2156499781"},{"id":"paper-w2008819895","cat":"papers","name":"When administered to rats in a cold environment, 3,4-methylenedioxymethamphetamine reduces brown adipose tissue thermogenesis and increases tail blood flow: Effects of pretreatment with 5-HT1A and dopamine D2 antagonists","year":"2008","cit":35,"pfa":"Daniel E. Rusyniak","psa":"William Walter Blessing","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2008819895","eid":"W2008819895"},{"id":"paper-w2922587153","cat":"papers","name":"Salvia divinorum: from recreational hallucinogenic use to analgesic and anti-inflammatory action","year":"2019","cit":35,"pfa":"Ulises Coffeen","psa":"Francisco Pellicer","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2922587153","eid":"W2922587153"},{"id":"paper-w4382918325","cat":"papers","name":"Psilocybin’s effects on cognition and creativity: A scoping review","year":"2023","cit":35,"pfa":"Justin N Bonnieux","psa":"Mauricio A. García-Barrera","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4382918325","eid":"W4382918325"},{"id":"paper-w2000422403","cat":"papers","name":"Comparison of (+)‐methamphetamine, ±‐Methylenedioxymethamphetamine, (+)‐amphetamine and ±‐fenfluramine in rats on egocentric learning in the Cincinnati water maze","year":"2010","cit":35,"pfa":"Charles V. Vorhees","psa":"Michael T. Williams","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2000422403","eid":"W2000422403"},{"id":"paper-w3044613632","cat":"papers","name":"Molecular Interaction Between Butorphanol and κ-Opioid Receptor","year":"2020","cit":35,"pfa":"Jiafu Ji","psa":"Renyu Liu","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3044613632","eid":"W3044613632"},{"id":"paper-w2073415205","cat":"papers","name":"An “Accidental” Acute Psychosis with Ecstasy Use","year":"2001","cit":35,"pfa":"Guillaume Vaïva","psa":"M. Goudemand","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2073415205","eid":"W2073415205"},{"id":"paper-w2901931229","cat":"papers","name":"Metabolomics predicts the pharmacological profile of new psychoactive substances","year":"2018","cit":35,"pfa":"Eulàlia Olesti","psa":"Rafael de la Torre","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2901931229","eid":"W2901931229"},{"id":"paper-w2142935222","cat":"papers","name":"Simultaneous Determination of HFBA-Derivatized Amphetamines and Ketamines in Urine by Gas Chromatography-Mass Spectrometry","year":"2011","cit":35,"pfa":"H. H. Lee","psa":"Bai‐Hsiun Chen","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2142935222","eid":"W2142935222"},{"id":"paper-w4214690845","cat":"papers","name":"Impact of Two Neuronal Sigma-1 Receptor Modulators, PRE084 and DMT, on Neurogenesis and Neuroinflammation in an Aβ1–42-Injected, Wild-Type Mouse Model of AD","year":"2022","cit":35,"pfa":"Emőke Borbély","psa":"Lívia Fülöp","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4214690845","eid":"W4214690845"},{"id":"paper-w3043077203","cat":"papers","name":"Perceived harm, motivations for use and subjective experiences of recreational psychedelic ‘magic’ mushroom use","year":"2020","cit":35,"pfa":"Carl Alexander Roberts","psa":"Paul Christiansen","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3043077203","eid":"W3043077203"},{"id":"paper-w4225005969","cat":"papers","name":"Past-year hallucinogen use in relation to psychological distress, depression, and suicidality among US adults","year":"2022","cit":35,"pfa":"Kevin H. Yang","psa":"Joseph J. Palamar","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4225005969","eid":"W4225005969"},{"id":"paper-w4401184397","cat":"papers","name":"A framework for assessment of adverse events occurring in psychedelic-assisted therapies","year":"2024","cit":35,"pfa":"Roman Palitsky","psa":"Boadie Waid Dunlop","topics":["Safety & adverse events","Dosing & pharmacology","Therapy practice"],"ptype":"editorial","src":"https://openalex.org/W4401184397","eid":"W4401184397"},{"id":"paper-w3153440465","cat":"papers","name":"Mapping an Agenda for Psychedelic-Assisted Therapy Research in Patients with Serious Illness","year":"2021","cit":35,"pfa":"Yvan Beaussant","psa":"Monnica T. Williams","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3153440465","eid":"W3153440465"},{"id":"paper-w2315851963","cat":"papers","name":"DPT as an Adjunct in Psychotherapy of Alcoholics","year":"2017","cit":35,"pfa":"S Grof","psa":"A. A. Kurland","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2315851963","eid":"W2315851963"},{"id":"paper-w4386894189","cat":"papers","name":"The Montreal model: an integrative biomedical-psychedelic approach to ketamine for severe treatment-resistant depression","year":"2023","cit":35,"pfa":"Nicolas Garel","psa":"Kyle T. Greenway","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4386894189","eid":"W4386894189"},{"id":"paper-w2414246970","cat":"papers","name":"Hallucinogens as discriminative stimuli.","year":"1974","cit":35,"pfa":"Winter Jc","ptype":"article","src":"https://openalex.org/W2414246970","eid":"W2414246970"},{"id":"paper-w2008476249","cat":"papers","name":"Plant hallucinogens: springboards for psychotherapeutic drug discovery","year":"1995","cit":35,"pfa":"Dennis J. McKenna","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2008476249","eid":"W2008476249"},{"id":"paper-w2043286171","cat":"papers","name":"Yanomamo Hallucinogens: Anthropological, Botanical, and Chemical Findings","year":"1971","cit":35,"pfa":"Napoleon A. Chagnon","psa":"James M. Cook","ptype":"article","src":"https://openalex.org/W2043286171","eid":"W2043286171"},{"id":"paper-w4245888828","cat":"papers","name":"Psychedelics alter metaphysical beliefs","year":"2021","cit":35,"pfa":"Christopher B. Timmermann","psa":"Robin Lester Carhart-Harris","topics":["Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4245888828","eid":"W4245888828"},{"id":"paper-w4382777067","cat":"papers","name":"Harnessing placebo: Lessons from psychedelic science","year":"2023","cit":35,"pfa":"Chloé Pronovost-Morgan","psa":"Johannes Gerardus Ramaekers","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4382777067","eid":"W4382777067"},{"id":"paper-w1899125083","cat":"papers","name":"Absolute oral bioavailability and pharmacokinetics of canagliflozin: A microdose study in healthy participants","year":"2014","cit":35,"pfa":"Damayanthi Devineni","psa":"Rao N. V. S. Mamidi","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1899125083","eid":"W1899125083"},{"id":"paper-w2137873203","cat":"papers","name":"A Review of Recent Studies of the Biosynthesis and Excretion of Hallucinogens Formed by Methylation of Neurotransmitters or Related Substances","year":"1976","cit":35,"pfa":"Helen Rosengarten","psa":"Arnold J. Friedhoff","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2137873203","eid":"W2137873203"},{"id":"paper-w3014476949","cat":"papers","name":"Factors driving cereal response to fertilizer microdosing in sub‐Saharan Africa: A meta‐analysis","year":"2020","cit":35,"pfa":"Yacouba Ouédraogo","psa":"Charles Louis Bielders","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3014476949","eid":"W3014476949"},{"id":"paper-w3093845316","cat":"papers","name":"Microdosing and standard‐dosing take‐home buprenorphine from the emergency department: A feasibility study","year":"2020","cit":35,"pfa":"Jessica Moe","psa":"Andy Kestler","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3093845316","eid":"W3093845316"},{"id":"paper-w3171199594","cat":"papers","name":"Reconciling Mystical Experiences with Naturalistic Psychedelic Science: Reply to Sanders and Zijlmans","year":"2021","cit":35,"pfa":"Jussi Jylkkä","ptype":"editorial","src":"https://openalex.org/W3171199594","eid":"W3171199594"},{"id":"paper-w4396599258","cat":"papers","name":"The Hopkins-Oxford Psychedelics Ethics (HOPE) Working Group Consensus Statement","year":"2024","cit":35,"pfa":"Edward Jacobs","psa":"David B. Yaden","topics":["Policy & ethics"],"ptype":"editorial","src":"https://openalex.org/W4396599258","eid":"W4396599258"},{"id":"paper-w4206328847","cat":"papers","name":"In vitro assays for the functional characterization of (psychedelic) substances at the serotonin receptor 5‐HT2AR","year":"2022","cit":35,"pfa":"Eline Pottie","psa":"Christophe P. Stove","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4206328847","eid":"W4206328847"},{"id":"paper-w4213229867","cat":"papers","name":"Contextual Parameters Associated with Positive and Negative Mental Health in Recreational Psychedelic Users","year":"2022","cit":35,"pfa":"Kevin O. St. Arnaud","psa":"Donald Sharpe","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4213229867","eid":"W4213229867"},{"id":"paper-w2098841791","cat":"papers","name":"A Combined Accelerator Mass Spectrometry-Positron Emission Tomography Human Microdose Study with 14C- and 11C-Labelled Verapamil","year":"2010","cit":35,"pfa":"Claudia Christina Wagner","psa":"Oliver Langer","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2098841791","eid":"W2098841791"},{"id":"paper-w1964317591","cat":"papers","name":"Stimulation of the young poor responder: comparison of the luteal estradiol/gonadotropin-releasing hormone antagonist priming protocol versus oral contraceptive microdose leuprolide","year":"2010","cit":35,"pfa":"S.M. Shastri","psa":"Zev Rosenwaks","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1964317591","eid":"W1964317591"},{"id":"paper-w2055144501","cat":"papers","name":"Nitric oxide donor molsidomine attenuates psychotomimetic effects of the NMDA receptor antagonist MK-801","year":"2006","cit":35,"pfa":"Nikolaos Pitsikas","psa":"Nikos Sakellaridis","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2055144501","eid":"W2055144501"},{"id":"paper-w2176305625","cat":"papers","name":"Phenomenologically distinct psychotomimetic effects of ketamine are associated with cerebral blood flow changes in functionally relevant cerebral foci: a continuous arterial spin labelling study","year":"2015","cit":35,"pfa":"Thomas Arthur Pollak","psa":"Mitul Ashok Mehta","ptype":"article","src":"https://openalex.org/W2176305625","eid":"W2176305625"},{"id":"paper-w2410279131","cat":"papers","name":"Harmaline inhibition of Na-dependent transport in renal microvillus membrane vesicles","year":"1980","cit":35,"pfa":"Peter S. Aronson","psa":"S. E. Bounds","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2410279131","eid":"W2410279131"},{"id":"paper-w1964855387","cat":"papers","name":"Chronic Phencyclidine (PCP) Abuse: A Psychiatric Perspective","year":"1980","cit":35,"pfa":"Michael A. Fauman","psa":"Beverly J. Fauman","ptype":"article","src":"https://openalex.org/W1964855387","eid":"W1964855387"},{"id":"paper-w2055582463","cat":"papers","name":"Interactive effects of mGlu5 and 5-HT2A receptors on locomotor activity in mice","year":"2010","cit":35,"pfa":"Adam L. Halberstadt","psa":"Susan B. Powell","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2055582463","eid":"W2055582463"},{"id":"paper-w3137881801","cat":"papers","name":"Variation of drugs involved in acute drug toxicity presentations based on age and sex: an epidemiological approach based on European emergency departments","year":"2021","cit":35,"pfa":"Òscar Miró","psa":"on behalf of the Euro-DEN Plus Research Group","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3137881801","eid":"W3137881801"},{"id":"paper-w67259617","cat":"papers","name":"Treatment of diabetic ketoacidosis in children and adolescents.","year":"2003","cit":35,"pfa":"Maurizio Vanelli","psa":"Francesco Chiarelli","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W67259617","eid":"W67259617"},{"id":"paper-w2076920165","cat":"papers","name":"The time-dependent stimulus effects of R(-)-2,5-dimethoxy-4-methamphetamine (DOM): implications for drug-induced stimulus control as a method for the study of hallucinogenic agents","year":"1995","cit":35,"pfa":"David J. Fiorella","psa":"Jerrold C. Winter","ptype":"article","src":"https://openalex.org/W2076920165","eid":"W2076920165"},{"id":"paper-w2685092086","cat":"papers","name":"The effects and toxicity of cathinones from the users' perspectives: A qualitative study","year":"2017","cit":35,"pfa":"Sulaf A. Assi","psa":"David Osselton","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2685092086","eid":"W2685092086"},{"id":"paper-w2438142625","cat":"papers","name":"Neurobiological vulnerability to low-dose amphetamine psychosis","year":"1978","cit":35,"pfa":"Mark S. Gold","psa":"Bowers Mb","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2438142625","eid":"W2438142625"},{"id":"paper-w3134502913","cat":"papers","name":"Cannabinoids, reward processing, and psychosis","year":"2021","cit":35,"pfa":"Brandon Gunasekera","psa":"Sagnik Bhattacharyya","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3134502913","eid":"W3134502913"},{"id":"paper-w4317871469","cat":"papers","name":"Medical Costs of Substance Use Disorders in the US Employer-Sponsored Insurance Population","year":"2023","cit":35,"pfa":"Mengyao Li","psa":"Feijun Luo","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4317871469","eid":"W4317871469"},{"id":"paper-w3160506754","cat":"papers","name":"Nutmegs and wild nutmegs: An update on ethnomedicines, phytochemicals, pharmacology, and toxicity of the Myristicaceae species","year":"2021","cit":35,"pfa":"Rubi Barman","psa":"Dipanwita Banik","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3160506754","eid":"W3160506754"},{"id":"paper-w2091751728","cat":"papers","name":"Synergistic Antinociceptive Effects of Ketamine and Morphine in the Orofacial Capsaicin Test in the Rat","year":"2003","cit":35,"pfa":"Pedro Álvarez","psa":"Teresa Pélissier","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2091751728","eid":"W2091751728"},{"id":"paper-w4206024818","cat":"papers","name":"Sex-dependent metabolism of ketamine and ( 2R,6R )-hydroxynorketamine in mice and humans","year":"2021","cit":35,"pfa":"Jaclyn N. Highland","psa":"Todd D. Gould","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4206024818","eid":"W4206024818"},{"id":"paper-w2690855127","cat":"papers","name":"Efficacy of Esketamine in the Treatment of Depression With Psychotic Features: A Case Series","year":"2017","cit":35,"pfa":"Elias Ajub","psa":"Acioly L.T. Lacerda","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2690855127","eid":"W2690855127"},{"id":"paper-w2951306962","cat":"papers","name":"Ketamine metabolite (2R,6R)-hydroxynorketamine enhances aggression via periaqueductal gray glutamatergic transmission","year":"2019","cit":35,"pfa":"Lichao Ye","psa":"Dylan Chou","ptype":"article","src":"https://openalex.org/W2951306962","eid":"W2951306962"},{"id":"paper-w4280528705","cat":"papers","name":"Acute effects of ketamine and esketamine on cognition in healthy subjects: A meta-analysis","year":"2022","cit":35,"pfa":"Simon Zhornitsky","psa":"Stéphane Potvin","topics":["Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4280528705","eid":"W4280528705"},{"id":"paper-w4220889716","cat":"papers","name":"BDNF-TrkB signaling-mediated upregulation of Narp is involved in the antidepressant-like effects of (2R,6R)-hydroxynorketamine in a chronic restraint stress mouse model","year":"2022","cit":35,"pfa":"Ling-Sha Ju","psa":"Jianjun Yang","topics":["Depression","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4220889716","eid":"W4220889716"},{"id":"paper-w4324374539","cat":"papers","name":"Effect of esketamine on postoperative depressive symptoms in patients undergoing thoracoscopic lung cancer surgery: A randomized controlled trial","year":"2023","cit":35,"pfa":"Shu-lin Gan","psa":"Fuhai Ji","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4324374539","eid":"W4324374539"},{"id":"paper-w4290584213","cat":"papers","name":"Comparison of the Effects of Esketamine/Propofol and Sufentanil/Propofol on the Incidence of Intraoperative Hypoxemia during Bronchoscopy: Protocol for a Randomized, Prospective, Parallel-Group Trial","year":"2022","cit":35,"pfa":"Xiao Dong Huang","psa":"Anshi Wu","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4290584213","eid":"W4290584213"},{"id":"paper-w3197456721","cat":"papers","name":"Treatment of difficult-to-treat depression – clinical guideline for selected interventions","year":"2021","cit":35,"pfa":"Stine Bjerrum Møeller","psa":"Poul Videbech","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3197456721","eid":"W3197456721"},{"id":"paper-w4318455355","cat":"papers","name":"Clinical Practice Guidelines for Management of Suicidal Behaviour","year":"2023","cit":35,"pfa":"Sujit Sarkhel","psa":"Lakshmi Vijayakumar","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4318455355","eid":"W4318455355"},{"id":"paper-w2411929905","cat":"papers","name":"Treatment of Chronic Alcoholism with Lysergic Acid Diethylamide","year":"1963","cit":34,"pfa":"S.E. Jensen","psa":"Ronald Ramsay","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2411929905","eid":"W2411929905"},{"id":"paper-w1995927106","cat":"papers","name":"Comparison of the action of lysergic acid diethylamide and apomorphine on the copulatory response in the female rat","year":"1976","cit":34,"pfa":"Mona Eliasson","psa":"Bengt J. Meyerson","ptype":"article","src":"https://openalex.org/W1995927106","eid":"W1995927106"},{"id":"paper-w4306912803","cat":"papers","name":"Ibogaine/Noribogaine in the Treatment of Substance Use Disorders: A Systematic Review of the Current Literature","year":"2022","cit":34,"pfa":"Alessio Mosca","psa":"Massimo Di Giannantonio","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4306912803","eid":"W4306912803"},{"id":"paper-w3000560651","cat":"papers","name":"Anxiety-like behavior induced by salicylate depends on age and can be prevented by a single dose of 5-MeO-DMT","year":"2020","cit":34,"pfa":"Jéssica Winne","psa":"Richardson Naves Leão","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3000560651","eid":"W3000560651"},{"id":"paper-w4236465381","cat":"papers","name":"Peyote","year":"1996","cit":34,"pfa":"Edward F. Anderson","ptype":"book","src":"https://openalex.org/W4236465381","eid":"W4236465381"},{"id":"paper-w2315156127","cat":"papers","name":"Observations on Taking Peyote \"(Anhalonium Lewinii)\"","year":"1923","cit":34,"pfa":"Samuel W. Fernberger","ptype":"article","src":"https://openalex.org/W2315156127","eid":"W2315156127"},{"id":"paper-w2417924401","cat":"papers","name":"Mescaline: the chemistry and pharmacology of its analogs.","year":"1973","cit":34,"pfa":"A T Shulgin","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2417924401","eid":"W2417924401"},{"id":"paper-w2025714662","cat":"papers","name":"Ayahuasca in Adolescence: Qualitative Results","year":"2005","cit":34,"pfa":"Marlene Dobkin de Ríos","psa":"Evelyn Doering-Silveira","topics":["Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2025714662","eid":"W2025714662"},{"id":"paper-w2154973551","cat":"papers","name":"MDMA and the “Ecstasy Paradigm”","year":"2014","cit":34,"pfa":"Jon C. Cole","ptype":"article","src":"https://openalex.org/W2154973551","eid":"W2154973551"},{"id":"paper-w2084375542","cat":"papers","name":"Stereochemistry of the metabolism of MDMA to MDA","year":"1989","cit":34,"pfa":"Robert L. Fitzgerald","psa":"Richard A. Glennon","ptype":"article","src":"https://openalex.org/W2084375542","eid":"W2084375542"},{"id":"paper-w2124650596","cat":"papers","name":"Discriminative Stimulus Effects of Psychostimulants and Hallucinogens in S(+)-3,4-Methylenedioxymethamphetamine (MDMA) and R(−)-MDMA Trained Mice","year":"2009","cit":34,"pfa":"Kevin Sean Murnane","psa":"William E. Fantegrossi","ptype":"article","src":"https://openalex.org/W2124650596","eid":"W2124650596"},{"id":"paper-w1987206736","cat":"papers","name":"O uso ritual da ayahuasca","year":"2003","cit":34,"pfa":"Marcelo Simão Mercante","ptype":"article","src":"https://openalex.org/W1987206736","eid":"W1987206736"},{"id":"paper-w1978920578","cat":"papers","name":"Neurocognitive impairments in MDMA and other drug users: MDMA alone may not be a cognitive risk factor","year":"2009","cit":34,"pfa":"Karen L. Hanson","psa":"Monica M. Luciana","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1978920578","eid":"W1978920578"},{"id":"paper-w1973550821","cat":"papers","name":"Repeated exposure to MDMA provides neuroprotection against subsequent MDMA-induced serotonin depletion in brain","year":"2009","cit":34,"pfa":"Nirmal Bhide","psa":"Gary A. Gudelsky","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1973550821","eid":"W1973550821"},{"id":"paper-w3044137056","cat":"papers","name":"Evaluation of Biased and Balanced Salvinorin A Analogs in Preclinical Models of Pain","year":"2020","cit":34,"pfa":"Kelly F. Paton","psa":"Bronwyn Maree Kivell","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3044137056","eid":"W3044137056"},{"id":"paper-w2072997824","cat":"papers","name":"The effects of N,N-dimethyltryptamine on operant behavior in squirrel monkeys","year":"1973","cit":34,"pfa":"John M. Cole","psa":"Walter A. Pieper","ptype":"article","src":"https://openalex.org/W2072997824","eid":"W2072997824"},{"id":"paper-w2042601718","cat":"papers","name":"Involvement of 5-HT receptor subtypes in the discriminative stimulus properties of mescaline","year":"1989","cit":34,"pfa":"James B. Appel","psa":"Patrick M. Callahan","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2042601718","eid":"W2042601718"},{"id":"paper-w4388641010","cat":"papers","name":"Psilocybin and Other Classic Psychedelics in Depression","year":"2023","cit":34,"pfa":"David Nutt","psa":"David Erritzøe","topics":["Depression"],"ptype":"book-chapter","src":"https://openalex.org/W4388641010","eid":"W4388641010"},{"id":"paper-w3195754779","cat":"papers","name":"Ayahuasca, a psychedelic beverage, modulates neuroplasticity induced by ethanol in mice","year":"2021","cit":34,"pfa":"Carolina Aparecida de Faria Almeida","psa":"Larissa Helena Torres","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3195754779","eid":"W3195754779"},{"id":"paper-w2198450968","cat":"papers","name":"Effects of Long-Term Ayahuasca Administration on Memory and Anxiety in Rats","year":"2015","cit":34,"pfa":"Vanessa Manchim Favaro","psa":"Maria Gabriela Menezes Oliveira","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2198450968","eid":"W2198450968"},{"id":"paper-w3131094168","cat":"papers","name":"Synthesis and in vitro pharmacological studies of C(4) modified salvinorin A analogues","year":"2005","cit":34,"pfa":"David Y.W. Lee","psa":"Bruce M. Cohen","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3131094168","eid":"W3131094168"},{"id":"paper-w2042388365","cat":"papers","name":"Second Thoughts on 3,4-Methylenedioxymethamphetamine (MDMA) Neurotoxicity","year":"1990","cit":34,"pfa":"Charles S. Grob","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2042388365","eid":"W2042388365"},{"id":"paper-w4399390472","cat":"papers","name":"MDMA therapy for PTSD rejected by FDA panel","year":"2024","cit":34,"pfa":"Sara Reardon","topics":["PTSD & trauma"],"ptype":"other","src":"https://openalex.org/W4399390472","eid":"W4399390472"},{"id":"paper-w2131364204","cat":"papers","name":"The serotonergic hallucinogen 5-methoxy-N,N-dimethyltryptamine disrupts cortical activity in a regionally-selective manner via 5-HT1A and 5-HT2A receptors","year":"2015","cit":34,"pfa":"Maurizio S. Riga","psa":"Pau Celada","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2131364204","eid":"W2131364204"},{"id":"paper-w2949169798","cat":"papers","name":"Intramolecular Diels−Alder/Tsuji Allylation Assembly of the Functionalized trans-Decalin of Salvinorin A","year":"2007","cit":34,"pfa":"Aaron C. Burns","psa":"Craig J. Forsyth","ptype":"article","src":"https://openalex.org/W2949169798","eid":"W2949169798"},{"id":"paper-w2096571901","cat":"papers","name":"Peyote, a Potential Ethnopharmacologic Agent for Alcoholism and Other Drug Dependencies: Possible Biochemical Rationale","year":"1977","cit":34,"pfa":"Kenneth Blum","psa":"Paul Pascarosa","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2096571901","eid":"W2096571901"},{"id":"paper-w2021358823","cat":"papers","name":"Biphasic dose-response effects of N-N-dimethyltryptamine on the rat startle reflex","year":"1974","cit":34,"pfa":"Michael E Davis","psa":"Michael H. Sheard","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2021358823","eid":"W2021358823"},{"id":"paper-w2121160760","cat":"papers","name":"Determination of psilocin in magic mushrooms and rat plasma by liquid chromatography with fluorimetry and electrospray ionization mass spectrometry","year":"2004","cit":34,"pfa":"Kimie Saito","psa":"Yukihiro Goda","ptype":"article","src":"https://openalex.org/W2121160760","eid":"W2121160760"},{"id":"paper-w2020354864","cat":"papers","name":"MDMA, cortisol, and heightened stress in recreational ecstasy users","year":"2014","cit":34,"pfa":"Andrew C. Parrott","psa":"Andrew B Scholey","topics":["Depression","Anxiety & end-of-life","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2020354864","eid":"W2020354864"},{"id":"paper-w2470405764","cat":"papers","name":"Comparison of chlordiazepoxide, methysergide, and cinanserin as modifiers of punished behavior and as antagonists of N,N-dimethyltryptamine.","year":"1972","cit":34,"pfa":"Winter Jc","ptype":"article","src":"https://openalex.org/W2470405764","eid":"W2470405764"},{"id":"paper-w4291162385","cat":"papers","name":"Psilocybin Efficacy and Mechanisms of Action in Major Depressive Disorder: a Review","year":"2022","cit":34,"pfa":"Damien Prouzeau","psa":"Jorge López‐Castromán","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4291162385","eid":"W4291162385"},{"id":"paper-w2146714987","cat":"papers","name":"Urinary Excretion Kinetics of 3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy) and Its Phase I and Phase II Metabolites in Humans following Controlled MDMA Administration","year":"2011","cit":34,"pfa":"Andrea Eva Steuer","psa":"Hans H. Maurer","ptype":"article","src":"https://openalex.org/W2146714987","eid":"W2146714987"},{"id":"paper-w2035605319","cat":"papers","name":"Comparison of solution conformational preferences for the hallucinogens bufotenin and psilocin using 360-MHz proton NMR spectroscopy","year":"1981","cit":34,"pfa":"Gerald P. Migliaccio","psa":"David E. Nichols","ptype":"article","src":"https://openalex.org/W2035605319","eid":"W2035605319"},{"id":"paper-w2045469853","cat":"papers","name":"MDMA powder, pills and crystal: the persistence of ecstasy and the poverty of policy","year":"2009","cit":34,"pfa":"Zoë Smith","psa":"Fiona Catherine Measham","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2045469853","eid":"W2045469853"},{"id":"paper-w2127789754","cat":"papers","name":"Multimodal dynamic multiple access (MDMA) in wireless packet networks","year":"2002","cit":34,"pfa":"S. Kandukuri","psa":"Nicholas Bambos","ptype":"conference-paper","src":"https://openalex.org/W2127789754","eid":"W2127789754"},{"id":"paper-w2140275963","cat":"papers","name":"Memory and mood during MDMA intoxication, with and without memantine pretreatment","year":"2014","cit":34,"pfa":"E. B. de Sousa Fernandes Perna","psa":"Johannes Gerardus Ramaekers","ptype":"article","src":"https://openalex.org/W2140275963","eid":"W2140275963"},{"id":"paper-w2103339553","cat":"papers","name":"Nonlinear Pharmacokinetics of (±)3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”) and Its Major Metabolites in Squirrel Monkeys at Plasma Concentrations of MDMA That Develop After Typical Psychoactive Doses","year":"2008","cit":34,"pfa":"Melanie Mueller","psa":"George A. Ricaurte","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2103339553","eid":"W2103339553"},{"id":"paper-w2036898191","cat":"papers","name":"Analysis of Ecstasy (MDMA)‐induced transcriptional responses in the rat cortex","year":"2002","cit":34,"pfa":"Nathalie Thiriet","psa":"Jean Lud Cadet","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2036898191","eid":"W2036898191"},{"id":"paper-w1982264171","cat":"papers","name":"The effects of repeated administration of MDMA on the expression of sexual behavior in the male rat","year":"1991","cit":34,"pfa":"Wayne A. Dornan","psa":"George A. Ricaurte","ptype":"article","src":"https://openalex.org/W1982264171","eid":"W1982264171"},{"id":"paper-w2160869008","cat":"papers","name":"Amphetamine analogs methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) differentially affect speech","year":"2009","cit":34,"pfa":"Gina F. Marrone","psa":"Carl L. Hart","ptype":"article","src":"https://openalex.org/W2160869008","eid":"W2160869008"},{"id":"paper-w2022745508","cat":"papers","name":"The effects of mescaline, amphetamine and four-ring substituted amphetamine derivatives on spontaneous brain electrical activity in the cat","year":"1967","cit":34,"pfa":"Matthew Fairchild","psa":"M. R. Mickey","ptype":"article","src":"https://openalex.org/W2022745508","eid":"W2022745508"},{"id":"paper-w2070596670","cat":"papers","name":"Fluoxetine Pretreatment Effects Pharmacokinetics of 3,4‐Methylenedioxymethamphetamine (MDMA, ECSTASY) in Rat","year":"2007","cit":34,"pfa":"Vijay V. Upreti","psa":"Natalie D. Eddington","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2070596670","eid":"W2070596670"},{"id":"paper-w1509982187","cat":"papers","name":"The receptor antagonist, dextrorphan, prevents the neurotoxic effects of 3,4-methylenedioxymethamphetamine (MDMA) in rats","year":"1989","cit":34,"pfa":"Kevin T. Finnegan","psa":"J. William Langston","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1509982187","eid":"W1509982187"},{"id":"paper-w4310735641","cat":"papers","name":"Single-dose psilocybin for treatment-resistant obsessive-compulsive disorder: A case report","year":"2022","cit":34,"pfa":"Benjamin Kelmendi","psa":"Christopher Pittenger","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4310735641","eid":"W4310735641"},{"id":"paper-w2046053029","cat":"papers","name":"The effect of MDMA (“Ecstasy”) and its optical isomers on schedule-controlled responding in mice","year":"1987","cit":34,"pfa":"Richard A. Glennon","psa":"Mamoun Yousif","ptype":"article","src":"https://openalex.org/W2046053029","eid":"W2046053029"},{"id":"paper-w1993422772","cat":"papers","name":"Attenuation of alcohol consumption by MDMA (ecstasy) in two strains of alcohol-preferring rats","year":"1992","cit":34,"pfa":"Amir H. Rezvani","psa":"Christopher James Gordon","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1993422772","eid":"W1993422772"},{"id":"paper-w2095117998","cat":"papers","name":"Use of MDMA and Other Illicit Drugs by Young Adult Males in Northern Spain","year":"2002","cit":34,"pfa":"Julio Bobes","psa":"U. McCann","ptype":"article","src":"https://openalex.org/W2095117998","eid":"W2095117998"},{"id":"paper-w2008667506","cat":"papers","name":"The profiling of MDMA tablets: A study of the combination of physical characteristics and organic impurities as sources of information","year":"2009","cit":34,"pfa":"Quentin Milliet","psa":"Pierre Esseiva","ptype":"article","src":"https://openalex.org/W2008667506","eid":"W2008667506"},{"id":"paper-w2082642884","cat":"papers","name":"Serotonin synthesis inhibition reveals distinct mechanisms of action for MDMA and its enantiomers in the mouse","year":"2005","cit":34,"pfa":"William E. Fantegrossi","psa":"James Henry Woods","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2082642884","eid":"W2082642884"},{"id":"paper-w2050559830","cat":"papers","name":"Association of caffeine to MDMA does not increase antinociception but potentiates adverse effects of this recreational drug","year":"2006","cit":34,"pfa":"Jordi Camarasa","psa":"Elena Escubedo","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2050559830","eid":"W2050559830"},{"id":"paper-w2045339004","cat":"papers","name":"Application of analytical methods for the structural characterization and purity assessment of N,N-dimethyltryptamine, a potent psychedelic agent isolated from Mimosa tenuiflora inner barks","year":"2012","cit":34,"pfa":"Alain Gaujac","psa":"Jaílson B. de Andrade","ptype":"article","src":"https://openalex.org/W2045339004","eid":"W2045339004"},{"id":"paper-w2021610558","cat":"papers","name":"MDMA (“ecstasy”) impairs learning in the Morris Water Maze and reduces hippocampal LTP in young rats","year":"2009","cit":34,"pfa":"Alejandra Arias‐Cavieres","psa":"Bernardo Morales","ptype":"article","src":"https://openalex.org/W2021610558","eid":"W2021610558"},{"id":"paper-w2581528830","cat":"papers","name":"MDMA-induced neurotoxicity of serotonin neurons involves autophagy and rilmenidine is protective against its pathobiology","year":"2017","cit":34,"pfa":"Linda D. Mercer","psa":"Philip M. Beart","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2581528830","eid":"W2581528830"},{"id":"paper-w4388574768","cat":"papers","name":"Psychedelics for treatment resistant depression: are they game changers?","year":"2023","cit":34,"pfa":"Michail Kalfas","psa":"Allan Hunter Young","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4388574768","eid":"W4388574768"},{"id":"paper-w2066251840","cat":"papers","name":"Sex Differences in 3,4-Methylenedioxymethamphetamine (MDMA; Ecstasy)-Induced Cytochrome P450 2D6 Inhibition in Humans","year":"2011","cit":34,"pfa":"Samanta Yubero‐Lahoz","psa":"Rafael de la Torre","ptype":"article","src":"https://openalex.org/W2066251840","eid":"W2066251840"},{"id":"paper-w2050762414","cat":"papers","name":"Nociception is enhanced after low doses and reduced after high doses of the serotonin receptor agonist 5-methoxy-N,N-dimethyltryptamine","year":"1980","cit":34,"pfa":"Odd‐Geir Berge","psa":"H. Dahle","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2050762414","eid":"W2050762414"},{"id":"paper-w2049280393","cat":"papers","name":"Effects of 3,4-methylenedioxymethamphetamine (MDMA, ‘Ecstasy’) and para-methoxyamphetamine on striatal 5-HT when co-administered with moclobemide","year":"2005","cit":34,"pfa":"Alexander Freezer","psa":"Rodney James Irvine","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2049280393","eid":"W2049280393"},{"id":"paper-w2058365449","cat":"papers","name":"Sprague–Dawley rats display metabolism-mediated sex differences in the acute toxicity of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)","year":"2008","cit":34,"pfa":"Julien Fonsart","psa":"Florence Noble","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2058365449","eid":"W2058365449"},{"id":"paper-w1836264777","cat":"papers","name":"Comparative potencies of 3,4‐methylenedioxymethamphetamine (MDMA) analogues as inhibitors of [3H]noradrenaline and [3H]5‐HT transport in mammalian cell lines","year":"2007","cit":34,"pfa":"Therese Montgomery","psa":"Gethin J. McBean","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W1836264777","eid":"W1836264777"},{"id":"paper-w2070953022","cat":"papers","name":"MDMA causes a redistribution of serotonin transporter from the cell surface to the intracellular compartment by a mechanism independent of phospho-p38-mitogen activated protein kinase activation","year":"2010","cit":34,"pfa":"Bronwyn Maree Kivell","psa":"Jeffrey D. Miller","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2070953022","eid":"W2070953022"},{"id":"paper-w4388731626","cat":"papers","name":"Assessment of the acute subjective psychedelic experience: A review of patient-reported outcome measures in clinical research on classical psychedelics","year":"2023","cit":34,"pfa":"Oliver Rumle Hovmand","psa":"Sidse Arnfred","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4388731626","eid":"W4388731626"},{"id":"paper-w4292136326","cat":"papers","name":"Psychedelic drug abuse potential assessment research for new drug applications and Controlled Substances Act scheduling","year":"2022","cit":34,"pfa":"Jack E. Henningfield","psa":"Farah Z. Zia","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4292136326","eid":"W4292136326"},{"id":"paper-w2407869099","cat":"papers","name":"Prohibited or regulated? LSD psychotherapy and the United States Food and Drug Administration","year":"2016","cit":34,"pfa":"Matthew Oram","topics":["Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2407869099","eid":"W2407869099"},{"id":"paper-w4294723946","cat":"papers","name":"The Safety and Efficacy of Psychedelic-Assisted Therapies for Older Adults: Knowns and Unknowns","year":"2022","cit":34,"pfa":"Catherine Bree Johnston","psa":"Brian T. Anderson","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4294723946","eid":"W4294723946"},{"id":"paper-w2090116739","cat":"papers","name":"Differential changes in 125I-LSD-labeled 5-HT-2 serotonin receptors in discrete regions of brain in the rat model of persistent dyskinesias induced by iminodipropionitrile (IDPN): evidence from autoradiographic studies","year":"1987","cit":34,"pfa":"Jean Lud Cadet","psa":"Errol B. De Souza","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2090116739","eid":"W2090116739"},{"id":"paper-w3150741773","cat":"papers","name":"LSD and ketanserin and their impact on the human autonomic nervous system","year":"2021","cit":34,"pfa":"Sebastian Olbrich","psa":"Franz X. Vollenweider","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3150741773","eid":"W3150741773"},{"id":"paper-w2567295262","cat":"papers","name":"The History of Psychedelics in Medicine","year":"2016","cit":34,"pfa":"Ben Sessa","ptype":"book-chapter","src":"https://openalex.org/W2567295262","eid":"W2567295262"},{"id":"paper-w2011877314","cat":"papers","name":"Activity of a non-hallucinogenic ergoline derivative, lisuride, in an animal behavior model for hallucinogens","year":"1981","cit":34,"pfa":"James L. Marini","psa":"Michael E. Trulson","ptype":"article","src":"https://openalex.org/W2011877314","eid":"W2011877314"},{"id":"paper-w2026149224","cat":"papers","name":"Stimulant effects of 3,4-methylenedioxymethamphetamine in the nucleus accumbens of rat","year":"1992","cit":34,"pfa":"Clifton W. Callaway","psa":"Mark A. Geyer","ptype":"article","src":"https://openalex.org/W2026149224","eid":"W2026149224"},{"id":"paper-w2013486896","cat":"papers","name":"Methylenedioxymethamphetamine Suppresses Production of the Proinflammatory Cytokine Tumor Necrosis Factor-α Independent of a β-Adrenoceptor-Mediated Increase in Interleukin-10","year":"2004","cit":34,"pfa":"Thomas J. Connor","psa":"John P. Kelly","ptype":"article","src":"https://openalex.org/W2013486896","eid":"W2013486896"},{"id":"paper-w2043591624","cat":"papers","name":"Protein kinase C inhibition differentially affects 3,4-methylenedioxymethamphetamine-induced dopamine release in the striatum and prefrontal cortex of the rat","year":"2004","cit":34,"pfa":"Sunila G Nair","psa":"Gary A. Gudelsky","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2043591624","eid":"W2043591624"},{"id":"paper-w4301605941","cat":"papers","name":"Predictors of Psychedelic Experience: A Thematic Analysis","year":"2022","cit":34,"pfa":"Annie McCartney","psa":"Alexander De Foe","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4301605941","eid":"W4301605941"},{"id":"paper-w2122310210","cat":"papers","name":"Rapid analysis of 3,4-methylenedioxymethamphetamine: a comparison of nonaqueous capillary electrophoresis/fluorescence detection with GC/MS","year":"2002","cit":34,"pfa":"Ching Fang","psa":"Cheng‐Huang Lin","ptype":"article","src":"https://openalex.org/W2122310210","eid":"W2122310210"},{"id":"paper-w3204569170","cat":"papers","name":"The Effects of Tryptamine Psychedelics in the Brain: A meta-Analysis of Functional and Review of Molecular Imaging Studies","year":"2021","cit":34,"pfa":"João Castelhano","psa":"Miguel Castelo‐Branco","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W3204569170","eid":"W3204569170"},{"id":"paper-w1977549232","cat":"papers","name":"Methamphetamine- and 3,4-Methylenedioxymethamphetamine–Induced Behavioral Changes in Histamine H3–Receptor Knockout Mice","year":"2009","cit":34,"pfa":"Tomohiro Okuda","psa":"Kazuhiko Yanai","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1977549232","eid":"W1977549232"},{"id":"paper-w1767497282","cat":"papers","name":"Salvia divinorum: from Mazatec medicinal and hallucinogenic plant to emerging recreational drug","year":"2013","cit":34,"pfa":"Jolanta Barbara Zawilska","psa":"Jakub Wojcieszak","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1767497282","eid":"W1767497282"},{"id":"paper-w2036789956","cat":"papers","name":"Morbidity Involving the Hallucinogenic Designer Amines MDA and 2C‐I*","year":"2009","cit":34,"pfa":"Julia C. Drees","psa":"Alan H.B. Wu","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2036789956","eid":"W2036789956"},{"id":"paper-w2141573236","cat":"papers","name":"Comparison of Three Commercial Amphetamine Immunoassays for Detection of Methamphetamine, Methylenedioxyamphetamine, Methylenedioxymethamphetamine, and Methylenedioxyethylamphetamine*","year":"1988","cit":34,"pfa":"Werawan Ruangyuttikarn","psa":"David E. Moody","ptype":"article","src":"https://openalex.org/W2141573236","eid":"W2141573236"},{"id":"paper-w2104147681","cat":"papers","name":"Gas Chromatographic Optimization Studies on the Side Chain and Ring Regioisomers of Methylenedioxymethamphetamine","year":"2004","cit":34,"pfa":"Laura Aalberg","psa":"Charles R. Clark","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2104147681","eid":"W2104147681"},{"id":"paper-w2083201152","cat":"papers","name":"A Psychological Study of the Effects of Surgery on Eighty‐six Elderly Patients","year":"1967","cit":34,"pfa":"ELIZABETH BLUNDELL","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2083201152","eid":"W2083201152"},{"id":"paper-w4293282462","cat":"papers","name":"Psychedelics as potent anti-inflammatory therapeutics","year":"2022","cit":34,"pfa":"Charles David Nichols","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4293282462","eid":"W4293282462"},{"id":"paper-w571550968","cat":"papers","name":"Manual of Therapeutics for Addictions","year":"1997","cit":34,"pfa":"Norman Stanley Miller","psa":"David Eugene Smith","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"book","src":"https://openalex.org/W571550968","eid":"W571550968"},{"id":"paper-w3151129275","cat":"papers","name":"Somatostatin interneurons activated by 5-HT2A receptor suppress slow oscillations in medial entorhinal cortex","year":"2021","cit":34,"pfa":"Roberto De Filippo","psa":"Dietmar Schmitz","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3151129275","eid":"W3151129275"},{"id":"paper-w3191608162","cat":"papers","name":"Cancer Healthcare Workers’ Perceptions toward Psychedelic-Assisted Therapy: A Preliminary Investigation","year":"2021","cit":34,"pfa":"Lisa Reynolds","psa":"William J. Evans","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3191608162","eid":"W3191608162"},{"id":"paper-w4387893542","cat":"papers","name":"Psychedelic use and psychiatric risks","year":"2023","cit":34,"pfa":"Otto Simonsson","psa":"Peter S. Hendricks","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4387893542","eid":"W4387893542"},{"id":"paper-w408340686","cat":"papers","name":"The invisible landscape : mind, hallucinogens, and the I Ching","year":"1975","cit":34,"pfa":"O. N. Oeric","psa":"Terence K. McKenna","ptype":"book","src":"https://openalex.org/W408340686","eid":"W408340686"},{"id":"paper-w1508223328","cat":"papers","name":"Microdose intravaginal levonorgestrel contraception: A multicentre clinical trial","year":"1990","cit":34,"pfa":"Suporn Koetsawang","psa":"Philip John Rowe","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1508223328","eid":"W1508223328"},{"id":"paper-w2090199452","cat":"papers","name":"CLINICAL PROFILES OF PAID NORMAL SUBJECTS VOLUNTEERING FOR HALLUCINOGEN DRUG STUDIES","year":"1961","cit":34,"pfa":"Harold Esecover","psa":"Bernard Wilkens","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2090199452","eid":"W2090199452"},{"id":"paper-w2973084510","cat":"papers","name":"Characteristics and circumstances of death related to new psychoactive stimulants and hallucinogens in Australia","year":"2019","cit":34,"pfa":"Shane G Darke","psa":"Julia Lappin","ptype":"article","src":"https://openalex.org/W2973084510","eid":"W2973084510"},{"id":"paper-w1574650603","cat":"papers","name":"MOKSHA - Writings on Psychedelics and the Visionary Experience 1931 - 1963","year":"1983","cit":34,"pfa":"Aldous Huxley","psa":"Cynthia L. Palmer","ptype":"book","src":"https://openalex.org/W1574650603","eid":"W1574650603"},{"id":"paper-w1984544799","cat":"papers","name":"Soma siddhas and alchemical enlightenment: psychedelic mushrooms in Buddhist tradition","year":"1995","cit":34,"pfa":"Scott Hajicek-Dobberstein","ptype":"article","src":"https://openalex.org/W1984544799","eid":"W1984544799"},{"id":"paper-w4307812812","cat":"papers","name":"Validation of a new instrument for assessing attitudes on psychedelics in the general population","year":"2022","cit":34,"pfa":"Marija Franka Žuljević","psa":"Darko Duplančić","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4307812812","eid":"W4307812812"},{"id":"paper-w3042714083","cat":"papers","name":"American Trip: Set, Setting, and the Psychedelic Experience in the Twentieth Century","year":"2020","cit":34,"pfa":"Ido Hartogsohn","ptype":"book","src":"https://openalex.org/W3042714083","eid":"W3042714083"},{"id":"paper-w2050491551","cat":"papers","name":"Age-specific patterns of hallucinogen use in the US population: an analysis using generalized additive models","year":"1996","cit":34,"pfa":"Howard D. Chilcoat","psa":"Christian G. Schütz","ptype":"article","src":"https://openalex.org/W2050491551","eid":"W2050491551"},{"id":"paper-w3122438795","cat":"papers","name":"Microdose Lithium Protects against Pancreatic Islet Destruction and Renal Impairment in Streptozotocin-Elicited Diabetes","year":"2021","cit":34,"pfa":"Jiahui Zhang","psa":"Rujun Gong","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3122438795","eid":"W3122438795"},{"id":"paper-w203982044","cat":"papers","name":"Fertilizer Microdosing and “Warrantage” or Inventory Credit System to Improve Food Security and Farmers’ Income in West Africa","year":"2011","cit":34,"pfa":"Ramadjita Tabo","psa":"Suzanne KOALA","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W203982044","eid":"W203982044"},{"id":"paper-w2000787398","cat":"papers","name":"Hallucinogen actions on 5-HT receptors reveal distinct mechanisms of activation and signaling by G protein-coupled receptors","year":"2005","cit":34,"pfa":"Harel Weinstein","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2000787398","eid":"W2000787398"},{"id":"paper-w2471586856","cat":"papers","name":"Round-Window Microcatheter-Administered Microdose Gentamicin: Results from Treatment of Tinnitus Associated with Menière's Disease.","year":"1998","cit":34,"pfa":"Michael Decicco","psa":"O'Leary","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2471586856","eid":"W2471586856"},{"id":"paper-w4205627344","cat":"papers","name":"Effects of Psychedelic Use on Racial Trauma Symptoms and Ethnic Identity among Asians in North America","year":"2022","cit":34,"pfa":"Terence H. W. Ching","psa":"Monnica T. Williams","topics":["PTSD & trauma","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4205627344","eid":"W4205627344"},{"id":"paper-w2087431887","cat":"papers","name":"Synthesis and evaluation of 2,3-dihydrobenzofuran analogs of the hallucinogen 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane: drug discrimination studies in rats","year":"1986","cit":34,"pfa":"David E. Nichols","psa":"Robert M. Riggs","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2087431887","eid":"W2087431887"},{"id":"paper-w592476765","cat":"papers","name":"The Archaic Revival: Speculations on Psychedelic Mushrooms, the Amazon, Virtual Reality, UFOs, Evolution, Shamanism, the Rebirth of the Goddess, and the End of History","year":"1991","cit":34,"pfa":"Terence K. McKenna","ptype":"book","src":"https://openalex.org/W592476765","eid":"W592476765"},{"id":"paper-w2409366871","cat":"papers","name":"N,N-dimethylglycine differentially modulates psychotomimetic and antidepressant-like effects of ketamine in mice","year":"2016","cit":34,"pfa":"Jen-Cheng Lin","psa":"Hwei‐Hsien Chen","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2409366871","eid":"W2409366871"},{"id":"paper-w2908330412","cat":"papers","name":"Increased spontaneous EEG signal diversity during stroboscopically-induced altered states of consciousness","year":"2019","cit":34,"pfa":"David J. Schwartzman","psa":"Anil K. Seth","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W2908330412","eid":"W2908330412"},{"id":"paper-w648838395","cat":"papers","name":"Brain Imaging in Substance Abuse: Research, Clinical, and Forensic Applications","year":"2001","cit":34,"topics":["Addiction","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W648838395","eid":"W648838395"},{"id":"paper-w2298139870","cat":"papers","name":"The Use of Ketamine for the Treatment of Depression in the Context of Psychotic Symptoms","year":"2015","cit":34,"pfa":"Carolina Medeiros da Frota Ribeiro","psa":"Robert B. Ostroff","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2298139870","eid":"W2298139870"},{"id":"paper-w1979913612","cat":"papers","name":"Time, action and psychosis: Using subjective time to investigate the effects of ketamine on sense of agency","year":"2012","cit":34,"pfa":"J.W. Moore","psa":"Paul Charles Fletcher","ptype":"article","src":"https://openalex.org/W1979913612","eid":"W1979913612"},{"id":"paper-w1971059741","cat":"papers","name":"Ceiling respiratory depression by dezocine","year":"1984","cit":34,"pfa":"Alexander Romagnoli","psa":"Arthur S. Keats","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1971059741","eid":"W1971059741"},{"id":"paper-w2085098559","cat":"papers","name":"Efficacy and Safety of an Opiate Sigma-Receptor Antagonist (SL 82.0715) in Schizophrenic Patients with Negative Symptoms: an Open Dose-Range Study","year":"1996","cit":34,"pfa":"Sieglinde Modell","psa":"R. Holzbach","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2085098559","eid":"W2085098559"},{"id":"paper-w3194618896","cat":"papers","name":"Long-Term Consequences of Adolescent Exposure to THC-Rich/CBD-Poor and CBD-Rich/THC-Poor Combinations: A Comparison with Pure THC Treatment in Female Rats","year":"2021","cit":34,"pfa":"Marina Gabaglio","psa":"Tiziana Rubino","topics":["Safety & adverse events","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3194618896","eid":"W3194618896"},{"id":"paper-w2969280713","cat":"papers","name":"Modulation of thalamo-cortical activity by the NMDA receptor antagonists ketamine and phencyclidine in the awake freely-moving rat","year":"2019","cit":34,"pfa":"Maria Amat-Foraster","psa":"Kjartan Frisch Herrik","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2969280713","eid":"W2969280713"},{"id":"paper-w1538420025","cat":"papers","name":"Current Psychiatric Therapy II","year":"1997","cit":34,"pfa":"David L. Dünner","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"book","src":"https://openalex.org/W1538420025","eid":"W1538420025"},{"id":"paper-w3037566241","cat":"papers","name":"The Pro-neurogenic Effects of Cannabidiol and Its Potential Therapeutic Implications in Psychiatric Disorders","year":"2020","cit":34,"pfa":"Miguel Ángel Luján","psa":"Olga Valverde","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3037566241","eid":"W3037566241"},{"id":"paper-w2964558517","cat":"papers","name":"Psychiatric Practice Patterns and Barriers to the Adoption of Esketamine","year":"2019","cit":34,"pfa":"Samuel T. Wilkinson","psa":"Susan H. Busch","ptype":"article","src":"https://openalex.org/W2964558517","eid":"W2964558517"},{"id":"paper-w4383740942","cat":"papers","name":"Comparison of remifentanil and esketamine in combination with propofol for patient sedation during fiberoptic bronchoscopy","year":"2023","cit":34,"pfa":"Jia Nie","psa":"Haiying Wang","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4383740942","eid":"W4383740942"},{"id":"paper-w4391440592","cat":"papers","name":"Safety and efficacy of low-dose esketamine in laparoscopic cholecystectomy: a prospective, double-blind randomized controlled trial","year":"2024","cit":34,"pfa":"Lu Zhao","psa":"Heng Yang","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4391440592","eid":"W4391440592"},{"id":"paper-w3036507891","cat":"papers","name":"Treatment Response of Add-On Esketamine Nasal Spray in Resistant Major Depression in Relation to Add-On Second-Generation Antipsychotic Treatment","year":"2020","cit":34,"pfa":"Markus Dold","psa":"Siegfried F. Kasper","topics":["Depression","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3036507891","eid":"W3036507891"},{"id":"paper-w4391569538","cat":"papers","name":"Efficacy of esketamine for the treatment of postpartum depression and pain control following cesarean section: a randomized, double-blind, controlled clinical trial","year":"2024","cit":34,"pfa":"Shurong Li","psa":"Kai-Kai Guo","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4391569538","eid":"W4391569538"},{"id":"paper-w4206666198","cat":"papers","name":"Efficacy and safety of esketamine nasal spray by sex in patients with treatment-resistant depression: findings from short-term randomized, controlled trials","year":"2022","cit":34,"pfa":"Robyn Jones","psa":"Susan Nicholson","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4206666198","eid":"W4206666198"},{"id":"paper-w2601838985","cat":"papers","name":"New drugs in psychiatry: focus on new pharmacological targets","year":"2017","cit":34,"pfa":"Filippo Caraci","psa":"Filippo Drago","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2601838985","eid":"W2601838985"},{"id":"paper-w2146365242","cat":"papers","name":"Quality of MR thermometry during palliative MR-guided high-intensity focused ultrasound (MR-HIFU) treatment of bone metastases","year":"2015","cit":34,"pfa":"Mie K Lam","psa":"Lambertus W. Bartels","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2146365242","eid":"W2146365242"},{"id":"paper-w2102297826","cat":"papers","name":"A Demand for Clarity Regarding a Case Report on the Ingestion of 5-Methoxy-N, N-Dimethyltryptamine (5-MeO-DMT) in an Ayahuasca Preparation","year":"2006","cit":33,"pfa":"J. C. Callaway","psa":"Kenneth W. Tupper","ptype":"article","src":"https://openalex.org/W2102297826","eid":"W2102297826"},{"id":"paper-w1856952423","cat":"papers","name":"Molecular Structures of Hallucinogenic Substances: Lysergic Acid Diethylamide, Psilocybin, and 2,4,5-Trimethoxyamphetamine","year":"1973","cit":33,"pfa":"Roy W. Baker","psa":"Hans Peter Weber","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1856952423","eid":"W1856952423"},{"id":"paper-w2036144836","cat":"papers","name":"Effects of d-lysergic acid diethylamide on operant behavior in the rat","year":"1963","cit":33,"pfa":"Leonard E. Jarrard","ptype":"article","src":"https://openalex.org/W2036144836","eid":"W2036144836"},{"id":"paper-w2034972863","cat":"papers","name":"[Effect of the d-lysergic acid diethylamide on the psychic functions and on electroencephalogram].","year":"1953","cit":33,"pfa":"Henri Gastaut","psa":"K. Luschnat","ptype":"article","src":"https://openalex.org/W2034972863","eid":"W2034972863"},{"id":"paper-w2271081800","cat":"papers","name":"Tolerance and limited cross-tolerance to the effects of N, N-dimethyltryptamine (DMT) and lysergic acid diethylamide-25 (LSD) on food-rewarded bar pressing in the rat.","year":"1976","cit":33,"pfa":"Beverly Kovacic","psa":"Edward F. Domino","ptype":"article","src":"https://openalex.org/W2271081800","eid":"W2271081800"},{"id":"paper-w3012221112","cat":"papers","name":"Use of Benefit Enhancement Strategies among 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) Users: Associations with Mystical, Challenging, and Enduring Effects","year":"2020","cit":33,"pfa":"Rafael Lancelotta","psa":"Alan K. Davis","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W3012221112","eid":"W3012221112"},{"id":"paper-w2078638048","cat":"papers","name":"Determination of Dimethyltryptamine And β-Carbolines (Ayahuasca Alkaloids) in Plasma Samples By Lc–MS/MS","year":"2012","cit":33,"pfa":"Carolina Dizioli Rodrigues de Oliveira","psa":"Maurı́cio Yonamine","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2078638048","eid":"W2078638048"},{"id":"paper-w1998491125","cat":"papers","name":"Thin-layer chromatography of the peyote alkaloids","year":"1967","cit":33,"pfa":"Jan Lundström","psa":"Stig Agurell","ptype":"article","src":"https://openalex.org/W1998491125","eid":"W1998491125"},{"id":"paper-w3114945764","cat":"papers","name":"The Peyote Religion among the Navaho","year":"1983","cit":33,"pfa":"Charlotte Johnson Frisbie","psa":"David F. Aberle","ptype":"article","src":"https://openalex.org/W3114945764","eid":"W3114945764"},{"id":"paper-w2092016283","cat":"papers","name":"Effects of Ayahuasca on the human EEG","year":"1998","cit":33,"pfa":"Neville S. Arachchige Don","psa":"Norman R. Farnsworth","ptype":"article","src":"https://openalex.org/W2092016283","eid":"W2092016283"},{"id":"paper-w2072286722","cat":"papers","name":"Reductive Heck coupling: an efficient approach toward the iboga alkaloids. Synthesis of ibogamine, epiibogamine and iboga analogs","year":"2012","cit":33,"pfa":"Goutam Kumar Jana","psa":"Surajit Sinha","ptype":"article","src":"https://openalex.org/W2072286722","eid":"W2072286722"},{"id":"paper-w2063967551","cat":"papers","name":"Urinary dimethyltryptamine and psychiatric symptomatology and classification","year":"1977","cit":33,"pfa":"Richard Rodnight","psa":"J. L. T. Birley","ptype":"article","src":"https://openalex.org/W2063967551","eid":"W2063967551"},{"id":"paper-w1994641285","cat":"papers","name":"NEW DEVELOPMENTS IN METABOLISM OF MESCALINE AND RELATED AMINES *","year":"1962","cit":33,"pfa":"Arnold J. Friedhoff","psa":"M. Goldstein","ptype":"article","src":"https://openalex.org/W1994641285","eid":"W1994641285"},{"id":"paper-w2139297332","cat":"papers","name":"The Quantitation of 2-Oxo-3-hydroxy Lysergic Acid Diethylamide (O-H-LSD)in Human Urine Specimens, a Metabolite of LSD: Comparative Analysis Using Liquid Chromatography-Selected Ion Monitoring Mass Spectrometry and Liquid","year":"2000","cit":33,"pfa":"Gregory K. Poch","psa":"Carolyn J. Anderson","ptype":"article","src":"https://openalex.org/W2139297332","eid":"W2139297332"},{"id":"paper-w2010371237","cat":"papers","name":"MDMA and Seizures: A Dangerous Liaison?","year":"2006","cit":33,"pfa":"Filippo Sean Giorgi","psa":"Francesco Fornai","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2010371237","eid":"W2010371237"},{"id":"paper-w2078935756","cat":"papers","name":"Studies on several 7-substituted N,N-dimethyltryptamines","year":"1980","cit":33,"pfa":"Richard A. Glennon","psa":"John A. Rosecrans","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2078935756","eid":"W2078935756"},{"id":"paper-w1970954001","cat":"papers","name":"MDMA and memory: the acute and chronic effects of MDMA in pigeons performing under a delayed-matching-to-sample procedure","year":"1993","cit":33,"pfa":"Mark G. LeSage","psa":"Alan D. Poling","ptype":"article","src":"https://openalex.org/W1970954001","eid":"W1970954001"},{"id":"paper-w4282982392","cat":"papers","name":"Classic Psychedelics in Addiction Treatment: The Case for Psilocybin in Tobacco Smoking Cessation","year":"2022","cit":33,"pfa":"Matthew W. Johnson","topics":["Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W4282982392","eid":"W4282982392"},{"id":"paper-w2281288236","cat":"papers","name":"Vobatensines A–F, Cytotoxic Iboga-Vobasine Bisindoles from Tabernaemontana corymbosa","year":"2016","cit":33,"pfa":"Dawn Su-Yin Sim","psa":"Toh‐Seok Kam","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2281288236","eid":"W2281288236"},{"id":"paper-w2085920567","cat":"papers","name":"Receptor Pharmacology of MDMA and Related Hallucinogensa","year":"1990","cit":33,"pfa":"Milt Teitler","psa":"Richard A. Glennon","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2085920567","eid":"W2085920567"},{"id":"paper-w4391898793","cat":"papers","name":"Brain dynamics predictive of response to psilocybin for treatment-resistant depression","year":"2024","cit":33,"pfa":"Jakub Vohryzek","psa":"Morten L. Kringelbach","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4391898793","eid":"W4391898793"},{"id":"paper-w2083837180","cat":"papers","name":"Analogs of the iboga alkaloids. Synthesis and reactions of (.+-.)-15-oxo-20-deethylcoronaridine derivatives","year":"1987","cit":33,"pfa":"Richard J. Sundberg","psa":"Avanthi M. Fernando","ptype":"article","src":"https://openalex.org/W2083837180","eid":"W2083837180"},{"id":"paper-w2893288063","cat":"papers","name":"MDMA alone affects sensorimotor and prepulse inhibition responses in mice and rats: tips in the debate on potential MDMA unsafety in human activity","year":"2018","cit":33,"pfa":"Matteo Marti","psa":"Emanuela Turillazzi","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2893288063","eid":"W2893288063"},{"id":"paper-w4210332402","cat":"papers","name":"Analysis of Psilocybin-Assisted Therapy in Medicine: A Narrative Review","year":"2022","cit":33,"pfa":"Shawn Ziff","psa":"Vasavi Rakesh Gorantla","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"review","src":"https://openalex.org/W4210332402","eid":"W4210332402"},{"id":"paper-w1967239709","cat":"papers","name":"New and Old Phenanthrene Derivatives from Oncidium cebolleta, a Peyote-Replacement Plant","year":"1983","cit":33,"pfa":"Frank R. Stermitz","psa":"Robert A. Bye","ptype":"article","src":"https://openalex.org/W1967239709","eid":"W1967239709"},{"id":"paper-w2022864631","cat":"papers","name":"Consumption of Ayahuasca by Children and Pregnant Women: Medical Controversies and Religious Perspectives","year":"2011","cit":33,"pfa":"Beatriz Caiuby Labate","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2022864631","eid":"W2022864631"},{"id":"paper-w2103665140","cat":"papers","name":"Post-mortem redistribution of 3,4-methylenedioxymethamphetamine (MDMA, \"ecstasy\") in the rabbit","year":"2002","cit":33,"pfa":"Els A. De Letter","psa":"Michel H A Piette","ptype":"article","src":"https://openalex.org/W2103665140","eid":"W2103665140"},{"id":"paper-w2107781663","cat":"papers","name":"The fragmentation of NN-dimethyltryptamine oxide and related compounds: a possible implication in indole alkaloid biosynthesis","year":"1970","cit":33,"pfa":"A. Ahond","psa":"Pierre F. Potier","ptype":"article","src":"https://openalex.org/W2107781663","eid":"W2107781663"},{"id":"paper-w1967641139","cat":"papers","name":"Gas chromatographic-mass spectrometric isotope dilution assay for N,N-dimethyltryptamine in human plasma","year":"1973","cit":33,"pfa":"Robert W. Walker","psa":"William J. A. VandenHeuvel","ptype":"article","src":"https://openalex.org/W1967641139","eid":"W1967641139"},{"id":"paper-w2073927607","cat":"papers","name":"CENTRAL SEROUS CHORIORETINOPATHY IN A PATIENT USING METHYLENEDIOXYMETHAMPHETAMINE (MDMA) OR “ECSTASY”","year":"2001","cit":33,"pfa":"LAMA HASSAN","psa":"SILVANO NEGRÃO","ptype":"article","src":"https://openalex.org/W2073927607","eid":"W2073927607"},{"id":"paper-w2734400052","cat":"papers","name":"MDMA-Induced Dissociative State not Mediated by the 5-HT2A Receptor","year":"2017","cit":33,"pfa":"Drew J. Puxty","psa":"Kim P. C. Kuypers","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2734400052","eid":"W2734400052"},{"id":"paper-w2145427462","cat":"papers","name":"The A2a adenosine receptor modulates the reinforcement efficacy and neurotoxicity of MDMA","year":"2011","cit":33,"pfa":"Jéssica Ruiz‐Medina","psa":"Olga Valverde","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2145427462","eid":"W2145427462"},{"id":"paper-w2951354228","cat":"papers","name":"Modified Ibogaine Fragments: Synthesis and Preliminary Pharmacological Characterization of 3-Ethyl-5-phenyl-1,2,3,4,5,6-hexahydroazepino[4,5-b]benzothiophenes","year":"1998","cit":33,"pfa":"Simon M. N. Efange","psa":"Quinjie Ouyang","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2951354228","eid":"W2951354228"},{"id":"paper-w2063424044","cat":"papers","name":"Ibogaine reduces amphetamine-induced locomotor stimulation in C57BL/6By mice, but stimulates locomotor activity in rats","year":"1992","cit":33,"pfa":"Henry W. Sershen","psa":"Ábel Lajtha","ptype":"article","src":"https://openalex.org/W2063424044","eid":"W2063424044"},{"id":"paper-w4380089845","cat":"papers","name":"Prevalence and therapeutic impact of adverse life event reexperiencing under ceremonial ayahuasca","year":"2023","cit":33,"pfa":"Brandon Weiss","psa":"William Keith Campbell","topics":["PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4380089845","eid":"W4380089845"},{"id":"paper-w4324045013","cat":"papers","name":"Preclinical perspectives on the mechanisms underlying the therapeutic actions of psilocybin in psychiatric disorders","year":"2023","cit":33,"pfa":"Andreas B. Wulff","psa":"Scott M. Thompson","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4324045013","eid":"W4324045013"},{"id":"paper-w2093510192","cat":"papers","name":"MDMA and fenfluramine alter the response of the circadian clock to a serotonin agonist in vitro","year":"2001","cit":33,"pfa":"Stephany M. Biello","psa":"Richard Ian Dafters","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2093510192","eid":"W2093510192"},{"id":"paper-w3112752637","cat":"papers","name":"The ritual use of ayahuasca during treatment of severe physical illnesses: a qualitative study","year":"2020","cit":33,"pfa":"Lucas Oliveira Maia","psa":"Luís Fernando Tófoli","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3112752637","eid":"W3112752637"},{"id":"paper-w2023603530","cat":"papers","name":"High performance liquid chromatographic quantification of salvinorin a from tissues ofsalvia divinorum epling & játiva-m","year":"1999","cit":33,"pfa":"John W. Gruber","psa":"Rick S. Hock","ptype":"article","src":"https://openalex.org/W2023603530","eid":"W2023603530"},{"id":"paper-w2297439341","cat":"papers","name":"Observations concerning the synthesis of tryptamine homologues and branched tryptamine derivatives via the borrowing hydrogen process: synthesis of psilocin, bufotenin, and serotonin","year":"2016","cit":33,"pfa":"Silvia Bartolucci","psa":"Giovanni Piersanti","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2297439341","eid":"W2297439341"},{"id":"paper-w1999770647","cat":"papers","name":"Validity of [123I]β‐CIT SPECT in detecting MDMA‐induced serotonergic neurotoxicity","year":"2002","cit":33,"pfa":"Liesbeth Reneman","psa":"George A. Ricaurte","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1999770647","eid":"W1999770647"},{"id":"paper-w3034487021","cat":"papers","name":"Use of the CytoSorb adsorption device in MDMA intoxication: a first-in-man application and in vitro study","year":"2020","cit":33,"pfa":"Corinna N. Lang","psa":"Achim Lother","topics":["Safety & adverse events","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3034487021","eid":"W3034487021"},{"id":"paper-w4412642858","cat":"papers","name":"Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial","year":"2025","cit":33,"pfa":"Amandine Luquiens","psa":"Felix Sergent","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4412642858","eid":"W4412642858"},{"id":"paper-w2529180204","cat":"papers","name":"Vobasinyl–Iboga Alkaloids from Tabernaemontana elegans: Cell Cycle Arrest and Apoptosis-Inducing Activity in HCT116 Colon Cancer Cells","year":"2016","cit":33,"pfa":"Angela Paterna","psa":"Maria‐José U. Ferreira","topics":["Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2529180204","eid":"W2529180204"},{"id":"paper-w2110459926","cat":"papers","name":"Chapter 13 “Returning to the path”: The use of iboga[ine] in an equatorial African ritual context and the binding of time, space, and social relationships","year":"2001","cit":33,"pfa":"James W. Fernández","psa":"Renate Lellep Fernandez","ptype":"book-chapter","src":"https://openalex.org/W2110459926","eid":"W2110459926"},{"id":"paper-w2012010803","cat":"papers","name":"Experimental studies on 3,4-methylenedioxymethamphetamine (MDMA, “ECSTASY”) and its potential to damage brain serotonin neurons","year":"2001","cit":33,"pfa":"George A. Ricaurte","psa":"Una D. McCann","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2012010803","eid":"W2012010803"},{"id":"paper-w3043268491","cat":"papers","name":"Quantification of MDMA in seized tablets using benchtop 1H NMR spectroscopy in the absence of internal standards","year":"2020","cit":33,"pfa":"Jannat Hena Hussain","psa":"Ryan E. Mewis","ptype":"article","src":"https://openalex.org/W3043268491","eid":"W3043268491"},{"id":"paper-w2001810623","cat":"papers","name":"Metabolites of MDMA Induce Oxidative Stress and Contractile Dysfunction in Adult Rat Left Ventricular Myocytes","year":"2009","cit":33,"pfa":"Sylvia K Shenouda","psa":"Pamela A. Lucchesi","ptype":"article","src":"https://openalex.org/W2001810623","eid":"W2001810623"},{"id":"paper-w3161462095","cat":"papers","name":"The Efficacy of MDMA (3,4-Methylenedioxymethamphetamine) for Post-traumatic Stress Disorder in Humans: A Systematic Review and Meta-Analysis","year":"2021","cit":33,"pfa":"Sarah Tedesco","psa":"Ayodeji Jolayemi","topics":["PTSD & trauma","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W3161462095","eid":"W3161462095"},{"id":"paper-w1967871718","cat":"papers","name":"Synthesis, in vitro formation, and behavioural effects of glutathione regioisomers of alpha-methyldopamine with relevance to MDA and MDMA (ecstasy)","year":"2003","cit":33,"pfa":"Neil Easton","psa":"Charles Alexander Marsden","ptype":"article","src":"https://openalex.org/W1967871718","eid":"W1967871718"},{"id":"paper-w2076125306","cat":"papers","name":"Direct determination of glucuronide and sulfate of 4-hydroxy-3-methoxymethamphetamine, the main metabolite of MDMA, in human urine","year":"2007","cit":33,"pfa":"Noriaki Shima","psa":"Nobuo Nemoto","ptype":"article","src":"https://openalex.org/W2076125306","eid":"W2076125306"},{"id":"paper-w2063602526","cat":"papers","name":"The effects of MDMA pretreatment on the behavioural effects of other drugs of abuse in the rat elevated plus-maze test","year":"2004","cit":33,"pfa":"Harry R. Sumnall","psa":"Jon C. Cole","ptype":"article","src":"https://openalex.org/W2063602526","eid":"W2063602526"},{"id":"paper-w2607270660","cat":"papers","name":"Motivations for Using MDMA (Ecstasy/Molly) among African Americans: Implications for Prevention and Harm-Reduction Programs","year":"2017","cit":33,"pfa":"Khary K. Rigg","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2607270660","eid":"W2607270660"},{"id":"paper-w3002888945","cat":"papers","name":"Detection of acute 3,4-methylenedioxymethamphetamine (MDMA) effects across protocols using automated natural language processing","year":"2020","cit":33,"pfa":"Carla Agurto","psa":"Gillinder Bedi","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W3002888945","eid":"W3002888945"},{"id":"paper-w4391617258","cat":"papers","name":"Psilocybin-induced changes in neural reactivity to alcohol and emotional cues in patients with alcohol use disorder: an fMRI pilot study","year":"2024","cit":33,"pfa":"Broc A. Pagni","psa":"Michael P. Bogenschutz","topics":["Addiction","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4391617258","eid":"W4391617258"},{"id":"paper-w2027011037","cat":"papers","name":"The effects of 3,4-methylenedioxymethamphetamine (MDMA) on nicotinic receptors: Intracellular calcium increase, calpain/caspase 3 activation, and functional upregulation","year":"2010","cit":33,"pfa":"Sara Garcia‐Ratés","psa":"David Pubill","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2027011037","eid":"W2027011037"},{"id":"paper-w2131963087","cat":"papers","name":"Application of the Syva EMIT and Abbott TDx Amphetamine Immunoassays to the Detection of 3,4-Methylenedioxymethamphetamine (MDMA) and 3,4-Methylenedioxyethamphetamine (MDEA) in Urine","year":"1990","cit":33,"pfa":"Gary W. Kunsman","psa":"Barbara R. Manno","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2131963087","eid":"W2131963087"},{"id":"paper-w2062097032","cat":"papers","name":"Full recovery after severe serotonin syndrome, severe rhabdomyolysis, multi-organ failure and disseminated intravascular coagulopathy from MDMA","year":"2014","cit":33,"pfa":"Oluwaseun Davies","psa":"Margaret Olibrice","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2062097032","eid":"W2062097032"},{"id":"paper-w2134824813","cat":"papers","name":"Mixed-Mode Solid-Phase Extraction Procedures for the Determination of MDMA and Metabolites in Urine Using LC-MS, LC-UV, or GC-NPD","year":"2004","cit":33,"pfa":"K. M. Jenkins","psa":"Albert A. Elian","ptype":"article","src":"https://openalex.org/W2134824813","eid":"W2134824813"},{"id":"paper-w2082869883","cat":"papers","name":"Development and validation of LC‐HRMS and GC‐NICI‐MS methods for stereoselective determination of MDMA and its phase I and II metabolites in human urine","year":"2011","cit":33,"pfa":"Andrea Eva Steuer","psa":"Hans H. Maurer","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2082869883","eid":"W2082869883"},{"id":"paper-w4406996996","cat":"papers","name":"Psychedelic‐assisted treatment for substance use disorder: A narrative systematic review","year":"2025","cit":33,"pfa":"Theodore Piper","psa":"John Marsden","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4406996996","eid":"W4406996996"},{"id":"paper-w4205576215","cat":"papers","name":"Analysis of recreational psychedelic substance use experiences classified by substance","year":"2022","cit":33,"pfa":"Adrian Hase","psa":"Gregor Hasler","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W4205576215","eid":"W4205576215"},{"id":"paper-w4406974730","cat":"papers","name":"Psychedelics in neuroinflammation: Mechanisms and therapeutic potential","year":"2025","cit":33,"pfa":"Júnia L. de Deus","psa":"Luiz G.S. Branco","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4406974730","eid":"W4406974730"},{"id":"paper-w4283275230","cat":"papers","name":"Associations between classic psychedelics and nicotine dependence in a nationally representative sample","year":"2022","cit":33,"pfa":"Grant M. Jones","psa":"Matthew K. Nock","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4283275230","eid":"W4283275230"},{"id":"paper-w4295755919","cat":"papers","name":"Discovery of β-Arrestin-Biased 25CN-NBOH-Derived 5-HT2AReceptor Agonists","year":"2022","cit":33,"pfa":"Christian B. M. Poulie","psa":"Jesper Langgaard Kristensen","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4295755919","eid":"W4295755919"},{"id":"paper-w1999395571","cat":"papers","name":"Chromosome Abnormality in Offspring of LSD User","year":"1970","cit":33,"pfa":"Lillian Y. F. Hsu","ptype":"article","src":"https://openalex.org/W1999395571","eid":"W1999395571"},{"id":"paper-w2146421878","cat":"papers","name":"A COMPARISON OF PSYCHOTOMIMETIC DRUG EFFECTS ON RAT BRAIN NOREPINEPHRINE METABOLISM","year":"1974","cit":33,"pfa":"Jon M. Stolk","psa":"Daniel X. Freedman","ptype":"article","src":"https://openalex.org/W2146421878","eid":"W2146421878"},{"id":"paper-w2082101850","cat":"papers","name":"Chronic Hallucinogenic Drug Use and Thought Disturbance","year":"1972","cit":33,"pfa":"GARY J. TUCKER","ptype":"article","src":"https://openalex.org/W2082101850","eid":"W2082101850"},{"id":"paper-w4360938230","cat":"papers","name":"Role of Psychedelics in Treatment-Resistant Depression","year":"2023","cit":33,"pfa":"Shubham Kamal","psa":"Rajiv Radhakrishnan","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4360938230","eid":"W4360938230"},{"id":"paper-w2035016636","cat":"papers","name":"THE PHARMACOLOGY OF A MOLLUSCAN SMOOTH MUSCLE","year":"1959","cit":33,"pfa":"Betty M. Twarog","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2035016636","eid":"W2035016636"},{"id":"paper-w4406240577","cat":"papers","name":"A systematic review of participant diversity in psychedelic-assisted psychotherapy trials","year":"2025","cit":33,"pfa":"Stephanie L. Haft","psa":"Joshua Woolley","topics":["Reviews & meta-analyses","Therapy practice"],"ptype":"review","src":"https://openalex.org/W4406240577","eid":"W4406240577"},{"id":"paper-w1968819785","cat":"papers","name":"LSD and Psychiatric Inpatients","year":"1967","cit":33,"pfa":"John D. Hensala","ptype":"article","src":"https://openalex.org/W1968819785","eid":"W1968819785"},{"id":"paper-w2894020209","cat":"papers","name":"Advances and challenges in neuroimaging studies on the effects of serotonergic hallucinogens: Contributions of the resting brain","year":"2018","cit":33,"pfa":"Felix Müller","psa":"Stefan Borgwardt","topics":["Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W2894020209","eid":"W2894020209"},{"id":"paper-w4391264321","cat":"papers","name":"Microdosing Psychedelics: Current Evidence From Controlled Studies","year":"2024","cit":33,"pfa":"Robin J. Murphy","psa":"Harriet de Wit","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4391264321","eid":"W4391264321"},{"id":"paper-w2082383749","cat":"papers","name":"The relationship between hyperthermia and glycogenolysis in 3,4-methylenedioxymethamphetamine-induced serotonin depletion in rats","year":"2004","cit":33,"pfa":"Altaf S. Darvesh","psa":"Gary A. Gudelsky","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2082383749","eid":"W2082383749"},{"id":"paper-w2169555375","cat":"papers","name":"A Case of Toxic Psychosis Induced by 'Eve' (3,4-Methylenedioxyethylam-phetamine)","year":"1993","cit":33,"pfa":"Euphrosyne Gouzoulis","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2169555375","eid":"W2169555375"},{"id":"paper-w2029633501","cat":"papers","name":"Differences in the in vivo dynamics of neurotransmitter release and serotonin uptake after acute para-methoxyamphetamine and 3,4-methylenedioxymethamphetamine revealed by chronoamperometry","year":"2005","cit":33,"pfa":"Paul D. Callaghan","psa":"Lynette C. Daws","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2029633501","eid":"W2029633501"},{"id":"paper-w2091546769","cat":"papers","name":"Putting an Ecstasy Test Kit to the Test: Harm Reduction or Harm Induction?","year":"2003","cit":33,"pfa":"Rebecca A. Murray","psa":"Bruce A. Goldberger","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2091546769","eid":"W2091546769"},{"id":"paper-w2014295769","cat":"papers","name":"Determination of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine enantiomers in whole blood","year":"1989","cit":33,"pfa":"R.L. Fitzgerald","psa":"A. Poklis","ptype":"article","src":"https://openalex.org/W2014295769","eid":"W2014295769"},{"id":"paper-w2011320995","cat":"papers","name":"Effects of methylenedioxymethamphetamine on local cerebral glucose utilization in the rat","year":"1989","cit":33,"pfa":"Gersham Wilkerson","psa":"Edythe D. London","ptype":"article","src":"https://openalex.org/W2011320995","eid":"W2011320995"},{"id":"paper-w2067020104","cat":"papers","name":"Effects of Glutamate Antagonists on Methamphetamine and 3,4‐Methylenedioxymethamphetamine‐Induced Striatal Dopamine Release In Vivo","year":"1996","cit":33,"pfa":"Kevin T. Finnegan","psa":"Terri Taraska","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2067020104","eid":"W2067020104"},{"id":"paper-w2073628201","cat":"papers","name":"Indolealkylamine and phenalkylamine hallucinogens: A brief overview","year":"1982","cit":33,"pfa":"Richard A. Glennon","psa":"John A. Rosecrans","ptype":"article","src":"https://openalex.org/W2073628201","eid":"W2073628201"},{"id":"paper-w1999688242","cat":"papers","name":"Following several days of continuous administration d-amphetamine acquires hallucinogenlike properties","year":"1980","cit":33,"pfa":"Erik B. Nielsen","psa":"Gaylord D. Ellison","ptype":"article","src":"https://openalex.org/W1999688242","eid":"W1999688242"},{"id":"paper-w2408327980","cat":"papers","name":"Activation and Allosteric Modulation of Human μ Opioid Receptor in Molecular Dynamics","year":"2015","cit":33,"pfa":"Damian Bartuzi","psa":"Dariusz Matosiuk","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2408327980","eid":"W2408327980"},{"id":"paper-w2901401125","cat":"papers","name":"Neuroscience Informed Prolonged Exposure Practice: Increasing Efficiency and Efficacy Through Mechanisms","year":"2018","cit":33,"pfa":"Monika Magdalena Stojek","psa":"Sheila A. M. Rauch","topics":["PTSD & trauma","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2901401125","eid":"W2901401125"},{"id":"paper-w2094239787","cat":"papers","name":"Photoaffinity Labeling of the Sigma-1 Receptor withN-[3-(4-Nitrophenyl)propyl]-N-dodecylamine: Evidence of Receptor Dimers","year":"2013","cit":33,"pfa":"Uyen Bao Chu","psa":"Arnold E. Ruoho","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2094239787","eid":"W2094239787"},{"id":"paper-w2007469372","cat":"papers","name":"5‐HT1B Receptor Modulation of Prepulse Inhibition: Recent Findings in Wild‐type and 5‐HT1B Knockout Micea","year":"1998","cit":33,"pfa":"Stephanie C. Dulawa","psa":"Mark A. Geyer","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2007469372","eid":"W2007469372"},{"id":"paper-w3115524456","cat":"papers","name":"Effects and safety of Psilocybe cubensis and Panaeolus cyanescens magic mushroom extracts on endothelin-1-induced hypertrophy and cell injury in cardiomyocytes","year":"2020","cit":33,"pfa":"Sanah Malomile Nkadimeng","psa":"Jacobus Nicolaas Eloff","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3115524456","eid":"W3115524456"},{"id":"paper-w32630608","cat":"papers","name":"Illicit Drug Use in the Pain Patient Population Decreases with Continued Drug Testing","year":"2011","cit":33,"pfa":"Amadeo J. Pesce","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W32630608","eid":"W32630608"},{"id":"paper-w2995176968","cat":"papers","name":"Adverse pharmacokinetic interactions between illicit substances and clinical drugs","year":"2019","cit":33,"pfa":"Kodye L. Abbott","psa":"Satyanarayana R. Pondugula","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2995176968","eid":"W2995176968"},{"id":"paper-w3110821178","cat":"papers","name":"Neurochemical and Behavioral Effects of a New Hallucinogenic Compound 25B-NBOMe in Rats","year":"2020","cit":33,"pfa":"Adam Wojtas","psa":"Krystyna Gołembiowska","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3110821178","eid":"W3110821178"},{"id":"paper-w2164665509","cat":"papers","name":"Psychiatric emergencies (part II): psychiatric disorders coexisting with organic diseases.","year":"2013","cit":33,"pfa":"Antonia Carla Testa","psa":"S Dain","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2164665509","eid":"W2164665509"},{"id":"paper-w2166000740","cat":"papers","name":"Neurotoxicity of d‐Amphetamine in the C57BL/6J and CD‐1 Mouse","year":"1996","cit":33,"pfa":"Diane Bemis Miller","psa":"James Patrick O'Callaghan","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2166000740","eid":"W2166000740"},{"id":"paper-w3212139410","cat":"papers","name":"Case Report: Unexpected Remission From Extreme and Enduring Bulimia Nervosa With Repeated Ketamine Assisted Psychotherapy","year":"2021","cit":33,"pfa":"Anya Ragnhildstveit","psa":"Patricia Henrie-Barrus","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3212139410","eid":"W3212139410"},{"id":"paper-w4220840388","cat":"papers","name":"Psychedelic Cognition—The Unreached Frontier of Psychedelic Science","year":"2022","cit":33,"pfa":"Maria Bălăeţ","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4220840388","eid":"W4220840388"},{"id":"paper-w2321243155","cat":"papers","name":"Exacerbation of Hallucinogen-Persisting Perception Disorder With Risperidone","year":"1997","cit":33,"pfa":"Daniel B. Morehead","ptype":"article","src":"https://openalex.org/W2321243155","eid":"W2321243155"},{"id":"paper-w3184845084","cat":"papers","name":"Psychedelics for Brain Injury: A Mini-Review","year":"2021","cit":33,"pfa":"Mia Khan","psa":"Julie A. Holland","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W3184845084","eid":"W3184845084"},{"id":"paper-w2052304994","cat":"papers","name":"The Psychedelic State, The Hypnotic Trance, And the Creative Act","year":"1968","cit":33,"pfa":"Stanley Krippner","ptype":"article","src":"https://openalex.org/W2052304994","eid":"W2052304994"},{"id":"paper-w4391678591","cat":"papers","name":"Exploring mechanisms of psychedelic action using neuroimaging","year":"2024","cit":33,"pfa":"David Erritzøe","psa":"Matthew B. Wall","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4391678591","eid":"W4391678591"},{"id":"paper-w4386924091","cat":"papers","name":"Beyond the psychedelic hype: Exploring the persistence of the neoliberal paradigm","year":"2023","cit":33,"pfa":"James Davies","psa":"Neşe Devenot","topics":["Depression","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4386924091","eid":"W4386924091"},{"id":"paper-w2250013156","cat":"papers","name":"The effects of psychedelic (LSD) therapy on values, personality, and behavior.","year":"1966","cit":33,"pfa":"Charles Savage","psa":"M H Allen","ptype":"article","src":"https://openalex.org/W2250013156","eid":"W2250013156"},{"id":"paper-w2504773786","cat":"papers","name":"A Public-Health-Based Vision for the Management and Regulation of Psychedelics","year":"2016","cit":33,"pfa":"Mark Haden","psa":"Kenneth W. Tupper","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2504773786","eid":"W2504773786"},{"id":"paper-w1112595011","cat":"papers","name":"To Apply Microdosing or Not? Recommendations to Single Out Compounds with Non-Linear Pharmacokinetics","year":"2015","cit":33,"pfa":"Sieto Bosgra","psa":"Wouter H. J. Vaes","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1112595011","eid":"W1112595011"},{"id":"paper-w3110303525","cat":"papers","name":"Entity encounters and the therapeutic effect of the psychedelic mystical experience","year":"2021","cit":33,"pfa":"Anna Lutkajtis","ptype":"article","src":"https://openalex.org/W3110303525","eid":"W3110303525"},{"id":"paper-w3167342352","cat":"papers","name":"How do serotonergic psychedelics treat depression: The potential role of neuroplasticity","year":"2021","cit":33,"pfa":"Hewa Artin","psa":"Dhakshin Ramanathan","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3167342352","eid":"W3167342352"},{"id":"paper-w4286817173","cat":"papers","name":"Are you tripping comfortably? Investigating the relationship between harm reduction and the psychedelic experience","year":"2022","cit":33,"pfa":"Madelene Palmer","psa":"Olivia Maynard","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4286817173","eid":"W4286817173"},{"id":"paper-w2038046505","cat":"papers","name":"Pediatric Microdose Study of [14C]Paracetamol to Study Drug Metabolism Using Accelerated Mass Spectrometry: Proof of Concept","year":"2014","cit":33,"pfa":"Miriam G. Mooij","psa":"Saskia N. de Wildt","topics":["Safety & adverse events","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2038046505","eid":"W2038046505"},{"id":"paper-w2615543798","cat":"papers","name":"Development and Design of Next-Generation Head-Mounted Ambulatory Microdose Positron-Emission Tomography (AM-PET) System","year":"2017","cit":33,"pfa":"Samantha Elizabeth Melroy","psa":"Thorsten Wuest","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2615543798","eid":"W2615543798"},{"id":"paper-w4410087846","cat":"papers","name":"Navigating groundlessness: An interview study on dealing with ontological shock and existential distress following psychedelic experiences","year":"2025","cit":33,"pfa":"Eirini K. Argyri","psa":"Oliver C. Robinson","topics":["Addiction","Anxiety & end-of-life","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4410087846","eid":"W4410087846"},{"id":"paper-w3211698153","cat":"papers","name":"Psychedelic use is associated with reduced daily opioid use among people who use illicit drugs in a Canadian setting","year":"2021","cit":33,"pfa":"Elena Argento","psa":"Kora DeBeck","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W3211698153","eid":"W3211698153"},{"id":"paper-w2084318079","cat":"papers","name":"GABA Deficits Enhance the Psychotomimetic Effects of Δ9-THC","year":"2015","cit":33,"pfa":"Rajiv Radhakrishnan","psa":"Deepak Cyril D’Souza","ptype":"article","src":"https://openalex.org/W2084318079","eid":"W2084318079"},{"id":"paper-w2163075568","cat":"papers","name":"Structure-activity correlations for psychotomimetics. 1. Phenylalkylamines: electronic, volume, and hydrophobicity parameters","year":"1990","cit":33,"pfa":"B.W. Clare","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2163075568","eid":"W2163075568"},{"id":"paper-w2087221664","cat":"papers","name":"Autoradiographic localization of binding sites for 125I-DOI, a new psychotomimetic radioligand, in the rat brain","year":"1987","cit":33,"pfa":"Dennis J. McKenna","psa":"Juan M. Saavedra","ptype":"article","src":"https://openalex.org/W2087221664","eid":"W2087221664"},{"id":"paper-w2039976129","cat":"papers","name":"Effects of various psychotomimetic agents on the eeg and acetylcholine release from the cerebral cortex of brainstem transected cats","year":"1972","cit":33,"pfa":"E F Domino","psa":"Alessandro Bartolini","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2039976129","eid":"W2039976129"},{"id":"paper-w2095312520","cat":"papers","name":"Diazepam Use by Patients in a Methadone Program – How Serious A Problem?","year":"1975","cit":33,"pfa":"GEORGE E. WOODY","psa":"Elton Hargrove","ptype":"article","src":"https://openalex.org/W2095312520","eid":"W2095312520"},{"id":"paper-w2140204416","cat":"papers","name":"Biochemical Processes in Schizophrenia: An Update","year":"1980","cit":33,"pfa":"Malcolm B. Bowers","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2140204416","eid":"W2140204416"},{"id":"paper-w2019185453","cat":"papers","name":"Evaluation and Treatment of Low Responders","year":"1996","cit":33,"pfa":"Richard Thomas Scott","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2019185453","eid":"W2019185453"},{"id":"paper-w3022689638","cat":"papers","name":"First-in-Human Trial of Epichaperome-Targeted PET in Patients with Cancer","year":"2020","cit":33,"pfa":"Mark P. Dunphy","psa":"Steven M. Larson","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3022689638","eid":"W3022689638"},{"id":"paper-w2324238693","cat":"papers","name":"Sedative Use Disorders in Opiate-Dependent Patients: Association with Psychiatric and Other Substance Use Disorders","year":"1997","cit":33,"pfa":"Mary Ann Chutuape","psa":"Maxine L. Stitzer","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2324238693","eid":"W2324238693"},{"id":"paper-w2120018727","cat":"papers","name":"Drug Abuse Patterns of Patients on Methadone Treatment in New York City","year":"1981","cit":33,"pfa":"Balkrishena Kaul","psa":"Bernard Davidow","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2120018727","eid":"W2120018727"},{"id":"paper-w2135106431","cat":"papers","name":"Ganirelix acetate causes a rapid reduction in estradiol levels without adversely affecting oocyte maturation in women pretreated with leuprolide acetate who are at risk of ovarian hyperstimulation syndrome*","year":"2006","cit":33,"pfa":"Robert L. Gustofson","psa":"Frederick W. Larsen","topics":["Safety & adverse events","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2135106431","eid":"W2135106431"},{"id":"paper-w4285065286","cat":"papers","name":"Slower Learning Rates from Negative Outcomes in Substance Use Disorder over a 1-Year Period and Their Potential Predictive Utility","year":"2022","cit":33,"pfa":"Ryan S. Smith","psa":"Martin P. Paulus","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4285065286","eid":"W4285065286"},{"id":"paper-w3122775756","cat":"papers","name":"Within-treatment changes in a novel addiction treatment program using traditional Amazonian medicine","year":"2021","cit":33,"pfa":"David M. O’Shaughnessy","psa":"Frances H. Quirk","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3122775756","eid":"W3122775756"},{"id":"paper-w2101617981","cat":"papers","name":"Do patients think cannabis causes schizophrenia? - A qualitative study on the causal beliefs of cannabis using patients with schizophrenia","year":"2010","cit":33,"pfa":"Anna Buadze","psa":"Michael Liebrenz","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2101617981","eid":"W2101617981"},{"id":"paper-w582649280","cat":"papers","name":"Neurochemistry and neuropharmacology of schizophrenia","year":"1987","cit":33,"pfa":"Fritz A. Henn","psa":"Lynn E. DeLisi","topics":["Dosing & pharmacology"],"ptype":"book","src":"https://openalex.org/W582649280","eid":"W582649280"},{"id":"paper-w2019305104","cat":"papers","name":"Comparative effects of LSD and lisuride: Clues to specific hallucinogenic drug actions","year":"1986","cit":33,"pfa":"Francis J. White","ptype":"article","src":"https://openalex.org/W2019305104","eid":"W2019305104"},{"id":"paper-w2091812013","cat":"papers","name":"A putative sigma1 receptor antagonist NE‐100 attenuates the discriminative stimulus effects of ketamine in rats","year":"2001","cit":33,"pfa":"Minoru Narita","psa":"Tsutomu Suzuki","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2091812013","eid":"W2091812013"},{"id":"paper-w2080002889","cat":"papers","name":"The effect of dopamine receptor blockade in the rodent nucleus accumbens on local field potential oscillations and motor activity in response to ketamine","year":"2010","cit":33,"pfa":"Paweł Matulewicz","psa":"Mark Jeremy Hunt","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2080002889","eid":"W2080002889"},{"id":"paper-w2005584210","cat":"papers","name":"The link between cannabis use and psychosis: furthering the debate","year":"2002","cit":33,"pfa":"Louisa J Degenhardt","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2005584210","eid":"W2005584210"},{"id":"paper-w4308988720","cat":"papers","name":"Cannabis sativa and Cannabidiol: A Therapeutic Strategy for the Treatment of Neurodegenerative Diseases?","year":"2022","cit":33,"pfa":"Milena de Barros Viana","psa":"Glauce Socorro de Barros Viana","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4308988720","eid":"W4308988720"},{"id":"paper-w2076254491","cat":"papers","name":"Activation of metabotropic glutamate (mGlu)2 receptors suppresses histamine release in limbic brain regions following acute ketamine challenge","year":"2009","cit":33,"pfa":"Matthew J. Fell","psa":"Kjell A. Svensson","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2076254491","eid":"W2076254491"},{"id":"paper-w2517785355","cat":"papers","name":"Behavioral and biochemical effects of ketamine and dextromethorphan relative to its antidepressant-like effects in Swiss Webster mice","year":"2016","cit":33,"pfa":"Linda Nguyen","psa":"Rae R. Matsumoto","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2517785355","eid":"W2517785355"},{"id":"paper-w1980942712","cat":"papers","name":"Remembering the lost neuroscience of pharmaco‐EEG","year":"2010","cit":33,"pfa":"Max Fink","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W1980942712","eid":"W1980942712"},{"id":"paper-w4400182307","cat":"papers","name":"Safety and tolerability of esketamine nasal spray versus quetiapine extended release in patients with treatment resistant depression","year":"2024","cit":33,"pfa":"Roger S. McIntyre","psa":"Andreas Reif","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4400182307","eid":"W4400182307"},{"id":"paper-w4394858592","cat":"papers","name":"Number needed to treat (NNT) for ketamine and esketamine in adults with treatment-resistant depression: A systematic review and meta-analysis","year":"2024","cit":33,"pfa":"Cameron N. Calder","psa":"Roger S. McIntyre","topics":["Depression","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4394858592","eid":"W4394858592"},{"id":"paper-w4386237971","cat":"papers","name":"Effect of Dexmedetomidine and Two Different Doses of Esketamine Combined Infusion on the Quality of Recovery in Patients Undergoing Modified Radical Mastectomy for Breast Cancer - A Randomised Controlled Study","year":"2023","cit":33,"pfa":"Zheng Huang","psa":"Shengbin Wang","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4386237971","eid":"W4386237971"},{"id":"paper-w4297492442","cat":"papers","name":"Effect of different doses of esketamine compared with fentanyl combined with propofol on hypotension in patients undergoing painless abortion surgery: a prospective, randomized, double-blind controlled clinical trial","year":"2022","cit":33,"pfa":"Jiejuan Chen","psa":"Minhuan Shen","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4297492442","eid":"W4297492442"},{"id":"paper-w3121350448","cat":"papers","name":"Ketamine-induced urological toxicity: potential mechanisms and translation for adults with mood disorders receiving ketamine treatment","year":"2021","cit":33,"pfa":"Jason Ng","psa":"Roger S. McIntyre","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3121350448","eid":"W3121350448"},{"id":"paper-w3086897971","cat":"papers","name":"Repurposing of Drugs–The Ketamine Story","year":"2020","cit":33,"pfa":"Joydip Das","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3086897971","eid":"W3086897971"},{"id":"paper-w4225272971","cat":"papers","name":"Comparative metabolomic analysis in plasma and cerebrospinal fluid of humans and in plasma and brain of mice following antidepressant-dose ketamine administration","year":"2022","cit":33,"pfa":"Ruin Moaddel","psa":"Carlos A. Zarate","topics":["Depression","PTSD & trauma","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4225272971","eid":"W4225272971"},{"id":"paper-w2082824088","cat":"papers","name":"Interactions of [3H]LSD with serotonin receptors in human brain","year":"1982","cit":33,"pfa":"Alan J. Cross","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2082824088","eid":"W2082824088"},{"id":"paper-w1971378818","cat":"papers","name":"Metabolism of Lysergic Acid Diethylamide","year":"1956","cit":32,"pfa":"Julius Axelrod","psa":"Edward V. Evarts","ptype":"article","src":"https://openalex.org/W1971378818","eid":"W1971378818"},{"id":"paper-w1986376052","cat":"papers","name":"Inhibition of noradrenaline release by lysergic acid diethylamide","year":"1973","cit":32,"pfa":"Joel W. Hughes","ptype":"article","src":"https://openalex.org/W1986376052","eid":"W1986376052"},{"id":"paper-w2050124337","cat":"papers","name":"Regional Localization of Lysergic Acid Diethylamide in Monkey Brain","year":"1966","cit":32,"pfa":"Solomon H. Snyder","psa":"Martin Reivich","ptype":"article","src":"https://openalex.org/W2050124337","eid":"W2050124337"},{"id":"paper-w2056625619","cat":"papers","name":"Noribogaine Generalization to the Ibogaine Stimulus Correlation with Noribogaine Concentration in Rat Brain","year":"1999","cit":32,"pfa":"Carlos Zúbaran","ptype":"article","src":"https://openalex.org/W2056625619","eid":"W2056625619"},{"id":"paper-w1979618059","cat":"papers","name":"Influence of Lysergic Acid Diethylamide (LSD-25) on Subjective Time","year":"1959","cit":32,"pfa":"H. Aronson","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1979618059","eid":"W1979618059"},{"id":"paper-w2007804367","cat":"papers","name":"Effects of Cannabis sativa and lysergic acid diethylamide on a visual discrimination task in pigeons","year":"1969","cit":32,"pfa":"Ronald K. Siegel","ptype":"article","src":"https://openalex.org/W2007804367","eid":"W2007804367"},{"id":"paper-w2334311979","cat":"papers","name":"Iboga Alkaloids. II.1 the Structures of Ibogaine, Ibogamine and Tabernanthine","year":"1957","cit":32,"pfa":"W. I. Taylor","ptype":"article","src":"https://openalex.org/W2334311979","eid":"W2334311979"},{"id":"paper-w2093239717","cat":"papers","name":"Lysergic Acid Diethylamide: Dissociation of Its Behavioral and Hyperthermic Actions by DL-α-Methyl-p-Tyrosine","year":"1969","cit":32,"pfa":"A. Horita","psa":"A. E. Hamilton","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2093239717","eid":"W2093239717"},{"id":"paper-w1988933381","cat":"papers","name":"THE EFFECTS OF LYSERGIC ACID DIETHYLAMIDE ON THE RESPONSE TO FIELD STIMULATION OF THE RAT VAS DEFERENS AND THE RAT AND CAT ANOCOCCYGEUS MUSCLES","year":"1975","cit":32,"pfa":"J.S. GILLESPIE","psa":"John Christie McGrath","ptype":"article","src":"https://openalex.org/W1988933381","eid":"W1988933381"},{"id":"paper-w4386069067","cat":"papers","name":"Co-use of MDMA with psilocybin/LSD may buffer against challenging experiences and enhance positive experiences","year":"2023","cit":32,"pfa":"Richard J. Zeifman","psa":"Robin Lester Carhart-Harris","topics":["Safety & adverse events","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4386069067","eid":"W4386069067"},{"id":"paper-w2003145446","cat":"papers","name":"A pharmacological analysis of processes underlying differential responding: a review and further experiments with scopolamine, amphetamine, lysergic acid diethylamide (LSD-25), chlordiazepoxide, physostigmine, and chlorp","year":"1976","cit":32,"pfa":"Marina Frontali","psa":"Giorgio Bignami","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2003145446","eid":"W2003145446"},{"id":"paper-w2029846690","cat":"papers","name":"The Absolute Stereochemistry of Salvinorins","year":"1990","cit":32,"pfa":"Masato Koreeda","psa":"Leander J. Valdés","ptype":"article","src":"https://openalex.org/W2029846690","eid":"W2029846690"},{"id":"paper-w2067405887","cat":"papers","name":"Determination of psilocin and psilocybin using flow injection analysis with acidic potassium permanganate and tris(2,2′-bipyridyl)ruthenium(II) chemiluminescence detection respectively","year":"2005","cit":32,"pfa":"Nicole Anastos","psa":"D SIMS","ptype":"article","src":"https://openalex.org/W2067405887","eid":"W2067405887"},{"id":"paper-w2111527292","cat":"papers","name":"Determination of salvinorin A and salvinorin B in Salvia divinorum-related products circulated in Japan","year":"2008","cit":32,"pfa":"Kenji Tsujikawa","psa":"Hiroyuki Inoue","ptype":"article","src":"https://openalex.org/W2111527292","eid":"W2111527292"},{"id":"paper-w2025275907","cat":"papers","name":"MDMA and Parkinsonism","year":"2003","cit":32,"pfa":"Sandra M. Kuniyoshi","psa":"Joseph J. Jankovic","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2025275907","eid":"W2025275907"},{"id":"paper-w1637025933","cat":"papers","name":"Ibogaine Produces Neurodegeneration in Rat, but Not Mouse, Cerebellum","year":"1996","cit":32,"pfa":"Andrew C. Scallet","psa":"Syed F. Ali","ptype":"article","src":"https://openalex.org/W1637025933","eid":"W1637025933"},{"id":"paper-w4224228883","cat":"papers","name":"New Insights into the Chemical Composition of Ayahuasca","year":"2022","cit":32,"pfa":"Luisina Castelli Rodríguez","psa":"Ignacio Carrera","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4224228883","eid":"W4224228883"},{"id":"paper-w2047110356","cat":"papers","name":"Toxic Psychosis After Intake of the Hallucinogen Salvinorin A","year":"2008","cit":32,"pfa":"Michael Paulzen","psa":"Gerhard Gründer","ptype":"article","src":"https://openalex.org/W2047110356","eid":"W2047110356"},{"id":"paper-w2013209814","cat":"papers","name":"MDMA: Historical Perspectives","year":"1990","cit":32,"pfa":"James W. Gibb","psa":"Glen R. Hanson","ptype":"article","src":"https://openalex.org/W2013209814","eid":"W2013209814"},{"id":"paper-w3166811306","cat":"papers","name":"Evaluating the toxicity and therapeutic potential of ibogaine in the treatment of chronic opioid abuse","year":"2021","cit":32,"pfa":"Matthias Luz","psa":"Deborah C. Mash","topics":["Addiction","Safety & adverse events"],"ptype":"editorial","src":"https://openalex.org/W3166811306","eid":"W3166811306"},{"id":"paper-w2299277295","cat":"papers","name":"Naltrexone but Not Ketanserin Antagonizes the Subjective, Cardiovascular, and Neuroendocrine Effects of Salvinorin-A in Humans","year":"2016","cit":32,"pfa":"Ana Elda Maqueda","psa":"Jordi Riba","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2299277295","eid":"W2299277295"},{"id":"paper-w2577966462","cat":"papers","name":"Salvinorin A Inhibits Airway Hyperreactivity Induced by Ovalbumin Sensitization","year":"2017","cit":32,"pfa":"Antonietta Rossi","psa":"Fiorentina Roviezzo","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2577966462","eid":"W2577966462"},{"id":"paper-w2122967709","cat":"papers","name":"Metabolic Changes in the Rodent Brain after Acute Administration of Salvinorin A","year":"2009","cit":32,"pfa":"Jacob M. Hooker","psa":"Wynne K. Schiffer","ptype":"article","src":"https://openalex.org/W2122967709","eid":"W2122967709"},{"id":"paper-w2744014135","cat":"papers","name":"Chapter 14 A contemporary history of ibogaine in the United States and Europe","year":"2001","cit":32,"pfa":"Kenneth Alper","psa":"Charles D. Kaplan","ptype":"book-chapter","src":"https://openalex.org/W2744014135","eid":"W2744014135"},{"id":"paper-w2332993900","cat":"papers","name":"t-Amine Oxide Rearrangements. N,N-Dimethyltryptamine Oxide","year":"1956","cit":32,"pfa":"M. S. Fish","psa":"Evan C. Horning","ptype":"article","src":"https://openalex.org/W2332993900","eid":"W2332993900"},{"id":"paper-w2028933987","cat":"papers","name":"Application of Mass Spectrometry to Structure Problems. V.1 Iboga Alkaloids2","year":"1961","cit":32,"pfa":"KLAUS BIEMANN","psa":"Margot Friedmann-Spiteller","ptype":"article","src":"https://openalex.org/W2028933987","eid":"W2028933987"},{"id":"paper-w2154673008","cat":"papers","name":"Convenient synthesis and in vitro pharmacological activity of 2-thioanalogs of salvinorins A and B","year":"2007","cit":32,"pfa":"R. V. Bikbulatov","psa":"Jordan Kordian Zjawiony","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2154673008","eid":"W2154673008"},{"id":"paper-w4221031753","cat":"papers","name":"Psilocybin-Assisted Compassion Focused Therapy for Depression","year":"2022","cit":32,"pfa":"Wendy T. M. Pots","psa":"Farid Chakhssi","topics":["Depression","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4221031753","eid":"W4221031753"},{"id":"paper-w4210325795","cat":"papers","name":"Psilocybin use is associated with lowered odds of crime arrests in US adults: A replication and extension","year":"2022","cit":32,"pfa":"Grant M. Jones","psa":"Matthew K. Nock","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4210325795","eid":"W4210325795"},{"id":"paper-w2051159235","cat":"papers","name":"Comparison of the behavioral effects of ibogaine from three sources: mediation of discriminative activity","year":"1993","cit":32,"pfa":"Martin Schechter","psa":"Timothy L. Gordon","ptype":"article","src":"https://openalex.org/W2051159235","eid":"W2051159235"},{"id":"paper-w2999478951","cat":"papers","name":"An Improved, Practical, and Scalable Five-Step Synthesis of Psilocybin","year":"2020","cit":32,"pfa":"Robert B. Kargbo","psa":"Gary Tarpley","ptype":"article","src":"https://openalex.org/W2999478951","eid":"W2999478951"},{"id":"paper-w2018967563","cat":"papers","name":"Cardiovascular autonomic dysregulation in users of MDMA (\"Ecstasy\")","year":"1998","cit":32,"pfa":"Stuart Brody","psa":"Harald Rau","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2018967563","eid":"W2018967563"},{"id":"paper-w77478258","cat":"papers","name":"A Phenomenological Examination of Psilocybin and its Positive and Persisting Aftereffects","year":"2016","cit":32,"pfa":"Joseph A. Zamaria","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W77478258","eid":"W77478258"},{"id":"paper-w2011293350","cat":"papers","name":"Jesus, Peyote, and the Holy People: Alcohol Abuse and the Ethos of Power in Navajo Healing","year":"2000","cit":32,"pfa":"John Garrity","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2011293350","eid":"W2011293350"},{"id":"paper-w2463498266","cat":"papers","name":"Spirituality, drugs, and tourism: tourists’ and shamans’ experiences of ayahuasca in Iquitos, Peru","year":"2016","cit":32,"pfa":"Girish Prayag","psa":"Julien Fontaine","ptype":"article","src":"https://openalex.org/W2463498266","eid":"W2463498266"},{"id":"paper-w4212880199","cat":"papers","name":"Ayahuasca and tobacco smoking cessation: results from an online survey in Brazil","year":"2022","cit":32,"pfa":"Dimitri Daldegan‐Bueno","psa":"Luís Fernando Tófoli","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4212880199","eid":"W4212880199"},{"id":"paper-w2020433931","cat":"papers","name":"Identification and quantification of the indole alkaloid ibogaine in biological samples by gas chromatography-mass spectrometry","year":"1995","cit":32,"pfa":"Carol A. Gallagher","psa":"Stanley D. Click","ptype":"article","src":"https://openalex.org/W2020433931","eid":"W2020433931"},{"id":"paper-w2885529564","cat":"papers","name":"Exposure to ayahuasca induces developmental and behavioral alterations on early life stages of zebrafish","year":"2018","cit":32,"pfa":"Thayres S. Andrade","psa":"Aline Pic‐Taylor","ptype":"article","src":"https://openalex.org/W2885529564","eid":"W2885529564"},{"id":"paper-w1979552996","cat":"papers","name":"New Age Seekers: MDMA Use as an Adjunct to Spiritual Pursuit","year":"1991","cit":32,"pfa":"Lynne Watson","psa":"Jerome Beck","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1979552996","eid":"W1979552996"},{"id":"paper-w2130553142","cat":"papers","name":"Effects of repeated treatment with MDMA on working memory and behavioural flexibility in mice","year":"2012","cit":32,"pfa":"Xavier Viñals","psa":"Patricia Robledo","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2130553142","eid":"W2130553142"},{"id":"paper-w2042460861","cat":"papers","name":"Acute effects of methylenedioxymethamphetamine (MDMA) on several complex brain functions in monkeys","year":"1995","cit":32,"pfa":"David Frederick","psa":"Merle G. Paule","ptype":"article","src":"https://openalex.org/W2042460861","eid":"W2042460861"},{"id":"paper-w2166086733","cat":"papers","name":"Nonlinear Pharmacokinetics of (±)3,4-Methylenedioxymethamphetamine (MDMA) and Its Pharmacodynamic Consequences in the Rat","year":"2013","cit":32,"pfa":"Marta Concheiro","psa":"Marilyn Ann Huestis","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2166086733","eid":"W2166086733"},{"id":"paper-w4390484931","cat":"papers","name":"Misinterpretations and Omissions: A Critical Response to Goodwin and Colleagues’ Commentary on Psilocybin-Assisted Therapy","year":"2024","cit":32,"pfa":"Kelley C. O’Donnell","psa":"Natalie Gukasyan","ptype":"article","src":"https://openalex.org/W4390484931","eid":"W4390484931"},{"id":"paper-w4391036082","cat":"papers","name":"CCH attack frequency reduction after psilocybin correlates with hypothalamic functional connectivity","year":"2024","cit":32,"pfa":"Martin Korsbak Madsen","psa":"Gitte M. Knudsen","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4391036082","eid":"W4391036082"},{"id":"paper-w4392203910","cat":"papers","name":"Predicting the outcome of psilocybin treatment for depression from baseline fMRI functional connectivity","year":"2024","cit":32,"pfa":"Débora Copa","psa":"Enzo Tagliazucchi","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4392203910","eid":"W4392203910"},{"id":"paper-w81714382","cat":"papers","name":"MDMA(\"Ecstasy\")-Konsum - ein Überblick zu psychiatrischen und medizinischen Folgen","year":"1997","cit":32,"pfa":"Rainer Thomasius","psa":"D. Kraus","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W81714382","eid":"W81714382"},{"id":"paper-w2156495536","cat":"papers","name":"Analyzing Salvia Divinorum and its Active Ingredient Salvinorin A Utilizing Thin Layer Chromatography and Gas Chromatography/Mass Spectrometry","year":"2009","cit":32,"pfa":"John D. Jermain","psa":"Hiram K. Evans","ptype":"article","src":"https://openalex.org/W2156495536","eid":"W2156495536"},{"id":"paper-w1995820073","cat":"papers","name":"PCR and PCR–RFLP of the 5S-rRNA-NTS region and salvinorin A analyses for the rapid and unequivocal determination of Salvia divinorum","year":"2006","cit":32,"pfa":"Cinzia  Margherita Bertea","psa":"Massimo Emilio Maffei","ptype":"article","src":"https://openalex.org/W1995820073","eid":"W1995820073"},{"id":"paper-w2016371015","cat":"papers","name":"Intravenous methamphetamine self-administration in rats: Effects of intravenous or intraperitoneal MDMA co-administration","year":"2006","cit":32,"pfa":"Kelly J. Clemens","psa":"Iain S. McGregor","ptype":"article","src":"https://openalex.org/W2016371015","eid":"W2016371015"},{"id":"paper-w2023331513","cat":"papers","name":"Psilocin analogs. 1. Synthesis of 3‐[2‐(dialkylamino)ethyl] ‐and 3‐[2‐(cycloalkylamino)ethyl] indol‐4‐ols","year":"1977","cit":32,"pfa":"David B. Repke","psa":"Dallas K. Bates","ptype":"article","src":"https://openalex.org/W2023331513","eid":"W2023331513"},{"id":"paper-w2140634520","cat":"papers","name":"MDMA-induced impairment in primates: antagonism by a selective norepinephrine or serotonin, but not by a dopamine/norepinephrine transport inhibitor","year":"2008","cit":32,"pfa":"Christopher D. Verrico","psa":"Bertha Kalifon Madras","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2140634520","eid":"W2140634520"},{"id":"paper-w4286285108","cat":"papers","name":"‘Everybody’s creating it along the way’: ethical tensions among globalized ayahuasca shamanisms and therapeutic integration practices","year":"2022","cit":32,"pfa":"Olivia Marcus","topics":["Safety & adverse events","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4286285108","eid":"W4286285108"},{"id":"paper-w4392550813","cat":"papers","name":"Unique Psychological Mechanisms Underlying Psilocybin Therapy Versus Escitalopram Treatment in the Treatment of Major Depressive Disorder","year":"2024","cit":32,"pfa":"Brandon Weiss","psa":"David Erritzøe","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4392550813","eid":"W4392550813"},{"id":"paper-w1974863336","cat":"papers","name":"Intermittent ethanol exposure increases long-lasting behavioral and neurochemical effects of MDMA in adolescent mice","year":"2011","cit":32,"pfa":"Marta Rodríguez‐Arias","psa":"José Miñarro","ptype":"article","src":"https://openalex.org/W1974863336","eid":"W1974863336"},{"id":"paper-w1031275343","cat":"papers","name":"EVALUATION OF THEORY OF PLANNED BEHAVIOR-BASED EDUCATION IN PREVENTION OF MDMA (ECSTASY) USE AMONG UNIVERSITY STUDENTS","year":"2011","cit":32,"pfa":"Barati Majid","psa":"Hossein Mahjub","ptype":"article","src":"https://openalex.org/W1031275343","eid":"W1031275343"},{"id":"paper-w3001345844","cat":"papers","name":"Computational design of synthetic receptors for drug detection: interaction between molecularly imprinted polymers and MDMA (3,4-methylenedioxymethamphetamine)","year":"2020","cit":32,"pfa":"Thaís Aparecida Sales","psa":"Teodorico C. Ramalho","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3001345844","eid":"W3001345844"},{"id":"paper-w1985227285","cat":"papers","name":"Determining the pharmacokinetics of psilocin in rat plasma using ultra-performance liquid chromatography coupled with a photodiode array detector after orally administering an extract of Gymnopilus spectabilis","year":"2011","cit":32,"pfa":"Jianbo Chen","psa":"Jong Seong Kang","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1985227285","eid":"W1985227285"},{"id":"paper-w309445281","cat":"papers","name":"Use of Dynamically Coated Capillaries for the Routine Analysis of Methamphetamine, Amphetamine, MDA, MDMA, MDEA, and Cocaine using Capillary Electrophoresis","year":"2001","cit":32,"pfa":"Ira S. Lurie","psa":"Robert Weinberger","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W309445281","eid":"W309445281"},{"id":"paper-w2074592758","cat":"papers","name":"Repeated intermittent MDMA binges reduce DAT density in mice and SERT density in rats in reward regions of the adolescent brain","year":"2007","cit":32,"pfa":"Anna M. S. Kindlundh-Högberg","psa":"Per Svenningsson","ptype":"article","src":"https://openalex.org/W2074592758","eid":"W2074592758"},{"id":"paper-w2596045336","cat":"papers","name":"3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) produces edema due to BBB disruption induced by MMP-9 activation in rat hippocampus","year":"2017","cit":32,"pfa":"Mercedes Pérez‐Hernández","psa":"María Isabel Colado","ptype":"article","src":"https://openalex.org/W2596045336","eid":"W2596045336"},{"id":"paper-w2002163005","cat":"papers","name":"Determination of synthesis route of 1-(3,4-methylenedioxyphenyl)-2-propanone (MDP-2-P) based on impurity profiles of MDMA","year":"2004","cit":32,"pfa":"M. Świst","psa":"A. Parczewski","ptype":"article","src":"https://openalex.org/W2002163005","eid":"W2002163005"},{"id":"paper-w2158425916","cat":"papers","name":"MDMA (ecstasy) effects on actual driving performance before and after sleep deprivation, as function of dose and concentration in blood and oral fluid","year":"2011","cit":32,"pfa":"Wendy M. Bosker","psa":"Johannes Gerardus Ramaekers","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2158425916","eid":"W2158425916"},{"id":"paper-w2894040486","cat":"papers","name":"GC–MS metabolomics reveals disturbed metabolic pathways in primary mouse hepatocytes exposed to subtoxic levels of 3,4-methylenedioxymethamphetamine (MDMA)","year":"2018","cit":32,"pfa":"Ana Margarida Araújo","psa":"Paula Guedes de Pinho","ptype":"article","src":"https://openalex.org/W2894040486","eid":"W2894040486"},{"id":"paper-w2084032626","cat":"papers","name":"Identification and quantitation of 3,4-methylenedioxy-N-methylamphetamine (MDMA, ecstasy) in human urine by 1H NMR spectroscopy. Application to five cases of intoxication","year":"2009","cit":32,"pfa":"Jonathan Liu","psa":"Élise Champeil","ptype":"article","src":"https://openalex.org/W2084032626","eid":"W2084032626"},{"id":"paper-w4405176234","cat":"papers","name":"Quality of reporting on psychological interventions in psychedelic treatments: a systematic review","year":"2024","cit":32,"pfa":"Carolina Seybert","psa":"Albino Jorge Oliveira-Maia","topics":["Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4405176234","eid":"W4405176234"},{"id":"paper-w2054221284","cat":"papers","name":"LSD: Autoradiographic Study on the Placental Transfer and Tissue Distribution in Mice","year":"1969","cit":32,"pfa":"Juhana E. Idänpään-Heikkilä","psa":"Joseph C. Schoolar","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2054221284","eid":"W2054221284"},{"id":"paper-w4391451768","cat":"papers","name":"Psychedelics for alzheimer's disease-related dementia: Unveiling therapeutic possibilities and pathways","year":"2024","cit":32,"pfa":"Jitendra Kumar Sinha","psa":"Abhishek Kumar Singh","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W4391451768","eid":"W4391451768"},{"id":"paper-w2132257230","cat":"papers","name":"Baeocystin in Psilocybe semilanceata","year":"1977","cit":32,"pfa":"David B. Repke","psa":"Dale Thomas Leslie","ptype":"article","src":"https://openalex.org/W2132257230","eid":"W2132257230"},{"id":"paper-w4386624716","cat":"papers","name":"Use of Psychedelics for Pain: A Scoping Review","year":"2023","cit":32,"pfa":"Akash Goel","psa":"Karim Shiraz Ladha","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4386624716","eid":"W4386624716"},{"id":"paper-w4366580975","cat":"papers","name":"The Canadian Psychedelic Survey: Characteristics, Patterns of Use, and Access in a Large Sample of People Who Use Psychedelic Drugs","year":"2023","cit":32,"pfa":"Stephanie Lake","psa":"Philippe Lucas","topics":["PTSD & trauma","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4366580975","eid":"W4366580975"},{"id":"paper-w2124965618","cat":"papers","name":"Chemistry and Pharmacology of Hallucinogens, Entactogens and Stimulants","year":"1998","cit":32,"pfa":"K.‐A. Kovar","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2124965618","eid":"W2124965618"},{"id":"paper-w4387893450","cat":"papers","name":"Ethopharmacological evaluation of antidepressant-like effect of serotonergic psychedelics in C57BL/6J male mice","year":"2023","cit":32,"pfa":"Rika Takaba","psa":"Masayuki Hiramatsu","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4387893450","eid":"W4387893450"},{"id":"paper-w2769531429","cat":"papers","name":":Psychedelic Psychiatry: LSD from Clinic to Campus","year":"2009","cit":32,"pfa":"Edward Shorter","topics":["Addiction","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2769531429","eid":"W2769531429"},{"id":"paper-w2109195750","cat":"papers","name":"Metabolism and Disposition of 3,4-Methylenedioxymethamphetamine (“Ecstasy”) in Baboons after Oral Administration: Comparison with Humans Reveals Marked Differences","year":"2011","cit":32,"pfa":"Melanie Mueller","psa":"George A. Ricaurte","ptype":"article","src":"https://openalex.org/W2109195750","eid":"W2109195750"},{"id":"paper-w2120611477","cat":"papers","name":"N-tert-butyl-alpha-phenylnitrone protects against 3,4-methylenedioxymethamphetamine-induced depletion of serotonin in rats","year":"1999","cit":32,"pfa":"S.Y. Yeh","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2120611477","eid":"W2120611477"},{"id":"paper-w1992154598","cat":"papers","name":"3,4-Methylenedioxymethamphetamine administration on postnatal day 11 in rats increases pituitary–adrenal output and reduces striatal and hippocampal serotonin without altering SERT activity","year":"2005","cit":32,"pfa":"Michael T. Williams","psa":"Charles V. Vorhees","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1992154598","eid":"W1992154598"},{"id":"paper-w2088545719","cat":"papers","name":"Comparison of the developmental effects of 5-methoxy-N,N-diisopropyltryptamine (Foxy) to (±)-3,4-methylenedioxymethamphetamine (ecstasy) in rats","year":"2009","cit":32,"pfa":"Matthew R. Skelton","psa":"Michael T. Williams","ptype":"article","src":"https://openalex.org/W2088545719","eid":"W2088545719"},{"id":"paper-w2885449523","cat":"papers","name":"Iterative l ‐Tryptophan Methylation in Psilocybe Evolved by Subdomain Duplication","year":"2018","cit":32,"pfa":"Felix Blei","psa":"Dirk Hoffmeister","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2885449523","eid":"W2885449523"},{"id":"paper-w2113620260","cat":"papers","name":"Identification and Characterization of Metallothionein-1 and -2 Gene Expression in the Context of (±)3,4-Methylenedioxymethamphetamine-Induced Toxicity to Brain Dopaminergic Neurons","year":"2004","cit":32,"pfa":"Tao Xie","psa":"George A. Ricaurte","topics":["Safety & adverse events","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2113620260","eid":"W2113620260"},{"id":"paper-w2558083079","cat":"papers","name":"Predicting the Abuse Liability of Entactogen-Class, New and Emerging Psychoactive Substances via Preclinical Models of Drug Self-administration","year":"2016","cit":32,"pfa":"Shawn M. Aarde","psa":"Michael A. Taffe","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"book-chapter","src":"https://openalex.org/W2558083079","eid":"W2558083079"},{"id":"paper-w2147928598","cat":"papers","name":"GC-MS Analysis of Acylated Derivatives of the Side-Chain Regioisomers of 4-Methoxy-3-Methyl-Phenethylamines Related to Methylenedioxymethamphetamine","year":"2007","cit":32,"pfa":"T. Awad","psa":"Jack DeRuiter","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2147928598","eid":"W2147928598"},{"id":"paper-w382761338","cat":"papers","name":"Inner Paths to Outer Space: Journeys to Alien Worlds through Psychedelics and Other Spiritual Technologies","year":"2008","cit":32,"pfa":"Rick J. Strassman","ptype":"book","src":"https://openalex.org/W382761338","eid":"W382761338"},{"id":"paper-w2318915556","cat":"papers","name":"1-[(1-Methyl-1H-imidazol-2-yl)methyl]-4-phenylpiperidines as mGluR2 Positive Allosteric Modulators for the Treatment of Psychosis","year":"2011","cit":32,"pfa":"Lei Zhang","psa":"Andy Q. Zhang","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2318915556","eid":"W2318915556"},{"id":"paper-w2107779923","cat":"papers","name":"Fluorine in psychedelic phenethylamines","year":"2012","cit":32,"pfa":"Daniel Trachsel","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2107779923","eid":"W2107779923"},{"id":"paper-w4319063611","cat":"papers","name":"LSD-induced increase of Ising temperature and algorithmic complexity of brain dynamics","year":"2023","cit":32,"pfa":"Giulio Ruffini","psa":"Gustavo Deco","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4319063611","eid":"W4319063611"},{"id":"paper-w3201103091","cat":"papers","name":"New Frontiers or a Bursting Bubble? Psychedelic Therapy Beyond the Dichotomy","year":"2021","cit":32,"pfa":"Tehseen N. Noorani","psa":"Jonny Martell","topics":["Depression","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3201103091","eid":"W3201103091"},{"id":"paper-w2041054520","cat":"papers","name":"The pathogenesis of the nervous syndrome of Phalaris aquatica toxicity in sheep","year":"1990","cit":32,"pfa":"CA BOURKE","psa":"RJ DIXON","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2041054520","eid":"W2041054520"},{"id":"paper-w4386863861","cat":"papers","name":"Expert Opinion on Psychedelic-Assisted Psychotherapy for People with Psychopathological Psychotic Experiences and Psychotic Disorders","year":"2023","cit":32,"pfa":"Joseph T. La Torre","psa":"Monnica T. Williams","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4386863861","eid":"W4386863861"},{"id":"paper-w2014428470","cat":"papers","name":"High sensitivity simultaneous determination in hair of the major constituents of ecstasy (3,4-methylenedioxymethamphetamine, 3,4-methylenedioxyamphetamine and 3,4-methylenedioxyethylamphetamine) by high-performance liqui","year":"1999","cit":32,"pfa":"Franco Tagliaro","psa":"M. Marigo","ptype":"article","src":"https://openalex.org/W2014428470","eid":"W2014428470"},{"id":"paper-w2131711520","cat":"papers","name":"Mad Thoughts on Mushrooms: Discourse and Power in the Study of Psychedelic Consciousness","year":"2007","cit":32,"pfa":"Andy Letcher","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2131711520","eid":"W2131711520"},{"id":"paper-w3178121559","cat":"papers","name":"A Complex Impact of Systemically Administered 5-HT2A Receptor Ligands on Conditioned Fear","year":"2021","cit":32,"pfa":"Sven Melker Hagsäter","psa":"Elias Eriksson","topics":["Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3178121559","eid":"W3178121559"},{"id":"paper-w2096302522","cat":"papers","name":"Evaluation of Commercial Enzyme-Linked Immunosorbent Assays to Identify Psychedelic Phenethylamines","year":"2011","cit":32,"pfa":"Sarah Kerrigan","psa":"Crystal Arndt","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2096302522","eid":"W2096302522"},{"id":"paper-w4313529411","cat":"papers","name":"Removal of residues of psychoactive substances during wastewater treatment, their occurrence in receiving river waters and environmental risk assessment","year":"2023","cit":32,"pfa":"Taja Verovšek","psa":"Ester Heath","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4313529411","eid":"W4313529411"},{"id":"paper-w4309244275","cat":"papers","name":"Understanding subjective experience in psychedelic-assisted psychotherapy: The need for phenomenology","year":"2022","cit":32,"pfa":"Riccardo Miceli McMillan","psa":"Anthony Vincent Fernandez","topics":["Mechanism & neuroscience","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4309244275","eid":"W4309244275"},{"id":"paper-w4220855512","cat":"papers","name":"Presence, Trust, and Empathy: Preferred Characteristics of Psychedelic Carers","year":"2022","cit":32,"pfa":"Sascha B. Thal","psa":"Stephen Jason Bright","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4220855512","eid":"W4220855512"},{"id":"paper-w2432168806","cat":"papers","name":"The clinical pharmacology of the hallucinogens","year":"1963","cit":32,"pfa":"Erik Jacobsen","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2432168806","eid":"W2432168806"},{"id":"paper-w4382682450","cat":"papers","name":"Psychedelic Prophets","year":"2018","cit":32,"ptype":"book","src":"https://openalex.org/W4382682450","eid":"W4382682450"},{"id":"paper-w2108817006","cat":"papers","name":"The persistence of the subjective in neuropsychopharmacology: observations of contemporary hallucinogen research","year":"2010","cit":32,"pfa":"Nicolas Langlitz","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2108817006","eid":"W2108817006"},{"id":"paper-w1541517801","cat":"papers","name":"Positron emission tomography for use in microdosing studies.","year":"2008","cit":32,"pfa":"Claudia Christina Wagner","psa":"Oliver Langer","topics":["Anxiety & end-of-life","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1541517801","eid":"W1541517801"},{"id":"paper-w3207365630","cat":"papers","name":"Serotonergic Psychedelics in Neural Plasticity","year":"2021","cit":32,"pfa":"Kacper Łukasiewicz","psa":"Ju Ming Lu","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3207365630","eid":"W3207365630"},{"id":"paper-w2618292488","cat":"papers","name":"The Use of Microdosing in the Development of Small Organic and Protein Therapeutics","year":"2017","cit":32,"pfa":"Mats Bergström","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2618292488","eid":"W2618292488"},{"id":"paper-w2008243350","cat":"papers","name":"Recreational use of benzydamine as a hallucinogen among street youth in Brazil","year":"2009","cit":32,"pfa":"Emérita Sátiro Opaleye","psa":"E.A. Carlini","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2008243350","eid":"W2008243350"},{"id":"paper-w581298302","cat":"papers","name":"Spaced out: radical environments of the psychedelic sixties","year":"2009","cit":32,"ptype":"book-review","src":"https://openalex.org/W581298302","eid":"W581298302"},{"id":"paper-w2493522780","cat":"papers","name":"An intravenous self-administration procedure for assessing the reinforcing effects of hallucinogens in nonhuman primates","year":"2016","cit":32,"pfa":"Amy K. Goodwin","ptype":"article","src":"https://openalex.org/W2493522780","eid":"W2493522780"},{"id":"paper-w4229333009","cat":"papers","name":"Manifest your desires: Psychedelics and the self-help industry","year":"2022","cit":32,"pfa":"Patric Plesa","psa":"Rotem Petranker","ptype":"article","src":"https://openalex.org/W4229333009","eid":"W4229333009"},{"id":"paper-w2006486543","cat":"papers","name":"Progressive rock and psychedelic coding in the work of Jimi Hendrix","year":"1990","cit":32,"pfa":"Sheila Whiteley","ptype":"article","src":"https://openalex.org/W2006486543","eid":"W2006486543"},{"id":"paper-w4401933230","cat":"papers","name":"Breathwork-induced psychedelic experiences modulate neural dynamics","year":"2024","cit":32,"pfa":"Evan Lewis-Healey","psa":"Tristán Bekinschtein","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4401933230","eid":"W4401933230"},{"id":"paper-w4309474895","cat":"papers","name":"Ethical Issues Regarding Nonsubjective Psychedelics as Standard of Care","year":"2022","cit":32,"pfa":"David B. Yaden","psa":"Roland R. Griffiths","topics":["Addiction","Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4309474895","eid":"W4309474895"},{"id":"paper-w2074901757","cat":"papers","name":"Tolerance and Cross-Tolerance to Head Twitch Behavior Elicited by Phenethylamine- and Tryptamine-Derived Hallucinogens in Mice","year":"2014","cit":32,"pfa":"Douglas Alton Smith","psa":"William E. Fantegrossi","ptype":"article","src":"https://openalex.org/W2074901757","eid":"W2074901757"},{"id":"paper-w1838400223","cat":"papers","name":"Microdose study of a P-glycoprotein substrate, fexofenadine, using a non-radioisotope-labelled drug and LC/MS/MS","year":"2010","cit":32,"pfa":"Akira Yamazaki","psa":"Mika Maeda","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1838400223","eid":"W1838400223"},{"id":"paper-w2033350616","cat":"papers","name":"Some behavioral effects of hallucinogens are mediated by a postsynaptic serotonergic action: Evidence from single unit studies in freely moving cats","year":"1984","cit":32,"pfa":"James H. Heym","psa":"Barry L. Jacobs","ptype":"article","src":"https://openalex.org/W2033350616","eid":"W2033350616"},{"id":"paper-w2327733380","cat":"papers","name":"Identification of Metabolite Biomarkers of the Designer Hallucinogen 25I-NBOMe in Mouse Hepatic Microsomal Preparations and Human Urine Samples Associated with Clinical Intoxication","year":"2015","cit":32,"pfa":"Justin L. Poklis","psa":"Alphonse Poklis","ptype":"article","src":"https://openalex.org/W2327733380","eid":"W2327733380"},{"id":"paper-w2957937196","cat":"papers","name":"Effects of the synthetic psychedelic 2,5-dimethoxy-4-iodoamphetamine (DOI) on ethanol consumption and place conditioning in male mice","year":"2019","cit":32,"pfa":"Aboagyewaah Oppong‐Damoah","psa":"Kevin Sean Murnane","ptype":"article","src":"https://openalex.org/W2957937196","eid":"W2957937196"},{"id":"paper-w2981936968","cat":"papers","name":"Sustainable Intensification of Sorghum and Pearl Millet Production by Seed Priming, Seed Treatment and Fertilizer Microdosing under Different Rainfall Regimes in Mali","year":"2019","cit":32,"pfa":"Adama Coulibaly","psa":"Jens B. Aune","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2981936968","eid":"W2981936968"},{"id":"paper-w2143918910","cat":"papers","name":"Relationships between Endogenous Plasma Biomarkers of Constitutive Cytochrome P 450 3 A Activity and Single‐Time‐Point Oral Midazolam Microdose Phenotype in Healthy Subjects","year":"2015","cit":32,"pfa":"Sarah Woolsey","psa":"Rommel G. Tirona","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2143918910","eid":"W2143918910"},{"id":"paper-w1997412196","cat":"papers","name":"ACEA 1021, a glycine site antagonist with minor psychotomimetic and amnestic effects in rats","year":"1997","cit":32,"pfa":"Beate D. Kretschmer","psa":"Michael Koch","ptype":"article","src":"https://openalex.org/W1997412196","eid":"W1997412196"},{"id":"paper-w1941333815","cat":"papers","name":"Acute and chronic LSD effects on rat startle: data supporting an LSD--rat model of schizophrenia.","year":"1980","cit":32,"pfa":"Braff Dl","psa":"M A Geyer","ptype":"article","src":"https://openalex.org/W1941333815","eid":"W1941333815"},{"id":"paper-w4212985500","cat":"papers","name":"Risk of self‐harm or suicide associated with specific drug use disorders, 2004–2016: a population‐based cohort study","year":"2022","cit":32,"pfa":"Yi Chai","psa":"Esther W. Chan","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4212985500","eid":"W4212985500"},{"id":"paper-w2116276354","cat":"papers","name":"Smoking characteristics of methadone patients.","year":"1972","cit":32,"pfa":"HERBERT W. BERGER","psa":"M Schweigler","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W2116276354","eid":"W2116276354"},{"id":"paper-w2060498682","cat":"papers","name":"Molecular and Functional Characterization of Proteins Interacting with the C-Terminal Domains of 5-HT2 Receptors: Emergence of 5-HT2 ?Receptosomes?","year":"2004","cit":32,"pfa":"Sophie Gavarini","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2060498682","eid":"W2060498682"},{"id":"paper-w2223753065","cat":"papers","name":"The Effect of Religious and Spiritual Interventions on the Biological, Psychological, and Spiritual Outcomes of Oncology Patients","year":"2004","cit":32,"pfa":"Mary E. Kaplar","psa":"William Hayes O’Brien","topics":["Anxiety & end-of-life","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2223753065","eid":"W2223753065"},{"id":"paper-w4308451495","cat":"papers","name":"A systematic review of the efficacy, effectiveness and cost-effectiveness of workplace-based interventions for the prevention and treatment of problematic substance use","year":"2022","cit":32,"pfa":"Ashleigh K Morse","psa":"Katherine L. Mills","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4308451495","eid":"W4308451495"},{"id":"paper-w1511264849","cat":"papers","name":"Live-birth rates in very poor prognosis patients, who are defined as poor responders under the Bologna criteria, with nonelective single embryo, two-embryo, and three or more embryos transferred","year":"2015","cit":32,"pfa":"Norbert Gleicher","psa":"Vitaly A. Kushnir","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1511264849","eid":"W1511264849"},{"id":"paper-w2053660179","cat":"papers","name":"Adverse Marijuana Reactions: A Critical Examination of the Literature with Selected Case Material","year":"1970","cit":32,"pfa":"Donald Bialos","topics":["Anxiety & end-of-life","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2053660179","eid":"W2053660179"},{"id":"paper-w3208078797","cat":"papers","name":"Evaluation of the abuse potential of difelikefalin, a selective kappa‐opioid receptor agonist, in recreational polydrug users","year":"2021","cit":32,"pfa":"Megan J. Shram","psa":"Frédérique Menzaghi","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3208078797","eid":"W3208078797"},{"id":"paper-w2800663121","cat":"papers","name":"Temporally dissociable effects of ketamine on neuronal discharge and gamma oscillations in rat thalamo-cortical networks","year":"2018","cit":32,"pfa":"Maria Amat-Foraster","psa":"Francesc Artigas","ptype":"article","src":"https://openalex.org/W2800663121","eid":"W2800663121"},{"id":"paper-w2397965070","cat":"papers","name":"Treatment of Alcoholism with Lysergide","year":"1967","cit":32,"pfa":"Wilson Van Dusen","psa":"Harry N. Hook","topics":["Addiction","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2397965070","eid":"W2397965070"},{"id":"paper-w2034995239","cat":"papers","name":"Has psychiatry tamed the “ketamine tiger?” Considerations on its use for depression and anxiety","year":"2015","cit":32,"pfa":"Keith G. Rasmussen","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2034995239","eid":"W2034995239"},{"id":"paper-w2011860462","cat":"papers","name":"Pharmacodynamic and pharmacokinetic interactions between ketamine and diazepam","year":"1983","cit":32,"pfa":"Jan Idvall","psa":"L Paalzow","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2011860462","eid":"W2011860462"},{"id":"paper-w1974449220","cat":"papers","name":"Introduction to Neuropsychopharmacology","year":"2009","cit":32,"pfa":"E. Szabadi","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1974449220","eid":"W1974449220"},{"id":"paper-w2760225182","cat":"papers","name":"Ketamine Self-Administration Elevates αCaMKII Autophosphorylation in Mood and Reward-Related Brain Regions in Rats","year":"2017","cit":32,"pfa":"Lucia Caffino","psa":"Fabio Fumagalli","ptype":"article","src":"https://openalex.org/W2760225182","eid":"W2760225182"},{"id":"paper-w4308365133","cat":"papers","name":"The therapeutic role of ketamine and esketamine in treating psychopathological domains of depression","year":"2022","cit":32,"pfa":"Muhammad Youshay Jawad","psa":"Roger S. McIntyre","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4308365133","eid":"W4308365133"},{"id":"paper-w3013077363","cat":"papers","name":"Brain-derived neurotrophic factor in the ventrolateral periaqueductal gray contributes to (2R,6R)-hydroxynorketamine-mediated actions","year":"2020","cit":32,"pfa":"Dylan Chou","ptype":"article","src":"https://openalex.org/W3013077363","eid":"W3013077363"},{"id":"paper-w4391444272","cat":"papers","name":"Efficacy and safety of ketamine and esketamine for unipolar and bipolar depression: an overview of systematic reviews with meta-analysis","year":"2024","cit":32,"pfa":"Alessandro Rodolico","psa":"Eugenio Aguglia","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W4391444272","eid":"W4391444272"},{"id":"paper-w4391474937","cat":"papers","name":"Efficacy and safety of perioperative application of esketamine on postpartum depression: A meta-analysis of randomized controlled studies","year":"2024","cit":32,"pfa":"Yazhou Wen","psa":"Shanwu Feng","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4391474937","eid":"W4391474937"},{"id":"paper-w4404728543","cat":"papers","name":"Effect of Low-Dose Esketamine on Postoperative Delirium in Elderly Patients Undergoing Total Hip or Knee Arthroplasty: A Randomized Controlled Trial","year":"2024","cit":32,"pfa":"Chao-Bang Ma","psa":"Zhongyu Wang","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4404728543","eid":"W4404728543"},{"id":"paper-w4283457792","cat":"papers","name":"Montgomery‐Åsberg Depression Rating Scale factors in treatment‐resistant depression at onset of treatment: Derivation, replication, and change over time during treatment with esketamine","year":"2022","cit":32,"pfa":"Stephane Borentain","psa":"Ella Daly","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4283457792","eid":"W4283457792"},{"id":"paper-w4388486331","cat":"papers","name":"Comparative efficacy, tolerability and acceptability of intravenous racemic ketamine with intranasal esketamine, aripiprazole and lithium as augmentative treatments for treatment-resistant unipolar depression: A systemat","year":"2023","cit":32,"pfa":"Itsuki Terao","psa":"Wakako Kodama","topics":["Depression","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4388486331","eid":"W4388486331"},{"id":"paper-w4353080920","cat":"papers","name":"Effects of opioid-free propofol or remimazolam balanced anesthesia on hypoxemia incidence in patients with obesity during gastrointestinal endoscopy: A prospective, randomized clinical trial","year":"2023","cit":32,"pfa":"Keyao Zhang","psa":"Fang Gao","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4353080920","eid":"W4353080920"},{"id":"paper-w2029837631","cat":"papers","name":"CE provides evidence of the stereoselective hydroxylation of norketamine in equines","year":"2009","cit":32,"pfa":"Andrea Schmitz","psa":"Wolfgang Thormann","ptype":"article","src":"https://openalex.org/W2029837631","eid":"W2029837631"},{"id":"paper-w3014110161","cat":"papers","name":"Ketamine for depression clinical issues","year":"2020","cit":32,"pfa":"Syed Iqbal","psa":"Sanjay J. Mathew","topics":["Depression"],"ptype":"book-chapter","src":"https://openalex.org/W3014110161","eid":"W3014110161"},{"id":"paper-w2892283864","cat":"papers","name":"Lack of deuterium isotope effects in the antidepressant effects of (R)-ketamine in a chronic social defeat stress model","year":"2018","cit":32,"pfa":"Kai Zhang","psa":"Kenji Hashimoto","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2892283864","eid":"W2892283864"},{"id":"paper-w2417235389","cat":"papers","name":"Mode of action of LSD on serotonergic neurons.","year":"1974","cit":32,"pfa":"George K. Aghajanian","psa":"Henry James Haigler","ptype":"article","src":"https://openalex.org/W2417235389","eid":"W2417235389"},{"id":"paper-w1975737422","cat":"papers","name":"Responses of the flexor reflex to LSD, tryptamine, 5-hydroxytryptophan, methoxamine, and d-amphetamine in acute and chronic spinal rats","year":"1977","cit":32,"pfa":"M Nozaki","psa":"William R. Martin","ptype":"article","src":"https://openalex.org/W1975737422","eid":"W1975737422"},{"id":"paper-w2054025907","cat":"papers","name":"LSD, 5-HT (serotonin), and the evolution of a behavioral assay","year":"2003","cit":32,"pfa":"James B. Appel","psa":"James Buggy","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2054025907","eid":"W2054025907"},{"id":"paper-w2049301468","cat":"papers","name":"Attenuation of forgetting by pharmacological stimulation of aminergic neurotransmitter systems","year":"1988","cit":32,"pfa":"David Quartermain","psa":"Paul Leo","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2049301468","eid":"W2049301468"},{"id":"paper-w2157753924","cat":"papers","name":"LYSERGIC ACID DIETHYLAMIDE ANTAGONISM OF CERTAIN DRUGS","year":"1957","cit":31,"pfa":"Barbara B. Brown","ptype":"article","src":"https://openalex.org/W2157753924","eid":"W2157753924"},{"id":"paper-w2084242663","cat":"papers","name":"Lysergic Acid Diethylamide (LSD-25) Antagonists","year":"1958","cit":31,"pfa":"Harold A. Abramson","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2084242663","eid":"W2084242663"},{"id":"paper-w2086297411","cat":"papers","name":"Effects of Chlorpromazine and Lysergic Acid Diethylamide on the Rate of Habituation of the Arousal Response","year":"1961","cit":31,"pfa":"B. J. KEY","ptype":"article","src":"https://openalex.org/W2086297411","eid":"W2086297411"},{"id":"paper-w2076385631","cat":"papers","name":"Comparative subjective effects of seven drugs including lysergic acid diethylamide (LSD-25).","year":"1955","cit":31,"pfa":"Murray E. Jarvik","psa":"M. W. Hirsch","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2076385631","eid":"W2076385631"},{"id":"paper-w2086009833","cat":"papers","name":"Phantom Limb Pain: Sub‐Hallucinogenic Treatment With Lysergic Acid Diethylamide (LSD‐25)","year":"1977","cit":31,"pfa":"Marcello Fanciullacci","psa":"F Sicuteri","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2086009833","eid":"W2086009833"},{"id":"paper-w2090692350","cat":"papers","name":"Gas chromatographic/mass spectrometric determination of lysergic acid diethylamide (LSD) in serum samples","year":"1997","cit":31,"pfa":"Frank Mußhoff","psa":"Thomas Daldrup","ptype":"article","src":"https://openalex.org/W2090692350","eid":"W2090692350"},{"id":"paper-w2082521851","cat":"papers","name":"Lysergic Acid Diethylamide (Lsd-25): X. Effect on Reaction Time to Auditory and Visual Stimuli","year":"1955","cit":31,"pfa":"Harold A. Abramson","psa":"M. W. Hirsch","ptype":"article","src":"https://openalex.org/W2082521851","eid":"W2082521851"},{"id":"paper-w4386914990","cat":"papers","name":"Open-label study of consecutive ibogaine and 5-MeO-DMT assisted-therapy for trauma-exposed male Special Operations Forces Veterans: prospective data from a clinical program in Mexico","year":"2023","cit":31,"pfa":"Alan K. Davis","psa":"Lynnette A. Averill","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4386914990","eid":"W4386914990"},{"id":"paper-w2411755101","cat":"papers","name":"The effect of amphetamine and D-lysergic acid diethylamide (LSD 25) on the electrical activity of the brain of the conscious cat.","year":"1953","cit":31,"pfa":"P B Bradley","psa":"Joel Elkes","ptype":"article","src":"https://openalex.org/W2411755101","eid":"W2411755101"},{"id":"paper-w2081116974","cat":"papers","name":"Developmental Changes in [3H]Lysergic Acid Diethylamide ([3H]LSD) Binding to Serotonin Receptors in the Human Brainstem","year":"1996","cit":31,"pfa":"Nataša Zec","psa":"Hannah C. Kinney","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2081116974","eid":"W2081116974"},{"id":"paper-w4214937728","cat":"papers","name":"Effects of ketamine optical isomers, psilocybin, psilocin and norpsilocin on time estimation and cognition in rats","year":"2022","cit":31,"pfa":"Piotr Popik","psa":"Joanna Gołębiowska","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4214937728","eid":"W4214937728"},{"id":"paper-w2054507715","cat":"papers","name":"Observations on Treatment With Ibogaine","year":"1998","cit":31,"pfa":"D Luciano","ptype":"article","src":"https://openalex.org/W2054507715","eid":"W2054507715"},{"id":"paper-w2114339416","cat":"papers","name":"Ayahuasca and cancer treatment","year":"2013","cit":31,"pfa":"Eduardo Ekman Schenberg","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2114339416","eid":"W2114339416"},{"id":"paper-w1972953931","cat":"papers","name":"Structure-activity relationship studies on mescaline: The effect of dimethoxyphenylethylamine and N:N-dimethyl mescaline on the conditioned avoidance response in the rat","year":"1965","cit":31,"pfa":"John Smythies","psa":"Elizabeth A. Sykes","ptype":"article","src":"https://openalex.org/W1972953931","eid":"W1972953931"},{"id":"paper-w2134304898","cat":"papers","name":"Life-threatening complications of ibogaine: three case reports.","year":"2012","cit":31,"pfa":"Fleur P. Paling","psa":"Henk J. Blom","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2134304898","eid":"W2134304898"},{"id":"paper-w2168757036","cat":"papers","name":"A Historical Review of MDMA","year":"2011","cit":31,"pfa":"Steven B. Karch","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2168757036","eid":"W2168757036"},{"id":"paper-w1594136548","cat":"papers","name":"Blockade of the stimulus properties of mescaline by a serotonin antagonist.","year":"1975","cit":31,"pfa":"Winter Jc","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1594136548","eid":"W1594136548"},{"id":"paper-w1994556193","cat":"papers","name":"The effect of antiserotonin on the experimental psychosis induced by dimethyltryptamine","year":"1962","cit":31,"pfa":"A.S. Sai-Halász","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1994556193","eid":"W1994556193"},{"id":"paper-w4220813054","cat":"papers","name":"How Important Is a Guide Who Has Taken Psilocybin in Psilocybin-Assisted Therapy for Depression?","year":"2022","cit":31,"pfa":"Mitch Earleywine","psa":"Joseph Anthony De Leo","topics":["Depression","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4220813054","eid":"W4220813054"},{"id":"paper-w1991282675","cat":"papers","name":"O uso ritual da ayahuasca","year":"2003","cit":31,"pfa":"Marco Tromboni","ptype":"article","src":"https://openalex.org/W1991282675","eid":"W1991282675"},{"id":"paper-w4240181245","cat":"papers","name":"New World Tryptamine Hallucinogens and the Neuroscience of Ayahuasca","year":"2015","cit":31,"pfa":"Dennis J. McKenna","psa":"Jordi Riba","ptype":"book-chapter","src":"https://openalex.org/W4240181245","eid":"W4240181245"},{"id":"paper-w2296326126","cat":"papers","name":"Identification of short time intervals under LSD25 and mescaline.","year":"1977","cit":31,"pfa":"Leon Mitrani","psa":"S Yanev","ptype":"article","src":"https://openalex.org/W2296326126","eid":"W2296326126"},{"id":"paper-w4281647364","cat":"papers","name":"MDMA for the Treatment of Negative Symptoms in Schizophrenia","year":"2022","cit":31,"pfa":"Mitchell D. Arnovitz","psa":"Timothy I. Michaels","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4281647364","eid":"W4281647364"},{"id":"paper-w2300596725","cat":"papers","name":"The hallucinogenic diterpene salvinorin A inhibits leukotriene synthesis in experimental models of inflammation","year":"2016","cit":31,"pfa":"Antonietta Rossi","psa":"Raffaele Capasso","ptype":"article","src":"https://openalex.org/W2300596725","eid":"W2300596725"},{"id":"paper-w2103743116","cat":"papers","name":"Ibogaine and Cocaine Abuse: Pharmacological Interactions at Dopamine and Serotonin Receptors","year":"1997","cit":31,"pfa":"Henry W. Sershen","psa":"Ábel Lajtha","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2103743116","eid":"W2103743116"},{"id":"paper-w2088056284","cat":"papers","name":"The effects of ibogaine on dopamine and serotonin transport in rat brain synaptosomes","year":"1999","cit":31,"pfa":"Gregg B. Wells","psa":"Jacqueline C. Tanaka","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2088056284","eid":"W2088056284"},{"id":"paper-w2042603095","cat":"papers","name":"Effects of ayahuasca on binocular rivalry with dichoptic stimulus alternation","year":"2004","cit":31,"pfa":"Ede Frecska","psa":"Luís Eduardo Luna","ptype":"article","src":"https://openalex.org/W2042603095","eid":"W2042603095"},{"id":"paper-w4390484761","cat":"papers","name":"Is Poorly Assisted Psilocybin Treatment an Increasing Risk?","year":"2024","cit":31,"pfa":"Eduardo Ekman Schenberg","psa":"Leor Roseman","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4390484761","eid":"W4390484761"},{"id":"paper-w2034918627","cat":"papers","name":"The Native American Church, Peyote, and Health: Expanding Consciousness for Healing Purposes","year":"2007","cit":31,"pfa":"Peter N. Jones","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2034918627","eid":"W2034918627"},{"id":"paper-w2039711411","cat":"papers","name":"Glucocorticoids and 3,4-methylenedioxymethamphetamine (MDMA)-induced neurotoxicity","year":"1989","cit":31,"pfa":"Michel Johnson","psa":"James W. Gibb","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2039711411","eid":"W2039711411"},{"id":"paper-w2071038167","cat":"papers","name":"Ecstasy (MDMA) exposure and neuropsychological functioning: A polydrug perspective","year":"2005","cit":31,"pfa":"Krista M. Lisdahl","psa":"Kevin J. Corcoran","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2071038167","eid":"W2071038167"},{"id":"paper-w2080741942","cat":"papers","name":"Prior morphine exposure enhances ibogaine antagonism of morphine-induced locomotor stimulation","year":"1995","cit":31,"pfa":"Sandra M. Pearl","psa":"D. W. Johnson","ptype":"article","src":"https://openalex.org/W2080741942","eid":"W2080741942"},{"id":"paper-w4307996361","cat":"papers","name":"Molecular Pathways of the Therapeutic Effects of Ayahuasca, a Botanical Psychedelic and Potential Rapid-Acting Antidepressant","year":"2022","cit":31,"pfa":"Giordano Novak Rossi","psa":"RAFAEL GUIMARÃES DOS SANTOS","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4307996361","eid":"W4307996361"},{"id":"paper-w2333821097","cat":"papers","name":"Co-administration of THC and MDMA (‘Ecstasy’) Synergistically Disrupts Memory in Rats","year":"2005","cit":31,"pfa":"June M Young","psa":"Paul E. Mallet","ptype":"article","src":"https://openalex.org/W2333821097","eid":"W2333821097"},{"id":"paper-w2802275412","cat":"papers","name":"Ibogaine Acute Administration in Rats Promotes Wakefulness, Long-Lasting REM Sleep Suppression, and a Distinctive Motor Profile","year":"2018","cit":31,"pfa":"Joaqúın González","psa":"Pablo Torterolo","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2802275412","eid":"W2802275412"},{"id":"paper-w2605223485","cat":"papers","name":"Addressing Structural Flexibility at the A-Ring on Salvinorin A: Discovery of a Potent Kappa-Opioid Agonist with Enhanced Metabolic Stability","year":"2017","cit":31,"pfa":"Alexander M. Sherwood","psa":"Thomas Edward Prisinzano","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2605223485","eid":"W2605223485"},{"id":"paper-w3159984005","cat":"papers","name":"LSD and psilocybin flatten the brain’s energy landscape: insights from receptor-informed network control theory","year":"2021","cit":31,"pfa":"S. Parker Singleton","psa":"Amy Kuceyeski","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W3159984005","eid":"W3159984005"},{"id":"paper-w2083645343","cat":"papers","name":"A comparison of N,N-dimethyltryptamine, harmaline, and selected congeners in rats trained with LSD as a discriminative stimulus","year":"1998","cit":31,"pfa":"Scott Helsley","psa":"Jerrold C. Winter","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2083645343","eid":"W2083645343"},{"id":"paper-w2034128635","cat":"papers","name":"Effects of MDMA (“ecstasy”) during adolescence on place conditioning and hippocampal neurogenesis","year":"2009","cit":31,"pfa":"Briony J. Catlow","psa":"Juan Sanchez‐Ramos","ptype":"article","src":"https://openalex.org/W2034128635","eid":"W2034128635"},{"id":"paper-w2003737313","cat":"papers","name":"The 2-methoxy methyl analogue of salvinorin A attenuates cocaine-induced drug seeking and sucrose reinforcements in rats","year":"2013","cit":31,"pfa":"Aashish S. Morani","psa":"Bronwyn Maree Kivell","ptype":"article","src":"https://openalex.org/W2003737313","eid":"W2003737313"},{"id":"paper-w2053933216","cat":"papers","name":"Comparison of the discriminative stimulus effects of 3,4-methylenedioxymethamphetamine (MDMA) and cocaine: asymmetric generalization","year":"2004","cit":31,"pfa":"Nantaka Khorana","psa":"Richard A. Glennon","ptype":"article","src":"https://openalex.org/W2053933216","eid":"W2053933216"},{"id":"paper-w3017189021","cat":"papers","name":"Ayahuasca Users in Estonia: Ceremonial Practices, Subjective Long-Term Effects, Mental Health, and Quality of Life","year":"2020","cit":31,"pfa":"Helle Kaasik","psa":"Kairi Kreegipuu","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3017189021","eid":"W3017189021"},{"id":"paper-w2046900599","cat":"papers","name":"Rhabdomyolysis in MDMA Intoxication: A Rapid and Underestimated Killer. “Clean” Ecstasy, a Safe Party Drug?","year":"2009","cit":31,"pfa":"Herve Vanden Eede","psa":"Elizabeth Norris","ptype":"article","src":"https://openalex.org/W2046900599","eid":"W2046900599"},{"id":"paper-w2045135727","cat":"papers","name":"Salvinorin A Administration after Global Cerebral Hypoxia/Ischemia Preserves Cerebrovascular Autoregulation via Kappa Opioid Receptor in Piglets","year":"2012","cit":31,"pfa":"Zhenhong Wang","psa":"Renyu Liu","topics":["Addiction","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2045135727","eid":"W2045135727"},{"id":"paper-w2050763074","cat":"papers","name":"Differential Response of nNOS Knockout Mice to MDMA (“Ecstasy”)‐ and Methamphetamine‐Induced Psychomotor Sensitization and Neurotoxicity","year":"2004","cit":31,"pfa":"Yossef Itzhak","psa":"Syed F. Ali","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2050763074","eid":"W2050763074"},{"id":"paper-w2006427761","cat":"papers","name":"Synthesis and capillary electrophoretic analysis of enantiomerically enriched reference standards of MDMA and its main metabolites","year":"2002","cit":31,"pfa":"Nieves Pizarro","psa":"Jesús Joglar","ptype":"article","src":"https://openalex.org/W2006427761","eid":"W2006427761"},{"id":"paper-w3137764424","cat":"papers","name":"Concomitant drugs associated with increased mortality for MDMA users reported in a drug safety surveillance database","year":"2021","cit":31,"pfa":"Isaac V. Cohen","psa":"Kelan L. H. Thomas","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W3137764424","eid":"W3137764424"},{"id":"paper-w2166311729","cat":"papers","name":"Low striatal serotonin transporter protein in a human polydrug MDMA (ecstasy) user: a case study","year":"2008","cit":31,"pfa":"SJ Kish","psa":"Junchao Tong","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2166311729","eid":"W2166311729"},{"id":"paper-w2314973408","cat":"papers","name":"A Cannabinoid CB1 Receptor Antagonist Ameliorates Impairment of Recognition Memory on Withdrawal from MDMA (Ecstasy)","year":"2009","cit":31,"pfa":"Yoko Nawata","psa":"Tsuneyuki Yamamoto","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2314973408","eid":"W2314973408"},{"id":"paper-w1965987414","cat":"papers","name":"Effect of adolescent exposure to WIN 55212-2 on the acquisition and reinstatement of MDMA-induced conditioned place preference","year":"2009","cit":31,"pfa":"Marta Rodríguez‐Arias","psa":"José Miñarro","ptype":"article","src":"https://openalex.org/W1965987414","eid":"W1965987414"},{"id":"paper-w2782327433","cat":"papers","name":"Instantly Hooked? Freebies and Samples of Opioids, Cannabis, MDMA, and Other Drugs in an Illicit E-Commerce Market","year":"2017","cit":31,"pfa":"Isak Ladegaard","topics":["Addiction","Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2782327433","eid":"W2782327433"},{"id":"paper-w2119812461","cat":"papers","name":"Ecstasy (MDMA) and high prevalence psychiatric symptomatology: somatic anxiety symptoms are associated with polydrug, not ecstasy, use","year":"2008","cit":31,"pfa":"Gillinder Bedi","psa":"Jennifer R. Redman","topics":["Depression","Anxiety & end-of-life","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2119812461","eid":"W2119812461"},{"id":"paper-w2013403154","cat":"papers","name":"The Effect of Catecholamine Depletion by Alpha-Methyl-Para-Tyrosine on Measures of Cognitive Performance and Sleep in Abstinent MDMA Users","year":"2007","cit":31,"pfa":"Una D. McCann","psa":"George A. Ricaurte","ptype":"article","src":"https://openalex.org/W2013403154","eid":"W2013403154"},{"id":"paper-w2619431722","cat":"papers","name":"The C-2 derivatives of salvinorin A, ethoxymethyl ether Sal B and β-tetrahydropyran Sal B, have anti-cocaine properties with minimal side effects","year":"2017","cit":31,"pfa":"Amy W.M. Ewald","psa":"Bronwyn Maree Kivell","ptype":"article","src":"https://openalex.org/W2619431722","eid":"W2619431722"},{"id":"paper-w2151867269","cat":"papers","name":"MDMA Stimulus Generalization to the 5-HT1A Serotonin Agonist 8-Hydroxy-2- (di-n-propylamino)tetralin","year":"2000","cit":31,"pfa":"Richard A. Glennon","psa":"Richard Young","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2151867269","eid":"W2151867269"},{"id":"paper-w1989123841","cat":"papers","name":"Residual social, memory and oxytocin-related changes in rats following repeated exposure to γ-hydroxybutyrate (GHB), 3,4-methylenedioxymethamphetamine (MDMA) or their combination","year":"2010","cit":31,"pfa":"Petra S. Van Nieuwenhuijzen","psa":"Iain S. McGregor","ptype":"article","src":"https://openalex.org/W1989123841","eid":"W1989123841"},{"id":"paper-w2145235773","cat":"papers","name":"Characterization of the Translocation of Protein Kinase C (PKC) by 3,4-methylenedioxymethamphetamine (MDMA/Ecstasy) in Synaptosomes: Evidence for a Presynaptic Localization Involving the Serotonin Transporter (SERT)","year":"1998","cit":31,"pfa":"H Kenneth Kramer","psa":"Efrain C. Azmitia","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2145235773","eid":"W2145235773"},{"id":"paper-w3173767391","cat":"papers","name":"Determination of the enantiomeric composition of amphetamine, methamphetamine and 3,4‐methylendioxy‐N‐methylamphetamine (MDMA) in seized street drug samples from southern Germany","year":"2021","cit":31,"pfa":"Moritz Losacker","psa":"Cornelius Heß","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3173767391","eid":"W3173767391"},{"id":"paper-w1989038222","cat":"papers","name":"Bacterial Plate Assays and Electrochemical Methods: An Efficient Tandem for Evaluating the Ability of Catechol−Thioether Metabolites of MDMA (“Ecstasy”) to Induce Toxic Effects through Redox-Cycling","year":"2007","cit":31,"pfa":"Anne Felim","psa":"Martine Largeron","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1989038222","eid":"W1989038222"},{"id":"paper-w2284711304","cat":"papers","name":"Screening for illicit drugs in pooled human urine and urinated soil samples and studies on the stability of urinary excretion products of cocaine, MDMA, and MDEA in wastewater by hyphenated mass spectrometry techniques","year":"2016","cit":31,"pfa":"Marie Mardal","psa":"Markus R. Meyer","ptype":"article","src":"https://openalex.org/W2284711304","eid":"W2284711304"},{"id":"paper-w4405955623","cat":"papers","name":"Benefits and Challenges of Ultra-Fast, Short-Acting Psychedelics in the Treatment of Depression","year":"2025","cit":31,"pfa":"Johannes Gerardus Ramaekers","psa":"Natasha Leigh Mason","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4405955623","eid":"W4405955623"},{"id":"paper-w2069812901","cat":"papers","name":"Comparative Effects of Stereoisomers of Hallucinogenic Amphetamines","year":"1973","cit":31,"pfa":"Frederick Benington","psa":"Ronald J. Bradley","ptype":"article","src":"https://openalex.org/W2069812901","eid":"W2069812901"},{"id":"paper-w4388923655","cat":"papers","name":"A Brief Historical Overview of Psychedelic Research","year":"2023","cit":31,"pfa":"Mark A. Geyer","ptype":"article","src":"https://openalex.org/W4388923655","eid":"W4388923655"},{"id":"paper-w2148993565","cat":"papers","name":"Alleviation of the Psychological Effects of LSD in Man by 5-Hydroxytryptophan","year":"1958","cit":31,"pfa":"Johannes C. Brengelmann","psa":"Mark B. Sandler","ptype":"article","src":"https://openalex.org/W2148993565","eid":"W2148993565"},{"id":"paper-w4388714298","cat":"papers","name":"Antidepressant- and anxiolytic-like activities and acute toxicity evaluation of the Psilocybe cubensis mushroom in experimental models in mice","year":"2023","cit":31,"pfa":"Alberto Hernández-León","psa":"María Eva González-Trujano","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4388714298","eid":"W4388714298"},{"id":"paper-w1971901005","cat":"papers","name":"Identification of planarian serotonin receptor by ligand binding and PCR studies","year":"1996","cit":31,"pfa":"Osamu Saitoh","psa":"Hiroyasu Nakata","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1971901005","eid":"W1971901005"},{"id":"paper-w2084385783","cat":"papers","name":"From Hofmann to the Haight Ashbury, and into the Future: The Past and Potential of Lysergic Acid Diethlyamide","year":"2014","cit":31,"pfa":"David Eugene Smith","psa":"Leigh Dickerson Davidson","topics":["PTSD & trauma","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2084385783","eid":"W2084385783"},{"id":"paper-w1973012654","cat":"papers","name":"Effects of LSD-25 and Amphetamine on a Running Response in the Rat","year":"1960","cit":31,"pfa":"CHARLES L. HAMILTON","ptype":"article","src":"https://openalex.org/W1973012654","eid":"W1973012654"},{"id":"paper-w2041732335","cat":"papers","name":"Effects of LSD on exploratory behavior and locomotion in rats","year":"1973","cit":31,"pfa":"R. N. Hughes","ptype":"article","src":"https://openalex.org/W2041732335","eid":"W2041732335"},{"id":"paper-w9273104","cat":"papers","name":"ANALYSIS OF PROTEIN SYNTHESIS IN THE MAMMALIAN BRAIN USING LSD AND HYPERTHERMIA AS EXPERIMENTAL PROBES","year":"1982","cit":31,"pfa":"Ian R. Brown","psa":"James W. Cosgrove","ptype":"book-chapter","src":"https://openalex.org/W9273104","eid":"W9273104"},{"id":"paper-w4363676306","cat":"papers","name":"Benzydamine—An Affordable Over-the-Counter Drug with Psychoactive Properties—From Chemical Structure to Possible Pharmacological Properties","year":"2023","cit":31,"pfa":"Bianca-Eugenia Ősz","psa":"Camil-Eugen Vari","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4363676306","eid":"W4363676306"},{"id":"paper-w3005820732","cat":"papers","name":"LSD Overdoses: Three Case Reports","year":"2020","cit":31,"pfa":"Mark Haden","psa":"Birgitta Woods","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W3005820732","eid":"W3005820732"},{"id":"paper-w2118506102","cat":"papers","name":"Gaddum and LSD: the birth and growth of experimental and clinical neuropharmacology research on 5‐HT in the UK","year":"2008","cit":31,"pfa":"Andrew R. Green","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2118506102","eid":"W2118506102"},{"id":"paper-w3094406522","cat":"papers","name":"Treatment of a Complex Personality Disorder Using Repeated Doses of LSD—A Case Report on Significant Improvements in the Absence of Acute Drug Effects","year":"2020","cit":31,"pfa":"Felix Müller","psa":"Stefan Borgwardt","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3094406522","eid":"W3094406522"},{"id":"paper-w1977896939","cat":"papers","name":"3,4-Methylenedioxymethamphetamine (Ecstasy) Activates Skeletal Muscle Nicotinic Acetylcholine Receptors","year":"2005","cit":31,"pfa":"Werner Klingler","psa":"Frank Lehmann‐Horn","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1977896939","eid":"W1977896939"},{"id":"paper-w2128301159","cat":"papers","name":"Influence of caffeine on 3,4‐methylenedioxymethamphetamine‐induced dopaminergic neuron degeneration and neuroinflammation is age‐dependent","year":"2015","cit":31,"pfa":"Lucia Frau","psa":"Micaela Morelli","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2128301159","eid":"W2128301159"},{"id":"paper-w2027033329","cat":"papers","name":"Uptake of 3,4-methylenedioxymethamphetamine and its related compounds by a proton-coupled transport system in Caco-2 cells","year":"2007","cit":31,"pfa":"Kenji Kuwayama","psa":"Tohru Kishi","ptype":"article","src":"https://openalex.org/W2027033329","eid":"W2027033329"},{"id":"paper-w4310466310","cat":"papers","name":"DNA Authentication and Chemical Analysis of Psilocybe Mushrooms Reveal Widespread Misdeterminations in Fungaria and Inconsistencies in Metabolites","year":"2022","cit":31,"pfa":"Alexander  James Bradshaw","psa":"Bryn T. M. Dentinger","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4310466310","eid":"W4310466310"},{"id":"paper-w2133886502","cat":"papers","name":"3,4‐Methylenedioxymethamphetamine (ecstasy)‐induced hepatotoxicity: effect on cytosolic calcium signals in isolated hepatocytes","year":"1999","cit":31,"pfa":"Guadalupe Beitia","psa":"Edurne Cenarruzabeitia","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2133886502","eid":"W2133886502"},{"id":"paper-w1565442","cat":"papers","name":"Neuroprotective properties of melissa officinalis L. Extract against ecstasy-induced neurotoxicity.","year":"2011","cit":31,"pfa":"Gholamreza Hassanzadeh","psa":"Abolfazl Azami Tameh","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1565442","eid":"W1565442"},{"id":"paper-w2030142991","cat":"papers","name":"The acute effects of 3,4-methylenedioxymethamphetamine and d-methamphetamine on human cognitive functioning","year":"2011","cit":31,"pfa":"Con K. K. Stough","psa":"Luke A. Downey","ptype":"article","src":"https://openalex.org/W2030142991","eid":"W2030142991"},{"id":"paper-w2066354229","cat":"papers","name":"Prenatal 3,4-methylenedioxymethamphetamine (ecstasy) exposure induces long-term alterations in the dopaminergic and serotonergic functions in the rat","year":"2004","cit":31,"pfa":"Laurent Galineau","psa":"Sylvie Chalon","ptype":"article","src":"https://openalex.org/W2066354229","eid":"W2066354229"},{"id":"paper-w2202621783","cat":"papers","name":"Stress-Induced In Vivo Recruitment of Human Cytotoxic Natural Killer Cells Favors Subsets with Distinct Receptor Profiles and Associates with Increased Epinephrine Levels","year":"2015","cit":31,"pfa":"Marc B. Bigler","psa":"Christoph T. Berger","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2202621783","eid":"W2202621783"},{"id":"paper-w2082806458","cat":"papers","name":"Argyreia nervosa (Burm. f.): Receptor profiling of lysergic acid amide and other potential psychedelic LSD-like compounds by computational and binding assay approaches","year":"2013","cit":31,"pfa":"Alexander Paulke","psa":"Holger Stark","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2082806458","eid":"W2082806458"},{"id":"paper-w4376105164","cat":"papers","name":"Tusi: a new ketamine concoction complicating the drug landscape","year":"2023","cit":31,"pfa":"Joseph J. Palamar","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4376105164","eid":"W4376105164"},{"id":"paper-w3021664365","cat":"papers","name":"Synthetic Studies of Neoclerodane Diterpenes from Salvia divinorum: Design, Synthesis, and Evaluation of Analogues with Improved Potency and G-protein Activation Bias at the μ-Opioid Receptor","year":"2020","cit":31,"pfa":"Rachel Saylor Crowley","psa":"Thomas Edward Prisinzano","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3021664365","eid":"W3021664365"},{"id":"paper-w2971831602","cat":"papers","name":"2018: A watershed year for psychedelic science","year":"2019","cit":31,"pfa":"Jacob S. Aday","psa":"Emily K. Bloesch","topics":["Depression","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2971831602","eid":"W2971831602"},{"id":"paper-w2024474626","cat":"papers","name":"Monoamines in the brain under the influence of muscimol and ibotenic acid, two psychoactive principles of amanita muscaria","year":"1970","cit":31,"pfa":"P. K�nig-Bersin","psa":"WALTER LICHTENSTEIGER","ptype":"article","src":"https://openalex.org/W2024474626","eid":"W2024474626"},{"id":"paper-w4392883849","cat":"papers","name":"Psychedelic Therapy as Form of Life","year":"2024","cit":31,"pfa":"Nicolas Langlitz","psa":"Alex K. Gearin","topics":["Addiction","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4392883849","eid":"W4392883849"},{"id":"paper-w3160485194","cat":"papers","name":"Migraine prevalence in visual snow with prior illicit drug use (hallucinogen persisting perception disorder) versus without","year":"2021","cit":31,"pfa":"Robin M. van Dongen","psa":"Gisela Marie Terwindt","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3160485194","eid":"W3160485194"},{"id":"paper-w2401792601","cat":"papers","name":"Pharmacological and ultrastructural maturation of serotonergic synapses during ontogeny.","year":"1975","cit":31,"pfa":"A H Tissari","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2401792601","eid":"W2401792601"},{"id":"paper-w2926601140","cat":"papers","name":"Descriptive assemblage of psychedelic microdosing: Netnographic study of Youtube™ videos and on-going research projects","year":"2019","cit":31,"pfa":"Aleksi Hupli","psa":"James Fadiman","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2926601140","eid":"W2926601140"},{"id":"paper-w3157058636","cat":"papers","name":"Entheogens and psychedelics in Canada: Proposal for a new paradigm.","year":"2021","cit":31,"pfa":"Jessica Rochester","psa":"Kate Caldwell","ptype":"article","src":"https://openalex.org/W3157058636","eid":"W3157058636"},{"id":"paper-w2068715994","cat":"papers","name":"Hallucinogen binding to dopamine/neuroleptic receptors","year":"1977","cit":31,"pfa":"Patricia M. Whitaker","psa":"Philip M. Seeman","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2068715994","eid":"W2068715994"},{"id":"paper-w3109765150","cat":"papers","name":"The Psychedelic Personality: Personality Structure and Associations in a Sample of Psychedelics Users","year":"2020","cit":31,"pfa":"Petter Grahl Johnstad","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3109765150","eid":"W3109765150"},{"id":"paper-w4394855468","cat":"papers","name":"Mind the Psychedelic Hype: Characterizing the Risks and Benefits of Psychedelics for Depression","year":"2024","cit":31,"pfa":"Daniel Meling","psa":"David B. Yaden","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4394855468","eid":"W4394855468"},{"id":"paper-w4381895482","cat":"papers","name":"Minorities’ diminished psychedelic returns","year":"2023","cit":31,"pfa":"Sean M. Viña","psa":"Amanda Layne Stephens","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4381895482","eid":"W4381895482"},{"id":"paper-w3210571302","cat":"papers","name":"Molecular targets of psychedelic‐induced plasticity","year":"2021","cit":31,"pfa":"Alaina M. Jaster","psa":"Javier González‐Maeso","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3210571302","eid":"W3210571302"},{"id":"paper-w2184278236","cat":"papers","name":"Hallucinogen Persisting Perception Disorder (HPPD) and Flashback-are they Identical?","year":"2013","cit":31,"pfa":"Hermle Leo Simon Melanie","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2184278236","eid":"W2184278236"},{"id":"paper-w4402624198","cat":"papers","name":"Rethinking the role of TRKB in the action of antidepressants and psychedelics","year":"2024","cit":31,"pfa":"Cecilia Anna Brunello","psa":"Eero Ċastrén","topics":["Depression","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W4402624198","eid":"W4402624198"},{"id":"paper-w4200020837","cat":"papers","name":"The Potential of Psychedelics for End of Life and Palliative Care","year":"2021","cit":31,"pfa":"David B. Yaden","psa":"Roland R. Griffiths","topics":["Anxiety & end-of-life"],"ptype":"book-chapter","src":"https://openalex.org/W4200020837","eid":"W4200020837"},{"id":"paper-w1588049995","cat":"papers","name":"Biphasic Elimination of Tenofovir Diphosphate and Nonlinear Pharmacokinetics of Zidovudine Triphosphate in a Microdosing Study","year":"2012","cit":31,"pfa":"Jianmeng Chen","psa":"Edward J. Fuchs","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W1588049995","eid":"W1588049995"},{"id":"paper-w3193605940","cat":"papers","name":"Prescription Psychedelics: The Road from FDA Approval to Clinical Practice","year":"2021","cit":31,"pfa":"Matt Lamkin","ptype":"article","src":"https://openalex.org/W3193605940","eid":"W3193605940"},{"id":"paper-w4391286658","cat":"papers","name":"Interactions between classic psychedelics and serotonergic antidepressants: Effects on the acute psychedelic subjective experience, well-being and depressive symptoms from a prospective survey study","year":"2024","cit":31,"pfa":"Jessica Barbut Siva","psa":"David Erritzøe","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4391286658","eid":"W4391286658"},{"id":"paper-w3033422973","cat":"papers","name":"Mystical Experiences in Retrospective Reports of First Times Using a Psychedelic in Finland","year":"2020","cit":31,"pfa":"Samuli Kangaslampi","psa":"Tarina Rauteenmaa","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3033422973","eid":"W3033422973"},{"id":"paper-w4288050717","cat":"papers","name":"5-HT2A SNPs Alter the Pharmacological Signaling of Potentially Therapeutic Psychedelics","year":"2022","cit":31,"pfa":"Gavin P. Schmitz","psa":"Bryan L. Roth","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4288050717","eid":"W4288050717"},{"id":"paper-w2006326313","cat":"papers","name":"Microdosing: A Valuable Tool for Accelerating Drug Development and The Role of Bioanalytical Methods in Meeting The Challenge","year":"2009","cit":31,"pfa":"Robert M. J. Ings","topics":["Safety & adverse events","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2006326313","eid":"W2006326313"},{"id":"paper-w2895529315","cat":"papers","name":"The renaissance in psychedelic research: What do preclinical models have to offer","year":"2018","cit":31,"pfa":"Kevin Sean Murnane","ptype":"book-chapter","src":"https://openalex.org/W2895529315","eid":"W2895529315"},{"id":"paper-w3189055936","cat":"papers","name":"Sex-specific effects of psychedelics on prepulse inhibition of startle in 129S6/SvEv mice","year":"2021","cit":31,"pfa":"Hiba Vohra","psa":"Javier González-Maeso","ptype":"article","src":"https://openalex.org/W3189055936","eid":"W3189055936"},{"id":"paper-w2787183840","cat":"papers","name":"A Microdose PET Study of the Safety, Immunogenicity, Biodistribution, and Radiation Dosimetry of18F-FB-A20FMDV2 for Imaging the Integrin αvβ6","year":"2018","cit":31,"pfa":"Nicholas Keat","psa":"Pauline T. Lukey","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2787183840","eid":"W2787183840"},{"id":"paper-w3162594411","cat":"papers","name":"Lifetime use of psychedelics is associated with better mental health indicators during the COVID-19 pandemic","year":"2021","cit":31,"pfa":"Federico Cavanna","psa":"Enzo Tagliazucchi","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3162594411","eid":"W3162594411"},{"id":"paper-w2330882032","cat":"papers","name":"Ultrasensitive Liquid Chromatography–Tandem Mass Spectrometric Methodologies for Quantification of Five HIV-1 Integrase Inhibitors in Plasma for a Microdose Clinical Trial","year":"2012","cit":31,"pfa":"Li Zhen Sun","psa":"Eric Woolf","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2330882032","eid":"W2330882032"},{"id":"paper-w2581855333","cat":"papers","name":"Ketamine and Psychosis History: Antidepressant Efficacy and Psychotomimetic Effects Postinfusion","year":"2017","cit":31,"pfa":"Steven J. Pennybaker","psa":"Carlos A. Zarate","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2581855333","eid":"W2581855333"},{"id":"paper-w2051053542","cat":"papers","name":"Efficacy of a potentized homoeopathic drug (Arsenicum Album-30) in reducing genotoxic effects produced by arsenic trioxide in mice: comparative studies of pre-, post- and combined pre- and post-oral administration and co","year":"1999","cit":31,"pfa":"S. Datta","psa":"A.R. Khuda Bukhsh","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2051053542","eid":"W2051053542"},{"id":"paper-w1982002913","cat":"papers","name":"Can Gradual Dose Titration of Ketamine for Management of Neuropathic Pain Prevent Psychotomimetic Effects in Patients With Advanced Cancer?","year":"2012","cit":31,"pfa":"Yoshiaki Okamoto","psa":"Etsuko Uejima","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1982002913","eid":"W1982002913"},{"id":"paper-w2601083671","cat":"papers","name":"Selective Pharmacological Augmentation of Hippocampal Activity Produces a Sustained Antidepressant-Like Response without Abuse-Related or Psychotomimetic Effects","year":"2017","cit":31,"pfa":"Flavia Regina Carreno","psa":"Daniel J. Lodge","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2601083671","eid":"W2601083671"},{"id":"paper-w2156075825","cat":"papers","name":"Profiles of Club Drug Users in Treatment","year":"2005","cit":31,"pfa":"Jane Carlisle Maxwell","psa":"Richard T. Spence","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2156075825","eid":"W2156075825"},{"id":"paper-w2045549932","cat":"papers","name":"Molecular and Cellular Mechanisms for the Polarized Sorting of Serotonin Receptors: Relevance for Genesis and Treatment of Psychosis","year":"2004","cit":31,"pfa":"Bryan L. Roth","psa":"Zongqi Xia","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2045549932","eid":"W2045549932"},{"id":"paper-w2995670389","cat":"papers","name":"Repurposing Potential of Ketamine: Opportunities and Challenges","year":"2019","cit":31,"pfa":"C S Gautam","psa":"Jagjit Singh","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2995670389","eid":"W2995670389"},{"id":"paper-w2769967484","cat":"papers","name":"Prenatal exposure to ketamine in rats: Implications on animal models of schizophrenia","year":"2017","cit":31,"pfa":"Carlos Coronel‐Oliveros","psa":"Renny Pacheco‐Calderón","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2769967484","eid":"W2769967484"},{"id":"paper-w1584418265","cat":"papers","name":"A Longitudinal Examination of the Relationships between Childhood Maltreatment and Patterns of Adolescent Substance Use among High‐Risk Adolescents","year":"2012","cit":31,"pfa":"Sunny Hyucksun Shin","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1584418265","eid":"W1584418265"},{"id":"paper-w2322564834","cat":"papers","name":"Some Considerations of the Tolerability of Ketamine for ECT Anesthesia","year":"2014","cit":31,"pfa":"Keith G. Rasmussen","psa":"Matthew J. Ritter","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2322564834","eid":"W2322564834"},{"id":"paper-w2090411141","cat":"papers","name":"NPS 1506, A Novel NMDA Receptor Antagonist and Neuroprotectant: Review of Preclinical and Clinical Studies","year":"1999","cit":31,"pfa":"Alan L. Mueller","psa":"David S. Wells","topics":["PTSD & trauma","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2090411141","eid":"W2090411141"},{"id":"paper-w3176326306","cat":"papers","name":"Gut microbiota is involved in the antidepressant-like effect of (S)-norketamine in an inflammation model of depression","year":"2021","cit":31,"pfa":"Yuan Yuan Wang","psa":"Chun Yang","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W3176326306","eid":"W3176326306"},{"id":"paper-w2152359266","cat":"papers","name":"Vulnerability to psychotogenic effects of ketamine is associated with elevated D2/3-receptor availability","year":"2012","cit":31,"pfa":"Ingo Vernaleken","psa":"Gerhard Gründer","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2152359266","eid":"W2152359266"},{"id":"paper-w2071307580","cat":"papers","name":"Halothane and Diazepam Inhibit Ketamine-induced c-fos Expression in the Rat Cingulate Cortex","year":"1996","cit":31,"pfa":"Shinichi Nakao","psa":"Kenjiro Mori","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2071307580","eid":"W2071307580"},{"id":"paper-w2559299318","cat":"papers","name":"Ketamine for Treatment-Resistant Depression","year":"2016","cit":31,"pfa":"Zarate Jr CA","psa":"Sanjay J. Mathew","topics":["Depression"],"ptype":"book","src":"https://openalex.org/W2559299318","eid":"W2559299318"},{"id":"paper-w1990822447","cat":"papers","name":"Isobutyl Nitrite Toxicity by Ingestion","year":"1980","cit":31,"pfa":"Suman Wason","psa":"FREDERICK H. LOVEJOY","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W1990822447","eid":"W1990822447"},{"id":"paper-w2027994548","cat":"papers","name":"Development of Rapidly Metabolized and Ultra-Short-Acting Ketamine Analogs","year":"2015","cit":31,"pfa":"Martyn G. Harvey","psa":"William Alexander Denny","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2027994548","eid":"W2027994548"},{"id":"paper-w2806149528","cat":"papers","name":"Sub-chronic treatment with cannabidiol but not with URB597 induced a mild antidepressant-like effect in diabetic rats","year":"2018","cit":31,"pfa":"Helen Morais","psa":"Janaína Menezes Zanoveli","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2806149528","eid":"W2806149528"},{"id":"paper-w2779084059","cat":"papers","name":"What Are the Causes for Discrepancies of Antidepressant Actions of (2R,6R)-Hydroxynorketamine?","year":"2017","cit":31,"pfa":"Kenji Hashimoto","psa":"Yukihiko Shirayama","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2779084059","eid":"W2779084059"},{"id":"paper-w3044806845","cat":"papers","name":"Urothelial toxicity of esketamine in the treatment of depression","year":"2020","cit":31,"pfa":"Hannelore Findeis","psa":"Philipp S. Ritter","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3044806845","eid":"W3044806845"},{"id":"paper-w4297905560","cat":"papers","name":"Esketamine prevents propofol-induced injection pain: Randomized controlled trial","year":"2022","cit":31,"pfa":"Chaozhi Xu","psa":"Xuehai Guan","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4297905560","eid":"W4297905560"},{"id":"paper-w4414084605","cat":"papers","name":"Real-World Safety of Esketamine Nasal Spray: A Comprehensive Analysis Almost 5 Years After First Approval","year":"2025","cit":31,"pfa":"Gerard Sanacora","psa":"Hannah E. Bowrey","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4414084605","eid":"W4414084605"},{"id":"paper-w4225815697","cat":"papers","name":"Neurological Adverse Events Associated With Esketamine: A Disproportionality Analysis for Signal Detection Leveraging the FDA Adverse Event Reporting System","year":"2022","cit":31,"pfa":"Haoning Guo","psa":"Jisheng Wang","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4225815697","eid":"W4225815697"},{"id":"paper-w4284958315","cat":"papers","name":"Efficacy and Safety of Intranasal Esketamine in Patients With Treatment-Resistant Depression and Comorbid Chronic Post-traumatic Stress Disorder: Open-Label Single-Arm Pilot Study","year":"2022","cit":31,"pfa":"Maud Rothärmel","psa":"Virginie Moulier","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4284958315","eid":"W4284958315"},{"id":"paper-w4363676487","cat":"papers","name":"Effect of Ketamine on Sleep in Treatment-Resistant Depression: A Systematic Review","year":"2023","cit":31,"pfa":"Aleksander Kwaśny","psa":"Wiesław Jerzy Cubała","topics":["Depression","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4363676487","eid":"W4363676487"},{"id":"paper-w4323538374","cat":"papers","name":"Esmethadone-HCl (REL-1017): a promising rapid antidepressant","year":"2023","cit":31,"pfa":"Maurizio Fava","psa":"Paolo L. Manfredi","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4323538374","eid":"W4323538374"},{"id":"paper-w3096985857","cat":"papers","name":"Candidate Strategies for Development of a Rapid-Acting Antidepressant Class That Does Not Result in Neuropsychiatric Adverse Effects: Prevention of Ketamine-Induced Neuropsychiatric Adverse Reactions","year":"2020","cit":31,"pfa":"Motohiro Okada","psa":"Takashi Shiroyama","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3096985857","eid":"W3096985857"},{"id":"paper-w2083420582","cat":"papers","name":"The Serotonergic System and Mysticism: Could LSD and the Nondrug-Induced Mystical Experience Share Common Neural Mechanisms?","year":"2002","cit":31,"pfa":"Neil F. Goodman","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2083420582","eid":"W2083420582"},{"id":"paper-w3192307046","cat":"papers","name":"Lysergic Acid Diethylamide, Psilocybin and Dimethyltryptamine in Depression Treatment: A Systematic Review","year":"2021","cit":30,"pfa":"Gniewko Więckiewicz","psa":"Robert Pudło","topics":["Depression","Addiction","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W3192307046","eid":"W3192307046"},{"id":"paper-w2065910919","cat":"papers","name":"Studies in the Effect of Lysergic Acid Diethylamide (LSD-25)","year":"1958","cit":30,"pfa":"Robert S. Liebert","ptype":"article","src":"https://openalex.org/W2065910919","eid":"W2065910919"},{"id":"paper-w4391574526","cat":"papers","name":"Comparative Pharmacological Effects of Lisuride and Lysergic Acid Diethylamide Revisited","year":"2024","cit":30,"pfa":"Grant C. Glatfelter","psa":"Michael H. Baumann","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4391574526","eid":"W4391574526"},{"id":"paper-w1976616797","cat":"papers","name":"Barbiturates, lysergic acid diethylamide, and the social behaviour of laboratory rats","year":"1966","cit":30,"pfa":"Adina Silverman","ptype":"article","src":"https://openalex.org/W1976616797","eid":"W1976616797"},{"id":"paper-w2003182853","cat":"papers","name":"Effects of pentobarbital, lysergic acid diethylamide and chlorpromazine on matching behavior in the pigeon","year":"1962","cit":30,"pfa":"Robert Berryman","psa":"John A. Nevin","ptype":"article","src":"https://openalex.org/W2003182853","eid":"W2003182853"},{"id":"paper-w2079491027","cat":"papers","name":"Generalization of morphine and lysergic acid diethylamide (LSD) stimulus properties to narcotic analgesics","year":"1976","cit":30,"pfa":"Ira D. Hirschhorn","psa":"John A. Rosecrans","ptype":"article","src":"https://openalex.org/W2079491027","eid":"W2079491027"},{"id":"paper-w1989626076","cat":"papers","name":"GLC-Mass Spectral Analysis of Psilocin and Psilocybin","year":"1977","cit":30,"pfa":"David B. Repke","psa":"Nicholas G. Kish","ptype":"article","src":"https://openalex.org/W1989626076","eid":"W1989626076"},{"id":"paper-w2041710025","cat":"papers","name":"Characterization of 125I‐Lysergic Acid Diethylamide Binding to Serotonin Receptors in Rat Frontal Cortex","year":"1984","cit":30,"pfa":"Michael J. Kadan","psa":"Paul R. Hartig","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2041710025","eid":"W2041710025"},{"id":"paper-w1964219526","cat":"papers","name":"qNMR: An applicable method for the determination of dimethyltryptamine in ayahuasca, a psychoactive plant preparation","year":"2010","cit":30,"pfa":"Sidnei Moura","psa":"Maurı́cio Yonamine","ptype":"article","src":"https://openalex.org/W1964219526","eid":"W1964219526"},{"id":"paper-w4402443939","cat":"papers","name":"Large-scale brain connectivity changes following the administration of lysergic acid diethylamide, d-amphetamine, and 3,4-methylenedioxyamphetamine","year":"2024","cit":30,"pfa":"Mihai Avram","psa":"Stefan Borgwardt","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4402443939","eid":"W4402443939"},{"id":"paper-w3168076653","cat":"papers","name":"Rapid and simple voltammetric screening method for Lysergic Acid Diethylamide (LSD) detection in seized samples using a boron-doped diamond electrode","year":"2021","cit":30,"pfa":"Dilton Martins Pimentel","psa":"Wallans Torres Pio dos Santos","ptype":"article","src":"https://openalex.org/W3168076653","eid":"W3168076653"},{"id":"paper-w2094444433","cat":"papers","name":"Cell‐Free Translation of Free and Membrane‐Bound Polysomes and Polyadenylated mRNA from Rabbit Brain Following Administration of d‐Lysergic Acid Diethylamide In Vivo","year":"1981","cit":30,"pfa":"John J. Heikkila","psa":"Ian R. Brown","ptype":"article","src":"https://openalex.org/W2094444433","eid":"W2094444433"},{"id":"paper-w2942451714","cat":"papers","name":"Dimethyltryptamine: Endogenous Role and Therapeutic Potential","year":"2019","cit":30,"pfa":"Alexandra VSL Rodrigues","psa":"Maria Augusta Vieira‐Coelho","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2942451714","eid":"W2942451714"},{"id":"paper-w2771643530","cat":"papers","name":"Breaking the cycle of opioid use disorder with Ibogaine","year":"2017","cit":30,"pfa":"Deborah C. Mash","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2771643530","eid":"W2771643530"},{"id":"paper-w2154961124","cat":"papers","name":"Nonlinear Pharmacokinetics of 5-Methoxy-N,N-dimethyltryptamine in Mice","year":"2011","cit":30,"pfa":"Hong-Wu Shen","psa":"Ai‐Ming Yu","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2154961124","eid":"W2154961124"},{"id":"paper-w2135667587","cat":"papers","name":"Ayahuasca in the treatment of Addictions","year":"2007","cit":30,"pfa":"Jacques Mabit","psa":"San Martin","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2135667587","eid":"W2135667587"},{"id":"paper-w3004872360","cat":"papers","name":"The Expanding World Ayahuasca Diaspora","year":"2018","cit":30,"pfa":"Mesturini, Silvia","topics":["Policy & ethics"],"ptype":"book","src":"https://openalex.org/W3004872360","eid":"W3004872360"},{"id":"paper-w4377019741","cat":"papers","name":"The evolution and ecology of psilocybin in nature","year":"2023","cit":30,"pfa":"Matthew J. Meyer","psa":"Jason C. Slot","ptype":"article","src":"https://openalex.org/W4377019741","eid":"W4377019741"},{"id":"paper-w2485099488","cat":"papers","name":"Ibogaine for treating drug dependence. What is a safe dose?","year":"2016","cit":30,"pfa":"L.J. Schep","psa":"David A. L. Newcombe","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2485099488","eid":"W2485099488"},{"id":"paper-w2090358173","cat":"papers","name":"Comparison of the metabolism of 3,4-dimethoxyphenylethylamine and mescaline in humans","year":"1966","cit":30,"pfa":"Arnold J. Friedhoff","psa":"Leo E. Hollister","ptype":"article","src":"https://openalex.org/W2090358173","eid":"W2090358173"},{"id":"paper-w2086581863","cat":"papers","name":"Studies on mescaline I. Action in schizophrenic patients","year":"1955","cit":30,"pfa":"Herman C.B. Denber","psa":"Sidney Merlis","ptype":"article","src":"https://openalex.org/W2086581863","eid":"W2086581863"},{"id":"paper-w2362837329","cat":"papers","name":"Oral noribogaine shows high brain uptake and anti-withdrawal effects not associated with place preference in rodents","year":"2016","cit":30,"pfa":"Deborah C. Mash","psa":"Émeline L. Maillet","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2362837329","eid":"W2362837329"},{"id":"paper-w1584697855","cat":"papers","name":"Chapter 16 Case studies of ibogaine treatment: Implications for patient management strategies","year":"2001","cit":30,"pfa":"Howard S. Lotsof","psa":"Norma E Alexander","ptype":"book-chapter","src":"https://openalex.org/W1584697855","eid":"W1584697855"},{"id":"paper-w2011350201","cat":"papers","name":"Assessing long-term effects of MDMA (Ecstasy)","year":"2001","cit":30,"pfa":"George A. Ricaurte","psa":"Una D. McCann","ptype":"article","src":"https://openalex.org/W2011350201","eid":"W2011350201"},{"id":"paper-w2088500790","cat":"papers","name":"A ayahuasca e o tratamento da dependência","year":"2013","cit":30,"pfa":"Marcelo Simão Mercante","ptype":"article","src":"https://openalex.org/W2088500790","eid":"W2088500790"},{"id":"paper-w5664263","cat":"papers","name":"Cactus alkaloids. XIX. Crystallization of mescaline HCl and 3-methoxytyramine HCl from Trichocereus pachanoi.","year":"1973","cit":30,"pfa":"Deborah Crosby","psa":"Jerry L. McLaughlin","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W5664263","eid":"W5664263"},{"id":"paper-w2091117407","cat":"papers","name":"Metabolism of 5-methoxy-N,N dimethyltryptamine-14C in the rat","year":"1969","cit":30,"pfa":"S Agurell","psa":"J.‐E. Lindgren","ptype":"article","src":"https://openalex.org/W2091117407","eid":"W2091117407"},{"id":"paper-w4391924240","cat":"papers","name":"Indigenous psilocybin mushroom practices: An annotated bibliography","year":"2024","cit":30,"pfa":"Nicholas Spiers","psa":"Nidia Olvera","ptype":"article","src":"https://openalex.org/W4391924240","eid":"W4391924240"},{"id":"paper-w2040523195","cat":"papers","name":"On the transmethylation hypothesis: stress, N,N-dimethyltryptamine, and positive symptoms of psychosis","year":"2014","cit":30,"pfa":"Dionysios Grammenos","psa":"Steven A. Barker","ptype":"article","src":"https://openalex.org/W2040523195","eid":"W2040523195"},{"id":"paper-w37700822","cat":"papers","name":"Therapist and Patient Perspectives on Ayahuasca-Assisted Treatment for Substance Dependence","year":"2013","cit":30,"pfa":"Anja Loizaga-Velder","psa":"Armando Loizaga Pazzi","topics":["Addiction","Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W37700822","eid":"W37700822"},{"id":"paper-w2081908636","cat":"papers","name":"Toxic effect of MDMA on brain serotonin neurons","year":"1999","cit":30,"pfa":"Laurence John Reed","psa":"Philip K. McGuire","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2081908636","eid":"W2081908636"},{"id":"paper-w2108954856","cat":"papers","name":"A Longitudinal Study of Urinary Excretion of N,N,-Dimethyltryptamine in Psychotic Patients","year":"1980","cit":30,"pfa":"Stuart A. Checkley","psa":"J. L. T. Birley","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2108954856","eid":"W2108954856"},{"id":"paper-w3132460522","cat":"papers","name":"Synthesis and in vitro pharmacological studies of new C(4)-modified salvinorin A analogues","year":"2006","cit":30,"pfa":"David Y.W. Lee","psa":"Bruce M. Cohen","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3132460522","eid":"W3132460522"},{"id":"paper-w1984364500","cat":"papers","name":"In vivo pharmacology of MDMA and its enantiomers in rhesus monkeys.","year":"2008","cit":30,"pfa":"William E. Fantegrossi","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1984364500","eid":"W1984364500"},{"id":"paper-w2042251241","cat":"papers","name":"Dissociation of the Neurochemical and Behavioral Toxicology of MDMA (‘Ecstasy’) by Citalopram","year":"2007","cit":30,"pfa":"Brian J. Piper","psa":"Jerrold S. Meyer","ptype":"article","src":"https://openalex.org/W2042251241","eid":"W2042251241"},{"id":"paper-w3138203691","cat":"papers","name":"Trends in MDMA‐related mortality across four countries","year":"2021","cit":30,"pfa":"Amanda Roxburgh","psa":"Isabelle Giraudon","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3138203691","eid":"W3138203691"},{"id":"paper-w3194966090","cat":"papers","name":"Ayahuasca may help to improve self‐compassion and self‐criticism capacities","year":"2021","cit":30,"pfa":"Elisabet Domínguez‐Clavé","psa":"Juan Carlos Pascual","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3194966090","eid":"W3194966090"},{"id":"paper-w2086860066","cat":"papers","name":"MDMA-Like Stimulus Effects of Hallucinogens in Male Fawn–Hooded Rats","year":"1998","cit":30,"pfa":"Martin T. Schechter","ptype":"article","src":"https://openalex.org/W2086860066","eid":"W2086860066"},{"id":"paper-w2415296890","cat":"papers","name":"The action of some ergot derivatives, mescaline and dibenamine on the metabolism of separated mammalian cerebral tissues","year":"1954","cit":30,"pfa":"Joyce L. Lewis","psa":"HENRY MCILWAIN","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2415296890","eid":"W2415296890"},{"id":"paper-w4318393298","cat":"papers","name":"Optimizing outcomes in psilocybin therapy: Considerations in participant evaluation and preparation","year":"2023","cit":30,"pfa":"Nadav Liam Modlin","psa":"Scott T. Aaronson","ptype":"article","src":"https://openalex.org/W4318393298","eid":"W4318393298"},{"id":"paper-w2116762720","cat":"papers","name":"Comparison of the diuretic effects of chemically diverse kappa opioid agonists in rats: nalfurafine, U50,488H, and salvinorin A","year":"2008","cit":30,"pfa":"Saadet Inan","psa":"A. Cowan","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2116762720","eid":"W2116762720"},{"id":"paper-w2064146773","cat":"papers","name":"Determination of N,N-dimethyltryptamine in Mimosa tenuiflora inner barks by matrix solid-phase dispersion procedure and GC–MS","year":"2011","cit":30,"pfa":"Alain Gaujac","psa":"Jaílson B. de Andrade","ptype":"article","src":"https://openalex.org/W2064146773","eid":"W2064146773"},{"id":"paper-w1997530403","cat":"papers","name":"Zur Pharmakologie von Psilocybin, einem Wirkstoff ausPsilocybe mexicana Heim","year":"1958","cit":30,"pfa":"Hans Weidmann","psa":"Heribert Konzett","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1997530403","eid":"W1997530403"},{"id":"paper-w2152415809","cat":"papers","name":"Acute and carryover effects in mice of MDMA (“ecstasy”) administration during periadolescence","year":"2002","cit":30,"pfa":"Sara Morley‐Fletcher","psa":"Giovanni Laviola","ptype":"article","src":"https://openalex.org/W2152415809","eid":"W2152415809"},{"id":"paper-w2993991001","cat":"papers","name":"S‐Adenosyl‐ l ‐Methionine Salvage Impacts Psilocybin Formation in “Magic” Mushrooms","year":"2019","cit":30,"pfa":"Richard Demmler","psa":"Dirk Hoffmeister","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2993991001","eid":"W2993991001"},{"id":"paper-w4200117112","cat":"papers","name":"Psilocybin-assisted psychotherapy for depression: Emerging research on a psychedelic compound with a rich history","year":"2021","cit":30,"pfa":"Craig Pearson","psa":"Jessica A. Gold","topics":["Depression","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4200117112","eid":"W4200117112"},{"id":"paper-w4391967348","cat":"papers","name":"The effect of psilocybin on empathy and prosocial behavior: a proposed mechanism for enduring antidepressant effects","year":"2024","cit":30,"pfa":"Kush V. Bhatt","psa":"Cory R. Weissman","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4391967348","eid":"W4391967348"},{"id":"paper-w2010744219","cat":"papers","name":"Repeated exposure to MDMA triggers long-term plasticity of noradrenergic and serotonergic neurons","year":"2013","cit":30,"pfa":"Christophe Lanteri","psa":"Jean‐Pol Tassin","ptype":"article","src":"https://openalex.org/W2010744219","eid":"W2010744219"},{"id":"paper-w2163391396","cat":"papers","name":"Hallucinogen Use Disorders Among Adult Users of MDMA and Other Hallucinogens","year":"2008","cit":30,"pfa":"Li-Tzy T. Wu","psa":"Ashwin A. Patkar","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2163391396","eid":"W2163391396"},{"id":"paper-w1981430494","cat":"papers","name":"Baeocystin, a Mono-Methyl Analog of Psilocybin from Psilocybe baeocystis Saprophytic Culture","year":"1967","cit":30,"pfa":"Albert Leung","psa":"Ara G. Paul","ptype":"article","src":"https://openalex.org/W1981430494","eid":"W1981430494"},{"id":"paper-w2025615695","cat":"papers","name":"The effect of MDA and MDMA (“ecstasy”) isomers in combination with pirenpirone on operant responding in mice","year":"1987","cit":30,"pfa":"John A. Rosecrans","psa":"Richard A. Glennon","ptype":"article","src":"https://openalex.org/W2025615695","eid":"W2025615695"},{"id":"paper-w2064127783","cat":"papers","name":"Characterization of the discriminable stimulus produced by 2‐BFI: effects of imidazoline I2‐site ligands, MAOIs, β‐carbolines, agmatine and ibogaine","year":"2002","cit":30,"pfa":"Nicholas MacInnes","psa":"Sheila L. Handley","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2064127783","eid":"W2064127783"},{"id":"paper-w1993233730","cat":"papers","name":"Psilocin analogs. III. Synthesis of 5‐methoxy‐ and 5‐hydroxy‐1,2,3,4‐tetrahydro‐9H‐pyrido[3,4‐b]indoles","year":"1982","cit":30,"pfa":"David B. Repke","psa":"Wilfred J. Ferguson","ptype":"article","src":"https://openalex.org/W1993233730","eid":"W1993233730"},{"id":"paper-w2075009166","cat":"papers","name":"The solid-state terahertz spectrum of MDMA (Ecstasy) – A unique test for molecular modeling assignments","year":"2008","cit":30,"pfa":"Damian G. Allis","psa":"Timothy M. Korter","ptype":"article","src":"https://openalex.org/W2075009166","eid":"W2075009166"},{"id":"paper-w4229447317","cat":"papers","name":"Toward a New Science of Psychedelic Social Psychology: The Effects of MDMA (Ecstasy) on Social Connection","year":"2022","cit":30,"pfa":"Sonja Lyubomirsky","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4229447317","eid":"W4229447317"},{"id":"paper-w2089262318","cat":"papers","name":"Attenuation of 3,4-methylenedioxymethamphetamine (MDMA) induced neurotoxicity with the serotonin precursors tryptophan and 5-hydroxytryptophan","year":"1994","cit":30,"pfa":"Jon E. Sprague","psa":"David E. Nichols","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2089262318","eid":"W2089262318"},{"id":"paper-w1997270984","cat":"papers","name":"Determination of N,N-dimethyltryptamine in beverages consumed in religious practices by headspace solid-phase microextraction followed by gas chromatography ion trap mass spectrometry","year":"2013","cit":30,"pfa":"Alain Gaujac","psa":"Jaílson B. de Andrade","ptype":"article","src":"https://openalex.org/W1997270984","eid":"W1997270984"},{"id":"paper-w2003435356","cat":"papers","name":"Elemental analysis of 3,4-methylenedioxymethamphetamine (MDMA): A tool to determine the synthesis method and trace links","year":"2006","cit":30,"pfa":"Carola Koper","psa":"Annabel Bolck","ptype":"article","src":"https://openalex.org/W2003435356","eid":"W2003435356"},{"id":"paper-w2025797117","cat":"papers","name":"Differential effects of cocaine and MDMA self-administration on cortical serotonin transporter availability in monkeys","year":"2011","cit":30,"pfa":"Robert W. Gould","psa":"Michael A. Nader","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2025797117","eid":"W2025797117"},{"id":"paper-w2056436158","cat":"papers","name":"Chronic ecstasy (MDMA) use is associated with deficits in task-switching but not inhibition or memory updating executive functions","year":"2005","cit":30,"pfa":"Richard Ian Dafters","ptype":"article","src":"https://openalex.org/W2056436158","eid":"W2056436158"},{"id":"paper-w2078998208","cat":"papers","name":"Effects of fenfluramine, m-CPP and triazolam on repeated-acquisition in squirrel monkeys before and after neurotoxic MDMA administration","year":"2002","cit":30,"pfa":"Peter John Winsauer","psa":"Joseph M. Moerschbaecher","ptype":"article","src":"https://openalex.org/W2078998208","eid":"W2078998208"},{"id":"paper-w4291553224","cat":"papers","name":"On‐site forensic analysis of colored seized materials: Detection of brown heroin and MDMA‐tablets by a portable NIR spectrometer","year":"2022","cit":30,"pfa":"Ruben F. Kranenburg","psa":"Arian  C. van Asten","ptype":"article","src":"https://openalex.org/W4291553224","eid":"W4291553224"},{"id":"paper-w4225857844","cat":"papers","name":"Can psilocybin be safely administered under medical supervision? A systematic review of adverse event reporting in clinical trials","year":"2022","cit":30,"pfa":"Jeremy Roscoe","psa":"Olivia Lozy","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4225857844","eid":"W4225857844"},{"id":"paper-w2162519480","cat":"papers","name":"Single treatments that have lasting effects: some thoughts on the antidepressant effects of ketamine and botulinum toxin and the anxiolytic effect of psilocybin","year":"2013","cit":30,"pfa":"Simon N. Young","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2162519480","eid":"W2162519480"},{"id":"paper-w2028334744","cat":"papers","name":"Salvinorin A Pretreatment Preserves Cerebrovascular Autoregulation After Brain Hypoxic/Ischemic Injury via Extracellular Signal-Regulated Kinase/Mitogen-Activated Protein Kinase in Piglets","year":"2011","cit":30,"pfa":"Diansan Su","psa":"Renyu Liu","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2028334744","eid":"W2028334744"},{"id":"paper-w2055332580","cat":"papers","name":"Total synthesis of indole and dihydroindole alkaloids. IV. Total synthesis of dl-dihydrocleavamine, dl-carbomethoxydihydrocleavamine, dl-coronaridine, dl-dihydrocatharanthine, and dl-ibogamine. General entry into the ibo","year":"1970","cit":30,"pfa":"James Peter Kutney","psa":"Edward Piers","ptype":"article","src":"https://openalex.org/W2055332580","eid":"W2055332580"},{"id":"paper-w2130400572","cat":"papers","name":"Sensitive Gas Chromatography-Mass Spectrometry Method for Simultaneous Measurement of MDEA, MDMA, and Metabolites HMA, MDA, and HMMA in Human Urine","year":"2006","cit":30,"pfa":"Stéphane Pirnay","psa":"Marilyn Ann Huestis","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2130400572","eid":"W2130400572"},{"id":"paper-w2083094794","cat":"papers","name":"Sprague–Dawley rats display sex-linked differences in the pharmacokinetics of 3,4-methylenedioxymethamphetamine (MDMA) and its metabolite 3,4-methylenedioxyamphetamine (MDA)","year":"2009","cit":30,"pfa":"Julien Fonsart","psa":"Xavier Declèves","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2083094794","eid":"W2083094794"},{"id":"paper-w1993158626","cat":"papers","name":"Development of a simultaneous analytical method for selected anorectics, methamphetamine, MDMA, and their metabolites in hair using LC-MS/MS to prove anorectics abuse","year":"2012","cit":30,"pfa":"Sooyeun Lee","psa":"Kyu Hyuck Chung","ptype":"article","src":"https://openalex.org/W1993158626","eid":"W1993158626"},{"id":"paper-w4319322412","cat":"papers","name":"Pilot study suggests DNA methylation of the glucocorticoid receptor gene (NR3C1) is associated with MDMA-assisted therapy treatment response for severe PTSD","year":"2023","cit":30,"pfa":"Candace R. Lewis","psa":"Baruch Rael Cahn","topics":["PTSD & trauma","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4319322412","eid":"W4319322412"},{"id":"paper-w4405955644","cat":"papers","name":"Multidimensional Personality Changes Following Psilocybin-Assisted Therapy in Patients With Alcohol Use Disorder: Results From a Double-Blind, Placebo-Controlled Clinical Trial","year":"2025","cit":30,"pfa":"Broc A. Pagni","psa":"Michael P. Bogenschutz","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4405955644","eid":"W4405955644"},{"id":"paper-w2300879313","cat":"papers","name":"Ultra-rapid targeted analysis of 40 drugs of abuse in oral fluid by LC-MS/MS using carbon-13 isotopes of methamphetamine and MDMA to reduce detector saturation","year":"2016","cit":30,"pfa":"Matthew Di Rago","psa":"Dimitri Gerostamoulos","ptype":"article","src":"https://openalex.org/W2300879313","eid":"W2300879313"},{"id":"paper-w1980607648","cat":"papers","name":"N-acetylaspartate (NAA) correlates inversely with cannabis use in a frontal language processing region of neocortex in MDMA (Ecstasy) polydrug users: A 3 T magnetic resonance spectroscopy study","year":"2008","cit":30,"pfa":"Ronald L. Cowan","psa":"Mary S. Dietrich","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1980607648","eid":"W1980607648"},{"id":"paper-w2078841976","cat":"papers","name":"THE PSYCHOTOMIMETIC DRUGS. AN OVERVIEW.","year":"1964","cit":30,"pfa":"Jonathan O Cole","psa":"Martin M. Katz","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2078841976","eid":"W2078841976"},{"id":"paper-w2309813531","cat":"papers","name":"Exploring Hallucinogen Pharmacology and Psychedelic Medicine with Zebrafish Models","year":"2016","cit":30,"pfa":"Evan J. Kyzar","psa":"Allan V. Kalueff","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W2309813531","eid":"W2309813531"},{"id":"paper-w2031351940","cat":"papers","name":"Substance Use, Suicidality, and Adolescent-Onset Schizophrenia: An Israeli 10-Year Retrospective Study","year":"2006","cit":30,"pfa":"Gal Shoval","psa":"Gil Zalsman","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2031351940","eid":"W2031351940"},{"id":"paper-w2033181602","cat":"papers","name":"Preclinical models of antipsychotic drug action","year":"2013","cit":30,"pfa":"José L. Moreno","psa":"Javier González‐Maeso","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2033181602","eid":"W2033181602"},{"id":"paper-w2005519473","cat":"papers","name":"Effects of LSD-25 on the EEG and Photic Evoked Responses","year":"1966","cit":30,"pfa":"E. Rodin�","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2005519473","eid":"W2005519473"},{"id":"paper-w2106375013","cat":"papers","name":"The Effect of Two Hallucinogenic Agents on Human Retinal Function","year":"1960","cit":30,"pfa":"Alex E. Krill","psa":"A. M. OSTFELD","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2106375013","eid":"W2106375013"},{"id":"paper-w2025604131","cat":"papers","name":"LSD and Creativity","year":"1989","cit":30,"pfa":"Oscar Janiger","psa":"Marlene Dobkin de Ríos","ptype":"article","src":"https://openalex.org/W2025604131","eid":"W2025604131"},{"id":"paper-w2056619031","cat":"papers","name":"Persisting Visual Hallucinations and Illusions in Previously Drug-Addicted Patients","year":"2003","cit":30,"pfa":"Marie‐Claire Gaillard","psa":"François‐Xavier Borruat","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2056619031","eid":"W2056619031"},{"id":"paper-w2074577073","cat":"papers","name":"Complex stimulus properties of LSD: a drug discrimination study with α2-adrenoceptor agonists and antagonists","year":"1995","cit":30,"pfa":"Danuta Marona‐Lewicka","psa":"David E. Nichols","ptype":"article","src":"https://openalex.org/W2074577073","eid":"W2074577073"},{"id":"paper-w1485763912","cat":"papers","name":"Zingiber Officinale Alters 3,4-methylenedioxymethamphetamine-Induced Neurotoxicity in Rat Brain.","year":"2012","cit":30,"pfa":"Mehdi Mehdizadeh","psa":"Sara Soleimani Asl","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1485763912","eid":"W1485763912"},{"id":"paper-w2509541959","cat":"papers","name":"The Role of κ Opioid Receptor in Brain Ischemia","year":"2016","cit":30,"pfa":"Chunhua Chen","psa":"Renyu Liu","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2509541959","eid":"W2509541959"},{"id":"paper-w2085923480","cat":"papers","name":"Oral administration of (±)3,4-methylenedioxymethamphetamine and (+)methamphetamine alters temperature and activity in rhesus macaques","year":"2007","cit":30,"pfa":"Rebecca D. Crean","psa":"Michael A. Taffe","ptype":"article","src":"https://openalex.org/W2085923480","eid":"W2085923480"},{"id":"paper-w2003128282","cat":"papers","name":"Alterations in diurnal and nocturnal locomotor activity in rats treated with a monoamine-depleting regimen of methamphetamine or 3,4-methylenedioxymethamphetamine","year":"2000","cit":30,"pfa":"Tanya L. Wallace","psa":"Charles V. Vorhees","ptype":"article","src":"https://openalex.org/W2003128282","eid":"W2003128282"},{"id":"paper-w373326752","cat":"papers","name":"Evaluation of Bcl-2 Family Gene Expression in Hippocampus of 3, 4-methylenedioxymethamphetamine Treated Rats.","year":"2012","cit":30,"pfa":"Sara Soleimani Asl","psa":"Mehdi Mehdizadeh","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W373326752","eid":"W373326752"},{"id":"paper-w2123172137","cat":"papers","name":"Effect of Drugs on Amino Acid Levels in Brain: Excitants and Depressants","year":"1961","cit":30,"pfa":"R. S. de Ropp","psa":"E. H. Snedeker","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2123172137","eid":"W2123172137"},{"id":"paper-w2056739756","cat":"papers","name":"Pharmacological and behavioral determinants of cocaine, methamphetamine, 3,4-methylenedioxymethamphetamine, and para-methoxyamphetamine-induced hyperthermia","year":"2007","cit":30,"pfa":"Emily Joy Jaehne","psa":"Rodney James Irvine","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2056739756","eid":"W2056739756"},{"id":"paper-w4387389328","cat":"papers","name":"Predicting the Intensity of Psychedelic-Induced Mystical and Challenging Experience in a Healthy Population: An Exploratory Post-Hoc Analysis","year":"2023","cit":30,"pfa":"Kwonmok Ko","psa":"James Rucker","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4387389328","eid":"W4387389328"},{"id":"paper-w3184995356","cat":"papers","name":"Serotonin Heteroreceptor Complexes and Their Integration of Signals in Neurons and Astroglia—Relevance for Mental Diseases","year":"2021","cit":30,"pfa":"Dasiel O. Borroto‐Escuela","psa":"Kjell Fuxé","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3184995356","eid":"W3184995356"},{"id":"paper-w2969663209","cat":"papers","name":"Beyond Cannabis: Psychedelic Decriminalization and Social Justice","year":"2019","cit":30,"pfa":"Dustin Marlan","topics":["Depression","Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2969663209","eid":"W2969663209"},{"id":"paper-w55568033","cat":"papers","name":"A test of the transmethylation hypothesis in acute schizophrenic patients","year":"1975","cit":30,"pfa":"William T. Carpenter","psa":"Harold E. Himwich","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W55568033","eid":"W55568033"},{"id":"paper-w2770450070","cat":"papers","name":"Psychedelics and reconsolidation of traumatic and appetitive maladaptive memories: focus on cannabinoids and ketamine","year":"2017","cit":30,"pfa":"Liana Fattore","psa":"Cristiano Chiamulera","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W2770450070","eid":"W2770450070"},{"id":"paper-w2142008584","cat":"papers","name":"ST elevation myocardial infarction in a young patient after ingestion of caffeinated energy drink and ecstasy","year":"2012","cit":30,"pfa":"Shlomo Hanan Israelit","psa":"Bennidor Raviv","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2142008584","eid":"W2142008584"},{"id":"paper-w2052911984","cat":"papers","name":"A high-throughput method based on microwave-assisted extraction and liquid chromatography–tandem mass spectrometry for simultaneous analysis of amphetamines, ketamine, opiates, and their metabolites in hair","year":"2014","cit":30,"pfa":"Yuan-Jhe Chang","psa":"Yan‐Zin Chang","ptype":"article","src":"https://openalex.org/W2052911984","eid":"W2052911984"},{"id":"paper-w4223566727","cat":"papers","name":"Effects of classic psychedelic drugs on turbulent signatures in brain dynamics","year":"2022","cit":30,"pfa":"Josephine Cruzat","psa":"Morten L. Kringelbach","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4223566727","eid":"W4223566727"},{"id":"paper-w3089027668","cat":"papers","name":"Cannabis as entheogen: survey and interview data on the spiritual use of cannabis","year":"2020","cit":30,"pfa":"Petter Grahl Johnstad","ptype":"article","src":"https://openalex.org/W3089027668","eid":"W3089027668"},{"id":"paper-w4386019370","cat":"papers","name":"Potential analgesic effects of psychedelics on select chronic pain conditions: A survey study","year":"2023","cit":30,"pfa":"Mauro Cavarra","psa":"Johannes Gerardus Ramaekers","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4386019370","eid":"W4386019370"},{"id":"paper-w4386824127","cat":"papers","name":"American Psychiatrists' Opinions About Classic Hallucinogens and Their Potential Therapeutic Applications: A 7-Year Follow-Up Survey","year":"2023","cit":30,"pfa":"Brian Scott Barnett","psa":"Harrison Graham Pope","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4386824127","eid":"W4386824127"},{"id":"paper-w1983828695","cat":"papers","name":"Extracting value from case reports: lessons from serotonin toxicity","year":"2006","cit":30,"pfa":"Peter Kenneth Gillman","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1983828695","eid":"W1983828695"},{"id":"paper-w4308953446","cat":"papers","name":"Psychedelic-Assisted Therapy for People with Eating Disorders","year":"2022","cit":30,"pfa":"Natalie Gukasyan","psa":"Ángela S. Guarda","ptype":"article","src":"https://openalex.org/W4308953446","eid":"W4308953446"},{"id":"paper-w4361272495","cat":"papers","name":"Ketamine-assisted psychotherapy in adolescents with multiple psychiatric diagnoses","year":"2023","cit":30,"pfa":"Philip E. Wolfson","psa":"Melissa Whippo","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4361272495","eid":"W4361272495"},{"id":"paper-w3197675985","cat":"papers","name":"Enhancing equity-oriented care in psychedelic medicine: Utilizing the EQUIP framework","year":"2021","cit":30,"pfa":"Kerri Rea","psa":"Bruce B. Wallace","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W3197675985","eid":"W3197675985"},{"id":"paper-w4323924535","cat":"papers","name":"History repeating: A roadmap to address common problems in psychedelic science","year":"2023","cit":30,"pfa":"Michiel van Elk","psa":"Eiko I. Fried","topics":["Safety & adverse events","Mechanism & neuroscience","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4323924535","eid":"W4323924535"},{"id":"paper-w4389035919","cat":"papers","name":"Call for evidence-based psychedelic integration.","year":"2023","cit":30,"pfa":"Jakub Greń","psa":"Marc Aixalà","topics":["Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4389035919","eid":"W4389035919"},{"id":"paper-w4245398523","cat":"papers","name":"Psychedelic Reflections","year":"1986","cit":30,"pfa":"Rick J. Strassman","ptype":"article","src":"https://openalex.org/W4245398523","eid":"W4245398523"},{"id":"paper-w2091257476","cat":"papers","name":"Fluidized bed granulation of a microdose pharmaceutical powder","year":"1978","cit":30,"pfa":"M. J. Crooks","psa":"H.W. Schade","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2091257476","eid":"W2091257476"},{"id":"paper-w4388407376","cat":"papers","name":"The Effects of Psychedelics on Neuronal Physiology","year":"2023","cit":30,"pfa":"Cassandra J. Hatzipantelis","psa":"David E. Olson","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W4388407376","eid":"W4388407376"},{"id":"paper-w1747250944","cat":"papers","name":"Microdose Gentamicin Administration via the Round Window Microcatheter","year":"2001","cit":30,"pfa":"Michael E. Hoffer","psa":"Derin C. Wester","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1747250944","eid":"W1747250944"},{"id":"paper-w2071100833","cat":"papers","name":"From Psychotic to Psychedelic: The Garage Contribution to Psychedelia","year":"2006","cit":30,"pfa":"Ann Johnson","psa":"Mike Stax","ptype":"article","src":"https://openalex.org/W2071100833","eid":"W2071100833"},{"id":"paper-w2179558318","cat":"papers","name":"Effects of Intravenous Diazepam or Microdose Medetomidine on Propofol-Induced Sedation in Dogs","year":"2006","cit":30,"pfa":"Jeff C. Ko","psa":"Tomohito Inoue","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2179558318","eid":"W2179558318"},{"id":"paper-w2168851339","cat":"papers","name":"The Psychedelic Explorer’s Guide: Safe, Therapeutic, and Sacred Journeys","year":"2014","cit":30,"pfa":"John Rhead","ptype":"article","src":"https://openalex.org/W2168851339","eid":"W2168851339"},{"id":"paper-w2782094652","cat":"papers","name":"Perception is in the details: A predictive coding account of the psychedelic phenomenon","year":"2017","cit":30,"pfa":"Sarit Pink-Hashkes","psa":"Johan Kwisthout","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2782094652","eid":"W2782094652"},{"id":"paper-w1980792308","cat":"papers","name":"AFN-1252 in vitro absorption studies and pharmacokinetics following microdosing in healthy subjects","year":"2013","cit":30,"pfa":"Nachum Kaplan","psa":"Barry Hafkin","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1980792308","eid":"W1980792308"},{"id":"paper-w175471603","cat":"papers","name":"Cosmic consciousness experience and psychedelic experiences: A first person comparison","year":"1998","cit":30,"pfa":"Allan Lloyd Smith","psa":"Charles T. Tart","ptype":"article","src":"https://openalex.org/W175471603","eid":"W175471603"},{"id":"paper-w2890727780","cat":"papers","name":"Microdose Lithium NP03 Diminishes Pre-Plaque Oxidative Damage and Neuroinflammation in a Rat Model of Alzheimer’s-like Amyloidosis","year":"2018","cit":30,"pfa":"Edward Norman Wilson","psa":"A. Claudio Cuello","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2890727780","eid":"W2890727780"},{"id":"paper-w4402762068","cat":"papers","name":"Ventral hippocampal parvalbumin interneurons gate the acute anxiolytic action of the serotonergic psychedelic DOI","year":"2024","cit":30,"pfa":"Praachi Tiwari","psa":"Vidita A. Vaidya","ptype":"article","src":"https://openalex.org/W4402762068","eid":"W4402762068"},{"id":"paper-w3081352606","cat":"papers","name":"Reframing Bummer Trips: Scientific and Cultural Explanations to Adverse Reactions to Psychedelic Drug Use","year":"2020","cit":30,"pfa":"Erika Dyck","psa":"Chris Elcock","topics":["PTSD & trauma","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3081352606","eid":"W3081352606"},{"id":"paper-w2407594647","cat":"papers","name":"Functional Neuroimaging of Psychedelic Experience: An Overview of Psychological and Neural Effects and their Relevance to Research on Creativity, Daydreaming, and Dreaming","year":"2018","cit":30,"pfa":"Kieran C. R. Fox","psa":"Kalina Christoff","topics":["Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W2407594647","eid":"W2407594647"},{"id":"paper-w2312413470","cat":"papers","name":"Analgesic and Psychotomimetic Properties of Dexoxadrol.","year":"1965","cit":30,"pfa":"Louis C. Lasagna","psa":"J. W. Pearson","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2312413470","eid":"W2312413470"},{"id":"paper-w4399078157","cat":"papers","name":"Coming back together: a qualitative survey study of coping and support strategies used by people to cope with extended difficulties after the use of psychedelic drugs","year":"2024","cit":30,"pfa":"Oliver C. Robinson","psa":"Ed Prideaux","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4399078157","eid":"W4399078157"},{"id":"paper-w2072773847","cat":"papers","name":"Pharmacological specificity of some psychotomimetic and antipsychotic agents for the sigma and PCP binding sites","year":"1988","cit":30,"pfa":"Yossef Itzhak","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2072773847","eid":"W2072773847"},{"id":"paper-w2091865768","cat":"papers","name":"Prenatal lipopolysaccharide treatment enhances MK-801-induced psychotomimetic effects in rats","year":"2011","cit":30,"pfa":"Agnieszka Basta‐Kaim","psa":"Krzysztof Wędzony","ptype":"article","src":"https://openalex.org/W2091865768","eid":"W2091865768"},{"id":"paper-w2077732197","cat":"papers","name":"Autoradiography of LSD and 2,5-dimethoxyphenylisopropylamine psychotomimetics demonstrates regional, specific cross-displacement in the rat brain","year":"1987","cit":30,"pfa":"Dennis J. McKenna","psa":"Juan M. Saavedra","ptype":"article","src":"https://openalex.org/W2077732197","eid":"W2077732197"},{"id":"paper-w2417370326","cat":"papers","name":"Maximum-Intensity-Projection and Computer-Aided-Detection Algorithms as Stand-Alone Reader Devices in Lung Cancer Screening Using Different Dose Levels and Reconstruction Kernels","year":"2016","cit":30,"pfa":"Lukas Ebner","psa":"Andreas Christe","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2417370326","eid":"W2417370326"},{"id":"paper-w4220721136","cat":"papers","name":"Ketamine Analgesia and Psychedelia: Can We Dissociate Dissociation?","year":"2022","cit":30,"pfa":"George A. Mashour","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4220721136","eid":"W4220721136"},{"id":"paper-w2151917063","cat":"papers","name":"Measurements of dose with individual FAMOS transistors","year":"1999","cit":30,"pfa":"Leif Z. Scheick","psa":"B. Mason","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2151917063","eid":"W2151917063"},{"id":"paper-w1983142671","cat":"papers","name":"Snuff Synergy: Preparation, Use and Pharmacology ofYopoandBanisteriopsis CaapiAmong the Piaroa of Southern Venezuela","year":"2002","cit":30,"pfa":"Robin Rodd","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1983142671","eid":"W1983142671"},{"id":"paper-w160001781","cat":"papers","name":"Diazepam-ketamine anaesthesia for open heart surgery a “micro-mini” drip administration technique","year":"1976","cit":30,"pfa":"S Hatano","psa":"Max S. Sadove","ptype":"article","src":"https://openalex.org/W160001781","eid":"W160001781"},{"id":"paper-w2905977615","cat":"papers","name":"Rapastinel - an investigational NMDA-R modulator for major depressive disorder: evidence to date","year":"2018","cit":30,"pfa":"Renee‐Marie Ragguett","psa":"Roger S. McIntyre","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2905977615","eid":"W2905977615"},{"id":"paper-w2469799262","cat":"papers","name":"Subanesthetic doses of ketamine stabilize the fusion pore in a narrow flickering state in astrocytes","year":"2016","cit":30,"pfa":"Eva Lasič","psa":"Robert Zorec","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2469799262","eid":"W2469799262"},{"id":"paper-w1985767324","cat":"papers","name":"Efficacy of Small Doses of Ketamine With Morphine to Decrease Procedural Pain Responses During Open Wound Care","year":"2011","cit":30,"pfa":"Carmen Mabel Arroyo-Novoa","psa":"Kathleen Puntillo","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1985767324","eid":"W1985767324"},{"id":"paper-w4291512787","cat":"papers","name":"Pharmacological Comparative Characterization of REL-1017 (Esmethadone-HCl) and Other NMDAR Channel Blockers in Human Heterodimeric N-Methyl-D-Aspartate Receptors","year":"2022","cit":30,"pfa":"Ezio Bettini","psa":"Paolo L. Manfredi","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4291512787","eid":"W4291512787"},{"id":"paper-w2547031711","cat":"papers","name":"Reply to: Antidepressant Actions of Ketamine Versus Hydroxynorketamine","year":"2016","cit":30,"pfa":"Panos Zanos","psa":"Todd D. Gould","topics":["Depression"],"ptype":"letter","src":"https://openalex.org/W2547031711","eid":"W2547031711"},{"id":"paper-w3158538936","cat":"papers","name":"A comparison of the pharmacokinetics and NMDAR antagonism-associated neurotoxicity of ketamine, (2R,6R)-hydroxynorketamine and MK-801","year":"2021","cit":30,"pfa":"Patrick J. Morris","psa":"Craig J. Thomas","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3158538936","eid":"W3158538936"},{"id":"paper-w3114863113","cat":"papers","name":"Ketamine and Esketamine augmentation for suicidal ideation: A randomized, double-blinded clinical trial","year":"2020","cit":30,"pfa":"Flávia Vieira","psa":"Lucas C. Quarantini","ptype":"article","src":"https://openalex.org/W3114863113","eid":"W3114863113"},{"id":"paper-w3198178298","cat":"papers","name":"Long-Term Efficacy of Intranasal Esketamine in Treatment-Resistant Major Depression: A Systematic Review","year":"2021","cit":30,"pfa":"Enrico Capuzzi","psa":"Antonios Dakanalis","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W3198178298","eid":"W3198178298"},{"id":"paper-w4377939837","cat":"papers","name":"Repeated oral esketamine in patients with treatment resistant depression and comorbid posttraumatic stress disorder","year":"2023","cit":30,"pfa":"Jolien K. E. Veraart","psa":"J. de Jong","topics":["Depression","PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4377939837","eid":"W4377939837"},{"id":"paper-w4327811652","cat":"papers","name":"Effects of Different Doses of Esketamine on Pain Sensitivity of Patients Undergoing Thyroidectomy: A Randomized Controlled Trial","year":"2023","cit":30,"pfa":"Yan-ling Ren","psa":"Wei Zhang","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4327811652","eid":"W4327811652"},{"id":"paper-w4378782174","cat":"papers","name":"Case report: Intramuscular ketamine or intranasal esketamine as a treatment in four patients with major depressive disorder and comorbid anorexia nervosa","year":"2023","cit":30,"pfa":"Johanna Louise Keeler","psa":"Reid J. Robison","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4378782174","eid":"W4378782174"},{"id":"paper-w4311067644","cat":"papers","name":"Determining the effective dose of esketamine for mitigating pain during propofol injection by Dixon’s up-and-down method: a double-blind, prospective clinical study of drug dose response","year":"2022","cit":30,"pfa":"Meiyun Tan","psa":"Ding Huang","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4311067644","eid":"W4311067644"},{"id":"paper-w4378349369","cat":"papers","name":"Evaluating efficacy and safety of sub-anesthetic dose esketamine as an adjuvant to propofol/remifentanil analgosedation and spontaneous respiration for children flexible fibreoptic bronchoscopy: a prospective, double-bli","year":"2023","cit":30,"pfa":"Yu Zhong","psa":"Yubo Xie","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4378349369","eid":"W4378349369"},{"id":"paper-w3137358118","cat":"papers","name":"Meta-Analysis: Hemodynamic Responses to Sub-anesthetic Doses of Ketamine in Patients With Psychiatric Disorders","year":"2021","cit":30,"pfa":"Jay Vankawala","psa":"Jennifer B. Dwyer","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3137358118","eid":"W3137358118"},{"id":"paper-w4391934235","cat":"papers","name":"Sustained antidepressant effects of ketamine metabolite involve GABAergic inhibition-mediated molecular dynamics in aPVT glutamatergic neurons","year":"2024","cit":30,"pfa":"Ayako Kawatake-Kuno","psa":"Shusaku Uchida","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4391934235","eid":"W4391934235"},{"id":"paper-w4213185490","cat":"papers","name":"The safety and efficacy of ketamine NMDA receptor blocker as a therapeutic intervention for PTSD review of a randomized clinical trial","year":"2022","cit":30,"pfa":"Wisam Al Jumaili","psa":"Shailesh Bobby Jain","topics":["PTSD & trauma","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4213185490","eid":"W4213185490"},{"id":"paper-w4365518366","cat":"papers","name":"Pharmacologic Approaches to Suicide Prevention","year":"2023","cit":30,"pfa":"Sidney Zisook","psa":"Jason N. Compton","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4365518366","eid":"W4365518366"},{"id":"paper-w2048274661","cat":"papers","name":"Progression of Effects of Lysergic Acid Diethylamide [LSD]","year":"1956","cit":29,"pfa":"Santo Salvatore","ptype":"article","src":"https://openalex.org/W2048274661","eid":"W2048274661"},{"id":"paper-w2052499997","cat":"papers","name":"Determination of ibogaine and noribogaine in biological fluids and hair by LC–MS/MS after Tabernanthe iboga abuse","year":"2007","cit":29,"pfa":"Marjorie Chèze","psa":"Gilbert Pépin","ptype":"article","src":"https://openalex.org/W2052499997","eid":"W2052499997"},{"id":"paper-w2011821120","cat":"papers","name":"Lysergic Acid Diethylamide: Mutagenic Effects in Drosophila","year":"1968","cit":29,"pfa":"Luolin S Browning","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2011821120","eid":"W2011821120"},{"id":"paper-w2149945973","cat":"papers","name":"Effects of Lysergic Acid Diethylamide (LSD-25) on Intellectual Functions","year":"1958","cit":29,"pfa":"Arthur B. Silverstein","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2149945973","eid":"W2149945973"},{"id":"paper-w2077215669","cat":"papers","name":"Lysergic Acid Diethylamide (LSD-25): IV. Effect on Attention and Concentration","year":"1955","cit":29,"pfa":"Murray E. Jarvik","psa":"M. W. Hirsch","ptype":"article","src":"https://openalex.org/W2077215669","eid":"W2077215669"},{"id":"paper-w2062293843","cat":"papers","name":"Specificity of the Antibody Receptor Site to D-Lysergamide: Model of a Physiological Receptor for Lysergic Acid Diethylamide","year":"1971","cit":29,"pfa":"Helen Van Vunakis","psa":"Lawrence Levine","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2062293843","eid":"W2062293843"},{"id":"paper-w2099868948","cat":"papers","name":"EFFECTS OF d-LYSERGIC ACID DIETHYLAMIDE AND ITS BROM DERIVATIVE ON CARDIOVASCULAR RESPONSES TO SEROTONIN AND ON ARTERIAL PRESSURE","year":"1957","cit":29,"pfa":"G. C. Salmoiraghi","psa":"Irvine H. Page","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2099868948","eid":"W2099868948"},{"id":"paper-w2082372794","cat":"papers","name":"Differentiation between the stimulus effects of (+)-lysergic acid diethylamide and lisuride using a three-choice, drug discrimination procedure","year":"1990","cit":29,"pfa":"Patrick M. Callahan","psa":"James B. Appel","ptype":"article","src":"https://openalex.org/W2082372794","eid":"W2082372794"},{"id":"paper-w2077333577","cat":"papers","name":"Gas chromatography of peyote alkaloids. A new peyote alkaloid","year":"1968","cit":29,"pfa":"Jan Lundström","psa":"Stig Agurell","ptype":"article","src":"https://openalex.org/W2077333577","eid":"W2077333577"},{"id":"paper-w2072387868","cat":"papers","name":"The effects of d-lysergic acid diethylamide (LSD), 2,5-dimethoxy-4-methylamphetamine (DOM), pentobarbital and methaqualone on punished responding in control and 5,7-dihydroxytryptamine-treated rats","year":"1981","cit":29,"pfa":"Randall L. Commissaris","psa":"Richard H. Rech","ptype":"article","src":"https://openalex.org/W2072387868","eid":"W2072387868"},{"id":"paper-w2062569461","cat":"papers","name":"PEYOTE, THE GIVER OF VISIONS","year":"1925","cit":29,"pfa":"Ruth Shonle","ptype":"article","src":"https://openalex.org/W2062569461","eid":"W2062569461"},{"id":"paper-w3102192881","cat":"papers","name":"DARK Classics in Chemical Neuroscience: Salvinorin A","year":"2020","cit":29,"pfa":"Ricardo Bruno Hernández-Alvarado","psa":"Karina Martínez‐Mayorga","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3102192881","eid":"W3102192881"},{"id":"paper-w2030773025","cat":"papers","name":"Structure-activity relationship studies on mescaline: II. Tolerance and Cross-tolerance between mescaline and its analogues in the rat","year":"1966","cit":29,"pfa":"John Smythies","psa":"C. P. Lord","ptype":"article","src":"https://openalex.org/W2030773025","eid":"W2030773025"},{"id":"paper-w2012231094","cat":"papers","name":"Molecular Connectivity Analysis of Hallucinogenic Mescaline Analogs","year":"1979","cit":29,"pfa":"Richard A. Glennon","psa":"Alexander T. Shulgin","ptype":"article","src":"https://openalex.org/W2012231094","eid":"W2012231094"},{"id":"paper-w2761209584","cat":"papers","name":"Salvinorin A reduces neuropathic nociception in the insular cortex of the rat","year":"2017","cit":29,"pfa":"Ulises Coffeen","psa":"Francisco Pellicer","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2761209584","eid":"W2761209584"},{"id":"paper-w2115699064","cat":"papers","name":"Drug or spirituality seekers? Consuming ayahuasca","year":"2015","cit":29,"pfa":"Girish Prayag","psa":"Julien Fontaine","ptype":"article","src":"https://openalex.org/W2115699064","eid":"W2115699064"},{"id":"paper-w2025224760","cat":"papers","name":"MDMA in Adolescent Male Rats","year":"2006","cit":29,"pfa":"RAQUEL FARIA","psa":"Teresa Summavielle","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2025224760","eid":"W2025224760"},{"id":"paper-w2583277970","cat":"papers","name":"Treating drug dependence with the aid of ibogaine: A qualitative study","year":"2017","cit":29,"pfa":"Eduardo Ekman Schenberg","psa":"Dartiu Xavier da Silveira","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2583277970","eid":"W2583277970"},{"id":"paper-w2119091317","cat":"papers","name":"Pharmacokinetic Interactions between Monoamine Oxidase A Inhibitor Harmaline and 5-Methoxy-N,N-Dimethyltryptamine, and the Impact of CYP2D6 Status","year":"2013","cit":29,"pfa":"Xi-Ling Jiang","psa":"Ai‐Ming Yu","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2119091317","eid":"W2119091317"},{"id":"paper-w3037497292","cat":"papers","name":"Psilocybin occasioned mystical‐type experiences","year":"2020","cit":29,"pfa":"Edward James","psa":"Ben Sessa","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3037497292","eid":"W3037497292"},{"id":"paper-w2171712253","cat":"papers","name":"Ayahuasca as Antidepressant? Psychedelics and Styles of Reasoning in Psychiatry","year":"2012","cit":29,"pfa":"Brian T. Anderson","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2171712253","eid":"W2171712253"},{"id":"paper-w2512668841","cat":"papers","name":"Return of the psychedelics: Psilocybin for treatment resistant depression","year":"2016","cit":29,"pfa":"Suravi Patra","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2512668841","eid":"W2512668841"},{"id":"paper-w2084127135","cat":"papers","name":"Endocannabinoids and 3,4-methylenedioxymethamphetamine (MDMA) interaction","year":"2005","cit":29,"pfa":"Mariaelvina Sala","psa":"Daniela Braida","ptype":"article","src":"https://openalex.org/W2084127135","eid":"W2084127135"},{"id":"paper-w67970964","cat":"papers","name":"Identifying Spiritual Content in Reports From Ayahuasca Sessions","year":"2000","cit":29,"pfa":"Stanley Krippner","psa":"Joseph Sulla","ptype":"article","src":"https://openalex.org/W67970964","eid":"W67970964"},{"id":"paper-w2083958927","cat":"papers","name":"A new behavior change program using psilocybin.","year":"1965","cit":29,"pfa":"Timothy Leary","psa":"Kinne Sara","ptype":"article","src":"https://openalex.org/W2083958927","eid":"W2083958927"},{"id":"paper-w4403080353","cat":"papers","name":"Impact of psilocybin on cognitive function: A systematic review","year":"2024","cit":29,"pfa":"Shakila Meshkat","psa":"Venkat Bhat","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4403080353","eid":"W4403080353"},{"id":"paper-w2338546826","cat":"papers","name":"AYAHUASCA BEYOND THE AMAZON THE BENEFITS AND RISKS OF A SPREADING TRADITION","year":"2010","cit":29,"pfa":"Stephen Trichter","topics":["Safety & adverse events","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2338546826","eid":"W2338546826"},{"id":"paper-w1977163759","cat":"papers","name":"The Effects of Ayahuasca Ritual Participation on Gay and Lesbian Identity","year":"2014","cit":29,"pfa":"Clancy Cavnar","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W1977163759","eid":"W1977163759"},{"id":"paper-w1875336531","cat":"papers","name":"A reinvenção do uso da ayahuasca nos centros urbanos","year":"2000","cit":29,"pfa":"Beatriz Caiuby Labate","ptype":"dissertation","src":"https://openalex.org/W1875336531","eid":"W1875336531"},{"id":"paper-w2067588211","cat":"papers","name":"Interaction of ibogaine with human α3β4-nicotinic acetylcholine receptors in different conformational states","year":"2010","cit":29,"pfa":"Hugo Rubén Arias","psa":"Irving W. Wainer","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2067588211","eid":"W2067588211"},{"id":"paper-w1970477170","cat":"papers","name":"Study with mescaline-8-C14 in mice: Effect of amine oxidase inhibitors on metabolism","year":"1971","cit":29,"pfa":"N S Shah","psa":"Harold E. Himwich","ptype":"article","src":"https://openalex.org/W1970477170","eid":"W1970477170"},{"id":"paper-w2509979524","cat":"papers","name":"Tracing hallucinations: contributing to a critical ethnohistory of Ayahuasca usage in the peruvian amazon","year":"2011","cit":29,"pfa":"Bernd Brabec de Mori","ptype":"article","src":"https://openalex.org/W2509979524","eid":"W2509979524"},{"id":"paper-w2083871873","cat":"papers","name":"MDMA toxicity: no evidence for a major influence of metabolic genotype at CYP2D6","year":"1998","cit":29,"pfa":"Alan O'Donohoe","psa":"Michael Gill","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2083871873","eid":"W2083871873"},{"id":"paper-w2000021284","cat":"papers","name":"Effects of the psychodysleptic drug psilocybin on visual perception. Changes in brightness preference","year":"1969","cit":29,"pfa":"R. Fischer","psa":"Diana Warshay","ptype":"article","src":"https://openalex.org/W2000021284","eid":"W2000021284"},{"id":"paper-w4210913256","cat":"papers","name":"Psilocybin for Treating Psychiatric Disorders: A Psychonaut Legend or a Promising Therapeutic Perspective?","year":"2022","cit":29,"pfa":"Maurizio Coppola","psa":"Raffaella Mondola","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4210913256","eid":"W4210913256"},{"id":"paper-w2301632466","cat":"papers","name":"Motor delays in MDMA (ecstasy) exposed infants persist to 2 years","year":"2016","cit":29,"pfa":"Lynn T. Singer","psa":"Andrew C. Parrott","ptype":"article","src":"https://openalex.org/W2301632466","eid":"W2301632466"},{"id":"paper-w2101548207","cat":"papers","name":"Human pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) after repeated doses taken 4h apart Human pharmacology of MDMA after repeated doses taken 4h apart","year":"2015","cit":29,"pfa":"Magı́ Farré","psa":"Rafael de la Torre","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2101548207","eid":"W2101548207"},{"id":"paper-w2155578222","cat":"papers","name":"In vitro immunopotentiating properties and tumour cell toxicity induced by Lophophora williamsii (peyote) cactus methanolic extract","year":"2003","cit":29,"pfa":"Moisés Ármides Franco-Molina","psa":"Cristina Rodrı́guez-Padilla","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2155578222","eid":"W2155578222"},{"id":"paper-w4292869909","cat":"papers","name":"Assessing the quality of publicly available videos on MDMA‐assisted psychotherapy for PTSD","year":"2022","cit":29,"pfa":"Mariam Kyarunts","psa":"Bhanu Prakash Kolla","topics":["PTSD & trauma","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4292869909","eid":"W4292869909"},{"id":"paper-w2086400191","cat":"papers","name":"Caffeine induces a profound and persistent tachycardia in response to MDMA (“Ecstasy”) administration","year":"2006","cit":29,"pfa":"Ruth McNamara","psa":"Andrew Harkin","ptype":"article","src":"https://openalex.org/W2086400191","eid":"W2086400191"},{"id":"paper-w2331382592","cat":"papers","name":"Teratogenic Effects of Mimosa tenuiflora in a Rat Model and Possible Role of N-Methyl- and N,N-Dimethyltryptamine","year":"2014","cit":29,"pfa":"Dale R. Gardner","psa":"Kip E. Panter","ptype":"article","src":"https://openalex.org/W2331382592","eid":"W2331382592"},{"id":"paper-w2917810478","cat":"papers","name":"The therapeutic potential of harmine and ayahuasca in depression: evidence from exploratory animal and human studies","year":"2011","cit":29,"pfa":"Flávia de Lima Osório","psa":"Jaime E. C. Hallak","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2917810478","eid":"W2917810478"},{"id":"paper-w2802058469","cat":"papers","name":"Too Hot to Handle: A Case Report of Extreme Pyrexia After MDMA Ingestion","year":"2018","cit":29,"pfa":"Fritz‐Patrick Jahns","psa":"Georg M. Auzinger","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2802058469","eid":"W2802058469"},{"id":"paper-w2061940435","cat":"papers","name":"Salvinorin A Produces Cerebrovasodilation through Activation of Nitric Oxide Synthase, κ Receptor, and Adenosine Triphosphate–sensitive Potassium Channel","year":"2011","cit":29,"pfa":"Diansan Su","psa":"Renyu Liu","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2061940435","eid":"W2061940435"},{"id":"paper-w4393118291","cat":"papers","name":"Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depression","year":"2024","cit":29,"pfa":"David Erritzøe","psa":"Robin Lester Carhart-Harris","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4393118291","eid":"W4393118291"},{"id":"paper-w4405978092","cat":"papers","name":"Compass Psychological Support Model for COMP360 Psilocybin Treatment of Serious Mental Health Conditions","year":"2025","cit":29,"pfa":"Namik Kirlić","psa":"Don Koelpin","topics":["Depression","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4405978092","eid":"W4405978092"},{"id":"paper-w1985777444","cat":"papers","name":"Effects of ambient temperature on the relative reinforcing strength of MDMA using a choice procedure in monkeys","year":"2007","cit":29,"pfa":"Matthew L. Banks","psa":"Michael A. Nader","ptype":"article","src":"https://openalex.org/W1985777444","eid":"W1985777444"},{"id":"paper-w2399518187","cat":"papers","name":"Involvement of NMDA glutamate receptors in the acquisition and reinstatement of the conditioned place preference induced by MDMA","year":"2015","cit":29,"pfa":"María Pilar García-Pardo","psa":"M.A. Aguilar","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2399518187","eid":"W2399518187"},{"id":"paper-w1991872667","cat":"papers","name":"Increased behavioural response to 5-methoxy-N,N-dimethyltryptamine but not to RU-24969 after intraventricular 5,7-dihydroxytryptamine administration","year":"1984","cit":29,"pfa":"Angus P. Nisbet","psa":"Charles Alexander Marsden","ptype":"article","src":"https://openalex.org/W1991872667","eid":"W1991872667"},{"id":"paper-w2395177923","cat":"papers","name":"Effects of acute social stress on the conditioned place preference induced by MDMA in adolescent and adult mice","year":"2014","cit":29,"pfa":"María Pilar García-Pardo","psa":"M.A. Aguilar","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2395177923","eid":"W2395177923"},{"id":"paper-w2152201062","cat":"papers","name":"Characteristics and trends of 3,4-methylenedioxymethamphetamine (MDMA) tablets found in Taiwan from 2002 to February 2005","year":"2006","cit":29,"pfa":"Shu-Fang Teng","psa":"Chun-Sheng Chien","ptype":"article","src":"https://openalex.org/W2152201062","eid":"W2152201062"},{"id":"paper-w4385827303","cat":"papers","name":"Serotonin 5-HT 2B receptor agonism and valvular heart disease: implications for the development of psilocybin and related agents","year":"2023","cit":29,"pfa":"Roger S. McIntyre","topics":["Mechanism & neuroscience"],"ptype":"editorial","src":"https://openalex.org/W4385827303","eid":"W4385827303"},{"id":"paper-w4387047256","cat":"papers","name":"Psilocybin analog 4-OH-DiPT enhances fear extinction and GABAergic inhibition of principal neurons in the basolateral amygdala","year":"2023","cit":29,"pfa":"Thomas J. Kelly","psa":"Qing-song Liu","ptype":"article","src":"https://openalex.org/W4387047256","eid":"W4387047256"},{"id":"paper-w1965557712","cat":"papers","name":"Reinforcing effects of methylenedioxy amphetamine congeners in rhesus monkeys: are intravenous self-administration experiments relevant to MDMA neurotoxicity?","year":"2006","cit":29,"pfa":"William E. Fantegrossi","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1965557712","eid":"W1965557712"},{"id":"paper-w4386954292","cat":"papers","name":"Drug-induced social connection: both MDMA and methamphetamine increase feelings of connectedness during controlled dyadic conversations","year":"2023","cit":29,"pfa":"Hanna M. Molla","psa":"Harriet de Wit","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4386954292","eid":"W4386954292"},{"id":"paper-w2132997021","cat":"papers","name":"MDMA enhances hippocampal-dependent learning and memory under restrictive conditions, and modifies hippocampal spine density","year":"2013","cit":29,"pfa":"Sònia Abad","psa":"Elena Escubedo","ptype":"article","src":"https://openalex.org/W2132997021","eid":"W2132997021"},{"id":"paper-w2057410419","cat":"papers","name":"Serotonergic modulation of 3,4-methylenedioxymethamphetamine (MDMA)-elicited reduction of response rate but not rewarding threshold in accumbal self-stimulation","year":"1997","cit":29,"pfa":"Hui Qiang Lin","psa":"Iain S. McGregor","ptype":"article","src":"https://openalex.org/W2057410419","eid":"W2057410419"},{"id":"paper-w1969418677","cat":"papers","name":"Sulfation of the 3,4-methylenedioxymethamphetamine (MDMA) metabolites 3,4-dihydroxymethamphetamine (DHMA) and 4-hydroxy-3-methoxymethamphetamine (HMMA) and their capability to inhibit human sulfotransferases","year":"2011","cit":29,"pfa":"Andrea Eva Steuer","psa":"Hans H. Maurer","ptype":"article","src":"https://openalex.org/W1969418677","eid":"W1969418677"},{"id":"paper-w2032352736","cat":"papers","name":"Acute and chronic effects of MDMA on molecular mechanisms implicated in memory formation in rat hippocampus: Surface expression of CaMKII and NMDA receptor subunits","year":"2005","cit":29,"pfa":"Sonia Moyano","psa":"Diana Frechilla","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2032352736","eid":"W2032352736"},{"id":"paper-w1977654997","cat":"papers","name":"Acutely applied MDMA enhances long-term potentiation in rat hippocampus involving D1/D5 and 5-HT2 receptors through a polysynaptic mechanism","year":"2011","cit":29,"pfa":"Carlos Rozas","psa":"Bernardo Morales","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1977654997","eid":"W1977654997"},{"id":"paper-w4403328142","cat":"papers","name":"Striking long-term beneficial effects of single dose psilocybin and psychedelic mushroom extract in the SAPAP3 rodent model of OCD-like excessive self-grooming","year":"2024","cit":29,"pfa":"Michal Brownstien","psa":"Bernard Lerer","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4403328142","eid":"W4403328142"},{"id":"paper-w2034745026","cat":"papers","name":"Single dose of MDMA causes extensive decrement of serotoninergic fibre density without blockage of the fast axonal transport in Dark Agouti rat brain and spinal cord","year":"2007","cit":29,"pfa":"Gábor Géza Kovács","psa":"György Bagdy","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2034745026","eid":"W2034745026"},{"id":"paper-w4366989647","cat":"papers","name":"Safety, tolerability, and clinical and neural effects of single-dose psilocybin in obsessive–compulsive disorder: protocol for a randomized, double-blind, placebo-controlled, non-crossover trial","year":"2023","cit":29,"pfa":"Terence H. W. Ching","psa":"Benjamin Kelmendi","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4366989647","eid":"W4366989647"},{"id":"paper-w4283206789","cat":"papers","name":"MDMA-assisted therapy for posttraumatic stress disorder: A pooled analysis of ethnoracial differences in efficacy and safety from two Phase 2 open-label lead-in trials and a Phase 3 randomized, blinded placebo-controlled","year":"2022","cit":29,"pfa":"Terence H. W. Ching","psa":"Rick Doblin","topics":["PTSD & trauma","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4283206789","eid":"W4283206789"},{"id":"paper-w2132410530","cat":"papers","name":"Club Drug Use among Youths in Treatment for Substance Abuse","year":"2006","cit":29,"pfa":"Christian Jean Hopfer","psa":"Sabrina Hooks","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2132410530","eid":"W2132410530"},{"id":"paper-w3012971106","cat":"papers","name":"Psychedelics and dissociative substances","year":"2020","cit":29,"pfa":"ADAM R. WINSTOCK","psa":"James Rucker","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"book-chapter","src":"https://openalex.org/W3012971106","eid":"W3012971106"},{"id":"paper-w4282930656","cat":"papers","name":"New Paradigms of Old Psychedelics in Schizophrenia","year":"2022","cit":29,"pfa":"Danish Mahmood","psa":"Mariusz Jaremko","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4282930656","eid":"W4282930656"},{"id":"paper-w1985072118","cat":"papers","name":"Persistent Increase in Brain Serotonin Turnover after Chronic Administration of LSD in the Rat","year":"1971","cit":29,"pfa":"José-Luis Díaz","psa":"MATTI O. HUTTUNEN","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1985072118","eid":"W1985072118"},{"id":"paper-w4327813391","cat":"papers","name":"Psychedelic Treatments for Substance Use Disorder and Substance Misuse: A Mixed Methods Systematic Review","year":"2023","cit":29,"pfa":"Raman Sharma","psa":"Jacqueline Sin","topics":["Addiction","Reviews & meta-analyses","Therapy practice"],"ptype":"review","src":"https://openalex.org/W4327813391","eid":"W4327813391"},{"id":"paper-w3167789562","cat":"papers","name":"Predicting changes in substance use following psychedelic experiences: natural language processing of psychedelic session narratives","year":"2021","cit":29,"pfa":"David J. Cox","psa":"Matthew W. Johnson","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W3167789562","eid":"W3167789562"},{"id":"paper-w2157837543","cat":"papers","name":"Hallucinogens Causing Seizures? A Case Report of the Synthetic Amphetamine 2,5-Dimethoxy-4-Chloroamphetamine","year":"2014","cit":29,"pfa":"Mark J. Burish","psa":"Maulik Shah","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2157837543","eid":"W2157837543"},{"id":"paper-w4229061392","cat":"papers","name":"Hallucinogenic Persisting Perception Disorder: A Case Series and Review of the Literature","year":"2022","cit":29,"pfa":"Hannah A. Ford","psa":"Anneke van der Walt","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4229061392","eid":"W4229061392"},{"id":"paper-w4322757924","cat":"papers","name":"Is the Requirement for First-Person Experience of Psychedelic Drugs a Justified Component of a Psychedelic Therapist’s Training?","year":"2023","cit":29,"pfa":"Nathan Emmerich","psa":"Bryce Humphries","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4322757924","eid":"W4322757924"},{"id":"paper-w1993801873","cat":"papers","name":"Effect of D-LSD and related compounds on release of norepinephrine-H3 and serotonin-H3 evoked from brain slices by electrical stimulation","year":"1969","cit":29,"pfa":"Richard I. Katz","psa":"Irwin J. Kopin","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1993801873","eid":"W1993801873"},{"id":"paper-w2600087165","cat":"papers","name":"Rapid Identification of Psychoactive Drugs in Drained Gastric Lavage Fluid and Whole Blood Specimens of Drug Overdose Patients Using Ambient Mass Spectrometry","year":"2017","cit":29,"pfa":"Chi‐Wei Lee","psa":"Jentaie Shiea","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2600087165","eid":"W2600087165"},{"id":"paper-w2013525285","cat":"papers","name":"The unique effect of methiothepin on the terminal serotonin autoreceptor in the rat hypothalamus could be an example of inverse agonism","year":"1993","cit":29,"pfa":"Chantal Moret","psa":"Mike Briley","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2013525285","eid":"W2013525285"},{"id":"paper-w4387745733","cat":"papers","name":"LSD-induced changes in the functional connectivity of distinct thalamic nuclei","year":"2023","cit":29,"pfa":"Stefano Delli Pizzi","psa":"Stefano Luca Sensi","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4387745733","eid":"W4387745733"},{"id":"paper-w2031679558","cat":"papers","name":"Observations on the metabolism of the psychotomimetic indolealkylamines: Implications for future clinical studies","year":"1990","cit":29,"pfa":"Balvant R. Sitaram","psa":"W. R. McLeod","ptype":"article","src":"https://openalex.org/W2031679558","eid":"W2031679558"},{"id":"paper-w2032530287","cat":"papers","name":"Persistent effects of chronic clozapine on the cellular and behavioral responses to LSD in mice","year":"2012","cit":29,"pfa":"José L. Moreno","psa":"Javier González‐Maeso","ptype":"article","src":"https://openalex.org/W2032530287","eid":"W2032530287"},{"id":"paper-w2519512536","cat":"papers","name":"Anxiogenic activity of methylenedioxymethamphetamine (Ecstasy): An experimental study","year":"1998","cit":29,"pfa":"Salil K. Bhattacharya","psa":"Shibnath Ghosal","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2519512536","eid":"W2519512536"},{"id":"paper-w2091625287","cat":"papers","name":"Tolerance to LSD and DOB induced shaking behaviour: Differential adaptations of frontocortical 5-HT2A and glutamate receptor binding sites","year":"2014","cit":29,"pfa":"Tobias Buchborn","psa":"Volker Höllt","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2091625287","eid":"W2091625287"},{"id":"paper-w2005700263","cat":"papers","name":"Detection of 1-Benzylpiperazine, 1-(3-Trifluoromethylphenyl)-piperazine, and 1-(3-Chlorophenyl)-piperazine in 3,4-Methylenedioxymethamphetamine-Positive Urine Samples","year":"2010","cit":29,"pfa":"A. J. Dickson","psa":"T. P. Lyons","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2005700263","eid":"W2005700263"},{"id":"paper-w1991642472","cat":"papers","name":"(±)3,4‐methylenedioxymethamphetamine (“ecstasy”) treatment modulates expression of neurotrophins and their receptors in multiple regions of adult rat brain","year":"2012","cit":29,"pfa":"Ann M. Hemmerle","psa":"Kim B. Seroogy","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1991642472","eid":"W1991642472"},{"id":"paper-w2947348227","cat":"papers","name":"Validation of an LC-MS/MS method for the quantitative analysis of 1P-LSD and its tentative metabolite LSD in fortified urine and serum samples including stability tests for 1P-LSD under different storage conditions","year":"2019","cit":29,"pfa":"Christina Grumann","psa":"Volker Auwärter","ptype":"article","src":"https://openalex.org/W2947348227","eid":"W2947348227"},{"id":"paper-w4382182909","cat":"papers","name":"Psychedelics, Meaningfulness, and the “Proper Scope” of Medicine: Continuing the Conversation","year":"2023","cit":29,"pfa":"Katherine Cheung","psa":"David B. Yaden","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W4382182909","eid":"W4382182909"},{"id":"paper-w4231328231","cat":"papers","name":"Disruptive Psychopharmacology","year":"2019","cit":29,"pfa":"Boris Dov Heifets","psa":"Robert C. Malenka","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4231328231","eid":"W4231328231"},{"id":"paper-w2009390034","cat":"papers","name":"Analysis of indole alkaloids in Norwegian Psilocybe semilanceata using high-performance liquid chromatography and mass spectrometry","year":"1982","cit":29,"pfa":"A.L. Christiansen","psa":"Knut E. Rasmussen","ptype":"article","src":"https://openalex.org/W2009390034","eid":"W2009390034"},{"id":"paper-w2982715891","cat":"papers","name":"Setup of a Serotonin 2A Receptor (5-HT2AR) Bioassay: Demonstration of Its Applicability To Functionally Characterize Hallucinogenic New Psychoactive Substances and an Explanation Why 5-HT2AR Bioassays Are Not Suited for","year":"2019","cit":29,"pfa":"Eline Pottie","psa":"Christophe Pol Stove","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2982715891","eid":"W2982715891"},{"id":"paper-w2058407731","cat":"papers","name":"Analysis of amphetamine, methamphetamine, methylenedioxyamphetamine and methylenedioxymethamphetamine in whole blood using in-matrix ethyl chloroformate derivatization and automated headspace solid-phase microextraction","year":"2008","cit":29,"pfa":"Jeff Wise","psa":"Richard C. Li","ptype":"article","src":"https://openalex.org/W2058407731","eid":"W2058407731"},{"id":"paper-w2183199254","cat":"papers","name":"Gender Differences in the Effect of Prenatal Methamphetamine Exposure and Challenge Dose of Other Drugs on Behavior of Adult Rats","year":"2013","cit":29,"pfa":"Romana Šlamberová","psa":"Richard Rokyta","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2183199254","eid":"W2183199254"},{"id":"paper-w4282962482","cat":"papers","name":"Psychedelics as preventive treatment in headache and chronic pain disorders","year":"2022","cit":29,"pfa":"Emmanuelle A. D. Schindler","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4282962482","eid":"W4282962482"},{"id":"paper-w3094549229","cat":"papers","name":"The Role of Psychedelics and Counseling in Mental Health Treatment","year":"2020","cit":29,"pfa":"Russ Curtis","psa":"Verena Wieloch","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W3094549229","eid":"W3094549229"},{"id":"paper-w2981681161","cat":"papers","name":"New psychoactive substances (NPS) prevalence over LSD in blotter seized in State of Santa Catarina, Brazil: A six-year retrospective study","year":"2019","cit":29,"pfa":"Bruna de Souza Boff","psa":"Kéttulin Zomer Rezin","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2981681161","eid":"W2981681161"},{"id":"paper-w4362508370","cat":"papers","name":"Are psychedelic medicines the reset for chronic pain? Preliminary findings and research needs","year":"2023","cit":29,"pfa":"Farah Z. Zia","psa":"Ann M. Berger","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4362508370","eid":"W4362508370"},{"id":"paper-w4200034096","cat":"papers","name":"Beating pain with psychedelics: Matter over mind?","year":"2021","cit":29,"pfa":"Igor Elman","psa":"David Borsook","ptype":"article","src":"https://openalex.org/W4200034096","eid":"W4200034096"},{"id":"paper-w3014217676","cat":"papers","name":"Continuous Ketamine Infusion for Pain as an Opportunity for Psychotherapy for PTSD: A Case Series of Ketamine-Enhanced Psychotherapy for PTSD and Pain (KEP-P2)","year":"2020","cit":29,"pfa":"Benjamin M. Keizer","psa":"John Harrison Krystal","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W3014217676","eid":"W3014217676"},{"id":"paper-w4390988530","cat":"papers","name":"Informed Consent to Psychedelic-Assisted Psychotherapy: Ethical Considerations","year":"2024","cit":29,"pfa":"Andrew G. Lee","psa":"Daniel Z. Buchman","topics":["Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4390988530","eid":"W4390988530"},{"id":"paper-w2085691122","cat":"papers","name":"Peak Experiences: Investigation of Their Relationship to Psychedelic Therapy and Self-Actualization","year":"1967","cit":29,"pfa":"Robert E. Klavetter","psa":"Robert E. Mogar","ptype":"article","src":"https://openalex.org/W2085691122","eid":"W2085691122"},{"id":"paper-w2032946581","cat":"papers","name":"Ketamine-Assisted Intravenous Sedation with Midazolam: Benefits and Potential Problems","year":"1999","cit":29,"pfa":"Ronald P. Gruber","psa":"Brendon Morley","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2032946581","eid":"W2032946581"},{"id":"paper-w3088530988","cat":"papers","name":"Ensuring the psychedelic renaissance and radical healing reach the Black community: Commentary on Culture and Psychedelic Psychotherapy","year":"2020","cit":29,"pfa":"NiCole T. Buchanan","topics":["PTSD & trauma","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3088530988","eid":"W3088530988"},{"id":"paper-w4298137791","cat":"papers","name":"Animal Behavior in Psychedelic Research","year":"2022","cit":29,"pfa":"Anna U. Odland","psa":"Jesper Tobias Andreasen","ptype":"article","src":"https://openalex.org/W4298137791","eid":"W4298137791"},{"id":"paper-w2810219073","cat":"papers","name":"Psychedelics and hypnosis: Commonalities and therapeutic implications","year":"2018","cit":29,"pfa":"Clément E. Lemercier","psa":"Devin Blair Terhune","topics":["Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2810219073","eid":"W2810219073"},{"id":"paper-w4293452910","cat":"papers","name":"Psychedelic Forum Member Preferences for Carer Experience and Consumption Behavior: Can “Trip Sitters” Help Inform Psychedelic Harm Reduction Services?","year":"2022","cit":29,"pfa":"Liam B. Engel","psa":"Stephen Jason Bright","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4293452910","eid":"W4293452910"},{"id":"paper-w4285152426","cat":"papers","name":"Philosophy and Psychedelics","year":"2022","cit":29,"topics":["Policy & ethics"],"ptype":"book","src":"https://openalex.org/W4285152426","eid":"W4285152426"},{"id":"paper-w4229938706","cat":"papers","name":"Hallucinogens: An Update: NIDA Research Monograph 146","year":"1994","cit":29,"pfa":"Geraline C. Lin","psa":"Richard A. Glennon","ptype":"dataset","src":"https://openalex.org/W4229938706","eid":"W4229938706"},{"id":"paper-w4281293221","cat":"papers","name":"The Psychedelic Integration Scales: Tools for Measuring Psychedelic Integration Behaviors and Experiences","year":"2022","cit":29,"pfa":"Tomas Frymann","psa":"Joshua Lipson","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4281293221","eid":"W4281293221"},{"id":"paper-w2078424422","cat":"papers","name":"Jimson seed poisoning — A new hallucinogen on the horizon","year":"1977","cit":29,"pfa":"Richard Levy","ptype":"article","src":"https://openalex.org/W2078424422","eid":"W2078424422"},{"id":"paper-w2093328760","cat":"papers","name":"Sertraline Treatment of Hallucinogen Persisting Perception Disorder","year":"1997","cit":29,"pfa":"Carl R. Young","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2093328760","eid":"W2093328760"},{"id":"paper-w3164016075","cat":"papers","name":"Tolerance to neurochemical and behavioral effects of the hallucinogen 25I-NBOMe","year":"2021","cit":29,"pfa":"Monika Herian","psa":"Krystyna Gołembiowska","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3164016075","eid":"W3164016075"},{"id":"paper-w4254332205","cat":"papers","name":"Plant Medicines, Healing and Psychedelic Science","year":"2018","cit":29,"ptype":"book","src":"https://openalex.org/W4254332205","eid":"W4254332205"},{"id":"paper-w645962376","cat":"papers","name":"Carlos Castaneda: Academic Opportunism and the Psychedelic Sixties","year":"1993","cit":29,"pfa":"Jay Courtney Fikes","psa":"Phil C. Weigand","ptype":"book","src":"https://openalex.org/W645962376","eid":"W645962376"},{"id":"paper-w4409730083","cat":"papers","name":"Psychedelic control of neuroimmune interactions governing fear","year":"2025","cit":29,"pfa":"Elizabeth N Chung","psa":"Michael A. Wheeler","ptype":"article","src":"https://openalex.org/W4409730083","eid":"W4409730083"},{"id":"paper-w2804529812","cat":"papers","name":"Amanita Muscaria (Fly Agaric): From a Shamanistic Hallucinogen to the Search for Acetylcholine","year":"2018","cit":29,"pfa":"M R Lee","psa":"Iain Milne","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2804529812","eid":"W2804529812"},{"id":"paper-w3090878082","cat":"papers","name":"Psychedelic experience and the narrative self: An exploratory qualitative study","year":"2020","cit":29,"pfa":"Nicole M. Amada","psa":"Jacob Shane","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3090878082","eid":"W3090878082"},{"id":"paper-w1968195188","cat":"papers","name":"Mixing and demixing of microdose quantities of sodium salicylate in a direct compression vehicle","year":"1979","cit":29,"pfa":"Lesley J. Bryan","psa":"Peter J. Stewart","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1968195188","eid":"W1968195188"},{"id":"paper-w2019692714","cat":"papers","name":"Personality change associated with psychedelic (LSD) therapy: A preliminary report.","year":"1964","cit":29,"pfa":"Robert E. Mogar","psa":"Charles Savage","ptype":"article","src":"https://openalex.org/W2019692714","eid":"W2019692714"},{"id":"paper-w2077572620","cat":"papers","name":"Psychedelic Drug-Induced Psychological Crises: Attitudes of the “Crisis Therapist”","year":"1979","cit":29,"pfa":"Stuart W. Twemlow","psa":"William Talbot Bowen","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2077572620","eid":"W2077572620"},{"id":"paper-w4385954214","cat":"papers","name":"Improvement in OCD symptoms associated with serotoninergic psychedelics: a retrospective online survey","year":"2023","cit":29,"pfa":"Anne Buot","psa":"Luc Mallet","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4385954214","eid":"W4385954214"},{"id":"paper-w4384695430","cat":"papers","name":"Imprinting: expanding the extra-pharmacological model of psychedelic drug action to incorporate delayed influences of sets and settings","year":"2023","cit":29,"pfa":"Nicolas Garel","psa":"Kyle T. Greenway","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4384695430","eid":"W4384695430"},{"id":"paper-w4322726467","cat":"papers","name":"Microtoxin for Improving Pore Size, Skin Laxity, Sebum Control, and Scars: A Roundtable on Integrating Intradermal Botulinum Toxin Type A Microdoses Into Clinical Practice","year":"2023","cit":29,"pfa":"Sabrina Guillen Fabi","psa":"Woffles T. L. Wu","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4322726467","eid":"W4322726467"},{"id":"paper-w4389725281","cat":"papers","name":"Unique effects of sedatives, dissociatives, psychedelics, stimulants, and cannabinoids on episodic memory: A review and reanalysis of acute drug effects on recollection, familiarity, and metamemory.","year":"2023","cit":29,"pfa":"Manoj K. Doss","psa":"Joshua D. Koen","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4389725281","eid":"W4389725281"},{"id":"paper-w1992636096","cat":"papers","name":"Phencyclidine, a Psychotomimetic Agent and Drug of Abuse, Is a Suicide Inhibitor of Brain Nitric Oxide Synthase","year":"1993","cit":29,"pfa":"Yoichi Osawa","psa":"J.C. Davila","ptype":"article","src":"https://openalex.org/W1992636096","eid":"W1992636096"},{"id":"paper-w2089024589","cat":"papers","name":"Subjective Effects ofSalvia Divinorum: LSD- or Marijuana-like?","year":"2009","cit":29,"pfa":"Dawn N. Albertson","psa":"Laura E. Grubbs","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2089024589","eid":"W2089024589"},{"id":"paper-w2106916988","cat":"papers","name":"Disruption of thalamocortical activity in schizophrenia models: relevance to antipsychotic drug action","year":"2013","cit":29,"pfa":"Pau Celada","psa":"Francesc Artigas","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2106916988","eid":"W2106916988"},{"id":"paper-w2505785527","cat":"papers","name":"Reducing the time to develop and manufacture formulations forfirst oral dose in humans","year":"2003","cit":29,"pfa":"Madhusudan Hariharan","psa":"P. Gatti","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2505785527","eid":"W2505785527"},{"id":"paper-w2072623373","cat":"papers","name":"Hallucinogenic plants of abuse","year":"2008","cit":29,"pfa":"Nicola Yumei Cunningham","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2072623373","eid":"W2072623373"},{"id":"paper-w2043715997","cat":"papers","name":"Predicted Structures and Dynamics for Agonists and Antagonists Bound to Serotonin 5-HT2B and 5-HT2C Receptors","year":"2011","cit":29,"pfa":"Soo‐Kyung Kim","psa":"William A. Goddard","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2043715997","eid":"W2043715997"},{"id":"paper-w2079727263","cat":"papers","name":"Propofol Inhibits Ketamine-Induced c-fos Expression in the Rat Posterior Cingulate Cortex","year":"1998","cit":29,"pfa":"Atsushi Nagata","psa":"Koh Shingu","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2079727263","eid":"W2079727263"},{"id":"paper-w4402190181","cat":"papers","name":"New Psychoactive Substances Toxicity: A Systematic Review of Acute and Chronic Psychiatric Effects","year":"2024","cit":29,"pfa":"Beldisa Taflaj","psa":"Ilaria D’Acquarica","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W4402190181","eid":"W4402190181"},{"id":"paper-w4321365791","cat":"papers","name":"Ketamine as a therapeutic agent in major depressive disorder and posttraumatic stress disorder: Potential medicinal and deleterious effects","year":"2023","cit":29,"pfa":"Bhuvi Sachdeva","psa":"Jitendra Kumar Sinha","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4321365791","eid":"W4321365791"},{"id":"paper-w4256643384","cat":"papers","name":"Xenon Inhibits but N2O Enhances Ketamine-Induced c-Fos Expression in the Rat Posterior Cingulate and Retrosplenial Cortices","year":"2001","cit":29,"pfa":"Atsushi Nagata","psa":"Koh Shingu","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4256643384","eid":"W4256643384"},{"id":"paper-w2014717229","cat":"papers","name":"Substance Use Disorders and Adoption: Findings from a National Sample","year":"2012","cit":29,"pfa":"Gihyun Yoon","psa":"Michael A. Kuskowski","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2014717229","eid":"W2014717229"},{"id":"paper-w3107846575","cat":"papers","name":"Disparities in Documented Drug Use Disorders Between Transgender and Cisgender U.S. Veterans Health Administration Patients","year":"2020","cit":29,"pfa":"Madeline C. Frost","psa":"Emily C. Williams","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3107846575","eid":"W3107846575"},{"id":"paper-w2143718635","cat":"papers","name":"Apomorphine and the dopamine hypothesis of schizophrenia: a dilemma?","year":"2001","cit":29,"pfa":"Lana Dépatie","psa":"Samarthji Lal","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2143718635","eid":"W2143718635"},{"id":"paper-w2097900465","cat":"papers","name":"Enhanced latent inhibition in dopamine receptor-deficient mice is sex-specific for the D1 but not D2 receptor subtype: implications for antipsychotic drug action","year":"2008","cit":29,"pfa":"Cecilie Bay-Richter","psa":"Paula M. Moran","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2097900465","eid":"W2097900465"},{"id":"paper-w2908623526","cat":"papers","name":"EEG 40 Hz Coherence Decreases in REM Sleep and Ketamine Model of Psychosis","year":"2019","cit":29,"pfa":"Santiago Castro‐Zaballa","psa":"Pablo Torterolo","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2908623526","eid":"W2908623526"},{"id":"paper-w2944167939","cat":"papers","name":"NMDA Receptor Antagonist Effects on Speech-Related Mismatch Negativity and Its Underlying Oscillatory and Source Activity in Healthy Humans","year":"2019","cit":29,"pfa":"Sara de la Salle","psa":"Verner Knott","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2944167939","eid":"W2944167939"},{"id":"paper-w2801183533","cat":"papers","name":"Ketamine enhances structural plasticity in human dopaminergic neurons: possible relevance for treatment-resistant depression","year":"2018","cit":29,"pfa":"Ginetta Collo","psa":"Emilio Merlo Pich","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2801183533","eid":"W2801183533"},{"id":"paper-w3215387264","cat":"papers","name":"Mechanisms of Action of Ketamine and Esketamine","year":"2021","cit":29,"pfa":"Alan F. Schatzberg","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3215387264","eid":"W3215387264"},{"id":"paper-w2936113533","cat":"papers","name":"Pharmacological evaluation of clinically relevant concentrations of (2R,6R)-hydroxynorketamine","year":"2019","cit":29,"pfa":"Christopher L. Shaffer","psa":"Derek L. Buhl","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2936113533","eid":"W2936113533"},{"id":"paper-w2773137913","cat":"papers","name":"The Ketamine Metabolite 2R,6R-Hydroxynorketamine Blocks NMDA Receptors and Impacts Downstream Signaling Linked to Antidepressant Effects","year":"2017","cit":29,"pfa":"Ege T. Kavalali","psa":"Lisa M. Monteggia","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2773137913","eid":"W2773137913"},{"id":"paper-w3062622103","cat":"papers","name":"Managing dissociative symptoms following the use of esketamine nasal spray: a case report","year":"2020","cit":29,"pfa":"Sophia Pereira","psa":"Michael R. Liebowitz","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3062622103","eid":"W3062622103"},{"id":"paper-w4309322003","cat":"papers","name":"Opioid-reduced anesthesia based on esketamine in gynecological day surgery: a randomized double-blind controlled study","year":"2022","cit":29,"pfa":"Teng Zhu","psa":"Guizhi Wang","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4309322003","eid":"W4309322003"},{"id":"paper-w3216474897","cat":"papers","name":"Effect of Sleep Disturbance on Efficacy of Esketamine in Treatment-Resistant Depression: Findings from Randomized Controlled Trials","year":"2021","cit":29,"pfa":"Stephane Borentain","psa":"Frank Wiegand","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3216474897","eid":"W3216474897"},{"id":"paper-w4226209427","cat":"papers","name":"The efficacy and safety of adjunctive intranasal esketamine treatment in major depressive disorder: a systematic review and meta-analysis","year":"2022","cit":29,"pfa":"Muhammad Youshay Jawad","psa":"Roger S. McIntyre","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4226209427","eid":"W4226209427"},{"id":"paper-w2741582082","cat":"papers","name":"The effects of intranasal esketamine (84 mg) and oral mirtazapine (30 mg) on on-road driving performance: a double-blind, placebo-controlled study","year":"2017","cit":29,"pfa":"Aurora J.A.E. van de Loo","psa":"Joris C. Verster","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2741582082","eid":"W2741582082"},{"id":"paper-w4296888858","cat":"papers","name":"Cost-effectiveness of esketamine nasal spray compared to intravenous ketamine for patients with treatment-resistant depression in the US utilizing clinical trial efficacy and real-world effectiveness estimates","year":"2022","cit":29,"pfa":"Madeline Brendle","psa":"Daniel C. Malone","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4296888858","eid":"W4296888858"},{"id":"paper-w2584228583","cat":"papers","name":"Gauging circadian variation in ketamine metabolism by real-time breath analysis","year":"2017","cit":29,"pfa":"Pablo Sinues","psa":"Robert Dallmann","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2584228583","eid":"W2584228583"},{"id":"paper-w2346745491","cat":"papers","name":"Ketamine steps out of the darkness","year":"2016","cit":29,"pfa":"Roberto Malinow","ptype":"article","src":"https://openalex.org/W2346745491","eid":"W2346745491"},{"id":"paper-w3040075005","cat":"papers","name":"The stress susceptibility factor FKBP51 controls S-ketamine-evoked release of mBDNF in the prefrontal cortex of mice","year":"2020","cit":29,"pfa":"Elmira A. Anderzhanova","psa":"Nils C. Gassen","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3040075005","eid":"W3040075005"},{"id":"paper-w2080970381","cat":"papers","name":"Lysergic Acid Diethylamide: Effects on the Developing Mouse Lens","year":"1969","cit":28,"pfa":"Joseph Hanaway","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2080970381","eid":"W2080970381"},{"id":"paper-w2088910614","cat":"papers","name":"Genetic toxicology of lysergic acid diethylamide (LSD-25)","year":"1977","cit":28,"pfa":"Maimon M. Cohen","psa":"Yosef Shiloh","ptype":"article","src":"https://openalex.org/W2088910614","eid":"W2088910614"},{"id":"paper-w2061406198","cat":"papers","name":"Effects of psilocybin, dimethyltryptamine, mescaline and various allergic acid derivatives on the EEG and on photically induced epilepsy in the baboon (Papio papio)","year":"1971","cit":28,"pfa":"Brian S. Meldrum","psa":"R Naquet","ptype":"article","src":"https://openalex.org/W2061406198","eid":"W2061406198"},{"id":"paper-w2043312960","cat":"papers","name":"Structure-activity relationships among 5-methoxy-N:N-dimethyltryptamine, 4-hydroxy-N:N-dimethyltryptamine (psilocin) and other substituted tryptamines","year":"1968","cit":28,"pfa":"Peter K. Gessner","psa":"J.M. McMullan","ptype":"article","src":"https://openalex.org/W2043312960","eid":"W2043312960"},{"id":"paper-w2020811787","cat":"papers","name":"Impairment by lysergic acid diethylamide of accuracy in performance of a delayed alternation test in monkeys","year":"1960","cit":28,"pfa":"Murray E. Jarvik","psa":"Stephan L. Chorover","ptype":"article","src":"https://openalex.org/W2020811787","eid":"W2020811787"},{"id":"paper-w2064035476","cat":"papers","name":"Discriminative control of behavior by electrical stimulation of the dorsal raphe nucleus: generalization to lysergic acid diethylamide (LSD)","year":"1975","cit":28,"pfa":"Ira D. Hirschhorn","psa":"John A. Rosecrans","ptype":"article","src":"https://openalex.org/W2064035476","eid":"W2064035476"},{"id":"paper-w2407151076","cat":"papers","name":"Handling of psilocybin and psilocin by everted sacs of rat jejunum and colon.","year":"1989","cit":28,"pfa":"K Eivindvik","psa":"R B Sund","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2407151076","eid":"W2407151076"},{"id":"paper-w4307773202","cat":"papers","name":"Race and ethnicity moderate the associations between lifetime psychedelic use (MDMA/ecstasy and psilocybin) and major depressive episodes","year":"2022","cit":28,"pfa":"Grant M. Jones","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W4307773202","eid":"W4307773202"},{"id":"paper-w4324263264","cat":"papers","name":"Automated Extraction of Lysergic Acid Diethylamide (LSD) and N-demethyl-LSD from Blood, Serum, Plasma, and Urine Samples Using the Zymark RapidTrace™ with LC/MS/MS Confirmation","year":"1998","cit":28,"pfa":"John de Kanel","psa":"Francis X. Diamond","ptype":"article","src":"https://openalex.org/W4324263264","eid":"W4324263264"},{"id":"paper-w2408785472","cat":"papers","name":"Effects of d-lysergic acid diethylamide, d-2-bromolysergic acid diethylamide, dl-2,5-dimethoxy-4-methylamphetamine and d-amphetamine on classical conditioning of the rabbit nictitating membrane response.","year":"1982","cit":28,"pfa":"J A Harvey","psa":"Valerie A. Cool","ptype":"article","src":"https://openalex.org/W2408785472","eid":"W2408785472"},{"id":"paper-w1932565198","cat":"papers","name":"Noribogaine reduces nicotine self-administration in rats","year":"2015","cit":28,"pfa":"Qing Chang","psa":"Émeline L. Maillet","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1932565198","eid":"W1932565198"},{"id":"paper-w2080355486","cat":"papers","name":"Studies Towards the Synthesis of Salvinorin A","year":"2006","cit":28,"pfa":"Anthony R. Lingham","psa":"Trevor J. Rook","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2080355486","eid":"W2080355486"},{"id":"paper-w1974728462","cat":"papers","name":"The metabolism of mescaline-14C in rats","year":"1967","cit":28,"pfa":"José M. Musacchio","psa":"Menek Goldstein","ptype":"article","src":"https://openalex.org/W1974728462","eid":"W1974728462"},{"id":"paper-w4390101689","cat":"papers","name":"Safety and tolerability of inhaled N,N-Dimethyltryptamine (BMND01 candidate): A phase I clinical trial","year":"2023","cit":28,"pfa":"Marcelo Falchi-Carvalho","psa":"Fernanda Palhano-Fontes","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4390101689","eid":"W4390101689"},{"id":"paper-w2072225106","cat":"papers","name":"Adolescent pre-exposure to ethanol or MDMA prolongs the conditioned rewarding effects of MDMA","year":"2011","cit":28,"pfa":"Bruno Ribeiro Do Couto","psa":"M.A. Aguilar","ptype":"article","src":"https://openalex.org/W2072225106","eid":"W2072225106"},{"id":"paper-w4384069906","cat":"papers","name":"A Route to Potent, Selective, and Biased Salvinorin Chemical Space","year":"2023","cit":28,"pfa":"Sarah J. Hill","psa":"Ryan A. Shenvi","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4384069906","eid":"W4384069906"},{"id":"paper-w2567380967","cat":"papers","name":"Ayahuasca: An ancient sacrament for treatment of contemporary psychiatric illness?","year":"2017","cit":28,"pfa":"Benjamin Malcolm","psa":"Kelly C. Lee","topics":["Depression","Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2567380967","eid":"W2567380967"},{"id":"paper-w4285591032","cat":"papers","name":"The influence of ceremonial settings on mystical and challenging experiences occasioned by ayahuasca: A survey among ritualistic and religious ayahuasca users","year":"2022","cit":28,"pfa":"Alexandre Augusto de Deus Pontual","psa":"Johannes Gerardus Ramaekers","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4285591032","eid":"W4285591032"},{"id":"paper-w2124465479","cat":"papers","name":"Identity of peyocactin, an antibiotic from peyote (Lophophora williamsii), and hordenine","year":"1970","cit":28,"pfa":"G Subba Rao","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2124465479","eid":"W2124465479"},{"id":"paper-w2089043951","cat":"papers","name":"Interactions between iboga agents and methamphetamine sensitization: studies of locomotion and stereotypy in rats","year":"2000","cit":28,"pfa":"Karen Kathleen Szumlinski","psa":"S.D. Glick","ptype":"article","src":"https://openalex.org/W2089043951","eid":"W2089043951"},{"id":"paper-w1980159291","cat":"papers","name":"Anti-HIV-1 Activity of the Iboga Alkaloid Congener 18-Methoxycoronaridine","year":"2004","cit":28,"pfa":"Edinete M. Silva","psa":"Dumith Chequer Bou‐Habib","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1980159291","eid":"W1980159291"},{"id":"paper-w2008873753","cat":"papers","name":"High affinity ibogaine binding to a mu opioid agonist site","year":"1995","cit":28,"pfa":"Ellen E. Codd","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2008873753","eid":"W2008873753"},{"id":"paper-w2036928246","cat":"papers","name":"Iboga compounds reverse the behavioural disinhibiting and corticosterone effects of acute methamphetamine: Implications for their antiaddictive properties","year":"2001","cit":28,"pfa":"Karen Kathleen Szumlinski","psa":"Stanley D. Glick","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2036928246","eid":"W2036928246"},{"id":"paper-w2002369990","cat":"papers","name":"Neuroendocrine and neurochemical effects of acute ibogaine administration: a time course evaluation","year":"1996","cit":28,"pfa":"Syed F. Ali","psa":"Michael H. Baumann","ptype":"article","src":"https://openalex.org/W2002369990","eid":"W2002369990"},{"id":"paper-w4392888270","cat":"papers","name":"Safety pharmacology of acute psilocybin administration in healthy participants","year":"2024","cit":28,"pfa":"Isabelle Straumann","psa":"Matthias E. Liechti","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4392888270","eid":"W4392888270"},{"id":"paper-w2012008744","cat":"papers","name":"Pipe, Bible, and peyote among the Oglala Lakota: a study in religious identity","year":"1990","cit":28,"ptype":"book-review","src":"https://openalex.org/W2012008744","eid":"W2012008744"},{"id":"paper-w2951642362","cat":"papers","name":"Dippinines A - D, New Iboga-derived Indole Alkaloids from Tabernaemontana","year":"2001","cit":28,"pfa":"Toh‐Seok Kam","psa":"Kooi‐Mow Sim","ptype":"article","src":"https://openalex.org/W2951642362","eid":"W2951642362"},{"id":"paper-w2088746567","cat":"papers","name":"Risky car following in abstinent users of MDMA","year":"2010","cit":28,"pfa":"Elizabeth Dastrup","psa":"Matthew Rizzo","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2088746567","eid":"W2088746567"},{"id":"paper-w1970140907","cat":"papers","name":"The effects of dimethoxyphenylethylamine and mescaline on classical conditioning in rats as measured by the potentiated startle response","year":"1967","cit":28,"pfa":"Wagner H. Bridger","psa":"Irwin J. Mandel","ptype":"article","src":"https://openalex.org/W1970140907","eid":"W1970140907"},{"id":"paper-w4409320785","cat":"papers","name":"The evolution of N, N-Dimethyltryptamine: from metabolic pathways to brain connectivity","year":"2025","cit":28,"pfa":"Swanti Gupta","psa":"Amla Chopra","ptype":"article","src":"https://openalex.org/W4409320785","eid":"W4409320785"},{"id":"paper-w2027679864","cat":"papers","name":"Determination of psilocybin in Psilocybe semilanceata by capillary zone electrophoresis","year":"1997","cit":28,"pfa":"Stig Pedersen‐Bjergaard","psa":"Finn Tønnesen","ptype":"article","src":"https://openalex.org/W2027679864","eid":"W2027679864"},{"id":"paper-w4318620298","cat":"papers","name":"Psychotherapeutic and neurobiological processes associated with ayahuasca: A proposed model and implications for therapeutic use","year":"2023","cit":28,"pfa":"Daniel Perkins","psa":"Jerome J. Sarris","topics":["Safety & adverse events","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4318620298","eid":"W4318620298"},{"id":"paper-w2015332250","cat":"papers","name":"Learning and Memory Impairment Induced by Salvinorin A, the Principal Ingredient of Salvia divinorum , in Wistar Rats","year":"2011","cit":28,"pfa":"Daniela Braida","psa":"Mariaelvina Sala","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2015332250","eid":"W2015332250"},{"id":"paper-w2605065122","cat":"papers","name":"Post-mortem redistribution of 3,4-methylenedioxymethamphetamine (MDMA, \"ecstasy\") in the rabbit","year":"2002","cit":28,"pfa":"Els A. De Letter","psa":"Michel H A Piette","ptype":"article","src":"https://openalex.org/W2605065122","eid":"W2605065122"},{"id":"paper-w2791096742","cat":"papers","name":"Maternal and developmental toxicity of the hallucinogenic plant-based beverage ayahuasca in rats","year":"2018","cit":28,"pfa":"Luciana Gueiros da Motta","psa":"Eloísa Dutra Caldas","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2791096742","eid":"W2791096742"},{"id":"paper-w2058065177","cat":"papers","name":"MDMA administration decreases serotonin but not N-acetylaspartate in the rat brain","year":"2010","cit":28,"pfa":"Shane Alan Perrine","psa":"Matthew P. Galloway","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2058065177","eid":"W2058065177"},{"id":"paper-w2039613893","cat":"papers","name":"Δ9-Tetrahydrocannabinol attenuates MDMA-induced hyperthermia in rhesus monkeys","year":"2011","cit":28,"pfa":"Michael A. Taffe","ptype":"article","src":"https://openalex.org/W2039613893","eid":"W2039613893"},{"id":"paper-w2044099738","cat":"papers","name":"The prevalence of MDMA/MDA in both hair and urine in drug users","year":"2005","cit":28,"pfa":"Eunyoung Han","psa":"Heesun Chung","ptype":"article","src":"https://openalex.org/W2044099738","eid":"W2044099738"},{"id":"paper-w2064406921","cat":"papers","name":"MDMA alters the response of the circadian clock to a photic and non-photic stimulus","year":"2002","cit":28,"pfa":"Suzanne Colbron","psa":"Stephany M. Biello","ptype":"article","src":"https://openalex.org/W2064406921","eid":"W2064406921"},{"id":"paper-w2017434974","cat":"papers","name":"Michael acceptor approach to the design of new salvinorin A-based high affinity ligands for the kappa-opioid receptor","year":"2014","cit":28,"pfa":"Prabhakar Reddy Polepally","psa":"Jordan Kordian Zjawiony","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2017434974","eid":"W2017434974"},{"id":"paper-w4409286565","cat":"papers","name":"Psilocybin therapy for mood dysfunction in Parkinson’s disease: an open-label pilot trial","year":"2025","cit":28,"pfa":"Ellen  R. Bradley","psa":"Joshua D. Woolley","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4409286565","eid":"W4409286565"},{"id":"paper-w3013080961","cat":"papers","name":"How does ayahuasca work from a psychiatric perspective? Pros and cons of the entheogenic therapy","year":"2020","cit":28,"pfa":"Laura Orsolini","psa":"Domenico De Berardis","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3013080961","eid":"W3013080961"},{"id":"paper-w2080454129","cat":"papers","name":"Patterns of Memory Dysfunction in Current and 2-year Abstinent MDMA Users","year":"2006","cit":28,"pfa":"Jeff Ward","psa":"Catherine Haslam","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2080454129","eid":"W2080454129"},{"id":"paper-w2001520420","cat":"papers","name":"Parallel changes in serotonin levels in brain and blood following acute administration of MDMA","year":"2012","cit":28,"pfa":"Cheryl M Collins","psa":"J. Martin Elliott","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2001520420","eid":"W2001520420"},{"id":"paper-w4245531894","cat":"papers","name":"Cerebral 1H MRS alterations in recreational 3,4‐methylenedioxymethamphetamine (MDMA, “ecstasy”) users","year":"1999","cit":28,"pfa":"L. Chang","psa":"R.E. Poland","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4245531894","eid":"W4245531894"},{"id":"paper-w2075748132","cat":"papers","name":"Circadian variation in the head twitch response produced by 5-methoxy-N1,N1-dimethyltryptamine and p-chloroamphetamine in the mouse","year":"1981","cit":28,"pfa":"C. Singleton","psa":"Charles Alexander Marsden","ptype":"article","src":"https://openalex.org/W2075748132","eid":"W2075748132"},{"id":"paper-w2017799163","cat":"papers","name":"Memory and mood during the night and in the morning after repeated evening doses of MDMA","year":"2008","cit":28,"pfa":"Kim P. C. Kuypers","psa":"JG Ramaekers","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2017799163","eid":"W2017799163"},{"id":"paper-w2071694134","cat":"papers","name":"An Appraisal of the Pharmacological and Toxicological Effects of a Single Oral Administration of 3,4‐Methylenedioxymethamphetamine (MDMA) in the Rat","year":"1997","cit":28,"pfa":"Ivone de Souza","psa":"B. E. Leonard","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2071694134","eid":"W2071694134"},{"id":"paper-w2037054886","cat":"papers","name":"MDMA pretreatment leads to mild chronic unpredictable stress-induced impairments in spatial learning.","year":"2009","cit":28,"pfa":"Jacobi I. Cunningham","psa":"Bryan K. Yamamoto","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2037054886","eid":"W2037054886"},{"id":"paper-w1964019892","cat":"papers","name":"Diazatetraester 1H-Pyrazole Crowns as Fluorescent Chemosensors for AMPH, METH, MDMA (Ecstasy), and Dopamine","year":"2008","cit":28,"pfa":"Felipe Reviriego","psa":"Enrique Ortı́","ptype":"article","src":"https://openalex.org/W1964019892","eid":"W1964019892"},{"id":"paper-w2170792539","cat":"papers","name":"MDMA assisted psychotherapy found to have a large effect for chronic post-traumatic stress disorder","year":"2013","cit":28,"pfa":"Henri Chabrol","topics":["PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2170792539","eid":"W2170792539"},{"id":"paper-w2765997654","cat":"papers","name":"Additive Effects of 3,4-Methylenedioxymethamphetamine (MDMA) and Compassionate Imagery on Self-Compassion in Recreational Users of Ecstasy","year":"2017","cit":28,"pfa":"Sunjeev K. Kamboj","psa":"Tom P. Freeman","ptype":"article","src":"https://openalex.org/W2765997654","eid":"W2765997654"},{"id":"paper-w4220804493","cat":"papers","name":"Role of 5-HT2A receptors in the effects of ayahuasca on ethanol self-administration using a two-bottle choice paradigm in male mice","year":"2022","cit":28,"pfa":"Yasmim A. Serra","psa":"E.A.V. Marinho","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4220804493","eid":"W4220804493"},{"id":"paper-w3122532724","cat":"papers","name":"A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT2A Receptor Density in the Pig Brain","year":"2020","cit":28,"pfa":"Nakul Ravi Raval","psa":"Gitte M. Knudsen","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W3122532724","eid":"W3122532724"},{"id":"paper-w4223957806","cat":"papers","name":"Components of Banisteriopsis caapi, a Plant Used in the Preparation of the Psychoactive Ayahuasca, Induce Anti-Inflammatory Effects in Microglial Cells","year":"2022","cit":28,"pfa":"Beatriz Werneck Lopes Santos","psa":"Eloísa Dutra Caldas","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4223957806","eid":"W4223957806"},{"id":"paper-w2987713023","cat":"papers","name":"Effects of the hallucinogenic beverage ayahuasca on voluntary ethanol intake by rats and on cFos expression in brain areas relevant to drug addiction","year":"2019","cit":28,"pfa":"Luciana Marangni Nolli","psa":"Eloísa Dutra Caldas","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2987713023","eid":"W2987713023"},{"id":"paper-w1964590918","cat":"papers","name":"Prior Exposure to Chronic Stress and MDMA Potentiates Mesoaccumbens Dopamine Release Mediated by the 5-HT1B Receptor","year":"2006","cit":28,"pfa":"Jennifer L Amato","psa":"Bryan K. Yamamoto","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1964590918","eid":"W1964590918"},{"id":"paper-w3100349700","cat":"papers","name":"The potential use of N-methyl-3,4-methylenedioxyamphetamine (MDMA) assisted psychotherapy in the treatment of eating disorders comorbid with PTSD","year":"2020","cit":28,"pfa":"Timothy D. Brewerton","psa":"Michael C. Mithoefer","topics":["PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3100349700","eid":"W3100349700"},{"id":"paper-w2006555556","cat":"papers","name":"Cellular determinants of reduced adaptability of the aging brain: neurotransmitter utilization and cell signaling responses after MDMA lesions","year":"2000","cit":28,"pfa":"Theodore A. Slotkin","psa":"Syed F. Ali","ptype":"article","src":"https://openalex.org/W2006555556","eid":"W2006555556"},{"id":"paper-w2155849144","cat":"papers","name":"Changes in interleukin-1 signal modulators induced by 3,4-methylenedioxymethamphetamine (MDMA): regulation by CB2 receptors and implications for neurotoxicity","year":"2011","cit":28,"pfa":"Elisa Torres","psa":"María Isabel Colado","topics":["Safety & adverse events","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2155849144","eid":"W2155849144"},{"id":"paper-w4311439362","cat":"papers","name":"“A sense of the bigger picture:” A qualitative analysis of follow-up interviews with people with bipolar disorder who self-reported psilocybin use","year":"2022","cit":28,"pfa":"Meghan A. DellaCrosse","psa":"Erin E. Michalak","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4311439362","eid":"W4311439362"},{"id":"paper-w4402912774","cat":"papers","name":"Single-dose psilocybin for U.S. military Veterans with severe treatment-resistant depression – A first-in-kind open-label pilot study","year":"2024","cit":28,"pfa":"Sara Ellis","psa":"Trisha M Suppes","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4402912774","eid":"W4402912774"},{"id":"paper-w2057607386","cat":"papers","name":"Gas chromatographic-mass spectrometric identification of N:N-dimethyltryptamine in urine samples from drug-free chronic schizophrenic patients and its quantitation by the technique of single (selective) ion monitoring","year":"1973","cit":28,"pfa":"N. Narasimhachari","psa":"Harold E. Himwich","ptype":"article","src":"https://openalex.org/W2057607386","eid":"W2057607386"},{"id":"paper-w4319869979","cat":"papers","name":"The therapeutic potential of psychedelics: the European regulatory perspective","year":"2023","cit":28,"pfa":"Florence Butlen‐Ducuing","psa":"Steffen Thirstrup","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4319869979","eid":"W4319869979"},{"id":"paper-w1995655033","cat":"papers","name":"Metabolism and toxicological analyses of hallucinogenic tryptamine analogues being abused in Japan","year":"2010","cit":28,"pfa":"Tooru Kamata","psa":"Hitoshi Tsuchihashi","ptype":"article","src":"https://openalex.org/W1995655033","eid":"W1995655033"},{"id":"paper-w2089510248","cat":"papers","name":"THE ACTION OF 5‐HYDROXYTRYPTAMINE AND SOME OF ITS ANTAGONISTS ON THE UMBILICAL VESSELS OF THE HUMAN PLACENTA","year":"1957","cit":28,"pfa":"Arne Åström","psa":"U. Samelius","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2089510248","eid":"W2089510248"},{"id":"paper-w2016681203","cat":"papers","name":"II. The Effects of Some Hallucinogens on Aggressiveness of Mice and Rats","year":"2008","cit":28,"pfa":"Wojciech Kostowski","psa":"Tadeusz Piechocki","ptype":"article","src":"https://openalex.org/W2016681203","eid":"W2016681203"},{"id":"paper-w2413687271","cat":"papers","name":"Hallucinogenic Plants in the Mediterranean Countries","year":"2016","cit":28,"pfa":"Ioannis D. Passos","psa":"Maria Mironidou‐Tzouveleki","ptype":"book-chapter","src":"https://openalex.org/W2413687271","eid":"W2413687271"},{"id":"paper-w4214940428","cat":"papers","name":"Virtual Reality as a Moderator of Psychedelic-Assisted Psychotherapy","year":"2022","cit":28,"pfa":"Agnieszka D. Sekula","psa":"Prashanth Puspanathan","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4214940428","eid":"W4214940428"},{"id":"paper-w4299558211","cat":"papers","name":"Use of Hallucinogenic Drugs on Campus","year":"1968","cit":28,"pfa":"Lillian L. Imperi","ptype":"article","src":"https://openalex.org/W4299558211","eid":"W4299558211"},{"id":"paper-w2011405831","cat":"papers","name":"The Rise, Decline, and Fall of LSD","year":"1991","cit":28,"pfa":"Robert F. Ulrich","psa":"Bernard M. Patten","topics":["Addiction","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2011405831","eid":"W2011405831"},{"id":"paper-w2164977754","cat":"papers","name":"Mescalina y ritual del cactus de san Pedro: evidencias arqueológicas y etnográficas en el norte de Perú","year":"2006","cit":28,"pfa":"Francisco Javier Carod-Artal","psa":"C Vázquez-Cabrera","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2164977754","eid":"W2164977754"},{"id":"paper-w4285194661","cat":"papers","name":"The White Sun of Substance: Spinozism and the Psychedelic amor Dei intellectualis","year":"2022","cit":28,"pfa":"Peter Sjöstedt-Hughes","topics":["Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W4285194661","eid":"W4285194661"},{"id":"paper-w3163918973","cat":"papers","name":"Opposite alterations of 5HT2A receptor brain density in subjects with schizophrenia: relevance of radiotracers pharmacological profile","year":"2021","cit":28,"pfa":"Rebeca Dı́ez-Alarcia","psa":"J. Javier Meana","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3163918973","eid":"W3163918973"},{"id":"paper-w2077344396","cat":"papers","name":"Restoration of 3,4-methylenedioxymethamphetamine-induced 5-HT depletion by the administration of l-5-hydroxytryptophan","year":"2007","cit":28,"pfa":"X. Wang","psa":"Richard B. Rothman","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2077344396","eid":"W2077344396"},{"id":"paper-w2021623983","cat":"papers","name":"Validated liquid chromatographic–electrospray ionization mass spectrometric assay for simultaneous determination of 3,4-methylenedioxymethamphetamine and its metabolites 3,4-methylenedioxyamphetamine, 3,4-dihydroxymetham","year":"2007","cit":28,"pfa":"Melanie Mueller","psa":"Hans H. Maurer","ptype":"article","src":"https://openalex.org/W2021623983","eid":"W2021623983"},{"id":"paper-w4411090921","cat":"papers","name":"Efficacy and safety of low- versus high-dose-LSD-assisted therapy in patients with major depression: A randomized trial","year":"2025","cit":28,"pfa":"Felix Müller","psa":"Matthias E. Liechti","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4411090921","eid":"W4411090921"},{"id":"paper-w2018460939","cat":"papers","name":"(±)-3,4-Methylenedioxymethamphetamine-induced changes in the basal activity and pharmacological responsiveness of nigrostriatal dopamine neurons","year":"1989","cit":28,"pfa":"M D Kelland","psa":"Louis A. Chiodo","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2018460939","eid":"W2018460939"},{"id":"paper-w4322502734","cat":"papers","name":"Application of Quantum–Chemical Methods in the Forensic Prediction of Psychedelic Drugs’ Spectra (IR, NMR, UV–VIS, and MS): A Case Study of LSD and Its Analogs","year":"2023","cit":28,"pfa":"Jelica Džodić","psa":"Dušan Dimić","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4322502734","eid":"W4322502734"},{"id":"paper-w2040633906","cat":"papers","name":"3,4-Methylenedioxymethamphetamine induces differential regulation of tryptophan hydroxylase 2 protein and mRNA levels in the rat dorsal raphe nucleus","year":"2008","cit":28,"pfa":"Willy L. Bonkale","psa":"M.C. Austin","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2040633906","eid":"W2040633906"},{"id":"paper-w1455488133","cat":"papers","name":"Chiral Plasma Pharmacokinetics of 3,4-Methylenedioxymethamphetamine and its Phase I and II Metabolites following Controlled Administration to Humans","year":"2015","cit":28,"pfa":"Andrea Eva Steuer","psa":"Thomas Kræmer","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1455488133","eid":"W1455488133"},{"id":"paper-w2098030211","cat":"papers","name":"Stacking and low‐temperature technique in nonaqueous capillary electrophoresis for the analysis of 3,4‐methylenedioxymethamphetamine","year":"2004","cit":28,"pfa":"Chih‐Hsin Tsai","psa":"Cheng‐Huang Lin","ptype":"article","src":"https://openalex.org/W2098030211","eid":"W2098030211"},{"id":"paper-w2063459474","cat":"papers","name":"Behavioral sensitization to 3,4-methylenedioxymethamphetamine is long-lasting and modulated by the context of drug administration","year":"2011","cit":28,"pfa":"Kevin T. Ball","psa":"Rachel Slack","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2063459474","eid":"W2063459474"},{"id":"paper-w1542988921","cat":"papers","name":"Traffic Fatality Related to the Use of Methylenedioxymethamphetamine","year":"1996","cit":28,"pfa":"Joseph A. Crifasi","psa":"Christopher W. Long","ptype":"article","src":"https://openalex.org/W1542988921","eid":"W1542988921"},{"id":"paper-w2041573502","cat":"papers","name":"Naltrindole, a δ-opioid antagonist, blocks MDMA's ability to enhance pressing for rewarding brain stimulation","year":"1996","cit":28,"pfa":"Larry D. Reid","psa":"Christopher A. Amendola","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2041573502","eid":"W2041573502"},{"id":"paper-w1979387198","cat":"papers","name":"Evaluation of the neurotoxicity of N-methyl-1-(4-methoxyphenyl)-2-aminopropane (para-methoxymethamphetamine, PMMA)","year":"1992","cit":28,"pfa":"Thomas Steele","psa":"George A. Ricaurte","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1979387198","eid":"W1979387198"},{"id":"paper-w2073098242","cat":"papers","name":"Synthesis markers in illegally manufactured 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine","year":"1993","cit":28,"pfa":"M. Bohn","psa":"Gottfried Blaschke","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2073098242","eid":"W2073098242"},{"id":"paper-w4200524305","cat":"papers","name":"A Spectrum of Selves Reinforced in Multilevel Coherence: A Contextual Behavioural Response to the Challenges of Psychedelic-Assisted Therapy Development","year":"2021","cit":28,"pfa":"Henry J. Whitfield","topics":["Depression","PTSD & trauma","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4200524305","eid":"W4200524305"},{"id":"paper-w4200231433","cat":"papers","name":"Cytochrome P450-Catalyzed Biosynthesis of a Dihydrofuran Neoclerodane in Magic Mint ( Salvia divinorum )","year":"2021","cit":28,"pfa":"Moonhyuk Kwon","psa":"Dae‐Kyun Ro","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4200231433","eid":"W4200231433"},{"id":"paper-w133660007","cat":"papers","name":"Breaking convention: Essays on psychedelic consciousness","year":"2013","cit":28,"pfa":"Cameron Adams","psa":"David King","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W133660007","eid":"W133660007"},{"id":"paper-w408741721","cat":"papers","name":"Les effets de l’ayahuasca sur le système nerveux central: étude comportementale","year":"2007","cit":28,"pfa":"Laís M. S. de Lima","psa":"J.C.T. Carvalho","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W408741721","eid":"W408741721"},{"id":"paper-w4280525486","cat":"papers","name":"Safety considerations in the evolving legal landscape of psychedelic-assisted psychotherapy","year":"2022","cit":28,"pfa":"Victor Mocanu","psa":"Elena Argento","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4280525486","eid":"W4280525486"},{"id":"paper-w1984887025","cat":"papers","name":"MOOD IN RELATION TO SUBCLINICAL OBSESSIVE-COMPULSIVE SYMPTOMS","year":"2005","cit":28,"pfa":"Marcello Spinella","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W1984887025","eid":"W1984887025"},{"id":"paper-w4315752589","cat":"papers","name":"Post-traumatic stress symptoms, post-traumatic stress disorder, and post-traumatic growth among cancer survivors: a systematic scoping review of interventions","year":"2023","cit":28,"pfa":"Jessica M. Capaldi","psa":"Celina H. Shirazipour","topics":["PTSD & trauma","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4315752589","eid":"W4315752589"},{"id":"paper-w4211193039","cat":"papers","name":"Friend of the Devil: Negative Social Influences Driving Substance Use Disorders","year":"2022","cit":28,"pfa":"Matthew B. Pomrenze","psa":"Rajani Maiya","topics":["Addiction","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4211193039","eid":"W4211193039"},{"id":"paper-w2130552984","cat":"papers","name":"Personality and the Prediction of High-Risk Trajectories of Alcohol Use During Adolescence","year":"2014","cit":28,"pfa":"Margot Peeters","psa":"Reinout W. H. J. Wiers","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2130552984","eid":"W2130552984"},{"id":"paper-w2081450830","cat":"papers","name":"In vivo pharmacological profile of 9‐hydroxyrisperidone, the major metabolite of the novel antipsychotic risperidone","year":"1994","cit":28,"pfa":"Anton A. H. P. Megens","psa":"Frans H. L. Awouters","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2081450830","eid":"W2081450830"},{"id":"paper-w2783399273","cat":"papers","name":"Mephedrone (4-Methylmethcathinone): Acute Behavioral Effects, Hyperthermic, and Pharmacokinetic Profile in Rats","year":"2018","cit":28,"pfa":"Klára Šíchová","psa":"Tomáš Páleníček","topics":["Safety & adverse events","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2783399273","eid":"W2783399273"},{"id":"paper-w4313515381","cat":"papers","name":"Racial Disparities in Access to Psychedelic Treatments and Inclusion in Research Trials","year":"2022","cit":28,"pfa":"Justin Morales","psa":"Ayana Jordan","ptype":"article","src":"https://openalex.org/W4313515381","eid":"W4313515381"},{"id":"paper-w2113009494","cat":"papers","name":"Research With Psychedelics","year":"1971","cit":28,"pfa":"Julian Silverman","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2113009494","eid":"W2113009494"},{"id":"paper-w2810131632","cat":"papers","name":"Mental health of a self-selected sample of psychedelic users and self-medication practices with psychedelics","year":"2018","cit":28,"pfa":"Natasha Leigh Mason","psa":"Kim P. C. Kuypers","ptype":"article","src":"https://openalex.org/W2810131632","eid":"W2810131632"},{"id":"paper-w4385265010","cat":"papers","name":"Psychedelics as Therapeutics—Potential and Challenges","year":"2023","cit":28,"pfa":"Nora D. Volkow","psa":"Eric M. Wargo","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4385265010","eid":"W4385265010"},{"id":"paper-w2669485610","cat":"papers","name":"Heads: A Biography of Psychedelic America","year":"2017","cit":28,"pfa":"Nick Bromell","ptype":"article","src":"https://openalex.org/W2669485610","eid":"W2669485610"},{"id":"paper-w2801451373","cat":"papers","name":"Palliative Nursing and Sacred Medicine: A Holistic Stance on Entheogens, Healing, and Spiritual Care","year":"2018","cit":28,"pfa":"William E. Rosa","psa":"Marianne LaPorte Matzo","topics":["Anxiety & end-of-life","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2801451373","eid":"W2801451373"},{"id":"paper-w1761634057","cat":"papers","name":"Pediatric microdose and microtracer studies using 14C in Europe","year":"2015","cit":28,"pfa":"MA Turner","psa":"Saskia N. de Wildt","topics":["Safety & adverse events","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1761634057","eid":"W1761634057"},{"id":"paper-w4399866284","cat":"papers","name":"A Transformative Trip? Experiences of Psychedelic Use","year":"2024","cit":28,"pfa":"Logan Neitzke‐Spruill","psa":"Amy L. McGuire","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4399866284","eid":"W4399866284"},{"id":"paper-w2129192432","cat":"papers","name":"New Ultrasensitive Detection Technologies and Techniques for Use in Microdosing Studies","year":"2009","cit":28,"pfa":"Graham Lappin","psa":"Nico van de Merbel","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2129192432","eid":"W2129192432"},{"id":"paper-w1140619094","cat":"papers","name":"EEG and Behavioral Aspects of the Interaction of Anticholinergic Hallucinogens with Centrally Active Compounds","year":"1968","cit":28,"pfa":"T.M. Itil","psa":"Max Fink","ptype":"book-chapter","src":"https://openalex.org/W1140619094","eid":"W1140619094"},{"id":"paper-w4280629250","cat":"papers","name":"Psychedelics and Anti-inflammatory Activity in Animal Models","year":"2022","cit":28,"pfa":"Thomas Wayne Flanagan","psa":"Charles David Nichols","ptype":"book-chapter","src":"https://openalex.org/W4280629250","eid":"W4280629250"},{"id":"paper-w2026525617","cat":"papers","name":"Microdose transdermal estrogen therapy for relief of vulvovaginal symptoms in postmenopausal women","year":"2009","cit":28,"pfa":"Gloria Ann Bachmann","psa":"Wulf H. Utian","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2026525617","eid":"W2026525617"},{"id":"paper-w4302793396","cat":"papers","name":"Sixties rock: garage, psychedelic, and other satisfactions","year":"1999","cit":28,"ptype":"book-review","src":"https://openalex.org/W4302793396","eid":"W4302793396"},{"id":"paper-w4388097035","cat":"papers","name":"A Comprehensive Review of the Current Status of the Cellular Neurobiology of Psychedelics","year":"2023","cit":28,"pfa":"Blerida Banushi","psa":"Vince Polito","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4388097035","eid":"W4388097035"},{"id":"paper-w2026447581","cat":"papers","name":"Microdose Clinical Trial: Quantitative Determination of Nicardipine and Prediction of Metabolites in Human Plasma","year":"2009","cit":28,"pfa":"Naoe Yamane","psa":"Yuji Kumagai","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2026447581","eid":"W2026447581"},{"id":"paper-w2068195663","cat":"papers","name":"The Synthesis of Some Analogs of the Hallucinogen 1-(2,5-Dimethoxy-4-methylphenyl)-2-aminopropane (DOM)","year":"1973","cit":28,"pfa":"Ronald T. Coutts","psa":"Jerry L. Malicky","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2068195663","eid":"W2068195663"},{"id":"paper-w4297324547","cat":"papers","name":"Decolonization is a metaphor towards a different ethic. The case from psychedelic studies","year":"2022","cit":28,"pfa":"Christine Hauskeller","psa":"Peter Sjöstedt-Hughes","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4297324547","eid":"W4297324547"},{"id":"paper-w3203785388","cat":"papers","name":"De Plantis Toxicariis E Mundo Novo Tropicale Commentationes V: Virola as an Orally administered Hallucinogen","year":"1969","cit":28,"pfa":"Richard Evans Schultes","ptype":"article","src":"https://openalex.org/W3203785388","eid":"W3203785388"},{"id":"paper-w2204342160","cat":"papers","name":"Psychedelic drugs should be legally reclassified so that researchers can investigate their therapeutic potential","year":"2015","cit":28,"pfa":"James Rucker","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2204342160","eid":"W2204342160"},{"id":"paper-w1674239359","cat":"papers","name":"Detection of recombinant EPO in blood and urine samples with EPO WGA MAIIA, IEF and SAR‐PAGE after microdose injections","year":"2013","cit":28,"pfa":"Yvette Dehnes","psa":"Linda Myrvold","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1674239359","eid":"W1674239359"},{"id":"paper-w4406968572","cat":"papers","name":"Psychotomimetic Drugs as Anticholinergic Agents","year":"1973","cit":28,"pfa":"Harel Weinstein","psa":"Mordechai Sokolovsky","ptype":"article","src":"https://openalex.org/W4406968572","eid":"W4406968572"},{"id":"paper-w4289885375","cat":"papers","name":"Schizophrenia and psychedelic state: Dysconnection versus hyper-connection. A perspective on two different models of psychosis stemming from dysfunctional integration processes","year":"2022","cit":28,"pfa":"Jacopo Sapienza","psa":"Roberto Cavallaro","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4289885375","eid":"W4289885375"},{"id":"paper-w2159387796","cat":"papers","name":"Reduction of the Psychotomimetic and Circulatory Side-effects of Ketamine by Droperidol","year":"1972","cit":28,"pfa":"L. Becsey","psa":"F. F. Földes","ptype":"article","src":"https://openalex.org/W2159387796","eid":"W2159387796"},{"id":"paper-w1978059219","cat":"papers","name":"Efficacy of a potentized homoeopathic drug (arsenicum album-30) in reducing genotoxic effects produced by arsenic trioxide in mice: II. Comparative efficacy of an antibiotic, actinomycin D alone and in combination with e","year":"1999","cit":28,"pfa":"S. Datta","psa":"A.R. Khuda Bukhsh","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1978059219","eid":"W1978059219"},{"id":"paper-w3206821144","cat":"papers","name":"Ketamine for psychotic depression: An overview of the glutamatergic system and ketamine's mechanisms associated with antidepressant and psychotomimetic effects","year":"2021","cit":28,"pfa":"Tuyen T. Le","psa":"Roger S. McIntyre","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3206821144","eid":"W3206821144"},{"id":"paper-w2070930207","cat":"papers","name":"The psychotomimetic drugs D-amphetamine and phencyclidine release calcitonin gene-related peptide in the limbic forebrain of the rat","year":"1996","cit":28,"pfa":"Aleksander A. Math�","psa":"Torgny H. Svensson","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2070930207","eid":"W2070930207"},{"id":"paper-w2809544973","cat":"papers","name":"Modulation of acute effects of delta-9-tetrahydrocannabinol on psychotomimetic effects, cognition and brain function by previous cannabis exposure","year":"2018","cit":28,"pfa":"Marco Colizzi","psa":"Sagnik Bhattacharyya","ptype":"article","src":"https://openalex.org/W2809544973","eid":"W2809544973"},{"id":"paper-w1987178721","cat":"papers","name":"Luteal and clinical response following administration of dinoprost tromethamine or cloprostenol at standard intramuscular sites or at the lumbosacral acupuncture point in mares","year":"2001","cit":28,"pfa":"Gary J. Nie","psa":"James G. W. Wenzel","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1987178721","eid":"W1987178721"},{"id":"paper-w2038116815","cat":"papers","name":"Validity and cost comparison of 14carbon urea breath test for diagnosis of H Pylori in dyspeptic patients","year":"2007","cit":28,"pfa":"Shahid Rasool","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2038116815","eid":"W2038116815"},{"id":"paper-w4390271950","cat":"papers","name":"Therapeutic frameworks in integration sessions in substance‐assisted psychotherapy: A systematised review","year":"2023","cit":28,"pfa":"Sascha B. Thal","psa":"Stephen Jason Bright","topics":["Addiction","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4390271950","eid":"W4390271950"},{"id":"paper-w3138420284","cat":"papers","name":"The Deceptive Mushroom: Accidental Amanita muscaria Poisoning","year":"2021","cit":28,"pfa":"Francesca Irene Rampolli","psa":"Francesca Bedussi","ptype":"article","src":"https://openalex.org/W3138420284","eid":"W3138420284"},{"id":"paper-w2035280228","cat":"papers","name":"Activation is Hallucinogenic and Antagonism is Therapeutic: Role of 5-HT2A Receptors in Atypical Antipsychotic Drug Actions","year":"1999","cit":28,"pfa":"Bryan L. Roth","psa":"Wesley K. Kroeze","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2035280228","eid":"W2035280228"},{"id":"paper-w2029719180","cat":"papers","name":"Applications of hypnotically elicited mystical states to the treatment of physical and emotional pain","year":"1977","cit":28,"pfa":"Paul Sacerdote","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2029719180","eid":"W2029719180"},{"id":"paper-w1968412381","cat":"papers","name":"Essays in Neurochemistry and Neuropharmacology","year":"1979","cit":28,"pfa":"G. Curzon","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1968412381","eid":"W1968412381"},{"id":"paper-w2793566445","cat":"papers","name":"Inside bad trips: Exploring extra-pharmacological factors","year":"2018","cit":28,"pfa":"Genís Oña","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2793566445","eid":"W2793566445"},{"id":"paper-w2176815674","cat":"papers","name":"Potential benefit of lamotrigine in managing ketamine use disorder","year":"2015","cit":28,"pfa":"Ming‐Chyi Huang","psa":"Shih‐Ku Lin","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2176815674","eid":"W2176815674"},{"id":"paper-w2066516099","cat":"papers","name":"Test-Retest Reliability of Psychoactive Substance Abuse and Dependence Diagnoses in Telephone Interviews Using a Modified Diagnostic Interview Schedule-Substance Abuse Module","year":"1997","cit":28,"pfa":"Georgia B. Aktan","psa":"Rafa Kasim","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2066516099","eid":"W2066516099"},{"id":"paper-w4236056565","cat":"papers","name":"Molecular and Functional Characterization of Proteins Interacting with the C‐Terminal Domains of 5‐HT2 Receptors: Emergence of 5‐HT2 “Receptosomes”","year":"2004","cit":28,"pfa":"Sophie Gavarini","psa":"Philippe Marin","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4236056565","eid":"W4236056565"},{"id":"paper-w2899078714","cat":"papers","name":"Addiction Potential of Abused Drugs and Drug Classes","year":"2013","cit":28,"pfa":"Barry Stimmel","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"book","src":"https://openalex.org/W2899078714","eid":"W2899078714"},{"id":"paper-w2074971552","cat":"papers","name":"Ketamine/Diazepam Infusion Anaesthesia With Special Attention to the Effect on Cerebrospinal Fluid Pressure and Arterial Blood Pressure","year":"1980","cit":28,"pfa":"Thor Thorsen","psa":"L Gran","ptype":"article","src":"https://openalex.org/W2074971552","eid":"W2074971552"},{"id":"paper-w4387654919","cat":"papers","name":"Half a Century of Research on Posttraumatic Stress Disorder: A Scientometric Analysis","year":"2023","cit":28,"pfa":"Michel Sabé","psa":"Marco Solmi","topics":["PTSD & trauma","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4387654919","eid":"W4387654919"},{"id":"paper-w2089203584","cat":"papers","name":"Adaptive response and human benefit: Part I. A microdosimetry dose-dependent model","year":"2007","cit":28,"pfa":"Bobby E. Leonard","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2089203584","eid":"W2089203584"},{"id":"paper-w3049516695","cat":"papers","name":"Acute serotonin 2A receptor activation impairs behavioral flexibility in mice","year":"2020","cit":28,"pfa":"Dionisio A. Amodeo","psa":"Susan B. Powell","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3049516695","eid":"W3049516695"},{"id":"paper-w2976551206","cat":"papers","name":"Low-dose S+ ketamine in target-controlled intravenous anaesthesia with remifentanil and propofol for open gynaecological surgery: A randomised controlled trial","year":"2019","cit":28,"pfa":"Farida Binte Ithnin","psa":"Ban Leong Sng","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2976551206","eid":"W2976551206"},{"id":"paper-w2539966020","cat":"papers","name":"Ketamine Self-Administration Reduces the Homeostasis of the Glutamate Synapse in the Rat Brain","year":"2016","cit":28,"pfa":"Lucia Caffino","psa":"Fabio Fumagalli","ptype":"article","src":"https://openalex.org/W2539966020","eid":"W2539966020"},{"id":"paper-w2076069221","cat":"papers","name":"Inhibition of cerebral type 1 cannabinoid receptors is associated with impaired auditory mismatch negativity generation in the ketamine model of schizophrenia","year":"2011","cit":28,"pfa":"Patrik Roser","psa":"Georg Juckel","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2076069221","eid":"W2076069221"},{"id":"paper-w2775137297","cat":"papers","name":"Cannabinoid–glutamate interactions and neural oscillations: implications for psychosis","year":"2017","cit":28,"pfa":"Mohamed A. Sherif","psa":"Patrick D. Skosnik","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2775137297","eid":"W2775137297"},{"id":"paper-w2904485888","cat":"papers","name":"Ketamine stakes in 2018","year":"2018","cit":28,"pfa":"Georges Mion","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2904485888","eid":"W2904485888"},{"id":"paper-w2045861350","cat":"papers","name":"N-methyl-D-aspartate antagonists for stroke and head trauma","year":"1997","cit":28,"pfa":"Paul L. Wood","psa":"Jon E. Hawkinson","topics":["PTSD & trauma","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2045861350","eid":"W2045861350"},{"id":"paper-w3157868786","cat":"papers","name":"Ketamine Metabolite (2R,6R)-Hydroxynorketamine Interacts with μ and κ Opioid Receptors","year":"2021","cit":28,"pfa":"Thomas T. Joseph","psa":"Grace H. Brannigan","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3157868786","eid":"W3157868786"},{"id":"paper-w4389431307","cat":"papers","name":"Effect of esketamine pretreatment on acute sepsis-associated encephalopathy","year":"2023","cit":28,"pfa":"Congmei Wang","psa":"He‐fan He","ptype":"article","src":"https://openalex.org/W4389431307","eid":"W4389431307"},{"id":"paper-w3000286872","cat":"papers","name":"Ketamine increases vmPFC activity: Effects of (R)- and (S)-stereoisomers and (2R,6R)-hydroxynorketamine metabolite","year":"2020","cit":28,"pfa":"Brendan D. Hare","psa":"Ronald S. Duman","ptype":"article","src":"https://openalex.org/W3000286872","eid":"W3000286872"},{"id":"paper-w4224243283","cat":"papers","name":"Mediation of the behavioral effects of ketamine and (2R,6R)-hydroxynorketamine in mice by kappa opioid receptors","year":"2022","cit":28,"pfa":"Hildegard A. Wulf","psa":"Irwin Lucki","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4224243283","eid":"W4224243283"},{"id":"paper-w4392767759","cat":"papers","name":"Antidepressant effects of esketamine via the BDNF/AKT/mTOR pathway in mice with postpartum depression and their offspring","year":"2024","cit":28,"pfa":"Han Qin","psa":"Jing Zhou","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4392767759","eid":"W4392767759"},{"id":"paper-w4366261923","cat":"papers","name":"Risk of esketamine anesthesia on the emergence delirium in preschool children after minor surgery: a prospective observational clinical study","year":"2023","cit":28,"pfa":"Sai Chen","psa":"Jianjun Yang","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4366261923","eid":"W4366261923"},{"id":"paper-w4312206333","cat":"papers","name":"Effects of preoperative nasal spray esketamine on separation anxiety and emergence agitation in pediatric strabismus surgery: A randomized clinical trial","year":"2022","cit":28,"pfa":"Wei Liu","psa":"Shuzhen Wang","topics":["Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4312206333","eid":"W4312206333"},{"id":"paper-w4377941059","cat":"papers","name":"Phenomenology and therapeutic potential of patient experiences during oral esketamine treatment for treatment-resistant depression: an interpretative phenomenological study","year":"2023","cit":28,"pfa":"Joost J. Breeksema","psa":"Robert A. Schoevers","topics":["Depression","Anxiety & end-of-life","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4377941059","eid":"W4377941059"},{"id":"paper-w4229000207","cat":"papers","name":"Low-Dose Esketamine as an Adjuvant to Propofol Sedation for Same-Visit Bidirectional Endoscopy: Protocol for a Multicenter Randomized Controlled Trial","year":"2022","cit":28,"pfa":"Nan Song","psa":"Fuhai Ji","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4229000207","eid":"W4229000207"},{"id":"paper-w2909384193","cat":"papers","name":"Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study","year":"2019","cit":28,"pfa":"Carla M. Canuso","psa":"Wayne Curtis Drevets","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2909384193","eid":"W2909384193"},{"id":"paper-w4304175350","cat":"papers","name":"Effects of Esketamine Combined with Ultrasound-Guided Pectoral Nerve Block Type II on the Quality of Early Postoperative Recovery in Patients Undergoing a Modified Radical Mastectomy for Breast Cancer: A Randomized Contr","year":"2022","cit":28,"pfa":"Lili Yu","psa":"Qiujun Wang","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4304175350","eid":"W4304175350"},{"id":"paper-w2492473386","cat":"papers","name":"Pharmacokinetics of ketamine and three metabolites in Beagle dogs under sevoflurane vs. medetomidine comedication assessed by enantioselective capillary electrophoresis","year":"2016","cit":28,"pfa":"Friederike A. Sandbaumhüter","psa":"Wolfgang Thormann","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2492473386","eid":"W2492473386"},{"id":"paper-w4391613025","cat":"papers","name":"Depression-like phenotypes in mice following common bile duct ligation: Insights into the gut–liver–brain axis via the vagus nerve","year":"2024","cit":28,"pfa":"Yong Hua Yang","psa":"Kenji Hashimoto","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4391613025","eid":"W4391613025"},{"id":"paper-w4388157929","cat":"papers","name":"Opioid-Free Anesthesia for Pain Relief After Laparoscopic Cholecystectomy: A Prospective Randomized Controlled Trial","year":"2023","cit":28,"pfa":"Jun‐Ma Yu","psa":"Ye Zhang","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4388157929","eid":"W4388157929"},{"id":"paper-w3080141158","cat":"papers","name":"Treatments for Self-Injurious Thoughts and Behaviors in Youth: Progress and Challenges","year":"2020","cit":28,"pfa":"Alexandra H. Bettis","psa":"Elisha David Klonsky","topics":["Safety & adverse events","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3080141158","eid":"W3080141158"},{"id":"paper-w2065168671","cat":"papers","name":"CLINICAL PHARMACOLOGY OF LYSERGIC ACID DIETHYLAMIDE","year":"1997","cit":27,"pfa":"Kari E. Blaho","psa":"Chantay Smartt","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2065168671","eid":"W2065168671"},{"id":"paper-w2057658427","cat":"papers","name":"Effect of N,N-Dimethyltryptamine and D-Lysergic Acid Diethylamide on the Release of 5-Hydroxyindoles in Rat Forebrain","year":"1971","cit":27,"pfa":"Mirjana Randić","psa":"Ante L. Padjen","ptype":"article","src":"https://openalex.org/W2057658427","eid":"W2057658427"},{"id":"paper-w2261959798","cat":"papers","name":"Discriminative stimulus properties of lysergic acid diethylamide in the monkey.","year":"1985","cit":27,"pfa":"E. B. Nielsen","ptype":"article","src":"https://openalex.org/W2261959798","eid":"W2261959798"},{"id":"paper-w2136547541","cat":"papers","name":"Placebo Reactions in a Study of Lysergic Acid Diethylamide (LSD-25)","year":"1962","cit":27,"pfa":"Harriet B. Linton","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2136547541","eid":"W2136547541"},{"id":"paper-w2039197476","cat":"papers","name":"Liquid chromatography–electrospray mass spectrometry determination of ibogaine and noribogaine in human plasma and whole bloodApplication to a poisoning involving Tabernanthe iboga root","year":"2006","cit":27,"pfa":"V. Kontrimaviciute","psa":"Françoise Bressolle","ptype":"article","src":"https://openalex.org/W2039197476","eid":"W2039197476"},{"id":"paper-w2398994708","cat":"papers","name":"Pharmacological assay of cardiac H2-receptor blockade by amitriptyline and lysergic acid diethylamide.","year":"1980","cit":27,"pfa":"James A. Angus","psa":"Black Jw","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2398994708","eid":"W2398994708"},{"id":"paper-w4389532441","cat":"papers","name":"5-MeO-DMT: An atypical psychedelic with unique pharmacology, phenomenology & risk?","year":"2023","cit":27,"pfa":"Haley Maria Dourron","psa":"Peter S. Hendricks","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4389532441","eid":"W4389532441"},{"id":"paper-w2085132635","cat":"papers","name":"Effect of Psilocybin, LSD, and mescaline on small, involuntary eye movements","year":"1966","cit":27,"pfa":"Frederick W. Hebbard","psa":"Roland Fischer","ptype":"article","src":"https://openalex.org/W2085132635","eid":"W2085132635"},{"id":"paper-w1966469610","cat":"papers","name":"Responses of midbrain neurones to micro-iontophoretically applied 5-hydroxytryptamine: Comparison with the response to intravenously administered lysergic acid diethylamide","year":"1976","cit":27,"pfa":"G.J. Bramwell","ptype":"article","src":"https://openalex.org/W1966469610","eid":"W1966469610"},{"id":"paper-w1994053072","cat":"papers","name":"Determination of lysergic acid diethylamide (LSD) in mouse blood by capillary electrophoresis/ fluorescence spectroscopy with sweeping techniques in micellar electrokinetic chromatography","year":"2003","cit":27,"pfa":"Ching Fang","psa":"Cheng‐Huang Lin","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1994053072","eid":"W1994053072"},{"id":"paper-w2084204788","cat":"papers","name":"Fatal Case of a 27‐Year‐Old Male After Taking Iboga in Withdrawal Treatment: GC ‐ MS / MS Determination of Ibogaine and Ibogamine in Iboga Roots and Postmortem Biological Material","year":"2013","cit":27,"pfa":"Cédric Mazoyer","psa":"Yvan Gaillard","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2084204788","eid":"W2084204788"},{"id":"paper-w3128197953","cat":"papers","name":"Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experience","year":"2021","cit":27,"pfa":"Martin Korsbak Madsen","psa":"Patrick M. Fisher","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W3128197953","eid":"W3128197953"},{"id":"paper-w2045514302","cat":"papers","name":"Investigation into the temporal stability of aqueous standard solutions of psilocin and psilocybin using high performance liquid chromatography","year":"2006","cit":27,"pfa":"Nicole Anastos","psa":"Simon W. Lewis","ptype":"article","src":"https://openalex.org/W2045514302","eid":"W2045514302"},{"id":"paper-w2046846721","cat":"papers","name":"The structure of ibogaine","year":"1960","cit":27,"pfa":"G. Arai","psa":"G. A. Jeffrey","ptype":"article","src":"https://openalex.org/W2046846721","eid":"W2046846721"},{"id":"paper-w2950394635","cat":"papers","name":"A New Synthesis of Psilocin","year":"1999","cit":27,"pfa":"Kunio Ogasawara","psa":"Hideki Sakagami","ptype":"article","src":"https://openalex.org/W2950394635","eid":"W2950394635"},{"id":"paper-w1988531943","cat":"papers","name":"Noribogaine stimulates naloxone-sensitive [35S]GTPγS binding","year":"1998","cit":27,"pfa":"John P. Pablo","psa":"Deborah C. Mash","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1988531943","eid":"W1988531943"},{"id":"paper-w55940662","cat":"papers","name":"The chemistry of peyote alkaloids.","year":"1973","cit":27,"pfa":"G. J. KAPADIA","psa":"Fayez Mb","ptype":"article","src":"https://openalex.org/W55940662","eid":"W55940662"},{"id":"paper-w3214152988","cat":"papers","name":"Ayahuasca for the Treatment of Depression","year":"2021","cit":27,"pfa":"Fernanda Palhano-Fontes","psa":"Dráulio Barros de Araújo","topics":["Depression"],"ptype":"book-chapter","src":"https://openalex.org/W3214152988","eid":"W3214152988"},{"id":"paper-w2790320734","cat":"papers","name":"Acute Intoxication following Dimethyltryptamine Ingestion","year":"2018","cit":27,"pfa":"Matthew H. Bilhimer","psa":"Nicole M. Acquisto","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2790320734","eid":"W2790320734"},{"id":"paper-w4408808337","cat":"papers","name":"Pharmacokinetics of Psilocybin: A Systematic Review","year":"2025","cit":27,"pfa":"Shakila Meshkat","psa":"Venkat Bhat","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4408808337","eid":"W4408808337"},{"id":"paper-w2222847961","cat":"papers","name":"THE ABSORPTION, DISTRIBUTION AND URINARY EXCRETION OF MESCALINE IN THE DOG","year":"1951","cit":27,"pfa":"Joseph Cochin","psa":"Maurice H. Seevers","ptype":"article","src":"https://openalex.org/W2222847961","eid":"W2222847961"},{"id":"paper-w4366089680","cat":"papers","name":"Psilocybin in Palliative Care: An Update","year":"2023","cit":27,"pfa":"Emily Whinkin","psa":"Sunil Kumar Aggarwal","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4366089680","eid":"W4366089680"},{"id":"paper-w4321238244","cat":"papers","name":"Pharmacological effects of methylone and MDMA in humans","year":"2023","cit":27,"pfa":"Lourdes Poyatos","psa":"Esther Papaseit","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4321238244","eid":"W4321238244"},{"id":"paper-w2748593001","cat":"papers","name":"Enzymatische Synthese von Psilocybin","year":"2017","cit":27,"pfa":"Janis Fricke","psa":"Dirk Hoffmeister","ptype":"article","src":"https://openalex.org/W2748593001","eid":"W2748593001"},{"id":"paper-w2080265450","cat":"papers","name":"Effects of yohimbine and mescaline on punished behavior in the rat","year":"1972","cit":27,"pfa":"Vimala H. Sethy","psa":"Jerrold C. Winter","ptype":"article","src":"https://openalex.org/W2080265450","eid":"W2080265450"},{"id":"paper-w2031348184","cat":"papers","name":"Salvinorins J from Salvia divinorum: Mutarotation in the Neoclerodane System","year":"2009","cit":27,"pfa":"Lukasz M. Kutrzeba","psa":"Jordan Kordian Zjawiony","ptype":"article","src":"https://openalex.org/W2031348184","eid":"W2031348184"},{"id":"paper-w3214305299","cat":"papers","name":"Psilocybin for the Treatment of Obsessive-Compulsive Disorders","year":"2021","cit":27,"pfa":"Katja Ehrmann","psa":"Francisco Moreno","ptype":"book-chapter","src":"https://openalex.org/W3214305299","eid":"W3214305299"},{"id":"paper-w3094580892","cat":"papers","name":"Ayahuasca Beverages: Phytochemical Analysis and Biological Properties","year":"2020","cit":27,"pfa":"Joana Gonçalves","psa":"Ana Paula Duarte","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3094580892","eid":"W3094580892"},{"id":"paper-w3135111051","cat":"papers","name":"The DMT and Psilocin Treatment Changes CD11b+ Activated Microglia Immunological Phenotype","year":"2021","cit":27,"pfa":"Urszula Kozłowska","psa":"Maciej Figiel","topics":["Depression","PTSD & trauma","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W3135111051","eid":"W3135111051"},{"id":"paper-w4309648711","cat":"papers","name":"Psilocybin as a Treatment for Psychiatric Illness: A Meta-Analysis","year":"2022","cit":27,"pfa":"Ricardo Irizarry","psa":"Jeanpaul Larice","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4309648711","eid":"W4309648711"},{"id":"paper-w4304690665","cat":"papers","name":"Potential Therapeutic Effects of Psilocybin: A Systematic Review","year":"2022","cit":27,"pfa":"Dev B Goel","psa":"Sarju Zilate","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"review","src":"https://openalex.org/W4304690665","eid":"W4304690665"},{"id":"paper-w2124911893","cat":"papers","name":"Ethanol increases the distribution of MDMA to the rat brain: possible implications in the ethanol-induced potentiation of the psychostimulant effects of MDMA","year":"2008","cit":27,"pfa":"Sami Ben Hamida","psa":"Jean‐Christophe Cassel","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2124911893","eid":"W2124911893"},{"id":"paper-w2421342421","cat":"papers","name":"Plant admixtures to Ayahuasca, the South American hallucinogenic drink.","year":"1969","cit":27,"pfa":"Homer V. Pinkley","ptype":"article","src":"https://openalex.org/W2421342421","eid":"W2421342421"},{"id":"paper-w3007563926","cat":"papers","name":"Rostral Anterior Cingulate Thickness Predicts the Emotional Psilocybin Experience","year":"2020","cit":27,"pfa":"Candace R. Lewis","psa":"Franz X. Vollenweider","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3007563926","eid":"W3007563926"},{"id":"paper-w2098478986","cat":"papers","name":"‘Is MDMA a Human Neurotoxin?’:Diverse Views from the Discussants","year":"2000","cit":27,"pfa":"John J. Turner","psa":"Andrew C. Parrott","topics":["Safety & adverse events","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2098478986","eid":"W2098478986"},{"id":"paper-w2036894718","cat":"papers","name":"Biological activities of some 5-substituted N,N-dimethyltryptamines, ?-methyltryptamines, and gramines","year":"1970","cit":27,"pfa":"Beng T. Ho","psa":"Mauno M. Airaksinen","ptype":"article","src":"https://openalex.org/W2036894718","eid":"W2036894718"},{"id":"paper-w4310207667","cat":"papers","name":"Reactivations after 5-methoxy-N,N-dimethyltryptamine use in naturalistic settings: An initial exploratory analysis of the phenomenon’s predictors and its emotional valence","year":"2022","cit":27,"pfa":"Ana María Ortiz Bernal","psa":"Alan K. Davis","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4310207667","eid":"W4310207667"},{"id":"paper-w2115935192","cat":"papers","name":"Differential effects of 3,4-methylenedioxypyrovalerone (MDPV) and 4-methylmethcathinone (mephedrone) in rats trained to discriminate MDMA or a d-amphetamine + MDMA mixture","year":"2015","cit":27,"pfa":"Eric L. Harvey","psa":"Lisa E. Baker","ptype":"article","src":"https://openalex.org/W2115935192","eid":"W2115935192"},{"id":"paper-w1969759785","cat":"papers","name":"Fatality due to the use of a designer drug MDMA (Ecstasy)","year":"2007","cit":27,"pfa":"Małgorzata Kłys","psa":"Ewa Rzepecka-Woźniak","ptype":"article","src":"https://openalex.org/W1969759785","eid":"W1969759785"},{"id":"paper-w3093673457","cat":"papers","name":"MDMA Use by Paris Medical Students: Prevalence and Characteristics","year":"2020","cit":27,"pfa":"Balthazar Bazin","psa":"Michel Lejoyeux","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3093673457","eid":"W3093673457"},{"id":"paper-w1997004865","cat":"papers","name":"Locomotor and pyretic effects of MDMA–ethanol associations in rats","year":"2004","cit":27,"pfa":"Jean‐Christophe Cassel","psa":"Byron C. Jones","ptype":"article","src":"https://openalex.org/W1997004865","eid":"W1997004865"},{"id":"paper-w1545232577","cat":"papers","name":"Spiritual healing and human development in the Native American church: toward a cultural psychiatry of peyote.","year":"1997","cit":27,"pfa":"Joseph D. Calabrese","ptype":"article","src":"https://openalex.org/W1545232577","eid":"W1545232577"},{"id":"paper-w1987847811","cat":"papers","name":"Effects of Salicylate on 3,4-Methylenedioxymethamphetamine (MDMA)-Induced Neurotoxicity in Rats","year":"1997","cit":27,"pfa":"Shuyuan Yeh","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1987847811","eid":"W1987847811"},{"id":"paper-w3162782552","cat":"papers","name":"Protocol for Outcome Evaluation of Ayahuasca-Assisted Addiction Treatment: The Case of Takiwasi Center","year":"2021","cit":27,"pfa":"Brian R. Rush","psa":"Fernando M. Mendive","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3162782552","eid":"W3162782552"},{"id":"paper-w2800893493","cat":"papers","name":"Plant Knowledges: Indigenous Approaches and Interspecies Listening Toward Decolonizing Ayahuasca Research","year":"2018","cit":27,"pfa":"Laura Dev","ptype":"book-chapter","src":"https://openalex.org/W2800893493","eid":"W2800893493"},{"id":"paper-w2010418141","cat":"papers","name":"Synergistic toxicity of ethanol and MDMA towards primary cultured rat hepatocytes","year":"2008","cit":27,"pfa":"Helena Pontes","psa":"Maria de Lourdes Bastos","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2010418141","eid":"W2010418141"},{"id":"paper-w4402966862","cat":"papers","name":"Acute dose-dependent effects of mescaline in a double-blind placebo-controlled study in healthy subjects","year":"2024","cit":27,"pfa":"Aaron Klaiber","psa":"Matthias E. Liechti","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4402966862","eid":"W4402966862"},{"id":"paper-w2063533374","cat":"papers","name":"A fatal case of myocardial damage due to misuse of the “designer drug” MDMA","year":"2009","cit":27,"pfa":"Rie Sano","psa":"Hideaki Itoh","ptype":"article","src":"https://openalex.org/W2063533374","eid":"W2063533374"},{"id":"paper-w4389728826","cat":"papers","name":"Psilocybin-induced default mode network hypoconnectivity is blunted in alcohol-dependent rats","year":"2023","cit":27,"pfa":"Jonathan Reinwald","psa":"Marcus W. Meinhardt","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4389728826","eid":"W4389728826"},{"id":"paper-w1999147287","cat":"papers","name":"Pneumomediastinum following Ecstasy (methylenedioxymetamphetamine, MDMA) ingestion in two people at the same ’rave’","year":"2002","cit":27,"pfa":"Darius Rejali","psa":"Nicholas J. Odom","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1999147287","eid":"W1999147287"},{"id":"paper-w1986761358","cat":"papers","name":"MDMA (ecstasy) effects in pubescent rats: Males are more sensitive than females","year":"2005","cit":27,"pfa":"J KOENIG","psa":"Jean‐Christophe Cassel","ptype":"article","src":"https://openalex.org/W1986761358","eid":"W1986761358"},{"id":"paper-w2010855554","cat":"papers","name":"A gas chromatographic procedure for determining N, N-dimethyltryptamine and N-monomethyltryptamine in urine using a nitrogen detector","year":"1977","cit":27,"pfa":"M.C.H. Oon","psa":"Richard Rodnight","ptype":"article","src":"https://openalex.org/W2010855554","eid":"W2010855554"},{"id":"paper-w2075996258","cat":"papers","name":"The impact of experimental design on assessing mechanism-based inactivation of CYP2D6 by MDMA (Ecstasy)","year":"2006","cit":27,"pfa":"Linh M. Van","psa":"Amin Rostami‐Hodjegan","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2075996258","eid":"W2075996258"},{"id":"paper-w3172805875","cat":"papers","name":"Serotonergic psychedelic drugs LSD and psilocybin reduce the hierarchical differentiation of unimodal and transmodal cortex","year":"2020","cit":27,"pfa":"Manesh Girn","psa":"R. Nathan Spreng","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W3172805875","eid":"W3172805875"},{"id":"paper-w3199377870","cat":"papers","name":"Hard Boiled: Alcohol Use as a Risk Factor for MDMA-Induced Hyperthermia: a Systematic Review","year":"2021","cit":27,"pfa":"Jan van Amsterdam","psa":"Wim van den Brink","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W3199377870","eid":"W3199377870"},{"id":"paper-w3026621572","cat":"papers","name":"MDMA-assisted psychotherapy for people diagnosed with treatment-resistant PTSD: what it is and what it isn’t","year":"2020","cit":27,"pfa":"Louise Morgan","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3026621572","eid":"W3026621572"},{"id":"paper-w2895147268","cat":"papers","name":"Role of NMDA and AMPA glutamatergic receptors in the effects of social defeat on the rewarding properties of MDMA in mice","year":"2018","cit":27,"pfa":"María Pilar García-Pardo","psa":"M.A. Aguilar","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2895147268","eid":"W2895147268"},{"id":"paper-w2098820509","cat":"papers","name":"Behavioral Effects and Central Nervous System Levels of the Broadly Available κ-Agonist Hallucinogen Salvinorin A Are Affected by P-Glycoprotein Modulation In Vivo","year":"2012","cit":27,"pfa":"Eduardo R. Butelman","psa":"Thomas Edward Prisinzano","ptype":"article","src":"https://openalex.org/W2098820509","eid":"W2098820509"},{"id":"paper-w2503753270","cat":"papers","name":"Ritanserin-sensitive receptors modulate the prosocial and the anxiolytic effect of MDMA derivatives, DOB and PMA, in zebrafish","year":"2016","cit":27,"pfa":"Luisa Ponzoni","psa":"Daniela Braida","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2503753270","eid":"W2503753270"},{"id":"paper-w2073506291","cat":"papers","name":"The use of o-phthalaldehyde as a spray reagent for the thin-layer chromatographic identification and quantitation of bufotenin and 5-methoxy-N: N-dimethyltryptamine","year":"1971","cit":27,"pfa":"N. Narasimhachari","psa":"Judith M. Plaut","ptype":"article","src":"https://openalex.org/W2073506291","eid":"W2073506291"},{"id":"paper-w2049950413","cat":"papers","name":"Searching the Internet for Drug‐Related Web Sites: Analysis of Online Available Information on Ecstasy (MDMA)","year":"2007","cit":27,"pfa":"Paolo Deluca","psa":"Fabrizio Schifano","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2049950413","eid":"W2049950413"},{"id":"paper-w2168194391","cat":"papers","name":"MDMA is certainly damaging after 25 years of empirical research: a reply and refutation of Doblinet al. (2014)","year":"2014","cit":27,"pfa":"Andrew C. Parrott","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2168194391","eid":"W2168194391"},{"id":"paper-w3193973488","cat":"papers","name":"A Comparison of Acute Pharmacological Effects of Methylone and MDMA Administration in Humans and Oral Fluid Concentrations as Biomarkers of Exposure","year":"2021","cit":27,"pfa":"Lourdes Poyatos","psa":"Magı́ Farré","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3193973488","eid":"W3193973488"},{"id":"paper-w2076133547","cat":"papers","name":"A PET study of effects of chronic 3,4‐methylenedioxymethamphetamine (MDMA, “ecstasy”) on serotonin markers in Göttingen minipig brain","year":"2007","cit":27,"pfa":"Paul D. Cumming","psa":"Aage Kristian Olsen Alstrup","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2076133547","eid":"W2076133547"},{"id":"paper-w4386170075","cat":"papers","name":"Microneedle array-based electrochemical sensor functionalized with SWCNTs for the highly sensitive monitoring of MDMA in interstitial fluid","year":"2023","cit":27,"pfa":"Ana-Maria Drăgan","psa":"Karolien De Wael","ptype":"article","src":"https://openalex.org/W4386170075","eid":"W4386170075"},{"id":"paper-w2127236638","cat":"papers","name":"Effects of MDMA and related analogs on plasma 5-HT: Relevance to 5-HT transporters in blood and brain","year":"2011","cit":27,"pfa":"Samanta Yubero‐Lahoz","psa":"Michael H. Baumann","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2127236638","eid":"W2127236638"},{"id":"paper-w4403255583","cat":"papers","name":"MDMA ‐assisted psychotherapy for the treatment of PTSD : A systematic review and meta‐analysis of randomized controlled trials ( RCTs )","year":"2024","cit":27,"pfa":"Ghada Shahrour","psa":"Abdulqadir J. J. Nashwan","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W4403255583","eid":"W4403255583"},{"id":"paper-w2064993847","cat":"papers","name":"Effects of adenosine A2a receptor agonist and antagonist on hippocampal nuclear factor-kB expression preceded by MDMA toxicity","year":"2012","cit":27,"pfa":"Fatemeh Kermanian","psa":"Mehdi Mehdizadeh","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2064993847","eid":"W2064993847"},{"id":"paper-w2622976027","cat":"papers","name":"Progression and Persistence of Neurotoxicity Induced by MDMA in Dopaminergic Regions of the Mouse Brain and Association with Noradrenergic, GABAergic, and Serotonergic Damage","year":"2017","cit":27,"pfa":"Giulia Costa","psa":"Nicola Simola","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2622976027","eid":"W2622976027"},{"id":"paper-w2162923155","cat":"papers","name":"3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) disrupts blood-brain barrier integrity through a mechanism involving P2X7 receptors","year":"2014","cit":27,"pfa":"Ana Rubio‐Araiz","psa":"María Isabel Colado","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2162923155","eid":"W2162923155"},{"id":"paper-w2082706542","cat":"papers","name":"Serotonin 5-HT4 receptors in the nucleus accumbens are specifically involved in the appetite suppressant and not locomotor stimulant effects of MDMA (‘ecstasy’)","year":"2010","cit":27,"pfa":"Heather Francis","psa":"Jennifer L. Cornish","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2082706542","eid":"W2082706542"},{"id":"paper-w2307584287","cat":"papers","name":"Evaluation of Monitoring Schemes for Wastewater-Based Epidemiology to Identify Drug Use Trends Using Cocaine, Methamphetamine, MDMA and Methadone","year":"2016","cit":27,"pfa":"Melissa Humphries","psa":"Jochen F. Mueller","ptype":"article","src":"https://openalex.org/W2307584287","eid":"W2307584287"},{"id":"paper-w2969407680","cat":"papers","name":"1 H quantitative NMR and UHPLC-MS analysis of seized MDMA/NPS mixtures and tablets from night-club venues","year":"2019","cit":27,"pfa":"Husain A. Naqi","psa":"Ian S. Blagbrough","ptype":"article","src":"https://openalex.org/W2969407680","eid":"W2969407680"},{"id":"paper-w2095334145","cat":"papers","name":"Higher sensitivity to the conditioned rewarding effects of cocaine and MDMA in High-Novelty-Seekers mice exposed to a cocaine binge during adolescence","year":"2014","cit":27,"pfa":"Ana Mateos-García","psa":"María Carmen Arenas","ptype":"article","src":"https://openalex.org/W2095334145","eid":"W2095334145"},{"id":"paper-w4308925280","cat":"papers","name":"Liquid chromatography–tandem mass spectrometry method for the bioanalysis of N,N-dimethyltryptamine (DMT) and its metabolites DMT-N-oxide and indole-3-acetic acid in human plasma","year":"2022","cit":27,"pfa":"Dino Luethi","psa":"Urs Duthaler","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4308925280","eid":"W4308925280"},{"id":"paper-w2072349976","cat":"papers","name":"Increased CRE-binding activity and tryptophan hydroxylase mRNA expression induced by 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) in the rat frontal cortex but not in the hippocampus","year":"2004","cit":27,"pfa":"Ana García‐Osta","psa":"Diana Frechilla","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2072349976","eid":"W2072349976"},{"id":"paper-w4245831050","cat":"papers","name":"Characterization of the Translocation of Protein Kinase C (PKC) by 3,4-methylenedioxymethamphetamine (MDMA/Ecstasy) in Synaptosomes: Evidence for a Presynaptic Localization Involving the Serotonin Transporter (SERT)","year":"1998","cit":27,"pfa":"H Kenneth Kramer","psa":"Efrain C. Azmitia","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4245831050","eid":"W4245831050"},{"id":"paper-w2199386545","cat":"papers","name":"Evaluation of brain SERT occupancy by resveratrol against MDMA-induced neurobiological and behavioral changes in rats: A 4-[ 18 F]-ADAM/small-animal PET study","year":"2015","cit":27,"pfa":"Jui‐Hu Shih","psa":"I‐Hsun Li","ptype":"article","src":"https://openalex.org/W2199386545","eid":"W2199386545"},{"id":"paper-w1711284114","cat":"papers","name":"CLINICAL STUDY: BRIEF REPORT: Ecstasy (MDMA)‐addicted subjects show increased serum levels of brain‐derived neurotrophic factor, independently from a rise of drug‐induced psychotic symptoms","year":"2010","cit":27,"pfa":"Francesco Angelucci","psa":"Pietro Bria","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1711284114","eid":"W1711284114"},{"id":"paper-w4323041020","cat":"papers","name":"A Single Administration of Psilocybin Persistently Rescues Cognitive Deficits Caused by Adolescent Chronic Restraint Stress Without Long-Term Changes in Synaptic Protein Gene Expression in a Rat Experimental System with","year":"2023","cit":27,"pfa":"Meghan Hibicke","psa":"Charles David Nichols","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4323041020","eid":"W4323041020"},{"id":"paper-w4389868195","cat":"papers","name":"Efficacy and Safety of Psychedelics in Treating Anxiety Disorders","year":"2023","cit":27,"pfa":"Leah Feulner","psa":"David W. Galarneau","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4389868195","eid":"W4389868195"},{"id":"paper-w1975222803","cat":"papers","name":"Inhibitory effects of lysergic acid derivatives and reserpine on 5-HT binding to nerve ending particles","year":"1967","cit":27,"pfa":"R. M. Marchbanks","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1975222803","eid":"W1975222803"},{"id":"paper-w2165392351","cat":"papers","name":"Multiple Systemic and Ocular Malformations Associated With Maternal LSD Usage","year":"1974","cit":27,"pfa":"David J Apple","psa":"Tina Bennett","ptype":"article","src":"https://openalex.org/W2165392351","eid":"W2165392351"},{"id":"paper-w2249124379","cat":"papers","name":"Antagonist properties of d-LSD at 5-hydroxytryptamine2 receptors.","year":"1991","cit":27,"pfa":"P A Pierce","psa":"Stephen J. Peroutka","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2249124379","eid":"W2249124379"},{"id":"paper-w2106326756","cat":"papers","name":"Determination of Buprenorphine, Fentanyl and LSD in Whole Blood by UPLC-MS-MS","year":"2013","cit":27,"pfa":"Thomas Berg","psa":"Dag Helge Strand","ptype":"article","src":"https://openalex.org/W2106326756","eid":"W2106326756"},{"id":"paper-w2981209825","cat":"papers","name":"Hallucinogen persisting perception disorder: A literature review and three case reports","year":"2018","cit":27,"pfa":"Valentin Yurievich Skryabin","psa":"Vladislav Vladimirovich Alekseyuk","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2981209825","eid":"W2981209825"},{"id":"paper-w4384923239","cat":"papers","name":"Structure–Activity Assessment and In-Depth Analysis of Biased Agonism in a Set of Phenylalkylamine 5-HT2A Receptor Agonists","year":"2023","cit":27,"pfa":"Eline Pottie","psa":"Christophe Pol Stove","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4384923239","eid":"W4384923239"},{"id":"paper-w1980348146","cat":"papers","name":"Cross-tolerance studies of serotonin receptors involved in behavioral effects of LSD in rats","year":"1994","cit":27,"pfa":"Kirsten M. Krebs","psa":"Mark A. Geyer","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1980348146","eid":"W1980348146"},{"id":"paper-w2076150500","cat":"papers","name":"Differential development of 5‐HT receptor and the serotonin transporter binding in the human infant medulla","year":"2004","cit":27,"pfa":"David S. Paterson","psa":"Hannah C. Kinney","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2076150500","eid":"W2076150500"},{"id":"paper-w2097406411","cat":"papers","name":"Ethanol co-administration moderates 3,4-methylenedioxymethamphetamine effects on human physiology","year":"2008","cit":27,"pfa":"Glenn Dumont","psa":"RJ Verkes","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2097406411","eid":"W2097406411"},{"id":"paper-w4388591571","cat":"papers","name":"Role of the gut–brain axis via the subdiaphragmatic vagus nerve in stress resilience of 3,4-methylenedioxymethamphetamine in mice exposed to chronic restrain stress","year":"2023","cit":27,"pfa":"Youge Qu","psa":"Kenji Hashimoto","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4388591571","eid":"W4388591571"},{"id":"paper-w2464987528","cat":"papers","name":"Metformin Prevented Dopaminergic Neurotoxicity Induced by 3,4-Methylenedioxymethamphetamine Administration","year":"2016","cit":27,"pfa":"Pier Francesca Porceddu","psa":"Micaela Morelli","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2464987528","eid":"W2464987528"},{"id":"paper-w2040849859","cat":"papers","name":"Direct Comparison of (±) 3,4-Methylenedioxymethamphetamine (“Ecstasy”) Disposition and Metabolism in Squirrel Monkeys and Humans","year":"2009","cit":27,"pfa":"Melanie Mueller","psa":"George A. Ricaurte","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2040849859","eid":"W2040849859"},{"id":"paper-w1972505484","cat":"papers","name":"Comparison of the effects of LSD and lisuride on A10 dopamine neurons in the rat","year":"1983","cit":27,"pfa":"Francis J. White","psa":"R.Y. Wang","ptype":"article","src":"https://openalex.org/W1972505484","eid":"W1972505484"},{"id":"paper-w2040294470","cat":"papers","name":"The effects of co-administration of 3,4-methylenedioxymethamphetamine (“ecstasy”) or para-methoxyamphetamine and moclobemide at elevated ambient temperatures on striatal 5-HT, body temperature and behavior in rats","year":"2007","cit":27,"pfa":"Nathan Stanley","psa":"R Julian Irvine","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2040294470","eid":"W2040294470"},{"id":"paper-w1981926152","cat":"papers","name":"Developmental exposure to 3,4-methylenedioxymethamphetamine results in downregulation of neurogenesis in the adult mouse hippocampus","year":"2008","cit":27,"pfa":"Kyung‐Ok Cho","psa":"Seong-Yun Kim","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1981926152","eid":"W1981926152"},{"id":"paper-w4387495509","cat":"papers","name":"The G protein biased serotonin 5-HT2A receptor agonist lisuride exerts anti-depressant drug-like activities in mice","year":"2023","cit":27,"pfa":"Vladimir M. Pogorelov","psa":"William C. Wetsel","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4387495509","eid":"W4387495509"},{"id":"paper-w2035136455","cat":"papers","name":"High‐performance liquid chromatography with fluorescence detection for the simultaneous determination of 3,4‐methylenedioxymethamphetamine, methamphetamine and their metabolites in human hair using DIB‐Cl as a label","year":"2004","cit":27,"pfa":"Amal Kaddoumi","psa":"Kenichiro Nakashima","ptype":"article","src":"https://openalex.org/W2035136455","eid":"W2035136455"},{"id":"paper-w1989188195","cat":"papers","name":"An index of fatal toxicity for drugs of misuse","year":"2010","cit":27,"pfa":"Leslie A. King","psa":"John Corkery","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1989188195","eid":"W1989188195"},{"id":"paper-w2745723818","cat":"papers","name":"Psychedelic Drugs as Therapeutics: No Illusions About the Challenges","year":"2017","cit":27,"pfa":"Edward M. Sellers","psa":"Deborah B. Leiderman","ptype":"article","src":"https://openalex.org/W2745723818","eid":"W2745723818"},{"id":"paper-w4281561886","cat":"papers","name":"Risky Sexual Practices, Sexually Transmitted Infections, Motivations, and Mental Health among Heterosexual Women and Men Who Practice Sexualized Drug Use in Spain","year":"2022","cit":27,"pfa":"Daniel Íncera-Fernández","psa":"Manuel Gámez‐Guadix","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4281561886","eid":"W4281561886"},{"id":"paper-w2005934786","cat":"papers","name":"IS THE U.S. EXPERIENCING AN INCIPIENT EPIDEMIC OF HALLUCINOGEN USE?","year":"2001","cit":27,"pfa":"Andrew Lang Golub","psa":"Howard J. Parker","ptype":"article","src":"https://openalex.org/W2005934786","eid":"W2005934786"},{"id":"paper-w3119707674","cat":"papers","name":"Narratives of the mystical among users of psychedelics","year":"2021","cit":27,"pfa":"Willy Pedersen","psa":"Liridona Gashi","ptype":"article","src":"https://openalex.org/W3119707674","eid":"W3119707674"},{"id":"paper-w2109110651","cat":"papers","name":"A Central Serotonin Receptor Agonist, 8‐Hydroxy‐2‐(di‐n‐propylamino)tetralin, has Different Effects on Prolactin Secretion in Male and Female Rats","year":"1986","cit":27,"pfa":"Maria Lizzie Carlsson","psa":"Elias Eriksson","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2109110651","eid":"W2109110651"},{"id":"paper-w4404604989","cat":"papers","name":"Strategies for resolving challenging psychedelic experiences: insights from a mixed-methods study","year":"2024","cit":27,"pfa":"Maximillian J. Wood","psa":"Sunjeev K. Kamboj","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4404604989","eid":"W4404604989"},{"id":"paper-w4400592711","cat":"papers","name":"Psychedelic experiences and long-term spiritual growth: a systematic review","year":"2024","cit":27,"pfa":"William A. Schutt","psa":"Joshua Adam Wilt","topics":["Addiction","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4400592711","eid":"W4400592711"},{"id":"paper-w2149469574","cat":"papers","name":"Recent Topics on Pharmacotherapy for Amphetamine-Type Stimulants Abuse and Dependence","year":"2010","cit":27,"pfa":"Hongxian Chen","psa":"Kenji Hashimoto","topics":["Addiction","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2149469574","eid":"W2149469574"},{"id":"paper-w1983424797","cat":"papers","name":"Comparative behavioural and neurochemical studies with a psychomotor stimulant, an hallucinogen and 3,4-methylenedioxy analogues of amphetamine","year":"1995","cit":27,"pfa":"Kathleen Hegadoren","psa":"Glen B. Baker","ptype":"article","src":"https://openalex.org/W1983424797","eid":"W1983424797"},{"id":"paper-w4390495773","cat":"papers","name":"Spiritual health practitioners’ contributions to psychedelic assisted therapy: A qualitative analysis","year":"2024","cit":27,"pfa":"Caroline Peacock","psa":"Roman Palitsky","topics":["Anxiety & end-of-life","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4390495773","eid":"W4390495773"},{"id":"paper-w2975066587","cat":"papers","name":"Intermittent administration of low dose ketamine can shorten the course of electroconvulsive therapy for depression and reduce complications: A randomized controlled trial","year":"2019","cit":27,"pfa":"Jun Dong","psa":"Li Ren","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2975066587","eid":"W2975066587"},{"id":"paper-w3088502206","cat":"papers","name":"Tripping over the other: Could psychedelics increase empathy?","year":"2020","cit":27,"pfa":"Emily Blatchford","psa":"Liam B. Engel","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3088502206","eid":"W3088502206"},{"id":"paper-w4382894922","cat":"papers","name":"Psychologists' and psychotherapists' knowledge, attitudes, and clinical practices regarding the therapeutic use of psychedelics","year":"2023","cit":27,"pfa":"Aileen Kucsera","psa":"Nancy A. Haug","topics":["Safety & adverse events","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4382894922","eid":"W4382894922"},{"id":"paper-w3162204693","cat":"papers","name":"Towards psychedelic apprenticeship: Developing a gentle touch for the mediation and validation of psychedelic-induced insights and revelations","year":"2020","cit":27,"pfa":"Christopher B. Timmermann","psa":"David Dupuis","topics":["Safety & adverse events","Therapy practice","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W3162204693","eid":"W3162204693"},{"id":"paper-w2067330083","cat":"papers","name":"Why Psychiatry Needs Psychedelics and Psychedelics Need Psychiatry","year":"2014","cit":27,"pfa":"Ben Sessa","ptype":"article","src":"https://openalex.org/W2067330083","eid":"W2067330083"},{"id":"paper-w2064001729","cat":"papers","name":"Plant hallucinogens, shamanism and nazca ceramics","year":"1980","cit":27,"pfa":"Marlene Dobkin de Ríos","psa":"Mercedes Cárdenas","ptype":"article","src":"https://openalex.org/W2064001729","eid":"W2064001729"},{"id":"paper-w4250806749","cat":"papers","name":"Psychedelics and Religious Experience","year":"1968","cit":27,"pfa":"Alan Watts","ptype":"article","src":"https://openalex.org/W4250806749","eid":"W4250806749"},{"id":"paper-w2312230785","cat":"papers","name":"Psychedelic Drugs and the Problem of Experience","year":"2014","cit":27,"pfa":"Sally Shortall","topics":["Addiction","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2312230785","eid":"W2312230785"},{"id":"paper-w2079181762","cat":"papers","name":"\"Psychedelic\" Effects Produced by Sensory Overload","year":"1972","cit":27,"pfa":"Arnold M. Ludwig","ptype":"article","src":"https://openalex.org/W2079181762","eid":"W2079181762"},{"id":"paper-w2980158818","cat":"papers","name":"The ethics of psychedelic research in disorders of consciousness","year":"2019","cit":27,"pfa":"Andrew H. Peterson","psa":"Charles Weijer","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2980158818","eid":"W2980158818"},{"id":"paper-w2066625085","cat":"papers","name":"Early Human ADME Using Microdoses and Microtracers: Bioanalytical Considerations","year":"2010","cit":27,"pfa":"Stephen R. Dueker","psa":"John S. Vogel","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2066625085","eid":"W2066625085"},{"id":"paper-w2883608373","cat":"papers","name":"A Gratuitous Grace: The Influence of Religious Set and Intent on the Psychedelic Experience","year":"2018","cit":27,"pfa":"Logan Neitzke‐Spruill","psa":"Carol L. Glasser","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2883608373","eid":"W2883608373"},{"id":"paper-w4285201277","cat":"papers","name":"Psychedelics as potential catalysts of scientific creativity and insight","year":"2022","cit":27,"pfa":"Sam Gandy","psa":"David P. Luke","topics":["Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4285201277","eid":"W4285201277"},{"id":"paper-w2017810409","cat":"papers","name":"The Hypnotic Trance, the Psychedelic Experience, and the Creative Act","year":"1964","cit":27,"pfa":"Stanley Krippner","ptype":"article","src":"https://openalex.org/W2017810409","eid":"W2017810409"},{"id":"paper-w605122444","cat":"papers","name":"QuaSAR : quantitative structure activity relationships of analgesics, narcotic antagonists, and hallucinogens","year":"1978","cit":27,"pfa":"Gene Barnett","psa":"Robert E. Willette","ptype":"book","src":"https://openalex.org/W605122444","eid":"W605122444"},{"id":"paper-w3046518651","cat":"papers","name":"Improved detection methods significantly increase the detection window for EPO microdoses","year":"2020","cit":27,"pfa":"Laurent Martin","psa":"Alexandre Marchand","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3046518651","eid":"W3046518651"},{"id":"paper-w4383988993","cat":"papers","name":"The potential of psychedelics for the treatment of Alzheimer's disease and related dementias","year":"2023","cit":27,"pfa":"Michael Winkelman","psa":"Ede Frecska","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4383988993","eid":"W4383988993"},{"id":"paper-w1983028008","cat":"papers","name":"Folk Curing With a Psychedelic Cactus in the North Coast of Peru","year":"1969","cit":27,"pfa":"Marlene Dobkin","ptype":"article","src":"https://openalex.org/W1983028008","eid":"W1983028008"},{"id":"paper-w4224043710","cat":"papers","name":"Hallucinogen persisting perceptual disorder: a scoping review covering frequency, risk factors, prevention, and treatment","year":"2022","cit":27,"pfa":"Marcus A. Doyle","psa":"Roger S. McIntyre","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4224043710","eid":"W4224043710"},{"id":"paper-w4290652664","cat":"papers","name":"Apophenia, absorption and anxiety: Evidence for individual differences in positive and negative experiences of Hallucinogen Persisting Perceptual Disorder","year":"2022","cit":27,"pfa":"Alexander Irvine","psa":"David P. Luke","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4290652664","eid":"W4290652664"},{"id":"paper-w2313890546","cat":"papers","name":"The New Psychedelic Culture: LSD, Ecstasy, \"Rave\" Parties and The Grateful Dead","year":"1994","cit":27,"pfa":"Robert B. Millman","psa":"Ann Bordwine Beeder","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2313890546","eid":"W2313890546"},{"id":"paper-w3133947388","cat":"papers","name":"Global drug survey (GDS) 2020 psychedelics key findings report.","year":"2021","cit":27,"pfa":"ADAM R. WINSTOCK","psa":"Kim P. C. Kuypers","ptype":"article","src":"https://openalex.org/W3133947388","eid":"W3133947388"},{"id":"paper-w4390795001","cat":"papers","name":"Trends in hallucinogen‐associated emergency department visits and hospitalizations in California, USA, from 2016 to 2022","year":"2024","cit":27,"pfa":"Nicolas Garel","psa":"Anna Lembke","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4390795001","eid":"W4390795001"},{"id":"paper-w4384564746","cat":"papers","name":"The relationship between the default mode network and the theory of mind network as revealed by psychedelics – A meta-analysis","year":"2023","cit":27,"pfa":"Carla Soares","psa":"Miguel Castelo‐Branco","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4384564746","eid":"W4384564746"},{"id":"paper-w3136795133","cat":"papers","name":"Quantification of CYP3A and Drug Transporters Activity in Healthy Young, Healthy Elderly and Chronic Kidney Disease Elderly Patients by a Microdose Cocktail Approach","year":"2021","cit":27,"pfa":"Punyabhorn Rattanacheeworn","psa":"Pajaree Chariyavilaskul","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3136795133","eid":"W3136795133"},{"id":"paper-w1992134039","cat":"papers","name":"Psychotomimetic Indole Compound in the Urine of Schizophrenics and Mentally Defective Patients","year":"1967","cit":27,"pfa":"Hiroshi Tanimukai","psa":"Harold E. Himwich","ptype":"article","src":"https://openalex.org/W1992134039","eid":"W1992134039"},{"id":"paper-w2398676493","cat":"papers","name":"A comparison of three psychotomimetic-induced models of psychosis in nonhuman primate social colonies.","year":"1983","cit":27,"pfa":"R. Francis Schlemmer","psa":"J M Davis","ptype":"article","src":"https://openalex.org/W2398676493","eid":"W2398676493"},{"id":"paper-w3034018344","cat":"papers","name":"A single psychotomimetic dose of ketamine decreases thalamocortical spindles and delta oscillations in the sedated rat","year":"2020","cit":27,"pfa":"A. Mahdavi","psa":"Didier Pinault","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3034018344","eid":"W3034018344"},{"id":"paper-w2208758069","cat":"papers","name":"EFFECTS OF PSYCHOTOMIMETICS ON VASCULAR STRIPS: STUDIES OF METHOXYLATED AMPHETAMINES AND OPTICAL ISOMERS OF 2,5-DIMETHOXY-4-METHYLAMPHETAMINE AND 2,5-DIMETHOXY-4-BROMOAMPHETAMINE","year":"1974","cit":27,"pfa":"Hsien C. Cheng","psa":"Charles F. Barfknecht","ptype":"article","src":"https://openalex.org/W2208758069","eid":"W2208758069"},{"id":"paper-w2152697141","cat":"papers","name":"LSD therapy in Dutch psychiatry: changing socio-political settings and medical sets","year":"2002","cit":27,"pfa":"Stephen Snelders","psa":"Charles Kaplan","ptype":"article","src":"https://openalex.org/W2152697141","eid":"W2152697141"},{"id":"paper-w3123949134","cat":"papers","name":"Zebrafish and Artemia salina in vivo evaluation of the recreational 25C-NBOMe drug demonstrates its high toxicity","year":"2021","cit":27,"pfa":"Natalie Álvarez-Alarcón","psa":"Zayra Viviana Garavito-Aguilar","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3123949134","eid":"W3123949134"},{"id":"paper-w2108684858","cat":"papers","name":"LSD Research: The Impact of Lay Publicity","year":"1968","cit":27,"pfa":"Charles Clay Dahlberg","psa":"Stanley Feldstein","ptype":"article","src":"https://openalex.org/W2108684858","eid":"W2108684858"},{"id":"paper-w2000978748","cat":"papers","name":"Lack of specificity of an animal behavior model for hallucinogenic drug action","year":"1981","cit":27,"pfa":"Francis J. White","psa":"James B. Appel","ptype":"article","src":"https://openalex.org/W2000978748","eid":"W2000978748"},{"id":"paper-w2054916272","cat":"papers","name":"Induction of Illusory and Hallucinatory Voices with Considerations of Behaviour Therapy","year":"1962","cit":27,"pfa":"Ian Oswald","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2054916272","eid":"W2054916272"},{"id":"paper-w2154803261","cat":"papers","name":"Alterations in consciousness produced by combinations of LSD, hypnosis and psychotherapy","year":"1965","cit":27,"pfa":"Jerome Levine","psa":"Arnold M. Ludwig","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2154803261","eid":"W2154803261"},{"id":"paper-w2058570539","cat":"papers","name":"Changes in body temperature after administration of antipyretics, LSD, Δ9-THC and related agents: II","year":"1987","cit":27,"pfa":"Wesley G. Clark","ptype":"article","src":"https://openalex.org/W2058570539","eid":"W2058570539"},{"id":"paper-w2731763738","cat":"papers","name":"The Comorbidity of Psychiatric and Substance Use Disorders Among Hispanic Adolescents","year":"2017","cit":27,"pfa":"Karina A. Gattamorta","psa":"Daniel A. Santisteban","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2731763738","eid":"W2731763738"},{"id":"paper-w2048272255","cat":"papers","name":"Motivations for Use of Opiates among Addicts Seeking Treatment in Shiraz","year":"2000","cit":27,"pfa":"Jamshid Ahmadi","psa":"Ahmad Javid Ghanizadeh","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2048272255","eid":"W2048272255"},{"id":"paper-w2069493037","cat":"papers","name":"Causes of death of patients with substance dependence: a record‐linkage study in a psychiatric hospital in Taiwan","year":"2001","cit":27,"pfa":"Chiao‐Chicy Chen","psa":"Shang‐Ying Tsai","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2069493037","eid":"W2069493037"},{"id":"paper-w4380483724","cat":"papers","name":"Efficacy and safety of esketamine for sedation among patients undergoing gastrointestinal endoscopy: a systematic review and meta-analysis","year":"2023","cit":27,"pfa":"Xianghong Lian","psa":"Yixin Guo","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W4380483724","eid":"W4380483724"},{"id":"paper-w2000560975","cat":"papers","name":"Electroconvulsive therapy-induced persistent retrograde amnesia: Could it be minimised by ketamine or other pharmacological approaches?","year":"2010","cit":27,"pfa":"Emily M. Gregory-Roberts","psa":"Ian Bernard Hickie","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2000560975","eid":"W2000560975"},{"id":"paper-w4385238162","cat":"papers","name":"A role of splenic heme biosynthesis pathway in the persistent prophylactic actions of arketamine in lipopolysaccharide-treated mice","year":"2023","cit":27,"pfa":"Li Ma","psa":"Kenji Hashimoto","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4385238162","eid":"W4385238162"},{"id":"paper-w4387859807","cat":"papers","name":"The Patient’s Perspective on the Effects of Intranasal Esketamine in Treatment-Resistant Depression","year":"2023","cit":27,"pfa":"Maria Pepe","psa":"Gabriele Sani","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4387859807","eid":"W4387859807"},{"id":"paper-w4311949512","cat":"papers","name":"Low-dose esketamine for the prevention of emergency agitation in children after tonsillectomy: A randomized controlled study","year":"2022","cit":27,"pfa":"Qi Li","psa":"Wangping Zhang","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4311949512","eid":"W4311949512"},{"id":"paper-w3119710654","cat":"papers","name":"Adverse Effects of Esketamine for the Treatment of Major Depression Disorder: Findings from Randomized Controlled Trials","year":"2021","cit":27,"pfa":"Siyuan Yang","psa":"Gang Chen","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3119710654","eid":"W3119710654"},{"id":"paper-w4281704306","cat":"papers","name":"[Retracted] Efficacy of Analgesic Propofol/Esketamine and Propofol/Fentanyl for Painless Induced Abortion: A Randomized Clinical Trial","year":"2022","cit":27,"pfa":"Naixing Xin","psa":"Shuangfen Jin","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4281704306","eid":"W4281704306"},{"id":"paper-w4321377125","cat":"papers","name":"Safety and tolerability of esketamine in propofol based sedation for endoscopic variceal ligation with or without injection sclerotherapy: Randomized controlled trial","year":"2023","cit":27,"pfa":"Yuanjing Chen","psa":"Guangyou Duan","topics":["Safety & adverse events","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4321377125","eid":"W4321377125"},{"id":"paper-w4361285872","cat":"papers","name":"Esketamine ameliorates post-stroke anxiety by modulating microglial HDAC3/NF-κB/COX1 inflammatory signaling in ischemic cortex","year":"2023","cit":27,"pfa":"Ailing Huang","psa":"Bin Deng","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4361285872","eid":"W4361285872"},{"id":"paper-w4324143645","cat":"papers","name":"Acute Effects of Intravenous Sub-Anesthetic Doses of Ketamine and Intranasal Inhaled Esketamine on Suicidal Ideation: A Systematic Review and Meta-Analysis","year":"2023","cit":27,"pfa":"Cheng‐Chuan Chen","psa":"Xiaobin Wang","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W4324143645","eid":"W4324143645"},{"id":"paper-w4408220847","cat":"papers","name":"Effect of intravenous esketamine on postoperative sleep disturbance, anxiety, and depression in elderly patients undergoing laparoscopic abdominal surgery: a randomized controlled trial","year":"2025","cit":27,"pfa":"Haijin Wang","psa":"Fengqi Zhou","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4408220847","eid":"W4408220847"},{"id":"paper-w4391910660","cat":"papers","name":"Efficacy of Intravenous Administration of Esketamine in Preventing and Treating Rebound Pain After Thoracic Paravertebral Nerve Block: A Prospective Randomized, Double-Blind, Placebo-Controlled Trial","year":"2024","cit":27,"pfa":"Xu Zeng","psa":"Xinyu Zhou","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4391910660","eid":"W4391910660"},{"id":"paper-w4309774287","cat":"papers","name":"Antidepressants in the post-ketamine Era: Pharmacological approaches targeting the glutamatergic system","year":"2022","cit":27,"pfa":"Shigeyuki Chaki","psa":"Mai Watanabe","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4309774287","eid":"W4309774287"},{"id":"paper-w4387109635","cat":"papers","name":"Ketamine for bipolar depression: an updated systematic review","year":"2023","cit":27,"pfa":"Farhan Fancy","psa":"Joshua Daniel Rosenblat","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W4387109635","eid":"W4387109635"},{"id":"paper-w2955038019","cat":"papers","name":"Keeping up with the clinical advances: depression","year":"2019","cit":27,"pfa":"Renee‐Marie Ragguett","psa":"Roger S. McIntyre","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W2955038019","eid":"W2955038019"},{"id":"paper-w4319294315","cat":"papers","name":"Guidelines’ recommendations for the treatment-resistant depression: A systematic review of their quality","year":"2023","cit":27,"pfa":"Franciele Cordeiro Gabriel","psa":"Eliane Ribeiro","topics":["Depression","Reviews & meta-analyses","Therapy practice"],"ptype":"review","src":"https://openalex.org/W4319294315","eid":"W4319294315"},{"id":"paper-w1536888392","cat":"papers","name":"Acute toxicity of ibogaine and noribogaine","year":"2008","cit":26,"pfa":"Asta Kubilienė","psa":"Leonid Ivanov","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1536888392","eid":"W1536888392"},{"id":"paper-w2087604852","cat":"papers","name":"Psychological and Biochemical Effects of Lysergic Acid Diethylamide","year":"1951","cit":26,"pfa":"W. Mayer-Groß","psa":"J. W. Walker","ptype":"article","src":"https://openalex.org/W2087604852","eid":"W2087604852"},{"id":"paper-w2121565455","cat":"papers","name":"Further Observations on the Effects of Lysergic Acid Diethylamide","year":"1953","cit":26,"pfa":"W. Mayer-Groß","psa":"J. W. Walker","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2121565455","eid":"W2121565455"},{"id":"paper-w2069530839","cat":"papers","name":"Nicotinic Acid Modified Lysergic Acid Diethylamide Psychosis","year":"1955","cit":26,"pfa":"Neil McK. Agnew","psa":"Abram Hoffer","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2069530839","eid":"W2069530839"},{"id":"paper-w2089111361","cat":"papers","name":"Some effects of lysergic acid diethylamide on visual discrimination in pigeons","year":"1967","cit":26,"pfa":"D. I. Becker","psa":"Daniel X. Freedman","ptype":"article","src":"https://openalex.org/W2089111361","eid":"W2089111361"},{"id":"paper-w2043696319","cat":"papers","name":"Effects of lysergic acid diethylamide on attack behavior of male albino mice","year":"1965","cit":26,"pfa":"Edward T. Uyeno","psa":"Wilbur M. Benson","ptype":"article","src":"https://openalex.org/W2043696319","eid":"W2043696319"},{"id":"paper-w2006783317","cat":"papers","name":"Lack of tolerance to the depression of raphe unit activity by lysergic acid diethylamide","year":"1977","cit":26,"pfa":"Michael E. Trulson","psa":"Barry L. Jacobs","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2006783317","eid":"W2006783317"},{"id":"paper-w2091346601","cat":"papers","name":"Patterns of exploration in rats distinguish lisuride from lysergic acid diethylamide","year":"1985","cit":26,"pfa":"Lynne M. Adams","psa":"Mark A. Geyer","ptype":"article","src":"https://openalex.org/W2091346601","eid":"W2091346601"},{"id":"paper-w4393364883","cat":"papers","name":"Spectral signatures of psilocybin, lysergic acid diethylamide (LSD) and ketamine in healthy volunteers and persons with major depressive disorder and treatment-resistant depression: A systematic review","year":"2024","cit":26,"pfa":"Gia Han Le","psa":"Roger S. McIntyre","topics":["Depression","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4393364883","eid":"W4393364883"},{"id":"paper-w4298838310","cat":"papers","name":"Analysis of Psilocybin and Psilocin in Mushroom Extracts by Reversed-Phase High Performance Liquid Chromatography","year":"1980","cit":26,"pfa":"BM Thomson","ptype":"article","src":"https://openalex.org/W4298838310","eid":"W4298838310"},{"id":"paper-w4376107756","cat":"papers","name":"The down-scheduling of MDMA and psilocybin(e): Too fast and too soon","year":"2023","cit":26,"pfa":"Steve R Kisely","ptype":"article","src":"https://openalex.org/W4376107756","eid":"W4376107756"},{"id":"paper-w1983802353","cat":"papers","name":"Circannual variations in the binding of [3H]lysergic acid diethylamide to serotonin2A receptors and of [3H]paroxetine to serotonin uptake sites in platelets from healthy volunteers","year":"1998","cit":26,"pfa":"Olav Spigset","psa":"Tom Mjörndal","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1983802353","eid":"W1983802353"},{"id":"paper-w2066419824","cat":"papers","name":"GC ‐ MS and GC ‐ MS / MS in PCI Mode Determination of Mescaline in Peyote Tea and in Biological Matrices","year":"2012","cit":26,"pfa":"Cristiana Gambelunghe","psa":"Riccardo Rossi","ptype":"article","src":"https://openalex.org/W2066419824","eid":"W2066419824"},{"id":"paper-w2034472253","cat":"papers","name":"Botulism from Peyote","year":"1998","cit":26,"pfa":"Hirofumi Hashimoto","psa":"Karen Parko","ptype":"article","src":"https://openalex.org/W2034472253","eid":"W2034472253"},{"id":"paper-w2087803194","cat":"papers","name":"Statement on ayahuasca","year":"2012","cit":26,"pfa":"Brian T. Anderson","psa":"Dennis J. McKenna","ptype":"article","src":"https://openalex.org/W2087803194","eid":"W2087803194"},{"id":"paper-w3204888224","cat":"papers","name":"Peyote (Lophophora williamsii) and Plants confused with it","year":"1937","cit":26,"pfa":"Richard Evans Schultes","ptype":"article","src":"https://openalex.org/W3204888224","eid":"W3204888224"},{"id":"paper-w2398819133","cat":"papers","name":"N,N-Dimethyltryptamine–Induced Psychosis","year":"2015","cit":26,"pfa":"Neil E. Paterson","psa":"Preetpal Sandhu","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2398819133","eid":"W2398819133"},{"id":"paper-w2116385569","cat":"papers","name":"Stimulus effects of ibogaine in rats trained with yohimbine, DOM, or LSD","year":"1992","cit":26,"pfa":"Patricia A. Palumbo","psa":"Jerrold C. Winter","ptype":"article","src":"https://openalex.org/W2116385569","eid":"W2116385569"},{"id":"paper-w2087067461","cat":"papers","name":"Healing with Plant Intelligence: A Report from Ayahuasca","year":"2012","cit":26,"pfa":"Richard Doyle","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W2087067461","eid":"W2087067461"},{"id":"paper-w1982525015","cat":"papers","name":"Biosynthesis and turnover of N,N-dimethyltryptamine and 5-methoxy-N,N-dimethyltryptamine in Phalaris tuberosa","year":"1972","cit":26,"pfa":"Claire Baxter","psa":"M. Slaytor","ptype":"article","src":"https://openalex.org/W1982525015","eid":"W1982525015"},{"id":"paper-w4400513312","cat":"papers","name":"Psilocybin for the treatment of Alzheimer’s disease","year":"2024","cit":26,"pfa":"Siyi Zheng","psa":"Gang� Li","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4400513312","eid":"W4400513312"},{"id":"paper-w4225114051","cat":"papers","name":"Assessment of Bioactivity‐Modulating Pseudo‐Ring Formation in Psilocin and Related Tryptamines","year":"2022","cit":26,"pfa":"Claudius Lenz","psa":"Dirk Hoffmeister","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4225114051","eid":"W4225114051"},{"id":"paper-w1847580901","cat":"papers","name":"DISTRIBUTION AND METABOLISM OF MESCALINE-C IN THE CAT BRAIN","year":"1964","cit":26,"pfa":"Norton H. Neff","psa":"Joseph L. Rabinowitz","ptype":"article","src":"https://openalex.org/W1847580901","eid":"W1847580901"},{"id":"paper-w4393270574","cat":"papers","name":"Methyl transfer in psilocybin biosynthesis","year":"2024","cit":26,"pfa":"Jesse D. Hudspeth","psa":"Sebastiaan Werten","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4393270574","eid":"W4393270574"},{"id":"paper-w4381309423","cat":"papers","name":"“Biosynthesis of psilocybin and its nonnatural derivatives by a promiscuous psilocybin synthesis pathway in Escherichia coli”","year":"2023","cit":26,"pfa":"Jessica E. Flower","psa":"J. Andrew Jones","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4381309423","eid":"W4381309423"},{"id":"paper-w2003119283","cat":"papers","name":"Behavioural and neurochemical assessment of salvinorin A abuse potential in the rat","year":"2014","cit":26,"pfa":"Veronica Serra","psa":"Paola Fadda","ptype":"article","src":"https://openalex.org/W2003119283","eid":"W2003119283"},{"id":"paper-w2094947385","cat":"papers","name":"A Five-Step Synthesis of Psilocin from Indole-3-carbaldehyde","year":"1998","cit":26,"pfa":"Masanori Somei","psa":"Mayumi Tamura","topics":["Depression","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2094947385","eid":"W2094947385"},{"id":"paper-w2157478055","cat":"papers","name":"The Scheduling of MDMA: A Pharmacist's Perspective","year":"1985","cit":26,"pfa":"June E. Riedlinger","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2157478055","eid":"W2157478055"},{"id":"paper-w2059687588","cat":"papers","name":"Potentiation action of ibogaine (bogadin TM) on morphine analgesia","year":"1956","cit":26,"pfa":"Jurg A. Schneider","psa":"Marie McArthur","ptype":"article","src":"https://openalex.org/W2059687588","eid":"W2059687588"},{"id":"paper-w2160095996","cat":"papers","name":"Development of a LC–MS/MS Method to Analyze 5-Methoxy-N,N-Dimethyltryptamine and Bufotenine: Application to Pharmacokinetic Study","year":"2009","cit":26,"pfa":"Hong-Wu Shen","psa":"Ai‐Ming Yu","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2160095996","eid":"W2160095996"},{"id":"paper-w2132998332","cat":"papers","name":"The Mescal Bean Cult of the Central and Southern Plains: An Ancestor of the Peyote Cult?","year":"1957","cit":26,"pfa":"James H. Howard","ptype":"article","src":"https://openalex.org/W2132998332","eid":"W2132998332"},{"id":"paper-w2091016019","cat":"papers","name":"Potentiation of 5-methoxy-N,N-dimethyltryptamine-induced hyperthermia by harmaline and the involvement of activation of 5-HT1A and 5-HT2A receptors","year":"2014","cit":26,"pfa":"Xi-Ling Jiang","psa":"Ai‐Ming Yu","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2091016019","eid":"W2091016019"},{"id":"paper-w2081663850","cat":"papers","name":"Oral fluid and plasma 3,4-methylenedioxymethamphetamine (MDMA) and metabolite correlation after controlled oral MDMA administration","year":"2013","cit":26,"pfa":"Nathalie A. Desrosiers","psa":"Marilyn Ann Huestis","ptype":"article","src":"https://openalex.org/W2081663850","eid":"W2081663850"},{"id":"paper-w4323825498","cat":"papers","name":"Receptor Binding Profiles for Tryptamine Psychedelics and Effects of 4-Propionoxy-N,N-dimethyltryptamine in Mice","year":"2023","cit":26,"pfa":"Grant C. Glatfelter","psa":"Michael H. Baumann","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4323825498","eid":"W4323825498"},{"id":"paper-w2050498247","cat":"papers","name":"MDMA use is associated with increased spatial BOLD fMRI visual cortex activation in human MDMA users","year":"2006","cit":26,"pfa":"Ronald L. Cowan","psa":"Perry Franklin Renshaw","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2050498247","eid":"W2050498247"},{"id":"paper-w2036754846","cat":"papers","name":"Neuroimaging in Human MDMA (Ecstasy) Users","year":"2008","cit":26,"pfa":"Ronald L. Cowan","psa":"James M. Joers","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2036754846","eid":"W2036754846"},{"id":"paper-w2585110642","cat":"papers","name":"The production of psilocybin in submerged culture by Psilocybe cubensis.","year":"1964","cit":26,"pfa":"Philip Catalfomo","psa":"Varro E. Tyler","ptype":"article","src":"https://openalex.org/W2585110642","eid":"W2585110642"},{"id":"paper-w2884472593","cat":"papers","name":"Convergent evolution of psilocybin biosynthesis by psychedelic mushrooms","year":"2018","cit":26,"pfa":"Ali R. Awan","psa":"Bryn T. M. Dentinger","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W2884472593","eid":"W2884472593"},{"id":"paper-w2081567246","cat":"papers","name":"Identification of N,N-dimethyltryptamine as the product of an in vitro enzymic methylation","year":"1972","cit":26,"pfa":"Robert W. Walker","psa":"William J. A. VandenHeuvel","ptype":"article","src":"https://openalex.org/W2081567246","eid":"W2081567246"},{"id":"paper-w2978003416","cat":"papers","name":"Antinociceptive effects of Salvia divinorum and bioactive salvinorins in experimental pain models in mice","year":"2019","cit":26,"pfa":"Lorenzo Leonel Tlacomulco-Flores","psa":"Francisco Pellicer","ptype":"article","src":"https://openalex.org/W2978003416","eid":"W2978003416"},{"id":"paper-w2071289935","cat":"papers","name":"Psilocybin: Biphasic dose-response effects on the acoustic startle reflex in the rat","year":"1977","cit":26,"pfa":"Michael T. Davis","psa":"James K. Walters","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2071289935","eid":"W2071289935"},{"id":"paper-w1921591043","cat":"papers","name":"Adolescent pre‐exposure to ethanol and 3,4‐methylenedioxymethylamphetamine (MDMA) increases conditioned rewarding effects of MDMA and drug‐induced reinstatement","year":"2011","cit":26,"pfa":"Bruno Ribeiro Do Couto","psa":"M.A. Aguilar","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1921591043","eid":"W1921591043"},{"id":"paper-w4403392138","cat":"papers","name":"Human brain changes after first psilocybin use","year":"2026","cit":26,"pfa":"T. Lyons","psa":"Robin Lester Carhart-Harris","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4403392138","eid":"W4403392138"},{"id":"paper-w2024964629","cat":"papers","name":"Persistent psychiatric symptoms after eating psilocybin mushrooms.","year":"1979","cit":26,"pfa":"Candice Benjamin","ptype":"article","src":"https://openalex.org/W2024964629","eid":"W2024964629"},{"id":"paper-w2076066147","cat":"papers","name":"Chronic administration of THC prevents the behavioral effects of intermittent adolescent MDMA administration and attenuates MDMA-induced hyperthermia and neurotoxicity in rats","year":"2011","cit":26,"pfa":"Erica Shen","psa":"Jerrold S. Meyer","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2076066147","eid":"W2076066147"},{"id":"paper-w2082731370","cat":"papers","name":"Evidence that ibogaine releases dopamine from the cytoplasmic pool in isolated mouse striatum","year":"1994","cit":26,"pfa":"László Gábor Hársing","psa":"Ábel Lajtha","ptype":"article","src":"https://openalex.org/W2082731370","eid":"W2082731370"},{"id":"paper-w118102967","cat":"papers","name":"Phenomenal qualities of ayahuasca ingestion and its relation to fringe consciousness and personality","year":"2006","cit":26,"pfa":"Terry A. Bresnick","psa":"Ross Levin","ptype":"article","src":"https://openalex.org/W118102967","eid":"W118102967"},{"id":"paper-w4280579129","cat":"papers","name":"Special considerations for evaluating psilocybin-facilitated psychotherapy in vulnerable populations","year":"2022","cit":26,"pfa":"Cynthia E. Ortiz","psa":"Peter S. Hendricks","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4280579129","eid":"W4280579129"},{"id":"paper-w1714715366","cat":"papers","name":"De novo sequencing and analysis of Lophophora williamsii transcriptome, and searching for putative genes involved in mescaline biosynthesis","year":"2015","cit":26,"pfa":"Enrique Ibarra‐Laclette","psa":"Luís Herrera‐Estrella","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1714715366","eid":"W1714715366"},{"id":"paper-w2025357068","cat":"papers","name":"Bilateral sixth nerve palsy associated with MDMA (“ecstasy”) abuse","year":"2000","cit":26,"pfa":"Bernd U. Schroeder","psa":"Silvia Brieden","ptype":"article","src":"https://openalex.org/W2025357068","eid":"W2025357068"},{"id":"paper-w2772229539","cat":"papers","name":"Acute Effects of Methylphenidate, Modafinil, and MDMA on Negative Emotion Processing","year":"2017","cit":26,"pfa":"André Schmidt","psa":"Stefan Borgwardt","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2772229539","eid":"W2772229539"},{"id":"paper-w4315619317","cat":"papers","name":"Psilocin suppresses methamphetamine‐induced hyperlocomotion and acquisition of conditioned place preference via D2R ‐mediated ERK signaling","year":"2023","cit":26,"pfa":"Jing Wang","psa":"Xinshe Liu","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4315619317","eid":"W4315619317"},{"id":"paper-w4284665615","cat":"papers","name":"Decreases in State and Trait Anxiety Post-psilocybin: A Naturalistic, Observational Study Among Retreat Attendees","year":"2022","cit":26,"pfa":"Maggie Kiraga","psa":"Natasha Leigh Mason","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4284665615","eid":"W4284665615"},{"id":"paper-w4312084004","cat":"papers","name":"Psychotherapists' openness to engage their patients in Psilocybin-Assisted Therapy for mental health treatment","year":"2022","cit":26,"pfa":"Priel Meir","psa":"Thomas Daniel Meyer","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4312084004","eid":"W4312084004"},{"id":"paper-w1980500034","cat":"papers","name":"Is Recreational Ecstasy (MDMA) Use Associated with Higher Levels of Depressive Symptoms?","year":"2007","cit":26,"pfa":"Casey R. Guillot","topics":["Depression","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1980500034","eid":"W1980500034"},{"id":"paper-w3119374612","cat":"papers","name":"EEG Gamma Band Alterations and REM-like Traits Underpin the Acute Effect of the Atypical Psychedelic Ibogaine in the Rat","year":"2021","cit":26,"pfa":"Joaqúın González","psa":"Pablo Torterolo","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3119374612","eid":"W3119374612"},{"id":"paper-w3132107090","cat":"papers","name":"Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo","year":"2021","cit":26,"pfa":"Ling-Xiao Shao","psa":"Alex C. Kwan","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W3132107090","eid":"W3132107090"},{"id":"paper-w2050585016","cat":"papers","name":"Inhibition of MAO-B protects against MDMA-induced neurotoxicity in the striatum","year":"1995","cit":26,"pfa":"Jon E. Sprague","psa":"David E. Nichols","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2050585016","eid":"W2050585016"},{"id":"paper-w2061939068","cat":"papers","name":"Neurotoxic effects of the alpha-ethyl homologue of MDMA following subacute administration","year":"1989","cit":26,"pfa":"Michael P. Johnson","psa":"David E. Nichols","ptype":"article","src":"https://openalex.org/W2061939068","eid":"W2061939068"},{"id":"paper-w2090237116","cat":"papers","name":"Oxidative Stress in Rat Retina and Hippocampus after Chronic MDMA (‘ecstasy’) Administration","year":"2007","cit":26,"pfa":"María Miranda","psa":"Francisco Javier Romero","ptype":"article","src":"https://openalex.org/W2090237116","eid":"W2090237116"},{"id":"paper-w2594685370","cat":"papers","name":"Pseudorotaxane capped mesoporous silica nanoparticles for 3,4-methylenedioxymethamphetamine (MDMA) detection in water","year":"2017","cit":26,"pfa":"Beatriz Lozano‐Torres","psa":"Félix Sancenón","ptype":"article","src":"https://openalex.org/W2594685370","eid":"W2594685370"},{"id":"paper-w2010071687","cat":"papers","name":"Methylenedioxymethamphetamine (MDMA; ‘Ecstasy’) suppresses antigen specific IgG2a and IFN-γ production","year":"2001","cit":26,"pfa":"Thomas J. Connor","psa":"John P. Kelly","ptype":"article","src":"https://openalex.org/W2010071687","eid":"W2010071687"},{"id":"paper-w759312680","cat":"papers","name":"Neural and behavioural changes in male periadolescent mice after prolonged nicotine-MDMA treatment","year":"2015","cit":26,"pfa":"Philip Adeyemi Adeniyi","psa":"Olalekan Michael Ogundele","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W759312680","eid":"W759312680"},{"id":"paper-w2131431635","cat":"papers","name":"Acute and long-term effects of a single dose of MDMA on aggression in Dark Agouti rats","year":"2005","cit":26,"pfa":"Eszter Kirilly","psa":"György Bagdy","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2131431635","eid":"W2131431635"},{"id":"paper-w2039427443","cat":"papers","name":"3,4-Methylenedioxymethamphetamine (MDMA) and metabolites disposition in blood and plasma following controlled oral administration","year":"2013","cit":26,"pfa":"Rebecca L. Hartman","psa":"Marilyn Ann Huestis","ptype":"article","src":"https://openalex.org/W2039427443","eid":"W2039427443"},{"id":"paper-w2174151587","cat":"papers","name":"MDMA Effects in Brain: Pharmacologic Profile and Evidence of Neurotoxicity from Neurochemical and Autoradiographic Studies","year":"1990","cit":26,"pfa":"George Battaglia","psa":"Errol B. De Souza","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W2174151587","eid":"W2174151587"},{"id":"paper-w2158570893","cat":"papers","name":"Studies of (±)-3,4-Methylenedioxymethamphetamine (MDMA) Metabolism and Disposition in Rats and Mice: Relationship to Neuroprotection and Neurotoxicity Profile","year":"2012","cit":26,"pfa":"Melanie Mueller","psa":"George A. Ricaurte","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2158570893","eid":"W2158570893"},{"id":"paper-w2770648950","cat":"papers","name":"Neurochemical and Neurotoxic Effects of MDMA (Ecstasy) and Caffeine After Chronic Combined Administration in Mice","year":"2017","cit":26,"pfa":"Anna Maria Górska","psa":"Krystyna Gołembiowska","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2770648950","eid":"W2770648950"},{"id":"paper-w1986562224","cat":"papers","name":"Attenuation of the disruptive effects of (+/-)3,4-methylene dioxymethamphetamine (MDMA) on delayed matching-to-sample performance in the rat.","year":"2006","cit":26,"pfa":"David N. Harper","psa":"Susan Schenk","ptype":"article","src":"https://openalex.org/W1986562224","eid":"W1986562224"},{"id":"paper-w2034671306","cat":"papers","name":"Investigating the Role of Serotonin in Visual Orientation Processing Using an ‘Ecstasy’ (MDMA)-Based Research Model","year":"2009","cit":26,"pfa":"Clare Dickson","psa":"John Brown","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2034671306","eid":"W2034671306"},{"id":"paper-w2463738554","cat":"papers","name":"Using the Theory of Planned Behavior to predict implementation of harm reduction strategies among MDMA/ecstasy users.","year":"2016","cit":26,"pfa":"Alan K. Davis","psa":"Harold Rosenberg","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2463738554","eid":"W2463738554"},{"id":"paper-w2943851251","cat":"papers","name":"MDMA Induced Cardio-toxicity and Pathological Myocardial Effects: A Systematic Review of Experimental Data and Autopsy Findings","year":"2019","cit":26,"pfa":"Alessandro Bonsignore","psa":"Francesco Ventura","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W2943851251","eid":"W2943851251"},{"id":"paper-w4394684735","cat":"papers","name":"The Promise of Therapeutic Psilocybin: An Evaluation of the 134 Clinical Trials, 54 Potential Indications, and 0 Marketing Approvals on ClinicalTrials.gov","year":"2024","cit":26,"pfa":"Sarah A. Norring","psa":"Michael G. Spigarelli","ptype":"article","src":"https://openalex.org/W4394684735","eid":"W4394684735"},{"id":"paper-w2046457267","cat":"papers","name":"Improved selective ion monitoring mass-spectrometric assay for the determination of n,n-dimethyltryptamine in human blood utilizing capillary column gas chromatography","year":"1979","cit":26,"pfa":"Robert W. Walker","psa":"William J. A. VandenHeuvel","ptype":"article","src":"https://openalex.org/W2046457267","eid":"W2046457267"},{"id":"paper-w2096541878","cat":"papers","name":"Acute effects of MDMA (3,4-methylenedioxymethamphetamine) on EEG oscillations: alone and in combination with ethanol or THC (delta-9-tetrahydrocannabinol)","year":"2010","cit":26,"pfa":"Marieke M. Lansbergen","psa":"Robbert‐Jan Verkes","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2096541878","eid":"W2096541878"},{"id":"paper-w4403605401","cat":"papers","name":"Psilocybin reduces heroin seeking behavior and modulates inflammatory gene expression in the nucleus accumbens and prefrontal cortex of male rats","year":"2024","cit":26,"pfa":"Gabriele Floris","psa":"Stephanie E. Daws","topics":["Addiction","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4403605401","eid":"W4403605401"},{"id":"paper-w2067144713","cat":"papers","name":"Environmental concentrations of 3,4-methylenedioxymethamphetamine (MDMA)-induced cellular stress and modulated antioxidant enzyme activity in the zebra mussel","year":"2014","cit":26,"pfa":"Marco Parolini","psa":"Andrea Binelli","ptype":"article","src":"https://openalex.org/W2067144713","eid":"W2067144713"},{"id":"paper-w1981370904","cat":"papers","name":"Methods for the Analysis of 1-(3,4-Methylenedioxyphenyl)-2-Butanamine and N-Methy 1-(3,4-Methylenedioxyphenyl)- 2-Propanamine (MDMA)","year":"1991","cit":26,"pfa":"F. T. Noggle","psa":"J. DeRuiter","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W1981370904","eid":"W1981370904"},{"id":"paper-w4282963889","cat":"papers","name":"Validation of the forced swim test in Drosophila, and its use to demonstrate psilocybin has long-lasting antidepressant-like effects in flies","year":"2022","cit":26,"pfa":"Meghan Hibicke","psa":"Charles David Nichols","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4282963889","eid":"W4282963889"},{"id":"paper-w3209897178","cat":"papers","name":"Potential processes of change in MDMA‐Assisted therapy for social anxiety disorder: Enhanced memory reconsolidation, self‐transcendence, and therapeutic relationships","year":"2021","cit":26,"pfa":"Jason B. Luoma","psa":"Anne Wagner","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3209897178","eid":"W3209897178"},{"id":"paper-w2163790481","cat":"papers","name":"Mice with Decreased Cerebral Dopamine Function following a Neurotoxic Dose of MDMA (3,4-Methylenedioxymethamphetamine, “Ecstasy”) Exhibit Increased Ethanol Consumption and Preference","year":"2007","cit":26,"pfa":"María Izco","psa":"M. Isabel Colado","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2163790481","eid":"W2163790481"},{"id":"paper-w2063373934","cat":"papers","name":"High concentrations of MDMA (‘ecstasy’) and its metabolite MDA inhibit calcium influx and depolarization-evoked vesicular dopamine release in PC12 cells","year":"2011","cit":26,"pfa":"Laura Hondebrink","psa":"Remco H.S. Westerink","ptype":"article","src":"https://openalex.org/W2063373934","eid":"W2063373934"},{"id":"paper-w2417217304","cat":"papers","name":"[Entactogenic drugs \"ecstasy\" (MDMA), \"eve\" (MDE) and other ring-substituted methamphetamine derivatives. A new class of substances among illegal designer drugs?].","year":"1996","cit":26,"pfa":"Euphrosyne Gouzoulis‐Mayfrank","psa":"H Sass","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2417217304","eid":"W2417217304"},{"id":"paper-w2015086898","cat":"papers","name":"Gas chromatography–ion trap mass spectrometry method for the simultaneous measurement of MDMA (ecstasy) and its metabolites, MDA, HMA, and HMMA in plasma and urine","year":"2010","cit":26,"pfa":"Daniel Gomes","psa":"Helena Carmo","ptype":"article","src":"https://openalex.org/W2015086898","eid":"W2015086898"},{"id":"paper-w2085994812","cat":"papers","name":"Mortality among individuals with cannabis, cocaine, amphetamine, MDMA, and opioid use disorders: a nationwide follow-up study of danish substance users in treatment","year":"2011","cit":26,"pfa":"Mikkel Christoffer Berg B. Arendt","psa":"S. O. W. Jensen","topics":["Addiction","Safety & adverse events"],"ptype":"conference-abstract","src":"https://openalex.org/W2085994812","eid":"W2085994812"},{"id":"paper-w1967567964","cat":"papers","name":"Comparative investigation of disposition of 3,4-(methylenedioxy)methamphetamine (MDMA) in the rat and the mouse by a capillary gas chromatography—mass spectrometry assay based on perfluorotributylamine-enhanced ammonia p","year":"1992","cit":26,"pfa":"Hyun Kyoon Lim","psa":"R. L. Foltz","ptype":"article","src":"https://openalex.org/W1967567964","eid":"W1967567964"},{"id":"paper-w1029054914","cat":"papers","name":"Fate and Metabolism of Some Hallucinogenic Indolealkylamines","year":"1968","cit":26,"pfa":"Ulf G. Ahlborg","psa":"J LINDGREN","ptype":"book-chapter","src":"https://openalex.org/W1029054914","eid":"W1029054914"},{"id":"paper-w2434465376","cat":"papers","name":"LSD: a new treatment emerging from the past","year":"2015","cit":26,"pfa":"Erika Dyck","ptype":"article","src":"https://openalex.org/W2434465376","eid":"W2434465376"},{"id":"paper-w2009866065","cat":"papers","name":"Central and peripheral adrenergic blocking actions of LSD and BOL","year":"1971","cit":26,"pfa":"Gene C. Palmer","psa":"Thomas  Francis Burks","ptype":"article","src":"https://openalex.org/W2009866065","eid":"W2009866065"},{"id":"paper-w4308055899","cat":"papers","name":"The Missing Piece? A Case for Microglia’s Prominent Role in the Therapeutic Action of Anesthetics, Ketamine, and Psychedelics","year":"2022","cit":26,"pfa":"Jared VanderZwaag","psa":"Marie‐Ève Tremblay","ptype":"article","src":"https://openalex.org/W4308055899","eid":"W4308055899"},{"id":"paper-w2054785654","cat":"papers","name":"False-Positive LSD Testing in Urine Samples from Intensive Care Patients","year":"1998","cit":26,"pfa":"J. Rohrich","psa":"Ch. Rittner","ptype":"article","src":"https://openalex.org/W2054785654","eid":"W2054785654"},{"id":"paper-w1997424836","cat":"papers","name":"In Vivo Effects of Illicit Hallucinogens on Human Lymphocyte Chromosomes","year":"1970","cit":26,"pfa":"David Dorrance","ptype":"article","src":"https://openalex.org/W1997424836","eid":"W1997424836"},{"id":"paper-w2040589398","cat":"papers","name":"THE NATURE OF THE BINDING BETWEEN LSD AND A 5‐HT RECEPTOR: A POSSIBLE EXPLANATION FOR HALLUCINOGENIC ACTIVITY","year":"1974","cit":26,"pfa":"M J Berridge","psa":"William Prince","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2040589398","eid":"W2040589398"},{"id":"paper-w2019210181","cat":"papers","name":"125I-LSD autoradiography confirms the preferential localization of caudate-putamen S2 receptors to the caudal (peripallidal) region","year":"1986","cit":26,"pfa":"C. Anthony Altar","psa":"Marc R. Marien","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2019210181","eid":"W2019210181"},{"id":"paper-w2946428937","cat":"papers","name":"Simultaneous analysis of 2Cs, 25-NBOHs, 25-NBOMes and LSD in seized exhibits using liquid chromatography–tandem mass spectrometry: A targeted approach","year":"2019","cit":26,"pfa":"Xue Wei Sarah Chia","psa":"Jong Lee Wendy Lim","ptype":"article","src":"https://openalex.org/W2946428937","eid":"W2946428937"},{"id":"paper-w948215016","cat":"papers","name":"Simultaneous determination of LSD and 2-oxo-3-hydroxy LSD in hair and urine by LC–MS/MS and its application to forensic cases","year":"2015","cit":26,"pfa":"Moonhee Jang","psa":"Wonkyung Yang","ptype":"article","src":"https://openalex.org/W948215016","eid":"W948215016"},{"id":"paper-w2002700337","cat":"papers","name":"Methylenedioxymethamphetamine (ecstasy)-related myocardial hypertrophy: An autopsy study","year":"2005","cit":26,"pfa":"Manish M. Patel","psa":"Michael A. Miller","ptype":"article","src":"https://openalex.org/W2002700337","eid":"W2002700337"},{"id":"paper-w3024403515","cat":"papers","name":"Pharmacokinetics and subjective effects of 1P‐LSD in humans after oral and intravenous administration","year":"2020","cit":26,"pfa":"Christina Grumann","psa":"Volker Auwärter","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3024403515","eid":"W3024403515"},{"id":"paper-w2107185052","cat":"papers","name":"A mechanistic insight into 3,4-methylenedioxymethamphetamine (“ecstasy”)-mediated hepatotoxicity","year":"2011","cit":26,"pfa":"Irene Antolino-Lobo","psa":"Majorie B.M. van Duursen","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2107185052","eid":"W2107185052"},{"id":"paper-w2050968705","cat":"papers","name":"Chronic unpredictable stress augments +3,4-methylenedioxymethamphetamine-induced monoamine depletions: The role of corticosterone","year":"2009","cit":26,"pfa":"B.N. Johnson","psa":"Bryan K. Yamamoto","ptype":"article","src":"https://openalex.org/W2050968705","eid":"W2050968705"},{"id":"paper-w2060772857","cat":"papers","name":"Protective effects of N-acetylcysteine on 3, 4-methylenedioxymethamphetamine-induced neurotoxicity in male Sprague–Dawley rats","year":"2013","cit":26,"pfa":"Sara Soleimani Asl","psa":"Mehdi Mehdizadeh","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2060772857","eid":"W2060772857"},{"id":"paper-w3177153100","cat":"papers","name":"Psychedelics as a Training Experience for Psychedelic Therapists: Drawing on History to Inform Current Practice","year":"2021","cit":26,"pfa":"Elizabeth M. Nielson","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W3177153100","eid":"W3177153100"},{"id":"paper-w2020931177","cat":"papers","name":"Ecstasy (3,4-methylenedioxymethamphetamine)","year":"1993","cit":26,"pfa":"Nadia Solowij","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2020931177","eid":"W2020931177"},{"id":"paper-w2137052872","cat":"papers","name":"Enhancing the anti-lymphoma potential of 3,4-methylenedioxymethamphetamine (‘ecstasy’) through iterative chemical redesign: mechanisms and pathways to cell death","year":"2011","cit":26,"pfa":"Agata Magdalena Wasik","psa":"John Gordon","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2137052872","eid":"W2137052872"},{"id":"paper-w1963510892","cat":"papers","name":"Effects of benzylpiperazine derivatives on the neurotoxicity of 3,4-methylenedioxymethamphetamine in rat brain","year":"1992","cit":26,"pfa":"Kenji Hashimoto","psa":"Tsuyoshi Goromaru","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1963510892","eid":"W1963510892"},{"id":"paper-w4390691843","cat":"papers","name":"Rapid-acting antidepressant drugs modulate affective bias in rats","year":"2024","cit":26,"pfa":"Justyna K. Hinchcliffe","psa":"Emma S. J. Robinson","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4390691843","eid":"W4390691843"},{"id":"paper-w2317019713","cat":"papers","name":"Behavioural changes in rats treated with a neurotoxic dose regimen of dextrorotatory amphetamine derivatives","year":"2003","cit":26,"pfa":"József Tı́már","psa":"Susanna Fürst","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2317019713","eid":"W2317019713"},{"id":"paper-w2157895460","cat":"papers","name":"P‐glycoprotein modulation by the designer drugs methylenedioxymethamphetamine, methylenedioxyethylamphetamine and paramethoxyamphetamine","year":"2003","cit":26,"pfa":"Nahal Ketabi‐Kiyanvash","psa":"Gerd Mikus","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2157895460","eid":"W2157895460"},{"id":"paper-w2001218722","cat":"papers","name":"LSD: Therapeutic Effects of the Psychedelic Experience","year":"1964","cit":26,"pfa":"Charles Savage","psa":"Willis W. Harman","ptype":"article","src":"https://openalex.org/W2001218722","eid":"W2001218722"},{"id":"paper-w2030294546","cat":"papers","name":"The 5HT2 antagonist pirenperone reverses disruption of FR-40 by hallucinogenic drugs","year":"1985","cit":26,"pfa":"David J. Mokler","psa":"Richard H. Rech","ptype":"article","src":"https://openalex.org/W2030294546","eid":"W2030294546"},{"id":"paper-w2170463971","cat":"papers","name":"Event related potential (ERP) evidence for selective impairment of verbal recollection in abstinent recreational methylenedioxymethamphetamine (“Ecstasy”)/polydrug users","year":"2011","cit":26,"pfa":"Adrian Burgess","psa":"Andrew C. Parrott","ptype":"article","src":"https://openalex.org/W2170463971","eid":"W2170463971"},{"id":"paper-w1975002578","cat":"papers","name":"Electrophysiological evidence for a dopaminergic action of LSD: Depression of unit activity in the substantia nigra of the rat","year":"1977","cit":26,"pfa":"Greg R. Christoph","psa":"Barry L. Jacobs","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W1975002578","eid":"W1975002578"},{"id":"paper-w1539913903","cat":"papers","name":"Music and altered states : consciousness, transcendence, therapy and addiction","year":"2006","cit":26,"pfa":"David Aldridge","psa":"Jörg Fachner","topics":["PTSD & trauma","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W1539913903","eid":"W1539913903"},{"id":"paper-w2056774128","cat":"papers","name":"Who is becoming hallucinogen dependent soon after hallucinogen use starts?","year":"2006","cit":26,"pfa":"Andrea L. Stone","psa":"James Christopher Anthony","ptype":"article","src":"https://openalex.org/W2056774128","eid":"W2056774128"},{"id":"paper-w4292227877","cat":"papers","name":"Does the trip matter? Investigating the role of the subjective effects of psychedelics in persisting therapeutic effects","year":"2022","cit":26,"pfa":"Katherine M. Nautiyal","psa":"David B. Yaden","ptype":"article","src":"https://openalex.org/W4292227877","eid":"W4292227877"},{"id":"paper-w3021274963","cat":"papers","name":"DMT alters cortical travelling waves","year":"2020","cit":26,"pfa":"Andrea Alamia","psa":"Robin Lester Carhart-Harris","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W3021274963","eid":"W3021274963"},{"id":"paper-w2774704972","cat":"papers","name":"Relationship Between Cigarette, Alcohol, Substance Use Disorders and Familial Drug Use in University Students","year":"2017","cit":26,"pfa":"Demet Havaçeliği Atlam","psa":"Zeki Yüncü","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2774704972","eid":"W2774704972"},{"id":"paper-w4382465647","cat":"papers","name":"Medical student attitudes and perceptions of psychedelic-assisted therapies","year":"2023","cit":26,"pfa":"Irene Li","psa":"Burton Jared Tabaac","topics":["Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4382465647","eid":"W4382465647"},{"id":"paper-w4387403624","cat":"papers","name":"The ego in psychedelic drug action – ego defenses, ego boundaries, and the therapeutic role of regression","year":"2023","cit":26,"pfa":"Tobias Buchborn","psa":"Marcus W. Meinhardt","topics":["Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4387403624","eid":"W4387403624"},{"id":"paper-w4322719007","cat":"papers","name":"Can psychedelics enhance group psychotherapy? A discussion on the therapeutic factors","year":"2023","cit":26,"pfa":"Polina Ponomarenko","psa":"Gregor Hasler","topics":["Addiction","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4322719007","eid":"W4322719007"},{"id":"paper-w4285495569","cat":"papers","name":"Analgesic potential of macrodoses and microdoses of classical psychedelics in chronic pain sufferers: a population survey","year":"2022","cit":26,"pfa":"Valérie Bonnelle","psa":"Amanda Feilding","topics":["Addiction","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4285495569","eid":"W4285495569"},{"id":"paper-w4401950708","cat":"papers","name":"Psychedelic Medicine","year":"2007","cit":26,"ptype":"book","src":"https://openalex.org/W4401950708","eid":"W4401950708"},{"id":"paper-w1970479981","cat":"papers","name":"The Use of Hyoscyamine as a Hallucinogen and Intoxicant","year":"1967","cit":26,"pfa":"MARTIN H. KEELER","psa":"Francis J. Kane","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1970479981","eid":"W1970479981"},{"id":"paper-w3188571791","cat":"papers","name":"Microdose intravaginal levonorgestrel contraception: A multicentre clinical trial","year":"1990","cit":26,"pfa":"Suporn Koetsawang","psa":"Philip John Rowe","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3188571791","eid":"W3188571791"},{"id":"paper-w2312933317","cat":"papers","name":"Chemical Ecstasy: Psychedelic Drugs and Religion","year":"1970","cit":26,"pfa":"Denez Gulyas","psa":"Walter Houston Clark","ptype":"article","src":"https://openalex.org/W2312933317","eid":"W2312933317"},{"id":"paper-w2519357635","cat":"papers","name":"Beware of blue pills and blotting paper hallucinogens severe toxicity with NBOMe","year":"2015","cit":26,"pfa":"Geoffrey Kennedy Isbister","psa":"Jeffrey Ernest Grice","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2519357635","eid":"W2519357635"},{"id":"paper-w4310781004","cat":"papers","name":"Classic psychedelics, health behavior, and physical health","year":"2022","cit":26,"pfa":"Otto Simonsson","psa":"Simon Benjamin Goldberg","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4310781004","eid":"W4310781004"},{"id":"paper-w2123580275","cat":"papers","name":"Phencyclidine (PCP): Another Illicit Psychedelic Drug","year":"1972","cit":26,"pfa":"Alan Reed","psa":"Andrew W. Kane","ptype":"article","src":"https://openalex.org/W2123580275","eid":"W2123580275"},{"id":"paper-w4409155786","cat":"papers","name":"Addressing blinding in classic psychedelic studies with innovative active placebos","year":"2025","cit":26,"pfa":"Jacob S. Aday","psa":"Deepak Cyril D’Souza","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4409155786","eid":"W4409155786"},{"id":"paper-w1975460665","cat":"papers","name":"Commentary on ACCP Position Statement on the Use of Microdosing in the Drug Development Process","year":"2007","cit":26,"pfa":"Malcolm Rowland","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"editorial","src":"https://openalex.org/W1975460665","eid":"W1975460665"},{"id":"paper-w4366464082","cat":"papers","name":"“How Do I Learn More About this?”: Utilization and Trust of Psychedelic Information Sources Among People Naturalistically Using Psychedelics","year":"2023","cit":26,"pfa":"Daniel J. Kruger","psa":"Kevin F. Boehnke","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4366464082","eid":"W4366464082"},{"id":"paper-w4380786298","cat":"papers","name":"Microdosing: A Conceptual Framework for use as Programming Strategy for Resistance Training in Team Sports","year":"2023","cit":26,"pfa":"Matthew Cuthbert","psa":"Paul Comfort","topics":["Dosing & pharmacology","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4380786298","eid":"W4380786298"},{"id":"paper-w2898920532","cat":"papers","name":"Comparison of the behavioral responses induced by phenylalkylamine hallucinogens and their tetrahydrobenzodifuran (“FLY”) and benzodifuran (“DragonFLY”) analogs","year":"2018","cit":26,"pfa":"Adam L. Halberstadt","psa":"Simon D. Brandt","ptype":"article","src":"https://openalex.org/W2898920532","eid":"W2898920532"},{"id":"paper-w2073011119","cat":"papers","name":"Psychedelic Drug (DPT)-Assisted Psychotherapy with Alcoholics: A Controlled Study","year":"1977","cit":26,"pfa":"John Rhead","psa":"Kay Y. Ota","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2073011119","eid":"W2073011119"},{"id":"paper-w2161947591","cat":"papers","name":"“This Is America”: Jimi Hendrix's Star Spangled Banner Journey as Psychedelic Citizenship","year":"2014","cit":26,"pfa":"Mark Clague","ptype":"article","src":"https://openalex.org/W2161947591","eid":"W2161947591"},{"id":"paper-w2793761191","cat":"papers","name":"Metabotropic Glutamate2 Receptors Play a Key Role in Modulating Head Twitches Induced by a Serotonergic Hallucinogen in Mice","year":"2018","cit":26,"pfa":"Mark J. Benvenga","psa":"Gerard J. Marek","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2793761191","eid":"W2793761191"},{"id":"paper-w1872359764","cat":"papers","name":"Associations between use of cocaine, amphetamines, or psychedelics and psychotic symptoms in a community sample","year":"2010","cit":26,"pfa":"Nina Kuzenko","psa":"Hans‐Ulrich Wïttchen","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1872359764","eid":"W1872359764"},{"id":"paper-w2086840204","cat":"papers","name":"Microdosing of a Carbon‐14 Labeled Protein in Healthy Volunteers Accurately Predicts Its Pharmacokinetics at Therapeutic Dosages","year":"2015","cit":26,"pfa":"MLH Vlaming","psa":"WHJ Vaes","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2086840204","eid":"W2086840204"},{"id":"paper-w4313339783","cat":"papers","name":"Subtypes of the psychedelic experience have reproducible and predictable effects on depression and anxiety symptoms","year":"2022","cit":26,"pfa":"Aki Nikolaidis","psa":"Alan K. Davis","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4313339783","eid":"W4313339783"},{"id":"paper-w1966272203","cat":"papers","name":"Development of rapid multistep carbon-11 radiosynthesis of the myeloperoxidase inhibitor AZD3241 to assess brain exposure by PET microdosing","year":"2015","cit":26,"pfa":"Peter Johnström","psa":"Lars Farde","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1966272203","eid":"W1966272203"},{"id":"paper-w1099116183","cat":"papers","name":"Preclinical characterization of toluene as a non-classical hallucinogen drug in rats: participation of 5-HT, dopamine and glutamate systems","year":"2015","cit":26,"pfa":"María Teresa Rivera-García","psa":"Silvia Lorenia Cruz","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1099116183","eid":"W1099116183"},{"id":"paper-w4405955633","cat":"papers","name":"Psychedelics for the Treatment of Psychiatric Disorders: Interpreting and Translating Available Evidence and Guidance for Future Research","year":"2025","cit":26,"pfa":"Roger S. McIntyre","psa":"Joshua Daniel Rosenblat","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4405955633","eid":"W4405955633"},{"id":"paper-w4382776828","cat":"papers","name":"Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":26,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4382776828","eid":"W4382776828"},{"id":"paper-w4385581517","cat":"papers","name":"Slouching towards engagement: interactions between people using psychedelics naturalistically and their healthcare providers","year":"2023","cit":26,"pfa":"Kevin F. Boehnke","psa":"Daniel J. Kruger","topics":["Depression","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4385581517","eid":"W4385581517"},{"id":"paper-w4390100281","cat":"papers","name":"The Rise of Psychedelic Drug Use Associated With Legalization/Decriminalization: An Assessment With the Nonmedical Use of Prescription Drugs Survey","year":"2023","cit":26,"pfa":"Andrew A. Monte","psa":"Richard C. Dart","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4390100281","eid":"W4390100281"},{"id":"paper-w2995286962","cat":"papers","name":"Buprenorphine Induction Without Opioid Withdrawal: A Case Series of 15 Opioid-Dependent Inpatients Induced on Buprenorphine Using Microdoses of Transdermal Buprenorphine","year":"2019","cit":26,"pfa":"Amer Raheemullah","psa":"Anna Lembke","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2995286962","eid":"W2995286962"},{"id":"paper-w2023064002","cat":"papers","name":"Impaired glycine-serine conversion and increased plasma taurine levels in episodic psychotic patients with psychedelic symptoms","year":"1984","cit":26,"pfa":"Jacques Bruinvels","psa":"Lolke P. Pepplinkhuizen","ptype":"article","src":"https://openalex.org/W2023064002","eid":"W2023064002"},{"id":"paper-w3160901898","cat":"papers","name":"Changes in self-rumination and self-compassion mediate the effect of psychedelic experiences on decreases in depression, anxiety, and stress.","year":"2021","cit":26,"pfa":"Baptiste Fauvel","psa":"Pascale Piolino","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3160901898","eid":"W3160901898"},{"id":"paper-w2129507956","cat":"papers","name":"Towards a quantitative representation of the cell signaling mechanisms of hallucinogens: Measurement and mathematical modeling of 5-HT1A and 5-HT2A receptor-mediated ERK1/2 activation","year":"2008","cit":26,"pfa":"Chiung-Wen Chang","psa":"Harel Weinstein","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2129507956","eid":"W2129507956"},{"id":"paper-w1968836796","cat":"papers","name":"A Possible Mechanism of Action of Calcium and Some Psychotomimetic Agents on Membranes","year":"1963","cit":26,"pfa":"Leo G. Abood","psa":"Hideo Kimizuka","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1968836796","eid":"W1968836796"},{"id":"paper-w1984674988","cat":"papers","name":"Potential psychotomimetics. 2. Rigid analogs of 2,5-dimethoxy-4-methylphenylisopropylamine (DOM, STP)","year":"1974","cit":26,"pfa":"David E. Nichols","psa":"Donald C. Dyer","ptype":"article","src":"https://openalex.org/W1984674988","eid":"W1984674988"},{"id":"paper-w2038887800","cat":"papers","name":"The effects of psychotomimetic and putative cognitive-enhancing drugs on the performance of a n-back working memory task in rats","year":"2008","cit":26,"pfa":"Tracey Ko","psa":"J. L. Evenden","ptype":"article","src":"https://openalex.org/W2038887800","eid":"W2038887800"},{"id":"paper-w2951496984","cat":"papers","name":"TAK-137, an AMPA receptor potentiator with little agonistic effect, produces antidepressant-like effect without causing psychotomimetic effects in rats","year":"2019","cit":26,"pfa":"Atsushi Suzuki","psa":"Haruhide Kimura","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2951496984","eid":"W2951496984"},{"id":"paper-w3209639332","cat":"papers","name":"Betaine prevents and reverses the behavioral deficits and synaptic dysfunction induced by repeated ketamine exposure in mice","year":"2021","cit":26,"pfa":"Shao‐Tsu Chen","psa":"Ming‐Huan Chan","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3209639332","eid":"W3209639332"},{"id":"paper-w3088893658","cat":"papers","name":"Peak-experience and the entheogenic use of cannabis in world religions","year":"2020","cit":26,"pfa":"Mark S. Ferrara","ptype":"article","src":"https://openalex.org/W3088893658","eid":"W3088893658"},{"id":"paper-w2035039726","cat":"papers","name":"Hallucinogenic Plants in Chinese Herbals","year":"1978","cit":26,"pfa":"Hui-Lin Li","ptype":"article","src":"https://openalex.org/W2035039726","eid":"W2035039726"},{"id":"paper-w4237810887","cat":"papers","name":"Propofol Inhibits Ketamine-Induced c-fos Expression in the Rat Posterior Cingulate Cortex","year":"1998","cit":26,"pfa":"Atsushi Nagata","psa":"Koh Shingu","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4237810887","eid":"W4237810887"},{"id":"paper-w1996757413","cat":"papers","name":"Interaction between LSD and dopamine D2/3 binding sites in pig brain","year":"2005","cit":26,"pfa":"Luciano Minuzzi","psa":"Paul D. Cumming","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1996757413","eid":"W1996757413"},{"id":"paper-w2144677370","cat":"papers","name":"Dopamine agonist action of phencyclidine","year":"2005","cit":26,"pfa":"Philip M. Seeman","psa":"Mercedes Lasaga","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2144677370","eid":"W2144677370"},{"id":"paper-w1987988427","cat":"papers","name":"Electroencephalographic and behavioral effects of harmaline in intact cats and in cats with chronic mesencephalic transection","year":"1970","cit":26,"pfa":"Jaime R. Villablanca","psa":"F. Riob�","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1987988427","eid":"W1987988427"},{"id":"paper-w3048561249","cat":"papers","name":"Distributed harmonic patterns of structure-function dependence orchestrate human consciousness","year":"2020","cit":26,"pfa":"Andrea I. Luppi","psa":"Emmanuel Andreas Stamatakis","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W3048561249","eid":"W3048561249"},{"id":"paper-w4402221259","cat":"papers","name":"Epigenetic mechanisms of rapid-acting antidepressants","year":"2024","cit":26,"pfa":"Antonio Inserra","psa":"Tiziana Rubino","topics":["Depression","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4402221259","eid":"W4402221259"},{"id":"paper-w2500529705","cat":"papers","name":"Neurotoxic Effects of 5-MeO-DIPT: A Psychoactive Tryptamine Derivative in Rats","year":"2016","cit":26,"pfa":"Karolina Noworyta","psa":"Krystyna Gołembiowska","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2500529705","eid":"W2500529705"},{"id":"paper-w2948895317","cat":"papers","name":"Ketamine disinhibits dendrites and enhances calcium signals in prefrontal dendritic spines","year":"2019","cit":26,"pfa":"Farhan Ali","psa":"Alex C. Kwan","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W2948895317","eid":"W2948895317"},{"id":"paper-w4402072299","cat":"papers","name":"Pharmacological Treatments for Methamphetamine Use Disorder: Current Status and Future Targets","year":"2024","cit":26,"pfa":"Justin R. Yates","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4402072299","eid":"W4402072299"},{"id":"paper-w2518876353","cat":"papers","name":"Chronic Kappa opioid receptor activation modulates NR2B: Implication in treatment resistant depression","year":"2016","cit":26,"pfa":"Shalini Dogra","psa":"Prem Narayan Yadav","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2518876353","eid":"W2518876353"},{"id":"paper-w2044059900","cat":"papers","name":"Glutamatergic Dysbalance and Oxidative Stress in In Vivo and In Vitro Models of Psychosis Based on Chronic NMDA Receptor Antagonism","year":"2013","cit":26,"pfa":"Just Genius","psa":"Dan Rujescu","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2044059900","eid":"W2044059900"},{"id":"paper-w2054713008","cat":"papers","name":"Long-term potentiation in the presence of NMDA receptor antagonist arylalkylamine spider toxins","year":"2000","cit":26,"pfa":"Benedict C. Albensi","psa":"Alan L. Mueller","topics":["PTSD & trauma","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2054713008","eid":"W2054713008"},{"id":"paper-w2789580118","cat":"papers","name":"The effect of estrogenic compounds on psychosis-like behaviour in female rats","year":"2018","cit":26,"pfa":"Alyssa M. Sbisa","psa":"Andrea Gogos","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2789580118","eid":"W2789580118"},{"id":"paper-w4385564032","cat":"papers","name":"Effect of S-ketamine on Postoperative Pain in Adults Post-Abdominal Surgery: A Systematic Review and Meta-analysis","year":"2023","cit":26,"pfa":"Tao Li","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4385564032","eid":"W4385564032"},{"id":"paper-w4241094250","cat":"papers","name":"Psychosis in Children and Youth: Focus on Early-Onset Schizophrenia","year":"2013","cit":26,"pfa":"Sabina Abidi","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4241094250","eid":"W4241094250"},{"id":"paper-w2159732068","cat":"papers","name":"A Retrospective Comparison of the Dose Ratio Between Subcutaneous and Oral Ketamine","year":"2003","cit":26,"pfa":"Miguel Ángel Benítez-Rosario","psa":"José Javier Martı́n-Ortega","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2159732068","eid":"W2159732068"},{"id":"paper-w2036565844","cat":"papers","name":"ON THE DYNAMICS OF THE MANIC-DEPRESSIVE PERSONALITY","year":"1959","cit":26,"pfa":"ROBERT W. GIBSON","psa":"ROBERT A. COHEN","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2036565844","eid":"W2036565844"},{"id":"paper-w4210447349","cat":"papers","name":"Hydroxynorketamine Pharmacokinetics and Antidepressant Behavioral Effects of (2,6)- and (5R)-Methyl-(2R,6R)-hydroxynorketamines","year":"2022","cit":26,"pfa":"Jaclyn N. Highland","psa":"Todd D. Gould","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4210447349","eid":"W4210447349"},{"id":"paper-w2596853570","cat":"papers","name":"What’s the Buzz About Hydroxynorketamine? Is It the History, the Story, the Debate, or the Promise?","year":"2017","cit":26,"pfa":"Chadi G. Abdallah","ptype":"article","src":"https://openalex.org/W2596853570","eid":"W2596853570"},{"id":"paper-w3119139278","cat":"papers","name":"FDA approves esketamine treatment for MDD, suicidal ideation","year":"2020","cit":26,"pfa":"Valerie A. Canady","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W3119139278","eid":"W3119139278"},{"id":"paper-w2999935452","cat":"papers","name":"Esketamine as a treatment for paediatric depression: questions of safety and efficacy","year":"2020","cit":26,"pfa":"Kelsey S. Zimmermann","psa":"Kathryn Baker","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2999935452","eid":"W2999935452"},{"id":"paper-w4310170169","cat":"papers","name":"(2R,6R)-hydroxynorketamine acts through GluA1-induced synaptic plasticity to alleviate PTSD-like effects in rat models","year":"2022","cit":26,"pfa":"Yu Li","psa":"Lin Sun","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4310170169","eid":"W4310170169"},{"id":"paper-w2954874961","cat":"papers","name":"Ketamine-induced regulation of TrkB-GSK3β signaling is accompanied by slow EEG oscillations and sedation but is independent of hydroxynorketamine metabolites","year":"2019","cit":26,"pfa":"Samuel Kohtala","psa":"Tomi Rantamäki","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2954874961","eid":"W2954874961"},{"id":"paper-w2953678808","cat":"papers","name":"Esketamine and rapastinel, but not imipramine, have antidepressant-like effect in a treatment-resistant animal model of depression","year":"2019","cit":26,"pfa":"Vitor Silva Pereira","psa":"Gregers Wegener","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2953678808","eid":"W2953678808"},{"id":"paper-w4389685675","cat":"papers","name":"The Efficacy and Safety of Intranasal Formulations of Ketamine and Esketamine for the Treatment of Major Depressive Disorder: A Systematic Review","year":"2023","cit":26,"pfa":"Ludivine Boudieu","psa":"Ludovic Samalin","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4389685675","eid":"W4389685675"},{"id":"paper-w4393154295","cat":"papers","name":"Oral esketamine in patients with treatment-resistant depression: a double-blind, randomized, placebo-controlled trial with open-label extension","year":"2024","cit":26,"pfa":"Sanne Y. Smith-Apeldoorn","psa":"Robert A. Schoevers","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4393154295","eid":"W4393154295"},{"id":"paper-w4385064000","cat":"papers","name":"Analysis of the efficacy of subclinical doses of esketamine in combination with propofol in non-intubated general anesthesia procedures - a systematic review and meta-analysis","year":"2023","cit":26,"pfa":"Haoming Chen","psa":"Peng Li","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W4385064000","eid":"W4385064000"},{"id":"paper-w4386544841","cat":"papers","name":"A comparative study of esketamine-dexmedetomidine and sufentanil-dexmedetomidine for sedation and analgesia in lung tumor percutaneous radiofrequency ablation (PRFA): a randomized double-blind clinical trial","year":"2023","cit":26,"pfa":"Zhonglan Lin","psa":"Jianliang Sun","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4386544841","eid":"W4386544841"},{"id":"paper-w3015008746","cat":"papers","name":"Appraising esketamine nasal spray for the management of treatment-resistant depression in adults: Number needed to treat, number needed to harm, and likelihood to be helped or harmed","year":"2020","cit":26,"pfa":"Leslie Citrome","psa":"Jaskaran B. Singh","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3015008746","eid":"W3015008746"},{"id":"paper-w4399934176","cat":"papers","name":"Ketamine treatment for anhedonia in unipolar and bipolar depression: a systematic review","year":"2024","cit":26,"pfa":"Aleksander Kwaśny","psa":"Wiesław Jerzy Cubała","topics":["Depression","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4399934176","eid":"W4399934176"},{"id":"paper-w4411178876","cat":"papers","name":"Unveiling the Anti-Inflammatory Effects of Antidepressants: A Systematic Review of Human Studies over the Last Decade","year":"2025","cit":26,"pfa":"Layla Bleibel","psa":"Anna Wiktorowska‐Owczarek","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4411178876","eid":"W4411178876"},{"id":"paper-w3206577345","cat":"papers","name":"Effects of somatic treatments on suicidal ideation and completed suicides","year":"2021","cit":26,"pfa":"Elise M Hawkins","psa":"Rif S. El‐Mallakh","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3206577345","eid":"W3206577345"},{"id":"paper-w2895068851","cat":"papers","name":"No Sex-Specific Differences in the Acute Antidepressant Actions of (R)-Ketamine in an Inflammation Model","year":"2018","cit":26,"pfa":"Lijia Chang","psa":"Kenji Hashimoto","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2895068851","eid":"W2895068851"},{"id":"paper-w4225014200","cat":"papers","name":"Antidepressants and Vertebral and Hip Risk Fracture: An Updated Systematic Review and Meta-Analysis","year":"2022","cit":26,"pfa":"Renato de Filippis","psa":"Olimpio Galasso","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4225014200","eid":"W4225014200"},{"id":"paper-w4200260163","cat":"papers","name":"Stable Gastric Pentadecapeptide BPC 157 Therapy for Primary Abdominal Compartment Syndrome in Rats","year":"2021","cit":26,"pfa":"Marijan Tepeš","psa":"Predrag Sikirić","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4200260163","eid":"W4200260163"},{"id":"paper-w2044921861","cat":"papers","name":"Comparative discriminative stimulus effects of 5-methoxy-N, Ndimethyltryptamine and LSD","year":"1982","cit":26,"pfa":"Richard Young","psa":"Richard A. Glennon","ptype":"article","src":"https://openalex.org/W2044921861","eid":"W2044921861"},{"id":"paper-w2022264424","cat":"papers","name":"Marked decrease of LSD-induced stimulus control in serotonin transporter knockout mice","year":"2007","cit":26,"pfa":"Catherine M. Krall","psa":"J WINTER","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2022264424","eid":"W2022264424"},{"id":"paper-w2041985606","cat":"papers","name":"The effect of citalopram treatment on platelet serotonin function in panic disorders","year":"2000","cit":26,"pfa":"Jolanta Neuger","psa":"R. Stain‐Malmgren","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2041985606","eid":"W2041985606"},{"id":"paper-w4401774886","cat":"papers","name":"Comparative oral monotherapy of psilocybin, lysergic acid diethylamide, 3,4-methylenedioxymethamphetamine, ayahuasca, and escitalopram for depressive symptoms: systematic review and Bayesian network meta-analysis","year":"2024","cit":25,"pfa":"Tien‐Wei Hsu","psa":"Chih‐Sung Liang","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W4401774886","eid":"W4401774886"},{"id":"paper-w2055367802","cat":"papers","name":"Lysergic acid diethylamide: Evidence for stimulation of pituitary dopamine receptors","year":"1977","cit":25,"pfa":"Herbert Y. Meltzer","psa":"Victor S. Fang","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2055367802","eid":"W2055367802"},{"id":"paper-w2336052531","cat":"papers","name":"Chromosome Studies on Patients (in Vivo) and Cells (in Vitro) Treated with Lysergic Acid Diethylamide","year":"1970","cit":25,"pfa":"Margaret J. Corey","psa":"W. E. Wilby","ptype":"article","src":"https://openalex.org/W2336052531","eid":"W2336052531"},{"id":"paper-w3013834281","cat":"papers","name":"A comparison of reactivation experiences following vaporization and intramuscular injection (IM) of synthetic 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting","year":"2020","cit":25,"pfa":"Malin Vedøy Uthaug","psa":"Johannes Gerardus Ramaekers","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3013834281","eid":"W3013834281"},{"id":"paper-w2093959772","cat":"papers","name":"Optimization of the separation of lysergic acid diethylamide in urine by a sweeping technique using micellar electrokinetic chromatography","year":"2002","cit":25,"pfa":"Chao Fang","psa":"C LIN","ptype":"article","src":"https://openalex.org/W2093959772","eid":"W2093959772"},{"id":"paper-w1996394158","cat":"papers","name":"Effect of the Administration of Lysergic Acid Diethylamide (LSD) on the Colloid Vesicles of the Pars Intermedia of the Toad Pituitary","year":"1964","cit":25,"pfa":"Fermı́n C. Iturriza","psa":"Osvaldo Raùl Koch","ptype":"article","src":"https://openalex.org/W1996394158","eid":"W1996394158"},{"id":"paper-w2018809369","cat":"papers","name":"Analysis of lysergic acid diethylamide: comparison of capillary electrophoresis with laser-induced fluorescence (CE-LIF) with conventional techniques","year":"1998","cit":25,"pfa":"M Frost","psa":"Helga Köhler","ptype":"article","src":"https://openalex.org/W2018809369","eid":"W2018809369"},{"id":"paper-w2019963944","cat":"papers","name":"Lysergic Acid Diethylamide (LSD-25): XXIX. The Response Index as a Measure of Threshold Activity of Psychotropic Drugs in Man","year":"1959","cit":25,"pfa":"Harold A. Abramson","ptype":"article","src":"https://openalex.org/W2019963944","eid":"W2019963944"},{"id":"paper-w2011807507","cat":"papers","name":"Suppressive effects of pyrilamine maleate and d-lysergic acid diethylamide (LSD-25) on early corneal lesions produced in vitro by Newcastle disease virus (NDV) and compound","year":"1960","cit":25,"pfa":"Jang O. Oh","psa":"CHARLES A. EVANS","ptype":"article","src":"https://openalex.org/W2011807507","eid":"W2011807507"},{"id":"paper-w4377695089","cat":"papers","name":"“In vivo biosynthesis of N,N-dimethyltryptamine, 5-MeO-N,N-dimethyltryptamine, and bufotenine in E. coli”","year":"2023","cit":25,"pfa":"Lucas M. Friedberg","psa":"J. Andrew Jones","ptype":"article","src":"https://openalex.org/W4377695089","eid":"W4377695089"},{"id":"paper-w2334669896","cat":"papers","name":"A New Synthesis of Mescaline","year":"1951","cit":25,"pfa":"Makepeace U. Tsao","ptype":"article","src":"https://openalex.org/W2334669896","eid":"W2334669896"},{"id":"paper-w1988785455","cat":"papers","name":"Mescaline as a mitotic spindle inhibitor","year":"1976","cit":25,"pfa":"C. M. H. HARRISSON","psa":"H.M. Keir","ptype":"article","src":"https://openalex.org/W1988785455","eid":"W1988785455"},{"id":"paper-w1627891247","cat":"papers","name":"Human pharmacology of ayahuasca","year":"2003","cit":25,"pfa":"Jordi Riba Serrano","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W1627891247","eid":"W1627891247"},{"id":"paper-w2141673211","cat":"papers","name":"The Analysis and Distribution of Mescaline in Postmortem Tissues","year":"2003","cit":25,"pfa":"J. L. Henry","psa":"Timothy P. Rohrig","ptype":"article","src":"https://openalex.org/W2141673211","eid":"W2141673211"},{"id":"paper-w2134194840","cat":"papers","name":"Cardiac arrest after ibogaine ingestion","year":"2014","cit":25,"pfa":"L. Vlaanderen","psa":"G. Aernout Somsen","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2134194840","eid":"W2134194840"},{"id":"paper-w1998827269","cat":"papers","name":"BLOOD AND URINARY DIMETHYLTRYPTAMINE IN ACUTE PSYCHOTIC DISORDERS","year":"1974","cit":25,"pfa":"T. George Bidder","psa":"Robert W. Walker","ptype":"article","src":"https://openalex.org/W1998827269","eid":"W1998827269"},{"id":"paper-w3077250840","cat":"papers","name":"Chemical syntheses of the salvinorin chemotype of KOR agonist","year":"2020","cit":25,"pfa":"Sarah J. Hill","psa":"Ryan A. Shenvi","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3077250840","eid":"W3077250840"},{"id":"paper-w4281790931","cat":"papers","name":"Ayahuasca and Public Health II: Health Status in a Large Sample of Ayahuasca-Ceremony Participants in the Netherlands","year":"2022","cit":25,"pfa":"Maja Kohek","psa":"José Carlos Bouso","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4281790931","eid":"W4281790931"},{"id":"paper-w2290061094","cat":"papers","name":"New iboga-type alkaloids from Ervatamia hainanensis","year":"2016","cit":25,"pfa":"Zhiwen Liu","psa":"Wen‐Cai Ye","ptype":"article","src":"https://openalex.org/W2290061094","eid":"W2290061094"},{"id":"paper-w2005645528","cat":"papers","name":"Reduced sensitivity to MDMA-induced facilitation of social behaviour in MDMA pre-exposed rats","year":"2008","cit":25,"pfa":"Murray R. Thompson","psa":"Iain S. McGregor","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2005645528","eid":"W2005645528"},{"id":"paper-w2587072764","cat":"papers","name":"Repeated MDMA administration increases MDMA-produced locomotor activity and facilitates the acquisition of MDMA self-administration: role of dopamine D2 receptor mechanisms.","year":"2017","cit":25,"pfa":"Ross van de Wetering","psa":"Susan Schenk","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2587072764","eid":"W2587072764"},{"id":"paper-w1981322835","cat":"papers","name":"Mescaline, 3,4-Dimethoxyphenylethylamine, and Adrenaline: Sites of Electroencephalographic Arousal","year":"1965","cit":25,"pfa":"Yuji Takeo","psa":"Harold E. Himwich","ptype":"article","src":"https://openalex.org/W1981322835","eid":"W1981322835"},{"id":"paper-w1574254440","cat":"papers","name":"Comparison of the brain levels of N,N-dimethyltryptamine and α,α,β,β-tetradeutero-N,N-dimethyltryptamine following intraperitoneal injection","year":"1982","cit":25,"pfa":"Steven A. Barker","psa":"Philip E. Morris","ptype":"article","src":"https://openalex.org/W1574254440","eid":"W1574254440"},{"id":"paper-w2160149905","cat":"papers","name":"Heat increases MDMA-enhanced NAcc 5-HT and body temperature, but not MDMA self-administration","year":"2010","cit":25,"pfa":"Allison A. Feduccia","psa":"Christine L. Duvauchelle","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2160149905","eid":"W2160149905"},{"id":"paper-w1964192569","cat":"papers","name":"The IBOGA alkaloids and their role as precursors of anti-neoplastic bisindole catharanthus alkaloids","year":"2002","cit":25,"pfa":"Richard J. Sundberg","psa":"Stanton Q. Smith","ptype":"book-chapter","src":"https://openalex.org/W1964192569","eid":"W1964192569"},{"id":"paper-w2153700207","cat":"papers","name":"Subjective Theories about (Self‐)Treatment with Ayahuasca","year":"2010","cit":25,"pfa":"Janine Tatjana Schmid","psa":"Rolf Verres","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2153700207","eid":"W2153700207"},{"id":"paper-w2465687219","cat":"papers","name":"Altered states and the study of consciousness: The case of Ayahuasca","year":"2003","cit":25,"pfa":"Benny Shanon","ptype":"article","src":"https://openalex.org/W2465687219","eid":"W2465687219"},{"id":"paper-w4399276098","cat":"papers","name":"Pharmacological and behavioural effects of tryptamines present in psilocybin‐containing mushrooms","year":"2024","cit":25,"pfa":"Ryan J. Rakoczy","psa":"Matthew Stephen McMurray","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4399276098","eid":"W4399276098"},{"id":"paper-w2010613922","cat":"papers","name":"Opposite effects of N,N-dimethyltryptamine (DMT) and 5-methoxy-N,N-dimethyltryptamine (5-MeODMT) on acoustic startle: Spinal vs brain sites of action","year":"1982","cit":25,"pfa":"Randall L. Commissaris","psa":"M. Davis","ptype":"article","src":"https://openalex.org/W2010613922","eid":"W2010613922"},{"id":"paper-w2397208947","cat":"papers","name":"Detection of psilocybin in species of Psilocybe, Panaeolus and Psathyrella.","year":"1976","cit":25,"pfa":"Ott J","psa":"Gastón Guzmán","ptype":"article","src":"https://openalex.org/W2397208947","eid":"W2397208947"},{"id":"paper-w2048137784","cat":"papers","name":"Effects of ibogaine on sensory-motor function, activity, and spatial learning in rats","year":"1995","cit":25,"pfa":"R Kesner","ptype":"article","src":"https://openalex.org/W2048137784","eid":"W2048137784"},{"id":"paper-w7138853109","cat":"papers","name":"Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression","year":"2026","cit":25,"pfa":"Lea Julia Mertens","psa":"Gerhard Gründer","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7138853109","eid":"W7138853109"},{"id":"paper-w2004598059","cat":"papers","name":"MDMA modifies active avoidance learning and recall in mice","year":"2008","cit":25,"pfa":"José Manuel Trigo","psa":"Patricia Robledo","ptype":"article","src":"https://openalex.org/W2004598059","eid":"W2004598059"},{"id":"paper-w2916651955","cat":"papers","name":"Comparison of the behavioral effects of mescaline analogs using the head twitch response in mice","year":"2019","cit":25,"pfa":"Adam L. Halberstadt","psa":"Simon D. Brandt","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2916651955","eid":"W2916651955"},{"id":"paper-w2058504664","cat":"papers","name":"Serotonergic Neurotoxicity of MDMA (Ecstasy) in the Developing Rat Brain","year":"2002","cit":25,"pfa":"Jerrold S. Meyer","psa":"Syed F. Ali","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2058504664","eid":"W2058504664"},{"id":"paper-w3129808111","cat":"papers","name":"Acute Psychological Adverse Reactions in First-Time Ritual Ayahuasca Users","year":"2021","cit":25,"pfa":"María de Lourdes Gómez-Sousa","psa":"José Carlos Bouso","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3129808111","eid":"W3129808111"},{"id":"paper-w4412738512","cat":"papers","name":"Control Group Outcomes in Trials of Psilocybin, SSRIs, or Esketamine for Depression","year":"2025","cit":25,"pfa":"Fredrik Hieronymus","psa":"Johan Lundberg","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4412738512","eid":"W4412738512"},{"id":"paper-w2160605415","cat":"papers","name":"A turn-on fluorogenic probe for detection of MDMA from ecstasy tablets","year":"2012","cit":25,"pfa":"Daniel Moreno","psa":"Tomás Torroba","ptype":"article","src":"https://openalex.org/W2160605415","eid":"W2160605415"},{"id":"paper-w3044178913","cat":"papers","name":"Voltammetric detection of 3,4-methylenedioxymethamphetamine (mdma) in saliva in low cost systems","year":"2020","cit":25,"pfa":"Érica Naomi Oiye","psa":"Marcelo Firmino de Oliveira","ptype":"article","src":"https://openalex.org/W3044178913","eid":"W3044178913"},{"id":"paper-w2017757634","cat":"papers","name":"Behavioral effects of 5-methoxy-N,N-dimethyltryptamine and dose-dependent antagonism by BC-105","year":"1983","cit":25,"pfa":"Richard Young","psa":"Richard A. Glennon","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2017757634","eid":"W2017757634"},{"id":"paper-w2095098984","cat":"papers","name":"Strenuous exercise aggravates MDMA-induced skeletal muscle damage in mice","year":"2004","cit":25,"pfa":"José Alberto Duarte","psa":"Félix Dias Carvalho","ptype":"article","src":"https://openalex.org/W2095098984","eid":"W2095098984"},{"id":"paper-w4388034792","cat":"papers","name":"The revival of the psychedelic experience scale: Revealing its extended-mystical, visual, and distressing experiential spectrum with LSD and psilocybin studies","year":"2023","cit":25,"pfa":"Kurt Stocker","psa":"Matthias E. Liechti","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4388034792","eid":"W4388034792"},{"id":"paper-w2738041208","cat":"papers","name":"MDMA-induced indifference to negative sounds is mediated by the 5-HT2A receptor","year":"2017","cit":25,"pfa":"Kim P. C. Kuypers","psa":"Johannes Gerardus Ramaekers","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2738041208","eid":"W2738041208"},{"id":"paper-w2955008892","cat":"papers","name":"Cognitive Effects of MDMA in Laboratory Animals: A Systematic Review Focusing on Dose","year":"2019","cit":25,"pfa":"Madeline M. Pantoni","psa":"Stephan Anagnostaras","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W2955008892","eid":"W2955008892"},{"id":"paper-w2073330474","cat":"papers","name":"The effects of multitasking on psychological stress reactivity in recreational users of cannabis and MDMA","year":"2012","cit":25,"pfa":"Mark A Wetherell","psa":"Andrew B Scholey","ptype":"article","src":"https://openalex.org/W2073330474","eid":"W2073330474"},{"id":"paper-w4414747399","cat":"papers","name":"Single-dose psilocybin rapidly and sustainably relieves allodynia and anxiodepressive-like behaviors in mouse models of chronic pain","year":"2025","cit":25,"pfa":"Ahmad Hammo","psa":"Joseph Cichon","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4414747399","eid":"W4414747399"},{"id":"paper-w2922477820","cat":"papers","name":"The influence of the host microbiome on 3,4-methylenedioxymethamphetamine (MDMA)-induced hyperthermia and vice versa","year":"2019","cit":25,"pfa":"Emily A. Ridge","psa":"Jon E. Sprague","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2922477820","eid":"W2922477820"},{"id":"paper-w2051910152","cat":"papers","name":"THE EFFECT OF AN EPILEPTOGENIC FOCUS, INDUCED BY TOPICAL APPLICATION OF MESCALINE, ON GLUTAMIC ACID, GLUTAMINE AND GABA IN THE NEOCORTEX OF THE CAT","year":"1964","cit":25,"pfa":"NELLA MISON-CRIGHEL","psa":"E Crighel","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2051910152","eid":"W2051910152"},{"id":"paper-w2588063511","cat":"papers","name":"The combined effects of 3,4-methylenedioxymethamphetamine (MDMA) and selected substituted methcathinones on measures of neurotoxicity","year":"2017","cit":25,"pfa":"Nicholas B. Miner","psa":"Aaron J. Janowsky","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2588063511","eid":"W2588063511"},{"id":"paper-w1578867327","cat":"papers","name":"Basic and neutral route specific impurities in MDMA prepared by different synthesis methods","year":"2005","cit":25,"pfa":"M. Świst","psa":"A. Parczewski","ptype":"article","src":"https://openalex.org/W1578867327","eid":"W1578867327"},{"id":"paper-w3039373667","cat":"papers","name":"Intranasal salvinorin A improves neurological outcome in rhesus monkey ischemic stroke model using autologous blood clot","year":"2020","cit":25,"pfa":"Longfei Wu","psa":"Xunming Ji","ptype":"article","src":"https://openalex.org/W3039373667","eid":"W3039373667"},{"id":"paper-w1804346067","cat":"papers","name":"Neurobehavioral, reflexological and physical development of Wistar rat offspring exposed to ayahuasca during pregnancy and lactation","year":"2011","cit":25,"pfa":"Carolina Dizioli Rodrigues de Oliveira","psa":"Maurı́cio Yonamine","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1804346067","eid":"W1804346067"},{"id":"paper-w2046446050","cat":"papers","name":"Effect of 5, 6-dihydroxytryptamine on the head twitches induced by 5-HTP, 5-HT, mescaline and fludiazepam in mice","year":"1978","cit":25,"pfa":"Mitsutaka Nakamura","psa":"Hideaki Fukushima","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2046446050","eid":"W2046446050"},{"id":"paper-w2744203125","cat":"papers","name":"MDMA and brain activity during neurocognitive performance: An overview of neuroimaging studies with abstinent ‘Ecstasy’ users","year":"2017","cit":25,"pfa":"Carl Alexander Roberts","psa":"Andrew C. Parrott","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2744203125","eid":"W2744203125"},{"id":"paper-w4391842082","cat":"papers","name":"Efficacy and acceptability of psilocybin for primary or secondary depression: A systematic review and meta-analysis of randomized controlled trials","year":"2024","cit":25,"pfa":"Shuping Fang","psa":"Wei Zhang","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W4391842082","eid":"W4391842082"},{"id":"paper-w1993157126","cat":"papers","name":"EMIT-d.a.u. monoclonal amphetamine/methamphetamine assay. II. Detection of methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA)","year":"1993","cit":25,"pfa":"Alphonse Poklis","psa":"Joseph J. Saady","ptype":"article","src":"https://openalex.org/W1993157126","eid":"W1993157126"},{"id":"paper-w2531655104","cat":"papers","name":"MDMA (‘Ecstasy’), oxytocin and vasopressin modulate social preference in rats: A role for handling and oxytocin receptors","year":"2016","cit":25,"pfa":"Linnet Ramos","psa":"Iain S. McGregor","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2531655104","eid":"W2531655104"},{"id":"paper-w2072444844","cat":"papers","name":"Analysis of Salvinorin A in plants, water, and urine using solid-phase microextraction-comprehensive two-dimensional gas chromatography–time of flight mass spectrometry","year":"2011","cit":25,"pfa":"Brian B. Barnes","psa":"Nicholas H. Snow","ptype":"article","src":"https://openalex.org/W2072444844","eid":"W2072444844"},{"id":"paper-w2000578798","cat":"papers","name":"Effect of a serotonin depleting regimen of 3,4-methylenedioxymethamphetamine (MDMA) on the subsequent stimulation of acetylcholine release in the rat prefrontal cortex","year":"2006","cit":25,"pfa":"Sunila G Nair","psa":"Gary A. Gudelsky","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2000578798","eid":"W2000578798"},{"id":"paper-w4385173317","cat":"papers","name":"Assessing the risk of symptom worsening in psilocybin-assisted therapy for depression: A systematic review and individual participant data meta-analysis","year":"2023","cit":25,"pfa":"Otto Simonsson","psa":"Simon Benjamin Goldberg","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W4385173317","eid":"W4385173317"},{"id":"paper-w2155433057","cat":"papers","name":"Determination of amphetamine, methamphetamine, MDA and MDMA in human hair by GC‐EI‐MS after derivatization with perfluorooctanoyl chloride","year":"2008","cit":25,"pfa":"Sys Stybe Johansen","psa":"Jakob Ross Jornil","ptype":"article","src":"https://openalex.org/W2155433057","eid":"W2155433057"},{"id":"paper-w4367053025","cat":"papers","name":"A critical evaluation of QIDS-SR-16 using data from a trial of psilocybin therapy versus escitalopram treatment for depression","year":"2023","cit":25,"pfa":"Brandon Weiss","psa":"Robin Lester Carhart-Harris","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4367053025","eid":"W4367053025"},{"id":"paper-w2010520228","cat":"papers","name":"The effect of ibogaine on κ-opioid- and 5-HT3-induced changes in stimulation-evoked dopamine release in vitro from striatum of C57BL/6BY mice","year":"1995","cit":25,"pfa":"Henry W. Sershen","psa":"Ábel Lajtha","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2010520228","eid":"W2010520228"},{"id":"paper-w3215511316","cat":"papers","name":"Psilocybin-assisted therapy for the treatment of resistant major depressive disorder (PsiDeR): protocol for a randomised, placebo-controlled feasibility trial","year":"2021","cit":25,"pfa":"James Rucker","psa":"Allan Hunter Young","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3215511316","eid":"W3215511316"},{"id":"paper-w1981598408","cat":"papers","name":"Psilocin analogs II. Synthesis of 3‐[2‐(dialkylamino)ethyl]‐, 3‐[2‐(N‐methyl‐N‐alkylamino)ethyl]‐, and 3‐[2‐(cycloalkylamino)ethyl]indol‐4‐ols","year":"1981","cit":25,"pfa":"David B. Repke","psa":"Dallas K. Bates","ptype":"article","src":"https://openalex.org/W1981598408","eid":"W1981598408"},{"id":"paper-w2151551372","cat":"papers","name":"Clandestine manufacture of 3,4-methylenedioxymethylamphetamine (MDMA) by low pressure reductive amination. A mass spectrometric study of some reaction mixtures","year":"1990","cit":25,"pfa":"Anthonie M.A. Verweij","ptype":"article","src":"https://openalex.org/W2151551372","eid":"W2151551372"},{"id":"paper-w2153134109","cat":"papers","name":"Decrease in REM latency and changes in sleep quality parallel serotonergic damage and recovery after MDMA: a longitudinal study over 180 days","year":"2008","cit":25,"pfa":"Eszter Kirilly","psa":"György Bagdy","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2153134109","eid":"W2153134109"},{"id":"paper-w2092056471","cat":"papers","name":"Association of MDMA/ecstasy and other substance use with self-reported sexually transmitted diseases among college-aged adults: A national study","year":"2009","cit":25,"pfa":"Li-Tzy T. Wu","psa":"Dan German Blazer","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2092056471","eid":"W2092056471"},{"id":"paper-w2055608364","cat":"papers","name":"Prior MDMA (Ecstasy) use is associated with increased basal ganglia–thalamocortical circuit activation during motor task performance in humans: An fMRI study","year":"2009","cit":25,"pfa":"John Karageorgiou","psa":"Ronald L. Cowan","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2055608364","eid":"W2055608364"},{"id":"paper-w4281899337","cat":"papers","name":"Don’t be afraid, try to meditate- potential effects on neural activity and connectivity of psilocybin-assisted mindfulness-based intervention for social anxiety disorder: A systematic review","year":"2022","cit":25,"pfa":"Corinna L. Felsch","psa":"Kim P. C. Kuypers","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4281899337","eid":"W4281899337"},{"id":"paper-w2092982594","cat":"papers","name":"The Acute Effect in Rats of 3, 4‐Methylenedioxyethamphetamine (MDEA, “Eve”) on Body Temperature and Long Term Degeneration of 5‐HT Neurones in Brain: A Comparison with MDMA (“Ecstasy”)","year":"1999","cit":25,"pfa":"María Isabel Colado","psa":"A. Richard Green","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2092982594","eid":"W2092982594"},{"id":"paper-w4388732506","cat":"papers","name":"Efficacy and Safety of Four Psychedelic-Assisted Therapies for Adults with Symptoms of Depression, Anxiety, and Posttraumatic Stress Disorder: A Systematic Review and Meta-Analysis","year":"2023","cit":25,"pfa":"Anees Bahji","psa":"Gustavo Héctor Vázquez","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"review","src":"https://openalex.org/W4388732506","eid":"W4388732506"},{"id":"paper-w4402564741","cat":"papers","name":"Exploring the regulatory framework of psychedelics in the US & Europe","year":"2024","cit":25,"pfa":"Hitesh Kumar Behera","psa":"Sandeep Kumar","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4402564741","eid":"W4402564741"},{"id":"paper-w2328960148","cat":"papers","name":"The Psychedelic Experience - A New Concept in Psychotherapy","year":"1968","cit":25,"pfa":"Janet Sherwood","psa":"Willis W. Harman","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2328960148","eid":"W2328960148"},{"id":"paper-w4391031028","cat":"papers","name":"Older adults in psychedelic-assisted therapy trials: A systematic review","year":"2024","cit":25,"pfa":"Lisa Bouchet","psa":"Yvan Beaussant","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"review","src":"https://openalex.org/W4391031028","eid":"W4391031028"},{"id":"paper-w2061100634","cat":"papers","name":"Percutaneous Transluminal Angioplasty in the Treatment of Extensive LSD-induced Lower Extremity Vasospasm Refractory to Pharmacologic Therapy","year":"2008","cit":25,"pfa":"Mehul V. Raval","psa":"Mark K. Eskandari","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2061100634","eid":"W2061100634"},{"id":"paper-w4380550627","cat":"papers","name":"Psychedelic treatments for mental health conditions pose challenges for informed consent","year":"2023","cit":25,"pfa":"Carolina Seybert","psa":"Albino Jorge Oliveira-Maia","ptype":"article","src":"https://openalex.org/W4380550627","eid":"W4380550627"},{"id":"paper-w2022817119","cat":"papers","name":"Botanical and Chemical Characterisation of a Forensic Mushroom Specimen of the Genus Psilocybe","year":"1966","cit":25,"pfa":"R. Heim","psa":"G. Belec","ptype":"article","src":"https://openalex.org/W2022817119","eid":"W2022817119"},{"id":"paper-w4252339940","cat":"papers","name":"Injury‐Triggered Blueing Reactions of Psilocybe “Magic” Mushrooms","year":"2019","cit":25,"pfa":"Claudius Lenz","psa":"Dirk Hoffmeister","ptype":"article","src":"https://openalex.org/W4252339940","eid":"W4252339940"},{"id":"paper-w2075776243","cat":"papers","name":"The stimulus properties of LSD in C57BL/6 mice","year":"2005","cit":25,"pfa":"Jerrold C. Winter","psa":"Jerry B. Richards","ptype":"article","src":"https://openalex.org/W2075776243","eid":"W2075776243"},{"id":"paper-w3031683123","cat":"papers","name":"Compassionate use of psychedelics","year":"2020","cit":25,"pfa":"Adam Greif","psa":"Martin Šurkala","ptype":"article","src":"https://openalex.org/W3031683123","eid":"W3031683123"},{"id":"paper-w2734565469","cat":"papers","name":"Connectome-harmonic decomposition of human brain activity reveals dynamical repertoire re-organization under LSD","year":"2017","cit":25,"pfa":"Selen Atasoy","psa":"Robin Lester Carhart-Harris","topics":["Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W2734565469","eid":"W2734565469"},{"id":"paper-w2071527820","cat":"papers","name":"Effects of a Hallucinogenic Agent in Totally Blind Subjects","year":"1963","cit":25,"pfa":"Alex E. Krill","psa":"A. M. OSTFELD","ptype":"article","src":"https://openalex.org/W2071527820","eid":"W2071527820"},{"id":"paper-w2108936204","cat":"papers","name":"AN ELECTROPHARMACOLOGICAL ANALYSIS OF THE EFFECTS OF SOME DRUGS ON NEUROMUSCULAR TRANSMISSION IN THE VAS DEFERENS OF THE GUINEA‐PIG","year":"1981","cit":25,"pfa":"Asa G. H. Blakeley","psa":"Stewart A Petersen","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2108936204","eid":"W2108936204"},{"id":"paper-w2057250996","cat":"papers","name":"Determination of lysergide (LSD) and phencyclidine in biosamples","year":"1998","cit":25,"pfa":"Serge Schneider","psa":"Robert Wennig","ptype":"article","src":"https://openalex.org/W2057250996","eid":"W2057250996"},{"id":"paper-w4295997603","cat":"papers","name":"Psychedelics and mindfulness: A systematic review and meta-analysis","year":"2022","cit":25,"pfa":"Chelsea Radakovic","psa":"Jo‐Anne Geere","topics":["Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4295997603","eid":"W4295997603"},{"id":"paper-w4376121908","cat":"papers","name":"Dose-response relationships of LSD-induced subjective experiences in humans","year":"2023","cit":25,"pfa":"Tim Hirschfeld","psa":"Timo Torsten Schmidt","topics":["Anxiety & end-of-life","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4376121908","eid":"W4376121908"},{"id":"paper-w1974562204","cat":"papers","name":"125I-LSD: A high sensitivity ligand for serotonin receptors","year":"1983","cit":25,"pfa":"Paul R. Hartig","psa":"A.M. Krohn","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1974562204","eid":"W1974562204"},{"id":"paper-w4317517597","cat":"papers","name":"Medications for the Treatment of Alcohol Dependence—Current State of Knowledge and Future Perspectives from a Public Health Perspective","year":"2023","cit":25,"pfa":"Iga Stokłosa","psa":"Piotr Wacław Gorczyca","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4317517597","eid":"W4317517597"},{"id":"paper-w2044674210","cat":"papers","name":"Vesicular Monoamine Transporter 2 and the Acute and Long-Term Response to 3,4-(±)-Methylenedioxymethamphetamine","year":"2014","cit":25,"pfa":"Lucina E. Lizarraga","psa":"Terrence J. Monks","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2044674210","eid":"W2044674210"},{"id":"paper-w2193378755","cat":"papers","name":"The Psychopharmacology of ±3,4 Methylenedioxymethamphetamine and its Role in the Treatment of Posttraumatic Stress Disorder","year":"2015","cit":25,"pfa":"Timothy Amoroso","topics":["PTSD & trauma","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2193378755","eid":"W2193378755"},{"id":"paper-w2093905703","cat":"papers","name":"Methylenedioxymethamphetamine-induced suppression of interleukin-1β and tumour necrosis factor-α is not mediated by serotonin","year":"2001","cit":25,"pfa":"Thomas J. Connor","psa":"John P. Kelly","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2093905703","eid":"W2093905703"},{"id":"paper-w2064950822","cat":"papers","name":"2‐Deoxy‐D‐Glucose Prevents and Nicotinamide Potentiates 3,4‐Methylenedioxymethamphetamine‐Induced Serotonin Neurotoxicity","year":"2000","cit":25,"pfa":"Isabel Hervías","psa":"Norberto Aguirre","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2064950822","eid":"W2064950822"},{"id":"paper-w2012209196","cat":"papers","name":"Drug interaction between ethanol and 3,4-methylenedioxymethamphetamine (“ecstasy”)","year":"2009","cit":25,"pfa":"Vijay V. Upreti","psa":"Insong James Lee","ptype":"article","src":"https://openalex.org/W2012209196","eid":"W2012209196"},{"id":"paper-w1969654279","cat":"papers","name":"Serotonergic function in major depression and effect of sertraline and paroxetine treatment","year":"2001","cit":25,"pfa":"R. Stain‐Malmgren","psa":"A. Tham","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1969654279","eid":"W1969654279"},{"id":"paper-w4312058472","cat":"papers","name":"Repeated use of 3,4-methylenedioxymethamphetamine is associated with the resilience in mice after chronic social defeat stress: A role of gut–microbiota–brain axis","year":"2022","cit":25,"pfa":"Youge Qu","psa":"Kenji Hashimoto","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4312058472","eid":"W4312058472"},{"id":"paper-w2064163148","cat":"papers","name":"Effect of the Repeated Administration of (±)-3,4-Methylenedioxymethamphetamine on the Behavioral Response of Rats to the 5-HT1A Receptor Agonist (±)-8-Hydroxy-(di-n-Propylamino)Tetralin","year":"2001","cit":25,"pfa":"Martin I. Granoff","psa":"Charles R. Ashby","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2064163148","eid":"W2064163148"},{"id":"paper-w4409310214","cat":"papers","name":"A multi-institutional investigation of psilocybin’s effects on mouse behavior","year":"2025","cit":25,"pfa":"Odilia Lu","psa":"Robert C. Malenka","topics":["Depression","Anxiety & end-of-life","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4409310214","eid":"W4409310214"},{"id":"paper-w2074134649","cat":"papers","name":"Temperature and 3,4-methylenedioxymethamphetamine alter human serotonin transporter-mediated dopamine uptake","year":"2003","cit":25,"pfa":"Shannon N. Saldaña","psa":"Eric L. Barker","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2074134649","eid":"W2074134649"},{"id":"paper-w2896569934","cat":"papers","name":"Pharmacological characterization of the LSD analog N-ethyl-N-cyclopropyl lysergamide (ECPLA)","year":"2018","cit":25,"pfa":"Adam L. Halberstadt","psa":"Simon D. Brandt","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2896569934","eid":"W2896569934"},{"id":"paper-w1982483542","cat":"papers","name":"Evidence for specific methylenedioxymethamphetamine (ecstasy) binding sites in the rat brain","year":"1985","cit":25,"pfa":"Donald R. Gehlert","psa":"Walter M. Lovenberg","ptype":"article","src":"https://openalex.org/W1982483542","eid":"W1982483542"},{"id":"paper-w4388822593","cat":"papers","name":"Altered stakes: Identifying gaps in the informed consent process for psychedelic-assisted therapy trials","year":"2023","cit":25,"pfa":"Tahlia R. Harrison","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4388822593","eid":"W4388822593"},{"id":"paper-w2929431332","cat":"papers","name":"Lessons to be learned from toxicological analyses in intoxicated patients and seized materials at an electronic music dance festival","year":"2019","cit":25,"pfa":"Paul A. Calle","psa":"Peter Blanckaert","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W2929431332","eid":"W2929431332"},{"id":"paper-w4391630740","cat":"papers","name":"Psychedelics and sexual functioning: a mixed-methods study","year":"2024","cit":25,"pfa":"Tommaso Barba","psa":"Bruna Giribaldi","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4391630740","eid":"W4391630740"},{"id":"paper-w2321068107","cat":"papers","name":"Essential Structure of the κ Opioid Receptor Agonist Nalfurafine for Binding to the κ Receptor","year":"2014","cit":25,"pfa":"Hiroshi Nagase","psa":"Hideaki Fujii","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2321068107","eid":"W2321068107"},{"id":"paper-w2036137762","cat":"papers","name":"CHEMICAL AND PHARMACOLOGICAL EVALUATION OF DESMODIUM PULCHELLUM","year":"1972","cit":25,"pfa":"S. Ghosal","psa":"A. Sanyal","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2036137762","eid":"W2036137762"},{"id":"paper-w2228447682","cat":"papers","name":"Evidence for and Mechanism of Action of Neurotoxicity of Amphetamine Related Compounds","year":"1998","cit":25,"pfa":"Robert Lew","psa":"Lewis S. Seiden","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W2228447682","eid":"W2228447682"},{"id":"paper-w2049244381","cat":"papers","name":"Hallucinogenic drug research— if so, so what?: Symposium summary and commentary","year":"1986","cit":25,"pfa":"Daniel X. Freedman","ptype":"article","src":"https://openalex.org/W2049244381","eid":"W2049244381"},{"id":"paper-w2613410096","cat":"papers","name":"Neuropathic and inflammatory antinociceptive effects and electrocortical changes produced by Salvia divinorum in rats","year":"2017","cit":25,"pfa":"Karina Simón‐Arceo","psa":"Francisco Pellicer","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2613410096","eid":"W2613410096"},{"id":"paper-w1974762960","cat":"papers","name":"A primate model for the study of hallucinogens","year":"1986","cit":25,"pfa":"R. Francis Schlemmer","psa":"John M. Davis","ptype":"article","src":"https://openalex.org/W1974762960","eid":"W1974762960"},{"id":"paper-w2890017048","cat":"papers","name":"Discrepancies in Kappa Opioid Agonist Binding Revealed through PET Imaging","year":"2018","cit":25,"pfa":"Michael S. Placzek","psa":"Jacob M. Hooker","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2890017048","eid":"W2890017048"},{"id":"paper-w4407181198","cat":"papers","name":"Psychedelics assisting therapy, or therapy assisting psychedelics? The importance of psychotherapy in psychedelic-assisted therapy","year":"2025","cit":25,"pfa":"Joseph A. Zamaria","psa":"Rachel Yehuda","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4407181198","eid":"W4407181198"},{"id":"paper-w2757758527","cat":"papers","name":"Intoxication with GHB/GBL: characteristics and trends from ambulance-attended overdoses","year":"2017","cit":25,"pfa":"Desiree Eide","psa":"Guttorm Brattebø","topics":["Safety & adverse events","Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2757758527","eid":"W2757758527"},{"id":"paper-w2758974267","cat":"papers","name":"Drug-related predictors of readmission for schizophrenia among patients admitted to treatment for drug use disorders","year":"2017","cit":25,"pfa":"Kristine Rømer Thomsen","psa":"Morten Hesse","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2758974267","eid":"W2758974267"},{"id":"paper-w2186557663","cat":"papers","name":"Psychiatric Research with Hallucinogens: What have we learned?","year":"2010","cit":25,"pfa":"Charles S. Grob","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2186557663","eid":"W2186557663"},{"id":"paper-w2010573282","cat":"papers","name":"Metoclopramide as a Possible Cause of Prolonged QT Syndrome and Torsade de Pointes in a Patient With Heart Failure and Renal Insufficiency","year":"2009","cit":25,"pfa":"Sultan M. Siddique","psa":"Tariq Hafiz","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2010573282","eid":"W2010573282"},{"id":"paper-w3209277823","cat":"papers","name":"Translating Psychedelic Therapies From Clinical Trials to Community Clinics: Building Bridges and Addressing Potential Challenges Ahead","year":"2021","cit":25,"pfa":"Martin L Williams","psa":"James Bennett–Levy","topics":["Safety & adverse events","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3209277823","eid":"W3209277823"},{"id":"paper-w4311747518","cat":"papers","name":"Psychedelic innovations and the crisis of psychopharmacology","year":"2022","cit":25,"pfa":"Nicolas Langlitz","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4311747518","eid":"W4311747518"},{"id":"paper-w4388419802","cat":"papers","name":"When the Trial Ends: The Case for Post-Trial Provisions in Clinical Psychedelic Research","year":"2023","cit":25,"pfa":"Edward Jacobs","psa":"Meg J. Spriggs","topics":["Dosing & pharmacology","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4388419802","eid":"W4388419802"},{"id":"paper-w1994361665","cat":"papers","name":"PCP and Hallucinogens","year":"1990","cit":25,"pfa":"Marilyn E. Carroll","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1994361665","eid":"W1994361665"},{"id":"paper-w2167237455","cat":"papers","name":"Studies with Ceruloplasmin and a New Hallucinogen","year":"1958","cit":25,"pfa":"Adrian M. Ostfeld","ptype":"article","src":"https://openalex.org/W2167237455","eid":"W2167237455"},{"id":"paper-w2941782170","cat":"papers","name":"Predictive Value of Microdose Pharmacokinetics","year":"2019","cit":25,"pfa":"Merel van Nuland","psa":"Jos H. Beijnen","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2941782170","eid":"W2941782170"},{"id":"paper-w2802426636","cat":"papers","name":"The Varieties of Psychedelic Experience","year":"1967","cit":25,"pfa":"William J. Wolf","ptype":"article","src":"https://openalex.org/W2802426636","eid":"W2802426636"},{"id":"paper-w4406324618","cat":"papers","name":"Psychedelic Medicine Exceptionalism","year":"2025","cit":25,"pfa":"Ivan Glenn Cohen","psa":"Mason Marks","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4406324618","eid":"W4406324618"},{"id":"paper-w4210461338","cat":"papers","name":"Psychedelic injustice: should bioethics tune in to the voices of psychedelic-using communities?","year":"2022","cit":25,"pfa":"Riccardo Miceli McMillan","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4210461338","eid":"W4210461338"},{"id":"paper-w2398555336","cat":"papers","name":"Naltrexone treatment of hallucinogen persisting perception disorder","year":"1997","cit":25,"pfa":"A G Lerner","psa":"M Sigal","ptype":"article","src":"https://openalex.org/W2398555336","eid":"W2398555336"},{"id":"paper-w1984635063","cat":"papers","name":"Phase 0 - Microdosing strategy in clinical trials","year":"2008","cit":25,"pfa":"PUsha Rani","psa":"M.U.R. Naidu","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1984635063","eid":"W1984635063"},{"id":"paper-w4205786821","cat":"papers","name":"Buprenorphine Microdosing for the Pain and Palliative Care Clinician","year":"2022","cit":25,"pfa":"Kyle C. Quirk","psa":"Maximillian H. Stevenson","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4205786821","eid":"W4205786821"},{"id":"paper-w4381191033","cat":"papers","name":"Philosophy and psychedelics: Frameworks for exceptional experience","year":"2023","cit":25,"pfa":"Tra-ill Dowie","psa":"Julien Tempone-Wiltshire","ptype":"article","src":"https://openalex.org/W4381191033","eid":"W4381191033"},{"id":"paper-w4407349274","cat":"papers","name":"On Minimizing Risk and Harm in the Use of Psychedelics","year":"2025","cit":25,"pfa":"Jules Evans","psa":"David B. Yaden","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4407349274","eid":"W4407349274"},{"id":"paper-w4244075482","cat":"papers","name":"Psychedelics and creativity: a review of the quantitative literature","year":"2015","cit":25,"pfa":"Matthew J. Baggott","topics":["Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4244075482","eid":"W4244075482"},{"id":"paper-w4391234830","cat":"papers","name":"The mechanistic divide in psychedelic neuroscience: An unbridgeable gap?","year":"2024","cit":25,"pfa":"Bryan R. Barksdale","psa":"Charles B. Nemeroff","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4391234830","eid":"W4391234830"},{"id":"paper-w2415479964","cat":"papers","name":"The use of psychedelic agents with autistic schizophrenic children.","year":"1969","cit":25,"pfa":"Robert E. Mogar","psa":"Robert W. Aldrich","topics":["Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2415479964","eid":"W2415479964"},{"id":"paper-w2802949656","cat":"papers","name":"Psychedelic Fauna for Psychonaut Hunters: A Mini-Review","year":"2018","cit":25,"pfa":"Laura Orsolini","psa":"Fabrizio Schifano","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W2802949656","eid":"W2802949656"},{"id":"paper-w2024639125","cat":"papers","name":"Psychedelic-Induced Social Behavior in Mice: A Preliminary Report","year":"1969","cit":25,"pfa":"Ronald K. Siegel","psa":"Jean Poole","ptype":"article","src":"https://openalex.org/W2024639125","eid":"W2024639125"},{"id":"paper-w2980427698","cat":"papers","name":"Hallucinogen use is associated with mental health and addictive problems and impulsivity in university students","year":"2019","cit":25,"pfa":"Jon Edgar Grant","psa":"Samuel Robin Chamberlain","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2980427698","eid":"W2980427698"},{"id":"paper-w2557599064","cat":"papers","name":"Microdose-Induced Drug–DNA Adducts as Biomarkers of Chemotherapy Resistance in Humans and Mice","year":"2016","cit":25,"pfa":"Maike Zimmermann","psa":"Paul T. Henderson","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2557599064","eid":"W2557599064"},{"id":"paper-w2065367797","cat":"papers","name":"Drugs on the Internet. I: Introduction and Web Sites on Psychedelic Drugs","year":"2008","cit":25,"pfa":"Michael Montagne","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2065367797","eid":"W2065367797"},{"id":"paper-w3118717131","cat":"papers","name":"Psychedelic-like Properties of Quipazine and Its Structural Analogues in Mice","year":"2021","cit":25,"pfa":"Mario de la Fuente Revenga","psa":"Javier González‐Maeso","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3118717131","eid":"W3118717131"},{"id":"paper-w2077945437","cat":"papers","name":"Average glandular dose in routine mammography screening using a Sectra MicroDose Mammography unit","year":"2005","cit":25,"pfa":"Bengt Hemdal","psa":"Magnus B. E. Olsson","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2077945437","eid":"W2077945437"},{"id":"paper-w4285092635","cat":"papers","name":"Cannabinoid extract in microdoses ameliorates mnemonic and nonmnemonic Alzheimer’s disease symptoms: a case report","year":"2022","cit":25,"pfa":"Ana Carolina Ruver-Martins","psa":"Francisney Pinto do Nascimento","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4285092635","eid":"W4285092635"},{"id":"paper-w2139094298","cat":"papers","name":"Characterization of Microdose Damage Caused by Single Heavy Ion Observed in Trench Type Power MOSFETs","year":"2010","cit":25,"pfa":"S. Kuboyama","psa":"Takashi Tamura","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2139094298","eid":"W2139094298"},{"id":"paper-w4400240498","cat":"papers","name":"A rapid narrative review of the clinical evolution of psychedelic treatment in clinical trials","year":"2024","cit":25,"pfa":"Ronit Kishon","psa":"James Rucker","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4400240498","eid":"W4400240498"},{"id":"paper-w2961337205","cat":"papers","name":"Combined administration of microdoses of growth hormone and erythropoietin: Effects on performance and evaluation of GH detection capability using anti‐doping methods","year":"2019","cit":25,"pfa":"Alexandre Marchand","psa":"Emmanuelle Varlet‐Marie","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2961337205","eid":"W2961337205"},{"id":"paper-w4206467216","cat":"papers","name":"Dynamic reconfiguration of frequency-specific cortical coactivation patterns during psychedelic and anesthetized states induced by ketamine","year":"2022","cit":25,"pfa":"Duan Li","psa":"George A. Mashour","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4206467216","eid":"W4206467216"},{"id":"paper-w4387002013","cat":"papers","name":"Psychedelic Science, Contemplative Practices, and Indigenous and Other Traditional Knowledge Systems: Towards Integrative Community-Based Approaches in Global Health","year":"2023","cit":25,"pfa":"Julián Urrutia","psa":"Veronica Magar","topics":["Addiction","Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4387002013","eid":"W4387002013"},{"id":"paper-w1980939750","cat":"papers","name":"Studies on the relationship of binding affinity to psychoactive and anticholinergic potency of a group of psychotomimetic glycolates","year":"1977","cit":25,"pfa":"Jesse Baumgold","psa":"Robert S. Aronstam","ptype":"article","src":"https://openalex.org/W1980939750","eid":"W1980939750"},{"id":"paper-w3110685581","cat":"papers","name":"Involvement of NMDA receptors containing the GluN2C subunit in the psychotomimetic and antidepressant-like effects of ketamine","year":"2020","cit":25,"pfa":"Mireia Tarrés-Gatius","psa":"Anna Castañé","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3110685581","eid":"W3110685581"},{"id":"paper-w2087986475","cat":"papers","name":"In vitro biochemical evidence that the psychotomimetics phencyclidine, ketamine and dizocilpine (MK-801) are inactive at cloned human and rat dopamine D2 receptors","year":"2006","cit":25,"pfa":"Shaun Jordan","psa":"Tetsuro Kikuchi","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2087986475","eid":"W2087986475"},{"id":"paper-w4233543774","cat":"papers","name":"Neuropsychedelia","year":"2012","cit":25,"pfa":"Nicolas Langlitz","topics":["Dosing & pharmacology"],"ptype":"book","src":"https://openalex.org/W4233543774","eid":"W4233543774"},{"id":"paper-w2610491090","cat":"papers","name":"Growing Evidence for Heterogeneous Synaptic Localization of 5-HT2A Receptors","year":"2017","cit":25,"pfa":"Carine Bécamel","psa":"Philippe Marin","topics":["Depression","Mechanism & neuroscience","Policy & ethics"],"ptype":"editorial","src":"https://openalex.org/W2610491090","eid":"W2610491090"},{"id":"paper-w2145844091","cat":"papers","name":"Synthesis and Pharmacological Evaluation of Ring-Methylated Derivatives of 3,4-(Methylenedioxy)amphetamine (MDA)","year":"1998","cit":25,"pfa":"Matthew Parker","psa":"David E. Nichols","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2145844091","eid":"W2145844091"},{"id":"paper-w1975023234","cat":"papers","name":"Women: Pregnancy, Children and Addiction","year":"1977","cit":25,"pfa":"Josette Escamilla-Mondanaro","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1975023234","eid":"W1975023234"},{"id":"paper-w1995164934","cat":"papers","name":"The Acquisition, Maintenance and Treatment of Polydrug Dependence: A Public Health Model","year":"1975","cit":25,"pfa":"David F. Duncan","ptype":"article","src":"https://openalex.org/W1995164934","eid":"W1995164934"},{"id":"paper-w2424820092","cat":"papers","name":"A Pharmacokinetic Study Examining Acetazolamide as a Novel Adherence Marker for Clinical Trials","year":"2016","cit":25,"pfa":"Aidan J. Hampson","psa":"SHARON L. WALSH","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2424820092","eid":"W2424820092"},{"id":"paper-w2146186658","cat":"papers","name":"THE ULTRASTRUCTURE OF LIVER CELLS IN WOMEN UNDER STEROID THERAPY","year":"1970","cit":25,"pfa":"Jorge Martínez-Manautou","psa":"Amador González-Angulo","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2146186658","eid":"W2146186658"},{"id":"paper-w1842257869","cat":"papers","name":"Identification of members of the genera Panaeolus and Psilocybe by a DNA test","year":"2000","cit":25,"pfa":"Lee Jc","psa":"Adrian M. T. Linacre","ptype":"article","src":"https://openalex.org/W1842257869","eid":"W1842257869"},{"id":"paper-w2474890852","cat":"papers","name":"Ketamine as a rapid antidepressant: the debate and implications","year":"2016","cit":25,"pfa":"Roger Ho","psa":"Melvyn W. Zhang","topics":["Depression","Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2474890852","eid":"W2474890852"},{"id":"paper-w3132130376","cat":"papers","name":"Effects of 5-HT2A receptor agonist 2,5-dimethoxy-4-iodoamphetamine on alcohol consumption in Long–Evans rats","year":"2021","cit":25,"pfa":"Michael D. Berquist","psa":"William E. Fantegrossi","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3132130376","eid":"W3132130376"},{"id":"paper-w2154471517","cat":"papers","name":"Adverse Drug Experiences and Drug Use Behaviors: A One-Year Longitudinal Study of Adolescents","year":"1986","cit":25,"pfa":"George J Huba","psa":"Peter M. Bentler","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2154471517","eid":"W2154471517"},{"id":"paper-w2990125288","cat":"papers","name":"Receptor Interaction Profiles of 4-Alkoxy-Substituted 2,5-Dimethoxyphenethylamines and Related Amphetamines","year":"2019","cit":25,"pfa":"Karolina E. Kolaczynska","psa":"Matthias E. Liechti","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2990125288","eid":"W2990125288"},{"id":"paper-w2015997434","cat":"papers","name":"Selective suppression of antigen-specific Th2 cells by continuous micro-dose oral tolerance","year":"1998","cit":25,"pfa":"Xiao-Mu Wu","psa":"Takeshi Watanabe","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2015997434","eid":"W2015997434"},{"id":"paper-w4392915294","cat":"papers","name":"Mitochondrial Metabolism in Major Depressive Disorder: From Early Diagnosis to Emerging Treatment Options","year":"2024","cit":25,"pfa":"Ane Larrea","psa":"Gabriel Barreda‐Gómez","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4392915294","eid":"W4392915294"},{"id":"paper-w3159763479","cat":"papers","name":"EEG Signal Diversity Varies With Sleep Stage and Aspects of Dream Experience","year":"2021","cit":25,"pfa":"Arnfinn Aamodt","psa":"Johan Frederik Storm","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3159763479","eid":"W3159763479"},{"id":"paper-w2035276574","cat":"papers","name":"Capgras Syndrome Induced by Ketamine in a Healthy Subject","year":"2010","cit":25,"pfa":"Philip Robert Corlett","psa":"John Harrison Krystal","ptype":"article","src":"https://openalex.org/W2035276574","eid":"W2035276574"},{"id":"paper-w4285613113","cat":"papers","name":"A systematic review of substance use and substance use disorder research in Kenya","year":"2022","cit":25,"pfa":"Florence Jaguga","psa":"Edith  Kamaru Kwobah","topics":["Addiction","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4285613113","eid":"W4285613113"},{"id":"paper-w211351899","cat":"papers","name":"Dysregulation of Mesoprefrontal Dopamine Neurons Induced by Acute and Repeated Phencyclidine Administration in the Nonhuman Primate: Implications for Schizophrenia","year":"1997","cit":25,"pfa":"David Jentsch","psa":"Robert Howard Roth","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W211351899","eid":"W211351899"},{"id":"paper-w2026776441","cat":"papers","name":"Role of the NMDA receptor subunit in the expression of the discriminative stimulus effect induced by ketamine","year":"2001","cit":25,"pfa":"Minoru Narita","psa":"Tsutomu Suzuki","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2026776441","eid":"W2026776441"},{"id":"paper-w2079814709","cat":"papers","name":"AZD9272 and AZD2066: Selective and Highly Central Nervous System Penetrant mGluR5 Antagonists Characterized by Their Discriminative Effects","year":"2014","cit":25,"pfa":"Michael D.B. Swedberg","psa":"Patrick Raboisson","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2079814709","eid":"W2079814709"},{"id":"paper-w4399786408","cat":"papers","name":"Role of oxidative phosphorylation in the antidepressant effects of arketamine via the vagus nerve-dependent spleen-brain axis","year":"2024","cit":25,"pfa":"Lijia Chang","psa":"Kenji Hashimoto","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4399786408","eid":"W4399786408"},{"id":"paper-w3041772408","cat":"papers","name":"Effects of subcutaneous esketamine on blood pressure and heart rate in treatment-resistant depression","year":"2020","cit":25,"pfa":"Lorena Catarina Del Sant","psa":"Jair de Jesus Mari","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3041772408","eid":"W3041772408"},{"id":"paper-w4360594655","cat":"papers","name":"The Glutamatergic System in Treatment-Resistant Depression and Comparative Effectiveness of Ketamine and Esketamine: Role of Inflammation?","year":"2023","cit":25,"pfa":"Angelos E Halaris","psa":"John T. Cook","topics":["Depression"],"ptype":"book-chapter","src":"https://openalex.org/W4360594655","eid":"W4360594655"},{"id":"paper-w4381309599","cat":"papers","name":"Remimazolam versus propofol in combination with esketamine for surgical abortion: A double‐blind randomized controlled trial","year":"2023","cit":25,"pfa":"Linli Yue","psa":"Lin Yang","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4381309599","eid":"W4381309599"},{"id":"paper-w3120978958","cat":"papers","name":"The use of esketamine sedation in the emergency department for manipulation of paediatric forearm fractures: A 5 year study","year":"2021","cit":25,"pfa":"Dhawal Patel","psa":"Eileen R. Byrne","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3120978958","eid":"W3120978958"},{"id":"paper-w4386838097","cat":"papers","name":"The Efficacy and Safety of Remimazolam Besylate Combined with Esketamine for Outpatient Colonoscopy: A Prospective, Randomized, Controlled Clinical Trial","year":"2023","cit":25,"pfa":"Wei Li","psa":"Zaijun Hao","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4386838097","eid":"W4386838097"},{"id":"paper-w4391062842","cat":"papers","name":"Association between esketamine interventions and postpartum depression and analgesia following cesarean delivery: a systematic review and meta-analysis","year":"2024","cit":25,"pfa":"Shijin Ma","psa":"Mengchang Yang","topics":["Depression","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4391062842","eid":"W4391062842"},{"id":"paper-w4398243966","cat":"papers","name":"Balanced opioid-free anesthesia with lidocaine and esketamine versus balanced anesthesia with sufentanil for gynecological endoscopic surgery: a randomized controlled trial","year":"2024","cit":25,"pfa":"Yang Hu","psa":"Yuan Gong","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4398243966","eid":"W4398243966"},{"id":"paper-w4405957303","cat":"papers","name":"Esketamine Treatment Trajectory of Patients with Treatment-Resistant Depression in the Mid and Long-Term Run: Data from REAL-ESK Study Group","year":"2025","cit":25,"pfa":"Gianluca Rosso","psa":"Giuseppe Maina","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4405957303","eid":"W4405957303"},{"id":"paper-w4319293638","cat":"papers","name":"Ketamine and its metabolite 2 R ,6 R ‐hydroxynorketamine promote ocular dominance plasticity and release tropomyosin‐related kinase B from inhibitory control without reducing perineuronal nets enwrapping parvalbumin inte","year":"2023","cit":25,"pfa":"Cecilia Cannarozzo","psa":"Eero Ċastrén","topics":["Depression","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4319293638","eid":"W4319293638"},{"id":"paper-w4297907182","cat":"papers","name":"Effective dose of propofol combined with a low-dose esketamine for gastroscopy in elderly patients: A dose finding study using dixon’s up-and-down method","year":"2022","cit":25,"pfa":"Yuling Zheng","psa":"Zhongqi Zhang","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4297907182","eid":"W4297907182"},{"id":"paper-w4379184377","cat":"papers","name":"Intraoperative intravenous low-dose esketamine improves quality of early recovery after laparoscopic radical resection of colorectal cancer: A prospective, randomized controlled trial","year":"2023","cit":25,"pfa":"Ying Xu","psa":"Yanqiu Ai","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4379184377","eid":"W4379184377"},{"id":"paper-w2966642329","cat":"papers","name":"Enantioselective Syntheses of ( S )-Ketamine and ( S )-Norketamine","year":"2019","cit":25,"pfa":"Cheng‐yi Chen","psa":"Xiaowei Lu","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2966642329","eid":"W2966642329"},{"id":"paper-w3128979814","cat":"papers","name":"Analgesia in adult trauma patients in physician-staffed Austrian helicopter rescue: a 12-year registry analysis","year":"2021","cit":25,"pfa":"Christopher Rugg","psa":"Mathias Ströhle","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3128979814","eid":"W3128979814"},{"id":"paper-w3145877401","cat":"papers","name":"Immediate and short-term efficacy of suicide-targeted interventions in suicidal individuals: A systematic review","year":"2021","cit":25,"pfa":"Aistė Lengvenytė","psa":"Philippe Courtet","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W3145877401","eid":"W3145877401"},{"id":"paper-w1791293205","cat":"papers","name":"Interference with testing for lysergic acid diethylamide","year":"1997","cit":24,"pfa":"Detlef G. Ritter","psa":"Christopher W. Long","ptype":"article","src":"https://openalex.org/W1791293205","eid":"W1791293205"},{"id":"paper-w4387540929","cat":"papers","name":"Use of Lysergic Acid Diethylamide by Major Depression Status","year":"2023","cit":24,"pfa":"Claire A. Walsh","psa":"Deborah S. Hasin","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4387540929","eid":"W4387540929"},{"id":"paper-w2088396006","cat":"papers","name":"Detection of Trace Amounts of Lysergic Acid Diethylamide in Sugar Cubes","year":"1966","cit":24,"pfa":"C. Radecka","psa":"Ishwar C. Nigam","ptype":"article","src":"https://openalex.org/W2088396006","eid":"W2088396006"},{"id":"paper-w2035724112","cat":"papers","name":"The effects of lysergic acid diethylamide on copulatory behaviour in the female rat","year":"1977","cit":24,"pfa":"Mona Eliasson","psa":"Bengt J. Meyerson","ptype":"article","src":"https://openalex.org/W2035724112","eid":"W2035724112"},{"id":"paper-w2082961668","cat":"papers","name":"The muscle findings in the neuroleptic malignant syndrome associated with lysergic acid diethylamide.","year":"1991","cit":24,"pfa":"W. M. H. Behan","psa":"Ian A. R. More","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2082961668","eid":"W2082961668"},{"id":"paper-w4386501987","cat":"papers","name":"Elucidation of the mescaline biosynthetic pathway in peyote (Lophophora williamsii)","year":"2023","cit":24,"pfa":"Jacinta L. Watkins","psa":"Peter J. Facchini","ptype":"article","src":"https://openalex.org/W4386501987","eid":"W4386501987"},{"id":"paper-w2332405135","cat":"papers","name":"Biosynthesis of the Peyote Alkaloids. The Incorporation of Tyrosine-2-C14 into Mescaline and Anhalonidine1","year":"1966","cit":24,"pfa":"Edward Leete","ptype":"article","src":"https://openalex.org/W2332405135","eid":"W2332405135"},{"id":"paper-w2028083485","cat":"papers","name":"Lysergic Acid Diethylamide (LSD-25): XIX. As an Adjunct to Brief Psychotherapy, with Special Reference to Ego Enhancement","year":"1956","cit":24,"pfa":"Harold A. Abramson","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2028083485","eid":"W2028083485"},{"id":"paper-w2051664774","cat":"papers","name":"RNA synthesis in isolated brian nuclei after administration of d-lysergic acid diethylamide (LSD) in vivo.","year":"1975","cit":24,"pfa":"Ian R. Brown","ptype":"article","src":"https://openalex.org/W2051664774","eid":"W2051664774"},{"id":"paper-w4392809290","cat":"papers","name":"Structure-activity relationships of serotonergic 5-MeO-DMT derivatives: insights into psychoactive and thermoregulatory properties","year":"2024","cit":24,"pfa":"Pol Puigseslloses","psa":"Raúl López‐Arnau","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4392809290","eid":"W4392809290"},{"id":"paper-w4403809829","cat":"papers","name":"Psilocin, the Psychoactive Metabolite of Psilocybin, Modulates Select Neuroimmune Functions of Microglial Cells in a 5-HT2 Receptor-Dependent Manner","year":"2024","cit":24,"pfa":"Kennedy R. Wiens","psa":"Andis Klegeris","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4403809829","eid":"W4403809829"},{"id":"paper-w3203842841","cat":"papers","name":"Peyote and plants used in the peyote ceremony","year":"1937","cit":24,"pfa":"Richard Evans Schultes","ptype":"article","src":"https://openalex.org/W3203842841","eid":"W3203842841"},{"id":"paper-w2010212334","cat":"papers","name":"Liquid Chromatography-Mass Spectrometric and Liquid Chromatography-Tandem Mass Spectrometric Determination of Hallucinogenic Indoles Psilocin and Psilocybin in “Magic Mushroom” Samples","year":"2005","cit":24,"pfa":"T Kamata","psa":"Hitoshi Tsuchihashi","ptype":"article","src":"https://openalex.org/W2010212334","eid":"W2010212334"},{"id":"paper-w2127436611","cat":"papers","name":"Binding of [3H]paroxetine to serotonin uptake sites and of [3H]lysergic acid diethylamide to 5-HT2A receptors in platelets from women with premenstrual dysphoric disorder during gonadotropin releasing hormone treatment","year":"2001","cit":24,"pfa":"Marie Bixo","psa":"Inger Sundström Poromaa","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2127436611","eid":"W2127436611"},{"id":"paper-w2155958103","cat":"papers","name":"Ibogaine affects brain energy metabolism","year":"2006","cit":24,"pfa":"Roman Paškulin","psa":"Borut Štrukelj","ptype":"article","src":"https://openalex.org/W2155958103","eid":"W2155958103"},{"id":"paper-w2089001095","cat":"papers","name":"Synthesis, hydrolysis and stability of psilocin glucuronide","year":"2014","cit":24,"pfa":"Rafaela Martin","psa":"Helga Köhler","ptype":"article","src":"https://openalex.org/W2089001095","eid":"W2089001095"},{"id":"paper-w2249782950","cat":"papers","name":"TOXICITY AND EFFECTS OF INCREASING DOSES OF MESCALINE","year":"1957","cit":24,"pfa":"Louise B. Speck","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2249782950","eid":"W2249782950"},{"id":"paper-w2149863815","cat":"papers","name":"O Uso Ritual Da Ayahuasca","year":"2004","cit":24,"pfa":"PETER GOW","ptype":"article","src":"https://openalex.org/W2149863815","eid":"W2149863815"},{"id":"paper-w2998604208","cat":"papers","name":"Inhaled 5-methoxy-N,N-dimethyltryptamine: Supportive context associated with positive acute and enduring effects","year":"2019","cit":24,"pfa":"Nathan D. Sepeda","psa":"Alan K. Davis","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2998604208","eid":"W2998604208"},{"id":"paper-w2078613896","cat":"papers","name":"Peyote Alkaloids: Identification in a Prehistoric Specimen of Lophophora from Coahuila, Mexico","year":"1978","cit":24,"pfa":"Jan G. Bruhn","psa":"James M. Adovasio","ptype":"article","src":"https://openalex.org/W2078613896","eid":"W2078613896"},{"id":"paper-w2095561142","cat":"papers","name":"Stereoselective urinary MDMA (ecstasy) and metabolites excretion kinetics following controlled MDMA administration to humans","year":"2011","cit":24,"pfa":"Andrea Eva Steuer","psa":"Hans H. Maurer","ptype":"article","src":"https://openalex.org/W2095561142","eid":"W2095561142"},{"id":"paper-w1982153117","cat":"papers","name":"Kappa-opioid receptor-selective dicarboxylic ester-derived salvinorin A ligands","year":"2013","cit":24,"pfa":"Prabhakar Reddy Polepally","psa":"Jordan Kordian Zjawiony","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1982153117","eid":"W1982153117"},{"id":"paper-w2159340798","cat":"papers","name":"Ecstasy (MDMA), amphetamine, and LSD: comparative mood profiles in recreational polydrug users","year":"1997","cit":24,"pfa":"Andrew C. Parrott","psa":"Marta Stuart","ptype":"article","src":"https://openalex.org/W2159340798","eid":"W2159340798"},{"id":"paper-w4390484734","cat":"papers","name":"Psilocybin Without Psychotherapy: A Cart Without a Horse?","year":"2024","cit":24,"pfa":"Mitch Earleywine","psa":"Karen Scott","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4390484734","eid":"W4390484734"},{"id":"paper-w1980563902","cat":"papers","name":"Psilocybin-induced contraction of nearby visual space","year":"1970","cit":24,"pfa":"Roland Fischer","psa":"James Scheib","ptype":"article","src":"https://openalex.org/W1980563902","eid":"W1980563902"},{"id":"paper-w3217665844","cat":"papers","name":"MDMA o El éxtasis químico","year":"1995","cit":24,"pfa":"Marc Capdevila","ptype":"article","src":"https://openalex.org/W3217665844","eid":"W3217665844"},{"id":"paper-w1963719599","cat":"papers","name":"Age-dependent (+)MDMA-mediated Neurotoxicity in Mice","year":"2005","cit":24,"pfa":"Maria Elena Reveron","psa":"Christine L. Duvauchelle","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1963719599","eid":"W1963719599"},{"id":"paper-w2065030773","cat":"papers","name":"Tolerance and cross-tolerance to mescaline and amphetamine as a function of central and peripheral administration","year":"1972","cit":24,"pfa":"Sheldon B. Sparber","psa":"H.A. Tilson","ptype":"article","src":"https://openalex.org/W2065030773","eid":"W2065030773"},{"id":"paper-w2405313241","cat":"papers","name":"Native use and occurence of N,N-Dimethyltryptamine in the leaves of Banisteriopsis rusbyana.","year":"1969","cit":24,"pfa":"Marderosian Ah","psa":"Dobbins Mf","ptype":"article","src":"https://openalex.org/W2405313241","eid":"W2405313241"},{"id":"paper-w2000495110","cat":"papers","name":"MDMA enhances associative and nonassociative learning in the rabbit","year":"1994","cit":24,"pfa":"Anthony G. Romano","psa":"John A. Harvey","ptype":"article","src":"https://openalex.org/W2000495110","eid":"W2000495110"},{"id":"paper-w4390732376","cat":"papers","name":"Do the therapeutic effects of psilocybin involve actions in the gut?","year":"2024","cit":24,"pfa":"Felicia M. Reed","psa":"Claire J. Foldi","ptype":"review","src":"https://openalex.org/W4390732376","eid":"W4390732376"},{"id":"paper-w2152553965","cat":"papers","name":"The Dimethyltryptamine-Forming Enzyme in Blood Platelets: A Study in Monozygotic Twins Discordant for Schizophrenia","year":"1973","cit":24,"pfa":"Richard Jed Wyatt","psa":"William Pollin","ptype":"article","src":"https://openalex.org/W2152553965","eid":"W2152553965"},{"id":"paper-w2978567744","cat":"papers","name":"Subacute effects of the psychedelic ayahuasca on the salience and default mode networks","year":"2019","cit":24,"pfa":"Lorenzo Pasquini","psa":"Dráulio Barros de Araújo","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W2978567744","eid":"W2978567744"},{"id":"paper-w9761492","cat":"papers","name":"Human Deaths and Toxic Reactions Attributed to MDMA and MDEA","year":"1990","cit":24,"pfa":"G Dowling","ptype":"book-chapter","src":"https://openalex.org/W9761492","eid":"W9761492"},{"id":"paper-w2088493482","cat":"papers","name":"Neurochemical investigations of the interaction of N,N-dimethyltryptamine with the dopaminergic system in rat brain","year":"1977","cit":24,"pfa":"P. C. Waldmeier","psa":"L. Ma�tre","ptype":"article","src":"https://openalex.org/W2088493482","eid":"W2088493482"},{"id":"paper-w2021801427","cat":"papers","name":"Differential signaling properties at the kappa opioid receptor of 12-epi-salvinorin A and its analogues","year":"2011","cit":24,"pfa":"Cécile Béguin","psa":"Bruce M. Cohen","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2021801427","eid":"W2021801427"},{"id":"paper-w3091727265","cat":"papers","name":"The Importance of Ritual Discourse in Framing Ayahuasca Experiences in the Context of Shamanic Tourism","year":"2020","cit":24,"pfa":"Evgenia Fotiou","ptype":"article","src":"https://openalex.org/W3091727265","eid":"W3091727265"},{"id":"paper-w1900226119","cat":"papers","name":"‘Whatever you want to believe’: kaleidoscopic individualism and ayahuasca healing in Australia","year":"2015","cit":24,"pfa":"Alex K. Gearin","ptype":"article","src":"https://openalex.org/W1900226119","eid":"W1900226119"},{"id":"paper-w2134199629","cat":"papers","name":"The Detection and Quantitative Analysis of the Psychoactive Component of Salvia divinorum, Salvinorin A, in Human Biological Fluids Using Liquid Chromatography-Mass Spectrometry*","year":"2008","cit":24,"pfa":"Pamela C. McDonough","psa":"Marilyn R. Past","topics":["Addiction","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2134199629","eid":"W2134199629"},{"id":"paper-w2048256512","cat":"papers","name":"Could MDMA be useful in the treatment of post‐traumatic stress disorder?","year":"2011","cit":24,"pfa":"Ben Sessa","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W2048256512","eid":"W2048256512"},{"id":"paper-w2979438468","cat":"papers","name":"The ayahuasca tourism boom: An undervalued demand driver for jaguar body parts?","year":"2019","cit":24,"pfa":"Alexander R. Braczkowski","psa":"Christopher J. O’Bryan","topics":["Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2979438468","eid":"W2979438468"},{"id":"paper-w4389891609","cat":"papers","name":"Intravenous psilocybin attenuates mechanical hypersensitivity in a rat model of chronic pain","year":"2023","cit":24,"pfa":"Nicholas Kolbman","psa":"Dinesh Pal","topics":["Depression","Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4389891609","eid":"W4389891609"},{"id":"paper-w2124714506","cat":"papers","name":"Effects of MDMA on blood glucose levels and brain glucose metabolism","year":"2007","cit":24,"pfa":"María Luisa Soto‐Montenegro","psa":"Manuel Desco","ptype":"article","src":"https://openalex.org/W2124714506","eid":"W2124714506"},{"id":"paper-w4388014221","cat":"papers","name":"The Tolerability and Safety of Psilocybin in Psychiatric and Substance-Dependence Conditions: A Systematic Review","year":"2023","cit":24,"pfa":"Dana Kaminski","psa":"Justin P. Reinert","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"review","src":"https://openalex.org/W4388014221","eid":"W4388014221"},{"id":"paper-w1980686663","cat":"papers","name":"In vivo kinetics and displacement study of a carbon-11-labeled hallucinogen, N,N-[11C]dimethyltryptamine","year":"1986","cit":24,"pfa":"Kazuhiko Yanai","psa":"Taiju Matsuzawa","ptype":"article","src":"https://openalex.org/W1980686663","eid":"W1980686663"},{"id":"paper-w4285403413","cat":"papers","name":"Antidepressant and anxiolytic-like effects of ayahuasca in rats subjected to LPS-induced neuroinflammation","year":"2022","cit":24,"pfa":"Marina Goulart da Silva","psa":"Rafael Mariano de Bitencourt","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4285403413","eid":"W4285403413"},{"id":"paper-w4402748917","cat":"papers","name":"Psilocybin for major depressive disorder: a systematic review of randomized controlled studies","year":"2024","cit":24,"pfa":"Lijuan Li","psa":"Wei Zheng","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W4402748917","eid":"W4402748917"},{"id":"paper-w4391611531","cat":"papers","name":"Ayahuasca‐enhanced extinction of fear behaviour: Role of infralimbic cortex 5‐HT2A and 5‐HT1A receptors","year":"2024","cit":24,"pfa":"Isabel Werle","psa":"Leandro Jose Bertoglio","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4391611531","eid":"W4391611531"},{"id":"paper-w3215445661","cat":"papers","name":"Ayahuasca blocks ethanol preference in an animal model of dependence and shows no acute toxicity","year":"2021","cit":24,"pfa":"Bruno Gianfratti","psa":"E.A. Carlini","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3215445661","eid":"W3215445661"},{"id":"paper-w2052874867","cat":"papers","name":"Impulsivity and BOLD fMRI activation in MDMA users and healthy control subjects","year":"2006","cit":24,"pfa":"Ignacio Valdes","psa":"Frederick Gerard Moeller","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2052874867","eid":"W2052874867"},{"id":"paper-w4223893856","cat":"papers","name":"Safety issues of psilocybin and LSD as potential rapid acting antidepressants and potential challenges","year":"2022","cit":24,"pfa":"Giordano Novak Rossi","psa":"RAFAEL GUIMARÃES DOS SANTOS","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4223893856","eid":"W4223893856"},{"id":"paper-w2079441863","cat":"papers","name":"Assessment of Chronic Exposure to MDMA in a Group of Consumers by Segmental Hair Analysis","year":"2006","cit":24,"pfa":"Simona Pichini","psa":"Rafael de la Torre","ptype":"article","src":"https://openalex.org/W2079441863","eid":"W2079441863"},{"id":"paper-w1988268113","cat":"papers","name":"Psychiatric Disorders and Their Correlates Among Young Adult MDMA Users in Ohio","year":"2006","cit":24,"pfa":"Rüssel S. Falck","psa":"Harvey Alan Siegal","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W1988268113","eid":"W1988268113"},{"id":"paper-w4308040950","cat":"papers","name":"Psilocybin for alcohol use disorder: Rationale and design considerations for a randomized controlled trial","year":"2022","cit":24,"pfa":"Kelley C. O’Donnell","psa":"Michael P. Bogenschutz","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4308040950","eid":"W4308040950"},{"id":"paper-w2120711761","cat":"papers","name":"Cognitive impairments from developmental exposure to serotonergic drugs: citalopram and MDMA","year":"2013","cit":24,"pfa":"Tori L. Schaefer","psa":"Charles V. Vorhees","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2120711761","eid":"W2120711761"},{"id":"paper-w4386046484","cat":"papers","name":"Psilocybin therapy for treatment resistant depression: prediction of clinical outcome by natural language processing","year":"2023","cit":24,"pfa":"Robert F. Dougherty","psa":"Gregory Ryslik","topics":["Depression","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4386046484","eid":"W4386046484"},{"id":"paper-w1970147835","cat":"papers","name":"The effects of binge MDMA on acquisition and reversal learning in a radial-arm maze task","year":"2011","cit":24,"pfa":"C. Kay","psa":"Maree J. Hunt","ptype":"article","src":"https://openalex.org/W1970147835","eid":"W1970147835"},{"id":"paper-w4295190209","cat":"papers","name":"Population pharmacokinetic/pharmacodynamic modeling of the psychedelic experience induced by N,N‐dimethyltryptamine – Implications for dose considerations","year":"2022","cit":24,"pfa":"Emma Eckernäs","psa":"Michael Ashton","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4295190209","eid":"W4295190209"},{"id":"paper-w2112606066","cat":"papers","name":"Behavioral and neurochemical effects of repeated MDMA administration during late adolescence in the rat","year":"2013","cit":24,"pfa":"Brittney M. Cox","psa":"Shane Alan Perrine","ptype":"article","src":"https://openalex.org/W2112606066","eid":"W2112606066"},{"id":"paper-w2169619126","cat":"papers","name":"C-(4,5,6-Trimethoxyindan-1-yl)methanamine: A Mescaline Analogue Designed Using a Homology Model of the 5-HT2AReceptor","year":"2006","cit":24,"pfa":"Thomas H. McLean","psa":"David E. Nichols","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2169619126","eid":"W2169619126"},{"id":"paper-w1988137292","cat":"papers","name":"MDMA: fact and fallacy, and the need to increase knowledge in both the scientific and popular press","year":"2004","cit":24,"pfa":"A. Richard Green","ptype":"article","src":"https://openalex.org/W1988137292","eid":"W1988137292"},{"id":"paper-w4401689244","cat":"papers","name":"Validation of the Swiss Psychedelic Side Effects Inventory: Standardized assessment of adverse effects in studies of psychedelics and MDMA","year":"2024","cit":24,"pfa":"Abigail E. Calder","psa":"Gregor Hasler","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4401689244","eid":"W4401689244"},{"id":"paper-w4383187376","cat":"papers","name":"Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-Assisted Psychotherapy Compared to Paroxetine and Sertraline","year":"2023","cit":24,"pfa":"Allison A. Feduccia","psa":"Rick Doblin","topics":["PTSD & trauma","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4383187376","eid":"W4383187376"},{"id":"paper-w4285605468","cat":"papers","name":"Magic Mushrooms – an exploratory look at how mental health professionals feel and think about Psilocybin","year":"2022","cit":24,"pfa":"Thomas Daniel Meyer","psa":"Jair C. Soares","ptype":"article","src":"https://openalex.org/W4285605468","eid":"W4285605468"},{"id":"paper-w2032272337","cat":"papers","name":"Quantification of MDMA and MDA in abusers' hair samples by semi‐micro column HPLC with fluorescence detection","year":"2006","cit":24,"pfa":"Shinichi Nakamura","psa":"Kenichiro Nakashima","ptype":"article","src":"https://openalex.org/W2032272337","eid":"W2032272337"},{"id":"paper-w2126943408","cat":"papers","name":"Opposite effects of 3,4-methylenedioxy-methamphetamine (MDMA) on sensorimotor gating in rats versus healthy humans","year":"1999","cit":24,"pfa":"F.X. Vollenweider","psa":"Daniel Hell","ptype":"article","src":"https://openalex.org/W2126943408","eid":"W2126943408"},{"id":"paper-w2007622927","cat":"papers","name":"Ethanol–MDMA interactions in rats: the importance of interval between repeated treatments in biobehavioral tolerance and sensitization to the combination","year":"2007","cit":24,"pfa":"Sami Ben Hamida","psa":"Jean‐Christophe Cassel","ptype":"article","src":"https://openalex.org/W2007622927","eid":"W2007622927"},{"id":"paper-w4312056223","cat":"papers","name":"Subacute effects of a single dose of psilocybin on biomarkers of inflammation in healthy humans: An open-label preliminary investigation","year":"2022","cit":24,"pfa":"Daniel Burmester","psa":"Patrick M. Fisher","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4312056223","eid":"W4312056223"},{"id":"paper-w2007893260","cat":"papers","name":"Mechanisms and environmental factors that underlying the intensification of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)-induced serotonin syndrome in rats","year":"2014","cit":24,"pfa":"Rui Tao","psa":"Zhiyuan Ma","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2007893260","eid":"W2007893260"},{"id":"paper-w3215842905","cat":"papers","name":"Electrochemical detection of MDMA and 2C-B in ecstasy tablets using a selectivity enhancement strategy by in-situ derivatization","year":"2021","cit":24,"pfa":"Robin Van Echelpoel","psa":"Karolien De Wael","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W3215842905","eid":"W3215842905"},{"id":"paper-w1990099425","cat":"papers","name":"The effects of 2,5-dimethoxy-4-methylamphetamine (DOM), 2,5-dimethoxy-4-ethylamphetamine (DOET), d-amphetamine, and cocaine in rats trained with mescaline as a discriminative stimulus","year":"1975","cit":24,"pfa":"Jerrold C. Winter","ptype":"article","src":"https://openalex.org/W1990099425","eid":"W1990099425"},{"id":"paper-w4285267304","cat":"papers","name":"The Cathinone Hydra: Increased Cathinone and caffeine adulteration in the English MDMA market after Brexit and COVID-19 lockdowns","year":"2022","cit":24,"pfa":"Michael Pascoe","psa":"Fiona Catherine Measham","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4285267304","eid":"W4285267304"},{"id":"paper-w2163018660","cat":"papers","name":"MDMA affects both error-rate dependent and independent aspects of decision-making in a two-choice prediction task","year":"2005","cit":24,"pfa":"Franz X. Vollenweider","psa":"Martin P. Paulus","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2163018660","eid":"W2163018660"},{"id":"paper-w565293858","cat":"papers","name":"Chronic MDMA induces neurochemical changes in the hippocampus of adolescent and young adult rats: Down-regulation of apoptotic markers","year":"2015","cit":24,"pfa":"Rubén García‐Cabrerizo","psa":"María Julia García-Fuster","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W565293858","eid":"W565293858"},{"id":"paper-w2810472102","cat":"papers","name":"Human Metabolome Changes after a Single Dose of 3,4-Methylenedioxymethamphetamine (MDMA) with Special Focus on Steroid Metabolism and Inflammation Processes","year":"2018","cit":24,"pfa":"Martina I. Boxler","psa":"Andrea Eva Steuer","topics":["Addiction","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2810472102","eid":"W2810472102"},{"id":"paper-w2919604118","cat":"papers","name":"Autophagy inhibition plays a protective role against 3, 4-methylenedioxymethamphetamine (MDMA)-induced loss of serotonin transporters and depressive-like behaviors in rats","year":"2019","cit":24,"pfa":"Jui‐Hu Shih","psa":"I‐Hsun Li","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2919604118","eid":"W2919604118"},{"id":"paper-w2047506594","cat":"papers","name":"GC–MS studies on acylated derivatives of 3-methoxy-4-methyl- and 4-methoxy-3-methyl-phenethylamines: Regioisomers related to 3,4-MDMA","year":"2008","cit":24,"pfa":"Tarek S. Belal","psa":"Charles R. Clark","ptype":"article","src":"https://openalex.org/W2047506594","eid":"W2047506594"},{"id":"paper-w2542604268","cat":"papers","name":"Opioid gene expression changes and post-translational histone modifications at promoter regions in the rat nucleus accumbens after acute and repeated 3,4-methylenedioxy-methamphetamine (MDMA) exposure","year":"2016","cit":24,"pfa":"Francesca Felicia Caputi","psa":"Patrizia Romualdi","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2542604268","eid":"W2542604268"},{"id":"paper-w4288063444","cat":"papers","name":"Psychedelic medicines for mood disorders: current evidence and clinical considerations","year":"2021","cit":24,"pfa":"Jerome J. Sarris","psa":"Daniel Perkins","topics":["Depression","PTSD & trauma","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4288063444","eid":"W4288063444"},{"id":"paper-w2046152571","cat":"papers","name":"Neurophysiological effects of hallucinogens on serotonergic neuronal systems","year":"1982","cit":24,"pfa":"Robert B. McCall","ptype":"article","src":"https://openalex.org/W2046152571","eid":"W2046152571"},{"id":"paper-w2019182701","cat":"papers","name":"Interaction of LSD and other hallucinogens with dopamine-sensitive adenylate cyclase in primate brain: Regional differences","year":"1979","cit":24,"pfa":"Ho Sam Ahn","psa":"Maynard H. Makman","ptype":"article","src":"https://openalex.org/W2019182701","eid":"W2019182701"},{"id":"paper-w4220724929","cat":"papers","name":"Mycotherapy: Potential of Fungal Bioactives for the Treatment of Mental Health Disorders and Morbidities of Chronic Pain","year":"2022","cit":24,"pfa":"Elaine Meade","psa":"Mary Garvey","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4220724929","eid":"W4220724929"},{"id":"paper-w2024261524","cat":"papers","name":"Stimulation of rat prolactin secretion by indolealkylamine hallucinogens","year":"1978","cit":24,"pfa":"Herbert Y. Meltzer","psa":"Victor S. Fang","ptype":"article","src":"https://openalex.org/W2024261524","eid":"W2024261524"},{"id":"paper-w1912499114","cat":"papers","name":"The role of psychotropic drugs in individual therapy.","year":"1959","cit":24,"pfa":"R. A. Sandison","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W1912499114","eid":"W1912499114"},{"id":"paper-w2016236883","cat":"papers","name":"Low Doses of Dipropyltryptamine in Psychotherapy","year":"1973","cit":24,"pfa":"Robert A. Soskin","topics":["Addiction","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2016236883","eid":"W2016236883"},{"id":"paper-w118892363","cat":"papers","name":"Serotonin and Serotonin Receptors in Hallucinogen Action","year":"2010","cit":24,"pfa":"Adam L. Halberstadt","psa":"David E. Nichols","topics":["Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W118892363","eid":"W118892363"},{"id":"paper-w4390973319","cat":"papers","name":"Psilocybe cubensis extract potently prevents fear memory recall and freezing behavior in short- but not long-term in a rat model of posttraumatic stress disorder.","year":"2024","cit":24,"pfa":"Zahra Ghofrani-Jahromi","psa":"Salar Vaseghi","topics":["PTSD & trauma","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4390973319","eid":"W4390973319"},{"id":"paper-w2412812307","cat":"papers","name":"Expression of 5-HT1C receptors in transfected MDCK cells is functionally and anatomically asymmetric","year":"1993","cit":24,"pfa":"H. Luo","psa":"Herbert S Chase","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2412812307","eid":"W2412812307"},{"id":"paper-w2083229818","cat":"papers","name":"Discriminative Stimulus Effects of 3,4-Methylenedioxymethamphetamine and Its Enantiomers in Mice: Pharmacokinetic Considerations","year":"2009","cit":24,"pfa":"William E. Fantegrossi","psa":"Rafael de la Torre","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2083229818","eid":"W2083229818"},{"id":"paper-w2060912961","cat":"papers","name":"Synthesis and receptor binding studies relevant to the neuroleptic activities of some 1-methyl-4-piperidylidene-9-substituted-pyrrolo[2,1-b][3]benzazepine derivatives","year":"1983","cit":24,"pfa":"David C. Remy","psa":"Yves Girard","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2060912961","eid":"W2060912961"},{"id":"paper-w1971644143","cat":"papers","name":"Effects of methylenedioxymethamphetamine on noradrenaline-evoked contractions of rat right ventricle and small mesenteric artery","year":"2001","cit":24,"pfa":"W Al-Sahli","psa":"James R. Docherty","ptype":"article","src":"https://openalex.org/W1971644143","eid":"W1971644143"},{"id":"paper-w2169019614","cat":"papers","name":"Performance Characteristics of Selected Immunoassays for Preliminary Test of 3,4-Methylenedioxymethamphetamine, Methamphetamine, and Related Drugs in Urine Specimens","year":"2003","cit":24,"pfa":"Jui Hsu","psa":"R. H. Liu","ptype":"article","src":"https://openalex.org/W2169019614","eid":"W2169019614"},{"id":"paper-w2762884552","cat":"papers","name":"TCB-2 [(7R)-3-bromo-2, 5-dimethoxy-bicyclo[4.2.0]octa-1,3,5-trien-7-yl]methanamine]: A hallucinogenic drug, a selective 5-HT2A receptor pharmacological tool, or none of the above?","year":"2017","cit":24,"pfa":"Giuseppe Di Giovanni","psa":"Philippe De Deurwaerdère","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2762884552","eid":"W2762884552"},{"id":"paper-w2030040543","cat":"papers","name":"Enantioselective metabolism of the designer drugs 3,4-methylenedioxymethamphetamine (‘ecstasy’) and 3,4-methylenedioxyethylamphetamine (‘eve’) isomers in rat brain and blood","year":"2002","cit":24,"pfa":"Anja Meyer","psa":"Werner Schmidt","ptype":"article","src":"https://openalex.org/W2030040543","eid":"W2030040543"},{"id":"paper-w2045512919","cat":"papers","name":"A new brain area affected by 3,4-methylenedioxymethamphetamine: A microdialysis–biotelemetry study","year":"2008","cit":24,"pfa":"Khalid Benamar","psa":"Martin W. Adler","ptype":"article","src":"https://openalex.org/W2045512919","eid":"W2045512919"},{"id":"paper-w3208674003","cat":"papers","name":"Low-dose LSD and the stream of thought: Increased Discontinuity of Mind, Deep Thoughts and abstract flow","year":"2021","cit":24,"pfa":"Isabel Wießner","psa":"Luís Fernando Tófoli","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3208674003","eid":"W3208674003"},{"id":"paper-w1997491665","cat":"papers","name":"Reversal of the acute effects of 3,4-methylenedioxymethamphetamine by 5-HT uptake inhibitors","year":"1990","cit":24,"pfa":"Christopher J. Schmidt","psa":"Vicki L. Taylor","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1997491665","eid":"W1997491665"},{"id":"paper-w2094823797","cat":"papers","name":"Development of Homogeneous High-Affinity Agonist Binding Assays for 5-HT 2 Receptor Subtypes","year":"2005","cit":24,"pfa":"Jianping Song","psa":"Alain Stricker‐Krongrad","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2094823797","eid":"W2094823797"},{"id":"paper-w2072168925","cat":"papers","name":"Blockade of the 3,4-methylenedioxymethamphetamine-induced changes in neurotensin and dynorphin A systems","year":"1991","cit":24,"pfa":"Michel Johnson","psa":"Glen R. Hanson","ptype":"article","src":"https://openalex.org/W2072168925","eid":"W2072168925"},{"id":"paper-w2090582516","cat":"papers","name":"(+) 3,4-Methylenedioxymethamphetamine (‘Ecstasy’) transiently increases striatal 5-HT1B binding sites without altering 5-HT1B mRNA in rat brain","year":"1999","cit":24,"pfa":"Timothy J. Sexton","psa":"John F. Neumaier","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2090582516","eid":"W2090582516"},{"id":"paper-w1985725289","cat":"papers","name":"On the Mechanisms Underlying 3,4-Methylenedioxymethamphetamine Toxicity: The Dilemma of the Chicken and the Egg","year":"2009","cit":24,"pfa":"Elena Puerta","psa":"Norberto Aguirre","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1985725289","eid":"W1985725289"},{"id":"paper-w2327475162","cat":"papers","name":"THE ELECTROENCEPHALOGRAM AND PSYCHOPATHOLOGICAL MANIFESTATIONS IN SCHIZOPHRENIA AS INFLUENCED BY DRUGS1","year":"1942","cit":24,"pfa":"Morton A. Rubin","psa":"Justin M. Hope","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2327475162","eid":"W2327475162"},{"id":"paper-w3160009784","cat":"papers","name":"Ecstasy (3,4-methylenedioxymethamphetamine): Cardiovascular effects and mechanisms","year":"2021","cit":24,"pfa":"Diogo A. Fonseca","psa":"Maria Dulce Cotrim","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3160009784","eid":"W3160009784"},{"id":"paper-w2142277208","cat":"papers","name":"Post-traumatic stress disorder: new directions in pharmacotherapy","year":"2013","cit":24,"pfa":"Ben Green","topics":["Depression","PTSD & trauma","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2142277208","eid":"W2142277208"},{"id":"paper-w4307987398","cat":"papers","name":"Therapeutic setting as an essential component of psychedelic research methodology: Reporting recommendations emerging from clinical trials of 3,4-methylenedioxymethamphetamine for post-traumatic stress disorder","year":"2022","cit":24,"pfa":"Lauren Okano","psa":"Wesley Hale","topics":["PTSD & trauma","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4307987398","eid":"W4307987398"},{"id":"paper-w2131640797","cat":"papers","name":"Blending Traditions - Using Indigenous Medicinal Knowledge to Treat Drug Addiction 1","year":"2001","cit":24,"pfa":"Jacques Mabit","psa":"Kartina Amin","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2131640797","eid":"W2131640797"},{"id":"paper-w2003621146","cat":"papers","name":"Recreational ecstasy use and depression","year":"2006","cit":24,"pfa":"Casey R. Guillot","psa":"David E. Greenway","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2003621146","eid":"W2003621146"},{"id":"paper-w1967205222","cat":"papers","name":"Halluzinogen-induzierte psychische Störungen","year":"2008","cit":24,"pfa":"Leo Hermle","psa":"Martin Ruchsow","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1967205222","eid":"W1967205222"},{"id":"paper-w3213175387","cat":"papers","name":"Baseline Power of Theta Oscillations Predicts Mystical-Type Experiences Induced by DMT in a Natural Setting","year":"2021","cit":24,"pfa":"Enzo Tagliazucchi","psa":"Carla Pallavicini","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3213175387","eid":"W3213175387"},{"id":"paper-w1992927986","cat":"papers","name":"Characterization of serotonin receptors in the iris + ciliary body of the albino rabbit","year":"1987","cit":24,"pfa":"Pierre J. Mallorga","psa":"Michael F. Sugrue","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1992927986","eid":"W1992927986"},{"id":"paper-w3022169380","cat":"papers","name":"The Viability of Microdosing Psychedelics as a Strategy to Enhance Cognition and Well-being - An Early Review","year":"2020","cit":24,"pfa":"Joel Bornemann","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3022169380","eid":"W3022169380"},{"id":"paper-w2077762003","cat":"papers","name":"Nicotiana an hallucinogen?","year":"1976","cit":24,"pfa":"Oscar Janiger","psa":"Marlene Dobkin de Ríos","ptype":"article","src":"https://openalex.org/W2077762003","eid":"W2077762003"},{"id":"paper-w4229763220","cat":"papers","name":"‘Microdose’ isotretinoin","year":"2000","cit":24,"pfa":"R.A. Palmer","psa":"Professor Guy Goodwin","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4229763220","eid":"W4229763220"},{"id":"paper-w1993685224","cat":"papers","name":"Microdose intrauterine levonorgestrel for contraception","year":"1987","cit":24,"pfa":"Damrong Reinprayoon","psa":"Timothy M.M. Farley","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1993685224","eid":"W1993685224"},{"id":"paper-w2399939699","cat":"papers","name":"The Stimulus Effects of Serotonergic Hallucinogens in Animals","year":"1994","cit":24,"pfa":"Jerrold C. Winter","ptype":"dataset","src":"https://openalex.org/W2399939699","eid":"W2399939699"},{"id":"paper-w1548751499","cat":"papers","name":"Psychedelics and Religious Experience","year":"1968","cit":24,"pfa":"Alan W. Watts","ptype":"article","src":"https://openalex.org/W1548751499","eid":"W1548751499"},{"id":"paper-w4399525469","cat":"papers","name":"Psychological effects of psychedelics in adolescents","year":"2024","cit":24,"pfa":"Nadhrah Izmi","psa":"Hannes Kettner","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4399525469","eid":"W4399525469"},{"id":"paper-w2080783304","cat":"papers","name":"Microdose vasal injection of sodium fluoride in the rat","year":"1991","cit":24,"pfa":"N. J. Chinoy","psa":"Erumala Neelakanta","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2080783304","eid":"W2080783304"},{"id":"paper-w1998147745","cat":"papers","name":"The Seeds of the Hawaiian Baby Woodrose Are a Powerful Hallucinogen","year":"1999","cit":24,"pfa":"S. E. Al-Assmar","ptype":"article","src":"https://openalex.org/W1998147745","eid":"W1998147745"},{"id":"paper-w2030812816","cat":"papers","name":"Strange Fires, Weird Smokes and Psychoactive Combustibles: Entheogens and Incense in Ancient Traditions","year":"2010","cit":24,"pfa":"Frederick R. Dannaway","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2030812816","eid":"W2030812816"},{"id":"paper-w1975830641","cat":"papers","name":"Psychedelic, Baby: An Interview with Pipilotti Rist","year":"2000","cit":24,"pfa":"Jane Harris","ptype":"article","src":"https://openalex.org/W1975830641","eid":"W1975830641"},{"id":"paper-w109862653","cat":"papers","name":"Effects of a microdose of medetomidine on diazepam-ketamine induced anesthesia in dogs","year":"1998","cit":24,"pfa":"Jeff C. Ko","psa":"Christopher D. Kuonen","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W109862653","eid":"W109862653"},{"id":"paper-w4285890909","cat":"papers","name":"The illusion of knowledge in the emerging field of psychedelic research","year":"2022","cit":24,"pfa":"Genís Oña","psa":"José Carlos Bouso","ptype":"article","src":"https://openalex.org/W4285890909","eid":"W4285890909"},{"id":"paper-w4378472787","cat":"papers","name":"Transpersonal Ecodelia: Surveying Psychedelically Induced Biophilia","year":"2023","cit":24,"pfa":"Alexander Irvine","psa":"Rosalind Watts","ptype":"article","src":"https://openalex.org/W4378472787","eid":"W4378472787"},{"id":"paper-w2117937229","cat":"papers","name":"LSD and phenithylamine hallucinogens: New structural analogy and implications for receptor geometry","year":"1978","cit":24,"pfa":"David E. Nichols","psa":"George K. W. Yim","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2117937229","eid":"W2117937229"},{"id":"paper-w4404345667","cat":"papers","name":"Emergency Department Visits Involving Hallucinogen Use and Risk of Schizophrenia Spectrum Disorder","year":"2024","cit":24,"pfa":"Daniel Thomas Myran","psa":"Marco Solmi","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4404345667","eid":"W4404345667"},{"id":"paper-w4303497403","cat":"papers","name":"Microdosing: Old Wine in a New Bottle? Current State of Affairs and Future Avenues","year":"2022","cit":24,"pfa":"José Afonso","psa":"Pedro Figueiredo","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4303497403","eid":"W4303497403"},{"id":"paper-w4220687484","cat":"papers","name":"Language as a Window Into the Altered State of Consciousness Elicited by Psychedelic Drugs","year":"2022","cit":24,"pfa":"Enzo Tagliazucchi","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4220687484","eid":"W4220687484"},{"id":"paper-w3204295756","cat":"papers","name":"Co-design of Guidance for Patient and Public Involvement in Psychedelic Research","year":"2021","cit":24,"pfa":"James B. Close","psa":"Meg J. Spriggs","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3204295756","eid":"W3204295756"},{"id":"paper-w3034516025","cat":"papers","name":"Microdose lithium reduces cellular senescence in human astrocytes - a potential pharmacotherapy for COVID-19?","year":"2020","cit":24,"pfa":"Tânia Araújo Viel","psa":"Julie Kay Andersen","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3034516025","eid":"W3034516025"},{"id":"paper-w2553572179","cat":"papers","name":"Microdose fluorescence imaging of ABY-029 on an operating microscope adapted by custom illumination and imaging modules","year":"2016","cit":24,"pfa":"Jonathan Thomas Elliott","psa":"Keith D. Paulsen","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2553572179","eid":"W2553572179"},{"id":"paper-w2074499868","cat":"papers","name":"Human in Vivo Pharmacokinetics of [14C]Dibenzo[def,p]chrysene by Accelerator Mass Spectrometry Following Oral Microdosing","year":"2014","cit":24,"pfa":"Erin P. Madeen","psa":"David E. Williams","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2074499868","eid":"W2074499868"},{"id":"paper-w4387580925","cat":"papers","name":"Back from the rabbit hole. Theoretical considerations and practical guidelines on psychedelic integration for mental health specialists","year":"2023","cit":24,"pfa":"Jakub Greń","psa":"Csaba Kiraly","topics":["Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4387580925","eid":"W4387580925"},{"id":"paper-w4396736384","cat":"papers","name":"Microdosing Plyometric Training Enhances Jumping Performance, Reactive Strength Index, and Acceleration among Youth Soccer Players: A Randomized Controlled Study Design","year":"2024","cit":24,"pfa":"Guiyang Liu","psa":"Qi Xu","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4396736384","eid":"W4396736384"},{"id":"paper-w1536104249","cat":"papers","name":"Structure-activity correlations for psychotomimetics","year":"1993","cit":24,"pfa":"Brian W. Clare","ptype":"article","src":"https://openalex.org/W1536104249","eid":"W1536104249"},{"id":"paper-w2093888629","cat":"papers","name":"STUDIES OF ANALGESIC DRUGS. VIII. A NARCOTIC ANTAGONIST ANALGESIC WITHOUT PSYCHOTOMIMETIC EFFECTS","year":"1965","cit":24,"pfa":"Arthur S. Keats","psa":"Louis R. Orkin","ptype":"article","src":"https://openalex.org/W2093888629","eid":"W2093888629"},{"id":"paper-w2168208060","cat":"papers","name":"Psychotomimetic sigma‐ligands, dexoxadrol and phencyclidine block the same presynaptic potassium channel in rat brain.","year":"1988","cit":24,"pfa":"Dieter K. Bartschat","psa":"M. P. Blaustein","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2168208060","eid":"W2168208060"},{"id":"paper-w3004821160","cat":"papers","name":"Oxaliplatin–DNA Adducts as Predictive Biomarkers of FOLFOX Response in Colorectal Cancer: A Potential Treatment Optimization Strategy","year":"2020","cit":24,"pfa":"Maike Zimmermann","psa":"Paul T. Henderson","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3004821160","eid":"W3004821160"},{"id":"paper-w2765344168","cat":"papers","name":"Perceptions of the medicinal value of hallucinogenic drugs among college students","year":"2017","cit":24,"pfa":"Jared Wildberger","psa":"Robert M. Hallock","topics":["PTSD & trauma","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2765344168","eid":"W2765344168"},{"id":"paper-w3130291626","cat":"papers","name":"Serotonin 2A Receptor (5-HT2AR) Activation by 25H-NBOMe Positional Isomers: In Vitro Functional Evaluation and Molecular Docking","year":"2021","cit":24,"pfa":"Eline Pottie","psa":"Christophe Pol Stove","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3130291626","eid":"W3130291626"},{"id":"paper-w2014957252","cat":"papers","name":"Use of naltrexone in ketamine dependence","year":"2014","cit":24,"pfa":"Amit X. Garg","psa":"Om Prakash","ptype":"article","src":"https://openalex.org/W2014957252","eid":"W2014957252"},{"id":"paper-w4392986055","cat":"papers","name":"A Narrative Review of Current and Emerging Trends in the Treatment of Alcohol Use Disorder","year":"2024","cit":24,"pfa":"Muhammet A. Celik","psa":"Brian Fuehrlein","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4392986055","eid":"W4392986055"},{"id":"paper-w2290378019","cat":"papers","name":"Clinical Manual of Addiction Psychopharmacology","year":"2013","cit":24,"topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"book","src":"https://openalex.org/W2290378019","eid":"W2290378019"},{"id":"paper-w3205184644","cat":"papers","name":"TAK-653, an AMPA receptor potentiator with minimal agonistic activity, produces an antidepressant-like effect with a favorable safety profile in rats","year":"2021","cit":24,"pfa":"Hiroe Hara","psa":"Haruhide Kimura","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3205184644","eid":"W3205184644"},{"id":"paper-w1941492808","cat":"papers","name":"Perceptual distortions and delusional thinking following ketamine administration are related to increased pharmacological MRI signal changes in the parietal lobe","year":"2015","cit":24,"pfa":"James M. Stone","psa":"Mitul Ashok Mehta","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1941492808","eid":"W1941492808"},{"id":"paper-w2018905508","cat":"papers","name":"Superstitious conditioning as a model of delusion formation following chronic but not acute ketamine in humans","year":"2009","cit":24,"pfa":"Tom P. Freeman","psa":"Helen Valerie Curran","ptype":"article","src":"https://openalex.org/W2018905508","eid":"W2018905508"},{"id":"paper-w2502303980","cat":"papers","name":"Possible role of endorphins in schizophrenia and other psychiatric disorders","year":"1979","cit":24,"pfa":"Lars‐M. Gunne","psa":"Erik Widerlöv","topics":["Depression","Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W2502303980","eid":"W2502303980"},{"id":"paper-w3143870738","cat":"papers","name":"Lasting effects of ketamine and isoflurane administration on anxiety- and panic-like behavioral responses in Wistar rats","year":"2021","cit":24,"pfa":"Máira Tereza Talma Chírico","psa":"Rodrigo Cunha Alvim de Menezes","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3143870738","eid":"W3143870738"},{"id":"paper-w3147992258","cat":"papers","name":"GLYX-13 Ameliorates Schizophrenia-Like Phenotype Induced by MK-801 in Mice: Role of Hippocampal NR2B and DISC1","year":"2018","cit":24,"pfa":"Dongsheng Zhou","psa":"Chuang Wang","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3147992258","eid":"W3147992258"},{"id":"paper-w2467194962","cat":"papers","name":"Effects of ketamine on brain function during smooth pursuit eye movements","year":"2016","cit":24,"pfa":"Michael Steffens","psa":"Ulrich Ettinger","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2467194962","eid":"W2467194962"},{"id":"paper-w2100736333","cat":"papers","name":"Primate Phencyclidine Model of Schizophrenia: Sex-Specific Effects on Cognition, Brain Derived Neurotrophic Factor, Spine Synapses, and Dopamine Turnover in Prefrontal Cortex","year":"2014","cit":24,"pfa":"John D. Elsworth","psa":"R. H. Roth","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2100736333","eid":"W2100736333"},{"id":"paper-w613192830","cat":"papers","name":"NeuroPET: Positron Emission Tomography in Neuroscience and Clinical Neurology","year":"2004","cit":24,"pfa":"Karl Herholz","psa":"Wolf‐Dieter Heiss","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"book","src":"https://openalex.org/W613192830","eid":"W613192830"},{"id":"paper-w4400103485","cat":"papers","name":"The Future of Enhanced Psychotherapy: Towards Precision Psychotherapy","year":"2024","cit":24,"pfa":"Stephan Zipfel","psa":"Katrin E. Giel","topics":["PTSD & trauma","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4400103485","eid":"W4400103485"},{"id":"paper-w2998434856","cat":"papers","name":"The Effectiveness and Value of Esketamine for the Management of Treatment-Resistant Depression","year":"2019","cit":24,"pfa":"Foluso Agboola","psa":"Steven D. Pearson","topics":["Depression","Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2998434856","eid":"W2998434856"},{"id":"paper-w4415411808","cat":"papers","name":"Gender Differences in Suicidal and Self-Harming Responses to Esketamine: A Real-World Retrospective Study","year":"2025","cit":24,"pfa":"Vassilis Martiadis","psa":"Domenico De Berardis","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4415411808","eid":"W4415411808"},{"id":"paper-w4390010987","cat":"papers","name":"A systematic review and meta-analysis of the efficacy of ketamine and esketamine on suicidal ideation in treatment-resistant depression","year":"2023","cit":24,"pfa":"Yating Wang","psa":"Yi Zhang","topics":["Depression","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4390010987","eid":"W4390010987"},{"id":"paper-w4200187090","cat":"papers","name":"Safety concerns on the abuse potential of esketamine: Multidimensional analysis of a new anti‐depressive drug on the market","year":"2021","cit":24,"pfa":"Jules Baudot","psa":"Joëlle Micallef","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4200187090","eid":"W4200187090"},{"id":"paper-w4384663661","cat":"papers","name":"Median effective dose (ED50) of esketamine combined with propofol for children to inhibit response of gastroscope insertion","year":"2023","cit":24,"pfa":"Ming Su","psa":"Quanyi Zhang","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4384663661","eid":"W4384663661"},{"id":"paper-w4320881661","cat":"papers","name":"Beneficial effects of arketamine on the reduced bone mineral density in susceptible mice after chronic social defeat stress: Role of the gut–microbiota–bone–brain axis","year":"2023","cit":24,"pfa":"Xiayun Wan","psa":"Kenji Hashimoto","ptype":"article","src":"https://openalex.org/W4320881661","eid":"W4320881661"},{"id":"paper-w4385662287","cat":"papers","name":"Comparison of propofol-esketamine versus propofol for anesthesia in gastroscopy: a double-blind, randomized controlled clinical trial","year":"2023","cit":24,"pfa":"Xiaoli Liu","psa":"Shaohui Zhuang","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4385662287","eid":"W4385662287"},{"id":"paper-w4380052437","cat":"papers","name":"Perioperative Administration of Pregabalin and Esketamine to Prevent Chronic Pain After Breast Cancer Surgery: A Randomized Controlled Trial","year":"2023","cit":24,"pfa":"Miao Wang","psa":"Qing-Ren Liu","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4380052437","eid":"W4380052437"},{"id":"paper-w4380991121","cat":"papers","name":"Comparing fast-acting interventions for treatment-resistant depression: An explorative study of accelerated HF-rTMS versus intranasal esketamine","year":"2023","cit":24,"pfa":"Mauro Pettorruso","psa":"Luca Carlone","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4380991121","eid":"W4380991121"},{"id":"paper-w2909560529","cat":"papers","name":"Comparability of blinded remote and site-based assessments of response to adjunctive esketamine or placebo nasal spray in patients with treatment resistant depression","year":"2019","cit":24,"pfa":"Steven D. Targum","psa":"Jaskaran B. Singh","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2909560529","eid":"W2909560529"},{"id":"paper-w4385694402","cat":"papers","name":"Efficacy and Safety of Esketamine Nasal Spray in Patients with Treatment-Resistant Depression Who Completed a Second Induction Period: Analysis of the Ongoing SUSTAIN-3 Study","year":"2023","cit":24,"pfa":"Meredith Castro","psa":"Patricia Cabrera","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4385694402","eid":"W4385694402"},{"id":"paper-w4210596400","cat":"papers","name":"Long-term Safety and Efficacy of Esketamine Nasal Spray Plus an Oral Antidepressant in Patients with Treatment-resistant Depression– an Asian Sub-group Analysis from the SUSTAIN-2 Study","year":"2022","cit":24,"pfa":"Hong Jin Jeon","psa":"Cheng‐Ta Li","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4210596400","eid":"W4210596400"},{"id":"paper-w4401830079","cat":"papers","name":"Esketamine vs. placebo combined with erector spinae plane block vs. intercostal nerve block on quality of recovery following thoracoscopic lung resection: a randomized controlled factorial trial","year":"2024","cit":24,"pfa":"Jing-Hui Hu","psa":"Ke Peng","ptype":"article","src":"https://openalex.org/W4401830079","eid":"W4401830079"},{"id":"paper-w4313655310","cat":"papers","name":"Intraoperative Intravenous Infusion of Esmketamine Has Opioid-Sparing Effect and Improves the Quality of Recovery in Patients Undergoing Thoracic Surgery: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.","year":"2022","cit":24,"pfa":"Jingjing Yuan","psa":"Xiaochong Fan","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4313655310","eid":"W4313655310"},{"id":"paper-w4307900260","cat":"papers","name":"Roles of the monoaminergic system in the antidepressant effects of ketamine and its metabolites","year":"2022","cit":24,"pfa":"Yukio Ago","psa":"Hitoshi Hashimoto","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4307900260","eid":"W4307900260"},{"id":"paper-w2558281515","cat":"papers","name":"Ketamine Mechanism of Action: Separating the Wheat from the Chaff","year":"2016","cit":24,"pfa":"Todd D. Gould","psa":"Carlos A. Zarate","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2558281515","eid":"W2558281515"},{"id":"paper-w3193921820","cat":"papers","name":"Consistently Modest Antidepressant Effects in Clinical Trials: the Role of Regulatory Requirements","year":"2025","cit":24,"pfa":"Arif Khan","psa":"Walter A. Brown","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3193921820","eid":"W3193921820"},{"id":"paper-w4401934571","cat":"papers","name":"Ketamine and Major Ketamine Metabolites Function as Allosteric Modulators of Opioid Receptors","year":"2024","cit":24,"pfa":"Ivone Gomes","psa":"Lakshmi A. Devi","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4401934571","eid":"W4401934571"},{"id":"paper-w4310477946","cat":"papers","name":"Intranasal (R, S)-ketamine delivery induces sustained antidepressant effects associated with changes in cortical balance of excitatory/inhibitory synaptic activity","year":"2022","cit":24,"pfa":"Thi Mai Loan Nguyen","psa":"Alain Michel Gardier","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4310477946","eid":"W4310477946"},{"id":"paper-w2018697268","cat":"papers","name":"Structure-activity-relationships of certain hallucinogenic substances based on brain levels","year":"1977","cit":24,"pfa":"Wolfgang H Vogel","psa":"B D Evans","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2018697268","eid":"W2018697268"},{"id":"paper-w2014882533","cat":"papers","name":"Evaluation of Teratogenicity of Lysergic Acid Diethylamide","year":"1968","cit":23,"pfa":"Joseph A. DiPaolo","psa":"HOWARD ERWIN","ptype":"article","src":"https://openalex.org/W2014882533","eid":"W2014882533"},{"id":"paper-w2074988531","cat":"papers","name":"THE PRESERVATION OF SUBSTANCE P BY LYSERGIC ACID DIETHYLAMIDE","year":"1957","cit":23,"pfa":"William A. Krivoy","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2074988531","eid":"W2074988531"},{"id":"paper-w2081181396","cat":"papers","name":"Studies on Lysergic Acid Diethylamide (LSD-25)","year":"1959","cit":23,"pfa":"Harris Isbell","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2081181396","eid":"W2081181396"},{"id":"paper-w2083198549","cat":"papers","name":"Studies in the Effects of Lysergic Acid Diethylamide (LSD-25)","year":"1957","cit":23,"pfa":"Robert S. Liebert","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2083198549","eid":"W2083198549"},{"id":"paper-w2070754666","cat":"papers","name":"Modulation of morphine-induced antinociception by ibogaine and noribogaine","year":"1996","cit":23,"pfa":"A.A. Bagal","psa":"S.D. Glick","ptype":"article","src":"https://openalex.org/W2070754666","eid":"W2070754666"},{"id":"paper-w2087798895","cat":"papers","name":"Lysergic Acid Diethylamide: Effect on Histone Acetylation in Rabbit Brain","year":"1975","cit":23,"pfa":"Ian R. Brown","psa":"C.C. Liew","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2087798895","eid":"W2087798895"},{"id":"paper-w2322990050","cat":"papers","name":"Lysergic Acid Diethylamide (LSD) Binding to Deoxyribonucleic Acid (DNA)","year":"1968","cit":23,"pfa":"K. L. Yielding","psa":"H. Sterglanz","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2322990050","eid":"W2322990050"},{"id":"paper-w4409659312","cat":"papers","name":"Exploring 5-MeO-DMT as a pharmacological model for deconstructed consciousness","year":"2025","cit":23,"pfa":"Christopher B. Timmermann","psa":"Malin Vedøy Uthaug","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4409659312","eid":"W4409659312"},{"id":"paper-w2024182754","cat":"papers","name":"Lysergic acid diethylamide block of lateral geniculate synapses and relief by repetitive stimulation","year":"1959","cit":23,"pfa":"P. O. Bishop","psa":"W.R. Hayhow","ptype":"article","src":"https://openalex.org/W2024182754","eid":"W2024182754"},{"id":"paper-w1995073666","cat":"papers","name":"Binding of d-Lysergic Acid Diethylamide to Subcellular Fractions from Rat Brain","year":"1972","cit":23,"pfa":"John T. Farrow","psa":"Helen Van Vunakis","ptype":"article","src":"https://openalex.org/W1995073666","eid":"W1995073666"},{"id":"paper-w2031439239","cat":"papers","name":"Studies on Lysergic Acid Diethylamide and Related Compounds.II.Mass Spectra of Lysergic Acid Derivatives","year":"1972","cit":23,"pfa":"TAKAKO INOUE","psa":"Tetsukichi Niwaguchi","ptype":"article","src":"https://openalex.org/W2031439239","eid":"W2031439239"},{"id":"paper-w4254288387","cat":"papers","name":"Effect of Intravenous Administration of d‐Lysergic Acid Diethylamide on Subsequent Protein Synthesis in a Cell‐Free System Derived from Brain","year":"1981","cit":23,"pfa":"James W. Cosgrove","psa":"Ian R. Brown","ptype":"article","src":"https://openalex.org/W4254288387","eid":"W4254288387"},{"id":"paper-w2100323979","cat":"papers","name":"Cross tolerance between d-2-brom-lysergic acid diethylamide (BOL-148) and the d-diethylamide of lysergic acid (LSD-25)","year":"1959","cit":23,"pfa":"Harris Isbell","psa":"C. R. Logan","ptype":"article","src":"https://openalex.org/W2100323979","eid":"W2100323979"},{"id":"paper-w4252518069","cat":"papers","name":"Correction: Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels","year":"2019","cit":23,"pfa":"Martin Korsbak Madsen","psa":"Gitte M. Knudsen","topics":["Mechanism & neuroscience"],"ptype":"erratum","src":"https://openalex.org/W4252518069","eid":"W4252518069"},{"id":"paper-w2430281846","cat":"papers","name":"Peyote: an introduction.","year":"1973","cit":23,"pfa":"McLaughlin Jl","ptype":"article","src":"https://openalex.org/W2430281846","eid":"W2430281846"},{"id":"paper-w4403065700","cat":"papers","name":"The Psychotherapy in MDMA-Assisted Psychotherapy","year":"2024","cit":23,"pfa":"Ioana A. Cristea","psa":"Joar Øveraas Halvorsen","topics":["PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4403065700","eid":"W4403065700"},{"id":"paper-w2038073864","cat":"papers","name":"Intramolecular Transacetylation in Salvinorins D and E","year":"2010","cit":23,"pfa":"Lukasz M. Kutrzeba","psa":"Jordan Kordian Zjawiony","ptype":"article","src":"https://openalex.org/W2038073864","eid":"W2038073864"},{"id":"paper-w2114512292","cat":"papers","name":"The Comparative Psychopharmacology of Some Mescaline Analogues","year":"1960","cit":23,"pfa":"John Smythies","psa":"C. K. Levy","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2114512292","eid":"W2114512292"},{"id":"paper-w4243484198","cat":"papers","name":"A Qualitative Study of Intention and Impact of Ayahuasca Use by Westerners","year":"2021","cit":23,"pfa":"Geoff J. Bathje","psa":"London Hill","topics":["Addiction","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4243484198","eid":"W4243484198"},{"id":"paper-w1998594575","cat":"papers","name":"Certain Effects of Mescaline and Lysergic Acid on Psychological Functions","year":"1954","cit":23,"pfa":"Carney Landis","psa":"Johs. Clausen","ptype":"article","src":"https://openalex.org/W1998594575","eid":"W1998594575"},{"id":"paper-w1545044925","cat":"papers","name":"O uso ritual da ayahuasca","year":"2003","cit":23,"pfa":"Beatriz Caiuby Labate","psa":"Congresso sobre o Uso Ritual da Ayahuasca","ptype":"article","src":"https://openalex.org/W1545044925","eid":"W1545044925"},{"id":"paper-w1974770964","cat":"papers","name":"Synthesis and biological evaluation of C-2 halogenated analogs of salvinorin A","year":"2010","cit":23,"pfa":"David Y.W. Lee","psa":"Lee‐Yuan Liu‐Chen","ptype":"article","src":"https://openalex.org/W1974770964","eid":"W1974770964"},{"id":"paper-w3096115014","cat":"papers","name":"Anti-inflammatory activity of ayahuasca: therapeutical implications in neurological and psychiatric diseases","year":"2020","cit":23,"pfa":"Marina Goulart da Silva","psa":"Rafael Mariano de Bitencourt","ptype":"article","src":"https://openalex.org/W3096115014","eid":"W3096115014"},{"id":"paper-w22242602","cat":"papers","name":"Long-Lasting Ibogaine Protection against NMDA-Induced Convulsions in Mice","year":"2000","cit":23,"pfa":"Mirna Bainy Leal","psa":"Elaine Elisabetsky","ptype":"article","src":"https://openalex.org/W22242602","eid":"W22242602"},{"id":"paper-w2093070630","cat":"papers","name":"Mescaline: excitatory effects on acoustic startle are blocked by serotonin2 antagonists","year":"1987","cit":23,"pfa":"M. Davis","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2093070630","eid":"W2093070630"},{"id":"paper-w2050711759","cat":"papers","name":"Effect of mescaline and L.S.D. on evoked responses especially of the optic system of the cat","year":"1956","cit":23,"pfa":"Piero Rovetta","ptype":"article","src":"https://openalex.org/W2050711759","eid":"W2050711759"},{"id":"paper-w1964397853","cat":"papers","name":"Ethnopsychedelic Therapy for Alcoholics: Observations In the Peyote Ritual of the Native American Church","year":"1976","cit":23,"pfa":"Paul Pascarosa","psa":"Sanford Futterman","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1964397853","eid":"W1964397853"},{"id":"paper-w1979816563","cat":"papers","name":"Effect of ibogaine on serotonergic and dopaminergic interactions in striatum from mice and rats","year":"1994","cit":23,"pfa":"Henry W. Sershen","psa":"Ábel Lajtha","ptype":"article","src":"https://openalex.org/W1979816563","eid":"W1979816563"},{"id":"paper-w2071735895","cat":"papers","name":"Synthesis and biological evaluation of C-12 triazole and oxadiazole analogs of salvinorin A","year":"2009","cit":23,"pfa":"Yang Lü","psa":"David Y.W. Lee","ptype":"article","src":"https://openalex.org/W2071735895","eid":"W2071735895"},{"id":"paper-w109817618","cat":"papers","name":"5-Methoxy-N,N-dimethyltryptamine: behavioral and toxicological effects in animals.","year":"1976","cit":23,"pfa":"J. Christian Gillin","psa":"Richard Jed Wyatt","ptype":"article","src":"https://openalex.org/W109817618","eid":"W109817618"},{"id":"paper-w2056609017","cat":"papers","name":"N,N-dimethyltryptamine lowers rat brain acetylcholine and dopamine","year":"1977","cit":23,"pfa":"Dean R. Haubrich","psa":"Paulina F.L. Wang","ptype":"article","src":"https://openalex.org/W2056609017","eid":"W2056609017"},{"id":"paper-w2998157771","cat":"papers","name":"Reflections on crafting an ayahuasca community guide for the awareness of sexual abuse","year":"2020","cit":23,"pfa":"Daniela M. Peluso","psa":"Clancy Cavnar","ptype":"article","src":"https://openalex.org/W2998157771","eid":"W2998157771"},{"id":"paper-w2077798462","cat":"papers","name":"Lipophilicity and serotonin agonist activity in a series of 4-substituted mescaline analogs","year":"1977","cit":23,"pfa":"David E. Nichols","psa":"Donald C. Dyer","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2077798462","eid":"W2077798462"},{"id":"paper-w2092704471","cat":"papers","name":"Ibogaine Signals Addiction Genes and Methamphetamine Alteration of Long‐Term Potentiation","year":"2002","cit":23,"pfa":"Emmanuel Shan Onaivi","psa":"Hiroki Ishiguro","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2092704471","eid":"W2092704471"},{"id":"paper-w2094931654","cat":"papers","name":"Reinforcement schedule effects in rats trained to discriminate 3,4-methylenedioxymethamphetamine (MDMA) or cocaine","year":"2006","cit":23,"pfa":"Daniel Kueh","psa":"Lisa E. Baker","ptype":"article","src":"https://openalex.org/W2094931654","eid":"W2094931654"},{"id":"paper-w4405510726","cat":"papers","name":"Psilocybin increases emotional empathy in patients with major depression","year":"2024","cit":23,"pfa":"Johannes Jungwirth","psa":"Katrin H. Preller","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4405510726","eid":"W4405510726"},{"id":"paper-w2001334856","cat":"papers","name":"Analysis of Salvinorin A in Urine Using Microextraction in Packed Syringe and GC–MS/MS","year":"2013","cit":23,"pfa":"Ivo Moreno","psa":"Eugénia Gallardo","ptype":"article","src":"https://openalex.org/W2001334856","eid":"W2001334856"},{"id":"paper-w4403450928","cat":"papers","name":"Psilocybin and the glutamatergic pathway: implications for the treatment of neuropsychiatric diseases","year":"2024","cit":23,"pfa":"Izabela Szpręgiel","psa":"Agnieszka Bysiek","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4403450928","eid":"W4403450928"},{"id":"paper-w2963533857","cat":"papers","name":"Soma and Haoma: Ayahuasca analogues from the Late Bronze Age","year":"2019","cit":23,"pfa":"Matthew Clark","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2963533857","eid":"W2963533857"},{"id":"paper-w2795995498","cat":"papers","name":"A Validated NMR Approach for MDMA Quantification in Ecstasy Tablets","year":"2018","cit":23,"pfa":"Nathália Siqueira Almeida","psa":"Aline Oliveira","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2795995498","eid":"W2795995498"},{"id":"paper-w2027463370","cat":"papers","name":"DPP IV inhibitor blocks mescaline-induced scratching and amphetamine-induced hyperactivity in mice","year":"2005","cit":23,"pfa":"Susan L. Lautar","psa":"Sergei A. Belyakov","ptype":"article","src":"https://openalex.org/W2027463370","eid":"W2027463370"},{"id":"paper-w4399215777","cat":"papers","name":"Protocols and practices in psilocybin assisted psychotherapy for depression: A systematic review","year":"2024","cit":23,"pfa":"Noah Chisamore","psa":"Joshua Daniel Rosenblat","topics":["Depression","Reviews & meta-analyses","Therapy practice"],"ptype":"review","src":"https://openalex.org/W4399215777","eid":"W4399215777"},{"id":"paper-w2131029789","cat":"papers","name":"Selection and Optimization of Hydrolysis Conditions for the Quantification of Urinary Metabolites of MDMA","year":"2006","cit":23,"pfa":"Stéphane Pirnay","psa":"Marilyn Ann Huestis","ptype":"article","src":"https://openalex.org/W2131029789","eid":"W2131029789"},{"id":"paper-w2157312060","cat":"papers","name":"Distribution of Methylenedioxymethamphetamine (MDMA) and Methylenedioxyamphetamine (MDA) in Postmortem and Antemortem Specimens","year":"2006","cit":23,"pfa":"R. H. Liu","psa":"Dongliang Lin","ptype":"article","src":"https://openalex.org/W2157312060","eid":"W2157312060"},{"id":"paper-w2049823315","cat":"papers","name":"MDMA Induces Caspase‐3 Activation in the Limbic System but not in Striatum","year":"2006","cit":23,"pfa":"Ilaria Tamburini","psa":"Francesco Fornai","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2049823315","eid":"W2049823315"},{"id":"paper-w2069637105","cat":"papers","name":"Hyperthermic and neurotoxic effect of 3,4-methylenedioxymethamphetamine (MDMA) in guinea pigs","year":"2004","cit":23,"pfa":"A. Richard Green","psa":"María Isabel Colado","ptype":"article","src":"https://openalex.org/W2069637105","eid":"W2069637105"},{"id":"paper-w1995682553","cat":"papers","name":"A Versatile Linkage Strategy for Solid-Phase Synthesis of N,N-Dimethyltryptamines and β-Carbolines","year":"2002","cit":23,"pfa":"Tom Y.-H. Wu","psa":"Peter G. Schultz","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1995682553","eid":"W1995682553"},{"id":"paper-w4387651512","cat":"papers","name":"Psilocybin, an Effective Treatment for Major Depressive Disorder in Adults - A Systematic Review","year":"2023","cit":23,"pfa":"Tessa Bo Watford","psa":"Naqash Masood","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W4387651512","eid":"W4387651512"},{"id":"paper-w2069096005","cat":"papers","name":"Distribution of the hallucinogens N,N-dimethyltryptamine and 5-methoxy-N,N-dimethyltryptamine in rat brain following intraperitoneal injection: application of a new solid-phase extraction LC–APcI–MS–MS–isotope dilution m","year":"2001","cit":23,"pfa":"Steven A. Barker","psa":"Connie M. David","ptype":"article","src":"https://openalex.org/W2069096005","eid":"W2069096005"},{"id":"paper-w4289316208","cat":"papers","name":"Development and validation of an LC-MS/MS method for the quantification of mescaline and major metabolites in human plasma","year":"2022","cit":23,"pfa":"Jan Thomann","psa":"Urs Duthaler","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4289316208","eid":"W4289316208"},{"id":"paper-w3211665760","cat":"papers","name":"Beyond the Psychoactive Effects of Ayahuasca: Cultural and Pharmacological Relevance of Its Emetic and Purging Properties","year":"2021","cit":23,"pfa":"Matteo Politi","psa":"Claudio Ferrante","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3211665760","eid":"W3211665760"},{"id":"paper-w3014008355","cat":"papers","name":"Direct Analysis of Psilocin and Muscimol in Urine Samples Using Single Drop Microextraction Technique In-Line with Capillary Electrophoresis","year":"2020","cit":23,"pfa":"Anna Poliwoda","psa":"Piotr Paweł Wieczorek","ptype":"article","src":"https://openalex.org/W3014008355","eid":"W3014008355"},{"id":"paper-w27340239","cat":"papers","name":"Neurotoxische Langzeitschäden bei Ecstasy (MDMA)-KonsumentenÜberblick über den aktuellen Wissensstand","year":"2002","cit":23,"pfa":"Euphrosyne Gouzoulis‐Mayfrank","psa":"Henning Saß","ptype":"article","src":"https://openalex.org/W27340239","eid":"W27340239"},{"id":"paper-w1983207330","cat":"papers","name":"MDMA (Ecstasy) association with impaired fMRI BOLD thalamic coherence and functional connectivity","year":"2011","cit":23,"pfa":"Ronald M. Salomon","psa":"Ronald L. Cowan","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1983207330","eid":"W1983207330"},{"id":"paper-w1996001397","cat":"papers","name":"Microinjection of muscimol into the dorsomedial hypothalamus suppresses MDMA-evoked sympathetic and behavioral responses","year":"2008","cit":23,"pfa":"Daniel E. Rusyniak","psa":"Joseph A. DiMicco","ptype":"article","src":"https://openalex.org/W1996001397","eid":"W1996001397"},{"id":"paper-w2118236406","cat":"papers","name":"LABATE, Beatriz Caiuby. 2004. A Reinvenção do Uso da Ayahuasca nos Centros Urbanos","year":"2005","cit":23,"pfa":"Marcelo Simão Mercante","ptype":"article","src":"https://openalex.org/W2118236406","eid":"W2118236406"},{"id":"paper-w2040261381","cat":"papers","name":"MDMA impairs mitochondrial neuronal trafficking in a Tau- and Mitofusin2/Drp1-dependent manner","year":"2014","cit":23,"pfa":"Daniel José Barbosa","psa":"Eduardo Soriano","ptype":"article","src":"https://openalex.org/W2040261381","eid":"W2040261381"},{"id":"paper-w4388126439","cat":"papers","name":"The unique neural signature of your trip: Functional connectome fingerprints of subjective psilocybin experience","year":"2023","cit":23,"pfa":"Hanna M. Tolle","psa":"Enrico Amico","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4388126439","eid":"W4388126439"},{"id":"paper-w2025934263","cat":"papers","name":"Constrasting effects of dopaminergic blockade on MDMA and d-amphetamine conditioned taste aversions","year":"1994","cit":23,"pfa":"Hui Qiang Lin","psa":"David M. Jackson","ptype":"article","src":"https://openalex.org/W2025934263","eid":"W2025934263"},{"id":"paper-w2060767773","cat":"papers","name":"MDMA-like stimulus effects of α-ethyltryptamine and the α-ethyl homolog of DOM","year":"1993","cit":23,"pfa":"Richard A. Glennon","ptype":"article","src":"https://openalex.org/W2060767773","eid":"W2060767773"},{"id":"paper-w1543635881","cat":"papers","name":"Inhibition of MDMA ‐induced increase in cortisol does not prevent acute impairment of verbal memory","year":"2012","cit":23,"pfa":"Kim P. C. Kuypers","psa":"JG Ramaekers","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1543635881","eid":"W1543635881"},{"id":"paper-w4389895437","cat":"papers","name":"Acceptability of psilocybin‐assisted group therapy in patients with cancer and major depressive disorder: Qualitative analysis","year":"2023","cit":23,"pfa":"Yvan Beaussant","psa":"Manish Agrawal","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4389895437","eid":"W4389895437"},{"id":"paper-w4220791846","cat":"papers","name":"Enlightening the “Spirit Molecule”: Photomodulation of the 5‐HT 2A Receptor by a Light‐Controllable N , N ‐Dimethyltryptamine Derivative","year":"2022","cit":23,"pfa":"Hubert Gerwe","psa":"Michael W. Decker","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4220791846","eid":"W4220791846"},{"id":"paper-w2155113343","cat":"papers","name":"MDMA‐evoked changes in cerebral blood flow in living porcine brain: Correlation with hyperthermia","year":"2004","cit":23,"pfa":"Pedro Rosa‐Neto","psa":"Paul D. Cumming","topics":["Safety & adverse events","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2155113343","eid":"W2155113343"},{"id":"paper-w2508048853","cat":"papers","name":"Sex differences in abuse-related neurochemical and behavioral effects of 3,4-methylenedioxymethamphetamine (MDMA) in rats","year":"2016","cit":23,"pfa":"Matthew F. Lazenka","psa":"Sidney Stevens Negus","ptype":"article","src":"https://openalex.org/W2508048853","eid":"W2508048853"},{"id":"paper-w2278182720","cat":"papers","name":"Adaptive Plasticity in the Hippocampus of Young Mice Intermittently Exposed to MDMA Could Be the Origin of Memory Deficits","year":"2015","cit":23,"pfa":"Sònia Abad","psa":"Elena Escubedo","ptype":"article","src":"https://openalex.org/W2278182720","eid":"W2278182720"},{"id":"paper-w3043557033","cat":"papers","name":"Ayahuasca blocks the reinstatement of methylphenidate-induced conditioned place preference in mice: behavioral and brain Fos expression evaluations","year":"2020","cit":23,"pfa":"Henrique Sousa Reis","psa":"E.A.V. Marinho","ptype":"article","src":"https://openalex.org/W3043557033","eid":"W3043557033"},{"id":"paper-w2441731579","cat":"papers","name":"MDMA- and p-chlorophenylalanine-induced reduction in 5-HT concentrations: effects on serotonin transporter densities","year":"2004","cit":23,"pfa":"George A. Ricaurte","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2441731579","eid":"W2441731579"},{"id":"paper-w1999899804","cat":"papers","name":"3,4-Methylenedioxymethamphetamine (MDMA, ecstasy)-induced egr-1 mRNA in rat brain: pharmacological manipulation","year":"2000","cit":23,"pfa":"Yukihiko Shirayama","psa":"Yoshio Minabe","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1999899804","eid":"W1999899804"},{"id":"paper-w4404043063","cat":"papers","name":"The conceptual framework for the therapeutic approach used in phase 3 trials of MDMA-assisted therapy for PTSD","year":"2024","cit":23,"pfa":"Kelley C. O’Donnell","psa":"Marcela Ot’alora G.","topics":["PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4404043063","eid":"W4404043063"},{"id":"paper-w2068950939","cat":"papers","name":"MDMA (ecstasy) delays pubertal development and alters sperm quality after developmental exposure in the rat","year":"2010","cit":23,"pfa":"Marta Barenys","psa":"J.M. Llobet","ptype":"article","src":"https://openalex.org/W2068950939","eid":"W2068950939"},{"id":"paper-w2925154057","cat":"papers","name":"Lack of Rhes Increases MDMA-Induced Neuroinflammation and Dopamine Neuron Degeneration: Role of Gender and Age","year":"2019","cit":23,"pfa":"Giulia Costa","psa":"Micaela Morelli","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2925154057","eid":"W2925154057"},{"id":"paper-w2095399080","cat":"papers","name":"Serotonin Syndrome, Disseminated Intravascular Coagulation, and Hepatitis After a Single Ingestion of MDMA in an Asian Woman","year":"2012","cit":23,"pfa":"Girish N. Nadkarni","psa":"Narender Annapureddy","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2095399080","eid":"W2095399080"},{"id":"paper-w2285475136","cat":"papers","name":"Ecstasy (MDMA) Alters Cardiac Gene Expression and DNA Methylation: Implications for Circadian Rhythm Dysfunction in the Heart","year":"2015","cit":23,"pfa":"Christopher A. Koczor","psa":"William Lewis","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2285475136","eid":"W2285475136"},{"id":"paper-w2050988442","cat":"papers","name":"Perceived adverse consequences associated with MDMA/Ecstasy use among young polydrug users in Ohio: implications for intervention","year":"2004","cit":23,"pfa":"Robert Gideon Carlson","psa":"Raminta Daniulaityte","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2050988442","eid":"W2050988442"},{"id":"paper-w3006954083","cat":"papers","name":"Correction to: Toxicity of ayahuasca after 28 days daily exposure and effects on monoamines and brain-derived neurotrophic factor (BDNF) in brain of Wistar rats","year":"2021","cit":23,"pfa":"Camila Schoueri Colaço","psa":"Eloísa Dutra Caldas","topics":["Safety & adverse events"],"ptype":"erratum","src":"https://openalex.org/W3006954083","eid":"W3006954083"},{"id":"paper-w2103350892","cat":"papers","name":"Effects of ethanol and 3,4-methylenedioxymethamphetamine (MDMA) alone or in combination on spontaneous and evoked overflow of dopamine, serotonin and acetylcholine in striatal slices of the rat brain","year":"2008","cit":23,"pfa":"Céline Riegert","psa":"Rolf Jackisch","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2103350892","eid":"W2103350892"},{"id":"paper-w2005732976","cat":"papers","name":"Ultrastructural characterization of tryptophan hydroxylase 2-specific cortical serotonergic fibers and dorsal raphe neuronal cell bodies after MDMA treatment in rat","year":"2010","cit":23,"pfa":"Csaba Ádori","psa":"György Bagdy","ptype":"article","src":"https://openalex.org/W2005732976","eid":"W2005732976"},{"id":"paper-w1981893132","cat":"papers","name":"Neonatal 3,4-methylenedioxymethamphetamine (MDMA) exposure alters neuronal protein kinase A activity, serotonin and dopamine content, and [35S]GTPγS binding in adult rats","year":"2006","cit":23,"pfa":"Cynthia A. Crawford","psa":"Charles V. Vorhees","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1981893132","eid":"W1981893132"},{"id":"paper-w4396223530","cat":"papers","name":"In the new era of psychedelic assisted therapy: A systematic review of study methodology in randomized controlled trials","year":"2024","cit":23,"pfa":"Paul Soliman","psa":"Carolina L. Haass‐Koffler","topics":["Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4396223530","eid":"W4396223530"},{"id":"paper-w2015375291","cat":"papers","name":"Acute Leukemia With Ph1-Like Chromosome in an LSD User","year":"1968","cit":23,"pfa":"Lionel Grossbard","ptype":"article","src":"https://openalex.org/W2015375291","eid":"W2015375291"},{"id":"paper-w1602251379","cat":"papers","name":"Antagonism of the lsd cue by putative serotonin antagonists","year":"1985","cit":23,"pfa":"Erik B. Nielsen","psa":"James B. Appel","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1602251379","eid":"W1602251379"},{"id":"paper-w2011691740","cat":"papers","name":"Molecular Structure of LSD","year":"1972","cit":23,"pfa":"Roy W. Baker","psa":"Hans Peter Weber","ptype":"article","src":"https://openalex.org/W2011691740","eid":"W2011691740"},{"id":"paper-w2059599782","cat":"papers","name":"LSD: No Teratogenic Action in Rats, Mice, and Hamsters","year":"1970","cit":23,"pfa":"C. Roux","psa":"M. Aubry","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2059599782","eid":"W2059599782"},{"id":"paper-w4388646562","cat":"papers","name":"Epidemiology of classic psychedelic substances: results from a Norwegian internet convenience sample","year":"2023","cit":23,"pfa":"Tor-Morten Kvam","psa":"Cato Grønnerød","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4388646562","eid":"W4388646562"},{"id":"paper-w1968279148","cat":"papers","name":"Monoamines and schizophrenia","year":"1990","cit":23,"pfa":"Göran Sedvall","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1968279148","eid":"W1968279148"},{"id":"paper-w1864708198","cat":"papers","name":"The Determination of Lysergide (LSD) in Urine by High-Performance Liquid Chromatography-Isotope Dilution Mass Spectrometry (IDMS)","year":"1999","cit":23,"pfa":"SA White","psa":"Kenneth S. Webb","ptype":"article","src":"https://openalex.org/W1864708198","eid":"W1864708198"},{"id":"paper-w2110193646","cat":"papers","name":"Hallucinogen Persisting Perception Disorder and Risk of Suicide","year":"2015","cit":23,"pfa":"Joy E. Brodrick","psa":"Brian G. Mitchell","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2110193646","eid":"W2110193646"},{"id":"paper-w160103081","cat":"papers","name":"DIRECT AND INDIRECT ACTIONS OF LSD, SEROTONIN AND RELATED COMPOUNDS ON SEROTONIN-CONTAINING NEURONS","year":"1973","cit":23,"pfa":"George K. Aghajanian","psa":"Henry James Haigler","topics":["Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W160103081","eid":"W160103081"},{"id":"paper-w4387372869","cat":"papers","name":"An open-label pilot trial assessing tolerability and feasibility of LSD microdosing in patients with major depressive disorder (LSDDEP1)","year":"2023","cit":23,"pfa":"Carina Joy Donegan","psa":"Suresh D Muthukumaraswamy","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4387372869","eid":"W4387372869"},{"id":"paper-w3155908906","cat":"papers","name":"MDLSD: study protocol for a randomised, double-masked, placebo-controlled trial of repeated microdoses of LSD in healthy volunteers","year":"2021","cit":23,"pfa":"Robin J. Murphy","psa":"Suresh D Muthukumaraswamy","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3155908906","eid":"W3155908906"},{"id":"paper-w2796238448","cat":"papers","name":"Cultural Neurophenomenology of Psychedelic Thought","year":"2018","cit":23,"pfa":"Michael Lifshitz","psa":"Laurence J. Kirmayer","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"book","src":"https://openalex.org/W2796238448","eid":"W2796238448"},{"id":"paper-w3116039714","cat":"papers","name":"Biased Ligands Differentially Shape the Conformation of the Extracellular Loop Region in 5-HT2B Receptors","year":"2020","cit":23,"pfa":"Katrin Denzinger","psa":"Marcel Bermúdez","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3116039714","eid":"W3116039714"},{"id":"paper-w2129761088","cat":"papers","name":"Epimerization Studies of LSD Using 1H Nuclear Magnetic Resonance (NMR) Spectroscopy","year":"1997","cit":23,"pfa":"Salvatore J. Salamone","psa":"R. S. Wu","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2129761088","eid":"W2129761088"},{"id":"paper-w2047426335","cat":"papers","name":"The neuropharmacology of prolactin secretion elicited by 3,4-methylenedioxymethamphetamine (“ecstasy”): A concurrent microdialysis and plasma analysis study","year":"2011","cit":23,"pfa":"Kevin Sean Murnane","psa":"LL Howell","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2047426335","eid":"W2047426335"},{"id":"paper-w2058237717","cat":"papers","name":"Study of metabolism of psychotomimetic indolealkylamines by rat tissue extracts using liquid chromatography","year":"1987","cit":23,"pfa":"Balvant R. Sitaram","psa":"W. R. McLeod","ptype":"article","src":"https://openalex.org/W2058237717","eid":"W2058237717"},{"id":"paper-w2035055624","cat":"papers","name":"On the role of tyrosine and peripheral metabolism in 3,4-methylenedioxymethamphetamine-induced serotonin neurotoxicity in rats","year":"2008","cit":23,"pfa":"Beatriz Goñi‐Allo","psa":"Norberto Aguirre","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2035055624","eid":"W2035055624"},{"id":"paper-w2161294654","cat":"papers","name":"Serotonin Reuptake Transporter Deficiency Modulates the Acute Thermoregulatory and Locomotor Activity Response to 3,4-(±)-Methylenedioxymethamphetamine, and Attenuates Depletions in Serotonin Levels in SERT-KO Rats","year":"2014","cit":23,"pfa":"Lucina E. Lizarraga","psa":"Terrence J. Monks","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2161294654","eid":"W2161294654"},{"id":"paper-w4319081635","cat":"papers","name":"Hofmann vs. Paracelsus: Do Psychedelics Defy the Basics of Toxicology?—A Systematic Review of the Main Ergolamines, Simple Tryptamines, and Phenylethylamines","year":"2023","cit":23,"pfa":"Luis Alberto Henríquez‐Hernández","psa":"Lucas F. Borkel","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W4319081635","eid":"W4319081635"},{"id":"paper-w1981546407","cat":"papers","name":"Current Status and Future Trends in Psychedelic (LSD) Research","year":"1965","cit":23,"pfa":"Robert E. Mogar","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1981546407","eid":"W1981546407"},{"id":"paper-w4378514735","cat":"papers","name":"Evaluation of Bcl-2 Family Gene Expression in Hippocampus of 3, 4-methylenedioxymethamphetamine Treated Rats","year":"2011","cit":23,"pfa":"Hamed Hashemi-Nasl","psa":"Mehdi Mehdizadeh","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4378514735","eid":"W4378514735"},{"id":"paper-w2087116701","cat":"papers","name":"Dantrolene Use in 3,4-Methylenedioxymethamphetamine (“Ecstasy”)–Mediated Hyperthermia","year":"2004","cit":23,"pfa":"Daniel E. Rusyniak","psa":"Jon E. Sprague","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2087116701","eid":"W2087116701"},{"id":"paper-w4385834760","cat":"papers","name":"Anti-Inflammatory Effects of Serotonin Receptor and Transient Receptor Potential Channel Ligands in Human Small Intestinal Epithelial Cells","year":"2023","cit":23,"pfa":"Gregory Ian Robinson","psa":"Igor Kovalchuk","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4385834760","eid":"W4385834760"},{"id":"paper-w2071689899","cat":"papers","name":"3,4-methylenedioxymethamphetamine-induced release of serotonin and inhibition of dorsal raphe cell firing: potentiation by L-tryptophan","year":"1990","cit":23,"pfa":"Jeffrey S. Sprouse","psa":"George K. Aghajanian","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2071689899","eid":"W2071689899"},{"id":"paper-w2100248076","cat":"papers","name":"Ibotenic acid lesions of the medial prefrontal cortex block the development and expression of 3,4-methylenedioxymethamphetamine-induced behavioral sensitization in rats","year":"2005","cit":23,"pfa":"María Ramos","psa":"Norberto Aguirre","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2100248076","eid":"W2100248076"},{"id":"paper-w4283809381","cat":"papers","name":"Psychedelic drugs for psychiatric disorders","year":"2022","cit":23,"pfa":"Sabrina Corrêa da Costa","psa":"Mark S. Gold","ptype":"article","src":"https://openalex.org/W4283809381","eid":"W4283809381"},{"id":"paper-w3170579367","cat":"papers","name":"Amazonian Medicine and the Psychedelic Revival: Considering the “Dieta”","year":"2021","cit":23,"pfa":"David M. O’Shaughnessy","psa":"Ilana Berlowitz","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3170579367","eid":"W3170579367"},{"id":"paper-w2117032262","cat":"papers","name":"Minoxidil prevents 3,4‐methylenedioxymethamphetamine‐induced serotonin depletions: role of mitochondrial ATP‐sensitive potassium channels, Akt and ERK","year":"2007","cit":23,"pfa":"Beatriz Goñi‐Allo","psa":"Norberto Aguirre","topics":["Safety & adverse events","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2117032262","eid":"W2117032262"},{"id":"paper-w2042592888","cat":"papers","name":"Crystal structures of a therapeutic single chain antibody in complex with two drugs of abuse—Methamphetamine and 3,4‐methylenedioxymethamphetamine","year":"2009","cit":23,"pfa":"Reha Celikel","psa":"Kottayil I. Varughese","ptype":"article","src":"https://openalex.org/W2042592888","eid":"W2042592888"},{"id":"paper-w1983125597","cat":"papers","name":"Sulfur Analogs of Psychotomimetic Amines","year":"1976","cit":23,"pfa":"Alexander T. Shulgin","psa":"David E. Nichols","ptype":"article","src":"https://openalex.org/W1983125597","eid":"W1983125597"},{"id":"paper-w2059264251","cat":"papers","name":"Vibrational spectra of ketamine hydrochloride and 3, 4-methylenedioxymethamphetamine in terahertz range","year":"2007","cit":23,"pfa":"Guangqin Wang","psa":"Yan Jia","ptype":"article","src":"https://openalex.org/W2059264251","eid":"W2059264251"},{"id":"paper-w4399528691","cat":"papers","name":"Neural mechanisms of psychedelic visual imagery","year":"2024","cit":23,"pfa":"Devon Stoliker","psa":"Adeel Razi","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4399528691","eid":"W4399528691"},{"id":"paper-w2278154876","cat":"papers","name":"Verbal Memory Impairment in Polydrug Ecstasy Users: A Clinical Perspective","year":"2016","cit":23,"pfa":"Kim P. C. Kuypers","psa":"Johannes Gerardus Ramaekers","ptype":"article","src":"https://openalex.org/W2278154876","eid":"W2278154876"},{"id":"paper-w2003158195","cat":"papers","name":"Stimulatory and inhibitory effects of serotonergic hallucinogens on spinal mono-and polysynaptic reflex pathways in the rat","year":"1992","cit":23,"pfa":"Jun Yamazaki","ptype":"article","src":"https://openalex.org/W2003158195","eid":"W2003158195"},{"id":"paper-w2010718821","cat":"papers","name":"Studies of the relationship between molecular structure and hallucinogenic activity","year":"1986","cit":23,"pfa":"David E. Nichols","ptype":"article","src":"https://openalex.org/W2010718821","eid":"W2010718821"},{"id":"paper-w2003063237","cat":"papers","name":"INVOLVEMENT OF OXIDATIVE AND L‐ARGININE‐NO PATHWAYS IN THE NEUROTOXICITY OF DRUGS OF ABUSE IN VITRO","year":"1995","cit":23,"pfa":"C. Cerruti","psa":"Johanne Cadet","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2003063237","eid":"W2003063237"},{"id":"paper-w1997434299","cat":"papers","name":"Reassessing the Cultural and Psychopharmacological Significance ofBanisteriopsis caapi: Preparation, Classification and Use Among the Piaroa of Southern Venezuela","year":"2008","cit":23,"pfa":"Robin Rodd","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1997434299","eid":"W1997434299"},{"id":"paper-w2103797614","cat":"papers","name":"Interacciones Planta‐Nodriza en Lophophora diffusa (Cactaceae) en un Desierto Subtropical de México1","year":"2005","cit":23,"pfa":"Bertha Zúñiga","psa":"Humberto Suzán","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2103797614","eid":"W2103797614"},{"id":"paper-w3014357916","cat":"papers","name":"Kappa Opioid Receptor on Pulmonary Macrophages and Immune Function","year":"2020","cit":23,"pfa":"Si Zeng","psa":"Renyu Liu","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3014357916","eid":"W3014357916"},{"id":"paper-w2033001097","cat":"papers","name":"Identification of serotonin 5HT2 receptors in bovine pineal gland","year":"1991","cit":23,"pfa":"Piyarat Govitrapong","psa":"Manuchair Ebadi","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2033001097","eid":"W2033001097"},{"id":"paper-w2945745191","cat":"papers","name":"Psychedelic-assisted therapies: The past, and the need to move forward responsibly","year":"2019","cit":23,"pfa":"John Gardner","psa":"Kate Seear","ptype":"article","src":"https://openalex.org/W2945745191","eid":"W2945745191"},{"id":"paper-w4353070324","cat":"papers","name":"Psychedelic Targeting of Metabotropic Glutamate Receptor 2 and Its Implications for the Treatment of Alcoholism","year":"2023","cit":23,"pfa":"Kevin Domanegg","psa":"Marcus W. Meinhardt","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4353070324","eid":"W4353070324"},{"id":"paper-w3201455011","cat":"papers","name":"Drug use, harm-reduction practices and attitudes toward the utilisation of drug safety testing services in an Irish cohort of festival-goers","year":"2021","cit":23,"pfa":"Jo‐Hanna Ivers","psa":"Eamon Keenan","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3201455011","eid":"W3201455011"},{"id":"paper-w4406325134","cat":"papers","name":"Wolves Among Sheep: Sexual Violations in Psychedelic-Assisted Therapy","year":"2025","cit":23,"pfa":"Tahlia R. Harrison","psa":"Monnica T. Williams","topics":["Addiction","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4406325134","eid":"W4406325134"},{"id":"paper-w4391444130","cat":"papers","name":"Ketamine-assisted psychotherapy, psychedelic methodologies, and the impregnable value of the subjective—a new and evolving approach","year":"2024","cit":23,"pfa":"Phil Wolfson","psa":"Gita Vaid","topics":["Safety & adverse events","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4391444130","eid":"W4391444130"},{"id":"paper-w4386828200","cat":"papers","name":"Psychedelics and Racial Justice","year":"2023","cit":23,"pfa":"Monnica T. Williams","psa":"Sonya C. Faber","ptype":"article","src":"https://openalex.org/W4386828200","eid":"W4386828200"},{"id":"paper-w4213134562","cat":"papers","name":"Microdosing as a Response to the Meaning Crisis: A Qualitative Analysis","year":"2022","cit":23,"pfa":"Rotem Petranker","psa":"Thomas Anderson","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4213134562","eid":"W4213134562"},{"id":"paper-w4248222636","cat":"papers","name":"Psychedelic Sacraments","year":"2005","cit":23,"pfa":"John Robert Baker","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4248222636","eid":"W4248222636"},{"id":"paper-w4307426414","cat":"papers","name":"Set and setting in microdosing: an oft-overlooked principle","year":"2022","cit":23,"pfa":"Ido Hartogsohn","psa":"Rotem Petranker","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4307426414","eid":"W4307426414"},{"id":"paper-w2093852855","cat":"papers","name":"Microdosing Studies in Children: A US Regulatory Perspective","year":"2015","cit":23,"pfa":"Michelle D. Roth-Cline","psa":"Nelson Rm","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2093852855","eid":"W2093852855"},{"id":"paper-w269811960","cat":"papers","name":"Ethnomedical, Botanical and Phytochemical Aspects of Natural Hallucinogens","year":"1980","cit":23,"pfa":"Richard Evans Schultes","psa":"Norman R. Farnsworth","topics":["Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W269811960","eid":"W269811960"},{"id":"paper-w4296009463","cat":"papers","name":"Psychedelics and schizophrenia: Distinct alterations to Bayesian inference","year":"2022","cit":23,"pfa":"Hardik Rajpal","psa":"Henrik J. Jensen","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4296009463","eid":"W4296009463"},{"id":"paper-w4220753264","cat":"papers","name":"Predictors and potentiators of psychedelic-occasioned mystical experiences","year":"2022","cit":23,"pfa":"Sam Gandy","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4220753264","eid":"W4220753264"},{"id":"paper-w2585054966","cat":"papers","name":"Successful Use of [14C]Paracetamol Microdosing to Elucidate Developmental Changes in Drug Metabolism","year":"2017","cit":23,"pfa":"Miriam G. Mooij","psa":"Saskia N. de Wildt","topics":["Safety & adverse events","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2585054966","eid":"W2585054966"},{"id":"paper-w2137780276","cat":"papers","name":"Psychedelic Medicine: New Evidence for Hallucinogenic Substances as Treatments","year":"2014","cit":23,"pfa":"John Rhead","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2137780276","eid":"W2137780276"},{"id":"paper-w3115306476","cat":"papers","name":"Secret Drugs of Buddhism: Psychedelic Sacraments and the Origins of the Vajrayana","year":"2019","cit":23,"pfa":"Mike Crowley","psa":"Ann Shulgin","ptype":"book","src":"https://openalex.org/W3115306476","eid":"W3115306476"},{"id":"paper-w2604711452","cat":"papers","name":"Drug–drug interaction of microdose and regular-dose omeprazole with a CYP2C19 inhibitor and inducer","year":"2017","cit":23,"pfa":"Gab-jin Park","psa":"Dong‐Seok Yim","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2604711452","eid":"W2604711452"},{"id":"paper-w2140629404","cat":"papers","name":"The link between use of psychedelic drugs and mental health problems","year":"2015","cit":23,"pfa":"Ragnar Nesvåg","psa":"Eivind Ystrøm","ptype":"article","src":"https://openalex.org/W2140629404","eid":"W2140629404"},{"id":"paper-w2000128958","cat":"papers","name":"Psychedelic symptoms of cannabis and cocaine use as a function of trait impulsivity","year":"2015","cit":23,"pfa":"JHP van Wel","psa":"JG Ramaekers","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2000128958","eid":"W2000128958"},{"id":"paper-w4306972467","cat":"papers","name":"Acid liberalism: Silicon Valley's enlightened technocrats, and the legalization of psychedelics","year":"2022","cit":23,"pfa":"Maxim Tvorun‐Dunn","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4306972467","eid":"W4306972467"},{"id":"paper-w2325057627","cat":"papers","name":"Improvement of Hallucinogen-Induced Persistent Perception Disorder by Treatment With a Combination of Fluoxetine and Olanzapine: Case Report","year":"2001","cit":23,"pfa":"Ghassan Aldurra","psa":"John W. Crayton","ptype":"article","src":"https://openalex.org/W2325057627","eid":"W2325057627"},{"id":"paper-w2036919030","cat":"papers","name":"Effective Use of Microdosing and Positron Emission Tomography (PET) Studies on New Drug Discovery and Development","year":"2009","cit":23,"pfa":"Yuichi Sugiyama","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2036919030","eid":"W2036919030"},{"id":"paper-w2061968416","cat":"papers","name":"Classification and short-term course of DSM-IV cannabis, hallucinogen, cocaine, and opioid disorders in treated adolescents.","year":"2005","cit":23,"pfa":"Tammy A. Chung","psa":"Christopher S. Martin","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2061968416","eid":"W2061968416"},{"id":"paper-w4392049752","cat":"papers","name":"RETRACTED: The effect of psychedelics on the level of brain-derived neurotrophic factor: A systematic review and meta-analysis","year":"2024","cit":23,"pfa":"Arman Shafiee","psa":"Mohammad Javad Amini","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4392049752","eid":"W4392049752"},{"id":"paper-w3158642864","cat":"papers","name":"Turn on, Tune in, and Drop out: Predictors of Attrition in a Prospective Observational Cohort Study on Psychedelic Use","year":"2021","cit":23,"pfa":"Sebastian Hübner","psa":"Hannes Kettner","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3158642864","eid":"W3158642864"},{"id":"paper-w2039224186","cat":"papers","name":"Potential psychotomimetics. Bromomethoxyamphetamines","year":"1971","cit":23,"pfa":"Charles F. Barfknecht","psa":"David E. Nichols","ptype":"article","src":"https://openalex.org/W2039224186","eid":"W2039224186"},{"id":"paper-w2164994747","cat":"papers","name":"Correlating the Metabolic Stability of Psychedelic 5-HT2A Agonists with Anecdotal Reports of Human Oral Bioavailability","year":"2014","cit":23,"pfa":"Sebastian Leth‐Petersen","psa":"Jesper Langgaard Kristensen","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2164994747","eid":"W2164994747"},{"id":"paper-w4404960507","cat":"papers","name":"An investigation into the varieties of extended difficulties following psychedelic drug use: Duration, severity and helpful coping strategies","year":"2024","cit":23,"pfa":"Oliver C. Robinson","psa":"David P. Luke","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4404960507","eid":"W4404960507"},{"id":"paper-w2010504744","cat":"papers","name":"Blocking Effect of Tetrahydroaminacrin on a New Psychotomimetic Agent","year":"1960","cit":23,"pfa":"Samuel Gershon","ptype":"article","src":"https://openalex.org/W2010504744","eid":"W2010504744"},{"id":"paper-w1902769688","cat":"papers","name":"Comparison of GnRh Agonist Microdose Flare Up and GnRh Antagonist/Letrozole in Treatment of Poor Responder Patients in Intra Cytoplaspic Sperm Injection: Randomized Clinical Trial","year":"2015","cit":23,"pfa":"Azar Nabati","psa":"Seyyed Abbas Hashemi","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1902769688","eid":"W1902769688"},{"id":"paper-w2315630574","cat":"papers","name":"Stereochemical Factors Related to the Potency of Anticholinergic Psychotomimetic Drugs","year":"1965","cit":23,"pfa":"Norman W. Gabel","psa":"Leo G. Abood","ptype":"article","src":"https://openalex.org/W2315630574","eid":"W2315630574"},{"id":"paper-w2022555435","cat":"papers","name":"In vitro O-demethylation of the psychotomimetic amine, 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane","year":"1977","cit":23,"pfa":"Jonathan S. Zweig","psa":"Neal Castagnoli","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2022555435","eid":"W2022555435"},{"id":"paper-w2037836554","cat":"papers","name":"Reduction of Psychotomimetic Side Effects of Ketalar® (Ketamine) by Rohypnol®(Flunitrazepam) A Randomized, Double‐Blind Trial","year":"1976","cit":23,"pfa":"I Freuchen","psa":"Birgit Ohrt Mikkelsen","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2037836554","eid":"W2037836554"},{"id":"paper-w3161388284","cat":"papers","name":"Cannabidiol prevents disruptions in sensorimotor gating induced by psychotomimetic drugs that last for 24-h with probable involvement of epigenetic changes in the ventral striatum","year":"2021","cit":23,"pfa":"João Francisco Cordeiro Pedrazzi","psa":"Elaine Aparecida Del Bel","ptype":"article","src":"https://openalex.org/W3161388284","eid":"W3161388284"},{"id":"paper-w2413458064","cat":"papers","name":"LSD","year":"1980","cit":23,"pfa":"Alexander T. Shulgin","ptype":"article","src":"https://openalex.org/W2413458064","eid":"W2413458064"},{"id":"paper-w1965831857","cat":"papers","name":"Blind Dosage Comparisons and Other Studies in a Large Methadone Program","year":"1971","cit":23,"pfa":"Avram Goldstein","ptype":"article","src":"https://openalex.org/W1965831857","eid":"W1965831857"},{"id":"paper-w2047653649","cat":"papers","name":"Heritability of illicit drug use and transition to dependence in Southwest California Indians","year":"2007","cit":23,"pfa":"Cindy L. Ehlers","psa":"Kirk Wilhelmsen","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2047653649","eid":"W2047653649"},{"id":"paper-w89187360","cat":"papers","name":"A review of the continuum of drug-induced states of excitation and depression","year":"1982","cit":23,"pfa":"Wendell D. Winters","topics":["Depression","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"book-chapter","src":"https://openalex.org/W89187360","eid":"W89187360"},{"id":"paper-w3216869366","cat":"papers","name":"Transition From Full Mu Opioid Agonists to Buprenorphine in Opioid Dependent Patients—A Critical Review","year":"2021","cit":23,"pfa":"Michael Soyka","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3216869366","eid":"W3216869366"},{"id":"paper-w4309043333","cat":"papers","name":"Self-transcendent experiences as promoters of ecological wellbeing? Exploration of the evidence and hypotheses to be tested","year":"2022","cit":23,"pfa":"Amy Isham","psa":"Tim P. Jackson","topics":["Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4309043333","eid":"W4309043333"},{"id":"paper-w1993690735","cat":"papers","name":"Cofactors for HIV Disease Progression in a Cohort of Homosexual and Bisexual Men","year":"2001","cit":23,"pfa":"Eric Vittinghoff","psa":"Susan Buchbinder","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1993690735","eid":"W1993690735"},{"id":"paper-w4399040580","cat":"papers","name":"At-home, telehealth-supported ketamine treatment for depression: Findings from longitudinal, machine learning and symptom network analysis of real-world data","year":"2024","cit":23,"pfa":"David S. Mathai","psa":"Matteo Malgaroli","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4399040580","eid":"W4399040580"},{"id":"paper-w2891853835","cat":"papers","name":"Rivaroxaban and macitentan can be coadministered without dose adjustment but the combination of rivaroxaban and St John's wort should be avoided","year":"2018","cit":23,"pfa":"Andrea Huppertz","psa":"Walter E. Haefeli","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2891853835","eid":"W2891853835"},{"id":"paper-w1818907718","cat":"papers","name":"Clinical Handbook of Psychotropic Drugs for Children and Adolescents","year":"2018","cit":23,"topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"book","src":"https://openalex.org/W1818907718","eid":"W1818907718"},{"id":"paper-w2169494471","cat":"papers","name":"Ketamine-induced affective switch in a patient with treatment-resistant depression","year":"2015","cit":23,"pfa":"Girish H. Banwari","psa":"Prahlad Patidar","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2169494471","eid":"W2169494471"},{"id":"paper-w4280634395","cat":"papers","name":"The antidepressant effect and safety of non-intranasal esketamine: A systematic review","year":"2022","cit":23,"pfa":"Sanne Y. Smith-Apeldoorn","psa":"Robert A. Schoevers","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4280634395","eid":"W4280634395"},{"id":"paper-w4409119056","cat":"papers","name":"Esketamine Combined With SSRI or SNRI for Treatment-Resistant Depression","year":"2025","cit":23,"pfa":"Antonio DEL CASALE","psa":"Maurizio Simmaco","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4409119056","eid":"W4409119056"},{"id":"paper-w4206622279","cat":"papers","name":"Comparison between dexmedetomidine and esketamine in pediatric dentistry surgery","year":"2021","cit":23,"pfa":"Naixing Xin","psa":"Chengjin Yue","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4206622279","eid":"W4206622279"},{"id":"paper-w4292454897","cat":"papers","name":"A Study on the Preventive Effect of Esketamine on Postpartum Depression (PPD) after Cesarean Section","year":"2022","cit":23,"pfa":"Qiwei Wang","psa":"Pengcheng Zhang","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4292454897","eid":"W4292454897"},{"id":"paper-w3197785285","cat":"papers","name":"Evaluating the Role of Ketamine/Esketamine in the Management of Major Depressive Disorder with Suicide Risk","year":"2021","cit":23,"pfa":"Sina Nikayin","psa":"Gerard Sanacora","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3197785285","eid":"W3197785285"},{"id":"paper-w4367608121","cat":"papers","name":"(2R,6R)-hydroxynorketamine improves PTSD-associated behaviors and structural plasticity via modulating BDNF-mTOR signaling in the nucleus accumbens","year":"2023","cit":23,"pfa":"Luping Gou","psa":"Lin Sun","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4367608121","eid":"W4367608121"},{"id":"paper-w4323035849","cat":"papers","name":"Evaluation of clinical effects of Esketamine on depression in patients with missed miscarriage: A randomized, controlled, double-blind trial","year":"2023","cit":23,"pfa":"Ming Jiang","psa":"Shanwu Feng","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4323035849","eid":"W4323035849"},{"id":"paper-w4398764036","cat":"papers","name":"Effects of esketamine on postoperative fatigue syndrome in patients after laparoscopic resection of gastric carcinoma: a randomized controlled trial","year":"2024","cit":23,"pfa":"Xinru Lin","psa":"Hai Lan Lin","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4398764036","eid":"W4398764036"},{"id":"paper-w3184710039","cat":"papers","name":"Cardiovascular Effects of Combining Subcutaneous or Intravenous Esketamine and the MAO Inhibitor Tranylcypromine for the Treatment of Depression: A Retrospective Cohort Study","year":"2021","cit":23,"pfa":"Vera Miriam Ludwig","psa":"Philipp S. Ritter","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3184710039","eid":"W3184710039"},{"id":"paper-w4376224605","cat":"papers","name":"Effect of Intraoperative Infusion of Esketamine on Quality of Postoperative Recovery in Patients Undergoing Laparoscopic Bariatric Surgery: A Randomized Controlled Trial","year":"2023","cit":23,"pfa":"Jingyue Zhang","psa":"Zhiping Wang","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4376224605","eid":"W4376224605"},{"id":"paper-w4402534987","cat":"papers","name":"Diurnal variation of postoperative delirium in elderly patients undergoing esketamine anesthesia for elective noncardiac surgery: a randomized clinical trial","year":"2024","cit":23,"pfa":"Yuan Zhang","psa":"Zhongyuan Xia","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4402534987","eid":"W4402534987"},{"id":"paper-w4220920429","cat":"papers","name":"Esketamine as an Adjuvant to Ciprofol or Propofol Sedation for Same-Day Bidirectional Endoscopy: Protocol for a Randomized, Double-Blind, Controlled Trial With Factorial Design","year":"2022","cit":23,"pfa":"Yu-qin Long","psa":"Ke Peng","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4220920429","eid":"W4220920429"},{"id":"paper-w4367185072","cat":"papers","name":"Effects of esketamine on postoperative rebound pain in patients undergoing unilateral total knee arthroplasty: a single-center, randomized, double-blind, placebo-controlled trial protocol","year":"2023","cit":23,"pfa":"Youzhuang Zhu","psa":"Yang William Zhao","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4367185072","eid":"W4367185072"},{"id":"paper-w3178922226","cat":"papers","name":"Effect of Esketamine Nasal Spray on Olfactory Function and Nasal Tolerability in Patients with Treatment-Resistant Depression: Results from Four Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Studie","year":"2021","cit":23,"pfa":"Richard L. Doty","psa":"Wayne Curtis Drevets","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3178922226","eid":"W3178922226"},{"id":"paper-w2339134523","cat":"papers","name":"Ketamine Metabolites Enantioselectively Decrease Intracellular D-Serine Concentrations in PC-12 Cells","year":"2016","cit":23,"pfa":"N. Singh","psa":"Irving W. Wainer","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2339134523","eid":"W2339134523"},{"id":"paper-w4281790437","cat":"papers","name":"Use of Clinical Global Impressions-Severity (CGI-S) to Assess Response to Antidepressant Treatment in Patients with Treatment-Resistant Depression","year":"2022","cit":23,"pfa":"Joachim Morrens","psa":"Qiaoyi Zhang","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4281790437","eid":"W4281790437"},{"id":"paper-w4390889547","cat":"papers","name":"An integrative view on the cell-type-specific mechanisms of ketamine's antidepressant actions","year":"2024","cit":23,"pfa":"Vern Lewis","psa":"Argel Aguilar‐Valles","topics":["Depression","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W4390889547","eid":"W4390889547"},{"id":"paper-w3013940553","cat":"papers","name":"The Ventrolateral Periaqueductal Gray Contributes to Depressive-Like Behaviors in Recovery of Inflammatory Bowel Disease Rat Model","year":"2020","cit":23,"pfa":"Chih-Yuan Ko","psa":"Jianhua Xu","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3013940553","eid":"W3013940553"},{"id":"paper-w4296349048","cat":"papers","name":"Depressive disorder and antidepressants from an epigenetic point of view","year":"2022","cit":23,"pfa":"Iris Šalamon Arčan","psa":"Alja Videtič Paska","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4296349048","eid":"W4296349048"},{"id":"paper-w1979203090","cat":"papers","name":"Evidence for an increase in functional platelet 5-HT2A receptors in depressed patients using the new ligand [125I]-DOI","year":"1999","cit":23,"pfa":"F. Serres","psa":"Régine Jeanningros","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1979203090","eid":"W1979203090"},{"id":"paper-w1988563049","cat":"papers","name":"Lysergic Acid Diethylamide","year":"1963","cit":22,"pfa":"ROY RICHARD GRINKER","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W1988563049","eid":"W1988563049"},{"id":"paper-w1983574733","cat":"papers","name":"Production of Cross-Tolerance to Psychosis-Producing Doses of Lysergic Acid Diethylamide and Psilocybin","year":"1960","cit":22,"pfa":"Harold A. Abramson","psa":"J. Stache","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1983574733","eid":"W1983574733"},{"id":"paper-w1985763734","cat":"papers","name":"Lysergic acid diethylamide and chromosome breakage","year":"2009","cit":22,"pfa":"Sören Sturelid","psa":"BENGT A. KIHLMAN","ptype":"article","src":"https://openalex.org/W1985763734","eid":"W1985763734"},{"id":"paper-w2197646199","cat":"papers","name":"SIMILARITIES AND DIFFERENCES BETWEEN MESCALINE, LYSERGIC ACID DIETHYLAMIDE-25 (LSD) AND d-AMPHETAMINE ON VARIOUS COMPONENTS OF FIXED INTERVAL RESPONDING IN THE RAT","year":"1973","cit":22,"pfa":"H.A. Tilson","psa":"Sheldon B. Sparber","ptype":"article","src":"https://openalex.org/W2197646199","eid":"W2197646199"},{"id":"paper-w1977451172","cat":"papers","name":"Lysergic Acid Diethylamide (Lsd-25): Xi. Content Analysis of Clinical Reactions","year":"1955","cit":22,"pfa":"Harold A. Abramson","psa":"M. W. Ferguson","ptype":"article","src":"https://openalex.org/W1977451172","eid":"W1977451172"},{"id":"paper-w3038479280","cat":"papers","name":"Development of a Pencil Drawn Paper‐based Analytical Device to Detect Lysergic Acid Diethylamide (LSD)*†","year":"2020","cit":22,"pfa":"Maria Fernanda Muzetti Ribeiro","psa":"Marcelo Firmino de Oliveira","ptype":"article","src":"https://openalex.org/W3038479280","eid":"W3038479280"},{"id":"paper-w2069110360","cat":"papers","name":"Lysergic Acid Diethylamide (Lsd-25): Xv. the Effects Produced By Substitution of a Tap Water Placebo","year":"1955","cit":22,"pfa":"Harold A. Abramson","psa":"M. W. Hirsch","ptype":"article","src":"https://openalex.org/W2069110360","eid":"W2069110360"},{"id":"paper-w2130749037","cat":"papers","name":"STUDIES OF TRYPTAMINE AND LYSERGIC ACID DIETHYLAMIDE (LSD) ON CUTANEOUS C-FIBER AND POLYSYNAPTIC REFLEXES IN THE CAT","year":"1974","cit":22,"pfa":"J.A. Bell","psa":"William R. Martin","ptype":"article","src":"https://openalex.org/W2130749037","eid":"W2130749037"},{"id":"paper-w2090610976","cat":"papers","name":"Serotonin Binding to Nerve-Ending Particles of the Rat Brain and Its Inhibition by Lysergic Acid Diethylamide","year":"1964","cit":22,"pfa":"R. M. Marchbanks","psa":"Richard D. O'Brien","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2090610976","eid":"W2090610976"},{"id":"paper-w1989057086","cat":"papers","name":"The behavioural effects of some derivatives of mescaline and N,N-dimethyltryptamine in the rat","year":"1967","cit":22,"pfa":"John Smythies","psa":"F. Leonard","ptype":"article","src":"https://openalex.org/W1989057086","eid":"W1989057086"},{"id":"paper-w2324554653","cat":"papers","name":"The influence of progesterone on behavioral changes induced by lysergic acid diethylamide (LSD-25) in normal males","year":"1961","cit":22,"pfa":"Donald M. Krus","psa":"Harry Freeman","ptype":"article","src":"https://openalex.org/W2324554653","eid":"W2324554653"},{"id":"paper-w4386522609","cat":"papers","name":"From prohibited to prescribed: The rescheduling of MDMA and psilocybin in Australia","year":"2023","cit":22,"pfa":"Octavian Victor Brinzei","psa":"Gabrielle Dixon Ritchie","ptype":"editorial","src":"https://openalex.org/W4386522609","eid":"W4386522609"},{"id":"paper-w1982034131","cat":"papers","name":"Platelet [3H]paroxetine and [3H]lysergic acid diethylamide binding in seasonal affective disorder and the effect of bright light therapy","year":"1999","cit":22,"pfa":"Kenneth Smedh","psa":"Rolf Adolfsson","ptype":"article","src":"https://openalex.org/W1982034131","eid":"W1982034131"},{"id":"paper-w2932153525","cat":"papers","name":"Optimized Analysis of Ergot Alkaloids in Rye Products by Liquid Chromatography-Fluorescence Detection Applying Lysergic Acid Diethylamide as an Internal Standard","year":"2019","cit":22,"pfa":"Iris Holderied","psa":"Paul Wilhelm Elsinghorst","topics":["Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2932153525","eid":"W2932153525"},{"id":"paper-w2064619677","cat":"papers","name":"Quantitation of Lysergic Acid Diethylamide in Urine Using Atmospheric Pressure Matrix-Assisted Laser Desorption/Ionization Ion Trap Mass Spectrometry","year":"2004","cit":22,"pfa":"Meng Cui","psa":"Zoltán Mester","ptype":"article","src":"https://openalex.org/W2064619677","eid":"W2064619677"},{"id":"paper-w3004469522","cat":"papers","name":"Identification of 1-Butyl-Lysergic Acid Diethylamide (1B-LSD) in Seized Blotter Paper Using an Integrated Workflow of Analytical Techniques and Chemo-Informatics","year":"2020","cit":22,"pfa":"Emmanouil Tsochatzis","psa":"Claude Guillou","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W3004469522","eid":"W3004469522"},{"id":"paper-w4237045317","cat":"papers","name":"Mescaline","year":"2019","cit":22,"pfa":"Mike Jay","ptype":"book","src":"https://openalex.org/W4237045317","eid":"W4237045317"},{"id":"paper-w2002569962","cat":"papers","name":"Right hemisphere involvement in mescaline-induced psychosis","year":"1989","cit":22,"pfa":"Godehard Oepen","psa":"Hanno Botsch","ptype":"article","src":"https://openalex.org/W2002569962","eid":"W2002569962"},{"id":"paper-w2610334581","cat":"papers","name":"Anxiolytic-like effects of noribogaine in zebrafish","year":"2017","cit":22,"pfa":"Allan V. Kalueff","psa":"Émeline L. Maillet","ptype":"article","src":"https://openalex.org/W2610334581","eid":"W2610334581"},{"id":"paper-w4407189569","cat":"papers","name":"Efficient and modular synthesis of ibogaine and related alkaloids","year":"2025","cit":22,"pfa":"Rishab N. Iyer","psa":"David E. Olson","ptype":"article","src":"https://openalex.org/W4407189569","eid":"W4407189569"},{"id":"paper-w2014858922","cat":"papers","name":"Ibogaine-associated ventricular tachyarrhythmias","year":"2012","cit":22,"pfa":"Aleš Pleskovič","psa":"Gordana Koželj","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2014858922","eid":"W2014858922"},{"id":"paper-w4302911246","cat":"papers","name":"Peyote Religion: A History","year":"1989","cit":22,"pfa":"Henry Warner Bowden","psa":"Omer C. Stewart","ptype":"article","src":"https://openalex.org/W4302911246","eid":"W4302911246"},{"id":"paper-w2286617854","cat":"papers","name":"Mescaline: no tolerance to excitatory effects.","year":"1973","cit":22,"pfa":"Wagner H. Bridger","psa":"David M. Stoff","ptype":"article","src":"https://openalex.org/W2286617854","eid":"W2286617854"},{"id":"paper-w2101160208","cat":"papers","name":"Ibogaine related sudden death: A case report","year":"2013","cit":22,"pfa":"Stavroula A. Papadodima","psa":"Sotiris Athanaselis","ptype":"article","src":"https://openalex.org/W2101160208","eid":"W2101160208"},{"id":"paper-w2027001066","cat":"papers","name":"Time Contraction and Psychomotor Performance produced by ‘Psilocybin’","year":"1966","cit":22,"pfa":"ROLAND FISCHER","psa":"E. L. MEAD","ptype":"article","src":"https://openalex.org/W2027001066","eid":"W2027001066"},{"id":"paper-w1985883197","cat":"papers","name":"The Psilocybin Mushroom Pandemic","year":"1975","cit":22,"pfa":"Steven Hayden Pollock","ptype":"article","src":"https://openalex.org/W1985883197","eid":"W1985883197"},{"id":"paper-w2528606967","cat":"papers","name":"Identification and characterization of N‐tert‐butoxycarbonyl‐MDMA: a new MDMA precursor","year":"2016","cit":22,"pfa":"Michael Collins","psa":"Helen Salouros","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2528606967","eid":"W2528606967"},{"id":"paper-w4401797635","cat":"papers","name":"Acute effects of R-MDMA, S-MDMA, and racemic MDMA in a randomized double-blind cross-over trial in healthy participants","year":"2024","cit":22,"pfa":"Isabelle Straumann","psa":"Matthias E. Liechti","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4401797635","eid":"W4401797635"},{"id":"paper-w2044306548","cat":"papers","name":"THE USE OF PEYOTE BY THE CARRIZO AND LIPAN APACHE TRIBES","year":"1938","cit":22,"pfa":"MORRIS EDWARD OPLER","ptype":"article","src":"https://openalex.org/W2044306548","eid":"W2044306548"},{"id":"paper-w2394501084","cat":"papers","name":"Remission of Severe Opioid Use Disorder with Ibogaine: A Case Report","year":"2016","cit":22,"pfa":"Laurie Cloutier-Gill","psa":"Maria Eugenia Socias","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2394501084","eid":"W2394501084"},{"id":"paper-w2021565498","cat":"papers","name":"A note on some therapeutic implications of the mescaline-induced state","year":"1954","cit":22,"pfa":"Herman C.B. Denber","psa":"Sidney Merlis","ptype":"article","src":"https://openalex.org/W2021565498","eid":"W2021565498"},{"id":"paper-w2087875473","cat":"papers","name":"MDMA and Metabolite Disposition in Expectorated Oral Fluid After Controlled Oral MDMA Administration","year":"2011","cit":22,"pfa":"Allan J. Barnes","psa":"Marilyn Ann Huestis","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2087875473","eid":"W2087875473"},{"id":"paper-w1608014282","cat":"papers","name":"Fatal peyote ingestion associated with Mallory-Weiss lacerations.","year":"1999","cit":22,"pfa":"Kurt B. Nolte","psa":"RE Zumwalt","ptype":"article","src":"https://openalex.org/W1608014282","eid":"W1608014282"},{"id":"paper-w2912970239","cat":"papers","name":"Greater empathy in MDMA users","year":"2019","cit":22,"pfa":"Molly Carlyle","psa":"Celia J. A. Morgan","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2912970239","eid":"W2912970239"},{"id":"paper-w1966988083","cat":"papers","name":"A biosynthetic sequence from tryptophan to psilocybin","year":"1968","cit":22,"pfa":"Stig Agurell","psa":"G. Nilsson","ptype":"article","src":"https://openalex.org/W1966988083","eid":"W1966988083"},{"id":"paper-w2143389076","cat":"papers","name":"Magic truffles or Philosopher's stones: a legal way to sell psilocybin?","year":"2012","cit":22,"pfa":"Manuela Pellegrini","psa":"Simona Pichini","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2143389076","eid":"W2143389076"},{"id":"paper-w2074397756","cat":"papers","name":"Mescaline elicits behavioral effects in cats by an action at both serotonin and dopamine receptors","year":"1983","cit":22,"pfa":"Michael E. Trulson","psa":"Leslie J. Henderson","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2074397756","eid":"W2074397756"},{"id":"paper-w2414812684","cat":"papers","name":"5-methoxy-N, N-dimethyltryptamine, a possible endogenous psychotoxin.","year":"1965","cit":22,"pfa":"Frederick Benington","psa":"Leland C. Clark","ptype":"article","src":"https://openalex.org/W2414812684","eid":"W2414812684"},{"id":"paper-w3023494493","cat":"papers","name":"Personality Traits in Former Spanish Substance Users Recovered with Ayahuasca","year":"2020","cit":22,"pfa":"Ismael Apud","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W3023494493","eid":"W3023494493"},{"id":"paper-w2021967205","cat":"papers","name":"Ibogaine in Acute Opioid Withdrawal: An Open Label Case Series","year":"2000","cit":22,"pfa":"Kenneth Alper","psa":"Jan Bastiaans","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2021967205","eid":"W2021967205"},{"id":"paper-w2027740687","cat":"papers","name":"Ethnobotany of psilocybin mushrooms, especially Psilocybe cubensis","year":"1984","cit":22,"pfa":"Edmond R. Badham","ptype":"article","src":"https://openalex.org/W2027740687","eid":"W2027740687"},{"id":"paper-w1966103449","cat":"papers","name":"Editors' Introduction: Ayahuasca Use in Cross-Cultural Perspective","year":"2005","cit":22,"pfa":"Marlene Dobkin de Ríos","psa":"Charles S. Grob","ptype":"article","src":"https://openalex.org/W1966103449","eid":"W1966103449"},{"id":"paper-w2019650516","cat":"papers","name":"Ontogeny of N,N-Dimethyltryptamine and related indolealkylamine levels in neonatal rats","year":"1984","cit":22,"pfa":"J. M. Beaton","psa":"Philip E. Morris","ptype":"article","src":"https://openalex.org/W2019650516","eid":"W2019650516"},{"id":"paper-w1999400659","cat":"papers","name":"Effects of mescaline and some of its analogs on cholinergic neuromuscular transmission","year":"1993","cit":22,"pfa":"Emmanuel Ghansah","psa":"A. BROSSI","ptype":"article","src":"https://openalex.org/W1999400659","eid":"W1999400659"},{"id":"paper-w2033407176","cat":"papers","name":"Syllogistic Reasoning Performance in MDMA (Ecstasy) Users.","year":"2005","cit":22,"pfa":"Catharine Montgomery","psa":"Philip N. Murphy","ptype":"article","src":"https://openalex.org/W2033407176","eid":"W2033407176"},{"id":"paper-w2055046158","cat":"papers","name":"Ibogaine effects on sweet preference and amphetamine induced locomotion: implications for drug addiction","year":"1997","cit":22,"pfa":"James Blackburn","psa":"Karen Kathleen Szumlinski","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2055046158","eid":"W2055046158"},{"id":"paper-w2131344314","cat":"papers","name":"MDMA attenuates THC withdrawal syndrome in mice","year":"2007","cit":22,"pfa":"Clara Touriño","psa":"Olga Valverde","ptype":"article","src":"https://openalex.org/W2131344314","eid":"W2131344314"},{"id":"paper-w1981594659","cat":"papers","name":"A complete biosynthetic sequence from tyrosine to mescaline in two cactus species.","year":"1969","cit":22,"pfa":"Jan Lundström","psa":"Stig Agurell","ptype":"article","src":"https://openalex.org/W1981594659","eid":"W1981594659"},{"id":"paper-w2090416615","cat":"papers","name":"Occurrence of bufotenin (5-hydroxy-N, N-dimethyltryptamine) in urine of schizophrenic patients","year":"1967","cit":22,"pfa":"Hiroshi Tanimukai","psa":"Harald E. Himwich","ptype":"article","src":"https://openalex.org/W2090416615","eid":"W2090416615"},{"id":"paper-w2945489582","cat":"papers","name":"N,N-dimethyltryptamine Prevents Renal Ischemia-Reperfusion Injury in a Rat Model","year":"2019","cit":22,"pfa":"Balázs Nemes","psa":"Ede Frecska","ptype":"article","src":"https://openalex.org/W2945489582","eid":"W2945489582"},{"id":"paper-w4310036716","cat":"papers","name":"Methylone and MDMA Pharmacokinetics Following Controlled Administration in Humans","year":"2022","cit":22,"pfa":"Lourdes Poyatos","psa":"Magı́ Farré","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4310036716","eid":"W4310036716"},{"id":"paper-w2026900114","cat":"papers","name":"Involvement of Nicotinic Receptors in Methamphetamine- and Mdma-Induced Neurotoxicity","year":"2009","cit":22,"pfa":"Elena Escubedo","psa":"David Pubill","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W2026900114","eid":"W2026900114"},{"id":"paper-w2077275332","cat":"papers","name":"Prospective memory impairment in abstinent MDMA (\"Ecstasy\") users","year":"2003","cit":22,"pfa":"Konstantine K. Zakzanis","psa":"Zachariah Campbell","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2077275332","eid":"W2077275332"},{"id":"paper-w2149018123","cat":"papers","name":"Effects of iproniazid and tranylcypromine on the half-life of N,N-dimethyltryptamine in rat brain and liver","year":"1976","cit":22,"pfa":"Li Lu","psa":"Edward F. Domino","ptype":"article","src":"https://openalex.org/W2149018123","eid":"W2149018123"},{"id":"paper-w4224988773","cat":"papers","name":"Toward Risk-Benefit Assessments in Psychedelic- and MDMA-Assisted Therapies","year":"2022","cit":22,"pfa":"Mazdak M. Bradberry","psa":"Charles L. Raison","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4224988773","eid":"W4224988773"},{"id":"paper-w4400737202","cat":"papers","name":"Longitudinal experiences of Canadians receiving compassionate access to psilocybin-assisted psychotherapy","year":"2024","cit":22,"pfa":"Sara de la Salle","psa":"Kyle T. Greenway","topics":["Depression","Anxiety & end-of-life","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4400737202","eid":"W4400737202"},{"id":"paper-w2004731160","cat":"papers","name":"Experience-dependent changes in temperature and behavioral activity induced by MDMA","year":"2006","cit":22,"pfa":"Maria Elena Reveron","psa":"Christine L. Duvauchelle","ptype":"article","src":"https://openalex.org/W2004731160","eid":"W2004731160"},{"id":"paper-w2076026140","cat":"papers","name":"Biosynthesis of Mescaline and Tetrahydroisoquinoline Alkaloids in Lophophora williamsii (Lem.) Coult. Occurrence and Biosynthesis of Catecholamine and Other Intermediates.","year":"1971","cit":22,"pfa":"Jan Lundström","psa":"Sukeji Kachi","ptype":"article","src":"https://openalex.org/W2076026140","eid":"W2076026140"},{"id":"paper-w2976260654","cat":"papers","name":"Salvinorin A attenuates early brain injury through PI3K/Akt pathway after subarachnoid hemorrhage in rat","year":"2019","cit":22,"pfa":"Juan Sun","psa":"Chunhua Chen","ptype":"article","src":"https://openalex.org/W2976260654","eid":"W2976260654"},{"id":"paper-w2767178731","cat":"papers","name":"Social Cognition and Interaction in Chronic Users of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)","year":"2017","cit":22,"pfa":"Michael D. Wunderli","psa":"Boris B. Quednow","ptype":"article","src":"https://openalex.org/W2767178731","eid":"W2767178731"},{"id":"paper-w2136043997","cat":"papers","name":"Optimization of extraction parameters for the chemical profiling of 3,4-methylenedioxymethamphetamine (MDMA) tablets","year":"2003","cit":22,"pfa":"Pascal Gimeno","psa":"Huguette Chaudron-Thozet","ptype":"article","src":"https://openalex.org/W2136043997","eid":"W2136043997"},{"id":"paper-w2921855306","cat":"papers","name":"Increased iNOS and Nitrosative Stress in Dopaminergic Neurons of MDMA-Exposed Rats","year":"2019","cit":22,"pfa":"Stefania Schiavone","psa":"Emanuela Turillazzi","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2921855306","eid":"W2921855306"},{"id":"paper-w2092476585","cat":"papers","name":"The hyperthermia mediated by 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) is sensitive to sex differences","year":"2008","cit":22,"pfa":"Richard P. Wyeth","psa":"Jon E. Sprague","ptype":"article","src":"https://openalex.org/W2092476585","eid":"W2092476585"},{"id":"paper-w2006290135","cat":"papers","name":"Ibogaine analogues. Synthesis and preliminary pharmacological evaluation of 7-heteroaryl-2-azabicyclo[2.2.2]oct-7-enes","year":"2003","cit":22,"pfa":"Daniele Passarella","psa":"Deborah C. Mash","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2006290135","eid":"W2006290135"},{"id":"paper-w4310700160","cat":"papers","name":"Psilocybin mitigates the cognitive deficits observed in a rat model of Fragile X syndrome","year":"2022","cit":22,"pfa":"Valeria Buzzelli","psa":"Viviana Trezza","ptype":"article","src":"https://openalex.org/W4310700160","eid":"W4310700160"},{"id":"paper-w2043976891","cat":"papers","name":"MDMA (Ecstacy): Useful Information for Health Professionals Involved in Drug Education Programs","year":"1996","cit":22,"pfa":"Carrie A. Elk","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2043976891","eid":"W2043976891"},{"id":"paper-w4392165205","cat":"papers","name":"Psilocybin Exposures Reported to U.S. Poison Centers: National Trends Over a Decade","year":"2024","cit":22,"pfa":"Rita Farah","psa":"Christopher P. Holstege","ptype":"article","src":"https://openalex.org/W4392165205","eid":"W4392165205"},{"id":"paper-w2335328756","cat":"papers","name":"Gas Liquid Chromatographic and Mass Spectrometric Studies on Trimethylsilyl Derivatives of N-Methyl- and N,N-Dimethyltryptamines","year":"1971","cit":22,"pfa":"N. Narasimhachari","psa":"BH Heller","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2335328756","eid":"W2335328756"},{"id":"paper-w4389137509","cat":"papers","name":"Psilocybin as a lead candidate molecule in preclinical therapeutic studies of psychiatric disorders: A systematic review","year":"2023","cit":22,"pfa":"James J Gattuso","psa":"Thibault Renoir","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W4389137509","eid":"W4389137509"},{"id":"paper-w2961636057","cat":"papers","name":"An Efficient Ambient Ionization Mass Spectrometric Approach to Detection and Quantification of the Mescaline Content of Commonly Abused Cacti from the Echinopsis Genus","year":"2019","cit":22,"pfa":"Cameron M. Longo","psa":"Rabi A. Musah","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2961636057","eid":"W2961636057"},{"id":"paper-w2074015840","cat":"papers","name":"Hallucinogen-related disorders in a national sample of adolescents: The influence of ecstasy/MDMA use","year":"2009","cit":22,"pfa":"Li-Tzy T. Wu","psa":"Dan German Blazer","ptype":"article","src":"https://openalex.org/W2074015840","eid":"W2074015840"},{"id":"paper-w2293769113","cat":"papers","name":"METABOLIC FATE OF BETA-(3,4,5-TRIMETHOXYPHENYL)-ETHYLAMINE (MESCALINE) IN HUMANS: ISOLATION AND IDENTIFICATION OF 3,4,5-TRIMETHOXYPHENYLACETIC ACID.","year":"1964","cit":22,"pfa":"Kyriakos Charalampous","psa":"John Kinross-Wright","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2293769113","eid":"W2293769113"},{"id":"paper-w1805321765","cat":"papers","name":"MDMA. Identification et annotation des marqueurs discursifs “potentiels” en contexte","year":"2015","cit":22,"pfa":"Catherine Bolly","psa":"Deniz Uygur","ptype":"article","src":"https://openalex.org/W1805321765","eid":"W1805321765"},{"id":"paper-w2605165201","cat":"papers","name":"A single administration of the hallucinogen, 4‐acetoxy‐dimethyltryptamine, prevents the shift to a drug‐dependent state and the expression of withdrawal aversions in rodents","year":"2017","cit":22,"pfa":"Héctor Vargas-Pérez","psa":"Derek van der Kooy","topics":["Addiction","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2605165201","eid":"W2605165201"},{"id":"paper-w2166856000","cat":"papers","name":"Kinetics of the time-dependent inactivation of CYP2D6 in cryopreserved human hepatocytes by methylenedioxymethamphetamine (MDMA)","year":"2007","cit":22,"pfa":"Linh M. Van","psa":"Amin Rostami‐Hodjegan","ptype":"article","src":"https://openalex.org/W2166856000","eid":"W2166856000"},{"id":"paper-w2994211639","cat":"papers","name":"Developmental neurotoxicity of MDMA. A systematic literature review summarized in a putative adverse outcome pathway","year":"2019","cit":22,"pfa":"Marta Barenys","psa":"Ellen Fritsche","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W2994211639","eid":"W2994211639"},{"id":"paper-w2051863901","cat":"papers","name":"Occipital cortical proton MRS at 4 Tesla in human moderate MDMA polydrug users","year":"2007","cit":22,"pfa":"Ronald L. Cowan","psa":"Perry Franklin Renshaw","ptype":"article","src":"https://openalex.org/W2051863901","eid":"W2051863901"},{"id":"paper-w4391115210","cat":"papers","name":"Social acceptability of psilocybin-assisted therapy for existential distress at the end of life: A population-based survey","year":"2024","cit":22,"pfa":"Louis Plourde","psa":"for the P3A Study Group","topics":["Anxiety & end-of-life","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4391115210","eid":"W4391115210"},{"id":"paper-w2130327966","cat":"papers","name":"Differential behavioral outcomes of 3,4-methylenedioxymethamphetamine (MDMA-ecstasy) in anxiety-like responses in mice","year":"2011","cit":22,"pfa":"V. Ferraz-de-Paula","psa":"João Palermo‐Neto","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2130327966","eid":"W2130327966"},{"id":"paper-w2171690332","cat":"papers","name":"Chronic Stress Enhances the Corticosterone Response and Neurotoxicity to +3,4-Methylenedioxymethamphetamine (MDMA): The Role of Ambient Temperature","year":"2010","cit":22,"pfa":"Bethann N. Johnson","psa":"Bryan K. Yamamoto","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2171690332","eid":"W2171690332"},{"id":"paper-w4382930196","cat":"papers","name":"Navigating the chaos of psychedelic fMRI brain-entropy via multi-metric evaluations of acute psilocybin effects","year":"2023","cit":22,"pfa":"Drummond E-Wen McCulloch","psa":"Patrick M. Fisher","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4382930196","eid":"W4382930196"},{"id":"paper-w2132596838","cat":"papers","name":"Persistent Nigrostriatal Dopaminergic Abnormalities in Ex-Users of MDMA (‘Ecstasy’): An 18F-Dopa PET Study","year":"2010","cit":22,"pfa":"Yen Tai","psa":"Paola P. Piccini","ptype":"article","src":"https://openalex.org/W2132596838","eid":"W2132596838"},{"id":"paper-w2165390017","cat":"papers","name":"Effects of Motivational Enhancement Therapy on Readiness to Change MDMA and Methamphetamine Use Behaviors in Taiwanese Adolescents","year":"2010","cit":22,"pfa":"Ya-Shune Huang","psa":"Cheng‐Fang Yen","ptype":"article","src":"https://openalex.org/W2165390017","eid":"W2165390017"},{"id":"paper-w2112171212","cat":"papers","name":"Persistent Neuropsychological Problems after 7 Years of Abstinence from Recreational Ecstasy (MDMA): A Case Study","year":"2004","cit":22,"pfa":"Kirstie Soar","psa":"Helen C Fox","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2112171212","eid":"W2112171212"},{"id":"paper-w2031482242","cat":"papers","name":"Long-term effects of MDMA (Ecstasy) on the human central nervous system revealed by visual evoked potentials","year":"2005","cit":22,"pfa":"Clara Casco","psa":"Gianluca Campana","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2031482242","eid":"W2031482242"},{"id":"paper-w194623495","cat":"papers","name":"Persistent Psychosis and Medical Complications After a Single Ingestion of MDMA \"Ecstasy\": A Case Report and Review of the Literature.","year":"2009","cit":22,"pfa":"Mordecai N Potash","psa":"Kristy L Conrad","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W194623495","eid":"W194623495"},{"id":"paper-w2082643057","cat":"papers","name":"Behavioral effects of (�) 3,4-methylenedioxyamphetamine (MDA) and (�) 3,4-methylenedioxymethamphetamine (MDMA) in the pigeon: interactions with noradrenergic and serotonergic systems","year":"1989","cit":22,"pfa":"Michael A. Nader","psa":"J. E. Barrett","ptype":"article","src":"https://openalex.org/W2082643057","eid":"W2082643057"},{"id":"paper-w2042298452","cat":"papers","name":"Sensitive determination of MDMA and its metabolite MDA in rat blood and brain microdialysates by HPLC with fluorescence detection","year":"2007","cit":22,"pfa":"Mamoru Tomita","psa":"Kenichiro Nakashima","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2042298452","eid":"W2042298452"},{"id":"paper-w4386849390","cat":"papers","name":"Nature-themed video intervention may improve cardiovascular safety of psilocybin-assisted therapy for alcohol use disorder","year":"2023","cit":22,"pfa":"Keith G. Heinzerling","psa":"Daniel F. Kelly","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4386849390","eid":"W4386849390"},{"id":"paper-w2139043086","cat":"papers","name":"A Caenorhabditis elegans p38 MAP kinase pathway mutant protects from dopamine, methamphetamine, and MDMA toxicity","year":"2011","cit":22,"pfa":"Matthew A. Schreiber","psa":"Steven L. McIntire","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2139043086","eid":"W2139043086"},{"id":"paper-w4411969620","cat":"papers","name":"Single-dose (10 mg) psilocybin reduces symptoms in adults with obsessive-compulsive disorder: A pharmacological challenge study","year":"2025","cit":22,"pfa":"Luca Pellegrini","psa":"David Erritzøe","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4411969620","eid":"W4411969620"},{"id":"paper-w2150463045","cat":"papers","name":"Changes in CYP1A2 Activity in Humans after 3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy) Administration Using Caffeine as a Probe Drug","year":"2012","cit":22,"pfa":"Samanta Yubero‐Lahoz","psa":"Rafael de la Torre","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2150463045","eid":"W2150463045"},{"id":"paper-w2000101285","cat":"papers","name":"Repeated intermittent methylenedioxymethamphetamine exposure protects against the behavioral and neurotoxic, but not hyperthermic, effects of an MDMA binge in adult rats","year":"2010","cit":22,"pfa":"Brian J. Piper","psa":"Jerrold S. Meyer","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2000101285","eid":"W2000101285"},{"id":"paper-w2009275235","cat":"papers","name":"Influences of the corticotropic axis and sympathetic activity on neurochemical consequences of 3,4‐methylenedioxymethamphetamine (MDMA) administration in Fischer 344 rats","year":"2002","cit":22,"pfa":"Francesca Fernandez","psa":"Francis Chaouloff","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2009275235","eid":"W2009275235"},{"id":"paper-w3175539416","cat":"papers","name":"Scaling Up: Multisite Open-Label Clinical Trials of MDMA-Assisted Therapy for Severe Posttraumatic Stress Disorder","year":"2021","cit":22,"pfa":"Julie B. Wang","psa":"Rick Doblin","topics":["PTSD & trauma","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3175539416","eid":"W3175539416"},{"id":"paper-w2071194220","cat":"papers","name":"MDMA (N-methyl-3,4-methylenedioxyamphetamine) and its stereoisomers: Similarities and differences in behavioral effects in an automated activity apparatus in mice","year":"2007","cit":22,"pfa":"Robert C. Young","psa":"Richard A. Glennon","ptype":"article","src":"https://openalex.org/W2071194220","eid":"W2071194220"},{"id":"paper-w4392372223","cat":"papers","name":"Combined colorimetric and electrochemical screening method using 3D printed devices: Towards the selective detection of MDMA in forensic samples","year":"2024","cit":22,"pfa":"Larissa Magalhães de Almeida Melo","psa":"Wallans Torres Pio dos Santos","ptype":"article","src":"https://openalex.org/W4392372223","eid":"W4392372223"},{"id":"paper-w4372336620","cat":"papers","name":"Study protocol of an open-label proof-of-concept trial examining the safety and clinical efficacy of psilocybin-assisted therapy for veterans with PTSD","year":"2023","cit":22,"pfa":"Alan K. Davis","psa":"Rafael Lancelotta","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4372336620","eid":"W4372336620"},{"id":"paper-w4283160987","cat":"papers","name":"Psilocybin—Mediated Attenuation of Gamma Band Auditory Steady-State Responses (ASSR) Is Driven by the Intensity of Cognitive and Emotional Domains of Psychedelic Experience","year":"2022","cit":22,"pfa":"Vojtěch Viktorin","psa":"Tomáš Páleníček","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4283160987","eid":"W4283160987"},{"id":"paper-w4306177192","cat":"papers","name":"Psilocybin-assisted therapy for reducing alcohol intake in patients with alcohol use disorder: protocol for a randomised, double-blinded, placebo-controlled 12-week clinical trial (The QUANTUM Trip Trial)","year":"2022","cit":22,"pfa":"Mathias Ebbesen Jensen","psa":"Anders Fink‐Jensen","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4306177192","eid":"W4306177192"},{"id":"paper-w2474779107","cat":"papers","name":"ELISA Detection of 30 New Amphetamine Designer Drugs in Whole Blood, Urine and Oral Fluid using Neogen®“Amphetamine” and “Methamphetamine/MDMA” Kits","year":"2016","cit":22,"pfa":"Maria Nieddu","psa":"Gianpiero Boatto","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2474779107","eid":"W2474779107"},{"id":"paper-w2035838969","cat":"papers","name":"A long hangover from party drugs: Residual proteomic changes in the hippocampus of rats 8 weeks after γ-hydroxybutyrate (GHB), 3,4-methylenedioxymethamphetamine (MDMA) or their combination","year":"2010","cit":22,"pfa":"Petra S. Van Nieuwenhuijzen","psa":"Iain S. McGregor","ptype":"article","src":"https://openalex.org/W2035838969","eid":"W2035838969"},{"id":"paper-w4388249137","cat":"papers","name":"Psychedelic renaissance: Revitalized potential therapies for psychiatric disorders","year":"2023","cit":22,"pfa":"Taeho Greg Rhee","psa":"Samuel T. Wilkinson","ptype":"article","src":"https://openalex.org/W4388249137","eid":"W4388249137"},{"id":"paper-w3173348028","cat":"papers","name":"Silencing indigenous pasts: critical Indigenous theory and the history of psychedelics","year":"2021","cit":22,"pfa":"Andrea Ens","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W3173348028","eid":"W3173348028"},{"id":"paper-w4398221612","cat":"papers","name":"Psychedelic therapy in depression and substance use disorders","year":"2024","cit":22,"pfa":"Nur Damla Korkmaz","psa":"Emrah Yücesan","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4398221612","eid":"W4398221612"},{"id":"paper-w2123991341","cat":"papers","name":"Dynamics of Psychedelic Drug Abuse","year":"1967","cit":22,"pfa":"Malcolm B. Bowers","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2123991341","eid":"W2123991341"},{"id":"paper-w2271310228","cat":"papers","name":"Effects of d-amphetamine, monomethoxyamphetamines and hallucinogens on schedule-controlled behavior.","year":"1978","cit":22,"pfa":"Robert Adron Harris","psa":"Horace H. Loh","ptype":"article","src":"https://openalex.org/W2271310228","eid":"W2271310228"},{"id":"paper-w2011203248","cat":"papers","name":"The identification of LSD-like hallucinogens using the chronic spinal dog","year":"1978","cit":22,"pfa":"William R. Martin","psa":"L.D. Bright","ptype":"article","src":"https://openalex.org/W2011203248","eid":"W2011203248"},{"id":"paper-w3214272829","cat":"papers","name":"Finding the divine within: exploring the role of the sacred in psychedelic integration therapy for sexual trauma and dysfunction","year":"2021","cit":22,"pfa":"Dee Dee Goldpaugh","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W3214272829","eid":"W3214272829"},{"id":"paper-w1987875860","cat":"papers","name":"Pharmacological Evidence for the Existence of Multiple Functional Pools of Brain Serotonin: Analysis of Brain Perfusate From Conscious Rats","year":"1983","cit":22,"pfa":"Mark S. Kleven","psa":"Sheldon B. Sparber","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1987875860","eid":"W1987875860"},{"id":"paper-w2126698385","cat":"papers","name":"Biotransformation of tryptamine derivatives in mycelial cultures of Psilocybe","year":"1989","cit":22,"pfa":"Jochen Gartz","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2126698385","eid":"W2126698385"},{"id":"paper-w4405565174","cat":"papers","name":"The Australia story: Current status and future challenges for the clinical applications of psychedelics","year":"2024","cit":22,"pfa":"David Nutt","psa":"Paul Bernard Fitzgerald","topics":["Depression","PTSD & trauma","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4405565174","eid":"W4405565174"},{"id":"paper-w2160300637","cat":"papers","name":"THE EFFECT OF 5-HYDROXYTRYPTAMINE AND TWO OF ITS ANTAGONISTS ON OVULATION IN THE MOUSE","year":"1967","cit":22,"pfa":"Pamela Brown","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2160300637","eid":"W2160300637"},{"id":"paper-w1969915143","cat":"papers","name":"Strategies for the capillary electrophoretic separation of indole alkaloids in Psilocybe semilanceata","year":"1998","cit":22,"pfa":"Stig Pedersen‐Bjergaard","psa":"Ellen Sannes","ptype":"article","src":"https://openalex.org/W1969915143","eid":"W1969915143"},{"id":"paper-w193406161","cat":"papers","name":"Neoclerodanes as Atypical Opioid Receptor Ligands","year":"2013","cit":22,"pfa":"Thomas Edward Prisinzano","topics":["Addiction","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W193406161","eid":"W193406161"},{"id":"paper-w2070593098","cat":"papers","name":"Chronic Phenethylamine Hallucinogen Treatment Alters Behavioral Sensitivity to a Metabotropic Glutamate 2/3 Receptor Agonist","year":"2007","cit":22,"pfa":"Michael A. Benneyworth","psa":"Elaine Sanders‐Bush","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2070593098","eid":"W2070593098"},{"id":"paper-w1980425643","cat":"papers","name":"Studies on striatal neurotoxicity caused by the 3,4-methylenedioxymethamphetamine/ malonate combination: implications for serotonin/dopamine interactions","year":"2006","cit":22,"pfa":"Beatriz Goñi‐Allo","psa":"Norberto Aguirre","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1980425643","eid":"W1980425643"},{"id":"paper-w4404836981","cat":"papers","name":"Psychedelics for the Treatment of Obsessive–Compulsive Disorder: Efficacy and Proposed Mechanisms","year":"2024","cit":22,"pfa":"Helen M Collins","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4404836981","eid":"W4404836981"},{"id":"paper-w2071720865","cat":"papers","name":"Methylenedioxymethamphetamine (Ecstasy) Decreases Neutrophil Activity and Alters Leukocyte Distribution in Bone Marrow, Spleen and Blood","year":"2009","cit":22,"pfa":"Viviane Ferraz de Paula","psa":"João Palermo‐Neto","ptype":"article","src":"https://openalex.org/W2071720865","eid":"W2071720865"},{"id":"paper-w2066316290","cat":"papers","name":"Effect of 3,4-methylenedioxymethamphetamine on [3H]paroxetine binding in the frontal cortex and blood platelets of rats","year":"1991","cit":22,"pfa":"J. Frank Nash","psa":"Herbert Y. Meltzer","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2066316290","eid":"W2066316290"},{"id":"paper-w2064647275","cat":"papers","name":"3,4-Methylenedioxymethamphetamine Activates Nuclear Factor-κB, Increases Intracellular Calcium, and Modulates Gene Transcription in Rat Heart Cells","year":"2005","cit":22,"pfa":"David A. Tiangco","psa":"Barbara Hargrave","ptype":"article","src":"https://openalex.org/W2064647275","eid":"W2064647275"},{"id":"paper-w1975370923","cat":"papers","name":"Demethyl analogs of psychoactive methoxyphenalkylamines: synthesis and serotonin receptor affinities","year":"1980","cit":22,"pfa":"Richard A. Glennon","psa":"John A. Rosecrans","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1975370923","eid":"W1975370923"},{"id":"paper-w2975755375","cat":"papers","name":"The psychedelic renaissance: the next trip for psychiatry?","year":"2019","cit":22,"pfa":"John Richard Kelly","psa":"Veronica O’Keane","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2975755375","eid":"W2975755375"},{"id":"paper-w1980185092","cat":"papers","name":"The Effect of the Repeated Administration of the Compound 3,4-Methylenedioxymethamphetamineon the Response of Rats to the5-HT2A,C Receptor Agonist (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)","year":"1997","cit":22,"pfa":"Martin I. Granoff","psa":"C. R. Ashby","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1980185092","eid":"W1980185092"},{"id":"paper-w4407024749","cat":"papers","name":"Effects of repeated administration of 3,4-methylenedioxymethamphetamine on 5-hydroxytryptamine neuronal activity and release in the rat brain in vivo.","year":"1996","cit":22,"pfa":"Sarah E. Gartside","psa":"T Sharp","ptype":"article","src":"https://openalex.org/W4407024749","eid":"W4407024749"},{"id":"paper-w2142270930","cat":"papers","name":"Synthetic studies of neoclerodane diterpenes from Salvia divinorum: role of the furan in affinity for opioid receptors","year":"2009","cit":22,"pfa":"Denise S. Simpson","psa":"Thomas Edward Prisinzano","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2142270930","eid":"W2142270930"},{"id":"paper-w4317355030","cat":"papers","name":"Group format psychedelic-assisted therapy interventions: Observations and impressions from the HOPE trial","year":"2023","cit":22,"pfa":"Benjamin R. Lewis","psa":"Anna Catherine Beck","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4317355030","eid":"W4317355030"},{"id":"paper-w1521941356","cat":"papers","name":"Nephrotoxicity of recreational party drugs","year":"2011","cit":22,"pfa":"Linda Berney‐Meyer","psa":"ROBERT WALKER","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1521941356","eid":"W1521941356"},{"id":"paper-w2143012104","cat":"papers","name":"Microwave-induced rapid preparation of fluoro-derivatives of amphetamine, methamphetamine, and 3,4-methylenedioxymethamphetamine for GC-MS confirmation assays","year":"1994","cit":22,"pfa":"W C Thompson","psa":"Amitava Dasgupta","ptype":"article","src":"https://openalex.org/W2143012104","eid":"W2143012104"},{"id":"paper-w2944291945","cat":"papers","name":"A validated GC–MS method for ketamine and norketamine in hair and its use in authentic cases","year":"2019","cit":22,"pfa":"José Manuel Matey","psa":"Gemma Montalvo","ptype":"article","src":"https://openalex.org/W2944291945","eid":"W2944291945"},{"id":"paper-w1988256028","cat":"papers","name":"Reckless behaviour related to the use of 3,4-methylenedioxymethamphetamine (ecstasy): Apropos of a fatal accident during car-surfing","year":"1994","cit":22,"pfa":"Peter J. Hooft","psa":"Herman P. van de Voorde","ptype":"article","src":"https://openalex.org/W1988256028","eid":"W1988256028"},{"id":"paper-w2003016481","cat":"papers","name":"Behavioral and EEG Changes Induced by Injection of Schizophrenic Urine Extract","year":"1959","cit":22,"pfa":"Jun Wada","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2003016481","eid":"W2003016481"},{"id":"paper-w2617950715","cat":"papers","name":"Specific harm reduction strategies employed by 3,4-methylenedioxymethamphetmine/ ecstasy users in the United States and the United Kingdom","year":"2017","cit":22,"pfa":"Alan K. Davis","psa":"Harold Rosenberg","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2617950715","eid":"W2617950715"},{"id":"paper-w2964974882","cat":"papers","name":"False positive amphetamines and 3,4-methylenedioxymethamphetamine immunoassays in the presence of metoprolol—two cases reported in clinical toxicology","year":"2019","cit":22,"pfa":"Marion Leclercq","psa":"Laurence Labat","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2964974882","eid":"W2964974882"},{"id":"paper-w2470545286","cat":"papers","name":"Antidepressant, Antipsychotic, and Hallucinogen Drugs for the Treatment of Psychiatric Disorders: A Convergence at the Serotonin-2A Receptor","year":"2016","cit":22,"pfa":"Robert H. Howland","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W2470545286","eid":"W2470545286"},{"id":"paper-w2409827928","cat":"papers","name":"[Acute higher funghi mushroom poisoning and its treatment].","year":"2003","cit":22,"pfa":"Philippe Saviuc","psa":"Françoise Flesch","topics":["Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W2409827928","eid":"W2409827928"},{"id":"paper-w2547276594","cat":"papers","name":"When plenty is too much: water intoxication in a patient with a simple urinary tract infection","year":"2016","cit":22,"pfa":"Laura Christine Lee","psa":"Maryann Noronha","ptype":"article","src":"https://openalex.org/W2547276594","eid":"W2547276594"},{"id":"paper-w1977949657","cat":"papers","name":"Role of Five Synthetic Reaction Conditions on the Stable Isotopic Composition of 3,4-Methylenedioxymethamphetamine","year":"2010","cit":22,"pfa":"Hilary A. S. Buchanan","psa":"Jenny C. Hill","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1977949657","eid":"W1977949657"},{"id":"paper-w2743042724","cat":"papers","name":"Marine Inspired 2-(5-Halo-1H-indol-3-yl)-N,N-dimethylethanamines as Modulators of Serotonin Receptors: An Example Illustrating the Power of Bromine as Part of the Uniquely Marine Chemical Space","year":"2017","cit":22,"pfa":"Mohamed A. Ibrahim","psa":"Mark T. Hamann","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2743042724","eid":"W2743042724"},{"id":"paper-w4400335852","cat":"papers","name":"Unraveling psilocybin’s therapeutic potential: behavioral and neuroplasticity insights in Wistar-Kyoto and Wistar male rat models of treatment-resistant depression","year":"2024","cit":22,"pfa":"Magdalena Kolasa","psa":"Agata Faron‐Górecka","topics":["Depression","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4400335852","eid":"W4400335852"},{"id":"paper-w4401122737","cat":"papers","name":"Psychedelic Therapy Scrutinized by FDA Advisory Committee?","year":"2024","cit":22,"pfa":"Mason Marks","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4401122737","eid":"W4401122737"},{"id":"paper-w2913227533","cat":"papers","name":"Current status of psychedelic therapy in Australia and New Zealand: Are we falling behind?","year":"2019","cit":22,"pfa":"Antonio Inserra","ptype":"article","src":"https://openalex.org/W2913227533","eid":"W2913227533"},{"id":"paper-w4210366495","cat":"papers","name":"Psychedelic Group Therapy","year":"2021","cit":22,"pfa":"Peter Gasser","ptype":"book-chapter","src":"https://openalex.org/W4210366495","eid":"W4210366495"},{"id":"paper-w4311498973","cat":"papers","name":"Therapeutic uses of psychedelics for eating disorders and body dysmorphic disorder","year":"2022","cit":22,"pfa":"Nicole Ledwos","psa":"David Jonathan Castle","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4311498973","eid":"W4311498973"},{"id":"paper-w4362584398","cat":"papers","name":"Not in the drug, not in the brain: Causality in psychedelic experiences from an enactive perspective","year":"2023","cit":22,"pfa":"Daniel Meling","psa":"Milan Scheidegger","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4362584398","eid":"W4362584398"},{"id":"paper-w4408734559","cat":"papers","name":"Insights on psychedelics: A systematic review of therapeutic effects","year":"2025","cit":22,"pfa":"Joshua Kugel","psa":"Paul Liknaitzky","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W4408734559","eid":"W4408734559"},{"id":"paper-w4281558645","cat":"papers","name":"If the Doors of Perception Were Cleansed, Would Chronic Pain be Relieved? Evaluating the Benefits and Risks of Psychedelics","year":"2022","cit":22,"pfa":"Robert H. Dworkin","psa":"Eric C. Strain","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4281558645","eid":"W4281558645"},{"id":"paper-w4246819011","cat":"papers","name":"Nicotiana an Hallucinogen?","year":"1976","cit":22,"pfa":"Oscar Janiger","psa":"Marlene Dobkin de Ríos","ptype":"article","src":"https://openalex.org/W4246819011","eid":"W4246819011"},{"id":"paper-w2417999625","cat":"papers","name":"Hallucinogens and serotonergic mechanisms.","year":"1992","cit":22,"pfa":"Richard A. Glennon","psa":"Elaine Sanders‐Bush","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2417999625","eid":"W2417999625"},{"id":"paper-w2025224709","cat":"papers","name":"Psychointegrators: Multidisciplinary Perspectives on the Therapeutic Effects of Hallucinogens","year":"2001","cit":22,"pfa":"Michael Winkelman","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2025224709","eid":"W2025224709"},{"id":"paper-w4366982137","cat":"papers","name":"Toward a Broader Psychedelic Bioethics","year":"2023","cit":22,"pfa":"Edward Jacobs","psa":"Brian David Earp","topics":["Addiction","Policy & ethics"],"ptype":"editorial","src":"https://openalex.org/W4366982137","eid":"W4366982137"},{"id":"paper-w4399650907","cat":"papers","name":"Personal psychedelic experience of psychedelic therapists during training: should it be required, optional, or prohibited?","year":"2024","cit":22,"pfa":"Daniel Villiger","topics":["Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4399650907","eid":"W4399650907"},{"id":"paper-w3210625928","cat":"papers","name":"Foundations for Training Psychedelic Therapists","year":"2021","cit":22,"pfa":"Janis Phelps","psa":"James Henry","topics":["Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W3210625928","eid":"W3210625928"},{"id":"paper-w4387267866","cat":"papers","name":"Bedside to bench: the outlook for psychedelic research","year":"2023","cit":22,"pfa":"Victor P. Acero","psa":"Daniel Kacy Cullen","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4387267866","eid":"W4387267866"},{"id":"paper-w2912087399","cat":"papers","name":"Hallucinogen-persisting Perception Disorder in a 21-year-old Man","year":"2019","cit":22,"pfa":"Muhannad Kurtom","psa":"Eduardo D Espiridion","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2912087399","eid":"W2912087399"},{"id":"paper-w4224309261","cat":"papers","name":"Psychedelic Mystical Experience: A New Agenda for Theology","year":"2022","cit":22,"pfa":"Ron Cole‐Turner","topics":["Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4224309261","eid":"W4224309261"},{"id":"paper-w2951354845","cat":"papers","name":"Simultaneous phenotyping of CYP2E1 and CYP3A using oral chlorzoxazone and midazolam microdoses","year":"2019","cit":22,"pfa":"Nicolas Hohmann","psa":"Walter E. Haefeli","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2951354845","eid":"W2951354845"},{"id":"paper-w4205515022","cat":"papers","name":"Philosophy and classic psychedelics: A review of some emerging themes","year":"2022","cit":22,"pfa":"Chris Letheby","psa":"Jaipreet Mattu","topics":["Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4205515022","eid":"W4205515022"},{"id":"paper-w4390485036","cat":"papers","name":"Psychotherapy in Psychedelic Treatment: Safe, Evidence-Based, and Necessary","year":"2024","cit":22,"pfa":"Michael D. Alpert","psa":"Michael C. Mithoefer","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4390485036","eid":"W4390485036"},{"id":"paper-w4391959916","cat":"papers","name":"Are Psychedelic Experiences Transformative? Can We Consent to Them?","year":"2024","cit":22,"pfa":"Brent Michael Kious","psa":"Amy L. McGuire","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4391959916","eid":"W4391959916"},{"id":"paper-w2970418576","cat":"papers","name":"Psychedelics for Psychological and Existential Distress in Palliative and Cancer Care","year":"2019","cit":22,"pfa":"Daniel Rosenbaum","psa":"Martin Robert Chasen","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2970418576","eid":"W2970418576"},{"id":"paper-w2074304759","cat":"papers","name":"Activation of adenosine1 (A1) receptors suppresses head shakes induced by a serotonergic hallucinogen in rats","year":"2009","cit":22,"pfa":"Gerard J. Marek","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2074304759","eid":"W2074304759"},{"id":"paper-w2971752404","cat":"papers","name":"Can Psychedelic Drugs Attenuate Age-Related Changes in Cognition and Affect?","year":"2019","cit":22,"pfa":"Jacob S. Aday","psa":"Christopher C. Davoli","ptype":"article","src":"https://openalex.org/W2971752404","eid":"W2971752404"},{"id":"paper-w2015210217","cat":"papers","name":"Clinical Relevance of Liquid Chromatography Tandem Mass Spectrometry as an Analytical Method in Microdose Clinical Studies","year":"2011","cit":22,"pfa":"Naoe Yamane","psa":"Yuichi Sugiyama","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2015210217","eid":"W2015210217"},{"id":"paper-w4404543186","cat":"papers","name":"Adverse psychiatric effects of psychedelic drugs: a systematic review of case reports","year":"2024","cit":22,"pfa":"B. Yildirim","psa":"Peter J. McKenna","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"review","src":"https://openalex.org/W4404543186","eid":"W4404543186"},{"id":"paper-w2206221553","cat":"papers","name":"Growth Hormone Supplementation in the Luteal Phase Before Microdose GnRH Agonist Flare Protocol for In Vitro Fertilization","year":"2015","cit":22,"pfa":"Caitlin Dunne","psa":"Jeffrey Roberts","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2206221553","eid":"W2206221553"},{"id":"paper-w2001007038","cat":"papers","name":"Investigating the Mechanisms of Hallucinogen-Induced Visions Using 3,4-Methylenedioxyamphetamine (MDA): A Randomized Controlled Trial in Humans","year":"2010","cit":22,"pfa":"Matthew J. Baggott","psa":"John E. Mendelson","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2001007038","eid":"W2001007038"},{"id":"paper-w3179395122","cat":"papers","name":"Perpetrator Characteristics of Azole Antifungal Drugs on Three Oral Factor Xa Inhibitors Administered as a Microdosed Cocktail","year":"2021","cit":22,"pfa":"Brit Silja Rohr","psa":"Gerd Mikus","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3179395122","eid":"W3179395122"},{"id":"paper-w4322744805","cat":"papers","name":"Psychedelic replications in virtual reality and their potential as a therapeutic instrument: an open-label feasibility study","year":"2023","cit":22,"pfa":"Kristjan Kaup","psa":"Jaan Aru","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W4322744805","eid":"W4322744805"},{"id":"paper-w2028939911","cat":"papers","name":"Comparative effects of stereoisomers of psychotomimetic phenylisopropylamines","year":"1973","cit":22,"pfa":"Donald C. Dyer","psa":"Charles F. Barfknecht","ptype":"article","src":"https://openalex.org/W2028939911","eid":"W2028939911"},{"id":"paper-w2026335552","cat":"papers","name":"Comparative Efficacy of Two Microdoses of a Potentized Homeopathic Drug, Arsenicum Album, to Ameliorate Toxicity Induced by Repeated Sublethal Injections of Arsenic Trioxide in Mice","year":"2008","cit":22,"pfa":"Pathikrit Banerjee","psa":"Anisur Rahman Khuda‐Bukhsh","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2026335552","eid":"W2026335552"},{"id":"paper-w4212983967","cat":"papers","name":"Investigational drugs for assisting psychotherapy for posttraumatic stress disorder (PTSD): emerging approaches and shifting paradigms in the era of psychedelic medicine","year":"2022","cit":22,"pfa":"Lynnette A. Averill","psa":"Chadi G. Abdallah","topics":["PTSD & trauma","Dosing & pharmacology","Therapy practice"],"ptype":"editorial","src":"https://openalex.org/W4212983967","eid":"W4212983967"},{"id":"paper-w1967343247","cat":"papers","name":"The comparision of effect of microdose GnRH-a flare-up, GnRH antagonist/aromatase inhibitor letrozole and GnRH antagonist/clomiphene citrate protocols on IVF outcomes in poor responder patients","year":"2014","cit":22,"pfa":"Pınar Özcan","psa":"Çiğdem Kaspar","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1967343247","eid":"W1967343247"},{"id":"paper-w1989252961","cat":"papers","name":"Intracerebral Injection of Psychotomimetic and Psychotherapeutic Drugs into Conscious Mice*)","year":"1957","cit":22,"pfa":"Thomas J. Haley","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W1989252961","eid":"W1989252961"},{"id":"paper-w4396734486","cat":"papers","name":"1-(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane (DOI): From an Obscure to Pivotal Member of the DOX Family of Serotonergic Psychedelic Agents – A Review","year":"2024","cit":22,"pfa":"Richard A. Glennon","psa":"Maƚgorzata Dukat","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4396734486","eid":"W4396734486"},{"id":"paper-w2323012693","cat":"papers","name":"Review and Evaluation of Current Drug Therapies in Alcoholism","year":"1966","cit":22,"pfa":"Keith S. Ditman","topics":["Depression","Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2323012693","eid":"W2323012693"},{"id":"paper-w2031458215","cat":"papers","name":"Psilocybian Mycetismus With Special Reference To Panaeolus","year":"1976","cit":22,"pfa":"Steven Hayden Pollock","ptype":"article","src":"https://openalex.org/W2031458215","eid":"W2031458215"},{"id":"paper-w2007986618","cat":"papers","name":"Relation of Pharmacological and Behavioral Effects of a Hallucinogenic Amphetamine to Distribution in Cat Brain","year":"1969","cit":22,"pfa":"Juhana E. Idänpään-Heikkilä","psa":"L. Wayne Tansey","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2007986618","eid":"W2007986618"},{"id":"paper-w3081094788","cat":"papers","name":"A Five-in-One First-in-Human Study To Assess Safety, Tolerability, and Pharmacokinetics of RO7049389, an Inhibitor of Hepatitis B Virus Capsid Assembly, after Single and Multiple Ascending Doses in Healthy Participants","year":"2020","cit":22,"pfa":"Sheng Feng","psa":"Yuyan Jin","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3081094788","eid":"W3081094788"},{"id":"paper-w3023298396","cat":"papers","name":"Phytochemicals, Pharmacological Properties and Biotechnological Aspects of Highly Medicinal Plant: Datura stramonium","year":"2020","cit":22,"pfa":"Aamana Batool","psa":"Naveed Iqbal Raja","topics":["Anxiety & end-of-life","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3023298396","eid":"W3023298396"},{"id":"paper-w2086242775","cat":"papers","name":"Glycopyrrolate compared with atropine in association with ketamine anaesthesia","year":"1987","cit":22,"pfa":"Palle Toft","psa":"U Rømer","ptype":"article","src":"https://openalex.org/W2086242775","eid":"W2086242775"},{"id":"paper-w4391480382","cat":"papers","name":"Novel rapid treatment options for adolescent depression","year":"2024","cit":22,"pfa":"Sandra Ledesma‐Corvi","psa":"María Julia García-Fuster","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4391480382","eid":"W4391480382"},{"id":"paper-w2148467252","cat":"papers","name":"Ketamine for pain management in France, an observational survey","year":"2015","cit":22,"pfa":"Valeria Martinez","psa":"Hélène Beloeil","ptype":"article","src":"https://openalex.org/W2148467252","eid":"W2148467252"},{"id":"paper-w2325423033","cat":"papers","name":"Nitrous Oxide (N2O)-Induced Acute Psychosis","year":"2014","cit":22,"pfa":"Sophia Wong","psa":"Ging‐Yuek Robin Hsiung","ptype":"article","src":"https://openalex.org/W2325423033","eid":"W2325423033"},{"id":"paper-w3034628751","cat":"papers","name":"Veterans Health and Well-Being—Collaborative Research Approaches: Toward Veteran Community Engagement","year":"2020","cit":22,"pfa":"Zeno E. Franco","psa":"Rae Anne Frey-Ho Fung","topics":["PTSD & trauma","Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3034628751","eid":"W3034628751"},{"id":"paper-w2070994067","cat":"papers","name":"Ketamine and Midazolam for Invasive Procedures in Children with Malignancy: A Comparison of Routes of Intravenous, Oral, and Rectal Administration","year":"2004","cit":22,"pfa":"D. Ozdemir","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2070994067","eid":"W2070994067"},{"id":"paper-w4310422008","cat":"papers","name":"Clinical Trial Design Challenges and Opportunities for Emerging Treatments for Opioid Use Disorder","year":"2022","cit":22,"pfa":"Brian D. Kiluk","psa":"Eric C. Strain","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4310422008","eid":"W4310422008"},{"id":"paper-w3093947739","cat":"papers","name":"In vitro characterization of new psychoactive substances at the μ-opioid, CB1, 5HT1A, and 5-HT2A receptors—On-target receptor potency and efficacy, and off-target effects","year":"2020","cit":22,"pfa":"Anna Åstrand","psa":"Henrik Gréen","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3093947739","eid":"W3093947739"},{"id":"paper-w2808053801","cat":"papers","name":"Effect of rectal douching/enema on rectal gonorrhoea and chlamydia among a cohort of men who have sex with men on HIV pre-exposure prophylaxis","year":"2018","cit":22,"pfa":"Adiba Hassan","psa":"Sheldon Morris","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2808053801","eid":"W2808053801"},{"id":"paper-w2265417724","cat":"papers","name":"Regional brain dysregulation of Ca2+-handling systems in ketamine-induced rat model of experimental psychosis","year":"2015","cit":22,"pfa":"Malwina Lisek","psa":"Ludmiła Żylińska","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2265417724","eid":"W2265417724"},{"id":"paper-w2598012703","cat":"papers","name":"A Neurophysiological Perspective on a Preventive Treatment against Schizophrenia Using Transcranial Electric Stimulation of the Corticothalamic Pathway","year":"2017","cit":22,"pfa":"Didier Pinault","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2598012703","eid":"W2598012703"},{"id":"paper-w1987258940","cat":"papers","name":"Solubilization and Characterization of σ‐Receptors from Guinea Pig Brain Membranes","year":"1989","cit":22,"pfa":"Michael P. Kavanaugh","psa":"E Weber","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1987258940","eid":"W1987258940"},{"id":"paper-w4200502758","cat":"papers","name":"Atypical, but not typical, antipsychotic drugs reduce hypersynchronized prefrontal-hippocampal circuits during psychosis-like states in mice: contribution of 5-HT2A and 5-HT1A receptors","year":"2021","cit":22,"pfa":"Cristina Delgado-Sallent","psa":"Maria Victoria Puig","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4200502758","eid":"W4200502758"},{"id":"paper-w2799440698","cat":"papers","name":"Agmatine potentiates neuroprotective effects of subthreshold concentrations of ketamine via mTOR/S6 kinase signaling pathway","year":"2018","cit":22,"pfa":"Mauren K. Tavares","psa":"Andiara E. Freitas","ptype":"article","src":"https://openalex.org/W2799440698","eid":"W2799440698"},{"id":"paper-w4402188899","cat":"papers","name":"Effects of arketamine on depression-like behaviors and demyelination in mice exposed to chronic restrain stress: A role of transforming growth factor-β1","year":"2024","cit":22,"pfa":"Dan Xu","psa":"Kenji Hashimoto","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4402188899","eid":"W4402188899"},{"id":"paper-w4385764533","cat":"papers","name":"Esketamine versus placebo on time to remission in major depressive disorder with acute suicidality","year":"2023","cit":22,"pfa":"Dong‐Jing Fu","psa":"Carla M. Canuso","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4385764533","eid":"W4385764533"},{"id":"paper-w4311498791","cat":"papers","name":"Dose‐dependent effects of esketamine on brain activity in awake mice: A BOLD phMRI study","year":"2022","cit":22,"pfa":"Kyrsten Kawazoe","psa":"Craig F. Ferris","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4311498791","eid":"W4311498791"},{"id":"paper-w4293531226","cat":"papers","name":"The association between stage of treatment-resistant depression and clinical utility of ketamine/esketamine: A systematic review","year":"2022","cit":22,"pfa":"Anastasia Levinta","psa":"Joshua Daniel Rosenblat","topics":["Depression","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4293531226","eid":"W4293531226"},{"id":"paper-w4401738383","cat":"papers","name":"Disembodiment and Affective Resonances in Esketamine Treatment of Depersonalized Depression Subtype: Two Case Studies","year":"2024","cit":22,"pfa":"Pietro Sarasso","psa":"Gilberto Di Petta","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4401738383","eid":"W4401738383"},{"id":"paper-w3183296242","cat":"papers","name":"Treatment Response With Esketamine Nasal Spray Plus an Oral Antidepressant in Patients With Treatment-Resistant Depression Without Evidence of Early Response","year":"2021","cit":22,"pfa":"Ibrahim Turkoz","psa":"J. Craig Nelson","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W3183296242","eid":"W3183296242"},{"id":"paper-w3162004623","cat":"papers","name":"Trait dissociation as a predictor of induced dissociation by ketamine or esketamine in treatment-resistant depression: Secondary analysis from a randomized controlled trial","year":"2021","cit":22,"pfa":"Rodrigo Paixão Mello","psa":"Lucas C. Quarantini","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W3162004623","eid":"W3162004623"},{"id":"paper-w4386732609","cat":"papers","name":"Short-term cognitive effects of repeated-dose esketamine in adolescents with major depressive disorder and suicidal ideation: a randomized controlled trial","year":"2023","cit":22,"pfa":"Xiaofeng Lan","psa":"Yanling Zhou","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4386732609","eid":"W4386732609"},{"id":"paper-w4392454334","cat":"papers","name":"Effect of subanesthetic dose of esketamine on postoperative pain in elderly patients undergoing laparoscopic gastrointestinal tumor Surgery:A prospective, double-blind, randomized controlled trial","year":"2024","cit":22,"pfa":"Zhaojun Jing","psa":"Peng Jiang","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4392454334","eid":"W4392454334"},{"id":"paper-w2969661467","cat":"papers","name":"Ketamine in the Treatment of Depressive Episodes","year":"2019","cit":22,"pfa":"Philipp S. Ritter","psa":"Michael Bauer","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2969661467","eid":"W2969661467"},{"id":"paper-w2966049677","cat":"papers","name":"Association between dynamic resting-state functional connectivity and ketamine plasma levels in visual processing networks","year":"2019","cit":22,"pfa":"Marie Spies","psa":"Rupert R. Lanzenberger","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2966049677","eid":"W2966049677"},{"id":"paper-w3112237162","cat":"papers","name":"The Ketamine Antidepressant Story: New Insights","year":"2020","cit":22,"pfa":"Tahani K. Alshammari","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3112237162","eid":"W3112237162"},{"id":"paper-w2042033499","cat":"papers","name":"LSD and tryptamine effects on sleep/wakefulness and electrocorticogram patterns in intact cats","year":"1978","cit":22,"pfa":"David C. Kay","psa":"William R. Martin","ptype":"article","src":"https://openalex.org/W2042033499","eid":"W2042033499"},{"id":"paper-w70378666","cat":"papers","name":"DMT at fifty.","year":"2007","cit":22,"pfa":"Stephen Szára","topics":["Addiction","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W70378666","eid":"W70378666"},{"id":"paper-w2414083585","cat":"papers","name":"Is it possible to predict the clinical effects of neuroleptics from animal data? Part V: From haloperidol and pipamperone to risperidone.","year":"1994","cit":22,"pfa":"Paul A. J. Janssen","psa":"Frans H. L. Awouters","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2414083585","eid":"W2414083585"},{"id":"paper-w2140348858","cat":"papers","name":"Lysergic Acid Diethylamide: An Historical Perspective","year":"1967","cit":21,"pfa":"David Eugene Smith","ptype":"article","src":"https://openalex.org/W2140348858","eid":"W2140348858"},{"id":"paper-w1971241492","cat":"papers","name":"Active Transport of Lysergic Acid Diethylamide","year":"1972","cit":21,"pfa":"Ernest Marshall Wright","ptype":"article","src":"https://openalex.org/W1971241492","eid":"W1971241492"},{"id":"paper-w2017936970","cat":"papers","name":"Permissive Group Therapy with Lysergic Acid Diethylamide","year":"1963","cit":21,"pfa":"A.M. Spencer","topics":["PTSD & trauma","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2017936970","eid":"W2017936970"},{"id":"paper-w2181864271","cat":"papers","name":"THE USE OF LYSERGIC ACID DIETHYLAMIDE (LSD) IN PSYCHOTHERAPY.","year":"1964","cit":21,"pfa":"E. F. W. Baker","topics":["Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2181864271","eid":"W2181864271"},{"id":"paper-w2130670746","cat":"papers","name":"Effects of Lysergic Acid Diethylamide (LSD) on the Time Sense of Normals","year":"1957","cit":21,"pfa":"William K. Boardman","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2130670746","eid":"W2130670746"},{"id":"paper-w1995579500","cat":"papers","name":"The Occurrence of Psilocybin and Psilocin in Finnish Fungi","year":"1987","cit":21,"pfa":"E. Ohenoja","psa":"M.M. Airaksinen","ptype":"article","src":"https://openalex.org/W1995579500","eid":"W1995579500"},{"id":"paper-w1802367830","cat":"papers","name":"The chromosomal and teratogenic effects of lysergic acid diethylamide: a review of the current literature.","year":"1968","cit":21,"pfa":"Reginald G. Smart","psa":"K Bateman","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1802367830","eid":"W1802367830"},{"id":"paper-w2344566138","cat":"papers","name":"Quantitative studies in humans on the antagonism of lysergic acid diethylamide by chlorpromazine and phenoxybenzamine","year":"1962","cit":21,"pfa":"Henry B. Murphree","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2344566138","eid":"W2344566138"},{"id":"paper-w1976269574","cat":"papers","name":"Occurrence of Psilocybin/Psilocin in Pluteus Salicinus (Pluteaceae)","year":"1981","cit":21,"pfa":"Stephen G. Saupe","ptype":"article","src":"https://openalex.org/W1976269574","eid":"W1976269574"},{"id":"paper-w2070775478","cat":"papers","name":"Lysergic Acid Diethylamide (Lsd-25): Xvi. the Effect on Intellectual Functioning as Measured By the Wechsler-Bellevue Intelligence Scale","year":"1955","cit":21,"pfa":"A. Levine","psa":"Sylvia Markham","ptype":"article","src":"https://openalex.org/W2070775478","eid":"W2070775478"},{"id":"paper-w4388493282","cat":"papers","name":"Main targets of ibogaine and noribogaine associated with its putative anti-addictive effects: A mechanistic overview","year":"2023","cit":21,"pfa":"Genís Oña","psa":"José Carlos Bouso","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4388493282","eid":"W4388493282"},{"id":"paper-w4282828286","cat":"papers","name":"Effects of acute lysergic acid diethylamide on intermittent ethanol and sucrose drinking and intracranial self-stimulation in C57BL/6 mice","year":"2022","cit":21,"pfa":"Lauri V. Elsilä","psa":"Esa R. Korpi","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4282828286","eid":"W4282828286"},{"id":"paper-w4406403059","cat":"papers","name":"Clinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post-Hoc Analysis","year":"2025","cit":21,"pfa":"Marije E. Otto","psa":"J. G. Coen van Hasselt","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4406403059","eid":"W4406403059"},{"id":"paper-w2039435942","cat":"papers","name":"Effect of Intravenous Administration of D‐Lysergic Acid Diethylamide on Initiation of Protein Synthesis in a Cell‐Free System Derived from Brain","year":"1984","cit":21,"pfa":"James W. Cosgrove","psa":"Ian R. Brown","ptype":"article","src":"https://openalex.org/W2039435942","eid":"W2039435942"},{"id":"paper-w2149515141","cat":"papers","name":"Comparison of EMIT(R) II, CEDIA(R) and DPC(R) RIA Assays for the Detection of Lysergic Acid Diethylamide in Forensic Urine Samples","year":"2002","cit":21,"pfa":"R. F. Wiegand","psa":"Jay M. Gehlhausen","ptype":"article","src":"https://openalex.org/W2149515141","eid":"W2149515141"},{"id":"paper-w3012391691","cat":"papers","name":"The Ibogaine Experience: A Qualitative Study on the Acute Subjective Effects of Ibogaine","year":"2020","cit":21,"pfa":"Maja Kohek","psa":"José Carlos Bouso","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3012391691","eid":"W3012391691"},{"id":"paper-w4391490374","cat":"papers","name":"Perceived Risk of Trying Lysergic Acid Diethylamide in the United States from 2015 to 2019: Are Americans Assessing Lysergic Acid Diethylamide's Risk Profile More Favorably?","year":"2024","cit":21,"pfa":"Brian Scott Barnett","psa":"Jeremy Weleff","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4391490374","eid":"W4391490374"},{"id":"paper-w2412743893","cat":"papers","name":"Biosynthesis of the peyote alkaloids.","year":"1973","cit":21,"pfa":"A G Paul","ptype":"article","src":"https://openalex.org/W2412743893","eid":"W2412743893"},{"id":"paper-w1981559928","cat":"papers","name":"Stereochemical Requirements of the Mescaline Receptor","year":"1972","cit":21,"pfa":"P. D. COOPER","psa":"Gary C. Walters","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1981559928","eid":"W1981559928"},{"id":"paper-w4402713429","cat":"papers","name":"Oxa-Iboga alkaloids lack cardiac risk and disrupt opioid use in animal models","year":"2024","cit":21,"pfa":"Václav Havel","psa":"Dalibor Sameš","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4402713429","eid":"W4402713429"},{"id":"paper-w2048571691","cat":"papers","name":"Flashbacks following MDMA","year":"1992","cit":21,"pfa":"Philip K. McGuire","psa":"Tom Fahy","ptype":"article","src":"https://openalex.org/W2048571691","eid":"W2048571691"},{"id":"paper-w1981089731","cat":"papers","name":"The Peyote Way: Implications for Culture Care Theory","year":"1994","cit":21,"pfa":"Kathleen W. Huttlinger","psa":"Dennis C. Tanner","ptype":"article","src":"https://openalex.org/W1981089731","eid":"W1981089731"},{"id":"paper-w2430149146","cat":"papers","name":"Death related to consumption of Rauvolfia sp. powder mislabeled as Tabernanthe iboga","year":"2016","cit":21,"pfa":"Thomas Gicquel","psa":"Isabelle Morel","ptype":"article","src":"https://openalex.org/W2430149146","eid":"W2430149146"},{"id":"paper-w2077803255","cat":"papers","name":"Absolute configuration of the iboga and voacanga alkaloids : chiroptical approach","year":"1972","cit":21,"pfa":"K. Bláha","psa":"Jan Trojánek","ptype":"article","src":"https://openalex.org/W2077803255","eid":"W2077803255"},{"id":"paper-w2027876584","cat":"papers","name":"Increased synthesis of striatal dopamine by N,N-dimethyltryptamine","year":"1977","cit":21,"pfa":"Thomas L. Smith","ptype":"article","src":"https://openalex.org/W2027876584","eid":"W2027876584"},{"id":"paper-w2412725455","cat":"papers","name":"The case for MDMA (ecstasy) regulation.","year":"2015","cit":21,"pfa":"Joshua Donelly","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2412725455","eid":"W2412725455"},{"id":"paper-w4312093969","cat":"papers","name":"Associations between MDMA/ecstasy, classic psychedelics, and suicidal thoughts and behaviors in a sample of U.S. adolescents","year":"2022","cit":21,"pfa":"Grant M. Jones","psa":"Matthew K. Nock","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4312093969","eid":"W4312093969"},{"id":"paper-w1974029982","cat":"papers","name":"Responses of the extrapyramidal and limbic substance P systems to ibogaine and cocaine treatments","year":"2000","cit":21,"pfa":"Mario E. Alburges","psa":"Glen R. Hanson","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1974029982","eid":"W1974029982"},{"id":"paper-w4394009974","cat":"papers","name":"Psilocybin for dementia prevention? The potential role of psilocybin to alter mechanisms associated with major depression and neurodegenerative diseases","year":"2024","cit":21,"pfa":"Zarah R. Haniff","psa":"Sandrine Thuret","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4394009974","eid":"W4394009974"},{"id":"paper-w2205661146","cat":"papers","name":"XXXVIII. Comparison with Action of Methysergide and Psilocybin on Test Subjects","year":"1965","cit":21,"pfa":"Harold A. Abramson","psa":"A. Rolo","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2205661146","eid":"W2205661146"},{"id":"paper-w2066099605","cat":"papers","name":"Effects of aminoacetonitrile, an amine oxidase inhibitor, on mescaline metabolism in the rabbit","year":"1975","cit":21,"pfa":"Louis J. Riceberg","psa":"Robert H. Abeles","ptype":"article","src":"https://openalex.org/W2066099605","eid":"W2066099605"},{"id":"paper-w2035693707","cat":"papers","name":"Differential effects of ibogaine pretreatment on brain levels of morphine and (+)-amphetamine","year":"1992","cit":21,"pfa":"Stanley D. Glick","psa":"Isabelle M. Maisonneuve","ptype":"article","src":"https://openalex.org/W2035693707","eid":"W2035693707"},{"id":"paper-w173279702","cat":"papers","name":"The Public Health Implications of MDMA Use","year":"1990","cit":21,"pfa":"Jerome Beck","ptype":"book-chapter","src":"https://openalex.org/W173279702","eid":"W173279702"},{"id":"paper-w2023124064","cat":"papers","name":"Elucidating the neurotoxic effects of MDMA and its analogs","year":"2014","cit":21,"pfa":"Senthilkumar S. Karuppagounder","psa":"Muralikrishnan Dhanasekaran","ptype":"article","src":"https://openalex.org/W2023124064","eid":"W2023124064"},{"id":"paper-w2327381916","cat":"papers","name":"Development of an Enzyme Immunoassay Using a Monoclonal Antibody against the Psychoactive Diterpenoid Salvinorin A","year":"2013","cit":21,"pfa":"Madan Kumar Paudel","psa":"Satoshi Morimoto","topics":["Addiction","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2327381916","eid":"W2327381916"},{"id":"paper-w4353020762","cat":"papers","name":"Identifying setting factors associated with improved ibogaine safety: a systematic review of clinical studies","year":"2023","cit":21,"pfa":"Juliana Mendes Rocha","psa":"RAFAEL GUIMARÃES DOS SANTOS","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4353020762","eid":"W4353020762"},{"id":"paper-w1989393468","cat":"papers","name":"Information processing speed in ecstasy (MDMA) users","year":"2007","cit":21,"pfa":"Michelle Wareing","psa":"Martin D. Chandler","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1989393468","eid":"W1989393468"},{"id":"paper-w2146719061","cat":"papers","name":"Occurrence of Psilocybin and Baeocystin in the genus Inocybe (Fr.) Fr","year":"1985","cit":21,"pfa":"T. Stijve","psa":"Th.W. Kuyper","ptype":"article","src":"https://openalex.org/W2146719061","eid":"W2146719061"},{"id":"paper-w2152268740","cat":"papers","name":"Ayahuasca Religions in A cre: Cultural Heritage in the B razilian Borderlands","year":"2012","cit":21,"pfa":"Beatriz Caiuby Labate","topics":["Addiction","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2152268740","eid":"W2152268740"},{"id":"paper-w2803176830","cat":"papers","name":"Total Synthesis of the Neoclerodane Diterpene Salvinorin A via an Intramolecular Diels–Alder Strategy","year":"2018","cit":21,"pfa":"Yuzhou Wang","psa":"Peter Metz","ptype":"article","src":"https://openalex.org/W2803176830","eid":"W2803176830"},{"id":"paper-w2014699634","cat":"papers","name":"Radioimmunoassays of 3,4,5-trimethoxyphenethylamine (mescaline) and 2,5-dimethoxy-4-methylphenyl-isopropylamine(DOM)","year":"1974","cit":21,"pfa":"Louis J. Riceberg","psa":"Lawrence Levine","ptype":"article","src":"https://openalex.org/W2014699634","eid":"W2014699634"},{"id":"paper-w2035799728","cat":"papers","name":"Crystal structures of the Teonanácatl hallucinogens. Part II. Psilocin, C 12 H 15 N 2 O","year":"1974","cit":21,"pfa":"Trevor James Petcher","psa":"Hans Peter Weber","ptype":"article","src":"https://openalex.org/W2035799728","eid":"W2035799728"},{"id":"paper-w2008974398","cat":"papers","name":"Epidemiology of MDMA and Associated Club Drugs in the Seattle Area","year":"2005","cit":21,"pfa":"Caleb J. Banta‐Green","psa":"Barry Kerr Logan","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2008974398","eid":"W2008974398"},{"id":"paper-w2069625646","cat":"papers","name":"Persistent cerebrovascular effects of MDMA and acute responses to the drug","year":"2006","cit":21,"pfa":"Linda Ferrington","psa":"Paul A. Kelly","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2069625646","eid":"W2069625646"},{"id":"paper-w2043873079","cat":"papers","name":"Persistent Psychosis After a Single Ingestion of “Ecstasy” (MDMA)","year":"2011","cit":21,"pfa":"Ankit Patel","psa":"Shakeel Raza","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2043873079","eid":"W2043873079"},{"id":"paper-w2726744335","cat":"papers","name":"A Physician’s Attempt to Self-Medicate Bipolar Depression with N,N-Dimethyltryptamine (DMT)","year":"2017","cit":21,"pfa":"Tanida Brown","psa":"Christian Cornelius","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2726744335","eid":"W2726744335"},{"id":"paper-w2807310333","cat":"papers","name":"A phenomenological investigation into the lived experience of ibogaine and its potential to treat opioid use disorders","year":"2018","cit":21,"pfa":"Thaddeus James Camlin","psa":"Martín Polanco","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2807310333","eid":"W2807310333"},{"id":"paper-w2550606017","cat":"papers","name":"Ecstasy (MDMA) and its effects on kidneys and their treatment: a review.","year":"2016","cit":21,"pfa":"Feyza Bora","psa":"Taner Bora","topics":["PTSD & trauma","Safety & adverse events","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W2550606017","eid":"W2550606017"},{"id":"paper-w2592787644","cat":"papers","name":"Reproductive effects of the psychoactive beverage ayahuasca in male Wistar rats after chronic exposure","year":"2017","cit":21,"pfa":"Alana de Fátima Andrade Santos","psa":"Eloísa Dutra Caldas","topics":["Safety & adverse events","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2592787644","eid":"W2592787644"},{"id":"paper-w4389794307","cat":"papers","name":"Psilocybin and Eugenol Reduce Inflammation in Human 3D EpiIntestinal Tissue","year":"2023","cit":21,"pfa":"Gregory Ian Robinson","psa":"Igor Kovalchuk","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4389794307","eid":"W4389794307"},{"id":"paper-w4293101872","cat":"papers","name":"Skepticism about Recent Evidence That Psilocybin “Liberates” Depressed Minds","year":"2022","cit":21,"pfa":"Manoj K. Doss","psa":"Philip Robert Corlett","topics":["Depression","Mechanism & neuroscience"],"ptype":"editorial","src":"https://openalex.org/W4293101872","eid":"W4293101872"},{"id":"paper-w2084911409","cat":"papers","name":"Biosynthesis of N,N-dimethyltryptamine (DMT) in a melanoma cell line and its metabolization by peroxidases","year":"2014","cit":21,"pfa":"Melissa Medrano Gomes","psa":"Ana Čampa","ptype":"article","src":"https://openalex.org/W2084911409","eid":"W2084911409"},{"id":"paper-w1841823983","cat":"papers","name":"Computational Studies on Effects of MDMA as an Anticancer Drug on DNA","year":"2010","cit":21,"pfa":"Siavash Riahi","psa":"Mohammad Reza Ganjali","topics":["Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1841823983","eid":"W1841823983"},{"id":"paper-w1684950225","cat":"papers","name":"“O meu avo deu a ayahuasca para o Mestre Irineu”: reflexoes sobre a entrada dos indios no circuito urbano de consumo de ayahuasca no Brasil","year":"2014","cit":21,"pfa":"Beatriz Caiuby Labate","psa":"Tiago Coutinho","ptype":"article","src":"https://openalex.org/W1684950225","eid":"W1684950225"},{"id":"paper-w2623470214","cat":"papers","name":"An ontogenic study of the behavioral effects of chronic intermittent exposure to ayahuasca in mice","year":"2017","cit":21,"pfa":"Nelson Francisco Correa-Netto","psa":"Alessandra Linardi","topics":["Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2623470214","eid":"W2623470214"},{"id":"paper-w4280614952","cat":"papers","name":"Chronic Treatment With Psilocybin Decreases Changes in Body Weight in a Rodent Model of Obesity","year":"2022","cit":21,"pfa":"Joyce Yongxu Huang","psa":"Alasdair M. Barr","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4280614952","eid":"W4280614952"},{"id":"paper-w2417295272","cat":"papers","name":"Serotonin antagonists fail to alter MDMA self-administration in rats","year":"2016","cit":21,"pfa":"Susan Schenk","psa":"Jeremy Webster","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2417295272","eid":"W2417295272"},{"id":"paper-w2048029955","cat":"papers","name":"Behavioural and neuroinflammatory effects of the combination of binge ethanol and MDMA in mice","year":"2011","cit":21,"pfa":"Clara Ros‐Simó","psa":"Olga Valverde","ptype":"article","src":"https://openalex.org/W2048029955","eid":"W2048029955"},{"id":"paper-w1986629763","cat":"papers","name":"Akutes Leberversagen nach dem Konsum von Ecstasy (MDMA)","year":"2002","cit":21,"pfa":"N. Lange-Brock","psa":"Hubert Mönnikes","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1986629763","eid":"W1986629763"},{"id":"paper-w4321258541","cat":"papers","name":"Effect of Ibogaine on the Various Sites of the NMDA Receptor Complex and Sigma Binding Sites in Rat Braina","year":"1998","cit":21,"pfa":"Yossef Itzhak","psa":"Syed F. Ali","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4321258541","eid":"W4321258541"},{"id":"paper-w1481921040","cat":"papers","name":"The Quantitation of Psilocybin in Hallucinogenic Mushrooms Using High Performance Liquid Chromatography","year":"1983","cit":21,"pfa":"SM Sottolano","psa":"Ira S. Lurie","ptype":"article","src":"https://openalex.org/W1481921040","eid":"W1481921040"},{"id":"paper-w1986724089","cat":"papers","name":"Effect of ibogaine on cocaine-induced efflux of [3H]dopamine and [3H]serotonin from mouse striatum","year":"1996","cit":21,"pfa":"S. Henry","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1986724089","eid":"W1986724089"},{"id":"paper-w4394602238","cat":"papers","name":"Psilocybin induces acute anxiety and changes in amygdalar phosphopeptides independently from the 5-HT2A receptor","year":"2024","cit":21,"pfa":"Ram Harari","psa":"Evan Elliott","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4394602238","eid":"W4394602238"},{"id":"paper-w2027447888","cat":"papers","name":"Effect of ibogaine on the various sites of the NMDA receptor complex and sigma binding sites in rat brain.","year":"1998","cit":21,"pfa":"Yossef Itzhak","psa":"Syed F. Ali","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2027447888","eid":"W2027447888"},{"id":"paper-w3196523365","cat":"papers","name":"“Meeting the Medicine Halfway”: Ayahuasca Ceremony Leaders’ Perspectives on Preparation and Integration Practices for Participants","year":"2021","cit":21,"pfa":"Cody Callon","psa":"Adèle Lafrance","topics":["Safety & adverse events","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3196523365","eid":"W3196523365"},{"id":"paper-w1985187852","cat":"papers","name":"Differential effects of modafinil, methamphetamine, and MDMA on agonistic behavior in male mice","year":"2012","cit":21,"pfa":"Alena Máchalová","psa":"Alexandra Šulcová","ptype":"article","src":"https://openalex.org/W1985187852","eid":"W1985187852"},{"id":"paper-w2092693515","cat":"papers","name":"Influences of activity wheel access on the body temperature response to MDMA and methamphetamine","year":"2011","cit":21,"pfa":"Nicholas W. Gilpin","psa":"Michael A. Taffe","ptype":"article","src":"https://openalex.org/W2092693515","eid":"W2092693515"},{"id":"paper-w2407942299","cat":"papers","name":"The Effect of MDMA-Induced Anxiety on Neuronal Apoptosis in Adult Male Rats' Hippocampus","year":"2014","cit":21,"pfa":"S. Karimi","psa":"Mohammad Jafar Golalipour","topics":["Addiction","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2407942299","eid":"W2407942299"},{"id":"paper-w3105750152","cat":"papers","name":"A randomized placebo-controlled trial on the antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression","year":"2017","cit":21,"pfa":"Fernanda Palhano-Fontes","psa":"Dráulio Barros de Araújo","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W3105750152","eid":"W3105750152"},{"id":"paper-w2106863270","cat":"papers","name":"Effect of adolescent exposure to MDMA and cocaine on acquisition and reinstatement of morphine-induce CPP","year":"2007","cit":21,"pfa":"Manuel Daza‐Losada","psa":"José Miñarro","ptype":"article","src":"https://openalex.org/W2106863270","eid":"W2106863270"},{"id":"paper-w2157411845","cat":"papers","name":"Anticataleptic activity of cathinone and MDMA (Ecstasy) upon acute and subchronic administration in rat","year":"2003","cit":21,"pfa":"Mehret Yerdaw Banjaw","psa":"Werner Schmidt","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2157411845","eid":"W2157411845"},{"id":"paper-w2121712138","cat":"papers","name":"Pizotyline effectively attenuates the stimulus effects of N-Methyl-3,4-methylenedioxyamphetamine (MDMA)","year":"2005","cit":21,"pfa":"Richard Young","psa":"Richard A. Glennon","ptype":"article","src":"https://openalex.org/W2121712138","eid":"W2121712138"},{"id":"paper-w3167072809","cat":"papers","name":"Ayahuasca prevents oxidative stress in a rat model of depression elicited by unpredictable chronic mild stress","year":"2021","cit":21,"pfa":"Janaína Xavier","psa":"Giana de Paula Cognato","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3167072809","eid":"W3167072809"},{"id":"paper-w2018959827","cat":"papers","name":"Noradrenergic loss enhances MDMA toxicity and induces ubiquitin-positive striatal whorls","year":"2002","cit":21,"pfa":"Michela Ferrucci","psa":"Francesco Fornai","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2018959827","eid":"W2018959827"},{"id":"paper-w4405738640","cat":"papers","name":"Concurrent stress modulates the acute and post-acute effects of psilocybin in a sex-dependent manner","year":"2024","cit":21,"pfa":"Miguel Farinha‐Ferreira","psa":"Ana Maria Sebastião","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4405738640","eid":"W4405738640"},{"id":"paper-w2020103323","cat":"papers","name":"Toxicity of ecstasy (MDMA) towards embryonic stem cell-derived cardiac and neural cells","year":"2010","cit":21,"pfa":"Rokhsareh Meamar","psa":"Hossein Baharvand","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2020103323","eid":"W2020103323"},{"id":"paper-w2039817320","cat":"papers","name":"The Role of MDMA (Ecstasy) in Coping with Negative Life Situations Among Urban Young Adults","year":"2011","cit":21,"pfa":"Lwendo S. Moonzwe","psa":"Kristin M. Kostick","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W2039817320","eid":"W2039817320"},{"id":"paper-w2041376968","cat":"papers","name":"Role of α1‐adrenoceptor subtypes in the effects of methylenedioxy methamphetamine (MDMA) on body temperature in the mouse","year":"2007","cit":21,"pfa":"Sotiria Bexis","psa":"James R. Docherty","ptype":"article","src":"https://openalex.org/W2041376968","eid":"W2041376968"},{"id":"paper-w2084716423","cat":"papers","name":"Behavioral and electroencephalographic effects of a serotonin receptor agonist (5-methoxy-N,N-dimethyltryptamine) in a feline model of photosensitive epilepsy","year":"1992","cit":21,"pfa":"Yuji Wada","psa":"Nariyoshi Yamaguchi","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2084716423","eid":"W2084716423"},{"id":"paper-w2073068371","cat":"papers","name":"Repeated exposure to methylenedioxymethamphetamine (MDMA) alters nucleus accumbens neuronal responses to dopamine and serotonin","year":"1998","cit":21,"pfa":"Tanja Obradovic","psa":"Susan R White","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2073068371","eid":"W2073068371"},{"id":"paper-w2123114949","cat":"papers","name":"Examining the effect of dl-3,4-methylenedioxymethamphetamine (MDMA) and methamphetamine on the standardized field sobriety tests","year":"2012","cit":21,"pfa":"Luke A. Downey","psa":"Con K. K. Stough","ptype":"article","src":"https://openalex.org/W2123114949","eid":"W2123114949"},{"id":"paper-w2175238810","cat":"papers","name":"Effects of MDMA on socioemotional feelings, authenticity, and autobiographical disclosure in healthy volunteers in a controlled setting","year":"2015","cit":21,"pfa":"Matthew J. Baggott","psa":"John E. Mendelson","topics":["Anxiety & end-of-life","Dosing & pharmacology","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W2175238810","eid":"W2175238810"},{"id":"paper-w2084232767","cat":"papers","name":"Behavioral effects and metabolic fate of N,N-dimethyltryptamine in mice pretreated with β-diethylaminoethyl-diphenylpropylacetate (SKF 525-A), iproniazid and chlorpromazine","year":"1978","cit":21,"pfa":"Nandkumar S. Shah","psa":"Martha P. Hedden","ptype":"article","src":"https://openalex.org/W2084232767","eid":"W2084232767"},{"id":"paper-w2064868268","cat":"papers","name":"Differential changes in mesolimbic dopamine following contingent and non-contingent MDMA self-administration in mice","year":"2009","cit":21,"pfa":"María Juliana Orejarena","psa":"Patricia Robledo","ptype":"article","src":"https://openalex.org/W2064868268","eid":"W2064868268"},{"id":"paper-w3166024754","cat":"papers","name":"Regulation of blood-brain barrier permeability by Salvinorin A via alleviating endoplasmic reticulum stress in brain endothelial cell after ischemia stroke","year":"2021","cit":21,"pfa":"Jihua Xin","psa":"Fuhai Ji","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3166024754","eid":"W3166024754"},{"id":"paper-w2767264947","cat":"papers","name":"Effects of MDMA (ecstasy) on apoptosis and heat shock protein (HSP70) expression in adult rat testis","year":"2017","cit":21,"pfa":"Fahimeh Mobaraki","psa":"Alireza Ebrahimzadeh‐Bideskan","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2767264947","eid":"W2767264947"},{"id":"paper-w1999901627","cat":"papers","name":"Recovery and aging of serotonergic fibers after single and intermittent MDMA treatment in dark agouti rat","year":"2011","cit":21,"pfa":"Csaba Ádori","psa":"György Bagdy","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1999901627","eid":"W1999901627"},{"id":"paper-w2033577954","cat":"papers","name":"The Effects of Ecstasy (MDMA) on Brain Serotonin Transporters Are Dependent on Age-of-First Exposure in Recreational Users and Animals","year":"2012","cit":21,"pfa":"Anne Klomp","psa":"Liesbeth Reneman","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2033577954","eid":"W2033577954"},{"id":"paper-w2034116014","cat":"papers","name":"Acute and chronic treatment with selective serotonin uptake inhibitors in mice: effects on nociceptive sensitivity and response to 5-methoxy- N, N -dimethyltryptamine","year":"1988","cit":21,"pfa":"Per Kristian Eide","psa":"Kjell Hole","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2034116014","eid":"W2034116014"},{"id":"paper-w1114010047","cat":"papers","name":"Yohimbine reinstates extinguished 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) seeking in rats with prior exposure to chronic yohimbine","year":"2015","cit":21,"pfa":"Kevin T. Ball","psa":"Jordan Schrock","ptype":"article","src":"https://openalex.org/W1114010047","eid":"W1114010047"},{"id":"paper-w4225321615","cat":"papers","name":"MDMA treatment paired with a trauma-cue promotes adaptive stress responses in a translational model of PTSD in rats","year":"2022","cit":21,"pfa":"Shira Arluk","psa":"Hagit Cohen","topics":["PTSD & trauma","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4225321615","eid":"W4225321615"},{"id":"paper-w4391069738","cat":"papers","name":"A comparison between psilocybin and esketamine in treatment-resistant depression using number needed to treat (NNT): A systematic review","year":"2024","cit":21,"pfa":"Sabrina Wong","psa":"Roger S. McIntyre","topics":["Depression","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4391069738","eid":"W4391069738"},{"id":"paper-w3025610192","cat":"papers","name":"Roles of DANCR/microRNA-518a-3p/MDMA ceRNA network in the growth and malignant behaviors of colon cancer cells","year":"2020","cit":21,"pfa":"Yi Sun","psa":"Jingzhen Zhou","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3025610192","eid":"W3025610192"},{"id":"paper-w1984290564","cat":"papers","name":"Caffeine promotes dopamine D1 receptor-mediated body temperature, heart rate and behavioural responses to MDMA (‘ecstasy’)","year":"2010","cit":21,"pfa":"Natacha Vanattou‐Saïfoudine","psa":"Andrew Harkin","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1984290564","eid":"W1984290564"},{"id":"paper-w2083823874","cat":"papers","name":"Application of Transcerebral, Weak (1 Microt) Complex Magnetic Fields and Mystical Experiences: Are They Generated by Field-Induced Dimethyltryptamine Release from the Pineal Organ?","year":"2003","cit":21,"pfa":"D. R. Hill","psa":"Michael A. Persinger","ptype":"article","src":"https://openalex.org/W2083823874","eid":"W2083823874"},{"id":"paper-w4210535254","cat":"papers","name":"Effects of ayahuasca on the endocannabinoid system of healthy volunteers and in volunteers with social anxiety disorder: Results from two pilot, proof‐of‐concept, randomized, placebo‐controlled trials","year":"2022","cit":21,"pfa":"RAFAEL GUIMARÃES DOS SANTOS","psa":"Jaime E. C. Hallak","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4210535254","eid":"W4210535254"},{"id":"paper-w2624286927","cat":"papers","name":"Widespread reduction of dopamine cell bodies and terminals in adult rats exposed to a low dose regimen of MDMA during adolescence","year":"2017","cit":21,"pfa":"Cristina Cadoni","psa":"G. Di Chiara","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2624286927","eid":"W2624286927"},{"id":"paper-w2963934185","cat":"papers","name":"Intersectional insights from an MDMA-assisted psychotherapy training trial: An open letter to racial/ethnic and sexual/gender minorities","year":"2019","cit":21,"pfa":"Terence H. W. Ching","topics":["Depression","PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2963934185","eid":"W2963934185"},{"id":"paper-w4408151066","cat":"papers","name":"Results From a Long-Term Observational Follow-Up Study of a Single Dose of Psilocybin for a Treatment-Resistant Episode of Major Depressive Disorder","year":"2025","cit":21,"pfa":"Guy M. Goodwin","psa":"Ekaterina Malievskaia","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4408151066","eid":"W4408151066"},{"id":"paper-w4405695737","cat":"papers","name":"Efficacy and safety of psilocybin in the treatment of Major Depressive Disorder (MDD): A dose-response network meta-analysis of randomized placebo-controlled clinical trials","year":"2024","cit":21,"pfa":"Damian Świeczkowski","psa":"Wiesław Jerzy Cubała","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W4405695737","eid":"W4405695737"},{"id":"paper-w2091064440","cat":"papers","name":"Reduced 3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy)-Initiated Oxidative DNA Damage and Neurodegeneration in Prostaglandin H Synthase-1 Knockout Mice","year":"2010","cit":21,"pfa":"Winnie Jeng","psa":"Peter G. Wells","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2091064440","eid":"W2091064440"},{"id":"paper-w3126191882","cat":"papers","name":"Psychedelics and Psychedelic-Assisted Psychotherapy","year":"2021","cit":21,"pfa":"Collin M. Reiff","psa":"William Maffitt McDonald","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W3126191882","eid":"W3126191882"},{"id":"paper-w2114888199","cat":"papers","name":"New “party pill” components in New Zealand: The synthesis and analysis of some β-ketone analogues of 3,4-methylenedioxymethamphetamine (MDMA) including βk-DMBDB (β-ketone-N,N-dimethyl-1-(1,3-benzodioxol-5-yl)-2-butanamin","year":"2011","cit":21,"pfa":"Matthew Russell","psa":"Ben Bogun","ptype":"article","src":"https://openalex.org/W2114888199","eid":"W2114888199"},{"id":"paper-w2099374885","cat":"papers","name":"Comparison and Evaluation of DRI® Methamphetamine, DRI Ecstasy, Abuscreen® ONLINE Amphetamine, and a Modified Abuscreen ONLINE Amphetamine Screening Immunoassays for the Detection of Amphetamine (AMP), Methamphetamine (M","year":"2003","cit":21,"pfa":"Peter R. Stout","psa":"Russell Wiegand","ptype":"article","src":"https://openalex.org/W2099374885","eid":"W2099374885"},{"id":"paper-w4297964908","cat":"papers","name":"The use of classic psychedelics among adults: a Danish online survey study","year":"2022","cit":21,"pfa":"Tobias Søgaard Juul","psa":"Anders Fink‐Jensen","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4297964908","eid":"W4297964908"},{"id":"paper-w4412792405","cat":"papers","name":"Implementing psychedelic-assisted therapy: History and characteristics of the Swiss limited medical use program","year":"2025","cit":21,"pfa":"Matthias E. Liechti","psa":"Yasmin Schmid","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4412792405","eid":"W4412792405"},{"id":"paper-w4220885585","cat":"papers","name":"Race, Ethnic, and Sex Differences in Prevalence of and Trends in Hallucinogen Consumption Among Lifetime Users in the United States Between 2015 and 2019","year":"2022","cit":21,"pfa":"Alan K. Davis","psa":"Monnica T. Williams","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4220885585","eid":"W4220885585"},{"id":"paper-w1983769767","cat":"papers","name":"Antagonism by derivatives of lysergic acid of the effect of dopamine on Helix neurones","year":"1971","cit":21,"pfa":"G.N. Woodruff","psa":"Gerald A. Kerkut","ptype":"article","src":"https://openalex.org/W1983769767","eid":"W1983769767"},{"id":"paper-w4384563223","cat":"papers","name":"Comparing Neural Correlates of Consciousness: From Psychedelics to Hypnosis and Meditation","year":"2023","cit":21,"pfa":"Flora Moujaes","psa":"Katrin H. Preller","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4384563223","eid":"W4384563223"},{"id":"paper-w2027862124","cat":"papers","name":"Comparison of the LSD-25 Experience and Delirium Tremens","year":"1959","cit":21,"pfa":"Keith S. Ditman","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2027862124","eid":"W2027862124"},{"id":"paper-w4398137313","cat":"papers","name":"Is it now time to prepare psychiatry for a psychedelic future?","year":"2024","cit":21,"pfa":"David Nutt","psa":"Allan Hunter Young","topics":["Depression","PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4398137313","eid":"W4398137313"},{"id":"paper-w4321088596","cat":"papers","name":"Rearing behaviour in the mouse behavioural pattern monitor distinguishes the effects of psychedelics from those of lisuride and TBG","year":"2023","cit":21,"pfa":"Yahong Chen","psa":"Ruibin Su","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4321088596","eid":"W4321088596"},{"id":"paper-w4321437539","cat":"papers","name":"Identification of LSD analogs, 1cP-AL-LAD, 1cP-MIPLA, 1V-LSD and LSZ in sheet products","year":"2023","cit":21,"pfa":"Rie Tanaka","psa":"Ruri Kikura‐Hanajiri","ptype":"article","src":"https://openalex.org/W4321437539","eid":"W4321437539"},{"id":"paper-w2611299108","cat":"papers","name":"The involvement of brain-derived neurotrophic factor in 3,4-methylenedioxymethamphetamine-induced place preference and behavioral sensitization","year":"2017","cit":21,"pfa":"Akihiro Mouri","psa":"Toshitaka Nabeshima","ptype":"article","src":"https://openalex.org/W2611299108","eid":"W2611299108"},{"id":"paper-w2938925240","cat":"papers","name":"Effects of the Psychedelic Amphetamine MDA (3,4-Methylenedioxyamphetamine) in Healthy Volunteers","year":"2019","cit":21,"pfa":"Matthew J. Baggott","psa":"John E. Mendelson","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2938925240","eid":"W2938925240"},{"id":"paper-w2164167652","cat":"papers","name":"Methylenedioxymethamphetamine-induced inhibition of neuronal firing in the nucleus accumbens is mediated by both serotonin and dopamine","year":"1996","cit":21,"pfa":"Tanja Obradovic","psa":"S.R. White","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2164167652","eid":"W2164167652"},{"id":"paper-w1503100980","cat":"papers","name":"[Ecstasy--the status in French-speaking Switzerland. Composition of seized drugs, analysis of biological specimens and short review of its pharmacological action and toxicity].","year":"1997","cit":21,"pfa":"Christine Giroud","psa":"Laurent Rivier","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W1503100980","eid":"W1503100980"},{"id":"paper-w1973806884","cat":"papers","name":"3,4-methylenedioxymethamphetamine (‘Ecstasy’) promotes the translocation of protein kinase C (PKC): requirement of viable serotonin nerve terminals","year":"1995","cit":21,"pfa":"H Kenneth Kramer","psa":"Efrain C. Azmitia","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1973806884","eid":"W1973806884"},{"id":"paper-w2131296907","cat":"papers","name":"The neurochemical and stimulatory effects of putative metabolites of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine in rats","year":"1991","cit":21,"pfa":"S.Y. Yeh","psa":"Fu‐Lian Hsu","ptype":"article","src":"https://openalex.org/W2131296907","eid":"W2131296907"},{"id":"paper-w2095368242","cat":"papers","name":"Total Synthesis of 20-Norsalvinorin A. 1. Preparation of a Key Intermediate","year":"2009","cit":21,"pfa":"Ylva E. Bergman","psa":"Patrick Perlmutter","ptype":"article","src":"https://openalex.org/W2095368242","eid":"W2095368242"},{"id":"paper-w812104970","cat":"papers","name":"The Fluorescence and Phosphorescence Spectra and Phosphorescence Decay Time of Harmine, Harmaline, Harmalol, Harmane, and Norharman in Aqueous Solutions and EPA at 77 K","year":"1974","cit":21,"pfa":"Steven G. Hadley","psa":"K Spitzer","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W812104970","eid":"W812104970"},{"id":"paper-w2061037866","cat":"papers","name":"The effects of psychoactive drugs and neuroleptics on language in normal subjects and schizophrenic patients: a review","year":"2000","cit":21,"pfa":"F. Salomé","psa":"Michel Fayol","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2061037866","eid":"W2061037866"},{"id":"paper-w4391843443","cat":"papers","name":"Psychedelika-assistierte Psychotherapie","year":"2024","cit":21,"pfa":"Helena Aicher","psa":"Peter Gasser","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4391843443","eid":"W4391843443"},{"id":"paper-w2949217235","cat":"papers","name":"Salvindolin elicits opioid system-mediated antinociceptive and antidepressant-like activities","year":"2019","cit":21,"pfa":"Adam W. Keasling","psa":"James Oluwagbamigbe Fajemiroye","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2949217235","eid":"W2949217235"},{"id":"paper-w4295093574","cat":"papers","name":"Narcotics and Narcotic Addiction.","year":"1954","cit":21,"topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4295093574","eid":"W4295093574"},{"id":"paper-w2322425518","cat":"papers","name":"How various drugs affect anxiety‐related behavior in male and female rats prenatally exposed to methamphetamine","year":"2016","cit":21,"pfa":"Eva Macuchova","psa":"Romana Šlamberová","topics":["Addiction","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2322425518","eid":"W2322425518"},{"id":"paper-w2126034236","cat":"papers","name":"Product ion mass spectra of amphetamine‐type substances, designer analogues, and ketamine using ultra‐performance liquid chromatography/tandem mass spectrometry","year":"2006","cit":21,"pfa":"Luigino G. Apollonio","psa":"William A. Maher","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2126034236","eid":"W2126034236"},{"id":"paper-w2888742286","cat":"papers","name":"Psychedelics and psychotherapy in Canada: Humphry Osmond and Aldous Huxley.","year":"2018","cit":21,"pfa":"Erika Dyck","psa":"Patrick Farrell","topics":["Depression","Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2888742286","eid":"W2888742286"},{"id":"paper-w4317677634","cat":"papers","name":"Psychedelics: Science sabotaged by Social Media","year":"2023","cit":21,"pfa":"Edward M. Sellers","psa":"Myroslava K. Romach","topics":["Safety & adverse events","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4317677634","eid":"W4317677634"},{"id":"paper-w2017405236","cat":"papers","name":"Effect of Hallucinogenic Drugs on the Electroretinogram","year":"1956","cit":21,"pfa":"Julia T. Apter","psa":"Carl C. Pfeiffer","ptype":"article","src":"https://openalex.org/W2017405236","eid":"W2017405236"},{"id":"paper-w4214918358","cat":"papers","name":"Novel Psychoactive Substances: The Razor’s Edge between Therapeutical Potential and Psychoactive Recreational Misuse","year":"2022","cit":21,"pfa":"Beatriz Correia","psa":"Alexandre Quintas","topics":["Depression","Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4214918358","eid":"W4214918358"},{"id":"paper-w4388557290","cat":"papers","name":"The psychedelic effects of cannabis: A review of the literature","year":"2023","cit":21,"pfa":"David Wolinsky","psa":"Ryan G. Vandrey","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4388557290","eid":"W4388557290"},{"id":"paper-w2802541851","cat":"papers","name":"A Study on Photostability of Amphetamines and Ketamine in Hair Irradiated under Artificial Sunlight","year":"2018","cit":21,"pfa":"Giorgia Miolo","psa":"Donata Favretto","ptype":"article","src":"https://openalex.org/W2802541851","eid":"W2802541851"},{"id":"paper-w1495392222","cat":"papers","name":"[Commentary] THE LONG ROAD TO PHARMACOTHERAPIES FOR STIMULANT DEPENDENCE","year":"2009","cit":21,"pfa":"John Marsden","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1495392222","eid":"W1495392222"},{"id":"paper-w2912561908","cat":"papers","name":"Changes in default-mode network activity and functional connectivity as an indicator of psychedelic-assisted psychotherapy effectiveness","year":"2018","cit":21,"pfa":"Anastasia Ruban","psa":"Aleksandra Kołodziej","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2912561908","eid":"W2912561908"},{"id":"paper-w4385706490","cat":"papers","name":"Psychedelics and neonihilism: connectedness in a meaningless world","year":"2023","cit":21,"pfa":"Patric Plesa","psa":"Rotem Petranker","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4385706490","eid":"W4385706490"},{"id":"paper-w4399590383","cat":"papers","name":"Esketamine combined with a mindfulness-based intervention for individuals with alcohol problems","year":"2024","cit":21,"pfa":"Emily M Gent","psa":"Celia J. A. Morgan","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4399590383","eid":"W4399590383"},{"id":"paper-w7124281655","cat":"papers","name":"Innovations to improve outcomes and uptake of psychotherapies for mental disorders: a state‐of‐the‐art review","year":"2026","cit":21,"pfa":"P. Cuijpers","psa":"Toshi A. Furukawa","topics":["Safety & adverse events","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7124281655","eid":"W7124281655"},{"id":"paper-w4402562789","cat":"papers","name":"Psychedelic Therapist Sexual Misconduct and Other Adverse Experiences Among a Sample of Naturalistic Psychedelic Users","year":"2024","cit":21,"pfa":"Daniel J. Kruger","psa":"Kevin F. Boehnke","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4402562789","eid":"W4402562789"},{"id":"paper-w1582590726","cat":"papers","name":"Hallucinogens: A Reader","year":"2002","cit":21,"pfa":"Charles S. Grob","psa":"Andrew Weil","ptype":"book","src":"https://openalex.org/W1582590726","eid":"W1582590726"},{"id":"paper-w2341561204","cat":"papers","name":"Hallucinogen Use Disorders","year":"2016","cit":21,"pfa":"Rashad Hardaway","psa":"Joji Suzuki","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2341561204","eid":"W2341561204"},{"id":"paper-w4398793187","cat":"papers","name":"Microdosing: Concept, application and relevance","year":"2010","cit":21,"pfa":"Tushar Tewari","psa":"Shoibal Mukherjee","topics":["Safety & adverse events","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4398793187","eid":"W4398793187"},{"id":"paper-w4251709179","cat":"papers","name":"Psychedelic Chile","year":"2017","cit":21,"pfa":"Patrick Barr-Melej","ptype":"book","src":"https://openalex.org/W4251709179","eid":"W4251709179"},{"id":"paper-w2768626284","cat":"papers","name":"A regulatory perspective on the evaluation of hallucinogen drugs for human use","year":"2017","cit":21,"pfa":"Silvia N. Calderon","psa":"Michael B. Klein","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2768626284","eid":"W2768626284"},{"id":"paper-w2084565722","cat":"papers","name":"On the specificity of a cat behavior model for the study of hallucinogens","year":"1981","cit":21,"pfa":"James L. Marini","psa":"Michael H. Sheard","ptype":"article","src":"https://openalex.org/W2084565722","eid":"W2084565722"},{"id":"paper-w2118284513","cat":"papers","name":"Clonidine Treatment for Hallucinogen Persisting Perception Disorder","year":"1998","cit":21,"pfa":"Arturo G. Lerner","psa":"Mircea Sigal","ptype":"article","src":"https://openalex.org/W2118284513","eid":"W2118284513"},{"id":"paper-w2149254660","cat":"papers","name":"Use of Microdose Phenotyping to Individualise Dosing of Patients","year":"2015","cit":21,"pfa":"Nicolas Hohmann","psa":"Gerd Mikus","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2149254660","eid":"W2149254660"},{"id":"paper-w2120932806","cat":"papers","name":"Hallucinogen persisting perception disorder in neuronal networks with adaptation","year":"2011","cit":21,"pfa":"Zachary P. Kilpatrick","psa":"Bard Ermentrout","ptype":"article","src":"https://openalex.org/W2120932806","eid":"W2120932806"},{"id":"paper-w3126746878","cat":"papers","name":"Psychedelic-Inspired Drug Discovery Using an Engineered Biosensor","year":"2020","cit":21,"pfa":"Chunyang Dong","psa":"Lin Tian","ptype":"preprint","src":"https://openalex.org/W3126746878","eid":"W3126746878"},{"id":"paper-w4367173668","cat":"papers","name":"Pressing regulatory challenges for psychedelic medicine","year":"2023","cit":21,"pfa":"Amy L. McGuire","psa":"I Glenn Cohen","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4367173668","eid":"W4367173668"},{"id":"paper-w4405021593","cat":"papers","name":"Practical considerations in the establishment of psychedelic research programs","year":"2024","cit":21,"pfa":"Brian Scott Barnett","psa":"Kevin Sean Murnane","topics":["Addiction","Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4405021593","eid":"W4405021593"},{"id":"paper-w4213423658","cat":"papers","name":"Psychedelic Psychotherapy: Building Wholeness Through Connection","year":"2022","cit":21,"pfa":"Gita Vaid","psa":"Barry Walker","topics":["PTSD & trauma","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4213423658","eid":"W4213423658"},{"id":"paper-w2394898718","cat":"papers","name":"Studies on phenethylamine hallucinogens. 2. Conformations of arylmethoxyl groups by carbon-13 NMR","year":"1981","cit":21,"pfa":"James J. Knittel","psa":"Alexandros Makriyannis","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2394898718","eid":"W2394898718"},{"id":"paper-w2173954060","cat":"papers","name":"Microdose Induced Drain Leakage Effects in Power Trench MOSFETs: Experiment and Modeling","year":"2014","cit":21,"pfa":"Gennady Ivanovich Zebrev","psa":"Kirill A. Yesenkov","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2173954060","eid":"W2173954060"},{"id":"paper-w2904128666","cat":"papers","name":"Confrontation with the Unconscious: Jungian Depth Psychology and Psychedelic Experience","year":"2013","cit":21,"pfa":"Scott J. Hill","ptype":"book","src":"https://openalex.org/W2904128666","eid":"W2904128666"},{"id":"paper-w104966348","cat":"papers","name":"LSD-induced Hallucinogen Persisting Perception Disorder treated with clonazepam: two case reports.","year":"2001","cit":21,"pfa":"A Lerner","psa":"Emi Shufman","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W104966348","eid":"W104966348"},{"id":"paper-w2148910583","cat":"papers","name":"Microdosing, Imaging Biomarkers and SPECT: A Multi-Sided Tripod to Accelerate Drug Development","year":"2009","cit":21,"pfa":"Ernest K. J. Pauwels","psa":"Kalevi Kairemo","topics":["Safety & adverse events","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2148910583","eid":"W2148910583"},{"id":"paper-w2122999085","cat":"papers","name":"Use of microdose GnRH agonist protocol in women with low ovarian volumes undergoing IVF","year":"2001","cit":21,"pfa":"Fady I. Sharara","psa":"Howard D. McClamrock","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2122999085","eid":"W2122999085"},{"id":"paper-w2332406580","cat":"papers","name":"SUBJECT EXPECTANCY AND ENVIRONMENTAL FACTORS AS DETERMINANTS OF PSYCHEDELIC FLASHBACK EXPERIENCES","year":"1975","cit":21,"pfa":"Robert K. Heaton","ptype":"article","src":"https://openalex.org/W2332406580","eid":"W2332406580"},{"id":"paper-w1978864789","cat":"papers","name":"Pharmacogenomic/pharmacokinetic assessment of a four-probe cocktail for CYPs and OATPs following oral microdosing","year":"2012","cit":21,"pfa":"Ichiro Ieiri","psa":"Yuichi Sugiyama","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1978864789","eid":"W1978864789"},{"id":"paper-w4383187132","cat":"papers","name":"The Intricate Interaction Between Expectations and Therapeutic Outcomes of Psychedelic Agents","year":"2023","cit":21,"pfa":"Luana Colloca","psa":"Gerard Sanacora","ptype":"article","src":"https://openalex.org/W4383187132","eid":"W4383187132"},{"id":"paper-w2947882889","cat":"papers","name":"The “Kamasutra” temples of India: A case for the encoding of psychedelically induced spirituality","year":"2019","cit":21,"pfa":"Meena Maillart-Garg","psa":"Michael Winkelman","ptype":"article","src":"https://openalex.org/W2947882889","eid":"W2947882889"},{"id":"paper-w2901423929","cat":"papers","name":"Chronic treatment with a metabotropic mGlu2/3 receptor agonist diminishes behavioral response to a phenethylamine hallucinogen","year":"2018","cit":21,"pfa":"Adam L. Halberstadt","psa":"Susan B. Powell","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2901423929","eid":"W2901423929"},{"id":"paper-w2284849622","cat":"papers","name":"Levels Of Serum Follicle-Stimulating Hormone, Luteinizing Hormone, And Plasma Progestin During Microdose Chlormadinone Treatment","year":"1971","cit":21,"pfa":"Melvin L. Taymor","psa":"Linda A. Levesque","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2284849622","eid":"W2284849622"},{"id":"paper-w2146209318","cat":"papers","name":"Microdose and Breakdown Effects Induced by Heavy Ions on Sub 32-nm Triple-Gate SOI FETs","year":"2008","cit":21,"pfa":"Alessio Griffoni","psa":"Cor L. Claeys","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2146209318","eid":"W2146209318"},{"id":"paper-w1533128445","cat":"papers","name":"Observational infant exploratory [14C]‐paracetamol pharmacokinetic microdose/therapeutic dose study with accelerator mass spectrometry bioanalysis","year":"2015","cit":21,"pfa":"Colin R. Garner","psa":"Mark A. Turner","topics":["Safety & adverse events","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1533128445","eid":"W1533128445"},{"id":"paper-w2008475591","cat":"papers","name":"Overcoming Bioanalytical Challenges in An Onglyza ® Intravenous [ 14 C]Microdose Absolute Bioavailability Study With Accelerator Ms","year":"2012","cit":21,"pfa":"Xiaohui Xu","psa":"Mark E. Arnold","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2008475591","eid":"W2008475591"},{"id":"paper-w3010727983","cat":"papers","name":"Application of a microdosed cocktail of 3 oral factor Xa inhibitors to study drug–drug interactions with different perpetrator drugs","year":"2020","cit":21,"pfa":"Gerd Mikus","psa":"Walter E. Haefeli","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3010727983","eid":"W3010727983"},{"id":"paper-w2050053870","cat":"papers","name":"Dimensionality of hallucinogen and inhalant/solvent abuse and dependence criteria: Implications for the diagnostic and statistical manual of mental disorders—Fifth edition","year":"2011","cit":21,"pfa":"Bradley Townsend Kerridge","psa":"Attila József Pulay","ptype":"article","src":"https://openalex.org/W2050053870","eid":"W2050053870"},{"id":"paper-w2954170568","cat":"papers","name":"De Plantis Toxicariis E Mundo Novo Tropicale Commentationes XVII: Virola as an Oral Hallucinogen among the Boras of Peru","year":"1977","cit":21,"pfa":"Richard Evans Schultes","psa":"Timothy Plowman","ptype":"article","src":"https://openalex.org/W2954170568","eid":"W2954170568"},{"id":"paper-w3175776235","cat":"papers","name":"The use of RNA‐based 5'‐aminolevulinate synthase 2 biomarkers in dried blood spots to detect recombinant human erythropoietin microdoses","year":"2021","cit":21,"pfa":"Francesco Loria","psa":"Nicolas Leuenberger","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3175776235","eid":"W3175776235"},{"id":"paper-w1985718235","cat":"papers","name":"Long-chain (Z)-9-alkenes are ‘Psychedelics’ to houseflies with regard to visually stimulated sex attraction and aggregation","year":"1976","cit":21,"pfa":"Ingolf Richter","psa":"Helmut K. Mangold","ptype":"article","src":"https://openalex.org/W1985718235","eid":"W1985718235"},{"id":"paper-w3095167357","cat":"papers","name":"Uncovering psychological mechanisms mediating the effects of drugs: some issues and comments using the example of psychedelic drugs","year":"2020","cit":21,"pfa":"Samuli Kangaslampi","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3095167357","eid":"W3095167357"},{"id":"paper-w1977921055","cat":"papers","name":"A highly sensitive LC‐MS/MS method capable of simultaneously quantitating celiprolol and atenolol in human plasma for a cassette cold‐microdosing study","year":"2011","cit":21,"pfa":"Yoshiyuki Minamide","psa":"Shinobu Kudoh","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1977921055","eid":"W1977921055"},{"id":"paper-w2810918993","cat":"papers","name":"Pregnancy outcome in delayed start antagonist versus microdose flare GnRH agonist protocol in poor responders undergoing IVF/ICSI: An RCT","year":"2018","cit":21,"pfa":"Robab Davar","psa":"Elham Naghshineh","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2810918993","eid":"W2810918993"},{"id":"paper-w2789878826","cat":"papers","name":"Cumulative effective dose and cancer risk for pediatric population in repetitive full spine follow-up imaging: How micro dose is the EOS microdose protocol?","year":"2018","cit":21,"pfa":"Martin Law","psa":"Wendy W. M. Lam","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2789878826","eid":"W2789878826"},{"id":"paper-w3123490313","cat":"papers","name":"Psychotomimetic symptoms after a moderate dose of a synthetic cannabinoid (JWH-018): implications for psychosis","year":"2021","cit":21,"pfa":"Eef Lien Theunissen","psa":"Johannes Gerardus Ramaekers","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3123490313","eid":"W3123490313"},{"id":"paper-w1978791397","cat":"papers","name":"Comparative Efficacy of Pre‐feeding, Post‐feeding and Combined Pre‐ and Post‐feeding of Two Microdoses of a Potentized Homeopathic Drug, Mercurius Solubilis, in Ameliorating Genotoxic Effects Produced by Mercuric Chlorid","year":"2004","cit":21,"pfa":"Swapna Datta","psa":"Anisur Rahman Khuda‐Bukhsh","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1978791397","eid":"W1978791397"},{"id":"paper-w1982971279","cat":"papers","name":"Psychotropic agents part III: Alcohol and psychotomimetics, psychotropic effects of central acting drugs","year":"1983","cit":21,"pfa":"K. Ba ̈ttig","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1982971279","eid":"W1982971279"},{"id":"paper-w2092973457","cat":"papers","name":"Brain serotonin depletion by lesions of the median raphe nucleus enhances the psychotomimetic action of phencyclidine, but not dizocilpine (MK-801), in rats","year":"2005","cit":21,"pfa":"Snezana Kusljic","psa":"Maarten van den Buuse","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2092973457","eid":"W2092973457"},{"id":"paper-w4382776218","cat":"papers","name":"This is your brain on death: a comparative analysis of a near-death experience and subsequent 5-Methoxy-DMT experience","year":"2023","cit":21,"pfa":"Pascal Michael","psa":"Oliver C. Robinson","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4382776218","eid":"W4382776218"},{"id":"paper-w1966400512","cat":"papers","name":"The Changing Patterns of Heroin Addiction in the Haight-Ashbury Subculture","year":"1971","cit":21,"pfa":"Charles W. Sheppard","psa":"David Eugene Smith","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1966400512","eid":"W1966400512"},{"id":"paper-w4213084702","cat":"papers","name":"Hallucinogenic drugs and their potential for treating fear‐related disorders: Through the lens of fear extinction","year":"2022","cit":21,"pfa":"Emilija Glavonic","psa":"Miroslav Adžić","topics":["PTSD & trauma","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4213084702","eid":"W4213084702"},{"id":"paper-w4408404416","cat":"papers","name":"First-in-Human Phase 0 Study of AB001, a Prostate-Specific Membrane Antigen–Targeted 212 Pb Radioligand, in Patients with Metastatic Castration-Resistant Prostate Cancer","year":"2025","cit":21,"pfa":"Kjetil Berner","psa":"Caroline Stokke","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4408404416","eid":"W4408404416"},{"id":"paper-w2165095670","cat":"papers","name":"Inner-City Substance Abuse Patterns: A Study of Psychiatric Inpatients","year":"1988","cit":21,"pfa":"Blanca Fernandez‐Pol","psa":"Mark S. Mizruchi","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2165095670","eid":"W2165095670"},{"id":"paper-w125094842","cat":"papers","name":"[Anesthesia and analgesia in addicts: basis for establishing a standard operating procedure].","year":"2006","cit":21,"pfa":"Jürgen Jage","psa":"F. Heid","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"other","src":"https://openalex.org/W125094842","eid":"W125094842"},{"id":"paper-w2030987273","cat":"papers","name":"Mitochondrial dysfunction and biotransformation of β-carboline alkaloids, harmine and harmaline, on isolated rat hepatocytes","year":"2010","cit":21,"pfa":"Yoshio Nakagawa","psa":"Dai Nakae","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2030987273","eid":"W2030987273"},{"id":"paper-w4288438976","cat":"papers","name":"Ketamine and Its Emergence in the Field of Neurology","year":"2022","cit":21,"pfa":"Luis Rueda Carrillo","psa":"Manan Shah","topics":["PTSD & trauma","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4288438976","eid":"W4288438976"},{"id":"paper-w2980702190","cat":"papers","name":"Harm reduction drug policy in Israel: what has been accomplished and what still needs to be done?","year":"2019","cit":21,"pfa":"Hagit Bonny‐Noach","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2980702190","eid":"W2980702190"},{"id":"paper-w3196262358","cat":"papers","name":"Disrupting phosphorylation of Tyr-1070 at GluN2B selectively produces resilience to depression-like behaviors","year":"2021","cit":21,"pfa":"Xiaofang Shi","psa":"Wei Yang","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3196262358","eid":"W3196262358"},{"id":"paper-w4200339573","cat":"papers","name":"Cortical Acetylcholine Levels Correlate With Neurophysiologic Complexity During Subanesthetic Ketamine and Nitrous Oxide Exposure in Rats","year":"2021","cit":21,"pfa":"Michael A. Brito","psa":"Dinesh Pal","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4200339573","eid":"W4200339573"},{"id":"paper-w2603241812","cat":"papers","name":"Modulation of the activity of N-methyl-D-aspartate receptors as a novel treatment option for depression: current clinical evidence and therapeutic potential of rapastinel (GLYX-13)","year":"2017","cit":21,"pfa":"Andrei-Nicolae Vasilescu","psa":"Sarah Eckart","topics":["Depression","PTSD & trauma","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2603241812","eid":"W2603241812"},{"id":"paper-w2082839418","cat":"papers","name":"Interaction between morphine and norketamine enantiomers in rodent models of nociception","year":"2008","cit":21,"pfa":"J HOLTMANJR","psa":"Elzbieta P. Wala","ptype":"article","src":"https://openalex.org/W2082839418","eid":"W2082839418"},{"id":"paper-w2031767814","cat":"papers","name":"Effects of low‐dose ketamine on neuropathic pain: An electroencephalogram–electrooculogram/behavioral study","year":"2002","cit":21,"pfa":"KENTARO OGA","psa":"Setsuro Ogawa","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2031767814","eid":"W2031767814"},{"id":"paper-w2032579664","cat":"papers","name":"Novel Potential Therapeutics for Schizophrenia: Focus on the Modulation of Metabotropic Glutamate Receptor Function","year":"2005","cit":21,"pfa":"Laura E. Chavez-Noriega","psa":"P. Jeffrey Conn","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2032579664","eid":"W2032579664"},{"id":"paper-w3154252478","cat":"papers","name":"Structure-activity relationships of dually-acting acetylcholinesterase inhibitors derived from tacrine on N-methyl-d-Aspartate receptors","year":"2021","cit":21,"pfa":"Lukáš Górecki","psa":"Ondřej Soukup","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3154252478","eid":"W3154252478"},{"id":"paper-w3175771699","cat":"papers","name":"Co-administration of cannabidiol and ketamine induces antidepressant-like effects devoid of hyperlocomotor side-effects","year":"2021","cit":21,"pfa":"Ariandra Guerini Sartim","psa":"Sâmia R.L. Joca","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3175771699","eid":"W3175771699"},{"id":"paper-w4392907688","cat":"papers","name":"The effects of prophylactic use of esketamine on postoperative depression and quality of life: a meta-analysis","year":"2024","cit":21,"pfa":"Guoweng NIU","psa":"Yang Mei","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W4392907688","eid":"W4392907688"},{"id":"paper-w3015729890","cat":"papers","name":"Managing Esketamine Treatment Frequency Toward Successful Outcomes: Analysis of Phase 3 Data","year":"2020","cit":21,"pfa":"Michel Nijs","psa":"Frank Wiegand","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W3015729890","eid":"W3015729890"},{"id":"paper-w4390698099","cat":"papers","name":"Esketamine pretreatment during cesarean section reduced the incidence of postpartum depression: a randomized controlled trail","year":"2024","cit":21,"pfa":"Shixia Xu","psa":"Jianjun Yang","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4390698099","eid":"W4390698099"},{"id":"paper-w4393987346","cat":"papers","name":"Efficacy and safety of low-dose esketamine for painless gastrointestinal endoscopy in adults: a systematic evaluation and meta-analysis","year":"2024","cit":21,"pfa":"Juan Deng","psa":"Chuan-Chuan Tan","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4393987346","eid":"W4393987346"},{"id":"paper-w4389264015","cat":"papers","name":"An Update on the Efficacy of Single and Serial Intravenous Ketamine Infusions and Esketamine for Bipolar Depression: A Systematic Review and Meta-Analysis","year":"2023","cit":21,"pfa":"Nicolás A. Núñez","psa":"Balwinder Singh","topics":["Depression","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4389264015","eid":"W4389264015"},{"id":"paper-w4387783293","cat":"papers","name":"Effect of Esketamine Gargle on Postoperative Sore Throat in Patients Undergoing Double-Lumen Endobronchial Intubation: A Randomised Controlled Trial","year":"2023","cit":21,"pfa":"Jianfen Liang","psa":"Xiang Li","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4387783293","eid":"W4387783293"},{"id":"paper-w4401482963","cat":"papers","name":"Opioid-free anesthesia with esketamine-dexmedetomidine versus opioid-based anesthesia with propofol-remifentanil in shoulder arthroscopy: a randomized controlled trial","year":"2024","cit":21,"pfa":"Zhouya Xue","psa":"Xiang Liu","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4401482963","eid":"W4401482963"},{"id":"paper-w4288009882","cat":"papers","name":"The Pharmacokinetics of Ketamine in the Breast Milk of Lactating Women: Quantification of Ketamine and Metabolites","year":"2022","cit":21,"pfa":"Philip E. Wolfson","psa":"Melissa Whippo","topics":["Depression","PTSD & trauma","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4288009882","eid":"W4288009882"},{"id":"paper-w4223472742","cat":"papers","name":"The Ketamine Side Effect Tool (KSET): A comprehensive measurement-based safety tool for ketamine treatment in psychiatry","year":"2022","cit":21,"pfa":"Adam J. Bayes","psa":"Colleen K A Loo","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4223472742","eid":"W4223472742"},{"id":"paper-w4309364487","cat":"papers","name":"Enantioselective CE–MS analysis of ketamine metabolites in urine","year":"2022","cit":21,"pfa":"Friederike A. Sandbaumhüter","psa":"Erik T. Jansson","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4309364487","eid":"W4309364487"},{"id":"paper-w3190797308","cat":"papers","name":"Role of Ketamine in the Treatment of Psychiatric Disorders","year":"2021","cit":21,"pfa":"Sahar Derakhshanian","psa":"Alan D. Kaye","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W3190797308","eid":"W3190797308"},{"id":"paper-w4405506163","cat":"papers","name":"Is there a risk of addiction to ketamine during the treatment of depression? A systematic review of available literature","year":"2024","cit":21,"pfa":"Gianmarco Ingrosso","psa":"Mário F. Juruena","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W4405506163","eid":"W4405506163"},{"id":"paper-w3048135528","cat":"papers","name":"Increased use of ketamine for the treatment of depression: Benefits and concerns","year":"2020","cit":21,"pfa":"Kyoung‐Sae Na","psa":"Yong‐Ku Kim","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W3048135528","eid":"W3048135528"},{"id":"paper-w4396973438","cat":"papers","name":"Ketamine for mood disorders, anxiety, and suicidality in children and adolescents: a systematic review","year":"2024","cit":21,"pfa":"Alisha M. Bruton","psa":"Rebecca D. Marshall","topics":["Anxiety & end-of-life","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4396973438","eid":"W4396973438"},{"id":"paper-w3004563893","cat":"papers","name":"Maintaining Rapid Antidepressant Effects Following Ketamine Infusion","year":"2020","cit":21,"pfa":"George I. Papakostas","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3004563893","eid":"W3004563893"},{"id":"paper-w2044822812","cat":"papers","name":"Hypothesis: Involvement of the Serotonergic System in the Clinical Expression of Monosymptomatic Hypochondriasis","year":"1990","cit":21,"pfa":"B. King","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2044822812","eid":"W2044822812"},{"id":"paper-w1991364035","cat":"papers","name":"Effect of Lysergic Acid Diethylamide on Absolute Visual Threshold of the Pigeon","year":"1957","cit":20,"pfa":"Donald S. Blough","ptype":"article","src":"https://openalex.org/W1991364035","eid":"W1991364035"},{"id":"paper-w2283294996","cat":"papers","name":"BLOCKADE BY BROM-LYSERGIC-ACID-DIETHYLAMIDE (BOL, OF THE POTENTIATING ACTION OF SEROTONIN AND RESERPINE ON HEXOBARBITAL HYPNOSIS","year":"1956","cit":20,"pfa":"G. C. Salmoiraghi","psa":"Irvine H. Page","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2283294996","eid":"W2283294996"},{"id":"paper-w2158827308","cat":"papers","name":"Detection of Lysergic Acid Diethylamide (LSD) in Urine by Gas Chromatography-Ion Trap Tandem Mass Spectrometry","year":"1999","cit":20,"pfa":"J. H. Sklerov","psa":"C. A. Ehorn","ptype":"article","src":"https://openalex.org/W2158827308","eid":"W2158827308"},{"id":"paper-w2328169530","cat":"papers","name":"Lysergic Acid Diethylamide (LSD-25): XXVI. Effect on Social Order of the Fighting Fish,Betta Splendens","year":"1958","cit":20,"pfa":"Llewellyn Thomas Evans","psa":"Harold A. Abramson","ptype":"article","src":"https://openalex.org/W2328169530","eid":"W2328169530"},{"id":"paper-w1976580014","cat":"papers","name":"Serotonergic and dopaminergic distinctions in the behavioral pharmacology of (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and lysergic acid diethylamide (LSD)","year":"2011","cit":20,"pfa":"Emmanuelle A. D. Schindler","psa":"John A. Harvey","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1976580014","eid":"W1976580014"},{"id":"paper-w2911904360","cat":"papers","name":"Abuse of Magic Mushroom, Peyote Cactus, LSD, Khat, and Volatiles","year":"2019","cit":20,"pfa":"Amitava Dasgupta","ptype":"book-chapter","src":"https://openalex.org/W2911904360","eid":"W2911904360"},{"id":"paper-w2076126386","cat":"papers","name":"Peyote identification on the basis of differences in morphology, mescaline content, and trnL/trnF sequence between Lophophora williamsii and L. diffusa","year":"2010","cit":20,"pfa":"Masako Aragane","psa":"Seiji Nagumo","ptype":"article","src":"https://openalex.org/W2076126386","eid":"W2076126386"},{"id":"paper-w2063282350","cat":"papers","name":"Action of biogenic amines on crustacean chromatophores—IV. Analysis of the synergistic erythrophoric pigment dispersion evoked by 5-hydroxytryptamine and lysergic acid diethylamide in the dwarf crayfish, Cambarellus shuf","year":"1975","cit":20,"pfa":"K. Ranga Rao","psa":"Milton Fingerman","ptype":"article","src":"https://openalex.org/W2063282350","eid":"W2063282350"},{"id":"paper-w2946994615","cat":"papers","name":"Bis(4-acetoxy-N,N-dimethyltryptammonium) fumarate: a new crystalline form of psilacetin, an alternative to psilocybin as a psilocin prodrug","year":"2019","cit":20,"pfa":"A.R. Chadeayne","psa":"David R. Manke","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2946994615","eid":"W2946994615"},{"id":"paper-w2125537330","cat":"papers","name":"Time-dependent interactions between iboga agents and cocaine","year":"1997","cit":20,"pfa":"Isabelle M. Maisonneuve","psa":"Stanley D. Glick","ptype":"article","src":"https://openalex.org/W2125537330","eid":"W2125537330"},{"id":"paper-w2325540070","cat":"papers","name":"REMARKS ON LSD AND MESCALINE","year":"1957","cit":20,"pfa":"Paul H. Hoch","ptype":"article","src":"https://openalex.org/W2325540070","eid":"W2325540070"},{"id":"paper-w2100834951","cat":"papers","name":"Psilocin Identified in a DUID Investigation","year":"2006","cit":20,"pfa":"Nicholas B Tiscione","psa":"M. I. Miller","ptype":"article","src":"https://openalex.org/W2100834951","eid":"W2100834951"},{"id":"paper-w4239622809","cat":"papers","name":"Ayahuasca Healing and Science","year":"2021","cit":20,"ptype":"book","src":"https://openalex.org/W4239622809","eid":"W4239622809"},{"id":"paper-w2025724911","cat":"papers","name":"Chemistry of Phenethylamines Related to Mescaline","year":"1979","cit":20,"pfa":"Alexander T. Shulgin","ptype":"article","src":"https://openalex.org/W2025724911","eid":"W2025724911"},{"id":"paper-w2401121324","cat":"papers","name":"Urinary Excretion of Dimethyltryptamine in Liver Disease","year":"1979","cit":20,"pfa":"Stuart A. Checkley","psa":"J. L. T. Birley","ptype":"article","src":"https://openalex.org/W2401121324","eid":"W2401121324"},{"id":"paper-w2084730114","cat":"papers","name":"Increased responsiveness to MDMA in adult rats treated neonatally with MDMA","year":"2005","cit":20,"pfa":"Brian J. Piper","psa":"Jerrold S. Meyer","ptype":"article","src":"https://openalex.org/W2084730114","eid":"W2084730114"},{"id":"paper-w3164319372","cat":"papers","name":"Structure Elucidation and Spectroscopic Analysis of Chromophores Produced by Oxidative Psilocin Dimerization","year":"2021","cit":20,"pfa":"Claudius Lenz","psa":"Dirk Hoffmeister","ptype":"article","src":"https://openalex.org/W3164319372","eid":"W3164319372"},{"id":"paper-w2417943488","cat":"papers","name":"VI. Therapeutic Aspects of the Mescaline-Chlorpromazine Combination","year":"1955","cit":20,"pfa":"Herman C.B. Denber","psa":"Sidney Merlis","ptype":"article","src":"https://openalex.org/W2417943488","eid":"W2417943488"},{"id":"paper-w2325470187","cat":"papers","name":"Psilocybin in Fruchtkörpern vonInocybe aeruginascens","year":"1986","cit":20,"pfa":"Marta Semerdžieva","psa":"Jochen Gartz","ptype":"article","src":"https://openalex.org/W2325470187","eid":"W2325470187"},{"id":"paper-w4404538392","cat":"papers","name":"O uso ritual da ayahuasca","year":"2003","cit":20,"pfa":"Laura Perez Gil","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4404538392","eid":"W4404538392"},{"id":"paper-w2104300777","cat":"papers","name":"Ecstasy: 3,4-Methylenedioxymethamphetamine (MDMA)","year":"1998","cit":20,"pfa":"Bruce H. Morimoto","psa":"Bart E. Kahr","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2104300777","eid":"W2104300777"},{"id":"paper-w2781765215","cat":"papers","name":"Key interindividual determinants in MDMA pharmacodynamics","year":"2018","cit":20,"pfa":"Esther Papaseit","psa":"Magı́ Farré","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2781765215","eid":"W2781765215"},{"id":"paper-w2087826893","cat":"papers","name":"3,4-methylenedioxymethamphetamine (mdma): A review","year":"2001","cit":20,"pfa":"Grace O’Leary","psa":"Roger D. Weiss","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2087826893","eid":"W2087826893"},{"id":"paper-w1968238515","cat":"papers","name":"Tolerance to the locomotor-activating effects of 3,4-methylenedioxymethamphetamine (MDMA) predicts escalation of MDMA self-administration and cue-induced reinstatement of MDMA seeking in rats","year":"2014","cit":20,"pfa":"Kevin T. Ball","psa":"Mylissa M. Slane","ptype":"article","src":"https://openalex.org/W1968238515","eid":"W1968238515"},{"id":"paper-w23338358","cat":"papers","name":"ibogaine in the treatment of chemical dependence disorders: clinical perspectives","year":"2016","cit":20,"pfa":"Howard S. Lotsof","ptype":"article","src":"https://openalex.org/W23338358","eid":"W23338358"},{"id":"paper-w2132067960","cat":"papers","name":"The Content of Psilocybin in Norwegian Psilocybe semilanceata","year":"1981","cit":20,"pfa":"A. Christiansen","psa":"Klaus Høiland","ptype":"article","src":"https://openalex.org/W2132067960","eid":"W2132067960"},{"id":"paper-w2070838469","cat":"papers","name":"Antibiotic activity of an extract of peyote (Lophophora Williamii (Lemaire) Coulter)","year":"1960","cit":20,"pfa":"James A. McCleary","psa":"David L. Walkington","ptype":"article","src":"https://openalex.org/W2070838469","eid":"W2070838469"},{"id":"paper-w2322972690","cat":"papers","name":"Recreational use of naturally occurring dimethyltryptamine – contributing to psychosis?","year":"2012","cit":20,"pfa":"Johanna M Birrell","psa":"Jacob Alexander","ptype":"article","src":"https://openalex.org/W2322972690","eid":"W2322972690"},{"id":"paper-w4308053113","cat":"papers","name":"Characterization of the Gateway Decarboxylase for Psilocybin Biosynthesis","year":"2022","cit":20,"pfa":"Tim Schäfer","psa":"Dirk Hoffmeister","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4308053113","eid":"W4308053113"},{"id":"paper-w2975681496","cat":"papers","name":"The Psilocybin-Telomere Hypothesis: An empirically falsifiable prediction concerning the beneficial neuropsychopharmacological effects of psilocybin on genetic aging","year":"2019","cit":20,"pfa":"Christopher B. Germann","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2975681496","eid":"W2975681496"},{"id":"paper-w2130382971","cat":"papers","name":"The expansion of the field of research on ayahuasca: Some reflections about the ayahuasca track at the 2010 MAPS “Psychedelic Science in the 21st Century” conference","year":"2010","cit":20,"pfa":"Beatriz Caiuby Labate","psa":"Clancy Cavnar","ptype":"article","src":"https://openalex.org/W2130382971","eid":"W2130382971"},{"id":"paper-w2791779541","cat":"papers","name":"Understanding the Healing Potential of Ibogaine through a Comparative and Interpretive Phenomenology of the Visionary Experience","year":"2018","cit":20,"pfa":"James Rodger","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2791779541","eid":"W2791779541"},{"id":"paper-w3213352763","cat":"papers","name":"Ayahuasca and the traveller: A scoping review of risks and possible benefits","year":"2021","cit":20,"pfa":"Sherilyn K. D. Houle","psa":"Patricia Schlagenhauf","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3213352763","eid":"W3213352763"},{"id":"paper-w2027544414","cat":"papers","name":"Photocyclizations of pharmacodynamic amines. V. Unusual rearrangements of the mescaline skeleton","year":"1970","cit":20,"pfa":"Osamu Yonemitsu","psa":"Bernhard Witkop","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2027544414","eid":"W2027544414"},{"id":"paper-w2419106406","cat":"papers","name":"Excitatory and inhibitory effects of mescaline on shuttle avoidance in the rat.","year":"1971","cit":20,"pfa":"Bridger Wh","psa":"Mandel Ij","ptype":"article","src":"https://openalex.org/W2419106406","eid":"W2419106406"},{"id":"paper-w4250495790","cat":"papers","name":"Effect of peyote on human chromosomes. Cytogenetic study of the Huichol Indians of Northern Mexico","year":"1975","cit":20,"pfa":"D. L. Dorrance","ptype":"article","src":"https://openalex.org/W4250495790","eid":"W4250495790"},{"id":"paper-w2017123797","cat":"papers","name":"Ibogaine selectively inhibits nicotinic receptor-mediated catecholamine release","year":"1996","cit":20,"pfa":"Allan S. Schneider","psa":"Stephanie J. Mah","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2017123797","eid":"W2017123797"},{"id":"paper-w3161894121","cat":"papers","name":"Medical risks associated with MDMA use.","year":"2001","cit":20,"pfa":"John Aaron Henry","psa":"Joseph G. Rella","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3161894121","eid":"W3161894121"},{"id":"paper-w2090557461","cat":"papers","name":"Preexposure to MDMA (“Ecstasy”) delays acquisition but facilitates MDMA-induced reinstatement of amphetamine self-administration behavior in rats","year":"2004","cit":20,"pfa":"Kirsten C. Morley","psa":"Iain S. McGregor","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2090557461","eid":"W2090557461"},{"id":"paper-w2278989131","cat":"papers","name":"Personality trait dependent performance under psilocybin.","year":"1970","cit":20,"pfa":"Karen Thatcher","psa":"R Fischer","ptype":"article","src":"https://openalex.org/W2278989131","eid":"W2278989131"},{"id":"paper-w4405376152","cat":"papers","name":"The safety of psilocybin-assisted psychotherapy: A systematic review","year":"2024","cit":20,"pfa":"Rosana Ramos de Freitas","psa":"Paul Bernard Fitzgerald","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W4405376152","eid":"W4405376152"},{"id":"paper-w1998121913","cat":"papers","name":"The crystal and molecular structure of bufotenine, 5-hydroxy-(N,N)-dimethyltryptamine","year":"1972","cit":20,"pfa":"Gerald Falkenberg","ptype":"article","src":"https://openalex.org/W1998121913","eid":"W1998121913"},{"id":"paper-w2086623065","cat":"papers","name":"Sulfur analogues of psychotomimetic agents. Monothio analogs of mescaline and isomescaline","year":"1981","cit":20,"pfa":"Peyton Jacob","psa":"Alexander T. Shulgin","ptype":"article","src":"https://openalex.org/W2086623065","eid":"W2086623065"},{"id":"paper-w2040595652","cat":"papers","name":"Late diagnosis of MDMA-related severe hyponatremia","year":"2014","cit":20,"pfa":"Julia Chia‐Yu Chang","psa":"Chen‐Chang Yang","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2040595652","eid":"W2040595652"},{"id":"paper-w1585359829","cat":"papers","name":"An Aqueous-Organic Extraction Method for the Isolation and Identification of Psilocin from Hallucinogenic Mushrooms","year":"1985","cit":20,"pfa":"JF Casale","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W1585359829","eid":"W1585359829"},{"id":"paper-w2096910728","cat":"papers","name":"Development and Clinical Application of an LC-MS-MS Method for Mescaline in Urine","year":"2008","cit":20,"pfa":"Kristian Björnstad","psa":"Olof Beck","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2096910728","eid":"W2096910728"},{"id":"paper-w1992275189","cat":"papers","name":"Ausdrucksphänomenologie der Modellpsychosen (Psilocybin); pp. 69–84","year":"2008","cit":20,"pfa":"Henri Lynn Heimann","ptype":"article","src":"https://openalex.org/W1992275189","eid":"W1992275189"},{"id":"paper-w2035103113","cat":"papers","name":"Effects of (+)-fenfluramine on 3,4-methylenedioxymethamphetamine (MDMA) discrimination in rats","year":"1996","cit":20,"pfa":"Lisa E. Baker","psa":"Malath M. Makhay","ptype":"article","src":"https://openalex.org/W2035103113","eid":"W2035103113"},{"id":"paper-w3004611165","cat":"papers","name":"MDMA and the Brain: A Short Review on the Role of Neurotransmitters in the Cause of Neurotoxicity","year":"2019","cit":20,"pfa":"Nor Suliana Mustafa","psa":"Nasir Mohamad","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3004611165","eid":"W3004611165"},{"id":"paper-w2135808894","cat":"papers","name":"Effects of MDMA, methamphetamine and methylphenidate on repeated acquisition and performance in rats","year":"2009","cit":20,"pfa":"Mark Galizio","psa":"Raymond C. Pitts","ptype":"article","src":"https://openalex.org/W2135808894","eid":"W2135808894"},{"id":"paper-w2329423531","cat":"papers","name":"The Influence of Aboriginal Pattern and White Contact on a Recently Introduced Ceremony, the Mescalero Peyote Rite","year":"1936","cit":20,"pfa":"MORRIS EDWARD OPLER","ptype":"article","src":"https://openalex.org/W2329423531","eid":"W2329423531"},{"id":"paper-w2016153198","cat":"papers","name":"Ecstasy: The Complete Guide. A Comprehensive Look at the Risks and Benefits of MDMA","year":"2002","cit":20,"pfa":"Griffith Edwards","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2016153198","eid":"W2016153198"},{"id":"paper-w4207006923","cat":"papers","name":"Reported Cases of Serotonin Syndrome in MDMA Users in FAERS Database","year":"2022","cit":20,"pfa":"Tigran Makunts","psa":"Alberdina de Boer","topics":["PTSD & trauma","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4207006923","eid":"W4207006923"},{"id":"paper-w3041361085","cat":"papers","name":"Rhabdomyolysis, Methamphetamine, Amphetamine and MDMA Use: Associated Factors and Risks","year":"2020","cit":20,"pfa":"John R. Richards","psa":"Samuel D. Turnipseed","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3041361085","eid":"W3041361085"},{"id":"paper-w2032460531","cat":"papers","name":"Inhibitory effect of 5-methoxy-N,N-dimethyltryptamine on the synaptosomal uptake of 5-hydroxytryptamine","year":"1983","cit":20,"pfa":"Odd‐Geir Berge","psa":"Kjell Hole","ptype":"article","src":"https://openalex.org/W2032460531","eid":"W2032460531"},{"id":"paper-w106906167","cat":"papers","name":"The Ayahuasca Patent Revocation: Raising Questions About Current U.S. Patent Policy","year":"2001","cit":20,"pfa":"Leanne M Fecteau","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W106906167","eid":"W106906167"},{"id":"paper-w4399706347","cat":"papers","name":"Is microdosing a placebo? A rapid review of low-dose LSD and psilocybin research","year":"2024","cit":20,"pfa":"Vince Polito","psa":"Paul Liknaitzky","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4399706347","eid":"W4399706347"},{"id":"paper-w1986694867","cat":"papers","name":"Ibogaine acts at the nicotinic acetylcholine receptor to inhibit catecholamine release1Published on the World Wide Web on 8 May 1998.1","year":"1998","cit":20,"pfa":"Stephanie J. Mah","psa":"Allan S. Schneider","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1986694867","eid":"W1986694867"},{"id":"paper-w4387442719","cat":"papers","name":"MDMA-assisted psychotherapy for PTSD in adolescents: rationale, potential, risks, and considerations","year":"2023","cit":20,"pfa":"Samuli Kangaslampi","psa":"Josjan Zijlmans","topics":["PTSD & trauma","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4387442719","eid":"W4387442719"},{"id":"paper-w2023925141","cat":"papers","name":"MDMA transiently alters biogenic amines and metabolites in mouse brain and heart","year":"1989","cit":20,"pfa":"Thomas Steele","psa":"George K. W. Yim","ptype":"article","src":"https://openalex.org/W2023925141","eid":"W2023925141"},{"id":"paper-w2904843452","cat":"papers","name":"Reply to “Ayahuasca turned on my mind’s eye”: A case of acquired versus congenital aphantasia, as evidenced with DMT use?","year":"2018","cit":20,"pfa":"David P. Luke","topics":["Addiction"],"ptype":"letter","src":"https://openalex.org/W2904843452","eid":"W2904843452"},{"id":"paper-w2064546587","cat":"papers","name":"Ecstasy (MDMA)-induced hyponatraemia is associated with genetic variants in CYP2D6 and COMT","year":"2012","cit":20,"pfa":"Katherine Jean Aitchison","psa":"Kim Wolff","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2064546587","eid":"W2064546587"},{"id":"paper-w2007945272","cat":"papers","name":"Hyponeophagia in the Roman rat strains: Effects of 5-methoxy-N,N-dimethyltryptamine, diazepam, methysergide and the stereoisomers of propranolol","year":"1983","cit":20,"pfa":"R.A. Shephard","psa":"P. L. Broadhurst","ptype":"article","src":"https://openalex.org/W2007945272","eid":"W2007945272"},{"id":"paper-w2046622508","cat":"papers","name":"Behavioural and neurotoxic long-lasting effects of MDMA plus cocaine in adolescent mice","year":"2008","cit":20,"pfa":"Manuel Daza‐Losada","psa":"José Miñarro","ptype":"article","src":"https://openalex.org/W2046622508","eid":"W2046622508"},{"id":"paper-w2286173925","cat":"papers","name":"IMAGES OF HEALING: SPONTANEOUS MENTAL IMAGERY AND HEALING PROCESS OF THE BARQUINHA, A BRAZILIAN AYAHUASCA RELIGIOUS SYSTEM","year":"2010","cit":20,"pfa":"Marcelo Simão Mercante","ptype":"book","src":"https://openalex.org/W2286173925","eid":"W2286173925"},{"id":"paper-w1972014766","cat":"papers","name":"Assessment of the abuse potential of MDMA in the conditioned place preference paradigm: Role of CB1 receptors","year":"2013","cit":20,"pfa":"Marta Rodríguez‐Arias","psa":"José Miñarro","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1972014766","eid":"W1972014766"},{"id":"paper-w2166432303","cat":"papers","name":"Active and passive MDMA (‘ecstasy’) intake induces differential transcriptional changes in the mouse brain","year":"2011","cit":20,"pfa":"Noèlia Fernàndez‐Castillo","psa":"Bru Cormand","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2166432303","eid":"W2166432303"},{"id":"paper-w2056798740","cat":"papers","name":"Time Course Analysis of the Discriminative Stimulus Effects of the Optical Isomers of 3,4-Methylenedioxymethamphetamine (MDMA)","year":"1997","cit":20,"pfa":"L Baker","ptype":"article","src":"https://openalex.org/W2056798740","eid":"W2056798740"},{"id":"paper-w2036448960","cat":"papers","name":"Increased oxidative‐modifications of cytosolic proteins in 3,4‐methylenedioxymethamphetamine (MDMA, ecstasy)‐exposed rat liver","year":"2010","cit":20,"pfa":"Vijay V. Upreti","psa":"Byoung‐Joon Song","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2036448960","eid":"W2036448960"},{"id":"paper-w120429996","cat":"papers","name":"Effects of Acute 3, 4-Methylenedioxymethamphetamine on Sleep and Daytime Sleepiness in MDMA Users: A Preliminary Study","year":"2009","cit":20,"pfa":"Surilla Randall","psa":"Timothy Roehrs","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W120429996","eid":"W120429996"},{"id":"paper-w2273674658","cat":"papers","name":"Highly selective non-opioid kappa opioid receptor (KOR) agonist salvinorin A protects against forebrain ischemia-induced brain injury in rats","year":"2016","cit":20,"pfa":"Jihua Xin","psa":"Zhenhong Wang","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2273674658","eid":"W2273674658"},{"id":"paper-w2022418335","cat":"papers","name":"Comparative neurochemical profile of 3,4-methylenedioxymethamphetamine and its metabolite alpha-methyldopamine on key targets of MDMA neurotoxicity","year":"2010","cit":20,"pfa":"Elena Escubedo","psa":"David Pubill","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2022418335","eid":"W2022418335"},{"id":"paper-w2108536425","cat":"papers","name":"Reinstatement of extinguished amphetamine self-administration by 3,4-methylenedioxymethamphetamine (MDMA) and its enantiomers in rhesus monkeys","year":"2010","cit":20,"pfa":"Jessica C. McClung","psa":"Leonard Lee Howell","ptype":"article","src":"https://openalex.org/W2108536425","eid":"W2108536425"},{"id":"paper-w4408581056","cat":"papers","name":"Preliminary safety and effectiveness of psilocybin-assisted therapy in adults with fibromyalgia: an open-label pilot clinical trial","year":"2025","cit":20,"pfa":"Jacob S. Aday","psa":"Kevin F. Boehnke","topics":["Safety & adverse events","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4408581056","eid":"W4408581056"},{"id":"paper-w4210769300","cat":"papers","name":"Development and application of a highly sensitive LC-MS/MS method for simultaneous quantification of N,N-dimethyltryptamine and two of its metabolites in human plasma","year":"2022","cit":20,"pfa":"Emma Eckernäs","psa":"Michael Ashton","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4210769300","eid":"W4210769300"},{"id":"paper-w2367812702","cat":"papers","name":"3,4-methylenedioxymethamphetamine (MDMA) abuse markedly inhibits acetylcholinesterase activity and induces severe oxidative damage and liperoxidative damage.","year":"2003","cit":20,"pfa":"Jun-Fu Zhou","psa":"Dong Qing Cai","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2367812702","eid":"W2367812702"},{"id":"paper-w2003660296","cat":"papers","name":"MDMA (3,4-Methylenedioxymethamphetamine)-Mediated Distortion of Somatosensory Signal Transmission and Neurotransmitter Efflux in the Ventral Posterior Medial Thalamus","year":"2008","cit":20,"pfa":"M.A. Starr","psa":"Barry D. Waterhouse","ptype":"article","src":"https://openalex.org/W2003660296","eid":"W2003660296"},{"id":"paper-w4214556654","cat":"papers","name":"The Costs and Health Benefits of Expanded Access to MDMA-assisted Therapy for Chronic and Severe PTSD in the USA: A Modeling Study","year":"2022","cit":20,"pfa":"Anton L.V. Avanceña","psa":"Elliot A. Marseille","topics":["PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4214556654","eid":"W4214556654"},{"id":"paper-w2088345763","cat":"papers","name":"Crystal structures of the Teonanácatl hallucinogens. Part I. Psilocybin C 12 H 17 N 2 O 4 P","year":"1974","cit":20,"pfa":"Hans Peter Weber","psa":"Trevor James Petcher","ptype":"article","src":"https://openalex.org/W2088345763","eid":"W2088345763"},{"id":"paper-w2049573499","cat":"papers","name":"5-Iodo-2-aminoindan (5-IAI): Chemistry, pharmacology, and toxicology of a research chemical producing MDMA-like effects","year":"2013","cit":20,"pfa":"Maurizio Coppola","psa":"Raffaella Mondola","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2049573499","eid":"W2049573499"},{"id":"paper-w2138719886","cat":"papers","name":"Potential Long-term Effects of MDMA on the Basal Ganglia–Thalamocortical Circuit: A Proton MR Spectroscopy and Diffusion-Tensor Imaging Study","year":"2011","cit":20,"pfa":"Hua-Shan Liu","psa":"Cheng‐Yu Chen","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2138719886","eid":"W2138719886"},{"id":"paper-w1996329528","cat":"papers","name":"The high prevalence of substance use disorders among recent MDMA users compared with other drug users: Implications for intervention","year":"2009","cit":20,"pfa":"Li-Tzy T. Wu","psa":"Dan German Blazer","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1996329528","eid":"W1996329528"},{"id":"paper-w2071316284","cat":"papers","name":"Pre-treatment with 3,4-methylenedioxymethamphetamine (MDMA) causes long-lasting changes in 5-HT2A receptor-mediated glucose utilization in the rat brain","year":"2006","cit":20,"pfa":"E Bull","psa":"Kevin C.F. Fone","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2071316284","eid":"W2071316284"},{"id":"paper-w2177990965","cat":"papers","name":"Expression of bax and bcl2 Genes in MDMA-induced Hepatotoxicity on Rat Liver Using Quantitative Real-Time PCR Method through Triggering Programmed Cell Death","year":"2015","cit":20,"pfa":"Mitra Behroozaghdam","psa":"Mansoureh Soleimani","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2177990965","eid":"W2177990965"},{"id":"paper-w4402327625","cat":"papers","name":"The immunomodulatory effects of classical psychedelics: A systematic review of preclinical studies","year":"2024","cit":20,"pfa":"Zhen Xuen Brandon Low","psa":"Yatinesh Kumari","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4402327625","eid":"W4402327625"},{"id":"paper-w2986818733","cat":"papers","name":"Hallucinogens and Their Therapeutic Use: A Literature Review","year":"2019","cit":20,"pfa":"Matthew J. Begola","psa":"Jason E. Schillerstrom","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2986818733","eid":"W2986818733"},{"id":"paper-w4407396574","cat":"papers","name":"Classification of psychedelics and psychoactive drugs based on brain-wide imaging of cellular c-Fos expression","year":"2025","cit":20,"pfa":"Farid Aboharb","psa":"Alex C. Kwan","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4407396574","eid":"W4407396574"},{"id":"paper-w7150978140","cat":"papers","name":"An international mega-analysis of psychedelic drug effects on brain circuit function","year":"2026","cit":20,"pfa":"Manesh Girn","psa":"Danilo Bzdok","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7150978140","eid":"W7150978140"},{"id":"paper-w2003532970","cat":"papers","name":"Turn on and tune in to evidence-based psychedelic research","year":"2015","cit":20,"pfa":"Ben Sessa","ptype":"article","src":"https://openalex.org/W2003532970","eid":"W2003532970"},{"id":"paper-w4396954050","cat":"papers","name":"Minorities’ Diminished Psychedelic Returns: Income and Educations Impact on Whites, Blacks, Hispanics, and Asians","year":"2024","cit":20,"pfa":"Sean M. Viña","ptype":"article","src":"https://openalex.org/W4396954050","eid":"W4396954050"},{"id":"paper-w4313680817","cat":"papers","name":"Interaction of psychedelic tryptamine derivatives with a lipid bilayer","year":"2023","cit":20,"pfa":"Fateme Zohairi","psa":"Ali Asghar Hakami Zanjani","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4313680817","eid":"W4313680817"},{"id":"paper-w1982463365","cat":"papers","name":"Die Wirkung von D-Lysergsäure-diäthylamid (LSD 25) und 5-Oxytryptamin auf die Chromatophoren vonPoecilia reticulatus","year":"1955","cit":20,"pfa":"A Cerletti","psa":"Botond Berde","ptype":"article","src":"https://openalex.org/W1982463365","eid":"W1982463365"},{"id":"paper-w4318827951","cat":"papers","name":"Prospective associations of psychedelic treatment for co-occurring alcohol misuse and posttraumatic stress symptoms among United States Special Operations Forces Veterans","year":"2023","cit":20,"pfa":"Stacey B. Armstrong","psa":"Alan K. Davis","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4318827951","eid":"W4318827951"},{"id":"paper-w2059637172","cat":"papers","name":"New characteristics of harmaline inhibition of intestinal transport systems","year":"1975","cit":20,"pfa":"Francisco V. Sepúlveda","psa":"J. W. L. Robinson","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2059637172","eid":"W2059637172"},{"id":"paper-w4406325139","cat":"papers","name":"Supportive Touch in Psychedelic Assisted Therapy","year":"2025","cit":20,"pfa":"Logan Neitzke‐Spruill","psa":"Amy L. McGuire","topics":["PTSD & trauma","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4406325139","eid":"W4406325139"},{"id":"paper-w1970606214","cat":"papers","name":"GH4ZD10 cells expressing rat 5‐HT1A receptors coupled to adenylyl cyclase are a model for the postsynaptic receptors in the rat hippocampus","year":"1992","cit":20,"pfa":"Christopher John Fowler","psa":"G Brännström","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1970606214","eid":"W1970606214"},{"id":"paper-w2088853653","cat":"papers","name":"Increased platelet membrane [3H]‐LSD binding in patients on chronic neuroleptic treatment.","year":"1985","cit":20,"pfa":"Michael Schächter","psa":"J. Martin Elliott","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2088853653","eid":"W2088853653"},{"id":"paper-w2083654840","cat":"papers","name":"Lethal Mutation Rate in Drosophila exposed to LSD-25 by Injection and Ingestion","year":"1969","cit":20,"pfa":"Edwin Vann","ptype":"article","src":"https://openalex.org/W2083654840","eid":"W2083654840"},{"id":"paper-w1950671782","cat":"papers","name":"Effects of LSD on Ca++ currents in central 5-HT-containing neurons: 5-HT1A receptors may play a role in hallucinogenesis.","year":"1994","cit":20,"pfa":"Nicholas J. Penington","psa":"A P Fox","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1950671782","eid":"W1950671782"},{"id":"paper-w4405027754","cat":"papers","name":"Synergistic, multi-level understanding of psychedelics: three systematic reviews and meta-analyses of their pharmacology, neuroimaging and phenomenology","year":"2024","cit":20,"pfa":"Kenneth Shinozuka","psa":"Morten L. Kringelbach","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W4405027754","eid":"W4405027754"},{"id":"paper-w2109859065","cat":"papers","name":"Validated Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry Method for Analyzing LSD, iso-LSD, nor-LSD, and O-H-LSD in Blood and Urine","year":"2009","cit":20,"pfa":"A. Chung","psa":"G. McKay","ptype":"article","src":"https://openalex.org/W2109859065","eid":"W2109859065"},{"id":"paper-w2616082649","cat":"papers","name":"Genie in a blotter: A comparative study of LSD and LSD analogues' effects and user profile","year":"2017","cit":20,"pfa":"Leigh Coney","psa":"Monica Jane Barratt","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2616082649","eid":"W2616082649"},{"id":"paper-w2081907244","cat":"papers","name":"d-LSD-induced c-Fos expression occurs in a population of oligodendrocytes in rat prefrontal cortex","year":"2008","cit":20,"pfa":"Chad J. Reissig","psa":"Cynthia A. Dlugos","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2081907244","eid":"W2081907244"},{"id":"paper-w4401244642","cat":"papers","name":"Therapeutic Potential of Psychedelic Drugs: Navigating High Hopes, Strong Claims, Weak Evidence, and Big Money","year":"2024","cit":20,"pfa":"Keith N. Humphreys","psa":"Wayne Hall","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"review","src":"https://openalex.org/W4401244642","eid":"W4401244642"},{"id":"paper-w2605774424","cat":"papers","name":"3,4-Methylenedioxymethamphetamine Increases Affiliative Behaviors in Squirrel Monkeys in a Serotonin 2A Receptor-Dependent Manner","year":"2017","cit":20,"pfa":"Elizabeth G. Pitts","psa":"Leonard Lee Howell","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2605774424","eid":"W2605774424"},{"id":"paper-w3146427719","cat":"papers","name":"Non-acute effects of different doses of 3, 4- methylenedioxymethamphetamine on spatial memory in the Morris water maze in Sprague-Dawley male rats","year":"2011","cit":20,"pfa":"Sara Sara","psa":"Mehdizadeh","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3146427719","eid":"W3146427719"},{"id":"paper-w4302212989","cat":"papers","name":"Ecstasy overdoses at a New Year's Eve rave--Los Angeles, California, 2010.","year":"2010","cit":20,"topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4302212989","eid":"W4302212989"},{"id":"paper-w4414407628","cat":"papers","name":"A lexicon for psychedelic research and treatment","year":"2025","cit":20,"pfa":"David John Nutt","psa":"Joanna Caroline Neill","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"editorial","src":"https://openalex.org/W4414407628","eid":"W4414407628"},{"id":"paper-w2164144657","cat":"papers","name":"Reduction of [3H]6‐nitroquipazine‐labelled 5‐hydroxytryptamine uptake sites in rat brain by 3,4‐methylenedioxymethamphetamine","year":"1990","cit":20,"pfa":"Kenji Hashimoto","psa":"Takeshi Goromaru","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2164144657","eid":"W2164144657"},{"id":"paper-w2417858510","cat":"papers","name":"Kappa Opioid Receptor Agonist and Brain Ischemia.","year":"2014","cit":20,"pfa":"Chunhua Chen","psa":"Renyu Liu","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2417858510","eid":"W2417858510"},{"id":"paper-w4391198586","cat":"papers","name":"A Hallucinogenic Tea, Laced with Controversy","year":"2008","cit":20,"pfa":"Marlene Dobkin de Ríos","psa":"Róger Rumrrill","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"book","src":"https://openalex.org/W4391198586","eid":"W4391198586"},{"id":"paper-w1507149892","cat":"papers","name":"PRECLINICAL STUDY: FULL ARTICLE: Tolerance to 3,4‐methylenedioxymethamphetamine is associated with impaired serotonin release","year":"2010","cit":20,"pfa":"Karen L. Jones","psa":"Susan Schenk","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1507149892","eid":"W1507149892"},{"id":"paper-w12742139","cat":"papers","name":"Prevalence and Risk Factors for LSD Use among Young Women","year":"2003","cit":20,"pfa":"後藤 道夫","psa":"Constance M Wiemann","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W12742139","eid":"W12742139"},{"id":"paper-w4283029950","cat":"papers","name":"Applying Lessons From Cannabis to the Psychedelic Highway","year":"2022","cit":20,"pfa":"Kevin F. Boehnke","psa":"Jenna McAfee","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4283029950","eid":"W4283029950"},{"id":"paper-w563138297","cat":"papers","name":"The Effect of 5-HT2A/1a Agonist Treatment On Social Cognition, Empathy, and Social Decision-making","year":"2015","cit":20,"pfa":"Katrin H. Preller","psa":"F.X. Vollenweider","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W563138297","eid":"W563138297"},{"id":"paper-w2065381205","cat":"papers","name":"Judgments of Body Size in a Schizophrenic and a Control Group","year":"1960","cit":20,"pfa":"Sidney E. Cleveland","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2065381205","eid":"W2065381205"},{"id":"paper-w2889440914","cat":"papers","name":"3,4-Methylenedioxymethamphetamine, mephedrone, and β-phenylethylamine release dopamine from the cytoplasm by means of transporters and keep the concentration high and constant by blocking reuptake","year":"2018","cit":20,"pfa":"G. Zsilla","psa":"E. Sylvester Vizi","ptype":"article","src":"https://openalex.org/W2889440914","eid":"W2889440914"},{"id":"paper-w1987211061","cat":"papers","name":"Distribution measurements of 3,4-methylenedioxymethamphetamine and its metabolites in organs by matrix-assisted laser desorption/ionization imaging mass spectrometry using an automatic matrix spraying system with an air","year":"2012","cit":20,"pfa":"Kenji Kuwayama","psa":"Hiroyuki Inoue","ptype":"article","src":"https://openalex.org/W1987211061","eid":"W1987211061"},{"id":"paper-w2962209228","cat":"papers","name":"Understanding the Removal and Fate of Selected Drugs of Abuse in Sludge and Biosolids from Australian Wastewater Treatment Operations","year":"2019","cit":20,"pfa":"Meena K. Yadav","psa":"Michael D. Short","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2962209228","eid":"W2962209228"},{"id":"paper-w4220968891","cat":"papers","name":"Phenomenological assessment of psychedelics induced experiences: Translation and validation of the German Challenging Experience Questionnaire (CEQ) and Ego-Dissolution Inventory (EDI)","year":"2022","cit":20,"pfa":"Katharina Dworatzyk","psa":"Timo Torsten Schmidt","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4220968891","eid":"W4220968891"},{"id":"paper-w2999013484","cat":"papers","name":"New psychoactive substances: Pharmacology influencing UK practice, policy and the law","year":"2020","cit":20,"pfa":"David Nutt","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2999013484","eid":"W2999013484"},{"id":"paper-w4243047549","cat":"papers","name":"Rhabdomyolysis After LSD Ingestion","year":"2010","cit":20,"pfa":"Zachary J. Berrens","psa":"Christopher White","ptype":"article","src":"https://openalex.org/W4243047549","eid":"W4243047549"},{"id":"paper-w4361214646","cat":"papers","name":"Systematic Review of Interventions for Demoralization in Patients With Cancer","year":"2023","cit":20,"pfa":"Yuejuan Wang","psa":"Pingting Zhu","topics":["Anxiety & end-of-life","Reviews & meta-analyses","Therapy practice"],"ptype":"review","src":"https://openalex.org/W4361214646","eid":"W4361214646"},{"id":"paper-w4382752812","cat":"papers","name":"Symmetry Perception and Psychedelic Experience","year":"2023","cit":20,"pfa":"Alexis D. J. Makin","psa":"Marco Bertamini","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4382752812","eid":"W4382752812"},{"id":"paper-w4402682742","cat":"papers","name":"A Phase 1 single ascending dose study of pure oral harmine in healthy volunteers","year":"2024","cit":20,"pfa":"Jessica L. Ables","psa":"Andrew F. Stewart","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4402682742","eid":"W4402682742"},{"id":"paper-w4290613434","cat":"papers","name":"Where do we go next in antidepressant drug discovery? A new generation of antidepressants: a pivotal role of AMPA receptor potentiation and mGlu2/3 receptor antagonism","year":"2022","cit":20,"pfa":"Andrzej Pilc","psa":"Jeffrey M. Witkin","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4290613434","eid":"W4290613434"},{"id":"paper-w4399441804","cat":"papers","name":"Crafting effective regulatory policies for psychedelics: What can be learned from the case of cannabis?","year":"2024","cit":20,"pfa":"Christina M. Andrews","psa":"John Marsden","topics":["Addiction","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4399441804","eid":"W4399441804"},{"id":"paper-w4405931389","cat":"papers","name":"Trends and characteristics in ketamine use among US adults with and without depression, 2015–2022","year":"2024","cit":20,"pfa":"Kevin H. Yang","psa":"Joseph J. Palamar","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4405931389","eid":"W4405931389"},{"id":"paper-w1982233118","cat":"papers","name":"Halluzinogene in der Psychotherapie","year":"1971","cit":20,"pfa":"H Leuner","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W1982233118","eid":"W1982233118"},{"id":"paper-w4397028963","cat":"papers","name":"Treatment Recommendations for Psychedelic-assisted Therapy","year":"2024","cit":20,"pfa":"Helena Aicher","psa":"Peter Gasser","ptype":"article","src":"https://openalex.org/W4397028963","eid":"W4397028963"},{"id":"paper-w4390484527","cat":"papers","name":"“Psychedelic Assisted Therapy” Must Not Be Retired","year":"2024","cit":20,"pfa":"Garrett Marie Deckel","psa":"Jeffrey R. Guss","ptype":"article","src":"https://openalex.org/W4390484527","eid":"W4390484527"},{"id":"paper-w4387115576","cat":"papers","name":"Psychedelic-assisted psychotherapy, patient vulnerability and abuses of power","year":"2023","cit":20,"pfa":"Sally E Meikle","psa":"Gillinder Bedi","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4387115576","eid":"W4387115576"},{"id":"paper-w4320507195","cat":"papers","name":"The prescription of psychedelic therapies in Australia and New Zealand: A brief survey of psychiatrists","year":"2023","cit":20,"pfa":"Joshua J Berger","psa":"Paul Bernard Fitzgerald","topics":["Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4320507195","eid":"W4320507195"},{"id":"paper-w4399918457","cat":"papers","name":"Attitudes toward psychedelics and psychedelic-assisted therapy among potential mental health service users and the general population in Australia","year":"2024","cit":20,"pfa":"Zohaib Nadeem","psa":"Lena Oestreich","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4399918457","eid":"W4399918457"},{"id":"paper-w4296481593","cat":"papers","name":"Scoping Review of Experiential Measures from Psychedelic Research and Clinical Trials","year":"2022","cit":20,"pfa":"Zachary M. Herrmann","psa":"Augustus John Rush","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4296481593","eid":"W4296481593"},{"id":"paper-w4200016418","cat":"papers","name":"Great Expectations: Recommendations for improving the methodological rigor of psychedelic clinical trials","year":"2021","cit":20,"pfa":"Jacob S. Aday","psa":"Joshua D. Woolley","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4200016418","eid":"W4200016418"},{"id":"paper-w4402354248","cat":"papers","name":"Social identity processes as a vehicle for therapeutic success in psychedelic treatment","year":"2024","cit":20,"pfa":"Martha Newson","psa":"Leor Roseman","ptype":"article","src":"https://openalex.org/W4402354248","eid":"W4402354248"},{"id":"paper-w4389954150","cat":"papers","name":"The impact of psychedelics on patients with alcohol use disorder: a systematic review with meta-analysis","year":"2023","cit":20,"pfa":"Dakota J. Sicignano","psa":"Charles Michael White","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4389954150","eid":"W4389954150"},{"id":"paper-w4407513864","cat":"papers","name":"On the varieties of conscious experiences: Altered Beliefs Under Psychedelics (ALBUS)","year":"2025","cit":20,"pfa":"Adam Safron","psa":"Matthew W. Johnson","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4407513864","eid":"W4407513864"},{"id":"paper-w4307569322","cat":"papers","name":"Microdosing with psychedelics to self-medicate for ADHD symptoms in adults: A prospective naturalistic study","year":"2022","cit":20,"pfa":"Eline C. H. M. Haijen","psa":"Kim P. C. Kuypers","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4307569322","eid":"W4307569322"},{"id":"paper-w2489758023","cat":"papers","name":"Man, Culture and Hallucinogens: An Overview","year":"1975","cit":20,"pfa":"Marlene Dobkin de Ríos","ptype":"book-chapter","src":"https://openalex.org/W2489758023","eid":"W2489758023"},{"id":"paper-w4388014245","cat":"papers","name":"Psychedelics action and schizophrenia","year":"2023","cit":20,"pfa":"Marzena Maćkowiak","topics":["Depression","PTSD & trauma","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4388014245","eid":"W4388014245"},{"id":"paper-w2802721090","cat":"papers","name":"The Psychedelic Experience","year":"1965","cit":20,"pfa":"William J. Wolf","ptype":"article","src":"https://openalex.org/W2802721090","eid":"W2802721090"},{"id":"paper-w2611460585","cat":"papers","name":"The philosophy of psychedelic transformation","year":"2017","cit":20,"pfa":"Chris Letheby","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W2611460585","eid":"W2611460585"},{"id":"paper-w3092471175","cat":"papers","name":"Microdosing flexibility in an efficient supply chain","year":"2020","cit":20,"pfa":"Lance W. Saunders","psa":"Mary Holcomb","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3092471175","eid":"W3092471175"},{"id":"paper-w4312270313","cat":"papers","name":"Psychedelic Psychoanalysis: Transformations of the Self","year":"2022","cit":20,"pfa":"Megan Rundel","topics":["PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4312270313","eid":"W4312270313"},{"id":"paper-w4386686930","cat":"papers","name":"Effects of Psychedelics on Inflammation and Immunity","year":"2019","cit":20,"pfa":"Attila Szabó","ptype":"other","src":"https://openalex.org/W4386686930","eid":"W4386686930"},{"id":"paper-w2089488100","cat":"papers","name":"Anorexia and hyperphagia produced by five pharmacologic classes of hallucinogens","year":"1982","cit":20,"pfa":"D. Bruce Vaupel","psa":"E.C. Morton","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2089488100","eid":"W2089488100"},{"id":"paper-w4205135950","cat":"papers","name":"Hallucinogens, alcohol and shifting leadership strategies in the ancient Peruvian Andes","year":"2022","cit":20,"pfa":"Matthew E. Biwer","psa":"Justin Jennings","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4205135950","eid":"W4205135950"},{"id":"paper-w2021572283","cat":"papers","name":"A Comparison of the Phenomenology of Hallucinogens and Schizophrenia From Some Autobiographical Accounts*","year":"1977","cit":20,"pfa":"J.E. Kleinman","psa":"Richard Jed Wyatt","ptype":"article","src":"https://openalex.org/W2021572283","eid":"W2021572283"},{"id":"paper-w2084110142","cat":"papers","name":"Failure to induce sterility in male rats with microdoses of cyproterone acetate (CPA)","year":"1975","cit":20,"pfa":"B. Schenck","psa":"Felix Neumann","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2084110142","eid":"W2084110142"},{"id":"paper-w2466101593","cat":"papers","name":"Some Reflections on the Possible Therapeutic Effects of the Hallucinogens. With Special Reference to Alcoholism","year":"1959","cit":20,"pfa":"Colin M. Smith","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2466101593","eid":"W2466101593"},{"id":"paper-w2404247894","cat":"papers","name":"Differential antagonism by metergoline of the behavioral effects of indolealkylamine and phenethylamine hallucinogens in the rat.","year":"1981","cit":20,"pfa":"Randall L. Commissaris","psa":"Richard H. Rech","ptype":"article","src":"https://openalex.org/W2404247894","eid":"W2404247894"},{"id":"paper-w3025361548","cat":"papers","name":"Anomalous Psychedelic Experiences: At the Neurochemical Juncture of the Humanistic and Parapsychological","year":"2020","cit":20,"pfa":"David P. Luke","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3025361548","eid":"W3025361548"},{"id":"paper-w4327716821","cat":"papers","name":"Psychedelics: preclinical insights provide directions for future research","year":"2023","cit":20,"pfa":"Ryan H. Gumpper","psa":"Bryan L. Roth","ptype":"article","src":"https://openalex.org/W4327716821","eid":"W4327716821"},{"id":"paper-w2617398493","cat":"papers","name":"Acid hype: American news media and the psychedelic experience","year":"2015","cit":20,"ptype":"book-review","src":"https://openalex.org/W2617398493","eid":"W2617398493"},{"id":"paper-w4317679425","cat":"papers","name":"Psychedelic discourses: A qualitative study of discussions in a Danish online forum","year":"2023","cit":20,"pfa":"Søren Holm","psa":"Morten Hesse","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4317679425","eid":"W4317679425"},{"id":"paper-w2520572294","cat":"papers","name":"DETERMINANTS OF FERTILIZER MICRODOSING-INDUCED YIELD INCREMENT OF PEARL MILLET ON AN ACID SANDY SOIL","year":"2015","cit":20,"pfa":"Ali Ibrahim","psa":"Andrews Opoku","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2520572294","eid":"W2520572294"},{"id":"paper-w1994888917","cat":"papers","name":"A Review: Development of a Microdose Model for Analysis of Adaptive Response and Bystander Dose Response Behavior","year":"2008","cit":20,"pfa":"Bobby E. Leonard","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1994888917","eid":"W1994888917"},{"id":"paper-w2167284787","cat":"papers","name":"The Effects of the Military's Antidrug Policies over the Life Course: The Case of Past-Year Hallucinogen Use","year":"2013","cit":20,"pfa":"Richard A. Miech","psa":"Stephen K. Koester","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2167284787","eid":"W2167284787"},{"id":"paper-w4360984947","cat":"papers","name":"‘More evolved than you’: Evolutionary spirituality as a cultural frame for psychedelic experiences","year":"2023","cit":20,"pfa":"Jules Evans","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4360984947","eid":"W4360984947"},{"id":"paper-w2482419350","cat":"papers","name":"Assessment of the Abuse Potentiality of Amphetamines and LSD-Like Hallucinogens in Man and its Relationship to Basic Animal Assessment Programs","year":"1973","cit":20,"pfa":"William R. Martin","ptype":"conference-paper","src":"https://openalex.org/W2482419350","eid":"W2482419350"},{"id":"paper-w3160854154","cat":"papers","name":"The Effects of Early Oropharyngeal Administration of Microdosed Colostrum on Feeding Status in Ventilated Extremely Low-Birth-Weight Infants","year":"2021","cit":20,"pfa":"Xiaochun Chen","psa":"Zhenlang Lin","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3160854154","eid":"W3160854154"},{"id":"paper-w2142859273","cat":"papers","name":"QSAR of benzene derivatives: comparison of classical descriptors, quantum theoretic parameters and flip regression, exemplified by phenylalkylamine hallucinogens","year":"2002","cit":20,"pfa":"Brian W. Clare","ptype":"article","src":"https://openalex.org/W2142859273","eid":"W2142859273"},{"id":"paper-w2516468032","cat":"papers","name":"Commentary: The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs","year":"2016","cit":20,"pfa":"David Papo","topics":["Mechanism & neuroscience"],"ptype":"editorial","src":"https://openalex.org/W2516468032","eid":"W2516468032"},{"id":"paper-w1974428472","cat":"papers","name":"Content uniformity of microdose tablets (dosage 1 μg-10 mg) produced by fluid bed granulation of interactive mixtures","year":"1986","cit":20,"pfa":"W.J. Thiel","psa":"F J Sberna","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1974428472","eid":"W1974428472"},{"id":"paper-w2012600128","cat":"papers","name":"Precycle administration of GnRH antagonist and microdose HCG decreases clinical pregnancy rates without affecting embryo quality and blastulation","year":"2006","cit":20,"pfa":"Orhan Bükülmez","psa":"Kevin J. Doody","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2012600128","eid":"W2012600128"},{"id":"paper-w2789244128","cat":"papers","name":"Differential role of nitric oxide in the psychedelic symptoms induced by racemic ketamine and esketamine in human volunteers","year":"2018","cit":20,"pfa":"Kelly Jonkman","psa":"Albert Dahan","ptype":"article","src":"https://openalex.org/W2789244128","eid":"W2789244128"},{"id":"paper-w3194881647","cat":"papers","name":"Prevalence and concentrations of new designer stimulants, synthetic opioids, benzodiazepines, and hallucinogens in postmortem hair samples: A 13‐year retrospective study","year":"2021","cit":20,"pfa":"André Niebel","psa":"Michael Tsokos","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W3194881647","eid":"W3194881647"},{"id":"paper-w3016741470","cat":"papers","name":"The multi-dimensional approach to drug-induced states: A commentary on Bayne and Carter’s “dimensions of consciousness and the psychedelic state”","year":"2020","cit":20,"pfa":"Martin Fortier-Davy","psa":"Raphaël Millière","ptype":"article","src":"https://openalex.org/W3016741470","eid":"W3016741470"},{"id":"paper-w4288060283","cat":"papers","name":"Reduced death anxiety and obsessive beliefs as mediators of the therapeutic effects of psychedelics on obsessive compulsive disorder symptomology","year":"2022","cit":20,"pfa":"Sam G. Moreton","psa":"Rachel E. Menzies","topics":["Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4288060283","eid":"W4288060283"},{"id":"paper-w4318933952","cat":"papers","name":"Reduced death anxiety as a mediator of the relationship between acute subjective effects of psychedelics and improved subjective well-being","year":"2023","cit":20,"pfa":"Sam G. Moreton","psa":"Rachel E. Menzies","topics":["Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4318933952","eid":"W4318933952"},{"id":"paper-w2102105886","cat":"papers","name":"The activation of pineal hydroxyindole-O-methyltransferase by psychotomimetic drugs","year":"1973","cit":20,"pfa":"R. Hartley","psa":"John A. Smith","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2102105886","eid":"W2102105886"},{"id":"paper-w2087624463","cat":"papers","name":"A REVIEW OF THE BIOCHEMICAL EFFECTS IN VITRO OF CERTAIN PSYCHOTOMIMETIC AGENTS","year":"1957","cit":20,"pfa":"James A. Bain","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2087624463","eid":"W2087624463"},{"id":"paper-w2418485198","cat":"papers","name":"Ultrasensitive quantification of the CYP2E1 probe chlorzoxazone and its main metabolite 6-hydroxychlorzoxazone in human plasma using ultra performance liquid chromatography coupled to tandem mass spectrometry after chlor","year":"2016","cit":20,"pfa":"Lukas Witt","psa":"Jürgen Burhenne","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2418485198","eid":"W2418485198"},{"id":"paper-w2023834196","cat":"papers","name":"Dopaminergic drugs antagonize the psychotomimetic effects of partial-agonist analgesics","year":"1975","cit":20,"pfa":"W. R. Buckett","psa":"Jill Shaw","ptype":"article","src":"https://openalex.org/W2023834196","eid":"W2023834196"},{"id":"paper-w2050788366","cat":"papers","name":"Use of An Intravenous Microdose of 14C-labeled drug and Accelerator Mass Spectrometry to measure Absolute Oral Bioavailability in Dogs; Cross-comparison of Assay Methods by Accelerator Mass Spectrometry and Liquid Chroma","year":"2009","cit":20,"pfa":"Yoshihiro Miyaji","psa":"Atsushi Kurihara","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2050788366","eid":"W2050788366"},{"id":"paper-w2477323223","cat":"papers","name":"Animal Models for Assessing Hallucinogenic Agents","year":"2003","cit":20,"pfa":"Richard A. Glennon","topics":["Addiction","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W2477323223","eid":"W2477323223"},{"id":"paper-w2587747611","cat":"papers","name":"Effect of a hallucinogenic serotonin 5‐HT2A receptor agonist on visually guided, hippocampal‐dependent spatial cognition in C57BL/6J mice","year":"2017","cit":20,"pfa":"Gongliang Zhang","psa":"Robert W. Stackman","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2587747611","eid":"W2587747611"},{"id":"paper-w2147053161","cat":"papers","name":"Pharmacokinetic analysis of 14C‐ursodiol in newborn infants using accelerator mass spectrometry","year":"2014","cit":20,"pfa":"Toufigh Gordi","psa":"Arlin B. Blood","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2147053161","eid":"W2147053161"},{"id":"paper-w4361285722","cat":"papers","name":"Rapid onset brain plasticity at novel pharmacologic targets hypothetically drives innovations for rapid onset antidepressant actions","year":"2023","cit":20,"pfa":"Takesha Cooper","psa":"Stephen M. Stahl","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4361285722","eid":"W4361285722"},{"id":"paper-w4400640877","cat":"papers","name":"Inter-individual variability in neural response to low doses of LSD","year":"2024","cit":20,"pfa":"Nadia R. P. W. Hutten","psa":"Johannes Gerardus Ramaekers","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4400640877","eid":"W4400640877"},{"id":"paper-w2085774921","cat":"papers","name":"An Analysis of Amphetamine Toxicity and Patterns of Use","year":"1972","cit":20,"pfa":"J. Fred E. Shick","psa":"Donald R. Wesson","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2085774921","eid":"W2085774921"},{"id":"paper-w164213004","cat":"papers","name":"Case report: an ingestion of Hawaiian Baby Woodrose seeds associated with acute psychosis.","year":"2003","cit":20,"pfa":"Jeffrey H. Gertsch","psa":"Christopher Wood","ptype":"article","src":"https://openalex.org/W164213004","eid":"W164213004"},{"id":"paper-w4391213632","cat":"papers","name":"Serotonin-2 Receptor Agonists Produce Anti-inflammatory Effects through Functionally Selective Mechanisms That Involve the Suppression of Disease-Induced Arginase 1 Expression","year":"2024","cit":20,"pfa":"Thomas Wayne Flanagan","psa":"Charles David Nichols","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4391213632","eid":"W4391213632"},{"id":"paper-w2024875809","cat":"papers","name":"Enzyme-Amplified Receptor Assay (ERA): A Novel Approach to Drug Detection","year":"1987","cit":20,"pfa":"S. F. Hallowed","psa":"GARRY A. RECHNITZ","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2024875809","eid":"W2024875809"},{"id":"paper-w2067960182","cat":"papers","name":"Use, indications and distribution in different countries of the stimulant and hallucinogenic amphetamine derivatives under consideration by WHO","year":"1986","cit":20,"pfa":"WOLFRAM KEUP","ptype":"article","src":"https://openalex.org/W2067960182","eid":"W2067960182"},{"id":"paper-w2097063953","cat":"papers","name":"DPT as an Adjunct in Brief Psychotherapy with Cancer Patients","year":"1980","cit":20,"pfa":"William A. Richards","psa":"Lockwood Rush","topics":["Anxiety & end-of-life","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2097063953","eid":"W2097063953"},{"id":"paper-w72633834","cat":"papers","name":"An approach to drug abuse, intoxication and withdrawal.","year":"2000","cit":20,"pfa":"A J Giannini","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W72633834","eid":"W72633834"},{"id":"paper-w2095232119","cat":"papers","name":"5-HT2A receptor signalling through phospholipase D1 associated with its C-terminal tail","year":"2011","cit":20,"pfa":"Zoë Barclay","psa":"Rory Mitchell","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2095232119","eid":"W2095232119"},{"id":"paper-w2016255114","cat":"papers","name":"Naloxone increases ketamine-induced hyperactivity in the open field in female rats","year":"2005","cit":20,"pfa":"C WILSON","psa":"J SUMNER","ptype":"article","src":"https://openalex.org/W2016255114","eid":"W2016255114"},{"id":"paper-w2613784656","cat":"papers","name":"Comparison of demographic characteristics and psychiatric comorbidity among methamphetamine-, heroin- and methamphetamine-heroin co- dependent males in Hunan, China","year":"2017","cit":20,"pfa":"Huixi Dong","psa":"Wei Hao","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2613784656","eid":"W2613784656"},{"id":"paper-w4387949493","cat":"papers","name":"Preclinical models of treatment-resistant depression: challenges and perspectives","year":"2023","cit":20,"pfa":"Magdalena Kolasa","psa":"Agata Faron‐Górecka","topics":["Depression","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4387949493","eid":"W4387949493"},{"id":"paper-w3013455635","cat":"papers","name":"Investigation of the 2,5-Dimethoxy Motif in Phenethylamine Serotonin 2A Receptor Agonists","year":"2020","cit":20,"pfa":"Emil Märcher-Rørsted","psa":"Jesper Langgaard Kristensen","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3013455635","eid":"W3013455635"},{"id":"paper-w3005158513","cat":"papers","name":"Determination of 5-MeO-DIPT in Human Urine Using Gas Chromatography Coupled with High-Resolution Orbitrap Mass Spectrometry","year":"2020","cit":20,"pfa":"Xiuying Yan","psa":"Hui Fang Yan","ptype":"article","src":"https://openalex.org/W3005158513","eid":"W3005158513"},{"id":"paper-w2461733912","cat":"papers","name":"Halluzinogen-induzierte Persistierende Wahrnehmungsstörung (HPPD) und Flashback-Phänomene – Differenzialdiagnose und Erklärungsmodelle","year":"2015","cit":20,"pfa":"Leo Hermle","psa":"K. Täschner","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2461733912","eid":"W2461733912"},{"id":"paper-w2410689534","cat":"papers","name":"Comparison of Antimicrobial Efficacy of Triclosan- Containing, Herbal and Homeopathy Toothpastes- An Invitro Study","year":"2015","cit":20,"pfa":"Basu Anushree","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2410689534","eid":"W2410689534"},{"id":"paper-w2086463502","cat":"papers","name":"Urinary Excretion of Phenolic Acids by Normal and Schizophrenic Male Patients","year":"1959","cit":20,"pfa":"MANN JAY D.","ptype":"article","src":"https://openalex.org/W2086463502","eid":"W2086463502"},{"id":"paper-w4309683083","cat":"papers","name":"Regulation of DNA Methylation by Cannabidiol and Its Implications for Psychiatry: New Insights from In Vivo and In Silico Models","year":"2022","cit":20,"pfa":"Luana Barreto Domingos","psa":"Sâmia R.L. Joca","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4309683083","eid":"W4309683083"},{"id":"paper-w4393970107","cat":"papers","name":"Cannabidiol and positive effects on object recognition memory in an in vivo model of Fragile X Syndrome: Obligatory role of hippocampal GPR55 receptors","year":"2024","cit":20,"pfa":"Antonia Manduca","psa":"Viviana Trezza","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4393970107","eid":"W4393970107"},{"id":"paper-w4320486196","cat":"papers","name":"Current approaches for the treatment of ketamine‐induced cystitis","year":"2023","cit":20,"pfa":"Juan Zhou","psa":"Christine Lehmann","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4320486196","eid":"W4320486196"},{"id":"paper-w1966303469","cat":"papers","name":"Electrophysiological and behavioral responses to ketamine in mice with reduced Akt1 expression","year":"2013","cit":20,"pfa":"Robert E. Featherstone","psa":"Steven J. Siegel","ptype":"article","src":"https://openalex.org/W1966303469","eid":"W1966303469"},{"id":"paper-w3186101592","cat":"papers","name":"Partial mGlu5 Negative Allosteric Modulator M-5MPEP Demonstrates Antidepressant-Like Effects on Sleep Without Affecting Cognition or Quantitative EEG","year":"2021","cit":20,"pfa":"Kimberly M. Holter","psa":"Robert W. Gould","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3186101592","eid":"W3186101592"},{"id":"paper-w2775504840","cat":"papers","name":"Hydroxynorketamine: Implications for the NMDA Receptor Hypothesis of Ketamine’s Antidepressant Action","year":"2017","cit":20,"pfa":"Lily R. Aleksandrova","psa":"Anthony G. Phillips","topics":["Depression","PTSD & trauma","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2775504840","eid":"W2775504840"},{"id":"paper-w4213434338","cat":"papers","name":"Ketamine and esketamine for crisis management in patients with depression: Why, whom, and how?","year":"2022","cit":20,"pfa":"Aistė Lengvenytė","psa":"Philippe Courtet","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4213434338","eid":"W4213434338"},{"id":"paper-w4312128936","cat":"papers","name":"Esketamine improves propofol-induced brain injury and cognitive impairment in rats","year":"2022","cit":20,"pfa":"Guiping Xu","psa":"Guichao Zhang","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4312128936","eid":"W4312128936"},{"id":"paper-w4312155094","cat":"papers","name":"Low dose of esketamine combined with propofol in painless fibronchoscopy in elderly patients","year":"2022","cit":20,"pfa":"Yankun Feng","psa":"Zhijun Chen","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4312155094","eid":"W4312155094"},{"id":"paper-w4404485078","cat":"papers","name":"Comparative Analysis of Hemodynamic Effects of Remimazolam and Propofol Combined with Esketamine in Colonoscopic Procedures in the Elderly","year":"2024","cit":20,"pfa":"Bo-Ran Deng","psa":"Qiao-Ling Wu","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4404485078","eid":"W4404485078"},{"id":"paper-w4289871905","cat":"papers","name":"Pretreatment with Low-Dose Esketamine for Reduction of Propofol Injection Pain: A Randomized Controlled Trial","year":"2022","cit":20,"pfa":"Danyun Fu","psa":"Jie Jia","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4289871905","eid":"W4289871905"},{"id":"paper-w4400093376","cat":"papers","name":"The ketamine metabolite ( 2R,6R )‐hydroxynorketamine rescues hippocampal mRNA translation, synaptic plasticity and memory in mouse models of Alzheimer's disease","year":"2024","cit":20,"pfa":"Felipe Campos Ribeiro","psa":"Sergio Teixeira Ferreira","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4400093376","eid":"W4400093376"},{"id":"paper-w4387382383","cat":"papers","name":"Opioid Free Total Intravenous Anesthesia With Dexmedetomidine-Esketamine-Lidocaine for Patients Undergoing Lumpectomy","year":"2023","cit":20,"pfa":"Xia Li Qian","psa":"Shanwu Feng","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4387382383","eid":"W4387382383"},{"id":"paper-w4391610073","cat":"papers","name":"Esketamine combined with sufentanil versus sufentanil in patient-controlled intravenous analgesia: a meta-analysis","year":"2024","cit":20,"pfa":"Manman Yao","psa":"Fuchao Chen","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4391610073","eid":"W4391610073"},{"id":"paper-w4399960079","cat":"papers","name":"Perioperative esketamine administration for prevention of postpartum depression after the cesarean section: A systematic review and meta-analysis","year":"2024","cit":20,"pfa":"Mohammadamin Parsaei","psa":"Giuseppe Delvecchio","topics":["Depression","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4399960079","eid":"W4399960079"},{"id":"paper-w4389141004","cat":"papers","name":"Role and mechanism of esketamine in improving postoperative cognitive dysfunction in aged mice through the TLR4 / MyD88 /p38 MAPK pathway","year":"2023","cit":20,"pfa":"H.M. Xu","psa":"Li‐Ye Han","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4389141004","eid":"W4389141004"},{"id":"paper-w4220734570","cat":"papers","name":"Efficacy and Safety of Remimazolam Tosilate Combined With Esketamine for Analgesic Sedation in Mechanically Ventilated ICU Patients: A Single-Arm Clinical Study Protocol","year":"2022","cit":20,"pfa":"Xuan Song","psa":"Chunting Wang","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4220734570","eid":"W4220734570"},{"id":"paper-w4391537315","cat":"papers","name":"Comparison of remimazolam and propofol combined with low dose esketamine for pediatric same-day painless bidirectional endoscopy: a randomized, controlled clinical trial","year":"2024","cit":20,"pfa":"Tiantian Chu","psa":"Aijun Xu","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4391537315","eid":"W4391537315"},{"id":"paper-w4324334807","cat":"papers","name":"Predictors of response and remission in patients with treatment-resistant depression: A post hoc pooled analysis of two acute trials of esketamine nasal spray","year":"2023","cit":20,"pfa":"Ibrahim Turkoz","psa":"Ella Daly","topics":["Depression","Anxiety & end-of-life","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4324334807","eid":"W4324334807"},{"id":"paper-w3172214963","cat":"papers","name":"Ketamine for Refractory Chronic Migraine: An Observational Pilot Study and Metabolite Analysis","year":"2021","cit":20,"pfa":"Eric S. Schwenk","psa":"Irving W. Wainer","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3172214963","eid":"W3172214963"},{"id":"paper-w2945336562","cat":"papers","name":"Subcritical Fluid Chromatography at Sub-Ambient Temperatures for the Chiral Resolution of Ketamine Metabolites with Rapid-Onset Antidepressant Effects","year":"2019","cit":20,"pfa":"Robert Klaus Hofstetter","psa":"Andreas Link","topics":["Depression","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2945336562","eid":"W2945336562"},{"id":"paper-w4316371452","cat":"papers","name":"Ketamine as Add-On Treatment in Psychotic Treatment-Resistant Depression","year":"2023","cit":20,"pfa":"Maria Gałuszko‐Węgielnik","psa":"Wiesław Jerzy Cubała","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4316371452","eid":"W4316371452"},{"id":"paper-w2966502749","cat":"papers","name":"Exploring patients’ and carers’ views about the clinical use of ketamine to inform policy and practical decisions: mixed-methods study","year":"2019","cit":20,"pfa":"Sagar Jilka","psa":"Rupert H. McShane","topics":["Depression","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2966502749","eid":"W2966502749"},{"id":"paper-w1976200965","cat":"papers","name":"Medullary serotonergic neurons are insensitive to 5-meodmt and LSD","year":"1982","cit":20,"pfa":"James H. Heym","psa":"Barry L. Jacobs","ptype":"article","src":"https://openalex.org/W1976200965","eid":"W1976200965"},{"id":"paper-w2095693935","cat":"papers","name":"Substituted Naphthofurans as Hallucinogenic Phenethylamine−Ergoline Hybrid Molecules with Unexpected Muscarinic Antagonist Activity","year":"1998","cit":20,"pfa":"Aaron P. Monte","psa":"David E. Nichols","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2095693935","eid":"W2095693935"},{"id":"paper-w2413734080","cat":"papers","name":"[Psychophysical correlations. VIII. Experimental tests in schizophrenia: lysergic acid diethylamide and mescaline].","year":"1951","cit":19,"pfa":"R FISCHER","psa":"R WEBER","ptype":"article","src":"https://openalex.org/W2413734080","eid":"W2413734080"},{"id":"paper-w2419284308","cat":"papers","name":"Unsurmountable antagonism of brain 5-hydroxytryptamine2 receptors by (+)-lysergic acid diethylamide and bromo-lysergic acid diethylamide.","year":"1992","cit":19,"pfa":"Kevin D. Burris","psa":"Elaine Sanders‐Bush","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2419284308","eid":"W2419284308"},{"id":"paper-w2321619994","cat":"papers","name":"Studies on Lysergic Acid Diethylamide and Related Compounds. I. Synthesis of d-N6-Demethyl-lysergic Acid Diethylamide","year":"1971","cit":19,"pfa":"Yuji Nakahara","psa":"Tetsukichi Niwaguchi","ptype":"article","src":"https://openalex.org/W2321619994","eid":"W2321619994"},{"id":"paper-w2142717621","cat":"papers","name":"Psychopharmacological Studies of Lysergic Acid Diethylamide (LSD-25) Intoxication","year":"1957","cit":19,"pfa":"Lincoln D. Clark","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2142717621","eid":"W2142717621"},{"id":"paper-w2154281418","cat":"papers","name":"Vesicular and juxtavesicular serotonin: effects of lysergic acid diethylamide and reserpine.","year":"1977","cit":19,"pfa":"Angelos E Halaris","psa":"Daniel X. Freedman","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2154281418","eid":"W2154281418"},{"id":"paper-w2072215879","cat":"papers","name":"A Controlled Trial of Abreaction with Lysergic Acid Diethylamide (Lsd-25)","year":"1963","cit":19,"pfa":"Jacqui T.C. Robinson","psa":"J. D. Morrissey","topics":["PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2072215879","eid":"W2072215879"},{"id":"paper-w2035918990","cat":"papers","name":"Lysergic acid diethylamide, amphetamine and chlorpromazine on water maze discrimination in mice","year":"1971","cit":19,"pfa":"Claudio Castellano","ptype":"article","src":"https://openalex.org/W2035918990","eid":"W2035918990"},{"id":"paper-w2075097665","cat":"papers","name":"Photoreactivity of lysergic acid diethylamide and its possible utility as a photoaffinity labeling reagent","year":"1983","cit":19,"pfa":"Edward B. Walker","psa":"Tag E. Mansour","ptype":"article","src":"https://openalex.org/W2075097665","eid":"W2075097665"},{"id":"paper-w3210847372","cat":"papers","name":"Lysergic acid diethylamide induces increased signalling entropy in rats’ prefrontal cortex","year":"2021","cit":19,"pfa":"Aurora Savino","psa":"Charles David Nichols","topics":["Addiction","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3210847372","eid":"W3210847372"},{"id":"paper-w2005489512","cat":"papers","name":"Detection of lysergic acid diethylamide, Δ9-tetrahydrocannabinol and related compounds by plasma chromatography","year":"1975","cit":19,"pfa":"F.W. Karasek","psa":"S.H. Kim","ptype":"article","src":"https://openalex.org/W2005489512","eid":"W2005489512"},{"id":"paper-w2053704134","cat":"papers","name":"Studies on Quantitative in situ fluorometry of lysergic acid diethylamide (lsd) on thin-layer chromatograms","year":"1971","cit":19,"pfa":"Tetsukichi Niwaguchi","psa":"Takako Inoue","ptype":"article","src":"https://openalex.org/W2053704134","eid":"W2053704134"},{"id":"paper-w2010263286","cat":"papers","name":"An inhibition of post‐ganglionic motor transmission in the mammalian vas deferens by D ‐lysergic acid diethylamide","year":"1973","cit":19,"pfa":"N Ambache","psa":"M. ABOO ZAR","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2010263286","eid":"W2010263286"},{"id":"paper-w2025879015","cat":"papers","name":"Detection and Interpretation of Lysergic Acid Diethylamide Results by Immunoassay Screening of Urine in Various Testing Groups","year":"1997","cit":19,"pfa":"AHB Wu","psa":"Jill E. Brown","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2025879015","eid":"W2025879015"},{"id":"paper-w4388941610","cat":"papers","name":"5-MeO-DMT for post-traumatic stress disorder: a real-world longitudinal case study","year":"2023","cit":19,"pfa":"Anya Ragnhildstveit","psa":"Lynnette A. Averill","topics":["PTSD & trauma","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4388941610","eid":"W4388941610"},{"id":"paper-w2166988128","cat":"papers","name":"Metabolic plasticity and the energy economizing effect of ibogaine, the principal alkaloid of Tabernanthe iboga","year":"2012","cit":19,"pfa":"Roman Paškulin","psa":"Borut Štrukelj","ptype":"article","src":"https://openalex.org/W2166988128","eid":"W2166988128"},{"id":"paper-w4391879161","cat":"papers","name":"Ayahuasca and Dimethyltryptamine Adverse Events and Toxicity Analysis: A Systematic Thematic Review","year":"2024","cit":19,"pfa":"Eleanor White","psa":"Jerome J. Sarris","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4391879161","eid":"W4391879161"},{"id":"paper-w2132591939","cat":"papers","name":"DISAGGREGATION OF BRAIN POLYSOMES AFTER d ‐LYSERGIC ACID DIETHYLAMIDE ADMINISTRATION IN VIVO: MECHANISM AND EFFECT OF AGE AND ENVIRONMENT1","year":"1977","cit":19,"pfa":"L. Holbrook","psa":"Ian R. Brown","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2132591939","eid":"W2132591939"},{"id":"paper-w2081680444","cat":"papers","name":"Effects of ibogaine and noribogaine on the antinociceptive action of μ-, δ- and κ-opioid receptor agonists in mice","year":"1997","cit":19,"pfa":"Hemendra N. Bhargava","psa":"Guomin Zhao","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2081680444","eid":"W2081680444"},{"id":"paper-w4200054299","cat":"papers","name":"Return of the lysergamides. Part VII: Analytical and behavioural characterization of 1‐valeroyl‐ d ‐lysergic acid diethylamide (1V‐LSD)","year":"2021","cit":19,"pfa":"Simon D. Brandt","psa":"Adam L. Halberstadt","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4200054299","eid":"W4200054299"},{"id":"paper-w4400349037","cat":"papers","name":"Serotonergic psychedelic 5-MeO-DMT alters plasticity-related gene expression and generates anxiolytic effects in stressed mice","year":"2024","cit":19,"pfa":"Margareth Nogueira","psa":"Richardson Naves Leão","ptype":"article","src":"https://openalex.org/W4400349037","eid":"W4400349037"},{"id":"paper-w4410735628","cat":"papers","name":"Psilocybin and psilocin regulate microglial immunomodulation and support neuroplasticity via serotonergic and AhR signaling","year":"2025","cit":19,"pfa":"Salma Laabi","psa":"Victor M. Jimenez","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4410735628","eid":"W4410735628"},{"id":"paper-w4383874233","cat":"papers","name":"Australia’s approval of MDMA and psilocybin for PTSD and depression is premature, say critics","year":"2023","cit":19,"pfa":"Bianca Nogrady","topics":["Depression","PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4383874233","eid":"W4383874233"},{"id":"paper-w3097829963","cat":"papers","name":"Detection and Quantification of Psychoactive N , N -Dimethyltryptamine in Ayahuasca Brews by Ambient Ionization High-Resolution Mass Spectrometry","year":"2020","cit":19,"pfa":"Megan Isabella Chambers","psa":"Rabi A. Musah","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3097829963","eid":"W3097829963"},{"id":"paper-w2323412239","cat":"papers","name":"An Improved Synthesis of Mescaline","year":"1951","cit":19,"pfa":"Fred Benington","psa":"Richard D. Morin","ptype":"article","src":"https://openalex.org/W2323412239","eid":"W2323412239"},{"id":"paper-w2029167187","cat":"papers","name":"Effects of N,N-Dimethyltryptamine (DMT) and 5-Methoxy-N,N-dimethyltryptamine (5-MeODMT) on shock elicited fighting in rats","year":"1978","cit":19,"pfa":"James K. Walters","psa":"Michael T. Davis","ptype":"article","src":"https://openalex.org/W2029167187","eid":"W2029167187"},{"id":"paper-w3110515087","cat":"papers","name":"Evaluation of the Cytotoxicity of Ayahuasca Beverages","year":"2020","cit":19,"pfa":"Ana Y. Simão","psa":"Eugénia Gallardo","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3110515087","eid":"W3110515087"},{"id":"paper-w2106291669","cat":"papers","name":"Immunological Effects of Ayahuasca in Humans","year":"2014","cit":19,"pfa":"RAFAEL GUIMARÃES DOS SANTOS","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2106291669","eid":"W2106291669"},{"id":"paper-w2001116453","cat":"papers","name":"Psilocybin as a discriminative stimulus: Lack of specificity in an animal behavior model for ?hallucinogens?","year":"1982","cit":19,"pfa":"Jon Koerner","psa":"James B. Appel","ptype":"article","src":"https://openalex.org/W2001116453","eid":"W2001116453"},{"id":"paper-w2053360140","cat":"papers","name":"Actions of noradrenaline and mescaline on cortical neurones","year":"1968","cit":19,"pfa":"M.H.T. Roberts","psa":"Donald W. Straughan","ptype":"article","src":"https://openalex.org/W2053360140","eid":"W2053360140"},{"id":"paper-w2122135126","cat":"papers","name":"Teratogenic effects of mescaline, epinephrine, and norepinephrine in the hamster","year":"1981","cit":19,"pfa":"Kenneth S. Hirsch","psa":"H. Ira Fritz","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2122135126","eid":"W2122135126"},{"id":"paper-w362928817","cat":"papers","name":"People of the peyote: Huichol Indian history, religion, & survival","year":"1997","cit":19,"ptype":"book-review","src":"https://openalex.org/W362928817","eid":"W362928817"},{"id":"paper-w4383553145","cat":"papers","name":"A Systematic Review on the Therapeutic Effects of Ayahuasca","year":"2023","cit":19,"pfa":"Joana Gonçalves","psa":"Ana Paula Duarte","topics":["Depression","Anxiety & end-of-life","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4383553145","eid":"W4383553145"},{"id":"paper-w1985302532","cat":"papers","name":"Differential effects of ibogaine on behavioural and dopamine sensitization to cocaine","year":"2000","cit":19,"pfa":"Karen Kathleen Szumlinski","psa":"Stanley D. Glick","ptype":"article","src":"https://openalex.org/W1985302532","eid":"W1985302532"},{"id":"paper-w2286750957","cat":"papers","name":"The Hallucinogenic Mushrooms of Mexico and Psilocybin: a Bibliography","year":"1962","cit":19,"pfa":"R. Gordon Wasson","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2286750957","eid":"W2286750957"},{"id":"paper-w2316564519","cat":"papers","name":"Salvinorin B derivatives, EOM-Sal B and MOM-Sal B, produce stimulus generalization in male Sprague-Dawley rats trained to discriminate salvinorin A","year":"2011","cit":19,"pfa":"M. Melissa Peet","psa":"Lisa E. Baker","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2316564519","eid":"W2316564519"},{"id":"paper-w2100744267","cat":"papers","name":"Effects of chronic ibogaine treatment on cerebellar Purkinje cells in the rat","year":"1997","cit":19,"pfa":"Scott Helsley","psa":"Jerrold C. Winter","ptype":"article","src":"https://openalex.org/W2100744267","eid":"W2100744267"},{"id":"paper-w2000447243","cat":"papers","name":"Os conteúdos das visões da ayahuasca","year":"2003","cit":19,"pfa":"Benny Shanon","ptype":"article","src":"https://openalex.org/W2000447243","eid":"W2000447243"},{"id":"paper-w4282945619","cat":"papers","name":"Natural language signatures of psilocybin microdosing","year":"2022","cit":19,"pfa":"Camila Sanz","psa":"Enzo Tagliazucchi","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4282945619","eid":"W4282945619"},{"id":"paper-w2059094517","cat":"papers","name":"Differential responses by neurotensin systems in extrapyramidal and limbic structures to ibogaine and cocaine","year":"1999","cit":19,"pfa":"Mario E. Alburges","psa":"Glen R. Hanson","ptype":"article","src":"https://openalex.org/W2059094517","eid":"W2059094517"},{"id":"paper-w4380681280","cat":"papers","name":"Life after Ayahuasca: A Qualitative Analysis of the Psychedelic Integration Experiences of 1630 Ayahuasca Drinkers from a Global Survey","year":"2023","cit":19,"pfa":"Tessa Cowley‐Court","psa":"Daniel Perkins","topics":["Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4380681280","eid":"W4380681280"},{"id":"paper-w2018585174","cat":"papers","name":"Neurotoxicity of MDMA (ecstasy): beyond metabolism","year":"2004","cit":19,"pfa":"Jon E. Sprague","psa":"David E. Nichols","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2018585174","eid":"W2018585174"},{"id":"paper-w130307109","cat":"papers","name":"Cactus alkaloids. XXXVI. Mescaline and related compounds from Trichocereus peruvianus.","year":"1978","cit":19,"pfa":"Pardanani Jh","psa":"Cooks Rg","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W130307109","eid":"W130307109"},{"id":"paper-w2471230217","cat":"papers","name":"Scratching response induced in mice by mescaline and related amphetamine derivatives.","year":"1973","cit":19,"pfa":"A S Kulkarni","ptype":"article","src":"https://openalex.org/W2471230217","eid":"W2471230217"},{"id":"paper-w2154832654","cat":"papers","name":"N,N-dimethyltryptamine alkaloid in Mimosa tenuiflora bark (tepescohuite).","year":"1991","cit":19,"pfa":"M Meckes-Lozoya","psa":"Arnason Jt","ptype":"article","src":"https://openalex.org/W2154832654","eid":"W2154832654"},{"id":"paper-w2068339114","cat":"papers","name":"Formation of Blue Oxidation Product from Psilocybin","year":"1967","cit":19,"pfa":"Walter G. Levine","ptype":"article","src":"https://openalex.org/W2068339114","eid":"W2068339114"},{"id":"paper-w1978206431","cat":"papers","name":"The effect of ibogaine on sigma- and NMDA-receptor- mediated release of [3H]dopamine","year":"1996","cit":19,"pfa":"Henry W. Sershen","psa":"Ábel Lajtha","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1978206431","eid":"W1978206431"},{"id":"paper-w2094881061","cat":"papers","name":"Ayahuasca: uma abordagem toxicológica do uso ritualístico","year":"2005","cit":19,"pfa":"Maria Carolina Meres Costa","psa":"Sílvia de Oliveira Santos Cazenave","ptype":"article","src":"https://openalex.org/W2094881061","eid":"W2094881061"},{"id":"paper-w2078901911","cat":"papers","name":"Salvinorin A content in legal high products of Salvia divinorum sold in Mexico","year":"2015","cit":19,"pfa":"Rafael Hernández-Bello","psa":"Alberto Sánchez-Medina","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2078901911","eid":"W2078901911"},{"id":"paper-w1998794695","cat":"papers","name":"Effects of Stress and MDMA on Hippocampal Gene Expression","year":"2014","cit":19,"pfa":"Georg F. Weber","psa":"Gary A. Gudelsky","topics":["PTSD & trauma","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1998794695","eid":"W1998794695"},{"id":"paper-w2148364002","cat":"papers","name":"Effects of salvinorin A on locomotor sensitization to D2/D3 dopamine agonist quinpirole","year":"2008","cit":19,"pfa":"Pieter Beerepoot","psa":"Henry Szechtman","ptype":"article","src":"https://openalex.org/W2148364002","eid":"W2148364002"},{"id":"paper-w3199319624","cat":"papers","name":"The Kappa Opioid Receptor and the Sleep of Reason: Cortico-Subcortical Imbalance Following Salvinorin-A","year":"2021","cit":19,"pfa":"Genís Oña","psa":"Jordi Riba","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3199319624","eid":"W3199319624"},{"id":"paper-w2107152115","cat":"papers","name":"Validation of an HPLC Method for Quantitation of MDMA in Tablets","year":"2005","cit":19,"pfa":"Irene Müller","psa":"Charlotte Norup Windberg","ptype":"article","src":"https://openalex.org/W2107152115","eid":"W2107152115"},{"id":"paper-w2339011795","cat":"papers","name":"Ibogaine-associated cardiac arrest and death: case report and review of the literature","year":"2016","cit":19,"pfa":"Jessica A. Meisner","psa":"Jeremy B. Richards","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2339011795","eid":"W2339011795"},{"id":"paper-w4313544662","cat":"papers","name":"Among psychedelic-experienced users, only past use of psilocybin reliably predicts nature relatedness","year":"2023","cit":19,"pfa":"Matthias Forstmann","psa":"David P. Luke","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4313544662","eid":"W4313544662"},{"id":"paper-w4322621514","cat":"papers","name":"The current state of ayahuasca research in animal models: A systematic review","year":"2023","cit":19,"pfa":"Dimitri Daldegan‐Bueno","psa":"Lucas Oliveira Maia","topics":["Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4322621514","eid":"W4322621514"},{"id":"paper-w4220914378","cat":"papers","name":"Ayahuasca, a potentially rapid acting antidepressant: focus on safety and tolerability","year":"2022","cit":19,"pfa":"Giordano Novak Rossi","psa":"RAFAEL GUIMARÃES DOS SANTOS","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4220914378","eid":"W4220914378"},{"id":"paper-w2234037461","cat":"papers","name":"Chemogenomics knowledgebase and systems pharmacology for hallucinogen target identification—Salvinorin A as a case study","year":"2016","cit":19,"pfa":"Xiaomeng Xu","psa":"Xiang‐Qun Xie","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2234037461","eid":"W2234037461"},{"id":"paper-w2040118600","cat":"papers","name":"Inhibitory effect of Iboga-type indole alkaloids on capsaicin-induced contraction in isolated mouse rectum","year":"2010","cit":19,"pfa":"Mee Wah Lo","psa":"Hiromitsu Takayama","ptype":"article","src":"https://openalex.org/W2040118600","eid":"W2040118600"},{"id":"paper-w4389396149","cat":"papers","name":"Shared functional connectome fingerprints following ritualistic ayahuasca intake","year":"2023","cit":19,"pfa":"Pablo Mallaroni","psa":"Johannes Gerardus Ramaekers","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4389396149","eid":"W4389396149"},{"id":"paper-w2163775575","cat":"papers","name":"Ibogaine reduces organ colonization in murine systemic and gastrointestinal Candida albicans infections","year":"2005","cit":19,"pfa":"M. Yordanov","psa":"Nina Ivanovska","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2163775575","eid":"W2163775575"},{"id":"paper-w2166782909","cat":"papers","name":"The ecstasy and the agony; compression studies of 3,4-methylenedioxymethamphetamine (MDMA)","year":"2015","cit":19,"pfa":"Lauren E. Connor","psa":"Iain D. H. Oswald","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2166782909","eid":"W2166782909"},{"id":"paper-w2054081110","cat":"papers","name":"The Phenomenology and Potential Religious Import of States of Consciousness Facilitated by Psilocybin","year":"2008","cit":19,"pfa":"William A. Richards","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2054081110","eid":"W2054081110"},{"id":"paper-w2013694786","cat":"papers","name":"MDMA can increase cortisol levels by 800% in dance clubbers","year":"2012","cit":19,"pfa":"A. C. Parrott","psa":"Johannes Thome","ptype":"article","src":"https://openalex.org/W2013694786","eid":"W2013694786"},{"id":"paper-w2597417601","cat":"papers","name":"The treatment and handling of substance dependence with Ayahuasca: Reflections on current and future research","year":"2013","cit":19,"pfa":"Harold Yc Tan","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2597417601","eid":"W2597417601"},{"id":"paper-w4320491739","cat":"papers","name":"Experiences of psilocybin treatment for clinical conditions: A qualitative meta‐synthesis","year":"2023","cit":19,"pfa":"Marie Crowe","psa":"Cameron James Lacey","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4320491739","eid":"W4320491739"},{"id":"paper-w2031907544","cat":"papers","name":"Behavioral characterization of alpha-ethyltryptamine, a tryptamine derivative with MDMA-like properties in rats","year":"1993","cit":19,"pfa":"Kirsten M. Krebs","psa":"Mark A. Geyer","ptype":"article","src":"https://openalex.org/W2031907544","eid":"W2031907544"},{"id":"paper-w2989680519","cat":"papers","name":"Psilocybin-assisted therapy for depression: How do we advance the field?","year":"2019","cit":19,"pfa":"Sally E Meikle","psa":"David Jonathan Castle","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2989680519","eid":"W2989680519"},{"id":"paper-w4206297427","cat":"papers","name":"Overcoming epistemic injustices in the biomedical study of ayahuasca: Towards ethical and sustainable regulation","year":"2022","cit":19,"pfa":"Eduardo Ekman Schenberg","psa":"Konstantin Gerber","topics":["Depression","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4206297427","eid":"W4206297427"},{"id":"paper-w2027074246","cat":"papers","name":"In vivo metabolism of α,α,β,β-tetradeutero-n, N-dimethyltryptamine in rodent brain","year":"1984","cit":19,"pfa":"Steven A. Barker","psa":"Philip E. Morris","ptype":"article","src":"https://openalex.org/W2027074246","eid":"W2027074246"},{"id":"paper-w4417046154","cat":"papers","name":"Psilocybin triggers an activity-dependent rewiring of large-scale cortical networks","year":"2025","cit":19,"pfa":"Quan Jiang","psa":"Alex C. Kwan","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4417046154","eid":"W4417046154"},{"id":"paper-w2048145118","cat":"papers","name":"Heteromeric nicotinic receptors are involved in the sensitization and addictive properties of MDMA in mice","year":"2013","cit":19,"pfa":"Andrés Ciudad‐Roberts","psa":"Elena Escubedo","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2048145118","eid":"W2048145118"},{"id":"paper-w2020152007","cat":"papers","name":"Loud noise enhances nigrostriatal dopamine toxicity induced by MDMA in mice","year":"2004","cit":19,"pfa":"Marco Gesi","psa":"Antonio Paparelli","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2020152007","eid":"W2020152007"},{"id":"paper-w2920410449","cat":"papers","name":"Cutting-Edge Search for Safer Opioid Pain Relief: Retrospective Review of Salvinorin A and Its Analogs","year":"2019","cit":19,"pfa":"Jordan Kordian Zjawiony","psa":"James Oluwagbamigbe Fajemiroye","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2920410449","eid":"W2920410449"},{"id":"paper-w4319827518","cat":"papers","name":"N,N‐dimethyltryptamine affects electroencephalography response in a concentration‐dependent manner—A pharmacokinetic/pharmacodynamic analysis","year":"2023","cit":19,"pfa":"Emma Eckernäs","psa":"Michael Ashton","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4319827518","eid":"W4319827518"},{"id":"paper-w2120309987","cat":"papers","name":"Mapping serotonergic dysfunction in MDMA (ecstasy) users using pharmacological MRI","year":"2011","cit":19,"pfa":"M.L.J. Schouw","psa":"Liesbeth Reneman","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2120309987","eid":"W2120309987"},{"id":"paper-w2911501953","cat":"papers","name":"Postmortem Brain–Blood Ratios of Amphetamine, Cocaine, Ephedrine, MDMA and Methylphenidate","year":"2019","cit":19,"pfa":"Michael Nedahl","psa":"Kristían Línnet","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2911501953","eid":"W2911501953"},{"id":"paper-w2021749386","cat":"papers","name":"An Extended Nondrug MDMA-Like Experience Evoked Through Posthypnotic Suggestion","year":"2006","cit":19,"pfa":"Arthur C. Hastings","ptype":"article","src":"https://openalex.org/W2021749386","eid":"W2021749386"},{"id":"paper-w4389992534","cat":"papers","name":"Limbic System Response to Psilocybin and Ketamine Administration in Rats: A Neurochemical and Behavioral Study","year":"2023","cit":19,"pfa":"Adam Wojtas","psa":"Krystyna Gołembiowska","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4389992534","eid":"W4389992534"},{"id":"paper-w2041124794","cat":"papers","name":"Induction of insulin secretion by an aqueous extract of Tabernanhte iboga Baill. (Apocynaceae) in rat pancreatic islets of Langerhans","year":"2010","cit":19,"pfa":"Alain Souza","psa":"André Herchuelz","ptype":"article","src":"https://openalex.org/W2041124794","eid":"W2041124794"},{"id":"paper-w2188415287","cat":"papers","name":"Gas chromatographic-mass spectrometric identification of urinary bufotenin and dimethyltryptamine in drug-free chronic schizophrenic patients.","year":"1974","cit":19,"pfa":"N. Narasimhachari","psa":"Harald E. Himwich","ptype":"article","src":"https://openalex.org/W2188415287","eid":"W2188415287"},{"id":"paper-w4402975017","cat":"papers","name":"Psilocybin increases optimistic engagement over time: computational modelling of behaviour in rats","year":"2024","cit":19,"pfa":"Elizabeth L. Fisher","psa":"Claire J. Foldi","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4402975017","eid":"W4402975017"},{"id":"paper-w1547587414","cat":"papers","name":"Salvinorin A analogues PR ‐37 and PR ‐38 attenuate compound 48/80‐induced itch responses in mice","year":"2015","cit":19,"pfa":"Maciej Sałaga","psa":"Jakub Fichna","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1547587414","eid":"W1547587414"},{"id":"paper-w1965989029","cat":"papers","name":"Chronic Treatment with Antidepressant Drugs and the Analgesia Induced by 5‐Methoxy‐N,N‐dimethyltryptamine: Attenuation by Desipramine","year":"1986","cit":19,"pfa":"Wojciech Danysz","psa":"Trevor Archer","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1965989029","eid":"W1965989029"},{"id":"paper-w2127195059","cat":"papers","name":"MDMA intoxication and verbal memory performance: a placebo-controlled pharmaco-MRI study","year":"2011","cit":19,"pfa":"Kim P. C. Kuypers","psa":"Johannes Gerardus Ramaekers","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2127195059","eid":"W2127195059"},{"id":"paper-w2110262610","cat":"papers","name":"Determination of Ibogaine and 12-Hydroxy-Ibogamine in Plasma by Gas Chromatography-Positive Ion Chemical Ionization-Mass Spectrometry","year":"1995","cit":19,"pfa":"M. E. Alburges","psa":"David E. Moody","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2110262610","eid":"W2110262610"},{"id":"paper-w2476957723","cat":"papers","name":"Quantification of Anti‐Addictive Alkaloids Ibogaine and Voacangine in In Vivo‐ and In Vitro‐Grown Plants of Two Mexican Tabernaemontana Species","year":"2016","cit":19,"pfa":"Felix Krengel","psa":"Ricardo Reyes‐Chilpa","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2476957723","eid":"W2476957723"},{"id":"paper-w2557428091","cat":"papers","name":"Psilocybin for anxiety and depression in cancer care? Lessons from the past and prospects for the future","year":"2016","cit":19,"pfa":"David Nutt","topics":["Depression","Anxiety & end-of-life"],"ptype":"editorial","src":"https://openalex.org/W2557428091","eid":"W2557428091"},{"id":"paper-w1965229137","cat":"papers","name":"Conformational, spectroscopic and nonlinear optical properties of biologically active N,N-dimethyltryptamine molecule: A theoretical study","year":"2014","cit":19,"pfa":"Nazmiye Öner","psa":"Yusuf Atalay","ptype":"article","src":"https://openalex.org/W1965229137","eid":"W1965229137"},{"id":"paper-w2059006476","cat":"papers","name":"Beiträge zur Chemie des Indols, VII. Synthesen in der Iboga‐Reihe, III. Ibogamin, Ibogain und Epiibogamin","year":"1975","cit":19,"pfa":"Peter Rosenmund","psa":"Rainer Frische","ptype":"article","src":"https://openalex.org/W2059006476","eid":"W2059006476"},{"id":"paper-w2084113951","cat":"papers","name":"Effects of MDMA (‘ecstasy’) on firing rates of serotonergic, dopaminergic, and noradrenergic neurons in the rat","year":"1990","cit":19,"pfa":"Montford F. Piercey","psa":"John R. Palmer","ptype":"article","src":"https://openalex.org/W2084113951","eid":"W2084113951"},{"id":"paper-w2083754020","cat":"papers","name":"Reduced efficacy of fluoxetine following MDMA (“Ecstasy”)-induced serotonin loss in rats","year":"2008","cit":19,"pfa":"Sarah Durkin","psa":"Andrew Harkin","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2083754020","eid":"W2083754020"},{"id":"paper-w2160033862","cat":"papers","name":"Density Functional Dependence in the Theoretical Analysis of the Terahertz Spectrum of the Illicit Drug MDMA (Ecstasy)","year":"2010","cit":19,"pfa":"Patrick M. Hakey","psa":"Timothy M. Korter","ptype":"article","src":"https://openalex.org/W2160033862","eid":"W2160033862"},{"id":"paper-w1877229764","cat":"papers","name":"Binge Ethanol and MDMA Combination Exacerbates Toxic Cardiac Effects by Inducing Cellular Stress","year":"2015","cit":19,"pfa":"Javier Navarro‐Zaragoza","psa":"M. Luisa Laorden","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1877229764","eid":"W1877229764"},{"id":"paper-w4310170807","cat":"papers","name":"What We Have Gained from Ibogaine: α3β4 Nicotinic Acetylcholine Receptor Inhibitors as Treatments for Substance Use Disorders","year":"2022","cit":19,"pfa":"Carolyn J. Straub","psa":"Andrew P. Riley","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4310170807","eid":"W4310170807"},{"id":"paper-w4389435230","cat":"papers","name":"Ayahuasca in the treatment of posttraumatic stress disorder: Mixed-methods case series evaluation in military combat veterans.","year":"2023","cit":19,"pfa":"Brandon Weiss","psa":"William Keith Campbell","topics":["PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4389435230","eid":"W4389435230"},{"id":"paper-w2330113925","cat":"papers","name":"Sensitization to MDMA locomotor effects and changes in the functionality of 5-HT2A and D2 receptors in mice","year":"2011","cit":19,"pfa":"María José Varela","psa":"Patricia Robledo","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2330113925","eid":"W2330113925"},{"id":"paper-w2048182968","cat":"papers","name":"Abnormal ACTH and prolactin responses to fenfluramine in rats exposed to single and multiple doses of MDMA","year":"1997","cit":19,"pfa":"Russell E. Poland","psa":"Robert N. Pechnick","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2048182968","eid":"W2048182968"},{"id":"paper-w2095469377","cat":"papers","name":"Gas Chromatographic--Mass Spectrometric and Liquid Chromatographic Analysis of Designer Butanamines Related to MDMA","year":"1995","cit":19,"pfa":"C. R. Clark","psa":"F. T. Noggle","ptype":"article","src":"https://openalex.org/W2095469377","eid":"W2095469377"},{"id":"paper-w2105110603","cat":"papers","name":"Effect of intermittent exposure to ethanol and MDMA during adolescence on learning and memory in adult mice","year":"2012","cit":19,"pfa":"Antonio Vidal‐Infer","psa":"Marta Rodríguez‐Arias","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2105110603","eid":"W2105110603"},{"id":"paper-w1969884083","cat":"papers","name":"The role of adenosine receptor agonist and antagonist on Hippocampal MDMA detrimental effects; a structural and behavioral study","year":"2012","cit":19,"pfa":"Fatemeh Kermanian","psa":"Hossein Haghir","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1969884083","eid":"W1969884083"},{"id":"paper-w176767905","cat":"papers","name":"Effect of morphine, hydromorphone, methadone, mescaline, trypan blue, vitamin A, sodium salicylate, and caffeine on the serum interferon level in response to viral infection.","year":"1975","cit":19,"pfa":"William F. Geber","psa":"Hung Cy","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W176767905","eid":"W176767905"},{"id":"paper-w2485201323","cat":"papers","name":"Effect of crowding, temperature and age on glia activation and dopaminergic neurotoxicity induced by MDMA in the mouse brain","year":"2016","cit":19,"pfa":"Lucia Frau","psa":"Micaela Morelli","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2485201323","eid":"W2485201323"},{"id":"paper-w1998839982","cat":"papers","name":"Enhanced hippocampal long-term potentiation following repeated MDMA treatment in Dark–Agouti rats","year":"2010","cit":19,"pfa":"Raffaella Morini","psa":"Renato Corradetti","ptype":"article","src":"https://openalex.org/W1998839982","eid":"W1998839982"},{"id":"paper-w3175607222","cat":"papers","name":"Media coverage about medical benefits of MDMA and ketamine affects perceived likelihood of engaging in recreational use","year":"2021","cit":19,"pfa":"Joseph J. Palamar","psa":"Austin Le","topics":["Depression","PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W3175607222","eid":"W3175607222"},{"id":"paper-w4400033755","cat":"papers","name":"Cognitive functioning associated with acute and subacute effects of classic psychedelics and MDMA - a systematic review and meta-analysis","year":"2024","cit":19,"pfa":"Lukas Andreas Basedow","psa":"Thomas Riemer","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4400033755","eid":"W4400033755"},{"id":"paper-w2013613171","cat":"papers","name":"Central amygdala nicotinic and 5-HT1A receptors mediate the reversal effect of nicotine and MDMA on morphine-induced amnesia","year":"2014","cit":19,"pfa":"Fatemeh Tirgar","psa":"M.R. Zarrindast","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2013613171","eid":"W2013613171"},{"id":"paper-w2033072866","cat":"papers","name":"Repeated adolescent MDMA (“Ecstasy”) exposure in rats increases behavioral and neuroendocrine responses to a 5-HT2A/2C agonist","year":"2008","cit":19,"pfa":"Dominik K. Biezonski","psa":"Jerrold S. Meyer","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2033072866","eid":"W2033072866"},{"id":"paper-w1986939775","cat":"papers","name":"In abstinent MDMA users the cortisol awakening response is off-set but associated with prefrontal serotonin transporter binding as in non-users","year":"2014","cit":19,"pfa":"Vibe G. Frøkjær","psa":"Gitte M. Knudsen","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1986939775","eid":"W1986939775"},{"id":"paper-w4407831006","cat":"papers","name":"Safety and efficacy of methylenedioxymethamphetamine (MDMA)-assisted psychotherapy in post-traumatic stress disorder: An overview of systematic reviews and meta-analyses","year":"2025","cit":19,"pfa":"Alene Sze Jing Yong","psa":"J. Simon Bell","topics":["PTSD & trauma","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4407831006","eid":"W4407831006"},{"id":"paper-w3199990896","cat":"papers","name":"Application of Homogeneous Liquid–Liquid Microextraction With Switchable Hydrophilicity Solvents to the Determination of MDMA, MDA and NBOMes in Postmortem Blood Samples","year":"2021","cit":19,"pfa":"Camila Scheid","psa":"Tiago Franco de Oliveira","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W3199990896","eid":"W3199990896"},{"id":"paper-w2082062998","cat":"papers","name":"Ethanol–ecstasy (MDMA) interactions in rats: Preserved attenuation of hyperthermia and potentiation of hyperactivity by ethanol despite prior ethanol treatment","year":"2006","cit":19,"pfa":"Sami Ben Hamida","psa":"Jean‐Christophe Cassel","ptype":"article","src":"https://openalex.org/W2082062998","eid":"W2082062998"},{"id":"paper-w2052087357","cat":"papers","name":"S100B overexpressing mutant mice exhibit prolonged behavioural and biochemical responses towards repeated intermittent binge treatments with MDMA","year":"2008","cit":19,"pfa":"Anna M. S. Kindlundh-Högberg","psa":"Per Svenningsson","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2052087357","eid":"W2052087357"},{"id":"paper-w2885543493","cat":"papers","name":"Kinetic mechanism of time-dependent inhibition of CYP2D6 by 3,4-methylenedioxymethamphetamine (MDMA): Functional heterogeneity of the enzyme and the reversibility of its inactivation","year":"2018","cit":19,"pfa":"John T. Rodgers","psa":"Dmitri R. Davydov","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2885543493","eid":"W2885543493"},{"id":"paper-w2768925507","cat":"papers","name":"Perceived Risk Associated with MDMA (Ecstasy/Molly) Use among African Americans: What Prevention and Treatment Providers Should Know","year":"2017","cit":19,"pfa":"Khary K. Rigg","psa":"Maayan Lawental","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2768925507","eid":"W2768925507"},{"id":"paper-w2082669178","cat":"papers","name":"Studies on the neuroprotective effect of the enantiomers of AR-A008055, a compound structurally related to clomethiazole, on MDMA (\"ecstasy\")-induced neurodegeneration in rat brain","year":"2001","cit":19,"pfa":"Isabel Colado","psa":"Richard R. Green","ptype":"article","src":"https://openalex.org/W2082669178","eid":"W2082669178"},{"id":"paper-w2041240790","cat":"papers","name":"Differential alteration of the effects of MDMA (ecstasy) on locomotor activity and cocaine conditioned place preference in male adolescent rats by social and environmental enrichment","year":"2012","cit":19,"pfa":"Amy Kathryn Starosciak","psa":"Sari Izenwasser","ptype":"article","src":"https://openalex.org/W2041240790","eid":"W2041240790"},{"id":"paper-w4362161","cat":"papers","name":"Identification and Quantitation of Amphetamine, Methamphetamine, MDMA, Pseudoephedrine, and Ephedrine in Blood, Plasma, and Serum Using Gas Chromatography-Mass Spectrometry (GC/MS)","year":"2009","cit":19,"pfa":"Josh Gunn","psa":"Andrea R. Terrell","ptype":"book-chapter","src":"https://openalex.org/W4362161","eid":"W4362161"},{"id":"paper-w3042486737","cat":"papers","name":"MDMA-related presentations to the emergency departments of the European Drug Emergencies Network plus (Euro-DEN Plus) over the four-year period 2014–2017","year":"2020","cit":19,"pfa":"Roberta Noseda","psa":"Ibolya Tóth","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3042486737","eid":"W3042486737"},{"id":"paper-w4206591786","cat":"papers","name":"Human Cortical Serotonin 2A Receptor Occupancy by Psilocybin Measured Using [11C]MDL 100,907 Dynamic PET and a Resting-State fMRI-Based Brain Parcellation","year":"2022","cit":19,"pfa":"Frederick Streeter Barrett","psa":"Dean Foster Wong","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4206591786","eid":"W4206591786"},{"id":"paper-w2134695382","cat":"papers","name":"Ecstasy (MDMA) does not have long-term effects on aggressive interpretative bias: A study comparing current and ex-ecstasy users with polydrug and drug-naive controls.","year":"2007","cit":19,"pfa":"Rosa Hoshi","psa":"Helen Valerie Curran","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2134695382","eid":"W2134695382"},{"id":"paper-w2138165331","cat":"papers","name":"The Interactions of MK‐801 with the Amphetamine Analogues d‐Methamphetamine (d‐METH), 3,4‐Methylenedioxymethamphetamine (d‐MDMA) or d‐Fenfluramine (d‐FEN): Neural Damage and Neural Protectiona","year":"1993","cit":19,"pfa":"Diane Bemis Miller","psa":"James Patrick O'Callaghan","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2138165331","eid":"W2138165331"},{"id":"paper-w2289271945","cat":"papers","name":"Benzylpiperizine-based party pills' impact on the Auckland City Hospital Emergency Department Overdose Database (2002-2004) compared with ecstasy (MDMA or methylene dioxymethamphetamine), gamma hydroxybutyrate (GHB), amp","year":"2007","cit":19,"pfa":"Lynn Theron","psa":"Jennifer Lynn Miles-Chan","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2289271945","eid":"W2289271945"},{"id":"paper-w2140594024","cat":"papers","name":"Simultaneous liquid chromatographic-electrospray ionization mass spectrometric quantification of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) and its metabolites 3,4-dihydroxymethamphetamine, 4-hydroxy-3-methoxymeth","year":"2009","cit":19,"pfa":"Melanie Mueller","psa":"Hans H. Maurer","ptype":"article","src":"https://openalex.org/W2140594024","eid":"W2140594024"},{"id":"paper-w3195506672","cat":"papers","name":"Pharmacologic Similarities and Differences Among Hallucinogens","year":"2021","cit":19,"pfa":"Kristin Waters","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3195506672","eid":"W3195506672"},{"id":"paper-w2999591814","cat":"papers","name":"Nanosensor for Sensitive Detection of the New Psychedelic Drug 25I‐NBOMe","year":"2020","cit":19,"pfa":"Eva María Nieto Garrido","psa":"Félix Sancenón","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2999591814","eid":"W2999591814"},{"id":"paper-w4280546985","cat":"papers","name":"Psychedelics in the Treatment of Headache and Chronic Pain Disorders","year":"2022","cit":19,"pfa":"Emmanuelle A. D. Schindler","ptype":"book-chapter","src":"https://openalex.org/W4280546985","eid":"W4280546985"},{"id":"paper-w4376504639","cat":"papers","name":"Time-resolved network control analysis links reduced control energy under DMT with the serotonin 2a receptor, signal diversity, and subjective experience","year":"2023","cit":19,"pfa":"S. Parker Singleton","psa":"Amy F. Kuceyeski","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4376504639","eid":"W4376504639"},{"id":"paper-w2074774325","cat":"papers","name":"Analytical study of some important hallucinogens by a combined fluorimetric and phosphorimetric method","year":"1973","cit":19,"pfa":"Jean Jacques Aaron","psa":"James D. Winefordner","ptype":"article","src":"https://openalex.org/W2074774325","eid":"W2074774325"},{"id":"paper-w1989946080","cat":"papers","name":"An observational study of hallucinogen-induced behavior in unrestrained Macaca mulatta","year":"1974","cit":19,"pfa":"Ronald K. Siegel","psa":"Murray E. Jarvik","ptype":"article","src":"https://openalex.org/W1989946080","eid":"W1989946080"},{"id":"paper-w4281661929","cat":"papers","name":"Optimization through a Box–Behnken Experimental Design of the Microwave-Assisted Extraction of the Psychoactive Compounds in Hallucinogenic Fungi (Psylocibe cubensis)","year":"2022","cit":19,"pfa":"Curro Polo-Castellano","psa":"Marta Ferreiro‐González","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4281661929","eid":"W4281661929"},{"id":"paper-w4381158131","cat":"papers","name":"Psychedelic medicines for end-of-life care: Pipeline clinical trial review 2022","year":"2023","cit":19,"pfa":"Xuepeng Jing","psa":"David Benjamin Menkes","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4381158131","eid":"W4381158131"},{"id":"paper-w2046472870","cat":"papers","name":"Inhibition of neurotransmitter receptor binding by ergot derivatives","year":"1981","cit":19,"pfa":"Robert E. Hruska","psa":"Ellen Kovner Silbergeld","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2046472870","eid":"W2046472870"},{"id":"paper-w4390671187","cat":"papers","name":"Psychedelic-like Activity of Norpsilocin Analogues","year":"2024","cit":19,"pfa":"Alexander M. Sherwood","psa":"Grant C. Glatfelter","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4390671187","eid":"W4390671187"},{"id":"paper-w3209922385","cat":"papers","name":"Patents on Psychedelics: The Next Legal Battlefront of Drug Development","year":"2021","cit":19,"pfa":"Mason Marks","psa":"Ivan Glenn Cohen","topics":["Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W3209922385","eid":"W3209922385"},{"id":"paper-w4391053730","cat":"papers","name":"Trauma-Informed Care in Psychedelic Therapy Research: A Qualitative Literature Review of Evidence-Based Psychotherapy Interventions in PTSD and Psychedelic Therapy Across Conditions","year":"2024","cit":19,"pfa":"Nadav Liam Modlin","psa":"Victoria Williamson","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4391053730","eid":"W4391053730"},{"id":"paper-w2256008574","cat":"papers","name":"PHARMACOLOGY OF d-LYSERGIC ACID MORPHOLIDE (LSM)","year":"1957","cit":19,"pfa":"John H. Gogerty","psa":"James M. Dille","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2256008574","eid":"W2256008574"},{"id":"paper-w4388291875","cat":"papers","name":"Plant based assisted therapy for the treatment of substance use disorders - part 1. The case of takiwasi center and other similar experiences","year":"2018","cit":19,"pfa":"Matteo Politi","psa":"Jacques Mabit","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4388291875","eid":"W4388291875"},{"id":"paper-w2922431302","cat":"papers","name":"Beyond LSD: A Broader Psychedelic Zeitgeist during the Early to Mid-20thCentury","year":"2019","cit":19,"pfa":"Jacob S. Aday","psa":"Christopher C. Davoli","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2922431302","eid":"W2922431302"},{"id":"paper-w2150850625","cat":"papers","name":"Selective natural kappa opioid and cannabinoid receptor agonists with a potential role in the treatment of gastrointestinal dysfunction","year":"2009","cit":19,"pfa":"Jakub Fichna","psa":"Martin Storr","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2150850625","eid":"W2150850625"},{"id":"paper-w2004582329","cat":"papers","name":"binding of 125I-LSD to serotonin 5-HT2 receptors in mouse brain","year":"1985","cit":19,"pfa":"Paul R. Hartig","psa":"Henry N. Wagner","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2004582329","eid":"W2004582329"},{"id":"paper-w2123927894","cat":"papers","name":"Photoaffinity Labeling of the 5‐HydroxytryptamineIAReceptor in Rat Hippocampus","year":"1986","cit":19,"pfa":"Richard W. Ransom","psa":"Jean Chen Shih","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2123927894","eid":"W2123927894"},{"id":"paper-w2431867045","cat":"papers","name":"Involvement of 5-hydroxytryptamine 2A (5-HT2A) receptors in the mediation of the discriminative stimulus properties of (+/-)DOI in rats.","year":"1998","cit":19,"pfa":"Ewa Chojnacka-Wójcik","psa":"Aleksandra Kłodzińska","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2431867045","eid":"W2431867045"},{"id":"paper-w2065023424","cat":"papers","name":"Receptors for 5-Hydroxytryptamine in Rabbit Isolated Ear Artery and Aorta","year":"2008","cit":19,"pfa":"Ralph Earl Purdy","psa":"Leslie A. Rains","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2065023424","eid":"W2065023424"},{"id":"paper-w2005473956","cat":"papers","name":"Determination of a new designer drug, N-hydroxy-3,4-methylenedioxymethamphetamine and its metabolites in rats using ultra-performance liquid chromatography–tandem mass spectrometry","year":"2010","cit":19,"pfa":"Ruri Kikura‐Hanajiri","psa":"Yukihiro Goda","ptype":"article","src":"https://openalex.org/W2005473956","eid":"W2005473956"},{"id":"paper-w2086097517","cat":"papers","name":"Differential Substitution for the Discriminative Stimulus Effects of 3,4-Methylenedioxymethamphetamine and Methylphenidate in Rats","year":"2014","cit":19,"pfa":"Tomohisa Mori","psa":"Tsutomu Suzuki","ptype":"article","src":"https://openalex.org/W2086097517","eid":"W2086097517"},{"id":"paper-w4237254834","cat":"papers","name":"The Effects of some Hallucinogens on Aggressiveness of Mice and Rats","year":"2008","cit":19,"pfa":"Wojciech Rewerski","psa":"M. Rylski","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4237254834","eid":"W4237254834"},{"id":"paper-w2054637652","cat":"papers","name":"Acute effects of 3,4-methylenedioxymethamphetamine on brain serotonin synthesis in the dog studied by positron emission tomography","year":"1999","cit":19,"pfa":"S Nishisawa","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2054637652","eid":"W2054637652"},{"id":"paper-w2052117688","cat":"papers","name":"3,4-Methylenedioxymethamphetamine (“Ecstasy”) Stimulates the Expression of α1(I) Procollagen mRNA in Hepatic Stellate Cells","year":"1999","cit":19,"pfa":"Marta Varela‐Rey","psa":"María J. Iraburu","ptype":"article","src":"https://openalex.org/W2052117688","eid":"W2052117688"},{"id":"paper-w1884478179","cat":"papers","name":"Protection against 3,4‐methylenedioxymethamphetamine‐induced neurodegeneration produced by glutathione depletion in rats is mediated by attenuation of hyperthermia","year":"2002","cit":19,"pfa":"Esther O’Shea","psa":"Charles Alexander Marsden","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1884478179","eid":"W1884478179"},{"id":"paper-w2000387138","cat":"papers","name":"Direct comparison of hallucinogenic phenethylamines and d-amphetamine on dorsal raphe neurons","year":"1986","cit":19,"pfa":"Nicholas J. Penington","psa":"Rhoderic J. Reiffenstein","ptype":"article","src":"https://openalex.org/W2000387138","eid":"W2000387138"},{"id":"paper-w3184413932","cat":"papers","name":"Forensic And Pharmaceutical Analysis Of Addictive Morbidity Because Of The Use Of Psychotropic Psychoactive Substances In Ukraine (Retrospective Aspect)","year":"2018","cit":19,"pfa":"Jr. Shapovalov V V","psa":"Valentyn Shapovalov","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3184413932","eid":"W3184413932"},{"id":"paper-w4297984090","cat":"papers","name":"Neurovascular Uncoupling: Multimodal Imaging Delineates the Acute Effects of 3,4-Methylenedioxymethamphetamine","year":"2022","cit":19,"pfa":"Tudor M. Ionescu","psa":"Kristina Herfert","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4297984090","eid":"W4297984090"},{"id":"paper-w2266041085","cat":"papers","name":"S alvia divinorum: An overview of the usage, misuse, and addiction processes","year":"2015","cit":19,"pfa":"Rathi Mahendran","psa":"Munidasa Winslow","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2266041085","eid":"W2266041085"},{"id":"paper-w2171758533","cat":"papers","name":"Psychotomimetic Effects of Kappa Opioid Receptor Agonists","year":"2012","cit":19,"pfa":"Kate L. White","psa":"Bryan L. Roth","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2171758533","eid":"W2171758533"},{"id":"paper-w2526165670","cat":"papers","name":"Oxytocin, cortisol and 3,4-methylenedioxymethamphetamine: neurohormonal aspects of recreational ‘ecstasy’","year":"2016","cit":19,"pfa":"Andrew C. Parrott","topics":["Safety & adverse events","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2526165670","eid":"W2526165670"},{"id":"paper-w2906444747","cat":"papers","name":"Difference in long-term relapse rates between youths with ketamine use and those with stimulants use","year":"2018","cit":19,"pfa":"Liang‐Jen Wang","psa":"Shing-Fang Lu","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2906444747","eid":"W2906444747"},{"id":"paper-w2888502690","cat":"papers","name":"Psychedelic fungus (Psilocybe sp.) authentication in a case of illegal drug traffic: sporological, molecular analysis and identification of the psychoactive substance","year":"2018","cit":19,"pfa":"Jaime Solano","psa":"David A. Gangitano","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2888502690","eid":"W2888502690"},{"id":"paper-w3211291416","cat":"papers","name":"Does ±3,4-methylenedioxymethamphetamine (ecstasy) induce subjective feelings of social connection in humans? A multilevel meta-analysis","year":"2021","cit":19,"pfa":"Annie Regan","psa":"Sonja Lyubomirsky","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3211291416","eid":"W3211291416"},{"id":"paper-w2085209816","cat":"papers","name":"The effect of long-term repeated exposure to 3,4-methylenedioxymethamphetamine on cardiovascular and thermoregulatory changes","year":"2008","cit":19,"pfa":"Emily Joy Jaehne","psa":"Rodney James Irvine","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2085209816","eid":"W2085209816"},{"id":"paper-w2056713599","cat":"papers","name":"Identification of metabolites of 3,4-methylenedioxymethamphetamine in rats","year":"1990","cit":19,"pfa":"Mamoun Yousif","psa":"Richard A. Glennon","ptype":"article","src":"https://openalex.org/W2056713599","eid":"W2056713599"},{"id":"paper-w2042783419","cat":"papers","name":"The effects of concurrent administration of (±)3,4-Methylenedioxymethamphetamine and cocaine on conditioned place preference in the adult male rat","year":"2007","cit":19,"pfa":"Anna Jean Diller","psa":"Jack R. Nation","ptype":"article","src":"https://openalex.org/W2042783419","eid":"W2042783419"},{"id":"paper-w1965269533","cat":"papers","name":"Long-term alteration in the central monoaminergic systems of the rat by 2,4,5-trihydroxyamphetamine but not by 2-hydroxy-4,5-methylenedioxymethamphetamine or2-hydroxy-4,5-methylenedioxyamphetamine","year":"1992","cit":19,"pfa":"Ikram Elayan","psa":"Michel Johnson","ptype":"article","src":"https://openalex.org/W1965269533","eid":"W1965269533"},{"id":"paper-w4391531737","cat":"papers","name":"Modulation of long-term potentiation following microdoses of LSD captured by thalamo-cortical modelling in a randomised, controlled trial","year":"2024","cit":19,"pfa":"Robin J. Murphy","psa":"Rachael L. Sumner","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4391531737","eid":"W4391531737"},{"id":"paper-w2944995076","cat":"papers","name":"Evolving Issues in the Treatment of Depression","year":"2019","cit":19,"pfa":"Ole Köhler‐Forsberg","psa":"Andrew Alan Nierenberg","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2944995076","eid":"W2944995076"},{"id":"paper-w2146074450","cat":"papers","name":"Mixtures of 3,4‐methylenedioxymethamphetamine (ecstasy) and its major human metabolites act additively to induce significant toxicity to liver cells when combined at low, non‐cytotoxic concentrations","year":"2013","cit":19,"pfa":"Diana Dias da Silva","psa":"Helena Carmo","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2146074450","eid":"W2146074450"},{"id":"paper-w3100749967","cat":"papers","name":"Determination of Ketamine and Norketamine in Hair and Evaluation of Polydrug Use in Ketamine Abusers Using Hair Analysis in Korea","year":"2020","cit":19,"pfa":"Jongsook Rhee","psa":"Sangki Lee","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W3100749967","eid":"W3100749967"},{"id":"paper-w4382517556","cat":"papers","name":"Psilocybin’s Potential Mechanisms in the Treatment of Depression: A Systematic Review","year":"2023","cit":19,"pfa":"H. Lee","psa":"Julius Elefante","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4382517556","eid":"W4382517556"},{"id":"paper-w4387063622","cat":"papers","name":"Perceptions of psychedelic-assisted therapy among Black Americans","year":"2023","cit":19,"pfa":"Sierra Elizabeth Carter","psa":"Jessica L. Maples‐Keller","topics":["Depression","PTSD & trauma","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4387063622","eid":"W4387063622"},{"id":"paper-w2108869201","cat":"papers","name":"Comparative Analysis of the Chemical Profiles of 3,4‐Methylenedioxymethamphetamine Based on Comprehensive Two‐Dimensional Gas Chromatography–Time‐of‐Flight Mass Spectrometry (GC × GC‐TOFMS)*","year":"2012","cit":19,"pfa":"Marion Schäffer","psa":"Ralf Zimmermann","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2108869201","eid":"W2108869201"},{"id":"paper-w2094647919","cat":"papers","name":"Behavioural Effects of some Derivatives of Amphetamine and LSD and their Significance","year":"1970","cit":19,"pfa":"John Smythies","psa":"Richard D. Morin","ptype":"article","src":"https://openalex.org/W2094647919","eid":"W2094647919"},{"id":"paper-w2033024511","cat":"papers","name":"PHARMACOLOGICAL STUDIES IN THE FUNCTIONS OF THE EXTRAPYRAMIDAL SYSTEM REPORT NO. 1","year":"1953","cit":19,"pfa":"SABURO HARA","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2033024511","eid":"W2033024511"},{"id":"paper-w3060509308","cat":"papers","name":"Who Turns to Amazonian Medicine for Treatment of Substance Use Disorder? Patient Characteristics at the Takiwasi Addiction Treatment Center","year":"2020","cit":19,"pfa":"Ilana Berlowitz","psa":"Chantal Martin-Söelch","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3060509308","eid":"W3060509308"},{"id":"paper-w1993601022","cat":"papers","name":"Conjugates of p-hydroxymethamphetamine and 4-hydroxy-3-methoxymethamphetamine in blood obtained from methamphetamine and 3,4-methylenedioxymethamphetamine users: analysis by LC-MS-MS","year":"2008","cit":19,"pfa":"Noriaki Shima","psa":"Nobuo Nemoto","ptype":"article","src":"https://openalex.org/W1993601022","eid":"W1993601022"},{"id":"paper-w4409687867","cat":"papers","name":"Drugs Used in “Chemsex”/Sexualized Drug Behaviour—Overview of the Related Clinical Psychopharmacological Issues","year":"2025","cit":19,"pfa":"Fabrizio Schifano","psa":"Nicolò Schifano","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4409687867","eid":"W4409687867"},{"id":"paper-w3216523708","cat":"papers","name":"Psychedelic Epistemology: William James and the “Noetic Quality” of Mystical Experience","year":"2021","cit":19,"pfa":"Ron Cole‐Turner","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3216523708","eid":"W3216523708"},{"id":"paper-w4391528529","cat":"papers","name":"A Systematic Review of Interventions for Demoralization in Patients with Chronic Diseases","year":"2024","cit":19,"pfa":"Dong Li","psa":"Liande Tao","topics":["Reviews & meta-analyses","Therapy practice"],"ptype":"review","src":"https://openalex.org/W4391528529","eid":"W4391528529"},{"id":"paper-w2078172249","cat":"papers","name":"Doxepin as a Blocker of Central Serotonin Receptors","year":"1977","cit":19,"pfa":"Joanna Maj","psa":"A. Rawłów","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2078172249","eid":"W2078172249"},{"id":"paper-w2954372647","cat":"papers","name":"“Go ask Alice, when she’s 10-feet tall”: Psychosocial correlates to lifetime LSD use among a national sample of US adults","year":"2019","cit":19,"pfa":"R. Andrew Yockey","psa":"Rebecca A. Vidourek","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2954372647","eid":"W2954372647"},{"id":"paper-w2131383817","cat":"papers","name":"Simultaneous Detection of Ten Psychedelic Phenethylamines in Urine by Gas Chromatography-Mass Spectrometry","year":"2011","cit":19,"pfa":"Sarah Kerrigan","psa":"B. Hardy","ptype":"article","src":"https://openalex.org/W2131383817","eid":"W2131383817"},{"id":"paper-w2801751337","cat":"papers","name":"Placebo Problems: Boundary Work in the Psychedelic Science Renaissance","year":"2018","cit":19,"pfa":"Katherine Hendy","ptype":"book-chapter","src":"https://openalex.org/W2801751337","eid":"W2801751337"},{"id":"paper-w4207022635","cat":"papers","name":"Psychedelic-assisted psychotherapy for the treatment of major depression: a synthesis of phenomenological explanations","year":"2022","cit":19,"pfa":"Riccardo Miceli McMillan","psa":"Christopher F. C. Jordens","topics":["Depression","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4207022635","eid":"W4207022635"},{"id":"paper-w2726611125","cat":"papers","name":"Recreational 3,4-methylenedioxymethamphetamine or ‘ecstasy’: Current perspective and future research prospects","year":"2017","cit":19,"pfa":"Andrew C. Parrott","psa":"Helen C Fox","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2726611125","eid":"W2726611125"},{"id":"paper-w2063765408","cat":"papers","name":"REVIEW: Modulation of high alcohol drinking in the inbred Fawn–Hooded (FH/Wjd) rat strain: implications for treatment","year":"2006","cit":19,"pfa":"David H. Overstreet","psa":"Andrew John Lawrence","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2063765408","eid":"W2063765408"},{"id":"paper-w4389035225","cat":"papers","name":"Management of Treatment-Resistant Depression: Challenges and Strategies","year":"2020","cit":19,"pfa":"Daphne Voineskos","psa":"Blumberger DM","topics":["Depression","Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4389035225","eid":"W4389035225"},{"id":"paper-w1997682832","cat":"papers","name":"Intensity dependence of auditory evoked dipole source activity in polydrug ecstasy users: evidence from an 18 months longitudinal study","year":"2006","cit":19,"pfa":"Jörg Daumann","psa":"Euphrosyne Gouzoulis‐Mayfrank","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1997682832","eid":"W1997682832"},{"id":"paper-w2028772969","cat":"papers","name":"Recent-onset ecstasy use: Association with deviant behaviors and psychiatric comorbidity.","year":"2006","cit":19,"pfa":"Silvia Saboia Martins","psa":"Howard D. Chilcoat","topics":["Depression","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2028772969","eid":"W2028772969"},{"id":"paper-w4407195838","cat":"papers","name":"Emerging Medications for Treatment-Resistant Depression: A Review with Perspective on Mechanisms and Challenges","year":"2025","cit":19,"pfa":"Michael J. Lucido","psa":"Boadie Waid Dunlop","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4407195838","eid":"W4407195838"},{"id":"paper-w4378471311","cat":"papers","name":"The impact of psychostimulants on central and peripheral neuro-immune regulation: a scoping review of cytokine profiles and their implications for addiction","year":"2023","cit":19,"pfa":"Joana Bravo","psa":"Teresa Summavielle","topics":["Addiction","Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4378471311","eid":"W4378471311"},{"id":"paper-w4386638059","cat":"papers","name":"Guidelines in Applying Psychedelic Therapies","year":"2019","cit":19,"pfa":"Friederike Meckel","ptype":"other","src":"https://openalex.org/W4386638059","eid":"W4386638059"},{"id":"paper-w4308057267","cat":"papers","name":"The perceptions of cancer health-care practitioners in New Zealand and the USA toward psychedelic-assisted therapy with cancer patients: A cross-sectional survey","year":"2022","cit":19,"pfa":"Lisa Reynolds","psa":"William J. Evans","topics":["Depression","Anxiety & end-of-life","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4308057267","eid":"W4308057267"},{"id":"paper-w4378220014","cat":"papers","name":"Safety and tolerability of intramuscular and sublingual ketamine for psychiatric treatment in the Roots To Thrive ketamine-assisted therapy program: a retrospective chart review","year":"2023","cit":19,"pfa":"Vivian W. L. Tsang","psa":"Pamela Kryskow","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4378220014","eid":"W4378220014"},{"id":"paper-w4391609632","cat":"papers","name":"Lasting dynamic effects of the psychedelic 2,5-dimethoxy-4-iodoamphetamine ((±)-DOI) on cognitive flexibility","year":"2024","cit":19,"pfa":"Merima Šabanović","psa":"David M. Bannerman","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4391609632","eid":"W4391609632"},{"id":"paper-w4403783474","cat":"papers","name":"How Psychedelics Modulate Multiple Memory Mechanisms in Posttraumatic Stress Disorder","year":"2024","cit":19,"pfa":"Manoj K. Doss","psa":"Charles B. Nemeroff","topics":["PTSD & trauma","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4403783474","eid":"W4403783474"},{"id":"paper-w2071577376","cat":"papers","name":"Entheogens and the Future of Religion","year":"1998","cit":19,"pfa":"Timothy S. Miller","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2071577376","eid":"W2071577376"},{"id":"paper-w4256694169","cat":"papers","name":"Classical Hallucinogens","year":"1996","cit":19,"pfa":"Richard A. Glennon","ptype":"book-chapter","src":"https://openalex.org/W4256694169","eid":"W4256694169"},{"id":"paper-w2490906577","cat":"papers","name":"On the Biochemistry and Pharmacology of Hallucinogens","year":"1976","cit":19,"pfa":"Kjell Fuxé","psa":"GÖSTA JONSSON","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W2490906577","eid":"W2490906577"},{"id":"paper-w4380988406","cat":"papers","name":"Psychedelics and workplace harm","year":"2023","cit":19,"pfa":"Sean M. Viña","psa":"Amanda Layne Stephens","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4380988406","eid":"W4380988406"},{"id":"paper-w4407150420","cat":"papers","name":"Cardiovascular effects and safety of classic psychedelics","year":"2025","cit":19,"pfa":"Acile Nahlawi","psa":"Jeremy N. Ruskin","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4407150420","eid":"W4407150420"},{"id":"paper-w3020940623","cat":"papers","name":"Some Comments on Psychedelic Research","year":"2020","cit":19,"pfa":"Alan F. Schatzberg","ptype":"article","src":"https://openalex.org/W3020940623","eid":"W3020940623"},{"id":"paper-w101381830","cat":"papers","name":"Discriminative Stimulus Properties of Hallucinogens: Behavioral Assay of Drug Action","year":"1977","cit":19,"pfa":"Donald M. Kuhn","psa":"James B. Appel","ptype":"book-chapter","src":"https://openalex.org/W101381830","eid":"W101381830"},{"id":"paper-w2908175819","cat":"papers","name":"Printable medicines: a microdosing device for producing personalised medicines","year":"2011","cit":19,"pfa":"Christine Voura","psa":"Andreas Zimmer","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2908175819","eid":"W2908175819"},{"id":"paper-w2282305224","cat":"papers","name":"Morphologic Changes in the Ovaries of Women Treated with Continuous Microdose Progestogens","year":"1972","cit":19,"pfa":"Kamran S. Moghissi","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2282305224","eid":"W2282305224"},{"id":"paper-w3185399139","cat":"papers","name":"Psychedelic drug use and schizotypy in young adults","year":"2021","cit":19,"pfa":"Alexander V. Lebedev","psa":"Predrag Petrović","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3185399139","eid":"W3185399139"},{"id":"paper-w4397049758","cat":"papers","name":"Effects of Psychedelics in Older Adults: A Prospective Cohort Study","year":"2024","cit":19,"pfa":"Hannes Kettner","psa":"Lorenzo Pasquini","topics":["Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4397049758","eid":"W4397049758"},{"id":"paper-w3153901006","cat":"papers","name":"Psychonauts’ psychedelics: A systematic, multilingual, web-crawling exercise","year":"2021","cit":19,"pfa":"Valeria Catalani","psa":"Fabrizio Schifano","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3153901006","eid":"W3153901006"},{"id":"paper-w4387866883","cat":"papers","name":"Cellular rules underlying psychedelic control of prefrontal pyramidal neurons","year":"2023","cit":19,"pfa":"Tyler G. Ekins","psa":"Omar J. Ahmed","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4387866883","eid":"W4387866883"},{"id":"paper-w4391513139","cat":"papers","name":"Who are you after psychedelics? A systematic review and a meta-analysis of the magnitude of long-term effects of serotonergic psychedelics on cognition/creativity, emotional processing and personality","year":"2024","cit":19,"pfa":"Ivana Solaja","psa":"Donel M Martin","topics":["Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4391513139","eid":"W4391513139"},{"id":"paper-w3188608552","cat":"papers","name":"A Phenomenology of Challenging Psychedelic Experiences: From Relational Trauma to Relational Healing","year":"2021","cit":19,"pfa":"Leland Guthrie","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W3188608552","eid":"W3188608552"},{"id":"paper-w4226064185","cat":"papers","name":"Reduced Precision Underwrites Ego Dissolution and Therapeutic Outcomes Under Psychedelics","year":"2022","cit":19,"pfa":"Devon Stoliker","psa":"Adeel Razi","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4226064185","eid":"W4226064185"},{"id":"paper-w2918643377","cat":"papers","name":"Measuring microdose ABY-029 fluorescence signal in a primary human soft-tissue sarcoma resection","year":"2019","cit":19,"pfa":"Kimberley S. Samkoe","psa":"Keith D. Paulsen","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"conference-paper","src":"https://openalex.org/W2918643377","eid":"W2918643377"},{"id":"paper-w4281697767","cat":"papers","name":"Self-Actualization and the Integration of Psychedelic Experience: The Mediating Role of Perceived Benefits to Narrative Self-Functioning","year":"2022","cit":19,"pfa":"Nicole M. Amada","psa":"Jacob Shane","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4281697767","eid":"W4281697767"},{"id":"paper-w2088932155","cat":"papers","name":"5-Hydroxytryptamine2A (5-HT2A) receptor regulation in rat prefrontal cortex: Interaction of a phenethylamine hallucinogen and the metabotropic glutamate2/3 receptor agonist LY354740","year":"2006","cit":19,"pfa":"Gerard J. Marek","psa":"Darryle D. Schoepp","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2088932155","eid":"W2088932155"},{"id":"paper-w2781211056","cat":"papers","name":"Ultra-sensitive LC–MS/MS method for the quantification of gemcitabine and its metabolite 2′,2′-difluorodeoxyuridine in human plasma for a microdose clinical trial","year":"2017","cit":19,"pfa":"Merel van Nuland","psa":"Jos H. Beijnen","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2781211056","eid":"W2781211056"},{"id":"paper-w2189163119","cat":"papers","name":"Structure-Activity Relationships in Psychotomimetic Phenylalkylamines","year":"1973","cit":19,"pfa":"Janice Taylor Gordon","psa":"J. Amer","ptype":"article","src":"https://openalex.org/W2189163119","eid":"W2189163119"},{"id":"paper-w1530867155","cat":"papers","name":"Comparative efficacy of two microdoses of a potentized homoeopathic drug, Cadmium Sulphoricum, in reducing genotoxic effects produced by cadmium chloride in mice: a time course study","year":"2001","cit":19,"pfa":"Swapna S Datta","psa":"Anisur Rahman Khuda‐Bukhsh","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1530867155","eid":"W1530867155"},{"id":"paper-w3124660397","cat":"papers","name":"Data from a microdosed recombinant human erythropoietin administration study applying the new biotinylated clone AE7A5 antibody and a further optimized sarcosyl polyacrylamide gel electrophoresis protocol","year":"2021","cit":19,"pfa":"Christian Reichel","psa":"Mario Thevis","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3124660397","eid":"W3124660397"},{"id":"paper-w1992572527","cat":"papers","name":"Lack of Psychotomimetic or Impairing Effects on Psychomotor Performance of Acamprosate","year":"1998","cit":19,"pfa":"Udo Schneider","psa":"H. M. Emrich","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1992572527","eid":"W1992572527"},{"id":"paper-w2771297659","cat":"papers","name":"Psychedelic Experiential Pharmacology: Pioneering Clinical Explorations with Salvador Roquet (How I Came to All of This: Ketamine, Admixtures and Adjuvants, Don Juan and Carlos Castaneda Too): An Interview with Richard Y","year":"2014","cit":19,"pfa":"Philip E. Wolfson","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2771297659","eid":"W2771297659"},{"id":"paper-w2809156141","cat":"papers","name":"Predicting transporter‐mediated drug interactions: Commentary on: “Pharmacokinetic evaluation of a drug transporter cocktail consisting of digoxin, furosemide, metformin and rosuvastatin” and “Validation of a microdose p","year":"2016","cit":19,"pfa":"L Zhang","psa":"Alex Sparreboom","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2809156141","eid":"W2809156141"},{"id":"paper-w2023628052","cat":"papers","name":"Effects of Administration Regime on the Psychotomimetic Properties of d-amphetamine in the Squirrel Monkey ( Saimiri sciureus )","year":"1997","cit":19,"pfa":"Frank Sams‐Dodd","psa":"John D. Newman","ptype":"article","src":"https://openalex.org/W2023628052","eid":"W2023628052"},{"id":"paper-w2049338045","cat":"papers","name":"In vitro stereoselective metabolism of the psychotomimetic amine, 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane. An apparent enantiomeric interaction","year":"1977","cit":19,"pfa":"N. Peter McGraw","psa":"Neal Castagnoli","ptype":"article","src":"https://openalex.org/W2049338045","eid":"W2049338045"},{"id":"paper-w2317105839","cat":"papers","name":"Stereochemical aspects and metabolite formation in the in vivo metabolism of the psychotomimetic amine, 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane","year":"1974","cit":19,"pfa":"S.B. Matin","psa":"Neal Castagnoli","ptype":"article","src":"https://openalex.org/W2317105839","eid":"W2317105839"},{"id":"paper-w2120977688","cat":"papers","name":"The Rise of a New Psychoactive Agent: Salvia divinorum","year":"2007","cit":19,"pfa":"Jonathan K. Appel","psa":"Dohee Kim-Appel","ptype":"article","src":"https://openalex.org/W2120977688","eid":"W2120977688"},{"id":"paper-w2010586770","cat":"papers","name":"Redefining Addiction II. The Meaning of Addiction in Our Lives","year":"1979","cit":19,"pfa":"Stanton Peele","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2010586770","eid":"W2010586770"},{"id":"paper-w4402414507","cat":"papers","name":"Classics in Chemical Neuroscience: Muscimol","year":"2024","cit":19,"pfa":"Diego Rivera-Illanes","psa":"Gonzalo Recabarren‐Gajardo","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4402414507","eid":"W4402414507"},{"id":"paper-w3195898454","cat":"papers","name":"Depression as a Disorder of Consciousness","year":"2021","cit":19,"pfa":"Cecily M. K. Whiteley","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W3195898454","eid":"W3195898454"},{"id":"paper-w4292324250","cat":"papers","name":"New investigational agents for the treatment of major depressive disorder","year":"2022","cit":19,"pfa":"Bartłomiej Pochwat","psa":"Bernadeta Szewczyk","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4292324250","eid":"W4292324250"},{"id":"paper-w2083420574","cat":"papers","name":"Epidemiology of adolescent Salvia divinorum use in Canada","year":"2012","cit":19,"pfa":"Cheryl L. Currie","ptype":"article","src":"https://openalex.org/W2083420574","eid":"W2083420574"},{"id":"paper-w4384820677","cat":"papers","name":"Measuring acute effects of subanesthetic ketamine on cerebrovascular hemodynamics in humans using TD-fNIRS","year":"2023","cit":19,"pfa":"Adelaida Castillo","psa":"Moriah Taylor","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4384820677","eid":"W4384820677"},{"id":"paper-w3135509722","cat":"papers","name":"Radiopharmaceutical Validation for Clinical Use","year":"2021","cit":19,"pfa":"Charles A. Kunos","psa":"Jacek Capala","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3135509722","eid":"W3135509722"},{"id":"paper-w2319014838","cat":"papers","name":"Fortune's Malice: Divination, Psychotherapy, and Folk Medicine in Peru","year":"1969","cit":19,"pfa":"Marlene Dobkin","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2319014838","eid":"W2319014838"},{"id":"paper-w2602079969","cat":"papers","name":"Multidrug Analyses in Patients Distinguish Efficacious Cancer Agents Based on Both Tumor Cell Killing and Immunomodulation","year":"2017","cit":19,"pfa":"Jason P. Frazier","psa":"Richard A. Klinghoffer","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2602079969","eid":"W2602079969"},{"id":"paper-w2261436329","cat":"papers","name":"The effects of harmaline on sodium transport in human erythrocytes: evidence in favor of action at interior sodium-sensitive sites.","year":"1975","cit":19,"pfa":"Michael James Dunn","psa":"W.A. Hunt","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2261436329","eid":"W2261436329"},{"id":"paper-w2336593588","cat":"papers","name":"At-Line Cellular Screening Methodology for Bioactives in Mixtures Targeting the α7-Nicotinic Acetylcholine Receptor","year":"2016","cit":19,"pfa":"Reka A. Otvos","psa":"Jeroen Kool","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2336593588","eid":"W2336593588"},{"id":"paper-w3153663428","cat":"papers","name":"Machine learning vs. field 3D-QSAR models for serotonin 2A receptor psychoactive substances identification","year":"2021","cit":19,"pfa":"Giuseppe Floresta","psa":"Vincenzo Abbate","topics":["Addiction","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3153663428","eid":"W3153663428"},{"id":"paper-w4402650878","cat":"papers","name":"Whole brain modelling for simulating pharmacological interventions on patients with disorders of consciousness","year":"2024","cit":19,"pfa":"Iván Mindlin","psa":"Yonatan Sanz Perl","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4402650878","eid":"W4402650878"},{"id":"paper-w3015314240","cat":"papers","name":"Development of an LC-MS/MS method for determining 5-MeO-DIPT in dried urine spots and application to forensic cases","year":"2020","cit":19,"pfa":"Xiuying Yan","psa":"Ping Xiang","ptype":"article","src":"https://openalex.org/W3015314240","eid":"W3015314240"},{"id":"paper-w2045793395","cat":"papers","name":"Socio-Cultural and Psychological Aspects of Contemporary LSD use in Germany","year":"2002","cit":19,"pfa":"Susanna Prepeliczay","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2045793395","eid":"W2045793395"},{"id":"paper-w3106135072","cat":"papers","name":"Contribution of serotonin receptor subtypes to hallucinogenic activity of 25I-NBOMe and to its effect on neurotransmission","year":"2020","cit":19,"pfa":"Monika Herian","psa":"Krystyna Gołembiowska","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3106135072","eid":"W3106135072"},{"id":"paper-w4297940481","cat":"papers","name":"Control of serotonergic function in medial prefrontal cortex by serotonin-2A receptors through a glutamate-dependent mechanism","year":"2020","cit":19,"pfa":"Francesc Artigas","psa":"Guadalupe Mengod","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4297940481","eid":"W4297940481"},{"id":"paper-w4221124789","cat":"papers","name":"Ketamine and sleep modulate neural complexity dynamics in cats","year":"2022","cit":19,"pfa":"Claudia Pascovich","psa":"Tristán Bekinschtein","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4221124789","eid":"W4221124789"},{"id":"paper-w2164672316","cat":"papers","name":"Smoking and depression","year":"1982","cit":19,"pfa":"John G. Flanagan","psa":"I Maany","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2164672316","eid":"W2164672316"},{"id":"paper-w4387948765","cat":"papers","name":"Oral ketamine may offer a solution to the ketamine conundrum","year":"2023","cit":19,"pfa":"Megan Dutton","psa":"Daniel Francis Hermens","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4387948765","eid":"W4387948765"},{"id":"paper-w4211003625","cat":"papers","name":"Physiologic and Pharmacologic Bases of Anesthesia","year":"1996","cit":19,"pfa":"Joseph M. Garfield","psa":"Steven J. Lisco","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4211003625","eid":"W4211003625"},{"id":"paper-w4223928463","cat":"papers","name":"Opioid withdrawal management in the fentanyl era","year":"2022","cit":19,"pfa":"Ashish P. Thakrar","psa":"Robert Andrew Kleinman","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4223928463","eid":"W4223928463"},{"id":"paper-w4229056653","cat":"papers","name":"Ketamine Modulates the Neural Correlates of Reward Processing in Unmedicated Patients in Remission From Depression","year":"2021","cit":19,"pfa":"Vasileia Kotoula","psa":"Mitul Ashok Mehta","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4229056653","eid":"W4229056653"},{"id":"paper-w1986037576","cat":"papers","name":"Low-dose Ketamine for Children and Adolescents with Acute Sickle Cell Disease Related Pain: A Single Center Experience","year":"2014","cit":19,"pfa":"Caitlin M. Neri","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1986037576","eid":"W1986037576"},{"id":"paper-w4400610733","cat":"papers","name":"Esketamine in depression: putative biomarkers from clinical research","year":"2024","cit":19,"pfa":"Jenessa N. Johnston","psa":"Mark D. Kvarta","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4400610733","eid":"W4400610733"},{"id":"paper-w4405080627","cat":"papers","name":"Esketamine and neurocognitive disorders in adult surgical patients: a meta-analysis","year":"2024","cit":19,"pfa":"Lin Xing","psa":"Ju Gao","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W4405080627","eid":"W4405080627"},{"id":"paper-w2769022006","cat":"papers","name":"Interactions of (2S,6S;2R,6R)‐Hydroxynorketamine, a Secondary Metabolite of (R,S)‐Ketamine, with Morphine","year":"2017","cit":19,"pfa":"Tuomas Olavi Lilius","psa":"Pekka Veli Rauhala","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2769022006","eid":"W2769022006"},{"id":"paper-w4407736038","cat":"papers","name":"The dopaminergic effects of esketamine are mediated by a dual mechanism involving glutamate and opioid receptors","year":"2025","cit":19,"pfa":"Arianna Rizzo","psa":"Jordi Bonaventura","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4407736038","eid":"W4407736038"},{"id":"paper-w4225009253","cat":"papers","name":"Key considerations for the use of ketamine and esketamine for the treatment of depression: focusing on administration, safety, and tolerability","year":"2022","cit":19,"pfa":"Michael D. Kritzer","psa":"Prakash S. Masand","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4225009253","eid":"W4225009253"},{"id":"paper-w4293767515","cat":"papers","name":"Efficacy and Safety of Subcutaneous Esketamine in the Treatment of Suicidality in Major Depressive Disorder and Bipolar Depression","year":"2022","cit":19,"pfa":"Juliana Canada Surjan","psa":"Acioly L.T. Lacerda","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4293767515","eid":"W4293767515"},{"id":"paper-w4306932139","cat":"papers","name":"Intranasal esketamine effectively treats treatment-resistant depression in adults regardless of baseline irritability","year":"2022","cit":19,"pfa":"Manish K. Jha","psa":"Madhukar H. Trivedi","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4306932139","eid":"W4306932139"},{"id":"paper-w3202767581","cat":"papers","name":"Longitudinal CSF proteome profiling in mice to uncover the acute and sustained mechanisms of action of rapid acting antidepressant (2R,6R)-hydroxynorketamine (HNK)","year":"2021","cit":19,"pfa":"David P. Herzog","psa":"Marianne B. Müller","topics":["Depression","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3202767581","eid":"W3202767581"},{"id":"paper-w4402337714","cat":"papers","name":"Esketamine alleviates ferroptosis-mediated acute lung injury by modulating the HIF-1α/HO-1 pathway","year":"2024","cit":19,"pfa":"Jinye Shi","psa":"Xiaotao Xu","ptype":"article","src":"https://openalex.org/W4402337714","eid":"W4402337714"},{"id":"paper-w4409634883","cat":"papers","name":"Patient Experience with Intranasal Esketamine in Treatment-Resistant Depression: Insights from a Multicentric Italian Study (REAL-ESKperience)","year":"2025","cit":19,"pfa":"Marco Di Nicola","psa":"REAL-ESKperience Study Group","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4409634883","eid":"W4409634883"},{"id":"paper-w4392591856","cat":"papers","name":"Hype or hope? High placebo response in major depression treatment with ketamine and esketamine: a systematic review and meta-analysis","year":"2024","cit":19,"pfa":"Alexandros Matsingos","psa":"Tilo T. J. Kircher","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W4392591856","eid":"W4392591856"},{"id":"paper-w4387824250","cat":"papers","name":"Analgesic Effect of Esketamine Combined with Tramadol for Patient-Controlled Intravenous Analgesia After Cesarean Section: A Randomized Controlled Trial","year":"2023","cit":19,"pfa":"Yihui Guo","psa":"Lifeng Zou","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4387824250","eid":"W4387824250"},{"id":"paper-w4388964150","cat":"papers","name":"Effect of single intravenous injection of esketamine on postpartum depression after labor analgesia and potential mechanisms: a randomized, double-blinded controlled trial","year":"2023","cit":19,"pfa":"Bin Ling","psa":"Wei Wang","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4388964150","eid":"W4388964150"},{"id":"paper-w2913492324","cat":"papers","name":"Long-term safety of esketamine nasal spray plus oral antidepressant in patients with treatment-resistant depression: SUSTAIN-2 phase 3 study","year":"2019","cit":19,"pfa":"Ewa Wajs","psa":"Jaskaran B. Singh","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2913492324","eid":"W2913492324"},{"id":"paper-w4395073542","cat":"papers","name":"Effects of a single subanesthetic dose of esketamine on postoperative subthreshold depressive symptoms in patients undergoing unilateral modified radical mastectomy: a randomised, controlled, double-blind trial","year":"2024","cit":19,"pfa":"Huanwei Wang","psa":"Wan Huang","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4395073542","eid":"W4395073542"},{"id":"paper-w4384694836","cat":"papers","name":"Exploring the Molecular Targets for the Antidepressant and Antisuicidal Effects of Ketamine Enantiomers by Using Network Pharmacology and Molecular Docking","year":"2023","cit":19,"pfa":"Glorister A. Altê","psa":"Ana Lúcia S. Rodrigues","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4384694836","eid":"W4384694836"},{"id":"paper-w4309771461","cat":"papers","name":"Ketamine, benzoate, and sarcosine for treating depression","year":"2022","cit":19,"pfa":"Yu‐Jung Cheng","psa":"Hsien‐Yuan Lane","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4309771461","eid":"W4309771461"},{"id":"paper-w4285793334","cat":"papers","name":"Genetic variables of the glutamatergic system associated with treatment-resistant depression: A review of the literature","year":"2022","cit":19,"pfa":"Estela Saez","psa":"Aurora Arrúe","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4285793334","eid":"W4285793334"},{"id":"paper-w4283704870","cat":"papers","name":"Imbalances in Kynurenines as Potential Biomarkers in the Diagnosis and Treatment of Psychiatric Disorders","year":"2022","cit":19,"pfa":"Aye-Mu Myint","psa":"Angelos E Halaris","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4283704870","eid":"W4283704870"},{"id":"paper-w3038489789","cat":"papers","name":"A systematic review of ketamine for the treatment of depression among older adults","year":"2020","cit":19,"pfa":"Aarti Gupta","psa":"Rajesh R. Tampi","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W3038489789","eid":"W3038489789"},{"id":"paper-w2042503412","cat":"papers","name":"The Pharmacology of Mescaline and D-Lysergic Acid Diethylamide (LSD)","year":"1958","cit":18,"pfa":"George B. Koelle","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2042503412","eid":"W2042503412"},{"id":"paper-w2436724179","cat":"papers","name":"Lysergic acid diethylamide (LSD)","year":"1970","cit":18,"pfa":"Morton A. Stenchever","psa":"Jane A. Jarvis","ptype":"article","src":"https://openalex.org/W2436724179","eid":"W2436724179"},{"id":"paper-w2139369768","cat":"papers","name":"Immunoassay Analysis of Lysergic Acid Diethylamide","year":"1997","cit":18,"pfa":"John T. Cody","psa":"Sandra Valtier","ptype":"article","src":"https://openalex.org/W2139369768","eid":"W2139369768"},{"id":"paper-w2462620510","cat":"papers","name":"TOLERANCE TO THE PYRETOGENIC EFFECTS OF LYSERGIC ACID DIETHYLAMIDE","year":"1956","cit":18,"pfa":"John H. Gogerty","psa":"James M. Dille","ptype":"article","src":"https://openalex.org/W2462620510","eid":"W2462620510"},{"id":"paper-w1984029453","cat":"papers","name":"Studies on enzymatic dealkylation of D-lysergic acid diethylamide (LSD)","year":"1974","cit":18,"pfa":"Tetsukichi Niwaguchi","psa":"Yuji Nakahara","ptype":"article","src":"https://openalex.org/W1984029453","eid":"W1984029453"},{"id":"paper-w1978885184","cat":"papers","name":"MMPI score changes induced by lysergic acid diethylamide (LSD-25)","year":"1956","cit":18,"pfa":"Richard E. Belleville","ptype":"article","src":"https://openalex.org/W1978885184","eid":"W1978885184"},{"id":"paper-w2041085224","cat":"papers","name":"Studies on the in vitro metabolism of compounds related to lysergic acid diethylamide (LSD)","year":"1974","cit":18,"pfa":"Tetsukichi Niwaguchi","psa":"T. Sakai","ptype":"article","src":"https://openalex.org/W2041085224","eid":"W2041085224"},{"id":"paper-w2031214128","cat":"papers","name":"Self-inflicted Testicular Amputation in First Lysergic Acid Diethylamide Use","year":"2012","cit":18,"pfa":"Christian Blacha","psa":"Carlos Schönfeldt‐Lecuona","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2031214128","eid":"W2031214128"},{"id":"paper-w2010915810","cat":"papers","name":"Alterations in the generalisation of visual stimuli induced by lysergic acid diethylamide in cats","year":"1964","cit":18,"pfa":"B. J. Key","ptype":"article","src":"https://openalex.org/W2010915810","eid":"W2010915810"},{"id":"paper-w2035230401","cat":"papers","name":"Enhancement by progesterone of lysergic acid diethylamide inhibition of the copulatory response in the female rat","year":"1980","cit":18,"pfa":"Anni Sietnieks","psa":"Bengt J. Meyerson","ptype":"article","src":"https://openalex.org/W2035230401","eid":"W2035230401"},{"id":"paper-w2121708495","cat":"papers","name":"INHIBITION OF THE SECRETION OF INTERMEDINE BY D-LYSERGIC ACID DIETHYLAMIDE (LSD 25) IN THE TOAD, XENOPUS LAEVIS","year":"1958","cit":18,"pfa":"A. C. J. Burgers","psa":"G. J. van Oordt","ptype":"article","src":"https://openalex.org/W2121708495","eid":"W2121708495"},{"id":"paper-w1881954819","cat":"papers","name":"AN EXPERIMENTAL STUDY OF THE PARTICIPATION OF THE SYMPATHETIC NERVOUS SYSTEM IN THE LYSERGIC ACID DIETHYLAMIDE (LSD) REACTION IN CATS","year":"1962","cit":18,"pfa":"John T. Elder","psa":"James M. Dille","ptype":"article","src":"https://openalex.org/W1881954819","eid":"W1881954819"},{"id":"paper-w2238988780","cat":"papers","name":"Alterations in sleep-wakefulness cycle in rats following treatment with (+)-lysergic acid diethylamide (LSD-25).","year":"1971","cit":18,"pfa":"Henri Depoortere","psa":"D M Loew","ptype":"article","src":"https://openalex.org/W2238988780","eid":"W2238988780"},{"id":"paper-w2298359274","cat":"papers","name":"EFFECTS OF LSD 25, BOL 148, BUFOTENINE, MESCALINE AND IBOGAINE ON THE POTENTIATION OF HEXOBARBITAL HYPNOSIS PRODUCED BY SEROTONIN AND RESERPINE","year":"1957","cit":18,"pfa":"G. C. Salmoiraghi","psa":"Irvine H. Page","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2298359274","eid":"W2298359274"},{"id":"paper-w2048765492","cat":"papers","name":"Occurrence of psilocybin and psilocin in Psilocybe pseudobullacea (Petch) Pegler from the Venezuelan Andes","year":"1994","cit":18,"pfa":"Vicente Marcano","psa":"L. Martinez","ptype":"article","src":"https://openalex.org/W2048765492","eid":"W2048765492"},{"id":"paper-w2049055498","cat":"papers","name":"N1‐Methyl‐2‐125I‐Lysergic Acid Diethylamide, a Preferred Ligand for In Vitro and In Vivo Characterization of Serotonin Receptors","year":"1987","cit":18,"pfa":"Beth J. Hoffman","psa":"Paul R. Hartig","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2049055498","eid":"W2049055498"},{"id":"paper-w2103938227","cat":"papers","name":"A Selective and Sensitive Method for Quantitation of Lysergic Acid Diethylamide (LSD) in Whole Blood by Gas Chromatography-Ion Trap Tandem Mass Spectrometry","year":"2003","cit":18,"pfa":"Danielle Libong","psa":"Ivan Ricordel","ptype":"article","src":"https://openalex.org/W2103938227","eid":"W2103938227"},{"id":"paper-w1828123038","cat":"papers","name":"Determination of Lysergic Acid Diethylamide in Body Fluids by High-Performance Liquid Chromatography and Fluorescence Detection—A More Sensitive Method Suitable for Routine Use","year":"1999","cit":18,"pfa":"D. Bergemann","psa":"Ludwig v. Meyer","ptype":"article","src":"https://openalex.org/W1828123038","eid":"W1828123038"},{"id":"paper-w4206762650","cat":"papers","name":"Mental health conditions and receipt of mental health care by illicit lysergic acid diethylamide (LSD) use status among young adults in the United States","year":"2022","cit":18,"pfa":"Beth Han","psa":"Wilson M. Compton","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4206762650","eid":"W4206762650"},{"id":"paper-w2055517081","cat":"papers","name":"Statement on Peyote","year":"1951","cit":18,"pfa":"Weston La Barre","psa":"Sol Tax","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2055517081","eid":"W2055517081"},{"id":"paper-w2884299727","cat":"papers","name":"“Ayahuasca turned on my mind’s eye”: Enhanced visual imagery after ayahuasca intake in a man with “blind imagination” (aphantasia)","year":"2018","cit":18,"pfa":"RAFAEL GUIMARÃES DOS SANTOS","psa":"Jaime E. C. Hallak","topics":["PTSD & trauma","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2884299727","eid":"W2884299727"},{"id":"paper-w2079152766","cat":"papers","name":"In Vitro Action of Mescaline","year":"1968","cit":18,"pfa":"E. Aurensanz Clemente","psa":"Vincent de Paul Lynch","ptype":"article","src":"https://openalex.org/W2079152766","eid":"W2079152766"},{"id":"paper-w3120387440","cat":"papers","name":"Death due to consumption of ibogaine: case report","year":"2021","cit":18,"pfa":"Tijana Aćimović","psa":"Milenko Bogdanović","ptype":"article","src":"https://openalex.org/W3120387440","eid":"W3120387440"},{"id":"paper-w4393117206","cat":"papers","name":"The pharmacokinetics and pharmacodynamics of ibogaine in opioid use disorder patients","year":"2024","cit":18,"pfa":"Thomas Knuijver","psa":"Cornelis Kramers","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4393117206","eid":"W4393117206"},{"id":"paper-w2807959330","cat":"papers","name":"Cardiac arrest after ibogaine intoxication","year":"2018","cit":18,"pfa":"Christian Steinberg","psa":"Marc William Deyell","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2807959330","eid":"W2807959330"},{"id":"paper-w2056356761","cat":"papers","name":"Autoxidation of Salvinorin A under Basic Conditions","year":"2005","cit":18,"pfa":"Thomas Anthony Munro","psa":"Mark A. Rizzacasa","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2056356761","eid":"W2056356761"},{"id":"paper-w4200597955","cat":"papers","name":"The Salvinorin Analogue, Ethoxymethyl Ether Salvinorin B, Promotes Remyelination in Preclinical Models of Multiple Sclerosis","year":"2021","cit":18,"pfa":"Kelly F. Paton","psa":"Bronwyn Maree Kivell","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4200597955","eid":"W4200597955"},{"id":"paper-w2790807435","cat":"papers","name":"Ayahuasca: A risk for travellers?","year":"2018","cit":18,"pfa":"Irmgard L. Bauer","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2790807435","eid":"W2790807435"},{"id":"paper-w2906657526","cat":"papers","name":"The Peyote Effect: From the Inquisition to the War on Drugs","year":"2018","cit":18,"pfa":"Alexander Dawson","ptype":"article","src":"https://openalex.org/W2906657526","eid":"W2906657526"},{"id":"paper-w1986378125","cat":"papers","name":"The crystal and molecular structure of (N,N)-dimethyltryptamine","year":"1972","cit":18,"pfa":"Gerald Falkenberg","ptype":"article","src":"https://openalex.org/W1986378125","eid":"W1986378125"},{"id":"paper-w2029071824","cat":"papers","name":"Development of a psilocin immunoassay for serum and blood samples","year":"2004","cit":18,"pfa":"C. Albers","psa":"J. Beike","ptype":"article","src":"https://openalex.org/W2029071824","eid":"W2029071824"},{"id":"paper-w2316686582","cat":"papers","name":"Ayahuasca psychedelic tested for depression","year":"2015","cit":18,"pfa":"Arran Frood","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2316686582","eid":"W2316686582"},{"id":"paper-w51584191","cat":"papers","name":"The biosynthesis of 5-methoxy-N,N-dimethyltryptamine","year":"1974","cit":18,"pfa":"LEWIS R. MANDEL","psa":"Robert W. Walker","ptype":"article","src":"https://openalex.org/W51584191","eid":"W51584191"},{"id":"paper-w2030897112","cat":"papers","name":"Facilitation of memory retrieval by the “anti-addictive” alkaloid, ibogaine","year":"1996","cit":18,"pfa":"Piotr Popik","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2030897112","eid":"W2030897112"},{"id":"paper-w3158176201","cat":"papers","name":"O uso ritual da Ayahuasca","year":"2003","cit":18,"pfa":"Henrique Soares Carneiro","ptype":"article","src":"https://openalex.org/W3158176201","eid":"W3158176201"},{"id":"paper-w2037682962","cat":"papers","name":"Neuropharmacological characterization of local ibogaine effects on dopamine release","year":"1996","cit":18,"pfa":"M. S. Reid","psa":"S. Paul Berger","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2037682962","eid":"W2037682962"},{"id":"paper-w4392119029","cat":"papers","name":"Deciphering psilocybin: Cytotoxicity, anti-inflammatory effects, and mechanistic insights","year":"2024","cit":18,"pfa":"Salma Laabi","psa":"Victor M. Jimenez","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4392119029","eid":"W4392119029"},{"id":"paper-w3092554874","cat":"papers","name":"HALLUCINOGENIC DRUGS: A PERSPECTIVE WITH SPECIAL REFERENCE TO PEYOTE AND CANNABIS,","year":"1964","cit":18,"pfa":"William H. McGlothlin","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3092554874","eid":"W3092554874"},{"id":"paper-w2619242792","cat":"papers","name":"Psilocybin: Good Trip or Bad Trip","year":"2017","cit":18,"pfa":"Edward M. Sellers","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2619242792","eid":"W2619242792"},{"id":"paper-w2037808065","cat":"papers","name":"Hyperkalemia in fatal MDMA (‘ecstasy’) toxicity","year":"2003","cit":18,"pfa":"Paula Raviña","psa":"Tomás Raviña","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2037808065","eid":"W2037808065"},{"id":"paper-w2036830485","cat":"papers","name":"Ibogaine attenuates morphine-induced conditioned place preference.","year":"1995","cit":18,"pfa":"Linda A. Parker","psa":"Tracey Luxton","ptype":"article","src":"https://openalex.org/W2036830485","eid":"W2036830485"},{"id":"paper-w3175128856","cat":"papers","name":"Efficient Access to the Iboga Skeleton: Optimized Procedure to Obtain Voacangine from Voacanga africana Root Bark","year":"2021","cit":18,"pfa":"Bruno González","psa":"Ignacio Carrera","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W3175128856","eid":"W3175128856"},{"id":"paper-w2325687330","cat":"papers","name":"THE CEREBRAL ELECTROGRAPHIC CHANGES INDUCED BY LSD AND MESCALINE ARE CORRECTED BY FRENQUEL","year":"1955","cit":18,"pfa":"Franco Rinaldi","psa":"Harold E. Himwich","ptype":"article","src":"https://openalex.org/W2325687330","eid":"W2325687330"},{"id":"paper-w1967353658","cat":"papers","name":"THE METABOLISM OF MESCALINE WITH A NOTE ON CORRELATIONS BETWEEN METABOLISM AND PSYCHOLOGICAL EFFECTS","year":"1959","cit":18,"pfa":"Lewis Carl Mokrasch","psa":"Ian H. Stevenson","ptype":"article","src":"https://openalex.org/W1967353658","eid":"W1967353658"},{"id":"paper-w2807830955","cat":"papers","name":"Psilocybin and Mental Health–Don't Lose Control","year":"2018","cit":18,"pfa":"Joseph Matthew Barnby","psa":"Mitul Ashok Mehta","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2807830955","eid":"W2807830955"},{"id":"paper-w2411278188","cat":"papers","name":"Accumulation of N,N-dimethyltryptamine in rat brain cortical slices.","year":"1979","cit":18,"pfa":"Subbiah Sangiah","psa":"Domino Ef","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2411278188","eid":"W2411278188"},{"id":"paper-w4382010877","cat":"papers","name":"The development of psilocybin therapy for treatment-resistant depression: an update","year":"2023","cit":18,"pfa":"Anna Borissova","psa":"James Rucker","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4382010877","eid":"W4382010877"},{"id":"paper-w2091459208","cat":"papers","name":"Determination of ibogaine in plasma by gas chromatography-chemical ionization mass spectrometry","year":"1996","cit":18,"pfa":"F. Robert Ley","psa":"Brian F. Thomas","ptype":"article","src":"https://openalex.org/W2091459208","eid":"W2091459208"},{"id":"paper-w2404175594","cat":"papers","name":"Regio- and stereospecific models for the biosynthesis of the indole alkaloids. Corynanthe/Strychnos-Iboga relation","year":"1972","cit":18,"pfa":"A. Ian Scott","psa":"C. C. Wei","ptype":"article","src":"https://openalex.org/W2404175594","eid":"W2404175594"},{"id":"paper-w2201265893","cat":"papers","name":"Psychiatric sequelae of MDMA (ecstasy) and related drugs","year":"1994","cit":18,"pfa":"Géraldine Cassidy","psa":"Clive G. Ballard","ptype":"article","src":"https://openalex.org/W2201265893","eid":"W2201265893"},{"id":"paper-w1968055251","cat":"papers","name":"Hair Analysis for Drugs of Abuse. XVIII. 3,4-Methylenedioxymethamphetamine (MDMA) Disposition in Hair Roots and Use in Identification of Acute MDMA Poisoning.","year":"1997","cit":18,"pfa":"Yuji Nakahara","psa":"Ruri Kikura","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1968055251","eid":"W1968055251"},{"id":"paper-w2318466421","cat":"papers","name":"Anti-addiction Drug Ibogaine Prolongs the Action Potential in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes","year":"2016","cit":18,"pfa":"Lena Rubi","psa":"Xaver Koenig","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2318466421","eid":"W2318466421"},{"id":"paper-w1994152793","cat":"papers","name":"Development of a Multiple-Stage Differential Mobility Analyzer (MDMA)","year":"2007","cit":18,"pfa":"Da‐Ren Chen","psa":"Meng‐Dawn Cheng","ptype":"article","src":"https://openalex.org/W1994152793","eid":"W1994152793"},{"id":"paper-w2053699938","cat":"papers","name":"Decreased pain tolerance and mood in recreational users of MDMA","year":"2004","cit":18,"pfa":"Margaret Claire O'Regan","psa":"Angela Clow","ptype":"article","src":"https://openalex.org/W2053699938","eid":"W2053699938"},{"id":"paper-w2137660200","cat":"papers","name":"Effects of ibogaine on the development of tolerance to antinociceptive action of μ-, δ- and κ-opioid receptor agonists in mice","year":"1997","cit":18,"pfa":"Ying‐Jun Cao","psa":"Hemendra N. Bhargava","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2137660200","eid":"W2137660200"},{"id":"paper-w2067258767","cat":"papers","name":"A concise route to iboga-analogues via the formation of suitably substituted-2-indoles","year":"2010","cit":18,"pfa":"Goutam Kumar Jana","psa":"Surajit Sinha","ptype":"article","src":"https://openalex.org/W2067258767","eid":"W2067258767"},{"id":"paper-w2333398807","cat":"papers","name":"The occurrence of the psychotomimetic agent psilocybin in an Australian agaric, Psilocybe subaeruginosa","year":"1970","cit":18,"pfa":"J. PICKER","psa":"R. W. RICKARDS","ptype":"article","src":"https://openalex.org/W2333398807","eid":"W2333398807"},{"id":"paper-w1966251882","cat":"papers","name":"Development of tolerance to repeated administration of 5-methoxy-N, N-dimethyltryptamine in rats","year":"1985","cit":18,"pfa":"Michael E. Trulson","psa":"George F. Keltch","ptype":"article","src":"https://openalex.org/W1966251882","eid":"W1966251882"},{"id":"paper-w2577391240","cat":"papers","name":"Determination of Tryptamines and β-Carbolines in Ayahuasca Beverage Consumed During Brazilian Religious Ceremonies","year":"2017","cit":18,"pfa":"Mônica C. Santos","psa":"Alain Gaujac","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2577391240","eid":"W2577391240"},{"id":"paper-w2048618982","cat":"papers","name":"Synthesis of iboga-like isoquinuclidines: Dual opioid receptors agonists having antinociceptive properties","year":"2014","cit":18,"pfa":"Tuhin Suvro Banerjee","psa":"Sumantra Das","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2048618982","eid":"W2048618982"},{"id":"paper-w2187837516","cat":"papers","name":"Effects of a Psychedelic, Tropical Tea, Ayahuasca, on the Electroencephalographic (EEG) Activity of the Human Brain during a Shamanistic Ritual","year":"2001","cit":18,"pfa":"Erik Hoffmann","psa":"M. da Silveira Barbosa","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2187837516","eid":"W2187837516"},{"id":"paper-w1977875777","cat":"papers","name":"Stimulus properties of mescaline and N-methylated derivatives: Difference in peripheral and direct central administration","year":"1974","cit":18,"pfa":"Ronald G. Browne","psa":"B. T. HO","ptype":"article","src":"https://openalex.org/W1977875777","eid":"W1977875777"},{"id":"paper-w2037513791","cat":"papers","name":"Influence of mao-inhibitors, neuroleptics, morphine, mescaline, divascan, aconitine, and pyrogenes on prostaglandin-biosynthesis","year":"1977","cit":18,"pfa":"H Bekemeier","psa":"Erich Vogel","ptype":"article","src":"https://openalex.org/W2037513791","eid":"W2037513791"},{"id":"paper-w2078006956","cat":"papers","name":"Synthetic studies and pharmacological evaluations on the MDMA (‘Ecstasy’) antagonist nantenine","year":"2009","cit":18,"pfa":"Onica LeGendre","psa":"Wayne Wesley Harding","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2078006956","eid":"W2078006956"},{"id":"paper-w1992257637","cat":"papers","name":"Maternal MDMA administration in mice leads to neonatal growth delay","year":"2014","cit":18,"pfa":"Asuka Kaizaki","psa":"Satoshi Numazawa","ptype":"article","src":"https://openalex.org/W1992257637","eid":"W1992257637"},{"id":"paper-w4406874124","cat":"papers","name":"Mice lacking the serotonin transporter do not respond to the behavioural effects of psilocybin","year":"2025","cit":18,"pfa":"James J Gattuso","psa":"Thibault Renoir","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4406874124","eid":"W4406874124"},{"id":"paper-w4408466018","cat":"papers","name":"Electrogenerated Chemiluminescence Coupled with Molecularly Imprinted Polymer for Sensitive and Selective Detection of N , N -Dimethyltryptamine","year":"2025","cit":18,"pfa":"Jesy Alka Motchaalangaram","psa":"Wujian Miao","ptype":"article","src":"https://openalex.org/W4408466018","eid":"W4408466018"},{"id":"paper-w2019378422","cat":"papers","name":"Time-resolved hair analysis of MDMA enantiomers by GC/MS-NCI","year":"2007","cit":18,"pfa":"Liliane Ferreira Martins","psa":"Robert Wennig","ptype":"article","src":"https://openalex.org/W2019378422","eid":"W2019378422"},{"id":"paper-w2092612491","cat":"papers","name":"Simple Syntheses of Lespedamine and 5-Bromo-N,N-dimethyltryptamine Based on 1-Hydroxyindole Chemistry","year":"1995","cit":18,"pfa":"Masanori Somei","psa":"Yashikazu Fukui","ptype":"article","src":"https://openalex.org/W2092612491","eid":"W2092612491"},{"id":"paper-w2515306146","cat":"papers","name":"It’s time to take psilocybin seriously as a possible treatment for substance use disorders","year":"2016","cit":18,"pfa":"Michael P. Bogenschutz","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2515306146","eid":"W2515306146"},{"id":"paper-w2101158246","cat":"papers","name":"Bem-estar subjetivo e qualidade de vida em adeptos de ayahuasca","year":"2014","cit":18,"pfa":"Cleber Lizardo de Assis","psa":"Laís Fernanda Tenório Lins","ptype":"article","src":"https://openalex.org/W2101158246","eid":"W2101158246"},{"id":"paper-w4394015461","cat":"papers","name":"Dynamic Functional Hyperconnectivity After Psilocybin Intake Is Primarily Associated With Oceanic Boundlessness","year":"2024","cit":18,"pfa":"Sepehr Mortaheb","psa":"Athéna Demertzi","ptype":"article","src":"https://openalex.org/W4394015461","eid":"W4394015461"},{"id":"paper-w2413330641","cat":"papers","name":"An analysis of spontaneous behavior following acute MDMA treatment in male and female rats.","year":"2007","cit":18,"pfa":"Tomáš Páleníček","psa":"Jiřı́ Horáček","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2413330641","eid":"W2413330641"},{"id":"paper-w2118424780","cat":"papers","name":"Synthesis and impurity profiling of MDMA prepared from commonly available starting materials","year":"2012","cit":18,"pfa":"Ryan P. Gallagher","psa":"Andrew M. McDonagh","ptype":"article","src":"https://openalex.org/W2118424780","eid":"W2118424780"},{"id":"paper-w4406062303","cat":"papers","name":"Early psilocybin intervention alleviates behavioral despair and cognitive impairment in stressed Wistar rats","year":"2025","cit":18,"pfa":"Zitong Wang","psa":"Yanbo Zhang","topics":["Depression","Anxiety & end-of-life","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4406062303","eid":"W4406062303"},{"id":"paper-w4411302754","cat":"papers","name":"Evaluation of behavioural and neurochemical effects of psilocybin in mice subjected to chronic unpredictable mild stress","year":"2025","cit":18,"pfa":"Ines Erkizia-Santamaría","psa":"Jorge Emilio Ortega","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4411302754","eid":"W4411302754"},{"id":"paper-w2986382938","cat":"papers","name":"Of mice and men on MDMA: A translational comparison of the neuropsychobiological effects of 3,4-methylenedioxymethamphetamine (‘Ecstasy’)","year":"2019","cit":18,"pfa":"M.A. Aguilar","psa":"Andrew C. Parrott","ptype":"article","src":"https://openalex.org/W2986382938","eid":"W2986382938"},{"id":"paper-w1985840787","cat":"papers","name":"The action of(±)-MDMA on medial prefrontal cortical neurons is mediated through the serotonergic system","year":"1991","cit":18,"pfa":"Helen S. Pan","psa":"Rex Y. Wang","ptype":"article","src":"https://openalex.org/W1985840787","eid":"W1985840787"},{"id":"paper-w4387374386","cat":"papers","name":"Functional imaging studies of acute administration of classic psychedelics, ketamine, and MDMA: Methodological limitations and convergent results","year":"2023","cit":18,"pfa":"Sophia Linguiti","psa":"Theodore Daniel Satterthwaite","ptype":"article","src":"https://openalex.org/W4387374386","eid":"W4387374386"},{"id":"paper-w2793274018","cat":"papers","name":"Salvinorin A preserves cerebral pial artery autoregulation after forebrain ischemia via the PI3K/AKT/cGMP pathway","year":"2018","cit":18,"pfa":"Haiping Dong","psa":"Z.H. Wang","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2793274018","eid":"W2793274018"},{"id":"paper-w3178288974","cat":"papers","name":"Exploring the Use of Psilocybin Therapy for Existential Distress: A Qualitative Study of Palliative Care Provider Perceptions","year":"2021","cit":18,"pfa":"Coryn E. Mayer","psa":"Kimberly Acquaviva","topics":["Anxiety & end-of-life","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3178288974","eid":"W3178288974"},{"id":"paper-w4416015783","cat":"papers","name":"Efficacy, all-cause discontinuation, and safety of serotonergic psychedelics and MDMA to treat mental disorders: A living systematic review with meta-analysis","year":"2025","cit":18,"pfa":"Mikkel Højlund","psa":"Marco Solmi","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"review","src":"https://openalex.org/W4416015783","eid":"W4416015783"},{"id":"paper-w4210716284","cat":"papers","name":"Remembering Molly: Immediate and delayed false memory formation after acute MDMA exposure","year":"2022","cit":18,"pfa":"Lilian Kloft","psa":"Johannes Gerardus Ramaekers","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4210716284","eid":"W4210716284"},{"id":"paper-w2048887241","cat":"papers","name":"Acute blockade of CB1 receptor leads to reinstatement of MDMA-induced conditioned place preference","year":"2011","cit":18,"pfa":"Manuel Daza‐Losada","psa":"Marta Rodríguez‐Arias","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2048887241","eid":"W2048887241"},{"id":"paper-w989201838","cat":"papers","name":"Coronaridine, an iboga type alkaloid from Tabernaemontana divaricata, inhibits the Wnt signaling pathway by decreasing β-catenin mRNA expression","year":"2015","cit":18,"pfa":"Kensuke Ohishi","psa":"Masami Ishibashi","ptype":"article","src":"https://openalex.org/W989201838","eid":"W989201838"},{"id":"paper-w1989569612","cat":"papers","name":"Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) are attenuated by the serotonin uptake inhibitor citalopram","year":"1999","cit":18,"pfa":"Matthias E. Liechti","psa":"F.X. Vollenweider","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1989569612","eid":"W1989569612"},{"id":"paper-w2899609131","cat":"papers","name":"Near-Death Experiences and Ayahuasca-Induced Experiences - Two Unique Pathways to a Phenomenologically Similar State of Consciousness","year":"2013","cit":18,"pfa":"Mitchell B. Liester","ptype":"article","src":"https://openalex.org/W2899609131","eid":"W2899609131"},{"id":"paper-w4390754503","cat":"papers","name":"Safety, tolerability, pharmacodynamic and wellbeing effects of SPL026 (dimethyltryptamine fumarate) in healthy participants: a randomized, placebo-controlled phase 1 trial","year":"2024","cit":18,"pfa":"Ellen James","psa":"Carol A. Routledge","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4390754503","eid":"W4390754503"},{"id":"paper-w4413190735","cat":"papers","name":"Psilocybin-assisted psychotherapy for depression and anxiety associated with life threatening illness: A phase 2b randomized controlled trial","year":"2025","cit":18,"pfa":"Margaret Ross","psa":"Justin L. Dwyer","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4413190735","eid":"W4413190735"},{"id":"paper-w4405021720","cat":"papers","name":"Randomized Controlled Trials of Psilocybin‐Assisted Therapy in the Treatment of Major Depressive Disorder: Systematic Review and Meta‐Analysis","year":"2024","cit":18,"pfa":"Vikas Menon","psa":"Chittaranjan Andrade","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4405021720","eid":"W4405021720"},{"id":"paper-w4200580018","cat":"papers","name":"Retrospective suspect and non-target screening combined with similarity measures to prioritize MDMA and amphetamine synthesis markers in wastewater","year":"2021","cit":18,"pfa":"Naomi Reymond","psa":"Frederic M. Béen","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4200580018","eid":"W4200580018"},{"id":"paper-w4408041085","cat":"papers","name":"Prolonged adverse effects from repeated psilocybin use in an underground psychedelic therapy training program: a case report","year":"2025","cit":18,"pfa":"John Perna","psa":"Ali John Zarrabi","topics":["Safety & adverse events","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4408041085","eid":"W4408041085"},{"id":"paper-w4402624021","cat":"papers","name":"Psychedelics: A review of their effects on recalled aversive memories and fear/anxiety expression in rodents","year":"2024","cit":18,"pfa":"Isabel Werle","psa":"Leandro Jose Bertoglio","topics":["PTSD & trauma","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4402624021","eid":"W4402624021"},{"id":"paper-w2883081960","cat":"papers","name":"Prácticas en búsqueda de legitimidad: el uso contemporáneo de la ayahuasca, entre reivindicaciones terapéuticas y religiosas","year":"2018","cit":18,"pfa":"David Dupuis","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2883081960","eid":"W2883081960"},{"id":"paper-w1543233311","cat":"papers","name":"Nephroprotective effects of Feijoa Sellowiana leaves extract on renal injury induced by acute dose of ecstasy (MDMA) in mice.","year":"2014","cit":18,"pfa":"Mohammad Yasin Karami","psa":"Farshad Naghshvar","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1543233311","eid":"W1543233311"},{"id":"paper-w2121449008","cat":"papers","name":"Procedural and declarative memory task performance, and the memory consolidation function of sleep, in recent and abstinent ecstasy/MDMA users","year":"2010","cit":18,"pfa":"Mark Blagrove","psa":"Michael John Morgan","ptype":"article","src":"https://openalex.org/W2121449008","eid":"W2121449008"},{"id":"paper-w2075412773","cat":"papers","name":"Cholecystokinin octapeptide (CCK-8), ceruletide and analogues of ceruletide: Effects on tremors induced by oxotremorine, harmine and ibogaine a comparison with prolyl-leucylglycine amide (MIF), anti-parkinsonian drugs an","year":"1983","cit":18,"pfa":"GERHARD ZETLER","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2075412773","eid":"W2075412773"},{"id":"paper-w2034316728","cat":"papers","name":"Unilateral infusion of a dopamine transporter antisense into the substantia nigra protects against MDMA-induced serotonergic deficits in the ipsilateral striatum","year":"2002","cit":18,"pfa":"Arthi Kanthasamy","psa":"David E. Nichols","ptype":"article","src":"https://openalex.org/W2034316728","eid":"W2034316728"},{"id":"paper-w4386209201","cat":"papers","name":"Is the psychedelic experience an essential aspect of the therapeutic effect of serotonergic psychedelics? Conceptual, discovery, development and implementation implications for psilocybin and related agents","year":"2023","cit":18,"pfa":"Roger S. McIntyre","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4386209201","eid":"W4386209201"},{"id":"paper-w4387330887","cat":"papers","name":"Insights, Life Changes and Lifestyle Changes Reported by Individuals Consuming Ayahuasca in Naturalistic Settings: Nature, Frequency and Associations with Mental Health and Wellbeing","year":"2023","cit":18,"pfa":"Daniel Perkins","psa":"Hana Šimonová","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4387330887","eid":"W4387330887"},{"id":"paper-w2085356013","cat":"papers","name":"A Study on the Mechanism by Which MDMA Protects Against Dopaminergic Dysfunction After Minimal Traumatic Brain Injury (mTBI) in Mice","year":"2014","cit":18,"pfa":"Shahaf Edut","psa":"Chaim G. Pick","topics":["PTSD & trauma","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2085356013","eid":"W2085356013"},{"id":"paper-w1975051479","cat":"papers","name":"A validated gas chromatographic–electron impact ionization mass spectrometric method for methamphetamine, methylenedioxymethamphetamine (MDMA), and metabolites in mouse plasma and brain","year":"2008","cit":18,"pfa":"Karl B. Scheidweiler","psa":"Marilyn Ann Huestis","ptype":"article","src":"https://openalex.org/W1975051479","eid":"W1975051479"},{"id":"paper-w2016394611","cat":"papers","name":"Sex-dependent effects of early maternal deprivation on MDMA-induced conditioned place preference in adolescent rats: Possible neurochemical correlates","year":"2012","cit":18,"pfa":"Alvaro Llorente‐Berzal","psa":"María‐Paz Viveros","ptype":"article","src":"https://openalex.org/W2016394611","eid":"W2016394611"},{"id":"paper-w2109879667","cat":"papers","name":"MDMA (ecstasy) use is associated with reduced BOLD signal change during semantic recognition in abstinent human polydrug users: a preliminary fMRI study","year":"2009","cit":18,"pfa":"V. Raj","psa":"RL Cowan","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2109879667","eid":"W2109879667"},{"id":"paper-w2301466677","cat":"papers","name":"Impact of Cytochrome P450 2D6 Function on the Chiral Blood Plasma Pharmacokinetics of 3,4-Methylenedioxymethamphetamine (MDMA) and Its Phase I and II Metabolites in Humans","year":"2016","cit":18,"pfa":"Andrea Eva Steuer","psa":"Matthias E. Liechti","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2301466677","eid":"W2301466677"},{"id":"paper-w4387345657","cat":"papers","name":"Development of enantioselective high-performance liquid chromatography-tandem mass spectrometry method for the quantitative determination of 3,4-methylenedioxy-methamphetamine (MDMA) and its phase-1 metabolites in human","year":"2023","cit":18,"pfa":"Alfredo Fabrizio Lo Faro","psa":"Bezhan Chankvetadze","ptype":"article","src":"https://openalex.org/W4387345657","eid":"W4387345657"},{"id":"paper-w3156704687","cat":"papers","name":"Back to the Future — The Therapeutic Potential of Psychedelic Drugs","year":"2021","cit":18,"pfa":"Jeffrey Alan Lieberman","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W3156704687","eid":"W3156704687"},{"id":"paper-w2038431201","cat":"papers","name":"Hallucinogenic drugs are partial agonists of the human platelet shape change response: A physiological model of the 5-HT2 receptor","year":"1989","cit":18,"pfa":"Steven J. McClue","psa":"Stephen M. Stahl","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2038431201","eid":"W2038431201"},{"id":"paper-w4293426683","cat":"papers","name":"Macrodosing to microdosing with psychedelics: Clinical, social, and cultural perspectives","year":"2022","cit":18,"pfa":"Ayse Ceren Kaypak","psa":"Amir Raz","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4293426683","eid":"W4293426683"},{"id":"paper-w4388520321","cat":"papers","name":"The entropic heart: Tracking the psychedelic state via heart rate dynamics","year":"2023","cit":18,"pfa":"Fernando E. Rosas","psa":"Robin Lester Carhart-Harris","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4388520321","eid":"W4388520321"},{"id":"paper-w2746282563","cat":"papers","name":"NATURALIZING PSYCHEDELIC SPIRITUALITY","year":"2017","cit":18,"pfa":"Chris Letheby","topics":["Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2746282563","eid":"W2746282563"},{"id":"paper-w4407265849","cat":"papers","name":"Psychedelics in the Treatment of Substance Use Disorders and Addictive Behaviors: A Scoping Review","year":"2025","cit":18,"pfa":"Jérémie Richard","psa":"Albert Garcia‐Romeu","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4407265849","eid":"W4407265849"},{"id":"paper-w4402680012","cat":"papers","name":"Naturalistic psychedelic therapy: The role of relaxation and subjective drug effects in antidepressant response","year":"2024","cit":18,"pfa":"Abigail E. Calder","psa":"Gregor Hasler","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4402680012","eid":"W4402680012"},{"id":"paper-w3133617718","cat":"papers","name":"Chemoenzymatic Synthesis of 5-Methylpsilocybin: A Tryptamine with Potential Psychedelic Activity","year":"2021","cit":18,"pfa":"Janis Fricke","psa":"Dirk Hoffmeister","ptype":"article","src":"https://openalex.org/W3133617718","eid":"W3133617718"},{"id":"paper-w2999340014","cat":"papers","name":"Social Work and Psychedelic-Assisted Therapies: Practice Considerations for Breakthrough Treatments","year":"2020","cit":18,"pfa":"Courtney A. Hutchison","psa":"Sara Bressi","ptype":"article","src":"https://openalex.org/W2999340014","eid":"W2999340014"},{"id":"paper-w4402936730","cat":"papers","name":"Meditating on psychedelics. A randomized placebo-controlled study of DMT and harmine in a mindfulness retreat","year":"2024","cit":18,"pfa":"Daniel Meling","psa":"Milan Scheidegger","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4402936730","eid":"W4402936730"},{"id":"paper-w2155574278","cat":"papers","name":"A Comparative Review of the Neuro-Psychopharmacology of Hallucinogen-Induced Altered States of Consciousness: The Uniqueness of Some Hallucinogens","year":"2012","cit":18,"pfa":"Ümit Sayın","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2155574278","eid":"W2155574278"},{"id":"paper-w2471523186","cat":"papers","name":"[Psychedelic experiences at the onset of productive episodes of endogenous psychoses].","year":"1994","cit":18,"pfa":"Euphrosyne Gouzoulis","psa":"H Sass","ptype":"article","src":"https://openalex.org/W2471523186","eid":"W2471523186"},{"id":"paper-w2089587320","cat":"papers","name":"An Untoward Reaction to Accidental Ingestion of LSD in a 5-Year-Old Girl","year":"1967","cit":18,"pfa":"Doris H. Milman","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2089587320","eid":"W2089587320"},{"id":"paper-w2402482580","cat":"papers","name":"The experimental use of psychedelic (LSD) psychotherapy.","year":"1971","cit":18,"pfa":"Pahnke Wn","psa":"S Grof","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2402482580","eid":"W2402482580"},{"id":"paper-w2052235304","cat":"papers","name":"Sex Differences in Self-Reported and Physiological Response to Oral Cocaine and Placebo in Humans","year":"2000","cit":18,"pfa":"Amrita K. Singha","psa":"Alison H. Oliveto","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2052235304","eid":"W2052235304"},{"id":"paper-w3200612329","cat":"papers","name":"LSD degrades hippocampal spatial representations and suppresses hippocampal-visual cortical interactions","year":"2021","cit":18,"pfa":"Carli M. Domenico","psa":"Daoyun Ji","ptype":"article","src":"https://openalex.org/W3200612329","eid":"W3200612329"},{"id":"paper-w2951531792","cat":"papers","name":"Psychedelic crossings: American mental health and LSD in the 1970s","year":"2019","cit":18,"pfa":"Lucas Richert","psa":"Erika Dyck","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2951531792","eid":"W2951531792"},{"id":"paper-w2589617347","cat":"papers","name":"Effects of Hallucinogens on Neuronal Activity","year":"2017","cit":18,"pfa":"Laia Lladó-Pelfort","psa":"Francesc Artigas","ptype":"book-chapter","src":"https://openalex.org/W2589617347","eid":"W2589617347"},{"id":"paper-w4384694190","cat":"papers","name":"Pharmacognostic, Forensic and Pharmaceutical, Organizational and Legal, Clinical and Pharmacological Multidisciplinary Study with an Assessment of Peculiarities of Circulation (Use) of Smoking Mixtures of Spices and Enth","year":"2023","cit":18,"pfa":"Вікторія Шаповалова","psa":"Serhii Nehretskii","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4384694190","eid":"W4384694190"},{"id":"paper-w3010070566","cat":"papers","name":"Natural Psychoplastogens As Antidepressant Agents","year":"2020","cit":18,"pfa":"Jakub Benko","psa":"Stanislava Vranková","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3010070566","eid":"W3010070566"},{"id":"paper-w2148111138","cat":"papers","name":"Involvement of 5-HT2 receptors in the LSD- and L-5-HTP-induced suppression of lordotic behavior in the female rat","year":"1985","cit":18,"pfa":"Anni Sietnieks","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2148111138","eid":"W2148111138"},{"id":"paper-w1982615690","cat":"papers","name":"Differential Membrane Targeting and Pharmacological Characterization of Chimeras of Rat Serotonin 5‐HT1A and 5‐HT1B Receptors Expressed in Epithelial LLC‐PK1 Cells","year":"1998","cit":18,"pfa":"Michèle C. Darmon","psa":"M. Hamon","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1982615690","eid":"W1982615690"},{"id":"paper-w2083525343","cat":"papers","name":"The effect of 5‐HT1Areceptor agonists on locomotor activity in the guinea‐pig","year":"1994","cit":18,"pfa":"J. L. Evenden","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2083525343","eid":"W2083525343"},{"id":"paper-w2524174825","cat":"papers","name":"Psychiatric comorbidities in a young man with subacute myelopathy induced by abusive nitrous oxide consumption: a case report","year":"2016","cit":18,"pfa":"Falk Mancke","psa":"Markus Weiler","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2524174825","eid":"W2524174825"},{"id":"paper-w4361246620","cat":"papers","name":"Spatial Correspondence of LSD-Induced Variations on Brain Functioning at Rest With Serotonin Receptor Expression","year":"2023","cit":18,"pfa":"Stefano Delli Pizzi","psa":"Stefano Luca Sensi","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4361246620","eid":"W4361246620"},{"id":"paper-w1999090821","cat":"papers","name":"Oxidative stress in rat kidneys due to 3,4‐methylenedioxymetamphetamine (ecstasy) toxicity","year":"2007","cit":18,"pfa":"Milica Ninković","psa":"Živorad Maličević","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1999090821","eid":"W1999090821"},{"id":"paper-w4402238710","cat":"papers","name":"Pharmacological and non-pharmacological predictors of the LSD experience in healthy participants","year":"2024","cit":18,"pfa":"Patrick Vizeli","psa":"Matthias E. Liechti","topics":["Addiction","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4402238710","eid":"W4402238710"},{"id":"paper-w4323854432","cat":"papers","name":"Role of 5-HT1A receptors in the basolateral amygdala on 3,4-methylenedioxymethamphetamine-induced prosocial effects in mice","year":"2023","cit":18,"pfa":"Hirohito Esaki","psa":"Katsuyuki Kaneda","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4323854432","eid":"W4323854432"},{"id":"paper-w4401061435","cat":"papers","name":"Methylenedioxymethamphetamine is a connectogen with empathogenic, entactogenic, and still further connective properties: It is time to reconcile “the great entactogen—empathogen debate”","year":"2024","cit":18,"pfa":"Kurt Stocker","psa":"Matthias E. Liechti","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4401061435","eid":"W4401061435"},{"id":"paper-w2150054862","cat":"papers","name":"Psychedelic Psychiatry: LSD From Clinic to Campus","year":"2009","cit":18,"pfa":"Alex Mold","topics":["Depression","Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2150054862","eid":"W2150054862"},{"id":"paper-w1645632161","cat":"papers","name":"Dopamine transporter down‐regulation following repeated cocaine: implications for 3,4‐methylenedioxymethamphetamine‐induced acute effects and long‐term neurotoxicity in mice","year":"2009","cit":18,"pfa":"Inés Peraile","psa":"Esther O’Shea","topics":["Safety & adverse events","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1645632161","eid":"W1645632161"},{"id":"paper-w2004626904","cat":"papers","name":"Chronic 3,4-methylenedioxymethamphetamine treatment suppresses cell proliferation in the adult mouse dentate gyrus","year":"2007","cit":18,"pfa":"Kyung‐Ok Cho","psa":"Seong-Yun Kim","ptype":"article","src":"https://openalex.org/W2004626904","eid":"W2004626904"},{"id":"paper-w2070960646","cat":"papers","name":"Induction of Fos protein by 3,4‐ methylenedioxymethamphetamine (Ecstasy) in rat brain: regional differences in pharmacological manipulation","year":"1997","cit":18,"pfa":"Kenji Hashimoto","psa":"Masaomi Iyo","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2070960646","eid":"W2070960646"},{"id":"paper-w2739335890","cat":"papers","name":"Semisynthesis and Kappa-Opioid Receptor Activity of Derivatives of Columbin, a Furanolactone Diterpene","year":"2017","cit":18,"pfa":"Anıl Yılmaz","psa":"Thomas Edward Prisinzano","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2739335890","eid":"W2739335890"},{"id":"paper-w2034110682","cat":"papers","name":"Effects of 3,4-methylenedioxymethamphetamine and related amphetamines on autonomic and behavioral thermoregulation","year":"2005","cit":18,"pfa":"Emily Joy Jaehne","psa":"R Julian Irvine","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2034110682","eid":"W2034110682"},{"id":"paper-w2109121812","cat":"papers","name":"3,4-Methylenedioxymethamphetamine’s (MDMA’s) Impact on Posttraumatic Stress Disorder","year":"2014","cit":18,"pfa":"Charles Michael White","topics":["PTSD & trauma","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2109121812","eid":"W2109121812"},{"id":"paper-w2150391426","cat":"papers","name":"Striatal Postsynaptic Ultrastructural Alterations Following Methylenedioxymethamphetamine Administration","year":"2002","cit":18,"pfa":"Francesco Fornai","psa":"Antonio Paparelli","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2150391426","eid":"W2150391426"},{"id":"paper-w2095016626","cat":"papers","name":"Diminished corticotropin and enhanced prolactin responses to 8-hydroxy-2(DI-n-propylamino)tetralin in methylenedioxymethamphetamine pretreated rats","year":"1990","cit":18,"pfa":"Russell E. Poland","ptype":"article","src":"https://openalex.org/W2095016626","eid":"W2095016626"},{"id":"paper-w2023508127","cat":"papers","name":"Characteristics of dual specificity phosphatases mRNA regulation by 3,4-methylenedioxymethamphetamine acute treatment in mice striatum","year":"2008","cit":18,"pfa":"Cynthia Marie‐Claire","psa":"Florence Noble","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2023508127","eid":"W2023508127"},{"id":"paper-w4408591537","cat":"papers","name":"Safety and Efficacy of Repeated Low-Dose LSD for ADHD Treatment in Adults","year":"2025","cit":18,"pfa":"Lorenz Mueller","psa":"Matthias E. Liechti","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4408591537","eid":"W4408591537"},{"id":"paper-w4315928547","cat":"papers","name":"Psychedelics for Patients With Cancer: A Comprehensive Literature Review","year":"2023","cit":18,"pfa":"Charles Michael White","psa":"Joseph D. Dalo","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4315928547","eid":"W4315928547"},{"id":"paper-w2020920278","cat":"papers","name":"Electrophysiological and structural alterations in striatum associated with behavioral sensitization to (±)3,4-methylenedioxymethamphetamine (ecstasy) in rats: role of drug context","year":"2010","cit":18,"pfa":"Kevin T. Ball","psa":"George V. Rebec","ptype":"article","src":"https://openalex.org/W2020920278","eid":"W2020920278"},{"id":"paper-w2616010457","cat":"papers","name":"Gas chromatography-mass spectrometry (GC-MS) analysis of amphetamine, methamphetamine, 3,4-methylenedioxy-amphetamine and 3,4-methylenedioxymethamphetamine in human hair and hair sections","year":"2020","cit":18,"pfa":"Dongliang Lin","psa":"R.H. Liu","ptype":"article","src":"https://openalex.org/W2616010457","eid":"W2616010457"},{"id":"paper-w1842423296","cat":"papers","name":"The Danger of Hallucinogenic Mushrooms","year":"1979","cit":18,"pfa":"Peter R. Mills","psa":"G Watkinson","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1842423296","eid":"W1842423296"},{"id":"paper-w4396728212","cat":"papers","name":"Psychedelic Experiences Increase Mind Perception but do not Change Atheist-Believer Status: A Prospective Longitudinal Study","year":"2024","cit":18,"pfa":"Sandeep Manel Nayak","psa":"David B. Yaden","ptype":"article","src":"https://openalex.org/W4396728212","eid":"W4396728212"},{"id":"paper-w3111061577","cat":"papers","name":"Neural network models for DMT-induced visual hallucinations","year":"2020","cit":18,"pfa":"Michael M. Schartner","psa":"Christopher B. Timmermann","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3111061577","eid":"W3111061577"},{"id":"paper-w2983072139","cat":"papers","name":"The Black Book of Psychotropic Dosing and Monitoring","year":"2025","cit":18,"pfa":"Charles DeBattista","psa":"Alan F Schatzberg","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W2983072139","eid":"W2983072139"},{"id":"paper-w2049786460","cat":"papers","name":"Review of Enquiries made to the NPIS Concerning Psilocybe Mushroom Ingestion, 1978-1981","year":"1983","cit":18,"pfa":"Jodi-Ann A. Francis","psa":"Virginia S.G. Murray","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2049786460","eid":"W2049786460"},{"id":"paper-w4391926727","cat":"papers","name":"Development of a digital intervention for psychedelic preparation (DIPP)","year":"2024","cit":18,"pfa":"Rosalind G. McAlpine","psa":"Sunjeev K. Kamboj","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4391926727","eid":"W4391926727"},{"id":"paper-w1479605545","cat":"papers","name":"Bufotenine - A Hallucinogen in Ancient Snuff Powders of South America and a Drug of Abuse on the Streets of New York City.","year":"1994","cit":18,"pfa":"Reddy P. Chamakura","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1479605545","eid":"W1479605545"},{"id":"paper-w1697448587","cat":"papers","name":"ENTHEOGENS IN A RELIGIOUS CONTEXT: THE CASE OF THE SANTO DAIME RELIGIOUS TRADITION","year":"2014","cit":18,"pfa":"G. William Barnard","ptype":"article","src":"https://openalex.org/W1697448587","eid":"W1697448587"},{"id":"paper-w2111555064","cat":"papers","name":"Investigation on the Enantioselectivity of the Sulfation of the Methylenedioxymethamphetamine Metabolites 3,4-Dihydroxymethamphetamine and 4-Hydroxy-3-Methoxymethamphetamine using the Substrate-Depletion Approach","year":"2011","cit":18,"pfa":"Andrea Eva Steuer","psa":"Hans H. Maurer","ptype":"article","src":"https://openalex.org/W2111555064","eid":"W2111555064"},{"id":"paper-w2309379990","cat":"papers","name":"Treatment of a young adult taking gamma-butyrolactone (GBL) in a primary care clinic.","year":"2002","cit":18,"pfa":"Arthur H. Herold","psa":"Kevin Sneed","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2309379990","eid":"W2309379990"},{"id":"paper-w2748929572","cat":"papers","name":"Could Hallucinogens Induce Permanent Pupillary Changes in (Ab)users? A Case Report from New Zealand","year":"2017","cit":18,"pfa":"Ahmed Al-Imam","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W2748929572","eid":"W2748929572"},{"id":"paper-w3165761271","cat":"papers","name":"Drug and alcohol positivity of traumatically injured patients related to COVID-19 stay-at-home orders","year":"2021","cit":18,"pfa":"Kirsten N. Young","psa":"Jeffry T. Nahmias","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3165761271","eid":"W3165761271"},{"id":"paper-w4306780560","cat":"papers","name":"Is good science leading the way in the therapeutic use of psychedelic drugs?","year":"2022","cit":18,"pfa":"Wayne Hall","psa":"Keith N. Humphreys","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"editorial","src":"https://openalex.org/W4306780560","eid":"W4306780560"},{"id":"paper-w4388532254","cat":"papers","name":"Synergistic psychedelic - NMDAR modulator treatment for neuropsychiatric disorders","year":"2023","cit":18,"pfa":"Uriel Heresco‐Levy","psa":"Bernard Lerer","ptype":"article","src":"https://openalex.org/W4388532254","eid":"W4388532254"},{"id":"paper-w2043530175","cat":"papers","name":"A proposal to evaluate mechanistic efficacy of hallucinogens in addiction treatment","year":"2013","cit":18,"pfa":"Brittany Vasae Burdick","psa":"Bryon H. Adinoff","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2043530175","eid":"W2043530175"},{"id":"paper-w2903351985","cat":"papers","name":"Sympathomimetic amine compounds and hepatotoxicity: Not all are alike—Key distinctions noted in a short review","year":"2018","cit":18,"pfa":"Cyril Willson","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2903351985","eid":"W2903351985"},{"id":"paper-w4402697795","cat":"papers","name":"Autonomic nervous system activity correlates with peak experiences induced by DMT and predicts increases in well-being","year":"2024","cit":18,"pfa":"Valérie Bonnelle","psa":"Christopher B. Timmermann","ptype":"article","src":"https://openalex.org/W4402697795","eid":"W4402697795"},{"id":"paper-w4410010524","cat":"papers","name":"An Update on Psychotherapy for the Treatment of PTSD","year":"2025","cit":18,"pfa":"BARBARA OLASOV ROTHBAUM","psa":"Laura E. Watkins","topics":["PTSD & trauma","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4410010524","eid":"W4410010524"},{"id":"paper-w4311766514","cat":"papers","name":"Experimental strategies to discover and develop the next generation of psychedelics and entactogens as medicines","year":"2022","cit":18,"pfa":"David J. Heal","psa":"C.K. Atterwill","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4311766514","eid":"W4311766514"},{"id":"paper-w4385377553","cat":"papers","name":"Detection of fentanyl, synthetic opioids, and ketamine in hair specimens from purposive samples of American and Italian populations","year":"2023","cit":18,"pfa":"Alberto Salomone","psa":"Marco Vincenti","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4385377553","eid":"W4385377553"},{"id":"paper-w2339935659","cat":"papers","name":"Adolescent Treatment: Its History and Current Renaissance","year":"2002","cit":18,"pfa":"William L. White","psa":"Frank M. Tims","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2339935659","eid":"W2339935659"},{"id":"paper-w4365998940","cat":"papers","name":"Utilization of mental health services in relation to the intention to reduce chemsex behavior among clients from an integrated sexual health services center in Taiwan","year":"2023","cit":18,"pfa":"Yu-Ru Hung","psa":"Carol Strong","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4365998940","eid":"W4365998940"},{"id":"paper-w4214689103","cat":"papers","name":"Toward the “helioscope” hypothesis of psychedelic therapy","year":"2022","cit":18,"pfa":"Gregor Hasler","ptype":"article","src":"https://openalex.org/W4214689103","eid":"W4214689103"},{"id":"paper-w4220891514","cat":"papers","name":"How Psychedelic-Assisted Treatment Works in the Bayesian Brain","year":"2022","cit":18,"pfa":"Daniel Villiger","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4220891514","eid":"W4220891514"},{"id":"paper-w4206900896","cat":"papers","name":"Expert Opinion on Psychedelic-Assisted Psychotherapy for People with Psychotic Symptoms","year":"2022","cit":18,"pfa":"Joseph T. La Torre","psa":"Monnica T. Williams","topics":["PTSD & trauma","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4206900896","eid":"W4206900896"},{"id":"paper-w7138880159","cat":"papers","name":"Psychedelic Therapy vs Antidepressants for the Treatment of Depression Under Equal Unblinding Conditions","year":"2026","cit":18,"pfa":"Zachary J. Williams","psa":"Balázs Szigeti","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7138880159","eid":"W7138880159"},{"id":"paper-w4205403234","cat":"papers","name":"Decreases in Suicidality Following Psychedelic Therapy: A Meta-Analysis of Individual Patient Data Across Clinical Trials.","year":"2022","cit":18,"pfa":"Richard J. Zeifman","psa":"Cory R. Weissman","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4205403234","eid":"W4205403234"},{"id":"paper-w4386758009","cat":"papers","name":"Do Psychedelics Facilitate Emergence of Unconscious Psychological Processes?","year":"2023","cit":18,"pfa":"Tomas Lindegaard","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4386758009","eid":"W4386758009"},{"id":"paper-w3214774976","cat":"papers","name":"Psychedelic treatment for co-occurring alcohol misuse and post-traumatic stress symptoms among United States Special Operations Forces Veterans","year":"2021","cit":18,"pfa":"Pratheek Mangini","psa":"Alan K. Davis","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3214774976","eid":"W3214774976"},{"id":"paper-w2439261208","cat":"papers","name":"Student use of hallucinogens.","year":"1965","cit":18,"pfa":"Herbert D. Kleber","ptype":"article","src":"https://openalex.org/W2439261208","eid":"W2439261208"},{"id":"paper-w7128069308","cat":"papers","name":"The science of psychedelic medicine","year":"2026","cit":18,"pfa":"Joshua S. Siegel","psa":"Michael P. Bogenschutz","ptype":"article","src":"https://openalex.org/W7128069308","eid":"W7128069308"},{"id":"paper-w4386686749","cat":"papers","name":"Training Psychedelic Therapists","year":"2019","cit":18,"pfa":"Janis Phelps","topics":["Therapy practice"],"ptype":"other","src":"https://openalex.org/W4386686749","eid":"W4386686749"},{"id":"paper-w2189304876","cat":"papers","name":"Mathematics and the Psychedelic Revolution","year":"2008","cit":18,"pfa":"Ralph Abraham","ptype":"article","src":"https://openalex.org/W2189304876","eid":"W2189304876"},{"id":"paper-w2031357816","cat":"papers","name":"PSYCHEDELIC DRUGS, STRESS, AND THE EGO","year":"1973","cit":18,"pfa":"George S. Glass","ptype":"article","src":"https://openalex.org/W2031357816","eid":"W2031357816"},{"id":"paper-w1969515439","cat":"papers","name":"Cost-effectiveness Analysis of Microdose Clinical Trials in Drug Development","year":"2013","cit":18,"pfa":"Naoe Yamane","psa":"Yuichi Sugiyama","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1969515439","eid":"W1969515439"},{"id":"paper-w2278601586","cat":"papers","name":"Prevention of Sperm Migration into the Uterine Cavity by a Microdose Progestagen","year":"1970","cit":18,"pfa":"Maxwell Roland","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2278601586","eid":"W2278601586"},{"id":"paper-w4361285916","cat":"papers","name":"Classic Psychedelic Use and Current Meditation Practice","year":"2023","cit":18,"pfa":"Charlotta Simonsson","psa":"Otto Simonsson","ptype":"article","src":"https://openalex.org/W4361285916","eid":"W4361285916"},{"id":"paper-w2005380714","cat":"papers","name":"An initial investigation of the psychedelic drug flashback phenomena.","year":"1974","cit":18,"pfa":"Robert E. Matefy","psa":"Roger G. Krall","ptype":"article","src":"https://openalex.org/W2005380714","eid":"W2005380714"},{"id":"paper-w1973493376","cat":"papers","name":"Clinical Characteristics of Individuals With Schizophrenia and Hallucinogen Persisting Perception Disorder: A Preliminary Investigation","year":"2014","cit":18,"pfa":"Shaul Lev‐Ran","psa":"Arturo G. Lerner","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1973493376","eid":"W1973493376"},{"id":"paper-w1989340345","cat":"papers","name":"Early Psychedelic Investigators Reflect on the Psychological and Social Implications of their Research","year":"2006","cit":18,"pfa":"ROGER N. WALSH","psa":"Charles S. Grob","topics":["Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1989340345","eid":"W1989340345"},{"id":"paper-w4408998446","cat":"papers","name":"Longitudinal associations of naturalistic psychedelic use with psychotic and manic symptoms","year":"2025","cit":18,"pfa":"Otto Simonsson","psa":"Peter S. Hendricks","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4408998446","eid":"W4408998446"},{"id":"paper-w4387643394","cat":"papers","name":"Prophylactic effects of arketamine, but not hallucinogenic psychedelic DOI nor non-hallucinogenic psychedelic analog lisuride, in lipopolysaccharide-treated mice and mice exposed to chronic restrain stress","year":"2023","cit":18,"pfa":"Guilin Liu","psa":"Kenji Hashimoto","ptype":"article","src":"https://openalex.org/W4387643394","eid":"W4387643394"},{"id":"paper-w1996369006","cat":"papers","name":"The major hallucinogens and the central cytoskeleton: An association beyond coincidence? Towards sub-cellular mechanisms in schizophrenia","year":"1990","cit":18,"pfa":"A. E. van Woerkom","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1996369006","eid":"W1996369006"},{"id":"paper-w2412155769","cat":"papers","name":"Synthetic Cannabis Substances (SPS) Use and Hallucinogen Persisting Perception Disorder (HPPD): Two Case Reports.","year":"2014","cit":18,"pfa":"Arturo G. Lerner","psa":"Shaul Lev‐Ran","topics":["Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2412155769","eid":"W2412155769"},{"id":"paper-w95252428","cat":"papers","name":"Psychedelic Psychiatry: LSD and Post-World War II Medical Experimentation in Canada","year":"2005","cit":18,"pfa":"Erika Dyck","ptype":"other","src":"https://openalex.org/W95252428","eid":"W95252428"},{"id":"paper-w2007758563","cat":"papers","name":"A microdose study of 14C-AR-709 in healthy men: pharmacokinetics, absolute bioavailability and concentrations in key compartments of the lung","year":"2013","cit":18,"pfa":"Graham Lappin","psa":"Steve Warrington","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2007758563","eid":"W2007758563"},{"id":"paper-w2938039109","cat":"papers","name":"Phase 0, Including Microdosing Approaches: Applying the Three Rs and Increasing the Efficiency of Human Drug Development","year":"2018","cit":18,"pfa":"Tal Burt","psa":"Robert D. Combes","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2938039109","eid":"W2938039109"},{"id":"paper-w2607702734","cat":"papers","name":"JWH-122 Consumption Adverse Effects: A Case of Hallucinogen Persisting Perception Disorder Five-Year Follow-Up","year":"2017","cit":18,"pfa":"Maurizio Coppola","psa":"Raffaella Mondola","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2607702734","eid":"W2607702734"},{"id":"paper-w4296794418","cat":"papers","name":"Association between Lifetime Classic Psychedelic Use and Sick Leave in a Population-Based Sample","year":"2022","cit":18,"pfa":"Christin Mellner","psa":"Otto Simonsson","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4296794418","eid":"W4296794418"},{"id":"paper-w4399697022","cat":"papers","name":"Therapeutic modulation of the kynurenine pathway in severe mental illness and comorbidities: A potential role for serotonergic psychedelics","year":"2024","cit":18,"pfa":"Antonella Campanale","psa":"Stefano Comai","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4399697022","eid":"W4399697022"},{"id":"paper-w4388812782","cat":"papers","name":"Reduction of alcohol use and increase in psychological flexibility after a naturalistic psychedelic experience: a retrospective survey","year":"2023","cit":18,"pfa":"Ewen Kervadec","psa":"Amine Benyamina","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4388812782","eid":"W4388812782"},{"id":"paper-w3203802365","cat":"papers","name":"Perspectives on psychedelic treatment and research in eating disorders: a web-based questionnaire study of people with eating disorders","year":"2021","cit":18,"pfa":"Fiona Harding","psa":"Carol Kan","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W3203802365","eid":"W3203802365"},{"id":"paper-w2493942159","cat":"papers","name":"Human Microdosing with Carcinogenic Polycyclic Aromatic Hydrocarbons: In Vivo Pharmacokinetics of Dibenzo[def,p]chrysene and Metabolites by UPLC Accelerator Mass Spectrometry","year":"2016","cit":18,"pfa":"Erin P. Madeen","psa":"David E. Williams","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2493942159","eid":"W2493942159"},{"id":"paper-w2100624860","cat":"papers","name":"Liquid chromatography/tandem mass spectrometry sensitivity enhancement via online sample dilution and trapping: applications in microdosing and dried blood spot (DBS) bioanalysis","year":"2010","cit":18,"pfa":"Fumin Li","psa":"Tom Addison","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2100624860","eid":"W2100624860"},{"id":"paper-w2051371945","cat":"papers","name":"The Synthesis of Analogs of the Hallucinogen 1-(2,5-Dimethoxy-4-methylphenyl)-2-aminopropane (DOM). II. Some Ring-methoxylated 1-Amino-and 2-Aminoindanes","year":"1974","cit":18,"pfa":"Ronald T. Coutts","psa":"Jerry L. Malicky","ptype":"article","src":"https://openalex.org/W2051371945","eid":"W2051371945"},{"id":"paper-w2573795919","cat":"papers","name":"Sex differences in psychotomimetic-induced behaviours in rats","year":"2017","cit":18,"pfa":"Andrea Gogos","psa":"Maarten van den Buuse","ptype":"article","src":"https://openalex.org/W2573795919","eid":"W2573795919"},{"id":"paper-w1963969117","cat":"papers","name":"Potential psychotomimetics. 2-Amino-1,2,3,4-tetrahydronaphthalene analogs","year":"1973","cit":18,"pfa":"Charles F. Barfknecht","psa":"D. C. Dyer","ptype":"article","src":"https://openalex.org/W1963969117","eid":"W1963969117"},{"id":"paper-w2734749193","cat":"papers","name":"Combining two model systems of psychosis: The effects of schizotypy and sleep deprivation on oculomotor control and psychotomimetic states","year":"2017","cit":18,"pfa":"Inga Meyhöfer","psa":"Ulrich Ettinger","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2734749193","eid":"W2734749193"},{"id":"paper-w2086126146","cat":"papers","name":"Psychotomimetic effects at initiation of cannabis use are associated with cannabinoid receptor 1 (CNR1) variants in healthy students","year":"2014","cit":18,"pfa":"Marie‐Odile Krebs","psa":"Oussama Kébir","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2086126146","eid":"W2086126146"},{"id":"paper-w1963829313","cat":"papers","name":"Sulfur analogs of psychotomimetic agents. 2. Analogs of (2,5-dimethoxy-4-methylphenyl)- and of (2,5-dimethoxy-4-ethylphenyl)isopropylamine","year":"1983","cit":18,"pfa":"Peyton Jacob","psa":"Alexander T. Shulgin","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1963829313","eid":"W1963829313"},{"id":"paper-w4402620338","cat":"papers","name":"Claustrum and dorsal endopiriform cortex complex cell-identity is determined by Nurr1 and regulates hallucinogenic-like states in mice","year":"2024","cit":18,"pfa":"Ioannis Mantas","psa":"Per Svenningsson","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4402620338","eid":"W4402620338"},{"id":"paper-w1917920525","cat":"papers","name":"From experimental psychosis to resolving traumatic pasts","year":"2015","cit":18,"pfa":"S. Marks","topics":["PTSD & trauma","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W1917920525","eid":"W1917920525"},{"id":"paper-w282344686","cat":"papers","name":"Corked up: Clinical hyoscine poisoning with alkaloids of the native corkwood, Duboisia","year":"1981","cit":18,"pfa":"John Hemsley Pearn","ptype":"article","src":"https://openalex.org/W282344686","eid":"W282344686"},{"id":"paper-w4281254572","cat":"papers","name":"Automated Computer Software Assessment of 5-Hydroxytryptamine 2A Receptor-Mediated Head Twitch Responses from Video Recordings of Mice","year":"2022","cit":18,"pfa":"Grant C. Glatfelter","psa":"Michael H. Baumann","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4281254572","eid":"W4281254572"},{"id":"paper-w4362458167","cat":"papers","name":"Clinical pharmacological innovation in the treatment of depression","year":"2023","cit":18,"pfa":"Jeffrey M. Witkin","psa":"Jodi L. Smith","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4362458167","eid":"W4362458167"},{"id":"paper-w4301061634","cat":"papers","name":"Smoking Characteristics Of Methadone Patients","year":"1972","cit":18,"pfa":"HERBERT W. BERGER","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W4301061634","eid":"W4301061634"},{"id":"paper-w1991905678","cat":"papers","name":"Effectiveness of the antagonist/letrozole protocol for treating poor responders undergoingin vitrofertilization/intracytoplasmic sperm injection: a systematic review and meta-analysis","year":"2014","cit":18,"pfa":"Yu Min Song","psa":"Bin Wang","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W1991905678","eid":"W1991905678"},{"id":"paper-w2084098936","cat":"papers","name":"An in-vitro toxicity testing - a reliable alternative to toxicity testing by reduction, replacement and refinement of animals.","year":"2010","cit":18,"pfa":"MittalM Bhanushali","psa":"Vivek Kadam","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2084098936","eid":"W2084098936"},{"id":"paper-w3044152939","cat":"papers","name":"Pediatric Pharmacokinetics and Dose Predictions: A Report of a Satellite Meeting to the 10th Juvenile Toxicity Symposium","year":"2020","cit":18,"pfa":"Bianca D. van Groen","psa":"Loeckie De Zwart","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3044152939","eid":"W3044152939"},{"id":"paper-w3178503622","cat":"papers","name":"Mental health, substance abuse, prison victimization and suicide attempts amongst incarcerated women","year":"2021","cit":18,"pfa":"Francisco Caravaca-Sánchez","psa":"Jorge J. Ricarte","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3178503622","eid":"W3178503622"},{"id":"paper-w1563034425","cat":"papers","name":"Physiologic and pharmacologic bases of anesthesia","year":"1996","cit":18,"pfa":"Vincent J. Collins","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"book","src":"https://openalex.org/W1563034425","eid":"W1563034425"},{"id":"paper-w2170694606","cat":"papers","name":"Use of salvia divinorum, an unscheduled hallucinogenic plant: a web-based survey of 500 users","year":"2004","cit":18,"pfa":"Matthew J. Baggott","topics":["Addiction","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2170694606","eid":"W2170694606"},{"id":"paper-w3144490877","cat":"papers","name":"Comorbid Substance Use Disorder Profiles and Receipt of Substance Use Disorder Treatment Services: A National Study","year":"2021","cit":18,"pfa":"Curtis David Von Gunten","psa":"Li-Tzy T. Wu","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3144490877","eid":"W3144490877"},{"id":"paper-w3020396452","cat":"papers","name":"Justicia secunda Vahl species : Phytochemistry, Pharmacology and Future Directions : a mini-review","year":"2019","cit":18,"pfa":"Pius Tshimankinda Mpiana","psa":"Jules Munganga Kitadi","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W3020396452","eid":"W3020396452"},{"id":"paper-w2038804964","cat":"papers","name":"A correlative evaluation of cyclazocine, LSD and naloxone on continuous discriminated avoidance in rats","year":"1972","cit":18,"pfa":"Samuel R. Wray","ptype":"article","src":"https://openalex.org/W2038804964","eid":"W2038804964"},{"id":"paper-w2473510258","cat":"papers","name":"Effects of ketamine on experimental animal models of aggression.","year":"1984","cit":18,"pfa":"Takahashi Rn","psa":"T C Monteiro-de-Lima","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2473510258","eid":"W2473510258"},{"id":"paper-w3207907986","cat":"papers","name":"A Single Low Dose of Dexmedetomidine Efficiently Attenuates Esketamine-Induced Overactive Behaviors and Neuronal Hyperactivities in Mice","year":"2021","cit":18,"pfa":"Qinjun Chu","psa":"Xiaogao Jin","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3207907986","eid":"W3207907986"},{"id":"paper-w3165774958","cat":"papers","name":"Resolvins as potential candidates for the treatment of major depressive disorder","year":"2021","cit":18,"pfa":"Satoshi Deyama","psa":"Katsuyuki Kaneda","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3165774958","eid":"W3165774958"},{"id":"paper-w1637788425","cat":"papers","name":"Psychopathology in Substance Use Disorder Patients with and without Substance-Induced Psychosis","year":"2015","cit":18,"pfa":"Simon Zhornitsky","psa":"Stéphane Potvin","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1637788425","eid":"W1637788425"},{"id":"paper-w2055850582","cat":"papers","name":"Phencyclidine produces changes in NMDA and kainate receptor binding in rat hippocampus over a 48-hour time course","year":"1996","cit":18,"pfa":"Xue-Min Gao","psa":"Carol A. Tamminga","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2055850582","eid":"W2055850582"},{"id":"paper-w3025967505","cat":"papers","name":"Do AKT1, COMT and FAAH influence reports of acute cannabis intoxication experiences in patients with first episode psychosis, controls and young adult cannabis users?","year":"2020","cit":18,"pfa":"Chandni N Hindocha","psa":"Marta Di Forti","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3025967505","eid":"W3025967505"},{"id":"paper-w3161844055","cat":"papers","name":"Analgesic and Antidepressant Effects of the Clinical Glutamate Modulators Acetyl-L-Carnitine and Ketamine","year":"2021","cit":18,"pfa":"Ulderico Freo","psa":"Gastone Zanette","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3161844055","eid":"W3161844055"},{"id":"paper-w3211595718","cat":"papers","name":"(R,S)-ketamine and (2R,6R)-hydroxynorketamine differentially affect memory as a function of dosing frequency","year":"2021","cit":18,"pfa":"Lace Marie Riggs","psa":"Todd D. Gould","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3211595718","eid":"W3211595718"},{"id":"paper-w4200179815","cat":"papers","name":"Cost-utility analysis of esketamine and electroconvulsive therapy in adults with treatment-resistant depression","year":"2021","cit":18,"pfa":"Kinza Degerlund Maldi","psa":"Fredrik Norström","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4200179815","eid":"W4200179815"},{"id":"paper-w4400297723","cat":"papers","name":"Intravenous esketamine as an adjuvant for sedation/analgesia outside the operating room: a systematic review and meta-analysis","year":"2024","cit":18,"pfa":"Ziheng Kan","psa":"Peng Zhang","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4400297723","eid":"W4400297723"},{"id":"paper-w4390519759","cat":"papers","name":"Low-dose esketamine improves acute postoperative pain in patients undergoing thoracoscopic surgery","year":"2024","cit":18,"pfa":"Qingwei Zhang","psa":"He-liang Sun","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4390519759","eid":"W4390519759"},{"id":"paper-w4400068564","cat":"papers","name":"Efficacy and safety of perioperative application of esketamine on postoperative depression: a meta-analysis of randomized controlled studies","year":"2024","cit":18,"pfa":"Yazhou Wen","psa":"Shanwu Feng","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4400068564","eid":"W4400068564"},{"id":"paper-w4402419910","cat":"papers","name":"Electroconvulsive therapy combined with esketamine improved depression through PI3K/AKT/GLT-1 pathway","year":"2024","cit":18,"pfa":"Xiangyang Zang","psa":"Shaoli Zhou","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4402419910","eid":"W4402419910"},{"id":"paper-w4405477230","cat":"papers","name":"The Effects of Opioid-Free Anesthesia with Dexmedetomidine and Esketamine on Postoperative Anesthetic-Related Complications for Hip Surgery in the Elderly","year":"2024","cit":18,"pfa":"Qiuping Ye","psa":"Ye Zhang","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4405477230","eid":"W4405477230"},{"id":"paper-w4406078848","cat":"papers","name":"Demographic and clinical predictors of response and remission in the treatment of major depressive disorder with ketamine and esketamine: A systematic review","year":"2025","cit":18,"pfa":"Juliana Lima Constantino","psa":"Jeanine Kamphuis","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4406078848","eid":"W4406078848"},{"id":"paper-w4381487574","cat":"papers","name":"Intraoperative Esketamine Is Effective at Reducing Acute Postoperative Pain in Bariatric Surgery Patients: a Randomized Control Trial","year":"2023","cit":18,"pfa":"Ting Yang","psa":"Qiang Fu","ptype":"article","src":"https://openalex.org/W4381487574","eid":"W4381487574"},{"id":"paper-w4310999137","cat":"papers","name":"The efficacy and safety of esketamine in the treatment of major depressive disorder with suicidal ideation: study protocol for a randomized controlled trial","year":"2022","cit":18,"pfa":"Haiyan Liu","psa":"Yanling Zhou","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4310999137","eid":"W4310999137"},{"id":"paper-w3010820583","cat":"papers","name":"Repeated subcutaneous esketamine administration for depressive symptoms and pain relief in a terminally ill cancer patient: A case report","year":"2020","cit":18,"pfa":"Matheus Ghossain Barbosa","psa":"Andrea Parolin Jackowski","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3010820583","eid":"W3010820583"},{"id":"paper-w3022227971","cat":"papers","name":"Intranasal Esketamine and Current Suicidal Ideation With Intent in Major Depression Disorder: Beat the Clock, Save a Life, Start a Strategy","year":"2020","cit":18,"pfa":"Maurizio Pompili","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W3022227971","eid":"W3022227971"},{"id":"paper-w4379768966","cat":"papers","name":"Intranasal esketamine combined with oral midazolam provides adequate sedation for outpatient pediatric dental procedures：a prospective cohort study","year":"2023","cit":18,"pfa":"Jing Wang","psa":"Cong Yu","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4379768966","eid":"W4379768966"},{"id":"paper-w4309668131","cat":"papers","name":"Effect of esketamine vs dexmedetomidine adjunct to propofol sedation for pediatric 3Tesla magnetic resonance imaging: a randomized, double-blind, controlled trial","year":"2022","cit":18,"pfa":"Shang-xian Xu","psa":"Qian Wang","topics":["Safety & adverse events","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4309668131","eid":"W4309668131"},{"id":"paper-w4375858531","cat":"papers","name":"Assessment of health-related quality of life and health status in patients with treatment-resistant depression treated with esketamine nasal spray plus an oral antidepressant","year":"2023","cit":18,"pfa":"Carol Jamieson","psa":"Jaskaran B. Singh","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4375858531","eid":"W4375858531"},{"id":"paper-w4389365922","cat":"papers","name":"Comparison of dexmedetomidine and a dexmedetomidine-esketamine combination for reducing dental anxiety in preschool children undergoing dental treatment under general anesthesia: A randomized controlled trial","year":"2023","cit":18,"pfa":"Fei Xing","psa":"Na Xing","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4389365922","eid":"W4389365922"},{"id":"paper-w4389045225","cat":"papers","name":"Low-dose Esketamine suppresses NLRP3-mediated apoptotic and pyroptotic cell death in microglial cells to ameliorate LPS-induced depression via ablating GSK-3β","year":"2023","cit":18,"pfa":"Sen Zhou","psa":"Pei-Gen Yuan","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4389045225","eid":"W4389045225"},{"id":"paper-w4403662920","cat":"papers","name":"Effect of small dose esketamine on perioperative neurocognitive disorder and postoperative depressive symptoms in elderly patients undergoing major elective noncardiac surgery for malignant tumors: A randomized clinical","year":"2024","cit":18,"pfa":"Cuifang Huang","psa":"Linghui Pan","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4403662920","eid":"W4403662920"},{"id":"paper-w4224244184","cat":"papers","name":"Evaluation of Individual Items of the Patient Health Questionnaire (PHQ-9) and Montgomery-Asberg Depression Rating Scale (MADRS) in Adults with Treatment-Resistant Depression Treated with Esketamine Nasal Spray Combined","year":"2022","cit":18,"pfa":"Lysbeth L. Floden","psa":"Jaskaran B. Singh","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4224244184","eid":"W4224244184"},{"id":"paper-w2580707514","cat":"papers","name":"Moderate-to-deep sedation technique, using propofol and ketamine, allowing synchronised breathing for magnetic resonance high-intensity focused ultrasound (MR-HIFU) treatment for uterine fibroids: a pilot study","year":"2017","cit":18,"pfa":"Hermanus H. B. Vaessen","psa":"J. T. A. Knape","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2580707514","eid":"W2580707514"},{"id":"paper-w3152792305","cat":"papers","name":"Rapid-Acting Antidepressants","year":"2019","cit":18,"pfa":"Bashkim Kadriu","psa":"Carlos A. Zarate","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W3152792305","eid":"W3152792305"},{"id":"paper-w4411333839","cat":"papers","name":"Pharmacological agents for procedural sedation and analgesia in patients undergoing gastrointestinal endoscopy: a systematic review and network meta-analysis","year":"2025","cit":18,"pfa":"Jiaxin Li","psa":"J.-Y Wang","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W4411333839","eid":"W4411333839"},{"id":"paper-w1581402254","cat":"papers","name":"[Guideline 'Pain management for trauma patients in the chain of emergency care'].","year":"2011","cit":18,"pfa":"Sivera A. A. Berben","psa":"Lisette Schoonhoven","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"other","src":"https://openalex.org/W1581402254","eid":"W1581402254"},{"id":"paper-w3171503165","cat":"papers","name":"Emerging Therapeutics Based on the Amino Acid Neurotransmitter System: An Update on the Pharmaceutical Pipeline for Mood Disorders","year":"2021","cit":18,"pfa":"Julia Hecking","psa":"Samuel T. Wilkinson","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3171503165","eid":"W3171503165"},{"id":"paper-w1977689647","cat":"papers","name":"HOMICIDE AFTER TREATMENT WITH LYSERGIC ACID DIETHYLAMIDE","year":"1964","cit":17,"pfa":"Knud Knudsen","ptype":"article","src":"https://openalex.org/W1977689647","eid":"W1977689647"},{"id":"paper-w1970728035","cat":"papers","name":"Biosynthesis of mescaline and anhalamine in peyote. II.","year":"1968","cit":17,"pfa":"Jan Lundström","psa":"Stig Agurell","ptype":"article","src":"https://openalex.org/W1970728035","eid":"W1970728035"},{"id":"paper-w1931027825","cat":"papers","name":"AN ELECTROGRAPHIC STUDY OF d-LYSERGIC ACID DIETHYLAMIDE AND NINE CONGENERS","year":"1966","cit":17,"pfa":"Arlene Schweigerdt","psa":"Harold E. Himwich","ptype":"article","src":"https://openalex.org/W1931027825","eid":"W1931027825"},{"id":"paper-w2418727367","cat":"papers","name":"On some effects of lysergic acid diethylamide (L.S.D. 25) in normal volunteers.","year":"1953","cit":17,"pfa":"P B Bradley","psa":"Joel Elkes","ptype":"article","src":"https://openalex.org/W2418727367","eid":"W2418727367"},{"id":"paper-w2090704126","cat":"papers","name":"Enhancement of Morphine Antinociception by Ibogaine and Noribogaine in Morphine-Tolerant Mice","year":"1998","cit":17,"pfa":"Shyam Sunder Sharma","psa":"Hemendra N. Bhargava","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2090704126","eid":"W2090704126"},{"id":"paper-w2411156300","cat":"papers","name":"The Use of L.S.D. 25 (D-Lysergic Acid Diethylamide) in the Treatment of the Sexual Perversions","year":"1961","cit":17,"pfa":"J. R. Ball","psa":"Jean J. Armstrong","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2411156300","eid":"W2411156300"},{"id":"paper-w4386019723","cat":"papers","name":"Lysergic Acid Diethylamide (LSD) for the Treatment of Anxiety Disorders: Preclinical and Clinical Evidence","year":"2023","cit":17,"pfa":"Antonio Inserra","psa":"Gabriella Gobbi","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4386019723","eid":"W4386019723"},{"id":"paper-w3044469818","cat":"papers","name":"Immunochemical monitoring of psilocybin and psilocin to identify hallucinogenic mushrooms","year":"2020","cit":17,"pfa":"Izumi Morita","psa":"Norihiro Kobayashi","ptype":"article","src":"https://openalex.org/W3044469818","eid":"W3044469818"},{"id":"paper-w1967708964","cat":"papers","name":"A new device for measuring spontaneous motor activity — Effects of lysergic acid diethylamide in rats","year":"1972","cit":17,"pfa":"J Kabeš","psa":"Zdeněk Roth","ptype":"article","src":"https://openalex.org/W1967708964","eid":"W1967708964"},{"id":"paper-w1976184068","cat":"papers","name":"Lysergic Acid Diethylamide (Lsd-25) Xiii. Effect on Bender-Gestalt Test Performance","year":"1955","cit":17,"pfa":"Harold A. Abramson","psa":"Conan H. Kornetsky","ptype":"article","src":"https://openalex.org/W1976184068","eid":"W1976184068"},{"id":"paper-w2068148110","cat":"papers","name":"Autoradiographic localization and characterization of [125I]Lysergic acid diethylamide binding to serotonin receptors in Aplysia","year":"1988","cit":17,"pfa":"Maura Kadan","psa":"Paul R. Hartig","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2068148110","eid":"W2068148110"},{"id":"paper-w3081047021","cat":"papers","name":"Plasma psilocin critically determines behavioral and neurobiological effects of psilocybin","year":"2020","cit":17,"pfa":"Martin Korsbak Madsen","psa":"Gitte M. Knudsen","ptype":"article","src":"https://openalex.org/W3081047021","eid":"W3081047021"},{"id":"paper-w2041650339","cat":"papers","name":"Ibogaine and noribogaine potentiate the inhibition of adenylyl cyclase activity by opioid and 5-HT receptors","year":"1996","cit":17,"pfa":"Richard A. Rabin","psa":"Jerrold C. Winter","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2041650339","eid":"W2041650339"},{"id":"paper-w2034326973","cat":"papers","name":"Effects of lysergic acid diethylamide on the spontaneous activity and visual receptive fields of cells in the lateral geniculate nucleus of the cat","year":"1973","cit":17,"pfa":"G. Horn","psa":"J.M. McKAY","ptype":"article","src":"https://openalex.org/W2034326973","eid":"W2034326973"},{"id":"paper-w4383058572","cat":"papers","name":"Lysergic acid diethylamide stimulates cardiac human H2 histamine and cardiac human 5-HT4-serotonin receptors","year":"2023","cit":17,"pfa":"Ulrich Gergs","psa":"Joachim Neumann","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4383058572","eid":"W4383058572"},{"id":"paper-w2002824488","cat":"papers","name":"Lysergic Acid Diethylamide (LSD-25): XVIII. Effects of LSD-25 and Six Related Drugs upon Handwriting","year":"1956","cit":17,"pfa":"M. W. Hirsch","psa":"Harold A. Abramson","ptype":"article","src":"https://openalex.org/W2002824488","eid":"W2002824488"},{"id":"paper-w4205329259","cat":"papers","name":"Mescaline","year":"2019","cit":17,"pfa":"Mike Jay","topics":["Dosing & pharmacology"],"ptype":"book","src":"https://openalex.org/W4205329259","eid":"W4205329259"},{"id":"paper-w2082426782","cat":"papers","name":"Severe aggression in rats induced by mescaline but not other hallucinogens","year":"1979","cit":17,"pfa":"Robert J. Sbordone","psa":"Mark L. Elliott","ptype":"article","src":"https://openalex.org/W2082426782","eid":"W2082426782"},{"id":"paper-w4224301560","cat":"papers","name":"Effect of -NBOMe Compounds on Sensorimotor, Motor, and Prepulse Inhibition Responses in Mice in Comparison With the 2C Analogs and Lysergic Acid Diethylamide: From Preclinical Evidence to Forensic Implication in Driving","year":"2022","cit":17,"pfa":"Micaela Tirri","psa":"Matteo Marti","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4224301560","eid":"W4224301560"},{"id":"paper-w2014684725","cat":"papers","name":"Alteration by Pretreatment with Iproniazid and an Inactive Mescaline Analogue of a Behaviour Change induced by Mescaline","year":"1967","cit":17,"pfa":"John Smythies","psa":"Ronald J. Bradley","ptype":"article","src":"https://openalex.org/W2014684725","eid":"W2014684725"},{"id":"paper-w1971075743","cat":"papers","name":"Ayahuasca and Human Destiny","year":"2005","cit":17,"pfa":"Dennis J. McKenna","ptype":"article","src":"https://openalex.org/W1971075743","eid":"W1971075743"},{"id":"paper-w4236954815","cat":"papers","name":"MDMA (Ecstasy)","year":"2007","cit":17,"pfa":"Rif S. El‐Mallakh","psa":"Henry David Abraham","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4236954815","eid":"W4236954815"},{"id":"paper-w1568893889","cat":"papers","name":"Mania following use of ibogaine: A case series","year":"2015","cit":17,"pfa":"Cole J. Marta","psa":"Ralph J. Koek","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1568893889","eid":"W1568893889"},{"id":"paper-w2211099546","cat":"papers","name":"Disposition of 14C-mescaline by rabbit lung.","year":"1977","cit":17,"pfa":"Robert A. Roth","psa":"C. N. Gillis","ptype":"article","src":"https://openalex.org/W2211099546","eid":"W2211099546"},{"id":"paper-w2084004994","cat":"papers","name":"Behavioral effects of intracerebroventricular administration of LSD, DOM, mescaline or lisuride","year":"1984","cit":17,"pfa":"David J. Mokler","psa":"Richard H. Rech","ptype":"article","src":"https://openalex.org/W2084004994","eid":"W2084004994"},{"id":"paper-w2040751890","cat":"papers","name":"Reflexivity and Transformation Symbolism in the Navajo Peyote Meeting","year":"1994","cit":17,"pfa":"Joseph D. Calabrese","ptype":"article","src":"https://openalex.org/W2040751890","eid":"W2040751890"},{"id":"paper-w4414267802","cat":"papers","name":"Emerging mechanisms of psilocybin-induced neuroplasticity","year":"2025","cit":17,"pfa":"Sonia Sonda","psa":"Andrea Mattarei","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W4414267802","eid":"W4414267802"},{"id":"paper-w2428578130","cat":"papers","name":"Inhibition of Axoplasmic Transport by Mescaline and Other Trimethoxyphenylalkylamines","year":"1973","cit":17,"pfa":"James C. Paulson","psa":"William O. McClure","ptype":"article","src":"https://openalex.org/W2428578130","eid":"W2428578130"},{"id":"paper-w2072677723","cat":"papers","name":"Ariocarpus retusus, the “False Peyote” of huichol tradition","year":"1971","cit":17,"pfa":"Peter T. Furst","ptype":"article","src":"https://openalex.org/W2072677723","eid":"W2072677723"},{"id":"paper-w2088517360","cat":"papers","name":"Drinking the South American hallucinogenic ayahuasca","year":"1978","cit":17,"pfa":"Franklin Ayala Flores","psa":"Walter H. Lewis","ptype":"article","src":"https://openalex.org/W2088517360","eid":"W2088517360"},{"id":"paper-w2800533563","cat":"papers","name":"Reaction of N , N -Dimethyltryptamine with Dichloromethane Under Common Experimental Conditions","year":"2018","cit":17,"pfa":"Lee E. Dunlap","psa":"David E. Olson","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2800533563","eid":"W2800533563"},{"id":"paper-w1948723120","cat":"papers","name":"A Case of Death Due to Ibogaine Use for Heroin Addiction","year":"2013","cit":17,"pfa":"Shwan Jalal","psa":"Raymond Hilu","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1948723120","eid":"W1948723120"},{"id":"paper-w3210091130","cat":"papers","name":"The Power of Social Attribution: Perspectives on the Healing Efficacy of Ayahuasca","year":"2021","cit":17,"pfa":"Bernd Brabec de Mori","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3210091130","eid":"W3210091130"},{"id":"paper-w2095005139","cat":"papers","name":"Pharmacodynamic interactions between MDMA and concomitants in MDMA tablets on extracellular dopamine and serotonin in the rat brain","year":"2011","cit":17,"pfa":"Rie Ikeda","psa":"Kenichiro Nakashima","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2095005139","eid":"W2095005139"},{"id":"paper-w3204600425","cat":"papers","name":"Rediscovering Psilocybin as an Antidepressive Treatment Strategy","year":"2021","cit":17,"pfa":"René Zeiss","psa":"Heiko Graf","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3204600425","eid":"W3204600425"},{"id":"paper-w2036874713","cat":"papers","name":"The influence of mescaline on the flexor reflex of the hind limb of the spinal rat","year":"1977","cit":17,"pfa":"Joanna Maj","psa":"A. Rawłów","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2036874713","eid":"W2036874713"},{"id":"paper-w1486542530","cat":"papers","name":"Oxidative metabolism of mescaline in the central nervous system-II","year":"1971","cit":17,"pfa":"Nikolaus Seiler","psa":"L. Demisch","ptype":"article","src":"https://openalex.org/W1486542530","eid":"W1486542530"},{"id":"paper-w2791843373","cat":"papers","name":"O6C-20-nor-salvinorin A is a stable and potent KOR agonist","year":"2018","cit":17,"pfa":"Shun Hirasawa","psa":"Ryan A. Shenvi","ptype":"article","src":"https://openalex.org/W2791843373","eid":"W2791843373"},{"id":"paper-w2318468418","cat":"papers","name":"Mescaline Analogs. VIII. Substituted 5-Methoxy-and 5,6,7-Trimethoxyindoles","year":"1958","cit":17,"pfa":"Frederick Benington","psa":"Leland C. Clark","ptype":"article","src":"https://openalex.org/W2318468418","eid":"W2318468418"},{"id":"paper-w4378084778","cat":"papers","name":"Acute psilocybin increased cortical activities in rats","year":"2023","cit":17,"pfa":"Junhong Liu","psa":"Ruibin Su","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4378084778","eid":"W4378084778"},{"id":"paper-w4225982601","cat":"papers","name":"Will psilocybin lose its magic in the clinical setting?","year":"2022","cit":17,"pfa":"Caroline Hayes","psa":"Stuart Watson","topics":["Depression","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4225982601","eid":"W4225982601"},{"id":"paper-w1924448282","cat":"papers","name":"The Expansion of Brazilian Ayahuasca Religions: Law, Culture and Locality","year":"2013","cit":17,"pfa":"Kevin Feeney","psa":"Beatriz Caiuby Labate","ptype":"book-chapter","src":"https://openalex.org/W1924448282","eid":"W1924448282"},{"id":"paper-w2317375072","cat":"papers","name":"The routes of a plant: ayahuasca and the global networks of Santo Daime","year":"2016","cit":17,"pfa":"Jonathan Thomas Lowell","psa":"Paul Channing Adams","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2317375072","eid":"W2317375072"},{"id":"paper-w2889048471","cat":"papers","name":"Therapeutic Potential Ascribed to Ayahuasca by Users in the Czech Republic","year":"2018","cit":17,"pfa":"Miroslav Horák","psa":"Nahanga Verter","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2889048471","eid":"W2889048471"},{"id":"paper-w2036386130","cat":"papers","name":"Peak Experiences of Psilocybin Users and Non-Users","year":"2013","cit":17,"pfa":"Christina Cummins","psa":"Jennifer A. Lyke","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2036386130","eid":"W2036386130"},{"id":"paper-w2028779158","cat":"papers","name":"Neuropsychiatric Alterations in MDMA Users: Preliminary Findings","year":"2005","cit":17,"pfa":"Ronald I. Herning","ptype":"article","src":"https://openalex.org/W2028779158","eid":"W2028779158"},{"id":"paper-w1966624539","cat":"papers","name":"The crystal and molecular structure of 5-methoxy-(N,N)-dimethyltryptamine hydrochloride","year":"1971","cit":17,"pfa":"Gerald Falkenberg","psa":"D. Carlström","ptype":"article","src":"https://openalex.org/W1966624539","eid":"W1966624539"},{"id":"paper-w4310600295","cat":"papers","name":"Underground ibogaine use for the treatment of substance use disorders: A qualitative analysis of subjective experiences","year":"2022","cit":17,"pfa":"Borja J. Rodríguez‐Cano","psa":"José Carlos Bouso","topics":["Addiction","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4310600295","eid":"W4310600295"},{"id":"paper-w2047207870","cat":"papers","name":"Survival after massive \"ecstasy\" (MDMA) ingestion","year":"1999","cit":17,"pfa":"Ralf Regenthal","psa":"Rainer Preiß","ptype":"article","src":"https://openalex.org/W2047207870","eid":"W2047207870"},{"id":"paper-w2559733313","cat":"papers","name":"Psilocybin for depression and anxiety associated with life-threatening illnesses","year":"2016","cit":17,"pfa":"John D. McCorvy","psa":"Bryan L. Roth","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2559733313","eid":"W2559733313"},{"id":"paper-w4280553494","cat":"papers","name":"A review on the mitochondrial toxicity of “ecstasy” (3,4-methylenedioxymethamphetamine, MDMA)","year":"2022","cit":17,"pfa":"João Paulo Capela","psa":"Félix Dias Carvalho","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4280553494","eid":"W4280553494"},{"id":"paper-w2992285764","cat":"papers","name":"The near-death experience: a cerebellar method to protect body and soul-lessons from the Iboga healing ceremony in Gabon.","year":"2008","cit":17,"pfa":"Süster Strubelt","psa":"Uwe Maas","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2992285764","eid":"W2992285764"},{"id":"paper-w4307481727","cat":"papers","name":"A Bayesian Reanalysis of a Trial of Psilocybin Versus Escitalopram for Depression","year":"2022","cit":17,"pfa":"Sandeep Manel Nayak","psa":"Robin Lester Carhart-Harris","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4307481727","eid":"W4307481727"},{"id":"paper-w1508791536","cat":"papers","name":"Immediate and Persistent Effects of Salvinorin A on the Kappa Opioid Receptor in Rodents, Monitored In Vivo with PET","year":"2015","cit":17,"pfa":"Michael S. Placzek","psa":"Jacob M. Hooker","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1508791536","eid":"W1508791536"},{"id":"paper-w2032348255","cat":"papers","name":"Cannabinoids, Opioids and MDMA: Neuropsychological Interactions Related to Addiction","year":"2010","cit":17,"pfa":"Patricia Robledo","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2032348255","eid":"W2032348255"},{"id":"paper-w2050060256","cat":"papers","name":"Ibogaine blocked methamphetamine-induced hyperthermia and induction of heat shock protein in mice","year":"1999","cit":17,"pfa":"Xinwen Yu","psa":"Syed F. Ali","ptype":"article","src":"https://openalex.org/W2050060256","eid":"W2050060256"},{"id":"paper-w2151841828","cat":"papers","name":"Metabolism of 18-Methoxycoronaridine, an Ibogaine Analog, to 18-Hydroxycoronaridine by Genetically Variable CYP2C19","year":"2002","cit":17,"pfa":"Wenjiang Zhang","psa":"Edward M. Sellers","ptype":"article","src":"https://openalex.org/W2151841828","eid":"W2151841828"},{"id":"paper-w4404396755","cat":"papers","name":"Oxytocin and the Role of Fluid Restriction in MDMA-Induced Hyponatremia","year":"2024","cit":17,"pfa":"Cihan Atila","psa":"Mirjam Christ‐Crain","topics":["PTSD & trauma","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4404396755","eid":"W4404396755"},{"id":"paper-w4324145541","cat":"papers","name":"Exploring psilocybin-assisted psychotherapy in the treatment of methamphetamine use disorder","year":"2023","cit":17,"pfa":"Jonathan Brett","psa":"Christopher S. Stauffer","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4324145541","eid":"W4324145541"},{"id":"paper-w1995528734","cat":"papers","name":"Differential effects of ibogaine on local cerebral glucose utilization in drug-naive and morphine-dependent rats","year":"2004","cit":17,"pfa":"Beth Levant","psa":"Thomas L. Pazdernik","ptype":"article","src":"https://openalex.org/W1995528734","eid":"W1995528734"},{"id":"paper-w4391560099","cat":"papers","name":"Evolution and diversification of carboxylesterase-like [4+2] cyclases in aspidosperma and iboga alkaloid biosynthesis","year":"2024","cit":17,"pfa":"Matthew D. DeMars","psa":"Sarah Ellen O'Connor","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4391560099","eid":"W4391560099"},{"id":"paper-w2066663353","cat":"papers","name":"Comparison of conditioned taste aversions produced by MDMA and d-amphetamine","year":"1993","cit":17,"pfa":"Hui Qiang Lin","psa":"Iain S. McGregor","ptype":"article","src":"https://openalex.org/W2066663353","eid":"W2066663353"},{"id":"paper-w2006790104","cat":"papers","name":"Comparison of the discriminative stimulus properties of Δ9-THC and psilocybin in rats","year":"1975","cit":17,"pfa":"Isaac Greenberg","psa":"James B. Appel","ptype":"article","src":"https://openalex.org/W2006790104","eid":"W2006790104"},{"id":"paper-w2091755872","cat":"papers","name":"Direct and indirect cardiovascular actions of cathinone and MDMA in the anaesthetized rat","year":"2015","cit":17,"pfa":"Hadeel A. Alsufyani","psa":"James R. Docherty","ptype":"article","src":"https://openalex.org/W2091755872","eid":"W2091755872"},{"id":"paper-w4401455877","cat":"papers","name":"The Antidepressant Effects of Vaporized N , N -Dimethyltryptamine: An Open-Label Pilot Trial in Treatment-Resistant Depression","year":"2024","cit":17,"pfa":"Marcelo Falchi-Carvalho","psa":"Fernanda Palhano-Fontes","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4401455877","eid":"W4401455877"},{"id":"paper-w2770941525","cat":"papers","name":"A Case of MDMA-Associated Cerebral and Pulmonary Edema Requiring ECMO","year":"2017","cit":17,"pfa":"A. Thakkar","psa":"E. M. Mohanraj","ptype":"article","src":"https://openalex.org/W2770941525","eid":"W2770941525"},{"id":"paper-w2086757101","cat":"papers","name":"Tolerance and cross-tolerance to 3,4-methylenedioxymethamphetamine (MDMA), methamphetamine and methylenedioxyamphetamine","year":"1990","cit":17,"pfa":"James P. Zacny","psa":"William L. Woolverton","ptype":"article","src":"https://openalex.org/W2086757101","eid":"W2086757101"},{"id":"paper-w2037327848","cat":"papers","name":"Marked Decline in 3,4-Methylenedioxymethamphetamine (MDMA) Based on Wastewater Analysis","year":"2011","cit":17,"pfa":"Chang Chen","psa":"Jason M. White","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2037327848","eid":"W2037327848"},{"id":"paper-w2103220243","cat":"papers","name":"The Prevalence, Intensity, and Assessment of Craving for MDMA/Ecstasy in Recreational Users","year":"2014","cit":17,"pfa":"Alan K. Davis","psa":"Harold Rosenberg","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2103220243","eid":"W2103220243"},{"id":"paper-w4243726603","cat":"papers","name":"Human Psychopharmacology and Dose-Effects of Salvinorin A, a Kappa-Opioid Agonist Hallucinogen Present in the Plant Salvia Divinorum","year":"2011","cit":17,"pfa":"Matthew W. Johnson","psa":"Roland R. Griffiths","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dataset","src":"https://openalex.org/W4243726603","eid":"W4243726603"},{"id":"paper-w4205238754","cat":"papers","name":"Evenings with Molly: Adult Couples’ Use of MDMA for Relationship Enhancement","year":"2022","cit":17,"pfa":"Robert Colbert","psa":"Shannon Hughes","ptype":"article","src":"https://openalex.org/W4205238754","eid":"W4205238754"},{"id":"paper-w4410137899","cat":"papers","name":"Reduced Brain Responsiveness to Emotional Stimuli With Escitalopram But Not Psilocybin Therapy for Depression","year":"2025","cit":17,"pfa":"Matthew B. Wall","psa":"Robin Lester Carhart-Harris","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4410137899","eid":"W4410137899"},{"id":"paper-w2147237840","cat":"papers","name":"Ibogaine interferes with motivational and somatic effects of naloxone-precipitated withdrawal from acutely administered morphine","year":"2002","cit":17,"pfa":"Linda A. Parker","psa":"Shepard Siegel","ptype":"article","src":"https://openalex.org/W2147237840","eid":"W2147237840"},{"id":"paper-w2081716945","cat":"papers","name":"The effect of caffeine on MDMA-induced hydroxyl radical production in the mouse striatum","year":"2014","cit":17,"pfa":"Anna Maria Górska","psa":"Krystyna Gołembiowska","ptype":"article","src":"https://openalex.org/W2081716945","eid":"W2081716945"},{"id":"paper-w4389203746","cat":"papers","name":"Current Understanding on Psilocybin for Major Depressive Disorder: A Review Focusing on Clinical Trials","year":"2023","cit":17,"pfa":"Sheng‐Min Wang","psa":"Won‐Myong Bahk","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4389203746","eid":"W4389203746"},{"id":"paper-w2946734509","cat":"papers","name":"Extraction and Conversion Studies of the Antiaddictive Alkaloids Coronaridine, Ibogamine, Voacangine, and Ibogaine from Two Mexican Tabernaemontana Species (Apocynaceae)","year":"2019","cit":17,"pfa":"Felix Krengel","psa":"Ricardo Reyes‐Chilpa","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2946734509","eid":"W2946734509"},{"id":"paper-w2022760815","cat":"papers","name":"Cognitive determinants of MDMA use among college students in Southern Taiwan","year":"2006","cit":17,"pfa":"Rwei‐Ling Yu","psa":"Huei‐Chen Ko","ptype":"article","src":"https://openalex.org/W2022760815","eid":"W2022760815"},{"id":"paper-w2970420720","cat":"papers","name":"MDMA-Associated Liver Toxicity: Pathophysiology, Management, and Current State of Knowledge","year":"2019","cit":17,"pfa":"Ruff Joseph Macale Cajanding","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2970420720","eid":"W2970420720"},{"id":"paper-w2009762063","cat":"papers","name":"Comparative levels of dimethyltryptamine- and tyramine-related alkaloid toxins in Australian cultivars and some wild populations of Phalaris aquatica","year":"2005","cit":17,"pfa":"R. A. Culvenor","psa":"Scott McDonald","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2009762063","eid":"W2009762063"},{"id":"paper-w4297252613","cat":"papers","name":"MDMA-assisted psychotherapy for post-traumatic stress disorder: The devil is in the detail","year":"2022","cit":17,"pfa":"Gillinder Bedi","psa":"Henry J. Jackson","topics":["PTSD & trauma","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4297252613","eid":"W4297252613"},{"id":"paper-w2951843065","cat":"papers","name":"High ambient temperature facilitates the acquisition of 3,4-methylenedioxymethamphetamine (MDMA) self-administration","year":"2017","cit":17,"pfa":"Shawn M. Aarde","psa":"Michael A. Taffe","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2951843065","eid":"W2951843065"},{"id":"paper-w18210184","cat":"papers","name":"Salvinorin A: A Mini Review of Physical and Chemical Properties Affecting Its Translation from Research to Clinical Applications in Humans","year":"2014","cit":17,"pfa":"Orton Edward","psa":"Renyu Liu","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W18210184","eid":"W18210184"},{"id":"paper-w4403151209","cat":"papers","name":"Meta-correlation of the effect of ketamine and psilocybin induced subjective effects on therapeutic outcome","year":"2024","cit":17,"pfa":"Jack D. C. Dahan","psa":"Albert Dahan","topics":["Depression","Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4403151209","eid":"W4403151209"},{"id":"paper-w2053610214","cat":"papers","name":"An in vivo microdialysis assessment of concurrent MDMA and cocaine administration in Sprague–Dawley rats","year":"2010","cit":17,"pfa":"J Panos","psa":"Lisa E. Baker","ptype":"article","src":"https://openalex.org/W2053610214","eid":"W2053610214"},{"id":"paper-w2013747071","cat":"papers","name":"Unhealthy weight control behaviors and MDMA (Ecstasy) use among adolescent females","year":"2005","cit":17,"pfa":"Jessica Duncan Cance","psa":"Michael A. Penne","ptype":"article","src":"https://openalex.org/W2013747071","eid":"W2013747071"},{"id":"paper-w3196833323","cat":"papers","name":"The Role of Psilocybin-Assisted Psychotherapy to Support Patients With Cancer: A Critical Scoping Review of the Research","year":"2021","cit":17,"pfa":"Rebecca H. Lehto","psa":"Jessica Shira Sender","topics":["Depression","Anxiety & end-of-life","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3196833323","eid":"W3196833323"},{"id":"paper-w2101897333","cat":"papers","name":"Role of dopamine transporters in the behavioral effects of 3,4-methylenedioxymethamphetamine (MDMA) in nonhuman primates","year":"2009","cit":17,"pfa":"William E. Fantegrossi","psa":"Leonard Lee Howell","ptype":"article","src":"https://openalex.org/W2101897333","eid":"W2101897333"},{"id":"paper-w2016007574","cat":"papers","name":"Methylenedioxymethamphetamine (MDMA, ‘Ecstasy‘) Serves as a Robust Positive Reinforcer in a Rat Runway Procedure","year":"2003","cit":17,"pfa":"Gudrun Wakonigg","psa":"Gerald Zernig","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2016007574","eid":"W2016007574"},{"id":"paper-w2327391441","cat":"papers","name":"The Total Synthesis of dl-Dihydrocleavamine, dl-Carbomethoxydihydrocleavamine, dl-Coronaridine, and dl-Dihydrocatharanthine. A General Entry into the Iboga and Vinca Alkaloids","year":"1966","cit":17,"pfa":"James Peter Kutney","psa":"Edward Piers","ptype":"article","src":"https://openalex.org/W2327391441","eid":"W2327391441"},{"id":"paper-w4220960061","cat":"papers","name":"Shared and distinct brain regions targeted for immediate early gene expression by ketamine and psilocybin","year":"2022","cit":17,"pfa":"Pasha A. Davoudian","psa":"Alex C. Kwan","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4220960061","eid":"W4220960061"},{"id":"paper-w2117144035","cat":"papers","name":"The Effects of Herkinorin, the First μ-Selective Ligand from a Salvinorin A-Derived Scaffold, in a Neuroendocrine Biomarker Assay in Nonhuman Primates","year":"2008","cit":17,"pfa":"Eduardo R. Butelman","psa":"Mary Jeanne Kreek","ptype":"article","src":"https://openalex.org/W2117144035","eid":"W2117144035"},{"id":"paper-w2054297638","cat":"papers","name":"Effect of 5-HT depletion by MDMA on hyperthermia and Arc mRNA induction in rat brain","year":"2004","cit":17,"pfa":"Thomas J.R. Beveridge","psa":"J. Martin Elliott","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2054297638","eid":"W2054297638"},{"id":"paper-w4408033191","cat":"papers","name":"Single-dose psilocybin therapy for alcohol use disorder: Pharmacokinetics, feasibility, safety and efficacy in an open-label study","year":"2025","cit":17,"pfa":"Mathias Ebbesen Jensen","psa":"Anders Fink‐Jensen","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4408033191","eid":"W4408033191"},{"id":"paper-w2950532024","cat":"papers","name":"Cryogenic infrared ion spectroscopy for the structural elucidation of drug molecules: MDMA and its metabolites","year":"2019","cit":17,"pfa":"Matthew R. Bell","psa":"Nicolas C. Polfer","ptype":"article","src":"https://openalex.org/W2950532024","eid":"W2950532024"},{"id":"paper-w2605835775","cat":"papers","name":"Ervaoffines E–G, three iboga-type alkaloids featuring ring C cleavage and rearrangement from Ervatamia officinalis","year":"2017","cit":17,"pfa":"Zhiwen Liu","psa":"Wen‐Cai Ye","ptype":"article","src":"https://openalex.org/W2605835775","eid":"W2605835775"},{"id":"paper-w2143401176","cat":"papers","name":"Prevalence and correlates of current depressive symptomatology among a community sample of MDMA users in Ohio","year":"2005","cit":17,"pfa":"Rüssel S. Falck","psa":"Harvey Alan Siegal","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2143401176","eid":"W2143401176"},{"id":"paper-w2125485571","cat":"papers","name":"Brief intervention for regular ecstasy (MDMA) users: Pilot randomized trial of a Check-up model","year":"2010","cit":17,"pfa":"Greg Martin","psa":"Jan Copeland","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2125485571","eid":"W2125485571"},{"id":"paper-w2000278712","cat":"papers","name":"A 3-lever discrimination procedure reveals differences in the subjective effects of low and high doses of MDMA","year":"2013","cit":17,"pfa":"David N. Harper","psa":"Susan Schenk","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2000278712","eid":"W2000278712"},{"id":"paper-w1969731723","cat":"papers","name":"Apparent active transport of MDMA is not mediated by P‐glycoprotein: a comparison with MDCK and Caco‐2 monolayers","year":"2006","cit":17,"pfa":"Kirk M. Bertelsen","psa":"Lisa Lvon Moltke","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1969731723","eid":"W1969731723"},{"id":"paper-w1608819448","cat":"papers","name":"Clinically Relevant Pharmacological Strategies That Reverse MDMA-Induced Brain Hyperthermia Potentiated by Social Interaction","year":"2015","cit":17,"pfa":"Eugene A. Kiyatkin","psa":"Yavin Shaham","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1608819448","eid":"W1608819448"},{"id":"paper-w4294670422","cat":"papers","name":"Coping motives mediate the relationship between PTSD and MDMA use in adolescents with substance use disorders","year":"2022","cit":17,"pfa":"Lukas Andreas Basedow","psa":"Sören Kuitunen‐Paul","topics":["PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4294670422","eid":"W4294670422"},{"id":"paper-w2501039762","cat":"papers","name":"MDMA: A Multi-Data and Multi-ACK Verified Selective Forwarding Attack Detection Scheme in WSNs","year":"2016","cit":17,"pfa":"Anfeng Liu","psa":"Jun Long","ptype":"article","src":"https://openalex.org/W2501039762","eid":"W2501039762"},{"id":"paper-w2049459298","cat":"papers","name":"Treatment with a serotonin-depleting regimen of MDMA prevents conditioned place preference to sex in male rats.","year":"2007","cit":17,"pfa":"Megan M. W. Straiko","psa":"Lique M. Coolen","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2049459298","eid":"W2049459298"},{"id":"paper-w1988002911","cat":"papers","name":"3,4-methylenedioxymethamphetamine (MDMA; Ecstasy) administration produces dose-dependent neurochemical, endocrine and immune changes in the rat","year":"1999","cit":17,"pfa":"Thomas J. Connor","psa":"Brian E. Leonard","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1988002911","eid":"W1988002911"},{"id":"paper-w2091653346","cat":"papers","name":"The effect of acute MDMA administration on body temperature, serum corticosterone and neurotransmitter concentrations in male and female rats","year":"1995","cit":17,"pfa":"Mairead Geraldine McNamara","psa":"Brian E. Leonard","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2091653346","eid":"W2091653346"},{"id":"paper-w2076650614","cat":"papers","name":"PRECLINICAL STUDY: Modulation of MDMA‐induced behavioral and transcriptional effects by the delta opioid antagonist naltrindole in mice","year":"2009","cit":17,"pfa":"Emilie Belkaï","psa":"Cynthia Marie‐Claire","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2076650614","eid":"W2076650614"},{"id":"paper-w2056999334","cat":"papers","name":"Postmortem distribution of 3,4-methylenedioxy-N,N-dimethyl-amphetamine (MDDM or MDDA) in a fatal MDMA overdose","year":"2006","cit":17,"pfa":"Els A. De Letter","psa":"Michel H A Piette","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2056999334","eid":"W2056999334"},{"id":"paper-w2102854608","cat":"papers","name":"Stability of 3,4-Methylenedioxymethampetamine (MDMA), 4-Methylmethcathinone (Mephedrone) and 3-Trifluromethylphenylpiperazine (3-TFMPP) in Formalin Solution","year":"2013","cit":17,"pfa":"Peter Maskell","psa":"Derrick J. Pounder","ptype":"article","src":"https://openalex.org/W2102854608","eid":"W2102854608"},{"id":"paper-w2163483684","cat":"papers","name":"Distribution of temperature changes and neurovascular coupling in rat brain following 3,4‐methylenedioxymethamphetamine (MDMA, “ecstasy”) exposure","year":"2015","cit":17,"pfa":"Daniel Coman","psa":"Kevin L. Behar","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2163483684","eid":"W2163483684"},{"id":"paper-w4399780176","cat":"papers","name":"Developing the Open Psychedelic Evaluation Nexus consensus measures for assessment of supervised psilocybin services: An e-Delphi study","year":"2024","cit":17,"pfa":"Philip Todd Korthuis","psa":"Christopher S. Stauffer","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4399780176","eid":"W4399780176"},{"id":"paper-w2134072993","cat":"papers","name":"Saturday night fever in ecstasy/MDMA dance clubbers: Heightened body temperature and associated psychobiological changes","year":"2014","cit":17,"pfa":"Andrew C. Parrott","psa":"Lucy Young","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2134072993","eid":"W2134072993"},{"id":"paper-w1924642053","cat":"papers","name":"Pentoxifylline Protects the Rat Liver Against Fibrosis and Apoptosis Induced by Acute Administration of 3,4-Methylenedioxymethamphetamine (MDMA or Ecstasy).","year":"2013","cit":17,"pfa":"Shabnam Movassaghi","psa":"Mansooreh Soleimani","ptype":"article","src":"https://openalex.org/W1924642053","eid":"W1924642053"},{"id":"paper-w4224440736","cat":"papers","name":"Psychosocial and Drug Use Assessment of Regular vs. Non-Regular Ayahuasca Users in a Brazilian Sample: a Web-Based Survey","year":"2022","cit":17,"pfa":"Dimitri Daldegan‐Bueno","psa":"Lucas Oliveira Maia","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4224440736","eid":"W4224440736"},{"id":"paper-w3083639366","cat":"papers","name":"Validated green phenyl reversed-phase LC method using ethanol to determine MDMA in seized ecstasy tablets","year":"2020","cit":17,"pfa":"Leandro Oka Duarte","psa":"Marcelo Firmino de Oliveira","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3083639366","eid":"W3083639366"},{"id":"paper-w1994498842","cat":"papers","name":"Spectral and inhibitory interactions of (±)−3, 4-methylenedioxyamphetamine (MDA) and (±)−3, 4-methylenedioxymethampetamine (MDMA) with rat hepatic microsomes","year":"1986","cit":17,"pfa":"J.F. Brady","psa":"A.K. Cho","ptype":"article","src":"https://openalex.org/W1994498842","eid":"W1994498842"},{"id":"paper-w2065540152","cat":"papers","name":"A role for adenosine A1 receptor blockade in the ability of caffeine to promote MDMA “Ecstasy”-induced striatal dopamine release","year":"2010","cit":17,"pfa":"Natacha Vanattou‐Saïfoudine","psa":"Andrew Harkin","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2065540152","eid":"W2065540152"},{"id":"paper-w1966664624","cat":"papers","name":"Aggressive behavior and jamming avoidance response in the weakly electric fish Gymnotus carapo: Effects of 3,4-methylenedioxymethamphetamine (MDMA)","year":"1997","cit":17,"pfa":"Alberto Capurro","psa":"Omar Macadar","ptype":"article","src":"https://openalex.org/W1966664624","eid":"W1966664624"},{"id":"paper-w2042501620","cat":"papers","name":"Alcaloides iboga de Peschiera affinis (Apocynaceae) - Atribuição inequívoca dos deslocamentos químicos dos átomos de hidrogênio e carbono: atividade antioxidante","year":"2009","cit":17,"pfa":"Allana Kellen L. Santos","psa":"Raimundo Braz‐Filho","ptype":"article","src":"https://openalex.org/W2042501620","eid":"W2042501620"},{"id":"paper-w4404843571","cat":"papers","name":"Ayahuasca Pretreatment Prevents Sepsis-Induced Anxiety-Like Behavior, Neuroinflammation, and Oxidative Stress, and Increases Brain-Derived Neurotrophic Factor","year":"2024","cit":17,"pfa":"Rick Wilhiam de Camargo","psa":"Rafael Mariano de Bitencourt","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4404843571","eid":"W4404843571"},{"id":"paper-w4393547236","cat":"papers","name":"A double-edged sword: Insights from practitioners on the short and long-term negative effects of psilocybin-assisted psychological interventions","year":"2024","cit":17,"pfa":"M. Nordin","psa":"Per Carlbring","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4393547236","eid":"W4393547236"},{"id":"paper-w2777421895","cat":"papers","name":"Nonmedical prescription drug use among African Americans who use MDMA (ecstasy/molly): Implications for risk reduction","year":"2017","cit":17,"pfa":"Khary K. Rigg","psa":"Amanda Sharp","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2777421895","eid":"W2777421895"},{"id":"paper-w2110162560","cat":"papers","name":"Reduced memory skills and increased hair cortisol levels in recent Ecstasy/MDMA users: significant but independent neurocognitive and neurohormonal deficits","year":"2015","cit":17,"pfa":"Luke A. Downey","psa":"Andrew C. Parrott","ptype":"article","src":"https://openalex.org/W2110162560","eid":"W2110162560"},{"id":"paper-w4388304929","cat":"papers","name":"MDMA-Based Psychotherapy in Treatment-Resistant Post-Traumatic Stress Disorder (PTSD): A Brief Narrative Overview of Current Evidence","year":"2023","cit":17,"pfa":"Kainat Riaz","psa":"Domenico De Berardis","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4388304929","eid":"W4388304929"},{"id":"paper-w4296403170","cat":"papers","name":"White matter alterations in chronic MDMA use: Evidence from diffusion tensor imaging and neurofilament light chain blood levels","year":"2022","cit":17,"pfa":"Josua Zimmermann","psa":"Boris B. Quednow","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4296403170","eid":"W4296403170"},{"id":"paper-w2023914130","cat":"papers","name":"The serotonin receptor agonist 5-methoxy-N,N-dimethyltryptamine facilitates noradrenaline release from rat spinal cord slices and inhibits monoamine oxidase activity","year":"1993","cit":17,"pfa":"Wolfgang Reimann","psa":"Frank Schneider","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2023914130","eid":"W2023914130"},{"id":"paper-w2609942353","cat":"papers","name":"Simultaneous determination of γ-hydroxybutyric acid, ibotenic acid and psilocybin in saliva samples by capillary electrophoresis coupled with a contactless conductivity detector","year":"2017","cit":17,"pfa":"Piret Saar‐Reismaa","psa":"Jekaterina Mazina-Šinkar","ptype":"article","src":"https://openalex.org/W2609942353","eid":"W2609942353"},{"id":"paper-w1975061705","cat":"papers","name":"Altered gene expression in frontal cortex and midbrain of 3,4‐methylenedioxymethamphetamine (MDMA) treated mice: Differential regulation of GABA transporter subtypes","year":"2003","cit":17,"pfa":"Weiping Peng","psa":"Rabi Simantov","topics":["Safety & adverse events","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W1975061705","eid":"W1975061705"},{"id":"paper-w4399701295","cat":"papers","name":"The efficacy and safety of MDMA-assisted psychotherapy for treatment of posttraumatic stress disorder: A systematic review and meta-analysis from randomized controlled trials","year":"2024","cit":17,"pfa":"Jianhua Yang","psa":"Junwei Gao","topics":["PTSD & trauma","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4399701295","eid":"W4399701295"},{"id":"paper-w1972035205","cat":"papers","name":"Disruption of prepulse inhibition by 3,4-methylenedioxymethamphetamine (MDMA): comparison between male and female wild-type and 5-HT1A receptor knockout mice","year":"2011","cit":17,"pfa":"Maarten van den Buuse","psa":"Victoria B. Risbrough","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1972035205","eid":"W1972035205"},{"id":"paper-w2036225537","cat":"papers","name":"Simultaneous enantiomeric determination of MDMA and its phase I and phase II metabolites in urine by liquid chromatography–tandem mass spectrometry with chiral derivatization","year":"2012","cit":17,"pfa":"Keiko Nakanishi","psa":"Koichi Suzuki","ptype":"article","src":"https://openalex.org/W2036225537","eid":"W2036225537"},{"id":"paper-w4378977419","cat":"papers","name":"Drug-drug interactions between classic psychedelics and psychoactive drugs: a systematic review","year":"2023","cit":17,"pfa":"Andreas Halman","psa":"Daniel Perkins","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4378977419","eid":"W4378977419"},{"id":"paper-w4400847605","cat":"papers","name":"Current Perspectives on the Clinical Research and Medicalization of Psychedelic Drugs for Addiction Treatments: Safety, Efficacy, Limitations and Challenges","year":"2024","cit":17,"pfa":"Anton Gomez-Escolar","psa":"Albert Batalla","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4400847605","eid":"W4400847605"},{"id":"paper-w3162774823","cat":"papers","name":"The need for publicly funded research on therapeutic use of psychedelic drugs","year":"2021","cit":17,"pfa":"Wayne Hall","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W3162774823","eid":"W3162774823"},{"id":"paper-w2060183029","cat":"papers","name":"Influence of psychotomimetics and lisuride on synaptosomal dopamine release in the nucleus accumbens of rats","year":"1983","cit":17,"pfa":"László Hetey","psa":"Wolfgang Oelssner","ptype":"article","src":"https://openalex.org/W2060183029","eid":"W2060183029"},{"id":"paper-w2208233562","cat":"papers","name":"Differential effects of hallucinogenic drugs on the activity of serotonin-containing neurons in the nucleus centralis superior and nucleus raphe pallidus in freely moving cats.","year":"1984","cit":17,"pfa":"Michael E. Trulson","psa":"Violet M. Trulson","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2208233562","eid":"W2208233562"},{"id":"paper-w2077070255","cat":"papers","name":"Effect of lysergic acid derivatives on the liver fluke Fasciola hepatica","year":"1963","cit":17,"pfa":"K. D. Beernink","psa":"Tag E. Mansour","ptype":"article","src":"https://openalex.org/W2077070255","eid":"W2077070255"},{"id":"paper-w3123414763","cat":"papers","name":"Sociological investigations of human enhancement drugs: The case of microdosing psychedelics","year":"2021","cit":17,"pfa":"Dimitrios Liokaftos","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3123414763","eid":"W3123414763"},{"id":"paper-w12820718","cat":"papers","name":"Pharmacology and Classification of LSD-like Hallucinogens","year":"1977","cit":17,"pfa":"William R. Martin","psa":"Jewell W. Sloan","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W12820718","eid":"W12820718"},{"id":"paper-w2981489145","cat":"papers","name":"Serotonergic hallucinogens/psychedelics could be promising treatments for depressive and anxiety disorders in end-stage cancer","year":"2019","cit":17,"pfa":"RAFAEL GUIMARÃES DOS SANTOS","psa":"Jaime E. C. Hallak","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2981489145","eid":"W2981489145"},{"id":"paper-w4386686883","cat":"papers","name":"Advances in Psychedelic Medicine","year":"2019","cit":17,"topics":["Depression","Addiction","Safety & adverse events"],"ptype":"book","src":"https://openalex.org/W4386686883","eid":"W4386686883"},{"id":"paper-w1990341665","cat":"papers","name":"LSD: Patterns of use by chemically dependent adolescents","year":"1987","cit":17,"pfa":"Richard H. Schwartz","psa":"John E. Meeks","ptype":"article","src":"https://openalex.org/W1990341665","eid":"W1990341665"},{"id":"paper-w1966210073","cat":"papers","name":"LSD-25 Does Not Intercalate in DNA","year":"1971","cit":17,"pfa":"Erik M. Smit","psa":"Piet Borst","ptype":"article","src":"https://openalex.org/W1966210073","eid":"W1966210073"},{"id":"paper-w2093793657","cat":"papers","name":"Alteration of a learned response of the squirrel monkey by hallucinogens","year":"1969","cit":17,"pfa":"Edward T. Uyeno","ptype":"article","src":"https://openalex.org/W2093793657","eid":"W2093793657"},{"id":"paper-w2034789549","cat":"papers","name":"Forensic Medicine and Toxicology: Drug Addiction","year":"1967","cit":17,"pfa":"Thomas H. Bewley","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2034789549","eid":"W2034789549"},{"id":"paper-w2082551067","cat":"papers","name":"Characterization of [3H]LSD binding to a serotonin-sensitive site in honeybee (Apis mellifera) brain","year":"1995","cit":17,"pfa":"Wolfgang Blenau","psa":"Joachim Erber","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2082551067","eid":"W2082551067"},{"id":"paper-w4300123600","cat":"papers","name":"Structural Features for Functional Selectivity at Serotonin Receptors","year":"2020","cit":17,"pfa":"V. Cherezov","psa":"F.Y. Siu","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4300123600","eid":"W4300123600"},{"id":"paper-w1970675498","cat":"papers","name":"The effects of dl-α-methyltyrosine and l-DOPA on the hyperthermic and behavioral actions of LSD in rabbits","year":"1973","cit":17,"pfa":"A. Horita","psa":"A. E. Hamilton","ptype":"article","src":"https://openalex.org/W1970675498","eid":"W1970675498"},{"id":"paper-w4386529973","cat":"papers","name":"Psychedelic-Assisted Therapy in Military and Veterans Healthcare Systems: Clinical, Legal, and Implementation Considerations","year":"2023","cit":17,"pfa":"Aaron S. Wolfgang","psa":"Charles W. Hoge","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4386529973","eid":"W4386529973"},{"id":"paper-w2075090213","cat":"papers","name":"LSD-induced alterations of investigatory responding in rats","year":"1979","cit":17,"pfa":"Mark A. Geyer","psa":"Roger K. Light","ptype":"article","src":"https://openalex.org/W2075090213","eid":"W2075090213"},{"id":"paper-w1992035323","cat":"papers","name":"Evolution of the identification of the myristicaceous hallucinogens of South America","year":"1979","cit":17,"pfa":"Richard Evans Schultes","ptype":"article","src":"https://openalex.org/W1992035323","eid":"W1992035323"},{"id":"paper-w2134106637","cat":"papers","name":"An OnLine Immunoassay for LSD: Comparison with GC-MS and the Abuscreen(R) RIA","year":"1996","cit":17,"pfa":"Alan J. McNally","psa":"Salvatore J. Salamone","ptype":"article","src":"https://openalex.org/W2134106637","eid":"W2134106637"},{"id":"paper-w2002488633","cat":"papers","name":"Quantitative Bestimmung der Indolderivate von Psilocybe semilanceata (Fr.) Kumm.","year":"1986","cit":17,"pfa":"Jochen Gartz","ptype":"article","src":"https://openalex.org/W2002488633","eid":"W2002488633"},{"id":"paper-w4387305009","cat":"papers","name":"A pilot study of cerebral metabolism and serotonin 5-HT2A receptor occupancy in rats treated with the psychedelic tryptamine DMT in conjunction with the MAO inhibitor harmine","year":"2023","cit":17,"pfa":"Klemens Egger","psa":"Mikael Palner","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4387305009","eid":"W4387305009"},{"id":"paper-w2085894483","cat":"papers","name":"Long‐lasting neuroprotective effect of sildenafil against 3,4‐methylenedioxymethamphetamine‐ induced 5‐hydroxytryptamine deficits in the rat brain","year":"2011","cit":17,"pfa":"Elena Puerta","psa":"Norberto Aguirre","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2085894483","eid":"W2085894483"},{"id":"paper-w2331273295","cat":"papers","name":"Absence of Psychostimulant Effects of a Supratherapeutic Dose of Tianeptine","year":"2011","cit":17,"pfa":"Katy Bernard","psa":"Yves Donazzolo","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2331273295","eid":"W2331273295"},{"id":"paper-w2031341893","cat":"papers","name":"Methylenedioxymethamphetamine induces spontaneous tail-flicks in the rat via 5-HT1A receptors","year":"1991","cit":17,"pfa":"Mark John Millan","psa":"Françis C. Colpaert","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2031341893","eid":"W2031341893"},{"id":"paper-w2013257918","cat":"papers","name":"Prenatal Exposure to Alcohol and 3,4-Methylenedioxymethamphetamine (Ecstasy) Alters Adult Hippocampal Neurogenesis and Causes Enduring Memory Deficits","year":"2014","cit":17,"pfa":"Juan J. Canales","psa":"Águeda Ferrer-Donato","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2013257918","eid":"W2013257918"},{"id":"paper-w3042474643","cat":"papers","name":"Determination of ketamine, methamphetamine and 3,4-methylenedioxymethamphetamine in human hair by flash evaporation-gas chromatography/mass spectrometry","year":"2020","cit":17,"pfa":"Yanshuxian Liu","psa":"Ichi Watanabe","ptype":"article","src":"https://openalex.org/W3042474643","eid":"W3042474643"},{"id":"paper-w2051893590","cat":"papers","name":"Evidence for a role of Hsp70 in the neuroprotection induced by heat shock pre‐treatment against 3,4‐methylenedioxymethamphetamine toxicity in rat brain","year":"2007","cit":17,"pfa":"Isabel Escobedo","psa":"Esther O’Shea","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2051893590","eid":"W2051893590"},{"id":"paper-w4293168287","cat":"papers","name":"Effects of Selective Serotonin Reuptake Inhibitor Use on 3,4-Methylenedioxymethamphetamine–Assisted Therapy for Posttraumatic Stress Disorder","year":"2022","cit":17,"pfa":"Collin M. Price","psa":"Katrina DeBonis","topics":["PTSD & trauma","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4293168287","eid":"W4293168287"},{"id":"paper-w1989572736","cat":"papers","name":"N-Methyl-3,4-methylenedioxyamphetamine-induced hepatotoxicity in rats: Oxidative stress after acute and chronic administration","year":"2004","cit":17,"pfa":"Milica Ninković","psa":"Ivana Vasiljević","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1989572736","eid":"W1989572736"},{"id":"paper-w2003006205","cat":"papers","name":"PSYCHEDELIC DRUGS, MAGICAL THINKING AND PSYCHOSIS","year":"2013","cit":17,"pfa":"Robin Lester Carhart-Harris","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2003006205","eid":"W2003006205"},{"id":"paper-w2105974451","cat":"papers","name":"Attentional Processes in Abstinent Methylenedioxymethamphetamine (Ecstasy) Users","year":"2002","cit":17,"pfa":"Konstantine K. Zakzanis","psa":"Nasim F. Radkhoshnoud","ptype":"article","src":"https://openalex.org/W2105974451","eid":"W2105974451"},{"id":"paper-w4390176357","cat":"papers","name":"Molecular and Medical Aspects of Psychedelics","year":"2023","cit":17,"pfa":"Adam Wojtas","psa":"Krystyna Gołembiowska","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4390176357","eid":"W4390176357"},{"id":"paper-w2883205168","cat":"papers","name":"Serotonin concentration enhancers at clinically relevant doses reduce [11C]AZ10419369 binding to the 5-HT1B receptors in the nonhuman primate brain","year":"2018","cit":17,"pfa":"Kai‐Chun Yang","psa":"Sjoerd J. Finnema","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2883205168","eid":"W2883205168"},{"id":"paper-w2056778099","cat":"papers","name":"The role of hallucinogenic drugs and sensory stimuli in Peruvian ritual healing","year":"1984","cit":17,"pfa":"Donald Joralemon","ptype":"article","src":"https://openalex.org/W2056778099","eid":"W2056778099"},{"id":"paper-w2147143010","cat":"papers","name":"4-Hydroxy-3-methoxymethamphetamine Glucuronide as a Phase II Metabolite of 3,4-Methylenedioxymethamphetamine: Enzyme-Assisted Synthesis and Involvement of Human Hepatic Uridine 5'-Diphosphate-Glucuronosyltransferase 2B15","year":"2009","cit":17,"pfa":"Takuji Shoda","psa":"Haruhiro Okuda","ptype":"article","src":"https://openalex.org/W2147143010","eid":"W2147143010"},{"id":"paper-w2058432331","cat":"papers","name":"Ring-substituted amphetamine interactions with neurotransmitter receptor binding sites in human cortex","year":"1988","cit":17,"pfa":"Pamela A. Pierce","psa":"Stephen J. Peroutka","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2058432331","eid":"W2058432331"},{"id":"paper-w2736575297","cat":"papers","name":"First Time View on Human Metabolome Changes after a Single Intake of 3,4-Methylenedioxymethamphetamine in Healthy Placebo-Controlled Subjects","year":"2017","cit":17,"pfa":"Martina I. Boxler","psa":"Andrea Eva Steuer","topics":["Safety & adverse events","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2736575297","eid":"W2736575297"},{"id":"paper-w2082598160","cat":"papers","name":"Examination of the hallucinogen 2,5-dimethoxy-4-methylamphetamine","year":"1969","cit":17,"pfa":"G F Phillips","psa":"Robert J. Mesley","ptype":"article","src":"https://openalex.org/W2082598160","eid":"W2082598160"},{"id":"paper-w4388482821","cat":"papers","name":"The Therapeutic Potential of Amphetamine-like Psychostimulants","year":"2023","cit":17,"pfa":"Bruno Pires","psa":"Eugénia Gallardo","topics":["PTSD & trauma","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4388482821","eid":"W4388482821"},{"id":"paper-w2919975207","cat":"papers","name":"Psychedelics and Dying Care: A Historical Look at the Relationship between Psychedelics and Palliative Care","year":"2019","cit":17,"pfa":"Erika Dyck","topics":["Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2919975207","eid":"W2919975207"},{"id":"paper-w2790867612","cat":"papers","name":"Out of the box: A psychedelic model to study the creative mind","year":"2018","cit":17,"pfa":"Kim P. C. Kuypers","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2790867612","eid":"W2790867612"},{"id":"paper-w2019879334","cat":"papers","name":"Salvia divinorum: A Psychopharmacological Riddle and a Mind-Body Prospect","year":"2013","cit":17,"pfa":"Jose-Luis Diaz","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2019879334","eid":"W2019879334"},{"id":"paper-w2909182658","cat":"papers","name":"L’ayahuasca et son ombre. L’apprentissage de la possession dans un centre chamanique d’Amazonie péruvienne","year":"2018","cit":17,"pfa":"David Dupuis","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2909182658","eid":"W2909182658"},{"id":"paper-w2587043970","cat":"papers","name":"The fast and furious : Cocaine, amphetamines and harm reduction","year":"2010","cit":17,"pfa":"J-P.C. Grund","psa":"Peter Blanken","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2587043970","eid":"W2587043970"},{"id":"paper-w3066868230","cat":"papers","name":"Neural and subjective effects of inhaled DMT in natural settings","year":"2020","cit":17,"pfa":"Carla Pallavicini","psa":"Enzo Tagliazucchi","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W3066868230","eid":"W3066868230"},{"id":"paper-w4394750772","cat":"papers","name":"Emerging drugs in phase II and III clinical development for the treatment of alcohol use disorder","year":"2024","cit":17,"pfa":"Sophie Köhne","psa":"Patrick Bach","topics":["Addiction","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4394750772","eid":"W4394750772"},{"id":"paper-w2095380148","cat":"papers","name":"Pharmacology of the serotonergic inhibition of steroid‐induced reinitiation of oocyte meiosis in the teleostFundulus heteroclitus","year":"1997","cit":17,"pfa":"Joan Cerdà","psa":"Robin A. Wallace","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2095380148","eid":"W2095380148"},{"id":"paper-w2126527315","cat":"papers","name":"Mirtazapine: only for depression?","year":"2006","cit":17,"pfa":"Luis San","psa":"Belén Arranz","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W2126527315","eid":"W2126527315"},{"id":"paper-w4206571545","cat":"papers","name":"Ulotaront, a novel TAAR1 agonist with 5-HT1A agonist activity, lacks abuse liability and attenuates cocaine cue-induced relapse in rats","year":"2021","cit":17,"pfa":"Colleen Synan","psa":"Kenneth S. Koblan","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4206571545","eid":"W4206571545"},{"id":"paper-w4360984887","cat":"papers","name":"An encounter with the self: A thematic and content analysis of the DMT experience from a naturalistic field study","year":"2023","cit":17,"pfa":"Pascal Michael","psa":"Oliver C. Robinson","topics":["Mechanism & neuroscience","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4360984887","eid":"W4360984887"},{"id":"paper-w4316143345","cat":"papers","name":"The drug treatment deadlock in psychiatry and the route forward","year":"2023","cit":17,"pfa":"Oliver Howes","psa":"Luke Baxter","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4316143345","eid":"W4316143345"},{"id":"paper-w2914888340","cat":"papers","name":"The tripping point: The potential role of psychedelic-assisted therapy in the response to the opioid crisis","year":"2019","cit":17,"pfa":"Elena Argento","psa":"Maria Eugenia Socias","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2914888340","eid":"W2914888340"},{"id":"paper-w4392961219","cat":"papers","name":"Psychedelics and Evidence-based Psychotherapy","year":"2024","cit":17,"pfa":"Lewis Leone","psa":"Gregory A. Fonzo","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4392961219","eid":"W4392961219"},{"id":"paper-w4397009314","cat":"papers","name":"How Do Psychedelics Reduce Fear of Death?","year":"2024","cit":17,"pfa":"Chris Letheby","topics":["Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4397009314","eid":"W4397009314"},{"id":"paper-w4401344585","cat":"papers","name":"Mind over matter: the microbial mindscapes of psychedelics and the gut-brain axis","year":"2024","cit":17,"pfa":"Giorgia Caspani","psa":"Wilfred Arthur Jefferies","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4401344585","eid":"W4401344585"},{"id":"paper-w4400112166","cat":"papers","name":"State Cannabis and Psychedelic Legislation and Microdosing Interest in the US","year":"2024","cit":17,"pfa":"Kevin H. Yang","psa":"Eric Craig Leas","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4400112166","eid":"W4400112166"},{"id":"paper-w1949655533","cat":"papers","name":"Pharmacology of Hallucinogens","year":"1998","cit":17,"pfa":"Richard A. Glennon","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W1949655533","eid":"W1949655533"},{"id":"paper-w2272881483","cat":"papers","name":"PHENIRAMINE AS AN HALLUCINOGEN","year":"1973","cit":17,"pfa":"Ivor H. Jones","psa":"G. N. Gibney","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2272881483","eid":"W2272881483"},{"id":"paper-w2119694234","cat":"papers","name":"HERE AND NOW: DISCOVERING THE SACRED WITH ENTHEOGENS","year":"2014","cit":17,"pfa":"William A. Richards","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2119694234","eid":"W2119694234"},{"id":"paper-w2440527852","cat":"papers","name":"The Hallucinogens and the Inhalants","year":"1984","cit":17,"pfa":"Sidney Cohen","ptype":"article","src":"https://openalex.org/W2440527852","eid":"W2440527852"},{"id":"paper-w2612418689","cat":"papers","name":"Hallucinogens in Drug Discrimination","year":"2017","cit":17,"pfa":"Lisa E. Baker","ptype":"book-chapter","src":"https://openalex.org/W2612418689","eid":"W2612418689"},{"id":"paper-w2559617585","cat":"papers","name":"Psycho-existential distress in cancer patients: A return to “entheogens”","year":"2016","cit":17,"pfa":"Craig D. Blinderman","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2559617585","eid":"W2559617585"},{"id":"paper-w1916363046","cat":"papers","name":"Detection of microdoses of rhEPO with the MAIIA test","year":"2013","cit":17,"pfa":"Jakob Mørkeberg","psa":"M. Ashenden","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1916363046","eid":"W1916363046"},{"id":"paper-w1977960258","cat":"papers","name":"The Controlled Psychedelic State","year":"1963","cit":17,"pfa":"Jerome Levine","psa":"W H Lyle","ptype":"article","src":"https://openalex.org/W1977960258","eid":"W1977960258"},{"id":"paper-w1983250273","cat":"papers","name":"Human Microdosing for The Prediction of Patient Response","year":"2010","cit":17,"pfa":"Paul T. Henderson","psa":"Chong‐Xian Pan","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1983250273","eid":"W1983250273"},{"id":"paper-w2470137087","cat":"papers","name":"The chemical identity of \"hog\"--a \"new\" hallucinogen.","year":"1969","cit":17,"pfa":"J E Lindgren","psa":"Bo R. Holmstedt","ptype":"article","src":"https://openalex.org/W2470137087","eid":"W2470137087"},{"id":"paper-w4409903629","cat":"papers","name":"Traumatic Psychedelic Experiences","year":"2025","cit":17,"pfa":"Abigail E. Calder","psa":"Gregor Hasler","topics":["PTSD & trauma"],"ptype":"book-chapter","src":"https://openalex.org/W4409903629","eid":"W4409903629"},{"id":"paper-w2137914237","cat":"papers","name":"Are Psychedelics Useful in the Practice of Buddhism?","year":"1999","cit":17,"pfa":"Myron J. Stolaroff","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2137914237","eid":"W2137914237"},{"id":"paper-w4293230573","cat":"papers","name":"The psychedelic ritual as a technique of the self","year":"2022","cit":17,"pfa":"David Dupuis","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4293230573","eid":"W4293230573"},{"id":"paper-w1990824220","cat":"papers","name":"MICRODOSE INTRATHECAL CLONIDINE AND MORPHINE FOR POSTOPERATIVE ANALGESIA","year":"1987","cit":17,"pfa":"Dennis W. Coombs","psa":"Carol A. Murphy","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1990824220","eid":"W1990824220"},{"id":"paper-w2025465847","cat":"papers","name":"Research on psychedelics moves into the mainstream","year":"2008","cit":17,"pfa":"Kelly Morris","ptype":"article","src":"https://openalex.org/W2025465847","eid":"W2025465847"},{"id":"paper-w4401199931","cat":"papers","name":"Set and Setting for Psychedelic Harm Reduction","year":"2024","cit":17,"pfa":"Ido Hartogsohn","topics":["Safety & adverse events","Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W4401199931","eid":"W4401199931"},{"id":"paper-w2954222477","cat":"papers","name":"Dose‐linearity of the pharmacokinetics of an intravenous [14C]midazolam microdose in children","year":"2019","cit":17,"pfa":"Bianca D. van Groen","psa":"Mark A. Turner","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2954222477","eid":"W2954222477"},{"id":"paper-w4391099882","cat":"papers","name":"Neural Geometrodynamics, Complexity, and Plasticity: A Psychedelics Perspective","year":"2024","cit":17,"pfa":"Giulio Ruffini","psa":"Roser Sanchez-Todo","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4391099882","eid":"W4391099882"},{"id":"paper-w2798132064","cat":"papers","name":"Psychedelics and related drugs: therapeutic possibilities, mechanisms and regulation","year":"2018","cit":17,"pfa":"Helen Valerie Curran","psa":"Harriet de Wit","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2798132064","eid":"W2798132064"},{"id":"paper-w4405599349","cat":"papers","name":"Effects of psychedelics on neurogenesis and broader neuroplasticity: a systematic review","year":"2024","cit":17,"pfa":"Rafael Vitor Lima da Cruz","psa":"Thiago C. Moulin","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4405599349","eid":"W4405599349"},{"id":"paper-w4404863611","cat":"papers","name":"Psychedelic risks and benefits: A cross-sectional survey study","year":"2024","cit":17,"pfa":"Sean P. Goldy","psa":"David B. Yaden","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4404863611","eid":"W4404863611"},{"id":"paper-w2100268589","cat":"papers","name":"Accelerator mass spectrometry offers new opportunities for microdosing of peptide and protein pharmaceuticals","year":"2010","cit":17,"pfa":"Mehran Salehpour","psa":"Göran Possnert","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2100268589","eid":"W2100268589"},{"id":"paper-w4399702604","cat":"papers","name":"Psychedelics and disorders of consciousness: the current landscape and the path forward","year":"2024","cit":17,"pfa":"Paolo Cardone","psa":"Charlotte Martial","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4399702604","eid":"W4399702604"},{"id":"paper-w4387357883","cat":"papers","name":"Psychedelics and Psychotherapy: Is the Whole Greater than the Sum of its Parts?","year":"2023","cit":17,"pfa":"Robert H. Dworkin","psa":"Eric C. Strain","topics":["Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4387357883","eid":"W4387357883"},{"id":"paper-w4283732753","cat":"papers","name":"Brain Wellness “Spas”—Anticipating the Off-label Promotion of Psychedelics","year":"2022","cit":17,"pfa":"Anna Wexler","psa":"Dominic A. Sisti","ptype":"article","src":"https://openalex.org/W4283732753","eid":"W4283732753"},{"id":"paper-w2968521938","cat":"papers","name":"Quantification of Microdosed Oral Yohimbine and its Major Metabolite in Human Plasma in the Picogram Range","year":"2019","cit":17,"pfa":"Manuela Vay","psa":"Jürgen Burhenne","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2968521938","eid":"W2968521938"},{"id":"paper-w2091459808","cat":"papers","name":"Radiolabeling of the cannabinoid receptor agonist AZD1940 with carbon-11 and PET microdosing in non-human primate","year":"2013","cit":17,"pfa":"Magnus Schou","psa":"Lars Farde","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2091459808","eid":"W2091459808"},{"id":"paper-w3016368875","cat":"papers","name":"Multiplexed Evaluation of Microdosed Antineoplastic Agents In Situ in the Tumor Microenvironment of Patients with Soft Tissue Sarcoma","year":"2020","cit":17,"pfa":"Kenneth R. Gundle","psa":"Robert G. Maki","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3016368875","eid":"W3016368875"},{"id":"paper-w2051449233","cat":"papers","name":"Religious implications of paranormal events occurring during chemically-induced ‘psychedelic’ experience","year":"1970","cit":17,"pfa":"Stanley Krippner","psa":"Richard J. Davidson","ptype":"article","src":"https://openalex.org/W2051449233","eid":"W2051449233"},{"id":"paper-w2032163394","cat":"papers","name":"The Synthesis of Four Possible in vitro Metabolites of the Hallucinogen 1-(2,5-Dimethoxy-4-methylphenyl)-2-aminopropane (DOM)","year":"1974","cit":17,"pfa":"Ronald T. Coutts","psa":"Jerry L. Malicky","ptype":"article","src":"https://openalex.org/W2032163394","eid":"W2032163394"},{"id":"paper-w3041870981","cat":"papers","name":"Microdose Lithium Treatment Reduced Inflammatory Factors and Neurodegeneration in Organotypic Hippocampal Culture of Old SAMP-8 Mice","year":"2020","cit":17,"pfa":"Mariana Toricelli","psa":"Tânia Araújo Viel","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3041870981","eid":"W3041870981"},{"id":"paper-w4387798345","cat":"papers","name":"Longitudinal associations between psychedelic use and meditation practices in the United States and the United Kingdom","year":"2023","cit":17,"pfa":"Otto Simonsson","psa":"Peter S. Hendricks","ptype":"article","src":"https://openalex.org/W4387798345","eid":"W4387798345"},{"id":"paper-w2234516142","cat":"papers","name":"Foliar application of microdoses of sucrose to reduce codling moth Cydia pomonella L. (Lepidoptera: Tortricidae) damage to apple trees","year":"2016","cit":17,"pfa":"Ingrid Arnault","psa":"Sylvie Derridj","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2234516142","eid":"W2234516142"},{"id":"paper-w2014112381","cat":"papers","name":"Associations between psychedelic use, abuse, and dependence and lifetime panic attack history in a representative sample","year":"2006","cit":17,"pfa":"Marcel O. Bonn‐Miller","psa":"Michael J. Zvolensky","ptype":"article","src":"https://openalex.org/W2014112381","eid":"W2014112381"},{"id":"paper-w4297493523","cat":"papers","name":"Self-Transcendent Positive Emotions as a Potential Mechanism Underpinning the Effects of Meaningful Psychedelic Experiences on Connectedness to Nature","year":"2022","cit":17,"pfa":"Katie Newton","psa":"Sam G. Moreton","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4297493523","eid":"W4297493523"},{"id":"paper-w3195827060","cat":"papers","name":"A microdosing framework for absolute bioavailability assessment of poorly soluble drugs: A case study on cold‐labeled venetoclax, from chemistry to the clinic","year":"2021","cit":17,"pfa":"Amr Alaarg","psa":"Ahmed Hamed Salem","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3195827060","eid":"W3195827060"},{"id":"paper-w2006634208","cat":"papers","name":"The Pharmacology of Psychotomimetic and Psychotherapeutic Drugs","year":"1957","cit":17,"pfa":"Seymour S. Kety","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2006634208","eid":"W2006634208"},{"id":"paper-w1985002148","cat":"papers","name":"Oral contraceptive pretreatment does not improve outcome in microdose gonadotrophin-releasing hormone agonist protocol among poor responder intracytoplasmic sperm injection patients","year":"2008","cit":17,"pfa":"Candan İltemir Duvan","psa":"Hakan Şatıroğlu","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1985002148","eid":"W1985002148"},{"id":"paper-w2978603557","cat":"papers","name":"Randomized controlled trial of gonadotropin‐releasing hormone agonist microdose flare‐up versus flare‐up among poor responders undergoing intracytoplasmic sperm injection","year":"2019","cit":17,"pfa":"Firouzeh Ghaffari","psa":"Mohammad Chehrazi","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2978603557","eid":"W2978603557"},{"id":"paper-w4410461651","cat":"papers","name":"Role of selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors and psychedelics in the treatment of major depressive disorder: A perspective on mechanistic insight and current status","year":"2025","cit":17,"pfa":"Niharika Singh","psa":"Anil Kumar Mishra","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4410461651","eid":"W4410461651"},{"id":"paper-w2342676877","cat":"papers","name":"A double-tracer technique to characterize absorption, distribution, metabolism and excretion (ADME) of [14C]-basimglurant and absolute bioavailability after oral administration and concomitant intravenous microdose admin","year":"2016","cit":17,"pfa":"Elena Guerini","psa":"Navita L. Mallalieu","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2342676877","eid":"W2342676877"},{"id":"paper-w2095451976","cat":"papers","name":"Acquisition of brightness discrimination in the rat is impaired by opiates with psychotomimetic properties","year":"1983","cit":17,"pfa":"A TANG","psa":"S FRANKLIN","ptype":"article","src":"https://openalex.org/W2095451976","eid":"W2095451976"},{"id":"paper-w1985876221","cat":"papers","name":"Ring-substituted β-methoxyphenethylamines: a new class of psychotomimetic agents active in man","year":"1985","cit":17,"pfa":"D Lemaire","psa":"Alexander T. Shulgin","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1985876221","eid":"W1985876221"},{"id":"paper-w2022600566","cat":"papers","name":"QSAR study with steric (MTD), electronic and hydrophobicity parameters on psychotomimetic phenylalkylamines","year":"1996","cit":17,"pfa":"Maria Mracec","psa":"Gábor Náray‐Szabó","ptype":"article","src":"https://openalex.org/W2022600566","eid":"W2022600566"},{"id":"paper-w3194934992","cat":"papers","name":"Opposite Roles for Cannabidiol and δ-9-Tetrahydrocannabinol in Psychotomimetic Effects of Cannabis Extracts","year":"2021","cit":17,"pfa":"Alberto Sainz-Cort","psa":"José Carlos Bouso","ptype":"article","src":"https://openalex.org/W3194934992","eid":"W3194934992"},{"id":"paper-w2056369802","cat":"papers","name":"Differential involvement of 5-HT projections within the amygdala in prepulse inhibition but not in psychotomimetic drug-induced hyperlocomotion","year":"2005","cit":17,"pfa":"Snezana Kusljic","psa":"Maarten van den Buuse","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2056369802","eid":"W2056369802"},{"id":"paper-w2093942415","cat":"papers","name":"The selective 5-HT6 receptor antagonist Ro 04-6790 attenuates psychotomimetic effects of the NMDA receptor antagonist MK-801","year":"2007","cit":17,"pfa":"Nikolaos Pitsikas","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2093942415","eid":"W2093942415"},{"id":"paper-w3005792611","cat":"papers","name":"Oral Yohimbine as a New Probe Drug to Predict CYP2D6 Activity: Results of a Fixed-Sequence Phase I Trial","year":"2020","cit":17,"pfa":"Manuela Vay","psa":"Gerd Mikus","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3005792611","eid":"W3005792611"},{"id":"paper-w2053886001","cat":"papers","name":"Visual Disturbances Experienced by Hallucinogenic Drug Abusers While Driving","year":"1970","cit":17,"pfa":"GEORGE E. WOODY","ptype":"article","src":"https://openalex.org/W2053886001","eid":"W2053886001"},{"id":"paper-w2052654582","cat":"papers","name":"N-acetylcysteine modulates hallucinogenic 5-HT2A receptor agonist-mediated responses: Behavioral, molecular, and electrophysiological studies","year":"2014","cit":17,"pfa":"Mei-Yi Lee","psa":"Hwei‐Hsien Chen","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2052654582","eid":"W2052654582"},{"id":"paper-w4281722184","cat":"papers","name":"Substance-Related and Addictive Disorders","year":"2022","cit":17,"topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"book-chapter","src":"https://openalex.org/W4281722184","eid":"W4281722184"},{"id":"paper-w2154618767","cat":"papers","name":"Intensive ketamine use for multiple years: A case report","year":"2015","cit":17,"pfa":"James X. Liu","psa":"Stephen Ross","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2154618767","eid":"W2154618767"},{"id":"paper-w3130459257","cat":"papers","name":"The selective 5-HT2A receptor agonist 25CN-NBOH does not affect reversal learning in mice","year":"2021","cit":17,"pfa":"Anna U. Odland","psa":"Jesper Tobias Andreasen","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3130459257","eid":"W3130459257"},{"id":"paper-w2046527784","cat":"papers","name":"The use of Reserpine in Chronic Psychotic Patients: A Controlled Trial","year":"1956","cit":17,"pfa":"Lorna Wing","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2046527784","eid":"W2046527784"},{"id":"paper-w2345327834","cat":"papers","name":"Treatment with rilpivirine does not alter plasma concentrations of the CYP3A substrates tadalafil and midazolam in humans","year":"2016","cit":17,"pfa":"Nicolas Hohmann","psa":"Walter E. Haefeli","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2345327834","eid":"W2345327834"},{"id":"paper-w2088674060","cat":"papers","name":"The Apolipoprotein E ε4 Allele Is Associated with Blunting of Ketamine-Induced Psychosis in Schizophrenia A Preliminary Report","year":"1998","cit":17,"pfa":"Anil K. Malhotra","ptype":"article","src":"https://openalex.org/W2088674060","eid":"W2088674060"},{"id":"paper-w2724660305","cat":"papers","name":"Differences in the Rates of Drug Polyconsumption and Psychiatric Comorbidity among Patients with Cocaine Use Disorders According to the Mental Health Service","year":"2017","cit":17,"pfa":"Pedro Fernando Araos","psa":"Fernando Rodrı́guez de Fonseca","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2724660305","eid":"W2724660305"},{"id":"paper-w1984194629","cat":"papers","name":"Predictors of Illicit Substance Dependence Among Individuals With Alcohol Dependence","year":"2009","cit":17,"pfa":"Nicole D. Sintov","psa":"Carol Arlene Prescott","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1984194629","eid":"W1984194629"},{"id":"paper-w4297338201","cat":"papers","name":"Non-sedative cortical EEG signatures of allopregnanolone and functional comparators","year":"2022","cit":17,"pfa":"Peter M. Lambert","psa":"Steven J. Mennerick","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4297338201","eid":"W4297338201"},{"id":"paper-w3130772182","cat":"papers","name":"Effects of ketamine on brain function during metacognition of episodic memory","year":"2021","cit":17,"pfa":"Mirko Lehmann","psa":"Ulrich Ettinger","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3130772182","eid":"W3130772182"},{"id":"paper-w2151943902","cat":"papers","name":"Taste Thresholds in Drug Addicts and Alcoholics","year":"1972","cit":17,"pfa":"Stephen E. P. Smith","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2151943902","eid":"W2151943902"},{"id":"paper-w4385690337","cat":"papers","name":"Governing therapeutic pluralism: An environmental scan of the statutory regulation and government reimbursement of traditional and complementary medicine practitioners in the United States","year":"2023","cit":17,"pfa":"Nadine Ijaz","psa":"Heather Carrie","topics":["Safety & adverse events","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4385690337","eid":"W4385690337"},{"id":"paper-w2106995394","cat":"papers","name":"Neuroprotective and Antiepileptic Activities of Ketamine in Nerve Agent Poisoning","year":"2003","cit":17,"pfa":"Georges Mion","psa":"Michel Ruttimann","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2106995394","eid":"W2106995394"},{"id":"paper-w1549179580","cat":"papers","name":"Different modulation of the binding to two phencyclidine (PCP) receptor subtypes: Effects of N- agonists and antagonists","year":"1989","cit":17,"pfa":"Yossef Itzhak","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1549179580","eid":"W1549179580"},{"id":"paper-w1978362179","cat":"papers","name":"Relationships Between the Structure of Dexoxadrol and Etoxadrol Analogues and their NMDA Receptor Affinity","year":"2006","cit":17,"pfa":"Michael Sax","psa":"Bernhard Wünsch","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1978362179","eid":"W1978362179"},{"id":"paper-w1725693380","cat":"papers","name":"Chronic estrogen and progesterone treatment inhibits ketamine-induced disruption of prepulse inhibition in rats","year":"2015","cit":17,"pfa":"Maarten van den Buuse","psa":"Andrea Gogos","ptype":"article","src":"https://openalex.org/W1725693380","eid":"W1725693380"},{"id":"paper-w4200025881","cat":"papers","name":"Repeated, low-dose oral esketamine in patients with treatment-resistant depression: pilot study","year":"2021","cit":17,"pfa":"Sanne Y. Smith-Apeldoorn","psa":"Robert A. Schoevers","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4200025881","eid":"W4200025881"},{"id":"paper-w2121473387","cat":"papers","name":"Sensitivity to MK-801 in phospholipase C-β1 knockout mice reveals a specific NMDA receptor deficit","year":"2009","cit":17,"pfa":"Laura J. Gray","psa":"Anthony John Hannan","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2121473387","eid":"W2121473387"},{"id":"paper-w1997123557","cat":"papers","name":"Subanalgesic ketamine enhances morphine-induced antinociceptive activity without cortical dysfunction in rats","year":"2013","cit":17,"pfa":"Hiroki Shikanai","psa":"Hiroko Togashi","ptype":"article","src":"https://openalex.org/W1997123557","eid":"W1997123557"},{"id":"paper-w2805569754","cat":"papers","name":"A review of ketamine’s role in ECT and non-ECT settings","year":"2018","cit":17,"pfa":"Vytautas Jankauskas","psa":"Pierre S. Chue","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2805569754","eid":"W2805569754"},{"id":"paper-w3099810950","cat":"papers","name":"P2X7 Receptor-Dependent Layer-Specific Changes in Neuron-Microglia Reactivity in the Prefrontal Cortex of a Phencyclidine Induced Mouse Model of Schizophrenia","year":"2020","cit":17,"pfa":"Stefano Calovi","psa":"Beáta Sperlágh","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3099810950","eid":"W3099810950"},{"id":"paper-w1981671807","cat":"papers","name":"Subanesthetic Ketamine for Cancer Pain: By Insisting on Level I/II Evidence, Do We Risk Throwing the Baby Out with the Bath Water?","year":"2005","cit":17,"pfa":"Kate Jackson","psa":"Colin S. Goodchild","topics":["Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1981671807","eid":"W1981671807"},{"id":"paper-w2779471433","cat":"papers","name":"Is Metabolism of (R)-Ketamine Essential for the Antidepressant Effects?","year":"2017","cit":17,"pfa":"Shigeyuki Chaki","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2779471433","eid":"W2779471433"},{"id":"paper-w4401835033","cat":"papers","name":"Ketamine and Esketamine for Depression in Daily Practice","year":"2024","cit":17,"pfa":"Balwinder Singh","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4401835033","eid":"W4401835033"},{"id":"paper-w4283788603","cat":"papers","name":"Antinociceptive and Analgesic Effects of (2 R,6 R)-Hydroxynorketamine","year":"2022","cit":17,"pfa":"Jonathan G. Yost","psa":"Irwin Lucki","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4283788603","eid":"W4283788603"},{"id":"paper-w2756392486","cat":"papers","name":"Simple Enantioselective Syntheses of (2R,6R)-Hydroxynorketamine and Related Potential Rapid-Onset Antidepressants","year":"2017","cit":17,"pfa":"Yi-Xin Han","psa":"Elias James Corey","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2756392486","eid":"W2756392486"},{"id":"paper-w3039531169","cat":"papers","name":"Hydroxynorketamine Blocks N-Methyl-d-Aspartate Receptor Currents by Binding to Closed Receptors","year":"2020","cit":17,"pfa":"Jamie A. Abbott","psa":"Gabriela Popescu","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3039531169","eid":"W3039531169"},{"id":"paper-w3036908632","cat":"papers","name":"Ketamine metabolite (2R,6R)-hydroxynorketamine reverses behavioral despair produced by adolescent trauma","year":"2020","cit":17,"pfa":"Gregory I. Elmer","psa":"Todd D. Gould","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W3036908632","eid":"W3036908632"},{"id":"paper-w3033312729","cat":"papers","name":"Targeted mass spectrometry of ketamine and its metabolites cis-6-hydroxynorketamine and norketamine in human blood serum","year":"2020","cit":17,"pfa":"Lisa Kurzweil","psa":"Sabrina Gensberger‐Reigl","ptype":"article","src":"https://openalex.org/W3033312729","eid":"W3033312729"},{"id":"paper-w4395110993","cat":"papers","name":"Evidence from preclinical and clinical metabolomics studies on the antidepressant effects of ketamine and esketamine","year":"2024","cit":17,"pfa":"Daniele Cavaleri","psa":"Francesco Bartoli","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4395110993","eid":"W4395110993"},{"id":"paper-w4366392927","cat":"papers","name":"Median effective dose of esketamine for intranasal premedication in children with congenital heart disease","year":"2023","cit":17,"pfa":"Jiajia Huang","psa":"Hongbin Gu","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4366392927","eid":"W4366392927"},{"id":"paper-w4310795198","cat":"papers","name":"Efficacy and Safety of Esketamine Combined with Antidepressants for Treatment-Resistant Depression: A Meta-Analysis","year":"2022","cit":17,"pfa":"Peng Liu","psa":"Buhuai Dong","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4310795198","eid":"W4310795198"},{"id":"paper-w4362604605","cat":"papers","name":"Chronic exposure to (2 R,6 R)-hydroxynorketamine induces developmental neurotoxicity in hESC-derived cerebral organoids","year":"2023","cit":17,"pfa":"Zhulin Du","psa":"Xiaotang Fan","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4362604605","eid":"W4362604605"},{"id":"paper-w4383199796","cat":"papers","name":"Preoperative Esketamine Alleviates Postoperative Pain after Endoscopic Plasma Adenotonsillectomy in Children","year":"2023","cit":17,"pfa":"Feng Liu","psa":"Jiang Wu","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4383199796","eid":"W4383199796"},{"id":"paper-w4401556803","cat":"papers","name":"Comparison Between Esketamine and Alfentanil for Hysteroscopy: A Prospective, Double-Blind, Randomized Controlled Trial","year":"2024","cit":17,"pfa":"Mengcao Weng","psa":"Yue Bo Jin","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4401556803","eid":"W4401556803"},{"id":"paper-w4214501787","cat":"papers","name":"The effects of intranasal esketamine on on-road driving performance in patients with major depressive disorder or persistent depressive disorder","year":"2022","cit":17,"pfa":"Francis M. Dijkstra","psa":"Joris C. Verster","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4214501787","eid":"W4214501787"},{"id":"paper-w2798253530","cat":"papers","name":"S114. Efficacy and Safety of Intranasal Esketamine Plus an Oral Antidepressant in Elderly Patients With Treatment-Resistant Depression","year":"2018","cit":17,"pfa":"Rachel Ochs-Ross","psa":"Jaskaran B. Singh","topics":["Depression","Safety & adverse events"],"ptype":"conference-abstract","src":"https://openalex.org/W2798253530","eid":"W2798253530"},{"id":"paper-w4400690252","cat":"papers","name":"Use of Esketamine Nasal Spray in Patients with Treatment‐Resistant Depression in Routine Practice: A Real‐World French Study","year":"2024","cit":17,"pfa":"Ludovic Samalin","psa":"E. Gaudre-Wattinne","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4400690252","eid":"W4400690252"},{"id":"paper-w4392660402","cat":"papers","name":"Efficacy and safety of esketamine for perioperative depression in patients undergoing elective surgery: A meta-analysis of randomized controlled trials","year":"2024","cit":17,"pfa":"Xue-jie Lou","psa":"Jianjun Yang","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4392660402","eid":"W4392660402"},{"id":"paper-w4388347864","cat":"papers","name":"Patient-reported side effects and satisfaction of pre-hospital analgesia with low-dose esketamine: a cross-sectional study","year":"2023","cit":17,"pfa":"David Häske","psa":"Benjamin Schempf","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4388347864","eid":"W4388347864"},{"id":"paper-w4408176333","cat":"papers","name":"Effect of Esketamine on Depressive Symptoms in Adolescents With Major Depressive Disorder at Imminent Suicide Risk: A Randomized Psychoactive-Controlled Study","year":"2025","cit":17,"pfa":"Colette Kosik‐Gonzalez","psa":"Carla M. Canuso","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4408176333","eid":"W4408176333"},{"id":"paper-w4390960876","cat":"papers","name":"Pharmacokinetics and Safety of Esketamine in Chinese Patients Undergoing Painless Gastroscopy in Comparison with Ketamine: A Randomized, Open-Label Clinical Study","year":"2019","cit":17,"pfa":"Jie Wang","psa":"Pei Q","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4390960876","eid":"W4390960876"},{"id":"paper-w4301370539","cat":"papers","name":"Characteristics of Real-world Commercially Insured Patients With Treatment-resistant Depression Initiated on Esketamine Nasal Spray or Conventional Therapies in the United States","year":"2022","cit":17,"pfa":"Swapna U. Karkare","psa":"Kruti Joshi","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4301370539","eid":"W4301370539"},{"id":"paper-w4412658277","cat":"papers","name":"Effectiveness of repeated Esketamine nasal spray administration on anhedonic symptoms in treatment-resistant bipolar and unipolar depression: A secondary analysis from the REAL-ESK study group","year":"2025","cit":17,"pfa":"Giacomo d’Andrea","psa":"Giovanni Martinotti","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4412658277","eid":"W4412658277"},{"id":"paper-w4399785192","cat":"papers","name":"Esketamine Combined with Dexmedetomidine to reduce Visceral Pain During elective Cesarean Section Under Combined Spinal-Epidural Anesthesia: A double-Blind Randomized Controlled Study","year":"2024","cit":17,"pfa":"Ji-Rong Yang","psa":"Pinjie Huang","ptype":"article","src":"https://openalex.org/W4399785192","eid":"W4399785192"},{"id":"paper-w4407271121","cat":"papers","name":"Improvements in functioning and workplace productivity with esketamine nasal spray versus quetiapine extended release in patients with treatment resistant depression: Findings from a 32-week randomised, open-label, rater","year":"2025","cit":17,"pfa":"Eduard Vieta","psa":"Benoît Rive","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4407271121","eid":"W4407271121"},{"id":"paper-w2301628323","cat":"papers","name":"Subchronic administration of (R,S)-ketamine induces ketamine ring hydroxylation in Wistar rats","year":"2016","cit":17,"pfa":"Ruin Moaddel","psa":"Irving W. Wainer","ptype":"article","src":"https://openalex.org/W2301628323","eid":"W2301628323"},{"id":"paper-w3211663360","cat":"papers","name":"Interpretation of the Montgomery–Åsberg Depression Rating Scale (MADRS)","year":"2021","cit":17,"pfa":"Susan Paketci","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3211663360","eid":"W3211663360"},{"id":"paper-w4402554991","cat":"papers","name":"Opioid-free anesthesia improves postoperative recovery quality of small and medium-sized surgery: a prospective, randomized controlled study","year":"2024","cit":17,"pfa":"Pei Wang","psa":"Wei Feng","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4402554991","eid":"W4402554991"},{"id":"paper-w4366242871","cat":"papers","name":"The diagnosis and treatment of unipolar depression—National Disease Management Guideline","year":"2023","cit":17,"pfa":"Martin Christian Härter","psa":"Peggy Prien","topics":["Depression","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4366242871","eid":"W4366242871"},{"id":"paper-w4393440396","cat":"papers","name":"Clinical characteristics and treatment exposure of patients with marked treatment-resistant unipolar major depressive disorder: A RECOVER trial report","year":"2024","cit":17,"pfa":"Charles R. Conway","psa":"Augustus John Rush","topics":["Depression","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4393440396","eid":"W4393440396"},{"id":"paper-w2048935643","cat":"papers","name":"Molecular determinants for binding of methylenedioxytryptamines at 5-HT/LSD receptors","year":"1981","cit":17,"pfa":"Patricia H. Reggio","psa":"Sid Topiol","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2048935643","eid":"W2048935643"},{"id":"paper-w2092677864","cat":"papers","name":"[125I]LSD binding to serotonin and dopamine receptors in bovine caudate membranes","year":"1985","cit":17,"pfa":"Paul R. Hartig","psa":"Doris A. Stoffers","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2092677864","eid":"W2092677864"},{"id":"paper-w2115155001","cat":"papers","name":"Increased Serotonin Receptor Density and Platelet GPIIb/IIIa Activation Among Smokers","year":"1999","cit":17,"pfa":"Jerome H. Markovitz","psa":"Suzan E. Winders","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2115155001","eid":"W2115155001"},{"id":"paper-w1973622069","cat":"papers","name":"ANALOGUES OF PSILOCIN AND LYSERGIC ACID DIETHYLAMIDE I. CHLORO, NITRO, AND AMINO DERIVATIVES OF 3-SUBSTITUTED INDOLES","year":"1963","cit":16,"pfa":"J. B. McKay","psa":"Wilfred A. Skinner","ptype":"article","src":"https://openalex.org/W1973622069","eid":"W1973622069"},{"id":"paper-w2409688628","cat":"papers","name":"Theoretical Studies on the Conformations of Psilocin and Mescaline","year":"1973","cit":16,"pfa":"Sungzong Kang","psa":"Jack Green","ptype":"article","src":"https://openalex.org/W2409688628","eid":"W2409688628"},{"id":"paper-w2162861328","cat":"papers","name":"ANTAGONISM OF LYSERGIC ACID DIETHYLAMIDE (LSD)-INDUCED HYPERTHERMIA","year":"1962","cit":16,"pfa":"John T. Elder","psa":"M. Kent Shellenberger","ptype":"article","src":"https://openalex.org/W2162861328","eid":"W2162861328"},{"id":"paper-w1976811656","cat":"papers","name":"Mental age Regression Induced by Lysergic Acid Diethylamide","year":"1966","cit":16,"pfa":"Gustav Adolf Lienert","ptype":"article","src":"https://openalex.org/W1976811656","eid":"W1976811656"},{"id":"paper-w2411018828","cat":"papers","name":"BROM-LYSERGIC ACID DIETHYLAMIDE: A HIGHLY POTENT SEROTONIN ANTAGONIST","year":"1956","cit":16,"pfa":"Lauro Sollero","psa":"G. C. Salmoiraghi","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2411018828","eid":"W2411018828"},{"id":"paper-w2000701936","cat":"papers","name":"Lysergic Acid Diethylamide (Lsd-25): Xxii. Effect on Transference","year":"1956","cit":16,"pfa":"Harold A. Abramson","ptype":"article","src":"https://openalex.org/W2000701936","eid":"W2000701936"},{"id":"paper-w2313621059","cat":"papers","name":"Effect of Lysergic Acid Diethylamide and Bufotenine on Performance of Trained Rats","year":"1959","cit":16,"pfa":"Delmar J. Mahler","psa":"Fred L. Humoller","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2313621059","eid":"W2313621059"},{"id":"paper-w2060182841","cat":"papers","name":"A comparison of 2,3-dihydro-lysergic acid diethylamide with LSD-25","year":"1964","cit":16,"pfa":"Charles W. Gorodetzky","psa":"Harris Isbell","ptype":"article","src":"https://openalex.org/W2060182841","eid":"W2060182841"},{"id":"paper-w4412553224","cat":"papers","name":"Complex slow waves in the human brain under 5-MeO-DMT","year":"2025","cit":16,"pfa":"George Blackburne","psa":"Jeremy I Skipper","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4412553224","eid":"W4412553224"},{"id":"paper-w2085948646","cat":"papers","name":"A REVIEW OF BIOCHEMICAL CHANGES INDUCED IN VIVO BY LYSERGIC ACID DIETHYLAMIDE AND SIMILAR DRUGS","year":"1957","cit":16,"pfa":"Hudson Hoagland","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2085948646","eid":"W2085948646"},{"id":"paper-w2088667762","cat":"papers","name":"LYSERGIC ACID DIETHYLAMIDE TARTRATE (LSD-25) DOSAGE LEVELS, GROUP DIFFERENCES, AND SOCIAL INTERACTION","year":"1971","cit":16,"pfa":"Frances E. Cheek","psa":"Carolyn M. Holstein","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2088667762","eid":"W2088667762"},{"id":"paper-w2014458542","cat":"papers","name":"Lysergic Acid Diethylamide (LSD-25): VII. Effect upon Two Measures of Motor Performance","year":"1955","cit":16,"pfa":"Harold A. Abramson","psa":"M. W. Hirsch","ptype":"article","src":"https://openalex.org/W2014458542","eid":"W2014458542"},{"id":"paper-w2143054520","cat":"papers","name":"DISAGGREGATION OF POLYSOMES IN FETAL ORGANS AND MATERNAL BRAIN AFTER ADMINISTRATION OF d‐LYSERGIC ACID DIETHYLAMIDE IN VIVO","year":"1979","cit":16,"pfa":"John J. Heikkila","psa":"Ian R. Brown","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2143054520","eid":"W2143054520"},{"id":"paper-w4389341784","cat":"papers","name":"An Overview on the Hallucinogenic Peyote and Its Alkaloid Mescaline: The Importance of Context, Ceremony and Culture","year":"2023","cit":16,"pfa":"Marjolein Doesburg-van Kleffens","psa":"Carsten Gründemann","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4389341784","eid":"W4389341784"},{"id":"paper-w2417403727","cat":"papers","name":"Studies on Lysergic Acid Diethylamide and Related Compounds. IV. Syntheses of Various Amide Derivatives of Norlysergic Acid and Related Compounds","year":"1976","cit":16,"pfa":"Tetsukichi Niwaguchi","psa":"Hisashi Ishii","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2417403727","eid":"W2417403727"},{"id":"paper-w4392032661","cat":"papers","name":"Peyote","year":"2016","cit":16,"topics":["Addiction","Policy & ethics"],"ptype":"book","src":"https://openalex.org/W4392032661","eid":"W4392032661"},{"id":"paper-w1996804727","cat":"papers","name":"Biosynthesis of peyote alkaloids","year":"1969","cit":16,"pfa":"Ara G. Paul","psa":"Michio Takido","ptype":"article","src":"https://openalex.org/W1996804727","eid":"W1996804727"},{"id":"paper-w2048034902","cat":"papers","name":"Peyotl and Mescaline","year":"1979","cit":16,"pfa":"Weston La Barre","ptype":"article","src":"https://openalex.org/W2048034902","eid":"W2048034902"},{"id":"paper-w650215808","cat":"papers","name":"The peyote dance","year":"1975","cit":16,"pfa":"Antonin Artaud","ptype":"book","src":"https://openalex.org/W650215808","eid":"W650215808"},{"id":"paper-w2917336765","cat":"papers","name":"Syntheses of Post-Iboga Alkaloids","year":"2019","cit":16,"pfa":"Hyeonggeun Lim","psa":"Sunkyu Han","ptype":"article","src":"https://openalex.org/W2917336765","eid":"W2917336765"},{"id":"paper-w2089376449","cat":"papers","name":"Hypnagogic Imagery and Mescaline","year":"1956","cit":16,"pfa":"J. Amor Ardis","psa":"Peter McKellar","ptype":"article","src":"https://openalex.org/W2089376449","eid":"W2089376449"},{"id":"paper-w1573609629","cat":"papers","name":"Chapter 9 Sigma receptors and iboga alkaloids","year":"2001","cit":16,"pfa":"Wayne D. Bowen","topics":["Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W1573609629","eid":"W1573609629"},{"id":"paper-w2032282436","cat":"papers","name":"Synthesis of new series of iboga analogues","year":"2011","cit":16,"pfa":"Sibasish Paul","psa":"Surajit Sinha","ptype":"article","src":"https://openalex.org/W2032282436","eid":"W2032282436"},{"id":"paper-w1967197768","cat":"papers","name":"Chiroptical investigations on the iboga and voacanga alkaloids","year":"1974","cit":16,"pfa":"K. Bláha","psa":"Jan Trojánek","ptype":"article","src":"https://openalex.org/W1967197768","eid":"W1967197768"},{"id":"paper-w1995987482","cat":"papers","name":"Mescaline and shock induced aggression in rats","year":"1974","cit":16,"pfa":"Robert J. Sbordone","psa":"Brooks Carder","ptype":"article","src":"https://openalex.org/W1995987482","eid":"W1995987482"},{"id":"paper-w2411165735","cat":"papers","name":"[Presence of mescaline in a Peruvian Cactaceae].","year":"1960","cit":16,"pfa":"Jacques E. Poisson","ptype":"article","src":"https://openalex.org/W2411165735","eid":"W2411165735"},{"id":"paper-w4394722301","cat":"papers","name":"The potential of 5‐methoxy‐ N,N ‐dimethyltryptamine in the treatment of alcohol use disorder: A first look at therapeutic mechanisms of action","year":"2024","cit":16,"pfa":"Stephan C. Tap","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4394722301","eid":"W4394722301"},{"id":"paper-w2093249512","cat":"papers","name":"Peyote Alkaloids: Identification in the Mexican Cactus Pelecyphora aselliformis Ehrenberg","year":"1972","cit":16,"pfa":"John M. Neal","psa":"Jerry L. McLaughlin","ptype":"article","src":"https://openalex.org/W2093249512","eid":"W2093249512"},{"id":"paper-w1979789914","cat":"papers","name":"Effect of mescaline on single cortical neurones","year":"1971","cit":16,"pfa":"C. M. Bradshaw","psa":"E. Szabadi","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1979789914","eid":"W1979789914"},{"id":"paper-w1975517351","cat":"papers","name":"Enantioselective Access to Key Intermediates for Salvinorin A and Analogues","year":"2011","cit":16,"pfa":"Don Antoine Lanfranchi","psa":"Gilles Hanquet","ptype":"article","src":"https://openalex.org/W1975517351","eid":"W1975517351"},{"id":"paper-w4415929140","cat":"papers","name":"Psilocybin Outside the Clinic","year":"2025","cit":16,"pfa":"Kent E. Hutchison","psa":"Hollis C. Karoly","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4415929140","eid":"W4415929140"},{"id":"paper-w1975121253","cat":"papers","name":"Effects of Δ9-tetrahydrocannabinol and mescaline on self-stimulation","year":"1972","cit":16,"pfa":"P.T. Bailey","psa":"S.N. Pradhan","ptype":"article","src":"https://openalex.org/W1975121253","eid":"W1975121253"},{"id":"paper-w2335758210","cat":"papers","name":"Notes: The Presence of Mescaline in Opuntia cylindrica","year":"1960","cit":16,"pfa":"William B. Turner","psa":"Jack Heyman","ptype":"article","src":"https://openalex.org/W2335758210","eid":"W2335758210"},{"id":"paper-w2469454758","cat":"papers","name":"N,N-dimethyltryptamine--a possible relationship to schizophrenia?","year":"1974","cit":16,"pfa":"Richard Jed Wyatt","psa":"Robert W. Walker","ptype":"article","src":"https://openalex.org/W2469454758","eid":"W2469454758"},{"id":"paper-w3159853265","cat":"papers","name":"A Qualitative Study of Intention and Impact of Ayahuasca Use by Westerners","year":"2021","cit":16,"pfa":"Geoff J. Bathje","psa":"London C. Hill","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3159853265","eid":"W3159853265"},{"id":"paper-w1527485375","cat":"papers","name":"Oxidative metabolism of mescaline in the central nervous system—IV","year":"1974","cit":16,"pfa":"Nikolaus Seiler","psa":"L. Demisch","ptype":"article","src":"https://openalex.org/W1527485375","eid":"W1527485375"},{"id":"paper-w2912341771","cat":"papers","name":"Morphing of Ibogaine: A Successful Attempt into the Search for Sigma-2 Receptor Ligands","year":"2019","cit":16,"pfa":"Giuseppe Floresta","psa":"Emanuele Amata","topics":["Addiction","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2912341771","eid":"W2912341771"},{"id":"paper-w2000035627","cat":"papers","name":"Persistent sensitisation to the locomotor activating effects of MDMA following MDMA self-administration in rats","year":"2015","cit":16,"pfa":"Susan Schenk","psa":"Sarah Bradbury","ptype":"article","src":"https://openalex.org/W2000035627","eid":"W2000035627"},{"id":"paper-w1983348446","cat":"papers","name":"Occurrence of psilocybin in the sporophores of Psilocybe semilanceata","year":"1969","cit":16,"pfa":"Peter G. Mantle","psa":"Eric S. Waight","ptype":"article","src":"https://openalex.org/W1983348446","eid":"W1983348446"},{"id":"paper-w1976062208","cat":"papers","name":"Effects of N, N-Dimethyltryptamine on behavioural habituation in the rat","year":"1977","cit":16,"pfa":"Sandra E. File","ptype":"article","src":"https://openalex.org/W1976062208","eid":"W1976062208"},{"id":"paper-w2058775684","cat":"papers","name":"Structure and absolute configuration of (+)-coronaridine hydrobromide. Absolute configuration of the Iboga alkaloids","year":"1973","cit":16,"pfa":"J. P. KUTNEY","psa":"Chunhua Wei","ptype":"article","src":"https://openalex.org/W2058775684","eid":"W2058775684"},{"id":"paper-w1987014266","cat":"papers","name":"Interconversion of Corynanthe, aspidosperma, and Iboga alkaloids. A model for indole alkaloid biosynthesis","year":"1968","cit":16,"pfa":"Asaf A. Qureshi","psa":"A. Ian Scott","ptype":"article","src":"https://openalex.org/W1987014266","eid":"W1987014266"},{"id":"paper-w3042432283","cat":"papers","name":"Ibogaine therapy for addiction: Consumer views from online fora","year":"2020","cit":16,"pfa":"Michaela Barber","psa":"Adrian Carter","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W3042432283","eid":"W3042432283"},{"id":"paper-w4313855425","cat":"papers","name":"Acute psilocybin enhances cognitive flexibility in rats","year":"2023","cit":16,"pfa":"Alejandro Torrado Pacheco","psa":"Bita Moghaddam","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4313855425","eid":"W4313855425"},{"id":"paper-w1925497939","cat":"papers","name":"“Herbal seizures” – atypical symptoms after ibogaine intoxication: a case report","year":"2015","cit":16,"pfa":"Lorenz Breuer","psa":"Helge Müller","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1925497939","eid":"W1925497939"},{"id":"paper-w2138275101","cat":"papers","name":"Internet-purchased ibogaine toxicity confirmed with serum, urine, and product content levels","year":"2014","cit":16,"pfa":"Charles W. O'Connell","psa":"Binh T. Ly","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2138275101","eid":"W2138275101"},{"id":"paper-w1986492765","cat":"papers","name":"Palladium-Catalyzed Transformations of Salvinorin A, a Neoclerodane Diterpene from Salvia divinorum","year":"2013","cit":16,"pfa":"Andrew P. Riley","psa":"Thomas Edward Prisinzano","ptype":"article","src":"https://openalex.org/W1986492765","eid":"W1986492765"},{"id":"paper-w2955233360","cat":"papers","name":"Examination of Recreational and Spiritual Peyote Use Among American Indian Youth","year":"2019","cit":16,"pfa":"Mark A. Prince","psa":"Randall C. Swaim","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2955233360","eid":"W2955233360"},{"id":"paper-w2055210452","cat":"papers","name":"Buying Ayahuasca and other entheogens online: A word of caution","year":"2008","cit":16,"pfa":"Phil Dalgarno","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2055210452","eid":"W2055210452"},{"id":"paper-w2751131870","cat":"papers","name":"Ayahuasca: what mental health professionals need to know","year":"2017","cit":16,"pfa":"RAFAEL GUIMARÃES DOS SANTOS","psa":"Jaime E. C. Hallak","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2751131870","eid":"W2751131870"},{"id":"paper-w2888882656","cat":"papers","name":"It’s Tea Time: Interference of Ayahuasca Brew on Discriminative Learning in Zebrafish","year":"2018","cit":16,"pfa":"Bruno Lobão Soares","psa":"Ana Carolina Luchiari","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2888882656","eid":"W2888882656"},{"id":"paper-w4391522039","cat":"papers","name":"Effects of Ayahuasca on Gratitude and Relationships with Nature: A Prospective, Naturalistic Study","year":"2024","cit":16,"pfa":"Jacob S. Aday","psa":"Christopher C. Davoli","ptype":"article","src":"https://openalex.org/W4391522039","eid":"W4391522039"},{"id":"paper-w3216485471","cat":"papers","name":"Psilocybin for the Treatment of Depression: A Promising New Pharmacotherapy Approach","year":"2021","cit":16,"pfa":"Gabrielle Agin-Liebes","psa":"Alan K. Davis","topics":["Depression"],"ptype":"book-chapter","src":"https://openalex.org/W3216485471","eid":"W3216485471"},{"id":"paper-w2980466947","cat":"papers","name":"Ibogaine Consumption With Seizure-Like Episodes, QTc-Prolongation, and Captured Cardiac Dysrhythmias","year":"2019","cit":16,"pfa":"James Grogan","psa":"Louise W. Kao","ptype":"article","src":"https://openalex.org/W2980466947","eid":"W2980466947"},{"id":"paper-w4399917337","cat":"papers","name":"Increased reactivity of the paraventricular nucleus of the hypothalamus and decreased threat responding in male rats following psilocin administration","year":"2024","cit":16,"pfa":"Devin P. Effinger","psa":"Melissa A. Herman","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4399917337","eid":"W4399917337"},{"id":"paper-w2114183716","cat":"papers","name":"MDMA for the treatment of mood disorder: all talk no substance?","year":"2015","cit":16,"pfa":"Rachel Patel","psa":"Daniel Titheradge","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2114183716","eid":"W2114183716"},{"id":"paper-w4210936573","cat":"papers","name":"Receptor Interaction Profiles of 4-Alkoxy-3,5-Dimethoxy-Phenethylamines (Mescaline Derivatives) and Related Amphetamines","year":"2022","cit":16,"pfa":"Karolina E. Kolaczynska","psa":"Matthias E. Liechti","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4210936573","eid":"W4210936573"},{"id":"paper-w4386638078","cat":"papers","name":"Bringing Psychedelics and Entactogens into Mainstream Pharmaceuticals: A Focus on MDMA","year":"2019","cit":16,"pfa":"Anne C. Wagner","psa":"Rick Doblin","topics":["Safety & adverse events"],"ptype":"other","src":"https://openalex.org/W4386638078","eid":"W4386638078"},{"id":"paper-w3034540273","cat":"papers","name":"Methamphetamine, Amphetamine, and MDMA Use and Emergency Department Recidivism","year":"2020","cit":16,"pfa":"John R. Richards","psa":"Erik G. Laurin","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3034540273","eid":"W3034540273"},{"id":"paper-w2079389558","cat":"papers","name":"Detection of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) by displacement of antibodies","year":"2011","cit":16,"pfa":"Inger Vikholm‐Lundin","psa":"Ann-Charlotte Hellgren","ptype":"article","src":"https://openalex.org/W2079389558","eid":"W2079389558"},{"id":"paper-w3137525876","cat":"papers","name":"Vegetative value: promissory horizons of therapeutic innovation in the global circulation of ayahuasca","year":"2021","cit":16,"pfa":"Emilia Sanabria","ptype":"article","src":"https://openalex.org/W3137525876","eid":"W3137525876"},{"id":"paper-w2081697885","cat":"papers","name":"The Effects of Sigma, PCP, and Opiate Receptor Ligands in Rats Trained With Ibogaine as a Discriminative Stimulus","year":"1998","cit":16,"pfa":"Scott Helsley","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2081697885","eid":"W2081697885"},{"id":"paper-w4308952246","cat":"papers","name":"Body mass index (BMI) does not predict responses to psilocybin","year":"2022","cit":16,"pfa":"Meg J. Spriggs","psa":"Robin Lester Carhart-Harris","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4308952246","eid":"W4308952246"},{"id":"paper-w2254082902","cat":"papers","name":"Identification of five substituted phenethylamine derivatives 5‐MAPDB, 5‐AEDB, MDMA methylene homolog, 6‐Br‐MDMA, and 5‐APB‐NBOMe","year":"2016","cit":16,"pfa":"Cuimei Liu","psa":"Zhendong Hua","ptype":"article","src":"https://openalex.org/W2254082902","eid":"W2254082902"},{"id":"paper-w2125458123","cat":"papers","name":"Urine adulteration: can bleach be used to mask MDMA use?","year":"2013","cit":16,"pfa":"Annie Pham","psa":"Shanlin Fu","ptype":"article","src":"https://openalex.org/W2125458123","eid":"W2125458123"},{"id":"paper-w150209179","cat":"papers","name":"Ausgeprägte Hyperthermie und Rhabdomyolyse nach Ecstasy (MDMA)-Intoxikation","year":"2003","cit":16,"pfa":"Oliver Kunitz","psa":"Rolf Rossaint","ptype":"article","src":"https://openalex.org/W150209179","eid":"W150209179"},{"id":"paper-w2085688436","cat":"papers","name":"Prior Morphine Exposure Enhances Ibogaine Antagonism of Morphine-induced Dopamine Release in Rats","year":"1996","cit":16,"pfa":"Sandra M. Pearl","psa":"Stanley D. Glick","ptype":"article","src":"https://openalex.org/W2085688436","eid":"W2085688436"},{"id":"paper-w2908351468","cat":"papers","name":"Technologies of the Body in Contemporary Ayahuasca Shamanism in the Peruvian Amazon: Implications for Future Research","year":"2019","cit":16,"pfa":"Evgenia Fotiou","ptype":"article","src":"https://openalex.org/W2908351468","eid":"W2908351468"},{"id":"paper-w4413116494","cat":"papers","name":"N , N -dimethyltryptamine mitigates experimental stroke by stabilizing the blood-brain barrier and reducing neuroinflammation","year":"2025","cit":16,"pfa":"Marcell Janos Laszlo","psa":"Sándor Nardai","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4413116494","eid":"W4413116494"},{"id":"paper-w1595101558","cat":"papers","name":"Prevalence of reported peyote use 1985–2010 effects of the American Indian Religious Freedom Act of 1994","year":"2013","cit":16,"pfa":"Bob Prue","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1595101558","eid":"W1595101558"},{"id":"paper-w2047258794","cat":"papers","name":"Baclofen prevents MDMA-induced rise in core body temperature in rats","year":"2004","cit":16,"pfa":"Sotiria Bexis","psa":"Rodney James Irvine","ptype":"article","src":"https://openalex.org/W2047258794","eid":"W2047258794"},{"id":"paper-w4409449345","cat":"papers","name":"Efficacy and safety of psilocybin for the treatment of substance use disorders: A systematic review","year":"2025","cit":16,"pfa":"Shakila Meshkat","psa":"Venkat Bhat","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4409449345","eid":"W4409449345"},{"id":"paper-w2065367261","cat":"papers","name":"5‐Methoxy‐N,N‐dimethyltryptamine‐induced analgesia is blocked by α‐adrenoceptor antagonists in rats","year":"1986","cit":16,"pfa":"Trevor Archer","psa":"Claes Post","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2065367261","eid":"W2065367261"},{"id":"paper-w2019690678","cat":"papers","name":"Organic impurity profiling of 3,4-methylenedioxymethamphetamine (MDMA) synthesised from catechol","year":"2015","cit":16,"pfa":"Erin Heather","psa":"Andrew M. McDonagh","ptype":"article","src":"https://openalex.org/W2019690678","eid":"W2019690678"},{"id":"paper-w4379094891","cat":"papers","name":"Psilocybin prevents reinstatement of alcohol seeking by disrupting the reconsolidation of alcohol-related memories","year":"2023","cit":16,"pfa":"F. Benvenuti","psa":"Roberto Ciccocioppo","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4379094891","eid":"W4379094891"},{"id":"paper-w2090853772","cat":"papers","name":"Variation in the accumulation levels ofn,n-dimethyltryptamine in micro-propagated trees and inin vitrocultures ofMimosa tenuiflora","year":"2004","cit":16,"pfa":"Pilar Nicasio-Torres","psa":"Marc‐André Fliniaux","ptype":"article","src":"https://openalex.org/W2090853772","eid":"W2090853772"},{"id":"paper-w3203772461","cat":"papers","name":"Psilocybin in the treatment of anorexia nervosa: The English transition of a French 1959 case study","year":"2021","cit":16,"pfa":"Vincent Verroust","psa":"Meg J. Spriggs","ptype":"article","src":"https://openalex.org/W3203772461","eid":"W3203772461"},{"id":"paper-w2116044167","cat":"papers","name":"CoMFA analyses of C-2 position Salvinorin A analogs at the kappa-opioid receptor provides insights into epimer selectivity","year":"2010","cit":16,"pfa":"Donna L. McGovern","psa":"Richard B. Westkaemper","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2116044167","eid":"W2116044167"},{"id":"paper-w2109058455","cat":"papers","name":"Validity of in vivo [I]?-CIT SPECT in detecting MDMA-induced neurotoxicity in rats","year":"2003","cit":16,"pfa":"M DEWIN","psa":"G DENHEETEN","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2109058455","eid":"W2109058455"},{"id":"paper-w3008069770","cat":"papers","name":"Investigation of Ayahuasca β-Carboline Alkaloids and Tryptamine in Sweat Samples from Religious Community Participants by GC-MS","year":"2020","cit":16,"pfa":"Lidiane Silva Tavares","psa":"Bruno Spinosa De Martinis","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3008069770","eid":"W3008069770"},{"id":"paper-w2555536889","cat":"papers","name":"Cognitive and behavioural effects induced by social stress plus MDMA administration in mice","year":"2016","cit":16,"pfa":"María Pilar García-Pardo","psa":"M.A. Aguilar","ptype":"article","src":"https://openalex.org/W2555536889","eid":"W2555536889"},{"id":"paper-w2032051892","cat":"papers","name":"ATG5 Expression Induced by MDMA (Ecstasy), Interferes with Neuronal Differentiation of Neuroblastoma Cells","year":"2009","cit":16,"pfa":"Myounghee Chae","psa":"Seung-Hoon Lee","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2032051892","eid":"W2032051892"},{"id":"paper-w2002520506","cat":"papers","name":"Cognitive Performance in Light Current Users and Ex-Users of Ecstasy (MDMA) and Controls","year":"2007","cit":16,"pfa":"John Foster Golding","psa":"Z. Denton","ptype":"article","src":"https://openalex.org/W2002520506","eid":"W2002520506"},{"id":"paper-w2015427019","cat":"papers","name":"Administration of a non-NMDA antagonist, gyki 52466, increases excitotoxic Purkinje cell degeneration caused by ibogaine","year":"2004","cit":16,"pfa":"Elizabeth O’Hearn","psa":"M.E. Molliver","ptype":"article","src":"https://openalex.org/W2015427019","eid":"W2015427019"},{"id":"paper-w1969295491","cat":"papers","name":"[3H]3,4-Methylenedioxymethamphetamine (MDMA) interactions with brain membranes and glass fiber filter paper","year":"1987","cit":16,"pfa":"Samuel S.‐H. Wang","psa":"Stephen J. Peroutka","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1969295491","eid":"W1969295491"},{"id":"paper-w4393183693","cat":"papers","name":"Psilocybin enhances insightfulness in meditation: a perspective on the global topology of brain imaging during meditation","year":"2024","cit":16,"pfa":"Berit Singer","psa":"Milan Scheidegger","ptype":"article","src":"https://openalex.org/W4393183693","eid":"W4393183693"},{"id":"paper-w4387638849","cat":"papers","name":"Psilocybin-induced changes in cerebral blood flow are associated with acute and baseline inter-individual differences","year":"2023","cit":16,"pfa":"Nathalie M. Rieser","psa":"Katrin H. Preller","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4387638849","eid":"W4387638849"},{"id":"paper-w4361267829","cat":"papers","name":"Validated portable device for the qualitative and quantitative electrochemical detection of MDMA ready for on-site use","year":"2023","cit":16,"pfa":"Robin Van Echelpoel","psa":"Karolien De Wael","ptype":"article","src":"https://openalex.org/W4361267829","eid":"W4361267829"},{"id":"paper-w2016216250","cat":"papers","name":"Hydrolysis of 3,4-methylenedioxymethamphetamine (MDMA) metabolite conjugates in human, squirrel monkey, and rat plasma","year":"2009","cit":16,"pfa":"Melanie Mueller","psa":"Hans H. Maurer","ptype":"article","src":"https://openalex.org/W2016216250","eid":"W2016216250"},{"id":"paper-w2076516462","cat":"papers","name":"Surviving life-threatening MDMA (3,4-methylenedioxymethamphetamine, ecstasy) toxicity caused by ritonavir (RTV)","year":"2012","cit":16,"pfa":"Esther Papaseit","psa":"Joan Nolla","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2076516462","eid":"W2076516462"},{"id":"paper-w1978681282","cat":"papers","name":"MDMA: further evidence that its action in the medial prefrontal cortex is mediated by the serotonergic system","year":"1991","cit":16,"pfa":"Helen S. Pan","psa":"Rex Y. Wang","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1978681282","eid":"W1978681282"},{"id":"paper-w3203215442","cat":"papers","name":"Self-reported PTSD is associated with increased use of MDMA in adolescents with substance use disorders","year":"2021","cit":16,"pfa":"Lukas Andreas Basedow","psa":"Yulia Golub","topics":["PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W3203215442","eid":"W3203215442"},{"id":"paper-w2055479889","cat":"papers","name":"Looking for prosocial genes: ITRAQ analysis of proteins involved in MDMA-induced sociability in mice","year":"2014","cit":16,"pfa":"Konstantin B. Kuteykin‐Teplyakov","psa":"Rafaël Maldonado","ptype":"article","src":"https://openalex.org/W2055479889","eid":"W2055479889"},{"id":"paper-w4295449270","cat":"papers","name":"A Research Domain Criteria (RDoC)-Guided Dashboard to Review Psilocybin Target Domains: A Systematic Review","year":"2022","cit":16,"pfa":"Niloufar Pouyan","psa":"Roger S. McIntyre","topics":["Mechanism & neuroscience","Reviews & meta-analyses","Policy & ethics"],"ptype":"review","src":"https://openalex.org/W4295449270","eid":"W4295449270"},{"id":"paper-w2172054723","cat":"papers","name":"Differentiation of MDMA or 5-MeO-DIPT induced cognitive deficits in rat following adolescent exposure.","year":"2011","cit":16,"pfa":"David M. Compton","psa":"Peter Otero","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2172054723","eid":"W2172054723"},{"id":"paper-w4224751771","cat":"papers","name":"The Effects of Psilocybin in Adults with Major Depressive Disorder and the General Population: Findings from Neuroimaging Studies","year":"2022","cit":16,"pfa":"Hartej Gill","psa":"Roger S. McIntyre","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4224751771","eid":"W4224751771"},{"id":"paper-w2472027187","cat":"papers","name":"Exploring functional data analysis and wavelet principal component analysis on ecstasy (MDMA) wastewater data","year":"2016","cit":16,"pfa":"Stefania Salvatore","psa":"Jo Røislien","ptype":"article","src":"https://openalex.org/W2472027187","eid":"W2472027187"},{"id":"paper-w2090935821","cat":"papers","name":"Intermittent prenatal MDMA exposure alters physiological but not mood related parameters in adult rat offspring","year":"2009","cit":16,"pfa":"Csaba Ádori","psa":"György Bagdy","ptype":"article","src":"https://openalex.org/W2090935821","eid":"W2090935821"},{"id":"paper-w4399729525","cat":"papers","name":"Non-hallucinogenic compounds derived from iboga alkaloids alleviate neuropathic and visceral pain in mice through a mechanism involving 5-HT2A receptor activation","year":"2024","cit":16,"pfa":"Hugo Rubén Arias","psa":"Lorenzo Di Cesare Mannelli","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4399729525","eid":"W4399729525"},{"id":"paper-w4280498396","cat":"papers","name":"Alternative Options for Complex, Recurrent Pain States Using Cannabinoids, Psilocybin, and Ketamine: A Narrative Review of Clinical Evidence","year":"2022","cit":16,"pfa":"Amber N. Edinoff","psa":"Alan D. Kaye","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4280498396","eid":"W4280498396"},{"id":"paper-w3134866310","cat":"papers","name":"P.214 (Sub)acute effects of psilocybin on creative cognition: a double-blind, placebo-controlled experimental study","year":"2021","cit":16,"pfa":"Natasha Leigh Mason","psa":"Johannes Gerardus Ramaekers","ptype":"article","src":"https://openalex.org/W3134866310","eid":"W3134866310"},{"id":"paper-w3202659233","cat":"papers","name":"Sub-acute and long-term effects of ayahuasca on mental health and well-being in healthy ceremony attendants: A replication study","year":"2021","cit":16,"pfa":"Kim I. M. van Oorsouw","psa":"Johannes Gerardus Ramaekers","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3202659233","eid":"W3202659233"},{"id":"paper-w2095234249","cat":"papers","name":"Involvement of 5-hydroxytryptamine 5-HT3 serotonergic receptors in the acquisition and reinstatement of the conditioned place preference induced by MDMA","year":"2013","cit":16,"pfa":"C. Roger-Sánchez","psa":"M.A. Aguilar","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2095234249","eid":"W2095234249"},{"id":"paper-w2063648254","cat":"papers","name":"Acute SSRI-induced anxiogenic and brain metabolic effects are attenuated 6 months after initial MDMA-induced depletion","year":"2009","cit":16,"pfa":"Rómeó D. Andó","psa":"György Bagdy","ptype":"article","src":"https://openalex.org/W2063648254","eid":"W2063648254"},{"id":"paper-w2083876519","cat":"papers","name":"Inhibition of neuronal nitric oxide synthase suppresses the maintenance but not the induction of psychomotor sensitization to MDMA (‘Ecstasy’) and p-chloroamphetamine in mice","year":"2003","cit":16,"pfa":"Karen L. Anderson","psa":"Yossef Itzhak","ptype":"article","src":"https://openalex.org/W2083876519","eid":"W2083876519"},{"id":"paper-w1836645280","cat":"papers","name":"Greater sexual risk‐taking in female and male recreational MDMA/ecstasy users compared with alcohol drinkers: a questionnaire study","year":"2015","cit":16,"pfa":"Aimee L. May","psa":"Andrew C. Parrott","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1836645280","eid":"W1836645280"},{"id":"paper-w2033038816","cat":"papers","name":"3,4-Methylenedioxymethamphetamine (MDMA) interacts with therapeutic drugs on CYP3A by inhibition of pregnane X receptor (PXR) activation and catalytic enzyme inhibition","year":"2011","cit":16,"pfa":"Irene Antolino-Lobo","psa":"Majorie B.M. van Duursen","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2033038816","eid":"W2033038816"},{"id":"paper-w2093331399","cat":"papers","name":"Augmentation of serotonin release by sustained exposure to MDMA and methamphetamine in rat organotypic mesencephalic slice cultures containing raphe serotonergic neurons","year":"2008","cit":16,"pfa":"Megumi Higuchi","psa":"Shuji Kaneko","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2093331399","eid":"W2093331399"},{"id":"paper-w1559463547","cat":"papers","name":"Immunohistochemical demonstration of the amphetamine derivatives 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) in human post-mortem brain tissues and the pituitary gland","year":"2003","cit":16,"pfa":"Els A. De Letter","psa":"Michel H A Piette","ptype":"article","src":"https://openalex.org/W1559463547","eid":"W1559463547"},{"id":"paper-w4401700752","cat":"papers","name":"Comparison between Single-Dose and Two-Dose Psilocybin Administration in the Treatment of Major Depression: A Systematic Review and Meta-Analysis of Current Clinical Trials","year":"2024","cit":16,"pfa":"G. Salvetti","psa":"Mattia Ferro","topics":["Depression","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4401700752","eid":"W4401700752"},{"id":"paper-w2314990747","cat":"papers","name":"Simple and Rapid Screening for Methamphetamine and 3,4-Methylene- dioxymethamphetamine (MDMA) and Their Metabolites in Urine Using Direct Analysis in Real Time (DART)-TOFMS","year":"2011","cit":16,"pfa":"Maiko Kawamura","psa":"Yukihiro Goda","ptype":"article","src":"https://openalex.org/W2314990747","eid":"W2314990747"},{"id":"paper-w2110307663","cat":"papers","name":"What evidence is there that the UK should tackle the potential emerging threat of methamphetamine toxicity rather than established recreational drugs such as MDMA ('ecstasy')?","year":"2008","cit":16,"pfa":"David Michael Wood","psa":"Paul Ivor Dargan","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2110307663","eid":"W2110307663"},{"id":"paper-w2070922607","cat":"papers","name":"Elevated BDNF protein level in cortex but not in hippocampus of MDMA-treated Dark Agouti rats: A potential link to the long-term recovery of serotonergic axons","year":"2010","cit":16,"pfa":"Csaba Ádori","psa":"György Bagdy","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2070922607","eid":"W2070922607"},{"id":"paper-w4376135699","cat":"papers","name":"Microbiome–Gut–Brain Axis Modulation: New Approaches in Treatment of Neuropsychological and Gastrointestinal Functional Disorders","year":"2023","cit":16,"pfa":"Robert B. Kargbo","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"editorial","src":"https://openalex.org/W4376135699","eid":"W4376135699"},{"id":"paper-w2009559742","cat":"papers","name":"In vivoanalysis of serotonin clearance in rat hippocampus reveals that repeated administration of p‐methoxyamphetamine (PMA), but not 3,4‐methylenedioxymethamphetamine (MDMA), leads to long‐lasting deficits in serotonin","year":"2006","cit":16,"pfa":"Paul D. Callaghan","psa":"Lynette C. Daws","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2009559742","eid":"W2009559742"},{"id":"paper-w110752286","cat":"papers","name":"The adverse effects of hallucinogens from intramural perspective.","year":"2006","cit":16,"pfa":"Ede Frecska","psa":"Luís Eduardo Luna","topics":["Safety & adverse events","Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W110752286","eid":"W110752286"},{"id":"paper-w4378084900","cat":"papers","name":"Modulation of Gut Microbiome in Ecstasy/MDMA-Induced Behavioral and Biochemical Impairment in Rats and Potential of Post-Treatment with Anacyclus pyrethrum L. Aqueous Extract to Mitigate Adverse Effects","year":"2023","cit":16,"pfa":"Abdelmounaim Baslam","psa":"Abderrahman Chait","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4378084900","eid":"W4378084900"},{"id":"paper-w2028151792","cat":"papers","name":"N-Methyl-1-(4-methoxyphenyl)-2-aminopropane (PMMA) and N-Methyl-1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA) produce non-identical discriminative stimuli in rats","year":"2007","cit":16,"pfa":"Richard A. Glennon","psa":"Mohamed Ayman El‐Zahabi","ptype":"article","src":"https://openalex.org/W2028151792","eid":"W2028151792"},{"id":"paper-w2005480796","cat":"papers","name":"Chronic co-administration of the cannabinoid receptor agonist WIN55,212-2 during puberty or adulthood reverses 3,4 methylenedioxymetamphetamine (MDMA)-induced deficits in recognition memory but not in effort-based decisi","year":"2013","cit":16,"pfa":"Sybille Schulz","psa":"Michael Koch","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2005480796","eid":"W2005480796"},{"id":"paper-w2109576847","cat":"papers","name":"Development and validation of an LC‐MS/MS method after chiral derivatization for the simultaneous stereoselective determination of methylenedioxy‐methamphetamine (MDMA) and its phase I and II metabolites in human blood p","year":"2014","cit":16,"pfa":"Andrea Eva Steuer","psa":"Thomas Kræmer","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2109576847","eid":"W2109576847"},{"id":"paper-w4301392523","cat":"papers","name":"A Critical Appraisal of Evidence on the Efficacy and Safety of Serotonergic Psychedelic Drugs as Emerging Antidepressants","year":"2022","cit":16,"pfa":"Nicole Ledwos","psa":"Muhammad Ishrat Husain","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4301392523","eid":"W4301392523"},{"id":"paper-w4317524271","cat":"papers","name":"The Psychotomimetic Drugs","year":"1964","cit":16,"pfa":"Jonathan O Cole","psa":"Martin M. Katz","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4317524271","eid":"W4317524271"},{"id":"paper-w2464426805","cat":"papers","name":"The response of normal men to lysergic acid derivatives (di- and monoethyl amides); correlation of personality and drug reactions.","year":"2002","cit":16,"pfa":"John M. von Felsinger","psa":"Henry K. Beecher","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2464426805","eid":"W2464426805"},{"id":"paper-w3200479165","cat":"papers","name":"Neuropsychological Functioning in Users of Serotonergic Psychedelics – A Systematic Review and Meta-Analysis","year":"2021","cit":16,"pfa":"Lukas Andreas Basedow","psa":"Tomislav Majić","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W3200479165","eid":"W3200479165"},{"id":"paper-w4406629036","cat":"papers","name":"Uncovering Psychedelics: From Neural Circuits to Therapeutic Applications","year":"2025","cit":16,"pfa":"Alice Melani","psa":"Marco Scarselli","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4406629036","eid":"W4406629036"},{"id":"paper-w1528725418","cat":"papers","name":"LSD-LIKE DELIRIUM FOLLOWING INGESTION OF A SMALL AMOUNT OF ITS BROM ANALOG (BOL-148)","year":"1958","cit":16,"pfa":"NELSON RICHARDS","psa":"Harold G. Wolff","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1528725418","eid":"W1528725418"},{"id":"paper-w4407224460","cat":"papers","name":"The Therapeutic Potential of Psychedelics in Treating Substance Use Disorders: A Review of Clinical Trials","year":"2025","cit":16,"pfa":"Lavinia Hogea","psa":"Teodora Anghel","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4407224460","eid":"W4407224460"},{"id":"paper-w4387039546","cat":"papers","name":"A suite of engineered mice for interrogating psychedelic drug actions","year":"2026","cit":16,"pfa":"Yi-Ting Chiu","psa":"Bryan L. Roth","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4387039546","eid":"W4387039546"},{"id":"paper-w4283657643","cat":"papers","name":"Three Naturally-Occurring Psychedelics and Their Significance in the Treatment of Mental Health Disorders","year":"2022","cit":16,"pfa":"Nataliya S. Vorobyeva","psa":"Alena A. Kozlova","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4283657643","eid":"W4283657643"},{"id":"paper-w3153217274","cat":"papers","name":"Psychedelic Medicines: A Paradigm Shift from Pharmacological Substitution Towards Transformation-Based Psychiatry","year":"2021","cit":16,"pfa":"Milan Scheidegger","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W3153217274","eid":"W3153217274"},{"id":"paper-w2079378095","cat":"papers","name":"The Identification of some Proscribed Psychedelic Drugs","year":"1967","cit":16,"pfa":"E G C Clarke","ptype":"article","src":"https://openalex.org/W2079378095","eid":"W2079378095"},{"id":"paper-w4280654174","cat":"papers","name":"Grounded in Biology: Why the Context-Dependency of Psychedelic Drug Effects Means Opportunities, Not Problems for Anthropology and Pharmacology","year":"2022","cit":16,"pfa":"Stephan Schleim","topics":["Addiction","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4280654174","eid":"W4280654174"},{"id":"paper-w4377564899","cat":"papers","name":"Determination of synthetic hallucinogens in oral fluids by microextraction by packed sorbent and liquid chromatography–tandem mass spectrometry","year":"2023","cit":16,"pfa":"Evan Lesne","psa":"Francesc Albert Esteve-Turrillas","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4377564899","eid":"W4377564899"},{"id":"paper-w2093131407","cat":"papers","name":"Ketamine or Phencyclidine","year":"1974","cit":16,"pfa":"Miles K. Crowder","ptype":"article","src":"https://openalex.org/W2093131407","eid":"W2093131407"},{"id":"paper-w4394808303","cat":"papers","name":"LSD increases sleep duration the night after microdosing","year":"2024","cit":16,"pfa":"Nathan T. Allen","psa":"Partha S. Roop","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4394808303","eid":"W4394808303"},{"id":"paper-w121270476","cat":"papers","name":"Biochemical Pharmacology of Psychotomimetics","year":"1982","cit":16,"pfa":"Daniel X. Freedman","psa":"William O. Boggan","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W121270476","eid":"W121270476"},{"id":"paper-w2588465615","cat":"papers","name":"NEUROPHARMACOLOGICAL STUDIES ON A NEW SERIES OF ERGOT ALKALOIDS","year":"1958","cit":16,"pfa":"TOHORU YUI","psa":"YUJI TAKEO","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2588465615","eid":"W2588465615"},{"id":"paper-w2414368675","cat":"papers","name":"LSD, alcoholism and transcendence.","year":"1962","cit":16,"pfa":"Charles Savage","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2414368675","eid":"W2414368675"},{"id":"paper-w1679347963","cat":"papers","name":"Developmental outcomes of 3,4‐methylenedioxymethamphetamine (ecstasy)‐exposed infants in the UK","year":"2015","cit":16,"pfa":"Lynn T. Singer","psa":"Andrew C. Parrott","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1679347963","eid":"W1679347963"},{"id":"paper-w3054886531","cat":"papers","name":"Psychedelic science in post-COVID-19 psychiatry","year":"2020","cit":16,"pfa":"John Richard Kelly","psa":"Veronica O’Keane","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3054886531","eid":"W3054886531"},{"id":"paper-w2068753101","cat":"papers","name":"Pharmacological actions of peptides and indoleamines on turtle retinal ganglion cells","year":"1989","cit":16,"pfa":"Alan R. Adolph","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2068753101","eid":"W2068753101"},{"id":"paper-w2045609931","cat":"papers","name":"Effects of the selective neurotensin antagonist SR 142948A on 3,4-methylenedioxymethamphetamine-induced behaviours in mice","year":"2008","cit":16,"pfa":"Cynthia Marie‐Claire","psa":"Florence Noble","ptype":"article","src":"https://openalex.org/W2045609931","eid":"W2045609931"},{"id":"paper-w1999906727","cat":"papers","name":"NEUROPHARMACOLOGICAL STUDIES ON A NEW SERIES OF ERGOT ALKALOIDS","year":"1958","cit":16,"pfa":"TOHORU YUI","psa":"YUJI TAKEO","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1999906727","eid":"W1999906727"},{"id":"paper-w2268232577","cat":"papers","name":"Effect of flunarizine and nimodipine on the decrease in tryptophan hydroxylase activity induced by methamphetamine and 3,4-methylenedioxymethamphetamine.","year":"1992","cit":16,"pfa":"Michel Johnson","psa":"James W. Gibb","ptype":"article","src":"https://openalex.org/W2268232577","eid":"W2268232577"},{"id":"paper-w2064627176","cat":"papers","name":"Methodological Issues of Human Experimental Research with Hallucinogens","year":"1998","cit":16,"pfa":"Euphrosyne Gouzoulis‐Mayfrank","psa":"H. Sass","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2064627176","eid":"W2064627176"},{"id":"paper-w2012088408","cat":"papers","name":"Vascular actions of 3,4-methylenedioxymethamphetamine in α2A/D-adrenoceptor knockout mice","year":"2002","cit":16,"pfa":"Catherine Vandeputte","psa":"James R. Docherty","ptype":"article","src":"https://openalex.org/W2012088408","eid":"W2012088408"},{"id":"paper-w2085622444","cat":"papers","name":"POTENTIATION OF 3,4‐METHYLENEDIOXYMETHAMPHETAMINE‐INDUCED 5‐HT RELEASE IN THE RAT SUBSTANTIA NIGRA BY CLORGYLINE, A MONOAMINE OXIDASE A INHIBITOR","year":"2007","cit":16,"pfa":"Ryan Hewton","psa":"Rodney James Irvine","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2085622444","eid":"W2085622444"},{"id":"paper-w2153350429","cat":"papers","name":"Revised structure of deacetyl-1,10-didehydrosalvinorin G","year":"2007","cit":16,"pfa":"Zhongze Ma","psa":"David Y.W. Lee","ptype":"article","src":"https://openalex.org/W2153350429","eid":"W2153350429"},{"id":"paper-w43678590","cat":"papers","name":"Hypotheses Regarding Ayahuasca’s Potential Mechanisms of Action in the Treatment of Addiction","year":"2013","cit":16,"pfa":"James I. Prickett","psa":"Mitchell B. Liester","topics":["Addiction","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W43678590","eid":"W43678590"},{"id":"paper-w2113388442","cat":"papers","name":"Phytochemical Investigation of Virola peruviana, A New Hallucinogenic Plant","year":"1973","cit":16,"pfa":"A. Lai","psa":"Norman R. Farnsworth","ptype":"article","src":"https://openalex.org/W2113388442","eid":"W2113388442"},{"id":"paper-w2125323332","cat":"papers","name":"Effects of antihistamines on 3,4-methylenedioxymethamphetamine-induced depletion of serotonin in rats","year":"1999","cit":16,"pfa":"S.Y. Yeh","psa":"Jean Lud Cadet","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2125323332","eid":"W2125323332"},{"id":"paper-w2027350267","cat":"papers","name":"Enhancement of morphine-induced analgesia after repeated injections of methylenedioxymethamphetamine","year":"1988","cit":16,"pfa":"Paolo Nencini","psa":"Lewis S. Seiden","ptype":"article","src":"https://openalex.org/W2027350267","eid":"W2027350267"},{"id":"paper-w2031910202","cat":"papers","name":"Antidepressant-like effects of 3,4-methylenedioxymethamphetamine in an animal model of depression","year":"2011","cit":16,"pfa":"Irina Majumder","psa":"Rodney James Irvine","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2031910202","eid":"W2031910202"},{"id":"paper-w4390859504","cat":"papers","name":"Daphnia magna an emerging environmental model of neuro and cardiotoxicity of illicit drugs.","year":"2024","cit":16,"pfa":"Marina Bellot","psa":"Carlos Barata","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4390859504","eid":"W4390859504"},{"id":"paper-w2067346881","cat":"papers","name":"Psychotomimetics potentiate locomotor hyperactivity induced by dopaminergic drugs","year":"1979","cit":16,"pfa":"Heidrun Fink","psa":"Wilhelm Oelssner","ptype":"article","src":"https://openalex.org/W2067346881","eid":"W2067346881"},{"id":"paper-w2906587679","cat":"papers","name":"Acute renal injury cause by confirmed Psilocybe cubensis mushroom ingestion","year":"2018","cit":16,"pfa":"Emily B. Austin","psa":"Constance A. Mackenzie","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2906587679","eid":"W2906587679"},{"id":"paper-w2115843974","cat":"papers","name":"An Experimental Evaluation of Protective Effects of Some Indigenous Drugs on Carbon Tetrachloride-Induced Hepatotoxicity in Mice and Rats","year":"1978","cit":16,"pfa":"Nidhi Singh","psa":"R. P. Kohli","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2115843974","eid":"W2115843974"},{"id":"paper-w942279227","cat":"papers","name":"Hallucinogenic Drugs and Orcadian Rhythms","year":"1972","cit":16,"pfa":"John A. Davies","psa":"Peter H. Redfern","ptype":"book-chapter","src":"https://openalex.org/W942279227","eid":"W942279227"},{"id":"paper-w4285087788","cat":"papers","name":"The effects of ketamine and classic hallucinogens on neurotrophic and inflammatory markers in unipolar treatment-resistant depression: a systematic review of clinical trials","year":"2022","cit":16,"pfa":"Giordano Novak Rossi","psa":"RAFAEL GUIMARÃES DOS SANTOS","topics":["Depression","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4285087788","eid":"W4285087788"},{"id":"paper-w2944652439","cat":"papers","name":"Patterns of use, desired effects, and mental health status of a sample of natural psychoactive drug users","year":"2019","cit":16,"pfa":"Marc Aixalà","psa":"José Carlos Bouso","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2944652439","eid":"W2944652439"},{"id":"paper-w4390875269","cat":"papers","name":"Synthetic surprise as the foundation of the psychedelic experience","year":"2024","cit":16,"pfa":"Roberto De Filippo","psa":"Dietmar Schmitz","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4390875269","eid":"W4390875269"},{"id":"paper-w2146018718","cat":"papers","name":"Banisteriopsis Species: A Source of Bioactive of Potential Medical Application","year":"2012","cit":16,"pfa":"de Frias","topics":["Anxiety & end-of-life","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2146018718","eid":"W2146018718"},{"id":"paper-w2915017317","cat":"papers","name":"Natural Products and their (Semi-)Synthetic Forms in the Treatment of Migraine: History and Current Status","year":"2019","cit":16,"pfa":"Jan Tauchen","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2915017317","eid":"W2915017317"},{"id":"paper-w2736440409","cat":"papers","name":"The hyperassociative mind: The psychedelic experience and Merleau-Ponty’s “wild being”","year":"2017","cit":16,"pfa":"Csaba Szummer","psa":"Kristóf Orzói","ptype":"article","src":"https://openalex.org/W2736440409","eid":"W2736440409"},{"id":"paper-w4231889404","cat":"papers","name":"Blinding and Expectancy Confounds in Psychedelic Randomised Controlled Trials","year":"2021","cit":16,"pfa":"Suresh D Muthukumaraswamy","psa":"Thomas Lumley","topics":["Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4231889404","eid":"W4231889404"},{"id":"paper-w4410309291","cat":"papers","name":"A systematic review of income and education reporting in psychedelic clinical trials","year":"2025","cit":16,"pfa":"Daniel H. Grossman","psa":"Peter S. Hendricks","topics":["Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4410309291","eid":"W4410309291"},{"id":"paper-w4385661344","cat":"papers","name":"Addiction specialists' attitudes toward psychedelics: A National Survey","year":"2023","cit":16,"pfa":"Amanda Kim","psa":"Joji Suzuki","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4385661344","eid":"W4385661344"},{"id":"paper-w4206169031","cat":"papers","name":"Effectiveness of a neuroscience-based, harm reduction program for older adolescents: A cluster randomised controlled trial of the Illicit Project","year":"2022","cit":16,"pfa":"Jennifer Debenham","psa":"Nicola Claire Newton","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4206169031","eid":"W4206169031"},{"id":"paper-w4406155950","cat":"papers","name":"Modifying Informed Consent to Help Address Functional Unmasking in Psychedelic Clinical Trials","year":"2025","cit":16,"pfa":"Michelle Matvey","psa":"Josh D. Woolley","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4406155950","eid":"W4406155950"},{"id":"paper-w2056485329","cat":"papers","name":"Reboxetine may be helpful in the treatment of amphetamine withdrawal","year":"2004","cit":16,"pfa":"D. Cox","psa":"Andrew J. McBride","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2056485329","eid":"W2056485329"},{"id":"paper-w4378745947","cat":"papers","name":"ARC: a framework for access, reciprocity and conduct in psychedelic therapies","year":"2023","cit":16,"pfa":"Meg J. Spriggs","psa":"Anne Katrin Schlag","topics":["Safety & adverse events","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4378745947","eid":"W4378745947"},{"id":"paper-w4403141830","cat":"papers","name":"Psychedelic therapy – refining the claim of a paradigm shift","year":"2024","cit":16,"pfa":"Helena Aicher","psa":"Uwe Herwig","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4403141830","eid":"W4403141830"},{"id":"paper-w4414994323","cat":"papers","name":"Common factors in altered states: Understanding psychedelic therapy through the lens of Grawe’s general change mechanisms.","year":"2025","cit":16,"pfa":"Max Wolff","psa":"Henrik Jungaberle","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4414994323","eid":"W4414994323"},{"id":"paper-w4388565270","cat":"papers","name":"Overcoming blinding confounds in psychedelic randomized controlled trials using biomarker driven causal mediation analysis","year":"2023","cit":16,"pfa":"Suresh D Muthukumaraswamy","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4388565270","eid":"W4388565270"},{"id":"paper-w4381598621","cat":"papers","name":"Psychedelic Experiences After Bereavement Improve Symptoms of Grief: The Influence of Emotional Breakthroughs and Challenging Experiences","year":"2023","cit":16,"pfa":"Fiona Low","psa":"Mitch Earleywine","ptype":"article","src":"https://openalex.org/W4381598621","eid":"W4381598621"},{"id":"paper-w3134742026","cat":"papers","name":"A quantitative exploration of the relationships between regular yoga practice, microdosing psychedelics, wellbeing and personality variables","year":"2021","cit":16,"pfa":"Stephen Jason Bright","psa":"Samantha Bettinson","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3134742026","eid":"W3134742026"},{"id":"paper-w1919860604","cat":"papers","name":"The expanding utility of microdosing","year":"2015","cit":16,"pfa":"Graham Lappin","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1919860604","eid":"W1919860604"},{"id":"paper-w4387780278","cat":"papers","name":"Psychedelic Experience","year":"2023","cit":16,"pfa":"Aidan Lyon","ptype":"book","src":"https://openalex.org/W4387780278","eid":"W4387780278"},{"id":"paper-w4221123335","cat":"papers","name":"Psychedelics and environmental virtues","year":"2022","cit":16,"pfa":"Nin Kirkham","psa":"Chris Letheby","ptype":"article","src":"https://openalex.org/W4221123335","eid":"W4221123335"},{"id":"paper-w4391537440","cat":"papers","name":"Keeping the promise: a critique of the current state of microdosing research","year":"2024","cit":16,"pfa":"Rotem Petranker","psa":"Paul Seli","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4391537440","eid":"W4391537440"},{"id":"paper-w3209154703","cat":"papers","name":"Toward a typology of hallucinogen users in the United States","year":"2021","cit":16,"pfa":"Christopher P. Salas‐Wright","psa":"Michael G. Vaughn","ptype":"article","src":"https://openalex.org/W3209154703","eid":"W3209154703"},{"id":"paper-w2119171766","cat":"papers","name":"Microdose analysis of ion strikes on SRAM cells","year":"2003","cit":16,"pfa":"Leif Z. Scheick","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2119171766","eid":"W2119171766"},{"id":"paper-w2296966501","cat":"papers","name":"Nitrous Oxide as a Psychedelic Drug","year":"1970","cit":16,"pfa":"George J. Wolcott","psa":"Thomas Hackett","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2296966501","eid":"W2296966501"},{"id":"paper-w1997328498","cat":"papers","name":"Psychedelic Effect ofPholiota spectabilis","year":"1967","cit":16,"pfa":"Robert W. Buck","ptype":"article","src":"https://openalex.org/W1997328498","eid":"W1997328498"},{"id":"paper-w1442829296","cat":"papers","name":"Clinical Experience with Microdose -Norgestrel as an Oral Contraceptive","year":"1973","cit":16,"pfa":"Ruben A. Apelo","psa":"Irma Veloso","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1442829296","eid":"W1442829296"},{"id":"paper-w4401584843","cat":"papers","name":"FDA rejects ecstasy as a therapy: what’s next for psychedelics?","year":"2024","cit":16,"pfa":"Sara Reardon","ptype":"other","src":"https://openalex.org/W4401584843","eid":"W4401584843"},{"id":"paper-w4391734876","cat":"papers","name":"What Predicts Beneficial Outcomes in Psychedelic Use? A Quantitative Content Analysis of Psychedelic Health Outcomes","year":"2024","cit":16,"pfa":"Elias C. Acevedo","psa":"Laith Al-Shawaf","ptype":"article","src":"https://openalex.org/W4391734876","eid":"W4391734876"},{"id":"paper-w2160603087","cat":"papers","name":"A Statistical Approach to Microdose Induced Degradation in FinFET Devices","year":"2009","cit":16,"pfa":"Alessio Griffoni","psa":"Cor L. Claeys","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2160603087","eid":"W2160603087"},{"id":"paper-w2902334221","cat":"papers","name":"Latanoprost with high precision, piezo-print microdose delivery for IOP lowering: clinical results of the PG21 study of 0.4 µg daily microdose","year":"2018","cit":16,"pfa":"Louis Robert Pasquale","psa":"Tsontcho Ianchulev","topics":["Safety & adverse events","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2902334221","eid":"W2902334221"},{"id":"paper-w2791411897","cat":"papers","name":"Otherworlds: Psychedelics and Exceptional Human Experience","year":"2017","cit":16,"pfa":"David P. Luke","topics":["Dosing & pharmacology"],"ptype":"book","src":"https://openalex.org/W2791411897","eid":"W2791411897"},{"id":"paper-w4385066508","cat":"papers","name":"What Is in a Name? The Many Meanings of “Psychedelic”","year":"2023","cit":16,"pfa":"Kelley C. O’Donnell","psa":"Christopher Pittenger","ptype":"article","src":"https://openalex.org/W4385066508","eid":"W4385066508"},{"id":"paper-w1608291762","cat":"papers","name":"A clinical pharmacokinetic microdosing study of docetaxel with Japanese patients with cancer","year":"2015","cit":16,"pfa":"Ken‐ichi Fujita","psa":"Yasutsuna Sasaki","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1608291762","eid":"W1608291762"},{"id":"paper-w2029425067","cat":"papers","name":"Failure of Outpatient Treatment of Drug Abuse: II. Amphetamines, Barbiturates, Hallucinogens","year":"1972","cit":16,"pfa":"William H. Anderson","psa":"Aaron Lazare","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2029425067","eid":"W2029425067"},{"id":"paper-w4390063984","cat":"papers","name":"Critical Doses: Nurturing Diversity in Psychedelic Studies","year":"2023","cit":16,"pfa":"Christine Hauskeller","psa":"Claudia G. Schwarz-Plaschg","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4390063984","eid":"W4390063984"},{"id":"paper-w4381469370","cat":"papers","name":"Impact of a Naturalistic Psychedelic Experience on Smoking: A Retrospective Survey","year":"2023","cit":16,"pfa":"Bruno Roméo","psa":"Amine Benyamina","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4381469370","eid":"W4381469370"},{"id":"paper-w2148949752","cat":"papers","name":"Dose and microdose measurement based on threshold shifts in MOSFET arrays in commercial SRAMs","year":"2002","cit":16,"pfa":"Leif Z. Scheick","psa":"Gary M. Swift","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2148949752","eid":"W2148949752"},{"id":"paper-w4251651807","cat":"papers","name":"AgriRobot: implementation and evaluation of an automatic robot for seeding and fertiliser microdosing in precision agriculture","year":"2020","cit":16,"pfa":"Ratnmala Nivrutti Bhimanpallewar","psa":"Manda Rama Narasingarao","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4251651807","eid":"W4251651807"},{"id":"paper-w4385636083","cat":"papers","name":"A Brief Review on the Potential of Psychedelics for Treating Alzheimer’s Disease and Related Depression","year":"2023","cit":16,"pfa":"Alexander R. Pilozzi","psa":"Xudong Huang","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4385636083","eid":"W4385636083"},{"id":"paper-w2982079589","cat":"papers","name":"Recent advances and concepts in the search for biological correlates of hallucinogen-induced altered states of consciousness","year":"1998","cit":16,"pfa":"Franz X. Vollenweider","ptype":"article","src":"https://openalex.org/W2982079589","eid":"W2982079589"},{"id":"paper-w4324123395","cat":"papers","name":"The psychedelic renaissance: a case of outlaw user innovation in the pharmaceutical industry","year":"2022","cit":16,"pfa":"Johan Söderberg","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4324123395","eid":"W4324123395"},{"id":"paper-w2104012843","cat":"papers","name":"Microdose follicular flare: a viable alternative for normal-responding patients undergoing in vitro fertilization?","year":"2008","cit":16,"pfa":"Eric D. Levens","psa":"Frederick W. Larsen","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2104012843","eid":"W2104012843"},{"id":"paper-w4291002705","cat":"papers","name":"Prevalence and associations of classic psychedelic-related seizures in a population-based sample","year":"2022","cit":16,"pfa":"Otto Simonsson","psa":"Peter S. Hendricks","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4291002705","eid":"W4291002705"},{"id":"paper-w2402293079","cat":"papers","name":"LSD-associated \"Alice in Wonderland Syndrome\"(AIWS): A Hallucinogen Persisting Perception Disorder (HPPD) Case Report.","year":"2015","cit":16,"pfa":"Arturo G. Lerner","psa":"Shaul Lev‐Ran","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2402293079","eid":"W2402293079"},{"id":"paper-w2010394633","cat":"papers","name":"Resolution and absolute configuration of trans-2-(2,5-dimethoxy-4-methylphenyl)cyclopropylamine, a potent hallucinogen analog","year":"1979","cit":16,"pfa":"David E. Nichols","psa":"George K. W. Yim","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2010394633","eid":"W2010394633"},{"id":"paper-w2093401839","cat":"papers","name":"Effect of microdose transdermal 17β-estradiol compared with raloxifene in the prevention of bone loss in healthy postmenopausal women","year":"2009","cit":16,"pfa":"Matthias Schaefers","psa":"Claus Christiansen","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2093401839","eid":"W2093401839"},{"id":"paper-w3022212541","cat":"papers","name":"Intensification of Pearl Millet Production in Niger through Mechanized Sowing and Weeding, Seed Priming, Seed Treatment, and Microdosing","year":"2020","cit":16,"pfa":"Abdourahamane Issa M. Nourou","psa":"Jens B. Aune","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3022212541","eid":"W3022212541"},{"id":"paper-w4396624687","cat":"papers","name":"Personality traits explain the relationship between psychedelic use and less depression in a comparative study","year":"2024","cit":16,"pfa":"David K. Sjöström","psa":"Petri Kajonius","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4396624687","eid":"W4396624687"},{"id":"paper-w3178122143","cat":"papers","name":"IL-10-Dependent Amelioration of Chronic Inflammatory Disease by Microdose Subcutaneous Delivery of a Prototypic Immunoregulatory Small Molecule","year":"2021","cit":16,"pfa":"Jorge Humberto Tabares-Guevara","psa":"José R. Ramírez‐Pineda","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3178122143","eid":"W3178122143"},{"id":"paper-w4319461950","cat":"papers","name":"Developmental Neurotoxicity Screen of Psychedelics and Other Drugs of Abuse in Larval Zebrafish ( Danio rerio )","year":"2023","cit":16,"pfa":"Robert J. Tombari","psa":"Pamela J. Lein","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4319461950","eid":"W4319461950"},{"id":"paper-w2511137868","cat":"papers","name":"Fertilizer Microdosing in the Humid Forest Zone of Ghana: An Efficient Strategy for Increasing Maize Yield and Income in Smallholder Farming","year":"2016","cit":16,"pfa":"Chinyere Blessing Okebalama","psa":"Vincent Logah","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2511137868","eid":"W2511137868"},{"id":"paper-w4200494186","cat":"papers","name":"Restructuring insight: An integrative review of insight in problem-solving, meditation, psychotherapy, delusions and psychedelics","year":"2021","cit":16,"pfa":"Kadi Tulver","psa":"Jaan Aru","topics":["Safety & adverse events","Reviews & meta-analyses","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4200494186","eid":"W4200494186"},{"id":"paper-w2940982719","cat":"papers","name":"New Psychoactive Substances (NPS), Psychedelic Experiences and Dissociation: Clinical and Clinical Pharmacological Issues","year":"2019","cit":16,"pfa":"Fabrizio Schifano","psa":"Alessandro Emiliano Vento","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2940982719","eid":"W2940982719"},{"id":"paper-w3023544283","cat":"papers","name":"Psychotomimetic Phenethylamines","year":"1971","cit":16,"pfa":"Karl A. Nieforth","ptype":"article","src":"https://openalex.org/W3023544283","eid":"W3023544283"},{"id":"paper-w2056589680","cat":"papers","name":"De Plantis Toxicariis e Mundo Novo Tropicale Commentationes XIII. Further Notes on Virola as an Orally Administered Hallucinogen","year":"1976","cit":16,"pfa":"Richard Evans Schultes","psa":"Tony Swain","ptype":"article","src":"https://openalex.org/W2056589680","eid":"W2056589680"},{"id":"paper-w3213088840","cat":"papers","name":"Psychedelic Experiences During the Early COVID-19 Pandemic: Findings From an International Online Survey","year":"2021","cit":16,"pfa":"Ricarda Evens","psa":"Tomislav Majić","topics":["Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3213088840","eid":"W3213088840"},{"id":"paper-w4396948614","cat":"papers","name":"Investigating the relationship between changes in metaphysical beliefs and death anxiety following a significant psychedelic experience","year":"2024","cit":16,"pfa":"Sam G. Moreton","psa":"Kayla J. Giese","topics":["Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4396948614","eid":"W4396948614"},{"id":"paper-w4396713345","cat":"papers","name":"Navigating Groundlessness: An interview study on dealing with ontological shock and existential distress following psychedelic experiences","year":"2024","cit":16,"pfa":"Eirini K. Argyri","psa":"Oliver C. Robinson","topics":["Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W4396713345","eid":"W4396713345"},{"id":"paper-w4401451313","cat":"papers","name":"Ketanserin exhibits dose- and concentration-proportional serotonin 2A receptor occupancy in healthy individuals: Relevance for psychedelic research","year":"2024","cit":16,"pfa":"Friederike Holze","psa":"Gitte M. Knudsen","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4401451313","eid":"W4401451313"},{"id":"paper-w2414792084","cat":"papers","name":"Psychotomimetic drugs: biochemistry and pharmacology.","year":"1973","cit":16,"pfa":"Brimblecombe Rw","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2414792084","eid":"W2414792084"},{"id":"paper-w2014906183","cat":"papers","name":"QSAR studies on psychotomimetic phenylalkylamines","year":"2003","cit":16,"pfa":"Mamta Thakur","ptype":"article","src":"https://openalex.org/W2014906183","eid":"W2014906183"},{"id":"paper-w2000832916","cat":"papers","name":"Potential for antipsychotic and psychotomimetic effects of A2Areceptor modulation","year":"2003","cit":16,"pfa":"Scott Μ. Weiss","psa":"Colin Trevor Dourish","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2000832916","eid":"W2000832916"},{"id":"paper-w4323050148","cat":"papers","name":"Effect of Clarithromycin, a Strong CYP3A and P-glycoprotein Inhibitor, on the Pharmacokinetics of Edoxaban in Healthy Volunteers and the Evaluation of the Drug Interaction with Other Oral Factor Xa Inhibitors by a Microd","year":"2023","cit":16,"pfa":"Alexander Lenard","psa":"Antje Blank","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4323050148","eid":"W4323050148"},{"id":"paper-w3157173992","cat":"papers","name":"Rapid Buprenorphine Microdosing for Opioid use Disorder in a Hospitalized Patient Receiving Very High Doses of Full Agonist Opioids for Acute Pain Management: Titration, Implementation Barriers, and Strategies to Overcom","year":"2021","cit":16,"pfa":"Jonathan P. DeWeese","psa":"Alyssa M. Peckham","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3157173992","eid":"W3157173992"},{"id":"paper-w1997275629","cat":"papers","name":"Substituent branching in phenethylamine-type hallucinogens: a comparison of 1-[2,5-dimethoxy-4-(2-butyl)phenyl]-2-aminopropane and 1-[2,5-dimethoxy-4-(2-methylpropyl)phenyl]-2-aminopropane","year":"1984","cit":16,"pfa":"Robert A. Oberlender","psa":"Joseph E. Zabik","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W1997275629","eid":"W1997275629"},{"id":"paper-w2793255565","cat":"papers","name":"Increased hippocampal engagement during learning as a marker of sensitivity to psychotomimetic effects ofδ-9-THC","year":"2018","cit":16,"pfa":"Sagnik Bhattacharyya","psa":"Philip K. McGuire","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2793255565","eid":"W2793255565"},{"id":"paper-w2043961724","cat":"papers","name":"Effects of psychotomimetic and antipsychotic agents on neocortical and striatal concentrations of various amino acids in the rat","year":"2004","cit":16,"pfa":"Shin‐ichiro Sakurai","psa":"Toru Nishikawa","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2043961724","eid":"W2043961724"},{"id":"paper-w2776651958","cat":"papers","name":"Effects of selective calcium-permeable AMPA receptor blockade by IEM 1460 on psychotomimetic-induced hyperactivity in the mouse","year":"2017","cit":16,"pfa":"Masakazu Umino","psa":"Toru Nishikawa","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2776651958","eid":"W2776651958"},{"id":"paper-w4221122043","cat":"papers","name":"Pharmacological modelling of dissociation and psychosis: an evaluation of the Clinician Administered Dissociative States Scale and Psychotomimetic States Inventory during nitrous oxide (‘laughing gas’)-induced anomalous","year":"2022","cit":16,"pfa":"Giulia G. Piazza","psa":"Sunjeev K. Kamboj","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4221122043","eid":"W4221122043"},{"id":"paper-w2113650519","cat":"papers","name":"“THEISTIC PSYCHOLOGY AND PSYCHOTHERAPY”: A THEOLOGICAL AND SCIENTIFIC CRITIQUE","year":"2010","cit":16,"pfa":"Daniel A. Helminiak","topics":["Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2113650519","eid":"W2113650519"},{"id":"paper-w2156498541","cat":"papers","name":"Relationship of Psychiatric I1lness to Drug Abuse","year":"1979","cit":16,"pfa":"Richard C.W. Hall","psa":"Auguste F. Lecann","ptype":"article","src":"https://openalex.org/W2156498541","eid":"W2156498541"},{"id":"paper-w2014037318","cat":"papers","name":"The Psychotic Heroin Addict","year":"1971","cit":16,"pfa":"David K. Wellisch","psa":"David Edward Smith","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2014037318","eid":"W2014037318"},{"id":"paper-w2050331614","cat":"papers","name":"Schizophreniform Psychosis Induced by Large-Dose Administration ofd-Amphetamine","year":"1969","cit":16,"pfa":"John D. Griffith","psa":"John Oates","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2050331614","eid":"W2050331614"},{"id":"paper-w3008454526","cat":"papers","name":"Mass Spectral Identification of Some Hallucinogenic Drugs","year":"1968","cit":16,"pfa":"Sander W Bellman","ptype":"article","src":"https://openalex.org/W3008454526","eid":"W3008454526"},{"id":"paper-w1978489084","cat":"papers","name":"The hypnodelic treatment technique","year":"1966","cit":16,"pfa":"Jerome Levine","psa":"Arnold M. Ludwig","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W1978489084","eid":"W1978489084"},{"id":"paper-w2513231883","cat":"papers","name":"5-HT2A/5-HT2C Receptor Pharmacology and Intrinsic Clearance of N-Benzylphenethylamines Modified at the Primary Site of Metabolism","year":"2016","cit":16,"pfa":"Sebastian Leth‐Petersen","psa":"Jesper Langgaard Kristensen","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2513231883","eid":"W2513231883"},{"id":"paper-w2001374803","cat":"papers","name":"Future of God in Recovery from Drug Addiction","year":"2007","cit":16,"pfa":"John Douglas Sellman","psa":"Lloyd Geering","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2001374803","eid":"W2001374803"},{"id":"paper-w1991661540","cat":"papers","name":"Potent agonist activity of DOB at 5-HT2 receptors in guinea pig trachea","year":"1987","cit":16,"pfa":"William A. Heller","psa":"Jay M. Baraban","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1991661540","eid":"W1991661540"},{"id":"paper-w2343729390","cat":"papers","name":"Substance Use Correlates of Depression among African American Male Inmates","year":"2016","cit":16,"pfa":"Rhonda Conerly Holliday","psa":"Charlene Powell","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W2343729390","eid":"W2343729390"},{"id":"paper-w4381248153","cat":"papers","name":"Paradoxical pharmacological dissociations result from drugs that enhance delta oscillations but preserve consciousness","year":"2023","cit":16,"pfa":"Joel Frohlich","psa":"Alireza Gharabaghi","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4381248153","eid":"W4381248153"},{"id":"paper-w346795517","cat":"papers","name":"Worldwide Survey of Nonmedical Drug Use and Alcohol Use among Military Personnel: 1980.","year":"1980","cit":16,"pfa":"Marvin R. Burt","psa":"Edward C Farley","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W346795517","eid":"W346795517"},{"id":"paper-w1985405451","cat":"papers","name":"Characterization of Substance Abuse Patients Presenting for Treatment at a University Psychiatric Hospital in Cairo, Egypt","year":"2008","cit":16,"pfa":"Afaf Hamed Khalil","psa":"Richard A. Rawson","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1985405451","eid":"W1985405451"},{"id":"paper-w2169027586","cat":"papers","name":"Former Heroin-Dependent Alcohol Use Disorder Patients. Prevalence, Addiction History and Clinical Features","year":"2015","cit":16,"pfa":"Matteo Pacini","psa":"Icro Maremmani","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2169027586","eid":"W2169027586"},{"id":"paper-w4240377190","cat":"papers","name":"Imprecise Action Selection in Substance Use Disorder: Evidence for Active Learning Impairments When Solving the Explore-Exploit Dilemma","year":"2020","cit":16,"pfa":"Ryan S. Smith","psa":"Martin P. Paulus","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4240377190","eid":"W4240377190"},{"id":"paper-w2976048362","cat":"papers","name":"Application of hair analysis to document illegal 5-methoxy-N,N-dissopropyltrptamine (5-MeO-DiPT) use","year":"2019","cit":16,"pfa":"Roujia Wang","psa":"Yan Shi","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2976048362","eid":"W2976048362"},{"id":"paper-w2103858155","cat":"papers","name":"Nymphaea cults in ancient Egypt and the New World: a lesson in empirical pharmacology","year":"2004","cit":16,"pfa":"Elisabetta Bertol","psa":"Irene Riezzo","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2103858155","eid":"W2103858155"},{"id":"paper-w4395006819","cat":"papers","name":"Ligand bias and inverse agonism on 5‐HT2A receptor‐mediated modulation of G protein activity in post‐mortem human brain","year":"2024","cit":16,"pfa":"Itziar Muneta‐Arrate","psa":"J. Javier Meana","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4395006819","eid":"W4395006819"},{"id":"paper-w4246700785","cat":"papers","name":"Treatment Episode Data Set -- Discharges (TEDS-D) -- Concatenated, 2006 to 2009","year":"2011","cit":16,"pfa":"United States Department Of Health And Human Services. Substance Abuse And…","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W4246700785","eid":"W4246700785"},{"id":"paper-w2077047316","cat":"papers","name":"8 The NMDA-antagonist ketamine for prevention and treatment of acute and chronic post-operative pain","year":"1995","cit":16,"pfa":"Per Kristian Eide","psa":"Ivar Øye","ptype":"article","src":"https://openalex.org/W2077047316","eid":"W2077047316"},{"id":"paper-w1981188218","cat":"papers","name":"Enhanced [3H]DOPA and [3H]Dopamine Turnover in Striatum and Frontal Cortex In Vivo Linked to Glutamate Receptor Antagonism","year":"1998","cit":16,"pfa":"Jakob Reith","psa":"ALBERT H. GJEDDE","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1981188218","eid":"W1981188218"},{"id":"paper-w2085498381","cat":"papers","name":"Psychopharmacology: An Introduction to Experimental and Clinical Principles","year":"1973","cit":16,"pfa":"Frank J. Ayd","topics":["Depression","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2085498381","eid":"W2085498381"},{"id":"paper-w1937663975","cat":"papers","name":"Phosphonate quinoxalinedione AMPA antagonists","year":"2000","cit":16,"pfa":"Lechosław Turski","psa":"Eckhard Ottow","topics":["PTSD & trauma","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1937663975","eid":"W1937663975"},{"id":"paper-w3073173737","cat":"papers","name":"Could ketamine be the answer to treating treatment‐resistant major depressive disorder?","year":"2020","cit":16,"pfa":"Abdullah Ramadan","psa":"Islam Mansour","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3073173737","eid":"W3073173737"},{"id":"paper-w4321082489","cat":"papers","name":"Association of the delayed changes in glutamate levels and functional connectivity with the immediate network effects of S-ketamine","year":"2023","cit":16,"pfa":"Lena Vera Danyeli","psa":"Martin Walter","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4321082489","eid":"W4321082489"},{"id":"paper-w4385622232","cat":"papers","name":"Reelin Rescues Behavioral, Electrophysiological, and Molecular Metrics of a Chronic Stress Phenotype in a Similar Manner to Ketamine","year":"2023","cit":16,"pfa":"Jenessa N. Johnston","psa":"Héctor J. Caruncho","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4385622232","eid":"W4385622232"},{"id":"paper-w1892488753","cat":"papers","name":"Effect of preinduction low-dose ketamine bolus on intra operative and immediate postoperative analgesia requirement in day care surgery: A randomized controlled trial","year":"2015","cit":16,"pfa":"Khalid Maudood Siddiqui","psa":"FauziaAnis Khan","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1892488753","eid":"W1892488753"},{"id":"paper-w2766798812","cat":"papers","name":"Long-term Administration of Antipsychotic Drugs in Schizophrenia and Influence of Substance and Drug Abuse on the Disease Outcome","year":"2017","cit":16,"pfa":"Felix-Martin Werner","psa":"Rafael Coveñas","topics":["Addiction","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2766798812","eid":"W2766798812"},{"id":"paper-w2040048231","cat":"papers","name":"Analgesia With Ketamine in a Patient With Perioperative Opioid Tolerance","year":"2002","cit":16,"pfa":"Michael A Duncan","psa":"Juliet Anne Spiller","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2040048231","eid":"W2040048231"},{"id":"paper-w2805366235","cat":"papers","name":"Ketamine Use in the Intensive Care Unit","year":"2018","cit":16,"pfa":"Patrick M. Wieruszewski","psa":"Sarah Y. Nelson","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W2805366235","eid":"W2805366235"},{"id":"paper-w4407514450","cat":"papers","name":"Intraoperative Esketamine and Postpartum Depression Among Women With Cesarean Delivery","year":"2025","cit":16,"pfa":"Li Ren","psa":"Gangming Wu","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4407514450","eid":"W4407514450"},{"id":"paper-w3016264041","cat":"papers","name":"(2R,6R)-Hydroxynorketamine (HNK) plasma level predicts poor antidepressant response: is this the end of the HNK pipeline?","year":"2020","cit":16,"pfa":"Chadi G. Abdallah","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W3016264041","eid":"W3016264041"},{"id":"paper-w4404017821","cat":"papers","name":"Transforming growth factor-β1 mediates the beneficial effects of arketamine on demyelination and remyelination in the brains of cuprizone-treated mice","year":"2024","cit":16,"pfa":"Mingming Zhao","psa":"Kenji Hashimoto","topics":["Depression","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4404017821","eid":"W4404017821"},{"id":"paper-w4402700840","cat":"papers","name":"Esketamine improves cognitive function in sepsis-associated encephalopathy by inhibiting microglia-mediated neuroinflammation","year":"2024","cit":16,"pfa":"Hui Li","psa":"Xiaohua Zou","ptype":"article","src":"https://openalex.org/W4402700840","eid":"W4402700840"},{"id":"paper-w4361299656","cat":"papers","name":"Safety and efficacy of the combination of esketamine and propofol in procedural sedation/analgesia: a systematic review and meta-analysis","year":"2023","cit":16,"pfa":"Xiaoci HUANG","psa":"Xianwen Hu","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4361299656","eid":"W4361299656"},{"id":"paper-w4388302883","cat":"papers","name":"The Application Value of Esketamine and Dexmedetomidine in Preventing Postoperative Delirium and Hyperalgesia in Elderly Patients with Thoracic Anesthesia.","year":"2024","cit":16,"pfa":"Yongjian Lu","psa":"Zhenhua Yang","ptype":"article","src":"https://openalex.org/W4388302883","eid":"W4388302883"},{"id":"paper-w4390498531","cat":"papers","name":"Effect of esketamine on postpartum depression after labor analgesia and potential mechanisms: a randomized, double-blinded controlled trial","year":"2024","cit":16,"pfa":"Wei Ting Wang","psa":"Qi Wang","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4390498531","eid":"W4390498531"},{"id":"paper-w4206311343","cat":"papers","name":"Intravenous esketamine leads to an increase in impulsive and suicidal behaviour in a patient with recurrent major depression and borderline personality disorder","year":"2022","cit":16,"pfa":"Thomas Vanicek","psa":"Nicole Praschak-Rieder","topics":["Depression","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4206311343","eid":"W4206311343"},{"id":"paper-w4392499028","cat":"papers","name":"Clinical efficacy of adjunctive esketamine anesthesia in electroconvulsive therapy for major depressive disorders: A pragmatic, randomized, controlled trial","year":"2024","cit":16,"pfa":"Li Ren","psa":"Su Min","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4392499028","eid":"W4392499028"},{"id":"paper-w4285273636","cat":"papers","name":"The use of Esketamine in CT-guided percutaneous liver tumor ablation reduces the consumption of remifentanil: a randomized, controlled, double-blind trial","year":"2022","cit":16,"pfa":"Yanbing Su","psa":"Wan Huang","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4285273636","eid":"W4285273636"},{"id":"paper-w4376875510","cat":"papers","name":"Neonatal outcomes when intravenous esketamine is added to the parturients transferred from labor analgesia to emergency cesarean section: a retrospective analysis report","year":"2023","cit":16,"pfa":"Zhaojia Liang","psa":"Yalan Li","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4376875510","eid":"W4376875510"},{"id":"paper-w4381741866","cat":"papers","name":"Effects of intraoperative esketamine addition on gastrointestinal function after benign gynaecological laparoscopic surgery: a double-blind, randomized controlled study","year":"2023","cit":16,"pfa":"Yuhua Ma","psa":"Weiwei Ma","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4381741866","eid":"W4381741866"},{"id":"paper-w4401895880","cat":"papers","name":"Subanesthetic Dose of Esketamine Improves the Sedative and Analgesic Effects of Dexmedetomidine and Remifentanil in Liposuction Anesthesia: A Prospective, Double-Blinded, Randomized Controlled Trial","year":"2024","cit":16,"pfa":"Haotian Chen","psa":"Lingxin Wei","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4401895880","eid":"W4401895880"},{"id":"paper-w4406598766","cat":"papers","name":"Esketamine at a Clinical Dose Attenuates Cerebral Ischemia/Reperfusion Injury by Inhibiting AKT Signaling Pathway to Facilitate Microglia M2 Polarization and Autophagy","year":"2025","cit":16,"pfa":"Ying Gao","psa":"Fu‐Shan Xue","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4406598766","eid":"W4406598766"},{"id":"paper-w4378903397","cat":"papers","name":"Esketamine opioid-free intravenous anesthesia versus opioid intravenous anesthesia in spontaneous ventilation video-assisted thoracic surgery: a randomized controlled trial","year":"2023","cit":16,"pfa":"Qisen Fan","psa":"Lan Lan","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4378903397","eid":"W4378903397"},{"id":"paper-w4403700170","cat":"papers","name":"Intranasal Dexmedetomidine-Esketamine Combination Premedication versus Monotherapy for Reducing Emergence Delirium and Postoperative Behavioral Changes in Pediatric Tonsillectomy and/or Adenoidectomy: A Randomized Contro","year":"2024","cit":16,"pfa":"Yanling Liao","psa":"Yusheng Yao","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4403700170","eid":"W4403700170"},{"id":"paper-w3178494086","cat":"papers","name":"Effect of Concomitant Benzodiazepine Use on Efficacy and Safety of Esketamine Nasal Spray in Patients with Major Depressive Disorder and Acute Suicidal Ideation or Behavior: Pooled Randomized, Controlled Trials","year":"2021","cit":16,"pfa":"Bettina Diekamp","psa":"Maju Mathews","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3178494086","eid":"W3178494086"},{"id":"paper-w2410192602","cat":"papers","name":"Breaking down ketamine's actions","year":"2016","cit":16,"pfa":"Katherine M. Whalley","ptype":"article","src":"https://openalex.org/W2410192602","eid":"W2410192602"},{"id":"paper-w4200011138","cat":"papers","name":"Analgesia in pediatric trauma patients in physician-staffed Austrian helicopter rescue: a 12-year registry analysis","year":"2021","cit":16,"pfa":"Christopher Rugg","psa":"Mathias Ströhle","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4200011138","eid":"W4200011138"},{"id":"paper-w4283071229","cat":"papers","name":"Investigational Drugs for the Treatment of Depression (Part 2): Glutamatergic, Cholinergic, Sestrin Modulators, and Other Agents","year":"2022","cit":16,"pfa":"Octavian Vasiliu","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4283071229","eid":"W4283071229"},{"id":"paper-w4309857356","cat":"papers","name":"The effect of ketamine on cognition, anxiety, and social functioning in adults with psychiatric disorders: A systematic review and meta-analysis","year":"2022","cit":16,"pfa":"Mattia Marchi","psa":"Gian Maria Galeazzi","topics":["Depression","Anxiety & end-of-life","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4309857356","eid":"W4309857356"},{"id":"paper-w116901517","cat":"papers","name":"Biochemistry and Pharmacology of the 5-HT1 Serotonin Binding Sites","year":"1988","cit":16,"pfa":"David L. Nelson","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W116901517","eid":"W116901517"},{"id":"paper-w4398156492","cat":"papers","name":"A retrospective study of the characteristics and toxicology of cases of lysergic acid diethylamide (LSD)‐ and psilocybin‐related death in Australia","year":"2024","cit":15,"pfa":"Shane G Darke","psa":"Julia Lappin","topics":["PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4398156492","eid":"W4398156492"},{"id":"paper-w1975835582","cat":"papers","name":"THE ACTION OF LYSERGIC ACID DIETHYLAMIDE ON MAMMALIAN CHOLINESTERASES","year":"1955","cit":15,"pfa":"Robert Henry Stewart Thompson","psa":"G. R. Webster","ptype":"article","src":"https://openalex.org/W1975835582","eid":"W1975835582"},{"id":"paper-w2326848552","cat":"papers","name":"Influence of Lysergic Acid Diethylamide on Experimental Allergic Encephalomyelitis.","year":"1962","cit":15,"pfa":"D. J. O'Brien","psa":"James W. Newberne","ptype":"article","src":"https://openalex.org/W2326848552","eid":"W2326848552"},{"id":"paper-w1986262328","cat":"papers","name":"Ibogaine and Noribogaine: Comparing Parent Compound to Metabolite","year":"2000","cit":15,"pfa":"Carlos Zúbaran","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1986262328","eid":"W1986262328"},{"id":"paper-w1947306506","cat":"papers","name":"False-Positive Lysergic Acid Diethylamide Immunoassay Screen Associated with Fentanyl Medication","year":"2002","cit":15,"pfa":"Angelique Gagajewski","psa":"Fred S. Apple","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1947306506","eid":"W1947306506"},{"id":"paper-w3025972109","cat":"papers","name":"An analytical study of iboga alkaloids contained in Tabernanthe iboga-derived products offered by ibogaine treatment providers","year":"2020","cit":15,"pfa":"José Carlos Bouso","psa":"Christopher Jenks","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3025972109","eid":"W3025972109"},{"id":"paper-w2305787153","cat":"papers","name":"Effect of and Interaction Between Tranquilizers, Serotonin and Lysergic Acid Diethylamide on the Body Temperature of Pigeons","year":"1958","cit":15,"pfa":"Roger A. Hoffman","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2305787153","eid":"W2305787153"},{"id":"paper-w2031146131","cat":"papers","name":"Effect of cannabis extract, Δ9-tetrahydrocannabinol and lysergic acid diethylamide on rat liver enzymes","year":"1972","cit":15,"pfa":"Mrinal Kanti Poddar","psa":"J. J. Ghosh","ptype":"article","src":"https://openalex.org/W2031146131","eid":"W2031146131"},{"id":"paper-w2981688273","cat":"papers","name":"The Effects of Low Doses of Lysergic Acid Diethylamide in Healthy Humans: Demystifying the Microdosing of Psychedelics","year":"2019","cit":15,"pfa":"Katrin H. Preller","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2981688273","eid":"W2981688273"},{"id":"paper-w2061820602","cat":"papers","name":"Fate of mRNA following disaggregation of brain polysomes after administration of (+)-lysergic acid diethylamide in vivo","year":"1979","cit":15,"pfa":"James B. Mahony","psa":"Ian R. Brown","ptype":"article","src":"https://openalex.org/W2061820602","eid":"W2061820602"},{"id":"paper-w3210511186","cat":"papers","name":"5-MeO-DMT: Potential Use of Psychedelic-Induced Experiences in the Treatment of Psychological Disorders","year":"2021","cit":15,"pfa":"Robert B. Kargbo","topics":["Anxiety & end-of-life"],"ptype":"editorial","src":"https://openalex.org/W3210511186","eid":"W3210511186"},{"id":"paper-w2167666776","cat":"papers","name":"Determination of Lysergic Acid Diethylamide (LSD) in Urine by Instrumental High-Performance Thin-Layer Chromatography","year":"1990","cit":15,"pfa":"Lee M. Blum","psa":"Fredric Rieders","ptype":"article","src":"https://openalex.org/W2167666776","eid":"W2167666776"},{"id":"paper-w2083617062","cat":"papers","name":"Human platelet 5-hydroxytryptamine receptors: Binding of [3H]-lysergic acid diethylamide (LSD). Effects of chronic neuroleptic and antidepressant drug administration","year":"1988","cit":15,"pfa":"A. David Smith","psa":"J. Martin Elliott","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2083617062","eid":"W2083617062"},{"id":"paper-w4375948532","cat":"papers","name":"Altered State of Consciousness and Mental Imagery as a Function of N, N-dimethyltryptamine Concentration in Ritualistic Ayahuasca Users","year":"2023","cit":15,"pfa":"Johannes Gerardus Ramaekers","psa":"Natasha Leigh Mason","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4375948532","eid":"W4375948532"},{"id":"paper-w4229757048","cat":"papers","name":"Peyote Effect","year":"2018","cit":15,"pfa":"Alexander Dawson","topics":["Policy & ethics"],"ptype":"book","src":"https://openalex.org/W4229757048","eid":"W4229757048"},{"id":"paper-w2139277097","cat":"papers","name":"In vitrostudies on metabolism of salvinorin A","year":"2009","cit":15,"pfa":"Lukasz M. Kutrzeba","psa":"Jordan Kordian Zjawiony","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2139277097","eid":"W2139277097"},{"id":"paper-w2013739869","cat":"papers","name":"THE MESCALINE PHENOMENA","year":"1953","cit":15,"pfa":"John Smythies","ptype":"article","src":"https://openalex.org/W2013739869","eid":"W2013739869"},{"id":"paper-w2323105924","cat":"papers","name":"Effects of Mescaline in Laboratory Animals and Influence of Ataraxics on Mescaline-Response","year":"1956","cit":15,"pfa":"Frank M. Sturtevant","psa":"Victor A. Drill","ptype":"article","src":"https://openalex.org/W2323105924","eid":"W2323105924"},{"id":"paper-w1972788215","cat":"papers","name":"THE ABSOLUTE CONFIGURATION OF THE IBOGA ALKALOIDS","year":"1966","cit":15,"pfa":"James Peter Kutney","psa":"Edward Piers","ptype":"article","src":"https://openalex.org/W1972788215","eid":"W1972788215"},{"id":"paper-w1829317757","cat":"papers","name":"The effect of succinate in mescaline hallucinations.","year":"1948","cit":15,"pfa":"Fred W. Schueler","ptype":"article","src":"https://openalex.org/W1829317757","eid":"W1829317757"},{"id":"paper-w4399327880","cat":"papers","name":"The biosynthetic pathway of the hallucinogen mescaline and its heterologous reconstruction","year":"2024","cit":15,"pfa":"Paula Berman","psa":"Asaph Aharoni","ptype":"article","src":"https://openalex.org/W4399327880","eid":"W4399327880"},{"id":"paper-w1977029524","cat":"papers","name":"On the similarity between hypnotic and mescaline hallucinations","year":"1961","cit":15,"pfa":"Seymour Lionel Halpern","ptype":"article","src":"https://openalex.org/W1977029524","eid":"W1977029524"},{"id":"paper-w2083774332","cat":"papers","name":"Interaction of asarone with mescaline, amphetamine and tremorine","year":"1965","cit":15,"pfa":"Prem C. Dandiya","psa":"M.K. Menon","ptype":"article","src":"https://openalex.org/W2083774332","eid":"W2083774332"},{"id":"paper-w2053061900","cat":"papers","name":"Intrathecal 5-methoxy-N, N-dimethyltryptamine in mice modulates 5-HT1 and 5-HT3 receptors","year":"1993","cit":15,"pfa":"Abdulqader A. Alhaider","psa":"George L. Wilcox","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2053061900","eid":"W2053061900"},{"id":"paper-w2118876564","cat":"papers","name":"Synthesis of the sulphur analogue of psilocin and some related compounds","year":"1972","cit":15,"pfa":"N. B. Chapman","psa":"Thomas Sutton","ptype":"article","src":"https://openalex.org/W2118876564","eid":"W2118876564"},{"id":"paper-w2034640170","cat":"papers","name":"Behavioral Psychopharmacology of MDMA and MDMA-Like Drugs: A Review of Human and Animal Studies","year":"2002","cit":15,"pfa":"Diana L. Martinez-Price","psa":"Mark A. Geyer","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2034640170","eid":"W2034640170"},{"id":"paper-w2091688594","cat":"papers","name":"Antagonism of catecholamine inhibition of brain stem neurones by mescaline","year":"1971","cit":15,"pfa":"J. A. Gonzalez-Vegas","ptype":"article","src":"https://openalex.org/W2091688594","eid":"W2091688594"},{"id":"paper-w4296038449","cat":"papers","name":"Evidence on the impairing effects of Ayahuasca on fear memory reconsolidation","year":"2022","cit":15,"pfa":"Daiane Momo Daneluz","psa":"Cristina Aparecida Jark Stern","ptype":"article","src":"https://openalex.org/W4296038449","eid":"W4296038449"},{"id":"paper-w2026566819","cat":"papers","name":"Comparative neurobiological effects of ibogaine and MK-801 in rats","year":"2000","cit":15,"pfa":"Michael H. Baumann","psa":"Syed F. Ali","ptype":"article","src":"https://openalex.org/W2026566819","eid":"W2026566819"},{"id":"paper-w3157692430","cat":"papers","name":"Effectiveness of Psilocybin on Depression: A Qualitative Study","year":"2021","cit":15,"pfa":"Hisham Alshaikhli","psa":"Gwen D. Erlam","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3157692430","eid":"W3157692430"},{"id":"paper-w4311778131","cat":"papers","name":"Effect of psilocybin on decision-making and motivation in the healthy rat","year":"2022","cit":15,"pfa":"Brianna F Roberts","psa":"Matthew Stephen McMurray","ptype":"article","src":"https://openalex.org/W4311778131","eid":"W4311778131"},{"id":"paper-w2906253063","cat":"papers","name":"Effect of Ritualistic Consumption of Ayahuasca on Hepatic Function in Chronic Users","year":"2018","cit":15,"pfa":"Sueli Moreira Mello","psa":"Alessandra Linardi","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2906253063","eid":"W2906253063"},{"id":"paper-w2966298156","cat":"papers","name":"MDMA enhances pleasantness of affective touch","year":"2019","cit":15,"pfa":"Harriet de Wit","psa":"Anya K. Bershad","ptype":"article","src":"https://openalex.org/W2966298156","eid":"W2966298156"},{"id":"paper-w2400129839","cat":"papers","name":"Regio- and stereospecific models for the biosynthesis of the indole alkaloids. Aspidosperma-Iboga relation","year":"1972","cit":15,"pfa":"A. Ian Scott","psa":"C. C. Wei","ptype":"article","src":"https://openalex.org/W2400129839","eid":"W2400129839"},{"id":"paper-w2003356753","cat":"papers","name":"Ex vivo effects of ibogaine on the activity of antioxidative enzymes in human erythrocytes","year":"2015","cit":15,"pfa":"Aleksandra Nikolić‐Kokić","psa":"Duško P. Blagojević","ptype":"article","src":"https://openalex.org/W2003356753","eid":"W2003356753"},{"id":"paper-w2147972658","cat":"papers","name":"Psychosis and recreational use of MDMA (“Ecstasy”)","year":"1993","cit":15,"pfa":"Eamon Keenan","psa":"John Joseph O'Connor","ptype":"article","src":"https://openalex.org/W2147972658","eid":"W2147972658"},{"id":"paper-w4406930915","cat":"papers","name":"Mushrooms, Microdosing, and Mental Illness: The Effect of Psilocybin on Neurotransmitters, Neuroinflammation, and Neuroplasticity","year":"2025","cit":15,"pfa":"Daniel A Kinderlehrer","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4406930915","eid":"W4406930915"},{"id":"paper-w2036790149","cat":"papers","name":"Effects of N-N-Dimethyltryptamine on retention of startle response habituation in the rat","year":"1972","cit":15,"pfa":"Michael E Davis","psa":"Harry D. Bear","ptype":"article","src":"https://openalex.org/W2036790149","eid":"W2036790149"},{"id":"paper-w4401648774","cat":"papers","name":"Salvinorin A ameliorates pilocarpine-induced seizures by regulating hippocampal microglia polarization","year":"2024","cit":15,"pfa":"Jiao Yang","psa":"Miao‐Jin Ji","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4401648774","eid":"W4401648774"},{"id":"paper-w2149496970","cat":"papers","name":"Actions of MDMA at glutamatergic neuromuscular junctions","year":"2004","cit":15,"pfa":"Garrett M. Sparks","psa":"R.L Cooper","ptype":"article","src":"https://openalex.org/W2149496970","eid":"W2149496970"},{"id":"paper-w2324218323","cat":"papers","name":"The Alkaloids of Tabernanthe iboga. IX.1 The Structures of the Ibogaline Derivatives, Kisantine and Gabonine","year":"1965","cit":15,"pfa":"W. I. Taylor","ptype":"article","src":"https://openalex.org/W2324218323","eid":"W2324218323"},{"id":"paper-w2974814938","cat":"papers","name":"Psilocybin for depression: Considerations for clinical trial design","year":"2019","cit":15,"pfa":"Kelley C. O’Donnell","psa":"Michael P. Bogenschutz","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2974814938","eid":"W2974814938"},{"id":"paper-w4405978069","cat":"papers","name":"Psilocybin: From Psychiatric Pariah to Perceived Panacea","year":"2025","cit":15,"pfa":"Gregory A. Fonzo","psa":"Charles B. Nemeroff","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4405978069","eid":"W4405978069"},{"id":"paper-w3211560547","cat":"papers","name":"Couple Therapy With MDMA—Proposed Pathways of Action","year":"2021","cit":15,"pfa":"Anne C. Wagner","topics":["PTSD & trauma","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3211560547","eid":"W3211560547"},{"id":"paper-w4307380201","cat":"papers","name":"MDMA-Assisted Psychotherapy for Borderline Personality Disorder","year":"2022","cit":15,"pfa":"Jenna M. Traynor","psa":"Lois Wonsun Choi-Kain","topics":["PTSD & trauma","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4307380201","eid":"W4307380201"},{"id":"paper-w2001908094","cat":"papers","name":"False-Positive Amphetamine/Ecstasy (MDMA/3,4-Methylenedioxymethamphetamine) (CEDIA) and Ecstasy (MDMA/3,4-Methylenedioxymethamphetamine) (DRI) Test Results With Fenofibrate","year":"2012","cit":15,"pfa":"Yusuf Cem Kaplan","psa":"Barş Karadaş","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2001908094","eid":"W2001908094"},{"id":"paper-w4238990361","cat":"papers","name":"False-Positive Amphetamine/Ecstasy (MDMA/3,4-Methylenedioxymethamphetamine) (CEDIA) and Ecstasy (MDMA/3,4-Methylenedioxymethamphetamine) (DRI) Test Results With Fenofibrate","year":"2012","cit":15,"pfa":"Yusuf Cem Kaplan","psa":"Barş Karadaş","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4238990361","eid":"W4238990361"},{"id":"paper-w2055941004","cat":"papers","name":"Ibogaine labeling with 99mTc-tricarbonyl: Synthesis and transport at the mouse blood–brain barrier","year":"2009","cit":15,"pfa":"Nicolas Tournier","psa":"Salvatore Cisternino","ptype":"article","src":"https://openalex.org/W2055941004","eid":"W2055941004"},{"id":"paper-w4405074416","cat":"papers","name":"Serotonin 1A Receptors Modulate Serotonin 2A Receptor-Mediated Behavioral Effects of 5-Methoxy- N , N -dimethyltryptamine Analogs in Mice","year":"2024","cit":15,"pfa":"Grant C. Glatfelter","psa":"Michael H. Baumann","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4405074416","eid":"W4405074416"},{"id":"paper-w4313471532","cat":"papers","name":"Psilocybin for Depression: From Credibility to Feasibility, What’s Missing?","year":"2022","cit":15,"pfa":"Antonio Munafò","psa":"Giuseppina Cantarella","topics":["Depression","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4313471532","eid":"W4313471532"},{"id":"paper-w4393098899","cat":"papers","name":"Psychedelic Therapy: A Primer for Primary Care Clinicians—Psilocybin","year":"2024","cit":15,"pfa":"Burton Jared Tabaac","psa":"Owen S. Muir","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4393098899","eid":"W4393098899"},{"id":"paper-w2396844307","cat":"papers","name":"Similarity of schizophrenia and the psilocybin syndrome as determined by objective methods.","year":"1965","cit":15,"pfa":"Keeler Mh","ptype":"article","src":"https://openalex.org/W2396844307","eid":"W2396844307"},{"id":"paper-w4234853127","cat":"papers","name":"Ecstasy/MDMA and cannabis: the complexities of their interactive neuropsychobiological effects","year":"2004","cit":15,"pfa":"Andrew C. Parrott","psa":"Nadia Solowij","ptype":"article","src":"https://openalex.org/W4234853127","eid":"W4234853127"},{"id":"paper-w4200256563","cat":"papers","name":"Fully Validated, Multi-Kilogram cGMP Synthesis of MDMA","year":"2021","cit":15,"pfa":"Jay B. Nair","psa":"Kathryn Paisner","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4200256563","eid":"W4200256563"},{"id":"paper-w2066418446","cat":"papers","name":"Differences between amine oxidases deaminating mescaline and the structurally related 3,4-dimethoxyphenylethyl amine","year":"1966","cit":15,"pfa":"Zsuzsanna Huszti","psa":"József Borsy","ptype":"article","src":"https://openalex.org/W2066418446","eid":"W2066418446"},{"id":"paper-w2611233367","cat":"papers","name":"Detoxification from methadone using low, repeated, and increasing doses of ibogaine: A case report","year":"2017","cit":15,"pfa":"Clare Wilkins","psa":"José Carlos Bouso","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2611233367","eid":"W2611233367"},{"id":"paper-w95877624","cat":"papers","name":"Ayahuasca–From Dangerous Drug to National Heritage: An Interview with Antonio A. Arantes","year":"2009","cit":15,"pfa":"Beatriz Caiuby Labate","psa":"Campinas State Univesity","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W95877624","eid":"W95877624"},{"id":"paper-w1965512102","cat":"papers","name":"Paradoxes of ayahuasca expansion: The UDV–DEA agreement and the limits of freedom of religion","year":"2011","cit":15,"pfa":"Beatriz Caiuby Labate","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1965512102","eid":"W1965512102"},{"id":"paper-w2071148671","cat":"papers","name":"Application of the Passionate Attachment Model to Recreational Use of MDMA/Ecstasy","year":"2015","cit":15,"pfa":"Alan K. Davis","psa":"Harold Rosenberg","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2071148671","eid":"W2071148671"},{"id":"paper-w2123660953","cat":"papers","name":"Consumo de MDMA (éxtasis) en estudiantes de secundaria","year":"2001","cit":15,"pfa":"Pilar Alejandra Sáiz","psa":"Julio Bobes","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2123660953","eid":"W2123660953"},{"id":"paper-w2103305447","cat":"papers","name":"Evaluation of a Rapid Oral Fluid Point-of-Care Test for MDMA","year":"2007","cit":15,"pfa":"L. Wilson","psa":"Richard H. Smith","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2103305447","eid":"W2103305447"},{"id":"paper-w4362452269","cat":"papers","name":"Examining the Therapeutic Effect of Ceremonial Ayahuasca on Narcissistic Personality and Antagonistic Externalizing in Adults","year":"2023","cit":15,"pfa":"Brandon Weiss","psa":"William Keith Campbell","ptype":"article","src":"https://openalex.org/W4362452269","eid":"W4362452269"},{"id":"paper-w1990597927","cat":"papers","name":"Ayahuasca e redução do uso abusivo de psicoativos: eficácia terapêutica?","year":"2006","cit":15,"pfa":"RAFAEL GUIMARÃES DOS SANTOS","psa":"Adriano Furtado Holanda","ptype":"article","src":"https://openalex.org/W1990597927","eid":"W1990597927"},{"id":"paper-w4409502094","cat":"papers","name":"Issues in Clinical Trial Design—Lessons From the FDA’s Rejection of MDMA","year":"2025","cit":15,"pfa":"Samuel T. Wilkinson","psa":"Gerard Sanacora","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4409502094","eid":"W4409502094"},{"id":"paper-w2773161592","cat":"papers","name":"No major role of norepinephrine transporter gene variations in the cardiostimulant effects of MDMA","year":"2017","cit":15,"pfa":"Patrick Vizeli","psa":"Matthias E. Liechti","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2773161592","eid":"W2773161592"},{"id":"paper-w2074360781","cat":"papers","name":"Attenuation of MDMA-induced hyperthermia by ethanol in rats depends on ambient temperature","year":"2007","cit":15,"pfa":"Jean‐Christophe Cassel","psa":"Byron C. Jones","ptype":"article","src":"https://openalex.org/W2074360781","eid":"W2074360781"},{"id":"paper-w1600084496","cat":"papers","name":"Valvular heart disease in a patient taking 3,4‐methylenedioxymethamphetamine (MDMA, ‘Ecstasy’)","year":"2012","cit":15,"pfa":"François Montastruc","psa":"Jean‐Louis Montastruc","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1600084496","eid":"W1600084496"},{"id":"paper-w2079687094","cat":"papers","name":"MDMA (Ecstasy) controls in concert a group of genes involved in GABA neurotransmission","year":"2004","cit":15,"pfa":"Rabi Simantov","psa":"Weiping Peng","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2079687094","eid":"W2079687094"},{"id":"paper-w2726166098","cat":"papers","name":"Ayahuasca Modifies Amphetamine Self Ingestion and ModifiesAnxiety and Locomotor Activity in Adolescent Rats","year":"2017","cit":15,"pfa":"Godinho Af","psa":"De Fraia D","topics":["Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2726166098","eid":"W2726166098"},{"id":"paper-w4410748059","cat":"papers","name":"Therapeutic emergence of dissociated traumatic memories during psilocybin treatment for anorexia nervosa","year":"2025","cit":15,"pfa":"Stephanie Knatz Peck","psa":"Walter H. Kaye","topics":["PTSD & trauma","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4410748059","eid":"W4410748059"},{"id":"paper-w1991220753","cat":"papers","name":"MDMA & Cannabis: A Mini-Review of Cognitive, Behavioral, and Neurobiological Effects of Co-Consumption","year":"2011","cit":15,"pfa":"Sybille Schulz","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W1991220753","eid":"W1991220753"},{"id":"paper-w4416410579","cat":"papers","name":"Sex-specific role of the 5-HT2A receptor in psilocybin-induced extinction of opioid reward","year":"2025","cit":15,"pfa":"Alaina M. Jaster","psa":"Javier González‐Maeso","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4416410579","eid":"W4416410579"},{"id":"paper-w2025525660","cat":"papers","name":"Tumour necrosis factor alpha suppression by MDMA is mediated by peripheral heteromeric nicotinic receptors","year":"2010","cit":15,"pfa":"Jorge Camarasa","psa":"Elena Escubedo","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2025525660","eid":"W2025525660"},{"id":"paper-w4389086750","cat":"papers","name":"Public Interest in Psilocybin and Psychedelic Therapy in the Context of the COVID-19 Pandemic: Google Trends Analysis","year":"2023","cit":15,"pfa":"George Danias","psa":"Jacob M. Appel","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4389086750","eid":"W4389086750"},{"id":"paper-w2167766292","cat":"papers","name":"Age differences in (±) 3,4‐methylenedioxymethamphetamine (MDMA)‐induced conditioned taste aversions and monoaminergic levels","year":"2013","cit":15,"pfa":"Jennifer L. Cobuzzi","psa":"Anthony Lee Riley","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2167766292","eid":"W2167766292"},{"id":"paper-w2094290942","cat":"papers","name":"MDMA induces cardiac contractile dysfunction through autophagy upregulation and lysosome destabilization in rats","year":"2014","cit":15,"pfa":"Kaori Shintani‐Ishida","psa":"Ken Yoshida","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2094290942","eid":"W2094290942"},{"id":"paper-w2142664803","cat":"papers","name":"The acute effects of MDMA and ethanol administration on electrophysiological correlates of performance monitoring in healthy volunteers","year":"2014","cit":15,"pfa":"Desirée B. Spronk","psa":"Ellen R. A. de Bruijn","ptype":"article","src":"https://openalex.org/W2142664803","eid":"W2142664803"},{"id":"paper-w1985183721","cat":"papers","name":"Concise syntheses of 5,6-dibromotryptamine and 5,6-dibromo-N,N-dimethyltryptamine en route to the antibiotic alternatamide D","year":"2011","cit":15,"pfa":"Jonathan Sperry","ptype":"article","src":"https://openalex.org/W1985183721","eid":"W1985183721"},{"id":"paper-w2035476405","cat":"papers","name":"Synaptotagmin I and IV are differentially regulated in the brain by the recreational drug 3,4-methylenedioxymethamphetamine (MDMA)","year":"2002","cit":15,"pfa":"Weiping Peng","psa":"Rabi Simantov","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2035476405","eid":"W2035476405"},{"id":"paper-w2923220681","cat":"papers","name":"Embracing Neurodiversity in Psychedelic Science: A Mixed-Methods Inquiry into the MDMA Experiences of Autistic Adults","year":"2019","cit":15,"pfa":"Alicia L. Danforth","topics":["PTSD & trauma","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2923220681","eid":"W2923220681"},{"id":"paper-w4410448036","cat":"papers","name":"Effects of Psilocybin on Religious and Spiritual Attitudes and Behaviors in Clergy from Various Major World Religions","year":"2025","cit":15,"pfa":"Roland R. Griffiths","psa":"Stephen Ross","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4410448036","eid":"W4410448036"},{"id":"paper-w1982203063","cat":"papers","name":"MDMA-induced loss of parvalbumin interneurons within the dentate gyrus is mediated by 5HT2A and NMDA receptors","year":"2015","cit":15,"pfa":"Stuart A. Collins","psa":"Bryan K. Yamamoto","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1982203063","eid":"W1982203063"},{"id":"paper-w2095863150","cat":"papers","name":"Serotonergic Neurotoxic Thioether Metabolites of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”): Synthesis, Isolation, and Characterization of Diastereoisomers","year":"2008","cit":15,"pfa":"Nieves Pizarro","psa":"Terrence J. Monks","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2095863150","eid":"W2095863150"},{"id":"paper-w1968696128","cat":"papers","name":"Gangliosides attenuate stress-induced changes on body weight, motor activity and on the behavioral response to 5-methoxy-N,N-dimethyltryptamine","year":"1996","cit":15,"pfa":"Liliana Marina Cancela","psa":"Victor Alejandro Molina","ptype":"article","src":"https://openalex.org/W1968696128","eid":"W1968696128"},{"id":"paper-w4221118250","cat":"papers","name":"Metabolomics and integrated network analysis reveal roles of endocannabinoids and large neutral amino acid balance in the ayahuasca experience","year":"2022","cit":15,"pfa":"Francisco Madrid-Gambín","psa":"Óscar J. Pozo","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4221118250","eid":"W4221118250"},{"id":"paper-w2443138776","cat":"papers","name":"Abuse potential of methylenedioxymethamphetamine (MDMA) and its derivatives in zebrafish: role of serotonin 5HT2-type receptors","year":"2016","cit":15,"pfa":"Luisa Ponzoni","psa":"Mariaelvina Sala","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2443138776","eid":"W2443138776"},{"id":"paper-w2058340335","cat":"papers","name":"Gender differences in hyperthermia and regional 5-HT and 5-HIAA depletion in the brain following MDMA administration in rats","year":"2011","cit":15,"pfa":"Alinde E. Wallinga","psa":"Bauke Buwalda","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2058340335","eid":"W2058340335"},{"id":"paper-w2028771195","cat":"papers","name":"Alcaloides e o chá de ayahuasca: uma correlação dos \"estados alterados da consciência\" induzido por alucinógenos","year":"2011","cit":15,"pfa":"Priscila Alves de Souza","ptype":"article","src":"https://openalex.org/W2028771195","eid":"W2028771195"},{"id":"paper-w2009889040","cat":"papers","name":"S(+)- and R(−)N-Methyl-1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA) as discriminative stimuli: Effect of cocaine","year":"2005","cit":15,"pfa":"Tatiana S Bondareva","psa":"Richard A. Glennon","ptype":"article","src":"https://openalex.org/W2009889040","eid":"W2009889040"},{"id":"paper-w1985355589","cat":"papers","name":"Chronic treatment with a serotonin2 receptor (5-HT2R) agonist modulates the behavioral and cellular response to (+)-3,4-methylenedioxymethamphetamine [(+)-MDMA]","year":"2005","cit":15,"pfa":"Julie D. Ross","psa":"Kathryn A. Cunningham","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1985355589","eid":"W1985355589"},{"id":"paper-w4236734931","cat":"papers","name":"In vivo detection of short‐ and long‐term MDMA neurotoxicity—a positron emission tomography study in the living baboon brain","year":"1998","cit":15,"pfa":"Ursula Scheffel","psa":"George A. Ricaurte","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4236734931","eid":"W4236734931"},{"id":"paper-w4390674606","cat":"papers","name":"Getting in Touch with Touch: The Importance of Studying Touch in MDMA-Assisted Therapy and the Development of a New Self-Report Measure","year":"2024","cit":15,"pfa":"Jason B. Luoma","psa":"Christopher S. Stauffer","topics":["Reviews & meta-analyses","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4390674606","eid":"W4390674606"},{"id":"paper-w2109121085","cat":"papers","name":"Determination of 3,4-methylenedioxymethamphetamine (MDMA) in Confiscated Tablets by High-Performance Liquid Chromatography (HPLC) with Diode Array Detector","year":"2010","cit":15,"pfa":"Natália Biziak de Figueiredo","psa":"Maria Cristina Brunini Silva","ptype":"article","src":"https://openalex.org/W2109121085","eid":"W2109121085"},{"id":"paper-w4297173008","cat":"papers","name":"Facing death, returning to life: A qualitative analysis of MDMA-assisted therapy for anxiety associated with life-threatening illness","year":"2022","cit":15,"pfa":"William P. Barone","psa":"Thomas Cody Swift","topics":["PTSD & trauma","Anxiety & end-of-life","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4297173008","eid":"W4297173008"},{"id":"paper-w4306804393","cat":"papers","name":"New mescaline-related N-acylhydrazone and its unsubstituted benzoyl derivative: Promising metallophores for copper-associated deleterious effects relief in Alzheimer's disease","year":"2022","cit":15,"pfa":"Alessandra Carvalho","psa":"Nicolás A. Rey","ptype":"article","src":"https://openalex.org/W4306804393","eid":"W4306804393"},{"id":"paper-w4405569216","cat":"papers","name":"Acute dose-dependent effects and self-guided titration of continuous N,N-dimethyltryptamine infusions in a double-blind placebo-controlled study in healthy participants","year":"2024","cit":15,"pfa":"Livio Erne","psa":"Matthias E. Liechti","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4405569216","eid":"W4405569216"},{"id":"paper-w4391687753","cat":"papers","name":"Altered States and Social Bonds: Effects of MDMA and Serotonergic Psychedelics on Social Behavior as a Mechanism Underlying Substance-Assisted Therapy","year":"2024","cit":15,"pfa":"Yasmin Schmid","psa":"Anya K. Bershad","topics":["PTSD & trauma","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4391687753","eid":"W4391687753"},{"id":"paper-w4413839750","cat":"papers","name":"Investigating the safety and tolerability of single-dose psilocybin for post-traumatic stress disorder: A nonrandomized open-label clinical trial","year":"2025","cit":15,"pfa":"Niall M. McGowan","psa":"Guy M. Goodwin","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4413839750","eid":"W4413839750"},{"id":"paper-w2066313444","cat":"papers","name":"A validated procedure for detection and quantitation of salvinorin a in pericardial fluid, vitreous humor, whole blood and plasma using solid phase extraction and gas chromatography–mass spectrometry","year":"2013","cit":15,"pfa":"Cláudia Margalho","psa":"Francisco Corte Real","ptype":"article","src":"https://openalex.org/W2066313444","eid":"W2066313444"},{"id":"paper-w1468324850","cat":"papers","name":"Cerebral oedema after MDMA (“ecstasy”) and unrestricted water intake: Values for plasma osmolality may have been wrong","year":"1996","cit":15,"pfa":"Tim M. Cook","ptype":"article","src":"https://openalex.org/W1468324850","eid":"W1468324850"},{"id":"paper-w4368356691","cat":"papers","name":"Why didn’t the TGA consult with Australian researchers and clinicians with experience in psilocybin-assisted psychotherapy for treatment-resistant major depressive disorder?","year":"2023","cit":15,"pfa":"Susan Lee Rossell","psa":"David Jonathan Castle","topics":["Depression","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4368356691","eid":"W4368356691"},{"id":"paper-w4394931126","cat":"papers","name":"Effects of psilocybin, psychedelic mushroom extract and 5-hydroxytryptophan on brain immediate early gene expression: Interaction with serotonergic receptor modulators","year":"2024","cit":15,"pfa":"Elad Lerer","psa":"Tzuri Lifschytz","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4394931126","eid":"W4394931126"},{"id":"paper-w1969186321","cat":"papers","name":"Effects of a short-course MDMA binge on dopamine transporter binding and on levels of dopamine and its metabolites in adult male rats","year":"2012","cit":15,"pfa":"Dominik K. Biezonski","psa":"Jerrold S. Meyer","ptype":"article","src":"https://openalex.org/W1969186321","eid":"W1969186321"},{"id":"paper-w1993611262","cat":"papers","name":"Cocaine potentiates MDMA-induced oxidative stress but not dopaminergic neurotoxicity in mice: implications for the pathogenesis of free radical-induced neurodegenerative disorders","year":"2013","cit":15,"pfa":"Inés Peraile","psa":"Esther O’Shea","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1993611262","eid":"W1993611262"},{"id":"paper-w4383533621","cat":"papers","name":"Perceived key change phenomena of MDMA-assisted psychotherapy for the treatment of severe PTSD: an interpretative phenomenological analysis of clinical integration sessions","year":"2023","cit":15,"pfa":"Macha Godes","psa":"Eric H. G. J. M. Vermetten","topics":["PTSD & trauma","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4383533621","eid":"W4383533621"},{"id":"paper-w1512234270","cat":"papers","name":"Qualitative detection of illegal drugs (cocaine, heroin and MDMA) in seized street samples based on SFS data and ANN: validation of method","year":"2012","cit":15,"pfa":"Jekaterina Mazina-Šinkar","psa":"Larissa Poryvkina","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1512234270","eid":"W1512234270"},{"id":"paper-w2892130546","cat":"papers","name":"A Gas Chromatography–Mass Spectrometry Method for Toxicological Analysis of MDA, MDEA and MDMA in Vitreous Humor Samples from Victims of Car Accidents","year":"2018","cit":15,"pfa":"Aline Akemi Ishikawa","psa":"Bruno Spinosa De Martinis","ptype":"article","src":"https://openalex.org/W2892130546","eid":"W2892130546"},{"id":"paper-w3084240078","cat":"papers","name":"Heart-cutting two-dimensional liquid chromatography coupled to quadrupole-orbitrap high resolution mass spectrometry for determination of N,N-dimethyltryptamine in rat plasma and brain; Method development and application","year":"2020","cit":15,"pfa":"Tímea Körmöczi","psa":"Róbert Berkecz","ptype":"article","src":"https://openalex.org/W3084240078","eid":"W3084240078"},{"id":"paper-w2732383286","cat":"papers","name":"Psychomotor Tremor and Proprioceptive Control Problems in Current and Former Stimulant Drug Users: An Accelerometer Study of Heavy Users of Amphetamine, MDMA, and Other Recreational Stimulants","year":"2017","cit":15,"pfa":"Luke A. Downey","psa":"Andrew C. Parrott","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2732383286","eid":"W2732383286"},{"id":"paper-w2048981485","cat":"papers","name":"MDMA Induces EPSP–Spike Potentiation in Rat Ventral Hippocampus In Vitro Via Serotonin and Noradrenaline Release and Coactivation of 5-HT4 and β1 Receptors","year":"2007","cit":15,"pfa":"Boris Mlinar","psa":"Renato Corradetti","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2048981485","eid":"W2048981485"},{"id":"paper-w2078576278","cat":"papers","name":"Chiral separation of 3,4-methylenedioxymethamphetamine (MDMA) enantiomers using batch chromatography with peak shaving recycling and its effects on oxidative stress status in rat liver","year":"2012","cit":15,"pfa":"Tiago C. Lourenço","psa":"Regina L. M. Moreau","ptype":"article","src":"https://openalex.org/W2078576278","eid":"W2078576278"},{"id":"paper-w2267860700","cat":"papers","name":"Repeated administration of the 5-HT1B/1A agonist, RU 24969, facilitates the acquisition of MDMA self-administration: role of 5-HT1A and 5-HT1B receptor mechanisms","year":"2016","cit":15,"pfa":"Dane Aronsen","psa":"Susan Schenk","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2267860700","eid":"W2267860700"},{"id":"paper-w2149537152","cat":"papers","name":"Myocardial Expression of TNF-α, IL-1β, IL-6, IL-8, IL-10 and MCP-1 After a Single MDMA Dose Administered in a Rat Model","year":"2010","cit":15,"pfa":"Margherita Neri","psa":"Vittorio Fineschi","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2149537152","eid":"W2149537152"},{"id":"paper-w2513619552","cat":"papers","name":"Hallucinogens and dissociative drugs","year":"2016","cit":15,"topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W2513619552","eid":"W2513619552"},{"id":"paper-w4315488427","cat":"papers","name":"The association between naturalistic use of psychedelics and co-occurring substance use disorders","year":"2023","cit":15,"pfa":"Jonina Rabinowitz","psa":"Raz Gross","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4315488427","eid":"W4315488427"},{"id":"paper-w3004031348","cat":"papers","name":"Reported effects of psychedelic use on those with low well-being given various emotional states and social contexts","year":"2020","cit":15,"pfa":"Natasha Leigh Mason","psa":"Kim P. C. Kuypers","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3004031348","eid":"W3004031348"},{"id":"paper-w4392378208","cat":"papers","name":"A Systematic Review of the Neurocognitive Effects of Psychedelics in Healthy Populations: Implications for Depressive Disorders and Post-Traumatic Stress Disorder","year":"2024","cit":15,"pfa":"Mario Renato Velit-Salazar","psa":"Eloise Cherian","topics":["Depression","PTSD & trauma","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W4392378208","eid":"W4392378208"},{"id":"paper-w2037210147","cat":"papers","name":"Pharmacological characterization of 3H-LSD binding sites in mouse brain in vivo","year":"1979","cit":15,"pfa":"Anne‐Marie Duchemin","psa":"Jean‐Charles Schwartz","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2037210147","eid":"W2037210147"},{"id":"paper-w2727276162","cat":"papers","name":"LSD treatment in Scandinavia: emphasizing indications and short-term treatment outcomes of 151 patients in Denmark","year":"2017","cit":15,"pfa":"Jens Knud Larsen","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2727276162","eid":"W2727276162"},{"id":"paper-w2005943870","cat":"papers","name":"Selective blocking action of LSD on inhibitory dopamine receptors","year":"1975","cit":15,"pfa":"Makoto Sato","psa":"Masaki Sawada","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2005943870","eid":"W2005943870"},{"id":"paper-w4408089698","cat":"papers","name":"Acute Effects and Pharmacokinetics of LSD after Paroxetine or Placebo Pre‐Administration in a Randomized, Double‐Blind, Cross‐Over Phase I Trial","year":"2025","cit":15,"pfa":"A. Becker","psa":"Matthias E. Liechti","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4408089698","eid":"W4408089698"},{"id":"paper-w2181673960","cat":"papers","name":"QEEG studies of the acute effects of the visionary tryptamine DMT.","year":"2015","cit":15,"pfa":"Juan Acosta‐Urquidi","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2181673960","eid":"W2181673960"},{"id":"paper-w1996267822","cat":"papers","name":"LSD-25 as a discriminative stimulus for response selection by pigeons","year":"1980","cit":15,"pfa":"Torbjörn U.C. Järbe","ptype":"article","src":"https://openalex.org/W1996267822","eid":"W1996267822"},{"id":"paper-w4411528016","cat":"papers","name":"Evidence that 5‐HT 2A receptor signalling efficacy and not biased agonism differentiates serotonergic psychedelic from non‐psychedelic drugs","year":"2025","cit":15,"pfa":"Aurelija Ippolito","psa":"Trevor Sharp","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4411528016","eid":"W4411528016"},{"id":"paper-w2047995810","cat":"papers","name":"Opioid-hallucinogen interactions","year":"1986","cit":15,"pfa":"Edward F. Domino","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2047995810","eid":"W2047995810"},{"id":"paper-w2520668028","cat":"papers","name":"Acid Brothers: Henry Beecher, Timothy Leary, and the psychedelic of the century","year":"2016","cit":15,"pfa":"Jonathan D. Moreno","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2520668028","eid":"W2520668028"},{"id":"paper-w4311273096","cat":"papers","name":"Psychedelic-Assisted Therapy and Psychedelic Science: A Review and Perspective on Opportunities in Neurosurgery and Neuro-Oncology","year":"2022","cit":15,"pfa":"Daniel F. Kelly","psa":"Regin Jay Mallari","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4311273096","eid":"W4311273096"},{"id":"paper-w4414845973","cat":"papers","name":"Psychedelic compounds directly excite 5-HT2A layer V medial prefrontal cortex neurons through 5-HT2A Gq activation","year":"2025","cit":15,"pfa":"Gavin P. Schmitz","psa":"Melissa A. Herman","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4414845973","eid":"W4414845973"},{"id":"paper-w1999553216","cat":"papers","name":"Differential Behavioral Responsivity to LSD-25","year":"1963","cit":15,"pfa":"Donald M. Krus","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1999553216","eid":"W1999553216"},{"id":"paper-w4281293006","cat":"papers","name":"Psychoactive Drugs in the Management of Post Traumatic Stress Disorder: A Promising New Horizon","year":"2022","cit":15,"pfa":"Kawther N Elsouri","psa":"Michelle Demory Beckler","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4281293006","eid":"W4281293006"},{"id":"paper-w4400605946","cat":"papers","name":"The versatile binding landscape of the TAAR1 pocket for LSD and other antipsychotic drug molecules","year":"2024","cit":15,"pfa":"Kexin Jiang","psa":"Fei Xu","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4400605946","eid":"W4400605946"},{"id":"paper-w3025495950","cat":"papers","name":"A mechanistic model of the neural entropy increase elicited by psychedelic drugs","year":"2020","cit":15,"pfa":"Ruben A Herzog","psa":"Rodrigo Cofré","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W3025495950","eid":"W3025495950"},{"id":"paper-w4309621724","cat":"papers","name":"Psychedelic compounds directly excite 5-HT 2A Layer 5 Pyramidal Neurons in the Prefrontal Cortex through a 5-HT 2A Gq -mediated activation mechanism","year":"2022","cit":15,"pfa":"Gavin P. Schmitz","psa":"Melissa A. Herman","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4309621724","eid":"W4309621724"},{"id":"paper-w2136930369","cat":"papers","name":"The Development and Application of a Gas Chromatography-Mass Spectrometric (GC-MS) Assay to Determine the Presence of 2-Oxo-3-Hydroxy-LSD in Urine","year":"2003","cit":15,"pfa":"B.T. Burnley","psa":"S. George","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2136930369","eid":"W2136930369"},{"id":"paper-w3095598531","cat":"papers","name":"Identification of LSD Derivatives, 1cP-LSD, MIPLA and 1B-LSD in Illegal Products as Paper Sheet","year":"2020","cit":15,"pfa":"Rie Tanaka","psa":"Ruri Kikura‐Hanajiri","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3095598531","eid":"W3095598531"},{"id":"paper-w2027397526","cat":"papers","name":"AntIdepressant-like effects of 5-hydroxytryptamine1A receptor agonists on operant responding under a response duration differentiation schedule","year":"1998","cit":15,"pfa":"Gene G. Kinney","psa":"Thomas J. Hudzik","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2027397526","eid":"W2027397526"},{"id":"paper-w3022972855","cat":"papers","name":"Identification and Analysis of LSD Derivatives in Illegal Products as Paper Sheet","year":"2020","cit":15,"pfa":"Rie Tanaka","psa":"Ruri Kikura‐Hanajiri","topics":["Addiction","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3022972855","eid":"W3022972855"},{"id":"paper-w4311509009","cat":"papers","name":"Moderators of ayahuasca’s biological antidepressant action","year":"2022","cit":15,"pfa":"Geovan Menezes de Sousa","psa":"Nicole Leite Galvão Coelho","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4311509009","eid":"W4311509009"},{"id":"paper-w2148734719","cat":"papers","name":"Single oral doses of (±) 3,4-methylenedioxymethamphetamine (‘Ecstasy’) produce lasting serotonergic deficits in non-human primates: relationship to plasma drug and metabolite concentrations","year":"2012","cit":15,"pfa":"Melanie Mueller","psa":"George A. Ricaurte","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2148734719","eid":"W2148734719"},{"id":"paper-w1981024699","cat":"papers","name":"A pharmacokinetic analysis of 3,4-methylenedioxymethamphetamine effects on monoamine concentrations in brain dialysates","year":"1991","cit":15,"pfa":"M. Hiramatsu","psa":"A.K. Cho","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1981024699","eid":"W1981024699"},{"id":"paper-w1977576973","cat":"papers","name":"3,4‐Methylenedioxymethamphetamine counteracts akinesia enantioselectively in rat rotational behavior and catalepsy","year":"2004","cit":15,"pfa":"Heike B. Lebsanft","psa":"Werner Schmidt","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1977576973","eid":"W1977576973"},{"id":"paper-w2428826819","cat":"papers","name":"“Ecstasy” toxicity to adolescent rats following an acute low binge dose","year":"2016","cit":15,"pfa":"A. Gomes","psa":"João Paulo Capela","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2428826819","eid":"W2428826819"},{"id":"paper-w2992757522","cat":"papers","name":"The acute toxic and neurotoxic effects of 3,4-methylenedioxymethamphetamine are more pronounced in adolescent than adult mice","year":"2019","cit":15,"pfa":"Neha Milind Chitre","psa":"Kevin Sean Murnane","ptype":"article","src":"https://openalex.org/W2992757522","eid":"W2992757522"},{"id":"paper-w2072641744","cat":"papers","name":"Reduction of in vivo binding of [3H]paroxetine in mouse brain by 3,4-methylenedioxymethamphetamine","year":"1990","cit":15,"pfa":"Kenji Hashimoto","psa":"Takeshi Goromaru","ptype":"article","src":"https://openalex.org/W2072641744","eid":"W2072641744"},{"id":"paper-w2149703987","cat":"papers","name":"Effects of 3,4‐methylenedioxymethamphetamine (‘Ecstasy’) on the jaw‐opening reflex and on the α2‐adrenoceptors which regulate this reflex in the anesthetized rat","year":"2004","cit":15,"pfa":"Aurora Arrúe","psa":"Maria Teresa Giralt","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2149703987","eid":"W2149703987"},{"id":"paper-w178037536","cat":"papers","name":"The trials of psychedelic medicine: LSD psychotherapy, clinical science, and pharmaceutical regulation in the United States, 1949-1976","year":"2014","cit":15,"pfa":"Matthew Oram","topics":["Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W178037536","eid":"W178037536"},{"id":"paper-w2171769684","cat":"papers","name":"Development and Validation of a Nonisotopic Immunoassay for the Detection of LSD in Human Urine","year":"1996","cit":15,"pfa":"N. P. Cassells","psa":"D. Baldwin","ptype":"article","src":"https://openalex.org/W2171769684","eid":"W2171769684"},{"id":"paper-w2072015889","cat":"papers","name":"Fetal exposure to (±)-methylenedioxymethamphetamine in utero enhances the development and metabolism of serotonergic neurons in three-dimensional reaggregate tissue culture","year":"2002","cit":15,"pfa":"Lisa Won","psa":"Alfred Heller","ptype":"article","src":"https://openalex.org/W2072015889","eid":"W2072015889"},{"id":"paper-w4225420820","cat":"papers","name":"Restorative Retelling for Processing Psychedelic Experiences: Rationale and Case Study of Complicated Grief","year":"2022","cit":15,"pfa":"Débora González","psa":"Magı́ Farré","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4225420820","eid":"W4225420820"},{"id":"paper-w2143459012","cat":"papers","name":"Methylenedioxymethamphetamine-Related Deaths in Taiwan: 2001-2008","year":"2009","cit":15,"pfa":"Dongliang Lin","psa":"R. H. Liu","ptype":"article","src":"https://openalex.org/W2143459012","eid":"W2143459012"},{"id":"paper-w4284698401","cat":"papers","name":"Synthesis, Structural Characterization, and Pharmacological Activity of Novel Quaternary Salts of 4-Substituted Tryptamines","year":"2022","cit":15,"pfa":"Grant C. Glatfelter","psa":"David R. Manke","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4284698401","eid":"W4284698401"},{"id":"paper-w2996738441","cat":"papers","name":"Therapeutic Potential of Natural Psychoactive Drugs for Central Nervous System Disorders: A Perspective from Polypharmacology","year":"2019","cit":15,"pfa":"Genís Oña","psa":"José Carlos Bouso","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2996738441","eid":"W2996738441"},{"id":"paper-w166725060","cat":"papers","name":"Effects of iproniazid, chlorpromazine and methiothepin on DMT-induced changes in body temperature, pupillary dilatation, blood pressure and EEG in the rabbit.","year":"1975","cit":15,"pfa":"Moore Rh","psa":"Domino Ef","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W166725060","eid":"W166725060"},{"id":"paper-w2089493913","cat":"papers","name":"Poisoning by hallucinogenic mushroom Hikageshibiretake (Psilocybe argentipes K. Yokoyama) indigenous to Japan.","year":"1986","cit":15,"pfa":"MORIHIRO MUSHA","psa":"Genjiro Kusano","topics":["Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2089493913","eid":"W2089493913"},{"id":"paper-w2014533187","cat":"papers","name":"3,4-Methylenedioxymethamphetamine increases neuropeptide messenger RNA expression in rat striatum","year":"2004","cit":15,"pfa":"David H. Adams","psa":"Kristen A. Keefe","ptype":"article","src":"https://openalex.org/W2014533187","eid":"W2014533187"},{"id":"paper-w4398133346","cat":"papers","name":"Allosteric Inhibition and Pharmacochaperoning of the Serotonin Transporter by the Antidepressant Drugs Trazodone and Nefazodone","year":"2024","cit":15,"pfa":"Ali El‐Kasaby","psa":"Walter Sandtner","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4398133346","eid":"W4398133346"},{"id":"paper-w2171749330","cat":"papers","name":"Isolation and Chemical Modification of Clerodane Diterpenoids fromSalviaSpecies as Potential Agonists at theκ‐Opioid Receptor","year":"2007","cit":15,"pfa":"Yiqiang Li","psa":"Michael G. Rowan","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2171749330","eid":"W2171749330"},{"id":"paper-w2160448447","cat":"papers","name":"Forensic analysis of Salvia divinorum using multivariate statistical procedures. Part I: discrimination from related Salvia species","year":"2011","cit":15,"pfa":"Melissa A. Bodnar Willard","psa":"Ruth Smith","ptype":"article","src":"https://openalex.org/W2160448447","eid":"W2160448447"},{"id":"paper-w2158366082","cat":"papers","name":"In Vivo Determination of 5‐Hydroxytryptamine Receptor‐Stimulated Phosphoinositide Turnover in Rat Brain","year":"1989","cit":15,"pfa":"Izumi Hide","psa":"Shigeto Yamawaki","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2158366082","eid":"W2158366082"},{"id":"paper-w4411169427","cat":"papers","name":"Neurochemical, Neurocircuitry, and Psychopathological Mechanisms of PTSD: Emerging Pharmacotherapies and Clinical Perspectives","year":"2025","cit":15,"pfa":"Santosh Kumar Prajapati","psa":"Sairam Krishnamurthy","topics":["PTSD & trauma","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4411169427","eid":"W4411169427"},{"id":"paper-w4415102484","cat":"papers","name":"Psychedelic 5-HT2A receptor agonism alters neurovascular coupling and differentially affects neuronal and hemodynamic measures of brain function","year":"2025","cit":15,"pfa":"Jonah A. Padawer-Curry","psa":"Adam Q. Bauer","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4415102484","eid":"W4415102484"},{"id":"paper-w2080691073","cat":"papers","name":"Further Studies on Oxygenated Tryptamines with LSD-like Activity Incorporating a Chiral Pyrrolidine Moiety into the Side Chain","year":"1999","cit":15,"pfa":"Madina R. Gerasimov","psa":"David E. Nichols","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2080691073","eid":"W2080691073"},{"id":"paper-w4386580656","cat":"papers","name":"A cane toad (Rhinella marina) N-methyltransferase converts primary indolethylamines to tertiary psychedelic amines","year":"2023","cit":15,"pfa":"Chen Xue","psa":"Peter J. Facchini","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4386580656","eid":"W4386580656"},{"id":"paper-w4410307225","cat":"papers","name":"Set and setting of psychedelics for therapeutic use in psychiatry: A systematic review","year":"2025","cit":15,"pfa":"Clémentine Estric","psa":"Jorge López‐Castromán","topics":["Safety & adverse events","Reviews & meta-analyses","Therapy practice"],"ptype":"review","src":"https://openalex.org/W4410307225","eid":"W4410307225"},{"id":"paper-w4408766037","cat":"papers","name":"Anhedonia: Current and future treatments","year":"2025","cit":15,"pfa":"Alessandro Serretti","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4408766037","eid":"W4408766037"},{"id":"paper-w4403848501","cat":"papers","name":"Co-use of psychedelics with other substances: Findings from the global psychedelic survey","year":"2024","cit":15,"pfa":"Stephanie Lake","psa":"Philippe Lucas","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4403848501","eid":"W4403848501"},{"id":"paper-w2001845696","cat":"papers","name":"Pharmacology should be at the centre of all preclinical and clinical studies on new psychoactive substances (recreational drugs)","year":"2014","cit":15,"pfa":"A. Richard Green","psa":"David Nutt","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2001845696","eid":"W2001845696"},{"id":"paper-w2900730712","cat":"papers","name":"Psychedelic drugs in the treatment of anxiety, depression and addiction","year":"2018","cit":15,"pfa":"Tor-Morten Kvam","psa":"Ole A. Andreassen","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2900730712","eid":"W2900730712"},{"id":"paper-w3025670032","cat":"papers","name":"Changing scenario of addiction psychiatry: Challenges and opportunities","year":"2020","cit":15,"pfa":"PK Dalal","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3025670032","eid":"W3025670032"},{"id":"paper-w4386843295","cat":"papers","name":"Indigenous Voices in Psychedelic Therapy: Experiential Learnings from a Community-Based Group Psychedelic Therapy Program","year":"2023","cit":15,"pfa":"Emmy Manson","psa":"Shannon Dames","topics":["Safety & adverse events","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4386843295","eid":"W4386843295"},{"id":"paper-w4394960999","cat":"papers","name":"Chronic pain as an emergent property of a complex system and the potential roles of psychedelic therapies","year":"2024","cit":15,"pfa":"Maya Armstrong","psa":"Devon Christie","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4394960999","eid":"W4394960999"},{"id":"paper-w1975646863","cat":"papers","name":"Ketamine-Assisted Intravenous Sedation with Midazolam: Benefits and Potential Problems","year":"1999","cit":15,"pfa":"Ronald P. Gruber","psa":"Jean P. Waddle","ptype":"article","src":"https://openalex.org/W1975646863","eid":"W1975646863"},{"id":"paper-w2999161944","cat":"papers","name":"A dangerous method? Psychedelic therapy at Modum Bad, Norway, 1961–76","year":"2020","cit":15,"pfa":"Petter Grahl Johnstad","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2999161944","eid":"W2999161944"},{"id":"paper-w3110773874","cat":"papers","name":"Psychedelic‐assisted therapy for functional neurological disorders: A theoretical framework and review of prior reports","year":"2020","cit":15,"pfa":"Benjamin Stewart","psa":"Vikas Kotagal","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3110773874","eid":"W3110773874"},{"id":"paper-w4322763614","cat":"papers","name":"Ketamine-Assisted Group Psychotherapy for Frontline Healthcare Workers with COVID-19-Related Burnout and PTSD: A Case Series of Effectiveness/Safety for 10 Participants","year":"2023","cit":15,"pfa":"Reid J. Robison","psa":"Scott Shannon","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4322763614","eid":"W4322763614"},{"id":"paper-w4320032931","cat":"papers","name":"A scoping review of spirituality in relation to substance use disorders: Psychological, biological, and cultural issues","year":"2023","cit":15,"pfa":"Marc S. Galanter","psa":"Helena Hansen","topics":["Addiction","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4320032931","eid":"W4320032931"},{"id":"paper-w631135001","cat":"papers","name":"The Psychopharmacology of hallucinogens","year":"1978","cit":15,"pfa":"Richard C. Stillman","psa":"Robert E. Willette","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W631135001","eid":"W631135001"},{"id":"paper-w2012463271","cat":"papers","name":"MICRODOSES OF FOLIC ACID IN PREGNANCY","year":"1966","cit":15,"pfa":"D. W. Dawson","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2012463271","eid":"W2012463271"},{"id":"paper-w2026848644","cat":"papers","name":"Editors' Introduction: Hallucinogens at the Turn of the Century","year":"1998","cit":15,"pfa":"Charles S. Grob","psa":"Mariavittoria Mangini","ptype":"article","src":"https://openalex.org/W2026848644","eid":"W2026848644"},{"id":"paper-w3216081297","cat":"papers","name":"Detection of testosterone microdosing in healthy females","year":"2021","cit":15,"pfa":"Sasha Savkovic","psa":"David J. Handelsman","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3216081297","eid":"W3216081297"},{"id":"paper-w4392055224","cat":"papers","name":"Psychedelic substitution: altered substance use patterns following psychedelic use in a global survey","year":"2024","cit":15,"pfa":"Nicolas G. Glynos","psa":"Philippe Lucas","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W4392055224","eid":"W4392055224"},{"id":"paper-w1970539105","cat":"papers","name":"Psychedelics and Psychological Well-Being","year":"1982","cit":15,"pfa":"ROGER N. WALSH","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W1970539105","eid":"W1970539105"},{"id":"paper-w1531975902","cat":"papers","name":"The Genus Datura: From Research Subject to Powerful Hallucinogen","year":"1998","cit":15,"pfa":"Kirsten Bonde","ptype":"article","src":"https://openalex.org/W1531975902","eid":"W1531975902"},{"id":"paper-w4402930760","cat":"papers","name":"Validation of the imperial psychedelic predictor scale","year":"2024","cit":15,"pfa":"Michael Angyus","psa":"Robin Lester Carhart-Harris","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4402930760","eid":"W4402930760"},{"id":"paper-w4313561415","cat":"papers","name":"SnapShot: Psychedelics and serotonin receptor signaling","year":"2023","cit":15,"pfa":"Ryan H. Gumpper","psa":"Bryan L. Roth","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4313561415","eid":"W4313561415"},{"id":"paper-w4286587482","cat":"papers","name":"Editorial: Psychedelic sociality: Pharmacological and extrapharmacological perspectives","year":"2022","cit":15,"pfa":"Leor Roseman","psa":"Michael Winkelman","topics":["Dosing & pharmacology","Reviews & meta-analyses","Therapy practice"],"ptype":"editorial","src":"https://openalex.org/W4286587482","eid":"W4286587482"},{"id":"paper-w4226168848","cat":"papers","name":"Psychedelic Experiences and Mindfulness are Associated with Improved Wellbeing","year":"2022","cit":15,"pfa":"Tianhong Tim Qiu","psa":"John Paul Minda","ptype":"article","src":"https://openalex.org/W4226168848","eid":"W4226168848"},{"id":"paper-w2493914883","cat":"papers","name":"Psychedelic, Psychoactive, and Addictive Drugs and States of Consciousness","year":"2005","cit":15,"pfa":"Ralph Metzner","topics":["Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W2493914883","eid":"W2493914883"},{"id":"paper-w4400620915","cat":"papers","name":"Psychedelic public health: State of the field and implications for equity","year":"2024","cit":15,"pfa":"Heather Kuiper","psa":"Veronica Magar","topics":["Safety & adverse events","Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4400620915","eid":"W4400620915"},{"id":"paper-w4281297733","cat":"papers","name":"Ketamine for Bipolar Depression: Biochemical, Psychotherapeutic, and Psychedelic Approaches","year":"2022","cit":15,"pfa":"Raquel Bennett","psa":"GARY L. BRAVO","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4281297733","eid":"W4281297733"},{"id":"paper-w4389507951","cat":"papers","name":"The relation between naturalistic use of psychedelics and perception of emotional stimuli: An event-related potential study comparing non-users and experienced users of classic psychedelics","year":"2023","cit":15,"pfa":"Paweł Orlowski","psa":"Michał Bola","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4389507951","eid":"W4389507951"},{"id":"paper-w2801518825","cat":"papers","name":"Integrating Psychedelic Medicines and Psychiatry: Theory and Methods of a Model Clinic","year":"2018","cit":15,"pfa":"Jordan Sloshower","ptype":"book-chapter","src":"https://openalex.org/W2801518825","eid":"W2801518825"},{"id":"paper-w4307848410","cat":"papers","name":"Microdoses of Recombinant Human Erythropoietin Enhance Time Trial Performance in Trained Males and Females","year":"2022","cit":15,"pfa":"Andreas Breenfeldt Andersen","psa":"Nikolai Baastrup Nordsborg","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4307848410","eid":"W4307848410"},{"id":"paper-w3095983849","cat":"papers","name":"Ambulatory microdose induction of buprenorphine‐naloxone in two adolescent patients with sickle cell disease","year":"2020","cit":15,"pfa":"Bradley M. Buchheit","psa":"Trisha E. Wong","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3095983849","eid":"W3095983849"},{"id":"paper-w2566843563","cat":"papers","name":"Selected fatty acids as biomarkers of exposure to microdoses of molluscicides in snails Helix pomatia (Gastropoda Pulmonata)","year":"2016","cit":15,"pfa":"Danuta Kowalczyk-Pecka","psa":"Edyta Kowalczuk-Vasilev","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2566843563","eid":"W2566843563"},{"id":"paper-w4321089284","cat":"papers","name":"Converging theories on dreaming: Between Freud, predictive processing, and psychedelic research","year":"2023","cit":15,"pfa":"Michael Koslowski","psa":"Tamara Fischmann","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4321089284","eid":"W4321089284"},{"id":"paper-w2156959562","cat":"papers","name":"Microdosing studies using accelerated mass spectrometry as exploratory investigational new drug trials","year":"2011","cit":15,"pfa":"Soo Kyung Bae","psa":"Ji‐Hong Shon","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2156959562","eid":"W2156959562"},{"id":"paper-w3205629683","cat":"papers","name":"Psychedelics, Mystical Experiences, and Meaning Making: A Renegotiation Process With the Challenges of Existence","year":"2021","cit":15,"pfa":"Benjamin Hearn","topics":["Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3205629683","eid":"W3205629683"},{"id":"paper-w7125930108","cat":"papers","name":"Psychedelics elicit their effects by 5-HT2A receptor-mediated Gi signalling","year":"2026","cit":15,"pfa":"Zheng Xu","psa":"Zhenhua Shao","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7125930108","eid":"W7125930108"},{"id":"paper-w1570479498","cat":"papers","name":"Activating adaptive cellular mechanisms of resistance following sublethal cytotoxic chemotherapy: Implications for diagnostic microdosing","year":"2014","cit":15,"pfa":"Gregory T. Wurz","psa":"Michael W. DeGregorio","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1570479498","eid":"W1570479498"},{"id":"paper-w2100467998","cat":"papers","name":"A quantum-chemical and experimental study of the hallucinogen (±)-1-(2,5-dimethoxy-4-nitrophenyl)-2-aminopropane (DON)","year":"1987","cit":15,"pfa":"Juan S. Gómez-Jeria","psa":"Juan Saavedra-Aguilar","ptype":"article","src":"https://openalex.org/W2100467998","eid":"W2100467998"},{"id":"paper-w2034594002","cat":"papers","name":"Accelerating drug development: methodology to support first‐in‐man pharmacokinetic studies by the use of drug candidate microdosing","year":"2007","cit":15,"pfa":"Matthew A. McLean","psa":"Gerald R. Galluppi","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2034594002","eid":"W2034594002"},{"id":"paper-w4311934842","cat":"papers","name":"Meditation trips: A thematic analysis of the combined naturalistic use of psychedelics with meditation practices.","year":"2022","cit":15,"pfa":"Kiana Azmoodeh","psa":"Sunjeev K. Kamboj","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4311934842","eid":"W4311934842"},{"id":"paper-w69907269","cat":"papers","name":"Integrated Blast and Weed Management and Microdosing in Finger Millet: A HOPE Project Manual for Increasing Finger Millet Productivity","year":"2013","cit":15,"pfa":"M. Mgonja","psa":"O Ojulong","topics":["Dosing & pharmacology"],"ptype":"book","src":"https://openalex.org/W69907269","eid":"W69907269"},{"id":"paper-w4324017621","cat":"papers","name":"The Impact of Psychedelic Drugs on Anxiety and Depression in Advanced Cancer or other Life-threatening Disease","year":"2023","cit":15,"pfa":"Dakota J. Sicignano","psa":"Charles Michael White","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4324017621","eid":"W4324017621"},{"id":"paper-w4402645543","cat":"papers","name":"‘Mind-Revealing’ Psychedelic States: Psychological Processes in Subjective Experiences That Drive Positive Change","year":"2024","cit":15,"pfa":"Rúna F. E. Walther","psa":"Hein T. van Schie","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4402645543","eid":"W4402645543"},{"id":"paper-w3029787959","cat":"papers","name":"A microdose clinical trial to evaluate [18F]Florastamin as a positron emission tomography imaging agent in patients with prostate cancer","year":"2020","cit":15,"pfa":"Inki Lee","psa":"Sang Moo Lim","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3029787959","eid":"W3029787959"},{"id":"paper-w2798526226","cat":"papers","name":"The Psychedelic Journey of Marlene Dobkin de Rios: 45 Years with Shamans, Ayahuasqueros, and Ethnobotanists","year":"2009","cit":15,"pfa":"Marlene Dobkin de Ríos","ptype":"book","src":"https://openalex.org/W2798526226","eid":"W2798526226"},{"id":"paper-w4319457565","cat":"papers","name":"A survey of Australian psychiatrists’ and psychiatry trainees’ knowledge of and attitudes towards psychedelics in the treatment of psychiatric disorders","year":"2023","cit":15,"pfa":"Cameron Grover","psa":"Mark Enea Montebello","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4319457565","eid":"W4319457565"},{"id":"paper-w4405955628","cat":"papers","name":"Psychedelic Regulation Beyond the Controlled Substances Act: A Three-Dimensional Framework for Characterizing Policy Options","year":"2025","cit":15,"pfa":"Maha N. Mian","psa":"Brian T. Anderson","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4405955628","eid":"W4405955628"},{"id":"paper-w3139535421","cat":"papers","name":"Using Microdosing to Induct Patients Into a Long-Acting Injectable Buprenorphine Depot Medication in Low Threshold Community Settings: A Case Study","year":"2021","cit":15,"pfa":"Joseph Tay Wee Teck","psa":"Con Lafferty","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3139535421","eid":"W3139535421"},{"id":"paper-w2094981784","cat":"papers","name":"Comparison of estradiol and progesterone priming/antagonist/letrozole and microdose flare-up protocols for poor responders undergoing intracytoplasmic sperm injection","year":"2014","cit":15,"pfa":"Oğuz Yücel","psa":"Serçin Karahüseyinoğlu","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2094981784","eid":"W2094981784"},{"id":"paper-w2724657121","cat":"papers","name":"Comparing triggers to visual disturbances among individuals with positive vs negative experiences of hallucinogen-persisting perception disorder (HPPD) following LSD use","year":"2017","cit":15,"pfa":"Shaul Lev‐Ran","psa":"Arturo G. Lerner","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2724657121","eid":"W2724657121"},{"id":"paper-w4292187617","cat":"papers","name":"Is psychedelic use associated with cancer?: Interrogating a half-century-old claim using contemporary population-level data","year":"2022","cit":15,"pfa":"Brian Scott Barnett","psa":"Andrew D. Carlo","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4292187617","eid":"W4292187617"},{"id":"paper-w2083478398","cat":"papers","name":"Psychotomimetic and Related Higher Plants","year":"1972","cit":15,"pfa":"Norman R. Farnsworth","ptype":"article","src":"https://openalex.org/W2083478398","eid":"W2083478398"},{"id":"paper-w2052499786","cat":"papers","name":"Structure-Activity Correlations for Psychotomimetics. III. Tryptamines","year":"1995","cit":15,"pfa":"BW Clare","ptype":"article","src":"https://openalex.org/W2052499786","eid":"W2052499786"},{"id":"paper-w4386522889","cat":"papers","name":"DNA methylation and the opposing NMDAR dysfunction in schizophrenia and major depression disorders: a converging model for the therapeutic effects of psychedelic compounds in the treatment of psychiatric illness","year":"2023","cit":15,"pfa":"L. Taylor Flynn","psa":"Wen‐Jun Gao","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4386522889","eid":"W4386522889"},{"id":"paper-w2112889814","cat":"papers","name":"The Psychotomimetic Amphetamines with Special Reference to DOM (STP) Toxicity","year":"1969","cit":15,"pfa":"David Eugene Smith","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2112889814","eid":"W2112889814"},{"id":"paper-w2057633938","cat":"papers","name":"Effect of psychotomimetics and some putative anxiolytics on stress-induced hyperthermia","year":"1991","cit":15,"pfa":"Alessandro Lecci","psa":"Alberto Meli","ptype":"article","src":"https://openalex.org/W2057633938","eid":"W2057633938"},{"id":"paper-w2124219161","cat":"papers","name":"Follicular synchronization using transdermal estradiol patch and GnRH antagonists in the luteal phase; does it increase oocyte yield in poor responders to gonadotropin stimulation for in vitro fertilization (IVF)? A comp","year":"2011","cit":15,"pfa":"Barış Ata","psa":"Seang Lin Tan","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2124219161","eid":"W2124219161"},{"id":"paper-w2051954104","cat":"papers","name":"Discordant behavioral effects of psychotomimetic drugs in mice with altered NMDA receptor function","year":"2010","cit":15,"pfa":"Michael A. Benneyworth","psa":"Joseph T. Coyle","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2051954104","eid":"W2051954104"},{"id":"paper-w2024935812","cat":"papers","name":"Suppression of serotonin-dependent cerebral activation: a possible mechanism of action of some psychotomimetic drugs","year":"1987","cit":15,"pfa":"C.H. Vanderwolf","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2024935812","eid":"W2024935812"},{"id":"paper-w4251244189","cat":"papers","name":"Sub-chronic psychotomimetic phencyclidine induces deficits in reversal learning and alterations in parvalbumin-immunoreactive expression in the rat","year":"2006","cit":15,"pfa":"Z. Abdul-Monim","psa":"G P Reynolds","ptype":"article","src":"https://openalex.org/W4251244189","eid":"W4251244189"},{"id":"paper-w3207603150","cat":"papers","name":"New trends in pharmacological control of neuropsychiatric symptoms of dementia","year":"2021","cit":15,"pfa":"Damiana Scuteri","psa":"Giacinto Bagetta","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W3207603150","eid":"W3207603150"},{"id":"paper-w2520525918","cat":"papers","name":"Multivariate optimization of the hollow fibre liquid phase microextraction of muscimol in human urine samples","year":"2016","cit":15,"pfa":"Somandla Ncube","psa":"Luke Chimuka","ptype":"article","src":"https://openalex.org/W2520525918","eid":"W2520525918"},{"id":"paper-w3123302588","cat":"papers","name":"Behavioral arrest and a characteristic slow waveform are hallmark responses to selective 5-HT2A receptor activation","year":"2021","cit":15,"pfa":"April Contreras","psa":"Dustin J. Hines","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3123302588","eid":"W3123302588"},{"id":"paper-w2898910091","cat":"papers","name":"Correlation of Platinum Cytotoxicity to Drug-DNA Adduct Levels in a Breast Cancer Cell Line Panel","year":"2018","cit":15,"pfa":"Sisi Wang","psa":"Paul T. Henderson","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2898910091","eid":"W2898910091"},{"id":"paper-w2151981119","cat":"papers","name":"Narcotics Dependence in Pregnancy","year":"1975","cit":15,"pfa":"Loretta P. Finnegan","ptype":"article","src":"https://openalex.org/W2151981119","eid":"W2151981119"},{"id":"paper-w2030630690","cat":"papers","name":"Psychiatry and homoeopathy","year":"1994","cit":15,"pfa":"Jonathan R. T. Davidson","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2030630690","eid":"W2030630690"},{"id":"paper-w2155244746","cat":"papers","name":"The Hallucinogenic Drugs—Curse or Blessing?","year":"1967","cit":15,"pfa":"Stephen Szára","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2155244746","eid":"W2155244746"},{"id":"paper-w144376617","cat":"papers","name":"Some Compounds With Hallucinogenic Activity","year":"1978","cit":15,"pfa":"Albert Fanchamps","ptype":"book-chapter","src":"https://openalex.org/W144376617","eid":"W144376617"},{"id":"paper-w110677432","cat":"papers","name":"Effect of pharmacological agents on male reproduction.","year":"1987","cit":15,"pfa":"A R Chowdhury","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W110677432","eid":"W110677432"},{"id":"paper-w1987333462","cat":"papers","name":"Vasopressin-like effects of a hallucinogenic drug-harmaline-on sodium and water transport","year":"1978","cit":15,"pfa":"R. C. de Sousa","psa":"A. Grosso","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1987333462","eid":"W1987333462"},{"id":"paper-w4409592678","cat":"papers","name":"The Power of Lifestyle Psychiatry: A New Approach to Mental Health","year":"2025","cit":15,"pfa":"Gia Merlo","psa":"Steven G. Sugden","topics":["PTSD & trauma","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4409592678","eid":"W4409592678"},{"id":"paper-w2087006737","cat":"papers","name":"Characteristics of Inner City Heroin Addicts Applying for Treatment in a Veteran Administration Hospital Drug Program (Chicago)","year":"1980","cit":15,"pfa":"Robert J. Craig","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2087006737","eid":"W2087006737"},{"id":"paper-w3158696162","cat":"papers","name":"Augmentation of Psychotherapy with Neurobiological Methods: Current State and Future Directions","year":"2021","cit":15,"pfa":"Elisabeth Hertenstein","psa":"Christoph Nissen","topics":["Anxiety & end-of-life","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3158696162","eid":"W3158696162"},{"id":"paper-w4301908460","cat":"papers","name":"Rapid modulation of spine morphology by the 5-HT2A serotonin receptor through kalirin-7 signaling","year":"2020","cit":15,"pfa":"P. Penzes","psa":"J. A. Allen","topics":["Depression","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4301908460","eid":"W4301908460"},{"id":"paper-w2118465968","cat":"papers","name":"A Kappa Opioid Model of Atypical Altered Consciousness and Psychosis: U50488, DOI, AC90179 Effects on Prepulse Inhibition and Locomotion in Mice.","year":"2009","cit":15,"pfa":"Michael A. Ruderman","psa":"Mark A. Geyer","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2118465968","eid":"W2118465968"},{"id":"paper-w1989543575","cat":"papers","name":"Long Lasting Effects of LSD on Normals","year":"1970","cit":15,"pfa":"William H. McGlothlin","psa":"Marcella S. McGlothlin","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W1989543575","eid":"W1989543575"},{"id":"paper-w4399940235","cat":"papers","name":"Lithium and its effects: does dose matter?","year":"2024","cit":15,"pfa":"Mirko Manchia","psa":"Tomáš Hájek","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4399940235","eid":"W4399940235"},{"id":"paper-w2331052169","cat":"papers","name":"FDA Introduces New Phase 0 for Clinical Trials","year":"2006","cit":15,"pfa":"Margot Joan Fromer","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2331052169","eid":"W2331052169"},{"id":"paper-w4406799600","cat":"papers","name":"Demystifying the Antidepressant Mechanism of Action of Stinels, a Novel Class of Neuroplastogens: Positive Allosteric Modulators of the NMDA Receptor","year":"2025","cit":15,"pfa":"John E. Donello","psa":"Stephen M. Stahl","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4406799600","eid":"W4406799600"},{"id":"paper-w2587748623","cat":"papers","name":"Rapid Antidepressant Activity of Ketamine Beyond NMDA Receptor","year":"2017","cit":15,"pfa":"Kenji Hashimoto","topics":["Depression","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W2587748623","eid":"W2587748623"},{"id":"paper-w3087361027","cat":"papers","name":"Cannabidiol Modulates the Motor Profile and NMDA Receptor-related Alterations Induced by Ketamine","year":"2020","cit":15,"pfa":"Charalampos Brakatselos","psa":"Katerina Antoniou","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3087361027","eid":"W3087361027"},{"id":"paper-w2735535979","cat":"papers","name":"GPR 88 in A2A receptor‐expressing neurons modulates locomotor response to dopamine agonists but not sensorimotor gating","year":"2017","cit":15,"pfa":"Aura Carole Meirsman","psa":"Abdel‐Mouttalib Ouagazzal","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2735535979","eid":"W2735535979"},{"id":"paper-w3125524977","cat":"papers","name":"IMPORTANCE trial: a provisional study-design of a single-center, phase II, double-blinded, placebo-controlled, randomized, 4-week study to compare the efficacy and safety of intranasal esketamine in chronic opioid refrac","year":"2021","cit":15,"pfa":"Mauricio Fernandes","psa":"Felipe Fregni","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3125524977","eid":"W3125524977"},{"id":"paper-w2047966230","cat":"papers","name":"Interaction of [3H](–)‐SKF‐10,047 with Brain σ Receptors: Characterization and Autoradiographic Visualization","year":"1986","cit":15,"pfa":"Stephen R. Zukin","psa":"Ruth Suzanne Zukin","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2047966230","eid":"W2047966230"},{"id":"paper-w2803676045","cat":"papers","name":"The acute and residual effects of escalating, analgesic-range doses of ketamine on driving performance: A simulator study","year":"2018","cit":15,"pfa":"Amie C. Hayley","psa":"Yahya Shehabi","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2803676045","eid":"W2803676045"},{"id":"paper-w1978075702","cat":"papers","name":"High-Dose Ketamine in the Management of Cancer-Related Neuropathic Pain","year":"2000","cit":15,"pfa":"Yoko Tarumi","psa":"Kunihiko Ishitani","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1978075702","eid":"W1978075702"},{"id":"paper-w2004534311","cat":"papers","name":"Happy 50th Anniversary Ketamine","year":"2013","cit":15,"pfa":"Frédéric Dorandeu","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2004534311","eid":"W2004534311"},{"id":"paper-w3158010847","cat":"papers","name":"Esketamine","year":"2021","cit":15,"pfa":"Nicholas Mischel","psa":"Richard Balon","ptype":"article","src":"https://openalex.org/W3158010847","eid":"W3158010847"},{"id":"paper-w4229005782","cat":"papers","name":"Craving and addictive potential of esketamine as side effects?","year":"2022","cit":15,"pfa":"Laura Orsolini","psa":"Umberto Volpe","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4229005782","eid":"W4229005782"},{"id":"paper-w2936959794","cat":"papers","name":"Esketamine nasal spray approved for treatment-resistant depression","year":"2019","cit":15,"pfa":"Kate Traynor","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2936959794","eid":"W2936959794"},{"id":"paper-w4296281078","cat":"papers","name":"Longitudinal Course of Adverse Events With Esketamine Nasal Spray","year":"2022","cit":15,"pfa":"David J. G. Williamson","psa":"Ella Daly","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4296281078","eid":"W4296281078"},{"id":"paper-w4389346328","cat":"papers","name":"cAMP-dependent protein kinase signaling is required for (2R,6R)-hydroxynorketamine to potentiate hippocampal glutamatergic transmission","year":"2023","cit":15,"pfa":"Lace Marie Riggs","psa":"Todd D. Gould","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4389346328","eid":"W4389346328"},{"id":"paper-w4386886825","cat":"papers","name":"Early effects predict trajectories of response to esketamine in treatment-resistant depression","year":"2023","cit":15,"pfa":"Isaure Estrade","psa":"Philip A. P. M. Gorwood","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4386886825","eid":"W4386886825"},{"id":"paper-w4403985542","cat":"papers","name":"Esketamine Nasal Spray: Rapid Relief for TRD and Suicide Prevention—Mechanisms and Pharmacodynamics","year":"2024","cit":15,"pfa":"Hui Song","psa":"Lingzhi Fang","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4403985542","eid":"W4403985542"},{"id":"paper-w4408518934","cat":"papers","name":"Rapid hippocampal synaptic potentiation induced by ketamine metabolite (2R,6R)-hydroxynorketamine persistently primes synaptic plasticity","year":"2025","cit":15,"pfa":"Kyle A. Brown","psa":"Todd D. Gould","ptype":"article","src":"https://openalex.org/W4408518934","eid":"W4408518934"},{"id":"paper-w4404027312","cat":"papers","name":"Intranasal esketamine for patients with major depressive disorder: A systematic review and meta-analysis","year":"2024","cit":15,"pfa":"Soroush Oraee","psa":"Mohammad Javad Nasiri","topics":["Depression","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4404027312","eid":"W4404027312"},{"id":"paper-w4390667466","cat":"papers","name":"Hypersomnia as a predictor of response to intravenous ketamine/intranasal esketamine in treatment resistant depression","year":"2024","cit":15,"pfa":"Liliana Patarroyo-Rodríguez","psa":"Balwinder Singh","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4390667466","eid":"W4390667466"},{"id":"paper-w3009413105","cat":"papers","name":"Enzyme-Mediated Two-Step Regio- and Stereoselective Synthesis of Potential Rapid-Acting Antidepressant (2S,6S)-Hydroxynorketamine","year":"2020","cit":15,"pfa":"Ansgar Bokel","psa":"Vlada B. Urlacher","topics":["Depression","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3009413105","eid":"W3009413105"},{"id":"paper-w3168592475","cat":"papers","name":"Improvement of functional neurological disorder after administration of esketamine nasal spray: a case report","year":"2021","cit":15,"pfa":"Júlia Vendrell-Serres","psa":"Josep Antoni Ramos‐Quiroga","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3168592475","eid":"W3168592475"},{"id":"paper-w4408740001","cat":"papers","name":"Efficacy and safety of esketamine in preventing perioperative neurocognitive disorders: a meta-analysis of randomized controlled studies","year":"2025","cit":15,"pfa":"Kuo‐Chuan Hung","psa":"I‐Wen Chen","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4408740001","eid":"W4408740001"},{"id":"paper-w4402920125","cat":"papers","name":"Effects of adjunctive esketamine on depression in elderly patients undergoing hip fracture surgery: a randomized controlled trial","year":"2024","cit":15,"pfa":"Jiajing Cai","psa":"Juncheng Xiong","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4402920125","eid":"W4402920125"},{"id":"paper-w4392429347","cat":"papers","name":"A randomized double-blind trial of intranasal dexmedetomidine versus intranasal esketamine for procedural sedation and analgesia in young children","year":"2024","cit":15,"pfa":"Anna Nikula","psa":"Lisa Kurland","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4392429347","eid":"W4392429347"},{"id":"paper-w4399463275","cat":"papers","name":"Comparison of propofol‐esketamine versus propofol‐sufentanil for deep sedation and analgesia in children with autism: A randomized double‐blind clinical trial","year":"2024","cit":15,"pfa":"Yanxiang Miao","psa":"Ning Yin","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4399463275","eid":"W4399463275"},{"id":"paper-w4389038588","cat":"papers","name":"Esketamine mitigates cognitive impairment following exposure to LPS by modulating the intestinal flora/subdiaphragmatic vagus nerve/spleen axis","year":"2023","cit":15,"pfa":"Yuming Wu","psa":"Shiying Yuan","ptype":"article","src":"https://openalex.org/W4389038588","eid":"W4389038588"},{"id":"paper-w4402419877","cat":"papers","name":"Efficacy and safety of esketamine versus propofol in electroconvulsive therapy for treatment-resistant depression: A randomized, double-blind, controlled, non-inferiority trial","year":"2024","cit":15,"pfa":"Qing-Bin Zeng","psa":"Wei Zheng","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4402419877","eid":"W4402419877"},{"id":"paper-w4398174045","cat":"papers","name":"Efficacy and safety of peri-partum Esketamine for prevention of post-partum depression in women undergoing caesarian section: A meta-analysis and systematic review of randomized controlled trials","year":"2024","cit":15,"pfa":"Muhammad Anas Nayyer","psa":"Madah Fatima","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4398174045","eid":"W4398174045"},{"id":"paper-w4411079702","cat":"papers","name":"Effect of Esketamine for Patient-Controlled Intravenous Analgesia on Postoperative Sleep Disturbance in the Elderly After Total Hip or Knee Arthroplasty: A Prospective, Randomized, Double-Blind, and Controlled Trial","year":"2025","cit":15,"pfa":"Yan Zhao","psa":"Ming Yan","ptype":"article","src":"https://openalex.org/W4411079702","eid":"W4411079702"},{"id":"paper-w4411538491","cat":"papers","name":"Effect of low-dose supplemental esketamine infusion on the intraoperative frontal electroencephalography dynamics and postoperative sleep disturbance during gynecological laparoscopic surgery: a double-blind, randomized","year":"2025","cit":15,"pfa":"Yanhong Zhou","psa":"Lili Xu","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4411538491","eid":"W4411538491"},{"id":"paper-w4400999874","cat":"papers","name":"Esketamine mitigates mechanical ventilation-induced lung injury in chronic obstructive pulmonary disease rats via inhibition of the MAPK/NF-κB signaling pathway and reduction of oxidative stress","year":"2024","cit":15,"pfa":"San-Ying Cai","psa":"Zhi-Yuan Chen","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4400999874","eid":"W4400999874"},{"id":"paper-w4389479506","cat":"papers","name":"Short-term ketamine use in bipolar depression: a review of the evidence for short-term treatment management","year":"2023","cit":15,"pfa":"Alina Wilkowska","psa":"Wiesław Jerzy Cubała","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4389479506","eid":"W4389479506"},{"id":"paper-w4391734563","cat":"papers","name":"Exploring Esketamine's Therapeutic Outcomes as an FDA-Designated Breakthrough for Treatment-Resistant Depression and Major Depressive Disorder With Suicidal Intent: A Narrative Review","year":"2024","cit":15,"pfa":"Suneeta Kumari","psa":"Saba Afzal","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W4391734563","eid":"W4391734563"},{"id":"paper-w4293870261","cat":"papers","name":"BDNF Alterations in Brain Areas and the Neurocircuitry Involved in the Antidepressant Effects of Ketamine in Animal Models, Suggest the Existence of a Primary Circuit of Depression","year":"2022","cit":15,"pfa":"Ezio Carboni","psa":"Anna Rosa Carta","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4293870261","eid":"W4293870261"},{"id":"paper-w2058447319","cat":"papers","name":"Cross tolerance to tryptamine in the LSD tolerant dog","year":"1972","cit":15,"pfa":"William R. Martin","psa":"C. G. Eades","ptype":"article","src":"https://openalex.org/W2058447319","eid":"W2058447319"},{"id":"paper-w1961057301","cat":"papers","name":"Lysergic Acid Diethylamide and Psilocybin Revisited","year":"2015","cit":14,"pfa":"Mark A. Geyer","ptype":"article","src":"https://openalex.org/W1961057301","eid":"W1961057301"},{"id":"paper-w2017145453","cat":"papers","name":"Hypersensitivity to lysergic acid diethylamide (LSD-25) and psilocybin in essential headache","year":"1974","cit":14,"pfa":"Marcello Fanciullacci","psa":"F Sicuteri","ptype":"article","src":"https://openalex.org/W2017145453","eid":"W2017145453"},{"id":"paper-w2086698362","cat":"papers","name":"Mass Spectrometry of Lysergic Acid Diethylamide","year":"1969","cit":14,"pfa":"Ishwar C. Nigam","psa":"John L. Holmes","ptype":"article","src":"https://openalex.org/W2086698362","eid":"W2086698362"},{"id":"paper-w1977262257","cat":"papers","name":"Synthesis of deuterium labeled standards of 5‐methoxy‐N,N‐dimethyltryptamine (5‐Meo‐DMT)","year":"2006","cit":14,"pfa":"Ya-Zhu Xu","psa":"Chinpiao Chen","ptype":"article","src":"https://openalex.org/W1977262257","eid":"W1977262257"},{"id":"paper-w51668826","cat":"papers","name":"Ocular effects of diacetyl morphine and lysergic acid diethylamide in rabbit.","year":"1975","cit":14,"pfa":"K Green","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W51668826","eid":"W51668826"},{"id":"paper-w4410466765","cat":"papers","name":"Psychedelic-like effects induced by 2,5-dimethoxy-4-iodoamphetamine, lysergic acid diethylamide, and psilocybin in male and female C57BL/6J mice","year":"2025","cit":14,"pfa":"Shelby A. McGriff","psa":"Grant C. Glatfelter","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4410466765","eid":"W4410466765"},{"id":"paper-w2075151719","cat":"papers","name":"Effects of lysergic acid diethylamide on autonomic post‐ganglionic transmission.","year":"1975","cit":14,"pfa":"N Ambache","psa":"M. ABOO ZAR","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2075151719","eid":"W2075151719"},{"id":"paper-w2038005696","cat":"papers","name":"Lysergic Acid Diethylamide and Stimulus Generalization: Rate-Dependent Effects","year":"1972","cit":14,"pfa":"Linda Dykstra","psa":"James B. Appel","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2038005696","eid":"W2038005696"},{"id":"paper-w3111213118","cat":"papers","name":"Effect of lysergic acid diethylamide (LSD) on reinforcement learning in humans","year":"2020","cit":14,"pfa":"Jonathan W. Kanen","psa":"Hanneke E.M. den Ouden","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W3111213118","eid":"W3111213118"},{"id":"paper-w1984549640","cat":"papers","name":"Lysergic Acid Diethylamide (LSD-25): VIII. Effect on Arithmetic Test Performance","year":"1955","cit":14,"pfa":"Murray E. Jarvik","psa":"A. T. Ewald","ptype":"article","src":"https://openalex.org/W1984549640","eid":"W1984549640"},{"id":"paper-w1991184925","cat":"papers","name":"d-Lysergic acid diethylamide (LSD-25): A constrictor of human umbilical vein","year":"1971","cit":14,"pfa":"D.W. Gant","psa":"D. C. Dyer","ptype":"article","src":"https://openalex.org/W1991184925","eid":"W1991184925"},{"id":"paper-w2063693121","cat":"papers","name":"THE INFLUENCE OF VARYING DOSAGE ON THE EFFECTS OF LYSERGIC ACID DIETHYLAMIDE (LSD-25) IN HUMANS","year":"1961","cit":14,"pfa":"Gerald D. Klee","psa":"Enoch Callaway","ptype":"article","src":"https://openalex.org/W2063693121","eid":"W2063693121"},{"id":"paper-w2010949579","cat":"papers","name":"Enzymatic formation of a phenolic metabolite from lysergic acid diethylamide by rat liver microsomes","year":"1963","cit":14,"pfa":"Stephen Szára","ptype":"article","src":"https://openalex.org/W2010949579","eid":"W2010949579"},{"id":"paper-w2403673974","cat":"papers","name":"Hyperthermic effects of D-lysergic acid diethylamide (LSD) and its derivatives in rabbits and rats.","year":"1977","cit":14,"pfa":"Hisakuni Hashimoto","psa":"Hisashi Ishii","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2403673974","eid":"W2403673974"},{"id":"paper-w2416837946","cat":"papers","name":"The isolation of an O-methyltransferase from peyote and its role in the biosynthesis of mescaline.","year":"1971","cit":14,"pfa":"Basmadjian Gp","psa":"A G Paul","ptype":"article","src":"https://openalex.org/W2416837946","eid":"W2416837946"},{"id":"paper-w2076195482","cat":"papers","name":"Ca2+ channel blockade prevents lysergic acid diethylamide-induced changes in dopamine and serotonin metabolism","year":"1997","cit":14,"pfa":"Lucyna Antkiewicz‐Michaluk","psa":"Jerzy Vetulani","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2076195482","eid":"W2076195482"},{"id":"paper-w4387681248","cat":"papers","name":"Comprehensive detection of lysergic acid diethylamide (LSD) in forensic samples using carbon nanotube screen-printed electrodes","year":"2023","cit":14,"pfa":"Anne Alves Macedo","psa":"Wallans Torres Pio dos Santos","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4387681248","eid":"W4387681248"},{"id":"paper-w4396733072","cat":"papers","name":"Enhanced detection of lysergic acid diethylamide using Ehrlich reagent and screen-printed electrodes: A hybrid method for application in forensic analysis","year":"2024","cit":14,"pfa":"Mariane O.B. Arrieiro","psa":"Wallans Torres Pio dos Santos","ptype":"article","src":"https://openalex.org/W4396733072","eid":"W4396733072"},{"id":"paper-w2075515333","cat":"papers","name":"THE INFLUENCE OF SEROTONIN, D‐LYSERGIC ACID DIETHYLAMIDE AND 2‐BROM‐LSD ON THE INCORPORATION OF [35S]METHIONINE INTO BRAIN PROTEINS AND ON THE LEVEL OF ATP IN THE BRAIN*","year":"1961","cit":14,"pfa":"Jerzy Krawczyński","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2075515333","eid":"W2075515333"},{"id":"paper-w3127123233","cat":"papers","name":"Sensitive quantitative analysis of psilocin and psilocybin in hair samples from suspected users and their distribution in seized hallucinogenic mushrooms","year":"2021","cit":14,"pfa":"Liying Zhou","psa":"Wanhui Liu","ptype":"article","src":"https://openalex.org/W3127123233","eid":"W3127123233"},{"id":"paper-w2415784735","cat":"papers","name":"The action of lysergic acid diethylamide (LSD 25), its 2-brom derivative (BOL 148) and of 5-hydroxytryptamine (5-HT) on the peristaltic reflex of the guinea-pig ileum.","year":"1957","cit":14,"pfa":"K. H. Ginzel","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2415784735","eid":"W2415784735"},{"id":"paper-w2071951457","cat":"papers","name":"Alicyclic Analogue of Mescaline","year":"1968","cit":14,"pfa":"Gary C. Walters","psa":"P. D. COOPER","ptype":"article","src":"https://openalex.org/W2071951457","eid":"W2071951457"},{"id":"paper-w3193440797","cat":"papers","name":"Psilocybin for Depression","year":"2021","cit":14,"pfa":"Robin Lester Carhart-Harris","psa":"David Nutt","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W3193440797","eid":"W3193440797"},{"id":"paper-w2042965512","cat":"papers","name":"Identification of N,N-dimethyltryptamine, 5-methoxy-N,N-dimethyltryptamine and bufotenin by cellulose TLC","year":"1973","cit":14,"pfa":"Pierre Baumann","psa":"N. Narasimhachari","ptype":"article","src":"https://openalex.org/W2042965512","eid":"W2042965512"},{"id":"paper-w2018843588","cat":"papers","name":"Unambiguous NMR spectral assignments of salvinorin A","year":"2007","cit":14,"pfa":"José‐Luis Giner","psa":"Jordan Kordian Zjawiony","ptype":"article","src":"https://openalex.org/W2018843588","eid":"W2018843588"},{"id":"paper-w2052780834","cat":"papers","name":"THE EFFECT OF MESCALINE ON DIFFERENTIATED CONDITIONAL REFLEXES","year":"1956","cit":14,"pfa":"Wagner H. Bridger","psa":"W. Horsley Gantt","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2052780834","eid":"W2052780834"},{"id":"paper-w4404546069","cat":"papers","name":"Ayahuasca: Pharmacology, Safety, and Therapeutic Effects","year":"2024","cit":14,"pfa":"RAFAEL GUIMARÃES DOS SANTOS","psa":"Jaime E. C. Hallak","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W4404546069","eid":"W4404546069"},{"id":"paper-w2306442299","cat":"papers","name":"THE ACTION OF MESCALINE AND SOME RELATED COMPOUNDS","year":"1934","cit":14,"pfa":"GEORGE S. GRACE","ptype":"article","src":"https://openalex.org/W2306442299","eid":"W2306442299"},{"id":"paper-w2065455020","cat":"papers","name":"Electroencephalographic studies on the development of tolerance and cross tolerance to mescaline in the rat","year":"1975","cit":14,"pfa":"Brenda K. Colasanti","psa":"Naim Khazan","ptype":"article","src":"https://openalex.org/W2065455020","eid":"W2065455020"},{"id":"paper-w2440357235","cat":"papers","name":"Psilocybin: a pharmacological profile.","year":"1974","cit":14,"pfa":"Aboul-Enein Hy","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2440357235","eid":"W2440357235"},{"id":"paper-w2408882290","cat":"papers","name":"[Dimethyltryptamine: a new psycho-active drug].","year":"2000","cit":14,"pfa":"A.S. Sai-Halász","psa":"St. Szára","ptype":"article","src":"https://openalex.org/W2408882290","eid":"W2408882290"},{"id":"paper-w2313297127","cat":"papers","name":"The Alkaloids of Tabernanthe Iboga. VII.1 Derivatives of Isoquinuclidine","year":"1958","cit":14,"pfa":"Lincoln H. Werner","psa":"S. Ricca","ptype":"article","src":"https://openalex.org/W2313297127","eid":"W2313297127"},{"id":"paper-w2092970959","cat":"papers","name":"Ayahuasca Alters Structural Parameters of the Rat Aorta","year":"2015","cit":14,"pfa":"Dimítrius Leonardo Pitol","psa":"Simone Cecílio Hallak Regalo","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2092970959","eid":"W2092970959"},{"id":"paper-w1564403634","cat":"papers","name":"A new metabolic pathway for N,N-dimethyltryptamine","year":"1986","cit":14,"pfa":"Lew Mykola Hryhorczuk","psa":"Edward A. Novak","ptype":"article","src":"https://openalex.org/W1564403634","eid":"W1564403634"},{"id":"paper-w2070189723","cat":"papers","name":"Studies on mescaline XI: Biochemical findings during the mescaline-induced state with observations on the blocking action of different psychotropic drugs","year":"1961","cit":14,"pfa":"Herman C.B. Denber","ptype":"article","src":"https://openalex.org/W2070189723","eid":"W2070189723"},{"id":"paper-w2138382252","cat":"papers","name":"Analysis of MDMA and its Metabolites in Urine and Plasma Following a Neurotoxic Dose of MDMA","year":"2007","cit":14,"pfa":"Sandra Valtier","psa":"John T. Cody","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2138382252","eid":"W2138382252"},{"id":"paper-w4386126549","cat":"papers","name":"Psilocybin desynchronizes brain networks","year":"2023","cit":14,"pfa":"Joshua S. Siegel","psa":"Ginger E. Nicol","topics":["Depression","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4386126549","eid":"W4386126549"},{"id":"paper-w2160339735","cat":"papers","name":"Stimulation of [14C] serotonin synthesis from [14C] tryptophan by mescaline in rat pineal organ cultures","year":"1971","cit":14,"pfa":"Harvey M. Shein","psa":"Richard Jay Wurtman","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2160339735","eid":"W2160339735"},{"id":"paper-w2080114144","cat":"papers","name":"Treating MDMA (‘Ecstasy’) toxicity","year":"1994","cit":14,"pfa":"A. Padkin","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2080114144","eid":"W2080114144"},{"id":"paper-w2335613911","cat":"papers","name":"Synthesis of Phenethylamines Related to Mescaline as Possible Psychotomimetic Agents1","year":"1963","cit":14,"pfa":"Orrie M. Friedman","psa":"SUMNER H. BURSTEIN","ptype":"article","src":"https://openalex.org/W2335613911","eid":"W2335613911"},{"id":"paper-w1546259857","cat":"papers","name":"Oxidative metabolism of mescaline in the central nervous system—III","year":"1974","cit":14,"pfa":"Nikolaus Seiler","psa":"L. Demisch","ptype":"article","src":"https://openalex.org/W1546259857","eid":"W1546259857"},{"id":"paper-w1781543641","cat":"papers","name":"3,4,5-Trimethoxybenzoic acid, a new mescaline metabolite in humans.","year":"1978","cit":14,"pfa":"L. Demisch","psa":"Nikolaus Seiler","ptype":"article","src":"https://openalex.org/W1781543641","eid":"W1781543641"},{"id":"paper-w2068537568","cat":"papers","name":"Ibogaine alters synaptosomal and glial glutamate release and uptake","year":"2001","cit":14,"pfa":"Mirna Bainy Leal","psa":"Elaine Elisabetsky","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2068537568","eid":"W2068537568"},{"id":"paper-w2064711048","cat":"papers","name":"Quantitation of ibogaine and 12-hydroxyibogamine in human plasma by liquid chromatography with fluorimetric detection","year":"2005","cit":14,"pfa":"Violeta Kontrimavičiūtė","psa":"Françoise Bressolle","ptype":"article","src":"https://openalex.org/W2064711048","eid":"W2064711048"},{"id":"paper-w2156852799","cat":"papers","name":"Pneumomediastinum in association with mdma ingestion","year":"2001","cit":14,"pfa":"John M. Ryan","psa":"A. Bong","ptype":"article","src":"https://openalex.org/W2156852799","eid":"W2156852799"},{"id":"paper-w4401554225","cat":"papers","name":"Psilocybin for clinical indications: A scoping review","year":"2024","cit":14,"pfa":"Kim Madden","psa":"Anthony F. Adili","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4401554225","eid":"W4401554225"},{"id":"paper-w4309360340","cat":"papers","name":"Psilocybin mushrooms for psychological and existential distress","year":"2022","cit":14,"pfa":"Ryan Patchett-Marble","psa":"Emma Hapke","topics":["Anxiety & end-of-life","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4309360340","eid":"W4309360340"},{"id":"paper-w3156705073","cat":"papers","name":"Analysis of 28 hair samples from users of the hallucinogenic beverage ayahuasca","year":"2021","cit":14,"pfa":"Mengxi Liu","psa":"Yan Shi","ptype":"article","src":"https://openalex.org/W3156705073","eid":"W3156705073"},{"id":"paper-w2557998092","cat":"papers","name":"Psilocybin and palliative end-of-life care","year":"2016","cit":14,"pfa":"Richard Charles Shelton","psa":"Peter S. Hendricks","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2557998092","eid":"W2557998092"},{"id":"paper-w2413842568","cat":"papers","name":"An electrographic study of psilocin and 4-methyl-alpha-methyl tryptamine (MP-809).","year":"1963","cit":14,"pfa":"James F. Brodey","psa":"Harold E. Himwich","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2413842568","eid":"W2413842568"},{"id":"paper-w2069822026","cat":"papers","name":"Neurochemical Substrates of MDMA Reward: Effects of the Inhibition of Serotonin Reuptake on the Acquisition and Reinstatement of MDMA-induced CPP","year":"2013","cit":14,"pfa":"C. Roger-Sánchez","psa":"Marta Rodríguez‐Arias","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2069822026","eid":"W2069822026"},{"id":"paper-w2183805917","cat":"papers","name":"EXTRACTION AND ANALYTICAL STUDY OF SALVINORIN A FROM LEAVES OF SALVIA DIVINORUM","year":"2015","cit":14,"pfa":"Marius Pentea","psa":"Monica Butnariu","ptype":"article","src":"https://openalex.org/W2183805917","eid":"W2183805917"},{"id":"paper-w4404004370","cat":"papers","name":"Optimized psilocybin production in tryptophan catabolism‐repressed fungi","year":"2024","cit":14,"pfa":"Slavica Janevska","psa":"Johann E. Kufs","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W4404004370","eid":"W4404004370"},{"id":"paper-w2415329247","cat":"papers","name":"Psychedelic and nonpsychedelic LSD and psilocybin for cluster headache","year":"2016","cit":14,"pfa":"Wm. Jeptha Davenport","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2415329247","eid":"W2415329247"},{"id":"paper-w2949881311","cat":"papers","name":"Bioisosteric Modification of Salvinorin A, a Potent and Selective Kappa-Opioid Receptor Agonist","year":"2011","cit":14,"pfa":"D. Stewart","psa":"Jordan Kordian Zjawiony","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2949881311","eid":"W2949881311"},{"id":"paper-w2016451689","cat":"papers","name":"A comparison of the behavioral effects of proteo- and deutero-N, N-dimethyltryptamine","year":"1982","cit":14,"pfa":"J. M. Beaton","psa":"Wu-Fu Liu","ptype":"article","src":"https://openalex.org/W2016451689","eid":"W2016451689"},{"id":"paper-w2202003347","cat":"papers","name":"THE EFFECTS OF 3,4-DIMETHOXYPHENYLETHYLAMINE IN RATS TRAINED WITH MESCALINE AS A DISCRIMINATIVE STIMULUS","year":"1974","cit":14,"pfa":"Jerrold C. Winter","ptype":"article","src":"https://openalex.org/W2202003347","eid":"W2202003347"},{"id":"paper-w1979307238","cat":"papers","name":"MDMA reinstates cocaine-seeking behaviour in mice","year":"2009","cit":14,"pfa":"José Manuel Trigo","psa":"Patricia Robledo","ptype":"article","src":"https://openalex.org/W1979307238","eid":"W1979307238"},{"id":"paper-w2080022465","cat":"papers","name":"Ibogaine Enhances the Expression of Locomotor Sensitization in Rats Chronically Treated With Cocaine","year":"1999","cit":14,"pfa":"Karen Kathleen Szumlinski","psa":"Stanley D. Glick","ptype":"article","src":"https://openalex.org/W2080022465","eid":"W2080022465"},{"id":"paper-w2794933555","cat":"papers","name":"Ecstasy: MDMA and other ring-substituted amphetamines","year":"2001","cit":14,"pfa":"Linda Gowing","psa":"Ali, Robert Leonard","ptype":"report","src":"https://openalex.org/W2794933555","eid":"W2794933555"},{"id":"paper-w2007341657","cat":"papers","name":"MDMA Misrepresentation: An Unresolved Problem for Ecstasy Users","year":"2002","cit":14,"pfa":"Gregory N. Hayner","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2007341657","eid":"W2007341657"},{"id":"paper-w2198838528","cat":"papers","name":"A Case of QT Prolongation and Torsades de Pointes Caused by Ibogaine Toxicity","year":"2015","cit":14,"pfa":"Catherine Hildyard","psa":"Yaver Bashir","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2198838528","eid":"W2198838528"},{"id":"paper-w2158122637","cat":"papers","name":"Synthetic Studies of Psilocin Analogs Having Either a Formyl Group or Bromine Atom at the 5- or 7-Position.","year":"2002","cit":14,"pfa":"Fumio Yamada","psa":"Masanori Somei","ptype":"article","src":"https://openalex.org/W2158122637","eid":"W2158122637"},{"id":"paper-w52034648","cat":"papers","name":"Ayahuasca: uma revisão dos aspectos farmacológicos e toxicológicos","year":"2010","cit":14,"pfa":"Ana Paula Salum Pires","psa":"Maurı́cio Yonamine","ptype":"article","src":"https://openalex.org/W52034648","eid":"W52034648"},{"id":"paper-w4385431636","cat":"papers","name":"Effective Connectivity of Thalamocortical Interactions Following d-Amphetamine, LSD, and MDMA Administration","year":"2023","cit":14,"pfa":"Mihai Avram","psa":"Stefan Borgwardt","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4385431636","eid":"W4385431636"},{"id":"paper-w2954505831","cat":"papers","name":"Sulfur analogs of psychotomimetic agents. 30. Ethyl homologs of mescaline and their monothioanalogs","year":"1984","cit":14,"pfa":"Peyton Jacob","psa":"Alexander T. Shulgin","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2954505831","eid":"W2954505831"},{"id":"paper-w2413065044","cat":"papers","name":"Additional evidence supporting the occurrence of psilocybin in Panaeolus foenisecii.","year":"1969","cit":14,"pfa":"J E Robbers","psa":"Ola'h Gm","ptype":"article","src":"https://openalex.org/W2413065044","eid":"W2413065044"},{"id":"paper-w2073425267","cat":"papers","name":"Chirality transfer in an Ireland–Claisen rearrangement: a new approach toward the Iboga alkaloids","year":"2004","cit":14,"pfa":"Stefan Höck","psa":"Hans‐Jürg Borschberg","ptype":"article","src":"https://openalex.org/W2073425267","eid":"W2073425267"},{"id":"paper-w2023008778","cat":"papers","name":"Prenatal exposure to MDMA alters noradrenergic neurodevelopment in the rat","year":"2011","cit":14,"pfa":"Valerie B. Thompson","psa":"Jack W. Lipton","ptype":"article","src":"https://openalex.org/W2023008778","eid":"W2023008778"},{"id":"paper-w2808605492","cat":"papers","name":"MDMA toxicity: management of acute and life-threatening presentations","year":"2018","cit":14,"pfa":"Nicola Davies","psa":"Johann Gründlingh","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2808605492","eid":"W2808605492"},{"id":"paper-w2467072872","cat":"papers","name":"The effect of a hallucinogen, 5-methoxy N,N-dimethyltryptamine, on primate social behavior.","year":"1977","cit":14,"pfa":"Schlemmer Rf","psa":"Davis Jm","ptype":"article","src":"https://openalex.org/W2467072872","eid":"W2467072872"},{"id":"paper-w3175545297","cat":"papers","name":"The Setting Questionnaire for the Ayahuasca Experience: Questionnaire Development and Internal Structure","year":"2021","cit":14,"pfa":"Alexandre Augusto de Deus Pontual","psa":"Clarissa Mendonça Corradi-Webster","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3175545297","eid":"W3175545297"},{"id":"paper-w4399361731","cat":"papers","name":"The molecular structure, vibrational spectra, solvation effect, non-covalent interactions investigations of psilocin","year":"2024","cit":14,"pfa":"Utkirjon Holikulov","psa":"Zhouyang Xiang","ptype":"article","src":"https://openalex.org/W4399361731","eid":"W4399361731"},{"id":"paper-w2018524305","cat":"papers","name":"Determination of MDMA and MDA in rat urine by semi‐micro column HPLC‐fluorescence detection with DBD‐F and their monitoring after MDMA administration to rat","year":"2005","cit":14,"pfa":"Mitsuhiro Wada","psa":"Kenichiro Nakashima","ptype":"article","src":"https://openalex.org/W2018524305","eid":"W2018524305"},{"id":"paper-w2046187868","cat":"papers","name":"Mescaline Analogs. V. p-Dialkylamino-β-phenethylamines and 9-(β-Aminoethyl)julolidine","year":"1956","cit":14,"pfa":"Frederick Benington","psa":"L. C. Clark","ptype":"article","src":"https://openalex.org/W2046187868","eid":"W2046187868"},{"id":"paper-w2768571567","cat":"papers","name":"Ayahuasca and Kambo intoxication after alternative natural therapy for depression, confirmed by mass spectrometry","year":"2017","cit":14,"pfa":"Damila Rodrigues de Morais","psa":"José Luiz Costa","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2768571567","eid":"W2768571567"},{"id":"paper-w2084310362","cat":"papers","name":"PRECLINICAL STUDY: Atypical development of behavioural sensitization to 3,4‐methylenedioxymethamphetamine (MDMA, ‘Ecstasy’) in adolescent rats and its expression in adulthood: role of the MDMA chirality","year":"2009","cit":14,"pfa":"Nora Von Ameln","psa":"Andreas von Ameln-Mayerhofer","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2084310362","eid":"W2084310362"},{"id":"paper-w1996783001","cat":"papers","name":"‘The agony and the ecstasy’: acute urinary retention after MDMA abuse","year":"2003","cit":14,"pfa":"Dominic Inman","psa":"D. Greene","ptype":"article","src":"https://openalex.org/W1996783001","eid":"W1996783001"},{"id":"paper-w4214934489","cat":"papers","name":"Detection of mescaline in human hair samples by UPLC-MS/MS: Application to 19 authentic forensic cases","year":"2022","cit":14,"pfa":"Shuo Yang","psa":"Bin Di","ptype":"article","src":"https://openalex.org/W4214934489","eid":"W4214934489"},{"id":"paper-w3165085554","cat":"papers","name":"Methylenedioxymethamphetamine (MDMA)-Induced Hyponatremia: Case Report and Literature Review","year":"2021","cit":14,"pfa":"Sherif Elkattawy","psa":"James Agresti","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3165085554","eid":"W3165085554"},{"id":"paper-w2904653815","cat":"papers","name":"Phytochemical characterization of Tabernanthe iboga root bark and its effects on dysfunctional metabolism and cognitive performance in high-fat-fed C57BL/6J mice","year":"2018","cit":14,"pfa":"Bayissi Bading-Taïka","psa":"Jan Frederik Stevens","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2904653815","eid":"W2904653815"},{"id":"paper-w2068280932","cat":"papers","name":"Vasopressin and oxytocin as neurohormonal mediators of MDMA (ecstasy) sociosexual behavioural effects","year":"2006","cit":14,"pfa":"Enzo Emanuele","psa":"Sara Pesenti","ptype":"article","src":"https://openalex.org/W2068280932","eid":"W2068280932"},{"id":"paper-w166684745","cat":"papers","name":"„Ecstasy” (MDMA): Pharmakologie, Toxikologie und Behandlung der akuten Intoxikation","year":"2003","cit":14,"pfa":"Matthias E. Liechti","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W166684745","eid":"W166684745"},{"id":"paper-w2804070515","cat":"papers","name":"It’s all you! Australian ayahuasca drinking, spiritual development, and immunitary individualism","year":"2018","cit":14,"pfa":"Robin Rodd","ptype":"article","src":"https://openalex.org/W2804070515","eid":"W2804070515"},{"id":"paper-w4395110324","cat":"papers","name":"Psilocybin therapy and anorexia nervosa: a narrative review of safety considerations for researchers and clinicians","year":"2024","cit":14,"pfa":"Amanda E. Downey","psa":"Marissa Raymond‐Flesch","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4395110324","eid":"W4395110324"},{"id":"paper-w4311684286","cat":"papers","name":"Application of machine learning and complex network measures to an EEG dataset from ayahuasca experiments","year":"2022","cit":14,"pfa":"Caroline L. Alves","psa":"Manuel Ciba","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4311684286","eid":"W4311684286"},{"id":"paper-w2111139037","cat":"papers","name":"Examining the psychological mechanisms of psilocybin-assisted smoking cessation treatment: A pilot study","year":"2014","cit":14,"pfa":"Albert Garcia‐Romeu","psa":"Roland R. Griffiths","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2111139037","eid":"W2111139037"},{"id":"paper-w4364356083","cat":"papers","name":"Predictors of Medical Students’ Perceptions of Psilocybin-Assisted Therapy for Use in Medical Practice","year":"2023","cit":14,"pfa":"Karina Wang","psa":"Robin J. Jacobs","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4364356083","eid":"W4364356083"},{"id":"paper-w4407271029","cat":"papers","name":"Examining the pharmacokinetic and pharmacodynamic interaction of N,N-dimethyltryptamine and harmine in healthy volunteers: Α factorial dose-escalation study","year":"2025","cit":14,"pfa":"Klemens Egger","psa":"Dario Dornbierer","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4407271029","eid":"W4407271029"},{"id":"paper-w2790968355","cat":"papers","name":"Effects of mesyl salvinorin B alone and in combination with naltrexone on alcohol deprivation effect in male and female mice","year":"2018","cit":14,"pfa":"Yan Zhou","psa":"Mary Jeanne Kreek","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2790968355","eid":"W2790968355"},{"id":"paper-w2040040084","cat":"papers","name":"The acute and long-term neurotoxic effects of MDMA on marble burying behaviour in mice","year":"2006","cit":14,"pfa":"Kathryn S. Saadat","psa":"A. Richard Green","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2040040084","eid":"W2040040084"},{"id":"paper-w3108440260","cat":"papers","name":"Salvinorin A protects against methicillin resistant staphylococcus aureus-induced acute lung injury via Nrf2 pathway","year":"2020","cit":14,"pfa":"Si Zeng","psa":"Tao Zhu","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3108440260","eid":"W3108440260"},{"id":"paper-w2610475225","cat":"papers","name":"Role of nitric oxide pathway in the conditioned rewarding effects of MDMA in mice","year":"2017","cit":14,"pfa":"María Pilar García-Pardo","psa":"M.A. Aguilar","ptype":"article","src":"https://openalex.org/W2610475225","eid":"W2610475225"},{"id":"paper-w4206714340","cat":"papers","name":"Tabernaemontana arborea and ibogaine induce paroxysmal EEG activity in freely moving mice: Involvement of serotonin 5-HT1A receptors","year":"2022","cit":14,"pfa":"María Eva González-Trujano","psa":"David Martı́nez-Vargas","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4206714340","eid":"W4206714340"},{"id":"paper-w4393951628","cat":"papers","name":"The flattening of spacetime hierarchy of the N,N-dimethyltryptamine brain state is characterized by harmonic decomposition of spacetime (HADES) framework","year":"2024","cit":14,"pfa":"Jakub Vohryzek","psa":"Morten L. Kringelbach","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4393951628","eid":"W4393951628"},{"id":"paper-w4401535500","cat":"papers","name":"MDMA assisted therapy: Three papers are retracted as FDA rejects PTSD application","year":"2024","cit":14,"pfa":"Elisabeth Mahase","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4401535500","eid":"W4401535500"},{"id":"paper-w2133498872","cat":"papers","name":"A Simple Synthesis of 5-Amino-3-(2-dimethylaminoethyl) indole [5-Amino-N,N-dimethyltryptamine]","year":"1993","cit":14,"pfa":"John E. Macor","psa":"Kevin Ryan","ptype":"article","src":"https://openalex.org/W2133498872","eid":"W2133498872"},{"id":"paper-w2799488000","cat":"papers","name":"De quem é a ayahuasca? Notas sobre a patrimonialização de uma “bebida sagrada” amazônica","year":"2017","cit":14,"pfa":"Glauber Loures de Assis","psa":"Jacqueline Alves Rodrigues","ptype":"article","src":"https://openalex.org/W2799488000","eid":"W2799488000"},{"id":"paper-w1975150101","cat":"papers","name":"Ibogaine and a Total Alkaloidal Extract of Voacanga africana Modulate Neuronal Excitability and Synaptic Transmission in the Rat Parabrachial Nucleus In Vitro","year":"1997","cit":14,"pfa":"Samuel B. Kombian","psa":"Quentin J. Pittman","ptype":"article","src":"https://openalex.org/W1975150101","eid":"W1975150101"},{"id":"paper-w3173469609","cat":"papers","name":"Effect of diatomite addition on crystalline phase formation of TiO 2 and photocatalytic degradation of MDMA","year":"2021","cit":14,"pfa":"Leila Bengotni","psa":"Rachida Hamacha","ptype":"article","src":"https://openalex.org/W3173469609","eid":"W3173469609"},{"id":"paper-w4225411286","cat":"papers","name":"Ayahuasca Ritual, Personality and Sociality: Observational Research Conducted in a Substance Use Disorder Rehabilitation Center in Uruguay","year":"2022","cit":14,"pfa":"Ismael Apud","psa":"Andrés Oliveri","topics":["Addiction","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4225411286","eid":"W4225411286"},{"id":"paper-w4386961159","cat":"papers","name":"Manic episode following psilocybin use in a man with bipolar II disorder: a case report","year":"2023","cit":14,"pfa":"Haniya J. Halim","psa":"Badari Birur","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4386961159","eid":"W4386961159"},{"id":"paper-w2086286564","cat":"papers","name":"Quantitative determination of salvinorin A, a natural hallucinogen with abuse liability, in Internet-available Salvia divinorum and endemic species of Salvia in Taiwan","year":"2014","cit":14,"pfa":"Po-Xiang Lin","psa":"Rebecca McKetin","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2086286564","eid":"W2086286564"},{"id":"paper-w2125530064","cat":"papers","name":"Characterization of the synthesis of N,N‐dimethyltryptamine by reductive amination using gas chromatography ion trap mass spectrometry","year":"2010","cit":14,"pfa":"Simon D. Brandt","psa":"Abu B. Kanu","ptype":"article","src":"https://openalex.org/W2125530064","eid":"W2125530064"},{"id":"paper-w2136538592","cat":"papers","name":"Acute effects of MDMA on autonomic cardiac activity and their relation to subjective prosocial and stimulant effects","year":"2014","cit":14,"pfa":"Christine M. Clark","psa":"Harriet de Wit","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2136538592","eid":"W2136538592"},{"id":"paper-w2160551057","cat":"papers","name":"Have Halpern et al. (2004) detected ‘residual neuropsychological effects’ of MDMA? Not likely","year":"2004","cit":14,"pfa":"Michael Lyvers","psa":"Penelope Anne Hasking","ptype":"article","src":"https://openalex.org/W2160551057","eid":"W2160551057"},{"id":"paper-w4390026164","cat":"papers","name":"Ayahuasca-induced personal death experiences: prevalence, characteristics, and impact on attitudes toward death, life, and the environment","year":"2023","cit":14,"pfa":"Jonathan David","psa":"Aviva Berkovich‐Ohana","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4390026164","eid":"W4390026164"},{"id":"paper-w4234227068","cat":"papers","name":"Correction: Sex-Dependent Psychoneuroendocrine Effects of THC and MDMA in an Animal Model of Adolescent Drug Consumption","year":"2013","cit":14,"pfa":"Alvaro Llorente‐Berzal","psa":"María‐Paz Viveros","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"erratum","src":"https://openalex.org/W4234227068","eid":"W4234227068"},{"id":"paper-w2080580866","cat":"papers","name":"The effect of bufotenine, melatonin, psilocybin, and related compounds on the 5-hydroxytryptamine excitatory receptors of Helix aspersa neurons","year":"1972","cit":14,"pfa":"Robert James Walker","psa":"G.N. Woodruff","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2080580866","eid":"W2080580866"},{"id":"paper-w2192869938","cat":"papers","name":"Learning, Memory, and Executive Function in New MDMA Users: A 2-Year Follow-Up Study","year":"2015","cit":14,"pfa":"Daniel R. Wagner","psa":"Jörg Daumann","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2192869938","eid":"W2192869938"},{"id":"paper-w2046522566","cat":"papers","name":"Pretreatment with the putative anti-addictive drug, ibogaine, increases the potency of cocaine to elicit locomotor responding: a study with acute and chronic cocaine-treated rats","year":"1999","cit":14,"pfa":"Karen Kathleen Szumlinski","psa":"Stanley D. Glick","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2046522566","eid":"W2046522566"},{"id":"paper-w2165468460","cat":"papers","name":"Redesigning the designer drug ecstasy: non-psychoactive MDMA analogues exhibiting Burkitt's lymphoma cytotoxicity","year":"2010","cit":14,"pfa":"Michael N. Gandy","psa":"Matthew Piggott","topics":["Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2165468460","eid":"W2165468460"},{"id":"paper-w2017717545","cat":"papers","name":"Changes in serotonin transporter (5-HTT) gene expression in peripheral blood cells after MDMA intake","year":"2014","cit":14,"pfa":"Samanta Yubero‐Lahoz","psa":"Rafael de la Torre","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2017717545","eid":"W2017717545"},{"id":"paper-w2953156098","cat":"papers","name":"8-OH-DPAT Induces Compulsive-like Deficit in Spontaneous Alternation Behavior: Reversal by MDMA but Not Citalopram","year":"2019","cit":14,"pfa":"Anna U. Odland","psa":"Jesper Tobias Andreasen","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2953156098","eid":"W2953156098"},{"id":"paper-w2096888976","cat":"papers","name":"3,4‐Methylenedioxymethamphetamine (MDMA) enhances the release of acetylcholine by 5‐HT4and D1receptor mechanisms in the rat prefrontal cortex","year":"2005","cit":14,"pfa":"Sunila G Nair","psa":"Gary A. Gudelsky","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2096888976","eid":"W2096888976"},{"id":"paper-w1981394811","cat":"papers","name":"Amnesic Syndrome and Severe Ataxia Following the Recreational Use of 3,4-methylene-dioxymethamphetamine (MDMA, ‘Ecstacy’) and other Substances","year":"2001","cit":14,"pfa":"Michael D. Kopelman","psa":"C. Isaac","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1981394811","eid":"W1981394811"},{"id":"paper-w2053410278","cat":"papers","name":"An improved reaction sequence for electrophilic cyclization of methyl 6-(2-indolyl)-2-azabicyclooct-7-ene-6-carboxylates iboga alkaloid analogs","year":"1991","cit":14,"pfa":"Richard J. Sundberg","psa":"Kumar G. Gadamasetti","ptype":"article","src":"https://openalex.org/W2053410278","eid":"W2053410278"},{"id":"paper-w4408540649","cat":"papers","name":"IUPHAR Article: Psilocybin induces long-lasting effects via 5-HT2A receptors in mouse models of chronic pain","year":"2025","cit":14,"pfa":"Eda Köşeli","psa":"M. Imad Damaj","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4408540649","eid":"W4408540649"},{"id":"paper-w2035861463","cat":"papers","name":"Recreational drugs, 3,4-Methylenedioxymethamphetamine(MDMA), 3,4-methylenedioxyamphetamine (MDA) and diphenylprolinol, inhibit neurite outgrowth in PC12 cells","year":"2010","cit":14,"pfa":"Asuka Kaizaki","psa":"Takemi Yoshida","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2035861463","eid":"W2035861463"},{"id":"paper-w4412982879","cat":"papers","name":"A dose of therapy with psilocybin - A meta-analysis of the relationship between the amount of therapy hours and treatment outcomes in psychedelic-assisted therapy","year":"2025","cit":14,"pfa":"Jennie Hultgren","psa":"Joel Gruneau Brulin","topics":["Depression","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4412982879","eid":"W4412982879"},{"id":"paper-w2027827306","cat":"papers","name":"Regulation of opioid gene expression in the rat brainstem by 3,4-methylenedioxymethamphetamine (MDMA): role of serotonin and involvement of CREB and ERK cascade","year":"2010","cit":14,"pfa":"Manuela Di Benedetto","psa":"Patrizia Romualdi","topics":["Addiction","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2027827306","eid":"W2027827306"},{"id":"paper-w3214251339","cat":"papers","name":"Development of a point‐of‐care test for the detection of MDMA in latent fingerprints using surface plasmon resonance and lateral flow technology","year":"2021","cit":14,"pfa":"Caroline Pollard","psa":"Kim Wolff","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3214251339","eid":"W3214251339"},{"id":"paper-w1554917432","cat":"papers","name":"Long-term neuronal damage and recovery after a single dose of MDMA: expression and distribution of serotonin transporter in the rat brain.","year":"2010","cit":14,"pfa":"Eszter Kirilly","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1554917432","eid":"W1554917432"},{"id":"paper-w4312129061","cat":"papers","name":"Probing the antidepressant potential of psilocybin: integrating insight from human research and animal models towards an understanding of neural circuit mechanisms","year":"2022","cit":14,"pfa":"Juliet Meccia","psa":"Rosemary C. Bagot","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4312129061","eid":"W4312129061"},{"id":"paper-w1993648598","cat":"papers","name":"Increased anxiety-related behavior in male and female adult rats following early and late adolescent exposure to 3,4-methylenedioxymethamphetamine (MDMA)","year":"2012","cit":14,"pfa":"Olga V. Kolyaduke","psa":"Robert N. Hughes","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W1993648598","eid":"W1993648598"},{"id":"paper-w2198168203","cat":"papers","name":"Inhibition potential of 3,4-methylenedioxymethamphetamine (MDMA) and its metabolites on the in vitro monoamine oxidase (MAO)-catalyzed deamination of the neurotransmitters serotonin and dopamine","year":"2015","cit":14,"pfa":"Andrea Eva Steuer","psa":"Thomas Kræmer","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2198168203","eid":"W2198168203"},{"id":"paper-w3214328313","cat":"papers","name":"Developmental exposure to MDMA (ecstasy) in zebrafish embryos reproduces the neurotoxicity adverse outcome ‘lower motor activity’ described in humans","year":"2021","cit":14,"pfa":"Marta Barenys","psa":"Jesús Gómez-Catalán","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3214328313","eid":"W3214328313"},{"id":"paper-w1808141640","cat":"papers","name":"Study of the Hepatoprotective Activity of Methanolic Extract of Feijoa sellowiana Fruits Against MDMA using the Isolated Rat Liver Perfusion System.","year":"2013","cit":14,"pfa":"Mohammad Yasin Karami","psa":"Anahita Nosrati","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1808141640","eid":"W1808141640"},{"id":"paper-w2130722147","cat":"papers","name":"Imaging DA release in a rat model of L-DOPA-induced dyskinesias: A longitudinal in vivo PET investigation of the antidyskinetic effect of MDMA","year":"2012","cit":14,"pfa":"Nadine Y. Lettfuss","psa":"Andreas von Ameln-Mayerhofer","ptype":"article","src":"https://openalex.org/W2130722147","eid":"W2130722147"},{"id":"paper-w2287198851","cat":"papers","name":"The synthesis and characterisation of MDMA derived from a catalytic oxidation of material isolated from black pepper reveals potential route specific impurities","year":"2016","cit":14,"pfa":"Christopher M. Plummer","psa":"Oliver A.H. Jones","ptype":"article","src":"https://openalex.org/W2287198851","eid":"W2287198851"},{"id":"paper-w2150381785","cat":"papers","name":"Development of a validated method for the simultaneous determination of amphetamine, methamphetamine and methylenedioxyamphetamines (MDA, MDMA, MDEA) in serum by GC-MS after derivatisation with perfluorooctanoyl chloride","year":"2007","cit":14,"pfa":"Folker Westphal","psa":"Gertrud Rochholz","ptype":"article","src":"https://openalex.org/W2150381785","eid":"W2150381785"},{"id":"paper-w2051718127","cat":"papers","name":"The Acute Effects of Monoamine Reuptake Inhibitors on the Stimulus Effects of Hallucinogens","year":"1999","cit":14,"pfa":"Jerrold C. Winter","ptype":"article","src":"https://openalex.org/W2051718127","eid":"W2051718127"},{"id":"paper-w4385173532","cat":"papers","name":"Natural psychedelics in the treatment of depression; a review focusing on neurotransmitters","year":"2023","cit":14,"pfa":"Samane Jahanabadi","psa":"Ali Razmi","topics":["Depression","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4385173532","eid":"W4385173532"},{"id":"paper-w2886319992","cat":"papers","name":"Gene expression analysis indicates reduced memory and cognitive functions in the hippocampus and increase in synaptic reorganization in the frontal cortex 3 weeks after MDMA administration in Dark Agouti rats","year":"2018","cit":14,"pfa":"Péter Petschner","psa":"György Bagdy","topics":["Depression","PTSD & trauma","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2886319992","eid":"W2886319992"},{"id":"paper-w2805186158","cat":"papers","name":"Psychedelics and Personality","year":"2018","cit":14,"pfa":"Marc Aixalà","psa":"José Carlos Bouso","topics":["Addiction","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"editorial","src":"https://openalex.org/W2805186158","eid":"W2805186158"},{"id":"paper-w2027526800","cat":"papers","name":"Prevalence of Use Study for Amphetamine (AMP), Methamphetamine (MAMP), 3,4-Methylenedioxyamphetamine (MDA) 3,4-Methylenedioxymethamphetamine (MDMA), and 3,4-Methylenedioxyethylamphetamine (MDEA) in Military Entrance Proc","year":"2006","cit":14,"pfa":"Kevin L. Klette","psa":"Matthew H. Jamerson","ptype":"article","src":"https://openalex.org/W2027526800","eid":"W2027526800"},{"id":"paper-w4408107853","cat":"papers","name":"Psychedelic-assisted therapy: An overview for the internist","year":"2025","cit":14,"pfa":"Brian Scott Barnett","psa":"Franklin King","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4408107853","eid":"W4408107853"},{"id":"paper-w2166900188","cat":"papers","name":"Inhibition of Synaptosomal Neurotransmitter Uptake by Hallucinogens","year":"1983","cit":14,"pfa":"Michael R. Whipple","psa":"Fred H. Gage","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2166900188","eid":"W2166900188"},{"id":"paper-w4289668466","cat":"papers","name":"Neuroimaging Correlates of Treatment Response with Psychedelics in Major Depressive Disorder: A Systematic Review","year":"2022","cit":14,"pfa":"Sarah Kuburi","psa":"Venkat Bhat","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4289668466","eid":"W4289668466"},{"id":"paper-w4221013630","cat":"papers","name":"Human behavioral pharmacology of psychedelics","year":"2022","cit":14,"pfa":"Justin C. Strickland","psa":"Matthew W. Johnson","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W4221013630","eid":"W4221013630"},{"id":"paper-w4399355126","cat":"papers","name":"Dose-dependent LSD effects on cortical/thalamic and cerebellar activity: brain oxygen level–dependent fMRI study in awake rats","year":"2024","cit":14,"pfa":"Ashley Ghaw","psa":"Craig F. Ferris","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4399355126","eid":"W4399355126"},{"id":"paper-w3084539237","cat":"papers","name":"Posttraumatic Stress Disorder After a Psychedelic Experience, a Case Report","year":"2020","cit":14,"pfa":"Dafna Sara Rubin-Kahana","psa":"Bernard Le Foll","topics":["PTSD & trauma","Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3084539237","eid":"W3084539237"},{"id":"paper-w4405244747","cat":"papers","name":"Psychedelics as an intervention for psychological, existential distress in terminally ill patients: A systematic review and network meta-analysis","year":"2024","cit":14,"pfa":"Mattia Marchi","psa":"Gian Maria Galeazzi","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W4405244747","eid":"W4405244747"},{"id":"paper-w1972625209","cat":"papers","name":"Determination of phenylethylamines in hallucinogenic cactus species by high-performance liquid chromatography with photodiode-array detection","year":"1992","cit":14,"pfa":"H. J. Helmlin","psa":"Rudolf Brenneisen","ptype":"article","src":"https://openalex.org/W1972625209","eid":"W1972625209"},{"id":"paper-w1973922653","cat":"papers","name":"Effect of LSD-25 on mitotic and meiotic chromosomes of mice and monkeys","year":"1969","cit":14,"pfa":"Jos� Egozcue","psa":"S. T. Irwin","ptype":"article","src":"https://openalex.org/W1973922653","eid":"W1973922653"},{"id":"paper-w2029653986","cat":"papers","name":"Optical Activity of LSD–DNA Mixtures","year":"1971","cit":14,"pfa":"Al H. Brady","psa":"F. C. BOUCEK","ptype":"article","src":"https://openalex.org/W2029653986","eid":"W2029653986"},{"id":"paper-w2012202993","cat":"papers","name":"Decreased Number of Benzodiazepine Receptors in Frontal Cortex of Rat Brain Following Long‐Term Lithium Treatment","year":"1983","cit":14,"pfa":"Ole Hetmar","psa":"Claus Bræstrup","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2012202993","eid":"W2012202993"},{"id":"paper-w2189323143","cat":"papers","name":"Effects of Psychotomimetic Compounds on Human Pseudocholinesterase","year":"1957","cit":14,"pfa":"George H. Fried","psa":"WILLIAM ANTOPOL","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2189323143","eid":"W2189323143"},{"id":"paper-w1994955697","cat":"papers","name":"Quantitative measurement of mixtures of hallucinogens by fluorometry and phosphorimetry","year":"1973","cit":14,"pfa":"D Fabrick","ptype":"article","src":"https://openalex.org/W1994955697","eid":"W1994955697"},{"id":"paper-w2004726518","cat":"papers","name":"LSD in pubic hair in a fatality","year":"2011","cit":14,"pfa":"Jean‐Michel Gaulier","psa":"Gérard Lachâtre","ptype":"article","src":"https://openalex.org/W2004726518","eid":"W2004726518"},{"id":"paper-w2142448516","cat":"papers","name":"LC-MS Analysis of 2-Oxo-3-Hydroxy LSD from Urine Using a Speedisk(R) Positive-Pressure Processor with Cerex(R) PolyChrom CLIN II Columns","year":"2003","cit":14,"pfa":"Carl K. Horn","psa":"P. R. Stout","ptype":"article","src":"https://openalex.org/W2142448516","eid":"W2142448516"},{"id":"paper-w2082036455","cat":"papers","name":"A Morphologic Study of the Effects of LSD on Neurons in Cultures of Cerebellum","year":"1972","cit":14,"pfa":"Walter J. Hendelman","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2082036455","eid":"W2082036455"},{"id":"paper-w2062533537","cat":"papers","name":"Characterization of a dopamine-sensitive [3H]LSD binding site in honeybee (Apis mellifera) brain","year":"1995","cit":14,"pfa":"Wolfgang Blenau","psa":"Joachim Erber","ptype":"article","src":"https://openalex.org/W2062533537","eid":"W2062533537"},{"id":"paper-w2036753123","cat":"papers","name":"Immunochemical extraction and detection of LSD in whole blood","year":"1999","cit":14,"pfa":"Sarah Kerrigan","psa":"Donald E. Brooks","ptype":"article","src":"https://openalex.org/W2036753123","eid":"W2036753123"},{"id":"paper-w2803539769","cat":"papers","name":"Classics in Neuroimaging: The Serotonergic 2A Receptor System—from Discovery to Modern Molecular Imaging","year":"2018","cit":14,"pfa":"Elina Tampio L’Estrade","psa":"Matthias M. Herth","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"editorial","src":"https://openalex.org/W2803539769","eid":"W2803539769"},{"id":"paper-w2129224176","cat":"papers","name":"Interactions between 3,4-methylenedioxymethamphetamine, methamphetamine, ketamine, and caffeine in human intestinal Caco-2 cells and in oral administration to rats","year":"2007","cit":14,"pfa":"Kenji Kuwayama","psa":"Tohru Kishi","ptype":"article","src":"https://openalex.org/W2129224176","eid":"W2129224176"},{"id":"paper-w2132605464","cat":"papers","name":"Rapid drug-screening and quantitation of 3,4-methylenedioxymethamphetamine in urine by MALDI-TOF mass spectrometry","year":"2005","cit":14,"pfa":"An-Kai Su","psa":"Cheng‐Huang Lin","ptype":"article","src":"https://openalex.org/W2132605464","eid":"W2132605464"},{"id":"paper-w2105243029","cat":"papers","name":"Glial Cell Response to 3,4-(±)-Methylenedioxymethamphetamine and Its Metabolites","year":"2013","cit":14,"pfa":"Joseph M. Herndon","psa":"Terrence J. Monks","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2105243029","eid":"W2105243029"},{"id":"paper-w2418206374","cat":"papers","name":"RX 336-M, a new chemical tool in the analysis of the quasi-morphine withdrawal syndrome.","year":"1981","cit":14,"pfa":"A. Cowan","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2418206374","eid":"W2418206374"},{"id":"paper-w79207928","cat":"papers","name":"Substance Abuse as a Risk Factor for Schizophrenia and Related Disorders","year":"2001","cit":14,"pfa":"Malcolm B. Bowers","psa":"Steven H. Madonick","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W79207928","eid":"W79207928"},{"id":"paper-w2406226550","cat":"papers","name":"Defining the histamine H2-receptor in brain: the interaction with LSD.","year":"1978","cit":14,"pfa":"J P Green","psa":"Saul Maayani","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2406226550","eid":"W2406226550"},{"id":"paper-w2014027156","cat":"papers","name":"Reserpine does not prevent 3,4-methylenedioxymethamphetamine-induced neurotoxicity in the rat","year":"1989","cit":14,"pfa":"Cameron R. Hekmatpanah","psa":"Stephen J. Peroutka","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2014027156","eid":"W2014027156"},{"id":"paper-w2141022288","cat":"papers","name":"Methylation of 3,4-Methylenedioxymethamphetamine in Formalin-Fixed Human Liver Tissue","year":"2005","cit":14,"pfa":"Diaá M. Shakleya","psa":"Patrick S. Callery","ptype":"article","src":"https://openalex.org/W2141022288","eid":"W2141022288"},{"id":"paper-w2155640608","cat":"papers","name":"Chromatographic and Mass Spectral Studies on Isobaric and Isomeric Substances Related to 3,4-Methylenedioxymethamphetamine","year":"2004","cit":14,"pfa":"Laura Aalberg","psa":"J. DeRuiter","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2155640608","eid":"W2155640608"},{"id":"paper-w4401847758","cat":"papers","name":"LSDDEP2: study protocol for a randomised, double-dummy, triple-blind, active placebo-controlled, parallel groups trial of LSD microdosing in patients with major depressive disorder","year":"2024","cit":14,"pfa":"Dimitri Daldegan‐Bueno","psa":"Suresh D Muthukumaraswamy","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4401847758","eid":"W4401847758"},{"id":"paper-w2313156770","cat":"papers","name":"Psychedelic drugs reconsidered","year":"1981","cit":14,"pfa":"Richard Evans Schultes","ptype":"book-review","src":"https://openalex.org/W2313156770","eid":"W2313156770"},{"id":"paper-w2036507295","cat":"papers","name":"3,4-Methylenedioxymethamphetamine Induces Gene Expression Changes in Rats Related to Serotonergic and Dopaminergic Systems, But Not to Neurotoxicity","year":"2013","cit":14,"pfa":"Elisabet Cuyàs","psa":"Rafael de la Torre","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2036507295","eid":"W2036507295"},{"id":"paper-w4408219591","cat":"papers","name":"Further education in psychedelic-assisted therapy – experiences from Switzerland","year":"2025","cit":14,"pfa":"Helena Aicher","psa":"Peter Gasser","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4408219591","eid":"W4408219591"},{"id":"paper-w2415376922","cat":"papers","name":"3,4-Methylenedioxymethamphetamine - Effects on Human Performance and Behavior.","year":"2003","cit":14,"pfa":"Barry Kerr Logan","psa":"Fiona J. Couper","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2415376922","eid":"W2415376922"},{"id":"paper-w1913161907","cat":"papers","name":"INTERACTIONS BETWEEN EPINEPHRINE AND SOME PSYCHOTOMIMETIC DRUGS","year":"1959","cit":14,"pfa":"E. Costa","psa":"GERHARD ZETLER","ptype":"article","src":"https://openalex.org/W1913161907","eid":"W1913161907"},{"id":"paper-w4414616693","cat":"papers","name":"Ethical issues with psychedelic-assisted treatments in psychiatry: A systematic scoping review","year":"2025","cit":14,"pfa":"Chiara Caporuscio","psa":"Dimitris Repantis","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4414616693","eid":"W4414616693"},{"id":"paper-w2099085710","cat":"papers","name":"Generalization of cocaine to the isomers of 3,4‐Methylenedioxyamphetamine and 3,4‐methylenedioxyamethamphetamine: Effects of training dose","year":"1989","cit":14,"pfa":"Julie Broadbent","psa":"James B. Appel","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2099085710","eid":"W2099085710"},{"id":"paper-w3023070793","cat":"papers","name":"The ‘enigma’ of Richard Schultes, Amazonian hallucinogenic plants, and the limits of ethnobotany","year":"2020","cit":14,"pfa":"Merlin William Alfred Sheldrake","ptype":"article","src":"https://openalex.org/W3023070793","eid":"W3023070793"},{"id":"paper-w2609742712","cat":"papers","name":"Psychedelic compound in ecstasy moves closer to approval to treat PTSD","year":"2017","cit":14,"pfa":"Amy Maxmen","topics":["PTSD & trauma"],"ptype":"other","src":"https://openalex.org/W2609742712","eid":"W2609742712"},{"id":"paper-w1976059390","cat":"papers","name":"Microdialysis assessment of the impact of (+)3,4‐methylenedioxymethamphetamine, cocaine, and cocaethylene on serotonergic neurons","year":"1994","cit":14,"pfa":"Charles W. Bradberry","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1976059390","eid":"W1976059390"},{"id":"paper-w4403269001","cat":"papers","name":"Memory, trauma, and self: Remembering and recovering from sexual abuse in psychedelic-assisted therapy","year":"2024","cit":14,"pfa":"Jarrett Robert Rose","topics":["Depression","PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4403269001","eid":"W4403269001"},{"id":"paper-w4385840367","cat":"papers","name":"Unraveling the In Vitro Toxicity Profile of Psychedelic 2C Phenethylamines and Their N-Benzylphenethylamine (NBOMe) Analogues","year":"2023","cit":14,"pfa":"Daniel Martins","psa":"Fernanda Borges","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4385840367","eid":"W4385840367"},{"id":"paper-w1975611948","cat":"papers","name":"Inhibition of the effects of LSD and p-bromo-methamphetamine (V-111) by p-chlorophenylalanine","year":"1970","cit":14,"pfa":"Joseph Edward Knoll","psa":"E. Sylvester Vizi","ptype":"article","src":"https://openalex.org/W1975611948","eid":"W1975611948"},{"id":"paper-w2066988775","cat":"papers","name":"Inactivation of CYP2D6 by methylenedioxymethamphetamine in different recombinant expression systems","year":"2007","cit":14,"pfa":"Linh M. Van","psa":"Amin Rostami‐Hodjegan","ptype":"article","src":"https://openalex.org/W2066988775","eid":"W2066988775"},{"id":"paper-w2003442353","cat":"papers","name":"Alkaloids from the hallucinogenic plant Virola sebifera","year":"1985","cit":14,"pfa":"K. Kawanishi","ptype":"article","src":"https://openalex.org/W2003442353","eid":"W2003442353"},{"id":"paper-w2016167674","cat":"papers","name":"Cross tolerance or tachyphylaxis among various psychotomimetic agents on cats","year":"1974","cit":14,"pfa":"Marshall B. Wallach","psa":"Samuel Gershon","ptype":"article","src":"https://openalex.org/W2016167674","eid":"W2016167674"},{"id":"paper-w1975035896","cat":"papers","name":"Behavioral and neurochemical effects of psychotomimetic drugs in neonate chicks","year":"1972","cit":14,"pfa":"Marshall B. Wallach","psa":"Samuel Gershon","ptype":"article","src":"https://openalex.org/W1975035896","eid":"W1975035896"},{"id":"paper-w4281640359","cat":"papers","name":"Postpartum depression: A role for psychedelics?","year":"2022","cit":14,"pfa":"Chaitra Jairaj","psa":"James Rucker","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4281640359","eid":"W4281640359"},{"id":"paper-w2066463920","cat":"papers","name":"Selective electrochemical discrimination between dopamine and phenethylamine-derived psychotropic drugs using electrodes modified with an acyclic receptor containing two terminal 3-alkoxy-5-nitroindazole rings","year":"2010","cit":14,"pfa":"Antonio Doménech‐Carbó","psa":"Enrique García‐España","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2066463920","eid":"W2066463920"},{"id":"paper-w2057546631","cat":"papers","name":"Pharmacologic inhibition of cerebral vasospasm in ischemia, hallucinogen ingestion, and hypomagnesemia: Barbiturates, calcium antagonists, and magnesium","year":"1983","cit":14,"pfa":"Burton M. Altura","psa":"Bella T. Altura","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2057546631","eid":"W2057546631"},{"id":"paper-w2007427429","cat":"papers","name":"Authentication and Ultra Performance Liquid Chromatography (UPLC)/MS Analysis of Magic Mint, Salvia divinorum and Its Related Plants","year":"2008","cit":14,"pfa":"Takuro Maruyama","psa":"Yukihiro Goda","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2007427429","eid":"W2007427429"},{"id":"paper-w2916100952","cat":"papers","name":"Fluorescence Excitation-Emission Spectroscopy: An Analytical Technique to Monitor Drugs of Addiction in Wastewater","year":"2019","cit":14,"pfa":"Meena K. Yadav","psa":"Christopher P. Saint","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2916100952","eid":"W2916100952"},{"id":"paper-w114122003","cat":"papers","name":"Phenylalkylamine stimulants, hallucinogens, and designer drugs.","year":"1990","cit":14,"pfa":"Richard A. Glennon","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W114122003","eid":"W114122003"},{"id":"paper-w2073182364","cat":"papers","name":"Adrenochrome As the Cause of Schizophrenia: Investigation of Some Deductions from this Hypothesis","year":"1955","cit":14,"pfa":"A. J. Lea","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2073182364","eid":"W2073182364"},{"id":"paper-w2155503965","cat":"papers","name":"Rhabdomyolysis After LSD Ingestion","year":"2010","cit":14,"pfa":"Zachary J. Berrens","psa":"Christopher White","ptype":"article","src":"https://openalex.org/W2155503965","eid":"W2155503965"},{"id":"paper-w2799884367","cat":"papers","name":"The Use of Salvia divinorum from a Mazatec Perspective","year":"2018","cit":14,"pfa":"Ana Elda Maqueda","ptype":"book-chapter","src":"https://openalex.org/W2799884367","eid":"W2799884367"},{"id":"paper-w4310170729","cat":"papers","name":"Considerations in assessing the abuse potential of psychedelics during drug development","year":"2022","cit":14,"pfa":"Silvia N. Calderon","psa":"Dominic Chiapperino","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4310170729","eid":"W4310170729"},{"id":"paper-w2091031090","cat":"papers","name":"Personality Characteristics of Adolescents with Hallucinogen, Methamphetamine, and Cannabis Dependence: A Comparative Study","year":"2005","cit":14,"pfa":"Glen A. Palmer","psa":"Doyle D. Daiss","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2091031090","eid":"W2091031090"},{"id":"paper-w2027730212","cat":"papers","name":"Effects of dopaminergic and serotonergic receptor blockade on neurochemical changes induced by acute administration of methamphetamine and 3,4-methylenedioxymethamphetamine","year":"1988","cit":14,"pfa":"Michel Johnson","psa":"James W. Gibb","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2027730212","eid":"W2027730212"},{"id":"paper-w1498660666","cat":"papers","name":"Quantitative Analysis of Narrative Reports of Psychedelic Drugs","year":"2012","cit":14,"pfa":"Jeremy Coyle","psa":"Matthew J. Baggott","topics":["Safety & adverse events","Dosing & pharmacology","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W1498660666","eid":"W1498660666"},{"id":"paper-w4407368235","cat":"papers","name":"Ibogalogs decrease neuropathic pain in mice through a mechanism involving crosstalk between 5-HT2A and mGlu2 receptors","year":"2025","cit":14,"pfa":"Hugo Rubén Arias","psa":"Lorenzo Di Cesare Mannelli","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4407368235","eid":"W4407368235"},{"id":"paper-w1993052253","cat":"papers","name":"Hallucinogen Rating Scale (HRS) - Versão brasileira: tradução e adaptação transcultural","year":"2011","cit":14,"pfa":"Suely Mizumoto","psa":"Rick J. Strassman","ptype":"article","src":"https://openalex.org/W1993052253","eid":"W1993052253"},{"id":"paper-w2772154324","cat":"papers","name":"Amphetamine Related Psychiatric Disorders","year":"2019","cit":14,"pfa":"Jeff M. Mullen","psa":"Adam Crawford","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2772154324","eid":"W2772154324"},{"id":"paper-w96265144","cat":"papers","name":"Non-Antidepressant Long-term Treatment in Post-Traumatic Stress Disorder (PTSD)","year":"2015","cit":14,"pfa":"Hala Kerbage","psa":"Sami Richa","topics":["Depression","PTSD & trauma","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W96265144","eid":"W96265144"},{"id":"paper-w435827728","cat":"papers","name":"Distinguishing Amphetamine, Methamphetamine and 3,4-Methylenedioxymethamphetamine from Other Sympathomimetic Amines After Rapid Derivatization with Propyl Chloroformate and Analysis by Gas Chromatography—Chemical Ionizat","year":"1997","cit":14,"pfa":"Amitava Dasgupta","psa":"Amy P. Hart","ptype":"article","src":"https://openalex.org/W435827728","eid":"W435827728"},{"id":"paper-w4318455394","cat":"papers","name":"Clinical Practice Guidelines for Assessment and Management of Patients with Substance Intoxication Presenting to the Emergency Department","year":"2023","cit":14,"pfa":"Siddharth Sarkar","psa":"Anju Dhawan","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4318455394","eid":"W4318455394"},{"id":"paper-w4378783566","cat":"papers","name":"Extrapharmacological Safety Topics in Psychedelic-Assisted Psychotherapy","year":"2023","cit":14,"pfa":"Abigail E. Calder","psa":"Gregor Hasler","topics":["Safety & adverse events","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4378783566","eid":"W4378783566"},{"id":"paper-w4398239833","cat":"papers","name":"Psychedelic-assisted therapy among sexual and gender minority communities","year":"2024","cit":14,"pfa":"Brady D. Hanshaw","psa":"Jack L. Turban","ptype":"article","src":"https://openalex.org/W4398239833","eid":"W4398239833"},{"id":"paper-w2738209342","cat":"papers","name":"Lessons to be learned from early psychedelic therapy in Denmark","year":"2017","cit":14,"pfa":"David Erritzøe","psa":"William A. Richards","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2738209342","eid":"W2738209342"},{"id":"paper-w4400650322","cat":"papers","name":"Interrupting the Psychedelic Experience Through Contextual Manipulation to Study Experience Efficacy","year":"2024","cit":14,"pfa":"Leor Roseman","psa":"Christopher B. Timmermann","ptype":"article","src":"https://openalex.org/W4400650322","eid":"W4400650322"},{"id":"paper-w4390818085","cat":"papers","name":"Psychedelics, epilepsy, and seizures: a review","year":"2024","cit":14,"pfa":"Ninon Freidel","psa":"Evan Cole Lewis","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4390818085","eid":"W4390818085"},{"id":"paper-w3133817777","cat":"papers","name":"What Can the Chemical Hold?: The Politics of Efficacy in the Psychedelic Renaissance","year":"2021","cit":14,"pfa":"Katherine Hendy","ptype":"article","src":"https://openalex.org/W3133817777","eid":"W3133817777"},{"id":"paper-w4311597067","cat":"papers","name":"Psychedelic Science of Spirituality and Religion: An Attachment-Informed Agenda Proposal","year":"2022","cit":14,"pfa":"Aaron D. Cherniak","psa":"Pehr Granqvist","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4311597067","eid":"W4311597067"},{"id":"paper-w2066387909","cat":"papers","name":"Indole Alkaloids In Plant Hallucinogens","year":"1976","cit":14,"pfa":"Richard Evans Schultes","ptype":"article","src":"https://openalex.org/W2066387909","eid":"W2066387909"},{"id":"paper-w1995644233","cat":"papers","name":"A Spectrofluorometric Study Of Selected Hallucinogens","year":"1969","cit":14,"pfa":"Allesia M. Gillespie","ptype":"article","src":"https://openalex.org/W1995644233","eid":"W1995644233"},{"id":"paper-w2076176509","cat":"papers","name":"Entheogens in the Study of Religious Experiences: Current Status*","year":"2005","cit":14,"pfa":"William A. Richards","ptype":"article","src":"https://openalex.org/W2076176509","eid":"W2076176509"},{"id":"paper-w4388735306","cat":"papers","name":"Psychedelic Justice: Toward a diverse and equitable psychedelic culture","year":"2023","cit":14,"pfa":"Danelle Jones","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4388735306","eid":"W4388735306"},{"id":"paper-w2038751593","cat":"papers","name":"An Ethologic Search for Self-Administration of Hallucinogens","year":"1973","cit":14,"pfa":"Ronald K. Siegel","ptype":"article","src":"https://openalex.org/W2038751593","eid":"W2038751593"},{"id":"paper-w2134054066","cat":"papers","name":"Plastic Cement: The Ten Cent Hallucinogen","year":"1967","cit":14,"pfa":"Edward Preble","psa":"Gabriel V. Laury","ptype":"article","src":"https://openalex.org/W2134054066","eid":"W2134054066"},{"id":"paper-w3193541843","cat":"papers","name":"The evolution of the psychedelic revolution","year":"2021","cit":14,"pfa":"Lindsay P. Cameron","psa":"David E. Olson","ptype":"article","src":"https://openalex.org/W3193541843","eid":"W3193541843"},{"id":"paper-w4403130693","cat":"papers","name":"History, Hype, and Responsible Psychedelic Medicine: A Qualitative Study of Psychedelic Researchers","year":"2024","cit":14,"pfa":"Michaela Barber","psa":"Adrian Carter","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4403130693","eid":"W4403130693"},{"id":"paper-w2497558064","cat":"papers","name":"The use of microdoses of oxytocin in mares to induce parturition","year":"2002","cit":14,"pfa":"Pascale Chavatte‐Palmer","psa":"F Clément","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2497558064","eid":"W2497558064"},{"id":"paper-w4402623622","cat":"papers","name":"Psychedelics and schizophrenia: a double-edged sword","year":"2024","cit":14,"pfa":"Jacopo Sapienza","psa":"Marta Bosia","ptype":"article","src":"https://openalex.org/W4402623622","eid":"W4402623622"},{"id":"paper-w2399819016","cat":"papers","name":"Beware of blotting paper hallucinogens: severe toxicity with NBOMes","year":"2015","cit":14,"pfa":"Geoffrey Kennedy Isbister","psa":"Jeffrey Ernest Grice","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2399819016","eid":"W2399819016"},{"id":"paper-w102658218","cat":"papers","name":"Other Agents: Phencyclidine, Marijuana, Hallucinogens, Inhalants, and Anticholinergics","year":"1993","cit":14,"pfa":"John C.M. Brust","ptype":"article","src":"https://openalex.org/W102658218","eid":"W102658218"},{"id":"paper-w2045217453","cat":"papers","name":"Antagonism of a PCP Drug Discrimination by Hallucinogens and Related Drugs","year":"2000","cit":14,"pfa":"William B West","ptype":"article","src":"https://openalex.org/W2045217453","eid":"W2045217453"},{"id":"paper-w1997587488","cat":"papers","name":"Comparative requirements for exploratory clinical trials — eIND, eCTA and microdosing","year":"2010","cit":14,"pfa":"Patrick Y Muller","topics":["Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W1997587488","eid":"W1997587488"},{"id":"paper-w2912280544","cat":"papers","name":"Serotonin Receptor Involvement in an Animal Model of the Acute Effects of Hallucinogens","year":"1994","cit":14,"pfa":"Mark A. Geyer","psa":"Kirsten M. Krebs","topics":["Mechanism & neuroscience"],"ptype":"dataset","src":"https://openalex.org/W2912280544","eid":"W2912280544"},{"id":"paper-w1553740247","cat":"papers","name":"Narcotic plants, hallucinogens, stimulants, inebriants and hypnotics - their origins and uses.","year":"1972","cit":14,"pfa":"William A. Emboden","ptype":"article","src":"https://openalex.org/W1553740247","eid":"W1553740247"},{"id":"paper-w3204873903","cat":"papers","name":"Driving while under the influence of hallucinogens: Prevalence, correlates, and risk profiles","year":"2021","cit":14,"pfa":"Christopher P. Salas‐Wright","psa":"Michael G. Vaughn","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3204873903","eid":"W3204873903"},{"id":"paper-w4389477450","cat":"papers","name":"State-Regulated Psychedelics on a Collision Course With FDA","year":"2023","cit":14,"pfa":"Mason Marks","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4389477450","eid":"W4389477450"},{"id":"paper-w3211168853","cat":"papers","name":"Acid Revival: The Psychedelic Renaissance and the Quest for Medical Legitimacy","year":"2021","cit":14,"pfa":"Sharon Greenwood","ptype":"article","src":"https://openalex.org/W3211168853","eid":"W3211168853"},{"id":"paper-w4400462265","cat":"papers","name":"Brain Networks, Neurotransmitters and Psychedelics: Towards a Neurochemistry of Self-Awareness","year":"2024","cit":14,"pfa":"Daniel C. Mograbi","psa":"Jonathan D. Huntley","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4400462265","eid":"W4400462265"},{"id":"paper-w4392545393","cat":"papers","name":"Diminished psychedelic returns on distress: Marital status and household size","year":"2024","cit":14,"pfa":"Sean M. Viña","ptype":"article","src":"https://openalex.org/W4392545393","eid":"W4392545393"},{"id":"paper-w4387532778","cat":"papers","name":"μ-opioid receptor agonists and psychedelics: pharmacological opportunities and challenges","year":"2023","cit":14,"pfa":"Leah M. Salinsky","psa":"Kathryn A. Cunningham","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4387532778","eid":"W4387532778"},{"id":"paper-w1966851009","cat":"papers","name":"Personality characteristics associated with psychedelic flashbacks in natural and experimental settings.","year":"1976","cit":14,"pfa":"Robert K. Heaton","psa":"Ralph G. Victor","ptype":"article","src":"https://openalex.org/W1966851009","eid":"W1966851009"},{"id":"paper-w4401554246","cat":"papers","name":"Autism, youth suicide, and psychedelics: A review of the 21st century evidence","year":"2024","cit":14,"pfa":"Mu‐Hong Chen","psa":"Shih‐Jen Tsai","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4401554246","eid":"W4401554246"},{"id":"paper-w4380742551","cat":"papers","name":"Learned Helplessness As a Potential Transdiagnostic Therapeutic Mechanism of Classic Psychedelics","year":"2023","cit":14,"pfa":"Praachi Tiwari","psa":"David B. Yaden","topics":["Addiction","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4380742551","eid":"W4380742551"},{"id":"paper-w2017394115","cat":"papers","name":"An item response theory analysis of DSM-IV criteria for hallucinogen abuse and dependence in adolescents","year":"2009","cit":14,"pfa":"Li-Tzy T. Wu","psa":"Dan German Blazer","ptype":"article","src":"https://openalex.org/W2017394115","eid":"W2017394115"},{"id":"paper-w4313646798","cat":"papers","name":"Microdosing Sprint Distribution as an Alternative to Achieve Better Sprint Performance in Field Hockey Players","year":"2023","cit":14,"pfa":"Víctor Cuadrado‐Peñafiel","psa":"Pedro Jiménez‐Reyes","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4313646798","eid":"W4313646798"},{"id":"paper-w4221077935","cat":"papers","name":"Behavioral Psychedelics: Integrating Mind and Behavior to Improve Health and Resilience","year":"2022","cit":14,"pfa":"Edmund C. Neuhaus","psa":"George M. Slavich","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4221077935","eid":"W4221077935"},{"id":"paper-w4289830898","cat":"papers","name":"Non-hallucinogenic Psychedelic Analog Design: A Promising Direction for Depression Treatment","year":"2022","cit":14,"pfa":"Yanan Yin","psa":"Tianming Gao","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4289830898","eid":"W4289830898"},{"id":"paper-w4220677776","cat":"papers","name":"How to account for hallucinations in the interpretation of the antidepressant effects of psychedelics: a translational framework","year":"2022","cit":14,"pfa":"Manon van den Berg","psa":"Joseph H. Porter","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4220677776","eid":"W4220677776"},{"id":"paper-w4387793665","cat":"papers","name":"Methodological concerns in psychedelic research: The issues of nonequivalent psychological support and generalizability","year":"2023","cit":14,"pfa":"Richard J. Zeifman","psa":"Lucas Oliveira Maia","ptype":"article","src":"https://openalex.org/W4387793665","eid":"W4387793665"},{"id":"paper-w4285589924","cat":"papers","name":"The Relationship Between Psychedelic Use, Mystical Experiences, and Pro-Environmental Behaviors","year":"2022","cit":14,"pfa":"Kelly Paterniti","psa":"Eyal Gringart","ptype":"article","src":"https://openalex.org/W4285589924","eid":"W4285589924"},{"id":"paper-w4295836068","cat":"papers","name":"In-Season Training Model for National Association of Intercollegiate Athletics Female Basketball Players Using “Microdosed” Programming","year":"2022","cit":14,"pfa":"Ian J. Bonder","psa":"Andrew Shim","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4295836068","eid":"W4295836068"},{"id":"paper-w2010182645","cat":"papers","name":"Efficacy of injectable and pour-on microdose ivermectin in the treatment of goat warble fly infestation by Przhevalskiana silenus (Diptera, Oestridae)","year":"2003","cit":14,"pfa":"Annunziata Giangaspero","psa":"C. Boulard","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2010182645","eid":"W2010182645"},{"id":"paper-w4377088288","cat":"papers","name":"Reducing the Harms of Nonclinical Psychedelics Use Through a Peer-Support Telephone Helpline","year":"2023","cit":14,"pfa":"Mollie M. Pleet","psa":"Rachel Yehuda","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4377088288","eid":"W4377088288"},{"id":"paper-w4282931971","cat":"papers","name":"Serotonergic psychedelic treatment for obesity and eating disorders: potential expectations and caveats for emerging studies","year":"2022","cit":14,"pfa":"Stephanie L. Borgland","psa":"Drew M. Neyens","topics":["Depression","Addiction"],"ptype":"editorial","src":"https://openalex.org/W4282931971","eid":"W4282931971"},{"id":"paper-w2595414645","cat":"papers","name":"The hallucinogen 2,5-dimethoxy-4-iodoamphetamine hydrochloride activates neurotrophin receptors in a neuronal cell line and promotes neurites extension","year":"2017","cit":14,"pfa":"Zoya Marinova","psa":"Edna Grünblatt","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2595414645","eid":"W2595414645"},{"id":"paper-w2128789722","cat":"papers","name":"Implications for burn shock resuscitation of a new in vivo human vascular microdosing technique (microdialysis) for dermal administration of noradrenaline","year":"2012","cit":14,"pfa":"Anders Samuelsson","psa":"Folke Sjöberg","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2128789722","eid":"W2128789722"},{"id":"paper-w2069085623","cat":"papers","name":"Accelerator mass spectrometry analysis of background 14C-concentrations in human blood: aiming at reference data for further microdosing studies","year":"2008","cit":14,"pfa":"Ryogo Minamimoto","psa":"Tomio Inoue","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2069085623","eid":"W2069085623"},{"id":"paper-w3013655406","cat":"papers","name":"Transitioning a patient from injectable opioid agonist therapy to sublingual buprenorphine/naloxone for the treatment of opioid use disorder using a microdosing approach","year":"2020","cit":14,"pfa":"Mackenzie Duncan Gregory Caulfield","psa":"Seonaid Nolan","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3013655406","eid":"W3013655406"},{"id":"paper-w1996020662","cat":"papers","name":"Potential psychotomimetics. New bromoalkoxyamphetamines","year":"1972","cit":14,"pfa":"Silvia Sepúlveda","psa":"Bruce K. Cassels","ptype":"article","src":"https://openalex.org/W1996020662","eid":"W1996020662"},{"id":"paper-w97662067","cat":"papers","name":"Microdose GnRH Agonist Flare-Up versus Ultrashort GnRH Agonist Combined with Fixed GnRH Antagonist in Poor Responders of Assisted Reproductive Techniques Cycles.","year":"2013","cit":14,"pfa":"Maryam Eftekhar","psa":"Parisa Khani","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W97662067","eid":"W97662067"},{"id":"paper-w2143936958","cat":"papers","name":"Psychedelic Drugs: A Study of Drug-Induced Experiences Obtained by Illegal Drug Users in Relation to Stanislav Grof's Model of Altered States of Consciousness","year":"2000","cit":14,"pfa":"Anette Kjellgren","psa":"Torsten Norlander","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2143936958","eid":"W2143936958"},{"id":"paper-w2043612424","cat":"papers","name":"COMPARISON OF TWO DRUGS WITH PSYCHOTOMIMETIC EFFECTS (LSD AND DITRAN)","year":"1964","cit":14,"pfa":"ROY EDWARD WILSON","psa":"Charles Shagass","ptype":"article","src":"https://openalex.org/W2043612424","eid":"W2043612424"},{"id":"paper-w2088825111","cat":"papers","name":"From Acid Revolution to Entheogenic Evolution: Psychedelic Philosophy in the Sixties and Beyond : Winner of the William M. Jones Best Graduate Student Paper Award at the 2013 American Culture Association Conference","year":"2013","cit":14,"pfa":"Chris Elcock","ptype":"article","src":"https://openalex.org/W2088825111","eid":"W2088825111"},{"id":"paper-w2063795447","cat":"papers","name":"OBSERVATION ON TWO PSYCHOTOMIMETIC DRUGS OF PIPERIDINE DERIVATION–CI 395 (SERNYL) AND CI 400","year":"1960","cit":14,"pfa":"LEONARD LEVY","psa":"R. C. B. Aitken","topics":["Depression","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2063795447","eid":"W2063795447"},{"id":"paper-w1992250986","cat":"papers","name":"Synthesis and characterization of an affinity label for brain receptors to psychotomimetic benzomorphans: differentiation of σ-type and phencyclidine receptors","year":"1987","cit":14,"pfa":"Joanne Tremblay Adams","psa":"Eckard Weber","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1992250986","eid":"W1992250986"},{"id":"paper-w2071378932","cat":"papers","name":"Effect of 4-substitution on psychotomimetic activity of 2,5-dimethoxy amphetamines as studied by means of different substituent parameter scales","year":"2006","cit":14,"pfa":"Kari Neuvonen","psa":"Ferenc Fülöp","ptype":"article","src":"https://openalex.org/W2071378932","eid":"W2071378932"},{"id":"paper-w4399353996","cat":"papers","name":"The Production of Entheogenic Communities in the United States","year":"2024","cit":14,"pfa":"Brad Stoddard","topics":["Addiction","Policy & ethics"],"ptype":"book","src":"https://openalex.org/W4399353996","eid":"W4399353996"},{"id":"paper-w2129319502","cat":"papers","name":"Hallucinogenic Plants: Their Earliest Botanical Descriptions","year":"1979","cit":14,"pfa":"Richard Evans Schultes","ptype":"article","src":"https://openalex.org/W2129319502","eid":"W2129319502"},{"id":"paper-w2075644208","cat":"papers","name":"Assessment of specific drug disorders in a sample of substance abuse patients: A comparison of the DIS and the SADS-L procedures","year":"1987","cit":14,"pfa":"Deborah S. Hasin","psa":"Bridget F. Grant","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2075644208","eid":"W2075644208"},{"id":"paper-w2399101879","cat":"papers","name":"Oxygen-Ozone Treatment of the Knee, Shoulder and Hip A Personal Experience","year":"2006","cit":14,"pfa":"Paolo Benvenuti","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2399101879","eid":"W2399101879"},{"id":"paper-w2122570507","cat":"papers","name":"Attitude and Personality Correlates of Hallucinogenic Drug Use","year":"1986","cit":14,"pfa":"Edward A. Mabry","psa":"Khalil Akhtar Khavari","ptype":"article","src":"https://openalex.org/W2122570507","eid":"W2122570507"},{"id":"paper-w4285605406","cat":"papers","name":"Self-treatment of psychosis and complex post-traumatic stress disorder with LSD and DMT—A retrospective case study","year":"2022","cit":14,"pfa":"Mika Turkia","topics":["PTSD & trauma","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4285605406","eid":"W4285605406"},{"id":"paper-w2337148883","cat":"papers","name":"Ketamine - From medicine to misuse","year":"2006","cit":14,"pfa":"Kim Wolff","psa":"ADAM R. WINSTOCK","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W2337148883","eid":"W2337148883"},{"id":"paper-w2161590467","cat":"papers","name":"Automated Drop-on-Demand System with Real-Time Gravimetric Control for Precise Dosage Formulation","year":"2013","cit":14,"pfa":"Abhishek Sahay","psa":"Paul Takhistov","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2161590467","eid":"W2161590467"},{"id":"paper-w1503018053","cat":"papers","name":"Psychopathology and mental health needs among drug-involved inmates","year":"1992","cit":14,"pfa":"Roger H. Peters","psa":"Addis S. Dolente","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1503018053","eid":"W1503018053"},{"id":"paper-w4409574171","cat":"papers","name":"Novel color via stimulation of individual photoreceptors at population scale","year":"2025","cit":14,"pfa":"James Fong","psa":"Ren Ng","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4409574171","eid":"W4409574171"},{"id":"paper-w2910157234","cat":"papers","name":"5-HT2 receptor binding, functional activity and selectivity in N-benzyltryptamines","year":"2019","cit":14,"pfa":"MIGUEL A TORO-SAZO","psa":"Bruce K. Cassels","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2910157234","eid":"W2910157234"},{"id":"paper-w4231718340","cat":"papers","name":"Characteristics of drug abusers admitted to a psychiatric hospital","year":"1968","cit":14,"pfa":"L. J. Hekimian","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4231718340","eid":"W4231718340"},{"id":"paper-w2066300149","cat":"papers","name":"Psychopathology and Psychopharmacology","year":"1973","cit":14,"pfa":"John F. Greden","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2066300149","eid":"W2066300149"},{"id":"paper-w2034980590","cat":"papers","name":"PhRMA Survey on the Conduct of First‐in‐Human Clinical Trials Under Exploratory Investigational New Drug Applications","year":"2010","cit":14,"pfa":"Adel H. Karara","psa":"John A. Wagner","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2034980590","eid":"W2034980590"},{"id":"paper-w3207421896","cat":"papers","name":"Pharmacokinetics and Metabolism of Ziritaxestat (GLPG1690) in Healthy Male Volunteers Following Intravenous and Oral Administration","year":"2021","cit":14,"pfa":"Eric Helmer","psa":"Sharan Sidhu","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3207421896","eid":"W3207421896"},{"id":"paper-w4285592961","cat":"papers","name":"Ketamine plus Alcohol: What We Know and What We Can Expect about This","year":"2022","cit":14,"pfa":"Natália Harumi Corrêa Kobayashi","psa":"Cristiane do Socorro Ferraz Maia","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4285592961","eid":"W4285592961"},{"id":"paper-w2087356732","cat":"papers","name":"Issues in the Pharmacological Treatment of Adolescent Substance Abuse","year":"1995","cit":14,"pfa":"Yifrah Kaminer","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2087356732","eid":"W2087356732"},{"id":"paper-w2057718463","cat":"papers","name":"The Use of Medication for Relapse Prevention in Substance Dependence Disorders","year":"2001","cit":14,"pfa":"Christopher Welsh","psa":"Joseph C. Liberto","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2057718463","eid":"W2057718463"},{"id":"paper-w2919457404","cat":"papers","name":"Patient attitudes toward novel glaucoma drug delivery approaches","year":"2018","cit":14,"pfa":"Benjamin B. Wang","psa":"Angela V. Turalba","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2919457404","eid":"W2919457404"},{"id":"paper-w4231319010","cat":"papers","name":"Addiction Medicine","year":"2016","cit":14,"topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"book","src":"https://openalex.org/W4231319010","eid":"W4231319010"},{"id":"paper-w2026021476","cat":"papers","name":"Toxic Psychoses as Pharmacological Models of Schizophrenia","year":"2005","cit":14,"pfa":"Stéphane Potvin","psa":"Jean- Roy","topics":["Addiction","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2026021476","eid":"W2026021476"},{"id":"paper-w4318156527","cat":"papers","name":"Inpatient Low-dose Transitions From Full Agonist Opioids Including Methadone Onto Long-acting Depot Buprenorphine: Case Series From a Multicenter Clinical Trial","year":"2023","cit":14,"pfa":"Nikhil Seval","psa":"Sandra Ann Springer","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4318156527","eid":"W4318156527"},{"id":"paper-w4376609254","cat":"papers","name":"A transdiagnostic meta-analysis of acute augmentations to psychological therapy","year":"2023","cit":14,"pfa":"Camilla L. Nord","psa":"Tim Dalgleish","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4376609254","eid":"W4376609254"},{"id":"paper-w4382060847","cat":"papers","name":"Age, Dose, and Locomotion: Decoding Vulnerability to Ketamine in C57BL/6J and BALB/c Mice","year":"2023","cit":14,"pfa":"Wen-Chien Chen","psa":"Yi-Chyan Chen","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4382060847","eid":"W4382060847"},{"id":"paper-w4366463245","cat":"papers","name":"Association of Mental Health Conditions, Recent Stressful Life Events, and Adverse Childhood Experiences with Postpartum Substance Use ― Seven States, 2019–2020","year":"2023","cit":14,"pfa":"Andrea Stewart","psa":"Wanda Denise Barfield","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4366463245","eid":"W4366463245"},{"id":"paper-w4321375743","cat":"papers","name":"A novel oral formulation of the melanocortin-1 receptor agonist PL8177 resolves inflammation in preclinical studies of inflammatory bowel disease and is gut restricted in rats, dogs, and humans","year":"2023","cit":14,"pfa":"John H. Dodd","psa":"Paul S. Kayne","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4321375743","eid":"W4321375743"},{"id":"paper-w3007426621","cat":"papers","name":"Structure–Activity Relationship Study of Psychostimulant Synthetic Cathinones Reveals Nanomolar Antagonist Potency of α-Pyrrolidinohexiophenone at Human Muscarinic M 2 Receptors","year":"2020","cit":14,"pfa":"Yiming Chen","psa":"Clinton Ernest Canal","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3007426621","eid":"W3007426621"},{"id":"paper-w2403944350","cat":"papers","name":"A competitive antagonist of NMDA receptors CGP 40116 attenuates experimental symptoms of schizophrenia evoked by MK-801.","year":"2004","cit":14,"pfa":"Wojciech Zajaczkowski","psa":"K Wedzony","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2403944350","eid":"W2403944350"},{"id":"paper-w1980922501","cat":"papers","name":"Impaired facial emotion recognition in a ketamine model of psychosis","year":"2012","cit":14,"pfa":"Andreas Ebert","psa":"Patrik Roser","ptype":"article","src":"https://openalex.org/W1980922501","eid":"W1980922501"},{"id":"paper-w64129582","cat":"papers","name":"Steroidal Modulation of Sigma Receptor Function","year":"1999","cit":14,"pfa":"Stéphane Bastianetto","psa":"Rémi Quirion","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W64129582","eid":"W64129582"},{"id":"paper-w2418729540","cat":"papers","name":"Clinical implications of behavioral pharmacology research on phencyclidine.","year":"1986","cit":14,"pfa":"Robert L. Balster","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"dataset","src":"https://openalex.org/W2418729540","eid":"W2418729540"},{"id":"paper-w3026250618","cat":"papers","name":"Rapastinel, an NMDAR positive modulator, produces distinct behavioral, sleep, and EEG profiles compared with ketamine","year":"2020","cit":14,"pfa":"Pradeep Banerjee","psa":"Ronald S. Duman","topics":["Depression","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3026250618","eid":"W3026250618"},{"id":"paper-w3211722577","cat":"papers","name":"Efficacy and safety of mij821 in patients with treatment-resistant depression: Results from a randomized, placebo-controlled, proof-of-concept study","year":"2021","cit":14,"pfa":"S. Nassir Ghaemi","psa":"Robert E. Litman","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3211722577","eid":"W3211722577"},{"id":"paper-w2172214944","cat":"papers","name":"Innovative approaches to treatment - refractory depression: The ketamine story","year":"2010","cit":14,"pfa":"T.SSathyanarayana Rao","psa":"Chittaranjan Andrade","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"editorial","src":"https://openalex.org/W2172214944","eid":"W2172214944"},{"id":"paper-w4281657729","cat":"papers","name":"(2R,6R)-hydroxynorketamine rapidly potentiates optically-evoked Schaffer collateral synaptic activity","year":"2022","cit":14,"pfa":"Lace Marie Riggs","psa":"Todd D. Gould","ptype":"article","src":"https://openalex.org/W4281657729","eid":"W4281657729"},{"id":"paper-w2791849368","cat":"papers","name":"Stereochemical and structural effects of (2R,6R)-hydroxynorketamine on the mitochondrial metabolome in PC-12 cells","year":"2018","cit":14,"pfa":"Andréa Tedesco Faccio","psa":"Irving W. Wainer","ptype":"article","src":"https://openalex.org/W2791849368","eid":"W2791849368"},{"id":"paper-w4403022097","cat":"papers","name":"Efficacy and Safety of Ketamine/Esketamine in Bipolar Depression in a Clinical Setting","year":"2024","cit":14,"pfa":"Mia C Santucci","psa":"Samuel T. Wilkinson","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4403022097","eid":"W4403022097"},{"id":"paper-w4205092562","cat":"papers","name":"Effects of subanesthetic ketamine and (2R,6R) hydroxynorketamine on working memory and synaptic transmission in the nucleus reuniens in mice","year":"2022","cit":14,"pfa":"Priyodarshan Goswamee","psa":"A. Rory McQuiston","ptype":"article","src":"https://openalex.org/W4205092562","eid":"W4205092562"},{"id":"paper-w4362600563","cat":"papers","name":"Safety and efficacy of esketamine for postoperative analgesia in pediatric patients with hypospadias","year":"2023","cit":14,"pfa":"Yong Xu","psa":"Xingrong Song","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4362600563","eid":"W4362600563"},{"id":"paper-w2588070663","cat":"papers","name":"Separation of hydroxynorketamine stereoisomers using capillary electrophoresis with sulfated β‐cyclodextrin and highly sulfated γ‐cyclodextrin","year":"2017","cit":14,"pfa":"Friederike A. Sandbaumhüter","psa":"Wolfgang Thormann","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2588070663","eid":"W2588070663"},{"id":"paper-w4408988817","cat":"papers","name":"(2R,6R)‐hydroxynorketamine prevents opioid abstinence‐related negative affect and stress‐induced reinstatement in mice","year":"2025","cit":14,"pfa":"Andria Michael","psa":"Panos Zanos","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4408988817","eid":"W4408988817"},{"id":"paper-w4381549422","cat":"papers","name":"Efficacy of repeated intravenous esketamine in adolescents with anxious versus non‐anxious depression","year":"2023","cit":14,"pfa":"Xiaofeng Lan","psa":"Yanling Zhou","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4381549422","eid":"W4381549422"},{"id":"paper-w4401709616","cat":"papers","name":"Effect of esketamine on serum neurotransmitters in patients with postpartum depression: a randomized controlled trial","year":"2024","cit":14,"pfa":"Qinyu Jiang","psa":"Liwei Wang","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4401709616","eid":"W4401709616"},{"id":"paper-w4390400369","cat":"papers","name":"State-related Electroencephalography Microstate Complexity during Propofol- and Esketamine-induced Unconsciousness","year":"2023","cit":14,"pfa":"Zhenhu Liang","psa":"Changwei Wei","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4390400369","eid":"W4390400369"},{"id":"paper-w4223950391","cat":"papers","name":"Esketamine inhaled as dry powder: Pharmacokinetic, pharmacodynamic and safety assessment in a preclinical study","year":"2022","cit":14,"pfa":"Mikołaj Matłoka","psa":"Jerzy Pieczykolan","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4223950391","eid":"W4223950391"},{"id":"paper-w7130643232","cat":"papers","name":"Integrating Psychiatric, Psychotherapeutic, and Nursing Care in Intranasal Esketamine for Treatment-Resistant Depression","year":"2026","cit":14,"pfa":"Vassilis Martiadis","psa":"Carlo Ignazio Cattaneo","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7130643232","eid":"W7130643232"},{"id":"paper-w4283758808","cat":"papers","name":"[Retracted] The Clinical Application of Remimazolam Benzenesulfonate Combined with Esketamine Intravenous Anesthesia in Endoscopic Retrograde Cholangiopancreatography","year":"2022","cit":14,"pfa":"Xiuna Yi","psa":"Aizhi Li","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4283758808","eid":"W4283758808"},{"id":"paper-w4405506171","cat":"papers","name":"Neuroanatomical and pharmaco-physiological effects of hypoxia and esketamine on breathing, the sympathetic nerve system, and cortical function","year":"2024","cit":14,"pfa":"Aiman Suleiman","psa":"Astrid G. Stucke","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4405506171","eid":"W4405506171"},{"id":"paper-w4315619450","cat":"papers","name":"Clinical experiences with intranasal esketamine for major depressive disorder resistant to treatment and with a psychiatric emergency: case presentations","year":"2022","cit":14,"pfa":"Maurizio Pompili","psa":"Anna Comparelli","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4315619450","eid":"W4315619450"},{"id":"paper-w4391384011","cat":"papers","name":"The role and mechanism of esketamine in preventing and treating remifentanil-induced hyperalgesia based on the NMDA receptor–CaMKII pathway","year":"2024","cit":14,"pfa":"Jiafang Wang","psa":"Degang Zhu","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4391384011","eid":"W4391384011"},{"id":"paper-w4384521176","cat":"papers","name":"Effect of esketamine nasal drops on pain in children after tonsillectomy using low temperature plasma ablation","year":"2023","cit":14,"pfa":"Qiu Qian","psa":"Yue Li","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4384521176","eid":"W4384521176"},{"id":"paper-w4280567598","cat":"papers","name":"Prediction of Drug–Drug Interactions After Esketamine Intranasal Administration Using a Physiologically Based Pharmacokinetic Model","year":"2022","cit":14,"pfa":"Marie‐Emilie Willemin","psa":"Jan Snoeys","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4280567598","eid":"W4280567598"},{"id":"paper-w4409661415","cat":"papers","name":"The Effects of Ketamine and Esketamine on Measures of Quality of Life in Major Depressive Disorder and Treatment-Resistant Depression: A Systematic Review","year":"2025","cit":14,"pfa":"Morgan C.H. Cheng","psa":"Roger S. McIntyre","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4409661415","eid":"W4409661415"},{"id":"paper-w4388108934","cat":"papers","name":"Efficacy of intraoperative subanesthetic dose of ketamine/esketamine in preventing postoperative cognitive dysfunction: a systematic review and meta-analysis","year":"2023","cit":14,"pfa":"Na Zhou","psa":"Yanhua Chen","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4388108934","eid":"W4388108934"},{"id":"paper-w4391345038","cat":"papers","name":"Treatment-resistant depression patients with baseline suicidal ideation required more treatments to achieve therapeutic response with ketamine/esketamine","year":"2024","cit":14,"pfa":"Balwinder Singh","psa":"Simon Kung","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4391345038","eid":"W4391345038"},{"id":"paper-w3199646961","cat":"papers","name":"The use of esketamine in comorbid treatment resistant depression and obsessive compulsive disorder following extensive pharmacogenomic testing: a case report","year":"2021","cit":14,"pfa":"Matteo Marcatili","psa":"Clerici Massimo","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3199646961","eid":"W3199646961"},{"id":"paper-w4405987316","cat":"papers","name":"Esketamine alleviates LPS-induced depression-like behavior by activating Nrf2-mediated anti-inflammatory response in adolescent mice","year":"2025","cit":14,"pfa":"Xinxu Ma","psa":"Min Cai","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4405987316","eid":"W4405987316"},{"id":"paper-w4392842805","cat":"papers","name":"Esketamine inhibits the c-Jun N-terminal kinase pathway in the spinal dorsal horn to relieve bone cancer pain in rats","year":"2024","cit":14,"pfa":"Chenxia Duan","psa":"Chenghuan Shi","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4392842805","eid":"W4392842805"},{"id":"paper-w4383709966","cat":"papers","name":"Effect of continuous subanesthetic esketamine infusion on postoperative fatigue in patients undergoing laparoscopic radical resection for colorectal cancer: a randomized controlled study.","year":"2023","cit":14,"pfa":"Lei Sun","psa":"Yinming Zeng","topics":["Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4383709966","eid":"W4383709966"},{"id":"paper-w4226226797","cat":"papers","name":"Sevoflurane in combination with esketamine is an effective sedation regimen in COVID-19 patients enabling assisted spontaneous breathing even during prone positioning","year":"2022","cit":14,"pfa":"Joachim Bansbach","psa":"Johannes Kalbhenn","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4226226797","eid":"W4226226797"},{"id":"paper-w4391166548","cat":"papers","name":"Effect of esketamine-based opioid-sparing anesthesia strategy on postoperative pain and recovery quality in patients undergoing total laparoscopic hysterectomy: A randomized controlled trail","year":"2024","cit":14,"pfa":"Jialei Liu","psa":"Yan Li","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4391166548","eid":"W4391166548"},{"id":"paper-w4412124374","cat":"papers","name":"Microglial BDNF modulates arketamine’s antidepressant-like effects through cortico-accumbal pathways","year":"2025","cit":14,"pfa":"Lujuan He","psa":"Ji‐chun Zhang","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4412124374","eid":"W4412124374"},{"id":"paper-w4385878238","cat":"papers","name":"Efficacy of Ketamine with and without Lamotrigine in Treatment-Resistant Depression: A Preliminary Report","year":"2023","cit":14,"pfa":"Boney Joseph","psa":"Balwinder Singh","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4385878238","eid":"W4385878238"},{"id":"paper-w4200167304","cat":"papers","name":"CYP 450 enzymes influence (R,S)-ketamine brain delivery and its antidepressant activity","year":"2021","cit":14,"pfa":"Thi Mai Loan Nguyen","psa":"Alain Michel Gardier","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4200167304","eid":"W4200167304"},{"id":"paper-w4402715472","cat":"papers","name":"Ketamine Prevents Inflammation-Induced Reduction of Human Hippocampal Neurogenesis via Inhibiting the Production of Neurotoxic Metabolites of the Kynurenine Pathway","year":"2024","cit":14,"pfa":"Gargi Mandal","psa":"Alessandra Borsini","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4402715472","eid":"W4402715472"},{"id":"paper-w4414085331","cat":"papers","name":"Ketamine for Depression, but at What Cost? A Review of Ketamine’s Neurotoxic Effects From Preclinical and Human Studies","year":"2025","cit":14,"pfa":"S. William Li","psa":"Samuel T. Wilkinson","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4414085331","eid":"W4414085331"},{"id":"paper-w4388924079","cat":"papers","name":"Cerebrospinal fluid exploratory proteomics and ketamine metabolite pharmacokinetics in human volunteers after ketamine infusion","year":"2023","cit":14,"pfa":"Ruin Moaddel","psa":"Carlos A. Zarate","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4388924079","eid":"W4388924079"},{"id":"paper-w3037046241","cat":"papers","name":"Patient preferences for ketamine-based antidepressant treatments in treatment-resistant depression: Results from a clinical trial and panel","year":"2020","cit":14,"pfa":"Angelyn Otteson Fairchild","psa":"Bennett S. Levitan","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W3037046241","eid":"W3037046241"},{"id":"paper-w4402246624","cat":"papers","name":"The Effect of Opioid-Free Anesthesia with Transversus Abdominis Plane Block on Patients Undergoing Laparoscopic Sleeve Gastrectomy: Randomized Controlled Study","year":"2024","cit":14,"pfa":"Xia Zhou","psa":"Pei Wang","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4402246624","eid":"W4402246624"},{"id":"paper-w2513347882","cat":"papers","name":"Ketamine modulates catecholamine transmission in the bed nucleus of stria terminalis: The possible role of this region in the antidepressant effects of ketamine","year":"2016","cit":14,"pfa":"Roberto Cadeddu","psa":"Ezio Carboni","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2513347882","eid":"W2513347882"},{"id":"paper-w4212899544","cat":"papers","name":"Comments to pharmacological and behavioral divergence of ketamine enantiomers by Jordi Bonaventura et al.","year":"2022","cit":14,"pfa":"Guang Chen","psa":"Wayne Curtis Drevets","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4212899544","eid":"W4212899544"},{"id":"paper-w2442774095","cat":"papers","name":"Actions of LSD-25 and reserpine on a serotonergic synapse.","year":"1970","cit":14,"pfa":"G A Cottrell","ptype":"article","src":"https://openalex.org/W2442774095","eid":"W2442774095"},{"id":"paper-w2468313538","cat":"papers","name":"[The use of narcotics (mescaline and lysergic acid diethylamide) in psychotherapy].","year":"1953","cit":13,"pfa":"Walter Frederking","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2468313538","eid":"W2468313538"},{"id":"paper-w2405542270","cat":"papers","name":"LYSERGIC ACID DIETHYLAMIDE IN PSYCHOTHERAPY","year":"1964","cit":13,"pfa":"L. Howard Whitaker","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2405542270","eid":"W2405542270"},{"id":"paper-w2059544190","cat":"papers","name":"Biosynthesis of mescaline in peyote","year":"1967","cit":13,"pfa":"Stig Agurell","psa":"Finn Sandberg","ptype":"article","src":"https://openalex.org/W2059544190","eid":"W2059544190"},{"id":"paper-w1894551243","cat":"papers","name":"ANTIEMETIC ACTIVITY OF D-LYSERGIC ACID DIETHYLAMIDE","year":"1961","cit":13,"pfa":"Bhola Nath Dhawan","psa":"G.P. Gupta","ptype":"article","src":"https://openalex.org/W1894551243","eid":"W1894551243"},{"id":"paper-w1991033521","cat":"papers","name":"Lysergic Acid Diethylamide-Induced Chronic Visual Disturbances in an Adolescent","year":"1991","cit":13,"pfa":"Yifrah Kaminer","psa":"Bohdan Hrecznyj","ptype":"article","src":"https://openalex.org/W1991033521","eid":"W1991033521"},{"id":"paper-w2023143393","cat":"papers","name":"THE ANALEPTIC ACTION OF LYSERGIC ACID DIETHYLAMIDE ON RESERPINE‐SEDATED MICE","year":"1957","cit":13,"pfa":"Robert Main Burton","ptype":"article","src":"https://openalex.org/W2023143393","eid":"W2023143393"},{"id":"paper-w2009219313","cat":"papers","name":"Serotonin-like and Antiserotonin Properties of Psilocybin and Psilocin","year":"1962","cit":13,"pfa":"D. W. Woolley","psa":"N.K. Campbell","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2009219313","eid":"W2009219313"},{"id":"paper-w4253479242","cat":"papers","name":"Occurrence of Psilocybin/Psilocin in Pluteus salicinus (Pluteaceae)","year":"1981","cit":13,"pfa":"Stephen G. Saupe","ptype":"article","src":"https://openalex.org/W4253479242","eid":"W4253479242"},{"id":"paper-w2009804953","cat":"papers","name":"Rapid Identification of Lysergic Acid Diethylamide in Blotter Paper by Microscope FT-IR","year":"1999","cit":13,"pfa":"Minemasa Hida","psa":"Toshiyuki Mitsui","ptype":"article","src":"https://openalex.org/W2009804953","eid":"W2009804953"},{"id":"paper-w2080631356","cat":"papers","name":"Detection of Psilocybin and Psilocin in Norwegian Species ofPluteusandConocybe","year":"1984","cit":13,"pfa":"A. Christiansen","psa":"Klaus Høiland","ptype":"article","src":"https://openalex.org/W2080631356","eid":"W2080631356"},{"id":"paper-w2067579651","cat":"papers","name":"The mutagenic effect or lysergic acid diethylamide II. Dominant lethal test in mice","year":"1974","cit":13,"pfa":"Radim J. Šrám","psa":"P Goetz","ptype":"article","src":"https://openalex.org/W2067579651","eid":"W2067579651"},{"id":"paper-w2096844680","cat":"papers","name":"The effects of noribogaine and harmaline in rats trained with ibogaine as a discriminative stimulus","year":"1997","cit":13,"pfa":"Scott Helsley","psa":"Jerrold C. Winter","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2096844680","eid":"W2096844680"},{"id":"paper-w2587200684","cat":"papers","name":"Toxicokinetics of ibogaine and noribogaine in a patient with prolonged multiple cardiac arrhythmias after ingestion of internet purchased ibogaine","year":"2017","cit":13,"pfa":"Marieke Jantien Henstra","psa":"Ferdi Sombogaard","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2587200684","eid":"W2587200684"},{"id":"paper-w1967129780","cat":"papers","name":"Development of a stand-alone affinity clean-up for lysergic acid diethylamide in urine","year":"1996","cit":13,"pfa":"John Francis","psa":"Derek H. Craston","ptype":"article","src":"https://openalex.org/W1967129780","eid":"W1967129780"},{"id":"paper-w1979384458","cat":"papers","name":"Lysergic Acid Diethylamide (Lsd-25): Xiv. Effect on Personality as Observed in Psychological Tests","year":"1955","cit":13,"pfa":"A. Levine","psa":"Conan H. Kornetsky","ptype":"article","src":"https://openalex.org/W1979384458","eid":"W1979384458"},{"id":"paper-w2313441518","cat":"papers","name":"PRELIMINARY STUDIES OF THE METABOLISM OF LYSERGIC ACID DIETHYLAMIDE USING RADIOACTIVE CARBON-MARKED MOLECULES","year":"1955","cit":13,"pfa":"E. S. BOYD","psa":"Harold Carpenter Hodge","ptype":"article","src":"https://openalex.org/W2313441518","eid":"W2313441518"},{"id":"paper-w1999910754","cat":"papers","name":"Behavioural and electrographic effects of d-lysergic acid diethylamide (LSD 25) on the photosensitive Papio papio","year":"1971","cit":13,"pfa":"S Walter","psa":"R Naquet","ptype":"article","src":"https://openalex.org/W1999910754","eid":"W1999910754"},{"id":"paper-w630470737","cat":"papers","name":"Efficiency of Capillary Column Gas Chromatography in Separating Lysergic Acid Diethylamide (LSD) and Lysergic Acid Methylpropylamide (LAMPA)","year":"1984","cit":13,"pfa":"David T. Stafford","psa":"William H. Anderson","ptype":"article","src":"https://openalex.org/W630470737","eid":"W630470737"},{"id":"paper-w4393098915","cat":"papers","name":"Psychedelic Therapy: A Primer for Primary Care Clinicians—N,N-Dimethyltryptamine and Ayahuasca","year":"2024","cit":13,"pfa":"Kenneth Shinozuka","psa":"Owen S. Muir","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4393098915","eid":"W4393098915"},{"id":"paper-w2051222028","cat":"papers","name":"Comparison of the chronic and acute effects of d-Lysergic Acid Diethylamide (LSD) treatment on rat brain serotonin and norepinephrine","year":"1974","cit":13,"pfa":"David A. Peters","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2051222028","eid":"W2051222028"},{"id":"paper-w2166126556","cat":"papers","name":"Immunoassay Screening of Lysergic Acid Diethylamide (LSD) and its Confirmation by HPLC and Fluorescence Detection Following LSD ImmunElute Extraction","year":"2002","cit":13,"pfa":"Thomas Grobosch","psa":"U. Lemm-Ahlers","ptype":"article","src":"https://openalex.org/W2166126556","eid":"W2166126556"},{"id":"paper-w2051555368","cat":"papers","name":"Determination of lysergic acid diethylamide (LSD) by application of online 77 K fluorescence spectroscopy and a sweeping technique in micellar electrokinetic chromatography","year":"2002","cit":13,"pfa":"Ching Fang","ptype":"article","src":"https://openalex.org/W2051555368","eid":"W2051555368"},{"id":"paper-w1974814463","cat":"papers","name":"Actions of D-lysergic acid diethylamide (LSD) and its derivatives on 5-hydroxytryptamine receptors in the isolated uterine smooth muscle of the rat","year":"1977","cit":13,"pfa":"Hisakuni Hashimoto","psa":"Hisashi Ishii","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1974814463","eid":"W1974814463"},{"id":"paper-w3106932992","cat":"papers","name":"Acute Lysergic Acid Diethylamide Does Not Influence Reward-Driven Decision Making of C57BL/6 Mice in the Iowa Gambling Task","year":"2020","cit":13,"pfa":"Lauri V. Elsilä","psa":"Esa R. Korpi","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3106932992","eid":"W3106932992"},{"id":"paper-w2140657981","cat":"papers","name":"New Synthesis and Characterization of (+)-Lysergic Acid Diethylamide (LSD) Derivatives and the Development of a Microparticle-Based Immunoassay for the Detection of LSD and Its Metabolites","year":"1997","cit":13,"pfa":"Zhuyin Li","psa":"Salvatore J. Salamone","ptype":"article","src":"https://openalex.org/W2140657981","eid":"W2140657981"},{"id":"paper-w4386045757","cat":"papers","name":"Characterization of the lysergic acid diethylamide analog, 1‐(thiophene‐2‐carbonyl)‐N,N‐diethyllysergamide (1T‐LSD) from a blotter product","year":"2023","cit":13,"pfa":"Rie Tanaka","psa":"Ruri Kikura‐Hanajiri","ptype":"article","src":"https://openalex.org/W4386045757","eid":"W4386045757"},{"id":"paper-w1980594996","cat":"papers","name":"Occurrence of Psilocin in Psilocybe baeocystis","year":"1962","cit":13,"pfa":"ROBERT G. BENEDICT","psa":"Varro E. Tyler","ptype":"article","src":"https://openalex.org/W1980594996","eid":"W1980594996"},{"id":"paper-w1987172752","cat":"papers","name":"Analysis of Psilocin, Bufotenine and LSD in Hair","year":"2014","cit":13,"pfa":"Rafaela Martin","psa":"Helga Köhler","ptype":"article","src":"https://openalex.org/W1987172752","eid":"W1987172752"},{"id":"paper-w2058243166","cat":"papers","name":"Ibogaine and the inhibition of acetylcholinesterase","year":"2011","cit":13,"pfa":"Kenneth Alper","psa":"Henry W. Sershen","ptype":"article","src":"https://openalex.org/W2058243166","eid":"W2058243166"},{"id":"paper-w4412714464","cat":"papers","name":"An overview of psilocybin, LSD, MDMA, and ketamine in revitalizing psychedelic-assisted therapy: Insights, limitations and future directions","year":"2025","cit":13,"pfa":"Kiana Askariyan","psa":"Nooshin Ahmadirad","ptype":"article","src":"https://openalex.org/W4412714464","eid":"W4412714464"},{"id":"paper-w2328274504","cat":"papers","name":"PHARMACODYNAMICS OF LSD AND MESCALINE","year":"1957","cit":13,"pfa":"Max Rinkel","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2328274504","eid":"W2328274504"},{"id":"paper-w4401310804","cat":"papers","name":"Global Ayahuasca","year":"2024","cit":13,"pfa":"Alex K. Gearin","topics":["Safety & adverse events"],"ptype":"book","src":"https://openalex.org/W4401310804","eid":"W4401310804"},{"id":"paper-w4386116467","cat":"papers","name":"Beyond Psilocybin: Reviewing the Therapeutic Potential of Other Serotonergic Psychedelics in Mental and Substance Use Disorders","year":"2023","cit":13,"pfa":"Stanley Wong","psa":"Muhammad Ishrat Husain","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4386116467","eid":"W4386116467"},{"id":"paper-w1998660188","cat":"papers","name":"THE INFLUENCE OF MESCALINE ON PSYCHODYNAMIC MATERIAL","year":"1954","cit":13,"pfa":"JAMES P. CATTELL","ptype":"article","src":"https://openalex.org/W1998660188","eid":"W1998660188"},{"id":"paper-w2419264929","cat":"papers","name":"Neuromyal blocking action of mescaline","year":"1961","cit":13,"pfa":"Robert T. Schopp","psa":"Steven V. Guzak","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2419264929","eid":"W2419264929"},{"id":"paper-w2313074146","cat":"papers","name":"THE EFFECTS OF MESCALINE SULFATE IN CHRONIC SCHIZOPHRENIA","year":"1957","cit":13,"pfa":"Sidney Merlis","ptype":"article","src":"https://openalex.org/W2313074146","eid":"W2313074146"},{"id":"paper-w2315497899","cat":"papers","name":"The Identification of a Chlorinated MDMA","year":"2005","cit":13,"pfa":"V. Marešová","psa":"Jirí Chadt","ptype":"article","src":"https://openalex.org/W2315497899","eid":"W2315497899"},{"id":"paper-w3178240388","cat":"papers","name":"The Alkaloids from Lophophora diffusa and Other “False Peyotes”","year":"2021","cit":13,"pfa":"Camilla B. Chan","psa":"Jesper Langgaard Kristensen","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3178240388","eid":"W3178240388"},{"id":"paper-w2044713900","cat":"papers","name":"OBSERVATIONS OF ALCOHOLICS IN THE PEYOTE RITUAL: A PILOT STUDY*","year":"1976","cit":13,"pfa":"Paul Pascarosa","psa":"Mark Halsweig","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2044713900","eid":"W2044713900"},{"id":"paper-w1988081587","cat":"papers","name":"Psilocin: Effects on Behaviour and Brain Serotonin in Mice","year":"1966","cit":13,"pfa":"Robert L. Collins","psa":"T. Samorajski","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1988081587","eid":"W1988081587"},{"id":"paper-w62341424","cat":"papers","name":"Neurochemical Effects of MDMA","year":"1990","cit":13,"pfa":"James W. Gibb","psa":"Glen R. Hanson","ptype":"book-chapter","src":"https://openalex.org/W62341424","eid":"W62341424"},{"id":"paper-w2017747360","cat":"papers","name":"Gas chromatographic determination of iboga ine in biological fluids","year":"1972","cit":13,"pfa":"Gian Paolo Cartoni","psa":"Alberto Giarusso","ptype":"article","src":"https://openalex.org/W2017747360","eid":"W2017747360"},{"id":"paper-w3179379226","cat":"papers","name":"A new approach methodology (NAM) for the prediction of (nor)ibogaine-induced cardiotoxicity in humans","year":"2021","cit":13,"pfa":"Miaoying Shi","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3179379226","eid":"W3179379226"},{"id":"paper-w2427001565","cat":"papers","name":"Biosynthetic studies on mescaline and related cactus alkaloids.","year":"1971","cit":13,"pfa":"J Lundström","ptype":"article","src":"https://openalex.org/W2427001565","eid":"W2427001565"},{"id":"paper-w2127532195","cat":"papers","name":"Dantrolene for the treatment of MDMA toxicity","year":"2010","cit":13,"pfa":"Brian E. Grunau","psa":"Marc Greidanus","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2127532195","eid":"W2127532195"},{"id":"paper-w2471155830","cat":"papers","name":"Distribution patterns of 14-C-psilocin in the brains of various animals.","year":"1974","cit":13,"pfa":"A Hopf","psa":"H Eckert","ptype":"article","src":"https://openalex.org/W2471155830","eid":"W2471155830"},{"id":"paper-w2065453247","cat":"papers","name":"β‐2: 4: 5‐Trimethoxyphenylethylamine, an isomer of mescaline","year":"1931","cit":13,"pfa":"Max. P. J. M. Jansen","ptype":"article","src":"https://openalex.org/W2065453247","eid":"W2065453247"},{"id":"paper-w4299636311","cat":"papers","name":"Neurochemical and Neuroendocrine Effects of Ibogaine in Rats: Comparison to MK‐801","year":"1998","cit":13,"pfa":"Michael H. Baumann","psa":"Syed F. Ali","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4299636311","eid":"W4299636311"},{"id":"paper-w2014834002","cat":"papers","name":"Mescaline-like activity of 2-amino-7-hydroxytetralin","year":"1973","cit":13,"pfa":"Jack Green","psa":"Naim Khazan","ptype":"article","src":"https://openalex.org/W2014834002","eid":"W2014834002"},{"id":"paper-w2316163282","cat":"papers","name":"MESCALINE ANALOGS. I. 2,4,6-TRIALKOXY-β-PHENETHYLAMINES","year":"1954","cit":13,"pfa":"Frederick Benington","psa":"Leland C. Clark","ptype":"article","src":"https://openalex.org/W2316163282","eid":"W2316163282"},{"id":"paper-w2321327000","cat":"papers","name":"BIOLOGICAL CHANGES IN MAN FOLLOWING INTRAVENOUS ADMINISTRATION OF MESCALINE","year":"1957","cit":13,"pfa":"Pierre Deniker","ptype":"article","src":"https://openalex.org/W2321327000","eid":"W2321327000"},{"id":"paper-w1999824646","cat":"papers","name":"In Vivo Ibogaine Blockade and In Vitro PKC Action of Cocainea","year":"1998","cit":13,"pfa":"Emmanuel Shan Onaivi","psa":"Amitabha Chakrabarti","topics":["Addiction","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1999824646","eid":"W1999824646"},{"id":"paper-w3038024932","cat":"papers","name":"Ayahuasca and Childhood Trauma: Potential Therapeutic Applications","year":"2021","cit":13,"pfa":"Daniel Perkins","psa":"Jerome J. Sarris","topics":["PTSD & trauma"],"ptype":"book-chapter","src":"https://openalex.org/W3038024932","eid":"W3038024932"},{"id":"paper-w3002869977","cat":"papers","name":"Psychosis induced by abuse of ayahuasca: a case report","year":"2020","cit":13,"pfa":"Raúl Felipe Palma-Álvarez","psa":"Carlos Roncero","ptype":"article","src":"https://openalex.org/W3002869977","eid":"W3002869977"},{"id":"paper-w2416190152","cat":"papers","name":"[Neuropsychiatric disorders induced by MDMA (\"Ecstasy\")].","year":"2000","cit":13,"pfa":"D. Bailly","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W2416190152","eid":"W2416190152"},{"id":"paper-w86395134","cat":"papers","name":"Effects of MDMA on the Human Nervous System","year":"2014","cit":13,"pfa":"Una D. McCann","psa":"George A. Ricaurte","ptype":"book-chapter","src":"https://openalex.org/W86395134","eid":"W86395134"},{"id":"paper-w2058443181","cat":"papers","name":"Cerebrovascular accident following MDMA ingestion","year":"2006","cit":13,"pfa":"Charles D. Muntan","psa":"V Tuckler","ptype":"article","src":"https://openalex.org/W2058443181","eid":"W2058443181"},{"id":"paper-w3196006476","cat":"papers","name":"Psychotherapy-supported MDMA treatment for PTSD","year":"2021","cit":13,"pfa":"John Harrison Krystal","psa":"Ismene L. Petrakis","topics":["PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3196006476","eid":"W3196006476"},{"id":"paper-w3207118785","cat":"papers","name":"Challenges with benchmarking of MDMA-assisted psychotherapy","year":"2021","cit":13,"pfa":"Joar Øveraas Halvorsen","psa":"Ioana A. Cristea","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W3207118785","eid":"W3207118785"},{"id":"paper-w2278540383","cat":"papers","name":"Modification of 5-methoxy-N,N-dimethyltryptamine-induced hyperactivity by monoamine oxidase A inhibitor harmaline in mice and the underlying serotonergic mechanisms","year":"2016","cit":13,"pfa":"Xi-Ling Jiang","psa":"Ai‐Ming Yu","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2278540383","eid":"W2278540383"},{"id":"paper-w4403083745","cat":"papers","name":"Mechanisms of psilocybin on the treatment of posttraumatic stress disorder","year":"2024","cit":13,"pfa":"Charles Q. Choi","psa":"Joshua Daniel Rosenblat","topics":["PTSD & trauma","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4403083745","eid":"W4403083745"},{"id":"paper-w2398800790","cat":"papers","name":"Altered states: psilocybin for treatment-resistant depression","year":"2016","cit":13,"pfa":"Philip J. Cowen","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2398800790","eid":"W2398800790"},{"id":"paper-w3213459283","cat":"papers","name":"New iboga-type alkaloids from Ervatamia officinalis and their anti-inflammatory activity","year":"2021","cit":13,"pfa":"Ben-Qin Tang","psa":"Xiao‐Qi Zhang","ptype":"article","src":"https://openalex.org/W3213459283","eid":"W3213459283"},{"id":"paper-w3038172304","cat":"papers","name":"Synthesis and characterization of high‐purity N,N ‐dimethyltryptamine hemifumarate for human clinical trials","year":"2020","cit":13,"pfa":"Nicholas V. Cozzi","psa":"Paul F. Daley","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3038172304","eid":"W3038172304"},{"id":"paper-w1979791754","cat":"papers","name":"Notes - Synthsesis of 5,6,7-Trimethoxyindole Possible Intermediary Metabolite of Mescaline","year":"1957","cit":13,"pfa":"R. Morin","psa":"Liz Clark","ptype":"article","src":"https://openalex.org/W1979791754","eid":"W1979791754"},{"id":"paper-w4214487871","cat":"papers","name":"Primitivist medicine and capitalist anxieties in ayahuasca tourism Peru","year":"2022","cit":13,"pfa":"Alex K. Gearin","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4214487871","eid":"W4214487871"},{"id":"paper-w2036243268","cat":"papers","name":"Determination of psilocin in rat urine by high-performance liquid chromatography with electrochemical detection","year":"1990","cit":13,"pfa":"Roman Kysilka","ptype":"article","src":"https://openalex.org/W2036243268","eid":"W2036243268"},{"id":"paper-w2012179025","cat":"papers","name":"Chemical and enzymatic oxidative coupling of 5-hydroxy-N-dimethyltryptamine with amines","year":"1987","cit":13,"pfa":"Fabienne Babin","psa":"Tam Huynh‐Dinh","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2012179025","eid":"W2012179025"},{"id":"paper-w2090590927","cat":"papers","name":"Assessment of the role of α-methylapinine in the neurotoxicity of MDMA","year":"1991","cit":13,"pfa":"Thomas Steele","psa":"George K. W. Yim","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2090590927","eid":"W2090590927"},{"id":"paper-w2069267725","cat":"papers","name":"Alteration in Electroencephalogram and Monoamine Concentrations in Rat Brain following Ibogaine Treatment","year":"1998","cit":13,"pfa":"ZBIGNIEW BINIENDA","psa":"Syed F. Ali","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2069267725","eid":"W2069267725"},{"id":"paper-w4412102657","cat":"papers","name":"Psilocybin treatment extends cellular lifespan and improves survival of aged mice","year":"2025","cit":13,"pfa":"Kosuke Kato","psa":"Louise Hecker","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4412102657","eid":"W4412102657"},{"id":"paper-w2084004305","cat":"papers","name":"Alkaloids of Acacia . I. NbNb-Dimethyltryptamine in Acacia phlebophylla F. Muell","year":"1967","cit":13,"pfa":"B Rovelli","psa":"GN Vaughan","ptype":"article","src":"https://openalex.org/W2084004305","eid":"W2084004305"},{"id":"paper-w2927414016","cat":"papers","name":"Sensitization to the prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA)","year":"2019","cit":13,"pfa":"Daniel W. Curry","psa":"Leonard Lee Howell","ptype":"article","src":"https://openalex.org/W2927414016","eid":"W2927414016"},{"id":"paper-w4315880873","cat":"papers","name":"Utility of preclinical models in the study of psilocybin – A comprehensive review","year":"2023","cit":13,"pfa":"Megan Pedicini","psa":"Zachary A. Cordner","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4315880873","eid":"W4315880873"},{"id":"paper-w4401606959","cat":"papers","name":"What’s next for psychedelics after MDMA rejection?","year":"2024","cit":13,"pfa":"Kai Kupferschmidt","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4401606959","eid":"W4401606959"},{"id":"paper-w1518812385","cat":"papers","name":"Peyote on the Prairies: Religion, Scientists, and Native-Newcomer Relations in Western Canada","year":"2012","cit":13,"pfa":"Erika Dyck","psa":"Tolly Bradford","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1518812385","eid":"W1518812385"},{"id":"paper-w2937031496","cat":"papers","name":"The enchanted snake and the forbidden fruit: the ayahuasca ‘fairy tale’ tourist","year":"2019","cit":13,"pfa":"Andrew Kristoffer Dean","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2937031496","eid":"W2937031496"},{"id":"paper-w2599023115","cat":"papers","name":"A hallucinogenic tea, laced with controversy: ayahuasca in the Amazon and the United States","year":"2009","cit":13,"ptype":"book-review","src":"https://openalex.org/W2599023115","eid":"W2599023115"},{"id":"paper-w4399866715","cat":"papers","name":"Bioisosteric analogs of MDMA : Improving the pharmacological profile?","year":"2024","cit":13,"pfa":"Ana Sofia Alberto‐Silva","psa":"Harald H. Sitte","topics":["PTSD & trauma","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4399866715","eid":"W4399866715"},{"id":"paper-w4308327396","cat":"papers","name":"Psilocybin containing mushrooms: a rapidly developing biotechnology industry in the psychiatry, biomedical and nutraceutical fields","year":"2022","cit":13,"pfa":"Dominique Strauss","psa":"Marieka Gryzenhout","ptype":"article","src":"https://openalex.org/W4308327396","eid":"W4308327396"},{"id":"paper-w3048223422","cat":"papers","name":"A potential role for psilocybin in the treatment of obsessive-compulsive disorder","year":"2020","cit":13,"pfa":"Edward Jacobs","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3048223422","eid":"W3048223422"},{"id":"paper-w2079956456","cat":"papers","name":"A COMPARISON OF THE EFFECT OF MESCALINE ON ACTIVITY AND EMOTIONAL DEFAECATION IN SEVEN STRAINS OF MICE","year":"1975","cit":13,"pfa":"Ian E. Lush","ptype":"article","src":"https://openalex.org/W2079956456","eid":"W2079956456"},{"id":"paper-w2069077333","cat":"papers","name":"Mescaline and other O-methylated β-phenylethylamines: Intrastriatal induction of tremor in rats","year":"1969","cit":13,"pfa":"M.D. Little","psa":"Russell E. Dill","ptype":"article","src":"https://openalex.org/W2069077333","eid":"W2069077333"},{"id":"paper-w2430978157","cat":"papers","name":"MDMA Impairs Response to Water Intake in Healthy Volunteers","year":"2016","cit":13,"pfa":"Matthew J. Baggott","psa":"John E. Mendelson","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2430978157","eid":"W2430978157"},{"id":"paper-w4404182837","cat":"papers","name":"Psychedelic and MDMA-Related Adverse Effects—A Call for Action","year":"2024","cit":13,"pfa":"Otto Simonsson","psa":"Peter S. Hendricks","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4404182837","eid":"W4404182837"},{"id":"paper-w4320879302","cat":"papers","name":"Premise, promise and challenges of MDMA assisted therapy for PTSD","year":"2023","cit":13,"pfa":"Santiago Madero","psa":"Óscar Álvarez Bobo","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4320879302","eid":"W4320879302"},{"id":"paper-w2085736384","cat":"papers","name":"Effects of MDMA on olfactory memory and reversal learning in rats","year":"2014","cit":13,"pfa":"Andrew B. Hawkey","psa":"Mark Galizio","ptype":"article","src":"https://openalex.org/W2085736384","eid":"W2085736384"},{"id":"paper-w2068537682","cat":"papers","name":"Prediction of mescaline clearance by rabbit lung and liver from enzyme kinetic data","year":"1980","cit":13,"pfa":"Katherine S. Hilliker","psa":"Robert A. Roth","ptype":"article","src":"https://openalex.org/W2068537682","eid":"W2068537682"},{"id":"paper-w2414210799","cat":"papers","name":"MDMA Toxicity Presenting with Severe Hyperpyrexia: A Case Report","year":"1999","cit":13,"pfa":"E. Connolly","psa":"G. O’Callaghan","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2414210799","eid":"W2414210799"},{"id":"paper-w2010578899","cat":"papers","name":"Acute and Chronic Administration of Ibogaine to the Rat Results in Astrogliosis That Is Not Confined to the Cerebellar Vermisae","year":"1996","cit":13,"pfa":"James Patrick O'Callaghan","psa":"John G. Page","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2010578899","eid":"W2010578899"},{"id":"paper-w1660771015","cat":"papers","name":"Differential effects of salvinorin A on endotoxin-induced hypermotility and neurogenic ion transport in mouse ileum","year":"2011","cit":13,"pfa":"Jakub Fichna","psa":"Martin Storr","topics":["Addiction","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1660771015","eid":"W1660771015"},{"id":"paper-w4377096690","cat":"papers","name":"Therapeutic role of psilocybin and 3,4-methylenedioxymethamphetamine in trauma: A literature review","year":"2023","cit":13,"pfa":"Lakshan N Fonseka","psa":"Benjamin K.P. Woo","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4377096690","eid":"W4377096690"},{"id":"paper-w3040931347","cat":"papers","name":"Management of overdoses of salvia, kratom, and psilocybin mushrooms: a literature review","year":"2020","cit":13,"pfa":"Justin P. Reinert","psa":"Rebecca L. Dunn","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3040931347","eid":"W3040931347"},{"id":"paper-w3209358220","cat":"papers","name":"A potential effect of psilocybin on anxiety in neurotic personality structures in adolescents","year":"2021","cit":13,"pfa":"Marija Bogadi","psa":"Snježana Kaštelan","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3209358220","eid":"W3209358220"},{"id":"paper-w2411921050","cat":"papers","name":"On similar linguistic structures in creative performance and psilocybin-induced experience.","year":"1970","cit":13,"pfa":"Melissa Landon","psa":"Ronald D. Fischer","ptype":"article","src":"https://openalex.org/W2411921050","eid":"W2411921050"},{"id":"paper-w4390485012","cat":"papers","name":"Psychological Support for Psilocybin Treatment: Reply to Letters on Our Commentary","year":"2024","cit":13,"pfa":"Guy M. Goodwin","psa":"Charles B. Nemeroff","ptype":"article","src":"https://openalex.org/W4390485012","eid":"W4390485012"},{"id":"paper-w2531356483","cat":"papers","name":"Acute behavioral effects of co-administration of mephedrone and MDMA in mice","year":"2016","cit":13,"pfa":"Barbara Budzyńska","psa":"Grażyna Biała","ptype":"article","src":"https://openalex.org/W2531356483","eid":"W2531356483"},{"id":"paper-w2496404111","cat":"papers","name":"Neurobiology of the Effects of Psilocybin in Relation to Its Potential Therapeutic Targets","year":"2016","cit":13,"pfa":"Filip Tylš","psa":"Jiřı́ Horáček","ptype":"book-chapter","src":"https://openalex.org/W2496404111","eid":"W2496404111"},{"id":"paper-w2025830863","cat":"papers","name":"Vegetative anatomy and micromorphology of Salvia divinorum (Lamiaceae) from Mexico, combined with chromatographic analysis of salvinorin A","year":"2013","cit":13,"pfa":"Anna Paulina Kowalczuk","psa":"Jordan Kordian Zjawiony","ptype":"article","src":"https://openalex.org/W2025830863","eid":"W2025830863"},{"id":"paper-w2018597789","cat":"papers","name":"Ibogaine fails to interrupt the expression of a previously established one-trial morphine place preference","year":"1996","cit":13,"pfa":"Tracey Luxton","psa":"Shepard Siegel","ptype":"article","src":"https://openalex.org/W2018597789","eid":"W2018597789"},{"id":"paper-w4399334341","cat":"papers","name":"Study protocol for “Psilocybin in patients with fibromyalgia: brain biomarkers of action”","year":"2024","cit":13,"pfa":"Julia Bornemann","psa":"Robin Lester Carhart-Harris","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4399334341","eid":"W4399334341"},{"id":"paper-w4404007256","cat":"papers","name":"Psilocybin reduces grooming in the SAPAP3 knockout mouse model of compulsive behaviour","year":"2024","cit":13,"pfa":"James J Gattuso","psa":"Thibault Renoir","ptype":"article","src":"https://openalex.org/W4404007256","eid":"W4404007256"},{"id":"paper-w2741681629","cat":"papers","name":"Fatal Diabetic Ketoacidosis—A Potential Complication of MDMA (Ecstasy) Use","year":"2017","cit":13,"pfa":"John D. Gilbert","psa":"Roger W. Byard","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2741681629","eid":"W2741681629"},{"id":"paper-w2557987083","cat":"papers","name":"Psilocybin-assisted psychotherapy for dying cancer patients – aiding the final trip","year":"2016","cit":13,"pfa":"David Spiegel","topics":["Anxiety & end-of-life","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2557987083","eid":"W2557987083"},{"id":"paper-w4391519062","cat":"papers","name":"Psilocybin-enhanced fear extinction linked to bidirectional modulation of cortical ensembles","year":"2024","cit":13,"pfa":"Sophie A. Rogers","psa":"Gregory F. Corder","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4391519062","eid":"W4391519062"},{"id":"paper-w4391340931","cat":"papers","name":"The Effects of Psilocybin on Lipopolysaccharide-Induced Inflammation in THP-1 Human Macrophages","year":"2024","cit":13,"pfa":"Esmaeel Ghasemi Gojani","psa":"Igor Kovalchuk","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4391340931","eid":"W4391340931"},{"id":"paper-w4386393168","cat":"papers","name":"Comparison of fragrance and flavor components in non-psilocybin and psilocybin mushrooms using vacuum-assisted headspace high-capacity solid-phase microextraction and gas chromatography–mass spectrometry","year":"2023","cit":13,"pfa":"Shannon L. Thomas","psa":"Kevin A. Schug","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4386393168","eid":"W4386393168"},{"id":"paper-w3156510154","cat":"papers","name":"Four individuals' experiences during and following a psilocybin truffle retreat in the Netherlands","year":"2021","cit":13,"pfa":"Anna Lutkajtis","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3156510154","eid":"W3156510154"},{"id":"paper-w2409951977","cat":"papers","name":"Dose response and time course effects of N,N-dimethyltryptamine on disruption of rat shuttlebox avoidance.","year":"1977","cit":13,"pfa":"Stoff Dm","psa":"Robert J. Wyatt","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2409951977","eid":"W2409951977"},{"id":"paper-w2028813302","cat":"papers","name":"Tremor Induction by Intracaudate Injections of Bretylium, Tetrabenazine, or Mescaline: Functional Deficits in Caudate Dopamine","year":"1973","cit":13,"pfa":"F.M. Lalley","psa":"Walter W. Baker","ptype":"article","src":"https://openalex.org/W2028813302","eid":"W2028813302"},{"id":"paper-w2077738824","cat":"papers","name":"Acute ibogaine injection induces expression of the immediate early genes, egr-1 and c-fos, in mouse brain","year":"1999","cit":13,"pfa":"Syed F. Ali","psa":"Jean Zwiller","ptype":"article","src":"https://openalex.org/W2077738824","eid":"W2077738824"},{"id":"paper-w2986926875","cat":"papers","name":"Prior MDMA administration aggravates MPTP-induced Parkinsonism in macaque monkeys","year":"2019","cit":13,"pfa":"Mathilde Millot","psa":"Véronique Sgambato","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2986926875","eid":"W2986926875"},{"id":"paper-w2998980563","cat":"papers","name":"Identification and characterization of chemically masked derivatives of pseudoephedrine, ephedrine, methamphetamine, and MDMA","year":"2020","cit":13,"pfa":"Alexandra Mayer","psa":"Gordon M. Miskelly","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2998980563","eid":"W2998980563"},{"id":"paper-w2114291512","cat":"papers","name":"MDMA (ecstasy) substitutes for the ethanol discriminative cue in HAD but not LAD rats","year":"1995","cit":13,"pfa":"Susanne M. Meehan","psa":"Martin Schechter","ptype":"article","src":"https://openalex.org/W2114291512","eid":"W2114291512"},{"id":"paper-w2006531407","cat":"papers","name":"Prenatal MDMA exposure delays postnatal development in the rat: A preliminary study","year":"2010","cit":13,"pfa":"Emilie Heuland","psa":"Catherine Belzung","ptype":"article","src":"https://openalex.org/W2006531407","eid":"W2006531407"},{"id":"paper-w2074820324","cat":"papers","name":"Cognitive deficits and cognitive normality in recreational cannabis and Ecstasy/MDMA users","year":"2003","cit":13,"pfa":"Andrew Parrott","ptype":"article","src":"https://openalex.org/W2074820324","eid":"W2074820324"},{"id":"paper-w2024331662","cat":"papers","name":"Influence of chronic caffeine on MDMA-induced behavioral and neuroinflammatory response in mice","year":"2012","cit":13,"pfa":"Jéssica Ruiz‐Medina","psa":"Olga Valverde","ptype":"article","src":"https://openalex.org/W2024331662","eid":"W2024331662"},{"id":"paper-w2060400363","cat":"papers","name":"Metabolic interactions between ethanol and MDMA in primary cultured rat hepatocytes","year":"2010","cit":13,"pfa":"Helena Pontes","psa":"Maria de Lourdes Bastos","ptype":"article","src":"https://openalex.org/W2060400363","eid":"W2060400363"},{"id":"paper-w2406267552","cat":"papers","name":"Identification of alkaloid intermediates by gas chromatography-mass spectrometry. I. Potential mescaline precursors in Trichocereus species.","year":"1969","cit":13,"pfa":"Stig Agurell","ptype":"article","src":"https://openalex.org/W2406267552","eid":"W2406267552"},{"id":"paper-w3102181967","cat":"papers","name":"Quantum chemical (QM:MM) investigation of the mechanism of enzymatic reaction of tryptamine and N , N -dimethyltryptamine with monoamine oxidase A","year":"2020","cit":13,"pfa":"Károly Kubicskó","psa":"Ödön Farkas","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3102181967","eid":"W3102181967"},{"id":"paper-w3017115797","cat":"papers","name":"A rapid analytical strategy for the determination of ayahuasca alkaloids in non-ritualistic approaches by UHPLC-MS/MS","year":"2020","cit":13,"pfa":"Sarah Eller","psa":"Tiago Franco de Oliveira","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3017115797","eid":"W3017115797"},{"id":"paper-w4388776294","cat":"papers","name":"Emotion regulation effects of Ayahuasca in experienced subjects during implicit aversive stimulation: An fMRI study","year":"2023","cit":13,"pfa":"Tiago Arruda Sanchez","psa":"Luís Eduardo Luna","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4388776294","eid":"W4388776294"},{"id":"paper-w1966867057","cat":"papers","name":"The novelty-seeking phenotype modulates the long-lasting effects of adolescent MDMA exposure","year":"2015","cit":13,"pfa":"Marta Rodríguez‐Arias","psa":"José Miñarro","ptype":"article","src":"https://openalex.org/W1966867057","eid":"W1966867057"},{"id":"paper-w2572528221","cat":"papers","name":"Case reports: Four concomitant non-fatal intoxications with AB-FUBINACA and MDMA","year":"2017","cit":13,"pfa":"Nathalie Allibé","psa":"Jean‐Michel Gaulier","ptype":"article","src":"https://openalex.org/W2572528221","eid":"W2572528221"},{"id":"paper-w4315874306","cat":"papers","name":"On blinding and suicide risk in a recent trial of psilocybin-assisted therapy for treatment-resistant depression","year":"2023","cit":13,"pfa":"Natalie Gukasyan","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4315874306","eid":"W4315874306"},{"id":"paper-w2765675552","cat":"papers","name":"Differential effects of MDMA and cocaine on inhibitory avoidance and object recognition tests in rodents","year":"2017","cit":13,"pfa":"María Pilar García-Pardo","psa":"Maria Asunción Aguilar Calpe","ptype":"article","src":"https://openalex.org/W2765675552","eid":"W2765675552"},{"id":"paper-w4405852569","cat":"papers","name":"A reflection on paradigmatic tensions within the FDA advisory committee for MDMA-assisted therapy","year":"2024","cit":13,"pfa":"Leor Roseman","topics":["Safety & adverse events","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4405852569","eid":"W4405852569"},{"id":"paper-w2087388617","cat":"papers","name":"High-dose MDMA does not result in long-term changes in impulsivity in the rat","year":"2006","cit":13,"pfa":"Kathryn S. Saadat","psa":"Paula M. Moran","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2087388617","eid":"W2087388617"},{"id":"paper-w4323871036","cat":"papers","name":"Withania somnifera influences MDMA-induced hyperthermic, cognitive, neurotoxic and neuroinflammatory effects in mice","year":"2023","cit":13,"pfa":"Giulia Costa","psa":"Micaela Morelli","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4323871036","eid":"W4323871036"},{"id":"paper-w4367664319","cat":"papers","name":"Psilocybin-assisted psychotherapy as a potential treatment for eating disorders: a narrative review of preliminary evidence","year":"2023","cit":13,"pfa":"Elena Koning","psa":"Elisa M. Brietzke","topics":["Reviews & meta-analyses","Therapy practice","Policy & ethics"],"ptype":"review","src":"https://openalex.org/W4367664319","eid":"W4367664319"},{"id":"paper-w4231226437","cat":"papers","name":"Determination of MDMA, MDEA and MDA in urine by high performance liquid chromatography with fluorescence detection","year":"2004","cit":13,"pfa":"J DACOSTA","psa":"Alice Aparecida da Matta Chasin","ptype":"article","src":"https://openalex.org/W4231226437","eid":"W4231226437"},{"id":"paper-w2906740378","cat":"papers","name":"Role of Serotonin Transporter and Receptor Gene Variations in the Acute Effects of MDMA in Healthy Subjects","year":"2018","cit":13,"pfa":"Patrick Vizeli","psa":"Matthias E. Liechti","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2906740378","eid":"W2906740378"},{"id":"paper-w4396646618","cat":"papers","name":"Psilocybin reduces alcohol self-administration via selective left nucleus accumbens activation in rats","year":"2024","cit":13,"pfa":"Jérôme Jeanblanc","psa":"Mickaël Naassïla","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4396646618","eid":"W4396646618"},{"id":"paper-w1978049658","cat":"papers","name":"Role of serotonin and/or norepinephrine in the MDMA-induced increase in extracellular glucose and glycogenolysis in the rat brain","year":"2010","cit":13,"pfa":"Rashida Pachmerhiwala","psa":"Gary A. Gudelsky","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1978049658","eid":"W1978049658"},{"id":"paper-w2151864786","cat":"papers","name":"Post-Mortem (Re)Distribution of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”): Human and Animal Data","year":"2010","cit":13,"pfa":"Els A. De Letter","psa":"Michel H A Piette","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2151864786","eid":"W2151864786"},{"id":"paper-w1976094135","cat":"papers","name":"Induction of energy metabolism related enzymes in yeast Saccharomyces cerevisiae exposed to ibogaine is adaptation to acute decrease in ATP energy pool","year":"2009","cit":13,"pfa":"Roman Paškulin","psa":"Borut Štrukelj","ptype":"article","src":"https://openalex.org/W1976094135","eid":"W1976094135"},{"id":"paper-w2161689983","cat":"papers","name":"Human ecstasy (MDMA) polydrug users have altered brain activation during semantic processing","year":"2012","cit":13,"pfa":"Tristan J. Watkins","psa":"Ronald L. Cowan","ptype":"article","src":"https://openalex.org/W2161689983","eid":"W2161689983"},{"id":"paper-w2789242557","cat":"papers","name":"Tata endy rekoe - fogo sagrado: encontros entre os Guarani, a ayahuasca e o Caminho Vermelho","year":"2012","cit":13,"pfa":"Isabel Santana de Rose","ptype":"article","src":"https://openalex.org/W2789242557","eid":"W2789242557"},{"id":"paper-w2146449228","cat":"papers","name":"Altered prolactin response to M‐chlorophenylpiperazine in monkeys previously treated with 3,4‐methylenedioxymethamphetamine (MDMA) or fenfluramine","year":"2002","cit":13,"pfa":"George Hatzidimitriou","psa":"George A. Ricaurte","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2146449228","eid":"W2146449228"},{"id":"paper-w1964769444","cat":"papers","name":"Êxtase (MDMA): efeitos farmacológicos e tóxicos, mecanismo de ação e abordagem clínica","year":"2008","cit":13,"pfa":"Caroline Addison Carvalho Xavier","psa":"Francisca Cléa Florenço de Sousa","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1964769444","eid":"W1964769444"},{"id":"paper-w1978441784","cat":"papers","name":"Analgesia induced by brief footshock: blockade by fenfluramine and 5-methoxy-N, N-dimethyltryptamine and prevention of blockade by 5-HT antagonists","year":"1983","cit":13,"pfa":"Peter H. Hutson","psa":"G. Curzon","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1978441784","eid":"W1978441784"},{"id":"paper-w1528065656","cat":"papers","name":"MDMA and heightened cortisol: a neurohormonal perspective on the pregnancy outcomes of mothers used ‘Ecstasy’ during pregnancy","year":"2014","cit":13,"pfa":"Andrew C. Parrott","psa":"Lynn T. Singer","ptype":"article","src":"https://openalex.org/W1528065656","eid":"W1528065656"},{"id":"paper-w4412555614","cat":"papers","name":"Mapping psilocybin therapy: A systematic review of therapeutic frameworks, adaptations, and standardization across contemporary clinical trials","year":"2025","cit":13,"pfa":"Mary E. Kittur","psa":"Muhammad Ishrat Husain","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W4412555614","eid":"W4412555614"},{"id":"paper-w4406306242","cat":"papers","name":"A critical evaluation of psilocybin-assisted therapy protocol components from clinical trial patients, facilitators, and caregivers.","year":"2025","cit":13,"pfa":"Roman Palitsky","psa":"Ali John Zarrabi","topics":["Anxiety & end-of-life","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4406306242","eid":"W4406306242"},{"id":"paper-w2176491621","cat":"papers","name":"Dorsal hippocampal NMDA receptors mediate the interactive effects of arachidonylcyclopropylamide and MDMA/ecstasy on memory retrieval in rats","year":"2015","cit":13,"pfa":"Marzieh Ghaderi","psa":"Mohammad‐Reza Zarrindast","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2176491621","eid":"W2176491621"},{"id":"paper-w4402965277","cat":"papers","name":"Harnessing Pharmacogenomics in Clinical Research on Psychedelic‐Assisted Therapy","year":"2024","cit":13,"pfa":"Andreas Halman","psa":"Daniel Perkins","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4402965277","eid":"W4402965277"},{"id":"paper-w4210748482","cat":"papers","name":"Antiproliferative and Microtubule-stabilizing Activities of Two Iboga-vobasine Bisindoles Alkaloids from Tabernaemontana corymbosa in Colorectal Adenocarcinoma HT-29 Cells","year":"2022","cit":13,"pfa":"Chun Hoe Tan","psa":"Kae Shin Sim","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4210748482","eid":"W4210748482"},{"id":"paper-w4313334084","cat":"papers","name":"Genome sequencing progenies of magic mushrooms (Psilocybe subaeruginosa) identifies tetrapolar mating and gene duplications in the psilocybin pathway","year":"2022","cit":13,"pfa":"Alistair R. McTaggart","psa":"A. Drenth","ptype":"article","src":"https://openalex.org/W4313334084","eid":"W4313334084"},{"id":"paper-w4293163764","cat":"papers","name":"Amphetamine, methamphetamine, and MDMA in hair samples from a rehabilitation facility: Validation and applicability of HF-LPME-GC-MS","year":"2022","cit":13,"pfa":"Mariana Aparecida Oliveira Madia","psa":"Simone Aparecida Galerani Mossini","ptype":"article","src":"https://openalex.org/W4293163764","eid":"W4293163764"},{"id":"paper-w4403893995","cat":"papers","name":"Increased functional connectivity between brain regions involved in social cognition, emotion and affective-value in psychedelic states induced by N,N-Dimethyltryptamine (DMT)","year":"2024","cit":13,"pfa":"Carla Soares","psa":"Miguel Castelo‐Branco","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4403893995","eid":"W4403893995"},{"id":"paper-w4391542137","cat":"papers","name":"Strong Bipartisan Support for Controlled Psilocybin Use as Treatment or Enhancement in a Representative Sample of US Americans: Need for Caution in Public Policy Persists","year":"2024","cit":13,"pfa":"Julian D. Sandbrink","psa":"Brian David Earp","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4391542137","eid":"W4391542137"},{"id":"paper-w2010559072","cat":"papers","name":"Photocyclizations of pharmacodynamic amines. III. Three-dimensional structure of 7-hydroxy-1,9,10-trimethoxy-4-azabicyclo[5.2.2]undeca-8,10-dien-3-one from mescaline","year":"1969","cit":13,"pfa":"Osamu Yonemitsu","psa":"Bernhard Witkop","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2010559072","eid":"W2010559072"},{"id":"paper-w2092166671","cat":"papers","name":"Serotonin mediates rapid changes of striatal glucose and lactate metabolism after systemic 3,4-methylenedioxymethamphetamine (MDMA, “Ecstasy”) administration in awake rats","year":"2007","cit":13,"pfa":"Jan Bert Gramsbergen","psa":"Paul D. Cumming","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2092166671","eid":"W2092166671"},{"id":"paper-w4391256257","cat":"papers","name":"Psilocybin-assisted therapy for severe alcohol use disorder: protocol for a double-blind, randomized, placebo-controlled, 7-month parallel-group phase II superiority trial","year":"2024","cit":13,"pfa":"Laetitia Vanderijst","psa":"Xavier Noël","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4391256257","eid":"W4391256257"},{"id":"paper-w2064225291","cat":"papers","name":"Induction of glutathione synthesis and conjugation by 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-dihydroxymethamphetamine (HHMA) in human and rat liver cells, including the protective role of some antioxidants","year":"2011","cit":13,"pfa":"Irene Antolino-Lobo","psa":"Majorie B.M. van Duursen","ptype":"article","src":"https://openalex.org/W2064225291","eid":"W2064225291"},{"id":"paper-w2290290435","cat":"papers","name":"Plant and Fungal Hallucinogens as Toxic and Therapeutic Agents","year":"2017","cit":13,"pfa":"E.A. Carlini","psa":"Lucas Oliveira Maia","ptype":"book-chapter","src":"https://openalex.org/W2290290435","eid":"W2290290435"},{"id":"paper-w4388447297","cat":"papers","name":"Present and future of metabolic and metabolomics studies focused on classical psychedelics in humans","year":"2023","cit":13,"pfa":"Francisco Madrid-Gambín","psa":"Óscar J. Pozo","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4388447297","eid":"W4388447297"},{"id":"paper-w4382141215","cat":"papers","name":"Changes in synaptic markers after administration of ketamine or psychedelics: a systematic scoping review","year":"2023","cit":13,"pfa":"Simon Zhornitsky","psa":"Gustavo A. Angarita","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4382141215","eid":"W4382141215"},{"id":"paper-w2063120770","cat":"papers","name":"A Review of Side Effects and Adverse Events of Non-Drug Medicine (Nonpharmaceutical Complementary and Alternative Medicine): Psychotherapy, Mind-Body Medicine and Clinical Holistic Medicine","year":"2009","cit":13,"pfa":"Søren Ventegodt","psa":"Joav Merrick","topics":["PTSD & trauma","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2063120770","eid":"W2063120770"},{"id":"paper-w1984075149","cat":"papers","name":"Mode of Action of Hallucinogenic Molecules","year":"1973","cit":13,"pfa":"M J Berridge","psa":"William Prince","ptype":"article","src":"https://openalex.org/W1984075149","eid":"W1984075149"},{"id":"paper-w2110145354","cat":"papers","name":"Physiological Effects of Schizophrenic Body Fluids","year":"1959","cit":13,"pfa":"Edith G. McGeer","psa":"Patrick L. McGeer","ptype":"article","src":"https://openalex.org/W2110145354","eid":"W2110145354"},{"id":"paper-w2001051137","cat":"papers","name":"Biotransformation of Tryptamine in Fruiting Mycelia ofPsilocybe cubensis","year":"1989","cit":13,"pfa":"Jochen Gartz","ptype":"article","src":"https://openalex.org/W2001051137","eid":"W2001051137"},{"id":"paper-w2970361823","cat":"papers","name":"Accounting for Microdosing Classic Psychedelics","year":"2019","cit":13,"pfa":"Blake Beaton","psa":"Peter S. Hendricks","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2970361823","eid":"W2970361823"},{"id":"paper-w2229185701","cat":"papers","name":"Chromosome Aberrations and LSD","year":"1974","cit":13,"pfa":"Jacqui T.C. Robinson","psa":"Jane Taylor.","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2229185701","eid":"W2229185701"},{"id":"paper-w2100958175","cat":"papers","name":"Naloxone enhancement of DMT and LSD-25 induced suppression of food-rewarded bar pressing behavior in the rat","year":"1979","cit":13,"pfa":"Diane M. Ruffing","psa":"Edward F. Domino","ptype":"article","src":"https://openalex.org/W2100958175","eid":"W2100958175"},{"id":"paper-w4283584752","cat":"papers","name":"Self-Reported Efficacy of Treatments in Cluster Headache: a Systematic Review of Survey Studies","year":"2022","cit":13,"pfa":"Sakari Santeri Rusanen","psa":"Markus Storvik","topics":["Addiction","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4283584752","eid":"W4283584752"},{"id":"paper-w2067339305","cat":"papers","name":"Discriminative Stimulus Effects of Hallucinogenic Drugs: a Possible Relation to Reinforcing and Aversive Effects","year":"2012","cit":13,"pfa":"Tomohisa Mori","psa":"Tsutomu Suzuki","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2067339305","eid":"W2067339305"},{"id":"paper-w3123670341","cat":"papers","name":"Psychedelic Psychiatry and the Consult-Liaison Psychiatrist: A Primer","year":"2021","cit":13,"pfa":"Brian Scott Barnett","psa":"George R. Greer","ptype":"article","src":"https://openalex.org/W3123670341","eid":"W3123670341"},{"id":"paper-w2092233974","cat":"papers","name":"Behavioral and Electroencephalographic Effects of LSD","year":"1965","cit":13,"pfa":"Zola P. Horovitz","psa":"Russell C. Leaf","ptype":"article","src":"https://openalex.org/W2092233974","eid":"W2092233974"},{"id":"paper-w2897447934","cat":"papers","name":"Research ethics aspects of experimentation with LSD on human subjects: a historical and ethical review","year":"2018","cit":13,"pfa":"Kristóf János Bodnár","psa":"Péter Kakuk","topics":["Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2897447934","eid":"W2897447934"},{"id":"paper-w1980700253","cat":"papers","name":"LSD and JB318: A Comparison of Two Hallucinogens","year":"1960","cit":13,"pfa":"Binyamin Z. Lebovits","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1980700253","eid":"W1980700253"},{"id":"paper-w4396744370","cat":"papers","name":"Clinical Research Trials of Psychedelic-Assisted Therapy in Adolescents Aged 16 to 17 Years: Rationale Balanced With Caution","year":"2024","cit":13,"pfa":"Jessica Kay Jeffrey","psa":"Charles S. Grob","ptype":"article","src":"https://openalex.org/W4396744370","eid":"W4396744370"},{"id":"paper-w3193251618","cat":"papers","name":"The Potential Role of Serotonergic Hallucinogens in Depression Treatment","year":"2021","cit":13,"pfa":"Dominika Psiuk","psa":"Marzena Samardakiewicz","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3193251618","eid":"W3193251618"},{"id":"paper-w2405225052","cat":"papers","name":"Potential therapeutic agents derived from the cannabinoid nucleus.","year":"1977","cit":13,"pfa":"Harry G. Pars","psa":"John F. Howes","topics":["Depression","Anxiety & end-of-life"],"ptype":"other","src":"https://openalex.org/W2405225052","eid":"W2405225052"},{"id":"paper-w2075012276","cat":"papers","name":"Direct interaction of LSD with central “beta”-adrenergic receptors","year":"1978","cit":13,"pfa":"ANNETTE C. DOLPHIN","psa":"Joël Bockaert","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2075012276","eid":"W2075012276"},{"id":"paper-w2461431287","cat":"papers","name":"LSD Flashbacks - The Appearance of New Visual Imagery Not Experienced During Initial Intoxication: Two Case Reports.","year":"2014","cit":13,"pfa":"Arturo G. Lerner","psa":"Shaul Lev‐Ran","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2461431287","eid":"W2461431287"},{"id":"paper-w1568476494","cat":"papers","name":"Decreased calcium uptake by rat fundal strips after pretreatment with neuraminidase or LSD in vitro","year":"1971","cit":13,"pfa":"Andrea Vaccari","psa":"A. Furlani","ptype":"article","src":"https://openalex.org/W1568476494","eid":"W1568476494"},{"id":"paper-w2067240620","cat":"papers","name":"Interrelationship of Phosphate Nutrition, Nitrogen Metabolism, and Accumulation of Key Secondary Metabolites in Saprophytic Cultures of Psilocybe cubensis, Psilocybe cyanescens, and Panaeolus campanulatus","year":"1968","cit":13,"pfa":"John M. Neal","psa":"L.R. Brady","ptype":"article","src":"https://openalex.org/W2067240620","eid":"W2067240620"},{"id":"paper-w2111988752","cat":"papers","name":"Discovery of a new caerulescent Psilocybe mushroom in Germany: Psilocybe germanica sp.nov.","year":"2015","cit":13,"pfa":"Jochen Gartz","psa":"Georg Wiedemann","ptype":"article","src":"https://openalex.org/W2111988752","eid":"W2111988752"},{"id":"paper-w2485556584","cat":"papers","name":"Ayahuasca’s Attractions and Distractions","year":"2014","cit":13,"pfa":"Daniela M. Peluso","ptype":"book-chapter","src":"https://openalex.org/W2485556584","eid":"W2485556584"},{"id":"paper-w4229376179","cat":"papers","name":"Structure-Activity Relationships of Dopamine Transporter Pharmacological Chaperones","year":"2022","cit":13,"pfa":"Charles Sutton","psa":"Ali Salahpour","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4229376179","eid":"W4229376179"},{"id":"paper-w2404058488","cat":"papers","name":"Voacanga-Alkaloide III. Voacristin: Identität mit Voacangarin und Abbau zu Iboxygain und Ibogain","year":"1959","cit":13,"pfa":"U. Renner","psa":"D. A. Prins","ptype":"article","src":"https://openalex.org/W2404058488","eid":"W2404058488"},{"id":"paper-w2176618730","cat":"papers","name":"Involvement of autophagy upregulation in 3,4-methylenedioxymethamphetamine (‘ecstasy’)-induced serotonergic neurotoxicity","year":"2015","cit":13,"pfa":"I‐Hsun Li","psa":"Yuahn‐Sieh Huang","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2176618730","eid":"W2176618730"},{"id":"paper-w2075771588","cat":"papers","name":"Hallucinogens and non-hallucinogens : A comparison of the effects on 5-hydroxytryptamine and noradrenaline","year":"1971","cit":13,"pfa":"Sally R. Tonge","psa":"B.E. Leonard","ptype":"article","src":"https://openalex.org/W2075771588","eid":"W2075771588"},{"id":"paper-w1532674678","cat":"papers","name":"Ecstasy-induced caspase expression alters following ginger treatment.","year":"2013","cit":13,"pfa":"Sara Soleimani Asl","psa":"Mehdi Mehdizadeh","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1532674678","eid":"W1532674678"},{"id":"paper-w3035201780","cat":"papers","name":"Methylenedioxymethamphetamine-like discriminative stimulus effects of pyrrolidinyl cathinones in rats","year":"2020","cit":13,"pfa":"Michael B. Gatch","psa":"Michael J. Forster","ptype":"article","src":"https://openalex.org/W3035201780","eid":"W3035201780"},{"id":"paper-w1522122924","cat":"papers","name":"Interaction of 3,4‐Methylenedioxymethamphetamine and Methamphetamine During Metabolism byIn VitroHuman Metabolic Enzymes and in Rats*","year":"2011","cit":13,"pfa":"Kenji Kuwayama","psa":"Hiroyuki Inoue","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1522122924","eid":"W1522122924"},{"id":"paper-w2056094968","cat":"papers","name":"Comparative effects of 3,4-methylenedioxymethamphetamine and 4-methylthioamphetamine on rat liver mitochondrial function","year":"2010","cit":13,"pfa":"José B.A. Custódio","psa":"Maria A.S. Fernandes","ptype":"article","src":"https://openalex.org/W2056094968","eid":"W2056094968"},{"id":"paper-w2087943818","cat":"papers","name":"Contribution of dopamine to mitochondrial complex I inhibition and dopaminergic deficits caused by methylenedioxymethamphetamine in mice","year":"2015","cit":13,"pfa":"Lucía Barros-Miñones","psa":"Elena Puerta","ptype":"article","src":"https://openalex.org/W2087943818","eid":"W2087943818"},{"id":"paper-w2050937255","cat":"papers","name":"Sustained Exposure to 3,4-Methylenedioxymethamphetamine Induces the Augmentation of Exocytotic Serotonin Release in Rat Organotypic Raphe Slice Cultures","year":"2010","cit":13,"pfa":"Kazuki Nagayasu","psa":"Shuji Kaneko","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2050937255","eid":"W2050937255"},{"id":"paper-w2041974264","cat":"papers","name":"Studies on the mechanisms underlying amiloride enhancement of 3,4-methylenedioxymethamphetamine-induced serotonin depletion in rats","year":"2007","cit":13,"pfa":"Beatriz Goñi‐Allo","psa":"Norberto Aguirre","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2041974264","eid":"W2041974264"},{"id":"paper-w2085512459","cat":"papers","name":"Hallucinogen-induced rotational behavior in rats","year":"1979","cit":13,"pfa":"Lloyd N. Fleisher","psa":"Stanley D. Glick","ptype":"article","src":"https://openalex.org/W2085512459","eid":"W2085512459"},{"id":"paper-w2026947053","cat":"papers","name":"The effect of 3,4-methylenedioxymethamphetamine (‘Ecstasy’) on serotonergic regulation of the mammalian circadian clock mechanism in rats: the role of dopamine and hyperthermia","year":"2003","cit":13,"pfa":"Richard Ian Dafters","psa":"Stephany M. Biello","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2026947053","eid":"W2026947053"},{"id":"paper-w3012499822","cat":"papers","name":"High ambient temperature increases the toxicity and lethality of 3,4-methylenedioxymethamphetamine and methcathinone","year":"2020","cit":13,"pfa":"Chen Yu","psa":"Frank Scott Hall","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3012499822","eid":"W3012499822"},{"id":"paper-w1977893735","cat":"papers","name":"Physiological disposition of ?-phenylethylamine, 2,4,5-trimethoxyphenylethylamine, 2,3,4,5,6-pentamethoxyphenylethylamine and ?-hydroxymescaline in rat brain, liver and plasma","year":"1974","cit":13,"pfa":"Irving M. Cohen","psa":"Wolfgang H Vogel","ptype":"article","src":"https://openalex.org/W1977893735","eid":"W1977893735"},{"id":"paper-w4388921945","cat":"papers","name":"Design of smart nanoparticles for the electrochemical detection of 3,4‐methylenedioxymethamphetamine to allow in field screening by law enforcement officers","year":"2023","cit":13,"pfa":"Florina Maria Truta","psa":"Cécilia Cristea","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4388921945","eid":"W4388921945"},{"id":"paper-w2006949123","cat":"papers","name":"Possible involvement of the central dopaminergic system in the antireserpine effect of LSD","year":"1977","cit":13,"pfa":"M.K. Menon","psa":"David T. Masuoka","ptype":"article","src":"https://openalex.org/W2006949123","eid":"W2006949123"},{"id":"paper-w2169236692","cat":"papers","name":"On-line identification of 3,4-methylenedioxymethamphetamine in human urine by non-aqueous capillary electrophoresis–fluorescence spectroscopy at 77 K","year":"2001","cit":13,"pfa":"Yu-Lin Chung","psa":"Cheng‐Huang Lin","ptype":"article","src":"https://openalex.org/W2169236692","eid":"W2169236692"},{"id":"paper-w2045194309","cat":"papers","name":"Effects of the Amazonian Psychoactive BeverageAyahuascaon Binocular Rivalry: Interhemispheric Switching or Interhemispheric Fusion?","year":"2003","cit":13,"pfa":"Ede Frecska","psa":"Luís Eduardo Luna","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2045194309","eid":"W2045194309"},{"id":"paper-w1997868739","cat":"papers","name":"Neurotransmitter basis of the behavioral effects of hallucinogens","year":"1982","cit":13,"pfa":"Richard H. Rech","psa":"Randall L. Commissaris","ptype":"article","src":"https://openalex.org/W1997868739","eid":"W1997868739"},{"id":"paper-w4284713495","cat":"papers","name":"From Relaxed Beliefs Under Psychedelics (REBUS) to Revised Beliefs After Psychedelics (REBAS): Preliminary Development of the RElaxed Beliefs Questionnaire (REB-Q)","year":"2022","cit":13,"pfa":"Richard J. Zeifman","psa":"Robin Lester Carhart-Harris","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4284713495","eid":"W4284713495"},{"id":"paper-w2791918973","cat":"papers","name":"Alteration of Depressive-like Behaviors by Psilocybe cubensis Alkaloid Extract in Mice: the Role of Glutamate Pathway","year":"2018","cit":13,"pfa":"Elaheh Mahmoudi","psa":"Ali Razmi","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2791918973","eid":"W2791918973"},{"id":"paper-w4290805750","cat":"papers","name":"Notes From the Field: Overdose Deaths Involving Eutylone (Psychoactive Bath Salts) — United States, 2020","year":"2022","cit":13,"pfa":"R. Matt Gladden","psa":"Bruce A. Goldberger","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4290805750","eid":"W4290805750"},{"id":"paper-w1995119988","cat":"papers","name":"Agonist action of indole derivatives at 5‐HT1‐like, 5‐HT2, 5‐HT3 and 5‐HT4 receptors in vitro","year":"1992","cit":13,"pfa":"Richard M. Eglen","psa":"Roger Lewis Whiting","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1995119988","eid":"W1995119988"},{"id":"paper-w2911493056","cat":"papers","name":"A First-in-Man Study with 4-Fluoroamphetamine Demonstrates it Produces a Mild Psychedelic State","year":"2019","cit":13,"pfa":"Kim P. C. Kuypers","psa":"Johannes Gerardus Ramaekers","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2911493056","eid":"W2911493056"},{"id":"paper-w2767416094","cat":"papers","name":"Natural Monophenols as Therapeutics, Antioxidants and Toxins; Electron Transfer, Radicals and Oxidative Stress","year":"2015","cit":13,"pfa":"Peter Kovacic","psa":"Marie-Caline Abadjian","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2767416094","eid":"W2767416094"},{"id":"paper-w2055519077","cat":"papers","name":"Dopamine uptake inhibitory activity of novel tryptamine 5‐HT1 receptor ligands","year":"1994","cit":13,"pfa":"Lorraine A. Lebel","psa":"B. Kenneth Koe","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2055519077","eid":"W2055519077"},{"id":"paper-w2914689341","cat":"papers","name":"Long-lasting analgesic effect of the psychedelic drug changa: A case report","year":"2019","cit":13,"pfa":"Genís Oña","psa":"Sebastián Troncoso","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2914689341","eid":"W2914689341"},{"id":"paper-w2123192074","cat":"papers","name":"ISONIAZID IN TREATMENT OF THE CHRONIC SCHIZOPHRENIC PATIENT","year":"1954","cit":13,"pfa":"Ivan F. Bennett","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2123192074","eid":"W2123192074"},{"id":"paper-w4403263004","cat":"papers","name":"The Neurocircuitry of Substance Use Disorder, Treatment, and Change: A Resource for Clinical Psychiatrists","year":"2024","cit":13,"pfa":"Caesar G. Imperio","psa":"Diana Martínez","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4403263004","eid":"W4403263004"},{"id":"paper-w2095447303","cat":"papers","name":"Serotonergic dorsal raphe neurons: Changes in spontaneous neuronal activity and responsiveness to 5-MeODMT following long-term amphetamine administration","year":"1989","cit":13,"pfa":"Byron A. Heidenreich","psa":"George V. Rebec","ptype":"article","src":"https://openalex.org/W2095447303","eid":"W2095447303"},{"id":"paper-w2344031085","cat":"papers","name":"LSD-induced Hallucinogen Persisting Perception Disorder with depressive features treated with reboxetine: case report.","year":"2002","cit":13,"pfa":"Arturo G. Lerner","psa":"Mircea Sigal","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2344031085","eid":"W2344031085"},{"id":"paper-w3141372037","cat":"papers","name":"Cardiovascular and temperature adverse actions of stimulants","year":"2021","cit":13,"pfa":"James R. Docherty","psa":"Hadeel A. Alsufyani","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3141372037","eid":"W3141372037"},{"id":"paper-w2056819227","cat":"papers","name":"Psychology of Craving","year":"2014","cit":13,"pfa":"Sushil Kumar Sharma","psa":"Michelle L. Firlit","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2056819227","eid":"W2056819227"},{"id":"paper-w4309556913","cat":"papers","name":"Échele Cabeza as a harm reduction project and activist movement in Colombia","year":"2022","cit":13,"pfa":"Mauro Díaz Moreno","psa":"Julián Quintero","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4309556913","eid":"W4309556913"},{"id":"paper-w4312067015","cat":"papers","name":"The woman who chose theterreiro. Lay care and medical landscapes in mental health care in Rio de Janeiro","year":"2022","cit":13,"pfa":"Manuela Rodrigues Müller","psa":"Ángel Martínez Hernáez","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4312067015","eid":"W4312067015"},{"id":"paper-w4404888606","cat":"papers","name":"Novel Pharmacologic and Other Somatic Treatment Approaches for Posttraumatic Stress Disorder in Adults: State of the Evidence","year":"2024","cit":13,"pfa":"Lauren M. Sippel","psa":"Paul E. Holtzheimer","topics":["Depression","PTSD & trauma","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4404888606","eid":"W4404888606"},{"id":"paper-w2044186880","cat":"papers","name":"REPEATED CHLORPROMAZINE ADMINISTRATION INCREASES A BEHAVIOURAL RESPONSE OF RATS TO 5‐HYDROXYTRYPTAMINE RECEPTOR STIMULATION","year":"1977","cit":13,"pfa":"A.R. Green","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2044186880","eid":"W2044186880"},{"id":"paper-w4313424238","cat":"papers","name":"Psychedelic drug abuse potential assessment for new drug applications and controlled substance scheduling: A United States perspective","year":"2023","cit":13,"pfa":"Jack E. Henningfield","psa":"Sharon L. Smith","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4313424238","eid":"W4313424238"},{"id":"paper-w4308053953","cat":"papers","name":"Accuracy of substance exposure history in patients attending emergency departments after substance misuse; a comparison with biological sample analysis","year":"2022","cit":13,"pfa":"Ishita Virmani","psa":"Simon H. L. Thomas","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4308053953","eid":"W4308053953"},{"id":"paper-w3213003503","cat":"papers","name":"Prevalence, beliefs and impact of drug-drug interactions between antiretroviral therapy and illicit drugs among people living with HIV in Spain","year":"2021","cit":13,"pfa":"Vanessa Castro-Granell","psa":"María José Fuster‐RuizdeApodaca","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3213003503","eid":"W3213003503"},{"id":"paper-w2101261434","cat":"papers","name":"The sigma-1 receptor: a molecular chaperone for the heart and the soul?","year":"2011","cit":13,"pfa":"Heimo Ehmke","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"editorial","src":"https://openalex.org/W2101261434","eid":"W2101261434"},{"id":"paper-w4401417544","cat":"papers","name":"Experiential Training in Psychedelic‐Assisted Therapy: A Risk‐Benefit Analysis","year":"2024","cit":13,"pfa":"Daniel Rosenbaum","psa":"Daniel Z. Buchman","topics":["Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4401417544","eid":"W4401417544"},{"id":"paper-w4410217856","cat":"papers","name":"In Psychedelic-Assisted Therapy, the Alliance in the Psychotherapy Component Is as Important as the Drug","year":"2025","cit":13,"pfa":"Christoph Flückiger","psa":"Bruce E. Wampold","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4410217856","eid":"W4410217856"},{"id":"paper-w4414745665","cat":"papers","name":"Psychedelic-assisted therapy as a complex intervention: implications for clinical trial design","year":"2025","cit":13,"pfa":"Suresh D Muthukumaraswamy","psa":"Tehseen N. Noorani","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4414745665","eid":"W4414745665"},{"id":"paper-w4281479472","cat":"papers","name":"Physical Disability and Psychedelic Therapies: An Agenda for Inclusive Research and Practice","year":"2022","cit":13,"pfa":"Kevin Todd Mintz","psa":"Dominic A. Sisti","topics":["Safety & adverse events","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4281479472","eid":"W4281479472"},{"id":"paper-w4284969838","cat":"papers","name":"Opening to Awe: Psychedelic-Assisted Self-Transcendence and Positive Adult Development","year":"2022","cit":13,"pfa":"Kevin O. St. Arnaud","psa":"Donald Sharpe","ptype":"article","src":"https://openalex.org/W4284969838","eid":"W4284969838"},{"id":"paper-w3113026224","cat":"papers","name":"Psychedelic-assisted psychotherapy for depression: How dire is the need? How could we do it?","year":"2020","cit":13,"pfa":"Mitch Earleywine","psa":"Joseph Anthony De Leo","topics":["Depression","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3113026224","eid":"W3113026224"},{"id":"paper-w4307715481","cat":"papers","name":"The Efficacy of Psychedelic-Assisted Therapy in Managing Post-traumatic Stress Disorder (PTSD): A New Frontier?","year":"2022","cit":13,"pfa":"Arafath Mohamed","psa":"Sara Fatima","topics":["PTSD & trauma","Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4307715481","eid":"W4307715481"},{"id":"paper-w4386021334","cat":"papers","name":"Differences in attitudes and beliefs about psychedelic-assisted therapy among social workers, psychiatrists, and psychologists in the United States","year":"2023","cit":13,"pfa":"Stacey B. Armstrong","psa":"Alan K. Davis","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4386021334","eid":"W4386021334"},{"id":"paper-w4391324489","cat":"papers","name":"Ketamine-Assisted Psychotherapy Provides Lasting and Effective Results in the Treatment of Depression, Anxiety, and Post-Traumatic Stress Disorder at 3 and 6 Months: Findings from a Large Retrospective Effectiveness Stud","year":"2024","cit":13,"pfa":"Ryan Yermus","psa":"Christopher Lo","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4391324489","eid":"W4391324489"},{"id":"paper-w4285095595","cat":"papers","name":"Expectancies for Cannabis-Induced Emotional Breakthrough, Mystical Experiences and Changes in Dysfunctional Attitudes: Perceptions of the Potential for Cannabis-Assisted Psychotherapy for Depression","year":"2022","cit":13,"pfa":"Mitch Earleywine","psa":"Joseph Anthony De Leo","topics":["Depression","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4285095595","eid":"W4285095595"},{"id":"paper-w4389071119","cat":"papers","name":"IUPHAR-review: The integration of classic psychedelics into current substance use disorder treatment models","year":"2023","cit":13,"pfa":"David B. Yaden","psa":"Albert Garcia‐Romeu","topics":["Addiction","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4389071119","eid":"W4389071119"},{"id":"paper-w4312384046","cat":"papers","name":"Psychedelic Psychodynamics: Relational Knowing and the Unthought Known","year":"2022","cit":13,"pfa":"Kevin Barrett","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4312384046","eid":"W4312384046"},{"id":"paper-w4403620011","cat":"papers","name":"Psychedelics and the treatment of eating disorders: considerations for future research and practice","year":"2024","cit":13,"pfa":"Emilie Lacroix","psa":"Aaron R. Keshen","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4403620011","eid":"W4403620011"},{"id":"paper-w3201277324","cat":"papers","name":"Global bioethical challenges of medicalising psychedelics","year":"2021","cit":13,"pfa":"Riccardo Miceli McMillan","topics":["Safety & adverse events","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3201277324","eid":"W3201277324"},{"id":"paper-w3175361219","cat":"papers","name":"Psychedelics as Reemerging Treatments for Anxiety Disorders: Possibilities and Challenges in a Nascent Field","year":"2021","cit":13,"pfa":"Franklin King","psa":"Rebecca Hammond","topics":["Anxiety & end-of-life","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3175361219","eid":"W3175361219"},{"id":"paper-w4285087819","cat":"papers","name":"Pattern Breaking: A Complex Systems Approach to Psychedelic Medicine","year":"2022","cit":13,"pfa":"Inês Hipólito","psa":"Robin Lester Carhart-Harris","topics":["Safety & adverse events","Mechanism & neuroscience","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4285087819","eid":"W4285087819"},{"id":"paper-w4294568041","cat":"papers","name":"Predictors of attitudes toward psychedelics among psychologists in the USA","year":"2022","cit":13,"pfa":"Jason B. Luoma","psa":"Sarah M. Smith","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4294568041","eid":"W4294568041"},{"id":"paper-w4408154704","cat":"papers","name":"Psychedelic iatrogenic structural dissociation: an exploratory hypothesis on dissociative risks in psychedelic use","year":"2025","cit":13,"pfa":"Steven Elfrink","psa":"Leigh Bergin","topics":["PTSD & trauma","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4408154704","eid":"W4408154704"},{"id":"paper-w3031575368","cat":"papers","name":"Hallucinogens/psychedelics resurrected as new tools in psychiatric therapy","year":"2020","cit":13,"pfa":"RAFAEL GUIMARÃES DOS SANTOS","psa":"Jaime E. C. Hallak","ptype":"article","src":"https://openalex.org/W3031575368","eid":"W3031575368"},{"id":"paper-w4324156208","cat":"papers","name":"Experiences of microdosing psychedelics in an attempt to support wellbeing and mental health","year":"2023","cit":13,"pfa":"Rebecca S. Ryan","psa":"Andrew P. Fox","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4324156208","eid":"W4324156208"},{"id":"paper-w4251128277","cat":"papers","name":"Hallucinogens","year":"1987","cit":13,"pfa":"Robert T. Brown","psa":"Nancy Jo Braden","ptype":"article","src":"https://openalex.org/W4251128277","eid":"W4251128277"},{"id":"paper-w2075080965","cat":"papers","name":"Entheogens II: On Entheology and Entheobotany","year":"1996","cit":13,"pfa":"Jonathan Ott","ptype":"article","src":"https://openalex.org/W2075080965","eid":"W2075080965"},{"id":"paper-w2122660451","cat":"papers","name":"The Botanical and Clinical Distribution of Hallucinogens","year":"1977","cit":13,"pfa":"Richard Evans Schultes","ptype":"article","src":"https://openalex.org/W2122660451","eid":"W2122660451"},{"id":"paper-w2078415452","cat":"papers","name":"A clinical comparsion of three related hallucinogens","year":"1960","cit":13,"pfa":"Sidney Malitz","psa":"Paul H. Hoch","ptype":"article","src":"https://openalex.org/W2078415452","eid":"W2078415452"},{"id":"paper-w2122877802","cat":"papers","name":"Hallucinogens and Obsessive-Compulsive Disorder","year":"1999","cit":13,"pfa":"Daniel M. Perrine","ptype":"article","src":"https://openalex.org/W2122877802","eid":"W2122877802"},{"id":"paper-w2164259188","cat":"papers","name":"Benzydamine Abuse as a Hallucinogen: A Case Report","year":"2013","cit":13,"pfa":"Özlem Devrim Balaban","psa":"Latif Alpkan","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2164259188","eid":"W2164259188"},{"id":"paper-w1601029306","cat":"papers","name":"Towards a biophysical understanding of hallucinogen action","year":"2007","cit":13,"pfa":"M. Braden","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"dissertation","src":"https://openalex.org/W1601029306","eid":"W1601029306"},{"id":"paper-w4311883477","cat":"papers","name":"The therapeutic potential of psychedelics","year":"2022","cit":13,"pfa":"Emmanuelle A. D. Schindler","psa":"Deepak Cyril D’Souza","ptype":"article","src":"https://openalex.org/W4311883477","eid":"W4311883477"},{"id":"paper-w2749574850","cat":"papers","name":"The trip of a lifetime: hallucinogen persisting perceptual disorder","year":"2017","cit":13,"pfa":"Lauren Anderson","psa":"Mark Walterfang","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2749574850","eid":"W2749574850"},{"id":"paper-w4318913756","cat":"papers","name":"Translational Challenges in Psychedelic Medicine","year":"2023","cit":13,"pfa":"Robin Lester Carhart-Harris","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4318913756","eid":"W4318913756"},{"id":"paper-w4311623181","cat":"papers","name":"Entheogenic Spirituality: Characteristics of Spiritually Motivated Psychedelics Use","year":"2022","cit":13,"pfa":"Petter Grahl Johnstad","ptype":"article","src":"https://openalex.org/W4311623181","eid":"W4311623181"},{"id":"paper-w2932277755","cat":"papers","name":"Classic psychedelics: the special role of the visual system","year":"2019","cit":13,"pfa":"Noémi Császár-Nagy","psa":"István Bókkon","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2932277755","eid":"W2932277755"},{"id":"paper-w77486606","cat":"papers","name":"Smarter Candidate Selection — Utilizing Microdosing in Exploratory Clinical Studies","year":"2007","cit":13,"pfa":"Peter Buchan","topics":["Dosing & pharmacology"],"ptype":"conference-paper","src":"https://openalex.org/W77486606","eid":"W77486606"},{"id":"paper-w2127603512","cat":"papers","name":"Psychedelic Drug Crises: Toxicity and Therapeutics","year":"1977","cit":13,"pfa":"O. Lee McCabe","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2127603512","eid":"W2127603512"},{"id":"paper-w3149676623","cat":"papers","name":"Exploring the relationship between microdosing, personality and emotional insight: A prospective study","year":"2021","cit":13,"pfa":"Hannah Marie Dressler","psa":"Vince Polito","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3149676623","eid":"W3149676623"},{"id":"paper-w2132015117","cat":"papers","name":"Ethical, legal, and social implications (ELSI) of microdose clinical trials","year":"2011","cit":13,"pfa":"Chieko Kurihara","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"review","src":"https://openalex.org/W2132015117","eid":"W2132015117"},{"id":"paper-w2769576293","cat":"papers","name":"A human microdose study of the antimalarial drug GSK3191607 in healthy volunteers","year":"2017","cit":13,"pfa":"Malek Okour","psa":"John N. Haselden","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2769576293","eid":"W2769576293"},{"id":"paper-w4388340501","cat":"papers","name":"How Should the FDA Evaluate Psychedelic Medicine?","year":"2023","cit":13,"pfa":"Mason Marks","psa":"Ivan Glenn Cohen","ptype":"article","src":"https://openalex.org/W4388340501","eid":"W4388340501"},{"id":"paper-w1577843362","cat":"papers","name":"Vision and viscosity in Goa's psychedelic trance scene","year":"2006","cit":13,"pfa":"Arun Saldanha","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1577843362","eid":"W1577843362"},{"id":"paper-w4212976254","cat":"papers","name":"The Psychedelic Renaissance: a Convergence of Indigenous Knowledge and Science","year":"2021","cit":13,"pfa":"Ronan Peck","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"dissertation","src":"https://openalex.org/W4212976254","eid":"W4212976254"},{"id":"paper-w4394676778","cat":"papers","name":"Informed Consent to Psychedelic Treatment—A Work in Progress","year":"2024","cit":13,"pfa":"Paul S. Appelbaum","ptype":"article","src":"https://openalex.org/W4394676778","eid":"W4394676778"},{"id":"paper-w4407252104","cat":"papers","name":"What is Psychological Support in the Context of Psychedelic Clinical Trials?","year":"2025","cit":13,"pfa":"Jérémie Richard","psa":"Michael Aaron Levine","topics":["Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4407252104","eid":"W4407252104"},{"id":"paper-w4411051263","cat":"papers","name":"Females in Psychedelic Research: A Perspective for Advancing Research and Practice","year":"2025","cit":13,"pfa":"Zahira Ziva Cohen","psa":"Grace Blest‐Hopley","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4411051263","eid":"W4411051263"},{"id":"paper-w2768158518","cat":"papers","name":"Microdosing, Isotopic Labeling, Radiotracers and Metabolomics: Relevance in Drug Discovery, Development and Safety","year":"2017","cit":13,"pfa":"Andrew T.L. Wotherspoon","psa":"Richard B. Banati","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2768158518","eid":"W2768158518"},{"id":"paper-w4390484913","cat":"papers","name":"Pharmacological and Nonpharmacological Components of Psychedelic Treatments: The Whole is Not the Sum of the Parts","year":"2024","cit":13,"pfa":"Michael P. Bogenschutz","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4390484913","eid":"W4390484913"},{"id":"paper-w303101135","cat":"papers","name":"Osteophloeum platyspermum andVirola duckei (myristicaceae): newly reported as hallucinogens from Amazonian Ecuador","year":"1994","cit":13,"pfa":"Bradley C. Bennett","psa":"Rocío Alarcón","ptype":"article","src":"https://openalex.org/W303101135","eid":"W303101135"},{"id":"paper-w4406363207","cat":"papers","name":"One Size Does Not Fit All: Understanding Microdosing Semaglutide for Diabetes in Multidose Pens","year":"2025","cit":13,"pfa":"Anne M. Komé","psa":"Klara Rachel Klein","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4406363207","eid":"W4406363207"},{"id":"paper-w4387011501","cat":"papers","name":"Evaluating the role of psychedelic psychotherapy in addressing societal alienation: Imaginaries of liberation","year":"2023","cit":13,"pfa":"Julien Tempone-Wiltshire","psa":"Floren Matthews","topics":["Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4387011501","eid":"W4387011501"},{"id":"paper-w4307277476","cat":"papers","name":"Psychedelic-supportive psychotherapy: A psychotherapeutic model for, before and beyond the medicine experience","year":"2022","cit":13,"pfa":"Elizabeth Wolfson","topics":["Safety & adverse events","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4307277476","eid":"W4307277476"},{"id":"paper-w4396900907","cat":"papers","name":"Disentangling the acute subjective effects of classic psychedelics from their enduring therapeutic properties","year":"2024","cit":13,"pfa":"Mazen A. Atiq","psa":"Doo‐Sup Choi","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4396900907","eid":"W4396900907"},{"id":"paper-w1815512759","cat":"papers","name":"Microdose flare protocol with interrupted follicle stimulating hormone and added androgen for poor responders—an observational pilot study","year":"2015","cit":13,"pfa":"Frederic Mitri","psa":"Yaakov Bentov","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1815512759","eid":"W1815512759"},{"id":"paper-w4379011605","cat":"papers","name":"The making of a mushroom people: Toward a moral anthropology of psychedelics beyond hype and anti‐hype","year":"2023","cit":13,"pfa":"Nicolas Langlitz","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4379011605","eid":"W4379011605"},{"id":"paper-w2920555099","cat":"papers","name":"Microdosed Cocktail of Three Oral Factor Xa Inhibitors to Evaluate Drug–Drug Interactions with Potential Perpetrator Drugs","year":"2019","cit":13,"pfa":"Gerd Mikus","psa":"Walter E. Haefeli","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2920555099","eid":"W2920555099"},{"id":"paper-w4386119957","cat":"papers","name":"Ethics of Psychedelic Use in Psychiatry and Beyond—Drawing upon Legal, Social and Clinical Challenges","year":"2023","cit":13,"pfa":"Nuno Azevedo","psa":"Luís Madeira","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4386119957","eid":"W4386119957"},{"id":"paper-w4301178901","cat":"papers","name":"Quantification of the Time Course of CYP3A Inhibition, Activation, and Induction Using a Population Pharmacokinetic Model of Microdosed Midazolam Continuous Infusion","year":"2022","cit":13,"pfa":"Yomna M. Nassar","psa":"Charlotte Kloft","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4301178901","eid":"W4301178901"},{"id":"paper-w961831786","cat":"papers","name":"Chemistry of Psychotomimetics","year":"1982","cit":13,"pfa":"Alexander T. Shulgin","ptype":"book-chapter","src":"https://openalex.org/W961831786","eid":"W961831786"},{"id":"paper-w4401355020","cat":"papers","name":"The serotonergic psychedelic N,N-dipropyltryptamine alters information-processing dynamics in in vitro cortical neural circuits","year":"2024","cit":13,"pfa":"Thomas F. Varley","psa":"John M. Beggs","topics":["Mechanism & neuroscience","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4401355020","eid":"W4401355020"},{"id":"paper-w2111967064","cat":"papers","name":"[Retracted] Evidences of Protective Potentials of Microdoses of Ultra‐High Diluted Arsenic Trioxide in Mice Receiving Repeated Injections of Arsenic Trioxide","year":"2009","cit":13,"pfa":"Pathikrit Banerjee","psa":"Anisur Rahman Khuda‐Bukhsh","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2111967064","eid":"W2111967064"},{"id":"paper-w2415437218","cat":"papers","name":"Psychotomimetic indoles in the Convolvulaceae.","year":"1967","cit":13,"pfa":"Marderosian Ah der","ptype":"article","src":"https://openalex.org/W2415437218","eid":"W2415437218"},{"id":"paper-w2394775046","cat":"papers","name":"Psychotomimetic effects of anorectic drugs.","year":"1987","cit":13,"pfa":"Khan SA","psa":"Jobe Pc","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2394775046","eid":"W2394775046"},{"id":"paper-w1967169865","cat":"papers","name":"A Review of Human Phase 0 (Microdosing) Clinical Trials Following the US Food and Drug Administration Exploratory Investigational New Drug Studies Guidance","year":"2006","cit":13,"pfa":"Graham Lappin","psa":"R. Colin Garner","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1967169865","eid":"W1967169865"},{"id":"paper-w2441219361","cat":"papers","name":"Microdose Flare-up Gonadotropin-releasing Hormone (GnRH) Agonist Versus GnRH Antagonist Protocols in Poor Ovarian Responders Undergoing Intracytoplasmic Sperm Injection.","year":"2016","cit":13,"pfa":"Ayşen Boza","psa":"Kenan Sofuoğlu","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2441219361","eid":"W2441219361"},{"id":"paper-w4386587706","cat":"papers","name":"“We don’t want to run before we walk”: the attitudes of Australian stakeholders towards using psychedelics for mental health conditions","year":"2023","cit":13,"pfa":"Breanne Kunstler","psa":"Melissa Anne Hatty","ptype":"article","src":"https://openalex.org/W4386587706","eid":"W4386587706"},{"id":"paper-w2122459284","cat":"papers","name":"Some Antagonists of Atropine-Like Psychotomimetics","year":"1963","cit":13,"pfa":"W.J. Lang","psa":"George Holan","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2122459284","eid":"W2122459284"},{"id":"paper-w2111469793","cat":"papers","name":"Role of serotonergic 5-HT2A receptors in the psychotomimetic actions of phencyclidine","year":"2000","cit":13,"pfa":"Richard A. Rabin","psa":"Jerrold C. Winter","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2111469793","eid":"W2111469793"},{"id":"paper-w2079673700","cat":"papers","name":"A COMPARISON BETWEEN TARAXEIN AND SOME PSYCHOTOMIMETICS","year":"1959","cit":13,"pfa":"Sten Mårtens","psa":"Bengt Melander","ptype":"article","src":"https://openalex.org/W2079673700","eid":"W2079673700"},{"id":"paper-w2069177714","cat":"papers","name":"Psychotomimetic phenalkylamines as serotonin agonists: An SAR analysis","year":"1978","cit":13,"pfa":"Lemont B. Kier","psa":"Richard A. Glennon","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2069177714","eid":"W2069177714"},{"id":"paper-w2887552786","cat":"papers","name":"Abstract CT013: Osimertinib displays high brain exposure in healthy subjects with intact blood-brain barrier: a microdose positron emission tomography (PET) study with 11C-labelled osimertinib","year":"2018","cit":13,"pfa":"Karthick Vishwanathan","psa":"Lars Farde","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W2887552786","eid":"W2887552786"},{"id":"paper-w1978914887","cat":"papers","name":"Esters of N-Methyl-3-hydroxypiperidine Having Psychotomimetic Activity. II1,2","year":"1962","cit":13,"pfa":"Saul B. Kadin","psa":"Joseph G. Cannon","ptype":"article","src":"https://openalex.org/W1978914887","eid":"W1978914887"},{"id":"paper-w1984076079","cat":"papers","name":"INDOLE ALKALOIDS IN PLANT HALLUCINOGENS1","year":"1976","cit":13,"pfa":"Richard Evans Schultes","ptype":"article","src":"https://openalex.org/W1984076079","eid":"W1984076079"},{"id":"paper-w2901078744","cat":"papers","name":"Combined effects of biochar and fertilizer application on maize production in dependence on the cultivation method in a sub-humid climate","year":"2018","cit":13,"pfa":"Hannah A. Graef","psa":"Bettina Eichler‐Löbermann","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2901078744","eid":"W2901078744"},{"id":"paper-w2340595824","cat":"papers","name":"LSD and Religious Experience","year":"2010","cit":13,"pfa":"Walter N. Pahnke","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2340595824","eid":"W2340595824"},{"id":"paper-w2121856090","cat":"papers","name":"Human Tissue in the Evaluation of Safety and Efficacy of New Medicines: A Viable Alternative to Animal Models?","year":"2011","cit":13,"pfa":"Robert A. Coleman","topics":["Safety & adverse events","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2121856090","eid":"W2121856090"},{"id":"paper-w2039580956","cat":"papers","name":"Addiction Paradigms II. Theory, Research and Practice","year":"1979","cit":13,"pfa":"Howard J. Shaffer","psa":"Blasé Gambino","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2039580956","eid":"W2039580956"},{"id":"paper-w2168161838","cat":"papers","name":"Propoxyphene Napsylate Treatment of Heroin and Methadone Dependence: One Year's Experience","year":"1974","cit":13,"pfa":"Forest S. Tennant","psa":"Mary Klute Cassas","ptype":"article","src":"https://openalex.org/W2168161838","eid":"W2168161838"},{"id":"paper-w2401176933","cat":"papers","name":"[Consumption patterns and motivation for use of addictive drugs in schizophrenic patients].","year":"1997","cit":13,"pfa":"Martin Lambert","psa":"Michael Reinhardt Krausz","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2401176933","eid":"W2401176933"},{"id":"paper-w2003333332","cat":"papers","name":"A Therapeutic Approach to the Acutely Overdosed Patient","year":"1980","cit":13,"pfa":"Regine Aronow","psa":"Alan K. Done","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2003333332","eid":"W2003333332"},{"id":"paper-w2087605498","cat":"papers","name":"Phenylalkylamines with potential psychotherapeutic utility. 2. Nuclear substituted 2-amino-1-phenylbutanes","year":"1980","cit":13,"pfa":"Robert T. Standridge","psa":"Alexander T. Shulgin","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2087605498","eid":"W2087605498"},{"id":"paper-w2402635048","cat":"papers","name":"Epidemiology of psychiatric disorders in Edmonton. Drug abuse and dependence.","year":"1994","cit":13,"pfa":"Russell Jm","psa":"Bland Rc","ptype":"article","src":"https://openalex.org/W2402635048","eid":"W2402635048"},{"id":"paper-w4382680834","cat":"papers","name":"Ethical considerations in rapid and novel treatments in psychiatry","year":"2023","cit":13,"pfa":"Tobias Haeusermann","psa":"Winston Chiong","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4382680834","eid":"W4382680834"},{"id":"paper-w4313414122","cat":"papers","name":"A Review of Synthetic Access to Therapeutic Compounds Extracted from Psilocybe","year":"2022","cit":13,"pfa":"Raphaël Serreau","psa":"Sabine Berteina‐Raboin","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4313414122","eid":"W4313414122"},{"id":"paper-w4249652401","cat":"papers","name":"Cofactors for HIV Disease Progression in a Cohort of Homosexual and Bisexual Men","year":"2001","cit":13,"pfa":"Eric Vittinghoff","psa":"Susan Buchbinder","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4249652401","eid":"W4249652401"},{"id":"paper-w4394855999","cat":"papers","name":"Spirituality as a Therapeutic Approach for Severe Mental Illness: Insights from Neural Networks","year":"2024","cit":13,"pfa":"Henderikus Knegtering","psa":"Symen Kornelis Spoelstra","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4394855999","eid":"W4394855999"},{"id":"paper-w4366083046","cat":"papers","name":"G protein-coupled receptors as targets for transformative neuropsychiatric therapeutics","year":"2023","cit":13,"pfa":"Gavin P. Schmitz","psa":"Bryan L. Roth","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4366083046","eid":"W4366083046"},{"id":"paper-w4214888276","cat":"papers","name":"Disruptive innovation in psychiatry","year":"2022","cit":13,"pfa":"Jerome J. Sarris","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4214888276","eid":"W4214888276"},{"id":"paper-w2086570374","cat":"papers","name":"Differences in substance abuse patterns: multiple drug abuse alone versus schizophrenia with multiple drug abuse","year":"2001","cit":13,"pfa":"M. Lammertink","psa":"Ralf Pukrop","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2086570374","eid":"W2086570374"},{"id":"paper-w2131601994","cat":"papers","name":"The acute transient polymorphic psychosis: a biochemical subtype of the cycloid psychosis","year":"2003","cit":13,"pfa":"Lolke P. Pepplinkhuizen","psa":"Durk Fekkes","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2131601994","eid":"W2131601994"},{"id":"paper-w2338260909","cat":"papers","name":"Differential Treatment of Young Abusers: A Quasi-Experimental Study of a “Therapeutic Community” in a Psychiatric Hospital","year":"1980","cit":13,"pfa":"Per Vaglum","psa":"Inge Fossheim","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2338260909","eid":"W2338260909"},{"id":"paper-w2002686710","cat":"papers","name":"Case studies addressing human pharmacokinetic uncertainty using a combination of pharmacokinetic simulation and alternative first in human paradigms","year":"2011","cit":13,"pfa":"Anthony C. Harrison","psa":"Paul Turnpenny","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2002686710","eid":"W2002686710"},{"id":"paper-w2802087326","cat":"papers","name":"Preferential accumulation of inorganic elements in Amanita muscaria from North-eastern Poland","year":"2018","cit":13,"pfa":"Krzysztof Lipka","psa":"Jerzy Falandysz","ptype":"article","src":"https://openalex.org/W2802087326","eid":"W2802087326"},{"id":"paper-w4320037519","cat":"papers","name":"Unblinding and demand characteristics in the treatment of depression","year":"2023","cit":13,"pfa":"Guy M. Goodwin","psa":"Ekaterina Malievskaia","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4320037519","eid":"W4320037519"},{"id":"paper-w4404012147","cat":"papers","name":"Current and Novel Therapies for Cluster Headache: A Narrative Review","year":"2024","cit":13,"pfa":"Bruna de Freitas Dias","psa":"Peter James Goadsby","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4404012147","eid":"W4404012147"},{"id":"paper-w2054625011","cat":"papers","name":"HTR2 Receptors in a Songbird Premotor Cortical-Like Area Modulate Spectral Characteristics of Zebra Finch Song","year":"2013","cit":13,"pfa":"William E. Wood","psa":"David J. Perkel","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2054625011","eid":"W2054625011"},{"id":"paper-w2147568357","cat":"papers","name":"Infrared identification of some hallucinogenic derivatives of tryptamine and amphetamine","year":"1970","cit":13,"pfa":"Robert J. Mesley","psa":"W H Evans","ptype":"article","src":"https://openalex.org/W2147568357","eid":"W2147568357"},{"id":"paper-w3105268519","cat":"papers","name":"Happiness During Low-Dose Ketamine Infusion Predicts Treatment Response","year":"2020","cit":13,"pfa":"Mu‐Hong Chen","psa":"Tung‐Ping Su","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3105268519","eid":"W3105268519"},{"id":"paper-w2023892200","cat":"papers","name":"The NMDA Receptor Partial Agonist, 1-Aminocyclopropanecarboxylic Acid (ACPC), Reduces Ethanol Consumption in the Rat","year":"1999","cit":13,"pfa":"Michael F. Stromberg","psa":"Scott A. Mackler","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2023892200","eid":"W2023892200"},{"id":"paper-w4206334349","cat":"papers","name":"Preclinical evaluation of [11C]GW457427 as a tracer for neutrophil elastase","year":"2022","cit":13,"pfa":"Sergio Estrada","psa":"Gunnar Antoni","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4206334349","eid":"W4206334349"},{"id":"paper-w4395045705","cat":"papers","name":"Differential effects of cannabis constituents on schizophrenia-related psychosis: a rationale for incorporating cannabidiol into a schizophrenia therapeutic regimen","year":"2024","cit":13,"pfa":"Kennadi Johnson","psa":"Melissa A. Burmeister","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4395045705","eid":"W4395045705"},{"id":"paper-w3022760047","cat":"papers","name":"Naphyrone (naphthylpyrovalerone): Pharmacokinetics, behavioural effects and thermoregulation in Wistar rats","year":"2020","cit":13,"pfa":"Nikola Pinterová","psa":"Tomáš Páleníček","topics":["Safety & adverse events","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3022760047","eid":"W3022760047"},{"id":"paper-w2033651926","cat":"papers","name":"Prolonged effects of LSD on EEG records during discriminative performance in cat; evaluation by computer analysis","year":"1965","cit":13,"pfa":"W. ROSS ADEY","psa":"Thomas S. Brown","ptype":"article","src":"https://openalex.org/W2033651926","eid":"W2033651926"},{"id":"paper-w2299824797","cat":"papers","name":"Practical application of the neuroregenerative properties of ketamine: real world treatment experience","year":"2016","cit":13,"pfa":"Theodore A. Henderson","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2299824797","eid":"W2299824797"},{"id":"paper-w4412062674","cat":"papers","name":"Dose‐dependent relationship between intra‐operative ketamine administration and postoperative delirium: a retrospective cohort study","year":"2025","cit":13,"pfa":"Lisa Kaiser","psa":"Maximilian Sebastian Schaefer","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4412062674","eid":"W4412062674"},{"id":"paper-w1586553628","cat":"papers","name":"Does Ketamine Improve Postoperative Analgesia? More Questions Than Answers","year":"2011","cit":13,"pfa":"Kurt W. Grathwohl","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1586553628","eid":"W1586553628"},{"id":"paper-w3012443828","cat":"papers","name":"Esketamine (Spravato) for Treatment-Resistant Depression.","year":"2020","cit":13,"pfa":"Mohamed A. Jalloh","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W3012443828","eid":"W3012443828"},{"id":"paper-w3004068133","cat":"papers","name":"Esketamine for treatment resistant depression is not recommended by NICE","year":"2020","cit":13,"pfa":"Elisabeth Mahase","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3004068133","eid":"W3004068133"},{"id":"paper-w4210624679","cat":"papers","name":"Prelimbic cortex miR-34a contributes to (2R,6R)-hydroxynorketamine-mediated antidepressant-relevant actions","year":"2022","cit":13,"pfa":"Lichao Ye","psa":"Dylan Chou","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4210624679","eid":"W4210624679"},{"id":"paper-w4322719848","cat":"papers","name":"Pronounced Regional Variation in Esketamine and Ketamine Prescribing to US Medicaid Patients","year":"2023","cit":13,"pfa":"Alexia G. Aguilar","psa":"Brian J. Piper","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4322719848","eid":"W4322719848"},{"id":"paper-w3178951027","cat":"papers","name":"Pharmacokinetic Modeling of Ketamine Enantiomers and Their Metabolites After Administration of Prolonged‐Release Ketamine With Emphasis on 2,6‐Hydroxynorketamines","year":"2021","cit":13,"pfa":"Michael Weiß","psa":"Werner Siegmund","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3178951027","eid":"W3178951027"},{"id":"paper-w4400933689","cat":"papers","name":"Benefits and risks of esketamine nasal spray continuation in treatment-resistant depression","year":"2024","cit":13,"pfa":"Maxwell Zachary Price","psa":"Richard L. Price","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4400933689","eid":"W4400933689"},{"id":"paper-w4406428856","cat":"papers","name":"Hepatic adverse events associated with ketamine and esketamine: A population-based disproportionality analysis","year":"2025","cit":13,"pfa":"Angela T.H. Kwan","psa":"Roger S. McIntyre","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4406428856","eid":"W4406428856"},{"id":"paper-w4304756592","cat":"papers","name":"Effects of Remimazolam Combined with Esketamine Anesthesia on Circulatory and Respiratory Function during Painless Gastroenteroscopy","year":"2022","cit":13,"pfa":"Cheng Lu","psa":"Jiang Qian","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4304756592","eid":"W4304756592"},{"id":"paper-w4405106914","cat":"papers","name":"Comparative safety of prescribed Esketamine and ketamine in relation to renal and urinary disorders: A pharmacovigilance perspective","year":"2024","cit":13,"pfa":"Stefania Chiappini","psa":"Fabrizio Schifano","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4405106914","eid":"W4405106914"},{"id":"paper-w4404195707","cat":"papers","name":"Acute effects of esketamine on hypoxic ventilatory response, haemodynamics, and brain function in healthy volunteers","year":"2024","cit":13,"pfa":"Simone C. Jansen","psa":"Rutger M. van der Schrier","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4404195707","eid":"W4404195707"},{"id":"paper-w4376610889","cat":"papers","name":"The use of esketamine in the treatment of patients with severe depression and suicidal ideation: systematic review and meta-analysis","year":"2023","cit":13,"pfa":"Idevaldo Floriano","psa":"Wanderley Marques Bernardo","topics":["Depression","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4376610889","eid":"W4376610889"},{"id":"paper-w3187403795","cat":"papers","name":"Effects of esketamine combined with ultrasound-guided nerve block on cognitive function in children with lower extremity fractures.","year":"2021","cit":13,"pfa":"Jian Wang","psa":"Meiting Pu","ptype":"article","src":"https://openalex.org/W3187403795","eid":"W3187403795"},{"id":"paper-w4401444166","cat":"papers","name":"An Immune‐Enhancing Injectable Hydrogel Loaded with Esketamine and DDP Promotes Painless Immunochemotherapy to Inhibit Breast Cancer Growth","year":"2024","cit":13,"pfa":"Xiali Yin","psa":"Xiaoping Gu","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4401444166","eid":"W4401444166"},{"id":"paper-w4386760125","cat":"papers","name":"Effect of esketamine on inflammatory factors in opioid-free anesthesia based on quadratus lumborum block: A randomized trial","year":"2023","cit":13,"pfa":"Jingwei Dai","psa":"Juan Li","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4386760125","eid":"W4386760125"},{"id":"paper-w3214818887","cat":"papers","name":"Remission of functional motor symptoms following esketamine administration in a patient with treatment-resistant depression: a single-case report","year":"2021","cit":13,"pfa":"Lorenzo Moccia","psa":"Gabriele Sani","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3214818887","eid":"W3214818887"},{"id":"paper-w4406300691","cat":"papers","name":"Intraoperative Administration of Esketamine is Associated with Reduced Opioid Consumption After Laparoscopic Gynecological Surgery: A Randomized Controlled Trial","year":"2025","cit":13,"pfa":"Huan Chen","psa":"Juying Jin","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4406300691","eid":"W4406300691"},{"id":"paper-w4391883943","cat":"papers","name":"Sub-anesthetic dose of esketamine decreases postoperative opioid self-administration after spine surgery: a retrospective cohort analysis","year":"2024","cit":13,"pfa":"Hongyu Zheng","psa":"Xingrui Gong","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4391883943","eid":"W4391883943"},{"id":"paper-w4404919493","cat":"papers","name":"Effect of continuous esketamine infusion on brain white matter microstructure in patients with major depression: A diffusion tensor imaging study","year":"2024","cit":13,"pfa":"Xiang Liu","psa":"Guangyao Wu","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4404919493","eid":"W4404919493"},{"id":"paper-w4404830440","cat":"papers","name":"Effect of esketamine on postoperative delirium in general anesthesia patients undergoing elective surgery: a meta-analysis of randomized controlled trials","year":"2024","cit":13,"pfa":"Wenhui Zhang","psa":"Congjie Bi","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4404830440","eid":"W4404830440"},{"id":"paper-w4406707700","cat":"papers","name":"Esketamine has promising anti-inflammatory effects in orthopedic surgery and plays a protective role in postoperative cognitive function and pain management","year":"2025","cit":13,"pfa":"Lichun Han","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4406707700","eid":"W4406707700"},{"id":"paper-w4384301702","cat":"papers","name":"Reduction in Cognitive Symptoms Following Intranasal Esketamine Administration in Patients With Chronic Treatment-resistant Depression: A 12-Week Case Series","year":"2023","cit":13,"pfa":"Maria Pepe","psa":"Gabriele Sani","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4384301702","eid":"W4384301702"},{"id":"paper-w4308624733","cat":"papers","name":"Corrigendum: Neurological adverse events associated with esketamine: A disproportionality analysis for signal detection leveraging the FDA adverse event reporting system","year":"2022","cit":13,"pfa":"Haoning Guo","psa":"Jisheng Wang","topics":["Safety & adverse events"],"ptype":"erratum","src":"https://openalex.org/W4308624733","eid":"W4308624733"},{"id":"paper-w4385264678","cat":"papers","name":"Access and real-world use patterns of esketamine nasal spray among patients with treatment-resistant depression covered by private or public insurance","year":"2023","cit":13,"pfa":"Amanda Teeple","psa":"Kruti Joshi","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4385264678","eid":"W4385264678"},{"id":"paper-w3202111075","cat":"papers","name":"Brain-derived neurotrophic factor serum levels following ketamine and esketamine intervention for treatment-resistant depression: secondary analysis from a randomized trial","year":"2021","cit":13,"pfa":"Ana Teresa Caliman‐Fontes","psa":"Lucas C. Quarantini","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3202111075","eid":"W3202111075"},{"id":"paper-w4400722546","cat":"papers","name":"A replication study using the World Health Organization pharmacovigilance database (VigiBase®) to evaluate whether an association between ketamine and esketamine and alcohol and substance misuse exists","year":"2024","cit":13,"pfa":"Angela T.H. Kwan","psa":"Roger S. McIntyre","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4400722546","eid":"W4400722546"},{"id":"paper-w4384120387","cat":"papers","name":"Effects of esketamine on patient-reported outcomes in major depressive disorder with active suicidal ideation and intent: a pooled analysis of two randomized phase 3 trials (ASPIRE I and ASPIRE II)","year":"2023","cit":13,"pfa":"Carol Jamieson","psa":"Dong‐Jing Fu","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4384120387","eid":"W4384120387"},{"id":"paper-w3202865917","cat":"papers","name":"U.S. Food and Drug Administration’s Patient-Focused Drug Development Initiative: Experience with Integration of Patient-Experience Data in a New Drug Application for Esketamine Nasal Spray Plus a Newly Initiated Oral Ant","year":"2021","cit":13,"pfa":"Eva G. Katz","psa":"Carol Jamieson","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3202865917","eid":"W3202865917"},{"id":"paper-w3161993383","cat":"papers","name":"Chiral Pharmacokinetics and Metabolite Profile of Prolonged-release Ketamine Tablets in Healthy Human Subjects","year":"2021","cit":13,"pfa":"Mahmoud Hasan","psa":"Werner Siegmund","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3161993383","eid":"W3161993383"},{"id":"paper-w4307341143","cat":"papers","name":"(Es)Ketamine for Suicidal Ideation and Behavior: Clinical Efficacy","year":"2022","cit":13,"pfa":"Alexandra A. Alario","psa":"Mark J. Niciu","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4307341143","eid":"W4307341143"},{"id":"paper-w2793284127","cat":"papers","name":"Enantioselective capillary electrophoresis provides insight into the phase II metabolism of ketamine and its metabolites in vivo and in vitro","year":"2018","cit":13,"pfa":"Friederike A. Sandbaumhüter","psa":"Wolfgang Thormann","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2793284127","eid":"W2793284127"},{"id":"paper-w4386385199","cat":"papers","name":"Ketamine metabolite alleviates morphine withdrawal-induced anxiety via modulating nucleus accumbens parvalbumin neurons in male mice","year":"2023","cit":13,"pfa":"Yuanyuan Chen","psa":"Qiang Zhou","topics":["Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4386385199","eid":"W4386385199"},{"id":"paper-w4409590058","cat":"papers","name":"Advances in the study of NMDA receptors in depression pathogenesis and the antidepressant efficacy of their antagonists","year":"2025","cit":13,"pfa":"Mingrui Chen","psa":"Yan Wang","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4409590058","eid":"W4409590058"},{"id":"paper-w4309679328","cat":"papers","name":"Effect of balanced opioid-free anaesthesia on postoperative nausea and vomiting after video-assisted thoracoscopic lung resection: protocol for a randomised controlled trial","year":"2022","cit":13,"pfa":"Yu-qin Long","psa":"Ke Peng","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4309679328","eid":"W4309679328"},{"id":"paper-w4293661368","cat":"papers","name":"Opioid-free total intravenous anesthesia for thyroid and parathyroid surgery: Protocol for a randomized, double-blind, controlled trial","year":"2022","cit":13,"pfa":"Dan Wang","psa":"Ke Peng","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4293661368","eid":"W4293661368"},{"id":"paper-w2039879021","cat":"papers","name":"LSD-potentiated apomorphine hypermotility: A model for differentiating antipsychotic drugs","year":"1983","cit":13,"pfa":"Rudolf Morgenstern","psa":"Wilhelm Oelssner","ptype":"article","src":"https://openalex.org/W2039879021","eid":"W2039879021"},{"id":"paper-w199481543","cat":"papers","name":"MOLECULAR DETERMINANTS FOR INTERACTION WITH THE LSD RECEPTOR: BIOLOGICAL STUDIES AND QUANTUM CHEMICAL ANALYSIS","year":"1978","cit":13,"pfa":"Jack Peter Green","psa":"David Chou","topics":["Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W199481543","eid":"W199481543"},{"id":"paper-w2771033573","cat":"papers","name":"Tolerance to Lysergic Acid Diethylamide","year":"2016","cit":12,"pfa":"Tobias Buchborn","psa":"Volker Höllt","ptype":"book-chapter","src":"https://openalex.org/W2771033573","eid":"W2771033573"},{"id":"paper-w2080070875","cat":"papers","name":"Effects ofd-lysergic acid diethylamide and 2-brom-lysergic acid diethylamide on dominance behavior of the rat","year":"1966","cit":12,"pfa":"Edward T. Uyeno","ptype":"article","src":"https://openalex.org/W2080070875","eid":"W2080070875"},{"id":"paper-w2004090952","cat":"papers","name":"Lysergic Acid Diethylamide in Patients with Excess Serotonin","year":"1956","cit":12,"pfa":"Albert Sjoerdsma","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2004090952","eid":"W2004090952"},{"id":"paper-w2011141455","cat":"papers","name":"Lysergic acid diethylamide (LSD-25) and chromosome breaks","year":"1968","cit":12,"pfa":"G Abbo","psa":"Hans Zellweger","ptype":"article","src":"https://openalex.org/W2011141455","eid":"W2011141455"},{"id":"paper-w74781511","cat":"papers","name":"effect of d-lysergic acid diethylamide on immunoglobulin synthesis","year":"1973","cit":12,"pfa":"Edward W. Voss","psa":"Jeffrey L. Winkelhake","ptype":"article","src":"https://openalex.org/W74781511","eid":"W74781511"},{"id":"paper-w1971773681","cat":"papers","name":"Behavioral Effects of Lysergic Acid Diethylamide (LSD-25)","year":"1959","cit":12,"pfa":"Seymour Wapner","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W1971773681","eid":"W1971773681"},{"id":"paper-w1981822612","cat":"papers","name":"Luminescence characteristics of lysergic acid diethylamide and related ergolines","year":"1973","cit":12,"pfa":"A. J. Bowd","psa":"James H. Turnbull","ptype":"article","src":"https://openalex.org/W1981822612","eid":"W1981822612"},{"id":"paper-w2090219812","cat":"papers","name":"The mutagenic effect of lysergic acid diethylamide I. Cytogenetic analysis","year":"1974","cit":12,"pfa":"P Goetz","psa":"Zdena Zudova","ptype":"article","src":"https://openalex.org/W2090219812","eid":"W2090219812"},{"id":"paper-w3040485460","cat":"papers","name":"Self-inflicted neck wounds under influence of lysergic acid diethylamide","year":"2020","cit":12,"pfa":"Brendan Le Daré","psa":"Renaud Bouvet","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3040485460","eid":"W3040485460"},{"id":"paper-w2465353484","cat":"papers","name":"Effects of mescaline and psilocybin on dominance behavior of the rat.","year":"1967","cit":12,"pfa":"Edward T. Uyeno","ptype":"article","src":"https://openalex.org/W2465353484","eid":"W2465353484"},{"id":"paper-w2062845041","cat":"papers","name":"Effect of Lysergic Acid Diethylamide (LSD-25) on Perception of Part-Whole Relationships","year":"1959","cit":12,"pfa":"Donald M. Krus","psa":"Seymour Wapner","ptype":"article","src":"https://openalex.org/W2062845041","eid":"W2062845041"},{"id":"paper-w4393065683","cat":"papers","name":"Psychedelic Therapy: A Primer for Primary Care Clinicians—Lysergic Acid Diethylamide (LSD)","year":"2024","cit":12,"pfa":"Bryce David Beutler","psa":"Owen S. Muir","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4393065683","eid":"W4393065683"},{"id":"paper-w1976059378","cat":"papers","name":"Interaction between narcotic antagonist (naloxone) and lysergic acid diethylamide (LSD) in the rat","year":"1977","cit":12,"pfa":"Allen P. Fertziger","psa":"Roland Fischer","ptype":"article","src":"https://openalex.org/W1976059378","eid":"W1976059378"},{"id":"paper-w4402272914","cat":"papers","name":"Multimodal creativity assessments following acute and sustained microdosing of lysergic acid diethylamide","year":"2024","cit":12,"pfa":"Robin J. Murphy","psa":"Suresh D Muthukumaraswamy","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4402272914","eid":"W4402272914"},{"id":"paper-w4385997324","cat":"papers","name":"Pharmacokinetics, pharmacodynamics and urinary recovery of oral lysergic acid diethylamide administration in healthy participants","year":"2023","cit":12,"pfa":"Friederike Holze","psa":"Matthias E. Liechti","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4385997324","eid":"W4385997324"},{"id":"paper-w4400002012","cat":"papers","name":"Acute Effects of Hallucinogens on Functional Connectivity: Psilocybin and Salvinorin-A","year":"2024","cit":12,"pfa":"Frederick A. Bagdasarian","psa":"Hsiao‐Ying Wey","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4400002012","eid":"W4400002012"},{"id":"paper-w2002174754","cat":"papers","name":"Blocking Effect of Brain Extract on Lysergic Acid Diethylamide Reaction in Siamese Fighting Fish","year":"1957","cit":12,"pfa":"Harold A. Abramson","psa":"Henriette H. Gettner","ptype":"article","src":"https://openalex.org/W2002174754","eid":"W2002174754"},{"id":"paper-w2129623817","cat":"papers","name":"LC-PAD Determination of Mescaline in Cactus “Peyote” (Lophophora williamsii)","year":"2008","cit":12,"pfa":"Raquel Casado","psa":"María Isabel Calvo","ptype":"article","src":"https://openalex.org/W2129623817","eid":"W2129623817"},{"id":"paper-w1968517715","cat":"papers","name":"Lysergic acid diethylamide affects blood flow to specific areas of the conscious rat brain","year":"1975","cit":12,"pfa":"Harold Goldman","psa":"Sharon Murphy","ptype":"article","src":"https://openalex.org/W1968517715","eid":"W1968517715"},{"id":"paper-w1552776892","cat":"papers","name":"Studies on lysergic acid diethylamide and related compounds. V. Syntheses of dihydrolysergic acid diethylamides and related compounds.","year":"1977","cit":12,"pfa":"Yuji Nakahara","psa":"Hisashi Ishii","ptype":"article","src":"https://openalex.org/W1552776892","eid":"W1552776892"},{"id":"paper-w2085100602","cat":"papers","name":"Lysergic Acid Diethylamide (LSD-25): XII. A Preliminary Statement of its Effects Upon Interpersonal Communication","year":"1956","cit":12,"pfa":"Henry L. Lennard","psa":"Harold A. Abramson","ptype":"article","src":"https://openalex.org/W2085100602","eid":"W2085100602"},{"id":"paper-w2124973010","cat":"papers","name":"The inhibition of food intake in the dog by LSD, mescaline, psilocin, -amphetamine and phenylisopropylamine derivatives","year":"1979","cit":12,"pfa":"D. Bruce Vaupel","psa":"E.C. Morton","ptype":"article","src":"https://openalex.org/W2124973010","eid":"W2124973010"},{"id":"paper-w4408226956","cat":"papers","name":"Extraction Yields of Psilocybin and Psilocin: A Short Review of Current Methods and Their Implications","year":"2025","cit":12,"pfa":"Taynah Pereira Galdino","psa":"Marcus Vinícius Lia Fook","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4408226956","eid":"W4408226956"},{"id":"paper-w1014902924","cat":"papers","name":"The Differentiation of Lysergic Acid Diethylamide (LSD) from N-Methyl-N-Propyl and N-Butyl Amides of Lysergic Acid","year":"1989","cit":12,"pfa":"CC Clark","ptype":"article","src":"https://openalex.org/W1014902924","eid":"W1014902924"},{"id":"paper-w4388970634","cat":"papers","name":"The effects of Lysergic Acid Diethylamide (LSD) on the Positive Valence Systems: A Research Domain Criteria (RDoC)-Informed Systematic Review","year":"2023","cit":12,"pfa":"Niloufar Pouyan","psa":"Jonathan D. Morrow","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4388970634","eid":"W4388970634"},{"id":"paper-w2579831332","cat":"papers","name":"HPLC Analysis of Hallucinogenic Mushroom Alkaloids (Psilocin and Psilocybin) Applying Hydrophilic Interaction Chromatography (HILIC)","year":"2016","cit":12,"pfa":"Júlia Nagy","psa":"Tibor Veress","ptype":"article","src":"https://openalex.org/W2579831332","eid":"W2579831332"},{"id":"paper-w3021906381","cat":"papers","name":"The Psilocin (4‐hydroxy‐N,N‐dimethyltryptamine) and Bufotenine (5‐hydroxy‐N,N‐dimethyltryptamine) Case: Ensuring the Correct Isomer has Been Identified","year":"2020","cit":12,"pfa":"Tehila Mishraki‐Berkowitz","psa":"Udi Wolf","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3021906381","eid":"W3021906381"},{"id":"paper-w2148670425","cat":"papers","name":"Some in Vitro Effects of Chlorpromazine, Lysergic Acid Diethylamide, and 5-Hydroxytryptamine on the Respiration of Rat Brain**University of Colorado, College of Pharmacy, Boulder","year":"1959","cit":12,"pfa":"Wesley C. Starbuck","psa":"Harold C. Heim","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2148670425","eid":"W2148670425"},{"id":"paper-w4205493537","cat":"papers","name":"Validation of a New Sensitive Method for the Detection and Quantification of R and S-Epimers of Ergot Alkaloids in Canadian Spring Wheat Utilizing Deuterated Lysergic Acid Diethylamide as an Internal Standard","year":"2021","cit":12,"pfa":"Jensen E. Cherewyk","psa":"Ahmad N Al-Dissi","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4205493537","eid":"W4205493537"},{"id":"paper-w2740495861","cat":"papers","name":"Advantages of analyzing postmortem brain samples in routine forensic drug screening—Case series of three non-natural deaths tested positive for lysergic acid diethylamide (LSD)","year":"2017","cit":12,"pfa":"Marie Mardal","psa":"Kristían Línnet","ptype":"article","src":"https://openalex.org/W2740495861","eid":"W2740495861"},{"id":"paper-w4233662525","cat":"papers","name":"Mescaline hydrobromide","year":"1973","cit":12,"pfa":"S. R. Ernst","psa":"F. William Cagle","ptype":"article","src":"https://openalex.org/W4233662525","eid":"W4233662525"},{"id":"paper-w2415647721","cat":"papers","name":"Psilocybin","year":"1980","cit":12,"pfa":"Alexander T. Shulgin","ptype":"article","src":"https://openalex.org/W2415647721","eid":"W2415647721"},{"id":"paper-w1484277973","cat":"papers","name":"The Attraction of Peyote: An Inquiry Into the Basic Conditions for the Diffusion of the Peyote Religion in North America","year":"1997","cit":12,"pfa":"Åke Hultkrantz","ptype":"book","src":"https://openalex.org/W1484277973","eid":"W1484277973"},{"id":"paper-w3196993476","cat":"papers","name":"Psychedelic-Assisted Psychotherapy After COVID-19: The Therapeutic Uses of Psilocybin and MDMA for Pandemic-Related Mental Health Problems","year":"2021","cit":12,"pfa":"Elena Argento","psa":"Zach Walsh","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W3196993476","eid":"W3196993476"},{"id":"paper-w2001152090","cat":"papers","name":"STUDIES ON MESCALINE VII","year":"1956","cit":12,"pfa":"Herman C.B. Denber","ptype":"article","src":"https://openalex.org/W2001152090","eid":"W2001152090"},{"id":"paper-w2084460127","cat":"papers","name":"Interaction of “Stress” and the Response to Mescaline","year":"1967","cit":12,"pfa":"John Smythies","psa":"Victor S. Johnston","ptype":"article","src":"https://openalex.org/W2084460127","eid":"W2084460127"},{"id":"paper-w2140322989","cat":"papers","name":"Special Ayahuasca Issue Introduction: Toward a Multidisciplinary Approach to Ayahuasca Studies","year":"2012","cit":12,"pfa":"Stephan V. Beyer","ptype":"article","src":"https://openalex.org/W2140322989","eid":"W2140322989"},{"id":"paper-w1976312153","cat":"papers","name":"Effects of ibogaine, and cocaine and morphine after ibogaine, on ventral tegmental dopamine neurons","year":"1996","cit":12,"pfa":"Edward D. French","psa":"Syed F. Ali","ptype":"article","src":"https://openalex.org/W1976312153","eid":"W1976312153"},{"id":"paper-w2558340393","cat":"papers","name":"The Therapeutic Potential of Ayahuasca","year":"2016","cit":12,"pfa":"Michael A. Coe","psa":"Dennis J. McKenna","ptype":"book-chapter","src":"https://openalex.org/W2558340393","eid":"W2558340393"},{"id":"paper-w2064519604","cat":"papers","name":"Comparisons of mescal bean alkaloids with mescaline, Δ9 - THC and other psychotogens","year":"1979","cit":12,"pfa":"William M. Bourn","psa":"J. Frank Bonfiglio","ptype":"article","src":"https://openalex.org/W2064519604","eid":"W2064519604"},{"id":"paper-w2140894070","cat":"papers","name":"PEYOTE AND THE MEXICAN INQUISITION, 1620","year":"1942","cit":12,"pfa":"John M. Goggin","ptype":"article","src":"https://openalex.org/W2140894070","eid":"W2140894070"},{"id":"paper-w3141198824","cat":"papers","name":"A Protecting‐Group‐Free Synthesis of (−)‐Salvinorin A","year":"2021","cit":12,"pfa":"Patrick Zimdars","psa":"Peter Metz","ptype":"article","src":"https://openalex.org/W3141198824","eid":"W3141198824"},{"id":"paper-w2395407178","cat":"papers","name":"Mescaline-induced changes of brain-cortex ribosomes. Effect of mescaline on the stability of brain-cortex ribosomes","year":"1970","cit":12,"pfa":"R. K. Datta","psa":"J. J. Ghosh","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2395407178","eid":"W2395407178"},{"id":"paper-w4406254344","cat":"papers","name":"Psilocybin and Hallucinogenic Mushrooms","year":"2024","cit":12,"pfa":"Mathieu Fradet","psa":"Trisha M Suppes","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W4406254344","eid":"W4406254344"},{"id":"paper-w2031246626","cat":"papers","name":"Potentiation of histamine and inhibition of diamine oxidase by mescaline","year":"1965","cit":12,"pfa":"E.A. Carlini","psa":"M. R. P. Sampaio","ptype":"article","src":"https://openalex.org/W2031246626","eid":"W2031246626"},{"id":"paper-w2557963836","cat":"papers","name":"Psilocybin: Psychotherapy or drug?","year":"2016","cit":12,"pfa":"Guy M. Goodwin","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2557963836","eid":"W2557963836"},{"id":"paper-w2020268410","cat":"papers","name":"The Need for Ibogaine in Drug and Alcohol Addiction Treatment","year":"2011","cit":12,"pfa":"Jennifer R. Donnelly","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2020268410","eid":"W2020268410"},{"id":"paper-w2109025285","cat":"papers","name":"Diagnosis and Management of Recreational Mescaline Self Poisoning","year":"1977","cit":12,"pfa":"Daniel Thau Teitelbaum","psa":"Dale C. Wingeleth","ptype":"article","src":"https://openalex.org/W2109025285","eid":"W2109025285"},{"id":"paper-w139836088","cat":"papers","name":"Peyote, Race, and Equal Protection in the United States","year":"2013","cit":12,"pfa":"Kevin Feeney","ptype":"book-chapter","src":"https://openalex.org/W139836088","eid":"W139836088"},{"id":"paper-w2035350185","cat":"papers","name":"Disruption of the discriminative stimulus effects of S(+)-3,4-methylenedioxymethamphetamine (MDMA) by (±)-MDMA neurotoxicity","year":"1999","cit":12,"pfa":"Thomas Virden","psa":"Lisa E. Baker","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2035350185","eid":"W2035350185"},{"id":"paper-w4409313347","cat":"papers","name":"The Emergence of Psilocybin in Psychiatry and Neuroscience","year":"2025","cit":12,"pfa":"Hossein Omidian","psa":"Alborz Omidian","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4409313347","eid":"W4409313347"},{"id":"paper-w4360616011","cat":"papers","name":"In silico characterization of the psilocybin biosynthesis pathway","year":"2023","cit":12,"pfa":"William A. Irvine","psa":"Rupika Delgoda","ptype":"article","src":"https://openalex.org/W4360616011","eid":"W4360616011"},{"id":"paper-w2169049100","cat":"papers","name":"20-Epiheyneanine, an iboga alkaloid from Peschiera affinis","year":"1976","cit":12,"pfa":"F. J. A. Matos","psa":"L.M. Madruga","ptype":"article","src":"https://openalex.org/W2169049100","eid":"W2169049100"},{"id":"paper-w4251672557","cat":"papers","name":"Ibogaine interferes with the establishment of amphetamine place preference learning.","year":"1997","cit":12,"pfa":"Isabella Moroz","psa":"Shepard Siegel","ptype":"article","src":"https://openalex.org/W4251672557","eid":"W4251672557"},{"id":"paper-w3153468411","cat":"papers","name":"Recent Evidence on the Antidepressant Effects of Ayahuasca","year":"2021","cit":12,"pfa":"Fernanda Palhano-Fontes","psa":"Dráulio Barros de Araújo","topics":["Depression"],"ptype":"book-chapter","src":"https://openalex.org/W3153468411","eid":"W3153468411"},{"id":"paper-w2009370860","cat":"papers","name":"Copper(II) complexes of β-phenethylamine and mescaline","year":"1974","cit":12,"pfa":"George W. Watt","psa":"Martin T. Durney","ptype":"article","src":"https://openalex.org/W2009370860","eid":"W2009370860"},{"id":"paper-w2036056030","cat":"papers","name":"Determination of Mescaline in Hallucinogenic Cactaceae by Ion-Interaction HPLC.","year":"1996","cit":12,"pfa":"M. C. Gennaro","psa":"D. Siccardi","ptype":"article","src":"https://openalex.org/W2036056030","eid":"W2036056030"},{"id":"paper-w7134891055","cat":"papers","name":"Psilocybin or Nicotine Patch for Smoking Cessation","year":"2026","cit":12,"pfa":"Matthew W. Johnson","psa":"Albert Garcia‐Romeu","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7134891055","eid":"W7134891055"},{"id":"paper-w4402554692","cat":"papers","name":"Less is more? A review of psilocybin microdosing","year":"2024","cit":12,"pfa":"Isabella A Savides","psa":"Kim Outhoff","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4402554692","eid":"W4402554692"},{"id":"paper-w3195216497","cat":"papers","name":"MDMA to Treat PTSD in Adults","year":"2025","cit":12,"pfa":"Dustin R. Latimer","psa":"Ivan Urits","topics":["PTSD & trauma","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3195216497","eid":"W3195216497"},{"id":"paper-w4225000363","cat":"papers","name":"Therapeutic Properties of Ayahuasca Components in Ischemia/Reperfusion Injury of the Eye","year":"2022","cit":12,"pfa":"Anna Szilágyi","psa":"Balázs Varga","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4225000363","eid":"W4225000363"},{"id":"paper-w2035882591","cat":"papers","name":"Mescaline produces pathological aggression in rats regardless of age or strain","year":"1978","cit":12,"pfa":"Robert J. Sbordone","psa":"John P. Jervey","ptype":"article","src":"https://openalex.org/W2035882591","eid":"W2035882591"},{"id":"paper-w2074119597","cat":"papers","name":"Differences in tolerance to mescaline produced by peripheral and direct central administration","year":"1971","cit":12,"pfa":"H.A. Tilson","psa":"Sheldon B. Sparber","ptype":"article","src":"https://openalex.org/W2074119597","eid":"W2074119597"},{"id":"paper-w2120203180","cat":"papers","name":"3,4-methylenedioxymethamphetamine (MDMA, or “ecstasy”) and associated hypoglycemia","year":"1997","cit":12,"pfa":"Hugh Montgomery","psa":"Saul G. Myerson","ptype":"article","src":"https://openalex.org/W2120203180","eid":"W2120203180"},{"id":"paper-w4402462242","cat":"papers","name":"Pharmacokinetics of Psilocybin, a Tryptamine Alkaloid in Magic Mushroom ( Psilocybe cubensis ): A Systematic Review","year":"2024","cit":12,"pfa":"Nilubon Thaoboonruang","psa":"Ornrat Lohitnavy","topics":["Depression","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4402462242","eid":"W4402462242"},{"id":"paper-w4402657045","cat":"papers","name":"Short-term safety and tolerability profile of 5-methoxy-N,N-dimethyltryptamine in human subjects: a systematic review of clinical trials","year":"2024","cit":12,"pfa":"Aleksander Kwaśny","psa":"Wiesław Jerzy Cubała","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4402657045","eid":"W4402657045"},{"id":"paper-w4200455094","cat":"papers","name":"Psilocybin Therapy of Psychiatric Disorders Is Not Hampered by hERG Potassium Channel–Mediated Cardiotoxicity","year":"2021","cit":12,"pfa":"Benjamin Hackl","psa":"Xaver Koenig","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4200455094","eid":"W4200455094"},{"id":"paper-w4412489091","cat":"papers","name":"Psilocybin as Transformative Fast‐Acting Antidepressant: Pharmacological Properties and Molecular Mechanisms","year":"2025","cit":12,"pfa":"Makiath Adebo","psa":"Alain Michel Gardier","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4412489091","eid":"W4412489091"},{"id":"paper-w4401779935","cat":"papers","name":"Psilocybin-assisted psychotherapy for existential distress: practical considerations for therapeutic application—a review","year":"2024","cit":12,"pfa":"Arum Kim","psa":"Stephen Ross","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4401779935","eid":"W4401779935"},{"id":"paper-w2407015251","cat":"papers","name":"Effect of ventilation and pH on removal of mescaline and biogenic amines by rabbit lung","year":"1978","cit":12,"pfa":"Robert A. Roth","psa":"C. N. Gillis","ptype":"article","src":"https://openalex.org/W2407015251","eid":"W2407015251"},{"id":"paper-w4381251017","cat":"papers","name":"Interactive Effects of Ayahuasca and Cannabidiol in Social Cognition in Healthy Volunteers","year":"2023","cit":12,"pfa":"Giordano Novak Rossi","psa":"RAFAEL GUIMARÃES DOS SANTOS","topics":["Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4381251017","eid":"W4381251017"},{"id":"paper-w2015460307","cat":"papers","name":"The antinociceptive effects of 3,4-methylenedioxymethamphetamine (MDMA) in the rat","year":"1989","cit":12,"pfa":"Terriann Crisp","psa":"Martin Schechter","ptype":"article","src":"https://openalex.org/W2015460307","eid":"W2015460307"},{"id":"paper-w2404570118","cat":"papers","name":"Salvinorin A decreases mortality and improves neurological outcome in a neonatal mouse hypoxia model.","year":"2014","cit":12,"pfa":"Chunhua Chen","psa":"Renyu Liu","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2404570118","eid":"W2404570118"},{"id":"paper-w1970854939","cat":"papers","name":"An assay procedure for mescaline and its determination in rat brain, liver and plasma","year":"1970","cit":12,"pfa":"Irving M. Cohen","psa":"Wolfgang H Vogel","ptype":"article","src":"https://openalex.org/W1970854939","eid":"W1970854939"},{"id":"paper-w4399572299","cat":"papers","name":"Unlocking the healing power of psilocybin: an overview of the role of psilocybin therapy in major depressive disorder, obsessive-compulsive disorder and substance use disorder","year":"2024","cit":12,"pfa":"Sandra Szafoni","psa":"Gniewko Więckiewicz","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4399572299","eid":"W4399572299"},{"id":"paper-w2072518541","cat":"papers","name":"Effects of mescaline, [Δ9]-tetrahydrocannabinol and pentobarbital on the auditory evoked responses in the cat","year":"1974","cit":12,"pfa":"Didipsha Guha","psa":"S.N. Pradhan","ptype":"article","src":"https://openalex.org/W2072518541","eid":"W2072518541"},{"id":"paper-w2913424696","cat":"papers","name":"An iboga alkaloid chemotaxonomic marker from endemic Tabernaemontana ternifolia with antitubercular activity","year":"2019","cit":12,"pfa":"Rhea C. Garcellano","psa":"Alicia M. Aguinaldo","ptype":"article","src":"https://openalex.org/W2913424696","eid":"W2913424696"},{"id":"paper-w4408958491","cat":"papers","name":"The effect of low-dose psilocybin on brain neurotransmission and rat behavior","year":"2025","cit":12,"pfa":"Agnieszka Bysiek","psa":"Krystyna Gołembiowska","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4408958491","eid":"W4408958491"},{"id":"paper-w2120296913","cat":"papers","name":"Mescaline Concentrations in Three Principal Tissues ofLophophora williamsii(Cactaceae): Implications for Sustainable Harvesting Practices","year":"2015","cit":12,"pfa":"Molly T. Klein","psa":"Martin Terry","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2120296913","eid":"W2120296913"},{"id":"paper-w2297134680","cat":"papers","name":"Time course of pharmacokinetic and hormonal effects of inhaled high-dose salvinorin A in humans","year":"2016","cit":12,"pfa":"Matthew W. Johnson","psa":"Roland R. Griffiths","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2297134680","eid":"W2297134680"},{"id":"paper-w2087382478","cat":"papers","name":"Biphasic effect of 5-methoxy-N,N-dimethyltryptamine on rat prolactin secretion","year":"1983","cit":12,"pfa":"Miljana Simonovic","psa":"Herbert Y. Meltzer","ptype":"article","src":"https://openalex.org/W2087382478","eid":"W2087382478"},{"id":"paper-w4409148851","cat":"papers","name":"De Novo Biosynthesis of Antidepressant Psilocybin in Escherichia coli","year":"2025","cit":12,"pfa":"Zhangrao Huang","psa":"Gang Liu","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4409148851","eid":"W4409148851"},{"id":"paper-w82179537","cat":"papers","name":"Psilocybin reactivity and time contraction as measured by psychomotor performance.","year":"1966","cit":12,"pfa":"R Fischer","psa":"R K Dean","ptype":"article","src":"https://openalex.org/W82179537","eid":"W82179537"},{"id":"paper-w4212784710","cat":"papers","name":"Ayahuasca as a Decoction Applied to Human: Analytical Methods, Pharmacology and Potential Toxic Effects","year":"2022","cit":12,"pfa":"Ľuboš Nižňanský","psa":"Anežka Zummerová","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4212784710","eid":"W4212784710"},{"id":"paper-w1996816024","cat":"papers","name":"Enhanced Hyperthermia Induced by MDMA in Parkin Knockout Mice","year":"2011","cit":12,"pfa":"Yukio Takamatsu","psa":"Ken‐ichi Ikeda","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1996816024","eid":"W1996816024"},{"id":"paper-w2736393586","cat":"papers","name":"Behavioral and Rewarding Effects of Methylone, an Analog of MDMA in Mice","year":"2011","cit":12,"pfa":"Maki Miyazawa","psa":"Shigeyuki Nakaji","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2736393586","eid":"W2736393586"},{"id":"paper-w2327433010","cat":"papers","name":"Alteration of behavioural changes induced by 3,4,5-trimethoxyphenylethylamine (mescaline) by pretreatment with 2,4,5-trimethoxyphenylethylamine","year":"1971","cit":12,"pfa":"A.-M. Dittrich","ptype":"article","src":"https://openalex.org/W2327433010","eid":"W2327433010"},{"id":"paper-w4302773323","cat":"papers","name":"Historical Pathways for Opioid Addiction, Withdrawal with Traditional and Alternative Treatment Options with Ketamine, Cannabinoids, and Noribogaine: A Narrative Review","year":"2022","cit":12,"pfa":"Amber N. Edinoff","psa":"Alan D. Kaye","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W4302773323","eid":"W4302773323"},{"id":"paper-w2948143360","cat":"papers","name":"Distinct neural mechanisms for the prosocial and rewarding properties of MDMA","year":"2019","cit":12,"pfa":"Boris Dov Heifets","psa":"Robert C. Malenka","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W2948143360","eid":"W2948143360"},{"id":"paper-w4304190256","cat":"papers","name":"Bibliometric Analysis of Academic Journal Articles Reporting Results of Psychedelic Clinical Studies","year":"2022","cit":12,"pfa":"Jeremy Weleff","psa":"Brian Scott Barnett","ptype":"article","src":"https://openalex.org/W4304190256","eid":"W4304190256"},{"id":"paper-w2021897255","cat":"papers","name":"Altered visual perception in long-term ecstasy (MDMA) users","year":"2013","cit":12,"pfa":"Claire White","psa":"Mark Edwards","ptype":"article","src":"https://openalex.org/W2021897255","eid":"W2021897255"},{"id":"paper-w4402581764","cat":"papers","name":"Evaluating the potential for psilocybin as a treatment for post-traumatic stress disorder","year":"2024","cit":12,"pfa":"Claire Miller","psa":"Phillip R. Zoladz","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4402581764","eid":"W4402581764"},{"id":"paper-w4391452100","cat":"papers","name":"A simple polyarginine membrane electrochemical sensor for the determination of MDMA and MDA","year":"2024","cit":12,"pfa":"Shimeng Duan","psa":"Huiping Bai","ptype":"article","src":"https://openalex.org/W4391452100","eid":"W4391452100"},{"id":"paper-w2030238247","cat":"papers","name":"Causes and Effects of Cellular Oxidative Stress as a Result of MDMA Abuse","year":"2010","cit":12,"pfa":"Anna Ida Fiaschi","psa":"Daniela Cerretani","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2030238247","eid":"W2030238247"},{"id":"paper-w2020138207","cat":"papers","name":"Über Umwandlungen der Iboga‐Alkaloide Voacangin und Conopharyngin 154. Mitteilung über Alkaloide","year":"1975","cit":12,"pfa":"Yutaka Morita","psa":"Hans Schmid","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2020138207","eid":"W2020138207"},{"id":"paper-w4308352594","cat":"papers","name":"Prophylactic action of ayahuasca in a non-human primate model of depressive-like behavior","year":"2022","cit":12,"pfa":"Maria Lara Porpino de Meiroz Grilo","psa":"Nicole Leite Galvão Coelho","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4308352594","eid":"W4308352594"},{"id":"paper-w2791961317","cat":"papers","name":"Role of AMPA glutamate receptors in the conditioned rewarding effects of MDMA in mice","year":"2018","cit":12,"pfa":"María Pilar García-Pardo","psa":"M.A. Aguilar","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2791961317","eid":"W2791961317"},{"id":"paper-w2087930905","cat":"papers","name":"MDMA Administration and Heat Shock Proteins Response: Foreseeing a Molecular Link","year":"2010","cit":12,"pfa":"Cristoforo Pomara","psa":"Giovanni Li Volti","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2087930905","eid":"W2087930905"},{"id":"paper-w2054460669","cat":"papers","name":"Timothy Leary, Richard Alpert (Ram Dass) and the changing definition of psilocybin","year":"2009","cit":12,"pfa":"Colin Wark","psa":"John F. Galliher","ptype":"article","src":"https://openalex.org/W2054460669","eid":"W2054460669"},{"id":"paper-w2173018972","cat":"papers","name":"Reduced Contextual Discrimination following Alcohol Consumption or MDMA Administration in Mice","year":"2015","cit":12,"pfa":"Emily M. Johansson","psa":"Olga Valverde","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2173018972","eid":"W2173018972"},{"id":"paper-w2095264818","cat":"papers","name":"D1 but not D4 Dopamine Receptors are Critical for MDMA-Induced Neurotoxicity in Mice","year":"2013","cit":12,"pfa":"Noelia Granado","psa":"Rosario Moratalla","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2095264818","eid":"W2095264818"},{"id":"paper-w2339813240","cat":"papers","name":"Ayahuasca rituals in Germany : The first steps of the brazilian Santo Daime religion in Europe","year":"2005","cit":12,"pfa":"Carsten Balzer","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2339813240","eid":"W2339813240"},{"id":"paper-w2978495845","cat":"papers","name":"MDMA Is Not Ecstasy: The Production of Pharmaceutical Safety through Documents in Clinical Trials","year":"2019","cit":12,"pfa":"Katherine Hendy","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2978495845","eid":"W2978495845"},{"id":"paper-w4390590130","cat":"papers","name":"Effect of a single psilocybin treatment on Fos protein expression in male rat brain","year":"2024","cit":12,"pfa":"Douglas R. Funk","psa":"Guy A. Higgins","ptype":"article","src":"https://openalex.org/W4390590130","eid":"W4390590130"},{"id":"paper-w2020493238","cat":"papers","name":"Effects of N,N-dimethyltryptamine on electrically evoked responses in the cat visual system and modification by neuroleptic agents","year":"1976","cit":12,"pfa":"R.H. Moore","psa":"Edward F. Domino","ptype":"article","src":"https://openalex.org/W2020493238","eid":"W2020493238"},{"id":"paper-w4412626160","cat":"papers","name":"5-HT2C receptors in the nucleus accumbens constrain the rewarding effects of MDMA","year":"2025","cit":12,"pfa":"Matthew B. Pomrenze","psa":"Boris Dov Heifets","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4412626160","eid":"W4412626160"},{"id":"paper-w2950050430","cat":"papers","name":"Harm reduction and quitting techniques used by heavy MDMA (ecstasy) users","year":"2019","cit":12,"pfa":"Ghazaleh Sharifimonfared","psa":"Richard Hammersley","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2950050430","eid":"W2950050430"},{"id":"paper-w2009731945","cat":"papers","name":"Prior experience of morphine application alters the c-fos response to MDMA (‘ecstasy’) and cocaine in the rat striatum","year":"2000","cit":12,"pfa":"Martina Erdtmann-Vourliotis","psa":"Volker Höllt","ptype":"article","src":"https://openalex.org/W2009731945","eid":"W2009731945"},{"id":"paper-w4409985142","cat":"papers","name":"Negative Affect Circuit Subtypes and Neural, Behavioral, and Affective Responses to MDMA","year":"2025","cit":12,"pfa":"Xue Zhang","psa":"Leanne Maree Williams","topics":["PTSD & trauma","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4409985142","eid":"W4409985142"},{"id":"paper-w2606770909","cat":"papers","name":"MDMA does not alter responses to the Trier Social Stress Test in humans","year":"2017","cit":12,"pfa":"Anya K. Bershad","psa":"Harriet de Wit","ptype":"article","src":"https://openalex.org/W2606770909","eid":"W2606770909"},{"id":"paper-w4407011158","cat":"papers","name":"Suicide of a patient shortly after psilocybin-assisted psychedelic therapy: A case report","year":"2025","cit":12,"pfa":"Felix Müller","psa":"Undine Emmi Lang","topics":["Depression","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4407011158","eid":"W4407011158"},{"id":"paper-w3214866017","cat":"papers","name":"Regulation of peyote (Lophophora williamsii: Cactaceae) in the U.S.A: A historical victory of religion and politics over science and medicine","year":"2017","cit":12,"pfa":"Martin Terry","psa":"Keeper Trout","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3214866017","eid":"W3214866017"},{"id":"paper-w2756891948","cat":"papers","name":"What’s in a Name? Correlates of Ecstasy Users Knowing or Agreeing that Molly is Ecstasy/MDMA","year":"2017","cit":12,"pfa":"Joseph J. Palamar","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2756891948","eid":"W2756891948"},{"id":"paper-w2090356802","cat":"papers","name":"Widespread oral and oropharyngeal mucosal oedema induced by ecstasy (MDMA): A case for concern","year":"2007","cit":12,"pfa":"M Ahmed","psa":"Gary Russell Hoffman","ptype":"article","src":"https://openalex.org/W2090356802","eid":"W2090356802"},{"id":"paper-w1532522548","cat":"papers","name":"A driving simulator study on the effects of MDMA (Ecstasy) on driving performance and traffic safety","year":"2000","cit":12,"pfa":"Dick de Waard","psa":"Laurent Pernot","topics":["Safety & adverse events"],"ptype":"conference-paper","src":"https://openalex.org/W1532522548","eid":"W1532522548"},{"id":"paper-w3126857985","cat":"papers","name":"Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals","year":"2021","cit":12,"pfa":"Drummond E-Wen McCulloch","psa":"Patrick M. Fisher","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W3126857985","eid":"W3126857985"},{"id":"paper-w2001679750","cat":"papers","name":"Sexual assault and MDMA: the distinction between consciousness and awareness when it comes to consent","year":"2008","cit":12,"pfa":"M. Abondo","psa":"Mariannick Le Gueut","ptype":"article","src":"https://openalex.org/W2001679750","eid":"W2001679750"},{"id":"paper-w2789869972","cat":"papers","name":"A genetic reduction in the serotonin transporter differentially influences MDMA and heroin induced behaviours","year":"2018","cit":12,"pfa":"Bridget W. Brox","psa":"Bart A. Ellenbroek","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2789869972","eid":"W2789869972"},{"id":"paper-w4408783890","cat":"papers","name":"Intravenous psilocybin induces dose-dependent changes in functional network organization in rat cortex","year":"2025","cit":12,"pfa":"Brian H. Silverstein","psa":"Dinesh Pal","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4408783890","eid":"W4408783890"},{"id":"paper-w2047530299","cat":"papers","name":"Treadmill running restores MDMA-mediated hyperthermia prevented by inhibition of the dorsomedial hypothalamus","year":"2015","cit":12,"pfa":"Dmitry V. Zaretsky","psa":"Daniel E. Rusyniak","ptype":"article","src":"https://openalex.org/W2047530299","eid":"W2047530299"},{"id":"paper-w3091924884","cat":"papers","name":"Fast Hollow Fiber Liquid-Phase Microextraction as a Greener Alternative for the Determination of N,N-Dimethyltryptamine and Harmala Alkaloids in Human Urine","year":"2020","cit":12,"pfa":"Gabriela de Oliveira Silveira","psa":"Maurı́cio Yonamine","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3091924884","eid":"W3091924884"},{"id":"paper-w4400697733","cat":"papers","name":"Investigating the therapeutic efficacy of psilocybin in advanced cancer patients: A comprehensive review and meta-analysis","year":"2024","cit":12,"pfa":"Husam Bader","psa":"Yazan Abu Omar","topics":["Depression","Anxiety & end-of-life","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4400697733","eid":"W4400697733"},{"id":"paper-w1982995481","cat":"papers","name":"Selective reduction of striatal type II glucocorticoid receptors in rats by 3,4-methylenedioxymethamphetamine (MDMA)","year":"1989","cit":12,"pfa":"Martin T. Lowy","psa":"Herbert Y. Meltzer","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1982995481","eid":"W1982995481"},{"id":"paper-w2013627605","cat":"papers","name":"The effect of mescaline, 3,4-dimethoxyphenethylamine and 2,5-dimethoxy-4-methylamphetamine on rat plasma prolactin: Evidence for serotonergic mediation","year":"1978","cit":12,"pfa":"Herbert Y. Meltzer","psa":"Victor S. Fang","ptype":"article","src":"https://openalex.org/W2013627605","eid":"W2013627605"},{"id":"paper-w2028749106","cat":"papers","name":"Morphine, MDMA, MDA, and nexus produce a conditioned place preference in newly hatched chickens.","year":"1996","cit":12,"pfa":"Maureen E. Bronson","psa":"et. al.","ptype":"article","src":"https://openalex.org/W2028749106","eid":"W2028749106"},{"id":"paper-w2888823258","cat":"papers","name":"MDMA-Assisted Psychotherapy for Posttraumatic Stress Disorder: Implications for Social Work Practice and Research","year":"2018","cit":12,"pfa":"Courtney A. Hutchison","psa":"Sara K. Bressi","topics":["PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2888823258","eid":"W2888823258"},{"id":"paper-w4390590273","cat":"papers","name":"Ayahuasca and its major component harmine promote antinociceptive effects in mouse models of acute and chronic pain","year":"2024","cit":12,"pfa":"Pedro Santana Sales Lauria","psa":"Cristiane Flora Villarreal","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4390590273","eid":"W4390590273"},{"id":"paper-w4402473042","cat":"papers","name":"Co-administration of midazolam and psilocybin: differential effects on subjective quality versus memory of the psychedelic experience","year":"2024","cit":12,"pfa":"Christopher R. N. Nicholas","psa":"Charles L. Raison","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4402473042","eid":"W4402473042"},{"id":"paper-w4206608634","cat":"papers","name":"6,5‐Fused Ring, C2‐Salvinorin Ester, Dual Kappa and Mu Opioid Receptor Agonists as Analgesics Devoid of Anxiogenic Effects**","year":"2022","cit":12,"pfa":"Nicholas S. Akins","psa":"Hoang V. Le","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4206608634","eid":"W4206608634"},{"id":"paper-w2397623891","cat":"papers","name":"Effects of MDMA and MDA on Brain Serotonin Neurons: Evidence from Neurochemical and Autoradiographic Studies","year":"1989","cit":12,"pfa":"Errol B. De Souza","psa":"George Battaglia","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dataset","src":"https://openalex.org/W2397623891","eid":"W2397623891"},{"id":"paper-w2952043477","cat":"papers","name":"Effects of MDMA on neuroplasticity, amyloid burden and phospho-tau expression in APPswe/PS1dE9 mice","year":"2019","cit":12,"pfa":"Sònia Abad","psa":"Elena Escubedo","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2952043477","eid":"W2952043477"},{"id":"paper-w4403943147","cat":"papers","name":"Psilocybin for major depressive disorder: An updated systematic review and meta-analysis of randomized clinical trials","year":"2024","cit":12,"pfa":"Sepehr Aghajanian","psa":"Mahmood Bakhtiyari","topics":["Depression","Reviews & meta-analyses","Therapy practice"],"ptype":"review","src":"https://openalex.org/W4403943147","eid":"W4403943147"},{"id":"paper-w4410158784","cat":"papers","name":"Self-compassion mediates treatment effects in MDMA-assisted therapy for posttraumatic stress disorder","year":"2025","cit":12,"pfa":"Gabrielle Agin-Liebes","psa":"Jennifer Mitchell","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4410158784","eid":"W4410158784"},{"id":"paper-w4396518351","cat":"papers","name":"Content analysis of Reddit posts about coadministration of selective serotonin reuptake inhibitors and psilocybin mushrooms","year":"2024","cit":12,"pfa":"Kimberly Sakai","psa":"Joshua D. Woolley","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4396518351","eid":"W4396518351"},{"id":"paper-w2144355595","cat":"papers","name":"LC–MS/MS Quantitative Determination of Tetrapterys mucronata Alkaloids, a Plant Occasionally used in Ayahuasca Preparation","year":"2015","cit":12,"pfa":"Marcos Marçal Ferreira Queiroz","psa":"Jean‐Luc Wolfender","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2144355595","eid":"W2144355595"},{"id":"paper-w4391720804","cat":"papers","name":"Subjective long-term emotional and social effects of recreational MDMA use: the role of setting and intentions","year":"2024","cit":12,"pfa":"Timon Elmer","psa":"Sonja Lyubomirsky","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4391720804","eid":"W4391720804"},{"id":"paper-w1964358688","cat":"papers","name":"Methamphetamine, amphetamine, MDMA (‘ecstasy’), MDA and mCPP modulate electrical and cholinergic input in PC12 cells","year":"2011","cit":12,"pfa":"Laura Hondebrink","psa":"Remco H.S. Westerink","ptype":"article","src":"https://openalex.org/W1964358688","eid":"W1964358688"},{"id":"paper-w4407268240","cat":"papers","name":"Shame, Guilt and Psychedelic Experience: Results from a Prospective, Longitudinal Survey of Real-World Psilocybin Use","year":"2025","cit":12,"pfa":"David S. Mathai","psa":"Albert Garcia‐Romeu","ptype":"article","src":"https://openalex.org/W4407268240","eid":"W4407268240"},{"id":"paper-w4301495005","cat":"papers","name":"Community-led guerrilla drug checking in response to deaths from adulterated MDMA in Victoria, Australia","year":"2022","cit":12,"pfa":"Monica Jane Barratt","psa":"Ash R. Blackwell","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4301495005","eid":"W4301495005"},{"id":"paper-w4386116082","cat":"papers","name":"Ayahuasca Treatment Outcome Project (ATOP): One-Year Results from Takiwasi Center and Implications for Psychedelic Science","year":"2023","cit":12,"pfa":"Brian R. Rush","psa":"Fernando M. Mendive","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4386116082","eid":"W4386116082"},{"id":"paper-w2556348829","cat":"papers","name":"Non-Serotonergic Neurotoxicity by MDMA (Ecstasy) in Neurons Derived from Mouse P19 Embryonal Carcinoma Cells","year":"2016","cit":12,"pfa":"Dina Popova","psa":"Stig O. P. Jacobsson","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2556348829","eid":"W2556348829"},{"id":"paper-w2006968718","cat":"papers","name":"Rats preexposed to MDMA display attenuated responses to its aversive effects in the absence of persistent monoamine depletions","year":"2011","cit":12,"pfa":"Daniel L. Albaugh","psa":"Anthony Lee Riley","ptype":"article","src":"https://openalex.org/W2006968718","eid":"W2006968718"},{"id":"paper-w1773815268","cat":"papers","name":"Postpartum weight alteration in hamster offspring from females injected during pregnancy with either heroin, methadone, a composite drug mixture, or mescaline","year":"1974","cit":12,"pfa":"William F. Geber","psa":"Lee C. Schramm","ptype":"article","src":"https://openalex.org/W1773815268","eid":"W1773815268"},{"id":"paper-w2782742955","cat":"papers","name":"Depressive mood ratings are reduced by MDMA in female polydrug ecstasy users homozygous for the l-allele of the serotonin transporter","year":"2018","cit":12,"pfa":"Kim P. C. Kuypers","psa":"Johannes Gerardus Ramaekers","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2782742955","eid":"W2782742955"},{"id":"paper-w4394969307","cat":"papers","name":"Chemical cousins with contrasting behavioural profiles: MDMA users and methamphetamine users differ in social-cognitive functions and aggression","year":"2024","cit":12,"pfa":"Amelie Zacher","psa":"Boris B. Quednow","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4394969307","eid":"W4394969307"},{"id":"paper-w4392183889","cat":"papers","name":"A narrative systematic review of associations and temporality between use of methamphetamine, ecstasy/MDMA, or cocaine with anxiety or depressive symptoms","year":"2024","cit":12,"pfa":"Zoe Duncan","psa":"Keith Sutton","topics":["Depression","Anxiety & end-of-life","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4392183889","eid":"W4392183889"},{"id":"paper-w2200308254","cat":"papers","name":"Prevention of drug priming- and cue-induced reinstatement of MDMA-seeking behaviors by the CB1 cannabinoid receptor antagonist AM251","year":"2015","cit":12,"pfa":"Yoko Nawata","psa":"Tsuneyuki Yamamoto","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2200308254","eid":"W2200308254"},{"id":"paper-w4403628871","cat":"papers","name":"Examining differences in the effects and contexts of naturalistic psilocybin use for White participants vs. Participants of Color: A longitudinal online survey study","year":"2024","cit":12,"pfa":"Grant M. Jones","psa":"Albert Garcia‐Romeu","ptype":"article","src":"https://openalex.org/W4403628871","eid":"W4403628871"},{"id":"paper-w4389056660","cat":"papers","name":"Treating posttraumatic stress disorder and alcohol use disorder comorbidity: Current pharmacological therapies and the future of MDMA-integrated psychotherapy","year":"2023","cit":12,"pfa":"Brian J. Gully","psa":"Carolina L. Haass‐Koffler","topics":["PTSD & trauma","Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4389056660","eid":"W4389056660"},{"id":"paper-w2535823840","cat":"papers","name":"MDMA decreases glutamic acid decarboxylase (GAD) 67-immunoreactive neurons in the hippocampus and increases seizure susceptibility: Role for glutamate","year":"2016","cit":12,"pfa":"Courtney Huff","psa":"Gary A. Gudelsky","ptype":"article","src":"https://openalex.org/W2535823840","eid":"W2535823840"},{"id":"paper-w4406512218","cat":"papers","name":"Psilocybin-assisted massed cognitive processing therapy for chronic posttraumatic stress disorder: Protocol for an open-label pilot feasibility trial","year":"2025","cit":12,"pfa":"Shakila Meshkat","psa":"Venkat Bhat","topics":["PTSD & trauma","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4406512218","eid":"W4406512218"},{"id":"paper-w3109706893","cat":"papers","name":"Increased Response to 3,4-Methylenedioxymethamphetamine (MDMA) Reward and Altered Gene Expression in Zebrafish During Short- and Long-Term Nicotine Withdrawal","year":"2020","cit":12,"pfa":"Luisa Ponzoni","psa":"Mariaelvina Sala","ptype":"article","src":"https://openalex.org/W3109706893","eid":"W3109706893"},{"id":"paper-w3181797329","cat":"papers","name":"Profile and correlates of colorimetric reagent kit use among people who use ecstasy/MDMA and other illegal stimulants in Australia","year":"2021","cit":12,"pfa":"Amy Peacock","psa":"Raimondo Bruno","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3181797329","eid":"W3181797329"},{"id":"paper-w4394566107","cat":"papers","name":"Psychedelics, OCD and related disorders: A systematic review","year":"2024","cit":12,"pfa":"Marianna Graziosi","psa":"David B. Yaden","topics":["Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4394566107","eid":"W4394566107"},{"id":"paper-w4402697828","cat":"papers","name":"Low‐dose psilocybin in short‐lasting unilateral neuralgiform headache attacks: results from an open‐label phase Ib ascending dose study","year":"2024","cit":12,"pfa":"James Rucker","psa":"Manjit Singh Matharu","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4402697828","eid":"W4402697828"},{"id":"paper-w2087382022","cat":"papers","name":"Psychiatric profiles of mothers who take Ecstasy/MDMA during pregnancy: Reduced depression 1 year after giving birth and quitting Ecstasy","year":"2013","cit":12,"pfa":"John J. Turner","psa":"Lynn T. Singer","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W2087382022","eid":"W2087382022"},{"id":"paper-w4402620268","cat":"papers","name":"Psychedelics as a potential treatment for tobacco use disorder: a systematic review","year":"2024","cit":12,"pfa":"Symen Kornelis Spoelstra","psa":"Henderikus Knegtering","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4402620268","eid":"W4402620268"},{"id":"paper-w4391480853","cat":"papers","name":"Effects of hallucinogenic drugs on the human heart","year":"2024","cit":12,"pfa":"Joachim Neumann","psa":"Ulrich Gergs","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4391480853","eid":"W4391480853"},{"id":"paper-w4409087109","cat":"papers","name":"Utilizing Psychedelics to Enhance Well-Being: A Systematic Review","year":"2025","cit":12,"pfa":"Samuel Thomson","psa":"Nikos Thomacos","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4409087109","eid":"W4409087109"},{"id":"paper-w4393098943","cat":"papers","name":"Psychedelic Therapy: A Primer for Primary Care Clinicians—Historical Perspective and Overview","year":"2024","cit":12,"pfa":"Burton Jared Tabaac","psa":"Owen S. Muir","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4393098943","eid":"W4393098943"},{"id":"paper-w3214407741","cat":"papers","name":"Psychedelic medicines for mood disorders: current evidence and clinical considerations.","year":"2022","cit":12,"pfa":"Jerome J. Sarris","psa":"Daniel Perkins","topics":["Depression","PTSD & trauma","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3214407741","eid":"W3214407741"},{"id":"paper-w4402992153","cat":"papers","name":"What should constitute a control condition in psychedelic drug trials?","year":"2024","cit":12,"pfa":"Luana Colloca","psa":"Maurizio Fava","ptype":"article","src":"https://openalex.org/W4402992153","eid":"W4402992153"},{"id":"paper-w2005015693","cat":"papers","name":"Hallucinogenic drugs attenuate the subjective response to alcohol in humans","year":"2000","cit":12,"pfa":"Sean P. Barrett","psa":"Robert O. Pihl","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2005015693","eid":"W2005015693"},{"id":"paper-w4411103150","cat":"papers","name":"Classic Psychedelics in Pain Modulation: Mechanisms, Clinical Evidence, and Future Perspectives","year":"2025","cit":12,"pfa":"Anna Czopek","psa":"Agnieszka Zagórska","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4411103150","eid":"W4411103150"},{"id":"paper-w130785204","cat":"papers","name":"Psychotomimetic effects of PCP, LSD, and Ecstasy: pharmacological models of schizophrenia?","year":"2010","cit":12,"pfa":"Vibeke S. Catts","psa":"Stanley Victor Catts","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W130785204","eid":"W130785204"},{"id":"paper-w2029102085","cat":"papers","name":"Drug-Induced Schizophrenia","year":"1960","cit":12,"pfa":"Abram Hoffer","psa":"M. J. Callbeck","ptype":"article","src":"https://openalex.org/W2029102085","eid":"W2029102085"},{"id":"paper-w1985511368","cat":"papers","name":"Microchemical synthesis of the serotonin receptor ligand, 125I-LSD","year":"1985","cit":12,"pfa":"Paul R. Hartig","psa":"S.A. Hirschman","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1985511368","eid":"W1985511368"},{"id":"paper-w1863507840","cat":"papers","name":"HALLUCINOGENIC COMPOUNDS AND SWIMMING RESPONSE","year":"1968","cit":12,"pfa":"Edward T. Uyeno","ptype":"article","src":"https://openalex.org/W1863507840","eid":"W1863507840"},{"id":"paper-w583416684","cat":"papers","name":"The Problems and Prospects of LSD","year":"1968","cit":12,"ptype":"article","src":"https://openalex.org/W583416684","eid":"W583416684"},{"id":"paper-w2051348974","cat":"papers","name":"Effects of selected opioid agonists and antagonists on DMT-and LSD-25-induced disruption of food-rewarded bar pressing behavior in the rat","year":"1981","cit":12,"pfa":"Diane M. Ruffing","psa":"Edward F. Domino","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2051348974","eid":"W2051348974"},{"id":"paper-w2007547872","cat":"papers","name":"Chromatographic methods for the identification of the new hallucinogen, 4-methyl-2,5-dimethoxy-α-methyl-phenethylamine, and related drugs","year":"1968","cit":12,"pfa":"KLAUS GENEST","psa":"Donald W. Hughes","ptype":"article","src":"https://openalex.org/W2007547872","eid":"W2007547872"},{"id":"paper-w1971526942","cat":"papers","name":"Genetic effects of LSD treatment on the post-meiotic stages of spermatogenesis in Drosophila melanogaster","year":"1969","cit":12,"pfa":"Eleanor Himoe Markowitz","psa":"Etan Markowitz","ptype":"article","src":"https://openalex.org/W1971526942","eid":"W1971526942"},{"id":"paper-w2266435781","cat":"papers","name":"[Automutilation after consumption of hallucinogenic mushrooms].","year":"2007","cit":12,"pfa":"Milly E. Attema-de Jonge","psa":"E. J. F. Franssen","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2266435781","eid":"W2266435781"},{"id":"paper-w2152673539","cat":"papers","name":"Effect of LSD on the tonic activity of the visual pathways of the cat","year":"1965","cit":12,"pfa":"Arthur S. Schwartz","psa":"Carl D. Cheney","ptype":"article","src":"https://openalex.org/W2152673539","eid":"W2152673539"},{"id":"paper-w2089623141","cat":"papers","name":"Comparison of the Effects of LSD, Heliotrine and X-irradiation on Chromosome Breakage, and the Effects of LSD on the Rate of Cell Division","year":"1970","cit":12,"pfa":"Y. A. E. Bick","ptype":"article","src":"https://openalex.org/W2089623141","eid":"W2089623141"},{"id":"paper-w4401233456","cat":"papers","name":"Clinical Effects of Psychedelic Substances Reported to United States Poison Centers: 2012 to 2022","year":"2024","cit":12,"pfa":"Mark William Simon","psa":"Andrew A. Monte","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4401233456","eid":"W4401233456"},{"id":"paper-w1965812297","cat":"papers","name":"LSD Use and Flashbacks in Alcoholic Patients","year":"1999","cit":12,"pfa":"Wayne Bemis Batzer","psa":"Christopher R. Brown","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1965812297","eid":"W1965812297"},{"id":"paper-w4404297527","cat":"papers","name":"Structural insights into tryptamine psychedelics: The role of hydroxyl indole ring site in 5-HT2A receptor activation and psychedelic-like activity","year":"2024","cit":12,"pfa":"Miyuan Zhang","psa":"Xiaohui Wang","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4404297527","eid":"W4404297527"},{"id":"paper-w4389150740","cat":"papers","name":"Exploring Psilocybe spp. mycelium and fruiting body chemistry for potential therapeutic compounds","year":"2023","cit":12,"pfa":"Adam Waldbillig","psa":"Sharan Sidhu","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4389150740","eid":"W4389150740"},{"id":"paper-w2029644138","cat":"papers","name":"Differentiation between the stimulus effects of 1-5-hydroxytryptophan and LSD","year":"1985","cit":12,"pfa":"Kathryn A. Cunningham","psa":"James B. Appel","ptype":"article","src":"https://openalex.org/W2029644138","eid":"W2029644138"},{"id":"paper-w2047631799","cat":"papers","name":"Model Psychoses Induced by LSD-25 in Normals","year":"1956","cit":12,"pfa":"Nicholas A. Bercel","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2047631799","eid":"W2047631799"},{"id":"paper-w193655439","cat":"papers","name":"Serotonin-Related Psychedelic Drugs","year":"2009","cit":12,"pfa":"Mark A. Geyer","psa":"Franz X. Vollenweider","topics":["Mechanism & neuroscience"],"ptype":"reference-entry","src":"https://openalex.org/W193655439","eid":"W193655439"},{"id":"paper-w4402500467","cat":"papers","name":"Efficacy, Safety, and Tolerability of Psychedelics in Treatment-Resistant Depression (TRD)","year":"2024","cit":12,"pfa":"Berend Olivier","psa":"Berend Olivier","topics":["Depression","Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W4402500467","eid":"W4402500467"},{"id":"paper-w4401710092","cat":"papers","name":"Psychedelic use and psychological flexibility: The role of meaningful intention and decentering","year":"2024","cit":12,"pfa":"William M. Campo","psa":"Ann Marie Yali","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4401710092","eid":"W4401710092"},{"id":"paper-w1988942707","cat":"papers","name":"Analytical investigation of legal high products containing Salvia divinorum traded in smartshops and internet","year":"2014","cit":12,"pfa":"Fernando Moreira","psa":"Paula Guedes de Pinho","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1988942707","eid":"W1988942707"},{"id":"paper-w4403667484","cat":"papers","name":"Expert recommendations for Germany’s integration of psychedelic-assisted therapy","year":"2024","cit":12,"pfa":"Sergio R Pérez Rosal","psa":"Sonya C. Faber","topics":["PTSD & trauma","Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4403667484","eid":"W4403667484"},{"id":"paper-w4234841085","cat":"papers","name":"LSD acutely impairs fear recognition and enhances emotional empathy and sociality","year":"2016","cit":12,"pfa":"Patrick C. Dolder","topics":["Anxiety & end-of-life","Therapy practice"],"ptype":"other","src":"https://openalex.org/W4234841085","eid":"W4234841085"},{"id":"paper-w2054375080","cat":"papers","name":"The effects of LSD and some analogues on the responses of single cortical neurons of the cat to optical stimulation","year":"1980","cit":12,"pfa":"A. Dray","psa":"George G. Somjen","ptype":"article","src":"https://openalex.org/W2054375080","eid":"W2054375080"},{"id":"paper-w4283171136","cat":"papers","name":"β-carboline-independent antidepressant-like effect of the standardized extract of the barks of Mimosa tenuiflora (Willd) Poir. occurs via 5-HT 2A/2C receptors in mice","year":"2022","cit":12,"pfa":"Luiz Antonio Miranda de Souza Duarte Filho","psa":"Luciano Augusto de Araújo Ribeiro","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4283171136","eid":"W4283171136"},{"id":"paper-w4392048822","cat":"papers","name":"Repeated microdoses of LSD do not alter anxiety or boldness in zebrafish","year":"2024","cit":12,"pfa":"Ethan V. Hagen","psa":"Trevor J. Hamilton","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4392048822","eid":"W4392048822"},{"id":"paper-w2728825966","cat":"papers","name":"A Single Dose of LSD Does Not Alter Gene Expression of the Serotonin 2A Receptor Gene (HTR2A) or Early Growth Response Genes (EGR1-3) in Healthy Subjects","year":"2017","cit":12,"pfa":"Patrick C. Dolder","psa":"Matthias E. Liechti","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2728825966","eid":"W2728825966"},{"id":"paper-w1969591864","cat":"papers","name":"Autoradiographic comparison of [125I]LSD-labeled 5-HT2A receptor distribution in rat and guinea pig brain","year":"1994","cit":12,"pfa":"Stephanie Wengert Watts","psa":"Marlene L. Cohen","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1969591864","eid":"W1969591864"},{"id":"paper-w2130863461","cat":"papers","name":"Endogenous ligands of a putative LSD-serotonin receptor in the cerebrospinal fluid: Higher level of LSD-displacing factors (LDF) in unmedicated psychotic patients","year":"1977","cit":12,"pfa":"E. Mehl","psa":"J. Redemann","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2130863461","eid":"W2130863461"},{"id":"paper-w4412464433","cat":"papers","name":"LSD's rapid antidepressant effects are modulated by 5-HT2B receptors","year":"2025","cit":12,"pfa":"Amel Bouloufa","psa":"Nasser Haddjeri","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4412464433","eid":"W4412464433"},{"id":"paper-w1989852870","cat":"papers","name":"Analysis of lysergic acid amide in human serum and urine after ingestion of Argyreia nervosa seeds","year":"2012","cit":12,"pfa":"Alexander Paulke","psa":"Stefan W. Toennes","ptype":"article","src":"https://openalex.org/W1989852870","eid":"W1989852870"},{"id":"paper-w1982736759","cat":"papers","name":"Schizophrenia: A New Approach","year":"1959","cit":12,"pfa":"H Osmond","psa":"Abram Hoffer","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1982736759","eid":"W1982736759"},{"id":"paper-w2468739713","cat":"papers","name":"Development of a Library Search‐Based Screening System for 3,4‐Methylenedioxymethamphetamine in Ecstasy Tablets Using a Portable Near‐Infrared Spectrometer","year":"2016","cit":12,"pfa":"Kenji Tsujikawa","psa":"Hiroyuki Inoue","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2468739713","eid":"W2468739713"},{"id":"paper-w2995893285","cat":"papers","name":"Multimodal imaging of hallucinogens 25C‐ and 25I‐NBOMe on blotter papers","year":"2019","cit":12,"pfa":"Elias Lützen","psa":"Uwe Kärst","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2995893285","eid":"W2995893285"},{"id":"paper-w2017801940","cat":"papers","name":"Influence of postmenopausal hormone replacement therapy on platelet serotonin uptake site and serotonin2a receptor binding","year":"2001","cit":12,"pfa":"Anna‐Carin Wihlbäck","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2017801940","eid":"W2017801940"},{"id":"paper-w3164659055","cat":"papers","name":"Separating the wheat from the chaff: Observations on the analysis of lysergamides LSD, MIPLA, and LAMPA","year":"2021","cit":12,"pfa":"Simon D. Brandt","psa":"Stephen J. Chapman","topics":["Addiction","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3164659055","eid":"W3164659055"},{"id":"paper-w3130528280","cat":"papers","name":"Combining ecstasy and ethanol: higher risk for toxicity? A review","year":"2021","cit":12,"pfa":"Eefje Vercoulen","psa":"Laura Hondebrink","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3130528280","eid":"W3130528280"},{"id":"paper-w4410030136","cat":"papers","name":"A landscape analysis of psychedelic retreat organizations advertising online","year":"2025","cit":12,"pfa":"Logan Neitzke‐Spruill","psa":"Amy L. McGuire","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4410030136","eid":"W4410030136"},{"id":"paper-w2414352904","cat":"papers","name":"3,4‐methylenedioxymethamphetamine increases excitability in the dentate gyrus: role of 5 HT 2A receptor‐induced PGE 2 signaling","year":"2015","cit":12,"pfa":"Stuart A. Collins","psa":"Bryan K. Yamamoto","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2414352904","eid":"W2414352904"},{"id":"paper-w4399505257","cat":"papers","name":"Need for a Public Health Response to the Unregulated Sales of Amanita muscaria Mushrooms","year":"2024","cit":12,"pfa":"Eric Craig Leas","psa":"Matthieu Rouffet","topics":["Addiction","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4399505257","eid":"W4399505257"},{"id":"paper-w2013638412","cat":"papers","name":"Ecstasy (3,4-Methylenedioxymethamphetamine)-Induced Inappropriate Antidiuretic Hormone Secretion","year":"2008","cit":12,"pfa":"Raymond E Farah","psa":"Rola Farah","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2013638412","eid":"W2013638412"},{"id":"paper-w1988308309","cat":"papers","name":"3,4-Methylenedioxymethamphetamine (Ecstasy) Decreases Inflammation and Airway Reactivity in a Murine Model of Asthma","year":"2012","cit":12,"pfa":"Daniel Stankevicius","psa":"João Palermo‐Neto","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1988308309","eid":"W1988308309"},{"id":"paper-w2043246427","cat":"papers","name":"Inhibition of 3,4‐methylenedioxymethamphetamine metabolism leads to marked decrease in 3,4‐dihydroxymethamphetamine formation but no change in serotonin neurotoxicity: Implications for mechanisms of neurotoxicity","year":"2011","cit":12,"pfa":"Melanie Mueller","psa":"George A. Ricaurte","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2043246427","eid":"W2043246427"},{"id":"paper-w2124557883","cat":"papers","name":"3,4‐Methylenedioxymethamphetamine Increases Susceptiblity to Genital Herpes Simplex Virus Infection in Mice","year":"2009","cit":12,"pfa":"Jeffry W. Pennock","psa":"Nigel Bourne","ptype":"article","src":"https://openalex.org/W2124557883","eid":"W2124557883"},{"id":"paper-w2162735987","cat":"papers","name":"Attenuation of the disruptive effects of (+/-)3,4-methylenedioxymethamphetamine and cocaine on delayed matching-to-sample performance with D1 versus D2 antagonists","year":"2011","cit":12,"pfa":"David N. Harper","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2162735987","eid":"W2162735987"},{"id":"paper-w2004789855","cat":"papers","name":"Absorption and clearance of ±3,4-methylenedioxymethamphetamine from the plasma of neonatal rats","year":"2004","cit":12,"pfa":"Michael T. Williams","psa":"Charles V. Vorhees","ptype":"article","src":"https://openalex.org/W2004789855","eid":"W2004789855"},{"id":"paper-w2037485491","cat":"papers","name":"Inhibition of dopamine release by methylenedioxymethamphetamine is mediated by serotonin","year":"1989","cit":12,"pfa":"Russell A. Gazzara","psa":"Sherrel G. Howard","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2037485491","eid":"W2037485491"},{"id":"paper-w2025650977","cat":"papers","name":"Comparative study of ATR and transflection IR spectroscopic techniques for the analysis of hallucinogenic mushrooms","year":"2009","cit":12,"pfa":"Ali Koçak","psa":"D.B. Hoffman","ptype":"article","src":"https://openalex.org/W2025650977","eid":"W2025650977"},{"id":"paper-w3197297571","cat":"papers","name":"Serotonin transporter availability, neurocognitive function and their correlation in abstinent 3,4‐methylenedioxymethamphetamine users","year":"2021","cit":12,"pfa":"Foke L. van de Blaak","psa":"Glenn Dumont","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3197297571","eid":"W3197297571"},{"id":"paper-w7125277592","cat":"papers","name":"Psychological Therapy Quantity and Depressive Symptom Reduction in Psychedelic-Assisted Therapy","year":"2026","cit":12,"pfa":"G.A. Florineth","psa":"Leila Maria Soravia","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7125277592","eid":"W7125277592"},{"id":"paper-w4386420994","cat":"papers","name":"Psychedelic-assisted psychotherapy: hope and dilemma","year":"2023","cit":12,"pfa":"The Lancet Regional Health – Europe","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4386420994","eid":"W4386420994"},{"id":"paper-w2058567736","cat":"papers","name":"The effects of hallucinogenic drugs on maze exploration in the rat over a 24 hour period","year":"1973","cit":12,"pfa":"John A. Davies","psa":"Peter H. Redfern","ptype":"article","src":"https://openalex.org/W2058567736","eid":"W2058567736"},{"id":"paper-w2759912686","cat":"papers","name":"Preventive effects of fructose and N‐acetyl‐ L ‐cysteine against cytotoxicity induced by the psychoactive compounds N‐methyl‐5‐(2‐aminopropyl)benzofuran and 3,4‐methylenedioxy‐N‐methamphetamine in isolated rat hepatocyte","year":"2017","cit":12,"pfa":"Yoshio Nakagawa","psa":"Akiko Inomata","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2759912686","eid":"W2759912686"},{"id":"paper-w4319791828","cat":"papers","name":"Toxicity of the 3,4-Methylenedioxymethamphetamine and Its Enantiomers to Daphnia magna after Isolation by Semipreparative Chromatography","year":"2023","cit":12,"pfa":"Ana Rita Fernandes Miranda da Costa","psa":"Cláudia Maria Rosa Ribeiro","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4319791828","eid":"W4319791828"},{"id":"paper-w2905495651","cat":"papers","name":"Modeling Retention Behavior on Analysis of Hallucinogenic Mushrooms Using Hydrophilic Interaction Liquid Chromatography","year":"2018","cit":12,"pfa":"Norbert Rácz","psa":"Tibor Veress","ptype":"article","src":"https://openalex.org/W2905495651","eid":"W2905495651"},{"id":"paper-w4200256404","cat":"papers","name":"Self-Administration of Entactogen Psychostimulants Dysregulates Gamma-Aminobutyric Acid (GABA) and Kappa Opioid Receptor Signaling in the Central Nucleus of the Amygdala of Female Wistar Rats","year":"2021","cit":12,"pfa":"Sophia Khom","psa":"Michael A. Taffe","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4200256404","eid":"W4200256404"},{"id":"paper-w3006438820","cat":"papers","name":"Synthetic psychoactive cathinones: hypothermia and reduced lethality compared to methamphetamine and methylenedioxymethamphetamine","year":"2020","cit":12,"pfa":"Dawn E. Muskiewicz","psa":"Frank Scott Hall","ptype":"article","src":"https://openalex.org/W3006438820","eid":"W3006438820"},{"id":"paper-w2128039266","cat":"papers","name":"Behavioral characterization of 2-O-desmethyl and 5-O-desmethyl metabolites of the phenylethylamine hallucinogen DOM","year":"2003","cit":12,"pfa":"J.R. Eckler","psa":"Jerrold C. Winter","ptype":"article","src":"https://openalex.org/W2128039266","eid":"W2128039266"},{"id":"paper-w4311350614","cat":"papers","name":"The influence of water of crystallization in NIR-based MDMA·HCl detection","year":"2022","cit":12,"pfa":"Ruben F. Kranenburg","psa":"Arian  C. van Asten","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4311350614","eid":"W4311350614"},{"id":"paper-w2152568026","cat":"papers","name":"Direct Analysis of Conjugate Metabolites of Methamphetamine, 3,4-Methylenedioxymethamphetamine, and Their Designer Drugs in Biological Fluids","year":"2009","cit":12,"pfa":"Noriaki Shima","psa":"Hitoshi Tsuchihashi","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2152568026","eid":"W2152568026"},{"id":"paper-w2078727583","cat":"papers","name":"The Commission on Narcotic Drugs' attempt to restrict ketamine","year":"2015","cit":12,"pfa":"Jason Nickerson","psa":"Amir Attaran","ptype":"article","src":"https://openalex.org/W2078727583","eid":"W2078727583"},{"id":"paper-w3092405045","cat":"papers","name":"Polypharmacology or “Pharmacological Promiscuity” In Psychedelic Research: What Are We Missing?","year":"2020","cit":12,"pfa":"Genís Oña","psa":"José Carlos Bouso","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"editorial","src":"https://openalex.org/W3092405045","eid":"W3092405045"},{"id":"paper-w1520578825","cat":"papers","name":"RESIDUAL NEUROCOGNITIVE FEATURES OF ECSTASY USE: A RE‐INTERPRETATION OF HALPERN ET AL. (2011) CONSISTENT WITH SEROTONERGIC NEUROTOXICITY","year":"2011","cit":12,"pfa":"Andrew C. Parrott","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1520578825","eid":"W1520578825"},{"id":"paper-w2052655500","cat":"papers","name":"Metabolic Hypotheses in Schizophrenia","year":"1975","cit":12,"pfa":"Ross J. Baldessarini","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2052655500","eid":"W2052655500"},{"id":"paper-w2129647857","cat":"papers","name":"DNA identification of Salvia divinorum samples","year":"2012","cit":12,"pfa":"Terence M. Murphy","psa":"Gurpreet Bola","ptype":"article","src":"https://openalex.org/W2129647857","eid":"W2129647857"},{"id":"paper-w1970963687","cat":"papers","name":"Eine experimentelle Untersuchung zur bewußtseinsverändernden Wirkung von N,N-Dimethyltryptamin (DMT)","year":"1976","cit":12,"pfa":"P. Bickel","psa":"J. Schoepf","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1970963687","eid":"W1970963687"},{"id":"paper-w108096345","cat":"papers","name":"[Fatal outcome of Ecstasy overdose].","year":"2003","cit":12,"pfa":"Guido Sticht","psa":"Herbert Käferstein","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W108096345","eid":"W108096345"},{"id":"paper-w4382011640","cat":"papers","name":"Social Psychopharmacology: Novel Approaches to Treat Deficits in Social Motivation in Schizophrenia","year":"2023","cit":12,"pfa":"Anya K. Bershad","psa":"Harriet de Wit","topics":["Depression","Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4382011640","eid":"W4382011640"},{"id":"paper-w1979162770","cat":"papers","name":"OBSERVATIONS ON EFFECT OF CORTICOTROPHIN IN SCHIZOPHRENIA","year":"1951","cit":12,"pfa":"Gilbert H. Glaser","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1979162770","eid":"W1979162770"},{"id":"paper-w2033892854","cat":"papers","name":"A Report of Nausea and Vomiting with Discontinuation of Chronic Use ofSalvia divinorum","year":"2012","cit":12,"pfa":"C. R. Travis","psa":"Karen F. Marlowe","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2033892854","eid":"W2033892854"},{"id":"paper-w4390754521","cat":"papers","name":"Knowledge gaps in psychedelic medicalisation: Clinical studies and regulatory aspects","year":"2024","cit":12,"pfa":"Drummond E-Wen McCulloch","psa":"Gitte M. Knudsen","topics":["Depression","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4390754521","eid":"W4390754521"},{"id":"paper-w2799435695","cat":"papers","name":"Undiscovering the Pueblo Mágico: Lessons from Huautla for the Psychedelic Renaissance","year":"2018","cit":12,"pfa":"Ben Feinberg","ptype":"book-chapter","src":"https://openalex.org/W2799435695","eid":"W2799435695"},{"id":"paper-w4292336343","cat":"papers","name":"Effect of drug use in the treatment of acute ischemic stroke: A scoping review","year":"2022","cit":12,"pfa":"Nisha Dabhi","psa":"Min Sik Park","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4292336343","eid":"W4292336343"},{"id":"paper-w4213073845","cat":"papers","name":"Sex Differences in Kappa Opioid Receptor Agonist Mediated Attenuation of Chemotherapy-Induced Neuropathic Pain in Mice","year":"2022","cit":12,"pfa":"Kelly F. Paton","psa":"Bronwyn Maree Kivell","topics":["Addiction","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4213073845","eid":"W4213073845"},{"id":"paper-w4313144374","cat":"papers","name":"Psychedelic use predicts objective knowledge about climate change via increases in nature relatedness","year":"2022","cit":12,"pfa":"Christina Sagioglou","psa":"Matthias Forstmann","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4313144374","eid":"W4313144374"},{"id":"paper-w3201661766","cat":"papers","name":"In Vitro and In Vivo Sequestration of Methamphetamine by a Sulfated Acyclic CB[n]‐Type Receptor","year":"2021","cit":12,"pfa":"Adam T. Brockett","psa":"Lyle Isaacs","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3201661766","eid":"W3201661766"},{"id":"paper-w4250842998","cat":"papers","name":"Microdosing Psychedelics: Personality, mental health, and creativity differences in microdosers","year":"2018","cit":12,"pfa":"Thomas Anderson","psa":"Norman A. S. Farb","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W4250842998","eid":"W4250842998"},{"id":"paper-w59722544","cat":"papers","name":"Effects of barbiturates, phencyclidine, ketamine and analogs on cerebral circulation and cerebrovascular muscle.","year":"1984","cit":12,"pfa":"Bella T. Altura","psa":"B. M. Altura","topics":["PTSD & trauma","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W59722544","eid":"W59722544"},{"id":"paper-w4396546274","cat":"papers","name":"New perspective on sustained antidepressant effect: focus on neurexins regulating synaptic plasticity","year":"2024","cit":12,"pfa":"Yuan Ruan","psa":"Nai‐Hong Chen","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4396546274","eid":"W4396546274"},{"id":"paper-w4382982394","cat":"papers","name":"Long-Term Impacts of the COVID-19 Pandemic on Drug/Alcohol Use Prevalence in a Population with Substance Use Disorders","year":"2023","cit":12,"pfa":"Alessio Gili","psa":"Cristiana Gambelunghe","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4382982394","eid":"W4382982394"},{"id":"paper-w121936730","cat":"papers","name":"Mechanism of action and therapeutic uses of psychostimulants.","year":"2005","cit":12,"pfa":"Kevin F Foley","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W121936730","eid":"W121936730"},{"id":"paper-w2039591391","cat":"papers","name":"“Bath Salts”–Induced Psychosis in a Young Woman","year":"2013","cit":12,"pfa":"Sadaf Khan","psa":"Saira Mushtaq","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2039591391","eid":"W2039591391"},{"id":"paper-w4365455369","cat":"papers","name":"Focusing on the negative: cases of long-term negative psychological responses to psychedelics","year":"2023","cit":12,"pfa":"Rebecka Bremler","psa":"Robin Lester Carhart-Harris","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4365455369","eid":"W4365455369"},{"id":"paper-w4404930798","cat":"papers","name":"How to Make Psychedelic-Assisted Therapy Safer","year":"2024","cit":12,"pfa":"Daniel Villiger","topics":["Safety & adverse events","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4404930798","eid":"W4404930798"},{"id":"paper-w4319344532","cat":"papers","name":"Psychedelic therapy as reality transformation: A phenomenological approach","year":"2023","cit":12,"pfa":"Mateo Sánchez Petrement","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4319344532","eid":"W4319344532"},{"id":"paper-w4382813188","cat":"papers","name":"On Redescribing the Indescribable: Trauma, Psychoanalysis and Psychedelic Therapy","year":"2023","cit":12,"pfa":"Nadav Liam Modlin","psa":"James Rucker","topics":["PTSD & trauma","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4382813188","eid":"W4382813188"},{"id":"paper-w2902938877","cat":"papers","name":"The Trials of Psychedelic Therapy: LSD Psychotherapy in America","year":"2018","cit":12,"pfa":"Matthew Oram","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2902938877","eid":"W2902938877"},{"id":"paper-w2903450698","cat":"papers","name":"Psychiatry might need some psychedelic therapy","year":"2018","cit":12,"pfa":"Matthew W. Johnson","ptype":"editorial","src":"https://openalex.org/W2903450698","eid":"W2903450698"},{"id":"paper-w4393098934","cat":"papers","name":"Psychedelic Therapy: A Primer for Primary Care Clinicians—Ketamine","year":"2024","cit":12,"pfa":"Viviana D. Evans","psa":"Owen S. Muir","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4393098934","eid":"W4393098934"},{"id":"paper-w4386569338","cat":"papers","name":"Psychedelic-Assisted Psychotherapy and Mindfulness-Based Cognitive Therapy: Potential Synergies","year":"2023","cit":12,"pfa":"Richard Chambers","psa":"Otto Simonsson","topics":["Dosing & pharmacology","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4386569338","eid":"W4386569338"},{"id":"paper-w3097475421","cat":"papers","name":"Prescribing meaning: hedonistic perspectives on the therapeutic use of psychedelic-assisted meaning enhancement","year":"2020","cit":12,"pfa":"Riccardo Miceli McMillan","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3097475421","eid":"W3097475421"},{"id":"paper-w4383823637","cat":"papers","name":"Exploring the Unique Therapeutic Potential of Psychedelics to Reduce Chronic Shame Among Sexual and Gender Minority Adults","year":"2023","cit":12,"pfa":"Nicholas A. Carlisle","psa":"Peter S. Hendricks","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W4383823637","eid":"W4383823637"},{"id":"paper-w4281688759","cat":"papers","name":"Mystical experiences without mysticism: An argument for mystical fictionalism in psychedelics","year":"2022","cit":12,"pfa":"Bradley Armour Garb","psa":"Mitch Earleywine","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4281688759","eid":"W4281688759"},{"id":"paper-w4414224125","cat":"papers","name":"Key competencies for psychedelic treatment in real-world mental health care settings","year":"2025","cit":12,"pfa":"Max Wolff","psa":"Henrik Jungaberle","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4414224125","eid":"W4414224125"},{"id":"paper-w4408502085","cat":"papers","name":"Psychedelics and autobiographical memory – six open questions","year":"2025","cit":12,"pfa":"Samuli Kangaslampi","psa":"Morten Peter Lietz","topics":["PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4408502085","eid":"W4408502085"},{"id":"paper-w4414171615","cat":"papers","name":"Psychedelic neuroplasticity of cortical neurons lacking 5-HT2A receptors","year":"2025","cit":12,"pfa":"Tyler G. Ekins","psa":"Omar J. Ahmed","topics":["Depression","PTSD & trauma","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4414171615","eid":"W4414171615"},{"id":"paper-w1985996159","cat":"papers","name":"Repression of death consciousness and the psychedelic trip","year":"2012","cit":12,"pfa":"Varsha Dutta","topics":["Anxiety & end-of-life","Therapy practice"],"ptype":"article","src":"https://openalex.org/W1985996159","eid":"W1985996159"},{"id":"paper-w4389477439","cat":"papers","name":"Perceptions of psychedelic personality change, determinants of use, setting and drug moderation: Toward a holistic model","year":"2023","cit":12,"pfa":"Brandon Weiss","psa":"William Keith Campbell","ptype":"article","src":"https://openalex.org/W4389477439","eid":"W4389477439"},{"id":"paper-w4232989343","cat":"papers","name":"A Systematic Study of Microdosing Psychedelics","year":"2018","cit":12,"pfa":"Vince Polito","psa":"Richard James Stevenson","topics":["Depression","Addiction","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4232989343","eid":"W4232989343"},{"id":"paper-w4281724869","cat":"papers","name":"Psychedelic Microdosing, Mindfulness, and Anxiety: A Cross-Sectional Mediation Study","year":"2022","cit":12,"pfa":"Vincent Hartong","psa":"Arnold van Emmerik","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4281724869","eid":"W4281724869"},{"id":"paper-w2887588413","cat":"papers","name":"Exploring the effect of microdosing psychedelics on creativity in an open-label natural setting","year":"2018","cit":12,"pfa":"Luisa Prochazkova","psa":"Bernhard Hommel","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W2887588413","eid":"W2887588413"},{"id":"paper-w4409653731","cat":"papers","name":"Prediction of hallucinogen persisting perception disorder and thought disturbance symptoms following psychedelic use","year":"2025","cit":12,"pfa":"Katie Zhou","psa":"Hannes Kettner","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4409653731","eid":"W4409653731"},{"id":"paper-w4247836582","cat":"papers","name":"Entheogens and the future of religion","year":"1997","cit":12,"ptype":"book-review","src":"https://openalex.org/W4247836582","eid":"W4247836582"},{"id":"paper-w2510084385","cat":"papers","name":"IS THERE A PLACE FOR PSYCHEDELICS IN PHILOSOPHY?","year":"2016","cit":12,"pfa":"Nicolas Langlitz","ptype":"article","src":"https://openalex.org/W2510084385","eid":"W2510084385"},{"id":"paper-w2046523910","cat":"papers","name":"INTERACTIONS OF HALLUCINOGENS AT THE CLINICAL LEVEL","year":"1976","cit":12,"pfa":"Richard Jed Wyatt","psa":"J. Christian Gillin","ptype":"article","src":"https://openalex.org/W2046523910","eid":"W2046523910"},{"id":"paper-w1979362741","cat":"papers","name":"Unexplored Pharmacokinetic Opportunities with Microdosing in Oncology","year":"2007","cit":12,"pfa":"Alex Sparreboom","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1979362741","eid":"W1979362741"},{"id":"paper-w2008957158","cat":"papers","name":"Actions of methoxylated amphetamine hallucinogen on serotonergic neurons of the brain","year":"1996","cit":12,"pfa":"Nicholas J. Penington","ptype":"article","src":"https://openalex.org/W2008957158","eid":"W2008957158"},{"id":"paper-w2439260760","cat":"papers","name":"Poetic Vision and the Psychedelic Experience","year":"1971","cit":12,"pfa":"Douglas Hubble","psa":"Robert Allen Durr","ptype":"article","src":"https://openalex.org/W2439260760","eid":"W2439260760"},{"id":"paper-w2125843727","cat":"papers","name":"Is It Time to Advance the Chemoprevention of Environmental Carcinogenesis with Microdosing Trials?","year":"2009","cit":12,"pfa":"Thomas W. Kensler","psa":"John D. Groopman","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2125843727","eid":"W2125843727"},{"id":"paper-w1921767483","cat":"papers","name":"Schizophrenia and hallucinogen persisting perception disorder: A clinical investigation","year":"2015","cit":12,"pfa":"Shaul Lev‐Ran","psa":"Lerner G. Arturo","ptype":"article","src":"https://openalex.org/W1921767483","eid":"W1921767483"},{"id":"paper-w3045627735","cat":"papers","name":"Entheogenic Spirituality: Exploring Spiritually Motivated Entheogen Use among Modern Westerners.","year":"2018","cit":12,"pfa":"Petter Grahl Johnstad","ptype":"article","src":"https://openalex.org/W3045627735","eid":"W3045627735"},{"id":"paper-w4296472247","cat":"papers","name":"Christianity and Psychedelic Medicine: A Pastoral Approach","year":"2022","cit":12,"pfa":"Bryan C. McCarthy","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4296472247","eid":"W4296472247"},{"id":"paper-w4395463889","cat":"papers","name":"Religion, Psychedelics, Risky Behavior, and Violence","year":"2024","cit":12,"pfa":"Sean M. Viña","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4395463889","eid":"W4395463889"},{"id":"paper-w4283789810","cat":"papers","name":"Classic Psychedelics and Human–Animal Relations","year":"2022","cit":12,"pfa":"Elin Pöllänen","psa":"Otto Simonsson","ptype":"article","src":"https://openalex.org/W4283789810","eid":"W4283789810"},{"id":"paper-w212305274","cat":"papers","name":"Microdose 14C-urea breath test in detection of Helicobacter pylori.","year":"1996","cit":12,"pfa":"Władysław Bielański","psa":"Barry James Marshall","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W212305274","eid":"W212305274"},{"id":"paper-w2151214776","cat":"papers","name":"Changes in human ovaries after long-term administration of microdose progestogens","year":"1973","cit":12,"pfa":"I. Aref","psa":"O Kandil","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2151214776","eid":"W2151214776"},{"id":"paper-w3109364475","cat":"papers","name":"Application of Microdosed Intravenous Omeprazole to Determine Hepatic CYP2C19 Activity","year":"2020","cit":12,"pfa":"Mazyar Mahmoudi","psa":"Walter E. Haefeli","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3109364475","eid":"W3109364475"},{"id":"paper-w4283208351","cat":"papers","name":"Microdosing of Compost for Sustainable Production of Improved Sorghum in Southern Mali","year":"2022","cit":12,"pfa":"Moumini Guindo","psa":"Ramadjita Tabo","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4283208351","eid":"W4283208351"},{"id":"paper-w4400311237","cat":"papers","name":"Applying the EU regulatory framework for the clinical use of psychedelics","year":"2024","cit":12,"pfa":"Florence Butlen‐Ducuing","psa":"Steffen Thirstrup","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4400311237","eid":"W4400311237"},{"id":"paper-w4383069440","cat":"papers","name":"An Integrated theory of false insights and beliefs under psychedelics","year":"2023","cit":12,"pfa":"Hugh McGovern","psa":"Ruben Laukkonen","topics":["Safety & adverse events","Reviews & meta-analyses","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4383069440","eid":"W4383069440"},{"id":"paper-w601732287","cat":"papers","name":"Kaleidoscope Eyes: Psychedelic Rock from the '60s to the '90s","year":"1996","cit":12,"pfa":"Jim DeRogatis","ptype":"book","src":"https://openalex.org/W601732287","eid":"W601732287"},{"id":"paper-w4377245738","cat":"papers","name":"Changed Substance Use After Psychedelic Experiences Among Individuals in Canada","year":"2023","cit":12,"pfa":"Kevin F. Boehnke","psa":"Philippe Lucas","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4377245738","eid":"W4377245738"},{"id":"paper-w4409716552","cat":"papers","name":"Historians on Drugs: Toward an Empirical Historiography of Global Psychedelic Cultures","year":"2025","cit":12,"pfa":"Joseph Christian Greer","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4409716552","eid":"W4409716552"},{"id":"paper-w4309472913","cat":"papers","name":"Skip the Trip? Five Arguments on the Use of Nonhallucinogenic Psychedelics in Psychiatry","year":"2022","cit":12,"pfa":"Andrew H. Peterson","psa":"Dominic A. Sisti","ptype":"article","src":"https://openalex.org/W4309472913","eid":"W4309472913"},{"id":"paper-w2608740459","cat":"papers","name":"A diagnostic microdosing approach to investigate platinum sensitivity in non-small cell lung cancer","year":"2017","cit":12,"pfa":"Si-Si Wang","psa":"Paul T. Henderson","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2608740459","eid":"W2608740459"},{"id":"paper-w2198081381","cat":"papers","name":"Microdosing of Mineral Fertilizer and Conservation Agriculture for Sustainable Agricultural Intensification in Sub-Saharan Africa","year":"2014","cit":12,"pfa":"Jens B. Aune","psa":"Adama Coulibaly","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W2198081381","eid":"W2198081381"},{"id":"paper-w3026210884","cat":"papers","name":"Midazolam microdosing applied in early clinical development for drug–drug interaction assessment","year":"2020","cit":12,"pfa":"Sabrina T. Wiebe","psa":"Gerd Mikus","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3026210884","eid":"W3026210884"},{"id":"paper-w4382752858","cat":"papers","name":"Case report: Psychedelic-induced seizures captured by intracranial electrocorticography","year":"2023","cit":12,"pfa":"Benjamin N. Blond","psa":"Emmanuelle A. D. Schindler","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4382752858","eid":"W4382752858"},{"id":"paper-w4407972458","cat":"papers","name":"Integration or commodification? A critical review of individual-centered approaches in psychedelic healing","year":"2025","cit":12,"pfa":"Emilia Sanabria","psa":"Luís Fernando Tófoli","topics":["Safety & adverse events","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4407972458","eid":"W4407972458"},{"id":"paper-w2809975315","cat":"papers","name":"Fertilizer Microdosing Technology in Sorghum, Millet and Maize Production at Small-Scale Level in Africa: A Review","year":"2018","cit":12,"pfa":"Walelign Demisie","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2809975315","eid":"W2809975315"},{"id":"paper-w2735338980","cat":"papers","name":"An economic risk analysis of fertiliser microdosing and rainwater harvesting in a semi-arid farming system in Tanzania","year":"2017","cit":12,"pfa":"Lutengano Mwinuka","psa":"Jean‐Claude Bizimana","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2735338980","eid":"W2735338980"},{"id":"paper-w4281556927","cat":"papers","name":"Psychedelic Medicine: Creating an Introductory Course for Mental Health Professionals and Trainees","year":"2022","cit":12,"pfa":"William L. Prueitt","psa":"Jordan Sloshower","ptype":"article","src":"https://openalex.org/W4281556927","eid":"W4281556927"},{"id":"paper-w4405955639","cat":"papers","name":"Primum Non Nocere: The Onus to Characterize the Potential Harms of Psychedelic Treatment","year":"2025","cit":12,"pfa":"Sharmin Ghaznavi","psa":"Jerrold F. Rosenbaum","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4405955639","eid":"W4405955639"},{"id":"paper-w3216074921","cat":"papers","name":"Virtual Reality and Psychedelics for the Treatment of Psychiatric Disease: A Systematic Literature Review.","year":"2020","cit":12,"pfa":"Federico J. Gómez-Busto","psa":"Mario Isidoro Ortiz","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"review","src":"https://openalex.org/W3216074921","eid":"W3216074921"},{"id":"paper-w4416769054","cat":"papers","name":"Recalled childhood trauma and post-psychedelic trajectories of change in a mixed-methods study","year":"2025","cit":12,"pfa":"Guy Simon","psa":"Oliver C. Robinson","topics":["PTSD & trauma","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4416769054","eid":"W4416769054"},{"id":"paper-w2910398701","cat":"papers","name":"Facteurs d’adoption de la technologie \"Microdose\" dans les zones agroécologiques au Burkina Faso","year":"2019","cit":12,"pfa":"Hamadé Sigue","psa":"Gauthier Biaou","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2910398701","eid":"W2910398701"},{"id":"paper-w2904507782","cat":"papers","name":"A convenient strategy to overcome interference in LC-MS/MS analysis: Application in a microdose absolute bioavailability study","year":"2018","cit":12,"pfa":"Long Yuan","psa":"Qin C. Ji","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2904507782","eid":"W2904507782"},{"id":"paper-w2052489572","cat":"papers","name":"Immediate postabortal contraception with a microdose combined preparation: Suppression of pituitary and ovarian function and elimination of HCG","year":"1978","cit":12,"pfa":"Pertti L.A. Lähteenmäki","psa":"Tapani Luukkainen","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2052489572","eid":"W2052489572"},{"id":"paper-w2971572021","cat":"papers","name":"Psychedelic Mysticism: Transforming Consciousness, Religious Experiences, and Voluntary Peasants in Postwar America","year":"2015","cit":12,"pfa":"Morgan Shipley","ptype":"article","src":"https://openalex.org/W2971572021","eid":"W2971572021"},{"id":"paper-w4406410195","cat":"papers","name":"Psychedelics and connectedness to natural and social worlds: An examination of the evidence and a proposed conceptual framework","year":"2025","cit":12,"pfa":"Matthias Forstmann","psa":"Christina Sagioglou","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"review","src":"https://openalex.org/W4406410195","eid":"W4406410195"},{"id":"paper-w4394840120","cat":"papers","name":"Single administration of a psychedelic [(R)-DOI] influences coping strategies to an escapable social stress","year":"2024","cit":12,"pfa":"Kevin T. Krupp","psa":"Cliff H. Summers","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4394840120","eid":"W4394840120"},{"id":"paper-w2171961700","cat":"papers","name":"A composite microdose Adaptive Response (AR) and Bystander Effect (BE) model–application to low LET and high LET AR and BE data","year":"2008","cit":12,"pfa":"Bobby E. Leonard","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2171961700","eid":"W2171961700"},{"id":"paper-w4289774615","cat":"papers","name":"Acute and enduring effects of naturalistic psychedelic use among Indigenous peoples in Canada and the United States.","year":"2022","cit":12,"pfa":"Sara de la Salle","psa":"Monnica T. Williams","ptype":"article","src":"https://openalex.org/W4289774615","eid":"W4289774615"},{"id":"paper-w4409674093","cat":"papers","name":"Single-dose psychedelic enhances cognitive flexibility and reversal learning in mice weeks after administration","year":"2025","cit":12,"pfa":"Elizabeth J. Brouns","psa":"Omar J. Ahmed","topics":["Depression","PTSD & trauma","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4409674093","eid":"W4409674093"},{"id":"paper-w4220722351","cat":"papers","name":"Feasibility of fluorescence imaging at microdosing using a hybrid PSMA tracer during robot-assisted radical prostatectomy in a large animal model","year":"2022","cit":12,"pfa":"Paolo Dell’Oglio","psa":"Tessa Buckle","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4220722351","eid":"W4220722351"},{"id":"paper-w2737553051","cat":"papers","name":"Détermination des doses optimales de fumures organo-minérales en microdose dans la zone soudano-sahélienne du Burkina Faso","year":"2017","cit":12,"pfa":"Béatrice B. Somda","psa":"P. Michel Sedogo","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2737553051","eid":"W2737553051"},{"id":"paper-w4402858406","cat":"papers","name":"The psychedelic drug DOI reduces heroin motivation by targeting 5-HT2A receptors in a heroin and alcohol co-use model","year":"2024","cit":12,"pfa":"Joel Bonilla","psa":"Jamie Peters","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4402858406","eid":"W4402858406"},{"id":"paper-w2902106935","cat":"papers","name":"Microhabitat selection and communal nesting in the insular Psychedelic Rock Gecko, Cnemaspis psychedelica, in Southern Vietnam with updated information on trade","year":"2018","cit":12,"pfa":"Hai Ngoc Ngo","psa":"Thomas Ziegler","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2902106935","eid":"W2902106935"},{"id":"paper-w2413775877","cat":"papers","name":"Chemical pharmacological and medical aspects of psychotomimetics.","year":"1961","cit":12,"pfa":"A HOFMANN","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2413775877","eid":"W2413775877"},{"id":"paper-w3115014467","cat":"papers","name":"How to Change Your Mind: What the new science of psychedelics teaches us about consciousness, dying, addiction depression, and transcendence","year":"2020","cit":12,"pfa":"Kathleen J. Farkas","topics":["Depression","Addiction"],"ptype":"book-review","src":"https://openalex.org/W3115014467","eid":"W3115014467"},{"id":"paper-w3023691240","cat":"papers","name":"Can Psychedelics Alleviate Symptoms of Cluster Headache and Accompanying Mental Health Problems? A Case Report Involving Hawaiian Baby Woodrose","year":"2020","cit":12,"pfa":"Shevaugn Johnson","psa":"Quentin C. Black","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W3023691240","eid":"W3023691240"},{"id":"paper-w4395956816","cat":"papers","name":"Metabolism and cytotoxicity studies of the two hallucinogens 1cP-LSD and 4-AcO-DET in human liver and zebrafish larvae models using LC-HRMS/MS and a high-content screening assay","year":"2024","cit":12,"pfa":"Tanja M. Gampfer","psa":"Markus R. Meyer","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4395956816","eid":"W4395956816"},{"id":"paper-w2051612503","cat":"papers","name":"The action of calcium and anticholinergic psychotomimetic agents on surface films","year":"1964","cit":12,"pfa":"Graham Rogeness","psa":"Leo G. Abood","ptype":"article","src":"https://openalex.org/W2051612503","eid":"W2051612503"},{"id":"paper-w2038833862","cat":"papers","name":"The interaction of the psychotomimetic glycolate esters with adenosine triphosphate, calcium and lecithin monolayers","year":"1966","cit":12,"pfa":"Graham Rogeness","psa":"Leo G. Abood","ptype":"article","src":"https://openalex.org/W2038833862","eid":"W2038833862"},{"id":"paper-w2013775054","cat":"papers","name":"Autoradiographic localization of 5HT2 receptors in rat brain using [125I]-DOI, a selective psychotomimetic radioligand","year":"1989","cit":12,"pfa":"Adil J. Nazarali","psa":"Juan M. Saavedra","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2013775054","eid":"W2013775054"},{"id":"paper-w2528267729","cat":"papers","name":"Psychotomimetic effects of different doses of MK-801 and the underlying mechanisms in a selective memory impairment model","year":"2016","cit":12,"pfa":"Weiqing Liu","psa":"Xiaogang Chen","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2528267729","eid":"W2528267729"},{"id":"paper-w2030639332","cat":"papers","name":"Chemical conversion of the psychotomimetic amine 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane to 5-hydroxy-2,6-dimethylindole","year":"1974","cit":12,"pfa":"Jonathan S. Zweig","psa":"Neal Castagnoli","ptype":"article","src":"https://openalex.org/W2030639332","eid":"W2030639332"},{"id":"paper-w2055797104","cat":"papers","name":"Effects of hallucinogenic drugs on serotonergic neuronal systems","year":"1986","cit":12,"pfa":"Robert B. McCall","ptype":"article","src":"https://openalex.org/W2055797104","eid":"W2055797104"},{"id":"paper-w4408026600","cat":"papers","name":"Physiologically Based Pharmacokinetic Model of Tyrosine Kinase Inhibitors to Predict Target Site Penetration, with PET ‐Guided Verification","year":"2025","cit":12,"pfa":"Suzanne van der Gaag","psa":"Imke Heleen Bartelink","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4408026600","eid":"W4408026600"},{"id":"paper-w2106667182","cat":"papers","name":"Enhancing action of LSD on neuronal responsiveness to serotonin in a brain structure involved in obsessive–compulsive disorder","year":"2003","cit":12,"pfa":"Tarek Zghoul","psa":"Pierre Ulrich Blier","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2106667182","eid":"W2106667182"},{"id":"paper-w1980933588","cat":"papers","name":"LSD use among US high school students","year":"1994","cit":12,"pfa":"Mark S. Gold","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1980933588","eid":"W1980933588"},{"id":"paper-w596553090","cat":"papers","name":"Clinical manual of chemical dependence","year":"1991","cit":12,"pfa":"Domenic A. Ciraulo","psa":"Richard I. Shader","topics":["Addiction","Therapy practice"],"ptype":"book","src":"https://openalex.org/W596553090","eid":"W596553090"},{"id":"paper-w2076934777","cat":"papers","name":"Pharmacologic Effects of Marijuana","year":"1968","cit":12,"pfa":"Frederick H. Meyers","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2076934777","eid":"W2076934777"},{"id":"paper-w2154301769","cat":"papers","name":"Emergency Room Treatment of the Drug-Abusing Patient","year":"1973","cit":12,"pfa":"James L. Chapel","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2154301769","eid":"W2154301769"},{"id":"paper-w1977718984","cat":"papers","name":"Identification and Determination of Lsd in Illicit Preparations Using Synchronous Spectro Fluorimetry","year":"1982","cit":12,"pfa":"Ph. Baudot","psa":"Julie André","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1977718984","eid":"W1977718984"},{"id":"paper-w4386530387","cat":"papers","name":"Molecular and structural insights into the 5‐HT 2C receptor as a therapeutic target for substance use disorders","year":"2023","cit":12,"pfa":"Maleesha Ubhayarathna","psa":"Gregory D. Stewart","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4386530387","eid":"W4386530387"},{"id":"paper-w2004644788","cat":"papers","name":"Structure-activity relationships in potentially hallucinogenic N,N-dialkyltryptamines substituted in the benzene moiety","year":"1982","cit":12,"pfa":"Toni B. Kline","psa":"J. M. Beaton","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2004644788","eid":"W2004644788"},{"id":"paper-w2466914798","cat":"papers","name":"In vitro fertilization in the older patient.","year":"2003","cit":12,"pfa":"Seth G. Derman","psa":"David B. Seifer","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2466914798","eid":"W2466914798"},{"id":"paper-w2387813913","cat":"papers","name":"[Effect of combined treatment of Shuanghuanglian and recombinant interferon alpha 2a on coxsackievirus B3 replication in vitro].","year":"2000","cit":12,"pfa":"Lu Ht","psa":"Yan Wh","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2387813913","eid":"W2387813913"},{"id":"paper-w1541107671","cat":"papers","name":"EEG Abnormalities Found in Healthy Women under Contraceptive Medication. I. Short Term Studies","year":"1972","cit":12,"pfa":"Marcos Velasco","psa":"Alfredo J. Gallegos","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1541107671","eid":"W1541107671"},{"id":"paper-w1979484932","cat":"papers","name":"Somatization, Anxiety and Depression in a Drug‐Free Residential Therapeutic Community","year":"2003","cit":12,"pfa":"Aaron S. Metrikin","psa":"Gregory C. Bunt","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W1979484932","eid":"W1979484932"},{"id":"paper-w2335200273","cat":"papers","name":"Change in Ibotenic Acid and Muscimol Contents in Amanita muscaria during Drying, Storing or Cooking","year":"1993","cit":12,"pfa":"Koujun Tsunoda","psa":"Tatsuyuki Sugahara","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2335200273","eid":"W2335200273"},{"id":"paper-w1982132205","cat":"papers","name":"Structure-activity relationships of the cycloalkyl ring of phencyclidine","year":"1981","cit":12,"pfa":"Roy L. McQuinn","psa":"Tsung‐Ping Su","ptype":"article","src":"https://openalex.org/W1982132205","eid":"W1982132205"},{"id":"paper-w1582342415","cat":"papers","name":"A pocket reference for psychiatrists","year":"1990","cit":12,"pfa":"Susan Jenkins","psa":"S. Szymanski","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"book","src":"https://openalex.org/W1582342415","eid":"W1582342415"},{"id":"paper-w2099793419","cat":"papers","name":"Partial generalization of (−)DOM to fluvoxamine in the rat: implications for SSRI-induced mania and psychosis","year":"1999","cit":12,"pfa":"Jerrold C. Winter","psa":"Richard A. Rabin","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2099793419","eid":"W2099793419"},{"id":"paper-w2072585167","cat":"papers","name":"Accelerator mass spectrometry for measuring low-dose carcinogen binding to DNA.","year":"1994","cit":12,"pfa":"J S Felton","psa":"Kenneth Wayne Turteltaub","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2072585167","eid":"W2072585167"},{"id":"paper-w1505478418","cat":"papers","name":"KETAMINE - REVES ET REALITES","year":"2002","cit":12,"pfa":"J. Arditti","psa":"Marc Valli","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1505478418","eid":"W1505478418"},{"id":"paper-w3195936982","cat":"papers","name":"N, N-dimethylglycine Protects Behavioral Disturbances and Synaptic Deficits Induced by Repeated Ketamine Exposure in Mice","year":"2021","cit":12,"pfa":"Chung-Pin Hsieh","psa":"Ming‐Huan Chan","ptype":"article","src":"https://openalex.org/W3195936982","eid":"W3195936982"},{"id":"paper-w4392294686","cat":"papers","name":"Substance use and its association with mental health among Swiss medical students: A cross-sectional study","year":"2024","cit":12,"pfa":"Jacques Gaume","psa":"Alexandre Berney","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4392294686","eid":"W4392294686"},{"id":"paper-w4213329095","cat":"papers","name":"Patterns and Correlates of Polysubstance Use Among Individuals With Severe Alcohol Use Disorder","year":"2022","cit":12,"pfa":"Mallory E. Stephenson","psa":"Alexis C. Edwards","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W4213329095","eid":"W4213329095"},{"id":"paper-w4412043431","cat":"papers","name":"Biased signaling via serotonin 5-HT2A receptor: From structural aspects to in vitro and in vivo pharmacology","year":"2025","cit":12,"pfa":"Michał K. Jastrzębski","psa":"Agnieszka Anna Kaczor","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4412043431","eid":"W4412043431"},{"id":"paper-w2039552292","cat":"papers","name":"Novel psychoactive substances (NPS): clinical and pharmacological issues","year":"2015","cit":12,"pfa":"Fabrizio Schifano","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2039552292","eid":"W2039552292"},{"id":"paper-w4210304474","cat":"papers","name":"Psychiatric Comorbidity and Psychopathology of Methamphetamine Users—Are There Gender Differences?","year":"2022","cit":12,"pfa":"Andreas Guenter Franke","psa":"Michael Soyka","topics":["PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4210304474","eid":"W4210304474"},{"id":"paper-w4323928476","cat":"papers","name":"Effects of drug and hazardous alcohol use on having a detectable HIV viral load: An adherence mediation analysis","year":"2023","cit":12,"pfa":"Edward R. Cachay","psa":"W. Christopher Mathews","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4323928476","eid":"W4323928476"},{"id":"paper-w4308079517","cat":"papers","name":"Systematic review of the efficacy, effectiveness, and cost-effectiveness of stepped-care interventions for the prevention and treatment of problematic substance use","year":"2022","cit":12,"pfa":"Ashleigh K Morse","psa":"Katherine L. Mills","topics":["Addiction","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4308079517","eid":"W4308079517"},{"id":"paper-w4226199437","cat":"papers","name":"Targeted effects of ketamine on perceptual expectation during mediated learning in rats","year":"2022","cit":12,"pfa":"Leah M. Fleming","psa":"Jane R. Taylor","ptype":"article","src":"https://openalex.org/W4226199437","eid":"W4226199437"},{"id":"paper-w4213122346","cat":"papers","name":"Schizophrenia-like endurable behavioral and neuroadaptive changes induced by ketamine administration involve Angiotensin II AT1 receptor","year":"2022","cit":12,"pfa":"Victoria Belén Occhieppo","psa":"Claudia Bregonzio","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4213122346","eid":"W4213122346"},{"id":"paper-w2032526377","cat":"papers","name":"The Use of Ketamine in Neuropathic Pain","year":"2014","cit":12,"pfa":"Sarah Lee O’Brien","psa":"Joshua P. Prager","ptype":"article","src":"https://openalex.org/W2032526377","eid":"W2032526377"},{"id":"paper-w2776187066","cat":"papers","name":"Antidepressant Response and Dissociative Effects After Ketamine Treatment","year":"2017","cit":12,"pfa":"Francesco Bartoli","psa":"Giuseppe Carrà","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2776187066","eid":"W2776187066"},{"id":"paper-w2096412145","cat":"papers","name":"The NMDA Receptor as a Site for Psychopathology","year":"1995","cit":12,"pfa":"Fritz A. Henn","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2096412145","eid":"W2096412145"},{"id":"paper-w2411405981","cat":"papers","name":"Opioid drugs and their receptors. A summary of the present state of knowledge.","year":"1984","cit":12,"pfa":"Johan Offermeier","psa":"Johannes Marthinus van Rooyen","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2411405981","eid":"W2411405981"},{"id":"paper-w1971883649","cat":"papers","name":"Ketamine induces hyperactivity in rats and hypersensitivity to nicotine in rat striatal slices","year":"2008","cit":12,"pfa":"KR Rodvelt","psa":"Dennis K. Miller","ptype":"article","src":"https://openalex.org/W1971883649","eid":"W1971883649"},{"id":"paper-w2064746513","cat":"papers","name":"Acute Phencyclidine Treatment Induces Extensive and Distinct Protein Phosphorylation in Rat Frontal Cortex","year":"2014","cit":12,"pfa":"Paweł Palmowski","psa":"Ole Nørregaard Jensen","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2064746513","eid":"W2064746513"},{"id":"paper-w2566358626","cat":"papers","name":"A Clickable Analogue of Ketamine Retains NMDA Receptor Activity, Psychoactivity, and Accumulates in Neurons","year":"2016","cit":12,"pfa":"Christine M. Emnett","psa":"Steven J. Mennerick","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2566358626","eid":"W2566358626"},{"id":"paper-w3172033446","cat":"papers","name":"Ketamine Modulates the Neural Correlates of Reward Processing in Unmedicated Patients in Remission From Depression.","year":"2022","cit":12,"pfa":"Vasileia Kotoula","psa":"Mitul A Mehta","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3172033446","eid":"W3172033446"},{"id":"paper-w2405192720","cat":"papers","name":"Structural neurotoxicologic investigation of the glycine antagonist 5-nitro-6,7-dichloroquinoxalinedione (ACEA-1021).","year":"1997","cit":12,"pfa":"Roland N. Auer","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2405192720","eid":"W2405192720"},{"id":"paper-w2621696090","cat":"papers","name":"GLYX-13, a NMDA Receptor Glycine-Site Functional Partial Agonist, Attenuates Cerebral Ischemia Injury In Vivo and Vitro by Differential Modulations of NMDA Receptors Subunit Components at Different Post-Ischemia Stage in","year":"2017","cit":12,"pfa":"Chen Zheng","psa":"Hui Shen","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2621696090","eid":"W2621696090"},{"id":"paper-w2280384830","cat":"papers","name":"From Mice to Men: Can Ketamine Enhance Resilience to Stress?","year":"2016","cit":12,"pfa":"Rebecca B. Price","ptype":"article","src":"https://openalex.org/W2280384830","eid":"W2280384830"},{"id":"paper-w4393349118","cat":"papers","name":"Single arketamine in treatment resistant depression: Presentation of 3 cases with regard to sick-leave duration","year":"2024","cit":12,"pfa":"Adam Włodarczyk","psa":"Wiesław Jerzy Cubała","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4393349118","eid":"W4393349118"},{"id":"paper-w4406947217","cat":"papers","name":"Is there a risk of esketamine misuse in clinical practice?","year":"2025","cit":12,"pfa":"Carlos Roncero","psa":"E. Alvarez","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4406947217","eid":"W4406947217"},{"id":"paper-w4313367642","cat":"papers","name":"(2R,6R)-hydroxynorketamine targeting the basolateral amygdala regulates fear memory","year":"2022","cit":12,"pfa":"Yuanyuan Xu","psa":"Dylan Chou","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4313367642","eid":"W4313367642"},{"id":"paper-w2979155524","cat":"papers","name":"Comment on a Word to the Wise About Intranasal Esketamine","year":"2019","cit":12,"pfa":"Wayne Curtis Drevets","psa":"Husseini K. Manji","ptype":"article","src":"https://openalex.org/W2979155524","eid":"W2979155524"},{"id":"paper-w4205302125","cat":"papers","name":"Pharmacology of ketamine and esketamine as rapid-acting antidepressants","year":"2021","cit":12,"pfa":"Pavlina Pavlidi","psa":"Christina Dalla","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4205302125","eid":"W4205302125"},{"id":"paper-w4389752927","cat":"papers","name":"Apoptotic mechanism of development inhibition in zebrafish induced by esketamine","year":"2023","cit":12,"pfa":"Wenjuan Yuan","psa":"Ju Gao","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4389752927","eid":"W4389752927"},{"id":"paper-w3184452078","cat":"papers","name":"Intranasal esketamine use in bipolar disorder: A case report","year":"2021","cit":12,"pfa":"Courtney Skriptshak","psa":"Ashley Reich","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3184452078","eid":"W3184452078"},{"id":"paper-w4320037142","cat":"papers","name":"Esketamine Anesthetizes Mice With a Similar Potency to Racemic Ketamine","year":"2023","cit":12,"pfa":"Xiaofan Ma","psa":"Hong Jiang","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4320037142","eid":"W4320037142"},{"id":"paper-w4392096037","cat":"papers","name":"A role of gut–brain axis on prophylactic actions of arketamine in male mice exposed to chronic restrain stress","year":"2024","cit":12,"pfa":"Li Ma","psa":"Kenji Hashimoto","ptype":"article","src":"https://openalex.org/W4392096037","eid":"W4392096037"},{"id":"paper-w4311678767","cat":"papers","name":"Rapidity of Symptom Improvement With Intranasal Esketamine for Major Depressive Disorder","year":"2022","cit":12,"pfa":"Rebecca S. Hock","psa":"George I. Papakostas","topics":["Depression","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4311678767","eid":"W4311678767"},{"id":"paper-w4386483615","cat":"papers","name":"The efficacy and safety of esketamine in pediatric anesthesia: A systematic review and meta-analysis","year":"2023","cit":12,"pfa":"Binsen Zhang","psa":"Chun-Ai Wang","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4386483615","eid":"W4386483615"},{"id":"paper-w4416193293","cat":"papers","name":"Intravenous ketamine versus esketamine for depression: a systematic review and meta-analysis","year":"2025","cit":12,"pfa":"Ahmed Elmosalamy","psa":"Balwinder Singh","topics":["Depression","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4416193293","eid":"W4416193293"},{"id":"paper-w4380488774","cat":"papers","name":"Hemodynamics and cutaneous microcirculation during induction of general anesthesia with and without esketamine","year":"2023","cit":12,"pfa":"Sarah Berger Veith","psa":"Torsten Richter","ptype":"article","src":"https://openalex.org/W4380488774","eid":"W4380488774"},{"id":"paper-w4295909089","cat":"papers","name":"Diversity inclusion in clinical trials investigating esketamine for depression: A systematic review.","year":"2022","cit":12,"pfa":"Katie Monahan","psa":"Emily Shepard","topics":["Depression","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4295909089","eid":"W4295909089"},{"id":"paper-w4313640506","cat":"papers","name":"Epidural esketamine and morphine for postoperative analgesia after caesarean delivery: A pilot study","year":"2023","cit":12,"pfa":"Ju Tang","psa":"Xiaoyong Tan","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4313640506","eid":"W4313640506"},{"id":"paper-w4400293249","cat":"papers","name":"A Systematic Review on Ketamine and Esketamine for Treatment-Resistant Depression and Suicidality in Adolescents: A New Hope?","year":"2024","cit":12,"pfa":"Simone Pardossi","psa":"Alessandro Cuomo","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4400293249","eid":"W4400293249"},{"id":"paper-w3126297008","cat":"papers","name":"Cost-per-remitter with esketamine nasal spray versus standard of care for treatment-resistant depression","year":"2021","cit":12,"pfa":"Urvi S. Desai","psa":"John J. Sheehan","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W3126297008","eid":"W3126297008"},{"id":"paper-w4392620444","cat":"papers","name":"Efficacy and safety of esketamine combined with propofol for curative endoscopic resection in colorectum: a prospective, randomized controlled trial","year":"2024","cit":12,"pfa":"Yimei Ma","psa":"Minmin Yao","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4392620444","eid":"W4392620444"},{"id":"paper-w3048289232","cat":"papers","name":"Self-reported review of the value of esketamine in patients with treatment-resistant depression: Understanding the patient experience in the STRIVE Study","year":"2020","cit":12,"pfa":"H. Lynn Starr","psa":"Michelle L. Kramer","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3048289232","eid":"W3048289232"},{"id":"paper-w4406593506","cat":"papers","name":"The efficacy and safety of patient-controlled intravenous analgesia with esketamine after total hip arthroplasty: a randomized controlled trial","year":"2025","cit":12,"pfa":"Song Qu","psa":"Wen-Jun Yan","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4406593506","eid":"W4406593506"},{"id":"paper-w4391842500","cat":"papers","name":"Effectiveness of perioperative low-dose esketamine infusion for postoperative pain management in pediatric urological surgery: a prospective clinical trial","year":"2024","cit":12,"pfa":"Yanle Xie","psa":"Jingjing Yuan","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4391842500","eid":"W4391842500"},{"id":"paper-w4413115615","cat":"papers","name":"Effect of a single low-dose esketamine administration during surgical abortion on postoperative sleep disturbance: a randomized controlled trial","year":"2025","cit":12,"pfa":"Zhenhua Song","psa":"Linlin Zhang","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4413115615","eid":"W4413115615"},{"id":"paper-w4385753850","cat":"papers","name":"Low-dose esketamine with sufentanil for postcesarean analgesia in women with gestational diabetes mellitus: a prospective, randomized, double-blind study","year":"2023","cit":12,"pfa":"Tao Han","psa":"Liang Chen","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4385753850","eid":"W4385753850"},{"id":"paper-w4391188916","cat":"papers","name":"Postoperative esketamine improves ventilation after video-assisted thoracoscopic lung resection: A double-blinded randomized controlled trial","year":"2024","cit":12,"pfa":"Mengyue Fu","psa":"Yuanjing Chen","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4391188916","eid":"W4391188916"},{"id":"paper-w4403894085","cat":"papers","name":"Efficacy and safety of esketamine combined with propofol for conscious sedation in painless colonoscopy: a prospective, randomized, double-blind controlled clinical trial","year":"2024","cit":12,"pfa":"Lizhu Xiao","psa":"Xiaohua Zou","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4403894085","eid":"W4403894085"},{"id":"paper-w4408947266","cat":"papers","name":"Effect and safety of perioperative ketamine/esketamine administration on postoperative pain and depression after breast cancer surgery: a systematic review and meta-analysis","year":"2025","cit":12,"pfa":"Xinyi Sun","psa":"Penghui Wei","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"review","src":"https://openalex.org/W4408947266","eid":"W4408947266"},{"id":"paper-w4327621717","cat":"papers","name":"Treatment patterns, healthcare utilization, and costs of patients with treatment-resistant depression initiated on esketamine intranasal spray and covered by US commercial health plans","year":"2023","cit":12,"pfa":"Kruti Joshi","psa":"Maryia Zhdanava","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4327621717","eid":"W4327621717"},{"id":"paper-w3122954494","cat":"papers","name":"At baseline patients treated with esketamine have higher burden of disease than other patients with treatment resistant depression: Learnings from a population based study","year":"2021","cit":12,"pfa":"M. Soledad Cepeda","psa":"Carla M. Canuso","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W3122954494","eid":"W3122954494"},{"id":"paper-w4384023679","cat":"papers","name":"Predicting efficacy of sub-anesthetic ketamine/esketamine i.v. dose during course of cesarean section for PPD prevention, utilizing traditional logistic regression and machine learning models","year":"2023","cit":12,"pfa":"Qiuwen Li","psa":"Saiying Wang","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4384023679","eid":"W4384023679"},{"id":"paper-w4392654219","cat":"papers","name":"Expert Consensus on the Clinical Utilization of Ketamine and Its Isomers in Intensive Care Units","year":"2024","cit":12,"pfa":"Zhiyong Peng","psa":"Haibo Zhang","topics":["Depression","Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4392654219","eid":"W4392654219"},{"id":"paper-w4392732022","cat":"papers","name":"Metabolomic biomarkers for (R, S)‐ketamine and (S)‐ketamine in treatment‐resistant depression and healthy controls: A systematic review","year":"2024","cit":12,"pfa":"Rakesh Kumar","psa":"Balwinder Singh","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4392732022","eid":"W4392732022"},{"id":"paper-w4412074124","cat":"papers","name":"Effects of ketamine on postoperative cognition: a scoping review","year":"2025","cit":12,"pfa":"Connor T. A. Brenna","psa":"Beverley Anne Orser","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4412074124","eid":"W4412074124"},{"id":"paper-w3095626073","cat":"papers","name":"Is ketamine a litmus test for capacity in assisted dying with depression?","year":"2020","cit":12,"pfa":"Joshua Daniel Rosenblat","psa":"Madeline Li","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W3095626073","eid":"W3095626073"},{"id":"paper-w4319444110","cat":"papers","name":"Profile of liver cholestatic biomarkers following prolonged ketamine administration in patients with COVID-19","year":"2023","cit":12,"pfa":"Julie Henrie","psa":"Philippe E. Hantson","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4319444110","eid":"W4319444110"},{"id":"paper-w4224213381","cat":"papers","name":"Ketamine for suicidality: An umbrella review","year":"2022","cit":12,"pfa":"Ahmad Shamabadi","psa":"Alireza Hasanzadeh","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4224213381","eid":"W4224213381"},{"id":"paper-w4392663314","cat":"papers","name":"Predicting non-response to ketamine for depression: An exploratory symptom-level analysis of real-world data among military veterans","year":"2024","cit":12,"pfa":"Eric A. Miller","psa":"Dhakshin Ramanathan","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4392663314","eid":"W4392663314"},{"id":"paper-w1942676701","cat":"papers","name":"EVIDENCE FOR THE ACTION OF d-LYSERGIC ACID DIETHYLAMIDE, MESCALINE AND BUFOTENINE ON 5-HYDROXYTRYPTAMINE RECEPTORS IN UMBILICAL VASCULATURE","year":"1974","cit":11,"pfa":"Donald C. Dyer","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1942676701","eid":"W1942676701"},{"id":"paper-w2399748014","cat":"papers","name":"[Distribution of lysergic acid diethylamide in the organism].","year":"1955","cit":11,"pfa":"U Lanz","psa":"E Rothlin","ptype":"article","src":"https://openalex.org/W2399748014","eid":"W2399748014"},{"id":"paper-w2052464066","cat":"papers","name":"Lysergic Acid Diethylamide (LSD-25) Antagonists","year":"1960","cit":11,"pfa":"Harold A. Abramson","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2052464066","eid":"W2052464066"},{"id":"paper-w2413113949","cat":"papers","name":"Differential diagnosis and treatment of lysergic acid diethylamide induced psychosis.","year":"1972","cit":11,"pfa":"Kenneth Dewhurst","psa":"Hatrick Ja","ptype":"article","src":"https://openalex.org/W2413113949","eid":"W2413113949"},{"id":"paper-w2409097048","cat":"papers","name":"LYSERGIC ACID DIETHYLAMIDE IN PSYCHOTHERAPY. PART I: CLINICAL ASPECTS","year":"1964","cit":11,"pfa":"L. Howard Whitaker","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2409097048","eid":"W2409097048"},{"id":"paper-w1976747940","cat":"papers","name":"Lysergic acid diethylamide antagonism by chlorpromazine, haloperidol, diazepam, and pentobarbital in the rabbit","year":"1977","cit":11,"pfa":"Paul F. Consroe","psa":"Parthena Martin","ptype":"article","src":"https://openalex.org/W1976747940","eid":"W1976747940"},{"id":"paper-w1968034994","cat":"papers","name":"Oxidation of lysergic acid diethylamide (LSD) by peroxidases: a new metabolic pathway","year":"2012","cit":11,"pfa":"Melissa M. Gomes","psa":"Ana Čampa","ptype":"article","src":"https://openalex.org/W1968034994","eid":"W1968034994"},{"id":"paper-w2005706591","cat":"papers","name":"The effect of Tremorine and lysergic acid diethylamide on the iron content of the rat brain","year":"1965","cit":11,"pfa":"S. Hadžovi","psa":"P. Štern","ptype":"article","src":"https://openalex.org/W2005706591","eid":"W2005706591"},{"id":"paper-w187808846","cat":"papers","name":"[Levels of psilocybin and psilocin in various types of mushrooms].","year":"2003","cit":11,"pfa":"Jan Stříbrný","psa":"M Sokol","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W187808846","eid":"W187808846"},{"id":"paper-w2316079645","cat":"papers","name":"Effects of Chlorpromazine and D-Lysergic Acid Diethylamide on Sex Behavior of Male Rats.","year":"1960","cit":11,"pfa":"E. Gillett","ptype":"article","src":"https://openalex.org/W2316079645","eid":"W2316079645"},{"id":"paper-w1970408128","cat":"papers","name":"Effects of lysergic acid diethylamide on the uptake and retention of brain 5-hydroxytryptamine in vivo and in vitro","year":"1973","cit":11,"pfa":"Michael G. Ziegler","psa":"Daniel X. Freedman","ptype":"article","src":"https://openalex.org/W1970408128","eid":"W1970408128"},{"id":"paper-w2078963776","cat":"papers","name":"The effect of D-Lysergic Acid Diethylamide (LSD) upon shock elicited fighting in rats","year":"1977","cit":11,"pfa":"Michael H. Sheard","psa":"Michael T. Davis","ptype":"article","src":"https://openalex.org/W2078963776","eid":"W2078963776"},{"id":"paper-w2081871093","cat":"papers","name":"Progesterone Enhancement of Lysergic Acid Diethylamide and Levo-5-Hydroxytryptophan Stimulation of the Copulatory Response in the Female Rat","year":"2008","cit":11,"pfa":"Anni Sietnieks","psa":"Bengt J. Meyerson","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2081871093","eid":"W2081871093"},{"id":"paper-w1853409021","cat":"papers","name":"Psilocin, psilocybin, serotonin and urea in Panaeolus cyanescens from various origin","year":"1992","cit":11,"pfa":"T. Stijve","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1853409021","eid":"W1853409021"},{"id":"paper-w2023495510","cat":"papers","name":"Comparison of the Effect of Intravenous Administration of d‐Lysergic Acid Diethylamide on Free and Membrane‐Bound Polysomes in the Rabbit Brain","year":"1981","cit":11,"pfa":"John J. Heikkila","psa":"Ian R. Brown","ptype":"article","src":"https://openalex.org/W2023495510","eid":"W2023495510"},{"id":"paper-w1974510877","cat":"papers","name":"Lysergic acid diethylamide (LSD-25) mimicks the effect of diffuse light input on EEG correlates of conditioned operant behavior in cats","year":"1972","cit":11,"pfa":"T.J. Marczynski","ptype":"article","src":"https://openalex.org/W1974510877","eid":"W1974510877"},{"id":"paper-w2059671852","cat":"papers","name":"Effects of mescaline and psilocin on acquisition, consolidation, and performance of light-dark discrimination in two inbred strains of mice","year":"1978","cit":11,"pfa":"Claudio Castellano","ptype":"article","src":"https://openalex.org/W2059671852","eid":"W2059671852"},{"id":"paper-w4243827813","cat":"papers","name":"Ibogaine","year":"1996","cit":11,"pfa":"Piotr Popik","psa":"S.D. Glick","ptype":"article","src":"https://openalex.org/W4243827813","eid":"W4243827813"},{"id":"paper-w2468697449","cat":"papers","name":"The effects of intraventricular injection of d-lysergic acid diethylamide (LSD 25) and 5-hydroxytryptamine (serotonin) on the electrical activity of the brain of the conscious cat.","year":"1956","cit":11,"pfa":"P B Bradley","psa":"A J Hance","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2468697449","eid":"W2468697449"},{"id":"paper-w3095141580","cat":"papers","name":"Kinetic profile of N,N‐dimethyltryptamine and β‐carbolines in saliva and serum after oral administration of ayahuasca in a religious context","year":"2020","cit":11,"pfa":"Rafael Lanaro","psa":"Alessandra Linardi","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3095141580","eid":"W3095141580"},{"id":"paper-w2014429426","cat":"papers","name":"The effects of d-lysergic acid diethylamide (LSD), 2,5-dimethoxy-4-methylamphetamine (DOM) and d-amphetamine on operant responding in control and 6-hydroxydopamine-treated rats","year":"1980","cit":11,"pfa":"Randall L. Commissaris","psa":"Richard H. Rech","ptype":"article","src":"https://openalex.org/W2014429426","eid":"W2014429426"},{"id":"paper-w1999491170","cat":"papers","name":"5-Hydroxytryptamine Antagonism by Lysergic Acid Diethylamide after Intracerebral Injection in Conscious Mice**Division of Pharmacology and Toxicology, Atomic Energy Project, School of Medicine, University of California a","year":"1957","cit":11,"pfa":"Thomas J. Haley","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1999491170","eid":"W1999491170"},{"id":"paper-w3120011307","cat":"papers","name":"PEYOTE CRISIS CONFRONTING MODERN INDIGENOUS PEOPLES: THE DECLINING PEYOTE POPULATION AND A DEMAND FOR CONSERVATION","year":"2020","cit":11,"pfa":"James D. Muneta","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3120011307","eid":"W3120011307"},{"id":"paper-w4214661730","cat":"papers","name":"Formal Total Synthesis of Salvinorin A","year":"2022","cit":11,"pfa":"Marc Halang","psa":"Martin Edmund Maier","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4214661730","eid":"W4214661730"},{"id":"paper-w2320497007","cat":"papers","name":"The Alkaloids of Tabernanthe iboga. Part VIII1","year":"1959","cit":11,"pfa":"M. Fred Bartlett","psa":"A. F. Smith","ptype":"article","src":"https://openalex.org/W2320497007","eid":"W2320497007"},{"id":"paper-w2072670605","cat":"papers","name":"Availability of Websites Offering to Sell Psilocybin Spores and Psilocybin","year":"2009","cit":11,"pfa":"Jason P. Lott","psa":"Robert F. Forman","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2072670605","eid":"W2072670605"},{"id":"paper-w4409938253","cat":"papers","name":"Ayahuasca as Liquid Divinity","year":"2023","cit":11,"pfa":"A.F.M. van der Braak","ptype":"book","src":"https://openalex.org/W4409938253","eid":"W4409938253"},{"id":"paper-w1976736060","cat":"papers","name":"Biosynthesis of phenolic tetrahydroisoquinoline alkaloids of peyote","year":"1970","cit":11,"pfa":"K.L. Khanna","psa":"Ara G. Paul","ptype":"article","src":"https://openalex.org/W1976736060","eid":"W1976736060"},{"id":"paper-w2055806208","cat":"papers","name":"Ibogaine pretreatment dramatically enhances the dynorphin response to cocaine","year":"1999","cit":11,"pfa":"Mario E. Alburges","psa":"Glen R. Hanson","ptype":"article","src":"https://openalex.org/W2055806208","eid":"W2055806208"},{"id":"paper-w3014150790","cat":"papers","name":"Ayahuasca: Between Cognition and Culture","year":"2020","cit":11,"pfa":"Ismael Eduardo Apud Peláez","ptype":"book","src":"https://openalex.org/W3014150790","eid":"W3014150790"},{"id":"paper-w2408845565","cat":"papers","name":"Teonanacatl und Psilocybin","year":"1959","cit":11,"pfa":"A Cerletti","ptype":"article","src":"https://openalex.org/W2408845565","eid":"W2408845565"},{"id":"paper-w1902265368","cat":"papers","name":"ELECTROENCEPHALOGRAPHIC CHANGES IN THE RAT WITH MESCALINE INTOXICATION","year":"1958","cit":11,"pfa":"Louise B. Speck","ptype":"article","src":"https://openalex.org/W1902265368","eid":"W1902265368"},{"id":"paper-w4253519664","cat":"papers","name":"The Touristic Use of Ayahuasca in Peru","year":"2020","cit":11,"pfa":"Tom John Wolff","ptype":"book","src":"https://openalex.org/W4253519664","eid":"W4253519664"},{"id":"paper-w2088881305","cat":"papers","name":"Failure of Ibogaine to Produce Phencyclidine-Like Discriminative Stimulus Effects in Rats and Monkeys","year":"1998","cit":11,"pfa":"Hendrée E. Jones","ptype":"article","src":"https://openalex.org/W2088881305","eid":"W2088881305"},{"id":"paper-w4381804317","cat":"papers","name":"Underlying pharmacological mechanisms of psilocin-induced broadband desynchronization and disconnection of EEG in rats","year":"2023","cit":11,"pfa":"Filip Tylš","psa":"Tomáš Pálení ček","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4381804317","eid":"W4381804317"},{"id":"paper-w2182403300","cat":"papers","name":"Indigenous Healing Practice: Ayahuasca. Opening a Discussion","year":"2014","cit":11,"pfa":"Robert Prue","psa":"Richard W. Voss","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2182403300","eid":"W2182403300"},{"id":"paper-w4393066485","cat":"papers","name":"Psychedelic Therapy: A Primer for Primary Care Clinicians—Ibogaine","year":"2024","cit":11,"pfa":"Kirsten N. Cherian","psa":"Owen S. Muir","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4393066485","eid":"W4393066485"},{"id":"paper-w1963536926","cat":"papers","name":"Ibogaine interferes with the establishment of amphetamine place preference learning.","year":"1997","cit":11,"pfa":"Isabella Moroz","psa":"Shepard Siegel","ptype":"article","src":"https://openalex.org/W1963536926","eid":"W1963536926"},{"id":"paper-w2163311384","cat":"papers","name":"Absence of psilocybin in species of fungi previously reported to contain psilocybin and related tryptamine derivatives","year":"1988","cit":11,"pfa":"T. Stijve","psa":"Th.W. Kuyper","ptype":"article","src":"https://openalex.org/W2163311384","eid":"W2163311384"},{"id":"paper-w4294740878","cat":"papers","name":"Ayahuasca-induced psychosis: A case report","year":"2022","cit":11,"pfa":"Harvey Ricardo Cerón Tapia","psa":"Sergio Andrés Córdoba Ortiz","ptype":"article","src":"https://openalex.org/W4294740878","eid":"W4294740878"},{"id":"paper-w2324509935","cat":"papers","name":"Studies toward the Development of Antiproliferative Neoclerodanes from Salvinorin A","year":"2014","cit":11,"pfa":"Tamara Vasiljevik","psa":"Thomas Edward Prisinzano","topics":["Addiction","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2324509935","eid":"W2324509935"},{"id":"paper-w2122510557","cat":"papers","name":"14C-Psilocin tissue distribution in pregnant rats after intravenous administration","year":"2014","cit":11,"pfa":"F. C. P. Law","psa":"Shao-Xiong He","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2122510557","eid":"W2122510557"},{"id":"paper-w2149504869","cat":"papers","name":"MDMA (ecstasy) in the emergency department","year":"2003","cit":11,"pfa":"Kathy Emde","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2149504869","eid":"W2149504869"},{"id":"paper-w4401224807","cat":"papers","name":"Psilocybin in pharmacotherapy of obsessive-compulsive disorder","year":"2024","cit":11,"pfa":"Maja Owe-Larsson","psa":"Agnieszka Cudnoch‐Jędrzejewska","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4401224807","eid":"W4401224807"},{"id":"paper-w4390608460","cat":"papers","name":"5-HT2A Receptor Knockout Mice Show Sex-Dependent Differences following Acute Noribogaine Administration","year":"2024","cit":11,"pfa":"Sofía Villalba","psa":"Verónica Bisagno","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4390608460","eid":"W4390608460"},{"id":"paper-w47763549","cat":"papers","name":"Therapeutic Applications of Ayahuasca and Other Sacred Medicines","year":"2013","cit":11,"pfa":"Michael Winkelman","ptype":"book-chapter","src":"https://openalex.org/W47763549","eid":"W47763549"},{"id":"paper-w2318376292","cat":"papers","name":"Mescaline and LSD‐25 in Activation of Temporal Lobe Epilepsy","year":"1956","cit":11,"pfa":"Bert E. Schwarz","psa":"Howard P Rome","ptype":"article","src":"https://openalex.org/W2318376292","eid":"W2318376292"},{"id":"paper-w4404119543","cat":"papers","name":"Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelics","year":"2024","cit":11,"pfa":"Cristiano Chaves","psa":"Jaime E. C. Hallak","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4404119543","eid":"W4404119543"},{"id":"paper-w2089582528","cat":"papers","name":"Pharmacological and behavioral components of tolerance to LSD and mescaline in rats","year":"1977","cit":11,"pfa":"Thomas F. Murray","psa":"Guenther Fischer","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2089582528","eid":"W2089582528"},{"id":"paper-w4387866078","cat":"papers","name":"Assessing potential of psilocybin for depressive disorders","year":"2023","cit":11,"pfa":"Zofia Kozak","psa":"Scott T. Aaronson","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4387866078","eid":"W4387866078"},{"id":"paper-w2036475082","cat":"papers","name":"MDMA (Ecstasy) use and psychiatric problems","year":"2006","cit":11,"pfa":"Casey R. Guillot","psa":"Mitchell E. Berman","ptype":"article","src":"https://openalex.org/W2036475082","eid":"W2036475082"},{"id":"paper-w2034398514","cat":"papers","name":"Comparison of the Hallucinogenic Indole Alkaloids Ibogaine and Harmaline for Potential Immunomodulatory Activity","year":"2008","cit":11,"pfa":"Robert V. House","psa":"Hemendra N. Bhargava","topics":["Safety & adverse events","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2034398514","eid":"W2034398514"},{"id":"paper-w2167706562","cat":"papers","name":"Optimization of separation and online sample concentration of N,N‐dimethyltryptamine and related compounds using MEKC","year":"2009","cit":11,"pfa":"M Wang","psa":"Cheng‐Huang Lin","ptype":"article","src":"https://openalex.org/W2167706562","eid":"W2167706562"},{"id":"paper-w2074249277","cat":"papers","name":"Notes - Mescaline Analogs. IX. Tetra- and Pentamethyl-β-phenethylamines","year":"1958","cit":11,"pfa":"Frederick Benington","psa":"Leland C. Clark","ptype":"article","src":"https://openalex.org/W2074249277","eid":"W2074249277"},{"id":"paper-w1974974524","cat":"papers","name":"Identification of 3,4,5-Trimethoxyphenylacetic Acid as the Major Metabolite of Mescaline in the Dog","year":"1961","cit":11,"pfa":"Elliot Spector","ptype":"article","src":"https://openalex.org/W1974974524","eid":"W1974974524"},{"id":"paper-w1976576985","cat":"papers","name":"The effects of psilocybin on a test of after-image perception","year":"1965","cit":11,"pfa":"MARTIN H. KEELER","ptype":"article","src":"https://openalex.org/W1976576985","eid":"W1976576985"},{"id":"paper-w2047529423","cat":"papers","name":"Psilocybin-induced Autonomic, Perceptual, and Behavioral Change","year":"1968","cit":11,"pfa":"Rainer Fischer","psa":"Diana Warshay","ptype":"article","src":"https://openalex.org/W2047529423","eid":"W2047529423"},{"id":"paper-w2967267835","cat":"papers","name":"The fumarate salts of the N-isopropyl-N-methyl derivatives of DMT and psilocin","year":"2019","cit":11,"pfa":"A.R. Chadeayne","psa":"David R. Manke","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2967267835","eid":"W2967267835"},{"id":"paper-w4302611510","cat":"papers","name":"Schedules of controlled substances: placement of 5-methoxy-N,N-dimethyltryptamine into Schedule I of the Controlled Substances Act. Final rule.","year":"2010","cit":11,"topics":["Addiction","Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4302611510","eid":"W4302611510"},{"id":"paper-w4220914774","cat":"papers","name":"Adverse Effects After Ayahuasca Administration in the Clinical Setting","year":"2022","cit":11,"pfa":"Juliana Mendes Rocha","psa":"Rafael Guimarães dos Santos","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4220914774","eid":"W4220914774"},{"id":"paper-w2330926476","cat":"papers","name":"The Deer-Maize-Peyote Symbol Complex among the Huichol Indians of Mexico","year":"1970","cit":11,"pfa":"Barbara G. Myerhoff","ptype":"article","src":"https://openalex.org/W2330926476","eid":"W2330926476"},{"id":"paper-w146555818","cat":"papers","name":"'Ecstasy'(MDMA)-induced pneumomediastinum and epidural pneumatosis.","year":"2005","cit":11,"pfa":"Hakan Mutlu","psa":"Eşref Kızılkaya","ptype":"article","src":"https://openalex.org/W146555818","eid":"W146555818"},{"id":"paper-w4387473380","cat":"papers","name":"Therapeutic Potential of Psilocybin for Treating Psychological Distress among Survivors of Adverse Childhood Experiences: Evidence on Acceptability and Potential Efficacy of Psilocybin Use","year":"2023","cit":11,"pfa":"Kiffer George Card","psa":"Zach Walsh","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4387473380","eid":"W4387473380"},{"id":"paper-w4395012640","cat":"papers","name":"Neurochemical and Neurophysiological Effects of Intravenous Administration of N,N -Dimethyltryptamine in Rats","year":"2024","cit":11,"pfa":"Nicolas G. Glynos","psa":"Dinesh Pal","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4395012640","eid":"W4395012640"},{"id":"paper-w1598185160","cat":"papers","name":"Chapter 3 Ibogaine as a glutamate antagonist: Relevance to its putative antiaddictive properties","year":"2001","cit":11,"pfa":"Phil Skolnick","topics":["Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W1598185160","eid":"W1598185160"},{"id":"paper-w2089982466","cat":"papers","name":"11C-radiolabeling of hallucinogenic psilocin, a potential radioligand for studying the role of serotonin receptors in psychotic symptom formation","year":"1998","cit":11,"pfa":"Simon Mensah Ametamey","psa":"Pius August Schubiger","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2089982466","eid":"W2089982466"},{"id":"paper-w2896993324","cat":"papers","name":"Hallucinogen Persisting Perception Disorder After Ibogaine Treatment for Opioid Dependence","year":"2018","cit":11,"pfa":"Thomas Knuijver","psa":"Arnt Schellekens","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2896993324","eid":"W2896993324"},{"id":"paper-w2773663265","cat":"papers","name":"Influence of Environmental Factors and Cultural Methods on the Content of N,N‑Dimethyltryptamine in Psychotria viridis (Rubiaceae)","year":"2017","cit":11,"pfa":"André D. Cavalcante","psa":"Sidney Augusto Vieira Filho","ptype":"article","src":"https://openalex.org/W2773663265","eid":"W2773663265"},{"id":"paper-w2558291661","cat":"papers","name":"The role of psychedelics in palliative care reconsidered: A case for psilocybin","year":"2016","cit":11,"pfa":"Benjamin Kelmendi","psa":"John Harrison Krystal","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2558291661","eid":"W2558291661"},{"id":"paper-w2559919438","cat":"papers","name":"One hundred days of Ayahuasca in France: The story of a legal decision","year":"2011","cit":11,"pfa":"Ghislaine Bourgogne","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2559919438","eid":"W2559919438"},{"id":"paper-w3160029097","cat":"papers","name":"Decreased brain modularity after psilocybin therapy for depression.","year":"2021","cit":11,"pfa":"Richard E. Daws","psa":"Robin Lester Carhart-Harris","topics":["Depression"],"ptype":"preprint","src":"https://openalex.org/W3160029097","eid":"W3160029097"},{"id":"paper-w4391234203","cat":"papers","name":"Psilocybin and eugenol prevent DSS-induced neuroinflammation in mice","year":"2024","cit":11,"pfa":"Timur Zanikov","psa":"Igor Kovalchuk","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4391234203","eid":"W4391234203"},{"id":"paper-w4393009407","cat":"papers","name":"Childhood trauma, challenging experiences, and posttraumatic growth in ayahuasca use","year":"2024","cit":11,"pfa":"Ksenia Cassidy","psa":"Wendy M. D'Andrea","topics":["PTSD & trauma","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4393009407","eid":"W4393009407"},{"id":"paper-w4292651768","cat":"papers","name":"Application of Deuterated N,N-Dimethyltryptamine in the Potential Treatment of Psychiatric and Neurological Disorders","year":"2022","cit":11,"pfa":"Robert B. Kargbo","topics":["Mechanism & neuroscience"],"ptype":"editorial","src":"https://openalex.org/W4292651768","eid":"W4292651768"},{"id":"paper-w2908858460","cat":"papers","name":"Metabolite Profiling of Anti‐Addictive Alkaloids from Four Mexican Tabernaemontana Species and the Entheogenic African Shrub Tabernanthe iboga (Apocynaceae)","year":"2019","cit":11,"pfa":"Felix Krengel","psa":"Ricardo Reyes‐Chilpa","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2908858460","eid":"W2908858460"},{"id":"paper-w3162780709","cat":"papers","name":"Return to Wirikuta: Ritual Reversal and Symbolic Continuity in the Huichol Peyote Hunt","year":"2019","cit":11,"pfa":"Barbara G. Myerhoff","ptype":"conference-paper","src":"https://openalex.org/W3162780709","eid":"W3162780709"},{"id":"paper-w1970108663","cat":"papers","name":"GLC-mass Spectral Determination of Mescaline in Plasma of Rabbits after Intravenous Injection","year":"1980","cit":11,"pfa":"Carlos Van Peteghem","psa":"W. Van Zele","ptype":"article","src":"https://openalex.org/W1970108663","eid":"W1970108663"},{"id":"paper-w1976777236","cat":"papers","name":"Synthesis and biological evaluation of new salvinorin A analogues incorporating natural amino acids","year":"2010","cit":11,"pfa":"Jakub Fichna","psa":"Jordan Kordian Zjawiony","ptype":"article","src":"https://openalex.org/W1976777236","eid":"W1976777236"},{"id":"paper-w2327770717","cat":"papers","name":"Synthesis and Biological Evaluation of New Salvinorin B-Sulfonate Ester Ligands to Opioid Receptors","year":"2013","cit":11,"pfa":"Prabhakar Reddy Polepally","psa":"JK Zjawiony","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2327770717","eid":"W2327770717"},{"id":"paper-w1993434628","cat":"papers","name":"Benzo[b]thiophene derivatives. XXI. On the proof of structure of the sulfur isostere of psilocin","year":"1973","cit":11,"pfa":"Ernest E. Campaigne","psa":"R. B. Rogers","ptype":"article","src":"https://openalex.org/W1993434628","eid":"W1993434628"},{"id":"paper-w4383186284","cat":"papers","name":"A Review of MDMA-Assisted Therapy for Posttraumatic Stress Disorder","year":"2023","cit":11,"pfa":"Benjamin R. Lewis","psa":"Kevin Byrne","topics":["PTSD & trauma","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4383186284","eid":"W4383186284"},{"id":"paper-w2949962853","cat":"papers","name":"Synthesis of iboga alkaloids by Pd-catalyzed heteroannulation of 2-iodoaniline with an internal alkyne as the key step","year":"2010","cit":11,"pfa":"Goutam Kumar Jana","psa":"Surajit Sinha","ptype":"article","src":"https://openalex.org/W2949962853","eid":"W2949962853"},{"id":"paper-w3197650165","cat":"papers","name":"On Revelations and Revolutions: Drinking Ayahuasca Among Palestinians Under Israeli Occupation","year":"2021","cit":11,"pfa":"Leor Roseman","psa":"Nadeem Karkabi","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3197650165","eid":"W3197650165"},{"id":"paper-w3149950773","cat":"papers","name":"Can MDMA Change Sociopolitical Values? Insights From a Research Participant","year":"2021","cit":11,"pfa":"Harriet de Wit","psa":"Michael P. Bremmer","ptype":"article","src":"https://openalex.org/W3149950773","eid":"W3149950773"},{"id":"paper-w4290756542","cat":"papers","name":"Experiences With Sacred Mushrooms and Psilocybin In Dialogue: Transdisciplinary Interpretations Of The “Velada”","year":"2022","cit":11,"pfa":"Antonella Fagetti","psa":"Roberto E. Mercadillo","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4290756542","eid":"W4290756542"},{"id":"paper-w3157182702","cat":"papers","name":"Challenges in translational research: MDMA in the laboratory versus therapeutic settings","year":"2021","cit":11,"pfa":"Harriet de Wit","psa":"Charles S. Grob","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3157182702","eid":"W3157182702"},{"id":"paper-w2073943398","cat":"papers","name":"The Supreme Court versus Peyote: Consciousness Alteration, Cultural Psychiatry and the Dilemma of Contemporary Subcultures","year":"2001","cit":11,"pfa":"Joseph D. Calabrese","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2073943398","eid":"W2073943398"},{"id":"paper-w2892036960","cat":"papers","name":"Comparison of the effects of abstinence on MDMA and cocaine self-administration in rats","year":"2018","cit":11,"pfa":"Quenten Highgate","psa":"Susan Schenk","ptype":"article","src":"https://openalex.org/W2892036960","eid":"W2892036960"},{"id":"paper-w4388686851","cat":"papers","name":"Expectancy Effects Cannot Be Neglected in MDMA-Assisted Therapy Research","year":"2023","cit":11,"pfa":"L. Jacob Flameling","psa":"Michiel van Elk","ptype":"editorial","src":"https://openalex.org/W4388686851","eid":"W4388686851"},{"id":"paper-w4406203901","cat":"papers","name":"Pharmacokinetics and pharmacodynamics of an innovative psychedelic N,N-dimethyltryptamine/harmine formulation in healthy participants: a randomized controlled trial","year":"2024","cit":11,"pfa":"Michael J Mueller","psa":"Milan Scheidegger","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4406203901","eid":"W4406203901"},{"id":"paper-w4406664906","cat":"papers","name":"Clinical Pharmacokinetics of N,N-Dimethyltryptamine (DMT): A Systematic Review and Post-hoc Analysis","year":"2025","cit":11,"pfa":"Katelijne V. van der Heijden","psa":"G. Jacobs","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4406664906","eid":"W4406664906"},{"id":"paper-w4409704666","cat":"papers","name":"Incremental efficacy systematic review and meta-analysis of psilocybin-for-depression RCTs","year":"2025","cit":11,"pfa":"Nicholas C. Borgogna","psa":"Benjamin David Hill","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W4409704666","eid":"W4409704666"},{"id":"paper-w4407980640","cat":"papers","name":"Acute psilocybin and ketanserin effects on cerebral blood flow: 5-HT2AR neuromodulation in healthy humans","year":"2025","cit":11,"pfa":"Kristian Larsen","psa":"Patrick M. Fisher","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4407980640","eid":"W4407980640"},{"id":"paper-w2042814913","cat":"papers","name":"Simple Preparative Isolation of Salvinorin A from the Hallucinogenic Sage, Salvia divinorum, by Centrifugal Partition Chromatography","year":"2007","cit":11,"pfa":"Osamu Shirota","psa":"Setsuko Sekita","ptype":"article","src":"https://openalex.org/W2042814913","eid":"W2042814913"},{"id":"paper-w4404460385","cat":"papers","name":"Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression in Bipolar II Disorder","year":"2024","cit":11,"pfa":"Shakila Meshkat","psa":"Joshua Daniel Rosenblat","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4404460385","eid":"W4404460385"},{"id":"paper-w4410910940","cat":"papers","name":"Neurocognitive effects of psilocybin: A systematic and comprehensive review of neuroimaging studies in humans","year":"2025","cit":11,"pfa":"Lucie Berkovitch","psa":"Raphaël Gaillard","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4410910940","eid":"W4410910940"},{"id":"paper-w1982203694","cat":"papers","name":"Measurement of handwriting area to pressure ratios during psilocybin-induced hallucinations","year":"1969","cit":11,"pfa":"Roland Fischer","psa":"Karen Thatcher","ptype":"article","src":"https://openalex.org/W1982203694","eid":"W1982203694"},{"id":"paper-w4410755082","cat":"papers","name":"Psilocybin-enhanced fear extinction linked to bidirectional modulation of cortical ensembles","year":"2025","cit":11,"pfa":"Sophie A. Rogers","psa":"Gregory F. Corder","ptype":"article","src":"https://openalex.org/W4410755082","eid":"W4410755082"},{"id":"paper-w2019125209","cat":"papers","name":"The effects of Psilocybin, dextro-amphetamine and placebo on performance of the trail making test","year":"1968","cit":11,"pfa":"Robert B. Duke","psa":"MARTIN H. KEELER","ptype":"article","src":"https://openalex.org/W2019125209","eid":"W2019125209"},{"id":"paper-w2595364446","cat":"papers","name":"Comparative study on MDMA method with OFSTF method in Transportation Problem","year":"2016","cit":11,"pfa":"A. Amaravathy","psa":"S. Vimala","ptype":"article","src":"https://openalex.org/W2595364446","eid":"W2595364446"},{"id":"paper-w2161919690","cat":"papers","name":"LACK OF ENHANCEMENT OF DIMETHYLTRYPTAMINE FORMATION IN RAT BRAIN AND RABBIT LUNG IN VIVO BY METHIONINE OR S‐ADENOSYLMETHIONINE","year":"1978","cit":11,"pfa":"Giorgio Stramentinoli","psa":"Ross J. Baldessarini","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2161919690","eid":"W2161919690"},{"id":"paper-w2061443619","cat":"papers","name":"Plasticity of the acoustic startle reflex in currently abstinent ecstasy (MDMA) users","year":"2004","cit":11,"pfa":"Karsten Heekeren","psa":"Euphrosyne Gouzoulis‐Mayfrank","ptype":"article","src":"https://openalex.org/W2061443619","eid":"W2061443619"},{"id":"paper-w1989902419","cat":"papers","name":"Altered pain responses in abstinent (±)3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) users","year":"2011","cit":11,"pfa":"Una D. McCann","psa":"George A. Ricaurte","ptype":"article","src":"https://openalex.org/W1989902419","eid":"W1989902419"},{"id":"paper-w4380882289","cat":"papers","name":"Prevalence and Correlates of Past Year Ecstasy/MDMA Use in the United States","year":"2023","cit":11,"pfa":"Kevin H. Yang","psa":"Joseph J. Palamar","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4380882289","eid":"W4380882289"},{"id":"paper-w2187560292","cat":"papers","name":"Ibogaine Effect on Cocaine Craving and Use in Dependent Patients - A Double- Blind, Placebo-Controlled Pilot Study","year":"2014","cit":11,"pfa":"Pedro Luis Prior","psa":"R. Armando","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2187560292","eid":"W2187560292"},{"id":"paper-w2432259727","cat":"papers","name":"Xylamidine tosylate: differential antagonism of the hypothermic effects of N,N-dimethyltryptamine, bufotenine, and 5-methoxytryptamine.","year":"1972","cit":11,"pfa":"Winter Jc","ptype":"article","src":"https://openalex.org/W2432259727","eid":"W2432259727"},{"id":"paper-w4409687565","cat":"papers","name":"Evaluating the effectiveness of psilocybin in alleviating distress among cancer patients: A systematic review","year":"2025","cit":11,"pfa":"Maria I. Lapid","psa":"Stacy D. D’Andre","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W4409687565","eid":"W4409687565"},{"id":"paper-w4297236751","cat":"papers","name":"Experiences of Listening to Icaros during Ayahuasca Ceremonies at Centro Takiwasi:An Interpretive Phenomenological Analysis","year":"2022","cit":11,"pfa":"Owain J. Graham","psa":"Matteo Politi","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4297236751","eid":"W4297236751"},{"id":"paper-w1975810107","cat":"papers","name":"MDMA (Ecstasy) Decreases the Number of Neurons and Stem Cells in Embryonic Cortical Cultures","year":"2009","cit":11,"pfa":"Anna M. S. Kindlundh-Högberg","psa":"Åsa Fex Svenningsen","ptype":"article","src":"https://openalex.org/W1975810107","eid":"W1975810107"},{"id":"paper-w2154818605","cat":"papers","name":"Inhibition of phrenic and sympathetic vasomotor neurons in cats by the serotonin analog 5-methoxy-N,N-dimethyltryptamine.","year":"1982","cit":11,"pfa":"Peter M. Lalley","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2154818605","eid":"W2154818605"},{"id":"paper-w2789822169","cat":"papers","name":"Salvinorin A ameliorates cerebral vasospasm through activation of endothelial nitric oxide synthase in a rat model of subarachnoid hemorrhage","year":"2018","cit":11,"pfa":"Juan Sun","psa":"Chunhua Chen","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2789822169","eid":"W2789822169"},{"id":"paper-w2473492351","cat":"papers","name":"Les aspects actuels de l’usage de l’ecstasy/MDMA en France","year":"2016","cit":11,"pfa":"Michel Spadari","psa":"Danièle Debruyne","ptype":"article","src":"https://openalex.org/W2473492351","eid":"W2473492351"},{"id":"paper-w2801875114","cat":"papers","name":"A planta redescoberta: um relato do encontro da ayahuasca com o povo Yudjá","year":"2018","cit":11,"pfa":"Tânia Stolze Lima","ptype":"article","src":"https://openalex.org/W2801875114","eid":"W2801875114"},{"id":"paper-w4366421959","cat":"papers","name":"US could soon approve MDMA therapy — opening an era of psychedelic medicine","year":"2023","cit":11,"pfa":"Sara Reardon","ptype":"article","src":"https://openalex.org/W4366421959","eid":"W4366421959"},{"id":"paper-w4392249465","cat":"papers","name":"Participation in an indigenous Amazonian-led ayahuasca retreat associated with increases in nature relatedness – a pilot study","year":"2024","cit":11,"pfa":"Simon Ruffell","psa":"Jerome J. Sarris","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4392249465","eid":"W4392249465"},{"id":"paper-w2045098693","cat":"papers","name":"Individual Differences in Acute Responses to MDMA in Humans: Effects of Sex and Past Ecstasy Use","year":"2011","cit":11,"pfa":"Gillinder Bedi","ptype":"article","src":"https://openalex.org/W2045098693","eid":"W2045098693"},{"id":"paper-w4391314181","cat":"papers","name":"The Impact of Psilocybin on High Glucose/Lipid-Induced Changes in INS-1 Cell Viability and Dedifferentiation","year":"2024","cit":11,"pfa":"Esmaeel Ghasemi Gojani","psa":"Igor Kovalchuk","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4391314181","eid":"W4391314181"},{"id":"paper-w4220986707","cat":"papers","name":"Effects of repeated ayahuasca administration on behaviour and c-Fos expression in male rats exposed to the open field","year":"2022","cit":11,"pfa":"Dimitri Daldegan‐Bueno","psa":"Maria Gabriela Menezes Oliveira","ptype":"article","src":"https://openalex.org/W4220986707","eid":"W4220986707"},{"id":"paper-w2041889432","cat":"papers","name":"Characterisation of a proposed internet synthesis of N,N-dimethyltryptamine using liquid chromatography/electrospray ionisation tandem mass spectrometry","year":"2009","cit":11,"pfa":"Cláudia P.B. Martins","psa":"Simon D. Brandt","ptype":"article","src":"https://openalex.org/W2041889432","eid":"W2041889432"},{"id":"paper-w4402516078","cat":"papers","name":"Personal Psychedelic Experience as a Training Qualification for Facilitators: A Thematic Analysis of Qualitative Interviews with Psilocybin Experts","year":"2024","cit":11,"pfa":"Adrianne R. Wilson‐Poe","psa":"Philip Todd Korthuis","topics":["Safety & adverse events","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4402516078","eid":"W4402516078"},{"id":"paper-w3201564161","cat":"papers","name":"A methanol extract and N,N-dimethyltryptamine from Psychotria viridis Ruiz & Pav. inhibit Zika virus infection in vitro","year":"2021","cit":11,"pfa":"Thaís de Fátima Silva Moraes","psa":"José Carlos de Magalhães","ptype":"article","src":"https://openalex.org/W3201564161","eid":"W3201564161"},{"id":"paper-w1970865228","cat":"papers","name":"Repeated administration of 5-methoxy-N,N-dimethyltryptamine to male rats potentiates stimulation of prolactine secretino by serotonin agonists","year":"1979","cit":11,"pfa":"Miljana Simonovic","psa":"Herbert Y. Meltzer","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1970865228","eid":"W1970865228"},{"id":"paper-w2083259880","cat":"papers","name":"Acute MDMA administration alters the distribution and circadian rhythm of wheel running activity in the rat","year":"2010","cit":11,"pfa":"Rowan P. Ogeil","psa":"Jillian Helen Broadbear","ptype":"article","src":"https://openalex.org/W2083259880","eid":"W2083259880"},{"id":"paper-w2033604596","cat":"papers","name":"Intrathecal substance P modulates the depressant effect of 5-methoxy-N,N-dimethyltryptamine on a reflex response to radiant heat in mice","year":"1988","cit":11,"pfa":"Per Kristian Eide","psa":"Kjell Hole","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W2033604596","eid":"W2033604596"},{"id":"paper-w2102609290","cat":"papers","name":"Identifying the serotonin transporter signal in Western blot studies of the neurotoxic potential of MDMA and related drugs","year":"2011","cit":11,"pfa":"Michael W. McLane","psa":"George A. Ricaurte","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2102609290","eid":"W2102609290"},{"id":"paper-w3035616021","cat":"papers","name":"N‐Methyl‐3,4‐methylendioxymethamphetamine (MDMA)‐related coagulopathy and rhabdomyolysis: A case series and literature review","year":"2020","cit":11,"pfa":"Andrew J. Doyle","psa":"Beverley Jane Hunt","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3035616021","eid":"W3035616021"},{"id":"paper-w2143739135","cat":"papers","name":"Effects of acute, subchronic and intermittent MDMA (‘ECSTASY’) administration on agonistic interactions between male mice","year":"2004","cit":11,"pfa":"José Francisco Navarro","psa":"E. Maldonado","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2143739135","eid":"W2143739135"},{"id":"paper-w4307553648","cat":"papers","name":"Study protocol for “MDMA-assisted therapy as a treatment for major depressive disorder: A proof of principle study”","year":"2022","cit":11,"pfa":"Tor-Morten Kvam","psa":"Ole A. Andreassen","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4307553648","eid":"W4307553648"},{"id":"paper-w2044970634","cat":"papers","name":"Effects of repeated exposure to MDMA on 5HT1a autoreceptor function: behavioral and neurochemical responses to 8-OHDPAT","year":"2013","cit":11,"pfa":"Susan Schenk","psa":"Jennifer Do","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2044970634","eid":"W2044970634"},{"id":"paper-w3095530399","cat":"papers","name":"PM506. Psilocybin Clinical Trial: Acute Effects and its relationship to the brain activity as measured by quantitative EEG","year":"2016","cit":11,"pfa":"Filip Tylš","psa":"Jiřı́ Horáček","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W3095530399","eid":"W3095530399"},{"id":"paper-w2283949253","cat":"papers","name":"Sleep, energy and self rated cognition across 7 nights following recreational ecstasy/MDMA use","year":"2008","cit":11,"pfa":"Andrew Parrott","ptype":"article","src":"https://openalex.org/W2283949253","eid":"W2283949253"},{"id":"paper-w2024379725","cat":"papers","name":"N‐Cyanomethyl‐N‐Methyl‐1‐(3′,4′‐methylenedioxyphenyl)‐2‐propylamine: An MDMA Manufacturing By‐Product","year":"2008","cit":11,"pfa":"Helen Salouros","psa":"Adrian V. George","ptype":"article","src":"https://openalex.org/W2024379725","eid":"W2024379725"},{"id":"paper-w2008318842","cat":"papers","name":"Neuroendocrine and subjective responses to pharmacological challenge with citalopram: a controlled study in male and female ecstasy/MDMA users","year":"2008","cit":11,"pfa":"Kelly Allott","psa":"Jennifer R. Redman","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2008318842","eid":"W2008318842"},{"id":"paper-w2015127287","cat":"papers","name":"Stable carbonium ions from .beta.-arylalkyl derivatives in antimony pentafluoride-sulfur dioxide (SbP5.SO2). II. Ions related to mescaline","year":"1974","cit":11,"pfa":"James A. Manner","psa":"Brian G. Ramsey","ptype":"article","src":"https://openalex.org/W2015127287","eid":"W2015127287"},{"id":"paper-w2252581538","cat":"papers","name":"O uso de extase(MDMA) na cidade de São Paulo e imediacoes: estudo etnografico","year":"2002","cit":11,"pfa":"Murilo Campos Baptista","ptype":"article","src":"https://openalex.org/W2252581538","eid":"W2252581538"},{"id":"paper-w1968869404","cat":"papers","name":"Brain serotonin synthesis in MDMA (ecstasy) polydrug users: an alpha‐[ 11 C]methyl‐ l ‐tryptophan study","year":"2014","cit":11,"pfa":"Linda Booij","psa":"Chawki Benkelfat","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1968869404","eid":"W1968869404"},{"id":"paper-w4322505390","cat":"papers","name":"National Institutes of Health psilocybin research speaker series: State of the science, regulatory and policy landscape, research gaps, and opportunities","year":"2023","cit":11,"pfa":"Dan Xi","psa":"Sean J. Belouin","topics":["Addiction","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4322505390","eid":"W4322505390"},{"id":"paper-w1540420078","cat":"papers","name":"Development of a high‐speed MALDI‐triple quadrupole mass spectrometric method for the determination of 3,4‐methylenedioxymethamphetamine (MDMA) in oral fluid","year":"2015","cit":11,"pfa":"Michael Poetzsch","psa":"Thomas Kræmer","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1540420078","eid":"W1540420078"},{"id":"paper-w4296468142","cat":"papers","name":"Effects of the Phenethylamine 2-Cl-4,5-MDMA and the Synthetic Cathinone 3,4-MDPHP in Adolescent Rats: Focus on Sex Differences","year":"2022","cit":11,"pfa":"Augusta Pisanu","psa":"Liana Fattore","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4296468142","eid":"W4296468142"},{"id":"paper-w4398238951","cat":"papers","name":"Long-term ayahuasca use is associated with preserved global cognitive function and improved memory: a cross-sectional study with ritual users","year":"2024","cit":11,"pfa":"Arilton Martins Fonseca","psa":"Eliana Rodrigues","ptype":"article","src":"https://openalex.org/W4398238951","eid":"W4398238951"},{"id":"paper-w1983578067","cat":"papers","name":"Molecular basis of the selective binding of MDMA enantiomers to the alpha4beta2 nicotinic receptor subtype: Synthesis, pharmacological evaluation and mechanistic studies","year":"2014","cit":11,"pfa":"Salomé Llabrés","psa":"Elena Escubedo","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1983578067","eid":"W1983578067"},{"id":"paper-w4399141100","cat":"papers","name":"Psilocybin decreases neural responsiveness and increases functional connectivity while preserving pure-tone frequency selectivity in mouse auditory cortex","year":"2024","cit":11,"pfa":"Adam T. Brockett","psa":"Nikolas A. Francis","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4399141100","eid":"W4399141100"},{"id":"paper-w2016854292","cat":"papers","name":"Effects of apomorphine, clonidine or 5-methoxy-NN-dimethyltryptamine on approach and escape components of lateral hypothalamic and mesencephalic central gray stimulation in two inbred strains of mice","year":"1983","cit":11,"pfa":"Pierre Cazala","psa":"Anne-Marie Garrigues","ptype":"article","src":"https://openalex.org/W2016854292","eid":"W2016854292"},{"id":"paper-w1012350797","cat":"papers","name":"Analysis of 3,4-Methylenedioxy- N -Methylamphetamine (MDMA) in “Ecstasy” Tablets by 13C Solid State Nuclear Magnetic Resonance (NMR) Spectroscopy","year":"1999","cit":11,"pfa":"GSH Lee","psa":"MA Wilson","ptype":"article","src":"https://openalex.org/W1012350797","eid":"W1012350797"},{"id":"paper-w3203372899","cat":"papers","name":"MDMA-Assisted Therapy as a Means to Alter Affective, Cognitive, Behavioral, and Neurological Systems Underlying Social Dysfunction in Social Anxiety Disorder","year":"2021","cit":11,"pfa":"Jason B. Luoma","psa":"Mary K. Lear","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3203372899","eid":"W3203372899"},{"id":"paper-w2043908377","cat":"papers","name":"3,4-methylenedioxymethamphetamine (MDMA)-induced release of endogenous serotonin from the rat dorsal raphe nucleus in vitro: Effects of fluoxetine and tryptophan","year":"1990","cit":11,"pfa":"Charles W. Bradberry","psa":"Robert Howard Roth","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2043908377","eid":"W2043908377"},{"id":"paper-w2161479942","cat":"papers","name":"3,4-Methylenedioxymethamphetamine (MDMA – Ecstasy) Decreases Neutrophil Activity Through the Glucocorticoid Pathway and Impairs Host Resistance to Listeria Monocytogenes Infection in Mice","year":"2014","cit":11,"pfa":"V. Ferraz-de-Paula","psa":"João Palermo‐Neto","ptype":"article","src":"https://openalex.org/W2161479942","eid":"W2161479942"},{"id":"paper-w2064822812","cat":"papers","name":"Effect of 8-hydroxy-2-(N,N-di-n-propylamino)tetralin and MDMA on the discriminative stimulus effects of the classical hallucinogen DOM in rats","year":"2008","cit":11,"pfa":"Nantaka Khorana","psa":"Richard A. Glennon","ptype":"article","src":"https://openalex.org/W2064822812","eid":"W2064822812"},{"id":"paper-w1970942892","cat":"papers","name":"A convenient biomimetic synthesis of optically active putative neurotoxic metabolites of MDMA (“ecstasy”) from R-(−)- and S-(+)-N-methyl-α-methyldopamine precursors","year":"2012","cit":11,"pfa":"Claire-Marie Martinez","psa":"Martine Largeron","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1970942892","eid":"W1970942892"},{"id":"paper-w4381337711","cat":"papers","name":"The Kappa Opioid Receptor Agonist 16-Bromo Salvinorin A Has Anti-Cocaine Effects without Significant Effects on Locomotion, Food Reward, Learning and Memory, or Anxiety and Depressive-like Behaviors","year":"2023","cit":11,"pfa":"Ross van de Wetering","psa":"Bronwyn Maree Kivell","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4381337711","eid":"W4381337711"},{"id":"paper-w4401484659","cat":"papers","name":"Retraction Note: Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials","year":"2024","cit":11,"pfa":"Lisa Jerome","psa":"Rick Doblin","topics":["PTSD & trauma","Therapy practice"],"ptype":"retraction","src":"https://openalex.org/W4401484659","eid":"W4401484659"},{"id":"paper-w4387764874","cat":"papers","name":"Effects of psilocybin, the 5-HT2A receptor agonist TCB-2, and the 5-HT2A receptor antagonist M100907 on visual attention in male mice in the continuous performance test","year":"2023","cit":11,"pfa":"Arya Rahbarnia","psa":"Paul Fletcher","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4387764874","eid":"W4387764874"},{"id":"paper-w2063504619","cat":"papers","name":"Effects of long-term exposure of 3,4-methylenedioxymethamphetamine (MDMA; “ecstasy”) on neuronal transmitter transport, brain immuno-regulatory systems and progression of experimental periodontitis in rats","year":"2014","cit":11,"pfa":"Torbjørn Jarle Breivik","psa":"Oddvar Myhre","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2063504619","eid":"W2063504619"},{"id":"paper-w2124120342","cat":"papers","name":"The preservation of in vivo phosphorylated and activated uncoupling protein 3 (UCP3) in isolated skeletal muscle mitochondria following administration of 3,4-methylenedioxymethamphetamine (MDMA aka ecstasy) to rats/mice","year":"2011","cit":11,"pfa":"Orlagh M. Kelly","psa":"Richard K. Porter","ptype":"article","src":"https://openalex.org/W2124120342","eid":"W2124120342"},{"id":"paper-w1589898996","cat":"papers","name":"O sentido do uso ritual da ayahuasca em trabalho voltado ao tratamento e recuperação da população em situação de rua em São Paulo","year":"2011","cit":11,"pfa":"Bruno Ramos Gomes","ptype":"dissertation","src":"https://openalex.org/W1589898996","eid":"W1589898996"},{"id":"paper-w4400936492","cat":"papers","name":"Ibogaine administration following repeated morphine administration upregulates myelination markers 2′, 3′-cyclic nucleotide 3′-phosphodiesterase (CNP) and myelin basic protein (MBP) mRNA and protein expression in the int","year":"2024","cit":11,"pfa":"Demi Govender","psa":"Tanya Calvey","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4400936492","eid":"W4400936492"},{"id":"paper-w7154469221","cat":"papers","name":"Blinding Integrity in Psychedelic Randomized Clinical Trials","year":"2026","cit":11,"pfa":"Diana K. Orsini","psa":"Joshua Daniel Rosenblat","topics":["Dosing & pharmacology","Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7154469221","eid":"W7154469221"},{"id":"paper-w4230596872","cat":"papers","name":"HALLUCINOGENIC AGENTS","year":"1963","cit":11,"pfa":"Dana L. Farnsworth","ptype":"article","src":"https://openalex.org/W4230596872","eid":"W4230596872"},{"id":"paper-w4402118451","cat":"papers","name":"Within-subject comparison of near-death and psychedelic experiences: acute and enduring effects","year":"2024","cit":11,"pfa":"Charlotte Martial","psa":"Christopher B. Timmermann","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4402118451","eid":"W4402118451"},{"id":"paper-w4411319821","cat":"papers","name":"Psychedelics, entactogens and psychoplastogens for depression and related disorders","year":"2025","cit":11,"pfa":"Daniël Hoyer","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4411319821","eid":"W4411319821"},{"id":"paper-w2503740944","cat":"papers","name":"Effects of chronic administration of antidepressant drugs on central serotonergic receptor mechanisms","year":"1983","cit":11,"pfa":"S-O Ögren","psa":"L.F. Agnati","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W2503740944","eid":"W2503740944"},{"id":"paper-w4318567455","cat":"papers","name":"Intoxication of dogs and cats with common stimulating, hallucinogenic and dissociative recreational drugs","year":"2023","cit":11,"pfa":"Ena Oster","psa":"Mario Gıorgı","topics":["Addiction","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4318567455","eid":"W4318567455"},{"id":"paper-w4406088503","cat":"papers","name":"Psychedelic Treatments in Adolescent Psychopharmacology: Considering Safety, Ethics, and Scientific Rigor","year":"2025","cit":11,"pfa":"Isabella Sutherland","psa":"Paul E. Croarkin","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4406088503","eid":"W4406088503"},{"id":"paper-w2145138901","cat":"papers","name":"ENTHEOGENS, MYSTICISM, AND NEUROSCIENCE","year":"2014","cit":11,"pfa":"Ron Cole‐Turner","ptype":"article","src":"https://openalex.org/W2145138901","eid":"W2145138901"},{"id":"paper-w4232722773","cat":"papers","name":"Chromosome abnormality in offspring of LSD user. D trisomy with D-D translocation","year":"1970","cit":11,"pfa":"L Y Hsu","ptype":"article","src":"https://openalex.org/W4232722773","eid":"W4232722773"},{"id":"paper-w2012360636","cat":"papers","name":"Catatonia LSD Induced?","year":"1995","cit":11,"pfa":"K. M. H. Perera","psa":"M. R. M. Pinto","ptype":"article","src":"https://openalex.org/W2012360636","eid":"W2012360636"},{"id":"paper-w4307758883","cat":"papers","name":"Microdosing with classical psychedelics: Research trajectories and practical considerations","year":"2022","cit":11,"pfa":"Alice Wong","psa":"Amir Raz","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4307758883","eid":"W4307758883"},{"id":"paper-w2091942717","cat":"papers","name":"Effects of 5-Hydroxytryptophan on Schizophrenia","year":"1959","cit":11,"pfa":"Johannes C. Brengelmann","psa":"Mark B. Sandler","ptype":"article","src":"https://openalex.org/W2091942717","eid":"W2091942717"},{"id":"paper-w4294349218","cat":"papers","name":"The Association of Classic Serotonergic Psychedelic Use and Intention of Future Use with Nature Relatedness","year":"2022","cit":11,"pfa":"Marcio S. C. Longo","psa":"Daniel C. Mograbi","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4294349218","eid":"W4294349218"},{"id":"paper-w2074135584","cat":"papers","name":"Differential Binding of Ergot Compounds to Human versus Rat 5-HT2 Cortical Receptors","year":"1994","cit":11,"pfa":"Jayne D. Hagen","psa":"Stephen J. Peroutka","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2074135584","eid":"W2074135584"},{"id":"paper-w2313586085","cat":"papers","name":"Determination of LSD in Urine With High-Performance Liquid Chromatography–Mass Spectrometry","year":"2001","cit":11,"pfa":"Karl Bodin","psa":"Jan‐Olof Svensson","ptype":"article","src":"https://openalex.org/W2313586085","eid":"W2313586085"},{"id":"paper-w4386765415","cat":"papers","name":"Tryptamines and Mental Health: Activating the 5‑HT Receptor for Therapeutic Potential","year":"2023","cit":11,"pfa":"Robert B. Kargbo","topics":["Depression","PTSD & trauma","Mechanism & neuroscience"],"ptype":"editorial","src":"https://openalex.org/W4386765415","eid":"W4386765415"},{"id":"paper-w2081684159","cat":"papers","name":"Urinary Excretion of Some Products of Tryptophan Metabolism in Schizophrenic Patients","year":"1958","cit":11,"pfa":"Edward J. Cafruny","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2081684159","eid":"W2081684159"},{"id":"paper-w2184086296","cat":"papers","name":"LSD, TRANSCENDENCE, AND THE NEW BEGINNING","year":"2010","cit":11,"pfa":"James Terrill","psa":"Donald Dale Jackson","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2184086296","eid":"W2184086296"},{"id":"paper-w2095178704","cat":"papers","name":"The effect of lsd upon spontaneous PGO wave activity and REM sleep in the cat","year":"1975","cit":11,"pfa":"Dana C. Brooks","ptype":"article","src":"https://openalex.org/W2095178704","eid":"W2095178704"},{"id":"paper-w4238881640","cat":"papers","name":"Dependence on LSD and Other Hallucinogenic Drugs","year":"1967","cit":11,"ptype":"article","src":"https://openalex.org/W4238881640","eid":"W4238881640"},{"id":"paper-w4388460814","cat":"papers","name":"The possible place for psychedelics in pharmacotherapy of mental disorders","year":"2023","cit":11,"pfa":"Adam Wojtas","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4388460814","eid":"W4388460814"},{"id":"paper-w1979694578","cat":"papers","name":"Reports of Wives of Alcoholics of Effects of LSD-25 Treatment of Their Husbands","year":"1966","cit":11,"pfa":"Mary Sarett","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1979694578","eid":"W1979694578"},{"id":"paper-w2043470253","cat":"papers","name":"Improvement of hallucinogen persisting perception disorder (HPPD) with oral risperidone: case report","year":"2013","cit":11,"pfa":"N Subramanian","psa":"Matthew Doran","ptype":"article","src":"https://openalex.org/W2043470253","eid":"W2043470253"},{"id":"paper-w1999363722","cat":"papers","name":"Resistance to lysergic acid in schizophrenic patients","year":"1956","cit":11,"pfa":"Cline Hs","psa":"Harry Freeman","ptype":"article","src":"https://openalex.org/W1999363722","eid":"W1999363722"},{"id":"paper-w4411787106","cat":"papers","name":"Psychedelic-Assisted Therapies for Psychosocial Symptoms in Cancer: A Systematic Review and Meta-Analysis","year":"2025","cit":11,"pfa":"Haley D. M. Schuman","psa":"Linda Ellen Carlson","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W4411787106","eid":"W4411787106"},{"id":"paper-w2020614877","cat":"papers","name":"Interactions of clozapine with the stimulus effects of DOM and LSD","year":"1994","cit":11,"pfa":"Patricia A. Palumbo","psa":"Jerrold C. Winter","ptype":"article","src":"https://openalex.org/W2020614877","eid":"W2020614877"},{"id":"paper-w2065131201","cat":"papers","name":"Patterns and Prevalence of Alcohol Use among University of Utopia Students in South Africa","year":"2014","cit":11,"pfa":"Lily Cherian","psa":"Mdumo Mboweni","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2065131201","eid":"W2065131201"},{"id":"paper-w4415115279","cat":"papers","name":"Zalsupindole is a Nondissociative, Nonhallucinogenic Neuroplastogen with Therapeutic Effects Comparable to Ketamine and Psychedelics","year":"2025","cit":11,"pfa":"Rajiv G. Agrawal","psa":"David E. Olson","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4415115279","eid":"W4415115279"},{"id":"paper-w4392123879","cat":"papers","name":"Exploring Novel Antidepressants Targeting G Protein-Coupled Receptors and Key Membrane Receptors Based on Molecular Structures","year":"2024","cit":11,"pfa":"Hanbo Yao","psa":"Jun‐Fa Xu","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4392123879","eid":"W4392123879"},{"id":"paper-w2986011340","cat":"papers","name":"THE EFFECT OF LSD AND RESERPINE ON THE CENTRAL NERVOUS SYSTEM OF THE CAT","year":"1958","cit":11,"pfa":"Hiroshi Takagi","psa":"Kikuo Ogiu","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2986011340","eid":"W2986011340"},{"id":"paper-w2054018500","cat":"papers","name":"Interactions between 3,4-Methylenedioxymethamphetamine and Ethanol in Humans and Rodents","year":"2009","cit":11,"pfa":"Wael M.Y. Mohamed","psa":"Byron C. Jones","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2054018500","eid":"W2054018500"},{"id":"paper-w1997139207","cat":"papers","name":"Sleep Deprivation Differentially Impairs Cognitive Performance in Abstinent Methylenedioxymethamphetamine (“Ecstasy”) Users","year":"2009","cit":11,"pfa":"Una D. McCann","psa":"George A. Ricaurte","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1997139207","eid":"W1997139207"},{"id":"paper-w2041720346","cat":"papers","name":"Drug effects on distribution of [3H]3,4-methylenedioxymethamphetamine in mice","year":"1993","cit":11,"pfa":"Kenji Hashimoto","psa":"Tsuyoshi Goromaru","ptype":"article","src":"https://openalex.org/W2041720346","eid":"W2041720346"},{"id":"paper-w4250426150","cat":"papers","name":"Liquid chromatographic–electrospray ionization mass spectrometric assay for simultaneous determination of 3,4-methylenedioxymethamphetamine and its metabolites 3,4-methylenedioxyamphetamine, 3,4-dihydroxymethamphetamine,","year":"2008","cit":11,"pfa":"M MUELLER","psa":"Hans H. Maurer","ptype":"article","src":"https://openalex.org/W4250426150","eid":"W4250426150"},{"id":"paper-w2032913594","cat":"papers","name":"3,4-Methylenedioxymethamphetamine Alters Left Ventricular Function and Activates Nuclear Factor-Kappa B (NF-kB) in a Time and Dose Dependent Manner","year":"2010","cit":11,"pfa":"David A. Tiangco","psa":"Barbara Hargrave","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2032913594","eid":"W2032913594"},{"id":"paper-w2612433529","cat":"papers","name":"Treadmill exercise attenuates 3,4‐methylenedioxymethamphetamine‐induced memory impairment through a decrease apoptosis in male rat hippocampus","year":"2017","cit":11,"pfa":"Alireza Gharebaghi","psa":"Sara Soleimani Asl","ptype":"article","src":"https://openalex.org/W2612433529","eid":"W2612433529"},{"id":"paper-w2611362676","cat":"papers","name":"Why Psychiatry Needs 3,4-Methylenedioxymethamphetamine: A Child Psychiatrist's Perspective","year":"2017","cit":11,"pfa":"Ben Sessa","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2611362676","eid":"W2611362676"},{"id":"paper-w2107181587","cat":"papers","name":"Rewarding effects of 3,4-methylenedioxymethamphetamine (“Ecstasy”) in dominant and subordinate OF-1 mice in the place preference conditioning paradigm","year":"2006","cit":11,"pfa":"Gabriel Rodríguez-Alarcón","psa":"Alicia Salvador","ptype":"article","src":"https://openalex.org/W2107181587","eid":"W2107181587"},{"id":"paper-w2883043654","cat":"papers","name":"Persistent Psychosis due to Single Dose of Ecstasy","year":"2018","cit":11,"pfa":"Sanya Virani","psa":"Saeed Ahmed","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2883043654","eid":"W2883043654"},{"id":"paper-w4393444557","cat":"papers","name":"Potential Serotonin 5-HT2A Receptor Agonist of Psychoactive Components of Silene undulata Aiton: LC-MS/MS, ADMET, and Molecular Docking Studies","year":"2024","cit":11,"pfa":"Maram B. Alhawarri","psa":"Suleiman Olimat","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4393444557","eid":"W4393444557"},{"id":"paper-w2160284989","cat":"papers","name":"Comparison of the use of aqueous and nonaqueous buffers in association with cyclodextrin for the chiral separation of 3,4‐methylenedioxymethamphetamine and related compounds","year":"2005","cit":11,"pfa":"Yu-San Huang","psa":"Cheng‐Huang Lin","ptype":"article","src":"https://openalex.org/W2160284989","eid":"W2160284989"},{"id":"paper-w1993266541","cat":"papers","name":"Thermal degradation products derived from the smoke of Salvia divinorum leaves","year":"2010","cit":11,"pfa":"Zhongze Ma","psa":"David Y.W. Lee","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1993266541","eid":"W1993266541"},{"id":"paper-w4404059132","cat":"papers","name":"Australian psychologists' attitudes towards psychedelic‐assisted therapy and training following a world‐first drug down‐scheduling","year":"2024","cit":11,"pfa":"Jordan J. Negrine","psa":"Timothy M. Piatkowski","topics":["Depression","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4404059132","eid":"W4404059132"},{"id":"paper-w4406599518","cat":"papers","name":"Catalyst for change: Psilocybin’s antidepressant mechanisms—A systematic review","year":"2025","cit":11,"pfa":"Joshua Liebnau","psa":"André Kerber","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W4406599518","eid":"W4406599518"},{"id":"paper-w2326031234","cat":"papers","name":"Depressant Effects ofSalvia divinorumInvolve Disruption of Physiological Sleep","year":"2016","cit":11,"pfa":"María Eva González-Trujano","psa":"Francisco Pellicer","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2326031234","eid":"W2326031234"},{"id":"paper-w4408336142","cat":"papers","name":"Psychedelics align brain activity with context","year":"2026","cit":11,"pfa":"Devon Stoliker","psa":"Adeel Razi","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4408336142","eid":"W4408336142"},{"id":"paper-w2138326272","cat":"papers","name":"MRI of toxic leukoencephalopathy syndrome associated with methylenedioxymethamphetamine","year":"2015","cit":11,"pfa":"Daniel Thomas Ginat","ptype":"article","src":"https://openalex.org/W2138326272","eid":"W2138326272"},{"id":"paper-w888186043","cat":"papers","name":"Mushrooms and Madness: Hallucinogenic Mushrooms and Some Psychopharmacological Implications","year":"1980","cit":11,"pfa":"Angus S. McDonald","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W888186043","eid":"W888186043"},{"id":"paper-w4400776523","cat":"papers","name":"Notes from the Field: Schedule I Substances Identified in Nootropic Gummies Containing Amanita muscaria or Other Mushrooms — Charlottesville, Virginia, 2023–2024","year":"2024","cit":11,"pfa":"Avery E. Michienzi","psa":"Lindsay A. L. Bazydlo","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4400776523","eid":"W4400776523"},{"id":"paper-w3123486575","cat":"papers","name":"Simultaneous Determination of Cortisol, Cortisone, and Multiple Illicit Drugs in Hair among Female Drug Addicts with LC-MS/MS","year":"2021","cit":11,"pfa":"Cailing Duan","psa":"Huihua Deng","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3123486575","eid":"W3123486575"},{"id":"paper-w2301531489","cat":"papers","name":"Effect of various psychotomimetic drugs on rate of appearance of carbon-14 in the brains of mice after administration of C14 glucose","year":"1959","cit":11,"pfa":"Margaret Elizabeth Greig","psa":"Anna J. Gibbons","ptype":"article","src":"https://openalex.org/W2301531489","eid":"W2301531489"},{"id":"paper-w2033634017","cat":"papers","name":"DMT self-administration by monkeys in isolation","year":"1980","cit":11,"pfa":"Ronald K. Siegel","psa":"Murray E. Jarvik","ptype":"article","src":"https://openalex.org/W2033634017","eid":"W2033634017"},{"id":"paper-w2909396647","cat":"papers","name":"Trait Openness and serotonin 2A receptors in healthy volunteers: A positron emission tomography study","year":"2019","cit":11,"pfa":"Dea Siggaard Stenbæk","psa":"Patrick M. Fisher","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2909396647","eid":"W2909396647"},{"id":"paper-w2586776955","cat":"papers","name":"Grand Challenge in Psychopharmacology: Setting Priorities to Shape a Bright Future","year":"2017","cit":11,"pfa":"Roberto Ciccocioppo","topics":["Depression","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2586776955","eid":"W2586776955"},{"id":"paper-w2021248579","cat":"papers","name":"Entheogens and the Public Mystery: The Rhetoric of R. Gordon Wasson","year":"2008","cit":11,"pfa":"Antonio Ceraso","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2021248579","eid":"W2021248579"},{"id":"paper-w2063172886","cat":"papers","name":"Psychedelic synaesthesia: Evidence for a serotonergic role in synaesthesia","year":"2012","cit":11,"pfa":"David P. Luke","psa":"Ross Friday","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2063172886","eid":"W2063172886"},{"id":"paper-w4380680822","cat":"papers","name":"Associations between the use of psychedelics and other recreational drugs with mental health and resilience during the COVID-19 pandemic","year":"2023","cit":11,"pfa":"Maria Bălăeţ","psa":"Adam Hampshire","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4380680822","eid":"W4380680822"},{"id":"paper-w1997058497","cat":"papers","name":"Repeated Acquisition in the Morris Swim Task: Effects of Methylenedioxymethamphetamine, Methamphetamine, and Methylphenidate","year":"2014","cit":11,"pfa":"Mark Galizio","psa":"L. Brooke April","ptype":"article","src":"https://openalex.org/W1997058497","eid":"W1997058497"},{"id":"paper-w2027471860","cat":"papers","name":"Could Sigma Receptor Ligands be a Treatment for Methamphetamine Addiction?","year":"2010","cit":11,"pfa":"Kelli Renee Rodvelt","psa":"Dennis K. Miller","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2027471860","eid":"W2027471860"},{"id":"paper-w4388203254","cat":"papers","name":"Psychedelic science and Indigenous shamanism: an urgent dialogue","year":"2023","cit":11,"pfa":"Adana Omágua-Kambeba","psa":"Sidarta Tollendal Gomes Ribeiro","ptype":"article","src":"https://openalex.org/W4388203254","eid":"W4388203254"},{"id":"paper-w4407062240","cat":"papers","name":"Rising incidence of recreational ketamine use: Clinical cases and management in emergency settings","year":"2025","cit":11,"pfa":"Sabrina Marongiu","psa":"Eric J. F. Franssen","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4407062240","eid":"W4407062240"},{"id":"paper-w4315434015","cat":"papers","name":"Methylone, a rapid acting entactogen with robust anxiolytic and antidepressant-like activity","year":"2023","cit":11,"pfa":"Jennifer L. Warner‐Schmidt","psa":"Benjamin Kelmendi","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4315434015","eid":"W4315434015"},{"id":"paper-w2747297585","cat":"papers","name":"Flibanserin toxicity in a toddler following ingestion","year":"2017","cit":11,"pfa":"Nicholas Granzella","psa":"Matthew J. Valento","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2747297585","eid":"W2747297585"},{"id":"paper-w4404109323","cat":"papers","name":"Global Trends in Psychedelic Microdosing: Demographics, Substance Testing Behavior, and Patterns of Use","year":"2024","cit":11,"pfa":"Omer A. Syed","psa":"Philippe Lucas","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4404109323","eid":"W4404109323"},{"id":"paper-w4323036224","cat":"papers","name":"A narrative review of the neuropharmacology of synthetic cathinones—Popular alternatives to classical drugs of abuse","year":"2023","cit":11,"pfa":"Patryk Kuropka","psa":"Paweł Szpot","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W4323036224","eid":"W4323036224"},{"id":"paper-w4322619226","cat":"papers","name":"Characterization of the recently detected cathinone N-cyclohexyl butylone: From structure elucidation to in silico supported pharmacological/toxicological considerations","year":"2023","cit":11,"pfa":"María Mata-Pesquera","psa":"María Ibáñez","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4322619226","eid":"W4322619226"},{"id":"paper-w4310675742","cat":"papers","name":"Psychedelic-Induced Serotonin 2A Receptor Downregulation Does Not Predict Swim Stress Coping in Mice","year":"2022","cit":11,"pfa":"Błażej D. Pędzich","psa":"Dimitri De Bundel","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4310675742","eid":"W4310675742"},{"id":"paper-w4386602493","cat":"papers","name":"First-Generation Synthetic Cathinones Produce Arrhythmia in Zebrafish Eleutheroembryos: A New Approach Methodology for New Psychoactive Substances Cardiotoxicity Evaluation","year":"2023","cit":11,"pfa":"Elisabet Teixidó","psa":"Raúl López‐Arnau","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4386602493","eid":"W4386602493"},{"id":"paper-w1533458386","cat":"papers","name":"[The new types of addiction].","year":"2009","cit":11,"pfa":"Pascal Semaille","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"other","src":"https://openalex.org/W1533458386","eid":"W1533458386"},{"id":"paper-w7129107552","cat":"papers","name":"A short-acting psychedelic intervention for major depressive disorder: a phase IIa randomized placebo-controlled trial","year":"2026","cit":11,"pfa":"David Erritzøe","psa":"Ellen James","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7129107552","eid":"W7129107552"},{"id":"paper-w2287154126","cat":"papers","name":"4-Fluoroamphetamine in Serum and Urine from an Intoxicated Patient with Life-Threatening Hyperpyrexia: Table I.","year":"2016","cit":11,"pfa":"Justin L. Poklis","psa":"Alphonse Poklis","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2287154126","eid":"W2287154126"},{"id":"paper-w2978804318","cat":"papers","name":"Prevalence of alcohol and other drugs in injured drivers and their association with clinical outcomes.","year":"2017","cit":11,"pfa":"Francesca Cittadini","psa":"Marcello Covino","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2978804318","eid":"W2978804318"},{"id":"paper-w4403579240","cat":"papers","name":"Psychedelic-related deaths in England, Wales and Northern Ireland (1997–2022)","year":"2024","cit":11,"pfa":"Emma I Kopra","psa":"Caroline S. Copeland","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4403579240","eid":"W4403579240"},{"id":"paper-w4312129485","cat":"papers","name":"Beliefs and Perceived Barriers Regarding Psychedelic-assisted Therapy in a Pilot Study of Service Members and Veterans With a History of Traumatic Brain Injury","year":"2022","cit":11,"pfa":"Joshua C. Gray","psa":"Jessica L. Maples‐Keller","topics":["Depression","PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4312129485","eid":"W4312129485"},{"id":"paper-w4224545480","cat":"papers","name":"Survey of substance use among adolescent drug offenders referred from juvenile courts in Taiwan: Clinical epidemiology of single versus multiple illicit substance use","year":"2022","cit":11,"pfa":"Yu-Hsiung Chen","psa":"Lian‐Yu Chen","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4224545480","eid":"W4224545480"},{"id":"paper-w3008649055","cat":"papers","name":"Emerging Psychedelic-Assisted Therapies: Implications for Nursing Practice","year":"2020","cit":11,"pfa":"Dominique Denis-Lalonde","psa":"Andrew Estefan","topics":["Addiction","Anxiety & end-of-life","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3008649055","eid":"W3008649055"},{"id":"paper-w2917513925","cat":"papers","name":"The Trials of Psychedelic Therapy: LSD Psychotherapy in America","year":"2019","cit":11,"pfa":"Pedro J. Ruiz","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2917513925","eid":"W2917513925"},{"id":"paper-w4409304233","cat":"papers","name":"Mitigating Ethical Issues in Training for Psychedelic Therapy","year":"2025","cit":11,"pfa":"Christopher J. Poppe","psa":"Manuel Trachsel","topics":["Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4409304233","eid":"W4409304233"},{"id":"paper-w4366983220","cat":"papers","name":"Ethical Considerations at the Intersection Between Psychedelic-Assisted Psychotherapy and Medical Assistance in Dying","year":"2023","cit":11,"pfa":"Daniel Rosenbaum","psa":"Daniel Z. Buchman","topics":["Anxiety & end-of-life","Therapy practice","Policy & ethics"],"ptype":"editorial","src":"https://openalex.org/W4366983220","eid":"W4366983220"},{"id":"paper-w4405955631","cat":"papers","name":"Research and Implementation of Psychedelic-Assisted Therapy in the Veterans Health Administration","year":"2025","cit":11,"pfa":"Aaron S. Wolfgang","psa":"Ilse R. Wiechers","ptype":"article","src":"https://openalex.org/W4405955631","eid":"W4405955631"},{"id":"paper-w4405978063","cat":"papers","name":"Healing, Harms, and Humility: Expanding the Scope of Psychedelic-Assisted Psychotherapy Research","year":"2025","cit":11,"pfa":"Kelley C. O’Donnell","psa":"Charles S. Grob","topics":["Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4405978063","eid":"W4405978063"},{"id":"paper-w4406696447","cat":"papers","name":"Ketamine and Ketamine-Assisted Psychotherapy for Psychiatric and Existential Distress in Patients with Serious Medical Illness: A Narrative Review","year":"2025","cit":11,"pfa":"Roxanne Sholevar","psa":"Yvan Beaussant","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W4406696447","eid":"W4406696447"},{"id":"paper-w4386346817","cat":"papers","name":"A Pilot Study Comparing a Community of Practice Program with and without Concurrent Ketamine-Assisted Therapy","year":"2023","cit":11,"pfa":"Vivian W. L. Tsang","psa":"Shannon Dames","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4386346817","eid":"W4386346817"},{"id":"paper-w4380264419","cat":"papers","name":"Case report: Improvement in refractory functional seizures, depression, and quality of life with ketamine-assisted therapy","year":"2023","cit":11,"pfa":"Elena Argento","psa":"Evan Cole Lewis","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4380264419","eid":"W4380264419"},{"id":"paper-w4390034582","cat":"papers","name":"Efficacy and safety of ketamine-assisted electroconvulsive therapy in major depressive episode: a systematic review and network meta-analysis","year":"2023","cit":11,"pfa":"Taeho Greg Rhee","psa":"Roger S. McIntyre","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4390034582","eid":"W4390034582"},{"id":"paper-w4386208848","cat":"papers","name":"Therapeutic Protocols Using Ketamine and Esketamine for Depressive Disorders: A Systematic Review","year":"2023","cit":11,"pfa":"JULIA MURIEL KUTNO FREIND","psa":"Daniel C. Mograbi","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W4386208848","eid":"W4386208848"},{"id":"paper-w2901367898","cat":"papers","name":"Should Australian Psychology Consider Enhancing Psychotherapeutic Interventions with Psychedelic Drugs? A Call for Research","year":"2018","cit":11,"pfa":"Stephen Jason Bright","psa":"Martin L Williams","topics":["Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2901367898","eid":"W2901367898"},{"id":"paper-w4229028484","cat":"papers","name":"The psychological processes of classic psychedelics in the treatment of depression: a systematic review protocol","year":"2022","cit":11,"pfa":"Lauren Johansen","psa":"Greg Murray","topics":["Depression","Reviews & meta-analyses","Therapy practice"],"ptype":"review","src":"https://openalex.org/W4229028484","eid":"W4229028484"},{"id":"paper-w4391672475","cat":"papers","name":"Therapeutic potential of psychedelics: History, advancements, and unexplored frontiers","year":"2024","cit":11,"pfa":"Juliana Marino Maia","psa":"Renato Nery Soriano","ptype":"article","src":"https://openalex.org/W4391672475","eid":"W4391672475"},{"id":"paper-w4411355052","cat":"papers","name":"Reframing psychedelic regulation: Tools, not treatments","year":"2025","cit":11,"pfa":"Max Wolff","psa":"Paul Liknaitzky","topics":["Dosing & pharmacology","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4411355052","eid":"W4411355052"},{"id":"paper-w4401512431","cat":"papers","name":"Attitudes of European psychiatrists on psychedelics: a cross-sectional survey study","year":"2024","cit":11,"pfa":"Marija Franka Žuljević","psa":"Darko Duplančić","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4401512431","eid":"W4401512431"},{"id":"paper-w4229018209","cat":"papers","name":"Sober sitter or coconsumer? Psychedelics, online forums and preferences for interpersonal interactions","year":"2022","cit":11,"pfa":"Sascha B. Thal","psa":"Stephen Jason Bright","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4229018209","eid":"W4229018209"},{"id":"paper-w4386924010","cat":"papers","name":"Psychedelics and critical theory","year":"2023","cit":11,"pfa":"Julien Tempone-Wiltshire","psa":"Tra-ill Dowie","topics":["Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4386924010","eid":"W4386924010"},{"id":"paper-w3014810763","cat":"papers","name":"Microdosing psychedelics as cognitive and emotional enhancers.","year":"2020","cit":11,"pfa":"Ben David Rifkin","psa":"Lorenza S. Colzato","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3014810763","eid":"W3014810763"},{"id":"paper-w1992158744","cat":"papers","name":"Toward an Entheogen Research Agenda","year":"2002","cit":11,"pfa":"Thomas B. Roberts","psa":"Paula Jo Hruby","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1992158744","eid":"W1992158744"},{"id":"paper-w29413007","cat":"papers","name":"The Pharmacology of Hallucinogens","year":"1983","cit":11,"pfa":"Henry B. Murphree","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W29413007","eid":"W29413007"},{"id":"paper-w2076825606","cat":"papers","name":"Studies with a New Hallucinogen","year":"1959","cit":11,"pfa":"Adrian M. Ostfeld","ptype":"article","src":"https://openalex.org/W2076825606","eid":"W2076825606"},{"id":"paper-w2025694209","cat":"papers","name":"Asthmador: A Legal Hallucinogen","year":"1974","cit":11,"pfa":"Keith W. Jacobs","topics":["Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2025694209","eid":"W2025694209"},{"id":"paper-w2320946752","cat":"papers","name":"The Psychedelic Reader.","year":"1966","cit":11,"pfa":"Jerome E. Singer","psa":"Timothy Leary","ptype":"article","src":"https://openalex.org/W2320946752","eid":"W2320946752"},{"id":"paper-w3146290235","cat":"papers","name":"The Promise of Psychedelic Science","year":"2021","cit":11,"pfa":"David E. Olson","topics":["Anxiety & end-of-life"],"ptype":"editorial","src":"https://openalex.org/W3146290235","eid":"W3146290235"},{"id":"paper-w4391817579","cat":"papers","name":"Effects of psychedelic microdosing versus conventional ADHD medication use on emotion regulation, empathy, and ADHD symptoms in adults with severe ADHD symptoms: A naturalistic prospective comparison study","year":"2024","cit":11,"pfa":"Eline C. H. M. Haijen","psa":"Kim P. C. Kuypers","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4391817579","eid":"W4391817579"},{"id":"paper-w4283024950","cat":"papers","name":"Microdose Induction of Buprenorphine in a Patient Using Tianeptine","year":"2022","cit":11,"pfa":"Laura M. Szczesniak","psa":"Ross W. Sullivan","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4283024950","eid":"W4283024950"},{"id":"paper-w4368368163","cat":"papers","name":"Cognitive liberty and the psychedelic humanities","year":"2023","cit":11,"pfa":"Osiris Sinuhé González Romero","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4368368163","eid":"W4368368163"},{"id":"paper-w2048754522","cat":"papers","name":"Arguments Heard for Psychedelics Probe","year":"1980","cit":11,"pfa":"Constance Holden","ptype":"article","src":"https://openalex.org/W2048754522","eid":"W2048754522"},{"id":"paper-w2095355589","cat":"papers","name":"Perception, Psychedelics and Social Change","year":"1974","cit":11,"pfa":"Charles Kaiser","psa":"Robert S. Gold","ptype":"article","src":"https://openalex.org/W2095355589","eid":"W2095355589"},{"id":"paper-w2884679410","cat":"papers","name":"Sacred Knowledge: Psychedelics and Religious Experience","year":"2018","cit":11,"pfa":"Ron Cole‐Turner","ptype":"article","src":"https://openalex.org/W2884679410","eid":"W2884679410"},{"id":"paper-w1572778841","cat":"papers","name":"Alcohol, tobacco, marijuana and hallucinogen use in Samoan adolescents","year":"2011","cit":11,"pfa":"Harold L. Odden","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1572778841","eid":"W1572778841"},{"id":"paper-w113276456","cat":"papers","name":"Role of Serotoninergic Neurons and 5-HT Receptors in the Action of Hallucinogens","year":"2000","cit":11,"pfa":"David E. Nichols","topics":["Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W113276456","eid":"W113276456"},{"id":"paper-w2972250751","cat":"papers","name":"Microbial population dynamics under microdoses of the essential oil arborvitae","year":"2019","cit":11,"pfa":"Rhegan McGregor","psa":"Leigh Clark Latta IV","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2972250751","eid":"W2972250751"},{"id":"paper-w2088935038","cat":"papers","name":"Hallucinogens antagonize histamine H1 receptors of cultured mouse neuroblastoma cells","year":"1979","cit":11,"pfa":"Paul A. Fredrickson","psa":"Elliott Richelson","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2088935038","eid":"W2088935038"},{"id":"paper-w4403695084","cat":"papers","name":"Home multifood oral immunotherapy microdosing with Dartmouth Spoon Sheets","year":"2024","cit":11,"pfa":"Sarah Jane Hughes","psa":"Marcus S Shaker","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4403695084","eid":"W4403695084"},{"id":"paper-w4402758733","cat":"papers","name":"Psychedelics and Consciousness: Expanding the Horizons of Mind and Therapy","year":"2024","cit":11,"pfa":"M. Zhang","psa":"Xiaohui Wang","topics":["Anxiety & end-of-life","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4402758733","eid":"W4402758733"},{"id":"paper-w4310955258","cat":"papers","name":"Psychedelics and fNIRS neuroimaging: exploring new opportunities","year":"2022","cit":11,"pfa":"Felix Scholkmann","psa":"Franz X. Vollenweider","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4310955258","eid":"W4310955258"},{"id":"paper-w1527664550","cat":"papers","name":"Psychedelic substances and paranormal phenomena: a review of the research","year":"2008","cit":11,"pfa":"David P. Luke","topics":["Addiction","Reviews & meta-analyses","Therapy practice"],"ptype":"review","src":"https://openalex.org/W1527664550","eid":"W1527664550"},{"id":"paper-w2794376646","cat":"papers","name":"Neurotransmissions: Essays on Psychedelics from Breaking Convention","year":"2015","cit":11,"pfa":"D. D. King","psa":"Aimee Tollan","ptype":"book","src":"https://openalex.org/W2794376646","eid":"W2794376646"},{"id":"paper-w4252094323","cat":"papers","name":"Neural Mechanisms and Psychology of Psychedelic Ego Dissolution","year":"2021","cit":11,"pfa":"Devon Stoliker","psa":"Adeel Razi","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4252094323","eid":"W4252094323"},{"id":"paper-w4398223107","cat":"papers","name":"The Oxford Handbook of Psychedelic, Religious, Spiritual, and Mystical Experiences","year":"2024","cit":11,"topics":["Reviews & meta-analyses"],"ptype":"book","src":"https://openalex.org/W4398223107","eid":"W4398223107"},{"id":"paper-w1982055210","cat":"papers","name":"Antagonist/letrozole protocol for patients failing microdose agonist flare stimulation","year":"2002","cit":11,"pfa":"William B. Schoolcraft","psa":"David K. Gardner","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1982055210","eid":"W1982055210"},{"id":"paper-w4387011484","cat":"papers","name":"TESCREAL hallucinations: Psychedelic and AI hype as inequality engines","year":"2023","cit":11,"pfa":"Neşe Devenot","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4387011484","eid":"W4387011484"},{"id":"paper-w4308625185","cat":"papers","name":"Psychedelic VR Experience: An Exploratory Study on Cosmic Flow","year":"2022","cit":11,"pfa":"Sangwon Jung","psa":"Juho Hamari","ptype":"conference-paper","src":"https://openalex.org/W4308625185","eid":"W4308625185"},{"id":"paper-w2969702913","cat":"papers","name":"Goa is a State of Mind: On the Ephemerality of Psychedelic Social Emplacements","year":"2010","cit":11,"pfa":"Luther C. Elliott","ptype":"article","src":"https://openalex.org/W2969702913","eid":"W2969702913"},{"id":"paper-w2971955765","cat":"papers","name":"The Performance Effects of Microdose Recombinant Human Erythropoietin Administration and Carbon Monoxide Rebreathing","year":"2018","cit":11,"pfa":"Shaun Sutehall","psa":"Yannis Paul Pitsiladis","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2971955765","eid":"W2971955765"},{"id":"paper-w2089857026","cat":"papers","name":"Back to the future: A return to psychedelic treatment models for addiction","year":"2014","cit":11,"pfa":"Peter S. Hendricks","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2089857026","eid":"W2089857026"},{"id":"paper-w4403074914","cat":"papers","name":"Chemistry/structural biology of psychedelic drugs and their receptor(s)","year":"2024","cit":11,"pfa":"Ryan H. Gumpper","psa":"David E. Nichols","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4403074914","eid":"W4403074914"},{"id":"paper-w2946595039","cat":"papers","name":"Psychedelic science as cosmic play, psychedelic humanities as perennial polemics? Or why we are still fighting over Max Weber’s Science as a Vocation","year":"2019","cit":11,"pfa":"Nicolas Langlitz","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2946595039","eid":"W2946595039"},{"id":"paper-w4386530513","cat":"papers","name":"Acute Subjective Effects of Psychedelics within and Beyond WEIRD Contexts","year":"2023","cit":11,"pfa":"Marianna Graziosi","psa":"David B. Yaden","ptype":"article","src":"https://openalex.org/W4386530513","eid":"W4386530513"},{"id":"paper-w1989598520","cat":"papers","name":"Targetability and Biodistribution of Radioiodinated Hypericin: Comparison between Microdosing and Carrier-Added Preparations","year":"2014","cit":11,"pfa":"Marlein Miranda Cona","psa":"Yicheng Ni","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1989598520","eid":"W1989598520"},{"id":"paper-w1999204349","cat":"papers","name":"The Use of Psychedelic Drugs in the Treatment of Severely Disturbed Children: A Review","year":"1977","cit":11,"pfa":"John Rhead","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1999204349","eid":"W1999204349"},{"id":"paper-w2791821348","cat":"papers","name":"Synesthetic hallucinations induced by psychedelic drugs in a congenitally blind man","year":"2018","cit":11,"pfa":"Sara Dell’Erba","psa":"Michael J. Proulx","ptype":"article","src":"https://openalex.org/W2791821348","eid":"W2791821348"},{"id":"paper-w2970011527","cat":"papers","name":"Microdosing clinical study to clarify pharmacokinetic and pharmacogenetic characteristics of atorvastatin in Japanese hypercholesterolemic patients","year":"2019","cit":11,"pfa":"Nora Lee","psa":"Yuichi Sugiyama","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2970011527","eid":"W2970011527"},{"id":"paper-w4399360556","cat":"papers","name":"Psychedelic group-based integration: ethical assessment and initial recommendations","year":"2024","cit":11,"pfa":"Katherine Cheung","psa":"David B. Yaden","topics":["Safety & adverse events","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4399360556","eid":"W4399360556"},{"id":"paper-w4385395867","cat":"papers","name":"The Relationship Between Naturalistic Psychedelic Use and Clinical Care in Canada","year":"2023","cit":11,"pfa":"Nicolas G. Glynos","psa":"Philippe Lucas","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4385395867","eid":"W4385395867"},{"id":"paper-w4403825824","cat":"papers","name":"Preclinical models for evaluating psychedelics in the treatment of major depressive disorder","year":"2024","cit":11,"pfa":"Laith Alexander","psa":"Emma S. J. Robinson","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4403825824","eid":"W4403825824"},{"id":"paper-w2003879236","cat":"papers","name":"Psychedelic (LSD) Therapy of Neurotic Disorders: Short-Term Effects","year":"1972","cit":11,"pfa":"O. Lee McCabe","psa":"Sanford M. Unger","ptype":"article","src":"https://openalex.org/W2003879236","eid":"W2003879236"},{"id":"paper-w2531780606","cat":"papers","name":"Pharmacodynamic Profile of Mydriatic Agents Delivered by Ocular Piezo-Ejection Microdosing Compared with Conventional Eyedropper","year":"2016","cit":11,"pfa":"Tsontcho Ianchulev","psa":"Robert Neal Weinreb","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2531780606","eid":"W2531780606"},{"id":"paper-w3211527688","cat":"papers","name":"Microdose induction of buprenorphine-naloxone in a patient using high dose methadone: A case report","year":"2021","cit":11,"pfa":"Shannon Menard","psa":"Archana Jhawar","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3211527688","eid":"W3211527688"},{"id":"paper-w4399984970","cat":"papers","name":"Stigma, psychedelics use, and the risk of reduced formal mental health care.","year":"2024","cit":11,"pfa":"Sean M. Viña","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4399984970","eid":"W4399984970"},{"id":"paper-w2945244900","cat":"papers","name":"The link between childhood trauma and dissociation in frequent users of classic psychedelics and dissociatives","year":"2019","cit":11,"pfa":"Sascha B. Thal","psa":"Henrik Jungaberle","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2945244900","eid":"W2945244900"},{"id":"paper-w3131550087","cat":"papers","name":"Prolonged epigenetic and synaptic plasticity alterations following single exposure to a psychedelic in mice","year":"2021","cit":11,"pfa":"Mario de la Fuente Revenga","psa":"Javier González‐Maeso","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W3131550087","eid":"W3131550087"},{"id":"paper-w2314380031","cat":"papers","name":"Comparison of microdose GnRH agonist protocol with GnRH antagonist / letrazole protocol in patients with poor ovarian response","year":"2013","cit":11,"pfa":"Yiğit Çakıroğlu","psa":"Birol Vural","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2314380031","eid":"W2314380031"},{"id":"paper-w4387501819","cat":"papers","name":"From Altered States to Metaphysics: The Epistemic Status of Psychedelic-induced Metaphysical Beliefs","year":"2023","cit":11,"pfa":"Paweł Gładziejewski","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4387501819","eid":"W4387501819"},{"id":"paper-w4399498713","cat":"papers","name":"Endorsement of metaphysical idealism mediates a link between past use of psychedelics and wellbeing","year":"2024","cit":11,"pfa":"Jussi Jylkkä","psa":"Patrick Jern","ptype":"article","src":"https://openalex.org/W4399498713","eid":"W4399498713"},{"id":"paper-w4378976526","cat":"papers","name":"Building Psychedelic Studies as an Interdisciplinary Academic Field: Its Urgency and Its Challenges","year":"2023","cit":11,"pfa":"Amy Bartlett","psa":"Raymond Feng","ptype":"article","src":"https://openalex.org/W4378976526","eid":"W4378976526"},{"id":"paper-w4385415188","cat":"papers","name":"Identification of 5-HT 2A Receptor Signaling Pathways Responsible for Psychedelic Potential","year":"2023","cit":11,"pfa":"Jason V. Wallach","psa":"John D. McCorvy","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4385415188","eid":"W4385415188"},{"id":"paper-w3118676612","cat":"papers","name":"Successful Transition from High-Dose Methadone to Buprenorphine via Microdosing in the Outpatient Setting: A Case Report","year":"2021","cit":11,"pfa":"Siavash Jafari","psa":"Reza Rafizadeh","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3118676612","eid":"W3118676612"},{"id":"paper-w2548665952","cat":"papers","name":"Dysregulated corticostriatal activity in open-field behavior and the head-twitch response induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine","year":"2016","cit":11,"pfa":"Claudia Rangel‐Barajas","psa":"George V. Rebec","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2548665952","eid":"W2548665952"},{"id":"paper-w2978076813","cat":"papers","name":"(Micro-) “Psychedelic” Experiences: from the 1960s creativity at the workplace to the 21st Century neuro-newspeak","year":"2019","cit":11,"pfa":"Milana Aronov","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2978076813","eid":"W2978076813"},{"id":"paper-w4388627197","cat":"papers","name":"Psychometric brahman , psychedelic science: Walter Stace, transnational Vedanta, and the Mystical Experience Questionnaire","year":"2023","cit":11,"pfa":"Jeffrey A. Breau","psa":"Paul Gillis‐Smith","ptype":"article","src":"https://openalex.org/W4388627197","eid":"W4388627197"},{"id":"paper-w3022628141","cat":"papers","name":"Psychotomimetic Agents","year":"1976","cit":11,"pfa":"Alexander T. Shulgin","ptype":"book-chapter","src":"https://openalex.org/W3022628141","eid":"W3022628141"},{"id":"paper-w4220759286","cat":"papers","name":"Ketamine for Depression: Advances in Clinical Treatment, Rapid Antidepressant Mechanisms of Action, and a Contrast with Serotonergic Psychedelics","year":"2022","cit":11,"pfa":"Marina Kojic","psa":"Christoph Kraus","topics":["Depression","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W4220759286","eid":"W4220759286"},{"id":"paper-w2766927849","cat":"papers","name":"High-precision piezo-ejection Ocular microdosing: Phase II Study on Local and Systemic Effects of Topical Phenylephrine","year":"2017","cit":11,"pfa":"Tsontcho Ianchulev","psa":"Louis Robert Pasquale","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2766927849","eid":"W2766927849"},{"id":"paper-w1845565868","cat":"papers","name":"Psychosis, psychedelic substance misuse and head injury: A case report and 23 year follow-up","year":"2015","cit":11,"pfa":"Musa Basseer Sami","psa":"Antonio Fialho","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1845565868","eid":"W1845565868"},{"id":"paper-w3158335389","cat":"papers","name":"A continuum hypothesis of psychotomimetic rapid antidepressants","year":"2021","cit":11,"pfa":"Joost Haarsma","psa":"Sandra Tamm","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3158335389","eid":"W3158335389"},{"id":"paper-w2092715857","cat":"papers","name":"Clinical use of psychotomimetic drugs","year":"1966","cit":11,"pfa":"Louis A. Faillace","ptype":"article","src":"https://openalex.org/W2092715857","eid":"W2092715857"},{"id":"paper-w4387013949","cat":"papers","name":"Microdosing of nitrogen fertiliser and cattle manure under in situ rainwater harvesting to improve maize production in smallholder farming system in a semiarid area of Zimbabwe","year":"2023","cit":11,"pfa":"Andrew Tapiwa Kugedera","psa":"Letticia Kudzai Kokerai","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4387013949","eid":"W4387013949"},{"id":"paper-w2088892297","cat":"papers","name":"The Psychotomimetic Nature of Dreams: An Experimental Study","year":"2012","cit":11,"pfa":"Oliver John Mason","psa":"Dominic Wakerley","ptype":"article","src":"https://openalex.org/W2088892297","eid":"W2088892297"},{"id":"paper-w1994258063","cat":"papers","name":"Experimental Anticholinergic Psychotomimetics: Antagonism of Yohimbine and Tacrine (THA)","year":"2008","cit":11,"pfa":"C. Bell","psa":"Samuel Gershon","ptype":"article","src":"https://openalex.org/W1994258063","eid":"W1994258063"},{"id":"paper-w2104367641","cat":"papers","name":"Phenycyclidine A widely abused but little understood psychotomimetic agent","year":"1982","cit":11,"pfa":"Graeme Henderson","ptype":"article","src":"https://openalex.org/W2104367641","eid":"W2104367641"},{"id":"paper-w2095877927","cat":"papers","name":"Supplementation with a recombinant human chorionic gonadotropin microdose leads to similar outcomes in ovarian stimulation with recombinant follicle-stimulating hormone using either a gonadotropin-releasing hormone agoni","year":"2009","cit":11,"pfa":"Mário Cavagna","psa":"Edson Borges","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2095877927","eid":"W2095877927"},{"id":"paper-w2066024628","cat":"papers","name":"PHENCYCLIDINE‐LIKE DISCRIMINATIVE STIMULUS PROPERTIES OF PSYCHOTOMIMETIC OPIOIDS *","year":"1982","cit":11,"pfa":"Stephen G. Holtzman","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2066024628","eid":"W2066024628"},{"id":"paper-w2068996818","cat":"papers","name":"Interaction of stress and psychotomimetic drug-action: Possible implication for psychosis","year":"1973","cit":11,"pfa":"Samuel R. Wray","ptype":"article","src":"https://openalex.org/W2068996818","eid":"W2068996818"},{"id":"paper-w4362497000","cat":"papers","name":"Investigating the associations of acute psychedelic experiences and changes in racial trauma symptoms, psychological flexibility, and substance use among People with Racial and Ethnic Minoritized Identities in the United","year":"2023","cit":11,"pfa":"Angela M. Haeny","psa":"Monnica T. Williams","topics":["PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4362497000","eid":"W4362497000"},{"id":"paper-w2754104338","cat":"papers","name":"Impairment of neural coordination in hippocampal neuronal ensembles after a psychotomimetic dose of dizocilpine","year":"2017","cit":11,"pfa":"Ewa Szczurowska","psa":"Aleš Stuchlı́k","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2754104338","eid":"W2754104338"},{"id":"paper-w2050218675","cat":"papers","name":"ChemInform Abstract: PSYCHOTOMIMETIC N‐METHYL‐N‐ISOPROPYLTRYPTAMINES. EFFECTS OF VARIATION OF AROMATIC OXYGEN SUBSTITUENTS","year":"1985","cit":11,"pfa":"David B. Repke","psa":"Alexander T. Shulgin","ptype":"article","src":"https://openalex.org/W2050218675","eid":"W2050218675"},{"id":"paper-w3117027168","cat":"papers","name":"Entheogenic Experience and Spirituality","year":"2020","cit":11,"pfa":"Petter Grahl Johnstad","ptype":"article","src":"https://openalex.org/W3117027168","eid":"W3117027168"},{"id":"paper-w2085148513","cat":"papers","name":"The Epidemiology, Attitudes, and Pharmacology of LSD Use in the 1990s","year":"1994","cit":11,"pfa":"Mark S. Gold","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2085148513","eid":"W2085148513"},{"id":"paper-w2901372675","cat":"papers","name":"Two immunoassays for the detection of 2C-B and related hallucinogenic phenethylamines","year":"2018","cit":11,"pfa":"Anna Šuláková","psa":"Martin Kuchař","ptype":"article","src":"https://openalex.org/W2901372675","eid":"W2901372675"},{"id":"paper-w4237755994","cat":"papers","name":"National Treatment Improvement Evaluation Study (NTIES), 1992-1997","year":"2000","cit":11,"pfa":"United States Department Of Health And Human Services. Substance Abuse And…","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"dataset","src":"https://openalex.org/W4237755994","eid":"W4237755994"},{"id":"paper-w2058173635","cat":"papers","name":"Entheogenic (Hallucinogenic) Effects of Methylergonovine","year":"1980","cit":11,"pfa":"Jonathan Ott","psa":"Patricia Neely","ptype":"article","src":"https://openalex.org/W2058173635","eid":"W2058173635"},{"id":"paper-w2033603885","cat":"papers","name":"Heroin in the Treatment of Morphine Addiction","year":"1977","cit":11,"pfa":"John C. Kramer","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2033603885","eid":"W2033603885"},{"id":"paper-w1986417077","cat":"papers","name":"Diagnosis and Treatment of the Phencyclidine Psychosis: Clinical Considerations","year":"1979","cit":11,"pfa":"Carol Russ","psa":"Dennis Wong","ptype":"article","src":"https://openalex.org/W1986417077","eid":"W1986417077"},{"id":"paper-w2005412309","cat":"papers","name":"Sex Role Differences In The Therapeutic Community: Moving From Sexism To Androgyny","year":"1975","cit":11,"pfa":"Stephen J. Levy","psa":"Marie Broudy","ptype":"article","src":"https://openalex.org/W2005412309","eid":"W2005412309"},{"id":"paper-w2088688597","cat":"papers","name":"Drug Abuse in Combat: The Crisis of Drugs and Addiction Among American Troops in Vietnam","year":"1971","cit":11,"pfa":"David J. Bentel","psa":"David Eugene Smith","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2088688597","eid":"W2088688597"},{"id":"paper-w3119598991","cat":"papers","name":"Peculiar plants and fantastic fungi: An ethnobotanical study of the use of hallucinogenic plants and mushrooms in Slovenia","year":"2021","cit":11,"pfa":"Karsten Fatur","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3119598991","eid":"W3119598991"},{"id":"paper-w4380853870","cat":"papers","name":"Phytochemical interventions for post-traumatic stress disorder: A cluster co-occurrence network analysis using CiteSpace","year":"2023","cit":11,"pfa":"Biao Gao","psa":"Hui Shen","topics":["PTSD & trauma","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4380853870","eid":"W4380853870"},{"id":"paper-w4405619936","cat":"papers","name":"A pilot human study using ketamine to treat disorders of consciousness","year":"2024","cit":11,"pfa":"Paolo Cardone","psa":"Olivia Gosseries","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4405619936","eid":"W4405619936"},{"id":"paper-w4367310158","cat":"papers","name":"25X-NBOMe compounds – chemistry, pharmacology and toxicology. A comprehensive review","year":"2023","cit":11,"pfa":"Monika Herian","psa":"Paweł Świt","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4367310158","eid":"W4367310158"},{"id":"paper-w2900974205","cat":"papers","name":"DMT Dialogues: Encounters with the Spirit Molecule","year":"2018","cit":11,"pfa":"David P. Luke","psa":"Rory Spowers","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2900974205","eid":"W2900974205"},{"id":"paper-w4408694510","cat":"papers","name":"Pharmacological Monotherapy for Depressive Disorders: Current and Future—A Narrative Review","year":"2025","cit":11,"pfa":"Keming Gao","psa":"Buket Koparal","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W4408694510","eid":"W4408694510"},{"id":"paper-w2527475179","cat":"papers","name":"NATURAL PSYCHODYSLEPTIC COMPOUNDS: SOURCES AND PHARMACOLOGY","year":"2016","cit":11,"pfa":"Sisira Padavala","psa":"Devaraj Ezhilarasan","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2527475179","eid":"W2527475179"},{"id":"paper-w3005995107","cat":"papers","name":"The serotonin 2A receptor agonist 25CN-NBOH increases murine heart rate and neck-arterial blood flow in a temperature-dependent manner","year":"2020","cit":11,"pfa":"Tobias Buchborn","psa":"Thomas Knöpfel","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3005995107","eid":"W3005995107"},{"id":"paper-w2010951570","cat":"papers","name":"Pharmacological characteristics of abnormal behavior induced by harmine with special reference to tremor in mice.","year":"1981","cit":11,"pfa":"Kazuko Kawanishi","psa":"Showa Ueki","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2010951570","eid":"W2010951570"},{"id":"paper-w157773173","cat":"papers","name":"Use of LSD in the Haight-Ashbury. Observations at a neighborhood clinic.","year":"1969","cit":11,"pfa":"David Eugene Smith","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W157773173","eid":"W157773173"},{"id":"paper-w2899127352","cat":"papers","name":"Characteristics and Correlates of Psychiatric Problems in Wives of Men with Substance-related Disorders, Kermanshah, Iran","year":"2018","cit":11,"pfa":"Toraj Ahmadi Juibari","psa":"Mostafa Alikhani","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2899127352","eid":"W2899127352"},{"id":"paper-w4385932969","cat":"papers","name":"Perioperative Considerations for Patients Exposed to Psychostimulants","year":"2023","cit":11,"pfa":"Trent D. Emerick","psa":"Douglas Gordon Ririe","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4385932969","eid":"W4385932969"},{"id":"paper-w4404108340","cat":"papers","name":"The Algorithmic Agent Perspective and Computational Neuropsychiatry: From Etiology to Advanced Therapy in Major Depressive Disorder","year":"2024","cit":11,"pfa":"Giulio Ruffini","psa":"Jakub Vohryzek","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4404108340","eid":"W4404108340"},{"id":"paper-w2990827848","cat":"papers","name":"Drug Addiction in Bangladesh: “A Consequence of Social Demoralization Rather Than Individual Flaws”","year":"2019","cit":11,"pfa":"Dr. M. Nasirullah Memorial Trust, Tejgaon, Dhaka 1215, Bangladesh","psa":"Abdul Kader Mohiuddin","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2990827848","eid":"W2990827848"},{"id":"paper-w2146560520","cat":"papers","name":"\"Designer\" amphetamines: effects on behavior and monoamines with or without reserpine and/or alpha-methyl-para-tyrosine pretreatment.","year":"1991","cit":11,"pfa":"Mathew Thomas Martin-Iverson","psa":"Bruce A. Lodge","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2146560520","eid":"W2146560520"},{"id":"paper-w3131795542","cat":"papers","name":"Nixing the nightshades: Traditional knowledge of intoxicating members of the Solanaceae among hallucinogenic plant and mushroom users in Slovenia","year":"2021","cit":11,"pfa":"Karsten Fatur","psa":"Samo Kreft","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3131795542","eid":"W3131795542"},{"id":"paper-w1567116736","cat":"papers","name":"NOUVELLES DROGUES DE « RAVE-PARTIES » : KETAMINE ET PROLINTANE","year":"2002","cit":11,"pfa":"Jean‐Michel Gaulier","psa":"Gérard Lachâtre","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1567116736","eid":"W1567116736"},{"id":"paper-w2771710721","cat":"papers","name":"Alcohol and Drug Use, Pain and Psychiatric Symptoms among Adults Seeking Outpatient Psychiatric Treatment: Latent Class Patterns and Relationship to Health Status","year":"2017","cit":11,"pfa":"Danielle E. Ramo","psa":"Derek D. Satre","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W2771710721","eid":"W2771710721"},{"id":"paper-w2041234637","cat":"papers","name":"Involvement of Serotonin Receptor Mechanisms in the Discriminative Stimulus Effects of Ketamine in Rats","year":"2013","cit":11,"pfa":"Kazumi Yoshizawa","psa":"Tsutomu Suzuki","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2041234637","eid":"W2041234637"},{"id":"paper-w2000689594","cat":"papers","name":"Using selected scenes from Brazilian films to teach about substance use disorders, within medical education","year":"2012","cit":11,"pfa":"João Maurício Castaldelli-Maia","psa":"Dinesh Bhugra","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2000689594","eid":"W2000689594"},{"id":"paper-w3205920106","cat":"papers","name":"Slower Learning Rates from Negative Outcomes in Substance Use Disorder over a 1-Year Period and their Potential Predictive Utility","year":"2021","cit":11,"pfa":"Ryan S. Smith","psa":"Martin P. Paulus","topics":["Addiction"],"ptype":"preprint","src":"https://openalex.org/W3205920106","eid":"W3205920106"},{"id":"paper-w4406986048","cat":"papers","name":"A Phase I/IIa Clinical Trial to Evaluate Safety and Adrenal Uptake of Para-Chloro-2-[18F]Fluoroethyletomidate in Healthy Volunteers and Patients with Primary Aldosteronism","year":"2025","cit":11,"pfa":"Daniel Gillett","psa":"Mark Gurnell","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4406986048","eid":"W4406986048"},{"id":"paper-w2892495140","cat":"papers","name":"Informativeness of Auditory Stimuli Does Not Affect EEG Signal Diversity","year":"2018","cit":11,"pfa":"Michał Bola","psa":"Artur Marchewka","ptype":"article","src":"https://openalex.org/W2892495140","eid":"W2892495140"},{"id":"paper-w2465156900","cat":"papers","name":"A Review of Nicotinic Acid, N-Methylated Indoleamines and Schizophrenia","year":"2017","cit":11,"pfa":"Daniel J. Luchins","psa":"Heinz E. Lehmann","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2465156900","eid":"W2465156900"},{"id":"paper-w4311422605","cat":"papers","name":"Patients' recovery and non-recovery narratives after intravenous ketamine for treatment-resistant depression","year":"2022","cit":11,"pfa":"Adrienne Lapidos","psa":"Sagar V. Parikh","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4311422605","eid":"W4311422605"},{"id":"paper-w2334245913","cat":"papers","name":"Chirality in anaesthesia - ropivacaine, ketamine and thiopentone","year":"1998","cit":11,"pfa":"Laurence E. Mather","psa":"Stephen R. Edwards","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2334245913","eid":"W2334245913"},{"id":"paper-w4387368918","cat":"papers","name":"The effects of (2R,6R)-hydroxynorketamine on oxycodone withdrawal and reinstatement","year":"2023","cit":11,"pfa":"Caryssa R. Drinkuth","psa":"Gregory C. Sartor","ptype":"article","src":"https://openalex.org/W4387368918","eid":"W4387368918"},{"id":"paper-w2076591387","cat":"papers","name":"Amphetamines and Related Compounds: Proceedings of the Mario Negri Institute for Pharmacological Research in Milan, Italy.","year":"1971","cit":11,"pfa":"R. C. Duvoisin","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2076591387","eid":"W2076591387"},{"id":"paper-w4387448490","cat":"papers","name":"A preclinical model of THC edibles that produces high-dose cannabimimetic responses","year":"2023","cit":11,"pfa":"Anthony English","psa":"Benjamin Bruce Land","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4387448490","eid":"W4387448490"},{"id":"paper-w2126872796","cat":"papers","name":"Role of the nitric oxide donor sodium nitroprusside in the antidepressant effect of ketamine in mice","year":"2015","cit":11,"pfa":"Miriam Annika Vogt","psa":"Dragoš Inta","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2126872796","eid":"W2126872796"},{"id":"paper-w1992037620","cat":"papers","name":"LSD: A missed opportunity?","year":"1994","cit":11,"pfa":"GORDON S. CLARIDGE","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W1992037620","eid":"W1992037620"},{"id":"paper-w1544537358","cat":"papers","name":"Phenomenology, Aetiology and Treatment of Schizophrenia","year":"2008","cit":11,"pfa":"Daniel C. Javitt","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"other","src":"https://openalex.org/W1544537358","eid":"W1544537358"},{"id":"paper-w3109657576","cat":"papers","name":"Corticosterone as a Potential Confounding Factor in Delineating Mechanisms Underlying Ketamine’s Rapid Antidepressant Actions","year":"2020","cit":11,"pfa":"Lauren Wegman‐Points","psa":"Li‐Lian Yuan","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3109657576","eid":"W3109657576"},{"id":"paper-w4313260030","cat":"papers","name":"Impact of Repeated Doses of Subcutaneous Esketamine on Acute Dissociative Symptoms in Treatment-Resistant Depression","year":"2022","cit":11,"pfa":"Lorena Catarina Del Sant","psa":"Jair de Jesus Mari","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4313260030","eid":"W4313260030"},{"id":"paper-w1988292186","cat":"papers","name":"Delayed stress-induced increase in tissue level of cholecystokinin in rat prefrontal cortex: modulation by microdialysis probe implantation and systemic ketamine","year":"2001","cit":11,"pfa":"Diana Radu","psa":"Nils Lindefors","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1988292186","eid":"W1988292186"},{"id":"paper-w4379600473","cat":"papers","name":"A systematic review of the print media representation of ketamine treatments for psychiatric disorders","year":"2023","cit":11,"pfa":"Nicollette L. R. Thornton","psa":"Nick Glozier","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W4379600473","eid":"W4379600473"},{"id":"paper-w2118262406","cat":"papers","name":"Stereoselective Differences in the Vasorelaxing Effects of S(+) and R(-) Ketamine on Rat Isolated Aorta","year":"1998","cit":11,"pfa":"Adriani Kanellopoulos","psa":"Bernd Mühlbauer","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2118262406","eid":"W2118262406"},{"id":"paper-w2903933014","cat":"papers","name":"Potential Mechanisms for the Ketamine-Induced Reduction of P3b Amplitudes","year":"2018","cit":11,"pfa":"Timm Rosburg","psa":"André Schmidt","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2903933014","eid":"W2903933014"},{"id":"paper-w3034228278","cat":"papers","name":"Comparative therapeutic index, lethal time and safety margin of various toxicants and snake antivenoms using newly derived and old formulas","year":"2020","cit":11,"pfa":"Saganuwan Alhaji Saganuwan","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3034228278","eid":"W3034228278"},{"id":"paper-w2062331070","cat":"papers","name":"Ketamine Metabolomics in the Treatment of Major Depression","year":"2014","cit":11,"pfa":"Monique van Velzen","psa":"Albert Dahan","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2062331070","eid":"W2062331070"},{"id":"paper-w3123182993","cat":"papers","name":"Cocaine-Positive Patients Undergoing Elective Surgery: From Avoiding Case Cancellations to Treating Substance Use Disorders","year":"2021","cit":11,"pfa":"Karsten Bartels","psa":"Joseph P. Schacht","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3123182993","eid":"W3123182993"},{"id":"paper-w2015911631","cat":"papers","name":"Functional psychopharmacology is the way to go in pharmacotherapy for psychiatric disorders","year":"2010","cit":11,"pfa":"ANTON J. M. LOONEN","psa":"Stephen M. Stahl","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2015911631","eid":"W2015911631"},{"id":"paper-w3212159111","cat":"papers","name":"Esketamine: uncertain safety and efficacy data in depression","year":"2021","cit":11,"pfa":"Mark Abie Horowitz","psa":"Joanna Moncrieff","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3212159111","eid":"W3212159111"},{"id":"paper-w4225256622","cat":"papers","name":"“Esketamine” in Borderline Personality Disorder: A Look Beyond Suicidality","year":"2022","cit":11,"pfa":"Neethu K Nandan","psa":"Aqeel Hashmi","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4225256622","eid":"W4225256622"},{"id":"paper-w4285402084","cat":"papers","name":"Adjunctive dopaminergic enhancement of esketamine in treatment-resistant depression","year":"2022","cit":11,"pfa":"John T. Cook","psa":"Angelos E Halaris","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4285402084","eid":"W4285402084"},{"id":"paper-w3127623726","cat":"papers","name":"Depression: EU approves expanded use of esketamine for rapid reduction of symptoms","year":"2021","cit":11,"pfa":"Elisabeth Mahase","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3127623726","eid":"W3127623726"},{"id":"paper-w4317567006","cat":"papers","name":"Cost-Utility Analysis of Esketamine for Patients with Treatment-Resistant Depression in Italy","year":"2023","cit":11,"pfa":"Carla Rognoni","psa":"Patrizio Armeni","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4317567006","eid":"W4317567006"},{"id":"paper-w4367368381","cat":"papers","name":"Prenatal Exposure to General Anesthesia Drug Esketamine Impaired Neurobehavior in Offspring","year":"2023","cit":11,"pfa":"Ronghua Huang","psa":"Yalan Li","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4367368381","eid":"W4367368381"},{"id":"paper-w4311675122","cat":"papers","name":"Adverse Events and Measurement of Dissociation After the First Dose of Esketamine in Patients With TRD","year":"2022","cit":11,"pfa":"David Williamson","psa":"Wayne Curtis Drevets","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4311675122","eid":"W4311675122"},{"id":"paper-w4385799056","cat":"papers","name":"Esketamine vs Midazolam in Boosting the Efficacy of Oral Antidepressants for Major Depressive Disorder","year":"2023","cit":11,"pfa":"Chunfeng Xiao","psa":"Gang Wang","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4385799056","eid":"W4385799056"},{"id":"paper-w4400595228","cat":"papers","name":"Comparing the adverse effects of ketamine and esketamine between genders using FAERS data","year":"2024","cit":11,"pfa":"Xinxia Yang","psa":"Dongdong Chen","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4400595228","eid":"W4400595228"},{"id":"paper-w4200248031","cat":"papers","name":"The drug liking and craving questionnaire (DLCQ) to evaluate addiction risk for ketamine and esketamine","year":"2021","cit":11,"pfa":"Jay Ching-Chieh Wang","psa":"Jennifer Swainson","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4200248031","eid":"W4200248031"},{"id":"paper-w4210646534","cat":"papers","name":"Esketamine increases neurotransmitter releases but simplifies neurotransmitter networks in mouse prefrontal cortex","year":"2022","cit":11,"pfa":"Ye Wang","psa":"Hailong Dong","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4210646534","eid":"W4210646534"},{"id":"paper-w4401793406","cat":"papers","name":"Optimizing esketamine administration for postoperative depression: a comprehensive study on laparoscopic bariatric surgery patients","year":"2024","cit":11,"pfa":"Jiabao Dai","psa":"Zhouquan Wu","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4401793406","eid":"W4401793406"},{"id":"paper-w4205424531","cat":"papers","name":"How to deprescribe esketamine in resistant depression? A point of view after first clinical uses","year":"2022","cit":11,"pfa":"Tanguy Taillefer de Laportalière","psa":"François Montastruc","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4205424531","eid":"W4205424531"},{"id":"paper-w4401555067","cat":"papers","name":"Effect of intraoperative injection of esketamine on postoperative analgesia and postoperative rehabilitation after cesarean section","year":"2024","cit":11,"pfa":"Hongzhuan Chen","psa":"Jin Zhang","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4401555067","eid":"W4401555067"},{"id":"paper-w4415651536","cat":"papers","name":"Comparative safety and tolerability of ketamine and esketamine for major depressive disorder: a systematic review and meta-analysis","year":"2025","cit":11,"pfa":"Haoning Guo","psa":"Xueli Tang","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W4415651536","eid":"W4415651536"},{"id":"paper-w3114905795","cat":"papers","name":"Combination of Electroconvulsive Therapy Alternating With Intravenous Esketamine Can Lead to Rapid Remission of Treatment Resistant Depression","year":"2020","cit":11,"pfa":"Erhan Kavakbasi","psa":"Bernhard Theodor Baune","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W3114905795","eid":"W3114905795"},{"id":"paper-w4402940976","cat":"papers","name":"Inflammatory cytokines, cortisol, and anhedonia in patients with treatment-resistant depression after consecutive infusions of low-dose esketamine","year":"2024","cit":11,"pfa":"Yue Wang","psa":"Kai Zhang","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4402940976","eid":"W4402940976"},{"id":"paper-w4407736293","cat":"papers","name":"Efficacy and safety of esketamine for emergency endotracheal intubation in ICU patients: a double-blind, randomized controlled clinical trial","year":"2025","cit":11,"pfa":"Xue Zhang","psa":"Jiancheng Zhang","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4407736293","eid":"W4407736293"},{"id":"paper-w4393196733","cat":"papers","name":"Effect of pretreatment with a small dose of esketamine on sufentanil-induced cough during anesthesia induction: a randomized controlled trial","year":"2024","cit":11,"pfa":"Liangliang Gao","psa":"Lei Wei","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4393196733","eid":"W4393196733"},{"id":"paper-w4399708484","cat":"papers","name":"Rapid and long-lasting effects of subcutaneous esketamine on suicidality: An open-label study in patients with treatment-resistant depression","year":"2024","cit":11,"pfa":"Eduardo Igor Torquato Cardoso Lopes","psa":"Nicole Leite Galvão Coelho","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4399708484","eid":"W4399708484"},{"id":"paper-w4404166152","cat":"papers","name":"Effect of Esketamine Nasal Spray on Cognition in Patients With Treatment-Resistant Depression: Results From Four Phase 3 Studies","year":"2024","cit":11,"pfa":"Randall L. Morrison","psa":"Wayne Curtis Drevets","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4404166152","eid":"W4404166152"},{"id":"paper-w4404774945","cat":"papers","name":"Clinical value of esketamine combined with ropivacaine in rebound pain after brachial plexus block in patients with upper limb fractures","year":"2024","cit":11,"pfa":"Shiyao Zhu","psa":"Shanshan Zhu","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4404774945","eid":"W4404774945"},{"id":"paper-w4387307204","cat":"papers","name":"Exploring the role of esketamine in alleviating depressive symptoms in mice via the PGC-1α/irisin/ERK1/2 signaling pathway","year":"2023","cit":11,"pfa":"Na Hu","psa":"Xiaobin Wang","topics":["Depression","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4387307204","eid":"W4387307204"},{"id":"paper-w4309880029","cat":"papers","name":"Chiral LC-MS/MS method for the simultaneous determination of (R,S)-ketamine, (R,S)-norketamine, and (2R,6R;2S,6S)-hydroxynorketamine in mouse plasma and brain","year":"2022","cit":11,"pfa":"Hidetoh Toki","psa":"Hiromi Endo","ptype":"article","src":"https://openalex.org/W4309880029","eid":"W4309880029"},{"id":"paper-w4392752702","cat":"papers","name":"Effects of perioperative intravenous lidocaine and esketamine on the quality of recovery and emotional state of patients after thyroidectomy: A randomised, double-blind, controlled trial","year":"2024","cit":11,"pfa":"Mengci Li","psa":"Chenglan Xie","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4392752702","eid":"W4392752702"},{"id":"paper-w4408464678","cat":"papers","name":"The Opioid-Sparing Effects of Intraoperative Esketamine Combined with Dexmedetomidine During Laparoscopic Major Abdominal Surgery: A Randomized Controlled Double-Blind Trial","year":"2025","cit":11,"pfa":"Wenjun Wang","psa":"Min Zhong","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4408464678","eid":"W4408464678"},{"id":"paper-w2797934327","cat":"papers","name":"S111. Randomized, Double-Blind Study of Flexibly-Dosed Intranasal Esketamine Plus Oral Antidepressant Vs. Active Control in Treatment-Resistant Depression","year":"2018","cit":11,"pfa":"Vanina Popova","psa":"Jaskaran B. Singh","topics":["Depression","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W2797934327","eid":"W2797934327"},{"id":"paper-w4404545865","cat":"papers","name":"Effects of esketamine combined with dexmedetomidine on postoperative delirium and quality of recovery in elderly patients undergoing thoracoscopic radical lung cancer surgery: a randomized controlled trial","year":"2024","cit":11,"pfa":"Cong-Li Zhang","psa":"Li Ren","topics":["Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4404545865","eid":"W4404545865"},{"id":"paper-w4404766647","cat":"papers","name":"Effects of Esketamine Combined with Dexmedetomidine on Early Postoperative Cognitive Function in Elderly Patients Undergoing Lumbar Spinal Surgery: A Double-Blind Randomized Controlled Clinical Trial","year":"2024","cit":11,"pfa":"Qing-Yu Tao","psa":"Jun‐Ma Yu","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4404766647","eid":"W4404766647"},{"id":"paper-w4386798470","cat":"papers","name":"Does the intensity of dissociation predict antidepressant effects 24 hours after infusion of racemic ketamine or esketamine in treatment-resistant depression? A secondary analysis from a randomized controlled trial","year":"2023","cit":11,"pfa":"Mariana V.F. Echegaray","psa":"Lucas C. Quarantini","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4386798470","eid":"W4386798470"},{"id":"paper-w4304991010","cat":"papers","name":"Dysregulation of AMPK-mTOR signaling leads to comorbid anxiety inDip2aKO mice","year":"2022","cit":11,"pfa":"Jun Ma","psa":"Hua‐Li Yu","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4304991010","eid":"W4304991010"},{"id":"paper-w4367839760","cat":"papers","name":"Ketamine supresses REM sleep and markedly increases EEG gamma oscillations in the Wistar Kyoto rat model of treatment-resistant depression","year":"2023","cit":11,"pfa":"Sándor Kántor","psa":"Mark S. Duxon","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4367839760","eid":"W4367839760"},{"id":"paper-w4395456111","cat":"papers","name":"Ketamine and its enantiomers for depression: a bibliometric analysis from 2000 to 2023","year":"2024","cit":11,"pfa":"Li-yuan Zhao","psa":"Jianjun Yang","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4395456111","eid":"W4395456111"},{"id":"paper-w4388486526","cat":"papers","name":"Nebulized and intraperitoneal ketamine have equivalent antidepressant-like effect in the forced swim and tail suspension tests in mice","year":"2023","cit":11,"pfa":"Aida A.C. Brandão","psa":"Luciano Augusto de Araújo Ribeiro","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4388486526","eid":"W4388486526"},{"id":"paper-w2016150092","cat":"papers","name":"Persistent effects of chronic administration of LSD on intracellular serotonin content in rat midbrain","year":"1980","cit":11,"pfa":"Eminy H.Y. Lee","psa":"Mark A. Geyer","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2016150092","eid":"W2016150092"},{"id":"paper-w2006091165","cat":"papers","name":"The indole hallucinogens, N,N-dimethyltryptamine (DMT) and 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT), have different effects from mescaline on rat shuttlebox avoidance","year":"1978","cit":10,"pfa":"David M. Stoff","psa":"Richard Jed Wyatt","ptype":"article","src":"https://openalex.org/W2006091165","eid":"W2006091165"},{"id":"paper-w2473572762","cat":"papers","name":"Therapy with lysergic acid diethylamide.","year":"2000","cit":10,"pfa":"D J LEWIS","psa":"Sloane Rb","ptype":"article","src":"https://openalex.org/W2473572762","eid":"W2473572762"},{"id":"paper-w1983299333","cat":"papers","name":"Lysergic Acid Diethylamide (LSD 25) and behaviour therapy","year":"1964","cit":10,"pfa":"C.G. Costello","ptype":"article","src":"https://openalex.org/W1983299333","eid":"W1983299333"},{"id":"paper-w2107140564","cat":"papers","name":"Relation of Physiological and Psychological Effects of Lysergic Acid Diethylamide","year":"1957","cit":10,"pfa":"Conan H. Kornetsky","ptype":"article","src":"https://openalex.org/W2107140564","eid":"W2107140564"},{"id":"paper-w2120070242","cat":"papers","name":"POTENTIATION OF SUBSTANCE P BY LYSERGIC ACID DIETHYLAMIDE IN VIVO","year":"1961","cit":10,"pfa":"William A. Krivoy","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2120070242","eid":"W2120070242"},{"id":"paper-w2125589221","cat":"papers","name":"Lysergic Acid Diethylamide (Lsd-25): Ix. Effect on Snails","year":"1955","cit":10,"pfa":"Harold A. Abramson","psa":"Murray E. Jarvik","ptype":"article","src":"https://openalex.org/W2125589221","eid":"W2125589221"},{"id":"paper-w2243555108","cat":"papers","name":"LYSERGIC ACID DIETHYLAMIDE INTAKE IN PREGNANCY: FETAL DAMAGE IN RATS","year":"1970","cit":10,"pfa":"George J. Alexander","psa":"Rita B. Alexander","ptype":"article","src":"https://openalex.org/W2243555108","eid":"W2243555108"},{"id":"paper-w1976195943","cat":"papers","name":"Unifying electron transfer mechanism for psilocybin and psilocin","year":"2009","cit":10,"pfa":"Peter Kovacic","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1976195943","eid":"W1976195943"},{"id":"paper-w2975850701","cat":"papers","name":"Acute effects of lysergic acid diethylamide (LSD) on resting brain function","year":"2019","cit":10,"pfa":"Felix Müller","psa":"Stefan Borgwardt","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2975850701","eid":"W2975850701"},{"id":"paper-w2093336878","cat":"papers","name":"Lysergic acid diethylamide. Photoelectron ionization potentials as indices of behavioral activity","year":"1977","cit":10,"pfa":"Linda N. Domelsmith","psa":"K. N. Houk","ptype":"article","src":"https://openalex.org/W2093336878","eid":"W2093336878"},{"id":"paper-w813015582","cat":"papers","name":"Occurrence of psilocybin, psilocin and baeocystin in Gymnopilus purpuratus","year":"1989","cit":10,"pfa":"Jochen Gartz","ptype":"article","src":"https://openalex.org/W813015582","eid":"W813015582"},{"id":"paper-w2063818783","cat":"papers","name":"Inhibitory Effect of Chlorpromazine on Alterations in Electroencephalograms induced by Lysergic Acid Diethylamide in Dogs","year":"1966","cit":10,"pfa":"BIJAN DJAHANGUIRI","psa":"Nasser Guiti","ptype":"article","src":"https://openalex.org/W2063818783","eid":"W2063818783"},{"id":"paper-w1969213958","cat":"papers","name":"Biosynthesis of the Iboga alkaloids : The incorporation of tryptophan-3-C14 into Ibogaine","year":"1964","cit":10,"pfa":"Mikio Yamasaki","psa":"Edward Leete","ptype":"article","src":"https://openalex.org/W1969213958","eid":"W1969213958"},{"id":"paper-w29905649","cat":"papers","name":"The Isolation and Identification of Lysergic Acid Diethylamide (LSD) from Sugar Cubes and a Liquid Substrate","year":"1994","cit":10,"pfa":"SD Kilmer","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W29905649","eid":"W29905649"},{"id":"paper-w3156520588","cat":"papers","name":"A cluster of lysergic acid diethylamide (LSD) poisonings following insufflation of a white powder sold as cocaine","year":"2021","cit":10,"pfa":"Darren M. Roberts","psa":"Jared A Brown","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3156520588","eid":"W3156520588"},{"id":"paper-w1998286964","cat":"papers","name":"d-Lysergic acid diethylamide differentially affects the dual actions of 5-hydroxytryptamine on cortical neurons","year":"1990","cit":10,"pfa":"P A Pierce","psa":"S J Peroutka","ptype":"article","src":"https://openalex.org/W1998286964","eid":"W1998286964"},{"id":"paper-w4390665254","cat":"papers","name":"In vivo validation of psilacetin as a prodrug yielding modestly lower peripheral psilocin exposure than psilocybin","year":"2024","cit":10,"pfa":"N. Jones","psa":"Cody J. Wenthur","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4390665254","eid":"W4390665254"},{"id":"paper-w2012392593","cat":"papers","name":"Alternative Method for Forensic Determination of Lysergic Acid Diethylamide and Related Compounds in Body Fluids by Liquid?Liquid Extraction and HPLC with Fluorescence Detection","year":"2004","cit":10,"pfa":"Jörg Pietsch","psa":"Manfred H. Gey","ptype":"article","src":"https://openalex.org/W2012392593","eid":"W2012392593"},{"id":"paper-w2025378109","cat":"papers","name":"The effects of D-lysergic acid diethylamide tartrate (LSD-25) on the cholinesterases and monoamine oxidase in the spinal cord: a possible factor in the mechanism of hallucination","year":"1964","cit":10,"pfa":"Kunal NANDY","psa":"Geoffrey H. Bourne","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2025378109","eid":"W2025378109"},{"id":"paper-w1964290959","cat":"papers","name":"Effect of fluvoxamine on platelet 5-HT 2A receptors as studied by [ 3 H]lysergic acid diethylamide ([ 3 H]LSD) binding in healthy volunteers","year":"1997","cit":10,"pfa":"Olav Spigset","psa":"Tom Mjörndal","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1964290959","eid":"W1964290959"},{"id":"paper-w1964255087","cat":"papers","name":"Discriminative stimulus properties of mescaline: Mescaline or metabolite?","year":"1975","cit":10,"pfa":"Ronald G. Browne","psa":"Beng T. Ho","ptype":"article","src":"https://openalex.org/W1964255087","eid":"W1964255087"},{"id":"paper-w2071541303","cat":"papers","name":"Effects of noribogaine on the development of tolerance to antinociceptive action of morphine in mice","year":"1997","cit":10,"pfa":"Hemendra N. Bhargava","psa":"Ying‐Jun Cao","ptype":"article","src":"https://openalex.org/W2071541303","eid":"W2071541303"},{"id":"paper-w4400495765","cat":"papers","name":"Magic of the Mushrooms: Effects of Psilocybin Decriminalization","year":"2024","cit":10,"pfa":"Ashutosh Bhave","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4400495765","eid":"W4400495765"},{"id":"paper-w3008779546","cat":"papers","name":"Determination of N,N-dimethyltryptamine and beta-carbolines in plants used to prepare ayahuasca beverages by means of solid-phase extraction and gas-chromatography–mass spectrometry","year":"2020","cit":10,"pfa":"Ana Y. Simão","psa":"Eugénia Gallardo","ptype":"article","src":"https://openalex.org/W3008779546","eid":"W3008779546"},{"id":"paper-w2920742167","cat":"papers","name":"Internet method for the extraction of N,N-dimethyltryptamine from Mimosa hostilis roots: Does it really extract dimethyltryptamine?","year":"2019","cit":10,"pfa":"Giordano Novak Rossi","psa":"RAFAEL GUIMARÃES DOS SANTOS","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2920742167","eid":"W2920742167"},{"id":"paper-w2070526033","cat":"papers","name":"Further observations on peyote intoxication.","year":"1932","cit":10,"pfa":"Samuel W. Fernberger","ptype":"article","src":"https://openalex.org/W2070526033","eid":"W2070526033"},{"id":"paper-w2937994262","cat":"papers","name":"Bwiti, iboga, trance and healing in Gabon","year":"2018","cit":10,"pfa":"Pierre Didier Nyongo Ndoua","psa":"Kaveh Vaghar","ptype":"article","src":"https://openalex.org/W2937994262","eid":"W2937994262"},{"id":"paper-w2346481026","cat":"papers","name":"Functional neurotoxicity evaluation of noribogaine using video-EEG in cynomolgus monkeys","year":"2016","cit":10,"pfa":"Simon Authier","psa":"Holger Weis","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2346481026","eid":"W2346481026"},{"id":"paper-w1973325262","cat":"papers","name":"Biosynthesis of Mescaline and N-Acetylmescaline by Mammalian Liver","year":"1972","cit":10,"pfa":"Arnold J. Friedhoff","psa":"Jeannette Miller","ptype":"article","src":"https://openalex.org/W1973325262","eid":"W1973325262"},{"id":"paper-w2807594165","cat":"papers","name":"Effects of mescaline on self stimulation in rats","year":"1971","cit":10,"pfa":"Bailey Pt","psa":"S.N. Pradhan","ptype":"article","src":"https://openalex.org/W2807594165","eid":"W2807594165"},{"id":"paper-w2770167300","cat":"papers","name":"Origin of the Peyote Religion in The United States","year":"1974","cit":10,"pfa":"Orner C. Stewart","ptype":"article","src":"https://openalex.org/W2770167300","eid":"W2770167300"},{"id":"paper-w1996165440","cat":"papers","name":"Enzymic oxidation of mescaline by mammalian plasma","year":"1958","cit":10,"pfa":"Hermann Karl Felix Blaschko","psa":"Rosemary Hawes","ptype":"article","src":"https://openalex.org/W1996165440","eid":"W1996165440"},{"id":"paper-w2063783771","cat":"papers","name":"Ayahuasca : une synthèse interdisciplinaire","year":"2002","cit":10,"pfa":"Frédérick Bois-Mariage","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2063783771","eid":"W2063783771"},{"id":"paper-w3010080009","cat":"papers","name":"Salvinorin A Does Not Affect Seizure Threshold in Mice","year":"2020","cit":10,"pfa":"Katarzyna Socała","psa":"Piotr Właź","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3010080009","eid":"W3010080009"},{"id":"paper-w2147686129","cat":"papers","name":"Bioactive Alkaloids from Fungi: Psilocybin","year":"2013","cit":10,"pfa":"Zafar Mahmood","ptype":"book-chapter","src":"https://openalex.org/W2147686129","eid":"W2147686129"},{"id":"paper-w2328567579","cat":"papers","name":"19-Epivoacristine, an Iboga Alkaloid Isolated fromPeschiera affinis","year":"1996","cit":10,"pfa":"Telma Leda Gomes de Lemos","psa":"Raimundo Braz‐Filho","ptype":"article","src":"https://openalex.org/W2328567579","eid":"W2328567579"},{"id":"paper-w2114095602","cat":"papers","name":"Stimulus control by 5-methoxy-N,N-dimethyltryptamine in wild-type and CYP2D6-humanized mice","year":"2011","cit":10,"pfa":"Jerrold C. Winter","psa":"Ai‐Ming Yu","ptype":"article","src":"https://openalex.org/W2114095602","eid":"W2114095602"},{"id":"paper-w2969932117","cat":"papers","name":"5-Methoxy-N,N-dimethyltryptamine: An Ego-Dissolving Endogenous Neurochemical Catalyst of Creativity","year":"2019","cit":10,"pfa":"Christopher B. Germann","ptype":"article","src":"https://openalex.org/W2969932117","eid":"W2969932117"},{"id":"paper-w4297886783","cat":"papers","name":"Ayahuasca in the Czech Republic: Extended Version","year":"2019","cit":10,"pfa":"Miroslav Horák","psa":"Nahanga Verter","ptype":"book","src":"https://openalex.org/W4297886783","eid":"W4297886783"},{"id":"paper-w1972129322","cat":"papers","name":"Toxicity of chronic ayahuasca administration to the pregnant rat: how relevant it is regarding the human, ritual use of ayahuasca?","year":"2010","cit":10,"pfa":"RAFAEL GUIMARÃES DOS SANTOS","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1972129322","eid":"W1972129322"},{"id":"paper-w2035218334","cat":"papers","name":"Studies on mescaline II. Electro-encephalogram in schizophrenics","year":"1955","cit":10,"pfa":"Sidney Merlis","psa":"Wallace Hunter","ptype":"article","src":"https://openalex.org/W2035218334","eid":"W2035218334"},{"id":"paper-w4280555039","cat":"papers","name":"Psilocybin-induced takotsubo cardiomyopathy","year":"2022","cit":10,"pfa":"Wiktoria Julia Kotts","psa":"David Connor","ptype":"article","src":"https://openalex.org/W4280555039","eid":"W4280555039"},{"id":"paper-w2902426748","cat":"papers","name":"Mutagenicity of Ayahuasca and Their Constituents to the Salmonella/Microsome Assay","year":"2018","cit":10,"pfa":"Fábio Kummrow","psa":"Alessandra Linardi","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2902426748","eid":"W2902426748"},{"id":"paper-w2809931078","cat":"papers","name":"MDMA-Assisted Psychotherapy for PTSD","year":"2018","cit":10,"pfa":"Anita J Slomski","topics":["PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2809931078","eid":"W2809931078"},{"id":"paper-w2101537157","cat":"papers","name":"PLACENTAL TRANSFER AND TISSUE DISTRIBUTION OF MESCALINE-14C IN THE MOUSE","year":"1973","cit":10,"pfa":"Nandkumar S. Shah","psa":"R.S. LAWRENCE","ptype":"article","src":"https://openalex.org/W2101537157","eid":"W2101537157"},{"id":"paper-w2214447382","cat":"papers","name":"Ayahuasca versus violence--a case report.","year":"2008","cit":10,"pfa":"Ede Frecska","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2214447382","eid":"W2214447382"},{"id":"paper-w4288064681","cat":"papers","name":"Ibogaine microdosing in a patient with bipolar depression: a case report","year":"2022","cit":10,"pfa":"Maria Helha Fernandes-Nascimento","psa":"Yuan‐Pang Wang","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4288064681","eid":"W4288064681"},{"id":"paper-w91045550","cat":"papers","name":"HALLUCINOGENIC AMINES AND SCHIZOPHRENIA (WITH A BRIEF ADDENDUM ON N-DIMETHYLTRYPTAMINE)","year":"1967","cit":10,"pfa":"Stephen Szára","ptype":"book-chapter","src":"https://openalex.org/W91045550","eid":"W91045550"},{"id":"paper-w2069089686","cat":"papers","name":"A new approach to tritium labelling; the synthesis of [3H]ibogaine","year":"1992","cit":10,"pfa":"Herbert H. Seltman","psa":"Christopher D. Wyrick","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2069089686","eid":"W2069089686"},{"id":"paper-w2988426557","cat":"papers","name":"New Iboga-Type Indole Alkaloids from Tabernaemontana divaricata","year":"2019","cit":10,"pfa":"Xiangmei Li","psa":"Fei Wang","ptype":"article","src":"https://openalex.org/W2988426557","eid":"W2988426557"},{"id":"paper-w2037268717","cat":"papers","name":"A new view of the structural relationship between LSD and mescaline","year":"1977","cit":10,"pfa":"David E. Nichols","psa":"R.J. Cosgrove","ptype":"article","src":"https://openalex.org/W2037268717","eid":"W2037268717"},{"id":"paper-w2904582742","cat":"papers","name":"Interpellations and challenges in the neoshamanic and ayahuasca fields in Uruguay","year":"2018","cit":10,"pfa":"Juan Scuro","topics":["Addiction","Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W2904582742","eid":"W2904582742"},{"id":"paper-w4406097304","cat":"papers","name":"Clinical and preclinical evidence of psilocybin as antidepressant. A narrative review","year":"2025","cit":10,"pfa":"Ines Erkizia-Santamaría","psa":"Jorge Emilio Ortega","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W4406097304","eid":"W4406097304"},{"id":"paper-w4390975880","cat":"papers","name":"The safety of supported psilocybin use in Oregon","year":"2024","cit":10,"pfa":"William Smith","psa":"Paul S. Appelbaum","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4390975880","eid":"W4390975880"},{"id":"paper-w1998603626","cat":"papers","name":"Salvinorin A and Related Compounds as Therapeutic Drugs for Psychostimulant-Related Disorders","year":"2015","cit":10,"pfa":"RAFAEL GUIMARÃES DOS SANTOS","psa":"Jaime E. C. Hallak","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1998603626","eid":"W1998603626"},{"id":"paper-w2012392031","cat":"papers","name":"Vorkommen von Psilocybin und Baeocystin in Fruchtkörpern vonPluteus salicinus","year":"1987","cit":10,"pfa":"Jochen Gartz","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2012392031","eid":"W2012392031"},{"id":"paper-w2066159138","cat":"papers","name":"Detection of biochemical intermediates by mass fragmentography: Mescaline and tetrahydroisoquinoline precursors","year":"1971","cit":10,"pfa":"J.‐E. Lindgren","psa":"Ulrika S.H. Svensson","ptype":"article","src":"https://openalex.org/W2066159138","eid":"W2066159138"},{"id":"paper-w2047411153","cat":"papers","name":"Cactus Alkaloids. LI. Lack of Mescaline Translocation in Grafted Trichocereus","year":"1982","cit":10,"pfa":"Sunibhond Pummangura","psa":"R. C. Schifferdecker","ptype":"article","src":"https://openalex.org/W2047411153","eid":"W2047411153"},{"id":"paper-w2900426082","cat":"papers","name":"Motivational structure of ayahuasca drinkers in social networks","year":"2018","cit":10,"pfa":"Tom John Wolff","psa":"Torsten Passie","ptype":"article","src":"https://openalex.org/W2900426082","eid":"W2900426082"},{"id":"paper-w2315784844","cat":"papers","name":"Synthesis and In Vitro Biological Evaluation of New Dicarboxylic Ester-type Salvinorin A Analogs","year":"2013","cit":10,"pfa":"Prabhakar Reddy Polepally","psa":"JK Zjawiony","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2315784844","eid":"W2315784844"},{"id":"paper-w2326450020","cat":"papers","name":"Convenient Synthesis and In Vitro Pharmacological Activity of Thioesters of Salvinorin B","year":"2013","cit":10,"pfa":"Prabhakar Reddy Polepally","psa":"JK Zjawiony","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2326450020","eid":"W2326450020"},{"id":"paper-w3199252247","cat":"papers","name":"In Vitro Study of the Bioavailability and Bioaccessibility of the Main Compounds Present in Ayahuasca Beverages","year":"2021","cit":10,"pfa":"Joana Gonçalves","psa":"Ana Paula Duarte","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3199252247","eid":"W3199252247"},{"id":"paper-w2397796038","cat":"papers","name":"Biosynthesis of mescaline and tetrahydroisoquinoline alkaloids in Lophophora williamsii (Lem.) Coult.","year":"1971","cit":10,"pfa":"J Lundström","psa":"Stig Agurell","ptype":"article","src":"https://openalex.org/W2397796038","eid":"W2397796038"},{"id":"paper-w4297856957","cat":"papers","name":"Brain dynamics predictive of response to psilocybin for treatment-resistant depression","year":"2022","cit":10,"pfa":"Jakub Vohryzek","psa":"Morten L. Kringelbach","topics":["Depression"],"ptype":"preprint","src":"https://openalex.org/W4297856957","eid":"W4297856957"},{"id":"paper-w2319380997","cat":"papers","name":"Synthesis and In Vitro Pharmacological Activity of C-2 Modified New Salvinorin A Analogues","year":"2013","cit":10,"pfa":"Prabhakar Reddy Polepally","psa":"JK Zjawiony","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2319380997","eid":"W2319380997"},{"id":"paper-w4401257064","cat":"papers","name":"Psilocybin-assisted therapy and HIV-related shame","year":"2024","cit":10,"pfa":"Nicky J. Mehtani","psa":"Brian T. Anderson","topics":["PTSD & trauma","Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4401257064","eid":"W4401257064"},{"id":"paper-w1561343844","cat":"papers","name":"Ecstasy cannot be assumed to be 3,4‐methylenedioxyamphetamine (MDMA)","year":"2012","cit":10,"pfa":"AR Green","psa":"Kevin C.F. Fone","ptype":"article","src":"https://openalex.org/W1561343844","eid":"W1561343844"},{"id":"paper-w1981242170","cat":"papers","name":"Effects of intraocular mescaline and LSD on visual-evoked responses in the rat","year":"1989","cit":10,"pfa":"Janis Thane Eells","psa":"Douglas M. Wilkison","ptype":"article","src":"https://openalex.org/W1981242170","eid":"W1981242170"},{"id":"paper-w2031458028","cat":"papers","name":"Mescaline-induced motor impairment in rats, assessed by two different methods","year":"1986","cit":10,"pfa":"Elizabeth A. Sykes","ptype":"article","src":"https://openalex.org/W2031458028","eid":"W2031458028"},{"id":"paper-w1986542669","cat":"papers","name":"Toxic effect of MDMA on brain serotonin neurons","year":"1999","cit":10,"pfa":"Jyrki T. Kuikka","psa":"Aapo K Ahonen","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1986542669","eid":"W1986542669"},{"id":"paper-w2313077927","cat":"papers","name":"Cactus Alkaloids. II. Condensation of Mescaline with Formaldehyde by the Eschweiler—Clarke Reaction","year":"1952","cit":10,"pfa":"J.A. Rodríguez Castrillón","ptype":"article","src":"https://openalex.org/W2313077927","eid":"W2313077927"},{"id":"paper-w2085903288","cat":"papers","name":"Ayahuasca : liane de l'âme, chamanes et soumission chimique","year":"2004","cit":10,"pfa":"Gilbert Pépin","psa":"Gaëlle Duffort","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2085903288","eid":"W2085903288"},{"id":"paper-w4409824886","cat":"papers","name":"The phenomenology of psilocybin: transformative insights for research and clinical practice","year":"2025","cit":10,"pfa":"Antonio Metastasio","psa":"Ornella Corazza","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4409824886","eid":"W4409824886"},{"id":"paper-w3152965122","cat":"papers","name":"Have Norwegians tried psilocybin, and do they accept it as a medicine?","year":"2021","cit":10,"pfa":"Henrik Børsting Jacobsen","psa":"Silje Endresen Rème","ptype":"article","src":"https://openalex.org/W3152965122","eid":"W3152965122"},{"id":"paper-w2781458779","cat":"papers","name":"Psicosis inducida por ayahuasca: reporte de un caso.","year":"2017","cit":10,"pfa":"Diego Neyra-Ontaneda","ptype":"article","src":"https://openalex.org/W2781458779","eid":"W2781458779"},{"id":"paper-w4402529371","cat":"papers","name":"Refractory CRPS pain treated with psilocybin: A case report","year":"2024","cit":10,"pfa":"David S. Jevotovsky","psa":"Joel P Castellanos","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4402529371","eid":"W4402529371"},{"id":"paper-w3199179808","cat":"papers","name":"A whole genome atlas of 81 Psilocybe genomes as a resource for psilocybin production.","year":"2021","cit":10,"pfa":"Kevin Judd McKernan","psa":"Stephen McLaughlin","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3199179808","eid":"W3199179808"},{"id":"paper-w200490887","cat":"papers","name":"[Consumption of psilocybin-containing hallucinogenic mushrooms by young people].","year":"1992","cit":10,"pfa":"Jens Flensted Lassen","psa":"J Skov","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W200490887","eid":"W200490887"},{"id":"paper-w3200052058","cat":"papers","name":"Ibogaine Blocks Cue- and Drug-Induced Reinstatement of Conditioned Place Preference to Ethanol in Male Mice","year":"2021","cit":10,"pfa":"Guilherme M. Henriques","psa":"Lais Fernanda Berro","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3200052058","eid":"W3200052058"},{"id":"paper-w2198383014","cat":"papers","name":"3,4-methylenedioxymethamphetamine (MDMA): an important cause of acute hepatitis.","year":"2006","cit":10,"pfa":"Nada Brnčić","psa":"Vera Vlahović–Palčevski","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2198383014","eid":"W2198383014"},{"id":"paper-w2805499440","cat":"papers","name":"Pre-clinical interaction of ayahuasca, a brew used in spiritual movements, with morphine and propofol","year":"2018","cit":10,"pfa":"Júlia Movilla Pires","psa":"E.A. Carlini","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2805499440","eid":"W2805499440"},{"id":"paper-w1490201335","cat":"papers","name":"Consideraciones acerca del brebaje ayahuasca y perspectivas terapéuticas","year":"2013","cit":10,"pfa":"Jacques Mabit","psa":"José Manuel Rodríguez Arce","ptype":"article","src":"https://openalex.org/W1490201335","eid":"W1490201335"},{"id":"paper-w2184829138","cat":"papers","name":"Why MDMA Should Not Have Been Made Illegal","year":"2010","cit":10,"pfa":"Marsha Rosenbaum","psa":"Rick Doblin","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2184829138","eid":"W2184829138"},{"id":"paper-w2159543395","cat":"papers","name":"Positron emission tomography findings in heavy users of MDMA","year":"1999","cit":10,"pfa":"Julie A. Holland","ptype":"article","src":"https://openalex.org/W2159543395","eid":"W2159543395"},{"id":"paper-w1982021062","cat":"papers","name":"Increased responsiveness to 5-methoxy-N, N-dimethyltryptamine in mice on a high tryptophan diet","year":"1979","cit":10,"pfa":"C Singleton","ptype":"article","src":"https://openalex.org/W1982021062","eid":"W1982021062"},{"id":"paper-w2009574194","cat":"papers","name":"Neurotoxic Effects of MDMA (Ecstasy) on the Developing Rodent Brain","year":"2010","cit":10,"pfa":"Mark Dzietko","psa":"Ursula Felderhoff‐Mueser","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2009574194","eid":"W2009574194"},{"id":"paper-w4391280546","cat":"papers","name":"MDMA enhances positive affective responses to social feedback","year":"2024","cit":10,"pfa":"Anya K. Bershad","psa":"Harriet de Wit","topics":["PTSD & trauma","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4391280546","eid":"W4391280546"},{"id":"paper-w2419604967","cat":"papers","name":"Peyote alkaloids. II. Anhalotine, lophotine, and peyotine, the quaternary alkaloids of Lophophora williamsii.","year":"1968","cit":10,"pfa":"G. J. KAPADIA","psa":"Theodore B. Zalucky","ptype":"article","src":"https://openalex.org/W2419604967","eid":"W2419604967"},{"id":"paper-w4297260890","cat":"papers","name":"Immunological Modulation and Control of Parasitaemia by Ayahuasca Compounds: Therapeutic Potential for Chagas's Disease","year":"2022","cit":10,"pfa":"Albert Katchborian Neto","psa":"Daniela Aparecida Chagas‐Paula","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4297260890","eid":"W4297260890"},{"id":"paper-w2950771642","cat":"papers","name":"Palladium-Catalyzed Alkylation-Alkenylation Reactions: Rapid Access to Tricyclic Mescaline Analogues","year":"2006","cit":10,"pfa":"Mark Lautens","psa":"Dino Alberico","ptype":"article","src":"https://openalex.org/W2950771642","eid":"W2950771642"},{"id":"paper-w2075740756","cat":"papers","name":"Functional Magnetic Resonance Imaging in Abstinent MDMA Users: A Review","year":"2015","cit":10,"pfa":"Aayushi Garg","psa":"Chittaranjan Behera","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2075740756","eid":"W2075740756"},{"id":"paper-w1975767568","cat":"papers","name":"Hair testing for “ecstasy” (MDMA) in volunteer Scottish drug users","year":"2000","cit":10,"pfa":"Jason Ditton","psa":"Iain David Smith","ptype":"article","src":"https://openalex.org/W1975767568","eid":"W1975767568"},{"id":"paper-w2013285313","cat":"papers","name":"Further studies on the dose-dependent stimulus properties of 5-methoxy-N,N-dimethyltryptamine","year":"1986","cit":10,"pfa":"Richard Young","psa":"Richard A. Glennon","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2013285313","eid":"W2013285313"},{"id":"paper-w44291495","cat":"papers","name":"Interaction of mescaline with phenothiazines: effect on behavior, body temperature, and tissue levels of hallucinogen in mice.","year":"1975","cit":10,"pfa":"N S Shah","psa":"Martha P. Hedden","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W44291495","eid":"W44291495"},{"id":"paper-w2624546207","cat":"papers","name":"Chronic intermittent exposure to ayahuasca during aging does not affect memory in mice","year":"2017","cit":10,"pfa":"Nelson Francisco Correa-Netto","psa":"Alessandra Linardi","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2624546207","eid":"W2624546207"},{"id":"paper-w3110980856","cat":"papers","name":"Population structure and reproductive biology of peyote (Lophophora diffusa, Cactaceae), a threatened species with pollen limitation1,2","year":"2020","cit":10,"pfa":"María Isabel Briseño-Sánchez","psa":"María C. Mandujano","ptype":"article","src":"https://openalex.org/W3110980856","eid":"W3110980856"},{"id":"paper-w2413755231","cat":"papers","name":"Measurement of 3,4-MDMA and related amines in diagnostic and forensic laboratories.","year":"2005","cit":10,"pfa":"Victor Skrinska","psa":"Susan B. Gock","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2413755231","eid":"W2413755231"},{"id":"paper-w1118765752","cat":"papers","name":"Sex differences in MDMA-induced toxicity in Sprague-Dawley rats","year":"2015","cit":10,"pfa":"Sara Soleimani Asl","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1118765752","eid":"W1118765752"},{"id":"paper-w2089487411","cat":"papers","name":"Structure–activity relationship of ibogaine analogs interacting with nicotinic acetylcholine receptors in different conformational states","year":"2011","cit":10,"pfa":"Hugo Rubén Arias","psa":"Krzysztof Jóźwiak","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2089487411","eid":"W2089487411"},{"id":"paper-w2016310367","cat":"papers","name":"Can Ayahuasca and sleep loss change sexual performance in male rats?","year":"2014","cit":10,"pfa":"Tathiana Aparecida Alvarenga","psa":"Mônica L. Andersen","ptype":"article","src":"https://openalex.org/W2016310367","eid":"W2016310367"},{"id":"paper-w4403046379","cat":"papers","name":"A chromosome level reference genome of Diviner’s sage (Salvia divinorum) provides insight into salvinorin A biosynthesis","year":"2024","cit":10,"pfa":"Scott A. Ford","psa":"Michael A. Phillips","topics":["PTSD & trauma","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4403046379","eid":"W4403046379"},{"id":"paper-w2486356005","cat":"papers","name":"Ayahuasca : physiological and subjective effects, comparison with d-amphetamine, and repeated dose assessment","year":"2012","cit":10,"pfa":"RAFAEL GUIMARÃES DOS SANTOS","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2486356005","eid":"W2486356005"},{"id":"paper-w2883189204","cat":"papers","name":"Altered trajectories in the dynamical repertoire of functional network states under psilocybin","year":"2018","cit":10,"pfa":"Louis-David Lord","psa":"Joana Cabral","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W2883189204","eid":"W2883189204"},{"id":"paper-w4291378437","cat":"papers","name":"Psilocybin and the Meaning Response: Exploring the Healing Process in a Retreat Setting in Jamaica","year":"2022","cit":10,"pfa":"María de Ángeles Equihua Orozco","psa":"Shana Harris","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4291378437","eid":"W4291378437"},{"id":"paper-w2003624061","cat":"papers","name":"Investigations into the polymorphic properties of N,N-dimethyltryptamine by X-ray diffraction and differential scanning calorimetry","year":"2013","cit":10,"pfa":"Alain Gaujac","psa":"Simon D. Brandt","ptype":"article","src":"https://openalex.org/W2003624061","eid":"W2003624061"},{"id":"paper-w2317912665","cat":"papers","name":"Notes- Alkaloids from Apocynaceae II. Ibogaline, A New Alkaloid From Tabernanthe Iboga Baill","year":"1959","cit":10,"pfa":"Norbert Neuss","ptype":"article","src":"https://openalex.org/W2317912665","eid":"W2317912665"},{"id":"paper-w173452531","cat":"papers","name":"Pipe, Bible, and Peyote among the Oglala Lakota. A Study in Religious Identity [Revised Edition].","year":"1990","cit":10,"pfa":"Paul B. Steinmetz","ptype":"article","src":"https://openalex.org/W173452531","eid":"W173452531"},{"id":"paper-w4393993372","cat":"papers","name":"A pilot study of the effect of group-administered psilocybin on psychological flexibility and outcomes","year":"2024","cit":10,"pfa":"Brian C. Pilecki","psa":"Kati M. Lear","ptype":"article","src":"https://openalex.org/W4393993372","eid":"W4393993372"},{"id":"paper-w4399897612","cat":"papers","name":"Hypertensive Emergency Secondary to Combining Psilocybin Mushrooms, Extended Release Dextroamphetamine-Amphetamine, and Tranylcypromine","year":"2024","cit":10,"pfa":"Brian Scott Barnett","psa":"J. Alexander Bodkin","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4399897612","eid":"W4399897612"},{"id":"paper-w2150025265","cat":"papers","name":"Cognitive Function in Ecstasy Naive Abstinent Drug Dependants and MDMA Users","year":"2013","cit":10,"pfa":"Adam Potter","psa":"Con K. K. Stough","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2150025265","eid":"W2150025265"},{"id":"paper-w4306680714","cat":"papers","name":"The complete organellar genomes of the entheogenic plant Psychotria viridis (Rubiaceae), a main component of the ayahuasca brew","year":"2022","cit":10,"pfa":"Alessandro M. Varani","psa":"Francisco Prosdocimi","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4306680714","eid":"W4306680714"},{"id":"paper-w2916866485","cat":"papers","name":"DFT characterization of MDMA methylene homologue, a chemical compound with psychoactive properties","year":"2019","cit":10,"pfa":"Steluța Gosav","psa":"Mirela Praisler","topics":["Safety & adverse events"],"ptype":"conference-paper","src":"https://openalex.org/W2916866485","eid":"W2916866485"},{"id":"paper-w1941185556","cat":"papers","name":"Persisting Continuous Visual Perception Disorder in a Chronic MDMA (‘Ecstasy’) User","year":"2002","cit":10,"pfa":"Torsten Passie","psa":"Hinderk Meiners Emrich","ptype":"article","src":"https://openalex.org/W1941185556","eid":"W1941185556"},{"id":"paper-w3203220537","cat":"papers","name":"Intranasal Salvinorin A Improves Long-term Neurological Function via Immunomodulation in a Mouse Ischemic Stroke Model","year":"2021","cit":10,"pfa":"Dilidaer Misilimu","psa":"Yanqin Gao","topics":["Addiction","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3203220537","eid":"W3203220537"},{"id":"paper-w2091663842","cat":"papers","name":"The effects of monoamine oxidase inhibitors on the ejaculatory response induced by 5‐methoxy‐N,N‐dimethyltryptamine in the rat","year":"1986","cit":10,"pfa":"Lucy Rényi","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2091663842","eid":"W2091663842"},{"id":"paper-w1996514482","cat":"papers","name":"MDMA (3,4-methylenedioxymethamphetamine) or ecstasy: the contemporary human and animal research perspective","year":"2006","cit":10,"pfa":"Andy C. Parrott","psa":"Charles Alexander Marsden","ptype":"editorial","src":"https://openalex.org/W1996514482","eid":"W1996514482"},{"id":"paper-w4230852304","cat":"papers","name":"Ecstasy (MDMA) in Recreational Users: Self‐Reported Psychological and Physiological Effects","year":"1997","cit":10,"pfa":"D. DAVISON","psa":"Andrew C. Parrott","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W4230852304","eid":"W4230852304"},{"id":"paper-w2044953576","cat":"papers","name":"Illicit Peyote Use Among American Indian Adolescents in Substance Abuse Treatment: A Preliminary Investigation","year":"2006","cit":10,"pfa":"Alexandra Fickenscher","psa":"Spero M. Manson","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2044953576","eid":"W2044953576"},{"id":"paper-w2191930067","cat":"papers","name":"Synthesis and biological evaluation of 2-alkyl-2-methoxymethyl-salvinorin ethers as selective κ-opioid receptor agonists","year":"2015","cit":10,"pfa":"David Y.W. Lee","psa":"Lee‐Yuan Liu‐Chen","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2191930067","eid":"W2191930067"},{"id":"paper-w4386165916","cat":"papers","name":"Race and ethnicity moderate the associations between lifetime psilocybin use and crime arrests","year":"2023","cit":10,"pfa":"Grant M. Jones","psa":"Matthew K. Nock","ptype":"article","src":"https://openalex.org/W4386165916","eid":"W4386165916"},{"id":"paper-w1996579690","cat":"papers","name":"Effects of risperidone on the acquisition and reinstatement of the conditioned place preference induced by MDMA","year":"2013","cit":10,"pfa":"C. Roger-Sánchez","psa":"M.A. Aguilar","ptype":"article","src":"https://openalex.org/W1996579690","eid":"W1996579690"},{"id":"paper-w4318563964","cat":"papers","name":"Understanding ayahuasca effects in major depressive disorder treatment through in vitro metabolomics and bioinformatics","year":"2023","cit":10,"pfa":"Flávia da Silva Zandonadi","psa":"Alessandra Sussulini","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4318563964","eid":"W4318563964"},{"id":"paper-w4297092825","cat":"papers","name":"Assessment of MDMA tablet and capsule dosages from seizures in Queensland, Australia","year":"2022","cit":10,"pfa":"Shiona Croft","psa":"Jenny McGowan","ptype":"article","src":"https://openalex.org/W4297092825","eid":"W4297092825"},{"id":"paper-w2133924120","cat":"papers","name":"3,4-Methylenedioxymethamphetamine (MDMA), but not morphine, alters APP processing in the rat brain","year":"2006","cit":10,"pfa":"Janos L. Kalman","psa":"Magdolna Pákáski","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2133924120","eid":"W2133924120"},{"id":"paper-w2121630389","cat":"papers","name":"Is behavioral sensitization to 3,4-methylenedioxymethamphetamine (MDMA) mediated in part by cholinergic receptors?","year":"2013","cit":10,"pfa":"Nadine Y. Lettfuss","psa":"Andreas von Ameln-Mayerhofer","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2121630389","eid":"W2121630389"},{"id":"paper-w2062949049","cat":"papers","name":"The American Indian Church and its sacramental use of peyote: A review for professionals in the mental-health arena","year":"2004","cit":10,"pfa":"Peter N. Jones","topics":["Dosing & pharmacology","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2062949049","eid":"W2062949049"},{"id":"paper-w4391574176","cat":"papers","name":"National and regional trends in seizures of shrooms (psilocybin) in the United States, 2017–2022","year":"2024","cit":10,"pfa":"Joseph J. Palamar","psa":"Linda Bauer Cottler","ptype":"article","src":"https://openalex.org/W4391574176","eid":"W4391574176"},{"id":"paper-w2104092715","cat":"papers","name":"Cocaine vs Ecstasy/MDMA: Comparative Effects on Mood and Cognition in Recreational Users","year":"2011","cit":10,"pfa":"Andrew C. Parrott","ptype":"article","src":"https://openalex.org/W2104092715","eid":"W2104092715"},{"id":"paper-w1242720541","cat":"papers","name":"The relationship of carbon and nitrogen nutrition of Psilocybe baeocystis to the production of psilocybin and its analogs.","year":"1969","cit":10,"pfa":"A Y Leung","psa":"Ara G. Paul","ptype":"article","src":"https://openalex.org/W1242720541","eid":"W1242720541"},{"id":"paper-w2159801474","cat":"papers","name":"MDMA-induced serotonergic neurotoxicity enhances aggressiveness in low- but not high-aggressive rats","year":"2009","cit":10,"pfa":"Alinde E. Wallinga","psa":"Bauke Buwalda","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2159801474","eid":"W2159801474"},{"id":"paper-w4389139111","cat":"papers","name":"The potential of psilocybin use to enhance well-being in healthy individuals – A scoping review","year":"2023","cit":10,"pfa":"Lennart Wiepking","psa":"Alexandra Ghiţă","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4389139111","eid":"W4389139111"},{"id":"paper-w1993650568","cat":"papers","name":"An in vitro approach to assessing a potential drug interaction between MDMA (ecstasy) and caffeine","year":"2013","cit":10,"pfa":"Cheyenne Downey","psa":"Kathy M. O’Boyle","ptype":"article","src":"https://openalex.org/W1993650568","eid":"W1993650568"},{"id":"paper-w4396230194","cat":"papers","name":"Review of Psilocybin Use for Depression among Cancer Patients after Approval in Oregon","year":"2024","cit":10,"pfa":"Val Bellman","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4396230194","eid":"W4396230194"},{"id":"paper-w2046995928","cat":"papers","name":"Cactus Alkaloids, LXI. Identification of Mescaline and Related Compounds in Eight Additional Species Using Tlc and Ms/ms","year":"1986","cit":10,"pfa":"W.-W. Ma","psa":"Carlos Ostolaza","ptype":"article","src":"https://openalex.org/W2046995928","eid":"W2046995928"},{"id":"paper-w2146909232","cat":"papers","name":"MDMA and MDA cross reactivity observed with Abbott TDx amphetamine/methamphetamine reagents.","year":"1988","cit":10,"pfa":"José Manuel Ramos","psa":"A Poklis","ptype":"article","src":"https://openalex.org/W2146909232","eid":"W2146909232"},{"id":"paper-w4403196849","cat":"papers","name":"Psilocybin-assisted psychotherapy improves psychiatric symptoms across multiple dimensions in patients with cancer","year":"2024","cit":10,"pfa":"Petros D. Petridis","psa":"Stephen Ross","topics":["Anxiety & end-of-life","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4403196849","eid":"W4403196849"},{"id":"paper-w2921512654","cat":"papers","name":"Syrian rue seeds interacted with acacia tree bark in an herbal stew resulted in N,N-dimethyltryptamine poisoning","year":"2019","cit":10,"pfa":"Chuan-Huai Liu","psa":"Chih-Chuan Lin","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2921512654","eid":"W2921512654"},{"id":"paper-w3018862587","cat":"papers","name":"Influence of environment on the leaf morpho-anatomy and histochemical of the ayahuasca leaf: Populations cultivated in extra-Amazonian regions","year":"2020","cit":10,"pfa":"Ordilena Ferreira de Miranda","psa":"Marcílio de Almeida","ptype":"article","src":"https://openalex.org/W3018862587","eid":"W3018862587"},{"id":"paper-w4291383525","cat":"papers","name":"Insights for Modern Applications of Psilocybin Therapy from a Case Study of Traditional Mazatec Medicine","year":"2022","cit":10,"pfa":"Jesús M. González Mariscal","psa":"Paulina E. Sosa‐Cortés","ptype":"article","src":"https://openalex.org/W4291383525","eid":"W4291383525"},{"id":"paper-w4236910206","cat":"papers","name":"Differential behavioral outcomes of 3,4-methylenedioxymethamphetamine (MDMA-ecstasy) in anxiety-like responses in mice","year":"2011","cit":10,"pfa":"V. Ferraz-de-Paula","psa":"João Palermo‐Neto","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4236910206","eid":"W4236910206"},{"id":"paper-w1974004688","cat":"papers","name":"Association of paradoxical sleep deprivation and ecstasy (MDMA) enhances genital reflexes in male rats","year":"2006","cit":10,"pfa":"Mônica L. Andersen","psa":"Sergio Brasil Tufik","ptype":"article","src":"https://openalex.org/W1974004688","eid":"W1974004688"},{"id":"paper-w4240814374","cat":"papers","name":"Morphine, MDMA, MDA, and nexus produce a conditioned place preference in newly hatched chickens.","year":"1996","cit":10,"pfa":"Maureen E. Bronson","psa":"James L. Scott","ptype":"article","src":"https://openalex.org/W4240814374","eid":"W4240814374"},{"id":"paper-w2140331434","cat":"papers","name":"Halogenated solvent interactions with N,N-dimethyltryptamine: Formation of quaternary ammonium salts and their artificially induced rearrangements during analysis","year":"2008","cit":10,"pfa":"Simon D. Brandt","psa":"John F. Alder","ptype":"article","src":"https://openalex.org/W2140331434","eid":"W2140331434"},{"id":"paper-w3093558467","cat":"papers","name":"Human hair tests to document drug environmental contamination: Application in a family law case involving N,N‐dimethyltryptamine","year":"2020","cit":10,"pfa":"Pascal Kintz","psa":"Jean‐Sébastien Raul","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3093558467","eid":"W3093558467"},{"id":"paper-w2044297861","cat":"papers","name":"Electrophysiologic Changes in Ventral Midbrain Dopaminergic Neurons Resulting from (+/−) -3,4-Methylenedioxymethamphetamine (MDMA—“Ecstasy”)","year":"2007","cit":10,"pfa":"Mauro Federici","psa":"Nicola Biagio Mercuri","ptype":"article","src":"https://openalex.org/W2044297861","eid":"W2044297861"},{"id":"paper-w2027838894","cat":"papers","name":"N,N-Dimethyltryptamine and dichloromethane: Rearrangement of quaternary ammonium salt product during GC–EI and CI-MS–MS analysis","year":"2007","cit":10,"pfa":"Simon D. Brandt","psa":"John F. Alder","ptype":"article","src":"https://openalex.org/W2027838894","eid":"W2027838894"},{"id":"paper-w4321442730","cat":"papers","name":"UNRAVELing the synergistic effects of psilocybin and environment on brain-wide immediate early gene expression in mice","year":"2023","cit":10,"pfa":"Daniel Ryskamp Rijsketic","psa":"Boris Dov Heifets","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4321442730","eid":"W4321442730"},{"id":"paper-w4400130919","cat":"papers","name":"Examining the Role of Oxytocinergic Signaling and Neuroinflammatory Markers in the Therapeutic Effects of MDMA in a Rat Model for PTSD","year":"2024","cit":10,"pfa":"Haron Avgana","psa":"Irit Akirav","topics":["PTSD & trauma","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4400130919","eid":"W4400130919"},{"id":"paper-w4406633420","cat":"papers","name":"A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research","year":"2025","cit":10,"pfa":"David B. Yaden","psa":"Mary Elizabeth Yaden","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4406633420","eid":"W4406633420"},{"id":"paper-w2527563110","cat":"papers","name":"MDMA, Methylone, and MDPV: Drug-Induced Brain Hyperthermia and Its Modulation by Activity State and Environment","year":"2016","cit":10,"pfa":"Eugene A. Kiyatkin","psa":"Suelynn E. Ren","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W2527563110","eid":"W2527563110"},{"id":"paper-w2036566149","cat":"papers","name":"RETRACTED: MDMA- and p-chlorophenylalanine-induced reduction in 5-HT concentrations: effects on serotonin transporter densities","year":"2002","cit":10,"pfa":"Brendon Phillip Boot","psa":"George A. Ricaurte","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2036566149","eid":"W2036566149"},{"id":"paper-w4401773612","cat":"papers","name":"Mapping consumptions and market size of cocaine, amphetamine and MDMA through wastewater analysis: A Dutch case study","year":"2024","cit":10,"pfa":"Thomas L. ter Laak","psa":"Pim de Voogt","ptype":"article","src":"https://openalex.org/W4401773612","eid":"W4401773612"},{"id":"paper-w4307999330","cat":"papers","name":"MDMA-assisted therapy is associated with a reduction in chronic pain among people with post-traumatic stress disorder","year":"2022","cit":10,"pfa":"Devon Christie","psa":"Elena Argento","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4307999330","eid":"W4307999330"},{"id":"paper-w4386285211","cat":"papers","name":"Double-Blind Comparison of the Two Hallucinogens Dextromethorphan and Psilocybin: Experience-Dependent and Enduring Psychological Effects in Healthy Volunteers","year":"2023","cit":10,"pfa":"David S. Mathai","psa":"Albert Garcia‐Romeu","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4386285211","eid":"W4386285211"},{"id":"paper-w2140918474","cat":"papers","name":"Application of ORAL{middle dot}screen Saliva Drug Test for the Screening of Methamphetamine, MDMA, and MDEA Incorporated in Hair","year":"2004","cit":10,"pfa":"Akihiro Miki","psa":"Hitoshi Tsuchihashi","ptype":"article","src":"https://openalex.org/W2140918474","eid":"W2140918474"},{"id":"paper-w2046701834","cat":"papers","name":"MDMA alters the response of the mammalian circadian clock in hamsters: Effects on re-entrainment and triazolam-induced phase shifts","year":"2005","cit":10,"pfa":"Maria Gardani","psa":"Stephany M. Biello","ptype":"article","src":"https://openalex.org/W2046701834","eid":"W2046701834"},{"id":"paper-w2791644610","cat":"papers","name":"3,4-Methylenedioxymethamphetamine (MDMA) Alters Synaptic Dopamine Release in the Dorsal Striatum Through Nicotinic Receptors and DAT Inhibition","year":"2018","cit":10,"pfa":"Francesca Romana Rizzo","psa":"Nicola Biagio Mercuri","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2791644610","eid":"W2791644610"},{"id":"paper-w2564911043","cat":"papers","name":"Effects of dextromethorphan on MDMA-induced serotonergic aberration in the brains of non-human primates using [123I]-ADAM/SPECT","year":"2016","cit":10,"pfa":"Kuo‐Hsing Ma","psa":"Cheng-Yi Cheng","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2564911043","eid":"W2564911043"},{"id":"paper-w2890854366","cat":"papers","name":"Substance usage intention does not affect attentional bias: implications from Ecstasy/MDMA users and alcohol drinkers","year":"2018","cit":10,"pfa":"Thomas D. W. Wilcockson","psa":"Andrew C. Parrott","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2890854366","eid":"W2890854366"},{"id":"paper-w3010632415","cat":"papers","name":"Blockade of nitric oxide signalling promotes resilience to the effects of social defeat stress on the conditioned rewarding properties of MDMA in mice","year":"2020","cit":10,"pfa":"María Pilar García-Pardo","psa":"M.A. Aguilar","ptype":"article","src":"https://openalex.org/W3010632415","eid":"W3010632415"},{"id":"paper-w2915066990","cat":"papers","name":"Binge ethanol and MDMA combination exacerbates HSP27 and Trx-1 (biomarkers of toxic cardiac effects) expression in right ventricle","year":"2019","cit":10,"pfa":"Javier Navarro‐Zaragoza","psa":"M. Luisa Laorden","ptype":"article","src":"https://openalex.org/W2915066990","eid":"W2915066990"},{"id":"paper-w4309556944","cat":"papers","name":"Size matters: comparing the MDMA content and weight of ecstasy tablets submitted to European drug checking services in 2012–2021","year":"2022","cit":10,"pfa":"Ruben Q. Vrolijk","psa":"Mireia Ventura","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4309556944","eid":"W4309556944"},{"id":"paper-w3016993897","cat":"papers","name":"One Dose of Psilocybin in Late Adolescence Mitigates Deleterious Effects of Developmental Stress on Cognition and Behavioral Despair in Adult Female Rats","year":"2020","cit":10,"pfa":"Meghan Hibicke","psa":"Charles David Nichols","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W3016993897","eid":"W3016993897"},{"id":"paper-w4210982168","cat":"papers","name":"MDMA-Assisted Therapy for Posttraumatic Stress Disorder: A Mixed-Methods Case Study of a Participant of Color From an Open-Label Trial","year":"2022","cit":10,"pfa":"Terence H. W. Ching","psa":"Rick Doblin","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4210982168","eid":"W4210982168"},{"id":"paper-w2401652346","cat":"papers","name":"Studies on psilocybin and related compounds. I. Communication. Structure/activity relationship of oxyindole-derivatives with regard to their effect on the knee jerk of spinal cats.","year":"1960","cit":10,"pfa":"Hans Weidmann","psa":"A Cerletti","ptype":"article","src":"https://openalex.org/W2401652346","eid":"W2401652346"},{"id":"paper-w4413389430","cat":"papers","name":"Chronic psilocybin administration increases sociability and alters the gut microbiome in male wild-type mice but not in a preclinical model of obsessive-compulsive disorder","year":"2025","cit":10,"pfa":"James J Gattuso","psa":"Thibault Renoir","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4413389430","eid":"W4413389430"},{"id":"paper-w2474009747","cat":"papers","name":"Adolescent exposure to MDMA induces dopaminergic toxicity in substantia nigra and potentiates the amyloid plaque deposition in the striatum of APPswe/PS1dE9 mice","year":"2016","cit":10,"pfa":"Sònia Abad","psa":"Elena Escubedo","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2474009747","eid":"W2474009747"},{"id":"paper-w2220023677","cat":"papers","name":"Effect of MDMA-Induced Axotomy on the Dorsal Raphe Forebrain Tract in Rats: An In Vivo Manganese-Enhanced Magnetic Resonance Imaging Study","year":"2015","cit":10,"pfa":"Chuang-Hsin Chiu","psa":"Kuo‐Hsing Ma","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2220023677","eid":"W2220023677"},{"id":"paper-w2948088388","cat":"papers","name":"‘Never drop without your significant other, cause that way lies ruin’: The boundary work of couples who use MDMA together","year":"2019","cit":10,"pfa":"Katie Anderson","psa":"Zoë Boden","ptype":"article","src":"https://openalex.org/W2948088388","eid":"W2948088388"},{"id":"paper-w4414366251","cat":"papers","name":"Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for frontline healthcare provider COVID-19-related depression and burnout: A randomized controlled trial","year":"2025","cit":10,"pfa":"Benjamin R. Lewis","psa":"Eric L. Garland","topics":["Depression","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4414366251","eid":"W4414366251"},{"id":"paper-w2143674475","cat":"papers","name":"Effects of chronic intracerebroventricular 3,4-methylenedioxy-N-methamphetamine (MDMA) or fluoxetine on the active avoidance test in rats with or without exposure to mild chronic stress","year":"2009","cit":10,"pfa":"Laura Andrea León","psa":"Fernando P. Cárdenas","ptype":"article","src":"https://openalex.org/W2143674475","eid":"W2143674475"},{"id":"paper-w4401484666","cat":"papers","name":"Retraction Note: MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials","year":"2024","cit":10,"pfa":"Michael C. Mithoefer","psa":"Rick Doblin","topics":["PTSD & trauma","Therapy practice"],"ptype":"retraction","src":"https://openalex.org/W4401484666","eid":"W4401484666"},{"id":"paper-w3192763830","cat":"papers","name":"Toxicity of psychedelic drugs","year":"2021","cit":10,"pfa":"Daniela Cornelia Călina","psa":"Anca Oana Docea","topics":["Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W3192763830","eid":"W3192763830"},{"id":"paper-w2075104053","cat":"papers","name":"RETRACTED ARTICLE: Gene expression analysis indicates CB1 receptor upregulation in the hippocampus and neurotoxic effects in the frontal cortex 3 weeks after single-dose MDMA administration in Dark Agouti rats","year":"2013","cit":10,"pfa":"Péter Petschner","psa":"György Bagdy","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2075104053","eid":"W2075104053"},{"id":"paper-w1909825542","cat":"papers","name":"Interaction of D-LSD with blood platelets of rabbits: shape change and specific binding.","year":"1981","cit":10,"pfa":"Andreas Laubscher","psa":"H Noll","ptype":"article","src":"https://openalex.org/W1909825542","eid":"W1909825542"},{"id":"paper-w4404342030","cat":"papers","name":"Associations between psychedelic use and cannabis use disorder in a nationally representative sample","year":"2024","cit":10,"pfa":"James M Zech","psa":"Grant M. Jones","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4404342030","eid":"W4404342030"},{"id":"paper-w1997299015","cat":"papers","name":"A STUDY OF ANTAGONISTS OF 5‐HYDROXYTRYPTAMINE AND CATECHOL AMINES ON THE RAT'S BLOOD PRESSURE","year":"1960","cit":10,"pfa":"Aubrey S. Outschoorn","psa":"J. Jacob","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1997299015","eid":"W1997299015"},{"id":"paper-w2117111419","cat":"papers","name":"Effects of LSD-25 on Tests of Personality","year":"1958","cit":10,"pfa":"Johannes C. Brengelmann","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2117111419","eid":"W2117111419"},{"id":"paper-w3096479563","cat":"papers","name":"Improved colour blindness symptoms associated with recreational psychedelic use: Results from the Global Drug Survey 2017","year":"2020","cit":10,"pfa":"JEC Anthony","psa":"David Nutt","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3096479563","eid":"W3096479563"},{"id":"paper-w4383197511","cat":"papers","name":"The Resurgence of Hallucinogen Drugs in Clinical Research","year":"2023","cit":10,"pfa":"Maria Teresa Rivera-Garcia","psa":"Silvia Lorenia Cruz","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4383197511","eid":"W4383197511"},{"id":"paper-w1959924683","cat":"papers","name":"New Onset LSD Flashback Syndrome Triggered by the Initiation of SSRIs.","year":"2007","cit":10,"pfa":"Sarah Goldman","psa":"Richard Friedman","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1959924683","eid":"W1959924683"},{"id":"paper-w2739569800","cat":"papers","name":"Psychotherapie mit adjuvanter Gabe von serotonergen psychoaktiven Substanzen – Möglichkeiten und Hindernisse","year":"2017","cit":10,"pfa":"Tomislav Majić","psa":"Jürgen Gallinat","topics":["Depression","PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2739569800","eid":"W2739569800"},{"id":"paper-w2060209417","cat":"papers","name":"Reviving research into psychedelic drugs","year":"2006","cit":10,"pfa":"Amanda Neidpath","ptype":"article","src":"https://openalex.org/W2060209417","eid":"W2060209417"},{"id":"paper-w2409505272","cat":"papers","name":"The Occurrence of Tryptamine Derivatives in Psilocybe semilanceata","year":"1988","cit":10,"pfa":"Rudolf Brenneisen","psa":"Stefan Borner","ptype":"article","src":"https://openalex.org/W2409505272","eid":"W2409505272"},{"id":"paper-w2113269485","cat":"papers","name":"Identification of post-generation effect of 3,4-methylenedioxymethamphetamine on the mouse brain by large-scale gene expression analysis","year":"2010","cit":10,"pfa":"Jung Woo Eun","psa":"Won Sang Park","ptype":"article","src":"https://openalex.org/W2113269485","eid":"W2113269485"},{"id":"paper-w4402644384","cat":"papers","name":"CCNP Innovations in Neuropsychopharmacology Award","year":"2024","cit":10,"pfa":"Gabriella Gobbi","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4402644384","eid":"W4402644384"},{"id":"paper-w2087836012","cat":"papers","name":"LSD and fixed-interval responding in the rat","year":"1975","cit":10,"pfa":"Jack L. Altman","psa":"J. B. Appel","ptype":"article","src":"https://openalex.org/W2087836012","eid":"W2087836012"},{"id":"paper-w4408254485","cat":"papers","name":"Current Evidence for the Role of Rapid-Acting Antidepressants in Bipolar Depression: A Perspective and Plan for Action","year":"2025","cit":10,"pfa":"Jonathan Repple","psa":"Andreas Reif","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4408254485","eid":"W4408254485"},{"id":"paper-w4231067112","cat":"papers","name":"Simulated abuse of tybamate in man. Failure to demonstrate withdrawal reactions","year":"1967","cit":10,"pfa":"J. Shelton","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4231067112","eid":"W4231067112"},{"id":"paper-w3128263216","cat":"papers","name":"Transcriptomics-informed large-scale cortical model captures topography of pharmacological neuroimaging effects of LSD","year":"2021","cit":10,"pfa":"Joshua B. Burt","psa":"John D. Murray","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W3128263216","eid":"W3128263216"},{"id":"paper-w2006839639","cat":"papers","name":"Inhibition of compound 48/80‐induced intradental sensory nerve activity by disodium cromoglycate and serotonin antagonists","year":"1978","cit":10,"pfa":"Leif M. Olgart","psa":"Bertil Gazelius","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2006839639","eid":"W2006839639"},{"id":"paper-w4405220796","cat":"papers","name":"LSD flattens the hierarchy of directed information flow in fast whole-brain dynamics","year":"2024","cit":10,"pfa":"Kenneth Shinozuka","psa":"Morten L. Kringelbach","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4405220796","eid":"W4405220796"},{"id":"paper-w2018025156","cat":"papers","name":"LSD: Effect of monoamine metabolites in rat prefrontal cortex","year":"1982","cit":10,"pfa":"Malcolm B. Bowers","psa":"Lena A. Salomonsson","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2018025156","eid":"W2018025156"},{"id":"paper-w4403543158","cat":"papers","name":"Effects of classical psychedelics on implicit and explicit emotional empathy and cognitive empathy: a meta-analysis of MET task","year":"2024","cit":10,"pfa":"Amit Olami","psa":"Leehe Peled‐Avron","topics":["Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4403543158","eid":"W4403543158"},{"id":"paper-w2185684752","cat":"papers","name":"Studies on the pharmacology of D-lysergic acid cycloalkylamides.","year":"1958","cit":10,"pfa":"Zdenek Votava","psa":"M. Semonský","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2185684752","eid":"W2185684752"},{"id":"paper-w2328009380","cat":"papers","name":"Design and synthesis of natural product-based ligands with high affinity to the kappa-opioid receptor","year":"2011","cit":10,"pfa":"JK Zjawiony","psa":"Eyal Vardy","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2328009380","eid":"W2328009380"},{"id":"paper-w2015537759","cat":"papers","name":"Use of a hallucinogenic mushroom, Copelandia cyanescens, in Samoa","year":"1981","cit":10,"pfa":"Paul Alan Cox","ptype":"article","src":"https://openalex.org/W2015537759","eid":"W2015537759"},{"id":"paper-w2037981371","cat":"papers","name":"Platelet serotonin transporter and 5-HT2Areceptor binding in adolescents with eating disorders","year":"2013","cit":10,"pfa":"Jeanette Sigurdh","psa":"Bruno Hägglöf","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2037981371","eid":"W2037981371"},{"id":"paper-w2133165005","cat":"papers","name":"( )-3,4-Methylenedioxymethamphetamine and Metabolite Disposition in Plasma and Striatum of Wild-Type and Multidrug Resistance Protein 1a Knock-Out Mice","year":"2011","cit":10,"pfa":"Karl B. Scheidweiler","psa":"Marilyn Ann Huestis","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2133165005","eid":"W2133165005"},{"id":"paper-w4401800884","cat":"papers","name":"Classic psychedelics and the treatment for alcoholism","year":"2024","cit":10,"pfa":"Guilherme Lodetti","psa":"Eduardo Pacheco Rico","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4401800884","eid":"W4401800884"},{"id":"paper-w4223930500","cat":"papers","name":"Brain-derived neurotrophic factor protects serotonergic neurons against 3,4-methylenedioxymethamphetamine (“Ecstasy”) induced cytoskeletal damage","year":"2022","cit":10,"pfa":"Francesco Bavato","psa":"Boris B. Quednow","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4223930500","eid":"W4223930500"},{"id":"paper-w2104317368","cat":"papers","name":"An Account of Healing Depression UsingAyahuascaPlant Teacher Medicine in a Santo Daime Ritual","year":"2013","cit":10,"pfa":"Jean-Francois Sobiecki","topics":["Depression","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2104317368","eid":"W2104317368"},{"id":"paper-w2045865407","cat":"papers","name":"Effects of 3,4-Methylenedioxymethamphetamine Administration on Retinal Physiology in the Rat","year":"2011","cit":10,"pfa":"João Martins","psa":"António Francisco Ambrósio","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2045865407","eid":"W2045865407"},{"id":"paper-w2042804264","cat":"papers","name":"Terguride, a dopamine D2 partial agonist, as a discriminative stimulus in rats","year":"1991","cit":10,"pfa":"M. Yamaguchi","psa":"H. Nakagawa","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2042804264","eid":"W2042804264"},{"id":"paper-w2071456562","cat":"papers","name":"Fingerprinting of 3, 4-Methylenedioxymethamphetamine Markers by Desorption/Ionization on Porous Silicon","year":"2006","cit":10,"pfa":"Agnieszka Kraj","psa":"Jerzy Silberringa","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2071456562","eid":"W2071456562"},{"id":"paper-w4392128395","cat":"papers","name":"Highly sensitive and disposable screen-printed graphene-based electrochemical sensor coupled with monolithic micro-solid-phase extraction for the determination of 3,4-methylenedioxymethamphetamine in forensic application","year":"2024","cit":10,"pfa":"Wichayaporn Kamsong","psa":"Chanpen Karuwan","ptype":"article","src":"https://openalex.org/W4392128395","eid":"W4392128395"},{"id":"paper-w1985156864","cat":"papers","name":"Ecstasy (3,4-methylenedioxymethamphetamine) limits murine gammaherpesvirus-68 induced monokine expression","year":"2008","cit":10,"pfa":"Daniel A. Nelson","psa":"Kenneth L. Bost","ptype":"article","src":"https://openalex.org/W1985156864","eid":"W1985156864"},{"id":"paper-w1992741842","cat":"papers","name":"Effects of Repeated 3,4-Methylenedioxymethamphetamine Administration on Neurotransmitter Efflux and Sensory-Evoked Discharge in the Ventral Posterior Medial Thalamus","year":"2011","cit":10,"pfa":"M.A. Starr","psa":"Barry D. Waterhouse","ptype":"article","src":"https://openalex.org/W1992741842","eid":"W1992741842"},{"id":"paper-w2086477145","cat":"papers","name":"Prejunctional actions of methylenedioxymethamphetamine in vas deferens from wild-type and α2A/D-adrenoceptor knockout mice","year":"2001","cit":10,"pfa":"Kushwin Rajamani","psa":"James R. Docherty","ptype":"article","src":"https://openalex.org/W2086477145","eid":"W2086477145"},{"id":"paper-w2024242144","cat":"papers","name":"Effects of ritanserin on the 3,4-methylenedioxymethamphetamine-induced decrease in striatal serotonin concentration and on the increase in striatal neurotensin and dynorphin A concentrations","year":"1993","cit":10,"pfa":"Michel Johnson","psa":"James W. Gibb","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2024242144","eid":"W2024242144"},{"id":"paper-w2150285574","cat":"papers","name":"Effectiveness of Multiple Internal Standards: Deuterated Analogues of Methylenedioxymethamphetamine, Methylenedioxyamphetamine, Methamphetamine, and Amphetamine","year":"2004","cit":10,"pfa":"Dongliang Lin","psa":"Ray H. Liu","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2150285574","eid":"W2150285574"},{"id":"paper-w2062201858","cat":"papers","name":"In vitro neuronal and vascular responses to 5-hydroxytryptamine: modulation by 4-methylthioamphetamine, 4-methylthiomethamphetamine and 3,4-methylenedioxymethamphetamine","year":"2002","cit":10,"pfa":"James E. Murphy","psa":"ALAN K. KEENAN","ptype":"article","src":"https://openalex.org/W2062201858","eid":"W2062201858"},{"id":"paper-w4385698697","cat":"papers","name":"Substance use, harm reduction attitudes and behaviors among attendees of nature rave parties in Israel","year":"2023","cit":10,"pfa":"Hagit Bonny‐Noach","psa":"Ariel Caduri","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4385698697","eid":"W4385698697"},{"id":"paper-w2151279870","cat":"papers","name":"Acute tryptophan depletion potentiates 3,4‐methylenedioxymethamphetamine‐induced cerebrovascular hyperperfusion in adult male wistar rats","year":"2009","cit":10,"pfa":"Eva L. van Donkelaar","psa":"Linda Ferrington","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2151279870","eid":"W2151279870"},{"id":"paper-w4409463726","cat":"papers","name":"From Efficacy to Effectiveness: Evaluating Psychedelic Randomized Controlled Trials for Trustworthy Evidence‐Based Policy and Practice","year":"2025","cit":10,"pfa":"Eduardo Ekman Schenberg","topics":["Depression","PTSD & trauma","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4409463726","eid":"W4409463726"},{"id":"paper-w2164453648","cat":"papers","name":"Application of Mass Spectrometry/Mass Spectrometry (MS/MS) to the Identification of Natural Products in Psilocybe Cyanescens","year":"1979","cit":10,"pfa":"S. E. Unger","psa":"R. Graham Cooks","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2164453648","eid":"W2164453648"},{"id":"paper-w2155390954","cat":"papers","name":"A Comparison Between Experimental and Authentic Blood/Serum Ratios of 3,4-Methylenedioxymethamphetamine and 3,4-Methylenedioxyamphetamine","year":"2009","cit":10,"pfa":"Regine Garcia Boy","psa":"Gisela Skopp","ptype":"article","src":"https://openalex.org/W2155390954","eid":"W2155390954"},{"id":"paper-w2277109734","cat":"papers","name":"[Clinical and toxicologic aspects of the use of Ecstasy].","year":"1998","cit":10,"pfa":"Ed J. M. Pennings","psa":"F. A. de Wolff","topics":["Depression","Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W2277109734","eid":"W2277109734"},{"id":"paper-w2401026297","cat":"papers","name":"Biochemistry and the Schizophrenias","year":"1979","cit":10,"pfa":"John Smythies","topics":["Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2401026297","eid":"W2401026297"},{"id":"paper-w3001305977","cat":"papers","name":"Classic psychedelics as therapeutics for psychiatric disorders","year":"2020","cit":10,"pfa":"Charles David Nichols","psa":"Peter S. Hendricks","ptype":"book-chapter","src":"https://openalex.org/W3001305977","eid":"W3001305977"},{"id":"paper-w4297906710","cat":"papers","name":"Knowing and being known: Psychedelic–assisted psychotherapy and the sense of authenticity","year":"2022","cit":10,"pfa":"Lawrence G. Fischman","topics":["Anxiety & end-of-life","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4297906710","eid":"W4297906710"},{"id":"paper-w2409970629","cat":"papers","name":"Caffeine alters the behavioural and body temperature responses to mephedrone without causing long-term neurotoxicity in rats","year":"2016","cit":10,"pfa":"Sinead E. Shortall","psa":"Madeleine V. King","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2409970629","eid":"W2409970629"},{"id":"paper-w4249319106","cat":"papers","name":"Classic psychedelic coadministration with lithium, but not lamotrigine, is associated with seizures: an analysis of online psychedelic experience reports","year":"2021","cit":10,"pfa":"Sandeep Manel Nayak","psa":"Roland R. Griffiths","topics":["Depression","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4249319106","eid":"W4249319106"},{"id":"paper-w1990006882","cat":"papers","name":"2,3-Dihydro and carbocyclic analogs of tryptamines: interaction with serotonin receptors","year":"1982","cit":10,"pfa":"Richard A. Glennon","psa":"John J. Salley","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1990006882","eid":"W1990006882"},{"id":"paper-w3172267869","cat":"papers","name":"A draft reference assembly of the Psilocybe cubensis genome","year":"2021","cit":10,"pfa":"Kevin Judd McKernan","psa":"Stephen McLaughlin","ptype":"article","src":"https://openalex.org/W3172267869","eid":"W3172267869"},{"id":"paper-w4206542610","cat":"papers","name":"Qualitative Screening of Amphetamine- and Ketamine-Type Abuse Drugs in Urine Employing Dual Mode Extraction Column by Liquid Chromatography–Tandem Mass Spectrometry (LC–MS-MS)","year":"2022","cit":10,"pfa":"George Fai Wong","psa":"Chi Kong Li","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4206542610","eid":"W4206542610"},{"id":"paper-w2023199333","cat":"papers","name":"Biochemistry and Schizophrenia","year":"1958","cit":10,"pfa":"Howard D. Fabing","ptype":"article","src":"https://openalex.org/W2023199333","eid":"W2023199333"},{"id":"paper-w2064252565","cat":"papers","name":"Neonatal treatment with 5-HT antiserum alters 5-HT metabolism and function in adult rats.","year":"1995","cit":10,"pfa":"Kochupurackal P. Mohanakumar","psa":"D K Ganguly","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2064252565","eid":"W2064252565"},{"id":"paper-w4385804242","cat":"papers","name":"Associations of psychoactive substances and steroid hormones in hair: Findings relevant to stress research from a large cohort of young adults","year":"2023","cit":10,"pfa":"Lydia Johnson‐Ferguson","psa":"Boris B. Quednow","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4385804242","eid":"W4385804242"},{"id":"paper-w4364356938","cat":"papers","name":"Children victims of drug abuser parents: Hair testing as a forensic tool to assess exposure—A cohort of 37 cases from Spain","year":"2023","cit":10,"pfa":"Carlos García‐Caballero","psa":"María Antonia Martínez‐González","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4364356938","eid":"W4364356938"},{"id":"paper-w1970264289","cat":"papers","name":"Blockade of central β‐adrenoceptors attenuates tremor induced by 5‐hydroxytryptamine (5‐HT)‐receptor activation in rats","year":"1987","cit":10,"pfa":"Heléne Hallberg","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1970264289","eid":"W1970264289"},{"id":"paper-w2803647531","cat":"papers","name":"Sense of reality, metacognition, and culture in schizophrenic and drug-induced hallucinations","year":"2018","cit":10,"pfa":"Martin Fortier","topics":["Mechanism & neuroscience"],"ptype":"book","src":"https://openalex.org/W2803647531","eid":"W2803647531"},{"id":"paper-w4409569643","cat":"papers","name":"Network control energy reductions under DMT relate to serotonin receptors, signal diversity, and subjective experience","year":"2025","cit":10,"pfa":"S. Parker Singleton","psa":"Amy F. Kuceyeski","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4409569643","eid":"W4409569643"},{"id":"paper-w3186726344","cat":"papers","name":"Safer Tripping: Serotonergic Psychedelics and Drug Checking. Submission and Detection Rates, Potential Harms, and Challenges for Drug Analysis","year":"2021","cit":10,"pfa":"Tim Hirschfeld","psa":"Tomislav Majić","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3186726344","eid":"W3186726344"},{"id":"paper-w1007252029","cat":"papers","name":"Biogenic amines as biomarkers for neurotoxicity.","year":"1991","cit":10,"pfa":"S F Ali","psa":"William Slikker","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1007252029","eid":"W1007252029"},{"id":"paper-w4280596317","cat":"papers","name":"Agonist-Promoted Phosphorylation and Internalization of the Kappa Opioid Receptor in Mouse Brains: Lack of Connection With Conditioned Place Aversion","year":"2022","cit":10,"pfa":"Chongguang Chen","psa":"Lee‐Yuan Liu‐Chen","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4280596317","eid":"W4280596317"},{"id":"paper-w4410698430","cat":"papers","name":"Neuropsychopharmacology of hallucinogenic and non‐hallucinogenic 5‐HT 2A receptor agonists","year":"2025","cit":10,"pfa":"Trevor Sharp","psa":"Aurelija Ippolito","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4410698430","eid":"W4410698430"},{"id":"paper-w4402487131","cat":"papers","name":"The Epidemiology of Psychedelic Use Among United States Military Veterans","year":"2024","cit":10,"pfa":"Alan K. Davis","psa":"Rachel Yehuda","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4402487131","eid":"W4402487131"},{"id":"paper-w4402649875","cat":"papers","name":"Going Underground: Demographics, Services, and Best Practices Endorsed by Practitioners Providing Support for Naturalistic Psychedelic Use","year":"2024","cit":10,"pfa":"Nicolas G. Glynos","psa":"Kevin F. Boehnke","topics":["Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4402649875","eid":"W4402649875"},{"id":"paper-w2962076178","cat":"papers","name":"Decreased Directed Functional Connectivity in the Psychedelic State","year":"2019","cit":10,"pfa":"Lionel Barnett","psa":"Anil K. Seth","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W2962076178","eid":"W2962076178"},{"id":"paper-w2589295853","cat":"papers","name":"DMT Gland","year":"2017","cit":10,"pfa":"Graham St John","ptype":"article","src":"https://openalex.org/W2589295853","eid":"W2589295853"},{"id":"paper-w4311377630","cat":"papers","name":"Gas Chromatography Mass Spectrometry (GCMS) analysis of the antagonistic potential of Trichoderma hamatum against Fusarium oxysporum f. sp. cepae causing basal rot disease of onion","year":"2022","cit":10,"pfa":"R. Oviya","psa":"Sampathrajan Vellaikumar","ptype":"article","src":"https://openalex.org/W4311377630","eid":"W4311377630"},{"id":"paper-w4385544537","cat":"papers","name":"Elucidation of Pharmacological Mechanism Underlying the Anti-Alzheimer’s Disease Effects of Evodia rutaecarpa and Discovery of Novel Lead Molecules: An In Silico Study","year":"2023","cit":10,"pfa":"Lulu Zhang","psa":"Qinwen Wang","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4385544537","eid":"W4385544537"},{"id":"paper-w4411969613","cat":"papers","name":"Acute pharmacological effects of α-PVP in humans: a naturalistic observational study","year":"2025","cit":10,"pfa":"Georgina De la Rosa","psa":"Clara Pérez‐Mañá","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4411969613","eid":"W4411969613"},{"id":"paper-w35265530","cat":"papers","name":"Neurochemical Effects of Methylenedioxymethamphetamine in the Rat: Acute Versus Long-Term Changes","year":"1990","cit":10,"pfa":"Christopher J. Schmidt","psa":"Vicki L. Taylor","ptype":"book-chapter","src":"https://openalex.org/W35265530","eid":"W35265530"},{"id":"paper-w4390694679","cat":"papers","name":"Aesthetic chills mitigate maladaptive cognition in depression","year":"2024","cit":10,"pfa":"Félix Schoeller","psa":"Nicco Reggente","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4390694679","eid":"W4390694679"},{"id":"paper-w1981396552","cat":"papers","name":"Poisonous and Hallucinogenic Mushrooms of India","year":"2006","cit":10,"pfa":"Sunil Kumar Deshmukh","psa":"K. Natarajan","topics":["Anxiety & end-of-life","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1981396552","eid":"W1981396552"},{"id":"paper-w4319767767","cat":"papers","name":"Cannabis-assisted psychotherapy for complex dissociative posttraumatic stress disorder: A case report","year":"2023","cit":10,"pfa":"Anya Ragnhildstveit","psa":"Lynnette A. Averill","topics":["PTSD & trauma","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4319767767","eid":"W4319767767"},{"id":"paper-w3102629752","cat":"papers","name":"Kétamine, psilocybine, et antidépresseurs d'action rapide : de nouvelles promesses pour la psychiatrie?","year":"2020","cit":10,"pfa":"Hugo Bottemanne","psa":"Philippe Fossati","ptype":"article","src":"https://openalex.org/W3102629752","eid":"W3102629752"},{"id":"paper-w4404123591","cat":"papers","name":"Ethical Aspects of Psychedelic-Assisted Treatments: An Overview","year":"2024","cit":10,"pfa":"Christopher J. Poppe","psa":"Dimitris Repantis","topics":["Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W4404123591","eid":"W4404123591"},{"id":"paper-w3090986803","cat":"papers","name":"Fostering Nurse Engagement in Psychedelic-Assisted Therapies for Patients with Serious Illness","year":"2020","cit":10,"pfa":"William E. Rosa","psa":"Andrew  D. Penn","ptype":"article","src":"https://openalex.org/W3090986803","eid":"W3090986803"},{"id":"paper-w4376618830","cat":"papers","name":"Applying Key Lessons from the Hospice and Palliative Care Movement to Inform Psychedelic-Assisted Therapy","year":"2023","cit":10,"pfa":"Megan Miller","psa":"Yvan Beaussant","topics":["Anxiety & end-of-life"],"ptype":"editorial","src":"https://openalex.org/W4376618830","eid":"W4376618830"},{"id":"paper-w4377139356","cat":"papers","name":"Ketamine-assisted psychotherapy treatment of chronic pain and comorbid depression: a pilot study of two approaches","year":"2023","cit":10,"pfa":"Daniella Batievsky","psa":"Denise Christina Vidot","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4377139356","eid":"W4377139356"},{"id":"paper-w3202256479","cat":"papers","name":"Ketamine-assisted psychotherapy for trauma-exposed patients in an outpatient setting: A clinical chart review study","year":"2021","cit":10,"pfa":"Alan K. Davis","psa":"Yitong Xin","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3202256479","eid":"W3202256479"},{"id":"paper-w4387515778","cat":"papers","name":"Disruption as an opportunity or threat: A qualitative analysis of factors influencing the attitudes of experts in serious illness care toward psychedelic-assisted therapies","year":"2023","cit":10,"pfa":"Roxanne Sholevar","psa":"Yvan Beaussant","topics":["Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4387515778","eid":"W4387515778"},{"id":"paper-w4416440535","cat":"papers","name":"Current perspectives on psychedelic treatments in Europe","year":"2025","cit":10,"pfa":"Santiago Madero","psa":"Eduard Vieta","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4416440535","eid":"W4416440535"},{"id":"paper-w3080444607","cat":"papers","name":"INTEGRATING PSYCHEDELIC EXPERIENCES UTILIZING THE INTERNAL FAMILY SYSTEMS THERAPEUTIC MODEL","year":"2020","cit":10,"pfa":"Nancy L. Morgan","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W3080444607","eid":"W3080444607"},{"id":"paper-w4280538032","cat":"papers","name":"Self-Care Practices with Psychedelics – A Qualitative Study of Users’ Perspectives","year":"2022","cit":10,"pfa":"Carla Soares","psa":"Marta Sofia de Sousa Pinto","topics":["Addiction","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4280538032","eid":"W4280538032"},{"id":"paper-w4401588473","cat":"papers","name":"Comforting delusions? How to evaluate the plausibility of mystical-type insights in psychedelic experiences","year":"2024","cit":10,"pfa":"Jussi Jylkkä","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4401588473","eid":"W4401588473"},{"id":"paper-w4408096046","cat":"papers","name":"Mortality risk among people receiving acute hospital care for hallucinogen use compared with the general population","year":"2025","cit":10,"pfa":"Daniel Thomas Myran","psa":"Marco Solmi","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4408096046","eid":"W4408096046"},{"id":"paper-w4391738678","cat":"papers","name":"PAM trial protocol: a randomised feasibility study of psychedelic microdosing–assisted meaning-centred psychotherapy in advanced stage cancer patients","year":"2024","cit":10,"pfa":"Alesha Wells","psa":"Lisa Reynolds","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4391738678","eid":"W4391738678"},{"id":"paper-w4308072532","cat":"papers","name":"An Assessment of Psychedelic Knowledge Among People Using Psychedelics Naturalistically","year":"2022","cit":10,"pfa":"Daniel J. Kruger","psa":"Kevin F. Boehnke","topics":["Safety & adverse events","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4308072532","eid":"W4308072532"},{"id":"paper-w2159423795","cat":"papers","name":"Bromo-DMA: The Australasian Hallucinogen?","year":"1983","cit":10,"pfa":"Neil Buhrich","psa":"Graham Cook","ptype":"article","src":"https://openalex.org/W2159423795","eid":"W2159423795"},{"id":"paper-w1981009917","cat":"papers","name":"The Psychedelic Experience","year":"1965","cit":10,"pfa":"Sidney Cohen","ptype":"article","src":"https://openalex.org/W1981009917","eid":"W1981009917"},{"id":"paper-w2135422203","cat":"papers","name":"Targeted and Microdose Chemical Applications","year":"2013","cit":10,"pfa":"Stephen L. Young","psa":"Durham Ken Giles","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W2135422203","eid":"W2135422203"},{"id":"paper-w4389694566","cat":"papers","name":"Psychedelic Revolutionaries","year":"2018","cit":10,"pfa":"P.W. Barber","topics":["Dosing & pharmacology"],"ptype":"book","src":"https://openalex.org/W4389694566","eid":"W4389694566"},{"id":"paper-w4220674606","cat":"papers","name":"Psychedelics and meditation","year":"2022","cit":10,"pfa":"Chris Letheby","ptype":"book-chapter","src":"https://openalex.org/W4220674606","eid":"W4220674606"},{"id":"paper-w1997018323","cat":"papers","name":"Microdosing in Early Lead Discovery","year":"2010","cit":10,"pfa":"AP Jekunen","psa":"Kairemo Kj","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1997018323","eid":"W1997018323"},{"id":"paper-w4404517659","cat":"papers","name":"Fragile promise of psychedelics in psychiatry","year":"2024","cit":10,"pfa":"Cédric Lemarchand","psa":"Florian Naudet","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4404517659","eid":"W4404517659"},{"id":"paper-w2144584973","cat":"papers","name":"BY ITS FRUITS? MYSTICAL AND VISIONARY STATES OF CONSCIOUSNESS OCCASIONED BY ENTHEOGENS","year":"2014","cit":10,"pfa":"Leonard M. Hummel","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2144584973","eid":"W2144584973"},{"id":"paper-w2921330449","cat":"papers","name":"Getting high with the most high: Entheogens in the Old Testament","year":"2019","cit":10,"pfa":"Danny Nemu","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2921330449","eid":"W2921330449"},{"id":"paper-w2013807862","cat":"papers","name":"Unpublicized hallucinogens. The dangerous belladonna alkaloids","year":"1967","cit":10,"pfa":"D Müller","ptype":"article","src":"https://openalex.org/W2013807862","eid":"W2013807862"},{"id":"paper-w2017804607","cat":"papers","name":"On the Comparative Ethnopharmacology of Malpighiaceous and Myristicaceous Hallucinogens","year":"1985","cit":10,"pfa":"Dennis J. McKenna","psa":"G.H.N. Towers","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2017804607","eid":"W2017804607"},{"id":"paper-w2035857713","cat":"papers","name":"Hallucinogen-Tranquilizer Interaction: Its Nature","year":"1969","cit":10,"pfa":"Michael F. Halasz","psa":"Amedeo S. Marrazzi","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2035857713","eid":"W2035857713"},{"id":"paper-w2793006256","cat":"papers","name":"Ecopsychology and the Psychedelic Experience","year":"2013","cit":10,"pfa":"David Luke","ptype":"book","src":"https://openalex.org/W2793006256","eid":"W2793006256"},{"id":"paper-w2171085033","cat":"papers","name":"An Analysis of Psychedelic Drug Flashbacks","year":"1976","cit":10,"pfa":"Donald R. Wesson","psa":"David Eugene Smith","ptype":"article","src":"https://openalex.org/W2171085033","eid":"W2171085033"},{"id":"paper-w4317511269","cat":"papers","name":"What good are psychedelic humanities?","year":"2023","cit":10,"pfa":"Nicolas Langlitz","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4317511269","eid":"W4317511269"},{"id":"paper-w4281492000","cat":"papers","name":"Trust and Psychedelic Moral Enhancement","year":"2022","cit":10,"pfa":"Emma C. Gordon","topics":["Dosing & pharmacology","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4281492000","eid":"W4281492000"},{"id":"paper-w1993397932","cat":"papers","name":"Psychedelic Theophanies and the Religious Life","year":"1970","cit":10,"pfa":"Huston Smith","ptype":"article","src":"https://openalex.org/W1993397932","eid":"W1993397932"},{"id":"paper-w2052436803","cat":"papers","name":"Genista canariensis: A minor psychedelic","year":"1965","cit":10,"pfa":"James Fadiman","ptype":"article","src":"https://openalex.org/W2052436803","eid":"W2052436803"},{"id":"paper-w4389223429","cat":"papers","name":"The bodily self from psychosis to psychedelics","year":"2023","cit":10,"pfa":"Amir Harduf","psa":"Roy Salomon","ptype":"article","src":"https://openalex.org/W4389223429","eid":"W4389223429"},{"id":"paper-w2346428090","cat":"papers","name":"Knowledge Diffusion and the Adoption of Fertilizer Microdosing in Northwest Benin","year":"2016","cit":10,"pfa":"David C. Natcher","psa":"Derek Peak","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2346428090","eid":"W2346428090"},{"id":"paper-w4387218683","cat":"papers","name":"Alternative beliefs in psychedelic drug users","year":"2023","cit":10,"pfa":"Alexander V. Lebedev","psa":"Predrag Petrović","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4387218683","eid":"W4387218683"},{"id":"paper-w2681791877","cat":"papers","name":"Humanistic Psychology, Psychedelics, and the Transpersonal Vision","year":"2017","cit":10,"pfa":"Charles S. Grob","psa":"Anthony P. Bossis","ptype":"article","src":"https://openalex.org/W2681791877","eid":"W2681791877"},{"id":"paper-w2045206978","cat":"papers","name":"The stimulants and hallucinogens under consideration: A brief overview of their chemistry and pharmacology","year":"1986","cit":10,"pfa":"Louis S. Harris","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2045206978","eid":"W2045206978"},{"id":"paper-w2345815474","cat":"papers","name":"Profitability and Institutional Constraints to the Adoption of Fertilizer Microdosing in Northwest Benin","year":"2016","cit":10,"pfa":"Erika Bachmann","psa":"Derek Peak","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2345815474","eid":"W2345815474"},{"id":"paper-w2522777159","cat":"papers","name":"Altered States: Buddhism and Psychedelic Spirituality in America","year":"2016","cit":10,"pfa":"Douglas Osto","ptype":"article","src":"https://openalex.org/W2522777159","eid":"W2522777159"},{"id":"paper-w4309475063","cat":"papers","name":"Psychedelics as Standard of Care? Many Questions Remain","year":"2022","cit":10,"pfa":"Kurt Rasmussen","psa":"David E. Olson","ptype":"article","src":"https://openalex.org/W4309475063","eid":"W4309475063"},{"id":"paper-w2605178562","cat":"papers","name":"Psychedelic research in Australia: Breaking through the stigma","year":"2017","cit":10,"pfa":"Prashanth Puspanathan","ptype":"article","src":"https://openalex.org/W2605178562","eid":"W2605178562"},{"id":"paper-w4296162186","cat":"papers","name":"Deepening our understanding of psychedelics by expanding psychedelic data collection in the United States National Survey on Drug Use and Health","year":"2022","cit":10,"pfa":"Brian Scott Barnett","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4296162186","eid":"W4296162186"},{"id":"paper-w2895603500","cat":"papers","name":"Molecular Modeling of the Interaction of LSD and Other Hallucinogens With 5-HT2 Receptors","year":"1994","cit":10,"pfa":"Richard B. Westkaemper","psa":"Richard A. Glennon","topics":["Mechanism & neuroscience"],"ptype":"dataset","src":"https://openalex.org/W2895603500","eid":"W2895603500"},{"id":"paper-w1994996480","cat":"papers","name":"Microdosing vs. Therapeutic dosing for evaluation of pharmacokinetic data: A comparative study","year":"2009","cit":10,"pfa":"Rajiv Mahajan","psa":"Kapil Gupta","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1994996480","eid":"W1994996480"},{"id":"paper-w2580888808","cat":"papers","name":"Quake Delirium: Remixing Psychedelic Video Games","year":"2011","cit":10,"pfa":"Jonathan Weinel","ptype":"article","src":"https://openalex.org/W2580888808","eid":"W2580888808"},{"id":"paper-w2304290945","cat":"papers","name":"Five years of fertility control with microdose norgestrel: An updated clinical review.","year":"1974","cit":10,"pfa":"Vladimir D. Korba","psa":"Samantha Paulson","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2304290945","eid":"W2304290945"},{"id":"paper-w2191987868","cat":"papers","name":"The application of human phase 0 microdosing trials: A systematic review and perspectives","year":"2015","cit":10,"pfa":"Pernille Svendsen","psa":"Hans Erik Johnsen","topics":["Dosing & pharmacology","Reviews & meta-analyses","Policy & ethics"],"ptype":"review","src":"https://openalex.org/W2191987868","eid":"W2191987868"},{"id":"paper-w1994695116","cat":"papers","name":"Genotoxic hazard of radiopharmaceuticals in humans: chemical and radiation aspects coupled to microdosing","year":"2007","cit":10,"pfa":"Hans Lundqvist","psa":"Bengt Långström","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1994695116","eid":"W1994695116"},{"id":"paper-w4390697941","cat":"papers","name":"Minorities’ diminished psychedelic returns: Cardio-metabolic health","year":"2024","cit":10,"pfa":"Sean M. Viña","ptype":"article","src":"https://openalex.org/W4390697941","eid":"W4390697941"},{"id":"paper-w4404362384","cat":"papers","name":"Beyond psychedelics: set and setting in general psychiatric practice","year":"2024","cit":10,"pfa":"Zofia Kozak","psa":"Christopher W. T. Miller","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4404362384","eid":"W4404362384"},{"id":"paper-w3023856410","cat":"papers","name":"AgriRobot: implementation and evaluation of an automatic robot for seeding and fertiliser microdosing in precision agriculture","year":"2020","cit":10,"pfa":"Ratnmala Nivrutti Bhimanpallewar","psa":"Manda Rama Narasingarao","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3023856410","eid":"W3023856410"},{"id":"paper-w4301397091","cat":"papers","name":"Factors that distinguish opioid withdrawal during induction with buprenorphine microdosing: a configurational analysis","year":"2022","cit":10,"pfa":"Kathleen K. Adams","psa":"Diana M Sobieraj","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4301397091","eid":"W4301397091"},{"id":"paper-w4392153618","cat":"papers","name":"Traditional and Indigenous Perspectives on Healing Trauma With Psychedelic Plant Medicines","year":"2024","cit":10,"pfa":"Christine Diindiisi McCleave","psa":"Joseph Tafur","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4392153618","eid":"W4392153618"},{"id":"paper-w2212628971","cat":"papers","name":"Influence of Fertilizer Microdosing on Strigolactone Production and Striga hermonthica Parasitism in Pearl Millet","year":"2014","cit":10,"pfa":"Muhammad Jamil","psa":"Harro J. Bouwmeester","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W2212628971","eid":"W2212628971"},{"id":"paper-w4255242138","cat":"papers","name":"Personality characteristics associated with psychedelic flashbacks in natural and experimental settings.","year":"1976","cit":10,"pfa":"Robert K. Heaton","psa":"Ralph G. Victor","ptype":"article","src":"https://openalex.org/W4255242138","eid":"W4255242138"},{"id":"paper-w2527391315","cat":"papers","name":"Australia should be initiating a psychedelic research program: What are the barriers?","year":"2016","cit":10,"pfa":"Nigel H. M. Strauss","psa":"Martin L Williams","ptype":"editorial","src":"https://openalex.org/W2527391315","eid":"W2527391315"},{"id":"paper-w2116607388","cat":"papers","name":"Steric effects of substituents on phenethylamine hallucinogens. 3,4-(Methylenedioxy)amphetamine analogs alkylated on the dioxole ring","year":"1979","cit":10,"pfa":"David E. Nichols","psa":"Linda J. Kostuba","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2116607388","eid":"W2116607388"},{"id":"paper-w1998843238","cat":"papers","name":"Continuous low-level apomorphine administration induces motor abnormalities and hallucinogen-like behaviors","year":"1985","cit":10,"pfa":"Robert E. Davis","psa":"Gaylord D. Ellison","ptype":"article","src":"https://openalex.org/W1998843238","eid":"W1998843238"},{"id":"paper-w3099018302","cat":"papers","name":"Designing Consciousness: Psychedelics as Ontological Design Tools for Decolonizing Consciousness","year":"2020","cit":10,"pfa":"Joshua Falcon","ptype":"article","src":"https://openalex.org/W3099018302","eid":"W3099018302"},{"id":"paper-w4377940368","cat":"papers","name":"Effect of Microdoses of Incisional Antibiotics on the Rate of Surgical Site Infections in Skin Cancer Surgery","year":"2023","cit":10,"pfa":"Maple Goh","psa":"Jon A. Mathy","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4377940368","eid":"W4377940368"},{"id":"paper-w4391309244","cat":"papers","name":"Bridging the gap: (a)typical psychedelic and near-death experience insights","year":"2024","cit":10,"pfa":"Pauline Fritz","psa":"Charlotte Martial","ptype":"review","src":"https://openalex.org/W4391309244","eid":"W4391309244"},{"id":"paper-w2071649034","cat":"papers","name":"When Opportunity Met Aspirational Goals: Accelerator Ms, Microdosing And Absolute Bioavailability Studies","year":"2012","cit":10,"pfa":"Mark E. Arnold","psa":"Frank P. LaCreta","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2071649034","eid":"W2071649034"},{"id":"paper-w3088848289","cat":"papers","name":"Transitioning From Intrathecal Hydromorphone to Sublingual Buprenorphine–Naloxone Through Microdosing: A Case Report","year":"2020","cit":10,"pfa":"Isaiah T. Crum","psa":"Alëna A. Balasanova","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3088848289","eid":"W3088848289"},{"id":"paper-w4383424424","cat":"papers","name":"Extended Difficulties Following the Use of Psychedelic Drugs: A Mixed Methods Study","year":"2023","cit":10,"pfa":"Jules Evans","psa":"Rosalind G. McAlpine","ptype":"preprint","src":"https://openalex.org/W4383424424","eid":"W4383424424"},{"id":"paper-w4317708620","cat":"papers","name":"Menstrual Changes and Reversal of Amenorrhea Induced by Classic Psychedelics: A Case Series","year":"2023","cit":10,"pfa":"Natalie Gukasyan","psa":"Sasha K. Narayan","topics":["Mechanism & neuroscience"],"ptype":"book-review","src":"https://openalex.org/W4317708620","eid":"W4317708620"},{"id":"paper-w4403468481","cat":"papers","name":"Acceptance as a possible link between past psychedelic experiences and psychological flexibility","year":"2024","cit":10,"pfa":"Andreas Krabbe","psa":"Jussi Jylkkä","ptype":"article","src":"https://openalex.org/W4403468481","eid":"W4403468481"},{"id":"paper-w128720273","cat":"papers","name":"Neurophysiologic Properties of Psychotomimetics","year":"1982","cit":10,"pfa":"George K. Aghajanian","ptype":"book-chapter","src":"https://openalex.org/W128720273","eid":"W128720273"},{"id":"paper-w4402116594","cat":"papers","name":"Ketamine, the First Associative Anesthetic? Some Considerations on Classifying Psychedelics, Entactogens, and Dissociatives","year":"2024","cit":10,"pfa":"Nicholas Denomme","psa":"Boris Dov Heifets","ptype":"article","src":"https://openalex.org/W4402116594","eid":"W4402116594"},{"id":"paper-w2035488066","cat":"papers","name":"Serine and folate metabolism in fibroblasts from episodic psychotic patients with psychedelic symptoms","year":"1986","cit":10,"pfa":"Durk Fekkes","psa":"Jacques Bruinvels","ptype":"article","src":"https://openalex.org/W2035488066","eid":"W2035488066"},{"id":"paper-w4383552452","cat":"papers","name":"A predictive coding approach to psychedelic virtual-induced hallucinations and creative cognition in aging","year":"2023","cit":10,"pfa":"Giulia Magni","psa":"Giuseppe Riva","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4383552452","eid":"W4383552452"},{"id":"paper-w4394873909","cat":"papers","name":"From taboo to treatment: The emergence of psychedelics in the management of pain and opioid use disorder","year":"2024","cit":10,"pfa":"Jeremy Weleff","psa":"João Paulo De Aquino","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4394873909","eid":"W4394873909"},{"id":"paper-w2918991138","cat":"papers","name":"Hallucinogens and Altered States of Consciousness in Cusco, Peru: A Path to Local Power during Wari State Expansion","year":"2019","cit":10,"pfa":"Véronique Bélisle","ptype":"article","src":"https://openalex.org/W2918991138","eid":"W2918991138"},{"id":"paper-w4392346541","cat":"papers","name":"Psychedelics in PERIL: The Commercial Determinants of Health, Financial Entanglements and Population Health Ethics","year":"2024","cit":10,"pfa":"Daniel Z. Buchman","psa":"Daniel Rosenbaum","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4392346541","eid":"W4392346541"},{"id":"paper-w2318599776","cat":"papers","name":"Influences of previous psychedelic drug experiences on students of Tibetan Buddhism：A preliminary exploration","year":"1991","cit":10,"pfa":"Charles T. Tart","ptype":"article","src":"https://openalex.org/W2318599776","eid":"W2318599776"},{"id":"paper-w3118554973","cat":"papers","name":"Solid-Contact Potentiometric Sensors Based on Main-Tailored Bio-Mimics for Trace Detection of Harmine Hallucinogen in Urine Specimens","year":"2021","cit":10,"pfa":"Abd El‐Galil E. Amr","psa":"Hisham S. M. Abd‐Rabboh","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3118554973","eid":"W3118554973"},{"id":"paper-w4294225693","cat":"papers","name":"A Multidisciplinary Hypothesis about Serotonergic Psychedelics. Is it Possible that a Portion of Brain Serotonin Comes From the Gut?","year":"2022","cit":10,"pfa":"Noémi Császár-Nagy","psa":"István Bókkon","topics":["Mechanism & neuroscience","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4294225693","eid":"W4294225693"},{"id":"paper-w3214577518","cat":"papers","name":"Digital localisation in an illicit market space: interactional creation of a psychedelic assemblage in a darknet community of exchange","year":"2021","cit":10,"pfa":"Maja Sawicka","psa":"Angus Bancroft","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3214577518","eid":"W3214577518"},{"id":"paper-w4416332324","cat":"papers","name":"Enhancing fertilizer-use-efficiency through fertilizer microdosing as climate-smart practices among crop farmers in North Central, Nigeria","year":"2025","cit":10,"pfa":"Adetomiwa Kolapo","psa":"Stefan Sieber","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4416332324","eid":"W4416332324"},{"id":"paper-w2258380010","cat":"papers","name":"The Psychotomimetic Side Effects of Pentazocine","year":"1978","cit":10,"pfa":"Chris E. Coursey","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2258380010","eid":"W2258380010"},{"id":"paper-w2790108110","cat":"papers","name":"Preclinical characterization of three transient receptor potential vanilloid receptor 1 antagonists for early use in human intradermal microdose analgesic studies","year":"2018","cit":10,"pfa":"Erik Sjögren","psa":"Anna K. Sundgren‐Andersson","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2790108110","eid":"W2790108110"},{"id":"paper-w4296163195","cat":"papers","name":"EPO and the athlete biological passport: Hematological results from a placebo‐controlled, boosting and microdose EPO administration in male recreational athletes","year":"2022","cit":10,"pfa":"Geoffrey D. Miller","psa":"Daniel Eichner","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4296163195","eid":"W4296163195"},{"id":"paper-w1498131831","cat":"papers","name":"An Assessment of the Oral Bioavailability of Three Ca-Channel Blockers Using a Cassette-Microdose Study: A New Strategy for Streamlining Oral Drug Development","year":"2015","cit":10,"pfa":"Shinji Yamashita","psa":"Yuichi Sugiyama","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1498131831","eid":"W1498131831"},{"id":"paper-w2089978804","cat":"papers","name":"Microdose pharmacogenetic study of 14C-tolbutamide in healthy subjects with accelerator mass spectrometry to examine the effects of CYP2C9∗3 on its pharmacokinetics and metabolism","year":"2013","cit":10,"pfa":"Toshihiko Ikeda","psa":"Yuichi Sugiyama","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2089978804","eid":"W2089978804"},{"id":"paper-w1970563593","cat":"papers","name":"Studies with a tritium-labeled psychotomimetic agent","year":"1959","cit":10,"pfa":"Leo G. Abood","psa":"F. Rinaldi","ptype":"article","src":"https://openalex.org/W1970563593","eid":"W1970563593"},{"id":"paper-w3184286957","cat":"papers","name":"The Ethic of Access: An AIDS Activist Won Public Access to Experimental Therapies, and This Must Now Extend to Psychedelics for Mental Illness","year":"2021","cit":10,"pfa":"Morgan Campbell","psa":"Monnica T. Williams","topics":["Anxiety & end-of-life","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3184286957","eid":"W3184286957"},{"id":"paper-w2036346580","cat":"papers","name":"QSARs with Orthogonal Descriptors on Psychotomimetic Phenylalkylamines","year":"1997","cit":10,"pfa":"Maria Mracec","psa":"Gábor Náray‐Szabó","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2036346580","eid":"W2036346580"},{"id":"paper-w2029830110","cat":"papers","name":"Psychotomimetic Effects of Drugs — A Common Pathway to Schizophrenia?","year":"2004","cit":10,"pfa":"David J. Gerber","psa":"Susumu Tonegawa","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2029830110","eid":"W2029830110"},{"id":"paper-w2794202340","cat":"papers","name":"Psychotomimetic-like behavioral effects of memantine in the mouse","year":"2018","cit":10,"pfa":"Nobue Kitanaka","psa":"Motohiko Takemura","ptype":"article","src":"https://openalex.org/W2794202340","eid":"W2794202340"},{"id":"paper-w2033872785","cat":"papers","name":"Correlation between animal and clinical findings with a psychotomimetic anticholinesterase","year":"1973","cit":10,"pfa":"Samuel R. Wray","psa":"A. Cowan","ptype":"article","src":"https://openalex.org/W2033872785","eid":"W2033872785"},{"id":"paper-w4304890735","cat":"papers","name":"The psychotomimetic ketamine disrupts the transfer of late sensory information in the corticothalamic network","year":"2022","cit":10,"pfa":"Yi Qin","psa":"Didier Pinault","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4304890735","eid":"W4304890735"},{"id":"paper-w2415339997","cat":"papers","name":"ACTIONS OF SOME TOXIC SUBSTANCES (PSYCHOTOMIMETICS) ON THE CENTRAL NERVOUS SYSTEM","year":"1969","cit":10,"pfa":"A. Bebbington","psa":"Roger W. Brimblecombe","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2415339997","eid":"W2415339997"},{"id":"paper-w2067002610","cat":"papers","name":"Serum CPK and aldolase activity in man following controlled administration of psychotomimetic drugs","year":"1970","cit":10,"pfa":"Herbert Y. Meltzer","psa":"Robert Irwin Henkin","ptype":"article","src":"https://openalex.org/W2067002610","eid":"W2067002610"},{"id":"paper-w2021096057","cat":"papers","name":"Inhibitory effects of psychotomimetic σ ligands on nicotine-induced K+ flux from differentiated PC12 cells","year":"1992","cit":10,"pfa":"Hiroshi Yamamoto","psa":"Takashi Moroji","ptype":"article","src":"https://openalex.org/W2021096057","eid":"W2021096057"},{"id":"paper-w2071738323","cat":"papers","name":"Digital Radiology in Trauma Using Small-Dose Exposure","year":"1979","cit":10,"pfa":"David J. Curtis","psa":"Kenneth S. Rugh","topics":["PTSD & trauma","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2071738323","eid":"W2071738323"},{"id":"paper-w4406870441","cat":"papers","name":"The ketamine chameleon: history, pharmacology, and the contested value of experience","year":"2025","cit":10,"pfa":"Danny Diep","psa":"Kyle T. Greenway","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4406870441","eid":"W4406870441"},{"id":"paper-w4392109313","cat":"papers","name":"Time Course of the Interaction Between Oral Short-Term Ritonavir Therapy with Three Factor Xa Inhibitors and the Activity of CYP2D6, CYP2C19, and CYP3A4 in Healthy Volunteers","year":"2024","cit":10,"pfa":"Brit Silja Rohr","psa":"Walter E. Haefeli","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4392109313","eid":"W4392109313"},{"id":"paper-w3018167725","cat":"papers","name":"Patterns of Simultaneous Polysubstance Use among Partygoers: Correlates and Differences in Adverse Acute Effects Experienced","year":"2020","cit":10,"pfa":"Fermín Fernández‐Calderón","psa":"Oscar Martin Lozano","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3018167725","eid":"W3018167725"},{"id":"paper-w1979617988","cat":"papers","name":"Evaluation of peroxyoxalate chemiluminescence for the sensitive determination of hallucinogenic alkaloids","year":"1995","cit":10,"pfa":"Juana Cepas","psa":"Dolores Pérez‐Bendito","ptype":"article","src":"https://openalex.org/W1979617988","eid":"W1979617988"},{"id":"paper-w2947317044","cat":"papers","name":"De Plantis Toxicariis E Mundo Novo Tropicale Commentationes XXVI: Ethnopharmacological Notes on the Flora of Northwestern South America","year":"1980","cit":10,"pfa":"Richard Evans Schultes","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2947317044","eid":"W2947317044"},{"id":"paper-w4401667571","cat":"papers","name":"Dose‐dependent induction of CYP3A activity by St. John's wort alone and in combination with rifampin","year":"2024","cit":10,"pfa":"Nicolas Hohmann","psa":"Walter E. Haefeli","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4401667571","eid":"W4401667571"},{"id":"paper-w2052341244","cat":"papers","name":"Psychopharmacology: A Biochemical and Behavioral Approach","year":"1977","cit":10,"pfa":"Frank J. Ayd","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2052341244","eid":"W2052341244"},{"id":"paper-w4312101495","cat":"papers","name":"Aesthetic chills foster self-acceptance and emotional breakthrough in depression","year":"2022","cit":10,"pfa":"Félix Schoeller","psa":"Pattie Maes","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4312101495","eid":"W4312101495"},{"id":"paper-w4392190482","cat":"papers","name":"Substance addictions and suicidal thoughts and behaviors: Evidence from a multi-wave epidemiological study","year":"2024","cit":10,"pfa":"Angela Giugovaz","psa":"Igor Marchetti","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4392190482","eid":"W4392190482"},{"id":"paper-w4405653307","cat":"papers","name":"Modern pharmacotherapy guidance for treating alcohol use disorders","year":"2024","cit":10,"pfa":"Michael Soyka","psa":"Susanne Rösner","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4405653307","eid":"W4405653307"},{"id":"paper-w2911845713","cat":"papers","name":"Dorsolateral Prefrontal Cortex Impairment in Methoxetamine-Induced Psychosis: An 18F-FDG PET/CT Case Study","year":"2019","cit":10,"pfa":"Lorenzo Moccia","psa":"Marco Di Nicola","topics":["Addiction","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2911845713","eid":"W2911845713"},{"id":"paper-w4393932812","cat":"papers","name":"Acute Dissociation and Ketamine’s Antidepressant and Anti-Suicidal Ideation Effects in a Midazolam-Controlled Trial","year":"2024","cit":10,"pfa":"Sumra Sajid","psa":"Michael F. Grunebaum","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4393932812","eid":"W4393932812"},{"id":"paper-w3087942436","cat":"papers","name":"Integrating Unified Medical Language System and Kleinberg’s Burst Detection Algorithm into Research Topics of Medications for Post-Traumatic Stress Disorder","year":"2020","cit":10,"pfa":"Shuang Xu","psa":"Peng Guan","topics":["PTSD & trauma","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3087942436","eid":"W3087942436"},{"id":"paper-w2133597486","cat":"papers","name":"Children Born to Heroin-Addicted Mothers: What’s the Outcome 25 Years Later?","year":"2014","cit":10,"pfa":"Gemma Sanjuan Herranz","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2133597486","eid":"W2133597486"},{"id":"paper-w4393903066","cat":"papers","name":"Analytical and behavioral characterization of 1‐dodecanoyl‐LSD (1DD‐LSD)","year":"2024","cit":10,"pfa":"Pierce V. Kavanagh","psa":"Simon D. Brandt","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4393903066","eid":"W4393903066"},{"id":"paper-w2010277307","cat":"papers","name":"Contributions of Experimental Psychiatry to Research on the Psychosis Prodrome","year":"2013","cit":10,"pfa":"Mitja Bodatsch","psa":"Jörg Daumann","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2010277307","eid":"W2010277307"},{"id":"paper-w3139035047","cat":"papers","name":"Acute Effects of Ketamine Infusion on Postoperative Mood Scores in Patients Undergoing Dilation and Curettage: A Randomized Double-Blind Controlled Study","year":"2021","cit":10,"pfa":"Raham Hasan Mostafa","psa":"Mohamed Abdulmohsen Abdulnaiem Ismaiel","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3139035047","eid":"W3139035047"},{"id":"paper-w2794512331","cat":"papers","name":"Substance-Induced Psychosis: An Indicator of Development of Primary Psychosis?","year":"2018","cit":10,"pfa":"Subroto Ghose","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2794512331","eid":"W2794512331"},{"id":"paper-w2306535381","cat":"papers","name":"PCP and sigma receptors in brain are not altered after repeated exposure to PCP in humans.","year":"1991","cit":10,"pfa":"Arthur D. Weissman","psa":"E B De Souza","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2306535381","eid":"W2306535381"},{"id":"paper-w4387341643","cat":"papers","name":"Restorative effect of NitroSynapsin on synaptic plasticity in an animal model of depression","year":"2023","cit":10,"pfa":"Wing Sze Tse","psa":"Jakub Włodarczyk","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4387341643","eid":"W4387341643"},{"id":"paper-w2510299540","cat":"papers","name":"Genetic Influences in Cannabis Use Disorder and Psychosis: Dopamine and Beyond","year":"2016","cit":10,"pfa":"Amine Benyamina","psa":"Lisa Blecha","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2510299540","eid":"W2510299540"},{"id":"paper-w2413551310","cat":"papers","name":"Effects of the noncompetitive N-methyl-D-aspartate receptor antagonist ketamine on visual signal detection performance in rats","year":"2015","cit":10,"pfa":"Todd M. Hillhouse","psa":"Joseph H. Porter","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2413551310","eid":"W2413551310"},{"id":"paper-w4318951458","cat":"papers","name":"Modulatory Effects of Ketamine and Lamotrigine on Cognition: Emotion Interaction in the Brain","year":"2023","cit":10,"pfa":"Matti Gärtner","psa":"Simone Grimm","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4318951458","eid":"W4318951458"},{"id":"paper-w4402310001","cat":"papers","name":"Multi-level therapeutic actions of cannabidiol in ketamine-induced schizophrenia psychopathology in male rats","year":"2024","cit":10,"pfa":"Charalampos Brakatselos","psa":"Katerina Antoniou","ptype":"article","src":"https://openalex.org/W4402310001","eid":"W4402310001"},{"id":"paper-w4210631796","cat":"papers","name":"Activity-State Dependent Reversal of Ketamine-Induced Resting State EEG Effects by Clozapine and Naltrexone in the Freely Moving Rat","year":"2022","cit":10,"pfa":"Christien Bowman","psa":"Kjartan Frisch Herrik","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4210631796","eid":"W4210631796"},{"id":"paper-w3209858332","cat":"papers","name":"CBD Effects on Motor Profile and Neurobiological Indices Related to Glutamatergic Function Induced by Repeated Ketamine Pre-Administration","year":"2021","cit":10,"pfa":"Nafsika Poulia","psa":"Katerina Antoniou","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3209858332","eid":"W3209858332"},{"id":"paper-w3020114952","cat":"papers","name":"Association of extent of cannabis use and psychotic like intoxication experiences in a multi-national sample of first episode psychosis patients and controls","year":"2020","cit":10,"pfa":"Musa Basseer Sami","psa":"Marta Di Forti","ptype":"article","src":"https://openalex.org/W3020114952","eid":"W3020114952"},{"id":"paper-w4375846829","cat":"papers","name":"A comparative analysis of antidepressant and anti-suicidal effects of repeated ketamine infusions in elderly and younger adults with depression","year":"2023","cit":10,"pfa":"Wei Zheng","psa":"Yuping Ning","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4375846829","eid":"W4375846829"},{"id":"paper-w2785368439","cat":"papers","name":"Mapping the central effects of (±)-ketamine and traxoprodil using pharmacological magnetic resonance imaging in awake rats","year":"2018","cit":10,"pfa":"Haiying Tang","psa":"Feng Roger Luo","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2785368439","eid":"W2785368439"},{"id":"paper-w2516675449","cat":"papers","name":"Algorithms, Best Practices, and Expert Clinical Consensus","year":"2000","cit":10,"pfa":"John M. Oldham","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2516675449","eid":"W2516675449"},{"id":"paper-w3025787629","cat":"papers","name":"Esketamine/ketamine for treatment-resistant depression","year":"2020","cit":10,"pfa":"Acioly L.T. Lacerda","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W3025787629","eid":"W3025787629"},{"id":"paper-w4386406935","cat":"papers","name":"Exploring the potential of Esketamine in the treatment of bipolar depression","year":"2023","cit":10,"pfa":"Bernardo Maria Dell’Osso","psa":"Giovanni Martinotti","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4386406935","eid":"W4386406935"},{"id":"paper-w3011390969","cat":"papers","name":"Process Research and Impurity Control Strategy of Esketamine","year":"2020","cit":10,"pfa":"Shenghua Gao","psa":"Fuli Zhang","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3011390969","eid":"W3011390969"},{"id":"paper-w4283259669","cat":"papers","name":"Esketamine for Unipolar Major Depression With Psychotic Features","year":"2022","cit":10,"pfa":"Breno Souza‐Marques","psa":"Lucas C. Quarantini","topics":["Depression","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4283259669","eid":"W4283259669"},{"id":"paper-w4388848512","cat":"papers","name":"The effects of esketamine on the intestinal microenvironment and intestinal microbiota in mice","year":"2023","cit":10,"pfa":"Ying Zhang","psa":"Hong Xie","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4388848512","eid":"W4388848512"},{"id":"paper-w4403952489","cat":"papers","name":"Efficacy of esketamine for perinatal depression: a systematic review and meta-analysis","year":"2024","cit":10,"pfa":"Sabrina Wong","psa":"Roger S. McIntyre","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4403952489","eid":"W4403952489"},{"id":"paper-w3126764153","cat":"papers","name":"(2R,6R)-Hydroxynorketamine Alleviates Electroconvulsive Shock-Induced Learning Impairment by Inhibiting Autophagy","year":"2021","cit":10,"pfa":"Xiaomei Zhong","psa":"Weiru Zhang","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3126764153","eid":"W3126764153"},{"id":"paper-w4391100163","cat":"papers","name":"Hydroxynorketamine, but not ketamine, acts via α7 nicotinic acetylcholine receptor to control presynaptic function and gene expression","year":"2024","cit":10,"pfa":"Debarpan Guhathakurta","psa":"Anna Fejtová","topics":["Depression","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4391100163","eid":"W4391100163"},{"id":"paper-w4287091878","cat":"papers","name":"Case report: Intranasal esketamine for severe major depressive disorder with psychotic features","year":"2022","cit":10,"pfa":"Maximilian Carter","psa":"Nicholas Mischel","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4287091878","eid":"W4287091878"},{"id":"paper-w4388659384","cat":"papers","name":"What clinicians need to know about intranasal esketamine for treatment-resistant depression?","year":"2023","cit":10,"pfa":"Judy Hope","psa":"Nicholas A Keks","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4388659384","eid":"W4388659384"},{"id":"paper-w4390770665","cat":"papers","name":"Esketamine Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder: A Retrospective Chart Review","year":"2024","cit":10,"pfa":"Raíza Alves-Pereira","psa":"Lucas C. Quarantini","topics":["Depression","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4390770665","eid":"W4390770665"},{"id":"paper-w4402862879","cat":"papers","name":"Repeated subcutaneous esketamine on treatment-resistant depression: An open-label dose titration study","year":"2024","cit":10,"pfa":"Fernanda Palhano-Fontes","psa":"Nicole Leite Galvão Coelho","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4402862879","eid":"W4402862879"},{"id":"paper-w4396934531","cat":"papers","name":"Effects of esketamine and fluoxetine on depression-like behaviors in chronic variable stress: a role of plasma inflammatory factors","year":"2024","cit":10,"pfa":"Hạixia Chen","psa":"Min Cai","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4396934531","eid":"W4396934531"},{"id":"paper-w4408030617","cat":"papers","name":"Efficacy of esketamine nasal spray for treatment-resistant depression: A meta-analysis of randomized controlled studies","year":"2025","cit":10,"pfa":"Yannan Ouyang","psa":"Juan Li","topics":["Depression","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4408030617","eid":"W4408030617"},{"id":"paper-w4390099191","cat":"papers","name":"The effects of esketamine on blood pressure and hypotension incidence during induction of bariatric surgery: A randomized controlled trial","year":"2023","cit":10,"pfa":"Ting Yang","psa":"Qiang Fu","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4390099191","eid":"W4390099191"},{"id":"paper-w4408935280","cat":"papers","name":"Effect of esketamine on postoperative depression in women with breast cancer and preoperative depressive symptoms: The EASE randomized trial","year":"2025","cit":10,"pfa":"Qingfeng Wei","psa":"Daniel I. Sessler","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4408935280","eid":"W4408935280"},{"id":"paper-w4394686890","cat":"papers","name":"Efficacy of Esketamine among patients with treatment resistant depression in a ‘real world' health-care setting in Israel","year":"2024","cit":10,"pfa":"Lior Dvorak","psa":"Kfir Feffer","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4394686890","eid":"W4394686890"},{"id":"paper-w4404033706","cat":"papers","name":"The effect of a subclinical dose of esketamine on depression and pain after cesarean section: A prospective, randomized, double-blinded controlled trial","year":"2024","cit":10,"pfa":"Wan X","psa":"Mingqing Peng","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4404033706","eid":"W4404033706"},{"id":"paper-w4400292744","cat":"papers","name":"Effect of esketamine on haemodynamic fluctuations in patients undergoing hysteroscopic surgery: A prospective, double‐blind randomized clinical trial","year":"2024","cit":10,"pfa":"Yingchao Guan","psa":"Songyang Yu","ptype":"article","src":"https://openalex.org/W4400292744","eid":"W4400292744"},{"id":"paper-w4408615381","cat":"papers","name":"A Real-World Study on the Use, Effectiveness, and Safety of Esketamine Nasal Spray in Patients with Treatment-Resistant Depression: INTEGRATE Study","year":"2025","cit":10,"pfa":"Patricio Molero","psa":"Pilar Alejandra Sáiz","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4408615381","eid":"W4408615381"},{"id":"paper-w4400950224","cat":"papers","name":"Effect of esketamine on hypotension in women with preoperative anxiety undergoing elective cesarean section: a randomized, double-blind, controlled trial","year":"2024","cit":10,"pfa":"Yu Qi","psa":"Liwei Wang","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4400950224","eid":"W4400950224"},{"id":"paper-w4411902150","cat":"papers","name":"Effect of intraoperative low-dose esketamine infusion on postoperative sleep disturbance after laparoscopic cholecystectomy: a randomized clinical trial","year":"2025","cit":10,"pfa":"Yanan Wu","psa":"Zhi Yu","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4411902150","eid":"W4411902150"},{"id":"paper-w4206385969","cat":"papers","name":"Stability evaluation of morphine, hydromorphone, metamizole and esketamine containing analgesic mixtures applied for patient‐controlled analgesia in hospice and palliative care","year":"2022","cit":10,"pfa":"Matthias Harder","psa":"Matthias Rainer","topics":["Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4206385969","eid":"W4206385969"},{"id":"paper-w4321605214","cat":"papers","name":"Early Clinical Experiences of Esketamine Nasal Spray in the UK in Adults with Treatment-Resistant Major Depressive Disorder: Advisory Panel Recommendations","year":"2023","cit":10,"pfa":"Allan Hunter Young","psa":"Ramin Nilforooshan","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4321605214","eid":"W4321605214"},{"id":"paper-w4406541944","cat":"papers","name":"Esketamine nasal spray versus quetiapine XR in adults with treatment-resistant depression: a secondary analysis of the ESCAPE-TRD randomized clinical trial","year":"2025","cit":10,"pfa":"Roger S. McIntyre","psa":"Oliver J. Lopena","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4406541944","eid":"W4406541944"},{"id":"paper-w4409316085","cat":"papers","name":"Effect of Different Doses of Esketamine on Postoperative Recovery in Patients Undergoing Gynecologic Laparoscopic Surgery, a Randomized, Double-Blind, Single-Center Clinical Study","year":"2025","cit":10,"pfa":"Tingting Li","psa":"Yiqiao Wang","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4409316085","eid":"W4409316085"},{"id":"paper-w4393944816","cat":"papers","name":"Observation on the Analgesic Effect of Different Doses of a Combination of Esketamine and Dexmedetomidine Administered for Percutaneous Endoscopic Transforaminal Discectomy: A Randomized, Double-Blind Controlled Trial","year":"2024","cit":10,"pfa":"Jianshun Zhou","psa":"Lifeng Wang","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4393944816","eid":"W4393944816"},{"id":"paper-w4367668703","cat":"papers","name":"Esketamine nasal spray for major depressive disorder with acute suicidal ideation or behavior: description of treatment access, utilization, and claims-based outcomes in the United States","year":"2023","cit":10,"pfa":"Maryia Zhdanava","psa":"Kruti Joshi","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4367668703","eid":"W4367668703"},{"id":"paper-w4413094100","cat":"papers","name":"The effects of esketamine on postoperative delirium in older patients with fragile brain function during the non-acute phase following lung cancer surgery: a randomized controlled trial","year":"2025","cit":10,"pfa":"Honglin Fu","psa":"Lihong Hu","topics":["PTSD & trauma","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4413094100","eid":"W4413094100"},{"id":"paper-w4402017293","cat":"papers","name":"Advancing past ketamine: emerging glutamatergic compounds for the treatment of depression","year":"2024","cit":10,"pfa":"Florian Freudenberg","psa":"Andreas Reif","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4402017293","eid":"W4402017293"},{"id":"paper-w4389135913","cat":"papers","name":"Effectiveness and safety of prehospital analgesia including nalbuphine and paracetamol by paramedics: an observational study","year":"2023","cit":10,"pfa":"Bernd Strickmann","psa":"Gerrit Jansen","topics":["PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4389135913","eid":"W4389135913"},{"id":"paper-w4310940347","cat":"papers","name":"Intranasal racemic ketamine for patients hospitalized with treatment-resistant depression: A retrospective analysis.","year":"2022","cit":10,"pfa":"Evyn M. Peters","psa":"Annabelle Wanson","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4310940347","eid":"W4310940347"},{"id":"paper-w3128865149","cat":"papers","name":"Panic disorder: A review of treatment options.","year":"2021","cit":10,"pfa":"Michael Ziffra","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3128865149","eid":"W3128865149"},{"id":"paper-w4411309396","cat":"papers","name":"Opioid-free anaesthesia to reduce postoperative nausea and vomiting after lower extremity wound surgery: a randomised double-blind crossover trial","year":"2025","cit":10,"pfa":"Yajuan Zhu","psa":"Ke Peng","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4411309396","eid":"W4411309396"},{"id":"paper-w4391224591","cat":"papers","name":"Analgesic Therapy with the Opioids Fentanyl and Morphine by Ambulance Personnel in Rural Areas: An Observational Study Over 7 Years","year":"2024","cit":10,"pfa":"Olga Scharonow","psa":"Maximilian Scharonow","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4391224591","eid":"W4391224591"},{"id":"paper-w4396685530","cat":"papers","name":"Adverse event profiles of drug-induced liver injury caused by antidepressant drugs: a disproportionality analysis","year":"2024","cit":10,"pfa":"Aidou Jiang","psa":"Bin Wu","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4396685530","eid":"W4396685530"},{"id":"paper-w4366578000","cat":"papers","name":"Clinical Effectiveness of N-Methyl-D-Aspartate (NMDA) Receptor Antagonists in Adult Obsessive-Compulsive Disorder (OCD) Treatment: A Systematic Review","year":"2023","cit":10,"pfa":"Asila A Ferguson","psa":"Jaafar A Hamdan","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4366578000","eid":"W4366578000"},{"id":"paper-w7124176003","cat":"papers","name":"Durability of the benefit of vagus nerve stimulation in markedly treatment-resistant major depression: a RECOVER trial report","year":"2025","cit":10,"pfa":"Charles R. Conway","psa":"Harold A. Sackeïm","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7124176003","eid":"W7124176003"},{"id":"paper-w2037437516","cat":"papers","name":"Selective labeling of apomorphine receptors by 3H-LSD","year":"1979","cit":10,"pfa":"Patricia M. Whitaker","psa":"Philip M. Seeman","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2037437516","eid":"W2037437516"},{"id":"paper-w2148615272","cat":"papers","name":"Antiserotoninergic properties of maprotiline and a new antidepressant, oxaprotiline: Two selective na uptake inhibitors","year":"1982","cit":10,"pfa":"A. Delini‐Stula","psa":"Elisabeth Radeke","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2148615272","eid":"W2148615272"},{"id":"paper-w2404238364","cat":"papers","name":"Central antiserotonergic and antidopaminergic action of pirenperone, a putative 5-HT2 receptor antagonist.","year":"1985","cit":10,"pfa":"Leszek Pawłowski","psa":"Edmund Przegaliński","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2404238364","eid":"W2404238364"},{"id":"paper-w2299944946","cat":"papers","name":"EFFECT OF MESCALINE AND LYSERGIC ACID DIETHYLAMIDE ON FLICKER DISCRIMINATION IN THE RAT","year":"1971","cit":9,"pfa":"Martin Schechter","psa":"Jerrold C. Winter","ptype":"article","src":"https://openalex.org/W2299944946","eid":"W2299944946"},{"id":"paper-w2984276255","cat":"papers","name":"Metabolism of Lysergic Acid Diethylamide","year":"1956","cit":9,"pfa":"E Rothlin","ptype":"article","src":"https://openalex.org/W2984276255","eid":"W2984276255"},{"id":"paper-w2044398489","cat":"papers","name":"Lysergic Acid Diethylamide (LSD) in the Treatment of Alcoholism.","year":"1968","cit":9,"pfa":"Charles Clay Dahlberg","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2044398489","eid":"W2044398489"},{"id":"paper-w1990653151","cat":"papers","name":"Lysergic Acid Diethylamide (LSD-25) Antagonists","year":"1957","cit":9,"pfa":"Harold A. Abramson","ptype":"article","src":"https://openalex.org/W1990653151","eid":"W1990653151"},{"id":"paper-w2414339614","cat":"papers","name":"The effect of lysergic acid diethylamide on Betta splendens. I.","year":"1956","cit":9,"pfa":"Turner Wj","ptype":"article","src":"https://openalex.org/W2414339614","eid":"W2414339614"},{"id":"paper-w1526126877","cat":"papers","name":"Studies on lysergic acid diethylamide and related compounds—VI","year":"1977","cit":9,"pfa":"Y. Nakahara","psa":"Hisashi Ishii","ptype":"article","src":"https://openalex.org/W1526126877","eid":"W1526126877"},{"id":"paper-w2087147469","cat":"papers","name":"Production of Tolerance to Psychosis-Producing Doses of Lysergic Acid Diethylamide","year":"1957","cit":9,"pfa":"Harold A. Abramson","psa":"N. Fremont-Smith","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2087147469","eid":"W2087147469"},{"id":"paper-w2003670024","cat":"papers","name":"The effect of lysergic acid diethylamide (LSD) and 2-bromo-lysergic acid diethylamide (BOL) on the striatal dopa accumulation: Influence of central 5-hydroxy-tryptaminergic pathways","year":"1978","cit":9,"pfa":"Sven‐Åke Persson","psa":"Ha ̊kan Johansson","ptype":"article","src":"https://openalex.org/W2003670024","eid":"W2003670024"},{"id":"paper-w1978939641","cat":"papers","name":"Behavioral thermoregulation in rats during hyperthermia induced by lysergic acid diethylamide","year":"1980","cit":9,"pfa":"Naotoshi Murakami","psa":"Shigeki Ooki","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1978939641","eid":"W1978939641"},{"id":"paper-w1963726230","cat":"papers","name":"THE EFFECT OF (+)‐LYSERGIC ACID DIETHYLAMIDE AND OTHER DRUGS ON THE CAROTID SINUS REFLEX","year":"1958","cit":9,"pfa":"K. H. Ginzel","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1963726230","eid":"W1963726230"},{"id":"paper-w2992790225","cat":"papers","name":"d-Lysergic acid diethylamide has major potential as a cognitive enhancer","year":"2019","cit":9,"pfa":"Felipe Augusto Cini da Silva","psa":"Sidarta Tollendal Gomes Ribeiro","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W2992790225","eid":"W2992790225"},{"id":"paper-w2227038610","cat":"papers","name":"Quantitative Determination by Circular Dichroism of Lysergic Acid Diethylamide in Confiscated Material","year":"1982","cit":9,"pfa":"JM Bowen","psa":"Neil Purdie","ptype":"article","src":"https://openalex.org/W2227038610","eid":"W2227038610"},{"id":"paper-w2170166219","cat":"papers","name":"Analeptic Action of Lysergic Acid Diethylamide (LSD-25) Against Pentobarbital","year":"1958","cit":9,"pfa":"Julia T. Apter","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2170166219","eid":"W2170166219"},{"id":"paper-w2051431188","cat":"papers","name":"METABOLIC AND ENDOCRINE EFFECTS OF LYSERGIC ACID DIETHYLAMIDE (LSD-25) ON MALE RATS","year":"1966","cit":9,"pfa":"A. Stanley Weltman","psa":"Arthur M. Sackler","ptype":"article","src":"https://openalex.org/W2051431188","eid":"W2051431188"},{"id":"paper-w1977795919","cat":"papers","name":"Effects of lysergic acid diethylamide on simple instrumental conditioning, extinction and discrimination learning in the rat","year":"1973","cit":9,"pfa":"Alexander J. Rosen","psa":"Joseph A. Buga","ptype":"article","src":"https://openalex.org/W1977795919","eid":"W1977795919"},{"id":"paper-w2129303433","cat":"papers","name":"Lysergic Acid Diethylamide (LSD-25): XXX. the Questionnaire Technique with Notes on its Use","year":"1960","cit":9,"pfa":"Harold A. Abramson","ptype":"article","src":"https://openalex.org/W2129303433","eid":"W2129303433"},{"id":"paper-w4300463725","cat":"papers","name":"Indirect enzyme-linked immunosorbent assay for the quantitative estimation of lysergic acid diethylamide in urine","year":"1998","cit":9,"pfa":"Sarah Kerrigan","psa":"Donald E. Brooks","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4300463725","eid":"W4300463725"},{"id":"paper-w4220719845","cat":"papers","name":"A cluster of 25B-NBOH poisonings following exposure to powder sold as lysergic acid diethylamide (LSD)","year":"2022","cit":9,"pfa":"Sean T. Ivory","psa":"Shaun L. Greene","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4220719845","eid":"W4220719845"},{"id":"paper-w2070953311","cat":"papers","name":"Drugs that antagonize limb flick behavior induced by d-lysergic acid diethylamide (LSD) in cats","year":"1979","cit":9,"pfa":"Henry James Haigler","psa":"Denise D. Spring","ptype":"article","src":"https://openalex.org/W2070953311","eid":"W2070953311"},{"id":"paper-w2607429763","cat":"papers","name":"Effects in man of single and combined oral doses of reserpine, iproniazid, and D‐lysergic acid diethylamide","year":"1960","cit":9,"pfa":"Edmund W. J. DeMaar","psa":"Carl C. Pfeiffer","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2607429763","eid":"W2607429763"},{"id":"paper-w3088264875","cat":"papers","name":"Re-evaluation of the discriminative stimulus effects of lysergic acid diethylamide with male and female Sprague-Dawley rats","year":"2020","cit":9,"pfa":"Keli A. Herr","psa":"Lisa E. Baker","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3088264875","eid":"W3088264875"},{"id":"paper-w2060339006","cat":"papers","name":"Comparison of Effect of Lysergic Acid Diethylamide with Potassium Cyanide and other Respiratory Inhibitors on the Siamese Fighting Fish","year":"1958","cit":9,"pfa":"Harold A. Abramson","psa":"M. O. Baron","ptype":"article","src":"https://openalex.org/W2060339006","eid":"W2060339006"},{"id":"paper-w1982312993","cat":"papers","name":"Reversed Phase Liquid Chromatographic Separation of Lysergic Acid Diethylamide (LSD) and Lysergic Acid Methylpropylamide (LAMPA)","year":"1987","cit":9,"pfa":"Jack DeRuiter","psa":"Charles R. Clark","ptype":"article","src":"https://openalex.org/W1982312993","eid":"W1982312993"},{"id":"paper-w2073587025","cat":"papers","name":"Krebs cycle conjugates of mescaline. Identification of fourteen new peyote alkaloid amides","year":"1968","cit":9,"pfa":"Govind J. Kapadia","psa":"Henry Marshall Fales","ptype":"article","src":"https://openalex.org/W2073587025","eid":"W2073587025"},{"id":"paper-w2026692279","cat":"papers","name":"Characterization of a Translational Inhibitor Isolated from Rabbit Brain Following Intravenous Administration of d‐Lysergic Acid Diethylamide","year":"1986","cit":9,"pfa":"Scott W. Fleming","psa":"Ian R. Brown","ptype":"article","src":"https://openalex.org/W2026692279","eid":"W2026692279"},{"id":"paper-w2140348679","cat":"papers","name":"Tricyclic antidepressant drugs: Attenuation of excitatory effects of d-lysergic acid diethylamide (LSD) on acoustic startle response","year":"1977","cit":9,"pfa":"Michael T. Davis","psa":"George K. Aghajanian","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2140348679","eid":"W2140348679"},{"id":"paper-w2224383288","cat":"papers","name":"Differences in d-[3H]lysergic acid diethylamide binding in mouse cortex and hippocampus in vivo and in vitro revealed by radioautography and rapid filtration studies.","year":"1984","cit":9,"pfa":"Barbara Jones Ebersole","psa":"Saul Maayani","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2224383288","eid":"W2224383288"},{"id":"paper-w2006959977","cat":"papers","name":"Lysergic Acid Diethylamide (LSD-25) XXXIII. Effect on Surfacing Behavior of the Carp and Possible Application to Game Conservation and Survival Kits","year":"1961","cit":9,"pfa":"Harold A. Abramson","psa":"G. Dean","ptype":"article","src":"https://openalex.org/W2006959977","eid":"W2006959977"},{"id":"paper-w4386624467","cat":"papers","name":"Synthetic Strategies toward Lysergic Acid Diethylamide: Ergoline Synthesis via α-Arylation, Borrowing Hydrogen Alkylation, and C–H Insertion","year":"2023","cit":9,"pfa":"Jeremy R. Tuck","psa":"David E. Olson","ptype":"article","src":"https://openalex.org/W4386624467","eid":"W4386624467"},{"id":"paper-w1999725391","cat":"papers","name":"On‐line identification of lysergic acid diethylamide (LSD) in tablets using a combination of a sweeping technique and micellar electrokinetic chromatography/77 K fluorescence spectroscopy","year":"2003","cit":9,"pfa":"Ching Fang","psa":"Cheng‐Huang Lin","ptype":"article","src":"https://openalex.org/W1999725391","eid":"W1999725391"},{"id":"paper-w4377010727","cat":"papers","name":"Psychoactive plant derivatives (ayahuasca, ibogaine, kratom) and their application in opioid withdrawal and use disorder – a narrative review","year":"2023","cit":9,"pfa":"Alexandra Arenson","psa":"Ilan Remler","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W4377010727","eid":"W4377010727"},{"id":"paper-w310877646","cat":"papers","name":"Ibogaine : proceedings of the first International Conference","year":"2001","cit":9,"pfa":"Kenneth Alper","psa":"Stanley D. Glick","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"book","src":"https://openalex.org/W310877646","eid":"W310877646"},{"id":"paper-w2087235567","cat":"papers","name":"Phospholipase C mediates (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-, but not lysergic acid diethylamide (LSD)-elicited head bobs in rabbit medial prefrontal cortex","year":"2012","cit":9,"pfa":"Emmanuelle A. D. Schindler","psa":"Vincent J. Aloyo","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2087235567","eid":"W2087235567"},{"id":"paper-w2401354923","cat":"papers","name":"[Ibolutein, new alkaloid extracted from iboga (Tabernanthe iboga H. Bn, Apocynaceae)].","year":"1953","cit":9,"pfa":"Robert Goutarel","psa":"M M Janot","ptype":"article","src":"https://openalex.org/W2401354923","eid":"W2401354923"},{"id":"paper-w4249972766","cat":"papers","name":"Psilocybin Intoxication","year":"1980","cit":9,"pfa":"Kenneth Dewhurst","ptype":"article","src":"https://openalex.org/W4249972766","eid":"W4249972766"},{"id":"paper-w2050357625","cat":"papers","name":"Iboga interactions with psychomotor stimulants: panacea in the paradox?","year":"2001","cit":9,"pfa":"Karen Kathleen Szumlinski","psa":"Stanley D. Glick","ptype":"article","src":"https://openalex.org/W2050357625","eid":"W2050357625"},{"id":"paper-w407643153","cat":"papers","name":"Mescaline and Related Compounds","year":"1968","cit":9,"pfa":"A. R. Patel","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"book-chapter","src":"https://openalex.org/W407643153","eid":"W407643153"},{"id":"paper-w4392078243","cat":"papers","name":"An Overview of Cacti and the Controversial Peyote","year":"2016","cit":9,"pfa":"Mariana Rojas-Areéchiga","psa":"Joel Flores","ptype":"other","src":"https://openalex.org/W4392078243","eid":"W4392078243"},{"id":"paper-w2033553365","cat":"papers","name":"Biogenetic-type synthesis of Iboga alkaloids: (±)-catharanthine","year":"1968","cit":9,"pfa":"Asaf A. Qureshi","psa":"A. Ian Scott","ptype":"article","src":"https://openalex.org/W2033553365","eid":"W2033553365"},{"id":"paper-w2111438123","cat":"papers","name":"A SOCIO‐CULTURAL INTERPRETATION OF THE PEYOTE CULT","year":"1941","cit":9,"pfa":"Frank Gouldsmith Speck","psa":"Bernard Barber","ptype":"article","src":"https://openalex.org/W2111438123","eid":"W2111438123"},{"id":"paper-w2164209299","cat":"papers","name":"Drug Dreams in Mescaline and LSD Addiction","year":"2010","cit":9,"pfa":"Claudio Colace","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2164209299","eid":"W2164209299"},{"id":"paper-w3137986470","cat":"papers","name":"A narrative review of the pharmacological, cultural and psychological literature on ibogaine","year":"2021","cit":9,"pfa":"Martie S. Underwood","psa":"Brian L. Lancaster","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W3137986470","eid":"W3137986470"},{"id":"paper-w4281567096","cat":"papers","name":"Ibogaine and Their Analogs as Therapeutics for Neurological and Psychiatric Disorders","year":"2022","cit":9,"pfa":"Robert B. Kargbo","topics":["Mechanism & neuroscience"],"ptype":"editorial","src":"https://openalex.org/W4281567096","eid":"W4281567096"},{"id":"paper-w2597563097","cat":"papers","name":"Ecstasy (MDMA)-Intoxikation","year":"1997","cit":9,"pfa":"H. Dinse","ptype":"article","src":"https://openalex.org/W2597563097","eid":"W2597563097"},{"id":"paper-w2328954058","cat":"papers","name":"Studies on mescaline III. Action in epileptics","year":"1955","cit":9,"pfa":"Herman C. B. Denberg","ptype":"article","src":"https://openalex.org/W2328954058","eid":"W2328954058"},{"id":"paper-w2998288775","cat":"papers","name":"Roadmaps to Regulation: MDMA","year":"2019","cit":9,"pfa":"Kevin L. Moore","psa":"Amanda Feilding","topics":["Safety & adverse events","Policy & ethics"],"ptype":"book","src":"https://openalex.org/W2998288775","eid":"W2998288775"},{"id":"paper-w1484571072","cat":"papers","name":"The therapeutic use of Peyote in the Native American Church","year":"2007","cit":9,"pfa":"JD Calabrese","ptype":"book-chapter","src":"https://openalex.org/W1484571072","eid":"W1484571072"},{"id":"paper-w3203128580","cat":"papers","name":"Homebrewed psilocybin: can new routes for pharmaceutical psilocybin production enable recreational use?","year":"2021","cit":9,"pfa":"William J. Gibbons","psa":"J. Andrew Jones","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3203128580","eid":"W3203128580"},{"id":"paper-w2273404799","cat":"papers","name":"EFFECTS OF CHLORPROMAZINE AND HALOPERIDOL ON THE DISPOSITION OF MESCALINE-14C IN MICE","year":"1973","cit":9,"pfa":"Nandkumar S. Shah","psa":"A.E. NEELY","ptype":"article","src":"https://openalex.org/W2273404799","eid":"W2273404799"},{"id":"paper-w2033688399","cat":"papers","name":"Effects of Ibogaine on Performance in the 8-Arm Radial Maze","year":"1997","cit":9,"pfa":"Scott Helsley","psa":"Jerrold C. Winter","ptype":"article","src":"https://openalex.org/W2033688399","eid":"W2033688399"},{"id":"paper-w376744781","cat":"papers","name":"Peyote and the Yankton Sioux: the life and times of Sam Necklace","year":"2005","cit":9,"ptype":"book-review","src":"https://openalex.org/W376744781","eid":"W376744781"},{"id":"paper-w1482722402","cat":"papers","name":"Chapter 6 Characterization of multiple sites of action of ibogaine","year":"2001","cit":9,"pfa":"Henry W. Sershen","psa":"Ábel Lajtha","ptype":"book-chapter","src":"https://openalex.org/W1482722402","eid":"W1482722402"},{"id":"paper-w2014075784","cat":"papers","name":"Further investigations of the serotonergic properties of the ibogaine-induced discriminative stimulus","year":"1999","cit":9,"pfa":"Scott Helsley","psa":"Jerrold C. Winter","ptype":"article","src":"https://openalex.org/W2014075784","eid":"W2014075784"},{"id":"paper-w2417628046","cat":"papers","name":"The effects of psilocybin on EEG and behaviour in monkeys.","year":"1974","cit":9,"pfa":"Masahiro HORIBE","ptype":"article","src":"https://openalex.org/W2417628046","eid":"W2417628046"},{"id":"paper-w2010342974","cat":"papers","name":"N,N-Dimethyltryptamine Production in Phalaris aquatica Seedlings","year":"1988","cit":9,"pfa":"Joseph P. G. Mack","psa":"M. Slaytor","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2010342974","eid":"W2010342974"},{"id":"paper-w2410907497","cat":"papers","name":"Evidence for dimethyltryptamine (DMT) as a naturally-occurring transmitter in mammalian brain.","year":"1976","cit":9,"pfa":"Christian St","psa":"J Pagel","ptype":"article","src":"https://openalex.org/W2410907497","eid":"W2410907497"},{"id":"paper-w2046020774","cat":"papers","name":"Mescaline convulsive spikes triggered by direct cortical stimulation","year":"1962","cit":9,"pfa":"Sidney Ochs","psa":"I. Steele Russell","ptype":"article","src":"https://openalex.org/W2046020774","eid":"W2046020774"},{"id":"paper-w2903100861","cat":"papers","name":"Ayahuasca: From the Amazon to a city near you*","year":"2018","cit":9,"pfa":"J. David Stiffler","ptype":"article","src":"https://openalex.org/W2903100861","eid":"W2903100861"},{"id":"paper-w2054458010","cat":"papers","name":"Morphine, mescaline and cocaine on water maze discrimination in mice","year":"1973","cit":9,"pfa":"Claudio Castellano","ptype":"article","src":"https://openalex.org/W2054458010","eid":"W2054458010"},{"id":"paper-w2520776955","cat":"papers","name":"Ayahuasca Treatment Center Safety for the Western Seeker","year":"2016","cit":9,"pfa":"Raven Renèe Ray","psa":"Kerry S. Lassiter","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2520776955","eid":"W2520776955"},{"id":"paper-w2333453434","cat":"papers","name":"Neurochemical substrates of the rewarding effects of MDMA","year":"2015","cit":9,"pfa":"C. Roger-Sánchez","psa":"M.A. Aguilar","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2333453434","eid":"W2333453434"},{"id":"paper-w2413050801","cat":"papers","name":"Ecstasy (MDMA): alerting users to the dangers.","year":"1995","cit":9,"pfa":"A Cook","ptype":"article","src":"https://openalex.org/W2413050801","eid":"W2413050801"},{"id":"paper-w1986214464","cat":"papers","name":"Facilitation and disruption by mescaline and 3,4-dimethoxyphenylethylamine of shock avoidance in rats","year":"1977","cit":9,"pfa":"David A. Gorelick","psa":"Wagner H. Bridger","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W1986214464","eid":"W1986214464"},{"id":"paper-w4408252744","cat":"papers","name":"Psilocybin for disorders of consciousness: A case-report study","year":"2025","cit":9,"pfa":"Paolo Cardone","psa":"Olivia Gosseries","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4408252744","eid":"W4408252744"},{"id":"paper-w1996323813","cat":"papers","name":"Some Considerations on the Prevalence of MDMA Use","year":"1986","cit":9,"pfa":"John A. Newmeyer","ptype":"article","src":"https://openalex.org/W1996323813","eid":"W1996323813"},{"id":"paper-w2069092959","cat":"papers","name":"Subcellular distribution of 8-14C-mescaline in the mouse brain and liver","year":"1971","cit":9,"pfa":"Nandkumar S. Shah","ptype":"article","src":"https://openalex.org/W2069092959","eid":"W2069092959"},{"id":"paper-w3214903520","cat":"papers","name":"Psilocybin Conspectus: Status, Production Methods, and Considerations","year":"2021","cit":9,"pfa":"Lauren Plotnik","psa":"Thomas Graham","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3214903520","eid":"W3214903520"},{"id":"paper-w4378640469","cat":"papers","name":"Evidence versus expectancy: the development of psilocybin therapy","year":"2023","cit":9,"pfa":"James Rucker","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4378640469","eid":"W4378640469"},{"id":"paper-w4409086968","cat":"papers","name":"Psilocybin Dispensaries and Online Health Claims in Canada","year":"2025","cit":9,"pfa":"Jenna Matsukubo","psa":"Daniel Thomas Myran","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4409086968","eid":"W4409086968"},{"id":"paper-w2012832420","cat":"papers","name":"Swallowing the Scroll: Legal Implications of the Recent Supreme Court Peyote Cases","year":"1990","cit":9,"pfa":"Ronald K. Bullis","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2012832420","eid":"W2012832420"},{"id":"paper-w2132708830","cat":"papers","name":"Consumo urbano de yajé (ayahuasca) en Colombia","year":"2004","cit":9,"pfa":"Andrea Vélez Cárdenas","psa":"Augusto Pérez Gómez","ptype":"article","src":"https://openalex.org/W2132708830","eid":"W2132708830"},{"id":"paper-w4401375939","cat":"papers","name":"Psilocybin and chronic neuropathic pain: a systematic review","year":"2024","cit":9,"pfa":"David S. Jevotovsky","psa":"Joel P Castellanos","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W4401375939","eid":"W4401375939"},{"id":"paper-w4414422195","cat":"papers","name":"Dissimilar Reactions and Enzymes for Psilocybin Biosynthesis in Inocybe and Psilocybe Mushrooms","year":"2025","cit":9,"pfa":"Tim Schäfer","psa":"Dirk Hoffmeister","ptype":"article","src":"https://openalex.org/W4414422195","eid":"W4414422195"},{"id":"paper-w4286634517","cat":"papers","name":"Brain dynamics predictive of response to psilocybin for treatment-resistant depression","year":"2022","cit":9,"pfa":"Jakub Vohryzek","psa":"Morten L. Kringelbach","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4286634517","eid":"W4286634517"},{"id":"paper-w2461774193","cat":"papers","name":"Ibogaine fails to reduce naloxone-precipitated withdrawal in the morphine dependent rat.","year":"1990","cit":9,"pfa":"L S SHARPE","psa":"Jerome H. Jaffe","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2461774193","eid":"W2461774193"},{"id":"paper-w2773143064","cat":"papers","name":"Réappropriations mutuelles. Ayahuasca et néochamanisme péruvien internationalisé","year":"2017","cit":9,"pfa":"Sébastien Baud","ptype":"article","src":"https://openalex.org/W2773143064","eid":"W2773143064"},{"id":"paper-w2032646496","cat":"papers","name":"152 PHARMACOKINETICS OF ECSTASY (MDMA) IN HEALTHY SUBJECTS","year":"1997","cit":9,"pfa":"R. de la Torre","psa":"Jordi Camı́","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2032646496","eid":"W2032646496"},{"id":"paper-w2101327642","cat":"papers","name":"A Perhaps Unexpected Role of Norepinephrine in Actions of MDMA","year":"2011","cit":9,"pfa":"Thomas F. Newton","ptype":"article","src":"https://openalex.org/W2101327642","eid":"W2101327642"},{"id":"paper-w2413192269","cat":"papers","name":"[MDMA or ecstasy: pharmacologic, toxicologic and clinical aspects].","year":"1996","cit":9,"pfa":"C Prada","psa":"E. Alvarez","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2413192269","eid":"W2413192269"},{"id":"paper-w2418094809","cat":"papers","name":"Behavioural studies in fish with mescaline, LSD, and thiopropazate and their interactions with serotonin and dopa.","year":"1962","cit":9,"pfa":"A SAXENA","psa":"B Mukerji","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2418094809","eid":"W2418094809"},{"id":"paper-w2586811222","cat":"papers","name":"SCIENCE, SPIRITUALITY, AND AYAHUASCA: THE PROBLEM OF CONSCIOUSNESS AND SPIRITUAL ONTOLOGIES IN THE ACADEMY","year":"2017","cit":9,"pfa":"Ismael Apud","ptype":"article","src":"https://openalex.org/W2586811222","eid":"W2586811222"},{"id":"paper-w3033680684","cat":"papers","name":"Determination of the Elemental Composition of Ayahuasca and Assessments Concerning Consumer Safety","year":"2020","cit":9,"pfa":"Ivanilce Cristina Guimarães","psa":"Alessandra Sussulini","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3033680684","eid":"W3033680684"},{"id":"paper-w1991642459","cat":"papers","name":"Peyote alkaloids IX: Identification and synthesis of 3-demethylmescaline, a plausible intermediate in the biosynthesis of the cactus alkaloids","year":"1969","cit":9,"pfa":"Govind J. Kapadia","psa":"M. Fayez","ptype":"article","src":"https://openalex.org/W1991642459","eid":"W1991642459"},{"id":"paper-w2032540534","cat":"papers","name":"An electroencephalographic analysis of personality-dependent performance under psilocybin","year":"1971","cit":9,"pfa":"Karen Thatcher","psa":"Roland Fischer","ptype":"article","src":"https://openalex.org/W2032540534","eid":"W2032540534"},{"id":"paper-w89058027","cat":"papers","name":"The psilocybin-induced \"state of drunkenness\" in normal volunteers and schizophrenics.","year":"1978","cit":9,"pfa":"Parashos Aj","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W89058027","eid":"W89058027"},{"id":"paper-w2320517754","cat":"papers","name":"New Michael Acceptor-type of Salvinorin A Ligands to Kappa-Opioid Receptor","year":"2013","cit":9,"pfa":"Prabhakar Reddy Polepally","psa":"JK Zjawiony","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2320517754","eid":"W2320517754"},{"id":"paper-w4409500508","cat":"papers","name":"Psilocybin biosynthesis enhancement through gene source optimization","year":"2025","cit":9,"pfa":"Madeleine R. Keller","psa":"J. Andrew Jones","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4409500508","eid":"W4409500508"},{"id":"paper-w3120324921","cat":"papers","name":"A “Trip” to the Intensive Care Unit: An Intravenous Injection of Psilocybin","year":"2021","cit":9,"pfa":"Nicholas B. Giancola","psa":"Curtis A. McKnight","ptype":"article","src":"https://openalex.org/W3120324921","eid":"W3120324921"},{"id":"paper-w1498002965","cat":"papers","name":"The Role of The A2A Receptor in Cell Apoptosis Caused by MDMA.","year":"2012","cit":9,"pfa":"Mansooreh Soleimani","psa":"Mehdi Mehdizadeh","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1498002965","eid":"W1498002965"},{"id":"paper-w2964429098","cat":"papers","name":"Regional changes in ∆FosB expression in rat brain following MDMA self‐administration predict increased sensitivity to effects of locally infused MDMA","year":"2019","cit":9,"pfa":"Ross van de Wetering","psa":"Susan Schenk","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2964429098","eid":"W2964429098"},{"id":"paper-w4295169116","cat":"papers","name":"An Interpretative Phenomenological Analysis of the use of psilocybin by veterans with symptoms of trauma","year":"2022","cit":9,"pfa":"F. N. Smith","psa":"Verity Wainwright","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4295169116","eid":"W4295169116"},{"id":"paper-w2166695939","cat":"papers","name":"Acute Paralysis Following Recreational MDMA (Ecstasy) Use","year":"2006","cit":9,"pfa":"Lee Hilary Goldstein","psa":"Matitiahu Berkovitch","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2166695939","eid":"W2166695939"},{"id":"paper-w4392166950","cat":"papers","name":"The Clinical Potential of Dimethyltryptamine: Breakthroughs into the Other Side of Mental Illness, Neurodegeneration, and Consciousness","year":"2024","cit":9,"pfa":"Frankie A. Colosimo","psa":"Thomas A. Vida","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4392166950","eid":"W4392166950"},{"id":"paper-w2056576520","cat":"papers","name":"Controlled sensory input: A note on the technic of drug evaluation with a preliminary report on a comparative study of sernyl, psilocybin, and LSD-25","year":"1960","cit":9,"pfa":"John C. Pollard","psa":"D.F. Feuerfile","ptype":"article","src":"https://openalex.org/W2056576520","eid":"W2056576520"},{"id":"paper-w2626697100","cat":"papers","name":"Diálogos (neo)xamânicos: encontros entre os Guarani e a ayahuasca","year":"2014","cit":9,"pfa":"Isabel Santana de Rose","psa":"Esther Jean Langdon","ptype":"article","src":"https://openalex.org/W2626697100","eid":"W2626697100"},{"id":"paper-w2326775641","cat":"papers","name":"Zkušenost s halucinogenní rostlinou ayahuasca v kontextu šamanského rituálu","year":"2014","cit":9,"pfa":"Veronika Kavenská","psa":"Hana Šimonová","ptype":"article","src":"https://openalex.org/W2326775641","eid":"W2326775641"},{"id":"paper-w634941344","cat":"papers","name":"Drugs and phantasy : the effects of LSD, psilocybin, and sernyl on college students","year":"1965","cit":9,"pfa":"John C. Pollard","psa":"Elizabeth Stein","ptype":"article","src":"https://openalex.org/W634941344","eid":"W634941344"},{"id":"paper-w1974308132","cat":"papers","name":"Neurogenic bladder and chronic urinary retention associated with MDMA abuse","year":"2008","cit":9,"pfa":"John R Beuerle","psa":"Fermin F. Barrueto","ptype":"article","src":"https://openalex.org/W1974308132","eid":"W1974308132"},{"id":"paper-w4413969371","cat":"papers","name":"Neurobiology of psilocybin: a comprehensive overview and comparative analysis of experimental models","year":"2025","cit":9,"pfa":"Dotun Adeleye Adeyinka","psa":"Nicoletta Faraone","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4413969371","eid":"W4413969371"},{"id":"paper-w2330735798","cat":"papers","name":"3,4,5-Trimethoxyphenylacetaldehyde, an Intermediate Metabolite of Mescaline, Is a Substrate for Microsomal Aldehyde Oxygenase in the Mouse Liver.","year":"1995","cit":9,"pfa":"Kazuhito WATANABE","psa":"Hidetoshi YOSHIMURA","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2330735798","eid":"W2330735798"},{"id":"paper-w2982146514","cat":"papers","name":"No Influence of Dopamine System Gene Variations on Acute Effects of MDMA","year":"2019","cit":9,"pfa":"Patrick Vizeli","psa":"Matthias E. Liechti","topics":["PTSD & trauma","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2982146514","eid":"W2982146514"},{"id":"paper-w4413322793","cat":"papers","name":"Serotonin and psilocybin activate 5-HT1B receptors to suppress cortical signaling through the claustrum","year":"2025","cit":9,"pfa":"Maxwell B. Madden","psa":"Brian N. Mathur","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4413322793","eid":"W4413322793"},{"id":"paper-w3120424265","cat":"papers","name":"Psilacetin derivatives: fumarate salts of the methyl–ethyl, methyl–allyl and diallyl variants of the psilocin prodrug","year":"2021","cit":9,"pfa":"Duyen N. K. Pham","psa":"David R. Manke","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3120424265","eid":"W3120424265"},{"id":"paper-w4214857406","cat":"papers","name":"Drug Transporters ABCB1 (P-gp) and OATP, but not Drug-Metabolizing Enzyme CYP3A4, Affect the Pharmacokinetics of the Psychoactive Alkaloid Ibogaine and its Metabolites","year":"2022","cit":9,"pfa":"Margarida L.F. Martins","psa":"Alfred H. Schinkel","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4214857406","eid":"W4214857406"},{"id":"paper-w4403332337","cat":"papers","name":"The impact of antidepressant discontinuation prior to treatment with psilocybin for treatment-resistant depression","year":"2024","cit":9,"pfa":"Lindsey Marwood","psa":"Guy M. Goodwin","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4403332337","eid":"W4403332337"},{"id":"paper-w2529169596","cat":"papers","name":"If tradition did not exist, it would have to be invented: retraditionalization and the world ayahuasca diaspora","year":"2016","cit":9,"pfa":"Andrew Dawson","topics":["Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W2529169596","eid":"W2529169596"},{"id":"paper-w4207058097","cat":"papers","name":"Iboga-type alkaloids with Indolizidino[8,7-b]Indole scaffold and bisindole alkaloids from Tabernaemontana bufalina Lour","year":"2022","cit":9,"pfa":"Chen Shun-qing","psa":"You‐Sheng Cai","ptype":"article","src":"https://openalex.org/W4207058097","eid":"W4207058097"},{"id":"paper-w4311816479","cat":"papers","name":"Effects of a single dose of psilocybin on cytokines, chemokines and leptin in rat serum","year":"2022","cit":9,"pfa":"Geoffrey M. Bove","psa":"David J. Mokler","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4311816479","eid":"W4311816479"},{"id":"paper-w2025750773","cat":"papers","name":"Studies toward bivalent κ opioids derived from salvinorin A: heteromethylation of the furan ring reduces affinity","year":"2013","cit":9,"pfa":"Thomas Anthony Munro","psa":"Bruce M. Cohen","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2025750773","eid":"W2025750773"},{"id":"paper-w2148020434","cat":"papers","name":"Beiträge zur Chemie des Indols, IV. Synthesen in der Iboga‐Reihe, I. (d,l)‐Desäthylibogamin","year":"1973","cit":9,"pfa":"Peter Rosenmund","psa":"Rainer Frische","ptype":"article","src":"https://openalex.org/W2148020434","eid":"W2148020434"},{"id":"paper-w2021619477","cat":"papers","name":"Gender Differences Among MDMA Users on Psychological and Drug History Variables","year":"2005","cit":9,"pfa":"Michelle Cororve Fingeret","psa":"Angela L. Stotts","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2021619477","eid":"W2021619477"},{"id":"paper-w2499578818","cat":"papers","name":"Conscious awareness versus optimistic beliefs in recreational Ecstasy/MDMA users","year":"2010","cit":9,"pfa":"Andrew Parrott","ptype":"book-chapter","src":"https://openalex.org/W2499578818","eid":"W2499578818"},{"id":"paper-w4405207112","cat":"papers","name":"The revival of psilocybin between scientific excitement, evidence of efficacy, and real-world challenges","year":"2024","cit":9,"pfa":"Mauro Scala","psa":"Alessandro Serretti","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4405207112","eid":"W4405207112"},{"id":"paper-w4398195443","cat":"papers","name":"Efficacy and safety of psilocybin on treatment-resistant depression: A systematic review and meta-analysis","year":"2024","cit":9,"pfa":"Qiwen Fang","psa":"Xue Li","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4398195443","eid":"W4398195443"},{"id":"paper-w1971070449","cat":"papers","name":"Umwandlung des Iboga‐Alkaloides Voacangin in das β‐Carbolin‐Derivat Voaketon. 156. Mitteilung über Alkaloide","year":"1976","cit":9,"pfa":"Yutaka Morita","psa":"Ulrich Renner","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1971070449","eid":"W1971070449"},{"id":"paper-w4249616857","cat":"papers","name":"Acute and subchronic effects of methylenedioxymethamphetamine [(±)MDMA)] on locomotion and serotonin syndrome behavior in the rat","year":"1989","cit":9,"topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4249616857","eid":"W4249616857"},{"id":"paper-w2001104439","cat":"papers","name":"Recent updates on drug abuse analyzed by neuroproteomics studies: Cocaine, Methamphetamine and MDMA","year":"2014","cit":9,"pfa":"Firas Kobeissy","psa":"Yehia S. Mechref","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2001104439","eid":"W2001104439"},{"id":"paper-w2769063767","cat":"papers","name":"Peripheral endocannabinoid concentrations are not associated with verbal memory impairment during MDMA intoxication","year":"2017","cit":9,"pfa":"Eline C. H. M. Haijen","psa":"Kim P. C. Kuypers","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2769063767","eid":"W2769063767"},{"id":"paper-w4394787538","cat":"papers","name":"Chiral analysis of amphetamine, methamphetamine, MDMA and MDA enantiomers in human hair samples","year":"2024","cit":9,"pfa":"Julian Bickel","psa":"Stefanie Iwersen‐Bergmann","ptype":"article","src":"https://openalex.org/W4394787538","eid":"W4394787538"},{"id":"paper-w4401432739","cat":"papers","name":"Exploring psychedelic use in athletes and their attitudes toward psilocybin-assisted therapy in concussion recovery","year":"2024","cit":9,"pfa":"Baeleigh VanderZwaag","psa":"Mauricio A. García-Barrera","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4401432739","eid":"W4401432739"},{"id":"paper-w4382632371","cat":"papers","name":"The Impact of Psilocybin on Patients Experiencing Psychiatric Symptoms: A Systematic Review of Randomized Clinical Trials.","year":"2023","cit":9,"pfa":"Waguih William IsHak","psa":"Itai Danovitch","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W4382632371","eid":"W4382632371"},{"id":"paper-w3107793629","cat":"papers","name":"Delayed Anxiolytic-Like Effects of Psilocybin in Male Mice Are Supported by Acute Glucocorticoid Release","year":"2020","cit":9,"pfa":"N. Jones","psa":"Cody J. Wenthur","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W3107793629","eid":"W3107793629"},{"id":"paper-w4394960869","cat":"papers","name":"Ayahuasca ceremonies, relationality, and inner-outer transformations to sustainability. Evidence from Takiwasi Center in Peru","year":"2024","cit":9,"pfa":"David Manuel‐Navarrete","psa":"Matteo Politi","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4394960869","eid":"W4394960869"},{"id":"paper-w7124734185","cat":"papers","name":"PSILOCYBIN-INDUCED CHANGES IN PSYCHOLOGIC FUNCTION, ELECTROENCEPHALOGRAM, AND LIGHT-EVOKED POTENTIALS IN HUMAN SUBJECTS","year":"1968","cit":9,"pfa":"Robert R. Rynearson","psa":"Reginald G. Bickford","ptype":"article","src":"https://openalex.org/W7124734185","eid":"W7124734185"},{"id":"paper-w1976261185","cat":"papers","name":"Protection by MK 801 and other drugs of methylenedioxy-methamphetamine (MDMA) neurotoxicity in rats and mice","year":"1990","cit":9,"pfa":"Richard Laverty","psa":"B.J. Logan","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1976261185","eid":"W1976261185"},{"id":"paper-w1997604550","cat":"papers","name":"STUDIES ON MESCALINE XIII: THE EFFECT OF PRIOR ADMINISTRATION OF VARIOUS PSYCHOTROPIC DRUGS ON DIFFERENT BIOCHEMICAL PARAMETERS: A PRELIMINARY REPORT","year":"1962","cit":9,"pfa":"Herman C.B. Denber","psa":"DOROTHY KAUFFMAN","ptype":"article","src":"https://openalex.org/W1997604550","eid":"W1997604550"},{"id":"paper-w2619173298","cat":"papers","name":"Hippocampal nicotinic receptors have a modulatory role for ethanol and MDMA interaction in memory retrieval","year":"2017","cit":9,"pfa":"Maryam Rostami","psa":"Khadijeh Alsadat Sharifi","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2619173298","eid":"W2619173298"},{"id":"paper-w4328053579","cat":"papers","name":"Ethnobotany and Wood Anatomy of Banisteriopsis caapi Ethnotaxa and Diplopterys cf. pubipetala, Components of Ayahuasca in Brazilian Rituals","year":"2023","cit":9,"pfa":"Regina Célia de Oliveira","psa":"Júlia Sonsin‐Oliveira","ptype":"article","src":"https://openalex.org/W4328053579","eid":"W4328053579"},{"id":"paper-w4406610992","cat":"papers","name":"OTFS-MDMA: An Elastic Multi-Domain Resource Utilization Mechanism for High Mobility Scenarios","year":"2025","cit":9,"pfa":"Jie Chen","psa":"Lajos Hanzo","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4406610992","eid":"W4406610992"},{"id":"paper-w4385987387","cat":"papers","name":"Medical Students' Attitudes and Beliefs Toward Psilocybin: Does Terminology and Personal Experience with Psychedelics Matter?","year":"2023","cit":9,"pfa":"Antonio F. Pagán","psa":"Thomas Daniel Meyer","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4385987387","eid":"W4385987387"},{"id":"paper-w1983546475","cat":"papers","name":"Effect of zotepine on head-twitch induced by L-5-Hydroxytryptophan,mescaline and 2,5-Dimethoxy-4-methylamphetamine in mice and rats.","year":"1983","cit":9,"pfa":"Tsuneyuki Yamamoto","psa":"Jo Mori","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1983546475","eid":"W1983546475"},{"id":"paper-w2811391639","cat":"papers","name":"Acute MDMA and Nicotine Co-administration: Behavioral Effects and Oxidative Stress Processes in Mice","year":"2018","cit":9,"pfa":"Barbara Budzyńska","psa":"Anna Boguszewska‐Czubara","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2811391639","eid":"W2811391639"},{"id":"paper-w3106208769","cat":"papers","name":"MDMA electrochemical determination in aqueous media containing illicit drugs and validation of a voltammetric methodology","year":"2021","cit":9,"pfa":"Juliana Midori Toia Katayama","psa":"Marcelo Firmino de Oliveira","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W3106208769","eid":"W3106208769"},{"id":"paper-w3115392333","cat":"papers","name":"Vegetative anatomy, morphology and histochemistry of three species of Malpighiaceae used in analogues of the Amazonian psychoactive beverage Ayahuasca","year":"2020","cit":9,"pfa":"Nívea Nagamine-Pinheiro","psa":"Júlia Sonsin‐Oliveira","ptype":"article","src":"https://openalex.org/W3115392333","eid":"W3115392333"},{"id":"paper-w2258883982","cat":"papers","name":"A study to model the post-mortem stability of 4-MMC, MDMA and BZP in putrefying remains","year":"2016","cit":9,"pfa":"Daniel S. Wenholz","psa":"Shanlin Fu","ptype":"article","src":"https://openalex.org/W2258883982","eid":"W2258883982"},{"id":"paper-w2992857734","cat":"papers","name":"A proof-of-principle study of the short-term effects of 3,4-methylenedioxymethamphetamine (MDMA) on tinnitus and neural connectivity","year":"2019","cit":9,"pfa":"Grant Donald Searchfield","psa":"Kim J. Wise","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2992857734","eid":"W2992857734"},{"id":"paper-w259156300","cat":"papers","name":"In-utero exposure to the popular 'recreational' drugs MDMA (Ecstasy) and Methamphetamine (Ice, crystal): preliminary findings.","year":"2011","cit":9,"pfa":"Derek G Moore","psa":"Andrew C. Parrott","ptype":"article","src":"https://openalex.org/W259156300","eid":"W259156300"},{"id":"paper-w1998790115","cat":"papers","name":"Roles of 3,4-methylenedioxymethamphetamine (MDMA)-induced alteration of connexin43 and intracellular Ca2+ oscillation in its cardiotoxicity","year":"2013","cit":9,"pfa":"Luo Zhuo","psa":"Liang Ren","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1998790115","eid":"W1998790115"},{"id":"paper-w2124043720","cat":"papers","name":"Is the Government Keeping the Peace or Acting Like Our Parents? Rationales for the Legal Prohibitions of GHB and MDMA","year":"2012","cit":9,"pfa":"O. Hayden Griffin","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2124043720","eid":"W2124043720"},{"id":"paper-w4406783070","cat":"papers","name":"Acute effects of psilocybin on attention and executive functioning in healthy volunteers: a systematic review and multilevel meta-analysis","year":"2025","cit":9,"pfa":"P. Yousefi","psa":"Stefanie Enriquez‐Geppert","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4406783070","eid":"W4406783070"},{"id":"paper-w2114391871","cat":"papers","name":"The effect of MDMA (3,4-methylenedioxymethamphetamine) on the 5-HT synthesis rate in the rat brain: an autoradiographic study","year":"1998","cit":9,"pfa":"Dorotea Mück‐Šeler","psa":"Mirko Dikšić","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2114391871","eid":"W2114391871"},{"id":"paper-w4378471176","cat":"papers","name":"Chronic 3,4-Methylenedioxymethamphetamine (MDMA) Use Is Related to Glutamate and GABA Concentrations in the Striatum But Not the Anterior Cingulate Cortex","year":"2023","cit":9,"pfa":"Josua Zimmermann","psa":"Boris B. Quednow","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4378471176","eid":"W4378471176"},{"id":"paper-w2076041450","cat":"papers","name":"Effect of repeated exposure to MDMA on the function of the 5-HT transporter as assessed by synaptosomal 5-HT uptake","year":"2013","cit":9,"pfa":"Courtney Huff","psa":"Gary A. Gudelsky","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2076041450","eid":"W2076041450"},{"id":"paper-w1750245744","cat":"papers","name":"MDMA. Un modèle pour l’identification et l’annotation des marqueurs discursifs « potentiels » en contexte","year":"2015","cit":9,"pfa":"Catherine Bolly","psa":"Deniz Uygur-Distexhe","ptype":"article","src":"https://openalex.org/W1750245744","eid":"W1750245744"},{"id":"paper-w4386497008","cat":"papers","name":"Therapeutic Effects of Ceremonial Ayahuasca Use for Methamphetamine Use Disorders and Other Mental Health Challenges: Case Studies in an Indigenous Community in Sonora, Mexico","year":"2023","cit":9,"pfa":"Anja Loizaga-Velder","psa":"Brian R. Rush","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4386497008","eid":"W4386497008"},{"id":"paper-w2999918985","cat":"papers","name":"Pharmacological Mechanisms Involved in Sensory Gating Disruption Induced by (±)-3,4-Methylene- Dioxymethamphetamine (MDMA): Relevance to Schizophrenia","year":"2020","cit":9,"pfa":"Jaime Lee","psa":"Maarten van den Buuse","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2999918985","eid":"W2999918985"},{"id":"paper-w4281633451","cat":"papers","name":"Altered brain activity and functional connectivity after MDMA-assisted therapy for post-traumatic stress disorder","year":"2022","cit":9,"pfa":"S. Parker Singleton","psa":"Amy F. Kuceyeski","topics":["PTSD & trauma","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4281633451","eid":"W4281633451"},{"id":"paper-w2165598842","cat":"papers","name":"The relationships of ‘ecstasy’ (MDMA) and cannabis use to impaired executive inhibition and access to semantic long‐term memory","year":"2011","cit":9,"pfa":"Philip N. Murphy","psa":"Richard Ralley","ptype":"article","src":"https://openalex.org/W2165598842","eid":"W2165598842"},{"id":"paper-w2120335653","cat":"papers","name":"High-throughput toxicological analysis of Methamphetamine, MDA and MDMA from human plasma by LC-MS/MS","year":"2009","cit":9,"pfa":"Laurian Vlase","psa":"Sorin Emilian Leucuta","ptype":"article","src":"https://openalex.org/W2120335653","eid":"W2120335653"},{"id":"paper-w4381059735","cat":"papers","name":"Psilocybin intoxication did not affect daytime or sleep-related declarative memory consolidation in a small sample exploratory analysis","year":"2023","cit":9,"pfa":"Marek Nikolič","psa":"Tomáš Páleníček","ptype":"article","src":"https://openalex.org/W4381059735","eid":"W4381059735"},{"id":"paper-w4394787545","cat":"papers","name":"Driving under the influence of cocaine and MDMA: Relationship between blood concentrations and results from clinical test of impairment","year":"2024","cit":9,"pfa":"Gunhild Heide","psa":"Gudrun Høiseth","ptype":"article","src":"https://openalex.org/W4394787545","eid":"W4394787545"},{"id":"paper-w4389304198","cat":"papers","name":"Psilocybin for Opioid Use Disorder in Two Adults Stabilized on Buprenorphine: A Technical Report on Study Modifications and Preliminary Findings","year":"2023","cit":9,"pfa":"Christopher R. N. Nicholas","psa":"Randall Brown","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4389304198","eid":"W4389304198"},{"id":"paper-w4410326100","cat":"papers","name":"Safety, Pharmacokinetics, and Pharmacodynamics of a 6‐h N , N ‐Dimethyltryptamine (DMT) Infusion in Healthy Volunteers: A Randomized, Double‐Blind, Placebo‐Controlled Trial","year":"2025","cit":9,"pfa":"Katelijne V. van der Heijden","psa":"Gabriël E. Jacobs","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4410326100","eid":"W4410326100"},{"id":"paper-w1989862082","cat":"papers","name":"The effects of dentate granule cell destruction on behavioral activity and Fos protein expression induced by systemic MDMA in rats","year":"2003","cit":9,"pfa":"Mujun Won","psa":"Norio Mori","ptype":"article","src":"https://openalex.org/W1989862082","eid":"W1989862082"},{"id":"paper-w2946762321","cat":"papers","name":"UPLC–MS/MS simultaneous determination of methamphetamine, amphetamine, morphine, monoacetylmorphine, ketamine, norketamine, MDMA, and MDA in hair","year":"2019","cit":9,"pfa":"Siyuan Chen","psa":"Peiwu Geng","ptype":"article","src":"https://openalex.org/W2946762321","eid":"W2946762321"},{"id":"paper-w1997631206","cat":"papers","name":"Inhibition of the dorsomedial hypothalamus, but not the medullary raphe pallidus, decreases hyperthermia and mortality from MDMA given in a warm environment","year":"2014","cit":9,"pfa":"Dmitry V. Zaretsky","psa":"Daniel E. Rusyniak","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1997631206","eid":"W1997631206"},{"id":"paper-w3162741197","cat":"papers","name":"Will MDMA-assisted psychotherapy become a breakthrough in treatment-resistant post-traumatic stress disorder? A critical narrative review.","year":"2021","cit":9,"pfa":"Sandra Szafoni","psa":"Magdalena Justyna Piegza","topics":["Depression","PTSD & trauma","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W3162741197","eid":"W3162741197"},{"id":"paper-w2062260008","cat":"papers","name":"Warning against co-administration of 3,4-methylenedioxymethamphetamine (MDMA) with methamphetamine from the perspective of pharmacokinetic and pharmacodynamic evaluations in rat brain","year":"2013","cit":9,"pfa":"Yuki Fuchigami","psa":"Kenichiro Nakashima","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2062260008","eid":"W2062260008"},{"id":"paper-w2117246580","cat":"papers","name":"P.1.e.025 Effects of the Amazonian psychoactive plant beverage ayahuasca on prefrontal and limbic regions during a language task: a fMRI study","year":"2009","cit":9,"pfa":"D. Almeida Prado","psa":"Jaime E. C. Hallak","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2117246580","eid":"W2117246580"},{"id":"paper-w4394684815","cat":"papers","name":"Long-term benefits to psychological health and well-being after ceremonial use of Ayahuasca in Middle Eastern and North African immigrants and refugees","year":"2024","cit":9,"pfa":"Matthew X. Lowe","psa":"Heather Jackson","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4394684815","eid":"W4394684815"},{"id":"paper-w2796445611","cat":"papers","name":"Repeated Administration of 3,4-Methylenedioxymethamphetamine (MDMA) Elevates the Levels of Neuronal Nitric Oxide Synthase in the Nigrostriatal System: Possible Relevance to Neurotoxicity","year":"2018","cit":9,"pfa":"Giulia Costa","psa":"Nicola Simola","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2796445611","eid":"W2796445611"},{"id":"paper-w1998281806","cat":"papers","name":"Repeated administration of MDMA down-regulates preprocholecystokinin mRNA expression but not tyrosine hydroxylase mRNA expression in neurones of the rat substantia nigra","year":"1994","cit":9,"pfa":"Glen Wotherspoon","psa":"Marcus Rattray","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1998281806","eid":"W1998281806"},{"id":"paper-w2525525910","cat":"papers","name":"A High-Resolution Magic Angle Spinning NMR Study of the Enantiodiscrimination of 3,4-Methylenedioxymethamphetamine (MDMA) by an Immobilized Polysaccharide-Based Chiral Phase","year":"2016","cit":9,"pfa":"Juliana Cristina Barreiro","psa":"Tiago Venâncio","ptype":"article","src":"https://openalex.org/W2525525910","eid":"W2525525910"},{"id":"paper-w2943868812","cat":"papers","name":"Extinction training following cocaine or MDMA self-administration produces discrete changes in D2-like and mGlu5 receptor density in the rat brain","year":"2019","cit":9,"pfa":"Małgorzata Frankowska","psa":"Małgorzata Filip","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2943868812","eid":"W2943868812"},{"id":"paper-w1980436825","cat":"papers","name":"MDMA treatment 6 months earlier attenuates the effects of CP-94,253, a 5-HT1B receptor agonist, on motor control but not sleep inhibition","year":"2008","cit":9,"pfa":"Norbert Gyöngyösi","psa":"György Bagdy","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1980436825","eid":"W1980436825"},{"id":"paper-w4323924592","cat":"papers","name":"Underground small-group therapy of treatment-resistant depression and complex post-traumatic stress disorder (C-PTSD) with psilocybin—A retrospective case study","year":"2023","cit":9,"pfa":"Mika Turkia","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4323924592","eid":"W4323924592"},{"id":"paper-w4396977515","cat":"papers","name":"The psychedelic call: analysis of Australian Poisons Information Centre calls associated with classic psychedelics","year":"2024","cit":9,"pfa":"Rachael Wilkes","psa":"Jonathan Brett","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4396977515","eid":"W4396977515"},{"id":"paper-w4401553097","cat":"papers","name":"Altered states of consciousness in Danish healthy volunteers and recreational users of psilocybin and the possible impact of setting and intention: Danish validation of the five-dimensional altered states of consciousnes","year":"2024","cit":9,"pfa":"Oliver Rumle Hovmand","psa":"Dea Siggaard Stenbæk","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4401553097","eid":"W4401553097"},{"id":"paper-w2001592986","cat":"papers","name":"A simple and sensitive HPLC‐fluorescence method for quantification of MDMA and MDA in blood with 4‐(4,5‐diphenyl‐1H‐imidazol‐2‐yl)benzoyl chloride (DIB‐Cl) as a label","year":"2006","cit":9,"pfa":"Mamoru Tomita","psa":"Kenichiro Nakashima","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2001592986","eid":"W2001592986"},{"id":"paper-w4390753253","cat":"papers","name":"Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled","year":"2024","cit":9,"pfa":"Terence H. W. Ching","psa":"Benjamin Kelmendi","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4390753253","eid":"W4390753253"},{"id":"paper-w4399304220","cat":"papers","name":"Minorities’ Diminished Psychedelic Returns: Gender, Perceived Stigma, and Distress","year":"2024","cit":9,"pfa":"Sean M. Viña","ptype":"article","src":"https://openalex.org/W4399304220","eid":"W4399304220"},{"id":"paper-w4317631458","cat":"papers","name":"Classic psychedelics do not affect T cell and monocyte immune responses","year":"2023","cit":9,"pfa":"Deborah Rudin","psa":"Carsten Gründemann","topics":["Safety & adverse events","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4317631458","eid":"W4317631458"},{"id":"paper-w4246627360","cat":"papers","name":"A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted Therapy","year":"2020","cit":9,"pfa":"Jason B. Luoma","psa":"Rafael Lancelotta","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W4246627360","eid":"W4246627360"},{"id":"paper-w4394993604","cat":"papers","name":"Discovery and Structure–Activity Relationships of 2,5-Dimethoxyphenylpiperidines as Selective Serotonin 5-HT2A Receptor Agonists","year":"2024","cit":9,"pfa":"Emil Märcher-Rørsted","psa":"Jesper Langgaard Kristensen","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4394993604","eid":"W4394993604"},{"id":"paper-w2001139996","cat":"papers","name":"Second thoughts on psychedelic drugs","year":"1998","cit":9,"pfa":"Steven J. Novak","ptype":"article","src":"https://openalex.org/W2001139996","eid":"W2001139996"},{"id":"paper-w4389107941","cat":"papers","name":"Hypothetical biosynthetic pathways of pharmaceutically potential hallucinogenic metabolites in Myristicaceae, mechanistic convergence and co-evolutionary trends in plants and humans","year":"2023","cit":9,"pfa":"Rubi Barman","psa":"Dipanwita Banik","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4389107941","eid":"W4389107941"},{"id":"paper-w3020219135","cat":"papers","name":"Changes in field concentrations of five phalaris alkaloids and their association with toxicity in pastures of Victoria, Australia","year":"2020","cit":9,"pfa":"Elizabeth S. Read","psa":"Simone J. Rochfort","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3020219135","eid":"W3020219135"},{"id":"paper-w1986404860","cat":"papers","name":"Effects of LSD and 2-bromo LSD on striatal DOPAC levels","year":"1977","cit":9,"pfa":"Sven‐Åke Persson","ptype":"article","src":"https://openalex.org/W1986404860","eid":"W1986404860"},{"id":"paper-w1896137998","cat":"papers","name":"Effects of LSD-25 Upon Betta splendens: Reliability of a Bioassay Technique","year":"1957","cit":9,"pfa":"Jack Arbit","ptype":"article","src":"https://openalex.org/W1896137998","eid":"W1896137998"},{"id":"paper-w2749229904","cat":"papers","name":"Horizontal gene cluster transfer increased hallucinogenic mushroom diversity","year":"2017","cit":9,"pfa":"Hannah T. Reynolds","psa":"Jason C. Slot","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W2749229904","eid":"W2749229904"},{"id":"paper-w2073357734","cat":"papers","name":"Relationship of CNS tryptaminergic processes and the action of LSD-like hallucinogens","year":"1986","cit":9,"pfa":"William R. Martin","psa":"Jewell W. Sloan","ptype":"article","src":"https://openalex.org/W2073357734","eid":"W2073357734"},{"id":"paper-w3135419810","cat":"papers","name":"Therapeutic Potential of Psychedelics in the Treatment of Psychiatric Disorders, Part 1","year":"2021","cit":9,"pfa":"Avinash Hosanagar","psa":"Rajiv Radhakrishnan","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3135419810","eid":"W3135419810"},{"id":"paper-w2002745362","cat":"papers","name":"Publication Trends in the Drug Dependence Literature","year":"1982","cit":9,"pfa":"Harold G. Boxenbaum","psa":"Jerome H. Jaffe","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2002745362","eid":"W2002745362"},{"id":"paper-w2801609980","cat":"papers","name":"The psychedelic religion of mystical consciousnessReviews","year":"2018","cit":9,"pfa":"Rick J. Strassman","topics":["Addiction","Anxiety & end-of-life","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2801609980","eid":"W2801609980"},{"id":"paper-w3092007620","cat":"papers","name":"Severe Neurological Sequelae after a Recreational Dose of LSD","year":"2020","cit":9,"pfa":"Rachel Aakerøy","psa":"Lars Slørdal","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3092007620","eid":"W3092007620"},{"id":"paper-w3009231910","cat":"papers","name":"2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOME): A Harmful Hallucinogen Review","year":"2020","cit":9,"pfa":"Katarzyna Kamińska","psa":"Kamilla Małek","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3009231910","eid":"W3009231910"},{"id":"paper-w4250551421","cat":"papers","name":"In vivo effects of illicit hallucinogens on human lymphocyte chromosomes","year":"1970","cit":9,"pfa":"D. L. Dorrance","ptype":"article","src":"https://openalex.org/W4250551421","eid":"W4250551421"},{"id":"paper-w1994921966","cat":"papers","name":"Psychopathology Of LSD Intoxication","year":"1964","cit":9,"pfa":"H Kuramochi","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1994921966","eid":"W1994921966"},{"id":"paper-w2088203537","cat":"papers","name":"Actions of hallucinogens on ants (Formica pratensis)—II. Effects of amphetamine, LSD and delta-9-tetrahydrocannabinol","year":"1978","cit":9,"pfa":"H.R. Frischknecht","psa":"Peter Gaudenz Waser","ptype":"article","src":"https://openalex.org/W2088203537","eid":"W2088203537"},{"id":"paper-w1983239429","cat":"papers","name":"Effects on in vitro brain protein synthesis of a translational inhibitor isolated from rabbit brain following intravenous administration of LSD","year":"1987","cit":9,"pfa":"Scott W. Fleming","psa":"Ian R. Brown","ptype":"article","src":"https://openalex.org/W1983239429","eid":"W1983239429"},{"id":"paper-w1997592434","cat":"papers","name":"Stereotyped behavior and cyclic changes in response produced by LSD in goats","year":"1964","cit":9,"pfa":"Werner P. Koella","psa":"John R. Bergen","ptype":"article","src":"https://openalex.org/W1997592434","eid":"W1997592434"},{"id":"paper-w263606684","cat":"papers","name":"[Intoxications by hallucinogenic mushrooms].","year":"2000","cit":9,"pfa":"M Pierrot","psa":"Henry Lambert","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W263606684","eid":"W263606684"},{"id":"paper-w2467267656","cat":"papers","name":"1-(1-Naphthyl)piperazine, a central serotonin agonist.","year":"1986","cit":9,"pfa":"Fuller Rw","psa":"Perry Kw","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2467267656","eid":"W2467267656"},{"id":"paper-w4410977433","cat":"papers","name":"Psychedelics in the Treatment of Neurologic and Psychiatric Disorders: Coincidence or a New Point of View","year":"2025","cit":9,"pfa":"Naser‐Aldin Lashgari","psa":"Hamed Shafaroodi","ptype":"article","src":"https://openalex.org/W4410977433","eid":"W4410977433"},{"id":"paper-w3000241987","cat":"papers","name":"The Psychedelic Renaissance and Its Forensic Implications.","year":"2020","cit":9,"pfa":"Brian James Holoyda","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3000241987","eid":"W3000241987"},{"id":"paper-w2954063160","cat":"papers","name":"The association between the OPRM1 A118G polymorphism and addiction in a Turkish population","year":"2019","cit":9,"pfa":"Hülya Türkan","psa":"Ali Esat Karakaya","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2954063160","eid":"W2954063160"},{"id":"paper-w4283725435","cat":"papers","name":"Interactions between facilitator species and Lophophora williamsii (Lem. ex Salm-Dyck) J.M.Coult. (Cactaceae) in a rosetophyllus desert scrub in México","year":"2022","cit":9,"pfa":"Leandro Schwertner-Charão","psa":"Eduardo Osorio-Hernández","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4283725435","eid":"W4283725435"},{"id":"paper-w2397377246","cat":"papers","name":"Reconstitution of human 5-hydroxytryptamine5A receptor--G protein coupling in E. coli and Sf9 cell membranes with membranes from Sf9 cells expressing mammalian G proteins.","year":"2001","cit":9,"pfa":"Bart J. B. Francken","psa":"Jos�e E. Leysen","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2397377246","eid":"W2397377246"},{"id":"paper-w2049352635","cat":"papers","name":"Dissociations between the effects of hallucinogens on behavior and raphe unit activity in behaving cats","year":"1986","cit":9,"pfa":"Michael E. Trulson","ptype":"article","src":"https://openalex.org/W2049352635","eid":"W2049352635"},{"id":"paper-w4383621299","cat":"papers","name":"Identification of 1-(thiophene-2-carbonyl)-LSD from blotter paper falsely labeled “1D-LSD”","year":"2023","cit":9,"pfa":"Yuki Okada","psa":"Yuko Togawa Iwata","ptype":"article","src":"https://openalex.org/W4383621299","eid":"W4383621299"},{"id":"paper-w4404109701","cat":"papers","name":"Masking Influences: A Systematic Review of Placebo Control and Masking in Psychedelic Studies","year":"2024","cit":9,"pfa":"Aleksandra Barstowe","psa":"Petri Kajonius","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"review","src":"https://openalex.org/W4404109701","eid":"W4404109701"},{"id":"paper-w2150184757","cat":"papers","name":"Population Pharmacokinetics of 3,4-Methylenedioxymethamphetamine and Main Metabolites in Rats","year":"2009","cit":9,"pfa":"Déborah Hirt","psa":"Jean‐Michel Scherrmann","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2150184757","eid":"W2150184757"},{"id":"paper-w4398158905","cat":"papers","name":"An innovative approach for selective and robust screening of NBOHs, NBOMes, and LSD in forensic samples using a 3D-Printed electrochemical double cell","year":"2024","cit":9,"pfa":"Larissa Magalhães de Almeida Melo","psa":"Wallans T. P. dos Santos","ptype":"article","src":"https://openalex.org/W4398158905","eid":"W4398158905"},{"id":"paper-w2075799317","cat":"papers","name":"3,4-Methylenedioxymethamphetamine and naloxone in rat rotational behaviour and open field","year":"2005","cit":9,"pfa":"Heike B. Lebsanft","psa":"Werner Schmidt","ptype":"article","src":"https://openalex.org/W2075799317","eid":"W2075799317"},{"id":"paper-w2168600268","cat":"papers","name":"Increased effects of 3,4-methylenedioxymethamphetamine (ecstasy) in a rat model of depression","year":"2010","cit":9,"pfa":"Emily Joy Jaehne","psa":"Rodney James Irvine","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2168600268","eid":"W2168600268"},{"id":"paper-w2148865375","cat":"papers","name":"GC--MS Evaluation of a Series of Acylated Derivatives of 3,4-Methylenedioxymethamphetamine","year":"2009","cit":9,"pfa":"Tarek S. Belal","psa":"Jack DeRuiter","ptype":"article","src":"https://openalex.org/W2148865375","eid":"W2148865375"},{"id":"paper-w1981109586","cat":"papers","name":"Gas chromatographic—mass spectroscopic characterisation of the psychotomimetic indolealkylamines and their in vivo metabolites","year":"1987","cit":9,"pfa":"Balvant R. Sitaram","psa":"W. R. McLeod","ptype":"article","src":"https://openalex.org/W1981109586","eid":"W1981109586"},{"id":"paper-w2063533143","cat":"papers","name":"3,4-Methylenedioxymethamphetamine enhances kainic acid convulsive susceptibility","year":"2014","cit":9,"pfa":"Sònia Abad","psa":"Antoni Camins","ptype":"article","src":"https://openalex.org/W2063533143","eid":"W2063533143"},{"id":"paper-w3197511105","cat":"papers","name":"Activation of Antioxidant and Proteolytic Pathways in the Nigrostriatal Dopaminergic System After 3,4-Methylenedioxymethamphetamine Administration: Sex-Related Differences","year":"2021","cit":9,"pfa":"Giulia Costa","psa":"Patrizia Romualdi","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3197511105","eid":"W3197511105"},{"id":"paper-w2148006355","cat":"papers","name":"Influence of ketanserin on the effects of methylenedioxymethamphetamine on body temperature in the mouse","year":"2013","cit":9,"pfa":"James R. Docherty","psa":"Sotiria Bexis","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2148006355","eid":"W2148006355"},{"id":"paper-w4285297088","cat":"papers","name":"Should Adolescents be Included in Emerging Psychedelic Research?","year":"2022","cit":9,"pfa":"Khaleel Rajwani","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4285297088","eid":"W4285297088"},{"id":"paper-w4232143763","cat":"papers","name":"Effects of antihistamines on 3,4-methylenedioxymethamphetamine-induced depletion of serotonin in rats","year":"1999","cit":9,"pfa":"S.Y. Yeh","psa":"Johanne Cadet","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4232143763","eid":"W4232143763"},{"id":"paper-w2163443978","cat":"papers","name":"Quantitative determination of 3,4-methylenedioxymethamphetamine by thin-layer chromatography in ecstasy illicit pills in Tehran","year":"2009","cit":9,"pfa":"Seyed Vahid Shetab Boushehri","psa":"Abbas Kebriaeezadeh","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2163443978","eid":"W2163443978"},{"id":"paper-w4402139667","cat":"papers","name":"Fire Kasina advanced meditation produces experiences comparable to psychedelic and near-death experiences: A pilot study","year":"2024","cit":9,"pfa":"Marjorie Hines Woollacott","psa":"Daniel M. Ingram","ptype":"article","src":"https://openalex.org/W4402139667","eid":"W4402139667"},{"id":"paper-w2075946774","cat":"papers","name":"Effects of 3,4-methylenedioxymethamphetamine on locomotor activity and extracellular dopamine in the nucleus accumbens of Fischer 344 and Lewis rats","year":"2003","cit":9,"pfa":"Francesca Fernandez","psa":"Francis Chaouloff","ptype":"article","src":"https://openalex.org/W2075946774","eid":"W2075946774"},{"id":"paper-w2039104411","cat":"papers","name":"The effect of some hallucinogenic and other drugs on the temperature of reserpinized mice","year":"1971","cit":9,"pfa":"B.E. Leonard","psa":"P. D. Stonier","ptype":"article","src":"https://openalex.org/W2039104411","eid":"W2039104411"},{"id":"paper-w4416154674","cat":"papers","name":"Psychedelics produce enduring behavioral effects and functional plasticity through mechanisms independent of structural plasticity","year":"2025","cit":9,"pfa":"Hannah M. Kramer","psa":"Charles David Nichols","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4416154674","eid":"W4416154674"},{"id":"paper-w2740318118","cat":"papers","name":"The Non-Peptide Arginine-Vasopressin v1a Selective Receptor Antagonist, SR49059, Blocks the Rewarding, Prosocial, and Anxiolytic Effects of 3,4-Methylenedioxymethamphetamine and Its Derivatives in Zebra Fish","year":"2017","cit":9,"pfa":"Luisa Ponzoni","psa":"Mariaelvina Sala","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2740318118","eid":"W2740318118"},{"id":"paper-w2420679128","cat":"papers","name":"Abuse liability assessment of eslicarbazepine acetate in healthy male and female recreational sedative users: A Phase I randomized controlled trial","year":"2016","cit":9,"pfa":"Naama Levy‐Cooperman","psa":"Hailong Cheng","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2420679128","eid":"W2420679128"},{"id":"paper-w2901944098","cat":"papers","name":"Reduced Efficacy of d-Amphetamine and 3,4-Methylenedioxymethamphetamine in Inducing Hyperactivity in Mice Lacking the Postsynaptic Scaffolding Protein SHANK1","year":"2018","cit":9,"pfa":"Ayse Özge Sungur","psa":"Markus Wöhr","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2901944098","eid":"W2901944098"},{"id":"paper-w3176899364","cat":"papers","name":"Mining chemical information in Swedish wastewaters for simultaneous assessment of population consumption, treatment efficiency and environmental discharge of illicit drugs","year":"2021","cit":9,"pfa":"Inga Haalck","psa":"Foon Yin Lai","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3176899364","eid":"W3176899364"},{"id":"paper-w2412140318","cat":"papers","name":"Characterization of Brain Interactions With Methylenedioxyamphetamine and Methylenedioxymethamphetamine","year":"1989","cit":9,"pfa":"Robert C. Zaczek","psa":"Errol B. De Souza","topics":["Addiction","Dosing & pharmacology"],"ptype":"dataset","src":"https://openalex.org/W2412140318","eid":"W2412140318"},{"id":"paper-w2020750209","cat":"papers","name":"Humphry Fortescue Osmond (1917–2004), a radical and conventional psychiatrist: The transcendent years","year":"2014","cit":9,"pfa":"Robert M. Kaplan","ptype":"article","src":"https://openalex.org/W2020750209","eid":"W2020750209"},{"id":"paper-w116087142","cat":"papers","name":"Reflections on Transpersonal Psychology’s 40th Anniversary, Ecopsychology, Transpersonal Science, and Psychedelics: A Conversation Forum","year":"2009","cit":9,"pfa":"Mark A. Schroll","psa":"Valerie Mojeiko","ptype":"article","src":"https://openalex.org/W116087142","eid":"W116087142"},{"id":"paper-w1954843021","cat":"papers","name":"Commentary on Morganet al.(2010): Ketamine abuse: first medical evidence of harms we should confront","year":"2009","cit":9,"pfa":"Rafael de la Torre","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"editorial","src":"https://openalex.org/W1954843021","eid":"W1954843021"},{"id":"paper-w4386069259","cat":"papers","name":"Hallucinogenic potential: a review of psychoplastogens for the treatment of opioid use disorder","year":"2023","cit":9,"pfa":"Mary G. Hornick","psa":"Ashley Stefanski","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4386069259","eid":"W4386069259"},{"id":"paper-w2423182818","cat":"papers","name":"Observational Determination of Dose-Response Curves in Hallucinogen-Treated Monkeys","year":"2017","cit":9,"pfa":"J.M. Brewster","psa":"Murray E. Jarvik","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2423182818","eid":"W2423182818"},{"id":"paper-w4385689299","cat":"papers","name":"Have Effective Antidepressants Finally Arrived? Developments in Major Depressive Disorder Therapy","year":"2023","cit":9,"pfa":"Michael E. Thase","topics":["Depression","Anxiety & end-of-life","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4385689299","eid":"W4385689299"},{"id":"paper-w4392866789","cat":"papers","name":"UK medical students’ self-reported knowledge and harm assessment of psychedelics and their application in clinical research: a cross-sectional study","year":"2024","cit":9,"pfa":"Charlie Song-Smith","psa":"Marco Schlosser","topics":["Safety & adverse events","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4392866789","eid":"W4392866789"},{"id":"paper-w4387993033","cat":"papers","name":"Songs of Life: Psychedelic-Assisted Psychotherapy and Deleuze and Guattari’s ‘Desiring-Production’","year":"2023","cit":9,"pfa":"Patricia Kubala","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4387993033","eid":"W4387993033"},{"id":"paper-w4387022287","cat":"papers","name":"Psychedelic 5-HT2A receptor agonism: neuronal signatures and altered neurovascular coupling.","year":"2023","cit":9,"pfa":"Jonah A. Padawer-Curry","psa":"Adam Q. Bauer","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4387022287","eid":"W4387022287"},{"id":"paper-w4365510033","cat":"papers","name":"Psychological and physiological effects of extended DMT","year":"2023","cit":9,"pfa":"Lisa Xiaolu Luan","psa":"Christopher B. Timmermann","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4365510033","eid":"W4365510033"},{"id":"paper-w4311627573","cat":"papers","name":"Hopelessness, Suicidality, and Co-Occurring Substance Use among Adolescent Hallucinogen Users—A National Survey Study","year":"2022","cit":9,"pfa":"Saral R. Desai","psa":"Wei Du","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4311627573","eid":"W4311627573"},{"id":"paper-w3081329585","cat":"papers","name":"Acute DOB and PMA Administration Impairs Motor and Sensorimotor Responses in Mice and Causes Hallucinogenic Effects in Adult Zebrafish","year":"2020","cit":9,"pfa":"Micaela Tirri","psa":"Matteo Marti","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W3081329585","eid":"W3081329585"},{"id":"paper-w4310378672","cat":"papers","name":"4-Isobutylmethcathinone—A Novel Synthetic Cathinone with High In Vitro Cytotoxicity and Strong Receptor Binding Preference of Enantiomers","year":"2022","cit":9,"pfa":"Martin Paškan","psa":"Michal Kohout","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4310378672","eid":"W4310378672"},{"id":"paper-w4402800548","cat":"papers","name":"Beyond Pharmacology: A Narrative Review of Alternative Therapies for Anxiety Disorders","year":"2024","cit":9,"pfa":"Zuzanna Antos","psa":"Napoleon Waszkiewicz","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W4402800548","eid":"W4402800548"},{"id":"paper-w4402408418","cat":"papers","name":"Recreational Drug Overdose—Clinical Value of Toxicological Analysis","year":"2024","cit":9,"pfa":"Tobias Zellner","psa":"Sabrina Schmoll","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4402408418","eid":"W4402408418"},{"id":"paper-w4244144958","cat":"papers","name":"Serotonin Syndrome: Recognition and Treatment","year":"2013","cit":9,"pfa":"Brad E. Cooper","psa":"Celeste A. Sejnowski","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4244144958","eid":"W4244144958"},{"id":"paper-w4212828624","cat":"papers","name":"Cognitive-behavioural treatment for amphetamine-type stimulants (ATS)-use disorders","year":"2019","cit":9,"pfa":"Takayuki Harada","psa":"David B. Wilson","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4212828624","eid":"W4212828624"},{"id":"paper-w4403965136","cat":"papers","name":"Epistemic Risk Reduction in Psychedelic-Assisted Therapy","year":"2024","cit":9,"pfa":"Chiara Caporuscio","psa":"Sascha Benjamin Fink","topics":["Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W4403965136","eid":"W4403965136"},{"id":"paper-w4383187382","cat":"papers","name":"Critical Period Plasticity as a Framework for Psychedelic-Assisted Psychotherapy","year":"2023","cit":9,"pfa":"Lauren Lepow","psa":"Rachel Yehuda","topics":["PTSD & trauma","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4383187382","eid":"W4383187382"},{"id":"paper-w4403254207","cat":"papers","name":"Existential feelings as a phenomenological framework for psychedelic therapy","year":"2024","cit":9,"pfa":"Floris Benjamin Tijhuis","psa":"Léon C. de Bruin","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4403254207","eid":"W4403254207"},{"id":"paper-w2795698014","cat":"papers","name":"A role for enhanced functions of sleep in psychedelic therapy?","year":"2018","cit":9,"pfa":"Tom Froese","psa":"Tomáš Páleníček","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2795698014","eid":"W2795698014"},{"id":"paper-w4312064886","cat":"papers","name":"Research into Psychedelic-Assisted Psychotherapy for Anorexia Nervosa Should be Funded","year":"2022","cit":9,"pfa":"Lauren S. Otterman","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4312064886","eid":"W4312064886"},{"id":"paper-w4283033140","cat":"papers","name":"From Underground to Mainstream: Establishing a Medical Lexicon for Psychedelic Therapy","year":"2022","cit":9,"pfa":"Andrew Beswerchij","psa":"Dominic A. Sisti","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4283033140","eid":"W4283033140"},{"id":"paper-w4408459373","cat":"papers","name":"The effects of psychedelic-assisted therapy on illness and death anxiety: A systematic review and meta-analysis","year":"2025","cit":9,"pfa":"Aron Amaev","psa":"Philip Gerretsen","topics":["Anxiety & end-of-life","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4408459373","eid":"W4408459373"},{"id":"paper-w4306914642","cat":"papers","name":"Psychedelic medicine at a crossroads: Advancing an integrative approach to research and practice","year":"2022","cit":9,"pfa":"Gabriella Gobbi","psa":"Laurence J. Kirmayer","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4306914642","eid":"W4306914642"},{"id":"paper-w4229029658","cat":"papers","name":"The Pharmacology and Clinical Applications of Psychedelic Medicines Within Midwifery Practice","year":"2022","cit":9,"pfa":"Cindy A. Stein","psa":"Mariavittoria Mangini","topics":["Dosing & pharmacology","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4229029658","eid":"W4229029658"},{"id":"paper-w4312113627","cat":"papers","name":"High time? Psychedelics on cannabis-like fast track to legalization","year":"2022","cit":9,"pfa":"Kevin Zannese","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4312113627","eid":"W4312113627"},{"id":"paper-w4398782381","cat":"papers","name":"Perspectives and preliminary experiences of psychedelics for the treatment of eating disorders: A systematic scoping review","year":"2024","cit":9,"pfa":"Karolina Cuerva","psa":"Jayanthi Raman","topics":["Safety & adverse events","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4398782381","eid":"W4398782381"},{"id":"paper-w4399580619","cat":"papers","name":"Improvement in depressive symptoms in a patient with severe and enduring anorexia nervosa and comorbid major depressive disorder using psychotherapy-assisted IV ketamine : a case report","year":"2024","cit":9,"pfa":"Amanda Timek","psa":"Stephen J. Ferrando","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4399580619","eid":"W4399580619"},{"id":"paper-w4387763972","cat":"papers","name":"Psychiatric risks for worsened mental health after psychedelic use","year":"2023","cit":9,"pfa":"Alessia Marrocu","psa":"Robin Lester Carhart-Harris","topics":["Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4387763972","eid":"W4387763972"},{"id":"paper-w4402993015","cat":"papers","name":"Beyond the numbers: reimagining healing with psychedelics for eating disorders","year":"2024","cit":9,"pfa":"Adèle Lafrance","psa":"Stephanie Knatz Peck","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4402993015","eid":"W4402993015"},{"id":"paper-w4387598943","cat":"papers","name":"Ensuring the affordable becomes accessible–lessons from ketamine, a new treatment for severe depression","year":"2023","cit":9,"pfa":"Anthony J. Rodgers","psa":"Colleen K A Loo","topics":["Depression","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4387598943","eid":"W4387598943"},{"id":"paper-w4412393028","cat":"papers","name":"Naturalistic psychedelic use and changes in depressive symptoms","year":"2025","cit":9,"pfa":"Otto Simonsson","psa":"Simon Benjamin Goldberg","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4412393028","eid":"W4412393028"},{"id":"paper-w4405261412","cat":"papers","name":"The library is open: a scoping review on queer representation in psychedelic research","year":"2024","cit":9,"pfa":"Amy Bartlett","psa":"Terence H. W. Ching","topics":["Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4405261412","eid":"W4405261412"},{"id":"paper-w1558213836","cat":"papers","name":"Hallucinogens and Cannabinoids for Headache","year":"2012","cit":9,"pfa":"Brian E. McGeeney","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1558213836","eid":"W1558213836"},{"id":"paper-w2416317003","cat":"papers","name":"Discriminable stimuli produced by hallucinogens.","year":"1976","cit":9,"pfa":"Kuhn Dm","psa":"Appel Jb","ptype":"article","src":"https://openalex.org/W2416317003","eid":"W2416317003"},{"id":"paper-w4391806642","cat":"papers","name":"Navigating Psychedelic Policy","year":"2024","cit":9,"pfa":"Sean M. Viña","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4391806642","eid":"W4391806642"},{"id":"paper-w2043278651","cat":"papers","name":"LSD and the Psychedelic Syndrome","year":"1969","cit":9,"pfa":"David Eugene Smith","ptype":"article","src":"https://openalex.org/W2043278651","eid":"W2043278651"},{"id":"paper-w4285295458","cat":"papers","name":"Decolonizing the Philosophy of Psychedelics","year":"2022","cit":9,"pfa":"Osiris Sinuhé González Romero","ptype":"book-chapter","src":"https://openalex.org/W4285295458","eid":"W4285295458"},{"id":"paper-w2596244747","cat":"papers","name":"THE REBIRTH OF RESEARCH WITH ENTHEOGENS: LESSONS FROM THE PAST AND HYPOTHESES FOR THE FUTURE","year":"2009","cit":9,"pfa":"William A. Richards","ptype":"article","src":"https://openalex.org/W2596244747","eid":"W2596244747"},{"id":"paper-w4322618102","cat":"papers","name":"Psychedelics and psychological strengths","year":"2023","cit":9,"pfa":"Trey J. Brasher","psa":"Marcello Spinella","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4322618102","eid":"W4322618102"},{"id":"paper-w4405890492","cat":"papers","name":"Phenomenology of Psychedelic Experiences and Psychedelic-Associated Distressing Effects: Quantifying Subjective Experiences","year":"2024","cit":9,"pfa":"Cyril Costines","psa":"Timo Torsten Schmidt","ptype":"book-chapter","src":"https://openalex.org/W4405890492","eid":"W4405890492"},{"id":"paper-w4321018047","cat":"papers","name":"Possible psychedelic therapeutic mechanism","year":"2023","cit":9,"pfa":"Evan M. Hess","psa":"Todd D. Gould","topics":["Mechanism & neuroscience"],"ptype":"editorial","src":"https://openalex.org/W4321018047","eid":"W4321018047"},{"id":"paper-w330627666","cat":"papers","name":"Psychedelic Research: Obstacles and Values","year":"1975","cit":9,"ptype":"article","src":"https://openalex.org/W330627666","eid":"W330627666"},{"id":"paper-w2016888237","cat":"papers","name":"Research in creativity and psychedelic drugs","year":"1977","cit":9,"pfa":"Stanley Krippiwr","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2016888237","eid":"W2016888237"},{"id":"paper-w2066742575","cat":"papers","name":"The Psychedelics: Love or Hostility Potion?","year":"1969","cit":9,"pfa":"Allan E. Edwards","psa":"Sidney Cohen","ptype":"article","src":"https://openalex.org/W2066742575","eid":"W2066742575"},{"id":"paper-w1971659956","cat":"papers","name":"Tactics of Legitimation in the Psychedelic Sciences","year":"2012","cit":9,"pfa":"Michelle Corbin","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1971659956","eid":"W1971659956"},{"id":"paper-w2023015778","cat":"papers","name":"Are psychedelic drug treatments seeing a comeback in psychiatry?","year":"2008","cit":9,"pfa":"Ben Sessa","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2023015778","eid":"W2023015778"},{"id":"paper-w2053797474","cat":"papers","name":"Identification of Hallucinogens in Illicit Seizures I: 2,5-Dimethoxyamphetamine","year":"1972","cit":9,"pfa":"Robert C. Shaler","psa":"John J. Padden","ptype":"article","src":"https://openalex.org/W2053797474","eid":"W2053797474"},{"id":"paper-w2415159583","cat":"papers","name":"[Effects of certain hallucinogens on the electroencephalogram and conditioned behavior of the rabbit].","year":"1966","cit":9,"pfa":"Leokadia Baran","psa":"Longo Vg","ptype":"article","src":"https://openalex.org/W2415159583","eid":"W2415159583"},{"id":"paper-w2439657477","cat":"papers","name":"Use of a desferrioxamine \"microdose\" to chelate aluminum in hemodialysis patients.","year":"1999","cit":9,"pfa":"Cristina Rego de Freitas Mendes Jorge","psa":"Aníbal Ferreira","topics":["Dosing & pharmacology"],"ptype":"letter","src":"https://openalex.org/W2439657477","eid":"W2439657477"},{"id":"paper-w1984229450","cat":"papers","name":"Psychedelic drug flashbacks: Attentional deficits?","year":"1979","cit":9,"pfa":"Robert E. Matefy","psa":"Jerrold Hirsch","ptype":"article","src":"https://openalex.org/W1984229450","eid":"W1984229450"},{"id":"paper-w2005887959","cat":"papers","name":"Early human studies of investigational agents: dose or microdose?","year":"2009","cit":9,"pfa":"Lionel D. Lewis","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2005887959","eid":"W2005887959"},{"id":"paper-w4361214978","cat":"papers","name":"Psychedelics and the Entropic Brain Beyond the Self","year":"2023","cit":9,"pfa":"Hans Van Eyghen","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4361214978","eid":"W4361214978"},{"id":"paper-w3177300439","cat":"papers","name":"Psychedelics: A New Treatment Paradigm in Psychiatry?","year":"2021","cit":9,"pfa":"Gerhard Gründer","ptype":"article","src":"https://openalex.org/W3177300439","eid":"W3177300439"},{"id":"paper-w2941829345","cat":"papers","name":"Microdose effects in SRAM cells under heavy ion irradiation","year":"2017","cit":9,"pfa":"Anna B. Boruzdina","psa":"Vyacheslav M. Uzhegov","topics":["Dosing & pharmacology"],"ptype":"conference-paper","src":"https://openalex.org/W2941829345","eid":"W2941829345"},{"id":"paper-w4214886483","cat":"papers","name":"Evaluation of CYP2C19 activity using microdosed oral omeprazole in humans","year":"2022","cit":9,"pfa":"Annika Elbe","psa":"Gerd Mikus","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4214886483","eid":"W4214886483"},{"id":"paper-w4405978077","cat":"papers","name":"Toward Translatable Biomarkers of Psychedelic-Induced Neuroplasticity","year":"2025","cit":9,"pfa":"David E. Olson","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4405978077","eid":"W4405978077"},{"id":"paper-w2912693327","cat":"papers","name":"Probes and Cocktails for Drug–Drug Interaction Evaluation: The Future Is Microdosing?","year":"2019","cit":9,"pfa":"Gerd Mikus","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2912693327","eid":"W2912693327"},{"id":"paper-w4402844104","cat":"papers","name":"Classical psychedelics’ action on brain monoaminergic systems","year":"2024","cit":9,"pfa":"Jasmine Jade Butler","psa":"Philippe De Deurwaerdère","ptype":"article","src":"https://openalex.org/W4402844104","eid":"W4402844104"},{"id":"paper-w4402149384","cat":"papers","name":"Considering distinct positive emotions in psychedelic science","year":"2024","cit":9,"pfa":"Sean P. Goldy","psa":"David B. Yaden","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4402149384","eid":"W4402149384"},{"id":"paper-w2121684620","cat":"papers","name":"Juvenile Hallucinogen Use: What do Multiple Theories Say about It?","year":"2014","cit":9,"pfa":"Anthony Gennaro Vito","psa":"Melissa L. Ricketts","ptype":"article","src":"https://openalex.org/W2121684620","eid":"W2121684620"},{"id":"paper-w2735692511","cat":"papers","name":"Erratum to: Phenomenology, Structure, and Dynamic of Psychedelic States","year":"2017","cit":9,"pfa":"Katrin H. Preller","psa":"Franz X. Vollenweider","ptype":"erratum","src":"https://openalex.org/W2735692511","eid":"W2735692511"},{"id":"paper-w2089688997","cat":"papers","name":"The Psychedelic \"Hip Scene\": Return of the Death Instinct","year":"1968","cit":9,"pfa":"Harry R. Brickman","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2089688997","eid":"W2089688997"},{"id":"paper-w1586161395","cat":"papers","name":"Postscript—Psychedelics in Unlocking the Unconscious: From Cancer to Addiction","year":"2013","cit":9,"pfa":"Gabor Maté","topics":["Addiction","Anxiety & end-of-life"],"ptype":"book-chapter","src":"https://openalex.org/W1586161395","eid":"W1586161395"},{"id":"paper-w2519318170","cat":"papers","name":"Acid Hype: American News Media and the Psychedelic Experience","year":"2016","cit":9,"pfa":"Chris Elcock","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2519318170","eid":"W2519318170"},{"id":"paper-w3044553637","cat":"papers","name":"Acid Revival : The Psychedelic Renaissance and the Quest for Medical Legitimacy","year":"2020","cit":9,"pfa":"Danielle M. Giffort","ptype":"article","src":"https://openalex.org/W3044553637","eid":"W3044553637"},{"id":"paper-w4382502470","cat":"papers","name":"THC-O-Acetate: Scarce Evidence for a Psychedelic Cannabinoid","year":"2023","cit":9,"pfa":"Daniel J. Kruger","psa":"Jessica Sloan Kruger","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4382502470","eid":"W4382502470"},{"id":"paper-w4406027414","cat":"papers","name":"Guruism and Cultic Social Dynamics in Psychedelic Practices and Organisations","year":"2024","cit":9,"pfa":"Jules Evans","psa":"Joseph Holcomb Adams","ptype":"book-chapter","src":"https://openalex.org/W4406027414","eid":"W4406027414"},{"id":"paper-w3082331760","cat":"papers","name":"Who takes the trip? Personality and hallucinogen use among college students and adolescents","year":"2020","cit":9,"pfa":"Jamie E. Parnes","psa":"Rachel Rebecca","ptype":"article","src":"https://openalex.org/W3082331760","eid":"W3082331760"},{"id":"paper-w1997687774","cat":"papers","name":"Psychedelic drug flashbacks: Psychotic manifestation or imaginative role playing?","year":"1975","cit":9,"pfa":"Robert E. Matefy","psa":"Roger G. Krall","ptype":"article","src":"https://openalex.org/W1997687774","eid":"W1997687774"},{"id":"paper-w2523253707","cat":"papers","name":"The use of henbane (Hyoscyamus nigerL.) as a hallucinogen at Neolithic ‘ritual’ sites: a re-evaluation","year":"2000","cit":9,"pfa":"Deborah J. Long","psa":"Paula Milburn","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2523253707","eid":"W2523253707"},{"id":"paper-w2001623974","cat":"papers","name":"Iodine-129 Microdosing for Protein and Peptide Drug Development: Erythropoietin as A Case Study","year":"2012","cit":9,"pfa":"Robert‐Jan A. N. Lamers","psa":"Jose Manuel Gómez-Guzmán","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2001623974","eid":"W2001623974"},{"id":"paper-w4401215711","cat":"papers","name":"Structural basis of psychedelic LSD recognition at dopamine D1 receptor","year":"2024","cit":9,"pfa":"Luyu Fan","psa":"Sheng Wang","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4401215711","eid":"W4401215711"},{"id":"paper-w4404540282","cat":"papers","name":"Moral enhancement and cheapened achievement: Psychedelics, virtual reality and AI","year":"2024","cit":9,"pfa":"Emma C. Gordon","psa":"Brian David Earp","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4404540282","eid":"W4404540282"},{"id":"paper-w4392452737","cat":"papers","name":"Perceived attachment history predicts psychedelic experiences: A naturalistic study","year":"2024","cit":9,"pfa":"Aaron D. Cherniak","psa":"Pehr Granqvist","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4392452737","eid":"W4392452737"},{"id":"paper-w4402097435","cat":"papers","name":"Distinct 5-HT receptor subtypes regulate claustrum excitability by serotonin and the psychedelic, DOI","year":"2024","cit":9,"pfa":"Tanner L. Anderson","psa":"Pavel I. Ortinski","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4402097435","eid":"W4402097435"},{"id":"paper-w3088649318","cat":"papers","name":"Absolute Bioavailability of Microdosed Midazolam After Buccal Administration Is Dependent on Buccal Exposure Time","year":"2020","cit":9,"pfa":"Jana Grass","psa":"Gerd Mikus","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3088649318","eid":"W3088649318"},{"id":"paper-w3122720075","cat":"papers","name":"Prevalence of Stimulant, Hallucinogen, and Dissociative Substances Detected in Biological Samples of NPS-Intoxicated Patients in Italy","year":"2021","cit":9,"pfa":"Pietro Papa","psa":"C. Locatelli","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W3122720075","eid":"W3122720075"},{"id":"paper-w4386440980","cat":"papers","name":"Predictors of psychedelic treatment outcomes among special operations forces veterans.","year":"2023","cit":9,"pfa":"Yitong Xin","psa":"Alan K. Davis","ptype":"article","src":"https://openalex.org/W4386440980","eid":"W4386440980"},{"id":"paper-w4367054491","cat":"papers","name":"Effects of serotonergic psychedelics on mitochondria: Transdiagnostic implications for mitochondria-related pathologies","year":"2023","cit":9,"pfa":"Patrick Fissler","psa":"Rainer Krähenmann","topics":["Mechanism & neuroscience","Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4367054491","eid":"W4367054491"},{"id":"paper-w4225281694","cat":"papers","name":"Disintegrating and Reintegrating the Self – (In)Flexible Self-Models in Depersonalisation and Psychedelic Experiences","year":"2022","cit":9,"pfa":"Anna Ciaunica","psa":"Adam Safron","topics":["Safety & adverse events","Mechanism & neuroscience","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4225281694","eid":"W4225281694"},{"id":"paper-w4297663087","cat":"papers","name":"Tripping to Cope: Coping Strategies and Use of Hallucinogens during the COVID-19 Pandemic in Three Cultural Contexts","year":"2022","cit":9,"pfa":"Genís Oña","psa":"José Carlos Bouso","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4297663087","eid":"W4297663087"},{"id":"paper-w3209179405","cat":"papers","name":"Highly sensitive quantification of pemetrexed in human plasma using UPLC‐MS/MS to support microdosing studies","year":"2021","cit":9,"pfa":"E.W.J. van Ewijk-Beneken Kolmer","psa":"Rob ter Heine","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3209179405","eid":"W3209179405"},{"id":"paper-w3046410360","cat":"papers","name":"GMP production of [68Ga]Ga-BOT5035 for imaging of liver fibrosis in microdosing phase 0 study","year":"2020","cit":9,"pfa":"Irina Velikyan","psa":"Gunnar Antoni","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3046410360","eid":"W3046410360"},{"id":"paper-w4390964646","cat":"papers","name":"AlphaFold found thousands of possible psychedelics. Will its predictions help drug discovery?","year":"2024","cit":9,"pfa":"Ewen Callaway","ptype":"article","src":"https://openalex.org/W4390964646","eid":"W4390964646"},{"id":"paper-w3027062298","cat":"papers","name":"Determination of the absolute bioavailability of oral imatinib using a stable isotopically labeled intravenous imatinib-d8 microdose","year":"2020","cit":9,"pfa":"Jeroen Roosendaal","psa":"Neeltje Steeghs","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3027062298","eid":"W3027062298"},{"id":"paper-w2400760979","cat":"papers","name":"Editorial (Hot Topic: The Potential of Psychedelics as a Preventative and Auxiliary Therapy for Drug Abuse)","year":"2013","cit":9,"pfa":"Héctor Vargas-Pérez","psa":"Rick Doblin","ptype":"editorial","src":"https://openalex.org/W2400760979","eid":"W2400760979"},{"id":"paper-w4399655672","cat":"papers","name":"Psychedelic-augmented psychotherapy for overcoming traumatic dissociation: A review of neuroscientific and phenomenological evidence","year":"2024","cit":9,"pfa":"Ansgar Rougemont-Bücking","psa":"Jean Naudin","topics":["PTSD & trauma","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4399655672","eid":"W4399655672"},{"id":"paper-w2153009802","cat":"papers","name":"On the enduring popularity of Cream's ‘Sunshine of Your Love’: sonic synecdoche of the ‘psychedelic 60s’","year":"1999","cit":9,"pfa":"Arnold S. Wolfe","psa":"Heather O'Donnell","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2153009802","eid":"W2153009802"},{"id":"paper-w2575583238","cat":"papers","name":"Compatibility study of a parenteral microdose polyethylene glycol formulation in medical devices and identification of degradation impurity by 2D-LC/MS","year":"2017","cit":9,"pfa":"Lulu Dai","psa":"Kelly Zhang","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2575583238","eid":"W2575583238"},{"id":"paper-w4386603647","cat":"papers","name":"Longitudinal and transcultural assessment of the relationship between hallucinogens, well-being, and post-traumatic growth during the COVID-19 pandemic","year":"2023","cit":9,"pfa":"José Carlos Bouso","psa":"Miguel Ángel Alcázar‐Córcoles","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4386603647","eid":"W4386603647"},{"id":"paper-w4404643198","cat":"papers","name":"Deepening Psychedelic Integration: Exploring Complex Settings, Understanding User’s Struggles, and Implementing Safe Interventions","year":"2024","cit":9,"pfa":"Marc Aixalà","topics":["Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W4404643198","eid":"W4404643198"},{"id":"paper-w3195071781","cat":"papers","name":"Stretching and squeezing of neuronal log firing rate distribution by psychedelic and intrinsic brain state transitions","year":"2021","cit":9,"pfa":"Bradley Dearnley","psa":"Michael Okun","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W3195071781","eid":"W3195071781"},{"id":"paper-w3185412836","cat":"papers","name":"Recreation and Realization: Reported Motivations of Use Among Persons Who Consume Psychedelics in Non-Clinical Settings","year":"2021","cit":9,"pfa":"Cindy Brooks Dollar","topics":["Addiction","Anxiety & end-of-life","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3185412836","eid":"W3185412836"},{"id":"paper-w2073394323","cat":"papers","name":"Comparison of the ultrashort gonadotropin-releasing hormone agonist-antagonist protocol with microdose flare -up protocol in poor responders: a preliminary study","year":"2010","cit":9,"pfa":"Bülent Berker","psa":"Hakan Şatıroğlu","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2073394323","eid":"W2073394323"},{"id":"paper-w1984104926","cat":"papers","name":"Response to “Can CYP3A Activity Be Evaluated for Drug Interaction Using a Nanogram Dose of Probe Drug?”: Evaluation of CYP3A Activity With Microdoses of Midazolam","year":"2014","cit":9,"pfa":"Nicolas Hohmann","psa":"Walter E. Haefeli","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1984104926","eid":"W1984104926"},{"id":"paper-w4408152440","cat":"papers","name":"The psychedelic (−)-2,5-dimethoxy-4-iodoamphetamine [(−)-DOI] demonstrates efficacy in reducing cocaine reward and motivation in male rats","year":"2025","cit":9,"pfa":"Leah M. Salinsky","psa":"Kathryn A. Cunningham","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4408152440","eid":"W4408152440"},{"id":"paper-w4403117133","cat":"papers","name":"Perceived changes in mental health and social engagement attributed to a single psychedelic experience in autistic adults: results from an online survey","year":"2024","cit":9,"pfa":"Jack Stroud","psa":"Sunjeev K. Kamboj","ptype":"article","src":"https://openalex.org/W4403117133","eid":"W4403117133"},{"id":"paper-w4391365321","cat":"papers","name":"Coming Back Together: A Qualitative Survey Study of Coping and Support Strategies Used by People to Cope With Extended Difficulties After the Use of Psychedelic Drugs","year":"2024","cit":9,"pfa":"Oliver C. Robinson","psa":"Ed Prideaux","ptype":"preprint","src":"https://openalex.org/W4391365321","eid":"W4391365321"},{"id":"paper-w2036692294","cat":"papers","name":"Genetic dissection of the psychotomimetic effects of cannabinoid exposure","year":"2013","cit":9,"pfa":"Colm M. P. O’Tuathaigh","psa":"John L. Waddington","ptype":"article","src":"https://openalex.org/W2036692294","eid":"W2036692294"},{"id":"paper-w2024494252","cat":"papers","name":"Interfacial Adsorption of a Psychotomimetic Drug Using Liquid Scintillation","year":"1973","cit":9,"pfa":"Hideo Kimizuka","psa":"Leo G. Abood","ptype":"article","src":"https://openalex.org/W2024494252","eid":"W2024494252"},{"id":"paper-w2408754098","cat":"papers","name":"Treatment of alcoholism with psychotomimetic drugs. A follow-up study.","year":"1978","cit":9,"pfa":"Z Rydzyński","psa":"Wojciech Gruszczyński","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2408754098","eid":"W2408754098"},{"id":"paper-w4385812388","cat":"papers","name":"Psychedelic Use Among Psychiatric Medication Prescribers: Effects on Well-Being, Depression, Anxiety, and Associations with Patterns of Use, Reported Harms, and Transformative Mental States","year":"2023","cit":9,"pfa":"Zachary M. Herrmann","psa":"Saundra Jain","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4385812388","eid":"W4385812388"},{"id":"paper-w2433128564","cat":"papers","name":"EFFECT OF ANTICHOLINERGIC PSYCHOTOMIMETICS ON MOTOR ACTIVITY AND BODY TEMPERATURE.","year":"1963","cit":9,"pfa":"V.C. Lipman","psa":"Leo G. Abood","ptype":"article","src":"https://openalex.org/W2433128564","eid":"W2433128564"},{"id":"paper-w2025682230","cat":"papers","name":"Increased plasma free fatty acids following psychotomimetic drugs","year":"1965","cit":9,"pfa":"Leo E. Hollister","psa":"Frances F. Moore","ptype":"article","src":"https://openalex.org/W2025682230","eid":"W2025682230"},{"id":"paper-w2503018823","cat":"papers","name":"Combining DFT and QSAR studies for predicting psychotomimetic activity of substituted phenethylamines using statistical methods","year":"2016","cit":9,"pfa":"Adnane Aouidate","psa":"Tahar Lakhlifi","ptype":"article","src":"https://openalex.org/W2503018823","eid":"W2503018823"},{"id":"paper-w4392923364","cat":"papers","name":"The application of Phase 0 and microtracer approaches in early clinical development: past, present, and future","year":"2024","cit":9,"pfa":"Ad F. Roffel","psa":"Ewoud J. van Hoogdalem","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4392923364","eid":"W4392923364"},{"id":"paper-w4401253530","cat":"papers","name":"Predicting the Hallucinogenic Potential of Molecules Using Artificial Intelligence","year":"2024","cit":9,"pfa":"Fabio Urbina","psa":"Sean Ekins","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4401253530","eid":"W4401253530"},{"id":"paper-w3204071146","cat":"papers","name":"Reddit discussions about buprenorphine associated precipitated withdrawal in the era of fentanyl","year":"2021","cit":9,"pfa":"Anthony Spadaro","psa":"Jeanmarie Perrone","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W3204071146","eid":"W3204071146"},{"id":"paper-w2944707881","cat":"papers","name":"The Fungus Amanita muscaria: From Neurotoxins to Vanadium Accumulation","year":"2019","cit":9,"pfa":"Catherine E. Housecroft","ptype":"article","src":"https://openalex.org/W2944707881","eid":"W2944707881"},{"id":"paper-w3123460287","cat":"papers","name":"Hallucinogenic Plants in Chinese Herbals","year":"1977","cit":9,"pfa":"Hui-Lin Li","ptype":"article","src":"https://openalex.org/W3123460287","eid":"W3123460287"},{"id":"paper-w4404774362","cat":"papers","name":"Assessing the effects of 5-HT2A and 5-HT5A receptor antagonists on DOI-induced head-twitch response in male rats using marker-less deep learning algorithms","year":"2024","cit":9,"pfa":"Ewelina Cyrano","psa":"Piotr Popik","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4404774362","eid":"W4404774362"},{"id":"paper-w2094609197","cat":"papers","name":"Depressive States Induced by Drugs of Abuse: Clinical Evidence, Theoretical Mechanisms and Proposed Treatment Part II","year":"1976","cit":9,"pfa":"Kenneth Blum","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2094609197","eid":"W2094609197"},{"id":"paper-w4403583574","cat":"papers","name":"International Perspectives in Philosophy and Psychiatry","year":"2024","cit":9,"pfa":"Gloria Sibson Ayob","topics":["Policy & ethics"],"ptype":"other","src":"https://openalex.org/W4403583574","eid":"W4403583574"},{"id":"paper-w2113481301","cat":"papers","name":"Visual Hallucinations During Hallucinogenic Experience and Schizophrenia","year":"1979","cit":9,"pfa":"A. Marsh","ptype":"article","src":"https://openalex.org/W2113481301","eid":"W2113481301"},{"id":"paper-w4221097543","cat":"papers","name":"Optimized Clinical Strategies for Treatment-Resistant Depression: Integrating Ketamine Protocols with Trauma- and Attachment-Informed Psychotherapy","year":"2022","cit":9,"pfa":"Sherry-Anne Muscat","psa":"Kevin W. Morin","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4221097543","eid":"W4221097543"},{"id":"paper-w4417292477","cat":"papers","name":"PDGFRß targeted positron emission tomography as a non-invasive biomarker for activated hepatic stellate cells: lasts steps before clinical translation","year":"2025","cit":9,"pfa":"Chittampalli N. Yashaswini","psa":"Olof Eriksson","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4417292477","eid":"W4417292477"},{"id":"paper-w4404543290","cat":"papers","name":"Placebo Effects: Neurological Mechanisms Inducing Physiological, Organic, and Belief Responses—A Prospective Analysis","year":"2024","cit":9,"pfa":"Sarfaraz K. Niazi","topics":["Addiction","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4404543290","eid":"W4404543290"},{"id":"paper-w2780068944","cat":"papers","name":"A comparison of treatment results of the different treatment protocols in patients with poor ovarian response","year":"2017","cit":9,"pfa":"İlhan Şanverdi","psa":"Adnan İncebıyık","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2780068944","eid":"W2780068944"},{"id":"paper-w2460296963","cat":"papers","name":"Analysis of Blotter Papers Employed in the Commercialization of New Hallucinogenic Substances of the 2,5-Dimethoxy-N-(2-methoxybenzyl) Phenethylamine Series Seized in the City of Bogotá by Applying Gas Chromatography Cou","year":"2015","cit":9,"pfa":"Diego A. Sánchez Robayo","psa":"Milton Rosero Moreano","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2460296963","eid":"W2460296963"},{"id":"paper-w2943104101","cat":"papers","name":"Pharmacokinetic and Pharmacodynamic Properties of a Micro-Dose Nasal Spray Formulation of Desmopressin (AV002) in Healthy Water-Loaded Subjects","year":"2019","cit":9,"pfa":"Karl‐Erik Andersson","psa":"Seymour H. Fein","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2943104101","eid":"W2943104101"},{"id":"paper-w650291867","cat":"papers","name":"Drugs, society and man : a guide to addiction and its treatment","year":"1974","cit":9,"pfa":"Max M. Glatt","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W650291867","eid":"W650291867"},{"id":"paper-w4253853190","cat":"papers","name":"Substance Use Disorders","year":"2018","cit":9,"pfa":"Franz Moeller","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4253853190","eid":"W4253853190"},{"id":"paper-w2342155963","cat":"papers","name":"Personality traits of in-patients with substance use disorders in a mental health facility in Nigeria","year":"2016","cit":9,"pfa":"Victor Chidi Onyencho","psa":"A Karatu Baba","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W2342155963","eid":"W2342155963"},{"id":"paper-w2020873619","cat":"papers","name":"D-serine deficiency attenuates the behavioral and cellular effects induced by the hallucinogenic 5-HT2A receptor agonist DOI","year":"2013","cit":9,"pfa":"Martin A. Santini","psa":"Joseph T. Coyle","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2020873619","eid":"W2020873619"},{"id":"paper-w3191809711","cat":"papers","name":"Pharmacokinetic modeling of over-the-counter drug diphenhydramine self-administered in overdoses in Japanese patients admitted to hospital","year":"2021","cit":9,"pfa":"Koichiro Adachi","psa":"Hiroshi Yamazaki","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3191809711","eid":"W3191809711"},{"id":"paper-w4404087463","cat":"papers","name":"Pharmacotherapeutic strategies for the treatment of anorexia nervosa – novel targets to break a vicious cycle","year":"2024","cit":9,"pfa":"Millie C. Kirchberg","psa":"Guido Frank","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4404087463","eid":"W4404087463"},{"id":"paper-w3089141037","cat":"papers","name":"Marginalisation, stigmatisation et abandon du LSD en médecine","year":"2020","cit":9,"pfa":"Zoë Dubus","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3089141037","eid":"W3089141037"},{"id":"paper-w4382402442","cat":"papers","name":"Developing non-opioid therapeutics to alleviate pain among persons with opioid use disorder: a review of the human evidence","year":"2023","cit":9,"pfa":"Débora Silva de Oliveira","psa":"João Paulo De Aquino","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4382402442","eid":"W4382402442"},{"id":"paper-w3088595900","cat":"papers","name":"Increased behavioral and neuronal responses to a hallucinogenic drug after adolescent toluene exposure in mice: Effects of antipsychotic treatment","year":"2020","cit":9,"pfa":"Mei-Yi Lee","psa":"Hwei‐Hsien Chen","ptype":"article","src":"https://openalex.org/W3088595900","eid":"W3088595900"},{"id":"paper-w4321478601","cat":"papers","name":"Correlates of substance use in a large naturalistic cohort of young people with early and emerging psychosis","year":"2023","cit":9,"pfa":"D. El-Hage","psa":"Ellie Brown","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4321478601","eid":"W4321478601"},{"id":"paper-w2995205878","cat":"papers","name":"Application of data mining techniques and logistic regression to model drug use transition to injection: a case study in drug use treatment centers in Kermanshah Province, Iran","year":"2019","cit":9,"pfa":"Somayeh Najafi-Ghobadi","psa":"Abbas Aghaei","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2995205878","eid":"W2995205878"},{"id":"paper-w3083100745","cat":"papers","name":"Polysubstance abuse associated with more frequent opioid use among patients in rural primary care settings","year":"2020","cit":9,"pfa":"David L. Albright","psa":"Shanna McIntosh","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3083100745","eid":"W3083100745"},{"id":"paper-w4401273211","cat":"papers","name":"Can mind-altering prescription medicines be safe? Lessons from ketamine and esketamine","year":"2024","cit":9,"pfa":"Richard C. Dart","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"editorial","src":"https://openalex.org/W4401273211","eid":"W4401273211"},{"id":"paper-w1852716069","cat":"papers","name":"The factors of ketamine that affect sedation in children with oncology procedures: parent satisfaction perspective.","year":"2014","cit":9,"pfa":"Chanchai Traivaree","psa":"Rachata Lumkul","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1852716069","eid":"W1852716069"},{"id":"paper-w2909901946","cat":"papers","name":"Treatment Episode Data Set -- Discharges (TEDS-D), 2008","year":"2011","cit":9,"pfa":"United States Department Of Health And Human Services. Substance Abuse And…","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W2909901946","eid":"W2909901946"},{"id":"paper-w4401831572","cat":"papers","name":"The Mechanisms of Persisting Disability in Schizophrenia: Imprecise Predictive Coding via Corticostriatothalamic-Cortical Loop Dysfunction","year":"2024","cit":9,"pfa":"Peter Francis Liddle","psa":"Musa Basseer Sami","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4401831572","eid":"W4401831572"},{"id":"paper-w4401494010","cat":"papers","name":"Developmental changes in brain structure and function following exposure to oral LSD during adolescence","year":"2024","cit":9,"pfa":"Lila Harris-Blum","psa":"Craig F. Ferris","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4401494010","eid":"W4401494010"},{"id":"paper-w4214480528","cat":"papers","name":"Combined Antagonism of 5-HT2 and NMDA Receptors Reduces the Aggression of Monoamine Oxidase a Knockout Mice","year":"2022","cit":9,"pfa":"Roberto Frau","psa":"Marco Bortolato","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4214480528","eid":"W4214480528"},{"id":"paper-w1976101809","cat":"papers","name":"A Study of the Influence of Schizophrenic Serum on the Behavior of the Spider Zilla-x-Notata","year":"1960","cit":9,"pfa":"Nicholas A. Bercel","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W1976101809","eid":"W1976101809"},{"id":"paper-w2465348227","cat":"papers","name":"[Physiological function of sigma receptors: central pharmacological effects of sigma ligands].","year":"1994","cit":9,"pfa":"Toshitaka Nabeshima","psa":"S. Okuyama","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W2465348227","eid":"W2465348227"},{"id":"paper-w4391875797","cat":"papers","name":"Neurophysiological treatment effects of mesdopetam, pimavanserin and clozapine in a rodent model of Parkinson's disease psychosis","year":"2024","cit":9,"pfa":"Tiberiu Loredan Stan","psa":"Per Petersson","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4391875797","eid":"W4391875797"},{"id":"paper-w4384296039","cat":"papers","name":"The synergistic mechanism of action of Dajianzhong decoction in conjunction with ketamine in the treatment of depression","year":"2023","cit":9,"pfa":"Chan Li","psa":"Yuan‐Wei Zhang","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4384296039","eid":"W4384296039"},{"id":"paper-w3111582686","cat":"papers","name":"Ketamine Modulates the Neural Correlates of Reward Processing in Unmedicated Patients in Remission from Depression","year":"2020","cit":9,"pfa":"Vasileia Kotoula","psa":"Mitul Ashok Mehta","topics":["Depression","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W3111582686","eid":"W3111582686"},{"id":"paper-w2065699800","cat":"papers","name":"Subtle effects of ketamine on memory when administered following stimulus presentation","year":"2005","cit":9,"pfa":"David J. LaPorte","psa":"Adrienne Carol Lahti","ptype":"article","src":"https://openalex.org/W2065699800","eid":"W2065699800"},{"id":"paper-w3137308367","cat":"papers","name":"Cannabinoid receptor agonists from Conus venoms alleviate pain-related behavior in rats","year":"2021","cit":9,"pfa":"Stanislava Jergová","psa":"Jacqueline Sagen","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3137308367","eid":"W3137308367"},{"id":"paper-w2162310166","cat":"papers","name":"Propofol acts at the sigma‐1 receptor and inhibits pentazocine‐induced c‐Fos expression in the mouse posterior cingulate and retrosplenial cortices","year":"2006","cit":9,"pfa":"Makiko Yamada","psa":"Koh Shingu","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2162310166","eid":"W2162310166"},{"id":"paper-w3158802832","cat":"papers","name":"Dose-Related Effects of Ketamine for Antidepressant-Resistant Symptoms of Posttraumatic Stress Disorder in Veterans and Active Duty Military: A Double-blind, Randomized, Placebo-Controlled Multi-Center Clinical Trial","year":"2021","cit":9,"pfa":"Chadi G. Abdallah","psa":"John Harrison Krystal","topics":["Depression","PTSD & trauma","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W3158802832","eid":"W3158802832"},{"id":"paper-w4404836998","cat":"papers","name":"Real-World Safety of Esketamine Nasal Spray: A Comprehensive Analysis of Esketamine and Respiratory Depression","year":"2024","cit":9,"pfa":"Craig Chepke","psa":"Nancy Parker","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4404836998","eid":"W4404836998"},{"id":"paper-w4404657290","cat":"papers","name":"Effect of esketamine on reducing postpartum pain and depression","year":"2024","cit":9,"pfa":"Brandon P. Lucke-Wold","psa":"Armin Karamian","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"editorial","src":"https://openalex.org/W4404657290","eid":"W4404657290"},{"id":"paper-w2955986775","cat":"papers","name":"Promises and concerns regarding the use of ketamine and esketamine in the treatment of depression","year":"2019","cit":9,"pfa":"Rodrigo Pérez‐Esparza","psa":"Alan Fonseca-Perezamador","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2955986775","eid":"W2955986775"},{"id":"paper-w3112154900","cat":"papers","name":"Molecular evolution of a cytochrome P450 for the synthesis of potential antidepressant (2 R ,6 R )-hydroxynorketamine","year":"2020","cit":9,"pfa":"Ansgar Bokel","psa":"Vlada B. Urlacher","topics":["Depression","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3112154900","eid":"W3112154900"},{"id":"paper-w2987147694","cat":"papers","name":"Esketamine and the Need for a New Type of Registry for Drugs With Abuse Potential","year":"2019","cit":9,"pfa":"Rupert H. McShane","psa":"Allan Hunter Young","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2987147694","eid":"W2987147694"},{"id":"paper-w4413184950","cat":"papers","name":"Ketamine and Esketamine for Late-Life Depression: A Systematic Review of Efficacy, Safety, and Tolerability","year":"2025","cit":9,"pfa":"Ronesh Sukhdeo","psa":"Roger S. McIntyre","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4413184950","eid":"W4413184950"},{"id":"paper-w7125435990","cat":"papers","name":"Personalizing esketamine treatment in TRD and TRBD: the role of mentalization, cognitive rigidity, psychache, and suicidality","year":"2026","cit":9,"pfa":"Miriam Olivola","psa":"Bernardo Maria Dell’Osso","topics":["Depression","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7125435990","eid":"W7125435990"},{"id":"paper-w4406248206","cat":"papers","name":"Esketamine Nasal Spray in Major Depressive Disorder: A Meta‐Analysis of Randomized Controlled Trials","year":"2025","cit":9,"pfa":"Zhibin Wang","psa":"Weiwei Yu","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4406248206","eid":"W4406248206"},{"id":"paper-w3012444739","cat":"papers","name":"Sexually Dimorphic Behavioral Profile in a Transgenic Model Enabling Targeted Recombination in Active Neurons in Response to Ketamine and (2R,6R)-Hydroxynorketamine Administration","year":"2020","cit":9,"pfa":"David P. Herzog","psa":"Giulia Treccani","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3012444739","eid":"W3012444739"},{"id":"paper-w4406630439","cat":"papers","name":"Effect of Esketamine on Cognitive Recovery After Propofol Sedation for Outpatient Colonoscopy: A Randomized Clinical Trial","year":"2025","cit":9,"pfa":"Deshan Liu","psa":"Yusheng Yao","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4406630439","eid":"W4406630439"},{"id":"paper-w4393409238","cat":"papers","name":"Effect of intraoperative and/or postoperative esketamine administration on preventing postpartum depression: A systematic review and meta-analysis","year":"2024","cit":9,"pfa":"Jinping Wang","psa":"Xinchuan Wei","topics":["Depression","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4393409238","eid":"W4393409238"},{"id":"paper-w4405558569","cat":"papers","name":"Esketamine Provides Neuroprotection After Intracerebral Hemorrhage in Mice via the NTF3 / PI3K / AKT Pathway","year":"2024","cit":9,"pfa":"Xiaoyu Niu","psa":"Changsheng Li","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4405558569","eid":"W4405558569"},{"id":"paper-w4400381262","cat":"papers","name":"The effect and mechanism of low-dose esketamine in neuropathic pain-related depression-like behavior in rats","year":"2024","cit":9,"pfa":"L. P. Wang","psa":"Chen Su","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4400381262","eid":"W4400381262"},{"id":"paper-w3012584959","cat":"papers","name":"Real-world approach to managing dysgeusia following the use of esketamine nasal spray: a case report","year":"2020","cit":9,"pfa":"Nicholas A. Bossaller","psa":"Richard Charles Shelton","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3012584959","eid":"W3012584959"},{"id":"paper-w4399887916","cat":"papers","name":"Nitric Oxide Donor Sodium Nitroprusside Reduces Racemic Ketamine─But Not Esketamine-Induced Pain Relief","year":"2024","cit":9,"pfa":"Albert Dahan","psa":"Marieke Niesters","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4399887916","eid":"W4399887916"},{"id":"paper-w4407229185","cat":"papers","name":"Efficacy and safety of ketamine and esketamine in reducing the incidence of postpartum depression: an updated systematic review and meta-analysis","year":"2025","cit":9,"pfa":"Moaz Yasser Darwish","psa":"Mohamed Abd‐ElGawad","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W4407229185","eid":"W4407229185"},{"id":"paper-w4388702475","cat":"papers","name":"Potential ‘anti-cancer’ effects of esketamine on proliferation, apoptosis, migration and invasion in esophageal squamous carcinoma cells","year":"2023","cit":9,"pfa":"Chao Li","psa":"Huiqun Jia","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4388702475","eid":"W4388702475"},{"id":"paper-w4408991269","cat":"papers","name":"Esketamine mitigates systemic inflammation via modulating phenotypic transformation of monocytes in patients undergoing thoracic surgery","year":"2025","cit":9,"pfa":"Weiyun Shen","psa":"Lin Yang","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4408991269","eid":"W4408991269"},{"id":"paper-w4393356427","cat":"papers","name":"Effects of New Psychoactive Substance Esketamine on Behaviors and Transcription of Genes in Dopamine and GABA Pathways in Zebrafish Larvae","year":"2024","cit":9,"pfa":"Siying Li","psa":"Guang‐Guo Ying","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4393356427","eid":"W4393356427"},{"id":"paper-w4398206082","cat":"papers","name":"Effect of Continuous Infusion of Different Doses of Esketamine on the Bispectral Index During Sevoflurane Anesthesia: A Randomized Controlled Trial","year":"2024","cit":9,"pfa":"Liyuan Ren","psa":"Yanping Wang","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4398206082","eid":"W4398206082"},{"id":"paper-w4377565657","cat":"papers","name":"ED90 of epidural esketamine with 0.075% ropivacaine for labor analgesia in nulliparous parturients: a prospective, randomized and dose-finding study","year":"2023","cit":9,"pfa":"Siwen Lou","psa":"Mei Zhong","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4377565657","eid":"W4377565657"},{"id":"paper-w4389001775","cat":"papers","name":"The ED50 and ED95 of esketamine for preventing early postoperative pain in patients undergoing laparoscopic cholecystectomy: a prospective, double-blinded trial","year":"2023","cit":9,"pfa":"Zhongling Xu","psa":"Dekun Yin","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4389001775","eid":"W4389001775"},{"id":"paper-w4398249880","cat":"papers","name":"The association between ketamine and esketamine with alcohol and substance misuse: Reports to the Food and Drug Administration adverse event reporting system (FAERS)","year":"2024","cit":9,"pfa":"Angela T.H. Kwan","psa":"Roger S. McIntyre","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4398249880","eid":"W4398249880"},{"id":"paper-w4392951680","cat":"papers","name":"Effect of esketamine combined with pregabalin on acute postsurgical pain in patients who underwent resection of spinal neoplasms: a randomized controlled trial","year":"2024","cit":9,"pfa":"Yang Zhou","psa":"Ruquan Han","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4392951680","eid":"W4392951680"},{"id":"paper-w4382241404","cat":"papers","name":"Efficacy and safety comparison of esketamine-propofol with nalbuphine-propofol for upper gastrointestinal endoscopy in children: a multi-center randomized controlled trial","year":"2023","cit":9,"pfa":"Xiaosu Zheng","psa":"Ying Sun","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4382241404","eid":"W4382241404"},{"id":"paper-w4390055739","cat":"papers","name":"Comparison of esketamine versus dexmedetomidine for attenuation of cardiovascular stress response to double-lumen tracheal tube intubation: a randomized controlled trial","year":"2023","cit":9,"pfa":"Chunyu Liu","psa":"Wenqian Lin","ptype":"article","src":"https://openalex.org/W4390055739","eid":"W4390055739"},{"id":"paper-w4409343367","cat":"papers","name":"Effect of Esketamine on Postoperative Delirium and Inflammatory Response in Patients Undergoing Off-Pump Coronary Artery Bypass Grafting: A Randomized Controlled Study","year":"2025","cit":9,"pfa":"Liang-yu Ju","psa":"Ai-jie Liu","ptype":"article","src":"https://openalex.org/W4409343367","eid":"W4409343367"},{"id":"paper-w4409079666","cat":"papers","name":"Effects of the subanesthetic dose of esketamine on postoperative sleep quality in patients undergoing modified radical mastectomy: a randomized, double-blind controlled trial","year":"2025","cit":9,"pfa":"Ying Chen","psa":"Wenxuan Zhang","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4409079666","eid":"W4409079666"},{"id":"paper-w4416535417","cat":"papers","name":"Effect of esketamine on postoperative depression and anxiety in patients undergoing cardiac valve surgery: A randomised, placebo-controlled, double-blinded clinical trial","year":"2025","cit":9,"pfa":"Zhuo-Ning Zhang","psa":"Li Tong","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4416535417","eid":"W4416535417"},{"id":"paper-w4225139627","cat":"papers","name":"Trigeminal extracranial thermocoagulation along with patient-controlled analgesia with esketamine for refractory postherpetic neuralgia after herpes zoster ophthalmicus: A case report","year":"2022","cit":9,"pfa":"Jiachun Tao","psa":"Ming Yao","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4225139627","eid":"W4225139627"},{"id":"paper-w4410080833","cat":"papers","name":"The effect of esketamine on postoperative anxiety and depression in patients with thyroid cancer: A randomized, double-blind, placebo-controlled, parallel-group trial","year":"2025","cit":9,"pfa":"Xiaobo Bi","psa":"Jin Li","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4410080833","eid":"W4410080833"},{"id":"paper-w4309113876","cat":"papers","name":"Is esketamine-based opioid-free anesthesia more superior for postoperative analgesia in obstructive sleep apnea patients undergoing bariatric surgery? A study protocol","year":"2022","cit":9,"pfa":"Yongle Guo","psa":"Yuelan Wang","topics":["Addiction","Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4309113876","eid":"W4309113876"},{"id":"paper-w4388104285","cat":"papers","name":"Cognitive behavioral therapy following esketamine for major depression and suicidal ideation for relapse prevention: The CBT-ENDURE randomized clinical trial study protocol","year":"2023","cit":9,"pfa":"Brandon M. Kitay","psa":"Samuel T. Wilkinson","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4388104285","eid":"W4388104285"},{"id":"paper-w4399920607","cat":"papers","name":"Esketamine use for primary intelligent analgesia in adults with severe burns: A double-blind randomized trial with effects on analgesic efficacy, gastrointestinal function and mental state","year":"2024","cit":9,"pfa":"Qiulan He","psa":"Zhongxing Wang","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4399920607","eid":"W4399920607"},{"id":"paper-w4404934330","cat":"papers","name":"Efficacy of esketamine nasal spray over quetiapine extended release over the short and long term: sensitivity analyses of ESCAPE-TRD, a randomised phase IIIb clinical trial","year":"2024","cit":9,"pfa":"Allan Hunter Young","psa":"Andreas Reif","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4404934330","eid":"W4404934330"},{"id":"paper-w4310526283","cat":"papers","name":"The safety and efficacy of esketamine in comparison to dexmedetomidine during drug-induced sleep endoscopy in children with obstructive sleep apnea hypopnea syndrome: A randomized, controlled and prospective clinical tri","year":"2022","cit":9,"pfa":"Zheng Yongping","psa":"Song Xuemin","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4310526283","eid":"W4310526283"},{"id":"paper-w4407185122","cat":"papers","name":"Safety and efficacy of low-dose esketamine weakly opioidized anesthesia in elderly patients with lumbar spinal stenosis undergoing surgery: a prospective, double-blind randomized controlled trial","year":"2025","cit":9,"pfa":"Nina Hou","psa":"Heng Yang","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4407185122","eid":"W4407185122"},{"id":"paper-w4387033813","cat":"papers","name":"A subanesthetic dose of esketamine combined with hip peripheral nerve block has good sedative and analgesic effects in elderly patients undergoing total hip arthroplasty: A randomized-controlled trial","year":"2023","cit":9,"pfa":"Bingling Dai","psa":"Yanhua Huo","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4387033813","eid":"W4387033813"},{"id":"paper-w4411298175","cat":"papers","name":"Effects of sub-anesthetic doses of esketamine on postoperative sleep disturbance and pain in patients undergoing lumbar interbody fusion—A randomized, double-blind, placebo-controlled, two-center trial","year":"2025","cit":9,"pfa":"Zheping Chen","psa":"Yanwu Jin","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4411298175","eid":"W4411298175"},{"id":"paper-w4394999603","cat":"papers","name":"Long-term follow-up of participants in ketamine clinical trials for mood disorders","year":"2024","cit":9,"pfa":"Kelly Theim Hurst","psa":"Elizabeth D. Ballard","ptype":"article","src":"https://openalex.org/W4394999603","eid":"W4394999603"},{"id":"paper-w3185727734","cat":"papers","name":"Ketamine in depression and electroconvulsive therapy","year":"2021","cit":9,"pfa":"Irene Rozet","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3185727734","eid":"W3185727734"},{"id":"paper-w4413922891","cat":"papers","name":"Mentalization and Emotional-Cognitive Rigidity as predictors of esketamine's effects on Treatment-Resistant Depression: Findings from a prospective observational study","year":"2025","cit":9,"pfa":"Miriam Olivola","psa":"Bernardo Maria Dell’Osso","topics":["Depression","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4413922891","eid":"W4413922891"},{"id":"paper-w4391817694","cat":"papers","name":"Cortisol-dependent impairment of dendrite plasticity in human dopaminergic neurons derived from hiPSCs is restored by ketamine: Relevance for major depressive disorders.","year":"2024","cit":9,"pfa":"Laura Cavalleri","psa":"Ginetta Collo","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4391817694","eid":"W4391817694"},{"id":"paper-w3007895161","cat":"papers","name":"Proteomic Study Reveals the Involvement of Energy Metabolism in the Fast Antidepressant Effect of (2R, 6R)‐Hydroxy Norketamine","year":"2020","cit":9,"pfa":"Shafiq Ur Rahman","psa":"Shupeng Li","topics":["Depression","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3007895161","eid":"W3007895161"},{"id":"paper-w2892231541","cat":"papers","name":"Characteristics of patients expressing an interest in ketamine treatment: results of an online survey","year":"2018","cit":9,"pfa":"Jolien K. E. Veraart","psa":"Rupert H. McShane","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2892231541","eid":"W2892231541"},{"id":"paper-w4366775072","cat":"papers","name":"Pharmacological Mechanism of Ketamine in Suicidal Behavior Based on Animal Models of Aggressiveness and Impulsivity: A Narrative Review","year":"2023","cit":9,"pfa":"Thi Mai Loan Nguyen","psa":"Alain Michel Gardier","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W4366775072","eid":"W4366775072"},{"id":"paper-w7116842619","cat":"papers","name":"From Monoamines to Systems Psychiatry: Rewiring Depression Science and Care (1960s–2025)","year":"2025","cit":9,"pfa":"Masaru Tanaka","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7116842619","eid":"W7116842619"},{"id":"paper-w4403828138","cat":"papers","name":"The influence of anesthetic drug strategy on the incidence of post-induction hypotension in elective, non-cardiac surgery – A prospective observational cohort study","year":"2024","cit":9,"pfa":"Lotte E. Terwindt","psa":"Denise Petra Veelo","topics":["Safety & adverse events","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4403828138","eid":"W4403828138"},{"id":"paper-w2079481436","cat":"papers","name":"Effect of pretreatment with tryptamine, tryptophan and DOPA on LSD reaction in tropical fish","year":"1964","cit":9,"pfa":"Richard D. Chessick","psa":"George Douglas Maier","ptype":"article","src":"https://openalex.org/W2079481436","eid":"W2079481436"},{"id":"paper-w2094005006","cat":"papers","name":"Actions of repeated injections of LSD and apomorphine on the copulatory response of female rats","year":"1976","cit":9,"pfa":"Mona Eliasson","ptype":"article","src":"https://openalex.org/W2094005006","eid":"W2094005006"},{"id":"paper-w2038790694","cat":"papers","name":"Amphetamine and LSD as discriminative stimuli: Alterations following neonatal monoamine reductions","year":"1984","cit":9,"pfa":"Daniel J. Minnema","psa":"John A. Rosecrans","ptype":"article","src":"https://openalex.org/W2038790694","eid":"W2038790694"},{"id":"paper-w2067923500","cat":"papers","name":"Rat brain aryl acylamidase: Multiple forms and inhibition effects of LSD, serotonin and related compounds","year":"1977","cit":9,"pfa":"Louise L. Hsu","psa":"Daniel X. Freedman","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2067923500","eid":"W2067923500"},{"id":"paper-w2334332858","cat":"papers","name":"PSYCHODYNAMIC AND THERAPEUTIC ASPECTS OF MESCALINE AND LYSERGIC ACID DIETHYLAMIDE ROUND TABLE","year":"1957","cit":8,"pfa":"Herman C.B. Denber","psa":"Max Rinkel","ptype":"article","src":"https://openalex.org/W2334332858","eid":"W2334332858"},{"id":"paper-w2023795787","cat":"papers","name":"Lysergic acid diethylamide and mutation","year":"2009","cit":8,"pfa":"GÖSTA ZETTERBERG","ptype":"article","src":"https://openalex.org/W2023795787","eid":"W2023795787"},{"id":"paper-w2031203953","cat":"papers","name":"Lysergic Acid Diethylamide (LSD-25)","year":"1958","cit":8,"pfa":"B. WEISS","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2031203953","eid":"W2031203953"},{"id":"paper-w2173025637","cat":"papers","name":"Lysergic Acid Diethylamide (LSD-25)","year":"1960","cit":8,"pfa":"Harold A. Abramson","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2173025637","eid":"W2173025637"},{"id":"paper-w1527711385","cat":"papers","name":"Studies on lysergic acid diethylamide and related compounds. VII. Microbial transformation of lysergic acid diethylamide and related compounds.","year":"1979","cit":8,"pfa":"Hisashi Ishii","psa":"Yuji Nakahara","ptype":"article","src":"https://openalex.org/W1527711385","eid":"W1527711385"},{"id":"paper-w4408225472","cat":"papers","name":"Side effects of microdosing lysergic acid diethylamide and psilocybin: A systematic review of potential physiological and psychiatric outcomes","year":"2025","cit":8,"pfa":"Stefan Modzelewski","psa":"Kacper Łukasiewicz","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W4408225472","eid":"W4408225472"},{"id":"paper-w1963731584","cat":"papers","name":"Some Clinical and Social Aspects of Lysergic Acid Diethylamide","year":"1972","cit":8,"pfa":"David B. Sarwer","ptype":"article","src":"https://openalex.org/W1963731584","eid":"W1963731584"},{"id":"paper-w2001904262","cat":"papers","name":"Mechanism of Lysergic Acid Diethylamide Interference with Rabbit Antibody Biosynthesis","year":"1974","cit":8,"pfa":"Edward W. Voss","psa":"Jeffrey L. Winkelhake","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2001904262","eid":"W2001904262"},{"id":"paper-w2289713069","cat":"papers","name":"INTERACTION OF SEROTONIN AND LYSERGIC ACID DIETHYLAMIDE IN THE SIAMESE FIGHTING FISH","year":"1957","cit":8,"pfa":"David L. Trout","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2289713069","eid":"W2289713069"},{"id":"paper-w2085071874","cat":"papers","name":"Urinary catecholamine excretion following lysergic acid diethylamide in man","year":"1967","cit":8,"pfa":"Leo E. Hollister","psa":"Frances F. Moore","ptype":"article","src":"https://openalex.org/W2085071874","eid":"W2085071874"},{"id":"paper-w1985760442","cat":"papers","name":"Medullary Vagal Effects of d-Lysergic Acid Diethylamide in the Decerebrate Cat","year":"1963","cit":8,"pfa":"Peter Cervoni","psa":"Leslie E. Geiger","ptype":"article","src":"https://openalex.org/W1985760442","eid":"W1985760442"},{"id":"paper-w1993827753","cat":"papers","name":"Modification of Aggressive Behavior of Green Sunfish with D-Lysergic Acid Diethylamide","year":"1964","cit":8,"pfa":"Arthur L. McDonald","psa":"Norman W. Heimstra","ptype":"article","src":"https://openalex.org/W1993827753","eid":"W1993827753"},{"id":"paper-w1916360600","cat":"papers","name":"A Technique for the Rapid Isolation and Identification of Psilocin from Psilocin/Psilocybin-Containing Mushrooms","year":"1985","cit":8,"pfa":"RE Lee","ptype":"article","src":"https://openalex.org/W1916360600","eid":"W1916360600"},{"id":"paper-w2094885738","cat":"papers","name":"The effect of lysergic acid diethylamide (delysid, LSD-25) on thiopentl recovery","year":"1960","cit":8,"pfa":"Allen B. Dobkin","psa":"James S. Barr","ptype":"article","src":"https://openalex.org/W2094885738","eid":"W2094885738"},{"id":"paper-w2335149718","cat":"papers","name":"Potentiating Actions of Indolealkylamines and Lysergic Acid Diethylamide On Reflexes Elicited by 5-Hydroxytryptamine","year":"1963","cit":8,"pfa":"Laszlo Gyermek","psa":"Takahiko Sumi","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2335149718","eid":"W2335149718"},{"id":"paper-w2308863365","cat":"papers","name":"Reversal learning facilitated by a single injection of lysergic acid diethylamide (LSD 25) in the rat.","year":"1972","cit":8,"pfa":"A R King","psa":"K A Seymour","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2308863365","eid":"W2308863365"},{"id":"paper-w2077201254","cat":"papers","name":"The Synthesis of Substituted Arylalkylaminopropionamide Analogues of Lysergic Acid Diethylamide and their Effect upon Isolated Cholinesterase Systems","year":"1960","cit":8,"pfa":"Andrew Lasslo","psa":"B. V. Rama Sastry","ptype":"article","src":"https://openalex.org/W2077201254","eid":"W2077201254"},{"id":"paper-w2058317752","cat":"papers","name":"Effects of Lysergic Acid Diethylamide on Urinary 17-Ketosteroid and 17-OH Corticosteroid Levels of Female Rats","year":"1963","cit":8,"pfa":"Arthur M. Sackler","psa":"H. OWENS","ptype":"article","src":"https://openalex.org/W2058317752","eid":"W2058317752"},{"id":"paper-w4403184817","cat":"papers","name":"Complex slow waves radically reorganise human brain dynamics under 5-MeO-DMT","year":"2024","cit":8,"pfa":"George Blackburne","psa":"Jeremy I Skipper","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4403184817","eid":"W4403184817"},{"id":"paper-w82192141","cat":"papers","name":"Physical Studies on the Interaction of Lysergic Acid Diethylamide and Trypanocidal Dyes with DNA and DNA-Containing Genetic Material","year":"1971","cit":8,"pfa":"Thomas E. Wagner","ptype":"book-chapter","src":"https://openalex.org/W82192141","eid":"W82192141"},{"id":"paper-w1946000721","cat":"papers","name":"Behaviorally inactive doses of mianserin antagonize the suppressant effect of lysergic acid diethylamide on a fixed-ratio operant.","year":"1983","cit":8,"pfa":"Linda P. Dwoskin","psa":"Sheldon B. Sparber","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1946000721","eid":"W1946000721"},{"id":"paper-w2128960464","cat":"papers","name":"Collision-induced dissociations of trimethylsilylated lysergic acid diethylamide (LSD) in ion trap multiple stage mass spectrometry","year":"2002","cit":8,"pfa":"Danielle Libong","psa":"Stéphane Bouchonnet","ptype":"article","src":"https://openalex.org/W2128960464","eid":"W2128960464"},{"id":"paper-w2069093846","cat":"papers","name":"THE EFFECTS OF REPEATED‐LYSERGIC ACID DIETHYLAMIDE INJECTIONS ON CATECHOLAMINE LEVELS AND TYROSINE HYDROXYLASE ACTIVITY IN RAT BRAIN REGIONS","year":"1977","cit":8,"pfa":"D. A. V. Peters","psa":"S. Tang","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2069093846","eid":"W2069093846"},{"id":"paper-w2067860604","cat":"papers","name":"Effects of lysergic acid diethylamide (LSD) on temporal recovery (pre-pulse inhibition) of the acoustic startle response in the rat","year":"1975","cit":8,"pfa":"Michael E Davis","psa":"Michael H. Sheard","ptype":"article","src":"https://openalex.org/W2067860604","eid":"W2067860604"},{"id":"paper-w2080271507","cat":"papers","name":"Lysergic Acid Diethylamide (LSD-25): XXV. Effect on Social Order of Newts, Triturus V. Viridescens (RAF.)","year":"1958","cit":8,"pfa":"Llewellyn Thomas Evans","psa":"Harold A. Abramson","ptype":"article","src":"https://openalex.org/W2080271507","eid":"W2080271507"},{"id":"paper-w2082102949","cat":"papers","name":"Comparative effects of the administration of taraxein, d-LSD, mescaline, and psilocybin to human volunteers","year":"1960","cit":8,"pfa":"F. Silva","psa":"W. Robinson","ptype":"article","src":"https://openalex.org/W2082102949","eid":"W2082102949"},{"id":"paper-w2012343662","cat":"papers","name":"Lysergic Acid Diethylamide (LSD) in the Treatment of Alcoholism: An Investigation of Its Effects on Drinking Behavior, Personality Structure, and Social Functioning","year":"1968","cit":8,"pfa":"Charles Savage","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2012343662","eid":"W2012343662"},{"id":"paper-w1979905339","cat":"papers","name":"[3H]lysergic acid diethylamide (LSD): differential agonist and antagonist binding properties at 5-HT receptor subtypes in rat brain","year":"1989","cit":8,"pfa":"Andrew B. Norman","psa":"Paul R. Sanberg","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1979905339","eid":"W1979905339"},{"id":"paper-w2063467212","cat":"papers","name":"Lysergic Acid Diethylamide (Lsd-25): Xxiii. Comparative Effects of Lsd-25 and Related Ergot Drugs on Brain Tissue Respiration and on Human Behavior","year":"1956","cit":8,"pfa":"Lippman H. Geronimus","psa":"Laura Ingraham","ptype":"article","src":"https://openalex.org/W2063467212","eid":"W2063467212"},{"id":"paper-w1975562407","cat":"papers","name":"Notes - Mescaline Anaologs. VI. Mescaline Homologs","year":"1956","cit":8,"pfa":"Frederick Benington","psa":"L. C. Clark, Jr.","ptype":"article","src":"https://openalex.org/W1975562407","eid":"W1975562407"},{"id":"paper-w2329462089","cat":"papers","name":"PEYOTE INTOXICATION","year":"1943","cit":8,"pfa":"Walter Bromberg","psa":"Charles L. Tranter","ptype":"article","src":"https://openalex.org/W2329462089","eid":"W2329462089"},{"id":"paper-w1583238204","cat":"papers","name":"Miserable miracle : mescaline.","year":"1967","cit":8,"pfa":"Henri Michaux","ptype":"book","src":"https://openalex.org/W1583238204","eid":"W1583238204"},{"id":"paper-w26444017","cat":"papers","name":"Peyote use during pregnancy.","year":"2001","cit":8,"pfa":"Gilmore Ht","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W26444017","eid":"W26444017"},{"id":"paper-w1996303612","cat":"papers","name":"Dimethyltryptamine, A Do-It-Yourself Hallucinogenic Drug","year":"1967","cit":8,"pfa":"D. R. Rubin","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1996303612","eid":"W1996303612"},{"id":"paper-w119449611","cat":"papers","name":"The biosynthesis of dimethyltryptamine in vivo.","year":"1977","cit":8,"pfa":"Mandel Lr","psa":"Walker Rw","ptype":"article","src":"https://openalex.org/W119449611","eid":"W119449611"},{"id":"paper-w2010566216","cat":"papers","name":"Washo Peyote Songs","year":"1957","cit":8,"pfa":"Alan P. Merriam","psa":"Warren L. D'Azevedo","ptype":"article","src":"https://openalex.org/W2010566216","eid":"W2010566216"},{"id":"paper-w2003999004","cat":"papers","name":"Ibogaine-Associated Psychosis in Schizophrenia","year":"2011","cit":8,"pfa":"Josselin Houenou","psa":"Noëmie Drancourt","ptype":"article","src":"https://openalex.org/W2003999004","eid":"W2003999004"},{"id":"paper-w2271182977","cat":"papers","name":"A STUDY ON MESCALINE IN HUMAN SUBJECTS","year":"1949","cit":8,"pfa":"Kurt Salomon","psa":"THOMAS THALE","ptype":"article","src":"https://openalex.org/W2271182977","eid":"W2271182977"},{"id":"paper-w2100879022","cat":"papers","name":"The Identification of Ibogaine in Biological Material","year":"1972","cit":8,"pfa":"H.I. Dhahir","psa":"John I. Thornton","ptype":"article","src":"https://openalex.org/W2100879022","eid":"W2100879022"},{"id":"paper-w2063185054","cat":"papers","name":"Hyperbolic: Divining Ayahuasca","year":"2005","cit":8,"pfa":"Richard Doyle","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2063185054","eid":"W2063185054"},{"id":"paper-w3004628237","cat":"papers","name":"Psilocybin, Magic Mushroom Grower's Guide: A Handbook for Psilocybin Enthusiasts","year":"1976","cit":8,"pfa":"O. N. Oeric","ptype":"book","src":"https://openalex.org/W3004628237","eid":"W3004628237"},{"id":"paper-w2414868417","cat":"papers","name":"Analysis of the cardiovascular action of ibogaine hydrochloride.","year":"1957","cit":8,"pfa":"J A SCHNEIDER","psa":"Roy K. Rinehart","ptype":"article","src":"https://openalex.org/W2414868417","eid":"W2414868417"},{"id":"paper-w2013195289","cat":"papers","name":"Stimulation of human prolactin secretion by mescaline","year":"1979","cit":8,"pfa":"L. Demisch","psa":"Manfred Neubauer","ptype":"article","src":"https://openalex.org/W2013195289","eid":"W2013195289"},{"id":"paper-w4386687776","cat":"papers","name":"Evidence for the Therapeutic Effects of Ayahuasca","year":"2019","cit":8,"pfa":"Dráulio Barros de Araújo","ptype":"other","src":"https://openalex.org/W4386687776","eid":"W4386687776"},{"id":"paper-w2406782759","cat":"papers","name":"Mescaline analogs: substitutions at the 4-position.","year":"1978","cit":8,"pfa":"U Braun","psa":"A T Shulgin","ptype":"article","src":"https://openalex.org/W2406782759","eid":"W2406782759"},{"id":"paper-w2189233847","cat":"papers","name":"Ayahuasca, entheogenic education & public policy","year":"2011","cit":8,"pfa":"Kenneth W. Tupper","topics":["Addiction","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W2189233847","eid":"W2189233847"},{"id":"paper-w2021013080","cat":"papers","name":"THE ANTIDOTAL ACTION OF SODIUM SUCCINATE IN THE MESCALINE PSYCHOSIS","year":"1957","cit":8,"pfa":"Ian H. Stevenson","psa":"ANDREW J. SANCHEZ","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2021013080","eid":"W2021013080"},{"id":"paper-w4385607029","cat":"papers","name":"The Nonclassic Psychedelic Ibogaine Disrupts Cognitive Maps","year":"2023","cit":8,"pfa":"Victorita E. Ivan","psa":"Aaron J. Gruber","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4385607029","eid":"W4385607029"},{"id":"paper-w73507388","cat":"papers","name":"Mescaline-induced changes of brain-cortex ribosomes. Effect of mescaline on the hydrogen-bonded structure of ribonucleic acid of brain-cortex ribosomes","year":"1970","cit":8,"pfa":"R. K. Datta","psa":"J. J. Ghosh","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W73507388","eid":"W73507388"},{"id":"paper-w2334926559","cat":"papers","name":"Cytotoxic Effects of Salvinorin A, A Major Constituent of Salvia divinorum","year":"2016","cit":8,"pfa":"Ana Martinho","psa":"Eugénia Gallardo","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2334926559","eid":"W2334926559"},{"id":"paper-w2494691398","cat":"papers","name":"Notes on the Expansion and Reinvention of Ayahuasca Shamanism","year":"2014","cit":8,"pfa":"Beatriz Caiuby Labate","psa":"Françoise Barbira Freedman","topics":["Reviews & meta-analyses"],"ptype":"book-chapter","src":"https://openalex.org/W2494691398","eid":"W2494691398"},{"id":"paper-w4252285082","cat":"papers","name":"EIGHT Policing Peyote Country in the Early Twentieth Century","year":"2020","cit":8,"pfa":"Lisa D. Barnett","ptype":"book-chapter","src":"https://openalex.org/W4252285082","eid":"W4252285082"},{"id":"paper-w4380422419","cat":"papers","name":"Formal Synthesis of (±)‐Salvinorin A via Gold(I) Catalysis","year":"2023","cit":8,"pfa":"Huy Hoàng Trần","psa":"Louis Barriault","ptype":"article","src":"https://openalex.org/W4380422419","eid":"W4380422419"},{"id":"paper-w2418370245","cat":"papers","name":"Mescaline-induced changes of brain-cortex ribosomes. Role of spermidine in counteracting the destabilizing effect of mescaline on brain-cortex ribosomes","year":"1971","cit":8,"pfa":"R. K. Datta","psa":"J. J. Ghosh","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2418370245","eid":"W2418370245"},{"id":"paper-w4403209589","cat":"papers","name":"Neuroprotective effects of psilocybin in a rat model of stroke","year":"2024","cit":8,"pfa":"Seong‐Jin Yu","psa":"Yun Wang","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4403209589","eid":"W4403209589"},{"id":"paper-w2309036947","cat":"papers","name":"THE EFFECT OF MESCALINE ON THE OPTIC EVOKED POTENTIALS IN THE UNANESTHETIZED RABBIT","year":"1960","cit":8,"pfa":"Werner P. Koella","psa":"John Smythies","ptype":"article","src":"https://openalex.org/W2309036947","eid":"W2309036947"},{"id":"paper-w1994356560","cat":"papers","name":"Ibogamin, ein neues Alkaloid aus Tabernanthe Iboga Baillon","year":"1952","cit":8,"pfa":"C. A. Burckhardt","psa":"Emil Schlittler","ptype":"article","src":"https://openalex.org/W1994356560","eid":"W1994356560"},{"id":"paper-w2013078039","cat":"papers","name":"Controls Over the Manufacture of MDMA","year":"1986","cit":8,"pfa":"Holsten Dw","psa":"David W. Schieser","ptype":"article","src":"https://openalex.org/W2013078039","eid":"W2013078039"},{"id":"paper-w2995742834","cat":"papers","name":"The influence of context on ayahuasca experiences: An analysis of experience reports","year":"2019","cit":8,"pfa":"Avery Sapoznikow","psa":"Fire Erowid","topics":["Addiction","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2995742834","eid":"W2995742834"},{"id":"paper-w2594824076","cat":"papers","name":"Peyote as Commodity: An Examination of Market Actors and Access Mechanisms","year":"2017","cit":8,"pfa":"Kevin Feeney","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2594824076","eid":"W2594824076"},{"id":"paper-w7160534089","cat":"papers","name":"Psilocybin in the Treatment of Cocaine Use Disorder","year":"2026","cit":8,"pfa":"Peter S. Hendricks","psa":"Cynthia E. Ortiz","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7160534089","eid":"W7160534089"},{"id":"paper-w2137524840","cat":"papers","name":"Synthesis of Baeocystin, a natural Psilocybin Analogue","year":"1988","cit":8,"pfa":"Rudolf Brenneisen","psa":"U. P. Schlunegger","ptype":"article","src":"https://openalex.org/W2137524840","eid":"W2137524840"},{"id":"paper-w2965306308","cat":"papers","name":"Translational evidence for ayahuasca as an antidepressant: what’s next?","year":"2019","cit":8,"pfa":"RAFAEL GUIMARÃES DOS SANTOS","psa":"José Carlos Bouso","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2965306308","eid":"W2965306308"},{"id":"paper-w2945209116","cat":"papers","name":"Denver votes to decriminalise psilocybin mushrooms","year":"2019","cit":8,"pfa":"Paul Christopher Webster","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2945209116","eid":"W2945209116"},{"id":"paper-w2007981886","cat":"papers","name":"Prevalence of MDMA (ecstasy) use and neurotoxicity","year":"2001","cit":8,"pfa":"Ingmar H. A. Franken","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2007981886","eid":"W2007981886"},{"id":"paper-w1707859645","cat":"papers","name":"Behavioural changes induced by N,N-dimethyltryptamine in rodents [proceedings].","year":"1978","cit":8,"pfa":"Peter Jenner","psa":"C. M. Thanki","ptype":"article","src":"https://openalex.org/W1707859645","eid":"W1707859645"},{"id":"paper-w2117395178","cat":"papers","name":"Evidence for state-dependent learning with mescaline in a passive avoidance task","year":"1971","cit":8,"pfa":"Ronald K. Siegel","psa":"Murray E. Jarvik","ptype":"article","src":"https://openalex.org/W2117395178","eid":"W2117395178"},{"id":"paper-w4386326110","cat":"papers","name":"Discovery and In Vitro Characterization of SPL028: Deuterated N , N -Dimethyltryptamine","year":"2023","cit":8,"pfa":"Marie Layzell","psa":"Carol A. Routledge","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4386326110","eid":"W4386326110"},{"id":"paper-w4408104451","cat":"papers","name":"Ayahuasca reverses ischemic stroke-induced neuroinflammation and oxidative stress","year":"2025","cit":8,"pfa":"Larissa da Silva Joaquim","psa":"Rafael Mariano de Bitencourt","ptype":"article","src":"https://openalex.org/W4408104451","eid":"W4408104451"},{"id":"paper-w169045476","cat":"papers","name":"Spectral analysis of mouse EEG after the administration of N,N-dimethyltryptamine.","year":"1977","cit":8,"pfa":"Barbara J. Morley","psa":"Ronald J. Bradley","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W169045476","eid":"W169045476"},{"id":"paper-w1974894107","cat":"papers","name":"Naloxone potentiates the disruptive effects of mescaline on operant responding in the rat","year":"1980","cit":8,"pfa":"Randall L. Commissaris","psa":"Richard H. Rech","ptype":"article","src":"https://openalex.org/W1974894107","eid":"W1974894107"},{"id":"paper-w4382345166","cat":"papers","name":"Psilocybin: The most effective moral bio‐enhancer?","year":"2023","cit":8,"pfa":"Vojin Rakić","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4382345166","eid":"W4382345166"},{"id":"paper-w2996555671","cat":"papers","name":"Mapping Psilocybin-Assisted Therapies: A Scoping Review","year":"2019","cit":8,"pfa":"Ron Joseph Shore","psa":"Éric C. Dumont","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"preprint","src":"https://openalex.org/W2996555671","eid":"W2996555671"},{"id":"paper-w1989324342","cat":"papers","name":"Identification of New Peyote Alkaloids. Isomers of the Main Phenolic Tetrahydroisoquinolines.","year":"1972","cit":8,"pfa":"Jan Lundström","psa":"Sigfrid Svensson","ptype":"article","src":"https://openalex.org/W1989324342","eid":"W1989324342"},{"id":"paper-w4292685646","cat":"papers","name":"Vobasine, vincamine, voaphylline, tacaman, and iboga alkaloids from Tabernaemontana corymbosa","year":"2022","cit":8,"pfa":"Dawn Su-Yin Sim","psa":"Toh‐Seok Kam","ptype":"article","src":"https://openalex.org/W4292685646","eid":"W4292685646"},{"id":"paper-w1922964413","cat":"papers","name":"Ayahuasca: entre o legal e o cultural","year":"2009","cit":8,"pfa":"Rodrigo Grazinoli Garrido","psa":"Bruno Duarte Sabino","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1922964413","eid":"W1922964413"},{"id":"paper-w1506334134","cat":"papers","name":"Chapter 10 Ibogaine neurotoxicity assessment: Electrophysiological, neurochemical, and neurohistological methods","year":"2001","cit":8,"pfa":"ZBIGNIEW K. BINIENDA","psa":"Syed F. Ali","topics":["Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W1506334134","eid":"W1506334134"},{"id":"paper-w745881052","cat":"papers","name":"A Constitutional Examination of the Federal Exemptions for Native American Religious Peyote Use","year":"2001","cit":8,"pfa":"Christopher S. Parker","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W745881052","eid":"W745881052"},{"id":"paper-w4315647963","cat":"papers","name":"Solving an Old Puzzle: Elucidation and Evaluation of the Binding Mode of Salvinorin A at the Kappa Opioid Receptor","year":"2023","cit":8,"pfa":"Kristina Puls","psa":"Gerhard Wolber","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4315647963","eid":"W4315647963"},{"id":"paper-w2072439527","cat":"papers","name":"Enzyme‐assisted synthesis of the glucuronide conjugate of psilocin, an hallucinogenic component of magic mushrooms","year":"2011","cit":8,"pfa":"Takuji Shoda","psa":"Haruhiro Okuda","ptype":"article","src":"https://openalex.org/W2072439527","eid":"W2072439527"},{"id":"paper-w4399202347","cat":"papers","name":"Effects of a Single Dose of Ayahuasca in College Students With Harmful Alcohol Use","year":"2024","cit":8,"pfa":"Lucas Silva Rodrigues","psa":"RAFAEL GUIMARÃES DOS SANTOS","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4399202347","eid":"W4399202347"},{"id":"paper-w2565294062","cat":"papers","name":"Ayahuasca Groups and Networks in the Netherlands: A Challenge to the Study of Contemporary Religion","year":"2026","cit":8,"pfa":"Wouter J. Hanegraaff","ptype":"conference-paper","src":"https://openalex.org/W2565294062","eid":"W2565294062"},{"id":"paper-w2146848408","cat":"papers","name":"Mescaline synthesis via tricarbonyl (η6-1,2,3-trimethoxybenzene)chromium complex","year":"2000","cit":8,"pfa":"Françoise Rose‐Munch","psa":"Éric Rose","ptype":"article","src":"https://openalex.org/W2146848408","eid":"W2146848408"},{"id":"paper-w4387432017","cat":"papers","name":"Peyote as Earth Medicine: Examining How Symbolic Meanings Shape Experiences With Psychedelics","year":"2023","cit":8,"pfa":"Heith Copes","psa":"Jared Ragland","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4387432017","eid":"W4387432017"},{"id":"paper-w2283955668","cat":"papers","name":"Methamphetamine and MDMA Neurotoxicity: Biochemical and Molecular Mechanisms","year":"2021","cit":8,"pfa":"Verónica Bisagno","psa":"Jean Lud Cadet","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W2283955668","eid":"W2283955668"},{"id":"paper-w4303509980","cat":"papers","name":"Self-administration of Psilocybin in the Setting of Treatment-resistant Depression.","year":"2022","cit":8,"pfa":"Ashley Lyons","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4303509980","eid":"W4303509980"},{"id":"paper-w2052470410","cat":"papers","name":"Induction and Extinction of Psilocybin Induced Transformations of Visual Space","year":"1973","cit":8,"pfa":"Richard Hill","psa":"Roland Fischer","ptype":"article","src":"https://openalex.org/W2052470410","eid":"W2052470410"},{"id":"paper-w4398182074","cat":"papers","name":"A Case Report of Psilocybin-induced Psychosis in a Predisposed Patient","year":"2024","cit":8,"pfa":"S Morris","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4398182074","eid":"W4398182074"},{"id":"paper-w4400037700","cat":"papers","name":"Psilocybin and 2C-B at Encoding Distort Episodic Familiarity","year":"2024","cit":8,"pfa":"Manoj K. Doss","psa":"Johannes Gerardus Ramaekers","ptype":"article","src":"https://openalex.org/W4400037700","eid":"W4400037700"},{"id":"paper-w4297965538","cat":"papers","name":"“Getting to the Root”: Ayahuasca Ceremony Leaders’ Perspectives on Eating Disorders","year":"2022","cit":8,"pfa":"Meris Williams","psa":"Adèle Lafrance","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4297965538","eid":"W4297965538"},{"id":"paper-w4290754923","cat":"papers","name":"Ayahuasca Calling: Sacredness and the Emergence of Shamanic Vocations in Denmark and Peru","year":"2022","cit":8,"pfa":"Margit Anne Petersen","psa":"Victor Sacha Cova","topics":["Safety & adverse events","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4290754923","eid":"W4290754923"},{"id":"paper-w3149891199","cat":"papers","name":"Effects of MDMA (ecstasy) use and abstention on serotonin neurons","year":"2002","cit":8,"pfa":"Peter Michael Haddad","psa":"SM Dursun","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3149891199","eid":"W3149891199"},{"id":"paper-w1982876345","cat":"papers","name":"Crime and Violence among MDMA Users in the United States","year":"2015","cit":8,"pfa":"Michael G. Vaughn","psa":"David Córdova","topics":["Addiction","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1982876345","eid":"W1982876345"},{"id":"paper-w1482236048","cat":"papers","name":"Acute Inflammatory CNS Disease after MDMA (‘Ecstasy’)","year":"2008","cit":8,"pfa":"Andreas Bitsch","psa":"Hilmar Walter Prange","ptype":"article","src":"https://openalex.org/W1482236048","eid":"W1482236048"},{"id":"paper-w2081906239","cat":"papers","name":"Effects of mescaline and amphetamine on simultaneous visual discrimination in two inbred strains of mice","year":"1979","cit":8,"pfa":"Claudio Castellano","ptype":"article","src":"https://openalex.org/W2081906239","eid":"W2081906239"},{"id":"paper-w2316795466","cat":"papers","name":"Effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin transporter and vesicular monoamine transporter 2 protein and gene expression in rats: Implications for MDMA neurotoxicity","year":"2010","cit":8,"pfa":"Dominik K. Biezonski","psa":"Jerrold S. Meyer","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2316795466","eid":"W2316795466"},{"id":"paper-w2520270604","cat":"papers","name":"A Cross-Reactivity of Fenofibric Acid With MDMA DRI Assay","year":"2016","cit":8,"pfa":"Sarah Bugier","psa":"Christophe Renard","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2520270604","eid":"W2520270604"},{"id":"paper-w2520648207","cat":"papers","name":"Introduction to the Special Issue: Ayahuasca, Plant‐Based Spirituality, and the Future of Amazonia","year":"2016","cit":8,"pfa":"Christina Callicott","ptype":"editorial","src":"https://openalex.org/W2520648207","eid":"W2520648207"},{"id":"paper-w2154307313","cat":"papers","name":"Increased interleukin-1β levels following low dose MDMA induces tolerance against the 5-HT neurotoxicity produced by challenge MDMA","year":"2011","cit":8,"pfa":"Andrea Mayado","psa":"Esther O’Shea","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2154307313","eid":"W2154307313"},{"id":"paper-w2802802362","cat":"papers","name":"Bubbling with Controversy: Legal Challenges for Ceremonial Ayahuasca Circles in the United States","year":"2018","cit":8,"pfa":"Kevin Feeney","psa":"Joanne Hudson","topics":["Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W2802802362","eid":"W2802802362"},{"id":"paper-w2023363612","cat":"papers","name":"Hypnotic Induction of the Interference of Psilocybin with Optically Induced Spatial Distortion","year":"1969","cit":8,"pfa":"Peter H. Gwynne","psa":"Richard Hill","ptype":"article","src":"https://openalex.org/W2023363612","eid":"W2023363612"},{"id":"paper-w4410718370","cat":"papers","name":"Role of endogenous serotonin in psychedelic-like effects of psilocybin in mice","year":"2025","cit":8,"pfa":"Ines Erkizia-Santamaría","psa":"Jorge Emilio Ortega","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4410718370","eid":"W4410718370"},{"id":"paper-w4389977617","cat":"papers","name":"Endocrinology-informed neuroimaging in eating disorders: GLP1, orexins, and psilocybin","year":"2023","cit":8,"pfa":"Trevor Steward","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4389977617","eid":"W4389977617"},{"id":"paper-w2128861746","cat":"papers","name":"Synthesis of the 3-(3,4,5-Trimethoxyphenyl)-pyrrolidine: A New Conformationally Constrained Mescaline Analogue","year":"2007","cit":8,"pfa":"Ricardo de L. Barreto","psa":"Carlos Roque D. Correia","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2128861746","eid":"W2128861746"},{"id":"paper-w4220938183","cat":"papers","name":"Psilocybin Combines Rapid Synaptogenic And Anti-Inflammatory Effects In Vitro","year":"2022","cit":8,"pfa":"Gabriella Smedfors","psa":"Tobias E. Karlsson","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4220938183","eid":"W4220938183"},{"id":"paper-w2314990242","cat":"papers","name":"General methods of synthesis of indole alkaloids. VIII. An attempted approach to the Iboga-Voacanga series","year":"1970","cit":8,"pfa":"Ernest Wenkert","psa":"GD Reynolds","ptype":"article","src":"https://openalex.org/W2314990242","eid":"W2314990242"},{"id":"paper-w2418639505","cat":"papers","name":"Cumulative alterations in rat behavior during continuous administration of LSD or mescaline: absence of tolerance?","year":"1980","cit":8,"pfa":"G Ellison","psa":"B Axelrood","ptype":"article","src":"https://openalex.org/W2418639505","eid":"W2418639505"},{"id":"paper-w2087180645","cat":"papers","name":"Estrogen effects on the hyperactivity induced by (+)-MDMA and cocaine in female rats.","year":"2003","cit":8,"pfa":"Wenxia Zhou","psa":"Mary L. Thomas","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2087180645","eid":"W2087180645"},{"id":"paper-w2092819637","cat":"papers","name":"Hippocampal remodelling after MDMA neurotoxicity: A single case study","year":"2008","cit":8,"pfa":"Francesco Nifosì","psa":"Giulia Perini","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2092819637","eid":"W2092819637"},{"id":"paper-w2098611436","cat":"papers","name":"Attributions for psychobiological changes in ecstasy/MDMA and other polydrug users","year":"2008","cit":8,"pfa":"Kirstie Soar","psa":"John J. Turner","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2098611436","eid":"W2098611436"},{"id":"paper-w2001178882","cat":"papers","name":"A STEREOTYPED RESPONSE INDUCED BY MESCALINE IN MICE AS A MEANS OF INVESTIGATING THE PROPERTIES OF DRUGS ACTING ON THE CNS","year":"1958","cit":8,"pfa":"Giulio Maffii","psa":"E Soncin","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2001178882","eid":"W2001178882"},{"id":"paper-w2127181312","cat":"papers","name":"Behavioral and developmental effects of two 3,4-methylenedioxymethamphetamine (MDMA) derivatives","year":"1994","cit":8,"pfa":"Maureen E. Bronson","psa":"M. Christopher Newland","ptype":"article","src":"https://openalex.org/W2127181312","eid":"W2127181312"},{"id":"paper-w2329508139","cat":"papers","name":"MESCALINE ANALOGS. III. 2,4,6-TRIALKYL- AND 3,4-DIHYDROXY-5-METHOXY-β-PHENETHYLAMINES","year":"1955","cit":8,"pfa":"Frederick Benington","psa":"Leland C. Clark","ptype":"article","src":"https://openalex.org/W2329508139","eid":"W2329508139"},{"id":"paper-w1964020347","cat":"papers","name":"Role of dantrolene in the management of the acute toxic effects of Ecstasy (MDMA)","year":"2007","cit":8,"pfa":"J. Moon","psa":"Jérôme Cros","ptype":"article","src":"https://openalex.org/W1964020347","eid":"W1964020347"},{"id":"paper-w3211947677","cat":"papers","name":"Ecstasy tablets: Rapid identification and determination of enantiomeric excess of MDMA","year":"2021","cit":8,"pfa":"Patrik Fagan","psa":"Vladimı́r Setnička","ptype":"article","src":"https://openalex.org/W3211947677","eid":"W3211947677"},{"id":"paper-w4387366289","cat":"papers","name":"Cortical structural differences following repeated ayahuasca use hold molecular signatures","year":"2023","cit":8,"pfa":"Pablo Mallaroni","psa":"Johannes Gerardus Ramaekers","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4387366289","eid":"W4387366289"},{"id":"paper-w4323043191","cat":"papers","name":"The Effectiveness of Microdosed Psilocybin in the Treatment of Neuropsychiatric Lyme Disease: A Case Study","year":"2023","cit":8,"pfa":"Daniel A Kinderlehrer","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4323043191","eid":"W4323043191"},{"id":"paper-w4413975912","cat":"papers","name":"Five-year outcomes of psilocybin-assisted therapy for Major Depressive Disorder","year":"2025","cit":8,"pfa":"Alan K. Davis","psa":"Frederick Streeter Barrett","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4413975912","eid":"W4413975912"},{"id":"paper-w4367043450","cat":"papers","name":"A suicide attempt following psilocybin ingestion in a patient with no prior psychiatric history","year":"2023","cit":8,"pfa":"Eric N. Kramer","psa":"Bryan B. Shapiro","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4367043450","eid":"W4367043450"},{"id":"paper-w3193400954","cat":"papers","name":"Induced fit, ensemble binding space docking and Monte Carlo simulations of MDMA ‘ecstasy’ and 3D pharmacophore design of MDMA derivatives on the human serotonin transporter (hSERT)","year":"2021","cit":8,"pfa":"Ángel A. Islas","psa":"Thomas Scior","topics":["PTSD & trauma","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3193400954","eid":"W3193400954"},{"id":"paper-w4225525501","cat":"papers","name":"Use of the Classic Hallucinogen Psilocybin for Treatment of Existential Distress Associated with Cancer","year":"2022","cit":8,"pfa":"Charles S. Grob","psa":"Roland R. Griffiths","topics":["Anxiety & end-of-life"],"ptype":"book-chapter","src":"https://openalex.org/W4225525501","eid":"W4225525501"},{"id":"paper-w4394601870","cat":"papers","name":"Derivatization-free determination of chiral plasma pharmacokinetics of MDMA and its enantiomers","year":"2024","cit":8,"pfa":"Dino Luethi","psa":"Urs Duthaler","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4394601870","eid":"W4394601870"},{"id":"paper-w2338450198","cat":"papers","name":"[Persisting and late onset psychotic disorder due to consumption of ecstasy (MDMA)].","year":"2000","cit":8,"pfa":"I. Boné Pina","psa":"J. Valle Fernández","ptype":"article","src":"https://openalex.org/W2338450198","eid":"W2338450198"},{"id":"paper-w2166907970","cat":"papers","name":"The Creative Cycle Processes Model of Spontaneous Imagery Narratives Applied to the Ayahuasca Shamanic Journey","year":"2012","cit":8,"pfa":"Frank Echenhofer","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2166907970","eid":"W2166907970"},{"id":"paper-w9469306","cat":"papers","name":"ACTIONS OF HYPERALGESIC SUBSTANCES {(-)NALOXONE, THEOPHYLLINE AND 5-METHOXY-N,N- DIMETHYLTRYPTAMINE} ON NOCICEPTIVE LEARNING","year":"1980","cit":8,"pfa":"Krishnaswami Ramabadran","psa":"J. Jacob","topics":["Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W9469306","eid":"W9469306"},{"id":"paper-w3035524447","cat":"papers","name":"How does it feel to be on psilocybin? Dose-response relationships of subjective experiences in humans","year":"2020","cit":8,"pfa":"Tim Hirschfeld","psa":"Timo Torsten Schmidt","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W3035524447","eid":"W3035524447"},{"id":"paper-w4387005979","cat":"papers","name":"Limbic System Response to Psilocybin and Ketamine Administration in Rats: A Neurochemical and Behavioral Study","year":"2023","cit":8,"pfa":"Adam Wojtas","psa":"Krystyna Gołembiowska","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W4387005979","eid":"W4387005979"},{"id":"paper-w4395467501","cat":"papers","name":"Genetic regulation of l-tryptophan metabolism in Psilocybe mexicana supports psilocybin biosynthesis","year":"2024","cit":8,"pfa":"Paula Sophie Seibold","psa":"Dirk Hoffmeister","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4395467501","eid":"W4395467501"},{"id":"paper-w4281943977","cat":"papers","name":"Application of machine learning and complex network measures to an EEG dataset from ayahuasca experiments","year":"2022","cit":8,"pfa":"Caroline L. Alves","psa":"Manuel Ciba","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4281943977","eid":"W4281943977"},{"id":"paper-w3154406565","cat":"papers","name":"Structural analysis of MDMA in solution by methods of chiroptical spectroscopy supported by DFT calculations","year":"2021","cit":8,"pfa":"Patrik Fagan","psa":"Vladimı́r Setnička","ptype":"article","src":"https://openalex.org/W3154406565","eid":"W3154406565"},{"id":"paper-w2420030687","cat":"papers","name":"Quantitative structure-activity studies on hallucinogenic mescaline analogs using modified first order valence connectivity.","year":"1982","cit":8,"pfa":"Gupta Sp","psa":"Pramila Singh","ptype":"article","src":"https://openalex.org/W2420030687","eid":"W2420030687"},{"id":"paper-w2742799454","cat":"papers","name":"“Strengthening the Moral Compass”: The Effects of MDMA (“Ecstasy”) Therapy on Moral and Spiritual Development","year":"2017","cit":8,"pfa":"June McDaniel","ptype":"article","src":"https://openalex.org/W2742799454","eid":"W2742799454"},{"id":"paper-w1872530014","cat":"papers","name":"Parkinson's disorder, psychomotor problems and dopaminergic neurotoxicity in recreational ecstasy/MDMA users","year":"2003","cit":8,"pfa":"Andrew C. Parrott","psa":"Jacqui Rodgers","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1872530014","eid":"W1872530014"},{"id":"paper-w4405122998","cat":"papers","name":"Psilocybin-assisted psychotherapy for methamphetamine dependence: a case report involving daily methamphetamine use","year":"2024","cit":8,"pfa":"Jonathan Brett","psa":"Jeffrey R. Guss","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4405122998","eid":"W4405122998"},{"id":"paper-w4402436863","cat":"papers","name":"Psilocybin alters brain activity related to sensory and cognitive processing in a time-dependent manner","year":"2024","cit":8,"pfa":"Marek Nikolič","psa":"Tomáš Páleníček","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4402436863","eid":"W4402436863"},{"id":"paper-w3121645043","cat":"papers","name":"Garcinia kola Attenuates MDMA-Induced Neuroinflammation in the CA1 Region of the Hippocampus in the Rat Model","year":"2020","cit":8,"pfa":"S Olatunji","psa":"Oluseyi Sunday Fabiyi","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3121645043","eid":"W3121645043"},{"id":"paper-w4395462414","cat":"papers","name":"The ‘PSILAUT’ protocol: an experimental medicine study of autistic differences in the function of brain serotonin targets of psilocybin","year":"2024","cit":8,"pfa":"Tobias P. Whelan","psa":"Grainne Mary McAlonan","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4395462414","eid":"W4395462414"},{"id":"paper-w4200597412","cat":"papers","name":"Ibogaine Has Sex-Specific Plasma Bioavailability, Histopathological and Redox/Antioxidant Effects in Rat Liver and Kidneys: A Study on Females","year":"2021","cit":8,"pfa":"Nikola Tatalović","psa":"Duško P. Blagojević","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4200597412","eid":"W4200597412"},{"id":"paper-w2947260413","cat":"papers","name":"Incorporating MDMA as an Adjunct in Emotionally Focused Couples Therapy With Clients Impacted by Trauma or PTSD","year":"2019","cit":8,"pfa":"Katie Almond","psa":"Robert Allan","topics":["PTSD & trauma","Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2947260413","eid":"W2947260413"},{"id":"paper-w852800022","cat":"papers","name":"Serotonin Release is Responsible for the Locomotor Hyperactivity in Rats Induced by Derivatives of Amphetamine Related to MDMA","year":"1991","cit":8,"pfa":"Christopher W. Callaway","psa":"Mark A. Geyer","topics":["Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W852800022","eid":"W852800022"},{"id":"paper-w2081328013","cat":"papers","name":"Distinct periods of developmental sensitivity to the effects of 3,4-(±)-methylenedioxymethamphetamine (MDMA) on behaviour and monoamines in rats","year":"2011","cit":8,"pfa":"Matthew R. Skelton","psa":"Charles V. Vorhees","ptype":"article","src":"https://openalex.org/W2081328013","eid":"W2081328013"},{"id":"paper-w2921293127","cat":"papers","name":"Case of Cardiac Arrest Treated with Extra-Corporeal Life Support after MDMA Intoxication","year":"2019","cit":8,"pfa":"Pierre Voizeux","psa":"Pierre‐Grégoire Guinot","topics":["Safety & adverse events","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2921293127","eid":"W2921293127"},{"id":"paper-w2022705385","cat":"papers","name":"Untreated rats develop “pathological” aggression when paired with a mescaline-treated rat in a shock-elicited aggression situation","year":"1977","cit":8,"pfa":"Robert J. Sbordone","psa":"John García","ptype":"article","src":"https://openalex.org/W2022705385","eid":"W2022705385"},{"id":"paper-w2040579179","cat":"papers","name":"Comment on the letter by Green, Gabrielsson, Marsden, and Fone, MDMA: on the translation from rodent to human dosing","year":"2009","cit":8,"pfa":"Rafael de la Torre","psa":"Norberto Aguirre","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2040579179","eid":"W2040579179"},{"id":"paper-w4402981355","cat":"papers","name":"Comparing psilocybin to metformin as neuroprotective agents against Parkinson's dementia: A systematic review of evidence and efficacy","year":"2024","cit":8,"pfa":"Randall Ordovich-Clarkson","psa":"Caleb Blake","topics":["Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4402981355","eid":"W4402981355"},{"id":"paper-w3006733917","cat":"papers","name":"Bucladesine Attenuates Spatial Learning and Hippocampal Mitochondrial Impairments Induced by 3, 4-Methylenedioxymethamphetamine (MDMA)","year":"2020","cit":8,"pfa":"Ghorban Taghizadeh","psa":"Mohammad Sharifzadeh","ptype":"article","src":"https://openalex.org/W3006733917","eid":"W3006733917"},{"id":"paper-w4385442764","cat":"papers","name":"On the mushrooming reports of “quiet quitting”: Employees’ lifetime psilocybin use predicts their overtime hours worked","year":"2023","cit":8,"pfa":"Benjamin A. Korman","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4385442764","eid":"W4385442764"},{"id":"paper-w3010852055","cat":"papers","name":"Lysosomal Dysfunction and Autophagy Blockade Contribute to MDMA-Induced Neurotoxicity in SH-SY5Y Neuroblastoma Cells","year":"2020","cit":8,"pfa":"I‐Hsun Li","psa":"Yuahn‐Sieh Huang","topics":["Safety & adverse events","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3010852055","eid":"W3010852055"},{"id":"paper-w2047664551","cat":"papers","name":"Peyote and related alkaloids. XV. O‐methylpeyoxylie acid and o‐methylpeyoruvic acid, the new cyclic amino acid analogs of mesealine","year":"1973","cit":8,"pfa":"Govind J. Kapadia","psa":"B.K. Chowdhury","ptype":"article","src":"https://openalex.org/W2047664551","eid":"W2047664551"},{"id":"paper-w2910919428","cat":"papers","name":"Serotonergic Psychedelics LSD & Psilocybin Increase the Fractal Dimension of Cortical Brain Activity in Spatial and Temporal Domains","year":"2019","cit":8,"pfa":"TF Varley","psa":"Emmanuel Andreas Stamatakis","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W2910919428","eid":"W2910919428"},{"id":"paper-w4413817374","cat":"papers","name":"Psilocybin-assisted therapy for treatment-resistant depression in the US: a model-based cost-effectiveness analysis","year":"2025","cit":8,"pfa":"Anton L.V. Avanceña","psa":"Elliot A. Marseille","topics":["Depression","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4413817374","eid":"W4413817374"},{"id":"paper-w4406354507","cat":"papers","name":"Ecstasy, molly, MDMA: What health practitioners need to know about this common recreational drug","year":"2025","cit":8,"pfa":"Andrew M. Farrar","psa":"Joseph J. Palamar","ptype":"article","src":"https://openalex.org/W4406354507","eid":"W4406354507"},{"id":"paper-w3212267978","cat":"papers","name":"Lack of evidence for positive reinforcing and prosocial effects of MDMA in pair-housed male and female rats","year":"2021","cit":8,"pfa":"Mark A. Smith","psa":"Kenzie M. Potter","ptype":"article","src":"https://openalex.org/W3212267978","eid":"W3212267978"},{"id":"paper-w2781973500","cat":"papers","name":"Isolated persistent acute global amnesia after acute abuse of 3,4-methylenedioxy-methamphetamine (MDMA)","year":"2018","cit":8,"pfa":"Fabien Hauw","psa":"T. de Broucker","ptype":"article","src":"https://openalex.org/W2781973500","eid":"W2781973500"},{"id":"paper-w3003390992","cat":"papers","name":"Organic impurity profiling of 3,4-methylenedioxymethamphetamine (MDMA) synthesised from catechol and eugenol via 4-allylcatechol","year":"2020","cit":8,"pfa":"Erin Heather","psa":"Andrew M. McDonagh","ptype":"article","src":"https://openalex.org/W3003390992","eid":"W3003390992"},{"id":"paper-w4410015941","cat":"papers","name":"Dose-dependent changes in global brain activity and functional connectivity following exposure to psilocybin: a BOLD MRI study in awake rats","year":"2025","cit":8,"pfa":"Evan Fuini","psa":"Craig F. Ferris","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4410015941","eid":"W4410015941"},{"id":"paper-w2056058936","cat":"papers","name":"Short-term effects of 3,4-methylen-dioxy-metamphetamine (MDMA) on 5-HT1A receptors in the rat hippocampus","year":"2007","cit":8,"pfa":"Gino Giannaccini","psa":"Antonio Lucacchini","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2056058936","eid":"W2056058936"},{"id":"paper-w4411347440","cat":"papers","name":"The molecular mechanisms through which psilocybin prevents suicide: evidence from network pharmacology and molecular docking analyses","year":"2025","cit":8,"pfa":"Ying Zhang","psa":"Chuanjun Zhuo","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4411347440","eid":"W4411347440"},{"id":"paper-w4414072214","cat":"papers","name":"Effect of psilocybin therapy on suicidal ideation, attempts, and deaths in people with psychiatric diagnoses: a systematic review and meta-analysis","year":"2025","cit":8,"pfa":"Stanley Wong","psa":"Muhammad Ishrat Husain","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4414072214","eid":"W4414072214"},{"id":"paper-w4411111467","cat":"papers","name":"Safety and tolerability of NN-dimethyltryptamine (DMT) in healthy volunteers and Major Depressive Disorder (MDD) patients: A systematic review of early-phase clinical trials","year":"2025","cit":8,"pfa":"Damian Świeczkowski","psa":"Wiesław Jerzy Cubała","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4411111467","eid":"W4411111467"},{"id":"paper-w4319984011","cat":"papers","name":"Natural or artificial: An example of topographic spatial distribution analysis of mescaline in cactus plants by matrix-assisted laser desorption/ionization mass spectrometry imaging","year":"2023","cit":8,"pfa":"Jiaman Lin","psa":"Hang Chen","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4319984011","eid":"W4319984011"},{"id":"paper-w2078257586","cat":"papers","name":"No effect of MDMA (ecstasy) on cell death and 5-HT2A receptor density in organotypic rat hippocampal cultures","year":"2004","cit":8,"pfa":"Marie‐Louise Sveen","psa":"Susana Aznar","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2078257586","eid":"W2078257586"},{"id":"paper-w1494251237","cat":"papers","name":"MDMA ‘ecstasy’ increases cerebral cortical perfusion determined by bolus‐tracking arterial spin labelling ( btASL ) MRI","year":"2013","cit":8,"pfa":"Jennifer Rouine","psa":"Andrew Harkin","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1494251237","eid":"W1494251237"},{"id":"paper-w4401603200","cat":"papers","name":"The association between diverse psychological protocols and the efficacy of psilocybin-assisted therapy for clinical depressive symptoms: a Bayesian meta-analysis","year":"2024","cit":8,"pfa":"Mu‐Hong Chen","psa":"Chih‐Sung Liang","topics":["Depression","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4401603200","eid":"W4401603200"},{"id":"paper-w2072423327","cat":"papers","name":"Antagonism of 5-methoxy-N,N-dimethyltryptamine-induced changes in postdecapitation convulsions in rats by repeated treatment with drugs enhancing 5-hydroxytryptamine neurotransmission","year":"1985","cit":8,"pfa":"Trevor Archer","psa":"Svante B. Ross","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2072423327","eid":"W2072423327"},{"id":"paper-w2419143027","cat":"papers","name":"Comparative study of the effects of stimulation or blockade of beta-adrenoceptors on the head-twitches induced in mice by 5-hydroxytryptophan versus 5-methoxy-N, N-dimethyltryptamine.","year":"1986","cit":8,"pfa":"P Martin","psa":"Philippe Yves Rémy Simon","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2419143027","eid":"W2419143027"},{"id":"paper-w4318455092","cat":"papers","name":"Corrigendum to ‘Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial’","year":"2023","cit":8,"pfa":"Robin von Rotz","psa":"Franz X. Vollenweider","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"erratum","src":"https://openalex.org/W4318455092","eid":"W4318455092"},{"id":"paper-w4308159475","cat":"papers","name":"MDMA administration attenuates hippocampal IL-β immunoreactivity and subsequent stress-enhanced fear learning: An animal model of PTSD","year":"2022","cit":8,"pfa":"Shveta V. Parekh","psa":"Donald T. Lysle","topics":["PTSD & trauma","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4308159475","eid":"W4308159475"},{"id":"paper-w4398156539","cat":"papers","name":"Effect of MDMA-assisted therapy on mood and anxiety symptoms in advanced-stage cancer (EMMAC): study protocol for a double-blind, randomised controlled trial","year":"2024","cit":8,"pfa":"Chiranth Bhagavan","psa":"David Benjamin Menkes","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4398156539","eid":"W4398156539"},{"id":"paper-w2162976220","cat":"papers","name":"Características farmacológicas de las drogas recreativas (MDMA y otras anfetaminas, Ketamina, GHB, LSD y otros alucinógenos)","year":"2003","cit":8,"pfa":"Pedro Lorenzo Fernández","psa":"Ignacio Lizasoaín","ptype":"article","src":"https://openalex.org/W2162976220","eid":"W2162976220"},{"id":"paper-w2081020542","cat":"papers","name":"Commentary on: Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance by Griffiths et al.","year":"2006","cit":8,"pfa":"David E. Nichols","ptype":"editorial","src":"https://openalex.org/W2081020542","eid":"W2081020542"},{"id":"paper-w4200369187","cat":"papers","name":"Microevidence for microdosing with psilocybin mushrooms: a double-blind placebo-controlled study of subjective effects, behavior, creativity, perception, cognition, and brain activity","year":"2021","cit":8,"pfa":"Federico Cavanna","psa":"Enzo Tagliazucchi","topics":["Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4200369187","eid":"W4200369187"},{"id":"paper-w2092906625","cat":"papers","name":"A One-Generation Reproductive Toxicity Study of 3,4-Methylenedioxy-N-Methamphetamine (MDMA, Ecstasy), an Amphetamine Derivative, in C57BL/6 Mice","year":"2014","cit":8,"pfa":"Seung Jun Kwack","psa":"Byung‐Mu Lee","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2092906625","eid":"W2092906625"},{"id":"paper-w3129536098","cat":"papers","name":"Increased kynurenine concentration attenuates serotonergic neurotoxicity induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats through activation of aryl hydrocarbon receptor","year":"2021","cit":8,"pfa":"Cristina Abuin-Martínez","psa":"María Isabel Colado","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3129536098","eid":"W3129536098"},{"id":"paper-w4237632560","cat":"papers","name":"Ascorbic acid prevents 3,4‐methylenedioxymethamphetamine (MDMA)‐induced hydroxyl radical formation and the behavioral and neurochemical consequences of the depletion of brain 5‐HT","year":"2001","cit":8,"pfa":"Mahalakshmi Shankaran","psa":"Gary A. Gudelsky","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4237632560","eid":"W4237632560"},{"id":"paper-w4414476150","cat":"papers","name":"Considerations and cautions for the integration of psilocybin into routine clinical care: a consensus statement from the US National Network of Depression Centers' Task Group on Psychedelics and Related Compounds","year":"2025","cit":8,"pfa":"Megan Hosein","psa":"Frederick Streeter Barrett","topics":["Depression","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4414476150","eid":"W4414476150"},{"id":"paper-w4254152619","cat":"papers","name":"Hallucinogenic Mushrooms","year":"2019","cit":8,"pfa":"Dagmara Ona Reingardienė","psa":"Robertas Lažauskas","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"book-chapter","src":"https://openalex.org/W4254152619","eid":"W4254152619"},{"id":"paper-w2087551627","cat":"papers","name":"Effect of the selective 5-HT3 receptor antagonists ICS 205-930 and MDL 72222 on 5-HTP-induced head shaking and behavioral symptoms induced by 5-methoxy-N,N,dimethyltryptamine in rats: comparison with some other 5-HT rece","year":"1987","cit":8,"pfa":"Gary T. Shearman","psa":"L. Tolcsvai","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2087551627","eid":"W2087551627"},{"id":"paper-w1987940120","cat":"papers","name":"The relative effectiveness of several hallucinogens in disrupting maze performance by rats","year":"1969","cit":8,"pfa":"Edward T. Uyeno","psa":"Chozo Mitoma","ptype":"article","src":"https://openalex.org/W1987940120","eid":"W1987940120"},{"id":"paper-w4407177057","cat":"papers","name":"Funding Success of United States Federal Grant Applications Proposing to Study Therapeutic Applications of Psychedelics: A Survey Study","year":"2025","cit":8,"pfa":"Brian Scott Barnett","ptype":"article","src":"https://openalex.org/W4407177057","eid":"W4407177057"},{"id":"paper-w4395685207","cat":"papers","name":"Neurobiology of the Antidepressant Effects of Serotonergic Psychedelics: A Narrative Review","year":"2024","cit":8,"pfa":"Noah Chisamore","psa":"Joshua Daniel Rosenblat","topics":["Depression","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4395685207","eid":"W4395685207"},{"id":"paper-w4385777618","cat":"papers","name":"Associations between individual hallucinogens and hallucinogen misuse among U.S. Adults who recently initiated hallucinogen use","year":"2023","cit":8,"pfa":"Grant M. Jones","psa":"Erica Wang","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4385777618","eid":"W4385777618"},{"id":"paper-w4403502370","cat":"papers","name":"Moving psychedelic-assisted therapies from promising research into routine clinical practice: Lessons from the field of implementation science","year":"2024","cit":8,"pfa":"Danielle R. Adams","psa":"Leopoldo J. Cabassa","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4403502370","eid":"W4403502370"},{"id":"paper-w2043899112","cat":"papers","name":"The behavioral effects of hallucinogens in rats following 5,7-dihydroxytryptamine administration into the medial forebrain bundle","year":"1981","cit":8,"pfa":"Randall L. Commissaris","psa":"Richard H. Rech","ptype":"article","src":"https://openalex.org/W2043899112","eid":"W2043899112"},{"id":"paper-w3187445852","cat":"papers","name":"What can we learn from the history of research on psychedelic drugs in the addictions?","year":"2021","cit":8,"pfa":"Wayne Hall","psa":"Michael Farrell","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W3187445852","eid":"W3187445852"},{"id":"paper-w2079308517","cat":"papers","name":"Lack of effect of antagonists on serotonin-induced inhibition in rat hippocampus","year":"1986","cit":8,"pfa":"Nicholas J. Penington","psa":"R. J. Reiffenstein","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2079308517","eid":"W2079308517"},{"id":"paper-w2084133249","cat":"papers","name":"Chemical Synthesis and Biological Evaluation of 18-Methoxycoronaridine (18-MC) as a Potential Anti-addictive Agent","year":"2001","cit":8,"pfa":"Upul K. Bandarage","psa":"Stanley D. Glick","topics":["Depression","Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2084133249","eid":"W2084133249"},{"id":"paper-w1996081072","cat":"papers","name":"A pointer to a new hallucinogen of insect origin","year":"1984","cit":8,"pfa":"E.B. Britton","ptype":"article","src":"https://openalex.org/W1996081072","eid":"W1996081072"},{"id":"paper-w3212789047","cat":"papers","name":"Suicidal cut‐throat wound during LSD intoxication","year":"2021","cit":8,"pfa":"Palash Kumar Bose","psa":"S. M. Yasir Arafat","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3212789047","eid":"W3212789047"},{"id":"paper-w4388636814","cat":"papers","name":"Psychedelic Drugs or Hallucinogens: Exploring Their Medicinal Potential","year":"2023","cit":8,"pfa":"Priyanshu Raj","psa":"Bhagyesh Sapkale","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4388636814","eid":"W4388636814"},{"id":"paper-w4236250256","cat":"papers","name":"LSD flashback syndrome exacerbated by selective serotonin reuptake inhibitor antidepressants in adolescents☆☆☆★★★","year":"1994","cit":8,"pfa":"H. Markel","psa":"Edward F. Domino","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4236250256","eid":"W4236250256"},{"id":"paper-w1842066504","cat":"papers","name":"False-positive LSD drug screening induced by a mucolytic medication.","year":"1998","cit":8,"pfa":"J Lotz","psa":"Winfried Prellwitz","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W1842066504","eid":"W1842066504"},{"id":"paper-w1996555747","cat":"papers","name":"Altered States: LSD and the Anesthesia Laboratory of Henry Knowles Beecher","year":"2005","cit":8,"pfa":"George A. Mashour","ptype":"article","src":"https://openalex.org/W1996555747","eid":"W1996555747"},{"id":"paper-w1972584258","cat":"papers","name":"Genotype, LSD and T-maze Learning in Mice","year":"1969","cit":8,"pfa":"John H. Stasik","psa":"JAMES F. KIDWELL","ptype":"article","src":"https://openalex.org/W1972584258","eid":"W1972584258"},{"id":"paper-w2999682477","cat":"papers","name":"TWO KINDS OF TRYPTAMINE RECEPTOR","year":"1997","cit":8,"pfa":"John Henry Gaddum","psa":"Zuleika P. Picarelli","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2999682477","eid":"W2999682477"},{"id":"paper-w2081202807","cat":"papers","name":"Action de la Psilocybine sur le cerveau du lapin","year":"1959","cit":8,"pfa":"Marcel Monnier","ptype":"article","src":"https://openalex.org/W2081202807","eid":"W2081202807"},{"id":"paper-w4408089796","cat":"papers","name":"Serotonergic Psychedelics Rapidly Modulate Evoked Glutamate Release in Cultured Cortical Neurons","year":"2025","cit":8,"pfa":"Aneta Petrušková","psa":"Anna Fejtová","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4408089796","eid":"W4408089796"},{"id":"paper-w2137529624","cat":"papers","name":"Empirical Dimensions of LSD-25 Reaction","year":"1964","cit":8,"pfa":"Harriet B. Linton","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2137529624","eid":"W2137529624"},{"id":"paper-w2059276156","cat":"papers","name":"Effect of LSD on the sleep cycle of the developing kitten","year":"1968","cit":8,"pfa":"Akira Shimizu","psa":"Harold E. Himwich","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2059276156","eid":"W2059276156"},{"id":"paper-w1975350691","cat":"papers","name":"Hallucinogenic Drugs and Their Psychotherapeutic Use.","year":"1963","cit":8,"pfa":"Harold A. Abramson","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W1975350691","eid":"W1975350691"},{"id":"paper-w3213181869","cat":"papers","name":"Hallucinogen Use and Misuse in Older Adults","year":"2021","cit":8,"pfa":"Wm Maurice Redden","psa":"Quratulanne Sheheryar","ptype":"article","src":"https://openalex.org/W3213181869","eid":"W3213181869"},{"id":"paper-w1992637103","cat":"papers","name":"FAILURE OF INDOMETHACIN AND d -2-BROMOLYSERGIC ACID DIETHYLAMIDE TO MODIFY THE ACUTE OEDEMATOUS REACTION TO OESTRADIOL IN THE UTERUS OF THE IMMATURE RAT","year":"1978","cit":8,"pfa":"Janet M. Brandon","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1992637103","eid":"W1992637103"},{"id":"paper-w4236926777","cat":"papers","name":"Use of hallucinogenic drugs on campus","year":"1968","cit":8,"pfa":"L. L. Imperi","ptype":"article","src":"https://openalex.org/W4236926777","eid":"W4236926777"},{"id":"paper-w4402625697","cat":"papers","name":"Psychedelic research at a crossroads","year":"2024","cit":8,"pfa":"Stacey B. Armstrong","psa":"Alan K. Davis","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4402625697","eid":"W4402625697"},{"id":"paper-w2736649468","cat":"papers","name":"Simple and Fast Analysis of LSD by Cyclic Voltammetry in Aqueous Medium","year":"2017","cit":8,"pfa":"Maria Fernanda Muzetti Ribeiro","psa":"Marcelo Firmino de Oliveira","ptype":"conference-paper","src":"https://openalex.org/W2736649468","eid":"W2736649468"},{"id":"paper-w4390802651","cat":"papers","name":"Modern Psychedelic Microdosing Research on Mental Health","year":"2024","cit":8,"pfa":"David F. Lo","psa":"Heather O’Donnell","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4390802651","eid":"W4390802651"},{"id":"paper-w2949805030","cat":"papers","name":"Effect of a Chiral 4-Alkyl Substituent in Hallucinogenic Amphetamines","year":"1995","cit":8,"pfa":"Robert A. Oberlender","psa":"David E. Nichols","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2949805030","eid":"W2949805030"},{"id":"paper-w4320497510","cat":"papers","name":"Stability studies of ALD ‐52 and its homologue 1P‐LSD","year":"2023","cit":8,"pfa":"Shu‐Hua Zhang","psa":"Cheuk‐Wai So","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4320497510","eid":"W4320497510"},{"id":"paper-w2111181135","cat":"papers","name":"Acute toxicity of Psilocybe cubensis (Ear.) Sing., Strophariaceae, aqueous extract in mice","year":"2010","cit":8,"pfa":"Thiago Berti Kirsten","psa":"Maria Martha Bernardi","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2111181135","eid":"W2111181135"},{"id":"paper-w2588539901","cat":"papers","name":"22-azidosalvinorin A exhibits antidepressant-like effect in mice","year":"2017","cit":8,"pfa":"James Oluwagbamigbe Fajemiroye","psa":"Jordan Kordian Zjawiony","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2588539901","eid":"W2588539901"},{"id":"paper-w4223514248","cat":"papers","name":"High-sensitivity method for the determination of LSD and 2-oxo-3-hydroxy-LSD in oral fluid by liquid chromatography‒tandem mass spectrometry","year":"2022","cit":8,"pfa":"Kelly Francisco da Cunha","psa":"José Luiz Costa","ptype":"article","src":"https://openalex.org/W4223514248","eid":"W4223514248"},{"id":"paper-w4415907617","cat":"papers","name":"LSD microdosing in major depressive disorder: results from an open-label trial","year":"2025","cit":8,"pfa":"Dimitri Daldegan‐Bueno","psa":"Suresh D Muthukumaraswamy","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4415907617","eid":"W4415907617"},{"id":"paper-w1992139505","cat":"papers","name":"Weekly γ-Hydroxybutyrate Exposure Sensitizes Locomotor Hyperactivity to Low-Dose 3,4-Methylenedioxymethamphetamine in Rats","year":"2009","cit":8,"pfa":"Petra S. Van Nieuwenhuijzen","psa":"Iain S. McGregor","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1992139505","eid":"W1992139505"},{"id":"paper-w4391513999","cat":"papers","name":"LSD use in the United States: Examining user demographics and their evolution from 2015–2019","year":"2024","cit":8,"pfa":"Jeremy Weleff","psa":"Brian Scott Barnett","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4391513999","eid":"W4391513999"},{"id":"paper-w4408221975","cat":"papers","name":"Psychedelics and Eating Disorders: Exploring the Therapeutic Potential for Anorexia Nervosa and Beyond","year":"2025","cit":8,"pfa":"Shuai Hu","psa":"Xiaohui Wang","topics":["Safety & adverse events","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4408221975","eid":"W4408221975"},{"id":"paper-w4409667310","cat":"papers","name":"Regulatory Challenges of Integrating Psychedelics into Mental Health Sector","year":"2025","cit":8,"pfa":"Kerem Kemal Soylemez","psa":"Joanne Marie Lusher","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4409667310","eid":"W4409667310"},{"id":"paper-w2613639344","cat":"papers","name":"Additive Effects of Former Methylenedioxymethamphetamine and Cannabis Use on Subclinical Psychotic Symptoms","year":"2017","cit":8,"pfa":"Berker Duman","psa":"Bora Başkak","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2613639344","eid":"W2613639344"},{"id":"paper-w2062635090","cat":"papers","name":"Degradation of N-hydroxy-3,4-methylenedioxymethamphetamine in aqueous solution and its prevention","year":"2009","cit":8,"pfa":"Kenji Tsujikawa","psa":"Hiroyuki Inoue","ptype":"article","src":"https://openalex.org/W2062635090","eid":"W2062635090"},{"id":"paper-w2012820656","cat":"papers","name":"Differences in the stimulus properties of barbital and hallucinogens","year":"1975","cit":8,"pfa":"Ira D. Hirschhorn","psa":"Jerrold C. Winter","ptype":"article","src":"https://openalex.org/W2012820656","eid":"W2012820656"},{"id":"paper-w1981832703","cat":"papers","name":"Morphological effects in the mouse myocardium after methylenedioxymethamphetamine administration combined with loud noise exposure","year":"2002","cit":8,"pfa":"Marco Gesi","psa":"Antonio Paparelli","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1981832703","eid":"W1981832703"},{"id":"paper-w4324128760","cat":"papers","name":"Rolling through TikTok : An analysis of 3,4‐methylenedioxymethamphetamine‐related content","year":"2023","cit":8,"pfa":"Jai Whelan","psa":"Ryan D. Ward","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4324128760","eid":"W4324128760"},{"id":"paper-w1508477413","cat":"papers","name":"The LSD syndrome. A review.","year":"1968","cit":8,"pfa":"Herbert H. Eveloff","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1508477413","eid":"W1508477413"},{"id":"paper-w4297493645","cat":"papers","name":"The psychedelic escape from depression","year":"2022","cit":8,"pfa":"Michael S. Eisenstein","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4297493645","eid":"W4297493645"},{"id":"paper-w2090358983","cat":"papers","name":"Identification of someN-hydroxylated metabolites of (±)-3,4-methylenedioxymethamphetamine in horse urine by gas chromatography-mass spectrometry","year":"2003","cit":8,"pfa":"MINOO C. DUMASIA","ptype":"article","src":"https://openalex.org/W2090358983","eid":"W2090358983"},{"id":"paper-w1969571280","cat":"papers","name":"3,4-Methylenedioxymethamphetamine induces a hyperthermic and hypermetabolic crisis in pigs with and without a genetic disposition for malignant hyperthermia","year":"2012","cit":8,"pfa":"Jan Karl Schütte","psa":"Mark Ulrich Gerbershagen","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1969571280","eid":"W1969571280"},{"id":"paper-w3006614669","cat":"papers","name":"Autoradiographische Untersuchungen zur Verteilung von Mescalin und dessen Einfluß auf die zentrale Erregung bei Mäusen","year":"1969","cit":8,"pfa":"Hubert Korr","psa":"Gottfried Werner","ptype":"article","src":"https://openalex.org/W3006614669","eid":"W3006614669"},{"id":"paper-w4324007078","cat":"papers","name":"Past Is Prologue: Ethical Issues in Pediatric Psychedelics Research and Treatment","year":"2023","cit":8,"pfa":"Gail Ann Edelsohn","psa":"Dominic A. Sisti","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4324007078","eid":"W4324007078"},{"id":"paper-w2039827824","cat":"papers","name":"Enhancement of Indole Alkaloids Produced by Psilocybe cubensis (Earle) Singer (Agaricomycetideae) in Controlled Harvesting Light Conditions","year":"2009","cit":8,"pfa":"Hasan Rafati","psa":"Ali Mohammadi","ptype":"article","src":"https://openalex.org/W2039827824","eid":"W2039827824"},{"id":"paper-w3101107609","cat":"papers","name":"Identifying the Perceived and Diagnosed Prevalence of Ecstasy Dependence Among Club Rave Attendees","year":"2005","cit":8,"pfa":"George S. Yacoubian","psa":"Tanja C. Link","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W3101107609","eid":"W3101107609"},{"id":"paper-w1978790152","cat":"papers","name":"Synthesis and in Vitro Cytotoxicity Profile of theR-Enantiomer of 3,4-Dihydroxymethamphetamine (R-(−)-HHMA): Comparison with Related Catecholamines","year":"2009","cit":8,"pfa":"Anne Felim","psa":"Martine Largeron","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1978790152","eid":"W1978790152"},{"id":"paper-w4407728103","cat":"papers","name":"Expanded access to psychedelic treatments: comparing American and Canadian policies","year":"2025","cit":8,"pfa":"Jérémie Richard","psa":"Jack E. Henningfield","topics":["PTSD & trauma","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4407728103","eid":"W4407728103"},{"id":"paper-w2007400484","cat":"papers","name":"Can ecstasy treat the agony of PTSD?","year":"2014","cit":8,"pfa":"Kai Kupferschmidt","topics":["PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2007400484","eid":"W2007400484"},{"id":"paper-w4282040347","cat":"papers","name":"Psychedelic assisted therapy for major depressive disorder: Recent work and clinical directions","year":"2022","cit":8,"pfa":"Annie McCartney","psa":"Alexander De Foe","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4282040347","eid":"W4282040347"},{"id":"paper-w2978597831","cat":"papers","name":"Julian Trevelyan, Walter Maclay and Eric Guttmann: drawing the boundary between psychiatry and art at the Maudsley Hospital","year":"2019","cit":8,"pfa":"Eilis Kempley","ptype":"article","src":"https://openalex.org/W2978597831","eid":"W2978597831"},{"id":"paper-w2914928106","cat":"papers","name":"Dexmedetomidine to Treat 3, 4-Methylenedioxymethamphetamine-Induced Agitation in a 13-Month-Old Infant: A Case Report and Literature Review","year":"2019","cit":8,"pfa":"Patricia J.L.T. Sanders","psa":"Jan Hanot","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2914928106","eid":"W2914928106"},{"id":"paper-w4210819143","cat":"papers","name":"Sind Psychedelika schnell wirksame Antidepressiva?","year":"2022","cit":8,"pfa":"Gerhard Gründer","psa":"Lea Julia Mertens","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4210819143","eid":"W4210819143"},{"id":"paper-w1964126648","cat":"papers","name":"Spectrum analysis of eeg changes induced by psychotomimetic agents","year":"1965","cit":8,"pfa":"E. Eidelberg","psa":"Morgan Miller","ptype":"article","src":"https://openalex.org/W1964126648","eid":"W1964126648"},{"id":"paper-w4385563866","cat":"papers","name":"The Potential of Psychedelics for the Treatment of Episodic Migraine","year":"2023","cit":8,"pfa":"Emmanuelle A. D. Schindler","ptype":"article","src":"https://openalex.org/W4385563866","eid":"W4385563866"},{"id":"paper-w1993080555","cat":"papers","name":"Relationships between substance use and hypomanic symptoms in a non-clinical sample.","year":"2011","cit":8,"pfa":"Thomas Hugh Richardson","psa":"Hugh P Garavan","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1993080555","eid":"W1993080555"},{"id":"paper-w4407207411","cat":"papers","name":"A qualitative analysis of the psychedelic mushroom come-up and come-down","year":"2025","cit":8,"pfa":"Ari Brouwer","psa":"Robin Lester Carhart-Harris","ptype":"article","src":"https://openalex.org/W4407207411","eid":"W4407207411"},{"id":"paper-w2518557383","cat":"papers","name":"The Discriminative Stimulus Properties of Hallucinogenic and Dissociative Anesthetic Drugs","year":"2016","cit":8,"pfa":"Tomohisa Mori","psa":"Tsutomu Suzuki","topics":["Addiction","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W2518557383","eid":"W2518557383"},{"id":"paper-w1987677522","cat":"papers","name":"Hallucinogens as discriminative stimuli: A comparison of 4-OMe and 5-OMe DMT with their methylthio counterparts","year":"1982","cit":8,"pfa":"Richard A. Glennon","psa":"Richard D. Morin","ptype":"article","src":"https://openalex.org/W1987677522","eid":"W1987677522"},{"id":"paper-w4225856497","cat":"papers","name":"Pharmacological characterization of 3,4-methylenedioxyamphetamine (MDA) analogs and two amphetamine-based compounds: ,α-DEPEA and DPIA","year":"2022","cit":8,"pfa":"Karolina E. Kolaczynska","psa":"Dino Luethi","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4225856497","eid":"W4225856497"},{"id":"paper-w2023137868","cat":"papers","name":"Adsorption and desorption characteristics of methamphetamine, 3,4-methylenedioxymethamphetamine, and pseudoephedrine in soils","year":"2014","cit":8,"pfa":"Raktim Pal","psa":"Ravi Naidu","ptype":"article","src":"https://openalex.org/W2023137868","eid":"W2023137868"},{"id":"paper-w564836020","cat":"papers","name":"Hughes' Outline of Modern Psychiatry","year":"2007","cit":8,"pfa":"David Gill","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"book","src":"https://openalex.org/W564836020","eid":"W564836020"},{"id":"paper-w2088028614","cat":"papers","name":"Rapid and Sensitive Detection of Lophophora williamsii by Loop-Mediated Isothermal Amplification","year":"2009","cit":8,"pfa":"Yohei Sasaki","psa":"Seiji Nagumo","ptype":"article","src":"https://openalex.org/W2088028614","eid":"W2088028614"},{"id":"paper-w4224269941","cat":"papers","name":"Positive Affect and Letheby's Naturalization of Psychedelic Therapy","year":"2022","cit":8,"pfa":"Sarah Hoffman","ptype":"article","src":"https://openalex.org/W4224269941","eid":"W4224269941"},{"id":"paper-w137213862","cat":"papers","name":"Vergleich ver�nderter Bewu�tseinszust�nde unter den Halluzinogenen (?)-?9-trans-Tetrahydrocannabinol (?9-THC) und N,N-Dimethyltryptamin (DMT)","year":"1976","cit":8,"pfa":"A.-M. Dittrich","psa":"Dagmar Zimmer","ptype":"article","src":"https://openalex.org/W137213862","eid":"W137213862"},{"id":"paper-w4372050159","cat":"papers","name":"Alkaloids from the entheogenic plant Peganum harmala","year":"2023","cit":8,"pfa":"Daniel G. Anstis","psa":"Jonathan Sperry","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4372050159","eid":"W4372050159"},{"id":"paper-w2765526863","cat":"papers","name":"Short-Term High-Dose Steroid Therapy in a Case of Rhabdomyolysis Refractory to Intravenous Fluids","year":"2017","cit":8,"pfa":"Fnu Zarlasht","psa":"M. Saleem Khan","topics":["PTSD & trauma","Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2765526863","eid":"W2765526863"},{"id":"paper-w577970538","cat":"papers","name":"Platelets : receptors, adhesion, secretion","year":"1989","cit":8,"pfa":"Jacek Hawiger","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"book","src":"https://openalex.org/W577970538","eid":"W577970538"},{"id":"paper-w4400236366","cat":"papers","name":"Rapid effects of tryptamine psychedelics on perceptual distortions and early visual cortical population receptive fields","year":"2024","cit":8,"pfa":"Marta Lapo Pais","psa":"Miguel Castelo‐Branco","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4400236366","eid":"W4400236366"},{"id":"paper-w4399262906","cat":"papers","name":"Time-resolved coupling between connectome harmonics and subjective experience under the psychedelic DMT","year":"2024","cit":8,"pfa":"Jakub Vohryzek","psa":"Morten L. Kringelbach","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4399262906","eid":"W4399262906"},{"id":"paper-w4229016234","cat":"papers","name":"Alcohol and drug use during sex and its association with sexually transmitted infections: a retrospective cohort study among young people aged under 25 years visiting Dutch STI clinics","year":"2022","cit":8,"pfa":"Ymke Joline Evers","psa":"Christian J. P. A. Hoebe","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4229016234","eid":"W4229016234"},{"id":"paper-w4406246123","cat":"papers","name":"Use of psychedelic treatments in psychiatric clinical practice: an EPA policy paper","year":"2025","cit":8,"pfa":"Marianne Destoop","psa":"Geert Dom","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4406246123","eid":"W4406246123"},{"id":"paper-w4389858660","cat":"papers","name":"An on‐line school‐based substance use harm reduction programme: The Illicit Project randomized controlled trial results","year":"2023","cit":8,"pfa":"Jennifer Debenham","psa":"Nicola Claire Newton","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4389858660","eid":"W4389858660"},{"id":"paper-w206856697","cat":"papers","name":"Tryptamines as Ligands and Modulators of the Serotonin 5‑HT2A Receptor and the Isolation of Aeruginascin from the Hallucinogenic Mushroom Inocybe aeruginascens","year":"2005","cit":8,"pfa":"Niels Jensen","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W206856697","eid":"W206856697"},{"id":"paper-w3028009423","cat":"papers","name":"Psychedelicacies: More Food For Thought From Breaking Convention","year":"2019","cit":8,"pfa":"Nikki Wyrd","psa":"David B. King","topics":["Anxiety & end-of-life"],"ptype":"book","src":"https://openalex.org/W3028009423","eid":"W3028009423"},{"id":"paper-w4410610851","cat":"papers","name":"Lessons learned from the regulatory alignment in ketamine, esketamine and arketamine clinical trials: A cross-sectional analysis of protocols from ClinicalTrials.gov","year":"2025","cit":8,"pfa":"Damian Świeczkowski","psa":"Wiesław Jerzy Cubała","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4410610851","eid":"W4410610851"},{"id":"paper-w3119281316","cat":"papers","name":"Clinical profile of designer drug “Strox” intoxicated cases presented to Poison control center Ain Shams University, Egypt from first of January 2017 to end of January 2018","year":"2021","cit":8,"pfa":"Mohy El-Masry","psa":"Salma Abdelkader","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3119281316","eid":"W3119281316"},{"id":"paper-w2598955760","cat":"papers","name":"Clinical applications of mass spectrometry: methods and protocols.","year":"2010","cit":8,"pfa":"Uttam C Garg","psa":"Catherine A. Hammett‐Stabler","topics":["Depression","Addiction"],"ptype":"book","src":"https://openalex.org/W2598955760","eid":"W2598955760"},{"id":"paper-w4310375389","cat":"papers","name":"Autonomy and autoheteronomy in psychedelically assisted psychotherapy","year":"2022","cit":8,"pfa":"Oliver Charles Minty Davis","topics":["Therapy practice","Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W4310375389","eid":"W4310375389"},{"id":"paper-w2494231507","cat":"papers","name":"LSD-type drugs and psychedelic therapy.","year":"1968","cit":8,"pfa":"Sanford M. Unger","psa":"Harry Shock","ptype":"book-chapter","src":"https://openalex.org/W2494231507","eid":"W2494231507"},{"id":"paper-w4402000183","cat":"papers","name":"Ketamine-assisted buprenorphine initiation: a pilot case series","year":"2024","cit":8,"pfa":"Lucinda A. Grande","psa":"Andrew A. Herring","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4402000183","eid":"W4402000183"},{"id":"paper-w4300862515","cat":"papers","name":"Expending Perspectives on the Potential for Psychedelic-Assisted Therapies to Improve the Experience of Aging","year":"2022","cit":8,"pfa":"Yvan Beaussant","psa":"Kabir B. Nigam","ptype":"article","src":"https://openalex.org/W4300862515","eid":"W4300862515"},{"id":"paper-w4301392567","cat":"papers","name":"Ketamine-assisted meaning-centered psychotherapy for a patient with severe suicidal behavior","year":"2022","cit":8,"pfa":"Fernando Espí Forcén","psa":"Maya Behn","topics":["Depression","Anxiety & end-of-life","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4301392567","eid":"W4301392567"},{"id":"paper-w4319444234","cat":"papers","name":"Dark Loops: Contagion effects, consistency and chemosocial matrices in psychedelic-assisted therapy trials","year":"2023","cit":8,"pfa":"Tehseen N. Noorani","psa":"Suresh D Muthukumaraswamy","ptype":"preprint","src":"https://openalex.org/W4319444234","eid":"W4319444234"},{"id":"paper-w4386317513","cat":"papers","name":"Healing Words: Effects of Psychoeducation on Likelihood to Seek and Refer Psychedelic-Assisted Psychotherapy Among BIPOC Individuals","year":"2023","cit":8,"pfa":"Raymond Feng","psa":"Monnica T. Williams","topics":["Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4386317513","eid":"W4386317513"},{"id":"paper-w4417035652","cat":"papers","name":"Psychedelics: The pathway to implementation in the European healthcare systems","year":"2025","cit":8,"pfa":"Gerhard Gründer","psa":"Henrik Jungaberle","topics":["Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4417035652","eid":"W4417035652"},{"id":"paper-w4381164174","cat":"papers","name":"Psychedelics to Relieve Psychological Suffering Associated with a Life-Threatening Diagnosis: Time for a Canadian Policy Discussion","year":"2023","cit":8,"pfa":"Sarah Kratina","psa":"Brian R. Rush","topics":["Addiction","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4381164174","eid":"W4381164174"},{"id":"paper-w4388419854","cat":"papers","name":"Psychedelic phenomenology and the role of affect in psychological transformation","year":"2023","cit":8,"pfa":"Christopher Kochevar","ptype":"article","src":"https://openalex.org/W4388419854","eid":"W4388419854"},{"id":"paper-w4396737535","cat":"papers","name":"Exploring the Therapeutic Potential of Virtual Reality: A Review on the Simulation of Psychedelic Effects for Treating Psychological Disorders","year":"2024","cit":8,"pfa":"Mirko Casu","psa":"Pasquale Caponnetto","topics":["Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4396737535","eid":"W4396737535"},{"id":"paper-w4399971233","cat":"papers","name":"Do classic psychedelics increase the risk of seizures? A scoping review","year":"2024","cit":8,"pfa":"Óscar Soto-Angona","psa":"Genís Oña","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4399971233","eid":"W4399971233"},{"id":"paper-w4391261105","cat":"papers","name":"The computational unconscious: Adaptive narrative control, psychopathology, and subjective well-being","year":"2024","cit":8,"pfa":"George E. Deane","psa":"Lars Sandved-Smith","topics":["Mechanism & neuroscience","Therapy practice","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4391261105","eid":"W4391261105"},{"id":"paper-w4386638044","cat":"papers","name":"Microdosing Psychedelics","year":"2019","cit":8,"pfa":"James Fadiman","psa":"Sophia Korb","topics":["Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W4386638044","eid":"W4386638044"},{"id":"paper-w4309187420","cat":"papers","name":"Predictors Of Hallucinogen Persisting Perception Disorder Symptoms, Delusional Ideation And Magical Thinking Following Naturalistic Psychedelic Use","year":"2022","cit":8,"pfa":"Katie Zhou","psa":"Hannes Kettner","topics":["Addiction","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4309187420","eid":"W4309187420"},{"id":"paper-w2399510226","cat":"papers","name":"Management of hallucinogen abuse.","year":"1976","cit":8,"pfa":"Lester M. Haddad","ptype":"article","src":"https://openalex.org/W2399510226","eid":"W2399510226"},{"id":"paper-w3112339954","cat":"papers","name":"Buprenorphine-naloxone microdosing","year":"2020","cit":8,"pfa":"Radhika Marwah","psa":"Zack J Dumont","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3112339954","eid":"W3112339954"},{"id":"paper-w4405824247","cat":"papers","name":"The Birth of the Psychedelic Industry: Capitalising on the Psychedelic Renaissance","year":"2024","cit":8,"pfa":"Minsu Yoo","psa":"Sofia Sakopoulos","topics":["Safety & adverse events","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4405824247","eid":"W4405824247"},{"id":"paper-w4315701643","cat":"papers","name":"Hallucinations and Hallucinogens: Psychopathology or Wisdom?","year":"2023","cit":8,"pfa":"José Carlos Bouso","psa":"Joan Obiols‐Llandrich","ptype":"article","src":"https://openalex.org/W4315701643","eid":"W4315701643"},{"id":"paper-w1981973056","cat":"papers","name":"Hallucinogen Use among Juvenile Probationers","year":"1999","cit":8,"pfa":"Jeffrey M. Jenson","psa":"Matthew O. Howard","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1981973056","eid":"W1981973056"},{"id":"paper-w4366775520","cat":"papers","name":"Entheogens and spiritual seeking: The quest for self-transcendence, psychological well-being, and psychospiritual growth","year":"2023","cit":8,"pfa":"Kevin O. St. Arnaud","psa":"Donald Sharpe","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4366775520","eid":"W4366775520"},{"id":"paper-w4200348112","cat":"papers","name":"Legalization of Psychedelic Substances","year":"2021","cit":8,"pfa":"Luke A. Downey","psa":"Daniel Perkins","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4200348112","eid":"W4200348112"},{"id":"paper-w1998317196","cat":"papers","name":"Psychedelic Drugs Reconsidered","year":"1980","cit":8,"pfa":"William A. Frosch","ptype":"article","src":"https://openalex.org/W1998317196","eid":"W1998317196"},{"id":"paper-w4297493652","cat":"papers","name":"Your brain on psychedelics","year":"2022","cit":8,"pfa":"Liam Drew","ptype":"article","src":"https://openalex.org/W4297493652","eid":"W4297493652"},{"id":"paper-w2523226757","cat":"papers","name":"Diagnostic Microdosing Approach to Study Gemcitabine Resistance","year":"2016","cit":8,"pfa":"Tiffany M. Scharadin","psa":"Paul T. Henderson","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2523226757","eid":"W2523226757"},{"id":"paper-w2500365701","cat":"papers","name":"THE MODE OF ACTION OF LSD-LIKE HALLUCINOGENS AND THEIR IDENTIFICATION","year":"1978","cit":8,"pfa":"William R. Martin","psa":"L.D. Bright","ptype":"book-chapter","src":"https://openalex.org/W2500365701","eid":"W2500365701"},{"id":"paper-w4311853422","cat":"papers","name":"Buprenorphine Microdosing Cross Tapers: A Time for Change","year":"2022","cit":8,"pfa":"Amer Raheemullah","psa":"Anna Lembke","topics":["Addiction","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4311853422","eid":"W4311853422"},{"id":"paper-w4252344822","cat":"papers","name":"Religious Aspects of Psychedelic Drugs","year":"1968","cit":8,"pfa":"Walter Houston Clark","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4252344822","eid":"W4252344822"},{"id":"paper-w2093645918","cat":"papers","name":"Influence of CNS Stimulants and Hallucinogens on Rats in Special Circumstances","year":"1970","cit":8,"pfa":"Prem C. Dandiya","psa":"M. L. Gupta","ptype":"article","src":"https://openalex.org/W2093645918","eid":"W2093645918"},{"id":"paper-w2012884406","cat":"papers","name":"Flow injection potentiometric determination of harmine and harmaline hallucinogens","year":"1995","cit":8,"pfa":"Saad S. M. Hassan","psa":"Marawan A. Hamada","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2012884406","eid":"W2012884406"},{"id":"paper-w2013208274","cat":"papers","name":"Hallucinogens as hard science: The adrenochrome hypothesis for the biogenesis of schizophrenia.","year":"2010","cit":8,"pfa":"John A. Mills","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2013208274","eid":"W2013208274"},{"id":"paper-w2914730376","cat":"papers","name":"Can Psychedelics be the Treatment for the Crisis in Psychopharmacology?","year":"2019","cit":8,"pfa":"Genís Oña","psa":"José Carlos Bouso","topics":["Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W2914730376","eid":"W2914730376"},{"id":"paper-w2061458105","cat":"papers","name":"Some Aspects of the Psychedelic-Drug Controversy","year":"1963","cit":8,"pfa":"Willis W. Harman","ptype":"article","src":"https://openalex.org/W2061458105","eid":"W2061458105"},{"id":"paper-w2063564649","cat":"papers","name":"Psychotherapy with Psychedelic Drugs: A Case Report","year":"1981","cit":8,"pfa":"Francesco B. Di Leo","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2063564649","eid":"W2063564649"},{"id":"paper-w2412984800","cat":"papers","name":"The use of hallucinogens and the shamanistic tradition of the Finno-Ugrian people.","year":"1980","cit":8,"pfa":"Czigány Lg","ptype":"other","src":"https://openalex.org/W2412984800","eid":"W2412984800"},{"id":"paper-w4392382030","cat":"papers","name":"Dried blood spot sampling of testosterone microdosing in healthy females","year":"2024","cit":8,"pfa":"Reena Desai","psa":"David J. Handelsman","topics":["Safety & adverse events","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4392382030","eid":"W4392382030"},{"id":"paper-w4413778031","cat":"papers","name":"The ABCs of psychedelics: a preclinical roadmap for drug discovery","year":"2025","cit":8,"pfa":"Alex C. Kwan","psa":"John D. McCorvy","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4413778031","eid":"W4413778031"},{"id":"paper-w2791430392","cat":"papers","name":"Microdosing Cocktail Assay Development for Drug–Drug Interaction Studies","year":"2018","cit":8,"pfa":"C.M. Chavez-Eng","psa":"Kevin P. Bateman","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2791430392","eid":"W2791430392"},{"id":"paper-w4224229666","cat":"papers","name":"Psychedelics Favour Understanding Rather Than Knowledge","year":"2022","cit":8,"pfa":"Sascha Benjamin Fink","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4224229666","eid":"W4224229666"},{"id":"paper-w4402238368","cat":"papers","name":"Adverse Events Should Not Be Surprising in Psychedelic Research","year":"2024","cit":8,"pfa":"Rebecca C. Ehrenkranz","psa":"David B. Yaden","topics":["Safety & adverse events"],"ptype":"editorial","src":"https://openalex.org/W4402238368","eid":"W4402238368"},{"id":"paper-w2397778078","cat":"papers","name":"Evaluation of the contraceptive efficacy of Quingestanol acetate in daily microdose and post coitum.","year":"1973","cit":8,"pfa":"Angel Victor Moggia","psa":"E Koremblit","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2397778078","eid":"W2397778078"},{"id":"paper-w4308180606","cat":"papers","name":"Do psychedelics have therapeutic potential for obesity?","year":"2022","cit":8,"pfa":"Nicole Fadahunsi","psa":"Christoffer Clemmensen","ptype":"article","src":"https://openalex.org/W4308180606","eid":"W4308180606"},{"id":"paper-w2624898548","cat":"papers","name":"Efficacy, Safety, and Feasibility of the Morphine Microdose Method in Community-Based Clinics","year":"2017","cit":8,"pfa":"Denise M Wilkes","psa":"Li-Yen Mae Huang","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2624898548","eid":"W2624898548"},{"id":"paper-w4298143470","cat":"papers","name":"Commentary: Psychedelics and psychotherapy: Cognitive-behavioral approaches as default","year":"2022","cit":8,"pfa":"John C. Burton","psa":"Jeffrey R. Guss","topics":["Therapy practice"],"ptype":"editorial","src":"https://openalex.org/W4298143470","eid":"W4298143470"},{"id":"paper-w4400352803","cat":"papers","name":"The nature of nonduality: The epistemic implications of meditative and psychedelic experiences","year":"2024","cit":8,"pfa":"Julien Tempone-Wiltshire","psa":"Floren Matthews","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4400352803","eid":"W4400352803"},{"id":"paper-w4406243626","cat":"papers","name":"Death Anxiety Among Users and Non-Users of Psychedelics","year":"2025","cit":8,"pfa":"Ana Cláudia Mesquita Garcia","psa":"Luís Fernando Tófoli","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4406243626","eid":"W4406243626"},{"id":"paper-w2070034205","cat":"papers","name":"Prairies, psychedelics and place: The dynamics of region in psychiatric research","year":"2009","cit":8,"pfa":"Erika Dyck","ptype":"article","src":"https://openalex.org/W2070034205","eid":"W2070034205"},{"id":"paper-w2559194937","cat":"papers","name":"Back to the future: Research renewed on the clinical utility of psychedelic drugs","year":"2016","cit":8,"pfa":"Jeffrey Alan Lieberman","psa":"Daniel Shalev","ptype":"article","src":"https://openalex.org/W2559194937","eid":"W2559194937"},{"id":"paper-w2050655306","cat":"papers","name":"William James in the Borderlands: Psychedelic Science and the \"Accidental Fences\" of Self","year":"2008","cit":8,"pfa":"Jodie Nicotra","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2050655306","eid":"W2050655306"},{"id":"paper-w4389339510","cat":"papers","name":"Cross-validation of the ego dissolution scale: implications for studying psychedelics","year":"2023","cit":8,"pfa":"Steven Jay Lynn","psa":"Richard E. Mattson","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4389339510","eid":"W4389339510"},{"id":"paper-w2562997287","cat":"papers","name":"Political neurotheology : emergence and revival of a psychedelic alternative to cosmetic psychopharmacology","year":"2011","cit":8,"pfa":"Nicolas Langlitz","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W2562997287","eid":"W2562997287"},{"id":"paper-w1979059887","cat":"papers","name":"Running out of Era: Some non-Pharmacological Notes on the Psychedelic Revolution","year":"1968","cit":8,"pfa":"Mark Messer","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1979059887","eid":"W1979059887"},{"id":"paper-w4395470693","cat":"papers","name":"Comment on: History repeating: guidelines to address common problems in psychedelic science","year":"2024","cit":8,"pfa":"Eduardo Ekman Schenberg","topics":["Reviews & meta-analyses"],"ptype":"letter","src":"https://openalex.org/W4395470693","eid":"W4395470693"},{"id":"paper-w1607208387","cat":"papers","name":"Disturbances in Serine-Glycine Metabolism in Relation to Acute Psychoses with Psychedelic Symptoms","year":"1985","cit":8,"pfa":"Jacques Bruinvels","psa":"Lolke P. Pepplinkhuizen","ptype":"book-chapter","src":"https://openalex.org/W1607208387","eid":"W1607208387"},{"id":"paper-w2314380100","cat":"papers","name":"Is There a Role for the [small alpha, Greek]2 Antagonism in the Exacerbation of Hallucinogen-Persisting Perception Disorder with Risperidone?","year":"1998","cit":8,"pfa":"A. G. Alcántara","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2314380100","eid":"W2314380100"},{"id":"paper-w4413889891","cat":"papers","name":"Out of control: Blinding, dose response, and psychosocial controls in psychedelic trials","year":"2025","cit":8,"pfa":"Sandeep Manel Nayak","psa":"Zarmeen Zahid","topics":["Safety & adverse events","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4413889891","eid":"W4413889891"},{"id":"paper-w2164150313","cat":"papers","name":"Relationship between Locus of Control and Drug Effects in Users of Narcotics, Stimulants, Hypnotic-Sedatives, and Hallucinogens","year":"1978","cit":8,"pfa":"James N. Hall","ptype":"article","src":"https://openalex.org/W2164150313","eid":"W2164150313"},{"id":"paper-w2571277542","cat":"papers","name":"Microdose acquisition in adolescent leg length discrepancy using a low-dose biplane imaging system","year":"2017","cit":8,"pfa":"Janni Jensen","psa":"Trine Torfing","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2571277542","eid":"W2571277542"},{"id":"paper-w4417288625","cat":"papers","name":"Difficulties following naturalistic psychedelic use and associations with adverse childhood experiences","year":"2025","cit":8,"pfa":"Michelle Olofsson","psa":"Otto Simonsson","topics":["PTSD & trauma","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4417288625","eid":"W4417288625"},{"id":"paper-w4311745487","cat":"papers","name":"Do Psychedelic Trips Open the Door to Messages from God, Spirits, Transcendent Realities, or the Devil? Links with Attitudes About Psychedelics, Opinions About Legalization, and Interest in Personal Use","year":"2022","cit":8,"pfa":"Julie Juola Exline","psa":"Joshua Adam Wilt","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4311745487","eid":"W4311745487"},{"id":"paper-w4400090894","cat":"papers","name":"Heavy ion-induced microdose effects on the reliability of planar and FinFET-based SRAM physical unclonable functions","year":"2024","cit":8,"pfa":"Jinjin Shao","psa":"Yaohua Wang","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4400090894","eid":"W4400090894"},{"id":"paper-w4367173846","cat":"papers","name":"Association of Bacterial Communities with Psychedelic Mushroom and Soil as Revealed in 16S rRNA Gene Sequencing","year":"2023","cit":8,"pfa":"Karthiyayini Balakrishnan","psa":"Dhanasekaran Dharumadurai","ptype":"article","src":"https://openalex.org/W4367173846","eid":"W4367173846"},{"id":"paper-w4389933573","cat":"papers","name":"Psychedelic concentrations of nitrous oxide reduce functional differentiation in frontoparietal and somatomotor cortical networks","year":"2023","cit":8,"pfa":"Rui Dai","psa":"George A. Mashour","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4389933573","eid":"W4389933573"},{"id":"paper-w2486548244","cat":"papers","name":"Magical mystery tours, and other trips: yellow submarines, newspaper taxis, and the Beatles' psychedelic years","year":"2009","cit":8,"pfa":"Russell Reising","psa":"Jim LeBlanc","topics":["Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W2486548244","eid":"W2486548244"},{"id":"paper-w4390143363","cat":"papers","name":"Longitudinal associations between psychedelic use and unusual visual experiences in the United States and the United Kingdom","year":"2023","cit":8,"pfa":"Otto Simonsson","psa":"Walter Osika","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4390143363","eid":"W4390143363"},{"id":"paper-w4393342301","cat":"papers","name":"Epigenetic drugs and psychedelics as emerging therapies for alcohol use disorder: insights from preclinical studies","year":"2024","cit":8,"pfa":"Fahd François Hilal","psa":"Sami Ben Hamida","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4393342301","eid":"W4393342301"},{"id":"paper-w4366241046","cat":"papers","name":"The effects of serotonergic psychedelics in synaptic and intrinsic properties of neurons in layer II/III of the orbitofrontal cortex","year":"2023","cit":8,"pfa":"Zi-Hang Tang","psa":"Haowei Shen","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4366241046","eid":"W4366241046"},{"id":"paper-w4318426627","cat":"papers","name":"The high frequency oscillation in orbitofrontal cortex is susceptible to phenethylamine psychedelic 25C–NBOMe in male rats","year":"2023","cit":8,"pfa":"Zhi-Peng Yu","psa":"Haowei Shen","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4318426627","eid":"W4318426627"},{"id":"paper-w4389373538","cat":"papers","name":"Exploring the subjective experience of rave party participants in Israel who consume psychedelic drugs: a qualitative inquiry","year":"2023","cit":8,"pfa":"Yula Milshteyn","psa":"Moshe Bensimon","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4389373538","eid":"W4389373538"},{"id":"paper-w4307425605","cat":"papers","name":"Presence of β2‐agonist growth promoters in human urine samples: GC‐MS/MS evaluation of the excretion profiles of ractopamine administered in microdoses","year":"2022","cit":8,"pfa":"Christiane Ayotte","psa":"A. T. Charlebois","topics":["Safety & adverse events","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4307425605","eid":"W4307425605"},{"id":"paper-w4393952303","cat":"papers","name":"Microdose lithium improves behavioral deficits and modulates molecular mechanisms of memory formation in female SAMP-8, a mouse model of accelerated aging","year":"2024","cit":8,"pfa":"Arthur Antônio Ruiz Pereira","psa":"Tânia Araújo Viel","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4393952303","eid":"W4393952303"},{"id":"paper-w2084804323","cat":"papers","name":"Human Lung Cancer Risks from Radon – Part II – Influence from Combined Adaptive Response and Bystander Effects – a Microdose Analysis","year":"2010","cit":8,"pfa":"Bobby E. Leonard","psa":"Georgia C. Beecher","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2084804323","eid":"W2084804323"},{"id":"paper-w4220892491","cat":"papers","name":"Interactive Effects of Drought-Tolerant Varieties and Fertilizer Microdosing on Maize Yield, Nutrients Use Efficiency, and Profitability in the Sub-Humid Region of Benin","year":"2022","cit":8,"pfa":"Pierre Gbènoukpo Tovihoudji","psa":"P. B. Irénikatché Akponikpè","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4220892491","eid":"W4220892491"},{"id":"paper-w2011988548","cat":"papers","name":"Immediate postabortal contraception with a microdose combined preparation: Gonadotropin, estradiol and progesterone levels during the last treatment cycle and after discontinuation of oral contraceptives","year":"1978","cit":8,"pfa":"Pekka Lähteenmäki","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2011988548","eid":"W2011988548"},{"id":"paper-w3182066808","cat":"papers","name":"Radiolabeling and PET–MRI microdosing of the experimental cancer therapeutic, MN-anti-miR10b, demonstrates delivery to metastatic lesions in a murine model of metastatic breast cancer","year":"2021","cit":8,"pfa":"Mariane Le Fur","psa":"Byunghee Yoo","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3182066808","eid":"W3182066808"},{"id":"paper-w1968698755","cat":"papers","name":"Psychotomimetic use of tobacco in Surinam and French Guiana","year":"1980","cit":8,"pfa":"Mark J. Plotkin","psa":"Isabel D. Constable","ptype":"article","src":"https://openalex.org/W1968698755","eid":"W1968698755"},{"id":"paper-w4410093668","cat":"papers","name":"How does psychedelic use relate to aspects of religiosity/spirituality? Preregistered report from a birth cohort study and a prospective longitudinal study.","year":"2025","cit":8,"pfa":"Aaron D. Cherniak","psa":"Pehr Granqvist","ptype":"article","src":"https://openalex.org/W4410093668","eid":"W4410093668"},{"id":"paper-w2008499513","cat":"papers","name":"The effect of psychotomimetic glycolate esters on central monoamine neurons","year":"1972","cit":8,"pfa":"N.‐E. Andén","psa":"Kjell Fuxé","ptype":"article","src":"https://openalex.org/W2008499513","eid":"W2008499513"},{"id":"paper-w2401851828","cat":"papers","name":"The effect of several psychotomimetic drugs on human serum cholinesterase","year":"1960","cit":8,"pfa":"Franklin T. Evans","ptype":"article","src":"https://openalex.org/W2401851828","eid":"W2401851828"},{"id":"paper-w2960129555","cat":"papers","name":"The effect of intradermal microdosing of a transient receptor potential cation channel subfamily V member 1 antagonist on heat evoked pain and thermal thresholds in normal and ultraviolet‐C exposed skin in healthy volunt","year":"2019","cit":8,"pfa":"Erik Sjögren","psa":"Anna K Sundgren","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2960129555","eid":"W2960129555"},{"id":"paper-w2424626853","cat":"papers","name":"Psychotomimetic properties and therapeutic potentials of dexoxadrol on convalescing alcoholics.","year":"1970","cit":8,"pfa":"A M Simopoulos","psa":"C Savage","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2424626853","eid":"W2424626853"},{"id":"paper-w134475980","cat":"papers","name":"Behavioral Effects of Anticholinergic Psychotomimetics and Their Antagonists in Man and Animals","year":"1966","cit":8,"pfa":"Samuel Gershon","ptype":"book-chapter","src":"https://openalex.org/W134475980","eid":"W134475980"},{"id":"paper-w2018263428","cat":"papers","name":"Behavioral effects and binding affinities of two stereoisomeric psychotomimetic glycolates","year":"1976","cit":8,"pfa":"Karl Löwy","psa":"Holly Raines","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2018263428","eid":"W2018263428"},{"id":"paper-w2417011629","cat":"papers","name":"Effects on rabbit brain of a new drug with psychotomimetic properties.","year":"1998","cit":8,"pfa":"Van Meter Wg","psa":"H E HIMWICH","ptype":"article","src":"https://openalex.org/W2417011629","eid":"W2417011629"},{"id":"paper-w2083275782","cat":"papers","name":"EFFECTS OF PSYCHOTOMIMETIC COMPOUNDS ON CERTAIN OXIDATIVE AND HYDROLYTIC ENZYMES IN MAMMALIAN BRAIN","year":"1956","cit":8,"pfa":"Leland C. Clark","psa":"Frederick Benington","ptype":"article","src":"https://openalex.org/W2083275782","eid":"W2083275782"},{"id":"paper-w4242396821","cat":"papers","name":"Effect of psychotomimetics (LSD and dextroamphetamine) on the use of primary- and secondary-process language.","year":"1978","cit":8,"pfa":"Michael Natale","psa":"Joseph Jaffe","ptype":"article","src":"https://openalex.org/W4242396821","eid":"W4242396821"},{"id":"paper-w2031989028","cat":"papers","name":"Effect of psychotomimetics (LSD and dextroamphetamine) on the use of primary- and secondary-process language.","year":"1978","cit":8,"pfa":"Michael Natale","psa":"Joseph Jaffe","ptype":"article","src":"https://openalex.org/W2031989028","eid":"W2031989028"},{"id":"paper-w2081719155","cat":"papers","name":"Effects of σ agonist compounds on local cerebral glucose utilization: relationship to psychotomimetic properties","year":"1986","cit":8,"pfa":"Michael R. Kozlowski","ptype":"article","src":"https://openalex.org/W2081719155","eid":"W2081719155"},{"id":"paper-w2952881675","cat":"papers","name":"ChemInform Abstract: CORRELATION OF PSYCHOTOMIMETIC ACTIVITY OF PHENETHYLAMINES AND AMPHETAMINES WITH 1‐OCTANOL‐WATER PARTITION COEFFICIENTS","year":"1975","cit":8,"pfa":"Charles F. Barfknecht","psa":"William J. Dunn","ptype":"article","src":"https://openalex.org/W2952881675","eid":"W2952881675"},{"id":"paper-w2024295073","cat":"papers","name":"A comparison of the effects of psychotomimetics and anxiolytics on punished and unpunished responding maintained by fixed interval schedules of food reinforcement in the rat","year":"2005","cit":8,"pfa":"J. L. Evenden","psa":"Tracey Ko","topics":["Depression","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2024295073","eid":"W2024295073"},{"id":"paper-w3093997243","cat":"papers","name":"Differential sensitivity to the acute psychotomimetic effects of delta-9-tetrahydrocannabinol associated with its differential acute effects on glial function and cortisol","year":"2020","cit":8,"pfa":"Marco Colizzi","psa":"Sagnik Bhattacharyya","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3093997243","eid":"W3093997243"},{"id":"paper-w2749393360","cat":"papers","name":"Pharmacological studies of Syrian rue (Peganum harmala L., Zygophyllaceae)","year":"2017","cit":8,"pfa":"Nazim Mamedov","psa":"Nilufar Z. Mamadalieva","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2749393360","eid":"W2749393360"},{"id":"paper-w2050803671","cat":"papers","name":"Withdrawal Syndrome with Methaqualone","year":"1972","cit":8,"pfa":"Sidney H. Schnoll","psa":"Ralph E. Fishkin","ptype":"article","src":"https://openalex.org/W2050803671","eid":"W2050803671"},{"id":"paper-w1988679058","cat":"papers","name":"The Effects of Heroin Addiction on Teeth","year":"1974","cit":8,"pfa":"P. G. Colon","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1988679058","eid":"W1988679058"},{"id":"paper-w2080902251","cat":"papers","name":"Biological microdosimetry based on radiation cytotoxicity data","year":"2012","cit":8,"pfa":"Bobby R. Scott","psa":"Charles A. Potter","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2080902251","eid":"W2080902251"},{"id":"paper-w2034959582","cat":"papers","name":"The Vibe of the Exiles: Aliens, Afropsychedelia and Psyculture","year":"2013","cit":8,"pfa":"Graham St John","ptype":"article","src":"https://openalex.org/W2034959582","eid":"W2034959582"},{"id":"paper-w2602083563","cat":"papers","name":"Using 124I-PU-H71 PET imaging to predict intratumoral concentration in patients on a phase I trial of PU-H71.","year":"2013","cit":8,"pfa":"John F. Gerecitano","psa":"Mark P. Dunphy","topics":["Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W2602083563","eid":"W2602083563"},{"id":"paper-w1991929020","cat":"papers","name":"Pilocarpine, a non-hallucinogenic cholinergic agonist, elicits limb flicking in cats","year":"1981","cit":8,"pfa":"James L. Marini","ptype":"article","src":"https://openalex.org/W1991929020","eid":"W1991929020"},{"id":"paper-w2091961952","cat":"papers","name":"A \"Free Clinic\" Patient Population and Drug Use Patterns","year":"1972","cit":8,"pfa":"Lewis L. Judd","psa":"Arnold J. Mandell","ptype":"article","src":"https://openalex.org/W2091961952","eid":"W2091961952"},{"id":"paper-w2118529673","cat":"papers","name":"The Psychology of Hallucinogenic Drug Discontinuers","year":"1972","cit":8,"pfa":"Carl Salzman","psa":"Jonathan D. Lieff","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2118529673","eid":"W2118529673"},{"id":"paper-w600783617","cat":"papers","name":"Understanding Drugs of Abuse: The Processes of Addiction, Treatment, and Recovery","year":"1993","cit":8,"pfa":"Mim J. Landry","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"book","src":"https://openalex.org/W600783617","eid":"W600783617"},{"id":"paper-w4391841405","cat":"papers","name":"A Critical View on New and Future Antidepressants","year":"2024","cit":8,"pfa":"Alessandro Serretti","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4391841405","eid":"W4391841405"},{"id":"paper-w2164764020","cat":"papers","name":"Bromo-DragonFly: Chemistry, Pharmacology and Toxicology of a Benzodifuran Derivative Producing LSD-Like Effects","year":"2012","cit":8,"pfa":"Maurizio Coppola","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2164764020","eid":"W2164764020"},{"id":"paper-w4405741904","cat":"papers","name":"Safety and cognitive pharmacodynamics following dose escalations with 3-methylmethcathinone (3-MMC): a first in human, designer drug study","year":"2024","cit":8,"pfa":"Johannes Gerardus Ramaekers","psa":"Eef Lien Theunissen","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4405741904","eid":"W4405741904"},{"id":"paper-w2807516377","cat":"papers","name":"KETAMINE AS A POSSIBLE MODERATOR OF HYPNOTIZABILITY: A Feasibility Study","year":"2018","cit":8,"pfa":"David R. Patterson","psa":"Sam R. Sharar","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2807516377","eid":"W2807516377"},{"id":"paper-w2738565983","cat":"papers","name":"LSD experiments by the United States Army","year":"2017","cit":8,"pfa":"Colin A. Ross","ptype":"article","src":"https://openalex.org/W2738565983","eid":"W2738565983"},{"id":"paper-w2883767674","cat":"papers","name":"Effects of exposure to 5-MeO-DIPT during adolescence on brain neurotransmission and neurotoxicity in adult rats","year":"2018","cit":8,"pfa":"Karolina Noworyta","psa":"Krystyna Gołembiowska","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2883767674","eid":"W2883767674"},{"id":"paper-w2197914267","cat":"papers","name":"The emergence of maternal drug addiction as a problem in Ireland 1981.","year":"1983","cit":8,"pfa":"A Ryan","psa":"Michael Kelly","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2197914267","eid":"W2197914267"},{"id":"paper-w2051440783","cat":"papers","name":"Multiple Drug Abuse Involving Nonopiate, Nonalcoholic Substances. II. Physical Damage, Long-Term Psychological Effects and Treatment Approaches and Success","year":"1981","cit":8,"pfa":"Alice B. Kornblith","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2051440783","eid":"W2051440783"},{"id":"paper-w4206788118","cat":"papers","name":"Transition from Oxycodone to Buprenorphine/Naloxone in a Hospitalized Patient with Sickle Cell Disease: A Case Report","year":"2022","cit":8,"pfa":"Sarah Leyde","psa":"Triveni DeFries","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4206788118","eid":"W4206788118"},{"id":"paper-w4303519567","cat":"papers","name":"A Cannabinoid Hypothesis of Schizophrenia: Pathways to Psychosis.","year":"2022","cit":8,"pfa":"Rachel Little","psa":"Dale A. D’Mello","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4303519567","eid":"W4303519567"},{"id":"paper-w2002330270","cat":"papers","name":"A New Concept and Further Support for the Importance and Occurrence of 3,4-Dimethoxyphenylethylamine (DMPEA) in Urine of Schizophrenic Patients","year":"2008","cit":8,"pfa":"D.A. Kalbhen","psa":"G. Braun","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2002330270","eid":"W2002330270"},{"id":"paper-w2534084935","cat":"papers","name":"Regarding the Transpersonal Nature of Ketamine Therapy: An Approach to the Work","year":"2014","cit":8,"pfa":"Jeffrey Becker","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2534084935","eid":"W2534084935"},{"id":"paper-w2005001147","cat":"papers","name":"Possible involvement of serotonin receptors in the facilitatory effect of a hallucinogenic phenethylamine on single facial motoneurons","year":"1986","cit":8,"pfa":"Nicholas J. Penington","psa":"R. J. Reiffenstein","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2005001147","eid":"W2005001147"},{"id":"paper-w2593253993","cat":"papers","name":"LSD instead of 25I-NBOMe: The revival of LSD? A case report","year":"2017","cit":8,"pfa":"Sandra Bodeau","psa":"Anne‐Sophie Lemaire‐Hurtel","ptype":"article","src":"https://openalex.org/W2593253993","eid":"W2593253993"},{"id":"paper-w2404592296","cat":"papers","name":"[Effects of diazepam and flunitrazepam on the undesired postoperative side-effects of ketamine anaesthesia (author's transl)].","year":"1978","cit":8,"pfa":"Eric Marshall Knoche","psa":"W. Dick","ptype":"article","src":"https://openalex.org/W2404592296","eid":"W2404592296"},{"id":"paper-w4223568964","cat":"papers","name":"Midazolam Attenuates Esketamine-Induced Overactive Behaviors in Mice Before the Sedation, but Not During the Recovery","year":"2022","cit":8,"pfa":"Qinjun Chu","psa":"Xiaogao Jin","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4223568964","eid":"W4223568964"},{"id":"paper-w2767152968","cat":"papers","name":"Inhaled Loxapine for Agitation in Intoxicated Patients: A Case Series","year":"2017","cit":8,"pfa":"Carlos Roncero","psa":"Lara Grau‐López","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2767152968","eid":"W2767152968"},{"id":"paper-w7140207905","cat":"papers","name":"Neural signaling mechanisms in depression: bridging classical monoamine hypotheses, animal models, and emerging antidepressant strategies","year":"2026","cit":8,"pfa":"Mizuki Yamamoto","psa":"Koji Toda","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7140207905","eid":"W7140207905"},{"id":"paper-w4405124948","cat":"papers","name":"Role of the amygdala and possible biomarkers in psychiatric disorders","year":"2024","cit":8,"pfa":"Gonzalo Flores","psa":"Julio César Morales‐Medina","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4405124948","eid":"W4405124948"},{"id":"paper-w4361190677","cat":"papers","name":"Survey of Buprenorphine Low-dose Regimens Used by Healthcare Institutions","year":"2023","cit":8,"pfa":"Monika Hardy","psa":"Michelle L. Pershing","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4361190677","eid":"W4361190677"},{"id":"paper-w4386327690","cat":"papers","name":"Ligand-Free Signaling of G-Protein-Coupled Receptors: Physiology, Pharmacology, and Genetics","year":"2023","cit":8,"pfa":"Wolfgang Sadée","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4386327690","eid":"W4386327690"},{"id":"paper-w4205820669","cat":"papers","name":"A retrospective analysis of the “Neverending Trip” after administration of a potent full agonist of 5-HT2A receptor – 25I-NBOMe","year":"2022","cit":8,"pfa":"Daria Barbara Schetz","psa":"Ivan Kocić","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4205820669","eid":"W4205820669"},{"id":"paper-w2550331392","cat":"papers","name":"Identifying A Drug Addict Person Using Artificial Neural Networks","year":"2016","cit":8,"pfa":"Mustafa Al Sukar","psa":"Bassam Kasasbeh","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2550331392","eid":"W2550331392"},{"id":"paper-w4220898779","cat":"papers","name":"Development of a computerized adaptive substance use disorder scale for screening, measurement and diagnosis – The CAT-SUD-E","year":"2022","cit":8,"pfa":"Leslie A. Hulvershorn","psa":"Robert David Gibbons","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4220898779","eid":"W4220898779"},{"id":"paper-w2086302386","cat":"papers","name":"Round-Window-Mikrokatheter-assistierte Mikrodosierung von Gentamycin: Alternative in der Behandlung des Tinnitus bei Patienten mit Morbus Menière","year":"2000","cit":8,"pfa":"Маркс","psa":"Hoffer","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2086302386","eid":"W2086302386"},{"id":"paper-w4403986152","cat":"papers","name":"Reported recreational drug and new psychoactive substance use versus laboratory detection of substances by high-resolution mass spectrometry in patients presenting to an emergency department in London with acute drug tox","year":"2024","cit":8,"pfa":"Caitlin E. Wolfe","psa":"David Michael Wood","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4403986152","eid":"W4403986152"},{"id":"paper-w4403174999","cat":"papers","name":"Prevalence and co‐occurrence of symptoms of mental and substance use disorders among people with HIV age 40 and older in low‐ and middle‐income countries: a cross‐sectional study","year":"2024","cit":8,"pfa":"Angela Marie Parcesepe","psa":"Kathryn Elizabeth Lancaster","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4403174999","eid":"W4403174999"},{"id":"paper-w3176728633","cat":"papers","name":"Mice Lacking GABAA Receptor δ Subunit Have Altered Pharmaco-EEG Responses to Multiple Drugs","year":"2021","cit":8,"pfa":"Milo Grotell","psa":"Esa R. Korpi","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3176728633","eid":"W3176728633"},{"id":"paper-w4399320006","cat":"papers","name":"It is time for more holistic practices in mental health","year":"2024","cit":8,"pfa":"Sidarta Tollendal Gomes Ribeiro","psa":"Paulo Amarante","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4399320006","eid":"W4399320006"},{"id":"paper-w4390585181","cat":"papers","name":"Effects of adding low-dose esketamine to sufentanil and propofol sedation during cervical conization: a single-centre, randomized controlled trial","year":"2024","cit":8,"pfa":"Jiguo Si","psa":"Min Cui","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4390585181","eid":"W4390585181"},{"id":"paper-w2422110870","cat":"papers","name":"[New therapeutic possibilities with low-affinity NMDA receptor antagonists].","year":"1996","cit":8,"pfa":"Johannes Kornhuber","psa":"Michael Weller","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W2422110870","eid":"W2422110870"},{"id":"paper-w2053277764","cat":"papers","name":"Physiologic and Pharmacologic Bases of Anesthesia","year":"1996","cit":8,"pfa":"Joseph M. Garfield","psa":"Steven J. Lisco","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2053277764","eid":"W2053277764"},{"id":"paper-w4294805031","cat":"papers","name":"CB1 Receptor Silencing Attenuates Ketamine-Induced Hyperlocomotion Without Compromising Its Antidepressant-Like Effects","year":"2022","cit":8,"pfa":"Pedro Henrique Gobira","psa":"Sâmia R.L. Joca","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4294805031","eid":"W4294805031"},{"id":"paper-w3132102464","cat":"papers","name":"Clinical Trials of Cannabidiol for Substance Use Disorders: Outcome Measures, Surrogate Endpoints, and Biomarkers","year":"2021","cit":8,"pfa":"Alix Morel","psa":"Vanessa Bloch","topics":["Addiction","Anxiety & end-of-life","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3132102464","eid":"W3132102464"},{"id":"paper-w4310684638","cat":"papers","name":"Effects of ketamine optical isomers, fluoxetine and naloxone on timing in differential reinforcement of low-rate response (DRL) 72-s task in rats","year":"2022","cit":8,"pfa":"Natalia Malikowska‐Racia","psa":"Piotr Popik","ptype":"article","src":"https://openalex.org/W4310684638","eid":"W4310684638"},{"id":"paper-w2921553125","cat":"papers","name":"[Research progress of depression and the application of esketamine].","year":"2016","cit":8,"pfa":"Fangbo Lin","psa":"Qiuping Tang","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2921553125","eid":"W2921553125"},{"id":"paper-w4291396912","cat":"papers","name":"A subclinical dose of esketamine pretreatment for propofol and rocuronium injection pain","year":"2022","cit":8,"pfa":"Chui-Yu Li","psa":"Liming Xu","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4291396912","eid":"W4291396912"},{"id":"paper-w2808863635","cat":"papers","name":"Efficacy of esketamine in the treatment of negative symptoms in schizophrenia – A case series","year":"2018","cit":8,"pfa":"Marcel Vella Nunes","psa":"Acioly L.T. Lacerda","ptype":"article","src":"https://openalex.org/W2808863635","eid":"W2808863635"},{"id":"paper-w4394957027","cat":"papers","name":"Analgesic Mechanism of Dexmedetomidine and Esketamine in Rats with Spinal Cord Injury","year":"2024","cit":8,"pfa":"Huiting Zhao","psa":"LI Zhuo-cheng","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4394957027","eid":"W4394957027"},{"id":"paper-w3211328869","cat":"papers","name":"Antipanic-like effect of esketamine and buprenorphine in rats exposed to acute hypoxia","year":"2021","cit":8,"pfa":"Jhonatan Christian Maraschin","psa":"Hélio Zangrossi","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3211328869","eid":"W3211328869"},{"id":"paper-w3205594036","cat":"papers","name":"Family of Structurally Related Bioconjugates Yields Antibodies with Differential Selectivity against Ketamine and 6-Hydroxynorketamine","year":"2021","cit":8,"pfa":"Zhen Zheng","psa":"Cody J. Wenthur","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3205594036","eid":"W3205594036"},{"id":"paper-w4411538043","cat":"papers","name":"Ketamine and Esketamine in Psychiatry: A Comparative Review Emphasizing Neuroplasticity and Clinical Applications","year":"2025","cit":8,"pfa":"Georgios Mikellides","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4411538043","eid":"W4411538043"},{"id":"paper-w4411978581","cat":"papers","name":"The effect of low-dose esketamine on maternal depression after cesarean delivery","year":"2025","cit":8,"pfa":"Yan Shang","psa":"Binrong Wang","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4411978581","eid":"W4411978581"},{"id":"paper-w4412974235","cat":"papers","name":"Treatment-resistant depression and intranasal esketamine: Spanish consensus on theoretical aspects","year":"2025","cit":8,"pfa":"Fernando Mora","psa":"Eduard Vieta","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4412974235","eid":"W4412974235"},{"id":"paper-w4386895384","cat":"papers","name":"Esketamine Inhibits Cocaine-Seeking Behaviour Subsequent to Various Abstinence Conditions in Rats","year":"2023","cit":8,"pfa":"Karolina Wydra","psa":"Małgorzata Filip","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4386895384","eid":"W4386895384"},{"id":"paper-w4395006079","cat":"papers","name":"Intravenous (IV) ketamine versus intranasal esketamine for depression– Advantage IV ketamine?","year":"2024","cit":8,"pfa":"Balwinder Singh","psa":"Jennifer L. Vande Voort","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4395006079","eid":"W4395006079"},{"id":"paper-w4395462558","cat":"papers","name":"Efficacy and safety of esketamine for pediatric gastrointestinal endoscopy: a meta-analysis and trial sequential analysis","year":"2024","cit":8,"pfa":"Yunfeng Yu","psa":"Chuanchuan Tan","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W4395462558","eid":"W4395462558"},{"id":"paper-w4411989581","cat":"papers","name":"Developmental toxicity and transcriptome analysis of zebrafish (Danio rerio) embryos exposed to anesthetic esketamine","year":"2025","cit":8,"pfa":"Jiao Wang","psa":"Qi Jiang","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4411989581","eid":"W4411989581"},{"id":"paper-w4401434878","cat":"papers","name":"Compassionate use of esketamine intranasal in patients with severe major depressive disorder resistant to the treatment","year":"2024","cit":8,"pfa":"Luís Gutiérrez-Rojas","psa":"Jesús García-Jiménez","topics":["Depression","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4401434878","eid":"W4401434878"},{"id":"paper-w4200553528","cat":"papers","name":"Efficacy and safety of repeated esketamine intravenous infusion in the treatment of treatment-resistant depression: A case series","year":"2021","cit":8,"pfa":"Kai Zhang","psa":"Huanzhong Liu","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4200553528","eid":"W4200553528"},{"id":"paper-w3007496975","cat":"papers","name":"Safety and efficacy of esketamine nasal spray in a depressed patient who was being treated with tranylcypromine: A case report","year":"2020","cit":8,"pfa":"David L. Dünner","psa":"Christina M. Demopulos","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3007496975","eid":"W3007496975"},{"id":"paper-w4414250031","cat":"papers","name":"Effects of perioperative intravenous esketamine on postoperative recovery quality in adult patients: a systematic review and meta-analysis","year":"2025","cit":8,"pfa":"Zhiyi He","psa":"Peng Jiang","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W4414250031","eid":"W4414250031"},{"id":"paper-w4409865607","cat":"papers","name":"Opioid-Free Anesthesia with Esketamine Combined with Iliac Fascia Block in Elderly Patients Undergoing Hip Surgery","year":"2025","cit":8,"pfa":"Lai-Lin Luo","psa":"Hao Yuan","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4409865607","eid":"W4409865607"},{"id":"paper-w4283017130","cat":"papers","name":"Letter to the Editor: Antidepressant and Antisuicidal Effects of Esketamine in Adolescents with Major Depressive Disorder and Suicidal Ideation: A Case Series","year":"2022","cit":8,"pfa":"Daniela Faria-Guimarães","psa":"Lucas C. Quarantini","topics":["Depression"],"ptype":"letter","src":"https://openalex.org/W4283017130","eid":"W4283017130"},{"id":"paper-w4410920879","cat":"papers","name":"Effect of Intraoperative Intravenous Infusion of Esketamine Combined with Dexmedetomidine on Postoperative Sleep Disturbance in Patients Undergoing Radical Mastectomy","year":"2025","cit":8,"pfa":"Xingyu Geng","psa":"Jingru Wu","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4410920879","eid":"W4410920879"},{"id":"paper-w4391969506","cat":"papers","name":"The effect of esketamine combined with propofol-induced general anesthesia on cerebral blood flow velocity: a randomized clinical trial","year":"2024","cit":8,"pfa":"Shuang Yan","psa":"Kaihua He","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4391969506","eid":"W4391969506"},{"id":"paper-w4415273953","cat":"papers","name":"Effects of Esketamine on Postoperative Delirium and Postoperative Cognitive Function in Elderly Gastrointestinal Tumor Patients with Preoperative Anxiety","year":"2025","cit":8,"pfa":"Jin Zha","psa":"Lingzhi Wang","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4415273953","eid":"W4415273953"},{"id":"paper-w7125983773","cat":"papers","name":"Systematic review and meta-analysis of intranasal esketamine for treatment-resistant depression: Evidence from real-world studies","year":"2026","cit":8,"pfa":"Clara de Oliveira Lapa","psa":"Lucas Spanemberg","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"review","src":"https://openalex.org/W7125983773","eid":"W7125983773"},{"id":"paper-w3084265147","cat":"papers","name":"(2 S ,6 S )- and (2 R ,6 R )-hydroxynorketamine inhibit the induction of NMDA receptor-dependent LTP at hippocampal CA1 synapses in mice","year":"2020","cit":8,"pfa":"Heather Kang","psa":"Graham L. Collingridge","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3084265147","eid":"W3084265147"},{"id":"paper-w4402127565","cat":"papers","name":"Exploring vortioxetine combination with intranasal esketamine: A feasible alternative to SSRI/SNRI? - Insights from the REAL-ESK study","year":"2024","cit":8,"pfa":"Giacomo d’Andrea","psa":"Giovanni Martinotti","ptype":"article","src":"https://openalex.org/W4402127565","eid":"W4402127565"},{"id":"paper-w4386564760","cat":"papers","name":"Exploring the potential of a bridge therapy: Synergistic approach integrating intravenous ketamine and intranasal esketamine for treatment‐resistant depression","year":"2023","cit":8,"pfa":"Giacomo d’Andrea","psa":"Giovanni Martinotti","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4386564760","eid":"W4386564760"},{"id":"paper-w4399747109","cat":"papers","name":"The association between ketamine and esketamine and suicidality: reports to the Food And Drug Administration Adverse Event Reporting System (FAERS)","year":"2024","cit":8,"pfa":"Roger S. McIntyre","psa":"Angela T.H. Kwan","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4399747109","eid":"W4399747109"},{"id":"paper-w4391538249","cat":"papers","name":"Comparison of the analgesic effect of dezocine and esketamine in combination with sufentanil respectively after laparoscopic cholecystectomy: a prospective randomized controlled study","year":"2024","cit":8,"pfa":"Bo-Ran Deng","psa":"Tu Shen","ptype":"article","src":"https://openalex.org/W4391538249","eid":"W4391538249"},{"id":"paper-w4410950518","cat":"papers","name":"Effect of low-dose esketamine on cardio-biliary reflex and postoperative pain during laparoscopic cholecystectomy surgery: A randomized, controlled trail","year":"2025","cit":8,"pfa":"Xiaodong Zhang","psa":"Qi Na","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4410950518","eid":"W4410950518"},{"id":"paper-w4387012628","cat":"papers","name":"Influence of low-dose esketamine on postoperative depressive symptoms in patients with breast cancer (EASE): study protocol for a randomised controlled trial","year":"2023","cit":8,"pfa":"Qingfeng Wei","psa":"Xuesheng Liu","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4387012628","eid":"W4387012628"},{"id":"paper-w4399095611","cat":"papers","name":"A real-world study examining the impact of esketamine nasal spray in people living with major depressive disorder in Australia and New Zealand","year":"2024","cit":8,"pfa":"Malcolm Hopwood","psa":"Ian Bernard Hickie","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4399095611","eid":"W4399095611"},{"id":"paper-w4407266355","cat":"papers","name":"Esketamine alleviated cardiomyocyte ferroptosis induced by oxygen–glucose deprivation/reoxygenation (OGD/R) via cyclic GMP-AMP synthase interactor","year":"2025","cit":8,"pfa":"Jianjun Ouyang","psa":"Yufang Li","ptype":"article","src":"https://openalex.org/W4407266355","eid":"W4407266355"},{"id":"paper-w4385837412","cat":"papers","name":"Effect of intravenous induction with different doses of Esketamine combined with propofol and sufentanil on intraocular pressure among pediatric strabismus surgery: a randomized clinical trial","year":"2023","cit":8,"pfa":"Jun Luo","psa":"Ruiqiang Sun","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4385837412","eid":"W4385837412"},{"id":"paper-w4392244800","cat":"papers","name":"Efficacy of epidural esketamine on postoperative sleep quality after laparoscopic and robotic lower abdominal surgeries: a study protocol for randomised, double-blind, controlled trial","year":"2024","cit":8,"pfa":"Yuecheng Yang","psa":"Jun Zhang","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4392244800","eid":"W4392244800"},{"id":"paper-w4405138754","cat":"papers","name":"Preoperative Anxiety’s Impact on the Median Effective Dose of Esketamine for Alleviating Propofol Injection Pain in Patients Undergoing Painless abortion: A Randomized, Double-Blind, Controlled Trial","year":"2024","cit":8,"pfa":"Yanping Shen","psa":"Liangguang Zhang","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4405138754","eid":"W4405138754"},{"id":"paper-w4211182554","cat":"papers","name":"Is approving esketamine as an antidepressant for treatment resistant depression associated with recreational use and risk perception of ketamine? Results from a longitudinal and cross-sectional survey in nightlife attend","year":"2022","cit":8,"pfa":"Meryem Grabski","psa":"Helen Valerie Curran","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4211182554","eid":"W4211182554"},{"id":"paper-w4404703791","cat":"papers","name":"A Comparative Study of Esketamine-Propofol and Sufentanil-Propofol for Analgesia and Sedation During Breast Minimally Invasive Rotary Resection with Local Anesthesia: A Randomized Double-Blind Clinical Trial","year":"2024","cit":8,"pfa":"Ningkang Li","psa":"Qingshan Ye","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4404703791","eid":"W4404703791"},{"id":"paper-w4413970518","cat":"papers","name":"The Effects of Low-Dose Esketamine Combined with Paravertebral Block on Postoperative Hyperalgesia and Enhanced Recovery in Non-Intubated Video-Assisted Thoracic Surgery: A Randomized Controlled Trial","year":"2025","cit":8,"pfa":"Rongbo Zhang","psa":"Tianhu Wang","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4413970518","eid":"W4413970518"},{"id":"paper-w4402055184","cat":"papers","name":"A Multi-Center, Open-Label, Single-Arm Study to Investigate the Early Effectiveness of Esketamine Nasal Spray in Patients with Treatment-Resistant Depression Using a Mobile Self-Monitoring Application","year":"2024","cit":8,"pfa":"Junhyung Kim","psa":"Changsu Han","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4402055184","eid":"W4402055184"},{"id":"paper-w4386480346","cat":"papers","name":"Treating Treatment-resistant Depression with Esketamine Nasal Spray When All Therapeutic Options Have Been Exhausted: Clinical Experience from a Spanish Cohort of Expanded Use","year":"2023","cit":8,"pfa":"Júlia Vendrell-Serres","psa":"Josep Antoni Ramos‐Quiroga","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4386480346","eid":"W4386480346"},{"id":"paper-w2915771341","cat":"papers","name":"Ketamine based drug should be available for treatment resistant depression, says FDA panel","year":"2019","cit":8,"pfa":"Joanne Silberner","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2915771341","eid":"W2915771341"},{"id":"paper-w4384820945","cat":"papers","name":"What is the best sedation method for high‐risk patients such as those with cirrhosis?","year":"2023","cit":8,"pfa":"Ryoji Ichijima","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4384820945","eid":"W4384820945"},{"id":"paper-w4406081479","cat":"papers","name":"Association of antidepressants with cataracts and glaucoma: a disproportionality analysis using the reports to the United States Food and Drug Administration Adverse Event Reporting System (FAERS) pharmacovigilance datab","year":"2024","cit":8,"pfa":"Gia Han Le","psa":"Roger S. McIntyre","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4406081479","eid":"W4406081479"},{"id":"paper-w4408884274","cat":"papers","name":"Innovative approaches in the treatment-resistant depression: exploring different therapeutic pathways","year":"2025","cit":8,"pfa":"Anna Łysik","psa":"Jerzy Leszek","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4408884274","eid":"W4408884274"},{"id":"paper-w4392755749","cat":"papers","name":"Access to interventional psychiatric treatments in the United States: Disparities and proposed solutions","year":"2024","cit":8,"pfa":"Deepinder S. Nagra","psa":"Lawrence G. Appelbaum","topics":["Depression","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4392755749","eid":"W4392755749"},{"id":"paper-w2592423279","cat":"papers","name":"Effect of the α2‐receptor agonists medetomidine, detomidine, xylazine, and romifidine on the ketamine metabolism in equines assessed with enantioselective capillary electrophoresis","year":"2017","cit":8,"pfa":"Friederike A. Sandbaumhüter","psa":"Wolfgang Thormann","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2592423279","eid":"W2592423279"},{"id":"paper-w4403982986","cat":"papers","name":"Country-specific psychopharmacological risk of reporting suicidality comparing 38 antidepressants and lithium from the FDA Adverse Event Reporting System, 2017–2023","year":"2024","cit":8,"pfa":"Andy Roger Eugene","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4403982986","eid":"W4403982986"},{"id":"paper-w4399177483","cat":"papers","name":"Widespread reductions in cortical thickness following ketamine abuse","year":"2024","cit":8,"pfa":"Jinsong Tang","psa":"Yanhui Liao","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4399177483","eid":"W4399177483"},{"id":"paper-w4386765493","cat":"papers","name":"The challenges of defining and managing treatment‐resistant depression in research and practice","year":"2023","cit":8,"pfa":"Maurizio Fava","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4386765493","eid":"W4386765493"},{"id":"paper-w2996381270","cat":"papers","name":"A human translational model based on neuroplasticity for pharmacological agents potentially effective in Treatment-Resistant Depression: focus on dopaminergic system","year":"2019","cit":8,"pfa":"Ginetta Collo","psa":"Emilio Merlo Pich","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2996381270","eid":"W2996381270"},{"id":"paper-w2425488162","cat":"papers","name":"Tryptamine in the brain and spinal cord: its role in the LSD response.","year":"1976","cit":8,"pfa":"W R Martin","psa":"Vaupel Db","ptype":"article","src":"https://openalex.org/W2425488162","eid":"W2425488162"},{"id":"paper-w1967646146","cat":"papers","name":"High-affinity platelet [3H]LSD binding is decreased in panic disorder","year":"1990","cit":8,"pfa":"Trevor Ronald Norman","psa":"Iain M. McIntyre","ptype":"article","src":"https://openalex.org/W1967646146","eid":"W1967646146"},{"id":"paper-w2520079204","cat":"papers","name":"Lysergic Acid Diethylamide (LSD)","year":"2018","cit":7,"ptype":"book-chapter","src":"https://openalex.org/W2520079204","eid":"W2520079204"},{"id":"paper-w2120293959","cat":"papers","name":"PYRETOGENIC EFFECT OF LYSERGIC ACID DIETHYLAMIDE","year":"1955","cit":7,"pfa":"Zlatko Supek","psa":"STEVAN MILKOVIĆ","ptype":"article","src":"https://openalex.org/W2120293959","eid":"W2120293959"},{"id":"paper-w2057712384","cat":"papers","name":"Lysergic acid diethylamide (LSD) and exstrophy of the bladder","year":"1970","cit":7,"pfa":"THOMAS D. GELEHRTER","ptype":"article","src":"https://openalex.org/W2057712384","eid":"W2057712384"},{"id":"paper-w2055652778","cat":"papers","name":"Photolabeling of brain membrane proteins by lysergic acid diethylamide","year":"1982","cit":7,"pfa":"Anne C. Mahon","psa":"Paul R. Hartig","ptype":"article","src":"https://openalex.org/W2055652778","eid":"W2055652778"},{"id":"paper-w2079279314","cat":"papers","name":"Effects of ibogaine and noribogaine on phosphoinositide hydrolysis","year":"1996","cit":7,"pfa":"Richard A. Rabin","psa":"Jerrold C. Winter","ptype":"article","src":"https://openalex.org/W2079279314","eid":"W2079279314"},{"id":"paper-w371661206","cat":"papers","name":"Drugs of hallucination : the uses and misuses of lysergic acid diethylamide","year":"1965","cit":7,"pfa":"Sidney Cohen","psa":"John Rowan Wilson","ptype":"book","src":"https://openalex.org/W371661206","eid":"W371661206"},{"id":"paper-w2058386935","cat":"papers","name":"Endocrine and metabolic effects of lysergic acid diethylamide on female rats","year":"1966","cit":7,"pfa":"Arthur M. Sackler","psa":"H. Owens","ptype":"article","src":"https://openalex.org/W2058386935","eid":"W2058386935"},{"id":"paper-w2333653384","cat":"papers","name":"THE FIGURAL AFTER-EFFECT AND LYSERGIC ACID DIETHYLAMIDE (LSD-25)","year":"1963","cit":7,"pfa":"Harold Kelm","psa":"R. W. RAMSAY","ptype":"article","src":"https://openalex.org/W2333653384","eid":"W2333653384"},{"id":"paper-w2024265378","cat":"papers","name":"The Use Of LSD (D-Lysergic Acid Diethylamide) In The Therapy Of Children","year":"1967","cit":7,"pfa":"Harold A. Abramson","ptype":"article","src":"https://openalex.org/W2024265378","eid":"W2024265378"},{"id":"paper-w1978184576","cat":"papers","name":"Ibogaine and Noribogaine: Structural Analysis and Stability Studies. Use of LC‐MS to Determine Alkaloid Contents of the Root Bark of Tabernanthe Iboga","year":"2007","cit":7,"pfa":"Violeta Kontrimavičiūtė","psa":"Françoise Bressolle","ptype":"article","src":"https://openalex.org/W1978184576","eid":"W1978184576"},{"id":"paper-w2992505888","cat":"papers","name":"Evidence for and against the involvement of N,N-dimethyl-tryptamine (DMT) and 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in schizophrenia.","year":"1976","cit":7,"pfa":"John Christian Gillin","psa":"Richard Jed Wyatt","ptype":"article","src":"https://openalex.org/W2992505888","eid":"W2992505888"},{"id":"paper-w4377940251","cat":"papers","name":"Reactivity of the Iboga Skeleton: Oxidation Study of Ibogaine and Voacangine","year":"2023","cit":7,"pfa":"Bruno González","psa":"Ignacio Carrera","ptype":"article","src":"https://openalex.org/W4377940251","eid":"W4377940251"},{"id":"paper-w2256553238","cat":"papers","name":"Dual actions of lysergic acid diethylamide tartrate (LSD), 2-bromo-D-lysergic acid diethylamide bitartrate (BOL) and methysergide on dorsal root potentials evoked by stimulation of raphe nuclei.","year":"1981","cit":7,"pfa":"Alice A. Larson","psa":"E.G. Anderson","ptype":"article","src":"https://openalex.org/W2256553238","eid":"W2256553238"},{"id":"paper-w4386001021","cat":"papers","name":"Mescaline, Peyote and San Pedro: Is sustainability important for cacti consumers?","year":"2023","cit":7,"pfa":"Liam B. Engel","psa":"ADAM R. WINSTOCK","ptype":"article","src":"https://openalex.org/W4386001021","eid":"W4386001021"},{"id":"paper-w2418497164","cat":"papers","name":"Studies on Lysergic Acid Diethylamide and Related Compounds. III. Improvement of Amidation of Lysergic Acid","year":"1974","cit":7,"pfa":"Yuji Nakahara","psa":"Tetsukichi Niwaguchi","ptype":"article","src":"https://openalex.org/W2418497164","eid":"W2418497164"},{"id":"paper-w2013518726","cat":"papers","name":"Quantitative Measurement of the Effect of Lysergic Acid Diethylamide on Mice and its Interactions with other Drugs","year":"1959","cit":7,"pfa":"John Smythies","ptype":"article","src":"https://openalex.org/W2013518726","eid":"W2013518726"},{"id":"paper-w2979620687","cat":"papers","name":"Pengalaman Anak Jalanan Usia Remaja Dalam Perilaku Inhalasi Lysergic Acid Diethylamide","year":"2019","cit":7,"pfa":"Chatarina Suryaningsih","psa":"Soleha Hendarsyah","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2979620687","eid":"W2979620687"},{"id":"paper-w2089807706","cat":"papers","name":"Effect of Epinephrine on Adrenal Ascorbic Acid Following Premedication With Lysergic Acid Diethylamides or 5-Hydroxyindolalkylamines","year":"1958","cit":7,"pfa":"E. Costa","psa":"GERHARD ZETLER","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2089807706","eid":"W2089807706"},{"id":"paper-w2061794418","cat":"papers","name":"Lysergic Acid Diethylamide (LSD-25): XXXV. Comparison of Effect on Siamese Fighting Fish and Goldfish","year":"1964","cit":7,"pfa":"Henriette H. Gettner","psa":"Harold A. Abramson","ptype":"article","src":"https://openalex.org/W2061794418","eid":"W2061794418"},{"id":"paper-w1977973087","cat":"papers","name":"THE EFFECT OF LYSERGIC ACID DIETHYLAMIDE ON THE ACETYLCHOLINESTERASE ACTIVITY OF SINGLE NERVE CELLS FROM THE RETICULAR FORMATION","year":"1963","cit":7,"pfa":"Rudi Pavlin","ptype":"article","src":"https://openalex.org/W1977973087","eid":"W1977973087"},{"id":"paper-w2132049006","cat":"papers","name":"Enzymic formation of dehydrogenated and hydroxylated metabolites from lysergic acid diethylamide by rat liver microsomes","year":"1980","cit":7,"pfa":"T. Inoue","psa":"T. Murata","ptype":"article","src":"https://openalex.org/W2132049006","eid":"W2132049006"},{"id":"paper-w2781978306","cat":"papers","name":"Lysergic acid diethylamide causes photoreceptor cell damage through inducing inflammatory response and oxidative stress","year":"2018","cit":7,"pfa":"Qidi Hu","psa":"Jianshu Yuan","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2781978306","eid":"W2781978306"},{"id":"paper-w2970511278","cat":"papers","name":"Serotonin type 5A receptor antagonists inhibit D-lysergic acid diethylamide discriminatory cue in rats","year":"2019","cit":7,"pfa":"Piotr Popik","psa":"Agnieszka Nikiforuk","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2970511278","eid":"W2970511278"},{"id":"paper-w2017067335","cat":"papers","name":"Lysergic acid diethylamide is a partial agonist at 5-HT2 receptors in ovine uterine artery of late pregnancy","year":"1993","cit":7,"pfa":"Li Zhang","psa":"Donald C. Dyer","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2017067335","eid":"W2017067335"},{"id":"paper-w2396670757","cat":"papers","name":"Delta-9-tetrahydrocannabinol and lysergic acid diethylamide: comparative changes in the supraoptic and paraventricular neurosecretory activities in rat hypothalamus.","year":"1975","cit":7,"pfa":"Bratati Biswas","psa":"Ghosh Jj","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2396670757","eid":"W2396670757"},{"id":"paper-w4415938616","cat":"papers","name":"Engineering artificial biosynthetic pathways for efficient microbial production of psilocybin and psilocin","year":"2025","cit":7,"pfa":"Cui Guo","psa":"Yuheng Lin","ptype":"article","src":"https://openalex.org/W4415938616","eid":"W4415938616"},{"id":"paper-w4321327263","cat":"papers","name":"Quantitative Analysis of Lysergic Acid Diethylamide and Metabolite in Urine by Automated Extraction and Liquid Chromatography–Tandem Mass Spectrometry","year":"2023","cit":7,"pfa":"Amy L Patton","psa":"Jeffrey P. Walterscheid","ptype":"article","src":"https://openalex.org/W4321327263","eid":"W4321327263"},{"id":"paper-w4397010929","cat":"papers","name":"5-MeO-DMT induces sleep-like LFP spectral signatures in the hippocampus and prefrontal cortex of awake rats","year":"2024","cit":7,"pfa":"Annie C. Souza","psa":"Sidarta Tollendal Gomes Ribeiro","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4397010929","eid":"W4397010929"},{"id":"paper-w2032637506","cat":"papers","name":"Effects of lysergic acid diethylamide (LSD) and adjuvant-induced inflammation on desensitization to and metabolism of substance P in the mouse spinal cord","year":"1989","cit":7,"pfa":"Alice A. Larson","psa":"Virginia S. Seybold","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2032637506","eid":"W2032637506"},{"id":"paper-w2063472035","cat":"papers","name":"RELEASE OF [3H]‐N0RADRENALINE FROM THE MOTOR ADRENERGIC NERVES OF THE ANOCOCCYGEUS MUSCLE BY LYSERGIC ACID DIETHYLAMIDE, TYRAMINE OR NERVE STIMULATION","year":"1978","cit":7,"pfa":"John Christie McGrath","psa":"Henry J. Olverman","ptype":"article","src":"https://openalex.org/W2063472035","eid":"W2063472035"},{"id":"paper-w3208594145","cat":"papers","name":"The potential role of lysergic acid diethylamide for psychological assisted therapy: A meta‐analysis of randomised controlled trials in healthy volunteers","year":"2021","cit":7,"pfa":"Hang Li","psa":"Gang Chen","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3208594145","eid":"W3208594145"},{"id":"paper-w4399983717","cat":"papers","name":"Synthesis and analytical characterization of 1‐(2‐thienoyl)‐6‐allyl‐nor‐d‐lysergic acid diethylamide (1T‐AL‐LAD)","year":"2024","cit":7,"pfa":"Yuki Okada","psa":"Yuko Togawa Iwata","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4399983717","eid":"W4399983717"},{"id":"paper-w4411214791","cat":"papers","name":"Immunomodulatory and behavioral effects of ayahuasca and N, N-dimethyltryptamine in a rat model of lipopolysaccharide-induced depression","year":"2025","cit":7,"pfa":"Daniel do Nascimento Sousa","psa":"Eloísa Dutra Caldas","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4411214791","eid":"W4411214791"},{"id":"paper-w4378085225","cat":"papers","name":"Systems-level analysis of local field potentials reveals differential effects of lysergic acid diethylamide and ketamine on neuronal activity and functional connectivity","year":"2023","cit":7,"pfa":"Azat Nasretdinov","psa":"Per Petersson","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4378085225","eid":"W4378085225"},{"id":"paper-w4399577263","cat":"papers","name":"Effects of psilocin and psilocybin on human 5-HT4 serotonin receptors in atrial preparations of transgenic mice and humans","year":"2024","cit":7,"pfa":"Joachim Neumann","psa":"Ulrich Gergs","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4399577263","eid":"W4399577263"},{"id":"paper-w2083494052","cat":"papers","name":"Effects of repeated administration of the monoamine oxidase inhibitor phenelzine on the discriminability of d-lysergic acid diethylamide (LSD) and 1-(m-trifluoromethylphenyl) piperazine (TFMPP)","year":"1986","cit":7,"pfa":"Kathryn A. Cunningham","psa":"James B. Appel","ptype":"article","src":"https://openalex.org/W2083494052","eid":"W2083494052"},{"id":"paper-w4307970834","cat":"papers","name":"Cardiac effects of ephedrine, norephedrine, mescaline, and 3,4-methylenedioxymethamphetamine (MDMA) in mouse and human atrial preparations","year":"2022","cit":7,"pfa":"Joachim Neumann","psa":"Ulrich Gergs","ptype":"article","src":"https://openalex.org/W4307970834","eid":"W4307970834"},{"id":"paper-w51306571","cat":"papers","name":"Effects of psilocybin, dimethyltryptamine and various lysergic acid derivatives on photically-induced epilepsy in the baboon (Papio papio).","year":"1970","cit":7,"pfa":"Brian S. Meldrum","psa":"R Naquet","ptype":"article","src":"https://openalex.org/W51306571","eid":"W51306571"},{"id":"paper-w2415793656","cat":"papers","name":"Mescaline: a survey.","year":"1988","cit":7,"pfa":"Schwartz Rh","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2415793656","eid":"W2415793656"},{"id":"paper-w2004924530","cat":"papers","name":"Ultrasensitive analysis of lysergic acid diethylamide and its C-8 isomer in hair by capillary zone electrophoresis in combination with a stacking technique and laser induced fluorescence detection","year":"2015","cit":7,"pfa":"Diego Airado‐Rodríguez","psa":"Ana María García-Campaña","ptype":"article","src":"https://openalex.org/W2004924530","eid":"W2004924530"},{"id":"paper-w2067311296","cat":"papers","name":"Biosynthesis of mescaline","year":"1969","cit":7,"pfa":"K. L. Khanna","psa":"Ara G. Paul","ptype":"article","src":"https://openalex.org/W2067311296","eid":"W2067311296"},{"id":"paper-w2081495708","cat":"papers","name":"Psilocybin in FinnishPsilocybe semilanceata","year":"1984","cit":7,"pfa":"J. Jokiranta","psa":"M.M. Airaksinen","ptype":"article","src":"https://openalex.org/W2081495708","eid":"W2081495708"},{"id":"paper-w2051113340","cat":"papers","name":"Bioassay of Ataractics Against Lethal Action of Mescaline in Mice","year":"1958","cit":7,"pfa":"Nicholas P. Plotnikoff","psa":"Helen Washington","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2051113340","eid":"W2051113340"},{"id":"paper-w2318978308","cat":"papers","name":"The biogenesis of theTabernanthe iboga alkaloids","year":"1957","cit":7,"pfa":"W. I. Taylor","ptype":"article","src":"https://openalex.org/W2318978308","eid":"W2318978308"},{"id":"paper-w2003697682","cat":"papers","name":"THE SOUTHERN UTE PEYOTE CULT","year":"1941","cit":7,"pfa":"Omer C. Stewart","ptype":"article","src":"https://openalex.org/W2003697682","eid":"W2003697682"},{"id":"paper-w4297493210","cat":"papers","name":"Finding medical value in mescaline","year":"2022","cit":7,"pfa":"Eric Bender","ptype":"article","src":"https://openalex.org/W4297493210","eid":"W4297493210"},{"id":"paper-w4401483141","cat":"papers","name":"Ayahuasca for the treatment of alcohol use disorder","year":"2024","cit":7,"pfa":"E.A.V. Marinho","psa":"Lais Fernanda Berro","topics":["Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W4401483141","eid":"W4401483141"},{"id":"paper-w1990719838","cat":"papers","name":"A Case of Prolonged Peyote-Induced Psychosis Resolved by Sleep","year":"2004","cit":7,"pfa":"Brett Y. Lu","psa":"Rodrigo Escalona","ptype":"article","src":"https://openalex.org/W1990719838","eid":"W1990719838"},{"id":"paper-w2074955499","cat":"papers","name":"AYAHUASCA: neuroquímica e farmacologia","year":"2007","cit":7,"pfa":"RAFAEL GUIMARÃES DOS SANTOS","ptype":"article","src":"https://openalex.org/W2074955499","eid":"W2074955499"},{"id":"paper-w2330883554","cat":"papers","name":"Observations on Meaningless Peyote Song Texts","year":"1953","cit":7,"pfa":"Bruno Nettl","ptype":"article","src":"https://openalex.org/W2330883554","eid":"W2330883554"},{"id":"paper-w1994027878","cat":"papers","name":"Relative potency of amphetamine derivatives and N,N-dimethyltryptamines","year":"1971","cit":7,"pfa":"Edward T. Uyeno","ptype":"article","src":"https://openalex.org/W1994027878","eid":"W1994027878"},{"id":"paper-w2037741021","cat":"papers","name":"Pharmacokinetic characterization of the indole alkaloid ibogaine in rats","year":"2000","cit":7,"pfa":"Lindsay B. Hough","psa":"S.D. Glick","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2037741021","eid":"W2037741021"},{"id":"paper-w2066842420","cat":"papers","name":"Anti-addiction drug ibogaine on trial","year":"1995","cit":7,"pfa":"Nancy A. Touchette","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2066842420","eid":"W2066842420"},{"id":"paper-w2909519526","cat":"papers","name":"MDMA-assisted psychotherapy","year":"2018","cit":7,"pfa":"A. C. Parrott","topics":["PTSD & trauma","Reviews & meta-analyses","Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W2909519526","eid":"W2909519526"},{"id":"paper-w4362588191","cat":"papers","name":"The molecular basis of the antidepressant action of the magic mushroom extract, psilocin","year":"2023","cit":7,"pfa":"Ali Asghar Hakami Zanjani","psa":"Himanshu Khandelia","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4362588191","eid":"W4362588191"},{"id":"paper-w2316780922","cat":"papers","name":"New salvinorin A - Derived ligands to opioid receptors","year":"2012","cit":7,"pfa":"Prabhakar Reddy Polepally","psa":"JK Zjawiony","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2316780922","eid":"W2316780922"},{"id":"paper-w2039003170","cat":"papers","name":"Synthesis of a psilocin hapten and a protein-hapten conjugate","year":"2002","cit":7,"pfa":"Christian Albers","psa":"Bernd Brinkmann","ptype":"article","src":"https://openalex.org/W2039003170","eid":"W2039003170"},{"id":"paper-w2329041578","cat":"papers","name":"MESCALINE ANALOGS. IV. SUBSTITUTED 4,5,6-TRIMETHOXYINDOLES","year":"1955","cit":7,"pfa":"Frederick Benington","psa":"Leland C. Clark","ptype":"article","src":"https://openalex.org/W2329041578","eid":"W2329041578"},{"id":"paper-w2408793027","cat":"papers","name":"Neurolepticlike actions of l-methadone: effect on mescaline-induced altered behavior and on tissue levels of mescaline in mice.","year":"1979","cit":7,"pfa":"N S Shah","psa":"J. O. Yates","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2408793027","eid":"W2408793027"},{"id":"paper-w1964675498","cat":"papers","name":"Mescaline treated rats attack immobile targets","year":"1975","cit":7,"pfa":"Brooks Carder","psa":"Robert J. Sbordone","ptype":"article","src":"https://openalex.org/W1964675498","eid":"W1964675498"},{"id":"paper-w4386519754","cat":"papers","name":"The zebrafish for preclinical psilocybin research","year":"2023","cit":7,"pfa":"Omer A. Syed","psa":"Robert T. Gerlai","ptype":"article","src":"https://openalex.org/W4386519754","eid":"W4386519754"},{"id":"paper-w2035181393","cat":"papers","name":"Liquid Chromatography-Electrospray Mass Spectrometry Determination of Ibogaine and 12-Hydroxy-Ibogamine in Human Urine","year":"2006","cit":7,"pfa":"Violeta Kontrimavičiūtė","psa":"Françoise Bressolle","ptype":"article","src":"https://openalex.org/W2035181393","eid":"W2035181393"},{"id":"paper-w4400475657","cat":"papers","name":"Potential therapeutic use of ayahuasca: A literature review","year":"2024","cit":7,"pfa":"Salvana Priscylla Manso Costa","psa":"José Marcos Teixeira de Alencar Filho","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4400475657","eid":"W4400475657"},{"id":"paper-w4392031990","cat":"papers","name":"Paradoxes of Peyote Regulation in Mexico: Drug Conventions and Environmental Laws","year":"2016","cit":7,"pfa":"Beatriz Caiuby Labate","psa":"Kevin Feeney","topics":["Policy & ethics"],"ptype":"other","src":"https://openalex.org/W4392031990","eid":"W4392031990"},{"id":"paper-w2510363069","cat":"papers","name":"Some reflections on the global expansion of Ayahuasca","year":"2011","cit":7,"pfa":"Luís Eduardo Luna","ptype":"article","src":"https://openalex.org/W2510363069","eid":"W2510363069"},{"id":"paper-w1987635663","cat":"papers","name":"Influence of psychotropic drugs and β-diethylaminoethyl-diphenylpropylacetate (SKF 525-A) on mescaline-induced behavior and on tissue levels of mescaline in mice","year":"1976","cit":7,"pfa":"Nandkumar S. Shah","ptype":"article","src":"https://openalex.org/W1987635663","eid":"W1987635663"},{"id":"paper-w4405029114","cat":"papers","name":"Psilocybin as a disease-modifying drug—a salutogenic approach in psychiatry","year":"2024","cit":7,"pfa":"Moritz Spangemacher","psa":"Gerhard Gründer","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4405029114","eid":"W4405029114"},{"id":"paper-w2417720340","cat":"papers","name":"Methods for the detection and determination of ibogaine in biological materials.","year":"1971","cit":7,"pfa":"H.I. Dhahir","psa":"Forney Rb","ptype":"article","src":"https://openalex.org/W2417720340","eid":"W2417720340"},{"id":"paper-w3023470335","cat":"papers","name":"N,N-Dimethyltryptamine: DMT-induced psychosis","year":"2020","cit":7,"pfa":"David Barbic","psa":"Apu Chakraborty","ptype":"article","src":"https://openalex.org/W3023470335","eid":"W3023470335"},{"id":"paper-w4406960487","cat":"papers","name":"Oregon’s Emerging Psilocybin Services Workforce: A Survey of the First Legal Psilocybin Facilitators and Their Training Programs","year":"2025","cit":7,"pfa":"Jason B. Luoma","psa":"Philip Todd Korthuis","topics":["PTSD & trauma","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4406960487","eid":"W4406960487"},{"id":"paper-w4404870815","cat":"papers","name":"Ayahuasca enhances the formation of hippocampal-dependent episodic memory without impacting false memory susceptibility in experienced ayahuasca users: An observational study","year":"2024","cit":7,"pfa":"Manoj K. Doss","psa":"Johannes Gerardus Ramaekers","ptype":"article","src":"https://openalex.org/W4404870815","eid":"W4404870815"},{"id":"paper-w2323174039","cat":"papers","name":"The development and expression of locomotor sensitization to nicotine in the presence of ibogaine","year":"2000","cit":7,"pfa":"Carlos Zúbaran","psa":"Ian P. Stolerman","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2323174039","eid":"W2323174039"},{"id":"paper-w1988652549","cat":"papers","name":"Psilocybin: Reaction with a Fraction of Rat Brain","year":"1967","cit":7,"pfa":"L. P. Gilmour","psa":"Richard D. O'Brien","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1988652549","eid":"W1988652549"},{"id":"paper-w1767698878","cat":"papers","name":"Oxidative metabolism of mescaline in the central nervous system—V","year":"1975","cit":7,"pfa":"L. Demisch","psa":"Nikolaus Seiler","ptype":"article","src":"https://openalex.org/W1767698878","eid":"W1767698878"},{"id":"paper-w2043158882","cat":"papers","name":"Psilocybin in Mycelkulturen von Inocybe aeruginascens","year":"1986","cit":7,"pfa":"Jochen Gartz","ptype":"article","src":"https://openalex.org/W2043158882","eid":"W2043158882"},{"id":"paper-w3213562265","cat":"papers","name":"Policy in focus: Is psilocybin the next cannabis?","year":"2021","cit":7,"pfa":"Greg Basky","topics":["Depression","Addiction","Policy & ethics"],"ptype":"other","src":"https://openalex.org/W3213562265","eid":"W3213562265"},{"id":"paper-w4235056346","cat":"papers","name":"Examining Changes in Personality Following Shamanic Ceremonial Use of Ayahuasca","year":"2020","cit":7,"pfa":"Brandon Weiss","psa":"William Keith Campbell","ptype":"preprint","src":"https://openalex.org/W4235056346","eid":"W4235056346"},{"id":"paper-w2417662769","cat":"papers","name":"The effect of MDMA on sensitivity to reinforcement rate.","year":"2016","cit":7,"pfa":"Celia Lie","psa":"David N. Harper","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2417662769","eid":"W2417662769"},{"id":"paper-w2418093020","cat":"papers","name":"Dimethyltryptamine from the leaves of certain Acacia species of northern Sudan.","year":"1975","cit":7,"pfa":"S K Wahba Khalil","psa":"Y. M. El-Kheir","ptype":"article","src":"https://openalex.org/W2418093020","eid":"W2418093020"},{"id":"paper-w2075300517","cat":"papers","name":"Clinical and toxic effects of MDMA (\"Ecstasy\").","year":"2002","cit":7,"pfa":"Rafael A. Rivas-Vazquez","psa":"Lizbhet Delgado","ptype":"article","src":"https://openalex.org/W2075300517","eid":"W2075300517"},{"id":"paper-w4404728829","cat":"papers","name":"Safety pharmacology of acute mescaline administration in healthy participants","year":"2024","cit":7,"pfa":"Aaron Klaiber","psa":"Matthias E. Liechti","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4404728829","eid":"W4404728829"},{"id":"paper-w2045731734","cat":"papers","name":"On the Metabolism of 3,4-Methylenedioxymethamphetamine (MDMA) in Man","year":"1993","cit":7,"pfa":"Hans H. Maurer","psa":"K.‐A. Kovar","ptype":"article","src":"https://openalex.org/W2045731734","eid":"W2045731734"},{"id":"paper-w1805879374","cat":"papers","name":"MDMA-induced angioedema treated with icatibant","year":"2015","cit":7,"pfa":"Francisco Antonio Escalante","psa":"August Supervía","ptype":"article","src":"https://openalex.org/W1805879374","eid":"W1805879374"},{"id":"paper-w2063033992","cat":"papers","name":"Nootropic Candidates Inhibit Head-Twitches Induced by Mescaline in Mice.","year":"1992","cit":7,"pfa":"Tsuneyuki Yamamoto","psa":"Showa Ueki","ptype":"article","src":"https://openalex.org/W2063033992","eid":"W2063033992"},{"id":"paper-w2040778079","cat":"papers","name":"Psychophysics of psilocybin and 48-148-148-1","year":"1973","cit":7,"pfa":"Jay H. Shaffer","psa":"Roland Fischer","ptype":"article","src":"https://openalex.org/W2040778079","eid":"W2040778079"},{"id":"paper-w2787425610","cat":"papers","name":"The Effects of Ibogaine on Uterine Smooth Muscle Contractions: Relation to the Activity of Antioxidant Enzymes","year":"2018","cit":7,"pfa":"Zorana Oreščanin-Dušić","psa":"Duško P. Blagojević","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2787425610","eid":"W2787425610"},{"id":"paper-w4412764217","cat":"papers","name":"Age- and estrous-dependent effects of psilocybin in rats","year":"2025","cit":7,"pfa":"Alexia L. Zylko","psa":"Matthew Stephen McMurray","topics":["Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4412764217","eid":"W4412764217"},{"id":"paper-w2982141611","cat":"papers","name":"Numerical Analysis of Time-Dependent Inhibition by MDMA","year":"2019","cit":7,"pfa":"John T. Rodgers","psa":"Jeffrey P. Jones","ptype":"article","src":"https://openalex.org/W2982141611","eid":"W2982141611"},{"id":"paper-w1542479804","cat":"papers","name":"Chapter 15 From the roots up: Ibogaine and addict self-help","year":"2001","cit":7,"pfa":"Geerte M. N. Frenken","topics":["Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W1542479804","eid":"W1542479804"},{"id":"paper-w3184589899","cat":"papers","name":"MDMA-Assisted Therapy Highly Effective for PTSD","year":"2021","cit":7,"pfa":"Anita J Slomski","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W3184589899","eid":"W3184589899"},{"id":"paper-w2987923941","cat":"papers","name":"Statistical comparison of mass spectra of salvinorins in Salvia divinorum and related Salvia species","year":"2019","cit":7,"pfa":"Melissa A. Bodnar Willard","psa":"Victoria L. McGuffin","ptype":"article","src":"https://openalex.org/W2987923941","eid":"W2987923941"},{"id":"paper-w2087761732","cat":"papers","name":"Metallation/reduction as a new approach to tritium labeling. The synthesis of [3H]ibogaine","year":"1994","cit":7,"pfa":"Herbert H. Seltzman","psa":"Christopher D. Wyrick","ptype":"article","src":"https://openalex.org/W2087761732","eid":"W2087761732"},{"id":"paper-w2998172719","cat":"papers","name":"Preparation and characterization of protected methylamphetamine and MDMA products","year":"2019","cit":7,"pfa":"Jenny Xu","psa":"Helen Salouros","ptype":"article","src":"https://openalex.org/W2998172719","eid":"W2998172719"},{"id":"paper-w4404152712","cat":"papers","name":"Amid magic and menace: psychiatrists’ attitudes to psilocybin therapy","year":"2024","cit":7,"pfa":"Andrew David Gribben","psa":"John Richard Kelly","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4404152712","eid":"W4404152712"},{"id":"paper-w1844502129","cat":"papers","name":"The Use of Peyote as Treatment for Alcoholism within the NAC Community: Reflections on a Study","year":"2011","cit":7,"pfa":"Hillary S. Webb","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1844502129","eid":"W1844502129"},{"id":"paper-w4386306332","cat":"papers","name":"Three Cases of Reported Improvement in Microsmia and Anosmia Following Naturalistic Use of Psilocybin and LSD","year":"2023","cit":7,"pfa":"Alexsandra Kovacevich","psa":"Brian Scott Barnett","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4386306332","eid":"W4386306332"},{"id":"paper-w1974645707","cat":"papers","name":"Mescaline increases startle responding equally in normal and raphe-lesioned rats","year":"1979","cit":7,"pfa":"Mark A. Geyer","psa":"Lyle R. Petersen","ptype":"article","src":"https://openalex.org/W1974645707","eid":"W1974645707"},{"id":"paper-w4316876990","cat":"papers","name":"Is psilocybin an effective antidepressant and what is its Mechanism of action?","year":"2023","cit":7,"pfa":"J. John Mann","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4316876990","eid":"W4316876990"},{"id":"paper-w2141646343","cat":"papers","name":"On the conformational varieties of 5-methoxy-N,N-dimethyltryptamine and serotonin in crystalline environment","year":"1977","cit":7,"pfa":"J. Caillet","psa":"B. Pullman","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2141646343","eid":"W2141646343"},{"id":"paper-w4294189301","cat":"papers","name":"Association of Psilocybin Use in Adolescents with Major Depressive Episode","year":"2022","cit":7,"pfa":"Kaushal Shah","psa":"W. Tankersley","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4294189301","eid":"W4294189301"},{"id":"paper-w4403500881","cat":"papers","name":"Misrepresentation of MDMA in the United States, 1999–2023","year":"2024","cit":7,"pfa":"Eric L. Sevigny","psa":"Russell Lea","ptype":"article","src":"https://openalex.org/W4403500881","eid":"W4403500881"},{"id":"paper-w3170584409","cat":"papers","name":"Salvinorin A inhibits ovalbumin‐stimulated allergic rhinitis and RBL‐2H3 cells degranulation","year":"2021","cit":7,"pfa":"Qiyang Shou","psa":"Faying Xu","ptype":"article","src":"https://openalex.org/W3170584409","eid":"W3170584409"},{"id":"paper-w4408302497","cat":"papers","name":"Transient destabilization of whole brain dynamics induced by N,N-Dimethyltryptamine (DMT)","year":"2025","cit":7,"pfa":"Juan Piccinini","psa":"Enzo Tagliazucchi","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4408302497","eid":"W4408302497"},{"id":"paper-w4388526165","cat":"papers","name":"Ayahuasca ceremony leaders’ perspectives on special considerations for eating disorders","year":"2023","cit":7,"pfa":"Meris Williams","psa":"Adèle Lafrance","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4388526165","eid":"W4388526165"},{"id":"paper-w4386541001","cat":"papers","name":"Psilocybin for anorexia nervosa: If it helps, let’s learn how","year":"2023","cit":7,"pfa":"Evelyn Attia","psa":"JOANNA E. STEINGLASS","ptype":"article","src":"https://openalex.org/W4386541001","eid":"W4386541001"},{"id":"paper-w4409788022","cat":"papers","name":"Dissociable effects of psilocybin and escitalopram for depression on processing of musical surprises","year":"2025","cit":7,"pfa":"Rebecca Harding","psa":"Leor Roseman","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4409788022","eid":"W4409788022"},{"id":"paper-w2124467358","cat":"papers","name":"CHARLATANS, SEEKERS, AND SHAMANS: THE AYAHUASCA BOOM IN WESTERN PERUVIAN AMAZONIA","year":"2011","cit":7,"pfa":"Joshua Homan","topics":["Reviews & meta-analyses"],"ptype":"dissertation","src":"https://openalex.org/W2124467358","eid":"W2124467358"},{"id":"paper-w4365457831","cat":"papers","name":"Mystical and Ego-Dissolution Experiences in Ayahuasca and Jurema Holistic Rituals: An Exploratory Study","year":"2023","cit":7,"pfa":"Robson Savoldi","psa":"Rita Clara de Oliveira Sales","ptype":"article","src":"https://openalex.org/W4365457831","eid":"W4365457831"},{"id":"paper-w2055503453","cat":"papers","name":"Substances Related to the Iboga Alkaloids. Synthesis and Reactions of 3-(2-Indolyl)piperidine","year":"1962","cit":7,"pfa":"John W. Huffman","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2055503453","eid":"W2055503453"},{"id":"paper-w2313223464","cat":"papers","name":"The “E” in Rave: A Profile of Young Ecstasy (MDMA) Users","year":"2003","cit":7,"pfa":"Fanitsa Helen Zervogiannis","psa":"E. Wiechers","ptype":"article","src":"https://openalex.org/W2313223464","eid":"W2313223464"},{"id":"paper-w2084757875","cat":"papers","name":"Acute MDMA and ethanol interaction effects on psychomotor performance","year":"2007","cit":7,"pfa":"Glenn Dumont","psa":"Robbert‐Jan Verkes","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2084757875","eid":"W2084757875"},{"id":"paper-w2904304002","cat":"papers","name":"Effects of ibogaine per os application on redox homeostasis in rat liver and erythrocytes","year":"2018","cit":7,"pfa":"Teodora Vidonja Uzelac","psa":"Duško P. Blagojević","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2904304002","eid":"W2904304002"},{"id":"paper-w2055645823","cat":"papers","name":"The role of the A2A receptor in cell apoptosis caused by MDMA","year":"2013","cit":7,"pfa":"Mehdi Mehdizadeh","psa":"Majid Katebi","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2055645823","eid":"W2055645823"},{"id":"paper-w2089142346","cat":"papers","name":"Drugs and Phantasy: The Effects of LSD, Psilocybin and Sernyl on College Students","year":"1966","cit":7,"pfa":"Sidney Cohen","ptype":"article","src":"https://openalex.org/W2089142346","eid":"W2089142346"},{"id":"paper-w4388420614","cat":"papers","name":"Three Decades of Research on the Development of Ibogaine Treatment of Substance Use Disorders: A Scientometric Analysis","year":"2023","cit":7,"pfa":"Maria Helha Fernandes-Nascimento","psa":"Yuan‐Pang Wang","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4388420614","eid":"W4388420614"},{"id":"paper-w2098513783","cat":"papers","name":"Peyote Alkaloids VI. Peyophorine, a Tetrahydroisoquinoline Cactus Alkaloid Containing an N-Ethyl Group","year":"1968","cit":7,"pfa":"Govind J. Kapadia","psa":"Henry Marshall Fales","ptype":"article","src":"https://openalex.org/W2098513783","eid":"W2098513783"},{"id":"paper-w4297090207","cat":"papers","name":"Development and initial validation of an MDMA/Ecstasy motives assessment","year":"2022","cit":7,"pfa":"James E. Sottile","psa":"Nancy A. Haug","ptype":"article","src":"https://openalex.org/W4297090207","eid":"W4297090207"},{"id":"paper-w3129564972","cat":"papers","name":"Accidental Environmentalism: Nature and Cultivated Affect in European Neoshamanic Ayahuasca Consumption","year":"2021","cit":7,"pfa":"Arne Harms","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W3129564972","eid":"W3129564972"},{"id":"paper-w2041207599","cat":"papers","name":"A comparative study of mescaline and 3,4-dimethoxyphenylethylamine in isolated brain mitochondria and brain homogenate","year":"1971","cit":7,"pfa":"N S Shah","psa":"Harold E. Himwich","ptype":"article","src":"https://openalex.org/W2041207599","eid":"W2041207599"},{"id":"paper-w2218541786","cat":"papers","name":"Validation of the revised mystical experiences questionnaire in experimental sessions with psilocybin","year":"2015","cit":7,"pfa":"Frederick Streeter Barrett","psa":"Roland R. Griffiths","ptype":"article","src":"https://openalex.org/W2218541786","eid":"W2218541786"},{"id":"paper-w3092127417","cat":"papers","name":"The role of dopamine D1 receptors in MDMA-induced memory impairments","year":"2020","cit":7,"pfa":"Hanna Squire","psa":"David N. Harper","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3092127417","eid":"W3092127417"},{"id":"paper-w4237472971","cat":"papers","name":"Ayahuasca–From Dangerous Drug to National Heritage: An Interview with Antonio A. Arantes","year":"2009","cit":7,"pfa":"Beatriz Caiuby Labate","psa":"Campinas State Univesity","ptype":"article","src":"https://openalex.org/W4237472971","eid":"W4237472971"},{"id":"paper-w4390144601","cat":"papers","name":"Quantification of psilocin in human whole blood using liquid chromatography–tandem mass spectrometry ( LC–MS / MS )","year":"2023","cit":7,"pfa":"Munchelou M Gomonit","psa":"Madeleine J. Swortwood","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4390144601","eid":"W4390144601"},{"id":"paper-w4390452945","cat":"papers","name":"Amygdala response to emotional faces following acute administration of psilocybin in healthy individuals","year":"2023","cit":7,"pfa":"Sophia Armand","psa":"Patrick M. Fisher","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4390452945","eid":"W4390452945"},{"id":"paper-w4406851907","cat":"papers","name":"Molecular insights into the modulation of the 5 HT 2 A receptor by serotonin, psilocin, and the G protein subunit Gqα","year":"2025","cit":7,"pfa":"Niklas Viohl","psa":"Himanshu Khandelia","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4406851907","eid":"W4406851907"},{"id":"paper-w4367723807","cat":"papers","name":"Case report: Prolonged amelioration of mild red-green color vision deficiency following psilocybin mushroom use","year":"2023","cit":7,"pfa":"Brian Scott Barnett","psa":"Peter S. Hendricks","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4367723807","eid":"W4367723807"},{"id":"paper-w4407830376","cat":"papers","name":"Long-Term Mental Health and Wellbeing Outcomes Associated with Naturalistic Ayahuasca Consumption","year":"2025","cit":7,"pfa":"Broc A. Pagni","psa":"Diana O. Perkins","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4407830376","eid":"W4407830376"},{"id":"paper-w4417520188","cat":"papers","name":"The serotonin 1B receptor is required for some of the behavioral effects of psilocybin in mice","year":"2025","cit":7,"pfa":"Sixtine Fleury","psa":"Katherine M. Nautiyal","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4417520188","eid":"W4417520188"},{"id":"paper-w4379284995","cat":"papers","name":"Reduced brain responsiveness to emotional stimuli with escitalopram but not psilocybin therapy for depression","year":"2023","cit":7,"pfa":"Matthew B. Wall","psa":"Robin Lester Carhart-Harris","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4379284995","eid":"W4379284995"},{"id":"paper-w2580886214","cat":"papers","name":"LC-MS/MS Analysis of MDMA in Ecstasy Tablets in Morocco","year":"2015","cit":7,"pfa":"Belafkih B Belouafa S","psa":"Bennamara A Skalli A","ptype":"article","src":"https://openalex.org/W2580886214","eid":"W2580886214"},{"id":"paper-w4412073006","cat":"papers","name":"The therapeutic potential of psilocybin beyond psychedelia through shared mechanisms with ketamine","year":"2025","cit":7,"pfa":"Dongsun Park","psa":"Ji‐Woon Kim","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4412073006","eid":"W4412073006"},{"id":"paper-w3199415517","cat":"papers","name":"Ayahuasca Lyophilization (Freeze-drying) Protocol with Pre- and Post-procedure Alkaloids Quantification","year":"2021","cit":7,"pfa":"Dimitri Daldegan‐Bueno","psa":"Maria Gabriela Menezes Oliveira","ptype":"article","src":"https://openalex.org/W3199415517","eid":"W3199415517"},{"id":"paper-w3118877797","cat":"papers","name":"A Systematic Review of the MDMA Model to Address Social Impairment in Autism","year":"2021","cit":7,"pfa":"Devahuti Rai Chaliha","psa":"Mauro Vaccarezza","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W3118877797","eid":"W3118877797"},{"id":"paper-w4385892627","cat":"papers","name":"Moving beyond a figurative psychedelic literacy: Metaphors of psychiatric symptoms in ayahuasca narratives","year":"2023","cit":7,"pfa":"Alex K. Gearin","ptype":"article","src":"https://openalex.org/W4385892627","eid":"W4385892627"},{"id":"paper-w7161045271","cat":"papers","name":"Inaugural year of regulated psilocybin services in Oregon: safety, motivations, and utilization","year":"2026","cit":7,"pfa":"Feliciano Yu","psa":"Stephen Dahmer","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7161045271","eid":"W7161045271"},{"id":"paper-w2171746192","cat":"papers","name":"Healing with Ayahuasca: Notes on Therapeutic Rituals and Effects in European Patients Treating Their Diseases","year":"2013","cit":7,"pfa":"Janine Tatjana Schmid","ptype":"book-chapter","src":"https://openalex.org/W2171746192","eid":"W2171746192"},{"id":"paper-w4231502627","cat":"papers","name":"Oxidative Cyclization of Nb-Dimethyltryptamine, 3-Indolepropanol, and 3-Indolepropnethiol with N-Bromo- or N-Chlorosuccinimide","year":"1975","cit":7,"pfa":"Tohru Hino","psa":"Masako Nakagawa","ptype":"article","src":"https://openalex.org/W4231502627","eid":"W4231502627"},{"id":"paper-w4411327114","cat":"papers","name":"Long‐term benefits of single‐dose psilocybin in depressed patients with cancer","year":"2025","cit":7,"pfa":"Manish Agrawal","psa":"Ezekiel Emanuel","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4411327114","eid":"W4411327114"},{"id":"paper-w4387661757","cat":"papers","name":"Acute but not long-lasting antidepressant-like effect of psilocybin in differential reinforcement of low-rate 72 schedule in rats","year":"2023","cit":7,"pfa":"Natalia Malikowska‐Racia","psa":"Piotr Popik","topics":["Depression","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4387661757","eid":"W4387661757"},{"id":"paper-w1772530809","cat":"papers","name":"Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans: Lost in translation","year":"2013","cit":7,"pfa":"Cédric M. Hysek","psa":"Matthias E. Liechti","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1772530809","eid":"W1772530809"},{"id":"paper-w2042252540","cat":"papers","name":"Effects of MDMA administration on scopolamine-induced disruptions of learning and performance in rats","year":"2004","cit":7,"pfa":"Peter John Winsauer","psa":"S.B. Stroble","ptype":"article","src":"https://openalex.org/W2042252540","eid":"W2042252540"},{"id":"paper-w2726157610","cat":"papers","name":"Isolated non-cardiogenic pulmonary edema — A rare complication of MDMA toxicity","year":"2017","cit":7,"pfa":"Astrid Haaland","psa":"Matt S. Friedman","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2726157610","eid":"W2726157610"},{"id":"paper-w3112419964","cat":"papers","name":"Two Decades of Ecstasy: Shifting Demographic Trends in Decedents Using MDMA","year":"2020","cit":7,"pfa":"Patil Armenian","psa":"Luke N. Rodda","ptype":"article","src":"https://openalex.org/W3112419964","eid":"W3112419964"},{"id":"paper-w4417166023","cat":"papers","name":"Psilocybin in late-life mental health: Addressing depression, loneliness, and existential anxiety","year":"2025","cit":7,"pfa":"Gerasimos Konstantinou","psa":"Daniel M. Blumberger","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4417166023","eid":"W4417166023"},{"id":"paper-w4412185797","cat":"papers","name":"MDMA-assisted therapy as a treatment for major depressive disorder: proof of principle study","year":"2025","cit":7,"pfa":"Tor-Morten Kvam","psa":"Ole A. Andreassen","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4412185797","eid":"W4412185797"},{"id":"paper-w4386852375","cat":"papers","name":"Dynamic Functional Hyperconnectivity after Psilocybin Intake is Primarily Associated with Oceanic Boundlessness","year":"2023","cit":7,"pfa":"Sepehr Mortaheb","psa":"Athéna Demertzi","ptype":"preprint","src":"https://openalex.org/W4386852375","eid":"W4386852375"},{"id":"paper-w2118739703","cat":"papers","name":"5-Methoxy-NN-dimethyltryptamine: differential modulation of the rewarding and aversive components of lateral hypothalamic self-stimulation","year":"1978","cit":7,"pfa":"John D. Sinden","psa":"Dale M. Atrens","ptype":"article","src":"https://openalex.org/W2118739703","eid":"W2118739703"},{"id":"paper-w2128258616","cat":"papers","name":"MDMA-induced acute pulmonary edema in a patient without other organ dysfunction","year":"2006","cit":7,"pfa":"Shih-Heng Chang","psa":"Cheng‐Chung Fang","ptype":"article","src":"https://openalex.org/W2128258616","eid":"W2128258616"},{"id":"paper-w4392116348","cat":"papers","name":"Building Alien Worlds - The Neuropsychological and Evolutionary Implications of the Astonishing Psychoactive Effects of N,N-Dimethyltryptamine (DMT)","year":"2013","cit":7,"pfa":"Andrew Gallimore","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4392116348","eid":"W4392116348"},{"id":"paper-w5824509","cat":"papers","name":"The effect of LSD, psilocybin, harmaline and amphetamine on the body temperature of para-chlorophenylalanine pretreated rabbits.","year":"1973","cit":7,"pfa":"Ole Ladefoged","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W5824509","eid":"W5824509"},{"id":"paper-w2147680927","cat":"papers","name":"Beiträge zur Chemie des Indols, V. Synthesen in der Iboga‐Reihe, II. 8‐Oxodesäthylibogain und Desäthylisoibogain","year":"1973","cit":7,"pfa":"Peter Rosenmund","psa":"Rainer Frische","ptype":"article","src":"https://openalex.org/W2147680927","eid":"W2147680927"},{"id":"paper-w2102065693","cat":"papers","name":"Hypothyroidism alters striatal dopamine release mediated by 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)","year":"2006","cit":7,"pfa":"Andrea L. Peterson","psa":"Jon E. Sprague","ptype":"article","src":"https://openalex.org/W2102065693","eid":"W2102065693"},{"id":"paper-w4411370385","cat":"papers","name":"Safety, tolerability and subjective effects of vaporized N,N-Dimethyltryptamine: A randomized double-blind clinical trial","year":"2025","cit":7,"pfa":"Isabel Wießner","psa":"Fernanda Palhano-Fontes","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4411370385","eid":"W4411370385"},{"id":"paper-w2610608883","cat":"papers","name":"Anxiety, panic, and hopelessness during and after ritual ayahuasca intake in a woman with generalized anxiety disorder: A case report","year":"2017","cit":7,"pfa":"RAFAEL GUIMARÃES DOS SANTOS","psa":"Jaime E. C. Hallak","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2610608883","eid":"W2610608883"},{"id":"paper-w4210846812","cat":"papers","name":"Psilocybin: Characterization of the Metastable Zone Width (MSZW), Control of Anhydrous Polymorphs, and Particle Size Distribution (PSD)","year":"2022","cit":7,"pfa":"Robert B. Kargbo","psa":"Solomon B. Abebe","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4210846812","eid":"W4210846812"},{"id":"paper-w97199188","cat":"papers","name":"The neurotoxic effects of methylenedioxymethamphetamine (MDMA) and its metabolites on rat brain spheroids in culture","year":"1999","cit":7,"pfa":"Tracy M. Walker","psa":"C.K. Atterwill","ptype":"article","src":"https://openalex.org/W97199188","eid":"W97199188"},{"id":"paper-w1994396147","cat":"papers","name":"In vitro neuronal and vascular responses to 5‐HT in rats chronically exposed to MDMA","year":"2001","cit":7,"pfa":"Dara M. Cannon","psa":"Gethin J. McBean","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1994396147","eid":"W1994396147"},{"id":"paper-w4410444635","cat":"papers","name":"Tū Wairua: Development of an Indigenous Rongoā Māori approach to healing with psilocybin containing mushrooms","year":"2025","cit":7,"pfa":"Anna-Leigh Hodge","psa":"Patrick McHugh","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4410444635","eid":"W4410444635"},{"id":"paper-w1975926010","cat":"papers","name":"5HT, MDMA (Ecstasy), and Nimodipine Effects on 45Ca‐Uptake into Rat Brain Synaptosomes","year":"1991","cit":7,"pfa":"W. K. Park","psa":"Efrain C. Azmitia","ptype":"article","src":"https://openalex.org/W1975926010","eid":"W1975926010"},{"id":"paper-w2757580232","cat":"papers","name":"Imaginação, linguagem, espíritos e agência: ayahuasca e o tratamento da dependência química","year":"2017","cit":7,"pfa":"Marcelo Simão Mercante","ptype":"article","src":"https://openalex.org/W2757580232","eid":"W2757580232"},{"id":"paper-w4396720923","cat":"papers","name":"Evolving Guidelines for the Use of Touch During a Clinical Trial of Group Psilocybin-Assisted Therapy","year":"2024","cit":7,"pfa":"Anthony L. Back","psa":"Bonnie McGregor","topics":["Safety & adverse events","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4396720923","eid":"W4396720923"},{"id":"paper-w4407595168","cat":"papers","name":"MDMA-Assisted Therapy for Post-Traumatic Stress Disorder: Regulatory Challenges and a Path Forward","year":"2025","cit":7,"pfa":"Balwinder Singh","topics":["PTSD & trauma","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4407595168","eid":"W4407595168"},{"id":"paper-w2080108774","cat":"papers","name":"Intrathecal noradrenaline restores 5-methoxy-N,N-dimethyltryptamine induced antinociception abolished by intrathecal 6-hydroxydopamine","year":"1988","cit":7,"pfa":"Bruce G. Minor","psa":"Trevor Archer","ptype":"article","src":"https://openalex.org/W2080108774","eid":"W2080108774"},{"id":"paper-w2314362530","cat":"papers","name":"Differentiation of the 2,3-Methylenedioxy Regioisomer of 3,4-MDMA (Ecstasy) by Gas Chromatography-Mass Spectrometry","year":"2002","cit":7,"pfa":"John T. Cody","psa":"Sandra Valtier","ptype":"article","src":"https://openalex.org/W2314362530","eid":"W2314362530"},{"id":"paper-w4307690516","cat":"papers","name":"On epistemic injustices, biomedical research with Indigenous people, and the legal regulation of ayahuasca in Brazil: The production of new injustices?","year":"2022","cit":7,"pfa":"Beatriz Caiuby Labate","psa":"Clancy Cavnar","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4307690516","eid":"W4307690516"},{"id":"paper-w1580556483","cat":"papers","name":"Cognitive and physiological effects of 3,4-methylenedioxymethamphetamine (MDMA or 'ecstasy') in combination with alcohol or cannabis in humans","year":"2009","cit":7,"pfa":"Glenn Dumont","topics":["Addiction"],"ptype":"dissertation","src":"https://openalex.org/W1580556483","eid":"W1580556483"},{"id":"paper-w2086947924","cat":"papers","name":"Effects of repeated MDMA administration on the motivation for palatable food and extinction of operant responding in mice","year":"2010","cit":7,"pfa":"Ainhoa Plaza‐Zabala","psa":"Patricia Robledo","ptype":"article","src":"https://openalex.org/W2086947924","eid":"W2086947924"},{"id":"paper-w4318054810","cat":"papers","name":"Dantrolene sodium fails to reverse robust brain hyperthermia induced by MDMA and methamphetamine in rats","year":"2023","cit":7,"pfa":"Keaton T. Cameron-Burr","psa":"Eugene A. Kiyatkin","ptype":"article","src":"https://openalex.org/W4318054810","eid":"W4318054810"},{"id":"paper-w4285999791","cat":"papers","name":"The promise of 3,4-methylenedioxymethamphetamine (MDMA) in combination with prolonged exposure therapy for posttraumatic stress disorder","year":"2022","cit":7,"pfa":"BARBARA OLASOV ROTHBAUM","psa":"Jessica L. Maples‐Keller","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4285999791","eid":"W4285999791"},{"id":"paper-w2397526061","cat":"papers","name":"Effects of LSD-25, n,n-dimethyltryptamine (DMT), and N,N-diethyltryptamine (DET) on the photic evoked responses in the unanesthetized rabbit.","year":"1965","cit":7,"pfa":"Naim Khazan","psa":"D McCash","ptype":"article","src":"https://openalex.org/W2397526061","eid":"W2397526061"},{"id":"paper-w4404876722","cat":"papers","name":"Estimating illicit production of MDMA from its production waste, a Dutch case study","year":"2024","cit":7,"pfa":"Thomas L. ter Laak","psa":"Pim de Voogt","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4404876722","eid":"W4404876722"},{"id":"paper-w2273177719","cat":"papers","name":"Effects of MDMA Injections on the Behavior of Socially-Housed Long-Tailed Macaques (Macaca fascicularis)","year":"2016","cit":7,"pfa":"Sébastien Ballesta","psa":"Jean‐René Duhamel","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2273177719","eid":"W2273177719"},{"id":"paper-w4385664009","cat":"papers","name":"“But the reality is it's happening”: A qualitative study of eating disorder providers about psilocybin‐assisted psychotherapy","year":"2023","cit":7,"pfa":"Amanda E. Downey","psa":"Marissa Raymond‐Flesch","topics":["Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4385664009","eid":"W4385664009"},{"id":"paper-w4387941143","cat":"papers","name":"Psilocybin-assisted psychotherapy for the treatment of PTSD in UK armed forces veterans: A feasibility study protocol","year":"2023","cit":7,"pfa":"Natasha Biscoe","psa":"Dominic Murphy","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4387941143","eid":"W4387941143"},{"id":"paper-w2989777633","cat":"papers","name":"Behavioral and Stereological Analysis of the Effects of Intermittent Feeding Diet on the Orally Administrated MDMA (\"ecstasy\") in Mice.","year":"2017","cit":7,"pfa":"Zeinab Ebrahimian","psa":"Mohsen Raza Haidari","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2989777633","eid":"W2989777633"},{"id":"paper-w4409693197","cat":"papers","name":"Comprehensive analysis of 42 psilocybin-producing fungal strains reveals metabolite diversity and species-specific clusters","year":"2025","cit":7,"pfa":"Jonathan A. Cohen","psa":"David Meiri","ptype":"article","src":"https://openalex.org/W4409693197","eid":"W4409693197"},{"id":"paper-w2134501828","cat":"papers","name":"Chemiluminescence detection of MDMA in street drug samples using tris(2,2′‐bipyridine)ruthenium(III)","year":"2015","cit":7,"pfa":"Ashton G. Theakstone","psa":"Paul S. Francis","ptype":"article","src":"https://openalex.org/W2134501828","eid":"W2134501828"},{"id":"paper-w4300688597","cat":"papers","name":"Associations between MDMA/ecstasy use and physical health in a U.S. population-based survey sample","year":"2022","cit":7,"pfa":"Grant M. Jones","psa":"Otto Simonsson","topics":["PTSD & trauma","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4300688597","eid":"W4300688597"},{"id":"paper-w1985877537","cat":"papers","name":"MDMA-evoked changes in the binding of dopamine D2receptor ligands in striatum of rats with unilateral serotonin depletion","year":"2009","cit":7,"pfa":"Søren Dinesen Østergaard","psa":"Paul D. Cumming","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1985877537","eid":"W1985877537"},{"id":"paper-w7125419354","cat":"papers","name":"No evidence of immediate or persistent analgesic effect from a single dose of psilocybin in three mouse models of pain","year":"2026","cit":7,"pfa":"Nicholas Gregory","psa":"Boris Dov Heifets","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7125419354","eid":"W7125419354"},{"id":"paper-w1539048949","cat":"papers","name":"Effects of Repeated Administration of 3,4-methylenedioxymethamphetamine (MDMA) on Avoidance Memory and Cell Density in Rats' Hippocampus.","year":"2013","cit":7,"pfa":"Mehrdad Jahanshahi","psa":"Fatemeh Babakordi","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1539048949","eid":"W1539048949"},{"id":"paper-w1984008918","cat":"papers","name":"Activation of 5-HT3 receptors leads to altered responses 6 months after MDMA treatment","year":"2010","cit":7,"pfa":"Norbert Gyöngyösi","psa":"György Bagdy","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1984008918","eid":"W1984008918"},{"id":"paper-w4404645307","cat":"papers","name":"Associations Between Ayahuasca Use in Naturalistic Settings and Mental Health and Wellbeing Outcomes: Analysis of a Large Global Dataset","year":"2024","cit":7,"pfa":"Daniel Perkins","psa":"Violeta Schubert","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4404645307","eid":"W4404645307"},{"id":"paper-w4327814238","cat":"papers","name":"Yale Program for Psychedelic Science (YPPS) Manual for Psilocybin Combined with Non-Directive Support in the Treatment of OCD","year":"2023","cit":7,"pfa":"Terence H. W. Ching","psa":"Benjamin Kelmendi","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4327814238","eid":"W4327814238"},{"id":"paper-w4306668934","cat":"papers","name":"Effect of MDMA exposure during pregnancy on cell apoptosis, astroglia, and microglia activity in rat offspring striatum.","year":"2022","cit":7,"pfa":"Zahra Nazari","psa":"Mohammad Jafar Golalipour","ptype":"article","src":"https://openalex.org/W4306668934","eid":"W4306668934"},{"id":"paper-w4401484649","cat":"papers","name":"Retraction Note: Discontinuation of medications classified as reuptake inhibitors affects treatment response of MDMA-assisted psychotherapy","year":"2024","cit":7,"pfa":"Allison A. Feduccia","psa":"Julie A. Holland","topics":["Therapy practice"],"ptype":"retraction","src":"https://openalex.org/W4401484649","eid":"W4401484649"},{"id":"paper-w1512363483","cat":"papers","name":"Análisis del Método de Evaluación de Riesgo (MER) del \"Falso peyote\" (Astrophytum asterias (Zucc) Lem.) en México","year":"2004","cit":7,"pfa":"José Guadalupe Martínez-Ávalos","psa":"Johannes Verhulst","ptype":"article","src":"https://openalex.org/W1512363483","eid":"W1512363483"},{"id":"paper-w4393052553","cat":"papers","name":"Harm reduction behaviours and harm experiences of people who use 3,4-methylenedioxymethamphetamine (MDMA) in Aotearoa New Zealand","year":"2024","cit":7,"pfa":"Jai Whelan","psa":"Ryan D. Ward","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4393052553","eid":"W4393052553"},{"id":"paper-w4401430306","cat":"papers","name":"Expert opinions on implementation of MDMA-assisted therapy in Europe: critical appraisal towards training, clinical practice, and regulation","year":"2024","cit":7,"pfa":"Jerome Herpers","psa":"Eric H. G. J. M. Vermetten","topics":["PTSD & trauma","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4401430306","eid":"W4401430306"},{"id":"paper-w4377023531","cat":"papers","name":"Concomitant medications associated with ischemic, hypertensive, and arrhythmic events in MDMA users in FDA adverse event reporting system","year":"2023","cit":7,"pfa":"Tigran Makunts","psa":"Ruben A Abagyan","topics":["PTSD & trauma","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4377023531","eid":"W4377023531"},{"id":"paper-w4407945019","cat":"papers","name":"Psilocin, A Psychedelic Drug, Exerts Anticonvulsant Effects Against PTZ‐ and MES‐Induced Seizures in Mice via 5‐HT1A and CB1 Receptors: Involvement of Nitrergic, Opioidergic, and Kynurenine Pathways","year":"2025","cit":7,"pfa":"Mohammad Balabandian","psa":"Ahmad Reza Dehpour","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4407945019","eid":"W4407945019"},{"id":"paper-w2127708912","cat":"papers","name":"Diseños materiales e inmateriales: la patrimonialización del kené shipibo-konibo y de la ayahuasca en el Perú","year":"2012","cit":7,"pfa":"Luisa Elvira Belaúnde","ptype":"article","src":"https://openalex.org/W2127708912","eid":"W2127708912"},{"id":"paper-w3041687470","cat":"papers","name":"Synchrotron far-infrared spectra for the characterisation of molecular crystals of forensic interest: Amphetamine, methamphetamine, MDA, MDMA and substituted methcathinones","year":"2020","cit":7,"pfa":"William F. Graf","psa":"Courtney P. Ennis","ptype":"article","src":"https://openalex.org/W3041687470","eid":"W3041687470"},{"id":"paper-w4404245243","cat":"papers","name":"Detection of low‐level fentanyl concentrations in mixtures of cocaine, MDMA , methamphetamine, and caffeine via surface‐enhanced Raman spectroscopy","year":"2024","cit":7,"pfa":"Saiqa Muneer","psa":"Joanne T. Blanchfield","ptype":"article","src":"https://openalex.org/W4404245243","eid":"W4404245243"},{"id":"paper-w4387965017","cat":"papers","name":"Does MDMA have treatment potential in sexual dysfunction? A systematic review of outcomes across the female and male sexual response cycles","year":"2023","cit":7,"pfa":"Ava Wexler","psa":"KARYN SCHLUNT EILBER","topics":["Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4387965017","eid":"W4387965017"},{"id":"paper-w2101492421","cat":"papers","name":"The Identification of 3,4-MDMA from Its Mass Equivalent Isomers and Isobaric Substances Using Fast LC-ESI-MS-MS","year":"2005","cit":7,"pfa":"Katja Pihlainen","psa":"Risto K. Kostiainen","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2101492421","eid":"W2101492421"},{"id":"paper-w1998199235","cat":"papers","name":"TLC Profiling of Impurities of 1‐(3,4‐Methylenedioxyphenyl)‐2‐nitropropene an Intermediate in MDMA Synthesis. Influence of Sample Preparation Methods and Conditions","year":"2004","cit":7,"pfa":"Jolanta Kochana","psa":"A. Parczewski","ptype":"article","src":"https://openalex.org/W1998199235","eid":"W1998199235"},{"id":"paper-w2038890629","cat":"papers","name":"Low ambient temperature reveals distinct mechanisms for MDMA-induced serotonergic toxicity and astroglial Hsp27 heat shock response in rat brain","year":"2011","cit":7,"pfa":"Csaba Ádori","psa":"György Bagdy","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2038890629","eid":"W2038890629"},{"id":"paper-w1972057756","cat":"papers","name":"The reality of psychomotor problems, and the possibility of Parkinson?s disorder, in some recreational ecstasy/MDMA users: a rejoinder to Sumnall et al. (2003)","year":"2004","cit":7,"pfa":"Andrew C. Parrott","psa":"Jonathan Ling","ptype":"article","src":"https://openalex.org/W1972057756","eid":"W1972057756"},{"id":"paper-w4405215942","cat":"papers","name":"Worsening suicidal ideation and prolonged adverse event following psilocybin administration in a clinical setting: case report and thematic analysis of one participant's experience","year":"2024","cit":7,"pfa":"Mourad Wahba","psa":"Hamish McAllister-Williams","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4405215942","eid":"W4405215942"},{"id":"paper-w2059839718","cat":"papers","name":"The psychobiology of MDMA or 'ecstasy': Symposium arranged by the Psychobiology Section, at the Annual Conference of the British Psychological Society, Heriot-Watt University, Edinburgh, April 1997","year":"1998","cit":7,"pfa":"Andrew C. Parrott","ptype":"article","src":"https://openalex.org/W2059839718","eid":"W2059839718"},{"id":"paper-w3110843322","cat":"papers","name":"In utero exposure to dexamethasone causes a persistent and age-dependent exacerbation of the neurotoxic effects and glia activation induced by MDMA in dopaminergic brain regions of C57BL/6J mice","year":"2020","cit":7,"pfa":"Giulia Costa","psa":"Micaela Morelli","ptype":"article","src":"https://openalex.org/W3110843322","eid":"W3110843322"},{"id":"paper-w4412197020","cat":"papers","name":"Unequal representation? A cross-sectional analysis of age, sex, race, and ethnicity in clinical trials of classic psychedelics","year":"2025","cit":7,"pfa":"Damian Świeczkowski","psa":"Wiesław Jerzy Cubała","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4412197020","eid":"W4412197020"},{"id":"paper-w1984851629","cat":"papers","name":"Determinação de 3,4-metilenodioximetanfetamina (MDMA) em comprimidos de Ecstasy por cromatografia líquida de alta eficiência com detecção por fluorescência (CLAE-DF)","year":"2009","cit":7,"pfa":"José Luiz Costa","psa":"Osvaldo Negrini Neto","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1984851629","eid":"W1984851629"},{"id":"paper-w3215301772","cat":"papers","name":"Psychedelics and Hallucinogens in Psychiatry: Finding New Pharmacological Targets","year":"2021","cit":7,"pfa":"Teresa Reynolds de Sousa","psa":"Filipa Novais","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3215301772","eid":"W3215301772"},{"id":"paper-w2995066639","cat":"papers","name":"Utilisation des psychédéliques en psychiatrie : lien avec les neurotrophines","year":"2019","cit":7,"pfa":"Rémi Corne","psa":"Raymond Mongeau","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W2995066639","eid":"W2995066639"},{"id":"paper-w2503194639","cat":"papers","name":"Molecular and Cellular Basis of Hallucinogen Action","year":"2016","cit":7,"pfa":"James B. Hanks","psa":"Javier González‐Maeso","ptype":"book-chapter","src":"https://openalex.org/W2503194639","eid":"W2503194639"},{"id":"paper-w4388895428","cat":"papers","name":"Biological studies of clavine alkaloids targeting CNS receptors","year":"2023","cit":7,"pfa":"Nikhil R. Tasker","psa":"Peter Wipf","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4388895428","eid":"W4388895428"},{"id":"paper-w4316511320","cat":"papers","name":"Recruitment discrimination of lifetime classic psychedelic users is unjustified: Evidence from employees' motivation-based workplace absenteeism","year":"2023","cit":7,"pfa":"Benjamin A. Korman","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4316511320","eid":"W4316511320"},{"id":"paper-w4402656108","cat":"papers","name":"Philosophical Perspectives on Psychedelic Psychiatry","year":"2024","cit":7,"pfa":"Chris Letheby","psa":"Philip Gerrans","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"book","src":"https://openalex.org/W4402656108","eid":"W4402656108"},{"id":"paper-w2422301477","cat":"papers","name":"Self-association and Binding Sites of Some Psychotomimetic Tryptamine Derivatives and Related Compounds: Nuclear Magnetic Resonance Investigations","year":"1976","cit":7,"pfa":"Helmut Sapper","psa":"W. LOHMANN","ptype":"article","src":"https://openalex.org/W2422301477","eid":"W2422301477"},{"id":"paper-w4406628630","cat":"papers","name":"Effects of psychedelics on opioid use disorder: a scoping review of preclinical studies","year":"2025","cit":7,"pfa":"Alejandra Pulido-Saavedra","psa":"Gustavo A. Angarita","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4406628630","eid":"W4406628630"},{"id":"paper-w4294911981","cat":"papers","name":"Psychedelics in the Treatment of Substance Use Disorders","year":"2022","cit":7,"pfa":"Brian Scott Barnett","psa":"Jeremy Weleff","topics":["Addiction","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4294911981","eid":"W4294911981"},{"id":"paper-w4400297240","cat":"papers","name":"Protective Behavioral Strategies for Psychedelic Use: A Mini Review of the Evidence","year":"2024","cit":7,"pfa":"Cianna J Piercey","psa":"Hollis C. Karoly","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4400297240","eid":"W4400297240"},{"id":"paper-w4401966685","cat":"papers","name":"Psychedelika und Dissoziativa in der Psychiatrie: Herausforderungen in der Behandlung","year":"2024","cit":7,"pfa":"Johannes Jungwirth","psa":"Boris B. Quednow","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4401966685","eid":"W4401966685"},{"id":"paper-w7117705718","cat":"papers","name":"Efficacy and Safety of Psychedelics in Mental Disorder Cases: An Umbrella Review of Meta-Analyses of Randomized Controlled Trials","year":"2025","cit":7,"pfa":"Monika Dominiak","psa":"Anna Zofia Antosik-Wójcińska","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7117705718","eid":"W7117705718"},{"id":"paper-w2328362373","cat":"papers","name":"LSD-Induced Decrease in Serum Prolactin in Rats","year":"1971","cit":7,"pfa":"S. KALEEM QUADRI","psa":"J. Meites","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2328362373","eid":"W2328362373"},{"id":"paper-w4294203445","cat":"papers","name":"A Review of Aeruginascin and Potential Entourage Effect in Hallucinogenic Mushrooms","year":"2022","cit":7,"pfa":"Pierre S. Chue","psa":"J. Chue","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4294203445","eid":"W4294203445"},{"id":"paper-w4404599367","cat":"papers","name":"Pattern of psychedelic substance use: a comparison between populations in Spain and South America using the Psychedelic Use Scale (PUS)","year":"2024","cit":7,"pfa":"Jaime Rojas‐Hernández","psa":"Luis Alberto Henríquez‐Hernández","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4404599367","eid":"W4404599367"},{"id":"paper-w2036816089","cat":"papers","name":"The design of some new compounds to block psychotomimetic drugs","year":"1972","cit":7,"pfa":"John Smythies","psa":"Richard D. Morin","ptype":"article","src":"https://openalex.org/W2036816089","eid":"W2036816089"},{"id":"paper-w3175025894","cat":"papers","name":"Psychedelics Improve the Mental Health of Rats","year":"2019","cit":7,"pfa":"Meghan Hibicke","psa":"Charles David Nichols","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3175025894","eid":"W3175025894"},{"id":"paper-w2002362539","cat":"papers","name":"Chemical Interactions with Pyramidal Neurons in Layer 5 of the Cerebral Cortex: Control of Pain and Anxiety","year":"2009","cit":7,"pfa":"J. Adams Jr.","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2002362539","eid":"W2002362539"},{"id":"paper-w4410132242","cat":"papers","name":"The Role of Touch in Psychedelic Therapy: Perspectives From a Survey of Practitioners in Research Settings","year":"2025","cit":7,"pfa":"David A. Bender","psa":"Eric J. Lenze","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4410132242","eid":"W4410132242"},{"id":"paper-w2413567287","cat":"papers","name":"The Lack of Correlation between Hallucinogenesis and Inhibition of Axoplasmic Transport","year":"1974","cit":7,"pfa":"James C. Paulson","psa":"Wllliam O. McCLURE","ptype":"article","src":"https://openalex.org/W2413567287","eid":"W2413567287"},{"id":"paper-w2033350770","cat":"papers","name":"Influence of naloxone on the effects of lsd in monkeys","year":"1984","cit":7,"pfa":"David C. Hadorn","psa":"J CONNOR","ptype":"article","src":"https://openalex.org/W2033350770","eid":"W2033350770"},{"id":"paper-w4391734692","cat":"papers","name":"Psychedelic Microdosing among Young Adults from Southern California","year":"2024","cit":7,"pfa":"Alyssa F. Harlow","psa":"Jessica L. Barrington‐Trimis","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4391734692","eid":"W4391734692"},{"id":"paper-w4407778998","cat":"papers","name":"Psychedelics and Suicide-Related Outcomes: A Systematic Review","year":"2025","cit":7,"pfa":"Shakila Meshkat","psa":"Venkat Bhat","topics":["PTSD & trauma","Safety & adverse events","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W4407778998","eid":"W4407778998"},{"id":"paper-w2044407236","cat":"papers","name":"The substanceou l’histoire mouvementée du LSD","year":"2013","cit":7,"pfa":"François Beck","psa":"Nicolas Bonnet","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2044407236","eid":"W2044407236"},{"id":"paper-w2024879690","cat":"papers","name":"Genetic effects of LSD-25 on E. coli","year":"1970","cit":7,"pfa":"Edwin Vann","psa":"H.W. Rossmoore","ptype":"article","src":"https://openalex.org/W2024879690","eid":"W2024879690"},{"id":"paper-w2918563737","cat":"papers","name":"A rare case of physical dependence with psychedelic LSD - A case report","year":"2019","cit":7,"pfa":"Tamonud Modak","psa":"Ravindra Rao","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2918563737","eid":"W2918563737"},{"id":"paper-w4404743266","cat":"papers","name":"Participants’ Experience of Psychedelic Integration Groups and Processes: A Qualitative Thematic Analysis","year":"2024","cit":7,"pfa":"Nadav Liam Modlin","psa":"James Rucker","topics":["Safety & adverse events","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4404743266","eid":"W4404743266"},{"id":"paper-w1985891145","cat":"papers","name":"EEG effects of hallucinogens and cannabinoids using sleep-waking behavior as baseline","year":"1980","cit":7,"pfa":"Matthew Fairchild","psa":"Coralee Yale","ptype":"article","src":"https://openalex.org/W1985891145","eid":"W1985891145"},{"id":"paper-w1977788868","cat":"papers","name":"Marihuana in an Adolescent Psychiatricfd Outpatient Population","year":"1971","cit":7,"pfa":"Arthur Kornhaber","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1977788868","eid":"W1977788868"},{"id":"paper-w1998954579","cat":"papers","name":"Characterization of the discriminative stimulus properties of centrally administered (−)-DOM and LSD","year":"2003","cit":7,"pfa":"Mireille Doat","psa":"Jerrold C. Winter","ptype":"article","src":"https://openalex.org/W1998954579","eid":"W1998954579"},{"id":"paper-w2131589619","cat":"papers","name":"Albert Hofmann, the Father of LSD (1906–2008)","year":"2008","cit":7,"pfa":"Paolo Fusar‐Poli","psa":"Stefan Borgwardt","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2131589619","eid":"W2131589619"},{"id":"paper-w4411961287","cat":"papers","name":"Chemical Composition and Biological Activities of Psilocybe Mushrooms: Gaps and Perspectives","year":"2025","cit":7,"pfa":"Mateus Araújo da Luz","psa":"Maria da Conceição de Menezes Torres","topics":["Depression","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4411961287","eid":"W4411961287"},{"id":"paper-w2661482446","cat":"papers","name":"LSD Detection and Interpretation in Hair","year":"2018","cit":7,"pfa":"Camille Richeval","psa":"Jean‐Michel Gaulier","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2661482446","eid":"W2661482446"},{"id":"paper-w2051196112","cat":"papers","name":"Effects of dopaminergic and cholinergic drugs, naloxone and l-prolyl-leucyl-glycinamide on LSD-induced catalepsy","year":"1980","cit":7,"pfa":"Simon Chiu","psa":"Ram K. Mishra","ptype":"article","src":"https://openalex.org/W2051196112","eid":"W2051196112"},{"id":"paper-w4221117412","cat":"papers","name":"Pathological Delta Oscillations in Hallucinogen Persisting Perception Disorder: A Case Report","year":"2022","cit":7,"pfa":"David Haslacher","psa":"Surjo Raphael Soekadar","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4221117412","eid":"W4221117412"},{"id":"paper-w4307365989","cat":"papers","name":"A mechanistic model of the neural entropy increase elicited by psychedelic drugs","year":"2022","cit":7,"pfa":"Ruben A Herzog","psa":"Rodrigo Cofré","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4307365989","eid":"W4307365989"},{"id":"paper-w4405890967","cat":"papers","name":"Informed Consent in Psychedelic-Assisted Therapy","year":"2024","cit":7,"pfa":"Mazdak M. Bradberry","psa":"Natalie Gukasyan","ptype":"book-chapter","src":"https://openalex.org/W4405890967","eid":"W4405890967"},{"id":"paper-w4250733563","cat":"papers","name":"Case Reports in Psychiatry","year":"2011","cit":7,"topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"paratext","src":"https://openalex.org/W4250733563","eid":"W4250733563"},{"id":"paper-w1969329406","cat":"papers","name":"The “Pink Spot” in Schizophrenics and its Absence in Homocystinurics","year":"1969","cit":7,"pfa":"J. Philip Welch","psa":"R. Neil Schimke","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1969329406","eid":"W1969329406"},{"id":"paper-w3013116485","cat":"papers","name":"Quantitative Evaluation of a Mexican and a Ghanaian Tabernaemontana Species as Alternatives to Voacanga africana for the Production of Antiaddictive Ibogan Type Alkaloids","year":"2020","cit":7,"pfa":"Felix Krengel","psa":"Ricardo Reyes‐Chilpa","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W3013116485","eid":"W3013116485"},{"id":"paper-w4386377261","cat":"papers","name":"History of the administration of psychedelics in France","year":"2023","cit":7,"pfa":"Zoë Dubus","psa":"Vincent Verroust","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4386377261","eid":"W4386377261"},{"id":"paper-w2136121016","cat":"papers","name":"In Vitro Metabolism of 3,4-Methylenedioxymethamphetamine in Human Hepatocytes","year":"2014","cit":7,"pfa":"Corinne Ramaley","psa":"Chengan Du","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2136121016","eid":"W2136121016"},{"id":"paper-w3019261195","cat":"papers","name":"Depression Onset in Long-term Adolescent Cannabinoid Use: A Neurobiological Review","year":"2020","cit":7,"pfa":"Shawn Y Forrester","psa":"Nusrat Jahan","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3019261195","eid":"W3019261195"},{"id":"paper-w2121687021","cat":"papers","name":"Catechol-O-Methyltransferase and 3,4-(±)-Methylenedioxymethamphetamine Toxicity","year":"2014","cit":7,"pfa":"Joseph M. Herndon","psa":"Terrence J. Monks","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2121687021","eid":"W2121687021"},{"id":"paper-w2049577739","cat":"papers","name":"Examination of the action of 3,4-methylenedioxymethamphetamine on rat A10 dopamine neurons","year":"1996","cit":7,"pfa":"Andrew N. Gifford","psa":"Charles R. Ashby","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2049577739","eid":"W2049577739"},{"id":"paper-w4281668214","cat":"papers","name":"Spatiotemporal Mapping of Online Interest in Cannabis and Popular Psychedelics before and during the COVID-19 Pandemic in Poland","year":"2022","cit":7,"pfa":"Ahmed Al-Imam","psa":"Michał Michalak","topics":["Addiction","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4281668214","eid":"W4281668214"},{"id":"paper-w3126980149","cat":"papers","name":"LSD’s effects are differentially modulated in arrestin knockout mice","year":"2021","cit":7,"pfa":"Ramona M. Rodriguiz","psa":"William C. Wetsel","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W3126980149","eid":"W3126980149"},{"id":"paper-w2558708710","cat":"papers","name":"Generalization of serotonin and dopamine ligands to the discriminative stimulus effects of different doses of ±3,4-methylenedioxymethamphetamine","year":"2016","cit":7,"pfa":"Jeremy Webster","psa":"Susan Schenk","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2558708710","eid":"W2558708710"},{"id":"paper-w2415048557","cat":"papers","name":"Salvia Divinorum : Toxicological Aspects and Analysis in Human Biological Specimens","year":"2016","cit":7,"pfa":"Cláudia Margalho","psa":"Eugénia Gallardo","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2415048557","eid":"W2415048557"},{"id":"paper-w3048553470","cat":"papers","name":"Better living through chemistry: MDMA’s prosocial mechanism as a starting point for improved therapeutics","year":"2020","cit":7,"pfa":"Boris Dov Heifets","psa":"Robert C. Malenka","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3048553470","eid":"W3048553470"},{"id":"paper-w4407080311","cat":"papers","name":"Repeated intermittent administration of 3,4-methylenedioxymethamphetamine mitigates demyelination in the brain from cuprizone-treated mice","year":"2025","cit":7,"pfa":"Mingming Zhao","psa":"Kenji Hashimoto","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4407080311","eid":"W4407080311"},{"id":"paper-w4413938545","cat":"papers","name":"Clinical psychedelic research in adolescents: a scoping review and overview of ethical considerations","year":"2025","cit":7,"pfa":"Khaleel Rajwani","psa":"Brian David Earp","topics":["Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4413938545","eid":"W4413938545"},{"id":"paper-w4317469231","cat":"papers","name":"LSD and language: Decreased structural connectivity, increased semantic similarity, changed vocabulary in healthy individuals","year":"2023","cit":7,"pfa":"Isabel Wießner","psa":"Luís Fernando Tófoli","ptype":"article","src":"https://openalex.org/W4317469231","eid":"W4317469231"},{"id":"paper-w4382602456","cat":"papers","name":"Psychedelic Assisted Psychotherapy preparing your target using psychohistoriography: a Jamaican perspective","year":"2023","cit":7,"pfa":"Winston De La Haye","psa":"Janelle Greene","topics":["Dosing & pharmacology","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4382602456","eid":"W4382602456"},{"id":"paper-w2026410018","cat":"papers","name":"Evaluation of hair roots for detection of methamphetamine and 3,4-methylenedioxymethamphetamine abuse by use of an HPLC–chemiluminescence method","year":"2012","cit":7,"pfa":"Mitsuhiro Wada","psa":"Kenichiro Nakashima","ptype":"article","src":"https://openalex.org/W2026410018","eid":"W2026410018"},{"id":"paper-w4361204700","cat":"papers","name":"View, meditation, action: A Tibetan framework to inform psychedelic-assisted therapy","year":"2023","cit":7,"pfa":"Colin H. Simonds","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4361204700","eid":"W4361204700"},{"id":"paper-w2303614667","cat":"papers","name":"Effects of 3,4-Methylenedioxymethamphetamine on Patient Utterances in a Psychotherapeutic Setting","year":"2016","cit":7,"pfa":"Vicka Corey","psa":"John H. Halpern","topics":["Depression","PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2303614667","eid":"W2303614667"},{"id":"paper-w4415401878","cat":"papers","name":"Changing your mind: neuroplastic mechanisms underlying the therapeutic effect of psychedelics in depression, PTSD, and addiction","year":"2025","cit":7,"pfa":"Marta L.C. Palhas","psa":"Raymond Mongeau","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4415401878","eid":"W4415401878"},{"id":"paper-w1954460706","cat":"papers","name":"Multisystem Organ Failure and Death Resulting From Ingestion of “Molly” (3,4-Methylenedioxymethamphetamine)","year":"2015","cit":7,"pfa":"Christopher P. Shelton","psa":"Jamie M. Rosini","ptype":"article","src":"https://openalex.org/W1954460706","eid":"W1954460706"},{"id":"paper-w4245475939","cat":"papers","name":"Set and Setting: A Randomized Study of Different Musical Genres in Supporting Psychedelic Therapy","year":"2020","cit":7,"pfa":"Justin C. Strickland","psa":"Matthew W. Johnson","topics":["Addiction","Mechanism & neuroscience","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4245475939","eid":"W4245475939"},{"id":"paper-w4412618898","cat":"papers","name":"Unraveling the policies, legislations, and regulations of psychedelics in Australia, Canada, Netherlands, New Zealand, and India","year":"2025","cit":7,"pfa":"Ramesh Joga","psa":"Saurabh Srivastava","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4412618898","eid":"W4412618898"},{"id":"paper-w4409105951","cat":"papers","name":"Sporadic use of classic psychedelics and neuropsychological performance: A cross-sectional analysis","year":"2025","cit":7,"pfa":"Simon Reiche","psa":"Tomislav Majić","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4409105951","eid":"W4409105951"},{"id":"paper-w4404933083","cat":"papers","name":"An investigation of acute physiological and psychological moderators of psychedelic-induced personality change among healthy volunteers","year":"2024","cit":7,"pfa":"Kate E.M. Godfrey","psa":"David Erritzøe","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4404933083","eid":"W4404933083"},{"id":"paper-w2417112325","cat":"papers","name":"[Minocycline as a therapeutic drug for methamphetamine use disorders].","year":"2008","cit":7,"pfa":"Kenji Hashimoto","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2417112325","eid":"W2417112325"},{"id":"paper-w2912649469","cat":"papers","name":"Qualitative analysis of synthetic opioids, synthetic hallucinogens and LSD in urine using LC-MS/MS","year":"2019","cit":7,"pfa":"Xue Qin Ng","psa":"Chi Pang Lui","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2912649469","eid":"W2912649469"},{"id":"paper-w4411107182","cat":"papers","name":"Enhanced meaning in life following psychedelic use: converging evidence from controlled and naturalistic studies","year":"2025","cit":7,"pfa":"William Roseby","psa":"Robin Lester Carhart-Harris","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4411107182","eid":"W4411107182"},{"id":"paper-w1979646443","cat":"papers","name":"Effect of an Hallucinogenic Agent on Verbal Behavior","year":"1963","cit":7,"pfa":"Gilbert Honigfeld","ptype":"article","src":"https://openalex.org/W1979646443","eid":"W1979646443"},{"id":"paper-w4410200405","cat":"papers","name":"Non-hallucinogenic psychedelics for mood and anxiety disorders: A systematic review","year":"2025","cit":7,"pfa":"Margery J.Q. Chen","psa":"Joshua Daniel Rosenblat","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W4410200405","eid":"W4410200405"},{"id":"paper-w4224232624","cat":"papers","name":"Is PTSD an Evolutionary Survival Adaptation Initiated by Unrestrained Cytokine Signaling and Maintained by Epigenetic Change?","year":"2022","cit":7,"pfa":"Stephan Rudzki","topics":["PTSD & trauma","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4224232624","eid":"W4224232624"},{"id":"paper-w4393390654","cat":"papers","name":"Trauma Under Psychedelics: How Psychoactive Substances Impact Trauma Processing","year":"2024","cit":7,"pfa":"Ophir Netzer","psa":"Roy Salomon","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"preprint","src":"https://openalex.org/W4393390654","eid":"W4393390654"},{"id":"paper-w1966002894","cat":"papers","name":"Interactions that define the alkylamine side-chain conformation in phenylalkylamine hallucinogens: an ab initio study","year":"2000","cit":7,"pfa":"Oscar E. Taurian","ptype":"article","src":"https://openalex.org/W1966002894","eid":"W1966002894"},{"id":"paper-w2999199163","cat":"papers","name":"Differential genetic risk for methamphetamine intake confers differential sensitivity to the temperature‐altering effects of other addictive drugs","year":"2020","cit":7,"pfa":"John R. K. Mootz","psa":"Tamara J. Phillips","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2999199163","eid":"W2999199163"},{"id":"paper-w4225106351","cat":"papers","name":"Virtual Daime: When Psychedelic Ritual Migrates Online","year":"2022","cit":7,"pfa":"Ido Hartogsohn","topics":["Anxiety & end-of-life","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4225106351","eid":"W4225106351"},{"id":"paper-w4410882061","cat":"papers","name":"Psychedelics, attachment, and enculturation dynamics: Prospects and challenges","year":"2025","cit":7,"pfa":"Esenia K. Cassidy","psa":"Pehr Granqvist","topics":["Mechanism & neuroscience","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4410882061","eid":"W4410882061"},{"id":"paper-w4319461336","cat":"papers","name":"Microbiota-derived psychedelics: Lessons from COVID-19","year":"2023","cit":7,"pfa":"Adonis Sfera","psa":"Carolina A. Klein","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4319461336","eid":"W4319461336"},{"id":"paper-w2124799616","cat":"papers","name":"Hypotensive spinal serotonergic effect. Are S1 or S2 receptors involved?","year":"1988","cit":7,"pfa":"Arturo Berger","psa":"Agustín José Ramirez","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2124799616","eid":"W2124799616"},{"id":"paper-w4408482611","cat":"papers","name":"The therapeutic effects of psychedelics for opioid use disorder: A systematic review of clinical studies","year":"2025","cit":7,"pfa":"Jeremy Weleff","psa":"Gustavo A. Angarita","topics":["Addiction","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4408482611","eid":"W4408482611"},{"id":"paper-w1572338521","cat":"papers","name":"Neural Bases of Addiction‐Related Impairments in Response Inhibition","year":"2015","cit":7,"pfa":"Hugh P Garavan","psa":"John J. Foxe","topics":["Addiction","Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W1572338521","eid":"W1572338521"},{"id":"paper-w4386021029","cat":"papers","name":"Harmonic decomposition of spacetime (HADES) framework characterises the spacetime hierarchy of the DMT brain state","year":"2023","cit":7,"pfa":"Jakub Vohryzek","psa":"Morten L. Kringelbach","topics":["Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4386021029","eid":"W4386021029"},{"id":"paper-w4410408434","cat":"papers","name":"Mitochondrial Calcium Uniporter (MCU)-Mediated Calcium Overload in Psychoactive Drug Neurotoxicity: From Pathogenesis to Therapeutic Targets","year":"2025","cit":7,"pfa":"Xinyan Yang","psa":"Peng Zhang","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4410408434","eid":"W4410408434"},{"id":"paper-w4400103673","cat":"papers","name":"Plasma oxytocin levels in response to glucagon in patients with arginine vasopressin deficiency (central diabetes insipidus) and healthy controls","year":"2024","cit":7,"pfa":"Cihan Atila","psa":"Mirjam Christ‐Crain","ptype":"article","src":"https://openalex.org/W4400103673","eid":"W4400103673"},{"id":"paper-w4321373481","cat":"papers","name":"Prevalence and Psychiatric Correlates of Illicit Substance Use in UK Undergraduate Students","year":"2023","cit":7,"pfa":"Holly Foster","psa":"Umair Akram","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4321373481","eid":"W4321373481"},{"id":"paper-w4385969211","cat":"papers","name":"A Proposal to Study the Safety and Efficacy of Psilocybe cubensis in Preclinical and Clinical Studies as a Therapeutic Alternative for Major Depressive Disorder","year":"2023","cit":7,"pfa":"Raúl Iván Escamilla-Orozco","psa":"Anja Loizaga-Velder","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4385969211","eid":"W4385969211"},{"id":"paper-w2015496389","cat":"papers","name":"Psychotherapy with the aid of LSD","year":"1996","cit":7,"pfa":"Jørgen Due Madsen","psa":"Asle Hoffart","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2015496389","eid":"W2015496389"},{"id":"paper-w3168422669","cat":"papers","name":"Natural and Experimental Evidence Drives Marmosets for Research on Psychiatric Disorders Related to Stress","year":"2021","cit":7,"pfa":"Maria Bernardete Cordeiro de Sousa","psa":"Nicole Leite Galvão Coelho","topics":["Depression","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3168422669","eid":"W3168422669"},{"id":"paper-w4407037724","cat":"papers","name":"Navigating the mainstreaming of psychedelics","year":"2025","cit":7,"pfa":"Beatriz Caiuby Labate","psa":"Clancy Cavnar","topics":["PTSD & trauma","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4407037724","eid":"W4407037724"},{"id":"paper-w4388302533","cat":"papers","name":"Mystical and Affective Aspects of Psychedelic Use in a Naturalistic Setting: A Linguistic Analysis of Online Experience Reports","year":"2023","cit":7,"pfa":"Marija Franka Žuljević","psa":"Darko Hren","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4388302533","eid":"W4388302533"},{"id":"paper-w4404302417","cat":"papers","name":"The Effect of Psilocybe cubensis on Spatial Memory and BDNF Expression in Male Rats Exposed to Chronic Unpredictable Mild Stress","year":"2024","cit":7,"pfa":"Reza Ghaffarzadegan","psa":"Salar Vaseghi","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4404302417","eid":"W4404302417"},{"id":"paper-w4412727285","cat":"papers","name":"Are we hallucinating or can psychedelic drugs modulate the immune system to control inflammation?","year":"2025","cit":7,"pfa":"Omar Qureshi","psa":"Nicholas M. Barnes","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4412727285","eid":"W4412727285"},{"id":"paper-w2803597790","cat":"papers","name":"Urine drug screen trends from 1998 through 2011 among emergency department patients treated in a University Teaching Hospital","year":"2018","cit":7,"pfa":"Nadejda L. Korneeva","psa":"Thomas Arnold","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2803597790","eid":"W2803597790"},{"id":"paper-w2784432284","cat":"papers","name":"Takiwasi: addiction treatment in the \"Singing House\"","year":"2017","cit":7,"pfa":"David M. O’Shaughnessy","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W2784432284","eid":"W2784432284"},{"id":"paper-w2021048157","cat":"papers","name":"A Novel Approach to the Identification of Psychiatric Drugs: Serotonin‐Glutamate Interactions in the Prefrontal Cortex","year":"2000","cit":7,"pfa":"Gerard J. Marek","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2021048157","eid":"W2021048157"},{"id":"paper-w4394786695","cat":"papers","name":"Catharanthine Modulates Mesolimbic Dopamine Transmission and Nicotine Psychomotor Effects via Inhibition of α6-Nicotinic Receptors and Dopamine Transporters","year":"2024","cit":7,"pfa":"Benjamin M. Williams","psa":"Scott C. Steffensen","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4394786695","eid":"W4394786695"},{"id":"paper-w4288143801","cat":"papers","name":"Hepatology Clinical","year":"2019","cit":7,"ptype":"article","src":"https://openalex.org/W4288143801","eid":"W4288143801"},{"id":"paper-w4411462140","cat":"papers","name":"Exploring Self-Reported Effects of Naturalistic Psychedelic Use Among Gender and Sexual Minorities: A Quantitative Survey Study","year":"2025","cit":7,"pfa":"Rafael Lancelotta","psa":"Alan K. Davis","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4411462140","eid":"W4411462140"},{"id":"paper-w4407380636","cat":"papers","name":"Psychedelics and chronic pain: self-reported outcomes on changed substance use patterns and health following naturalistic psychedelic use","year":"2025","cit":7,"pfa":"Nicolas G. Glynos","psa":"Philippe Lucas","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4407380636","eid":"W4407380636"},{"id":"paper-w4414152565","cat":"papers","name":"Concomitant use of antidepressants and classic psychedelics: A scoping review","year":"2025","cit":7,"pfa":"Stephan C. Tap","psa":"Robert A. Schoevers","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4414152565","eid":"W4414152565"},{"id":"paper-w4412418522","cat":"papers","name":"Attitudes toward psychedelics and psychedelic-assisted psychotherapy among Australian mental healthcare providers","year":"2025","cit":7,"pfa":"Zohaib Nadeem","psa":"Lena Oestreich","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4412418522","eid":"W4412418522"},{"id":"paper-w1975502433","cat":"papers","name":"Structural Characterization of a Therapeutic Anti-Methamphetamine Antibody Fragment: Oligomerization and Binding of Active Metabolites","year":"2013","cit":7,"pfa":"Eric Charles Peterson","psa":"Kottayil I. Varughese","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1975502433","eid":"W1975502433"},{"id":"paper-w2971436467","cat":"papers","name":"Treatment and outcomes at Takiwasi Center, a Peruvian therapeutic community: identifying patient-related indicators","year":"2019","cit":7,"pfa":"Victoria M. Defelippe","psa":"Matteo Politi","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2971436467","eid":"W2971436467"},{"id":"paper-w4410051026","cat":"papers","name":"Trends in ketamine use among nightclub attendees in New York City, 2017–2024","year":"2025","cit":7,"pfa":"Joseph J. Palamar","ptype":"article","src":"https://openalex.org/W4410051026","eid":"W4410051026"},{"id":"paper-w4392498741","cat":"papers","name":"EMBARK Psychedelic Therapy for Depression","year":"2024","cit":7,"pfa":"Bill Brennan","psa":"Alex Belser","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"book","src":"https://openalex.org/W4392498741","eid":"W4392498741"},{"id":"paper-w4250851207","cat":"papers","name":"Drug Abuse Treatment Outcome Study (DATOS), 1991-1994: [United States]","year":"2000","cit":7,"pfa":"United States Department Of Health And Human Services. National Institutes Of…","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"dataset","src":"https://openalex.org/W4250851207","eid":"W4250851207"},{"id":"paper-w3048448953","cat":"papers","name":"Sigma-1 receptor: culprit and rescuer in motor neuron diseases","year":"2020","cit":7,"pfa":"Jean-Charles Liévens","psa":"Tangui Maurice","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3048448953","eid":"W3048448953"},{"id":"paper-w1992191390","cat":"papers","name":"Update in Addiction Medicine","year":"2001","cit":7,"pfa":"Robert K. Schneider","psa":"Sidney H. Schnoll","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1992191390","eid":"W1992191390"},{"id":"paper-w4224280555","cat":"papers","name":"Self and Knowledge in Psychedelic Therapy","year":"2022","cit":7,"pfa":"Chris Letheby","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4224280555","eid":"W4224280555"},{"id":"paper-w4393234491","cat":"papers","name":"Psychedelic-assisted therapy for people with gambling disorder?","year":"2024","cit":7,"pfa":"Pedro Romero","psa":"Zsolt Demetrovics","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4393234491","eid":"W4393234491"},{"id":"paper-w4392453668","cat":"papers","name":"An examination of internal family systems interventions for trauma with implications for ethical psychedelic-assisted treatment","year":"2024","cit":7,"pfa":"Mitch Earleywine","psa":"Robyn Banks","topics":["PTSD & trauma","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4392453668","eid":"W4392453668"},{"id":"paper-w4220700438","cat":"papers","name":"Perspective: Can psychedelic-assisted therapy be a promising aid in compulsive sexual behavior disorder treatment?","year":"2022","cit":7,"pfa":"Magdalena Wizła","psa":"Karol Lewczuk","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4220700438","eid":"W4220700438"},{"id":"paper-w4396509933","cat":"papers","name":"Psychedelic-Assisted Therapy Training: An Argument in Support of Firsthand Experience of Nonordinary States of Consciousness in the Development of Competence","year":"2024","cit":7,"pfa":"Shannon Dames","psa":"Vivian W. L. Tsang","topics":["Safety & adverse events","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4396509933","eid":"W4396509933"},{"id":"paper-w4405615445","cat":"papers","name":"From Isolation to Social (and Psychedelic) Integration: A Sociology of Collective Effervescence and Therapeutic Community in Psychedelic‐Assisted Therapy","year":"2024","cit":7,"pfa":"Jarrett Robert Rose","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4405615445","eid":"W4405615445"},{"id":"paper-w4396624510","cat":"papers","name":"Optimizing real-world benefit and risk of new psychedelic medications: the need for innovative postmarket surveillance","year":"2024","cit":7,"pfa":"Joshua Curtis Black","psa":"Richard C. Dart","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4396624510","eid":"W4396624510"},{"id":"paper-w4224212274","cat":"papers","name":"Serotonin, Predictive Processing and Psychedelics","year":"2022","cit":7,"pfa":"Matteo Colombo","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4224212274","eid":"W4224212274"},{"id":"paper-w4283028336","cat":"papers","name":"Cyberdelics: Context engineering psychedelics for altered traits","year":"2022","cit":7,"pfa":"Carl Hayden Smith","psa":"Melissa Warner","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"conference-paper","src":"https://openalex.org/W4283028336","eid":"W4283028336"},{"id":"paper-w4206839967","cat":"papers","name":"The therapeutic potential of psychedelic substances in Hospice and Palliative Care","year":"2022","cit":7,"pfa":"Ana Cláudia Mesquita Garcia","psa":"Lucas Oliveira Maia","topics":["Addiction","Anxiety & end-of-life"],"ptype":"editorial","src":"https://openalex.org/W4206839967","eid":"W4206839967"},{"id":"paper-w4386219256","cat":"papers","name":"Preventing the Gaps in Psychedelic Research from Becoming Practice Pitfalls: A Translational Research Agenda","year":"2023","cit":7,"pfa":"Andrew  D. Penn","psa":"Rachel Yehuda","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"editorial","src":"https://openalex.org/W4386219256","eid":"W4386219256"},{"id":"paper-w2029733312","cat":"papers","name":"Mysticism and psychedelics: The case of the dark night","year":"1991","cit":7,"pfa":"Christopher M. Bache","ptype":"article","src":"https://openalex.org/W2029733312","eid":"W2029733312"},{"id":"paper-w4404602449","cat":"papers","name":"The historical opposition to psychedelic research and implications for credibility in psychiatry","year":"2024","cit":7,"pfa":"Elena Koning","psa":"Elisa M. Brietzke","topics":["Addiction","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4404602449","eid":"W4404602449"},{"id":"paper-w4398780811","cat":"papers","name":"Attitudes of European psychiatrists on psychedelics: a qualitative study","year":"2024","cit":7,"pfa":"Marija Franka Žuljević","psa":"Darko Hren","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4398780811","eid":"W4398780811"},{"id":"paper-w4413037134","cat":"papers","name":"Ethical Issues and Recommendations in Psychedelic Research and Practice: A Scoping Review","year":"2025","cit":7,"pfa":"N Brittain","psa":"John F. Gardner","topics":["Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4413037134","eid":"W4413037134"},{"id":"paper-w4391967385","cat":"papers","name":"Bio-Psycho-Spiritual Perspectives on Psychedelics: Clinical and Ethical Implications","year":"2024","cit":7,"pfa":"Logan Neitzke‐Spruill","psa":"Amy L. McGuire","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4391967385","eid":"W4391967385"},{"id":"paper-w4382812259","cat":"papers","name":"Suicide prevention and ketamine: insights from computational modeling","year":"2023","cit":7,"pfa":"Colleen E. Charlton","psa":"Andreea Oliviana Diaconescu","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4382812259","eid":"W4382812259"},{"id":"paper-w4409277430","cat":"papers","name":"Metacognitive Feelings of Epistemic Gain are Central to the Understanding of Psychedelic-Induced Mystical-Type Experiences","year":"2025","cit":7,"pfa":"Federico Seragnoli","psa":"Joël Billieux","topics":["PTSD & trauma","Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4409277430","eid":"W4409277430"},{"id":"paper-w4220929673","cat":"papers","name":"Seeing oneself through the eyes of another: A look at psychedelic insight","year":"2022","cit":7,"pfa":"Lawrence G. Fischman","topics":["Addiction","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4220929673","eid":"W4220929673"},{"id":"paper-w4396691439","cat":"papers","name":"Psychedelics, the Bible, and the Divine","year":"2024","cit":7,"pfa":"Jaime Clark‐Soles","topics":["Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4396691439","eid":"W4396691439"},{"id":"paper-w4402738871","cat":"papers","name":"Association between lifetime hallucinogen use and psychological distress varies by sexual identity in a nationally representative sample","year":"2024","cit":7,"pfa":"B. M. Altman","psa":"Manya Magnus","ptype":"article","src":"https://openalex.org/W4402738871","eid":"W4402738871"},{"id":"paper-w4406630811","cat":"papers","name":"Cosmology of belonging: The role of community in the therapeutic use of psychedelics","year":"2025","cit":7,"pfa":"Caroline G. Dorsen","psa":"William E. Rosa","topics":["Addiction","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4406630811","eid":"W4406630811"},{"id":"paper-w4238887908","cat":"papers","name":"Entheogens (Psychedelic Drugs) and the Ancient Mystery Religions","year":"2018","cit":7,"pfa":"Mark Anthony Hoffman","ptype":"book-chapter","src":"https://openalex.org/W4238887908","eid":"W4238887908"},{"id":"paper-w3159281195","cat":"papers","name":"The Psychedelic Gospels: The Secret History of Hallucinogens in Christianity","year":"2016","cit":7,"pfa":"Jerry B. Brown","psa":"Julie M. Brown","ptype":"book","src":"https://openalex.org/W3159281195","eid":"W3159281195"},{"id":"paper-w2498783845","cat":"papers","name":"Hallucinogens and Club Drugs","year":"2014","cit":7,"pfa":"Katherine A. MacLean","psa":"Roland R. Griffiths","ptype":"book-chapter","src":"https://openalex.org/W2498783845","eid":"W2498783845"},{"id":"paper-w4401986972","cat":"papers","name":"A Psychedelic Experience:","year":"2017","cit":7,"ptype":"book-chapter","src":"https://openalex.org/W4401986972","eid":"W4401986972"},{"id":"paper-w2067021261","cat":"papers","name":"An improved field test for hallucinogens","year":"1971","cit":7,"pfa":"Geraldine V. Alliston","psa":"G F Phillips","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2067021261","eid":"W2067021261"},{"id":"paper-w2902765136","cat":"papers","name":"Psychedelic Prophets","year":"2018","cit":7,"pfa":"Aldous Huxley","psa":"Humphry Osmond","ptype":"book","src":"https://openalex.org/W2902765136","eid":"W2902765136"},{"id":"paper-w2400338452","cat":"papers","name":"[A case of hallucinogen-like action of glaucine].","year":"1989","cit":7,"pfa":"V I ROVINSKII","ptype":"article","src":"https://openalex.org/W2400338452","eid":"W2400338452"},{"id":"paper-w2408087114","cat":"papers","name":"Identification of Some Analogs of the Hallucinogen Phencyclidine","year":"1976","cit":7,"pfa":"Keith Bailey","psa":"Richard K Pike","ptype":"article","src":"https://openalex.org/W2408087114","eid":"W2408087114"},{"id":"paper-w4307481692","cat":"papers","name":"Past, Present, and Future of Psychedelics: A Psychedelic Medicine Roundtable Discussion","year":"2022","cit":7,"pfa":"Peter S. Hendricks","psa":"David E. Nichols","ptype":"article","src":"https://openalex.org/W4307481692","eid":"W4307481692"},{"id":"paper-w582192697","cat":"papers","name":"Mushrooms, psychedelic fungi","year":"1986","cit":7,"pfa":"Peter E. Furst","ptype":"book","src":"https://openalex.org/W582192697","eid":"W582192697"},{"id":"paper-w2134806558","cat":"papers","name":"Research on psychedelic substances","year":"2012","cit":7,"pfa":"Simon D. Brandt","psa":"Torsten Passie","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2134806558","eid":"W2134806558"},{"id":"paper-w1970583087","cat":"papers","name":"The Varieties of Psychedelic Experience.","year":"1967","cit":7,"pfa":"Louis L. Lunsky","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W1970583087","eid":"W1970583087"},{"id":"paper-w21953461","cat":"papers","name":"Psychedelics and species connectedness","year":"2014","cit":7,"pfa":"Stanley Krippner","psa":"David P. Luke","ptype":"book-chapter","src":"https://openalex.org/W21953461","eid":"W21953461"},{"id":"paper-w2073130331","cat":"papers","name":"Mexico and Colombia: Two Major Centres of Aboriginal Use of Hallucinogens","year":"1977","cit":7,"pfa":"Richard Evans Schultes","ptype":"article","src":"https://openalex.org/W2073130331","eid":"W2073130331"},{"id":"paper-w3186222443","cat":"papers","name":"Liminality (Re‐)Realized in the Psychedelic Rave","year":"2021","cit":7,"pfa":"Leandros Kyriakopoulos","ptype":"article","src":"https://openalex.org/W3186222443","eid":"W3186222443"},{"id":"paper-w2117861046","cat":"papers","name":"Poetic Vision and the Psychedelic Experience","year":"1970","cit":7,"pfa":"Elliot Krieger","psa":"Robert Allen Durr","ptype":"article","src":"https://openalex.org/W2117861046","eid":"W2117861046"},{"id":"paper-w4285136978","cat":"papers","name":"Individualization and Alienation in Psychedelic Psychotherapy","year":"2022","cit":7,"pfa":"Christine Hauskeller","topics":["Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W4285136978","eid":"W4285136978"},{"id":"paper-w2405813293","cat":"papers","name":"History and pharmacology of psychedelic drugs.","year":"1971","cit":7,"pfa":"W. J. R. Taylor","topics":["Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W2405813293","eid":"W2405813293"},{"id":"paper-w647037485","cat":"papers","name":"Psychedelic phenethylamines and related compounds","year":"2011","cit":7,"pfa":"Alexander T. Shulgin","psa":"Paul F. Daley","ptype":"book","src":"https://openalex.org/W647037485","eid":"W647037485"},{"id":"paper-w1481136496","cat":"papers","name":"Religious Aspects of Psychedelic Drugs","year":"1968","cit":7,"pfa":"Walter Houston Clark","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1481136496","eid":"W1481136496"},{"id":"paper-w4413112426","cat":"papers","name":"Biased Signaling in Psychedelic Action","year":"2025","cit":7,"pfa":"Daniel Wacker","psa":"John D. McCorvy","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W4413112426","eid":"W4413112426"},{"id":"paper-w4236111125","cat":"papers","name":"The bad trip: An epidemiological survey of youthful hallucinogen use","year":"1977","cit":7,"pfa":"David R. Rubinow","psa":"Robert Cancro","ptype":"article","src":"https://openalex.org/W4236111125","eid":"W4236111125"},{"id":"paper-w2069535699","cat":"papers","name":"The use of electron-acceptor reagents for the detection of some hallucinogens","year":"1973","cit":7,"pfa":"Ronald A. Heacock","psa":"Janet E. Forrest","ptype":"article","src":"https://openalex.org/W2069535699","eid":"W2069535699"},{"id":"paper-w2123636897","cat":"papers","name":"Ketamine Use in a Burn Center: Hallucinogen or Debridement Facilitator?","year":"1985","cit":7,"pfa":"Suzanne Martinez","psa":"Marlene Dobkin de Ríos","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2123636897","eid":"W2123636897"},{"id":"paper-w2057408582","cat":"papers","name":"Personality and hallucinogen abuse in a college population from India","year":"1994","cit":7,"pfa":"Pallavi Nishith","psa":"Prabha Gupta","ptype":"article","src":"https://openalex.org/W2057408582","eid":"W2057408582"},{"id":"paper-w2326404202","cat":"papers","name":"No link found between psychedelics and psychosis","year":"2015","cit":7,"pfa":"Zoe Cormier","ptype":"article","src":"https://openalex.org/W2326404202","eid":"W2326404202"},{"id":"paper-w1981901211","cat":"papers","name":"The psychedelic properties of banana peel: an appraisal","year":"1968","cit":7,"pfa":"A. D. Krikorian","ptype":"article","src":"https://openalex.org/W1981901211","eid":"W1981901211"},{"id":"paper-w2287641458","cat":"papers","name":"Studies on the Mechanism of Action of Continuous Microdose Quingestanol Acetate","year":"1975","cit":7,"pfa":"Kamran S. Moghissi","psa":"Frank N. Syner","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2287641458","eid":"W2287641458"},{"id":"paper-w2899500940","cat":"papers","name":"Psychedelic tourism in Mexico, a thriving trend","year":"2018","cit":7,"pfa":"Universidad de Guadalajara (México)","psa":"Universidad de Guadalajara (México)","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2899500940","eid":"W2899500940"},{"id":"paper-w2049701709","cat":"papers","name":"Microdose computed tomographic cardiac angiography in normal cats","year":"2014","cit":7,"pfa":"Kiira T. Rodriguez","psa":"Robert T. O’Brien","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2049701709","eid":"W2049701709"},{"id":"paper-w195512786","cat":"papers","name":"[Psychedelic effects of subanesthetic doses of ketamine].","year":"2009","cit":7,"pfa":"Liang Zou","psa":"Tie-hu Ye","topics":["Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W195512786","eid":"W195512786"},{"id":"paper-w4406326391","cat":"papers","name":"Same Same but Different: On Psychedelic Exceptionalism","year":"2025","cit":7,"pfa":"Daniel Villiger","ptype":"editorial","src":"https://openalex.org/W4406326391","eid":"W4406326391"},{"id":"paper-w2888341208","cat":"papers","name":"Psychedelics – Re-opening the doors of perception","year":"2018","cit":7,"pfa":"David J. Heal","psa":"Sharon L. Smith","ptype":"article","src":"https://openalex.org/W2888341208","eid":"W2888341208"},{"id":"paper-w4412538319","cat":"papers","name":"Detection of a Single Microdose of Testosterone and Recombinant EPO in Healthy Volunteers","year":"2025","cit":7,"pfa":"Carmel E. Heiland","psa":"Lena Ekström","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4412538319","eid":"W4412538319"},{"id":"paper-w1541161377","cat":"papers","name":"The “Feeling of Knowing,” the Psychedelic Sensorium, and Contemporary Neuroscience","year":"2011","cit":7,"pfa":"Kim Hewitt","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1541161377","eid":"W1541161377"},{"id":"paper-w4390908236","cat":"papers","name":"Psychedelics in Addiction Treatment—Navigating a Sociopolitical Rift","year":"2024","cit":7,"pfa":"Nicky J. Mehtani","psa":"Jennifer Mitchell","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4390908236","eid":"W4390908236"},{"id":"paper-w4317881824","cat":"papers","name":"Editorial: The psychotherapeutic framing of psychedelic drug administration","year":"2023","cit":7,"pfa":"Maria Beckman","psa":"Dea Siggaard Stenbæk","topics":["Therapy practice"],"ptype":"editorial","src":"https://openalex.org/W4317881824","eid":"W4317881824"},{"id":"paper-w4386319405","cat":"papers","name":"A perspective on psychedelic teratogenicity: the utility of zebrafish models","year":"2023","cit":7,"pfa":"Omer A. Syed","psa":"Robert T. Gerlai","ptype":"review","src":"https://openalex.org/W4386319405","eid":"W4386319405"},{"id":"paper-w4313441617","cat":"papers","name":"Malpractice and Other Civil Liability in Psychedelic Psychiatry","year":"2023","cit":7,"pfa":"Brian James Holoyda","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4313441617","eid":"W4313441617"},{"id":"paper-w4385697551","cat":"papers","name":"Applications and Potential of In Silico Approaches for Psychedelic Chemistry","year":"2023","cit":7,"pfa":"Sedat Karabulut","psa":"James W. Gauld","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4385697551","eid":"W4385697551"},{"id":"paper-w1964281506","cat":"papers","name":"Opinion: Microdosing: Safer Clinical Trials and Fewer Animal Tests","year":"2010","cit":7,"pfa":"Gill Langley","psa":"Sébastien Farnaud","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1964281506","eid":"W1964281506"},{"id":"paper-w2558967867","cat":"papers","name":"Psychedelic trips: travel and drugs in contemporary literature","year":"2008","cit":7,"pfa":"Lindsey Michael Banco","ptype":"dissertation","src":"https://openalex.org/W2558967867","eid":"W2558967867"},{"id":"paper-w4385458879","cat":"papers","name":"Subjective and Objective Measurements of the Facial Effects of Microdoses of Botulinum Toxin","year":"2023","cit":7,"pfa":"Doris Maria Hexsel","psa":"Vitor Costa Fabris","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4385458879","eid":"W4385458879"},{"id":"paper-w4392858001","cat":"papers","name":"Naturalism and the hard problem of mysticism in psychedelic science","year":"2024","cit":7,"pfa":"Jussi Jylkkä","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4392858001","eid":"W4392858001"},{"id":"paper-w1930038940","cat":"papers","name":"Beyond Religious Freedom: Psychedelics and Cognitive Liberty","year":"2013","cit":7,"pfa":"Charlotte Walsh","ptype":"book-chapter","src":"https://openalex.org/W1930038940","eid":"W1930038940"},{"id":"paper-w4239827113","cat":"papers","name":"Psychedelic drugs as a long-needed innovation in psychiatry","year":"2020","cit":7,"pfa":"Genís Oña","psa":"José Carlos Bouso","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4239827113","eid":"W4239827113"},{"id":"paper-w2950136678","cat":"papers","name":"Expanding the Scientific Study of Self-Experience with Psychedelics","year":"2018","cit":7,"pfa":"Manesh Girn","psa":"Kalina Christoff","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2950136678","eid":"W2950136678"},{"id":"paper-w2090134033","cat":"papers","name":"Natural Childbirth and Cooperative Child Rearing in Psychedelic Communes","year":"1970","cit":7,"pfa":"David Eugene Smith","psa":"James L. Sternfield","ptype":"article","src":"https://openalex.org/W2090134033","eid":"W2090134033"},{"id":"paper-w2057343453","cat":"papers","name":"Trends in Microdosing and Other Exploratory Human Pharmacokinetic Studies for Early Drug Development","year":"2010","cit":7,"pfa":"Berend Oosterhuis","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2057343453","eid":"W2057343453"},{"id":"paper-w4408244928","cat":"papers","name":"Harnessing psychedelics for stroke recovery: therapeutic potential and mechanisms","year":"2025","cit":7,"pfa":"Yupeng Yang","psa":"Xiaohui Wang","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4408244928","eid":"W4408244928"},{"id":"paper-w4403403856","cat":"papers","name":"Epiphanies and Aspirations: How Psychedelic Experiences Affect Values","year":"2024","cit":7,"pfa":"Juuso Kähönen","ptype":"book-chapter","src":"https://openalex.org/W4403403856","eid":"W4403403856"},{"id":"paper-w4408195887","cat":"papers","name":"Educational moderation of gender disparities in psychedelic health outcomes","year":"2025","cit":7,"pfa":"Sean M. Viña","ptype":"article","src":"https://openalex.org/W4408195887","eid":"W4408195887"},{"id":"paper-w4401918669","cat":"papers","name":"Guiding Through Challenging Psychedelic Experiences and “Bad Trips”","year":"2024","cit":7,"pfa":"Michael Koslowski","psa":"Peter Gasser","ptype":"book-chapter","src":"https://openalex.org/W4401918669","eid":"W4401918669"},{"id":"paper-w3158215085","cat":"papers","name":"Situating Psychedelics and the War on Drugs Within the Decolonization of Consciousness","year":"2019","cit":7,"pfa":"Joshua Falcon","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3158215085","eid":"W3158215085"},{"id":"paper-w4300028042","cat":"papers","name":"PSD-95 Is Essential for Hallucinogen and Atypical Antipsychotic Drug Actions at Serotonin Receptors","year":"2020","cit":7,"pfa":"M. G. Caron","psa":"Anam Abbas","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4300028042","eid":"W4300028042"},{"id":"paper-w4410586655","cat":"papers","name":"Targeting the 5-HT2A Receptor for Developing Psychedelic Drugs and Beyond","year":"2025","cit":7,"pfa":"Saghir Ali","psa":"Jia Zhou","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4410586655","eid":"W4410586655"},{"id":"paper-w4288052269","cat":"papers","name":"A Dose of Creativity: An Integrative Review of the Effects of Serotonergic Psychedelics on Creativity","year":"2022","cit":7,"pfa":"Miguel Ângelo Costa","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4288052269","eid":"W4288052269"},{"id":"paper-w3202194210","cat":"papers","name":"Panpsychism and Spiritual Flourishing: Constructive Engagement with the New Science of Psychedelics","year":"2021","cit":7,"pfa":"Sarah Lane Ritchie","ptype":"article","src":"https://openalex.org/W3202194210","eid":"W3202194210"},{"id":"paper-w4377103749","cat":"papers","name":"Global species diversity and distribution of the psychedelic fungal genus Panaeolus","year":"2023","cit":7,"pfa":"Dominique Strauss","psa":"Marieka Gryzenhout","topics":["Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4377103749","eid":"W4377103749"},{"id":"paper-w4411627933","cat":"papers","name":"Offering Psychedelic Treatments Before Assisted Dying for Psychiatric Conditions","year":"2025","cit":7,"pfa":"Christopher J. Poppe","psa":"Dimitris Repantis","ptype":"article","src":"https://openalex.org/W4411627933","eid":"W4411627933"},{"id":"paper-w1527587391","cat":"papers","name":"Psychedelic Induced Transpersonal Experiences, Therapies, and Their Implications for Transpersonal Psychology","year":"2013","cit":7,"pfa":"Thomas B. Roberts","psa":"Michael Winkelman","topics":["Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W1527587391","eid":"W1527587391"},{"id":"paper-w4386032319","cat":"papers","name":"Ensuring psychedelic treatments and research do not leave anyone behind","year":"2023","cit":7,"pfa":"Melissa Andrea Simon","ptype":"article","src":"https://openalex.org/W4386032319","eid":"W4386032319"},{"id":"paper-w1975288962","cat":"papers","name":"Microdose gentamicin delivered via the round window microcatheter: A therapeutic option in Menière's disease","year":"2001","cit":7,"pfa":"Peter A. Weisskopf","psa":"Derin C. Wester","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1975288962","eid":"W1975288962"},{"id":"paper-w4384666195","cat":"papers","name":"Hippocampal differential expression underlying the neuroprotective effect of delta-9-tetrahydrocannabinol microdose on old mice","year":"2023","cit":7,"pfa":"Guy Shapira","psa":"Noam Shomron","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4384666195","eid":"W4384666195"},{"id":"paper-w4401385907","cat":"papers","name":"Chiral Switches of Tramadol Hydrochloride, a Potential Psychedelic Drug─Past and Future","year":"2024","cit":7,"pfa":"Israel Agranat","psa":"Ilaria D’Acquarica","topics":["Addiction"],"ptype":"editorial","src":"https://openalex.org/W4401385907","eid":"W4401385907"},{"id":"paper-w1977712788","cat":"papers","name":"Eicosanoid and amino acid metabolism in transient acute psychoses with psychedelic symptoms","year":"1996","cit":7,"pfa":"Durk Fekkes","psa":"Lolke P. Pepplinkhuizen","ptype":"article","src":"https://openalex.org/W1977712788","eid":"W1977712788"},{"id":"paper-w140060397","cat":"papers","name":"Nitrous oxide inhalation as a fad. Dangers in uncontrolled sniffing for psychedelic effect.","year":"1967","cit":7,"pfa":"John B. Dillon","ptype":"article","src":"https://openalex.org/W140060397","eid":"W140060397"},{"id":"paper-w3046257553","cat":"papers","name":"A Study of the Effect of Cyclosporine on Fevipiprant Pharmacokinetics and its Absolute Bioavailability Using an Intravenous Microdose Approach","year":"2020","cit":7,"pfa":"H. Weiss","psa":"Markus Zollinger","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3046257553","eid":"W3046257553"},{"id":"paper-w2759742154","cat":"papers","name":"Comparison of pharmacokinetics of newly discovered aromatase inhibitors by a cassette microdosing approach in healthy Japanese subjects","year":"2017","cit":7,"pfa":"Hiroyuki Kusuhara","psa":"Yasuyoshi Watanabe","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2759742154","eid":"W2759742154"},{"id":"paper-w4384347202","cat":"papers","name":"Extended Difficulties Following the Use of Psychedelic Drugs: A Mixed Methods Study","year":"2023","cit":7,"pfa":"Jules Evans","psa":"Rosalind G. McAlpine","ptype":"preprint","src":"https://openalex.org/W4384347202","eid":"W4384347202"},{"id":"paper-w4414167960","cat":"papers","name":"Trauma under psychedelics: how psychoactive substances impact trauma processing","year":"2025","cit":7,"pfa":"Ophir Netzer","psa":"Roy Salomon","topics":["PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4414167960","eid":"W4414167960"},{"id":"paper-w4403350173","cat":"papers","name":"A perspective on Alzheimer’s disease: exploring the potential of terminal/paradoxical lucidity and psychedelics","year":"2024","cit":7,"pfa":"Cong Lin","psa":"Xiaohui Wang","ptype":"article","src":"https://openalex.org/W4403350173","eid":"W4403350173"},{"id":"paper-w4388110984","cat":"papers","name":"Psychedelic treatments are speeding towards approval — but no one knows how they work","year":"2023","cit":7,"pfa":"Sara Reardon","ptype":"article","src":"https://openalex.org/W4388110984","eid":"W4388110984"},{"id":"paper-w4416987269","cat":"papers","name":"Hospital-based care for hallucinogens and risk of mania and bipolar disorder: A population-based cohort study","year":"2025","cit":7,"pfa":"Daniel Thomas Myran","psa":"Marco Solmi","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4416987269","eid":"W4416987269"},{"id":"paper-w3137857123","cat":"papers","name":"Entering the Fifth Dimension: modular modernities, psychedelic sensibilities, and the architectures of lived experience","year":"2021","cit":7,"pfa":"Luke Dickens","psa":"Tim Edensor","ptype":"article","src":"https://openalex.org/W3137857123","eid":"W3137857123"},{"id":"paper-w4390441815","cat":"papers","name":"Whole-brain modelling supports the use of serotonergic psychedelics for the treatment of disorders of consciousness","year":"2023","cit":7,"pfa":"Iván Mindlin","psa":"Yonatan Sanz Perl","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4390441815","eid":"W4390441815"},{"id":"paper-w4213225896","cat":"papers","name":"Paradise is paradise: Reflections on psychedelic drugs, mystical experience, and the near-death experience","year":"1988","cit":7,"pfa":"Kenneth Ring","ptype":"article","src":"https://openalex.org/W4213225896","eid":"W4213225896"},{"id":"paper-w4405023493","cat":"papers","name":"Developing a short form of the Awe Experience Scale (AWE-SF) in psychedelic samples","year":"2024","cit":7,"pfa":"Marianna Graziosi","psa":"David B. Yaden","ptype":"article","src":"https://openalex.org/W4405023493","eid":"W4405023493"},{"id":"paper-w4413108514","cat":"papers","name":"How low can you go? Intraoperative microdosing of indocyanine green for fluorescence cholangiography during laparoscopic cholecystectomy","year":"2025","cit":7,"pfa":"Ryan C. Broderick","psa":"Garth R. Jacobsen","topics":["Dosing & pharmacology","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4413108514","eid":"W4413108514"},{"id":"paper-w4406387788","cat":"papers","name":"Integration of personal psychedelic experiences into clinical practice: A phenomenological study in mental health professionals","year":"2025","cit":7,"pfa":"Nir Tadmor","psa":"Guy Simon","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4406387788","eid":"W4406387788"},{"id":"paper-w4408957076","cat":"papers","name":"Perceived Impact of Psychedelics on Sexual, Gender, and Intimate Relationship Dynamics: A Mixed-Methods Investigation","year":"2025","cit":7,"pfa":"Daniel J. Kruger","psa":"Kevin F. Boehnke","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4408957076","eid":"W4408957076"},{"id":"paper-w4376956190","cat":"papers","name":"Lifetime classic psychedelic use is associated with greater psychological distress in unemployed job seekers","year":"2023","cit":7,"pfa":"Benjamin A. Korman","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4376956190","eid":"W4376956190"},{"id":"paper-w4283812637","cat":"papers","name":"Psychedelic replications in virtual reality and their potential as a therapeutic instrument: an open-label feasibility study","year":"2022","cit":7,"pfa":"Kristjan Kaup","psa":"Jaan Aru","topics":["Depression","Addiction"],"ptype":"preprint","src":"https://openalex.org/W4283812637","eid":"W4283812637"},{"id":"paper-w4381953040","cat":"papers","name":"Impact of phenanthrene co-administration on the toxicokinetics of benzo[a]pyrene in humans. UPLC-accelerator mass spectrometry following oral microdosing","year":"2023","cit":7,"pfa":"Monica L. Vermillion Maier","psa":"David E. Williams","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4381953040","eid":"W4381953040"},{"id":"paper-w4391613592","cat":"papers","name":"Microdosing ketamine in Drosophila does not block serotonin reuptake, but causes complex behavioral changes mediated by glutamate and serotonin receptors","year":"2024","cit":7,"pfa":"Kelly E. Dunham","psa":"B. Jill Venton","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4391613592","eid":"W4391613592"},{"id":"paper-w4405641103","cat":"papers","name":"Restoring Oscillatory Dynamics in Alzheimer’s Disease: A Laminar Whole-Brain Model of Serotonergic Psychedelic Effects","year":"2024","cit":7,"pfa":"Jan C. Gendra","psa":"the Alzheimer’s Disease Neuroimaging Initiative","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4405641103","eid":"W4405641103"},{"id":"paper-w3088476465","cat":"papers","name":"Dr. Valentina Wasson: Questioning what we think we know about the foundations of psychedelic science","year":"2020","cit":7,"pfa":"Monnica T. Williams","psa":"Jamilah R. George","ptype":"article","src":"https://openalex.org/W3088476465","eid":"W3088476465"},{"id":"paper-w2995054683","cat":"papers","name":"Investigation of the Technology of Microdosed supply of Lubricant Compositions with Nanoparticles during Grinding of Heat-Resistant Ni-based with Additional Air Cooling","year":"2019","cit":7,"pfa":"A. P. Mitrofanov","psa":"Vladimir Andreevich Nosenko","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2995054683","eid":"W2995054683"},{"id":"paper-w2210321474","cat":"papers","name":"3 Psychotomimetics of the Convolvulaceae","year":"1975","cit":7,"pfa":"Ronald A. Heacock","ptype":"book-chapter","src":"https://openalex.org/W2210321474","eid":"W2210321474"},{"id":"paper-w1988102919","cat":"papers","name":"Central Actions of Psychotomimetics","year":"1963","cit":7,"pfa":"Daniel Curtis","psa":"R. W. Ryall","ptype":"article","src":"https://openalex.org/W1988102919","eid":"W1988102919"},{"id":"paper-w2907858474","cat":"papers","name":"Increased signal diversity/complexity of spontaneous EEG, but not evoked EEG responses, in ketamine-induced psychedelic state in humans","year":"2019","cit":7,"pfa":"Nadine Farnes","psa":"Johan F. Storm","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W2907858474","eid":"W2907858474"},{"id":"paper-w4409139776","cat":"papers","name":"Naturalistic Psychedelic Use and Psychotic Symptoms: A Cross-Sectional Study of Individuals with a Personal or Family History of Psychotic or Bipolar Disorders","year":"2025","cit":7,"pfa":"Haley Maria Dourron","psa":"Peter S. Hendricks","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4409139776","eid":"W4409139776"},{"id":"paper-w1557109980","cat":"papers","name":"A Flexible Multidose GnRH Antagonist versus a Microdose Flare-Up GnRH Agonist Combined with a Flexible Multidose GnRH Antagonist Protocol in Poor Responders to IVF","year":"2015","cit":7,"pfa":"Gayem İnayet Turgay Çelik","psa":"Münire Erman Akar","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1557109980","eid":"W1557109980"},{"id":"paper-w4409647928","cat":"papers","name":"Peri-traumatic consumption of classic psychedelics is associated with lower anxiety and post-traumatic responses 3 weeks after exposure","year":"2025","cit":7,"pfa":"Einat Karp Barnir","psa":"Mario Mikulincer","topics":["PTSD & trauma","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4409647928","eid":"W4409647928"},{"id":"paper-w2130319646","cat":"papers","name":"High‐sensitive LC ‐ MS / MS method for the simultaneous determination of mirodenafil and its major metabolite, SK ‐3541, in human plasma: Application to microdose clinical trials of mirodenafil","year":"2012","cit":7,"pfa":"Doo‐Yeoun Cho","psa":"Soo Kyung Bae","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2130319646","eid":"W2130319646"},{"id":"paper-w2397290395","cat":"papers","name":"BEHAVIOURAL ANTAGONISM TO A NEW PSYCHOTOMIMETIC: JB--329.","year":"1964","cit":7,"pfa":"C BELL","psa":"George Holan","ptype":"article","src":"https://openalex.org/W2397290395","eid":"W2397290395"},{"id":"paper-w145213428","cat":"papers","name":"[NMDA receptor antagonist neurotoxicity and psychotomimetic activity].","year":"2003","cit":7,"pfa":"Shinichi Nakao","psa":"Koh Shingu","topics":["PTSD & trauma","Safety & adverse events","Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W145213428","eid":"W145213428"},{"id":"paper-w2970040332","cat":"papers","name":"Effet des composantes de la technologie microdose sur la performance économique et financière des exploitations agricoles du Kouritenga et du Zondoma au Burkina Faso","year":"2019","cit":7,"pfa":"Hamadé Sigue","psa":"Gauthier Biaou","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2970040332","eid":"W2970040332"},{"id":"paper-w1600216088","cat":"papers","name":"Role of GABA Deficit in Sensitivity to the Psychotomimetic Effects of Amphetamine","year":"2015","cit":7,"pfa":"Kyung-Heup Ahn","psa":"Deepak Cyril D’Souza","ptype":"article","src":"https://openalex.org/W1600216088","eid":"W1600216088"},{"id":"paper-w1987692925","cat":"papers","name":"The effect of psychotomimetics on therapist-patient matching of speech “rhythms”","year":"1979","cit":7,"pfa":"Michael Natale","psa":"J. Jaffe","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W1987692925","eid":"W1987692925"},{"id":"paper-w4309862078","cat":"papers","name":"C57BL/6N mice show a sub-strain specific resistance to the psychotomimetic effects of ketamine","year":"2022","cit":7,"pfa":"Zofia Harda","psa":"Jan M. Rodriguez Parkitna","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4309862078","eid":"W4309862078"},{"id":"paper-w2033333511","cat":"papers","name":"THE ACTION OF SOME PSYCHOTOMIMETIC AGENTS ON THE EXCITATORY AND BIOCHEMICAL PROCESSES OF FROG SARTORIUS MUSCLE*","year":"1963","cit":7,"pfa":"Leo G. Abood","psa":"Kyozo KOKETSU","ptype":"article","src":"https://openalex.org/W2033333511","eid":"W2033333511"},{"id":"paper-w4400786426","cat":"papers","name":"Is the antidepressant effect of ketamine separate from its psychotomimetic effect? A review of rodent models","year":"2024","cit":7,"pfa":"María Camila Acero-Castillo","psa":"Rafael Souto Maior","topics":["Depression","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4400786426","eid":"W4400786426"},{"id":"paper-w1985875005","cat":"papers","name":"Antagonism by cholinergic drugs of behavioural effects in cats of an anticholinergic psychotomimetic drug and enhancement by nicotine","year":"1977","cit":7,"pfa":"Karl Löwy","psa":"Leo G. Abood","ptype":"article","src":"https://openalex.org/W1985875005","eid":"W1985875005"},{"id":"paper-w4280538899","cat":"papers","name":"A Comparison of Acute Neurocognitive and Psychotomimetic Effects of a Synthetic Cannabinoid and Natural Cannabis at Psychotropic Dose Equivalence","year":"2022","cit":7,"pfa":"Eef Lien Theunissen","psa":"Johannes Gerardus Ramaekers","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4280538899","eid":"W4280538899"},{"id":"paper-w2060471223","cat":"papers","name":"Psychotomimetic Ergot Alkaloid Contents of Seed from Calonyction muricatum, Jacquemontia tamnifolia, Quamoclit lobata, and Q. sloteri","year":"1988","cit":7,"pfa":"Robert E. Wilkinson","psa":"Cynthia S. McCormick","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2060471223","eid":"W2060471223"},{"id":"paper-w2892843713","cat":"papers","name":"Adrenolutin as a Psychotomimetic Agent11Research supported by National Health Grants, Ottawa; Rockefeller Foundation, New York; and Saskatchewan Committee on Schizophrenia Research.","year":"1957","cit":7,"pfa":"Abram Hoffer","ptype":"book-chapter","src":"https://openalex.org/W2892843713","eid":"W2892843713"},{"id":"paper-w1607956734","cat":"papers","name":"HARM REDUCTION—AN ETHICAL IMPERATIVE","year":"2009","cit":7,"pfa":"Ingrid van Beek","topics":["Safety & adverse events","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1607956734","eid":"W1607956734"},{"id":"paper-w4408840603","cat":"papers","name":"The Selective 5HT2A Receptor Agonist, 25CN‐NBOH Exerts Excitatory and Inhibitory Cellular Actions on Mouse Medial Prefrontal Cortical Neurons","year":"2025","cit":7,"pfa":"Yang Wang","psa":"Kristi A. Kohlmeier","topics":["Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4408840603","eid":"W4408840603"},{"id":"paper-w4310942082","cat":"papers","name":"Use of the head-twitch response to investigate the structure–activity relationships of 4-thio-substituted 2,5-dimethoxyphenylalkylamines","year":"2022","cit":7,"pfa":"Adam L. Halberstadt","psa":"Matthias E. Liechti","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4310942082","eid":"W4310942082"},{"id":"paper-w1607508523","cat":"papers","name":"HARM REDUCTION IS A GOOD LABEL FOR A CRITERION ALL DRUG PROGRAMS SHOULD MEET","year":"2009","cit":7,"pfa":"Robert J. MacCoun","topics":["Safety & adverse events","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1607508523","eid":"W1607508523"},{"id":"paper-w2153825775","cat":"papers","name":"Mammogram and diagnostic X-rays–evidence of protective Bystander, Adaptive Response (AR) radio-protection and AR retention at high dose levels","year":"2008","cit":7,"pfa":"Bobby E. Leonard","psa":"Verna F. Leonard","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2153825775","eid":"W2153825775"},{"id":"paper-w4295413107","cat":"papers","name":"Comments to behavioral tests for antidepressant-like actions of (2R,6R)–hydroxynorketamine by Bonaventura et al.","year":"2022","cit":7,"pfa":"Lijia Chang","psa":"Kenji Hashimoto","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4295413107","eid":"W4295413107"},{"id":"paper-w1976747145","cat":"papers","name":"The effect of target-controlled infusion of low-dose ketamine on heat pain and temporal summation threshold","year":"2011","cit":7,"pfa":"Joon-Ho Lee","psa":"Yong-Ik Kim","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1976747145","eid":"W1976747145"},{"id":"paper-w2518260861","cat":"papers","name":"Inherent Calibration of Microdosemeters for Dose Distribution in Lineal Energy","year":"1994","cit":7,"pfa":"J.S.P. Crossman","psa":"D.E. Watt","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2518260861","eid":"W2518260861"},{"id":"paper-w2555191792","cat":"papers","name":"An Update on Drug Dependence in the Elderly","year":"1979","cit":7,"pfa":"Emil F. Pascarelli","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W2555191792","eid":"W2555191792"},{"id":"paper-w3024263401","cat":"papers","name":"Economic Conditions, Illicit Drug Use, and Substance Use Disorders in the United States","year":"2016","cit":7,"pfa":"Christopher S. Carpenter","psa":"Daniel I. Rees","topics":["Addiction"],"ptype":"report","src":"https://openalex.org/W3024263401","eid":"W3024263401"},{"id":"paper-w2240696409","cat":"papers","name":"Psychotropic Drugs in the Management of Psychiatric Emergencies","year":"1975","cit":7,"pfa":"Richard Ketai","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2240696409","eid":"W2240696409"},{"id":"paper-w4367847261","cat":"papers","name":"Dosing and Therapeutic Conduct in Administration Sessions in Substance-Assisted Psychotherapy: A Systematized Review","year":"2023","cit":7,"pfa":"Sascha B. Thal","psa":"Stephen Jason Bright","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4367847261","eid":"W4367847261"},{"id":"paper-w2899418770","cat":"papers","name":"Abuse and Effects of Salvia divinorum in a Sample of Patients Hospitalized for Substance Dependence","year":"2018","cit":7,"pfa":"Antoine Karam","psa":"François Kazour","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2899418770","eid":"W2899418770"},{"id":"paper-w4206296712","cat":"papers","name":"LSD Flashbacks","year":"1984","cit":7,"pfa":"Johanna A. Hoffman","ptype":"article","src":"https://openalex.org/W4206296712","eid":"W4206296712"},{"id":"paper-w4403123312","cat":"papers","name":"Substance use and risk of suicide among adults who sought mental health and addiction specialty services through a centralised intake process in Nova Scotia: a cross-sectional study","year":"2024","cit":7,"pfa":"Matiwos Soboka","psa":"JianLi Wang","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4403123312","eid":"W4403123312"},{"id":"paper-w3138086555","cat":"papers","name":"Rotenoids and Other Specialized Metabolites from the Roots of Mirabilis multiflora: Opioid and Cannabinoid Receptor Radioligand Binding Affinities","year":"2021","cit":7,"pfa":"Vimal Kant Sharma","psa":"Ikhlas Ahmed Khan","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3138086555","eid":"W3138086555"},{"id":"paper-w4408988602","cat":"papers","name":"Comparing the prevalence of substance use disorders between persons with and without autism spectrum disorders","year":"2025","cit":7,"pfa":"Viktor Lushin","psa":"Lindsay Shea","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4408988602","eid":"W4408988602"},{"id":"paper-w3177443271","cat":"papers","name":"Ketamine and sleep modulate neural complexity dynamics in cats","year":"2021","cit":7,"pfa":"Claudia Pascovich","psa":"Tristán Bekinschtein","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W3177443271","eid":"W3177443271"},{"id":"paper-w4400111393","cat":"papers","name":"Understanding and treating postpartum depression: a narrative review","year":"2024","cit":7,"pfa":"Vincenzo Cardaci","psa":"Raffaella Zanardi","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W4400111393","eid":"W4400111393"},{"id":"paper-w2049886140","cat":"papers","name":"A Strategy for the Biological Assessment of Addiction","year":"1984","cit":7,"pfa":"Janice F. Kauffman","psa":"Milton Earl Burglass","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2049886140","eid":"W2049886140"},{"id":"paper-w3080829832","cat":"papers","name":"Nonclinical safety testing of imaging agents, contrast agents and radiopharmaceuticals","year":"2020","cit":7,"pfa":"Paul Baldrick","topics":["Safety & adverse events","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3080829832","eid":"W3080829832"},{"id":"paper-w3010611789","cat":"papers","name":"Ketamine Abuse: Past and Present","year":"2020","cit":7,"pfa":"Ming‐Chyi Huang","psa":"Shih‐Ku Lin","ptype":"book-chapter","src":"https://openalex.org/W3010611789","eid":"W3010611789"},{"id":"paper-w4381051605","cat":"papers","name":"Retigabine promotes ketamine's antidepressant effect in the forced swim test in male and female C57BL/6J mice","year":"2023","cit":7,"pfa":"Yixue Qin","psa":"Hongxing Zhang","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4381051605","eid":"W4381051605"},{"id":"paper-w2774062784","cat":"papers","name":"Detection and Identification of Psilocybe cubensis DNA Using a Real‐Time Polymerase Chain Reaction High Resolution Melt Assay,","year":"2017","cit":7,"pfa":"Ashley F. Cowan","psa":"Kelly M. Elkins","ptype":"article","src":"https://openalex.org/W2774062784","eid":"W2774062784"},{"id":"paper-w2430992911","cat":"papers","name":"Ketamine as continuous intravenous infusion combined with diazepam in non-abdominal surgery. A randomized double-blind study.","year":"1981","cit":7,"pfa":"T Pedersen","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2430992911","eid":"W2430992911"},{"id":"paper-w4405675944","cat":"papers","name":"Emerging medications and pharmacological treatment approaches for substance use disorders","year":"2024","cit":7,"pfa":"Joel S. Raymond","psa":"Morgan H. James","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4405675944","eid":"W4405675944"},{"id":"paper-w4221037530","cat":"papers","name":"Trend Analysis of Substance Use Disorder During Pregnancy","year":"2022","cit":7,"pfa":"Memory Ndanga","psa":"Abimbola K. Saka","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4221037530","eid":"W4221037530"},{"id":"paper-w4391192079","cat":"papers","name":"Characteristics and physical outcomes of kratom users at a substance abuse treatment center","year":"2019","cit":7,"pfa":"Somreudee Eaimchaloay","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4391192079","eid":"W4391192079"},{"id":"paper-w4387539676","cat":"papers","name":"Effects of NMDA-receptor blockade by ketamine on mentalizing and its neural correlates in humans: a randomized control trial","year":"2023","cit":7,"pfa":"Sven Wasserthal","psa":"Johannes Schultz","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4387539676","eid":"W4387539676"},{"id":"paper-w3126278713","cat":"papers","name":"Race-based differences in drug use prior to onset of opioid use disorder","year":"2021","cit":7,"pfa":"Sasha Deutsch‐Link","psa":"Eric D. Wish","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3126278713","eid":"W3126278713"},{"id":"paper-w4379231441","cat":"papers","name":"Recommendations for selection and adaptation of rating scales for clinical studies of rapid-acting antidepressants","year":"2023","cit":7,"pfa":"Christian Yavorsky","psa":"William R. Lenderking","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4379231441","eid":"W4379231441"},{"id":"paper-w2061293991","cat":"papers","name":"Some Effects of a Hallucinogenic Compound (Cyprenorphine Hydrochloride; M 285) on the Light Reinforced Behaviour of Rats","year":"1969","cit":7,"pfa":"Geoffrey Lowe","psa":"D. I. Williams","ptype":"article","src":"https://openalex.org/W2061293991","eid":"W2061293991"},{"id":"paper-w289102249","cat":"papers","name":"Broken Images, Broken Selves—Dissociative Narratives in Clinical Practice","year":"1999","cit":7,"pfa":"Colin A. Ross","ptype":"article","src":"https://openalex.org/W289102249","eid":"W289102249"},{"id":"paper-w4403084519","cat":"papers","name":"Visual mismatch negativity in Parkinson's psychosis and potential for testing treatment mechanisms","year":"2024","cit":7,"pfa":"Miriam Vignando","psa":"Mitul Ashok Mehta","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4403084519","eid":"W4403084519"},{"id":"paper-w68670728","cat":"papers","name":"The Influence of Harmaline on Sodium and Sodium-Dependent Transport Mechanisms","year":"1976","cit":7,"pfa":"Francisco V. Sepúlveda","psa":"J. W. L. Robinson","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W68670728","eid":"W68670728"},{"id":"paper-w1536255414","cat":"papers","name":"Electrophysiological interactions of isomers of cyclazocine with the phencyclidine antagonist metaphit in rat cerebellar Purkinje neurons","year":"1986","cit":7,"pfa":"Yun Wang","psa":"BJ Hoffer","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1536255414","eid":"W1536255414"},{"id":"paper-w194268694","cat":"papers","name":"Hallucinations: Common Features and Causes: Awareness of Manifestations, Nonpsychiatric Etiologies Can Help Pinpoint a Diagnosis","year":"2011","cit":7,"pfa":"Shahid I. Ali","psa":"Wayne J. Riley","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W194268694","eid":"W194268694"},{"id":"paper-w4243406965","cat":"papers","name":"Cannabidiol presents an inverted U-shaped dose-response curve in the simulated public speaking test","year":"2016","cit":7,"pfa":"Ila Marques Porto Linares","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W4243406965","eid":"W4243406965"},{"id":"paper-w4405424211","cat":"papers","name":"Arketamine: a scoping review of its use in humans","year":"2024","cit":7,"pfa":"Gustavo Carneiro-Gomes Leal","psa":"Lucas C. Quarantini","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4405424211","eid":"W4405424211"},{"id":"paper-w4389850620","cat":"papers","name":"Sexual dimorphism of G protein-coupled receptor signaling in the brain","year":"2023","cit":7,"pfa":"Sara Aljoudi","psa":"Khaled S. Abd‐Elrahman","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4389850620","eid":"W4389850620"},{"id":"paper-w3094573864","cat":"papers","name":"Esketamine for Postpartum Suicidality","year":"2020","cit":7,"pfa":"Catarina Machado","psa":"Cristiano de Souza Noto","ptype":"article","src":"https://openalex.org/W3094573864","eid":"W3094573864"},{"id":"paper-w3083042315","cat":"papers","name":"NICE reconsiders esketamine for depression","year":"2020","cit":7,"pfa":"Elisabeth Mahase","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W3083042315","eid":"W3083042315"},{"id":"paper-w3022060934","cat":"papers","name":"Esketamine Nasal Spray for Treatment-Resistant Depression","year":"2020","cit":7,"pfa":"Heidi Collins Fantasia","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W3022060934","eid":"W3022060934"},{"id":"paper-w4401641097","cat":"papers","name":"Esketamine as an adjuvant to propofol sedation for gastrointestinal endoscopy","year":"2024","cit":7,"pfa":"Nan Song","psa":"Ke Peng","ptype":"article","src":"https://openalex.org/W4401641097","eid":"W4401641097"},{"id":"paper-w2902650228","cat":"papers","name":"Is the History Repeated? Can (2 R ,6 R )-Hydroxynorketamine be Another Antidepressant?","year":"2018","cit":7,"pfa":"Shigeyuki Chaki","psa":"Junichi Yamaguchi","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"editorial","src":"https://openalex.org/W2902650228","eid":"W2902650228"},{"id":"paper-w4362469351","cat":"papers","name":"(2R,6R)-Hydroxynorketamine Treatment of Rats Exposed to Repetitive Low-Level Blast Injury","year":"2023","cit":7,"pfa":"Georgina Pérez Garcia","psa":"Gregory A. Elder","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4362469351","eid":"W4362469351"},{"id":"paper-w3008491249","cat":"papers","name":"Approval of esketamine for treatment-resistant depression – Authors' reply","year":"2020","cit":7,"pfa":"Florian Naudet","psa":"Ioana A. Cristea","topics":["Depression"],"ptype":"letter","src":"https://openalex.org/W3008491249","eid":"W3008491249"},{"id":"paper-w4308844340","cat":"papers","name":"Intranasal (2R, 6R)‐hydroxynorketamine for acute pain: Behavioural and neurophysiological safety analysis in mice","year":"2022","cit":7,"pfa":"Nidhi Goswami","psa":"Kailash Manda","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4308844340","eid":"W4308844340"},{"id":"paper-w4399030457","cat":"papers","name":"Efficacy of ketamine versus esketamine in the treatment of perioperative depression: A review","year":"2024","cit":7,"pfa":"Wen Wen","psa":"Jun Ma","topics":["Depression","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4399030457","eid":"W4399030457"},{"id":"paper-w4300003367","cat":"papers","name":"(2R,6R)-hydroxynorketamine (HNK) reverses mechanical hypersensitivity in a model of localized inflammatory pain","year":"2022","cit":7,"pfa":"Jonathan G. Yost","psa":"Irwin Lucki","ptype":"article","src":"https://openalex.org/W4300003367","eid":"W4300003367"},{"id":"paper-w2977354530","cat":"papers","name":"More Thoughts on Intranasal Esketamine: Response to Drevets et al.","year":"2019","cit":7,"pfa":"Alan F. Schatzberg","ptype":"article","src":"https://openalex.org/W2977354530","eid":"W2977354530"},{"id":"paper-w4224224851","cat":"papers","name":"[Effects of subanesthetic dose of esketamine on opioid consumption after thoracoscopic surgery].","year":"2022","cit":7,"pfa":"Jianqiao Yuan","psa":"Jinjian Yang","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4224224851","eid":"W4224224851"},{"id":"paper-w4401557450","cat":"papers","name":"CircKat6b Mediates the Antidepressant Effect of Esketamine by Regulating Astrocyte Function","year":"2024","cit":7,"pfa":"Na Hu","psa":"Xiaobin Wang","topics":["Depression","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4401557450","eid":"W4401557450"},{"id":"paper-w3216910382","cat":"papers","name":"Ketamine and Esketamine for Treatment-Resistant Depression: Response to Reus, Mattes, and Schatzberg","year":"2021","cit":7,"pfa":"Roger S. McIntyre","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W3216910382","eid":"W3216910382"},{"id":"paper-w4414371874","cat":"papers","name":"Clinical Benefits and Challenges of Esketamine in Elderly Patients During the Perioperative Period","year":"2025","cit":7,"pfa":"Shuai Zhang","psa":"Xin Zhao","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4414371874","eid":"W4414371874"},{"id":"paper-w4380785934","cat":"papers","name":"A Pharmacological Evaluation of the Analgesic Effect and Hippocampal Protein Modulation of the Ketamine Metabolite (2R,6R)-Hydroxynorketamine in Murine Pain Models","year":"2023","cit":7,"pfa":"Vaskar Das","psa":"Robert J. McCarthy","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4380785934","eid":"W4380785934"},{"id":"paper-w2912505514","cat":"papers","name":"Safety and pharmacokinetics study of inhaled esketamine after a single dose in healthy volunteers","year":"2019","cit":7,"pfa":"Sylwia Janowska","psa":"Maciej Wieczorek","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2912505514","eid":"W2912505514"},{"id":"paper-w2955147224","cat":"papers","name":"PMH19 COST-EFFECTIVENESS ANALYSIS OF ESKETAMINE IN TREATMENT-RESISTANT DEPRESSION IN THE UNITED STATES","year":"2019","cit":7,"pfa":"Luis Hernández","psa":"H. Le","topics":["Depression"],"ptype":"conference-abstract","src":"https://openalex.org/W2955147224","eid":"W2955147224"},{"id":"paper-w4387210182","cat":"papers","name":"Effects of Esketamine Combined with Propofol for Hysteroscopy Anesthesia on Patient Hemodynamics and Adverse Reactions.","year":"2024","cit":7,"pfa":"Jianying Wang","psa":"Qiong Xu","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4387210182","eid":"W4387210182"},{"id":"paper-w4412048333","cat":"papers","name":"Esketamine disinhibits brain networks in depression: Evidence from oscillatory and aperiodic activity","year":"2025","cit":7,"pfa":"Verina Guirguis","psa":"Tobias Schwippel","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4412048333","eid":"W4412048333"},{"id":"paper-w4385798011","cat":"papers","name":"Analysis of the Analgesic Effect, Emotion, and Safety of Esketamine in Cesarean Section Analgesia for Puerperae.","year":"2023","cit":7,"pfa":"Fanfan Lou","psa":"Zhenhua Yang","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4385798011","eid":"W4385798011"},{"id":"paper-w4379233330","cat":"papers","name":"Intranasal esketamine as therapeutic option: a case report of an adolescent with treatment resistant depression","year":"2023","cit":7,"pfa":"Katrin Skala","psa":"Paul Lukas Plener","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4379233330","eid":"W4379233330"},{"id":"paper-w4410783913","cat":"papers","name":"Comparison of Esketamine/Propofol and Sufentanil/Propofol on Intraoperative Hypoxemia During Bronchoscopy: A Randomized Trial","year":"2025","cit":7,"pfa":"Xiao Dong Huang","psa":"Pan Ai","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4410783913","eid":"W4410783913"},{"id":"paper-w4316511392","cat":"papers","name":"Registered clinical trials investigating ketamine and esketamine for treatment-resistant depression: A systematic review","year":"2023","cit":7,"pfa":"Madeline Brendle","psa":"Reid J. Robison","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W4316511392","eid":"W4316511392"},{"id":"paper-w4405456337","cat":"papers","name":"Determining the effective dose of esketamine combined with propofol for painless hysteroscopy: a prospective dose-finding study","year":"2024","cit":7,"pfa":"Zhimin Sheng","psa":"Xiaowei Qian","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4405456337","eid":"W4405456337"},{"id":"paper-w4406892217","cat":"papers","name":"Esketamine alleviates depressive-like behavior in neuropathic pain mice through the METTL3-GluA1 pathway","year":"2025","cit":7,"pfa":"Xiaoming Ji","psa":"Tianyun Zhang","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4406892217","eid":"W4406892217"},{"id":"paper-w4414383528","cat":"papers","name":"Comparative Effects of Repeated Ketamine Infusion Versus Intranasal Esketamine in Patients With Treatment-Resistant Depression","year":"2025","cit":7,"pfa":"Robert C. Meisner","psa":"Steve J. Seiner","topics":["Depression","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4414383528","eid":"W4414383528"},{"id":"paper-w4412804974","cat":"papers","name":"Long-Term Outcomes in Patients With Treatment-Refractory Depression Receiving Intravenous Ketamine and Intranasal Esketamine","year":"2025","cit":7,"pfa":"Balwinder Singh","psa":"Jennifer L. Vande Voort","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4412804974","eid":"W4412804974"},{"id":"paper-w4406844530","cat":"papers","name":"Long-Term Cognitive Outcomes of Esketamine Nasal Spray in Treatment-Resistant Depression: A Preliminary Report","year":"2025","cit":7,"pfa":"Matildes de Freitas Menezes Sobreiro","psa":"Renério Fráguas","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4406844530","eid":"W4406844530"},{"id":"paper-w4353015077","cat":"papers","name":"Progesterone alleviates esketamine-induced hypomyelination via PI3K/Akt signaling pathway in the developing rat brain","year":"2023","cit":7,"pfa":"Peiwen Liu","psa":"Jijian Zheng","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4353015077","eid":"W4353015077"},{"id":"paper-w4399247076","cat":"papers","name":"Effect of esketamine on the ED50 of propofol for successful insertion of ureteroscope in elderly male patients: a randomized controlled trial","year":"2024","cit":7,"pfa":"Xin Luo","psa":"Li‐Xin An","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4399247076","eid":"W4399247076"},{"id":"paper-w4367601089","cat":"papers","name":"Changing the paradigm in treatment-resistant depression: A review of long-term efficacy and tolerability of esketamine nasal spray.","year":"2023","cit":7,"pfa":"Jesús Herrera-Imbroda","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4367601089","eid":"W4367601089"},{"id":"paper-w4378348538","cat":"papers","name":"Mapping metabolite change in the mouse brain after esketamine injection by ambient mass spectrometry imaging and metabolomics","year":"2023","cit":7,"pfa":"Guanxi Liu","psa":"Yuping Ning","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4378348538","eid":"W4378348538"},{"id":"paper-w4385664324","cat":"papers","name":"Differential effectiveness between Ketamine and Esketamine: the predictive role of dissociative features. A treatment-resistant depression case","year":"2023","cit":7,"pfa":"Nicola Ragone","psa":"Cristina Colombo","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4385664324","eid":"W4385664324"},{"id":"paper-w4396524973","cat":"papers","name":"Esketamine alleviates hypoxia/reoxygenation injury of cardiomyocytes by regulating TRPV1 expression and inhibiting intracellular Ca2+ concentration","year":"2024","cit":7,"pfa":"Ying Zhang","psa":"QiHong Zhao","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4396524973","eid":"W4396524973"},{"id":"paper-w4407673797","cat":"papers","name":"Esketamine reduces postoperative depression in breast cancer through TREK-1 channel inhibition and neurotransmitter modulation","year":"2025","cit":7,"pfa":"Jiachi Xu","psa":"Hui Xia Zhou","topics":["Depression","Anxiety & end-of-life","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4407673797","eid":"W4407673797"},{"id":"paper-w4410562302","cat":"papers","name":"Impact of perioperative esketamine on the perioperative neurocognitive dysfunction: a systematic review and meta-analysis of randomised controlled studies","year":"2025","cit":7,"pfa":"Xuesen Su","psa":"Shouyuan Tian","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4410562302","eid":"W4410562302"},{"id":"paper-w4412581192","cat":"papers","name":"Effect of low-dose esketamine on postoperative quality of recovery in total laparoscopic hysterectomy: a randomized controlled trial","year":"2025","cit":7,"pfa":"Jing Zhang","psa":"Dunyi Qi","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4412581192","eid":"W4412581192"},{"id":"paper-w4401585981","cat":"papers","name":"Heart Rate Variability as a Potential Predictor of Response to Intranasal Esketamine in Patients with Treatment-Resistant Depression: A Preliminary Report","year":"2024","cit":7,"pfa":"Lorenzo Moccia","psa":"Gabriele Sani","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4401585981","eid":"W4401585981"},{"id":"paper-w4417045769","cat":"papers","name":"Role of Esketamine in Attenuating Neuroinflammation and Improving Postoperative Cognitive Function via Autophagy Activation Through PARP1 Targeting","year":"2025","cit":7,"pfa":"Zhao","psa":"Wang","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4417045769","eid":"W4417045769"},{"id":"paper-w4385751341","cat":"papers","name":"Esketamine nasal spray in severe bipolar depression with borderline personality disorder and history of multiple substance abuse: A case report","year":"2023","cit":7,"pfa":"Renato de Filippis","psa":"Pasquale De Fazio","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W4385751341","eid":"W4385751341"},{"id":"paper-w4224981950","cat":"papers","name":"Effect of esketamine on perioperative depressive symptoms in major surgery patients (PASSION II): study protocol for a randomised controlled trial","year":"2022","cit":7,"pfa":"Yang Zhou","psa":"Ruquan Han","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4224981950","eid":"W4224981950"},{"id":"paper-w4396521249","cat":"papers","name":"Dose-response study of propofol combined with two different doses of esketamine for laryngeal mask airway insertion in women undergoing hysteroscopy","year":"2024","cit":7,"pfa":"Yanjun Lin","psa":"Liang-Yuan Lu","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4396521249","eid":"W4396521249"},{"id":"paper-w4407371907","cat":"papers","name":"Efficacy of intranasal dexmedetomidine-esketamine sedation for pediatric acceptance of facemask: single-center, double-blind, randomized, controlled trial","year":"2025","cit":7,"pfa":"Kan Zhang","psa":"Yujuan Tao","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4407371907","eid":"W4407371907"},{"id":"paper-w4413005437","cat":"papers","name":"Risk of manic switch and suicidal outcomes in bipolar depression treated with esketamine: A one-year retrospective cohort study of 2126 patients","year":"2025","cit":7,"pfa":"Tinghui Liu","psa":"Chih‐Cheng Lai","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4413005437","eid":"W4413005437"},{"id":"paper-w4409845273","cat":"papers","name":"Oral esketamine for patients with severe treatment-resistant depression: Effectiveness, safety, and tolerability of a six-week open-label treatment program","year":"2025","cit":7,"pfa":"Jolien K. E. Veraart","psa":"Jeanine Kamphuis","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4409845273","eid":"W4409845273"},{"id":"paper-w4408536034","cat":"papers","name":"Effect of Esketamine-Based Opioid-Sparing Anesthesia Protocol on the Quality of Early Recovery After Urological Surgery: A Randomized Clinical Trial","year":"2025","cit":7,"pfa":"Yu Qi","psa":"Liwei Wang","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4408536034","eid":"W4408536034"},{"id":"paper-w7154703368","cat":"papers","name":"Esketamine in treatment-resistant depression with and without comorbid borderline personality disorder: A real-world longitudinal study of suicidal ideation and self-harm","year":"2026","cit":7,"pfa":"F. Raffone","psa":"Vassilis Martiadis","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7154703368","eid":"W7154703368"},{"id":"paper-w4407310031","cat":"papers","name":"Esketamine alleviates cognitive impairment signs induced by modified electroconvulsive therapy in a depression rat model via the KLF4/p38 MAPK pathway","year":"2025","cit":7,"pfa":"Xiaohui Zhou","psa":"Li Wang","topics":["Depression","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4407310031","eid":"W4407310031"},{"id":"paper-w4395113521","cat":"papers","name":"Effects of intraoperative low‐dose esketamine on postoperative pain after vestibular schwannoma resection: A prospective randomized, double‐blind, placebo‐controlled study","year":"2024","cit":7,"pfa":"Kaizheng Chen","psa":"Xia Shen","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4395113521","eid":"W4395113521"},{"id":"paper-w4385668042","cat":"papers","name":"Long-term remission following esketamine nasal spray sessions in a patient with severe and highly treatment-resistant depression: a single-case report","year":"2023","cit":7,"pfa":"Lucas Arrighi","psa":"Raphaëlle Marie Richieri","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4385668042","eid":"W4385668042"},{"id":"paper-w4389095860","cat":"papers","name":"Clinical case report: considerable improvement of severe and difficult-to-treat obsessive-compulsive disorder with comorbid depression under treatment with esketamine and concomitant psychotherapy","year":"2023","cit":7,"pfa":"Alexander Kaltenboeck","psa":"Fabian Friedrich","topics":["Depression","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4389095860","eid":"W4389095860"},{"id":"paper-w3107482517","cat":"papers","name":"Erratum to “Comparative efficacy of racemic ketamine and esketamine for depression: a systematic review and meta-analysis” [Journal of Affective Disorders 278C (2021) 542–555]","year":"2020","cit":7,"pfa":"Anees Bahji","psa":"Carlos A. Zarate","topics":["Depression","Reviews & meta-analyses"],"ptype":"erratum","src":"https://openalex.org/W3107482517","eid":"W3107482517"},{"id":"paper-w4321184908","cat":"papers","name":"Social determinants and distance from certified treatment centers are associated with initiation of esketamine nasal spray among patients with challenging-to-treat major depressive disorder","year":"2023","cit":7,"pfa":"Joshua N. Liberman","psa":"Lisa Harding","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W4321184908","eid":"W4321184908"},{"id":"paper-w4295242519","cat":"papers","name":"Effects of GRIN2B, GRIA1, and BDNF Polymorphisms on the Therapeutic Action of Ketamine and Esketamine in Treatment-Resistant Depression Patients: Secondary Analysis From a Randomized Clinical Trial","year":"2022","cit":7,"pfa":"Graziele Beanes","psa":"Lucas C. Quarantini","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4295242519","eid":"W4295242519"},{"id":"paper-w4389545926","cat":"papers","name":"Esketamine Combined with Propofol TCI versus Propofol TCI for Deep Sedation during Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration: A Prospective, Randomized, and Controlled Trial","year":"2023","cit":7,"pfa":"Sichen Cui","psa":"Lining Huang","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4389545926","eid":"W4389545926"},{"id":"paper-w4404902054","cat":"papers","name":"The effect of esketamine combined with sufentanil based patient-controlled intravenous analgesia for postoperative pain in patients undergoing third molar surgery and maxillofacial trauma: a randomized clinical trial","year":"2024","cit":7,"pfa":"Xue Li","psa":"Ying Chen","topics":["PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4404902054","eid":"W4404902054"},{"id":"paper-w4411452877","cat":"papers","name":"Abuse liability for esketamine in a cohort of patients undergoing an acute treatment course to manage treatment-resistant depression: a secondary analysis of an observational study in real-world clinical practicee","year":"2025","cit":7,"pfa":"Gilmar Gutiérrez","psa":"Jennifer Swainson","topics":["Depression","Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4411452877","eid":"W4411452877"},{"id":"paper-w4405655505","cat":"papers","name":"Inhibitory effect of low-dose esketamine on cough induced by sufentanil during the induction of anesthesia and postoperative impact on mental health status: a prospective, single-center, randomized controlled trial","year":"2024","cit":7,"pfa":"Ju Qian","psa":"Shuang Zhou","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4405655505","eid":"W4405655505"},{"id":"paper-w4317716307","cat":"papers","name":"Ketamine for the Treatment of Major Depression: A Systematic Review and Meta-Analysis","year":"2023","cit":7,"pfa":"Stevan Nikolin","psa":"Colleen K A Loo","topics":["Depression","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4317716307","eid":"W4317716307"},{"id":"paper-w3133554621","cat":"papers","name":"Compounded intranasal racemic ketamine for major depressive disorder: A case report.","year":"2021","cit":7,"pfa":"Lindsey Ziegler","psa":"Katelyn Halpape","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3133554621","eid":"W3133554621"},{"id":"paper-w4414196302","cat":"papers","name":"Spravato for Treatment-Resistant Depression: Efficacy and Sexual Side Effect Profile","year":"2025","cit":7,"pfa":"Ahmed Asad Raza","psa":"Abedin Samadi","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4414196302","eid":"W4414196302"},{"id":"paper-w4229052563","cat":"papers","name":"Prioritizing Patient Preferences","year":"2022","cit":7,"pfa":"Joshua Berman","psa":"Adrian Jacques H. Ambrose","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4229052563","eid":"W4229052563"},{"id":"paper-w4307164566","cat":"papers","name":"Safety of Ketamine Augmentation to Monoamine Oxidase Inhibitors in Treatment-Resistant Depression","year":"2022","cit":7,"pfa":"Jolien K. E. Veraart","psa":"Robert A. Schoevers","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4307164566","eid":"W4307164566"},{"id":"paper-w2558932523","cat":"papers","name":"Isoflurane-Associated Mydriasis Mimicking Blown Pupils in a Patient Treated in a Neurointensive Care Unit","year":"2016","cit":7,"pfa":"Eva Magdalena Korf","psa":"Jan Nils Küchler","topics":["PTSD & trauma","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2558932523","eid":"W2558932523"},{"id":"paper-w4409375262","cat":"papers","name":"Study of metabolic pathways of racemic ketamine and its (S)-enantiomer in rat blood plasma using CE-ESI/MS with partial filling of dual chiral selector system","year":"2025","cit":7,"pfa":"Renáta Konášová","psa":"Václav Kašička","ptype":"article","src":"https://openalex.org/W4409375262","eid":"W4409375262"},{"id":"paper-w4221124694","cat":"papers","name":"Importance of Exploring N-Methyl-D-Aspartate (NMDA) as a Future Perspective Target in Depression","year":"2022","cit":7,"pfa":"Gaurav Doshi","psa":"Pravin Popatrao Kale","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4221124694","eid":"W4221124694"},{"id":"paper-w4380151713","cat":"papers","name":"An update on pharmacotherapy for recurrent depression in 2022","year":"2023","cit":7,"pfa":"Jean-Baptiste Belge","psa":"Bernard Sabbe","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4380151713","eid":"W4380151713"},{"id":"paper-w4404141396","cat":"papers","name":"Notes from the Field: Ketamine Detection and Involvement in Drug Overdose Deaths — United States, July 2019–June 2023","year":"2024","cit":7,"pfa":"Alana Marie Vivolo-Kantor","psa":"María Zlotorzynska","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4404141396","eid":"W4404141396"},{"id":"paper-w3031705377","cat":"papers","name":"Anesthesia for patients with psychiatric illnesses: a narrative review with emphasis on preoperative assessment and postoperative recovery and pain","year":"2020","cit":7,"pfa":"Dušica Stamenković","psa":"Davide Cattano","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W3031705377","eid":"W3031705377"},{"id":"paper-w7117485589","cat":"papers","name":"Molecular Mechanisms of Emerging Antidepressant Strategies: From Ketamine to Neuromodulation","year":"2025","cit":7,"pfa":"Mateusz Kowalczyk","psa":"Gabriela A. Henrykowska","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7117485589","eid":"W7117485589"},{"id":"paper-w4400745264","cat":"papers","name":"Overcoming treatment-resistant depression with machine-learning based tools: a study protocol combining EEG and clinical data to personalize glutamatergic and brain stimulation interventions (SelecTool Project)","year":"2024","cit":7,"pfa":"Mauro Pettorruso","psa":"Giovanni Martinotti","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4400745264","eid":"W4400745264"},{"id":"paper-w4243170313","cat":"papers","name":"Chronic Pain and Suicide: Is There a Role for Ketamine?","year":"2017","cit":7,"pfa":"Madeleine Baldwin","psa":"Georgine Lamvu","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4243170313","eid":"W4243170313"},{"id":"paper-w4409670427","cat":"papers","name":"Opioid-Free versus Opioid-Sparing Anesthesia for Postoperative Pain and Early Recovery After Laparoscopic Cholecystectomy: A Randomized Controlled Trial","year":"2025","cit":7,"pfa":"Miaomiao Xiong","psa":"Ming Fang","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4409670427","eid":"W4409670427"},{"id":"paper-w4407939047","cat":"papers","name":"Evaluation of different intramuscular injectable anesthetic combinations in rabbits: Impact on anesthetic depth, physiological parameters, and EEG recordings","year":"2025","cit":7,"pfa":"Marie-Louise Schmid","psa":"Christine M. Baumgartner","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4407939047","eid":"W4407939047"},{"id":"paper-w7115178570","cat":"papers","name":"Perioperative Ketamine Exposure and Postoperative Atrial Fibrillation/Flutter Risk After Video-Assisted Thoracoscopic Surgery: A Multi-Institutional Study","year":"2025","cit":7,"pfa":"Kuo-Chuan Hung","psa":"I-Wen Chen","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7115178570","eid":"W7115178570"},{"id":"paper-w2060949542","cat":"papers","name":"Action of LSD on raphe neurons and effect on presumed serotonergic raphe synapses","year":"1976","cit":7,"pfa":"J.R. Couch","ptype":"article","src":"https://openalex.org/W2060949542","eid":"W2060949542"},{"id":"paper-w2399047217","cat":"papers","name":"Effects of atypical antidepressants on LSD potentiated apomorphine hypermotility in rats.","year":"1980","cit":7,"pfa":"R. Gold","psa":"Heidrun Fink","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2399047217","eid":"W2399047217"},{"id":"paper-w2136071110","cat":"papers","name":"Quasi-atomistic Receptor Surrogates for the 5-HT2A Receptor: A 3D-QSAR Study on Hallucinogenic Substances","year":"1999","cit":7,"pfa":"Meike Schulze‐Alexandru","psa":"Angelo Vedani","topics":["Addiction","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2136071110","eid":"W2136071110"},{"id":"paper-w3094683111","cat":"papers","name":"Lysergic Acid Diethylamide Toxicity","year":"2021","cit":6,"pfa":"Maximo Baquiran","psa":"Yasir Al Khalili","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3094683111","eid":"W3094683111"},{"id":"paper-w2104054856","cat":"papers","name":"Steroids and Moods: Correlations in Schizophrenics and Subjects Treated With Lysergic Acid Diethylamide (LSD), Mescaline, Tetrahydrocannabinol, and Synhexyl","year":"1969","cit":6,"pfa":"Leo E. Hollister","ptype":"article","src":"https://openalex.org/W2104054856","eid":"W2104054856"},{"id":"paper-w2129427539","cat":"papers","name":"Lysergic Acid Diethylamide (LSD-25): XXXIV. Comparison with Effect of Psilocybin on the Siamese Fighting Fish","year":"1963","cit":6,"pfa":"Harold A. Abramson","psa":"G. Dean","ptype":"article","src":"https://openalex.org/W2129427539","eid":"W2129427539"},{"id":"paper-w2163545065","cat":"papers","name":"Antidiuretic Effect of Lysergic Acid Diethylamide in Humans","year":"1957","cit":6,"pfa":"Marian Wood Kies","ptype":"article","src":"https://openalex.org/W2163545065","eid":"W2163545065"},{"id":"paper-w2017989004","cat":"papers","name":"The psychopharmacology of lysergic acid diethylamide (LSD-25).","year":"1957","cit":6,"pfa":"Leonard S. Rubin","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2017989004","eid":"W2017989004"},{"id":"paper-w1553052874","cat":"papers","name":"Studies on lysergic acid diethylamide and related compounds. IX. Microbial transformation of amides related to lysergic acid diethylamide by Streptomyces roseochromogenes.","year":"1979","cit":6,"pfa":"Hisashi Ishii","psa":"Yuji Nakahara","ptype":"article","src":"https://openalex.org/W1553052874","eid":"W1553052874"},{"id":"paper-w2402452720","cat":"papers","name":"Lysergic acid diethylamide (LSD-25) antagonists: chlorpromazine.","year":"1998","cit":6,"pfa":"H A ABRAMSON","psa":"J. Stache","ptype":"article","src":"https://openalex.org/W2402452720","eid":"W2402452720"},{"id":"paper-w1981806499","cat":"papers","name":"Electrophysiological studies of d-lysergic acid diethylamide in the visual system","year":"1982","cit":6,"pfa":"Warren E. Foote","ptype":"article","src":"https://openalex.org/W1981806499","eid":"W1981806499"},{"id":"paper-w1993295963","cat":"papers","name":"Lysergic acid diethylamide: Morphological study of its effect on synapses","year":"1980","cit":6,"pfa":"Milena Kemali","psa":"DARGUT KEMALI","ptype":"article","src":"https://openalex.org/W1993295963","eid":"W1993295963"},{"id":"paper-w2008675536","cat":"papers","name":"Effect of Lysergic Acid Diethylamide on the Surfacing Behaviour of Large Carp","year":"1962","cit":6,"pfa":"Harold A. Abramson","psa":"G. Dean","ptype":"article","src":"https://openalex.org/W2008675536","eid":"W2008675536"},{"id":"paper-w2049435396","cat":"papers","name":"Lysergic Acid Diethylamide (LSD) and JB 318: A Comparison of Two Hallucinogens","year":"1960","cit":6,"pfa":"Binyamin Z. Lebovits","ptype":"article","src":"https://openalex.org/W2049435396","eid":"W2049435396"},{"id":"paper-w2474053215","cat":"papers","name":"Effects of marihuana and lysergic acid diethylamide on leukocyte chromosomes of the golden hamster.","year":"1973","cit":6,"pfa":"Nicholson Mt","psa":"Davis Wm","ptype":"article","src":"https://openalex.org/W2474053215","eid":"W2474053215"},{"id":"paper-w2049501760","cat":"papers","name":"The effect of lysergic acid diethylamide (LSD-25) on perception with stabilized images","year":"1965","cit":6,"pfa":"Bruno Kohn","psa":"M. Philip Bryden","ptype":"article","src":"https://openalex.org/W2049501760","eid":"W2049501760"},{"id":"paper-w2464702662","cat":"papers","name":"Marching to a different cactus: peyote (mescaline) intoxication.","year":"1986","cit":6,"pfa":"Mack Rb","ptype":"article","src":"https://openalex.org/W2464702662","eid":"W2464702662"},{"id":"paper-w1988872547","cat":"papers","name":"Studies on lysergic acid diethylamide and related compounds. Part 8. Structural identification of new metabolites of lysergic acid diethylamide obtained by microbial transformation using Streptomyces roseochromogenes","year":"1980","cit":6,"pfa":"Hisashi Ishii","psa":"Makoto Hayashi","ptype":"article","src":"https://openalex.org/W1988872547","eid":"W1988872547"},{"id":"paper-w2142045493","cat":"papers","name":"EFFECT OF LYSERGIC ACID DIETHYLAMIDE ON ADRENOCORTICAL AND ADRENAL MEDULLARY FUNCTION IN THE DOG","year":"1961","cit":6,"pfa":"William F. Ganong","psa":"Angela T. Boryczka","ptype":"article","src":"https://openalex.org/W2142045493","eid":"W2142045493"},{"id":"paper-w2477079400","cat":"papers","name":"Assays for Detection of Fungal Hallucinogens Such as Psilocybin and Psilocin","year":"2016","cit":6,"pfa":"Katarzyna Stebelska","ptype":"book-chapter","src":"https://openalex.org/W2477079400","eid":"W2477079400"},{"id":"paper-w2083846420","cat":"papers","name":"Lysergic Acid Diethylamide (LSD-25): V. Effect on Spatial Relations Abilities","year":"1955","cit":6,"pfa":"Harold A. Abramson","psa":"A. T. Ewald","ptype":"article","src":"https://openalex.org/W2083846420","eid":"W2083846420"},{"id":"paper-w2065669935","cat":"papers","name":"Studies on deoxyribonucleic acid metabolism in human cells treated with lysergic acid diethylamide","year":"1971","cit":6,"pfa":"James Edward Trosko","ptype":"article","src":"https://openalex.org/W2065669935","eid":"W2065669935"},{"id":"paper-w2029657790","cat":"papers","name":"ASCORBIC ACID, GLUCOSE-1-PHOSPHATE, AND LYSERGIC-ACID DIETHYLAMIDE IN RHEUMATOID ARTHRITIS","year":"1953","cit":6,"pfa":"R. R. H. Lovell","psa":"B. Hudson","ptype":"article","src":"https://openalex.org/W2029657790","eid":"W2029657790"},{"id":"paper-w2052844960","cat":"papers","name":"The mutagenic effect of lysergic acid diethylamide III. Evaluation of the genetic risk of LSD in man","year":"1974","cit":6,"pfa":"Radim J. Šrám","psa":"P Goetz","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2052844960","eid":"W2052844960"},{"id":"paper-w4242017567","cat":"papers","name":"Peyote","year":"2014","cit":6,"pfa":"Christine M. Stork","psa":"S.M. Schreffler","ptype":"reference-entry","src":"https://openalex.org/W4242017567","eid":"W4242017567"},{"id":"paper-w2146689939","cat":"papers","name":"Selective inhibition of [3H]lysergic acid diethylamide binding to mouse brain membranes by ethanol","year":"1981","cit":6,"pfa":"James D. Hirsch","ptype":"article","src":"https://openalex.org/W2146689939","eid":"W2146689939"},{"id":"paper-w2412321237","cat":"papers","name":"[Effects of D-Lysergic acid diethylamide and 5-hydroxytryptamine (serotonin) on spinal reflexes in cats].","year":"1957","cit":6,"pfa":"Hans Weidmann","psa":"A Cerletti","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2412321237","eid":"W2412321237"},{"id":"paper-w4391045578","cat":"papers","name":"Evaluation of the Indazole Analogs of 5-MeO-DMT and Related Tryptamines as Serotonin Receptor 2 Agonists","year":"2024","cit":6,"pfa":"Navoda Jayakodiarachchi","psa":"Aaron M. Bender","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4391045578","eid":"W4391045578"},{"id":"paper-w4292136284","cat":"papers","name":"Lysergic Acid Diethylamide Produces Anxiogenic Effects in the Rat Light/Dark Test and Elevated Plus Maze","year":"2022","cit":6,"pfa":"Catherine N. Conway","psa":"Lisa E. Baker","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4292136284","eid":"W4292136284"},{"id":"paper-w2156747256","cat":"papers","name":"Lysergic Acid Diethylamide: Its Effects on Human Chromosomes and the Human Organismin UteroA Review of Current Findings","year":"1972","cit":6,"pfa":"Robert J. Titus","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2156747256","eid":"W2156747256"},{"id":"paper-w2041531671","cat":"papers","name":"Mass spectral studies of ultraviolet irradiated and nonirradiated lysergic acid diethylamide extracts from illicit preparations","year":"1975","cit":6,"pfa":"R. W. Ulrich","psa":"Jodi L. Pflug","ptype":"article","src":"https://openalex.org/W2041531671","eid":"W2041531671"},{"id":"paper-w1964154539","cat":"papers","name":"THE EFFECT OF D-LYSERGIC ACID DIETHYLAMIDE ON THE MELANOPHORES OF THE TOAD BUFO ARENARUM UNDER DIFFERENT EXPERIMENTAL CONDITIONS","year":"1965","cit":6,"pfa":"Fermı́n C. Iturriza","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1964154539","eid":"W1964154539"},{"id":"paper-w4244097459","cat":"papers","name":"Agonist-Directed Signaling of Serotonin 5-HT2C Receptors: Differences Between Serotonin and Lysergic Acid Diethylamide (LSD)","year":"1999","cit":6,"pfa":"Jon R. Backstrom","psa":"Elaine Sanders‐Bush","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4244097459","eid":"W4244097459"},{"id":"paper-w2411089230","cat":"papers","name":"Synaptosomal uptake and release of dopamine and 5-hydroxy-tryptamine in the nucleus accumbens in vitro following in vivo administration of lysergic acid diethylamide in rats.","year":"1980","cit":6,"pfa":"László Hetey","psa":"Klaus Quiring","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2411089230","eid":"W2411089230"},{"id":"paper-w4399135187","cat":"papers","name":"Long‐COVID symptoms improved after MDMA and psilocybin therapy: A case report","year":"2024","cit":6,"pfa":"Harman Chopra","psa":"Joel P Castellanos","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4399135187","eid":"W4399135187"},{"id":"paper-w3137772046","cat":"papers","name":"Development of a physiologically based pharmacokinetic (PBPK) model of psilocybin and psilocin from magic mushroom in rats and humans","year":"2021","cit":6,"pfa":"Prinya Musikaphongsakul","psa":"Manupat Lohitnavy","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3137772046","eid":"W3137772046"},{"id":"paper-w4386741350","cat":"papers","name":"Determination of Lysergic Acid Diethylamide and 2-Oxo-3-Hydroxy-LSD in Blood: Validation and Comparison of Two Liquid Chromatography–Tandem Mass Spectrometry Methods","year":"2023","cit":6,"pfa":"Alexandra Dimitrova","psa":"Fabio Vaiano","ptype":"article","src":"https://openalex.org/W4386741350","eid":"W4386741350"},{"id":"paper-w4412138274","cat":"papers","name":"Exploring the Frontiers of Psychedelics: A New Chromatographic Method for Detection and Quantification of Psilocybin and Psilocin in Psilocybe cubensis Mushrooms","year":"2025","cit":6,"pfa":"Taynah Pereira Galdino","psa":"Marcus Vinícius Lia Fook","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4412138274","eid":"W4412138274"},{"id":"paper-w4206461344","cat":"papers","name":"Cytotoxic, genotoxic, and oxidative stress-related effects of lysergic acid diethylamide (LSD) and phencyclidine (PCP) in the human neuroblastoma SH-SY5Y cell line","year":"2021","cit":6,"pfa":"Andreja Jurič","psa":"Irena Brčić Karačonji","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4206461344","eid":"W4206461344"},{"id":"paper-w4409623005","cat":"papers","name":"Development of a PBPK model of psilocybin/psilocin from Psilocybe cubensis (magic mushroom) in mice, rats, and humans","year":"2025","cit":6,"pfa":"Nilubon Thaoboonruang","psa":"Manupat Lohitnavy","topics":["Depression","Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4409623005","eid":"W4409623005"},{"id":"paper-w4412411664","cat":"papers","name":"Safety and tolerability of multiple sublingual microdoses of 5-MeO-DMT in adults with moderate symptoms of depression and/or anxiety: a randomized, double-blind, placebo-controlled study","year":"2025","cit":6,"pfa":"María Beatriz Bistué Millón","psa":"Martin Alejandro Bruno","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4412411664","eid":"W4412411664"},{"id":"paper-w7125471543","cat":"papers","name":"Consistency of protocol and safety data reporting in clinical trial registrations and corresponding publications of interventions involving MDMA and psilocybin","year":"2026","cit":6,"pfa":"Marija Franka Žuljević","psa":"Diana Gujinović","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7125471543","eid":"W7125471543"},{"id":"paper-w2143873787","cat":"papers","name":"Peyote and the Definition of Narcotic","year":"1959","cit":6,"pfa":"Carroll G. Barber","ptype":"article","src":"https://openalex.org/W2143873787","eid":"W2143873787"},{"id":"paper-w2082785119","cat":"papers","name":"An approach to the synthesis of ibogaine","year":"1964","cit":6,"pfa":"Stephen I. Sallay","ptype":"article","src":"https://openalex.org/W2082785119","eid":"W2082785119"},{"id":"paper-w2996217463","cat":"papers","name":"Intoxicación por ayahuasca","year":"2017","cit":6,"pfa":"Bernat de Pablo Márquez","psa":"Beatriz Dietl Gómez-Luengo","ptype":"article","src":"https://openalex.org/W2996217463","eid":"W2996217463"},{"id":"paper-w2053963101","cat":"papers","name":"Ibogaine therapy in the treatment of opiate dependency","year":"2010","cit":6,"pfa":"Peter Brackenridge","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2053963101","eid":"W2053963101"},{"id":"paper-w2071225313","cat":"papers","name":"Effect of Mescaline on Cardiopulmonary Dynamics","year":"1967","cit":6,"pfa":"Vincent de Paul Lynch","psa":"Steven Carson","ptype":"article","src":"https://openalex.org/W2071225313","eid":"W2071225313"},{"id":"paper-w4413851486","cat":"papers","name":"US Poison Center Encounters for Psilocybin-Related Exposures: 2013-2022","year":"2025","cit":6,"pfa":"Juan Carlos C. Montoy","psa":"Brian T. Anderson","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4413851486","eid":"W4413851486"},{"id":"paper-w4321781691","cat":"papers","name":"Incilius alvarius Cell-Based Synthesis of 5-Methoxy-N,N-Dimethyltryptamine","year":"2023","cit":6,"pfa":"Leonard B. Lerer","psa":"Bernard Lerer","ptype":"article","src":"https://openalex.org/W4321781691","eid":"W4321781691"},{"id":"paper-w2052693557","cat":"papers","name":"Synthesis of psilocin labelled with 14C and 3H","year":"1986","cit":6,"pfa":"Grace K. Poon","psa":"F. C. P. Law","ptype":"article","src":"https://openalex.org/W2052693557","eid":"W2052693557"},{"id":"paper-w2148519662","cat":"papers","name":"HALLUCINATION AND IMAGERY INDUCED BY MESCALINE","year":"1950","cit":6,"pfa":"THOMAS THALE","psa":"Kurt Salomon","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2148519662","eid":"W2148519662"},{"id":"paper-w3157861361","cat":"papers","name":"Psilocybin: Magic Mushroom Grower's Guide: A Handbook for Psilocybin Enthusiasts","year":"1993","cit":6,"pfa":"Terence K. McKenna","psa":"Dennis J. McKenna","ptype":"book","src":"https://openalex.org/W3157861361","eid":"W3157861361"},{"id":"paper-w4379233107","cat":"papers","name":"Infoveillance and Critical Analysis of the Systematically Reviewed Literature on Dimethyltryptamine and the “God Molecule”","year":"2023","cit":6,"pfa":"Ahmed Al-Imam","psa":"Michał Michalak","topics":["Safety & adverse events","Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4379233107","eid":"W4379233107"},{"id":"paper-w1572552383","cat":"papers","name":"Chapter 12 Anxiogenic action of ibogaine","year":"2001","cit":6,"pfa":"Piotr Popik","psa":"Małgorzata Wróbel","ptype":"book-chapter","src":"https://openalex.org/W1572552383","eid":"W1572552383"},{"id":"paper-w2020536267","cat":"papers","name":"Panaeolus bisporus — an adventitious fungus in central Europe, rich in psilocin","year":"1999","cit":6,"pfa":"Béatrice Senn-Irlet","psa":"Rudolf Brenneisen","ptype":"article","src":"https://openalex.org/W2020536267","eid":"W2020536267"},{"id":"paper-w4297898112","cat":"papers","name":"AYAHUASCA V ČESKÉ REPUBLICE","year":"2017","cit":6,"pfa":"Miroslav Horák","ptype":"book","src":"https://openalex.org/W4297898112","eid":"W4297898112"},{"id":"paper-w2337504444","cat":"papers","name":"El Peyote y el Ololiuhqui.","year":"1903","cit":6,"pfa":"Manuel Urbina","ptype":"article","src":"https://openalex.org/W2337504444","eid":"W2337504444"},{"id":"paper-w3209107667","cat":"papers","name":"Sumisión química por «ayahuasca»","year":"2020","cit":6,"pfa":"Cesáreo Fernández Alonso","psa":"Andrés E. Santiago Sáez","ptype":"article","src":"https://openalex.org/W3209107667","eid":"W3209107667"},{"id":"paper-w3154302291","cat":"papers","name":"Ayahuasca and Psychotherapy: Beyond Integration","year":"2021","cit":6,"pfa":"Mauricio Diament","psa":"Luís Fernando Tófoli","topics":["Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W3154302291","eid":"W3154302291"},{"id":"paper-w2030206590","cat":"papers","name":"STUDIES ON MESCALINE VIII: PSYCHODYNAMIC OBSERVATIONS","year":"1958","cit":6,"pfa":"Herman C.B. Denber","topics":["Anxiety & end-of-life","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2030206590","eid":"W2030206590"},{"id":"paper-w93838318","cat":"papers","name":"Mescaline: receptor interaction in the rat striatum.","year":"1972","cit":6,"pfa":"R E Dill","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W93838318","eid":"W93838318"},{"id":"paper-w2293985332","cat":"papers","name":"Ayahuasca: Etnomedicina y mitología","year":"1983","cit":6,"pfa":"Plutarco Naranjo","ptype":"book","src":"https://openalex.org/W2293985332","eid":"W2293985332"},{"id":"paper-w2072668781","cat":"papers","name":"Mescaline-induced changes of brain cortex ribosomes. effect of mescaline on amino acid incorporating ability of ribosomes","year":"1971","cit":6,"pfa":"R. K. Datta","psa":"J. J. Ghosh","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2072668781","eid":"W2072668781"},{"id":"paper-w4372405576","cat":"papers","name":"Cardiac Arrest Associated With Psilocybin Use and Hereditary Hemochromatosis","year":"2023","cit":6,"pfa":"Suhwoo Bae","psa":"Matthew Pierce","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4372405576","eid":"W4372405576"},{"id":"paper-w123780797","cat":"papers","name":"Chromosomendefekte bei Psilocybin-Patienten","year":"1970","cit":6,"pfa":"Paul Eberlé","psa":"H Leuner","ptype":"article","src":"https://openalex.org/W123780797","eid":"W123780797"},{"id":"paper-w4249955352","cat":"papers","name":"Salvia divinorum and Salvinorin A: An Update on Pharmacology and Analytical Methodology","year":"2007","cit":6,"pfa":"Oliver Grundmann","psa":"Veronika Butterweck","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4249955352","eid":"W4249955352"},{"id":"paper-w2315712805","cat":"papers","name":"COMMENTS ON THE PSYCHOLOGICAL EFFECTS OF MESCALINE AND ALLIED DRUGS","year":"1957","cit":6,"pfa":"Ian Stevenson","ptype":"article","src":"https://openalex.org/W2315712805","eid":"W2315712805"},{"id":"paper-w1998475126","cat":"papers","name":"THE CHARACTER AND HISTORY OF THE SOUTHERN UTE PEYOTE RITE","year":"1940","cit":6,"pfa":"Marvin K. Opler","ptype":"article","src":"https://openalex.org/W1998475126","eid":"W1998475126"},{"id":"paper-w4322495849","cat":"papers","name":"Religious Freedom and the Global Regulation of Ayahuasca","year":"2023","cit":6,"pfa":"Beatriz Caiuby Labate","psa":"Clancy Cavnar","topics":["Policy & ethics"],"ptype":"book","src":"https://openalex.org/W4322495849","eid":"W4322495849"},{"id":"paper-w4406991208","cat":"papers","name":"MDMA-Assisted Therapy: Challenges, Clinical Trials, and the Future of MDMA in Treating Behavioral Disorders","year":"2025","cit":6,"pfa":"Steve O’Brien","psa":"David Nutt","topics":["PTSD & trauma","Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W4406991208","eid":"W4406991208"},{"id":"paper-w4399675773","cat":"papers","name":"Ibogaine Induces Cardiotoxic Necrosis in Rats—The Role of Redox Processes","year":"2024","cit":6,"pfa":"Teodora Vidonja Uzelac","psa":"Duško P. Blagojević","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4399675773","eid":"W4399675773"},{"id":"paper-w1517799902","cat":"papers","name":"Ayahuasca, dependência química e alcoolismo","year":"2009","cit":6,"pfa":"Marcelo Simão Mercante","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1517799902","eid":"W1517799902"},{"id":"paper-w66673495","cat":"papers","name":"Pharmacological Effects of MDMA in Man","year":"2009","cit":6,"pfa":"Enno Christian Kurt Freye","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W66673495","eid":"W66673495"},{"id":"paper-w1514092515","cat":"papers","name":"Mirtazepine for MDMA‐induced Depression","year":"2005","cit":6,"pfa":"Jeffrey C. Fetter","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W1514092515","eid":"W1514092515"},{"id":"paper-w88856458","cat":"papers","name":"Spirituality for sale An analysis of ayahuasca tourism","year":"2010","cit":6,"pfa":"Christine L. Holman","ptype":"article","src":"https://openalex.org/W88856458","eid":"W88856458"},{"id":"paper-w3164988241","cat":"papers","name":"Putting the MD back into MDMA","year":"2021","cit":6,"pfa":"David Nutt","psa":"Harriet de Wit","ptype":"article","src":"https://openalex.org/W3164988241","eid":"W3164988241"},{"id":"paper-w4308867926","cat":"papers","name":"MDMA for the treatment of misophonia, a proposal","year":"2022","cit":6,"pfa":"Jadon Webb","psa":"Shannon Keane","topics":["PTSD & trauma","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4308867926","eid":"W4308867926"},{"id":"paper-w1996705795","cat":"papers","name":"Psilocybin-Induced Transformations of Visual Space","year":"1970","cit":6,"pfa":"Richard Hill","psa":"R. Fischer","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1996705795","eid":"W1996705795"},{"id":"paper-w2027493657","cat":"papers","name":"LC-MS/MS quantification of salvinorin A from biological fluids","year":"2013","cit":6,"pfa":"Michael J. Caspers","psa":"Thomas Edward Prisinzano","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2027493657","eid":"W2027493657"},{"id":"paper-w4300981180","cat":"papers","name":"Psilocybin for Treatment of Alcohol Use Disorder","year":"2022","cit":6,"pfa":"Anita J Slomski","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4300981180","eid":"W4300981180"},{"id":"paper-w4386469135","cat":"papers","name":"Psychedelics, With a Focus on Psilocybin: Issues for the Clinician","year":"2023","cit":6,"pfa":"Amir Garakani","psa":"David A. Baron","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4386469135","eid":"W4386469135"},{"id":"paper-w2185917553","cat":"papers","name":"Ayahuasca: el encuentro de dos paradigmas.","year":"2014","cit":6,"pfa":"Daniel Rojas-Bolívar","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2185917553","eid":"W2185917553"},{"id":"paper-w1974467147","cat":"papers","name":"On The Neurotoxicity of MDMA and Related Amphetamine Derivatives","year":"1995","cit":6,"pfa":"Una D. McCann","psa":"George A. Ricaurte","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1974467147","eid":"W1974467147"},{"id":"paper-w2523854677","cat":"papers","name":"THE UPTAKE AND DISTRIBUTION OF 14C-MESCALINE IN DIFFERENT ORGANS OF DEVELOPING RAT","year":"1975","cit":6,"pfa":"Nandkumar S. Shah","psa":"A.E. NEELY","ptype":"article","src":"https://openalex.org/W2523854677","eid":"W2523854677"},{"id":"paper-w4404925563","cat":"papers","name":"Emerging Psychotropic Drug for the Treatment of Trigeminal Pain: Salvinorin A","year":"2024","cit":6,"pfa":"Geovanna Nallely Quiñonez‐Bastidas","psa":"Andrés Navarrete","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4404925563","eid":"W4404925563"},{"id":"paper-w3033481836","cat":"papers","name":"Ayahuasca and Arabidopsis: The Philosopher Plant and the Scientist’s Specimen","year":"2020","cit":6,"pfa":"Ruth Goldstein","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W3033481836","eid":"W3033481836"},{"id":"paper-w3186222117","cat":"papers","name":"Ayahuasca imagery and the therapeutic property of harmala alkaloids.","year":"1987","cit":6,"pfa":"Claudio A. Naranjo","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3186222117","eid":"W3186222117"},{"id":"paper-w4388232073","cat":"papers","name":"N, N -dimethyltryptamine forms oxygenated metabolites via CYP2D6 - an in vitro investigation","year":"2023","cit":6,"pfa":"Emma Eckernäs","psa":"Michael Ashton","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4388232073","eid":"W4388232073"},{"id":"paper-w2031033680","cat":"papers","name":"The effects of β-carbolines in rats trained with ibogaine as a discriminative stimulus","year":"1998","cit":6,"pfa":"Scott Helsley","psa":"Jerrold C. Winter","ptype":"article","src":"https://openalex.org/W2031033680","eid":"W2031033680"},{"id":"paper-w2080532935","cat":"papers","name":"Effects of mescaline sulfate on extinction of conditional avoidance response (CAR).","year":"1961","cit":6,"pfa":"Stephan L. Chorover","ptype":"article","src":"https://openalex.org/W2080532935","eid":"W2080532935"},{"id":"paper-w2131227115","cat":"papers","name":"Studies on Mescaline XIX: A New Theory Concerning the Nature of Schizophrenia","year":"1968","cit":6,"pfa":"Herman C.B. Denber","psa":"David N. Teller","ptype":"article","src":"https://openalex.org/W2131227115","eid":"W2131227115"},{"id":"paper-w1990492302","cat":"papers","name":"Development of tolerance to the antinociceptive effect of mescaline intraventricularly administered to rabbits","year":"1976","cit":6,"pfa":"S. Ferri","psa":"P. C. Braga","ptype":"article","src":"https://openalex.org/W1990492302","eid":"W1990492302"},{"id":"paper-w4328125144","cat":"papers","name":"Neural Network Modulation of Ayahuasca: A Systematic Review of Human Studies","year":"2023","cit":6,"pfa":"Guilherme Henrique de Morais Santos","psa":"RAFAEL GUIMARÃES DOS SANTOS","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4328125144","eid":"W4328125144"},{"id":"paper-w2802152404","cat":"papers","name":"Constitutional Law: Freedom of Religion: Peyote and the Native American Church","year":"1974","cit":6,"pfa":"George de Verges","ptype":"article","src":"https://openalex.org/W2802152404","eid":"W2802152404"},{"id":"paper-w3118857539","cat":"papers","name":"Psilocybin, Spirituality, and Palliative Care: Research and Implications","year":"2021","cit":6,"pfa":"Anthony P. Bossis","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3118857539","eid":"W3118857539"},{"id":"paper-w2582614382","cat":"papers","name":"Oral surgery: Mutilation following MDMA","year":"2017","cit":6,"pfa":"G. Nugent","psa":"M. Cameron","ptype":"article","src":"https://openalex.org/W2582614382","eid":"W2582614382"},{"id":"paper-w2080401014","cat":"papers","name":"The Light from the Forest: The Ritual Use of Ayahuasca in Brazil","year":"2011","cit":6,"pfa":"David P. Luke","ptype":"article","src":"https://openalex.org/W2080401014","eid":"W2080401014"},{"id":"paper-w4405172984","cat":"papers","name":"Treatment Expectancies and Psilocybin vs Escitalopram for Depression","year":"2024","cit":6,"pfa":"Ethan G. Dutcher","psa":"Andrew D. Krystal","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4405172984","eid":"W4405172984"},{"id":"paper-w2042470875","cat":"papers","name":"Rates of methiodide formation and the stereochemistry of the ethyl side chain of iboga type alkaloids","year":"1964","cit":6,"pfa":"Maurice Shamma","psa":"H. E. Soyster","ptype":"article","src":"https://openalex.org/W2042470875","eid":"W2042470875"},{"id":"paper-w2796183211","cat":"papers","name":"A Study of Musical Diffusion Based on the Wandering of the Opening Peyote Song","year":"1958","cit":6,"pfa":"Willard Rhodes","ptype":"article","src":"https://openalex.org/W2796183211","eid":"W2796183211"},{"id":"paper-w2810171990","cat":"papers","name":"Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) and R(-) MDMA on actigraphy-based daytime activity and sleep parameters in rhesus monkeys.","year":"2018","cit":6,"pfa":"Lais Fernanda Berro","psa":"Leonard Lee Howell","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2810171990","eid":"W2810171990"},{"id":"paper-w2049444913","cat":"papers","name":"The Effects of Ecstasy (MDMA) on Rat Liver Bioenergetics","year":"2004","cit":6,"pfa":"Daniel E. Rusyniak","psa":"James E. Klaunig","ptype":"article","src":"https://openalex.org/W2049444913","eid":"W2049444913"},{"id":"paper-w2307690641","cat":"papers","name":"An Amazonian shamanic brew in Australia: ayahuasca healing and individualism","year":"2015","cit":6,"pfa":"Alex K. Gearin","topics":["Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W2307690641","eid":"W2307690641"},{"id":"paper-w4252556180","cat":"papers","name":"paraChlorophenylalanine potentiates facilitatory effects of mescaline on shuttlebox escape/avoidance in rats","year":"1976","cit":6,"pfa":"David M. Stoff","psa":"J. Christian Gillin","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4252556180","eid":"W4252556180"},{"id":"paper-w4389339661","cat":"papers","name":"Voltammetric MDMA Analysis of Seized Ecstasy Samples","year":"2023","cit":6,"pfa":"Maraine Catarina Tadini","psa":"Marcelo Firmino de Oliveira","ptype":"article","src":"https://openalex.org/W4389339661","eid":"W4389339661"},{"id":"paper-w2054797820","cat":"papers","name":"Methylenedioxymethamphetamine (MDMA, 'Ecstasy'): Neurodegeneration versus Neuromodulation","year":"2011","cit":6,"pfa":"Elena Puerta","psa":"Norberto Aguirre","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2054797820","eid":"W2054797820"},{"id":"paper-w2067092746","cat":"papers","name":"Pharmacodynamic characterization of insulin on MDMA-induced thermogenesis","year":"2009","cit":6,"pfa":"Matthew L. Banks","psa":"Jon E. Sprague","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2067092746","eid":"W2067092746"},{"id":"paper-w4307556203","cat":"papers","name":"Preliminary evidence of links between ayahuasca use and the corpus callosum","year":"2022","cit":6,"pfa":"Otto Simonsson","psa":"Eileen Lüders","ptype":"article","src":"https://openalex.org/W4307556203","eid":"W4307556203"},{"id":"paper-w3084164707","cat":"papers","name":"Psilocybin rescues sociability deficits in an animal model of autism","year":"2020","cit":6,"pfa":"Irene Mollinedo-Gajate","psa":"Thomas Knöpfel","ptype":"preprint","src":"https://openalex.org/W3084164707","eid":"W3084164707"},{"id":"paper-w4402575862","cat":"papers","name":"Streamlined screening platforms lead to the discovery of pachysiphine synthase from Tabernanthe iboga","year":"2024","cit":6,"pfa":"Mohamed Omar Kamileen","psa":"Sarah Ellen O'Connor","ptype":"article","src":"https://openalex.org/W4402575862","eid":"W4402575862"},{"id":"paper-w4414422524","cat":"papers","name":"Compassionate use of psilocybin for treatment-resistant depression in Germany","year":"2025","cit":6,"pfa":"Gerhard Gründer","psa":"Moritz Spangemacher","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4414422524","eid":"W4414422524"},{"id":"paper-w1975019312","cat":"papers","name":"Agony of the ecstasy: Report of five cases of MDMA smuggling","year":"2005","cit":6,"pfa":"V. H. S. Low","psa":"EK Dillon","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1975019312","eid":"W1975019312"},{"id":"paper-w2004807558","cat":"papers","name":"Ethanol and MDMA: a comment on the paper by Dumont et al.","year":"2008","cit":6,"pfa":"Jean‐Christophe Cassel","psa":"Byron C. Jones","ptype":"article","src":"https://openalex.org/W2004807558","eid":"W2004807558"},{"id":"paper-w2028140002","cat":"papers","name":"paraChlorophenylalanine potentiates facilitatory effects of Mescaline on shuttlebox escape/avoidance in rats","year":"1976","cit":6,"pfa":"David M. Stoff","psa":"J. Christian Gillin","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2028140002","eid":"W2028140002"},{"id":"paper-w2045411897","cat":"papers","name":"Klinische Erfahrungen mit Psilocybin (CY 39 Sandoz)","year":"2008","cit":6,"pfa":"M. Sercl","psa":"O. Jaros","ptype":"article","src":"https://openalex.org/W2045411897","eid":"W2045411897"},{"id":"paper-w2956116703","cat":"papers","name":"Disentangling the ayahuasca boom: local impacts in Western Peruvian Amazonia","year":"2016","cit":6,"pfa":"Joshua Homan","ptype":"book-chapter","src":"https://openalex.org/W2956116703","eid":"W2956116703"},{"id":"paper-w2411206474","cat":"papers","name":"Urine Mescaline Screening With a Biochip Array Immunoassay and Quantification by Gas Chromatography–Mass Spectrometry","year":"2015","cit":6,"pfa":"Dīlek Battal","psa":"Marilyn Ann Huestis","ptype":"article","src":"https://openalex.org/W2411206474","eid":"W2411206474"},{"id":"paper-w4386466628","cat":"papers","name":"Potential Benefits of Psilocybin for Lupus Pain: A Case Report","year":"2023","cit":6,"pfa":"Sofia Audrey B. Gonzales","psa":"Daniel G. Arkfeld","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4386466628","eid":"W4386466628"},{"id":"paper-w1992178207","cat":"papers","name":"Mice in Ecstasy: Advanced Animal Models in the Study of MDMA","year":"2010","cit":6,"pfa":"Christophe Pol Stove","psa":"Willy E. Lambert","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1992178207","eid":"W1992178207"},{"id":"paper-w4322102598","cat":"papers","name":"Striatal Iron Deposition in Recreational MDMA (Ecstasy) Users","year":"2023","cit":6,"pfa":"Rebecca C. Coray","psa":"Boris B. Quednow","ptype":"article","src":"https://openalex.org/W4322102598","eid":"W4322102598"},{"id":"paper-w2779809922","cat":"papers","name":"Genuine sildenafil tablets sold in Brazil disguised as MDMA","year":"2017","cit":6,"pfa":"José Coelho Neto","psa":"Yuri Machado","ptype":"article","src":"https://openalex.org/W2779809922","eid":"W2779809922"},{"id":"paper-w3022892503","cat":"papers","name":"MDMA Intoxication in a Potential Organ Donor with Cardiac Arrest","year":"2020","cit":6,"pfa":"André L. Castro","psa":"Helena M. Teixeira","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3022892503","eid":"W3022892503"},{"id":"paper-w3150962929","cat":"papers","name":"Effects of MDMA (ecstasy) use and abstention on serotonin neurons","year":"2002","cit":6,"pfa":"Stephen J. Kish","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3150962929","eid":"W3150962929"},{"id":"paper-w2538877601","cat":"papers","name":"The comeback of Ecstasy: New designs and increased MDMA content","year":"2016","cit":6,"pfa":"Camille Richeval","psa":"Jean‐Michel Gaulier","ptype":"article","src":"https://openalex.org/W2538877601","eid":"W2538877601"},{"id":"paper-w2103818286","cat":"papers","name":"Personalidad y uso-abuso de éxtasis (MDMA)","year":"2003","cit":6,"pfa":"María Paz García‐Portilla","psa":"Julio Bobes","ptype":"article","src":"https://openalex.org/W2103818286","eid":"W2103818286"},{"id":"paper-w1804327592","cat":"papers","name":"Electrocortical effects of MDMA are potentiated by acoustic stimulation in rats","year":"2006","cit":6,"pfa":"Michelangelo Iannone","psa":"Domenicantonio Rotiroti","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1804327592","eid":"W1804327592"},{"id":"paper-w4408792078","cat":"papers","name":"LPS-Induced Liver Inflammation Is Inhibited by Psilocybin and Eugenol in Mice","year":"2025","cit":6,"pfa":"Gregory Ian Robinson","psa":"Igor Kovalchuk","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4408792078","eid":"W4408792078"},{"id":"paper-w4387516129","cat":"papers","name":"Self-administration of Psilocybin for the Acute Treatment of Migraine: A Case Report.","year":"2023","cit":6,"pfa":"David Wyndham Lawrence","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4387516129","eid":"W4387516129"},{"id":"paper-w318330468","cat":"papers","name":"Toro, venado, maíz, peyote. El cuadrante de la cultura wixarika","year":"2014","cit":6,"pfa":"Frédéric Saumade","ptype":"article","src":"https://openalex.org/W318330468","eid":"W318330468"},{"id":"paper-w2996717893","cat":"papers","name":"Tolerability, assessment, and prediction of psilocybin-induced altered states of consciousness","year":"2012","cit":6,"pfa":"Erich Studerus","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W2996717893","eid":"W2996717893"},{"id":"paper-w4385898071","cat":"papers","name":"Psilocybin‐assisted psychotherapy for treatment‐resistant depression: Which psychotherapy?","year":"2023","cit":6,"pfa":"Marie Crowe","psa":"Cameron James Lacey","topics":["Depression","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4385898071","eid":"W4385898071"},{"id":"paper-w3154609880","cat":"papers","name":"Ayahuasca as a Healing Tool Along the Continuum of Recovery from Eating Disorders","year":"2021","cit":6,"pfa":"Adèle Lafrance","psa":"Anja Loizaga-Velder","ptype":"book-chapter","src":"https://openalex.org/W3154609880","eid":"W3154609880"},{"id":"paper-w4321004482","cat":"papers","name":"Alleviation of Cocaine Withdrawal and Pertinent Interactions between Salvinorin-Based Antagonists and Kappa Opioid Receptor","year":"2023","cit":6,"pfa":"Nicholas S. Akins","psa":"Hoang V. Le","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4321004482","eid":"W4321004482"},{"id":"paper-w2093612776","cat":"papers","name":"Identifying Spiritual Content in First-Person Reports from Ayahuasca Sessions","year":"2011","cit":6,"pfa":"Stanley Krippner","psa":"Joseph Sulla","ptype":"article","src":"https://openalex.org/W2093612776","eid":"W2093612776"},{"id":"paper-w2281900020","cat":"papers","name":"[Acute psychosis with aggressive behavior as a consequence of MDMA (Ecstasy) consumption].","year":"2000","cit":6,"pfa":"Mijo Milas","ptype":"article","src":"https://openalex.org/W2281900020","eid":"W2281900020"},{"id":"paper-w4221134954","cat":"papers","name":"Caffeine and MDMA (Ecstasy) Exacerbate ER Stress Triggered by Hyperthermia","year":"2022","cit":6,"pfa":"Kathleen A. Trychta","psa":"Brandon K. Harvey","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4221134954","eid":"W4221134954"},{"id":"paper-w2009956035","cat":"papers","name":"Assessment of Neurotoxicity from Potential Medications for Drug Abuse: Ibogaine Testing and Brain Imaging","year":"1997","cit":6,"pfa":"Frank J. Vocci","psa":"Edythe D. London","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2009956035","eid":"W2009956035"},{"id":"paper-w1989963195","cat":"papers","name":"MDMA and Performance Under a Progressive-Ratio Schedule of Water Delivery.","year":"2003","cit":6,"pfa":"Sean Laraway","psa":"Alan D. Poling","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1989963195","eid":"W1989963195"},{"id":"paper-w4206882396","cat":"papers","name":"A Trip Through Employment Law: Protecting Therapeutic Psilocybin Users in the Workplace.","year":"2021","cit":6,"pfa":"Benjamin Sheppard","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4206882396","eid":"W4206882396"},{"id":"paper-w4391014875","cat":"papers","name":"A transcriptomic analysis in mice following a single dose of ibogaine identifies new potential therapeutic targets","year":"2024","cit":6,"pfa":"Judit Biosca-Brull","psa":"María Teresa Colomina","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4391014875","eid":"W4391014875"},{"id":"paper-w4220845216","cat":"papers","name":"Potent Anti-amoebic Effects of Ibogaine, Voacangine and the Root Bark Alkaloid Fraction of Tabernaemontana arborea","year":"2022","cit":6,"pfa":"Julio César Carrero","psa":"Juan Pedro Laclette","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4220845216","eid":"W4220845216"},{"id":"paper-w2157711405","cat":"papers","name":"Thin-layer chromatography method for the detection ofN,N-dimethyltryptamine in seized street samples","year":"2014","cit":6,"pfa":"Boris Ettienne Duffau","psa":"Paula Fuentes","ptype":"article","src":"https://openalex.org/W2157711405","eid":"W2157711405"},{"id":"paper-w42293853","cat":"papers","name":"The effects of a low dosage of mescaline and 3,4-dimethoxyphenylethylamine under two levels of aversive stimulation.","year":"1971","cit":6,"pfa":"D J Levis","psa":"D. F. Caldwell","ptype":"article","src":"https://openalex.org/W42293853","eid":"W42293853"},{"id":"paper-w3094637780","cat":"papers","name":"Psilocybin-Assisted Supportive Psychotherapy in the Treatment of Major Depression—Quo Vadis?","year":"2020","cit":6,"pfa":"Charles F. Reynolds","topics":["Depression","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3094637780","eid":"W3094637780"},{"id":"paper-w2141978575","cat":"papers","name":"Some Observations on MDMA Experiences Induced Through Posthypnotic Suggestion","year":"1994","cit":6,"pfa":"Arthur C. Hastings","ptype":"article","src":"https://openalex.org/W2141978575","eid":"W2141978575"},{"id":"paper-w4406141451","cat":"papers","name":"Neurobiological mechanisms of antidepressant properties of psilocybin: A systematic review of blood biomarkers","year":"2025","cit":6,"pfa":"Juliana Lima Constantino","psa":"Robert A. Schoevers","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4406141451","eid":"W4406141451"},{"id":"paper-w1711527398","cat":"papers","name":"Contrastes e continuidades em uma tradição Amazonica : as regiões da Ayahuasca","year":"2004","cit":6,"pfa":"Sandra Lucia Goulart","ptype":"dissertation","src":"https://openalex.org/W1711527398","eid":"W1711527398"},{"id":"paper-w2164390650","cat":"papers","name":"A Simple and Sensitive Quantitation of N,N-Dimethyltryptamine by Gas Chromatography with Surface Ionization Detection","year":"1997","cit":6,"pfa":"A. Ishii","psa":"Takeshi Kumazawa","ptype":"article","src":"https://openalex.org/W2164390650","eid":"W2164390650"},{"id":"paper-w4417535188","cat":"papers","name":"Breaking the chains of depression: A systematic review and meta-analysis of psilocybin therapy","year":"2025","cit":6,"pfa":"Faheem Ahmed Khan","psa":"Siriporn Chuchawankul","topics":["Depression","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4417535188","eid":"W4417535188"},{"id":"paper-w2698297409","cat":"papers","name":"Por que a ayahuasca? Da internacionalização de uma prática ritual ameríndia","year":"2011","cit":6,"pfa":"Anne‐Marie Losonczy","psa":"Silvia Mesturini","ptype":"article","src":"https://openalex.org/W2698297409","eid":"W2698297409"},{"id":"paper-w2035106305","cat":"papers","name":"The pathology of the ring-substituted amphetamine analogue 3,4-methylenedioxymethylamphetamine (MDMA, ‘Ecstasy’)","year":"1997","cit":6,"pfa":"G.N. Rutty","psa":"Christopher Mark Milroy","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2035106305","eid":"W2035106305"},{"id":"paper-w2030309850","cat":"papers","name":"Pharmacological comparison of the effect of ibogaine and 18‐methoxycoronaridine on isolated smooth muscle from the rat and guinea‐pig","year":"2000","cit":6,"pfa":"M K Mundey","psa":"Vincent G. Wilson","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2030309850","eid":"W2030309850"},{"id":"paper-w3110886438","cat":"papers","name":"Lectotypification of Banisteriopsis caapi and B. quitensis (Malpighiaceae), names associated with an important ingredient of Ayahuasca","year":"2020","cit":6,"pfa":"Regina Célia de Oliveira","psa":"Renata Sebastiani","ptype":"article","src":"https://openalex.org/W3110886438","eid":"W3110886438"},{"id":"paper-w2466480620","cat":"papers","name":"Aortic thrombus causing myocardial infarction after recreational MDMA use","year":"2016","cit":6,"pfa":"Alexandros Papachristidis","psa":"Philip A. MacCarthy","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2466480620","eid":"W2466480620"},{"id":"paper-w2805071211","cat":"papers","name":"PM502. Effect of psilocybin on EEG brain connectivity in healthy volunteers – preliminary report","year":"2016","cit":6,"pfa":"Tomáš Páleníček","psa":"Jiřı́ Horáček","topics":["Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W2805071211","eid":"W2805071211"},{"id":"paper-w4389895405","cat":"papers","name":"Innovations in group‐based psilocybin‐assisted therapy of major depression in patients with cancer","year":"2023","cit":6,"pfa":"Johannes Thrul","psa":"David B. Yaden","topics":["Depression","Anxiety & end-of-life"],"ptype":"editorial","src":"https://openalex.org/W4389895405","eid":"W4389895405"},{"id":"paper-w2404524356","cat":"papers","name":"How MDMA flows across the USA: evidence from price data","year":"2016","cit":6,"pfa":"Siddharth Chandra","psa":"Vinay Bihani","ptype":"article","src":"https://openalex.org/W2404524356","eid":"W2404524356"},{"id":"paper-w2031788992","cat":"papers","name":"Geonotoxicity study of illegal drug MDMA and its nitroso derivative N-MDMA by micronucleus and chromosomal aberration tests using Chinese hamsger lung fibroblast cell line","year":"2007","cit":6,"pfa":"Hayato Yoshioka","psa":"Ryo Takagi","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2031788992","eid":"W2031788992"},{"id":"paper-w4390640257","cat":"papers","name":"Assessing the utility of in silico tools in early drug development: The case of a pharmaceutically relevant formulation of the prodrug psilocybin","year":"2024","cit":6,"pfa":"L. Richter","psa":"Raimar Löbenberg","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4390640257","eid":"W4390640257"},{"id":"paper-w3183399682","cat":"papers","name":"A case study on MDMA. Two fatal cases involving young adults","year":"2021","cit":6,"pfa":"Caterina Politi","psa":"Jennifer Paola Pascali","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3183399682","eid":"W3183399682"},{"id":"paper-w4403229738","cat":"papers","name":"Identification of clerodane diterpene modifying cytochrome P450 ( CYP728D26 ) in Salvia divinorum ‐ en route to psychotropic salvinorin A biosynthesis","year":"2024","cit":6,"pfa":"Iris Ngo","psa":"Dae‐Kyun Ro","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4403229738","eid":"W4403229738"},{"id":"paper-w2240468504","cat":"papers","name":"Cura, cura cuerpecito: Reflexiones sobre las posibilidades terapéuticas de la ayahuasca","year":"2013","cit":6,"pfa":"Beatriz Caiuby Labate","psa":"José Carlos Bouso","ptype":"article","src":"https://openalex.org/W2240468504","eid":"W2240468504"},{"id":"paper-w4294225551","cat":"papers","name":"Psychological effects and subjective experiences of ayahuasca rituals in participants of two neoshamanic centers of Uruguay","year":"2022","cit":6,"pfa":"Ismael Apud","psa":"Andrés Oliveri","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4294225551","eid":"W4294225551"},{"id":"paper-w7135170485","cat":"papers","name":"A randomized clinical trial of repeated doses of psilocybin for the treatment of obsessive–compulsive disorder","year":"2026","cit":6,"pfa":"Francisco A. Moreno","psa":"John J. B. Allen","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7135170485","eid":"W7135170485"},{"id":"paper-w2030017425","cat":"papers","name":"Cannabis, ecstasy/mdma and memory: a commentary on Simon & Mattick's recent study","year":"2003","cit":6,"pfa":"Andy C. Parrott","psa":"RAFAELLA MARGHERITA MILANI","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2030017425","eid":"W2030017425"},{"id":"paper-w7216985","cat":"papers","name":"Patrón de distribución espacial y nodricismo del peyote (Lophophora williamsii) en Cuatrociénegas, México","year":"2010","cit":6,"pfa":"Adrian Huerta","psa":"María C. Mandujano","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7216985","eid":"W7216985"},{"id":"paper-w2125458378","cat":"papers","name":"Ecstasy (MDMA) ingestion related with severe hyponatremia in patients with mild head injury.","year":"2005","cit":6,"pfa":"Pataravit Rukskul","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2125458378","eid":"W2125458378"},{"id":"paper-w4244075313","cat":"papers","name":"Structure-Activity Relationships of MDMA and Related Compounds: A New Class of Psychoactive Agents?","year":"1990","cit":6,"pfa":"David F. Nichols","psa":"Robert A. Oberlender","ptype":"book-chapter","src":"https://openalex.org/W4244075313","eid":"W4244075313"},{"id":"paper-w3207914538","cat":"papers","name":"Reply to: Caution at psychiatry’s psychedelic frontier and Challenges with benchmarking of MDMA-assisted psychotherapy","year":"2021","cit":6,"pfa":"Jennifer Mitchell","psa":"Berra Yazar‐Klosinski","topics":["Therapy practice"],"ptype":"letter","src":"https://openalex.org/W3207914538","eid":"W3207914538"},{"id":"paper-w3113270460","cat":"papers","name":"Ayahuasca Ethno-tourism and its Impact on the Indigenous Shuar Community (Ecuador) and Western Participants","year":"2020","cit":6,"pfa":"Dima Salibová","ptype":"article","src":"https://openalex.org/W3113270460","eid":"W3113270460"},{"id":"paper-w4393098409","cat":"papers","name":"Psychedelic Therapy: A Primer for Primary Care Clinicians—3,4-Methylenedioxy-methamphetamine (MDMA)","year":"2024","cit":6,"pfa":"Kenneth Shinozuka","psa":"Owen S. Muir","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4393098409","eid":"W4393098409"},{"id":"paper-w4403117441","cat":"papers","name":"Exploring the biocatalysis of psilocybin and other tryptamines: Enzymatic pathways, synthetic strategies, and industrial implications","year":"2024","cit":6,"pfa":"Lucas Henrique Junges","psa":"Marcelo Müller‐Santos","topics":["Depression","Anxiety & end-of-life","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4403117441","eid":"W4403117441"},{"id":"paper-w4404378875","cat":"papers","name":"An estimate of the number of people with clinical depression eligible for psilocybin-assisted therapy in the United States","year":"2024","cit":6,"pfa":"Syed F. Rab","psa":"Elliot A. Marseille","topics":["Depression","Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4404378875","eid":"W4404378875"},{"id":"paper-w4307859676","cat":"papers","name":"Psilocybin induces acute and persisting alterations in immune status and the stress response in healthy volunteers","year":"2022","cit":6,"pfa":"Natasha Leigh Mason","psa":"Johannes Gerardus Ramaekers","topics":["Depression","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4307859676","eid":"W4307859676"},{"id":"paper-w2088180509","cat":"papers","name":"Spinal and locus coeruleus noradrenergic lesions abolish the analgesic effects of 5-methoxy-N,N-dimethyltryptamine","year":"1986","cit":6,"pfa":"Wojciech Danysz","psa":"Trevor Archer","ptype":"article","src":"https://openalex.org/W2088180509","eid":"W2088180509"},{"id":"paper-w4391609673","cat":"papers","name":"Methylone is a rapid-acting neuroplastogen with less off-target activity than MDMA","year":"2024","cit":6,"pfa":"Jennifer L. Warner‐Schmidt","psa":"Benjamin Kelmendi","topics":["Depression","PTSD & trauma","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4391609673","eid":"W4391609673"},{"id":"paper-w4210347461","cat":"papers","name":"Iboga Inspired N-Indolylethyl-Substituted Isoquinuclidines as a Bioactive Scaffold: Chemoenzymatic Synthesis and Characterization as GDNF Releasers and Antitrypanosoma Agents","year":"2022","cit":6,"pfa":"Mariana Pazos","psa":"Ignacio Carrera","ptype":"article","src":"https://openalex.org/W4210347461","eid":"W4210347461"},{"id":"paper-w2007976884","cat":"papers","name":"Effects of Acute Administration of 5‐Methoxy‐N,N‐dimethyltryptamine upon the Latency and Duration of Post‐decapitation Convulsions","year":"1984","cit":6,"pfa":"Trevor Archer","psa":"Bengt Tandberg","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2007976884","eid":"W2007976884"},{"id":"paper-w4291721232","cat":"papers","name":"Psilocybin use patterns and perception of risk among a cohort of Black individuals with Opioid Use Disorder","year":"2022","cit":6,"pfa":"John M Clifton","psa":"Alan K. Davis","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4291721232","eid":"W4291721232"},{"id":"paper-w1596967787","cat":"papers","name":"Aspectos preliminares al estudio fármaco-psiquiátrico del Ayahuasca y su principio activo","year":"2014","cit":6,"pfa":"Oscar Ríos","ptype":"article","src":"https://openalex.org/W1596967787","eid":"W1596967787"},{"id":"paper-w2921202452","cat":"papers","name":"Comparing Mental Health across Distinct Groups of Users of Psychedelics, MDMA, Psychostimulants, and Cannabis","year":"2019","cit":6,"pfa":"Ansgar Rougemont-Bücking","psa":"Joseph Studer","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2921202452","eid":"W2921202452"},{"id":"paper-w4385932674","cat":"papers","name":"Developing a Direct Observation Measure of Therapeutic Connection in Psilocybin-Assisted Therapy: A Feasibility Study","year":"2023","cit":6,"pfa":"Robert E. Gramling","psa":"Manish Agrawal","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4385932674","eid":"W4385932674"},{"id":"paper-w4396890678","cat":"papers","name":"The entactogen 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) as a treatment aid in psychotherapy and its safety concerns","year":"2024","cit":6,"pfa":"Brian A. Baldo","topics":["PTSD & trauma","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4396890678","eid":"W4396890678"},{"id":"paper-w4386741146","cat":"papers","name":"Psychedelic drug MDMA moves closer to US approval following success in PTSD trial","year":"2023","cit":6,"pfa":"Sara Reardon","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4386741146","eid":"W4386741146"},{"id":"paper-w2010744174","cat":"papers","name":"Effects of L-type calcium channel antagonists on the serotonin-depleting actions of MDMA in rats","year":"1993","cit":6,"pfa":"Kevin T. Finnegan","psa":"Ralph Karler","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2010744174","eid":"W2010744174"},{"id":"paper-w2519175228","cat":"papers","name":"Ayahuasca and Sumak Kawsay: Challenges to the Implementation of the Principle of “Buen Vivir,” Religious Freedom, and Cultural Heritage Protection","year":"2016","cit":6,"pfa":"Carlos Teodoro José Hugueney Irigaray","psa":"Carolina Joana da Silva","ptype":"article","src":"https://openalex.org/W2519175228","eid":"W2519175228"},{"id":"paper-w4414374510","cat":"papers","name":"Psilocybin‐assisted psychotherapy for methamphetamine use disorder: A pilot open‐label safety and feasibility study","year":"2025","cit":6,"pfa":"Elizabeth Knock","psa":"Jonathan Brett","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4414374510","eid":"W4414374510"},{"id":"paper-w4406965109","cat":"papers","name":"METABOLIC FATE OF ν-(3, 4, 5-TRIMETHOXYPHENYL)-ETHYLAMINE (MESCALINE) IN HUMANS: ISOLATION AND IDENTIFICATION OF 3,4, 5-TRIMETHOXYPHENYLACETIC ACID","year":"1964","cit":6,"pfa":"Kyriakos Charalampous","psa":"John Kinross-Wright","ptype":"article","src":"https://openalex.org/W4406965109","eid":"W4406965109"},{"id":"paper-w2796098532","cat":"papers","name":"Bilateral pneumothorax, surgical emphysema and pneumomediastinum in a young male patient following MDMA intake","year":"2018","cit":6,"pfa":"N Obiechina","psa":"James Bass","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2796098532","eid":"W2796098532"},{"id":"paper-w1520275716","cat":"papers","name":"Dopamine D1Receptor‐Mediated Intracellular Responses in the Hypothalamus after Co‐Administration of Caffeine with MDMA","year":"2011","cit":6,"pfa":"Natacha Vanattou‐Saïfoudine","psa":"Andrew Harkin","topics":["Safety & adverse events","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1520275716","eid":"W1520275716"},{"id":"paper-w4399390201","cat":"papers","name":"The effects of psilocybin on cognition and emotional processing in healthy adults and adults with depression: a systematic literature review","year":"2024","cit":6,"pfa":"Laura Ramos","psa":"Selene Vicente","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W4399390201","eid":"W4399390201"},{"id":"paper-w3153682295","cat":"papers","name":"Perspectives on Healing and Recovery from Addiction with Ayahuasca-Based Therapy Among Members of an Indigenous Community in Canada","year":"2021","cit":6,"pfa":"Elena Argento","psa":"Kenneth W. Tupper","topics":["Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W3153682295","eid":"W3153682295"},{"id":"paper-w2994797071","cat":"papers","name":"Effects of psilocybin on functional connectivity measured with fNIRS: Insights from a single-subject pilot study","year":"2019","cit":6,"pfa":"Felix Scholkmann","psa":"Franz X. Vollenweider","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2994797071","eid":"W2994797071"},{"id":"paper-w4293242421","cat":"papers","name":"P450. Pilot Study Evaluation of Psilocybin Therapy for Anorexia Nervosa: Safety, Acceptability, and Preliminary Efficacy","year":"2022","cit":6,"pfa":"Stephanie Knatz Peck","psa":"Walter H. Kaye","topics":["Safety & adverse events"],"ptype":"conference-abstract","src":"https://openalex.org/W4293242421","eid":"W4293242421"},{"id":"paper-w4404286681","cat":"papers","name":"Single-dose psilocybin alters resting state functional networks in patients with body dysmorphic disorder","year":"2024","cit":6,"pfa":"Xi Zhu","psa":"Franklin R. Schneier","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4404286681","eid":"W4404286681"},{"id":"paper-w4398769425","cat":"papers","name":"MDMA-assisted brief cognitive behavioral conjoint therapy for PTSD: Study protocol for a pilot study","year":"2024","cit":6,"pfa":"Leslie A. Morland","psa":"A.C. Wagner","topics":["PTSD & trauma","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4398769425","eid":"W4398769425"},{"id":"paper-w3165630488","cat":"papers","name":"Protective effects of atorvastatin and rosuvastatin on 3,4-methylenedioxymethamphetamine (MDMA)-induced spatial learning and memory impairment","year":"2021","cit":6,"pfa":"Seyyed Majid Eslami","psa":"Ruhollah Mirjani","ptype":"article","src":"https://openalex.org/W3165630488","eid":"W3165630488"},{"id":"paper-w4403615858","cat":"papers","name":"Psilocybin-assisted neurofeedback for the improvement of executive functions: a randomized semi-naturalistic-lab feasibility study","year":"2024","cit":6,"pfa":"Stefanie Enriquez‐Geppert","psa":"Morten Peter Lietz","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4403615858","eid":"W4403615858"},{"id":"paper-w2206998043","cat":"papers","name":"Constructing the ecstasy of MDMA from its component mental organs: Proposing the primer/probe method","year":"2015","cit":6,"pfa":"Thomas S. Ray","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2206998043","eid":"W2206998043"},{"id":"paper-w2099992160","cat":"papers","name":"Development of Microwave‐Assisted Extraction Procedure for Organic Impurity Profiling of Seized 3,4‐Methylenedioxymethamphetamine (MDMA)*,†","year":"2011","cit":6,"pfa":"Patricia J. Giebink","psa":"Ruth Smith","ptype":"article","src":"https://openalex.org/W2099992160","eid":"W2099992160"},{"id":"paper-w4382052741","cat":"papers","name":"MDMA: Multimodal Data and Multi-attention Based Deep Learning Model for Alzheimer’s Disease Diagnosis","year":"2023","cit":6,"pfa":"Chang Ge","psa":"Huyue Ren","ptype":"conference-paper","src":"https://openalex.org/W4382052741","eid":"W4382052741"},{"id":"paper-w4415564062","cat":"papers","name":"Intermittent MDMA Attenuates Ovariectomy-induced Bone Loss via a Gut Microbiota–Bone Axis","year":"2025","cit":6,"pfa":"Xiayun Wan","psa":"Kenji Hashimoto","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4415564062","eid":"W4415564062"},{"id":"paper-w3127542477","cat":"papers","name":"Developing a new national MDMA policy: Results of a multi-decision multi-criterion decision analysis","year":"2021","cit":6,"pfa":"Jan van Amsterdam","psa":"Wim van den Brink","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3127542477","eid":"W3127542477"},{"id":"paper-w2999059563","cat":"papers","name":"In vivo effects of 3,4-methylenedioxymethamphetamine (MDMA) and its deuterated form in rodents: Drug discrimination and thermoregulation","year":"2020","cit":6,"pfa":"Michael D. Berquist","psa":"William E. Fantegrossi","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2999059563","eid":"W2999059563"},{"id":"paper-w4391312515","cat":"papers","name":"A Multimodal Preclinical Assessment of MDMA in Female and Male Rats: Prohedonic, Cognition Disruptive, and Prosocial Effects","year":"2024","cit":6,"pfa":"Abshir S. Adam","psa":"Brian D. Kangas","topics":["Depression","PTSD & trauma","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4391312515","eid":"W4391312515"},{"id":"paper-w4400956499","cat":"papers","name":"Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocol","year":"2024","cit":6,"pfa":"Matthew Butler","psa":"Timothy R. Nicholson","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4400956499","eid":"W4400956499"},{"id":"paper-w4386021261","cat":"papers","name":"Exploring the relationship between mental health, drug use, personality, and attitudes towards psilocybin-assisted therapy","year":"2023","cit":6,"pfa":"Benjamin M. Ross","psa":"James T. Neill","topics":["Safety & adverse events","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4386021261","eid":"W4386021261"},{"id":"paper-w1599344528","cat":"papers","name":"O processo de regulamentação da ayahuasca no Brasil e na esfera internacional: desafios e implicações","year":"2011","cit":6,"pfa":"Beatriz Caiuby Labate","psa":"Kevin Feeney","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1599344528","eid":"W1599344528"},{"id":"paper-w3040519471","cat":"papers","name":"Differential sensitivity to detect prosocial effects of 3,4‐methylenedioxymethamphetamine (MDMA) in different social approach paradigms in mice","year":"2020","cit":6,"pfa":"Satoko Mukai","psa":"Katsuyuki Kaneda","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3040519471","eid":"W3040519471"},{"id":"paper-w4236559077","cat":"papers","name":"Enhancement of conditioned place preference response to cocaine in rats following subchronic administration of 3,4‐methylenedioxymethamphetamine (MDMA)","year":"2000","cit":6,"pfa":"Bryan Horan","psa":"Charles R. Ashby","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4236559077","eid":"W4236559077"},{"id":"paper-w2088694849","cat":"papers","name":"Involvement of a central dopaminergic system in 5-methoxy-N,N-dimethyltryptamine-induced turning behaviour in rats with lesions of the dorsal raph� nuclei","year":"1982","cit":6,"pfa":"Thomas P. Blackburn","psa":"T. F. Lee","ptype":"article","src":"https://openalex.org/W2088694849","eid":"W2088694849"},{"id":"paper-w4393387457","cat":"papers","name":"Self-Rated Effectiveness of Ayahuasca and Breathwork on Well-Being, Psychological Resilience, Self-Compassion, and Personality: An Observational Comparison Study","year":"2024","cit":6,"pfa":"Rishma S. I. Khubsing","psa":"Kim P. C. Kuypers","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4393387457","eid":"W4393387457"},{"id":"paper-w2901556809","cat":"papers","name":"3,4-Methylenedioxymethamphetamine (Mdma; Ecstasy) Use and Transitions to Injection Drug Use among Street-Involved Youth","year":"2018","cit":6,"pfa":"Stephanie Lake","psa":"Kora DeBeck","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2901556809","eid":"W2901556809"},{"id":"paper-w4415713367","cat":"papers","name":"Psilocybin as a fast-acting and long-lasting antidepressant for adolescence: Proposing NeuroD1 as a biomarker of its long-term plasticity","year":"2025","cit":6,"pfa":"Rubén García‐Cabrerizo","psa":"María Julia García-Fuster","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4415713367","eid":"W4415713367"},{"id":"paper-w4415851344","cat":"papers","name":"Psilocybin-assisted physiotherapy for refractory motor functional neurological disorder: protocol for a randomised dose-comparison pilot study","year":"2025","cit":6,"pfa":"Chiranth Bhagavan","psa":"Richard Kanaan","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4415851344","eid":"W4415851344"},{"id":"paper-w2986266161","cat":"papers","name":"Locomotor effects of 3,4-methylenedioxymethamphetamine (MDMA) and its deuterated form in mice: psychostimulant effects, stereotypy, and sensitization","year":"2019","cit":6,"pfa":"Michael D. Berquist","psa":"William E. Fantegrossi","ptype":"article","src":"https://openalex.org/W2986266161","eid":"W2986266161"},{"id":"paper-w2029302536","cat":"papers","name":"Mice Lacking Multidrug Resistance Protein 1a Show Altered Dopaminergic Responses to Methylenedioxymethamphetamine (MDMA) in Striatum","year":"2009","cit":6,"pfa":"Karl B. Scheidweiler","psa":"Marilyn Ann Huestis","ptype":"article","src":"https://openalex.org/W2029302536","eid":"W2029302536"},{"id":"paper-w4413555983","cat":"papers","name":"Integrated Heterogeneous Service Provisioning: Unifying Beyond-Communication Capabilities with MDMA in 6G and Future Wireless Networks","year":"2025","cit":6,"pfa":"Pengyi Jia","psa":"Robert Schober","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4413555983","eid":"W4413555983"},{"id":"paper-w4292248697","cat":"papers","name":"Cystathionine Gamma-Lyase Regulate Psilocybin Biosynthesis in Gymnopilus dilepis Mushroom via Amino Acid Metabolism Pathways","year":"2022","cit":6,"pfa":"Sen Yao","psa":"Baogui Xie","topics":["Depression","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4292248697","eid":"W4292248697"},{"id":"paper-w4410737616","cat":"papers","name":"Psilocybin mitigates behavioral despair and cognitive impairment in treatment-resistant depression model using wistar kyoto rats","year":"2025","cit":6,"pfa":"Zitong Wang","psa":"Yanbo Zhang","topics":["Depression","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4410737616","eid":"W4410737616"},{"id":"paper-w2313287844","cat":"papers","name":"Some neurochemical and neuropharmacological studies on the interactions between mescaline and 1-methyl-1,2,5,6-tetrahydropyridine-3-(N,N-diethylcarboxamide) (THPC)","year":"1972","cit":6,"pfa":"B.E. Leonard","psa":"P. D. Stonier","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2313287844","eid":"W2313287844"},{"id":"paper-w2032256864","cat":"papers","name":"Interaction of synthetic opioid metenkephalin peptide analogs, lilly 127623 and FK 33-824 with indole hallucinogens: Antagonism of N,N-dimethyltryptamine- and LSD-induced disruption of food-rewarded bar pressing behavior","year":"1983","cit":6,"pfa":"Diane M. Ruffing","psa":"Edward F. Domino","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2032256864","eid":"W2032256864"},{"id":"paper-w2090298970","cat":"papers","name":"Using psilocybin to investigate the relationship between attention, working memory and the serotonin 5-HT1A and 5-HT2A receptors","year":"2010","cit":6,"pfa":"Olivia L. Carter","psa":"Franz X. Vollenweider","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2090298970","eid":"W2090298970"},{"id":"paper-w1972042299","cat":"papers","name":"Studies on Mode of Antagonism between Adrenergic β-Mimetics and β-Blocking Agents (I). β-Blocking Action of Mescaline and its Derivatives","year":"1975","cit":6,"pfa":"Yoshio Iwasawa","psa":"Akio Kiyomoto","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1972042299","eid":"W1972042299"},{"id":"paper-w2384989559","cat":"papers","name":"Syndrome sérotoninergique après intoxication à la MDMA, une drogue de synthèse toujours d’actualité","year":"2016","cit":6,"pfa":"M. Loilier","psa":"V. Lelong-Boulouard","ptype":"article","src":"https://openalex.org/W2384989559","eid":"W2384989559"},{"id":"paper-w2088774149","cat":"papers","name":"Administration of MDMA to ethanol-deprived rats increases ethanol operant self-administration and dopamine release during reinstatement","year":"2009","cit":6,"pfa":"Guillermo Moreno‐Sanz","psa":"José Antonio López‐Moreno","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2088774149","eid":"W2088774149"},{"id":"paper-w4308711080","cat":"papers","name":"Voltammetric Responses of a CYP2D6‐Based Biosensor to 3,4‐methylenedioxymethamphetamine (MDMA) and the Synthetic Cathinone α‐pyrrolidinopentiophenone (α‐PVP).","year":"2022","cit":6,"pfa":"Andrés Felipe Lugo Vargas","psa":"Jaime Fernando Martínez Suárez","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4308711080","eid":"W4308711080"},{"id":"paper-w2470759954","cat":"papers","name":"Long-term follow-up of psilocybin-facilitated smoking cessation: Abstinence outcomes and qualitative analysis of participant accounts","year":"2015","cit":6,"pfa":"Albert Garcia‐Romeu","psa":"Matthew W. Johnson","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2470759954","eid":"W2470759954"},{"id":"paper-w3005677117","cat":"papers","name":"Dose concentration and spatial memory and brain mitochondrial function association after 3,4-methylenedioxymethamphetamine (MDMA) administration in rats","year":"2020","cit":6,"pfa":"Ghorban Taghizadeh","psa":"Mohammad Reza Rouini","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3005677117","eid":"W3005677117"},{"id":"paper-w170375078","cat":"papers","name":"[Rhabdomyolysis, disseminated intravascular coagulation and acute renal failure after severe narcotics intoxication (MDMA, THC, amphetamine)].","year":"2005","cit":6,"pfa":"Anna Kunsdorf-Wnuk","psa":"Danuta Arct-Danielak","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W170375078","eid":"W170375078"},{"id":"paper-w2027791421","cat":"papers","name":"Effet de la mescaline, du lsd 25 et de derives de l'adrenochrome sur la decarboxlyase glutamique du cerveau","year":"1959","cit":6,"pfa":"Guy-H. Deltour","psa":"Ad. Claus","ptype":"article","src":"https://openalex.org/W2027791421","eid":"W2027791421"},{"id":"paper-w2329203857","cat":"papers","name":"Effects of adenosine A2a receptor agonist and antagonist on cerebellar nuclear factor-kB expression preceded by MDMA toxicity.","year":"2014","cit":6,"pfa":"Fatemeh Kermanian","psa":"Mehdi Mehdizadeh","topics":["Safety & adverse events","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2329203857","eid":"W2329203857"},{"id":"paper-w1991259267","cat":"papers","name":"Self-reported Ecstasy (MDMA) Use and Past Occurrence of Sexually Transmitted Infections (STIs) in a Cohort Juvenile Detainees in the USA","year":"2014","cit":6,"pfa":"Torrance Stephens","psa":"Jerriyauna Jarboe","ptype":"article","src":"https://openalex.org/W1991259267","eid":"W1991259267"},{"id":"paper-w2342087940","cat":"papers","name":"Optimizing ALD HfO2 for Advanced Gate Stacks with Interspersed UV and Thermal Treatments- DADA and MDMA Variations, Combinations, and Optimization","year":"2011","cit":6,"pfa":"Robert D. Clark","psa":"Gert J. Leusink","ptype":"conference-paper","src":"https://openalex.org/W2342087940","eid":"W2342087940"},{"id":"paper-w2181924000","cat":"papers","name":"Chronic and Sub-acute Effects of 3,4-methylenedioxy methamphetamine (MDMA) on Spatial Memory and Passive Avoidance Learning in Wistar Rats","year":"2013","cit":6,"pfa":"Fatemeh Mirzaei","psa":"Maryam Sohrabi","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2181924000","eid":"W2181924000"},{"id":"paper-w4245645581","cat":"papers","name":"Ayahuasca en el tratamiento de adicciones. Estudio de cuatro casos tratados en IDEAA, desde una perspectiva interdisciplinaria","year":"2019","cit":6,"pfa":"Ismael Apud","ptype":"article","src":"https://openalex.org/W4245645581","eid":"W4245645581"},{"id":"paper-w4297107027","cat":"papers","name":"4‐Fluoroamphetamine (4‐FA) intoxication results in exaggerated blood pressure effects compared to MDMA and amphetamine: A retrospective analysis","year":"2022","cit":6,"pfa":"Femke M. J. Gresnigt","psa":"Robert K. Riezebos","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4297107027","eid":"W4297107027"},{"id":"paper-w2041150066","cat":"papers","name":"Rapid development of semistarvation-induced hyperactivity in Dark Agouti rats. Excessive wheel running and effect of 3,4-methylenedioxymethamphetamine (MDMA)","year":"2012","cit":6,"pfa":"Pedro Vidal","psa":"Ricardo Pellón","ptype":"article","src":"https://openalex.org/W2041150066","eid":"W2041150066"},{"id":"paper-w2513457040","cat":"papers","name":"P.1.i.005 The 5-HT2A/1A agonist psilocybin reduces social pain and enhances empathy in healthy volunteers","year":"2015","cit":6,"pfa":"Katrin H. Preller","psa":"F.X. Vollenweider","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2513457040","eid":"W2513457040"},{"id":"paper-w4402831597","cat":"papers","name":"Direct photochemical intramolecular [4 + 2] cycloadditions of dehydrosecodine-type substrates for the synthesis of the iboga -type scaffold and divergent [2 + 2] cycloadditions employing micro-flow system","year":"2024","cit":6,"pfa":"Gavin Tay","psa":"Hiroki Oguri","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4402831597","eid":"W4402831597"},{"id":"paper-w1972797120","cat":"papers","name":"Commentary on: Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance by Griffiths et al.","year":"2006","cit":6,"pfa":"Solomon H. Snyder","ptype":"editorial","src":"https://openalex.org/W1972797120","eid":"W1972797120"},{"id":"paper-w2188483661","cat":"papers","name":"The Hepatoprotective Effects of Corn Silk against Dose-induced Injury of Ecstasy (MDMA) Using Isolated Rat Liver Perfusion System","year":"2016","cit":6,"pfa":"Mohammad Yasin Karami","psa":"Farshad Naghshvar","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2188483661","eid":"W2188483661"},{"id":"paper-w2889910254","cat":"papers","name":"Regular MDMA use is associated with decreased risk of drug injection among street-involved youth who use illicit drugs","year":"2018","cit":6,"pfa":"Andrew Gaddis","psa":"Kora DeBeck","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2889910254","eid":"W2889910254"},{"id":"paper-w2165867256","cat":"papers","name":"Regional Distribution to Recovery of 5‐HT Levels after Administration of “Atrophins” MDMA and D, L‐Fenfluramine Stereospecificity and Comparison with 5,7‐Dihydroxytryptamine","year":"1992","cit":6,"pfa":"John C Lehmann","psa":"Robert C. Zaczek","ptype":"article","src":"https://openalex.org/W2165867256","eid":"W2165867256"},{"id":"paper-w3172154790","cat":"papers","name":"A Randomized, Double-Blind, Placebo Controlled Phase 3 Study Assessing Efficacy and Safety of MDMA-Assisted Therapy for the Treatment of Severe PTSD","year":"2021","cit":6,"pfa":"Berra Yazar‐Klosinski","psa":"Jennifer Mitchell","topics":["PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3172154790","eid":"W3172154790"},{"id":"paper-w4389704441","cat":"papers","name":"Psilocybin prevents activity-based anorexia in female rats by enhancing cognitive flexibility: contributions from 5-HT1A and 5-HT2A receptor mechanisms","year":"2023","cit":6,"pfa":"Kyna‐Anne Conn","psa":"Claire J. Foldi","topics":["Depression","Mechanism & neuroscience","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4389704441","eid":"W4389704441"},{"id":"paper-w1561255535","cat":"papers","name":"A driving simulator study on driving performance and traffic safety after multiple drug use, consisting of MDMA (Ecstasy) and various other psychoactive compounds","year":"2000","cit":6,"pfa":"Karel Brookhuis","psa":"Laurent Pernot","topics":["Addiction","Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W1561255535","eid":"W1561255535"},{"id":"paper-w7113899315","cat":"papers","name":"Acute and post-dosing effects of single-dose psilocybin for obsessive-compulsive disorder in a randomized, double-blind, placebo-controlled trial: an interpretative phenomenological analysis","year":"2025","cit":6,"pfa":"T. H. W. Ching","psa":"B. Kelmendi","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7113899315","eid":"W7113899315"},{"id":"paper-w2934779063","cat":"papers","name":"Comparing methamphetamine, MDMA, cocaine, codeine and methadone use between the Auckland region and four Australian states using wastewater-based epidemiology (WBE).","year":"2018","cit":6,"pfa":"Chris Wilkins","psa":"Jochen F. Mueller","ptype":"article","src":"https://openalex.org/W2934779063","eid":"W2934779063"},{"id":"paper-w1464447176","cat":"papers","name":"Ethylenedioxy homologs of N-methyl-(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA) and its corresponding cathinone analog methylenedioxymethcathinone: Interactions with transporters for serotonin, dopamine, and norepine","year":"2015","cit":6,"pfa":"Fabio Del Bello","psa":"Richard A. Glennon","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1464447176","eid":"W1464447176"},{"id":"paper-w4389435295","cat":"papers","name":"Acute psychotropic, autonomic, and endocrine effects of 5,6‐methylenedioxy‐2‐aminoindane (MDAI) compared with 3,4‐methylenedioxymethamphetamine (MDMA) in human volunteers: A self‐administration study","year":"2023","cit":6,"pfa":"Verena Angerer","psa":"Volker Auwärter","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4389435295","eid":"W4389435295"},{"id":"paper-w2094201895","cat":"papers","name":"Validação de método para determinação de 3,4-metilenodioximetanfetamina (MDMA) em comprimidos de ecstasy por cromatografia em fase gasosa","year":"2004","cit":6,"pfa":"Silvio Fernandes Lapachinske","psa":"Regina Lúcia de Moraes Moreau","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2094201895","eid":"W2094201895"},{"id":"paper-w4412487756","cat":"papers","name":"MDMA-assisted therapy and current treatment options for chronic, treatment-resistant, moderate or higher severity post-traumatic stress disorder: Systematic literature review","year":"2025","cit":6,"pfa":"Filip Stanicic","psa":"Debra de Angelo","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W4412487756","eid":"W4412487756"},{"id":"paper-w4411193165","cat":"papers","name":"MDMA-assisted psychotherapy for AUD: Bayesian analysis of WHO drinking risk level and exploratory analysis of drinking behavior and psychosocial functioning at 3 months follow-up","year":"2025","cit":6,"pfa":"Hannah Thurgur","psa":"David John Nutt","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4411193165","eid":"W4411193165"},{"id":"paper-w2326241514","cat":"papers","name":"Chronic exposure to MDMA (ecstasy)induces DNA damage, impairs functional antioxidant cellular defenses, enhances the lipid peroxidation process and alters testes histopathology in male rat.","year":"2013","cit":6,"pfa":"Nadia Gamal Zaki","psa":"Laila Abdel Kawy","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2326241514","eid":"W2326241514"},{"id":"paper-w4392203647","cat":"papers","name":"Optimization of enantioselective high-performance liquid chromatography-tandem mass spectrometry method for the quantitative determination of 3,4-methylenedioxy-methamphetamine (MDMA) and its phase-1 metabolites in human","year":"2024","cit":6,"pfa":"Giorgia Sprega","psa":"Bezhan Chankvetadze","ptype":"article","src":"https://openalex.org/W4392203647","eid":"W4392203647"},{"id":"paper-w4407310923","cat":"papers","name":"Psychedelics and Pro-Social Behaviors: A Perspective on Autism Spectrum Disorders","year":"2025","cit":6,"pfa":"Xue Wang","psa":"Xiaohui Wang","topics":["Mechanism & neuroscience"],"ptype":"editorial","src":"https://openalex.org/W4407310923","eid":"W4407310923"},{"id":"paper-w4409661707","cat":"papers","name":"Race and Gender Differences in the Moderating Relationship of Psychedelics on Stigma and Distress","year":"2025","cit":6,"pfa":"Sean M. Viña","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4409661707","eid":"W4409661707"},{"id":"paper-w4234313192","cat":"papers","name":"A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted Therapy","year":"2020","cit":6,"pfa":"Jason B. Luoma","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W4234313192","eid":"W4234313192"},{"id":"paper-w2020244098","cat":"papers","name":"Response to: Parrott AC, Buchanan T, Heffernan TM, Scholey A, Ling J, Rodgers J (2003) Parkinson?s disorder, psychomotor problems and dopaminergic neurotoxicity in recreational ecstasy/MDMA users. Psychopharmacology 167(","year":"2004","cit":6,"pfa":"Rick Doblin","psa":"Lisa Jerome","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2020244098","eid":"W2020244098"},{"id":"paper-w4229720389","cat":"papers","name":"Acute leukemia with Ph1-like chromosome in an LSD user","year":"1968","cit":6,"pfa":"L. Grossbard","ptype":"article","src":"https://openalex.org/W4229720389","eid":"W4229720389"},{"id":"paper-w962142130","cat":"papers","name":"Animal Models and Hallucinogenic Drugs","year":"2012","cit":6,"pfa":"Alexey Kozlenkov","psa":"Javier González‐Maeso","ptype":"book-chapter","src":"https://openalex.org/W962142130","eid":"W962142130"},{"id":"paper-w3161737512","cat":"papers","name":"New Insights Into the Clinical and Nonclinical Effects of Psychedelic Substances","year":"2021","cit":6,"pfa":"Matthias Forstmann","psa":"Christina Sagioglou","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3161737512","eid":"W3161737512"},{"id":"paper-w4408845950","cat":"papers","name":"Classic Psychedelics for the Treatment of Depression: Potential Benefits and Challenges","year":"2025","cit":6,"pfa":"Sharmin Ghaznavi","psa":"Sarah G. Richter","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4408845950","eid":"W4408845950"},{"id":"paper-w4323307067","cat":"papers","name":"Perceived risk of LSD varies with age and race: evidence from 2019 United States cross-sectional data","year":"2023","cit":6,"pfa":"Nicholas L. Bormann","psa":"Alison C. Lynch","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4323307067","eid":"W4323307067"},{"id":"paper-w2057777779","cat":"papers","name":"DESIGNATION OF \"TRANQUILIZING AGENTS\" IN NEUROPHARMACOLOGY","year":"1955","cit":6,"pfa":"Howard D. Fabing","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2057777779","eid":"W2057777779"},{"id":"paper-w4407903095","cat":"papers","name":"Exploring factors associated with the intensity of a mystical experience following naturalistic psychedelic use: A retrospective survey","year":"2025","cit":6,"pfa":"Bruno Roméo","psa":"Amine Benyamina","ptype":"article","src":"https://openalex.org/W4407903095","eid":"W4407903095"},{"id":"paper-w4246821632","cat":"papers","name":"A Phenomenological Comparison of Lsd and Schizophrenic States","year":"1974","cit":6,"pfa":"Barry G. Young","ptype":"article","src":"https://openalex.org/W4246821632","eid":"W4246821632"},{"id":"paper-w1969172997","cat":"papers","name":"Comment on \"Diverse Psychotomimetics Act Through a Common Signaling Pathway\"","year":"2004","cit":6,"pfa":"Philip M. Seeman","topics":["Mechanism & neuroscience"],"ptype":"letter","src":"https://openalex.org/W1969172997","eid":"W1969172997"},{"id":"paper-w2921629172","cat":"papers","name":"Imagining a Role for Psychedelics in Dementia Care","year":"2019","cit":6,"pfa":"Daniel R. George","psa":"Ryan Hanson","ptype":"article","src":"https://openalex.org/W2921629172","eid":"W2921629172"},{"id":"paper-w4402678596","cat":"papers","name":"Quantitative LC-QToF-MS Analysis of Mycochemicals in Amanita muscaria, Psilocybe spp. (Agaricomycetes), and Consumer Products","year":"2024","cit":6,"pfa":"Kumar Katragunta","psa":"Ikhlas Ahmed Khan","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4402678596","eid":"W4402678596"},{"id":"paper-w2020090445","cat":"papers","name":"LSD and 5-HTP: Tolerance and cross-tolerance relationships","year":"1978","cit":6,"pfa":"Richard B. Carter","psa":"James B. Appel","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2020090445","eid":"W2020090445"},{"id":"paper-w4394982292","cat":"papers","name":"Visual hallucinations originating in the retinofugal pathway under clinical and psychedelic conditions","year":"2024","cit":6,"pfa":"Zeus Tipado","psa":"Johannes Gerardus Ramaekers","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4394982292","eid":"W4394982292"},{"id":"paper-w2089008908","cat":"papers","name":"A Study of LSD-Serotonin Central Interaction**College of Pharmacy, University of Florida, Gainesville","year":"1959","cit":6,"pfa":"Paul Zanowiak","psa":"Morton J. Rodman","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2089008908","eid":"W2089008908"},{"id":"paper-w4220970406","cat":"papers","name":"Tentative identification of in vitro metabolites of O‐acetylpsilocin (psilacetin, 4‐AcO‐DMT) by UHPLC‐Q‐Orbitrap MS","year":"2022","cit":6,"pfa":"Wenya Zhai","psa":"Yonghui Dang","ptype":"article","src":"https://openalex.org/W4220970406","eid":"W4220970406"},{"id":"paper-w4386956871","cat":"papers","name":"Paradigm Lost: Towards an Evidence-based Ontology in Psychedelic Medicine?","year":"2023","cit":6,"pfa":"Olivia Marcus","psa":"Elias Dakwar","ptype":"article","src":"https://openalex.org/W4386956871","eid":"W4386956871"},{"id":"paper-w4412096805","cat":"papers","name":"Exploring the Therapeutic Effects of Psychedelics Administered to Military Veterans in Naturalistic Retreat Settings","year":"2025","cit":6,"pfa":"Megan Calnan","psa":"Robin Lester Carhart-Harris","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4412096805","eid":"W4412096805"},{"id":"paper-w4404975481","cat":"papers","name":"Analytical and Pharmacological Characterization of 1‐(Furan‐2‐Carbonyl)‐LSD (1F‐LSD) and Comparison With 1‐(Thiophene‐2‐Carbonyl)‐LSD (1T‐LSD)","year":"2024","cit":6,"pfa":"Simon D. Brandt","psa":"Adam L. Halberstadt","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4404975481","eid":"W4404975481"},{"id":"paper-w3100320203","cat":"papers","name":"Advancing elite athlete mental health treatment with psychedelic-assisted psychotherapy","year":"2020","cit":6,"pfa":"Courtney Campbell Walton","psa":"Paul Liknaitzky","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3100320203","eid":"W3100320203"},{"id":"paper-w1995946353","cat":"papers","name":"LSD \"Mainlining\"","year":"1967","cit":6,"pfa":"Barry J. Materson","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1995946353","eid":"W1995946353"},{"id":"paper-w2413204231","cat":"papers","name":"Detection and determination of abused hallucinogens in biological material.","year":"2006","cit":6,"pfa":"Peter Ondra","psa":"Ivo Válka","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2413204231","eid":"W2413204231"},{"id":"paper-w1966871905","cat":"papers","name":"Phenothiazine and Biperiden in LSD Reactions","year":"1971","cit":6,"pfa":"Leon Tec","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1966871905","eid":"W1966871905"},{"id":"paper-w3086321512","cat":"papers","name":"Voltammetric Determination of LSD with a Schiff Base – Chemically Modified Electrode in Aqueous Solution","year":"2020","cit":6,"pfa":"Maria Fernanda Muzetti Ribeiro","psa":"Marcelo Firmino de Oliveira","ptype":"article","src":"https://openalex.org/W3086321512","eid":"W3086321512"},{"id":"paper-w4378782490","cat":"papers","name":"Ethical considerations for psychedelic-assisted therapy in military clinical settings","year":"2023","cit":6,"pfa":"Scott Hoener","psa":"Edmund G. Howe","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4378782490","eid":"W4378782490"},{"id":"paper-w4398248553","cat":"papers","name":"Narrative review of the potential for psychedelics to treat Prolonged Grief Disorder","year":"2024","cit":6,"pfa":"Rebecca C. Ehrenkranz","psa":"David B. Yaden","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"review","src":"https://openalex.org/W4398248553","eid":"W4398248553"},{"id":"paper-w7131088236","cat":"papers","name":"Psychedelic medicine: mechanisms, evidence, and translation to practice","year":"2026","cit":6,"pfa":"Edward Jacobs","psa":"David B. Yaden","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7131088236","eid":"W7131088236"},{"id":"paper-w2111092816","cat":"papers","name":"A further study on alleviation of the psychological effects of LSD in man by pretreatment with 5-hydroxytryptophan","year":"1963","cit":6,"pfa":"C. M. B. Pare","psa":"Elwood H. Labrosse","ptype":"article","src":"https://openalex.org/W2111092816","eid":"W2111092816"},{"id":"paper-w2413801177","cat":"papers","name":"3-Dimensional anatomic relationship of serotonergic and muscarinic receptor binding in the pontine reticular formation of the human infant brainstem.","year":"1999","cit":6,"pfa":"A Panigraphy","psa":"Hannah C. Kinney","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2413801177","eid":"W2413801177"},{"id":"paper-w3142712722","cat":"papers","name":"Psychedelic Medicines in Major Depression: Progress and Future Challenges","year":"2021","cit":6,"pfa":"José Carlos Bouso","psa":"Jaime E. C. Hallak","topics":["Depression"],"ptype":"book-chapter","src":"https://openalex.org/W3142712722","eid":"W3142712722"},{"id":"paper-w1979096075","cat":"papers","name":"Naloxone alters the effects of LSD, DOM and quipazine on operant behavior of rats","year":"1984","cit":6,"pfa":"David J. Mokler","psa":"Richard H. Rech","ptype":"article","src":"https://openalex.org/W1979096075","eid":"W1979096075"},{"id":"paper-w3163497962","cat":"papers","name":"The Failed Globalization of Psychedelic Drugs in the Early Modern World","year":"2021","cit":6,"pfa":"Benjamin Breen","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W3163497962","eid":"W3163497962"},{"id":"paper-w2799782352","cat":"papers","name":"Gnosis Potency: DMT Breakthroughs and Paragnosis","year":"2018","cit":6,"pfa":"Graham St John","ptype":"book-chapter","src":"https://openalex.org/W2799782352","eid":"W2799782352"},{"id":"paper-w2059450414","cat":"papers","name":"L’Ayahuasca : clinique, neurobiologie et ambiguïté thérapeutique","year":"2007","cit":6,"pfa":"Xavier Laqueille","psa":"S. Martins","ptype":"article","src":"https://openalex.org/W2059450414","eid":"W2059450414"},{"id":"paper-w3173085310","cat":"papers","name":"Early LSD treatment in Denmark from 1960 to 1974","year":"2021","cit":6,"pfa":"Jens Knud Larsen","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3173085310","eid":"W3173085310"},{"id":"paper-w4400368474","cat":"papers","name":"Analytical and behavioral characterization of 1‐hexanoyl‐LSD (1H‐LSD)","year":"2024","cit":6,"pfa":"Simon D. Brandt","psa":"Adam L. Halberstadt","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4400368474","eid":"W4400368474"},{"id":"paper-w2111474010","cat":"papers","name":"Preliminary evidence of motor impairment among polysubstance 3,4-methylenedioxymethamphetamine users with intact neuropsychological functioning","year":"2010","cit":6,"pfa":"Chad Bousman","psa":"THE HNRC GROUP","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2111474010","eid":"W2111474010"},{"id":"paper-w2394698222","cat":"papers","name":"Quantitative and autoradiographic analyses of alpha-adrenergic and serotonergic receptors on aorta and coronary artery","year":"1990","cit":6,"pfa":"H Tsutsui","psa":"M. Nakamura","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2394698222","eid":"W2394698222"},{"id":"paper-w4410746032","cat":"papers","name":"Absolute Oral Bioavailability and Bioequivalence of LSD Base and Tartrate in a Double‐Blind, Placebo‐Controlled, Crossover Study","year":"2025","cit":6,"pfa":"Denis Arikci","psa":"Matthias E. Liechti","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4410746032","eid":"W4410746032"},{"id":"paper-w2027904311","cat":"papers","name":"Influence of thyroid hormones on 3,4-methylenedioxymethamphetamine-induced thermogenesis and reinforcing strength in monkeys","year":"2008","cit":6,"pfa":"Matthew L. Banks","psa":"Michael A. Nader","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2027904311","eid":"W2027904311"},{"id":"paper-w2122427874","cat":"papers","name":"E cstasy (3, 4‐methylenedioxymethamphetamine) use among J apanese rave population","year":"2013","cit":6,"pfa":"Takuya Shimane","psa":"Masahiko Funada","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2122427874","eid":"W2122427874"},{"id":"paper-w2323835206","cat":"papers","name":"Modulation of 3,4-Methylenedioxymethamphetamine Effects by Endocannabinoid System","year":"2013","cit":6,"pfa":"Olga Valverde","psa":"Marta Rodríguez‐Arias","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2323835206","eid":"W2323835206"},{"id":"paper-w4411777589","cat":"papers","name":"A Scoping Review of Research in Naturalistic Studies with Psychedelics","year":"2025","cit":6,"pfa":"Laura Lopes de Carvalho","psa":"Pedro J. Teixeira","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4411777589","eid":"W4411777589"},{"id":"paper-w4409639821","cat":"papers","name":"Psychedelics and substance use disorder treatment","year":"2025","cit":6,"pfa":"Caitlin Marie DuPont","psa":"Matthew W. Johnson","topics":["Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W4409639821","eid":"W4409639821"},{"id":"paper-w2954889264","cat":"papers","name":"Locomotor sensitization in male Sprague-Dawley rats following repeated concurrent treatment with 4-methylmethcathinone and 3,4-methylenedioxymethamphetamine","year":"2019","cit":6,"pfa":"Trent A. Bullock","psa":"Lisa E. Baker","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2954889264","eid":"W2954889264"},{"id":"paper-w2031457279","cat":"papers","name":"Memantine attenuates 3,4-methylenedioxymethamphetamine-induced hyperthermia in rats","year":"2012","cit":6,"pfa":"Koichi Nisijima","psa":"Satoshi Kato","ptype":"article","src":"https://openalex.org/W2031457279","eid":"W2031457279"},{"id":"paper-w2142254131","cat":"papers","name":"Ketamine pretreatment exacerbated 3,4-methylenedioxymethamphetamine-induced central dopamine toxicity.","year":"2008","cit":6,"pfa":"Jing-Jer Ke","psa":"Lung Yu","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2142254131","eid":"W2142254131"},{"id":"paper-w2997581046","cat":"papers","name":"Methylenedioxymethamphetamine-like discriminative stimulus effects of seven cathinones in rats","year":"2019","cit":6,"pfa":"Michael B. Gatch","psa":"Michael J. Forster","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2997581046","eid":"W2997581046"},{"id":"paper-w2026873328","cat":"papers","name":"Structure-activity relationships for hallucinogenic N,N-dialkyltryptamines: photoelectron spectra and serotonin receptor affinities of methylthio and methylenedioxy derivatives","year":"1982","cit":6,"pfa":"Toni B. Kline","psa":"Melvin D. Rozeboom","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2026873328","eid":"W2026873328"},{"id":"paper-w2109551168","cat":"papers","name":"Determination of 3,4-methylenedioxymethamphetamine and its five main metabolites in rat urine by solid-phase extraction and high performance liquid chromatography with on line mass spectrometry","year":"2010","cit":6,"pfa":"Marie‐Claude Menet","psa":"Jean‐Michel Scherrmann","ptype":"article","src":"https://openalex.org/W2109551168","eid":"W2109551168"},{"id":"paper-w4406326126","cat":"papers","name":"From Theory to Practice: The Importance of Operationalizing and Measuring Ethical Touch in Psychedelic-Assisted Therapy","year":"2025","cit":6,"pfa":"Jason B. Luoma","psa":"Jenna T. LeJeune","topics":["Policy & ethics"],"ptype":"editorial","src":"https://openalex.org/W4406326126","eid":"W4406326126"},{"id":"paper-w3163192585","cat":"papers","name":"The Effects of Folic Acid on Testicular Histology, Sperm Quality, and Spermatogenesis Indices Following 3,4-Methylenedioxymethamphetamine Exposure in Adult Male Rats.","year":"2021","cit":6,"pfa":"Iman Rad","psa":"Saeideh Nikpour","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3163192585","eid":"W3163192585"},{"id":"paper-w4402279238","cat":"papers","name":"Psychedelics as a tool for a more connected and sustainable world? Considering the importance of rituals, boundaries, and commitment.","year":"2024","cit":6,"pfa":"Katie Anderson","psa":"Amy Isham","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4402279238","eid":"W4402279238"},{"id":"paper-w4405002539","cat":"papers","name":"Forensic Aspects of Designer LSD Analogs Identification by GC–MS (EI) and UV Spectroscopy","year":"2024","cit":6,"pfa":"Kaja Tusiewicz","psa":"Paweł Szpot","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4405002539","eid":"W4405002539"},{"id":"paper-w2021504564","cat":"papers","name":"MAE–GC Determination of Methamphetamine, 3,4-Methylenedioxyamphetamine and 3,4-Methylenedioxymethamphetamine in Human Urine","year":"2009","cit":6,"pfa":"Nengsheng Ye","psa":"Yueqin Zhang","ptype":"article","src":"https://openalex.org/W2021504564","eid":"W2021504564"},{"id":"paper-w4200001754","cat":"papers","name":"Predictors of Psychedelic Experience: A Thematic Analysis","year":"2021","cit":6,"pfa":"Annie McCartney","psa":"Alexander De Foe","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4200001754","eid":"W4200001754"},{"id":"paper-w2022639716","cat":"papers","name":"The effects of psychotomimetics and psychomotor stimulants on two schedules promoting response switching in the rat","year":"2002","cit":6,"pfa":"J. L. Evenden","ptype":"article","src":"https://openalex.org/W2022639716","eid":"W2022639716"},{"id":"paper-w1586005786","cat":"papers","name":"PRECLINICAL STUDY: The effects of p‐chloroamphetamine, methamphetamine and 3,4‐methylenedioxymethamphetamine (ecstasy) on the gene expression of cytoskeletal proteins in the rat brain","year":"2007","cit":6,"pfa":"Jörg Putzke","psa":"Karl‐Heinz Smalla","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1586005786","eid":"W1586005786"},{"id":"paper-w2136384496","cat":"papers","name":"Impact of reaction parameters on the chemical profile of 3,4-methylenedioxymethamphetamine synthesized via reductive amination: Target analysis based on GC-qMS compared to non-targeted analysis based on GC×GC–TOF-MS","year":"2013","cit":6,"pfa":"M. Schäffer","psa":"Ralf Zimmermann","ptype":"article","src":"https://openalex.org/W2136384496","eid":"W2136384496"},{"id":"paper-w2020341353","cat":"papers","name":"Comparison of stimulants and hallucinogens on shuttle avoidance in rats","year":"1987","cit":6,"pfa":"W. Marvin Davis","psa":"Hind T. Hatoum","ptype":"article","src":"https://openalex.org/W2020341353","eid":"W2020341353"},{"id":"paper-w4411326423","cat":"papers","name":"The phenomenology of psilocybin’s experience mediates subsequent persistent psychological effects independently of sex, previous experience, or setting","year":"2025","cit":6,"pfa":"Tereza Klučková","psa":"Tomáš Páleníček","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4411326423","eid":"W4411326423"},{"id":"paper-w3007154054","cat":"papers","name":"Analytical Procedures Used in FDA Laboratories for the Analysis of Hallucinogenic Drugs","year":"1968","cit":6,"pfa":"Robert J. Martin","psa":"Thomas G Alexander","ptype":"article","src":"https://openalex.org/W3007154054","eid":"W3007154054"},{"id":"paper-w4300599326","cat":"papers","name":"False-Positive LSD Drug Screening Induced by a Mucolytic Medication","year":"1998","cit":6,"pfa":"Johannes Lotz","psa":"Winfried Prellwitz","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4300599326","eid":"W4300599326"},{"id":"paper-w2773534994","cat":"papers","name":"Psychedelic Medicine for Mental Illness and Substance Use Disorders: Overcoming Social and Legal Obstacles","year":"2017","cit":6,"pfa":"Mason Marks","topics":["Addiction","Anxiety & end-of-life","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2773534994","eid":"W2773534994"},{"id":"paper-w4405028178","cat":"papers","name":"Prefrontal electrophysiological biomarkers and mechanism-based drug effects in a rat model of alcohol addiction","year":"2024","cit":6,"pfa":"Bettina Habelt","psa":"Nadine Rabe Bernhardt","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4405028178","eid":"W4405028178"},{"id":"paper-w3041571684","cat":"papers","name":"Enhancement of the rewarding effects of 3,4-methylenedioxymethamphetamine in orexin knockout mice","year":"2020","cit":6,"pfa":"Tomohisa Mori","psa":"Tsutomu Suzuki","ptype":"article","src":"https://openalex.org/W3041571684","eid":"W3041571684"},{"id":"paper-w4413323217","cat":"papers","name":"Exploring the therapeutic potential of psychedelics in treating substance use disorders","year":"2025","cit":6,"pfa":"Y Li","psa":"Xiaohui Wang","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4413323217","eid":"W4413323217"},{"id":"paper-w2127594247","cat":"papers","name":"The high-affinity binding site for tricyclic antidepressants resides in the outer vestibule of the serotonin transporter","year":"2010","cit":6,"pfa":"Subhodeep Sarker","psa":"Sonja Sučić","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2127594247","eid":"W2127594247"},{"id":"paper-w4206385503","cat":"papers","name":"Reviving research into psychedelic drugs","year":"2006","cit":6,"pfa":"The Lancet","ptype":"article","src":"https://openalex.org/W4206385503","eid":"W4206385503"},{"id":"paper-w4386317658","cat":"papers","name":"Adapting psychedelic medicine for headache and chronic pain disorders","year":"2023","cit":6,"pfa":"Emmanuelle A. D. Schindler","psa":"Peter S. Hendricks","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4386317658","eid":"W4386317658"},{"id":"paper-w4407528802","cat":"papers","name":"Metabolism of m -CPP, trazodone, nefazodone, and etoperidone: clinical and forensic aspects","year":"2025","cit":6,"pfa":"Mariana Duarte Costa Alegre","psa":"Ricardo Jorge Dinis‐Oliveira","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4407528802","eid":"W4407528802"},{"id":"paper-w4285800360","cat":"papers","name":"Asymmetric Syntheses of (+)- and (−)-Collybolide Enable Reevaluation of kappa -Opioid Receptor Agonism","year":"2022","cit":6,"pfa":"Sophia L. Shevick","psa":"Ryan A. Shenvi","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4285800360","eid":"W4285800360"},{"id":"paper-w4281387812","cat":"papers","name":"Unique Effects of Sedatives, Dissociatives, Psychedelics, Stimulants, and Cannabinoids on Episodic Memory: A Review and Reanalysis of Acute Drug Effects on Recollection, Familiarity, and Metamemory","year":"2022","cit":6,"pfa":"Manoj K. Doss","psa":"Joshua D. Koen","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4281387812","eid":"W4281387812"},{"id":"paper-w2406701120","cat":"papers","name":"Detection of Methamphetamine, Methylenedioxymethamphetamine, and 3,4-Methylenedioxy-N-ethylamphetamine in Spiked Plasma by HPLC and TLC","year":"2010","cit":6,"pfa":"Aysel Öztunç","psa":"Sıdıka Ertürk Toker","ptype":"article","src":"https://openalex.org/W2406701120","eid":"W2406701120"},{"id":"paper-w4390915995","cat":"papers","name":"Validation of the Danish Translation of the Revised Mystical Experience Questionnaire (MEQ30) and Possible Impact of Setting, Dose and Intention","year":"2024","cit":6,"pfa":"Oliver Rumle Hovmand","psa":"Dea Siggaard Stenbæk","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4390915995","eid":"W4390915995"},{"id":"paper-w4307339405","cat":"papers","name":"Natural Products for the Treatment of Drug Addiction: Narrative Review","year":"2022","cit":6,"pfa":"Mona A. Raslan","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4307339405","eid":"W4307339405"},{"id":"paper-w2187053618","cat":"papers","name":"Cult-Hoasca: A Model for Schizophrenia.","year":"2003","cit":6,"pfa":"Alicia Beatriz Pomilio","psa":"Jorge Ciprian‐Ollivier","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2187053618","eid":"W2187053618"},{"id":"paper-w3040125782","cat":"papers","name":"Hallucinogenic mushroom misuse reported to Texas poison centers","year":"2020","cit":6,"pfa":"Mathias B. Forrester","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3040125782","eid":"W3040125782"},{"id":"paper-w4311667760","cat":"papers","name":"Depressione resistente a trattamento. Dalla classificazione alle nuove terapie","year":"2022","cit":6,"pfa":"Walter Paganin","psa":"Antonio Sciarretta","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4311667760","eid":"W4311667760"},{"id":"paper-w2408297962","cat":"papers","name":"[Changes in 5-HT2 receptor density induced by repeated treatment with 5-HT uptake inhibitor or 5-HT agonist].","year":"1989","cit":6,"pfa":"M Kubota","psa":"H Kitagawa","topics":["Depression","Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W2408297962","eid":"W2408297962"},{"id":"paper-w4367153945","cat":"papers","name":"A roadmap for psychedelic pharmacy in Canada: A proposed policy and operations approach for controlled access to select psychedelics for treatment of mental illness","year":"2023","cit":6,"pfa":"Jaden Brandt","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4367153945","eid":"W4367153945"},{"id":"paper-w2324620923","cat":"papers","name":"A Case of Fatal Benzylpiperazine (BZP) and Trifluoromethylphenylpiperazine (TFMPP) Toxicity","year":"2012","cit":6,"pfa":"Craig N. Chatterton","psa":"Peter P. Singer","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2324620923","eid":"W2324620923"},{"id":"paper-w1965066817","cat":"papers","name":"Structure-activity studies on hallucinogenic amphetamines using model interaction calculations","year":"1978","cit":6,"pfa":"Thérèse Di Paolo","psa":"Lemont B. Kier","ptype":"article","src":"https://openalex.org/W1965066817","eid":"W1965066817"},{"id":"paper-w2419823458","cat":"papers","name":"Synthesis, Identification, and Acute Toxicity of Some 7V-AlkyI Derivatives of 3,4-Methylenedioxyamphetamine","year":"1987","cit":6,"pfa":"F. T. Noggle","psa":"Randall C. Clark","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2419823458","eid":"W2419823458"},{"id":"paper-w2086660329","cat":"papers","name":"Hallucinogen research inspires “neurotheology”","year":"2006","cit":6,"pfa":"Kelly Morris","ptype":"article","src":"https://openalex.org/W2086660329","eid":"W2086660329"},{"id":"paper-w2139380955","cat":"papers","name":"Doctors' knowledge of the appropriate use and route of administration of antidotes in the management of recreational drug toxicity","year":"2008","cit":6,"pfa":"Satnam Lidder","psa":"David Michael Wood","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2139380955","eid":"W2139380955"},{"id":"paper-w2397477825","cat":"papers","name":"[Antibiotic drug minocycline: a potential therapeutic drug for methamphetamine-related disorders].","year":"2013","cit":6,"pfa":"Kenji Hashimoto","psa":"Lin Zhang","topics":["Safety & adverse events"],"ptype":"other","src":"https://openalex.org/W2397477825","eid":"W2397477825"},{"id":"paper-w4231995493","cat":"papers","name":"Two kinds of tryptamine receptor","year":"1997","cit":6,"pfa":"J. H. Gaddum","psa":"J.R. Fozard","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4231995493","eid":"W4231995493"},{"id":"paper-w4285118826","cat":"papers","name":"5-HT2CR Is as Important as 5-HT2AR in Inducing Hallucinogenic Effects in Serotonergic Compounds","year":"2022","cit":6,"pfa":"Raly James Perez Custodio","psa":"Hee Jin Kim","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4285118826","eid":"W4285118826"},{"id":"paper-w2501549796","cat":"papers","name":"Marijuana’s Perceived Addictiveness: A Survey of Clinicians and Researchers","year":"2006","cit":6,"pfa":"Robert Gore","psa":"Mitch Earleywine","topics":["Addiction","Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W2501549796","eid":"W2501549796"},{"id":"paper-w4396832190","cat":"papers","name":"Quantifying the Pollan Effect: Investigating the Impact of Emerging Psychiatric Interventions on Online Mental Health Discourse","year":"2024","cit":6,"pfa":"Sachin R. Pendse","psa":"Munmun De Choudhury","topics":["Depression"],"ptype":"conference-paper","src":"https://openalex.org/W4396832190","eid":"W4396832190"},{"id":"paper-w4413020215","cat":"papers","name":"Between enhancement and risk: A critical review of psychedelic microdosing","year":"2025","cit":6,"pfa":"Iva Totomanova","psa":"Kim P. C. Kuypers","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W4413020215","eid":"W4413020215"},{"id":"paper-w4405381556","cat":"papers","name":"Psychedelic use and bipolar disorder – An investigation of recreational use and its impact on mental health","year":"2024","cit":6,"pfa":"Thomas Daniel Meyer","psa":"Jair C. Soares","ptype":"article","src":"https://openalex.org/W4405381556","eid":"W4405381556"},{"id":"paper-w3158400141","cat":"papers","name":"Therapeutic Use of Hallucinogens","year":"2021","cit":6,"pfa":"Victor Distefano Wiltenburg","psa":"Fúlvio Rieli Mendes","ptype":"book-chapter","src":"https://openalex.org/W3158400141","eid":"W3158400141"},{"id":"paper-w4395684287","cat":"papers","name":"Psychedelic Mysticism and Christian Spirituality: From Science to Love","year":"2024","cit":6,"pfa":"Ron Cole‐Turner","ptype":"article","src":"https://openalex.org/W4395684287","eid":"W4395684287"},{"id":"paper-w2335873271","cat":"papers","name":"Strategies for Detecting Subclinical Monoamine Depletions in Humans","year":"1993","cit":6,"pfa":"Una D. McCann","psa":"George A. Ricaurte","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"dataset","src":"https://openalex.org/W2335873271","eid":"W2335873271"},{"id":"paper-w4244671125","cat":"papers","name":"Exploring the Aversive and Anxiogenic Effects of Novel Kappa Opioid Receptor Agonists in Rats","year":"2016","cit":6,"pfa":"Aimee Culverhouse","topics":["Addiction","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W4244671125","eid":"W4244671125"},{"id":"paper-w2320831509","cat":"papers","name":"LSD Screening in Urine Performed by CEDIA(R) LSD Assay: Positive Interference with Sertraline","year":"2012","cit":6,"pfa":"Antony Citterio‐Quentin","psa":"Mustapha Moulsma","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2320831509","eid":"W2320831509"},{"id":"paper-w2318778817","cat":"papers","name":"Biological Markers for the Schizophrenic and Atypical Psychoses","year":"1982","cit":6,"pfa":"John Smythies","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2318778817","eid":"W2318778817"},{"id":"paper-w3210973148","cat":"papers","name":"Harmine impairs memory performance of treated rats and nontreated cagemates.","year":"2021","cit":6,"pfa":"Tânia Cristina Libânio","psa":"Vanessa Costhek Abílio","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3210973148","eid":"W3210973148"},{"id":"paper-w2606890020","cat":"papers","name":"The science of therapeutic images","year":"2017","cit":6,"pfa":"Connor Cummings","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2606890020","eid":"W2606890020"},{"id":"paper-w4410350230","cat":"papers","name":"The pharmacological treatment of anxiety in people with eating disorders: A systematic review","year":"2025","cit":6,"pfa":"R. Crawford Morris","psa":"Hubertus Himmerich","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W4410350230","eid":"W4410350230"},{"id":"paper-w4410359464","cat":"papers","name":"Micro-phenomenology of immersion and perceived presences under DMT","year":"2026","cit":6,"pfa":"James W Sanders","psa":"Christopher B. Timmermann","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4410359464","eid":"W4410359464"},{"id":"paper-w4406192291","cat":"papers","name":"Psychotic-Like Experiences in Young Recreational Users of Ketamine: A Case Study","year":"2025","cit":6,"pfa":"Valerio Ricci","psa":"Giuseppe Maina","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4406192291","eid":"W4406192291"},{"id":"paper-w2808807060","cat":"papers","name":"Evaluation of morphine‐like effects of the mixed mu/delta agonist morphine‐6‐O‐sulfate in rats: Drug discrimination and physical dependence","year":"2018","cit":6,"pfa":"Jai Shankar K. Yadlapalli","psa":"William E. Fantegrossi","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2808807060","eid":"W2808807060"},{"id":"paper-w2888229685","cat":"papers","name":"Comparing the Detection of Endogenous Psychedelics in Individuals With and Without Alleged Mediumistic Experiences","year":"2018","cit":6,"pfa":"Marco Aurélio Vinhosa Bastos","psa":"Giancarlo Lucchetti","ptype":"article","src":"https://openalex.org/W2888229685","eid":"W2888229685"},{"id":"paper-w4392842873","cat":"papers","name":"A history of the European Medical Society for Psycholytic Therapy (EPT) 1964–1974","year":"2024","cit":6,"pfa":"Torsten Passie","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4392842873","eid":"W4392842873"},{"id":"paper-w1970434963","cat":"papers","name":"Donepezil in a chronic drug user—a potential treatment?","year":"2003","cit":6,"pfa":"Diana Jovanovski","psa":"Konstantine K. Zakzanis","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1970434963","eid":"W1970434963"},{"id":"paper-w7117296074","cat":"papers","name":"The 3D-ASCr scale: A revalidation of the core dimensions of the Altered States of Consciousness Rating Scale 5D(11)-ASC for psychedelic research","year":"2025","cit":6,"pfa":"Kurt Stocker","psa":"Matthias E. Liechti","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7117296074","eid":"W7117296074"},{"id":"paper-w2021324578","cat":"papers","name":"Hallucinogènes et psychiatrie, au milieu du siècle dernier","year":"2000","cit":6,"pfa":"Jacques Arveiller","ptype":"article","src":"https://openalex.org/W2021324578","eid":"W2021324578"},{"id":"paper-w2476213517","cat":"papers","name":"Empathogenic agents: their use, abuse, mechanism of action and addiction potential","year":"2007","cit":6,"pfa":"Dan Véléa","psa":"Michel Hautefeuille","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"book-chapter","src":"https://openalex.org/W2476213517","eid":"W2476213517"},{"id":"paper-w2253442135","cat":"papers","name":"That deep internal voice: Controlled administration of Salvia divinorum","cit":6,"pfa":"Peter H. Addy","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W2253442135","eid":"W2253442135"},{"id":"paper-w2802485209","cat":"papers","name":"Psychedelic Naturalism and Interspecies Alliance: Views from the Emerging Do-It-Yourself Mycology Movement","year":"2018","cit":6,"pfa":"Joanna Steinhardt","ptype":"book-chapter","src":"https://openalex.org/W2802485209","eid":"W2802485209"},{"id":"paper-w4390511188","cat":"papers","name":"A fatal case of aspiration due to consumption of the hallucinogenic tryptamine derivative dipropyltryptamine (DPT)","year":"2024","cit":6,"pfa":"Merja A. Neukamm","psa":"Volker Auwärter","ptype":"article","src":"https://openalex.org/W4390511188","eid":"W4390511188"},{"id":"paper-w4400581002","cat":"papers","name":"Psychedelic intimacy: Altered states of consciousness in romantic relationships","year":"2024","cit":6,"pfa":"Jonas J. Neubert","psa":"Natasha Leigh Mason","topics":["Addiction","Anxiety & end-of-life","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4400581002","eid":"W4400581002"},{"id":"paper-w4405484832","cat":"papers","name":"Exploring the role of psychedelic-assisted therapy in enhancing spirituality and mystical experiences in patients with life-threatening illnesses: A systematic review","year":"2024","cit":6,"pfa":"Ana Esteves Ferreira","psa":"Paulo Reis-Pina","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W4405484832","eid":"W4405484832"},{"id":"paper-w4406955835","cat":"papers","name":"A primer for culturally attuned psychedelic clinical trials","year":"2025","cit":6,"pfa":"Terence H. W. Ching","psa":"Benjamin Kelmendi","topics":["Reviews & meta-analyses","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4406955835","eid":"W4406955835"},{"id":"paper-w4411679609","cat":"papers","name":"Treatment approaches and efficacy in psychedelic-induced psychosis: A systematic review","year":"2025","cit":6,"pfa":"Adi Sulstarova","psa":"Michel Sabé","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4411679609","eid":"W4411679609"},{"id":"paper-w3121923864","cat":"papers","name":"A Study on Photostability of Amphetamines and Ketamine in Hair Irradiated under Artificial Sunlight","year":"2018","cit":6,"pfa":"Giorgia Miolo","psa":"Donata Favretto","ptype":"preprint","src":"https://openalex.org/W3121923864","eid":"W3121923864"},{"id":"paper-w4213271306","cat":"papers","name":"Policies and Toxicological Screenings for No Drug Addiction: An Example from the Civil Aviation Workforce","year":"2022","cit":6,"pfa":"Michele Treglia","psa":"Roberta Tittarelli","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4213271306","eid":"W4213271306"},{"id":"paper-w2946352239","cat":"papers","name":"Acute Psychiatric Disorders Related to Fake Cathinone: Ephylone","year":"2019","cit":6,"pfa":"Anaïs Serre","psa":"Hélène Peyrière","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2946352239","eid":"W2946352239"},{"id":"paper-w2410647679","cat":"papers","name":"Urinary Excretion of N,N-Dimethylated Tryptamines in Chronic Schizophrenia: A Review of the Present Status of the Hypothesis","year":"1976","cit":6,"pfa":"Louis Huszka","psa":"John W. Lovett Doust","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2410647679","eid":"W2410647679"},{"id":"paper-w4309307634","cat":"papers","name":"Differences between users’ and addiction medicine experts’ harm and benefit assessments of licit and illicit psychoactive drugs: Input for psychoeducation and legalization/restriction debates","year":"2022","cit":6,"pfa":"Udo Bonnet","psa":"Norbert Scherbaum","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4309307634","eid":"W4309307634"},{"id":"paper-w2036393569","cat":"papers","name":"Interseizure EEG Slowing after ECT is not NCSE","year":"2006","cit":6,"pfa":"Max Fink","topics":["Depression","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2036393569","eid":"W2036393569"},{"id":"paper-w1568759083","cat":"papers","name":"Commentary on B oileau et al. (2013): Distinguishing D2/D3 dopaminergic contributions to addictions","year":"2013","cit":6,"pfa":"Marc Nicholas Potenza","psa":"Arthur L. Brody","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"editorial","src":"https://openalex.org/W1568759083","eid":"W1568759083"},{"id":"paper-w3195582223","cat":"papers","name":"Indian Rauwolfia research led to the evolution of neuropsychopharmacology & the 2000 Nobel Prize (Part II)","year":"2021","cit":6,"pfa":"PrakashN Tandon","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3195582223","eid":"W3195582223"},{"id":"paper-w4376116905","cat":"papers","name":"Integral Psychedelic Therapy","year":"2023","cit":6,"pfa":"Jason A. Butler","psa":"Richard Louis Miller","ptype":"book","src":"https://openalex.org/W4376116905","eid":"W4376116905"},{"id":"paper-w4391316679","cat":"papers","name":"Psychedelics in Psychiatry, the Nursing Influence, and the Future of Psychedelic Therapies","year":"2024","cit":6,"pfa":"Carlton J. Spotswood","topics":["Reviews & meta-analyses","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4391316679","eid":"W4391316679"},{"id":"paper-w4414031406","cat":"papers","name":"Experiments in medicalization: psychedelic therapy in Switzerland and Australia","year":"2025","cit":6,"pfa":"Nicolas Langlitz","ptype":"article","src":"https://openalex.org/W4414031406","eid":"W4414031406"},{"id":"paper-w4391951027","cat":"papers","name":"An Occupational Perspective on Psychedelic Therapy: A Scoping Review","year":"2024","cit":6,"pfa":"Gabriella Ann Hogan","psa":"Tim Barlott","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4391951027","eid":"W4391951027"},{"id":"paper-w4389430540","cat":"papers","name":"The “Third” Eye: Ethics of Video Recording in the Context of Psychedelic-Assisted Therapy","year":"2023","cit":6,"pfa":"Khaleel Rajwani","topics":["Safety & adverse events","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4389430540","eid":"W4389430540"},{"id":"paper-w4390611559","cat":"papers","name":"Commentary: On the need for metaphysics in psychedelic therapy and research","year":"2024","cit":6,"pfa":"Katherine Cheung","psa":"David B. Yaden","ptype":"editorial","src":"https://openalex.org/W4390611559","eid":"W4390611559"},{"id":"paper-w3194993653","cat":"papers","name":"Inclusion of People of Color in Psychedelic-Assisted Psychotherapy: A Review of the Literature","year":"2018","cit":6,"pfa":"Timothy I. Michaels","psa":"Monnica T. Williams","topics":["Reviews & meta-analyses","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W3194993653","eid":"W3194993653"},{"id":"paper-w4387047645","cat":"papers","name":"Psychedelic-assisted Psychotherapy in 3-D: Acceptance, Connectedness, and Defensiveness","year":"2023","cit":6,"pfa":"Lawrence G. Fischman","topics":["PTSD & trauma","Anxiety & end-of-life","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4387047645","eid":"W4387047645"},{"id":"paper-w4376134384","cat":"papers","name":"Exploring the Potential Utility of Psychedelic Therapy for Patients With Amyotrophic Lateral Sclerosis","year":"2023","cit":6,"pfa":"Noah D. Gold","psa":"Stephen Ross","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4376134384","eid":"W4376134384"},{"id":"paper-w4401981685","cat":"papers","name":"Understanding Psychedelic-Assisted Psychotherapy Providers’ Perspective and Insights: A Qualitative Analysis","year":"2024","cit":6,"pfa":"Crystal Lederhos Smith","psa":"John M. Roll","topics":["Safety & adverse events","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4401981685","eid":"W4401981685"},{"id":"paper-w2916249111","cat":"papers","name":"Psychedelic therapy in the Czech Republic: A theoretical concept or a realistic goal?","year":"2019","cit":6,"pfa":"Zuzana Postránecká","psa":"Filip Tylš","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2916249111","eid":"W2916249111"},{"id":"paper-w4411021677","cat":"papers","name":"Leveraging family and caregiver support in psychedelic-assisted therapy: considerations for the treatment of adolescents","year":"2025","cit":6,"pfa":"Sarah Forsberg","psa":"Marissa Raymond‐Flesch","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4411021677","eid":"W4411021677"},{"id":"paper-w4412514554","cat":"papers","name":"Rethinking placebo-controlled clinical trials in psychedelic therapies for psychiatric illness","year":"2025","cit":6,"pfa":"Amy Lehrner","psa":"Rachel Yehuda","ptype":"article","src":"https://openalex.org/W4412514554","eid":"W4412514554"},{"id":"paper-w3000674126","cat":"papers","name":"Integrating contextual behavioral science with research on psychedelic assisted therapy: Introduction to the special section","year":"2020","cit":6,"pfa":"Jason B. Luoma","psa":"Lance M. McCracken","ptype":"article","src":"https://openalex.org/W3000674126","eid":"W3000674126"},{"id":"paper-w4395078240","cat":"papers","name":"Exploring psychedelic-assisted therapy in the treatment of functional seizures: A review of underlying mechanisms and associated brain networks","year":"2024","cit":6,"pfa":"Evan Cole Lewis","psa":"Elena Argento","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4395078240","eid":"W4395078240"},{"id":"paper-w4220734699","cat":"papers","name":"Interest in receiving psychedelic-assisted therapy among marginalized women: Implications and findings from a community-based study in Canada","year":"2022","cit":6,"pfa":"Elena Argento","psa":"Kate Shannon","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4220734699","eid":"W4220734699"},{"id":"paper-w3197017670","cat":"papers","name":"Ketamine-Assisted and Culturally Attuned Trauma Informed Psychotherapy as Adjunct to Traditional Indigenous Healing: Effecting Cultural Collaboration in Canadian Mental Health Care","year":"2021","cit":6,"pfa":"Sherry-Anne Muscat","psa":"Glenn Hartelius","topics":["Depression","PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3197017670","eid":"W3197017670"},{"id":"paper-w4322622776","cat":"papers","name":"Psychedelic Medicine's Future Depends on Proactive Development of a Robust Medical Billing and Coding Strategy","year":"2023","cit":6,"pfa":"Brian Scott Barnett","psa":"Andrey Ostrovsky","topics":["Dosing & pharmacology","Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4322622776","eid":"W4322622776"},{"id":"paper-w2904478412","cat":"papers","name":"The effect of ketamine on delirium and opioid-induced hyperalgesia in the Intensive Care Unit","year":"2018","cit":6,"pfa":"Christina J. Hayhurst","psa":"Christopher G. Hughes","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2904478412","eid":"W2904478412"},{"id":"paper-w4401759827","cat":"papers","name":"Psychedelics and psychoanalysis: The journey from talking cure to transformation","year":"2024","cit":6,"pfa":"Jonathan Lichtenstein","psa":"Nicholas R. Hoeh","topics":["Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4401759827","eid":"W4401759827"},{"id":"paper-w4389399662","cat":"papers","name":"Peer support and psychedelics","year":"2023","cit":6,"pfa":"Zach Skiles","psa":"Christopher S. Stauffer","topics":["Reviews & meta-analyses","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4389399662","eid":"W4389399662"},{"id":"paper-w4400479543","cat":"papers","name":"Novel treatments of depression: bridging the gap in current therapeutic approaches","year":"2024","cit":6,"pfa":"Amit Jagtiani","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4400479543","eid":"W4400479543"},{"id":"paper-w4280520428","cat":"papers","name":"Views on Using Psychoactive Substances to Self-Manage Functional Neurological Disorder: Online Patient Survey Results","year":"2022","cit":6,"pfa":"Matthew Butler","psa":"James Rucker","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4280520428","eid":"W4280520428"},{"id":"paper-w4401210839","cat":"papers","name":"The influence of stakeholder interests on safety outcome reporting in psychedelic research and implications for science communication","year":"2024","cit":6,"pfa":"Elena Koning","psa":"Elisa M. Brietzke","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4401210839","eid":"W4401210839"},{"id":"paper-w4414578814","cat":"papers","name":"Emerging Interventions in Behavioral Addictions: A Narrative Review of Psychedelics and Neuromodulation","year":"2025","cit":6,"pfa":"Krista Ulisse","psa":"James H. Berry","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4414578814","eid":"W4414578814"},{"id":"paper-w3043366879","cat":"papers","name":"2 The history of psychedelics in psychiatry","year":"2020","cit":6,"pfa":"Mike Jay","ptype":"article","src":"https://openalex.org/W3043366879","eid":"W3043366879"},{"id":"paper-w4308266180","cat":"papers","name":"(De)criminalisation of psychedelics in the Czech Republic—Where are we heading in drug policy and legislation?","year":"2022","cit":6,"pfa":"Tereza Dleštíková","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4308266180","eid":"W4308266180"},{"id":"paper-w4385273428","cat":"papers","name":"Microbiome: The Next Frontier in Psychedelic Renaissance","year":"2023","cit":6,"pfa":"Robert B. Kargbo","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4385273428","eid":"W4385273428"},{"id":"paper-w4403638627","cat":"papers","name":"Anxiety and Affective Symptoms Related to the Use of Classic Psychedelics: A Systematic Review","year":"2024","cit":6,"pfa":"Grace Viljoen","psa":"Felix Betzler","topics":["Anxiety & end-of-life","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4403638627","eid":"W4403638627"},{"id":"paper-w4400334025","cat":"papers","name":"Significant Psychedelic Experiences Evaluated for Mystical Characteristics Associated with Cannabis Use Reduction and Psychological Flexibility Improvement: A Naturalistic Cross-Sectional Retrospective Survey","year":"2024","cit":6,"pfa":"Bruno Roméo","psa":"Amine Benyamina","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4400334025","eid":"W4400334025"},{"id":"paper-w4401216555","cat":"papers","name":"Experiences of psychedelic drug use among people with psychotic symptoms and disorders: Personal growth and mystical experiences","year":"2024","cit":6,"pfa":"Joseph T. La Torre","psa":"Monnica T. Williams","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4401216555","eid":"W4401216555"},{"id":"paper-w4384153518","cat":"papers","name":"Confronting the figure of the “mad scientist” in psychedelic history: LSD’s use as a correctional tool in the postwar period","year":"2023","cit":6,"pfa":"Andrew Jones","topics":["Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4384153518","eid":"W4384153518"},{"id":"paper-w4404341874","cat":"papers","name":"Leveraging meditation research for the study of psychedelic-related adverse effects","year":"2024","cit":6,"pfa":"Roman Palitsky","psa":"Willoughby B. Britton","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4404341874","eid":"W4404341874"},{"id":"paper-w4205574383","cat":"papers","name":"Effective connectivity of LSD-induced ego dissolution","year":"2021","cit":6,"pfa":"Devon Stoliker","psa":"Adeel Razi","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4205574383","eid":"W4205574383"},{"id":"paper-w4406133128","cat":"papers","name":"Observational cohort study of a group-based VR program to improve mental health and wellbeing in people with life-threatening illnesses","year":"2025","cit":6,"pfa":"Hannes Kettner","psa":"Joseph L. Hardy","topics":["Depression","Anxiety & end-of-life","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4406133128","eid":"W4406133128"},{"id":"paper-w4396674778","cat":"papers","name":"Exploring effects and experiences of ketamine in group couples therapy","year":"2024","cit":6,"pfa":"Mark Cornfield","psa":"Monnica T. Williams","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4396674778","eid":"W4396674778"},{"id":"paper-w4378069990","cat":"papers","name":"Unlocking the self: Can microdosing psychedelics make one feel more authentic?","year":"2023","cit":6,"pfa":"Ioana Andreea Pop","psa":"Jannis Dinkelacker","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4378069990","eid":"W4378069990"},{"id":"paper-w2418048454","cat":"papers","name":"Do entheogen-induced mystical experiences boost the immune system? Psychedelics, peak experiences, and wellness.","year":"1999","cit":6,"pfa":"Thomas B. Roberts","ptype":"article","src":"https://openalex.org/W2418048454","eid":"W2418048454"},{"id":"paper-w2396685176","cat":"papers","name":"Hallucinogens","year":"2016","cit":6,"pfa":"James B. Hanks","psa":"Javier González‐Maeso","ptype":"book-chapter","src":"https://openalex.org/W2396685176","eid":"W2396685176"},{"id":"paper-w4254043282","cat":"papers","name":"Unpublicized Hallucinogens","year":"1967","cit":6,"pfa":"DAVID J. MULLER","ptype":"article","src":"https://openalex.org/W4254043282","eid":"W4254043282"},{"id":"paper-w2403897873","cat":"papers","name":"Nutmeg as an Hallucinogen","year":"1976","cit":6,"pfa":"R G Schulze","ptype":"article","src":"https://openalex.org/W2403897873","eid":"W2403897873"},{"id":"paper-w2472583736","cat":"papers","name":"Microdosing of protein drugs","year":"2015","cit":6,"pfa":"Malcolm Rowland","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2472583736","eid":"W2472583736"},{"id":"paper-w156585725","cat":"papers","name":"Microdose-mediated immune modulation","year":"1993","cit":6,"pfa":"A. M. Denman","psa":"John M. Grange","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W156585725","eid":"W156585725"},{"id":"paper-w113114368","cat":"papers","name":"Implications of untoward reactions to hallucinogens.","year":"1967","cit":6,"pfa":"EDWIN S. ROBBINS","psa":"Marvin Stern","ptype":"article","src":"https://openalex.org/W113114368","eid":"W113114368"},{"id":"paper-w4386827794","cat":"papers","name":"The Elephant in the Room: Personal Use of Psychedelics Among Psychedelic Researchers","year":"2023","cit":6,"pfa":"Peter S. Hendricks","psa":"Charles David Nichols","ptype":"editorial","src":"https://openalex.org/W4386827794","eid":"W4386827794"},{"id":"paper-w65486837","cat":"papers","name":"Fertility control with continuous microdose norgestrel.","year":"1972","cit":6,"pfa":"Laurie Re","psa":"Vladimir D. Korba","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W65486837","eid":"W65486837"},{"id":"paper-w2412929156","cat":"papers","name":"HALLUCINOGENS. TOOLS FOR RESEARCH OR THERAPEUTIC AGENTS.","year":"1963","cit":6,"pfa":"Charalampous Kd","psa":"John Kinross-Wright","ptype":"article","src":"https://openalex.org/W2412929156","eid":"W2412929156"},{"id":"paper-w4210811201","cat":"papers","name":"Psychedelics without hallucinations?","year":"2022","cit":6,"pfa":"Robert F. Service","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4210811201","eid":"W4210811201"},{"id":"paper-w1560933656","cat":"papers","name":"Psychedelics, psychosis and dreaming","year":"2001","cit":6,"pfa":"Solomon H. Snyder","ptype":"article","src":"https://openalex.org/W1560933656","eid":"W1560933656"},{"id":"paper-w4382777664","cat":"papers","name":"Psychedelics and neural plasticity","year":"2023","cit":6,"pfa":"Rachael L. Sumner","psa":"Kacper Łukasiewicz","topics":["Mechanism & neuroscience"],"ptype":"editorial","src":"https://openalex.org/W4382777664","eid":"W4382777664"},{"id":"paper-w2042593614","cat":"papers","name":"Analytical studies on some nitrogenous hallucinogens","year":"1980","cit":6,"pfa":"Nadia Gamal Zaki","psa":"M.O. Abdel-Rahman","ptype":"article","src":"https://openalex.org/W2042593614","eid":"W2042593614"},{"id":"paper-w4386866171","cat":"papers","name":"Psychedelics and the Neurobiology of Meaningfulness","year":"2023","cit":6,"pfa":"John Harrison Krystal","psa":"Alfred P. Kaye","ptype":"article","src":"https://openalex.org/W4386866171","eid":"W4386866171"},{"id":"paper-w4411920176","cat":"papers","name":"Psychedelic Trips: Travel Within the United States to Use Psychedelic Drugs After Legalization","year":"2025","cit":6,"pfa":"Joshua Curtis Black","psa":"Andrew A. Monte","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4411920176","eid":"W4411920176"},{"id":"paper-w2015230543","cat":"papers","name":"Response to Comments on ACCP Position Statement on Microdosing","year":"2007","cit":6,"pfa":"Joseph Bertino","psa":"Michae D. Reed","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2015230543","eid":"W2015230543"},{"id":"paper-w143018514","cat":"papers","name":"Electrophysiology of 5-HT2A Receptors and Relevance for Hallucinogen and Atypical Antipsychotic Drug Actions","year":"2008","cit":6,"pfa":"Evelyn K. Lambe","psa":"George K. Aghajanian","topics":["Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W143018514","eid":"W143018514"},{"id":"paper-w2316125469","cat":"papers","name":"The Psychedelic Experience: A Sociological Study.","year":"1973","cit":6,"pfa":"James M. Calonico","psa":"W. David Watts","ptype":"article","src":"https://openalex.org/W2316125469","eid":"W2316125469"},{"id":"paper-w4402726404","cat":"papers","name":"Artificial intelligence and psychedelic medicine","year":"2024","cit":6,"pfa":"Jerome J. Sarris","psa":"Daniel Perkins","topics":["Mechanism & neuroscience","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4402726404","eid":"W4402726404"},{"id":"paper-w4405613500","cat":"papers","name":"The Hallucinogen Rating Scale: Updated Factor Structure in a Large, Multistudy Sample","year":"2024","cit":6,"pfa":"Abigail E. Calder","psa":"Rick J. Strassman","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4405613500","eid":"W4405613500"},{"id":"paper-w4297493193","cat":"papers","name":"Psychedelic research and the real world","year":"2022","cit":6,"pfa":"Paul S. Appelbaum","ptype":"article","src":"https://openalex.org/W4297493193","eid":"W4297493193"},{"id":"paper-w4414168782","cat":"papers","name":"Psychedelic-Associated Depersonalization-Derealization Disorder","year":"2025","cit":6,"pfa":"Matthias Michal","ptype":"book-chapter","src":"https://openalex.org/W4414168782","eid":"W4414168782"},{"id":"paper-w2419043785","cat":"papers","name":"[Electrographic and behavioral effects of various hallucinogens in the free cat].","year":"1969","cit":6,"pfa":"Arlette Rougeul","psa":"A Letalle","ptype":"article","src":"https://openalex.org/W2419043785","eid":"W2419043785"},{"id":"paper-w2546598224","cat":"papers","name":"Evolving Ethics in Psychedelic Drug Taking","year":"1988","cit":6,"pfa":"Elvin D. Smith","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2546598224","eid":"W2546598224"},{"id":"paper-w1985971778","cat":"papers","name":"A positron emission tomography microdosing study with sertraline in healthy volunteers","year":"2012","cit":6,"pfa":"Kwang-Hee Shin","psa":"Kyung‐Sang Yu","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1985971778","eid":"W1985971778"},{"id":"paper-w2328772339","cat":"papers","name":"Do Psychedelics Have Religious Implications?","year":"1971","cit":6,"pfa":"Huston Smith","psa":"R. H. Prince","ptype":"article","src":"https://openalex.org/W2328772339","eid":"W2328772339"},{"id":"paper-w206989191","cat":"papers","name":"An Introduction To the Psychedelic Psychotherapy of Salvador Roquet","year":"1977","cit":6,"topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W206989191","eid":"W206989191"},{"id":"paper-w3177584466","cat":"papers","name":"Island: Aldous Huxley's Psychedelic Utopia","year":"1990","cit":6,"pfa":"Gorman Beauchamp","ptype":"article","src":"https://openalex.org/W3177584466","eid":"W3177584466"},{"id":"paper-w4414955417","cat":"papers","name":"Psychedelics, Eleusis, and the Invention of Religious Experience","year":"2025","cit":6,"pfa":"Sharday Catherine Mosurinjohn","psa":"Richard S. Ascough","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4414955417","eid":"W4414955417"},{"id":"paper-w2500308331","cat":"papers","name":"HALLUCINOGENS AND ATTENTIONAL DYSFUNCTION: A MODEL FOR DRUG EFFECTS AND REALITY TESTING","year":"1978","cit":6,"pfa":"Ronald K. Siegel","ptype":"book-chapter","src":"https://openalex.org/W2500308331","eid":"W2500308331"},{"id":"paper-w4410093655","cat":"papers","name":"How psychedelic experiences can cause, worsen, or resolve spiritual struggles: A mixed-methods study of psychedelic users.","year":"2025","cit":6,"pfa":"William A. Schutt","psa":"Kathleen C. Pait","ptype":"article","src":"https://openalex.org/W4410093655","eid":"W4410093655"},{"id":"paper-w4244974083","cat":"papers","name":"Consciousness, Religion, and Gurus: Pitfalls of Psychedelic Medicine","year":"2020","cit":6,"pfa":"Matthew W. Johnson","topics":["Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4244974083","eid":"W4244974083"},{"id":"paper-w4404196695","cat":"papers","name":"Religious Social Integration, Psychedelics, and Psychological Distress","year":"2024","cit":6,"pfa":"Sean M. Viña","topics":["Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4404196695","eid":"W4404196695"},{"id":"paper-w2788880545","cat":"papers","name":"β2-Adrenergic Receptor Activation Suppresses the Rat Phenethylamine Hallucinogen-Induced Head Twitch Response: Hallucinogen-Induced Excitatory Post-synaptic Potentials as a Potential Substrate","year":"2018","cit":6,"pfa":"Gerard J. Marek","psa":"Brian P. Ramos","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2788880545","eid":"W2788880545"},{"id":"paper-w2499528847","cat":"papers","name":"Research in psychedelic drug therapy: A critical analysis.","year":"1968","cit":6,"pfa":"Robert E. Mogar","ptype":"book-chapter","src":"https://openalex.org/W2499528847","eid":"W2499528847"},{"id":"paper-w4309197266","cat":"papers","name":"Psychedelic drugs: more emphasis on safety issues","year":"2022","cit":6,"pfa":"Florian Naudet","psa":"Ioana A. Cristea","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4309197266","eid":"W4309197266"},{"id":"paper-w4403978234","cat":"papers","name":"Framework for Microdosing Odors in Virtual Reality for Psychophysiological Stress Training","year":"2024","cit":6,"pfa":"Daniel Anheuer","psa":"Cornelia Küsel","topics":["Safety & adverse events","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4403978234","eid":"W4403978234"},{"id":"paper-w4252708500","cat":"papers","name":"Drug Addiction and Oral Health; A Comparison of Hallucinogen and NonHallucinogen Drug Users","year":"2016","cit":6,"pfa":"Taghi KM","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4252708500","eid":"W4252708500"},{"id":"paper-w2524235381","cat":"papers","name":"Abraham Maslow’s Interest in Psychedelic Research: A Tribute","year":"2016","cit":6,"pfa":"William A. Richards","ptype":"article","src":"https://openalex.org/W2524235381","eid":"W2524235381"},{"id":"paper-w2007300742","cat":"papers","name":"Epidemiologic issues pertinent to international regulation of 28 stimulant-hallucinogen drugs","year":"1986","cit":6,"pfa":"James Christopher Anthony","psa":"Alison M. Trinkoff","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2007300742","eid":"W2007300742"},{"id":"paper-w3038082671","cat":"papers","name":"Psychedelic drugs as new tools in psychiatric therapeutics","year":"2020","cit":6,"pfa":"Eduardo Ekman Schenberg","ptype":"article","src":"https://openalex.org/W3038082671","eid":"W3038082671"},{"id":"paper-w2922218499","cat":"papers","name":"The Witches' Ointment: The Secret History of Psychedelic Magic","year":"2015","cit":6,"pfa":"Thomas Hatsis","ptype":"book","src":"https://openalex.org/W2922218499","eid":"W2922218499"},{"id":"paper-w2110848840","cat":"papers","name":"Continuous microdose (0.3 mg) quingestanol acetate as an oral contraceptive agent","year":"1974","cit":6,"pfa":"Shelley Jubhari","psa":"Aquiles J. Sobrero","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2110848840","eid":"W2110848840"},{"id":"paper-w2069320464","cat":"papers","name":"Clinical microdose study of gossypol: Effect on sperm motility and renal function","year":"1988","cit":6,"pfa":"J. Frick","psa":"Natwar Raj Kalla","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2069320464","eid":"W2069320464"},{"id":"paper-w3016699155","cat":"papers","name":"Psychedelic Birth: Bodies, Boundaries and the Perception of Pain in the 1970s","year":"2020","cit":6,"pfa":"Wendy Kline","ptype":"article","src":"https://openalex.org/W3016699155","eid":"W3016699155"},{"id":"paper-w4387670228","cat":"papers","name":"Trait mindfulness and personality characteristics in a microdosing ADHD sample: a naturalistic prospective survey study","year":"2023","cit":6,"pfa":"Eline C. H. M. Haijen","psa":"Kim P. C. Kuypers","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4387670228","eid":"W4387670228"},{"id":"paper-w4388355487","cat":"papers","name":"Progressive Rock and Psychedelic Coding in the Work of Jimi Hendrix","year":"2000","cit":6,"pfa":"Sheila Whiteley","ptype":"book-chapter","src":"https://openalex.org/W4388355487","eid":"W4388355487"},{"id":"paper-w4412116181","cat":"papers","name":"Psychedelics and the Gut Microbiome: Unraveling the Interplay and Therapeutic Implications","year":"2025","cit":6,"pfa":"Xue Bing Wang","psa":"Xiaohui Wang","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4412116181","eid":"W4412116181"},{"id":"paper-w4390795044","cat":"papers","name":"How should psychotherapy proceed when adjoined with psychedelics?","year":"2024","cit":6,"pfa":"Marc J. Weintraub","psa":"David J. Miklowitz","topics":["Depression","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4390795044","eid":"W4390795044"},{"id":"paper-w4394873441","cat":"papers","name":"Trainees Unprepared for Advances in Psychedelic Medicine: A Survey Study","year":"2024","cit":6,"pfa":"Jamarie A. Geller","psa":"Avinash Hosanagar","topics":["Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4394873441","eid":"W4394873441"},{"id":"paper-w2966737886","cat":"papers","name":"Erratum: Making psychedelics into medicines: The politics and paradoxes of medicalization","year":"2021","cit":6,"pfa":"Tehseen N. Noorani","ptype":"erratum","src":"https://openalex.org/W2966737886","eid":"W2966737886"},{"id":"paper-w4302425406","cat":"papers","name":"Drivers of sorghum response to fertilizer microdosing on smallholder farms across Burkina Faso","year":"2022","cit":6,"pfa":"Yacouba Ouédraogo","psa":"Charles Louis Bielders","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4302425406","eid":"W4302425406"},{"id":"paper-w2904513772","cat":"papers","name":"Employing Synergistic Interactions of Virtual Reality and Psychedelics in Neuropsychopharmacology","year":"2018","cit":6,"pfa":"Matthew Moroz","psa":"Robin Lester Carhart-Harris","topics":["Dosing & pharmacology"],"ptype":"conference-paper","src":"https://openalex.org/W2904513772","eid":"W2904513772"},{"id":"paper-w2406738587","cat":"papers","name":"The possible role of tryptamine in brain function and its relationship to the actions of LSD-like hallucinogens.","year":"1974","cit":6,"pfa":"W. R. Wayne Martin","psa":"Jewell W. Sloan","ptype":"article","src":"https://openalex.org/W2406738587","eid":"W2406738587"},{"id":"paper-w2105809812","cat":"papers","name":"Psychedelic Trance: ritual, belief and transcendental experience in modern raves","year":"2009","cit":6,"pfa":"Panagiotis Papadimitropoulos","ptype":"article","src":"https://openalex.org/W2105809812","eid":"W2105809812"},{"id":"paper-w4400076439","cat":"papers","name":"Griby i Mukhi: A Historical Contextualization of the Esoteric Mushroom Religion of Moscow Conceptualism: Fungal Erotic Imagery of Entheogens and Insects","year":"2024","cit":6,"pfa":"Dennis G. Ioffe","ptype":"article","src":"https://openalex.org/W4400076439","eid":"W4400076439"},{"id":"paper-w2227371342","cat":"papers","name":"User perceptions of mental health consequences of hallucinogen use in self-identified spiritual contexts","year":"2015","cit":6,"pfa":"Petter Grahl Johnstad","topics":["Safety & adverse events","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2227371342","eid":"W2227371342"},{"id":"paper-w4382068885","cat":"papers","name":"Systematic review and rationale of using psychedelics in the treatment of cannabis use disorder","year":"2023","cit":6,"pfa":"Angela N. Phan","psa":"Garth E. Terry","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W4382068885","eid":"W4382068885"},{"id":"paper-w2032960729","cat":"papers","name":"An investigation regarding the action on diastase of microdoses of mercuric chloride when prepared with and without mechanical shock","year":"1946","cit":6,"pfa":"William Edgar Boyd","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2032960729","eid":"W2032960729"},{"id":"paper-w7156277488","cat":"papers","name":"Trump’s psychedelic executive order: president expands access to psychoactive drugs","year":"2026","cit":6,"pfa":"Rob Reddick","ptype":"article","src":"https://openalex.org/W7156277488","eid":"W7156277488"},{"id":"paper-w4380225095","cat":"papers","name":"Cortical Correlates of Psychedelic-Induced Shaking Behavior Revealed by Voltage Imaging","year":"2023","cit":6,"pfa":"Tobias Buchborn","psa":"Thomas Knöpfel","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4380225095","eid":"W4380225095"},{"id":"paper-w4393281734","cat":"papers","name":"Human pluripotent stem cells as a translational toolkit in psychedelic research in vitro","year":"2024","cit":6,"pfa":"José Alexandre Salerno","psa":"Stevens Kastrup Rehen","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4393281734","eid":"W4393281734"},{"id":"paper-w4366990186","cat":"papers","name":"Changes in Immature Reticulocytes Aid the Indirect Detection of Microdose Recombinant Erythropoietin Use in Men and Women","year":"2023","cit":6,"pfa":"Andreas Breenfeldt Andersen","psa":"Nikolai Baastrup Nordsborg","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4366990186","eid":"W4366990186"},{"id":"paper-w2291511782","cat":"papers","name":"Ex-post Impact Assessment of Fertilizer Microdosing as a Climate-Smart Technology in Sub-Saharan Africa","year":"2015","cit":6,"pfa":"Conrad Murendo","psa":"Meike Wollni","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"report","src":"https://openalex.org/W2291511782","eid":"W2291511782"},{"id":"paper-w3015882206","cat":"papers","name":"A Chemical Love Story: Considering Microdosing as Somatechnic Individuation Vis-à-Vis the Philosophy of Simondon","year":"2020","cit":6,"pfa":"Chantelle Gray","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3015882206","eid":"W3015882206"},{"id":"paper-w4385331269","cat":"papers","name":"CYP3A and CYP2C19 Activity Determined by Microdosed Probe Drugs Accurately Predict Voriconazole Clearance in Healthy Adults","year":"2023","cit":6,"pfa":"Amin Muhareb","psa":"Gerd Mikus","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4385331269","eid":"W4385331269"},{"id":"paper-w4313895193","cat":"papers","name":"Transcriptomic Analysis of Glycosylation and Neuroregulatory Pathways in Rodent Models in Response to Psychedelic Molecules","year":"2023","cit":6,"pfa":"Anup Mammen Oommen","psa":"Stephen Cunningham","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4313895193","eid":"W4313895193"},{"id":"paper-w4387607826","cat":"papers","name":"The Key Role of Intracellular 5-HT2A Receptors: A Turning Point in Psychedelic Research?","year":"2023","cit":6,"pfa":"Jacopo Sapienza","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4387607826","eid":"W4387607826"},{"id":"paper-w2082185310","cat":"papers","name":"Isomeric cyclopropyl ring-methylated homologs of trans-2-(2,5-dimethoxy-4-methylphenyl)cyclopropylamine, an hallucinogen analog","year":"1982","cit":6,"pfa":"James N. Jacob","psa":"David E. Nichols","ptype":"article","src":"https://openalex.org/W2082185310","eid":"W2082185310"},{"id":"paper-w2345334752","cat":"papers","name":"An Analysis of Risk Reduction among Organized Groups That Promote Marijuana and Psychedelic Drugs","year":"1995","cit":6,"pfa":"Shepherd M. Jenks","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2345334752","eid":"W2345334752"},{"id":"paper-w2006403098","cat":"papers","name":"What Can Neuroscience Tell Us About the Potential of Psychedelics in Healthcare? How the Neurophenomenology of Psychedelics Research Could Help us to Flourish Throughout Our Lives, as Well as to Enhance Our Dying","year":"2015","cit":6,"pfa":"Robin Mackenzie","topics":["Addiction","Anxiety & end-of-life","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2006403098","eid":"W2006403098"},{"id":"paper-w4408617043","cat":"papers","name":"Naturalistic psychedelic experiences and gender-based self-acceptance in transgender and gender-expansive people","year":"2025","cit":6,"pfa":"Skylar J. Gaughan","psa":"Jae M. Sevelius","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4408617043","eid":"W4408617043"},{"id":"paper-w4200484997","cat":"papers","name":"An age-period-cohort analysis of trends in psychedelic and ecstasy use in the Australian population","year":"2021","cit":6,"pfa":"Gary Chan","psa":"Janni Leung","ptype":"article","src":"https://openalex.org/W4200484997","eid":"W4200484997"},{"id":"paper-w4412654044","cat":"papers","name":"Narrating the psychoneuroimmunomodulatory properties of serotonin 5-HT2A receptor psychedelics from a transdiagnostic perspective","year":"2025","cit":6,"pfa":"Guillaume Thuery","psa":"Andrew Harkin","topics":["Mechanism & neuroscience","Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4412654044","eid":"W4412654044"},{"id":"paper-w3008619796","cat":"papers","name":"Perspectives on the phase 0 clinical trial of microdose administration of ABY-029 for fluorescence guided surgery: stability testing","year":"2020","cit":6,"pfa":"Kimberley S. Samkoe","psa":"Keith D. Paulsen","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"conference-paper","src":"https://openalex.org/W3008619796","eid":"W3008619796"},{"id":"paper-w2021311841","cat":"papers","name":"Treatment of Acute, Adverse Psychedelic Reactions: “I've Tripped And I Can't Get Down”","year":"1992","cit":6,"pfa":"Penny L. Miller","psa":"Steven Anderson","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2021311841","eid":"W2021311841"},{"id":"paper-w2098795163","cat":"papers","name":"ABUSE OF PSYCHOTOMIMETICS","year":"1968","cit":6,"pfa":"Finn Stener Jørgensen","ptype":"article","src":"https://openalex.org/W2098795163","eid":"W2098795163"},{"id":"paper-w3046756819","cat":"papers","name":"Automated GMP-Compliant Production of [68Ga]Ga-DO3A-Tuna-2 for PET Microdosing Studies of the Glucagon Receptor in Humans","year":"2020","cit":6,"pfa":"Michael Wagner","psa":"Irina Velikyan","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3046756819","eid":"W3046756819"},{"id":"paper-w1993091755","cat":"papers","name":"Conformational energy differences between side chain alkylated analogs of the hallucinogen 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane","year":"1980","cit":6,"pfa":"Herschel J. R. Weintraub","psa":"Stephen W. Fesik","ptype":"article","src":"https://openalex.org/W1993091755","eid":"W1993091755"},{"id":"paper-w4200392805","cat":"papers","name":"Recreational Psychedelic Users Frequently Encounter Complete Mystical Experiences: Trip Content and Implications for Wellbeing","year":"2021","cit":6,"pfa":"Tianhong Tim Qiu","psa":"John Paul Minda","topics":["Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4200392805","eid":"W4200392805"},{"id":"paper-w2909231057","cat":"papers","name":"Effect Of Fertilizer Microdosing And In Situ Moisture Conservation On Yield And Resource Use Efficiency Of Pearl Millet In Makueni County-Kenya","year":"2018","cit":6,"pfa":"Peter Musau Mutiso","topics":["Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W2909231057","eid":"W2909231057"},{"id":"paper-w4224065652","cat":"papers","name":"Psychedelics and Mental Health: An Alternative Strategy to Treat Mental Impairments Triggered or Aggravated by COVID-19.","year":"2022","cit":6,"pfa":"Vítor Bruno","psa":"Tânia Marcourakis","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4224065652","eid":"W4224065652"},{"id":"paper-w4391872589","cat":"papers","name":"Understanding marijuana use initiation vs. frequency of use on risk for hallucinogen use: testing for mediating mechanisms underlying the gateway hypothesis","year":"2024","cit":6,"pfa":"Thomas Walter Wojciechowski","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4391872589","eid":"W4391872589"},{"id":"paper-w2027633395","cat":"papers","name":"Psychotomimetic Agents Related to the Catecholamines","year":"1969","cit":6,"pfa":"Alexander T. Shulgin","ptype":"article","src":"https://openalex.org/W2027633395","eid":"W2027633395"},{"id":"paper-w4404158896","cat":"papers","name":"Psychedelic medicine and cultural responsiveness: A call for Aboriginal and Torres Strait Islander engagement in Australian clinical trials and practice","year":"2024","cit":6,"pfa":"Bianca Sebben","psa":"Vanessa L. Beesley","ptype":"article","src":"https://openalex.org/W4404158896","eid":"W4404158896"},{"id":"paper-w2782888429","cat":"papers","name":"Effets de la microdose sur la production du niébé, du mil et du sorgho en fonction la toposéquence","year":"2018","cit":6,"pfa":"Fatimata Saba","psa":"Adama Kabre","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2782888429","eid":"W2782888429"},{"id":"paper-w4379283575","cat":"papers","name":"Multiplexed trackable intratumor microdosing of the investigational STING agonist TAK-676 alone and in combination in the native tumor microenvironment of patients with head and neck cancer: A phase 0 trial.","year":"2023","cit":6,"pfa":"Karthik Rajasekaran","psa":"Richard A. Klinghoffer","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W4379283575","eid":"W4379283575"},{"id":"paper-w3195669168","cat":"papers","name":"Identification of seven psychedelic 2,5‐dimethoxy‐phenylethyl‐amine‐based designer drugs via benchtop 1 H nuclear magnetic resonance spectroscopy","year":"2021","cit":6,"pfa":"Juan Felipe Araneda","psa":"Susanne D. Riegel","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W3195669168","eid":"W3195669168"},{"id":"paper-w4386825504","cat":"papers","name":"The Psychedelic N , N -Dipropyltryptamine Prevents Seizures in a Mouse Model of Fragile X Syndrome via a Mechanism that Appears Independent of Serotonin and Sigma1 Receptors","year":"2023","cit":6,"pfa":"Richa Tyagi","psa":"Clinton Ernest Canal","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4386825504","eid":"W4386825504"},{"id":"paper-w4255884864","cat":"papers","name":"Psychotomimetic agent BZ (3-quinuclidinyl benzilate)","year":"2020","cit":6,"pfa":"Josef Fusek","psa":"Jan Misík","ptype":"book-chapter","src":"https://openalex.org/W4255884864","eid":"W4255884864"},{"id":"paper-w2412014361","cat":"papers","name":"Lack of Psychotomimetic Effect of Para-Methoxyphenylethylamine and 3,4-Dimethoxyphenylethylamine in Man","year":"1968","cit":6,"pfa":"Wm. T. Brown","psa":"I. Moser","ptype":"article","src":"https://openalex.org/W2412014361","eid":"W2412014361"},{"id":"paper-w2424897216","cat":"papers","name":"Dextromethorphan sites, sigma receptors, and the psychotomimetic effects of sigma opiates.","year":"1990","cit":6,"pfa":"J M Musacchio","psa":"Peter Canoll","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2424897216","eid":"W2424897216"},{"id":"paper-w2002345709","cat":"papers","name":"Differential Responses to an Anticholinergic Psychotomimetic (Ditran) in a Mixed Psychiatric Population","year":"2008","cit":6,"pfa":"Harry Neubauer","psa":"Donald M. Sundland","ptype":"article","src":"https://openalex.org/W2002345709","eid":"W2002345709"},{"id":"paper-w2070288751","cat":"papers","name":"Chemical factors influencing the psychotomimetic potency of glycolate esters","year":"1975","cit":6,"pfa":"Jesse Baumgold","psa":"Wayne P. Hoss","ptype":"article","src":"https://openalex.org/W2070288751","eid":"W2070288751"},{"id":"paper-w4409349026","cat":"papers","name":"Acute subjective effects of psychedelics in naturalistic group settings prospectively predict longitudinal improvements in trauma symptoms, trait shame, and connectedness among adults with childhood maltreatment historie","year":"2025","cit":6,"pfa":"C. J. Healy","psa":"Wendy M. D'Andrea","topics":["PTSD & trauma","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4409349026","eid":"W4409349026"},{"id":"paper-w2081267385","cat":"papers","name":"Response to Comment on \"Diverse Psychotomimetics Act Through a Common Signaling Pathway\"","year":"2004","cit":6,"pfa":"Per Svenningsson","psa":"Paul Greengard","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2081267385","eid":"W2081267385"},{"id":"paper-w1679698747","cat":"papers","name":"Human Plasma Concentrations of Tolbutamide and Acetaminophen Extrapolated from in vivo Animal Pharmacokinetics Using in vitro Human Hepatic Clearances and Simple Physiologically Based Pharmacokinetic Modeling for Radio-l","year":"2015","cit":6,"pfa":"Hiroshi Yamazaki","psa":"Toshihiko IKEDA","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1679698747","eid":"W1679698747"},{"id":"paper-w2469249684","cat":"papers","name":"Unity and covariance of perception and behavior. Perceptual variability: a predictor of psychotomimetic drug-induced behavior.","year":"1969","cit":6,"pfa":"Rainer Fischer","psa":"Philip Wisecup","ptype":"article","src":"https://openalex.org/W2469249684","eid":"W2469249684"},{"id":"paper-w3120164329","cat":"papers","name":"Does variation in trait schizotypy and frequency of cannabis use influence the acute subjective, cognitive and psychotomimetic effects of delta-9-tetrahydrocannabinol? A mega-analysis","year":"2021","cit":6,"pfa":"Abigail M. Freeman","psa":"Helen Valerie Curran","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3120164329","eid":"W3120164329"},{"id":"paper-w4391814529","cat":"papers","name":"ACD856, a novel positive allosteric modulator of Trk receptors, single ascending doses in healthy subjects: Safety and pharmacokinetics","year":"2024","cit":6,"pfa":"Boel Nilsson","psa":"Märta Segerdahl","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4391814529","eid":"W4391814529"},{"id":"paper-w2313214595","cat":"papers","name":"Introducing Biological Microdosimetry for Ionising Radiation","year":"2000","cit":6,"pfa":"Bobby R. Scott","psa":"H. Sch llnberger","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2313214595","eid":"W2313214595"},{"id":"paper-w1527282995","cat":"papers","name":"Addictive and Toxic Disorders","year":"2009","cit":6,"pfa":"Mayur Bodani","psa":"Michael D. Kopelman","topics":["Addiction"],"ptype":"other","src":"https://openalex.org/W1527282995","eid":"W1527282995"},{"id":"paper-w2090549014","cat":"papers","name":"A Diagnostic-Treatment Model for Effective Group Treatment of Drug Abusers","year":"1977","cit":6,"pfa":"Jerry P. Flanzer","psa":"Floyd A. Aprill","ptype":"article","src":"https://openalex.org/W2090549014","eid":"W2090549014"},{"id":"paper-w2015196954","cat":"papers","name":"Interactions of partial LSD analogs with behavioral disrupting effects of LSD and DMT in the rat","year":"1978","cit":6,"pfa":"Beverly Kovacic","psa":"Edward F. Domino","ptype":"article","src":"https://openalex.org/W2015196954","eid":"W2015196954"},{"id":"paper-w2079088321","cat":"papers","name":"The Treatment of Adolescent Phencyclidine (PCP) Abusers. Part II","year":"1980","cit":6,"pfa":"G. G. Deangelis","psa":"E. Goldstein","ptype":"article","src":"https://openalex.org/W2079088321","eid":"W2079088321"},{"id":"paper-w2009502672","cat":"papers","name":"Pharmacokinetic Bases for the Diagnosis and Treatment of Acute PCP Intoxication","year":"1980","cit":6,"pfa":"Alan K. Done","psa":"Joseph N. Miceli","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2009502672","eid":"W2009502672"},{"id":"paper-w4412453588","cat":"papers","name":"5-HT2A receptors shape whole-brain monoaminergic coherence in male mice","year":"2025","cit":6,"pfa":"Jasmine Jade Butler","psa":"Philippe De Deurwaerdère","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4412453588","eid":"W4412453588"},{"id":"paper-w2158512229","cat":"papers","name":"New Approaches to the Treatment of Heroin Addiction: STEPS (Sequential Treatment Employing Pharmacological Supports)","year":"1976","cit":6,"pfa":"Avram Goldsteln","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2158512229","eid":"W2158512229"},{"id":"paper-w2590022494","cat":"papers","name":"Hallucinogenic Drugs: A New Study Answers Old Questions about LSD","year":"2017","cit":6,"pfa":"Adam L. Halberstadt","ptype":"article","src":"https://openalex.org/W2590022494","eid":"W2590022494"},{"id":"paper-w1576319914","cat":"papers","name":"Land of the Living Sky with Diamonds: A Place for Radical Psychiatry?","year":"2007","cit":6,"pfa":"Erika Dyck","ptype":"article","src":"https://openalex.org/W1576319914","eid":"W1576319914"},{"id":"paper-w4389145778","cat":"papers","name":"Non‐Labeled, Stable Labeled, or Radiolabelled Approaches for Provision of Intravenous Pharmacokinetics in Humans: A Discussion Piece","year":"2023","cit":6,"pfa":"Graeme C. Young","psa":"Graeme B. Scarfe","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4389145778","eid":"W4389145778"},{"id":"paper-w640081541","cat":"papers","name":"Understanding Addiction Behaviours: Theoretical and Clinical Practice in Health and Social Care","year":"2011","cit":6,"pfa":"G. Hussein Rassool","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"book","src":"https://openalex.org/W640081541","eid":"W640081541"},{"id":"paper-w1587493533","cat":"papers","name":"Quantified LSD Effects on Ego Strength","year":"1967","cit":6,"pfa":"Amedeo S. Marrazzi","psa":"Thomas G. Bieter","ptype":"book-chapter","src":"https://openalex.org/W1587493533","eid":"W1587493533"},{"id":"paper-w2396423958","cat":"papers","name":"The synthesis of [14C]AZD5122. Incorporation of an IV 14C‐microtracer dose into a first in human study to determine the absolute oral bioavailability of AZD5122","year":"2016","cit":6,"pfa":"Michael J. Hickey","psa":"David J. Wilkinson","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2396423958","eid":"W2396423958"},{"id":"paper-w4386161773","cat":"papers","name":"Molecular Docking Assessment of Cathinones as 5-HT2AR Ligands: Developing of Predictive Structure-Based Bioactive Conformations and Three-Dimensional Structure-Activity Relationships Models for Future Recognition of Abus","year":"2023","cit":6,"pfa":"Nevena Tomašević","psa":"Milan P. Mladenović","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4386161773","eid":"W4386161773"},{"id":"paper-w2003713211","cat":"papers","name":"Effects of LSD-25 on avoidance behavior and locomotor activity in mice","year":"1979","cit":6,"pfa":"Claudio Castellano","ptype":"article","src":"https://openalex.org/W2003713211","eid":"W2003713211"},{"id":"paper-w3138557938","cat":"papers","name":"Mydriasis With Micro-Array Print Touch-Free Tropicamide-Phenylephrine Fixed Combination MIST: Pooled Randomized Phase III Trials","year":"2021","cit":6,"pfa":"David Wirta","psa":"Tsontcho Ianchulev","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3138557938","eid":"W3138557938"},{"id":"paper-w3110123519","cat":"papers","name":"Animal Safety, Toxicology, and Pharmacokinetic Studies According to the ICH S9 Guideline for a Novel Fusion Protein tTF-NGR Targeting Procoagulatory Activity into Tumor Vasculature: Are Results Predictive for Humans?","year":"2020","cit":6,"pfa":"Wolfgang E. Berdel","psa":"Christian Schwöppe","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3110123519","eid":"W3110123519"},{"id":"paper-w2032712511","cat":"papers","name":"College Mental Health and Social Change","year":"1970","cit":6,"pfa":"Dana L. Farnsworth","ptype":"article","src":"https://openalex.org/W2032712511","eid":"W2032712511"},{"id":"paper-w2084886451","cat":"papers","name":"Is Social Anxiety Disorder Unrecognized in Patients With Substance Dependence?","year":"2006","cit":6,"pfa":"Samar El-Sayegh","psa":"David J. Muzina","topics":["Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2084886451","eid":"W2084886451"},{"id":"paper-w2328902997","cat":"papers","name":"Natural History of Addiction in Psychotic Heroin-addicted Patients at Their First Agonist Opioid Treatment","year":"2012","cit":6,"pfa":"Angelo Giovanni Icro Maremmani","psa":"Icro Maremmani","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W2328902997","eid":"W2328902997"},{"id":"paper-w4224932137","cat":"papers","name":"Machine-learning aided in situ drug sensitivity screening predicts treatment outcomes in ovarian PDX tumors","year":"2022","cit":6,"pfa":"Max J. Cotler","psa":"Michael J. Cima","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4224932137","eid":"W4224932137"},{"id":"paper-w2067223209","cat":"papers","name":"Effects of harmaline on the visual system of the rat","year":"1971","cit":6,"pfa":"Arístides Rojas","psa":"Felipe Riobó","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2067223209","eid":"W2067223209"},{"id":"paper-w2553546933","cat":"papers","name":"Embryotoxicity of Harmaline and harmalol Hydrochloride on Pregnant Rats","year":"2016","cit":6,"pfa":"Mohaisen H. Adaay","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2553546933","eid":"W2553546933"},{"id":"paper-w2342356081","cat":"papers","name":"Possible Use of Paliperidone Palmitate in Ketamine Addiction.","year":"2015","cit":6,"pfa":"L. Pérez Gómez","psa":"G. Gutiérrez Vázquez","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2342356081","eid":"W2342356081"},{"id":"paper-w2600964397","cat":"papers","name":"Effets psychoactifs des « legal high » : à propos de l’acide lysergique amide (LSA)","year":"2017","cit":6,"pfa":"Camille Ponté","psa":"Maryse Lapeyre‐Mestre","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2600964397","eid":"W2600964397"},{"id":"paper-w2407451392","cat":"papers","name":"Sentinel Node Biopsy in Clinical Stage 1 Melanoma: Rationale for Restaging and Follow-Up","year":"2000","cit":6,"pfa":"N Mazzuca","psa":"Viviano Morini","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2407451392","eid":"W2407451392"},{"id":"paper-w2973047008","cat":"papers","name":"Family Aggregation of Substance Use Disorders: Substance Specific, Nonspecific, and Intrafamilial Sources of Risk","year":"2019","cit":6,"pfa":"Richard F. Farmer","psa":"Daniel N. Klein","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2973047008","eid":"W2973047008"},{"id":"paper-w2115315037","cat":"papers","name":"A PROSPECTIVE STUDY OF NON‐FATAL HEROIN OVERDOSE","year":"2008","cit":6,"pfa":"Daniel M Fatovich","psa":"F. Daly","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2115315037","eid":"W2115315037"},{"id":"paper-w2111218350","cat":"papers","name":"Phase 0 clinical trials: theoretical and practical implications in oncologic drug development","year":"2013","cit":6,"pfa":"Preciosa M. Coloma","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2111218350","eid":"W2111218350"},{"id":"paper-w3178830554","cat":"papers","name":"Trips and Neurotransmitters: Discovering Principled Patterns across 6,850 Hallucinogenic Experiences","year":"2021","cit":6,"pfa":"Galen Ballentine","psa":"Danilo Bzdok","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W3178830554","eid":"W3178830554"},{"id":"paper-w2942776144","cat":"papers","name":"A novel analytical method of TFMPP and mCPP in fluids of drug addicts using LLE-GC/NPD","year":"2019","cit":6,"pfa":"Yifei Ren","psa":"Hongxia Hao","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2942776144","eid":"W2942776144"},{"id":"paper-w4256462093","cat":"papers","name":"Nurse-Led Interventions in the De-Addiction Setting: Current State of Evidence","year":"2020","cit":6,"topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4256462093","eid":"W4256462093"},{"id":"paper-w2990599516","cat":"papers","name":"Neurophysiological effects of various music genres on electroencephalographic (EEG) cerebral cortex activity","year":"2019","cit":6,"pfa":"Abraham Hafiz Rodriguez","psa":"Norman Scott Litofsky","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2990599516","eid":"W2990599516"},{"id":"paper-w2114498793","cat":"papers","name":"Optimizing the preclinical/clinical interface: an Informa Life Sciences conference","year":"2007","cit":6,"pfa":"Icilio Cavero","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2114498793","eid":"W2114498793"},{"id":"paper-w4410310535","cat":"papers","name":"Neuropharmacology of Neurotransmitter Systems: Current Drugs and Their Effects on Neural and Neuroendocrine Pathways","year":"2025","cit":6,"pfa":"Xiaofeng Qi","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4410310535","eid":"W4410310535"},{"id":"paper-w4210272538","cat":"papers","name":"Reassessment of amphetamine- and phencyclidine-induced locomotor hyperactivity as a model of psychosis-like behavior in rats","year":"2022","cit":6,"pfa":"Snezana Kusljic","psa":"Andrea Gogos","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4210272538","eid":"W4210272538"},{"id":"paper-w1978909976","cat":"papers","name":"Schizophrenia: A Review of Diagnostic and Biological Issues II. Biological Issues","year":"1983","cit":6,"pfa":"Stephen I. Deutsch","psa":"Kenneth L. Davis","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1978909976","eid":"W1978909976"},{"id":"paper-w2068908775","cat":"papers","name":"Multiple 5‐HT receptors in the guinea‐pig superior cervical ganglion","year":"1996","cit":6,"pfa":"Clare J. Watkins","psa":"Nigel R. Newberry","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2068908775","eid":"W2068908775"},{"id":"paper-w4399326173","cat":"papers","name":"Initial clinical experience with the first-in-class anti-metastasis therapeutic TTX-MC138.","year":"2024","cit":6,"pfa":"Zdravka O. Medarova","psa":"Andreas S. Varkaris","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W4399326173","eid":"W4399326173"},{"id":"paper-w4402399395","cat":"papers","name":"Initiation and/or re-initiation of drug use among people who use drugs in Vancouver, Canada from 2021 to 2022: a prospective cohort study","year":"2024","cit":6,"pfa":"Anjali Sergeant","psa":"Kanna Hayashi","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4402399395","eid":"W4402399395"},{"id":"paper-w4410311075","cat":"papers","name":"Clinical Handbook of Psychotropic Drugs","year":"2025","cit":6,"topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"book","src":"https://openalex.org/W4410311075","eid":"W4410311075"},{"id":"paper-w2409539494","cat":"papers","name":"[Disruption of prepulse inhibition of acoustic startle as an animal model for schizophrenia].","year":"2000","cit":6,"pfa":"Shigeto Yamada","topics":["Mechanism & neuroscience","Reviews & meta-analyses","Policy & ethics"],"ptype":"other","src":"https://openalex.org/W2409539494","eid":"W2409539494"},{"id":"paper-w4252098122","cat":"papers","name":"THERAPEUTIC MECHANISMS OF KETAMINE","year":"2020","cit":6,"pfa":"Slobodan Mihaljević","psa":"Marko Čačić","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4252098122","eid":"W4252098122"},{"id":"paper-w2292732055","cat":"papers","name":"Short-Term Ketamine Treatment Decreases Oxidative Stress Without Influencing TRPM2 and TRPV1 Channel Gating in the Hippocampus and Dorsal Root Ganglion of Rats","year":"2016","cit":6,"pfa":"Arif Demirdaş","psa":"İshak Suat Övey","ptype":"article","src":"https://openalex.org/W2292732055","eid":"W2292732055"},{"id":"paper-w4385161861","cat":"papers","name":"Potential Roles for the GluN2D NMDA Receptor Subunit in Schizophrenia","year":"2023","cit":6,"pfa":"Chitra Vinnakota","psa":"Rachel Hill","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4385161861","eid":"W4385161861"},{"id":"paper-w2027576932","cat":"papers","name":"Nonpeptide Analogues of Dynorphin A(1−8): Design, Synthesis, and Pharmacological Evaluation of κ-Selective Agonists","year":"2000","cit":6,"pfa":"Giuseppe Ronsisvalle","psa":"Santi Mario Spampinato","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2027576932","eid":"W2027576932"},{"id":"paper-w2415464255","cat":"papers","name":"Quantitative structure-activity relationships in the 2,4,5-ring substituted phenylisopropylamines.","year":"1978","cit":6,"pfa":"Gary Anderson","psa":"kollman Pa","ptype":"article","src":"https://openalex.org/W2415464255","eid":"W2415464255"},{"id":"paper-w4384342281","cat":"papers","name":"Effects of opioid-free total intravenous anesthesia on postoperative nausea and vomiting after treatments of lower extremity wounds: protocol for a randomized double-blind crossover trial","year":"2023","cit":6,"pfa":"Yajuan Zhu","psa":"Ke Peng","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4384342281","eid":"W4384342281"},{"id":"paper-w4388869983","cat":"papers","name":"Supplemental low-dose esketamine to propofol versus propofol alone on perioperative characteristics in children undergoing surgery: a prospective randomized controlled trial","year":"2023","cit":6,"pfa":"Han Ding","psa":"Shoudong Pan","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4388869983","eid":"W4388869983"},{"id":"paper-w3192594239","cat":"papers","name":"Structural connectivity and subcellular changes after antidepressant doses of ketamine and Ro 25-6981 in the rat: an MRI and immuno-labeling study","year":"2021","cit":6,"pfa":"Raquel Pascual-Antón","psa":"Albert Adell","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3192594239","eid":"W3192594239"},{"id":"paper-w4323045317","cat":"papers","name":"Cannabidiol enhances cerebral glucose utilization and ameliorates psychopathology and cognition: A case report in a clinically high-risk mental state","year":"2023","cit":6,"pfa":"Dagmar Koethe","psa":"F. Markus Leweke","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4323045317","eid":"W4323045317"},{"id":"paper-w204744619","cat":"papers","name":"[Current aspects of using ketamine in childhood].","year":"1998","cit":6,"pfa":"A D Krüger","topics":["Depression","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W204744619","eid":"W204744619"},{"id":"paper-w3001515762","cat":"papers","name":"The effects of cannabidiol on cue- and stress-induced reinstatement of cocaine seeking behavior in mice are reverted by the CB1 receptor antagonist AM4113","year":"2020","cit":6,"pfa":"Miguel Ángel Luján","psa":"Olga Valverde","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W3001515762","eid":"W3001515762"},{"id":"paper-w2765894187","cat":"papers","name":"Distinct retrosplenial cortex cell populations and their spike dynamics during ketamine-induced unconscious state","year":"2017","cit":6,"pfa":"Grace E. Fox","psa":"Joe Z. Tsien","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2765894187","eid":"W2765894187"},{"id":"paper-w4388719689","cat":"papers","name":"Study protocol for Ketamine as an adjunctive therapy for major depression (2): a randomised controlled trial (KARMA-Dep [2])","year":"2023","cit":6,"pfa":"Ana Jelovac","psa":"Declan M. McLoughlin","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4388719689","eid":"W4388719689"},{"id":"paper-w4392295517","cat":"papers","name":"Ketamine for Adults With Substance Use Disorders","year":"2024","cit":6,"pfa":"Khai Trieu Tran","psa":"Danielle MacDougall","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4392295517","eid":"W4392295517"},{"id":"paper-w3193307905","cat":"papers","name":"Management of Opioid Agonist Treatment for Opioid Use Disorder in the Setting of Solid Organ Transplant","year":"2021","cit":6,"pfa":"Kayla Joyal","psa":"Georgina Waldman","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3193307905","eid":"W3193307905"},{"id":"paper-w3041017255","cat":"papers","name":"Three Months of Treatment With Esketamine","year":"2020","cit":6,"pfa":"Debra J. Stultz","psa":"Robin Walton","ptype":"article","src":"https://openalex.org/W3041017255","eid":"W3041017255"},{"id":"paper-w4323294568","cat":"papers","name":"TRKB interaction with PSD95 is associated with latency of fluoxetine and 2R,6R‐hydroxynorketamine","year":"2023","cit":6,"pfa":"Senem Merve Fred","psa":"Eero Ċastrén","topics":["Depression","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4323294568","eid":"W4323294568"},{"id":"paper-w2890738240","cat":"papers","name":"Now is the time for (2R,6R)-hydroxynorketamine to be viewed independently from its parent drug","year":"2018","cit":6,"pfa":"Shigeyuki Chaki","psa":"Junichi Yamaguchi","ptype":"article","src":"https://openalex.org/W2890738240","eid":"W2890738240"},{"id":"paper-w4402428790","cat":"papers","name":"A real-world pharmacovigilance study of esketamine nasal spray","year":"2024","cit":6,"pfa":"Yaqing Chen","psa":"Yong Chen","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4402428790","eid":"W4402428790"},{"id":"paper-w3018406703","cat":"papers","name":"Esketamine clinical trials: reply to Maju et al.","year":"2020","cit":6,"pfa":"Chiara Gastaldon","psa":"Corrado Barbui","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3018406703","eid":"W3018406703"},{"id":"paper-w2996769492","cat":"papers","name":"Dissociating the Clinical Role and Economic Value of Intranasal Esketamine","year":"2019","cit":6,"pfa":"David Dadiomov","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2996769492","eid":"W2996769492"},{"id":"paper-w4395465187","cat":"papers","name":"Perspectives in treatment-resistant depression: esketamine and electroconvulsive therapy","year":"2024","cit":6,"pfa":"P. Baldinger","psa":"Richard Frey","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4395465187","eid":"W4395465187"},{"id":"paper-w4399606127","cat":"papers","name":"Esketamine Exposure Impairs Cardiac Development and Function in Zebrafish Larvae","year":"2024","cit":6,"pfa":"Shuo Huang","psa":"Zhiyuan Chen","topics":["Safety & adverse events","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4399606127","eid":"W4399606127"},{"id":"paper-w4405680374","cat":"papers","name":"Arketamine alleviates cognitive impairments and demyelination in mice with postoperative cognitive dysfunction via TGF-β1 activation","year":"2024","cit":6,"pfa":"Tingting Zhu","psa":"Kenji Hashimoto","ptype":"article","src":"https://openalex.org/W4405680374","eid":"W4405680374"},{"id":"paper-w4366350976","cat":"papers","name":"Esketamine versus Sufentanil Applied Prior to Placement of Suspension Laryngoscope","year":"2023","cit":6,"pfa":"Yiying Zhang","psa":"Changsheng Huang","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4366350976","eid":"W4366350976"},{"id":"paper-w4409466518","cat":"papers","name":"Efficacy of perioperative esketamine on postoperative depression: a systematic review and meta-analysis","year":"2025","cit":6,"pfa":"Haoyan Li","psa":"Huanliang Wang","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W4409466518","eid":"W4409466518"},{"id":"paper-w4396814296","cat":"papers","name":"Barriers to Esketamine Nasal Spray Treatment Among Adults With Treatment-Resistant Depression","year":"2024","cit":6,"pfa":"Kruti Joshi","psa":"Lisa Harding","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4396814296","eid":"W4396814296"},{"id":"paper-w4412791421","cat":"papers","name":"Effect of ketamine and esketamine on RNA expression and its relevance for depression: A systematic review","year":"2025","cit":6,"pfa":"Claudia Pisanu","psa":"Alessandra Minelli","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4412791421","eid":"W4412791421"},{"id":"paper-w3093124387","cat":"papers","name":"The probability of response after each subcutaneous injection of esketamine in treatment-resistant depression","year":"2020","cit":6,"pfa":"Victor Augusto Rodovalho Fava","psa":"Hugo Cogo‐Moreira","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W3093124387","eid":"W3093124387"},{"id":"paper-w4391264670","cat":"papers","name":"Loss of the sustained antidepressant-like effect of (2R,6R)-hydroxynorketamine in NMDA receptor GluN2D subunit knockout mice","year":"2024","cit":6,"pfa":"Aimi Yamagishi","psa":"Soichiro Ide","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4391264670","eid":"W4391264670"},{"id":"paper-w4393166479","cat":"papers","name":"Formulary Coverage of Esketamine and Ketamine for Depression in Ohio Health Insurance Marketplace and Medicaid Plans","year":"2024","cit":6,"pfa":"Brian Scott Barnett","topics":["Depression","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4393166479","eid":"W4393166479"},{"id":"paper-w4408168466","cat":"papers","name":"Esketamine attenuates traumatic brain injury by modulating STAT3-mediated Glycolysis and immune responses","year":"2025","cit":6,"pfa":"Yufang Liu","psa":"Xingzhi Liao","topics":["PTSD & trauma","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4408168466","eid":"W4408168466"},{"id":"paper-w4406183614","cat":"papers","name":"Prevention of sufentanil-induced cough during induction of general anesthesia by low-dose esketamine","year":"2025","cit":6,"pfa":"Xueyue Zhou","psa":"Jun Ji","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4406183614","eid":"W4406183614"},{"id":"paper-w4417361865","cat":"papers","name":"Esketamine/Ketamine: Dual‐Action Mechanisms and Clinical Prospects beyond Anesthesia in Psychiatry, Immunology, and Oncology","year":"2025","cit":6,"pfa":"Yinxin Wang","psa":"Zhen Yang","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4417361865","eid":"W4417361865"},{"id":"paper-w4400348028","cat":"papers","name":"Effects of perioperative application of esketamine on postpartum depression in cesarean section: A systematic review and meta-analysis","year":"2024","cit":6,"pfa":"Baoyu Ma","psa":"Shoushi Wang","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4400348028","eid":"W4400348028"},{"id":"paper-w4406657302","cat":"papers","name":"Intravenous esketamine in pediatric Rett syndrome: An open-label, early phase 1 pilot study","year":"2025","cit":6,"pfa":"Huiping Li","psa":"Xiu Xu","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4406657302","eid":"W4406657302"},{"id":"paper-w4410868221","cat":"papers","name":"Effect of Low-Dose Esketamine Combined with Propofol on Postoperative Fatigue in Colonoscopy: A Randomized Clinical Trial","year":"2025","cit":6,"pfa":"Xuemei Sun","psa":"Xuesheng Liu","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4410868221","eid":"W4410868221"},{"id":"paper-w4406130470","cat":"papers","name":"Effects of epidural esketamine versus sufentanil on labor analgesia and postpartum depression: a retrospective cohort study","year":"2025","cit":6,"pfa":"Kunyue Li","psa":"Tao Wang","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4406130470","eid":"W4406130470"},{"id":"paper-w4410132614","cat":"papers","name":"The effect of an intravenous analgesic pump with esketamine on postoperative pain and postpartum depression in women with cesarean section","year":"2025","cit":6,"pfa":"Hong Xiao","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4410132614","eid":"W4410132614"},{"id":"paper-w3195226188","cat":"papers","name":"A Clinical Rationale for Assessing the Impact of Childhood Sexual Abuse on Adjunctive Subcutaneous Esketamine for Treatment-Resistant Depression","year":"2021","cit":6,"pfa":"Eric Thomas Paiva Magalhães","psa":"Andréa F. Mello","topics":["Depression","Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3195226188","eid":"W3195226188"},{"id":"paper-w4402588804","cat":"papers","name":"Impact of different doses of esketamine on the incidence of hypotension in propofol-based sedation for colonoscopy: a randomized controlled trial","year":"2024","cit":6,"pfa":"Mengyue Fu","psa":"Yuanjing Chen","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4402588804","eid":"W4402588804"},{"id":"paper-w2911519626","cat":"papers","name":"Efficacy and safety of esketamine nasal spray plus an oral antidepressant in elderly patients with treatment-resistant depression","year":"2019","cit":6,"pfa":"Rachel Ochs-Ross","psa":"Jaskaran B. Singh","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2911519626","eid":"W2911519626"},{"id":"paper-w4224989421","cat":"papers","name":"Comparative Effectiveness of Intravenous Ketamine and Intranasal Esketamine in Real-World Setting Among Patients with Treatment Refractory Depression","year":"2022","cit":6,"pfa":"Balwinder Singh","psa":"Jennifer L. Vande Voort","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4224989421","eid":"W4224989421"},{"id":"paper-w2541937716","cat":"papers","name":"Comment on FDA's Breakthrough Therapy Designation of Intranasal Esketamine for the Treatment of Major Depressive Disorder with Imminent Risk of Suicide","year":"2016","cit":6,"pfa":"Reji Thomas","psa":"Serdar Murat Dursun","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2541937716","eid":"W2541937716"},{"id":"paper-w7117353905","cat":"papers","name":"Efficacy of esketamine in reducing nausea and vomiting after anesthesia: a systematic review and meta-analysis of randomized controlled trials","year":"2025","cit":6,"pfa":"Ling Fung Paul Tang","psa":"Jing Wang","topics":["Anxiety & end-of-life","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7117353905","eid":"W7117353905"},{"id":"paper-w4412046886","cat":"papers","name":"Comparison of the effects of esketamine/midazolam and remifentanil/midazolam on respiratory mechanics in mechanically ventilated patients with acute respiratory distress syndrome","year":"2025","cit":6,"pfa":"Dujuan Qiao","psa":"Linong Yao","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4412046886","eid":"W4412046886"},{"id":"paper-w4415196282","cat":"papers","name":"Esketamine improves postoperative sleep quality in women undergoing gynecological laparoscopy: A prospective, randomized, double-blind, and controlled trial","year":"2025","cit":6,"pfa":"Bo Yuan","psa":"Zhuan Zhang","ptype":"article","src":"https://openalex.org/W4415196282","eid":"W4415196282"},{"id":"paper-w4408301277","cat":"papers","name":"Repeated administration of esketamine ameliorates mechanical allodynia in mice with chemotherapy-induced peripheral neuropathy: A role of gut microbiota and metabolites","year":"2025","cit":6,"pfa":"Wei-Wei Luan","psa":"Xingming Wang","ptype":"article","src":"https://openalex.org/W4408301277","eid":"W4408301277"},{"id":"paper-w4413606286","cat":"papers","name":"The Impact of Esketamine on Depression: Targeting Oxidative Stress and Neuronal Apoptosis Through BDNF/TrkB/PI3K/AKT Pathway Activation","year":"2025","cit":6,"pfa":"Yueyi Zhang","psa":"Bei Zhang","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4413606286","eid":"W4413606286"},{"id":"paper-w4391251040","cat":"papers","name":"Differed spontaneous dissociative symptoms following the use of esketamine intranasal spray in a patient suffering from treatment-resistant depression: a case report","year":"2024","cit":6,"pfa":"Louis Chevalier","psa":"Andrew Laurin","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4391251040","eid":"W4391251040"},{"id":"paper-w4407390474","cat":"papers","name":"Esketamine mitigates endotoxin-induced hippocampal injury by regulating calcium transient and synaptic plasticity via the NF-α1/CREB pathway","year":"2025","cit":6,"pfa":"Mu Xu","psa":"Jianbo Yu","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4407390474","eid":"W4407390474"},{"id":"paper-w3126495858","cat":"papers","name":"Comparative efficacy and side-effect profile of ketamine and esketamine in the treatment of unipolar and bipolar depression: protocol for a systematic review and network meta-analysis","year":"2021","cit":6,"pfa":"Zhiqing Zhan","psa":"Bin Zhang","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W3126495858","eid":"W3126495858"},{"id":"paper-w4396561280","cat":"papers","name":"A Study on the Effects of Esketamine Combined with Comprehensive Nursing Intervention on Postoperative Pain, Postpartum Depression, and Quality of Life in Women Undergoing Cesarean Section.","year":"2024","cit":6,"pfa":"Mei Jiang","psa":"Jing Xu","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4396561280","eid":"W4396561280"},{"id":"paper-w4394400620","cat":"papers","name":"Brain-derived neurotrophic factor serum levels following ketamine and esketamine intervention for treatment-resistant depression: secondary analysis from a randomized trial","year":"2023","cit":6,"pfa":"Ana Teresa Caliman‐Fontes","psa":"Lucas C. Quarantini","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dataset","src":"https://openalex.org/W4394400620","eid":"W4394400620"},{"id":"paper-w4409249060","cat":"papers","name":"The Impact of Preoperative Low-Dose Esketamine and Dexmedetomidine Nasal Administration on the Emergence Delirium in Children Undergoing Fiber Bronchoscopy: A Prospective Randomized Controlled Trial","year":"2025","cit":6,"pfa":"Wei Xie","psa":"Li Wang","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4409249060","eid":"W4409249060"},{"id":"paper-w4414737950","cat":"papers","name":"The Comparison of the Efficacy of Esketamine Over Sufentanil to Reduce Postoperative Nausea and Vomiting in Gynecological Laparoscopic Surgery: A Prospective, Double-Blind, Randomized Controlled Trial","year":"2025","cit":6,"pfa":"Zhuolin Qiu","psa":"Xiang Li","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4414737950","eid":"W4414737950"},{"id":"paper-w4412113933","cat":"papers","name":"Efficacy of Intranasal Esketamine in Treatment‐Resistant Depression: A Six‐Month Real‐World Follow‐Up Study of Depressive Symptoms, Hopelessness, and Suicide Risk","year":"2025","cit":6,"pfa":"Maurizio Pompili","psa":"Isabella Berardelli","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4412113933","eid":"W4412113933"},{"id":"paper-w4285018246","cat":"papers","name":"Assessing the meaningful change threshold of Quality of Life in Depression Scale using data from two phase 3 studies of esketamine nasal spray","year":"2022","cit":6,"pfa":"Heather Rozjabek","psa":"Carol Jamieson","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4285018246","eid":"W4285018246"},{"id":"paper-w4361301479","cat":"papers","name":"Intermittent versus continuous esketamine infusions for long-term pain modulation in complex regional pain syndrome: protocol of a randomized controlled non-inferiority study (KetCRPS-2)","year":"2023","cit":6,"pfa":"Thomas J. P. Mangnus","psa":"Frank J.P.M. Huygen","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4361301479","eid":"W4361301479"},{"id":"paper-w4416769789","cat":"papers","name":"Efficacy and safety of esketamine for “treatment resistant depression”: registered report for a systematic review with an individual patient data meta-analysis of randomized, double-blind, placebo-controlled trials","year":"2025","cit":6,"pfa":"Florian Naudet","psa":"Ioana A. Cristea","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4416769789","eid":"W4416769789"},{"id":"paper-w2976183732","cat":"papers","name":"Molecular Modeling of the antagonist compound esketamine and its molecular docking study with non-competitive N-methyl-D-aspartate (NMDA) receptors NR1, NR2A, NR2B and NR2D","year":"2019","cit":6,"pfa":"Mehdi Nabati","psa":"Saman Sarshar","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2976183732","eid":"W2976183732"},{"id":"paper-w4385619296","cat":"papers","name":"An Intraoperative Sub-Anesthetic Dose of Esketamine on Postoperative Depressive Symptoms in Perimenopausal Women with Breast Cancer Undergoing Modified Radical Mastectomy: Protocol for a Randomized, Triple-Blinded, Contr","year":"2023","cit":6,"pfa":"Linlin Liu","psa":"Ke Peng","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4385619296","eid":"W4385619296"},{"id":"paper-w4288702534","cat":"papers","name":"Treatment response to esketamine nasal spray in patients with major depressive disorder and acute suicidal ideation or behavior without evidence of early response: a pooled post hoc analysis of ASPIRE","year":"2022","cit":6,"pfa":"Ibrahim Turkoz","psa":"Dong‐Jing Fu","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4288702534","eid":"W4288702534"},{"id":"paper-w4388086970","cat":"papers","name":"Indirect adjusted comparison of 6-month clinical outcomes between esketamine nasal spray and other real-world polypharmacy treatment strategies for treatment resistant depression: results from the ICEBERG study","year":"2023","cit":6,"pfa":"Albino Jorge Oliveira-Maia","psa":"Siobhán Mulhern-Haughey","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4388086970","eid":"W4388086970"},{"id":"paper-w4213274495","cat":"papers","name":"Time will tell. Reply to “Comments to pharmacological and behavioral divergence of ketamine enantiomers by Jordi Bonaventura et al.” by Chen et al.","year":"2022","cit":6,"pfa":"Jordi Bonaventura","psa":"Michael Michaelides","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4213274495","eid":"W4213274495"},{"id":"paper-w4396907243","cat":"papers","name":"Effect of Ketamine Treatment on Social Withdrawal in Autism and Autism-Like Conditions","year":"2024","cit":6,"pfa":"Megan Jayne Ralston","psa":"Elissa Cleland","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4396907243","eid":"W4396907243"},{"id":"paper-w4313334473","cat":"papers","name":"Ketamine-Induced Acute Interstitial Nephritis","year":"2022","cit":6,"pfa":"Michael Brucculeri","psa":"Helmut G. Rennke","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4313334473","eid":"W4313334473"},{"id":"paper-w2843670892","cat":"papers","name":"Synthesis of carbon‐14 labeled ketamine and norketamine","year":"2018","cit":6,"pfa":"Lu Chen","psa":"Rhys Salter","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2843670892","eid":"W2843670892"},{"id":"paper-w4405651300","cat":"papers","name":"Safety outcomes of ketamine for treatment-resistant depression in clinical settings and development of the ketamine side effect tool-revised (KSET-R)","year":"2024","cit":6,"pfa":"Adam J. Bayes","psa":"Colleen K A Loo","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4405651300","eid":"W4405651300"},{"id":"paper-w4393282826","cat":"papers","name":"Depression, an unmet health need in Africa: Understanding the promise of ketamine","year":"2024","cit":6,"pfa":"Aletta M. E. Millen","psa":"Sooraj Baijnath","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4393282826","eid":"W4393282826"},{"id":"paper-w4411194423","cat":"papers","name":"Non-prescribed ketamine use is rising in the UK","year":"2025","cit":6,"pfa":"Irene Guerrini","psa":"John Strang","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4411194423","eid":"W4411194423"},{"id":"paper-w4411411283","cat":"papers","name":"Opioid-Free Anesthesia Improved the Quality of Recovery After Thyroidectomy Through Pre-Emptive and Preventive Analgesia: A Randomized Controlled Trial","year":"2025","cit":6,"pfa":"Ye Zhang","psa":"Yun Lin WU","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4411411283","eid":"W4411411283"},{"id":"paper-w4283723068","cat":"papers","name":"Clinical use of ketamine in psychiatric disorders","year":"2022","cit":6,"pfa":"Sina Dehestani","psa":"Amirhossein Sahebkar","ptype":"article","src":"https://openalex.org/W4283723068","eid":"W4283723068"},{"id":"paper-w4410029104","cat":"papers","name":"New Agents in the Treatment of Psychiatric Disorders: What Innovations and in What Areas of Psychopathology?","year":"2025","cit":6,"pfa":"Paola Bozzatello","psa":"Silvio Bellino","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4410029104","eid":"W4410029104"},{"id":"paper-w4400459604","cat":"papers","name":"Utilization and outcomes of transcranial magnetic stimulation and usual care for MDD in a large group psychiatric practice","year":"2024","cit":6,"pfa":"Jesse Bastiaens","psa":"Tobias F. Marton","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4400459604","eid":"W4400459604"},{"id":"paper-w3112995693","cat":"papers","name":"Intraoperative Ketamine for the Opioid-Naïve Patients: Move Along Folks, Nothing to See Here?","year":"2020","cit":6,"pfa":"Anuj Bhatia","psa":"Steven Paul Cohen","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W3112995693","eid":"W3112995693"},{"id":"paper-w2083865784","cat":"papers","name":"LSD but not methysergide reduces the inhibitory effect of the medullary raphe stimulation on the spinal reflex in rats","year":"1984","cit":6,"pfa":"Tsugio Kaneko","psa":"Hideomi Fukuda","ptype":"article","src":"https://openalex.org/W2083865784","eid":"W2083865784"},{"id":"paper-w2047072607","cat":"papers","name":"No Difference Between Platelet Serotonin—5-HT 2A Receptors from Children With and Without ADHD","year":"1999","cit":6,"pfa":"Chanvit Pornnoppadol","psa":"Richard D. Todd","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2047072607","eid":"W2047072607"},{"id":"paper-w2442419124","cat":"papers","name":"Selective influence of ergot alkaloids on cortical and striatal dopaminergic and sergotonergic receptors.","year":"1980","cit":6,"pfa":"Myrna R. Rosenfeld","psa":"Robert Katzman","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2442419124","eid":"W2442419124"},{"id":"paper-w2077229301","cat":"papers","name":"Lysergic acid diethylamide.","year":"1966","cit":5,"pfa":"John Buckman","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2077229301","eid":"W2077229301"},{"id":"paper-w341594525","cat":"papers","name":"Lysergic Acid Diethylamide","year":"2014","cit":5,"pfa":"Christine M. Stork","psa":"B. Henriksen","ptype":"reference-entry","src":"https://openalex.org/W341594525","eid":"W341594525"},{"id":"paper-w2403437166","cat":"papers","name":"Lysergic acid diethylamide","year":"1965","cit":5,"pfa":"Brian O’Shea","psa":"J Fagan","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2403437166","eid":"W2403437166"},{"id":"paper-w2089577177","cat":"papers","name":"Possible biosynthesis of D-lysergic acid diethylamide-like compounds from mescaline","year":"1955","cit":5,"pfa":"R. Fischer","ptype":"article","src":"https://openalex.org/W2089577177","eid":"W2089577177"},{"id":"paper-w1986357444","cat":"papers","name":"Lysergic acid diethylamide intoxication.","year":"1968","cit":5,"pfa":"Henry Matthew","ptype":"article","src":"https://openalex.org/W1986357444","eid":"W1986357444"},{"id":"paper-w4412433881","cat":"papers","name":"Examining the potential of psilocybin and 5-MeO-DMT as therapeutics for traumatic brain injury","year":"2025","cit":5,"pfa":"Zoe Plummer","psa":"Brian R. Christie","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4412433881","eid":"W4412433881"},{"id":"paper-w2976380413","cat":"papers","name":"The metabolism of lysergic acid diethylamide.","year":"1959","cit":5,"pfa":"E S BOYD","ptype":"article","src":"https://openalex.org/W2976380413","eid":"W2976380413"},{"id":"paper-w1963726546","cat":"papers","name":"Field screening test for lysergic acid diethylamide","year":"1967","cit":5,"pfa":"James M Look","ptype":"article","src":"https://openalex.org/W1963726546","eid":"W1963726546"},{"id":"paper-w2087839287","cat":"papers","name":"A CASE OF FETISHISM TREATED WITH LYSERGIC ACID DIETHYLAMIDE","year":"1959","cit":5,"pfa":"J. D. A. Whitelaw","ptype":"article","src":"https://openalex.org/W2087839287","eid":"W2087839287"},{"id":"paper-w2018054798","cat":"papers","name":"The synthesis of 14C‐diethylamine and lysergic acid diethylamide","year":"1974","cit":5,"pfa":"Roger D. Barnes","ptype":"article","src":"https://openalex.org/W2018054798","eid":"W2018054798"},{"id":"paper-w1968700354","cat":"papers","name":"Ontogeny of the behavioral effects of lysergic acid diethylamide in cats","year":"1984","cit":5,"pfa":"Michael E. Trulson","psa":"Gailyn A. Howell","ptype":"article","src":"https://openalex.org/W1968700354","eid":"W1968700354"},{"id":"paper-w4392973065","cat":"papers","name":"Defining 5-MeO-DMT in Historical and Cultural Contexts","year":"2024","cit":5,"pfa":"Azul Delgrasso","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4392973065","eid":"W4392973065"},{"id":"paper-w4408996040","cat":"papers","name":"Clinical Research on Lysergic Acid Diethylamide (LSD) in Psychiatry and Neuroscience","year":"2025","cit":5,"pfa":"Hossein Omidian","psa":"Alborz Omidian","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4408996040","eid":"W4408996040"},{"id":"paper-w2028126509","cat":"papers","name":"Effect of Administration of Lysergic Acid Diethylamide on Serotonin-Levels in the Body","year":"1961","cit":5,"pfa":"D. V. Siva Sankar","psa":"Eleanor Gold","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2028126509","eid":"W2028126509"},{"id":"paper-w2036739753","cat":"papers","name":"Lowered ‘Capillary Resistance’ after Iontophoresis of Lysergic Acid Diethylamide","year":"1955","cit":5,"pfa":"E. L. BLAIR","psa":"P. ABMITAGE","ptype":"article","src":"https://openalex.org/W2036739753","eid":"W2036739753"},{"id":"paper-w2061642252","cat":"papers","name":"Lysergic acid diethylamide: antagonism of supraspinal inhibition of spinal reflexes","year":"1969","cit":5,"pfa":"Bradley V. Clineschmidt","psa":"Edmund G. Anderson","ptype":"article","src":"https://openalex.org/W2061642252","eid":"W2061642252"},{"id":"paper-w2238109494","cat":"papers","name":"EFFECT OF LYSERGIC ACID DIETHYLAMIDE (LSD-25) ON IMPULSE CONTROL","year":"1960","cit":5,"pfa":"H. Aronson","psa":"Gerald D. Klee","ptype":"article","src":"https://openalex.org/W2238109494","eid":"W2238109494"},{"id":"paper-w2438707758","cat":"papers","name":"The analeptic action of lysergic acid diethylamide and d-amphetamine on reserpinesedated mice.","year":"1957","cit":5,"pfa":"R. M. Burton","psa":"A Goldin","ptype":"article","src":"https://openalex.org/W2438707758","eid":"W2438707758"},{"id":"paper-w2302292251","cat":"papers","name":"Peyote cult, mescaline hallucinations, and model psychosis.","year":"1967","cit":5,"pfa":"Louis Pelner","ptype":"article","src":"https://openalex.org/W2302292251","eid":"W2302292251"},{"id":"paper-w2187772571","cat":"papers","name":"EFFECT OF D-LYSERGIC ACID DIETHYLAMIDE ON HIGHER NERVOUS ACTIVITY IN BABOONS.","year":"1996","cit":5,"pfa":"Lagutina Ni","psa":"Norkina Ln","topics":["Depression","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2187772571","eid":"W2187772571"},{"id":"paper-w2401703897","cat":"papers","name":"Chromosome examinations after medically administered lysergic acid diethylamide and dextroamphetamine.","year":"1974","cit":5,"pfa":"L. F. Jarvik","psa":"E. Moralishvili","ptype":"article","src":"https://openalex.org/W2401703897","eid":"W2401703897"},{"id":"paper-w2066096254","cat":"papers","name":"Effects of Lysergic Acid Diethylamide on the Total Leukocytes and Eosinophils of the Female Rat","year":"1963","cit":5,"pfa":"Arthur M. Sackler","psa":"Sheldon B. Sparber","ptype":"article","src":"https://openalex.org/W2066096254","eid":"W2066096254"},{"id":"paper-w4409182182","cat":"papers","name":"Identification of two lysergic acid diethylamide analogs, 1-(3-(trimethylsilyl) propionyl) lysergic acid diethylamide (1S-LSD) and 1-(2-thienoyl)-6-allyl-nor-d-lysergic acid diethylamide (1T-AL-LAD), in paper sheet produ","year":"2025","cit":5,"pfa":"Rie Tanaka","psa":"Ruri Kikura‐Hanajiri","ptype":"article","src":"https://openalex.org/W4409182182","eid":"W4409182182"},{"id":"paper-w1992561160","cat":"papers","name":"Interaction of 5-hydroxytryptamine and d-lysergic acid diethylamide in the transcallosal response","year":"1968","cit":5,"pfa":"H.William Bond","psa":"Paul S. Guth","ptype":"article","src":"https://openalex.org/W1992561160","eid":"W1992561160"},{"id":"paper-w2414209851","cat":"papers","name":"Psychological response to d-lysergic acid diethylamide and its relationship to adrenochrome levels.","year":"2000","cit":5,"pfa":"Axel Hoffer","psa":"M. E. Mahon","ptype":"article","src":"https://openalex.org/W2414209851","eid":"W2414209851"},{"id":"paper-w2394599692","cat":"papers","name":"Therapeutic trial of lysergic Acid diethylamide (LSD) and thioridazine in chronic schizophrenia.","year":"1966","cit":5,"pfa":"Shirvaikar Rv","psa":"Kelkar Yw","ptype":"article","src":"https://openalex.org/W2394599692","eid":"W2394599692"},{"id":"paper-w2205630561","cat":"papers","name":"5-[3H]hydroxytryptamine and [3H]lysergic acid diethylamide binding to human platelets","year":"1992","cit":5,"pfa":"John R. Peters","psa":"A. David Smith","ptype":"book-chapter","src":"https://openalex.org/W2205630561","eid":"W2205630561"},{"id":"paper-w2326545970","cat":"papers","name":"EFFECT OF LYSERGIC ACID DIETHYLAMIDE [LSD-25] AND OTHER DRUGS ON TROPICAL FISH","year":"1963","cit":5,"pfa":"RICHARD D. CHESGICB","psa":"George Douglas Maier","ptype":"article","src":"https://openalex.org/W2326545970","eid":"W2326545970"},{"id":"paper-w1998580243","cat":"papers","name":"D-lysergic acid diethylamide (LSD)—Effect on biogenic amines excretion in man","year":"1973","cit":5,"pfa":"Fathy S Messiha","psa":"Stanislav Grof","ptype":"article","src":"https://openalex.org/W1998580243","eid":"W1998580243"},{"id":"paper-w2058214160","cat":"papers","name":"The Effect of Lysergic Acid Diethylamide on the White Blood Cell Count of the Guinea Pig.","year":"1958","cit":5,"pfa":"P. Härkönen","psa":"Yrjö Konttinen","ptype":"article","src":"https://openalex.org/W2058214160","eid":"W2058214160"},{"id":"paper-w1982321026","cat":"papers","name":"Pupil Dilatation in Normal and Schizophrenic Subjects Following Lysergic Acid Diethylamide Ingestion","year":"1958","cit":5,"pfa":"Harry Freeman","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1982321026","eid":"W1982321026"},{"id":"paper-w1964112964","cat":"papers","name":"Some test findings associated with susceptibility to psychosis induced by lysergic acid diethylamide","year":"1961","cit":5,"pfa":"Zdenek D. Pauk","psa":"Charles Shagass","ptype":"article","src":"https://openalex.org/W1964112964","eid":"W1964112964"},{"id":"paper-w4415961580","cat":"papers","name":"Mapping the phenomenology of intranasal 5-MeO-DMT in psychedelic-naïve healthy adults","year":"2025","cit":5,"pfa":"Anna O. Ermakova","psa":"Raphaël Millière","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4415961580","eid":"W4415961580"},{"id":"paper-w4417194611","cat":"papers","name":"5‐Methoxy‐ N , N ‐dimethyltryptamine (5‐MeO‐DMT) for alcohol use disorder: An open‐label, phase 2, proof‐of‐concept, clinical trial","year":"2025","cit":5,"pfa":"John Marsden","psa":"Mathieu Seynaeve","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4417194611","eid":"W4417194611"},{"id":"paper-w2057084935","cat":"papers","name":"The effects of intracranial administration of hallucinogens on operant behavior in the rat I. lysergic acid diethylamide","year":"1986","cit":5,"pfa":"David J. Mokler","psa":"Richard H. Rech","ptype":"article","src":"https://openalex.org/W2057084935","eid":"W2057084935"},{"id":"paper-w4308304334","cat":"papers","name":"5-MeO-DMT modifies innate behaviors and promotes structural neural plasticity in mice","year":"2022","cit":5,"pfa":"Sarah J. Jefferson","psa":"Alex C. Kwan","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4308304334","eid":"W4308304334"},{"id":"paper-w4311112540","cat":"papers","name":"Sleep-like state during wakefulness induced by psychedelic 5-MeO-DMT in mice","year":"2022","cit":5,"pfa":"Benjamin J. B. Bréant","psa":"Vladyslav V. Vyazovskiy","topics":["Depression","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4311112540","eid":"W4311112540"},{"id":"paper-w1972039488","cat":"papers","name":"Separation ofD-lysergic acid diethylamide derivatives using micellar electrokinetic capillary chromatography","year":"2000","cit":5,"pfa":"M. Nebojsa Djordjevic","psa":"Fabrice Houdiere","ptype":"article","src":"https://openalex.org/W1972039488","eid":"W1972039488"},{"id":"paper-w2094588004","cat":"papers","name":"Studies on the P-450 difference spectra induced by lysergic acid diethylamide in rat liver microsomes.","year":"1975","cit":5,"pfa":"Tetsukichi Niwaguchi","psa":"Takako Inoue","ptype":"article","src":"https://openalex.org/W2094588004","eid":"W2094588004"},{"id":"paper-w4239275189","cat":"papers","name":"Actions of d -Lysergic Acid Diethylamide and Its 2-Bromo Derivative on Heart of Venus mercenaria","year":"1957","cit":5,"pfa":"John H. Welsh","psa":"Anne C. McCoy","ptype":"article","src":"https://openalex.org/W4239275189","eid":"W4239275189"},{"id":"paper-w1972452284","cat":"papers","name":"Comparative aspects of selected psychoactive compounds: Biogenic amines, monoamine oxidase inhibitors, and lysergic acid diethylamide","year":"1968","cit":5,"pfa":"GORDON R. PSCHEIDT","ptype":"article","src":"https://openalex.org/W1972452284","eid":"W1972452284"},{"id":"paper-w1979042449","cat":"papers","name":"Inhibition of Cholinesterase Hydrolysis of Dihydromurexine by Lysergic Acid Diethylamide and its 2-Bromo Derivative: a Selective Relationship","year":"1958","cit":5,"pfa":"IRVING I. A. TABACHNICK","psa":"M. E. GRELIS","ptype":"article","src":"https://openalex.org/W1979042449","eid":"W1979042449"},{"id":"paper-w2067179213","cat":"papers","name":"Differential effects of lysergic acid diethylamide, methysergide, and cyproheptadine on modality-specific and nonspecific sensory evoked potentials","year":"1983","cit":5,"pfa":"Douglas M. Wilkison","psa":"Michael J. Hosko","ptype":"article","src":"https://openalex.org/W2067179213","eid":"W2067179213"},{"id":"paper-w2157288726","cat":"papers","name":"Peyote and Related Alkaloids XVI: Synthesis of 3,4,5-Trimethoxyphenylalanine, an Amino Acid Analog of Mescaline","year":"1973","cit":5,"pfa":"Manohar L. Sethi","psa":"Govind J. Kapadia","ptype":"article","src":"https://openalex.org/W2157288726","eid":"W2157288726"},{"id":"paper-w2083189256","cat":"papers","name":"Direct quantitative analysis of lysergic acid diethylamide (LSD) and 2,5-dimethoxy-4-methylamphetamine (STP) on thin-layer chromatograms","year":"1976","cit":5,"pfa":"Tetsukichi Niwaguchi","psa":"Takako Inoue","ptype":"article","src":"https://openalex.org/W2083189256","eid":"W2083189256"},{"id":"paper-w2403525433","cat":"papers","name":"Potential Therapeutic Effects of Psilocybin/Psilocin are Minimized While Possible Adverse Reactions are Overrated","year":"2014","cit":5,"pfa":"RAFAEL GUIMARÃES DOS SANTOS","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2403525433","eid":"W2403525433"},{"id":"paper-w577549255","cat":"papers","name":"A Method for Identification of Lysergic Acid Diethylamide (LSD) Using a Microscope Sampling Device with Fourier Transform Infrared (FT/IR) Spectroscopy","year":"1991","cit":5,"pfa":"HA Harris","psa":"T Kane","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W577549255","eid":"W577549255"},{"id":"paper-w4213059553","cat":"papers","name":"Lysergic acid diethylamide (LSD) promotes social behaviour through 5-HT 2A and ampa in the medial prefrontal cortex (MPFC)","year":"2021","cit":5,"pfa":"A. Markopoulos","psa":"Gabriella Gobbi","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4213059553","eid":"W4213059553"},{"id":"paper-w2407874509","cat":"papers","name":"[Studies on the problem of schizophrenia. IV. Distribution of C-14-radioactive lysergic acid diethylamide (C-14-LSD 25) in the animal organism].","year":"1958","cit":5,"pfa":"O H ARNOLD","psa":"H Leupold-Lowenthal","ptype":"article","src":"https://openalex.org/W2407874509","eid":"W2407874509"},{"id":"paper-w2009874376","cat":"papers","name":"Binding of [3H]lysergic Acid Diethylamide to Serotonin 5-HT2A Receptors and of [3H]paroxetine to Serotonin Uptake Sites in Platelets from Healthy Children, Adolescents and Adults","year":"1999","cit":5,"pfa":"Jeanette Sigurdh","psa":"Bruno Hägglöf","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2009874376","eid":"W2009874376"},{"id":"paper-w2082611456","cat":"papers","name":"Identification of Peyote via Major Non-Phenolic Peyote Alkaloids","year":"1974","cit":5,"pfa":"P.W.L. Lum","psa":"P. Lebish","ptype":"article","src":"https://openalex.org/W2082611456","eid":"W2082611456"},{"id":"paper-w2062339923","cat":"papers","name":"Histochemical studies on the mechanism of action of the hallucinogens d-lysergic acid diethylamide tartrate (LSD-25) and d-2-bromo-lysergic acid tartrate (BOL-148) in rat brain","year":"1963","cit":5,"pfa":"Totada R. Shanthaveerappa","psa":"Geoffrey H. Bourne","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2062339923","eid":"W2062339923"},{"id":"paper-w2411565494","cat":"papers","name":"[Structure of iboga alkaloids].","year":"1957","cit":5,"pfa":"Robert Goutarel","psa":"Janot Mm","ptype":"article","src":"https://openalex.org/W2411565494","eid":"W2411565494"},{"id":"paper-w2165554771","cat":"papers","name":"Preparation of Monoclonal Antibodies Reactive to a Hallucinogenic Drug, Psilocin","year":"2004","cit":5,"pfa":"Mitsune Yamaguchi","psa":"Hiroshi Hojo","ptype":"article","src":"https://openalex.org/W2165554771","eid":"W2165554771"},{"id":"paper-w4404295609","cat":"papers","name":"Cost-effectiveness of midomafetamine-assisted therapy (MDMA-AT) in chronic and treatment-resistant post-traumatic stress disorder of moderate or higher severity: A health-economic model","year":"2024","cit":5,"pfa":"Filip Stanicic","psa":"Debra de Angelo","topics":["Depression","PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4404295609","eid":"W4404295609"},{"id":"paper-w4392032671","cat":"papers","name":"Peyote in the Colonial Imagination","year":"2016","cit":5,"pfa":"Alexander Dawson","ptype":"other","src":"https://openalex.org/W4392032671","eid":"W4392032671"},{"id":"paper-w3202820902","cat":"papers","name":"The Biogeography of Peyote in South Texas","year":"1983","cit":5,"pfa":"George Morgan","ptype":"article","src":"https://openalex.org/W3202820902","eid":"W3202820902"},{"id":"paper-w3014530659","cat":"papers","name":"Salvinorin A as a Potential Medication for Stroke","year":"2019","cit":5,"pfa":"Grothusen John","psa":"Renyu Liu","ptype":"article","src":"https://openalex.org/W3014530659","eid":"W3014530659"},{"id":"paper-w2408463391","cat":"papers","name":"The synthesis of a new homologue of mescaline.","year":"2010","cit":5,"pfa":"P HEY","ptype":"article","src":"https://openalex.org/W2408463391","eid":"W2408463391"},{"id":"paper-w4400428397","cat":"papers","name":"Disrupting Substance Use Disorder: The Chemistry of Iboga Alkaloids","year":"2024","cit":5,"pfa":"Alexander J. Hughes","psa":"Steven D. Townsend","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4400428397","eid":"W4400428397"},{"id":"paper-w2411718298","cat":"papers","name":"[Psilocybin - public available psychodysleptic].","year":"2015","cit":5,"pfa":"Karolina Dydak","psa":"Halina Milnerowicz","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2411718298","eid":"W2411718298"},{"id":"paper-w4376851995","cat":"papers","name":"A review of psilocybin: chemistry, clinical uses and future research directions","year":"2023","cit":5,"pfa":"Eliza Jane Temple Milliken","psa":"Jenny Martin","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4376851995","eid":"W4376851995"},{"id":"paper-w4384939529","cat":"papers","name":"The History of MDMA","year":"2023","cit":5,"pfa":"Torsten Passie","topics":["Safety & adverse events","Therapy practice","Policy & ethics"],"ptype":"book","src":"https://openalex.org/W4384939529","eid":"W4384939529"},{"id":"paper-w2016346510","cat":"papers","name":"A preliminary report on the safety and pharmacokinetics of ibogaine","year":"1995","cit":5,"pfa":"Deborah C. Mash","psa":"Juan Sanchez‐Ramos","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2016346510","eid":"W2016346510"},{"id":"paper-w2127329675","cat":"papers","name":"Conformationally Constrained Analogs of Mescaline II","year":"1975","cit":5,"pfa":"Robert J. Wolters","psa":"N. S. TANNER","ptype":"article","src":"https://openalex.org/W2127329675","eid":"W2127329675"},{"id":"paper-w122767548","cat":"papers","name":"Ibogaine therapy for substance abuse disorders","year":"2010","cit":5,"pfa":"Deborah C. Mash","topics":["Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W122767548","eid":"W122767548"},{"id":"paper-w2055721532","cat":"papers","name":"388. The amino-acid analogue of mescaline","year":"1963","cit":5,"pfa":"Roy M. Acheson","psa":"V. C. Porter","ptype":"article","src":"https://openalex.org/W2055721532","eid":"W2055721532"},{"id":"paper-w4392169314","cat":"papers","name":"An Overview of Syntheses of Salvinorin A and its Analogues","year":"2024","cit":5,"pfa":"Soufian Tibouti","psa":"Louis Barriault","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4392169314","eid":"W4392169314"},{"id":"paper-w150087402","cat":"papers","name":"The peyote ceremony among the American Indians.","year":"1951","cit":5,"pfa":"Nolie Mumey","ptype":"article","src":"https://openalex.org/W150087402","eid":"W150087402"},{"id":"paper-w2484194416","cat":"papers","name":"DUAL EFFECTS OF LSD, MESCALINE AND DMT","year":"1978","cit":5,"pfa":"Wagner H. Bridger","psa":"David A. Gorelick","ptype":"book-chapter","src":"https://openalex.org/W2484194416","eid":"W2484194416"},{"id":"paper-w2950006264","cat":"papers","name":"Catharanthinol and dihydrocatharanthinol: two Iboga-class alkaloids","year":"2004","cit":5,"pfa":"Lionel Moisan","psa":"P. Thuéry","ptype":"article","src":"https://openalex.org/W2950006264","eid":"W2950006264"},{"id":"paper-w3007099556","cat":"papers","name":"The Origins of the Ayahuasca/Yagé Concept:","year":"2018","cit":5,"pfa":"Constantino Manuel Torres","ptype":"book-chapter","src":"https://openalex.org/W3007099556","eid":"W3007099556"},{"id":"paper-w2905367151","cat":"papers","name":"Ayahuasca and the Healing of Eating Disorders","year":"2018","cit":5,"pfa":"Marika Renelli","psa":"Adèle Lafrance","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W2905367151","eid":"W2905367151"},{"id":"paper-w2407293282","cat":"papers","name":"Sixty seconds on . . . psilocybin","year":"2016","cit":5,"pfa":"Nigel Hawkes","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2407293282","eid":"W2407293282"},{"id":"paper-w4399444087","cat":"papers","name":"Psilocin fosters neuroplasticity in iPSC-derived human cortical neurons","year":"2024","cit":5,"pfa":"Målin Schmidt","psa":"Philipp Koch","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4399444087","eid":"W4399444087"},{"id":"paper-w2410667591","cat":"papers","name":"Comparison of metabolism of mescaline and 3,4-dimethoxyphenylethylamine in humans.","year":"1971","cit":5,"pfa":"Charalampous Kd","ptype":"article","src":"https://openalex.org/W2410667591","eid":"W2410667591"},{"id":"paper-w3156750443","cat":"papers","name":"The Therapeutic Use of Ayahuasca in Grief","year":"2021","cit":5,"pfa":"Débora González","psa":"Maria Carmo Carvalho","ptype":"book-chapter","src":"https://openalex.org/W3156750443","eid":"W3156750443"},{"id":"paper-w2498493075","cat":"papers","name":"Pipe, Bible, and peyote among the Oglala Lakota","year":"1980","cit":5,"pfa":"Paul B. Steinmetz","ptype":"book","src":"https://openalex.org/W2498493075","eid":"W2498493075"},{"id":"paper-w2141957242","cat":"papers","name":"NOTE ON RICHARD SCHULTES‘«THE APPEAL OF PEYOTE.»","year":"1939","cit":5,"pfa":"Weston La Barre","ptype":"article","src":"https://openalex.org/W2141957242","eid":"W2141957242"},{"id":"paper-w637331395","cat":"papers","name":"Pharmacognostic studies of peyote and related psychoactive cacti","year":"1975","cit":5,"pfa":"Jan G. Bruhn","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W637331395","eid":"W637331395"},{"id":"paper-w2022195796","cat":"papers","name":"The development and validation of the methylenedioxymethamphetamine (MDMA) beliefs questionnaire (MDMA-BQ) in college students","year":"2008","cit":5,"pfa":"Michael S. Businelle","psa":"Amy L. Copeland","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2022195796","eid":"W2022195796"},{"id":"paper-w4321482687","cat":"papers","name":"Psilocybin for Treatment-Resistant Depression","year":"2023","cit":5,"pfa":"Bruno Roméo","psa":"Amine Benyamina","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4321482687","eid":"W4321482687"},{"id":"paper-w4408109557","cat":"papers","name":"Psilocin fosters neuroplasticity in iPSC-derived human cortical neurons","year":"2025","cit":5,"pfa":"Malin Schmidt","psa":"Philipp Koch","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W4408109557","eid":"W4408109557"},{"id":"paper-w4296804051","cat":"papers","name":"Evaluation of the In Vitro Wound-Healing Potential of Ayahuasca","year":"2022","cit":5,"pfa":"Joana Gonçalves","psa":"Ana Paula Duarte","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4296804051","eid":"W4296804051"},{"id":"paper-w4408739043","cat":"papers","name":"Structural basis for psilocybin biosynthesis","year":"2025","cit":5,"pfa":"Chunyan Meng","psa":"Baixing Wu","topics":["Depression","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4408739043","eid":"W4408739043"},{"id":"paper-w4280638934","cat":"papers","name":"PHARMACOKINETICS OF N,N-DIMETHYLTRYPTAMINE FUMARATE IN HUMANS","year":"2022","cit":5,"pfa":"Meghan Good","psa":"Ellen James","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4280638934","eid":"W4280638934"},{"id":"paper-w1619876621","cat":"papers","name":"Neuropsychiatric Alterations in MDMA Users","year":"2005","cit":5,"pfa":"Ronald I. Herning","psa":"Jean Lud Cadet","ptype":"article","src":"https://openalex.org/W1619876621","eid":"W1619876621"},{"id":"paper-w2904799681","cat":"papers","name":"The global expansion of ayahuasca through the Internet","year":"2018","cit":5,"pfa":"Matthew Conrad","topics":["Therapy practice","Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W2904799681","eid":"W2904799681"},{"id":"paper-w4315929105","cat":"papers","name":"Polyneurines A−H, iboga alkaloids from Tabernaemontana polyneura","year":"2023","cit":5,"pfa":"Sin-Yee Tang","psa":"Siew‐Huah Lim","ptype":"article","src":"https://openalex.org/W4315929105","eid":"W4315929105"},{"id":"paper-w2084792842","cat":"papers","name":"Facilitation of avoidance behaviour by LSD-25 and mescaline in hamsters","year":"1974","cit":5,"pfa":"Mario Sansone","psa":"Patrizia Messeri","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2084792842","eid":"W2084792842"},{"id":"paper-w2404625683","cat":"papers","name":"[Immunomodulator properties of ecstasy (MDMA)].","year":"2000","cit":5,"pfa":"Roberta Pacifici","psa":"R. de la Torre","topics":["Policy & ethics"],"ptype":"other","src":"https://openalex.org/W2404625683","eid":"W2404625683"},{"id":"paper-w2076141774","cat":"papers","name":"Mescaline-induced changes of brain-cortex ribosomes","year":"1973","cit":5,"pfa":"R. K. Datta","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2076141774","eid":"W2076141774"},{"id":"paper-w2063826354","cat":"papers","name":"Possible source of error in studies of enzymatic formation of dimethyltryptamine","year":"1976","cit":5,"pfa":"Helen Rosengarten","psa":"Arnold J. Friedhoff","ptype":"article","src":"https://openalex.org/W2063826354","eid":"W2063826354"},{"id":"paper-w4392242985","cat":"papers","name":"Impact of Psilocybin on Peripheral Cytokine Production","year":"2024","cit":5,"pfa":"Dana DiRenzo","psa":"Roland R. Griffiths","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4392242985","eid":"W4392242985"},{"id":"paper-w2046360300","cat":"papers","name":"Personality of Subjects Who Volunteer for Research on a Drug (Mescaline)","year":"1960","cit":5,"pfa":"Thomas W. Richards","ptype":"article","src":"https://openalex.org/W2046360300","eid":"W2046360300"},{"id":"paper-w2425523432","cat":"papers","name":"Influencing of Spatial Memory in Rats by DSP-4 and Mescaline","year":"1999","cit":5,"pfa":"Marie Koupilová","psa":"Otakar Krs","ptype":"article","src":"https://openalex.org/W2425523432","eid":"W2425523432"},{"id":"paper-w2769861949","cat":"papers","name":"MDMA (Ecstasy) and the rave: A review","year":"1998","cit":5,"pfa":"Roger E Alexander","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2769861949","eid":"W2769861949"},{"id":"paper-w2394551936","cat":"papers","name":"Chapter 11 Modulation of the effects of rewarding drugs by ibogaine","year":"2001","cit":5,"pfa":"Linda A. Parker","psa":"Shepard Siegel","ptype":"book-chapter","src":"https://openalex.org/W2394551936","eid":"W2394551936"},{"id":"paper-w3037166788","cat":"papers","name":"Accidental death involving psilocin from ingesting “magic mushroom”","year":"2020","cit":5,"pfa":"Uttam C Garg","psa":"Mary H. Dudley","ptype":"book-chapter","src":"https://openalex.org/W3037166788","eid":"W3037166788"},{"id":"paper-w4291677178","cat":"papers","name":"Therapeutic Potential of Salvinorin A and Its Analogues in Various Neurological Disorders.","year":"2022","cit":5,"pfa":"Joseph Cichon","psa":"Hoang V. Le","ptype":"article","src":"https://openalex.org/W4291677178","eid":"W4291677178"},{"id":"paper-w4411210736","cat":"papers","name":"Salvinorin A and Salvia divinorum: Toxicology, Pharmacological Profile, and Therapeutic Potential","year":"2025","cit":5,"pfa":"Sara Calado","psa":"Ana Paula Duarte","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4411210736","eid":"W4411210736"},{"id":"paper-w4324125719","cat":"papers","name":"Psilocybin therapy for depression. A good trip?","year":"2023","cit":5,"pfa":"James Rucker","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4324125719","eid":"W4324125719"},{"id":"paper-w2416951334","cat":"papers","name":"[Therapeutic effect of psilocybin on convulsive neurosis].","year":"1959","cit":5,"pfa":"Jean-Christian Delay","psa":"A M QUETIN","ptype":"article","src":"https://openalex.org/W2416951334","eid":"W2416951334"},{"id":"paper-w1035932889","cat":"papers","name":"'For export only': Ayahuasca tourism and hyper-traditionalism.","year":"2006","cit":5,"pfa":"Daniela M. Peluso","ptype":"article","src":"https://openalex.org/W1035932889","eid":"W1035932889"},{"id":"paper-w4313187856","cat":"papers","name":"Therapeutic Potential of Salvinorin A and Its Analogues in Various Neurological Disorders","year":"2022","cit":5,"pfa":"Cichon Joseph","psa":"Hoang V. Le","ptype":"article","src":"https://openalex.org/W4313187856","eid":"W4313187856"},{"id":"paper-w4236867577","cat":"papers","name":"Toxicity of Methylenedioxymethamphetamine (MDMA) in the Dog and the Rat","year":"1987","cit":5,"pfa":"Chris Frith","psa":"RICHARD DOBLIN","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4236867577","eid":"W4236867577"},{"id":"paper-w189251903","cat":"papers","name":"Man, plant, and religion : peyote trade on the Mustang Plains of Texas","year":"1976","cit":5,"pfa":"George Morgan","ptype":"article","src":"https://openalex.org/W189251903","eid":"W189251903"},{"id":"paper-w2023870879","cat":"papers","name":"Notes - Mescaline Analogs. VII. 3,4,5-Trimethyl-β-phenethylamine","year":"1957","cit":5,"pfa":"Frederick Benington","psa":"Leland C. Clark","ptype":"article","src":"https://openalex.org/W2023870879","eid":"W2023870879"},{"id":"paper-w4415017943","cat":"papers","name":"The translational potential of salvinorin A: systematic review and meta-analysis of preclinical studies","year":"2025","cit":5,"pfa":"Wolfgang Emanuel Zürrer","psa":"Benjamin Victor Ineichen","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W4415017943","eid":"W4415017943"},{"id":"paper-w3109402068","cat":"papers","name":"Ecstasy (MDMA): A rebellion coherent with the system","year":"2020","cit":5,"pfa":"José M. García‐Montes","psa":"Laura C. Sánchez-Sánchez","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3109402068","eid":"W3109402068"},{"id":"paper-w2745725592","cat":"papers","name":"Phonological Markers of Oxytocin and MDMA Ingestion","year":"2017","cit":5,"pfa":"Carla Agurto","psa":"Guillermo Cecchi","topics":["Dosing & pharmacology"],"ptype":"conference-paper","src":"https://openalex.org/W2745725592","eid":"W2745725592"},{"id":"paper-w2902122071","cat":"papers","name":"The economics of ayahuasca: money, markets, and the value of the vine","year":"2016","cit":5,"pfa":"Kenneth W. Tupper","topics":["Safety & adverse events","Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W2902122071","eid":"W2902122071"},{"id":"paper-w4240457647","cat":"papers","name":"Is there a case for MDMA-assisted psychotherapy in the UK?","year":"2006","cit":5,"pfa":"Ben Sessa","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4240457647","eid":"W4240457647"},{"id":"paper-w2414838772","cat":"papers","name":"Proceedings: Dimethyltryptamine: its biosynthesis and possible role in mental disease.","year":"1974","cit":5,"pfa":"Mandel Lr","ptype":"article","src":"https://openalex.org/W2414838772","eid":"W2414838772"},{"id":"paper-w4301398984","cat":"papers","name":"Conformational Landscape and Properties of Psilocybin: A Computational Approach","year":"2022","cit":5,"pfa":"Poonam Bhadoria","psa":"V. Ramanathan","ptype":"article","src":"https://openalex.org/W4301398984","eid":"W4301398984"},{"id":"paper-w2412830035","cat":"papers","name":"Ultraviolet Absorption Spectra of Mescaline Sulfate and β-Phenylethylamine Sulfate","year":"1946","cit":5,"pfa":"Kurt Salomon","psa":"Albert F. Bina","ptype":"article","src":"https://openalex.org/W2412830035","eid":"W2412830035"},{"id":"paper-w3153721312","cat":"papers","name":"Ayahuasca as an Addiction Treatment in Catalonia: Cognitive and Cultural Perspectives","year":"2021","cit":5,"pfa":"Ismael Apud","topics":["Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W3153721312","eid":"W3153721312"},{"id":"paper-w2625497072","cat":"papers","name":"How Postmortem Redistribution of MDMA in Acute Alcohol-MDMA Combined-Use Rats Change under Effects of Alcohol","year":"2017","cit":5,"pfa":"Man Liang","psa":"Liang Liu","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2625497072","eid":"W2625497072"},{"id":"paper-w4283698346","cat":"papers","name":"Methylenedioxymethamphetamine (MDMA)-Assisted Therapy in Hawaii: A Brief Review","year":"2022","cit":5,"pfa":"Ann M. Inouye","psa":"Aaron S. Wolfgang","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4283698346","eid":"W4283698346"},{"id":"paper-w4386958768","cat":"papers","name":"Expectancies for Subjective and Antidepressant Effects in Psilocybin Users","year":"2023","cit":5,"pfa":"Mitch Earleywine","psa":"Joseph Anthony De Leo","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W4386958768","eid":"W4386958768"},{"id":"paper-w2065181855","cat":"papers","name":"Effect of ventilation on removal of [14C]mescaline by perfused rabbit lung","year":"1977","cit":5,"pfa":"Robert A. Roth","psa":"C. N. Gillis","ptype":"article","src":"https://openalex.org/W2065181855","eid":"W2065181855"},{"id":"paper-w4245235474","cat":"papers","name":"Methamphetamine and MDMA Neurotoxicity: Biochemical and Molecular Mechanisms","year":"2014","cit":5,"pfa":"Verónica Bisagno","psa":"Jean Lud Cadet","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W4245235474","eid":"W4245235474"},{"id":"paper-w4281986024","cat":"papers","name":"Deaths associated with MDMA in the period 2000–2019","year":"2022","cit":5,"pfa":"Ragnhild Elén Gjulem Jamt","psa":"Vigdis Vindenes","ptype":"article","src":"https://openalex.org/W4281986024","eid":"W4281986024"},{"id":"paper-w4405137183","cat":"papers","name":"The many faces of psilocybin-related psychosis: A case series","year":"2024","cit":5,"pfa":"Yumin Kim","psa":"Paul Sasha Nestadt","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4405137183","eid":"W4405137183"},{"id":"paper-w3089864945","cat":"papers","name":"Psilocybin-assisted group therapy: A new hope for demoralization","year":"2020","cit":5,"pfa":"Peter S. Hendricks","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3089864945","eid":"W3089864945"},{"id":"paper-w2443429332","cat":"papers","name":"Genotoxic evaluations in Wistar rats of the hallucinogenic plant extract ayahuasca","year":"2016","cit":5,"pfa":"Aline Pic‐Taylor","psa":"Eloísa Dutra Caldas","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2443429332","eid":"W2443429332"},{"id":"paper-w2045261350","cat":"papers","name":"Perception of heading in abstinent MDMA and THC users","year":"2010","cit":5,"pfa":"M. Rizzo","psa":"G. J. Andersen","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2045261350","eid":"W2045261350"},{"id":"paper-w2050209375","cat":"papers","name":"Autoradiographic studies on the distribution of 3H-mescaline in the brain of the marmoset, Callithrix jacchus","year":"1976","cit":5,"pfa":"Hubert Korr","ptype":"article","src":"https://openalex.org/W2050209375","eid":"W2050209375"},{"id":"paper-w638101490","cat":"papers","name":"Ecstasy: PMMA, MDMA en hooggedoseerde pillen","year":"2015","cit":5,"pfa":"Raymond J.M. Niesink","psa":"Esther A. Croes","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W638101490","eid":"W638101490"},{"id":"paper-w2759057719","cat":"papers","name":"MDMA-assisted Psychotherapy for Posttraumatic Stress Disorder","year":"2015","cit":5,"pfa":"Felix Schuldt","topics":["PTSD & trauma","Therapy practice"],"ptype":"other","src":"https://openalex.org/W2759057719","eid":"W2759057719"},{"id":"paper-w2953067668","cat":"papers","name":"The Cactus and the Anthropologist: The Evolution of Cultural Expertise on the Entheogenic Use of Peyote in the United States","year":"2019","cit":5,"pfa":"Aurélien Bouayad","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2953067668","eid":"W2953067668"},{"id":"paper-w4399671641","cat":"papers","name":"Benzofuran Iboga‐Analogs Modulate Nociception and Inflammation in an Acute Mouse Pain Model","year":"2024","cit":5,"pfa":"Tuhin Bhattacharya","psa":"Surajit Sinha","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4399671641","eid":"W4399671641"},{"id":"paper-w4390722038","cat":"papers","name":"The antidepressant effects of vaporized N,N-Dimethyltryptamine: a preliminary report in treatment-resistant depression","year":"2024","cit":5,"pfa":"Marcelo Falchi-Carvalho","psa":"Fernanda Palhano-Fontes","topics":["Depression","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4390722038","eid":"W4390722038"},{"id":"paper-w1970950253","cat":"papers","name":"Toxic effect of MDMA on brain serotonin neurons","year":"1999","cit":5,"pfa":"Karl LR Jansen","psa":"ARW Forres","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1970950253","eid":"W1970950253"},{"id":"paper-w4223461155","cat":"papers","name":"Psilocybin increases brain network integration in patients with depression","year":"2022","cit":5,"topics":["Depression","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4223461155","eid":"W4223461155"},{"id":"paper-w4387825991","cat":"papers","name":"Chippiine, iboga, cleavamine, vobasine, and cytotoxic bisindole alkaloids from Tabernaemontana polyneura","year":"2023","cit":5,"pfa":"Sin-Yee Tang","psa":"Siew‐Huah Lim","ptype":"article","src":"https://openalex.org/W4387825991","eid":"W4387825991"},{"id":"paper-w311473200","cat":"papers","name":"Studies on Mescaline XII: Effects of Prior Administration of Various Psychotropic Drugs","year":"1962","cit":5,"pfa":"Paul Rajotte","psa":"Sidney Merlis","ptype":"book-chapter","src":"https://openalex.org/W311473200","eid":"W311473200"},{"id":"paper-w2558351690","cat":"papers","name":"Psilocybin in end of life care: Implications for further research","year":"2016","cit":5,"pfa":"Paul Summergrad","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2558351690","eid":"W2558351690"},{"id":"paper-w4409449430","cat":"papers","name":"Psilocybin has a narrow therapeutic window as an antidepressant treatment","year":"2025","cit":5,"pfa":"Lenka Seillier","psa":"Romana Šlamberová","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4409449430","eid":"W4409449430"},{"id":"paper-w2602873327","cat":"papers","name":"Ayahuasca et vulnérabilité chimique : à propos d’un cas","year":"2017","cit":5,"pfa":"Guillaume Hoizey","psa":"Marc Deveaux","ptype":"article","src":"https://openalex.org/W2602873327","eid":"W2602873327"},{"id":"paper-w1971368277","cat":"papers","name":"Species variation in blood pressure responses to mescaline: Evidence of histamine release","year":"1973","cit":5,"pfa":"Raymond F. Orzechowski","psa":"Frederick J. Goldstein","ptype":"article","src":"https://openalex.org/W1971368277","eid":"W1971368277"},{"id":"paper-w1998141885","cat":"papers","name":"The visionary cure of the addiction war? Ibogaine: social context, subcultural identity, and implications for drug policy","year":"2011","cit":5,"pfa":"James Rodger","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W1998141885","eid":"W1998141885"},{"id":"paper-w4323275663","cat":"papers","name":"Influence of adrenalectomy on the gut microbiome and MDMA-induced hyperthermia","year":"2023","cit":5,"pfa":"Amal Aburahma","psa":"Jon E. Sprague","ptype":"article","src":"https://openalex.org/W4323275663","eid":"W4323275663"},{"id":"paper-w4366963247","cat":"papers","name":"Natural vs. Synthetic Psilocybin: The Same or Completely Different?","year":"2023","cit":5,"pfa":"Amza Ali","psa":"Justin Grant","ptype":"book-chapter","src":"https://openalex.org/W4366963247","eid":"W4366963247"},{"id":"paper-w89123573","cat":"papers","name":"Farmacología y toxicidad de la MDMA (Éxtasis)","year":"1995","cit":5,"pfa":"Jordi Camı́","ptype":"article","src":"https://openalex.org/W89123573","eid":"W89123573"},{"id":"paper-w4391653423","cat":"papers","name":"Aggressive behaviours associated with MDMA and psychedelics: a narrative review","year":"2024","cit":5,"pfa":"Negar Sayrafizadeh","psa":"David Jonathan Castle","topics":["Addiction","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4391653423","eid":"W4391653423"},{"id":"paper-w4399634369","cat":"papers","name":"Synthesis and Biological Analysis of Iso-dimethyltryptamines in a Model of Light-Induced Retinal Degeneration","year":"2024","cit":5,"pfa":"Ethan J. Pazur","psa":"Peter Wipf","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4399634369","eid":"W4399634369"},{"id":"paper-w4401973643","cat":"papers","name":"Pharmacogenomics of 3,4-Methylenedioxymethamphetamine (MDMA): A Narrative Review of the Literature","year":"2024","cit":5,"pfa":"Guillaume Drevin","psa":"Chadi Abbara","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W4401973643","eid":"W4401973643"},{"id":"paper-w1980797447","cat":"papers","name":"The anti-addictive drug ibogaine modulates voltage-gated ion channels and may trigger cardiac arrhythmias","year":"2011","cit":5,"pfa":"Michael Kovar","psa":"Karlheinz Hilber","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1980797447","eid":"W1980797447"},{"id":"paper-w1136814671","cat":"papers","name":"a-Adrenergic receptors contribute to the acute effects of MDMA in humans","year":"2013","cit":5,"pfa":"C.M. Hysek","psa":"Matthias E. Liechti","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1136814671","eid":"W1136814671"},{"id":"paper-w4234788622","cat":"papers","name":"Long-Term Neuropsychiatric Consequences of \"Ecstasy\" (MDMA): A Review","year":"2002","cit":5,"pfa":"Alonso G. Montoya","psa":"Bruce Heimburger Price","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4234788622","eid":"W4234788622"},{"id":"paper-w2805995173","cat":"papers","name":"Effects of mescaline and delta 9 tetrahydro cannabinol on the auditory evoked responses in the cat","year":"1973","cit":5,"pfa":"Dipak Guha","psa":"S.N. Pradhan","ptype":"article","src":"https://openalex.org/W2805995173","eid":"W2805995173"},{"id":"paper-w2144265588","cat":"papers","name":"A Methodology for Studying Various Interpretations of the N,N-dimethyltryptamine-Induced Alternate Reality","year":"2006","cit":5,"pfa":"Marko A. Rodriguez","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2144265588","eid":"W2144265588"},{"id":"paper-w4200041309","cat":"papers","name":"Neuroprotective effects of thymoquinone against MDMA-induced neurotoxicity","year":"2021","cit":5,"pfa":"Mustafa NS.","psa":"Ahmad NZ.","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4200041309","eid":"W4200041309"},{"id":"paper-w1969051169","cat":"papers","name":"Effects of MDMA (ecstasy) use and abstention on serotonin neurons","year":"2002","cit":5,"pfa":"Liesbeth Reneman","psa":"Wim van den Brink","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1969051169","eid":"W1969051169"},{"id":"paper-w4392032043","cat":"papers","name":"From Solid to Frothy: Use of Peyote in the Cora and Huichol Easter in Western Mexico","year":"2016","cit":5,"pfa":"María Benciolini","psa":"Arturo Gutiérrez delÁngel","ptype":"other","src":"https://openalex.org/W4392032043","eid":"W4392032043"},{"id":"paper-w4313489829","cat":"papers","name":"Rapid Detection and Quantification of Hallucinogenic Salvinorin A in Commercial Salvia divinorum Products by DART-HRMS","year":"2022","cit":5,"pfa":"Megan Isabella Chambers","psa":"Rabi A. Musah","topics":["Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4313489829","eid":"W4313489829"},{"id":"paper-w2041548507","cat":"papers","name":"Does increasing stress change the behavioral action of mescaline from disruption to facilitation?","year":"1975","cit":5,"pfa":"David A. Gorelick","psa":"Wagner H. Bridger","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2041548507","eid":"W2041548507"},{"id":"paper-w2003924077","cat":"papers","name":"The in vitro inhibitory effect of psilocybin and related compounds on human cholinesterases","year":"1963","cit":5,"pfa":"Elmer K. Zsigmond","psa":"Francis F. Foldes","ptype":"article","src":"https://openalex.org/W2003924077","eid":"W2003924077"},{"id":"paper-w4414499137","cat":"papers","name":"Acute effects of MDMA, MDA, lysine-MDMA, and lysine-MDA in a randomized, double-blind, placebo-controlled, crossover trial in healthy participants","year":"2025","cit":5,"pfa":"Isabelle Straumann","psa":"Matthias E. Liechti","topics":["PTSD & trauma","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4414499137","eid":"W4414499137"},{"id":"paper-w4322496186","cat":"papers","name":"“Authorization? That's Outrageous:” Ayahuasca Environmental Legislation and Indigenous Populations in Brazil","year":"2023","cit":5,"pfa":"Beatriz Caiuby Labate","psa":"Igor Fernandes Antunes","topics":["Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W4322496186","eid":"W4322496186"},{"id":"paper-w2944447259","cat":"papers","name":"Ayahuasca-induzierte Psychose bei einem Patienten mit bipolarer Störung","year":"2019","cit":5,"pfa":"Nicolas Zellner","psa":"Jan C. Warninghoff","ptype":"article","src":"https://openalex.org/W2944447259","eid":"W2944447259"},{"id":"paper-w2791081540","cat":"papers","name":"A Single Dose Of Ayahuasca Modulates Salivary Cortisol In Treatment-Resistant Depression","year":"2018","cit":5,"pfa":"Ana Cecília de Menezes Galvão","psa":"Nicole Leite Galvão Coelho","topics":["Depression","Dosing & pharmacology","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W2791081540","eid":"W2791081540"},{"id":"paper-w4311648018","cat":"papers","name":"The content of complex psychedelic experiences resulting from inhalation of N,N-dimethyltryptamine","year":"2022","cit":5,"pfa":"Stephen Kagan","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4311648018","eid":"W4311648018"},{"id":"paper-w7131357000","cat":"papers","name":"Pilot study of psilocybin in patients with post-treatment lyme disease","year":"2026","cit":5,"pfa":"Albert Garcia‐Romeu","psa":"John N. Aucott","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7131357000","eid":"W7131357000"},{"id":"paper-w4389244819","cat":"papers","name":"The potential of keratinized matrices for the retrospective exploration of repeated ayahuasca use by patients","year":"2023","cit":5,"pfa":"Alexandr Gish","psa":"Gaël Le Roux","ptype":"article","src":"https://openalex.org/W4389244819","eid":"W4389244819"},{"id":"paper-w4404665633","cat":"papers","name":"The METEMP protocol: Massed exposure therapy enhanced with MDMA for PTSD","year":"2024","cit":5,"pfa":"Jessica L. Maples‐Keller","psa":"BARBARA OLASOV ROTHBAUM","topics":["PTSD & trauma","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4404665633","eid":"W4404665633"},{"id":"paper-w4205672632","cat":"papers","name":"Attenuated Psychotic Symptoms in Adolescents With Chronic Cannabis and MDMA Use","year":"2022","cit":5,"pfa":"Melina Felicitas Wiedmann","psa":"Yulia Golub","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4205672632","eid":"W4205672632"},{"id":"paper-w2097240309","cat":"papers","name":"Memory Performance in Abstinent 3,4-Methylenedioxymethamphetamine (Mdma, “Ecstasy”) Users","year":"2007","cit":5,"pfa":"Gary Groth‐Marnat","psa":"Ali Marsh","ptype":"article","src":"https://openalex.org/W2097240309","eid":"W2097240309"},{"id":"paper-w2089147946","cat":"papers","name":"MDMA as a clinical tool: a note of caution. A response to Sessa and Nutt","year":"2008","cit":5,"pfa":"AR Green","psa":"Kevin C.F. Fone","ptype":"article","src":"https://openalex.org/W2089147946","eid":"W2089147946"},{"id":"paper-w4400333801","cat":"papers","name":"Addressing a major interference in the quantification of psilocin in mouse plasma: Development of a validated liquid chromatography tandem mass spectrometry method","year":"2024","cit":5,"pfa":"Amir Khajavinia","psa":"Anas El‐Aneed","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4400333801","eid":"W4400333801"},{"id":"paper-w4414745551","cat":"papers","name":"Psilocybin with psychotherapeutic support for treatment-resistant depression: a pilot clinical trial","year":"2025","cit":5,"pfa":"Sally E Meikle","psa":"Susan Lee Rossell","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4414745551","eid":"W4414745551"},{"id":"paper-w2167592039","cat":"papers","name":"Paradoxical effects of low dose MDMA on latent inhibition in the rat","year":"2012","cit":5,"pfa":"Andrew J. D. Nelson","psa":"Helen Joan Cassaday","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2167592039","eid":"W2167592039"},{"id":"paper-w1966781051","cat":"papers","name":"B58 A RELIABLE MODEL OF INTRAVENOUS MDMA SELF-ADMINISTRATION IN MICE","year":"2005","cit":5,"pfa":"J.M. Trigo-D az","psa":"Patricia Robledo","ptype":"conference-abstract","src":"https://openalex.org/W1966781051","eid":"W1966781051"},{"id":"paper-w2085196452","cat":"papers","name":"Synthesis and Action on the Central Nervous System of Mescaline Analogues Containing Piperazine or Homopiperazine Rings","year":"1983","cit":5,"pfa":"Michał W. Majchrzak","psa":"Kazimierz Kowalczyk","ptype":"article","src":"https://openalex.org/W2085196452","eid":"W2085196452"},{"id":"paper-w1994146471","cat":"papers","name":"A New Digitized Method of the Compulsive Gnawing Test Revealed Dopaminergic Activity of Salvinorin AIn Vivo","year":"2010","cit":5,"pfa":"Stephen M. Phipps","psa":"Veronika Butterweck","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1994146471","eid":"W1994146471"},{"id":"paper-w4404387065","cat":"papers","name":"Mescaline-induced behavioral alterations are mediated by 5-HT2A and 5-HT2C receptors in rats","year":"2024","cit":5,"pfa":"Lucie Olejníková","psa":"Tomáš Páleníček","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4404387065","eid":"W4404387065"},{"id":"paper-w4313557238","cat":"papers","name":"The Therapeutic Potential of Psilocybin in Alcohol Use Disorder Recovery: A Literature Review","year":"2023","cit":5,"pfa":"Kaden Venugopal","psa":"Nefissa Bedri","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4313557238","eid":"W4313557238"},{"id":"paper-w4391991129","cat":"papers","name":"Synthesis and bioactivity of psilocybin analogues containing a stable carbon–phosphorus bond","year":"2024","cit":5,"pfa":"Marthe Vandevelde","psa":"Christian  Victor Stevens","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4391991129","eid":"W4391991129"},{"id":"paper-w4410022119","cat":"papers","name":"Cross-Species Evidence for Psilocin-Induced Visual Distortions: Apparent Motion Is Perceived by Both Humans and Rats","year":"2025","cit":5,"pfa":"Čestmír Vejmola","psa":"Tomáš Páleníček","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4410022119","eid":"W4410022119"},{"id":"paper-w2734175656","cat":"papers","name":"Por uma abordagem ecológica dos efeitos anti-depressivos da ayahuasca","year":"2017","cit":5,"pfa":"Danielli Katherine Pascoal da Silva","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2734175656","eid":"W2734175656"},{"id":"paper-w4410824431","cat":"papers","name":"The Potential Role of Psilocybin in Traumatic Brain Injury Recovery: A Narrative Review","year":"2025","cit":5,"pfa":"Charles Palmer","psa":"Brian David Greenwald","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"review","src":"https://openalex.org/W4410824431","eid":"W4410824431"},{"id":"paper-w7117561589","cat":"papers","name":"Time-resolved Neural and Experience Dynamics of Medium- and High-dose N,N-Dimethyltryptamine (DMT)","year":"2025","cit":5,"pfa":"Evan Lewis-Healey","psa":"Tristán Bekinschtein","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7117561589","eid":"W7117561589"},{"id":"paper-w2411609992","cat":"papers","name":"[Physiology of the 14C-radioactive mescaline in animal experiment. II. Distribution of radioactivity in organs in relation to time].","year":"1952","cit":5,"pfa":"Wolfram Block","psa":"Bernhard Patzig","ptype":"article","src":"https://openalex.org/W2411609992","eid":"W2411609992"},{"id":"paper-w2081456314","cat":"papers","name":"Ecstasy (3, 4-methylenedioxymethamphetamine, MDMA) related necrotising ulcerative gingivitis","year":"2009","cit":5,"pfa":"Jaume Miranda‐Rius","psa":"Eduard Lahor‐Soler","ptype":"article","src":"https://openalex.org/W2081456314","eid":"W2081456314"},{"id":"paper-w4286355111","cat":"papers","name":"El ritual de la Ayahuasca: patrimonio cultural nacional de Perú","year":"2022","cit":5,"pfa":"Rosa Giove","ptype":"article","src":"https://openalex.org/W4286355111","eid":"W4286355111"},{"id":"paper-w2794286050","cat":"papers","name":"Acute antidepressant effect of ayahuasca in juvenile non-human primate model of depression","year":"2018","cit":5,"pfa":"Flávia Santos da Silva","psa":"Nicole Leite Galvão Coelho","topics":["Depression","Addiction","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W2794286050","eid":"W2794286050"},{"id":"paper-w2549731540","cat":"papers","name":"Ecstasy research: will increasing observational data aid our understanding of MDMA?","year":"2016","cit":5,"pfa":"Tim Amoroso","ptype":"article","src":"https://openalex.org/W2549731540","eid":"W2549731540"},{"id":"paper-w56258514","cat":"papers","name":"Effects of various neuroleptics on rabbit hyperthermia induced by N, N-Dimethyltryptamine (DMT) and d-amphetamine.","year":"1977","cit":5,"pfa":"Edward F. Domino","psa":"Beverly Kovacic","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W56258514","eid":"W56258514"},{"id":"paper-w4308444860","cat":"papers","name":"Psilocybin reduces symptoms in treatment resistant depression, trial results show","year":"2022","cit":5,"pfa":"Gareth Iacobucci","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4308444860","eid":"W4308444860"},{"id":"paper-w3162880368","cat":"papers","name":"Role of acute social stress in the rewarding effects of MDMA in adolescent mice","year":"2021","cit":5,"pfa":"María Pilar García-Pardo","psa":"M.A. Aguilar","ptype":"article","src":"https://openalex.org/W3162880368","eid":"W3162880368"},{"id":"paper-w2323886621","cat":"papers","name":"Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder","year":"2008","cit":5,"pfa":"James C. Ballenger","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2323886621","eid":"W2323886621"},{"id":"paper-w3015121565","cat":"papers","name":"ELECTROCHEMICAL DETERMINATION OF N,N-DIMETHYLTRYPTAMINE IN WATER BASED ON TETRARUTHENATED PORPHYRINS AND IONIC LIQUID MODIFIED ELECTRODES","year":"2020","cit":5,"pfa":"Gonzalo Plaza","psa":"Karla Calfumán","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W3015121565","eid":"W3015121565"},{"id":"paper-w4391462932","cat":"papers","name":"Screening and confirmation of psilocin, mitragynine, phencyclidine, ketamine and ketamine metabolites by liquid chromatography–tandem mass spectrometry","year":"2024","cit":5,"pfa":"Madeleine E Wood","psa":"Jeffrey P. Walterscheid","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4391462932","eid":"W4391462932"},{"id":"paper-w2410375940","cat":"papers","name":"Lack of neurotoxicity after intra-raphe micro-injections of MDMA (\"ecstasy\").","year":"1990","cit":5,"pfa":"Joseph M. Paris","psa":"Kathryn A. Cunningham","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2410375940","eid":"W2410375940"},{"id":"paper-w2262516912","cat":"papers","name":"A Ritual Key to Mystical Solutions: Ayahuasca Therapy, Secularism, & the Santo Daime Religion in Belgium","year":"2013","cit":5,"pfa":"Marc G. Blainey","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2262516912","eid":"W2262516912"},{"id":"paper-w4255139263","cat":"papers","name":"One-Year Outcomes of Prenatal Exposure to MDMA and Other Recreational Drugs","year":"2012","cit":5,"topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4255139263","eid":"W4255139263"},{"id":"paper-w4400234012","cat":"papers","name":"Effects of psilocybin on body weight, body composition, and metabolites in male and female mice","year":"2024","cit":5,"pfa":"Jasmine Shakir","psa":"Zachary A. Cordner","ptype":"article","src":"https://openalex.org/W4400234012","eid":"W4400234012"},{"id":"paper-w2015792524","cat":"papers","name":"Impaired cognitive performance in drug free users of recreational ecstasy (MDMA)","year":"2000","cit":5,"pfa":"P. A T KELLY","ptype":"article","src":"https://openalex.org/W2015792524","eid":"W2015792524"},{"id":"paper-w2765930136","cat":"papers","name":"MDMA (Ecstasy/Molly) Use Among African Americans: Patterns of Initiation","year":"2017","cit":5,"pfa":"Khary K. Rigg","ptype":"article","src":"https://openalex.org/W2765930136","eid":"W2765930136"},{"id":"paper-w4402535787","cat":"papers","name":"Post mortem chiral analysis of MDMA and MDA in human blood and hair","year":"2024","cit":5,"pfa":"Julian Bickel","psa":"Stefanie Iwersen‐Bergmann","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4402535787","eid":"W4402535787"},{"id":"paper-w4283204986","cat":"papers","name":"Einstellungen von Expertinnen und Experten für psychische Gesundheit gegenüber Psilocybin","year":"2022","cit":5,"pfa":"Christopher Schmidt","psa":"Henrik Jungaberle","topics":["Depression","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4283204986","eid":"W4283204986"},{"id":"paper-w2946285292","cat":"papers","name":"T137. Psilocybin-Assisted Group Therapy for Demoralization in Long-Term AIDS Survivors","year":"2019","cit":5,"pfa":"Brian T. Anderson","psa":"Joshua D. Woolley","ptype":"conference-abstract","src":"https://openalex.org/W2946285292","eid":"W2946285292"},{"id":"paper-w3037215372","cat":"papers","name":"Gamma band alterations and REM-like traits underpin the acute effect of the atypical psychedelic ibogaine","year":"2020","cit":5,"pfa":"Joaqúın González","psa":"Pablo Torterolo","topics":["Addiction"],"ptype":"preprint","src":"https://openalex.org/W3037215372","eid":"W3037215372"},{"id":"paper-w2732564866","cat":"papers","name":"Inhibition of mirtazapine metabolism by Ecstasy (MDMA) in isolated perfused rat liver model","year":"2017","cit":5,"pfa":"Sanaz Jamshidfar","psa":"Mohammad Reza Rouini","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2732564866","eid":"W2732564866"},{"id":"paper-w2555390688","cat":"papers","name":"Acute ascending aortic dissection after MDMA/ecstasy use: A case report","year":"2016","cit":5,"pfa":"Satoko M. Kanahara","psa":"Rashed Tabbaa","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2555390688","eid":"W2555390688"},{"id":"paper-w2895569510","cat":"papers","name":"Uma bebida, muitas visões: apontamentos sociológicos sobre a II Conferência Mundial da Ayahuasca","year":"2018","cit":5,"pfa":"Glauber Loures de Assis","psa":"Jacqueline Alves Rodrigues","ptype":"article","src":"https://openalex.org/W2895569510","eid":"W2895569510"},{"id":"paper-w4309364316","cat":"papers","name":"Impact of fluoxetine preexposure on MDMA-induced taste avoidance in male and female rats.","year":"2022","cit":5,"pfa":"Sara K Bowman","psa":"Anthony Lee Riley","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4309364316","eid":"W4309364316"},{"id":"paper-w4406127324","cat":"papers","name":"Ayahuasca-assisted meaning reconstruction therapy for grief: a non-randomized clinical trial protocol","year":"2025","cit":5,"pfa":"Pablo Sabucedo","psa":"Débora González","topics":["PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4406127324","eid":"W4406127324"},{"id":"paper-w2936074596","cat":"papers","name":"Oxytocin as a mediator of the unique interoceptive effects of 3,4-Methylenedioxymethamphetamine (MDMA, \"Ecstasy\") in the rat","year":"2008","cit":5,"pfa":"Katherine Beringer","psa":"Jillian Helen Broadbear","ptype":"article","src":"https://openalex.org/W2936074596","eid":"W2936074596"},{"id":"paper-w4399975483","cat":"papers","name":"Bile acids and the gut microbiome are involved in the hyperthermia mediated by 3,4-methylenedioxymethamphetamine (MDMA)","year":"2024","cit":5,"pfa":"Srishti Rana","psa":"Jon E. Sprague","ptype":"article","src":"https://openalex.org/W4399975483","eid":"W4399975483"},{"id":"paper-w4414272692","cat":"papers","name":"Psilocybin ameliorates neuropathic pain-like behaviour in mice and facilitates gabapentin-mediated analgesia","year":"2026","cit":5,"pfa":"Tatum Askey","psa":"Maria Maiarù","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4414272692","eid":"W4414272692"},{"id":"paper-w3214521610","cat":"papers","name":"Ibogaine-Mediated ROS/Antioxidant Elevation in Isolated Rat Uterus Is β-Adrenergic Receptors and KATP Channels Mediated","year":"2021","cit":5,"pfa":"Nikola Tatalović","psa":"Duško P. Blagojević","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3214521610","eid":"W3214521610"},{"id":"paper-w2036915214","cat":"papers","name":"Serotonin transporter expression is not sufficient to confer cytotoxicity to 3,4-methylenedioxymethamphetamine (MDMA) in vitro","year":"2006","cit":5,"pfa":"Shaista Hayat","psa":"Marcus Rattray","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2036915214","eid":"W2036915214"},{"id":"paper-w4281769158","cat":"papers","name":"Espiritualidad y chamanismo: Rituales de ayahuasca bajo el giro subjetivo en Colombia","year":"2022","cit":5,"pfa":"Jean Paul Sarrazín","ptype":"article","src":"https://openalex.org/W4281769158","eid":"W4281769158"},{"id":"paper-w2106282476","cat":"papers","name":"Sexual Intercourse Experience and Engagement in Unprotected Sex in Adolescent MDMA Users in Taiwan","year":"2010","cit":5,"pfa":"Tzu‐Ting Chen","psa":"Cheng‐Fang Yen","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2106282476","eid":"W2106282476"},{"id":"paper-w2359628890","cat":"papers","name":"[Long-term neurotoxic effects of MDMA result in cortical and hippocampal structural changes].","year":"2006","cit":5,"pfa":"Su‐Xia Li","psa":"Mingsheng Huang","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W2359628890","eid":"W2359628890"},{"id":"paper-w2321444420","cat":"papers","name":"Self-administration of oxycodone alone or as a mixture with the kappa agonist, salvinorin a, by monkeys under a progressive ratio schedule of reinforcement","year":"2014","cit":5,"pfa":"Jennifer E. Naylor","psa":"Kevin B. Freeman","ptype":"article","src":"https://openalex.org/W2321444420","eid":"W2321444420"},{"id":"paper-w4224253073","cat":"papers","name":"In silico study of dimethyltryptamine analogues against 5-HT1B receptor: Molecular docking, dynamic simulations and ADMET prediction","year":"2022","cit":5,"pfa":"Neyder Contreras‐Puentes","psa":"Isabella Manzur-Villalobos","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4224253073","eid":"W4224253073"},{"id":"paper-w2320330123","cat":"papers","name":"A Working Paper: Memo on the Religious Implications of the Consciousness-Changing Drugs (LSD, Mescalin, Psilocybin)","year":"1964","cit":5,"pfa":"Joseph Havens","ptype":"article","src":"https://openalex.org/W2320330123","eid":"W2320330123"},{"id":"paper-w2054258113","cat":"papers","name":"Response to O'Shea and Colado: the MDMA neurotoxicity profile might provide clues to mechanisms","year":"2003","cit":5,"pfa":"George A. Ricaurte","psa":"Una D. McCann","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2054258113","eid":"W2054258113"},{"id":"paper-w2465200176","cat":"papers","name":"[Expressive phenomenology of model psychoses (psilocybin). Comparison with self-description and psychic deficiency of performance].","year":"1961","cit":5,"pfa":"Henri Lynn Heimann","ptype":"article","src":"https://openalex.org/W2465200176","eid":"W2465200176"},{"id":"paper-w4399977372","cat":"papers","name":"Race and ethnicity moderate the associations between lifetime psilocybin use and past year hypertension","year":"2024","cit":5,"pfa":"Grant M. Jones","psa":"Matthew K. Nock","ptype":"article","src":"https://openalex.org/W4399977372","eid":"W4399977372"},{"id":"paper-w2033866019","cat":"papers","name":"Effects of Repeated Low Doses of MDMA on EEG Activity and Fluoro‐Jade B Histochemistry","year":"2004","cit":5,"pfa":"Francesco Fornai","psa":"Antonio Paparelli","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2033866019","eid":"W2033866019"},{"id":"paper-w2552608475","cat":"papers","name":"Ayahuasca : l’importance du cadre et de l’intention lors de prise de psychédéliques","year":"2016","cit":5,"pfa":"Jean-Charles Bernard","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2552608475","eid":"W2552608475"},{"id":"paper-w4394924908","cat":"papers","name":"Palliative care patients’ attitudes and openness towards psilocybin-assisted psychotherapy for existential distress","year":"2024","cit":5,"pfa":"Julia R. Wang","psa":"Kristopher Kaliebe","topics":["Anxiety & end-of-life","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4394924908","eid":"W4394924908"},{"id":"paper-w2057385310","cat":"papers","name":"Acute MDMA Exposure Causes Reference Memory Impairments in the Radial Arm Maze with Rats","year":"2011","cit":5,"pfa":"David N. Harper","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2057385310","eid":"W2057385310"},{"id":"paper-w2031630386","cat":"papers","name":"Neonatal Citalopram Treatment Inhibits the 5-HT Depleting Effects of MDMA Exposure in Rats","year":"2011","cit":5,"pfa":"Tori L. Schaefer","psa":"Michael T. Williams","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2031630386","eid":"W2031630386"},{"id":"paper-w2221011162","cat":"papers","name":"Contribution of Impulsivity and Serotonin Receptor Neuroadaptations to the Development of an MDMA (‘Ecstasy’) Substance Use Disorder","year":"2015","cit":5,"pfa":"Susan Schenk","psa":"Dane Aronsen","topics":["Addiction","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W2221011162","eid":"W2221011162"},{"id":"paper-w2970200705","cat":"papers","name":"Psilocybin exerts distinct effects on resting state networks associated with serotonin and dopamine in mice","year":"2019","cit":5,"pfa":"Joanes Grandjean","psa":"Markus Rudin","topics":["Depression","Mechanism & neuroscience","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W2970200705","eid":"W2970200705"},{"id":"paper-w2140454299","cat":"papers","name":"Behavioral Effects and Pharmacokinetics of (±)-3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy) after Intragastric Administration to Baboons","year":"2013","cit":5,"pfa":"Amy K. Goodwin","psa":"Nancy Almand Ator","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2140454299","eid":"W2140454299"},{"id":"paper-w4378611681","cat":"papers","name":"0665 Ibogaine treatment in combat Veterans significantly improves sleep, beyond alleviating Posttraumatic Stress Disorder symptoms","year":"2023","cit":5,"pfa":"Afik Faerman","psa":"Nolan Williams","topics":["PTSD & trauma","Addiction","Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W4378611681","eid":"W4378611681"},{"id":"paper-w2802337530","cat":"papers","name":"3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in service personnel","year":"2018","cit":5,"pfa":"Andrea Cipriani","psa":"Philip J. Cowen","topics":["PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2802337530","eid":"W2802337530"},{"id":"paper-w4205317646","cat":"papers","name":"COMT Val158Met polymorphism is associated with ecstasy (MDMA)-induced psychotic symptoms in the Turkish population","year":"2022","cit":5,"pfa":"Hasan Mervan Aytaç","psa":"Sacide Pehlivan","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4205317646","eid":"W4205317646"},{"id":"paper-w4413683528","cat":"papers","name":"Short- and long-term modulation of rat prefrontal cortical activity following single doses of psilocybin","year":"2025","cit":5,"pfa":"Ross J. Purple","psa":"Matthew W. Jones","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4413683528","eid":"W4413683528"},{"id":"paper-w7127132673","cat":"papers","name":"Stereoselective, sex-dependent 5-HT2A receptor modulation of cortical plasticity by MDMA in mice","year":"2026","cit":5,"pfa":"Maya Gaines-Smith","psa":"Javier González‐Maeso","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7127132673","eid":"W7127132673"},{"id":"paper-w4414669838","cat":"papers","name":"Psilocybin during the postpartum period induces long-lasting adverse effects in both mothers and offspring","year":"2025","cit":5,"pfa":"Cassandra J. Hatzipantelis","psa":"Danielle S. Stolzenberg","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4414669838","eid":"W4414669838"},{"id":"paper-w2091860538","cat":"papers","name":"MDMA (ecstasy) enhances loud noise‐induced morphofunctional alterations in heart and adrenal gland","year":"2010","cit":5,"pfa":"Federica Fulceri","psa":"Marco Gesi","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2091860538","eid":"W2091860538"},{"id":"paper-w2034067521","cat":"papers","name":"Acceleration of serotonin transporter transport-associated current by 3,4-methylenedioxymethanphetamine (MDMA) under acidic conditions","year":"2007","cit":5,"pfa":"Yosuke Yamauchi","psa":"Shuji Kaneko","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2034067521","eid":"W2034067521"},{"id":"paper-w4379983053","cat":"papers","name":"Naturalistic Psilocybin Use Increases Mind Perception but not Atheist-Believer status: A Prospective Longitudinal Study","year":"2023","cit":5,"pfa":"Sandeep Manel Nayak","psa":"David B. Yaden","ptype":"preprint","src":"https://openalex.org/W4379983053","eid":"W4379983053"},{"id":"paper-w4409029858","cat":"papers","name":"Premorbid characteristics of the SAPAP3 mouse model of obsessive-compulsive disorder: behavior, neuroplasticity, and psilocybin treatment","year":"2025","cit":5,"pfa":"Michal Lazar","psa":"Bernard Lerer","topics":["Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4409029858","eid":"W4409029858"},{"id":"paper-w4285012361","cat":"papers","name":"Psilocybin-induced reduction in chronic cluster headache attack frequency correlates with changes in hypothalamic functional connectivity","year":"2022","cit":5,"pfa":"Martin Korsbak Madsen","psa":"Gitte M. Knudsen","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4285012361","eid":"W4285012361"},{"id":"paper-w4307403087","cat":"papers","name":"Biotic interactions prior to seed dispersal determine recruitment probability of peyote (Lophophora diffusa, Cactaceae), a threatened species pollinator-dependent","year":"2022","cit":5,"pfa":"María Isabel Briseño-Sánchez","psa":"María C. Mandujano","ptype":"article","src":"https://openalex.org/W4307403087","eid":"W4307403087"},{"id":"paper-w2573528768","cat":"papers","name":"Hyperthermia Severely Affects the Vascular Effects of MDMA and Metabolites in the Human Internal Mammary Artery In Vitro","year":"2017","cit":5,"pfa":"Diogo A. Fonseca","psa":"Maria Dulce Cotrim","ptype":"article","src":"https://openalex.org/W2573528768","eid":"W2573528768"},{"id":"paper-w2118813659","cat":"papers","name":"Validating the Consumption of Mdma (3,4- Methylenedioxymethamphetamine) in an Examination of the Behavioural Effects of “Ecstasy” Amongst Recreational Users","year":"1999","cit":5,"pfa":"Kellie Sherlock","psa":"Mark T. Conner","ptype":"article","src":"https://openalex.org/W2118813659","eid":"W2118813659"},{"id":"paper-w4303187823","cat":"papers","name":"Yale Program for Psychedelic Science (YPPS) Manual for Psilocybin-OCD Session Monitors for Protocol HIC: 2000020355","year":"2022","cit":5,"pfa":"Terence H. W. Ching","psa":"Benjamin Kelmendi","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4303187823","eid":"W4303187823"},{"id":"paper-w4313436183","cat":"papers","name":"First DNA barcode efficiency assessment for an important ingredient in the Amazonian ayahuasca tea: mariri/jagube, Banisteriopsis (Malpighiaceae)","year":"2022","cit":5,"pfa":"Thalita Zanquetta Luz","psa":"Jacqueline da Silva Batista","ptype":"article","src":"https://openalex.org/W4313436183","eid":"W4313436183"},{"id":"paper-w2030260610","cat":"papers","name":"Disruption of conditioned avoidance behavior by N, N-dimethyltryptamine (DMT) and stereotype by β-phenylethylamine (PEA): Animal models of attentional defects in schizophrenia","year":"1978","cit":5,"pfa":"David M. Stoff","psa":"Richard Jed Wyatt","ptype":"article","src":"https://openalex.org/W2030260610","eid":"W2030260610"},{"id":"paper-w4388451627","cat":"papers","name":"Investigation of the structure, stability, and relative solubility of psilocybin in water and pure organic solvents: A molecular simulation study","year":"2023","cit":5,"pfa":"Lucas A. Paul","psa":"Andrew S. Paluch","ptype":"article","src":"https://openalex.org/W4388451627","eid":"W4388451627"},{"id":"paper-w2011976824","cat":"papers","name":"Methodological Weaknesses in Non-Randomized Studies of Ecstasy (MDMA) Use: A Cautionary Note to Readers and Reviewers","year":"2012","cit":5,"pfa":"Teri Suzanne Krebs","psa":"Pål-Ørjan Johansen","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2011976824","eid":"W2011976824"},{"id":"paper-w2765211375","cat":"papers","name":"Case study and performance evaluation of MDMA–A non-orthogonal multiple access scheme for 5G cellular systems","year":"2017","cit":5,"pfa":"Wei‐Han Hsiao","psa":"Chia-Chi Huang","ptype":"article","src":"https://openalex.org/W2765211375","eid":"W2765211375"},{"id":"paper-w2091883144","cat":"papers","name":"Administration of neurotoxic doses of MDMA reduces sensitivity to ethanol and increases GAT-1 immunoreactivity in mice striatum","year":"2009","cit":5,"pfa":"María Izco","psa":"María Isabel Colado","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2091883144","eid":"W2091883144"},{"id":"paper-w4389144405","cat":"papers","name":"User perceptions of long-term costs and benefits of MDMA use: findings from a large online sample","year":"2023","cit":5,"pfa":"James W. B. Elsey","psa":"Anouk Fieten","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4389144405","eid":"W4389144405"},{"id":"paper-w1679633846","cat":"papers","name":"PRECLINICAL STUDY: Long‐term voluntary consumption of MDMA and THC in rats is modified by individual and situational factors","year":"2006","cit":5,"pfa":"Carola Reinhard","psa":"Jochen Wolffgramm","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1679633846","eid":"W1679633846"},{"id":"paper-w4220834371","cat":"papers","name":"Heart rate (HR) and heart rate variability (HRV) response to inhaled N, N-dimethyltryptamine (N, N-DMT): A case report","year":"2022","cit":5,"pfa":"David Wyndham Lawrence","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4220834371","eid":"W4220834371"},{"id":"paper-w1972783378","cat":"papers","name":"Investigation of the mechanisms mediating MDMA “Ecstasy”-induced increases in cerebro-cortical perfusion determined by btASL MRI","year":"2014","cit":5,"pfa":"Jennifer Rouine","psa":"Andrew Harkin","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1972783378","eid":"W1972783378"},{"id":"paper-w3145308050","cat":"papers","name":"PERSISTENT NEUROPSYCHOLOGICAL PROBLEMS AFTER 7 YEARS OF ABSTINENCE FROM RECREATIONAL ECSTASY (MDMA): A CASE STUDY","year":"2004","cit":5,"pfa":"K. SOA","ptype":"article","src":"https://openalex.org/W3145308050","eid":"W3145308050"},{"id":"paper-w2577870460","cat":"papers","name":"Psilocybin in long-term meditators: Effects on default mode network functional connectivity and retrospective ratings of qualitative experience","year":"2017","cit":5,"pfa":"Frederick Streeter Barrett","psa":"Roland R. Griffiths","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2577870460","eid":"W2577870460"},{"id":"paper-w4385806956","cat":"papers","name":"Increased clonal growth in heavily harvested ecosystems failed to rescue ayahuasca lianas from decline in the Peruvian Amazon rainforest","year":"2023","cit":5,"pfa":"Michael A. Coe","psa":"Orou G. Gaoue","ptype":"article","src":"https://openalex.org/W4385806956","eid":"W4385806956"},{"id":"paper-w4414123257","cat":"papers","name":"The Legal Perspective on Psilocybin for Medical Use in Czechia: A Key Milestone and the Case for Broader Consideration Beyond the Clinical Setting","year":"2025","cit":5,"pfa":"Tereza Dleštíková","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4414123257","eid":"W4414123257"},{"id":"paper-w4414130775","cat":"papers","name":"Psilocybin Enhances Cued Fear Extinction and Extinction Recall in Stress-Naïve, Acutely Stressed, and Chronically Stressed Mice","year":"2025","cit":5,"pfa":"John A. Razidlo","psa":"Cody J. Wenthur","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4414130775","eid":"W4414130775"},{"id":"paper-w1975501582","cat":"papers","name":"Simulated Driving and Attention of Repeat Users of MDMA and THC Compared with THC Users and Non-Drug-Using Controls","year":"2006","cit":5,"pfa":"C. T. J. Lamers","psa":"Jan G. Ramaekers","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1975501582","eid":"W1975501582"},{"id":"paper-w4414414148","cat":"papers","name":"High dose of psilocybin induces acute behavioral changes without inducing conditioned place preference in Sprague-Dawley rats","year":"2025","cit":5,"pfa":"Vítor Bruno","psa":"Gabriella Gobbi","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4414414148","eid":"W4414414148"},{"id":"paper-w2015549032","cat":"papers","name":"Dissociation between Serotonin Neurotoxicity and Brain-Derived Neurotrophic Factor Induction following Neonatal MDMA Exposure in Rats","year":"2009","cit":5,"pfa":"Brian J. Piper","psa":"Jerrold S. Meyer","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2015549032","eid":"W2015549032"},{"id":"paper-w4406799069","cat":"papers","name":"Preliminary results from a community-based ayahuasca-assisted mental health program among a Yaqui Indigenous population in Sonora, Mexico","year":"2025","cit":5,"pfa":"Cecile Giovannetti","psa":"Brian R. Rush","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4406799069","eid":"W4406799069"},{"id":"paper-w3118379705","cat":"papers","name":"P.804A single dose of psilocybin increases synaptic density and decreases 5-HT2A receptor density in the pig brain","year":"2020","cit":5,"pfa":"Nakul Ravi Raval","psa":"Gitte M. Knudsen","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3118379705","eid":"W3118379705"},{"id":"paper-w4403184188","cat":"papers","name":"Author Correction: MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial","year":"2024","cit":5,"pfa":"Jennifer Mitchell","psa":"MAPP2 Study Collaborator Group","topics":["PTSD & trauma"],"ptype":"erratum","src":"https://openalex.org/W4403184188","eid":"W4403184188"},{"id":"paper-w7151101131","cat":"papers","name":"A living systematic review, meta-analysis and open-data resource of randomized controlled trials of psilocybin treatment for symptoms of depression","year":"2026","cit":5,"pfa":"S. Parker Singleton","psa":"Theodore Daniel Satterthwaite","topics":["Depression","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7151101131","eid":"W7151101131"},{"id":"paper-w1998291798","cat":"papers","name":"SPE?TLC Profiling of Impurities in 1-(3,4-Methylenedioxyphenyl)-2-nitropropene, an Intermediate in 3,4-Methylenedioxy- methamphetamine (MDMA) Synthesis","year":"2004","cit":5,"pfa":"Jolanta Kochana","psa":"A. Parczewski","ptype":"article","src":"https://openalex.org/W1998291798","eid":"W1998291798"},{"id":"paper-w1965550602","cat":"papers","name":"Les cycles de mode des drogues illicites : l'exemple de la MDMA et de la cocaïne","year":"2014","cit":5,"pfa":"Miléna Spach","psa":"Aude Wyart","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1965550602","eid":"W1965550602"},{"id":"paper-w2964348785","cat":"papers","name":"Ayahuasca en el tratamiento de adicciones. Estudio de cuatro casos tratados en IDEAA, desde una perspectiva interdisciplinaria","year":"2019","cit":5,"pfa":"Ismael Apud","ptype":"article","src":"https://openalex.org/W2964348785","eid":"W2964348785"},{"id":"paper-w1978062527","cat":"papers","name":"Schizophrenia-like disruptions of sensory gating by serotonin receptor stimulation in rats: Effect of MDMA, DOI and 8-OH-DPAT","year":"2013","cit":5,"pfa":"Shane J. Thwaites","psa":"Maarten van den Buuse","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1978062527","eid":"W1978062527"},{"id":"paper-w4391145890","cat":"papers","name":"Factors associated with the use of psychedelics, ketamine and MDMA among sexual and gender minority youths in Canada: a machine learning analysis","year":"2024","cit":5,"pfa":"Christoffer Dharma","psa":"Michael Chaiton","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W4391145890","eid":"W4391145890"},{"id":"paper-w7130402425","cat":"papers","name":"Sex-dependent developmental changes in behavior, brain structure, functional connectivity, and sensory perception following exposure to psilocybin during adolescence","year":"2026","cit":5,"pfa":"Itishree Sahoo","psa":"Craig F. Ferris","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7130402425","eid":"W7130402425"},{"id":"paper-w2997858585","cat":"papers","name":"Chronicle of an unintentional MDMA intoxication of a field hockey team to prevent its qualification for the Beijing 2008 Olympics: A case report","year":"2019","cit":5,"pfa":"Gabriel Baltazar‐Martins","psa":"Juan Del Coso","topics":["Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2997858585","eid":"W2997858585"},{"id":"paper-w2086213049","cat":"papers","name":"Corrigendum to “Synthesis and in vitro evaluation of salvinorin A analogues: Effect of configuration at C(2) and substitution at C(18)” [Bioorg. Med. Chem. Lett. 16 (2006) 4679–4685]","year":"2008","cit":5,"pfa":"Cécile Béguin","psa":"Bruce M. Cohen","ptype":"erratum","src":"https://openalex.org/W2086213049","eid":"W2086213049"},{"id":"paper-w1785617827","cat":"papers","name":"Correlates of African American female adolescent offenders 3, 4-Methylenedioxymethamphetamine (MDMA or “Ecstasy”) use and sexually transmitted infection morbidity","year":"2015","cit":5,"pfa":"Torrance Stephens","psa":"Selina A. Smith","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1785617827","eid":"W1785617827"},{"id":"paper-w4313647762","cat":"papers","name":"Repeated low doses of psilocybin increase resilience to stress, lower compulsive actions, and strengthen cortical connections to the paraventricular thalamic nucleus in rats","year":"2023","cit":5,"pfa":"Kat F. Kiilerich","psa":"Mikael Palner","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4313647762","eid":"W4313647762"},{"id":"paper-w2089341780","cat":"papers","name":"Solid phase extraction for GC-FID determination of 3,4-methylenedioxymethamphetamine (MDMA), 3,4-methylenedioxyamphetamine (MDA) and methamphetamine (MA) in human urine","year":"2012","cit":5,"pfa":"Apichai Phonchai","psa":"Sittipoom Thainchaiwattana","ptype":"article","src":"https://openalex.org/W2089341780","eid":"W2089341780"},{"id":"paper-w2995380747","cat":"papers","name":"Volumetric properties, viscosity and taste behavior of MDMA-HCl in aqueous binary and (water + D-lactose) ternary mixtures at different temperatures","year":"2019","cit":5,"pfa":"Marija Petrin Miličević","psa":"Slobodan B. Gadžurić","ptype":"article","src":"https://openalex.org/W2995380747","eid":"W2995380747"},{"id":"paper-w4413002573","cat":"papers","name":"Improved mental health outcomes and normalised spontaneous EEG activity in veterans reporting a history of traumatic brain injuries following participation in a psilocybin retreat","year":"2025","cit":5,"pfa":"Grace Blest‐Hopley","psa":"Robin Lester Carhart-Harris","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4413002573","eid":"W4413002573"},{"id":"paper-w4300981861","cat":"papers","name":"Methylone pre-exposure differentially impacts the aversive effects of MDPV and MDMA in male and female Sprague-Dawley rats: Implications for abuse vulnerability","year":"2022","cit":5,"pfa":"Hayley N. Manke","psa":"Anthony Lee Riley","ptype":"article","src":"https://openalex.org/W4300981861","eid":"W4300981861"},{"id":"paper-w4388869869","cat":"papers","name":"A multivariable analysis delineating hair color, hair dyeing, and hat wearing as predictors of level of cocaine and MDMA detection in human hair samples","year":"2023","cit":5,"pfa":"Joseph J. Palamar","psa":"Alberto Salomone","ptype":"article","src":"https://openalex.org/W4388869869","eid":"W4388869869"},{"id":"paper-w4286780144","cat":"papers","name":"Role of 5-HT2A, 5-HT2C, 5-HT1A and TAAR1 receptors in the head twitch response induced by 5-hydroxytryptophan and psilocybin: Translational implications","year":"2022","cit":5,"pfa":"Orr Shahar","psa":"Tzuri Lifschytz","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4286780144","eid":"W4286780144"},{"id":"paper-w4400174410","cat":"papers","name":"Striking Long Term Beneficial Effects of Single Dose Psilocybin and Psychedelic Mushroom Extract in the SAPAP3 Rodent Model of OCD-Like Excessive Self-Grooming","year":"2024","cit":5,"pfa":"Michal Brownstien","psa":"Bernard Lerer","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4400174410","eid":"W4400174410"},{"id":"paper-w1827868570","cat":"papers","name":"Evidence from behavioural reactions to fenfluramine, 5-hydroxytryptophan, and 5-methoxy-N,N-dimethyltryptamine for differential effects of short-term and long-term lithium on indoleaminergic mechanisms in rats [proceedin","year":"1979","cit":5,"pfa":"Harrison-Read Pe","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1827868570","eid":"W1827868570"},{"id":"paper-w4411137642","cat":"papers","name":"Long-term outcomes of single-dose psilocybin for U.S. military Veterans with severe treatment-resistant depression – 12-month data from an open-label pilot study","year":"2025","cit":5,"pfa":"Sara Ellis","psa":"Trisha M Suppes","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4411137642","eid":"W4411137642"},{"id":"paper-w2316548348","cat":"papers","name":"Uso de plantas psicoactivas en el norte de chile: evidencia química del consumo de ayahuasca durante el Periodo Medio (500–1000 d.C.)","year":"2010","cit":5,"pfa":"Juan Pablo Ogalde","psa":"Elia C. Soto","ptype":"article","src":"https://openalex.org/W2316548348","eid":"W2316548348"},{"id":"paper-w1973067793","cat":"papers","name":"Correlation between 5‐HT Content and Uptake Site Density following (S)‐MDMA and Dexfenfluramine‐induced Depletion, and with Neuroprotection by the Glycine Site‐specific NMDA Antagonist ACEA 1021","year":"2000","cit":5,"pfa":"B. R. RUSSELL","psa":"Richard Laverty","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1973067793","eid":"W1973067793"},{"id":"paper-w4383113073","cat":"papers","name":"Introduction to the chemistry and pharmacology of psychedelic drugs","year":"2023","cit":5,"pfa":"Scott R. Walker","psa":"Peter J. Duggan","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4383113073","eid":"W4383113073"},{"id":"paper-w4240897905","cat":"papers","name":"Hallucinogenic Drugs","year":"2012","cit":5,"pfa":"Katherine R. Bonson","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"reference-entry","src":"https://openalex.org/W4240897905","eid":"W4240897905"},{"id":"paper-w4391838869","cat":"papers","name":"Multimodal Neuroimaging of the Effect of Serotonergic Psychedelics on the Brain","year":"2024","cit":5,"pfa":"Paloma C. Frautschi","psa":"John‐Paul J. Yu","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4391838869","eid":"W4391838869"},{"id":"paper-w4396803137","cat":"papers","name":"What is needed for the roll-out of psychedelic treatments?","year":"2024","cit":5,"pfa":"Stephen N. Xenakis","psa":"Scott M. Shannon","topics":["PTSD & trauma","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4396803137","eid":"W4396803137"},{"id":"paper-w3179543896","cat":"papers","name":"Psychedelic-Assisted Psychotherapy for Post-Traumatic Stress Disorder, Anxiety Disorders, Mood Disorders, or Substance Use Disorders","year":"2021","cit":5,"pfa":"Yi‐Sheng Chao","psa":"Jennifer Horton","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W3179543896","eid":"W3179543896"},{"id":"paper-w4200180816","cat":"papers","name":"1H Nuclear Magnetic Resonance: A Future Approach to the Metabolic Profiling of Psychedelics in Human Biofluids?","year":"2021","cit":5,"pfa":"Sylvana Vilca-Melendez","psa":"Julian Leether Griffin","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4200180816","eid":"W4200180816"},{"id":"paper-w4415412000","cat":"papers","name":"Landscape analysis of pre-registered clinical trials involving classical psychedelics","year":"2025","cit":5,"pfa":"Abdo Uyar","psa":"Ricarda Evens","topics":["Addiction","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4415412000","eid":"W4415412000"},{"id":"paper-w4294911993","cat":"papers","name":"Psychedelics for Psychiatric Disorders: Promise, Not Panacea","year":"2022","cit":5,"pfa":"Mitch Earleywine","psa":"Zachary M. Herrmann","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4294911993","eid":"W4294911993"},{"id":"paper-w3081685631","cat":"papers","name":"Hallucinogens and Psychedelics","year":"2020","cit":5,"pfa":"Amanda J. Jenkins","psa":"Madeleine J. Gates","ptype":"book-chapter","src":"https://openalex.org/W3081685631","eid":"W3081685631"},{"id":"paper-w4415725218","cat":"papers","name":"Psychedelics and ketamine/esketamine in depressive disorders: biological mechanisms and associated neuroimaging and clinical changes","year":"2025","cit":5,"pfa":"Giacomo d’Andrea","psa":"Giovanni Martinotti","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4415725218","eid":"W4415725218"},{"id":"paper-w2089219270","cat":"papers","name":"Correlation between Psychotropic Potency of Psychotomimetic Methoxyamphetamines and their Inhibition of 3H-Normetanephrine Uptake in Rat Cerebral Cortex","year":"1971","cit":5,"pfa":"Edith D. Hendley","psa":"Solomon H. Snyder","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2089219270","eid":"W2089219270"},{"id":"paper-w4408246467","cat":"papers","name":"Psychedelics for Cancer Pain and Associated Psychological Distress: A Narrative Review of a Potential Strategy","year":"2025","cit":5,"pfa":"Erika Belitzky","psa":"Maryam B. Lustberg","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"review","src":"https://openalex.org/W4408246467","eid":"W4408246467"},{"id":"paper-w4411816478","cat":"papers","name":"Psychedelic-Assisted Therapy: Potential Benefits and Challenges in Mental Health Treatment","year":"2025","cit":5,"pfa":"Andrzej Silczuk","psa":"Agata Szulc","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4411816478","eid":"W4411816478"},{"id":"paper-w4392988383","cat":"papers","name":"The Psychedelic Policy Quagmire","year":"2015","cit":5,"topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"book","src":"https://openalex.org/W4392988383","eid":"W4392988383"},{"id":"paper-w4417399627","cat":"papers","name":"Psychedelic experiences elicited by serotonergic psychedelics: Molecular mechanisms and functional connectivity changes in the brain","year":"2025","cit":5,"pfa":"Rivka Vollebregt","psa":"Metten Somers","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4417399627","eid":"W4417399627"},{"id":"paper-w4250225377","cat":"papers","name":"S125. Subjective and Behavioral Effects of Microdoses of LSD in Healthy Human Volunteers","year":"2019","cit":5,"pfa":"Anya K. Bershad","psa":"Harriet de Wit","topics":["Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W4250225377","eid":"W4250225377"},{"id":"paper-w2079763563","cat":"papers","name":"Effects of LSD and BOL on the catecholamine synthesis and turnover in various brain regions","year":"1978","cit":5,"pfa":"Sven-�ke Persson","ptype":"article","src":"https://openalex.org/W2079763563","eid":"W2079763563"},{"id":"paper-w4408724900","cat":"papers","name":"Psychedelic Drugs in Mental Disorders: Current Clinical Scope and Deep Learning‐Based Advanced Perspectives","year":"2025","cit":5,"pfa":"Sung‐Hyun Kim","psa":"Jae‐Yeol Joo","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4408724900","eid":"W4408724900"},{"id":"paper-w4295605197","cat":"papers","name":"Ketamine Pharmacodynamics Entangled: Comment","year":"2022","cit":5,"pfa":"Andrew Bowdle","psa":"Charles Chavkin","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4295605197","eid":"W4295605197"},{"id":"paper-w4240620862","cat":"papers","name":"Extreme hyperthermia after LSD ingestion","year":"1971","cit":5,"pfa":"S. A. Friedman","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4240620862","eid":"W4240620862"},{"id":"paper-w4410445332","cat":"papers","name":"The Relationships Between Healthcare Access, Gender, and Psychedelics and Their Effects on Distress","year":"2025","cit":5,"pfa":"Sean M. Viña","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4410445332","eid":"W4410445332"},{"id":"paper-w4297872495","cat":"papers","name":"Long-term transformative effects and integration challenges of psychedelic experiences","year":"2022","cit":5,"pfa":"Victor Jivanescu","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4297872495","eid":"W4297872495"},{"id":"paper-w4233802713","cat":"papers","name":"Effect of LSD on human pregnancy","year":"1970","cit":5,"pfa":"William H. McGlothlin","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4233802713","eid":"W4233802713"},{"id":"paper-w2606394595","cat":"papers","name":"Should addiction researchers be interested in psychedelic science?","year":"2017","cit":5,"pfa":"Stephen Jason Bright","psa":"David G. E. Caldicott","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W2606394595","eid":"W2606394595"},{"id":"paper-w4285394551","cat":"papers","name":"Mapping Pharmacologically-induced Functional Reorganisation onto the Brain’s Neurotransmitter Landscape","year":"2022","cit":5,"pfa":"Andrea I. Luppi","psa":"Emmanuel Andreas Stamatakis","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4285394551","eid":"W4285394551"},{"id":"paper-w4400386882","cat":"papers","name":"Psychedelics relax predictive processing in the post-acute period by remodeling cortico-cortical feedback circuits","year":"2024","cit":5,"pfa":"Chloe L. West","psa":"Jordan P. Hamm","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4400386882","eid":"W4400386882"},{"id":"paper-w4409071717","cat":"papers","name":"The Afterglow Inventory (AGI): Validation of a new instrument for measuring subacute effects of classic serotonergic psychedelics","year":"2025","cit":5,"pfa":"Tomislav Majić","psa":"Ricarda Evens","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4409071717","eid":"W4409071717"},{"id":"paper-w2062337180","cat":"papers","name":"Cytogenetic Studies in the Offspring of Lsd Users","year":"1974","cit":5,"pfa":"José Gutiérrez Fernández","psa":"MONICA M. POWER","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2062337180","eid":"W2062337180"},{"id":"paper-w3129289556","cat":"papers","name":"Critique of the Royal Australian and New Zealand College of Psychiatrists Psychedelic Therapy Clinical Memorandum, Dated May 2020","year":"2021","cit":5,"pfa":"Victor Chiruta","psa":"John A Hannan","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3129289556","eid":"W3129289556"},{"id":"paper-w3036009606","cat":"papers","name":"Controlled Substance Regulation for the COVID-19 Mental Health Crisis","year":"2020","cit":5,"pfa":"Mason Marks","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3036009606","eid":"W3036009606"},{"id":"paper-w4385989785","cat":"papers","name":"Persons With Spinal Cord Injury Report Peripherally Dominant Serotonin-Like Syndrome After Use of Serotonergic Psychedelics","year":"2023","cit":5,"pfa":"Stephanie Karzon Abrams","psa":"Evan Cole Lewis","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4385989785","eid":"W4385989785"},{"id":"paper-w1972152568","cat":"papers","name":"Human Figure Drawings of Schizophrenic and Normal Adults","year":"1960","cit":5,"pfa":"Karen Machover","ptype":"article","src":"https://openalex.org/W1972152568","eid":"W1972152568"},{"id":"paper-w4361263761","cat":"papers","name":"Psychedelics as Psychiatric Medications","year":"2023","cit":5,"pfa":"David Nutt","psa":"David Jonathan Castle","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"book","src":"https://openalex.org/W4361263761","eid":"W4361263761"},{"id":"paper-w1988121614","cat":"papers","name":"The Effects of LSD Upon Group Interaction","year":"1963","cit":5,"pfa":"Philip E. Slater","ptype":"article","src":"https://openalex.org/W1988121614","eid":"W1988121614"},{"id":"paper-w4380357539","cat":"papers","name":"A regulatory framework review of Schedule I psychedelics in the United States","year":"2023","cit":5,"pfa":"Kevin Herkenham","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4380357539","eid":"W4380357539"},{"id":"paper-w4246065347","cat":"papers","name":"Benign Schizophrenia","year":"1957","cit":5,"pfa":"Abram Blau","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4246065347","eid":"W4246065347"},{"id":"paper-w4255569174","cat":"papers","name":"Serotonin-Related Psychedelic Drugs ☆","year":"2017","cit":5,"pfa":"Mark A. Geyer","psa":"Franz X. Vollenweider","topics":["Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W4255569174","eid":"W4255569174"},{"id":"paper-w1977360308","cat":"papers","name":"The Problems and Prospects of LSD.","year":"1969","cit":5,"pfa":"Leo E. Hollister","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1977360308","eid":"W1977360308"},{"id":"paper-w1980038555","cat":"papers","name":"LSD and JB 318: A Comparison of Two Hallucinogens","year":"1962","cit":5,"pfa":"Binyamin Z. Lebovits","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W1980038555","eid":"W1980038555"},{"id":"paper-w2025981954","cat":"papers","name":"Effects of LSD on Receptive Fields of Single Cells in the Lateral Geniculate Nucleus of the Cat","year":"1971","cit":5,"pfa":"JENNIFER M. MCKAY","psa":"Gabriel Horn","ptype":"article","src":"https://openalex.org/W2025981954","eid":"W2025981954"},{"id":"paper-w309077236","cat":"papers","name":"Long-Lasting Effects of LSD on Certain Attitudes in Normals: An Experimental Proposal","year":"1962","cit":5,"pfa":"William H. McGlothlin","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W309077236","eid":"W309077236"},{"id":"paper-w2771106498","cat":"papers","name":"Quantification of LSD in seized samples using one chromatographic methodology for diode array detection and electrochemical detection","year":"2017","cit":5,"pfa":"Érica Naomi Oiye","psa":"Marcelo Firmino de Oliveira","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2771106498","eid":"W2771106498"},{"id":"paper-w2484110577","cat":"papers","name":"Psychotomimetic Agent BZ (3-Quinuclidinyl Benzilate)","year":"2009","cit":5,"pfa":"Josef Fusek","psa":"Daniel Jun","ptype":"book-chapter","src":"https://openalex.org/W2484110577","eid":"W2484110577"},{"id":"paper-w2003076101","cat":"papers","name":"Endocrine Effects of Chronic Administration of Psychoactive Drugs to Prepubertal Male Rats. II. LSD","year":"1975","cit":5,"pfa":"ROBERT COLLU","psa":"JACQUES R. DUCHARME","ptype":"article","src":"https://openalex.org/W2003076101","eid":"W2003076101"},{"id":"paper-w4395954760","cat":"papers","name":"LSD flattens the hierarchy of directed information flow in fast whole-brain dynamics","year":"2024","cit":5,"pfa":"Kenneth Shinozuka","psa":"Morten L. Kringelbach","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4395954760","eid":"W4395954760"},{"id":"paper-w2023662910","cat":"papers","name":"Drugs of abuse (amfetamines, BZP, cannabis, cocaine, GHB, LSD)","year":"2012","cit":5,"pfa":"Allister Vale","ptype":"article","src":"https://openalex.org/W2023662910","eid":"W2023662910"},{"id":"paper-w2007438357","cat":"papers","name":"Synthesis of deacetyl-1,10-didehydrosalvinorin G","year":"2008","cit":5,"pfa":"Zhongze Ma","psa":"David Y.W. Lee","ptype":"article","src":"https://openalex.org/W2007438357","eid":"W2007438357"},{"id":"paper-w2316476404","cat":"papers","name":"The effects of LSD in the guinea-pig ileum","year":"1985","cit":5,"pfa":"I. Pfeuffer‐Friederich","psa":"Heinz J. Kilbinger","ptype":"article","src":"https://openalex.org/W2316476404","eid":"W2316476404"},{"id":"paper-w3211901825","cat":"papers","name":"DMT entity encounters: dialogues on the spirit molecule","year":"2021","cit":5,"pfa":"David P. Luke","psa":"Rory Spowers","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3211901825","eid":"W3211901825"},{"id":"paper-w3029354975","cat":"papers","name":"Editorial: Hallucinogens and Entactogens: Establishing a New Class of Psychotherapeutic Drugs?","year":"2020","cit":5,"pfa":"Felix Müller","psa":"Stefan Borgwardt","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"editorial","src":"https://openalex.org/W3029354975","eid":"W3029354975"},{"id":"paper-w4220890557","cat":"papers","name":"Using Psychedelics in Clinical Practice: Comparing Therapeutic Uses and Potential Harms","year":"2022","cit":5,"pfa":"Rabeet Tariq","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4220890557","eid":"W4220890557"},{"id":"paper-w3080697786","cat":"papers","name":"[Psychedelics in the treatment of PTSD].","year":"2020","cit":5,"pfa":"Eric H. G. J. M. Vermetten","psa":"Willem Johan van den Brink","topics":["PTSD & trauma","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3080697786","eid":"W3080697786"},{"id":"paper-w2737292501","cat":"papers","name":"Screening of Hallucinogenic Compounds and Genomic Characterisation of 40 Anatolian Salvia Species","year":"2017","cit":5,"pfa":"Seda Damla Hatıpoğlu","psa":"Gülaçtı Topçu","ptype":"article","src":"https://openalex.org/W2737292501","eid":"W2737292501"},{"id":"paper-w4366003487","cat":"papers","name":"LSD microdosing attenuates the impact of temporal priors in time perception","year":"2023","cit":5,"pfa":"Renata Sadibolova","psa":"Devin Blair Terhune","topics":["Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4366003487","eid":"W4366003487"},{"id":"paper-w4235567041","cat":"papers","name":"Psychedelics and Mindfulness: A Systematic Review and Meta-Analysis","year":"2021","cit":5,"pfa":"Chelsea Radakovic","psa":"Jo‐Anne Geere","topics":["Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4235567041","eid":"W4235567041"},{"id":"paper-w4200266012","cat":"papers","name":"Towards the Use of Whole Natural Products in Psychedelic Research and Therapy: Synergy, Multi-Target Profiles, and Beyond","year":"2021","cit":5,"topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W4200266012","eid":"W4200266012"},{"id":"paper-w4392968070","cat":"papers","name":"Detection of contraband drugs in forensic-correctional mental health services using TeknoScan-a gas chromatography tool","year":"2024","cit":5,"pfa":"Andrew T Olagunju","psa":"Gary Andrew Chaimowitz","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4392968070","eid":"W4392968070"},{"id":"paper-w4413906381","cat":"papers","name":"Psychedelics as pharmacotherapeutics for substance use disorders: A scoping review on clinical trials and perspectives on underlying neurobiology","year":"2025","cit":5,"pfa":"Lucas M Wittenkeller","psa":"Davide Amato","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4413906381","eid":"W4413906381"},{"id":"paper-w4413116294","cat":"papers","name":"Toward Standardized Products Containing Biomass of Psilocybe Cubensis Fungi","year":"2025","cit":5,"pfa":"Kimberley Foster","psa":"Rupika Delgoda","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4413116294","eid":"W4413116294"},{"id":"paper-w145928346","cat":"papers","name":"The effect of Psilocybe cubensis extract on hippocampal neurons in vitro.","year":"2001","cit":5,"pfa":"Mykhaylo G. Moldavan","psa":"V M Storozhuk","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W145928346","eid":"W145928346"},{"id":"paper-w4412043788","cat":"papers","name":"Efficacy and Safety of LSD in the treatment of mental and substance use disorders: A systematic review of randomized controlled trials","year":"2025","cit":5,"pfa":"Maria Helha Fernandes-Nascimento","psa":"André Brooking Negrão","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4412043788","eid":"W4412043788"},{"id":"paper-w4402603050","cat":"papers","name":"Single-dose 1cp-LSD administration for canine anxiety: a pilot study","year":"2024","cit":5,"pfa":"Luis Alberto Henríquez‐Hernández","psa":"Lucas F. Borkel","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4402603050","eid":"W4402603050"},{"id":"paper-w2139827535","cat":"papers","name":"The \"Angel Dust\" States: Phencyclidine Toxicity","year":"1979","cit":5,"pfa":"S. Cohen","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2139827535","eid":"W2139827535"},{"id":"paper-w4380852994","cat":"papers","name":"Analytical and behavioral characterization of N‐ethyl‐N‐isopropyllysergamide (EIPLA), an isomer of N6–ethylnorlysergic acid N,N‐diethylamide (ETH‐LAD)","year":"2023","cit":5,"pfa":"Simon D. Brandt","psa":"Adam L. Halberstadt","ptype":"article","src":"https://openalex.org/W4380852994","eid":"W4380852994"},{"id":"paper-w4400742861","cat":"papers","name":"Clinical utility of fMRI in evaluating of LSD effect on pain-related brain networks in healthy subjects","year":"2024","cit":5,"pfa":"A. Faramarzi","psa":"Hamid Sharini","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4400742861","eid":"W4400742861"},{"id":"paper-w4367175099","cat":"papers","name":"Adverse drug effects as a deterrent against willingness to use in the future among nightclub/festival attendees","year":"2023","cit":5,"pfa":"Joseph J. Palamar","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4367175099","eid":"W4367175099"},{"id":"paper-w2053085572","cat":"papers","name":"Two 5-HT1A Receptor-Interactive Tryptamine Derivatives from the Unripe Fruit of Evodia rutaecarpa","year":"1997","cit":5,"pfa":"Lili Yu","psa":"Chieh‐Fu Chen","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2053085572","eid":"W2053085572"},{"id":"paper-w4410487155","cat":"papers","name":"Can the gut-brain axis provide insight into psilocybin's therapeutic value in reducing stress?","year":"2025","cit":5,"pfa":"Ah Kit","psa":"Brian R. Christie","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4410487155","eid":"W4410487155"},{"id":"paper-w4405491406","cat":"papers","name":"Effects of 3,4-methylenedioxymethamphetamine on the gut microbiota and metabolites in the small intestine, cecum, and colon of male rats","year":"2024","cit":5,"pfa":"Dan Xu","psa":"Kenji Hashimoto","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4405491406","eid":"W4405491406"},{"id":"paper-w4410237490","cat":"papers","name":"The effect of psychedelic microdosing on animal behavior: A review with recommendations for the field","year":"2025","cit":5,"pfa":"Omer A. Syed","psa":"Benjamin Tsang","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4410237490","eid":"W4410237490"},{"id":"paper-w2083546659","cat":"papers","name":"Effect of once weekly treatment with 3,4-methylenedioxymethamphetamine on schedule-controlled behavior in rats","year":"1998","cit":5,"pfa":"Rakesh Nagilla","psa":"Maureen E. Bronson","ptype":"article","src":"https://openalex.org/W2083546659","eid":"W2083546659"},{"id":"paper-w2168419584","cat":"papers","name":"Ecstasy, driving and traffic safety","year":"2009","cit":5,"pfa":"Kim P. C. Kuypers","psa":"Johannes Gerardus Ramaekers","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W2168419584","eid":"W2168419584"},{"id":"paper-w4297493685","cat":"papers","name":"The psychedelic remedy for chronic pain","year":"2022","cit":5,"pfa":"Clare Watson","ptype":"article","src":"https://openalex.org/W4297493685","eid":"W4297493685"},{"id":"paper-w2319247797","cat":"papers","name":"Contractile effects of 3,4-methylenedioxymethamphetamine on the human internal mammary artery","year":"2016","cit":5,"pfa":"Sónia Silva","psa":"Maria Dulce Cotrim","ptype":"article","src":"https://openalex.org/W2319247797","eid":"W2319247797"},{"id":"paper-w4400734028","cat":"papers","name":"A psychedelic state arises from desynchronized brain activity","year":"2024","cit":5,"pfa":"Petros D. Petridis","ptype":"article","src":"https://openalex.org/W4400734028","eid":"W4400734028"},{"id":"paper-w4212788488","cat":"papers","name":"Isotope fractionation during the synthesis of MDMA.HCl from helional","year":"2022","cit":5,"pfa":"Justin Cormick","psa":"Sarah L. Cresswell","ptype":"article","src":"https://openalex.org/W4212788488","eid":"W4212788488"},{"id":"paper-w2079811430","cat":"papers","name":"Effects of benzylpiperazine derivatives on the acute effects of 3,4-methylenedioxymethamphetamine in rat brain","year":"1993","cit":5,"pfa":"Kenji Hashimoto","ptype":"article","src":"https://openalex.org/W2079811430","eid":"W2079811430"},{"id":"paper-w2417514549","cat":"papers","name":"Response of HeLa cells to selected pesticides and hallucinogens.","year":"1978","cit":5,"pfa":"Blevins Rd","psa":"Sholes Te","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2417514549","eid":"W2417514549"},{"id":"paper-w1991733615","cat":"papers","name":"Antagonism of 3,4-methylenedioxymethamphetamine-induced neurotoxicity in rat brain by 1-piperonylpiperazine","year":"1992","cit":5,"pfa":"Kenji Hashimoto","psa":"Tsuyoshi Goromaru","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1991733615","eid":"W1991733615"},{"id":"paper-w2008131878","cat":"papers","name":"Synthesis and Neurotoxicity Profile of 2,4,5-Trihydroxymethamphetamine and Its 6-(N-Acetylcystein-S-yl) Conjugate","year":"2011","cit":5,"pfa":"Anne Neudörffer","psa":"Martine Largeron","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2008131878","eid":"W2008131878"},{"id":"paper-w4411744352","cat":"papers","name":"Exploring the integration of psychedelic-assisted therapy and digital mental health interventions in trauma recovery for underserved adults with high-functioning autism","year":"2025","cit":5,"pfa":"Paul Okugo Imoh","psa":"Emmanuel Oluwasayomi Ahmadu","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4411744352","eid":"W4411744352"},{"id":"paper-w4388463377","cat":"papers","name":"Comparison of poisoning deaths with wastewater‐based consumption estimates and assessment of fatal toxicity for amphetamine‐type stimulant drugs","year":"2023","cit":5,"pfa":"Pirkko Kriikku","psa":"Ilkka Antero Ojanperä","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4388463377","eid":"W4388463377"},{"id":"paper-w4411662399","cat":"papers","name":"Serotonin 5-HT2A receptor expression is chronically decreased in the anterior cerebral cortex of male rats following repetitive low-level blast exposure","year":"2025","cit":5,"pfa":"Rita De Gasperi","psa":"Gregory A. Elder","topics":["Depression","PTSD & trauma","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4411662399","eid":"W4411662399"},{"id":"paper-w1916983487","cat":"papers","name":"Rave drug (ecstasy) and selective serotonin reuptake inhibitor anti-depressants.","year":"2000","cit":5,"pfa":"Singh An","psa":"J. Catalan","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1916983487","eid":"W1916983487"},{"id":"paper-w4406325096","cat":"papers","name":"Psychedelic Exceptionalism, Indigeneity, and the War on Drugs: Antiracism and Decolonizing Psychedelic Plant Medicine","year":"2025","cit":5,"pfa":"Skylar J. Gaughan","psa":"Jennifer Elyse James","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4406325096","eid":"W4406325096"},{"id":"paper-w2104271291","cat":"papers","name":"Hallucinogenic Drug-Induced Behavior Under Sensory Attenuation","year":"1973","cit":5,"pfa":"Yvonne Panton","ptype":"article","src":"https://openalex.org/W2104271291","eid":"W2104271291"},{"id":"paper-w2990048234","cat":"papers","name":"Reflexiones sobre la expansión y legalidad del campo peyotero en México","year":"2019","cit":5,"pfa":"Mauricio Guzmán","psa":"Beatriz Caiuby Labate","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2990048234","eid":"W2990048234"},{"id":"paper-w4392109611","cat":"papers","name":"The Temporal Trajectory of the Psychedelic Mushroom Experience Mimics the Narrative Arc of the Hero’s Journey","year":"2024","cit":5,"pfa":"Ari Brouwer","psa":"Robin Lester Carhart-Harris","ptype":"preprint","src":"https://openalex.org/W4392109611","eid":"W4392109611"},{"id":"paper-w4388500089","cat":"papers","name":"Managing expectations with psychedelic microdosing","year":"2023","cit":5,"pfa":"Omer A. Syed","psa":"Benjamin Tsang","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4388500089","eid":"W4388500089"},{"id":"paper-w1525301347","cat":"papers","name":"Anxiety Disorder and Its Types","year":"2012","cit":5,"pfa":"Malihe Shiri","psa":"N. Gerami","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"book-chapter","src":"https://openalex.org/W1525301347","eid":"W1525301347"},{"id":"paper-w2073079459","cat":"papers","name":"Opening Doors of Perception: Psychedelic Drugs and End-of-Life Care","year":"2012","cit":5,"pfa":"Norra MacReady","topics":["Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2073079459","eid":"W2073079459"},{"id":"paper-w4295048220","cat":"papers","name":"Neural mechanisms of psychedelic visual imagery","year":"2022","cit":5,"pfa":"Devon Stoliker","psa":"Adeel Razi","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4295048220","eid":"W4295048220"},{"id":"paper-w4398224810","cat":"papers","name":"The dual-configured hydrogen bonds induced by polymerized deep eutectic solvents-modified magnetic biochar enhanced the selectivity for 3,4-methylenedioxymethamphetamine","year":"2024","cit":5,"pfa":"Xin Wei","psa":"Zhiqiong Chen","ptype":"article","src":"https://openalex.org/W4398224810","eid":"W4398224810"},{"id":"paper-w4399756902","cat":"papers","name":"The cyclical revival of psychedelics in psychiatric treatment","year":"2024","cit":5,"pfa":"Francisco José Appiani","psa":"Stanley N. Caroff","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4399756902","eid":"W4399756902"},{"id":"paper-w4411071772","cat":"papers","name":"Psilocybin’s acute and persistent brain effects: a precision imaging drug trial","year":"2025","cit":5,"pfa":"Subha Subramanian","psa":"Joshua S. Siegel","topics":["Mechanism & neuroscience"],"ptype":"data-paper","src":"https://openalex.org/W4411071772","eid":"W4411071772"},{"id":"paper-w4388105579","cat":"papers","name":"The Psychedelic Social Club: a regulatory concept for people who use psychedelics?","year":"2023","cit":5,"pfa":"Henry Harder","psa":"Maja Kohek","topics":["Safety & adverse events","Policy & ethics"],"ptype":"editorial","src":"https://openalex.org/W4388105579","eid":"W4388105579"},{"id":"paper-w4413467146","cat":"papers","name":"Interventional Psychiatry and Emerging Treatments for Posttraumatic Stress Disorder (PTSD): A Systematic Review","year":"2025","cit":5,"pfa":"Reinhard Janssen‐Aguilar","psa":"Venkat Bhat","topics":["PTSD & trauma","Safety & adverse events","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W4413467146","eid":"W4413467146"},{"id":"paper-w4412488390","cat":"papers","name":"Informed Consent Documents from Psychedelic Clinical Trials: A Descriptive Ethical Analysis","year":"2025","cit":5,"pfa":"Katherine Cheung","psa":"David B. Yaden","topics":["Safety & adverse events","Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4412488390","eid":"W4412488390"},{"id":"paper-w2981025143","cat":"papers","name":"PROLONGED LYSERGIC ACID DIETHYLMIDE INDUCED SEROTONIN SYNDROME","year":"2019","cit":5,"pfa":"Anita Singh","psa":"Rebecca Saunders","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2981025143","eid":"W2981025143"},{"id":"paper-w4416713567","cat":"papers","name":"Effects of psychedelic microdosing on cognitive functions: A systematic review and meta-analysis","year":"2025","cit":5,"pfa":"Netta Pinhas","psa":"Leehe Peled‐Avron","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W4416713567","eid":"W4416713567"},{"id":"paper-w3097449446","cat":"papers","name":"Addiction of Hallucinogens, Dissociatives, Designer Drugs and “Legal Highs”: Update on Potential Therapeutic Use","year":"2020","cit":5,"pfa":"Magı́ Farré","psa":"Marta Torrens","topics":["Addiction","Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W3097449446","eid":"W3097449446"},{"id":"paper-w4408338895","cat":"papers","name":"Insights into therapeutic potential and practical applications of natural toxins from poisonous mushrooms","year":"2025","cit":5,"pfa":"Tharuka Wijesekara","psa":"Baojun Xu","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4408338895","eid":"W4408338895"},{"id":"paper-w2902189128","cat":"papers","name":"Molecular Docking Studies of Methamphetamine and Amphetamine- Related Derivatives as an Inhibitor against Dopamine Receptor","year":"2018","cit":5,"pfa":"Kobra Foroughi","psa":"Asghar Shayannia","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2902189128","eid":"W2902189128"},{"id":"paper-w2905053527","cat":"papers","name":"On ‘Moralistic Therapeutic Deism’ as US Teenagers’ Actual, Tacit, De Facto Religious Faith","year":"2016","cit":5,"pfa":"Pirjo Kristiina Virtanen","ptype":"book-chapter","src":"https://openalex.org/W2905053527","eid":"W2905053527"},{"id":"paper-w3118817849","cat":"papers","name":"The use of psychedelics in the treatment of disorders of consciousness. An interview with Olivia Gosseries by Charlotte Martial.","year":"2020","cit":5,"pfa":"Olivia Gosseries","psa":"Charlotte Martial","topics":["Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W3118817849","eid":"W3118817849"},{"id":"paper-w4388141328","cat":"papers","name":"Psychedelics and treatment of mental disorders: A survey of attitudes and knowledge among psychiatrists, general practitioners and psychologists in Iceland","year":"2023","cit":5,"pfa":"Ragnar Pétur Ólafsson","psa":"Engilbert Sigurðsson","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4388141328","eid":"W4388141328"},{"id":"paper-w1984893758","cat":"papers","name":"Forensic analysis of Salvia divinorum using multivariate statistical procedures. Part II: association of adulterated samples to S. divinorum","year":"2011","cit":5,"pfa":"Melissa A. Bodnar Willard","psa":"Ruth Smith","ptype":"article","src":"https://openalex.org/W1984893758","eid":"W1984893758"},{"id":"paper-w4362614112","cat":"papers","name":"Use of Selective Alternative Therapies for Treatment of OCD","year":"2023","cit":5,"pfa":"Iman Khan","psa":"Abubakr Yosufi","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4362614112","eid":"W4362614112"},{"id":"paper-w2562489384","cat":"papers","name":"Flashbacks und anhaltende Wahrnehmungsstörungen nach Einnahme von serotonergen Halluzinogenen","year":"2017","cit":5,"pfa":"Tomislav Majić","psa":"Leo Hermle","ptype":"book-chapter","src":"https://openalex.org/W2562489384","eid":"W2562489384"},{"id":"paper-w4417184349","cat":"papers","name":"Stepping back into life: How Psychedelic Assisted Psychotherapy transforms the way of life of the terminally ill","year":"2025","cit":5,"pfa":"Justin L. Dwyer","psa":"Margaret Ross","topics":["Anxiety & end-of-life","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4417184349","eid":"W4417184349"},{"id":"paper-w3083433593","cat":"papers","name":"Total Recall: Lateral Habenula and Psychedelics in the Study of Depression and Comorbid Brain Disorders","year":"2020","cit":5,"pfa":"Matas Vitkauskas","psa":"Ajay  Sriram Mathuru","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3083433593","eid":"W3083433593"},{"id":"paper-w3093989508","cat":"papers","name":"Treatment-Resistant Depression","year":"2020","cit":5,"pfa":"Charles E. Dean","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W3093989508","eid":"W3093989508"},{"id":"paper-w3082405884","cat":"papers","name":"Editorial: Sigma Receptors","year":"2020","cit":5,"pfa":"Ebru Aydar","psa":"Stephen T. Safrany","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"editorial","src":"https://openalex.org/W3082405884","eid":"W3082405884"},{"id":"paper-w4292451578","cat":"papers","name":"Pharmacological Strategies for Suicide Prevention Based on the Social Pain Model: A Scoping Review","year":"2022","cit":5,"pfa":"Ravi Philip Rajkumar","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4292451578","eid":"W4292451578"},{"id":"paper-w2405118753","cat":"papers","name":"Tiny Jungle: Psychedelic Techniques in Audio-Visual Composition","year":"2011","cit":5,"pfa":"Jonathan Weinel","ptype":"conference-paper","src":"https://openalex.org/W2405118753","eid":"W2405118753"},{"id":"paper-w2297120223","cat":"papers","name":"Hypoglycæmia as an Experimental Psychosis","year":"1943","cit":5,"pfa":"W. Mayer-Groß","ptype":"conference-abstract","src":"https://openalex.org/W2297120223","eid":"W2297120223"},{"id":"paper-w4413470543","cat":"papers","name":"Above the threshold, beyond the trip: the role of the 5-HT2A receptor in psychedelic-induced neuroplasticity and antidepressant effects","year":"2025","cit":5,"pfa":"Adam J. Drewko","psa":"Tibor M. Brunt","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4413470543","eid":"W4413470543"},{"id":"paper-w4414162276","cat":"papers","name":"Serotonin 5-HT2C Receptor Signaling Analysis Reveals Psychedelic Biased Agonism","year":"2025","cit":5,"pfa":"Emma M. Bonniwell","psa":"John D. McCorvy","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4414162276","eid":"W4414162276"},{"id":"paper-w4293730015","cat":"papers","name":"LSD-induced increase of Ising temperature and algorithmic complexity of brain dynamics","year":"2022","cit":5,"pfa":"Giulio Ruffini","psa":"Gustavo Deco","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4293730015","eid":"W4293730015"},{"id":"paper-w4411913879","cat":"papers","name":"What fMRI studies say about the nature of the psychedelic effect: a scoping review","year":"2025","cit":5,"pfa":"Michal Beneš","psa":"Jiřı́ Horáček","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4411913879","eid":"W4411913879"},{"id":"paper-w4384339800","cat":"papers","name":"Translation and Initial Psychometric Evaluation of Spanish Versions of Three Psychedelic Acute Effects Measures: Mystical, Challenging, and Insight Experiences","year":"2023","cit":5,"pfa":"Alan K. Davis","psa":"Roland R. Griffiths","ptype":"article","src":"https://openalex.org/W4384339800","eid":"W4384339800"},{"id":"paper-w2000642865","cat":"papers","name":"Differences in agonist dissociation constant estimates for 5‐HT at 5‐HT2‐receptors: a problem of acute desensitization?","year":"1988","cit":5,"pfa":"P. Leff","psa":"Graeme R. Martin","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2000642865","eid":"W2000642865"},{"id":"paper-w4378515555","cat":"papers","name":"The Need for Psychiatric Treatment among Polish Users of Psychoactive Substances Is Increasing: This and Other Results from the Newest PolDrugs Survey","year":"2023","cit":5,"pfa":"Gniewko Więckiewicz","psa":"Robert Pudło","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4378515555","eid":"W4378515555"},{"id":"paper-w2271562270","cat":"papers","name":"[Current situation of and the political measures for drug abuse/dependence].","year":"2008","cit":5,"pfa":"Kiyoshi Wada","psa":"Ayumi Kondo","topics":["Safety & adverse events","Policy & ethics"],"ptype":"other","src":"https://openalex.org/W2271562270","eid":"W2271562270"},{"id":"paper-w4224225566","cat":"papers","name":"Naturalistic Entheogenics","year":"2022","cit":5,"pfa":"Chris Letheby","topics":["Mechanism & neuroscience","Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4224225566","eid":"W4224225566"},{"id":"paper-w4402309456","cat":"papers","name":"Banisteriopsis caapi extract: Implications for neuroinflammatory pathways in Locus coeruleus lesion rodent model","year":"2024","cit":5,"pfa":"Santhiago Calvelo Graça","psa":"Ariadiny Lima Caetano","ptype":"article","src":"https://openalex.org/W4402309456","eid":"W4402309456"},{"id":"paper-w4409274889","cat":"papers","name":"Harnessing neuroplasticity with psychoplastogens: the essential role of psychotherapy in psychedelic treatment optimization","year":"2025","cit":5,"pfa":"Jennifer Lynn Jones","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4409274889","eid":"W4409274889"},{"id":"paper-w4324333884","cat":"papers","name":"Enhanced adsorption of 3,4-methylenedioxymethamphetamine by magnetic graphene oxide-polydopamine nanohybrid modified zeolitic imidazolate framework-67 and its micro-mechanism: Experiments and calculations","year":"2023","cit":5,"pfa":"Shurui Cao","psa":"Zhiqiong Chen","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4324333884","eid":"W4324333884"},{"id":"paper-w4415601078","cat":"papers","name":"Ecotoxicological risk and seasonal removal of licit and illicit drugs in wastewater treatment plants: A comparison of secondary and tertiary processes","year":"2025","cit":5,"pfa":"Natalia Melones-Peña","psa":"Emma Gracia‐Lor","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4415601078","eid":"W4415601078"},{"id":"paper-w4214776176","cat":"papers","name":"Micro-dosing psychedelics as a plausible adjunct to psychosexual and couple’s therapy: a qualitative insight","year":"2022","cit":5,"pfa":"Lucy Jacobs","psa":"Joanne Marie Lusher","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4214776176","eid":"W4214776176"},{"id":"paper-w7128483955","cat":"papers","name":"The potential of event-related beta oscillations as biomarkers for neuromodulatory treatment efficacy","year":"2026","cit":5,"pfa":"Bettina Habelt","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7128483955","eid":"W7128483955"},{"id":"paper-w4411162630","cat":"papers","name":"A model training curriculum for psychedelic, psycholytic, and entactogen-assisted psychotherapy","year":"2025","cit":5,"pfa":"Torsten Passie","psa":"Jeffrey R. Guss","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4411162630","eid":"W4411162630"},{"id":"paper-w4414052687","cat":"papers","name":"Psychedelics beyond medicine: Treatment, enhancement, hype, consent, and the limits of medicalization","year":"2025","cit":5,"pfa":"Mina Caraccio","psa":"Brian David Earp","topics":["Safety & adverse events","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4414052687","eid":"W4414052687"},{"id":"paper-w4401920710","cat":"papers","name":"Microdosing psychedelics in the treatment of ADHD and comorbid disorders","year":"2024","cit":5,"pfa":"Kim P. C. Kuypers","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4401920710","eid":"W4401920710"},{"id":"paper-w3193012633","cat":"papers","name":"Use of hallucinogens in Slovakia: Does it differ from global trends?","year":"2021","cit":5,"pfa":"Marek Lukačovič","psa":"Radomír Masaryk","ptype":"article","src":"https://openalex.org/W3193012633","eid":"W3193012633"},{"id":"paper-w4412513351","cat":"papers","name":"Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous RE104","year":"2025","cit":5,"pfa":"Guy Ludbrook","psa":"Mark H. Pollack","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4412513351","eid":"W4412513351"},{"id":"paper-w4414342713","cat":"papers","name":"Advancing drug safety in psychiatry: insights from pharmacogenomics of hypersensitivity reactions","year":"2025","cit":5,"pfa":"Hamid A. Alhaj","psa":"Maha Mohamed Saber-Ayad","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4414342713","eid":"W4414342713"},{"id":"paper-w4405270370","cat":"papers","name":"Comparison of Laboratory Confirmed Drugs in Acute Recreational Drug Toxicity Presentations to an Urban Hospital in London, UK, 2016/17 versus 2019/20","year":"2024","cit":5,"pfa":"Caitlin E. Wolfe","psa":"Paul Ivor Dargan","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4405270370","eid":"W4405270370"},{"id":"paper-w4393053917","cat":"papers","name":"Autonomic Nervous System activity correlates with peak experiences induced by DMT and predicts increases in wellbeing","year":"2024","cit":5,"pfa":"Valérie Bonnelle","psa":"Christopher B. Timmermann","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4393053917","eid":"W4393053917"},{"id":"paper-w4390746318","cat":"papers","name":"On the advances in machine learning and complex network measures to an EEG dataset from DMT experiments","year":"2024","cit":5,"pfa":"Caroline L. Alves","psa":"Francisco A. Rodrigues","topics":["Addiction","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4390746318","eid":"W4390746318"},{"id":"paper-w4386765469","cat":"papers","name":"Recent developments pertaining to treatment‐resistant depression: a 40‐year perspective","year":"2023","cit":5,"pfa":"Michael E. Thase","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4386765469","eid":"W4386765469"},{"id":"paper-w4388461124","cat":"papers","name":"Psychedelic-assisted psychotherapy: Where is the psychotherapy research?","year":"2023","cit":5,"pfa":"Jacob S. Aday","psa":"Joshua D. Woolley","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4388461124","eid":"W4388461124"},{"id":"paper-w4400090887","cat":"papers","name":"Clarifying the ethical landscape of psychedelic-assisted psychotherapy","year":"2024","cit":5,"pfa":"Christopher Kochevar","topics":["Safety & adverse events","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4400090887","eid":"W4400090887"},{"id":"paper-w4403734657","cat":"papers","name":"Psychedelic therapies: healing for the wrong reasons?","year":"2024","cit":5,"pfa":"Eduardo Ekman Schenberg","psa":"Franklin King","ptype":"article","src":"https://openalex.org/W4403734657","eid":"W4403734657"},{"id":"paper-w3211388374","cat":"papers","name":"Psychedelic-Assisted Therapy for Social Adaptability in Autistic Adults","year":"2021","cit":5,"pfa":"Alicia L. Danforth","ptype":"book-chapter","src":"https://openalex.org/W3211388374","eid":"W3211388374"},{"id":"paper-w4416514886","cat":"papers","name":"The Role and Ethics of Touch and Non-touch in Psychedelic-Assisted Therapy","year":"2025","cit":5,"pfa":"Helena Aicher","psa":"Manuela Brand","topics":["Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W4416514886","eid":"W4416514886"},{"id":"paper-w4361278612","cat":"papers","name":"Pharmacotherapy and Ketamine Assisted Psychotherapy for Treatment-Resistant Depression","year":"2023","cit":5,"pfa":"Albert Yeung","psa":"Fernando Espí Forcén","topics":["Depression","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4361278612","eid":"W4361278612"},{"id":"paper-w4412072125","cat":"papers","name":"Informed Consent and Transformative Experiences in Psychedelic Therapy: A Nuanced Approach","year":"2025","cit":5,"pfa":"Joel Janhonen","psa":"Joona Räsänen","ptype":"editorial","src":"https://openalex.org/W4412072125","eid":"W4412072125"},{"id":"paper-w4410093130","cat":"papers","name":"Ketamine-Assisted Psychotherapy for Treatment-Resistant Depression: a Systematic Review","year":"2025","cit":5,"pfa":"Ana Malta Gomes","psa":"Filipa Novais","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"review","src":"https://openalex.org/W4410093130","eid":"W4410093130"},{"id":"paper-w4417397706","cat":"papers","name":"Eligibility for psychedelic therapy: Clinical trial medical exclusion criteria and their implications for hospital practice","year":"2025","cit":5,"pfa":"Martin L Williams","psa":"Simon A. Beck","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4417397706","eid":"W4417397706"},{"id":"paper-w7127092115","cat":"papers","name":"Ketamine-assisted psychotherapies for mental disorders: A historical overview and systematic review","year":"2026","cit":5,"pfa":"Jolien K. E. Veraart","psa":"Robert A. Schoevers","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"review","src":"https://openalex.org/W7127092115","eid":"W7127092115"},{"id":"paper-w4401083555","cat":"papers","name":"Conceptualizing your new reality: Should philosophers play a role in psychedelic-assisted therapy?","year":"2024","cit":5,"pfa":"Christopher Quasti","psa":"Dominic A. Sisti","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4401083555","eid":"W4401083555"},{"id":"paper-w4391971469","cat":"papers","name":"Case report: Adult with bipolar disorder and autism treated with ketamine assisted psychotherapy","year":"2024","cit":5,"pfa":"Christopher P. Harris","psa":"Meredith S. Berry","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4391971469","eid":"W4391971469"},{"id":"paper-w4393065700","cat":"papers","name":"Psychedelic Therapy: A Primer for Primary Care Clinicians—The Strengths, Weaknesses, Opportunities, and Threats of Psychedelic Therapeutics","year":"2024","cit":5,"pfa":"Owen S. Muir","psa":"Burton Jared Tabaac","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4393065700","eid":"W4393065700"},{"id":"paper-w4387140507","cat":"papers","name":"How psychedelic-assisted therapy works for depression: expert views and practical implications from an exploratory Delphi study","year":"2023","cit":5,"pfa":"Lauren Johansen","psa":"Greg Murray","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4387140507","eid":"W4387140507"},{"id":"paper-w4283577726","cat":"papers","name":"Psychedelic Therapies at the Crossroads of Trauma and Substance Use: Historical Perspectives and Future Directions, Taking a Lead From New Mexico","year":"2022","cit":5,"pfa":"Snehal R. Bhatt","psa":"Douglas M. Ziedonis","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4283577726","eid":"W4283577726"},{"id":"paper-w4309378524","cat":"papers","name":"Psychedelics and Desistance From Crime: Lessons From the Concord Prison Experiment","year":"2022","cit":5,"pfa":"Logan Neitzke‐Spruill","topics":["Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4309378524","eid":"W4309378524"},{"id":"paper-w4403399004","cat":"papers","name":"Rapid and sustained reduction of treatment-resistant PTSD symptoms after intravenous ketamine in a real-world, psychedelic paradigm","year":"2024","cit":5,"pfa":"Henry A. MacConnel","psa":"Steven Radowitz","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4403399004","eid":"W4403399004"},{"id":"paper-w4410701100","cat":"papers","name":"Therapeutic benefit versus epistemic risk: Need for empirical research in psychedelic epistemology","year":"2025","cit":5,"pfa":"Lucas F. Borkel","psa":"Luis Alberto Henríquez‐Hernández","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4410701100","eid":"W4410701100"},{"id":"paper-w4393533308","cat":"papers","name":"Gayze through the looking glass: The curious absence of queer narratives in psychedelia","year":"2024","cit":5,"pfa":"Stefanie Desrochers","topics":["Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4393533308","eid":"W4393533308"},{"id":"paper-w2127198730","cat":"papers","name":"Psychotherapy with Hallucinogenic Adjuncts from a Learning Perspective","year":"1981","cit":5,"pfa":"Alan Grieco","psa":"Robert B. Bloom","topics":["Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2127198730","eid":"W2127198730"},{"id":"paper-w4381195671","cat":"papers","name":"Commentary: Access to Psychedelics for Psychological Suffering at the End of Life – Prioritizing Our Priorities","year":"2023","cit":5,"pfa":"Daniel Rosenbaum","psa":"Daniel Z. Buchman","topics":["Anxiety & end-of-life","Policy & ethics"],"ptype":"editorial","src":"https://openalex.org/W4381195671","eid":"W4381195671"},{"id":"paper-w4211151898","cat":"papers","name":"Seminars in the Psychotherapies","year":"2021","cit":5,"topics":["Safety & adverse events","Therapy practice"],"ptype":"book","src":"https://openalex.org/W4211151898","eid":"W4211151898"},{"id":"paper-w4409653629","cat":"papers","name":"Racial Differences in Naturalistic Psychedelic Use — Motivations for Use, Communication with Health Care Providers, and Outcomes","year":"2025","cit":5,"pfa":"Nicolas G. Glynos","psa":"Philippe Lucas","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4409653629","eid":"W4409653629"},{"id":"paper-w4381838955","cat":"papers","name":"Preferences and Support for Psychedelic Policies and Practices Among Those Using Psychedelics","year":"2023","cit":5,"pfa":"Daniel J. Kruger","psa":"Kevin F. Boehnke","topics":["Addiction","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4381838955","eid":"W4381838955"},{"id":"paper-w3133469981","cat":"papers","name":"The Pharmacokinetics of Ketamine in the Breast Milk of Lactating Women: Quantification of ketamine and metabolites","year":"2021","cit":5,"pfa":"Philip E. Wolfson","psa":"Melissa Whippo","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W3133469981","eid":"W3133469981"},{"id":"paper-w4393928423","cat":"papers","name":"Is Personal Experience Essential for Effective Psychedelic Therapists?: The Challenges of Small, Accumulating Therapist Effects","year":"2024","cit":5,"pfa":"Mitch Earleywine","psa":"Samantha G. Gomez","topics":["Safety & adverse events","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4393928423","eid":"W4393928423"},{"id":"paper-w4416895864","cat":"papers","name":"Ontologically Challenging Psychedelic Experiences: Considerations for Managing Associated Distress","year":"2025","cit":5,"pfa":"Eirini K. Argyri","psa":"Jules Evans","ptype":"book-chapter","src":"https://openalex.org/W4416895864","eid":"W4416895864"},{"id":"paper-w4413115695","cat":"papers","name":"Building standards of psychedelic care: Qualitative examination of expert perspectives on safety, inclusion, and accountability","year":"2025","cit":5,"pfa":"Christina Chwyl","psa":"Philip Todd Korthuis","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4413115695","eid":"W4413115695"},{"id":"paper-w4313502928","cat":"papers","name":"Case report: Medical student types journals during ketamine infusions for suicidal ideation, treatment-resistant depression, post-traumatic stress disorder, and generalized anxiety disorder","year":"2022","cit":5,"pfa":"Joshua O. Willms","psa":"Jonathan J. Kopel","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4313502928","eid":"W4313502928"},{"id":"paper-w2535312025","cat":"papers","name":"Hallucinogens and Entheogens","year":"2015","cit":5,"pfa":"Michael Winkelman","psa":"Mark Anthony Hoffman","ptype":"dataset","src":"https://openalex.org/W2535312025","eid":"W2535312025"},{"id":"paper-w3134211783","cat":"papers","name":"Asking questions of psychedelic microdosing","year":"2021","cit":5,"pfa":"Lindsay P Cameron","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3134211783","eid":"W3134211783"},{"id":"paper-w4391107584","cat":"papers","name":"Psychedelic Drug Microdosing Practices: A Qualitative Online Exploration","year":"2024","cit":5,"pfa":"Estelle Miller","psa":"Rhys Ponton","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4391107584","eid":"W4391107584"},{"id":"paper-w4248063358","cat":"papers","name":"Hallucinogens","year":"2010","cit":5,"pfa":"Adam L. Halberstadt","psa":"Mark A. Geyer","ptype":"reference-entry","src":"https://openalex.org/W4248063358","eid":"W4248063358"},{"id":"paper-w2168422581","cat":"papers","name":"Therapeutic Effects of Hallucinogens","year":"1991","cit":5,"pfa":"Michael Winkelman","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2168422581","eid":"W2168422581"},{"id":"paper-w2416590971","cat":"papers","name":"Are hallucinogens psychoheuristic?","year":"1994","cit":5,"pfa":"Stephen Szára","ptype":"other","src":"https://openalex.org/W2416590971","eid":"W2416590971"},{"id":"paper-w2029922228","cat":"papers","name":"Soma of the Aryans: An Ancient Hallucinogen?","year":"1971","cit":5,"pfa":"R. Gordon Wasson","ptype":"article","src":"https://openalex.org/W2029922228","eid":"W2029922228"},{"id":"paper-w2664778","cat":"papers","name":"Molecular Pharmacology of Hallucinogens","year":"1968","cit":5,"pfa":"Victor S. Johnston","psa":"Ronald J. Bradley","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W2664778","eid":"W2664778"},{"id":"paper-w2430817721","cat":"papers","name":"An electrophysiological analysis of hallucinogens.","year":"1973","cit":5,"pfa":"M A Cowen","psa":"D Hammack","ptype":"article","src":"https://openalex.org/W2430817721","eid":"W2430817721"},{"id":"paper-w4252587084","cat":"papers","name":"The death and rebirth of hallucinogens","year":"2016","cit":5,"ptype":"article","src":"https://openalex.org/W4252587084","eid":"W4252587084"},{"id":"paper-w2038008921","cat":"papers","name":"Petunia violacea: hallucinogen or not?","year":"1981","cit":5,"pfa":"Edward G. Butler","psa":"Richard Evans Schultes","ptype":"article","src":"https://openalex.org/W2038008921","eid":"W2038008921"},{"id":"paper-w1557290402","cat":"papers","name":"Hallucinogen‐Related Disorders","year":"2010","cit":5,"pfa":"Olivia Y. Hung","psa":"Charles F. Gillespie","topics":["Anxiety & end-of-life"],"ptype":"reference-entry","src":"https://openalex.org/W1557290402","eid":"W1557290402"},{"id":"paper-w2913658881","cat":"papers","name":"Psychedelic Feminism: A Radical Interpretation of Psychedelic Consciousness?","year":"2019","cit":5,"pfa":"Kim Hewitt","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2913658881","eid":"W2913658881"},{"id":"paper-w2471552893","cat":"papers","name":"[Action of hallucinogens on electroencephalograms].","year":"1972","cit":5,"pfa":"Oughourlian Jm","psa":"J Verdeaux","ptype":"article","src":"https://openalex.org/W2471552893","eid":"W2471552893"},{"id":"paper-w2405898571","cat":"papers","name":"Current status of hallucinogens in the cactaceae.","year":"1967","cit":5,"pfa":"Der Marderosian A","ptype":"article","src":"https://openalex.org/W2405898571","eid":"W2405898571"},{"id":"paper-w2044344557","cat":"papers","name":"The Cyclic Psychedelics","year":"1968","cit":5,"pfa":"Sidney Cohen","ptype":"article","src":"https://openalex.org/W2044344557","eid":"W2044344557"},{"id":"paper-w2012917899","cat":"papers","name":"Microdosing: The New Pharmacokinetic Paradigm?","year":"2006","cit":5,"pfa":"Guido R. Zanni","psa":"Jeannette Y. Wick","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2012917899","eid":"W2012917899"},{"id":"paper-w123370846","cat":"papers","name":"Entheogens, Elves and Other Entities: Encountering the Spirits of Shamanic Plants and Substances","year":"2018","cit":5,"pfa":"Des Tramacchi","topics":["Addiction","Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W123370846","eid":"W123370846"},{"id":"paper-w4231263071","cat":"papers","name":"Psychedelic Healing?","year":"2007","cit":5,"pfa":"David Jay Brown","ptype":"article","src":"https://openalex.org/W4231263071","eid":"W4231263071"},{"id":"paper-w4409619685","cat":"papers","name":"Anthropology of Psychedelics","year":"2025","cit":5,"pfa":"Joshua Falcon","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4409619685","eid":"W4409619685"},{"id":"paper-w4249350513","cat":"papers","name":"PSYCHEDELIC DRUGS","year":"1966","cit":5,"pfa":"Max Rinkel","ptype":"article","src":"https://openalex.org/W4249350513","eid":"W4249350513"},{"id":"paper-w4400744923","cat":"papers","name":"The psychedelic mind: Current user perceptions of psychedelic drugs and their use","year":"2024","cit":5,"pfa":"Sarah McGruddy","psa":"Ryan D. Ward","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4400744923","eid":"W4400744923"},{"id":"paper-w4401198885","cat":"papers","name":"Neurobiological Correlates of Psychedelic Experiences and Psychedelic-Associated Adverse Effects","year":"2024","cit":5,"pfa":"Nathalie M. Rieser","psa":"Katrin H. Preller","topics":["Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W4401198885","eid":"W4401198885"},{"id":"paper-w2411300723","cat":"papers","name":"An explanation of the behavioral and therapeutic effects of the hallucinogens.","year":"1965","cit":5,"pfa":"Barrios Aa","ptype":"article","src":"https://openalex.org/W2411300723","eid":"W2411300723"},{"id":"paper-w1995607306","cat":"papers","name":"Chemical Detection Of Selected Hallucinogens In Water","year":"1981","cit":5,"pfa":"Edward J. Poziomek","psa":"Eleanor V. Crabtree","ptype":"article","src":"https://openalex.org/W1995607306","eid":"W1995607306"},{"id":"paper-w2084212617","cat":"papers","name":"A field test for hallucinogens: further improvements","year":"1974","cit":5,"pfa":"M J de Faubert Maunder","ptype":"article","src":"https://openalex.org/W2084212617","eid":"W2084212617"},{"id":"paper-w4401753304","cat":"papers","name":"Editorial: Psychedelic humanities","year":"2024","cit":5,"pfa":"Tehseen N. Noorani","psa":"Erika Dyck","topics":["Therapy practice"],"ptype":"editorial","src":"https://openalex.org/W4401753304","eid":"W4401753304"},{"id":"paper-w2064003032","cat":"papers","name":"The Psychedelic Plague and Polypsychotropia","year":"1971","cit":5,"pfa":"Patrick T. Donlon","ptype":"article","src":"https://openalex.org/W2064003032","eid":"W2064003032"},{"id":"paper-w4210326781","cat":"papers","name":"Psychedelics, connectedness, and compassion","year":"2022","cit":5,"pfa":"Enzo Tagliazucchi","psa":"Natali Gumiy","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"book-chapter","src":"https://openalex.org/W4210326781","eid":"W4210326781"},{"id":"paper-w4200280391","cat":"papers","name":"Legalization of Psychedelic Substances","year":"2021","cit":5,"pfa":"Mason Marks","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4200280391","eid":"W4200280391"},{"id":"paper-w4409645112","cat":"papers","name":"American Indian areas and psychedelics: A test of the minorities’ diminished psychedelic returns.","year":"2025","cit":5,"pfa":"Sean M. Viña","ptype":"article","src":"https://openalex.org/W4409645112","eid":"W4409645112"},{"id":"paper-w4392549735","cat":"papers","name":"‘Psychedelics are no magic pill’: the narrative and embodied dimensions of psychedelic integration in Denmark","year":"2024","cit":5,"pfa":"Sidsel Marie","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4392549735","eid":"W4392549735"},{"id":"paper-w1993404617","cat":"papers","name":"Marihuana—A Psychedelic Drug?","year":"1974","cit":5,"pfa":"E. Robert Sinnett","psa":"William M. Harvey","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W1993404617","eid":"W1993404617"},{"id":"paper-w4413275647","cat":"papers","name":"The emotional architecture of the psychedelic brain","year":"2025","cit":5,"pfa":"Flora Moujaes","psa":"Katrin H. Preller","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4413275647","eid":"W4413275647"},{"id":"paper-w3012440158","cat":"papers","name":"Trip: Psychedelics, Alienation, and Change","year":"2018","cit":5,"pfa":"Tao Lin","ptype":"book","src":"https://openalex.org/W3012440158","eid":"W3012440158"},{"id":"paper-w4211104201","cat":"papers","name":"Designing nonhallucinogenic psychedelic analogues","year":"2022","cit":5,"pfa":"Sarah Crunkhorn","ptype":"article","src":"https://openalex.org/W4211104201","eid":"W4211104201"},{"id":"paper-w4293104100","cat":"papers","name":"Psychedelic drugs take on depression","year":"2022","cit":5,"pfa":"Cassandra Willyard","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4293104100","eid":"W4293104100"},{"id":"paper-w2331687003","cat":"papers","name":"New Hope for Hallucinogen-Induced Persistent Perceptual Disorder?","year":"2001","cit":5,"pfa":"Henry David Abraham","ptype":"article","src":"https://openalex.org/W2331687003","eid":"W2331687003"},{"id":"paper-w2949293433","cat":"papers","name":"Entheogen-Enhanced Transpersonal Psychotherapy of Addictions:Focus on Clinical Applications of Ketamine for Treating Alcoholism","year":"2009","cit":5,"pfa":"Eli Kolp","psa":"M. Scott Young","topics":["Addiction","Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W2949293433","eid":"W2949293433"},{"id":"paper-w4400091227","cat":"papers","name":"On the social epistemology of psychedelic experience","year":"2024","cit":5,"pfa":"Mette Marie Pedersen","psa":"Asbjørn Steglich‐Petersen","topics":["Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4400091227","eid":"W4400091227"},{"id":"paper-w2557454621","cat":"papers","name":"The successful return of psychedelics to psychiatry","year":"2016","cit":5,"pfa":"Herbert D. Kleber","ptype":"article","src":"https://openalex.org/W2557454621","eid":"W2557454621"},{"id":"paper-w2066882775","cat":"papers","name":"Sacred Plants and the Gnostic Church: Speculations on Entheogen-Use in Early Christian Ritual","year":"2014","cit":5,"pfa":"Jerry B. Brown","psa":"Matthew Lupu","ptype":"article","src":"https://openalex.org/W2066882775","eid":"W2066882775"},{"id":"paper-w2416881849","cat":"papers","name":"Experimental psychiatry. IV. Hallucinogens: tools in experimental psychiatry.","year":"1955","cit":5,"pfa":"Max Rinkel","psa":"Solomon Hc","ptype":"article","src":"https://openalex.org/W2416881849","eid":"W2416881849"},{"id":"paper-w1976749275","cat":"papers","name":"The bad trip: An epidemiological survey of youthful hallucinogen use","year":"1977","cit":5,"pfa":"David R. Rubinow","psa":"Robert Cancro","ptype":"article","src":"https://openalex.org/W1976749275","eid":"W1976749275"},{"id":"paper-w13000249","cat":"papers","name":"ANALYSIS OF DOSE-EFFECT RELATIONSHIPS BASED ON THE MICRODOSE CONCEPT.","year":"1971","cit":5,"pfa":"Nobuhiro Oda","psa":"S. Ohtani","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W13000249","eid":"W13000249"},{"id":"paper-w378923526","cat":"papers","name":"Neural correlates of hallucinogen-induced altered states of consciousness","year":"1999","cit":5,"pfa":"Franz X. Vollenweider","psa":"M. F. I. Vollenweider-Scherpenhuyzen","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W378923526","eid":"W378923526"},{"id":"paper-w4388188104","cat":"papers","name":"Introduction to Deleuze and Guattari and the Psychedelic Revival","year":"2023","cit":5,"pfa":"Patricia Pisters","ptype":"article","src":"https://openalex.org/W4388188104","eid":"W4388188104"},{"id":"paper-w4390741844","cat":"papers","name":"Exercise microdosing for skeletal muscle health applications to spaceflight","year":"2024","cit":5,"pfa":"Adam Christopher Voss","psa":"Scott W. Trappe","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4390741844","eid":"W4390741844"},{"id":"paper-w4405955622","cat":"papers","name":"Psychedelics in Psychiatry: Oh, What A Trip!","year":"2025","cit":5,"pfa":"Gregory A. Fonzo","psa":"Ned H. Kalin","ptype":"article","src":"https://openalex.org/W4405955622","eid":"W4405955622"},{"id":"paper-w4396813176","cat":"papers","name":"Considering the nocebo effect in the psychedelic discourse","year":"2024","cit":5,"pfa":"Maria Bălăeţ","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4396813176","eid":"W4396813176"},{"id":"paper-w2121495950","cat":"papers","name":"Moksha: Writings on Psychedelics and the Visionary Experience","year":"1982","cit":5,"pfa":"Stanley Krippner","ptype":"article","src":"https://openalex.org/W2121495950","eid":"W2121495950"},{"id":"paper-w2416195800","cat":"papers","name":"Conformational studies on phenethylamine hallucinogens: the role of alpha alkyl substitution.","year":"1978","cit":5,"pfa":"Alex Makriyannis","psa":"James J. Knittel","ptype":"article","src":"https://openalex.org/W2416195800","eid":"W2416195800"},{"id":"paper-w4210348456","cat":"papers","name":"Psychedelics and schizophrenia: Distinct alterations to Bayesian inference","year":"2022","cit":5,"pfa":"Hardik Rajpal","psa":"Henrik Jeldtoft Jensen","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4210348456","eid":"W4210348456"},{"id":"paper-w2401202707","cat":"papers","name":"An economical screen for phenethylamine-type hallucinogens: mouse ear scratching.","year":"1979","cit":5,"pfa":"Yim Gk","psa":"D E Nichols","ptype":"article","src":"https://openalex.org/W2401202707","eid":"W2401202707"},{"id":"paper-w4224242521","cat":"papers","name":"Stepping through the Psychedelic Looking-Glass","year":"2022","cit":5,"pfa":"Aidan Lyon","psa":"Anya Farennikova","topics":["Mechanism & neuroscience","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4224242521","eid":"W4224242521"},{"id":"paper-w1017422679","cat":"papers","name":"The Fifth Freedom: The Politics of Psychedelic Patriotism","year":"2015","cit":5,"pfa":"Chris Elcock","ptype":"article","src":"https://openalex.org/W1017422679","eid":"W1017422679"},{"id":"paper-w4381739471","cat":"papers","name":"Psychedelics and ketamine are a symptom of psychiatry’s woes, not a cure","year":"2023","cit":5,"pfa":"Andrew H. Miller","psa":"Charles L. Raison","ptype":"article","src":"https://openalex.org/W4381739471","eid":"W4381739471"},{"id":"paper-w2413879837","cat":"papers","name":"Evaluation of substituted-amphetamine hallucinogens using the cat limb flick model.","year":"1977","cit":5,"pfa":"Rusterholz Db","psa":"Barfknecht Cf","ptype":"article","src":"https://openalex.org/W2413879837","eid":"W2413879837"},{"id":"paper-w4391617281","cat":"papers","name":"Membrane Permeation of Psychedelic Tryptamines by Dynamic Simulations","year":"2024","cit":5,"pfa":"Vito Federico Palmisano","psa":"Juan José Nogueira","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4391617281","eid":"W4391617281"},{"id":"paper-w4210778796","cat":"papers","name":"1589 Levetiracetam efficacy in hallucinogen persisting perception disorders: a prospective study","year":"2005","cit":5,"ptype":"article","src":"https://openalex.org/W4210778796","eid":"W4210778796"},{"id":"paper-w4241699299","cat":"papers","name":"Psychedelic, Psychoactive and Addictive Drugs and States of Consciousness","year":"2004","cit":5,"pfa":"Ralph Metzner","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W4241699299","eid":"W4241699299"},{"id":"paper-w137135097","cat":"papers","name":"Cannabis and the Psychedelics: Reviewing the UN Drug Conventions","year":"2013","cit":5,"pfa":"Amanda Feilding","topics":["Reviews & meta-analyses"],"ptype":"book-chapter","src":"https://openalex.org/W137135097","eid":"W137135097"},{"id":"paper-w2967433491","cat":"papers","name":"Demographic Characteristics and Frequency of Use among Current Users of Classic Hallucinogens","year":"2019","cit":5,"pfa":"Jennifer A. Lyke","psa":"Julia Kuti","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2967433491","eid":"W2967433491"},{"id":"paper-w2264278711","cat":"papers","name":"Sacred chemicals: Psychedelic drugs and mystical experience","year":"2003","cit":5,"pfa":"Christopher H. Partridge","ptype":"book-chapter","src":"https://openalex.org/W2264278711","eid":"W2264278711"},{"id":"paper-w2481982585","cat":"papers","name":"The Psychedelic Transmogrification of the Soul in Vercelli Homily IV","year":"2003","cit":5,"pfa":"Thomas N. Hall","ptype":"book-chapter","src":"https://openalex.org/W2481982585","eid":"W2481982585"},{"id":"paper-w2024824570","cat":"papers","name":"An analysis of a peer network using psychedelic drugs","year":"1969","cit":5,"pfa":"Edward F. Foulks","psa":"Russell Eisenman","ptype":"article","src":"https://openalex.org/W2024824570","eid":"W2024824570"},{"id":"paper-w4407056685","cat":"papers","name":"Impact of psychedelics on craving in addiction: A systematic review","year":"2025","cit":5,"pfa":"Sophie‐Athéna Chapron","psa":"Marc Auriacombe","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4407056685","eid":"W4407056685"},{"id":"paper-w4405319731","cat":"papers","name":"Suggestibility and psychedelics: From therapeutics to social context.","year":"2024","cit":5,"pfa":"Alison Kate Oliver","psa":"Amir Raz","ptype":"article","src":"https://openalex.org/W4405319731","eid":"W4405319731"},{"id":"paper-w2394538579","cat":"papers","name":"Alsactide: ACTH-agonist for use in microdoses in brain-adrenal and other feedsidewards.","year":"1987","cit":5,"pfa":"Andrea Angeli","psa":"L. Martini","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2394538579","eid":"W2394538579"},{"id":"paper-w3002040796","cat":"papers","name":"Pilot Study to Predict Pharmacokinetics of a Therapeutic Gemcitabine Dose From a Microdose","year":"2020","cit":5,"pfa":"Merel van Nuland","psa":"Jos H. Beijnen","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3002040796","eid":"W3002040796"},{"id":"paper-w4405478459","cat":"papers","name":"Ethical Considerations Regarding Psychedelics for Clinical Pain Research","year":"2024","cit":5,"pfa":"Christopher Louis Robinson","psa":"Trent D. Emerick","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4405478459","eid":"W4405478459"},{"id":"paper-w4408343206","cat":"papers","name":"Meaningful Psychedelic Experiences Predict Increased Moral Expansiveness","year":"2025","cit":5,"pfa":"Will Olteanu","psa":"Sam G. Moreton","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4408343206","eid":"W4408343206"},{"id":"paper-w353275238","cat":"papers","name":"Spirituality and Hallucinogen Use: Results from a Pilot Study among College Students","year":"2012","cit":5,"pfa":"Adam Stasko","psa":"Amy Pilley","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W353275238","eid":"W353275238"},{"id":"paper-w4404685833","cat":"papers","name":"The Use of Classic Psychedelics for Depressive and Anxiety-Spectrum Disorders","year":"2024","cit":5,"pfa":"Vivian Kim","psa":"Mary E. Woesner","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4404685833","eid":"W4404685833"},{"id":"paper-w123992934","cat":"papers","name":"Testing Psychotherapies and Drug Therapies: The Case of Psychedelic Drugs","year":"1990","cit":5,"pfa":"James B. Bakalar","psa":"Lester Grinspoon","topics":["Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W123992934","eid":"W123992934"},{"id":"paper-w4293106346","cat":"papers","name":"Psychedelics: Their Limited Understanding and Future in the Treatment of Chronic Pain","year":"2022","cit":5,"pfa":"Vedant N Hedau","psa":"Ashish P Anjankar","topics":["PTSD & trauma","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4293106346","eid":"W4293106346"},{"id":"paper-w4402027252","cat":"papers","name":"Functional Unblinding in Pivotal Studies and the Future of Psychedelic Medicine.","year":"2024","cit":5,"pfa":"Jerrold F. Rosenbaum","ptype":"article","src":"https://openalex.org/W4402027252","eid":"W4402027252"},{"id":"paper-w4416008623","cat":"papers","name":"Gaps in US Psychedelic Policy and How to Close Them","year":"2025","cit":5,"pfa":"Caleigh Propes","psa":"David B. Yaden","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4416008623","eid":"W4416008623"},{"id":"paper-w4409639782","cat":"papers","name":"Serotonin, immune function, and psychedelics as potent anti-inflammatories","year":"2025","cit":5,"pfa":"Charles David Nichols","psa":"Timothy P. Foster","topics":["Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W4409639782","eid":"W4409639782"},{"id":"paper-w2792462128","cat":"papers","name":"Developing a cassette microdosing approach to enhance the throughput of PET imaging agent screening","year":"2018","cit":5,"pfa":"Hao Xiao","psa":"Jinping Qiao","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2792462128","eid":"W2792462128"},{"id":"paper-w7119212462","cat":"papers","name":"Zalsupindole: A Non-Hallucinogenic Psychoplastogen Advancing Psychedelic-Inspired Therapeutics","year":"2026","cit":5,"pfa":"Miguel Salfiti","psa":"Georgios Mikellides","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7119212462","eid":"W7119212462"},{"id":"paper-w3035178171","cat":"papers","name":"Psychotic and Still Tripping—Hallucinogen Persisting Perception Disorder and First Break Psychosis in an Adolescent","year":"2020","cit":5,"pfa":"Sean Nutting","psa":"Taranjeet S. Jolly","ptype":"article","src":"https://openalex.org/W3035178171","eid":"W3035178171"},{"id":"paper-w4401842468","cat":"papers","name":"Microdosing: A Conceptual Framework for Use as Programming Strategy for Resistance Training in Team Sports","year":"2024","cit":5,"pfa":"Matthew Cuthbert","psa":"Paul Comfort","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4401842468","eid":"W4401842468"},{"id":"paper-w798068542","cat":"papers","name":"Charge deposition model for investigating SE-microdose effect in trench power MOSFETs","year":"2015","cit":5,"pfa":"Xin Wan","psa":"Jun Xu","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W798068542","eid":"W798068542"},{"id":"paper-w4409566387","cat":"papers","name":"“Ontological shocks”: new transformations for sustainability through psychedelic tourism","year":"2025","cit":5,"pfa":"Alexandra Coghlan","psa":"Girish Prayag","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4409566387","eid":"W4409566387"},{"id":"paper-w4405850617","cat":"papers","name":"The serotonergic psychedelic DOI impairs deviance detection in the auditory cortex","year":"2024","cit":5,"pfa":"Max Horrocks","psa":"Santiago Jaramillo","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4405850617","eid":"W4405850617"},{"id":"paper-w4404723884","cat":"papers","name":"Psychedelics for treating psychiatric disorders: from circuit mechanisms to applications","year":"2024","cit":5,"pfa":"Jie Jia Li","psa":"Ti‐Fei Yuan","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4404723884","eid":"W4404723884"},{"id":"paper-w4384663276","cat":"papers","name":"Automated Detection of Psychedelic-Induced Head-Twitch Response in Mice","year":"2023","cit":5,"pfa":"Alaina M. Jaster","psa":"Javier González‐Maeso","ptype":"book-chapter","src":"https://openalex.org/W4384663276","eid":"W4384663276"},{"id":"paper-w4407686798","cat":"papers","name":"Psychedelics and the Autonomic Nervous System: A Perspective on Their Interplay and Therapeutic Potential","year":"2025","cit":5,"pfa":"Hongyuan Li","psa":"Xiaohui Wang","ptype":"editorial","src":"https://openalex.org/W4407686798","eid":"W4407686798"},{"id":"paper-w3212356139","cat":"papers","name":"Natural Language as a Window into the Subjective Effects and Neurochemistry of Psychedelic Drugs","year":"2021","cit":5,"pfa":"Enzo Tagliazucchi","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W3212356139","eid":"W3212356139"},{"id":"paper-w4297849010","cat":"papers","name":"Classic psychedelics: past uses, present trends, future possibilities","year":"2022","cit":5,"pfa":"Adam Safron","psa":"Matthew W. Johnson","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4297849010","eid":"W4297849010"},{"id":"paper-w1974301044","cat":"papers","name":"Both indoleamine and phenylethylamine hallucinogens increase serotonin in both dorsal and median raphe neurons","year":"1980","cit":5,"pfa":"Mark A. Geyer","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1974301044","eid":"W1974301044"},{"id":"paper-w2339233284","cat":"papers","name":"Perception and Knowledge: Reflections on Psychological and Spiritual Learning in the Psychedelic Experience","year":"2010","cit":5,"pfa":"Lester Grinspoon","psa":"James B. Bakalar","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2339233284","eid":"W2339233284"},{"id":"paper-w4407958909","cat":"papers","name":"Exploring End-of-Life Experiences and Consciousness through the Lens of Psychedelics","year":"2025","cit":5,"pfa":"Hongyuan Li","psa":"Xiaohui Wang","topics":["Anxiety & end-of-life"],"ptype":"editorial","src":"https://openalex.org/W4407958909","eid":"W4407958909"},{"id":"paper-w4409620999","cat":"papers","name":"Exploring the Role of Psychedelics in Modulating Ego and Treating Neuropsychiatric Disorders","year":"2025","cit":5,"pfa":"Hongshuang Wang","psa":"Xiaohui Wang","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4409620999","eid":"W4409620999"},{"id":"paper-w3085849185","cat":"papers","name":"Analysis of labor opportunity cost on the economic profitability of fertilizer microdosing (FM) in Burkina Faso","year":"2020","cit":5,"pfa":"Mamadou Sanogo","psa":"Kestemont Marie-Paule","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3085849185","eid":"W3085849185"},{"id":"paper-w2131724767","cat":"papers","name":"Editor’s Introduction: Psychedelic Resurgence—Research and Therapeutic Uses, Past and Present","year":"2014","cit":5,"pfa":"Terry Chambers","ptype":"article","src":"https://openalex.org/W2131724767","eid":"W2131724767"},{"id":"paper-w2154690139","cat":"papers","name":"Early and late hormonal responses to the microdose gonadotropin-releasing hormone agonist in normal menstruating women","year":"2004","cit":5,"pfa":"Won I. Park","psa":"Jin Yong Lee","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2154690139","eid":"W2154690139"},{"id":"paper-w1545624832","cat":"papers","name":"Goa: 20 Years of Psychedelic Trance (Tom Rom and Pascal Querner)","year":"2015","cit":5,"pfa":"Joshua Schmidt","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1545624832","eid":"W1545624832"},{"id":"paper-w4399804893","cat":"papers","name":"Psychedelics in developmental stuttering to modulate brain functioning: a new therapeutic perspective?","year":"2024","cit":5,"pfa":"Giuseppe Pasculli","psa":"Robin Lester Carhart-Harris","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4399804893","eid":"W4399804893"},{"id":"paper-w4296185647","cat":"papers","name":"Heads, Seekers, Psychonauts, and One-Timers: Patterns in Stories of Psychedelic Consumption","year":"2022","cit":5,"pfa":"Cindy Brooks Dollar","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4296185647","eid":"W4296185647"},{"id":"paper-w4387661891","cat":"papers","name":"Psychedelic Research and Therapeutic Practices: Embracing Communities, Groups, and Traditional Knowledge","year":"2023","cit":5,"pfa":"Veronica Magar","psa":"Brian T. Anderson","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4387661891","eid":"W4387661891"},{"id":"paper-w4383224193","cat":"papers","name":"Altered states of leadership: mindfulness meditation, psychedelic use, and leadership development","year":"2023","cit":5,"pfa":"Otto Simonsson","psa":"Walter Osika","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4383224193","eid":"W4383224193"},{"id":"paper-w2021327393","cat":"papers","name":"A study of ring‐substituent influence on pharmacological activity in a series of phenethylamine‐type psychedelics","year":"2004","cit":5,"pfa":"James W. King","psa":"Stephen P. Molnar","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2021327393","eid":"W2021327393"},{"id":"paper-w3164510732","cat":"papers","name":"On the degrees of freedom worth having: psychedelics as means of understanding and expanding free will","year":"2021","cit":5,"pfa":"Adam Safron","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W3164510732","eid":"W3164510732"},{"id":"paper-w2089208419","cat":"papers","name":"Microdose α-interferon shows clinical and antiangiogenic effect in extramedullary myeloid tumor: a case report","year":"2003","cit":5,"pfa":"Pier Paolo Piccaluga","psa":"Stefano Aldo Pileri","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2089208419","eid":"W2089208419"},{"id":"paper-w7213551688","cat":"papers","name":"Employment-Related Risks in a Clinical Trial of Psychedelic Treatment for Chronic Pain","year":"2026","cit":5,"pfa":"Liza Dawson","psa":"Liza‐Marie Johnson","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7213551688","eid":"W7213551688"},{"id":"paper-w2795736974","cat":"papers","name":"Improving Agronomic Efficiency of Mineral Fertilizers through Microdose on Sorghum in the Sub-arid Zone of Burkina Faso","year":"2018","cit":5,"pfa":"Bala Mamadou OUATTARA","psa":"A. Bationo","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W2795736974","eid":"W2795736974"},{"id":"paper-w4310423867","cat":"papers","name":"Transformative agents of change and investigative neurotechnologies: A qualitative study of psychedelic technology identities","year":"2022","cit":5,"pfa":"Michaela Barber","psa":"Adrian Carter","ptype":"article","src":"https://openalex.org/W4310423867","eid":"W4310423867"},{"id":"paper-w2178440045","cat":"papers","name":"Analysis of a New Potent Hallucinogen, 25-B-NBOMe, in Blotters by High-Performance Thin-Layer Chromatography","year":"2015","cit":5,"pfa":"Boris Ettienne Duffau","psa":"Edwar Fuentes","ptype":"article","src":"https://openalex.org/W2178440045","eid":"W2178440045"},{"id":"paper-w2074704428","cat":"papers","name":"Sensitivity and Proportionality Assessment of Metabolites from Microdose to High Dose in Rats Using LC–MS/MS","year":"2010","cit":5,"pfa":"Jinsong Ni","psa":"Gabriella Szekely‐Klepser","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2074704428","eid":"W2074704428"},{"id":"paper-w4233996129","cat":"papers","name":"Psychotomimetic Drugs","year":"2006","cit":5,"ptype":"book-chapter","src":"https://openalex.org/W4233996129","eid":"W4233996129"},{"id":"paper-w4253016188","cat":"papers","name":"Psychotomimetic drugs","year":"1958","cit":5,"pfa":"Henry K. Beecher","ptype":"article","src":"https://openalex.org/W4253016188","eid":"W4253016188"},{"id":"paper-w4399982789","cat":"papers","name":"Psychotomimetic compensation versus sensitization","year":"2024","cit":5,"pfa":"Ari Brouwer","psa":"Charles L. Raison","topics":["Depression","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4399982789","eid":"W4399982789"},{"id":"paper-w2050652548","cat":"papers","name":"Human Lung Cancer Risks from Radon – Part I - Influence from Bystander Effects - A Microdose Analysis","year":"2010","cit":5,"pfa":"Bobby E. Leonard","psa":"Georgia C. Beecher","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2050652548","eid":"W2050652548"},{"id":"paper-w2743381408","cat":"papers","name":"6. ‘Just Say Know’: Criminalizing LSD and the Politics of Psychedelic Expertise, 1961–8","year":"2011","cit":5,"pfa":"Erika Dyck","ptype":"book-chapter","src":"https://openalex.org/W2743381408","eid":"W2743381408"},{"id":"paper-w4414139712","cat":"papers","name":"A Sensitive and Comprehensive LC‐MS/MS Method for the Analysis of Hallucinogens, Synthetic Cathinones, and Synthetic Cannabinoids in Urine Samples","year":"2025","cit":5,"pfa":"Bruno Pereira dos Santos","psa":"Tiago Franco de Oliveira","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4414139712","eid":"W4414139712"},{"id":"paper-w4385458750","cat":"papers","name":"Could classic psychedelics influence immigrants’ acculturation process? A narrative review contemplating how","year":"2023","cit":5,"pfa":"Benjamin A. Korman","topics":["Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4385458750","eid":"W4385458750"},{"id":"paper-w4221093671","cat":"papers","name":"The doors of precision: Reenergizing psychiatric drug development with psychedelics and open access computational tools","year":"2022","cit":5,"pfa":"Daniel S. Barron","psa":"Richard A. Friedman","ptype":"article","src":"https://openalex.org/W4221093671","eid":"W4221093671"},{"id":"paper-w4400383201","cat":"papers","name":"Effects of psychedelic, DOI, on nucleus accumbens dopamine signaling to predictable rewards and cues in rats","year":"2024","cit":5,"pfa":"David Alexander Martin","psa":"Donna J. Calu","ptype":"article","src":"https://openalex.org/W4400383201","eid":"W4400383201"},{"id":"paper-w4388268207","cat":"papers","name":"Psychedelic and nutraceutical interventions as therapeutic strategies for military-related mild traumatic brain injuries","year":"2023","cit":5,"pfa":"Amy Claire Reichelt","psa":"Benjamin Thomas Dunkley","topics":["PTSD & trauma","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4388268207","eid":"W4388268207"},{"id":"paper-w1765201057","cat":"papers","name":"The Psychedelic Journey of Marlene Dobkin de Rios: 45 Years with Shamans, Ayahuasqueros, and Ethnobotanists","year":"2011","cit":5,"pfa":"David E. Smith","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1765201057","eid":"W1765201057"},{"id":"paper-w4417145594","cat":"papers","name":"Practitioner perspectives on extended difficulties and optimal support strategies following psychedelic experiences: a qualitative analysis","year":"2025","cit":5,"pfa":"Eirini K. Argyri","psa":"Celia J. A. Morgan","topics":["PTSD & trauma","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4417145594","eid":"W4417145594"},{"id":"paper-w1994190136","cat":"papers","name":"Guest editorial: Paradise is paradise: Reflections on psychedelic drugs, mystical experience, and the near-death experience","year":"1988","cit":5,"pfa":"Kenneth Ring","ptype":"editorial","src":"https://openalex.org/W1994190136","eid":"W1994190136"},{"id":"paper-w2899264449","cat":"papers","name":"Dream over life: Psychedelic terphenyl derivative induce hallucination via cannabinoid receptor 1","year":"2018","cit":5,"pfa":"F A Fauzi","psa":"Muhamad Fairus Noor Hassim","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"conference-paper","src":"https://openalex.org/W2899264449","eid":"W2899264449"},{"id":"paper-w4396821024","cat":"papers","name":"Divergent Effects of Ketamine and the Serotoninergic Psychedelic 2,5-Dimethoxy-4-Iodoamphetamine on Hippocampal Plasticity and Metaplasticity","year":"2024","cit":5,"pfa":"Zarmeen Zahid","psa":"Matthew I. Banks","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4396821024","eid":"W4396821024"},{"id":"paper-w4249513140","cat":"papers","name":"Correction: Chronic Microdose Lithium Treatment Prevented Memory Loss and Neurohistopathological Changes in a Transgenic Mouse Model of Alzheimer's Disease","year":"2015","cit":5,"pfa":"Marielza Andrade Nunes","psa":"Hudson Sousa Buck","topics":["Dosing & pharmacology"],"ptype":"erratum","src":"https://openalex.org/W4249513140","eid":"W4249513140"},{"id":"paper-w4406044673","cat":"papers","name":"Unveiling Psychedelics: One of the Most Meaningful Events in Life Associated with Improved Well-Being in Swedish Users","year":"2025","cit":5,"pfa":"Petri Kajonius","psa":"Emma Claesdotter‐Knutsson","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4406044673","eid":"W4406044673"},{"id":"paper-w7152959768","cat":"papers","name":"Pathway-selective signaling of serotonergic psychedelics at 5-HT receptors: Implications for psychoactivity, safety, and therapeutic potential","year":"2026","cit":5,"pfa":"Deborah Rudin","psa":"Dino Luethi","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7152959768","eid":"W7152959768"},{"id":"paper-w2993173737","cat":"papers","name":"Molecular Scale Studies of Phosphorus Speciation and Transformation in Manure Amended and Microdose Fertilized Indigenous Vegetable Production Systems of Nigeria and Republic of Benin","year":"2020","cit":5,"pfa":"Abimfoluwa Olaleye","psa":"Derek Peak","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2993173737","eid":"W2993173737"},{"id":"paper-w2409767289","cat":"papers","name":"PSYCHOTOMIMETICS: PHARMACODYNAMIC AND PSYCHOTHERAPEUTIC PROPERTIES.","year":"1963","cit":5,"pfa":"Ditman Ks","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2409767289","eid":"W2409767289"},{"id":"paper-w2027642369","cat":"papers","name":"The Synthesis of Some Analogs of the Hallucinogen 1-(2,5-Dimethoxy-4-methyl-phenyl)-2-aminopropane (DOM). III. Some Derivatives of 3-phenylalanine","year":"1974","cit":5,"pfa":"Ronald T. Coutts","psa":"Jerry L. Malicky","ptype":"article","src":"https://openalex.org/W2027642369","eid":"W2027642369"},{"id":"paper-w4399854154","cat":"papers","name":"Meaningfulness and attachment: what dreams, psychosis and psychedelic states tell us about our need for connection","year":"2024","cit":5,"pfa":"Lawrence G. Fischman","ptype":"article","src":"https://openalex.org/W4399854154","eid":"W4399854154"},{"id":"paper-w2477767344","cat":"papers","name":"CNS stimulants and psychotomimetic drugs","year":"2007","cit":5,"pfa":"HP Rang","psa":"RJ Flower","ptype":"book-chapter","src":"https://openalex.org/W2477767344","eid":"W2477767344"},{"id":"paper-w4308334894","cat":"papers","name":"What Is the ‘Unitive Mystical Experience’ Triggered by Psychedelic Medicines an Experience of? An Exploration of Aldous Huxley’s Viewpoint in Light of Current Data","year":"2022","cit":5,"pfa":"Dana W. Sawyer","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4308334894","eid":"W4308334894"},{"id":"paper-w187256382","cat":"papers","name":"[Emergencies associated with the consumption of designer drugs, hallucinogens and amphetamines treated at 15 Spanish hospitals in 1994. Work Group on the Study of Emergencies due to Psychostimulants].","year":"1997","cit":5,"pfa":"M. Ángeles Rodríguez-Arenas","psa":"Luis Royuela","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W187256382","eid":"W187256382"},{"id":"paper-w4392591323","cat":"papers","name":"Improvements in well-being following naturalistic psychedelic use and underlying mechanisms of change in older adults: A prospective cohort study","year":"2024","cit":5,"pfa":"Hannes Kettner","psa":"Lorenzo Pasquini","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4392591323","eid":"W4392591323"},{"id":"paper-w2729638561","cat":"papers","name":"Neuroendocrine effects of psychotomimetic drugs","year":"1981","cit":5,"pfa":"H.Y. Meltzer","psa":"David J. Goode","ptype":"article","src":"https://openalex.org/W2729638561","eid":"W2729638561"},{"id":"paper-w2417364184","cat":"papers","name":"Antagonism of psychotomimetic agents in the conscious cat.","year":"1960","cit":5,"pfa":"W. B. Rice","psa":"McColl Jd","ptype":"article","src":"https://openalex.org/W2417364184","eid":"W2417364184"},{"id":"paper-w4378193560","cat":"papers","name":"The Potentially Significant Role of CYP3A-Mediated Oxidative Metabolism of Dabigatran Etexilate and Its Intermediate Metabolites in Drug-Drug Interaction Assessments Using Microdose Dabigatran Etexilate","year":"2023","cit":5,"pfa":"Udomsak Udomnilobol","psa":"Thomayant Prueksaritanont","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4378193560","eid":"W4378193560"},{"id":"paper-w4360838483","cat":"papers","name":"Cleansing Frames: How Digital ‘Consumer Reports’ of Cannabis and Psychedelics Normalise Drug-Taking and Neutralise its Counter-Cultural Potential","year":"2023","cit":5,"pfa":"Isak Ladegaard","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4360838483","eid":"W4360838483"},{"id":"paper-w4394574066","cat":"papers","name":"Naturalistic use of psychedelics does not modulate processing of self‐related stimuli (but it might modulate attentional mechanisms): An event‐related potentials study","year":"2024","cit":5,"pfa":"Paweł Orlowski","psa":"Michał Bola","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4394574066","eid":"W4394574066"},{"id":"paper-w2491098635","cat":"papers","name":"Basic functions involved in the psychotherapeutic effect of psychotomimetics.","year":"1968","cit":5,"pfa":"H Leuner","topics":["Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W2491098635","eid":"W2491098635"},{"id":"paper-w1884563449","cat":"papers","name":"Validation of a liquid chromatography‐triple quadrupole mass spectrometric method for the determination of 5‐nitro‐5′‐hydroxy‐indirubin‐3′‐oxime (AGM‐130) in human plasma and its application to microdose clinical trial","year":"2015","cit":5,"pfa":"Min‐Ho Park","psa":"Young Geun Shin","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1884563449","eid":"W1884563449"},{"id":"paper-w2082726121","cat":"papers","name":"An Alternative Interpretation of “The Psychotomimetic Effects of Short-Term Sensory Deprivation”","year":"2010","cit":5,"pfa":"Vaughan Bell","ptype":"article","src":"https://openalex.org/W2082726121","eid":"W2082726121"},{"id":"paper-w63539267","cat":"papers","name":"The comparison of microdose flare-up and multiple dose antagonist protocols based on hCG day estradiol (E2), progesterone (P) and P/E2 ratio among poor responder patients in ICSI-ET cycles.","year":"2015","cit":5,"pfa":"M N Cicek","psa":"Serkan Kahyaoğlu","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W63539267","eid":"W63539267"},{"id":"paper-w2044334260","cat":"papers","name":"Psychotomimetics moderately affect dopamine receptor binding in the rat brain","year":"2000","cit":5,"pfa":"Mirko Tomić","psa":"Jelena Joksimović","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2044334260","eid":"W2044334260"},{"id":"paper-w4401009434","cat":"papers","name":"Acute subjective effects of psychedelics in naturalistic group settings prospectively predict longitudinal improvements in trauma symptoms, trait shame, and connectedness among adults with childhood maltreatment historie","year":"2024","cit":5,"pfa":"C. J. Healy","psa":"Wendy M. D'Andrea","topics":["PTSD & trauma","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4401009434","eid":"W4401009434"},{"id":"paper-w2319350426","cat":"papers","name":"Esters of Benzilic Acids and Congeners Having Potential Psychotomimetic Activity","year":"1960","cit":5,"pfa":"Joseph G. Cannon","ptype":"article","src":"https://openalex.org/W2319350426","eid":"W2319350426"},{"id":"paper-w2066635610","cat":"papers","name":"Influence of an anticholinergic psychotomimetic agent on behaviour in cats controlled by an auditory stimulus","year":"1974","cit":5,"pfa":"Karl Löwy","psa":"Leo G. Abood","ptype":"article","src":"https://openalex.org/W2066635610","eid":"W2066635610"},{"id":"paper-w1967805411","cat":"papers","name":"Impact of postnatal dexamethasone on psychotomimetic effects of MK-801 measured on adult rats","year":"2009","cit":5,"pfa":"Krzysztof Wędzony","psa":"Marzena Maćkowiak","ptype":"article","src":"https://openalex.org/W1967805411","eid":"W1967805411"},{"id":"paper-w1988551169","cat":"papers","name":"Glycogen phosphorylase levels in the brain of rats treated with psychotomimetic drugs and with tranquilizers","year":"1965","cit":5,"pfa":"Tom T. Iriye","psa":"Francis A. Simmonds","ptype":"article","src":"https://openalex.org/W1988551169","eid":"W1988551169"},{"id":"paper-w2397844180","cat":"papers","name":"Effects of the psychotomimetic benzomorphan N -allylnormetazocine (SKF 10,047) on prepulse inhibition of startle in mice","year":"2016","cit":5,"pfa":"Adam L. Halberstadt","psa":"Susan B. Powell","ptype":"article","src":"https://openalex.org/W2397844180","eid":"W2397844180"},{"id":"paper-w1981092813","cat":"papers","name":"C-Formylation in the presence of rat brain mitochondria of the 2,3,4,5-tetrahydropyridinium metabolite derived from the psychotomimetic drug phencyclidine","year":"1991","cit":5,"pfa":"Zhiyang Zhao","psa":"Neal Castagnoli","ptype":"article","src":"https://openalex.org/W1981092813","eid":"W1981092813"},{"id":"paper-w4410095934","cat":"papers","name":"Are the LSD-analogs lisuride and ergotamine examples of non-hallucinogenic serotonin 5-HT2A receptor agonists?","year":"2025","cit":5,"pfa":"Jan Kehler","psa":"Morten Skøtt Thomsen Lindskov","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4410095934","eid":"W4410095934"},{"id":"paper-w4319460860","cat":"papers","name":"Effects of Ketanserin, M100907 and Olanzapine on hallucinogenic like action induced by 2,5-dimethoxy-4-methylamphetamine","year":"2022","cit":5,"pfa":"Kaixi Li","psa":"Ruibin Su","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4319460860","eid":"W4319460860"},{"id":"paper-w2800789487","cat":"papers","name":"Who Is Keeping Tabs? LSD Lessons from the Past for the Future","year":"2018","cit":5,"pfa":"Erika Dyck","ptype":"book-chapter","src":"https://openalex.org/W2800789487","eid":"W2800789487"},{"id":"paper-w4409365229","cat":"papers","name":"Effect of the frequently used antiepileptic drugs carbamazepine, gabapentin, and pregabalin on the pharmacokinetics of edoxaban and other oral factor xa inhibitors in healthy volunteers","year":"2025","cit":5,"pfa":"Alexander Lenard","psa":"Antje Blank","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4409365229","eid":"W4409365229"},{"id":"paper-w4407278829","cat":"papers","name":"DMT-induced shifts in criticality correlate with ego-dissolution","year":"2025","cit":5,"pfa":"Mona Irrmischer","psa":"Christopher B. Timmermann","topics":["Addiction","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4407278829","eid":"W4407278829"},{"id":"paper-w2338593360","cat":"papers","name":"Brain scans reveal how LSD affects consciousness","year":"2016","cit":5,"pfa":"Zoe Cormier","ptype":"article","src":"https://openalex.org/W2338593360","eid":"W2338593360"},{"id":"paper-w1513506428","cat":"papers","name":"Psychopharmacology of Drugs of Abuse","year":"2003","cit":5,"pfa":"Brian E. Leonard","topics":["Addiction","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W1513506428","eid":"W1513506428"},{"id":"paper-w1986973989","cat":"papers","name":"Emergency Treatment of Acute Reactions to CNS Stimulants","year":"1972","cit":5,"pfa":"Everett H. Ellinwood","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1986973989","eid":"W1986973989"},{"id":"paper-w2080521279","cat":"papers","name":"Hallucinogenic Ritual as Theatre","year":"1977","cit":5,"pfa":"Marlene Dobkin de Ríos","ptype":"article","src":"https://openalex.org/W2080521279","eid":"W2080521279"},{"id":"paper-w1500454052","cat":"papers","name":"De plantis toxicariis e mundo novo tropicale commentationes XXXVI.Justicia (Acanthaceae) as a source of an hallucinogenic snuff","year":"1990","cit":5,"pfa":"Richard Evans Schultes","ptype":"article","src":"https://openalex.org/W1500454052","eid":"W1500454052"},{"id":"paper-w4296493271","cat":"papers","name":"Combined effect of fertilizer micro-dosing and intercropped millet/cowpea effect on agronomic and economic advantages in prone Sahel area, Niger","year":"2022","cit":5,"pfa":"Toudou Daouda Abdoul‐Karim","psa":"Yacoubou Bakasso","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4296493271","eid":"W4296493271"},{"id":"paper-w1993416434","cat":"papers","name":"Synthesis and 5‐HT2A Radioligand Receptor Binding Assays of DOMCl and DOMOM, Two Novel 5‐HT2A Receptor Ligands","year":"2003","cit":5,"pfa":"Antje Harms","psa":"Karl‐Artur Kovar","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1993416434","eid":"W1993416434"},{"id":"paper-w2409344985","cat":"papers","name":"Pharmacologic management of acute abstinence syndromes.","year":"1992","cit":5,"pfa":"Milhorn Ht","topics":["Depression","Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2409344985","eid":"W2409344985"},{"id":"paper-w4287219364","cat":"papers","name":"Buddhist-like opposite diminishing and non-judging during ketamine infusion are associated with antidepressant response: an open-label personalized-dosing study","year":"2022","cit":5,"pfa":"Kurt F. Stocker","psa":"Matthias E. Liechti","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4287219364","eid":"W4287219364"},{"id":"paper-w2579977767","cat":"papers","name":"An Ultra-Sensitive LC–MS/MS Method to Determine Midazolam Levels in Human Plasma: Development, Validation and Application to A Clinical Study","year":"2017","cit":5,"pfa":"Mu Chen","psa":"Giorgio Ottaviani","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2579977767","eid":"W2579977767"},{"id":"paper-w857522976","cat":"papers","name":"Substance (Ab)use During Methadone and Naltrexone Treatment","year":"2002","cit":5,"pfa":"Icro Maremmani","psa":"Alessandro Tagliamonte","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W857522976","eid":"W857522976"},{"id":"paper-w1997942410","cat":"papers","name":"Mental Health Status of Infrequent Adolescent Substance Users","year":"2004","cit":5,"pfa":"Robert John Williams","psa":"R. Meghan Davis","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1997942410","eid":"W1997942410"},{"id":"paper-w1548499277","cat":"papers","name":"Psychopharmacology: Pharmacologic Effects on Behavior","year":"1958","cit":5,"topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1548499277","eid":"W1548499277"},{"id":"paper-w2018210435","cat":"papers","name":"A Case Study of Space-Time Distortion During a Total Lunar Eclipse Following Street Use of LSD","year":"2001","cit":5,"pfa":"Kym A. Dawson","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2018210435","eid":"W2018210435"},{"id":"paper-w2171327087","cat":"papers","name":"Complete objective response of neuroblastoma to biological treatment.","year":"2009","cit":5,"pfa":"Giuseppe Di Bella","psa":"Biagio Colori","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2171327087","eid":"W2171327087"},{"id":"paper-w2463412546","cat":"papers","name":"Systematic approach to optimize a pretreatment method for ultrasensitive liquid chromatography with tandem mass spectrometry analysis of multiple target compounds in biological samples","year":"2016","cit":5,"pfa":"Kazutaka Togashi","psa":"Shinji Yamashita","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2463412546","eid":"W2463412546"},{"id":"paper-w4323667917","cat":"papers","name":"Acute pharmacological profile of 2C-B-Fly-NBOMe in male Wistar rats—pharmacokinetics, effects on behaviour and thermoregulation","year":"2023","cit":5,"pfa":"Kateřina Syrová","psa":"Tomáš Páleníček","topics":["Addiction","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4323667917","eid":"W4323667917"},{"id":"paper-w3022792327","cat":"papers","name":"Crash: Find the Exit- A neuroscience board game as a tool to discuss mechanisms of drug abuse and addiction issues in the classroom","year":"2020","cit":5,"pfa":"Luana da Silva Chagas","psa":"Priscilla Oliveira-Silva","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3022792327","eid":"W3022792327"},{"id":"paper-w2348035142","cat":"papers","name":"“Quite a Profoundly Strange Experience”: An Analysis of the Experiences of Salvia divinorum Users","year":"2016","cit":5,"pfa":"Fiona Hutton","psa":"Otis Boyle","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2348035142","eid":"W2348035142"},{"id":"paper-w2015898202","cat":"papers","name":"Peer support, perceptions of adverse effects, and the hallucinogenic drug experience","year":"1997","cit":5,"pfa":"Michael Wayne Dunsmore","psa":"Howard B. Kaplan","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2015898202","eid":"W2015898202"},{"id":"paper-w4392915086","cat":"papers","name":"The algorithmic agent perspective and computational neuropsychiatry: from etiology to advanced therapy in major depressive disorder","year":"2024","cit":5,"pfa":"Giulio Ruffini","psa":"Jakub Vohryzek","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4392915086","eid":"W4392915086"},{"id":"paper-w3183972452","cat":"papers","name":"A Nationwide Study Comparing Mental Health Professionals’ Willingness to Try Hallucinogenic Drugs in Basic Research or Clinical Practice","year":"2021","cit":5,"pfa":"Yotam D. Ginati","psa":"Gal Shoval","ptype":"article","src":"https://openalex.org/W3183972452","eid":"W3183972452"},{"id":"paper-w2725599356","cat":"papers","name":"Trends and patterns of marijuana use in men and women seeking drug treatment","year":"2017","cit":5,"pfa":"David Bruno Díaz-Negrete","psa":"Dirección General, Centros de Integración Juvenil, Ciudad de México, México.","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2725599356","eid":"W2725599356"},{"id":"paper-w2100216626","cat":"papers","name":"Study of the fragmentation pattern of ketamine‐heptafluorobutyramide by gas chromatography/electron ionization mass spectrometry","year":"2009","cit":5,"pfa":"Maria Chiara Pieri","psa":"Elvira Della Casa","ptype":"article","src":"https://openalex.org/W2100216626","eid":"W2100216626"},{"id":"paper-w4410466715","cat":"papers","name":"Toxicity study of TEoS-DAZA, a chemical precursor for functional liver imaging with PET/CT","year":"2025","cit":5,"pfa":"Julia Greiser","psa":"Martin G. Freesmeyer","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4410466715","eid":"W4410466715"},{"id":"paper-w3174731845","cat":"papers","name":"Bioavailability and pharmacokinetic profile of balovaptan, a selective, brain-penetrant vasopressin 1a receptor antagonist, in healthy volunteers","year":"2021","cit":5,"pfa":"Michael Derks","psa":"Heidemarie Kletzl","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3174731845","eid":"W3174731845"},{"id":"paper-w4391995075","cat":"papers","name":"Uncovering Structure–Activity Relationships of Phenethylamines: Paving the Way for Innovative Mental Health Treatments","year":"2024","cit":5,"pfa":"Sedat Karabulut","psa":"James W. Gauld","topics":["PTSD & trauma","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4391995075","eid":"W4391995075"},{"id":"paper-w589997928","cat":"papers","name":"Traditional healing practices originating in Aruba, Bonaire, and Curaçao: A review of the literature on psychiatry and Brua","year":"2015","cit":5,"pfa":"Jan Dirk Blom","psa":"Hans Wijbrand Hoek","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W589997928","eid":"W589997928"},{"id":"paper-w3205238541","cat":"papers","name":"An Update of Ketamine Illicit Use","year":"2021","cit":5,"pfa":"Patrycja Kleczkowska","psa":"Małgorzata Zaremba","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W3205238541","eid":"W3205238541"},{"id":"paper-w3202092370","cat":"papers","name":"5-HT2 Receptor Subfamily and the Halogen Bond Promise","year":"2021","cit":5,"pfa":"Angélica Fierro","psa":"Gerald Zapata‐Torres","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3202092370","eid":"W3202092370"},{"id":"paper-w3008901859","cat":"papers","name":"Absolute Bioavailability of Vemurafenib in Patients With BRAFV600 Mutation–Positive Malignancies","year":"2020","cit":5,"pfa":"Weijiang Zhang","psa":"Thomas Härtung","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3008901859","eid":"W3008901859"},{"id":"paper-w4413740910","cat":"papers","name":"Ketamine’s Therapeutic Role in Substance Use Disorders: A Narrative Review","year":"2025","cit":5,"pfa":"Alexander Thomas","psa":"R. Andrew Chambers","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W4413740910","eid":"W4413740910"},{"id":"paper-w2038603113","cat":"papers","name":"Ketamine as Continuous Intravenous Infusion Combined with Diazepam in Non-Abdominal Surgery. A Randomized Double-Blind Study","year":"1982","cit":5,"pfa":"T. PEDERSEN","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2038603113","eid":"W2038603113"},{"id":"paper-w6332820","cat":"papers","name":"[New drugs at \"rave parties\": ketamine and prolintane].","year":"2002","cit":5,"pfa":"J.-M. Gaulier","psa":"Gérard Lachâtre","topics":["Addiction","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W6332820","eid":"W6332820"},{"id":"paper-w4253793084","cat":"papers","name":"Some Characteristics of an Ex‐Addict Self‐Help Therapeutic Community and its Members","year":"1973","cit":5,"pfa":"Robert S. Weppner","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4253793084","eid":"W4253793084"},{"id":"paper-w2414965990","cat":"papers","name":"[The involvement of 5-HT1a serotonin receptors in the pathophysiology and pharmacotherapy of schizophrenia].","year":"2000","cit":5,"pfa":"Marzena Maćkowiak","psa":"Krzysztof Wędzony","topics":["Addiction","Mechanism & neuroscience","Policy & ethics"],"ptype":"other","src":"https://openalex.org/W2414965990","eid":"W2414965990"},{"id":"paper-w4293544694","cat":"papers","name":"Sexual Orientation, Mental Illness, and Substance Use Disorders Among Criminal Legal System–Involved Individuals","year":"2022","cit":5,"pfa":"Abinaya Ramakrishnan","psa":"Gilbert Gonzales","topics":["Depression","Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4293544694","eid":"W4293544694"},{"id":"paper-w4379278528","cat":"papers","name":"Does drug use affect the efficacy of amisulpride, aripiprazole and olanzapine in patients with schizophrenia spectrum disorders? Results from a pragmatic, randomised study","year":"2023","cit":5,"pfa":"Renata Alisauskiene","psa":"Else‐Marie Løberg","ptype":"article","src":"https://openalex.org/W4379278528","eid":"W4379278528"},{"id":"paper-w4407315370","cat":"papers","name":"Connectome harmonic decomposition tracks the presence of disconnected consciousness during ketamine-induced unresponsiveness","year":"2025","cit":5,"pfa":"Milan Van Maldegem","psa":"Andrea I. Luppi","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4407315370","eid":"W4407315370"},{"id":"paper-w4386084337","cat":"papers","name":"Better Biomarkers, Faster Drugs, Stronger Models: Progress Towards Precision Psychiatry.","year":"2023","cit":5,"pfa":"Joshua S. Siegel","psa":"Eric J. Lenze","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4386084337","eid":"W4386084337"},{"id":"paper-w4390050358","cat":"papers","name":"DSM-5 conduct disorder and symptoms in youths at high risk of psychosis in Kenya with DSM-5 mental disorders and substance use: towards integrated management","year":"2023","cit":5,"pfa":"David Musyimi Ndetei","psa":"Daniel T. Mamah","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4390050358","eid":"W4390050358"},{"id":"paper-w3049359011","cat":"papers","name":"Analytical profile of N‐ethyl‐N‐cyclopropyl lysergamide (ECPLA), an isomer of lysergic acid 2,4‐dimethylazetidide (LSZ)","year":"2020","cit":5,"pfa":"Simon D. Brandt","psa":"Adam L. Halberstadt","ptype":"article","src":"https://openalex.org/W3049359011","eid":"W3049359011"},{"id":"paper-w2242895666","cat":"papers","name":"Brain and tumor penetration of carbon-11–labeled lapatinib ([11C]Lap) in patients (pts) with HER2-overexpressing metastatic breast cancer (MBC).","year":"2013","cit":5,"pfa":"Azeem Saleem","psa":"R. Charles Coombes","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W2242895666","eid":"W2242895666"},{"id":"paper-w3009235617","cat":"papers","name":"The implementation of per-se limits for driving under the influence of benzodiazepines and related drugs: No increased risk for arrest during therapeutic use in Norway","year":"2020","cit":5,"pfa":"Asbjørg S. Christophersen","psa":"Hallvard Gjerde","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3009235617","eid":"W3009235617"},{"id":"paper-w4414095154","cat":"papers","name":"Preliminary Findings on Low-Dose 1cp-LSD for Canine Anxiety: Exploring the Role of Owner Neuroticism and Psychopathology","year":"2025","cit":5,"pfa":"Elisa Hernández‐Álvarez","psa":"Luis Alberto Henríquez‐Hernández","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4414095154","eid":"W4414095154"},{"id":"paper-w4379382704","cat":"papers","name":"The G protein biased serotonin 5-HT 2A receptor agonist lisuride exerts anti-depressant drug-like activities in mice","year":"2023","cit":5,"pfa":"Vladimir M. Pogorelov","psa":"William C. Wetsel","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4379382704","eid":"W4379382704"},{"id":"paper-w2280533702","cat":"papers","name":"[Involvement of sigma receptors in schizophrenic syndromes. Pathophysiological approach].","year":"1993","cit":5,"pfa":"François P. Monnet","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"other","src":"https://openalex.org/W2280533702","eid":"W2280533702"},{"id":"paper-w4389719555","cat":"papers","name":"Long-lasting anti-despair and anti-anhedonia effects of (S)-norketamine in social isolation-reared mice","year":"2023","cit":5,"pfa":"Rei Yokoyama","psa":"Hitoshi Hashimoto","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4389719555","eid":"W4389719555"},{"id":"paper-w1517318937","cat":"papers","name":"The effect of excipients on pharmacokinetic parameters of parenteral drugs","year":"2005","cit":5,"pfa":"Barbara Egger-Heigold","topics":["Addiction","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W1517318937","eid":"W1517318937"},{"id":"paper-w2068505441","cat":"papers","name":"The effects of LSD−25 and dextroamphetamine on the use of defensive language","year":"1979","cit":5,"pfa":"Michael Natale","psa":"Joseph Jaffe","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2068505441","eid":"W2068505441"},{"id":"paper-w4237203894","cat":"papers","name":"Novel Δ9-tetrahydrocannabinol formulation Namisol® has beneficial pharmacokinetics and promising pharmacodynamic effects","year":"2011","cit":5,"pfa":"Linda E. Klumpers","psa":"Joop van Gerven","topics":["Anxiety & end-of-life","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4237203894","eid":"W4237203894"},{"id":"paper-w2796305420","cat":"papers","name":"General anesthesia with propofol for ovarian teratoma excision associated with anti-N-methyl-D-aspartate receptor encephalitis","year":"2018","cit":5,"pfa":"Masami Sato","psa":"Toshiyuki Arai","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2796305420","eid":"W2796305420"},{"id":"paper-w4230706061","cat":"papers","name":"Memantine as an Example of a Fast, Voltage-Dependent, Open Channel N-Methyl-D-Aspartate Receptor Blocker","year":"2007","cit":5,"pfa":"Chris G. Parsons","psa":"Kate E. Gilling","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W4230706061","eid":"W4230706061"},{"id":"paper-w2075430479","cat":"papers","name":"Involvement of dopamine D2 receptor signal transduction in the discriminative stimulus effects of the κ-opioid receptor agonist U-50,488H in rats","year":"2013","cit":5,"pfa":"Tomohisa Mori","psa":"Tsutomu Suzuki","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2075430479","eid":"W2075430479"},{"id":"paper-w2559314181","cat":"papers","name":"Ketamine and Electroconvulsive Therapy","year":"2016","cit":5,"pfa":"Colleen K A Loo","psa":"Verònica Gálvez","ptype":"book-chapter","src":"https://openalex.org/W2559314181","eid":"W2559314181"},{"id":"paper-w3094964418","cat":"papers","name":"Resolvins as novel targets for rapid-acting antidepressants","year":"2020","cit":5,"pfa":"Satoshi Deyama","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3094964418","eid":"W3094964418"},{"id":"paper-w4324325399","cat":"papers","name":"A Meta-Analysis of Functional Neuroimaging Studies of Ketamine Administration in Healthy Volunteers","year":"2023","cit":5,"pfa":"Karim Ait Bentaleb","psa":"Stéphane Potvin","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W4324325399","eid":"W4324325399"},{"id":"paper-w4309562181","cat":"papers","name":"β‐caryophyllene, a cannabinoid receptor 2 agonist, decreases the motivational salience and conditioning place preference for palatable food in female mice","year":"2022","cit":5,"pfa":"Lucas Antônio dos Santos Barbosa","psa":"Cristiane Ribeiro de Carvalho","topics":["Addiction","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4309562181","eid":"W4309562181"},{"id":"paper-w141394074","cat":"papers","name":"Reversible Worsening of Psychosis Due to Benzydamine in a Schizoaffective Young Girl Who is Already under Treatment with Antipsychotics","year":"2009","cit":5,"pfa":"Mehmet Kerem Doksat","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W141394074","eid":"W141394074"},{"id":"paper-w2081550080","cat":"papers","name":"Glutamate and Schizophrenia: Pathophysiology and Therapeutics","year":"2002","cit":5,"pfa":"Gerard J. Marek","topics":["Safety & adverse events","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2081550080","eid":"W2081550080"},{"id":"paper-w4383058873","cat":"papers","name":"Pharmacokinetics of Nasal Esketamine in Patients with Allergic Rhinitis with and Without Nasal Decongestant Pretreatment and in Healthy Subjects with and Without Nasal Corticosteroid Pretreatment","year":"2023","cit":5,"pfa":"Peter Zannikos","psa":"Jaskaran B. Singh","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4383058873","eid":"W4383058873"},{"id":"paper-w4387949197","cat":"papers","name":"Assessing evidence supporting cannabis harm reduction practices for adolescents at clinical high-risk for psychosis: a review and clinical implementation tool","year":"2023","cit":5,"pfa":"Simon Kapler","psa":"Carrie E. Bearden","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4387949197","eid":"W4387949197"},{"id":"paper-w2781512025","cat":"papers","name":"Management of Chronic Pain in the Elderly: A Review of Current and Upcoming Novel Therapeutics","year":"2018","cit":5,"pfa":"Neal Murphy","psa":"Sam Anandan","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2781512025","eid":"W2781512025"},{"id":"paper-w2039637567","cat":"papers","name":"Treatment of Hallucinogenic-Plant Toxicity","year":"1976","cit":5,"pfa":"George Mendelson","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2039637567","eid":"W2039637567"},{"id":"paper-w4238512369","cat":"papers","name":"Demographic and behavioral predictors of sexual risk in the NIMH Multisite HIV Prevention Trial","year":"1997","cit":5,"topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4238512369","eid":"W4238512369"},{"id":"paper-w4409253614","cat":"papers","name":"The antidepressant potential of (2R,6R)-hydroxynorketamine: A detailed review of pre-clinical findings","year":"2025","cit":5,"pfa":"Isis Koutrouli","psa":"Rachel R. Horsley","topics":["Depression","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4409253614","eid":"W4409253614"},{"id":"paper-w4293252735","cat":"papers","name":"Esketamine nasal spray (Spravato) for treatment-resistant depression.","year":"2019","cit":5,"topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4293252735","eid":"W4293252735"},{"id":"paper-w4320733532","cat":"papers","name":"Esketamine in the treatment of chronic endometriosis-induced pain: a case report","year":"2023","cit":5,"pfa":"Rozemarijn de Koning","psa":"Andries R. H. Twijnstra","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4320733532","eid":"W4320733532"},{"id":"paper-w4409255426","cat":"papers","name":"Effect of esketamine on the EC50 of remifentanil for suppression of choking cough during extubation","year":"2025","cit":5,"pfa":"Shouyi Chen","psa":"Lanying Lin","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4409255426","eid":"W4409255426"},{"id":"paper-w4409404413","cat":"papers","name":"The 50% effective dose of remimazolam combined with different doses of esketamine for painless gastroscopy","year":"2025","cit":5,"pfa":"Li Zhao","psa":"Linji Li","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4409404413","eid":"W4409404413"},{"id":"paper-w4391677050","cat":"papers","name":"Is Intravenous Ketamine Better Than Intranasal Esketamine for Treating Treatment-Resistant Depression?","year":"2024","cit":5,"pfa":"Zeeshan Mansuri","psa":"Anil Krishna Bachu","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4391677050","eid":"W4391677050"},{"id":"paper-w3196168587","cat":"papers","name":"Switching to Intranasal Esketamine Maintains the Antidepressant Response to Intravenous Racemic Ketamine Administration","year":"2021","cit":5,"pfa":"Michael D. Banov","psa":"Steven T. Szabo","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3196168587","eid":"W3196168587"},{"id":"paper-w4367174203","cat":"papers","name":"Characteristics of Esketamine Prescribers Among Medicare Beneficiaries in the United States, 2019-2020","year":"2023","cit":5,"pfa":"John L. Havlik","psa":"John Harrison Krystal","ptype":"article","src":"https://openalex.org/W4367174203","eid":"W4367174203"},{"id":"paper-w4403270117","cat":"papers","name":"Prophylactic (R,S)-Ketamine and (2S,6S)-Hydroxynorketamine Decrease Fear Expression by Differentially Modulating Fear Neural Ensembles","year":"2024","cit":5,"pfa":"Alessia Mastrodonato","psa":"Christine Ann Denny","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4403270117","eid":"W4403270117"},{"id":"paper-w4412520478","cat":"papers","name":"Perioperative use of esketamine for the prevention of postpartum depression after cesarean section: a meta-analysis","year":"2025","cit":5,"pfa":"Yanhong Li","psa":"Jun Zhou","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4412520478","eid":"W4412520478"},{"id":"paper-w4399690209","cat":"papers","name":"Pharmacovigilance of esketamine nasal spray: an analysis of the FDA adverse event reporting system database","year":"2024","cit":5,"pfa":"Ruixue Liu","psa":"Ying Wang","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4399690209","eid":"W4399690209"},{"id":"paper-w4376871070","cat":"papers","name":"Efficacy of Patient-Controlled Intravenous Analgesia with Esketamine for Herpes Zoster Associated with Breakthrough Pain","year":"2023","cit":5,"pfa":"Ming Yao","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4376871070","eid":"W4376871070"},{"id":"paper-w3020535857","cat":"papers","name":"142 Withdrawal Symptom Assessment in an Esketamine Safety Study in Patients with Treatment-resistant Depression","year":"2020","cit":5,"pfa":"Leah E. Aluisio","psa":"Jaskaran B. Singh","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3020535857","eid":"W3020535857"},{"id":"paper-w4411189658","cat":"papers","name":"Prophylactic esketamine for postpartum depression after cesarean section: a systematic review and meta-analysis","year":"2025","cit":5,"pfa":"Haibin Shi","psa":"Bin Zhu","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4411189658","eid":"W4411189658"},{"id":"paper-w4405220381","cat":"papers","name":"Esketamine facilitate psychotherapies for Post-Traumatic stress disorder: A retrospective case series of six patients","year":"2024","cit":5,"pfa":"Pascal Roullet","psa":"Philippe Raynaud de Prigny","topics":["Depression","PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4405220381","eid":"W4405220381"},{"id":"paper-w4404365067","cat":"papers","name":"Effects of Small-Dose Esketamine on Postoperative Analgaesia and Sleep Quality in Patients with Total Hip Replacement","year":"2024","cit":5,"topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4404365067","eid":"W4404365067"},{"id":"paper-w7116854868","cat":"papers","name":"Dexamethasone, but Not Esketamine, Reduces Rebound Pain After Interscalene Nerve Block: A Randomized Factorial Trial","year":"2025","cit":5,"pfa":"Jiahui Yao","psa":"Dongping Du","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7116854868","eid":"W7116854868"},{"id":"paper-w4414193695","cat":"papers","name":"Esketamine for postoperative analgesia after cesarean section: Effects on pain, mood, sleep quality, and safety","year":"2025","cit":5,"pfa":"Bing Zhang","psa":"Qun Zhou","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4414193695","eid":"W4414193695"},{"id":"paper-w4403733756","cat":"papers","name":"Effect of different doses of esketamine on the median effective concentration of propofol for inhibiting body movement during hysteroscopy","year":"2024","cit":5,"pfa":"Jixiang Wan","psa":"Fangjun Wang","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4403733756","eid":"W4403733756"},{"id":"paper-w4412172433","cat":"papers","name":"When mood and time align: nasal esketamine reduces lived time disturbances in treatment-resistant depression","year":"2025","cit":5,"pfa":"Stefan Jerotić","psa":"Marcin Moskalewicz","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4412172433","eid":"W4412172433"},{"id":"paper-w4417335139","cat":"papers","name":"Inflammatory response to repeated subcutaneous esketamine in treatment-resistant depression: The role of baseline C-reactive protein","year":"2025","cit":5,"pfa":"Patrícia Cavalcanti-Ribeiro","psa":"Nicole Leite Galvão Coelho","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4417335139","eid":"W4417335139"},{"id":"paper-w4377028033","cat":"papers","name":"A New Solution to an Age-old Problem: A Review of Ketamine and Esketamine for Treatment-resistant Depression in Late Life","year":"2023","cit":5,"pfa":"Kripa Balaram","psa":"Phelan E. Maruca-Sullivan","topics":["Depression","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4377028033","eid":"W4377028033"},{"id":"paper-w4407565665","cat":"papers","name":"Esketamine reduces the risk of postpartum depression in women undergoing cesarean section: A systematic review and meta-analysis","year":"2025","cit":5,"pfa":"Lőrinc Frivaldszky","psa":"Márton Keszthelyi","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4407565665","eid":"W4407565665"},{"id":"paper-w4415373265","cat":"papers","name":"Effectiveness and safety of esketamine in laparoscopic surgery patients: a systematic review and meta-analysis of randomized controlled trials","year":"2025","cit":5,"pfa":"Shuhui Wang","psa":"Lifang Wu","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W4415373265","eid":"W4415373265"},{"id":"paper-w4408581009","cat":"papers","name":"Effective doses of remimazolam and esketamine combined with remifentanil for endotracheal intubation without muscle relaxants in pediatric patients","year":"2025","cit":5,"pfa":"Jinming Chen","psa":"Zhongqi Zhang","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4408581009","eid":"W4408581009"},{"id":"paper-w4397009539","cat":"papers","name":"Comparison of Effects of Propofol Combined with Different Doses of Esketamine for ECT in the Treatment of Depression: A Randomized Controlled Trial Protocol","year":"2024","cit":5,"pfa":"Xuemeng Chen","psa":"Leqiang Xia","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4397009539","eid":"W4397009539"},{"id":"paper-w4413883471","cat":"papers","name":"Changes in dynamic and static functional connectivity in amygdala subregions in major depressive disorder treated with esketamine in and sertraline: A pilot study","year":"2025","cit":5,"pfa":"Xiang Liu","psa":"Xueming Zhou","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4413883471","eid":"W4413883471"},{"id":"paper-w4409775027","cat":"papers","name":"Effectiveness of intravenous administration of a combination of sufentanil and esketamine on post-cardiac surgery pain management and depression: a randomized controlled trial","year":"2025","cit":5,"pfa":"Sen Xu","psa":"Weicai Xu","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4409775027","eid":"W4409775027"},{"id":"paper-w4391722753","cat":"papers","name":"Combination of Acute and Maintenance Esketamine Treatment With Adjunctive Long-Term Vagus Nerve Stimulation in Difficult-to-Treat Depression","year":"2024","cit":5,"pfa":"Erhan Kavakbasi","psa":"Bernhard Theodor Baune","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4391722753","eid":"W4391722753"},{"id":"paper-w4403243821","cat":"papers","name":"Efficacy of racemic ketamine or esketamine monotherapy for reducing suicidal ideation in uni- or bipolar depression: a systematic review and meta-analysis","year":"2024","cit":5,"pfa":"Jiafeng Li","psa":"Jiajun Xu","topics":["Depression","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4403243821","eid":"W4403243821"},{"id":"paper-w4409119170","cat":"papers","name":"Respiratory depression in women receiving propofol/esketamine versus propofol/fentanyl for abortion surgery or curettage: a randomized clinical trial","year":"2025","cit":5,"pfa":"Cuiwen Zhang","psa":"Xuehai Guan","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4409119170","eid":"W4409119170"},{"id":"paper-w4281252890","cat":"papers","name":"Different symptomatic improvement pattern revealed by factor analysis between placebo response and response to Esketamine in treatment resistant depression","year":"2022","cit":5,"pfa":"Takashi Ohnishi","psa":"Hisanori Kobayashi","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4281252890","eid":"W4281252890"},{"id":"paper-w4389410019","cat":"papers","name":"Management of treatment-resistant depression with esketamine nasal spray: clinical questions for daily practice in Gulf Cooperation Council countries","year":"2023","cit":5,"pfa":"Nahida Nayaz Ahmed","psa":"Samer Makhoul","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4389410019","eid":"W4389410019"},{"id":"paper-w4410246701","cat":"papers","name":"Delirium risk associated with esketamine, sevoflurane, propofol, and dexmedetomidine: A real-world study based on the FDA adverse event reporting system","year":"2025","cit":5,"pfa":"Yichun Shuai","psa":"Xin Wang","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4410246701","eid":"W4410246701"},{"id":"paper-w4415711923","cat":"papers","name":"Efficacy of intranasal esketamine versus rTMS for treatment-resistant depression: analysis of individual participant data from two clinical trials","year":"2025","cit":5,"pfa":"Tyler S. Kaster","psa":"Taeho Greg Rhee","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4415711923","eid":"W4415711923"},{"id":"paper-w4402773930","cat":"papers","name":"(2R, 6R)-hydroxynorketamine ameliorates PTSD-like behaviors during the reconsolidation phase of fear memory in rats by modulating the VGF/BDNF/GluA1 signaling pathway in the hippocampus","year":"2024","cit":5,"pfa":"Han Wang","psa":"Lin Sun","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4402773930","eid":"W4402773930"},{"id":"paper-w4412391868","cat":"papers","name":"Effect of dexmedetomidine-assisted esketamine on hemodynamics and stress level in patients undergoing total laparoscopic hysterectomy under general anesthesia","year":"2025","cit":5,"pfa":"Xiuli Ye","psa":"Youchun Li","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4412391868","eid":"W4412391868"},{"id":"paper-w2953974969","cat":"papers","name":"Randomized, Double-Blind Study of Fixed-Dose Intranasal Esketamine Plus Oral Antidepressant vs. Active Control in Treatment-Resistant Depression","year":"2019","cit":5,"pfa":"Maggie M Fedgchin","psa":"Jaskaran B. Singh","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2953974969","eid":"W2953974969"},{"id":"paper-w4403699388","cat":"papers","name":"Improvement in pain by using lidocaine combined with esketamine in elderly patients receiving local anaesthesia for percutaneous kyphoplasty: a randomized controlled study","year":"2024","cit":5,"pfa":"Longyuan Zhou","psa":"Lihong Hu","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4403699388","eid":"W4403699388"},{"id":"paper-w4396798879","cat":"papers","name":"Treatment Patterns, Acute Healthcare Resource Use, and Costs of Patients with Treatment-Resistant Depression Completing Induction Phase of Esketamine in the United States","year":"2024","cit":5,"pfa":"Lisa Harding","psa":"Dominic Pilon","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4396798879","eid":"W4396798879"},{"id":"paper-w4401899994","cat":"papers","name":"Intravenous patient-controlled analgesia with esketamine improves early depressive symptoms in patients with postherpetic neuralgia: a single-center retrospective cohort study","year":"2024","cit":5,"pfa":"Ling Qiu","psa":"Xiaobin Wang","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4401899994","eid":"W4401899994"},{"id":"paper-w4400475479","cat":"papers","name":"Effects of esketamine on depression-like behavior and dendritic spine plasticity in the prefrontal cortex neurons of spared nerve injury-induced depressed mice","year":"2024","cit":5,"pfa":"Bixin Huang","psa":"Zhongqi Zhang","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4400475479","eid":"W4400475479"},{"id":"paper-w4400259332","cat":"papers","name":"Effect of esketamine combined with dexmedetomidine on delirium in sedation for mechanically ventilated ICU patients: protocol for a nested substudy within a randomized controlled trial","year":"2024","cit":5,"pfa":"Wenhui Zhang","psa":"Xiangrong Zuo","topics":["Safety & adverse events","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4400259332","eid":"W4400259332"},{"id":"paper-w7117563652","cat":"papers","name":"A systematic review of ketamine and esketamine-induced long-term potentiation and synaptic scaling: Do the molecular and synaptic plasticity effects inform dosing intervals?","year":"2025","cit":5,"pfa":"Gia Han Le","psa":"Roger S. McIntyre","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W7117563652","eid":"W7117563652"},{"id":"paper-w4409709143","cat":"papers","name":"Efficacy and safety of esketamine for smoking cessation among patients diagnosed with lung cancer and major depression disorder: A randomized, placebo-controlled clinical trial","year":"2025","cit":5,"pfa":"Xinya Hong","psa":"Wenyuan Wang","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4409709143","eid":"W4409709143"},{"id":"paper-w4393379364","cat":"papers","name":"Effects of esketamine nasal spray on depressive symptom severity in adults with treatment-resistant depression and associations between the Montgomery–Åsberg Depression Rating Scale and the 9-item Patient Health Question","year":"2024","cit":5,"pfa":"Jennifer Kern Sliwa","psa":"Madhukar H. Trivedi","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4393379364","eid":"W4393379364"},{"id":"paper-w4412755810","cat":"papers","name":"Compare the Effects of 0 mg/kg, 0.1 mg/kg, 0.3 mg/kg and 0.5 mg/kg Esketamine on Emergence Agitation After Tonsillectomy and Adenoidectomy in Children: A Randomized Control Trial","year":"2025","cit":5,"pfa":"P. Jiang","psa":"San Yuan Huang","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4412755810","eid":"W4412755810"},{"id":"paper-w4387157209","cat":"papers","name":"Efficacy and safety of esketamine nasal spray in addition to standard of care in patients with major depressive disorder who have active suicidal ideation with intent: A subgroup analysis of the Asian cohort of ASPIRE I","year":"2023","cit":5,"pfa":"Jin Pyo Hong","psa":"Po‐Chung Ju","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4387157209","eid":"W4387157209"},{"id":"paper-w4410595477","cat":"papers","name":"Can ketamine therapy overcome treatment-resistant depression in Alzheimer's disease and older adults? Preclinical and clinical evidence","year":"2025","cit":5,"pfa":"Altamura Mario","psa":"Lozupone Madia","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4410595477","eid":"W4410595477"},{"id":"paper-w4384639830","cat":"papers","name":"A Broadly Applicable Diels–Alder-Based Synthesis of Ketamine-Related Arylcyclohexylamines","year":"2023","cit":5,"pfa":"Henrik Weber","psa":"Sherif El Sheikh","ptype":"article","src":"https://openalex.org/W4384639830","eid":"W4384639830"},{"id":"paper-w3034068891","cat":"papers","name":"Process for (S)-Ketamine and (S)-Norketamine via Resolution Combined with Racemization","year":"2020","cit":5,"pfa":"Shenghua Gao","psa":"Fuli Zhang","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W3034068891","eid":"W3034068891"},{"id":"paper-w3161504148","cat":"papers","name":"Is ketamine effective and safe for treatment-resistant depression?","year":"2021","cit":5,"pfa":"Zorn","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3161504148","eid":"W3161504148"},{"id":"paper-w4409415646","cat":"papers","name":"Mapping the Use of Ketamine in Treatment-Resistant Depression and Other Psychiatric Disorders: A Scoping Review of Practice Patterns, Efficacy, and Patient Demographic Trends","year":"2025","cit":5,"pfa":"Amna Aslam","psa":"Burton Jared Tabaac","topics":["Depression","Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4409415646","eid":"W4409415646"},{"id":"paper-w4224928096","cat":"papers","name":"Suicide versus Accidental Death by Autoerotic Asphyxiation in a Patient Receiving Intravenous Ketamine for Depression","year":"2022","cit":5,"pfa":"Jeremy Weleff","psa":"Brian Scott Barnett","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4224928096","eid":"W4224928096"},{"id":"paper-w4220784332","cat":"papers","name":"A comparison of the safety, feasibility, and tolerability of ECT and ketamine for treatment-resistant depression","year":"2022","cit":5,"pfa":"Amanda J. F. Tamman","psa":"Sanjay J. Mathew","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4220784332","eid":"W4220784332"},{"id":"paper-w2938045345","cat":"papers","name":"Structural Plasticity Induced by Ketamine in Human Dopaminergic Neurons as Mechanism Relevant for Treatment-Resistant Depression","year":"2019","cit":5,"pfa":"Ginetta Collo","psa":"Emilio Merlo Pich","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"editorial","src":"https://openalex.org/W2938045345","eid":"W2938045345"},{"id":"paper-w4408160782","cat":"papers","name":"Understanding social media discourse on antidepressants: unsupervised and sentiment analysis using X","year":"2025","cit":5,"pfa":"Juan Pablo Chart‐Pascual","psa":"Miguel Ángel Álvarez-Mon","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4408160782","eid":"W4408160782"},{"id":"paper-w4386817498","cat":"papers","name":"The not so little matter of how to dose ketamine in patients with depression","year":"2023","cit":5,"pfa":"Chittaranjan Andrade","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4386817498","eid":"W4386817498"},{"id":"paper-w4412856102","cat":"papers","name":"Efficacy of opioid-free anesthesia in reducing postoperative nausea and vomiting following gynecological laparoscopic surgery: a randomized controlled trial","year":"2025","cit":5,"pfa":"Yanan Shen","psa":"Jianwei Wang","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4412856102","eid":"W4412856102"},{"id":"paper-w2910400858","cat":"papers","name":"Searching for ketamine's antidepressant mechanisms: From synaptic plasticity to dentate gyrus cell proliferation","year":"2019","cit":5,"pfa":"Tomi Rantamäki","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2910400858","eid":"W2910400858"},{"id":"paper-w4307977011","cat":"papers","name":"FDA Approves Rapid-Acting Oral Antidepressant","year":"2022","cit":5,"pfa":"Nick Zagorski","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4307977011","eid":"W4307977011"},{"id":"paper-w4311917158","cat":"papers","name":"Application of Opioid-Free General Anesthesia for Gynecological Laparoscopic Surgery Under ERAS Protocol: A Non-inferiority Randomized Controlled Trial","year":"2022","cit":5,"pfa":"Liang Chen","psa":"Yuanhai Li","topics":["Addiction"],"ptype":"preprint","src":"https://openalex.org/W4311917158","eid":"W4311917158"},{"id":"paper-w3088143922","cat":"papers","name":"The next psychoactive drugs: From imipramine to ketamine","year":"2020","cit":5,"pfa":"Pablo Carrillo","psa":"Fabien Vinckier","ptype":"article","src":"https://openalex.org/W3088143922","eid":"W3088143922"},{"id":"paper-w4313446549","cat":"papers","name":"A Serotonergic Theory of Schizophrenia*","year":"2023","cit":5,"pfa":"Avraham Bleich","psa":"Herman M. van Praag","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W4313446549","eid":"W4313446549"},{"id":"paper-w2043164414","cat":"papers","name":"Rat brain de-acetylating activity: Stereospecific inhibition by LSD and serotonin-related compounds","year":"1976","cit":5,"pfa":"Steven M. Paul","psa":"Angelos E. Halaris","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2043164414","eid":"W2043164414"},{"id":"paper-w2076780080","cat":"papers","name":"Lysergic Acid Diethylamide","year":"1966","cit":4,"pfa":"A. M. Spencer","ptype":"article","src":"https://openalex.org/W2076780080","eid":"W2076780080"},{"id":"paper-w2793534456","cat":"papers","name":"Lysergic Acid Diethylamide (LSD)","year":"2024","cit":4,"ptype":"reference-entry","src":"https://openalex.org/W2793534456","eid":"W2793534456"},{"id":"paper-w2395130513","cat":"papers","name":"[Central effects of lysergic acid diethylamide; studies on the localization of lysergic acid diethylamide effects].","year":"1957","cit":4,"pfa":"K. Neuhold","psa":"A Cerletti","ptype":"article","src":"https://openalex.org/W2395130513","eid":"W2395130513"},{"id":"paper-w2402772873","cat":"papers","name":"[Variations of the cholinergic activity of the cerebral cortex tissue caused by bulbocapnine, lysergic acid diethylamide and mescaline].","year":"2003","cit":4,"pfa":"A POLONI","psa":"G Maffezzoni","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2402772873","eid":"W2402772873"},{"id":"paper-w2401357844","cat":"papers","name":"Cholinesterase inhibition by lysergic acid diethylamide.","year":"1954","cit":4,"pfa":"Thompson Rh","psa":"Webster Gr","ptype":"article","src":"https://openalex.org/W2401357844","eid":"W2401357844"},{"id":"paper-w2412718556","cat":"papers","name":"Behavioural effects of lysergic acid diethylamide in monkeys.","year":"1967","cit":4,"pfa":"Jonathan O Cole","psa":"Paul Glees","ptype":"article","src":"https://openalex.org/W2412718556","eid":"W2412718556"},{"id":"paper-w2184885123","cat":"papers","name":"The effect of lysergic acid diethylamide on digit span.","year":"1998","cit":4,"pfa":"A B Silverstein","psa":"Klee Gd","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2184885123","eid":"W2184885123"},{"id":"paper-w2083738656","cat":"papers","name":"HOSPITAL ADMISSIONS DUE TO LYSERGIC-ACID DIETHYLAMIDE","year":"1970","cit":4,"pfa":"Ashleigh Baker","ptype":"article","src":"https://openalex.org/W2083738656","eid":"W2083738656"},{"id":"paper-w288223494","cat":"papers","name":"Peyote, a Mescaline-Containing Cactus","year":"2009","cit":4,"pfa":"Enno Christian Kurt Freye","ptype":"book-chapter","src":"https://openalex.org/W288223494","eid":"W288223494"},{"id":"paper-w4327544242","cat":"papers","name":"Orally Active Forms of DMT, 5-MeO-DMT, and Long-Acting MDMA for the Treatment of Neuropsychiatric Disorders","year":"2023","cit":4,"pfa":"Robert B. Kargbo","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"editorial","src":"https://openalex.org/W4327544242","eid":"W4327544242"},{"id":"paper-w2006414838","cat":"papers","name":"The subcellular distribution of lysergic acid diethylamide in the rat brain","year":"1972","cit":4,"pfa":"Farouk F. Faragalla","ptype":"article","src":"https://openalex.org/W2006414838","eid":"W2006414838"},{"id":"paper-w2186241206","cat":"papers","name":"D-Lysergic Acid Diethylamide (LSD) Investigator's Brochure","year":"2008","cit":4,"pfa":"Lisa Jerome","ptype":"article","src":"https://openalex.org/W2186241206","eid":"W2186241206"},{"id":"paper-w2031900563","cat":"papers","name":"Peyote (Mescaline) and Human Chromosomes","year":"1975","cit":4,"pfa":"Arthur D. Bloom","ptype":"article","src":"https://openalex.org/W2031900563","eid":"W2031900563"},{"id":"paper-w2411265587","cat":"papers","name":"The effects of lysergic acid diethylamide on the excitability cycle of the lateral geniculate.","year":"2003","cit":4,"pfa":"Edward V. Evarts","psa":"Marshall Wh","ptype":"article","src":"https://openalex.org/W2411265587","eid":"W2411265587"},{"id":"paper-w2477037153","cat":"papers","name":"Neuropharmacology of Lysergic Acid Diethylamide (LSD) and Other Hallucinogens","year":"2013","cit":4,"pfa":"Adam L. Halberstadt","psa":"Mark A. Geyer","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W2477037153","eid":"W2477037153"},{"id":"paper-w2418551422","cat":"papers","name":"The effect of lysergic acid diethylamide on Betta splendens. II. Frenquel.","year":"1956","cit":4,"pfa":"W. J. Turner","ptype":"article","src":"https://openalex.org/W2418551422","eid":"W2418551422"},{"id":"paper-w4385568648","cat":"papers","name":"Understanding the effects of lysergic acid diethylamide and the importance of its prevention","year":"2023","cit":4,"pfa":"Burak Okumuş","psa":"İshak Afşin Kari̇per","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4385568648","eid":"W4385568648"},{"id":"paper-w4322622716","cat":"papers","name":"Lysergic Acid Diethylamide Alters the Effects of Brain Stimulation in Rodents","year":"2023","cit":4,"pfa":"Lucas L. Dwiel","psa":"Wilder T. Doucette","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4322622716","eid":"W4322622716"},{"id":"paper-w2015499724","cat":"papers","name":"Some Acute Effects of D-Lysergic Acid Diethylamide on the Rat","year":"1957","cit":4,"pfa":"Peter H. Glow","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2015499724","eid":"W2015499724"},{"id":"paper-w2413295819","cat":"papers","name":"Incorporation of a Lysergic Acid Diethylamide Intermediate into Antibody Protein in Vitro","year":"1973","cit":4,"pfa":"Edward W. Voss","psa":"Jeffrey L. Winkelhake","ptype":"article","src":"https://openalex.org/W2413295819","eid":"W2413295819"},{"id":"paper-w4407575065","cat":"papers","name":"Exploring Gender-Themed Lysergic Acid Diethylamide Experiences: A Subreddit Analysis","year":"2025","cit":4,"pfa":"Rahul Katkar","psa":"Brian Scott Barnett","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4407575065","eid":"W4407575065"},{"id":"paper-w2400142537","cat":"papers","name":"VERBATIM RECORDING AND TRANSFERENCE STUDIES WITH LYSERGIC ACID DIETHYLAMIDE (LSD-25)","year":"1957","cit":4,"pfa":"Harold A. Abramson","ptype":"article","src":"https://openalex.org/W2400142537","eid":"W2400142537"},{"id":"paper-w2076097611","cat":"papers","name":"Solvent-dependent photolysis for identification of lysergic acid diethylamide and other indolamines","year":"1979","cit":4,"pfa":"David A. Stoney","psa":"John I. Thornton","ptype":"article","src":"https://openalex.org/W2076097611","eid":"W2076097611"},{"id":"paper-w2405091073","cat":"papers","name":"The effect of D-lysergic acid diethylamide (LSD-25) on learning and retention.","year":"1998","cit":4,"pfa":"H. Aronson","psa":"Klee Gd","ptype":"article","src":"https://openalex.org/W2405091073","eid":"W2405091073"},{"id":"paper-w2416523549","cat":"papers","name":"Effect of glutamic acid and glutamine on the pyretogenic action of lysergic acid diethylamide.","year":"1998","cit":4,"pfa":"A J Friedhoff","psa":"B Abrams","ptype":"article","src":"https://openalex.org/W2416523549","eid":"W2416523549"},{"id":"paper-w1929789114","cat":"papers","name":"Binding and Circular Dichroism Studies on Interactions of Lysergic Acid Diethylamide with Deoxyribonucleic Acid","year":"1972","cit":4,"pfa":"C. Allen Bush","psa":"Vinojini B. Nair","ptype":"article","src":"https://openalex.org/W1929789114","eid":"W1929789114"},{"id":"paper-w2883691282","cat":"papers","name":"“Eye Dropping”—A Case Report of Transconjunctival Lysergic Acid Diethylamide Drug Abuse","year":"2018","cit":4,"pfa":"Danielle M. Lo","psa":"Yasha S. Modi","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2883691282","eid":"W2883691282"},{"id":"paper-w2474544796","cat":"papers","name":"[Detection of lysergic acid diethylamide in human urine: elimination, screening and analytical confirmation].","year":"1991","cit":4,"pfa":"Trinh Vu‐Duc","psa":"A Calanca","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2474544796","eid":"W2474544796"},{"id":"paper-w4409592105","cat":"papers","name":"Pharmacokinetics and pharmacodynamics of sublingual microdosed lysergic acid diethylamide in healthy adult volunteers","year":"2025","cit":4,"pfa":"James D. Morse","psa":"Rachael L. Sumner","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4409592105","eid":"W4409592105"},{"id":"paper-w2035323231","cat":"papers","name":"CHRONIC LYSERGIC ACID DIETHYLAMIDE ADMINISTRATION AND SEROTONIN TURNOVER IN VARIOUS REGIONS OF RAT BRAIN","year":"1974","cit":4,"pfa":"David A. Peters","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2035323231","eid":"W2035323231"},{"id":"paper-w315090991","cat":"papers","name":"Proceedings of the Round Table on Lysergic Acid Diethylamide and Mescaline in Experimental Psychiatry : held at the annual meeting of the American Psychiatric Association, Atlantic City, New Jersey, May 12, 1955","year":"1956","cit":4,"pfa":"Miscalin in Experimental Psychiatry","psa":"Louis Cholden","ptype":"book","src":"https://openalex.org/W315090991","eid":"W315090991"},{"id":"paper-w2410490416","cat":"papers","name":"The Synthesis of Arylalkylaminopropionamide Analogs of Lysergic Acid Diethylamide and their Effect upon Isolated Cholinesterase Systems. II1","year":"1963","cit":4,"pfa":"Andrew Lasslo","psa":"Glenda J. Epperson","ptype":"article","src":"https://openalex.org/W2410490416","eid":"W2410490416"},{"id":"paper-w2331787704","cat":"papers","name":"The Use of LSD in Psychotherapy; Transactions of Conference on J-Lysergic Acid Diethylamide (LSD-25), 1959","year":"1961","cit":4,"pfa":"Milton Greenblatt","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2331787704","eid":"W2331787704"},{"id":"paper-w4403412963","cat":"papers","name":"Innovative Psychedelic Therapies: Harnessing 5-MeO-DMT and DMT for Mental Health Treatment","year":"2024","cit":4,"pfa":"Robert B. Kargbo","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4403412963","eid":"W4403412963"},{"id":"paper-w2088360046","cat":"papers","name":"Effect of Lysergic Acid Diethylamide (LSD-25) on Growth Metabolism and the Resistance of Male Rats to Histamine Stress","year":"1965","cit":4,"pfa":"A. Stanley Weltman","psa":"Arthur M. Sackler","ptype":"article","src":"https://openalex.org/W2088360046","eid":"W2088360046"},{"id":"paper-w2075876020","cat":"papers","name":"THE EFFECTS OF LYSERGIC ACID DIETHYLAMIDE (LSD-25) UPON THE HISTOCHEMICAL REACTIONS FOR CHOLINESTERASE IN THE CENTRAL NERVOUS SYSTEM","year":"2008","cit":4,"pfa":"Michael E. Goldberger","ptype":"article","src":"https://openalex.org/W2075876020","eid":"W2075876020"},{"id":"paper-w2603708727","cat":"papers","name":"A Preliminary Investigation into the Effects of Lysergic Acid Diethylamide and Lithium Ions on the Amine and Amino Acids in the Snail Central Ganglia","year":"1973","cit":4,"pfa":"Neville N. Osborne","psa":"Volker NEUHOFF","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2603708727","eid":"W2603708727"},{"id":"paper-w2020137259","cat":"papers","name":"Comparison of the effects of d-amphetamine and lysergic acid diethylamide in two strains of rats having different behavioral baselines","year":"1976","cit":4,"pfa":"H.A. Tilson","psa":"Richard H. Rech","ptype":"article","src":"https://openalex.org/W2020137259","eid":"W2020137259"},{"id":"paper-w2541405457","cat":"papers","name":"The role of the serotonin 2A receptor in the fabric and modulation of personal meaning in lysergic acid diethylamide (LSD)-induced states","year":"2016","cit":4,"pfa":"Katrin H. Preller","psa":"F.X. Vollenweider","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2541405457","eid":"W2541405457"},{"id":"paper-w2199187221","cat":"papers","name":"Unexplained inhibitory action of D-lysergic acid diethylamide (LSD) on postganglionic motor transmission in the guinea-pig vas deferens.","year":"1971","cit":4,"pfa":"N Ambache","psa":"M. ABOO ZAR","ptype":"article","src":"https://openalex.org/W2199187221","eid":"W2199187221"},{"id":"paper-w4200465239","cat":"papers","name":"Psilocybin modulation of dynamic functional connectivity is associated with plasma psilocin and subjective effects","year":"2021","cit":4,"pfa":"Anders S. Olsen","psa":"Patrick M. Fisher","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4200465239","eid":"W4200465239"},{"id":"paper-w2027986765","cat":"papers","name":"Persistent effects of repeated injections of d-lysergic acid diethylamide on rat brain 5-hydroxytryptamine and 5-hydroxyindoleacetic acid levels","year":"1977","cit":4,"pfa":"David A.V. Peters","psa":"Shun Tang","ptype":"article","src":"https://openalex.org/W2027986765","eid":"W2027986765"},{"id":"paper-w2410228139","cat":"papers","name":"[Lysergic acid diethylamide blockade of the brain serotoninergic receptors prevents the facilitating effect of phenamine on self-stimulation in rats with destruction of the medial prefrontal cortex].","year":"1995","cit":4,"pfa":"Shabanov Pd","psa":"Lebedev Aa","topics":["Mechanism & neuroscience","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2410228139","eid":"W2410228139"},{"id":"paper-w1983537491","cat":"papers","name":"The Use of LSD in Psychotherapy: Transactions of a Conference on Lysergic Acid Diethylamide (LSD-25), April 22, 23, and 24, 1059, Princeton, N. J","year":"1960","cit":4,"pfa":"Louis L. Lunsky","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W1983537491","eid":"W1983537491"},{"id":"paper-w4229753311","cat":"papers","name":"Mescaline","year":"1979","cit":4,"pfa":"Alexander T. Shulgin","ptype":"article","src":"https://openalex.org/W4229753311","eid":"W4229753311"},{"id":"paper-w2036583053","cat":"papers","name":"Analysis of psilocybin and psilocin in psilocybe subcubensis Guzman by ion mobility spectrometry and gas chromatography-mass spectrometry","year":"1999","cit":4,"pfa":"Thomas Keller","psa":"Wolfgang Kisser","ptype":"article","src":"https://openalex.org/W2036583053","eid":"W2036583053"},{"id":"paper-w7131654097","cat":"papers","name":"Ayahuasca and Its Main Component N,N-Dimethyltryptamine (DMT) for the Treatment of Mental Disorders: Mechanisms of Action, Clinical Studies, and Tools to Explore the Human Mind","year":"2026","cit":4,"pfa":"Alice Melani","psa":"Marco Scarselli","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7131654097","eid":"W7131654097"},{"id":"paper-w2811298804","cat":"papers","name":"On the Peyote Road","year":"1997","cit":4,"pfa":"Mike Kiyaani","psa":"Thomas J. Csordas","ptype":"article","src":"https://openalex.org/W2811298804","eid":"W2811298804"},{"id":"paper-w4242440230","cat":"papers","name":"Corrigendum: A Single Dose of 5-MeO-DMT Stimulates Cell Proliferation, Neuronal Survivability, Morphological and Functional Changes in Adult Mice Ventral Dentate Gyrus","year":"2019","cit":4,"pfa":"Rafael Vitor Lima da Cruz","psa":"Richardson Naves Leão","topics":["Dosing & pharmacology"],"ptype":"erratum","src":"https://openalex.org/W4242440230","eid":"W4242440230"},{"id":"paper-w2083658471","cat":"papers","name":"STUDIES ON MESCALINE","year":"1956","cit":4,"pfa":"Sidney Merlis","psa":"Herman C.B. Denber","ptype":"article","src":"https://openalex.org/W2083658471","eid":"W2083658471"},{"id":"paper-w2943880235","cat":"papers","name":"The fourfold discovery of Mescaline (1896–1919)","year":"2019","cit":4,"pfa":"Ivo Gurschler","ptype":"article","src":"https://openalex.org/W2943880235","eid":"W2943880235"},{"id":"paper-w2885270137","cat":"papers","name":"Prolonged reactions to mescaline","year":"1960","cit":4,"pfa":"Ian H. Stevenson","psa":"Thomas W. Richards","ptype":"article","src":"https://openalex.org/W2885270137","eid":"W2885270137"},{"id":"paper-w2416634158","cat":"papers","name":"Pharmacology and metabolism of mescaline.","year":"1958","cit":4,"pfa":"R Fischer","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2416634158","eid":"W2416634158"},{"id":"paper-w2917007870","cat":"papers","name":"Chapter 9 The Iboga and Voacanga Alkaloids","year":"1965","cit":4,"pfa":"W. I. Taylor","ptype":"book-chapter","src":"https://openalex.org/W2917007870","eid":"W2917007870"},{"id":"paper-w2023849856","cat":"papers","name":"The internationalization of Ayahuasca","year":"2014","cit":4,"pfa":"Gabriel Svobodny","ptype":"article","src":"https://openalex.org/W2023849856","eid":"W2023849856"},{"id":"paper-w4392713516","cat":"papers","name":"Noribogaine acute administration in rats promotes wakefulness and suppresses REM sleep","year":"2024","cit":4,"pfa":"Juan Pedro Castro‐Nin","psa":"Joaqúın González","ptype":"article","src":"https://openalex.org/W4392713516","eid":"W4392713516"},{"id":"paper-w2420705170","cat":"papers","name":"The biosynthesis of mescaline in Lophophora williamsii.","year":"1969","cit":4,"pfa":"H Rosenberg","psa":"A G Paul","ptype":"article","src":"https://openalex.org/W2420705170","eid":"W2420705170"},{"id":"paper-w2024259423","cat":"papers","name":"Synthesis of Potential Mescaline Antagonists","year":"1976","cit":4,"pfa":"F. JUN. DESANTIS","psa":"Karl A. Nieforth","ptype":"article","src":"https://openalex.org/W2024259423","eid":"W2024259423"},{"id":"paper-w4405760007","cat":"papers","name":"God hasn’t died, it has merely been encapsulated – Psilocybin and ayahuasca in the psychedelic renaissance: Intersections between religion, indigenous cosmologies, spirituality, and science","year":"2024","cit":4,"pfa":"Juan Scuro","ptype":"article","src":"https://openalex.org/W4405760007","eid":"W4405760007"},{"id":"paper-w2796173591","cat":"papers","name":"The Hermeneutics of Silence: Michaux and Mescaline","year":"1974","cit":4,"pfa":"Reinhard Clifford Kuhn","ptype":"article","src":"https://openalex.org/W2796173591","eid":"W2796173591"},{"id":"paper-w4235813296","cat":"papers","name":"MDMA Reconsidered","year":"1986","cit":4,"pfa":"Robert Leverant","ptype":"article","src":"https://openalex.org/W4235813296","eid":"W4235813296"},{"id":"paper-w4389079887","cat":"papers","name":"A review of the mechanisms involved in the neuroprotection and neurotoxicity of Iboga alkaloids","year":"2023","cit":4,"pfa":"Boukandou Mounanga Marlaine Michele","psa":"Aboughe Angone Sophie","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4389079887","eid":"W4389079887"},{"id":"paper-w2045188328","cat":"papers","name":"POTENTIATION BY DESIPRAMINE OF NEURONAL RESPONSES TO MESCALINE","year":"1976","cit":4,"pfa":"Paul Bevan","psa":"E. Szabadi","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2045188328","eid":"W2045188328"},{"id":"paper-w2611235609","cat":"papers","name":"An immunochromatographic assay for rapid etection of salvinorin A","year":"2017","cit":4,"pfa":"Madan Kumar Paudel","psa":"Hiroyuki Tanaka","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2611235609","eid":"W2611235609"},{"id":"paper-w2405672477","cat":"papers","name":"THE EFFECT OF D-LYSERGIC ACID DIETHYLAMIDE TARTRATE (LSD-25) AND D-2-BROMO LYSERGIC ACID TARTRATE (BOL-148) ON SPECIFIC CHOLINESTERASE AND MONOAMINE OXIDASE OF RAT LIVER AS POSSIBLE FACTORS IN THE MECHANISM OF HALLUCINAT","year":"1964","cit":4,"pfa":"Kunal NANDY","psa":"Geoffrey H. Bourne","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2405672477","eid":"W2405672477"},{"id":"paper-w4206100886","cat":"papers","name":"Becoming Peyote, or the Flowers of Wirikuta","year":"2021","cit":4,"pfa":"Johannes Neurath","ptype":"book-chapter","src":"https://openalex.org/W4206100886","eid":"W4206100886"},{"id":"paper-w3212371457","cat":"papers","name":"Ayahuasca: the consciousness of expansion","year":"2016","cit":4,"ptype":"book-chapter","src":"https://openalex.org/W3212371457","eid":"W3212371457"},{"id":"paper-w3021331719","cat":"papers","name":"Conformationally Constrained Analogs of Mescaline","year":"1974","cit":4,"pfa":"Robert J. Wolters","psa":"N. S. TANNER","ptype":"article","src":"https://openalex.org/W3021331719","eid":"W3021331719"},{"id":"paper-w4247530259","cat":"papers","name":"Brazilian Ayahuasca religions in perspective","year":"2016","cit":4,"pfa":"Sérgio Brissac","psa":"Lyzette Goes Telles Brissac","ptype":"book-chapter","src":"https://openalex.org/W4247530259","eid":"W4247530259"},{"id":"paper-w2509877995","cat":"papers","name":"Psilocybin: panacea or placebo?","year":"2016","cit":4,"pfa":"Colin A. Hendrie","psa":"Alasdair R. Pickles","ptype":"article","src":"https://openalex.org/W2509877995","eid":"W2509877995"},{"id":"paper-w4408648372","cat":"papers","name":"Synthesis and In Vitro Profiling of Psilocin Derivatives: Improved Stability and Synthetic Properties","year":"2025","cit":4,"pfa":"Julia Eklund","psa":"Luke R. Odell","ptype":"article","src":"https://openalex.org/W4408648372","eid":"W4408648372"},{"id":"paper-w1480099210","cat":"papers","name":"En la tierra mágica del peyote","year":"1968","cit":4,"pfa":"Fernando Benítez","ptype":"book","src":"https://openalex.org/W1480099210","eid":"W1480099210"},{"id":"paper-w2095058873","cat":"papers","name":"Simple and Convenient Synthesis of Iboga-Functionalized Isoquinuclidines","year":"2004","cit":4,"pfa":"A. MAIA","psa":"Christian Marazano","ptype":"article","src":"https://openalex.org/W2095058873","eid":"W2095058873"},{"id":"paper-w2417878815","cat":"papers","name":"Psychostimulant properties of MDMA.","year":"1989","cit":4,"pfa":"Lisa H. Gold","psa":"George F. Koob","ptype":"dataset","src":"https://openalex.org/W2417878815","eid":"W2417878815"},{"id":"paper-w2122105385","cat":"papers","name":"STUDIES ON MESCALINE X: PSYCHOLOGICAL CHANGES BEFORE AND AFTER MESCALINE AS MEASURED BY THE M. M. P. I","year":"1958","cit":4,"pfa":"Herman C.B. Denber","psa":"ALEXANDER VAN WEST","ptype":"article","src":"https://openalex.org/W2122105385","eid":"W2122105385"},{"id":"paper-w2795563359","cat":"papers","name":"A Descriptive Introduction to the Taos Peyote Ceremony","year":"1968","cit":4,"pfa":"John James Collins","ptype":"article","src":"https://openalex.org/W2795563359","eid":"W2795563359"},{"id":"paper-w2474656092","cat":"papers","name":"[Treatment by induced psychosis (mescaline and chlorpromazine)].","year":"1956","cit":4,"pfa":"J Postel","psa":"P Cossa","ptype":"article","src":"https://openalex.org/W2474656092","eid":"W2474656092"},{"id":"paper-w1991899726","cat":"papers","name":"The utilization of tyrosine for mescaline and protein biosynthesis in Lophophora williamsii","year":"1974","cit":4,"pfa":"H. Rosenberg","psa":"SIDNEY J. STOHS","ptype":"article","src":"https://openalex.org/W1991899726","eid":"W1991899726"},{"id":"paper-w2055584028","cat":"papers","name":"Psychopharmacology of MDMA (Ecstasy)","year":"2001","cit":4,"pfa":"Mark S. Gold","psa":"Kimberly Frost-Pineda","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2055584028","eid":"W2055584028"},{"id":"paper-w2062420171","cat":"papers","name":"A Description of a Tonkawa Peyote Meeting Held in 1902","year":"1939","cit":4,"pfa":"MORRIS EDWARD OPLER","ptype":"article","src":"https://openalex.org/W2062420171","eid":"W2062420171"},{"id":"paper-w1166646943","cat":"papers","name":"Legal Status of Peyote: Forensic and Botanical Aspects","year":"1978","cit":4,"pfa":"J Chao","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1166646943","eid":"W1166646943"},{"id":"paper-w2225438379","cat":"papers","name":"Ecstasy (MDMA): An Update","year":"1999","cit":4,"pfa":"R.J. Hadfield","psa":"Michael J. Parr","ptype":"book-chapter","src":"https://openalex.org/W2225438379","eid":"W2225438379"},{"id":"paper-w11222163","cat":"papers","name":"Ibogaine--be informed before you promote or prescribe.","year":"2011","cit":4,"pfa":"Susanna Galea","psa":"Amanda Wheeler","ptype":"letter","src":"https://openalex.org/W11222163","eid":"W11222163"},{"id":"paper-w94372082","cat":"papers","name":"Chapter 4 Drug discrimination studies with ibogaine","year":"2001","cit":4,"pfa":"Scott Helsley","psa":"Jerrold C. Winter","ptype":"book-chapter","src":"https://openalex.org/W94372082","eid":"W94372082"},{"id":"paper-w2404939780","cat":"papers","name":"[The effects of psilocybin in a case of hysteria].","year":"1961","cit":4,"pfa":"Duché Dj","ptype":"article","src":"https://openalex.org/W2404939780","eid":"W2404939780"},{"id":"paper-w1980390863","cat":"papers","name":"Apparent intermediates in the biosynthesis of mescaline and related tetrahydroisoquinolines","year":"1968","cit":4,"pfa":"Stig Agurell","psa":"J. Lundström","ptype":"article","src":"https://openalex.org/W1980390863","eid":"W1980390863"},{"id":"paper-w401538729","cat":"papers","name":"Ayahuasca: Current Interest in an Ancient Ritual","year":"2010","cit":4,"pfa":"Eduardo Gastelumendi","ptype":"book-chapter","src":"https://openalex.org/W401538729","eid":"W401538729"},{"id":"paper-w2150452537","cat":"papers","name":"Mescaline facilitates retention of passive avoidance in rats","year":"1974","cit":4,"pfa":"Jeffrey Paul Kahn","psa":"Wagner H. Bridger","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2150452537","eid":"W2150452537"},{"id":"paper-w2289372502","cat":"papers","name":"PLACENTAL TRANSFER AND FETAL DISTRIBUTION OF MESCALINE-14C IN MONKEYS","year":"1972","cit":4,"pfa":"Ronald J. Taska","psa":"Joseph C. Schoolar","ptype":"article","src":"https://openalex.org/W2289372502","eid":"W2289372502"},{"id":"paper-w4403860154","cat":"papers","name":"“The mushroom was more alive and vibrant”: Patient reports of synthetic versus organic forms of psilocybin","year":"2024","cit":4,"pfa":"Pamela Kryskow","psa":"Monnica T. Williams","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4403860154","eid":"W4403860154"},{"id":"paper-w1975420364","cat":"papers","name":"The Peyote Controversy and the Demise of the Society of American Indians","year":"2013","cit":4,"pfa":"Thomas C. Maroukis","ptype":"article","src":"https://openalex.org/W1975420364","eid":"W1975420364"},{"id":"paper-w3012245592","cat":"papers","name":"The Novelty of Ayahuasca Scale and the prediction of intentions to use","year":"2020","cit":4,"pfa":"Brianna R. Altman","psa":"Mitch Earleywine","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W3012245592","eid":"W3012245592"},{"id":"paper-w2735483252","cat":"papers","name":"Anti-addiction drug ibogaine and the heart: a delicate relation","year":"2015","cit":4,"pfa":"Lena Rubi","topics":["Addiction"],"ptype":"conference-abstract","src":"https://openalex.org/W2735483252","eid":"W2735483252"},{"id":"paper-w2114013636","cat":"papers","name":"Neuroendocrinological Effects of MDMA in the Rat","year":"1990","cit":4,"pfa":"J. Frank Nash","psa":"Herbert Y. Meltzer","ptype":"book-chapter","src":"https://openalex.org/W2114013636","eid":"W2114013636"},{"id":"paper-w1566797965","cat":"papers","name":"Mescaline-induced changes of brain cortex ribosomes","year":"1974","cit":4,"pfa":"Ranajit Kumar Datta","psa":"WILLIAM ANTOPOL","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1566797965","eid":"W1566797965"},{"id":"paper-w2003536280","cat":"papers","name":"O Uso Ritual da Ayahuasca","year":"2005","cit":4,"pfa":"Christian Frenopoulo","ptype":"article","src":"https://openalex.org/W2003536280","eid":"W2003536280"},{"id":"paper-w1573959920","cat":"papers","name":"Substance Abuse: Hallucinogen‐ and MDMA‐Related Disorders","year":"2015","cit":4,"pfa":"Rif S. El‐Mallakh","psa":"Henry David Abraham","topics":["Addiction"],"ptype":"other","src":"https://openalex.org/W1573959920","eid":"W1573959920"},{"id":"paper-w7135031005","cat":"papers","name":"Psilocybin Trends in States That Decriminalized Use","year":"2026","cit":4,"pfa":"Joshua Curtis Black","psa":"Andrew A. Monte","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7135031005","eid":"W7135031005"},{"id":"paper-w4399224722","cat":"papers","name":"Subjective ibogaine experiences across intersecting social-ecological dimensions","year":"2024","cit":4,"pfa":"Evan E. Ozmat","psa":"Jessica L. Martin","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4399224722","eid":"W4399224722"},{"id":"paper-w3032024086","cat":"papers","name":"Ayahuasca – potential therapeutic properties in psychiatry. Research review","year":"2020","cit":4,"pfa":"Aleksandra Barabasz-Gembczyk","psa":"Krzysztof Artur Kucia","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3032024086","eid":"W3032024086"},{"id":"paper-w1979174934","cat":"papers","name":"Action of a chronic administration of mescaline in dynamic behavioural situations","year":"1986","cit":4,"pfa":"Anna Fundaro'","psa":"Marco Orsetti","ptype":"article","src":"https://openalex.org/W1979174934","eid":"W1979174934"},{"id":"paper-w2414767607","cat":"papers","name":"Phenomenally phunny phungi--psilocybin toxicity.","year":"1983","cit":4,"pfa":"Mack Rb","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2414767607","eid":"W2414767607"},{"id":"paper-w4293778673","cat":"papers","name":"The use of psilocybin for treatment-resistant depression","year":"2022","cit":4,"pfa":"Arny Johannesdottir","psa":"Engilbert Sigurðsson","topics":["Depression","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4293778673","eid":"W4293778673"},{"id":"paper-w2410955337","cat":"papers","name":"First Total Synthesis of the Neo-Clerodane Diterpenoid Salvinorin F","year":"2011","cit":4,"pfa":"Hisahiro Hagiwara","psa":"Toshio Suzuki","ptype":"article","src":"https://openalex.org/W2410955337","eid":"W2410955337"},{"id":"paper-w4399926705","cat":"papers","name":"Effects of psilocybin on uncertain punishment learning","year":"2024","cit":4,"pfa":"David S. Jacobs","psa":"Bita Moghaddam","ptype":"article","src":"https://openalex.org/W4399926705","eid":"W4399926705"},{"id":"paper-w2560353104","cat":"papers","name":"Ayahuasca in Canada: Cultural Phenomenon and policy issue","year":"2011","cit":4,"pfa":"Kenneth W. Tupper","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2560353104","eid":"W2560353104"},{"id":"paper-w4380576872","cat":"papers","name":"The Perilous Policy of Oregon's Psilocybin Services.","year":"2023","cit":4,"pfa":"Brian James Holoyda","topics":["Policy & ethics"],"ptype":"editorial","src":"https://openalex.org/W4380576872","eid":"W4380576872"},{"id":"paper-w2095213240","cat":"papers","name":"Methamphetamine and MDMA: ‘Safe’ drugs of abuse","year":"2013","cit":4,"pfa":"Allana M. Krolikowski","psa":"Alex Koyfman","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2095213240","eid":"W2095213240"},{"id":"paper-w2070664560","cat":"papers","name":"Investigation of adrenergic beta-receptor blockade and mescaline-induced bradycardia","year":"1969","cit":4,"pfa":"Joseph J.P. Morton","psa":"Marvin H. Malone","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2070664560","eid":"W2070664560"},{"id":"paper-w4407111596","cat":"papers","name":"Treatment of neuropathic pain with repeated low-dose MDMA: a case report","year":"2025","cit":4,"pfa":"Peter Gasser","psa":"Friederike Holze","topics":["PTSD & trauma","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4407111596","eid":"W4407111596"},{"id":"paper-w2013990894","cat":"papers","name":"Solution-Phase Parallel Synthesis of N,6-Disubstituted Isoquinuclidines as Ibogaine Analogs","year":"2005","cit":4,"pfa":"Mark S. Levi","psa":"Ronald F. Borne","ptype":"article","src":"https://openalex.org/W2013990894","eid":"W2013990894"},{"id":"paper-w2408354644","cat":"papers","name":"[The psychic effect of ibogaline hydrochloride (alkaloid from Tabernanthe iboga Baill)].","year":"1967","cit":4,"pfa":"P. Schmid","ptype":"article","src":"https://openalex.org/W2408354644","eid":"W2408354644"},{"id":"paper-w2079586194","cat":"papers","name":"MDMA and Related Compounds: Session Summary","year":"1990","cit":4,"pfa":"Lewis S. Seiden","ptype":"article","src":"https://openalex.org/W2079586194","eid":"W2079586194"},{"id":"paper-w2047195103","cat":"papers","name":"The Toxicity of Chlorpromazine and Mescaline on Mouse Cerebellum and Fibroblast Cells in Culture*","year":"1973","cit":4,"pfa":"I. F. Roubein","psa":"WOLFRAM KEUP","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2047195103","eid":"W2047195103"},{"id":"paper-w2465869748","cat":"papers","name":"The effect of mescaline and bufotenine on some central actions of noradrenaline.","year":"1971","cit":4,"pfa":"F Ratcliffe","ptype":"article","src":"https://openalex.org/W2465869748","eid":"W2465869748"},{"id":"paper-w3092923527","cat":"papers","name":"MDMA-assisted psychotherapy for the treatment of PTSD","year":"2020","cit":4,"pfa":"Collin M. Reiff","psa":"William Maffitt McDonald","topics":["PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3092923527","eid":"W3092923527"},{"id":"paper-w2069315127","cat":"papers","name":"The effect of LSD, mescaline, and D-amphetamine on the evoked “secondary discharge”","year":"1966","cit":4,"pfa":"Walton T. Roth","ptype":"article","src":"https://openalex.org/W2069315127","eid":"W2069315127"},{"id":"paper-w6441646","cat":"papers","name":"Malignant hyperpyrexia in an MDMA (\"Ecstasy\") abuser.","year":"1994","cit":4,"pfa":"Eamon P. McCoy","psa":"Gavin G. Lavery","ptype":"article","src":"https://openalex.org/W6441646","eid":"W6441646"},{"id":"paper-w3181403041","cat":"papers","name":"Any Questions? A Sober Look at MDMA","year":"2021","cit":4,"pfa":"Luke G. Petry","psa":"Joseph J. Cooper","ptype":"article","src":"https://openalex.org/W3181403041","eid":"W3181403041"},{"id":"paper-w2031029380","cat":"papers","name":"O-methylpellotine, a new peyote alkaloid from Lophophora diffusa","year":"1975","cit":4,"pfa":"Jan G. Brugh","psa":"Stig Agurell","ptype":"article","src":"https://openalex.org/W2031029380","eid":"W2031029380"},{"id":"paper-w4386098723","cat":"papers","name":"Women and MDMA: particularities of gender and sex","year":"2023","cit":4,"pfa":"Fábio Carezzato","psa":"João Maurício Castaldelli-Maia","topics":["PTSD & trauma","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4386098723","eid":"W4386098723"},{"id":"paper-w4412382700","cat":"papers","name":"Pharmacokinetics, Pharmacodynamics, and Urinary Recovery of Oral Mescaline Hydrochloride in Healthy Participants","year":"2025","cit":4,"pfa":"Lorenz Mueller","psa":"Matthias E. Liechti","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4412382700","eid":"W4412382700"},{"id":"paper-w2802227139","cat":"papers","name":"Constitutional Law: Dubious Intrusions: Peyote, Drug Laws, and Religious Freedom","year":"1980","cit":4,"pfa":"John T. Doyle","ptype":"article","src":"https://openalex.org/W2802227139","eid":"W2802227139"},{"id":"paper-w2159868723","cat":"papers","name":"Application of Electrophysiological Method to Study Interactions between Ibogaine and Cocaine","year":"2000","cit":4,"pfa":"ZBIGNIEW K. BINIENDA","psa":"Syed F. Ali","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2159868723","eid":"W2159868723"},{"id":"paper-w4295028212","cat":"papers","name":"Effective connectivity of emotion and cognition under psilocybin","year":"2022","cit":4,"pfa":"Devon Stoliker","psa":"Adeel Razi","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4295028212","eid":"W4295028212"},{"id":"paper-w4386034635","cat":"papers","name":"A mechanistic insight for the biosynthesis of N,N-dimethyltryptamine: An ONIOM theoretical approach","year":"2023","cit":4,"pfa":"Lucas Pinheiro Coutinho","psa":"Norberto de Kássio Vieira Monteiro","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4386034635","eid":"W4386034635"},{"id":"paper-w2029770865","cat":"papers","name":"Teorías, Actores y Redes de la Ayahuasca","year":"2014","cit":4,"pfa":"Óscar Calavia Sáez","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2029770865","eid":"W2029770865"},{"id":"paper-w4387516067","cat":"papers","name":"Potential use of psilocybin drugs in the treatment of depression","year":"2023","cit":4,"pfa":"Katarzyna Śladowska","psa":"Andrzej Pilc","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4387516067","eid":"W4387516067"},{"id":"paper-w2407026695","cat":"papers","name":"Biosynthesis of mescaline and 3,4-dimethoxyphenethylamine in Trichocereus pachanoi Br&R.","year":"1970","cit":4,"pfa":"J Lundström","ptype":"article","src":"https://openalex.org/W2407026695","eid":"W2407026695"},{"id":"paper-w3000047266","cat":"papers","name":"Effects of plant-derived analgesic compounds sinomenine and salvinorin A in infant rats","year":"2020","cit":4,"pfa":"Conrad Mascarenhas","psa":"Gordon A. Barr","ptype":"article","src":"https://openalex.org/W3000047266","eid":"W3000047266"},{"id":"paper-w3134165829","cat":"papers","name":"Psilocin acutely disrupts sleep and affects local but not global sleep homeostasis in laboratory mice","year":"2021","cit":4,"pfa":"Christopher W. Thomas","psa":"Vladyslav V. Vyazovskiy","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W3134165829","eid":"W3134165829"},{"id":"paper-w4214680731","cat":"papers","name":"Biological activity and 13C NMR spectral data of iboga-type skeleton alkaloids","year":"2022","cit":4,"pfa":"Fabíola Damasceno de Lourdes","psa":"Ivo José Curcino Vieira","ptype":"book-chapter","src":"https://openalex.org/W4214680731","eid":"W4214680731"},{"id":"paper-w96191375","cat":"papers","name":"[Fatal MDMA-intoxication with postmortem diagnosis of hyperthermia].","year":"2008","cit":4,"pfa":"Ingo Wirth","psa":"Andreas Schmeling","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W96191375","eid":"W96191375"},{"id":"paper-w2397915858","cat":"papers","name":"[MDMA (\"Ecstasy\")--a dangerous drug or psychotherapeutic drug?].","year":"1994","cit":4,"pfa":"M. Szukaj","topics":["Addiction","Therapy practice"],"ptype":"other","src":"https://openalex.org/W2397915858","eid":"W2397915858"},{"id":"paper-w1971765902","cat":"papers","name":"Treatment Implications for Young Adult Users of MDMA","year":"2006","cit":4,"pfa":"Brian J. Dew","psa":"Claire E. Sterk","ptype":"article","src":"https://openalex.org/W1971765902","eid":"W1971765902"},{"id":"paper-w4401827155","cat":"papers","name":"Hitting the Reset Button: Ceremonial Use of Peyote and Experiences of Personal Change","year":"2024","cit":4,"pfa":"Heith Copes","psa":"Peter S. Hendricks","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4401827155","eid":"W4401827155"},{"id":"paper-w1978610961","cat":"papers","name":"Evaluating the Contribution of Serotonin Receptor Subtypes and ‘Binge’ 3,4-Methylenedioxymethamphetamine (MDMA) Exposure to the Discriminative Stimulus Effects of MDMA in Rats","year":"2011","cit":4,"pfa":"Vanessa Gwendoline Smithies","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1978610961","eid":"W1978610961"},{"id":"paper-w4206581017","cat":"papers","name":"MDMA related neuro-inflammation and adenosine receptors","year":"2022","cit":4,"pfa":"Fatemeh Kermanian","psa":"Simin Mahakizadeh","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4206581017","eid":"W4206581017"},{"id":"paper-w1981210001","cat":"papers","name":"A FURTHER NOTE ON THE MECHANISM OF THE ANTIDOTAL ACTION OF SODIUM SUCCINATE IN THE MESCALINE PSYCHOSIS","year":"1958","cit":4,"pfa":"Ian H. Stevenson","psa":"Lewis Carl Mokrasch","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1981210001","eid":"W1981210001"},{"id":"paper-w2943631710","cat":"papers","name":"On the occasion of the 100th anniversary: Ernst Späth and his mescaline synthesis of 1919","year":"2019","cit":4,"pfa":"Rudolf Werner Soukup","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2943631710","eid":"W2943631710"},{"id":"paper-w4414162012","cat":"papers","name":"Psilocybin Use in the Autism Spectrum Disorder: A Scoping Review","year":"2025","cit":4,"pfa":"Jaime Moreno‐Chaparro","psa":"Javier Hernando Eslava-Schmalbach","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4414162012","eid":"W4414162012"},{"id":"paper-w2940892820","cat":"papers","name":"MDMA-related deaths: About 3 cases","year":"2019","cit":4,"pfa":"Jenny Becam","psa":"Anne‐Laure Pélissier‐Alicot","ptype":"article","src":"https://openalex.org/W2940892820","eid":"W2940892820"},{"id":"paper-w2050702721","cat":"papers","name":"Further studies on the chlorpromazine-induced prolongation of the disappearance of mescaline from mouse tissues","year":"1975","cit":4,"pfa":"Nandkumar S. Shah","psa":"O.D. Gulati","ptype":"article","src":"https://openalex.org/W2050702721","eid":"W2050702721"},{"id":"paper-w1991717620","cat":"papers","name":"A Comparison of MDMA and Amphetamine in the Drug Discrimination Paradigm","year":"2011","cit":4,"pfa":"David N. Harper","ptype":"article","src":"https://openalex.org/W1991717620","eid":"W1991717620"},{"id":"paper-w1993370959","cat":"papers","name":"Personal Report: Significance of Community in an Ayahuasca Jungle Dieta","year":"2012","cit":4,"pfa":"Bethe Hagens","psa":"Steve Lansky","ptype":"article","src":"https://openalex.org/W1993370959","eid":"W1993370959"},{"id":"paper-w4392456300","cat":"papers","name":"The Effects of Ayahuasca on Psychological Disorders: A Systematic Literature Review","year":"2024","cit":4,"pfa":"Reena Sheth","psa":"Deepesh Khanna","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"review","src":"https://openalex.org/W4392456300","eid":"W4392456300"},{"id":"paper-w2917984400","cat":"papers","name":"Effects of ibogaine per os treatment on redox homeostasis in rat kidney","year":"2019","cit":4,"pfa":"Teodora Vidonja Uzelac","psa":"Duško P. Blagojević","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2917984400","eid":"W2917984400"},{"id":"paper-w4396794464","cat":"papers","name":"Psilocybin Treatment for Mental Health Gets Legal Framework","year":"2021","cit":4,"pfa":"Zoe Cormier","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4396794464","eid":"W4396794464"},{"id":"paper-w3047998072","cat":"papers","name":"Medicinal use of psilocybin: Reducing restrictions on research and treatment.","year":"2020","cit":4,"pfa":"James Rucker","psa":"Joanna Caroline Neill","ptype":"article","src":"https://openalex.org/W3047998072","eid":"W3047998072"},{"id":"paper-w4386255164","cat":"papers","name":"Development and validation of a sensitive LC–MS-MS method to quantify psilocin in authentic oral fluid samples","year":"2023","cit":4,"pfa":"Marilia Santoro Cardoso","psa":"José Luiz Costa","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4386255164","eid":"W4386255164"},{"id":"paper-w2471986297","cat":"papers","name":"[N,N-dimethyltryptamine and bufotenin in the urine of patients with chronic and acute schizophrenic psychoses].","year":"1970","cit":4,"pfa":"Helen Rosengarten","psa":"A Jus","ptype":"article","src":"https://openalex.org/W2471986297","eid":"W2471986297"},{"id":"paper-w4226390862","cat":"papers","name":"A whole genome atlas of 81 Psilocybe genomes as a resource for psilocybin production.","year":"2021","cit":4,"pfa":"Kevin Judd McKernan","psa":"Stephen McLaughlin","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4226390862","eid":"W4226390862"},{"id":"paper-w2186744397","cat":"papers","name":"THE EFFECTS OF PARTICIPATION IN AYAHUASCA RITUALS ON GAYS' AND LESBIANS' SELF PERCEPTION","year":"2011","cit":4,"pfa":"John F. Kennedy","ptype":"article","src":"https://openalex.org/W2186744397","eid":"W2186744397"},{"id":"paper-w4405591944","cat":"papers","name":"Therapeutic Potential of MDMA- and Psychedelic-Assisted Psychotherapy for Adolescent Depression and Trauma","year":"2024","cit":4,"pfa":"Jamarie A. Geller","psa":"Eric Whitney","topics":["Depression","PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4405591944","eid":"W4405591944"},{"id":"paper-w2484808062","cat":"papers","name":"Pre-clinical pharmacokinetics of the hERG blocking iboga alkaloid voacangine from Voacanga africana","year":"2015","cit":4,"pfa":"CE Mair","psa":"Judith Maria Rollinger","topics":["Safety & adverse events","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2484808062","eid":"W2484808062"},{"id":"paper-w4280584826","cat":"papers","name":"The Efficacy of Psilocybin in the Treatment of Depression and Anxiety: A Meta-Analysis","year":"2022","cit":4,"pfa":"Andrew Troy Hodge","psa":"Robert C. Strayhan","topics":["Depression","Anxiety & end-of-life","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4280584826","eid":"W4280584826"},{"id":"paper-w2055520697","cat":"papers","name":"Nociception is enhanced by the intrathecal injection of 5-methoxy-N,N-dimethyltryptamine in the rat","year":"1982","cit":4,"pfa":"Alice A. Larson","ptype":"article","src":"https://openalex.org/W2055520697","eid":"W2055520697"},{"id":"paper-w2514091604","cat":"papers","name":"Long-term effects of the ritual use of Ayahuasca on mental health","year":"2011","cit":4,"pfa":"José Carlos Bouso","psa":"Xabier Fernández","ptype":"article","src":"https://openalex.org/W2514091604","eid":"W2514091604"},{"id":"paper-w4289793536","cat":"papers","name":"The current state of ayahuasca research in animal models: A systematic review","year":"2022","cit":4,"pfa":"Dimitri Daldegan‐Bueno","psa":"Lucas Oliveira Maia","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4289793536","eid":"W4289793536"},{"id":"paper-w2414278346","cat":"papers","name":"[Estimation of mescaline and pellotine in Lophophora coulter plants (Cactaceae) by means of the oscillographic polarography].","year":"1978","cit":4,"pfa":"V Gabermann","ptype":"article","src":"https://openalex.org/W2414278346","eid":"W2414278346"},{"id":"paper-w2317252554","cat":"papers","name":"The Role of Oxidative Stress in Methamphetamine and MDMA-induced Toxicity","year":"2013","cit":4,"pfa":"Irene Riezzo","psa":"Vittorio Fineschi","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2317252554","eid":"W2317252554"},{"id":"paper-w3100680462","cat":"papers","name":"Sacred and Profane Uses of the Cactus Lophophora Williamsii from the South Texas Peyote Gardens","year":"2004","cit":4,"pfa":"Clarissa T. Kimber","psa":"Darrel L. McDonald","ptype":"book-chapter","src":"https://openalex.org/W3100680462","eid":"W3100680462"},{"id":"paper-w4411265929","cat":"papers","name":"Synergistic behavioral and neuroplastic effects of psilocybin-NMDAR modulator administration","year":"2025","cit":4,"pfa":"Tom Ben-Tal","psa":"Bernard Lerer","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4411265929","eid":"W4411265929"},{"id":"paper-w4396664832","cat":"papers","name":"Psilocybin facilitates fear extinction: importance of dose, context, and serotonin receptors","year":"2024","cit":4,"pfa":"Samuel C. Woodburn","psa":"Alex C. Kwan","topics":["PTSD & trauma","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4396664832","eid":"W4396664832"},{"id":"paper-w4415419918","cat":"papers","name":"History, pharmacology and therapeutic mechanisms of 3,4‐methylenedioxymethamphetamine (MDMA)","year":"2025","cit":4,"pfa":"Austen B. Casey","psa":"Boris Dov Heifets","topics":["PTSD & trauma","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4415419918","eid":"W4415419918"},{"id":"paper-w4388441105","cat":"papers","name":"LSD and psilocybin for chronic nociplastic pain: A narrative review of the literature supporting the use of classic psychedelic agents in chronic pain","year":"2023","cit":4,"pfa":"J Van Der Walt","psa":"Romy Parker","topics":["Depression","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4388441105","eid":"W4388441105"},{"id":"paper-w2024250091","cat":"papers","name":"IBOGA AGENTS ENHANCE THE EXPRESSION OF COCAINE-INDUCED STEREOTYPY IN ACUTE AND CHRONIC COCAINE-TREATED RATS","year":"1999","cit":4,"pfa":"Karen Kathleen Szumlinski","topics":["Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W2024250091","eid":"W2024250091"},{"id":"paper-w2326208220","cat":"papers","name":"The challenging experience questionnaire: Characterization of acute adverse reactions to psilocybin","year":"2014","cit":4,"pfa":"Frederick Streeter Barrett","psa":"Roland R. Griffiths","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2326208220","eid":"W2326208220"},{"id":"paper-w3118914023","cat":"papers","name":"Psicosis por consumo de ayahuasca: un reporte de caso","year":"2021","cit":4,"pfa":"Harvey Ricardo Cerón Tapia","psa":"Sergio Andrés Córdoba Ortiz","ptype":"article","src":"https://openalex.org/W3118914023","eid":"W3118914023"},{"id":"paper-w2805729745","cat":"papers","name":"Effects of mescaline dextro amphetamine and 2 hallucinogenic methoxy amphetamines on conditioned avoidance in rats","year":"1976","cit":4,"pfa":"Wade Davis","psa":"Monique C. Braude","ptype":"article","src":"https://openalex.org/W2805729745","eid":"W2805729745"},{"id":"paper-w4403779143","cat":"papers","name":"Substrate recognition by the 4‐hydroxytryptamine kinase PsiK in psilocybin biosynthesis","year":"2024","cit":4,"pfa":"Kai Rogge","psa":"Sebastiaan Werten","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4403779143","eid":"W4403779143"},{"id":"paper-w4412796320","cat":"papers","name":"Psilocybin Prolongs the Neurovascular Coupling Response in Mouse Visual Cortex","year":"2025","cit":4,"pfa":"Rick T. Zirkel","psa":"Chris B. Schaffer","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4412796320","eid":"W4412796320"},{"id":"paper-w2418897601","cat":"papers","name":"Effects of various neuroleptics, phenobarbital and SKF 525-A on dimethyltryptamine content in rat brain and liver.","year":"1978","cit":4,"pfa":"Li Lu","psa":"E F Domino","ptype":"article","src":"https://openalex.org/W2418897601","eid":"W2418897601"},{"id":"paper-w4417164953","cat":"papers","name":"Psilocybin induces sex- and context-specific recruitment of the stress axis","year":"2025","cit":4,"pfa":"Sarah G. Cook","psa":"Tamás Füzesi","topics":["Depression","PTSD & trauma","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4417164953","eid":"W4417164953"},{"id":"paper-w1791236591","cat":"papers","name":"Aproximación terapéutica del uso-abuso de MDMA (Extasis)","year":"2000","cit":4,"pfa":"Pilar Alejandra Sáiz","psa":"Julio Bobes","ptype":"article","src":"https://openalex.org/W1791236591","eid":"W1791236591"},{"id":"paper-w4232520261","cat":"papers","name":"MDMA-Assisted Psychotherapy for the Treatment of PTSD, Current International Research","year":"2008","cit":4,"pfa":"Michael C. Mithoefer","topics":["PTSD & trauma","Therapy practice"],"ptype":"dataset","src":"https://openalex.org/W4232520261","eid":"W4232520261"},{"id":"paper-w4304471516","cat":"papers","name":"Ritualistic use of ayahuasca enhances a shared functional connectome identity with others","year":"2022","cit":4,"pfa":"Pablo Mallaroni","psa":"Johannes Gerardus Ramaekers","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4304471516","eid":"W4304471516"},{"id":"paper-w2157563754","cat":"papers","name":"Response to Sprague and Nichols: Contribution of metabolic activation to MDMA neurotoxicity","year":"2004","cit":4,"pfa":"Rafael de la Torre","psa":"Douglas C. Jones","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2157563754","eid":"W2157563754"},{"id":"paper-w4281568156","cat":"papers","name":"Future directions for clinical psilocybin research: The relaxed symptom network.","year":"2022","cit":4,"pfa":"Evan Lewis-Healey","psa":"Michiel van Elk","topics":["Depression","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4281568156","eid":"W4281568156"},{"id":"paper-w4313007465","cat":"papers","name":"Eficacia de la terapia asistida de drogadicción con ayahuasca","year":"2015","cit":4,"pfa":"Miroslav Horák","psa":"Kristina Somerlíková","ptype":"book-chapter","src":"https://openalex.org/W4313007465","eid":"W4313007465"},{"id":"paper-w3147311264","cat":"papers","name":"literatura antropológica e a reconstituição histórica do uso da ayahuasca no Brasil","year":"2011","cit":4,"pfa":"Henrique Fernandes Antunes","ptype":"article","src":"https://openalex.org/W3147311264","eid":"W3147311264"},{"id":"paper-w2079495481","cat":"papers","name":"Hispano-indian trade of an Indian ceremonial plant, peyote (Lophophohora williamsii), on the mustang plains of Texas","year":"1983","cit":4,"pfa":"George Morgan","ptype":"article","src":"https://openalex.org/W2079495481","eid":"W2079495481"},{"id":"paper-w2149467623","cat":"papers","name":"The impact of recreational MDMA ‘ecstasy’ use on global form processing","year":"2014","cit":4,"pfa":"Claire White","psa":"Jason Bell","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2149467623","eid":"W2149467623"},{"id":"paper-w4383749998","cat":"papers","name":"N, N-Dimethyltryptamine (DMT)-Occasioned Familiarity and the Sense of Familiarity Questionnaire (SOF-Q)","year":"2023","cit":4,"pfa":"David Wyndham Lawrence","psa":"Christopher B. Timmermann","ptype":"article","src":"https://openalex.org/W4383749998","eid":"W4383749998"},{"id":"paper-w2001445210","cat":"papers","name":"Cross tolerance to antinociception elicited by intracerebroventricular administration of mescaline and morphine to rabbits, and EEG correlates","year":"1976","cit":4,"pfa":"S. Ferri","psa":"Pier Carlo Braga","ptype":"article","src":"https://openalex.org/W2001445210","eid":"W2001445210"},{"id":"paper-w3131223223","cat":"papers","name":"MDMA – hopes and fears associated with therapeutic use in mental disorders","year":"2020","cit":4,"pfa":"Kamil Kozera","psa":"Małgorzata Honorata Janas-Kozik","topics":["PTSD & trauma","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3131223223","eid":"W3131223223"},{"id":"paper-w2809218809","cat":"papers","name":"The role of Ecstasy (MDMA) in managing intimacy and conflict in stable relationships","year":"2018","cit":4,"pfa":"Kristin M. Kostick","psa":"Jean J. Schensul","ptype":"article","src":"https://openalex.org/W2809218809","eid":"W2809218809"},{"id":"paper-w4403590843","cat":"papers","name":"The serotonin 1B receptor is required for some of the behavioral effects of psilocybin in mice","year":"2024","cit":4,"pfa":"Sixtine Fleury","psa":"Katherine M. Nautiyal","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4403590843","eid":"W4403590843"},{"id":"paper-w2161522666","cat":"papers","name":"Determination of MDMA and Its Three Metabolites in the Rat Perfused Liver","year":"2013","cit":4,"pfa":"Bardia Jamali","psa":"Mohammad Reza Rouini","ptype":"article","src":"https://openalex.org/W2161522666","eid":"W2161522666"},{"id":"paper-w4406569171","cat":"papers","name":"N, N-dimethyltryptamine (DMT) in rodent brain: Concentrations, distribution, and recent pharmacological data","year":"2025","cit":4,"pfa":"Steven A. Barker","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4406569171","eid":"W4406569171"},{"id":"paper-w2298660688","cat":"papers","name":"Effects of MDMA (Ecstasy) on Oocyte Quality and Fertilization Rate in Mice","year":"2010","cit":4,"pfa":"F Haji Maghsoudi","psa":"Atieh Karimzadeh","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2298660688","eid":"W2298660688"},{"id":"paper-w2229526896","cat":"papers","name":"Avaliação Hepática em Ratos Wistar Expostos ao Chá de Ayahuasca","year":"2015","cit":4,"pfa":"Bruno Acharezzi","psa":"Wilson Roberto Malfará","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2229526896","eid":"W2229526896"},{"id":"paper-w2046167402","cat":"papers","name":"The crystal structure of bis(3,4,5-trimethoxyphenethylammonium) tetrachlorocuprate(II) monohydrate, a complex salt of mescaline","year":"1979","cit":4,"pfa":"H. J. Buser","psa":"George W. Watt","ptype":"article","src":"https://openalex.org/W2046167402","eid":"W2046167402"},{"id":"paper-w4387033334","cat":"papers","name":"Ayahuasca, Personality and Acute Psychological Effects in Neo-Shamanic and Religious Settings in Uruguay","year":"2023","cit":4,"pfa":"Ismael Apud","psa":"Juan Ignacio Retta","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4387033334","eid":"W4387033334"},{"id":"paper-w2062401933","cat":"papers","name":"Cocaine enhances the conditioned rewarding effects of MDMA in adolescent mice","year":"2015","cit":4,"pfa":"M.A. Aguilar","psa":"José Miñarro","ptype":"article","src":"https://openalex.org/W2062401933","eid":"W2062401933"},{"id":"paper-w1963995476","cat":"papers","name":"A CLINICAL STUDY OF THE MESCALINE PSYCHOSIS, WITH SPECIAL REFERENCE TO THE MECHANISM OF THE GENESIS OF SCHIZOPHRENIC AND OTHER PSYCHOTIC STATES","year":"1940","cit":4,"pfa":"G. Tayleur Stockings","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1963995476","eid":"W1963995476"},{"id":"paper-w4408493993","cat":"papers","name":"Analysis of N,N‐dimethyltryptamine ( DMT ) and its metabolites using LC – MS / MS for forensic purposes","year":"2025","cit":4,"pfa":"Munchelou M Gomonit","psa":"Britni N. Skillman","ptype":"article","src":"https://openalex.org/W4408493993","eid":"W4408493993"},{"id":"paper-w2410861842","cat":"papers","name":"[Three cases of acute serotonin syndrome due to psilocybin mushroom poisoning].","year":"2016","cit":4,"pfa":"Keiko Suzuki","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2410861842","eid":"W2410861842"},{"id":"paper-w2410846526","cat":"papers","name":"[Physiology of the 14-C radioactive mescaline in animal experiment. I. Fermental experiments and excretion products].","year":"1952","cit":4,"pfa":"Wolfram Block","psa":"Bernhard Patzig","ptype":"article","src":"https://openalex.org/W2410846526","eid":"W2410846526"},{"id":"paper-w4412640287","cat":"papers","name":"Magnesium–ibogaine therapy effects on cortical oscillations and neural complexity in veterans with traumatic brain injury","year":"2025","cit":4,"pfa":"Jennifer I. Lissemore","psa":"Nolan Williams","topics":["PTSD & trauma","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4412640287","eid":"W4412640287"},{"id":"paper-w4408302164","cat":"papers","name":"Lasting effect of psilocybin on sociability can be blocked by DNA methyltransferase inhibition","year":"2025","cit":4,"pfa":"Chenchen Song","psa":"Thomas Knöpfel","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4408302164","eid":"W4408302164"},{"id":"paper-w4206767983","cat":"papers","name":"Exploring the Credibility of Psilocybin-assisted Therapy and Cognitive-behavioral Therapy for Depression","year":"2022","cit":4,"pfa":"Brianna R. Altman","psa":"Joseph Anthony De Leo","topics":["Depression","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4206767983","eid":"W4206767983"},{"id":"paper-w802688023","cat":"papers","name":"Marijuana as a Holy Sacrament: Is the Use of Peyote Constitutionally Distinguishable from That of Marijuana in Bona Fide Religious Ceremonies","year":"1991","cit":4,"pfa":"Cynthia S. Manzur","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W802688023","eid":"W802688023"},{"id":"paper-w3088884604","cat":"papers","name":"Influência da Ayahuasca na Resolução de Problemas com Ratos Wistar","year":"2019","cit":4,"pfa":"Sofia Azevêdo De Araújo","psa":"Francisco Edimar do Nascimento","ptype":"article","src":"https://openalex.org/W3088884604","eid":"W3088884604"},{"id":"paper-w4409954307","cat":"papers","name":"Ayahuasca-inspired DMT/HAR formulation reduces brain differentiation between self and other faces","year":"2025","cit":4,"pfa":"Dila Suay","psa":"Davide Bottari","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4409954307","eid":"W4409954307"},{"id":"paper-w3098759296","cat":"papers","name":"False‐positive urine screen test for MDMA in a patient exposed to mebeverine","year":"2020","cit":4,"pfa":"Francesca Bedussi","psa":"Alessandro Ceschi","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3098759296","eid":"W3098759296"},{"id":"paper-w4400913466","cat":"papers","name":"Psilocybin and Motor Function: A Triple‐Blind, Dose‐Finding Study in Healthy Participants","year":"2024","cit":4,"pfa":"Chiranth Bhagavan","psa":"Alexander Bryson","topics":["Safety & adverse events","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4400913466","eid":"W4400913466"},{"id":"paper-w2076933526","cat":"papers","name":"The acute cardiovascular effects of 3,4‐methylenedioxymethamphetamine (MDMA) and p‐methoxyamphetamine (PMA)","year":"2001","cit":4,"pfa":"Rodney James Irvine","psa":"Tanya Lewanowitsch","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2076933526","eid":"W2076933526"},{"id":"paper-w2014157816","cat":"papers","name":"The effects of mirtazapine and fluoxetine on hyperthermia induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats","year":"2011","cit":4,"pfa":"Makiko Kasai","psa":"Satoshi Kato","ptype":"article","src":"https://openalex.org/W2014157816","eid":"W2014157816"},{"id":"paper-w2024167718","cat":"papers","name":"Scoring Ecstasy: MDMA, Consumerism and Spirituality in the Early Fiction of Irvine Welsh","year":"2003","cit":4,"pfa":"William Stephenson","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2024167718","eid":"W2024167718"},{"id":"paper-w1972066754","cat":"papers","name":"GC–IRD methods for the identification of some tertiary amines related to MDMA","year":"2010","cit":4,"pfa":"Hadir Mohamed Maher","psa":"Charles R. Clark","ptype":"article","src":"https://openalex.org/W1972066754","eid":"W1972066754"},{"id":"paper-w2915320952","cat":"papers","name":"Drugs, Religion, and Cultural Heritage: An Analysis of the Public Policies Regarding the Use of Ayahuasca in Brazil","year":"2019","cit":4,"pfa":"Henrique Fernandes Antunes","ptype":"article","src":"https://openalex.org/W2915320952","eid":"W2915320952"},{"id":"paper-w2043931784","cat":"papers","name":"Aromatic hydroxylation of methylenedioxybenzene (MDB) and methylenedioxymethamphetamine (MDMA) by rabbit liver microsomes","year":"1992","cit":4,"pfa":"Yoshito Kumagai","psa":"A. K. Cho","ptype":"article","src":"https://openalex.org/W2043931784","eid":"W2043931784"},{"id":"paper-w4415918505","cat":"papers","name":"MDMA-Assisted Psychotherapy for PTSD: A Systematic Review of Randomized Control Trials","year":"2025","cit":4,"pfa":"Barbara A. Brett","psa":"Christine Bynum","topics":["PTSD & trauma","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4415918505","eid":"W4415918505"},{"id":"paper-w2028508065","cat":"papers","name":"Possible mechanism of 5-methoxy-N, N-dimethyltryptamine-induced turning behaviour in DRN lesioned rats","year":"1982","cit":4,"pfa":"Thomas P. Blackburn","psa":"T. F. Lee","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2028508065","eid":"W2028508065"},{"id":"paper-w4239128101","cat":"papers","name":"MDMA-assisted psychotherapy may help individuals with treatment-resistant PTSD","year":"2011","cit":4,"pfa":"Michael C. Mithoefer","psa":"R. Doblin","topics":["Depression","PTSD & trauma","Therapy practice"],"ptype":"dataset","src":"https://openalex.org/W4239128101","eid":"W4239128101"},{"id":"paper-w2704145885","cat":"papers","name":"Interculturalidad en torno al uso del peyote. Un patrimonio biocultural en condición de ilegalidad","year":"2017","cit":4,"pfa":"Mauricio Genet Guzmán Chávez","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2704145885","eid":"W2704145885"},{"id":"paper-w4407170392","cat":"papers","name":"Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis","year":"2025","cit":4,"pfa":"David Qixiang Chen","psa":"Jonathan E. Dickinson","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4407170392","eid":"W4407170392"},{"id":"paper-w7125613611","cat":"papers","name":"Methodological moderators of psilocybin-assisted therapy in depression: A systematic review and meta-analysis","year":"2026","cit":4,"pfa":"Omer A. Syed","psa":"Peter Giacobbe","topics":["Depression","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7125613611","eid":"W7125613611"},{"id":"paper-w4416669801","cat":"papers","name":"A comparative assessment of the antidepressant efficacy of ketamine, psilocybin, and fluoxetine in a chronic stress model","year":"2025","cit":4,"pfa":"Małgorzata Domżalska","psa":"Ewa Sokołowska","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4416669801","eid":"W4416669801"},{"id":"paper-w1992984286","cat":"papers","name":"On Travels in the Universe of the Soul: Reports on Self-Experiments with Delysid (LSD) and Psilocybin (CY)","year":"1981","cit":4,"pfa":"Rudolf Gelpke","ptype":"article","src":"https://openalex.org/W1992984286","eid":"W1992984286"},{"id":"paper-w2964657072","cat":"papers","name":"An Adaptive Cognitive Temporal-Causal Model for Extreme Emotion Extinction Using Psilocybin","year":"2019","cit":4,"pfa":"Seyed Sahand Mohammadi Ziabari","psa":"Jan Treur","ptype":"conference-paper","src":"https://openalex.org/W2964657072","eid":"W2964657072"},{"id":"paper-w4363675215","cat":"papers","name":"96. An Open Label Study of Synthetic Psilocybin in Bipolar Type II Depression","year":"2023","cit":4,"pfa":"Scott Aaronson","psa":"Trisha M Suppes","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4363675215","eid":"W4363675215"},{"id":"paper-w4411880520","cat":"papers","name":"Examining mystical experiences as a predictor of psilocybin-assisted psychotherapy for treatment-resistant depression","year":"2025","cit":4,"pfa":"Ryan M. Brudner","psa":"Joshua Daniel Rosenblat","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4411880520","eid":"W4411880520"},{"id":"paper-w2042756310","cat":"papers","name":"THE EFFECT OF AN ECTOSYLVIAN EPILEPTOGENIC FOCUS INDUCED BY TOPICAL APPLICATION OF MESCALINE ON NITROGENOUS COMPOUNDS IN THE NEOCORTEX OF CAT","year":"1966","cit":4,"pfa":"G Badiu","psa":"NELLA MISON-CRIGHEL","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2042756310","eid":"W2042756310"},{"id":"paper-w2559775474","cat":"papers","name":"Transcultual Perspective on Consciousness: Traditional Use of Ayahuasca in Psychiatry in the 21st Century in the Western World","year":"2016","cit":4,"pfa":"Tania Simona Re","psa":"Marriete Goncalves Simoes","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2559775474","eid":"W2559775474"},{"id":"paper-w4308131725","cat":"papers","name":"Episodios psicóticos inducidos por ayahuasca: revisión sistemática a partir de un caso.","year":"2022","cit":4,"pfa":"Laura Alcantarilla","psa":"Celia Almonacid","ptype":"article","src":"https://openalex.org/W4308131725","eid":"W4308131725"},{"id":"paper-w2412173674","cat":"papers","name":"[Psychiatric disorders and consumption of ecstasy drug (MDMA): review of published case reports].","year":"1999","cit":4,"pfa":"J.I. Bango","psa":"J Santo-Domingo","topics":["Depression","Addiction","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W2412173674","eid":"W2412173674"},{"id":"paper-w4313035531","cat":"papers","name":"Selling the Priceless Mushroom: A History of Psilocybin Mushroom Trade in the Sierra Mazateca (Oaxaca)","year":"2022","cit":4,"pfa":"Marcos Garcia de Teresa","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4313035531","eid":"W4313035531"},{"id":"paper-w4296052905","cat":"papers","name":"Cerebrospinal Fluid Serotonin level as Biomarker for Neurotoxicity after 3,4-Methylenedioxymethamphetamine (MDMA)","year":"2022","cit":4,"pfa":"Fatin Haniza Zakaria","psa":"Khadijah N.M.J","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4296052905","eid":"W4296052905"},{"id":"paper-w2908716216","cat":"papers","name":"A tale of two cacti-the complex relationship between peyote ( Lophophora williamsii ) and endangered star cactus (Astrophytum asterias)","year":"2007","cit":4,"pfa":"Martin Terry","psa":"Jackie M. Poole","ptype":"article","src":"https://openalex.org/W2908716216","eid":"W2908716216"},{"id":"paper-w4308540436","cat":"papers","name":"“Returning to the path”. The use of iboga(ine) in an equatorial african ritual context and the binding of time, space, and social relationships","year":"2006","cit":4,"pfa":"Julien Bonhomme","ptype":"other","src":"https://openalex.org/W4308540436","eid":"W4308540436"},{"id":"paper-w2470452365","cat":"papers","name":"Biosynthesis of psilocybin in submerged culture of Psilocybe cubensis. 1. Incorporation of labelled tryptophan and tryptamine.","year":"1966","cit":4,"pfa":"Stig Agurell","psa":"Philip Catalfomo","ptype":"article","src":"https://openalex.org/W2470452365","eid":"W2470452365"},{"id":"paper-w4403136437","cat":"papers","name":"Psilocybin reduces functional correlation and the encoding of spatial information by neurons in mouse retrosplenial cortex","year":"2024","cit":4,"pfa":"Victorita E. Ivan","psa":"Aaron J. Gruber","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4403136437","eid":"W4403136437"},{"id":"paper-w2397938443","cat":"papers","name":"Comparison of the behavioral and neurochemical effects of 5,7-DHT, MDMA and D,L-fenfluramine.","year":"1989","cit":4,"pfa":"Lorens Sa","psa":"Hamilton Me","ptype":"article","src":"https://openalex.org/W2397938443","eid":"W2397938443"},{"id":"paper-w562130067","cat":"papers","name":"Little evidence for central executive impairment among light/moderate users of MDMA","year":"2002","cit":4,"pfa":"M. Wareing","psa":"John E. Fisk","ptype":"conference-paper","src":"https://openalex.org/W562130067","eid":"W562130067"},{"id":"paper-w4404133386","cat":"papers","name":"Long-term effects of psilocybin on dynamic and effectivity connectivity of fronto-striatal-thalamic circuits","year":"2024","cit":4,"pfa":"Lorenzo Pasquini","psa":"Gustavo Deco","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4404133386","eid":"W4404133386"},{"id":"paper-w2782763081","cat":"papers","name":"Ghrelin Alleviates MDMA-Induced Disturbance of Serum Glucose and Lipids Levels in the Rat.","year":"2017","cit":4,"pfa":"Ravieh Golchoobian","psa":"Maryam Mohammadian","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2782763081","eid":"W2782763081"},{"id":"paper-w2964900244","cat":"papers","name":"Differential role of dose and environment in initiating and intensifying neurotoxicity caused by MDMA in rats","year":"2019","cit":4,"pfa":"Ibrahim M. Shokry","psa":"Rui Tao","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2964900244","eid":"W2964900244"},{"id":"paper-w4379801323","cat":"papers","name":"Swim in the Chiral Pool: MDMA and MDA Enantiomers from Alanine-Derived Precursors","year":"2023","cit":4,"pfa":"Alexander M. Sherwood","psa":"Michael T. Faley","ptype":"article","src":"https://openalex.org/W4379801323","eid":"W4379801323"},{"id":"paper-w4410946123","cat":"papers","name":"Self-inflicted transorbital intracranial foreign body following ingestion of hallucinogenic psilocybin mushrooms","year":"2025","cit":4,"pfa":"Abigail M. Blanton","psa":"Ronald Mancini","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4410946123","eid":"W4410946123"},{"id":"paper-w4404321372","cat":"papers","name":"Preliminary Evidence of Sleep Improvements Following Psilocybin Administration, and their Involvement in Antidepressant Therapeutic Action","year":"2024","cit":4,"pfa":"Matthew James Reid","psa":"Robin Lester Carhart-Harris","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4404321372","eid":"W4404321372"},{"id":"paper-w2558041581","cat":"papers","name":"Psilocybin: promising results in double-blind trials require confirmation by real-world evidence","year":"2016","cit":4,"pfa":"Alasdair M. Breckenridge","psa":"Diederick E. Grobbee","ptype":"article","src":"https://openalex.org/W2558041581","eid":"W2558041581"},{"id":"paper-w4404701866","cat":"papers","name":"Psilocybin-Assisted Therapy May Enhance Conservation Values in Patients with Alcohol Use Disorder","year":"2024","cit":4,"pfa":"Noah D. Gold","psa":"Michael P. Bogenschutz","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4404701866","eid":"W4404701866"},{"id":"paper-w4407209307","cat":"papers","name":"Psilocybin as a treatment for repetitive mild head injury: evidence from neuroradiology and molecular biology","year":"2026","cit":4,"pfa":"Eric K. Brengel","psa":"Craig F. Ferris","topics":["PTSD & trauma","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4407209307","eid":"W4407209307"},{"id":"paper-w184402432","cat":"papers","name":"Motive für den Konsum psychoaktiver Substanzen am Beispiel des Ayahuasca-Gebrauchs in der Santo-Daime-Gemeinschaft","year":"2011","cit":4,"pfa":"Lisa Fiedler","psa":"Rolf Verres","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W184402432","eid":"W184402432"},{"id":"paper-w2142047468","cat":"papers","name":"Psychophysische Korrelationen unter der Einwirkung von Psycholytika (LSD, Psilocybin und ähnl.)","year":"2008","cit":4,"pfa":"Heinz Holfeld","ptype":"article","src":"https://openalex.org/W2142047468","eid":"W2142047468"},{"id":"paper-w4388732776","cat":"papers","name":"A Scoping Review of Australian Literature on People Who Use MDMA and Their Harm Reduction Practices","year":"2023","cit":4,"pfa":"Chloe Span","psa":"Oisin Stronach","topics":["Safety & adverse events","Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4388732776","eid":"W4388732776"},{"id":"paper-w4365516156","cat":"papers","name":"Perspectives on the therapeutic potential of MDMA: A nation-wide exploratory survey among substance users","year":"2023","cit":4,"pfa":"Jennifer Lynn Jones","topics":["PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4365516156","eid":"W4365516156"},{"id":"paper-w4406141686","cat":"papers","name":"Moderating factors in psilocybin-assisted treatment affecting mood and personality: A naturalistic, open-label investigation","year":"2025","cit":4,"pfa":"Mona Irrmischer","psa":"Hessel Engelbregt","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4406141686","eid":"W4406141686"},{"id":"paper-w4396616292","cat":"papers","name":"Comparative study of sample preparation procedures to determine the main compounds in ayahuasca beverages by QuEChERS and high‐performance liquid chromatography analysis","year":"2024","cit":4,"pfa":"Joana Gonçalves","psa":"Ana Paula Duarte","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4396616292","eid":"W4396616292"},{"id":"paper-w4406797458","cat":"papers","name":"Bringing MDMA-assisted therapy for PTSD to traditional healthcare systems: tending to set and setting","year":"2025","cit":4,"pfa":"Dimitri Perivoliotis","psa":"Leslie A. Morland","topics":["PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4406797458","eid":"W4406797458"},{"id":"paper-w2089683490","cat":"papers","name":"Cocaine and MDMA Induce Cellular and Molecular Changes in Adult Neurogenic Systems: Functional Implications","year":"2011","cit":4,"pfa":"Vivian Capilla‐González","psa":"Vicente Hernández‐Rabaza","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2089683490","eid":"W2089683490"},{"id":"paper-w2077872432","cat":"papers","name":"MDMA induces Per1, Per2 and c-fos gene expression in rat suprachiasmatic nuclei","year":"2011","cit":4,"pfa":"Rowan P. Ogeil","psa":"Jillian Helen Broadbear","ptype":"article","src":"https://openalex.org/W2077872432","eid":"W2077872432"},{"id":"paper-w4386469528","cat":"papers","name":"Psilocybin-Assisted Cognitive Behavioral Therapy for Adults with Major Depressive Disorder: Rationale and Treatment Development","year":"2023","cit":4,"pfa":"Marc J. Weintraub","psa":"David J. Miklowitz","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4386469528","eid":"W4386469528"},{"id":"paper-w4404189888","cat":"papers","name":"Prospective Preference Assessment for the Psilocybin for Enhanced Analgesia in Chronic nEuropathic PAIN (PEACE-PAIN) Trial","year":"2024","cit":4,"pfa":"Jiwon Lee","psa":"Karim Shiraz Ladha","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4404189888","eid":"W4404189888"},{"id":"paper-w2072371534","cat":"papers","name":"Effect of acute brain tyrosine depletion on MDMA-induced changes in brain 5-HT","year":"2009","cit":4,"pfa":"Ratchanee Rodsiri","psa":"Kevin C.F. Fone","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2072371534","eid":"W2072371534"},{"id":"paper-w2083254847","cat":"papers","name":"Liquid Chromatographic and Spectral Methods for the Differentiation of 3,4-Methylenedioxymethamphetamine (MDMA) from Regioisomeric Phenethylamines","year":"1991","cit":4,"pfa":"F. T. Noggle","psa":"Jack De Ruiter","ptype":"article","src":"https://openalex.org/W2083254847","eid":"W2083254847"},{"id":"paper-w7128912015","cat":"papers","name":"Network pharmacology and molecular simulation reveal the entourage effect mechanisms of psilocybin-producing mushrooms on the brain","year":"2026","cit":4,"pfa":"Zurika Murray","psa":"Abdul Rashid Issahaku","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7128912015","eid":"W7128912015"},{"id":"paper-w2768161925","cat":"papers","name":"Analysis and simulation of MDMA—A spectrum efficient non-orthogonal multiple access scheme for 5G communication","year":"2017","cit":4,"pfa":"Wei‐Han Hsiao","psa":"Chia-Chi Huang","ptype":"article","src":"https://openalex.org/W2768161925","eid":"W2768161925"},{"id":"paper-w1986255003","cat":"papers","name":"The Effect of Mescaline and Yohimbine on the Respiration of Rat Brain Homogenate**Research Laboratories of the Faculty of Pharmacy, University of British Columbia, Vancouver 8, Canada","year":"1959","cit":4,"pfa":"Paul Shatzko","psa":"Stephen K. Sim","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1986255003","eid":"W1986255003"},{"id":"paper-w2314155783","cat":"papers","name":"Liquid Chromatographic and Mass Spectral Analysis of 1-(3,4-Dimethoxyphenyl)-2-propanamines: Analogs of MDMA","year":"1991","cit":4,"pfa":"F. T. Noggle","psa":"J. DeRuiter","ptype":"article","src":"https://openalex.org/W2314155783","eid":"W2314155783"},{"id":"paper-w4411126613","cat":"papers","name":"Clinical conceptualisation of PTSD in psilocybin treatment: disrupting a pre-determined and over-determined maladaptive interpretive framework","year":"2025","cit":4,"pfa":"Nadav Liam Modlin","psa":"James Rucker","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4411126613","eid":"W4411126613"},{"id":"paper-w2989991863","cat":"papers","name":"MDMA Abuse in Relation to MicroRNA Variation in Human Brain Ventral Tegmental Area and Nucleus Accumbens.","year":"2019","cit":4,"pfa":"Göksun Demirel","psa":"Türkan Yurdun","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2989991863","eid":"W2989991863"},{"id":"paper-w4408574959","cat":"papers","name":"The psychedelic psilocybin and light exposure have similar and synergistic effects on gene expression patterns in the visual cortex","year":"2025","cit":4,"pfa":"Ram Harari","psa":"Evan Elliott","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4408574959","eid":"W4408574959"},{"id":"paper-w4410539818","cat":"papers","name":"Separate or inseparable? Serotonin and dopamine system interactions may underlie the therapeutic potential of psilocybin for anorexia nervosa","year":"2025","cit":4,"pfa":"Kaspar McCoy","psa":"Claire J. Foldi","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4410539818","eid":"W4410539818"},{"id":"paper-w1967029878","cat":"papers","name":"Reply to ‘MDMA can increase cortical levels by 800% in dance clubbers’ Parrott et al.","year":"2012","cit":4,"pfa":"Kim Wolff","psa":"Katherine Jean Aitchison","ptype":"letter","src":"https://openalex.org/W1967029878","eid":"W1967029878"},{"id":"paper-w2329379609","cat":"papers","name":"The U.S. Supreme Court Decision on Peyote in Employment Division v. Smith: A Case Study in the Suppression of Native American Religious Freedom","year":"1992","cit":4,"pfa":"Steve Pavlik","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2329379609","eid":"W2329379609"},{"id":"paper-w2248248757","cat":"papers","name":"King Alcohol to Chief Peyote: A grounded theory investigation of the supportive Factors of the Native American Church for Drug and Alcohol Abuse Recovery","year":"2008","cit":4,"pfa":"Prue, Robert Eugene","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"dissertation","src":"https://openalex.org/W2248248757","eid":"W2248248757"},{"id":"paper-w4323928995","cat":"papers","name":"Self-treatment of depression and complex post-traumatic stress disorder with psilocybin and LSD—A retrospective case study","year":"2023","cit":4,"pfa":"Mika Turkia","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W4323928995","eid":"W4323928995"},{"id":"paper-w2801355086","cat":"papers","name":"The Effects of Vitamin E on Prevention of Damages Due to MDMA (Ecstasy) Exposure on Sperm Parameters in Mice","year":"2017","cit":4,"pfa":"Sayed Soran Ghafori","psa":"Sima Modirkhamene","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2801355086","eid":"W2801355086"},{"id":"paper-w1996515185","cat":"papers","name":"Independent of 5-HT1A receptors, neurons in the paraventricular hypothalamus mediate ACTH responses from MDMA","year":"2013","cit":4,"pfa":"Dmitry V. Zaretsky","psa":"Daniel E. Rusyniak","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1996515185","eid":"W1996515185"},{"id":"paper-w2888859082","cat":"papers","name":"3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy) Intoxication in a Young Adult with Giant Coronary Aneurysms from Kawasaki Disease","year":"2018","cit":4,"pfa":"Renee L. Eigsti","psa":"Marcus B. Nashelsky","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2888859082","eid":"W2888859082"},{"id":"paper-w2051138544","cat":"papers","name":"Developmental exposure to 3,4-methylenedioxymethamphetamine (MDMA) in rats produces persistent deficits in Cincinnati water maze performance","year":"1997","cit":4,"pfa":"Harry W. Broening","psa":"Charles V. Vorhees","ptype":"article","src":"https://openalex.org/W2051138544","eid":"W2051138544"},{"id":"paper-w4404211652","cat":"papers","name":"Ayahuasca rituals for the treatment of substance use disorders: Three narratives of former patients of a neo‐shamanic center from Uruguay","year":"2024","cit":4,"pfa":"Juan Scuro","psa":"Vanessa Martínez","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4404211652","eid":"W4404211652"},{"id":"paper-w3116486217","cat":"papers","name":"Synergistic effects of MDMA and ethanol on behavior: Possible effects of ethanol on dopamine D2‐receptor‐related signaling","year":"2020","cit":4,"pfa":"Tomohisa Mori","psa":"Tsutomu Suzuki","topics":["Addiction","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3116486217","eid":"W3116486217"},{"id":"paper-w4297220769","cat":"papers","name":"Forensic Identification of 3,4-Methylendioxy-N-methylamphetamine (MDMA), Ketamine, and Benzodiazepine by Handheld Infrared Spectroscopy and Chemometrics","year":"2022","cit":4,"pfa":"Mi Zhu","psa":"Hongjian Zhu","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4297220769","eid":"W4297220769"},{"id":"paper-w4412523410","cat":"papers","name":"Development of an Australian Clinical Practice Guideline on methylenedioxymethamphetamine (MDMA)-assisted Psychotherapy for Post-traumatic Stress Disorder","year":"2025","cit":4,"pfa":"Alene Sze Jing Yong","psa":"J. Simon Bell","topics":["PTSD & trauma","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4412523410","eid":"W4412523410"},{"id":"paper-w4392242849","cat":"papers","name":"A Plea for Nuance: Should People with a Family History of Bipolar Disorder Be Excluded from Clinical Trials of Psilocybin Therapy?","year":"2024","cit":4,"pfa":"Amanda E. Downey","psa":"Joshua D. Woolley","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4392242849","eid":"W4392242849"},{"id":"paper-w4406080228","cat":"papers","name":"Single-nucleus transcriptomics reveals cell type-specific and time-dependent effects of psilocybin and ketamine on gene expression","year":"2025","cit":4,"pfa":"Clara Liao","psa":"Alex C. Kwan","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4406080228","eid":"W4406080228"},{"id":"paper-w4388770214","cat":"papers","name":"Subjective Effects of a Single Dose of Ayahuasca among College Students with Harmful Alcohol Use: Qualitative Analysis of Participant Accounts","year":"2023","cit":4,"pfa":"Anna Beatriz Vicentini","psa":"RAFAEL GUIMARÃES DOS SANTOS","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4388770214","eid":"W4388770214"},{"id":"paper-w2170740284","cat":"papers","name":"The effect of (R)-HA966 or ACEA 1021 on dexfenfluramine or (S)-MDMA-induced changes in temperature, activity, and neurotoxicity","year":"2001","cit":4,"pfa":"B.R. Russell","psa":"Richard Laverty","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2170740284","eid":"W2170740284"},{"id":"paper-w4412107589","cat":"papers","name":"Caffeine, nicotine, cannabis, and psilocybin: Pharmacology, toxicology, and potential therapeutic uses of four naturally occurring psychoactive substances","year":"2025","cit":4,"pfa":"Samuel E Christen","psa":"Evangelia Liakoni","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4412107589","eid":"W4412107589"},{"id":"paper-w7118979083","cat":"papers","name":"An exploration of the relationships between the effects of psilocybin on behavior, 5-HT 2A receptor occupancy, and neuroplastic effects in mice","year":"2026","cit":4,"pfa":"Connor J. Maltby","psa":"Zoe Hughes","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7118979083","eid":"W7118979083"},{"id":"paper-w4410999022","cat":"papers","name":"Utilizing in Vivo and Imaginal Exposure in the Context of MDMA-Assisted Therapy for Social Anxiety Disorder: A Case Report","year":"2025","cit":4,"pfa":"Jason B. Luoma","psa":"Brian C. Pilecki","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4410999022","eid":"W4410999022"},{"id":"paper-w2398119378","cat":"papers","name":"New Insights on Different Response of MDMA-Elicited Serotonin Syndrome to Systemic and Intracranial Administrations in the Rat Brain","year":"2016","cit":4,"pfa":"Ibrahim M. Shokry","psa":"Rui Tao","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2398119378","eid":"W2398119378"},{"id":"paper-w4415356003","cat":"papers","name":"Cognitive and subjective effects of psilocybin microdosing: Results from two double-blind placebo-controlled longitudinal trials","year":"2025","cit":4,"pfa":"Luisa Prochazkova","psa":"Bernhard Hommel","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4415356003","eid":"W4415356003"},{"id":"paper-w3035022639","cat":"papers","name":"Sexual Risk Behaviors among African Americans Who Use MDMA (Molly/Ecstasy): Implications for HIV Prevention","year":"2020","cit":4,"pfa":"Khary K. Rigg","psa":"Alexandra Mills","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3035022639","eid":"W3035022639"},{"id":"paper-w4406731587","cat":"papers","name":"Subdiaphragmatic vagotomy reduces hypothalamic oxytocin expression and blood levels after oral MDMA administration in male rats","year":"2025","cit":4,"pfa":"Yong Gang Yue","psa":"Kenji Hashimoto","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4406731587","eid":"W4406731587"},{"id":"paper-w4300994684","cat":"papers","name":"O uso da Ayahuasca e a experiência de alívio, transformação e cura na união do vegetal - UDV","year":"2009","cit":4,"pfa":"Gabriela Santos Ricciardi","ptype":"book-chapter","src":"https://openalex.org/W4300994684","eid":"W4300994684"},{"id":"paper-w4409797469","cat":"papers","name":"Psilocybin-assisted psychotherapy as a rapid-acting treatment for cancer-related depression and anxiety: Evidence from a network meta-analysis","year":"2025","cit":4,"pfa":"Damian Świeczkowski","psa":"Wiesław Jerzy Cubała","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4409797469","eid":"W4409797469"},{"id":"paper-w4410910917","cat":"papers","name":"Implementation of a miniaturized sensor system using screen-printed carbon electrodes for on-site detection of MDMA in seized drugs","year":"2025","cit":4,"pfa":"Paweł Stelmaszczyk","psa":"Renata Wietecha‐Posłuszny","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4410910917","eid":"W4410910917"},{"id":"paper-w4408811330","cat":"papers","name":"Exploring the impact of MDMA and oxytocin ligands on anxiety and social responses: A comprehensive behavioural and molecular study in the zebrafish model","year":"2025","cit":4,"pfa":"Monika Maciąg","psa":"Barbara Budzyńska","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4408811330","eid":"W4408811330"},{"id":"paper-w4410998694","cat":"papers","name":"A Case Example of a Female Veteran Completing Brief Cognitive Behavioral Conjoint Therapy Augmented With 3,4-methylenedioxymethamphetamine (MDMA)","year":"2025","cit":4,"pfa":"Leslie A. Morland","psa":"Anne C. Wagner","ptype":"article","src":"https://openalex.org/W4410998694","eid":"W4410998694"},{"id":"paper-w4406985911","cat":"papers","name":"Inhibition of Dimethyltryptamine Biosynthesis by N,N'-Bis-(3-methyl-2-thiazolidinylidene)Succinamide (I) and 2-Imino-3-Methylthiazolidine (II)","year":"1978","cit":4,"pfa":"LEWIS R. MANDEL","psa":"Edward J. Cragoe","ptype":"article","src":"https://openalex.org/W4406985911","eid":"W4406985911"},{"id":"paper-w4410998806","cat":"papers","name":"A Case Study of the METEMP Protocol: Massed Exposure Therapy Enhanced With 3,4-Methylenedioxymethamphetamine (MDMA) for Posttraumatic Stress Disorder","year":"2025","cit":4,"pfa":"Jessica L. Maples‐Keller","psa":"BARBARA OLASOV ROTHBAUM","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4410998806","eid":"W4410998806"},{"id":"paper-w4386029055","cat":"papers","name":"MDMA Assisted Psychotherapy Decreases PTSD Symptoms, Dissociation, Functional Disability, and Depression: A Systematic Review and Meta-Analysis","year":"2023","cit":4,"pfa":"W. M. Green","psa":"Luke R. Johnson","topics":["Depression","PTSD & trauma","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4386029055","eid":"W4386029055"},{"id":"paper-w4382517468","cat":"papers","name":"Risk for Ecstasy Use Disorder and Other Substance Use Among International Users of Recreational Ecstasy/Molly/MDMA","year":"2023","cit":4,"pfa":"Nancy A. Haug","psa":"James E. Sottile","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4382517468","eid":"W4382517468"},{"id":"paper-w4415775160","cat":"papers","name":"Microdosing psilocybin and its effect on creativity: Lessons learned from three double-blind placebo controlled longitudinal trials","year":"2025","cit":4,"pfa":"Luisa Prochazkova","psa":"Bernhard Hommel","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4415775160","eid":"W4415775160"},{"id":"paper-w4415459730","cat":"papers","name":"Adverse event reporting and management in psilocybin therapy clinical trials: A systematic review to guide clinical and research protocol development","year":"2025","cit":4,"pfa":"Danielle Bukovsky","psa":"Philip Gerretsen","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"review","src":"https://openalex.org/W4415459730","eid":"W4415459730"},{"id":"paper-w2331452785","cat":"papers","name":"Prospective associations between meth/amphetamine (speed) and MDMA (ecstasy) use and depressive symptoms in secondary school students","year":"2012","cit":4,"pfa":"A.H. Mack","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2331452785","eid":"W2331452785"},{"id":"paper-w3145893950","cat":"papers","name":"POTENCIAL USO DA PSILOCIBINA NO TRATAMENTO DA DEPRESSÃO: UMA REVISÃO / POTENTIAL USE OF PSILOCYBIN IN THE DEPRESSION TREATMENT: A REVIEW","year":"2021","cit":4,"pfa":"Vagner Fagnani Linartevichi","psa":"Francisney Pinto do Nascimento","topics":["Depression","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3145893950","eid":"W3145893950"},{"id":"paper-w4407756926","cat":"papers","name":"Ayahuasca partially preserves striatal integrity in juvenile non-human primates exposed to chronic stress: evidence from stereological evaluation","year":"2025","cit":4,"pfa":"Wigínio Gabriel de Lira-Bandeira","psa":"Expedito Silva do Nascimento","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4407756926","eid":"W4407756926"},{"id":"paper-w4404059935","cat":"papers","name":"Enhanced visual contrast suppression during peak psilocybin effects: Psychophysical results from a pilot randomized controlled trial","year":"2024","cit":4,"pfa":"Link Ray Swanson","psa":"Michael‐Paul Schallmo","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4404059935","eid":"W4404059935"},{"id":"paper-w2170989336","cat":"papers","name":"Implications of MDMA use for prospective memory function and substance use patterns in an Australian sample: A web‐based pilot study","year":"2011","cit":4,"pfa":"Joseph Ciorciari","psa":"Alicia Marotte","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2170989336","eid":"W2170989336"},{"id":"paper-w4310589078","cat":"papers","name":"Matrix-assisted laser-desorption/ionization–mass spectrometric imaging of psilocybin and its analogues in psychedelic mushrooms using a cesium chloride-coated target plate","year":"2022","cit":4,"pfa":"Hang Wang","psa":"Ying Wang","ptype":"article","src":"https://openalex.org/W4310589078","eid":"W4310589078"},{"id":"paper-w2181558727","cat":"papers","name":"Study of Histopathology and Antioxidant Activity of Methanolic Extract of Feijoa Sellowiana against Dosage Induced by MDMA in Mouse Liver","year":"2008","cit":4,"pfa":"Mohammad Yasin Karami","psa":"Farshad Naghshvar","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2181558727","eid":"W2181558727"},{"id":"paper-w2752635665","cat":"papers","name":"The Mediating Role of A2A Adenosine Receptors in the Mitochondrial Pathway of Apoptotic Hippocampal Cell Death, Following the Administration of MDMA in Rat","year":"2017","cit":4,"pfa":"Masoomeh Bakhshayesh","psa":"Majid Katebi","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2752635665","eid":"W2752635665"},{"id":"paper-w4400306738","cat":"papers","name":"Engaging Mood Brain Circuits with Psilocybin (EMBRACE): a study protocol for a randomized, placebo-controlled and delayed-start, neuroimaging trial in depression","year":"2024","cit":4,"pfa":"Joshua M. Poulin","psa":"Sean M. Nestor","topics":["Depression","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4400306738","eid":"W4400306738"},{"id":"paper-w1988927772","cat":"papers","name":"Factor Structure of the Chinese Version of the University of Rhode Island Change Assessment in Taiwanese Adolescents Who Abuse MDMA or Methamphetamine","year":"2010","cit":4,"pfa":"Cheng‐Fang Yen","psa":"Chung‐Ping Cheng","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1988927772","eid":"W1988927772"},{"id":"paper-w794338362","cat":"papers","name":"Estudo da Influência do metabolismo na toxicidade de derivados anfetamínicos : 4-MTA, 2C-B e MDMA","year":"2007","cit":4,"pfa":"Helena Carmo","ptype":"article","src":"https://openalex.org/W794338362","eid":"W794338362"},{"id":"paper-w2039531525","cat":"papers","name":"Commentary on Halpern et al. (2011): Strengthening the case against functionally significant serotonergic neurotoxicity in human MDMA (ecstasy) users","year":"2011","cit":4,"pfa":"Michael Lyvers","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"editorial","src":"https://openalex.org/W2039531525","eid":"W2039531525"},{"id":"paper-w4410998887","cat":"papers","name":"A New Generation of Psychedelic-Assisted Psychotherapy: The Example of Combining MDMA With Trauma-Focused Cognitive-Behavioral Therapy for Posttraumatic Stress Disorder","year":"2025","cit":4,"pfa":"BARBARA OLASOV ROTHBAUM","psa":"Paula P. Schnurr","topics":["PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4410998887","eid":"W4410998887"},{"id":"paper-w4404077742","cat":"papers","name":"Therapeutic Potential of Psychedelic Compounds for Substance Use Disorders","year":"2024","cit":4,"pfa":"Tamara Valdez","psa":"Mary G. Hornick","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4404077742","eid":"W4404077742"},{"id":"paper-w4416393230","cat":"papers","name":"Long-term neurocognitive side effects of MDMA in recreational ecstasy users following sustained abstinence: A systematic review and meta-analysis","year":"2025","cit":4,"pfa":"Hillary Ung","psa":"Mark R. C. Daglish","topics":["Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4416393230","eid":"W4416393230"},{"id":"paper-w2918279877","cat":"papers","name":"Aromatic Bromination Abolishes the Psychomotor Features and Pro-social Responses of MDMA (“Ecstasy”) in Rats and Preserves Affinity for the Serotonin Transporter (SERT)","year":"2019","cit":4,"pfa":"Patricio Sáez‐Briones","psa":"Bruce K. Cassels","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2918279877","eid":"W2918279877"},{"id":"paper-w4412767570","cat":"papers","name":"Computational insights into the interaction of MDMA with boron- and nitrogen-doped c20 fullerenes for drug detection applications: DFT and QTAIM-based analysis","year":"2025","cit":4,"pfa":"Saad Hmoud Alotaibi","ptype":"article","src":"https://openalex.org/W4412767570","eid":"W4412767570"},{"id":"paper-w4406579984","cat":"papers","name":"A prospective ecological momentary assessment study of an ayahuasca retreat: exploring the salutary impact of acute psychedelic experiences on subacute affect and mindfulness skills in daily life","year":"2025","cit":4,"pfa":"Sharon R. Sznitman","psa":"Amit Bernstein","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4406579984","eid":"W4406579984"},{"id":"paper-w3108809916","cat":"papers","name":"Dissemination of Erroneous Research Findings and Subsequent Retraction in High-Circulation Newspapers: A Case Study of Alleged MDMA-Induced Dopaminergic Neurotoxicity in Primates","year":"2020","cit":4,"pfa":"Brian Scott Barnett","psa":"Rick Doblin","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3108809916","eid":"W3108809916"},{"id":"paper-w2332423811","cat":"papers","name":"Tripping the light fantastic: Modeling the consequences of recreational use of MDMA or 5-MeO-DIPT in humans using weekend “rave” exposures in rat.","year":"2016","cit":4,"pfa":"David M. Compton","psa":"Esther Watkins","ptype":"article","src":"https://openalex.org/W2332423811","eid":"W2332423811"},{"id":"paper-w4403219178","cat":"papers","name":"What do health professionals think about implementing psilocybin-assisted therapy in palliative care for existential distress? A World Café qualitative study","year":"2024","cit":4,"pfa":"Marianne Masse-Grenier","psa":"Michel Dorval","topics":["Anxiety & end-of-life","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4403219178","eid":"W4403219178"},{"id":"paper-w4400653113","cat":"papers","name":"Zinc Supplementation Reduces ROS Production and Prevents MDMA-Induced Apoptosis in TM3 Leydig Cells via the Inhibition of Pro-Apoptotic Proteins","year":"2024","cit":4,"pfa":"Salar Mahmoudi-Nejad","psa":"Morteza Bagheri","ptype":"article","src":"https://openalex.org/W4400653113","eid":"W4400653113"},{"id":"paper-w2521044505","cat":"papers","name":"The external gate of the human and Drosophila serotonin transporters requires a basic/acidic amino acid pair for 3,4-methylenedioxymethamphetamine (MDMA) translocation and the induction of substrate efflux","year":"2016","cit":4,"pfa":"Natalie R. Sealover","psa":"Loren Keith Henry","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2521044505","eid":"W2521044505"},{"id":"paper-w2050922916","cat":"papers","name":"Aspectos clínicos y terapéuticos de la intoxicación o sobredosis por “éxtasis” (MDMA), “éxtasis líquido” (GHB) y “super-K” (ketamina)","year":"2002","cit":4,"pfa":"Santiago Nogué","ptype":"article","src":"https://openalex.org/W2050922916","eid":"W2050922916"},{"id":"paper-w4405969659","cat":"papers","name":"Psilocybin-Assisted Group Psychotherapy + Mindfulness Based Stress Reduction (MBSR) for Frontline Healthcare Provider COVID-19 Related Depression and Burnout: A Randomized Clinical Trial","year":"2025","cit":4,"pfa":"Benjamin R. Lewis","psa":"Eric L. Garland","topics":["Depression","Safety & adverse events","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4405969659","eid":"W4405969659"},{"id":"paper-w4280638175","cat":"papers","name":"Preliminary Results on the Long-Term Effects of Dextromethorphan on MDMA-Mediated Serotonergic Deficiency and Volumetric Changes in Primates Based on 4-[18F]-ADAM PET/MRI","year":"2022","cit":4,"pfa":"Skye Hsin‐Hsien Yeh","psa":"Kuo‐Hsing Ma","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4280638175","eid":"W4280638175"},{"id":"paper-w4229363478","cat":"papers","name":"Allosteric Binding of MDMA to the Human Serotonin Transporter (hSERT) via Ensemble Binding Space Analysis with ΔG Calculations, Induced Fit Docking and Monte Carlo Simulations","year":"2022","cit":4,"pfa":"Ángel A. Islas","psa":"Thomas Scior","topics":["Depression","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4229363478","eid":"W4229363478"},{"id":"paper-w2115690516","cat":"papers","name":"MDMA and d-Amphetamine Produce Comparable Effects in Pigeons Performing under a Multiple Fixed-Ratio Interresponse-Time-Greater-than-t Schedule of Food Delivery","year":"1997","cit":4,"pfa":"Mark G. LeSage","psa":"Alan D. Poling","ptype":"article","src":"https://openalex.org/W2115690516","eid":"W2115690516"},{"id":"paper-w4412434810","cat":"papers","name":"Simultaneous determination of methamphetamine, MDMA, and ketamine and their metabolites in urine using a rapid and simple HS-SPME-GC–MS method: A forensic study on drug abuse patterns in South Korea","year":"2025","cit":4,"pfa":"Juhyun Sim","psa":"Suncheun Kim","ptype":"article","src":"https://openalex.org/W4412434810","eid":"W4412434810"},{"id":"paper-w2051659053","cat":"papers","name":"Consumidores de «speed» (metanfetamina): un viaje de ida y vuelta entre el «éxtasis» (MDMA) y la cocaína. Algunos aspectos clínicos, preventivos y asistenciales","year":"2004","cit":4,"pfa":"Jordi Royo-Isach","psa":"L. Ruiz","ptype":"article","src":"https://openalex.org/W2051659053","eid":"W2051659053"},{"id":"paper-w4394914647","cat":"papers","name":"Trips through the Skin: Reviewing Cutaneous Drug Reactions to Psychedelics and Hallucinogens","year":"2024","cit":4,"pfa":"Syed Minhaj Rahman","psa":"Aamir N. Hussain","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4394914647","eid":"W4394914647"},{"id":"paper-w2209361400","cat":"papers","name":"The intracranial injection of drugs in goldfish. I: Hallucinogens and their antagonism to smooth muscle activity","year":"1979","cit":4,"pfa":"Harold A. Abramson","psa":"Leonard W. Krinsky","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2209361400","eid":"W2209361400"},{"id":"paper-w1968897167","cat":"papers","name":"LSD and related drugs as DA antagonists: Receptor-mediated effects on the synthesis and turnover of DA","year":"1978","cit":4,"pfa":"Sven‐Åke Persson","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1968897167","eid":"W1968897167"},{"id":"paper-w4400004141","cat":"papers","name":"The Therapeutic Effects of Classic Psychedelics in Alcohol Use Disorder","year":"2024","cit":4,"pfa":"Broc A. Pagni","psa":"Michael P. Bogenschutz","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4400004141","eid":"W4400004141"},{"id":"paper-w4295183047","cat":"papers","name":"Psychedelics for Alzheimer's Disease Palliative Care","year":"2022","cit":4,"pfa":"Kaitlin R. McManus","psa":"Marc Scott Weinberg","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4295183047","eid":"W4295183047"},{"id":"paper-w2411970754","cat":"papers","name":"The Effects of Hallucinogens on Blind Monkeys","year":"2017","cit":4,"pfa":"Ronald K. Siegel","psa":"Murray E. Jarvik","ptype":"article","src":"https://openalex.org/W2411970754","eid":"W2411970754"},{"id":"paper-w4383533322","cat":"papers","name":"Ethopharmacological evaluation of antidepressant-like effect of serotonergic psychedelics in C57BL/6J male mice","year":"2023","cit":4,"pfa":"Rika Takaba","psa":"Masayuki Hiramatsu","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4383533322","eid":"W4383533322"},{"id":"paper-w4399694115","cat":"papers","name":"Psychedelic Use by Sexual Minority Adults in the United States, 2022","year":"2024","cit":4,"pfa":"Juhan Lee","psa":"Maria A. Parker","ptype":"article","src":"https://openalex.org/W4399694115","eid":"W4399694115"},{"id":"paper-w1965385908","cat":"papers","name":"Therapeutic Usefulness of Hallucinogenic Drugs as a Function of their Chemical Structure","year":"1975","cit":4,"pfa":"R. Fischer","psa":"H. Goldman","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1965385908","eid":"W1965385908"},{"id":"paper-w7119094076","cat":"papers","name":"Psychedelic Modulation of Excitation/Inhibition Balance: A Dual-Phase Neurodevelopmental Model","year":"2026","cit":4,"pfa":"Charalampos L. Kandilakis","psa":"Costas Papatheodoropoulos","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7119094076","eid":"W7119094076"},{"id":"paper-w2479426708","cat":"papers","name":"Development of a mechanism-based pharmacokinetic/pharmacodynamic model to characterize the thermoregulatory effects of serotonergic drugs in mice","year":"2016","cit":4,"pfa":"Xi-Ling Jiang","psa":"Ai‐Ming Yu","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2479426708","eid":"W2479426708"},{"id":"paper-w4400732567","cat":"papers","name":"Psychedelic trip sitting, dosages and intensities: Supplementing clinical studies with anecdotal reports","year":"2024","cit":4,"pfa":"Liam B. Engel","psa":"Mitchell Low","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4400732567","eid":"W4400732567"},{"id":"paper-w4384154266","cat":"papers","name":"Outcomes of usage of psychedelics by people reporting an eating disorder in clinical and non-clinical settings: a scoping review","year":"2023","cit":4,"pfa":"Jorge Valdiviezo‐Oña","psa":"Clara Paz","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4384154266","eid":"W4384154266"},{"id":"paper-w4409677856","cat":"papers","name":"Minorities’ diminished psychedelic returns: Depression, suicide, distress, and serious mental illness","year":"2025","cit":4,"pfa":"Sean M. Viña","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4409677856","eid":"W4409677856"},{"id":"paper-w4401868722","cat":"papers","name":"Traditional Medicine, Culture, and Psychedelic Science: New Pathways for Recovery From Substance Use Disorders","year":"2024","cit":4,"pfa":"Anja Loizaga-Velder","psa":"Armando Loizaga Pazzi","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4401868722","eid":"W4401868722"},{"id":"paper-w4410385203","cat":"papers","name":"Pathway engineering for the biosynthesis of psychedelics","year":"2025","cit":4,"pfa":"Zachary N Abrahms","psa":"J. Andrew Jones","topics":["Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W4410385203","eid":"W4410385203"},{"id":"paper-w4412163366","cat":"papers","name":"Psychedelics for Alcohol Use Disorder: A Narrative Review with Candidate Mechanisms of Action","year":"2025","cit":4,"pfa":"Eric A. Miller","psa":"Carolina L. Haass‐Koffler","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4412163366","eid":"W4412163366"},{"id":"paper-w2915910581","cat":"papers","name":"Psychedelic-assisted therapy for anxiety and depression in the face of death: A critical review with an anthropological lens","year":"2019","cit":4,"pfa":"Jenna Varley","topics":["Depression","Anxiety & end-of-life","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2915910581","eid":"W2915910581"},{"id":"paper-w4407937116","cat":"papers","name":"Cardiac effects of two hallucinogenic natural products, N,N-dimethyl-tryptamine and 5-methoxy-N,N-dimethyl-tryptamine","year":"2025","cit":4,"pfa":"Joachim Neumann","psa":"Ulrich Gergs","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4407937116","eid":"W4407937116"},{"id":"paper-w4408366447","cat":"papers","name":"Lifetime classic psychedelic use and headaches: A cross-sectional study","year":"2025","cit":4,"pfa":"Zusanna Bjurenfalk","psa":"Caroline Ran","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4408366447","eid":"W4408366447"},{"id":"paper-w4292197886","cat":"papers","name":"Testicular Choriocarcinoma in LSD Users","year":"1971","cit":4,"pfa":"Leonard J. Levick","ptype":"article","src":"https://openalex.org/W4292197886","eid":"W4292197886"},{"id":"paper-w4240475717","cat":"papers","name":"Homicide during a psychosis induced by LSD","year":"1972","cit":4,"pfa":"P. Reich","ptype":"article","src":"https://openalex.org/W4240475717","eid":"W4240475717"},{"id":"paper-w4406757831","cat":"papers","name":"Comprehensive Guide to Hallucinogenic Plants","year":"2025","cit":4,"pfa":"Noureddine Chaachouay","psa":"Lahcen Zidane","topics":["Dosing & pharmacology"],"ptype":"book","src":"https://openalex.org/W4406757831","eid":"W4406757831"},{"id":"paper-w2013680198","cat":"papers","name":"The effect of particular active substances of hallucinogenic mushrooms","year":"2014","cit":4,"pfa":"Marek Wieczorek","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2013680198","eid":"W2013680198"},{"id":"paper-w4413420616","cat":"papers","name":"Assessing the Potential Cardiovascular Risk of Microdosing the Psychedelic LSD in Mice","year":"2025","cit":4,"pfa":"Devin P. Effinger","psa":"Scott M. Thompson","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4413420616","eid":"W4413420616"},{"id":"paper-w2081736988","cat":"papers","name":"An Experimental Approach to Facilitation of Psychotherapy by Psychotomimetic Drugs","year":"1962","cit":4,"pfa":"Leo E. Hollister","psa":"S. Don Schultz","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2081736988","eid":"W2081736988"},{"id":"paper-w2797803761","cat":"papers","name":"Pharmacies as potential providers of harm reduction services: A preliminary online survey","year":"2018","cit":4,"pfa":"Edward James","psa":"Andrew Paul Smith","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2797803761","eid":"W2797803761"},{"id":"paper-w2071455706","cat":"papers","name":"Influence of Long‐term Zimeldine Treatment on LSD‐induced Behavioural Effects","year":"1984","cit":4,"pfa":"Lena A. C. Smith","psa":"Bengt J. Meyerson","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2071455706","eid":"W2071455706"},{"id":"paper-w4417011188","cat":"papers","name":"Defining ‘psychedelic’","year":"2026","cit":4,"pfa":"Avery E. Ostrand","psa":"Robin Lester Carhart-Harris","ptype":"article","src":"https://openalex.org/W4417011188","eid":"W4417011188"},{"id":"paper-w4406325093","cat":"papers","name":"From Safe Touch to Sexual Abuse: Walking the Tightrope of Patient Safety in Psychedelic Therapy","year":"2025","cit":4,"pfa":"Y. Tony Yang","topics":["Safety & adverse events"],"ptype":"editorial","src":"https://openalex.org/W4406325093","eid":"W4406325093"},{"id":"paper-w2327765357","cat":"papers","name":"LSD: Teratogenic Action in Chick Blastoderms","year":"1971","cit":4,"pfa":"Nathan H. Hart","psa":"M. Greene","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2327765357","eid":"W2327765357"},{"id":"paper-w3013341994","cat":"papers","name":"LSD: My Problem Child and Insights/Outlooks","year":"2020","cit":4,"pfa":"Ely Fish","ptype":"article","src":"https://openalex.org/W3013341994","eid":"W3013341994"},{"id":"paper-w284712147","cat":"papers","name":"Synthesis and Physical Evaluation of99mTc(CO)3-labeled Cysteine-arylpiperazines for a Neuroreceptor(5-HT1A) Imaging","year":"2006","cit":4,"pfa":"Kang-Hyuk Choi","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W284712147","eid":"W284712147"},{"id":"paper-w4395961884","cat":"papers","name":"Psychedelic Renaissance","year":"2024","cit":4,"pfa":"Jose Miranda","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4395961884","eid":"W4395961884"},{"id":"paper-w4394851673","cat":"papers","name":"A dual-receptor model of serotonergic psychedelics","year":"2024","cit":4,"pfa":"Arthur Juliani","psa":"Adam Safron","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4394851673","eid":"W4394851673"},{"id":"paper-w2312189969","cat":"papers","name":"Comparative Effects of ACTH and LSD on Urinary Corticosteriods in Guinea Pigs","year":"1957","cit":4,"pfa":"Eli M. Nadel","psa":"Hudson Hoagland","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2312189969","eid":"W2312189969"},{"id":"paper-w4401199705","cat":"papers","name":"Pharmacological Properties of Psychedelics with a Special Focus on Potential Harms","year":"2024","cit":4,"pfa":"Friederike Holze","psa":"Felix Müller","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W4401199705","eid":"W4401199705"},{"id":"paper-w3037684237","cat":"papers","name":"Hallucinogens—psychedelics and dissociative drugs","year":"2020","cit":4,"pfa":"Mark Petersen","psa":"Hemamalini Ketha","ptype":"book-chapter","src":"https://openalex.org/W3037684237","eid":"W3037684237"},{"id":"paper-w2424303561","cat":"papers","name":"Identification and quantitative determination of LSD by fluorescence: new data.","year":"1986","cit":4,"pfa":"Ph. Baudot","psa":"J C André","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2424303561","eid":"W2424303561"},{"id":"paper-w2184310855","cat":"papers","name":"Evaluating Hallucinogenic or Psychedelic Drug Intoxication in an Emergency Setting","year":"2000","cit":4,"pfa":"Robert H. Williams","psa":"Timothy B. Erickson","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2184310855","eid":"W2184310855"},{"id":"paper-w4242508705","cat":"papers","name":"Serotonin and serotonin receptors in hallucinogen action","year":"2020","cit":4,"pfa":"Adam L. Halberstadt","psa":"David E. Nichols","topics":["Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W4242508705","eid":"W4242508705"},{"id":"paper-w2095118346","cat":"papers","name":"LSD-25 and Accommodative Convergence Ratios","year":"1965","cit":4,"pfa":"J. W. PAYNE","topics":["Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W2095118346","eid":"W2095118346"},{"id":"paper-w1519715389","cat":"papers","name":"Drug Dependence and Abuse","year":"2001","cit":4,"pfa":"Anthony Henry Dickenson","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W1519715389","eid":"W1519715389"},{"id":"paper-w4294127245","cat":"papers","name":"To treat or not to treat? High-potency benzodiazepine use in a case of comorbid hallucinogen persisting perception disorder and alcohol use disorder.","year":"2022","cit":4,"pfa":"Julie A. Christensen","psa":"J Michael Bostwick","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4294127245","eid":"W4294127245"},{"id":"paper-w1986684863","cat":"papers","name":"Urinary Aromatic Excretion Patterns in Schizophrenia","year":"1960","cit":4,"pfa":"Harry Goldenberg","ptype":"article","src":"https://openalex.org/W1986684863","eid":"W1986684863"},{"id":"paper-w4206159650","cat":"papers","name":"LSD Used As Analgesic","year":"1964","cit":4,"topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4206159650","eid":"W4206159650"},{"id":"paper-w4411571625","cat":"papers","name":"Assessing the Attitudes of Dutch Mental Health Care Professionals Toward Psychedelic-Assisted Psychotherapy: A Cross-Sectional Exploratory Study","year":"2025","cit":4,"pfa":"Martijn H B Koolen","psa":"Michiel van Elk","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4411571625","eid":"W4411571625"},{"id":"paper-w132158298","cat":"papers","name":"[Hallucinogenic fungi (psilocybe). Part II. Identification of Psilocybe semilanceata by PCR].","year":"2007","cit":4,"pfa":"Aldona Adamczyk","psa":"Tadeusz Dobosz","ptype":"article","src":"https://openalex.org/W132158298","eid":"W132158298"},{"id":"paper-w3112731703","cat":"papers","name":"Free energy calculations of the functional selectivity of 5-HT2B G protein-coupled receptor","year":"2020","cit":4,"pfa":"Brandon L. Peters","psa":"Andrew L. Ferguson","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3112731703","eid":"W3112731703"},{"id":"paper-w164228739","cat":"papers","name":"Psychotomimetics: Behavioral Pharmacology","year":"1982","cit":4,"pfa":"J. B. Appel","psa":"D. M. Kuhn","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W164228739","eid":"W164228739"},{"id":"paper-w2038127453","cat":"papers","name":"Treatment of dependence upon stimulants and hallucinogens","year":"1983","cit":4,"pfa":"Forest S. Tennant","ptype":"article","src":"https://openalex.org/W2038127453","eid":"W2038127453"},{"id":"paper-w2585722437","cat":"papers","name":"Disrupted integration of sensory stimuli with information about the movement of the body as a mechanism explaining LSD-induced experience","year":"2017","cit":4,"pfa":"Grzegorz Roman Juszczak","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2585722437","eid":"W2585722437"},{"id":"paper-w2345359385","cat":"papers","name":"The role of psychotropic drugs in group therapy.","year":"1959","cit":4,"pfa":"Sandison Ra","ptype":"article","src":"https://openalex.org/W2345359385","eid":"W2345359385"},{"id":"paper-w4387563472","cat":"papers","name":"The Rising Use of LSD among Business Managers","year":"2023","cit":4,"pfa":"Benjamin A. Korman","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4387563472","eid":"W4387563472"},{"id":"paper-w4412163208","cat":"papers","name":"Evaluating the Potential of Microdosing 1cp‐LSD for the Treatment of Canine Anxiety: A One‐Month Case Study","year":"2025","cit":4,"pfa":"Elisa Hernández‐Álvarez","psa":"Luis Alberto Henríquez‐Hernández","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4412163208","eid":"W4412163208"},{"id":"paper-w4376645831","cat":"papers","name":"Henri Michaux's program for the psychedelic humanities","year":"2023","cit":4,"pfa":"Oliver Charles Minty Davis","ptype":"article","src":"https://openalex.org/W4376645831","eid":"W4376645831"},{"id":"paper-w4308387583","cat":"papers","name":"Dose-response relationships of LSD-induced subjective experiences in humans","year":"2022","cit":4,"pfa":"Tim Hirschfeld","psa":"Timo Torsten Schmidt","topics":["Anxiety & end-of-life","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4308387583","eid":"W4308387583"},{"id":"paper-w2298429985","cat":"papers","name":"Psychopharmacological dinner: A metaphoric learning of psychedelics from gustatory revelations of a pillbox","year":"2016","cit":4,"pfa":"Ajeet Kumar Khilnani","psa":"Rakesh Ranjan Pathak","topics":["Addiction","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2298429985","eid":"W2298429985"},{"id":"paper-w4384827611","cat":"papers","name":"A Systematic Review of Reporting Practices in Psychedelic Clinical Trials: Psychological Support, Therapy, and Psychosocial Interventions","year":"2023","cit":4,"pfa":"Bill Brennan","psa":"Alexander Belser","topics":["Safety & adverse events","Reviews & meta-analyses","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4384827611","eid":"W4384827611"},{"id":"paper-w4405735206","cat":"papers","name":"Preferences, Perceptions, and Environmental Considerations of Natural and Synthetic Psychedelic Substances: Findings from the Global Psychedelic Survey","year":"2024","cit":4,"pfa":"Omer A. Syed","psa":"Philippe Lucas","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4405735206","eid":"W4405735206"},{"id":"paper-w2081543835","cat":"papers","name":"Effect of LSD on Pace of Performing a Variety of Tasks","year":"1962","cit":4,"pfa":"Donald M. Krus","psa":"Seymour Wapner","ptype":"article","src":"https://openalex.org/W2081543835","eid":"W2081543835"},{"id":"paper-w4415015365","cat":"papers","name":"LSD: Mechanisms and relevance to the treatment of depression","year":"2025","cit":4,"pfa":"Amel Bouloufa","psa":"Nasser Haddjeri","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4415015365","eid":"W4415015365"},{"id":"paper-w2072941041","cat":"papers","name":"Transcriptomic configuration of mouse brain induced by adolescent exposure to 3,4-methylenedioxymethamphetamine","year":"2009","cit":4,"pfa":"Jung Woo Eun","psa":"Suk Woo Nam","ptype":"article","src":"https://openalex.org/W2072941041","eid":"W2072941041"},{"id":"paper-w4403276607","cat":"papers","name":"Psychedelic research, assisted therapy and the role of the anaesthetist: A review and insights for experimental and clinical practices","year":"2024","cit":4,"pfa":"Gisela Lima","psa":"Miguel Castelo‐Branco","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4403276607","eid":"W4403276607"},{"id":"paper-w4403895310","cat":"papers","name":"A narrative exploration of psilocybin’s potential in mental health","year":"2024","cit":4,"pfa":"Huitae Min","psa":"Young-Tae Park","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4403895310","eid":"W4403895310"},{"id":"paper-w4408015406","cat":"papers","name":"History of psychedelic drug science and molecular pharmacology","year":"2025","cit":4,"pfa":"David E. Nichols","psa":"Charles David Nichols","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W4408015406","eid":"W4408015406"},{"id":"paper-w2809819267","cat":"papers","name":"Poisons, Hallucinogens, Teratogens, Pesticides, and Xenobiotics—Their Sources, Classification, Chemistry, and Metabolism","year":"2018","cit":4,"pfa":"A. N. M. Alamgir","ptype":"book-chapter","src":"https://openalex.org/W2809819267","eid":"W2809819267"},{"id":"paper-w4386219996","cat":"papers","name":"Designing of molecularly imprinted polymer with carboxylic acid functionality for chiral separation of (±)‐3,4‐methylenedioxymethamphetamine","year":"2023","cit":4,"pfa":"Hussam Y. Alharbi","psa":"Mohammed Monier","ptype":"article","src":"https://openalex.org/W4386219996","eid":"W4386219996"},{"id":"paper-w4413854356","cat":"papers","name":"Qualitative content analysis of expectations in participants with depression about to begin LSD microdosing treatment: Identifying the need for psychedelic expectancy measures","year":"2025","cit":4,"pfa":"Carina Joy Donegan","psa":"Lisa Reynolds","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4413854356","eid":"W4413854356"},{"id":"paper-w7129628102","cat":"papers","name":"LSD microdosing for major depressive disorder: Mood and pharmacokinetic outcomes from a Phase 2a trial","year":"2026","cit":4,"pfa":"Dimitri Daldegan‐Bueno","psa":"Suresh D Muthukumaraswamy","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7129628102","eid":"W7129628102"},{"id":"paper-w4391644221","cat":"papers","name":"Weiterbildung in Psychedelika-assistierter Therapie – Erfahrungen aus der Schweiz","year":"2024","cit":4,"pfa":"Helena Aicher","psa":"Peter Gasser","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4391644221","eid":"W4391644221"},{"id":"paper-w2095099669","cat":"papers","name":"FDA Approves Study of Ecstasy In Some Terminally Ill Patients","year":"2005","cit":4,"pfa":"Eve Bender","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2095099669","eid":"W2095099669"},{"id":"paper-w4409304630","cat":"papers","name":"The Role of the Dorsolateral Prefrontal Cortex in Ego Dissolution and Emotional Arousal During the Psychedelic State","year":"2025","cit":4,"pfa":"Clayton R. Coleman","psa":"Robin Lester Carhart-Harris","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4409304630","eid":"W4409304630"},{"id":"paper-w2292676678","cat":"papers","name":"A tale of two cacti: studies in Astrophytum asterias and Lophophora williamsii","year":"2007","cit":4,"pfa":"Martin Terry","ptype":"dissertation","src":"https://openalex.org/W2292676678","eid":"W2292676678"},{"id":"paper-w4402098372","cat":"papers","name":"Psychedelic‐assisted therapy for palliative care within a home treatment setting: A case report","year":"2024","cit":4,"pfa":"Federico Seragnoli","psa":"Zullino Daniele","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4402098372","eid":"W4402098372"},{"id":"paper-w4313256422","cat":"papers","name":"Traditional Indigenous Medicine of the Peruvian Amazon and its Potential for Psychological Treatment and Personal Growth","year":"2014","cit":4,"pfa":"Veronika Kavenská","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W4313256422","eid":"W4313256422"},{"id":"paper-w193662791","cat":"papers","name":"Action de la psilocybine sur le comportement d'un cercopithecinae papio-papio","year":"1969","cit":4,"pfa":"F. Bermond","psa":"Julien Bert","ptype":"article","src":"https://openalex.org/W193662791","eid":"W193662791"},{"id":"paper-w2125364332","cat":"papers","name":"Neuronal Nicotinic Receptors as New Targets for Amphetamine-Induced Oxidative Damage and Neurotoxicity","year":"2011","cit":4,"pfa":"David Pubill","psa":"Elena Escubedo","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2125364332","eid":"W2125364332"},{"id":"paper-w4407959310","cat":"papers","name":"A review of psychedelics trials completed in depression, informed by European regulatory perspectives","year":"2025","cit":4,"pfa":"Francisca Silva","psa":"Pavel Balabanov","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4407959310","eid":"W4407959310"},{"id":"paper-w1998718338","cat":"papers","name":"Chloral hydrate anesthesia antagonizes the neurotoxicity of 3,4-methylenedioxymethamphetamine","year":"1990","cit":4,"pfa":"Christopher J. Schmidt","psa":"Vicki L. Taylor","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1998718338","eid":"W1998718338"},{"id":"paper-w4405841183","cat":"papers","name":"High-quality draft genomes of ecologically and geographically diverse Psilocybe species","year":"2024","cit":4,"pfa":"Ian M. Bollinger","psa":"Victor Angel-Mosti","ptype":"article","src":"https://openalex.org/W4405841183","eid":"W4405841183"},{"id":"paper-w2128109879","cat":"papers","name":"Conference Review: Notes on the “International Congress of Traditional Medicine, Interculturality, and Mental Health,” Takiwasi Center, Tarapoto, Peru, June 7–10, 20091","year":"2010","cit":4,"pfa":"Beatriz Caiuby Labate","topics":["Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2128109879","eid":"W2128109879"},{"id":"paper-w3043703078","cat":"papers","name":"Conservation Status, Germination, and Establishment of the Divine Cactus, Lophophora williamsii (Lem. Ex Salm-Dyck) J. M. Coult., at Cuatro Ciénegas","year":"2020","cit":4,"pfa":"María C. Mandujano","psa":"Jordan K. Golubov","ptype":"book-chapter","src":"https://openalex.org/W3043703078","eid":"W3043703078"},{"id":"paper-w4394061312","cat":"papers","name":"Mechanisms of therapeutic change after psychedelic treatment in OCD","year":"2024","cit":4,"pfa":"Gayle Maloney","psa":"Benjamin Kelmendi","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4394061312","eid":"W4394061312"},{"id":"paper-w2412328004","cat":"papers","name":"Zingiber officinale alters 3,4-methylenedioxymethamphetamine-/INS;induced neurotoxicity in rat brain","year":"2013","cit":4,"pfa":"Mehdi Mehdizadeh","psa":"Sara Soleimani Asl","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2412328004","eid":"W2412328004"},{"id":"paper-w2079662181","cat":"papers","name":"The acute effects of 3,4-methylenedioxymethamphetamine on oxidative stress in rat brain","year":"2008","cit":4,"pfa":"Ivan Simić","psa":"Živorad Maličević","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2079662181","eid":"W2079662181"},{"id":"paper-w2205016816","cat":"papers","name":"Anesthetic implications of acute methylenedioxymethamphetamine intoxication in a patient with traumatic intracerebral hemorrhage.","year":"2009","cit":4,"pfa":"Samuel DeMaria","psa":"Elizabeth A. M. Frost","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2205016816","eid":"W2205016816"},{"id":"paper-w4415243157","cat":"papers","name":"Biological markers of treatment response to serotonergic psychedelic therapies: a systematic review","year":"2025","cit":4,"pfa":"Stanley Wong","psa":"Muhammad Ishrat Husain","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4415243157","eid":"W4415243157"},{"id":"paper-w4417346643","cat":"papers","name":"Selective Delivery of Anticancer Natural G-Quadruplex Ligands by the AT11 Aptamer for Gastric Cancer Treatment","year":"2025","cit":4,"pfa":"Chiara Platella","psa":"Daniela Montesarchio","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4417346643","eid":"W4417346643"},{"id":"paper-w4385476011","cat":"papers","name":"Behavioral metabolomics: how behavioral data can guide metabolomics research on neuropsychiatric disorders","year":"2023","cit":4,"pfa":"Ross van de Wetering","psa":"Susan Schenk","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4385476011","eid":"W4385476011"},{"id":"paper-w4412074774","cat":"papers","name":"Meditation and psychedelics facilitate similar types of mystical, psychological, and philosophical-existential insights predictive of wellbeing: a qualitative-quantitative approach","year":"2025","cit":4,"pfa":"Jussi Jylkkä","psa":"Pilleriin Sikka","topics":["Addiction","Anxiety & end-of-life","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4412074774","eid":"W4412074774"},{"id":"paper-w2119918433","cat":"papers","name":"Electroencephalographic and Convulsive Effects of Binge Doses of (+)- Methamphetamine, 5-methoxydiisopropyltryptamine, and (±)-3,4- Methylenedioxymethamphetamine in Rats","year":"2012","cit":4,"pfa":"Devon L. Graham","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2119918433","eid":"W2119918433"},{"id":"paper-w2276143719","cat":"papers","name":"PROTECTIVE EFFECTS OF N-ACETYL-L-CYSTEIN ON 3, 4-METHYLENE DIOXYMETHAMPHETAMIE-INDUCED NEUROTOXICITY IN CEREBELLUM OF MALE RATS","year":"2011","cit":4,"pfa":"Soleimani Asl Sara","psa":"Mehdizadeh Mehdi","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2276143719","eid":"W2276143719"},{"id":"paper-w4392474380","cat":"papers","name":"Where do the symptoms come from in depression? Topography and dynamics matter","year":"2024","cit":4,"pfa":"Yasir Çatal","psa":"Georg Northoff","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4392474380","eid":"W4392474380"},{"id":"paper-w2044033523","cat":"papers","name":"Synthesis of racemic, S(+)‐ and R(‐)‐N‐[methyl‐3H]3,4‐methylenedioxymethamphetamine","year":"1990","cit":4,"pfa":"Kenji Hashimoto","psa":"Tsuyoshi Goromaru","ptype":"article","src":"https://openalex.org/W2044033523","eid":"W2044033523"},{"id":"paper-w4390401606","cat":"papers","name":"Unlocking the biosynthesis of psychedelic-inspired indolethylamines","year":"2023","cit":4,"pfa":"Abhishek K. Sen","psa":"J. Andrew Jones","ptype":"article","src":"https://openalex.org/W4390401606","eid":"W4390401606"},{"id":"paper-w4410826214","cat":"papers","name":"Attitudes Toward Psychedelic Treatments by Individuals With Histories of Substance Use or Psychiatric Disorders: A Survey Study","year":"2025","cit":4,"pfa":"Sara Prostko","psa":"Joji Suzuki","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4410826214","eid":"W4410826214"},{"id":"paper-w7127167117","cat":"papers","name":"Real-world effectiveness and safety of psychedelic-assisted psychotherapy: Outcomes from a large-scale compassionate use cohort in Switzerland","year":"2026","cit":4,"pfa":"Tatiana Aboulafia Brakha","psa":"Louise E. Penzenstadler","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7127167117","eid":"W7127167117"},{"id":"paper-w2940658810","cat":"papers","name":"Illicit Substance Use in First Episode Psychosis (FEP): A Natural Language Processing (NLP) Electronic Health Record Study","year":"2018","cit":4,"pfa":"Rashmi Patel","psa":"Philip K. McGuire","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2940658810","eid":"W2940658810"},{"id":"paper-w148233103","cat":"papers","name":"Structure-activity relationships among desmethyl derivatives of neuroleptics and antidepressants for substrate specificty to indolethylamine N-methyltransferase from rabbit lung.","year":"1976","cit":4,"pfa":"N. Narasimhachari","psa":"Lin Rl","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W148233103","eid":"W148233103"},{"id":"paper-w2022883008","cat":"papers","name":"A neuropharmacological investigation on hallucinogenic drugs. Laboratory results versus clinical trials","year":"1964","cit":4,"pfa":"Vincenzo G. Longo","psa":"Daniel Bovet","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2022883008","eid":"W2022883008"},{"id":"paper-w2077678499","cat":"papers","name":"GC-FID optimization and validation for determination of 3,4-methylenedioxymethamphetamine, 3,4-methylenedioxyamphetamine and methamphetamine in ecstasy tablets","year":"2010","cit":4,"pfa":"Apichai Phonchai","psa":"Sittipoom Thainchaiwattana","ptype":"article","src":"https://openalex.org/W2077678499","eid":"W2077678499"},{"id":"paper-w2099874852","cat":"papers","name":"Isolation and Identification of Putative Hallucinogenic Constituents from the Roots of Mimosa ophthalmocentra","year":"1999","cit":4,"pfa":"Leônia Maria Batista","psa":"José Maria Barbosa‐Filho","ptype":"article","src":"https://openalex.org/W2099874852","eid":"W2099874852"},{"id":"paper-w2787425069","cat":"papers","name":"Illicit drugs: environmental occurrence, fate and toxicity","year":"2016","cit":4,"pfa":"Pandian Govindarasu (21293966)","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W2787425069","eid":"W2787425069"},{"id":"paper-w2774400037","cat":"papers","name":"Dying to live: The Power of Transcendence in the Treatment of Existential Anxiety","year":"2017","cit":4,"pfa":"Sam Gandy","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2774400037","eid":"W2774400037"},{"id":"paper-w1567945459","cat":"papers","name":"The Psychopharmacology of Herbal Medicine: Plant Drugs That Alter Mind, Brain and Behavior","year":"2003","cit":4,"pfa":"Ronald T. Coutts","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W1567945459","eid":"W1567945459"},{"id":"paper-w1979905038","cat":"papers","name":"Extractive-spectrophotometric determination of amine-type stimulants and antidepressants with anionic indicator dyes","year":"2013","cit":4,"pfa":"Erol Erçağ","psa":"Reşat Apak","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W1979905038","eid":"W1979905038"},{"id":"paper-w1989481661","cat":"papers","name":"Lived fictions: moving from pharmacology to ethnography","year":"1993","cit":4,"pfa":"John FitzGerald","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1989481661","eid":"W1989481661"},{"id":"paper-w3045546233","cat":"papers","name":"Single Nucleotide Polymorphism Assay for Genetic Identification of Lophophora williamsii*","year":"2020","cit":4,"pfa":"Minji Lee","psa":"In Kwan Hwang","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3045546233","eid":"W3045546233"},{"id":"paper-w4323350332","cat":"papers","name":"Information parity increases on functional brain networks under influence of a psychedelic substance","year":"2023","cit":4,"pfa":"Aline Viol","psa":"Philipp Hövel","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4323350332","eid":"W4323350332"},{"id":"paper-w3052496855","cat":"papers","name":"Plant based assisted therapy for the treatment of substance use disorders part 2 : beyond blurred boundaries.","year":"2019","cit":4,"pfa":"Matteo Politi","psa":"Jacques Mabit","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3052496855","eid":"W3052496855"},{"id":"paper-w4400099913","cat":"papers","name":"Considering Alternatives to Psychedelic Drug Prohibition","year":"2024","cit":4,"pfa":"Kilmer, Beau","psa":"Palmer, Keytin","topics":["Addiction"],"ptype":"book","src":"https://openalex.org/W4400099913","eid":"W4400099913"},{"id":"paper-w7118708255","cat":"papers","name":"Reported Safety Practices of Publicly Advertised Psychedelic Retreats","year":"2026","cit":4,"pfa":"Amy L. McGuire","psa":"Lynnette A. Averill","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7118708255","eid":"W7118708255"},{"id":"paper-w4406475778","cat":"papers","name":"Exploring the Potential of Psychedelics in the Treatment of Headache Disorders: Clinical Considerations and Exploratory Insights","year":"2025","cit":4,"pfa":"Isabella Henderson","psa":"Robert Duarte","ptype":"article","src":"https://openalex.org/W4406475778","eid":"W4406475778"},{"id":"paper-w4387993045","cat":"papers","name":"Towards a New Materialism in Psychedelic Studies","year":"2023","cit":4,"pfa":"Daan F. Oostveen","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4387993045","eid":"W4387993045"},{"id":"paper-w2019048979","cat":"papers","name":"A crystallographic and theoretical study of the conformation of DOET and its significance for the hallucinogenic amphetamines","year":"1975","cit":4,"pfa":"Alan S. Horn","psa":"L. Riva di Sanseverino","ptype":"article","src":"https://openalex.org/W2019048979","eid":"W2019048979"},{"id":"paper-w4389503765","cat":"papers","name":"The effect of casing and gypsum on the yield and psychoactive tryptamine content of Psilocybe cubensis (Earle) Singer","year":"2023","cit":4,"pfa":"Kimberley Foster","psa":"Rupika Delgoda","ptype":"article","src":"https://openalex.org/W4389503765","eid":"W4389503765"},{"id":"paper-w4400573076","cat":"papers","name":"Innovative and Emerging Treatments for Anorexia Nervosa","year":"2024","cit":4,"pfa":"Amanda E. Downey","psa":"Sasha Gorrell","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4400573076","eid":"W4400573076"},{"id":"paper-w2419369120","cat":"papers","name":"[Ecstasy: psychostimulant, hallucinogen and toxic substance].","year":"1996","cit":4,"pfa":"Pascal Burnat","psa":"Pailler Fm","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W2419369120","eid":"W2419369120"},{"id":"paper-w2071126380","cat":"papers","name":"A Physiological Difference Between Hallucinosis and Schizophrenia","year":"1973","cit":4,"pfa":"Russell A. Meares","psa":"Thomas Horvath","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2071126380","eid":"W2071126380"},{"id":"paper-w4411116696","cat":"papers","name":"“Wood-lover paralysis”: Describing a toxidrome with symptoms of weakness caused by some lignicolous “wood-loving” Psilocybe mushrooms","year":"2025","cit":4,"pfa":"Simon A. Beck","psa":"Monica Jane Barratt","topics":["Safety & adverse events","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4411116696","eid":"W4411116696"},{"id":"paper-w4319655691","cat":"papers","name":"Ketamine detection in urine samples from patients poisoned by recreational drugs: epidemiologic, clinical, and toxicologic profiles","year":"2024","cit":4,"pfa":"Isabel Gomila","psa":"Bernardino Barceló Martín","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4319655691","eid":"W4319655691"},{"id":"paper-w4401362632","cat":"papers","name":"Teaching a new dog old tricks: bringing rigor, grounding, and specificity to psychedelic neuropsychopharmacology","year":"2024","cit":4,"pfa":"Nathan H. Heller","psa":"Frederick Streeter Barrett","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4401362632","eid":"W4401362632"},{"id":"paper-w4394941329","cat":"papers","name":"The Influence of Health Coaching in Controlling Blood Sugar in Type 2 Diabetes Mellitus Patients: A Systematic Review","year":"2023","cit":4,"pfa":"Andi Sulfikar","psa":"Indah Restika","topics":["Reviews & meta-analyses","Policy & ethics"],"ptype":"review","src":"https://openalex.org/W4394941329","eid":"W4394941329"},{"id":"paper-w4405084592","cat":"papers","name":"Consistent evidence that brain serotonin 2A receptor binding is positively associated with personality-based risk markers of depression","year":"2024","cit":4,"pfa":"Emma Sofie Høgsted","psa":"Anjali Sankar","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4405084592","eid":"W4405084592"},{"id":"paper-w4386194078","cat":"papers","name":"Recent developments involving psychedelics","year":"2023","cit":4,"topics":["Depression","PTSD & trauma","Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W4386194078","eid":"W4386194078"},{"id":"paper-w4407154479","cat":"papers","name":"Psychological Support Approaches in Psychedelic Therapy","year":"2025","cit":4,"pfa":"David A. Bender","psa":"Eric J. Lenze","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4407154479","eid":"W4407154479"},{"id":"paper-w2496294445","cat":"papers","name":"Psychopharmacological Indole Alkaloids from Terrestrial Plants","year":"2014","cit":4,"pfa":"Robert B. Raffa","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W2496294445","eid":"W2496294445"},{"id":"paper-w1570109705","cat":"papers","name":"Uji Efek Antidepresan Ekstrak Metanol Jamur Tlethong (Psilocybe cubensis) Pada Tikus Putih Jantan (Rattus norvegicus): ditinjau dari Immobility Time Dengan Metode Forced Swim Test","year":"2013","cit":4,"pfa":"Nofri P. Kurama","psa":"Weny Wiyono","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1570109705","eid":"W1570109705"},{"id":"paper-w2496610147","cat":"papers","name":"Mu, Delta and Kappa Opioid Agonist Effects In Novel Assays of Pain-Depressed Behavior","year":"2013","cit":4,"pfa":"Sidney Stevens Negus","psa":"Ahmad Altarifi","topics":["Depression","Addiction","Reviews & meta-analyses"],"ptype":"conference-paper","src":"https://openalex.org/W2496610147","eid":"W2496610147"},{"id":"paper-w2017914942","cat":"papers","name":"Electroconvulsive therapy in the treatment of depression in a former ecstasy user","year":"2006","cit":4,"pfa":"Roland W. Freudenmann","psa":"Georg Grön","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2017914942","eid":"W2017914942"},{"id":"paper-w2896848207","cat":"papers","name":"In vivo Pharmacodynamics Studies of Acacia tortilis Found in Kingdom of Saudi Arabia on Cardiovascular System of Rats","year":"2018","cit":4,"pfa":"Abdulhalim Salim Serafi","psa":"Zahir Hussain","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2896848207","eid":"W2896848207"},{"id":"paper-w4386293160","cat":"papers","name":"Disruptive mutations in the serotonin transporter associate serotonin dysfunction with treatment-resistant affective disorder","year":"2023","cit":4,"pfa":"Jonatan Fullerton Støier","psa":"Freja Herborg","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4386293160","eid":"W4386293160"},{"id":"paper-w2958355436","cat":"papers","name":"Neural correlates of the DMT experience as assessed via multivariate EEG","year":"2019","cit":4,"pfa":"Christopher B. Timmermann","psa":"Robin Lester Carhart-Harris","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W2958355436","eid":"W2958355436"},{"id":"paper-w1969198430","cat":"papers","name":"Psychopharmacological effects of flutazolam (MS-4101)","year":"1978","cit":4,"pfa":"Takashi MITSUSHIMA","psa":"Showa Ueki","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1969198430","eid":"W1969198430"},{"id":"paper-w4400547863","cat":"papers","name":"The trajectory of psychedelic, spiritual, and psychotic experiences: implications for cognitive scientific perspectives on religion","year":"2024","cit":4,"pfa":"Ari Brouwer","psa":"F. LeRon Shults","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4400547863","eid":"W4400547863"},{"id":"paper-w13453725","cat":"papers","name":"Addiction to Hallucinogens, Dissociatives, Designer Drugs and “Legal Highs”","year":"2014","cit":4,"pfa":"Magı́ Farré","psa":"Marta Torrens","topics":["Addiction","Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W13453725","eid":"W13453725"},{"id":"paper-w4407820969","cat":"papers","name":"Development and validation of a HPLC-DAD method for determining the content of tryptamines in methanolic extracts of fruiting bodies of mushrooms belonging to species of the Psilocybe genus","year":"2025","cit":4,"pfa":"Juan Pablo Yasmo Perez","psa":"Sergio Andrés Urrego Restrepo","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4407820969","eid":"W4407820969"},{"id":"paper-w2769632532","cat":"papers","name":"Role of Glial Cells in μ-Opioid Receptor-Mediated Vasodilation in the Rat Retina","year":"2017","cit":4,"pfa":"Eriko Someya","psa":"Tsutomu Nakahara","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2769632532","eid":"W2769632532"},{"id":"paper-w2789388572","cat":"papers","name":"Breaking Convention: Psychedelic Pharmacology for the 21st Century","year":"2017","cit":4,"pfa":"Ben Sessa","psa":"Nikki Wyrd","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W2789388572","eid":"W2789388572"},{"id":"paper-w4405921710","cat":"papers","name":"Neuropsychological profiles of patients suffering from hallucinogen persisting perception disorder (HPPD): A comparative analysis with psychedelic-using and non-using controls","year":"2024","cit":4,"pfa":"Georg Leistenschneider","psa":"Thomas Riemer","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4405921710","eid":"W4405921710"},{"id":"paper-w2030072373","cat":"papers","name":"Nerve terminal effects of indoleamine psychotomimetics on 5-hydroxytryptamine","year":"1982","cit":4,"pfa":"Angelos E Halaris","ptype":"article","src":"https://openalex.org/W2030072373","eid":"W2030072373"},{"id":"paper-w4416839319","cat":"papers","name":"A causal pluralist theory of the interaction of substance, set and setting in psychedelic experience","year":"2025","cit":4,"pfa":"Julian D Kiverstein","psa":"Michiel van Elk","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4416839319","eid":"W4416839319"},{"id":"paper-w7125965074","cat":"papers","name":"Single-dose DMT reverses anhedonia and cognitive deficits via restoration of neurogenesis in a stress-induced depression model","year":"2026","cit":4,"pfa":"Rafael Vitor Lima da Cruz","psa":"Richardson Naves Leão","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7125965074","eid":"W7125965074"},{"id":"paper-w4393353006","cat":"papers","name":"Use of Prescribed and Non-Prescribed Treatments for Cluster Headache in a Swedish Cohort","year":"2024","cit":4,"pfa":"Gabriella Smedfors","psa":"Andrea Carmine Belin","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4393353006","eid":"W4393353006"},{"id":"paper-w4284958599","cat":"papers","name":"Hordenine: Pharmacological, phytochemical, pharmacokinetic and analytical review of the literature","year":"2022","cit":4,"pfa":"Lavanya Athilli","psa":"Arumugam Balasubramaniam","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4284958599","eid":"W4284958599"},{"id":"paper-w4406406191","cat":"papers","name":"My Bad, You Got This: witnessing, therapist attitude and the synergy between psychedelics and inner healing intelligence in the treatment of trauma","year":"2025","cit":4,"pfa":"Lawrence G. Fischman","topics":["PTSD & trauma","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4406406191","eid":"W4406406191"},{"id":"paper-w4312994437","cat":"papers","name":"Standards Without Labs: Drug Development in the Psychedelic Underground","year":"2022","cit":4,"pfa":"John Bailey","psa":"Joanna Kempner","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4312994437","eid":"W4312994437"},{"id":"paper-w4391931941","cat":"papers","name":"Dynamic medial parietal and hippocampal deactivations under DMT relate to sympathetic output and altered sense of time, space, and the self","year":"2024","cit":4,"pfa":"Lorenzo Pasquini","psa":"Christopher B. Timmermann","topics":["Safety & adverse events","Mechanism & neuroscience","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4391931941","eid":"W4391931941"},{"id":"paper-w7128528342","cat":"papers","name":"Psychedelics in functional disorders: A scoping review","year":"2026","cit":4,"pfa":"Chiranth Bhagavan","psa":"Richard Kanaan","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7128528342","eid":"W7128528342"},{"id":"paper-w4413770781","cat":"papers","name":"Brain changes associated with depression treatment: a meta-analysis","year":"2025","cit":4,"pfa":"Gianna M. Perez","psa":"Desmond J. Oathes","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W4413770781","eid":"W4413770781"},{"id":"paper-w4233659158","cat":"papers","name":"Spontaneous Spiritual Awakenings: Phenomenology, Altered States, Individual Differences, and Wellbeing","year":"2021","cit":4,"pfa":"Jessica Sophie Corneille","psa":"David Luke","ptype":"preprint","src":"https://openalex.org/W4233659158","eid":"W4233659158"},{"id":"paper-w4383497638","cat":"papers","name":"Hair analysis: Assessment of homemade hair treatment effects on drug concentrations in the keratin matrix","year":"2023","cit":4,"pfa":"Serena Mestria","psa":"Sabina Strano Rossi","ptype":"article","src":"https://openalex.org/W4383497638","eid":"W4383497638"},{"id":"paper-w3166100102","cat":"papers","name":"Microdosing psychedelics and its effect on creativity: Lessons learned from three double-blind placebo controlled longitudinal trials","year":"2021","cit":4,"pfa":"Luisa Prochazkova","psa":"Bernhard Hommel","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W3166100102","eid":"W3166100102"},{"id":"paper-w4397049703","cat":"papers","name":"Stutterers’ experiences on classic psychedelics: A preliminary self-report study","year":"2024","cit":4,"pfa":"Eric S. Jackson","psa":"Noah D. Gold","ptype":"article","src":"https://openalex.org/W4397049703","eid":"W4397049703"},{"id":"paper-w3081101043","cat":"papers","name":"[Epidemiology of hallucinogenic drug use in the Netherlands].","year":"2020","cit":4,"pfa":"Margriet van Laar","psa":"Charlotte J. A. van Miltenburg","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3081101043","eid":"W3081101043"},{"id":"paper-w2165085820","cat":"papers","name":"Knowledge, attitude, and practice of Iranian adolescent girls towards 3-4-methylenedioxymethamphetamine.","year":"2011","cit":4,"pfa":"Zahra Rahnavard","psa":"Shahin Akhondzadeh","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2165085820","eid":"W2165085820"},{"id":"paper-w4411132101","cat":"papers","name":"Emerging Risks of Amanita Muscaria: Case Reports on Increasing Consumption and Health Risks","year":"2025","cit":4,"pfa":"Emilija Savickaitė","psa":"Gabija Laubner-Sakalauskienė","topics":["Safety & adverse events","Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4411132101","eid":"W4411132101"},{"id":"paper-w3021969930","cat":"papers","name":"LSD alters eyes-closed functional connectivity within the early visual cortex in a retinotopic fashion","year":"2016","cit":4,"pfa":"Leor Roseman","psa":"Robin Lester Carhart-Harris","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3021969930","eid":"W3021969930"},{"id":"paper-w4410733614","cat":"papers","name":"Adverse reactions among psychedelic users: Norwegian validation of the Challenging Experience Questionnaire","year":"2025","cit":4,"pfa":"Kristoffer Andreas Aamodt Andersen","psa":"Matthew W. Johnson","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4410733614","eid":"W4410733614"},{"id":"paper-w4392872289","cat":"papers","name":"Effect of a selective personality-targeted prevention program on 7-year illicit substance related outcomes: A secondary analysis of a cluster randomized controlled trial","year":"2024","cit":4,"pfa":"Katrina Elizabeth Champion","psa":"Nicola Claire Newton","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4392872289","eid":"W4392872289"},{"id":"paper-w22798272","cat":"papers","name":"[Current situation of substance abuse/dependence in psychiatric hospital settings].","year":"2004","cit":4,"pfa":"Shigeru Ozaki","topics":["PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W22798272","eid":"W22798272"},{"id":"paper-w4407587677","cat":"papers","name":"The role of mitochondrial dysfunction and calcium dysregulation in 2C-I and 25I-NBOMe-induced neurotoxicity","year":"2025","cit":4,"pfa":"Eva Gil-Martins","psa":"Renata Silva","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4407587677","eid":"W4407587677"},{"id":"paper-w7134122582","cat":"papers","name":"The microbiome and PTSD: a scoping review across preclinical and clinical studies","year":"2026","cit":4,"pfa":"Ronja Berendse","psa":"A. Lok","topics":["PTSD & trauma","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7134122582","eid":"W7134122582"},{"id":"paper-w2991569128","cat":"papers","name":"Functional imaging investigation of psychedelic visual imagery","year":"2019","cit":4,"pfa":"Leor Roseman","topics":["Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W2991569128","eid":"W2991569128"},{"id":"paper-w4408158656","cat":"papers","name":"Characteristics and mental health of psychedelic mushroom and multi-psychedelic users relative to non-psychedelic users in American adults, 2020–2021","year":"2025","cit":4,"pfa":"Sofia Abramsky-Sze","psa":"Leonard B. Lerer","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4408158656","eid":"W4408158656"},{"id":"paper-w283469069","cat":"papers","name":"Psychedelic Substances and Paranormal Phenomena: A Review of the research/Substancias Psicodelicas Y Fenomenos Paranormales: Una Revision De la investigacion/Psychedelische Substanzen Und Paranormale Phanomene: Eine fors","year":"2008","cit":4,"pfa":"David P. Luke","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W283469069","eid":"W283469069"},{"id":"paper-w3201415722","cat":"papers","name":"Culture, Context, and Community in Contemporary Psychedelic Research","year":"2021","cit":4,"pfa":"Brian David Earp","psa":"David B. Yaden","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W3201415722","eid":"W3201415722"},{"id":"paper-w4399880551","cat":"papers","name":"Liver injury in patients with substance use disorder","year":"2024","cit":4,"pfa":"Kevin Robinson","psa":"Victor J. Navarro","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4399880551","eid":"W4399880551"},{"id":"paper-w2064119943","cat":"papers","name":"Violent Behavior and Hallucination in a 32-Year-Old Patient","year":"2013","cit":4,"pfa":"Steven M. Truscott","psa":"Saeed A. Jortani","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2064119943","eid":"W2064119943"},{"id":"paper-w4376117107","cat":"papers","name":"A Somatic Approach to Psychedelic-Assisted Therapy","year":"2023","cit":4,"pfa":"Veronika Gold","topics":["PTSD & trauma","Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W4376117107","eid":"W4376117107"},{"id":"paper-w4391852961","cat":"papers","name":"Deliberate practice in psychedelic-assisted therapy.","year":"2024","cit":4,"pfa":"Shannon Dames","psa":"Alexandre Vaz","ptype":"book","src":"https://openalex.org/W4391852961","eid":"W4391852961"},{"id":"paper-w4399332960","cat":"papers","name":"Psychoanalyst attitudes towards psychedelic-assisted therapy","year":"2024","cit":4,"pfa":"Eli Kraiem","psa":"Sally Saban","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4399332960","eid":"W4399332960"},{"id":"paper-w4407883822","cat":"papers","name":"Shrinking the know–do gap in psychedelic-assisted therapy","year":"2025","cit":4,"pfa":"Ginger E. Nicol","psa":"Leopoldo J. Cabassa","ptype":"article","src":"https://openalex.org/W4407883822","eid":"W4407883822"},{"id":"paper-w3168903623","cat":"papers","name":"Psychedelic-Assisted Psychotherapy and Carl Jung’s Red Book","year":"2021","cit":4,"pfa":"James C. Harris","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W3168903623","eid":"W3168903623"},{"id":"paper-w4411964422","cat":"papers","name":"Psychiatric Residents’ Perspectives on Psychedelics and Psychedelic Assisted Therapy","year":"2025","cit":4,"pfa":"Brian Scott Barnett","psa":"Tatiana Falcone","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4411964422","eid":"W4411964422"},{"id":"paper-w4417304665","cat":"papers","name":"Predictors of therapeutic response to psychedelic-assisted therapy: A systematic review","year":"2025","cit":4,"pfa":"Grace Viljoen","psa":"Felix Betzler","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"review","src":"https://openalex.org/W4417304665","eid":"W4417304665"},{"id":"paper-w4294912011","cat":"papers","name":"Psychedelic-Assisted Therapies in Patients With Serious Illness: Opportunities and Challenges","year":"2022","cit":4,"pfa":"Michael Ljuslin","psa":"Yvan Beaussant","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4294912011","eid":"W4294912011"},{"id":"paper-w4392663744","cat":"papers","name":"A Framework for Assessment of Adverse Events Occurring in Psychedelic Assisted Therapies","year":"2024","cit":4,"pfa":"Roman Palitsky","psa":"Boadie Waid Dunlop","topics":["Safety & adverse events","Dosing & pharmacology","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4392663744","eid":"W4392663744"},{"id":"paper-w4411709727","cat":"papers","name":"The promise and challenges of psychedelic-assisted therapy: lessons from Canada’s Special Access Program","year":"2025","cit":4,"pfa":"Nicolas Garel","psa":"Michel Dorval","ptype":"article","src":"https://openalex.org/W4411709727","eid":"W4411709727"},{"id":"paper-w4399332429","cat":"papers","name":"Psychedelic therapies and belief change: are there risks of epistemic harm or epistemic injustice?","year":"2024","cit":4,"pfa":"Maximiliano Zeller","topics":["Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4399332429","eid":"W4399332429"},{"id":"paper-w4389078581","cat":"papers","name":"Women, Mental Illness, and Psychedelic Therapy in Postwar France","year":"2023","cit":4,"pfa":"Zoë Dubus","ptype":"book-chapter","src":"https://openalex.org/W4389078581","eid":"W4389078581"},{"id":"paper-w4407866135","cat":"papers","name":"Psychedelic Assisted Therapy as a Complex Intervention: Implications for clinical trial design","year":"2025","cit":4,"pfa":"Suresh D Muthukumaraswamy","psa":"Tehseen N. Noorani","topics":["Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4407866135","eid":"W4407866135"},{"id":"paper-w4403913372","cat":"papers","name":"Into the wild frontier: Mapping the terrain of adverse events in psychedelic-assisted therapies","year":"2024","cit":4,"pfa":"Otto Simonsson","psa":"Peter S. Hendricks","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4403913372","eid":"W4403913372"},{"id":"paper-w4407799938","cat":"papers","name":"The Effect of Ketamine-Assisted Group Therapy on Treatment-Resistant Mental Health Conditions in Firefighters","year":"2025","cit":4,"pfa":"Vivian W. L. Tsang","psa":"Pamela Kryskow","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4407799938","eid":"W4407799938"},{"id":"paper-w4411081193","cat":"papers","name":"Patient–therapist relationship in psychedelic-assisted therapy: Implications for future real-world settings","year":"2025","cit":4,"pfa":"Daniel Villiger","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4411081193","eid":"W4411081193"},{"id":"paper-w4387115706","cat":"papers","name":"Letter to the editor regarding “Understanding subjective experience in psychedelic-assisted psychotherapy: The need for phenomenology”","year":"2023","cit":4,"pfa":"Bianca Ventura","topics":["Therapy practice"],"ptype":"letter","src":"https://openalex.org/W4387115706","eid":"W4387115706"},{"id":"paper-w4414383424","cat":"papers","name":"A clinical protocol for group-based ketamine-assisted therapy in a community of practice: the Roots To Thrive model","year":"2025","cit":4,"pfa":"Shannon Dames","psa":"Elena Argento","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4414383424","eid":"W4414383424"},{"id":"paper-w4320153102","cat":"papers","name":"Thanatotherapy: How psychedelic-assisted psychotherapy and the near-death experience can mutually benefit one another","year":"2022","cit":4,"pfa":"Pascal Michael","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4320153102","eid":"W4320153102"},{"id":"paper-w4399360244","cat":"papers","name":"Seeing the forest for the trees: An ecological systems theory approach to addressing emergent issues in psychedelic-assisted therapy research","year":"2024","cit":4,"pfa":"Meghan A. DellaCrosse","psa":"Alan K. Davis","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4399360244","eid":"W4399360244"},{"id":"paper-w4408784017","cat":"papers","name":"Qualitative analysis of a patient's experience of ketamine-assisted psychotherapy for substance use disorder: Empirical synergies with twelve-step programs","year":"2025","cit":4,"pfa":"Dan Petrovitch","psa":"Ben McCauley","topics":["Addiction","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4408784017","eid":"W4408784017"},{"id":"paper-w4386309433","cat":"papers","name":"Reductions in anxiety and depression symptoms in a subset of outpatients with problematic substance use who received ketamine-assisted psychotherapy: a two-year retrospective chart review","year":"2023","cit":4,"pfa":"Emily Whinkin","psa":"Sunil Kumar Aggarwal","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4386309433","eid":"W4386309433"},{"id":"paper-w4399121585","cat":"papers","name":"Exploring Psychedelics for Alleviating Existential and Spiritual Suffering in People With Serious Illnesses: Links to the Theory of Self-Transcendence","year":"2024","cit":4,"pfa":"Ana Cláudia Mesquita Garcia","psa":"Pamela G. Reed","topics":["Anxiety & end-of-life","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4399121585","eid":"W4399121585"},{"id":"paper-w4408328158","cat":"papers","name":"Exploring serotonergic psychedelics as a treatment for personality disorders","year":"2025","cit":4,"pfa":"Brennan M. Carrithers","psa":"Richard J. Zeifman","ptype":"article","src":"https://openalex.org/W4408328158","eid":"W4408328158"},{"id":"paper-w4384298124","cat":"papers","name":"Muslim Women and Psychedelics: a Look at the Past, Present, and Future","year":"2023","cit":4,"pfa":"Manzar Zare","psa":"Monnica T. Williams","ptype":"article","src":"https://openalex.org/W4384298124","eid":"W4384298124"},{"id":"paper-w4403887414","cat":"papers","name":"Acute Psychedelic Reactions, Post-Acute Changes in Dysfunctional Attitudes, and Psychedelic-Associated Changes in Wellbeing","year":"2024","cit":4,"pfa":"Mitch Earleywine","psa":"Fiona Low","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4403887414","eid":"W4403887414"},{"id":"paper-w4411214911","cat":"papers","name":"Break on Through: Betty Eisner's Problematic Use of Psychedelics, Groups, and Control for Integrative Experiences","year":"2025","cit":4,"pfa":"Tal Davidson","psa":"Patric Plesa","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4411214911","eid":"W4411214911"},{"id":"paper-w4413303112","cat":"papers","name":"Active inference and psychodynamics: a novel integration with applications to depression and stress disorders","year":"2025","cit":4,"pfa":"Hebert W. Harris","topics":["Depression","PTSD & trauma","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4413303112","eid":"W4413303112"},{"id":"paper-w3200738743","cat":"papers","name":"Carl Jung and the Psychedelic Brain","year":"2021","cit":4,"pfa":"Gary Clark","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3200738743","eid":"W3200738743"},{"id":"paper-w4404729790","cat":"papers","name":"The phenomenology of psychedelic temporality: current knowledge, open questions, and clinical applications","year":"2024","cit":4,"pfa":"Riccardo Miceli McMillan","psa":"Anthony Vincent Fernandez","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4404729790","eid":"W4404729790"},{"id":"paper-w4410743061","cat":"papers","name":"What are set and setting: Reducing vagueness to improve research and clinical practice","year":"2025","cit":4,"pfa":"Kyle Patch","psa":"William Smith","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4410743061","eid":"W4410743061"},{"id":"paper-w4409676357","cat":"papers","name":"Psychedelics for the treatment of end-of-life distress in patients with a life-threatening disease","year":"2025","cit":4,"pfa":"Stephan C. Tap","psa":"Robert A. Schoevers","topics":["Anxiety & end-of-life"],"ptype":"book-chapter","src":"https://openalex.org/W4409676357","eid":"W4409676357"},{"id":"paper-w4200103650","cat":"papers","name":"Psychedelic Science of Spirituality and Religion: An Attachment-Informed Agenda Proposal","year":"2021","cit":4,"pfa":"Aaron D. Cherniak","psa":"Pehr Granqvist","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4200103650","eid":"W4200103650"},{"id":"paper-w4381251139","cat":"papers","name":"In naturalistic psychedelic use, group use is common and acceptable","year":"2023","cit":4,"pfa":"Kevin Byrne","psa":"Ben Lewis","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4381251139","eid":"W4381251139"},{"id":"paper-w4379799656","cat":"papers","name":"Ketamine Augmentation of Electroconvulsive Therapy: A Scoping Review of Dose-Dependent Effects in Major Depressive Disorder","year":"2023","cit":4,"pfa":"Tarika Nagi","psa":"Meenal Pathak","topics":["Depression","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4379799656","eid":"W4379799656"},{"id":"paper-w4404326143","cat":"papers","name":"That men should put an enemy in their mouths to steal away their brains: Reconsidering the origins of model psychosis","year":"2024","cit":4,"pfa":"Matthew Perkins-McVey","ptype":"article","src":"https://openalex.org/W4404326143","eid":"W4404326143"},{"id":"paper-w4415593207","cat":"papers","name":"Psychedelics Reverse the Polarity of Long-Term Synaptic Plasticity in Cortical-Projecting Claustrum Neurons","year":"2025","cit":4,"pfa":"Tanner L. Anderson","psa":"Pavel I. Ortinski","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4415593207","eid":"W4415593207"},{"id":"paper-w4396512892","cat":"papers","name":"Is Use of Psychedelic Drugs a Risk or Protective Factor for Late-Life Cognitive Decline?","year":"2024","cit":4,"pfa":"Kaeleigh Fearn","psa":"Kallol Kumar Bhattacharyya","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4396512892","eid":"W4396512892"},{"id":"paper-w4396224633","cat":"papers","name":"Depression with comorbid borderline personality disorder - could ketamine be a treatment catalyst?","year":"2024","cit":4,"pfa":"Magdalena Więdłocha","psa":"Agata Szulc","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4396224633","eid":"W4396224633"},{"id":"paper-w4384028768","cat":"papers","name":"Exploring the role of mu opioid receptors in the therapeutic potential and abuse liability of (S)-ketamine","year":"2023","cit":4,"pfa":"Marjorie R. Levinstein","psa":"Michael Michaelides","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4384028768","eid":"W4384028768"},{"id":"paper-w3135367912","cat":"papers","name":"LSD et soins palliatifs dans les années 1960, un rendez-vous manqué ?","year":"2021","cit":4,"pfa":"Zoë Dubus","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3135367912","eid":"W3135367912"},{"id":"paper-w4390975747","cat":"papers","name":"Ketamine for Adults With Treatment-Resistant Depression or Posttraumatic Stress Disorder: A 2023 Update","year":"2024","cit":4,"pfa":"Angela M. Barbara","psa":"Angie Hamson","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4390975747","eid":"W4390975747"},{"id":"paper-w4396801115","cat":"papers","name":"Professionals in psychiatry need reflective competence","year":"2024","cit":4,"pfa":"Damiaan A J P Denys","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4396801115","eid":"W4396801115"},{"id":"paper-w4317036022","cat":"papers","name":"Microdosing psychedelics – Does it have an impact on emodiversity?","year":"2023","cit":4,"pfa":"Ioana Andreea Pop","psa":"Jannis Dinkelacker","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4317036022","eid":"W4317036022"},{"id":"paper-w4392059289","cat":"papers","name":"Exploring the discourses around microdosing psychedelics within the r/microdosing online community","year":"2024","cit":4,"pfa":"Ioana Andreea Pop","psa":"Peter Achterberg","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4392059289","eid":"W4392059289"},{"id":"paper-w4238189211","cat":"papers","name":"Hallucinogens","year":"2005","cit":4,"pfa":"Rick J. Strassman","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W4238189211","eid":"W4238189211"},{"id":"paper-w4243499389","cat":"papers","name":"Entheogens in Ancient Times","year":"2018","cit":4,"pfa":"Carl A. P. Ruck","ptype":"book-chapter","src":"https://openalex.org/W4243499389","eid":"W4243499389"},{"id":"paper-w2743113249","cat":"papers","name":"Entheogens in Ancient Times","year":"2014","cit":4,"pfa":"Carl A. P. Ruck","ptype":"book-chapter","src":"https://openalex.org/W2743113249","eid":"W2743113249"},{"id":"paper-w4241717911","cat":"papers","name":"Entheogens in the Study of Mystical and Archetypal Experiences","year":"2002","cit":4,"pfa":"William A. Richards","topics":["Therapy practice","Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W4241717911","eid":"W4241717911"},{"id":"paper-w4302433846","cat":"papers","name":"Are Hallucinogens Psychoheuristic?","year":"1994","cit":4,"pfa":"Stephen Szára","ptype":"dataset","src":"https://openalex.org/W4302433846","eid":"W4302433846"},{"id":"paper-w4406325989","cat":"papers","name":"Excusing Psychedelics and Accommodating Psychedelics","year":"2025","cit":4,"pfa":"Edward Jacobs","topics":["Policy & ethics"],"ptype":"editorial","src":"https://openalex.org/W4406325989","eid":"W4406325989"},{"id":"paper-w3048336546","cat":"papers","name":"Microdosing as a response to the meaning crisis","year":"2020","cit":4,"pfa":"Rotem Petranker","psa":"Thomas Anderson","topics":["Addiction","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W3048336546","eid":"W3048336546"},{"id":"paper-w2069526637","cat":"papers","name":"Persephone's Quest: Entheogens and the Origins of Religion","year":"1988","cit":4,"pfa":"Andrew Weil","ptype":"article","src":"https://openalex.org/W2069526637","eid":"W2069526637"},{"id":"paper-w4251887854","cat":"papers","name":"Rise of Hallucinogen Use","year":"1997","cit":4,"pfa":"Dana Eser Hunt","ptype":"dataset","src":"https://openalex.org/W4251887854","eid":"W4251887854"},{"id":"paper-w4221022301","cat":"papers","name":"184. Hallucinogens on TikTok","year":"2022","cit":4,"pfa":"Amrutha Garimella","psa":"Megan Andreas Moreno","ptype":"article","src":"https://openalex.org/W4221022301","eid":"W4221022301"},{"id":"paper-w2143518214","cat":"papers","name":"Entheogens, the Conscious Brain and Existential Reality: Part 1","year":"2012","cit":4,"pfa":"Chris C. King","topics":["Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2143518214","eid":"W2143518214"},{"id":"paper-w2597998530","cat":"papers","name":"PET microdosing of CNS drugs","year":"2017","cit":4,"pfa":"Magnus Schou","psa":"Katarina Varnäs","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2597998530","eid":"W2597998530"},{"id":"paper-w4410650211","cat":"papers","name":"Psychedelic Mysticism","year":"2015","cit":4,"pfa":"Morgan Shipley","topics":["Anxiety & end-of-life","Safety & adverse events","Policy & ethics"],"ptype":"book","src":"https://openalex.org/W4410650211","eid":"W4410650211"},{"id":"paper-w4396794282","cat":"papers","name":"A Psychedelic for Trauma","year":"2022","cit":4,"pfa":"Jennifer M. Mitchell","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4396794282","eid":"W4396794282"},{"id":"paper-w4392988368","cat":"papers","name":"Psychedelic Medicines","year":"2015","cit":4,"pfa":"Michael Winkelman","ptype":"other","src":"https://openalex.org/W4392988368","eid":"W4392988368"},{"id":"paper-w2408019017","cat":"papers","name":"Anti-asthmatic drugs as hallucinogens.","year":"1967","cit":4,"pfa":"Tramontana Ja","psa":"Marderosian Ah der","ptype":"article","src":"https://openalex.org/W2408019017","eid":"W2408019017"},{"id":"paper-w4240609879","cat":"papers","name":"Psychedelic Neuroscience","year":"2018","cit":4,"ptype":"book","src":"https://openalex.org/W4240609879","eid":"W4240609879"},{"id":"paper-w4412117934","cat":"papers","name":"Psychedelic assemblages","year":"2025","cit":4,"pfa":"Joshua Falcon","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4412117934","eid":"W4412117934"},{"id":"paper-w2972222469","cat":"papers","name":"The Varieties of Psychedelic Epistemology","year":"2019","cit":4,"pfa":"Chris Letheby","topics":["Reviews & meta-analyses","Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W2972222469","eid":"W2972222469"},{"id":"paper-w4392757592","cat":"papers","name":"Perception of hallucinogen use risks and associated hallucinogen use in the United States: results from a large national sample","year":"2024","cit":4,"pfa":"Yen‐Han Lee","psa":"Stephan V. Arndt","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4392757592","eid":"W4392757592"},{"id":"paper-w2116522808","cat":"papers","name":"Microdosing for early biokinetic studies in humans","year":"2010","cit":4,"pfa":"Kristina Eriksson Stenström","psa":"S. Mattsson","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2116522808","eid":"W2116522808"},{"id":"paper-w253117020","cat":"papers","name":"The Varieties of Psychedelic Experiences.","year":"1968","cit":4,"pfa":"Peter Berndt","ptype":"article","src":"https://openalex.org/W253117020","eid":"W253117020"},{"id":"paper-w2790529871","cat":"papers","name":"The Psychedelic Book of the Dead","year":"2018","cit":4,"pfa":"Erik W. Davis","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2790529871","eid":"W2790529871"},{"id":"paper-w2905200637","cat":"papers","name":"The dissociative psychedelic renaissance","year":"2018","cit":4,"pfa":"Lowan Han Stewart","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2905200637","eid":"W2905200637"},{"id":"paper-w2798082256","cat":"papers","name":"Psychedelics and Religious Freedom","year":"1968","cit":4,"pfa":"Joel Jay Finer","ptype":"article","src":"https://openalex.org/W2798082256","eid":"W2798082256"},{"id":"paper-w2417061415","cat":"papers","name":"The mode of action of indolamine and other hallucinogens.","year":"1977","cit":4,"pfa":"M R Boarder","ptype":"article","src":"https://openalex.org/W2417061415","eid":"W2417061415"},{"id":"paper-w4413225364","cat":"papers","name":"John Allegro and the Psychedelic Mysteries Hypothesis","year":"2025","cit":4,"pfa":"Richard S. Ascough","ptype":"article","src":"https://openalex.org/W4413225364","eid":"W4413225364"},{"id":"paper-w2021666922","cat":"papers","name":"Microdose therapy: dilution versus potentiation?","year":"1997","cit":4,"pfa":"J. Widakowich","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2021666922","eid":"W2021666922"},{"id":"paper-w1970563766","cat":"papers","name":"The microdose problem and the most commonly used metals","year":"1992","cit":4,"pfa":"V. Foà","psa":"Adalberto Ferioli","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1970563766","eid":"W1970563766"},{"id":"paper-w4393026463","cat":"papers","name":"A Brief History Of Psychedelics In Medical Practices: Psychedelic Medical History “Before The Hiatus”","year":"2015","cit":4,"pfa":"Ben Sessa","ptype":"other","src":"https://openalex.org/W4393026463","eid":"W4393026463"},{"id":"paper-w2017659211","cat":"papers","name":"New class of hallucinogens: GABA‐enhancing agents","year":"1990","cit":4,"pfa":"Leo E. Hollister","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2017659211","eid":"W2017659211"},{"id":"paper-w2326263095","cat":"papers","name":"The Use and Abuse of Psychedelic Drugs","year":"1968","cit":4,"pfa":"Daniel X. Freedman","ptype":"article","src":"https://openalex.org/W2326263095","eid":"W2326263095"},{"id":"paper-w3087973715","cat":"papers","name":"Psychedelic Telepathy: An Interview Study","year":"2020","cit":4,"pfa":"Petter Grahl Johnstad","ptype":"article","src":"https://openalex.org/W3087973715","eid":"W3087973715"},{"id":"paper-w4224245688","cat":"papers","name":"Agency-First Epistemology of Psychedelics","year":"2022","cit":4,"pfa":"Lisa Bortolotti","psa":"Kathleen Murphy‐Hollies","ptype":"article","src":"https://openalex.org/W4224245688","eid":"W4224245688"},{"id":"paper-w4402576289","cat":"papers","name":"The Psychedelic Renaissance: A Catholic Perspective","year":"2024","cit":4,"pfa":"Thomas Carroll","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4402576289","eid":"W4402576289"},{"id":"paper-w2795582633","cat":"papers","name":"Case series: Salvia divinorum as a potential addictive hallucinogen","year":"2018","cit":4,"pfa":"Joseph El‐Khoury","psa":"Evelyne Baroud","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2795582633","eid":"W2795582633"},{"id":"paper-w180551148","cat":"papers","name":"[Hallucinogen persisting perception disorder after ecstasy use].","year":"2013","cit":4,"pfa":"Loes Hanck","psa":"Arnt Schellekens","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W180551148","eid":"W180551148"},{"id":"paper-w4200594327","cat":"papers","name":"Do Psychedelics Change Beliefs?","year":"2021","cit":4,"pfa":"Hugh McGovern","psa":"Philip Robert Corlett","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4200594327","eid":"W4200594327"},{"id":"paper-w4391344309","cat":"papers","name":"Making Sense of Psychedelics in the CNS","year":"2024","cit":4,"pfa":"Blake A Fordyce","psa":"Bryan L. Roth","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4391344309","eid":"W4391344309"},{"id":"paper-w2945919572","cat":"papers","name":"Drugs as part of the psychedelic trance dance party","year":"2019","cit":4,"pfa":"Alena Kajanová","psa":"Tomáš Mrhálek","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2945919572","eid":"W2945919572"},{"id":"paper-w3007095464","cat":"papers","name":"„Visual snow“ bei „Hallucinogen Persisting Perception Disorder“","year":"2020","cit":4,"pfa":"Hannah Schatten","psa":"Nataša Mihailovic","ptype":"article","src":"https://openalex.org/W3007095464","eid":"W3007095464"},{"id":"paper-w7128708636","cat":"papers","name":"Trends in the psychedelic renaissance: applying artificial intelligence to measure media portrayal of psychedelic drugs in the 21st century","year":"2026","cit":4,"pfa":"David A. Bender","psa":"Charles B. Nemeroff","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7128708636","eid":"W7128708636"},{"id":"paper-w4403603409","cat":"papers","name":"Effects of a Serotonergic Psychedelic on the Lipid Bilayer","year":"2024","cit":4,"pfa":"Debsankar Saha Roy","psa":"Sudipta Maiti","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4403603409","eid":"W4403603409"},{"id":"paper-w2411727231","cat":"papers","name":"Perspectives on the use an abuse of psychedelic drugs.","year":"1967","cit":4,"pfa":"L D Holmes","ptype":"article","src":"https://openalex.org/W2411727231","eid":"W2411727231"},{"id":"paper-w4283716589","cat":"papers","name":"Belief changes associated with psychedelic use","year":"2022","cit":4,"pfa":"Sandeep Manel Nayak","psa":"Roland R. Griffiths","ptype":"preprint","src":"https://openalex.org/W4283716589","eid":"W4283716589"},{"id":"paper-w2145917463","cat":"papers","name":"The noetic connection: synaesthesia, psychedelics, and language","year":"2005","cit":4,"pfa":"Diana Reed Slattery","ptype":"article","src":"https://openalex.org/W2145917463","eid":"W2145917463"},{"id":"paper-w3092637237","cat":"papers","name":"Chronic pain and psychedelics: proceeding with caution","year":"2020","cit":4,"pfa":"Taif J. Mukhdomi","psa":"Junaid Mukhdomi","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3092637237","eid":"W3092637237"},{"id":"paper-w4410963474","cat":"papers","name":"The psychedelic-peptide paradox: a hormetic hypothesis","year":"2025","cit":4,"pfa":"C. Sue Carter","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4410963474","eid":"W4410963474"},{"id":"paper-w3200316189","cat":"papers","name":"Pharmacology and toxicology of N-Benzyl-phenylethylamines (25X-NBOMe) hallucinogens","year":"2021","cit":4,"pfa":"Adam J. Potts","psa":"Simon L. Hill","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W3200316189","eid":"W3200316189"},{"id":"paper-w4408286400","cat":"papers","name":"Cognitive and affective models of psychedelics in rodents","year":"2025","cit":4,"pfa":"Dasha Anderson","psa":"Emma S. J. Robinson","ptype":"book-chapter","src":"https://openalex.org/W4408286400","eid":"W4408286400"},{"id":"paper-w2921411210","cat":"papers","name":"Mineral fertilisation by microdose: Incentives for widespread adoption in Burkina Faso","year":"2019","cit":4,"pfa":"Alhousseiny Samba TRAORE","psa":"François Lompo","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2921411210","eid":"W2921411210"},{"id":"paper-w2953358281","cat":"papers","name":"Ambulatory Microdose PET: A Wearable PET Scanner for Neurologic Imaging","year":"2019","cit":4,"pfa":"Rani M. Noble","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2953358281","eid":"W2953358281"},{"id":"paper-w2773166480","cat":"papers","name":"La recherche sur les microdoses de substances psychédéliques","year":"2017","cit":4,"pfa":"Vittorio Biancardi","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2773166480","eid":"W2773166480"},{"id":"paper-w2335305745","cat":"papers","name":"Psychedelic-facilitated smoking cessation: An online survey","year":"2014","cit":4,"pfa":"Albert Garcia‐Romeu","psa":"Matthew W. Johnson","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2335305745","eid":"W2335305745"},{"id":"paper-w4385931346","cat":"papers","name":"Neural geometrodynamics, complexity, and plasticity: a psychedelics perspective","year":"2023","cit":4,"pfa":"Giulio Ruffini","psa":"Roser Sanchez-Todo","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4385931346","eid":"W4385931346"},{"id":"paper-w3011165643","cat":"papers","name":"Comparison of sandwich, conventional antagonist and microdose protocols in poor responders","year":"2019","cit":4,"pfa":"Milal Muhammad Al-Jeborry","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3011165643","eid":"W3011165643"},{"id":"paper-w2939636573","cat":"papers","name":"Sciencing the mystical: the trickery of the psychedelic trip report","year":"2019","cit":4,"pfa":"Tehseen N. Noorani","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2939636573","eid":"W2939636573"},{"id":"paper-w4285265809","cat":"papers","name":"Transpersonal Gratitude and Psychedelic Altered States of Consciousness","year":"2022","cit":4,"pfa":"Taline Artinian","ptype":"book-chapter","src":"https://openalex.org/W4285265809","eid":"W4285265809"},{"id":"paper-w2441011595","cat":"papers","name":"[Microdoses of BCG vaccine for prophylaxis in bladder cancer stage T1].","year":"1993","cit":4,"pfa":"Pilar García de la Torre Rivera","psa":"A Ubilla","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W2441011595","eid":"W2441011595"},{"id":"paper-w2031776415","cat":"papers","name":"Helping at the edges of life: Perspectives of a psychedelic therapist","year":"1988","cit":4,"pfa":"Richard Yensen","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2031776415","eid":"W2031776415"},{"id":"paper-w2923494913","cat":"papers","name":"Relapse Prevention for Abuse of Club Drugs, Hallucinogens, Inhalants, and Steroids.","year":"2005","cit":4,"pfa":"Jason R. Kilmer","psa":"Rebekka S. Palmer","ptype":"article","src":"https://openalex.org/W2923494913","eid":"W2923494913"},{"id":"paper-w1979133564","cat":"papers","name":"Role-play theory of psychedelic drug flashbacks.","year":"1980","cit":4,"pfa":"Robert E. Matefy","ptype":"article","src":"https://openalex.org/W1979133564","eid":"W1979133564"},{"id":"paper-w4220661210","cat":"papers","name":"A mind-changing approach to the therapeutic use of psychedelics","year":"2022","cit":4,"pfa":"Sara Osman","ptype":"article","src":"https://openalex.org/W4220661210","eid":"W4220661210"},{"id":"paper-w3020172582","cat":"papers","name":"Psychedelic drugs as a long-needed innovation in psychiatry","year":"2020","cit":4,"pfa":"Genís Oña","psa":"José Carlos Bouso","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W3020172582","eid":"W3020172582"},{"id":"paper-w7123039939","cat":"papers","name":"The Therapeutic Potential of Psychedelics for Treatment-resistant Depression","year":"2026","cit":4,"pfa":"Natia Horato","psa":"Antônio Egídio Nardi","topics":["Depression","Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7123039939","eid":"W7123039939"},{"id":"paper-w7138948813","cat":"papers","name":"Electrophysiological mechanisms of psychedelic drugs: A systematic review","year":"2026","cit":4,"pfa":"Javier Hidalgo Jiménez","psa":"Jaan Aru","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7138948813","eid":"W7138948813"},{"id":"paper-w4385986336","cat":"papers","name":"Pioneering Changes in Psychiatry: Biomarkers, Psychedelics, and AI","year":"2023","cit":4,"pfa":"Robert B. Kargbo","ptype":"editorial","src":"https://openalex.org/W4385986336","eid":"W4385986336"},{"id":"paper-w4206102250","cat":"papers","name":"Shedding Light on Classic Psychedelics and Self-Harm","year":"2022","cit":4,"pfa":"Daniel H. Grossman","psa":"Peter S. Hendricks","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4206102250","eid":"W4206102250"},{"id":"paper-w4205231711","cat":"papers","name":"Role-play theory of psychedelic drug flashbacks.","year":"1980","cit":4,"pfa":"Robert E. Matefy","ptype":"article","src":"https://openalex.org/W4205231711","eid":"W4205231711"},{"id":"paper-w4403403593","cat":"papers","name":"How to End the Mysticism Wars in Psychedelic Science","year":"2024","cit":4,"pfa":"Chris Letheby","psa":"Eric Hochstein","ptype":"book-chapter","src":"https://openalex.org/W4403403593","eid":"W4403403593"},{"id":"paper-w3004330769","cat":"papers","name":"Screening for NBOMe Hallucinogens based on Artificial Neural Networks and Structural Descriptors","year":"2019","cit":4,"pfa":"Adelina Ion","psa":"Mirela Praisler","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"conference-paper","src":"https://openalex.org/W3004330769","eid":"W3004330769"},{"id":"paper-w4388501680","cat":"papers","name":"Introducing psychedelics to end-of-life mental healthcare","year":"2023","cit":4,"pfa":"Mason Marks","psa":"Ivan Glenn Cohen","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4388501680","eid":"W4388501680"},{"id":"paper-w4396721407","cat":"papers","name":"Navigating the “Psychedelic Renaissance”: From Research to Reality","year":"2024","cit":4,"pfa":"Doris E. Payer","psa":"Brian R. Rush","ptype":"article","src":"https://openalex.org/W4396721407","eid":"W4396721407"},{"id":"paper-w4416186741","cat":"papers","name":"Trends in Hallucinogen-Related Emergency Department and Hospital Admissions, 2016 to 2023","year":"2025","cit":4,"pfa":"Jacob T. Steinle","psa":"Kevin Young Xu","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4416186741","eid":"W4416186741"},{"id":"paper-w1941626612","cat":"papers","name":"The Texas Armadillo: From Psychedelic Totem to Regional Icon","year":"2003","cit":4,"pfa":"Seth Bovey","ptype":"article","src":"https://openalex.org/W1941626612","eid":"W1941626612"},{"id":"paper-w2903323930","cat":"papers","name":"“To learn healing knowledge”: Philosophy, psychedelic studies and transformation","year":"2018","cit":4,"pfa":"David Anthony Pittaway","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2903323930","eid":"W2903323930"},{"id":"paper-w4383186044","cat":"papers","name":"FDA Proposes First Guidance for Researchers Studying Psychedelics","year":"2023","cit":4,"pfa":"Emily Harris","ptype":"article","src":"https://openalex.org/W4383186044","eid":"W4383186044"},{"id":"paper-w4406236054","cat":"papers","name":"An initiative for living evidence synthesis in clinical psychedelic research","year":"2025","cit":4,"pfa":"S. Parker Singleton","psa":"Theodore Daniel Satterthwaite","ptype":"article","src":"https://openalex.org/W4406236054","eid":"W4406236054"},{"id":"paper-w4404724326","cat":"papers","name":"The immunomodulatory effects of psychedelics in Alzheimer’s disease-related dementia","year":"2024","cit":4,"pfa":"Alireza Mohammad Hosseini","psa":"Atena Rahimi","ptype":"article","src":"https://openalex.org/W4404724326","eid":"W4404724326"},{"id":"paper-w4396795414","cat":"papers","name":"Johns Hopkins Scientists Give Psychedelics the Serious Treatment","year":"2020","cit":4,"pfa":"Tanya Lewis","ptype":"article","src":"https://openalex.org/W4396795414","eid":"W4396795414"},{"id":"paper-w4313011770","cat":"papers","name":"Introduction to the Symposium on Psychedelics and Psychoanalysis: A Conversation Long Overdue","year":"2022","cit":4,"pfa":"Philip A. Ringstrom","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4313011770","eid":"W4313011770"},{"id":"paper-w3080304034","cat":"papers","name":"[Psychedelics in the treatment of depression, anxiety, and obsessive-compulsive disorder].","year":"2020","cit":4,"pfa":"Joost J. Breeksema","psa":"Robert A. Schoevers","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3080304034","eid":"W3080304034"},{"id":"paper-w4386638050","cat":"papers","name":"Psychedelics and Psychiatry: A New Treatment Model for the 21st Century","year":"2019","cit":4,"pfa":"Charles S. Grob","psa":"GARY L. BRAVO","ptype":"other","src":"https://openalex.org/W4386638050","eid":"W4386638050"},{"id":"paper-w4405031067","cat":"papers","name":"Dilemmas in psychedelic medicine: From ethics to regulation and equity","year":"2024","cit":4,"pfa":"Albino Jorge Oliveira-Maia","psa":"Carolina Seybert","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4405031067","eid":"W4405031067"},{"id":"paper-w4407218497","cat":"papers","name":"Practitioner perspectives on meditation-based preparation for psychedelic experiences","year":"2025","cit":4,"pfa":"Rosalind G. McAlpine","psa":"Matthew D. Sacchet","topics":["Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4407218497","eid":"W4407218497"},{"id":"paper-w4407050788","cat":"papers","name":"Classical psychedelics in therapy: Essential psychotherapy or minimal support?","year":"2025","cit":4,"pfa":"Gitte M. Knudsen","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4407050788","eid":"W4407050788"},{"id":"paper-w4406096959","cat":"papers","name":"Sex and psychedelics: a wide-lens look at a burgeoning field","year":"2025","cit":4,"pfa":"Alex Dymock","psa":"Zoë Dubus","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4406096959","eid":"W4406096959"},{"id":"paper-w2023095306","cat":"papers","name":"Sympathetic autonomic dysfunction. Programmed subcutaneous noradrenaline administration via microdosing pump","year":"1991","cit":4,"pfa":"Manfred J. Lehmann","psa":"A. -N. Khalaf","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2023095306","eid":"W2023095306"},{"id":"paper-w4414615042","cat":"papers","name":"The Role of Psychedelics in the Treatment of Substance Use Disorders: An Overview of Systematic Reviews","year":"2025","cit":4,"pfa":"Sabrina Corrêa da Costa","psa":"Mark S. Gold","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4414615042","eid":"W4414615042"},{"id":"paper-w3012983258","cat":"papers","name":"The determinants of fertilizer microdosing adoption and impact on sorghum and maize yields in Burkina Faso","year":"2020","cit":4,"pfa":"Mamadou Sanogo","psa":"Marie‐Paule Kestemont","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3012983258","eid":"W3012983258"},{"id":"paper-w4307826332","cat":"papers","name":"Psychedelics and the Military: What a Long, Strange Trip It’s Been","year":"2022","cit":4,"pfa":"CYNTHIA M. A. GEPPERT","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4307826332","eid":"W4307826332"},{"id":"paper-w4237437867","cat":"papers","name":"Higher Wisdom: Eminent Elders Explore the Continuing Impact of Psychedelics","year":"2006","cit":4,"pfa":"Charles Savage","ptype":"article","src":"https://openalex.org/W4237437867","eid":"W4237437867"},{"id":"paper-w4389613903","cat":"papers","name":"Psychedelics for military and Veteran communities? Research, practice, and policy considerations","year":"2023","cit":4,"pfa":"Ron Joseph Shore","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4389613903","eid":"W4389613903"},{"id":"paper-w4235609350","cat":"papers","name":"Report of the committee on problems of drug dependence consensus committee on the abuse liability of 28 stimulants and hallucinogens","year":"1986","cit":4,"ptype":"article","src":"https://openalex.org/W4235609350","eid":"W4235609350"},{"id":"paper-w4387447434","cat":"papers","name":"The Evolving Role of History in the Past, Present, and Future of Psychedelic Patenting","year":"2023","cit":4,"pfa":"Shahin Shams","psa":"Tom Isenbarger","ptype":"article","src":"https://openalex.org/W4387447434","eid":"W4387447434"},{"id":"paper-w4415622018","cat":"papers","name":"Ketamine, Psychedelics, and Psychotherapy: Reframing, Redefining, Renaming Treatment Models","year":"2025","cit":4,"pfa":"Jennifer Swainson","psa":"Cláudio N. Soares","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4415622018","eid":"W4415622018"},{"id":"paper-w4281804395","cat":"papers","name":"Microdosing of Strength Training in Basketball During Congested Game Weeks: A Practical-Methodological Approach","year":"2022","cit":4,"pfa":"Adriano Vretaros","topics":["Dosing & pharmacology","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4281804395","eid":"W4281804395"},{"id":"paper-w4414781535","cat":"papers","name":"Harm reduction practises for users of psychedelic drugs: a scoping review","year":"2025","cit":4,"pfa":"Carissa Dutton","psa":"Petra Skeffington","topics":["Safety & adverse events","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4414781535","eid":"W4414781535"},{"id":"paper-w4379390511","cat":"papers","name":"Psychedelics bind to TrkB to induce neuroplasticity and antidepressant-like effects","year":"2023","cit":4,"pfa":"Eero Ċastrén","psa":"Rafael Moliner","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4379390511","eid":"W4379390511"},{"id":"paper-w4402655885","cat":"papers","name":"Belief change and agnostic frames in psychedelic research and clinical contexts","year":"2024","cit":4,"pfa":"David B. Yaden","psa":"Roland R. Griffiths","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"book-chapter","src":"https://openalex.org/W4402655885","eid":"W4402655885"},{"id":"paper-w2120358817","cat":"papers","name":"Vision and Viscosity in Goa’s Psychedelic Trance Scene Arun Saldanha","year":"2015","cit":4,"pfa":"Arun Saldanha","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2120358817","eid":"W2120358817"},{"id":"paper-w4403583236","cat":"papers","name":"Eigenmodes of the deep unconscious: The neuropsychology of Jungian archetypes and psychedelic experience.","year":"2024","cit":4,"pfa":"Hugh McGovern","psa":"Robin Lester Carhart-Harris","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4403583236","eid":"W4403583236"},{"id":"paper-w3152419674","cat":"papers","name":"Alan Watts, Psychedelic Buddhism, and Religious Play in Postwar America","year":"2021","cit":4,"pfa":"Morgan Shipley","topics":["Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W3152419674","eid":"W3152419674"},{"id":"paper-w4405570262","cat":"papers","name":"Evaluating the value and risks of psychedelics for psychiatric medicine: a clinical perspective","year":"2024","cit":4,"pfa":"Donatella Marazziti","psa":"Giulio Perugi","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4405570262","eid":"W4405570262"},{"id":"paper-w2951600445","cat":"papers","name":"ChemInform Abstract: STUDIES ON PHENETHYLAMINE HALLUCINOGENS. 2. CONFORMATIONS OF ARYLMETHOXYL GROUPS BY CARBON‐13 NMR","year":"1981","cit":4,"pfa":"James J. Knittel","psa":"Alexandros Makriyannis","ptype":"article","src":"https://openalex.org/W2951600445","eid":"W2951600445"},{"id":"paper-w4389966440","cat":"papers","name":"Trip-killers: a concerning practice associated with psychedelic drug use","year":"2023","cit":4,"pfa":"Gregory P. Yates","psa":"Emily Melon","ptype":"article","src":"https://openalex.org/W4389966440","eid":"W4389966440"},{"id":"paper-w2183114226","cat":"papers","name":"The Transformative Power of Ketamine: Psychedelic States and a Personal History of Transformation","year":"2014","cit":4,"pfa":"Philip E. Wolfson","ptype":"article","src":"https://openalex.org/W2183114226","eid":"W2183114226"},{"id":"paper-w3033864391","cat":"papers","name":"The metaphysics behind pharmacotherapy: treating depression with conventional and psychedelic drugs","year":"2018","cit":4,"pfa":"Virginia Ballesteros","topics":["Depression","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3033864391","eid":"W3033864391"},{"id":"paper-w4404596738","cat":"papers","name":"Fully Integrated MEMS Micropump and Miniaturized Mass Flow Sensor as Basic Components for a Microdosing System","year":"2024","cit":4,"pfa":"Martin Seidl","psa":"Gabriele Schrag","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4404596738","eid":"W4404596738"},{"id":"paper-w2049765111","cat":"papers","name":"Actions of hallucinogens on ants (formica pratensis)—III. Social behavior under the influence of LSD and tetrahydrocannabinol","year":"1980","cit":4,"pfa":"H.R. Frischknecht","psa":"Peter Gaudenz Waser","ptype":"article","src":"https://openalex.org/W2049765111","eid":"W2049765111"},{"id":"paper-w1871783998","cat":"papers","name":"Psychedelics and psychosis : LSD and changing ideas of mental illness, 1943-1966","year":"2002","cit":4,"pfa":"Kimberly Allyn Hewitt","ptype":"article","src":"https://openalex.org/W1871783998","eid":"W1871783998"},{"id":"paper-w4407219565","cat":"papers","name":"The neverending trip: Associations between Hallucinogen Persisting Perception Disorder (HPPD) and non-visual perceptual disturbances","year":"2025","cit":4,"pfa":"Anneliese McConnell","psa":"Paul F. Sowman","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4407219565","eid":"W4407219565"},{"id":"paper-w2731322063","cat":"papers","name":"Human microdosing and mice xenograft data of AGM-130 applied to estimate efficacious doses in patients","year":"2017","cit":4,"pfa":"Wan-Su Park","psa":"Dong‐Seok Yim","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2731322063","eid":"W2731322063"},{"id":"paper-w4406816685","cat":"papers","name":"Psychedelic-mediated Reversal of General Anesthesia and Restoration of Brain Dynamics in Rat","year":"2025","cit":4,"pfa":"Emma R. Huels","psa":"Dinesh Pal","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4406816685","eid":"W4406816685"},{"id":"paper-w4394932680","cat":"papers","name":"Nurses' Perceptions of Psychedelics to Address Mental Health Problems in the United States","year":"2024","cit":4,"pfa":"Carolyn M. Porta","psa":"Caroline G. Dorsen","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4394932680","eid":"W4394932680"},{"id":"paper-w3199245801","cat":"papers","name":"Psychedelic mushrooms in the USA: Knowledge, patterns of use and association with health outcomes","year":"2021","cit":4,"pfa":"Richard Matzopoulos","psa":"Leonard B. Lerer","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W3199245801","eid":"W3199245801"},{"id":"paper-w2794814192","cat":"papers","name":"Supple bodies, healthy minds: yoga, psychedelics and American mental health","year":"2018","cit":4,"pfa":"Lucas Richert","psa":"Matthew DeCloedt","ptype":"article","src":"https://openalex.org/W2794814192","eid":"W2794814192"},{"id":"paper-w2969592124","cat":"papers","name":"Psychosocial Correlates and Early Substance Abuse Associated With Lifetime Hallucinogen Use Among Hispanic Young Adults","year":"2019","cit":4,"pfa":"R. Andrew Yockey","psa":"Rebecca A. Vidourek","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2969592124","eid":"W2969592124"},{"id":"paper-w4408217915","cat":"papers","name":"Exploring Motivations, Experiences, and Consequences of Psychedelic Use in Aotearoa New Zealand","year":"2025","cit":4,"pfa":"Ethan A. Mills","psa":"Ryan D. Ward","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4408217915","eid":"W4408217915"},{"id":"paper-w4404992430","cat":"papers","name":"Application of microarray patches for the transdermal administration of psychedelic drugs in micro-doses","year":"2024","cit":4,"pfa":"Octavio E. Fandiño","psa":"Ryan F. Donnelly","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4404992430","eid":"W4404992430"},{"id":"paper-w4309862434","cat":"papers","name":"A naïve pooled data approach for extrapolation of Phase 0 microdose trials to therapeutic dosing regimens","year":"2022","cit":4,"pfa":"Lisa T. van der Heijden","psa":"Thomas P. C. Dorlo","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4309862434","eid":"W4309862434"},{"id":"paper-w2993150276","cat":"papers","name":"Fertilizer microdosing enhances biomass yield and water use efficiency of African indigenous leafy vegetable","year":"2019","cit":4,"pfa":"Dagnon Didier Likpètè","psa":"C.N.A. Sossa-Vihotogbe","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2993150276","eid":"W2993150276"},{"id":"paper-w4406988911","cat":"papers","name":"The Psychosocial Environment as Therapeutic Context: Family-Centered Approaches to Adolescent Psychedelic Research","year":"2025","cit":4,"pfa":"Edward Jacobs","psa":"Bryony Insua‐Summerhays","ptype":"article","src":"https://openalex.org/W4406988911","eid":"W4406988911"},{"id":"paper-w2982610328","cat":"papers","name":"Artificial neural network designed to identify NBOMe hallucinogens based on 3D- MoRSE descriptors and topological descriptors","year":"2019","cit":4,"pfa":"Adelina Ion","psa":"Cătălin Negoiţă","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"conference-paper","src":"https://openalex.org/W2982610328","eid":"W2982610328"},{"id":"paper-w4293101311","cat":"papers","name":"Are You Tripping Comfortably? Investigating the Relationship Between Harm Reduction and the Psychedelic experience","year":"2022","cit":4,"pfa":"Maddie Palmer","psa":"Olivia Maynard","topics":["Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4293101311","eid":"W4293101311"},{"id":"paper-w4396558572","cat":"papers","name":"The Use of Microdosing for In vivo Phenotyping of Cytochrome P450 Enzymes: Where Do We Stand? A Narrative Review","year":"2024","cit":4,"pfa":"Lisa T. van der Heijden","psa":"Alwin D. R. Huitema","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4396558572","eid":"W4396558572"},{"id":"paper-w3202762479","cat":"papers","name":"De Plantis Toxicariis E Mundo Novo Tropicale Commentationes XV: Desfontainia: A New Andean Hallucinogen","year":"1977","cit":4,"pfa":"Richard Evans Schultes","ptype":"article","src":"https://openalex.org/W3202762479","eid":"W3202762479"},{"id":"paper-w2152977557","cat":"papers","name":"Psychedelic Drug Use on the Canadian Pacific Coast—Notes on the New Drug Scene","year":"1969","cit":4,"pfa":"Ingeborg Paulus","ptype":"article","src":"https://openalex.org/W2152977557","eid":"W2152977557"},{"id":"paper-w2940770629","cat":"papers","name":"Alteration of drug-metabolizing enzyme activity in palliative care patients: Microdosed assessment of cytochrome P450 3A","year":"2019","cit":4,"pfa":"Marcus J. P. Geist","psa":"Gerd Mikus","topics":["Addiction","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2940770629","eid":"W2940770629"},{"id":"paper-w2054525312","cat":"papers","name":"Comparison of microdose and standard doses of GnRH analogue in flare protocols for controlled ovarian hyperstimulation in poor responders.","year":"2001","cit":4,"pfa":"Kayhan Yakın","psa":"Necati Fındıklı","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2054525312","eid":"W2054525312"},{"id":"paper-w4404501621","cat":"papers","name":"Registered Nurses' Knowledge and Attitudes Towards Psychedelics in Healthcare: Statewide Survey Results","year":"2024","cit":4,"pfa":"Anna Graefe","psa":"Carolyn M. Porta","topics":["Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4404501621","eid":"W4404501621"},{"id":"paper-w3034249793","cat":"papers","name":"Mineral Fertilizer Microdosing Alone or Combined with Urea on Maize and According to the Soil Chemical Elements Variation (Thies, Senegal)","year":"2020","cit":4,"pfa":"Rabi Housseini Malam Laminou","psa":"Aliou Guissé","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3034249793","eid":"W3034249793"},{"id":"paper-w4412883205","cat":"papers","name":"Psychedelics meet human brain organoids: insights into proteomics and potential for Alzheimer’s disease treatment","year":"2025","cit":4,"pfa":"Xenia Androni","psa":"Vasiliki Mahairaki","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4412883205","eid":"W4412883205"},{"id":"paper-w2009160805","cat":"papers","name":"14C sample preparation for AMS microdosing studies at Lund University using online combustion and septa-sealed vials","year":"2009","cit":4,"pfa":"Marie Sydoff","psa":"Kristina Eriksson Stenström","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2009160805","eid":"W2009160805"},{"id":"paper-w4401152982","cat":"papers","name":"From chaos to kaleidoscope: Exploring factors in psychedelic self-treatment for mental health conditions","year":"2024","cit":4,"pfa":"Claire Walker","psa":"Cheneal Puljević","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4401152982","eid":"W4401152982"},{"id":"paper-w2532674082","cat":"papers","name":"Preclinical Characterization and Human Microdose Pharmacokinetics of ITMN-8187, a Nonmacrocyclic Inhibitor of the Hepatitis C Virus NS3 Protease","year":"2016","cit":4,"pfa":"Ravi Rajagopalan","psa":"Brad O. Buckman","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2532674082","eid":"W2532674082"},{"id":"paper-w2888844522","cat":"papers","name":"Toward Predicting Acute Myeloid Leukemia Patient Response to 7 + 3 Induction Chemotherapy via Diagnostic Microdosing","year":"2018","cit":4,"pfa":"Tiffany M. Scharadin","psa":"Brian Andrew Jonas","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2888844522","eid":"W2888844522"},{"id":"paper-w4293240964","cat":"papers","name":"Observations on 25 Years of Cannabis Law Reforms and Their Implications for the Psychedelic Renaissance in the United States","year":"2022","cit":4,"pfa":"Robert A. Mikos","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"review","src":"https://openalex.org/W4293240964","eid":"W4293240964"},{"id":"paper-w2419752762","cat":"papers","name":"Building of a Conservation Breeding Facility for the Psychedelic Rock Gecko (Cnemaspis psychedelica) in Southern Vietnam","year":"2016","cit":4,"pfa":"Thomas Ziegler","psa":"Truong Quang Nguyen","ptype":"article","src":"https://openalex.org/W2419752762","eid":"W2419752762"},{"id":"paper-w2267835642","cat":"papers","name":"SEQUENTIAL EFFECTS OF MINIMUM TILLAGE, SEED PRIMING, FERTILIZER MICRODOSING AND MULCHING IN MAIZE, SEMIARID CENTRAL RIFT VALLEY OF ETHIOPIA","year":"2015","cit":4,"pfa":"Getachew Sime","psa":"Jens B. Aune","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2267835642","eid":"W2267835642"},{"id":"paper-w4404117718","cat":"papers","name":"Construction of an electrochemical aptamer-based sensors for rapid quantification of the anticancer drug imatinib in blood to improve drug bioavailability at microdoses","year":"2024","cit":4,"pfa":"Sai-Nan Qin","psa":"Jian‐Jun Sun","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4404117718","eid":"W4404117718"},{"id":"paper-w4392604398","cat":"papers","name":"Robust Methods For Quantifying Neuronal Morphology And Molecular Signaling Reveal That Psychedelics Do Not Induce Neuroplasticity","year":"2024","cit":4,"pfa":"Umed Boltaev","psa":"Dalibor Sameš","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4392604398","eid":"W4392604398"},{"id":"paper-w2060071489","cat":"papers","name":"Endogenous gonadotropin flare following microdose leuprolide (MDL) stimulation protocol does not correlate with in vitro fertilization (IVF) outcome","year":"2010","cit":4,"pfa":"J.S. Mann","psa":"JOHN C. NULSEN","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2060071489","eid":"W2060071489"},{"id":"paper-w4376616415","cat":"papers","name":"A phase 1 study to investigate the absorption, distribution, metabolism and excretion of brepocitinib in healthy males using a 14C‐microdose approach","year":"2023","cit":4,"pfa":"Ruolun Qiu","psa":"Martin E. Dowty","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4376616415","eid":"W4376616415"},{"id":"paper-w4283171286","cat":"papers","name":"Studying Close Entity Encounters of the Psychedelic Kind: Insights from the Cognitive Evolutionary Science of Religion","year":"2022","cit":4,"pfa":"F. LeRon Shults","ptype":"article","src":"https://openalex.org/W4283171286","eid":"W4283171286"},{"id":"paper-w4365998167","cat":"papers","name":"Commentary: Evidence-Informed Recommendation to Achieve Approximate Parity in the Allowed Number of Doses for Common Psychedelics","year":"2023","cit":4,"pfa":"Kelan L. H. Thomas","psa":"Brian T. Anderson","topics":["Addiction","Dosing & pharmacology","Policy & ethics"],"ptype":"editorial","src":"https://openalex.org/W4365998167","eid":"W4365998167"},{"id":"paper-w2114428325","cat":"papers","name":"The Implications of Psychedelic Drug Research for Integration and Sealing Over as Recovery Styles from Acute Psychosis","year":"1978","cit":4,"pfa":"John Rhead","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2114428325","eid":"W2114428325"},{"id":"paper-w3090243975","cat":"papers","name":"Development and validation of an ultrasensitive LC–MS/MS method for the quantification of cetagliptin in human plasma and its application in a microdose clinical trial","year":"2020","cit":4,"pfa":"Haihong Bai","psa":"Xinghe Wang","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3090243975","eid":"W3090243975"},{"id":"paper-w4309778430","cat":"papers","name":"Psychedelic/entactogen-assisted therapy for treatment of anxiety, depression and existential distress in adult palliative care","year":"2022","cit":4,"pfa":"Sivan Schipper","psa":"Christopher S. Boehlke","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4309778430","eid":"W4309778430"},{"id":"paper-w4391018088","cat":"papers","name":"Effect of Bulky N-Dibenzofuranylmethyl Substitution on the 5-HT2 Receptor Affinity and Efficacy of a Psychedelic Phenethylamine","year":"2024","cit":4,"pfa":"Breno A. Soares","psa":"Bruce K. Cassels","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4391018088","eid":"W4391018088"},{"id":"paper-w2417652823","cat":"papers","name":"Reply letter: Mental health of people who have used classical psychedelics and no other illicit drugs.","year":"2015","cit":4,"pfa":"Teri Suzanne Krebs","psa":"Pål-Ørjan Johansen","ptype":"letter","src":"https://openalex.org/W2417652823","eid":"W2417652823"},{"id":"paper-w4395465052","cat":"papers","name":"Perceptions of psychedelic use by adults in the United States: Perceived psychospiritual benefits and risks, including spiritual struggles.","year":"2024","cit":4,"pfa":"Julie Juola Exline","psa":"Kathleen C. Pait","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4395465052","eid":"W4395465052"},{"id":"paper-w3144080048","cat":"papers","name":"Time-trends in cocaine, hallucinogen, amphetamine, and sedative/anxiolytic/hypnotic use disorder hospitalizations in rheumatic diseases: a national time-trends study","year":"2021","cit":4,"pfa":"Jasvinder A. Singh","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W3144080048","eid":"W3144080048"},{"id":"paper-w3164785658","cat":"papers","name":"IVF Outcomes of Microdose Flare-up, GnRH Antagonist, and Long Protocols in Patients having a Poor Ovarian Response in the First Treatment Cycle","year":"2021","cit":4,"pfa":"Erhan Demirdağ","psa":"Mehmet Erdem","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3164785658","eid":"W3164785658"},{"id":"paper-w4285076866","cat":"papers","name":"Rapid-acting antidepressants in psychiatry: psychedelics, episodic treatments, innovation, and clarion call for methodologic rigor in drug development","year":"2022","cit":4,"pfa":"Roger S. McIntyre","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4285076866","eid":"W4285076866"},{"id":"paper-w144900623","cat":"papers","name":"Psychotomimetic Drugs in Man","year":"1978","cit":4,"pfa":"Leo E. Hollister","ptype":"book-chapter","src":"https://openalex.org/W144900623","eid":"W144900623"},{"id":"paper-w2105513601","cat":"papers","name":"Clinical and endocrine impact of pretreatment with oral contraceptive pills in poor responders undergoing IVF with a combination of microdose flare leuprolide acetate and high dose gonadotropins","year":"2003","cit":4,"pfa":"Sebastián Mirkin","psa":"Sergio Oehninger","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2105513601","eid":"W2105513601"},{"id":"paper-w4387310531","cat":"papers","name":"Psychedelics sea slugs: Observations on colour ontogeny in two nudibranch species from the genus Nembrotha (Doridina: Polyceridae)","year":"2023","cit":4,"pfa":"Marta Pola","psa":"Juan Lucas Cervera","ptype":"article","src":"https://openalex.org/W4387310531","eid":"W4387310531"},{"id":"paper-w3036581123","cat":"papers","name":"Stable Isotopically Labeled Intravenous Microdose Pharmacokinetic Trials as a Tool to Assess Absolute Bioavailability: Feasibility and Paradigm to Apply for Protein Kinase Inhibitors in Oncology","year":"2020","cit":4,"pfa":"Jeroen Roosendaal","psa":"Jos H. Beijnen","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3036581123","eid":"W3036581123"},{"id":"paper-w4411991482","cat":"papers","name":"Should we skip the trip? Clinical implications of psychedelic-associated subjective effects and the potential role of non-hallucinogenic alternatives","year":"2025","cit":4,"pfa":"Kush V. Bhatt","psa":"Stephen M. Stahl","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4411991482","eid":"W4411991482"},{"id":"paper-w4406249067","cat":"papers","name":"Microdose Cocktail Study Reveals the Activity and Key Influencing Factors of OATP1B , P‐Gp, BCRP, and CYP3A in End‐Stage Renal Disease Patients","year":"2025","cit":4,"pfa":"Weijie Kong","psa":"Dongyang Liu","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4406249067","eid":"W4406249067"},{"id":"paper-w3111930447","cat":"papers","name":"A simple method for assessing the psychotomimetic activity of the substituted phenethylamines","year":"2020","cit":4,"pfa":"Mohammad Hossein Keshavarz","psa":"Mohammad Ali Rezayat","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W3111930447","eid":"W3111930447"},{"id":"paper-w3164344005","cat":"papers","name":"Dissolving yourself in connection to others: shared experiences of ego attenuation and connectedness during group VR experiences can be comparable to psychedelics","year":"2021","cit":4,"pfa":"David R. Glowacki","psa":"Mike Chatziapostolou","ptype":"preprint","src":"https://openalex.org/W3164344005","eid":"W3164344005"},{"id":"paper-w2075521177","cat":"papers","name":"Has Alcohol Psychotomimetic and Convulsant Properties?","year":"1974","cit":4,"pfa":"David H. Marjot","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2075521177","eid":"W2075521177"},{"id":"paper-w4237402900","cat":"papers","name":"Synthesis of compounds with potential psychotomimetic activity. IV","year":"1968","cit":4,"pfa":"Edward R. Freiter","psa":"Leo G. Abood","ptype":"article","src":"https://openalex.org/W4237402900","eid":"W4237402900"},{"id":"paper-w2064861288","cat":"papers","name":"Choline Antagonism to Indolic Psychotomimetic Compounds","year":"1960","cit":4,"pfa":"Herbert Sprince","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2064861288","eid":"W2064861288"},{"id":"paper-w4299940751","cat":"papers","name":"Microdose intrauterine levonorgestrel for contraception. World Health Organization Special Programme of Research, Development and Research Training in Human Reproduction: Task Force on Intrauterine Devices for Fertility","year":"1987","cit":4,"topics":["Safety & adverse events","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4299940751","eid":"W4299940751"},{"id":"paper-w2082291207","cat":"papers","name":"Development of a Highly Sensitive Methodology for Quantitative Determination of Fexofenadine in a Microdose Study by Multiple Injection Method Using Ultra-High Performance Liquid Chromatography with Tandem Mass Spectrome","year":"2012","cit":4,"pfa":"Yukari Tanaka","psa":"Hiroyuki Yasui","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2082291207","eid":"W2082291207"},{"id":"paper-w4409360702","cat":"papers","name":"Feel connected to create: Self-reported psychedelic drug users exhibit higher sense of connectedness and better divergent thinking skills compared to non-users","year":"2025","cit":4,"pfa":"Christian Rominger","psa":"Carolina Subow","ptype":"article","src":"https://openalex.org/W4409360702","eid":"W4409360702"},{"id":"paper-w2004739453","cat":"papers","name":"Psychotomimetic drugs, animal behavior, and human psychopathology","year":"1972","cit":4,"pfa":"Wagner H. Bridger","ptype":"article","src":"https://openalex.org/W2004739453","eid":"W2004739453"},{"id":"paper-w2746400439","cat":"papers","name":"Melanoma and chronic exposure to contraceptives containing microdoses of ethinylestradiol in young women: a retrospective study from the Research on Adverse Drug Events and Reports ( RADAR ) project comprising a large Mi","year":"2017","cit":4,"pfa":"Kelly A. Mueller","psa":"D. P. West","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2746400439","eid":"W2746400439"},{"id":"paper-w4282962986","cat":"papers","name":"Abstract CT139: Intratumoral (IT) microdosing of the investigational SUMOylation Inhibitor TAK-981 in a phase 0 CIVO trial demonstrates the reactivation of type I Interferon (IFN1) signaling in head and neck squamous cel","year":"2022","cit":4,"pfa":"Jeffrey J. Houlton","psa":"Karuppiah Kannan","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W4282962986","eid":"W4282962986"},{"id":"paper-w2072932257","cat":"papers","name":"A benzilate ester of pyrrolizidine and its stereochemical relationship to other psychotomimetic glycolates","year":"1974","cit":4,"pfa":"Daniel D. Sternbach","psa":"Wayne P. Hoss","ptype":"article","src":"https://openalex.org/W2072932257","eid":"W2072932257"},{"id":"paper-w4252834132","cat":"papers","name":"Abdominal and Thoracic Surgery in Adults With Ketamine, Nitrous Oxide, and d-Tubocurarine","year":"1974","cit":4,"pfa":"Robert W. Vaughan","psa":"C. Ronald Stephen","ptype":"article","src":"https://openalex.org/W4252834132","eid":"W4252834132"},{"id":"paper-w4237134472","cat":"papers","name":"Drug Discrimination and In Vivo Structure–Activity Relationships","year":"2011","cit":4,"pfa":"Richard A. Glennon","psa":"Richard Young","topics":["Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W4237134472","eid":"W4237134472"},{"id":"paper-w2105202907","cat":"papers","name":"Psychiatric and Physiological Reactions Produced by Over-the-Counter Medications","year":"1978","cit":4,"pfa":"Richard C.W. Hall","psa":"Betty J. Pfefferbaum","ptype":"article","src":"https://openalex.org/W2105202907","eid":"W2105202907"},{"id":"paper-w4232002315","cat":"papers","name":"Gnostic Psychedelia","year":"2020","cit":4,"pfa":"Erik W. Davis","ptype":"article","src":"https://openalex.org/W4232002315","eid":"W4232002315"},{"id":"paper-w2070540004","cat":"papers","name":"Alpinism: The Social, Scientific and Treatment Aspect of Getting High and Its Prohibition","year":"1978","cit":4,"pfa":"Hugh Cann Phallov","ptype":"article","src":"https://openalex.org/W2070540004","eid":"W2070540004"},{"id":"paper-w2743398450","cat":"papers","name":"Entheogenesis: Toward an Expanded Worldview for Our Time","year":"2017","cit":4,"pfa":"Ralph Metzner","ptype":"article","src":"https://openalex.org/W2743398450","eid":"W2743398450"},{"id":"paper-w4392199267","cat":"papers","name":"Method development for 14C-labeling of IgG antibodies in preparation for clinical trials","year":"2024","cit":4,"pfa":"Soo‐Young Kim","psa":"Soonsil Hyun","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4392199267","eid":"W4392199267"},{"id":"paper-w2093360993","cat":"papers","name":"The Cost of Heroin to the Addict and the Community","year":"1971","cit":4,"pfa":"Steven E. Lerner","psa":"Irving Klompus","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2093360993","eid":"W2093360993"},{"id":"paper-w1965295583","cat":"papers","name":"Risk of Psychoactive Substance Dependence Among Substance Users in a Trauma Inpatient Population","year":"2007","cit":4,"pfa":"Silvia Saboia Martins","psa":"David A. Gorelick","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1965295583","eid":"W1965295583"},{"id":"paper-w2073548500","cat":"papers","name":"COLLEGE STUDENTS AND LSD","year":"1973","cit":4,"pfa":"Herbert Hendin","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2073548500","eid":"W2073548500"},{"id":"paper-w2034529391","cat":"papers","name":"Some Pharmacological Perspectives on the Opiate Narcotics with Special Consideration of Heroin","year":"1971","cit":4,"pfa":"George R. Gay","psa":"E. Leong Way","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2034529391","eid":"W2034529391"},{"id":"paper-w2045943872","cat":"papers","name":"The neuropharmacology of inadvertent drug effects in patients with traumatic brain injuries","year":"1990","cit":4,"pfa":"Thomas GuaUieri","topics":["PTSD & trauma","Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2045943872","eid":"W2045943872"},{"id":"paper-w4317908150","cat":"papers","name":"Binding and functional structure-activity similarities of 4-substituted 2,5-dimethoxyphenyl isopropylamine analogues at 5-HT2A and 5-HT2B serotonin receptors","year":"2023","cit":4,"pfa":"Prithvi Hemanth","psa":"Maƚgorzata Dukat","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4317908150","eid":"W4317908150"},{"id":"paper-w4405310872","cat":"papers","name":"Psychedelika in der Psychiatrie: eine offene Debatte","year":"2024","cit":4,"pfa":"Uwe Herwig","psa":"Stefan Borgwardt","topics":["Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4405310872","eid":"W4405310872"},{"id":"paper-w2105861331","cat":"papers","name":"Treatment Techniques for Narcotic Withdrawal With Special Reference to Mixed Narcotic-Sedative Addictions","year":"1971","cit":4,"pfa":"Donald R. Wesson","psa":"David Eugene Smith","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2105861331","eid":"W2105861331"},{"id":"paper-w2025702964","cat":"papers","name":"Hypnosis, Depth Perception and Schizophrenia","year":"1971","cit":4,"pfa":"Bernard S. Aaronson","ptype":"article","src":"https://openalex.org/W2025702964","eid":"W2025702964"},{"id":"paper-w4406321070","cat":"papers","name":"Validity, reliability and clinical utility of ASSIST-Y in assessing risk of substance-related harm and dependence in Spanish male adolescents","year":"2025","cit":4,"pfa":"Nuria Ibañez-Martinez","psa":"Robert L. Ali","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4406321070","eid":"W4406321070"},{"id":"paper-w4293577359","cat":"papers","name":"Emerging drugs for the treatment of major depressive disorder","year":"2022","cit":4,"pfa":"Jennifer Hong","psa":"Stephen Stahl","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4293577359","eid":"W4293577359"},{"id":"paper-w2059119113","cat":"papers","name":"Identifying the Substance Abuser in Clinical Practice","year":"1992","cit":4,"pfa":"Kitty Bell","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2059119113","eid":"W2059119113"},{"id":"paper-w2129242","cat":"papers","name":"How to spot illicit drug abuse in your patients","year":"1999","cit":4,"pfa":"Michael D. Johnson","psa":"Clarke St. Dennis","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2129242","eid":"W2129242"},{"id":"paper-w4200093548","cat":"papers","name":"Turkish Disco: The Intersection of Anatolian Pop, Groove and Psychedelia","year":"2021","cit":4,"pfa":"Yaprak Melike Uyar","ptype":"article","src":"https://openalex.org/W4200093548","eid":"W4200093548"},{"id":"paper-w4414677590","cat":"papers","name":"Plyometric jump training micro- and high-dose effects on amateur basketball players athletic performance: a randomized controlled trial","year":"2025","cit":4,"pfa":"Bitai Wu","psa":"Ken Zhang","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4414677590","eid":"W4414677590"},{"id":"paper-w2405181546","cat":"papers","name":"[Bladder pain and urinary tract symptoms as a consequence of ketamine abuse].","year":"2014","cit":4,"pfa":"Susanne Reinhardt","psa":"Mikkel Mejlgaard Fode","ptype":"article","src":"https://openalex.org/W2405181546","eid":"W2405181546"},{"id":"paper-w4256073855","cat":"papers","name":"ASAM Handbook of Addiction Medicine","year":"2020","cit":4,"topics":["Addiction","Dosing & pharmacology","Policy & ethics"],"ptype":"book","src":"https://openalex.org/W4256073855","eid":"W4256073855"},{"id":"paper-w4405412668","cat":"papers","name":"Editorial: Biological Therapies and Eating Disorders","year":"2024","cit":4,"pfa":"Hubertus Himmerich","psa":"Sabrina Mörkl","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"editorial","src":"https://openalex.org/W4405412668","eid":"W4405412668"},{"id":"paper-w4378232277","cat":"papers","name":"Endocannabinoid system components as potential neuroimmune therapeutic targets in tinnitus","year":"2023","cit":4,"pfa":"Vishweshwara Bhat","psa":"Venkatanarayanan Sharma","topics":["Safety & adverse events","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4378232277","eid":"W4378232277"},{"id":"paper-w2897802193","cat":"papers","name":"PHYTOCHEMISTRY AND PHARMACOLOGICAL PROFILE OF TRADITIONALLY USED MEDICINAL PLANT ARGYREIA SPECIOSA (LINN. F.)","year":"2018","cit":4,"pfa":"Bhagat Singh Jaiswal","psa":"Mukul Tailang","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2897802193","eid":"W2897802193"},{"id":"paper-w4402726443","cat":"papers","name":"Learning how to make use of dissociative therapies","year":"2024","cit":4,"pfa":"David S. Mathai","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4402726443","eid":"W4402726443"},{"id":"paper-w2282407960","cat":"papers","name":"Cervical mucus changes and urinary hormone excretion patterns in progestagen-treated patients.","year":"1970","cit":4,"pfa":"Max Elstein","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2282407960","eid":"W2282407960"},{"id":"paper-w2051031152","cat":"papers","name":"QSAR studies of hallucinogenic phenylalkylamines by using neural network and support vector machine approaches","year":"2010","cit":4,"pfa":"Zhuoyong Zhang","psa":"Liying An","topics":["Mechanism & neuroscience"],"ptype":"conference-paper","src":"https://openalex.org/W2051031152","eid":"W2051031152"},{"id":"paper-w4311135311","cat":"papers","name":"Hemodialysis treatment for poisoning patients in the emergency department","year":"2022","cit":4,"pfa":"Ugur Orhan","psa":"Gökben Oral Sonmez","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4311135311","eid":"W4311135311"},{"id":"paper-w2415651933","cat":"papers","name":"Comparative efficacy of different insecticides in the treatment of cattle hypodermosis in north-eastern Algeria.","year":"1998","cit":4,"pfa":"Ahmed Benakhla","psa":"Djamel Eddine Benouareth","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2415651933","eid":"W2415651933"},{"id":"paper-w2587429336","cat":"papers","name":"A Coaxial Double Cylindrical TEPC for the Microdosimetry of Selected Neutron Energy Bands in Mixed Fields of Fast Neutrons","year":"1990","cit":4,"pfa":"Elias B Saion","psa":"Paolo Colautti","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2587429336","eid":"W2587429336"},{"id":"paper-w2186393936","cat":"papers","name":"A Brief Summary for 5-HT Receptors","year":"2013","cit":4,"pfa":"Watry S and Lu J","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2186393936","eid":"W2186393936"},{"id":"paper-w4416396720","cat":"papers","name":"Physiologically‐Based Pharmacokinetic Modeling to Support Pediatric Clinical Development: An IQ Working Group Perspective on the Current Status and Challenges","year":"2025","cit":4,"pfa":"James W.T. Yates","psa":"S. Y. Amy Cheung","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4416396720","eid":"W4416396720"},{"id":"paper-w4220665153","cat":"papers","name":"NBOMe Toxicity and Fatalities: A Review of the Literature","year":"2022","cit":4,"pfa":"Matthew Lipow","psa":"Eduardo D Espiridion","topics":["PTSD & trauma","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4220665153","eid":"W4220665153"},{"id":"paper-w2097249491","cat":"papers","name":"Understanding Substance Addictions: Assessment and Intervention,","year":"2005","cit":4,"pfa":"N. Wood","topics":["Depression","Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2097249491","eid":"W2097249491"},{"id":"paper-w4413117404","cat":"papers","name":"Antipsychotic Potential of Opioids: Rethinking Substance-Induced Psychosis and Treatment Stratification","year":"2025","cit":4,"pfa":"Angelo Giovanni Icro Maremmani","psa":"Icro Maremmani","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4413117404","eid":"W4413117404"},{"id":"paper-w4301837282","cat":"papers","name":"Endogenous ketamine-like compounds and the NDE: If so, so what?","year":"1997","cit":4,"pfa":"Rick J. Strassman","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4301837282","eid":"W4301837282"},{"id":"paper-w4409304622","cat":"papers","name":"Exploring a Druggable Hydrophobic Tunnel in the 5-HT2A Receptor with Potent Phenethylamines","year":"2025","cit":4,"pfa":"Ícaro A. Simon","psa":"Christian B. M. Poulie","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4409304622","eid":"W4409304622"},{"id":"paper-w4411400973","cat":"papers","name":"Design, Synthesis, and In Vitro Characterization of a Tryptamine-Based Visible-Light Photoswitchable 5-HT 2A R Ligand Showing Efficacy Preference for β-Arrestin over Mini-Gq","year":"2025","cit":4,"pfa":"Alexandra Sink","psa":"Michael W. Decker","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4411400973","eid":"W4411400973"},{"id":"paper-w2007676286","cat":"papers","name":"Structure-activity relationships of phenylethylamine analogs in their serotonergic depressant effects on the spinal monosynaptic reflex in rats.","year":"1989","cit":4,"pfa":"Hideki ONO","psa":"Masaaki Hirobe","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2007676286","eid":"W2007676286"},{"id":"paper-w4409880118","cat":"papers","name":"Liquid chromatography–tandem mass spectrometry–based pharmacokinetic and metabolic analysis of 4-bromo-2,5-dimethoxyphenethylamine and its metabolites in human plasma","year":"2025","cit":4,"pfa":"Jan Thomann","psa":"Dino Luethi","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4409880118","eid":"W4409880118"},{"id":"paper-w2789392390","cat":"papers","name":"Clinical testing of three novel transient receptor potential cation channel subfamily V member 1 antagonists in a pharmacodynamic intradermal capsaicin model","year":"2018","cit":4,"pfa":"Erik Sjögren","psa":"Anna K. Sundgren‐Andersson","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2789392390","eid":"W2789392390"},{"id":"paper-w4392555168","cat":"papers","name":"Assessing the relative contribution of CYP3A-and P-gp-mediated pathways to the overall disposition and drug-drug interaction of dabigatran etexilate using a comprehensive mechanistic physiological-based pharmacokinetic m","year":"2024","cit":4,"pfa":"Udomsak Udomnilobol","psa":"Thomayant Prueksaritanont","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4392555168","eid":"W4392555168"},{"id":"paper-w4413024974","cat":"papers","name":"Neuroplasticity in Post-Traumatic Stress Disorder","year":"2025","cit":4,"pfa":"Beatriz López-López","psa":"Inmaculada Crespo","topics":["PTSD & trauma","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4413024974","eid":"W4413024974"},{"id":"paper-w647697819","cat":"papers","name":"Mind, Brain, and Drug: An Introduction to Psychopharmacology","year":"2005","cit":4,"pfa":"William O. Dawson","psa":"Colin M. Burchfield","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"book","src":"https://openalex.org/W647697819","eid":"W647697819"},{"id":"paper-w4327573057","cat":"papers","name":"Sexual minority status, illicit drug use, and depressive symptoms","year":"2023","cit":4,"pfa":"Jonathan K. Noel","psa":"Samantha R. Rosenthal","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4327573057","eid":"W4327573057"},{"id":"paper-w4389199229","cat":"papers","name":"Sex Differences in the Acute Effects of Oral THC: A Randomized, Placebo-Controlled, Crossover Human Laboratory Study","year":"2023","cit":4,"pfa":"Ardavan Mohammad Aghaei","psa":"Mohini Ranganathan","topics":["Addiction","Dosing & pharmacology","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4389199229","eid":"W4389199229"},{"id":"paper-w4417449335","cat":"papers","name":"Rethinking Treatment-Resistant Depression: A Systematic Review of Novel Therapeutic Strategies and Precision Medicine Approaches","year":"2025","cit":4,"pfa":"Safiye Zeynep Tatlı","psa":"Murat İlhan Atagün","topics":["Depression","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4417449335","eid":"W4417449335"},{"id":"paper-w4401624374","cat":"papers","name":"Empowering understanding: navigating consent to ketamine treatment in adolescent mental health","year":"2024","cit":4,"pfa":"Aakash V. Sathappan","psa":"Benjamin Yudkoff","topics":["Depression","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4401624374","eid":"W4401624374"},{"id":"paper-w4416859822","cat":"papers","name":"Relapse risk, frustration tolerance, and motivational readiness for change in substance use disorders","year":"2025","cit":4,"pfa":"Ahmed Zaher","psa":"Fatma Mohammed Ibrahim","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4416859822","eid":"W4416859822"},{"id":"paper-w2084851080","cat":"papers","name":"P03-145 - Addiction Syndrome in Schizophrenia: One Independent Dimension","year":"2010","cit":4,"pfa":"M.L. Vargas","psa":"S. Lopez","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2084851080","eid":"W2084851080"},{"id":"paper-w4386704031","cat":"papers","name":"A comprehensive evaluation of adverse childhood experiences, social–emotional impairments, and neurodevelopmental disorders in cannabis-use disorder: Implications for clinical practice","year":"2023","cit":4,"pfa":"Giada Trovini","psa":"Sergio De Filippis","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4386704031","eid":"W4386704031"},{"id":"paper-w2265447152","cat":"papers","name":"Evaluation of Addiction among Students in First Year of a French University","year":"2016","cit":4,"pfa":"Godet Andrea","psa":"Godet Sébastien","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2265447152","eid":"W2265447152"},{"id":"paper-w2345062715","cat":"papers","name":"25I-NBOMe: The legal LSD","year":"2016","cit":4,"pfa":"I. Ezquiaga","psa":"Magı́ Farré","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2345062715","eid":"W2345062715"},{"id":"paper-w4394767965","cat":"papers","name":"Early, precise, and safe clinical evaluation of the pharmacodynamic effects of novel agents in the intact human tumor microenvironment","year":"2024","cit":4,"pfa":"Kenneth R. Gundle","psa":"Richard A. Klinghoffer","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4394767965","eid":"W4394767965"},{"id":"paper-w1975185418","cat":"papers","name":"Open label, three period, single sequence, study of 5, 25, 50 mg sertraline pharmacokinetics in healthy male Korean volunteers","year":"2011","cit":4,"pfa":"Min Kyu Park","psa":"K‐S Yu","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1975185418","eid":"W1975185418"},{"id":"paper-w2161844493","cat":"papers","name":"The conservative connection: the chairman of the board took LSD before Timothy Leary.","year":"1980","cit":4,"pfa":"Eckard V. Toy","ptype":"other","src":"https://openalex.org/W2161844493","eid":"W2161844493"},{"id":"paper-w4411183850","cat":"papers","name":"Preclinical Pharmacokinetic Evaluation of Mithramycin and Mithramycin SA Tryptophan-Conjugated Analog","year":"2025","cit":4,"pfa":"Kumar Kulldeep Niloy","psa":"Markos L. Leggas","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4411183850","eid":"W4411183850"},{"id":"paper-w2909655882","cat":"papers","name":"Treatment Episode Data Set -- Admissions (TEDS-A), 2011","year":"2013","cit":4,"pfa":"United States Department Of Health And Human Services. Substance Abuse And…","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W2909655882","eid":"W2909655882"},{"id":"paper-w4243407091","cat":"papers","name":"Treatment Episode Data Set -- Admissions (TEDS-A) -- Concatenated, 1992 to 2010","year":"2009","cit":4,"pfa":"United States Department Of Health And Human Services. Substance Abuse And…","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W4243407091","eid":"W4243407091"},{"id":"paper-w4389060654","cat":"papers","name":"Intravenous Ketamine Exacerbating Symptoms of Acute Stress Disorder: A Case Report and Systematized Review of Existing Literature","year":"2023","cit":4,"pfa":"Charalambia Louka","psa":"Stephanie Chiao","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4389060654","eid":"W4389060654"},{"id":"paper-w4387856725","cat":"papers","name":"Opiate Receptors: Opioid Agonist‐Antagonist Effects","year":"1991","cit":4,"pfa":"DAVID J. GOLDSTEIN","psa":"James H. Meador‐Woodruff","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4387856725","eid":"W4387856725"},{"id":"paper-w4416177243","cat":"papers","name":"Central Nervous System Biodistribution and Pharmacokinetics of Radiolabeled Tofersen in Rodents, Nonhuman Primates, and Humans","year":"2025","cit":4,"pfa":"Brendon E. Cook","psa":"Luca Passamonti","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4416177243","eid":"W4416177243"},{"id":"paper-w4416608582","cat":"papers","name":"Developing a Standardised National Model of Care for Treatment of Peanut Allergy in Infants: The ADAPT Peanut Oral Immunotherapy Program","year":"2025","cit":4,"pfa":"Tim Brettig","psa":"Kirsten P. Perrett","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4416608582","eid":"W4416608582"},{"id":"paper-w4210874727","cat":"papers","name":"Treatment Episode Data Set -- Discharges (TEDS-D), 2010","year":"2013","cit":4,"pfa":"United States Department of Health and Human Services. Substance Abuse and…","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W4210874727","eid":"W4210874727"},{"id":"paper-w2470315347","cat":"papers","name":"Antipsychotic Drugs and Fitness to Stand Trial: The Right of the Unfit Accused to Refuse Treatment","year":"1985","cit":4,"pfa":"Steve Tomashefsky","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2470315347","eid":"W2470315347"},{"id":"paper-w2077371888","cat":"papers","name":"Synthesis and Brain Regional Distribution of [11C]NPS 1506 in Mice and Rat: an N-Methyl-D-aspartate (NMDA) Receptor Antagonist","year":"2003","cit":4,"pfa":"Takeshi Fuchigami","psa":"Minoru Maëda","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2077371888","eid":"W2077371888"},{"id":"paper-w2024817813","cat":"papers","name":"Effect of LSD-25 and 1-methyl-d-lysergic acid butanolamide on rat brain and platelet serotonin levels","year":"1974","cit":4,"pfa":"Michele Torre","psa":"Eugenio Torre","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2024817813","eid":"W2024817813"},{"id":"paper-w110009282","cat":"papers","name":"[Paroxysmal perceptual alteration in comparison with hallucination--a review of its clinical reports and discussion of its pathophysiological mechanism in the present day, when second generation antipsychotics are widely","year":"2009","cit":4,"pfa":"Ken Watanabe","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W110009282","eid":"W110009282"},{"id":"paper-w3100194029","cat":"papers","name":"Isoflurane produces antidepressant effects and induces TrkB signaling in rodents","year":"2016","cit":4,"pfa":"Hanna Antila","psa":"Tomi Rantamäki","topics":["Depression","Mechanism & neuroscience","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W3100194029","eid":"W3100194029"},{"id":"paper-w2901072671","cat":"papers","name":"The Role of Ketamine in Object Recognition Memory in Rodents","year":"2018","cit":4,"pfa":"Nikolaos Pitsikas","ptype":"book-chapter","src":"https://openalex.org/W2901072671","eid":"W2901072671"},{"id":"paper-w2552375956","cat":"papers","name":"On the Eve of Upgrading Antidepressants: (R)-Ketamine and Its Metabolites","year":"2016","cit":4,"pfa":"Kai Yuan","psa":"Lin Lü","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2552375956","eid":"W2552375956"},{"id":"paper-w1912763004","cat":"papers","name":"Blockade of growth hormone secretagogue receptor 1A signaling by JMV 2959 attenuates the NMDAR antagonist, phencyclidine-induced impairments in prepulse inhibition","year":"2015","cit":4,"pfa":"Jörgen A. Engel","psa":"Emil Egecioglu","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1912763004","eid":"W1912763004"},{"id":"paper-w3179372652","cat":"papers","name":"Impaired discrimination of a subanesthetic dose of ketamine in a maternal immune activation model of schizophrenia risk","year":"2021","cit":4,"pfa":"Wayne Meighan","psa":"Ryan D. Ward","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3179372652","eid":"W3179372652"},{"id":"paper-w3003815617","cat":"papers","name":"Amphetamine promotes cortical Up state: Role of adrenergic receptors","year":"2020","cit":4,"pfa":"Guofang Shen","psa":"Wei‐Xing Shi","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3003815617","eid":"W3003815617"},{"id":"paper-w4411142297","cat":"papers","name":"Computational modeling of ketamine-induced changes in gamma-band oscillations: The contribution of parvalbumin and somatostatin interneurons","year":"2025","cit":4,"pfa":"Jessie Rademacher","psa":"Peter J. Uhlhaas","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4411142297","eid":"W4411142297"},{"id":"paper-w4385319037","cat":"papers","name":"The Impact of Muscarinic Antagonism on Psychosis-Relevant Behaviors and Striatal [11C] Raclopride Binding in Tau Mouse Models of Alzheimer’s Disease","year":"2023","cit":4,"pfa":"Heidy T. Jimenez","psa":"Jeremy L. Koppel","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4385319037","eid":"W4385319037"},{"id":"paper-w4280582049","cat":"papers","name":"Ketamine increases fronto-posterior functional connectivity during meta-perceptual confidence ratings","year":"2022","cit":4,"pfa":"Mirko Lehmann","psa":"Ulrich Ettinger","ptype":"article","src":"https://openalex.org/W4280582049","eid":"W4280582049"},{"id":"paper-w2465710758","cat":"papers","name":"Recent Topics of Phencyclidine, the Drug Induces Psychosis","year":"1987","cit":4,"pfa":"Toshitaka Nabeshima","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2465710758","eid":"W2465710758"},{"id":"paper-w4254580375","cat":"papers","name":"Glutamate pharmacology and the treatment of schizophrenia","year":"1995","cit":4,"pfa":"Carol A. Tamminga","psa":"Adrienne Carol Lahti","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4254580375","eid":"W4254580375"},{"id":"paper-w1997785988","cat":"papers","name":"Alprazolam Withdrawal Delirium and Brief Reversible Psychosis","year":"2014","cit":4,"pfa":"Ralph R. McKenzie","psa":"Taral R. Sharma","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W1997785988","eid":"W1997785988"},{"id":"paper-w4213054724","cat":"papers","name":"The CannTeen Study: Cannabis use disorder, depression, anxiety, and psychotic-like symptoms in adolescent and adult cannabis users and age-matched controls PRE-PRINT","year":"2022","cit":4,"pfa":"Will Lawn","psa":"Val Curran","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W4213054724","eid":"W4213054724"},{"id":"paper-w3194022193","cat":"papers","name":"Drug Addiction in Pakistan: A step towards alleviation of sufferings","year":"2021","cit":4,"pfa":"Ali Burhan Mustafa","psa":"Bisma Jamil Makhdoom","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3194022193","eid":"W3194022193"},{"id":"paper-w2171733967","cat":"papers","name":"Reply to: Acute Stress Symptoms Do Not Worsen in Posttraumatic Stress Disorder and Abuse with a Single Subanesthetic Dose of Ketamine","year":"2012","cit":4,"pfa":"Akira Kishimoto","psa":"Kenji Hashimoto","topics":["PTSD & trauma","Dosing & pharmacology"],"ptype":"letter","src":"https://openalex.org/W2171733967","eid":"W2171733967"},{"id":"paper-w1968500592","cat":"papers","name":"Low-dose ketamine with clonidine and midazolam for adult day care surgery","year":"2005","cit":4,"pfa":"Massimiliano Dalsasso","psa":"C. Ori","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W1968500592","eid":"W1968500592"},{"id":"paper-w2052008399","cat":"papers","name":"Opiate Receptor Revisited","year":"2007","cit":4,"pfa":"Solomon H. Snyder","psa":"David S. Warner","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2052008399","eid":"W2052008399"},{"id":"paper-w4389477764","cat":"papers","name":"Augmentation in depression: Esketamine, a new standard?","year":"2023","cit":4,"pfa":"Joshua Daniel Rosenblat","psa":"Roger S. McIntyre","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4389477764","eid":"W4389477764"},{"id":"paper-w4298129434","cat":"papers","name":"Pros and cons of esketamine treatment in psychiatry","year":"2022","cit":4,"pfa":"Gilmar Gutiérrez","psa":"Gustavo Héctor Vázquez","ptype":"article","src":"https://openalex.org/W4298129434","eid":"W4298129434"},{"id":"paper-w4400609209","cat":"papers","name":"Study on the antidepressant activity of (2R,6R; 2S,6S)-Hydroxynorketamine (HNK) and its derivatives","year":"2024","cit":4,"pfa":"Dongdong Zang","psa":"Zhen Tan","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4400609209","eid":"W4400609209"},{"id":"paper-w4394686703","cat":"papers","name":"A First Trimester Exposure to Ketamine and Esketamine for Depression","year":"2024","cit":4,"pfa":"Megan N. Kummerlowe","psa":"Hannah K. Betcher","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4394686703","eid":"W4394686703"},{"id":"paper-w3088489142","cat":"papers","name":"The Antisuicidal Effect of Esketamine Should Be Further Investigated","year":"2020","cit":4,"pfa":"Émilie Olié","psa":"Philippe Courtet","ptype":"article","src":"https://openalex.org/W3088489142","eid":"W3088489142"},{"id":"paper-w4406132717","cat":"papers","name":"Effects of repeated intravenous esketamine administration on affective biases","year":"2025","cit":4,"pfa":"Christine Reif-Leonhard","psa":"Asad Malik","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4406132717","eid":"W4406132717"},{"id":"paper-w4404413521","cat":"papers","name":"Splenic γδ T cells mediate antidepressant and prophylactic actions of arketamine in lipopolysaccharide-induced depression in mice","year":"2024","cit":4,"pfa":"Guilin Liu","psa":"Kenji Hashimoto","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4404413521","eid":"W4404413521"},{"id":"paper-w2994804114","cat":"papers","name":"Ketamine and esketamine for suicidal ideation: Recent progress and practical issues","year":"2019","cit":4,"pfa":"Francesco Bartoli","psa":"Samuel T Wlkinson","ptype":"article","src":"https://openalex.org/W2994804114","eid":"W2994804114"},{"id":"paper-w4408379139","cat":"papers","name":"Beneficial effects of Esketamine on Morphine preference reacquisition in male rats","year":"2025","cit":4,"pfa":"Murilo Barboza Fontoura","psa":"Marilise Escobar Bürger","ptype":"article","src":"https://openalex.org/W4408379139","eid":"W4408379139"},{"id":"paper-w4394951971","cat":"papers","name":"Effects of (2R,6R)-hydroxynorketamine in assays of acute pain-stimulated and pain-depressed behaviors in mice","year":"2024","cit":4,"pfa":"Todd M. Hillhouse","psa":"Joseph H. Porter","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4394951971","eid":"W4394951971"},{"id":"paper-w4417447533","cat":"papers","name":"Intestinal γδ T17–IL-17A signaling disrupts hippocampal mitophagy in stress-induced depression and is restored by arketamine","year":"2025","cit":4,"pfa":"Mengqi Han","psa":"Jiancheng Zhang","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4417447533","eid":"W4417447533"},{"id":"paper-w7125969573","cat":"papers","name":"Is the antidepressant efficacy of ketamine and esketamine mediated via opioid mechanisms?","year":"2026","cit":4,"pfa":"Andy Lu","psa":"Roger S. McIntyre","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7125969573","eid":"W7125969573"},{"id":"paper-w4412199576","cat":"papers","name":"Esketamine Optimized the Efficacy of Dexmedetomidine in Treating Sleep Disorders with Comorbid Depression","year":"2025","cit":4,"pfa":"Yitong Ding","psa":"Zhouquan Wu","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4412199576","eid":"W4412199576"},{"id":"paper-w4390743955","cat":"papers","name":"[Comparison of clinical effects and safety of remidazolam and esketamine for preoperative sedation in children].","year":"2023","cit":4,"pfa":"Mei‐Hwan Wu","psa":"N Cai","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4390743955","eid":"W4390743955"},{"id":"paper-w3193566133","cat":"papers","name":"Esketamine may be an ideal substitute for ketamine during cochlear function measurement","year":"2021","cit":4,"pfa":"Yufeng Li","psa":"Xia Shen","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3193566133","eid":"W3193566133"},{"id":"paper-w4403113406","cat":"papers","name":"The Resistant Depression Response to Esketamine Assessing Metabolomics (ReDREAM) Project-Untargeted Metabolomics to Identify Biomarkers of Treatment Response to Intranasal Esketamine in Individuals with Treatment-Resista","year":"2024","cit":4,"pfa":"Francesco Bartoli","psa":"Giuseppe Carrà","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4403113406","eid":"W4403113406"},{"id":"paper-w4413844021","cat":"papers","name":"Effects of esketamine on electrophysiology and metabolic reprogramming in brain organoids: insights into antidepressant mechanisms","year":"2025","cit":4,"pfa":"Mengjie Li","psa":"Shi Changhe","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4413844021","eid":"W4413844021"},{"id":"paper-w4410020262","cat":"papers","name":"Treatment-resistant depression and intranasal esketamine: Spanish clinical consensus on practical aspects","year":"2025","cit":4,"pfa":"Josep Antoni Ramos‐Quiroga","psa":"Eduard Vieta","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4410020262","eid":"W4410020262"},{"id":"paper-w4414710603","cat":"papers","name":"Esketamine 5 Years After Approval: Welcome New Data With Continuing Questions","year":"2025","cit":4,"pfa":"Alan F. Schatzberg","psa":"Konstantinos Ν. Fountoulakis","ptype":"article","src":"https://openalex.org/W4414710603","eid":"W4414710603"},{"id":"paper-w2953471810","cat":"papers","name":"PMH23 BUDGET IMPACT ANALYSIS OF ESKETAMINE IN TREATMENT-RESISTANT DEPRESSION IN THE UNITED STATES","year":"2019","cit":4,"pfa":"H.H. Le","psa":"John J. Sheehan","topics":["Depression"],"ptype":"conference-abstract","src":"https://openalex.org/W2953471810","eid":"W2953471810"},{"id":"paper-w4408126287","cat":"papers","name":"Effects of esketamine on postoperative pain and inflammatory factors in children undergoing tonsillectomy and adenoidectomy","year":"2025","cit":4,"pfa":"yuchang zhu","psa":"Yi Zhang","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4408126287","eid":"W4408126287"},{"id":"paper-w4388441159","cat":"papers","name":"Establishing an esketamine clinic in Australia: Practical recommendations and clinical guidance from an expert panel","year":"2023","cit":4,"pfa":"Nicollette L. R. Thornton","psa":"Dennis Liu","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4388441159","eid":"W4388441159"},{"id":"paper-w4409816588","cat":"papers","name":"Baseline perceived stress as a predictor of ketamine/esketamine treatment response in treatment-resistant depression","year":"2025","cit":4,"pfa":"Stefanie Cavalcanti","psa":"Balwinder Singh","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4409816588","eid":"W4409816588"},{"id":"paper-w4414673701","cat":"papers","name":"Combined Esketamine and Dexmedetomidine Decreases the Risk of Postoperative Delirium in Neurosurgical Pediatrics: A Randomized Controlled Trial","year":"2025","cit":4,"pfa":"Chen-Yu Wen","psa":"Ting Ding","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4414673701","eid":"W4414673701"},{"id":"paper-w4285819962","cat":"papers","name":"Effects of different dosages esketamine on cardiac conduction and heterogeneity of Cx43: the epicardial mapping in guinea pigs","year":"2022","cit":4,"pfa":"Ying Cao","psa":"Hong Zhi Gao","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4285819962","eid":"W4285819962"},{"id":"paper-w4411566911","cat":"papers","name":"Efficacy and safety of intraoperative esketamine for postoperative sleep quality: a systematic review and meta-analysis of RCTs","year":"2025","cit":4,"pfa":"Min Zeng","psa":"Ying Peng","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4411566911","eid":"W4411566911"},{"id":"paper-w4407416605","cat":"papers","name":"Effects of Esketamine on Haemodynamics and Inflammatory Stress Response in Elderly Patients Undergoing Proximal Femoral Surgery","year":"2025","cit":4,"pfa":"Xuandong Jia","psa":"Maitao Zhou","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4407416605","eid":"W4407416605"},{"id":"paper-w7128221526","cat":"papers","name":"Narrative Experiences of Esketamine-Induced Dissociation in Patients with Treatment-Resistant Depression: A Qualitative Exploratory Study","year":"2026","cit":4,"pfa":"Miriam Olivola","psa":"Bernardo Maria Dell’Osso","topics":["Depression","PTSD & trauma","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7128221526","eid":"W7128221526"},{"id":"paper-w4399010142","cat":"papers","name":"Esketamine induces tripartite motif-containing protein 24 to improve cognitive dysfunction in Alzheimer’s disease","year":"2024","cit":4,"pfa":"Yingbing Tu","psa":"Bin Xu","ptype":"article","src":"https://openalex.org/W4399010142","eid":"W4399010142"},{"id":"paper-w4285741094","cat":"papers","name":"Use of intranasal esketamine in a girl with treatment-resistant depression and autism spectrum disorders: a case report","year":"2022","cit":4,"pfa":"Miriam Olivola","psa":"Natascia Brondino","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4285741094","eid":"W4285741094"},{"id":"paper-w4409174427","cat":"papers","name":"Does BMI matter when treating depression with esketamine? A retrospective analysis of real-world data","year":"2025","cit":4,"pfa":"Mina Ansari","psa":"Sina Nikayin","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4409174427","eid":"W4409174427"},{"id":"paper-w4416543346","cat":"papers","name":"The role of frontal EEG in predicting clinical response of major depressive disorder to intranasal ketamine and esketamine","year":"2025","cit":4,"pfa":"Carlos Trenado","psa":"Stefano Ferrea","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4416543346","eid":"W4416543346"},{"id":"paper-w4415679865","cat":"papers","name":"The effects of ketamine and esketamine on functional outcomes in major depressive disorder and treatment-resistant depression: A systematic review","year":"2025","cit":4,"pfa":"Isabella S Ji","psa":"Roger S. McIntyre","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4415679865","eid":"W4415679865"},{"id":"paper-w2980974597","cat":"papers","name":"The Efficacy and Safety of Esketamine for the Treatment-Resistant Depression in Older Adults: Comments on TRANSFORM-3 Trial Results","year":"2019","cit":4,"pfa":"Helen Lavretsky","psa":"Steven P. Roose","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2980974597","eid":"W2980974597"},{"id":"paper-w4415612986","cat":"papers","name":"Efficacy and safety of esketamine on major depression, postpartum depression and perioperative depression: a systematic review and meta-analysis","year":"2025","cit":4,"pfa":"Chunxia Huang","psa":"Lin Lü","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4415612986","eid":"W4415612986"},{"id":"paper-w3113458052","cat":"papers","name":"Response to commentary on the comparative efficacy of esketamine vs. ketamine meta-analysis: Putting the cart before the horse?","year":"2020","cit":4,"pfa":"Anees Bahji","psa":"Carlos A. Zarate","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3113458052","eid":"W3113458052"},{"id":"paper-w4408068787","cat":"papers","name":"Six Years After Approval of Esketamine Nasal Spray for Serious Depression: Clinical Conundrums and Unanswered Questions","year":"2025","cit":4,"pfa":"Sanjay J. Mathew","psa":"Nicholas Murphy","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4408068787","eid":"W4408068787"},{"id":"paper-w4394740788","cat":"papers","name":"Effect of Esketamine on perioperative anxiety and depression in women with systemic tumors based on big data medical background.","year":"2024","cit":4,"pfa":"C-H Wang","psa":"Zhao Lx","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4394740788","eid":"W4394740788"},{"id":"paper-w4402766217","cat":"papers","name":"Effects of subanesthetic repeated esketamine infusions on memory function and NGF in patients with depression: An open-label study","year":"2024","cit":4,"pfa":"Qiongyao Yang","psa":"Kai Zhang","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4402766217","eid":"W4402766217"},{"id":"paper-w4412363451","cat":"papers","name":"Antidepressant effects of esketamine are associated with functional connectivity in the hippocampal subregion: A resting state magnetic resonance study","year":"2025","cit":4,"pfa":"Xiang Liu","psa":"Guangyao Wu","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4412363451","eid":"W4412363451"},{"id":"paper-w4311805846","cat":"papers","name":"The Incidental Resolution of Severe Alcohol Use Disorder during Esketamine Treatment of Major Depressive Disorder: A Case Report","year":"2022","cit":4,"pfa":"Zeeshan Faruqui","psa":"Christopher Kim","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4311805846","eid":"W4311805846"},{"id":"paper-w4395451921","cat":"papers","name":"Epidural dexmedetomidine or esketamine versus fentanyl to decrease ropivacaine use for labor analgesia: A randomized non-inferiority study","year":"2024","cit":4,"pfa":"Lifeng Ni","psa":"Jing Yu","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4395451921","eid":"W4395451921"},{"id":"paper-w4404001170","cat":"papers","name":"Esketamine administered epidurally as an adjuvant to epidural ropivacaine for labour analgesia: a prospective, double-blind dose-response study","year":"2024","cit":4,"pfa":"Lili Xu","psa":"Xinzhong Chen","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4404001170","eid":"W4404001170"},{"id":"paper-w4390691143","cat":"papers","name":"Esketamine-induced post-traumatic stress disorder flashbacks during treatment-resistant depression indication: is it just a side effect?","year":"2024","cit":4,"pfa":"Maud Rothärmel","psa":"Lucie Berkovitch","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4390691143","eid":"W4390691143"},{"id":"paper-w4404469138","cat":"papers","name":"Perioperative administration of sub-anesthetic ketamine/esketamine for preventing postpartum depression symptoms: A trial sequential meta-analysis","year":"2024","cit":4,"pfa":"Kuo-Chuan Hung","psa":"I‐Wen Chen","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4404469138","eid":"W4404469138"},{"id":"paper-w4385563941","cat":"papers","name":"The effect of obstructive sleep apnea severity on PTSD symptoms during the course of esketamine treatment: a retrospective clinical study","year":"2023","cit":4,"pfa":"Madison K. Titone","psa":"Peter J. Colvonen","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4385563941","eid":"W4385563941"},{"id":"paper-w7143964984","cat":"papers","name":"Lidocaine combined with low‐dose esketamine for movement‐evoked pain after hepatectomy: a double‐blind randomised controlled trial","year":"2026","cit":4,"pfa":"Yan Xu","psa":"Chunling Jiang","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7143964984","eid":"W7143964984"},{"id":"paper-w4234862677","cat":"papers","name":"The median effective concentration of propofol with different doses of esketamine during gastrointestinal endoscopy in elderly patients：a randomized controlled trial","year":"2021","cit":4,"pfa":"Hua Yang","psa":"Jin‐Chao Song","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4234862677","eid":"W4234862677"},{"id":"paper-w4410857552","cat":"papers","name":"Effects of Remimazolam Tosilate Combined with Esketamine on Anesthetic Efficacy and Psychiatric Symptoms in Patients Undergoing Ambulatory Surgery: A Randomized Controlled Study","year":"2025","cit":4,"pfa":"Xuan Yu","psa":"Yi Zhang","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4410857552","eid":"W4410857552"},{"id":"paper-w4414811839","cat":"papers","name":"Intravenous esketamine for the prevention of emergence delirium and negative behavioural changes after paediatric adenotonsillectomy: a randomised controlled trial","year":"2025","cit":4,"pfa":"Huifen Lin","psa":"Yusheng Yao","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4414811839","eid":"W4414811839"},{"id":"paper-w4401155413","cat":"papers","name":"Exploring the Analgesic Efficacy and mechanisms of low-dose esketamine in pregnant women undergoing cesarean section: A randomized controlled trial","year":"2024","cit":4,"pfa":"Junhua Zhang","psa":"Guangyou Duan","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4401155413","eid":"W4401155413"},{"id":"paper-w4410543981","cat":"papers","name":"Effects of Esketamine Versus Remifentanil on Hemodynamics and Prognosis in Patients with Septic Shock Receiving Invasive Mechanical Ventilation: A Randomized Controlled Trial","year":"2025","cit":4,"pfa":"Yuting Li","psa":"Dong Zhang","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4410543981","eid":"W4410543981"},{"id":"paper-w4405638624","cat":"papers","name":"Impact of social determinants of health on esketamine nasal spray initiation among patients with treatment-resistant depression in the United States","year":"2024","cit":4,"pfa":"Kristin Clemens","psa":"Dominic Pilon","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4405638624","eid":"W4405638624"},{"id":"paper-w4411217197","cat":"papers","name":"Ropivacaine combined with esketamine in ultrasound-guided thoracic paravertebral nerve block in lung cancer patients undergoing thoracoscopic radical surgery","year":"2025","cit":4,"pfa":"Jian Wen","psa":"Juan Zhang","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4411217197","eid":"W4411217197"},{"id":"paper-w4386001721","cat":"papers","name":"Effect of postoperative application of esketamine on postoperative depression and postoperative analgesia in patients undergoing pancreatoduodenectomy: a randomized controlled trial protocol","year":"2023","cit":4,"pfa":"Kaili Yu","psa":"Yiqing Yin","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"conference-abstract","src":"https://openalex.org/W4386001721","eid":"W4386001721"},{"id":"paper-w4413594654","cat":"papers","name":"Esketamine/dexmedetomidine–based opioid-free anesthesia and its association with postoperative bowel and cognitive dysfunction after total laparoscopic hysterectomy","year":"2025","cit":4,"pfa":"Guohua Li","psa":"Xiao Li","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4413594654","eid":"W4413594654"},{"id":"paper-w3019314169","cat":"papers","name":"175 Determining Meaningful Change in Depression Symptoms Assessed with PHQ-9 and SDS in Treatment-resistant Depression Trials of Esketamine Nasal Spray","year":"2020","cit":4,"pfa":"Stacie A. Hudgens","psa":"Jaskaran B. Singh","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3019314169","eid":"W3019314169"},{"id":"paper-w4404059374","cat":"papers","name":"Repeated high-dose esketamine in early postnatal rats leads to behavioural deficits with long-term modifications in white matter microstructural integrity","year":"2024","cit":4,"pfa":"Lijie Zhou","psa":"Lining Huang","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4404059374","eid":"W4404059374"},{"id":"paper-w4403714412","cat":"papers","name":"Functional Connectivity Between Glutamate Receptor Antagonism and Insulin Pathways: Implications for Modeling Mechanism of Action of Ketamine/Esketamine and Dextromethorphan in Depression Treatment","year":"2024","cit":4,"pfa":"Sabrina Wong","psa":"Roger S. McIntyre","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4403714412","eid":"W4403714412"},{"id":"paper-w4406935945","cat":"papers","name":"Effect of perioperative esketamine use on emergency delirium in children undergoing tonsillectomy and adenoidectomy: a systematic review and meta-analysis of randomized controlled trials","year":"2025","cit":4,"pfa":"Junfeng Liu","psa":"Chao Han","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4406935945","eid":"W4406935945"},{"id":"paper-w4401068979","cat":"papers","name":"Effect of a subanesthetic dose of esketamine combined with propofol on postoperative fatigue syndrome in patients undergoing gastroenterological endoscopy under anaesthesia: A retrospective study","year":"2024","cit":4,"pfa":"Guofang Fei","psa":"Yuehua Gan","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4401068979","eid":"W4401068979"},{"id":"paper-w4415813430","cat":"papers","name":"Low-Dose Esketamine Plus Dexmedetomidine in Patient-Controlled Intravenous Analgesia Improves Post-Cesarean Sleep Quality: A Double-Blind Randomized Trial","year":"2025","cit":4,"pfa":"Longyi Zhang","psa":"Ying Xie","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4415813430","eid":"W4415813430"},{"id":"paper-w4410459358","cat":"papers","name":"Esketamine mitigates lung injury in COPD rat models under mechanical ventilation: An RNA-sequencing and bioinformatics analysis of serum exosome miRNA profiles","year":"2025","cit":4,"pfa":"Ang Liu","psa":"Zhi-Yuan Chen","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4410459358","eid":"W4410459358"},{"id":"paper-w4401438006","cat":"papers","name":"Adjunctive Intranasal Esketamine for Comorbid Treatment-Resistant Depression with Suicidal Ideation in Patients Receiving Palliative Care at a Comprehensive Cancer Center: A Case Series","year":"2024","cit":4,"pfa":"Mercy Tomy","psa":"Amy Allen Case","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4401438006","eid":"W4401438006"},{"id":"paper-w4385764092","cat":"papers","name":"The effects of esketamine and treatment expectation in acute major depressive disorder (Expect): study protocol for a pharmacological fMRI study using a balanced placebo design","year":"2023","cit":4,"pfa":"Irina Falkenberg","psa":"Tilo T. J. Kircher","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4385764092","eid":"W4385764092"},{"id":"paper-w7134909280","cat":"papers","name":"Efficacy and Safety of Dexmedetomidine‐Esketamine Versus Dexmedetomidine Alone as Premedication for Pediatric Anesthesia Induction: A Systematic Review, Meta‐Analysis, and Trial Sequential Analysis","year":"2026","cit":4,"pfa":"Munder Lateiresh","psa":"Muhammed Elhadi","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7134909280","eid":"W7134909280"},{"id":"paper-w4412846757","cat":"papers","name":"Effect of Perioperative Subanesthetic Dose of Esketamine on Postoperative Recovery Quality in Patients Undergoing Laparoscopic Gastrointestinal Surgery: A Randomised, Double-Blind, Controlled Trial","year":"2025","cit":4,"pfa":"Ye Zhang","psa":"Jian Guang Lu","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4412846757","eid":"W4412846757"},{"id":"paper-w4388127492","cat":"papers","name":"Efficacy and Safety of a Subanesthetic Dose of Esketamine Combined with Propofol in Patients with Obesity Undergoing Painless Gastroscopy: A Prospective, Double-Blind, Randomized Controlled Trial [Corrigendum]","year":"2023","cit":4,"pfa":"Longbin Zheng","psa":"Ning Yin","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"erratum","src":"https://openalex.org/W4388127492","eid":"W4388127492"},{"id":"paper-w4387493081","cat":"papers","name":"Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Depressive Symptoms in Adolescents With MDD at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Psychoactive-Controlled Study","year":"2023","cit":4,"pfa":"Melissa P. DelBello","psa":"Carla M. Canuso","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4387493081","eid":"W4387493081"},{"id":"paper-w4412753744","cat":"papers","name":"Low-dose esketamine combined with propofol versus fentanyl-propofol for preventing hypoxemia during gastroscopy sedation in high-altitude residents: a randomized controlled trial","year":"2025","cit":4,"pfa":"Hui Xue","psa":"Wei Song","topics":["Safety & adverse events","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4412753744","eid":"W4412753744"},{"id":"paper-w4388042961","cat":"papers","name":"ICEBERG study: an indirect adjusted comparison estimating the long-term benefit of esketamine nasal spray when compared with routine treatment of treatment resistant depression in general psychiatry","year":"2023","cit":4,"pfa":"Albino Jorge Oliveira-Maia","psa":"Siobhán Mulhern-Haughey","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4388042961","eid":"W4388042961"},{"id":"paper-w4394762792","cat":"papers","name":"[Lung-protective effect of esketamine combined with distal limb ischemic preconditioning in elderly patients undergoing thoracoscopic radical surgery for lung cancer: a randomized controlled trial in 160 cases].","year":"2024","cit":4,"pfa":"Y Yang","psa":"Wen Lu","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4394762792","eid":"W4394762792"},{"id":"paper-w3009249085","cat":"papers","name":"Antidepressant Actions of Ketamine and Its Two Enantiomers","year":"2020","cit":4,"pfa":"Lijia Chang","psa":"Kenji Hashimoto","topics":["Depression"],"ptype":"book-chapter","src":"https://openalex.org/W3009249085","eid":"W3009249085"},{"id":"paper-w4402955251","cat":"papers","name":"Effect of intravenous different drugs on the prevention of restlessness during recovery period of pediatric laparoscopic surgery: a randomized control trial","year":"2024","cit":4,"pfa":"Zhi-Jie Liang","psa":"Yu-Nan Lin","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4402955251","eid":"W4402955251"},{"id":"paper-w4388738508","cat":"papers","name":"General intravenous anesthetics - pharmacodynamics, pharmacokinetics and chiral properties","year":"2023","cit":4,"pfa":"R Cizmáriková","psa":"Mário Markuliak","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4388738508","eid":"W4388738508"},{"id":"paper-w4361297225","cat":"papers","name":"Oral and Intranasal Ketamine Use in Treatment-Resistant Catatonia: A Clinical Case Report","year":"2023","cit":4,"pfa":"Elizabeth Gregor","psa":"Wanhong Zheng","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4361297225","eid":"W4361297225"},{"id":"paper-w4385726409","cat":"papers","name":"Suicidal ideation and suicide attempt following ketamine prescription in patients with treatment-resistant depression: a nation-wide cohort study","year":"2023","cit":4,"pfa":"Rong Xu","psa":"Susan M. De Luca","topics":["Depression"],"ptype":"preprint","src":"https://openalex.org/W4385726409","eid":"W4385726409"},{"id":"paper-w3027566423","cat":"papers","name":"Reply to Hashimoto: Ketamine is not an opioid but requires opioid system for antidepressant actions","year":"2020","cit":4,"pfa":"Roberto Malinow","psa":"Matthew E Klein","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"letter","src":"https://openalex.org/W3027566423","eid":"W3027566423"},{"id":"paper-w4397007459","cat":"papers","name":"Ahnak in the prefrontal cortex mediates behavioral correlates of stress resilience and rapid antidepressant action in mice","year":"2024","cit":4,"pfa":"Dionnet L. Bhatti","psa":"Yong Deok Kim","topics":["Depression","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4397007459","eid":"W4397007459"},{"id":"paper-w4416396757","cat":"papers","name":"Impact of opioid-free anesthesia on the overall benefit of analgesia score after laparoscopic cholecystectomy: protocol and statistical analysis plan for a multicenter, randomized, controlled trial","year":"2025","cit":4,"pfa":"Han-xue Zhao","psa":"Ke Peng","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4416396757","eid":"W4416396757"},{"id":"paper-w3135860787","cat":"papers","name":"The Sustained Antidepressant Effects of Ketamine Are Independent of the Lateral Habenula","year":"2021","cit":4,"pfa":"Xuelong Zhou","psa":"Cunming Liu","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3135860787","eid":"W3135860787"},{"id":"paper-w7118121491","cat":"papers","name":"Procedural sedation and analgesia in the emergency department: a review of current practices and clinical implications","year":"2026","cit":4,"pfa":"Burcu Özen Karabulut","psa":"Metin Akgün","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7118121491","eid":"W7118121491"},{"id":"paper-w4200152861","cat":"papers","name":"The Safety, Clinical, and Neurophysiological Effects of Intranasal Ketamine in Patients Who Do Not Respond to Electroconvulsive Therapy: Protocol for a Pilot, Open-Label Clinical Trial","year":"2021","cit":4,"pfa":"Yuliya Knyahnytska","psa":"Daniel M. Blumberger","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4200152861","eid":"W4200152861"},{"id":"paper-w4416271913","cat":"papers","name":"Interventions to prevent postoperative neurocognitive complications: an umbrella review of meta‐analyses of randomised controlled trials","year":"2025","cit":4,"pfa":"Filippo D’Amico","psa":"Luigi Beretta","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4416271913","eid":"W4416271913"},{"id":"paper-w4401037647","cat":"papers","name":"Effect of modified opioid sparing anaesthesia on postoperative quality of recovery in patients undergoing laparoscopic bariatric surgery: protocol for a monocentre, double-blind randomised controlled trial – the MOSA stu","year":"2024","cit":4,"pfa":"Shikuo Li","psa":"Liang He","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4401037647","eid":"W4401037647"},{"id":"paper-w4386019631","cat":"papers","name":"On the Origins of MAOI Misconceptions: Reaffirming their Role in Melancholic Depression","year":"2025","cit":4,"pfa":"Vincent Van den Eynde","psa":"Peter Kenneth Gillman","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4386019631","eid":"W4386019631"},{"id":"paper-w4410415035","cat":"papers","name":"Balanced Opioid-Free Anesthesia on Chronic Postsurgical Pain After Video-Assisted Thoracoscopic Surgery: A Randomized Controlled Trial Protocol","year":"2025","cit":4,"pfa":"Wenwen Huo","psa":"Ke Peng","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4410415035","eid":"W4410415035"},{"id":"paper-w7158466122","cat":"papers","name":"Inflammation and treatment strategies for suicidal behavior","year":"2026","cit":4,"pfa":"Chittaranjan Behera","psa":"Yogesh Dwivedi","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7158466122","eid":"W7158466122"},{"id":"paper-w7134908612","cat":"papers","name":"A Global Delphi-Based Expert Consensus on Relapse Prevention Strategies Following Successful Electroconvulsive Therapy for Major Depressive Disorder","year":"2026","cit":4,"pfa":"J. J. E. Rovers","psa":"Annemiek Dols","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7134908612","eid":"W7134908612"},{"id":"paper-w4402343252","cat":"papers","name":"Perioperative anesthetic management of patients with hypoplastic left heart syndrome undergoing the comprehensive stage II surgery—A review of 148 cases","year":"2024","cit":4,"pfa":"Matthias Müller","psa":"Hakan Akintürk","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4402343252","eid":"W4402343252"},{"id":"paper-w4400902523","cat":"papers","name":"Real-world treatment patterns of patients with major depressive disorder treated with Auvelity in the United States","year":"2024","cit":4,"pfa":"Andrew J. Muzyk","psa":"Yang Zhao","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4400902523","eid":"W4400902523"},{"id":"paper-w4386765460","cat":"papers","name":"Challenges of research on treatment‐resistant depression: a clinician's perspective","year":"2023","cit":4,"pfa":"Augustus John Rush","topics":["Depression","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4386765460","eid":"W4386765460"},{"id":"paper-w2535818642","cat":"papers","name":"CYP2B6*6 or Not CYP2B6*6—That Remains a Question for Precision Medicine and Ketamine!","year":"2016","cit":4,"pfa":"Scott D. Cook‐Sather","psa":"Hakon H. Hakonarson","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2535818642","eid":"W2535818642"},{"id":"paper-w4360603119","cat":"papers","name":"Special Report: Autism Spectrum Disorder and Inflexible Thinking—Affecting Patients Across the Lifespan","year":"2023","cit":4,"pfa":"Eric Hollander","psa":"Casara Jean Ferretti","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"other","src":"https://openalex.org/W4360603119","eid":"W4360603119"},{"id":"paper-w2055770757","cat":"papers","name":"The raphe neuronal system and serotonergic effects of LSD","year":"1982","cit":4,"pfa":"Angelos E Halaris","psa":"D FREEDMAN","ptype":"article","src":"https://openalex.org/W2055770757","eid":"W2055770757"},{"id":"paper-w2168574132","cat":"papers","name":"Theoretical models for molecular mechanisms in biological systems: Tryptamine congeners acting on an LSD-Serotonin receptor","year":"2009","cit":4,"pfa":"Harel Weinstein","psa":"Jack Green","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2168574132","eid":"W2168574132"},{"id":"paper-w2775825098","cat":"papers","name":"Hyperespace dans le cyberespace : DMT et méta-ritualisation","year":"2017","cit":4,"pfa":"Graham St John","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2775825098","eid":"W2775825098"},{"id":"paper-w2057823099","cat":"papers","name":"Correlation of 125I‐LSD autoradiographic labeling with serotonin voltage clamp responses in Aplysia neurons","year":"1991","cit":4,"pfa":"Martyn L. Evans","psa":"David O. Carpenter","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2057823099","eid":"W2057823099"},{"id":"paper-w1773862921","cat":"papers","name":"[Psychedelics and quasi-psychedelics in the light of contemporary research: medical cannabis, MDMA, salvinorin A, ibogaine and ayahuasca].","year":"2015","cit":3,"pfa":"Attila Szabó","psa":"Zoltán Brys","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1773862921","eid":"W1773862921"},{"id":"paper-w223983669","cat":"papers","name":"Lysergic Acid Diethylamide","year":"2007","cit":3,"pfa":"S.J. Enna","psa":"David B. Bylund","ptype":"book-chapter","src":"https://openalex.org/W223983669","eid":"W223983669"},{"id":"paper-w2013064844","cat":"papers","name":"Lysergic Acid Diethylamide","year":"1966","cit":3,"pfa":"J P Christen","ptype":"article","src":"https://openalex.org/W2013064844","eid":"W2013064844"},{"id":"paper-w2075625507","cat":"papers","name":"Lysergic Acid Diethylamide","year":"1966","cit":3,"pfa":"B. Bhattacharya","ptype":"article","src":"https://openalex.org/W2075625507","eid":"W2075625507"},{"id":"paper-w2898004847","cat":"papers","name":"d-Lysergic Acid Diethylamide","year":"1967","cit":3,"pfa":"Abram Hoffer","psa":"H Osmond","ptype":"book-chapter","src":"https://openalex.org/W2898004847","eid":"W2898004847"},{"id":"paper-w2409467038","cat":"papers","name":"[Psychic effects of lysergic acid diethylamide].","year":"1957","cit":3,"pfa":"Haase Hj","ptype":"article","src":"https://openalex.org/W2409467038","eid":"W2409467038"},{"id":"paper-w1010693489","cat":"papers","name":"Photodecomposition of Lysergic Acid Diethylamide (LSD)","year":"1971","cit":3,"pfa":"Tetsukichi Niwaguchi","psa":"Takako Inoue","ptype":"article","src":"https://openalex.org/W1010693489","eid":"W1010693489"},{"id":"paper-w234859299","cat":"papers","name":"MODIFICATION OF RELEASE BY LYSERGIC ACID DIETHYLAMIDE","year":"1979","cit":3,"pfa":"John Christie McGrath","ptype":"book-chapter","src":"https://openalex.org/W234859299","eid":"W234859299"},{"id":"paper-w2407015025","cat":"papers","name":"[Body scheme disorders in lysergic acid diethylamide].","year":"1953","cit":3,"pfa":"O H ARNOLD","psa":"H Hoff","ptype":"article","src":"https://openalex.org/W2407015025","eid":"W2407015025"},{"id":"paper-w2028746881","cat":"papers","name":"Histamine-binding Action of Lysergic Acid Diethylamide","year":"1963","cit":3,"pfa":"D. V. Siva Sankar","psa":"NORMAN GATES","ptype":"article","src":"https://openalex.org/W2028746881","eid":"W2028746881"},{"id":"paper-w2034876770","cat":"papers","name":"Lysergic Acid Diethylamide (LSD-25): XXVIII. Assay OF 2-Bromo-Lysergic Acid Diethylamide by the Siamese Fighting Fish","year":"1958","cit":3,"pfa":"M. O. Baron","psa":"Harold A. Abramson","ptype":"article","src":"https://openalex.org/W2034876770","eid":"W2034876770"},{"id":"paper-w4247461601","cat":"papers","name":"Interaction of Reserpine, Serotonin, and Lysergic Acid Diethylamide in Brain","year":"1955","cit":3,"pfa":"Parkhurst A. Shore","psa":"Bernard B. Brodie","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4247461601","eid":"W4247461601"},{"id":"paper-w2412308078","cat":"papers","name":"The Effect of Lysergic Acid Diethylamide (L.S.D.) on Size Constancy","year":"1959","cit":3,"pfa":"Thaddeus E. Weckowicz","ptype":"article","src":"https://openalex.org/W2412308078","eid":"W2412308078"},{"id":"paper-w2067403332","cat":"papers","name":"Antagonism of lysergic acid diethylamide (LSD)-induced hyperglycemia","year":"1964","cit":3,"pfa":"John T. Elder","ptype":"article","src":"https://openalex.org/W2067403332","eid":"W2067403332"},{"id":"paper-w2410952044","cat":"papers","name":"Lysergic acid diethylamide and dominance behavior of the squirrel monkey.","year":"1967","cit":3,"pfa":"Edward T. Uyeno","ptype":"article","src":"https://openalex.org/W2410952044","eid":"W2410952044"},{"id":"paper-w2012447278","cat":"papers","name":"Effect of d-Lysergic Acid Diethylamide on Spinal Reflexes","year":"1958","cit":3,"pfa":"Lee E. Geiger","psa":"Peter Cervoni","topics":["Depression","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2012447278","eid":"W2012447278"},{"id":"paper-w2038730063","cat":"papers","name":"Effects of Lysergic Acid Diethylamide on the Maternal Behavior of the Rat","year":"1970","cit":3,"pfa":"Edward T. Uyeno","ptype":"article","src":"https://openalex.org/W2038730063","eid":"W2038730063"},{"id":"paper-w1543615173","cat":"papers","name":"Ayahuasca, Harmala Alkaloids, and Dimethyltryptamines","year":"2012","cit":3,"pfa":"Donald G. Barceloux","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W1543615173","eid":"W1543615173"},{"id":"paper-w2439790364","cat":"papers","name":"Intracerebral infection of lysergic acid diethylamide in conscious dogs and cats.","year":"1958","cit":3,"pfa":"Haley Tj","psa":"Dasgupta","ptype":"article","src":"https://openalex.org/W2439790364","eid":"W2439790364"},{"id":"paper-w4400840484","cat":"papers","name":"Lysergic acid diethylamide induces behavioral changes in Caenorhabditis elegans","year":"2024","cit":3,"pfa":"Isis Moraes Ornelas","psa":"Stevens Kastrup Rehen","ptype":"article","src":"https://openalex.org/W4400840484","eid":"W4400840484"},{"id":"paper-w2417809314","cat":"papers","name":"The effects of lysergic acid diethylamide I: critical flicker frequency.","year":"1965","cit":3,"pfa":"A R Holliday","psa":"Sharpley Rp","ptype":"article","src":"https://openalex.org/W2417809314","eid":"W2417809314"},{"id":"paper-w2422296865","cat":"papers","name":"[Configuration frequency analysis of some lysergic acid diethylamide effects].","year":"1970","cit":3,"pfa":"G A Lienert","ptype":"article","src":"https://openalex.org/W2422296865","eid":"W2422296865"},{"id":"paper-w2410731216","cat":"papers","name":"Effects of lysergic acid diethylamide on the modification of a learned jumping response.","year":"1998","cit":3,"pfa":"Pawlowski Aa","ptype":"article","src":"https://openalex.org/W2410731216","eid":"W2410731216"},{"id":"paper-w2029065067","cat":"papers","name":"Changes in the liver protein pattern due to lysergic acid diethylamide (LSD)","year":"1961","cit":3,"pfa":"G Missere","psa":"Mario Babbini","ptype":"article","src":"https://openalex.org/W2029065067","eid":"W2029065067"},{"id":"paper-w2048840822","cat":"papers","name":"Analysis of lysergic acid diethylamide in whole blood by HPLC-fluorescence detection","year":"1996","cit":3,"pfa":"Abdelkader Battah","psa":"Robert A. Anderson","ptype":"article","src":"https://openalex.org/W2048840822","eid":"W2048840822"},{"id":"paper-w2411040808","cat":"papers","name":"[Specific inhibition of serotonin effects by lysergic acid diethylamide and similar compounds].","year":"1956","cit":3,"pfa":"A Cerletti","psa":"Heribert Konzett","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2411040808","eid":"W2411040808"},{"id":"paper-w2969038880","cat":"papers","name":"Lysergic acid diethylamide–associated intoxication in Hong Kong: a case series","year":"2019","cit":3,"pfa":"C Li","psa":"Tony WL Mak","ptype":"article","src":"https://openalex.org/W2969038880","eid":"W2969038880"},{"id":"paper-w1523194364","cat":"papers","name":"The Analysis of Psilocybin and Psilocin from Fungi","year":"2003","cit":3,"pfa":"Michael Cole","ptype":"other","src":"https://openalex.org/W1523194364","eid":"W1523194364"},{"id":"paper-w1987398581","cat":"papers","name":"Plasma creatine phosphokinase levels in rats following lysergic acid diethylamide","year":"1975","cit":3,"pfa":"Herbert Y. Meltzer","ptype":"article","src":"https://openalex.org/W1987398581","eid":"W1987398581"},{"id":"paper-w2158713019","cat":"papers","name":"Effects of inducers and/or inhibitors on metabolism of lysergic acid diethylamide in rat liver microsomes","year":"1980","cit":3,"pfa":"Tomio Inoue","psa":"TOSHIRO MURATA","ptype":"article","src":"https://openalex.org/W2158713019","eid":"W2158713019"},{"id":"paper-w2042090163","cat":"papers","name":"Optimization and Immunological Characterization of a Photochemically Coupled Lysergic Acid Diethylamide (LSD) Immunogen","year":"1998","cit":3,"pfa":"Sarah Kerrigan","psa":"Donald E. Brooks","ptype":"article","src":"https://openalex.org/W2042090163","eid":"W2042090163"},{"id":"paper-w2409482160","cat":"papers","name":"Effect of lysergic acid diethylamide and its brom analogue on arterial hypertension in the rat","year":"1961","cit":3,"pfa":"Stephen Sugaar","psa":"WILLIAM ANTOPOL","ptype":"article","src":"https://openalex.org/W2409482160","eid":"W2409482160"},{"id":"paper-w2027457135","cat":"papers","name":"Lysergic acid diethylamide: Photodynamic inactivation of repair deficient E. Coli and Tl bacteriophage","year":"1970","cit":3,"pfa":"Bruno Papirmeister","psa":"Jack S. Wolpert","ptype":"article","src":"https://openalex.org/W2027457135","eid":"W2027457135"},{"id":"paper-w2475677564","cat":"papers","name":"From Psychiatry to Flower Power and Back Again: The Amazing Story of Lysergic Acid Diethylamide","year":"2016","cit":3,"pfa":"Hermann AM Mucke","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2475677564","eid":"W2475677564"},{"id":"paper-w4389574669","cat":"papers","name":"Guidelines for Establishing Safety in Ayahuasca and Ibogaine Administration in Clinical Settings","year":"2023","cit":3,"pfa":"Juliana Mendes Rocha","psa":"RAFAEL GUIMARÃES DOS SANTOS","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4389574669","eid":"W4389574669"},{"id":"paper-w2311758533","cat":"papers","name":"Effects on homeostasis of 5-hydroxytryptamine, lysergic acid diethylamide and 2-brom-d-lysergic acid","year":"1959","cit":3,"pfa":"J. Paul McNeill","psa":"John K. Hampton","topics":["PTSD & trauma","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2311758533","eid":"W2311758533"},{"id":"paper-w4286203017","cat":"papers","name":"Psychedelic compound 5-MeO-DMT induces an altered wake state in mice","year":"2022","cit":3,"pfa":"B.J.-B. Bréant","psa":"V.V. Vyazovskiy","ptype":"article","src":"https://openalex.org/W4286203017","eid":"W4286203017"},{"id":"paper-w2070815384","cat":"papers","name":"Liver function and pyrexia caused by a pyrogen from Escherichia coli, lysergic acid diethylamide and dinitrophenol","year":"1966","cit":3,"pfa":"Jan Venulet","psa":"Anna Desperak-naciazek","ptype":"article","src":"https://openalex.org/W2070815384","eid":"W2070815384"},{"id":"paper-w2470025686","cat":"papers","name":"Comparative Inhibitory Action of D- and L-Tryptophan on the Effect of d-Lysergic Acid Diethylamide in Vitro","year":"1974","cit":3,"pfa":"Jeffrey L. Winkelhake","psa":"Dennis E. Lopatin","ptype":"article","src":"https://openalex.org/W2470025686","eid":"W2470025686"},{"id":"paper-w1968186660","cat":"papers","name":"EFFECTS OF LYSERGIC ACID DIETHYLAMIDE (LSD‐25) ON NORMAL SUBJECTS IN A SCHIZOPHRENIA‐DISCRIMINATING TEST BATTERY","year":"1963","cit":3,"pfa":"B Netz","psa":"Siwart Bergqvist","ptype":"article","src":"https://openalex.org/W1968186660","eid":"W1968186660"},{"id":"paper-w2530944765","cat":"papers","name":"Possible role of biochemiluminescent photons for lysergic acid diethylamide (LSD)-induced phosphenes and visual hallucinations","year":"2016","cit":3,"pfa":"Gábor Kapócs","psa":"István Bókkon","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2530944765","eid":"W2530944765"},{"id":"paper-w2419527197","cat":"papers","name":"Presynaptic inhibition of adrenergic motor transmission in rat anococcygeus muscle by D-lysergic acid diethylamide (LSD).","year":"1973","cit":3,"pfa":"N Ambache","psa":"Aboo Zar M","ptype":"article","src":"https://openalex.org/W2419527197","eid":"W2419527197"},{"id":"paper-w2443847196","cat":"papers","name":"Tricyclic antidepressant drugs: antagonism of effect of D-lysergic acid diethylamide (LSD) on shock elicited aggression.","year":"1977","cit":3,"pfa":"M.H. Sheard","psa":"Margaret R. Davis","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2443847196","eid":"W2443847196"},{"id":"paper-w215635444","cat":"papers","name":"Carbon-11 and radioiodinated derivatives of lysergic acid diethylamide: Ligands for the study of serotonin S2 receptors in vivo","year":"1985","cit":3,"pfa":"John R. Lever","psa":"H. Donald Burns","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W215635444","eid":"W215635444"},{"id":"paper-w2029950637","cat":"papers","name":"Chronic intraventricular administration of lysergic acid diethylamide (LSD) affects the sensitivity of cortical cells to monocular deprivation","year":"1982","cit":3,"pfa":"Maureen A. McCall","psa":"Helmut V. B. Hirsch","ptype":"article","src":"https://openalex.org/W2029950637","eid":"W2029950637"},{"id":"paper-w3007639845","cat":"papers","name":"Lysergic acid diethylamide causes mouse retinal damage by up-regulating p-JAK1/p-STAT1","year":"2020","cit":3,"pfa":"Kang Chen","psa":"Ying Li","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3007639845","eid":"W3007639845"},{"id":"paper-w2004307577","cat":"papers","name":"Responses of serotonergic and non-serotonergic neurons in the rat nucleus raphe magnus to systemic lysergic acid diethylamide","year":"1986","cit":3,"pfa":"Jin-Bo Wei","psa":"Chen‐Yu Chiang","ptype":"article","src":"https://openalex.org/W2004307577","eid":"W2004307577"},{"id":"paper-w4410976477","cat":"papers","name":"Evaluation of the peak experience scale as a rapid assessment tool for the strength of a psychoactive experience with 5-MeO-DMT","year":"2025","cit":3,"pfa":"Johannes T. Reckweg","psa":"Johannes Gerardus Ramaekers","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4410976477","eid":"W4410976477"},{"id":"paper-w2444572659","cat":"papers","name":"[Model psychosis induced by lysergic acid diethylamide; various psychopathological aspects of experimental LSD poisoning in normal subjects].","year":"2000","cit":3,"pfa":"Danilo Cargnello","psa":"N Lukinovich","ptype":"article","src":"https://openalex.org/W2444572659","eid":"W2444572659"},{"id":"paper-w2068438903","cat":"papers","name":"Lysergic Acid Diethylamide (LSD-25): XXXII. Resolution of Counter-Identification Conflict of Father During Oedipal Phase of Son","year":"1961","cit":3,"pfa":"Harold A. Abramson","ptype":"article","src":"https://openalex.org/W2068438903","eid":"W2068438903"},{"id":"paper-w1984135821","cat":"papers","name":"Lysergic Acid Diethylamide (LSD 25): XXXX. Effect of pH on Transport of Methysergide and LSD 25 Across Gill Membrane","year":"1973","cit":3,"pfa":"Henriette H. Gettner","psa":"Harold A. Abramson","ptype":"article","src":"https://openalex.org/W1984135821","eid":"W1984135821"},{"id":"paper-w1992261380","cat":"papers","name":"5-Hydroxytryptamine and (+)-lysergic acid diethylamide displace [3H]thyrotropin-releasing hormone at its binding sites in the rat limbic forebrain","year":"1986","cit":3,"pfa":"Shigeki Teshima","psa":"Kazutoyo Inanaga","ptype":"article","src":"https://openalex.org/W1992261380","eid":"W1992261380"},{"id":"paper-w4308468771","cat":"papers","name":"Molecular Structure, Reactivity and Spectroscopic Properties of Hallucinogens Psilocybin, Mescaline and their Derivatives – A Computational Study","year":"2022","cit":3,"topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4308468771","eid":"W4308468771"},{"id":"paper-w4414250218","cat":"papers","name":"Multianalytical Investigation of Psilocybe cubensis Mushrooms: Physicochemical Characterization and Biological Evaluation of Psilocybin and Psilocin Compounds","year":"2025","cit":3,"pfa":"Taynah Pereira Galdino","psa":"Marcus Vinícius Lia Fook","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4414250218","eid":"W4414250218"},{"id":"paper-w1996094003","cat":"papers","name":"Inhibition of catecholamine and 5-hydroxytryptamine induced enzyme secretion from the guinea-pig submandibular gland by 2-bromo-d-lysergic acid diethylamide","year":"1975","cit":3,"pfa":"Bengt Carlsöö","psa":"Torgny I. Stigbrand","ptype":"article","src":"https://openalex.org/W1996094003","eid":"W1996094003"},{"id":"paper-w4386573288","cat":"papers","name":"Systematic characterization of Lysergic Acid Diethylamide metabolites in Caenorhabditis elegans by ultra-high performance liquid chromatography coupled with high-resolution tandem mass spectrometry","year":"2023","cit":3,"pfa":"Christiane Martins de Vasconcellos Silveira","psa":"Magno Junqueira","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4386573288","eid":"W4386573288"},{"id":"paper-w3165206653","cat":"papers","name":"Ayahuasca","year":"2021","cit":3,"pfa":"Deana Shevit Goldin","psa":"Deborah A. Salani","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3165206653","eid":"W3165206653"},{"id":"paper-w2045125835","cat":"papers","name":"The Peyote Cult","year":"1952","cit":3,"pfa":"J. COLLIER","ptype":"article","src":"https://openalex.org/W2045125835","eid":"W2045125835"},{"id":"paper-w4251991181","cat":"papers","name":"Peyote Jokes","year":"1962","cit":3,"pfa":"James H. Howard","ptype":"article","src":"https://openalex.org/W4251991181","eid":"W4251991181"},{"id":"paper-w2090012651","cat":"papers","name":"Mescaline and Schizophrenia","year":"1951","cit":3,"pfa":"Humphry Osmond","psa":"John Smythies","ptype":"article","src":"https://openalex.org/W2090012651","eid":"W2090012651"},{"id":"paper-w2412793189","cat":"papers","name":"On the toxicity of ibogaine","year":"2016","cit":3,"pfa":"Luke Yip","psa":"Jou‐Fang Deng","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2412793189","eid":"W2412793189"},{"id":"paper-w2405894516","cat":"papers","name":"[The illusions of mescaline].","year":"1950","cit":3,"pfa":"Jean-Christian Delay","psa":"H. P. Gerard","ptype":"article","src":"https://openalex.org/W2405894516","eid":"W2405894516"},{"id":"paper-w3196730070","cat":"papers","name":"Ayahuasca","year":"2021","cit":3,"pfa":"Alhena Caicedo Fernández","ptype":"article","src":"https://openalex.org/W3196730070","eid":"W3196730070"},{"id":"paper-w594459257","cat":"papers","name":"The way of a peyote roadman","year":"1990","cit":3,"ptype":"book-review","src":"https://openalex.org/W594459257","eid":"W594459257"},{"id":"paper-w2189027194","cat":"papers","name":"Forensic Identification of Salvia divinorum and Salvinorin A","year":"2010","cit":3,"pfa":"Dana Nontell","psa":"Douglas Armstrong","ptype":"article","src":"https://openalex.org/W2189027194","eid":"W2189027194"},{"id":"paper-w2260665154","cat":"papers","name":"[The synthesthesias in mescaline poisoning].","year":"1951","cit":3,"pfa":"J Delay","psa":"P. C. Racamier","ptype":"article","src":"https://openalex.org/W2260665154","eid":"W2260665154"},{"id":"paper-w2037779153","cat":"papers","name":"In the magic land of Peyote","year":"1977","cit":3,"pfa":"Fernando Benítez","ptype":"book","src":"https://openalex.org/W2037779153","eid":"W2037779153"},{"id":"paper-w2499234077","cat":"papers","name":"Ibogaine and the Treatment of Opiate Addiction","year":"2009","cit":3,"pfa":"Emily J. Richer","topics":["Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W2499234077","eid":"W2499234077"},{"id":"paper-w2888385649","cat":"papers","name":"Parapsychology, N,N-Dimethyltryptamine and the Pineal Gland","year":"2018","cit":3,"pfa":"Nicola Luigi Bragazzi","psa":"Tania Simona Re","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2888385649","eid":"W2888385649"},{"id":"paper-w2401525960","cat":"papers","name":"Mescaline: a pharmacological profile.","year":"1973","cit":3,"pfa":"Aboul-Enein Hy","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2401525960","eid":"W2401525960"},{"id":"paper-w2091691976","cat":"papers","name":"Tissue levels of mescaline in mice: Influence of chlorpromazine on repeated administration of mescaline","year":"1973","cit":3,"pfa":"Nandkumar S. Shah","psa":"Carl Green","ptype":"article","src":"https://openalex.org/W2091691976","eid":"W2091691976"},{"id":"paper-w2167607705","cat":"papers","name":"Cumulation of Tabernanthe Iboga alkaloid and its metabolite in organs of mice","year":"2012","cit":3,"pfa":"Kubilienė Asta","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2167607705","eid":"W2167607705"},{"id":"paper-w2913453568","cat":"papers","name":"Psilocybin occupancy of brain serotonin 2A receptors correlates with psilocin levels and subjective experience: a [11C]Cimbi-36 PET study in humans","year":"2019","cit":3,"pfa":"Martin Korsbak Madsen","psa":"Gitte M. Knudsen","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2913453568","eid":"W2913453568"},{"id":"paper-w2044316143","cat":"papers","name":"Acetylation of mescaline in rat brains","year":"1973","cit":3,"pfa":"B. T. HO","psa":"Kenneth E. Walker","ptype":"article","src":"https://openalex.org/W2044316143","eid":"W2044316143"},{"id":"paper-w140563993","cat":"papers","name":"The Peyote Religion and the Ghost Dance.","year":"1972","cit":3,"pfa":"Omer C. Stewart","ptype":"article","src":"https://openalex.org/W140563993","eid":"W140563993"},{"id":"paper-w4234601789","cat":"papers","name":"N,N-Dimethyltryptamine (DMT)","year":"2020","cit":3,"pfa":"Virgil Zeigler-Hill","psa":"Todd K. Shackelford","ptype":"reference-entry","src":"https://openalex.org/W4234601789","eid":"W4234601789"},{"id":"paper-w2094752901","cat":"papers","name":"URINARY DIMETHYLTRYPTAMINE IN PSYCHIATRIC PATIENTS","year":"1975","cit":3,"pfa":"M.C.H. Oon","psa":"J. L. T. Birley","ptype":"article","src":"https://openalex.org/W2094752901","eid":"W2094752901"},{"id":"paper-w2414783754","cat":"papers","name":"[Dimethyltryptamine as a new psychotic agent].","year":"1957","cit":3,"pfa":"I Szara","psa":"Zoltán Böszörményi","ptype":"article","src":"https://openalex.org/W2414783754","eid":"W2414783754"},{"id":"paper-w4392032056","cat":"papers","name":"Peyote and Psychedelics on the Canadian Prairies","year":"2016","cit":3,"pfa":"Erika Dyck","ptype":"other","src":"https://openalex.org/W4392032056","eid":"W4392032056"},{"id":"paper-w1988293208","cat":"papers","name":"Mescaline in multi-coloured statuettes","year":"1996","cit":3,"pfa":"Nadia Fucci","psa":"Marcello Chiarotti","ptype":"article","src":"https://openalex.org/W1988293208","eid":"W1988293208"},{"id":"paper-w2070640329","cat":"papers","name":".beta.-Chloroethylamines related to mescaline","year":"1973","cit":3,"pfa":"Paul D. Cooper","ptype":"article","src":"https://openalex.org/W2070640329","eid":"W2070640329"},{"id":"paper-w2892545447","cat":"papers","name":"Ayahuasca-Tourismus in Südamerika","year":"2018","cit":3,"pfa":"Tom John Wolff","ptype":"book-chapter","src":"https://openalex.org/W2892545447","eid":"W2892545447"},{"id":"paper-w2054433173","cat":"papers","name":"Pharmacokinetic parameters of mescaline in rabbits","year":"1982","cit":3,"pfa":"Carlos Van Peteghem","psa":"W. Van Zele","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2054433173","eid":"W2054433173"},{"id":"paper-w4246391611","cat":"papers","name":"Methylenedioxymethamphetamine (MDMA)","year":"2014","cit":3,"pfa":"Iain S. McGregor","psa":"Murray R. Thompson","ptype":"reference-entry","src":"https://openalex.org/W4246391611","eid":"W4246391611"},{"id":"paper-w3210958390","cat":"papers","name":"Ayahuasca potential benefits","year":"2021","cit":3,"pfa":"R. Pinilla","psa":"B. Ordoñez","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3210958390","eid":"W3210958390"},{"id":"paper-w2011798393","cat":"papers","name":"The influence of mescaline on Rorschach responses","year":"1954","cit":3,"pfa":"Joseph Kelly","ptype":"article","src":"https://openalex.org/W2011798393","eid":"W2011798393"},{"id":"paper-w2903758162","cat":"papers","name":"What ayahuasca wants","year":"2018","cit":3,"pfa":"Silvia Mesturini Cappo","topics":["Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W2903758162","eid":"W2903758162"},{"id":"paper-w2319705179","cat":"papers","name":"Peyote and the Native American Church","year":"1968","cit":3,"pfa":"Charolette Cardon","ptype":"article","src":"https://openalex.org/W2319705179","eid":"W2319705179"},{"id":"paper-w1970254811","cat":"papers","name":"Hapten-immunological studies on mescaline","year":"1975","cit":3,"pfa":"R. Utzinger","ptype":"article","src":"https://openalex.org/W1970254811","eid":"W1970254811"},{"id":"paper-w2040777478","cat":"papers","name":"Brazilian Ayahuasca Religions","year":"2008","cit":3,"pfa":"Robin Michel Wright","topics":["Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2040777478","eid":"W2040777478"},{"id":"paper-w3100807566","cat":"papers","name":"Inhibition of Opioid Abstinent Phenomena by Ibogaine","year":"1996","cit":3,"pfa":"Takeshi Koja","psa":"E. Lukas","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W3100807566","eid":"W3100807566"},{"id":"paper-w2086799451","cat":"papers","name":"Skinner, Maslow, and Psilocybin","year":"1993","cit":3,"pfa":"Robert S. Gable","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2086799451","eid":"W2086799451"},{"id":"paper-w1490230204","cat":"papers","name":"Psilocybin and Hallucinogenic Mushrooms","year":"2012","cit":3,"pfa":"Donald G. Barceloux","topics":["Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W1490230204","eid":"W1490230204"},{"id":"paper-w2333466889","cat":"papers","name":"Anesthesia for Opiate Detoxification and the Ibogaine Controversy","year":"2011","cit":3,"pfa":"Clifford Mark Gevirtz","ptype":"article","src":"https://openalex.org/W2333466889","eid":"W2333466889"},{"id":"paper-w2770497160","cat":"papers","name":"Factors in the Persistence Of Peyote in the Northern Plains","year":"1960","cit":3,"pfa":"Wesley R. Hurt","ptype":"article","src":"https://openalex.org/W2770497160","eid":"W2770497160"},{"id":"paper-w4406036520","cat":"papers","name":"Elucidating the Phase I metabolism of psilocin in vitro","year":"2025","cit":3,"pfa":"Junqi Chen","psa":"Eric Chun Yong Chan","ptype":"article","src":"https://openalex.org/W4406036520","eid":"W4406036520"},{"id":"paper-w2021011334","cat":"papers","name":"Música Brasileira de Ayahuasca","year":"2009","cit":3,"pfa":"José Eliézer Mikosz","ptype":"article","src":"https://openalex.org/W2021011334","eid":"W2021011334"},{"id":"paper-w2027207552","cat":"papers","name":"The Values and Control of MDMA","year":"2007","cit":3,"pfa":"Justin F. Smith","ptype":"article","src":"https://openalex.org/W2027207552","eid":"W2027207552"},{"id":"paper-w7118172518","cat":"papers","name":"The effect of psilocin on neurotransmitters release in the claustrum and on rat behavior","year":"2026","cit":3,"pfa":"Zuzanna Kościuk","psa":"Krystyna Gołembiowska","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7118172518","eid":"W7118172518"},{"id":"paper-w1984345786","cat":"papers","name":"Peyote Religion: A History. OMER C. STEWART","year":"1989","cit":3,"pfa":"Peter T. Furst","ptype":"article","src":"https://openalex.org/W1984345786","eid":"W1984345786"},{"id":"paper-w2969806162","cat":"papers","name":"A RARE CASE: AYAHUASCA TEA INTOXICATION","year":"2019","cit":3,"pfa":"Selman Yeniocak","psa":"Burak Katipoğlu","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2969806162","eid":"W2969806162"},{"id":"paper-w4392086557","cat":"papers","name":"Peyote, Conservation, and Indian Rights in the United States","year":"2016","cit":3,"pfa":"Kevin Feeney","ptype":"other","src":"https://openalex.org/W4392086557","eid":"W4392086557"},{"id":"paper-w2614227879","cat":"papers","name":"Mescaline-induced changes of brain-cortex ribosomes","year":"1973","cit":3,"pfa":"R. K. Datta","psa":"J. J. Ghosh","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2614227879","eid":"W2614227879"},{"id":"paper-w4289522296","cat":"papers","name":"Plants and Healing on the Wixárika (Huichol) Peyote Pilgrimage","year":"2022","cit":3,"pfa":"Stacy B. Schaefer","ptype":"book-chapter","src":"https://openalex.org/W4289522296","eid":"W4289522296"},{"id":"paper-w4396221537","cat":"papers","name":"Psilocybin Desynchronizes Brain Networks","year":"2024","cit":3,"pfa":"Joshua S. Siegel","psa":"Ginger E. Nicol","ptype":"article","src":"https://openalex.org/W4396221537","eid":"W4396221537"},{"id":"paper-w2087651775","cat":"papers","name":"Physostigmine Reversal of Psilocybin Intoxication","year":"1982","cit":3,"pfa":"J. F. van Poorten","psa":"Jože Rupreht","ptype":"article","src":"https://openalex.org/W2087651775","eid":"W2087651775"},{"id":"paper-w4307285557","cat":"papers","name":"Electrical spiking of psilocybin fungi","year":"2022","cit":3,"pfa":"Antoni Gandía","psa":"Andrew Adamatzky","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4307285557","eid":"W4307285557"},{"id":"paper-w4414161822","cat":"papers","name":"N,N-dimethyltryptamine effects on connectome harmonics, subjective experience and comparative psychedelic experiences","year":"2025","cit":3,"pfa":"Jakub Vohryzek","psa":"Morten L. Kringelbach","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4414161822","eid":"W4414161822"},{"id":"paper-w1996662801","cat":"papers","name":"Urinary catecholamine excretion after mescaline in man","year":"1968","cit":3,"pfa":"Leo E. Hollister","psa":"Frances F. Moore","ptype":"article","src":"https://openalex.org/W1996662801","eid":"W1996662801"},{"id":"paper-w3043534601","cat":"papers","name":"A tropane-based ibogaine analog rescues folding-deficient SERT and DAT","year":"2020","cit":3,"pfa":"Shreyas Bhat","psa":"Amy Hauck Newman","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W3043534601","eid":"W3043534601"},{"id":"paper-w2921864394","cat":"papers","name":"5-methoxy-N,N-dimethyltryptamine: An ego-dissolving endogenous neurochemical catalyst of creativity","year":"2019","cit":3,"pfa":"Christopher B. Germann","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W2921864394","eid":"W2921864394"},{"id":"paper-w2399024516","cat":"papers","name":"[Biologically active stable radicals. Paramagnetic model of mescaline].","year":"1975","cit":3,"pfa":"R I Zhdanov","psa":"E G Rozantsev","ptype":"article","src":"https://openalex.org/W2399024516","eid":"W2399024516"},{"id":"paper-w4321459245","cat":"papers","name":"Ayahuasca – a review of historical, pharmacological, and therapeutic aspects","year":"2023","cit":3,"pfa":"Simon Ruffell","psa":"Jerome J. Sarris","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4321459245","eid":"W4321459245"},{"id":"paper-w2408890429","cat":"papers","name":"Concise Synthesis of N,N -Dimethyltryptamine and 5-Methoxy- N,N -dimethyltryptamine Starting with Bufotenine from Brazilian Anadenanthera ssp","year":"2015","cit":3,"pfa":"Leandro Andrade Moreira","psa":"Maria Lucília dos Santos","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2408890429","eid":"W2408890429"},{"id":"paper-w4403619346","cat":"papers","name":"The original caretakers of salvinorin A and recognizing Indigenous contributions to science","year":"2024","cit":3,"pfa":"Khalyd J. Clay","psa":"Ryan A. Shenvi","ptype":"article","src":"https://openalex.org/W4403619346","eid":"W4403619346"},{"id":"paper-w2954139197","cat":"papers","name":"Amada's blessings from the peyote gardens of South Texas","year":"2016","cit":3,"ptype":"book-review","src":"https://openalex.org/W2954139197","eid":"W2954139197"},{"id":"paper-w2599793598","cat":"papers","name":"Brazil’s Ayahuasca Religions: Comparisons and Contrasts","year":"2016","cit":3,"pfa":"Andrew Dawson","ptype":"book-chapter","src":"https://openalex.org/W2599793598","eid":"W2599793598"},{"id":"paper-w56316689","cat":"papers","name":"PSYCHOSPIRITUAL INTEGRATION OF AN AYAHUASCA RETREAT EXPERIENCE","year":"2009","cit":3,"pfa":"Deborah J. Quevedo","psa":"Deborah J. Quevedo","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W56316689","eid":"W56316689"},{"id":"paper-w4292370110","cat":"papers","name":"Examining Attitudes to Psilocybin: Should Candidates for Medical Psilocybin be Required to Pass a Contextual Suitability Test?","year":"2022","cit":3,"pfa":"Mark Molumby","psa":"Róisín McNamara","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4292370110","eid":"W4292370110"},{"id":"paper-w2475187204","cat":"papers","name":"Effects of mescaline on flinch and movement shock thresholds in rats.","year":"1976","cit":3,"pfa":"Leifer Mw","psa":"Bridger Wh","ptype":"article","src":"https://openalex.org/W2475187204","eid":"W2475187204"},{"id":"paper-w2401197998","cat":"papers","name":"The mescaline or strychnine spikes as a tool for physiological and pharmacological studies.","year":"1977","cit":3,"pfa":"Ramos Jg","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2401197998","eid":"W2401197998"},{"id":"paper-w2015628703","cat":"papers","name":"Movement Disorders and MDMA Abuse","year":"2009","cit":3,"pfa":"JAMES ALLEN WILCOX","psa":"Aidee Herrera Wilcox","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2015628703","eid":"W2015628703"},{"id":"paper-w644962608","cat":"papers","name":"The neurochemistry of drugs of abuse : cocaine, ibogaine, and substituted amphetamines","year":"1998","cit":3,"pfa":"Syed F. Ali","ptype":"article","src":"https://openalex.org/W644962608","eid":"W644962608"},{"id":"paper-w2087494300","cat":"papers","name":"The effects of chronic mescaline administration on operant behavior in the pigeon","year":"1976","cit":3,"pfa":"David C. Hadorn","psa":"David S. Segal","ptype":"article","src":"https://openalex.org/W2087494300","eid":"W2087494300"},{"id":"paper-w4409045029","cat":"papers","name":"Psilocybin Dispensaries and Advertising—Buyer Beware","year":"2025","cit":3,"pfa":"Paul R. Hutson","ptype":"article","src":"https://openalex.org/W4409045029","eid":"W4409045029"},{"id":"paper-w2471708535","cat":"papers","name":"Tolerance to behavioral effects of N, N-dimethyltryptamine in mice.","year":"1981","cit":3,"pfa":"Cooper Sg","psa":"Bridger Wh","ptype":"article","src":"https://openalex.org/W2471708535","eid":"W2471708535"},{"id":"paper-w4246073219","cat":"papers","name":"Court Decision Regarding Peyote and the Native American Church","year":"1961","cit":3,"ptype":"article","src":"https://openalex.org/W4246073219","eid":"W4246073219"},{"id":"paper-w4365137546","cat":"papers","name":"The Theoretical Description for Psilocin Electrochemical Determination over Cobalt Oxyhydroxide","year":"2023","cit":3,"pfa":"Volodymyr Tkach","psa":"Жолт Кормош","ptype":"article","src":"https://openalex.org/W4365137546","eid":"W4365137546"},{"id":"paper-w2800304176","cat":"papers","name":"The deer that is peyote and the deer that is maize: the hunt in the Huichol \"trinity\"","year":"1996","cit":3,"pfa":"Denis Lemaistre","psa":"Karin Simoneau","ptype":"article","src":"https://openalex.org/W2800304176","eid":"W2800304176"},{"id":"paper-w4400070561","cat":"papers","name":"Being Better People: Drug Using Careers and Peyote","year":"2024","cit":3,"pfa":"Heith Copes","psa":"Peter S. Hendricks","topics":["PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4400070561","eid":"W4400070561"},{"id":"paper-w4234691134","cat":"papers","name":"Effect of ibogaine on the development of tolerance to the analgesic effect of morphine.","year":"1996","cit":3,"pfa":"Shepard Siegel","psa":"Linda A. Parker","ptype":"article","src":"https://openalex.org/W4234691134","eid":"W4234691134"},{"id":"paper-w4392032237","cat":"papers","name":"State and Federal Legal Protections for Peyote Use in the United States","year":"2016","cit":3,"pfa":"John P. Forren","topics":["Policy & ethics"],"ptype":"other","src":"https://openalex.org/W4392032237","eid":"W4392032237"},{"id":"paper-w4404571675","cat":"papers","name":"Legal and Ethics Concerns of Psilocybin as Medicine.","year":"2024","cit":3,"pfa":"Stephanie M. Schonholz","psa":"Michael R. MacIntyre","topics":["Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4404571675","eid":"W4404571675"},{"id":"paper-w4408829649","cat":"papers","name":"Is there room for ethics of authenticity in psilocybin research?","year":"2025","cit":3,"pfa":"Stefan Jerotić","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4408829649","eid":"W4408829649"},{"id":"paper-w2410264287","cat":"papers","name":"Behavioral effects of N,N-dimethyltryptamine in rats and mice.","year":"1970","cit":3,"pfa":"Haiti Moussatché","psa":"M dos SANTOS","ptype":"article","src":"https://openalex.org/W2410264287","eid":"W2410264287"},{"id":"paper-w2552418244","cat":"papers","name":"Ayahuasca, mitos y leyendas del Amazonas","year":"1943","cit":3,"pfa":"W. K. J.","psa":"Arturo Burga Freitas","ptype":"article","src":"https://openalex.org/W2552418244","eid":"W2552418244"},{"id":"paper-w7140141563","cat":"papers","name":"Voacangine/coronaridine hydroxylases catalyze C19-hydroxylation in iboga alkaloid synthesis","year":"2026","cit":3,"pfa":"Ana Luisa López-Vázquez","psa":"Vincent Courdavault","ptype":"article","src":"https://openalex.org/W7140141563","eid":"W7140141563"},{"id":"paper-w4386638047","cat":"papers","name":"Psilocybin for the Treatment of Substance Use Disorders","year":"2019","cit":3,"pfa":"Ishani Rao","psa":"Greg J. Lydall","topics":["Addiction"],"ptype":"other","src":"https://openalex.org/W4386638047","eid":"W4386638047"},{"id":"paper-w4411981579","cat":"papers","name":"Is There More to Magic Mushrooms than Psilocybin?","year":"2025","cit":3,"pfa":"Mara Johnson-Groh","ptype":"other","src":"https://openalex.org/W4411981579","eid":"W4411981579"},{"id":"paper-w192195550","cat":"papers","name":"Recepción de la ayahuasca en España","year":"2008","cit":3,"pfa":"Santiago López-Pavillard","ptype":"dissertation","src":"https://openalex.org/W192195550","eid":"W192195550"},{"id":"paper-w84907772","cat":"papers","name":"A Tissue Culture Model of MDMA Toxicity","year":"1990","cit":3,"pfa":"Whitaker-Azmitia Pm","psa":"Efrain C. Azmitia","topics":["Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W84907772","eid":"W84907772"},{"id":"paper-w4230846186","cat":"papers","name":"Some observations on psilocybin, a new hallucinogen, in volunteer subjects","year":"1960","cit":3,"pfa":"Sidney Malitz","psa":"Paul H. Hoch","ptype":"article","src":"https://openalex.org/W4230846186","eid":"W4230846186"},{"id":"paper-w4235219262","cat":"papers","name":"Ecstasy (MDMA), amphetamine, and LSD: comparative mood profiles in recreational polydrug users","year":"1997","cit":3,"pfa":"Andrew C. Parrott","psa":"Marta Stuart","ptype":"article","src":"https://openalex.org/W4235219262","eid":"W4235219262"},{"id":"paper-w2756010777","cat":"papers","name":"Effect of indole hallucinogens, mescaline and DMPEA on rat plasma prolactin","year":"1977","cit":3,"pfa":"Herbert Y. Meltzer","psa":"Victor S. Fang","ptype":"article","src":"https://openalex.org/W2756010777","eid":"W2756010777"},{"id":"paper-w2409543570","cat":"papers","name":"Quantitative measurement of time contraction induced by psilocybin.","year":"1968","cit":3,"pfa":"O Tosi","psa":"R Fischer","ptype":"article","src":"https://openalex.org/W2409543570","eid":"W2409543570"},{"id":"paper-w4313481594","cat":"papers","name":"Conformational Landscape and Hydrogen Bonding Pattern of Psilocin: Computational Insights","year":"2023","cit":3,"pfa":"Poonam Bhadoria","psa":"V. Ramanathan","ptype":"article","src":"https://openalex.org/W4313481594","eid":"W4313481594"},{"id":"paper-w4390656905","cat":"papers","name":"Behavioural Investigations of Psilocybin in Animals 1962-2021: A Scoping Review","year":"2024","cit":3,"pfa":"Ron Joseph Shore","psa":"Éric C. Dumont","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4390656905","eid":"W4390656905"},{"id":"paper-w2234700669","cat":"papers","name":"Approximate Molecular Potentials of Mescaline Analogues in a Study of Similarities to 5-Hydroxytryptamine","year":"1980","cit":3,"pfa":"Sheryl Baldwin","psa":"Donald D. Shillady","ptype":"article","src":"https://openalex.org/W2234700669","eid":"W2234700669"},{"id":"paper-w2114711911","cat":"papers","name":"Objects of Purpose—Objects of Prayer: Peyote Boxes of the Native American Church","year":"2010","cit":3,"pfa":"Daniel C. Swan","ptype":"article","src":"https://openalex.org/W2114711911","eid":"W2114711911"},{"id":"paper-w7164654902","cat":"papers","name":"Balancing safety and access in Oregon’s psilocybin services","year":"2026","cit":3,"pfa":"Katherine Cheung","psa":"David B. Yaden","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7164654902","eid":"W7164654902"},{"id":"paper-w3155744776","cat":"papers","name":"A Qualitative Assessment of Risks and Benefits of Ayahuasca for Trauma Survivors","year":"2021","cit":3,"pfa":"Jessica L. Nielson","psa":"Clancy Cavnar","topics":["PTSD & trauma","Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W3155744776","eid":"W3155744776"},{"id":"paper-w194098116","cat":"papers","name":"Effects of chlorpromazine and psilocin on pregnancy of c57bl/10 mice and their offspring at birth. Abstr.","year":"1967","cit":3,"pfa":"Carolyn Rolsten","ptype":"article","src":"https://openalex.org/W194098116","eid":"W194098116"},{"id":"paper-w2021993439","cat":"papers","name":"Bioisosteric Modification of Salvinorin A, a Potent and Selective ϰ‐Opioid Receptor Agonist.","year":"2006","cit":3,"pfa":"D. Jeremy Stewart","psa":"Jordan Kordian Zjawiony","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2021993439","eid":"W2021993439"},{"id":"paper-w4410851090","cat":"papers","name":"Understanding the Psychological Effects of Psilocybin and 3,4-Methylenedioxymethamphetamine in a Non-Clinical Population","year":"2025","cit":3,"pfa":"Paul Bernard Fitzgerald","psa":"Neil Wayne Bailey","topics":["Addiction","Dosing & pharmacology","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4410851090","eid":"W4410851090"},{"id":"paper-w4403185032","cat":"papers","name":"Healing with Ayahuasca the Plant Teacher: Psychedelic Metaphoricity and Polyontologies","year":"2024","cit":3,"pfa":"Alex K. Gearin","ptype":"article","src":"https://openalex.org/W4403185032","eid":"W4403185032"},{"id":"paper-w4406324616","cat":"papers","name":"Relationality and Ethics in MDMA-Assisted Therapy","year":"2025","cit":3,"pfa":"Jamie Beachy","psa":"Kelley C. O’Donnell","topics":["PTSD & trauma","Therapy practice","Policy & ethics"],"ptype":"editorial","src":"https://openalex.org/W4406324616","eid":"W4406324616"},{"id":"paper-w4400173130","cat":"papers","name":"Multiple Episodes of Cardiac Arrest Induced by Treatment With Ibogaine: A Case Report","year":"2024","cit":3,"pfa":"David Mestre","psa":"José Vaz","topics":["Addiction","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4400173130","eid":"W4400173130"},{"id":"paper-w4235066019","cat":"papers","name":"A Study of Psilocybin for Major Depressive Disorder (MDD)","year":"2019","cit":3,"topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4235066019","eid":"W4235066019"},{"id":"paper-w2442737633","cat":"papers","name":"Studies on mescaline XIV: (comparative biochemical effects of different drugs).","year":"1963","cit":3,"pfa":"Herman C.B. Denber","psa":"DOROTHY KAUFFMAN","ptype":"article","src":"https://openalex.org/W2442737633","eid":"W2442737633"},{"id":"paper-w4415436138","cat":"papers","name":"Clinical pharmacology of ayahuasca: potential applications and future considerations","year":"2025","cit":3,"pfa":"Lorena Terene Lopes Guerra","psa":"RAFAEL GUIMARÃES DOS SANTOS","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4415436138","eid":"W4415436138"},{"id":"paper-w2321588070","cat":"papers","name":"Design, synthesis and pharmacological activity of new C(2)-modified salvinorin A analogues","year":"2014","cit":3,"pfa":"Prabhakar Reddy Polepally","psa":"JK Zjawiony","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2321588070","eid":"W2321588070"},{"id":"paper-w2555036245","cat":"papers","name":"7 YEARS OF 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA) TOXICITY","year":"2001","cit":3,"pfa":"Joseph G. Rella","psa":"Robert S. Hoffman","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2555036245","eid":"W2555036245"},{"id":"paper-w1996981839","cat":"papers","name":"6-Hydroxydopamine inhibits some effects of mescaline centrally administered to rabbits","year":"1977","cit":3,"pfa":"S. Ferri","psa":"P. C. Braga","ptype":"article","src":"https://openalex.org/W1996981839","eid":"W1996981839"},{"id":"paper-w4285132328","cat":"papers","name":"Psilocybin and magic mushrooms: Patterns of abuse and consequences of recreational misuse","year":"2022","cit":3,"pfa":"Andreia Machado Brito-da-Costa","psa":"Ricardo Jorge Dinis‐Oliveira","ptype":"book-chapter","src":"https://openalex.org/W4285132328","eid":"W4285132328"},{"id":"paper-w2473528672","cat":"papers","name":"A Comparison of The Clinical Abuse Liability of Mdma and Mephedrone","year":"2015","cit":3,"pfa":"M. Llobet Farré","psa":"Esther Papaseit","ptype":"article","src":"https://openalex.org/W2473528672","eid":"W2473528672"},{"id":"paper-w4416839507","cat":"papers","name":"Sudden Loss of Consciousness Following Psilocybin Ingestion","year":"2025","cit":3,"pfa":"Amanda E. Downey","psa":"Josh D. Woolley","ptype":"article","src":"https://openalex.org/W4416839507","eid":"W4416839507"},{"id":"paper-w1974364441","cat":"papers","name":"Ibogaine Interferes with the Establishment of Conditioned Taste Avoidance Produced by Morphine and Lithium","year":"1996","cit":3,"pfa":"Linda A. Parker","psa":"Shepard Siegel","ptype":"article","src":"https://openalex.org/W1974364441","eid":"W1974364441"},{"id":"paper-w4416338510","cat":"papers","name":"Inner-Directed Therapy in MDMA-Assisted Psychotherapy","year":"2025","cit":3,"pfa":"Michael D. Alpert","psa":"Chantelle Thomas","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4416338510","eid":"W4416338510"},{"id":"paper-w2935527395","cat":"papers","name":"Aussiewaska: a cultural history of changa and ayahuasca analogues in Australia","year":"2016","cit":3,"pfa":"Graham St John","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W2935527395","eid":"W2935527395"},{"id":"paper-w2418954309","cat":"papers","name":"[Concentration of selected microelements in blood serum of rats exposed to the action of psilocin and phenylethylamine].","year":"2007","cit":3,"pfa":"Sławomir Majdanik","psa":"Anna Machoy‐Mokrzyńska","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2418954309","eid":"W2418954309"},{"id":"paper-w2088769265","cat":"papers","name":"Toxic effect of MDMA on brain serotonin neurons","year":"1999","cit":3,"pfa":"UD McCann","psa":"G.A. Ricaurte","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2088769265","eid":"W2088769265"},{"id":"paper-w2087726997","cat":"papers","name":"The Biblical Merkava Vision and Ayahuasca Visions - A Comparative Commentary","year":"2003","cit":3,"pfa":"Benny Shanon","ptype":"article","src":"https://openalex.org/W2087726997","eid":"W2087726997"},{"id":"paper-w4313569216","cat":"papers","name":"Self-experience in MDMA assisted therapy of PTSD","year":"2023","cit":3,"pfa":"Bessel A. van der Kolk","psa":"Rick Doblin","topics":["PTSD & trauma","Addiction","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4313569216","eid":"W4313569216"},{"id":"paper-w2300807028","cat":"papers","name":"Acute amnestic syndrome due to MDMA exposure","year":"2016","cit":3,"pfa":"Norbert Brüggemann","psa":"Thomas Frank Münte","ptype":"article","src":"https://openalex.org/W2300807028","eid":"W2300807028"},{"id":"paper-w4200622676","cat":"papers","name":"The protective role of dimethyltryptamine and its analogues against ischemiareperfusion injury: Commentary","year":"2021","cit":3,"pfa":"Ede Frecska","psa":"Attila Istvan Kovacs","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4200622676","eid":"W4200622676"},{"id":"paper-w2468290322","cat":"papers","name":"Enzymic pattern changes in the cat neocortex produced by a mescaline epileptogenic focus.","year":"1971","cit":3,"pfa":"NELLA MISON-CRIGHEL","psa":"G Badiu","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2468290322","eid":"W2468290322"},{"id":"paper-w4405922737","cat":"papers","name":"Exploring Psychedelics Pharmacology: A Scoping Review Charting the Course of Psilocybin Pharmacokinetics","year":"2024","cit":3,"pfa":"Ramiro Manzano-Núñez","psa":"Ana Aldea‐Perona","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4405922737","eid":"W4405922737"},{"id":"paper-w2317303115","cat":"papers","name":"Survey study of challenging experiences after ingesting psilocybin mushrooms: Demographics and phenomenology","year":"2014","cit":3,"pfa":"Theresa M. Carbonaro","psa":"Roland R. Griffiths","ptype":"article","src":"https://openalex.org/W2317303115","eid":"W2317303115"},{"id":"paper-w4233004824","cat":"papers","name":"Substance Abuse: Hallucinogen‐ and MDMA‐Related Disorders","year":"2008","cit":3,"pfa":"Rif S. El‐Mallakh","psa":"Henry David Abraham","topics":["Addiction"],"ptype":"other","src":"https://openalex.org/W4233004824","eid":"W4233004824"},{"id":"paper-w4414517913","cat":"papers","name":"Old Dog, New Tricks: Ibogaine and Its Analogs as Potential Neurotherapeutics","year":"2025","cit":3,"pfa":"Saghir Ali","psa":"Jia Zhou","ptype":"editorial","src":"https://openalex.org/W4414517913","eid":"W4414517913"},{"id":"paper-w4385669489","cat":"papers","name":"A systematic review to assess the use of psilocybin in the treatment of headaches","year":"2023","cit":3,"pfa":"Saundarai Bhanot","psa":"Vivian W. L. Tsang","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W4385669489","eid":"W4385669489"},{"id":"paper-w4366774867","cat":"papers","name":"The right to privacy in the decriminalisation of psilocybin mushrooms in South Africa","year":"2023","cit":3,"pfa":"Sebastian William Foster","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4366774867","eid":"W4366774867"},{"id":"paper-w4414482106","cat":"papers","name":"Psilocybin-assisted psychotherapy in adults with depression – A literature review","year":"2025","cit":3,"pfa":"Marie Celine Dorczok","psa":"Verena Steiner‐Hofbauer","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4414482106","eid":"W4414482106"},{"id":"paper-w2126467522","cat":"papers","name":"Pattern transference: making a ‘Nova Scotia tartan’ bracelet using the peyote stitch","year":"2009","cit":3,"pfa":"Eva Knoll","ptype":"article","src":"https://openalex.org/W2126467522","eid":"W2126467522"},{"id":"paper-w4287102283","cat":"papers","name":"A whole genome atlas of 81 Psilocybe genomes as a resource for psilocybin production.","year":"2021","cit":3,"pfa":"Kevin Judd McKernan","psa":"Stephen McLaughlin","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4287102283","eid":"W4287102283"},{"id":"paper-w3153807981","cat":"papers","name":"Acute and Long-Term Effects of Ayahuasca on (Higher-Order) Cognitive Processes","year":"2021","cit":3,"pfa":"Natasha Leigh Mason","psa":"Kim P. C. Kuypers","ptype":"book-chapter","src":"https://openalex.org/W3153807981","eid":"W3153807981"},{"id":"paper-w7123730053","cat":"papers","name":"The Psychological Support Model in Psilocybin Research: Psychotherapy in Disguise?","year":"2026","cit":3,"pfa":"Celia Faye Jacobsen","psa":"Sophia Armand","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W7123730053","eid":"W7123730053"},{"id":"paper-w2002436743","cat":"papers","name":"Combating Substance Abuse with Ibogaine: Pre- and Posttreatment Recommendations and an Example of Successive Model Fitting Analyses","year":"2004","cit":3,"pfa":"James Bryant Hittner","psa":"Susan B. Quello","topics":["Addiction","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2002436743","eid":"W2002436743"},{"id":"paper-w2495418288","cat":"papers","name":"The Widely Available Hallucinogenic Plant Salvia divinorum and Its Main Component, Salvinorin A","year":"2016","cit":3,"pfa":"Eduardo R. Butelman","psa":"Mary Jeanne Kreek","ptype":"book-chapter","src":"https://openalex.org/W2495418288","eid":"W2495418288"},{"id":"paper-w4231385556","cat":"papers","name":"The Effects of Ecstasy (MDMA) on Rat Liver Bioenergetics","year":"2004","cit":3,"pfa":"Daniel E. Rusyniak","psa":"James E. Klaunig","ptype":"article","src":"https://openalex.org/W4231385556","eid":"W4231385556"},{"id":"paper-w4412363706","cat":"papers","name":"Population pharmacokinetic-pharmacodynamic modeling of co-administered N,N-dimethyltryptamine and harmine in healthy subjects","year":"2025","cit":3,"pfa":"Angela Äbelö","psa":"Milan Scheidegger","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4412363706","eid":"W4412363706"},{"id":"paper-w4401626310","cat":"papers","name":"Drug-induced psychosis following use of Ayahuasca: a presentation to forensic psychiatric services","year":"2024","cit":3,"pfa":"M. Baker","psa":"Christopher Iain O'Shea","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4401626310","eid":"W4401626310"},{"id":"paper-w3021503960","cat":"papers","name":"Effects of MDMA (ecstasy) use and abstention on serotonin neurons","year":"2002","cit":3,"pfa":"Elisabeth Ratzenböck","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3021503960","eid":"W3021503960"},{"id":"paper-w3161056788","cat":"papers","name":"Good Mother Nature: ayahuasca neoshamanism as cultural critique in Australia","year":"2016","cit":3,"pfa":"Alex K. Gearin","ptype":"book-chapter","src":"https://openalex.org/W3161056788","eid":"W3161056788"},{"id":"paper-w1990488132","cat":"papers","name":"MDMA: The doubts surrounding Ecstasy and the response of the emergency nurse","year":"1993","cit":3,"pfa":"Chris A. Jones","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1990488132","eid":"W1990488132"},{"id":"paper-w2808964351","cat":"papers","name":"Is utility maximization compromised by acute intoxication with THC or MDMA?","year":"2018","cit":3,"pfa":"Gillinder Bedi","psa":"Daniel R. Burghart","ptype":"article","src":"https://openalex.org/W2808964351","eid":"W2808964351"},{"id":"paper-w4400180748","cat":"papers","name":"Preserving the Sacred Medicine: Why Peyote Should Be Excluded from Entheogenic Plant Decriminalization Efforts","year":"2024","cit":3,"pfa":"Sophia Palumbo","topics":["Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4400180748","eid":"W4400180748"},{"id":"paper-w4405762768","cat":"papers","name":"Characterizing psilocybin as an antidepressant for adolescence in male and female rats","year":"2024","cit":3,"pfa":"Rubén García‐Cabrerizo","psa":"María Julia García-Fuster","topics":["Depression","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4405762768","eid":"W4405762768"},{"id":"paper-w2517737110","cat":"papers","name":"The risks and potential benefits of ayahuasca use from a psychopharmacological perspective.","year":"2011","cit":3,"pfa":"Ede Frecska","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W2517737110","eid":"W2517737110"},{"id":"paper-w2792016544","cat":"papers","name":"Ayahuasca y resistencia indígena en la Amazonía peruana","year":"2006","cit":3,"pfa":"Riccardo Badini","ptype":"book-chapter","src":"https://openalex.org/W2792016544","eid":"W2792016544"},{"id":"paper-w2048389906","cat":"papers","name":"A reinvenção do uso da ayahuasca nos centros urbanos","year":"2005","cit":3,"pfa":"Benny Shanon","ptype":"article","src":"https://openalex.org/W2048389906","eid":"W2048389906"},{"id":"paper-w4405283320","cat":"papers","name":"MDMA for PTSD and beyond: a new paradigm brings hope","year":"2024","cit":3,"pfa":"Scott Shannon","psa":"Jamarie A. Geller","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4405283320","eid":"W4405283320"},{"id":"paper-w4403380436","cat":"papers","name":"Reassessing ayahuasca regulation in Brazil: strategic framing and cumulative gains","year":"2024","cit":3,"pfa":"Felipe Krause","topics":["Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4403380436","eid":"W4403380436"},{"id":"paper-w1974741243","cat":"papers","name":"Positron emission tomography findings in heavy users of MDMA","year":"1999","cit":3,"pfa":"UD McCann","psa":"G.A. Ricaurte","ptype":"article","src":"https://openalex.org/W1974741243","eid":"W1974741243"},{"id":"paper-w4244331270","cat":"papers","name":"Does N,N-dimethyltryptamine (DMT) adequately explain near-death experiences?","year":"2012","cit":3,"pfa":"Michael Potts","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4244331270","eid":"W4244331270"},{"id":"paper-w3027895549","cat":"papers","name":"“Figure 4, Peyote”: Comics and Graphic Narrative in Anarchist Cookbooks, 1971-Present","year":"2020","cit":3,"pfa":"Hilary A. Sarat-St. Peter","psa":"Austin L. St. Peter","ptype":"article","src":"https://openalex.org/W3027895549","eid":"W3027895549"},{"id":"paper-w4404780287","cat":"papers","name":"MDMA pharmacokinetics: A population and physiologically based pharmacokinetics model‐informed analysis","year":"2024","cit":3,"pfa":"Marilyn Ann Huestis","psa":"Berra Yazar‐Klosinski","topics":["PTSD & trauma","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4404780287","eid":"W4404780287"},{"id":"paper-w4294891736","cat":"papers","name":"MDMA and Their Analogs as Therapeutics for Mental Disorder and Response Predictor","year":"2022","cit":3,"pfa":"Robert B. Kargbo","topics":["PTSD & trauma","Addiction","Dosing & pharmacology"],"ptype":"editorial","src":"https://openalex.org/W4294891736","eid":"W4294891736"},{"id":"paper-w2915253893","cat":"papers","name":"Yubaka Hayrá: Notas sobre a Conferência Indígena da Ayahuasca","year":"2019","cit":3,"pfa":"Domingos Bueno Da Silva","ptype":"article","src":"https://openalex.org/W2915253893","eid":"W2915253893"},{"id":"paper-w4400695899","cat":"papers","name":"Serotoninergic antidepressants combination in psilocybin-assisted psychotherapy: a case report","year":"2024","cit":3,"pfa":"André Do","psa":"Philippe D. Vincent","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4400695899","eid":"W4400695899"},{"id":"paper-w4416977442","cat":"papers","name":"Questioning the recovery of dissociated traumatic memories under psilocybin: comment on “Therapeutic emergence of dissociated traumatic memories during psilocybin treatment for anorexia nervosa”","year":"2025","cit":3,"pfa":"Samuli Kangaslampi","psa":"Henry Otgaar","topics":["PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4416977442","eid":"W4416977442"},{"id":"paper-w2475151299","cat":"papers","name":"MDMA «Extasis» : Revisión y puesta al día","year":"1991","cit":3,"pfa":"Ignacio Blasco Mascaró","psa":"E. Martí‐Bonmatí","ptype":"article","src":"https://openalex.org/W2475151299","eid":"W2475151299"},{"id":"paper-w4294199694","cat":"papers","name":"A Phase 1, Dose-Ranging Study to Assess Safety and Psychoactive Effects of a Vaporized 5-Methoxy-N,N-Dimethyltryptamine Formulation (GH001) in Healthy Volunteers","year":"2022","cit":3,"pfa":"Johannes T. Reckweg","psa":"J. Ramaekers","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4294199694","eid":"W4294199694"},{"id":"paper-w2162136327","cat":"papers","name":"Modelling the Adverse Effects Associated With Ecstasy (MDMA) Usage","year":"2011","cit":3,"pfa":"John E. Fisk","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2162136327","eid":"W2162136327"},{"id":"paper-w2402858413","cat":"papers","name":"[A PSYCHOPATHOLOGICAL STUDY OF THE PSILOCYBIN PSYCHOSIS; COMPARISON WITH THE LSD-25 PSYCHOSIS].","year":"1964","cit":3,"pfa":"Akimitsu Miyoshi","ptype":"article","src":"https://openalex.org/W2402858413","eid":"W2402858413"},{"id":"paper-w2106813676","cat":"papers","name":"Editors' Introduction: The State of Ecstasy: MDMA—Science and Policy","year":"2002","cit":3,"pfa":"Steve Heilig","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2106813676","eid":"W2106813676"},{"id":"paper-w4247078599","cat":"papers","name":"NIDA Conference Highlights Scientific Findings on MDMA/Ecstasy","year":"2001","cit":3,"pfa":"Robert Mathias","psa":"Patrick Zickler","ptype":"dataset","src":"https://openalex.org/W4247078599","eid":"W4247078599"},{"id":"paper-w3169192423","cat":"papers","name":"Psilocybin: A brief overview for psychiatric mental health nurse practitioners","year":"2021","cit":3,"pfa":"Dina Fradkin","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3169192423","eid":"W3169192423"},{"id":"paper-w3016845493","cat":"papers","name":"MDMA and TAAR1‐mediated RhoA Activation in Serotonin Neurons","year":"2020","cit":3,"pfa":"Suzanne M. Underhill","psa":"Susan Amara","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"conference-abstract","src":"https://openalex.org/W3016845493","eid":"W3016845493"},{"id":"paper-w2415563674","cat":"papers","name":"The electronic and serotonin receptor binding affinity properties of N,N-dimethyltryptamine analogs.","year":"1977","cit":3,"pfa":"Richard A. Glennon","psa":"Gessner Pk","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2415563674","eid":"W2415563674"},{"id":"paper-w2125020536","cat":"papers","name":"Elimination Half-Lives of Benzoylecgonine and MDMA in an Apprehended Driver","year":"2008","cit":3,"pfa":"Alan Wayne Jones","ptype":"article","src":"https://openalex.org/W2125020536","eid":"W2125020536"},{"id":"paper-w2018388105","cat":"papers","name":"An assessment of the stability of MDMA, methamphetamine and THC in oral fluid","year":"2014","cit":3,"pfa":"Sophie C. Turfus","psa":"Olaf H. Drummer","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2018388105","eid":"W2018388105"},{"id":"paper-w4242103620","cat":"papers","name":"Future Directions for Clinical Psilocybin Research: The Relaxed Symptom Network","year":"2021","cit":3,"pfa":"Evan Lewis-Healey","psa":"Michiel van Elk","topics":["Depression","Mechanism & neuroscience","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4242103620","eid":"W4242103620"},{"id":"paper-w3005155714","cat":"papers","name":"The Touristic Use of Ayahuasca in Peru : Expectations, Experiences, Meanings and Subjective Effects","year":"2020","cit":3,"pfa":"Tom John Wolff","ptype":"book","src":"https://openalex.org/W3005155714","eid":"W3005155714"},{"id":"paper-w4386702998","cat":"papers","name":"Predictors of Pharmacy Students' Attitudes About the Therapeutic Use of Psilocybin","year":"2023","cit":3,"pfa":"N. M. Mahmudul Alam Bhuiya","psa":"Joshua Caballero","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4386702998","eid":"W4386702998"},{"id":"paper-w1983329325","cat":"papers","name":"Psilocybin slows binocular rivalry switching through serotonin modulation","year":"2010","cit":3,"pfa":"Olivia L. Carter","psa":"Franz X. Vollenweider","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1983329325","eid":"W1983329325"},{"id":"paper-w4376279288","cat":"papers","name":"Cognitive liberty and the constitutionality of criminalising psilocybin mushrooms in South Africa","year":"2023","cit":3,"pfa":"Sebastian William Foster","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4376279288","eid":"W4376279288"},{"id":"paper-w2908507995","cat":"papers","name":"The role of ceremonial ayahuasca use and the healing of eating disorders: a qualitative study","year":"2018","cit":3,"pfa":"Marika Renelli","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"dissertation","src":"https://openalex.org/W2908507995","eid":"W2908507995"},{"id":"paper-w2041734391","cat":"papers","name":"Effects of pargyline and SKF-525A on brain N,N-dimethyltryptamine concentrations and hyperactivity in mice","year":"1981","cit":3,"pfa":"Alun Morinan","psa":"Jonathan G. Collier","ptype":"article","src":"https://openalex.org/W2041734391","eid":"W2041734391"},{"id":"paper-w4413958478","cat":"papers","name":"Therapeutic Use of Psilocybin in Depression: a Systematic Review of Clinical Evidence","year":"2025","cit":3,"pfa":"Filipe Reis Teodoro Andrade","psa":"Rosa M. M. de Almeida","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W4413958478","eid":"W4413958478"},{"id":"paper-w4403180565","cat":"papers","name":"Continuous flow synthesis of N , N -dimethyltryptamine (DMT) analogues with therapeutic potential","year":"2024","cit":3,"pfa":"Andreas Simoens","psa":"Christian  Victor Stevens","ptype":"article","src":"https://openalex.org/W4403180565","eid":"W4403180565"},{"id":"paper-w2607091484","cat":"papers","name":"Pharmacology and Structure-Activity Relationship of Natural Products With Psychoactive Effects From Salvia divinorum, Mitragyna speciosa, and Ayahuasca","year":"2017","cit":3,"pfa":"S.M. Phipps","psa":"Oliver Grundmann","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W2607091484","eid":"W2607091484"},{"id":"paper-w3157975835","cat":"papers","name":"Effects of Psilocybin on Suicidal Ideation in Patients With Life-Threatening Cancer","year":"2021","cit":3,"pfa":"Julia Benville","psa":"Stephen Ross","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3157975835","eid":"W3157975835"},{"id":"paper-w4313445584","cat":"papers","name":"Opening Death’s Door: Psilocybin and Existential Suffering in Palliative Care","year":"2023","cit":3,"pfa":"Duff R. Waring","topics":["Anxiety & end-of-life"],"ptype":"book-chapter","src":"https://openalex.org/W4313445584","eid":"W4313445584"},{"id":"paper-w2327332074","cat":"papers","name":"Is the 5-iodo-2-aminoindan (5-IAI) the New MDMA?","year":"2012","cit":3,"pfa":"Maurizio Coppola","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2327332074","eid":"W2327332074"},{"id":"paper-w126510638","cat":"papers","name":"THE NORMAL OCCURRENCE OF TRYPTAMINE IN BRAIN AND ITS CONVERSION TO N-METHYL AND N-DIMETHYLTRYPTAMINE IN VITRO AND IN VIVO","year":"1973","cit":3,"pfa":"Juan M. Saavedra","psa":"Joshua L. Axelrod","ptype":"book-chapter","src":"https://openalex.org/W126510638","eid":"W126510638"},{"id":"paper-w4281784879","cat":"papers","name":"The safety and efficacy of psilocybin therapy in patients with cancer and major depressive disorder.","year":"2022","cit":3,"pfa":"Manish Agrawal","psa":"Sarah Shnayder","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"conference-abstract","src":"https://openalex.org/W4281784879","eid":"W4281784879"},{"id":"paper-w4407078896","cat":"papers","name":"Psilocybin-assisted psychotherapy for Parkinson's disease without depression: A case-report","year":"2025","cit":3,"pfa":"Vanessa Fleury","psa":"Louise E. Penzenstadler","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4407078896","eid":"W4407078896"},{"id":"paper-w4387406668","cat":"papers","name":"MDMA-assisted therapy for PTSD passes phase III trial","year":"2023","cit":3,"pfa":"Asher Mullard","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4387406668","eid":"W4387406668"},{"id":"paper-w4387689286","cat":"papers","name":"Shamans, peyote, and coca sacraments: a path that maintains indigenous traditions and identity in a time of globalization","year":"2005","cit":3,"pfa":"Stacy B. Schaefer","ptype":"article","src":"https://openalex.org/W4387689286","eid":"W4387689286"},{"id":"paper-w2140286070","cat":"papers","name":"Evolución histórica del uso y abuso de MDMA","year":"2003","cit":3,"pfa":"Pilar Alejandra Sáiz","psa":"Julio Bobes","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2140286070","eid":"W2140286070"},{"id":"paper-w1644488269","cat":"papers","name":"Peyote, enfermedad y regeneración de la vida entre huicholes y tarahumaras","year":"2012","cit":3,"pfa":"Cario Bonfiglioli","psa":"Arturo Gutiérrez del Ángel","ptype":"article","src":"https://openalex.org/W1644488269","eid":"W1644488269"},{"id":"paper-w7161294763","cat":"papers","name":"Short-Term and Late-Term Effects of Psilocybin on Symptoms in Major Depression","year":"2026","cit":3,"pfa":"Hampus Yngwe","psa":"J O Lundberg","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7161294763","eid":"W7161294763"},{"id":"paper-w2893009334","cat":"papers","name":"Pedagogia da Ayahuasca: Por uma decolonização epistêmica do saber","year":"2018","cit":3,"pfa":"Maria Betânia Barbosa Albuquerque","ptype":"article","src":"https://openalex.org/W2893009334","eid":"W2893009334"},{"id":"paper-w2405365507","cat":"papers","name":"The effect of psilocybin upon the systemic, pulmonary, and coronary circulation of the intact dog.","year":"1962","cit":3,"pfa":"George M. Maxwell","psa":"Reidar Elliott","ptype":"article","src":"https://openalex.org/W2405365507","eid":"W2405365507"},{"id":"paper-w3162082816","cat":"papers","name":"MDMA scores PTSD success in a landmark phase III trial","year":"2021","cit":3,"pfa":"Asher Mullard","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W3162082816","eid":"W3162082816"},{"id":"paper-w7126381155","cat":"papers","name":"Single-dose psilocybin promotes cell-type-specific changes of neurons in the orbitofrontal cortex","year":"2026","cit":3,"pfa":"Ziran Huang","psa":"Wen Zhang","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7126381155","eid":"W7126381155"},{"id":"paper-w4225909831","cat":"papers","name":"Alleviation of Cocaine Withdrawal and Pertinent Interactions between Salvinorin-based Antagonists and Kappa Opioid Receptor","year":"2022","cit":3,"pfa":"Nicholas S. Akins","psa":"Hoang V. Le","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W4225909831","eid":"W4225909831"},{"id":"paper-w4313200314","cat":"papers","name":"Pharmacokinetics and pharmacokinetic-pharmacodynamic relationship of oral psilocybin administration in healthy subjects","year":"2022","cit":3,"pfa":"Friederike Holze","psa":"Matthias E. Liechti","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4313200314","eid":"W4313200314"},{"id":"paper-w4387781098","cat":"papers","name":"Christian Responses to Psilocybin-Assisted Therapy and Potential Religious and Spiritual Experiences","year":"2023","cit":3,"pfa":"Brian Claude Macallan","ptype":"article","src":"https://openalex.org/W4387781098","eid":"W4387781098"},{"id":"paper-w2310605463","cat":"papers","name":"Listening for the logos : a study of reports of audible voices at high doses of psilocybin","year":"1996","cit":3,"pfa":"Horace J. Beach","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2310605463","eid":"W2310605463"},{"id":"paper-w2407646321","cat":"papers","name":"The roles of 3,4,5-trihydroxy-beta-phenethylamine and 3,4-dimethoxy-beta-phenethylamine in the biosynthesis of Mescaline.","year":"1969","cit":3,"pfa":"A G Paul","psa":"Khanna Kl","ptype":"article","src":"https://openalex.org/W2407646321","eid":"W2407646321"},{"id":"paper-w4388566656","cat":"papers","name":"A quantitative textual analysis of the subjective effects of ayahuasca in naïve users with and without depression","year":"2023","cit":3,"pfa":"Lucas Villar Magalhães da Cruz","psa":"Daniel C. Mograbi","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4388566656","eid":"W4388566656"},{"id":"paper-w4409425095","cat":"papers","name":"PsiConnect: A Multimodal Neuroimaging Study of Psilocybin-Induced Changes in Brain and Behaviour","year":"2025","cit":3,"pfa":"Leonardo Novelli","psa":"Adeel Razi","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4409425095","eid":"W4409425095"},{"id":"paper-w1978014151","cat":"papers","name":"SPE/TLC Profiling of the Impurities of MDMA: The Influence of an Agglutinant, Diluents, and Adulterants","year":"2006","cit":3,"pfa":"Jolanta Kochana","psa":"Jarosław Wilamowski","ptype":"article","src":"https://openalex.org/W1978014151","eid":"W1978014151"},{"id":"paper-w2911853638","cat":"papers","name":"A genetic deletion of the serotonin transporter differentially influences the behavioural effects of MDMA","year":"2019","cit":3,"pfa":"Michaela A. Pettie","psa":"Bart A. Ellenbroek","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2911853638","eid":"W2911853638"},{"id":"paper-w3217719554","cat":"papers","name":"Bibliometric Analysis of Academic Journal Articles Reporting Results of Psychedelic Clinical Studies","year":"2021","cit":3,"pfa":"Jeremy Weleff","psa":"Brian Scott Barnett","topics":["Addiction","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W3217719554","eid":"W3217719554"},{"id":"paper-w4224250487","cat":"papers","name":"Syndrome of Inappropriate Antidiuretic Hormone Secretion Following Ayahuasca Use in a Satanic Ritual: A Case Report","year":"2022","cit":3,"pfa":"Maryam Bayat Mokhtari","psa":"Ivan D Rodriguez","ptype":"article","src":"https://openalex.org/W4224250487","eid":"W4224250487"},{"id":"paper-w2335652815","cat":"papers","name":"Michael Acceptor Approach to the Design of New Salvinorin A- Based High Affinity Ligands to the Kappa-Opioid Receptor","year":"2012","cit":3,"pfa":"Prabhakar Reddy Polepally","psa":"Jordan Kordian Zjawiony","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2335652815","eid":"W2335652815"},{"id":"paper-w1763137762","cat":"papers","name":"Westerners in search of the legendary potion : ayahuasca travel in the borderland between tourism and pilgrimage","year":"2013","cit":3,"pfa":"Ville Mantere","ptype":"dissertation","src":"https://openalex.org/W1763137762","eid":"W1763137762"},{"id":"paper-w4405489563","cat":"papers","name":"Effects of ayahuasca on fear and anxiety: cross-talk between 5HT1A and 5HT2A receptors","year":"2024","cit":3,"pfa":"Lorena Terene Lopes Guerra","psa":"Jaime E. C. Hallak","topics":["PTSD & trauma","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4405489563","eid":"W4405489563"},{"id":"paper-w2422718028","cat":"papers","name":"Brain levels of serotonin (5-HT) and norepinephrine (NE) during mescaline-induced behavior in mice.","year":"1973","cit":3,"pfa":"Shah Ns","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2422718028","eid":"W2422718028"},{"id":"paper-w2748331273","cat":"papers","name":"Life-threatening intoxications related to persistent MDMA (3,4-methylenedioxymethamphetamine) concentrations","year":"2017","cit":3,"pfa":"Laura Di Trapani","psa":"Hélène Peyrière","ptype":"article","src":"https://openalex.org/W2748331273","eid":"W2748331273"},{"id":"paper-w4412611593","cat":"papers","name":"Avoiding Stigma and Sensationalism in Therapeutic Psilocybin Communications: Considerations for Reaching Older Patients","year":"2025","cit":3,"pfa":"Charlotte M. Gillespie","psa":"Jesse M. Bering","ptype":"article","src":"https://openalex.org/W4412611593","eid":"W4412611593"},{"id":"paper-w2089647094","cat":"papers","name":"MDMA (ecstasy) modulates locomotor and prefrontal cortex sensory evoked activity","year":"2009","cit":3,"pfa":"Kristal D. Atkins","psa":"Nachum Dafny","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2089647094","eid":"W2089647094"},{"id":"paper-w2095259213","cat":"papers","name":"Effects of MDMA (ecstasy) and two of its metabolites on rat embryos in vitro","year":"2012","cit":3,"pfa":"Marta Barenys","psa":"J.M. Llobet","ptype":"article","src":"https://openalex.org/W2095259213","eid":"W2095259213"},{"id":"paper-w4409534321","cat":"papers","name":"Regulatory Alignment of Psilocybin Clinical Trials in Major Depressive Disorder on ClinicalTrials.gov: A Cross-Sectional Analysis","year":"2025","cit":3,"pfa":"Damian Świeczkowski","psa":"Wiesław Jerzy Cubała","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4409534321","eid":"W4409534321"},{"id":"paper-w2330715843","cat":"papers","name":"Neural correlates of working memory in pure and polyvalent ecstasy (MDMA) users","year":"2004","cit":3,"pfa":"Jörg Daumann","psa":"Euphrosyne Gouzoulis‐Mayfrank","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2330715843","eid":"W2330715843"},{"id":"paper-w4384933712","cat":"papers","name":"Distinctive Molecular and Metabolic Profiles of Chemically Synthesized Psilocybin and Psychedelic Mushroom Extract","year":"2023","cit":3,"pfa":"Orr Shahar","psa":"Tzuri Lifschytz","ptype":"preprint","src":"https://openalex.org/W4384933712","eid":"W4384933712"},{"id":"paper-w4391757540","cat":"papers","name":"Psilocybin induces dose-dependent changes in functional network organization in rat cortex","year":"2024","cit":3,"pfa":"Brian H. Silverstein","psa":"Dinesh Pal","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4391757540","eid":"W4391757540"},{"id":"paper-w4409528946","cat":"papers","name":"Roadmap for Equitable Access and Responsible Use of Psilocybin-Assisted Psychotherapy in Palliative Care","year":"2025","cit":3,"pfa":"Michel Dorval","psa":"Jean‐Sébastien Fallu","topics":["Anxiety & end-of-life","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4409528946","eid":"W4409528946"},{"id":"paper-w2014048128","cat":"papers","name":"Application of Carbon Adsorbents for Extraction of MDMA Impurities in TLC Drug Profiling","year":"2008","cit":3,"pfa":"Jolanta Kochana","psa":"A. Parczewski","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2014048128","eid":"W2014048128"},{"id":"paper-w4322769999","cat":"papers","name":"Incidence of Intoxications in the Emergency Department of Galati Hospital with Examples of Cardiovascular Effects of MDMA Intoxication","year":"2023","cit":3,"pfa":"Liliana Dragomir","psa":"Cosmina-Alina Moscu","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4322769999","eid":"W4322769999"},{"id":"paper-w3183856202","cat":"papers","name":"Out of the night-time and into the day: Ketamine and MDMA as therapies for mental disorders","year":"2021","cit":3,"pfa":"Christopher G. Davey","ptype":"article","src":"https://openalex.org/W3183856202","eid":"W3183856202"},{"id":"paper-w2155056269","cat":"papers","name":"Saberes da ayahuasca e processos educativos na religião do Santo Daime","year":"2025","cit":3,"pfa":"Maria Betânia Barbosa Albuquerque","ptype":"article","src":"https://openalex.org/W2155056269","eid":"W2155056269"},{"id":"paper-w4303942594","cat":"papers","name":"Statistics-Based Optimization of the Extraction Process of N,N-dimethyltryptamine from Mimosa tenuiflora Stem Bark","year":"2022","cit":3,"pfa":"Isabela Araújo e Amariz","psa":"Larissa Araújo Rolim","ptype":"article","src":"https://openalex.org/W4303942594","eid":"W4303942594"},{"id":"paper-w4411451805","cat":"papers","name":"Investigating the Synergistic Neuroprotective Effects of Plant-Derived Antioxidants and the Psychedelic N,N-Dimethyltryptamine in Alzheimer’s Disease Therapy","year":"2025","cit":3,"pfa":"Júlia Jarné‐Ferrer","psa":"Aina Bellver‐Sanchís","ptype":"article","src":"https://openalex.org/W4411451805","eid":"W4411451805"},{"id":"paper-w2315104287","cat":"papers","name":"Notes- Mescaline Analogs. X. 3,4-Dimethyl-, 3,4-Dichloro- and 3,5-Dimethoxy-4-methyl-β-phenethylamines","year":"1960","cit":3,"pfa":"Frederick Benington","psa":"L. M. Clark","ptype":"article","src":"https://openalex.org/W2315104287","eid":"W2315104287"},{"id":"paper-w4313551340","cat":"papers","name":"An Integrative Review of Measures of Spirituality in Experimental Studies of Psilocybin in Serious Illness Populations","year":"2023","cit":3,"pfa":"Kayla M. Baker","psa":"Salimah H. Meghani","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4313551340","eid":"W4313551340"},{"id":"paper-w4390660590","cat":"papers","name":"Psilocybin Promotes Cell-Type-Specific Changes in the Orbitofrontal Cortex Revealed by Single-Nucleus RNA-seq","year":"2024","cit":3,"pfa":"Ziran Huang","psa":"Wen Zhang","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4390660590","eid":"W4390660590"},{"id":"paper-w4386374699","cat":"papers","name":"Case report: Ibogaine reduced severe neuropathic pain associated with a case of brachial plexus nerve root avulsion","year":"2023","cit":3,"pfa":"Jonathan E. Dickinson","psa":"Abhiram P. Pushparaj","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4386374699","eid":"W4386374699"},{"id":"paper-w4415081303","cat":"papers","name":"Set and setting in psilocybin-assisted therapy: A qualitative study of patients with cancer and depression","year":"2025","cit":3,"pfa":"Yvan Beaussant","psa":"Manish Agrawal","topics":["Depression","Anxiety & end-of-life","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4415081303","eid":"W4415081303"},{"id":"paper-w4387215851","cat":"papers","name":"Psilocybin-Assisted Therapy: A scoping review of participants’ and facilitators’ experiences in qualitative studies","year":"2023","cit":3,"pfa":"Nicole Schuitmaker","topics":["Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4387215851","eid":"W4387215851"},{"id":"paper-w4298395858","cat":"papers","name":"Psilocybin Therapy for Treatment Resistant Depression: Prediction of Clinical Outcome by Natural Language Processing","year":"2022","cit":3,"pfa":"Robert F. Dougherty","psa":"Gregory Ryslik","topics":["Depression","Safety & adverse events","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4298395858","eid":"W4298395858"},{"id":"paper-w2137672182","cat":"papers","name":"Intracerebral and oral adiministration of methylenedioxymethamphetamine (MDMA): distribution and neurochemical alterations in rat brain","year":"1990","cit":3,"pfa":"Syed F. Ali","psa":"William Slikker","ptype":"article","src":"https://openalex.org/W2137672182","eid":"W2137672182"},{"id":"paper-w4280498616","cat":"papers","name":"Soumission chimique impliquant la MDMA : à propos d’un cas inhabituel","year":"2022","cit":3,"pfa":"Anne‐Laure Pélissier‐Alicot","psa":"Georges Léonetti","ptype":"article","src":"https://openalex.org/W4280498616","eid":"W4280498616"},{"id":"paper-w2418709346","cat":"papers","name":"Occurrence of 5-methoxy-N,N-dimethyltryptamine oxide and other tryptamines in Desmodium pulchellum Benth ex Baker.","year":"1965","cit":3,"pfa":"S Ghosal","psa":"B Mukherjee","ptype":"article","src":"https://openalex.org/W2418709346","eid":"W2418709346"},{"id":"paper-w4256618606","cat":"papers","name":"Memory and mood during the night and in the morning after repeated evening doses of MDMA","year":"2008","cit":3,"pfa":"K.P.C. Kuypers","psa":"Johannes Gerardus Ramaekers","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4256618606","eid":"W4256618606"},{"id":"paper-w4225282848","cat":"papers","name":"Entre sucuris e queixadas: transformações nos mitos pano de origem da ayahuasca","year":"2022","cit":3,"pfa":"Marcos de Almeida Matos","ptype":"article","src":"https://openalex.org/W4225282848","eid":"W4225282848"},{"id":"paper-w4399777542","cat":"papers","name":"Detection of Psychoactive N,N-Dimethyltryptamine Alkaloid Based on Surface‑Enhanced Raman Scattering Using Gold Nanostars in Flexible Inkjet‑Printing Paper Substrates","year":"2024","cit":3,"pfa":"Edison Huertas-Montoya","psa":"Ítalo Odone Mazali","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4399777542","eid":"W4399777542"},{"id":"paper-w4366590080","cat":"papers","name":"A Phase I trial to inform clinical protocols for the safe administration of psilocybin-assisted psychotherapy","year":"2023","cit":3,"pfa":"Jennifer N. Bennett","psa":"Ravinder Bains","topics":["Safety & adverse events","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4366590080","eid":"W4366590080"},{"id":"paper-w1966466606","cat":"papers","name":"Alterations to global but not local motion processing in long-term ecstasy (MDMA) users","year":"2014","cit":3,"pfa":"Claire White","psa":"Mark Edwards","ptype":"article","src":"https://openalex.org/W1966466606","eid":"W1966466606"},{"id":"paper-w2578015169","cat":"papers","name":"Comparison of anomalous experiences after ingesting psilocybin mushrooms in research and non-research settings","year":"2017","cit":3,"pfa":"Theresa M. Carbonaro","psa":"Roland R. Griffiths","ptype":"article","src":"https://openalex.org/W2578015169","eid":"W2578015169"},{"id":"paper-w2797159874","cat":"papers","name":"T263. Psilocybin Improves Cognitive Control and Downregulates Parietal Cortex in Treatment-Seeking Smokers","year":"2018","cit":3,"pfa":"Michael McKenna","psa":"Elliot A. Stein","topics":["Addiction","Mechanism & neuroscience","Policy & ethics"],"ptype":"conference-abstract","src":"https://openalex.org/W2797159874","eid":"W2797159874"},{"id":"paper-w4413878303","cat":"papers","name":"Ayahuasca-assisted meaning reconstruction therapy as an early resource for bereavement: a non-randomized clinical trial","year":"2025","cit":3,"pfa":"Óscar Soto-Angona","psa":"Débora González","topics":["PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4413878303","eid":"W4413878303"},{"id":"paper-w2234087568","cat":"papers","name":"Caiuby Labate Beatriz and Henrik Jungaberle (eds), The internationalization of ayahuasca . Lit Verlag, Münster, 2011","year":"2013","cit":3,"pfa":"David Dupuis","ptype":"article","src":"https://openalex.org/W2234087568","eid":"W2234087568"},{"id":"paper-w4309971310","cat":"papers","name":"Evaluating the attitudes of mental health professionals towards trials of MDMA: a randomised vignette trial","year":"2022","cit":3,"pfa":"Dean J. Wright","psa":"Nick Glozier","topics":["Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4309971310","eid":"W4309971310"},{"id":"paper-w2006246479","cat":"papers","name":"Addressing the Threats of MDMA (Ecstasy): Implications for School Health Professionals, Parents, and Community Members","year":"2001","cit":3,"pfa":"Ralph Wood","psa":"Linda Baily Synovitz","ptype":"article","src":"https://openalex.org/W2006246479","eid":"W2006246479"},{"id":"paper-w4366088653","cat":"papers","name":"High-resolution tracking of unconfined zebrafish behavior reveals stimulatory and anxiolytic effects of psilocybin","year":"2023","cit":3,"pfa":"Dotan Braun","psa":"Takashi Kawashima","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4366088653","eid":"W4366088653"},{"id":"paper-w4386696837","cat":"papers","name":"Synthetic studies toward the marine alkaloid convolutindole A, a structurally remarkable derivative of the hallucinogen N,N-Dimethyltryptamine (DMT)","year":"2023","cit":3,"pfa":"Karen Ichikawa","psa":"Jonathan Sperry","ptype":"article","src":"https://openalex.org/W4386696837","eid":"W4386696837"},{"id":"paper-w4283835227","cat":"papers","name":"3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder (PTSD) in adults","year":"2022","cit":3,"pfa":"Marija Franka Žuljević","psa":"Tina Poklepović Peričić","topics":["PTSD & trauma","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4283835227","eid":"W4283835227"},{"id":"paper-w3081283678","cat":"papers","name":"Hypoglycaemic and anti-hyperglycaemic activity of Tabernanthe iboga aqueous extract in fructose-fed streptozotocin type 2 diabetic rats","year":"2020","cit":3,"pfa":"Bayissi Bading-Taïka","psa":"Lisa A. Lione","ptype":"article","src":"https://openalex.org/W3081283678","eid":"W3081283678"},{"id":"paper-w4412594980","cat":"papers","name":"Antinociceptive effect of salvinorin A from the extract of Salvia divinorum in formalin-evoked trigeminal pain behavior in mice: Underlying mechanisms","year":"2025","cit":3,"pfa":"Geovanna Nallely Quiñonez‐Bastidas","psa":"Andrés Navarrete","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4412594980","eid":"W4412594980"},{"id":"paper-w2283428982","cat":"papers","name":"Increased body temperature in recreational ecstasy/MDMA users out clubbing and dancing","year":"2005","cit":3,"pfa":"Parrott, A. C.","psa":"Young, L.","ptype":"article","src":"https://openalex.org/W2283428982","eid":"W2283428982"},{"id":"paper-w2503589561","cat":"papers","name":"Transcultural Keys: Humor, Creativity and Other Relational Artifacts in the Transposition of a Brazilian Ayahuasca Religion to the Netherlands","year":"2013","cit":3,"pfa":"Alberto Groisman","ptype":"book-chapter","src":"https://openalex.org/W2503589561","eid":"W2503589561"},{"id":"paper-w4415817857","cat":"papers","name":"Hormonal Influences on Psilocybin Responsivity Across the Female Lifespan: Toward Personalized Psychedelic-Assisted Therapy","year":"2025","cit":3,"pfa":"Faith Ekoh","psa":"Ersilia Mirabelli","topics":["Mechanism & neuroscience","Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4415817857","eid":"W4415817857"},{"id":"paper-w2885366962","cat":"papers","name":"Assessment of CYP2D6 re-activation after inhibitory effect of MDMA using tramadol as a probe","year":"2018","cit":3,"pfa":"Shahin Nilchi","psa":"Yalda H. Ardakani","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2885366962","eid":"W2885366962"},{"id":"paper-w4386569162","cat":"papers","name":"MDMA targets miR-124/MEKK3 via MALAT1 to promote Parkinson’s disease progression","year":"2023","cit":3,"pfa":"Xin Geng","psa":"Hualin Yu","topics":["Safety & adverse events","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4386569162","eid":"W4386569162"},{"id":"paper-w4415782096","cat":"papers","name":"Reporting of side-effects in clinical trials of psilocybin-assisted psychotherapy for psychiatric conditions: systematic review","year":"2025","cit":3,"pfa":"Jonathon Marinis","psa":"Gillinder Bedi","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"review","src":"https://openalex.org/W4415782096","eid":"W4415782096"},{"id":"paper-w3128054002","cat":"papers","name":"Errors in a Response Rate and in Effect Sizes in Study of Psilocybin-Assisted Therapy for Major Depressive Disorder","year":"2021","cit":3,"pfa":"Alan K. Davis","psa":"Roland R. Griffiths","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W3128054002","eid":"W3128054002"},{"id":"paper-w2901866515","cat":"papers","name":"Downregulation of the Vitamin D Receptor Regulated Gene Set in the Hippocampus After MDMA Treatment","year":"2018","cit":3,"pfa":"Péter Petschner","psa":"György Bagdy","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2901866515","eid":"W2901866515"},{"id":"paper-w4413982784","cat":"papers","name":"Too big to fail? Comparing effect sizes of MDMA assisted therapy to unmasking bias","year":"2025","cit":3,"pfa":"Balázs Szigeti","psa":"Joshua D. Woolley","ptype":"article","src":"https://openalex.org/W4413982784","eid":"W4413982784"},{"id":"paper-w2592124770","cat":"papers","name":"Erratum: Loss of Serotonin Transporter Protein after MDMA and Other Ring-Substituted Amphetamines","year":"2007","cit":3,"pfa":"Tao Xie","psa":"George A. Ricaurte","topics":["Mechanism & neuroscience"],"ptype":"erratum","src":"https://openalex.org/W2592124770","eid":"W2592124770"},{"id":"paper-w1973981782","cat":"papers","name":"Dopamine Receptors Gene Expression in Male Rat Hippocampus after Administration of MDMA (Ecstasy)","year":"2015","cit":3,"pfa":"Mahakizadeh Simin","psa":"Majid Shahbazi","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1973981782","eid":"W1973981782"},{"id":"paper-w4307030469","cat":"papers","name":"A rapid scoping review of harm reduction strategies for ecstasy (MDMA) users in recreational settings","year":"2022","cit":3,"pfa":"Deborah J. Edwards","psa":"Jane Harden","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4307030469","eid":"W4307030469"},{"id":"paper-w4399693455","cat":"papers","name":"Co-administration of midazolam and psilocybin: Differential effects on subjective quality versus memory of the psychedelic experience","year":"2024","cit":3,"pfa":"Christopher R. N. Nicholas","psa":"Charles L. Raison","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4399693455","eid":"W4399693455"},{"id":"paper-w2030485609","cat":"papers","name":"The Effects of MDMA and Methamphetamine on Car Driving Simulator Performance, Cognitive Skills, and Mood States","year":"2011","cit":3,"pfa":"Con K. K. Stough","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2030485609","eid":"W2030485609"},{"id":"paper-w7140125435","cat":"papers","name":"The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysis","year":"2026","cit":3,"pfa":"Guy M. Goodwin","psa":"Ekaterina Malievskaia","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7140125435","eid":"W7140125435"},{"id":"paper-w4409012746","cat":"papers","name":"Mushroom bioactives—polysaccharides to psilocybin: a viewpoint on the therapeutic use of mushrooms for consumers and patients for health and neuroplasticity","year":"2025","cit":3,"pfa":"Charles Stephen Brennan","psa":"Margaret Anne Brennan","topics":["PTSD & trauma","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4409012746","eid":"W4409012746"},{"id":"paper-w2416802403","cat":"papers","name":"A comparative study on the metabolism of 3,4-dimethoxyphenylethylamine-C 14 and mescaline-C 14 by rabbit, mouse and rat brain homogenates.","year":"1971","cit":3,"pfa":"Shah Ns","ptype":"article","src":"https://openalex.org/W2416802403","eid":"W2416802403"},{"id":"paper-w4410542411","cat":"papers","name":"Establishment of Psychotria viridis Ruiz & Pav. callus cultures, plantlet regeneration and in vitro production of the hallucinogenic indole alkaloid N,N-dimethyltryptamine","year":"2025","cit":3,"pfa":"Camila Moreno Lopes de Andrade","psa":"Vanessa Cristina Stein","ptype":"article","src":"https://openalex.org/W4410542411","eid":"W4410542411"},{"id":"paper-w2410085939","cat":"papers","name":"SIMULTANEOUS STUDIES OF BLOOD SUGAR, BEHAVIOURAL CHANGES AND EEG ON THE WAKE RABBIT AFTER ADMINISTRATION OF PSILOCYBIN.","year":"1963","cit":3,"pfa":"J E Steiner","psa":"Sulman Fg","ptype":"article","src":"https://openalex.org/W2410085939","eid":"W2410085939"},{"id":"paper-w2140074652","cat":"papers","name":"Attenuating Glial Activation with Minocycline Reduces the Hyperthermic Response to 3, 4-Methylenedioxymethamphetamine (MDMA) In the Rat","year":"2011","cit":3,"pfa":"Paul Anderson","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2140074652","eid":"W2140074652"},{"id":"paper-w4239872970","cat":"papers","name":"6,5-Fused Ring, C2-Salvinorin Ester, Dual Kappa and Mu Opioid Receptor Agonists as Analgesics Devoid of Anxiogenic Effects","year":"2021","cit":3,"pfa":"Nicholas S. Akins","psa":"Hoang V. Le","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4239872970","eid":"W4239872970"},{"id":"paper-w2138449248","cat":"papers","name":"Prior MDMA exposure inhibits learning and produces both tolerance and sensitization in the radial-arm maze","year":"2013","cit":3,"pfa":"David N. Harper","psa":"Maree J. Hunt","ptype":"article","src":"https://openalex.org/W2138449248","eid":"W2138449248"},{"id":"paper-w3200456146","cat":"papers","name":"Reply to Knuijver et al . on the ‘Safety of ibogaine administration in detoxification of opioid‐dependent individuals: a descriptive open‐label observational study’","year":"2021","cit":3,"pfa":"Matthias Luz","psa":"Deborah C. Mash","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"letter","src":"https://openalex.org/W3200456146","eid":"W3200456146"},{"id":"paper-w2030232516","cat":"papers","name":"Modulatory effects of low-dose MDMA on cocaine-induced locomotor activity and place conditioning in rats","year":"2011","cit":3,"pfa":"J Panos","psa":"Lisa E. Baker","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2030232516","eid":"W2030232516"},{"id":"paper-w2320885515","cat":"papers","name":"Liquid Chromatographic and Mass Spectral Analysis of 1-(3,4-Methylenedioxyphenyl)-3-Propanamines: Regioisomers of MDMA","year":"1991","cit":3,"pfa":"F. T. Noggle","psa":"J. DeRuiter","ptype":"article","src":"https://openalex.org/W2320885515","eid":"W2320885515"},{"id":"paper-w2901546161","cat":"papers","name":"MDMA modulates 5-HT1-mediated contractile response of the human internal thoracic artery in vitro","year":"2018","cit":3,"pfa":"Diogo A. Fonseca","psa":"Maria Dulce Cotrim","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2901546161","eid":"W2901546161"},{"id":"paper-w2182602674","cat":"papers","name":"One-Year Outcomes of Infants Exposed to MDMA (Ecstasy) and Other Recreational Drugs During Pregnancy","year":"2012","cit":3,"pfa":"Lynn T. Singer","psa":"Sarah E. Fulton","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2182602674","eid":"W2182602674"},{"id":"paper-w4387655381","cat":"papers","name":"Shame, guilt and psychedelic experience: Results from a prospective, longitudinal survey of real-world psilocybin use","year":"2023","cit":3,"pfa":"David S. Mathai","psa":"Albert Garcia‐Romeu","ptype":"preprint","src":"https://openalex.org/W4387655381","eid":"W4387655381"},{"id":"paper-w4404961618","cat":"papers","name":"Psychedelic treatment for anorexia nervosa: A first-hand view of how psilocybin treatment did and did not help","year":"2024","cit":3,"pfa":"Stephanie Knatz Peck","psa":"Walter H. Kaye","ptype":"article","src":"https://openalex.org/W4404961618","eid":"W4404961618"},{"id":"paper-w7124768174","cat":"papers","name":"Systematic study of Panaeolus (Agaricales, Galeropsidaceae) sensu lato and psilocybin-producing traits of species from China","year":"2026","cit":3,"pfa":"Mao-Qiang He","psa":"Rui-Lin Zhao","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7124768174","eid":"W7124768174"},{"id":"paper-w181320826","cat":"papers","name":"[Mescaline induced bradycardia and its antagonistic modification by chlorpromazine, pentobarbital and scopolamine after injection into lateral cerebral ventricle of mouse].","year":"1970","cit":3,"pfa":"Erich Lehr","psa":"Gottfried Werner","ptype":"article","src":"https://openalex.org/W181320826","eid":"W181320826"},{"id":"paper-w4379983055","cat":"papers","name":"Self-treatment of parental neglect-induced mixed anxiety and depressive disorder with psilocybin – A retrospective case study","year":"2023","cit":3,"pfa":"Mika Turkia","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W4379983055","eid":"W4379983055"},{"id":"paper-w4409659459","cat":"papers","name":"Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocol","year":"2025","cit":3,"pfa":"Matthew Butler","psa":"Timothy R. Nicholson","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4409659459","eid":"W4409659459"},{"id":"paper-w2541159474","cat":"papers","name":"Classic Psychedelics and Rational Suicide in the Elderly: Exploring the Potential Utility of a Reemerging Treatment Paradigm","year":"2016","cit":3,"pfa":"Peter S. Hendricks","psa":"Charles S. Grob","ptype":"book-chapter","src":"https://openalex.org/W2541159474","eid":"W2541159474"},{"id":"paper-w4406168575","cat":"papers","name":"Cell-type specific transcriptional modulation by psilocybin induces sustained plasticity in mouse medial prefrontal cortex","year":"2025","cit":3,"pfa":"Heike Schuler","psa":"Rosemary C. Bagot","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4406168575","eid":"W4406168575"},{"id":"paper-w1808703319","cat":"papers","name":"SOCIAL/CULTURAL ANTHROPOLOGY: Ayahuasca Visions: The Religious Iconography of a Peruvian Shaman. Luis Eduardo Luna and Pablo Amaringo.","year":"1993","cit":3,"pfa":"Norman E. Whitten","ptype":"article","src":"https://openalex.org/W1808703319","eid":"W1808703319"},{"id":"paper-w176797448","cat":"papers","name":"[Analysis of MDMA and PCP by GC-MS from patients admitted to the critical care medical center].","year":"2002","cit":3,"pfa":"Makoto Nihira","psa":"Yasuhiro Yamamoto","ptype":"article","src":"https://openalex.org/W176797448","eid":"W176797448"},{"id":"paper-w3084530120","cat":"papers","name":"Investigation of MDMA Inhibitory Effect on CytochromeP450 3A4 in Isolated Perfused Rat Liver Model Using Tramadol","year":"2020","cit":3,"pfa":"Behjat Sheikholeslami","psa":"Mohammad Reza Rouini","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3084530120","eid":"W3084530120"},{"id":"paper-w4417362478","cat":"papers","name":"Psilocybin-assisted psychotherapy for treatment-resistant obsessive–compulsive disorder: protocol for an open-label pilot study","year":"2025","cit":3,"pfa":"Nicole Ledwos","psa":"Gwyneth C. Zai","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4417362478","eid":"W4417362478"},{"id":"paper-w7126258550","cat":"papers","name":"PSilocybin for psYCHological and existential distress in PALliative care (PSYCHED-PAL): A single arm unblinded clinical trial","year":"2026","cit":3,"pfa":"James Downar","psa":"Peter Gerard Lawlor","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7126258550","eid":"W7126258550"},{"id":"paper-w4312244142","cat":"papers","name":"D’invisibles à hyper-médiatisées : femmes chamanes shipibo-konibo et tourisme par ayahuasca en Amazonie occidentale","year":"2022","cit":3,"pfa":"Anne‐Marie Colpron","ptype":"article","src":"https://openalex.org/W4312244142","eid":"W4312244142"},{"id":"paper-w4381715858","cat":"papers","name":"Health Benefits and Positive Acute Effects of Psilocybin Consumption: A Quantitative Textual Analysis of User Self-Reported Data","year":"2023","cit":3,"pfa":"Bheatrix Bienemann","psa":"Daniel C. Mograbi","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4381715858","eid":"W4381715858"},{"id":"paper-w4318014946","cat":"papers","name":"A ground truth data set of gas chromatography mass spectrometry (GCMS) analysed synthesised methylenedioxymethylamphetamine (MDMA)","year":"2023","cit":3,"pfa":"Jonathan Miller","psa":"Niamh Nic Daéid","topics":["Reviews & meta-analyses"],"ptype":"data-paper","src":"https://openalex.org/W4318014946","eid":"W4318014946"},{"id":"paper-w4416754698","cat":"papers","name":"MDMA-assisted therapy for major depressive disorder: A seven-month follow-up proof of principle trial","year":"2025","cit":3,"pfa":"Tor-Morten Kvam","psa":"Ole A. Andreassen","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4416754698","eid":"W4416754698"},{"id":"paper-w4409722026","cat":"papers","name":"Embracing change: impermanence acceptance mediates differences in death processing between long-term ayahuasca users and non-users","year":"2025","cit":3,"pfa":"Jonathan David","psa":"Yair Dor‐Ziderman","topics":["Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4409722026","eid":"W4409722026"},{"id":"paper-w4393256691","cat":"papers","name":"Characterization of the Neurochemical and Behavioral Effects of the Phenethylamine 2-Cl-4,5-MDMA in Adolescent and Adult Male Rats","year":"2024","cit":3,"pfa":"Gessica Piras","psa":"Maria Antonietta De Luca","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4393256691","eid":"W4393256691"},{"id":"paper-w2089371572","cat":"papers","name":"Corrigendum to “Synthesis and in vitro pharmacological studies of new C(4) modified salvinorin A analogues” [Bioorg. Med. Chem. Lett. 16 (2006) 5498–5502]","year":"2008","cit":3,"pfa":"David Y.W. Lee","psa":"Bruce Cohen","topics":["Dosing & pharmacology"],"ptype":"erratum","src":"https://openalex.org/W2089371572","eid":"W2089371572"},{"id":"paper-w1995685597","cat":"papers","name":"Amnésie antérograde consécutive à l’absorption de MDMA et d’alcool : à propos d’un cas","year":"2012","cit":3,"pfa":"Caroline Sastre","psa":"Anne‐Laure Pélissier‐Alicot","ptype":"article","src":"https://openalex.org/W1995685597","eid":"W1995685597"},{"id":"paper-w4245770344","cat":"papers","name":"Biochemical effects of the monoamine neurotoxins DSP‐4 and MDMA in specific brain regions of MAO‐B‐deficient mice","year":"2001","cit":3,"pfa":"Francesco Fornai","psa":"Jean Chen Shih","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4245770344","eid":"W4245770344"},{"id":"paper-w2338445471","cat":"papers","name":"HPLC Measurement of MDMA Content in Ecstasy Tablets Available in the Black Market of West Azerbaijan Province, Northwestern Iran","year":"2014","cit":3,"pfa":"Reza Ghafari","psa":"Azam Akbari","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2338445471","eid":"W2338445471"},{"id":"paper-w4408138323","cat":"papers","name":"Prevalence and Correlates of Lifetime Ecstasy/MDMA Use Among Asian American and Pacific Islander Adult Populations in the United States, 2015–2020","year":"2025","cit":3,"pfa":"Wayne E. Kepner","psa":"Joseph J. Palamar","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4408138323","eid":"W4408138323"},{"id":"paper-w2120420469","cat":"papers","name":"Could MDMA Promote Stemness Characteristics in Mouse Embryonic Stem Cells via mGlu5 Metabotropic Glutamate Receptors?","year":"2012","cit":3,"pfa":"Rokhsareh Meamar","psa":"Mohammad Hossein Nasr‐Esfahani","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2120420469","eid":"W2120420469"},{"id":"paper-w4238489741","cat":"papers","name":"A comparison of mdma-assisted psychotherapy to non-assisted psychotherapy in treatment-resistant PTSD: A systematic review and meta-analysis","year":"2021","cit":3,"pfa":"B. Illingworth","psa":"James Rucker","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W4238489741","eid":"W4238489741"},{"id":"paper-w4399269886","cat":"papers","name":"Psilocybin reduces heroin seeking behavior and modulates inflammatory gene expression in the nucleus accumbens and prefrontal cortex of male rats","year":"2024","cit":3,"pfa":"Gabriele Floris","psa":"Stephanie E. Daws","topics":["Addiction","Mechanism & neuroscience","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4399269886","eid":"W4399269886"},{"id":"paper-w4388844031","cat":"papers","name":"De crecer en la selva a practicar la ayahuasca en la ciudad: una exploración de la globalización de la ayahuasca en términos de autenticidad, autoatención y de los retos de dicha globalización para la antropología médica","year":"2023","cit":3,"pfa":"Maja Kohek","psa":"Genís Oña","ptype":"article","src":"https://openalex.org/W4388844031","eid":"W4388844031"},{"id":"paper-w3148428564","cat":"papers","name":"The effects of dentate granule cell destruction on behavioral activity and Fos protein expression induced by systemic MDMA in rats","year":"2003","cit":3,"pfa":"武俊 元","ptype":"dissertation","src":"https://openalex.org/W3148428564","eid":"W3148428564"},{"id":"paper-w4385564685","cat":"papers","name":"Prevalence of psilocybin use in vaping and associated factors: a study among amphetamine-type stimulants (ATS) use disorder in Malaysia","year":"2023","cit":3,"pfa":"Ruzmayuddin Mamat","psa":"Azmir Ahmad","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4385564685","eid":"W4385564685"},{"id":"paper-w4402169650","cat":"papers","name":"Psilocybin administered following extinction sessions does not affect subsequent cocaine cue reinstatement in male and female rats and mice","year":"2024","cit":3,"pfa":"Veronika Pohořalá","psa":"Rick Eugene Bernardi","ptype":"article","src":"https://openalex.org/W4402169650","eid":"W4402169650"},{"id":"paper-w1922336347","cat":"papers","name":"Tratamiento de los problemas psíquicos relacionados con el consumo de drogas de diseño (MDMA, Éxtasis)","year":"1999","cit":3,"pfa":"Miguel Angel Landabaso Vázquez","psa":"Josetxo Etxebarria","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1922336347","eid":"W1922336347"},{"id":"paper-w4313199626","cat":"papers","name":"The safety and efficacy of COMP360 psilocybin therapy in treatment-resistant depression: results from a phase IIb randomised controlled trial","year":"2022","cit":3,"pfa":"G M Goodwin","psa":"E. Malievskaia","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4313199626","eid":"W4313199626"},{"id":"paper-w4248281263","cat":"papers","name":"Ayahuasca en el tratamiento de adicciones. Estudio de cuatro casos tratados en IDEAA, desde una perspectiva interdisciplinaria","year":"2019","cit":3,"pfa":"Ismael Apud","ptype":"article","src":"https://openalex.org/W4248281263","eid":"W4248281263"},{"id":"paper-w908680128","cat":"papers","name":"Guiado por la luna : shamanismo y uso ritual de la ayahuasca en el culto de Santo Daime","year":"1998","cit":3,"pfa":"Edward MacRae","ptype":"article","src":"https://openalex.org/W908680128","eid":"W908680128"},{"id":"paper-w3044343999","cat":"papers","name":"Successful Use of Early Therapeutic Hypothermia in an MDMA and Amphetamine Intoxication–Induced Out-of-Hospital Cardiac Arrest: A Case Report","year":"2020","cit":3,"pfa":"Celalettin Dağlı","psa":"İpek Duman","ptype":"article","src":"https://openalex.org/W3044343999","eid":"W3044343999"},{"id":"paper-w4378374022","cat":"papers","name":"Bridging the translational neuroscience gap: Development of the ‘shiftability’ paradigm and an exemplar protocol to capture psilocybin-elicited ‘shift’ in neurobiological mechanisms in autism","year":"2023","cit":3,"pfa":"Tobias P. Whelan","psa":"Grainne Mary McAlonan","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4378374022","eid":"W4378374022"},{"id":"paper-w2351235362","cat":"papers","name":"Analysis of the Acquisition of Drug Discrimination Reveals Differences Between a High Versus Low Training Dose of ±3,4-methylenedioxymethamphetamine (MDMA)","year":"2016","cit":3,"pfa":"Jeremy Webster","psa":"Susan Schenk","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2351235362","eid":"W2351235362"},{"id":"paper-w7162646021","cat":"papers","name":"Transient multidomain functional improvement in advanced Alzheimer’s disease following high-dose psilocybin-containing mushroom administration: a case report","year":"2026","cit":3,"pfa":"Marcos Lago","psa":"Joe Xavier Simonet","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7162646021","eid":"W7162646021"},{"id":"paper-w7125776842","cat":"papers","name":"Psilocybin-induced alterations in EEG power, connectivity and network dynamics in healthy subjects: Correlations with subjective experience and implications for therapeutic applications","year":"2026","cit":3,"pfa":"Cheng-Teng Ip","psa":"Franz Vollenweider","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7125776842","eid":"W7125776842"},{"id":"paper-w2040953464","cat":"papers","name":"MDMA Use among a Group of Friends in Oslo, Norway, between Self-Development and Social Participation: Dilemmas of a Pharmaceutical Normalcy?","year":"2009","cit":3,"pfa":"Per Kristian Hilden","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2040953464","eid":"W2040953464"},{"id":"paper-w2792097476","cat":"papers","name":"Chamanismo y etnoturismo: la venta de rituales de ayahuasca y la compra de sentidos en el Alto Napo.","year":"2017","cit":3,"pfa":"Pablo Hermida Salas","ptype":"article","src":"https://openalex.org/W2792097476","eid":"W2792097476"},{"id":"paper-w4417031290","cat":"papers","name":"Investigational psilocybin treatment for post-traumatic stress disorder: a qualitative study of participant experience, trauma engagement, and differences from standard treatment","year":"2025","cit":3,"pfa":"Nadav Liam Modlin","psa":"James Rucker","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4417031290","eid":"W4417031290"},{"id":"paper-w4409765928","cat":"papers","name":"Patterns of Internalizing Problems, Substance Use and Cognitive Flexibility Before and After Naturalistic Psilocybin Use: A Repeated Measures Latent Profile Analysis","year":"2025","cit":3,"pfa":"Jérémie Richard","psa":"Albert Garcia‐Romeu","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4409765928","eid":"W4409765928"},{"id":"paper-w3200514659","cat":"papers","name":"Ginkgo Biloba aqueous extract attenuated MDMA-induced Neurodegeneration and its accompanying memory aberrations in experimental Wistar rats model","year":"2021","cit":3,"pfa":"Olanrewaju John Afees","psa":"Fabiyi Oluwaseyi Sunday","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W3200514659","eid":"W3200514659"},{"id":"paper-w4283734206","cat":"papers","name":"Neuroimaging in psychedelic drug development: Past, present, and future","year":"2022","cit":3,"pfa":"Matthew B. Wall","psa":"David Erritzøe","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"preprint","src":"https://openalex.org/W4283734206","eid":"W4283734206"},{"id":"paper-w2011892468","cat":"papers","name":"Éxtasis (MDMA) y drogas de diseño: estructura, farmacología, mecanismos de acción y efectos en el ser humano","year":"2008","cit":3,"pfa":"M. Isabel Colado","ptype":"article","src":"https://openalex.org/W2011892468","eid":"W2011892468"},{"id":"paper-w4281994902","cat":"papers","name":"Correction: Updated cost-effectiveness of MDMA-assisted therapy for the treatment of posttraumatic stress disorder in the United States: Findings from a phase 3 trial","year":"2022","cit":3,"pfa":"Elliot A. Marseille","psa":"James G. Kahn","topics":["PTSD & trauma"],"ptype":"erratum","src":"https://openalex.org/W4281994902","eid":"W4281994902"},{"id":"paper-w4387035369","cat":"papers","name":"Comparing Substance Use Consequences between Serotonergic Psychedelics, MDMA, and other Drugs of Abuse Among United States Adults with History of Psychiatric Illness","year":"2023","cit":3,"pfa":"Joshua Curtis Black","psa":"Richard C. Dart","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4387035369","eid":"W4387035369"},{"id":"paper-w4254574615","cat":"papers","name":"Molecular docking and binding interaction between psychedelic drugs and human serum albumin","year":"2020","cit":3,"pfa":"Hossein Orcid Khastar","psa":"Moslem Jafarisani","ptype":"article","src":"https://openalex.org/W4254574615","eid":"W4254574615"},{"id":"paper-w2801159002","cat":"papers","name":"Author Correction: Well-being, problematic alcohol consumption and acute subjective drug effects in past-year ayahuasca users: a large, international, self-selecting online survey","year":"2018","cit":3,"pfa":"Will Lawn","psa":"Celia J. A. Morgan","topics":["Addiction"],"ptype":"erratum","src":"https://openalex.org/W2801159002","eid":"W2801159002"},{"id":"paper-w2124780703","cat":"papers","name":"International conference on memory (ICOM-4), University of New South Wales, Sydney, Australia, 16—21 July 2006 Ecstasy/MDMA and Memory Symposium","year":"2007","cit":3,"pfa":"Andy C. Parrott","psa":"Michael John Morgan","ptype":"article","src":"https://openalex.org/W2124780703","eid":"W2124780703"},{"id":"paper-w4404004168","cat":"papers","name":"Phytochemical screening, phenolic and flavonoid contents, psilocybin, antioxidant, and acetylcholinesterase inhibition activities of the aqueous extract from the fungi Cyathus striatus, Laternea dringii, and Marasmius ha","year":"2024","cit":3,"pfa":"Diego Belinelli Ursulino da Silva","psa":"Matheus Vinícius Abadia Ventura","ptype":"article","src":"https://openalex.org/W4404004168","eid":"W4404004168"},{"id":"paper-w4246451433","cat":"papers","name":"Direct effects of 3,4‐methylenedioxymethamphetamine (MDMA) on serotonin or dopamine release and uptake in the caudate putamen, nucleus accumbens, substantia nigra pars reticulata, and the dorsal raphé nucleus slices","year":"2000","cit":3,"pfa":"Mahmoud M. Iravani","psa":"Zygmunt L. Kruk","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4246451433","eid":"W4246451433"},{"id":"paper-w4410402984","cat":"papers","name":"The Intersection of Psychedelics and Sleep: Exploring the Impacts on Sleep Architecture, Dream States, and Therapeutic Implications","year":"2025","cit":3,"pfa":"Haojiang Zhai","psa":"Xiaohui Wang","ptype":"editorial","src":"https://openalex.org/W4410402984","eid":"W4410402984"},{"id":"paper-w4232071388","cat":"papers","name":"Plant and Fungal Hallucinogens as Toxic and Therapeutic Agents","year":"2019","cit":3,"pfa":"E.A. Carlini","psa":"Lucas Oliveira Maia","ptype":"book-chapter","src":"https://openalex.org/W4232071388","eid":"W4232071388"},{"id":"paper-w7117317655","cat":"papers","name":"Deciphering Ibogaine’s Matrix Pharmacology: Multiple Transporter Modulation at Serotonin Synapses","year":"2025","cit":3,"pfa":"Christopher Hwu","psa":"Dalibor Sameš","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7117317655","eid":"W7117317655"},{"id":"paper-w4399033061","cat":"papers","name":"Classification of psychedelics and psychoactive drugs based on brain-wide imaging of cellular c-Fos expression","year":"2024","cit":3,"pfa":"Farid Aboharb","psa":"Alex C. Kwan","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4399033061","eid":"W4399033061"},{"id":"paper-w4400918620","cat":"papers","name":"Toxicology and Pharmacological Interactions of Classic Psychedelics","year":"2024","cit":3,"pfa":"Kelan L. H. Thomas","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W4400918620","eid":"W4400918620"},{"id":"paper-w4312059979","cat":"papers","name":"Psychedelics for treating psychiatric disorders: Are they safe?","year":"2022","cit":3,"pfa":"Madonna Thakur","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4312059979","eid":"W4312059979"},{"id":"paper-w7131628064","cat":"papers","name":"Classifying Psychedelic-Related Complications","year":"2026","cit":3,"pfa":"Tomislav Majić","psa":"Ricarda Evens","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W7131628064","eid":"W7131628064"},{"id":"paper-w4414751415","cat":"papers","name":"The transformational power of psychedelics: catalysts for creativity, consciousness, and mental health","year":"2025","cit":3,"pfa":"Xiubo Du","psa":"Xiaohui Wang","ptype":"article","src":"https://openalex.org/W4414751415","eid":"W4414751415"},{"id":"paper-w4401587111","cat":"papers","name":"How psychedelics legalization debates could differ from cannabis","year":"2024","cit":3,"pfa":"Beau Kilmer","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4401587111","eid":"W4401587111"},{"id":"paper-w4399883823","cat":"papers","name":"Treatment and therapy of mental health conditions in the Global South using psychedelics: A scoping review and narrative synthesis","year":"2024","cit":3,"pfa":"Caroline Griffin","psa":"Alec Knight","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4399883823","eid":"W4399883823"},{"id":"paper-w7126158169","cat":"papers","name":"Indigenous Knowledge Systems & Psychedelic Science: Towards Ethical and Reciprocal Collaboration","year":"2026","cit":3,"pfa":"Magar","psa":"Sandor Iron Rope","topics":["Safety & adverse events","Policy & ethics"],"ptype":"editorial","src":"https://openalex.org/W7126158169","eid":"W7126158169"},{"id":"paper-w2005828715","cat":"papers","name":"Acute and chronic effects of LSD and 5-MeODMT on raphe-evoked dorsal root potentials in the cat","year":"1984","cit":3,"pfa":"Alice A. Larson","ptype":"article","src":"https://openalex.org/W2005828715","eid":"W2005828715"},{"id":"paper-w4244555616","cat":"papers","name":"Testicular choriocarcinoma in LSD users. Coincidence or cause?","year":"1971","cit":3,"pfa":"L. J. Levick","ptype":"article","src":"https://openalex.org/W4244555616","eid":"W4244555616"},{"id":"paper-w4410009678","cat":"papers","name":"Halluzinogene Pilze in der Tschechoslowakei.","year":"1973","cit":3,"pfa":"Marta Semerdžieva","psa":"František Nerud","ptype":"article","src":"https://openalex.org/W4410009678","eid":"W4410009678"},{"id":"paper-w4295605431","cat":"papers","name":"Ketamine Pharmacodynamics Entangled: Reply","year":"2022","cit":3,"pfa":"Albert Dahan","psa":"Marieke Niesters","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4295605431","eid":"W4295605431"},{"id":"paper-w4416398262","cat":"papers","name":"A Virtual Clinical Trial of Psychedelics to Treat Patients With Disorders of Consciousness","year":"2025","cit":3,"pfa":"Naji Alnagger","psa":"Jitka Annen","ptype":"article","src":"https://openalex.org/W4416398262","eid":"W4416398262"},{"id":"paper-w4410859687","cat":"papers","name":"The Selective Serotonin 5-HT2A Receptor Agonist (S)-3-(2,5-Dimethoxy-4-(trifluoromethyl)phenyl)piperidine (LPH-5) Induces Persistent and Robust Antidepressant-Like Effects in Rodents","year":"2025","cit":3,"pfa":"Anders A. Jensen","psa":"Jesper Langgaard Kristensen","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4410859687","eid":"W4410859687"},{"id":"paper-w4385829163","cat":"papers","name":"Australia Legalizes Psychedelics for Use in Depression, PTSD Therapy","year":"2023","cit":3,"pfa":"Nick Zagorski","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4385829163","eid":"W4385829163"},{"id":"paper-w4414813775","cat":"papers","name":"Modification of natural tryptamines for the treatment of neuropsychiatric diseases","year":"2025","cit":3,"pfa":"Michael G. Palfreyman","psa":"Alex Nivorozhkin","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4414813775","eid":"W4414813775"},{"id":"paper-w2289315084","cat":"papers","name":"[Narcotic mushrooms with LSD?].","year":"1978","cit":3,"pfa":"Elisabeth Stahl","psa":"Derk Eskes","ptype":"article","src":"https://openalex.org/W2289315084","eid":"W2289315084"},{"id":"paper-w3195370529","cat":"papers","name":"079 Hallucinogenic persisting perception disorder: a case series and review of the literature","year":"2021","cit":3,"pfa":"Hannah HF Ford","psa":"Anneke AVWVan der Walt","topics":["Addiction","Reviews & meta-analyses"],"ptype":"conference-paper","src":"https://openalex.org/W3195370529","eid":"W3195370529"},{"id":"paper-w2028717386","cat":"papers","name":"MULTIPLE SYSTEMIC AND OCULAR MALFORMATIONS ASSOCIATED WITH MATERNAL LSD USAGE","year":"1975","cit":3,"pfa":"David J. Apple","psa":"Thomas O. Bennett","ptype":"article","src":"https://openalex.org/W2028717386","eid":"W2028717386"},{"id":"paper-w2395809390","cat":"papers","name":"[Synesthesias in the context of hallucinogen-induced persistent perception disorder following the use of lsd].","year":"2014","cit":3,"pfa":"A Neven","psa":"Jan Dirk Blom","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2395809390","eid":"W2395809390"},{"id":"paper-w2321404219","cat":"papers","name":"Putative Perception of Rotating Permanent Magnetic Fields following Ingestion of LSD","year":"1998","cit":3,"pfa":"Michael A. Persinger","ptype":"article","src":"https://openalex.org/W2321404219","eid":"W2321404219"},{"id":"paper-w48786120","cat":"papers","name":"Pharmacology and Toxicology of Psychotomimetics","year":"1982","cit":3,"pfa":"Leo E. Hollister","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W48786120","eid":"W48786120"},{"id":"paper-w2131205288","cat":"papers","name":"Morning Glory Seed Psychosis","year":"1967","cit":3,"pfa":"PAUL JAY FINK","psa":"I.M.S. Surgeon-major Lyons","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2131205288","eid":"W2131205288"},{"id":"paper-w131984714","cat":"papers","name":"A Comparison of Short-Term Treatment Effects of Intravenous Sodium Amytal-Methedrine and LSD in the Alcoholic","year":"1970","cit":3,"pfa":"F.G. Johnson","topics":["Depression","Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W131984714","eid":"W131984714"},{"id":"paper-w2291725332","cat":"papers","name":"Monoamine oxidase inhibitors in Amazonian hallucinogenic plants : ethnobotanical, phytochemical, and pharmacological investigations","year":"2010","cit":3,"pfa":"Dennis J. McKenna","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W2291725332","eid":"W2291725332"},{"id":"paper-w2076429389","cat":"papers","name":"Lack of a Long-term Effect of LSD on Y-maze Learning in Mice","year":"1970","cit":3,"pfa":"Roy C. Miller","psa":"EDWARD K. MILLER","ptype":"article","src":"https://openalex.org/W2076429389","eid":"W2076429389"},{"id":"paper-w4286845093","cat":"papers","name":"Psychedelic and related medicines at the end of life.","year":"2021","cit":3,"pfa":"David Benjamin Menkes","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"letter","src":"https://openalex.org/W4286845093","eid":"W4286845093"},{"id":"paper-w2277594421","cat":"papers","name":"Chromatic Responses of Fundulus to Lysergic Acid","year":"1958","cit":3,"pfa":"Charles G. Wilber","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2277594421","eid":"W2277594421"},{"id":"paper-w2090594848","cat":"papers","name":"LSD and Mystical Experiences","year":"1963","cit":3,"pfa":"George R. Jordan","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2090594848","eid":"W2090594848"},{"id":"paper-w1565936587","cat":"papers","name":"Psychedelic‐Induced Experiences","year":"2013","cit":3,"pfa":"James Fadiman","psa":"Andrew Kornfeld","topics":["Addiction","Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W1565936587","eid":"W1565936587"},{"id":"paper-w4415615338","cat":"papers","name":"Psilocybin's effects on obsessive-compulsive behaviors: A systematic review of preclinical and clinical evidence","year":"2025","cit":3,"pfa":"James J Gattuso","psa":"Thibault Renoir","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W4415615338","eid":"W4415615338"},{"id":"paper-w2025803174","cat":"papers","name":"Effects of LSD on Cortex of Cat Correlated with Changes in Vital Signs","year":"1959","cit":3,"pfa":"Th. W. Langfitt","psa":"Louis A. Finney","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2025803174","eid":"W2025803174"},{"id":"paper-w4399715661","cat":"papers","name":"Licit use of illicit drugs for treating depression: the pill and the process","year":"2024","cit":3,"pfa":"Alejandro Torrado Pacheco","psa":"Bita Moghaddam","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4399715661","eid":"W4399715661"},{"id":"paper-w3134372300","cat":"papers","name":"Herbal High: Substance-Induced Psychosis after Consumption of Seeds of the Hawaiian Baby Woodrose","year":"2021","cit":3,"pfa":"Esther Sobanski","psa":"Michael Huß","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3134372300","eid":"W3134372300"},{"id":"paper-w2414000506","cat":"papers","name":"[Biological addictive drugs--is there a change in drug taking behavior of young drug addicts?].","year":"1999","cit":3,"pfa":"Frank Löhrer","psa":"M Albers","topics":["Addiction"],"ptype":"other","src":"https://openalex.org/W2414000506","eid":"W2414000506"},{"id":"paper-w4237199400","cat":"papers","name":"Possible reproductive detriment in LSD users","year":"1972","cit":3,"pfa":"C. B. Jacobson","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4237199400","eid":"W4237199400"},{"id":"paper-w4386765441","cat":"papers","name":"The psychedelic experience and treatment‐resistant depression","year":"2023","cit":3,"pfa":"Guy M. Goodwin","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4386765441","eid":"W4386765441"},{"id":"paper-w4242698627","cat":"papers","name":"Hallucinogen Persistent Perception Disorder Induced by New Psychoactive Substituted Phenethylamines; A Review with Illustrative Case","year":"2016","cit":3,"pfa":"Cornel N. Stanciu","psa":"Thomas M. Penders","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4242698627","eid":"W4242698627"},{"id":"paper-w2059320662","cat":"papers","name":"Prognostic impact of psychoactive substances use during hospitalization for intentional drug overdose","year":"2005","cit":3,"pfa":"Marie Tournier","psa":"Hélène Verdoux","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2059320662","eid":"W2059320662"},{"id":"paper-w4255793831","cat":"papers","name":"Carotid artery obstruction following LSD capsule ingestion","year":"1971","cit":3,"pfa":"J. Sobel","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4255793831","eid":"W4255793831"},{"id":"paper-w2157579899","cat":"papers","name":"P4‐246: ACTIVATION OF THE SIGMA‐1 RECEPTOR BY SPECIFIC LIGANDS INHIBITS HUMAN INFLAMMATORY DENDRITIC CELL FUNCTIONS AND EFFECTOR T‐LYMPHOCYTE RESPONSES","year":"2014","cit":3,"pfa":"Attila Szabó","psa":"Éva Rajnavölgyi","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2157579899","eid":"W2157579899"},{"id":"paper-w4413961399","cat":"papers","name":"Psychedelics and mental health: reimagining care through science, insight, and compassion","year":"2025","cit":3,"pfa":"Georgios Mikellides","psa":"Marios Kyriazis","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4413961399","eid":"W4413961399"},{"id":"paper-w4408804839","cat":"papers","name":"LSD reconfigures the frequency-specific network landscape of the human brain","year":"2025","cit":3,"pfa":"Kenneth Shinozuka","psa":"Leonardo Bonetti","topics":["Addiction","Mechanism & neuroscience","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4408804839","eid":"W4408804839"},{"id":"paper-w4412452258","cat":"papers","name":"Biochemical Insights into Diverse Psilocybe Mushrooms and Their Metabolites as Sources of Neuroactive Agents: A Review","year":"2025","cit":3,"pfa":"Gokul Sudhakaran","psa":"Jesu Arockiaraj","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4412452258","eid":"W4412452258"},{"id":"paper-w4415915342","cat":"papers","name":"Simple Analogs of the LSD D-Ring: A Consideration of Structure–Activity Relationships and Their Potential as Therapeutics","year":"2025","cit":3,"pfa":"Steven A. Barker","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4415915342","eid":"W4415915342"},{"id":"paper-w2145879190","cat":"papers","name":"Halluzinogene, Amphetamine und Entactogene","year":"2003","cit":3,"pfa":"Franz X. Vollenweider","psa":"M. F. I. Vollenweider-Scherpenhuyzen","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2145879190","eid":"W2145879190"},{"id":"paper-w4241015893","cat":"papers","name":"Hallucinogens","year":"2010","cit":3,"pfa":"John H. Halpern","psa":"Torsten Passie","ptype":"book-chapter","src":"https://openalex.org/W4241015893","eid":"W4241015893"},{"id":"paper-w4401642670","cat":"papers","name":"LSD Modulates Proteins Involved in Cell Proteostasis, Energy Metabolism and Neuroplasticity in Human Cerebral Organoids","year":"2024","cit":3,"pfa":"Marcelo N. Costa","psa":"Stevens Kastrup Rehen","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4401642670","eid":"W4401642670"},{"id":"paper-w4283577141","cat":"papers","name":"The detection and determination of new LSD derivatives in biological material using the LC-MS/MS technique","year":"2022","cit":3,"pfa":"Piotr Adamowicz","psa":"Karolina Mulka Piotr Adamowicz","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4283577141","eid":"W4283577141"},{"id":"paper-w2064524092","cat":"papers","name":"SOME PHARMACOLOGICAL PROPERTIES OF BRAIN GANGLIOSIDE","year":"1962","cit":3,"pfa":"Samuel Bogoch","psa":"ULLRICH TRENDELENBURG","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2064524092","eid":"W2064524092"},{"id":"paper-w4297148822","cat":"papers","name":"Decomposition behavior of 1-Acyl-LSD in Gas Chromatography/Mass Spectrometry (GC/MS)","year":"2022","cit":3,"pfa":"Yuki Okada","psa":"Yuko Togawa Iwata","ptype":"article","src":"https://openalex.org/W4297148822","eid":"W4297148822"},{"id":"paper-w4401191408","cat":"papers","name":"AA, Bill Wilson, Carl Jung and LSD","year":"2024","cit":3,"pfa":"Robert McDonnell","psa":"Emily Higgins","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4401191408","eid":"W4401191408"},{"id":"paper-w4285412529","cat":"papers","name":"Psychedelic use in India, its pattern and personal significance – findings from an online survey","year":"2022","cit":3,"pfa":"Gokul Raj","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4285412529","eid":"W4285412529"},{"id":"paper-w4408657279","cat":"papers","name":"Acute Effects of the Psychedelic Phenethylamine 25I-NBOMe in C57BL/6J Male Mice","year":"2025","cit":3,"pfa":"Sabrine Bilel","psa":"Matteo Marti","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4408657279","eid":"W4408657279"},{"id":"paper-w3039177208","cat":"papers","name":"Matthew Oram. The Trials of Psychedelic Therapy: LSD Psychotherapy in America.","year":"2020","cit":3,"pfa":"Claire D. Clark","topics":["Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3039177208","eid":"W3039177208"},{"id":"paper-w3156592400","cat":"papers","name":"Multi-Locus Identification of Psilocybe Cubensis by High-Resolution Melting (HRM)","year":"2021","cit":3,"pfa":"Xiaochun Zhang","psa":"Chengtao Li","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W3156592400","eid":"W3156592400"},{"id":"paper-w4414162243","cat":"papers","name":"Pharmacological Treatment of Hallucinogen Persisting Perception Disorder (HPPD): A Systematic Review","year":"2025","cit":3,"pfa":"A. Knuistingh Neven","psa":"Jan Dirk Blom","topics":["Depression","Addiction","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W4414162243","eid":"W4414162243"},{"id":"paper-w396189109","cat":"papers","name":"Metabolism and Urinary Excretion of N-Hydroxy-3,4-methylenedioxymethamphetamine, a Recently Banned Narcotic in Japan","year":"2010","cit":3,"pfa":"Tooru Kamata","psa":"Hitoshi Tsuchihashi","ptype":"article","src":"https://openalex.org/W396189109","eid":"W396189109"},{"id":"paper-w4319025564","cat":"papers","name":"Concentrations of LSD, 2-oxo-3-hydroxy-LSD, and iso-LSD in hair segments of 18 drug abusers","year":"2023","cit":3,"pfa":"Jiaming Zheng","psa":"Ping Xiang","ptype":"article","src":"https://openalex.org/W4319025564","eid":"W4319025564"},{"id":"paper-w1976622787","cat":"papers","name":"Family, peer and individual factors related to methylenedioxymethamphetamine use in Taiwanese adolescents","year":"2007","cit":3,"pfa":"Cheng‐Fang Yen","psa":"Sen-Yen Hsu","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1976622787","eid":"W1976622787"},{"id":"paper-w4386931181","cat":"papers","name":"Lifeboat ethics, risk, and therapeutic opportunity: an appeal for equitable psychedelic therapy access in the “high-risk” addiction patient","year":"2023","cit":3,"pfa":"Taylor Black","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4386931181","eid":"W4386931181"},{"id":"paper-w4416941976","cat":"papers","name":"Three Cases of Depersonalization/Derealization Disorder Related to the Use of Classic Psychedelics","year":"2025","cit":3,"pfa":"Dario Jalilzadeh Masah","psa":"Tomislav Majić","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4416941976","eid":"W4416941976"},{"id":"paper-w4414207875","cat":"papers","name":"Reconsidering evidence for psychedelic-induced psychosis: An overview of reviews, a systematic review, and meta-analysis of human studies","year":"2025","cit":3,"pfa":"Michel Sabé","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4414207875","eid":"W4414207875"},{"id":"paper-w3155407419","cat":"papers","name":"Symptom specificity of ayahuasca's effect on depressive symptoms","year":"2021","cit":3,"pfa":"Cody Gilbert","psa":"Brianna R. Altman","topics":["Depression","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3155407419","eid":"W3155407419"},{"id":"paper-w2738477074","cat":"papers","name":"3,4-Methylenedioxymethamphetamine causes cytotoxicity on 661W cells through inducing macrophage polarization","year":"2017","cit":3,"pfa":"Xin Liu","psa":"Chun-sheng Luan","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2738477074","eid":"W2738477074"},{"id":"paper-w4383912387","cat":"papers","name":"Psychoactive substance use in patients diagnosed with attention-deficit/hyperactivity disorder: an exploratory study","year":"2023","cit":3,"pfa":"Gniewko Więckiewicz","psa":"Tomasz Maciej Gondek","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4383912387","eid":"W4383912387"},{"id":"paper-w2952905284","cat":"papers","name":"Minocycline attenuates 3,4-methylenedioxymethamphetamine-induced hyperthermia in the rat brain","year":"2019","cit":3,"pfa":"Stefan T. Musolino","psa":"Abdallah Salem","ptype":"article","src":"https://openalex.org/W2952905284","eid":"W2952905284"},{"id":"paper-w2770953018","cat":"papers","name":"Changes in global brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor","year":"2017","cit":3,"pfa":"Katrin H. Preller","psa":"Alan Anticevic","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W2770953018","eid":"W2770953018"},{"id":"paper-w4412645629","cat":"papers","name":"Psychedelic use in individuals living with eating disorders or disordered eating: findings from the international MED–FED survey","year":"2025","cit":3,"pfa":"Sarah-Catherine Rodan","psa":"Iain S. McGregor","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4412645629","eid":"W4412645629"},{"id":"paper-w3036257381","cat":"papers","name":"RETRACTED: 3,4-Methylenedioxymethamphetamine causes retinal damage in C57BL/6J mice","year":"2020","cit":3,"pfa":"Yuanye Ma","psa":"Ruili Nie","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3036257381","eid":"W3036257381"},{"id":"paper-w4229967237","cat":"papers","name":"A Pharmacologic Analysis of the Functions of the Spontaneous Electrical Activity of the Cerebral Cortex","year":"1954","cit":3,"pfa":"Abraham Wikler","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4229967237","eid":"W4229967237"},{"id":"paper-w3089439385","cat":"papers","name":"The ameliorating effects of Vitamin E on hepatotoxicity of ecstasy","year":"2020","cit":3,"pfa":"Khadije Meghrazi","psa":"Mojtaba Karimipour","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3089439385","eid":"W3089439385"},{"id":"paper-w4297493663","cat":"papers","name":"Taking the tripping out of psychedelic medicine","year":"2022","cit":3,"pfa":"Elie Dolgin","ptype":"article","src":"https://openalex.org/W4297493663","eid":"W4297493663"},{"id":"paper-w2053254220","cat":"papers","name":"Neuronal reorganization in adult rats neonatally exposed to (±)-3,4-methylenedioxymethamphetamine","year":"2014","cit":3,"pfa":"Michael T. Williams","psa":"Russell W. Brown","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2053254220","eid":"W2053254220"},{"id":"paper-w4394960920","cat":"papers","name":"The 3,4‐methylenedioxymethamphetamine enhances early visual processing for salient socio‐emotional stimuli","year":"2024","cit":3,"pfa":"Connor J. Haggarty","psa":"Harriet de Wit","topics":["Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4394960920","eid":"W4394960920"},{"id":"paper-w2579699693","cat":"papers","name":"Psychedelic-associated addiction remission: An online survey","year":"2017","cit":3,"pfa":"Albert Garcia‐Romeu","psa":"Matthew W. Johnson","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2579699693","eid":"W2579699693"},{"id":"paper-w2592252540","cat":"papers","name":"Interspecies In Vitro Evaluation of Stereoselective Protein Binding for 3,4-Methylenedioxymethamphetamine","year":"2017","cit":3,"pfa":"Wan Raihana Wan Aasim","psa":"Siew Hua Gan","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2592252540","eid":"W2592252540"},{"id":"paper-w4412475877","cat":"papers","name":"The Causal Role of Consciousness in Psychedelic Therapy for Treatment-Resistant Depression: Hypothesis and Proposal","year":"2025","cit":3,"pfa":"Tobías Fernández‐Borkel","psa":"Luis Alberto Henríquez‐Hernández","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"editorial","src":"https://openalex.org/W4412475877","eid":"W4412475877"},{"id":"paper-w4406930020","cat":"papers","name":"Down the Rabbit Hole: A Large-Scale Survey of Psychedelic Users’ Patterns of Use and Perceived Effects","year":"2025","cit":3,"pfa":"Carrie Cuttler","psa":"Leah M. Mayo","topics":["Anxiety & end-of-life","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4406930020","eid":"W4406930020"},{"id":"paper-w4285589424","cat":"papers","name":"Evaluation of Cytotoxic, Necrotic, Apoptotic, and Autophagic Effects of Methamphetamine and 3,4-Methylenedioxymethamphetamine on U-87 MG (Glial) and B104-1–1 (Neuronal) Cell Lines","year":"2022","cit":3,"pfa":"Asieh Hosseini","psa":"Seyed Vahid Shetab-Boushehri","ptype":"article","src":"https://openalex.org/W4285589424","eid":"W4285589424"},{"id":"paper-w4406325209","cat":"papers","name":"Focused Bodywork as Facilitated Communication: Cautionary Perspectives on Touch in Psychedelic Therapy","year":"2025","cit":3,"pfa":"Neşe Devenot","topics":["Therapy practice"],"ptype":"editorial","src":"https://openalex.org/W4406325209","eid":"W4406325209"},{"id":"paper-w3168490559","cat":"papers","name":"Nicotine and modafinil combination protects against the neurotoxicity induced by 3,4-Methylenedioxymethamphetamine in hippocampal neurons of male rats","year":"2021","cit":3,"pfa":"Golshad Kowsari","psa":"Mehdi Mehdizadeh","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3168490559","eid":"W3168490559"},{"id":"paper-w4409800962","cat":"papers","name":"A systematic review of psychedelic use and its relationship with meaning and purpose in life","year":"2025","cit":3,"pfa":"Przemysław Rupiński","psa":"Paweł Holas","topics":["Addiction","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4409800962","eid":"W4409800962"},{"id":"paper-w4387112716","cat":"papers","name":"High Performance Thin Layer Chromatography method for analysis of 3,4-methylenedioxymethamphetamine in seized tablets","year":"2015","cit":3,"pfa":"Boris Ettienne Duffau","psa":"Sebastian A. Jofre","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4387112716","eid":"W4387112716"},{"id":"paper-w4399789048","cat":"papers","name":"Hepatic injury and hepatic failure adverse events in 3,4-methylenedioxymethamphetamine users reported to the FDA Adverse Event Reporting System","year":"2024","cit":3,"pfa":"Tigran Makunts","psa":"Ruben A Abagyan","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4399789048","eid":"W4399789048"},{"id":"paper-w1976774440","cat":"papers","name":"Nature-inspired indolyl-2-azabicyclo[2.2.2]oct-7-ene derivatives as promising agents for the attenuation of withdrawal symptoms: synthesis of 20-desethyl-20-hydroxymethyl-11-demethoxyibogaine","year":"2006","cit":3,"pfa":"Daniele Passarella","psa":"Bruno Danieli","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1976774440","eid":"W1976774440"},{"id":"paper-w4256346306","cat":"papers","name":"A Simple and Fast Analysis of LSD By Cyclic Voltammetry in Aqueous Medium","year":"2017","cit":3,"pfa":"Marcelo Firmino de Oliveira","psa":"Juliana Midori Toia Katayama","ptype":"conference-abstract","src":"https://openalex.org/W4256346306","eid":"W4256346306"},{"id":"paper-w3023914846","cat":"papers","name":"Hallucinogens","year":"2014","cit":3,"pfa":"Ryan H.A. Chan","psa":"John E. Mendelson","ptype":"book-chapter","src":"https://openalex.org/W3023914846","eid":"W3023914846"},{"id":"paper-w2164194860","cat":"papers","name":"Acute and Chronic Effects of 3-4, Methylenedioxymethamphetamine on Pyramidal Cells of Hippocampus","year":"2014","cit":3,"pfa":"Mohamad Bakhtiar Hesam Shariati","psa":"Maryam Sohrabi","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2164194860","eid":"W2164194860"},{"id":"paper-w4297492851","cat":"papers","name":"Hope that psychedelic drugs can erase trauma","year":"2022","cit":3,"pfa":"Lauren Gravitz","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4297492851","eid":"W4297492851"},{"id":"paper-w2464208506","cat":"papers","name":"Residual solvents in methylenedioxymethamphetamine tablets as a source of strategic information and as a tool for comparative analysis: the development and application of a static headspace gas chromatography/mass spectr","year":"2005","cit":3,"pfa":"Visser Ha","psa":"Henk Huizer","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2464208506","eid":"W2464208506"},{"id":"paper-w4210573958","cat":"papers","name":"A New Method for Enantiomeric Determination of 3,4-Methylenedioxymethamphetamine and p-Methoxymethamphetamine in Human Urine","year":"2022","cit":3,"pfa":"Wei-Jay Chen","psa":"Tsong-Yung Chou","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4210573958","eid":"W4210573958"},{"id":"paper-w2803390161","cat":"papers","name":"État des lieux de la recherche sur les capacités thérapeutiques des « substances hallucinogènes » au 21 e siècle","year":"2018","cit":3,"pfa":"Christian Sueur","topics":["PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W2803390161","eid":"W2803390161"},{"id":"paper-w4401705246","cat":"papers","name":"Including Sexually and Gender Diverse Populations in 3,4-Methylenedioxymethamphetamine–Assisted Psychotherapy Trial Research","year":"2024","cit":3,"pfa":"Ziad Saade","psa":"Alex Sogomon Keuroghlian","topics":["PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4401705246","eid":"W4401705246"},{"id":"paper-w2087897676","cat":"papers","name":"A novel serotonin antagonist 2,2′‐bis[3‐(2‐N,N‐dimethylaminoethyl)indolyl]sulfide (BDIS)","year":"1984","cit":3,"pfa":"C. K. Chu","psa":"Kun Chae","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2087897676","eid":"W2087897676"},{"id":"paper-w4394787536","cat":"papers","name":"Characterization of iso-LSD metabolism using human liver microsomes in comparison to LSD and its applicability as urinary biomarker for LSD consumption","year":"2024","cit":3,"pfa":"Xue Qin Ng","psa":"Hooi Yan Moy","ptype":"article","src":"https://openalex.org/W4394787536","eid":"W4394787536"},{"id":"paper-w4280489053","cat":"papers","name":"Traditional Amazonian medicine in addiction treatment: Qualitative results","year":"2022","cit":3,"pfa":"David M. O’Shaughnessy","psa":"Robin Rodd","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4280489053","eid":"W4280489053"},{"id":"paper-w4362712598","cat":"papers","name":"Psychedelics for Use and Wellbeing Cultural Context and Recent Developments: A Jamaican Perspective","year":"2022","cit":3,"pfa":"Winston De La Haye","ptype":"article","src":"https://openalex.org/W4362712598","eid":"W4362712598"},{"id":"paper-w4220739780","cat":"papers","name":"Extracorporeal Membrane Oxygenation Support in Refractory Multi-organ Failure by 3,4-Methylenedioxymethamphetamine Intoxication (“Ecstasy”)","year":"2022","cit":3,"pfa":"Victoria Ruiz","psa":"Marcos Las Heras","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4220739780","eid":"W4220739780"},{"id":"paper-w4414873651","cat":"papers","name":"Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases","year":"2025","cit":3,"pfa":"Nathan H. Heller","psa":"Pantelis Leptourgos","topics":["Mechanism & neuroscience","Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4414873651","eid":"W4414873651"},{"id":"paper-w3175197034","cat":"papers","name":"Acute effects of d‐methamphetamine, 3,4‐methylenedioxypyrovalerone, 3,4‐methylenedioxymethamphetamine, and 4‐methylmethcathinone on wheel activity in rats","year":"2012","cit":3,"pfa":"Pai-Kai Huang","psa":"Michael A. Taffe","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3175197034","eid":"W3175197034"},{"id":"paper-w4400492401","cat":"papers","name":"Tratamiento con microdosis de hongos con psilocibina en trastorno depresivo mayor: reporte de un caso","year":"2024","cit":3,"pfa":"Mariana Zarankin","psa":"Francisco Zenteno","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4400492401","eid":"W4400492401"},{"id":"paper-w4399601934","cat":"papers","name":"Psychedelics field looks ahead after FDA advisers’ rejection","year":"2024","cit":3,"pfa":"Kai Kupferschmidt","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4399601934","eid":"W4399601934"},{"id":"paper-w4303438708","cat":"papers","name":"Dans l’ivresse mescalinique : Jean-Paul Sartre, clinicien de l’imagination ?","year":"2022","cit":3,"pfa":"Gautier Dassonneville","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4303438708","eid":"W4303438708"},{"id":"paper-w4409639899","cat":"papers","name":"Effects of psychedelics on human oscillatory brain activity","year":"2025","cit":3,"pfa":"Kate E.M. Godfrey","psa":"Christopher B. Timmermann","ptype":"book-chapter","src":"https://openalex.org/W4409639899","eid":"W4409639899"},{"id":"paper-w4292089187","cat":"papers","name":"A-118 Psychedelic Interventions for Neuropsychological Conditions","year":"2022","cit":3,"pfa":"Brian Peacock","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"conference-abstract","src":"https://openalex.org/W4292089187","eid":"W4292089187"},{"id":"paper-w2321780200","cat":"papers","name":"Synthesis of Phenethylamine Derivatives as Hallucinogen.","year":"1992","cit":3,"pfa":"Toshitaka Ohshita","psa":"HIROAKI ANDO","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2321780200","eid":"W2321780200"},{"id":"paper-w2369379147","cat":"papers","name":"PHARMACOLOGIC ACTIONS OF TETRAHYDROBERBERINE ON THE CENTRAL NERVOUS SYSTEM","year":"1962","cit":3,"pfa":"Kin Kuo","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2369379147","eid":"W2369379147"},{"id":"paper-w2462439371","cat":"papers","name":"Behavioural effects of long term inhibition of 5-hydroxytryptamine receptors using metergoline.","year":"1981","cit":3,"pfa":"Stolz Jf","psa":"C A Marsden","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2462439371","eid":"W2462439371"},{"id":"paper-w4391360045","cat":"papers","name":"Die Rolle der Psychotherapie in klinischen Studien mit Psychedelika","year":"2024","cit":3,"pfa":"Ricarda Evens","psa":"Max Wolff","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4391360045","eid":"W4391360045"},{"id":"paper-w4399299007","cat":"papers","name":"A scoping review of the effects of mushroom and fungus extracts in rodent models of depression and tests of antidepressant activity","year":"2024","cit":3,"pfa":"Catherine K. Wang","psa":"Alasdair M. Barr","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4399299007","eid":"W4399299007"},{"id":"paper-w3215289461","cat":"papers","name":"Anxiety-related Symptoms following the Sporadic Use of Ecstasy – A Case Study","year":"2021","cit":3,"pfa":"Tomislav Majić","psa":"Christiane Montag","topics":["PTSD & trauma","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3215289461","eid":"W3215289461"},{"id":"paper-w562065783","cat":"papers","name":"5HT2a Receptors – a New Target for Depression?","year":"2015","cit":3,"pfa":"David Nutt","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W562065783","eid":"W562065783"},{"id":"paper-w4402536039","cat":"papers","name":"Psychedelic mushroom-containing chocolate exposures: Case series","year":"2024","cit":3,"pfa":"H. Gärtner","psa":"Sophia Sheikh","ptype":"article","src":"https://openalex.org/W4402536039","eid":"W4402536039"},{"id":"paper-w4388191420","cat":"papers","name":"A brain imaging study of dopamine receptor D2 availability in cannabis dependent users after recovery from cannabis-induced psychosis","year":"2023","cit":3,"pfa":"Aviv Malkiel Weinstein","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4388191420","eid":"W4388191420"},{"id":"paper-w4241833815","cat":"papers","name":"The effect of novel kappa opioid peptide receptor agonists on learning and memory in rats","year":"2017","cit":3,"pfa":"Susan Adele Welsh","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W4241833815","eid":"W4241833815"},{"id":"paper-w3152690906","cat":"papers","name":"A draft sequence reference of the Psilocybe cubensis genome","year":"2021","cit":3,"pfa":"Kevin Judd McKernan","psa":"Stephen McLaughlin","ptype":"article","src":"https://openalex.org/W3152690906","eid":"W3152690906"},{"id":"paper-w132163482","cat":"papers","name":"Neurotoxicity of Drugs of Abuse","year":"1999","cit":3,"pfa":"Jean Lud Cadet","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W132163482","eid":"W132163482"},{"id":"paper-w2577034209","cat":"papers","name":"Conducting Qualitative Research With Psychedelic Psychopharmacologists: Challenges of Co-Production in an Era of Interdisciplinarity","year":"2017","cit":3,"pfa":"Tehseen N. Noorani","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"reference-entry","src":"https://openalex.org/W2577034209","eid":"W2577034209"},{"id":"paper-w4401687704","cat":"papers","name":"A virtual clinical trial of psychedelics to treat patients with disorders of consciousness","year":"2024","cit":3,"pfa":"Naji Alnagger","psa":"Jitka Annen","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4401687704","eid":"W4401687704"},{"id":"paper-w237350008","cat":"papers","name":"Structure-Activity Relationship among Hallucinogenic Agents","year":"1970","cit":3,"pfa":"WOLFRAM KEUP","ptype":"book-chapter","src":"https://openalex.org/W237350008","eid":"W237350008"},{"id":"paper-w4317708836","cat":"papers","name":"Educational Materials and Image Induction Increase Treatment Credibility","year":"2023","cit":3,"pfa":"Fiona Low","psa":"Mitch Earleywine","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4317708836","eid":"W4317708836"},{"id":"paper-w2397905897","cat":"papers","name":"Effekte von N,N-Dimethyltryptamin (DMT) auf Psychotizismus-Tests","year":"1977","cit":3,"pfa":"P. Bickel","psa":"Josef Schöpf","ptype":"article","src":"https://openalex.org/W2397905897","eid":"W2397905897"},{"id":"paper-w4385666098","cat":"papers","name":"Psychoplastogens: A Novel Therapeutic Approach for Neurological Diseases and Disorders","year":"2023","cit":3,"pfa":"Robert B. Kargbo","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"editorial","src":"https://openalex.org/W4385666098","eid":"W4385666098"},{"id":"paper-w4412527161","cat":"papers","name":"Perturbing whole‐brain models of brain hierarchy: An application for depression following pharmacological treatment","year":"2025","cit":3,"pfa":"Marcel Socoró‐Garrigosa","psa":"Gustavo Deco","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4412527161","eid":"W4412527161"},{"id":"paper-w2512744128","cat":"papers","name":"Pharmacology and pathophysiology","year":"2016","cit":3,"topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W2512744128","eid":"W2512744128"},{"id":"paper-w2018481092","cat":"papers","name":"Effects of various serotoninergic agonists and an antagonist on a nociceptive reaction in mice.","year":"1982","cit":3,"pfa":"Krishnaswami Ramabadran","psa":"Joseph Jacob","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2018481092","eid":"W2018481092"},{"id":"paper-w4245340141","cat":"papers","name":"Reflections on Transpersonal Psychology ’s 40th Anniversary, Ecopsychology, Transpersonal Science, and Psychedelics: A Conversation Forum","year":"2009","cit":3,"pfa":"Mark A. Schroll","psa":"Valerie Mojeiko","ptype":"article","src":"https://openalex.org/W4245340141","eid":"W4245340141"},{"id":"paper-w2341456524","cat":"papers","name":"Pre-clinical Anti-Addictive and Side-Effect profiles of Novel Kappa-opioid Agonists","year":"2015","cit":3,"pfa":"David Alan Young","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W2341456524","eid":"W2341456524"},{"id":"paper-w3160694117","cat":"papers","name":"Phenomenological assessment of psychedelic induced experiences: Translation and validation of the German Challenging Experience Questionnaire (CEQ) and Ego-Dissolution Inventory (EDI)","year":"2021","cit":3,"pfa":"Katharina Dworatzyk","psa":"Timo Torsten Schmidt","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W3160694117","eid":"W3160694117"},{"id":"paper-w4405194813","cat":"papers","name":"Evidence-Based Medicine is inadequate to develop evidence-based psychedelic therapies.","year":"2024","cit":3,"pfa":"Eduardo Ekman Schenberg","topics":["PTSD & trauma","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4405194813","eid":"W4405194813"},{"id":"paper-w2030990493","cat":"papers","name":"Chronic stress reduced GH response to the serotonin agonist 5‐methoxy‐n, n‐dimethyltriptamine but did not alter pituitary–adrenal, prolactin or TSH responses in the rat","year":"1990","cit":3,"pfa":"Antonio Armario","psa":"Trinidad Jolín","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2030990493","eid":"W2030990493"},{"id":"paper-w4386801300","cat":"papers","name":"Substance use in sexual minority youth: prevalence in an urban cohort","year":"2023","cit":3,"pfa":"Florian Vock","psa":"Boris B. Quednow","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4386801300","eid":"W4386801300"},{"id":"paper-w2285022856","cat":"papers","name":"Kappa Opioid Receptor Agonists: New Targets In The Treatment Of Pain","year":"2014","cit":3,"pfa":"Nitin Kumar","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W2285022856","eid":"W2285022856"},{"id":"paper-w2591149829","cat":"papers","name":"Harm reduction – the right policy approach for Africa?","year":"2011","cit":3,"pfa":"Axel Klein","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2591149829","eid":"W2591149829"},{"id":"paper-w2006297964","cat":"papers","name":"Neurotropic Effect of Extracts from the Hallucinogenic Mushroom Psilocybe cubensis (Earle) Sing. (Agaricomycetideae). In Vitro Studies","year":"2000","cit":3,"pfa":"Mykhaylo G. Moldavan","psa":"Margarita Lomberg","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2006297964","eid":"W2006297964"},{"id":"paper-w4301293041","cat":"papers","name":"Structure of the human κ-opioid receptor in complex with JDTic","year":"2019","cit":3,"pfa":"Xi‐Ping Huang","psa":"Eyal Vardy","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4301293041","eid":"W4301293041"},{"id":"paper-w2883854139","cat":"papers","name":"Are the neurocognitive deficits associated with 3,4-methylenedioxymethamphetamine caused by statistical deficits in ecstasy research? A systematic review","year":"2018","cit":3,"pfa":"Timothy Amoroso","topics":["Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W2883854139","eid":"W2883854139"},{"id":"paper-w2914472600","cat":"papers","name":"One Ultimate Journey? AKA the Huxley’s Method: Perspectives of (Ab)Users of Hallucinogens and Entheogens on Having Planned Pre-Mortem Psychedelic Trip","year":"2019","cit":3,"pfa":"Ahmed Al-Imam","psa":"Faris Lami","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2914472600","eid":"W2914472600"},{"id":"paper-w2188754078","cat":"papers","name":"The Relationship between Psychoactive Drugs, the Brain and Psychosis","year":"2015","cit":3,"pfa":"Sutapa Basu","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2188754078","eid":"W2188754078"},{"id":"paper-w2437074361","cat":"papers","name":"Search for new treatment approaches in schizophrenia: in vitro studies of potential N-methyltransferase inhibitors.","year":"1976","cit":3,"pfa":"Domino Ef","ptype":"article","src":"https://openalex.org/W2437074361","eid":"W2437074361"},{"id":"paper-w4407194293","cat":"papers","name":"Psychedelics for Moral Bioenhancement in Healthy Individuals—A Violation of the Non-Maleficence Principle?","year":"2025","cit":3,"pfa":"Bor Luen Tang","topics":["Safety & adverse events","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4407194293","eid":"W4407194293"},{"id":"paper-w2408776301","cat":"papers","name":"Pharmacological effects of oxaprotiline enantiomers on the central serotonin system.","year":"1990","cit":3,"pfa":"Joanna Maj","psa":"Elisabeta Moryl","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2408776301","eid":"W2408776301"},{"id":"paper-w4300519501","cat":"papers","name":"Response to commentaries on \"The ketamine model of the near-death experience ...\"","year":"1997","cit":3,"pfa":"Jansen, Karl L. R.","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4300519501","eid":"W4300519501"},{"id":"paper-w3137072769","cat":"papers","name":"Baseline power of theta oscillations predicts mystical-type experiences induced by DMT","year":"2021","cit":3,"pfa":"Enzo Tagliazucchi","psa":"Carla Pallavicini","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W3137072769","eid":"W3137072769"},{"id":"paper-w3127367126","cat":"papers","name":"Psychedelic philanthropy: The nonprofit sector and Timothy Leary's 1960s psychedelic movement","year":"2021","cit":3,"pfa":"Chris Elcock","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3127367126","eid":"W3127367126"},{"id":"paper-w2421831335","cat":"papers","name":"[Neurologic complications of drug addiction. General aspects. Complications caused by cannabis, designer drugs and volatile substances].","year":"1989","cit":3,"pfa":"Farre Albaladejo M","topics":["Addiction","Safety & adverse events"],"ptype":"other","src":"https://openalex.org/W2421831335","eid":"W2421831335"},{"id":"paper-w2462559877","cat":"papers","name":"Some Current Biochemical Theories of Psychosis","year":"1956","cit":3,"pfa":"Theodore L. Sourkes","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2462559877","eid":"W2462559877"},{"id":"paper-w3083963533","cat":"papers","name":"LSD auf dem Land. Produktion und kollektive Wirkung psychotroper Stoffe","year":"2020","cit":3,"pfa":"Beat Bächi","ptype":"article","src":"https://openalex.org/W3083963533","eid":"W3083963533"},{"id":"paper-w2114153316","cat":"papers","name":"A 23-Year-Old Man With Schizophrenia","year":"2002","cit":3,"pfa":"DONALD C. GOFF","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2114153316","eid":"W2114153316"},{"id":"paper-w1885757504","cat":"papers","name":"Kappa Opioid Receptor‐Based Treatments for Pain (LB88)","year":"2014","cit":3,"pfa":"C. Assana","psa":"Christopher W. Cunningham","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1885757504","eid":"W1885757504"},{"id":"paper-w2791033194","cat":"papers","name":"Interactions between Over-the-Counter and Illicit Drugs Utilizing Cytochrome P450 Metabolism: Potential for Exacerbation of Pharmacological Response","year":"2017","cit":3,"pfa":"David Robert Wallace","psa":"Kara Kelley Crosswy","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2791033194","eid":"W2791033194"},{"id":"paper-w2063225452","cat":"papers","name":"Phenylalkylamine abuse among opiate addicts attending a methadone treatment programme in the Republic of Ireland","year":"2001","cit":3,"pfa":"P. V. Kavanagh","psa":"Jim Burdett","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2063225452","eid":"W2063225452"},{"id":"paper-w2075760129","cat":"papers","name":"Acid redux: revisiting LSD use in therapy","year":"2008","cit":3,"pfa":"Adam L. Jacobs","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2075760129","eid":"W2075760129"},{"id":"paper-w4385333005","cat":"papers","name":"Concomitant Drug Use among Opioid-Dependent Patients with and without Attention Deficit Hyperactivity Disorder: Does Methylphenidate Merit a Trial?","year":"2023","cit":3,"pfa":"Letizia Tschudi","psa":"Jochen Mutschler","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4385333005","eid":"W4385333005"},{"id":"paper-w4402534416","cat":"papers","name":"Emerging Illicit Drug “2C”: A Case Report on Its Hallucinogenic and Stimulant Properties","year":"2024","cit":3,"pfa":"Marina Nasr","psa":"Manoj Puthiyathu","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4402534416","eid":"W4402534416"},{"id":"paper-w2397471800","cat":"papers","name":"A Profile of Those Who Use Hallucinogenic Mushrooms","year":"2016","cit":3,"pfa":"Mitchell G. Spring","psa":"Robert M. Hallock","ptype":"book-chapter","src":"https://openalex.org/W2397471800","eid":"W2397471800"},{"id":"paper-w4402126097","cat":"papers","name":"Spinal muscular atrophy in an upper-middle-income nation before the advent of reimbursed disease-modifying therapies","year":"2024","cit":3,"pfa":"Kullasate Sakpichaisakul","psa":"Oranee Sanmaneechai","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4402126097","eid":"W4402126097"},{"id":"paper-w4403366569","cat":"papers","name":"Latin American adults who regularly use macrodoses of psychedelics: a cross-sectional study","year":"2024","cit":3,"pfa":"Óscar Véliz‐García","psa":"Marcos Domic‐Siede","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4403366569","eid":"W4403366569"},{"id":"paper-w4410016959","cat":"papers","name":"Single-dose DMT reverses anhedonia and cognitive deficits via restoration of neurogenesis in a stress-induced depression model","year":"2025","cit":3,"pfa":"Rafael Vitor Lima da Cruz","psa":"Richardson Naves Leão","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4410016959","eid":"W4410016959"},{"id":"paper-w2781501895","cat":"papers","name":"As protagonistas femininas nos filmes da cineasta peruana Nora de Izcue","year":"2017","cit":3,"pfa":"Marina Cavalcanti Tedesco","ptype":"article","src":"https://openalex.org/W2781501895","eid":"W2781501895"},{"id":"paper-w4319786581","cat":"papers","name":"Prevalence & Psychiatric Correlates of Illicit Substance Use in UK Undergraduate students","year":"2023","cit":3,"pfa":"Holly Foster","psa":"Umair Akram","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W4319786581","eid":"W4319786581"},{"id":"paper-w2315785830","cat":"papers","name":"Functional interaction between 5-HT1B and 5-HT1A or 5-HT2 receptors in mice.","year":"1993","cit":3,"pfa":"Ewa Chojnacka-Wójcik","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2315785830","eid":"W2315785830"},{"id":"paper-w3013689395","cat":"papers","name":"Anaesthetic management and considerations in a patient with chronic dicyclomine addiction","year":"2020","cit":3,"pfa":"Prabakaran Parameswaran","psa":"Mridul Dhar","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3013689395","eid":"W3013689395"},{"id":"paper-w4396801998","cat":"papers","name":"Expanding mindscapes: A global history of psychedelics","year":"2024","cit":3,"pfa":"Jarrett Robert Rose","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4396801998","eid":"W4396801998"},{"id":"paper-w3155007967","cat":"papers","name":"Salvia divinorum increases alcohol intake and tonic immobility whilst decreasing food intake in Wistar rats","year":"2021","cit":3,"pfa":"Priscila Vázquez-León","psa":"Abraham Miranda-Páez","topics":["Addiction","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3155007967","eid":"W3155007967"},{"id":"paper-w7128814597","cat":"papers","name":"Trip sitting or just sitting? Session facilitators substantially influence psychedelic experiences in clinical trials but not in healthy ones","year":"2026","cit":3,"pfa":"Sean P. Goldy","psa":"Sandeep Manel Nayak","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W7128814597","eid":"W7128814597"},{"id":"paper-w7124468322","cat":"papers","name":"Psychedelic therapeutics in psychiatric conditions","year":"2026","cit":3,"pfa":"Philip D. Harvey","psa":"Charles B. Nemeroff","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7124468322","eid":"W7124468322"},{"id":"paper-w4407589940","cat":"papers","name":"Setting the Stage for the Inner Journey: Unraveling the Interplay of Contextual Factors and the Intensity of Psychedelic-Induced Ego Dissolution","year":"2025","cit":3,"pfa":"Stanisław Adamczyk","psa":"Paweł Orlowski","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4407589940","eid":"W4407589940"},{"id":"paper-w2991548627","cat":"papers","name":"Le façonnement neuropharmacologique de la culture. Anthropologie comparée des rituels à hallucinogènes sérotoninergiques et anticholinergiques","year":"2019","cit":3,"pfa":"Martin Fortier","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2991548627","eid":"W2991548627"},{"id":"paper-w2617050853","cat":"papers","name":"Synthetic cathinone “bath salts”: the mechanism of action, toxicological aspects, clinic, dependence development","year":"2017","cit":3,"pfa":"Andrey Viktorovich Antsyborov","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2617050853","eid":"W2617050853"},{"id":"paper-w4401918931","cat":"papers","name":"Development of a diagnostic variable number tandem repeat marker and dual TaqMan genotyping assay to distinguish Lophophora species","year":"2024","cit":3,"pfa":"Eun‐Mi Hwang","psa":"Joo‐Young Kim","ptype":"article","src":"https://openalex.org/W4401918931","eid":"W4401918931"},{"id":"paper-w2128252727","cat":"papers","name":"Lhermitte’s sign, electric shock sensations and high dose ecstasy consumption: preliminary findings","year":"2009","cit":3,"pfa":"Billy Boland","psa":"Kim Wolff","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2128252727","eid":"W2128252727"},{"id":"paper-w3116603287","cat":"papers","name":"Describing the Unspeakable: Psychedelic Communication Technologies and the Development of a Posthuman Language","year":"2020","cit":3,"pfa":"Benjamin Dueck","ptype":"article","src":"https://openalex.org/W3116603287","eid":"W3116603287"},{"id":"paper-w4413981705","cat":"papers","name":"Psychedelics and Mental Health Treatment Seeking Among Asians and Hawaiians","year":"2025","cit":3,"pfa":"Sean M. Viña","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4413981705","eid":"W4413981705"},{"id":"paper-w324643892","cat":"papers","name":"Resolving Erroneous Reports in Toxicology and Therapeutic Drug Monitoring: A Comprehensive Guide","year":"2012","cit":3,"pfa":"Amitava Dasgupta","topics":["Depression","Addiction"],"ptype":"book","src":"https://openalex.org/W324643892","eid":"W324643892"},{"id":"paper-w4407939414","cat":"papers","name":"Psychedelic-assisted Therapy as a Promising Treatment for Irritable Bowel Syndrome","year":"2025","cit":3,"pfa":"Erin E. Mauney","psa":"Braden Kuo","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"editorial","src":"https://openalex.org/W4407939414","eid":"W4407939414"},{"id":"paper-w3009868700","cat":"papers","name":"Steroids, Dissociatives, Club Drugs, Inhalants, and Hallucinogens","year":"2020","cit":3,"pfa":"Mashal Khan","psa":"Anil Abraham Thomas","ptype":"book-chapter","src":"https://openalex.org/W3009868700","eid":"W3009868700"},{"id":"paper-w3011114480","cat":"papers","name":"Aspectos Farmacológicos e Toxicológicos do Alcaloide N, N – Dimetiltriptamina (DMT)","year":"2020","cit":3,"pfa":"Lilian Carvalho Machado","psa":"Robson Seriani","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3011114480","eid":"W3011114480"},{"id":"paper-w4401937554","cat":"papers","name":"Can Psychedelic Use Benefit Meditation Practice? Examining Individual, Psychedelic, and Meditation-Related Factors","year":"2024","cit":3,"pfa":"Zishan Jiwani","psa":"Marco Schlosser","ptype":"preprint","src":"https://openalex.org/W4401937554","eid":"W4401937554"},{"id":"paper-w4406822940","cat":"papers","name":"Quantitative evaluation of multiple treatment regimens for treatment-resistant depression","year":"2025","cit":3,"pfa":"Yulin Feng","psa":"Lujin Li","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4406822940","eid":"W4406822940"},{"id":"paper-w2067285240","cat":"papers","name":"A Reevaluation of Psychotomimetic Amphetamine Derivatives in Humans","year":"1985","cit":3,"pfa":"Bruce K. Cassels","psa":"Juan S. Gómez-Jeria","topics":["Addiction","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2067285240","eid":"W2067285240"},{"id":"paper-w4405599715","cat":"papers","name":"A Rapid Review of Psychedelic-Assisted Therapy in the Context of Palliative Care","year":"2024","cit":3,"pfa":"Megan Miller","psa":"William E. Rosa","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4405599715","eid":"W4405599715"},{"id":"paper-w1192593943","cat":"papers","name":"Healing With Plants and Spirits A Phenomenological and Ontological Perspective of the Treatment Practice of Patients and Visitors in Takiwasi, Peru.","year":"2014","cit":3,"pfa":"Roger Håland","topics":["Addiction","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W1192593943","eid":"W1192593943"},{"id":"paper-w4296882666","cat":"papers","name":"Raising awareness: The implementation of medical cannabis and psychedelics used as an adjunct to standard therapy in the treatment of advanced metastatic breast cancer","year":"2022","cit":3,"pfa":"Rayyan R. Zafar","psa":"Anne Katrin Schlag","topics":["Anxiety & end-of-life","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4296882666","eid":"W4296882666"},{"id":"paper-w4413296887","cat":"papers","name":"Endocannabinoids, depression, and treatment resistance: Perspectives on effective therapeutic interventions","year":"2025","cit":3,"pfa":"Ilenia Rosa","psa":"Giovanni Martinotti","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4413296887","eid":"W4413296887"},{"id":"paper-w4297518071","cat":"papers","name":"Reasonable expectations for replications of psychedelic-assisted therapy: The case for prediction intervals rather than P-values","year":"2022","cit":3,"pfa":"Mitch Earleywine","psa":"Philip Kamilar-Britt","topics":["PTSD & trauma","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4297518071","eid":"W4297518071"},{"id":"paper-w165170515","cat":"papers","name":"USE OF UNCONDITIONED AND CONDITIONED BEHAVIORS IN EVALUATING POSSIBLE HALLUCINOGENIC AGENTS","year":"1978","cit":3,"pfa":"W. Marvin Davis","psa":"Monique C. Braude","ptype":"book-chapter","src":"https://openalex.org/W165170515","eid":"W165170515"},{"id":"paper-w4416815476","cat":"papers","name":"Oxytocin: a neglected hormone in pituitary disease – From function to the diagnosis of a deficiency, resulting clinical relevance, and potential treatment options in endocrinology","year":"2026","cit":3,"pfa":"Svenja Leibnitz","psa":"Cihan Atila","topics":["Anxiety & end-of-life","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4416815476","eid":"W4416815476"},{"id":"paper-w4409194506","cat":"papers","name":"Do AMPA/kainate antagonists possess potential in the treatment of addiction? Evidence from animal behavioural studies","year":"2025","cit":3,"pfa":"Maria Hrickova","psa":"Jana Kučerová","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4409194506","eid":"W4409194506"},{"id":"paper-w2469551422","cat":"papers","name":"Serotonin receptor site in human platelets from control and chlorpromazine treated subjects.","year":"1980","cit":3,"pfa":"Bina Oppenheim","psa":"M.B.H. Youdim","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2469551422","eid":"W2469551422"},{"id":"paper-w2483663979","cat":"papers","name":"Evaluation of treatment outcomes in pelvic floor muscle training with biofeedback versus intra-vaginal electrical stimulation in women with urinary incontinence in Hong Kong Pamela Youde Nethersole Eastern Hospital","year":"2016","cit":3,"pfa":"Simon K. W. Yeung","psa":"Changmin Tang","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2483663979","eid":"W2483663979"},{"id":"paper-w1526646885","cat":"papers","name":"Using Psychedelics Wisely","year":"1993","cit":3,"pfa":"Franklin Merrell-Wol","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1526646885","eid":"W1526646885"},{"id":"paper-w4392967247","cat":"papers","name":"Transitions to polysubstance use: Prospective cohort study of adolescents in Australia","year":"2024","cit":3,"pfa":"Nicola Black","psa":"Amy Peacock","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4392967247","eid":"W4392967247"},{"id":"paper-w4407924112","cat":"papers","name":"Chemicals of emerging concern in wastewater treatment plants from Mendoza: Environmental study in a semiarid region of Argentina","year":"2025","cit":3,"pfa":"Kathryn Proctor","psa":"Barbara Kasprzyk‐Hordern","topics":["Depression","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4407924112","eid":"W4407924112"},{"id":"paper-w2137930730","cat":"papers","name":"The behavioural pharmacology of stress","year":"2014","cit":3,"pfa":"Paul Willner","psa":"Bart A. Ellenbroek","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W2137930730","eid":"W2137930730"},{"id":"paper-w982137422","cat":"papers","name":"Pharmacological approaches to the study of social behaviour","year":"2015","cit":3,"pfa":"Paul Willner","psa":"Bart A. Ellenbroek","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W982137422","eid":"W982137422"},{"id":"paper-w4384663200","cat":"papers","name":"Drug analysis: Comparison between dried plasma spots and liquid plasma samples of trauma patients from Cameroon—A feasibility study","year":"2023","cit":3,"pfa":"Hallvard Gjerde","psa":"Elisabeth Leere Øiestad","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4384663200","eid":"W4384663200"},{"id":"paper-w4399401412","cat":"papers","name":"Treatment of alcohol use disorder in patients with liver disease","year":"2024","cit":3,"pfa":"Gordon S Hill","psa":"Melissa B. Weimer","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4399401412","eid":"W4399401412"},{"id":"paper-w4200581092","cat":"papers","name":"Special Report: Ethical Decision-Making in Contemporary Psychiatric Practice—An Evolving Challenge","year":"2021","cit":3,"pfa":"Laura Weiss Roberts","psa":"Gabriel Termuehlen","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4200581092","eid":"W4200581092"},{"id":"paper-w4389614011","cat":"papers","name":"Mechanisms of integration in psychedelic-assisted therapy","year":"2023","cit":3,"pfa":"Nicole S. Coverdale","psa":"Douglas J. Cook","topics":["Mechanism & neuroscience","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4389614011","eid":"W4389614011"},{"id":"paper-w7132839262","cat":"papers","name":"Chaplains in Psychedelic Assisted Therapy: Rationale and Competencies","year":"2026","cit":3,"pfa":"Stephen P. Lewis","psa":"Aaron D. Cherniak","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7132839262","eid":"W7132839262"},{"id":"paper-w4406298316","cat":"papers","name":"Perspectives of Psychotherapists Regarding Psychedelic Assisted Therapy","year":"2025","cit":3,"pfa":"Sean P. Kinahan","psa":"Elizabeth Jane Wilson","topics":["Safety & adverse events","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4406298316","eid":"W4406298316"},{"id":"paper-w4391718103","cat":"papers","name":"(Dis)connectedness, suicidality and group psychedelic therapies.","year":"2024","cit":3,"pfa":"Rosalind G. McAlpine","psa":"George Blackburne","topics":["Safety & adverse events","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4391718103","eid":"W4391718103"},{"id":"paper-w4406325367","cat":"papers","name":"Holding Without Touch: Supportive Touch in Psychedelic-Assisted Psychotherapy","year":"2025","cit":3,"pfa":"Bryony Insua‐Summerhays","psa":"Edward Jacobs","topics":["Safety & adverse events","Therapy practice"],"ptype":"editorial","src":"https://openalex.org/W4406325367","eid":"W4406325367"},{"id":"paper-w4413177866","cat":"papers","name":"The potential risks of opening the mind’s eye with psychedelic therapies","year":"2025","cit":3,"pfa":"Roger Koenig‐Robert","psa":"Joel Pearson","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4413177866","eid":"W4413177866"},{"id":"paper-w4409101193","cat":"papers","name":"Shifting Paradigms: Exploring Multicultural Approaches to Psychedelic-Assisted Therapy in Counseling","year":"2025","cit":3,"pfa":"Brittany L. Prioleau","psa":"Shama Panjwani","ptype":"article","src":"https://openalex.org/W4409101193","eid":"W4409101193"},{"id":"paper-w4324355992","cat":"papers","name":"Examining the Rationale for Studying Psychedelic-Assisted Psychotherapy for the Treatment of Caregiver Distress","year":"2023","cit":3,"pfa":"Noah D. Gold","psa":"Petros D. Petridis","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4324355992","eid":"W4324355992"},{"id":"paper-w2035714518","cat":"papers","name":"Changes on the Myers-Briggs following Psychedelic Therapy: A Pilot Study","year":"1970","cit":3,"pfa":"Robert E. Klavetter","psa":"James B. Watt","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2035714518","eid":"W2035714518"},{"id":"paper-w4412902872","cat":"papers","name":"Applying relational spirituality to develop spiritual and religious competencies in psychedelic-assisted psychotherapy training.","year":"2025","cit":3,"pfa":"Roman Palitsky","psa":"Steven J. Sandage","topics":["Anxiety & end-of-life","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4412902872","eid":"W4412902872"},{"id":"paper-w4402581745","cat":"papers","name":"Lost in translation? Qualitative interviews with Australian psychedelic‐assisted therapy trial clinicians","year":"2024","cit":3,"pfa":"Michaela Barber","psa":"Adrian Carter","topics":["Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4402581745","eid":"W4402581745"},{"id":"paper-w4399451558","cat":"papers","name":"In a setback for psychedelic therapy, FDA advisers vote against medical use of ecstasy","year":"2024","cit":3,"ptype":"dataset","src":"https://openalex.org/W4399451558","eid":"W4399451558"},{"id":"paper-w4361270141","cat":"papers","name":"It is not and never has been just about the drug: The need to emphasise psychotherapy in psychedelic‐assisted psychotherapy","year":"2023","cit":3,"pfa":"Richard Lakeman","psa":"Mary Emeleus","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4361270141","eid":"W4361270141"},{"id":"paper-w4412110518","cat":"papers","name":"Research Letters: What do clinicians think about psychedelic-assisted therapy? An Australian perspective","year":"2025","cit":3,"pfa":"Zachary Bryant","psa":"Tim N Slade","ptype":"article","src":"https://openalex.org/W4412110518","eid":"W4412110518"},{"id":"paper-w4416128102","cat":"papers","name":"Commentary on Methods for Addressing Functional Unblinding and Mechanistic Uncertainty in Clinical Trials of Psychedelic-Assisted Treatments","year":"2025","cit":3,"pfa":"Dan Petrovitch","psa":"Andrew K. Littlefield","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"editorial","src":"https://openalex.org/W4416128102","eid":"W4416128102"},{"id":"paper-w4413929522","cat":"papers","name":"Why psychedelic-assisted therapy studies in eating disorders risk missing the mark on outcomes: a phenomenological psychopathology perspective","year":"2025","cit":3,"pfa":"Elena Koning","psa":"Stephen William Touyz","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4413929522","eid":"W4413929522"},{"id":"paper-w7140802012","cat":"papers","name":"Ketamine-assisted Mindfulness-Oriented Recovery Enhancement for opioid use disorder: a randomized controlled trial","year":"2026","cit":3,"pfa":"Eric L. Garland","psa":"Jincheng Shen","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7140802012","eid":"W7140802012"},{"id":"paper-w4409885809","cat":"papers","name":"Ketamine-Assisted Psychotherapy for Treatment of Co-occurring Borderline Personality Disorder and Depression: A Case Study","year":"2025","cit":3,"pfa":"Albert Yeung","psa":"David Mischoulon","topics":["Depression","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4409885809","eid":"W4409885809"},{"id":"paper-w4399205399","cat":"papers","name":"Recurrent Serotonin Syndrome After Ketamine-assisted Electroconvulsive Therapy: A Case Report and Review of the Literature","year":"2024","cit":3,"pfa":"Aniruddha Deka","psa":"Jonathan Kaplan","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4399205399","eid":"W4399205399"},{"id":"paper-w4409914963","cat":"papers","name":"What motivates spiritual health practitioners in psychedelic-assisted therapy? A qualitative study and implications for facilitator training practices","year":"2025","cit":3,"pfa":"Ishan Pasricha","psa":"Deanna M. Kaplan","topics":["Safety & adverse events","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4409914963","eid":"W4409914963"},{"id":"paper-w4402027439","cat":"papers","name":"“This is you teaching you:” Exploring providers’ perspectives on experiential learning and enhancing patient safety and outcomes in ketamine-assisted therapy","year":"2024","cit":3,"pfa":"Elena Argento","psa":"Zach Walsh","topics":["PTSD & trauma","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4402027439","eid":"W4402027439"},{"id":"paper-w4415502235","cat":"papers","name":"How to Change Minds Ethically: Doxastic Vulnerability, Epistemic Harm Reduction, and the Role of Therapists in Psychedelic Therapy","year":"2025","cit":3,"pfa":"Christoph Bublitz","topics":["Safety & adverse events","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4415502235","eid":"W4415502235"},{"id":"paper-w4411177710","cat":"papers","name":"Reconnecting through dissociation: a 5-month follow-up case study on ketamine-assisted psychotherapy for anorexia nervosa","year":"2025","cit":3,"pfa":"Camilla Lindvall Dahlgren","psa":"Lowan Han Stewart","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4411177710","eid":"W4411177710"},{"id":"paper-w4414572066","cat":"papers","name":"“ Facing Death. . . Now, That’s a Serious Thing to Confront ” A Qualitative Analysis of Patient Perspectives on Psychedelic-Assisted Therapy for Cancer-Related Psychosocial Symptoms","year":"2025","cit":3,"pfa":"Haley D.M. Schuman","psa":"Linda Ellen Carlson","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4414572066","eid":"W4414572066"},{"id":"paper-w4317207628","cat":"papers","name":"Ketamine-assisted psychotherapy provides lasting and effective results in the treatment of depression, anxiety and post traumatic stress disorder at 3 and 6 months: Findings from a large single-arm retrospective effectiv","year":"2023","cit":3,"pfa":"Ryan Yermus","psa":"Christopher Lo","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W4317207628","eid":"W4317207628"},{"id":"paper-w4385259855","cat":"papers","name":"Scientifically Integrating Psychedelics with Counseling: Education, Guidance, and Implications for Mental Health Practitioners","year":"2023","cit":3,"pfa":"Isaac Burt","topics":["Depression","Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4385259855","eid":"W4385259855"},{"id":"paper-w4412088945","cat":"papers","name":"The role of self-transcendent emotions in psychedelic experiences: a two-process proposal","year":"2025","cit":3,"pfa":"Florián Cova","psa":"Federico Seragnoli","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4412088945","eid":"W4412088945"},{"id":"paper-w3213565178","cat":"papers","name":"Psychedelic knowledge and opinions in psychiatric professional conference attendees: Survey instrument","year":"2020","cit":3,"pfa":"Brian Scott Barnett","psa":"Rick Doblin","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W3213565178","eid":"W3213565178"},{"id":"paper-w4403215285","cat":"papers","name":"Neuroimaging and the Investigation of Drug-Drug Interactions Involving Psychedelics","year":"2024","cit":3,"pfa":"Matthew B. Wall","psa":"David Erritzøe","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"editorial","src":"https://openalex.org/W4403215285","eid":"W4403215285"},{"id":"paper-w3207408624","cat":"papers","name":"An Overview of Decriminalization Efforts in Regard to Psychedelic Plants in the United States, 2019-2020","year":"2021","cit":3,"pfa":"Aaron Roberts","topics":["Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W3207408624","eid":"W3207408624"},{"id":"paper-w4409045316","cat":"papers","name":"Psychedelics, spirituality, and existential distress in patients at the end of life","year":"2025","cit":3,"pfa":"Nicole Cornish","psa":"Christopher Spevak","topics":["Anxiety & end-of-life","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4409045316","eid":"W4409045316"},{"id":"paper-w4376277318","cat":"papers","name":"Psychedelics and Related Pharmacotherapies as Integrative Medicine for Older Adults in Palliative Care","year":"2023","cit":3,"pfa":"Kabir B. Nigam","psa":"Yvan Beaussant","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4376277318","eid":"W4376277318"},{"id":"paper-w4402655959","cat":"papers","name":"Psychedelic visuals in context","year":"2024","cit":3,"pfa":"Link Ray Swanson","ptype":"book-chapter","src":"https://openalex.org/W4402655959","eid":"W4402655959"},{"id":"paper-w4408087600","cat":"papers","name":"The role of psychotherapy and pharmacotherapy in managing major depressive disorder","year":"2025","cit":3,"pfa":"Mohamed Mahmoud Ahmed Ibrahim","topics":["Depression","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4408087600","eid":"W4408087600"},{"id":"paper-w4405179833","cat":"papers","name":"Psychedelic Harm Reduction and Integration: A Transtheoretical Model for Clinical Practice","year":"2024","cit":3,"pfa":"Xinrong Hu","psa":"Elizabeth M. Nielson","topics":["Safety & adverse events","Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W4405179833","eid":"W4405179833"},{"id":"paper-w4400240387","cat":"papers","name":"Disability rights and experiential use of psychedelics in clinical research and practice","year":"2024","cit":3,"pfa":"Maryam Golafshani","psa":"Muhammad Ishrat Husain","topics":["Depression","Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4400240387","eid":"W4400240387"},{"id":"paper-w4382679767","cat":"papers","name":"Does acute stress play a role in the lasting therapeutic effects of psychedelic drugs?","year":"2023","cit":3,"pfa":"Harriet de Wit","psa":"Anya K. Bershad","ptype":"article","src":"https://openalex.org/W4382679767","eid":"W4382679767"},{"id":"paper-w4412512287","cat":"papers","name":"Deconstructing Psychedelic Phenomenology: A Thematic Analysis of Discrete Phases of the Psychedelic Experience","year":"2025","cit":3,"pfa":"Hugh T. McGovern","psa":"Brendan T. Hutchinson","ptype":"article","src":"https://openalex.org/W4412512287","eid":"W4412512287"},{"id":"paper-w7119511108","cat":"papers","name":"Sanitizing psychedelics: the biopolitics of non-hallucinogenic psychoplastogens","year":"2026","cit":3,"pfa":"Ido Hartogsohn","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7119511108","eid":"W7119511108"},{"id":"paper-w3124666101","cat":"papers","name":"Recent developments in geriatric psychopharmacology","year":"2021","cit":3,"pfa":"Awais Aftab","psa":"Martha Sajatovic","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3124666101","eid":"W3124666101"},{"id":"paper-w4393157656","cat":"papers","name":"Psychedelics: reconnecting the brain to heal the mind","year":"2024","cit":3,"pfa":"David Nutt","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4393157656","eid":"W4393157656"},{"id":"paper-w4405461490","cat":"papers","name":"Therapeutic Use of Psychedelics for Mental Disorders: A Systematized Review","year":"2024","cit":3,"pfa":"Norah Mohammed Alyahya","psa":"Eithar A. Al Saleem","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4405461490","eid":"W4405461490"},{"id":"paper-w7117303867","cat":"papers","name":"Learning as the unifying mechanism of psychedelic action","year":"2025","cit":3,"pfa":"Alice Caulfield","psa":"Mitul M. Mehta","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7117303867","eid":"W7117303867"},{"id":"paper-w4414067156","cat":"papers","name":"The shifting fortunes of corporate psychedelia","year":"2025","cit":3,"pfa":"Sandy Brian Hager","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4414067156","eid":"W4414067156"},{"id":"paper-w4399172660","cat":"papers","name":"Attitudes of psychedelic users regarding cost of treatment and non-hallucinogenic alternatives","year":"2024","cit":3,"pfa":"Jacob S. Aday","psa":"Daniel J. Kruger","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4399172660","eid":"W4399172660"},{"id":"paper-w4414518364","cat":"papers","name":"Time‐Dependent Therapeutic Effect of S ‐Ketamine on PTSD Mediated by VTA‐OFC Dopaminergic Neurocircuit","year":"2025","cit":3,"pfa":"Ye Wang","psa":"Guangchao Zhao","topics":["PTSD & trauma","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4414518364","eid":"W4414518364"},{"id":"paper-w4417146176","cat":"papers","name":"How do psychedelics impact people with a history of non-affective psychosis? A qualitative study","year":"2025","cit":3,"pfa":"Haley Maria Dourron","psa":"Peter S. Hendricks","topics":["Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4417146176","eid":"W4417146176"},{"id":"paper-w2945612032","cat":"papers","name":"\"WIsh I would be normal\": LSD and Homosexuality at Hollywood Hospital, 1955-1973","year":"2019","cit":3,"pfa":"Andrea Ens","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W2945612032","eid":"W2945612032"},{"id":"paper-w4389145264","cat":"papers","name":"Intérêt et mécanismes d’action de la kétamine dans le traitement de l’addiction à l’alcool – Revue des études cliniques et précliniques","year":"2023","cit":3,"pfa":"Fahd François Hilal","psa":"Mickaël Naassïla","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4389145264","eid":"W4389145264"},{"id":"paper-w4388288381","cat":"papers","name":"Entheogens: Psychedelic religion in the United States, part two","year":"2023","cit":3,"pfa":"Brad Stoddard","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4388288381","eid":"W4388288381"},{"id":"paper-w4405666764","cat":"papers","name":"Towards a dynamic processual model of psychedelic microdosing","year":"2024","cit":3,"pfa":"Jason Hughes","psa":"Hannah R. Farrimond","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4405666764","eid":"W4405666764"},{"id":"paper-w4414251745","cat":"papers","name":"Microdosing Psychedelics to Restore Synaptic Density in Schizophrenia","year":"2025","cit":3,"pfa":"Jacopo Sapienza","psa":"Marta Bosia","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4414251745","eid":"W4414251745"},{"id":"paper-w4385739079","cat":"papers","name":"Microdosing psychedelics has no impact on cognitive function in naturalistic settings","year":"2023","cit":3,"pfa":"Jannis Dinkelacker","psa":"Ioana Pop","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4385739079","eid":"W4385739079"},{"id":"paper-w4288924979","cat":"papers","name":"Turn On, Tune In, Drop Out? A Typology of Psychedelic Microdosing as Technologies of the Self","year":"2022","cit":3,"pfa":"Kamile Grusauskaite","psa":"Koen van Eijck","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4288924979","eid":"W4288924979"},{"id":"paper-w4313199617","cat":"papers","name":"Microdosing with psychedelics to self-medicate for ADHD symptoms in adults: a prospective naturalistic study","year":"2022","cit":3,"pfa":"E.C.H.M. Haijen","psa":"K. Kuypers","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4313199617","eid":"W4313199617"},{"id":"paper-w4281493819","cat":"papers","name":"The difference between 'placebo group' and 'placebo control': a case study in psychedelic microdosing","year":"2022","cit":3,"pfa":"Balázs Szigeti","psa":"David Erritzøe","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4281493819","eid":"W4281493819"},{"id":"paper-w4406091421","cat":"papers","name":"The Psych Behind Psychedelics: Exploring Hallucinogen Use as a Marker for Untreated Mental Health Disorders","year":"2025","cit":3,"pfa":"Liyana Ahmed","psa":"Latha Ganti","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4406091421","eid":"W4406091421"},{"id":"paper-w4301041091","cat":"papers","name":"Proprietary hallucinogens.","year":"1968","cit":3,"pfa":"Robert M. Leff","psa":"S Bernstein","ptype":"article","src":"https://openalex.org/W4301041091","eid":"W4301041091"},{"id":"paper-w2082650984","cat":"papers","name":"Entheogens: The interaction of biology and culture","year":"1981","cit":3,"pfa":"Bernard R. Ortiz de Montellano","ptype":"article","src":"https://openalex.org/W2082650984","eid":"W2082650984"},{"id":"paper-w4251037982","cat":"papers","name":"Hallucinogen Dependence","year":"2017","cit":3,"pfa":"H. Thomas Milhorn","ptype":"book-chapter","src":"https://openalex.org/W4251037982","eid":"W4251037982"},{"id":"paper-w4409788590","cat":"papers","name":"Entheogen: an evolutionary medicine for neuropsychiatric disorders","year":"2025","cit":3,"pfa":"Yibo Wang","psa":"Xiaohui Wang","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4409788590","eid":"W4409788590"},{"id":"paper-w1718722192","cat":"papers","name":"Hallucinogens and Related Compounds","year":"2012","cit":3,"pfa":"Charles S. Grob","psa":"Marlene Dobkin de Ríos","ptype":"other","src":"https://openalex.org/W1718722192","eid":"W1718722192"},{"id":"paper-w4248084098","cat":"papers","name":"Hallucinogens in Morning Glory","year":"1966","cit":3,"ptype":"article","src":"https://openalex.org/W4248084098","eid":"W4248084098"},{"id":"paper-w2244409968","cat":"papers","name":"Behavioral Pharmacology of the Hallucinogens","year":"1970","cit":3,"pfa":"Ronald J. Bradley","psa":"Victor S. Johnston","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W2244409968","eid":"W2244409968"},{"id":"paper-w259747336","cat":"papers","name":"Mushrooms and hallucinogens: neurotoxicological aspects.","year":"1995","cit":3,"pfa":"F. A. de Wolff","psa":"Ed J. M. Pennings","ptype":"article","src":"https://openalex.org/W259747336","eid":"W259747336"},{"id":"paper-w4385810690","cat":"papers","name":"On microdosing with the Mario mushroom","year":"2023","cit":3,"pfa":"Kevin Feeney","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4385810690","eid":"W4385810690"},{"id":"paper-w4200441175","cat":"papers","name":"Microdosing of Psychoactive Substances in Business Practice","year":"2021","cit":3,"pfa":"Karel Lehmert","psa":"Jiří Koleňák","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4200441175","eid":"W4200441175"},{"id":"paper-w4413101529","cat":"papers","name":"Psychedelic researchers’ own experiences of psychedelic substances, their link to opinions of psychedelics, and reflections on positionality","year":"2025","cit":3,"pfa":"Jussi Jylkkä","psa":"Aila Mustamo","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4413101529","eid":"W4413101529"},{"id":"paper-w1993510104","cat":"papers","name":"A New Hallucinogen from Andean Colombia:Iochroma fuchsioides","year":"1977","cit":3,"pfa":"Richard Evans Schultes","ptype":"article","src":"https://openalex.org/W1993510104","eid":"W1993510104"},{"id":"paper-w2198373309","cat":"papers","name":"Naturally Occurring Hallucinogens III","year":"1972","cit":3,"pfa":"Gunnar Gjerstad","ptype":"article","src":"https://openalex.org/W2198373309","eid":"W2198373309"},{"id":"paper-w4233876032","cat":"papers","name":"Use of specific hallucinogens: 2006","year":"2008","cit":3,"pfa":"Substance Abuse and Mental Health Services Administration, Office of Applied…","ptype":"dataset","src":"https://openalex.org/W4233876032","eid":"W4233876032"},{"id":"paper-w4399833820","cat":"papers","name":"Psychedelic Humanities","year":"2024","cit":3,"topics":["Reviews & meta-analyses"],"ptype":"book","src":"https://openalex.org/W4399833820","eid":"W4399833820"},{"id":"paper-w2098369375","cat":"papers","name":"Metates and Hallucinogens in Costa Rica","year":"1991","cit":3,"pfa":"Ursula Jones","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2098369375","eid":"W2098369375"},{"id":"paper-w2923941391","cat":"papers","name":"The Role of the Journal of Psychedelic Drugs in the Evolution of Psychedelic Medicine","year":"2019","cit":3,"pfa":"David Eugene Smith","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2923941391","eid":"W2923941391"},{"id":"paper-w4230408374","cat":"papers","name":"Correction to: “Psychedelics”","year":"2016","cit":3,"ptype":"erratum","src":"https://openalex.org/W4230408374","eid":"W4230408374"},{"id":"paper-w4210504394","cat":"papers","name":"The age of psychedelics","year":"2022","cit":3,"pfa":"Allan Hunter Young","ptype":"editorial","src":"https://openalex.org/W4210504394","eid":"W4210504394"},{"id":"paper-w2409251422","cat":"papers","name":"Human microdosing; a boon or a bane?","year":"2009","cit":3,"pfa":"S D Seth","psa":"Pradeep Kumar Dua","topics":["Dosing & pharmacology"],"ptype":"letter","src":"https://openalex.org/W2409251422","eid":"W2409251422"},{"id":"paper-w2606124126","cat":"papers","name":"Effects of hallucinogens on operant behavior","year":"1976","cit":3,"pfa":"Rebecca Nowland","psa":"Chauncey D. Leake","ptype":"article","src":"https://openalex.org/W2606124126","eid":"W2606124126"},{"id":"paper-w4387243526","cat":"papers","name":"Set and Setting of the Brain on Hallucinogen","year":"2023","cit":3,"pfa":"Patricia Pisters","topics":["Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W4387243526","eid":"W4387243526"},{"id":"paper-w4391212915","cat":"papers","name":"Psychedelic Psychiatry","year":"2024","cit":3,"pfa":"David A. Bender","psa":"Joshua S. Siegel","ptype":"book-chapter","src":"https://openalex.org/W4391212915","eid":"W4391212915"},{"id":"paper-w4401952316","cat":"papers","name":"Psychedelic Medicine","year":"2007","cit":3,"ptype":"book","src":"https://openalex.org/W4401952316","eid":"W4401952316"},{"id":"paper-w65146091","cat":"papers","name":"Indole Hallucinogens as Animal Models of Schizophrenia","year":"1976","cit":3,"pfa":"Edward F. Domino","ptype":"book-chapter","src":"https://openalex.org/W65146091","eid":"W65146091"},{"id":"paper-w35060995","cat":"papers","name":"Researchers Explore New Visions for Hallucinogens.","year":"2006","cit":3,"pfa":"Susan Brown","ptype":"article","src":"https://openalex.org/W35060995","eid":"W35060995"},{"id":"paper-w2073573818","cat":"papers","name":"Nutmeg and Epená Snuff: Differing Hallucinogens","year":"1979","cit":3,"pfa":"Norman R. Farnsworth","ptype":"article","src":"https://openalex.org/W2073573818","eid":"W2073573818"},{"id":"paper-w2335004260","cat":"papers","name":"Psychedelics, Spirituality, and Transformation","year":"2011","cit":3,"pfa":"Phil Wolfson","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W2335004260","eid":"W2335004260"},{"id":"paper-w4255599428","cat":"papers","name":"Pharmacological studies of hallucinogens; Report 1","year":"1962","cit":3,"pfa":"Hideo HOSHIKAWA","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4255599428","eid":"W4255599428"},{"id":"paper-w4321480601","cat":"papers","name":"The Promise and Perils of Psychedelics","year":"2023","cit":3,"ptype":"article","src":"https://openalex.org/W4321480601","eid":"W4321480601"},{"id":"paper-w609947415","cat":"papers","name":"Rhino's Psychedelic Trip","year":"2000","cit":3,"pfa":"Alan Bisbort","psa":"P.G. Puterbaugh","ptype":"book","src":"https://openalex.org/W609947415","eid":"W609947415"},{"id":"paper-w57424597","cat":"papers","name":"A Psychedelic Neurochemistry of Time","year":"2005","cit":3,"pfa":"Kim A. Dawson","ptype":"preprint","src":"https://openalex.org/W57424597","eid":"W57424597"},{"id":"paper-w2317989912","cat":"papers","name":"The Varieties of Psychedelic Experience","year":"1967","cit":3,"pfa":"Mary Rose Barral","ptype":"article","src":"https://openalex.org/W2317989912","eid":"W2317989912"},{"id":"paper-w4401855082","cat":"papers","name":"Responding to existential distress at the end of life: Psychedelics and psychedelic experiences and/ as medicine","year":"2024","cit":3,"pfa":"Nathan Emmerich","topics":["Anxiety & end-of-life","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4401855082","eid":"W4401855082"},{"id":"paper-w4285274414","cat":"papers","name":"Are Psychedelic Drugs Distorting?","year":"2022","cit":3,"pfa":"Ole Martin Moen","ptype":"book-chapter","src":"https://openalex.org/W4285274414","eid":"W4285274414"},{"id":"paper-w2432706882","cat":"papers","name":"The use of rigid analogues to probe hallucinogen receptors.","year":"1978","cit":3,"pfa":"D E Nichols","psa":"Yim Gk","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2432706882","eid":"W2432706882"},{"id":"paper-w4224937819","cat":"papers","name":"Classical Hallucinogens As Antidepressant Drugs: A Cautionary Approach","year":"2022","cit":3,"pfa":"RAFAEL GUIMARÃES DOS SANTOS","psa":"Serdar Murat Dursun","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4224937819","eid":"W4224937819"},{"id":"paper-w2082423293","cat":"papers","name":"Microdosing for Reduction of the Time and Resources for Drug Development","year":"2007","cit":3,"pfa":"Kenichi Sudo","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2082423293","eid":"W2082423293"},{"id":"paper-w4389663191","cat":"papers","name":"From Entheogens to Evangelicalism: Spiritual Practices Among Hispanic/Latin Americans","year":"2023","cit":3,"pfa":"Fernando Espí Forcén","ptype":"article","src":"https://openalex.org/W4389663191","eid":"W4389663191"},{"id":"paper-w4382395149","cat":"papers","name":"LSD increases sleep duration the night after microdosing","year":"2023","cit":3,"pfa":"Nathan T. Allen","psa":"Partha S. Roop","topics":["Depression","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4382395149","eid":"W4382395149"},{"id":"paper-w3011879014","cat":"papers","name":"Hallucinogen Use in College Students: Current Trends and Consequences of Use","year":"2020","cit":3,"pfa":"Lena S. Jia","psa":"Jessica A. Gold","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3011879014","eid":"W3011879014"},{"id":"paper-w4406325212","cat":"papers","name":"Psychedelic Ethics in Palliative Care","year":"2025","cit":3,"pfa":"Keenan Davis","psa":"Ali John Zarrabi","topics":["Anxiety & end-of-life","Policy & ethics"],"ptype":"editorial","src":"https://openalex.org/W4406325212","eid":"W4406325212"},{"id":"paper-w4221154758","cat":"papers","name":"Microdosing: Knowledge Distillation for GAN based Compression","year":"2022","cit":3,"pfa":"Leonhard Helminger","psa":"Christopher Schroers","topics":["Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4221154758","eid":"W4221154758"},{"id":"paper-w4389265622","cat":"papers","name":"Psychedelics and schizophrenia: A mystery in history","year":"2023","cit":3,"pfa":"Mark Haden","psa":"Sarah A. Paschall","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4389265622","eid":"W4389265622"},{"id":"paper-w2092370962","cat":"papers","name":"Psychedelics: My Problem Discourse","year":"2008","cit":3,"pfa":"Diana Reed Slattery","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2092370962","eid":"W2092370962"},{"id":"paper-w3013386679","cat":"papers","name":"Psychedelic Drugs and Jungian Therapy","year":"2020","cit":3,"pfa":"Greg Mahr","psa":"Jamie Sweigart","topics":["Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3013386679","eid":"W3013386679"},{"id":"paper-w1974958265","cat":"papers","name":"Perception, Psychedelics, and Social Change","year":"1973","cit":3,"pfa":"Charles F. Kaiser","psa":"Robert S. Gold","ptype":"article","src":"https://openalex.org/W1974958265","eid":"W1974958265"},{"id":"paper-w3125542608","cat":"papers","name":"A review of common psychedelic drugs","year":"2020","cit":3,"pfa":"Saad Usman Mayet","topics":["Depression","Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3125542608","eid":"W3125542608"},{"id":"paper-w4283157098","cat":"papers","name":"Decoloniality in the Psychedelic Research Space","year":"2022","cit":3,"pfa":"Juliet Raphael","topics":["Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4283157098","eid":"W4283157098"},{"id":"paper-w584485547","cat":"papers","name":"Development of the psychedelic individual : a psychological analysis of the psychedelic state and its attendant psychic powers","year":"1974","cit":3,"pfa":"John Curtis Gowan","ptype":"book","src":"https://openalex.org/W584485547","eid":"W584485547"},{"id":"paper-w92226963","cat":"papers","name":"Microdose intrauterine progestagen associated with intrauterine contraceptive devices.","year":"1971","cit":3,"pfa":"Herbert W. Horne","psa":"Richard H. Underwood","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W92226963","eid":"W92226963"},{"id":"paper-w4200405349","cat":"papers","name":"Legalization of Psychedelic Substances—Reply","year":"2021","cit":3,"pfa":"William Smith","psa":"Paul S. Appelbaum","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4200405349","eid":"W4200405349"},{"id":"paper-w4229336530","cat":"papers","name":"A pilot psychedelic psychopharmacology elective","year":"2022","cit":3,"pfa":"Joseph Michael Cusimano","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4229336530","eid":"W4229336530"},{"id":"paper-w2801480210","cat":"papers","name":"Psychedelic Experiences in Acute Psychoses","year":"1967","cit":3,"pfa":"Edwin L. Rabiner","ptype":"article","src":"https://openalex.org/W2801480210","eid":"W2801480210"},{"id":"paper-w2798569748","cat":"papers","name":"Heads: A Biography of Psychedelic America","year":"2016","cit":3,"pfa":"Jesse Jarnow","ptype":"book","src":"https://openalex.org/W2798569748","eid":"W2798569748"},{"id":"paper-w3204398597","cat":"papers","name":"CHAPTER 1. Sandcastles of the Mind: Hallucinogens and Cultural Memory","year":"2017","cit":3,"pfa":"Martin Nesvig","ptype":"book-chapter","src":"https://openalex.org/W3204398597","eid":"W3204398597"},{"id":"paper-w4285596783","cat":"papers","name":"Outpatient Microdose Induction with Transdermal Buprenorphine: A Case Series","year":"2022","cit":3,"pfa":"Shannon Menard","psa":"Archana Jhawar","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4285596783","eid":"W4285596783"},{"id":"paper-w2009281580","cat":"papers","name":"A PET microdosing study with the P-glycoprotein inhibitor tariquidar","year":"2012","cit":3,"pfa":"Martin Bauer","psa":"Oliver Langer","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2009281580","eid":"W2009281580"},{"id":"paper-w4393253768","cat":"papers","name":"Catholicism, Psychedelics, and Mysticism: Correlations and Displacements","year":"2024","cit":3,"pfa":"Mark Slatter","ptype":"article","src":"https://openalex.org/W4393253768","eid":"W4393253768"},{"id":"paper-w2148058706","cat":"papers","name":"Psychedelics and the Western World A Fateful Marriage","year":"2005","cit":3,"pfa":"ROGER N. WALSH","psa":"Charles S. Grob","ptype":"article","src":"https://openalex.org/W2148058706","eid":"W2148058706"},{"id":"paper-w4324088608","cat":"papers","name":"Editorial: What is up with psychedelics anyway?","year":"2023","cit":3,"pfa":"Candace R. Lewis","psa":"Stephen Helms Tillery","topics":["Dosing & pharmacology"],"ptype":"editorial","src":"https://openalex.org/W4324088608","eid":"W4324088608"},{"id":"paper-w4408517636","cat":"papers","name":"Molecular brain imaging of psychedelic action","year":"2025","cit":3,"pfa":"Paul D. Cumming","psa":"Gitte M. Knudsen","ptype":"book-chapter","src":"https://openalex.org/W4408517636","eid":"W4408517636"},{"id":"paper-w4319457504","cat":"papers","name":"A potential role for onabotulinumtoxinA in the management of Hallucinogen persisting perception disorder","year":"2023","cit":3,"pfa":"Ella Ryan","psa":"Jayashri Kulkarni","ptype":"article","src":"https://openalex.org/W4319457504","eid":"W4319457504"},{"id":"paper-w2416250858","cat":"papers","name":"Recognition and activation of a 5-HT receptor by hallucinogens and indole derivatives.","year":"1988","cit":3,"pfa":"Harel Weinstein","psa":"Géraldine Mercier","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2416250858","eid":"W2416250858"},{"id":"paper-w4388768282","cat":"papers","name":"Factor analysis of the MEQ43 suggests non-psychedelic mystical experiences are different from psychedelic mystical experiences","year":"2023","cit":3,"pfa":"Kirsti A. Formoso","ptype":"article","src":"https://openalex.org/W4388768282","eid":"W4388768282"},{"id":"paper-w4392988228","cat":"papers","name":"Psychedelic Psychotherapy Near The End Of Life","year":"2015","cit":3,"pfa":"Charles S. Grob","psa":"Alicia L. Danforth","topics":["Anxiety & end-of-life","Therapy practice"],"ptype":"other","src":"https://openalex.org/W4392988228","eid":"W4392988228"},{"id":"paper-w328785946","cat":"papers","name":"Psychedelic Drugs and the Student: Educational Strategies.","year":"1969","cit":3,"pfa":"Allan Y. Cohen","ptype":"article","src":"https://openalex.org/W328785946","eid":"W328785946"},{"id":"paper-w3155660512","cat":"papers","name":"Psychedelics: Old drugs, new trips","year":"2021","cit":3,"pfa":"James Rucker","psa":"Pallab Seth","ptype":"editorial","src":"https://openalex.org/W3155660512","eid":"W3155660512"},{"id":"paper-w4412703513","cat":"papers","name":"Suggestion Effects in Psychedelics: Confounds and Opportunities","year":"2025","cit":3,"pfa":"Madeline V. Stein","psa":"Devin Blair Terhune","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4412703513","eid":"W4412703513"},{"id":"paper-w4244564763","cat":"papers","name":"Psychedelic drug flashbacks: Attentional deficits?","year":"1979","cit":3,"pfa":"Robert E. Matefy","psa":"Jerrold Hirsch","ptype":"article","src":"https://openalex.org/W4244564763","eid":"W4244564763"},{"id":"paper-w4380550391","cat":"papers","name":"Timing is key for behavioural benefits of psychedelics","year":"2023","cit":3,"pfa":"Samuel C. Woodburn","psa":"Alex C. Kwan","ptype":"article","src":"https://openalex.org/W4380550391","eid":"W4380550391"},{"id":"paper-w4402655444","cat":"papers","name":"Psychedelics and moral psychology: the case of forgiveness","year":"2024","cit":3,"pfa":"Samir Chopra","psa":"Chris Letheby","ptype":"book-chapter","src":"https://openalex.org/W4402655444","eid":"W4402655444"},{"id":"paper-w4361802037","cat":"papers","name":"Could Psychedelics Treat Personality Disorders?","year":"2022","cit":3,"topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4361802037","eid":"W4361802037"},{"id":"paper-w2147469631","cat":"papers","name":"Microdose effects of drugs and chemicals on the enzymes urease, diastase and trypsin","year":"1987","cit":3,"pfa":"W.M. Persson","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2147469631","eid":"W2147469631"},{"id":"paper-w1995963973","cat":"papers","name":"Beyond Alienation: The End of the Psychedelic Road","year":"1974","cit":3,"pfa":"Herbert Hendin","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1995963973","eid":"W1995963973"},{"id":"paper-w2395375648","cat":"papers","name":"Photoelectron spectroscopic studies of hallucinogens: the use of ionization potentials in QSAR.","year":"1978","cit":3,"pfa":"Linda N. Domelsmith","psa":"Kendall N. Houk","ptype":"article","src":"https://openalex.org/W2395375648","eid":"W2395375648"},{"id":"paper-w3021656235","cat":"papers","name":"AN ANIMAL BEHAVIOR MODEL FOR STUDYING THE ACTIONS OF LSD AND RELATED HALLUCINOGENS","year":"1978","cit":3,"pfa":"Barry L. Jacobs","psa":"Michael E. Trulson","ptype":"book-chapter","src":"https://openalex.org/W3021656235","eid":"W3021656235"},{"id":"paper-w4389344669","cat":"papers","name":"Neural correlates of stroboscopic stimulation to test a model of psychedelic hallucination","year":"2023","cit":3,"pfa":"Nathan H. Heller","psa":"Viola S. Störmer","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4389344669","eid":"W4389344669"},{"id":"paper-w4320857764","cat":"papers","name":"The use of psychedelics in psychiatric treatment – evolutionary perspectives","year":"2023","cit":3,"pfa":"Gurjot Brar","psa":"Henry P. O'Connell","ptype":"article","src":"https://openalex.org/W4320857764","eid":"W4320857764"},{"id":"paper-w2070525857","cat":"papers","name":"The HIT Clinical Profile of Psychedelic Drug Users","year":"1980","cit":3,"pfa":"Jurgen R. Hartung","psa":"Darlene Skorka","ptype":"article","src":"https://openalex.org/W2070525857","eid":"W2070525857"},{"id":"paper-w2801049740","cat":"papers","name":"Religion: The Psychedelic Perspective: The Freedom of Religion Defense","year":"1983","cit":3,"pfa":"Mark Brown","ptype":"article","src":"https://openalex.org/W2801049740","eid":"W2801049740"},{"id":"paper-w3167575407","cat":"papers","name":"Psychedelic Experiences and Mindfulness are Associated with Improved Wellbeing","year":"2021","cit":3,"pfa":"Tianhong Tim Qiu","psa":"John Paul Minda","ptype":"preprint","src":"https://openalex.org/W3167575407","eid":"W3167575407"},{"id":"paper-w2015443121","cat":"papers","name":"Phase 0 trials (microdosing): A new paradigm in clinical research","year":"2013","cit":3,"pfa":"PrasanR Bhandari","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2015443121","eid":"W2015443121"},{"id":"paper-w4289886584","cat":"papers","name":"Psychiatry organization does not endorse psychedelic treatment","year":"2022","cit":3,"pfa":"Alison Knopf","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4289886584","eid":"W4289886584"},{"id":"paper-w578485436","cat":"papers","name":"Psychedelic drugs;: Psychological, medical and social issues;","year":"1973","cit":3,"pfa":"Brian Wells","ptype":"book","src":"https://openalex.org/W578485436","eid":"W578485436"},{"id":"paper-w3081487644","cat":"papers","name":"[Psychedelics in the treatment of substance use disorders and psychosis].","year":"2020","cit":3,"pfa":"Willem Johan van den Brink","psa":"Robert A. Schoevers","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3081487644","eid":"W3081487644"},{"id":"paper-w2800100732","cat":"papers","name":"Sixties Rock: Garage, Psychedelic, and Other Satisfactions","year":"2000","cit":3,"pfa":"Sharon Carla Hochhauser","psa":"Michael Hicks","ptype":"article","src":"https://openalex.org/W2800100732","eid":"W2800100732"},{"id":"paper-w4220846497","cat":"papers","name":"Intratarget Microdosing for Deep Phenotyping of Multiple Drug Effects in the Live Brain","year":"2022","cit":3,"pfa":"Jennifer S. Kim","psa":"Oliver H. Jonas","topics":["Dosing & pharmacology","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4220846497","eid":"W4220846497"},{"id":"paper-w4401845564","cat":"papers","name":"A bibliometric analysis of research on psychedelics for depression treatment","year":"2024","cit":3,"pfa":"Hao Hua","psa":"Chun Yang","topics":["Depression","Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4401845564","eid":"W4401845564"},{"id":"paper-w909402506","cat":"papers","name":"Microcrystalline Identification of Drugs of Abuse: The Psychedelic Amphetamines","year":"1990","cit":3,"pfa":"Edward A. Julian","ptype":"article","src":"https://openalex.org/W909402506","eid":"W909402506"},{"id":"paper-w3007917543","cat":"papers","name":"Eco-consciousness, species connectedness and the psychedelic experience","year":"2019","cit":3,"pfa":"David P. Luke","ptype":"book-chapter","src":"https://openalex.org/W3007917543","eid":"W3007917543"},{"id":"paper-w1998674132","cat":"papers","name":"EFFECT OF CHOLINOLYTIG HALLUCINOGENS ON ACETYLCHOLINE CONTENT OF CERTAIN PARTS OF RABBIT BRAIN","year":"1968","cit":3,"pfa":"M.A. Matin","psa":"Rameshwar Vijayvargiya","ptype":"article","src":"https://openalex.org/W1998674132","eid":"W1998674132"},{"id":"paper-w2056505215","cat":"papers","name":"Automated Microdosing System for Integration With a Miniaturized High‐pressure Reactor System","year":"2005","cit":3,"pfa":"Norbert Stoll","psa":"Kerstin Thurow","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2056505215","eid":"W2056505215"},{"id":"paper-w2015307350","cat":"papers","name":"Bibliometric study of radiation application on microdose useful for new drug development","year":"2009","cit":3,"pfa":"Fumio Komoda","psa":"Tomio Inoue","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2015307350","eid":"W2015307350"},{"id":"paper-w4400774068","cat":"papers","name":"Psychedelics in Older Adults: Difficulties of a Clear Therapeutic Evidence","year":"2024","cit":3,"pfa":"Melissa Maia","psa":"Luísa Weber Bisol","ptype":"article","src":"https://openalex.org/W4400774068","eid":"W4400774068"},{"id":"paper-w4294771452","cat":"papers","name":"Study Finds Historic Levels of Marijuana, Hallucinogen Use Among Young Adults","year":"2022","cit":3,"pfa":"Joan Stephenson","ptype":"article","src":"https://openalex.org/W4294771452","eid":"W4294771452"},{"id":"paper-w4406325188","cat":"papers","name":"Critiquing Medical Exceptionalism: Toward a Transcultural Psychedelic Bioethics","year":"2025","cit":3,"pfa":"Khaleel Rajwani","topics":["Policy & ethics"],"ptype":"editorial","src":"https://openalex.org/W4406325188","eid":"W4406325188"},{"id":"paper-w4407087452","cat":"papers","name":"Exploring Psychedelics for Unmet Needs in Women’s Reproductive Health","year":"2025","cit":3,"pfa":"Sara Shoar","psa":"Chaitra Jairaj","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4407087452","eid":"W4407087452"},{"id":"paper-w4405531043","cat":"papers","name":"Psychedelic Therapeutics for Adolescents: Ethics, Safety, Opportunities, and Equipoise","year":"2024","cit":3,"pfa":"Samuel J. Dotson","psa":"James Luccarelli","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4405531043","eid":"W4405531043"},{"id":"paper-w4405948586","cat":"papers","name":"Psychedelic Futures and Altered States in the Religions of the Ancient Mediterranean","year":"2024","cit":3,"pfa":"Charles M. Stang","ptype":"article","src":"https://openalex.org/W4405948586","eid":"W4405948586"},{"id":"paper-w2279747555","cat":"papers","name":"The psychedelic explorer’s guide: safe, therapeutic, and sacred journeys","year":"2014","cit":3,"pfa":"Jennifer Walklate","ptype":"book-review","src":"https://openalex.org/W2279747555","eid":"W2279747555"},{"id":"paper-w4390941035","cat":"papers","name":"Psychedelic Tied to Better Function in Veterans With Head Injuries","year":"2024","cit":3,"pfa":"Emily Harris","ptype":"article","src":"https://openalex.org/W4390941035","eid":"W4390941035"},{"id":"paper-w2326323943","cat":"papers","name":"How psychedelics informed by sex life and sex work","year":"2003","cit":3,"pfa":"Annie Sprinkle","ptype":"article","src":"https://openalex.org/W2326323943","eid":"W2326323943"},{"id":"paper-w4223929277","cat":"papers","name":"Manifest Your Desires: Psychedelics and the Self-Help Industry","year":"2022","cit":3,"pfa":"Patric Plesa","psa":"Rotem Petranker","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4223929277","eid":"W4223929277"},{"id":"paper-w587110582","cat":"papers","name":"Hallucinating the End of History: Nishida, Zen, And The Psychedelic Eschaton","year":"2007","cit":3,"pfa":"E. James Cunningham","ptype":"article","src":"https://openalex.org/W587110582","eid":"W587110582"},{"id":"paper-w3004972885","cat":"papers","name":"Psychedelics move from agents of rebellion towards therapeutics","year":"2020","cit":3,"pfa":"Becky McCall","ptype":"article","src":"https://openalex.org/W3004972885","eid":"W3004972885"},{"id":"paper-w4412476952","cat":"papers","name":"Big Five personality and the psychedelic experience: An initial report","year":"2025","cit":3,"pfa":"Petri Kajonius","psa":"Emma Claesdotter‐Knutsson","ptype":"article","src":"https://openalex.org/W4412476952","eid":"W4412476952"},{"id":"paper-w4392604873","cat":"papers","name":"Breathwork-Induced Psychedelic Experiences Modulate Neural Dynamics","year":"2024","cit":3,"pfa":"Evan Lewis-Healey","psa":"Tristán Bekinschtein","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4392604873","eid":"W4392604873"},{"id":"paper-w2130446904","cat":"papers","name":"Psychedelic Experience as a Heuristic Tool for Exploring the Mind and the Brain","year":"2011","cit":3,"pfa":"Alexey Alyushin","ptype":"article","src":"https://openalex.org/W2130446904","eid":"W2130446904"},{"id":"paper-w1978831293","cat":"papers","name":"Electrochemical study of the hallucinogen (±)-1-(2,5-dimethoxy-4-nitrophenyl)-2-aminopropane","year":"1988","cit":3,"pfa":"Pablo Richter","psa":"Demian. Morales-Lagos","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1978831293","eid":"W1978831293"},{"id":"paper-w3210803732","cat":"papers","name":"2 The Psychedelic Sixties in North America: Drugs and Identity","year":"2012","cit":3,"pfa":"Erika Dyck","ptype":"book-chapter","src":"https://openalex.org/W3210803732","eid":"W3210803732"},{"id":"paper-w2982542773","cat":"papers","name":"Philanthropists Fund Johns Hopkins Center for Study of Psychedelics","year":"2019","cit":3,"pfa":"Rita Rubin","ptype":"article","src":"https://openalex.org/W2982542773","eid":"W2982542773"},{"id":"paper-w4413696680","cat":"papers","name":"The development of translational tasks for preclinical psychedelic research in psychiatry","year":"2025","cit":3,"pfa":"Emma S. J. Robinson","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4413696680","eid":"W4413696680"},{"id":"paper-w4416118125","cat":"papers","name":"Cognitive control as a transdiagnostic mechanism of action in psychedelic effects","year":"2025","cit":3,"pfa":"Ceyda Sayalı","psa":"Frederick Streeter Barrett","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4416118125","eid":"W4416118125"},{"id":"paper-w4377085523","cat":"papers","name":"Yield response of African leafy vegetables to combined manure and urea microdosing in West Africa","year":"2023","cit":3,"pfa":"André Adjogboto","psa":"Kossi Euloge Agbossou","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4377085523","eid":"W4377085523"},{"id":"paper-w4292937070","cat":"papers","name":"Treating Alcohol Use Disorder With Hallucinogens—Renewed Interest After a 50-Year Hiatus","year":"2022","cit":3,"pfa":"Henry R. Kranzler","psa":"Emily E. Hartwell","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4292937070","eid":"W4292937070"},{"id":"paper-w2292888024","cat":"papers","name":"High New York: The Birth of a Psychedelic Subculture in the American City","year":"2015","cit":3,"pfa":"Chris Elcock","topics":["Addiction"],"ptype":"dissertation","src":"https://openalex.org/W2292888024","eid":"W2292888024"},{"id":"paper-w4396509952","cat":"papers","name":"New Billing Codes Offer Opportunity to Investigate Psychedelic Treatment","year":"2024","cit":3,"pfa":"Andrey Ostrovsky","psa":"Brian Scott Barnett","ptype":"editorial","src":"https://openalex.org/W4396509952","eid":"W4396509952"},{"id":"paper-w2487206640","cat":"papers","name":"Shamanism, Trance, Hallucinogens, and Psychical Events: Concepts, Methods, and Techniques for Fieldwork among Primitives","year":"1976","cit":3,"pfa":"Joseph K. Long","ptype":"book-chapter","src":"https://openalex.org/W2487206640","eid":"W2487206640"},{"id":"paper-w2910941191","cat":"papers","name":"The metaphysics behind pharmacotherapy: treating depression with conventional and psychedelic drugs","year":"2018","cit":3,"pfa":"Virginia Ballesteros","topics":["Depression","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2910941191","eid":"W2910941191"},{"id":"paper-w4399120589","cat":"papers","name":"Psychedelic 25H-NBOMe attenuates post-sepsis depression in rats","year":"2024","cit":3,"pfa":"Barbara G. Ferri","psa":"Alexandre Giusti‐Paiva","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4399120589","eid":"W4399120589"},{"id":"paper-w4380267162","cat":"papers","name":"Prairie Psychedelics Mental Health Research in Saskatchewan, 1951–1967","year":"2006","cit":3,"pfa":"Erika Dyck","ptype":"book-chapter","src":"https://openalex.org/W4380267162","eid":"W4380267162"},{"id":"paper-w2264540728","cat":"papers","name":"Motivational factors in psychedelic drug use by male college students.","year":"1967","cit":3,"pfa":"Edwin Lipinski","psa":"Beatrice Grace Lipinski","ptype":"article","src":"https://openalex.org/W2264540728","eid":"W2264540728"},{"id":"paper-w3014068988","cat":"papers","name":"Alternative Therapies: Sociodrama, Nude Therapy, Primal Scream, Psychedelic","year":"2020","cit":3,"pfa":"Erika Dyck","psa":"Emmanuel Delille","topics":["Anxiety & end-of-life","Therapy practice"],"ptype":"reference-entry","src":"https://openalex.org/W3014068988","eid":"W3014068988"},{"id":"paper-w4230754939","cat":"papers","name":"Psychedelic research and the need for transparency - Polishing Alice’s Looking Glass","year":"2020","cit":3,"pfa":"Rotem Petranker","psa":"Norman A. S. Farb","ptype":"preprint","src":"https://openalex.org/W4230754939","eid":"W4230754939"},{"id":"paper-w4399284142","cat":"papers","name":"Next-generation psychedelics: should new agents skip the trip?","year":"2024","cit":3,"pfa":"Mark Peplow","ptype":"article","src":"https://openalex.org/W4399284142","eid":"W4399284142"},{"id":"paper-w4411065278","cat":"papers","name":"From molecules to meaning: unpacking the antidepressant mechanisms of psychedelic drugs","year":"2025","cit":3,"pfa":"Victor P. Acero","psa":"Alan K. Davis","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4411065278","eid":"W4411065278"},{"id":"paper-w4416844791","cat":"papers","name":"Persistent Altered States: Psychological Treatment of Psychedelic Adverse Effects","year":"2025","cit":3,"pfa":"Bjørn Holmøy","psa":"Kristoffer Andreas Aamodt Andersen","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4416844791","eid":"W4416844791"},{"id":"paper-w2963113567","cat":"papers","name":"Spaces in Time: The Influence of Aubrey Beardsley on Psychedelic Graphic Design","year":"2019","cit":3,"pfa":"Juliana F. Duque","ptype":"article","src":"https://openalex.org/W2963113567","eid":"W2963113567"},{"id":"paper-w608744788","cat":"papers","name":"Shoegaze as the Third Wave: Affective Psychedelic Noise, 1965–91","year":"2013","cit":3,"pfa":"Benjamin Halligan","ptype":"other","src":"https://openalex.org/W608744788","eid":"W608744788"},{"id":"paper-w4407174206","cat":"papers","name":"Tripping into Treatment: Comparing Initial and Current Motivations for Psychedelic Use","year":"2025","cit":3,"pfa":"Daniel J. Kruger","psa":"Kevin F. Boehnke","topics":["PTSD & trauma","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4407174206","eid":"W4407174206"},{"id":"paper-w2264259029","cat":"papers","name":"MICRODOSE 14C UREA BREATH TEST FOR THE DIAGNOSIS OF HELICOBACTER PYLORI: A SURVEY IN IRANIAN POPULATION","year":"2005","cit":3,"pfa":"Rohit Bazaz","psa":"M R Khoushayand","topics":["Safety & adverse events","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2264259029","eid":"W2264259029"},{"id":"paper-w2070690114","cat":"papers","name":"Comparison of Microdose Flare-up and Antagonist Multiple Dose Protocols in Poor Responder Patients","year":"2005","cit":3,"pfa":"Aygül Demi̇rol","psa":"Timur Gürgan","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2070690114","eid":"W2070690114"},{"id":"paper-w2992474716","cat":"papers","name":"Considerations for psychedelic therapists when working with Native American people and communities","year":"2019","cit":3,"pfa":"Belinda Eriacho","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2992474716","eid":"W2992474716"},{"id":"paper-w4402016158","cat":"papers","name":"Mycorrhizal inoculation and fertilizer microdosing interactions in pearl millet (Pennisetum glaucum) under greenhouse conditions","year":"2024","cit":3,"pfa":"Malick Ndiaye","psa":"Tahir Abdoulaye Diop","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4402016158","eid":"W4402016158"},{"id":"paper-w4408521996","cat":"papers","name":"Associations between psychedelic-related and meditation-related variables: A longitudinal study","year":"2025","cit":3,"pfa":"Otto Simonsson","psa":"Simon Benjamin Goldberg","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4408521996","eid":"W4408521996"},{"id":"paper-w3040914937","cat":"papers","name":"Artificial Neural Networks designed to identify NBOMe hallucinogens based on the most sensitive molecular descriptors","year":"2019","cit":3,"pfa":"Adelina Ion","psa":"Mirela Praisler","topics":["Mechanism & neuroscience"],"ptype":"conference-paper","src":"https://openalex.org/W3040914937","eid":"W3040914937"},{"id":"paper-w354088906","cat":"papers","name":"Preparing the Gaia connection: An ecological exposition of psychedelic literature 1954-1963","year":"2013","cit":3,"pfa":"Robert Dickins","ptype":"article","src":"https://openalex.org/W354088906","eid":"W354088906"},{"id":"paper-w4284969988","cat":"papers","name":"Neuro‐plastic Shamanism? Towards a Political Ontology of Whiteness and the Psychedelic Zeitgeist","year":"2022","cit":3,"pfa":"Mat Keel","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4284969988","eid":"W4284969988"},{"id":"paper-w4408588003","cat":"papers","name":"Psychedelics, OCD and Related Disorders: Setting methodological strategies for future studies","year":"2025","cit":3,"pfa":"Rodolfo Leuzzi","psa":"Naomi Anne Fineberg","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4408588003","eid":"W4408588003"},{"id":"paper-w2037278925","cat":"papers","name":"Microdose X-ray imaging systems of the budker institute of nuclear physics and the fields of their optimal use","year":"2015","cit":3,"pfa":"E.A. Babichev","psa":"G.A. Savinov","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2037278925","eid":"W2037278925"},{"id":"paper-w3168131388","cat":"papers","name":"Blister-Packing of 2 mg Buprenorphine Monoproduct as a Patient-Centered Method of Microdosing for Buprenorphine Induction","year":"2021","cit":3,"pfa":"Anthony J. Accurso","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3168131388","eid":"W3168131388"},{"id":"paper-w4413920415","cat":"papers","name":"Psychedelics for substance use disorders: are women being addressed? A scoping review","year":"2025","cit":3,"pfa":"Alexandra Wojdyslawski Nigri","psa":"Fábio Carezzato","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4413920415","eid":"W4413920415"},{"id":"paper-w4210687838","cat":"papers","name":"WHITE HAND SOCIETY: THE PSYCHEDELIC PARTNERSHIP OF TIMOTHY LEARY AND ALLEN GINSBERG","year":"2011","cit":3,"pfa":"William Lawlor","ptype":"article","src":"https://openalex.org/W4210687838","eid":"W4210687838"},{"id":"paper-w4406325491","cat":"papers","name":"Embracing Epistemic Humility: Rethinking Psychedelic Exceptionalism Through Diverse Perspectives","year":"2025","cit":3,"pfa":"Jarrel De Matas","psa":"Hasan Yasin","topics":["Policy & ethics"],"ptype":"editorial","src":"https://openalex.org/W4406325491","eid":"W4406325491"},{"id":"paper-w2809510466","cat":"papers","name":"Safety of Microdose Dexamethasone Acetate in the Eversense Long-Term Implantable Continuous Glucose Monitoring System","year":"2018","cit":3,"pfa":"E. L. KELLEY","psa":"Carrie Lorenz","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2809510466","eid":"W2809510466"},{"id":"paper-w4406627764","cat":"papers","name":"Exploring the Therapeutic Potential of Psychedelics in Chronic Pain Management: A New Frontier in Medicine","year":"2025","cit":3,"pfa":"Cong Lin","psa":"Xiaohui Wang","ptype":"article","src":"https://openalex.org/W4406627764","eid":"W4406627764"},{"id":"paper-w2944785211","cat":"papers","name":"What application method would be appropriate in fertilizer microdosing of traditional leafy vegetables in West Africa?","year":"2019","cit":3,"pfa":"André Adjogboto","psa":"Euloge K. Agbossou","topics":["Dosing & pharmacology"],"ptype":"conference-paper","src":"https://openalex.org/W2944785211","eid":"W2944785211"},{"id":"paper-w2053386979","cat":"papers","name":"Actions of hallucinogens on ants (Formica pratensis)—I. Brain levels of LSD and THC following oral administration","year":"1978","cit":3,"pfa":"H.R. Frischknecht","psa":"Peter Gaudenz Waser","ptype":"article","src":"https://openalex.org/W2053386979","eid":"W2053386979"},{"id":"paper-w4386752352","cat":"papers","name":"Psychotomimetic Compensation and Sensitization","year":"2023","cit":3,"pfa":"Ari Brouwer","psa":"Charles L. Raison","topics":["Depression","Safety & adverse events","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4386752352","eid":"W4386752352"},{"id":"paper-w2904743756","cat":"papers","name":"Within and without: Sgt. Pepper’s Lonely Hearts Club Band and psychedelic insight","year":"2018","cit":3,"pfa":"Russell Reising","psa":"Jim LeBlanc","ptype":"book-chapter","src":"https://openalex.org/W2904743756","eid":"W2904743756"},{"id":"paper-w4401072563","cat":"papers","name":"Investigating the impact of psychedelic drugs on social cognition defects: A scoping review protocol","year":"2024","cit":3,"pfa":"Sarah Ann Smith","psa":"Yanbo Zhang","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4401072563","eid":"W4401072563"},{"id":"paper-w3204905076","cat":"papers","name":"De Plantis Toxicariis E Mundo Novo Tropicale Commentationes XXIX. A Suspected New Amazonian Hallucinogen","year":"1980","cit":3,"pfa":"Richard Evans Schultes","ptype":"article","src":"https://openalex.org/W3204905076","eid":"W3204905076"},{"id":"paper-w2892795511","cat":"papers","name":"Integrating Underground Psychedelic Use: A Cautionary Note for Licensed Health Care Providers","year":"2018","cit":3,"pfa":"Rose Jade","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W2892795511","eid":"W2892795511"},{"id":"paper-w4205644599","cat":"papers","name":"Psychotomimetic Drugs","year":"2012","cit":3,"ptype":"reference-entry","src":"https://openalex.org/W4205644599","eid":"W4205644599"},{"id":"paper-w4296027614","cat":"papers","name":"Retraction Note: A mechanistic model of the neural entropy increase elicited by psychedelic drugs","year":"2022","cit":3,"pfa":"Ruben A Herzog","psa":"Rodrigo Cofré","topics":["Mechanism & neuroscience"],"ptype":"retraction","src":"https://openalex.org/W4296027614","eid":"W4296027614"},{"id":"paper-w4408921376","cat":"papers","name":"Motivation and retrospective appraisal of psychedelic study participation: a qualitative study in healthy volunteers","year":"2025","cit":3,"pfa":"Laura Ley","psa":"Yasmin Schmid","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4408921376","eid":"W4408921376"},{"id":"paper-w4376140413","cat":"papers","name":"Evaluation of the Effect of Stone Lines and Microdosing Adoption on Sorghum Yield and Income: A Case of Smallholder Farmers in Burkina Faso","year":"2023","cit":3,"pfa":"Didier Sawadogo","psa":"Asres Elias Baya","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4376140413","eid":"W4376140413"},{"id":"paper-w4402491675","cat":"papers","name":"Psychedelic medicine in psychiatry residency training: a survey of psychiatric residency program directors","year":"2024","cit":3,"pfa":"Mary E. Yaden","psa":"Kelley C. O’Donnell","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4402491675","eid":"W4402491675"},{"id":"paper-w4390144224","cat":"papers","name":"Endorsement of metaphysical idealism mediates a link between past use of psychedelics and wellbeing","year":"2023","cit":3,"pfa":"Jussi Jylkkä","psa":"Patrick Jern","ptype":"preprint","src":"https://openalex.org/W4390144224","eid":"W4390144224"},{"id":"paper-w4362556903","cat":"papers","name":"Effect Of Hallucinogenic And Non-Hallucinogenic Psychedelic Analogs On Chronic Neuropathic Pain In Mice","year":"2023","cit":3,"pfa":"Eda Köşeli","psa":"Mohamad Imad Damaj","ptype":"article","src":"https://openalex.org/W4362556903","eid":"W4362556903"},{"id":"paper-w4246553418","cat":"papers","name":"Corrigendum: The Experience Elicited by Hallucinogens Presents the Highest Similarity to Dreaming within a Large Database of Psychoactive Substance Reports","year":"2018","cit":3,"pfa":"Camila Sanz","psa":"Enzo Tagliazucchi","topics":["Addiction","Dosing & pharmacology"],"ptype":"erratum","src":"https://openalex.org/W4246553418","eid":"W4246553418"},{"id":"paper-w3088453285","cat":"papers","name":"The Legume Pod Motif as a Symbolic Representation of the Shamanic Hallucinogen, Vilca (Anadenanthera spp.), in Pre-Columbian Andean Cultures","year":"2020","cit":3,"pfa":"Colin Domnauer","ptype":"article","src":"https://openalex.org/W3088453285","eid":"W3088453285"},{"id":"paper-w4396495531","cat":"papers","name":"Inpatient Transition from Methadone to Buprenorphine–Naloxone Using a Microdosing Strategy in a Postoperative Cancer Patient: A Case Report","year":"2024","cit":3,"pfa":"Minji Kim","psa":"Akhila Sunkepally Reddy","topics":["Addiction","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4396495531","eid":"W4396495531"},{"id":"paper-w4387879962","cat":"papers","name":"Case study: Acceptance and commitment therapy plus psychedelics in treating sexual and cannabis addiction.","year":"2023","cit":3,"pfa":"Lana Strika-Bruneau","psa":"Amine Benyamina","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4387879962","eid":"W4387879962"},{"id":"paper-w3174266357","cat":"papers","name":"Psychedelic psychodrama: Raising and expanding consciousness in Jane Arden’s The Other Side of the Underneath (1973)","year":"2021","cit":3,"pfa":"Sophia Satchell-Baeza","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W3174266357","eid":"W3174266357"},{"id":"paper-w4399392485","cat":"papers","name":"Decoupling of cortical activity from behavioral state following administration of the classic psychedelic DOI","year":"2024","cit":3,"pfa":"Randall J. Olson","psa":"Atheir I. Abbas","ptype":"article","src":"https://openalex.org/W4399392485","eid":"W4399392485"},{"id":"paper-w4390012180","cat":"papers","name":"Evaluation of Hydroxychloroquine as a Perpetrator on Cytochrome P450 (CYP) 3A and CYP2D6 Activity with Microdosed Probe Drugs in Healthy Volunteers","year":"2023","cit":3,"pfa":"Felicitas Stoll","psa":"Walter E. Haefeli","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4390012180","eid":"W4390012180"},{"id":"paper-w4403414039","cat":"papers","name":"The Effect of Psychedelics on Individuals with a Personality Disorder: Results from two Prospective Cohort Studies","year":"2024","cit":3,"pfa":"Alexandra R. Gordon","psa":"Richard J. Zeifman","ptype":"preprint","src":"https://openalex.org/W4403414039","eid":"W4403414039"},{"id":"paper-w2006952818","cat":"papers","name":"S.26.01 From sacred plants to psychotherapy: the history and re-emergence of psychedelics in medicine","year":"2007","cit":3,"pfa":"Ben Sessa","topics":["Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2006952818","eid":"W2006952818"},{"id":"paper-w4388722763","cat":"papers","name":"Spiritual Well-Being Among Users and Non-Users of Psychedelics: A Cross-Sectional Study","year":"2023","cit":3,"pfa":"Ana Cláudia Mesquita Garcia","psa":"Luís Fernando Tófoli","topics":["Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4388722763","eid":"W4388722763"},{"id":"paper-w4395467217","cat":"papers","name":"The Effect of Psychedelics on Individuals with a Personality Disorder: Results from two Prospective Cohort Studies","year":"2024","cit":3,"pfa":"Alexandra R. Gordon","psa":"Richard J. Zeifman","ptype":"preprint","src":"https://openalex.org/W4395467217","eid":"W4395467217"},{"id":"paper-w4321765811","cat":"papers","name":"Typology of Users of Psychedelics and Alike Psychoactive Substances in Czechia: Results of the National Online Survey","year":"2023","cit":3,"pfa":"Filip Kňažek","psa":"Rita Kočárová","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4321765811","eid":"W4321765811"},{"id":"paper-w3126456578","cat":"papers","name":"Experiences without for-me-ness? Reconsidering alleged counter examples from psychopathology and psychedelics","year":"2020","cit":3,"pfa":"Mads Gram Henriksen","psa":"Josef Parnas","ptype":"article","src":"https://openalex.org/W3126456578","eid":"W3126456578"},{"id":"paper-w4394932635","cat":"papers","name":"Patients' Experiences Discussing Psychedelics for Therapeutic Purposes with Physicians and Other Health Care Providers","year":"2024","cit":3,"pfa":"Michelle St. Pierre","psa":"Zach Walsh","topics":["PTSD & trauma","Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4394932635","eid":"W4394932635"},{"id":"paper-w4416292698","cat":"papers","name":"The Relationship Between Psychedelic Use and Positive Adult Development in Emerging Adulthood: An Integrative Review","year":"2025","cit":3,"pfa":"Jake Payne","psa":"Greg Murray","topics":["Reviews & meta-analyses","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4416292698","eid":"W4416292698"},{"id":"paper-w4297093958","cat":"papers","name":"Transitioning From High-dose Methadone to Buprenorphine Using a Microdosing Approach: Unique Considerations at ASAM Level 3 Facilities","year":"2022","cit":3,"pfa":"Carolyn J. Anderson","psa":"Dustin V. Patil","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4297093958","eid":"W4297093958"},{"id":"paper-w3193119206","cat":"papers","name":"Facilitating discontinuation of intravenous opioids by concurrent use of sublingual buprenorphine with rapid microdosing induction: A pain management case study","year":"2021","cit":3,"pfa":"Arjun Tara","psa":"Yi Zhang","topics":["Addiction","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3193119206","eid":"W3193119206"},{"id":"paper-w590438574","cat":"papers","name":"Becoming Jimi Hendrix: From Southern Crossroads to Psychedelic London, the Untold Story of a Musical Genius","year":"2010","cit":3,"pfa":"Steven Roby","psa":"Brad Schreiber","ptype":"other","src":"https://openalex.org/W590438574","eid":"W590438574"},{"id":"paper-w4400089350","cat":"papers","name":"Attitudes on Psychedelics in a Sample of Croatian Mental Health Professionals: A Cross-Sectional National Survey Study","year":"2024","cit":3,"pfa":"Tonći Mastelić","psa":"Trpimir Glavina","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4400089350","eid":"W4400089350"},{"id":"paper-w4413003561","cat":"papers","name":"Tabernanthalog, a Non-Hallucinogenic Psychedelic, Alleviates Cancer-Induced Cognitive Deficits via Serotonergic Pathways","year":"2025","cit":3,"pfa":"Masahide Arinaga","psa":"Shozo Jinno","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4413003561","eid":"W4413003561"},{"id":"paper-w4411424725","cat":"papers","name":"Naturalistic use of psychedelics is associated with longitudinal improvements in anxiety and depression during global crisis times","year":"2025","cit":3,"pfa":"Maria Bălăeţ","psa":"Adam Hampshire","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4411424725","eid":"W4411424725"},{"id":"paper-w4407091607","cat":"papers","name":"Serotonergic psychedelics as potential therapeutics for post-COVID-19 syndrome (or Long COVID): A comprehensive review","year":"2025","cit":3,"pfa":"Zhen Xuen Brandon Low","psa":"Ali Ahmed Rabaan","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4407091607","eid":"W4407091607"},{"id":"paper-w4409205258","cat":"papers","name":"Psychedelics as pharmacotherapeutics for substance use disorders: a scoping review on clinical trials and perspectives on underlying neurobiology","year":"2025","cit":3,"pfa":"Lucas M Wittenkeller","psa":"Davide Amato","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4409205258","eid":"W4409205258"},{"id":"paper-w4401438279","cat":"papers","name":"Large language models auto-profile conscious awareness changes under psychedelic drug effects","year":"2024","cit":3,"pfa":"Danilo Bzdok","psa":"Steven Laureys","ptype":"preprint","src":"https://openalex.org/W4401438279","eid":"W4401438279"},{"id":"paper-w4378349492","cat":"papers","name":"Corrigendum: Psychedelic replications in virtual reality and their potential as a therapeutic instrument: an open-label feasibility study","year":"2023","cit":3,"pfa":"Kristjan Kaup","psa":"Jaan Aru","ptype":"erratum","src":"https://openalex.org/W4378349492","eid":"W4378349492"},{"id":"paper-w4390619801","cat":"papers","name":"Treatment of Hallucinogen-Persisting Perception Disorder: A case report on repetitive transcranial magnetic stimulation targeting the right temporoparietal junction","year":"2024","cit":3,"pfa":"Sylvain Creton","psa":"Dominique Drapier","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4390619801","eid":"W4390619801"},{"id":"paper-w4414119500","cat":"papers","name":"Microdose Intrathecal Morphine Injection in Teenagers Undergoing Scoliosis Surgery Decreases Length of Stay, Pain Scores, and Opioid Consumption","year":"2025","cit":3,"pfa":"Vishal Sarwahi","psa":"Terry D. Amaral","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4414119500","eid":"W4414119500"},{"id":"paper-w2540281281","cat":"papers","name":"EFFICACY OF MICRODOSES POTENTIZED HOMEOPATHIC DRUG, ARSENICUM ALBUM INDUCED BY ARSENIC TRIOXIDE IN ZEBRAFISH (DANIO RERIO)-A FTIR STUDY IN GILLS","year":"2016","cit":3,"pfa":"Vijay Velu","psa":"Ramesh Uthandakalaipandian","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2540281281","eid":"W2540281281"},{"id":"paper-w3047388975","cat":"papers","name":"At the Intersection of Palliative Care, Psychedelic Medicine, and Healthcare Reform: A Call for a New Hospice and Palliative Care Movement","year":"2020","cit":3,"pfa":"Ilan Bernstein","topics":["Anxiety & end-of-life"],"ptype":"editorial","src":"https://openalex.org/W3047388975","eid":"W3047388975"},{"id":"paper-w4298111915","cat":"papers","name":"The effect of androgen administration on in vitro fertilization outcome in poor responders undergoing ovarian stimulation with microdose protocol: A randomized clinical trial","year":"2022","cit":3,"pfa":"Abbas Aflatoonain","psa":"Robabe Hosseinisadat","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4298111915","eid":"W4298111915"},{"id":"paper-w4285251143","cat":"papers","name":"The Unconscious in Zen and Psychedelic Experience: A Response to D. T. Suzuki’s Zen Critique of Drug-Induced Satori","year":"2022","cit":3,"pfa":"Steve Odin","ptype":"book-chapter","src":"https://openalex.org/W4285251143","eid":"W4285251143"},{"id":"paper-w2297099760","cat":"papers","name":"Reframing the Good Death: Enhancing Choice in Dying, Neuroscience, End-of-Life Research and the Potential of Psychedelics in Palliative Care","year":"2017","cit":3,"pfa":"Robin Mackenzie","topics":["Anxiety & end-of-life","Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W2297099760","eid":"W2297099760"},{"id":"paper-w2471514752","cat":"papers","name":"Peripheral effects of anticholinergic psychotomimetics.","year":"1971","cit":3,"pfa":"Josef Fusek","psa":"Z Fink","ptype":"article","src":"https://openalex.org/W2471514752","eid":"W2471514752"},{"id":"paper-w2339152869","cat":"papers","name":"Impact of Mineral Fertilizer Microdosing on the Yield of Sorghum in Adoption Fields of Women Trained in Farmers’ Field School of Niako in South Sudan Area of Mali","year":"2016","cit":3,"pfa":"Diakalia Sogodogo","psa":"Karamoko Sacko","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2339152869","eid":"W2339152869"},{"id":"paper-w2054393382","cat":"papers","name":"Improvement of the exercise capacity of a patient with primary orthostatic hypotension (primary sympathetic insufficiency) by programmed subcutaneous Noradrenaline administration via microdosing pump","year":"1990","cit":3,"pfa":"Manfred J. Lehmann","psa":"Karlheinz Peter","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2054393382","eid":"W2054393382"},{"id":"paper-w4387302903","cat":"papers","name":"Intellectual Property of Psychedelics for Addiction Treatment: Enabling Access and Protecting Innovation Opportunities Through Preserving the Public Domain","year":"2023","cit":3,"pfa":"Sisi Li","psa":"Sean Rudi","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4387302903","eid":"W4387302903"},{"id":"paper-w4411583047","cat":"papers","name":"Reimagining Neuropsychiatric and Neurological Disorders through the Lens of Brain Network Dynamics: Psychedelics as Catalysts for System-Level Plasticity","year":"2025","cit":3,"pfa":"Cong Zhang","psa":"Xiaohui Wang","topics":["Mechanism & neuroscience"],"ptype":"editorial","src":"https://openalex.org/W4411583047","eid":"W4411583047"},{"id":"paper-w4396850098","cat":"papers","name":"Pharmacological profiles and psychedelic-like effects of 4-hydroxy-, 4-acetoxy-, and 4-methoxy-N- methyl- N- isopropyltryptamine","year":"2024","cit":3,"pfa":"Grant C. Glatfelter","psa":"Michael H. Baumann","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4396850098","eid":"W4396850098"},{"id":"paper-w4389193930","cat":"papers","name":"Making sense of a transformative, mystical psychedelic experience: Will people frame it as spiritual, supernatural, psychological, physical, or a sign of mental illness?","year":"2023","cit":3,"pfa":"Julie Juola Exline","psa":"William A. Schutt","ptype":"article","src":"https://openalex.org/W4389193930","eid":"W4389193930"},{"id":"paper-w2144579171","cat":"papers","name":"Microdose gonadotrophin releasing hormone agonist (GnRH-A) flare protocol compared with standard long protocol GnRH-A for ovarian stimulation in patients undergoing in vitro fertilization","year":"2002","cit":3,"pfa":"Simon M. Kelly","psa":"Seang Lin Tan","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2144579171","eid":"W2144579171"},{"id":"paper-w4415377219","cat":"papers","name":"Neuropharmacology of halogenated DMT analogs: psychoplastogenic and antidepressant properties of 5-Br-DMT, a psychedelic derivative with low hallucinogenic potential","year":"2025","cit":3,"pfa":"Pol Puigseslloses","psa":"Raúl López‐Arnau","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4415377219","eid":"W4415377219"},{"id":"paper-w4409329853","cat":"papers","name":"Contextual and experiential aspects of the psychedelic experience predicting improvement in subjective wellbeing: results from a Norwegian internet convenience sample","year":"2025","cit":3,"pfa":"Paula Aarseth Tunstad","psa":"Cato Grønnerød","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4409329853","eid":"W4409329853"},{"id":"paper-w4393041501","cat":"papers","name":"Breaking through the doors of perception, consciousness, and existence: to what extent does psychedelic phenomenology ontologically depend on external factors?","year":"2024","cit":3,"pfa":"Denis Fradkin","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4393041501","eid":"W4393041501"},{"id":"paper-w2751574038","cat":"papers","name":"How recording studios used technology to invoke the psychedelic experience: the difference in staging techniques in British and American recordings in the late 1960s","year":"2017","cit":3,"pfa":"Anthony Meynell","ptype":"dissertation","src":"https://openalex.org/W2751574038","eid":"W2751574038"},{"id":"paper-w4386704523","cat":"papers","name":"\"We don't want to run before we walk\": the attitudes of Australian stakeholders towards using psychedelics for mental health conditions.","year":"2023","cit":3,"pfa":"Breanne Kunstler","psa":"Melissa Anne Hatty","ptype":"article","src":"https://openalex.org/W4386704523","eid":"W4386704523"},{"id":"paper-w2128056118","cat":"papers","name":"Human Lung Cancer Risks from Radon – Part III - Evidence of Influence of Combined Bystander and Adaptive Response Effects on Radon Case-Control Studies - A Microdose Analysis","year":"2010","cit":3,"pfa":"Bobby E. Leonard","psa":"Georgia C. Beecher","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2128056118","eid":"W2128056118"},{"id":"paper-w4392203338","cat":"papers","name":"Exposure to the psychedelic substance 25 H-NBOMe disrupts maternal care in lactating rats and subsequently impairs the social play behavior of the offspring","year":"2024","cit":3,"pfa":"Lidia Maria Melo","psa":"Alexandre Giusti‐Paiva","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4392203338","eid":"W4392203338"},{"id":"paper-w2063508810","cat":"papers","name":"Synthesis of Compounds with Potential Psychotomimetic Activity. III1,2a","year":"1965","cit":3,"pfa":"Robert J. Adamski","psa":"Joseph G. Cannon","ptype":"article","src":"https://openalex.org/W2063508810","eid":"W2063508810"},{"id":"paper-w2750630404","cat":"papers","name":"Psychotomimetic and Cognitive Effects of Cannabis Use in the General Population","year":"2017","cit":3,"pfa":"Nadia Solowij","ptype":"book-chapter","src":"https://openalex.org/W2750630404","eid":"W2750630404"},{"id":"paper-w2414194325","cat":"papers","name":"A major psychotomimetic complication of multidrug intravenous sedation.","year":"1985","cit":3,"pfa":"Jastak Jt","psa":"Marshall Fj","ptype":"article","src":"https://openalex.org/W2414194325","eid":"W2414194325"},{"id":"paper-w4365512243","cat":"papers","name":"Abstract CT246: An open-label, single-center, phase 0, microdose study to demonstrate delivery of TTX-MC138-NODAGA-Cu64 to radiographically confirmed metastases in subjects with advanced solid tumors","year":"2023","cit":3,"pfa":"Andreas S. Varkaris","psa":"Susan Duggan","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W4365512243","eid":"W4365512243"},{"id":"paper-w2415196675","cat":"papers","name":"Symposium on scanning electron microscopy of fertility and infertility, Eighth World Congress of Fertility and Sterility, Buenos Aires, Argentina, November 1974. Endometrium and endosalpinx of women treated with microdos","year":"1975","cit":3,"pfa":"Kamran S. Moghissi","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2415196675","eid":"W2415196675"},{"id":"paper-w2412840504","cat":"papers","name":"[Contribution to the study of the central effects of hallucinogenic and psychotomimetic medicines].","year":"1967","cit":3,"pfa":"Longo Vg","ptype":"article","src":"https://openalex.org/W2412840504","eid":"W2412840504"},{"id":"paper-w4308396108","cat":"papers","name":"569 A CIVO intratumor microdose Phase 0 Trial of subasumstat (TAK-981) in combination with cetuximab or avelumab reveals Type 1 Interferon induction and immune activation in head and neck cancer patients","year":"2022","cit":3,"pfa":"Jeffrey J. Houlton","psa":"Richard A. Klinghoffer","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W4308396108","eid":"W4308396108"},{"id":"paper-w2752645257","cat":"papers","name":"Psychotomimetic and Cognitive Effects of Δ 9 -Tetrahydrocannabinol in Laboratory Settings","year":"2017","cit":3,"pfa":"John Daniel Cahill","psa":"Deepak Cyril D’Souza","ptype":"book-chapter","src":"https://openalex.org/W2752645257","eid":"W2752645257"},{"id":"paper-w2062357258","cat":"papers","name":"Cognitive effects of psychotomimetic drugs in rats discriminating number cues","year":"2008","cit":3,"pfa":"Catherine B. Willmore","psa":"Gregory I. Elmer","ptype":"article","src":"https://openalex.org/W2062357258","eid":"W2062357258"},{"id":"paper-w1979128218","cat":"papers","name":"The Illicit Use of the Psychotomimetic Amphetamines With Special Reference to STP (DOM) Toxicity","year":"1972","cit":3,"pfa":"J. Fred E. Shick","psa":"David Eugene Smith","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1979128218","eid":"W1979128218"},{"id":"paper-w2096638806","cat":"papers","name":"Inhibition of [3H]5-HT binding to rat brain membranes by psychotomimetic amphetamines","year":"1982","cit":3,"pfa":"Adrie P. De Jong","psa":"Alexandros Makriyannis","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2096638806","eid":"W2096638806"},{"id":"paper-w3081020920","cat":"papers","name":"Correction: R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects","year":"2020","cit":3,"pfa":"Chun Yang","psa":"Kenji Hashimoto","topics":["Depression"],"ptype":"erratum","src":"https://openalex.org/W3081020920","eid":"W3081020920"},{"id":"paper-w2472993031","cat":"papers","name":"Brain and retina uptake of a radio-iodine labeled psychotomimetic in dog and monkey.","year":"1978","cit":3,"pfa":"T. Sargent","psa":"A T Shulgin","ptype":"article","src":"https://openalex.org/W2472993031","eid":"W2472993031"},{"id":"paper-w2007110949","cat":"papers","name":"Δ 1-tetrahydrocannabinol-induced circling behavior in rats: A possible measure of psychotomimetic activity?","year":"1984","cit":3,"pfa":"I. Nir","psa":"Jan M. van Ree","ptype":"article","src":"https://openalex.org/W2007110949","eid":"W2007110949"},{"id":"paper-w2030667531","cat":"papers","name":"A postmortem study of the effect of chronic opiate abuse on psychotomimetic binding sites of human frontal cortex","year":"1987","cit":3,"pfa":"Richard B. Rothman","psa":"Joel E. Kleinman","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2030667531","eid":"W2030667531"},{"id":"paper-w2059335973","cat":"papers","name":"Identification of Seeds of Ipomea Purpurea (Morning Glory Family reported to have Psychotomimetic Properties) by Paper Chromatography","year":"1966","cit":3,"pfa":"James W. Brackett","psa":"Paul M. Dougherty","ptype":"article","src":"https://openalex.org/W2059335973","eid":"W2059335973"},{"id":"paper-w4220948127","cat":"papers","name":"Delta-9-Tetrahydrocannabinol, Cannabidiol, and Acute Psychotomimetic States: A Balancing Act of the Principal Phyto-Cannabinoids on Human Brain and Behavior","year":"2022","cit":3,"pfa":"Suhas Ganesh","psa":"Mohini Ranganathan","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4220948127","eid":"W4220948127"},{"id":"paper-w4313647233","cat":"papers","name":"Interval delivery of 5HT2A agonists using multilayered polymer films","year":"2023","cit":3,"pfa":"Mehjabeen Hossain","psa":"Thomas A. Werfel","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4313647233","eid":"W4313647233"},{"id":"paper-w3103234089","cat":"papers","name":"Psychobiological, Medical, and Psychiatric Implications of New/Novel Psychoactive Substance (NPS) Use","year":"2020","cit":3,"pfa":"Fabrizio Schifano","psa":"John Corkery","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W3103234089","eid":"W3103234089"},{"id":"paper-w4375949535","cat":"papers","name":"Pupil Dilation Evaluation of Two Mydriatic Dosing Profiles Delivered By the Optejet ®","year":"2023","cit":3,"pfa":"Arturo S. Chayet","psa":"Tsontcho Ianchulev","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4375949535","eid":"W4375949535"},{"id":"paper-w4391652728","cat":"papers","name":"Cortical thickness of the posterior cingulate cortex is associated with the ketamine-induced altered sense of self: An ultra-high field MRI study","year":"2024","cit":3,"pfa":"Lena Vera Danyeli","psa":"Meng Li","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4391652728","eid":"W4391652728"},{"id":"paper-w2566929422","cat":"papers","name":"Micro dose and N and P fertilizer application for pearl millet in West Africa","year":"2014","cit":3,"pfa":"Waldorf N. Garner","psa":"Colwell A. Rodgers","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2566929422","eid":"W2566929422"},{"id":"paper-w4297249053","cat":"papers","name":"Accelerator mass spectrometry for quantification of micro- and therapeutic-dose diclofenac in microdialysis samples","year":"2022","cit":3,"pfa":"Oliver Langer","psa":"Martin Bauer","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4297249053","eid":"W4297249053"},{"id":"paper-w4410645269","cat":"papers","name":"Current use of holy mushrooms of the genus Psilocybe in a Zapotec community in Oaxaca, Mexico","year":"2025","cit":3,"pfa":"Mara Ximena Haro-Luna","psa":"Laura Guzmán‐Dávalos","ptype":"article","src":"https://openalex.org/W4410645269","eid":"W4410645269"},{"id":"paper-w2140631776","cat":"papers","name":"LSD, Violence and Radical Religious Beliefs","year":"1970","cit":3,"pfa":"David Eugene Smith","ptype":"article","src":"https://openalex.org/W2140631776","eid":"W2140631776"},{"id":"paper-w4248092266","cat":"papers","name":"LSD Use Among US High School Students","year":"1994","cit":3,"pfa":"Keith Schuchard","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4248092266","eid":"W4248092266"},{"id":"paper-w4396792199","cat":"papers","name":"General Anesthesia Occludes Ketamine's Antidepressant Response in a Rodent Model of Chronic Stress","year":"2024","cit":3,"pfa":"Daniel Markman","psa":"Joseph Cichon","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4396792199","eid":"W4396792199"},{"id":"paper-w1975987149","cat":"papers","name":"Some Fluoro and Nitro Analogues of Hallucinogenic Amphetamines","year":"1994","cit":3,"pfa":"Aida Neira Jara","psa":"Marcos Caroli Rezende","ptype":"article","src":"https://openalex.org/W1975987149","eid":"W1975987149"},{"id":"paper-w2413119903","cat":"papers","name":"[Ketamine-induced psychopathological changes in normal volunteers during conditions used for experimental psychoses (author's transl)].","year":"1981","cit":3,"pfa":"Gerhard A. Baer","psa":"P Parkas","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2413119903","eid":"W2413119903"},{"id":"paper-w2068462569","cat":"papers","name":"Cultural Therapy - A New Conception of Treatment","year":"1974","cit":3,"pfa":"Wilson Van Dusen","psa":"S Sherman","ptype":"article","src":"https://openalex.org/W2068462569","eid":"W2068462569"},{"id":"paper-w2077442100","cat":"papers","name":"Physician Attitudes and the Treatment of Alcohol and Drug Dependent Patients","year":"1978","cit":3,"pfa":"John N. Chappel","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2077442100","eid":"W2077442100"},{"id":"paper-w2055131353","cat":"papers","name":"The Recreational Use of LSD-25 and Drug Prohibition","year":"1976","cit":3,"pfa":"Jaseph L. Zentner","ptype":"article","src":"https://openalex.org/W2055131353","eid":"W2055131353"},{"id":"paper-w2163398986","cat":"papers","name":"Flashbacks and schizophrenia","year":"1993","cit":3,"pfa":"H Obaydi","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2163398986","eid":"W2163398986"},{"id":"paper-w1975345439","cat":"papers","name":"Narcolepsy: Evaluation and Treatment","year":"1978","cit":3,"pfa":"Constantin R. Soldatos","psa":"Roger J. Cadieux","ptype":"article","src":"https://openalex.org/W1975345439","eid":"W1975345439"},{"id":"paper-w2057927246","cat":"papers","name":"The Sociology of a Multimodality Strategy 1n the Treatment of Narcotics Addicts","year":"1971","cit":3,"pfa":"Arnold J. Mandel","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2057927246","eid":"W2057927246"},{"id":"paper-w2056132479","cat":"papers","name":"Epidemiologic Field Projects to Reduce the Incidence and Prevalence of Heroin Addiction in Chicago","year":"1971","cit":3,"pfa":"Patrick H. Hughes","psa":"Gail A. Crawford","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2056132479","eid":"W2056132479"},{"id":"paper-w4388450442","cat":"papers","name":"α-Ethyltryptamine: A Ratiocinatory Review of a Forgotten Antidepressant","year":"2023","cit":3,"pfa":"Richard A. Glennon","psa":"Maƚgorzata Dukat","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4388450442","eid":"W4388450442"},{"id":"paper-w4389208371","cat":"papers","name":"Psychedelika in Psychiatrie und Psychotherapie - Trend oder Therapie?","year":"2023","cit":3,"pfa":"Moritz Spangemacher","psa":"Gerhard Gründer","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4389208371","eid":"W4389208371"},{"id":"paper-w2102908319","cat":"papers","name":"\"DELIRIUM TREMENS\" FOLLOWING WITHDRAWAL OF ETHCHLORVINOL","year":"1965","cit":3,"pfa":"Howard P. Wood","psa":"Harrison F. Flippin","ptype":"article","src":"https://openalex.org/W2102908319","eid":"W2102908319"},{"id":"paper-w4386187337","cat":"papers","name":"Neuroscience and Technology: Innovations in Brain Research and Therapy","year":"2023","cit":3,"pfa":"Aliasghar Tabatabaei Mohammadi","psa":"Saeed Hasani Mehraban","topics":["Addiction","Mechanism & neuroscience"],"ptype":"book","src":"https://openalex.org/W4386187337","eid":"W4386187337"},{"id":"paper-w2405775811","cat":"papers","name":"Recreational Use of Ketamine and Its Interaction with NMDA Receptors","year":"2016","cit":3,"pfa":"Luís Manuel Félix","psa":"Ana Maria Coimbra","topics":["Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W2405775811","eid":"W2405775811"},{"id":"paper-w2030862220","cat":"papers","name":"Long-term psychiatric and neurologic treatment after a traumatic midbrain lesion","year":"1997","cit":3,"pfa":"Edward C. Lauterbach","psa":"T.Elisabeth Spears","topics":["PTSD & trauma","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2030862220","eid":"W2030862220"},{"id":"paper-w35260151","cat":"papers","name":"Progress in first-in-human trial of Hsp90-targeted PET imaging in cancer patients","year":"2013","cit":3,"pfa":"Mark P. Dunphy","psa":"Steven M. Larson","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W35260151","eid":"W35260151"},{"id":"paper-w71637958","cat":"papers","name":"Present Knowledge of Hallucinogenically used Plants: A Tabular Study","year":"1975","cit":3,"pfa":"Richard Evans Schultes","ptype":"book-chapter","src":"https://openalex.org/W71637958","eid":"W71637958"},{"id":"paper-w2616890462","cat":"papers","name":"Ketamine","year":"2012","cit":3,"pfa":"Kim Wolff","ptype":"book-chapter","src":"https://openalex.org/W2616890462","eid":"W2616890462"},{"id":"paper-w3009824473","cat":"papers","name":"Laboratory Testing for Substance Use Disorders","year":"2020","cit":3,"pfa":"David Dadiomov","psa":"Kyle Street","topics":["Addiction","Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W3009824473","eid":"W3009824473"},{"id":"paper-w2807032765","cat":"papers","name":"Substance abuse and its psychiatric effect on adolescence","year":"2018","cit":3,"pfa":"Badr Alghamdi","psa":"Marwan ahmed jaafari","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2807032765","eid":"W2807032765"},{"id":"paper-w4221101962","cat":"papers","name":"Neuroimaging in Visual Snow - A Review of the Literature","year":"2022","cit":3,"pfa":"Subahari Raviskanthan","psa":"Andrew G. Lee","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4221101962","eid":"W4221101962"},{"id":"paper-w4313855443","cat":"papers","name":"Acute effects of subanesthetic ketamine on cerebrovascular hemodynamics in humans: A TD-fNIRS neuroimaging study","year":"2023","cit":3,"pfa":"Adelaida Castillo","psa":"Moriah Taylor","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4313855443","eid":"W4313855443"},{"id":"paper-w2747583033","cat":"papers","name":"Infusions Are the Optimal Dosing Method in Intravenous ADME Studies Rather Than Bolus Dosing","year":"2017","cit":3,"pfa":"April Barbour","psa":"Michael J. Fossler","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2747583033","eid":"W2747583033"},{"id":"paper-w2752237513","cat":"papers","name":"Research with Chemistry and Pharmacology of Natural Products in Brazil: A Comparison with 70 Selected Countries from 5 Continents","year":"2017","cit":3,"pfa":"Lúcio Ferreira Alves","psa":"Tatiana V. C. Pontes","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2752237513","eid":"W2752237513"},{"id":"paper-w2011876313","cat":"papers","name":"Medical marijuana in cancer: harmful or harm reduction?","year":"2013","cit":3,"pfa":"Alexandra Thielmann","psa":"Paul Joseph Daeninck","topics":["Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2011876313","eid":"W2011876313"},{"id":"paper-w4233852862","cat":"papers","name":"Drug Abuse Treatment Outcome Study--Adolescent (DATOS-A), 1993-1995: [United States]","year":"2004","cit":3,"pfa":"United States Department Of Health And Human Services. National Institutes Of…","topics":["Depression","Addiction","Therapy practice"],"ptype":"dataset","src":"https://openalex.org/W4233852862","eid":"W4233852862"},{"id":"paper-w4319962465","cat":"papers","name":"Antidepressants: A content analysis of healthcare providers' tweets","year":"2023","cit":3,"pfa":"Yijun Dong","psa":"Natalie Weir","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4319962465","eid":"W4319962465"},{"id":"paper-w4388744659","cat":"papers","name":"Modification of the Suprachoroidal Buckling Technique for the Treatment of Rhegmatogenous Retinal Detachment","year":"2023","cit":3,"pfa":"Damir Bosnar","psa":"Senad Ramić","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4388744659","eid":"W4388744659"},{"id":"paper-w2013780407","cat":"papers","name":"Effects of chronic treatment of rats with \"designer\" amphetamines on brain regional monoamines","year":"1991","cit":3,"pfa":"Mathew Thomas Martin-Iverson","psa":"Bruce A. Lodge","ptype":"article","src":"https://openalex.org/W2013780407","eid":"W2013780407"},{"id":"paper-w4323521853","cat":"papers","name":"Pros and Cons of Cannabinoids as a Potential Therapeutic Target for Treating Parkinson's Disease","year":"2023","cit":3,"pfa":"Mahesh Pattabhiramaiah","psa":"Baishali Bedi Sarma","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"book-chapter","src":"https://openalex.org/W4323521853","eid":"W4323521853"},{"id":"paper-w2922609828","cat":"papers","name":"Decreased Cytochrome P450 3A activity in palliative patients with haematological diseases: Potential impact on supportive drug therapies","year":"2019","cit":3,"pfa":"Marcus J. P. Geist","psa":"Gerd Mikus","topics":["Addiction","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2922609828","eid":"W2922609828"},{"id":"paper-w4409293694","cat":"papers","name":"Screening of Bioactive Molecules and Phytopharmacological Potential Of Ipomoea Cairica: A Comprehensive Review","year":"2025","cit":3,"pfa":"Asish Bhaumik","topics":["Anxiety & end-of-life","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4409293694","eid":"W4409293694"},{"id":"paper-w2784231491","cat":"papers","name":"In Vivo CYP3A Activity in Palliative Care Patients: Study Protocol for a Single Arm Prospective Trial","year":"2018","cit":3,"pfa":"Marcus J. P. Geist","psa":"Gerd Mikus","topics":["Addiction","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2784231491","eid":"W2784231491"},{"id":"paper-w4311582583","cat":"papers","name":"Funnel metadynamics and behavioral studies reveal complex effect of D2AAK1 ligand on anxiety-like processes","year":"2022","cit":3,"pfa":"Damian Bartuzi","psa":"Agnieszka Anna Kaczor","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4311582583","eid":"W4311582583"},{"id":"paper-w4416697383","cat":"papers","name":"The future of psychiatry: clinical practice, diagnosis, and treatment","year":"2025","cit":3,"pfa":"Stephen Turner","psa":"Anjali Bhat","topics":["Addiction","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4416697383","eid":"W4416697383"},{"id":"paper-w4407113982","cat":"papers","name":"Bioavailability, Metabolism, and Excretion of [14C]‐Tazemetostat in Patients With B‐Cell Lymphomas or Advanced Solid Tumors","year":"2025","cit":3,"pfa":"Yingxue Chen","psa":"Julien R. Ogier","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4407113982","eid":"W4407113982"},{"id":"paper-w3178687704","cat":"papers","name":"“Plants of the Gods” and their hallucinogenic powers in neuropharmacology — A review of two books","year":"2021","cit":3,"pfa":"Miguel Faria","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3178687704","eid":"W3178687704"},{"id":"paper-w3178321258","cat":"papers","name":"Diagnosis of acute poisoning by addictive and psychotropic substances based on the toxidrome","year":"2021","cit":3,"pfa":"Natalia V. Kurdil","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3178321258","eid":"W3178321258"},{"id":"paper-w2034352101","cat":"papers","name":"A report from the 167th American Psychiatric Association Annual Meeting (May 3-7 - New York, U.S.A.)","year":"2014","cit":3,"pfa":"Xavier Rabasseda","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2034352101","eid":"W2034352101"},{"id":"paper-w3155024793","cat":"papers","name":"5-Methoxy-N,N-di-n-propyltryptamine (5-MeO-DPT): freebase and fumarate","year":"2021","cit":3,"pfa":"Duyen N. K. Pham","psa":"David R. Manke","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3155024793","eid":"W3155024793"},{"id":"paper-w4390907476","cat":"papers","name":"Investigating Associations of Substance Use and Dependence With Planned Versus Unplanned Suicide Attempt","year":"2024","cit":3,"pfa":"Mallory E. Stephenson","psa":"Alexis C. Edwards","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4390907476","eid":"W4390907476"},{"id":"paper-w4385897445","cat":"papers","name":"Absolute and Relative Bioavailability of Oral Solid Dosage Formulations of Deucravacitinib in Humans","year":"2023","cit":3,"pfa":"Anjaneya Chimalakonda","psa":"Bindu Murthy","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4385897445","eid":"W4385897445"},{"id":"paper-w2006795325","cat":"papers","name":"A study of the psychotropic prescriptions of people attending an addiction service in England","year":"2013","cit":3,"pfa":"Adejoke Obirenjeyi Oluyase","psa":"Charlie Lloyd","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W2006795325","eid":"W2006795325"},{"id":"paper-w3170102005","cat":"papers","name":"Tag2Risk: Harnessing social music tags for characterizing depression risk","year":"2020","cit":3,"pfa":"Aayush Surana","psa":"Vinoo Alluri","topics":["Depression","Safety & adverse events"],"ptype":"conference-paper","src":"https://openalex.org/W3170102005","eid":"W3170102005"},{"id":"paper-w4411914199","cat":"papers","name":"Additional jump interval training as a form of warm-up on enhancing aerobic capacity, muscular strength, and power in female dancers: a cohort study","year":"2025","cit":3,"pfa":"Qianqian Sun","psa":"Yike Ni","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4411914199","eid":"W4411914199"},{"id":"paper-w4414080279","cat":"papers","name":"Emerging pharmacological strategies for the treatment of cannabis use disorder","year":"2025","cit":3,"pfa":"Anees Bahji","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4414080279","eid":"W4414080279"},{"id":"paper-w3044768623","cat":"papers","name":"Tag2Risk: Harnessing Social Music Tags for Characterizing Depression Risk","year":"2020","cit":3,"pfa":"Aayush Surana","psa":"Vinoo Alluri","topics":["Depression","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W3044768623","eid":"W3044768623"},{"id":"paper-w2150410212","cat":"papers","name":"Treatment with hydroxyurea in a patient compound heterozygote for a high oxygen affinity hemoglobin and β‐thalassemia minor","year":"2009","cit":3,"pfa":"P. Gaudreau","psa":"Denis Soulières","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2150410212","eid":"W2150410212"},{"id":"paper-w2097929911","cat":"papers","name":"The Healing Power of the Unconscious: How Can We Understand past Life Experiences in Psychotherapy?","year":"1995","cit":3,"pfa":"Zelda Gillian Knight","topics":["Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2097929911","eid":"W2097929911"},{"id":"paper-w3045366729","cat":"papers","name":"Effects of Child-Pugh B Cirrhosis on Pharmacokinetics of Tofogliflozin, a New Sodium-Glucose Co-Transporter (SGLT2) Inhibitor","year":"2020","cit":3,"pfa":"Haruki Yamada","psa":"Akihiro Ohnishi","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3045366729","eid":"W3045366729"},{"id":"paper-w3015652461","cat":"papers","name":"Treatment of Plaque Psoriasis With an Excimer Laser Utilizing an Optimal Therapeutic UVB Dose Protocol","year":"2020","cit":3,"pfa":"Quinn G. Thibodeaux","psa":"Tina Bhutani","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3015652461","eid":"W3015652461"},{"id":"paper-w4399814833","cat":"papers","name":"Rotation from methadone to buprenorphine using a micro‐dosing regime in patients with opioid use disorder and serious mental illness: A case series","year":"2024","cit":3,"pfa":"Vivian C. Praeger","psa":"Shalini Arunogiri","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4399814833","eid":"W4399814833"},{"id":"paper-w607716470","cat":"papers","name":"Pharmacological therapies for drug & alcohol addictions","year":"1995","cit":3,"pfa":"Norman Stanley Miller","psa":"Mark S. Gold","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"book","src":"https://openalex.org/W607716470","eid":"W607716470"},{"id":"paper-w3193510627","cat":"papers","name":"Assessment of antidepressant-like effects of dextromethorphan on differential reinforcement of low-rate 72-s performance in rats","year":"2021","cit":3,"pfa":"Cayla J. Lynch","psa":"Adam Joseph Prus","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3193510627","eid":"W3193510627"},{"id":"paper-w4399084700","cat":"papers","name":"Tripping into the unknown: Exploring the experiences of first-time LSD users through global drug survey insights","year":"2024","cit":3,"pfa":"Luke Baxter","psa":"ADAM R. WINSTOCK","topics":["Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4399084700","eid":"W4399084700"},{"id":"paper-w4387798439","cat":"papers","name":"Correlates of Stimulant Use among People Who Use Heroin Undergoing Treatment in Out-Patient Facilities in France, 2010–2020","year":"2023","cit":3,"pfa":"Éric Janssen","psa":"Michael Vuolo","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4387798439","eid":"W4387798439"},{"id":"paper-w4221074183","cat":"papers","name":"Evaluation of a Highly Efficient Multidrug Biochip Array Technology for a Simultaneous and High-Throughput Urine Drug Screening in Clinical and Toxicological Settings","year":"2022","cit":3,"pfa":"Marisol S. Castaneto","psa":"Eva Calero","ptype":"article","src":"https://openalex.org/W4221074183","eid":"W4221074183"},{"id":"paper-w2472122899","cat":"papers","name":"LSD-25 as an Adjunct to Long-Term Psychotherapy","year":"1966","cit":3,"pfa":"Robert Pos","topics":["Therapy practice"],"ptype":"conference-abstract","src":"https://openalex.org/W2472122899","eid":"W2472122899"},{"id":"paper-w2337130224","cat":"papers","name":"ATNT-06EVALUATION OF THE SAFETY OF GSK2256098 AND PHARMACOKINETICS OF11C-GSK2256098 IN PATIENTS WITH RECURRENT GLIOBLASTOMA BY POSITRON EMISSION TOMOGRAPHY (PET) IMAGING","year":"2015","cit":3,"pfa":"Paul James Mulholland","psa":"Sarah Patricia Blagden","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2337130224","eid":"W2337130224"},{"id":"paper-w2956791285","cat":"papers","name":"Dynamical circular inference in the general population and the psychosis spectrum : insights from perceptual decision making","year":"2018","cit":3,"pfa":"Pantelis Leptourgos","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W2956791285","eid":"W2956791285"},{"id":"paper-w4294189343","cat":"papers","name":"“Walking with myself by my side” - non-medical use of Ketamine","year":"2022","cit":3,"pfa":"R. P. Vaz","psa":"P. Carriço","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4294189343","eid":"W4294189343"},{"id":"paper-w4413108930","cat":"papers","name":"Biased agonism in psychopharmacology: an opportunity to improve efficacy and safety of treatments","year":"2025","cit":3,"pfa":"Gia Han Le","psa":"Roger S. McIntyre","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4413108930","eid":"W4413108930"},{"id":"paper-w1968039486","cat":"papers","name":"LSD Analogs","year":"1966","cit":3,"pfa":"Kenneth J. Liska","psa":"Marie L. Steenberg","ptype":"article","src":"https://openalex.org/W1968039486","eid":"W1968039486"},{"id":"paper-w4292707853","cat":"papers","name":"Editorial: Ketamine for treatment of acute and chronic pain: The relationship of mechanism and exposure to therapeutic outcome","year":"2022","cit":3,"pfa":"Albert Dahan","psa":"Thomas K. Henthorn","topics":["Depression","PTSD & trauma","Mechanism & neuroscience"],"ptype":"editorial","src":"https://openalex.org/W4292707853","eid":"W4292707853"},{"id":"paper-w4211065907","cat":"papers","name":"Treatment Episode Data Set -- Admissions (TEDS-A), 2008","year":"2010","cit":3,"pfa":"United States Department of Health and Human Services. Substance Abuse and…","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W4211065907","eid":"W4211065907"},{"id":"paper-w2910214682","cat":"papers","name":"Treatment Episode Data Set -- Admissions (TEDS-A), 2007","year":"2009","cit":3,"pfa":"United States Department Of Health And Human Services. Substance Abuse And…","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W2910214682","eid":"W2910214682"},{"id":"paper-w2910972103","cat":"papers","name":"Treatment Episode Data Set -- Admissions (TEDS-A), 2001","year":"2004","cit":3,"pfa":"United States Department of Health and Human Services. Substance Abuse and…","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W2910972103","eid":"W2910972103"},{"id":"paper-w2026369592","cat":"papers","name":"Methysergide-Induced Psychosis: Case Report with Long-Term Follow-Up","year":"2008","cit":3,"pfa":"Anna Skórzewska","psa":"S. K. Lal","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2026369592","eid":"W2026369592"},{"id":"paper-w4413140803","cat":"papers","name":"Safety and Efficacy of the NMDA‐2b‐Selective Negative Allosteric Modulator BI 1569912: A Phase Ib Randomized Trial in Major Depressive Disorder","year":"2025","cit":3,"pfa":"Roger S. McIntyre","psa":"Franco De Crescenzo","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4413140803","eid":"W4413140803"},{"id":"paper-w7158900293","cat":"papers","name":"Polysubstance use disorders among US adults","year":"2026","cit":3,"pfa":"Beth Han","psa":"Wilson M. Compton","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7158900293","eid":"W7158900293"},{"id":"paper-w3037147694","cat":"papers","name":"Impact of pantoprazole on absorption and disposition of hydroxychloroquine, a drug used in Corona Virus Disease-19 (Covid-19): A structured summary of a study protocol for a randomised controlled trial","year":"2020","cit":3,"pfa":"Felicitas Stoll","psa":"Walter E. Haefeli","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3037147694","eid":"W3037147694"},{"id":"paper-w2043138237","cat":"papers","name":"Recreational Drugs' Scenario and Compulsory Treatment in the United Kingdom","year":"2008","cit":3,"pfa":"Fabrizio Schifano","psa":"Daniela Tedeschi","ptype":"article","src":"https://openalex.org/W2043138237","eid":"W2043138237"},{"id":"paper-w679575","cat":"papers","name":"The influence of haloperidol and propranolol on behavior and biochemical changes in the brain of mice treated with LSD.","year":"1977","cit":3,"pfa":"Józef Kocur","psa":"J Kȩdziora","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W679575","eid":"W679575"},{"id":"paper-w3154533549","cat":"papers","name":"Brunfelsia Hopeana - Pharmacologic Screening: Isolation And Characterization Of Hopeanine","year":"1978","cit":3,"pfa":"Radhakrishnan P. Iyer","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3154533549","eid":"W3154533549"},{"id":"paper-w4406014031","cat":"papers","name":"Effects of ketamine and propofol on muscarinic plateau potentials in rat neocortical pyramidal cells","year":"2025","cit":3,"pfa":"Anne S. Fleiner","psa":"Johan Frederik Storm","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4406014031","eid":"W4406014031"},{"id":"paper-w3047702799","cat":"papers","name":"Prevalence of Substance Use Disorders and Effectiveness of Educational Package on Knowledge Regarding the Disorders among Adolescents in Selected Schools of Lekhnath, Nepal","year":"2020","cit":3,"pfa":"Deepa Gurung","psa":"Amrita Paudel","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3047702799","eid":"W3047702799"},{"id":"paper-w1507772469","cat":"papers","name":"Factors Affecting Fatigue in Chronic Renal Failure Patients under Hemodialysis Treatment at Qena University Hospital in Upper Egypt","year":"2015","cit":3,"pfa":"Hayah Abou Elazayiem Bayumi","ptype":"article","src":"https://openalex.org/W1507772469","eid":"W1507772469"},{"id":"paper-w4408219029","cat":"papers","name":"An encounter with death: a comparative thematic and content analysis of naturalistic DMT experiences and the near-death experience","year":"2025","cit":3,"pfa":"Pascal Michael","psa":"Oliver C. Robinson","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4408219029","eid":"W4408219029"},{"id":"paper-w119819921","cat":"papers","name":"[Phencyclidine abuse, dependence, intoxication, and psychosis].","year":"2010","cit":3,"pfa":"Takenao Koseki","psa":"Toshitaka Nabeshima","topics":["Reviews & meta-analyses"],"ptype":"other","src":"https://openalex.org/W119819921","eid":"W119819921"},{"id":"paper-w4415651061","cat":"papers","name":"Language Models for Standardising Clinical Notes and Information Extraction in Addiction Psychiatry—An Empirical Study","year":"2025","cit":3,"pfa":"Haritha Gireesh","psa":"Pratima Murthy","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4415651061","eid":"W4415651061"},{"id":"paper-w2163485976","cat":"papers","name":"Cannabinoids, anxiety, and the periaqueductal gray.","year":"2010","cit":3,"pfa":"Viviane M. Saito","psa":"Fabrício A. Moreira","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2163485976","eid":"W2163485976"},{"id":"paper-w1975392443","cat":"papers","name":"Screening, brief intervention, and referral to treatment among homeless and marginally housed primary-care patients in Skid Row","year":"2012","cit":3,"pfa":"Lillian Gelberg","psa":"STEVEN J. SHOPTAW","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1975392443","eid":"W1975392443"},{"id":"paper-w2075484918","cat":"papers","name":"The relation between cerebral serotonin levels and conditioned behaviour in the rat following the administration of LSD-25 and UML","year":"1975","cit":3,"pfa":"Michele Torre","psa":"Filippo Bogetto","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2075484918","eid":"W2075484918"},{"id":"paper-w2491637274","cat":"papers","name":"[Safety and efficacy of ketamine for pain relief].","year":"2016","cit":3,"pfa":"Marieke Niesters","psa":"Maarten van Kleef","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2491637274","eid":"W2491637274"},{"id":"paper-w1211416771","cat":"papers","name":"Structure Activity Relationship of Four Tetrahydrocannabinols and the Pharmacological Activity of Five Semi-Purified Extracts","year":"1970","cit":3,"pfa":"E. A. CARLn","psa":"Friedhelm KORTE","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1211416771","eid":"W1211416771"},{"id":"paper-w182294985","cat":"papers","name":"[The syndromes of oculogyric crisis and paroxysmal perceptual alteration in chronic schizophrenic patients--a clinical inquiry into their pathophysiology].","year":"1991","cit":3,"pfa":"Ken Watanabe","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W182294985","eid":"W182294985"},{"id":"paper-w4390818798","cat":"papers","name":"A preclinical model of THC edibles that produces high-dose cannabimimetic responses","year":"2024","cit":3,"pfa":"Anthony English","psa":"Benjamin Bruce Land","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4390818798","eid":"W4390818798"},{"id":"paper-w2330872010","cat":"papers","name":"Recent Developments in Group I Metabotropic Glutamate Receptor Allosteric Modulators for the Treatment of Psychiatric and Neurological Disorders (2014-May 2015)","year":"2016","cit":3,"pfa":"Guiying Li","psa":"Darı́o Doller","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2330872010","eid":"W2330872010"},{"id":"paper-w4390058979","cat":"papers","name":"Ketamine for Chronic Non-Cancer Pain: A 2023 Update","year":"2023","cit":3,"pfa":"Khai Trieu Tran","psa":"Danielle MacDougall","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4390058979","eid":"W4390058979"},{"id":"paper-w4377027576","cat":"papers","name":"Potential Roles for the GluN2D NMDA Receptor Subunit in Schizophrenia","year":"2023","cit":3,"pfa":"Chitra Vinnakota","psa":"Rachel Hill","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4377027576","eid":"W4377027576"},{"id":"paper-w1585173580","cat":"papers","name":"Dopamine and Glutamate Hypotheses of Schizophrenia","year":"2007","cit":3,"pfa":"Bita Moghaddam","psa":"Houman Homayoun","topics":["Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W1585173580","eid":"W1585173580"},{"id":"paper-w2485753275","cat":"papers","name":"Gestational MAM (Methylazoxymethanol) Administration: A Promising Animal Model for Psychosis Onset","year":"2011","cit":3,"pfa":"Gwenaëlle Le Pen","psa":"Thérèse M. Jay","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W2485753275","eid":"W2485753275"},{"id":"paper-w4360830138","cat":"papers","name":"Maintaining Evidence-based Opioid Agonist Treatment During a Methadone to Buprenorphine Rotation With Slow-release Oral Morphine","year":"2023","cit":3,"pfa":"Tianna Costa","psa":"Nitin Chopra","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4360830138","eid":"W4360830138"},{"id":"paper-w2094853742","cat":"papers","name":"Differentiating nmda dysregulation in schizophrenia and alcoholism using ketamine","year":"1995","cit":3,"pfa":"John Harrison Krystal","psa":"Dennis S. Charney","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2094853742","eid":"W2094853742"},{"id":"paper-w2614358575","cat":"papers","name":"Influence of difference in timing of perioperative administration of low-dose ketamine on postoperative analgesia","year":"2017","cit":3,"pfa":"Ragi Jain","psa":"Namrata Kochhar","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2614358575","eid":"W2614358575"},{"id":"paper-w313649770","cat":"papers","name":"Techniques for Dealing with Prenatal and Perinatal Issues in Therapy: A Bodymind Perspective","year":"1987","cit":3,"pfa":"Kathlyn Hendricks","topics":["PTSD & trauma","Anxiety & end-of-life","Therapy practice"],"ptype":"article","src":"https://openalex.org/W313649770","eid":"W313649770"},{"id":"paper-w2488684598","cat":"papers","name":"Clinical applications and side effects of ketamine","year":"2015","cit":3,"pfa":"Ou Sha","psa":"Li Zhou","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"book-chapter","src":"https://openalex.org/W2488684598","eid":"W2488684598"},{"id":"paper-w4206230858","cat":"papers","name":"Behavioral and Neuroanatomical Consequences of Cell-Type Specific Loss of Dopamine D2 Receptors in the Mouse Cerebral Cortex","year":"2022","cit":3,"pfa":"Gloria S. Lee","psa":"Gregg D. Stanwood","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4206230858","eid":"W4206230858"},{"id":"paper-w1484554960","cat":"papers","name":"SOME REMARKS CONCERNING PROPOSALS FOR DIMENSIONAL CRITERIA FOR SUBSTANCE USE DISORDERS IN DSM‐V","year":"2007","cit":3,"pfa":"Francisco González‐Sáiz","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1484554960","eid":"W1484554960"},{"id":"paper-w2783466666","cat":"papers","name":"Association studies of WD repeat domain 3 and chitobiosyldiphosphodolichol beta-mannosyltransferase genes with schizophrenia in a Japanese population","year":"2018","cit":3,"pfa":"Momoko Kobayashi","psa":"Toru Nishikawa","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2783466666","eid":"W2783466666"},{"id":"paper-w1511141685","cat":"papers","name":"The little black book of psychiatry","year":"2000","cit":3,"pfa":"David P. Moore","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"book","src":"https://openalex.org/W1511141685","eid":"W1511141685"},{"id":"paper-w3006508602","cat":"papers","name":"Cannabis Use and Plasma Human Immunodeficiency Virus (HIV) RNA Levels in Patients Coinfected With HIV and Hepatitis C Virus Receiving Antiretroviral Therapy: Data From the ANRS CO13 HEPAVIH Cohort","year":"2020","cit":3,"pfa":"Fabienne Marcellin","psa":"D Zucman","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3006508602","eid":"W3006508602"},{"id":"paper-w4244767213","cat":"papers","name":"Low-dose ketamine with clonidine and midazolam for adult day care surgery","year":"2005","cit":3,"pfa":"Massimiliano Dalsasso","psa":"C. Ori","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4244767213","eid":"W4244767213"},{"id":"paper-w2134572471","cat":"papers","name":"Ketamine in the management of chronic pancreatic pain","year":"2003","cit":3,"pfa":"Stephen Mannion","psa":"Tony O’Brien","ptype":"article","src":"https://openalex.org/W2134572471","eid":"W2134572471"},{"id":"paper-w4408225330","cat":"papers","name":"Plasma esketamine and noresketamine levels and antidepressant response with oral esketamine treatment","year":"2025","cit":3,"pfa":"Jolien K. E. Veraart","psa":"Robert A. Schoevers","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4408225330","eid":"W4408225330"},{"id":"paper-w4255527198","cat":"papers","name":"Esketamine for treatment-resistant depression","year":"2020","cit":3,"topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4255527198","eid":"W4255527198"},{"id":"paper-w7131624024","cat":"papers","name":"Progress in the Application of Esketamine During the Perioperative Period","year":"2026","cit":3,"pfa":"Jiasheng Wang","psa":"Lifeng Wang","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7131624024","eid":"W7131624024"},{"id":"paper-w4411436568","cat":"papers","name":"Genetics of Response to ECT , TMS , Ketamine and Esketamine","year":"2025","cit":3,"pfa":"Clio E. Franklin","psa":"James B. Potash","topics":["Depression","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4411436568","eid":"W4411436568"},{"id":"paper-w2802377589","cat":"papers","name":"Adjunctive Intranasal Esketamine in Treatment-Resistant Depression","year":"2018","cit":3,"pfa":"Anish Shouan","psa":"Sandeep Grover","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2802377589","eid":"W2802377589"},{"id":"paper-w4402074171","cat":"papers","name":"Intranasal esketamine versus esketamine-dexmedetomidine combination for premedication in pediatric patients undergoing strabismus surgery: a randomized controlled trial","year":"2024","cit":3,"pfa":"Hui Qiao","psa":"Jie Jia","topics":["Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4402074171","eid":"W4402074171"},{"id":"paper-w4385669275","cat":"papers","name":"Intranasal Esketamine administration in catatonia: a case report.","year":"2023","cit":3,"pfa":"J.M. Suárez Romay","psa":"M. Gomez Revuelta","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4385669275","eid":"W4385669275"},{"id":"paper-w4412654383","cat":"papers","name":"Esketamine Monotherapy Effective for Treatment-Resistant Depression","year":"2025","cit":3,"pfa":"Samantha Anderer","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4412654383","eid":"W4412654383"},{"id":"paper-w3176147662","cat":"papers","name":"Binding of esketamine to human serum albumin for clinical implications","year":"2021","cit":3,"pfa":"Yan Li","psa":"Yulin Zhu","ptype":"article","src":"https://openalex.org/W3176147662","eid":"W3176147662"},{"id":"paper-w4406871214","cat":"papers","name":"Esketamine Nasal Spray vs Quetiapine Extended-Release","year":"2025","cit":3,"pfa":"Kristin Clemens","psa":"Yordan Godinov","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4406871214","eid":"W4406871214"},{"id":"paper-w2963768270","cat":"papers","name":"Esketamine Nasal Spray Effective in Treatment-Resistant Depression","year":"2019","cit":3,"pfa":"Anita Slomski","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2963768270","eid":"W2963768270"},{"id":"paper-w4401194537","cat":"papers","name":"Case report: two cases of rhabdomyolysis following esketamine treatment","year":"2024","cit":3,"pfa":"René Zeiss","psa":"Kathrin Malejko","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4401194537","eid":"W4401194537"},{"id":"paper-w4403779282","cat":"papers","name":"Use of esketamine for tracheoscopic drug injection: a randomized controlled trial","year":"2024","cit":3,"pfa":"Xiaoming Zhao","psa":"Yuanyuan Yu","topics":["Safety & adverse events","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4403779282","eid":"W4403779282"},{"id":"paper-w7121214516","cat":"papers","name":"Is there an independant anti-suicidal effect of esketamine in treatment resistant depression?","year":"2026","cit":3,"pfa":"Michel Danon","psa":"Philip A. P. M. Gorwood","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7121214516","eid":"W7121214516"},{"id":"paper-w4416143341","cat":"papers","name":"Effectiveness of ketamine/esketamine in alleviating postoperative fatigue: a systematic review","year":"2025","cit":3,"pfa":"Qijing Liu","psa":"Yatao Liu","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W4416143341","eid":"W4416143341"},{"id":"paper-w4403118166","cat":"papers","name":"(2R,6R)-hydroxynorketamine alleviates PTSD-like endophenotypes by regulating the PI3K/AKT signaling pathway in rats","year":"2024","cit":3,"pfa":"Lifen Liu","psa":"Lin Sun","topics":["PTSD & trauma","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4403118166","eid":"W4403118166"},{"id":"paper-w4401920578","cat":"papers","name":"Esketamine for resistant depression in older people with cognitive impairment: a case report","year":"2024","cit":3,"pfa":"Filippo Mazzoni","psa":"Miriam Olivola","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4401920578","eid":"W4401920578"},{"id":"paper-w4386002998","cat":"papers","name":"Esketamine for resistant depression in older people with cognitive impairment: A case report","year":"2023","cit":3,"pfa":"Serena Romani","psa":"Sandrine Louchart","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4386002998","eid":"W4386002998"},{"id":"paper-w4318755701","cat":"papers","name":"Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs","year":"2023","cit":3,"pfa":"Margarete A. Wallner","psa":"John Zajecka","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4318755701","eid":"W4318755701"},{"id":"paper-w4400863494","cat":"papers","name":"Balancing Evidence and Need: Variation in US Commercial Payer Coverage of Esketamine","year":"2024","cit":3,"pfa":"Ekwu B. Ochigbo","psa":"James D. Chambers","ptype":"article","src":"https://openalex.org/W4400863494","eid":"W4400863494"},{"id":"paper-w3134346012","cat":"papers","name":"Consistency of the Antidepressant Effect of Intranasal Esketamine in Phase 3 Clinical Trials","year":"2021","cit":3,"pfa":"Sheldon Preskorn","topics":["Depression","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3134346012","eid":"W3134346012"},{"id":"paper-w4415905114","cat":"papers","name":"Esketamine for postoperative sleep disturbance: clinical evidence, mechanisms, and future directions","year":"2025","cit":3,"pfa":"Qijing Liu","psa":"Yatao Liu","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4415905114","eid":"W4415905114"},{"id":"paper-w4409240218","cat":"papers","name":"Impact of esketamine intravenous analgesic pump on pain and depression post-cesarean","year":"2025","cit":3,"pfa":"Xiao-Qiang Zhang","psa":"Xiao-Lin Qin","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4409240218","eid":"W4409240218"},{"id":"paper-w2770336617","cat":"papers","name":"Common neurotransmission recruited in (R,S)-ketamine and (2R,6R)-hydroxynorketamine-induced sustained antidepressant-like effects","year":"2017","cit":3,"pfa":"Thu Ha Pham","psa":"Alain Michel Gardier","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2770336617","eid":"W2770336617"},{"id":"paper-w1520074489","cat":"papers","name":"Transmucosal nasal drug delivery : pharmacokinetics and pharmacodynamics of nasally applied esketamine","year":"2011","cit":3,"pfa":"Christoph Bitter","topics":["Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W1520074489","eid":"W1520074489"},{"id":"paper-w4366602997","cat":"papers","name":"Routine Prophylactic Esketamine for the Prevention of Maternal Pain During Cesarean Delivery","year":"2023","cit":3,"pfa":"Rachel Joyce Kearns","psa":"Scott McGill Nelson","ptype":"article","src":"https://openalex.org/W4366602997","eid":"W4366602997"},{"id":"paper-w4323925320","cat":"papers","name":"Completed suicides and intranasal esketamine therapy: A case report and case series","year":"2023","cit":3,"pfa":"William F. Rayburn","psa":"Brittany B. Albright","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4323925320","eid":"W4323925320"},{"id":"paper-w4412546836","cat":"papers","name":"Development and Validation of a Rapid LC–MS/MS Method for Plasma Analysis of Ketamine, Norketamine, Dehydronorketamine, and Hydroxynorketamine","year":"2025","cit":3,"pfa":"Jan Thomann","psa":"Dino Luethi","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4412546836","eid":"W4412546836"},{"id":"paper-w4409680385","cat":"papers","name":"Case Report: Successful management of psychogenic non-epileptic seizures with intranasal esketamine","year":"2025","cit":3,"pfa":"Muneeb Hashmi","psa":"Sarah Alnaher","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4409680385","eid":"W4409680385"},{"id":"paper-w4390811460","cat":"papers","name":"Esketamine induces apoptosis of nasopharyngeal carcinoma cells through the PERK/CHOP pathway","year":"2024","cit":3,"pfa":"Yuling Cao","psa":"Xinjin Chi","ptype":"article","src":"https://openalex.org/W4390811460","eid":"W4390811460"},{"id":"paper-w7134955624","cat":"papers","name":"Neuroprotective Effects of Esketamine in Central Nervous System Disorders: Mechanisms and Cellular Targets","year":"2026","cit":3,"pfa":"Chendi Zhao","psa":"Hong Cheng","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7134955624","eid":"W7134955624"},{"id":"paper-w4409694935","cat":"papers","name":"New Psychoactive Substance Esketamine Causes Endocrine-Disrupting Effects and Developmental Toxicity","year":"2025","cit":3,"pfa":"Siying Li","psa":"Guang‐Guo Ying","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4409694935","eid":"W4409694935"},{"id":"paper-w4403370999","cat":"papers","name":"Effect of intravenous esketamine in emergency cesarean deliveries: a retrospective analysis of maternal and neonatal outcomes","year":"2024","cit":3,"pfa":"Xiao-Mei Huang","psa":"Hong-Xia Qiu","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4403370999","eid":"W4403370999"},{"id":"paper-w4416416069","cat":"papers","name":"Esketamine attenuates post-traumatic stress disorder via suppressing neuroinflammation and abnormal myelination","year":"2025","cit":3,"pfa":"Zhaoliang Gu","psa":"Aijie Liu","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4416416069","eid":"W4416416069"},{"id":"paper-w4412790924","cat":"papers","name":"Effect of opioid sparing anesthesia with esketamine on PONV in laparoscopic sleeve gastrectomy randomized trial","year":"2025","cit":3,"pfa":"Kai-Rui Shi","psa":"Chun Yang","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4412790924","eid":"W4412790924"},{"id":"paper-w4405093063","cat":"papers","name":"Effect of Pretreatment with a Small Dose of Esketamine on Myoclonus Induced by Etomidate: A Randomized Controlled Trial","year":"2024","cit":3,"pfa":"Liangliang Gao","psa":"Lei Wei","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4405093063","eid":"W4405093063"},{"id":"paper-w4414452897","cat":"papers","name":"Efficacy of intraoperative ketamine/esketamine in the prevention of postoperative delirium: a systematic review and meta-analysis","year":"2025","cit":3,"pfa":"Chengchuan Chen","psa":"J. Hou","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4414452897","eid":"W4414452897"},{"id":"paper-w2602596332","cat":"papers","name":"Intranasal esketamine in treatment resistant depression – a double-blind, randomized, efficacy and dose response study","year":"2016","cit":3,"pfa":"Ella Daly","psa":"Wayne Curtis Drevets","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W2602596332","eid":"W2602596332"},{"id":"paper-w4404995516","cat":"papers","name":"Pretreatment with Esketamine Reduces Etomidate-Induced Myoclonus During the Induction of Anesthesia: A Randomized Controlled Trial","year":"2024","cit":3,"pfa":"J.-Y Wang","psa":"Lijian Chen","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4404995516","eid":"W4404995516"},{"id":"paper-w4390277011","cat":"papers","name":"A Meta-Analysis of the Antidepressant Responses in Pivotal Trials on Esketamine Nasal Spray and Atypical Antipsychotics","year":"2023","cit":3,"pfa":"Lien Wang","psa":"Guang Chen","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4390277011","eid":"W4390277011"},{"id":"paper-w4318694145","cat":"papers","name":"Effects of intraoperative intravenous esketamine infusion on the quality of recovery and pain after laparoscopic cholecystectomy","year":"2023","cit":3,"pfa":"Lifang Li","psa":"Liwei Wang","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4318694145","eid":"W4318694145"},{"id":"paper-w4406399858","cat":"papers","name":"Comparative Efficacy of Esketamine vs Sufentanil with Propofol for Sedation in EUS: A Randomized, Controlled Study","year":"2025","cit":3,"pfa":"Cuicui Liu","psa":"Zangong Zhou","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4406399858","eid":"W4406399858"},{"id":"paper-w7147667636","cat":"papers","name":"Effect of perioperative esketamine administration on the incidence of postoperative delirium: a systematic review and meta-analysis","year":"2026","cit":3,"pfa":"Xuemiao Tang","psa":"Qiang Fu","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7147667636","eid":"W7147667636"},{"id":"paper-w3133556843","cat":"papers","name":"Letter to the editor about “comparative effectiveness of esketamine in the treatment of anhedonia in bipolar and unipolar depression”","year":"2021","cit":3,"pfa":"Daniel H. Lins-Silva","psa":"Lucas C. Quarantini","topics":["Depression"],"ptype":"letter","src":"https://openalex.org/W3133556843","eid":"W3133556843"},{"id":"paper-w4416346272","cat":"papers","name":"Response of iPSC-derived neurons from individuals with treatment-resistant depression to (2 R,6 R)-hydroxynorketamine and reelin: an exploratory study","year":"2025","cit":3,"pfa":"Jenessa N. Johnston","psa":"Héctor J. Caruncho","topics":["Depression","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4416346272","eid":"W4416346272"},{"id":"paper-w4413831371","cat":"papers","name":"The post-marketing safety of Esketamine among older adults(≥ 65): an real-world pharmacovigilance study","year":"2025","cit":3,"pfa":"Bin Deng","psa":"Yongning Lv","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4413831371","eid":"W4413831371"},{"id":"paper-w4416399054","cat":"papers","name":"Efficacy of esketamine after cesarean section for women with symptoms of prenatal depression: A randomized controlled trial","year":"2025","cit":3,"pfa":"Xuesong","psa":"Dengxin Zhang","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4416399054","eid":"W4416399054"},{"id":"paper-w4417351644","cat":"papers","name":"Impact of Low-Dose Esketamine Pretreatment on Etomidate-Induced Myoclonus: A Randomized Controlled Trial","year":"2023","cit":3,"pfa":"Laura Schmidt","psa":"Jonas Weber","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4417351644","eid":"W4417351644"},{"id":"paper-w4382023542","cat":"papers","name":"The use of esketamine in the treatment of patients with oral antidepressant-resistant depression: systematic review and meta-analysis","year":"2023","cit":3,"pfa":"Idevaldo Floriano","psa":"Wanderley Marques Bernardo","topics":["Depression","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4382023542","eid":"W4382023542"},{"id":"paper-w4402443354","cat":"papers","name":"Analysis of clinical application effects of Esketamine combining Sufentanil in labor analgesia and their impacts on postpartum depression","year":"2024","cit":3,"pfa":"Haoyu Jiang","psa":"Xuefeng Zhang","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4402443354","eid":"W4402443354"},{"id":"paper-w4415983015","cat":"papers","name":"The effect of esketamine on postoperative delirium in patients undergoing general anesthesia: a systematic review and meta-analysis","year":"2025","cit":3,"pfa":"Chao-Xu","psa":"Jing Zhao","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4415983015","eid":"W4415983015"},{"id":"paper-w4410941082","cat":"papers","name":"Esketamine implementation challenges in psychiatry: A qualitative analysis of mental healthcare providers’ social media commentary","year":"2025","cit":3,"pfa":"Brian Scott Barnett","topics":["Depression","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4410941082","eid":"W4410941082"},{"id":"paper-w4402176234","cat":"papers","name":"Real-world demographic and clinical profiles of patients with treatment-resistant depression initiated on esketamine nasal spray","year":"2024","cit":3,"pfa":"Ludovic Samalin","psa":"Maud Rothärmel","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4402176234","eid":"W4402176234"},{"id":"paper-w2921192919","cat":"papers","name":"EFFICACY AND SAFETY OF ESKETAMINE NASAL SPRAY PLUS AN ORAL ANTIDEPRESSANT IN ELDERLY PATIENTS WITH TREATMENT-RESISTANT DEPRESSION","year":"2019","cit":3,"pfa":"Rachel Ochs-Ross","psa":"Jaskaran B. Singh","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2921192919","eid":"W2921192919"},{"id":"paper-w4407425156","cat":"papers","name":"Esketamine ameliorates prenatal stress-induced postpartum depression and sex-related behavioral differences in adolescent progeny","year":"2025","cit":3,"pfa":"Yazhou Wen","psa":"Shanwu Feng","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4407425156","eid":"W4407425156"},{"id":"paper-w4411875382","cat":"papers","name":"Intranasal esketamine significantly alleviates depression severity and suicidal ideations in electroconvulsive therapy (ECT) non-responders","year":"2025","cit":3,"pfa":"Erhan Kavakbasi","psa":"Bernhard Theodor Baune","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4411875382","eid":"W4411875382"},{"id":"paper-w2315683246","cat":"papers","name":"Pimobendan, etilefrine, moxifloxacin, and esketamine as reference compounds to validate the DSI Physiotel Digital System in cynomolgus monkeys","year":"2014","cit":3,"pfa":"Marc O. Niehoff","psa":"Dusty Sarazan","ptype":"article","src":"https://openalex.org/W2315683246","eid":"W2315683246"},{"id":"paper-w7124602312","cat":"papers","name":"Efficacy and safety of esketamine for sedation during colonoscopy: A systematic review and Meta-analysis of randomized controlled trials","year":"2026","cit":3,"pfa":"Zainab Ali Hussein","psa":"Ismail Elkhattib","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7124602312","eid":"W7124602312"},{"id":"paper-w7118933974","cat":"papers","name":"Ketamine and Esketamine for the Prevention of Delirium in Surgical Patients: A Systematic Review and Meta-analysis of Randomized Controlled Trials","year":"2026","cit":3,"pfa":"Nestor Cordeiro dos Santos Neto","psa":"Hildegard Loren Rebouças Santos","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W7118933974","eid":"W7118933974"},{"id":"paper-w4408945853","cat":"papers","name":"Esketamine modulates postoperative biochemical markers of oxidative stress, inflammation, and immune dysregulation in laparoscopic colorectal cancer surgery","year":"2025","cit":3,"pfa":"Peng Chen","psa":"Liu Dajin","topics":["PTSD & trauma","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4408945853","eid":"W4408945853"},{"id":"paper-w4411857776","cat":"papers","name":"Effects of Intranasal dexmedetomidine and esketamine for premedication on postoperative pain after tonsillectomy and adenoidectomy in children: a randomized clinical trial","year":"2025","cit":3,"pfa":"JunLiang Qi","psa":"Yueying Zhang","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4411857776","eid":"W4411857776"},{"id":"paper-w4207057367","cat":"papers","name":"US budget impact analysis of esketamine nasal spray in major depressive disorder with acute suicidal ideation/behavior","year":"2022","cit":3,"pfa":"Jennifer Voelker","psa":"Kruti Joshi","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4207057367","eid":"W4207057367"},{"id":"paper-w4407357850","cat":"papers","name":"Efficacy of combined theta burst stimulation (TBS) and intranasal esketamine in an ECT-resistant depressive patient: A case report","year":"2025","cit":3,"pfa":"Álvaro Moleón-Ruiz","psa":"Manuela Martín-Bejarano García","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4407357850","eid":"W4407357850"},{"id":"paper-w4415879370","cat":"papers","name":"Personalizing ketamine therapy: Real-world predictors of response to IV ketamine and intranasal esketamine in treatment-resistant depression","year":"2025","cit":3,"pfa":"Ahmed Z. Elmaadawi","psa":"Mohamed Eltohami","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4415879370","eid":"W4415879370"},{"id":"paper-w7131661494","cat":"papers","name":"Long-term treatment with esketamine nasal spray in patients with treatment resistant depression: Results from the ESCAPE-LTE study","year":"2026","cit":3,"pfa":"Andreas Reif","psa":"Wiesław Jerzy Cubała","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7131661494","eid":"W7131661494"},{"id":"paper-w4411131537","cat":"papers","name":"The effect of esketamine on emergence delirium in pediatric patients undergoing general anesthesia: a meta-analysis of randomized controlled trials","year":"2025","cit":3,"pfa":"Shiyue Li","psa":"Pengfei Gao","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4411131537","eid":"W4411131537"},{"id":"paper-w4402952283","cat":"papers","name":"The CB2-PKC pathway is involved in esketamine-induced anti-inflammation in BV-2 microglial cells exposed to lipopolysaccharides","year":"2024","cit":3,"pfa":"Yuqing Wang","topics":["Depression","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4402952283","eid":"W4402952283"},{"id":"paper-w4414861565","cat":"papers","name":"Propofol-esketamine versus propofol-fentanyl combinations for sedation in pediatric flexible fiberoptic bronchoscopy: a randomized controlled trial","year":"2025","cit":3,"pfa":"Xiaomei Wang","psa":"Dan Wang","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4414861565","eid":"W4414861565"},{"id":"paper-w4396690416","cat":"papers","name":"A study of hemodynamic effects, postoperative recovery, and safety of esketamine (right handed) during flexible bronchoscopy under general anesthesia","year":"2024","cit":3,"pfa":"Qin Ding","psa":"Suyang Yue","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4396690416","eid":"W4396690416"},{"id":"paper-w4414373873","cat":"papers","name":"Lamotrigine is not associated with differential clinical outcomes in a real-world sample of patients with unipolar depression receiving ketamine or esketamine","year":"2025","cit":3,"pfa":"Mia C Santucci","psa":"Samuel T. Wilkinson","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4414373873","eid":"W4414373873"},{"id":"paper-w4415654188","cat":"papers","name":"Effects of Continuous Perioperative Esketamine Infusion on Postoperative Depression in Breast Cancer Patients: A Randomized Controlled Double-Blind Trial","year":"2025","cit":3,"pfa":"Mengting Shen","psa":"Xinlei Lu","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4415654188","eid":"W4415654188"},{"id":"paper-w4411845413","cat":"papers","name":"Efficacy and safety of ketamine and esketamine for preventing opioid-induced cough: a systematic review and meta-analysis of randomized controlled trials","year":"2025","cit":3,"pfa":"Kuo‐Chuan Hung","psa":"I‐Wen Chen","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4411845413","eid":"W4411845413"},{"id":"paper-w4410236026","cat":"papers","name":"Safety Profile and Suicidality Associated with the Use of Esketamine in the Treatment of Major Depressive Disorder in European Countries: An EudraVigilance Database Analysis","year":"2025","cit":3,"pfa":"Ilaria Ammendolia","psa":"Fabrizio Calapai","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4410236026","eid":"W4410236026"},{"id":"paper-w4408137653","cat":"papers","name":"Esketamine Regulates Mitophagy through ULK1/FUNDC1 Signaling Pathway to Improve LPS-induced Acute Respiratory Distress Syndrome","year":"2025","cit":3,"pfa":"Mei Ding","psa":"Wenli Yu","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4408137653","eid":"W4408137653"},{"id":"paper-w4396969234","cat":"papers","name":"The Relationship Between Perioperative Use of Esketamine and Postpartum Depression Risk: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","year":"2024","cit":3,"pfa":"Yuansheng Cao","psa":"Rui Zhou","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4396969234","eid":"W4396969234"},{"id":"paper-w4409816516","cat":"papers","name":"Feasibility of Closed-Loop TCI Based on New EEG Baseline in the Presence of Low Dose of Esketamine: A Randomized Controlled Equivalence Trial","year":"2025","cit":3,"pfa":"Xiaoshan Li","psa":"Bo Xu","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4409816516","eid":"W4409816516"},{"id":"paper-w4413867053","cat":"papers","name":"Esketamine alleviates depressive-like behavior in mice via modulation of the microbiota-gut-brain axis and amino acid metabolism","year":"2025","cit":3,"pfa":"Xue Gong","psa":"Qiang Mao","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4413867053","eid":"W4413867053"},{"id":"paper-w4406526161","cat":"papers","name":"Optimal doses of intranasal esketamine plus dexmedetomidine for sedating toddlers during transthoracic echocardiography: a prospective, double-blind, randomized trial","year":"2025","cit":3,"pfa":"Dongjie Pei","psa":"Shuangquan Qu","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4406526161","eid":"W4406526161"},{"id":"paper-w3033417559","cat":"papers","name":"Adjunctive intranasal esketamine for major depressive disorder: a systematic review of randomized double-blind controlled-placebo studies - Authors’ reply","year":"2020","cit":3,"pfa":"Wei Zheng","psa":"Yu‐Tao Xiang","topics":["Depression","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W3033417559","eid":"W3033417559"},{"id":"paper-w7116684394","cat":"papers","name":"A real-world pharmacovigilance study of adverse events associated with esketamine: disproportionality analysis and detection of potential drug-drug interaction signals","year":"2025","cit":3,"pfa":"Claudia Pisanu","psa":"Satoko Hori","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7116684394","eid":"W7116684394"},{"id":"paper-w4416180614","cat":"papers","name":"Ascorbic acid enhances antidepressant-like efficacy of esketamine: Hippocampal TARP-γ8-containing AMPA receptors mediate synaptic modulation","year":"2025","cit":3,"pfa":"Zhaojuan Ke","psa":"Baihang Cai","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4416180614","eid":"W4416180614"},{"id":"paper-w4410197998","cat":"papers","name":"The effect of perioperative ketamine and esketamine administration on postoperative nausea and vomiting in patients undergoing general anesthesia: a systematic review and meta-analysis","year":"2025","cit":3,"pfa":"Kwon Hui Seo","psa":"Na Jin Kim","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W4410197998","eid":"W4410197998"},{"id":"paper-w4406022227","cat":"papers","name":"Perioperative esketamine combined with butorphanol versus butorphanol alone for pain management following video-assisted lobectomy: a randomized controlled trial","year":"2025","cit":3,"pfa":"Hongjian Wang","psa":"Xianwen Hu","ptype":"article","src":"https://openalex.org/W4406022227","eid":"W4406022227"},{"id":"paper-w4415878492","cat":"papers","name":"The additive effect of esketamine and clonidine in patients at high risk for acute postoperative pain undergoing laparoscopic surgery: A randomised controlled trial","year":"2025","cit":3,"pfa":"Krister Mogianos","psa":"Anna K. M. Persson","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4415878492","eid":"W4415878492"},{"id":"paper-w4322009712","cat":"papers","name":"Esketamine combined with pregabalin on acute postoperative pain in patients undergoing resection of spinal neoplasms: study protocol for a randomized controlled trial","year":"2023","cit":3,"pfa":"Wanchen Sun","psa":"Ruquan Han","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4322009712","eid":"W4322009712"},{"id":"paper-w4405635336","cat":"papers","name":"Efficacy and safety of esketamine nasal spray as monotherapy in adults with treatment-resistant depression: a randomized, double-blind, placebo-controlled study","year":"2024","cit":3,"pfa":"Adam Janik","psa":"Dong‐Jing Fu","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4405635336","eid":"W4405635336"},{"id":"paper-w4312113336","cat":"papers","name":"Evaluation of Ethnicity Effect on Intranasal Esketamine Pharmacokinetics by Population Pharmacokinetic Modeling Using Data From a Japanese Phase 2b Study","year":"2022","cit":3,"pfa":"Ken Kurosawa","psa":"Carlos Pérez‐Ruixo","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4312113336","eid":"W4312113336"},{"id":"paper-w4415960533","cat":"papers","name":"Opioid-free anesthesia with quadratus lumborum block and Esketamine enhances postoperative recovery in laparoscopic colon cancer surgery: A randomized controlled trial","year":"2025","cit":3,"pfa":"Chuan-xi Cheng","psa":"Xiaobo Chen","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4415960533","eid":"W4415960533"},{"id":"paper-w4417449516","cat":"papers","name":"Effects of Esketamine on Postoperative Cognitive Function in Elderly Patients Undergoing Pulmonary Lobectomy: A Randomised, Single-Blind Controlled Clinical Trial","year":"2025","cit":3,"pfa":"Xueping Li","psa":"Yan Qiu","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4417449516","eid":"W4417449516"},{"id":"paper-w7125404847","cat":"papers","name":"Esketamine alleviates COPD-depression comorbidity in rats via MAPK/NF-κB inhibition and gut-lung-brain axis modulation","year":"2026","cit":3,"pfa":"Ang Liu","psa":"Zhi-Yuan Chen","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W7125404847","eid":"W7125404847"},{"id":"paper-w7140127108","cat":"papers","name":"Esketamine ameliorates postoperative cognitive dysfunction aggravated by preoperative acute sleep deprivation in aged mice via the TLR4/NF-κB pathway","year":"2026","cit":3,"pfa":"Bo Han","psa":"Jinliang Teng","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7140127108","eid":"W7140127108"},{"id":"paper-w2912877547","cat":"papers","name":"Randomized, double-blind study of flexibly-dosed intranasal esketamine plus oral antidepressant vs. active control in treatment-resistant depression","year":"2019","cit":3,"pfa":"Vanina Popova","psa":"Jaskaran B. Singh","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2912877547","eid":"W2912877547"},{"id":"paper-w4403199683","cat":"papers","name":"Estimating the benefit of esketamine nasal spray versus real-world treatment on patient-reported functional remission: results from the ICEBERG study","year":"2024","cit":3,"pfa":"Albino Jorge Oliveira-Maia","psa":"Siobhán Mulhern-Haughey","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4403199683","eid":"W4403199683"},{"id":"paper-w4407934138","cat":"papers","name":"Esketamine combined with ultrasound-guided superficial cervical plexus block to complete pediatric subglottic stenosis tracheotomy-a case report and literature review","year":"2025","cit":3,"pfa":"Guangyan Zhang","psa":"Haifeng Li","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4407934138","eid":"W4407934138"},{"id":"paper-w4390953820","cat":"papers","name":"Esketamine use is associated with shortened postoperative hospital stay in patients after knee arthroscopic surgery: a propensity score–matched cohort study","year":"2024","cit":3,"pfa":"Jing Liu","psa":"Yue Peng","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4390953820","eid":"W4390953820"},{"id":"paper-w4386566312","cat":"papers","name":"Effect of single intravenous injection of esketamine on quality of recovery during early period after modified radical mastectomy for breast cancer: A retrospective study","year":"2023","cit":3,"pfa":"Guofang Fei","psa":"Huaqi Yao","topics":["Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4386566312","eid":"W4386566312"},{"id":"paper-w4386790733","cat":"papers","name":"The Effect of Low-Dose Esketamine on Postoperative Neurocognitive Dysfunction in Elderly Patients Undergoing General Anesthesia for Gastrointestinal Tumors: A Randomized Controlled Trial [Letter]","year":"2023","cit":3,"pfa":"Yongjian Lin","psa":"Mingyang Jiang","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4386790733","eid":"W4386790733"},{"id":"paper-w4309323040","cat":"papers","name":"Albumin alleviated esketamine-induced neuronal apoptosis of rat retina through downregulation of Zn2+-dependent matrix metalloproteinase 9 during the early development","year":"2022","cit":3,"pfa":"Kan Zhang","psa":"Jijian Zheng","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4309323040","eid":"W4309323040"},{"id":"paper-w7167330130","cat":"papers","name":"Esketamine protects against LPS-induced septic lung injury via NMDA receptor and NF-κB/NLRP3/Caspase-1/GSDMD pathway","year":"2026","cit":3,"pfa":"Qin Hu","psa":"Jiafeng Wang","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7167330130","eid":"W7167330130"},{"id":"paper-w4392018387","cat":"papers","name":"Effect of esketamine on the EC50 of remifentanil for blunting cardiovascular responses to endotracheal intubation in female patients under general anesthesia: a sequential allocation dose-finding study","year":"2024","cit":3,"pfa":"Fan Ziqiang","psa":"Bai Yiping","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4392018387","eid":"W4392018387"},{"id":"paper-w4414545038","cat":"papers","name":"Effects of low-dose esketamine on hypoxemia during gastroscopy in patients with moderate-to-high risk obstructive sleep apnea: protocol for a prospective, randomized, controlled trial","year":"2025","cit":3,"pfa":"Xin-Ming Li","psa":"Li‐Xin An","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4414545038","eid":"W4414545038"},{"id":"paper-w7134058900","cat":"papers","name":"Effect of Preoperative Esketamine Nebulized Inhalation on Cough Reflex, Sedation, and Postoperative Sore Throat in Extubation of Surgical Patients: A Prospective, Double-Blind, Randomized Controlled Trial","year":"2026","cit":3,"pfa":"Zheng-Qin Zhang","psa":"Shao-Hua Hu","ptype":"article","src":"https://openalex.org/W7134058900","eid":"W7134058900"},{"id":"paper-w4414887568","cat":"papers","name":"Effect of Intravenous Esketamine on Rebound Pain Following Single-Shot Brachial Plexus Block in Patients Undergoing Shoulder Arthroscopic Surgery: A Prospective, Randomized, Placebo-Controlled Study","year":"2025","cit":3,"pfa":"Jiale Chen","psa":"Jinwei Zheng","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4414887568","eid":"W4414887568"},{"id":"paper-w4406061650","cat":"papers","name":"Health Care Resource Use and Medical Costs Among Patients With Major Depressive Disorder and Acute Suicidal Ideation or Behavior Initiated on Esketamine Nasal Spray or Traditional Treatments in the United States","year":"2025","cit":3,"pfa":"Lisa Harding","psa":"Kruti Joshi","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4406061650","eid":"W4406061650"},{"id":"paper-w4410562316","cat":"papers","name":"Effects of mini-dose esketamine–dexmedetomidine combination supplemented intravenous analgesia on postoperative sleep quality in elderly patients after total knee arthroplasty: a protocol of double-blind randomised trial","year":"2025","cit":3,"pfa":"Xiaoyan Wang","psa":"Jinfeng Liu","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4410562316","eid":"W4410562316"},{"id":"paper-w4390580156","cat":"papers","name":"Comparison of the effects of esketamine, sufentanil, or lidocaine combined with propofol on tussis reflection during upper gastrointestinal endoscopy: study protocol for a randomised, two centre, three-blind, controlled","year":"2024","cit":3,"pfa":"Hai‐Jun Hou","psa":"Fu‐Shan Xue","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4390580156","eid":"W4390580156"},{"id":"paper-w3136355272","cat":"papers","name":"Post hoc analyses of an open-label long-term study of esketamine nasal spray plus an oral antidepressant comparing results in older versus younger adults with treatment-resistant depression","year":"2021","cit":3,"pfa":"Rachel Ochs-Ross","psa":"Jaskaran B. Singh","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W3136355272","eid":"W3136355272"},{"id":"paper-w4378803855","cat":"papers","name":"Exploring the Molecular Targets for the Antidepressant and Antisuicidal Effects of Ketamine Enantiomers by using Network Pharmacology and Molecular Docking","year":"2023","cit":3,"pfa":"Glorister A. Altê","psa":"Ana Lúcia S. Rodrigues","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4378803855","eid":"W4378803855"},{"id":"paper-w4394768497","cat":"papers","name":"A Phase 2 Open Label Study of Efficacy, Safety, and Tolerability of SLS-002 (Intranasal Racemic Ketamine) in Adults with MDD at Imminent Risk of Suicide","year":"2025","cit":3,"pfa":"Timothy Whitaker","psa":"Michael E. Thase","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4394768497","eid":"W4394768497"},{"id":"paper-w4304190231","cat":"papers","name":"Commentary on Cochrane review: “Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder”","year":"2022","cit":3,"pfa":"Stephane Borentain","psa":"Carla M. Canuso","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"editorial","src":"https://openalex.org/W4304190231","eid":"W4304190231"},{"id":"paper-w4414326998","cat":"papers","name":"Ketamine Reduces Suicidality-Associated Emergency Department Utilization in Patients With Treatment-Resistant Depression","year":"2025","cit":3,"pfa":"Liliana Patarroyo-Rodríguez","psa":"Balwinder Singh","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4414326998","eid":"W4414326998"},{"id":"paper-w2084354100","cat":"papers","name":"UP-3.073: Dystrophic Calcification of Urinary Bladder Associated with Ketamine Use","year":"2009","cit":3,"pfa":"Sumayya Shahzad","psa":"Suresh Ganta","ptype":"article","src":"https://openalex.org/W2084354100","eid":"W2084354100"},{"id":"paper-w4414043489","cat":"papers","name":"Enantioselective capillary electrophoresis with sulfated cyclodextrins for monitoring ketamine and its metabolites in biosamples and its application to assess metabolic steps and kinetic parameters","year":"2025","cit":3,"pfa":"Wolfgang Thormann","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4414043489","eid":"W4414043489"},{"id":"paper-w4404871970","cat":"papers","name":"The role of ketamine and its enantiomer in managing depression and pain in cancer patients: A narrative review","year":"2024","cit":3,"pfa":"Michael S. Bodnar","psa":"Jeffery Huang","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W4404871970","eid":"W4404871970"},{"id":"paper-w4313201118","cat":"papers","name":"Real-life effectiveness of vortioxetine on goal achievement and work productivity in Japanese patients with major depressive disorder – the VGOAL-J study","year":"2022","cit":3,"pfa":"Kazuhiro Watanabe","psa":"Maëlys Touya","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4313201118","eid":"W4313201118"},{"id":"paper-w2946165915","cat":"papers","name":"O33 Towards personalised weaning of sedatives and analgesics using mechanism-based modelling of iatrogenic withdrawal in critically ill children","year":"2019","cit":3,"pfa":"Sebastiaan Camiel Goulooze","psa":"Catherijne A. J. Knibbe","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2946165915","eid":"W2946165915"},{"id":"paper-w4300629777","cat":"papers","name":"Effects of Ketamine and Ketamine Metabolites on Evoked Striatal Dopamine Release, Dopamine Receptors, and Monoamine Transporters","year":"2020","cit":3,"pfa":"Hye Jin Kang","psa":"Ruin Moaddel","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4300629777","eid":"W4300629777"},{"id":"paper-w4413933196","cat":"papers","name":"Peripartum Depression Pharmacotherapies Targeting GABA–Glutamate Neurotransmission","year":"2025","cit":3,"pfa":"Alan C. Courtes","psa":"Rodrigo Machado‐Vieira","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4413933196","eid":"W4413933196"},{"id":"paper-w4406091635","cat":"papers","name":"Insights for the Next Generation of Ketamine for the Treatment of Depressive Disorder","year":"2025","cit":3,"pfa":"Allana Cristina Faustino Martins","psa":"Roberto da Silva Gomes","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4406091635","eid":"W4406091635"},{"id":"paper-w7148582501","cat":"papers","name":"Metabolomic Profiling of Extracellular Vesicles Reveals Distinct Metabolic Dysregulation and Treatment-Specific Signatures in Depression","year":"2026","cit":3,"pfa":"Nikola Balic","psa":"Matea Nikolac Perković","topics":["Depression","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7148582501","eid":"W7148582501"},{"id":"paper-w3048737551","cat":"papers","name":"Treatment‐resistant depression: An overview for psychiatric advanced practice nurses","year":"2020","cit":3,"pfa":"Brayden Kameg","psa":"Kirstyn Marie Kameg","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3048737551","eid":"W3048737551"},{"id":"paper-w4389941607","cat":"papers","name":"The “new wave” of antidepressants: are these agents paradigm-shifters in treating major depression?","year":"2023","cit":3,"pfa":"Bogdan Mircea Petrescu","psa":"Cristian A. Cândea","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4389941607","eid":"W4389941607"},{"id":"paper-w4393992716","cat":"papers","name":"Very Low-Dose Sublingual Ketamine for Borderline Personality Disorder and Treatment-Resistant Depression","year":"2024","cit":3,"pfa":"Mitchell B. Liester","psa":"Bertrand C. Liang","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4393992716","eid":"W4393992716"},{"id":"paper-w4404604849","cat":"papers","name":"Treatment-resistant depression","year":"2024","cit":3,"pfa":"Leesa A. McBroom","psa":"Melissa Timmons","topics":["Depression","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4404604849","eid":"W4404604849"},{"id":"paper-w4324144291","cat":"papers","name":"S-ketamine: Is it a ride worth taking? Adverse effects associated with S-ketamine use as an adjuvant or single agent drug","year":"2023","cit":3,"pfa":"Tafadzwa P. Mawere-Mubvumbi","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4324144291","eid":"W4324144291"},{"id":"paper-w4410590900","cat":"papers","name":"Bioactive ketamine metabolite exerts in vivo neuroplastogenic effects to improve hippocampal function in a treatment-resistant depression model","year":"2025","cit":3,"pfa":"Lace Marie Riggs","psa":"Todd D. Gould","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4410590900","eid":"W4410590900"},{"id":"paper-w4407392333","cat":"papers","name":"The Assessment of the Safety Profile of Selective Serotonin Reuptake Inhibitors Versus Other Antidepressants: Drug–Drug Interaction Insights from EudraVigilance","year":"2025","cit":3,"pfa":"Carmen Maximiliana Dobrea","psa":"Andreea Loredana Vonica-Țincu","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4407392333","eid":"W4407392333"},{"id":"paper-w4413015304","cat":"papers","name":"Blood-based biomarkers in ketamine treatment: A blueprint for translational drug development in mood disorders","year":"2025","cit":3,"pfa":"Alan C. Courtes","psa":"Rodrigo Machado‐Vieira","ptype":"article","src":"https://openalex.org/W4413015304","eid":"W4413015304"},{"id":"paper-w4400612761","cat":"papers","name":"Ketamine metabolism via hepatic CYP450 isoforms contributes to its sustained antidepressant actions","year":"2024","cit":3,"pfa":"Thi Mai Loan Nguyen","psa":"Alain Michel Gardier","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4400612761","eid":"W4400612761"},{"id":"paper-w2924820247","cat":"papers","name":"Pharmacologically diverse antidepressant drugs disrupt the interaction of BDNF receptor TRKB and the endocytic adaptor AP-2","year":"2019","cit":3,"pfa":"Senem Merve Fred","psa":"Eero Ċastrén","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W2924820247","eid":"W2924820247"},{"id":"paper-w4409250217","cat":"papers","name":"Sex specific effects of ketamine, but not other glutamate receptor modulators, on ethanol self-administration and reinstatement of ethanol seeking in rats","year":"2025","cit":3,"pfa":"Megan L. Bertholomey","psa":"Mary M. Torregrossa","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4409250217","eid":"W4409250217"},{"id":"paper-w4409504585","cat":"papers","name":"Ketamine for unipolar depression: A systematic review of efficacy and safety","year":"2025","cit":3,"pfa":"Tharshanan Edwin Peiris","psa":"Yuvaraj Paudel","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4409504585","eid":"W4409504585"},{"id":"paper-w4411495880","cat":"papers","name":"A randomized, double-blind, placebo-controlled, Phase 1 study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of an immediate-release oral ketamine capsule in healthy volunteers","year":"2025","cit":3,"pfa":"Mutahira M. Qureshi","psa":"Mário F. Juruena","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4411495880","eid":"W4411495880"},{"id":"paper-w3201267348","cat":"papers","name":"Later is not necessarily better: limitations of survival analysis in studies of long-term drug treatment of psychiatric conditions","year":"2021","cit":3,"pfa":"Joanna Moncrieff","psa":"Max Oscar Bachmann","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3201267348","eid":"W3201267348"},{"id":"paper-w4396803450","cat":"papers","name":"Hype or hope? Ketamine for the treatment of depression: results from the application of deep learning to Twitter posts from 2010 to 2023","year":"2024","cit":3,"pfa":"Qin Xiang Ng","psa":"Tau Ming Liew","topics":["Depression","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4396803450","eid":"W4396803450"},{"id":"paper-w4401359527","cat":"papers","name":"Vergleich der präklinischen Analgesiequalität von Notarzt und Notfallsanitäter anhand traumatologischer Patienten","year":"2024","cit":3,"pfa":"Julian Thomas","psa":"Werner Armbruster","topics":["PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4401359527","eid":"W4401359527"},{"id":"paper-w7131898828","cat":"papers","name":"Ketamine pharmacotherapy for major depressive disorder: A narrative review","year":"2026","cit":3,"pfa":"Chris H. Miller","psa":"Dawson W. Hedges","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W7131898828","eid":"W7131898828"},{"id":"paper-w4417445984","cat":"papers","name":"From Monoamines to Systems Psychiatry: Rewiring Depression Science and Care (1960s–2025)","year":"2025","cit":3,"pfa":"Masaru Tanaka","topics":["Depression","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4417445984","eid":"W4417445984"},{"id":"paper-w3136067473","cat":"papers","name":"A systematic review of ketamine for the treatment of depression among older adults","year":"2021","cit":3,"pfa":"Syeda Arshiya Farheen","psa":"Rajesh R. Tampi","topics":["Depression","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3136067473","eid":"W3136067473"},{"id":"paper-w2020658520","cat":"papers","name":"Molecular orbital studies on tryptamines active on the lsd receptor of the rat fundus strip","year":"2009","cit":3,"pfa":"Carl Lynn Johnson","psa":"Jack Peter Green","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2020658520","eid":"W2020658520"},{"id":"paper-w2411698430","cat":"papers","name":"Modification of the effects of LSD-25, d-amphetamine and tryptamine on electrically evoked responses in the visual system by methiothepin and octoclothepin.","year":"1978","cit":3,"pfa":"Moore Rh","psa":"Domino Ef","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2411698430","eid":"W2411698430"},{"id":"paper-w2438018854","cat":"papers","name":"Antidiuresis in man following lysergic acid diethylamide and mescaline.","year":"1970","cit":2,"pfa":"L E Hollister","psa":"Adrian Dronkert","ptype":"article","src":"https://openalex.org/W2438018854","eid":"W2438018854"},{"id":"paper-w4220732228","cat":"papers","name":"5‐MeO‐DMT has not been found in traditional ayahuasca preparations and the combination of 5‐MeO‐DMT with MAOIs is dangerous","year":"2022","cit":2,"pfa":"Rafael Lancelotta","ptype":"article","src":"https://openalex.org/W4220732228","eid":"W4220732228"},{"id":"paper-w1999169330","cat":"papers","name":"Lysergic Acid Diethylamide","year":"1966","cit":2,"pfa":"R. A. Sandison","ptype":"article","src":"https://openalex.org/W1999169330","eid":"W1999169330"},{"id":"paper-w2073306332","cat":"papers","name":"Lysergic Acid Diethylamide","year":"1966","cit":2,"pfa":"S. E. Browne","ptype":"article","src":"https://openalex.org/W2073306332","eid":"W2073306332"},{"id":"paper-w2156578780","cat":"papers","name":"Lysergic Acid Diethylamide (LSD)","year":"2012","cit":2,"pfa":"Donald G. Barceloux","topics":["Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W2156578780","eid":"W2156578780"},{"id":"paper-w2758013717","cat":"papers","name":"Lysergic Acid Diethylamide (LSD)","year":"2020","cit":2,"pfa":"Virgil Zeigler‐Hill","psa":"Todd K. Shackelford","ptype":"reference-entry","src":"https://openalex.org/W2758013717","eid":"W2758013717"},{"id":"paper-w4250342648","cat":"papers","name":"Lysergic Acid Diethylamide (LSD)","year":"2014","cit":2,"pfa":"Paul William May","psa":"Simon Cotton","ptype":"book-chapter","src":"https://openalex.org/W4250342648","eid":"W4250342648"},{"id":"paper-w2048153341","cat":"papers","name":"Microcrystalloptic tests for lysergic acid diethylamide and other hallucinogens","year":"1970","cit":2,"pfa":"KLAUS GENEST","psa":"Lorna J. Lowry","ptype":"article","src":"https://openalex.org/W2048153341","eid":"W2048153341"},{"id":"paper-w1998906142","cat":"papers","name":"Nonpsychic Effects of Lysergic Acid Diethylamide","year":"1967","cit":2,"pfa":"Kurt Hirschhorn","psa":"Maimon M. Cohen","topics":["Dosing & pharmacology"],"ptype":"editorial","src":"https://openalex.org/W1998906142","eid":"W1998906142"},{"id":"paper-w2402253937","cat":"papers","name":"Lysergic acid diethylamide and acute leukemia.","year":"1978","cit":2,"pfa":"Goh K","psa":"A W Bauman","ptype":"article","src":"https://openalex.org/W2402253937","eid":"W2402253937"},{"id":"paper-w2486349571","cat":"papers","name":"Schizophrenia Modeling Using Lysergic Acid Diethylamide","year":"2016","cit":2,"pfa":"Charles David Nichols","ptype":"book-chapter","src":"https://openalex.org/W2486349571","eid":"W2486349571"},{"id":"paper-w2413245082","cat":"papers","name":"[Therapeutic effect of lysergic acid diethylamide (LSD)].","year":"1962","cit":2,"pfa":"Jiri Roubicek","ptype":"article","src":"https://openalex.org/W2413245082","eid":"W2413245082"},{"id":"paper-w2014537713","cat":"papers","name":"Injury to the bladderUnusual complication of lysergic acid diethylamide","year":"1974","cit":2,"pfa":"Alexander Sotiropoulos","ptype":"article","src":"https://openalex.org/W2014537713","eid":"W2014537713"},{"id":"paper-w2428798320","cat":"papers","name":"[A review on the use of lysergic acid diethylamide in psychiatry].","year":"1960","cit":2,"pfa":"Henricus Wijsenbeek","psa":"R LANDAU","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2428798320","eid":"W2428798320"},{"id":"paper-w1584731204","cat":"papers","name":"Lysergic Acid Diethylamide (LSD) in the Treatment of Alcoholism.","year":"1968","cit":2,"pfa":"Mary E. Purdy","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1584731204","eid":"W1584731204"},{"id":"paper-w2064476913","cat":"papers","name":"Effect of Lysergic Acid Diethylamide on Larval Growth","year":"1960","cit":2,"pfa":"D. V. Siva Sankar","psa":"Eleanor Gold","ptype":"article","src":"https://openalex.org/W2064476913","eid":"W2064476913"},{"id":"paper-w2181344335","cat":"papers","name":"Lysergic Acid Diethylamide Effects Modified by Hydroxyzine Hydrochloride","year":"2007","cit":2,"pfa":"F.L. Jenkner","psa":"Otto Buschor","ptype":"article","src":"https://openalex.org/W2181344335","eid":"W2181344335"},{"id":"paper-w2409519843","cat":"papers","name":"[LSD treatment. Psychotherapy with the aid of lysergic acid diethylamide].","year":"1961","cit":2,"pfa":"Herluf Andersen","psa":"Knud Knudsen","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2409519843","eid":"W2409519843"},{"id":"paper-w2024604198","cat":"papers","name":"Action of Steroids on Lysergic Acid Diethylamide (LSD) Metabolism.","year":"1962","cit":2,"pfa":"John R. Bergen","psa":"Mika Hayano","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2024604198","eid":"W2024604198"},{"id":"paper-w2419147111","cat":"papers","name":"Experiences with D-lysergic acid diethylamide (LSD); a symposium.","year":"1956","cit":2,"pfa":"Booysen Pj","psa":"Van Wyk Aj","ptype":"article","src":"https://openalex.org/W2419147111","eid":"W2419147111"},{"id":"paper-w2410262871","cat":"papers","name":"[Effects of D-lysergic acid diethylamide (LSD-25) and 2-bromo-D-lysergic acid diethylamide (BOL-148) on sleeping behavior in rats].","year":"1970","cit":2,"pfa":"D M Loew","psa":"Jean M. Vigouret","ptype":"article","src":"https://openalex.org/W2410262871","eid":"W2410262871"},{"id":"paper-w2007869809","cat":"papers","name":"The effect of lysergic acid diethylamide on swimming time in albino mice","year":"1963","cit":2,"pfa":"Charles G. Wilber","psa":"John A. Burke","ptype":"article","src":"https://openalex.org/W2007869809","eid":"W2007869809"},{"id":"paper-w2412046710","cat":"papers","name":"[Action of lysergic acid diethylamide (LSD-25) in obsessive neuroses].","year":"1960","cit":2,"pfa":"David Jm","ptype":"article","src":"https://openalex.org/W2412046710","eid":"W2412046710"},{"id":"paper-w2995393447","cat":"papers","name":"Lysergic Acid Diethylamide as an Analgesic Agent in Patients with Terminal Illnesses","year":"2019","cit":2,"pfa":"Saibal Das","psa":"Tanay Maiti","ptype":"article","src":"https://openalex.org/W2995393447","eid":"W2995393447"},{"id":"paper-w2282827726","cat":"papers","name":"D-Lysergic Acid Diethylamide (LSD-25): A Survey of the Literature","year":"1967","cit":2,"pfa":"Melvin J. Schwartz","ptype":"article","src":"https://openalex.org/W2282827726","eid":"W2282827726"},{"id":"paper-w7118195776","cat":"papers","name":"Vigilance state dissociation induced by 5-MeO-DMT in mice","year":"2026","cit":2,"pfa":"Benjamin J. B. Bréant","psa":"Vladyslav V. Vyazovskiy","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7118195776","eid":"W7118195776"},{"id":"paper-w4387798543","cat":"papers","name":"Breaking bad buttons: mescaline biosynthesis in peyote","year":"2023","cit":2,"pfa":"Gwendolyn K. Kirschner","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4387798543","eid":"W4387798543"},{"id":"paper-w2407162295","cat":"papers","name":"[Effect of d-lysergic acid diethylamide and related compounds on melanophores].","year":"1956","cit":2,"pfa":"Botond Berde","psa":"A Cerletti","ptype":"article","src":"https://openalex.org/W2407162295","eid":"W2407162295"},{"id":"paper-w2306287423","cat":"papers","name":"Proceedings: Effects of lysergic acid diethylamide on auditory and visual discrimination in the rat.","year":"1975","cit":2,"pfa":"K Brown","psa":"S.J. Cooper","ptype":"article","src":"https://openalex.org/W2306287423","eid":"W2306287423"},{"id":"paper-w2072624893","cat":"papers","name":"The biliary excretion of [3H] lysergic acid diethylamide in Wistar and gunn rats","year":"1976","cit":2,"pfa":"David J. Back","psa":"Jagmohan K. G. Singh","ptype":"article","src":"https://openalex.org/W2072624893","eid":"W2072624893"},{"id":"paper-w4200537269","cat":"papers","name":"P.0835 Synergistic effects of lysergic acid diethylamide (LSD) and cannabidiol (CBD)","year":"2021","cit":2,"pfa":"Antonio Inserra","psa":"Gabriella Gobbi","ptype":"article","src":"https://openalex.org/W4200537269","eid":"W4200537269"},{"id":"paper-w784888165","cat":"papers","name":"Proceedings: The effect of lysergic acid diethylamide (LSD) on the vas deferens and anococcygeus muscle.","year":"1974","cit":2,"pfa":"J S Gillespie","psa":"John Christie McGrath","ptype":"article","src":"https://openalex.org/W784888165","eid":"W784888165"},{"id":"paper-w2072884046","cat":"papers","name":"Distortions of Vision and Pain: Two Functional Facets of D-Lysergic Acid Diethylamide","year":"1979","cit":2,"pfa":"John Michael Williams","ptype":"article","src":"https://openalex.org/W2072884046","eid":"W2072884046"},{"id":"paper-w2026452443","cat":"papers","name":"Morphologic alterations in the Purkinje neuron of the rat induced by lysergic acid diethylamide and fixation","year":"1983","cit":2,"pfa":"Walter J. Hendelman","psa":"R. Ferguson","ptype":"article","src":"https://openalex.org/W2026452443","eid":"W2026452443"},{"id":"paper-w2546362100","cat":"papers","name":"The serotonergic hallucinogen 5-MeO-DMT disrupts cortical activity in rodents","year":"2016","cit":2,"pfa":"Francesc Artigas","psa":"Pau Celada","ptype":"article","src":"https://openalex.org/W2546362100","eid":"W2546362100"},{"id":"paper-w2050970288","cat":"papers","name":"Lysergic Acid Diethylamide (Lsd 25) : XXXIX. The Effect of High Temperatures on Stability","year":"1970","cit":2,"pfa":"Henriette H. Gettner","psa":"Harold A. Abramson","ptype":"article","src":"https://openalex.org/W2050970288","eid":"W2050970288"},{"id":"paper-w2048241773","cat":"papers","name":"ANTAGONISM OF CENTRAL VASOMOTOR EFFECTS OF LYSERGIC ACID DIETHYLAMIDE (LSD-25) BY MORPHINE","year":"1968","cit":2,"pfa":"G.P. Gupta","psa":"Bhola Nath Dhawan","ptype":"article","src":"https://openalex.org/W2048241773","eid":"W2048241773"},{"id":"paper-w4411963639","cat":"papers","name":"Perceived Availability of Lysergic Acid Diethylamide in the United States from 2015 to 2019","year":"2025","cit":2,"pfa":"Brian Scott Barnett","psa":"Jeremy Weleff","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4411963639","eid":"W4411963639"},{"id":"paper-w4313201346","cat":"papers","name":"Adverse experiences resulting in emergency medical treatment seeking following the use of lysergic acid diethylamide","year":"2022","cit":2,"pfa":"Emma I Kopra","psa":"ADAM R. WINSTOCK","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4313201346","eid":"W4313201346"},{"id":"paper-w4225114100","cat":"papers","name":"Production and extraction of psilocybin and psilocin from Psilocybe spp. mushrooms","year":"2022","cit":2,"pfa":"Joana Fernandes","psa":"Ricardo Jorge Dinis‐Oliveira","ptype":"article","src":"https://openalex.org/W4225114100","eid":"W4225114100"},{"id":"paper-w2485759335","cat":"papers","name":"Mescaline abuse via peyote cactus: the first case report in Turkey","year":"2016","cit":2,"pfa":"Cengiz Cengisiz","psa":"Nebile Dağlıoğlu","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2485759335","eid":"W2485759335"},{"id":"paper-w2413819707","cat":"papers","name":"[TOLERANCE PHENOMENA NOTED DURING ALTERATION OF CONDITIONED REACTIONS BY NORADRENALIN, SEROTONIN AND LYSERGIC ACID DIETHYLAMIDE].","year":"1963","cit":2,"pfa":"Heinrich J. G. Matthies","psa":"W POHLE","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2413819707","eid":"W2413819707"},{"id":"paper-w7160535156","cat":"papers","name":"Neuroplastic white matter changes in patients with major depression following lysergic acid diethylamide treatment","year":"2026","cit":2,"pfa":"Mihai Avram","psa":"Stefan Borgwardt","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7160535156","eid":"W7160535156"},{"id":"paper-w4225128078","cat":"papers","name":"Evaluation of a quantitative analytical method for psilocin and psilocybin using HPLC-DAD","year":"2022","cit":2,"pfa":"Cesar Filho","psa":"Ricardo Jorge Dinis‐Oliveira","ptype":"article","src":"https://openalex.org/W4225128078","eid":"W4225128078"},{"id":"paper-w2058797284","cat":"papers","name":"Direct action of d-lysergic acid diethylamide on dispersed mucosal cells from guinea pig stomach","year":"1982","cit":2,"pfa":"Shmuel Batzri","psa":"Jean M. Dyer","ptype":"article","src":"https://openalex.org/W2058797284","eid":"W2058797284"},{"id":"paper-w2418127225","cat":"papers","name":"[First trials of psychopharmacological antagonism; experimental psychoses induced with d-lysergic acid diethylamide and treated with chlorpromazine and reserpine].","year":"2003","cit":2,"pfa":"Franco Giberti","psa":"L GREGORETTI","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2418127225","eid":"W2418127225"},{"id":"paper-w3198314838","cat":"papers","name":"A Single Administration of the Atypical Psychedelic Ibogaine or its Metabolite Noribogaine Induces an Antidepressant-like Effect in Rats","year":"2020","cit":2,"pfa":"Paola Rodríguez","psa":"Ignacio Carrera","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W3198314838","eid":"W3198314838"},{"id":"paper-w3182271154","cat":"papers","name":"Waiting for a Miracle: Medical Psilocybin and Mdma under 'Right to Try'","year":"2021","cit":2,"pfa":"Jacob Evans","ptype":"preprint","src":"https://openalex.org/W3182271154","eid":"W3182271154"},{"id":"paper-w4396896805","cat":"papers","name":"Structural characterization and comparative analysis of polymorphic forms of psilocin (4-hydroxy-N,N-dimethyltryptamine)","year":"2024","cit":2,"pfa":"Mat­thias Zeller","psa":"N. Schultheiss","ptype":"article","src":"https://openalex.org/W4396896805","eid":"W4396896805"},{"id":"paper-w2312713706","cat":"papers","name":"Lysergic Acid Diethylamide (LSD 25): XXXVI. Comparison of Effect of Methysergide (Uml 491) on Goldfish and Siamese Fighting Fish","year":"1965","cit":2,"pfa":"Henriette H. Gettner","psa":"Harold A. Abramson","ptype":"article","src":"https://openalex.org/W2312713706","eid":"W2312713706"},{"id":"paper-w7160017394","cat":"papers","name":"Prevalence and Reasons for Microdosing Cannabis, Psilocybin, LSD, and MDMA Among U.S. Adults","year":"2026","cit":2,"pfa":"Kevin H. Yang","psa":"Eric Craig Leas","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7160017394","eid":"W7160017394"},{"id":"paper-w2412001113","cat":"papers","name":"[On the effect of lysergic acid diethylamide and of guaiacol glycerine ether (\"neuroton\") on the behavior of Siamese fighting fish (Betta splendens Regan)].","year":"1959","cit":2,"pfa":"D. G. MUELLER","ptype":"article","src":"https://openalex.org/W2412001113","eid":"W2412001113"},{"id":"paper-w2059998797","cat":"papers","name":"Potentiation of (DL)‐3,4‐methylenedioxymethamphetamine (MDMA)‐induced toxicity by the serotonin 2A receptior partial agonist d‐lysergic acid diethylamide (LSD), and the protection of same by the serotonin 2A/2C receptor","year":"2004","cit":2,"pfa":"Brian D. Armstrong","psa":"Sherrel G. Howard","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2059998797","eid":"W2059998797"},{"id":"paper-w4390341471","cat":"papers","name":"Serotonergic psychedelic 5-MeO-DMT alters plasticity-related gene expression and generates anxiolytic effects in stressed mice","year":"2023","cit":2,"pfa":"Margareth Nogueira","psa":"Richardson Naves Leão","ptype":"preprint","src":"https://openalex.org/W4390341471","eid":"W4390341471"},{"id":"paper-w1979289978","cat":"papers","name":"Failure of the urethane antagonist—Lysergic acid-diethylamide (LSD-25)—To inhibit lung carcinogenesis or the initiating phase of skin carcinogenesis in mice","year":"1959","cit":2,"pfa":"Isaac Berenblum","psa":"Nathan Trainin","ptype":"article","src":"https://openalex.org/W1979289978","eid":"W1979289978"},{"id":"paper-w98884255","cat":"papers","name":"THE IBOGA ALKALOIDS","year":"1966","cit":2,"pfa":"W. I. Taylor","ptype":"book-chapter","src":"https://openalex.org/W98884255","eid":"W98884255"},{"id":"paper-w3186546456","cat":"papers","name":"Analysis of over-the-counter analgesics purported to contain mescaline from the peyote cactus (Lophophora williamsii: Cactaceae)","year":"2021","cit":2,"pfa":"Robert LeBlanc","psa":"Martin Terry","ptype":"article","src":"https://openalex.org/W3186546456","eid":"W3186546456"},{"id":"paper-w7160933471","cat":"papers","name":"Therapeutic properties of ayahuasca component N,N-Dimethyltryptamine in a pre-clinical model of Parkinson's disease","year":"2026","cit":2,"pfa":"Javier Calleja‐Conde","psa":"Jose Angel Morales-Garcia","ptype":"article","src":"https://openalex.org/W7160933471","eid":"W7160933471"},{"id":"paper-w4387597707","cat":"papers","name":"Structural analysis of an lysergic acid diethylamide (LSD) analogue N‐methyl‐N‐isopropyllysergamide (MiPLA): Insights from Rotamers in NMR spectra","year":"2023","cit":2,"pfa":"Takuji Shoda","psa":"Yosuke Demizu","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4387597707","eid":"W4387597707"},{"id":"paper-w4405802280","cat":"papers","name":"Dimethyltryptamine (DMT) and ibogaine elicit membrane effects in HEK cells transiently transfected with the human 5-HT2A receptor","year":"2024","cit":2,"pfa":"Jannik Nicklas Eliasen","psa":"Kristi A. Kohlmeier","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4405802280","eid":"W4405802280"},{"id":"paper-w2950142201","cat":"papers","name":"ChemInform Abstract: Improvements to the Synthesis of Psilocybin and a Facile Method for Preparing the O‐Acetyl Prodrug of Psilocin.","year":"1999","cit":2,"pfa":"David E. Nichols","psa":"Steward Frescas","ptype":"article","src":"https://openalex.org/W2950142201","eid":"W2950142201"},{"id":"paper-w127597547","cat":"papers","name":"Dimethyltryptamine (DMT) a Psychedelic","year":"2009","cit":2,"pfa":"Enno Christian Kurt Freye","ptype":"book-chapter","src":"https://openalex.org/W127597547","eid":"W127597547"},{"id":"paper-w2443480825","cat":"papers","name":"Tabernanthe iboga : a Comprehensive Review","year":"2009","cit":2,"pfa":"Chiara Gallo","psa":"Regina Elena","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W2443480825","eid":"W2443480825"},{"id":"paper-w4385397146","cat":"papers","name":"All-natural 5-MeO-DMT sigma receptor 1 agonist and its therapeutic impact in mental and neurodegener-ative diseases through mitochondrial activation","year":"2023","cit":2,"pfa":"Milena Batalla","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4385397146","eid":"W4385397146"},{"id":"paper-w4230626221","cat":"papers","name":"Psilocybin","year":"2007","cit":2,"pfa":"Zoe Clarke","ptype":"book-chapter","src":"https://openalex.org/W4230626221","eid":"W4230626221"},{"id":"paper-w2401090211","cat":"papers","name":"[MESCALINE AND CURARIZATION].","year":"1996","cit":2,"pfa":"J Cheymol","psa":"R Lebars","ptype":"article","src":"https://openalex.org/W2401090211","eid":"W2401090211"},{"id":"paper-w4386964191","cat":"papers","name":"Neuromodulatory mechanisms of N,N-dimethyltryptamine","year":"2023","cit":2,"pfa":"Javier Hidalgo Jiménez","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4386964191","eid":"W4386964191"},{"id":"paper-w3032991347","cat":"papers","name":"Peyote and the Indian","year":"1943","cit":2,"pfa":"D’Arcy McNickle","ptype":"article","src":"https://openalex.org/W3032991347","eid":"W3032991347"},{"id":"paper-w2949923880","cat":"papers","name":"Structure of ibogaine","year":"1992","cit":2,"pfa":"Manuel Soriano-García","ptype":"article","src":"https://openalex.org/W2949923880","eid":"W2949923880"},{"id":"paper-w2460154480","cat":"papers","name":"SUGGESTION AND MESCALINE SULPHATE.","year":"1964","cit":2,"pfa":"D J Levis","psa":"B Mahlman","ptype":"article","src":"https://openalex.org/W2460154480","eid":"W2460154480"},{"id":"paper-w1911347258","cat":"papers","name":"El controvertido peyote","year":"2008","cit":2,"pfa":"Mariana Rojas Aréchiga","ptype":"article","src":"https://openalex.org/W1911347258","eid":"W1911347258"},{"id":"paper-w4402375429","cat":"papers","name":"Peyote and the Mystic Vision","year":"2024","cit":2,"pfa":"Barbara G. Myerhoff","topics":["Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W4402375429","eid":"W4402375429"},{"id":"paper-w1965993892","cat":"papers","name":"Defining Peyote as a Narcotic","year":"1960","cit":2,"pfa":"Oliver La Farge","ptype":"article","src":"https://openalex.org/W1965993892","eid":"W1965993892"},{"id":"paper-w3090934610","cat":"papers","name":"Illusions and hallucinations of mescaline.","year":"1949","cit":2,"pfa":"Jean-Christian Delay","psa":"D Allaix","ptype":"article","src":"https://openalex.org/W3090934610","eid":"W3090934610"},{"id":"paper-w4400135924","cat":"papers","name":"Modification of a liquid chromatography‐tandem mass spectrometry (LC‐MS/MS) method targeting lysergic acid diethylamide ( LSD ) and its primary metabolite ( OH ‐ LSD ) to include nine LSD analogs","year":"2024","cit":2,"pfa":"Amy L Patton","psa":"J.M. González García","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4400135924","eid":"W4400135924"},{"id":"paper-w775431868","cat":"papers","name":"Metal Jewelry of the Peyote Cult","year":"1942","cit":2,"pfa":"Frederic H. Douglas","psa":"Alice Marriott","ptype":"article","src":"https://openalex.org/W775431868","eid":"W775431868"},{"id":"paper-w2025927532","cat":"papers","name":"Immunotoxicokinetic of MDMA in mice","year":"1999","cit":2,"pfa":"Roberta Pacifici","psa":"P. Zuccaro","ptype":"article","src":"https://openalex.org/W2025927532","eid":"W2025927532"},{"id":"paper-w3181834881","cat":"papers","name":"Peyote, Wine, and the First Amendment","year":"1989","cit":2,"pfa":"Douglas Laycock","ptype":"article","src":"https://openalex.org/W3181834881","eid":"W3181834881"},{"id":"paper-w2123618575","cat":"papers","name":"Salvinorin B methoxymethyl ether","year":"2012","cit":2,"pfa":"Thomas Anthony Munro","psa":"Bruce M. Cohen","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2123618575","eid":"W2123618575"},{"id":"paper-w4322496058","cat":"papers","name":"Ayahuasca Vision 2021","year":"2023","cit":2,"pfa":"Sean T. McAllister","topics":["Addiction","Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W4322496058","eid":"W4322496058"},{"id":"paper-w4249588684","cat":"papers","name":"Mushroom, Psilocybin","year":"2014","cit":2,"pfa":"T.R. Peredy","psa":"H. Bradford","ptype":"reference-entry","src":"https://openalex.org/W4249588684","eid":"W4249588684"},{"id":"paper-w4396588870","cat":"papers","name":"Psilocybin for depression","year":"2024","cit":2,"pfa":"Riccardo De Giorgi","psa":"Roger Ede","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4396588870","eid":"W4396588870"},{"id":"paper-w2313252373","cat":"papers","name":"MESCALINE AND THE PSYCHOLOGY OF OPTIC HALLUCINATIONS","year":"1913","cit":2,"pfa":"William James Maloney","psa":"Alwyn Knauer","ptype":"article","src":"https://openalex.org/W2313252373","eid":"W2313252373"},{"id":"paper-w4298159919","cat":"papers","name":"The Excretion of Dimethyltryptamine in Psychiatric Patients","year":"1976","cit":2,"pfa":"Robin M. Murray","psa":"M.C.H. Oon","ptype":"conference-abstract","src":"https://openalex.org/W4298159919","eid":"W4298159919"},{"id":"paper-w3089446948","cat":"papers","name":"Development of an improved psilocybin synthesis","year":"2020","cit":2,"pfa":"Reham Shaba","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"dissertation","src":"https://openalex.org/W3089446948","eid":"W3089446948"},{"id":"paper-w93235807","cat":"papers","name":"Detection and Identification of Ibogaine and Heroin","year":"1967","cit":2,"pfa":"Vincent T. Sullivan","psa":"Arnold Dihrberg","ptype":"article","src":"https://openalex.org/W93235807","eid":"W93235807"},{"id":"paper-w4238494227","cat":"papers","name":"MDMA (Methylenedioxymethamphetamine)","year":"2000","cit":2,"topics":["Reviews & meta-analyses"],"ptype":"book","src":"https://openalex.org/W4238494227","eid":"W4238494227"},{"id":"paper-w1953649429","cat":"papers","name":"Jurisprudence, Peyote and the Native American Church","year":"1986","cit":2,"pfa":"Paul E. Lawson","psa":"Jennifer Scholes","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1953649429","eid":"W1953649429"},{"id":"paper-w2245625630","cat":"papers","name":"Psychotropic effect of mescaline-like drugs.","year":"1967","cit":2,"pfa":"M Vojtĕchovský","psa":"Donald M. Krus","ptype":"article","src":"https://openalex.org/W2245625630","eid":"W2245625630"},{"id":"paper-w2416347606","cat":"papers","name":"Subcellular localization of mescaline at the synapse.","year":"1970","cit":2,"pfa":"Herman C.B. Denber","psa":"David N. Teller","ptype":"article","src":"https://openalex.org/W2416347606","eid":"W2416347606"},{"id":"paper-w2162426461","cat":"papers","name":"THE AYAHUASCA AND JAGÉ CULTS.","year":"1929","cit":2,"pfa":"Macdonald Critchley","ptype":"article","src":"https://openalex.org/W2162426461","eid":"W2162426461"},{"id":"paper-w2411672810","cat":"papers","name":"[Experimental intoxication by mescaline. 1948].","year":"2007","cit":2,"pfa":"Jean Delay","psa":"H. P. Gerard","ptype":"other","src":"https://openalex.org/W2411672810","eid":"W2411672810"},{"id":"paper-w2316310919","cat":"papers","name":"ARTIFICIAL PSYCHOSES PRODUCED BY MESCALINE","year":"1937","cit":2,"pfa":"E. Guttmann","ptype":"article","src":"https://openalex.org/W2316310919","eid":"W2316310919"},{"id":"paper-w4412479365","cat":"papers","name":"Rise of the Mushrooms: Effects of Psilocybin Reforms on Psychedelic Usage Patterns","year":"2025","cit":2,"pfa":"Ashutosh Bhave","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4412479365","eid":"W4412479365"},{"id":"paper-w4408109556","cat":"papers","name":"Psilocin fosters neuroplasticity in iPSC-derived human cortical neurons","year":"2025","cit":2,"pfa":"Målin Schmidt","psa":"Philipp Koch","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W4408109556","eid":"W4408109556"},{"id":"paper-w2433784497","cat":"papers","name":"Consistency in the Psychologic Reaction to Mescaline","year":"1961","cit":2,"pfa":"Thomas W. Richards","psa":"IAN P. STEVENSON","ptype":"article","src":"https://openalex.org/W2433784497","eid":"W2433784497"},{"id":"paper-w4405107436","cat":"papers","name":"Psilocin fosters neuroplasticity in iPSC-derived human cortical neurons","year":"2024","cit":2,"pfa":"Målin Schmidt","psa":"Philipp Koch","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4405107436","eid":"W4405107436"},{"id":"paper-w4214883937","cat":"papers","name":"Methylenedioxymethamphetamine (MDMA)","year":"2012","cit":2,"ptype":"reference-entry","src":"https://openalex.org/W4214883937","eid":"W4214883937"},{"id":"paper-w4392032236","cat":"papers","name":"Introduction— Peyote: Past, Present, and Future","year":"2016","cit":2,"pfa":"Beatriz Caiuby Labate","psa":"Alexander Dawson","ptype":"other","src":"https://openalex.org/W4392032236","eid":"W4392032236"},{"id":"paper-w1580244641","cat":"papers","name":"Conditions for the spread of the Peyote cult in North America","year":"1975","cit":2,"pfa":"Åke Hultkrantz","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1580244641","eid":"W1580244641"},{"id":"paper-w3208562946","cat":"papers","name":"Ayahuasca: Ruhların Sarmaşığı","year":"2021","cit":2,"pfa":"Nadide Şahin","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3208562946","eid":"W3208562946"},{"id":"paper-w7127681443","cat":"papers","name":"Acute psilocin increased cortical activity in rat","year":"2026","cit":2,"pfa":"Junhong Liu","psa":"Ruibin Su","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7127681443","eid":"W7127681443"},{"id":"paper-w108080335","cat":"papers","name":"The Mushroom Psilocybin with Psychedelic Properties","year":"2009","cit":2,"pfa":"Enno Christian Kurt Freye","ptype":"book-chapter","src":"https://openalex.org/W108080335","eid":"W108080335"},{"id":"paper-w4308256200","cat":"papers","name":"Psilocin – The “real deal” or an extraction byproduct","year":"2022","cit":2,"pfa":"Ori Gutman","psa":"Uriel Bretler","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4308256200","eid":"W4308256200"},{"id":"paper-w2531786949","cat":"papers","name":"Global ayahuasca: an entrepreneurial ecosystem","year":"2016","cit":2,"pfa":"Daniela M. Peluso","ptype":"book-chapter","src":"https://openalex.org/W2531786949","eid":"W2531786949"},{"id":"paper-w4322496220","cat":"papers","name":"The Landscapes of Ayahuasca in Contemporary France","year":"2023","cit":2,"pfa":"Clara Novaes","psa":"Jo Ann Cahn","ptype":"book-chapter","src":"https://openalex.org/W4322496220","eid":"W4322496220"},{"id":"paper-w4402832811","cat":"papers","name":"The effectiveness and value of midomafetamine-assisted psychotherapy for posttraumatic stress disorder","year":"2024","cit":2,"pfa":"Dmitriy Nikitin","psa":"Foluso Agboola","topics":["PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4402832811","eid":"W4402832811"},{"id":"paper-w1983480444","cat":"papers","name":"Mescaline-induced changes of brain-cortex ribosomes mescaline demethylase activity of brain-cortex soluble supernatant","year":"1977","cit":2,"pfa":"R. K. Datta","psa":"J. J. Ghosh","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1983480444","eid":"W1983480444"},{"id":"paper-w2062600657","cat":"papers","name":"Actions of Mescaline on Isolated Rat Atria","year":"1977","cit":2,"pfa":"Peter K. S. Siegl","psa":"Raymond F. Orzechowski","ptype":"article","src":"https://openalex.org/W2062600657","eid":"W2062600657"},{"id":"paper-w7155375380","cat":"papers","name":"Brain-body integromics of the ayahuasca experience","year":"2026","cit":2,"pfa":"Francisco Madrid-Gambín","psa":"Johannes Gerardus Ramaekers","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7155375380","eid":"W7155375380"},{"id":"paper-w1491441860","cat":"papers","name":"Methylenedioxymethamphetamine (Ecstasy, MDMA)","year":"2012","cit":2,"pfa":"Nicholas Allan Buckley","ptype":"other","src":"https://openalex.org/W1491441860","eid":"W1491441860"},{"id":"paper-w2059470409","cat":"papers","name":"A Clinical Crossroads for MDMA","year":"2005","cit":2,"pfa":"Casey R. Guillot","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2059470409","eid":"W2059470409"},{"id":"paper-w2594589325","cat":"papers","name":"Short term changes in the proteome of human cerebral organoids induced by 5-methoxy-N,N-dimethyltryptamine","year":"2017","cit":2,"pfa":"Vanja Dakic","psa":"Stevens Kastrup Rehen","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W2594589325","eid":"W2594589325"},{"id":"paper-w4409922403","cat":"papers","name":"Untargeted analysis of psilocybin and non-psilocybin mushrooms using liquid chromatography quadrupole time of flight mass spectrometry","year":"2025","cit":2,"pfa":"Sabrina Islam","psa":"Kevin A. Schug","ptype":"article","src":"https://openalex.org/W4409922403","eid":"W4409922403"},{"id":"paper-w2481961638","cat":"papers","name":"Peyote and Huichol Worldview: The Structure of a Mystic Vision","year":"1975","cit":2,"pfa":"Barbara G. Myerhoff","ptype":"book-chapter","src":"https://openalex.org/W2481961638","eid":"W2481961638"},{"id":"paper-w4385213680","cat":"papers","name":"Psilocybin for the treatment of anorexia nervosa","year":"2023","cit":2,"pfa":"Tomislav Majić","psa":"Stefan Ehrlich","ptype":"article","src":"https://openalex.org/W4385213680","eid":"W4385213680"},{"id":"paper-w4241015801","cat":"papers","name":"Rapid quantification of Psilocybin with reversed-phase HPLC and single-wavelength detection","year":"2021","cit":2,"pfa":"Alexzander Samuelsson","psa":"Markus Roggen","ptype":"preprint","src":"https://openalex.org/W4241015801","eid":"W4241015801"},{"id":"paper-w4284960488","cat":"papers","name":"A sacred plant of neuronal effect: the use of ibogaine in addiction treatments in Brazil","year":"2022","cit":2,"pfa":"Bruno Ramos Gomes","psa":"Luís Fernando Tófoli","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W4284960488","eid":"W4284960488"},{"id":"paper-w4388498988","cat":"papers","name":"Pharmacists’ perspectives on psilocybin in Canada","year":"2023","cit":2,"pfa":"Elizabeth Sugiarto","psa":"Jamie Yuen","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4388498988","eid":"W4388498988"},{"id":"paper-w4407157019","cat":"papers","name":"Psilocybin mushroom stewardship: A qualitative inquiry into practices and priorities of “underground” psilocybin mushroom practitioners","year":"2025","cit":2,"pfa":"Shannon Hughes","psa":"Dylan Rivard","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4407157019","eid":"W4407157019"},{"id":"paper-w4281664591","cat":"papers","name":"Unraveling the Mysteries of Mental Illness With Psilocybin","year":"2022","cit":2,"pfa":"Robert Sotille","psa":"Thomas Vida","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4281664591","eid":"W4281664591"},{"id":"paper-w4249849540","cat":"papers","name":"Effects of Psilocybin in Anorexia Nervosa","year":"2019","cit":2,"ptype":"article","src":"https://openalex.org/W4249849540","eid":"W4249849540"},{"id":"paper-w1039468090","cat":"papers","name":"Psilocin multiple intake resulted and in cardiotoxic effects","year":"2006","cit":2,"pfa":"Krzysztof S. Borowiak","psa":"Mirosław Parafiniuk","ptype":"article","src":"https://openalex.org/W1039468090","eid":"W1039468090"},{"id":"paper-w2409699506","cat":"papers","name":"Assays for MDMA and Its Metabolites","year":"2016","cit":2,"pfa":"Bardia Jamali","psa":"Mohammad Reza Rouini","ptype":"book-chapter","src":"https://openalex.org/W2409699506","eid":"W2409699506"},{"id":"paper-w4297493671","cat":"papers","name":"How MDMA resensitizes the brain","year":"2022","cit":2,"pfa":"Alla Katsnelson","ptype":"article","src":"https://openalex.org/W4297493671","eid":"W4297493671"},{"id":"paper-w2413267959","cat":"papers","name":"The role of mescaline and D-lysergic acid in psychiatric treatment.","year":"1966","cit":2,"pfa":"Sidney Malitz","ptype":"article","src":"https://openalex.org/W2413267959","eid":"W2413267959"},{"id":"paper-w4386686748","cat":"papers","name":"The Protective Role of Dimethyltryptamine against Ischemia-Reperfusion Injury","year":"2019","cit":2,"pfa":"Ede Frecska","psa":"Attila Jozsef Szabo","ptype":"other","src":"https://openalex.org/W4386686748","eid":"W4386686748"},{"id":"paper-w2419461447","cat":"papers","name":"[CLINICAL AND PSYCHOPATHOLOGICAL STUDY OF PSILOCYBIN].","year":"1964","cit":2,"pfa":"Reda Gc","psa":"E D AGOSTINO","ptype":"article","src":"https://openalex.org/W2419461447","eid":"W2419461447"},{"id":"paper-w4283785805","cat":"papers","name":"Electrical spiking of psilocybin fungi","year":"2022","cit":2,"pfa":"Antoni Gandía","psa":"Andrew Adamatzky","topics":["Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4283785805","eid":"W4283785805"},{"id":"paper-w201924748","cat":"papers","name":"Interaction of ibogaine analogs with the nicotinic acetylcholine receptor","year":"2008","cit":2,"pfa":"Krzysztof Jóźwiak","psa":"Hugo Arias","topics":["Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W201924748","eid":"W201924748"},{"id":"paper-w2404123845","cat":"papers","name":"[COMPARATIVE PHARMACODYNAMIC STUDY OF MESCALINE AND SEVERAL SYNTHETIC DERIVATIVES].","year":"1996","cit":2,"pfa":"O Blanpin","psa":"Jean Chopin","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2404123845","eid":"W2404123845"},{"id":"paper-w1978801492","cat":"papers","name":"EEG correlates of mescaline-induced pathological aggression in rats","year":"1981","cit":2,"pfa":"Ronald N. Shull","psa":"David A. Gorelick","ptype":"article","src":"https://openalex.org/W1978801492","eid":"W1978801492"},{"id":"paper-w4367313527","cat":"papers","name":"A route to potent, selective and biased salvinorin chemical space","year":"2023","cit":2,"pfa":"Sarah J. Hill","psa":"Ryan A. Shenvi","topics":["Addiction","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4367313527","eid":"W4367313527"},{"id":"paper-w2889008495","cat":"papers","name":"Use of Coconut Charcoal and Menthone-Thiosemicarbazone Polymer as Solid Phase Materials for the Determination of N,N-Dimethyltryptamine, Harmine, Harmaline, Harmalol, and Tetrahydroharmine in Ayahuasca Beverage by Liquid","year":"2018","cit":2,"pfa":"Sandro Navickiene","psa":"Alain Gaujac","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2889008495","eid":"W2889008495"},{"id":"paper-w4379983031","cat":"papers","name":"The treatment of abandonment anxiety with MDMA and LSD","year":"2023","cit":2,"pfa":"Mika Turkia","topics":["PTSD & trauma","Addiction","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W4379983031","eid":"W4379983031"},{"id":"paper-w1551525503","cat":"papers","name":"Pictographs, Patterns, and Peyote in the Lower Pecos Canyonlands of Texas","year":"2012","cit":2,"pfa":"Carolyn Boyd","topics":["Reviews & meta-analyses"],"ptype":"other","src":"https://openalex.org/W1551525503","eid":"W1551525503"},{"id":"paper-w2415182200","cat":"papers","name":"The effect of local mescaline application on learning and memory in rats.","year":"1991","cit":2,"pfa":"Marie Koupilová","psa":"V Hrdina","ptype":"article","src":"https://openalex.org/W2415182200","eid":"W2415182200"},{"id":"paper-w2410366853","cat":"papers","name":"Some properties of cortical dendrites as revealed by the effects of mescaline.","year":"1971","cit":2,"pfa":"J GARCIA RAMOS","ptype":"article","src":"https://openalex.org/W2410366853","eid":"W2410366853"},{"id":"paper-w2059002546","cat":"papers","name":"Inhibition of lectin stimulation of murine lymphocytes by mescaline","year":"1978","cit":2,"pfa":"Daniel L. Sissors","psa":"Edward W. Voss","ptype":"article","src":"https://openalex.org/W2059002546","eid":"W2059002546"},{"id":"paper-w4413509066","cat":"papers","name":"Reconsidering Ibogaine for the treatment of severe mental illness and substance use disorders","year":"2025","cit":2,"pfa":"R Andrew Yockey","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4413509066","eid":"W4413509066"},{"id":"paper-w1894962503","cat":"papers","name":"Adolescent MDMA exposure diminishes the physiological and neurotoxic consequences of an MDMA binge in female rats","year":"2013","cit":2,"pfa":"Brian J. Piper","psa":"Jerrold S. Meyer","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1894962503","eid":"W1894962503"},{"id":"paper-w2039832260","cat":"papers","name":"Peyote and the Yankton Sioux: The Life and Times of Sam Necklace","year":"2006","cit":2,"pfa":"Rani‐Henrik Andersson","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2039832260","eid":"W2039832260"},{"id":"paper-w3007437034","cat":"papers","name":"Introduction: the shifting journey of ayahuasca in diaspora","year":"2016","cit":2,"pfa":"CLANCY CAVNAR BEATRIZ CAIUBY LABATE","ptype":"book-chapter","src":"https://openalex.org/W3007437034","eid":"W3007437034"},{"id":"paper-w4417184087","cat":"papers","name":"Rare but relevant: MDMA and hyponatraemia","year":"2025","cit":2,"pfa":"Maria Rita Garcia","psa":"Diana Dias da Silva","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4417184087","eid":"W4417184087"},{"id":"paper-w156619612","cat":"papers","name":"3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)","year":"2009","cit":2,"pfa":"A.R. Green","psa":"M. Isabel Colado","ptype":"reference-entry","src":"https://openalex.org/W156619612","eid":"W156619612"},{"id":"paper-w4245835955","cat":"papers","name":"Peyote as medicine: An examination of therapeutic factors that contribute to healing","year":"2012","cit":2,"pfa":"Kevin Feeney","ptype":"dataset","src":"https://openalex.org/W4245835955","eid":"W4245835955"},{"id":"paper-w7157683682","cat":"papers","name":"Acute dose-dependent effects of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) compared with 3,4-methylenedioxymethamphetamine (MDMA) and psilocybin in a double-blind, placebo-controlled study in healthy participants","year":"2026","cit":2,"pfa":"Denis Arikci","psa":"Friederike Holze","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7157683682","eid":"W7157683682"},{"id":"paper-w4200397343","cat":"papers","name":"Examining attitudes to psilocybin: Should candidates for medical psilocybin be required to pass a contextual suitability test","year":"2021","cit":2,"pfa":"Mark Molumby","psa":"Suzanne Guérin","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4200397343","eid":"W4200397343"},{"id":"paper-w2019777571","cat":"papers","name":"Effect of ibogaine on the development of tolerance to the analgesic effect of morphine.","year":"1996","cit":2,"pfa":"Shepard Siegel","psa":"Linda A. Parker","ptype":"article","src":"https://openalex.org/W2019777571","eid":"W2019777571"},{"id":"paper-w2413924068","cat":"papers","name":"6-hydroxylated N,N-dimethyltryptamines and hallucinogenic potency.","year":"1969","cit":2,"pfa":"Edward T. Uyeno","ptype":"article","src":"https://openalex.org/W2413924068","eid":"W2413924068"},{"id":"paper-w2331273657","cat":"papers","name":"The Peyote Road: Religious Freedom and the Native American Church","year":"2013","cit":2,"pfa":"Mark A. Nicholas","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2331273657","eid":"W2331273657"},{"id":"paper-w4377233162","cat":"papers","name":"Neurobiological Correlates of Psilocybin Response in Depression","year":"2023","cit":2,"pfa":"Saleha Qasim","psa":"Mujeeb Uddin Shad","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4377233162","eid":"W4377233162"},{"id":"paper-w2518528442","cat":"papers","name":"Pharmacology of Ayahuasca: Clinical trials in healthy volunteers","year":"2011","cit":2,"pfa":"Jordi Riba","psa":"M. Barbanoj","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2518528442","eid":"W2518528442"},{"id":"paper-w2769255825","cat":"papers","name":"Potawatomi Mescalism and Its Relationship to the Diffusion of the Peyote Cult","year":"1962","cit":2,"pfa":"James H. Howard","ptype":"article","src":"https://openalex.org/W2769255825","eid":"W2769255825"},{"id":"paper-w4235995685","cat":"papers","name":"Psilocybin in Smoking Cessation: A Pilot Study","year":"2010","cit":2,"pfa":"Matthew W. Johnson","psa":"Roland R. Griffiths","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W4235995685","eid":"W4235995685"},{"id":"paper-w4386686242","cat":"papers","name":"Psilocybin Therapy for Major Depressive Disorder","year":"2019","cit":2,"pfa":"James Rucker","topics":["Depression"],"ptype":"other","src":"https://openalex.org/W4386686242","eid":"W4386686242"},{"id":"paper-w2085692192","cat":"papers","name":"A Case of MDMA Toxicity with Unusual Clinical and Neuroradiological Features 2CO1","year":"2014","cit":2,"pfa":"Ravi K. Narang","psa":"Bryan Carr","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2085692192","eid":"W2085692192"},{"id":"paper-w4399038841","cat":"papers","name":"Medical Uses and Adverse Effects of Psilocybin","year":"2024","cit":2,"pfa":"Sharmin Ghaznavi","psa":"Theodore A. Stern","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4399038841","eid":"W4399038841"},{"id":"paper-w3035553796","cat":"papers","name":"Ayahuasca – Religion, Life-style oder Droge?","year":"2020","cit":2,"pfa":"Peter Neu","topics":["Addiction","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3035553796","eid":"W3035553796"},{"id":"paper-w7129773189","cat":"papers","name":"Effects of LSD, DMT and psilocybin on cognitive and psychological functions: A systematic review of the literature","year":"2026","cit":2,"pfa":"Marten Kase","psa":"Jaan Aru","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7129773189","eid":"W7129773189"},{"id":"paper-w2331744545","cat":"papers","name":"Le problème du vrai et des faux Iboga.","year":"1940","cit":2,"pfa":"Raymond‐Hamet","ptype":"article","src":"https://openalex.org/W2331744545","eid":"W2331744545"},{"id":"paper-w4253355874","cat":"papers","name":"Psychosis induced by abuse of ayahuasca: a case report","year":"2021","cit":2,"pfa":"Raúl Felipe Palma-Álvarez","psa":"Carlos Roncero","ptype":"article","src":"https://openalex.org/W4253355874","eid":"W4253355874"},{"id":"paper-w7160664550","cat":"papers","name":"Registered Clinical Trials of Ayahuasca and DMT : A Scoping Review","year":"2026","cit":2,"pfa":"Tijana Stojanovic","psa":"Thiago C. Moulin","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7160664550","eid":"W7160664550"},{"id":"paper-w4386686498","cat":"papers","name":"Therapeutic Applications of 3,4-methylenedioxymethamphetamine (MDMA)","year":"2019","cit":2,"pfa":"Ben Sessa","ptype":"other","src":"https://openalex.org/W4386686498","eid":"W4386686498"},{"id":"paper-w2416307252","cat":"papers","name":"A bit on the Wilde side: MDMA abuse.","year":"1985","cit":2,"pfa":"Mack Rb","ptype":"article","src":"https://openalex.org/W2416307252","eid":"W2416307252"},{"id":"paper-w587145068","cat":"papers","name":"Neurobiological mechanisms of drugs of abuse : cocaine, ibogaine, and substituted amphetamines","year":"2000","cit":2,"pfa":"Syed F. Ali","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W587145068","eid":"W587145068"},{"id":"paper-w4303984784","cat":"papers","name":"\"SPIRITUAL AWAKENING” WITH IBOGAINE INSTEAD AWAKENS ACUTE LIVER INJURY AND RHABDOMYOLYSIS: A CASE REPORT","year":"2022","cit":2,"pfa":"RUDRA RAMANATHAN","psa":"DEEPAK R PRADHAN","ptype":"article","src":"https://openalex.org/W4303984784","eid":"W4303984784"},{"id":"paper-w2949610928","cat":"papers","name":"ChemInform Abstract: Salvinorin A Analogues as Probes in Opioid Pharmacology","year":"2008","cit":2,"pfa":"Thomas Edward Prisinzano","psa":"Richard B. Rothman","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2949610928","eid":"W2949610928"},{"id":"paper-w3001648164","cat":"papers","name":"Mike Jay, Mescaline: A Global History of the First Psychedelic","year":"2019","cit":2,"pfa":"Peder Clark","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3001648164","eid":"W3001648164"},{"id":"paper-w4406946828","cat":"papers","name":"Effects of Psilocybin on Mouse Brain Microstructure","year":"2025","cit":2,"pfa":"Paloma C. Frautschi","psa":"John‐Paul J. Yu","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4406946828","eid":"W4406946828"},{"id":"paper-w1980510564","cat":"papers","name":"Studies on Indole Alkaloid Biosynthesis IX. The Laer Stages of Iboga Alkaloid Biosynthesis","year":"1973","cit":2,"pfa":"James Peter Kutney","psa":"Nigel J. Eggers","ptype":"article","src":"https://openalex.org/W1980510564","eid":"W1980510564"},{"id":"paper-w4396663031","cat":"papers","name":"Suspension of Short‐lasting, Unilateral, Neuralgiform headache attacks with Conjunctival injection and Tearing (SUNCT) symptoms with ayahuasca and serotonergic psychedelics","year":"2024","cit":2,"pfa":"Jonathan A. Leighton","psa":"Brian E. McGeeney","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4396663031","eid":"W4396663031"},{"id":"paper-w4416466349","cat":"papers","name":"Psilocybin alters visual contextual computations","year":"2025","cit":2,"pfa":"Marco Aqil","psa":"Serge Olaf Dumoulin","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4416466349","eid":"W4416466349"},{"id":"paper-w2391446045","cat":"papers","name":"Entactogènes (MDMA) et soumission chimique","year":"2016","cit":2,"pfa":"Pascal Kintz","psa":"Jean Sébastien Raul","ptype":"article","src":"https://openalex.org/W2391446045","eid":"W2391446045"},{"id":"paper-w2800166462","cat":"papers","name":"The Legality of the Religious Use of Peyote by the Native American Church: A Commentary on the Free Exercise, Equal Protection, and Establishment Issues Raised by the Peyote Way Church of God Case","year":"1997","cit":2,"pfa":"J. T. Bannon","topics":["Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2800166462","eid":"W2800166462"},{"id":"paper-w4392032020","cat":"papers","name":"Protecting the Peyote for Future Generations: Building on a Legacy of Perseverance","year":"2016","cit":2,"pfa":"Bob Prue","ptype":"other","src":"https://openalex.org/W4392032020","eid":"W4392032020"},{"id":"paper-w4392081261","cat":"papers","name":"Peyote, Christianity, and Constitutional Law: Toward an Antisubordination Jurisprudence","year":"2016","cit":2,"pfa":"Varun Soni","ptype":"other","src":"https://openalex.org/W4392081261","eid":"W4392081261"},{"id":"paper-w2787492022","cat":"papers","name":"MDMA in Psychiatry: Past, Present, and Future","year":"2018","cit":2,"pfa":"Michael Cooper","psa":"Anna Kim","ptype":"article","src":"https://openalex.org/W2787492022","eid":"W2787492022"},{"id":"paper-w4251938867","cat":"papers","name":"Clinical and toxic effects of MDMA (\"Ecstasy\").","year":"2002","cit":2,"pfa":"Rafael A. Rivas-Vazquez","psa":"Lizbhet Delgado","ptype":"article","src":"https://openalex.org/W4251938867","eid":"W4251938867"},{"id":"paper-w2067807300","cat":"papers","name":"Ecstasy in the Emergency Department: MDMA Ingestion","year":"2008","cit":2,"pfa":"Karin Reuter‐Rice","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2067807300","eid":"W2067807300"},{"id":"paper-w2089799744","cat":"papers","name":"Le swing cosmique. Whitehead à la mescaline","year":"2009","cit":2,"pfa":"Frédéric Bisson","psa":"Les Éditions Chromatika","ptype":"article","src":"https://openalex.org/W2089799744","eid":"W2089799744"},{"id":"paper-w2145237175","cat":"papers","name":"Amphetamine, not MDMA, is associated with intracranial hemorrhage.","year":"1995","cit":2,"pfa":"G Galloway","psa":"Sydney Frederick","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W2145237175","eid":"W2145237175"},{"id":"paper-w4389078439","cat":"papers","name":"Mescaline, between Psychopathology and Phenomenology: Sartre and Experimentation in 1930s France","year":"2023","cit":2,"pfa":"Gautier Dassonneville","topics":["Depression"],"ptype":"book-chapter","src":"https://openalex.org/W4389078439","eid":"W4389078439"},{"id":"paper-w2421736727","cat":"papers","name":"Effect of single or repeated administration of chlorpromazine on the disappearance of mescaline in mouse.","year":"1973","cit":2,"pfa":"Shah Ns","psa":"Gibson Br","ptype":"article","src":"https://openalex.org/W2421736727","eid":"W2421736727"},{"id":"paper-w4395673343","cat":"papers","name":"The Potential Use of Dimethyltryptamine against Ischemia-reperfusion Injury of the Brain","year":"2024","cit":2,"pfa":"Kovacs Attila","psa":"Ede Frecska","topics":["Safety & adverse events","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4395673343","eid":"W4395673343"},{"id":"paper-w147256947","cat":"papers","name":"Éxtasis (MDMA): un abordaje comprehensivo","year":"1997","cit":2,"pfa":"Julio Bobes","psa":"Pedro de Lorenzo Fernández","ptype":"article","src":"https://openalex.org/W147256947","eid":"W147256947"},{"id":"paper-w7125209473","cat":"papers","name":"Rare but relevant: Ibogaine and cardiovascular complications—prolonged QT interval and ventricular arrhythmias","year":"2026","cit":2,"pfa":"Tibor M. Brunt","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7125209473","eid":"W7125209473"},{"id":"paper-w4409288174","cat":"papers","name":"In Vitro Psilocybin Synthesis by Co‐Immobilized Enzymes","year":"2025","cit":2,"pfa":"Tim Schäfer","psa":"Dirk Hoffmeister","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4409288174","eid":"W4409288174"},{"id":"paper-w2411395638","cat":"papers","name":"Pathologic laughter as manifestation of the psychotomimetic action of psilocybin.","year":"1965","cit":2,"pfa":"Brooke Hopkins Dubansky","psa":"M Vyhnánková","ptype":"article","src":"https://openalex.org/W2411395638","eid":"W2411395638"},{"id":"paper-w1970074052","cat":"papers","name":"The relevance of performing developmental toxicity studies about ayahuasca","year":"2010","cit":2,"pfa":"Carolina Dizioli Rodrigues de Oliveira","psa":"Maurı́cio Yonamine","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1970074052","eid":"W1970074052"},{"id":"paper-w1613913293","cat":"papers","name":"RITUAL DE AYAHUASCA, PATRIMONIO CULTURAL DEL PERÚ","year":"2014","cit":2,"pfa":"Rosa A. Giove Nakazawa","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1613913293","eid":"W1613913293"},{"id":"paper-w4362580850","cat":"papers","name":"Liquid light. Ayahuasca spirituality and the Santo Daime tradition","year":"2023","cit":2,"pfa":"Stefano Bigliardi","ptype":"book-review","src":"https://openalex.org/W4362580850","eid":"W4362580850"},{"id":"paper-w2438505389","cat":"papers","name":"[Clinical experiences with psilocybin (CY 39 Sandoz)].","year":"1961","cit":2,"pfa":"M. Sercl","psa":"O. Jaros","ptype":"article","src":"https://openalex.org/W2438505389","eid":"W2438505389"},{"id":"paper-w2795147221","cat":"papers","name":"La thérapeutique par la psychose induite (mescaline et chlorpromazine).","year":"1956","cit":2,"pfa":"J Postel","psa":"P Cossa","ptype":"article","src":"https://openalex.org/W2795147221","eid":"W2795147221"},{"id":"paper-w2422484095","cat":"papers","name":"Healing from the gods : ayahuasca and the curing of disease states","year":"2001","cit":2,"pfa":"Maggi Quinlan","ptype":"article","src":"https://openalex.org/W2422484095","eid":"W2422484095"},{"id":"paper-w2006451488","cat":"papers","name":"Mescaline action on “memory decay” and “problem solving” behavior in the rat","year":"1986","cit":2,"pfa":"Luigi Molinengo","psa":"Marco Orsetti","ptype":"article","src":"https://openalex.org/W2006451488","eid":"W2006451488"},{"id":"paper-w2802992105","cat":"papers","name":"Constitutional Law: Whitehorn v. State: Peyote and Religious Freedom in Oklahoma","year":"1977","cit":2,"pfa":"Robert Johnston","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2802992105","eid":"W2802992105"},{"id":"paper-w3023867606","cat":"papers","name":"Ayahuasca Therapies: The Making and Remaking of Traditional Healing in Peru","year":"2020","cit":2,"pfa":"Olivia Marcus","topics":["Therapy practice","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W3023867606","eid":"W3023867606"},{"id":"paper-w4320035163","cat":"papers","name":"The History, Legalization and Potentials of Psilocybin-Assisted Psychotherapy","year":"2023","cit":2,"pfa":"Jeffery Heilman","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4320035163","eid":"W4320035163"},{"id":"paper-w2405436942","cat":"papers","name":"[MDMA (\"ecstasy\"): a currently used drug in Spain].","year":"1991","cit":2,"pfa":"A Prat","psa":"P. Sánz","ptype":"article","src":"https://openalex.org/W2405436942","eid":"W2405436942"},{"id":"paper-w4298373857","cat":"papers","name":"Pipe, Bible and Peyote among the Oglala Lakota: A Study in Religious Identity","year":"1985","cit":2,"pfa":"Bruce David Forbes","psa":"Paul R. Steinmetz","ptype":"article","src":"https://openalex.org/W4298373857","eid":"W4298373857"},{"id":"paper-w2415134823","cat":"papers","name":"[Psychopathological effects of dimethyltryptamine; a further contribution on pharmacopsychiatry; preliminary report].","year":"1957","cit":2,"pfa":"O H ARNOLD","psa":"G Hofmann","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2415134823","eid":"W2415134823"},{"id":"paper-w4402902154","cat":"papers","name":"MDMA for treatment of PTSD and neurorehabilitation in military populations","year":"2024","cit":2,"pfa":"Walter Dunn","psa":"Eric H. G. J. M. Vermetten","topics":["PTSD & trauma","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4402902154","eid":"W4402902154"},{"id":"paper-w2414653862","cat":"papers","name":"[On the treatment of therapy-resistant neuroses with model psychoses (psilocybin)].","year":"1962","cit":2,"pfa":"Henri Lynn Heimann","ptype":"article","src":"https://openalex.org/W2414653862","eid":"W2414653862"},{"id":"paper-w4313399545","cat":"papers","name":"Methamphetamine and MDMA Neurotoxicity: Biochemical and Molecular Mechanisms","year":"2022","cit":2,"pfa":"Verónica Bisagno","psa":"Jean Lud Cadet","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W4313399545","eid":"W4313399545"},{"id":"paper-w4408806351","cat":"papers","name":"A UHPLC-(ESI)MS/MS method for the determination of the psychedelic secondary metabolite mescaline in San Pedro (Trichocereus spp.) and its applicability for screening mescaline in other cacti varieties.","year":"2025","cit":2,"pfa":"Pragna Gaur","psa":"Mitchell Low","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4408806351","eid":"W4408806351"},{"id":"paper-w2412838053","cat":"papers","name":"Responses to i.v. L-tryptophan in MDMA users.","year":"1989","cit":2,"pfa":"Lawrence H. Price","psa":"George R. Heninger","ptype":"article","src":"https://openalex.org/W2412838053","eid":"W2412838053"},{"id":"paper-w1971521059","cat":"papers","name":"Regional localization of [14C]mescaline in rabbit brain after intraventricular administration","year":"1977","cit":2,"pfa":"Nandkumar S. Shah","psa":"Vicki Kleinburd","ptype":"article","src":"https://openalex.org/W1971521059","eid":"W1971521059"},{"id":"paper-w181569804","cat":"papers","name":"Aspectos médico-legales del éxtasis (MDMA)","year":"1994","cit":2,"pfa":"Julio Bobes","psa":"Silvia García Herrero","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W181569804","eid":"W181569804"},{"id":"paper-w4406142619","cat":"papers","name":"Therapeutic potential of psilocybin: a promising agent in treating major depressive disorder","year":"2023","cit":2,"pfa":"Dragana Marković","psa":"Eleonora Čapelja","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4406142619","eid":"W4406142619"},{"id":"paper-w4285288435","cat":"papers","name":"Intersectional Identities, Stigma and MDMA/Ecstasy Use","year":"2022","cit":2,"pfa":"Karenza Moore","ptype":"book-chapter","src":"https://openalex.org/W4285288435","eid":"W4285288435"},{"id":"paper-w3091916591","cat":"papers","name":"Unveiling ayahuasca psychopharmacology: the accomplishments of Jordi Riba (1968-2020)","year":"2020","cit":2,"pfa":"RAFAEL GUIMARÃES DOS SANTOS","psa":"Jaime E. C. Hallak","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3091916591","eid":"W3091916591"},{"id":"paper-w4387589906","cat":"papers","name":"Ayahuasca ceremonies: set and setting features across Italy and Colombia","year":"2023","cit":2,"pfa":"Federica Ambrosini","psa":"Roberta Biolcati","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4387589906","eid":"W4387589906"},{"id":"paper-w2572466674","cat":"papers","name":"Psilocybin as an alternative medicine for patients suffering from depression","year":"2016","cit":2,"pfa":"Karolina Dydak","psa":"Halina Milnerowicz","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2572466674","eid":"W2572466674"},{"id":"paper-w4387867376","cat":"papers","name":"Pharmacological and behavioral effects of tryptamines present in psilocybin-containing mushrooms","year":"2023","cit":2,"pfa":"Ryan J. Rakoczy","psa":"Matthew Stephen McMurray","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4387867376","eid":"W4387867376"},{"id":"paper-w4246326434","cat":"papers","name":"Working with \"La Medicina\": Elements of healing in contemporary Ayahuasca rituals","year":"2010","cit":2,"pfa":"Evgenia Fotiou","ptype":"dataset","src":"https://openalex.org/W4246326434","eid":"W4246326434"},{"id":"paper-w3153395906","cat":"papers","name":"Beyond the Peyote Dance: The Raramuri Tribe and ‘Mexico’ Representations in Antonin Artaud’s Work","year":"2021","cit":2,"pfa":"Luciana da Costa Dias","ptype":"book-chapter","src":"https://openalex.org/W3153395906","eid":"W3153395906"},{"id":"paper-w2598077992","cat":"papers","name":"Does N,N-dimethyltryptamine (DMT) adequately explain near-death experiences?","year":"2012","cit":2,"pfa":"Michael Potts","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2598077992","eid":"W2598077992"},{"id":"paper-w4417507857","cat":"papers","name":"Neurochemical and Neurophysiological Effects of Intravenous Administration of N,N -Dimethyltryptamine in Rats","year":"2025","cit":2,"pfa":"Nicolas G. Glynos","psa":"Dinesh Pal","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4417507857","eid":"W4417507857"},{"id":"paper-w2913845158","cat":"papers","name":"The inhibitory effect of psilocybin and related compounds on human cholinesterases","year":"1961","cit":2,"pfa":"Elemér K. Zsigmond","psa":"V. M. Foldes","ptype":"article","src":"https://openalex.org/W2913845158","eid":"W2913845158"},{"id":"paper-w2809187294","cat":"papers","name":"O Potencial Terapêutico da Ayahuasca na Doença Mental","year":"2016","cit":2,"pfa":"Thábata Barros de Sá Teles","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2809187294","eid":"W2809187294"},{"id":"paper-w2900545389","cat":"papers","name":"The Utility of Psilocybin in Managing Anxiety and Depression in Cancer Patients","year":"2018","cit":2,"pfa":"Chu Hsien Lim","psa":"Jack Bergman","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2900545389","eid":"W2900545389"},{"id":"paper-w4400321155","cat":"papers","name":"The mitogenomic landscape of Banisteriopsis caapi (Malpighiaceae), the sacred liana used for ayahuasca preparation","year":"2024","cit":2,"pfa":"Edisson Chavarro‐Mesa","psa":"Alessandro M. Varani","ptype":"article","src":"https://openalex.org/W4400321155","eid":"W4400321155"},{"id":"paper-w2607510993","cat":"papers","name":"Effects of d amphetamine, monomethoxyamphetamines and mescaline on fixed interval responding in rats","year":"1975","cit":2,"pfa":"Diane Snell","psa":"Horace H. Loh","ptype":"article","src":"https://openalex.org/W2607510993","eid":"W2607510993"},{"id":"paper-w2625663774","cat":"papers","name":"Psilocybin‐assisted therapy for anxiety and depression: implications for euthanasia","year":"2017","cit":2,"pfa":"Nigel H. M. Strauss","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2625663774","eid":"W2625663774"},{"id":"paper-w4320040225","cat":"papers","name":"Examining associations between MDMA/ecstasy and classic psychedelic use and impairments in social functioning in a U.S. adult sample","year":"2023","cit":2,"pfa":"Grant M. Jones","psa":"Erica Wang","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4320040225","eid":"W4320040225"},{"id":"paper-w4413121359","cat":"papers","name":"The psychedelic renaissance: psilocybin, a breakthrough for treatment resistant depression?","year":"2025","cit":2,"pfa":"Trevor Ronald Norman","topics":["Depression","Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4413121359","eid":"W4413121359"},{"id":"paper-w2177544480","cat":"papers","name":"Acute effects of mescaline HCl on behavior, resistance, and endocrine function of male mice.","year":"1971","cit":2,"pfa":"Sackler Am","psa":"L Johnson","ptype":"article","src":"https://openalex.org/W2177544480","eid":"W2177544480"},{"id":"paper-w4253095534","cat":"papers","name":"Ethanol and MDMA: a comment on the paper by Izco et al.","year":"2007","cit":2,"pfa":"Byron C. Jones","psa":"Jean‐Christophe Cassel","ptype":"article","src":"https://openalex.org/W4253095534","eid":"W4253095534"},{"id":"paper-w3045692829","cat":"papers","name":"CytoSorb removes MDMA in vitro, but is it an effective therapy in vivo?","year":"2020","cit":2,"pfa":"Patrick M. Honoré","psa":"Thomas Datzmann","ptype":"article","src":"https://openalex.org/W3045692829","eid":"W3045692829"},{"id":"paper-w4408073069","cat":"papers","name":"Irremediable Psychiatric Suffering, a Potential Indication for Psilocybin Treatment","year":"2025","cit":2,"pfa":"Metten Somers","psa":"Floortje E. Scheepers","ptype":"article","src":"https://openalex.org/W4408073069","eid":"W4408073069"},{"id":"paper-w2806470868","cat":"papers","name":"Effects of lysergic acid di ethylamide and mescaline on the discrimination of flicker in the rat","year":"1970","cit":2,"pfa":"MS Schechter","psa":"Jerrold C. Winter","ptype":"article","src":"https://openalex.org/W2806470868","eid":"W2806470868"},{"id":"paper-w997472741","cat":"papers","name":"Mescaline and Phenothiazines: Recent Studies on Sub-cellular Localization and Effects upon Membranes","year":"1970","cit":2,"pfa":"David N. Teller","psa":"Herman C.B. Denber","ptype":"book-chapter","src":"https://openalex.org/W997472741","eid":"W997472741"},{"id":"paper-w2414798782","cat":"papers","name":"Peripheral tissue distribution, brain distribution and metabolism of mescaline- 14 C in monkeys.","year":"1973","cit":2,"pfa":"Taska Rj","psa":"Schoolar Jc","ptype":"article","src":"https://openalex.org/W2414798782","eid":"W2414798782"},{"id":"paper-w4230850854","cat":"papers","name":"10-step Synthesis of 20-nor-Salvinorin A by Dynamic Strategic Bond Analysis","year":"2017","cit":2,"pfa":"Jeremy J. Roach","psa":"Ryan A. Shenvi","topics":["Addiction","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4230850854","eid":"W4230850854"},{"id":"paper-w4291188592","cat":"papers","name":"Phenomenology and Content of the Inhaled N, N-Dimethyltryptamine (N, N-DMT) Experience","year":"2022","cit":2,"pfa":"David Wyndham Lawrence","psa":"Christopher B. Timmermann","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4291188592","eid":"W4291188592"},{"id":"paper-w4384661659","cat":"papers","name":"Psilocybin-assisted psychotherapy for cancer-related anxiety and depression","year":"2023","cit":2,"pfa":"Dan Yaniv","psa":"Moran Amit","topics":["Depression","Anxiety & end-of-life","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4384661659","eid":"W4384661659"},{"id":"paper-w2336992387","cat":"papers","name":"Evaluation of immunoassays for the determination of MDMA and cannabinoids in urine samples","year":"2020","cit":2,"pfa":"Ahai Chang Lua","psa":"Y.-T. Tseng","ptype":"article","src":"https://openalex.org/W2336992387","eid":"W2336992387"},{"id":"paper-w2082859199","cat":"papers","name":"Rebuttal to “Regarding ‘Cerebral Accident Following MDMA Ingestion’”","year":"2006","cit":2,"pfa":"Charles D. Muntan","ptype":"article","src":"https://openalex.org/W2082859199","eid":"W2082859199"},{"id":"paper-w4403366793","cat":"papers","name":"Characterization and Identification of an Antimicrobial Compound Psilocybin from Psychedelic Mushroom","year":"2024","cit":2,"pfa":"Balakrishnan Karthiyayini","psa":"Dhanasekaran Dharumadurai","ptype":"article","src":"https://openalex.org/W4403366793","eid":"W4403366793"},{"id":"paper-w2953087337","cat":"papers","name":"Highly Oxygenated Diterpenoids Associated to the Central Nervous System: Syntheses of Salvinorin and Forskolin","year":"2009","cit":2,"pfa":"Hisahiro Hagiwara","psa":"Masato Nozawa","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2953087337","eid":"W2953087337"},{"id":"paper-w224683584","cat":"papers","name":"Antagonism of Adenosine A 1 or A 2A Receptors Amplifies the Effects of MDMA on Glial Activation in the Mouse Brain: Relevance to Caffeine–MDMA Interactions","year":"2014","cit":2,"pfa":"Amit Khairnar","psa":"Nicola Simola","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W224683584","eid":"W224683584"},{"id":"paper-w4254863543","cat":"papers","name":"Second Thoughts on 3,4-Methylenedioxymethamphetamine (MDMA) Neurotoxicity-Reply","year":"1990","cit":2,"pfa":"Lawrence H. Price","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4254863543","eid":"W4254863543"},{"id":"paper-w4386864795","cat":"papers","name":"Self-perception and self-recognition while looking in the mirror on psilocybin","year":"2023","cit":2,"pfa":"Sam Elias","psa":"Julian Paul Keenan","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4386864795","eid":"W4386864795"},{"id":"paper-w4224300194","cat":"papers","name":"Behavioural effects of MDMA on Zebrafish Larvae: preliminary data","year":"2022","cit":2,"pfa":"Ana Rita Cruz","psa":"João Soares Carrola","ptype":"article","src":"https://openalex.org/W4224300194","eid":"W4224300194"},{"id":"paper-w4361000075","cat":"papers","name":"Heteroaromatic salvinorin A analogue (P-3 l) elicits antinociceptive and anxiolytic-like effects","year":"2023","cit":2,"pfa":"Caroline V. L. Moreira","psa":"James Oluwagbamigbe Fajemiroye","ptype":"article","src":"https://openalex.org/W4361000075","eid":"W4361000075"},{"id":"paper-w110034207","cat":"papers","name":"Éxtasis (MDMA): una droga para la controversia","year":"1998","cit":2,"pfa":"Gabriel Rubio Valladolid","psa":"Cecilio Álamo González","ptype":"article","src":"https://openalex.org/W110034207","eid":"W110034207"},{"id":"paper-w4403684873","cat":"papers","name":"Ayahuasca drinking using a two-bottle choice procedure in male mice","year":"2024","cit":2,"pfa":"Natali D. Kisaki","psa":"E.A.V. Marinho","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4403684873","eid":"W4403684873"},{"id":"paper-w4410371399","cat":"papers","name":"Psilocybin and Obsessive-Compulsive Disorder: Exploring New Therapeutic Horizons","year":"2025","cit":2,"pfa":"Longwei Yang","psa":"Xiaohui Wang","ptype":"article","src":"https://openalex.org/W4410371399","eid":"W4410371399"},{"id":"paper-w4403304874","cat":"papers","name":"A psilocybin haven: the use of comparison to legitimate transgression at a psychedelic retreat","year":"2024","cit":2,"pfa":"Jesper Dunell","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4403304874","eid":"W4403304874"},{"id":"paper-w4366251179","cat":"papers","name":"Intoxication Associated with Ayahuasca Consumption, Characterization, and Comparative Analysis of the Beverage's Components: A Case Report","year":"2023","cit":2,"pfa":"Edgar Antonio Estrella-Parra","psa":"Francisco Javier Alarcón-Aguilar","ptype":"article","src":"https://openalex.org/W4366251179","eid":"W4366251179"},{"id":"paper-w196937702","cat":"papers","name":"Studies on mescaline XVIII: effect of phenothiazines, amphetamine and amobarbital sodium on uptake into brain and viscera.","year":"1968","cit":2,"pfa":"Herman C.B. Denber","psa":"David N. Teller","ptype":"article","src":"https://openalex.org/W196937702","eid":"W196937702"},{"id":"paper-w2319702781","cat":"papers","name":"MDMA and the Loss of Reinforcement in Fantegrossi et al (2004)","year":"2004","cit":2,"pfa":"Andy C. Parrott","ptype":"article","src":"https://openalex.org/W2319702781","eid":"W2319702781"},{"id":"paper-w4401961518","cat":"papers","name":"Ayahuasca Tourism: Curating Authenticity in Transformative Times (Field Note)","year":"2024","cit":2,"pfa":"Brad Stoddard","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4401961518","eid":"W4401961518"},{"id":"paper-w2404518741","cat":"papers","name":"[The impact of psilocybin on visual perception and spatial orientation--neuropsychological approach].","year":"2014","cit":2,"pfa":"Mikolaj Jastrzebski","psa":"Aleksandra Bala","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2404518741","eid":"W2404518741"},{"id":"paper-w2147061947","cat":"papers","name":"Palladium‐Catalyzed Alkylation—Alkenylation Reactions: Rapid Access to Tricyclic Mescaline Analogues.","year":"2007","cit":2,"pfa":"Dino Alberico","psa":"Mark Lautens","ptype":"article","src":"https://openalex.org/W2147061947","eid":"W2147061947"},{"id":"paper-w2990706501","cat":"papers","name":"3 The religion of the forest: reflections on the international expansion of a Brazilian ayahuasca religion","year":"2016","cit":2,"pfa":"BEATRIZ CAIUBY LABATE AND GLAUBER LOURES DE ASSIS","ptype":"book-chapter","src":"https://openalex.org/W2990706501","eid":"W2990706501"},{"id":"paper-w4362604463","cat":"papers","name":"Psilocybin to promote synaptogenesis in the brains of patients with mild cognitive impairment","year":"2023","cit":2,"pfa":"Jianmeng Song","psa":"Philip Gerretsen","ptype":"article","src":"https://openalex.org/W4362604463","eid":"W4362604463"},{"id":"paper-w762670480","cat":"papers","name":"Towards a molecular approach for the identification of fungal taxa that contain psilocybin","year":"2001","cit":2,"pfa":"Lee Jc","ptype":"dissertation","src":"https://openalex.org/W762670480","eid":"W762670480"},{"id":"paper-w2318258968","cat":"papers","name":"Neuronal quantification in mice cerebral cortex under use of Ayahuasca tea","year":"2014","cit":2,"pfa":"Janille Santos Corrêa","psa":"Alessandra Esteves","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2318258968","eid":"W2318258968"},{"id":"paper-w2410541047","cat":"papers","name":"Different reaction of focal and diffuse epileptic EEG activity to psilocybin.","year":"1971","cit":2,"pfa":"J Kolarík","ptype":"article","src":"https://openalex.org/W2410541047","eid":"W2410541047"},{"id":"paper-w4313680598","cat":"papers","name":"Healing at death’s door: one patient’s mystical experience with psilocybin","year":"2023","cit":2,"pfa":"Houman Farzin","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4313680598","eid":"W4313680598"},{"id":"paper-w4389397300","cat":"papers","name":"Psilocybin in Bipolar II Study Provides Preliminary Data on Safety","year":"2023","cit":2,"pfa":"David B. Yaden","psa":"Sandeep Manel Nayak","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4389397300","eid":"W4389397300"},{"id":"paper-w4390005347","cat":"papers","name":"Unveiling the Psychedelic Journey: An Appraisal of Psilocybin as a Profound Antidepressant Therapy","year":"2023","cit":2,"pfa":"Fatima Iftikhar Shah","psa":"Sehrish Ashfaq","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4390005347","eid":"W4390005347"},{"id":"paper-w3168656991","cat":"papers","name":"Ontologías en desigualdad: coca, ayahuasca y la agencia histórica","year":"2016","cit":2,"pfa":"María Eugenia Flores","psa":"Ana Gretel Echazú Böschemeier","ptype":"article","src":"https://openalex.org/W3168656991","eid":"W3168656991"},{"id":"paper-w4381666654","cat":"papers","name":"Revisión bibliográfica de la ayahuasca y su uso terapéutico","year":"2020","cit":2,"pfa":"Edison Chávez Castillo","psa":"Jorge Zuquitana Godoyc","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4381666654","eid":"W4381666654"},{"id":"paper-w4316649823","cat":"papers","name":"Behavioral characterization of ayahuasca treatment on Wistar rats in the open field test","year":"2022","cit":2,"pfa":"Cid Pinheiro Farias","psa":"Hudson W. de Carvalho","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4316649823","eid":"W4316649823"},{"id":"paper-w7127568629","cat":"papers","name":"Moral Considerations and the Experience of Ego Dissolution: Insights from Psilocybin","year":"2025","cit":2,"pfa":"Azimjon Karimov","psa":"Dilshodbek Rasulov","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7127568629","eid":"W7127568629"},{"id":"paper-w1970943947","cat":"papers","name":"525. Synthesis of 3 : 4-dihydroxy-5-methoxyphenylacetic acid, a metabolite of mescaline in man","year":"1959","cit":2,"pfa":"John Harley-Mason","psa":"A.H. Laird","ptype":"article","src":"https://openalex.org/W1970943947","eid":"W1970943947"},{"id":"paper-w4389617510","cat":"papers","name":"Position of the Ceremony with the Psychedelic Drink Ayahuasca in the Society of the Amero-Indians of the Amazon","year":"2023","cit":2,"pfa":"Matea Stiperski Matoc","psa":"Tomica Hruška","topics":["Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W4389617510","eid":"W4389617510"},{"id":"paper-w1497658030","cat":"papers","name":"FENÓMENOS TRANSFERENCIALES EN LAS TOMAS RITUALES URBANAS DE AYAHUASCA","year":"2012","cit":2,"pfa":"Martha Isabel Córdoba","psa":"Juan Manuel Saa","ptype":"article","src":"https://openalex.org/W1497658030","eid":"W1497658030"},{"id":"paper-w2323265420","cat":"papers","name":"Longitudinal outcomes of MDMA (ecstasy)-exposed infants in the United Kingdom","year":"2013","cit":2,"pfa":"Lynn T. Singer","psa":"Andrew C. Parrott","ptype":"article","src":"https://openalex.org/W2323265420","eid":"W2323265420"},{"id":"paper-w3042388762","cat":"papers","name":"Ventral striatum regulates behavioral response to ethanol and MDMA combination","year":"2020","cit":2,"pfa":"Sami Ben Hamida","psa":"Jean‐Christophe Cassel","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3042388762","eid":"W3042388762"},{"id":"paper-w2594608604","cat":"papers","name":"Hepatic oxidative stress induced by methylone and MDPV: A comparison to MDMA","year":"2015","cit":2,"pfa":"Maria João Valente","psa":"Márcia C. Carvalho","ptype":"article","src":"https://openalex.org/W2594608604","eid":"W2594608604"},{"id":"paper-w3166466171","cat":"papers","name":"Demographic and health characteristics of 3,4-methylenedioxymethamphetamine users (MDMA, ecstasy)","year":"2021","cit":2,"pfa":"Gniewko Więckiewicz","psa":"Robert Pudło","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W3166466171","eid":"W3166466171"},{"id":"paper-w2165974397","cat":"papers","name":"Detection of Psilocybin Mushroom Analogs in Chocolate: Incorporating Current Events into the Undergraduate Teaching Laboratory","year":"2009","cit":2,"pfa":"Brandon Huskins","psa":"Christopher R. Dockery","ptype":"article","src":"https://openalex.org/W2165974397","eid":"W2165974397"},{"id":"paper-w2024938178","cat":"papers","name":"Studies on Accumulation of ( 14 C)-Mescaline in Brain Homogenates: Effects of Psychotropic and Other Agents","year":"2008","cit":2,"pfa":"Nandkumar S. Shah","psa":"O.D. Gulati","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2024938178","eid":"W2024938178"},{"id":"paper-w2066632082","cat":"papers","name":"RE: MDMA-Associated Cerebral Edema Resembling Psychogenic Polydipsia?","year":"2014","cit":2,"pfa":"Jack J. M. Ligtenberg","psa":"Jan C. ter Maaten","ptype":"letter","src":"https://openalex.org/W2066632082","eid":"W2066632082"},{"id":"paper-w4397030992","cat":"papers","name":"Time-Dependent Molecular Changes Following MDMA-Induced Nephrotoxicity","year":"2024","cit":2,"pfa":"Mehrdad Roghani","psa":"Saba Gilaki-Bisheh","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4397030992","eid":"W4397030992"},{"id":"paper-w4411734930","cat":"papers","name":"Risk management in a global market of alternative addiction care: a case study of the ibogaine medical subculture","year":"2025","cit":2,"pfa":"Johan Söderberg","psa":"Jakob Lundgren","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4411734930","eid":"W4411734930"},{"id":"paper-w4239569067","cat":"papers","name":"Estrogen effects on the hyperactivity induced by (+)-MDMA and cocaine in female rats.","year":"2003","cit":2,"pfa":"Wenxia Zhou","psa":"Mary L. Thomas","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4239569067","eid":"W4239569067"},{"id":"paper-w1554456229","cat":"papers","name":"Psychedelic bliss : memory and risk taking during MDMA intoxication","year":"2007","cit":2,"pfa":"Kim P. C. Kuypers","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W1554456229","eid":"W1554456229"},{"id":"paper-w2526432628","cat":"papers","name":"Working memory and executive deficits among MDMA (Ecstasy) users.","year":"2005","cit":2,"pfa":"M. Wareing","ptype":"dissertation","src":"https://openalex.org/W2526432628","eid":"W2526432628"},{"id":"paper-w4242522952","cat":"papers","name":"MDMA induced hyperthermia: report of a fatality and review of current therapy","year":"1996","cit":2,"pfa":"Khavar J. Dar","psa":"M. E. McBrien","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4242522952","eid":"W4242522952"},{"id":"paper-w4415045379","cat":"papers","name":"Differential effects of psilocybin and lisuride on serotonin and dopamine neuronal activity and behavior","year":"2025","cit":2,"pfa":"Brandon Richardson","psa":"Gabriella Gobbi","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4415045379","eid":"W4415045379"},{"id":"paper-w3081543645","cat":"papers","name":"Case Report: Resolution of Rheumatoid Arthritis in a Patient Consuming Psilocybin Mushrooms","year":"2020","cit":2,"pfa":"Lin Denise S","ptype":"article","src":"https://openalex.org/W3081543645","eid":"W3081543645"},{"id":"paper-w4403872098","cat":"papers","name":"Differentiation of Ayahuasca Samples According to Preparation Mode and Botanical Varieties Using Metabolomics","year":"2024","cit":2,"pfa":"Taynara Simão Matos","psa":"Alessandra Sussulini","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4403872098","eid":"W4403872098"},{"id":"paper-w7117732707","cat":"papers","name":"Psilocybin: clinical potential, mechanistic insights, and biotechnological advances for scalable production","year":"2025","cit":2,"pfa":"José Islas-Vargas","psa":"Oscar Arce-Cervantes","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7117732707","eid":"W7117732707"},{"id":"paper-w2105208324","cat":"papers","name":"A relationship between hexobarbitone sleeping time and susceptibility to mescaline in mice from different strains","year":"1975","cit":2,"pfa":"Ian E. Lush","ptype":"article","src":"https://openalex.org/W2105208324","eid":"W2105208324"},{"id":"paper-w2511696593","cat":"papers","name":"Ayahuasca healing: A qualitative study about fifteen european people handling their diseases","year":"2011","cit":2,"pfa":"Janine Tatjana Schmid","ptype":"article","src":"https://openalex.org/W2511696593","eid":"W2511696593"},{"id":"paper-w2053406869","cat":"papers","name":"Is MDMA Present in Hair Samples Consistent with Reported Ecstasy Use?","year":"2011","cit":2,"pfa":"Andrew B Scholey","ptype":"article","src":"https://openalex.org/W2053406869","eid":"W2053406869"},{"id":"paper-w4410591657","cat":"papers","name":"Age and cannabis co-use moderate experience and perceived benefits of psilocybin","year":"2025","cit":2,"pfa":"Jake Hooper","psa":"Kent E. Hutchison","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W4410591657","eid":"W4410591657"},{"id":"paper-w1985444184","cat":"papers","name":"5‐Hydroxytryptamine Antagonists and the 5‐Methoxy‐N,N‐dimethyltryptamine‐induced Changes of Postdecapitation Convulsions","year":"1987","cit":2,"pfa":"Trevor Archer","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1985444184","eid":"W1985444184"},{"id":"paper-w4214855816","cat":"papers","name":"Psilocybin induces spatially constrained alterations in thalamic functional organizaton and connectivity","year":"2022","cit":2,"pfa":"Andrew Gaddis","psa":"Frederick Streeter Barrett","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4214855816","eid":"W4214855816"},{"id":"paper-w7139105479","cat":"papers","name":"Psilocybin effects on brain functional connectivity: a systematic review of fMRI studies","year":"2026","cit":2,"pfa":"Àlvar Farré‐Colomés","psa":"Óscar Soto-Angona","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7139105479","eid":"W7139105479"},{"id":"paper-w2442462345","cat":"papers","name":"[THE EXPERIENCE OF ORAL REGRESSION DUE TO THE EFFECT OF HALLUCINOGENS (LSD-25 AND PSILOCYBIN)].","year":"1996","cit":2,"pfa":"A Fernandez-Cerdeno","psa":"H Leuner","ptype":"article","src":"https://openalex.org/W2442462345","eid":"W2442462345"},{"id":"paper-w4397047853","cat":"papers","name":"A Rare Case of Magic Mushroom (Psilocybin) Related AKI and Hypertensive Emergency","year":"2022","cit":2,"pfa":"Syed Rizwan A. Bokhari","psa":"Raquel M. Rosen","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W4397047853","eid":"W4397047853"},{"id":"paper-w4412810429","cat":"papers","name":"Psychedelic Treatment with Psilocybin: Addressing Medical Malpractice Risk and Physicians’ Concerns","year":"2025","cit":2,"pfa":"Katherine Cheung","psa":"for the P3A Study Group","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4412810429","eid":"W4412810429"},{"id":"paper-w4387460241","cat":"papers","name":"Examining risk and risk perception on LSD and MDMA in online marketplaces","year":"2023","cit":2,"pfa":"Maria Bada","psa":"Yi Ting Chua","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4387460241","eid":"W4387460241"},{"id":"paper-w7134166104","cat":"papers","name":"Psilocybin microdosing in the United States: Insights from a nationally representative survey","year":"2026","cit":2,"pfa":"Michelle Priest","psa":"Samer Atshan","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7134166104","eid":"W7134166104"},{"id":"paper-w4402543724","cat":"papers","name":"B - 61 Psilocybin as a First-Line Treatment of ADHD in Adult Populations","year":"2024","cit":2,"pfa":"James Perry","psa":"Julie H. Williams","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4402543724","eid":"W4402543724"},{"id":"paper-w2427722495","cat":"papers","name":"Studies on the mechanism of learning. II. On the ionic nature of the dendritic action potentials and mescaline spikes.","year":"1973","cit":2,"pfa":"J GARCIA RAMOS","psa":"Ibarra Bh","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2427722495","eid":"W2427722495"},{"id":"paper-w7135085070","cat":"papers","name":"State of the Science: MDMA‐assisted psychotherapy for the treatment of posttraumatic stress disorder","year":"2026","cit":2,"pfa":"Leslie A. Morland","psa":"Paula P. Schnurr","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7135085070","eid":"W7135085070"},{"id":"paper-w4389763815","cat":"papers","name":"Psychotropics: A scientific, regulatory, and public view on the medicinal uses of cannabinoids and psilocybin","year":"2023","cit":2,"pfa":"Ivana Turek","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4389763815","eid":"W4389763815"},{"id":"paper-w7143417129","cat":"papers","name":"Psychedelics in NHS services: exploring a model for real-world implementation of psilocybin","year":"2026","cit":2,"pfa":"Katharine Smith","psa":"Andrea Cipriani","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7143417129","eid":"W7143417129"},{"id":"paper-w2414540200","cat":"papers","name":"METABOLISM OF ADENOSINE TRIPHOSPHATE IN EPILEPTOGENIC FOCUS INDUCED BY TOPICAL APPLICATION OF MESCALINE TO CAT BRAIN CORTEX.","year":"1965","cit":2,"pfa":"I Dosseva","psa":"Svetoslav Dimov","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2414540200","eid":"W2414540200"},{"id":"paper-w4406667777","cat":"papers","name":"Overview and Specificity of Psilocybin Use in the Treatment of Mental Disorders: A Scientometric Analysis","year":"2025","cit":2,"pfa":"Maria Helha Fernandes-Nascimento","psa":"André Brooking Negrão","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4406667777","eid":"W4406667777"},{"id":"paper-w4402321753","cat":"papers","name":"New Territory: Ethical Challenges Associated With MDMA-Assisted Psychotherapy for PTSD","year":"2024","cit":2,"pfa":"G. Luke Hartstein","psa":"Sahit N. Menon","topics":["PTSD & trauma","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4402321753","eid":"W4402321753"},{"id":"paper-w4321015037","cat":"papers","name":"Assessment of the acute effects of 2C-B vs psilocybin on subjective experience, mood and cognition","year":"2023","cit":2,"pfa":"Pablo Mallaroni","psa":"Johannes Gerardus Ramaekers","topics":["Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4321015037","eid":"W4321015037"},{"id":"paper-w2410589318","cat":"papers","name":"Subarachnoid hemorrhage and death following coingestion of MDMA with other drugs.","year":"2004","cit":2,"pfa":"Min‐Po Ho","psa":"Yin-Kin Wong","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2410589318","eid":"W2410589318"},{"id":"paper-w2037087675","cat":"papers","name":"Regarding the case report “Cerebral Accident Following MDMA Ingestion”","year":"2006","cit":2,"pfa":"Michael C. Beuhler","ptype":"article","src":"https://openalex.org/W2037087675","eid":"W2037087675"},{"id":"paper-w4396599639","cat":"papers","name":"At the Forefront: Social Workers’ Role in Psilocybin Treatment for Depression and Substance Misuse","year":"2024","cit":2,"pfa":"Claire Parker","psa":"Bethany Marie Wood","topics":["Depression","Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4396599639","eid":"W4396599639"},{"id":"paper-w4408103852","cat":"papers","name":"Opinion Mining of Erowid’s Experience Reports on LSD and Psilocybin-Containing Mushrooms","year":"2025","cit":2,"pfa":"Ahmed Al-Imam","psa":"Michał Michalak","ptype":"article","src":"https://openalex.org/W4408103852","eid":"W4408103852"},{"id":"paper-w7148828949","cat":"papers","name":"Surface swabbing of nightclub venues to monitor the presence of cocaine, ketamine, and MDMA","year":"2026","cit":2,"pfa":"Joseph J. Palamar","psa":"Alex J. Krotulski","ptype":"article","src":"https://openalex.org/W7148828949","eid":"W7148828949"},{"id":"paper-w4310537515","cat":"papers","name":"Ayahuasca: significados entre la historia, la medicina y la cultura","year":"2022","cit":2,"pfa":"Ana María Flores Núñez","psa":"Henry César Rivas Sucari","ptype":"article","src":"https://openalex.org/W4310537515","eid":"W4310537515"},{"id":"paper-w2405518050","cat":"papers","name":"Commentary: Effects of psilocybin on time perception and temporal control of behavior in humans","year":"2016","cit":2,"pfa":"Katarina L. Shebloski","psa":"James M. Broadway","ptype":"editorial","src":"https://openalex.org/W2405518050","eid":"W2405518050"},{"id":"paper-w3144991243","cat":"papers","name":"Changes in aminoacidergic and monoaminergic neurotransmission in the hippocampus and amygdala of rats after ayahuasca ingestion","year":"2013","cit":2,"pfa":"Eduardo Eduardo","psa":"Naffah-Mazzacoratti","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3144991243","eid":"W3144991243"},{"id":"paper-w3028320050","cat":"papers","name":"Identification of a new M-ALPHA analog and MDMA in an illegal health product","year":"2020","cit":2,"pfa":"Ji Hyun Lee","psa":"Hoil Kang","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3028320050","eid":"W3028320050"},{"id":"paper-w4414194445","cat":"papers","name":"Meditation, psychedelics, and brain connectivity: A randomized controlled resting-state fMRI study of N,N -dimethyltryptamine and harmine in a meditation retreat","year":"2025","cit":2,"pfa":"Klemens Egger","psa":"Milan Scheidegger","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4414194445","eid":"W4414194445"},{"id":"paper-w4401333370","cat":"papers","name":"Revisiting The Potential Of \"Money Blinds\": Lessons From Lykos's MDMA Research","year":"2024","cit":2,"pfa":"Daniel Eisenkraft\n    Klein","psa":"Aaron S.\n    Kesselheim","ptype":"dataset","src":"https://openalex.org/W4401333370","eid":"W4401333370"},{"id":"paper-w4396991658","cat":"papers","name":"Psilocybin increases optimistic engagement over time: computational modelling of behavior in rats","year":"2024","cit":2,"pfa":"Elizabeth L. Fisher","psa":"Claire J. Foldi","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4396991658","eid":"W4396991658"},{"id":"paper-w7124418318","cat":"papers","name":"Bridging the reporting gap: Application of the ReSPCT guidelines in psilocybin clinical trial protocols","year":"2026","cit":2,"pfa":"Damian Świeczkowski","psa":"Wiesław Jerzy Cubała","ptype":"article","src":"https://openalex.org/W7124418318","eid":"W7124418318"},{"id":"paper-w4388460206","cat":"papers","name":"Psilocybin does not induce the vulnerability marker HSP70 in neurons susceptible to Olney’s lesions","year":"2023","cit":2,"pfa":"Ana-Maria Iorgu","psa":"Peter Gass","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4388460206","eid":"W4388460206"},{"id":"paper-w4379281082","cat":"papers","name":"Long term efficacy of psilocybin in patients with cancer and major depressive disorder (MDD).","year":"2023","cit":2,"pfa":"Manish Agrawal","psa":"Paul M. Thambi","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W4379281082","eid":"W4379281082"},{"id":"paper-w4412459077","cat":"papers","name":"Stronger visual surround suppression under psilocybin: A psychophysical and EEG pilot study","year":"2025","cit":2,"pfa":"Michael-Paul Schallmo","psa":"Link Ray Swanson","topics":["Depression","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4412459077","eid":"W4412459077"},{"id":"paper-w2085139429","cat":"papers","name":"Éxtasis (3,4-metilendioximetanfetamina, MDMA): aspectos farmacológicos, clínicos y criminológicos","year":"2004","cit":2,"pfa":"Francisco Javier Lopez-Munoz","psa":"Cecilio Álamo","ptype":"article","src":"https://openalex.org/W2085139429","eid":"W2085139429"},{"id":"paper-w2414029824","cat":"papers","name":"[The meaning of the use of ayahuasca among the Chama(Ese'ejja) natives of Eastern Bolivia: a transcultural study].","year":"1979","cit":2,"pfa":"Pagés Larraya F","ptype":"other","src":"https://openalex.org/W2414029824","eid":"W2414029824"},{"id":"paper-w2286948003","cat":"papers","name":"Effects of 3,4‐methylenedioxymethamphetamine (MDMA) and its metabolites on cardiovascular function in rats","year":"2012","cit":2,"pfa":"Charles W. Schindler","psa":"Steven R. Goldberg","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2286948003","eid":"W2286948003"},{"id":"paper-w2417388134","cat":"papers","name":"[Effects of Tabermanthe iboga H. Bn. alkaloids on the isolated organ responses to catecholamines and the role of calcium exchanges. Tabernanthine].","year":"1977","cit":2,"pfa":"G Valette","psa":"Leclair Mf","topics":["Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W2417388134","eid":"W2417388134"},{"id":"paper-w2041347476","cat":"papers","name":"Through the Gateway of the Heart: Accounts of Experiences with MDMA and Other Empathogenic Substances","year":"1987","cit":2,"pfa":"Richard B. Seymour","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2041347476","eid":"W2041347476"},{"id":"paper-w2884985338","cat":"papers","name":"Accusations of Peyote-Induced Hallucinations, Bigamy, and Witchcraft Presented to the Commissaries of the Inquisition in New Mexico1628-1632","year":"2018","cit":2,"pfa":"Jerry R Craddock","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2884985338","eid":"W2884985338"},{"id":"paper-w4405750840","cat":"papers","name":"Interest and limits of using pharmacogenetics in MDMA-related fatalities: A case report","year":"2024","cit":2,"pfa":"Guillaume Drevin","psa":"Chadi Abbara","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4405750840","eid":"W4405750840"},{"id":"paper-w1651014729","cat":"papers","name":"Ayahuasca Mamancuma merci beaucoup : internacionalização e diversificação do vegetalismo ayahuasqueiro peruano","year":"2011","cit":2,"pfa":"Beatriz Caiuby Labate","psa":"Mauro William Barbosa de Almeida","ptype":"dissertation","src":"https://openalex.org/W1651014729","eid":"W1651014729"},{"id":"paper-w2040542039","cat":"papers","name":"From ecstasy to agony: chronic effects of MDMA use on emotional processing","year":"2009","cit":2,"pfa":"TZ Ramsøy","psa":"Arnold Skimminge","ptype":"article","src":"https://openalex.org/W2040542039","eid":"W2040542039"},{"id":"paper-w7153732577","cat":"papers","name":"The astrocytes in the prefrontal cortex contribute to the rapid antidepressant-like effects of psilocybin in the chronic restraint stress mouse model","year":"2026","cit":2,"pfa":"Yong-Xing Qiao","psa":"Liming Zhang","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7153732577","eid":"W7153732577"},{"id":"paper-w2014956211","cat":"papers","name":"P20: MDMA and life-threatening complication: About of 2 unusual cases","year":"2014","cit":2,"pfa":"Hélène Geniaux","psa":"Mathiéu Molimard","ptype":"conference-abstract","src":"https://openalex.org/W2014956211","eid":"W2014956211"},{"id":"paper-w4417442090","cat":"papers","name":"Ayahuasca modulation of traumatic-like fear memories requires infralimbic cortex BDNF-dependent mechanisms in rats","year":"2025","cit":2,"pfa":"Isabel Werle","psa":"Leandro Jose Bertoglio","topics":["PTSD & trauma","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4417442090","eid":"W4417442090"},{"id":"paper-w75880954","cat":"papers","name":"Al trasluz de la ayahuasca: antropología cognitiva, oniromancia y consciencias alternativas","year":"1997","cit":2,"pfa":"Josep Maria Fericgla","ptype":"article","src":"https://openalex.org/W75880954","eid":"W75880954"},{"id":"paper-w2040836967","cat":"papers","name":"Identification of a possible role for atrial natiuretic peptide in MDMA-induced hyperthermia","year":"2011","cit":2,"pfa":"Sandra L. Hrometz","psa":"Jon E. Sprague","ptype":"article","src":"https://openalex.org/W2040836967","eid":"W2040836967"},{"id":"paper-w4382814055","cat":"papers","name":"MDMA-assisted psychotherapy for PTSD in adolescents – rationale, potential, risks, and considerations","year":"2023","cit":2,"pfa":"Samuli Kangaslampi","psa":"Josjan Zijlmans","topics":["PTSD & trauma","Safety & adverse events","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4382814055","eid":"W4382814055"},{"id":"paper-w4408456788","cat":"papers","name":"Therapeutic Potential of Psilocybin for Treating Neuropsychiatric Long COVID Symptoms: A Reddit Investigation","year":"2025","cit":2,"pfa":"Lukas Bobak","psa":"Brian Scott Barnett","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4408456788","eid":"W4408456788"},{"id":"paper-w2317427999","cat":"papers","name":"People of the Peyote: Huichol Indian History, Religion, and Survival. Stacy B. Schaefer , Peter T. Furst","year":"1998","cit":2,"pfa":"Paul Liffman","ptype":"book-review","src":"https://openalex.org/W2317427999","eid":"W2317427999"},{"id":"paper-w2192519573","cat":"papers","name":"Native American Drinking: Life Styles, Alcohol Use, Drunken Comportment, Problem Drinking, and the Peyote Religion","year":"2013","cit":2,"pfa":"Thomas W. Hill","topics":["Addiction"],"ptype":"book","src":"https://openalex.org/W2192519573","eid":"W2192519573"},{"id":"paper-w2342287995","cat":"papers","name":"Blocking of 5-methoxy-n-dimethyltryptamine-induced EEG alerting in the rabbit by previous administration of antiserum to this compound.","year":"1971","cit":2,"pfa":"Meir Strahilevitz","psa":"H E HIMWICH","ptype":"article","src":"https://openalex.org/W2342287995","eid":"W2342287995"},{"id":"paper-w7118088637","cat":"papers","name":"The effects of psilocybin on psychological distress in cancer patients: a systematic review and meta-analysis","year":"2026","cit":2,"pfa":"Reza Moshfeghinia","psa":"Mehdi Pasalar","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W7118088637","eid":"W7118088637"},{"id":"paper-w7128687864","cat":"papers","name":"Low-income group psilocybin assisted therapy for depression: An Oregon feasibility study","year":"2026","cit":2,"pfa":"Matthew Hicks","psa":"Heather L. Zwickey","topics":["Depression","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7128687864","eid":"W7128687864"},{"id":"paper-w3160286462","cat":"papers","name":"Assessment of environmental condition and drying process of the plants on the concentration of alkaloids and cytotoxicity of traditional Ayahuasca Tea","year":"2021","cit":2,"pfa":"Miranda Ordilena Ferreira de","psa":"Mary Ann Foglio","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3160286462","eid":"W3160286462"},{"id":"paper-w7207797910","cat":"papers","name":"Psilocybin prevents chemotherapy-induced peripheral neuropathy through mitochondrial trafficking preservation","year":"2026","cit":2,"pfa":"Mario Heles","psa":"Moran Amit","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7207797910","eid":"W7207797910"},{"id":"paper-w2979645192","cat":"papers","name":"Psilocybin based therapy for cancer related distress, a systematic review and meta analysis","year":"2019","cit":2,"pfa":"Camile Bahi","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"review","src":"https://openalex.org/W2979645192","eid":"W2979645192"},{"id":"paper-w1975217726","cat":"papers","name":"Ayahuasca: expansão de usos rituais e de formas de apreensão científica","year":"2003","cit":2,"pfa":"Edmundo Marcelo Mendes Pereira","ptype":"article","src":"https://openalex.org/W1975217726","eid":"W1975217726"},{"id":"paper-w4402476560","cat":"papers","name":"Psilocybin-Assisted Therapy for Brain Cancer Related Existential Distress: A Case-Report","year":"2024","cit":2,"pfa":"Jean-François Stephan","psa":"Sani Karam","topics":["Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4402476560","eid":"W4402476560"},{"id":"paper-w4386566280","cat":"papers","name":"Can a single dose of psilocybin improve cognitive control in functional dissociative seizures?","year":"2023","cit":2,"pfa":"Julien Chupin","psa":"Ismaël Conejero","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4386566280","eid":"W4386566280"},{"id":"paper-w1974575425","cat":"papers","name":"Measuring effects of MDMA (ecstasy) abuse on the rate of cerebral serotonin synthesis","year":"2014","cit":2,"pfa":"Paul D. Cumming","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1974575425","eid":"W1974575425"},{"id":"paper-w56501332","cat":"papers","name":"Multimodal Dynamic Multiple Access (MDMA) in Power Controlled Wireless Packet Networks.","year":"2001","cit":2,"pfa":"S. Kandukuri","psa":"Nicholas Bambos","ptype":"conference-paper","src":"https://openalex.org/W56501332","eid":"W56501332"},{"id":"paper-w7118124310","cat":"papers","name":"An open-label pilot study of psilocybin-assisted therapy for binge eating disorder","year":"2026","cit":2,"pfa":"Jesse Dallery","psa":"Beverlee Loeser","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7118124310","eid":"W7118124310"},{"id":"paper-w2914915254","cat":"papers","name":"Protective Effects of Thymoquinone on the MDMA-induced Cerebrospinal Fluid Serotonin Depletion in Rats","year":"2018","cit":2,"pfa":"Nor Suliana Mustafa","psa":"Nasir Mohamad","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2914915254","eid":"W2914915254"},{"id":"paper-w4417431364","cat":"papers","name":"Psilocybin in the real world: Regulatory, ethical, and operational challenges in Australia’s clinical landscape","year":"2025","cit":2,"pfa":"Megan Dutton","psa":"Adem Can","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4417431364","eid":"W4417431364"},{"id":"paper-w2181707613","cat":"papers","name":"What All Social Workers Should Know About MDMA (Ecstasy)","year":"2004","cit":2,"pfa":"Gardenia Harris","ptype":"article","src":"https://openalex.org/W2181707613","eid":"W2181707613"},{"id":"paper-w4239975527","cat":"papers","name":"Overall Teen Drug Use Stays Level, Use of MDMA and Steroids Increases","year":"2000","cit":2,"pfa":"Steven Stocker","ptype":"dataset","src":"https://openalex.org/W4239975527","eid":"W4239975527"},{"id":"paper-w7140135052","cat":"papers","name":"N,N-dimethyltryptamine elicits antidepressant and anxiolytic effects in helpless mice: a comparative study with S-ketamine","year":"2026","cit":2,"pfa":"Anne Nathalia de Sousa-Silva","psa":"Elaine Cristina Gavioli","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7140135052","eid":"W7140135052"},{"id":"paper-w2413151283","cat":"papers","name":"Studies on human cerebral function: the effects of mescaline and lysergic acid on cerebral processes pertinent to creative activity.","year":"2003","cit":2,"pfa":"L Berlin","psa":"Wolff Hg","ptype":"article","src":"https://openalex.org/W2413151283","eid":"W2413151283"},{"id":"paper-w4384570838","cat":"papers","name":"Unique biological and physiological properties of endogenous N, N-dimethyltryptamine from the perspective of functioning of the nervous system","year":"2023","cit":2,"pfa":"Jakub Schimmelpfennig","psa":"Kamila Jankowiak-Siuda","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4384570838","eid":"W4384570838"},{"id":"paper-w7134978111","cat":"papers","name":"Case Report: Amplified psychoanalysis? Psychoanalysis, OCD and MDMA in a clinical case study","year":"2026","cit":2,"pfa":"Filippo Dellanoce","topics":["PTSD & trauma","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7134978111","eid":"W7134978111"},{"id":"paper-w7140041737","cat":"papers","name":"Psilocybin-assisted therapy for major depressive disorder: Perspective from meta-analysis","year":"2026","cit":2,"pfa":"Taro Kishi","psa":"Nakao Iwata","topics":["Depression","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7140041737","eid":"W7140041737"},{"id":"paper-w4415905404","cat":"papers","name":"Divergent effects of ketamine and psilocybin on EEG power spectral density in a mismatch negativity paradigm","year":"2025","cit":2,"pfa":"Milad Soltanzadeh","psa":"Andreea Oliviana Diaconescu","ptype":"article","src":"https://openalex.org/W4415905404","eid":"W4415905404"},{"id":"paper-w4394676727","cat":"papers","name":"Treating Bipolar Depression Using Psilocybin—Validity Threats Regarding Efficacy and Safety","year":"2024","cit":2,"pfa":"Eiko I. Fried","psa":"Florian Naudet","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4394676727","eid":"W4394676727"},{"id":"paper-w2413490245","cat":"papers","name":"Effects of mescaline and its derivative N-[3,4,5-trimethoxyphenylethyl]-aziridine on the spatial orientation of rats in a T-maze.","year":"1989","cit":2,"pfa":"Marie Koupilová","psa":"Josef Herink","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2413490245","eid":"W2413490245"},{"id":"paper-w3082498591","cat":"papers","name":"Ayahuasca experiences for sale on the internet—systematic analysis of health information provided to travellers in commercial websites","year":"2020","cit":2,"pfa":"Chia-Chi A Fu","psa":"Miguel M. Cabada","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3082498591","eid":"W3082498591"},{"id":"paper-w2067273048","cat":"papers","name":"220. Subjective effects of MDMA and MCPP: a human dose run-up study","year":"2000","cit":2,"pfa":"Manuel E. Tancer","psa":"Chris Ellyn Johanson","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2067273048","eid":"W2067273048"},{"id":"paper-w1484345343","cat":"papers","name":"Entre el orden y la transgresión: el consumo ritual del peyote entre los coras","year":"2012","cit":2,"pfa":"María Benciolini","ptype":"article","src":"https://openalex.org/W1484345343","eid":"W1484345343"},{"id":"paper-w2611020076","cat":"papers","name":"Takiwasi: o uso da Ayahuasca no tratamento da adicção em uma comunidade terapêutica","year":"2016","cit":2,"pfa":"Gabriela Santos Ricciardi","ptype":"dissertation","src":"https://openalex.org/W2611020076","eid":"W2611020076"},{"id":"paper-w4402695637","cat":"papers","name":"Psilocybin ameliorates neuropathic pain-like behaviour in mice and facilitates the gabapentin-mediated analgesia","year":"2024","cit":2,"pfa":"Tatum Askey","psa":"Maria Maiarù","topics":["Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4402695637","eid":"W4402695637"},{"id":"paper-w4378952975","cat":"papers","name":"Exposure to 3,4-methylenedioxymethamphetamine (MDMA) induced biochemical but not behavioral effects in Daphnia magna","year":"2023","cit":2,"pfa":"Beatrice De Felice","psa":"Marco Parolini","ptype":"article","src":"https://openalex.org/W4378952975","eid":"W4378952975"},{"id":"paper-w2034845484","cat":"papers","name":"ChemInform Abstract: Salvinorin C, a New Neoclerodane Diterpene from a Bioactive Fraction of the Hallucinogenic Mexican Mint Salvia divinorum.","year":"2002","cit":2,"pfa":"Leander J. Valdés","psa":"Masato Koreeda","ptype":"article","src":"https://openalex.org/W2034845484","eid":"W2034845484"},{"id":"paper-w4403701845","cat":"papers","name":"The forgotten psychedelic: Spatiotemporal mapping of brain organisation following the administration of 2C-B and psilocybin","year":"2024","cit":2,"pfa":"Pablo Mallaroni","psa":"Johannes Gerardus Ramaekers","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4403701845","eid":"W4403701845"},{"id":"paper-w2146970728","cat":"papers","name":"ASSESSING MUTAGENICITY OF THE DRUG MDMA (ECSTASY) AVAILABLE IN IRAN USING AMES BIOASSAY","year":"2010","cit":2,"pfa":"Muhammad Nur Hariri","psa":"E Khajeamiri","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2146970728","eid":"W2146970728"},{"id":"paper-w4232058677","cat":"papers","name":"Erratum: Brain Serotonin Function in MDMA (Ecstasy) Users: Evidence for Persisting Neurotoxicity","year":"2013","cit":2,"pfa":"Margaret M. Benningfield","psa":"Ronald L. Cowan","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"erratum","src":"https://openalex.org/W4232058677","eid":"W4232058677"},{"id":"paper-w2117221245","cat":"papers","name":"Epistemologia da Ayahuasca e a Dissolução das Fronteiras Natureza/Cultura da Ciência Moderna","year":"2014","cit":2,"pfa":"Maria Betânia Barbosa Albuquerque","ptype":"article","src":"https://openalex.org/W2117221245","eid":"W2117221245"},{"id":"paper-w2739893356","cat":"papers","name":"Erratum to: MDMA-induced indifference to negative sounds is mediated by the 5-HT2A receptor","year":"2017","cit":2,"pfa":"Kim P. C. Kuypers","psa":"Johannes Gerardus Ramaekers","topics":["Mechanism & neuroscience"],"ptype":"erratum","src":"https://openalex.org/W2739893356","eid":"W2739893356"},{"id":"paper-w2054553779","cat":"papers","name":"Selective Neurocognitive Deficits Associated with Multiple Doses of Ecstasy/MDMA: A Reply to Cole","year":"2003","cit":2,"pfa":"Helen C Fox","psa":"Andrew C. Parrott","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2054553779","eid":"W2054553779"},{"id":"paper-w4396634501","cat":"papers","name":"EXPRESSION OF CONCERN: Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis","year":"2024","cit":2,"pfa":"British Medical Journal Publishing Group","topics":["Depression","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4396634501","eid":"W4396634501"},{"id":"paper-w4401058984","cat":"papers","name":"Embracing Change: Impermanence Acceptance Mediates Differences in Death Processing Between Ayahuasca Users and Non-users","year":"2024","cit":2,"pfa":"Jonathan david","psa":"Yair Dor‐Ziderman","topics":["Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4401058984","eid":"W4401058984"},{"id":"paper-w7118560421","cat":"papers","name":"The case for an integrative model: Hypotheses and rationale for integrative MDMA-Assisted Psychotherapy (IMAP)","year":"2026","cit":2,"pfa":"Rachel Yehuda","psa":"Lauren Lepow","topics":["PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7118560421","eid":"W7118560421"},{"id":"paper-w7117248788","cat":"papers","name":"Evolution and horizontal transfer of the psilocybin biosynthetic gene cluster drive the diversification of magic mushrooms","year":"2025","cit":2,"pfa":"Fei Liu","psa":"Rui-Lin Zhao","topics":["Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7117248788","eid":"W7117248788"},{"id":"paper-w4205375512","cat":"papers","name":"REAPROPIACIÓN SIMBÓLICA DE LA AYAHUASCA ENTRE PRÁCTICAS DE REPRESENTACIÓN Y PARTICIPACIÓN POLÍTICA","year":"2017","cit":2,"pfa":"Riccardo Badini","ptype":"book-chapter","src":"https://openalex.org/W4205375512","eid":"W4205375512"},{"id":"paper-w4410148514","cat":"papers","name":"Race/ethnicity moderates the associations between lifetime psilocybin use and opioid use disorder","year":"2025","cit":2,"pfa":"Grant M. Jones","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4410148514","eid":"W4410148514"},{"id":"paper-w4400572892","cat":"papers","name":"Psilocybin Therapy for Females With Anorexia Nervosa: A Phase 1, Open-Label Feasibility Study","year":"2024","cit":2,"pfa":"Stephanie Knatz Peck","psa":"Walter H. Kaye","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4400572892","eid":"W4400572892"},{"id":"paper-w4401862457","cat":"papers","name":"Selective Serotonin Reuptake Inhibitor Discontinuation for Psilocybin Treatment and Contributions to Alcohol Addiction Relapse","year":"2024","cit":2,"pfa":"Mark A. Frye","psa":"Tyler Oesterle","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4401862457","eid":"W4401862457"},{"id":"paper-w4412080495","cat":"papers","name":"Psilocybin has no immediate or persistent analgesic effect in acute and chronic mouse pain models","year":"2025","cit":2,"pfa":"Nicholas Gregory","psa":"Boris Dov Heifets","topics":["Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4412080495","eid":"W4412080495"},{"id":"paper-w2051361924","cat":"papers","name":"Drug interaction—Effect of chlorpromazine on the disposition of 8-14C-mescaline in fetal and maternal brain and liver in pregnant mouse","year":"1973","cit":2,"pfa":"Nandkumar S. Shah","psa":"A.E. NEELY","ptype":"article","src":"https://openalex.org/W2051361924","eid":"W2051361924"},{"id":"paper-w7126375504","cat":"papers","name":"Accelerated recovery using magnesium ibogaine: characterizing the subjective experience of its rapid healing from neuropsychiatric disorders","year":"2026","cit":2,"pfa":"Clayton Olash","psa":"Nolan Williams","topics":["PTSD & trauma","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7126375504","eid":"W7126375504"},{"id":"paper-w4306913732","cat":"papers","name":"Epistemic losses, cultural exclusions, and the risk of biopiracy in the globalization of ayahuasca: A reply to Labate et al.","year":"2022","cit":2,"pfa":"Eduardo Ekman Schenberg","psa":"Konstantin Gerber","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4306913732","eid":"W4306913732"},{"id":"paper-w4415537424","cat":"papers","name":"MDMA-Assisted Psychotherapy for PTSD: Evidence Synthesis and Methodological Challenges in a Rapidly Evolving Field","year":"2025","cit":2,"pfa":"Marija Franka Žuljević","psa":"Tina Poklepović Peričić","topics":["PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4415537424","eid":"W4415537424"},{"id":"paper-w4362733849","cat":"papers","name":"347. Changes in Resting State Functional Connectivity After Psilocybin for Body Dysmorphic Disorder","year":"2023","cit":2,"pfa":"Xi Zhu","psa":"Franklin R. Schneier","ptype":"article","src":"https://openalex.org/W4362733849","eid":"W4362733849"},{"id":"paper-w571049766","cat":"papers","name":"Land, Nahrung und Peyote : soziale Identität von Rarámuri und Mestizen nahe der Grenze USA-Mexiko","year":"2007","cit":2,"pfa":"Ingrid Kümmels","ptype":"dissertation","src":"https://openalex.org/W571049766","eid":"W571049766"},{"id":"paper-w2034808337","cat":"papers","name":"Is Ecstasy (MDMA) Use Associated with Symptoms of Anxiety or Depression Among Incarcerated Juvenile Offenders?","year":"2005","cit":2,"pfa":"Michael G. Vaughn","psa":"Mary P. Curtis","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2034808337","eid":"W2034808337"},{"id":"paper-w4283379213","cat":"papers","name":"Participation in an indigenous Amazonian led ayahuasca retreat associated with increases in nature relatedness – a pilot study","year":"2022","cit":2,"pfa":"Simon Ruffell","psa":"Jack Hollingdale","topics":["Depression","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W4283379213","eid":"W4283379213"},{"id":"paper-w2416875999","cat":"papers","name":"Correlation between bioelectric activity and adenosine-5'-triphosphate metabolism in cat brain mescaline induced epileptogenic focus.","year":"1966","cit":2,"pfa":"I Dosseva","psa":"Svetoslav Dimov","ptype":"article","src":"https://openalex.org/W2416875999","eid":"W2416875999"},{"id":"paper-w4406988749","cat":"papers","name":"A case series of ibogaine toxicity reported to the United Kingdom National Poisons Information Service (NPIS) over a 10-year period","year":"2025","cit":2,"pfa":"Ella P. Edwards","psa":"James Coulson","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4406988749","eid":"W4406988749"},{"id":"paper-w25897653","cat":"papers","name":"Distribution of 3,4-Methylenedioxymethamphetamine (MDMA) in non conventional matrices and its applications in clinical toxicology","year":"2005","cit":2,"pfa":"Simona Pichini","topics":["Safety & adverse events","Dosing & pharmacology","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W25897653","eid":"W25897653"},{"id":"paper-w2148806776","cat":"papers","name":"LABATE, Beatriz Caiuby e ARAÚJO, Wladimyr Sena. 2002. O Uso Ritual da Ayahuasca","year":"2003","cit":2,"pfa":"Marcelo Simão Mercante","ptype":"article","src":"https://openalex.org/W2148806776","eid":"W2148806776"},{"id":"paper-w1992914587","cat":"papers","name":"Decreased serotonin-2A binding in MDMA and hallucinogen users: An [18F]altanserin PET study","year":"2008","cit":2,"pfa":"David Erritzøe","psa":"Gitte M. Knudsen","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1992914587","eid":"W1992914587"},{"id":"paper-w3214576207","cat":"papers","name":"Severe epileptic seizures after accidental MDMA exposure in a 14-month-old child","year":"2021","cit":2,"pfa":"Daan W. Huntjens","psa":"Eric J. F. Franssen","ptype":"article","src":"https://openalex.org/W3214576207","eid":"W3214576207"},{"id":"paper-w4413344940","cat":"papers","name":"Psilocybin treatment for symptoms of depression: a living systematic review, meta-analysis, and data resource","year":"2025","cit":2,"pfa":"S. Parker Singleton","psa":"Theodore Daniel Satterthwaite","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4413344940","eid":"W4413344940"},{"id":"paper-w2950394230","cat":"papers","name":"Multivisceral Failure in a Context of Serotonin Syndrome Induced by MDMA: The Investigation of a Unique and Nationwide Network","year":"2019","cit":2,"pfa":"Élise Humeau","psa":"Redwan Maatoug","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2950394230","eid":"W2950394230"},{"id":"paper-w2201483667","cat":"papers","name":"Stellenwert und Funktion von Ayahuasca: Ein Vergleich der Anwendungen durch Schamanen und Kirchen","year":"2015","cit":2,"pfa":"Sylvia Linhart","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2201483667","eid":"W2201483667"},{"id":"paper-w4256001993","cat":"papers","name":"EFFECT OF ZOTEPINE ON HEAD-TWITCH INDUCED BY L-5-HYDROXYTRYPTOPHAN, MESCALINE AND 2,5-DIMETHOXY-4-METHYLAMPHETAMINE IN MICE AND RATS","year":"1983","cit":2,"pfa":"Tsuneyuki Yamamoto","psa":"Jo Mori","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4256001993","eid":"W4256001993"},{"id":"paper-w2730186353","cat":"papers","name":"O uso de ayahuasca em um contexto religioso por ex-dependentes de alcool","year":"1998","cit":2,"pfa":"Eliseu Labigalini","ptype":"article","src":"https://openalex.org/W2730186353","eid":"W2730186353"},{"id":"paper-w3206850014","cat":"papers","name":"O Uso da Ayahuasca como terapia alternativa na depressão: efeitos farmacológicos e adversos","year":"2021","cit":2,"pfa":"Beatriz Souza Silva","psa":"Alyne Alexandrino Antunes","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3206850014","eid":"W3206850014"},{"id":"paper-w4383900179","cat":"papers","name":"Synthesis of R- and S-MDMA via nucleophilic ring-opening of homochiral N-tosylaziridines","year":"2023","cit":2,"pfa":"Katie D. Lewis","psa":"Matthew Piggott","ptype":"article","src":"https://openalex.org/W4383900179","eid":"W4383900179"},{"id":"paper-w4411009513","cat":"papers","name":"MDMA-Assisted Acceptance and Commitment Therapy for Posttraumatic Stress Disorder: Rationale for a New Approach","year":"2025","cit":2,"pfa":"Matthew Scott Herbert","psa":"Josh D. Woolley","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4411009513","eid":"W4411009513"},{"id":"paper-w4411534125","cat":"papers","name":"The effects of psilocybin therapy versus escitalopram on cognitive bias: A secondary analysis of a randomized controlled trial","year":"2025","cit":2,"pfa":"Jessica S. Henry","psa":"Taylor Lyons","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4411534125","eid":"W4411534125"},{"id":"paper-w4406273313","cat":"papers","name":"Theoretical Description for Psilocin and Coprine Electrochemical Determination in Mushroom Pulp and Biological Liquids over Cobalt (II) Oxyhydroxide-Modified Electrode","year":"2024","cit":2,"ptype":"article","src":"https://openalex.org/W4406273313","eid":"W4406273313"},{"id":"paper-w3209570117","cat":"papers","name":"Preclinical Behavioral Assessment of Chronic, Intermittent Low-Dose Psilocybin in Rodent Models of Depression and Anxiety","year":"2021","cit":2,"pfa":"Harmony I. Risca","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3209570117","eid":"W3209570117"},{"id":"paper-w4411009450","cat":"papers","name":"The effect of MDMA on anterior pituitary hormones: a secondary analysis of a randomized placebo-controlled trial","year":"2025","cit":2,"pfa":"Cihan Atila","psa":"Mirjam Christ‐Crain","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4411009450","eid":"W4411009450"},{"id":"paper-w2577025601","cat":"papers","name":"LIMITAÇÕES ENTRE O RELIGIOSO E O PÚBLICO: O USO POLÍTICO-RELIGIOSO DA AYAHUASCA","year":"2016","cit":2,"pfa":"Laionel Vieira da Silva","psa":"Bruno Rafael Silva Nogueira Barbosa","ptype":"article","src":"https://openalex.org/W2577025601","eid":"W2577025601"},{"id":"paper-w4410841592","cat":"papers","name":"Clinical treatment of cluster headache with the serotonergic indoleamine psychedelics psilocybin and LSD and with ketamine: A case series","year":"2025","cit":2,"pfa":"Jonathan A. Leighton","psa":"Livia Granata","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4410841592","eid":"W4410841592"},{"id":"paper-w7127273528","cat":"papers","name":"Computational Analysis of Psilocybin Effects on Three-Choice Touchscreen Reversal Learning in Rats: A Pilot Study","year":"2026","cit":2,"pfa":"Anton T Gregersen","psa":"Mikael Palner","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W7127273528","eid":"W7127273528"},{"id":"paper-w3217192781","cat":"papers","name":"Ex Vivo Effect of Ibogaine on the Transcriptional Level of Antioxidant Defense Related Genes in Honey Bee (Apis mellifera, L.) Midgut","year":"2021","cit":2,"pfa":"Elvira L. Vukašinović","psa":"Duško P. Blagojević","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3217192781","eid":"W3217192781"},{"id":"paper-w4408765639","cat":"papers","name":"The effects of psilocybin therapy versus escitalopram on cognitive bias: A secondary analysis of a randomized controlled trial","year":"2025","cit":2,"pfa":"Jessica S. Henry","psa":"Taylor Lyons","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4408765639","eid":"W4408765639"},{"id":"paper-w4415408355","cat":"papers","name":"Memory deficits of MDMA users are linked to cortical thinning related to 5-HT receptor densities","year":"2025","cit":2,"pfa":"Rebecca C. Coray","psa":"Boris B. Quednow","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4415408355","eid":"W4415408355"},{"id":"paper-w7138831903","cat":"papers","name":"Cost-Effectiveness of Psilocybin-Assisted Therapy Versus Standard of Care for Patients With Treatment-Resistant Depression","year":"2026","cit":2,"pfa":"Yosr Ziadi","psa":"Taehwan Park","topics":["Depression","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7138831903","eid":"W7138831903"},{"id":"paper-w3007749511","cat":"papers","name":"Quantificação neuronal no córtex cerebral de camundongos sob o uso do chá de Ayahuasca","year":"2014","cit":2,"pfa":"Janille Santos Corrêa","psa":"Alessandra Esteves","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3007749511","eid":"W3007749511"},{"id":"paper-w3121448993","cat":"papers","name":"Evaluation of sibutramine, its active metabolites and dexfenfluramine in the MDMA-cued drug discrimination test","year":"1998","cit":2,"pfa":"Jane Gosden","psa":"David J. Heal","ptype":"article","src":"https://openalex.org/W3121448993","eid":"W3121448993"},{"id":"paper-w1567860248","cat":"papers","name":"Búsqueda de sensaciones, consumo de alcohol y de éxtasis (MDMA) en adolescentes","year":"2003","cit":2,"pfa":"José Luis González","psa":"Mónica Ramiro Herredor","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1567860248","eid":"W1567860248"},{"id":"paper-w7117472051","cat":"papers","name":"Adverse events associated with classic psychedelics and MDMA: a real-world population-based study using the WHO pharmacovigilance database (VigiBase)","year":"2025","cit":2,"pfa":"Omer A. Syed","psa":"Peter Giacobbe","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7117472051","eid":"W7117472051"},{"id":"paper-w2520679875","cat":"papers","name":"A Case of 3,4-Dimethoxyamphetamine (3,4-DMA) and 3,4-Methylenedioxymethamphetamine (MDMA) Toxicity with Possible Metabolic Interaction","year":"2016","cit":2,"pfa":"Michael A. Darracq","psa":"Roy R. L. Gerona","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2520679875","eid":"W2520679875"},{"id":"paper-w4200369167","cat":"papers","name":"A Quantitative and Qualitative Report of Psilocybin Induced Mystical-Type Experiences and Their Relation to Lasting Positive Effects","year":"2021","cit":2,"pfa":"Drummond E-Wen McCulloch","psa":"Dea Siggaard Stenbæk","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4200369167","eid":"W4200369167"},{"id":"paper-w7125792237","cat":"papers","name":"Effects of psilocybin on personality, psychiatric symptoms, and values: Exploring mediating effects of the acute psychedelic experience","year":"2026","cit":2,"pfa":"Jess Kerr‐Gaffney","psa":"James Rucker","ptype":"article","src":"https://openalex.org/W7125792237","eid":"W7125792237"},{"id":"paper-w4243395140","cat":"papers","name":"MDMA (ecstasy) delays pubertal development and alters sperm quality after developmental exposure in the rat","year":"2010","cit":2,"pfa":"Marta Barenys","psa":"J.M. Llobet","ptype":"article","src":"https://openalex.org/W4243395140","eid":"W4243395140"},{"id":"paper-w3043527047","cat":"papers","name":"Use of MDMA and marijuana among arrestees in Taiwan -A survey based on laboratory test of urine specimens","year":"2020","cit":2,"pfa":"C. Liu","psa":"J.-H. Li","ptype":"article","src":"https://openalex.org/W3043527047","eid":"W3043527047"},{"id":"paper-w2986213691","cat":"papers","name":"Protective Effects of Vitamin E on Heart and Testis Histology Following MDMA (Ecstasy) Exposure in Mice","year":"2019","cit":2,"pfa":"Sayed Soran Ghafori","psa":"Tahmineh Peirouvi","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2986213691","eid":"W2986213691"},{"id":"paper-w4392974861","cat":"papers","name":"Salience, Sensemaking, and Setting in Psilocybin Microdosing: Methodological Lessons and Preliminary Findings of a Mixed Method Qualitative Study","year":"2024","cit":2,"pfa":"Aleš Oblak","psa":"Jurij Bon","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4392974861","eid":"W4392974861"},{"id":"paper-w4416412154","cat":"papers","name":"Pharmacodynamic biomarker — or psychotherapeutic process? Comment on “The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression”","year":"2025","cit":2,"pfa":"Max Wolff","psa":"Samuli Kangaslampi","topics":["Depression","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4416412154","eid":"W4416412154"},{"id":"paper-w2036837223","cat":"papers","name":"P.1.c.009 Role of the norepinephrine uptake transporter in the mechanism of action of MDMA (Ecstasy)","year":"2010","cit":2,"pfa":"C.M. Hysek","psa":"Matthias E. Liechti","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2036837223","eid":"W2036837223"},{"id":"paper-w4391849046","cat":"papers","name":"Conflict monitoring and emotional processing in 3,4-methylenedioxymethamphetamine (MDMA) and methamphetamine users – A comparative neurophysiological study","year":"2024","cit":2,"pfa":"Antje Opitz","psa":"Ann‐Kathrin Stock","topics":["Addiction","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4391849046","eid":"W4391849046"},{"id":"paper-w4213324766","cat":"papers","name":"Psychedelics: A new era of treatment?","year":"2021","cit":2,"pfa":"S. Torres","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4213324766","eid":"W4213324766"},{"id":"paper-w4401509813","cat":"papers","name":"FDA rejected MDMA-assisted PTSD therapy. Other psychedelics firms intend to avoid that fate","year":"2024","cit":2,"topics":["PTSD & trauma"],"ptype":"dataset","src":"https://openalex.org/W4401509813","eid":"W4401509813"},{"id":"paper-w4390356646","cat":"papers","name":"“It Is Not Solved Just by Writing It Down on Paper”: Patrimonialization Policies and the Religious Use of Ayahuasca as a Brazilian Intangible Cultural Heritage","year":"2023","cit":2,"pfa":"Henrique Fernandes Antunes","ptype":"book-chapter","src":"https://openalex.org/W4390356646","eid":"W4390356646"},{"id":"paper-w2275862732","cat":"papers","name":"Correction: Binge Ethanol and MDMA Combination Exacerbates Toxic Cardiac Effects by Inducing Cellular Stress","year":"2015","cit":2,"pfa":"Javier Navarro‐Zaragoza","psa":"M. Luisa Laorden","ptype":"erratum","src":"https://openalex.org/W2275862732","eid":"W2275862732"},{"id":"paper-w4400001663","cat":"papers","name":"Psilocybin: Medicine for My Soul. Relief from Emotional and Spiritual Pain as a Hospice Nurse Diagnosed with Cancer","year":"2024","cit":2,"pfa":"Mary P. Clark","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4400001663","eid":"W4400001663"},{"id":"paper-w4226478689","cat":"papers","name":"Behavioural and Neurochemical Effects of Acute (±) 3,4 methylenedioxymethamphetamine (MDMA) in the Dopamine D1 Receptor Mutant Rat","year":"2016","cit":2,"pfa":"Hanna Squire","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"dissertation","src":"https://openalex.org/W4226478689","eid":"W4226478689"},{"id":"paper-w4398241968","cat":"papers","name":"A thematic analysis of MDMA-related harm and harm reduction experiences and knowledge in Aotearoa New Zealand","year":"2024","cit":2,"pfa":"Jai Whelan","psa":"Geoff Noller","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4398241968","eid":"W4398241968"},{"id":"paper-w4413300087","cat":"papers","name":"Intracranial Pressure-Guided Therapy in 3,4-Methylenedioxymethamphetamine (MDMA)-Induced Cerebral Edema: A Case Report","year":"2025","cit":2,"pfa":"Haytham Khalifa","psa":"Mohamed Abdulmajeed","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4413300087","eid":"W4413300087"},{"id":"paper-w4221085675","cat":"papers","name":"First DNA barcode efficiency assessment for an important ingredient in the Amazonian ayahuasca tea: mariri/jagube, Banisteriopsis (Malpighiaceae)","year":"2022","cit":2,"pfa":"Thalita Zanquetta Luz","psa":"Jacqueline da Silva Batista","ptype":"preprint","src":"https://openalex.org/W4221085675","eid":"W4221085675"},{"id":"paper-w2331400020","cat":"papers","name":"Psychopathological effects of S-ketamine and dimethyltryptamine (DMT) in humans: a double-blind, cross-over human experimental study of the NMDA antagonist and the 5HT2A agonist model of psychosis","year":"2005","cit":2,"pfa":"Euphrosyne Gouzoulis‐Mayfrank","psa":"Karsten Heekeren","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2331400020","eid":"W2331400020"},{"id":"paper-w3164048627","cat":"papers","name":"O papel da Psilocibina no tratamento de depressão resistente / The role of Psilocybin in the treatment of resistant depression","year":"2021","cit":2,"pfa":"Giovanni Pereira Pio","psa":"Rodrigo Pereira Pio","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3164048627","eid":"W3164048627"},{"id":"paper-w2417702099","cat":"papers","name":"THE EFFECT OF MESCALINE ON BLOOD SUGAR, SEROTONIN METABOLISM, ELECTRICAL ACTIVITY OF THE BRAIN, LIGHT STIMULI REACTION AND BEHAVIOURAL PATTERN IN THE WAKE RABBIT.","year":"1963","cit":2,"pfa":"MARCEL ASSAEL","psa":"Felix Gad Sulman","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2417702099","eid":"W2417702099"},{"id":"paper-w2326421123","cat":"papers","name":"[Poisoning by the hallucinogenic mushroom hikageshibiretake (Psilocybe argentipes)--with special reference to subjective experiences during psilocybin poisoning].","year":"1988","cit":2,"pfa":"MORIHIRO MUSHA","psa":"Atsushi Ishii","ptype":"article","src":"https://openalex.org/W2326421123","eid":"W2326421123"},{"id":"paper-w7151786749","cat":"papers","name":"Subjective and neurocognitive profiling of clinical doses of 3,4-methylenedioxymethamphetamine (MDMA) in healthy volunteers: implications for therapeutic use","year":"2026","cit":2,"pfa":"Johannes Gerardus Ramaekers","psa":"Franz X. Vollenweider","topics":["PTSD & trauma","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7151786749","eid":"W7151786749"},{"id":"paper-w4377227269","cat":"papers","name":"(267) Ecstasy' - Accurate or Deceptive Name? A Systematic Review of MDMA Effects on the Male Sexual Response Cycle","year":"2023","cit":2,"pfa":"J Suyama","psa":"Jennifer T. Anger","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4377227269","eid":"W4377227269"},{"id":"paper-w4402861954","cat":"papers","name":"Salience, sensemaking, and setting in psilocybin microdosing: Methodological lessons and preliminary findings of a mixed method qualitative study","year":"2024","cit":2,"pfa":"Aleš Oblak","psa":"Jurij Bon","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4402861954","eid":"W4402861954"},{"id":"paper-w3097578130","cat":"papers","name":"Identifikasi Ekstasi/MDMA Menggunakan Analisis Tes Warna dan Gas Chromatography-Mass Spectrometry (GCMS)","year":"2020","cit":2,"pfa":"Yunita Suci Rahayu","psa":"Eko Fery Prasetya","ptype":"article","src":"https://openalex.org/W3097578130","eid":"W3097578130"},{"id":"paper-w4417260851","cat":"papers","name":"Inhaled N, N-dimethyltryptamine diminishes connectivity between the ventral tegmental area and the nucleus accumbens: relevance to pathologies of mesolimbic and mesocortical pathways","year":"2025","cit":2,"pfa":"Gisela Lima","psa":"Miguel Castelo‐Branco","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4417260851","eid":"W4417260851"},{"id":"paper-w4411457516","cat":"papers","name":"Enhancing mindfulness and compassion through an ayahuasca-inspired formulation containing N,N-DMT and harmine: A randomized controlled trial in healthy subjects","year":"2025","cit":2,"pfa":"Helena Aicher","psa":"Milan Scheidegger","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4411457516","eid":"W4411457516"},{"id":"paper-w4413782868","cat":"papers","name":"Voacandial and Voacanginone A, Iboga-Type Monoterpenoid Indole Alkaloids from Voacanga africana Root Bark: Isolation, Structure Elucidation, and Asymmetric Total Syntheses","year":"2025","cit":2,"pfa":"Satoshi Matsumiya","psa":"Mariko Kitajima","ptype":"article","src":"https://openalex.org/W4413782868","eid":"W4413782868"},{"id":"paper-w4401509416","cat":"papers","name":"Performance Analysis of MDMA-Based Cooperative MRC Green Networks with Relays in Dissimilar Rayleigh Fading Channels","year":"2024","cit":2,"pfa":"Lei Teng","psa":"Xiaodong Xu","ptype":"conference-paper","src":"https://openalex.org/W4401509416","eid":"W4401509416"},{"id":"paper-w4380028871","cat":"papers","name":"The Structural Organization and Construct Validity Evidence of the Brazilian Versions of the Mysticism Scale and the Ego-Dissolution Inventory in a Major Religion of the Ayahuasca","year":"2023","cit":2,"pfa":"Robson Savoldi","psa":"Robin Lester Carhart-Harris","ptype":"article","src":"https://openalex.org/W4380028871","eid":"W4380028871"},{"id":"paper-w7155048769","cat":"papers","name":"Improving Best Practice Indicators for Psilocybin Assisted Therapy Using a Mul-tiphase Mixed Methods Delphi Study","year":"2025","cit":2,"pfa":"Kim A. Hoffman","psa":"David John Morgan","topics":["Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7155048769","eid":"W7155048769"},{"id":"paper-w7125425090","cat":"papers","name":"Psychoactive Synthetic Adulterants in Tablets Sold as MDMA after the COVID-19 Pandemic: Implications for Central Effects","year":"2026","cit":2,"pfa":"Maria Antonietta De Luca","psa":"Giulia Costa","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7125425090","eid":"W7125425090"},{"id":"paper-w4414244121","cat":"papers","name":"Temporal dynamics in neuroimaging as correlates of therapeutic response to psilocybin in major depressive disorder: A systematic review and critical appraisal","year":"2025","cit":2,"pfa":"Sami George Sabbah","psa":"Roger S. McIntyre","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W4414244121","eid":"W4414244121"},{"id":"paper-w4404063451","cat":"papers","name":"Psilocybin Mushrooms and Public Health in Brazil: Insights from a Retrospective Analysis of Adverse Events and Their Implications for Regulatory Discussions","year":"2024","cit":2,"pfa":"Marcel Nogueira","psa":"Leonardo Zanella Marques","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4404063451","eid":"W4404063451"},{"id":"paper-w2021788990","cat":"papers","name":"MDMA (ecstasy) and pCPA (para-chlorophenylalanine) effects on embryo development assessed with whole embryo culture (WEC)","year":"2009","cit":2,"pfa":"Burkhard Flick","psa":"Juan M. Llobet","ptype":"article","src":"https://openalex.org/W2021788990","eid":"W2021788990"},{"id":"paper-w2088274967","cat":"papers","name":"Protracted treatment with MDMA induces heteromeric nicotinic receptor up-regulation in the rat brain: An autoradiography study","year":"2014","cit":2,"pfa":"Andrés Ciudad‐Roberts","psa":"Elena Escubedo","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2088274967","eid":"W2088274967"},{"id":"paper-w2239427196","cat":"papers","name":"Ayahuasca e saúde: efeitos de uma bebida sacramental psicoativa na saúde mental de religiosos ayahuasqueiros","year":"2012","cit":2,"pfa":"José Arturo Costa Escobar","topics":["Depression"],"ptype":"dissertation","src":"https://openalex.org/W2239427196","eid":"W2239427196"},{"id":"paper-w172715519","cat":"papers","name":"Esrar Kullanımı Sırasında Başlayan ve N, N- Dimetiltriptamin (Dmt) Kullanımı ile Psikotik Özellikler Eklenen Duygudurum Bozukluğu: Bir Olgu Sunumu / A Mood Disorder Episode with an Onset Under Chronic Cannabis Consumptio","year":"2011","cit":2,"pfa":"Gökhan Umut","psa":"Ahmet Türkcan","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W172715519","eid":"W172715519"},{"id":"paper-w7196979420","cat":"papers","name":"Psilocybin-assisted therapy for treatment-resistant major depressive disorder in a public healthcare setting: a randomized controlled trial","year":"2026","cit":2,"pfa":"James Rucker","psa":"Allan Hunter Young","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7196979420","eid":"W7196979420"},{"id":"paper-w4412984428","cat":"papers","name":"Inappropriate comparator and high pricing in MDMA-assisted therapy for PTSD: A critique of the Lykos cost-effectiveness analysis","year":"2025","cit":2,"pfa":"Elliot A. Marseille","psa":"Jennifer Mitchell","topics":["PTSD & trauma","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4412984428","eid":"W4412984428"},{"id":"paper-w4386385744","cat":"papers","name":"MDMA-assisted psychotherapy with adolescents suffering from PTSD: Do or don’t? a qualitative study with youth, parents, and clinicians","year":"2023","cit":2,"pfa":"Anoek S van Vugt","psa":"Levi van Dam","topics":["PTSD & trauma","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4386385744","eid":"W4386385744"},{"id":"paper-w7134262081","cat":"papers","name":"Exploring the Utility and Appropriateness of Dose Thresholds for Issuing of Public Drug Alerts on High‐Dose MDMA : A Qualitative Study","year":"2026","cit":2,"pfa":"Jack Freestone","psa":"Nadine Ezard","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7134262081","eid":"W7134262081"},{"id":"paper-w7117472148","cat":"papers","name":"Comparing single‐ and repeat‐dose psilocybin with active placebo for migraine prevention in an exploratory randomized controlled clinical trial","year":"2025","cit":2,"pfa":"Emmanuelle A. D. Schindler","psa":"Deepak D'Souza","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7117472148","eid":"W7117472148"},{"id":"paper-w4221066480","cat":"papers","name":"Eficácia terapêutica da ayahuasca em pacientes com transtornos mentais baseada em estudos clínicos: uma revisão integrativa","year":"2022","cit":2,"pfa":"Alexandre Machado de Moura","psa":"Karoline Belém Seixas","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4221066480","eid":"W4221066480"},{"id":"paper-w4392133478","cat":"papers","name":"3,4-Methylenedioxymethamphetamine (MDMA) impairs cognitive function during withdrawal via activation of the arachidonic acid cascade in the hippocampus","year":"2024","cit":2,"pfa":"Yoko Nawata","psa":"Taku Yamaguchi","ptype":"article","src":"https://openalex.org/W4392133478","eid":"W4392133478"},{"id":"paper-w2290018768","cat":"papers","name":"The Adverse Psychiatric Consequences of Recreational Stimulant Drugs Such as Methamphetamine, Cocaine, Ecstasy/mdma, and Mephedrone: a Unified Psychobiological Explanation.","year":"2015","cit":2,"pfa":"Andrew Parrott","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2290018768","eid":"W2290018768"},{"id":"paper-w138439528","cat":"papers","name":"Los jíbaros, cazadores de sueños: diario de un antropólogo entre los shuar : experimentos con la ayahuasca","year":"1994","cit":2,"pfa":"Josep Maria Fericgla","ptype":"article","src":"https://openalex.org/W138439528","eid":"W138439528"},{"id":"paper-w2116092599","cat":"papers","name":"Differences in Binding Affinities of MDA, MDMA, MDEA, Amphetamine, Methamphetamine, and their Deuterated Analogues to Solid-Phase Extraction Cartridges*","year":"2011","cit":2,"pfa":"Robert W. Romberg","psa":"Eric R. Welsh","ptype":"article","src":"https://openalex.org/W2116092599","eid":"W2116092599"},{"id":"paper-w4405829539","cat":"papers","name":"Exploring the neurobiological correlates of psilocybin-assisted psychotherapy in eating disorders: a review of potential methodologies and implications for the psychedelic study design","year":"2024","cit":2,"pfa":"Elena Koning","psa":"Elisa M. Brietzke","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4405829539","eid":"W4405829539"},{"id":"paper-w4415923681","cat":"papers","name":"Psilocybin mitigates chronic behavioral and neurobiological alterations in a rat model of recurrent intimate partner violence-related brain injury","year":"2025","cit":2,"pfa":"Josh Allen","psa":"Sandy R. Shultz","ptype":"article","src":"https://openalex.org/W4415923681","eid":"W4415923681"},{"id":"paper-w4312186363","cat":"papers","name":"Effects of Moringa oleifera on 3, 4-Methylenedioxymethamphetamine (MDMA) Induced Neurotoxicity in the Pre-Frontal Cortex of Experimental Wistar Rats","year":"2022","cit":2,"pfa":"Fabiyi Sunday","psa":"Sambo Ayuba Jacob","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4312186363","eid":"W4312186363"},{"id":"paper-w4414532717","cat":"papers","name":"Three-day blues after ecstasy/MDMA use: Evidence from a longitudinal and daily analysis in the European nightlife scene","year":"2025","cit":2,"pfa":"Matthijs Blankers","psa":"Margriet van Laar","ptype":"article","src":"https://openalex.org/W4414532717","eid":"W4414532717"},{"id":"paper-w3024678393","cat":"papers","name":"Development of an Electrochemical Method Employing Carbon Screen-Printed Electrodes (C-SPEs) for Detection and Study of MDMA Redox Process","year":"2020","cit":2,"pfa":"Marcelo Firmino de Oliveira","psa":"Alex Soares Castro","topics":["Addiction"],"ptype":"conference-abstract","src":"https://openalex.org/W3024678393","eid":"W3024678393"},{"id":"paper-w2466440476","cat":"papers","name":"La vida como proceso de sanación: prácticas chamánicas del alto Amazonas en torno a la ayahuasca en España","year":"2015","cit":2,"pfa":"Santiago López Pavillard","ptype":"dissertation","src":"https://openalex.org/W2466440476","eid":"W2466440476"},{"id":"paper-w2184949608","cat":"papers","name":"Estudio poblacional del falso peyote Astrophytum asterias (Zucc.) Lem. (Cactaceae) en una fracción del matorral espinoso tamaulipeco en Villagrán, Tamaulipas","year":"1995","cit":2,"pfa":"Luis Rocha Domínguez","ptype":"dissertation","src":"https://openalex.org/W2184949608","eid":"W2184949608"},{"id":"paper-w2056898688","cat":"papers","name":"3,4-Methylenedioxymethamphetamine (MDMA) alters acute gammaherpesvirus burden and limits interleukin 27 responses in a mouse model of viral infection","year":"2011","cit":2,"pfa":"Daniel A. Nelson","psa":"Kenneth L. Bost","ptype":"article","src":"https://openalex.org/W2056898688","eid":"W2056898688"},{"id":"paper-w4387939730","cat":"papers","name":"Uso ritual de alucinógenos y medicina psicodélica: Articulaciones alrededor del uso clínico de la ayahuasca en Brasil","year":"2023","cit":2,"pfa":"Genís Oña","ptype":"article","src":"https://openalex.org/W4387939730","eid":"W4387939730"},{"id":"paper-w4406932478","cat":"papers","name":"Study Protocol for ‘PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity’","year":"2025","cit":2,"pfa":"Sorcha O'Connor","psa":"David Erritzøe","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4406932478","eid":"W4406932478"},{"id":"paper-w2240145921","cat":"papers","name":"Alcaloides de las especies rauwolfia sprucei, stemmadenia obovata, delphinium cardiopetalum y withania aristata. Contribución a la química de los alcaloides tipo iboga","year":"1998","cit":2,"pfa":"Alberto Madinaveitia Martín","ptype":"dissertation","src":"https://openalex.org/W2240145921","eid":"W2240145921"},{"id":"paper-w970274164","cat":"papers","name":"Toxicidade aguda e crônica do chá ayahuasca (Banisteriopsis caapi e Psychotria viridis), por análise histológica em ratas Wistar","year":"2014","cit":2,"pfa":"Juliana Alves de Morais","ptype":"dissertation","src":"https://openalex.org/W970274164","eid":"W970274164"},{"id":"paper-w4403684446","cat":"papers","name":"Rapid Effects of MDMA Administration on Self-Reported Personality Traits and Affect State: A Randomized, Placebo-Controlled Trial in Healthy Adults","year":"2024","cit":2,"pfa":"Jessica L. Maples‐Keller","psa":"BARBARA OLASOV ROTHBAUM","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4403684446","eid":"W4403684446"},{"id":"paper-w2188837941","cat":"papers","name":"A Phase 1 Placebo-Controlled, Double-Blind Crossover Study to Assess Psychological Effects of MDMA when Administered to Healthy Volunteers","year":"2009","cit":2,"pfa":"Protocol Mt","ptype":"article","src":"https://openalex.org/W2188837941","eid":"W2188837941"},{"id":"paper-w4415912582","cat":"papers","name":"Psilocybin reduces depressive-like behavior and improves cognition in healthy aging mice via epigenetic regulation of plasticity- and immune-related genes","year":"2025","cit":2,"pfa":"Sarah E. Mennenga","psa":"Candace R. Lewis","topics":["Depression","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4415912582","eid":"W4415912582"},{"id":"paper-w4288436734","cat":"papers","name":"Author Correction: Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls","year":"2022","cit":2,"pfa":"Joseph M. Rootman","psa":"Zach Walsh","topics":["Dosing & pharmacology"],"ptype":"erratum","src":"https://openalex.org/W4288436734","eid":"W4288436734"},{"id":"paper-w1971794969","cat":"papers","name":"Substance Use Disorders and Treatment Utilization among MDMA Users: Results from the National Epidemiologic Survey on Alcohol and Related Conditions","year":"2010","cit":2,"pfa":"Noosha Niv","psa":"Mitchell P. Karno","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1971794969","eid":"W1971794969"},{"id":"paper-w4283573862","cat":"papers","name":"Amitriptyline Accelerates SERT Binding Recovery in a Rat 3,4-Methylenedioxymethamphetamine (MDMA) Model: In Vivo 4-[18F]-ADAM PET Imaging","year":"2022","cit":2,"pfa":"Chi-Jung Tsai","psa":"Kuo‐Hsing Ma","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4283573862","eid":"W4283573862"},{"id":"paper-w7124682544","cat":"papers","name":"Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Symptoms of Anxiety and Depression: Safety and Efficacy Outcomes of a Phase 1/2 Study","year":"2026","cit":2,"pfa":"Anthony L. Back","psa":"Cheryl Sesnon","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7124682544","eid":"W7124682544"},{"id":"paper-w4409449177","cat":"papers","name":"Psilocybin-Assisted suppoRtive psychoTherapy IN the treatment of prolonged Grief (PARTING) trial: protocol for an open-label pilot trial for cancer-related bereavement","year":"2025","cit":2,"pfa":"Vanessa L. Beesley","psa":"Stephen Parker","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4409449177","eid":"W4409449177"},{"id":"paper-w4390915346","cat":"papers","name":"Abstract C001: A pilot study of palliadelic treatment with psilocybin to reduce psychological distress and improve quality of life in patients with advanced pancreatic adenocarcinoma","year":"2024","cit":2,"pfa":"Kelsey A. Klute","psa":"Jody Koenig Kellas","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"conference-abstract","src":"https://openalex.org/W4390915346","eid":"W4390915346"},{"id":"paper-w7135088876","cat":"papers","name":"Efficacy of 3,4-methylenedioxymethamphetamine (MDMA)-assisted therapy for posttraumatic stress disorder: A systematic review and meta-analysis of clinical and functional outcomes","year":"2026","cit":2,"pfa":"Natalia E. Fares‐Otero","psa":"Soraya Seedat","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W7135088876","eid":"W7135088876"},{"id":"paper-w4312617752","cat":"papers","name":"SACRALIZAÇÃO DA NATUREZA E O USO RELIGIOSO DA AYAHUASCA: PERCEPÇÃO E ÉTICA AMBIENTAL DA FLORESTA AMAZÔNICA AOS CENTROS URBANOS","year":"2021","cit":2,"pfa":"Julien Marius Reis Thévenin","psa":"Carlos Teodoro José Hugueney Irigaray","ptype":"article","src":"https://openalex.org/W4312617752","eid":"W4312617752"},{"id":"paper-w2410865898","cat":"papers","name":"Editorial [Hot topic: MDMA (Ecstasy) Toxicity: Pharmacokinetic, Metabolism, Cell Response and Pathological Consequences (Guest Editor: Vittorio Fineschi)]","year":"2010","cit":2,"pfa":"Vittorio Fineschi","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"editorial","src":"https://openalex.org/W2410865898","eid":"W2410865898"},{"id":"paper-w4409535666","cat":"papers","name":"Pre-exposure to eutylone attenuates its own aversive effects but has no impact on cocaine or MDMA: A possible role of eutylone's hybrid pharmacology","year":"2025","cit":2,"pfa":"Negar Ghasem Ardabili","psa":"Anthony Lee Riley","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4409535666","eid":"W4409535666"},{"id":"paper-w2148340641","cat":"papers","name":"GC-MS and GC-IRD Studies on the Ring Isomers of N-Methyl-2-Methoxyphenyl-3-Butanamines (MPBA) Related to 3,4-MDMA","year":"2011","cit":2,"pfa":"T. Awad","psa":"Charles R. Clark","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2148340641","eid":"W2148340641"},{"id":"paper-w2074099294","cat":"papers","name":"Reply to letter by Green, Marsden and Fone (2007) about Sessa and Nutt's editorial (MDMA: baby with the bath water) in the November 2007 Journal","year":"2008","cit":2,"pfa":"Ben Sessa","psa":"David Nutt","ptype":"letter","src":"https://openalex.org/W2074099294","eid":"W2074099294"},{"id":"paper-w3175593615","cat":"papers","name":"La psychothérapie assistée par la MDMA dans la prise en charge du syndrome de stress post-traumatique","year":"2021","cit":2,"pfa":"Baptiste Fauvel","psa":"Pascale Piolino","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W3175593615","eid":"W3175593615"},{"id":"paper-w3081122312","cat":"papers","name":"MDMA-Assisted Psychotherapy for Posttraumatic Stress Disorder: Examining Ethnoracial Differences in Efficacy and Safety, and a Mixed-Methods Case Study of a Participant of Color","year":"2020","cit":2,"pfa":"Terence H. W. Ching","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W3081122312","eid":"W3081122312"},{"id":"paper-w4407923015","cat":"papers","name":"Case report: Well-tolerated MDMA-assisted therapy in a 32-year old female patient with advanced alcohol-induced liver cirrhosis","year":"2025","cit":2,"pfa":"Elias Kraus","psa":"Marc Vogel","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4407923015","eid":"W4407923015"},{"id":"paper-w4239756250","cat":"papers","name":"Entheogens","year":"2018","cit":2,"pfa":"Katie Givens Kime","ptype":"reference-entry","src":"https://openalex.org/W4239756250","eid":"W4239756250"},{"id":"paper-w237679189","cat":"papers","name":"An experimental model for study of the renal protective activity of corn silk against dosage induced by MDMA using in situ rat renal system.","year":"2013","cit":2,"pfa":"Mohammad Yasin Karami","psa":"M. Makhloogh","ptype":"article","src":"https://openalex.org/W237679189","eid":"W237679189"},{"id":"paper-w4390245559","cat":"papers","name":"Established sensitization of ethanol-induced locomotor activity is not reversed by psilocybin or the 5-HT2A receptor agonist TCB-2 in male DBA/2J mice","year":"2023","cit":2,"pfa":"Paul Fletcher","psa":"Anh Dzung Lê","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4390245559","eid":"W4390245559"},{"id":"paper-w4412510542","cat":"papers","name":"“I’ve learned that I’m open-minded to this possibility”: A qualitative study to evaluate the acceptability of a psilocybin-aided smoking cessation treatment for people with HIV who smoke","year":"2025","cit":2,"pfa":"Patricia A. Cioe","psa":"Sarah Dugal","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4412510542","eid":"W4412510542"},{"id":"paper-w4385308753","cat":"papers","name":"“Why would you open someone’s brain up?” Lived experience insights inform a psilocybin-assisted psychotherapy treatment manual for body image disturbance","year":"2023","cit":2,"pfa":"Claire Finkelstein","psa":"Susan Lee Rossell","topics":["Safety & adverse events","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4385308753","eid":"W4385308753"},{"id":"paper-w4389854594","cat":"papers","name":"Psychedelics and cognitive function: A systematic review","year":"2023","cit":2,"pfa":"Caíque Gois Cardoso","psa":"Milena de Barros Viana","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4389854594","eid":"W4389854594"},{"id":"paper-w2102596910","cat":"papers","name":"Dual, Postsynaptic 5-HT2B Antagonist and 5-HT1A Agonist Approach to the Treatment of METH/MDMA Addiction and Related Problems. Part 1. The Hypothesis.","year":"2014","cit":2,"topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2102596910","eid":"W2102596910"},{"id":"paper-w4281771396","cat":"papers","name":"Prelimbic medial prefrontal cortex has bidirectional control over the expression of behavioral sensitization to 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) depending on the context of drug administration","year":"2022","cit":2,"pfa":"Jacob A. Plocinski","psa":"Kevin T. Ball","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4281771396","eid":"W4281771396"},{"id":"paper-w4405868041","cat":"papers","name":"Discriminative stimulus properties of α-ethyltryptamine (α-ET) in rats: α-ET-like effects of MDMA, MDA and aryl-monomethoxy substituted derivatives of α-ET","year":"2024","cit":2,"pfa":"Carmen Abate","psa":"Richard A. Glennon","ptype":"article","src":"https://openalex.org/W4405868041","eid":"W4405868041"},{"id":"paper-w4296440963","cat":"papers","name":"Identifikasi Senyawa Mdma dan Paracetamol dalam Sampel Urine Menggunakan Metode Kromatografi Lapis Tipis dan Kromatografi Gas – Spektrofotometri Massa (Gc-Ms)","year":"2022","cit":2,"pfa":"Adella Aisiyah","psa":"Silvana Lestari Irwansyah","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4296440963","eid":"W4296440963"},{"id":"paper-w4386272089","cat":"papers","name":"The changing outlook of psychedelic drugs: The importance of risk assessment and occupational exposure limits","year":"2023","cit":2,"pfa":"Natália Bernardi Videira","psa":"Dean Calhoun","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4386272089","eid":"W4386272089"},{"id":"paper-w2034396609","cat":"papers","name":"Corrigendum to “Concurrent use of methamphetamine, MDMA, LSD, ketamine, GHB, and flunitrazepam among American youths” [Drug and Alcohol Dependence 84 (1) (2006) 102–113]","year":"2006","cit":2,"pfa":"Li-Tzy T. Wu","psa":"Deborah M. Galvin","topics":["Addiction"],"ptype":"erratum","src":"https://openalex.org/W2034396609","eid":"W2034396609"},{"id":"paper-w2363278100","cat":"papers","name":"Effet des extraits de Jatropha curcas L. et de Tabernanthe iboga Baill. dans la lutte contre le scolyte du caféier (Hypothenemus hampei Ferrari) au Sud-Est du Gabon","year":"2016","cit":2,"pfa":"Pamphile Nguema Ndoutoumou","psa":"Jeff Steeve Olery Okoumba","ptype":"article","src":"https://openalex.org/W2363278100","eid":"W2363278100"},{"id":"paper-w4400850217","cat":"papers","name":"Design and methodology of the first open-label trial of MDMA-assisted therapy for veterans with post-traumatic stress disorder and alcohol use disorder: Considerations for a randomized controlled trial","year":"2024","cit":2,"pfa":"Erica M. Eaton","psa":"Carolina L. Haass‐Koffler","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4400850217","eid":"W4400850217"},{"id":"paper-w4408692899","cat":"papers","name":"Is there a place for psychedelics in sports practice?","year":"2025","cit":2,"pfa":"Marina A. M. Portes","psa":"Leandro Jose Bertoglio","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4408692899","eid":"W4408692899"},{"id":"paper-w7121845165","cat":"papers","name":"Blunted Psychedelic Drug Effects in Older Adults","year":"2026","cit":2,"pfa":"Jacob S. Aday","psa":"Kevin F. Boehnke","ptype":"article","src":"https://openalex.org/W7121845165","eid":"W7121845165"},{"id":"paper-w4385952741","cat":"papers","name":"“Diversity makes the richness of humanity”: the emergence of mental imagery after self-reported psilocybin mushrooms intake in an autistic woman with “blind imagination” (aphantasia): a 1-year retrospective case report","year":"2023","cit":2,"pfa":"Kevin Rebecchi","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4385952741","eid":"W4385952741"},{"id":"paper-w7155075079","cat":"papers","name":"Case Report: Repeated low doses of psilocybin reduce perceived symptom severity but fail to restore cognitive flexibility in a case of severe obsessive-compulsive disorder: an observational case study of identical twins","year":"2026","cit":2,"pfa":"Sivert Drange","psa":"Mikael Palner","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7155075079","eid":"W7155075079"},{"id":"paper-w4409195444","cat":"papers","name":"Letter to the editor: Comments on ‘Striking long-term beneficial effects of single-dose psilocybin and psychedelic mushroom extract in the SAPAP3 rodent model of OCD-like excessive self-grooming’ by Brownstien et al. (20","year":"2025","cit":2,"pfa":"James J Gattuso","psa":"Thibault Renoir","topics":["Dosing & pharmacology"],"ptype":"letter","src":"https://openalex.org/W4409195444","eid":"W4409195444"},{"id":"paper-w4408279532","cat":"papers","name":"Deciphering Ibogaine’s Matrix Pharmacology: Multiple Transporter Modulation at Serotonin Synapses","year":"2025","cit":2,"pfa":"Christopher Hwu","psa":"Dalibor Sameš","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"preprint","src":"https://openalex.org/W4408279532","eid":"W4408279532"},{"id":"paper-w2023091272","cat":"papers","name":"Une interférence analytique peut en cacher une autre : l’exemple de l’urapidil, du dépistage de MDMA et de l’identification d’un stimulant de synthèse, la 2-MeOPP","year":"2014","cit":2,"pfa":"Nathalie Allibé","psa":"Françoise Stanke‐Labesque","ptype":"article","src":"https://openalex.org/W2023091272","eid":"W2023091272"},{"id":"paper-w1481847883","cat":"papers","name":"Determinação de 3,4-metilenodioximetanfetamina (MDMA - Ecstasy), 3,4-metilenodioxietilanfetamina (MDEA - Eve) e 3,4-metilenodioxianfetamina (MDA) em fluidos biológicos por cromatografia líquida de alta eficiência: aspect","year":"2004","cit":2,"pfa":"José Luiz Costa","ptype":"dissertation","src":"https://openalex.org/W1481847883","eid":"W1481847883"},{"id":"paper-w4403113128","cat":"papers","name":"Rapid and Prolonged Antidepressant and Antianxiety Effects of Psychedelics and 3,4-Methylenedioxy-methamphetamine—A Systematic Review and Meta-Analysis","year":"2024","cit":2,"pfa":"Dimy Fluyau","psa":"Neelambika Revadigar","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"review","src":"https://openalex.org/W4403113128","eid":"W4403113128"},{"id":"paper-w3214961119","cat":"papers","name":"Hallucinogen-Related Disorders","year":"2021","cit":2,"pfa":"Katherine K. Kim","psa":"Daniel E. Roberts","ptype":"book-chapter","src":"https://openalex.org/W3214961119","eid":"W3214961119"},{"id":"paper-w4414440106","cat":"papers","name":"With great power comes great responsibility: Promise and caution in the new psychedelic renaissance","year":"2025","cit":2,"pfa":"Matthew T. J. Halma","psa":"Joseph Varón","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4414440106","eid":"W4414440106"},{"id":"paper-w4416671509","cat":"papers","name":"Best practices for first psychedelic experiences: harm reduction advice from the psychedelic community","year":"2025","cit":2,"pfa":"Daniel J. Kruger","psa":"Kevin F. Boehnke","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4416671509","eid":"W4416671509"},{"id":"paper-w3139936469","cat":"papers","name":"Do Hallucinogens Have a Role in the Treatment of Addictions? A Review of the Current Literature","year":"2021","cit":2,"pfa":"Kabir B. Nigam","psa":"Ananda K. Pandurangi","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3139936469","eid":"W3139936469"},{"id":"paper-w4413791859","cat":"papers","name":"Freedom of Recreation: A Critique of the Prohibition, Decriminalization, and Legal Regulation of Psychedelics for Recreational Use","year":"2025","cit":2,"pfa":"Jason K. Day","psa":"Michael Th. Grooff","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4413791859","eid":"W4413791859"},{"id":"paper-w2376514477","cat":"papers","name":"The “Endless Trip”: Psychopathology and psychopharmacology in the Hallucinogen Persisting Perception Disorder (HPPD)","year":"2016","cit":2,"pfa":"Laura Orsolini","psa":"Domenico De Berardis","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"conference-abstract","src":"https://openalex.org/W2376514477","eid":"W2376514477"},{"id":"paper-w4410442378","cat":"papers","name":"Optimized Parenteral and Intranasal Formulations of Tryptamine Psychedelics for Rapid-Acting Antidepressant Therapy","year":"2025","cit":2,"pfa":"Robert B. Kargbo","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4410442378","eid":"W4410442378"},{"id":"paper-w4415494538","cat":"papers","name":"Structural Pharmacology of Bufotenine Derivatives in Activating the 5-HT 1A Receptor for Therapeutic Potential in Depression and Anxiety","year":"2025","cit":2,"pfa":"Shu-jie Li","psa":"Hongyue Ma","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4415494538","eid":"W4415494538"},{"id":"paper-w4410841687","cat":"papers","name":"Effects of serotonergic psychedelics on synaptogenesis and immediate early genes expression – comparison with ketamine, fluoxetine and lithium","year":"2025","cit":2,"pfa":"Yana Vella","psa":"Tomáš Páleníček","topics":["Depression","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4410841687","eid":"W4410841687"},{"id":"paper-w2789668681","cat":"papers","name":"Psychedelic Drug (LSD, PCP, Hallucinogenic Mushrooms) Intoxication","year":"2017","cit":2,"pfa":"Julien J. Cavanagh","psa":"Teresa Y. Smith","ptype":"book-chapter","src":"https://openalex.org/W2789668681","eid":"W2789668681"},{"id":"paper-w4248067575","cat":"papers","name":"Hallucinogens and Dissociatives","year":"2020","cit":2,"pfa":"Darius A. Rastegar","ptype":"book-chapter","src":"https://openalex.org/W4248067575","eid":"W4248067575"},{"id":"paper-w2018392825","cat":"papers","name":"Protecting the human rights of people who use psychedelics","year":"2015","cit":2,"pfa":"Teri Suzanne Krebs","ptype":"article","src":"https://openalex.org/W2018392825","eid":"W2018392825"},{"id":"paper-w4411976075","cat":"papers","name":"Beyond prohibition: A public health analysis of naturalistic psychedelic use","year":"2025","cit":2,"pfa":"Mark Haden","psa":"Birgitta Woods","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4411976075","eid":"W4411976075"},{"id":"paper-w4410355943","cat":"papers","name":"Serotonergic psychedelics for depression: A comprehensive overview","year":"2025","cit":2,"pfa":"Aleksandra Wingert","psa":"David Erritzøe","topics":["Depression"],"ptype":"book-chapter","src":"https://openalex.org/W4410355943","eid":"W4410355943"},{"id":"paper-w4413116806","cat":"papers","name":"Pharmacological Evaluation of Tropane Analogues at the Serotonin Transporter","year":"2025","cit":2,"pfa":"Arabo A. Avanes","psa":"David E. Olson","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4413116806","eid":"W4413116806"},{"id":"paper-w3208437486","cat":"papers","name":"An Overview of Alkaloids Derived from Tryptophan and Their Potential Antidepressant Action","year":"2021","cit":2,"pfa":"Maria Emanuelle Damazio Lima","psa":"Alessandra Leda Valverde","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3208437486","eid":"W3208437486"},{"id":"paper-w3084681378","cat":"papers","name":"Classic Psychedelics as a Psychotherapeutic Aid in the Treatment of Stimulant Use Disorder: a Case Report","year":"2020","cit":2,"pfa":"Shevaugn Johnson","psa":"Quentin C. Black","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3084681378","eid":"W3084681378"},{"id":"paper-w4393392318","cat":"papers","name":"From Outsider to Insider: A Look at the Subculture of Microdosing","year":"2024","cit":2,"pfa":"Blake Beaton","psa":"Jurg Gerber","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4393392318","eid":"W4393392318"},{"id":"paper-w4413253749","cat":"papers","name":"Computational design of an improved photoswitchable psychedelic based on light absorption, membrane permeation and protein binding","year":"2025","cit":2,"pfa":"Vito Federico Palmisano","psa":"Juan J. Nogueira","ptype":"article","src":"https://openalex.org/W4413253749","eid":"W4413253749"},{"id":"paper-w7161640395","cat":"papers","name":"Association Between Lifetime Hallucinogen Use and Valvular Heart Disease: Findings from the All of Us Research Program","year":"2026","cit":2,"pfa":"Kevin H. Yang","psa":"Jaclyn Bergstrom","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7161640395","eid":"W7161640395"},{"id":"paper-w2003615214","cat":"papers","name":"Indole Alkaloids From Tissue-CulturedTabernanthe IbogaH. Bn","year":"1999","cit":2,"pfa":"Dominick V. Basile","psa":"Deborah C. Mash","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2003615214","eid":"W2003615214"},{"id":"paper-w2950544971","cat":"papers","name":"Faces of HPPD: Hallucinogen Persisting Perception Disorder Patient Survey Results and a Descriptive Analysis of Patient Demographics, Medical Background, Drug Use History, Symptoms, and Treatments","year":"2019","cit":2,"pfa":"Doreen M. Lewis","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2950544971","eid":"W2950544971"},{"id":"paper-w4318710233","cat":"papers","name":"Turn On and Tune In: Psychedelics, Narcotics and Euphoriants","year":"2009","cit":2,"pfa":"John Mann","psa":"Henry Oakeley","topics":["Addiction","Dosing & pharmacology"],"ptype":"book","src":"https://openalex.org/W4318710233","eid":"W4318710233"},{"id":"paper-w7147305730","cat":"papers","name":"Complete biosynthesis of psychedelic tryptamines from three kingdoms in plants","year":"2026","cit":2,"pfa":"Paula Berman","psa":"Asaph Aharoni","ptype":"article","src":"https://openalex.org/W7147305730","eid":"W7147305730"},{"id":"paper-w3184512811","cat":"papers","name":"Author response: Transcriptomics-informed large-scale cortical model captures topography of pharmacological neuroimaging effects of LSD","year":"2021","cit":2,"pfa":"Joshua B. Burt","psa":"John D. Murray","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"peer-review","src":"https://openalex.org/W3184512811","eid":"W3184512811"},{"id":"paper-w4409431830","cat":"papers","name":"Assessing the potential cardiovascular risk of microdosing the psychedelic LSD in mice","year":"2025","cit":2,"pfa":"Devin P. Effinger","psa":"Scott M. Thompson","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4409431830","eid":"W4409431830"},{"id":"paper-w4414679647","cat":"papers","name":"Real-world use of classic and non-classic psychedelics in Hispanic/Latino adults with obsessive-compulsive disorder: international findings from the LATINO Study","year":"2025","cit":2,"pfa":"David S. Mathai","psa":"Amy L. McGuire","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4414679647","eid":"W4414679647"},{"id":"paper-w7128430445","cat":"papers","name":"Exploring a Decade of Microdosing Research: A Qualitative Meta-synthesis of Microdosing Literature","year":"2026","cit":2,"pfa":"Blake Beaton","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7128430445","eid":"W7128430445"},{"id":"paper-w3176879092","cat":"papers","name":"Microdosing Psychedelics as a Promising New Pharmacotherapeutic","year":"2021","cit":2,"pfa":"Kim P. C. Kuypers","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W3176879092","eid":"W3176879092"},{"id":"paper-w2969353379","cat":"papers","name":"The Trials of Psychedelic Therapy: Lsd Psychotherapy in America","year":"2019","cit":2,"pfa":"William J. Rorabaugh","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W2969353379","eid":"W2969353379"},{"id":"paper-w4413942727","cat":"papers","name":"Psychedelic use in Poland: prevalence, correlates and social attitudes","year":"2025","cit":2,"pfa":"Paweł Holas","psa":"Justyna Kamińska","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4413942727","eid":"W4413942727"},{"id":"paper-w7131633077","cat":"papers","name":"Psychedelic-Related Psychosis: From Model Psychosis to Psychotherapy","year":"2026","cit":2,"pfa":"Anna‐Lena Bröcker","psa":"Christiane Montag","topics":["Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W7131633077","eid":"W7131633077"},{"id":"paper-w3160754267","cat":"papers","name":"Will psychedelics be ‘a revolution in psychiatry’?","year":"2021","cit":2,"pfa":"Asher Mullard","ptype":"article","src":"https://openalex.org/W3160754267","eid":"W3160754267"},{"id":"paper-w4413411862","cat":"papers","name":"Psychedelics and the Serotonin Hypothesis of Eating Disorders","year":"2025","cit":2,"pfa":"Dean Bilenker","psa":"Nicole M. Avena","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4413411862","eid":"W4413411862"},{"id":"paper-w2085872027","cat":"papers","name":"Early preclinical studies of discriminable sedative and hallucinogenic drug effects","year":"2008","cit":2,"pfa":"Herbert Barry","psa":"James B. Appel","ptype":"article","src":"https://openalex.org/W2085872027","eid":"W2085872027"},{"id":"paper-w4383562700","cat":"papers","name":"Overview of the synthetic approaches to lysergic acid as a precursor to the psychedelic LSD","year":"2023","cit":2,"pfa":"Michael J. Nutt","psa":"Scott G. Stewart","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4383562700","eid":"W4383562700"},{"id":"paper-w4313201302","cat":"papers","name":"Management of obesity with semaglutide in antipsychotic-induced weight gain (MOSA) - a non-randomized open-label pilot study: research proposal","year":"2022","cit":2,"pfa":"Bea C. M. Campforts","psa":"Maarten Bak","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4313201302","eid":"W4313201302"},{"id":"paper-w2094464999","cat":"papers","name":"Association of some psychotomimetic compounds with 6-methylpurine in aqueous solutions","year":"1978","cit":2,"pfa":"Helmut Sapper","psa":"Wolfgang Lohmann","ptype":"article","src":"https://openalex.org/W2094464999","eid":"W2094464999"},{"id":"paper-w4386040548","cat":"papers","name":"Psychedelic Microdosing: What Is It Good For?","year":"2023","cit":2,"pfa":"Anya K. Bershad","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4386040548","eid":"W4386040548"},{"id":"paper-w1491281220","cat":"papers","name":"CLINICAL INVESTIGATION OF EA 1729","year":"1961","cit":2,"pfa":"Van M. Sim","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"report","src":"https://openalex.org/W1491281220","eid":"W1491281220"},{"id":"paper-w4392231460","cat":"papers","name":"Preadministration of Lorazepam Reduces Efficacy and Longevity of Antidepressant-Like Effect from a Psychedelic","year":"2024","cit":2,"pfa":"Meghan Hibicke","psa":"Charles David Nichols","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4392231460","eid":"W4392231460"},{"id":"paper-w4225266504","cat":"papers","name":"Sex-Specific Effects of Psychedelic Drug Exposure on Central Amygdala Reactivity and Behavioral Responding","year":"2022","cit":2,"pfa":"Devin P. Effinger","psa":"MA Herman","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4225266504","eid":"W4225266504"},{"id":"paper-w2056388351","cat":"papers","name":"Oxytocic Effect of some d-Lysergic Acid cycloAlkylamides","year":"1957","cit":2,"pfa":"Zdenek Votava","psa":"M. Semonský","ptype":"article","src":"https://openalex.org/W2056388351","eid":"W2056388351"},{"id":"paper-w4318619964","cat":"papers","name":"On the Edges: The Ethics of Human Studies with Psychedelic Substances","year":"2023","cit":2,"pfa":"Sabrina Corrêa da Costa","psa":"Mehmet Sofuoglu","topics":["Addiction","Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W4318619964","eid":"W4318619964"},{"id":"paper-w4396721972","cat":"papers","name":"Advancements in Psychoactive Alkaloid Delivery, Neuroenhancement, and Psychedelic Therapies: Exploring the Frontiers of Modern Pharmacology","year":"2024","cit":2,"pfa":"Robert B. Kargbo","topics":["Addiction","Dosing & pharmacology"],"ptype":"editorial","src":"https://openalex.org/W4396721972","eid":"W4396721972"},{"id":"paper-w2032589929","cat":"papers","name":"ETHNOBOTANICAL SEARCH FOR HALLUCINOGENIC CACTI1","year":"1973","cit":2,"pfa":"Jan G. Bruhn","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2032589929","eid":"W2032589929"},{"id":"paper-w2548226831","cat":"papers","name":"Rehabilitating LSD history in postwar America: Dilworth Wayne Woolley and the serotonin hypothesis of mental illness","year":"2016","cit":2,"pfa":"Kim Hewitt","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2548226831","eid":"W2548226831"},{"id":"paper-w2050477559","cat":"papers","name":"LSD AND CHROMOSOMES","year":"1970","cit":2,"pfa":"Joe‐Hin Tjio","psa":"Albert A. Kurland","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2050477559","eid":"W2050477559"},{"id":"paper-w115221485","cat":"papers","name":"LSD and Psychiatry: A Personal Trip","year":"1992","cit":2,"pfa":"Daniel X. Freedman","ptype":"book-chapter","src":"https://openalex.org/W115221485","eid":"W115221485"},{"id":"paper-w4251306086","cat":"papers","name":"An untoward reaction to accidental ingestion of LSD in a 5-year-old girl","year":"1967","cit":2,"pfa":"Milman Dh","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4251306086","eid":"W4251306086"},{"id":"paper-w2979859018","cat":"papers","name":"Acid trip: The history of LSD -- the original psychedelic drug","year":"2007","cit":2,"pfa":"Erika Dyck","ptype":"article","src":"https://openalex.org/W2979859018","eid":"W2979859018"},{"id":"paper-w3127181543","cat":"papers","name":"Cannabinoids is a “No-Go” While a Cancer Patient is on Immunotherapy; but is It Safe to Use Psychedelics During Cancer Immunotherapy?","year":"2021","cit":2,"pfa":"E. Amit Romach","psa":"I. Lamensdorf","topics":["Depression","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W3127181543","eid":"W3127181543"},{"id":"paper-w7166155623","cat":"papers","name":"U.S. Psychedelic Use and Microdosing in 2025: Insights from a Probability-Based and Nationally Representative Survey","year":"2026","cit":2,"pfa":"Michelle Priest","psa":"Claude Setodji","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7166155623","eid":"W7166155623"},{"id":"paper-w2114440371","cat":"papers","name":"The medical record as legal document: When can the patient dictate the content? An ethics case from the Department of Neurology","year":"2014","cit":2,"pfa":"Robert E. Accordino","psa":"Stephen C. Krieger","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2114440371","eid":"W2114440371"},{"id":"paper-w2982389199","cat":"papers","name":"Acid Hype: American News Media and the Psychedelic Experience","year":"2016","cit":2,"pfa":"Rick Dodgson","ptype":"article","src":"https://openalex.org/W2982389199","eid":"W2982389199"},{"id":"paper-w3005692866","cat":"papers","name":"The Psychopharmacological Revolution","year":"2015","cit":2,"pfa":"Petteri Pietikainen","topics":["Depression","Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W3005692866","eid":"W3005692866"},{"id":"paper-w3177409032","cat":"papers","name":"LSD induces increased signalling entropy in rats’ prefrontal cortex","year":"2021","cit":2,"pfa":"Aurora Savino","psa":"Charles David Nichols","topics":["Addiction","Mechanism & neuroscience","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W3177409032","eid":"W3177409032"},{"id":"paper-w4300716142","cat":"papers","name":"LSD, Madness and Healing: Mystical Experiences as Possible Link Between Psychosis Model and Therapy Model","year":"2022","cit":2,"pfa":"Isabel Wießner","psa":"Luís Fernando Tófoli","topics":["Dosing & pharmacology"],"ptype":"report","src":"https://openalex.org/W4300716142","eid":"W4300716142"},{"id":"paper-w4246437093","cat":"papers","name":"Psychedelic medicines","year":"2016","cit":2,"pfa":"Jyllian N. Kemsley","ptype":"article","src":"https://openalex.org/W4246437093","eid":"W4246437093"},{"id":"paper-w1573447894","cat":"papers","name":"Chapter 4 Hallucinogens","year":"2007","cit":2,"pfa":"John T. Cody","ptype":"book-chapter","src":"https://openalex.org/W1573447894","eid":"W1573447894"},{"id":"paper-w3172535731","cat":"papers","name":"Psychedelic-Assisted Psychotherapy","year":"2021","cit":2,"pfa":"Tim Read","topics":["Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W3172535731","eid":"W3172535731"},{"id":"paper-w2979003464","cat":"papers","name":"INVESTIGATIONS ON SOME COMPARATIVE PHARMACOLOGY OF PALMATINE AND dl-TETRAHYDROPALMATINE","year":"1965","cit":2,"pfa":"En M","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2979003464","eid":"W2979003464"},{"id":"paper-w2027676546","cat":"papers","name":"The effect of LSD on the histology and ultrastructure of the neuroepithelium of young chick embryos: A stereological study","year":"1976","cit":2,"pfa":"Paul-Emil Messier","psa":"Marie Bellemare","ptype":"article","src":"https://openalex.org/W2027676546","eid":"W2027676546"},{"id":"paper-w3206776814","cat":"papers","name":"The Natural History of Lsd Use","year":"2017","cit":2,"pfa":"Richard Blum","psa":"Mary Lou Funkhouser","topics":["Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3206776814","eid":"W3206776814"},{"id":"paper-w4415450779","cat":"papers","name":"A Systematic Review and Meta-Analysis Investigating the Efficacy of Various Psychedelic Drugs for the Treatment of Substance Use Disorder","year":"2025","cit":2,"pfa":"Eve E. Keighley","psa":"Ahmed A. Moustafa","topics":["Addiction","Reviews & meta-analyses","Therapy practice"],"ptype":"review","src":"https://openalex.org/W4415450779","eid":"W4415450779"},{"id":"paper-w4401937696","cat":"papers","name":"The phenomenology of psilocybin’s experience mediates subsequent persistent psychological effects independently of sex, previous experience or setting","year":"2024","cit":2,"pfa":"Tereza Klučková","psa":"Tomáš Páleníček","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4401937696","eid":"W4401937696"},{"id":"paper-w2890634320","cat":"papers","name":"LSD acutely impairs fear recognition and enhances emotional empathy and sociality","year":"2016","cit":2,"pfa":"Patrick C. Dolder","psa":"Matthias E. Liechti","topics":["Anxiety & end-of-life","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2890634320","eid":"W2890634320"},{"id":"paper-w4408579473","cat":"papers","name":"Exploring the potential of psychedelic-assisted psychotherapy for moral injury: A scoping review","year":"2025","cit":2,"pfa":"Viktoriia Kurkova","psa":"Lisa Burback","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4408579473","eid":"W4408579473"},{"id":"paper-w4387461265","cat":"papers","name":"Synergistic, Multi-level Understanding of Psychedelics: Three Systematic Reviews and Meta-analyses of Their Pharmacology, Neuroimaging and Phenomenology","year":"2023","cit":2,"pfa":"Kenneth Shinozuka","psa":"Morten L. Kringelbach","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4387461265","eid":"W4387461265"},{"id":"paper-w3018197658","cat":"papers","name":"Integrating the ineffable: a social phenomenological analysis of the psychedelic experience","year":"2025","cit":2,"pfa":"Logan Neitzke‐Spruill","topics":["Addiction"],"ptype":"dissertation","src":"https://openalex.org/W3018197658","eid":"W3018197658"},{"id":"paper-w2308457744","cat":"papers","name":"Psychopharmacology of a prominent HIV antiretroviral drug","year":"2013","cit":2,"pfa":"John A. Schetz","psa":"Javier González Maeso","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2308457744","eid":"W2308457744"},{"id":"paper-w2131989305","cat":"papers","name":"Problems encountered when testing for LSD in a regional medium secure unit","year":"2002","cit":2,"pfa":"Alexis Acosta‐Armas","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2131989305","eid":"W2131989305"},{"id":"paper-w4385669019","cat":"papers","name":"Psychedelics for depression: from neurobiology to treatment","year":"2023","cit":2,"pfa":"Kim P. C. Kuypers","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4385669019","eid":"W4385669019"},{"id":"paper-w4410878629","cat":"papers","name":"Exploring Public Sentiments of Psychedelics Versus Other Substances: A Reddit-Based Natural Language Processing Study","year":"2025","cit":2,"pfa":"Brandon-Joe Biba","psa":"Brian A. O’Shea","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4410878629","eid":"W4410878629"},{"id":"paper-w4401784123","cat":"papers","name":"Low-Dose LSD Alters Early and Late Event-Related Potentials to Emotional Faces","year":"2024","cit":2,"pfa":"Connor J. Haggarty","psa":"Royce Lee","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4401784123","eid":"W4401784123"},{"id":"paper-w4233285953","cat":"papers","name":"Case Report: Magic Mushroom (Psilocybe Cubensis) Intoxication","year":"2021","cit":2,"pfa":"Andrian Fajar Kusumadewi","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4233285953","eid":"W4233285953"},{"id":"paper-w2913437043","cat":"papers","name":"LSD impairs working memory, executive functions, and cognitive flexibility, but not risk-based decision making","year":"2019","cit":2,"pfa":"Thomas Pokorny","psa":"Katrin H. Preller","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W2913437043","eid":"W2913437043"},{"id":"paper-w4385688416","cat":"papers","name":"An application of the magnetometer detection system to Crl:CD1 (ICR) mice for head twitch response induced by hallucinogenic 5-HT2A agonists","year":"2023","cit":2,"pfa":"Mari Nakamura","psa":"Akiko Inomata","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4385688416","eid":"W4385688416"},{"id":"paper-w4246031945","cat":"papers","name":"Investigating the Effects of Novel Kappa Opioid Receptor Agonists on the Dopamine Transporter","year":"2011","cit":2,"pfa":"Bridget Simonson","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W4246031945","eid":"W4246031945"},{"id":"paper-w4411781566","cat":"papers","name":"Evaluation of Interactions Between Transient Receptor Potential Vanilloid 1 and Active Constituents Using Molecular Docking","year":"2025","cit":2,"pfa":"Sahar Majdi Jaffal","psa":"Muhammad Ibrar Khan","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4411781566","eid":"W4411781566"},{"id":"paper-w7136340032","cat":"papers","name":"Psychedelic Terminology Preference in the 2024 National Survey Investigating Hallucinogenic Trends (NSIHT)","year":"2026","cit":2,"pfa":"Faith E. Lyons","psa":"Richard C. Dart","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7136340032","eid":"W7136340032"},{"id":"paper-w2063134563","cat":"papers","name":"Effect of 3,4-Methylenedioxymethamphetamine on the Toxicokinetics and Sedative Effects of the Drug of Abuse, γ-Hydroxybutyric Acid","year":"2014","cit":2,"pfa":"Nisha Vijay","psa":"Marilyn E. Morris","ptype":"article","src":"https://openalex.org/W2063134563","eid":"W2063134563"},{"id":"paper-w4379792537","cat":"papers","name":"No trip needed for psychedelics to lift mood?","year":"2023","cit":2,"pfa":"Cathleen O’Grady","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4379792537","eid":"W4379792537"},{"id":"paper-w4390014659","cat":"papers","name":"Psilocybin's Erasure of EGO","year":"2023","cit":2,"pfa":"Gary R. Ahlskog","ptype":"article","src":"https://openalex.org/W4390014659","eid":"W4390014659"},{"id":"paper-w4413352745","cat":"papers","name":"Deconstructing the trip treatment: are hallucinogenic effects critical to the therapeutic benefits of psychedelics?","year":"2025","cit":2,"pfa":"Albert Garcia‐Romeu","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4413352745","eid":"W4413352745"},{"id":"paper-w4229533752","cat":"papers","name":"Influence of Postmenopausal Hormone Replacement Therapy on Platelet Serotonin Uptake Site and Serotonin2A Receptor Binding","year":"2001","cit":2,"pfa":"Anna‐Carin Wihlbäck","psa":"Torbjörn Bäckström","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4229533752","eid":"W4229533752"},{"id":"paper-w2931876969","cat":"papers","name":"Concurrent Inhibition of Vesicular Monoamine Transporter 2 Does Not Protect Against 3,4-Methylenedioxymethamphetamine (Ecstasy) Induced Neurotoxicity","year":"2019","cit":2,"pfa":"Aram B. Cholanians","psa":"Terrence J. Monks","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2931876969","eid":"W2931876969"},{"id":"paper-w4408726292","cat":"papers","name":"Bioproduction of 3,4-methylenedioxymethamphetamine and derivatives","year":"2025","cit":2,"pfa":"Natali Özber","psa":"Peter J. Facchini","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4408726292","eid":"W4408726292"},{"id":"paper-w2065227274","cat":"papers","name":"In vivo study on the roles of cytochrome P450 enzymes for metabolism of 3,4-methylenedioxymethamphetamine (Ecstasy) in rats","year":"2008","cit":2,"pfa":"Nasrin Akhter","psa":"Takemi Yoshida","ptype":"article","src":"https://openalex.org/W2065227274","eid":"W2065227274"},{"id":"paper-w2306868728","cat":"papers","name":"[Hallucinogenic psilocybine containing mushrooms. Toxins contained in Danish wild mushrooms].","year":"1990","cit":2,"pfa":"Jens Flensted Lassen","psa":"S. F. Lassen","topics":["Anxiety & end-of-life","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2306868728","eid":"W2306868728"},{"id":"paper-w4402046019","cat":"papers","name":"Classifying Unconscious, Psychedelic, and Neuropsychiatric Brain States with Functional Connectivity, Graph Theory, and Cortical Gradient Analysis","year":"2024","cit":2,"pfa":"Hyunwoo Jang","psa":"Zirui Huang","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4402046019","eid":"W4402046019"},{"id":"paper-w1990716604","cat":"papers","name":"Doctor is suspended for prescribing a drug for pornography \"addiction\" without giving the risks","year":"2011","cit":2,"pfa":"Clare Dyer","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1990716604","eid":"W1990716604"},{"id":"paper-w2096461657","cat":"papers","name":"CALCIUM‐DEPENDENCY OF THE PRESSOR RESPONSES TO SELECTIVE 5‐HYDROXYTRYPTAMINE RECEPTOR AGONISTS IN PITHED RATS","year":"1983","cit":2,"pfa":"Hans O. Kalkman","psa":"P. A. van Zwieten","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2096461657","eid":"W2096461657"},{"id":"paper-w4293349023","cat":"papers","name":"Dantrolene Administration in the Management of the Prehospital Patient with Methylenedioxymethamphetamine Overdose: A Case Series and Literature Review","year":"2022","cit":2,"pfa":"Kia Nikoomanesh","psa":"Michael M. Neeki","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4293349023","eid":"W4293349023"},{"id":"paper-w4391316923","cat":"papers","name":"An ancient psychedelic for traumatic brain injury","year":"2024","cit":2,"pfa":"David L. Brody","psa":"Shan  H. Siddiqi","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4391316923","eid":"W4391316923"},{"id":"paper-w4377286931","cat":"papers","name":"How to sample a seizure plant: the role of the visualization spatial distribution analysis of Lophophora williamsii as an example","year":"2023","cit":2,"pfa":"Jiaman Lin","psa":"Hang Chen","ptype":"article","src":"https://openalex.org/W4377286931","eid":"W4377286931"},{"id":"paper-w3207602336","cat":"papers","name":"Psychological Antecedents to the Effects of Psychedelics on Workplace Productivity: Interview Evidence of a Naturalistic Setting","year":"2021","cit":2,"pfa":"Greg Ferenstein","ptype":"preprint","src":"https://openalex.org/W3207602336","eid":"W3207602336"},{"id":"paper-w4404862184","cat":"papers","name":"Psychedelic Research for Alcohol Use Disorder with Comorbid Major Depressive Disorder: An Unmet Need","year":"2024","cit":2,"pfa":"Daan de Jonge","psa":"Arnt Schellekens","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W4404862184","eid":"W4404862184"},{"id":"paper-w4309534681","cat":"papers","name":"Effects of 3,4‐methylenedioxymethamphetamine and methamphetamine on motor vehicle driving performance: A systematic review of experimental and observational studies","year":"2022","cit":2,"pfa":"Ian R. McGrane","psa":"Faddy A. Omar","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4309534681","eid":"W4309534681"},{"id":"paper-w7163421420","cat":"papers","name":"Inhaled Mebufotenin (GH001) for Adult Patients With Postpartum Depression","year":"2026","cit":2,"pfa":"Martin Johnson","psa":"Kristina M. Deligiannidis","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7163421420","eid":"W7163421420"},{"id":"paper-w1972577135","cat":"papers","name":"Anxiolytic effects of lisuride and its agonistic action to central 5-HT1A receptors.","year":"1991","cit":2,"pfa":"Tetsuo Akai","psa":"Motonori YAMAGUCHI","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1972577135","eid":"W1972577135"},{"id":"paper-w7154564588","cat":"papers","name":"Substance use predictors of arrest and self-reported criminal behavior in the United States: The role of psychedelics and rarely used drugs","year":"2026","cit":2,"pfa":"Jesse J. Norris","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7154564588","eid":"W7154564588"},{"id":"paper-w4412950224","cat":"papers","name":"Latent Classes of Lifetime Use of Seven Hallucinogens in the United States","year":"2025","cit":2,"pfa":"Meredith C. Meacham","psa":"Juan Carlos C. Montoy","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4412950224","eid":"W4412950224"},{"id":"paper-w4306173878","cat":"papers","name":"Use of psychedelics in the Czech Republic: results of recent population surveys","year":"2022","cit":2,"pfa":"Pavla Chomynová","psa":"Viktor Mravčík","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4306173878","eid":"W4306173878"},{"id":"paper-w2753340042","cat":"papers","name":"Longitudinal Examination of Learning and Memory in Rats Following Adolescent Exposure to 3,4-Methylenedioxymethamphetamine or 5-Methoxy-N,N-Diisopropyltryptamine","year":"2017","cit":2,"pfa":"David M. Compton","psa":"Corina Garcia","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2753340042","eid":"W2753340042"},{"id":"paper-w4405031695","cat":"papers","name":"Neuroplasticity and Psychedelics: a comprehensive examination of classic and non-classic compounds in pre and clinical models","year":"2024","cit":2,"pfa":"Claudio Agnorelli","psa":"David Erritzøe","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4405031695","eid":"W4405031695"},{"id":"paper-w2315053281","cat":"papers","name":"3,4-Methylenedioxymethamphetamine (Ecstasy) increases the sensitivity of the contractile apparatus to calcium ions in both malignant hyperthermia-susceptible and normal skeletal muscle fibres","year":"2011","cit":2,"pfa":"Mark Ulrich Gerbershagen","psa":"Wolfgang Zink","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2315053281","eid":"W2315053281"},{"id":"paper-w2891775584","cat":"papers","name":"Dopamine and serotonin antagonists fail to alter the discriminative stimulus properties of ±methylenedioxymethamphetamine","year":"2018","cit":2,"pfa":"Susan Schenk","psa":"Quenten Highgate","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2891775584","eid":"W2891775584"},{"id":"paper-w4413435066","cat":"papers","name":"Psychedelic Therapy, Positive Emotional Experiences, and the Central Role of Self-Compassion","year":"2025","cit":2,"pfa":"Richard J. Zeifman","psa":"Robin Lester Carhart-Harris","ptype":"preprint","src":"https://openalex.org/W4413435066","eid":"W4413435066"},{"id":"paper-w2411538546","cat":"papers","name":"A depressant cortical reaction induced by afferent stimulation.","year":"1976","cit":2,"pfa":"Juan García Ramos","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2411538546","eid":"W2411538546"},{"id":"paper-w4407985590","cat":"papers","name":"Transdiagnostic use of 3,4-methylenedioxymethamphetamine-assisted therapy to treat obsessive–compulsive disorder","year":"2025","cit":2,"pfa":"Ziad Saade","psa":"Alex Sogomon Keuroghlian","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4407985590","eid":"W4407985590"},{"id":"paper-w4386765447","cat":"papers","name":"Treatment‐resistant depression: where to find hope?","year":"2023","cit":2,"pfa":"Daniel Souery","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4386765447","eid":"W4386765447"},{"id":"paper-w2007737185","cat":"papers","name":"LSD and other related hallucinogens elicit myoclonic jumping behavior in the guinea pig","year":"1989","cit":2,"pfa":"Paul M. Carvey","psa":"Harold Klhhans","ptype":"article","src":"https://openalex.org/W2007737185","eid":"W2007737185"},{"id":"paper-w2781638584","cat":"papers","name":"Therapeutic potential of psychedelic agents","year":"2015","cit":2,"pfa":"Rani Pathania","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2781638584","eid":"W2781638584"},{"id":"paper-w2101751929","cat":"papers","name":"Therapeutic potential of psychedelic agents","year":"2015","cit":2,"pfa":"Matthew M. Nour","psa":"Jacob Krzanowski","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2101751929","eid":"W2101751929"},{"id":"paper-w2024394203","cat":"papers","name":"Highly Specific and Convenient Color Reaction for Methylenedioxymethamphetamine and Related Drugs Using Chromotropic Acid. Application as a Drug Screening Test","year":"1999","cit":2,"pfa":"Hideyuki Yamada","psa":"Kazuta Oguri","ptype":"article","src":"https://openalex.org/W2024394203","eid":"W2024394203"},{"id":"paper-w3215001165","cat":"papers","name":"Therapeutic interventions for PTSD – current evidence on the the role of psychedelics","year":"2021","cit":2,"pfa":"I. Figueiredo","psa":"João Victor Oliveira Miranda","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3215001165","eid":"W3215001165"},{"id":"paper-w4290721317","cat":"papers","name":"Reversing depression: A plethora of therapeutic strategies and mechanisms","year":"2022","cit":2,"pfa":"Nasrallah","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4290721317","eid":"W4290721317"},{"id":"paper-w4409228190","cat":"papers","name":"Psilocybin’s Effects on Headache Frequency are Not Related to Acute Psychedelic Effects or Measures of Mental Health: Secondary Analysis of Clinical Trials in Migraine and Cluster Headache (P7-12.001)","year":"2025","cit":2,"pfa":"Emmanuelle A. D. Schindler","psa":"Deepak Cyril D’Souza","ptype":"article","src":"https://openalex.org/W4409228190","eid":"W4409228190"},{"id":"paper-w3161618878","cat":"papers","name":"A psychedelic win raises questions for PTSD therapy","year":"2021","cit":2,"pfa":"Kelly Servick","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W3161618878","eid":"W3161618878"},{"id":"paper-w2413718189","cat":"papers","name":"[Amphetamine and its analogues determination in urine from patients hospitalized in the Department of Toxicology Jagiellonian University Collegium Medicum in Krakow].","year":"2009","cit":2,"pfa":"Ewa Gomółka","psa":"Tomasz Gawlikowski","topics":["Addiction"],"ptype":"other","src":"https://openalex.org/W2413718189","eid":"W2413718189"},{"id":"paper-w4384826730","cat":"papers","name":"Molecular Docking Analysis of Piperonal and its Analogues as Promising Cancer Therapeutics by Modulating Angiogenesis","year":"2023","cit":2,"pfa":"V. Anuradha","psa":"Sankar Muthumanickam","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4384826730","eid":"W4384826730"},{"id":"paper-w2795225485","cat":"papers","name":"T203. ILLICIT DRUGS USE AND ULTRA-HIGH RISK (UHR) FOR PSYCHOSIS STATUS IN A LATIN-AMERICAN SAMPLE","year":"2018","cit":2,"pfa":"Maurício Henriques Serpa","psa":"Wulf Rössler","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W2795225485","eid":"W2795225485"},{"id":"paper-w3006392372","cat":"papers","name":"Case Study: Species Identification of Lophophora williamsii (Psychoactive cactus) using Botanical DNA Barcodes","year":"2020","cit":2,"pfa":"Minji Lee","psa":"In Kwan Hwang","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W3006392372","eid":"W3006392372"},{"id":"paper-w4407570589","cat":"papers","name":"The Acceptability of Psychedelic‐Assisted Therapy Amongst Mental Health Consumers: Utilising the Theory of Planned Behaviour","year":"2025","cit":2,"pfa":"Eva Louie","psa":"Kirsten C. Morley","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4407570589","eid":"W4407570589"},{"id":"paper-w4417423291","cat":"papers","name":"Subjective Effects of Psychedelics Are the Plausible Mechanism of Psychedelic Moral Enhancement Rather than a Risk. Comment on Tang, B.L. Psychedelics for Moral Bioenhancement in Healthy Individuals—A Violation of the No","year":"2025","cit":2,"pfa":"Juuso Kähönen","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4417423291","eid":"W4417423291"},{"id":"paper-w4414213011","cat":"papers","name":"Clinical Psychedelic Therapy Research Involving Adolescents: Protocol for a Scoping Review of Intervention Studies","year":"2025","cit":2,"pfa":"Khaleel Rajwani","psa":"Brian David Earp","topics":["Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4414213011","eid":"W4414213011"},{"id":"paper-w1966640029","cat":"papers","name":"Profiling of 3,4-methylenedioxymethamphetamine by means of high-performance liquid chromatography","year":"2007","cit":2,"pfa":"Bogumiła Byrska","psa":"Dariusz Zuba","ptype":"article","src":"https://openalex.org/W1966640029","eid":"W1966640029"},{"id":"paper-w4415972440","cat":"papers","name":"Development and validation of a simple and fast method for routine analysis of new synthetic opioids and hallucinogens in whole blood using protein precipitation and UHPLC-MS/MS","year":"2025","cit":2,"pfa":"Joana R.P. Pereira","psa":"Suzana Fonseca","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4415972440","eid":"W4415972440"},{"id":"paper-w4394753853","cat":"papers","name":"Pharmacology of Classical Psychedelic in Mouse Models of Chronic Pain","year":"2024","cit":2,"pfa":"M. Imad Damaj","psa":"Javier González‐Maeso","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4394753853","eid":"W4394753853"},{"id":"paper-w1999605178","cat":"papers","name":"Intoxication mortelle à l’iboga: quantification de l’ibogaïne et de l’ibogamine dans des racines d’ibogaet dans des prélèvementspost-mortempar CPG-SM/SM","year":"2012","cit":2,"pfa":"Cédric Mazoyer","psa":"Yvan Gaillard","ptype":"article","src":"https://openalex.org/W1999605178","eid":"W1999605178"},{"id":"paper-w1965375227","cat":"papers","name":"Exposure to Potent Hallucinogens in an Adolescent","year":"2013","cit":2,"pfa":"Deepak Prabhakar","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1965375227","eid":"W1965375227"},{"id":"paper-w4399750332","cat":"papers","name":"Commentary on Darke et al .: Expanded psychedelic access requires new safety monitoring systems","year":"2024","cit":2,"pfa":"Philip Todd Korthuis","psa":"Andrew A. Monte","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"editorial","src":"https://openalex.org/W4399750332","eid":"W4399750332"},{"id":"paper-w4384939549","cat":"papers","name":"Early Use in Psychotherapy","year":"2023","cit":2,"pfa":"Torsten Passie","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W4384939549","eid":"W4384939549"},{"id":"paper-w4408707151","cat":"papers","name":"Underreporting of synthetic cathinone poisoning with clinical immunoassays: An experimental and observational study","year":"2025","cit":2,"pfa":"Théo Willeman","psa":"Françoise Stanke‐Labesque","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4408707151","eid":"W4408707151"},{"id":"paper-w2007512682","cat":"papers","name":"N-Arylsulfonyl-2-vinyltryptamines as new 5-HT6serotonin receptor Ligands","year":"2006","cit":2,"pfa":"Marion Raoul","psa":"Jean‐Yves Laronze","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2007512682","eid":"W2007512682"},{"id":"paper-w4247212320","cat":"papers","name":"Herbs That Madden, Herbs That Cure: A History of Hallucinogenic Plant Use in Colonial Mexico","year":"2017","cit":2,"pfa":"Melissa Frost","topics":["Addiction"],"ptype":"dissertation","src":"https://openalex.org/W4247212320","eid":"W4247212320"},{"id":"paper-w2120853326","cat":"papers","name":"Cerebral and peripheral demethylation of psychotomimetics measured by expired 14CO2","year":"1989","cit":2,"pfa":"S. W. Thornton","psa":"K S Bristol","ptype":"article","src":"https://openalex.org/W2120853326","eid":"W2120853326"},{"id":"paper-w4409574757","cat":"papers","name":"Comparative Efficacy and Functional Outcomes of Psychedelic-Assisted Therapies in Treatment-Resistant Depression: A Systematic Review of Recent Clinical Trials","year":"2025","cit":2,"pfa":"Ciara S Mimms","psa":"Abdul Khaliq","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W4409574757","eid":"W4409574757"},{"id":"paper-w4405628036","cat":"papers","name":"Psychedelic Nation? (De)Provincializing the Psychedelic Renaissance from Brazil","year":"2024","cit":2,"pfa":"Pietro Benedito","psa":"Emilia Sanabria","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4405628036","eid":"W4405628036"},{"id":"paper-w2047864845","cat":"papers","name":"The Effects of the 3,4-Methylenedioxymethamphetamine (Ecstasy) in Some Cerebral Areas: Role of the Oxidative Stress","year":"2008","cit":2,"pfa":"Sergio Franzese","psa":"Anna Capasso","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2047864845","eid":"W2047864845"},{"id":"paper-w3006076922","cat":"papers","name":"Effects of long-term neurotoxicity of 3, 4-methylenedioxymethamphetamine on spatial learning and memory function","year":"2006","cit":2,"pfa":"Su‐Xia Li","psa":"Mingsheng Huang","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3006076922","eid":"W3006076922"},{"id":"paper-w2809642892","cat":"papers","name":"Impure but not inactive: Behavioral pharmacology of dibenzylpiperazine, a common by-product of benzylpiperazine synthesis","year":"2018","cit":2,"pfa":"Sean B. Dolan","psa":"Michael B. Gatch","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2809642892","eid":"W2809642892"},{"id":"paper-w4388441865","cat":"papers","name":"Interaction of hallucinogenic rapid-acting antidepressants with mGlu2/3 receptor ligands as a window for more effective therapies","year":"2023","cit":2,"pfa":"Barbara Chruścicka‐Smaga","psa":"Andrzej Pilc","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4388441865","eid":"W4388441865"},{"id":"paper-w4306947630","cat":"papers","name":"Evidence for tolerance in psychedelic microdosing from the self-blinding microdose trial","year":"2022","cit":2,"pfa":"Stefan Baumann","psa":"Balázs Szigeti","topics":["Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4306947630","eid":"W4306947630"},{"id":"paper-w4321014012","cat":"papers","name":"Psychedelics for the Neuropsychiatric Symptoms of Alzheimer's disease","year":"2023","cit":2,"pfa":"Ashish Sarangi","psa":"Omotola Akinkunmi","ptype":"article","src":"https://openalex.org/W4321014012","eid":"W4321014012"},{"id":"paper-w2186688780","cat":"papers","name":"A Psychological Exploration of Long-Term LSD Users","year":"2015","cit":2,"pfa":"Stefanos Tsalavoutas","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"dissertation","src":"https://openalex.org/W2186688780","eid":"W2186688780"},{"id":"paper-w2422211812","cat":"papers","name":"Receptorome screening: A powerful, facile approach to better understand and engineer drugs","year":"2009","cit":2,"pfa":"Vincent Setola","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2422211812","eid":"W2422211812"},{"id":"paper-w4320888625","cat":"papers","name":"Psychotherapy and psychedelic drugs","year":"2023","cit":2,"pfa":"Gregor Hasler","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4320888625","eid":"W4320888625"},{"id":"paper-w3210930415","cat":"papers","name":"Turn On, Tune In, Drop In: Psychedelics, Creativity and Entrepreneurship","year":"2020","cit":2,"pfa":"Lawrence Silver","topics":["Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3210930415","eid":"W3210930415"},{"id":"paper-w4406218914","cat":"papers","name":"Street Pharmacology: Toxico‐Dermatology of Injection Drug Use","year":"2025","cit":2,"pfa":"David F. Lehmann","psa":"Ramsay Sami Farah","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4406218914","eid":"W4406218914"},{"id":"paper-w4410998737","cat":"papers","name":"Charting a New Frontier: Integrating Cognitive Behavioral Therapy Approaches with 3,4-methylenedioxymethamphetamine","year":"2025","cit":2,"pfa":"Leslie A. Morland","psa":"Christopher S. Stauffer","ptype":"article","src":"https://openalex.org/W4410998737","eid":"W4410998737"},{"id":"paper-w2335619322","cat":"papers","name":"Biochemical Implications of Ecstasy Toxicity","year":"1997","cit":2,"pfa":"B. V. S. Murthy","psa":"R.G. Wilkes","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2335619322","eid":"W2335619322"},{"id":"paper-w2024051010","cat":"papers","name":"Hallucinogen-induced behaviors of free-moving chimpanzees","year":"1977","cit":2,"pfa":"Kirk J. Brower","psa":"Ronald K. Siegel","ptype":"article","src":"https://openalex.org/W2024051010","eid":"W2024051010"},{"id":"paper-w2041539074","cat":"papers","name":"Primitive Group Treatment","year":"2010","cit":2,"pfa":"Moïsès Lemlij","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2041539074","eid":"W2041539074"},{"id":"paper-w2563448382","cat":"papers","name":"Genetics and phytochemistry of Salvia divinorum","year":"2016","cit":2,"pfa":"Ivan Casselman","topics":["Reviews & meta-analyses"],"ptype":"dissertation","src":"https://openalex.org/W2563448382","eid":"W2563448382"},{"id":"paper-w4389751274","cat":"papers","name":"Knowledge gaps in psychedelic medicalisation: Preclinical and neuroimaging mechanisms","year":"2023","cit":2,"pfa":"Drummond E-Wen McCulloch","psa":"Gitte M. Knudsen","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4389751274","eid":"W4389751274"},{"id":"paper-w4410779110","cat":"papers","name":"Pharmacologic interventions for alcohol use disorder","year":"2025","cit":2,"pfa":"Jordan Menge","psa":"Bernadette Evitt","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4410779110","eid":"W4410779110"},{"id":"paper-w4389355720","cat":"papers","name":"The relationship between cryptomarket drug purchase, social networks and adverse drug events: A cross-sectional study","year":"2023","cit":2,"pfa":"Leigh Coney","psa":"Monica Jane Barratt","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4389355720","eid":"W4389355720"},{"id":"paper-w4313903356","cat":"papers","name":"When art therapy went chemical: Alfred Bader, pharmacology, and art brut, c.1950-1970s","year":"2022","cit":2,"pfa":"Jelena Martinovic","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4313903356","eid":"W4313903356"},{"id":"paper-w2949038984","cat":"papers","name":"Cynthia Carson Bisbee, Paul Bisbee, Erika Dyck, Patrick Farrell, James Sexton and James W. Spisak (eds), Psychedelic Prophets: The Letters of Aldous Huxley and Humphry Osmond","year":"2019","cit":2,"pfa":"NANCY D. CAMPBELL","ptype":"article","src":"https://openalex.org/W2949038984","eid":"W2949038984"},{"id":"paper-w2284448340","cat":"papers","name":"[Prevalence and network-characteristics of risky sexual behaviors among clients receiving methadone maintenance treatment at clinics in Taizhou prefecture of Zhejiang province].","year":"2015","cit":2,"pfa":"Hongling Bai","psa":"Na He","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2284448340","eid":"W2284448340"},{"id":"paper-w4321602477","cat":"papers","name":"A Comprehensive Review on Potentially Therapeutic Agents against COVID-19 from Natural Sources","year":"2023","cit":2,"pfa":"Ali Shahali","psa":"Rashid Alijani Ardeshir","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4321602477","eid":"W4321602477"},{"id":"paper-w2506913868","cat":"papers","name":"Use of LSD by Mental Health Professionals","year":"2016","cit":2,"pfa":"Petr Winkler","psa":"Rita Kočárová","ptype":"book-chapter","src":"https://openalex.org/W2506913868","eid":"W2506913868"},{"id":"paper-w1494239091","cat":"papers","name":"Studies of perceptiotropic phenethylamines: Determinants of affinity for the 5-HT(2A) receptor","year":"1998","cit":2,"pfa":"Matthew Parker","topics":["Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W1494239091","eid":"W1494239091"},{"id":"paper-w972780416","cat":"papers","name":"Discussion of the Fate and Metabolism of Some Hallucinogenic Indolealkylamines","year":"1968","cit":2,"pfa":"Stephen Szára","ptype":"editorial","src":"https://openalex.org/W972780416","eid":"W972780416"},{"id":"paper-w3197478362","cat":"papers","name":"Unseen Women in Psychedelic History","year":"2021","cit":2,"pfa":"Mariavittoria Mangini","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W3197478362","eid":"W3197478362"},{"id":"paper-w4220697070","cat":"papers","name":"Cannabinoids and Psychedelics for Neuropsychiatric Symptoms of Alzheimer's: Addressing Disparities Through Clinical Trials","year":"2022","cit":2,"pfa":"Brent P. Forester","psa":"Paul B. Rosenberg","ptype":"article","src":"https://openalex.org/W4220697070","eid":"W4220697070"},{"id":"paper-w4411149610","cat":"papers","name":"Psychedelic fungi","year":"2025","cit":2,"pfa":"Jason C. Slot","psa":"Dirk Hoffmeister","topics":["Addiction","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4411149610","eid":"W4411149610"},{"id":"paper-w4291291293","cat":"papers","name":"Analyses of LSD analogs in illegal products: The identification of 1cP-AL-LAD, 1cP-MIPLA and 1V-LSD","year":"2022","cit":2,"pfa":"Rie Tanaka","psa":"Ruri Kikura‐Hanajiri","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4291291293","eid":"W4291291293"},{"id":"paper-w4407555538","cat":"papers","name":"Editorial: Case reports in psychopharmacology, volume II","year":"2025","cit":2,"pfa":"Matej Štuhec","psa":"Patricia Di Ciano","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"editorial","src":"https://openalex.org/W4407555538","eid":"W4407555538"},{"id":"paper-w3150371472","cat":"papers","name":"Optimizing psychedelic compounds for neuropsychiatric therapy","year":"2021","cit":2,"pfa":"Scott M. Thompson","ptype":"article","src":"https://openalex.org/W3150371472","eid":"W3150371472"},{"id":"paper-w2410169794","cat":"papers","name":"[Epidemiology of drug abuse and dependence].","year":"2010","cit":2,"pfa":"Kiyoshi Wada","topics":["Safety & adverse events"],"ptype":"other","src":"https://openalex.org/W2410169794","eid":"W2410169794"},{"id":"paper-w7161565928","cat":"papers","name":"Amendment LXXVIII — Psychedelic and Cannabinoid Pharmacology as Phi Modulation (v2 — Corrigendum: f_pulse=220Hz not 7.83Hz)","year":"2026","cit":2,"pfa":"Justin McCaul","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"erratum","src":"https://openalex.org/W7161565928","eid":"W7161565928"},{"id":"paper-w4313201420","cat":"papers","name":"Antipsychotic prescribing trends in schizophrenia between 2011 and 2021: real-world data from a US electronic health record database","year":"2022","cit":2,"pfa":"K. Griffiths","psa":"Rashmi Patel","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4313201420","eid":"W4313201420"},{"id":"paper-w4252557745","cat":"papers","name":"Acute hypereosinophilic syndrome. Successful treatment with vincristine, cytarabine, and prednisone","year":"1979","cit":2,"pfa":"Ellis J. Van Slyck","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4252557745","eid":"W4252557745"},{"id":"paper-w1568590164","cat":"papers","name":"PHARMACOLOGICAL CHARACTERIZATION OF TERPENIC SECONDARY METABOLITES ISOLATED FROM SALVIA SPECIES","year":"2009","cit":2,"pfa":"Maria Carmela Bonito","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1568590164","eid":"W1568590164"},{"id":"paper-w2991036280","cat":"papers","name":"Chamanisation des visions de l’iboga","year":"2019","cit":2,"pfa":"Nadège Chabloz","ptype":"article","src":"https://openalex.org/W2991036280","eid":"W2991036280"},{"id":"paper-w4405966740","cat":"papers","name":"Time-resolved neural and experience dynamics of medium- and high-dose DMT","year":"2024","cit":2,"pfa":"Evan Lewis-Healey","psa":"Tristán Bekinschtein","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4405966740","eid":"W4405966740"},{"id":"paper-w4408390219","cat":"papers","name":"A Machine Learning Using NLP to Predict Long-Term Patient Response","year":"2025","cit":2,"pfa":"K. Suresh Kumar","psa":"Pramoda Patro","topics":["Depression","Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W4408390219","eid":"W4408390219"},{"id":"paper-w4253712083","cat":"papers","name":"Integrative Addiction and Recovery","year":"2018","cit":2,"topics":["PTSD & trauma","Addiction","Reviews & meta-analyses"],"ptype":"book","src":"https://openalex.org/W4253712083","eid":"W4253712083"},{"id":"paper-w2336290667","cat":"papers","name":"Behavioral interactions of opioid agonists and antagonists with serotonergic systems.","year":"1984","cit":2,"pfa":"Richard H. Rech","psa":"Judith W. Henck","topics":["Addiction","Mechanism & neuroscience"],"ptype":"dataset","src":"https://openalex.org/W2336290667","eid":"W2336290667"},{"id":"paper-w4389496179","cat":"papers","name":"The Pharmacognosy of Salvia Divinorum (Epling and Jativa-M): an Investigation of Ska Maria Pastora (Mexico).","year":"1983","cit":2,"pfa":"Leander J. Valdés","topics":["Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W4389496179","eid":"W4389496179"},{"id":"paper-w7124831931","cat":"papers","name":"Hallucinogen use in the United States, 2021–2023: Diverging trends and subgroup patterns","year":"2026","cit":2,"pfa":"Jing-Jer Chen","psa":"Y. Tony Yang","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7124831931","eid":"W7124831931"},{"id":"paper-w4407619442","cat":"papers","name":"De-Centering the Organism: Psychedelic Therapies, Fungi and the Body without Organs","year":"2025","cit":2,"pfa":"Ernesto Grillo Rabello","psa":"Fábio Hebert da Silva","topics":["Safety & adverse events","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4407619442","eid":"W4407619442"},{"id":"paper-w2044771448","cat":"papers","name":"Mental health projects in developing countries share $19m investment","year":"2012","cit":2,"pfa":"Anne Gulland","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2044771448","eid":"W2044771448"},{"id":"paper-w3090724191","cat":"papers","name":"Amphetamine and methamphetamine poisonings attended in hospital emergency departments: clinical features and the usefulness of laboratory confirmation.","year":"2020","cit":2,"pfa":"Carolina Roset Ferrer","psa":"Bernardino Barceló Martín","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3090724191","eid":"W3090724191"},{"id":"paper-w4409215134","cat":"papers","name":"The compulsive eating paradigm: can psychedelics help in treating obesity?","year":"2025","cit":2,"pfa":"Dhanush Ammineni","psa":"Rebecca J. Park","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4409215134","eid":"W4409215134"},{"id":"paper-w3015888265","cat":"papers","name":"[Occurrence and Removal of N-nitrosamines in the Wastewater Treatment Plants Using Different Treatment Processes].","year":"2019","cit":2,"pfa":"Wang-Rong Liu","psa":"Guang‐Guo Ying","ptype":"other","src":"https://openalex.org/W3015888265","eid":"W3015888265"},{"id":"paper-w2432157518","cat":"papers","name":"[Biogenic amines and schizophrenia].","year":"1975","cit":2,"pfa":"Josef Schöpf","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W2432157518","eid":"W2432157518"},{"id":"paper-w3209354001","cat":"papers","name":"A “GENERAL THEORY OF MENTAL SUFFERING”, AND THE ROLE OF AN INNOVATIVE NARRATIVE THERAPEUTIC APPROACH","year":"2021","cit":2,"pfa":"Derek Botha","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3209354001","eid":"W3209354001"},{"id":"paper-w4413908189","cat":"papers","name":"Neuroplasticity and Neuro-Generation: The Promise of Psychedelics in Dementia Care","year":"2025","cit":2,"pfa":"Kerem Kemal Soylemez","psa":"Joanne Marie Lusher","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4413908189","eid":"W4413908189"},{"id":"paper-w4379387401","cat":"papers","name":"Is Microdosing a Placebo?","year":"2023","cit":2,"pfa":"Vince Polito","psa":"Paul Liknaitzky","topics":["Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4379387401","eid":"W4379387401"},{"id":"paper-w4410201696","cat":"papers","name":"Updates in the treatment of eating disorders in 2024: a year in review in Eating Disorders: The Journal of Treatment & Prevention","year":"2025","cit":2,"pfa":"Krista Tabuenca","psa":"Stuart B. Murray","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4410201696","eid":"W4410201696"},{"id":"paper-w4389663240","cat":"papers","name":"The Bad Seed: Mystical Experience and Time Travel in the Treatment of Psychopathy","year":"2023","cit":2,"pfa":"Noelle Burton","ptype":"article","src":"https://openalex.org/W4389663240","eid":"W4389663240"},{"id":"paper-w4407813754","cat":"papers","name":"Biological treatments for co-occurring eating disorders and psychological trauma: a systematic review","year":"2025","cit":2,"pfa":"Ella van Beers","psa":"Elske M. van den Berg","topics":["PTSD & trauma","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4407813754","eid":"W4407813754"},{"id":"paper-w4214920410","cat":"papers","name":"Prevalence, psychiatric correlates, and psychosocial determinants of illicit substance use among UK undergraduate students","year":"2022","cit":2,"pfa":"Umair Akram","psa":"Holly Foster","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W4214920410","eid":"W4214920410"},{"id":"paper-w7162546150","cat":"papers","name":"Improving access to novel treatments for treatment-resistant depression: The potential role of specialist clinics in Australia","year":"2026","cit":2,"pfa":"Yash Giri","psa":"Prashant Tibrewal","topics":["Depression","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7162546150","eid":"W7162546150"},{"id":"paper-w4407044130","cat":"papers","name":"Investigating novel pharmacological strategies for treatment-resistant depression: focus on new mechanisms and approaches","year":"2025","cit":2,"pfa":"Aline Silva de Miranda","psa":"Antônio Lúcio Teixeira","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4407044130","eid":"W4407044130"},{"id":"paper-w2593514639","cat":"papers","name":"Locomotor activating effects and addiction-like features of MDPV as assessed in preclinical studies: a review.","year":"2017","cit":2,"pfa":"Josep M. Montero Moreno","psa":"Marta Miquel","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2593514639","eid":"W2593514639"},{"id":"paper-w1601167274","cat":"papers","name":"Monitoring the depth of anaesthesia using simplified electroencephalogram (EEG)","year":"2026","cit":2,"pfa":"Tai Nguyen‐Ky","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W1601167274","eid":"W1601167274"},{"id":"paper-w2974666845","cat":"papers","name":"Analysis and subsequent molecular docking of selected phytochemicals with SLC6A3 and SLC6A4 as potential therapeutic agents for Obsessive-Compulsive Disorder (OCD)","year":"2019","cit":2,"pfa":"Swarn Singh Warshaneyan","psa":"Prachi Srivastava","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W2974666845","eid":"W2974666845"},{"id":"paper-w2102246120","cat":"papers","name":"The Adrenochrome Hypothesis and Psychiatry","year":"1990","cit":2,"pfa":"Abram Hoffer","psa":"H Osmond","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2102246120","eid":"W2102246120"},{"id":"paper-w2989474691","cat":"papers","name":"WHAT KIND OF HEALING DOES PSYCHEDELIC-ASSISTED PSYCHOTHERAPY FOSTER?","year":"2019","cit":2,"pfa":"Candice L. Shelby","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W2989474691","eid":"W2989474691"},{"id":"paper-w4391440566","cat":"papers","name":"Sweating for Sobriety: Exploring the Relationship Between Exercise Engagement and Substance Use Disorders","year":"2024","cit":2,"pfa":"Baldur Jón Gústafsson","psa":"Timothy M. Piatkowski","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4391440566","eid":"W4391440566"},{"id":"paper-w2970574043","cat":"papers","name":"Anti‐inflammatory effects of serotonin 5‐HT 2A receptor activation in ovalbumin‐induced allergic asthma models","year":"2017","cit":2,"pfa":"Thomas Wayne Flanagan","psa":"Charles David Nichols","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2970574043","eid":"W2970574043"},{"id":"paper-w4400581008","cat":"papers","name":"Assessment of psychedelic--induced states: Norwegian translation and adaptation of the revised Mystical Experience Questionnaire (MEQ-30)","year":"2024","cit":2,"pfa":"Kristoffer Andreas Aamodt Andersen","psa":"Lowan Han Stewart","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4400581008","eid":"W4400581008"},{"id":"paper-w4414705311","cat":"papers","name":"Digital Enablement of Psychedelic-Assisted Therapy in Non-Clinical Settings: A Systematic Review of Safety, Efficacy, and Implementation Models","year":"2025","cit":2,"pfa":"Brendan Driscoll","psa":"Shaheen Emmanuel Lakhan","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W4414705311","eid":"W4414705311"},{"id":"paper-w2962400686","cat":"papers","name":"Comparing the detection of endogenous psychedelics in individuals with and without alleged mediumistic experiences","year":"2019","cit":2,"pfa":"Marco Aurélio Vinhosa Bastos","psa":"Giancarlo Lucchetti","ptype":"article","src":"https://openalex.org/W2962400686","eid":"W2962400686"},{"id":"paper-w2909439728","cat":"papers","name":"LSD treatment in Scandinavia: the early enthusiasm and the resurgent interest","year":"2018","cit":2,"pfa":"Jens Knud Larsen","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2909439728","eid":"W2909439728"},{"id":"paper-w7141898289","cat":"papers","name":"Mapping cognitive-behavioral approach in psychedelic-assisted treatment: a systematic review across phases with classic and non-classic psychedelics","year":"2026","cit":2,"pfa":"Yves Martins Varela","psa":"Nicole Leite Galvão Coelho","topics":["Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7141898289","eid":"W7141898289"},{"id":"paper-w3081065706","cat":"papers","name":"[Microdosing with psychedelics: what do we know?]","year":"2020","cit":2,"pfa":"Kim P. C. Kuypers","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3081065706","eid":"W3081065706"},{"id":"paper-w4386946244","cat":"papers","name":"Early onset Parkinson’s disease in the cycle of 3,4-methylenedioxymethamphetamine and substance use: a case report","year":"2023","cit":2,"pfa":"Tianyi Hui","psa":"Guo Song","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4386946244","eid":"W4386946244"},{"id":"paper-w4388646216","cat":"papers","name":"Aesthetic Chills Mitigate Maladaptive Cognition In Depression","year":"2023","cit":2,"pfa":"Félix Schoeller","psa":"Nicco Reggente","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4388646216","eid":"W4388646216"},{"id":"paper-w4399025585","cat":"papers","name":"Resetting the Hippocampal Buffer: A Neurocognitive Account of Psychedelic Therapy for Anxiety-Related Psychopathology","year":"2024","cit":2,"pfa":"Hugh McGovern","psa":"Manoj K. Doss","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4399025585","eid":"W4399025585"},{"id":"paper-w4396883255","cat":"papers","name":"Psychotherapeutisches Setting und Integration bei psychedelikaassistierter Therapie","year":"2024","cit":2,"pfa":"Manuela Brand","psa":"Gerhard Gründer","topics":["Depression","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4396883255","eid":"W4396883255"},{"id":"paper-w4376254936","cat":"papers","name":"The case for reverse engineering ketamine and psychedelics: lessons from translational oncology. A Response to Miller et al. “Burning down the house: reinventing drug discovery in psychiatry for the development of target","year":"2023","cit":2,"pfa":"Gregory H. Jones","psa":"Rodrigo Machado‐Vieira","ptype":"article","src":"https://openalex.org/W4376254936","eid":"W4376254936"},{"id":"paper-w4416780344","cat":"papers","name":"Approved and Pipeline Pharmacological Interventions for Eating Disorders (2010–2025): 15 Years of Progress (or Lack Thereof)","year":"2025","cit":2,"pfa":"Drew Hirsch","psa":"Rebecca Hedrick","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4416780344","eid":"W4416780344"},{"id":"paper-w2086150312","cat":"papers","name":"Quantum chemical, other theoretical and physicochemical studies on narcotics and narcotic antagonists to understand their mechanism of action","year":"2009","cit":2,"pfa":"Joyce J. Kaufman","psa":"Walter S. Koski","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2086150312","eid":"W2086150312"},{"id":"paper-w3132993084","cat":"papers","name":"Drug addiction profile and monitoring liver functions tests of addicts at a specialized psychiatric treatment center","year":"2021","cit":2,"pfa":"Benhaddou ISMAIL","psa":"Mohamed Achouri","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W3132993084","eid":"W3132993084"},{"id":"paper-w4400793036","cat":"papers","name":"A case of severe and prolonged γ‐hydroxybutyrate ( GHB ) withdrawal syndrome successfully managed with a slow benzodiazepine and baclofen taper","year":"2024","cit":2,"pfa":"Rachit Gupta","psa":"Adam Pastor","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4400793036","eid":"W4400793036"},{"id":"paper-w7131675232","cat":"papers","name":"Psychedelic therapy and cultural humility","year":"2026","cit":2,"pfa":"Alex K. Gearin","psa":"Peter Tanuseputro","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7131675232","eid":"W7131675232"},{"id":"paper-w4389848792","cat":"papers","name":"Rewarding Effects of the Hallucinogen 4-AcO-DMT Administration and Withdrawal in Rats: A Challenge to the Opponent-Process Theory","year":"2023","cit":2,"pfa":"Héctor Vargas-Pérez","psa":"Derek van der Kooy","ptype":"article","src":"https://openalex.org/W4389848792","eid":"W4389848792"},{"id":"paper-w4416050056","cat":"papers","name":"Straightforward screening of ketamine in forensic samples using voltammetry with screen-printed carbon graphite electrodes","year":"2025","cit":2,"pfa":"Camila D. Lima","psa":"Wallans Torres Pio dos Santos","ptype":"article","src":"https://openalex.org/W4416050056","eid":"W4416050056"},{"id":"paper-w3102002123","cat":"papers","name":"Patterns of Recreational Drug Use and Harm Reduction Strategies among Women at Music Festivals: The Case of Hungary and Poland","year":"2020","cit":2,"pfa":"Iga Jeziorska","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W3102002123","eid":"W3102002123"},{"id":"paper-w4391002240","cat":"papers","name":"Mechanisms of psychiatric disorders induced by amphetamines: A comprehensive review","year":"2024","cit":2,"pfa":"Saud D AlOtaibi","psa":"Hossam Abdelkader Elsisi","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4391002240","eid":"W4391002240"},{"id":"paper-w4385283640","cat":"papers","name":"The Potential for Psychedelics to Improve Coping Skills and Resilience in Persons With Newly Diagnosed Mild Cognitive Impairment or Early Alzheimer’s Disease","year":"2023","cit":2,"pfa":"Martin I. Steinberg","psa":"Albert Garcia‐Romeu","ptype":"article","src":"https://openalex.org/W4385283640","eid":"W4385283640"},{"id":"paper-w4407394179","cat":"papers","name":"Can psychedelic use benefit meditation practice? Examining individual, psychedelic, and meditation-related factors","year":"2025","cit":2,"pfa":"Zishan Jiwani","psa":"Marco Schlosser","ptype":"article","src":"https://openalex.org/W4407394179","eid":"W4407394179"},{"id":"paper-w4415267479","cat":"papers","name":"Review of Selected 2-Phenylethylamine Derivatives and Opioids, Systematic Review of Their Effects on Psychomotor Abilities and Driving Performance: Psychopharmacology in the Context of Road Safety","year":"2025","cit":2,"pfa":"Kacper Żełabowski","psa":"Agnieszka Chłopaś‐Konowałek","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W4415267479","eid":"W4415267479"},{"id":"paper-w4399993439","cat":"papers","name":"Ketamine-Induced Unresponsiveness Shows a Harmonic Shift from Global to Localised Functional Organisation","year":"2024","cit":2,"pfa":"Milan Van Maldegem","psa":"Andrea I. Luppi","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4399993439","eid":"W4399993439"},{"id":"paper-w7132822659","cat":"papers","name":"5‐HT 2A receptors in the prelimbic cortex VIP‐expressing interneurons: A mechanism for psychedelic‐induced innate fear attenuation","year":"2026","cit":2,"pfa":"Yuanyuan Wang","psa":"Haitao Yan","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7132822659","eid":"W7132822659"},{"id":"paper-w4412984573","cat":"papers","name":"Beyond the Journey: A Qualitative Analysis of Therapists’ Perspectives on Psychedelic Integration Challenges","year":"2025","cit":2,"pfa":"Christina Chwyl","psa":"Eva Therese Næss","topics":["Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4412984573","eid":"W4412984573"},{"id":"paper-w4408462954","cat":"papers","name":"Editorial: Safety and side effects of psychotropic medications, volume III","year":"2025","cit":2,"pfa":"Renato de Filippis","psa":"Mohammadreza Shalbafan","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"editorial","src":"https://openalex.org/W4408462954","eid":"W4408462954"},{"id":"paper-w4323967832","cat":"papers","name":"An Encounter with the Self: A Thematic and Content Analysis of the DMT Experience from a Naturalistic Field Study","year":"2023","cit":2,"pfa":"Pascal Michael","psa":"Oliver C. Robinson","ptype":"preprint","src":"https://openalex.org/W4323967832","eid":"W4323967832"},{"id":"paper-w4415348981","cat":"papers","name":"The THRIVE Model of Psychedelic Integration: A Holistic Framework Bridging Indigenous Knowledge and Evidence-Based Practice","year":"2025","cit":2,"pfa":"Ashvind N. Adkins Singh","psa":"Glauber Loures de Assis","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4415348981","eid":"W4415348981"},{"id":"paper-w7163544069","cat":"papers","name":"Substance-induced manic psychosis in which delusions were corroborated by a chatbot - case report","year":"2026","cit":2,"pfa":"Sachin Shah","psa":"Hamilton Morrin","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7163544069","eid":"W7163544069"},{"id":"paper-w2050733815","cat":"papers","name":"Manifestations and treatment of central nervous system complications associated with synthetic cathinone (“bath salts”) toxicities","year":"2013","cit":2,"pfa":"Ryan Gries","psa":"Kristyn Straw","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2050733815","eid":"W2050733815"},{"id":"paper-w4403807810","cat":"papers","name":"Recreational drugs use as prognostic factor of major adverse cardiovascular and cerebrovascular events in patients hospitalised for acute cardiovascular events","year":"2024","cit":2,"pfa":"Raphaël Mirailles","psa":"Théo Pezel","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4403807810","eid":"W4403807810"},{"id":"paper-w4413015545","cat":"papers","name":"Are Intravenous Subnarcotic Ketamine Infusions as an Adjunct Treatment for Treatment-Resistant Depression Ready to be Recommended in European Guidelines?","year":"2025","cit":2,"pfa":"Udo Bonnet","psa":"Tom Bschor","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4413015545","eid":"W4413015545"},{"id":"paper-w4232529846","cat":"papers","name":"Investigating the antinociceptive effects of N-docosahexaenoyl ethanolamine and novel kappa opioid receptor agonists","year":"2018","cit":2,"pfa":"Kelly F. Paton","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W4232529846","eid":"W4232529846"},{"id":"paper-w4385217800","cat":"papers","name":"Die richtige Einstellung : Microdosing und die Medikamentierung des Alltags","year":"2023","cit":2,"pfa":"Stefan Höhne","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4385217800","eid":"W4385217800"},{"id":"paper-w3115206633","cat":"papers","name":"How Can Routine Clinical Laboratories Keep Up with the Opioid Crisis?","year":"2020","cit":2,"pfa":"Christine L.H. Snozek","psa":"Danyel Hermes Tacker","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3115206633","eid":"W3115206633"},{"id":"paper-w2530188143","cat":"papers","name":"Ketamine-Assisted Psychedelic Therapy","year":"1993","cit":2,"pfa":"Evgeny M. Krupitsky","psa":"A. Y. Grinenko","topics":["Addiction","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2530188143","eid":"W2530188143"},{"id":"paper-w4235315057","cat":"papers","name":"Psychedelic therapy.","year":"1968","cit":2,"pfa":"Charles Savage","ptype":"book-chapter","src":"https://openalex.org/W4235315057","eid":"W4235315057"},{"id":"paper-w4376117044","cat":"papers","name":"Psychedelic-Assisted Internal Family Systems Therapy","year":"2023","cit":2,"pfa":"Robert M. Grant","topics":["Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W4376117044","eid":"W4376117044"},{"id":"paper-w4376117093","cat":"papers","name":"Relational Touch in Psychedelic-Assisted Therapy","year":"2023","cit":2,"pfa":"Shirley Dvir","psa":"Jacki Hull","topics":["PTSD & trauma","Therapy practice","Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W4376117093","eid":"W4376117093"},{"id":"paper-w4212926858","cat":"papers","name":"The mechanisms of psychedelic therapy","year":"2021","cit":2,"pfa":"Chris Letheby","topics":["Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W4212926858","eid":"W4212926858"},{"id":"paper-w4387338542","cat":"papers","name":"Psychedelic Therapy: Beyond Brain, Embracing Culture","year":"2023","cit":2,"pfa":"Inês Hipólito","psa":"Sofia Tzima","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4387338542","eid":"W4387338542"},{"id":"paper-w4389312302","cat":"papers","name":"Ketamine-Assisted Psychodynamic Psychotherapy","year":"2023","cit":2,"pfa":"John G. Cottone","topics":["PTSD & trauma","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4389312302","eid":"W4389312302"},{"id":"paper-w4400993238","cat":"papers","name":"Psychedelic experiences in psychedelic-assisted therapy for depression","year":"2024","cit":2,"pfa":"Uzair Khan","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4400993238","eid":"W4400993238"},{"id":"paper-w4401208216","cat":"papers","name":"Ketamine-Assisted Psychotherapy: opportunities and challenges","year":"2024","cit":2,"pfa":"Daniël Kleinloog","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4401208216","eid":"W4401208216"},{"id":"paper-w4410075856","cat":"papers","name":"Psychedelic Therapies as Resistance to Neoliberalism: A Brazilian Schizoanalytical Perspective","year":"2025","cit":2,"pfa":"Ernesto Grillo Rabello","psa":"Fábio Hebert da Silva","topics":["Dosing & pharmacology","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4410075856","eid":"W4410075856"},{"id":"paper-w4412088001","cat":"papers","name":"Psychedelic-Assisted Therapy Training in the US: A Landscape Analysis","year":"2025","cit":2,"pfa":"Roman Palitsky","psa":"Gosia Sklodowska","topics":["Anxiety & end-of-life","Safety & adverse events","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4412088001","eid":"W4412088001"},{"id":"paper-w4323346033","cat":"papers","name":"Psychedelic-Assisted Psychotherapy: Great Promise and Great Challenges","year":"2022","cit":2,"pfa":"Franklin King","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4323346033","eid":"W4323346033"},{"id":"paper-w4411236005","cat":"papers","name":"Pasifika healthcare professionals' perspectives on psychedelic-assisted therapy","year":"2025","cit":2,"pfa":"Musheerah Nuha","psa":"Jessee Fia’Ali’i","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4411236005","eid":"W4411236005"},{"id":"paper-w4317212751","cat":"papers","name":"Psychedelic-Assisted Neuroplasticity for the Treatment of Mental Health Disorders","year":"2023","cit":2,"pfa":"Robert B. Kargbo","topics":["Depression","PTSD & trauma","Mechanism & neuroscience"],"ptype":"editorial","src":"https://openalex.org/W4317212751","eid":"W4317212751"},{"id":"paper-w4323363512","cat":"papers","name":"Psychedelic-Assisted Psychotherapy, Patient Vulnerability and Abuses of Power","year":"2023","cit":2,"pfa":"Sally E Meikle","psa":"Gillinder Bedi","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4323363512","eid":"W4323363512"},{"id":"paper-w4229370876","cat":"papers","name":"Corrigendum to “Decreases in Suicidality Following Psychedelic Therapy","year":"2022","cit":2,"pfa":"Richard J. Zeifman","psa":"Cory R. Weissman","ptype":"erratum","src":"https://openalex.org/W4229370876","eid":"W4229370876"},{"id":"paper-w4408396635","cat":"papers","name":"Māori healthcare professionals’ perceptions of psychedelic-assisted therapy: a qualitative study","year":"2025","cit":2,"pfa":"Carly Hanna","psa":"Lisa Reynolds","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4408396635","eid":"W4408396635"},{"id":"paper-w4406146769","cat":"papers","name":"Ketamine-Assisted Psychotherapy for Antisocial Personality Disorder: A Case Report","year":"2025","cit":2,"pfa":"Matthew Hicks","psa":"Ryan D. Bradley","topics":["Depression","Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4406146769","eid":"W4406146769"},{"id":"paper-w4413868564","cat":"papers","name":"Psychedelic therapy: bridging neuroplasticity, phenomenology, and clinical outcomes","year":"2025","cit":2,"pfa":"Ronit Kishon","psa":"Yael M. Cycowicz","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4413868564","eid":"W4413868564"},{"id":"paper-w4411951927","cat":"papers","name":"Understanding the Experience of Ketamine-Assisted Therapy and the Importance of Context","year":"2025","cit":2,"pfa":"Grace Stockwell","psa":"Lisa Reynolds","topics":["Depression","PTSD & trauma","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4411951927","eid":"W4411951927"},{"id":"paper-w4407686725","cat":"papers","name":"Psychedelic Assisted Therapy as a Complex Intervention: Implications for clinical trial design","year":"2025","cit":2,"pfa":"Suresh D Muthukumaraswamy","psa":"Tehseen N. Noorani","topics":["Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4407686725","eid":"W4407686725"},{"id":"paper-w4390611291","cat":"papers","name":"Ketamine-Assisted Psychotherapy for Suicide Crisis Syndrome: Case report","year":"2023","cit":2,"pfa":"Program Director Of General Psychiatry Residency","psa":"Eyuel Terefe","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4390611291","eid":"W4390611291"},{"id":"paper-w4399055776","cat":"papers","name":"Real-world evidence of the collective effects of psychedelic therapy: Evaluating from the grassroots","year":"2024","cit":2,"pfa":"Tehseen N. Noorani","psa":"Rachel Jane Liebert","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4399055776","eid":"W4399055776"},{"id":"paper-w4399519673","cat":"papers","name":"Reeling from FDA setback, researchers plot the future of psychedelic-assisted medicine","year":"2024","cit":2,"ptype":"dataset","src":"https://openalex.org/W4399519673","eid":"W4399519673"},{"id":"paper-w4403403504","cat":"papers","name":"Therapist, Trip Sitter Or Guide? A Second-Person Perspective on Psychedelic-Assisted Psychotherapy","year":"2024","cit":2,"pfa":"Chiara Caporuscio","psa":"Adrian Kind","topics":["Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W4403403504","eid":"W4403403504"},{"id":"paper-w4400517916","cat":"papers","name":"Contributions of the compassionate care approach to psychedelic-assisted therapies in hospice and palliative care","year":"2024","cit":2,"pfa":"Ana Cláudia Mesquita Garcia","psa":"Lucas Oliveira Maia","topics":["Anxiety & end-of-life","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4400517916","eid":"W4400517916"},{"id":"paper-w7134129907","cat":"papers","name":"Safety and efficacy are hardly separable in psychedelic therapy: A mechanism-based critique","year":"2026","cit":2,"pfa":"Max Wolff","psa":"Helena Aicher","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7134129907","eid":"W7134129907"},{"id":"paper-w4319943862","cat":"papers","name":"Psychedelic-Assisted Therapies and Pediatric Palliative Care: New Tools for Hope and Healing (TH118A)","year":"2023","cit":2,"pfa":"Elisha D. Waldman","psa":"Dingle Spence","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4319943862","eid":"W4319943862"},{"id":"paper-w4412157241","cat":"papers","name":"“Honoring Beautiful Connections”: LGBTQA+ Perspectives on Providing Safe and Inclusive Psychedelic-Assisted Therapy","year":"2025","cit":2,"pfa":"Riccardo Miceli McMillan","psa":"Amy B. Mullens","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4412157241","eid":"W4412157241"},{"id":"paper-w4408969337","cat":"papers","name":"Human Service Professionals’, Educators’, and Students’ Attitudes Toward Psychedelics and Psychedelic Therapy","year":"2025","cit":2,"pfa":"Michelle Kelley Shuler","psa":"Elizabeth A. Keller-Dupree","topics":["Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4408969337","eid":"W4408969337"},{"id":"paper-w4396599183","cat":"papers","name":"Exploring Cultural Competence, Inclusivity, and Diversity in Ketamine Assisted Psychotherapy: A Phenomenological Study","year":"2024","cit":2,"pfa":"Dave Rojas","psa":"Irina Alexander","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4396599183","eid":"W4396599183"},{"id":"paper-w4397038221","cat":"papers","name":"Navigating the Future of Psychedelic-Assisted Therapies in Psychiatry: Ethical Considerations, Nursing Roles, and Research Imperatives","year":"2024","cit":2,"pfa":"Chang Jui-Man","psa":"Lien‐Chung Wei","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4397038221","eid":"W4397038221"},{"id":"paper-w4415459223","cat":"papers","name":"Queer healing in altered states: A critical interpretive synthesis of psychedelic therapy in queer and non-binary individuals","year":"2025","cit":2,"pfa":"Sónia David","psa":"Anupama Sadasivan","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4415459223","eid":"W4415459223"},{"id":"paper-w7117113196","cat":"papers","name":"The CAnadian Network for Psychedelic-Assisted Cancer Therapy (CAN-PACT): A Multi-Phase Program Overview","year":"2025","cit":2,"pfa":"Linda Ellen Carlson","psa":"Monnica T. Williams","topics":["Anxiety & end-of-life","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7117113196","eid":"W7117113196"},{"id":"paper-w4415849302","cat":"papers","name":"Ketamine Assisted EMDR Therapy™ for PTSD: investigating the synergistic effects of pharmacotherapy and psychotherapy","year":"2025","cit":2,"pfa":"Michele Topel","psa":"Danielle Ciccone","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4415849302","eid":"W4415849302"},{"id":"paper-w4415620857","cat":"papers","name":"Unfolding States of Mind: A Dissociative-Psychedelic Model of Ketamine-Assisted Psychotherapy in Palliative Care","year":"2025","cit":2,"pfa":"Alessandro Gonçalves Campolina","psa":"Marco Aurélio Tuena de Oliveira","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4415620857","eid":"W4415620857"},{"id":"paper-w4388415916","cat":"papers","name":"Author reply to Letter to the Editor regarding ‘Understanding subjective experience in psychedelic-assisted psychotherapy: The need for phenomenology’","year":"2023","cit":2,"pfa":"Riccardo Miceli McMillan","psa":"Anthony Vincent Fernandez","topics":["Therapy practice"],"ptype":"letter","src":"https://openalex.org/W4388415916","eid":"W4388415916"},{"id":"paper-w4406296410","cat":"papers","name":"Psychedelic-assisted therapy - supposedly paradigm-shifting research with poor attempts at hypotheses falsifying and questionable ethics","year":"2024","cit":2,"pfa":"Bor Luen Tang","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4406296410","eid":"W4406296410"},{"id":"paper-w4400041008","cat":"papers","name":"“Angry at the Wrong Thing:” Queering Ketamine Assisted Psychotherapy for Clients Experiencing Body Image and Eating Distress","year":"2024","cit":2,"pfa":"Jessalyn Maguire","topics":["Depression","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4400041008","eid":"W4400041008"},{"id":"paper-w4385669338","cat":"papers","name":"A Pilot Study Comparing a Community of Practice Group Therapy Program with and without Concurrent Ketamine-assisted Therapy","year":"2023","cit":2,"pfa":"Vivian W. L. Tsang","psa":"Shannon Dames","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4385669338","eid":"W4385669338"},{"id":"paper-w4385896825","cat":"papers","name":"Efficacy and Safety of Ketamine-assisted Electroconvulsive Therapy in Major Depressive Episode: A Systematic Review and Network Meta-Analysis","year":"2023","cit":2,"pfa":"Taeho Greg Rhee","psa":"Roger S. McIntyre","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4385896825","eid":"W4385896825"},{"id":"paper-w4404639109","cat":"papers","name":"Maintenance Intramuscular Ketamine-Assisted Psychotherapy, a Retrospective Chart Review of Efficacy, Adverse Events, and Dropouts from a Community Practice","year":"2024","cit":2,"pfa":"Wesley C. Ryan","psa":"Boris Dov Heifets","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4404639109","eid":"W4404639109"},{"id":"paper-w4285795874","cat":"papers","name":"Corrigendum: A cohort-based case report: The impact of ketamine-assisted therapy embedded in a community of practice framework for healthcare providers with PTSD and depression","year":"2022","cit":2,"pfa":"Shannon Dames","psa":"Crosbie Watler","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"erratum","src":"https://openalex.org/W4285795874","eid":"W4285795874"},{"id":"paper-w7108067906","cat":"papers","name":"Not all psychedelics are created equal","year":"2025","cit":2,"pfa":"Johannes G. Ramaekers","psa":"Mihai Avram","ptype":"article","src":"https://openalex.org/W7108067906","eid":"W7108067906"},{"id":"paper-w4383315772","cat":"papers","name":"Dutch newspapers on war victims and their LSD-treatment by Jan Bastiaans, from KZ-syndrome to PTSD","year":"2023","cit":2,"pfa":"Edgar Jones","topics":["PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4383315772","eid":"W4383315772"},{"id":"paper-w4210634962","cat":"papers","name":"New center to take personalized care to next level, embracing psychedelics","year":"2022","cit":2,"pfa":"Gary A. Enos","ptype":"article","src":"https://openalex.org/W4210634962","eid":"W4210634962"},{"id":"paper-w4405274608","cat":"papers","name":"Harnessing Artificial Intelligence to Overcome Key Challenges in Psychedelic Research and Therapy","year":"2024","cit":2,"pfa":"Robert B. Kargbo","ptype":"editorial","src":"https://openalex.org/W4405274608","eid":"W4405274608"},{"id":"paper-w4416234138","cat":"papers","name":"Psychedelics - A Cure for Sexual Trauma or a Risk Factor in Recreational and Treatment Settings?","year":"2025","cit":2,"pfa":"Cara Ann Struble","topics":["PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4416234138","eid":"W4416234138"},{"id":"paper-w7124501171","cat":"papers","name":"Neuropsychiatric Treatment in Functional Neurological Disorder: Foundations and Future","year":"2026","cit":2,"pfa":"Irene Gonsalvez","psa":"Gaston C. Baslet","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7124501171","eid":"W7124501171"},{"id":"paper-w7125578384","cat":"papers","name":"Examining the Perspectives of Key Stakeholders on the Problems, Policies, and Politics Regarding Accessing Psychedelic Interventions to Alleviate End‐of‐Life Distress","year":"2026","cit":2,"pfa":"Sarah Kratina","psa":"Brian R. Rush","topics":["Anxiety & end-of-life","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7125578384","eid":"W7125578384"},{"id":"paper-w4376273578","cat":"papers","name":"Considerations in the Application of Psychedelic-Augmented Psychotherapy: A Commentary on Clinical Mechanisms","year":"2023","cit":2,"pfa":"Alexander De Foe","topics":["Addiction","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4376273578","eid":"W4376273578"},{"id":"paper-w4408240582","cat":"papers","name":"Societal perspectives on psychedelics use in clinical context: Development of Concerns and Openness towards Psychedelic Scale (COPS)","year":"2025","cit":2,"pfa":"Paweł Holas","psa":"Marcin Zajenkowski","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4408240582","eid":"W4408240582"},{"id":"paper-w4408153100","cat":"papers","name":"Exploring the Role of Psychedelic Experiences on Wellbeing and Symptoms of Disordered Eating","year":"2025","cit":2,"pfa":"Nadine Loh","psa":"David P. Luke","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4408153100","eid":"W4408153100"},{"id":"paper-w4414930864","cat":"papers","name":"Examining Volunteer Bias in Psychedelic Research","year":"2025","cit":2,"pfa":"Samantha G. Gomez","psa":"Mitch Earleywine","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4414930864","eid":"W4414930864"},{"id":"paper-w4389078973","cat":"papers","name":"Psychedelics in Israel: A Brief History","year":"2023","cit":2,"pfa":"Ido Hartogsohn","psa":"Itamar Zadoff","topics":["Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W4389078973","eid":"W4389078973"},{"id":"paper-w4413302478","cat":"papers","name":"Fearful symmetry in altered states: a bi-logic account of psychedelic action","year":"2025","cit":2,"pfa":"Matthew Goldreich","topics":["Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4413302478","eid":"W4413302478"},{"id":"paper-w4413942537","cat":"papers","name":"From “bad trips” to “transformative and potentially therapeutic trips”: harnessing the potential of psychedelics – narrative review","year":"2025","cit":2,"pfa":"Nikolaos Statharakos","psa":"Aikaterini Mara","topics":["PTSD & trauma","Addiction","Anxiety & end-of-life"],"ptype":"review","src":"https://openalex.org/W4413942537","eid":"W4413942537"},{"id":"paper-w7147251955","cat":"papers","name":"Mystical Experience Induced by Esketamine Treatment: A Real-World Observational Study","year":"2026","cit":2,"pfa":"Maia Mallevays","psa":"Lucie Berkovitch","topics":["Depression","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7147251955","eid":"W7147251955"},{"id":"paper-w4410356264","cat":"papers","name":"Psychedelic Policy, Religious Freedom, and Public Safety: An Overview","year":"2025","cit":2,"pfa":"Victoria Litman","topics":["Safety & adverse events","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4410356264","eid":"W4410356264"},{"id":"paper-w7162849784","cat":"papers","name":"Psychedelics do not always enhance cognitive flexibility: The potential role of time-varying effects on reward learning processes","year":"2026","cit":2,"pfa":"Raquel Kosted","psa":"Gregory A. Fonzo","ptype":"article","src":"https://openalex.org/W7162849784","eid":"W7162849784"},{"id":"paper-w4405207242","cat":"papers","name":"Health Care Workers’ Attitudes Toward and Knowledge of the Clinical Application of Classic Psychedelics for People with Serious Illness: A Systematic Review","year":"2024","cit":2,"pfa":"Sam Barta","psa":"Clare C. O’Callaghan","topics":["Reviews & meta-analyses","Therapy practice"],"ptype":"review","src":"https://openalex.org/W4405207242","eid":"W4405207242"},{"id":"paper-w7141159419","cat":"papers","name":"Psychedelic Experiences and Finitude in Serious Illness: A Qualitative Synthesis","year":"2026","cit":2,"pfa":"Ana Cláudia Mesquita Garcia","psa":"Cremilson de Paula Silva","topics":["Anxiety & end-of-life","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7141159419","eid":"W7141159419"},{"id":"paper-w4390166216","cat":"papers","name":"UK medical students’ self-reported knowledge and harm assessment of psychedelics and their application in clinical research: a cross-sectional study","year":"2023","cit":2,"pfa":"Charlie Song-Smith","psa":"Marco Schlosser","topics":["Safety & adverse events","Dosing & pharmacology","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4390166216","eid":"W4390166216"},{"id":"paper-w4381733796","cat":"papers","name":"Commentary: Not in the drug, not in the brain: causality in psychedelic experiences from an enactive perspective","year":"2023","cit":2,"pfa":"Ignacio Cea","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"editorial","src":"https://openalex.org/W4381733796","eid":"W4381733796"},{"id":"paper-w1965775359","cat":"papers","name":"NicolasLanglitz. NEUROPSYCHEDELIA: The Revival of Hallucinogen Research since the Decade of the Brain. Berkeley: University of California Press, 2012.","year":"2014","cit":2,"pfa":"Erika Dyck","topics":["Addiction","Anxiety & end-of-life","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1965775359","eid":"W1965775359"},{"id":"paper-w2488739807","cat":"papers","name":"Entheogens (Psychedelic Drugs) and the Ancient Mystery Religions","year":"2014","cit":2,"pfa":"Mark Anthony Hoffman","ptype":"book-chapter","src":"https://openalex.org/W2488739807","eid":"W2488739807"},{"id":"paper-w3174775181","cat":"papers","name":"Entheogens and Psychotherapy","year":"2001","cit":2,"pfa":"Andrew Feldmar","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W3174775181","eid":"W3174775181"},{"id":"paper-w3128328291","cat":"papers","name":"Entheogens in Buddhism","year":"2021","cit":2,"pfa":"Michael Winkelman","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3128328291","eid":"W3128328291"},{"id":"paper-w4200293030","cat":"papers","name":"The emerging science of microdosing: A systematic review of research on low dose psychedelics (1955 – 2021)","year":"2021","cit":2,"pfa":"Vince Polito","psa":"Paul Liknaitzky","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4200293030","eid":"W4200293030"},{"id":"paper-w4247910573","cat":"papers","name":"A quantitative exploration of the relationships between regular yoga practice, microdosing psychedelics, wellbeing and personality variables","year":"2020","cit":2,"pfa":"Stephen Jason Bright","psa":"Samantha Bettinson","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4247910573","eid":"W4247910573"},{"id":"paper-w4248306409","cat":"papers","name":"Hallucinogens","year":"1968","cit":2,"ptype":"article","src":"https://openalex.org/W4248306409","eid":"W4248306409"},{"id":"paper-w4290908284","cat":"papers","name":"HALLUCINOGENS.","year":"1964","cit":2,"pfa":"R. A. Sandison","ptype":"article","src":"https://openalex.org/W4290908284","eid":"W4290908284"},{"id":"paper-w4205857339","cat":"papers","name":"Psychedelic Drugs","year":"2021","cit":2,"pfa":"David E. Nichols","psa":"Charles David Nichols","ptype":"reference-entry","src":"https://openalex.org/W4205857339","eid":"W4205857339"},{"id":"paper-w4211170370","cat":"papers","name":"Serotonergic Hallucinogens","year":"2010","cit":2,"pfa":"Mireille M. Meyerhoefer","ptype":"book-chapter","src":"https://openalex.org/W4211170370","eid":"W4211170370"},{"id":"paper-w2029795501","cat":"papers","name":"Welcome to ‘Microdosing‘","year":"2010","cit":2,"pfa":"RMJ Ings","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2029795501","eid":"W2029795501"},{"id":"paper-w3169584082","cat":"papers","name":"[Microdosing LSD: practices and risks].","year":"2021","cit":2,"pfa":"Federico Seragnoli","psa":"Gabriel Thorens","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3169584082","eid":"W3169584082"},{"id":"paper-w4398695697","cat":"papers","name":"Fertilizer Microdosing","year":"2017","cit":2,"pfa":"World Agroforestry Center","psa":"Sokoine University Of Agriculture","topics":["Safety & adverse events","Dosing & pharmacology","Therapy practice"],"ptype":"dataset","src":"https://openalex.org/W4398695697","eid":"W4398695697"},{"id":"paper-w2471633225","cat":"papers","name":"[Abuse of hallucinogens].","year":"1971","cit":2,"pfa":"Erica Schuster","ptype":"article","src":"https://openalex.org/W2471633225","eid":"W2471633225"},{"id":"paper-w2471635836","cat":"papers","name":"MAGIC MUSHROOMS: from sacred entheogen to Class A drug","year":"2016","cit":2,"pfa":"Charlotte Walsh","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2471635836","eid":"W2471635836"},{"id":"paper-w2008742871","cat":"papers","name":"Stramonium and Belladonna Hallucinogens","year":"1968","cit":2,"pfa":"Bro. Thomas Brown","ptype":"article","src":"https://openalex.org/W2008742871","eid":"W2008742871"},{"id":"paper-w1544389354","cat":"papers","name":"Bioanalytics for Human Microdosing","year":"2012","cit":2,"pfa":"Bruce A. Buchholz","psa":"Kenneth Wayne Turteltaub","topics":["Dosing & pharmacology"],"ptype":"reference-entry","src":"https://openalex.org/W1544389354","eid":"W1544389354"},{"id":"paper-w4410425795","cat":"papers","name":"Microdosing Narrative Medicine","year":"2025","cit":2,"pfa":"Sneha Mantri","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4410425795","eid":"W4410425795"},{"id":"paper-w4399761448","cat":"papers","name":"Neurological Effects of Stimulants and Hallucinogens","year":"2024","cit":2,"pfa":"Reece M. Hass","psa":"Derek W. Stitt","topics":["Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4399761448","eid":"W4399761448"},{"id":"paper-w4235279708","cat":"papers","name":"Naturally Occurring Hallucinogens I","year":"1971","cit":2,"pfa":"Gunnar Gjerstad","ptype":"article","src":"https://openalex.org/W4235279708","eid":"W4235279708"},{"id":"paper-w4240252375","cat":"papers","name":"Drug Fact Sheet: Hallucinogens","year":"2012","cit":2,"ptype":"dataset","src":"https://openalex.org/W4240252375","eid":"W4240252375"},{"id":"paper-w2152903509","cat":"papers","name":"An Evolutionary Perspective on the Use of Hallucinogens","year":"2015","cit":2,"pfa":"Washington Soares Ferreira Júnior","psa":"Ulysses Paulino Albuquerque","ptype":"book-chapter","src":"https://openalex.org/W2152903509","eid":"W2152903509"},{"id":"paper-w4285329307","cat":"papers","name":"Psychedelic Wars","year":"2021","cit":2,"topics":["Addiction","Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W4285329307","eid":"W4285329307"},{"id":"paper-w2405287841","cat":"papers","name":"[Antiparkinsonism drug (Parkan) as a hallucinogen].","year":"1973","cit":2,"pfa":"O Kisszékelyi","ptype":"article","src":"https://openalex.org/W2405287841","eid":"W2405287841"},{"id":"paper-w4250243396","cat":"papers","name":"Naturally Occurring Hallucinogens II","year":"1971","cit":2,"pfa":"Gunnar Gjerstad","ptype":"article","src":"https://openalex.org/W4250243396","eid":"W4250243396"},{"id":"paper-w4246881777","cat":"papers","name":"Psychedelic Science","year":"1972","cit":2,"pfa":"Albert William Levi","ptype":"article","src":"https://openalex.org/W4246881777","eid":"W4246881777"},{"id":"paper-w2394744988","cat":"papers","name":"The medical and scientific importance of hallucinogens.","year":"1973","cit":2,"pfa":"H Osmond","ptype":"other","src":"https://openalex.org/W2394744988","eid":"W2394744988"},{"id":"paper-w2942414783","cat":"papers","name":"Iconography of New World Hallucinogens","year":"1981","cit":2,"pfa":"Richard Evans Schultes","ptype":"article","src":"https://openalex.org/W2942414783","eid":"W2942414783"},{"id":"paper-w4296387493","cat":"papers","name":"Psychedelics and psychotherapy","year":"2022","cit":2,"topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4296387493","eid":"W4296387493"},{"id":"paper-w4229637326","cat":"papers","name":"Psychedelic Drugs—Volume 1: (Psychedelic Drugs and the Law)","year":"1967","cit":2,"ptype":"article","src":"https://openalex.org/W4229637326","eid":"W4229637326"},{"id":"paper-w1036352866","cat":"papers","name":"A “Psychedelic Method”","year":"2013","cit":2,"pfa":"Albert L. Refiti","topics":["Reviews & meta-analyses"],"ptype":"book-chapter","src":"https://openalex.org/W1036352866","eid":"W1036352866"},{"id":"paper-w4394608873","cat":"papers","name":"A Psychedelic Experience","year":"2017","cit":2,"ptype":"book-chapter","src":"https://openalex.org/W4394608873","eid":"W4394608873"},{"id":"paper-w4253245083","cat":"papers","name":"Psychedelic pollution","year":"2014","cit":2,"pfa":"Aviva Hope Rutkin","ptype":"article","src":"https://openalex.org/W4253245083","eid":"W4253245083"},{"id":"paper-w163348828","cat":"papers","name":"Psychotoxic or Psychedelic?","year":"1972","cit":2,"pfa":"GR Nakamura","psa":"N. Adler","ptype":"article","src":"https://openalex.org/W163348828","eid":"W163348828"},{"id":"paper-w4239750608","cat":"papers","name":"Psychedelic Shamanism","year":"2018","cit":2,"pfa":"Christopher H. Partridge","topics":["Safety & adverse events"],"ptype":"book","src":"https://openalex.org/W4239750608","eid":"W4239750608"},{"id":"paper-w2139756357","cat":"papers","name":"Intrathecal “Microdosing”: Reality or Artifact?","year":"2012","cit":2,"pfa":"Salim Michel Hayek","topics":["Addiction","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2139756357","eid":"W2139756357"},{"id":"paper-w4324045564","cat":"papers","name":"Psychedelic Experience","year":"2022","cit":2,"pfa":"Krzysztof Sikorski","ptype":"article","src":"https://openalex.org/W4324045564","eid":"W4324045564"},{"id":"paper-w2120665726","cat":"papers","name":"Psychedelics in psychiatry","year":"2005","cit":2,"pfa":"Danilo Arnone","psa":"Fabrizio Schifano","ptype":"article","src":"https://openalex.org/W2120665726","eid":"W2120665726"},{"id":"paper-w2784496661","cat":"papers","name":"Demography of Microdosing Community Survey","year":"2017","cit":2,"pfa":"Thomas Anderson","psa":"Lê-Anh Dinh-Williams","topics":["Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W2784496661","eid":"W2784496661"},{"id":"paper-w1523956906","cat":"papers","name":"Toward a molecular understanding of hallucinogen action","year":"2006","cit":2,"pfa":"Jason C. Parrish","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W1523956906","eid":"W1523956906"},{"id":"paper-w2326745800","cat":"papers","name":"Pharmacological studies of hallucinogens; Report 1","year":"1962","cit":2,"pfa":"Hideo HOSHIKAWA","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2326745800","eid":"W2326745800"},{"id":"paper-w2444222717","cat":"papers","name":"Not imagining it. Research into hallucinogens cautiously resumes.","year":"2006","cit":2,"pfa":"David Biello","ptype":"other","src":"https://openalex.org/W2444222717","eid":"W2444222717"},{"id":"paper-w3166514269","cat":"papers","name":"Iconography of New World plant hallucinogens.","year":"1981","cit":2,"pfa":"Schultes Re","ptype":"article","src":"https://openalex.org/W3166514269","eid":"W3166514269"},{"id":"paper-w4398222813","cat":"papers","name":"Psychedelic Experiences and the Enactive Approach","year":"2024","cit":2,"pfa":"Daniel Meling","psa":"Milan Scheidegger","ptype":"book-chapter","src":"https://openalex.org/W4398222813","eid":"W4398222813"},{"id":"paper-w4200092990","cat":"papers","name":"Legalization of Psychedelic Substances","year":"2021","cit":2,"pfa":"Michael D. Alpert","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4200092990","eid":"W4200092990"},{"id":"paper-w4385809997","cat":"papers","name":"Psychedelics, embodiment, and intersubjectivity","year":"2023","cit":2,"pfa":"Kai River Blevins","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4385809997","eid":"W4385809997"},{"id":"paper-w2403145213","cat":"papers","name":"Philosophical aspects of psychedelics.","year":"1971","cit":2,"pfa":"Humphry Osmond","ptype":"other","src":"https://openalex.org/W2403145213","eid":"W2403145213"},{"id":"paper-w4410860688","cat":"papers","name":"Psychedelics in Palliative Care","year":"2025","cit":2,"topics":["Depression","PTSD & trauma","Addiction"],"ptype":"book","src":"https://openalex.org/W4410860688","eid":"W4410860688"},{"id":"paper-w4392988396","cat":"papers","name":"Changing Psychedelics Policy","year":"2015","cit":2,"pfa":"Neal M. Goldsmith","topics":["Policy & ethics"],"ptype":"other","src":"https://openalex.org/W4392988396","eid":"W4392988396"},{"id":"paper-w4404737755","cat":"papers","name":"Ethics in Psychedelic Science","year":"2024","cit":2,"pfa":"Dominic A. Sisti","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4404737755","eid":"W4404737755"},{"id":"paper-w4406671335","cat":"papers","name":"Psychedelics: Safety and Efficacy","year":"2025","cit":2,"pfa":"Norman Miller","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4406671335","eid":"W4406671335"},{"id":"paper-w4213244015","cat":"papers","name":"The Promise of Psychedelic Research","year":"2022","cit":2,"pfa":"Carina Peritore","topics":["Depression","Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4213244015","eid":"W4213244015"},{"id":"paper-w2903595332","cat":"papers","name":"Eksplorasi Visual Psychedelic Experience melalui Ilustrasi Berbasis Seni Psychedelic","year":"2017","cit":2,"pfa":"Muhammad Iqbal Qeis","psa":"M Fauzan Azizi","ptype":"article","src":"https://openalex.org/W2903595332","eid":"W2903595332"},{"id":"paper-w2490060607","cat":"papers","name":"Psychedelic Trance on the Web","year":"2015","cit":2,"pfa":"Emília Simão","psa":"Armando Malheiro da Silva","ptype":"book-chapter","src":"https://openalex.org/W2490060607","eid":"W2490060607"},{"id":"paper-w4403403629","cat":"papers","name":"The Paradoxes of Psychedelic Humanities","year":"2024","cit":2,"pfa":"Nicolas Langlitz","ptype":"book-chapter","src":"https://openalex.org/W4403403629","eid":"W4403403629"},{"id":"paper-w4398222347","cat":"papers","name":"Psychedelics and Supernatural Agents","year":"2024","cit":2,"pfa":"Patrick McNamara","psa":"Jordan Henry Grafman","topics":["Mechanism & neuroscience","Reviews & meta-analyses","Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W4398222347","eid":"W4398222347"},{"id":"paper-w2013545757","cat":"papers","name":"Plants of the Gods: Origins of Hallucinogen Use","year":"1981","cit":2,"pfa":"Weston La Barre","ptype":"article","src":"https://openalex.org/W2013545757","eid":"W2013545757"},{"id":"paper-w4403403528","cat":"papers","name":"The Epistemology of Psychedelic Experience","year":"2024","cit":2,"pfa":"Jack Lyons","ptype":"book-chapter","src":"https://openalex.org/W4403403528","eid":"W4403403528"},{"id":"paper-w4409716543","cat":"papers","name":"History of Psychedelics: An Overview","year":"2025","cit":2,"pfa":"Erika Dyck","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4409716543","eid":"W4409716543"},{"id":"paper-w3216092798","cat":"papers","name":"LSD: Psychedelic or psychodysleptic?","year":"2021","cit":2,"pfa":"Zoë Dubus","ptype":"article","src":"https://openalex.org/W3216092798","eid":"W3216092798"},{"id":"paper-w2424753145","cat":"papers","name":"[Pathology caused by microdoses of chemical substances].","year":"1990","cit":2,"pfa":"Foà","psa":"Adalberto Ferioli","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W2424753145","eid":"W2424753145"},{"id":"paper-w4399368657","cat":"papers","name":"Psychiatric Applications of Psychedelics","year":"2024","cit":2,"pfa":"Praachi Tiwari","psa":"David B. Yaden","ptype":"article","src":"https://openalex.org/W4399368657","eid":"W4399368657"},{"id":"paper-w2571286537","cat":"papers","name":"Addressing the need for rigor in the rebirth of hallucinogen research","year":"2016","cit":2,"pfa":"David E. Nichols","psa":"George R. Greer","ptype":"article","src":"https://openalex.org/W2571286537","eid":"W2571286537"},{"id":"paper-w3215654964","cat":"papers","name":"HALLUCINOGEN PERSISTENT PERCEPTION DISORDER (HPPD): A LITERATURE REVIEW","year":"2021","cit":2,"pfa":"Yu.M. Scheidegger","psa":"Т.В. Клименко","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3215654964","eid":"W3215654964"},{"id":"paper-w2075494115","cat":"papers","name":"Microdose flare versus antagonist for poor responders","year":"2010","cit":2,"pfa":"David Roy Meldrum","psa":"William B. Schoolcraft","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2075494115","eid":"W2075494115"},{"id":"paper-w21129969","cat":"papers","name":"Salvia divinorum, Hallucinogens, and the Determination of Medical Utility","year":"2013","cit":2,"pfa":"O. Hayden Griffin","ptype":"book-chapter","src":"https://openalex.org/W21129969","eid":"W21129969"},{"id":"paper-w2054923799","cat":"papers","name":"Psychedelic Experience and the Language Process","year":"1970","cit":2,"pfa":"Stanley Krippner","ptype":"article","src":"https://openalex.org/W2054923799","eid":"W2054923799"},{"id":"paper-w4406326347","cat":"papers","name":"Psychedelic Exceptionalism: The Oregon Example","year":"2025","cit":2,"pfa":"Trevor Findley","topics":["Policy & ethics"],"ptype":"editorial","src":"https://openalex.org/W4406326347","eid":"W4406326347"},{"id":"paper-w4309664031","cat":"papers","name":"Carbon‐13 labeling of ibrutinib for human microdosing","year":"2022","cit":2,"pfa":"Yong Gong","psa":"Rhys Salter","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4309664031","eid":"W4309664031"},{"id":"paper-w2106855274","cat":"papers","name":"The effect of microdoses of ionizing radiation on poultry ontogenesis","year":"1960","cit":2,"pfa":"H. F. Kushner","psa":"M. G. Salganik","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2106855274","eid":"W2106855274"},{"id":"paper-w3049707251","cat":"papers","name":"Drug-craft : On the configurations of psychedelic efficacies","year":"2020","cit":2,"pfa":"Shiva Raj Mishra","topics":["Addiction","Dosing & pharmacology","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W3049707251","eid":"W3049707251"},{"id":"paper-w4409656765","cat":"papers","name":"Psychedelics alter metaphysical beliefs","year":"2021","cit":2,"pfa":"Christopher B. Timmermann","psa":"Robin Lester Carhart-Harris","topics":["Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4409656765","eid":"W4409656765"},{"id":"paper-w4410521736","cat":"papers","name":"Microdose EOS Imaging: Just as Good, and Safer","year":"2025","cit":2,"pfa":"Mak Macapagal","psa":"Lui Darren","topics":["Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4410521736","eid":"W4410521736"},{"id":"paper-w4392988409","cat":"papers","name":"Regulation of The Prescription Use of Psychedelics","year":"2015","cit":2,"pfa":"Rick Doblin","topics":["Policy & ethics"],"ptype":"other","src":"https://openalex.org/W4392988409","eid":"W4392988409"},{"id":"paper-w4312189730","cat":"papers","name":"In Becoming. Instability of Psychedelic Substances","year":"2022","cit":2,"pfa":"Zuzanna Sadowska","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4312189730","eid":"W4312189730"},{"id":"paper-w4406325090","cat":"papers","name":"Managing the Hope and Hype of Psychedelics","year":"2025","cit":2,"pfa":"Keisha Shantel Ray","ptype":"editorial","src":"https://openalex.org/W4406325090","eid":"W4406325090"},{"id":"paper-w1968057773","cat":"papers","name":"Study of factors influencing the microdosing of unfilled adhesives","year":"2001","cit":2,"pfa":"Ulrich Dilthey","psa":"Markus Möller","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1968057773","eid":"W1968057773"},{"id":"paper-w3200408764","cat":"papers","name":"Psychedelics and meditation: a neurophilosophical perspective","year":"2022","cit":2,"pfa":"Chris Letheby","ptype":"article","src":"https://openalex.org/W3200408764","eid":"W3200408764"},{"id":"paper-w4413141656","cat":"papers","name":"Psychedelics and the future evolution of humanity","year":"2025","cit":2,"pfa":"Michael Winkelman","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4413141656","eid":"W4413141656"},{"id":"paper-w2423627524","cat":"papers","name":"Psychedelic drugs--a threat to reproduction?","year":"1972","cit":2,"pfa":"Cheston A. Berlin","psa":"Candice Jacobson","ptype":"article","src":"https://openalex.org/W2423627524","eid":"W2423627524"},{"id":"paper-w4413352801","cat":"papers","name":"Conceptualizing Psychedelic Pure Consciousness","year":"2025","cit":2,"pfa":"Márk Losoncz","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4413352801","eid":"W4413352801"},{"id":"paper-w4413054152","cat":"papers","name":"Psychedelics and Headache Disorders: an Update","year":"2025","cit":2,"pfa":"James J.H. Im","psa":"Claire H. Sandoe","ptype":"article","src":"https://openalex.org/W4413054152","eid":"W4413054152"},{"id":"paper-w4408490145","cat":"papers","name":"Psychedelic Use and Behavioral Addictions","year":"2025","cit":2,"pfa":"Trey J. Brasher","psa":"Marcello Spinella","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4408490145","eid":"W4408490145"},{"id":"paper-w2257778211","cat":"papers","name":"Niacin and acute psychedelic psychosis.","year":"1984","cit":2,"pfa":"J A Goldstein","ptype":"letter","src":"https://openalex.org/W2257778211","eid":"W2257778211"},{"id":"paper-w2796941056","cat":"papers","name":"Poetic Vision and the Psychedelic Experience","year":"1971","cit":2,"pfa":"Gordon Westland","psa":"Robert Allen Durr","ptype":"article","src":"https://openalex.org/W2796941056","eid":"W2796941056"},{"id":"paper-w2888390765","cat":"papers","name":"The anechoic darkroom as a psychedelic state","year":"2018","cit":2,"pfa":"David Luke","psa":"B. Bell-Langford","ptype":"book-chapter","src":"https://openalex.org/W2888390765","eid":"W2888390765"},{"id":"paper-w1972510561","cat":"papers","name":"Demographic Effects on the Trail Making Test in Hallucinogen Abusers","year":"2001","cit":2,"pfa":"Charles Roberts And","psa":"Arthur MacNeill Horton","ptype":"article","src":"https://openalex.org/W1972510561","eid":"W1972510561"},{"id":"paper-w4415917482","cat":"papers","name":"Virtual Tourism Microdosing: A New Prescription for Tourist Wellbeing","year":"2025","cit":2,"pfa":"Minh Nhan","psa":"Biqiang Liu","topics":["Safety & adverse events","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4415917482","eid":"W4415917482"},{"id":"paper-w4411386799","cat":"papers","name":"A framework to assess risks for non-medical use of psychedelics: The liability for abuse of psychedelics questionnaire (LAPQ)","year":"2025","cit":2,"pfa":"Jennifer Swainson","psa":"Ron Joseph Shore","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4411386799","eid":"W4411386799"},{"id":"paper-w2271254009","cat":"papers","name":"EXPERIENCE WITH THE USE OF MICRODOSES OF GAMMA IRRADIATION IN POULTRY BREEDING","year":"1960","cit":2,"pfa":"I.G. Kostin","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2271254009","eid":"W2271254009"},{"id":"paper-w2098713739","cat":"papers","name":"Dose-response relationship within the potentized microdoses phenomenon","year":"1993","cit":2,"pfa":"Jorge Herkovits","psa":"Cristina S. Pérez‐Coll","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2098713739","eid":"W2098713739"},{"id":"paper-w1971366052","cat":"papers","name":"SEROTONERGIC RECEPTOR SUBTYPES AND HALLUCINOGEN-INDUCED STIMULUS CONTROL","year":"1998","cit":2,"pfa":"Jerrold C. Winter","psa":"R.A. Rabin","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1971366052","eid":"W1971366052"},{"id":"paper-w2028015433","cat":"papers","name":"Psychedelic (LSD) psychotherapy: A case report.","year":"1974","cit":2,"pfa":"O. Lee McCabe","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2028015433","eid":"W2028015433"},{"id":"paper-w4410522946","cat":"papers","name":"Psychedelic Churches Need Philosophy of Religion","year":"2025","cit":2,"pfa":"Eric Charles Steinhart","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4410522946","eid":"W4410522946"},{"id":"paper-w4402667474","cat":"papers","name":"Psychoanalysis and psychedelics: The censored story in Argentina","year":"2024","cit":2,"pfa":"Rodolfo Olivieri","psa":"Luís Fernando Tófoli","ptype":"article","src":"https://openalex.org/W4402667474","eid":"W4402667474"},{"id":"paper-w4406325324","cat":"papers","name":"Ketamine and the Consequences of Positive Psychedelic Exceptionalism","year":"2025","cit":2,"pfa":"Zachary J. Verne","psa":"Jeffrey Zabinski","topics":["Safety & adverse events","Policy & ethics"],"ptype":"editorial","src":"https://openalex.org/W4406325324","eid":"W4406325324"},{"id":"paper-w2898945310","cat":"papers","name":"Making your Mark in the Psychedelic Renaissance","year":"2014","cit":2,"pfa":"Garcia-Romeu Albert","ptype":"article","src":"https://openalex.org/W2898945310","eid":"W2898945310"},{"id":"paper-w2476689863","cat":"papers","name":"Psychedelic Trance and Multimedia Neo-Rituals","year":"2015","cit":2,"pfa":"Emília Simão","psa":"Sérgio Tenreiro de Magalhães","topics":["Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W2476689863","eid":"W2476689863"},{"id":"paper-w201469791","cat":"papers","name":"Physical Evaluation of a Prototype for the Sectra Microdose Mammography System","year":"2003","cit":2,"pfa":"Mats A. Lundqvist","psa":"Magnus Åslund","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W201469791","eid":"W201469791"},{"id":"paper-w4390874766","cat":"papers","name":"Microdose Effect of SGT MOSFETs induced by Heavy Ions","year":"2023","cit":2,"pfa":"Zhuojun Chen","psa":"Xin Wan","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"conference-paper","src":"https://openalex.org/W4390874766","eid":"W4390874766"},{"id":"paper-w3195174663","cat":"papers","name":"Hallucinogen Persisting Perception Disorder Following Recreational Dextromethorphan Use","year":"2021","cit":2,"pfa":"Robert Rymowicz","psa":"Tiffany Tsuang","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3195174663","eid":"W3195174663"},{"id":"paper-w2008255203","cat":"papers","name":"Paul's Mysticism in the Light of Psychedelic Experience","year":"1970","cit":2,"pfa":"John L. Cheek","ptype":"article","src":"https://openalex.org/W2008255203","eid":"W2008255203"},{"id":"paper-w4293230816","cat":"papers","name":"Psychedelic Sociality: Pharmacological and Extrapharmacological Perspectives","year":"2022","cit":2,"topics":["Dosing & pharmacology"],"ptype":"book","src":"https://openalex.org/W4293230816","eid":"W4293230816"},{"id":"paper-w2836097393","cat":"papers","name":"Microdosing technology of fertilizer for sorghum production at Shambat, Sudan","year":"2017","cit":2,"pfa":"MONIRAH BABIKER MOHAMED ARBAB","psa":"Y. M. I. Dagash","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2836097393","eid":"W2836097393"},{"id":"paper-w4285154693","cat":"papers","name":"Arguments for the Psychedelic Cure of Western Philosophy","year":"2022","cit":2,"pfa":"Michel Weber","ptype":"book-chapter","src":"https://openalex.org/W4285154693","eid":"W4285154693"},{"id":"paper-w4297493631","cat":"papers","name":"Psychedelic medicine faces the acid test","year":"2022","cit":2,"pfa":"Herb Brody","ptype":"article","src":"https://openalex.org/W4297493631","eid":"W4297493631"},{"id":"paper-w7117146120","cat":"papers","name":"Psychedelic research must be grounded in pharmacology","year":"2025","cit":2,"pfa":"Charles David Nichols","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7117146120","eid":"W7117146120"},{"id":"paper-w4388950389","cat":"papers","name":"De-Siloing the Psychology of Religion and Psychedelic Science: Introduction to the Special Issue on Psychedelics and Mystical-type Experiences","year":"2023","cit":2,"pfa":"Michiel van Elk","psa":"David B. Yaden","ptype":"editorial","src":"https://openalex.org/W4388950389","eid":"W4388950389"},{"id":"paper-w4414402560","cat":"papers","name":"Hypnosis, Psychedelics, and Creativity: An Overview and Analysis","year":"2025","cit":2,"pfa":"Sheryl Attig","psa":"Stanley Krippner","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4414402560","eid":"W4414402560"},{"id":"paper-w7155513463","cat":"papers","name":"Characterising the clinical associations of hallucinogen persisting perception disorder: a retrospective cohort study","year":"2026","cit":2,"pfa":"Matt Butler","psa":"Thomas Arthur Pollak","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7155513463","eid":"W7155513463"},{"id":"paper-w3091336245","cat":"papers","name":"A simple technique for microdosing copper using the Delepine reaction.","year":"2010","cit":2,"pfa":"P FLEURY","psa":"J COURTOIS","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3091336245","eid":"W3091336245"},{"id":"paper-w2959259118","cat":"papers","name":"Management of Acute Substance Use Disorders: Hallucinogens and Associated Compounds","year":"2019","cit":2,"pfa":"Mladen Nisavic","psa":"Melisa W. Lai-Becker","topics":["Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W2959259118","eid":"W2959259118"},{"id":"paper-w2966428325","cat":"papers","name":"Microdose PET for the metabotropic glutamate receptor type 5 (mGluR5)","year":"2018","cit":2,"pfa":"James Robert Brašić","psa":"S. Hossein Fatemi","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2966428325","eid":"W2966428325"},{"id":"paper-w7160699293","cat":"papers","name":"Setting, context and the regulatory atmospheres of psychedelic medicine","year":"2026","cit":2,"pfa":"Alex K. Gearin","psa":"Albert Garcia‐Romeu","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7160699293","eid":"W7160699293"},{"id":"paper-w4409240416","cat":"papers","name":"In vivo effects of bempedoic acid on microdosed CYP probe drugs","year":"2025","cit":2,"pfa":"Felicitas Stoll","psa":"Antje Blank","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4409240416","eid":"W4409240416"},{"id":"paper-w2312539744","cat":"papers","name":"[Daily administration of microdoses of chlormadinone and its effects on breast feeding].","year":"1969","cit":2,"pfa":"Cásares Ponce Hj","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2312539744","eid":"W2312539744"},{"id":"paper-w2962300530","cat":"papers","name":"Mothers’ experience in caregiving for stimulant and hallucinogen drug-abusing adolescent","year":"2019","cit":2,"pfa":"Wahyudi Mulyaningrat","psa":"Novy Helena Catharina Daulima","ptype":"article","src":"https://openalex.org/W2962300530","eid":"W2962300530"},{"id":"paper-w3201784551","cat":"papers","name":"Purple Haze: The Psychedelic Sound of Nuclear Deterrence","year":"2021","cit":2,"pfa":"M Mulvihill","ptype":"article","src":"https://openalex.org/W3201784551","eid":"W3201784551"},{"id":"paper-w4389039677","cat":"papers","name":"A Heuristic Approach: Against Consensus Definitions of Psychedelics","year":"2023","cit":2,"pfa":"Lauren Lepow","psa":"Rachel Yehuda","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4389039677","eid":"W4389039677"},{"id":"paper-w1992796007","cat":"papers","name":"The Case For Victor A. Reko--An Unrecognized Pioneer Writer on New-World Hallucinogens","year":"1979","cit":2,"pfa":"Varro E. Tyler","ptype":"article","src":"https://openalex.org/W1992796007","eid":"W1992796007"},{"id":"paper-w4413289403","cat":"papers","name":"Psychedelics, psychiatry and pharmacokinetics - where are we now?","year":"2025","cit":2,"pfa":"Alice Caulfield","psa":"Allan Hunter Young","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4413289403","eid":"W4413289403"},{"id":"paper-w4295943370","cat":"papers","name":"A long trip into the universe: Psychedelics and space travel","year":"2022","cit":2,"pfa":"Leonard B. Lerer","psa":"Jeet Chandrakant Varia","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4295943370","eid":"W4295943370"},{"id":"paper-w7142071235","cat":"papers","name":"The Allostatic Reset Model (ARM) of Psychedelic Action","year":"2026","cit":2,"pfa":"David Lawrence","psa":"Charles L. Raison","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7142071235","eid":"W7142071235"},{"id":"paper-w4414610236","cat":"papers","name":"The Role of Psychedelics in Contemporary Psychological and Interdisciplinary Inquiry","year":"2025","cit":2,"pfa":"Kerem Kemal Soylemez","psa":"Joanne Marie Lusher","topics":["PTSD & trauma","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4414610236","eid":"W4414610236"},{"id":"paper-w2083230782","cat":"papers","name":"Women with small ovarian volume and microdose GnRH agonist protocol","year":"2001","cit":2,"pfa":"Fady I. Sharara","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2083230782","eid":"W2083230782"},{"id":"paper-w3108458518","cat":"papers","name":"Commentary: Psychedelic Psychiatry's Brave New World","year":"2020","cit":2,"pfa":"Bénédicte Nobile","psa":"Philippe Courtet","ptype":"editorial","src":"https://openalex.org/W3108458518","eid":"W3108458518"},{"id":"paper-w4401384905","cat":"papers","name":"Completing the Circle: A History of Psychedelics and Harm Reduction","year":"2024","cit":2,"pfa":"Erika Dyck","psa":"James Dixon","topics":["Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W4401384905","eid":"W4401384905"},{"id":"paper-w2415713813","cat":"papers","name":"[Significance of the cortical tracings of \"sleep\" induced in the waking cat by 3 hallucinogens].","year":"1966","cit":2,"pfa":"Arlette Rougeul","psa":"P Buser","ptype":"article","src":"https://openalex.org/W2415713813","eid":"W2415713813"},{"id":"paper-w4385494146","cat":"papers","name":"Could Psychedelics Treat Neuropathic Chronic Pain?","year":"2023","cit":2,"ptype":"article","src":"https://openalex.org/W4385494146","eid":"W4385494146"},{"id":"paper-w4285184635","cat":"papers","name":"Walter Benjamin and Herbert Marcuse: Psychedelics and Revolution","year":"2022","cit":2,"pfa":"Fernando Huesca Ramón","ptype":"book-chapter","src":"https://openalex.org/W4285184635","eid":"W4285184635"},{"id":"paper-w4398223004","cat":"papers","name":"Shamanism and Psychedelic, Religious, Spiritual, and Mystical Experiences","year":"2024","cit":2,"pfa":"Michael Winkelman","topics":["Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W4398223004","eid":"W4398223004"},{"id":"paper-w2399392058","cat":"papers","name":"The relationship of social and personality characteristics to hallucinogen use among college females.","year":"1974","cit":2,"pfa":"John H. Wackwitz","psa":"David E. Stenmark","ptype":"article","src":"https://openalex.org/W2399392058","eid":"W2399392058"},{"id":"paper-w2992653021","cat":"papers","name":"Choosing relevant functional groups for optimizing Artificial Neural Networks detecting NBOMe hallucinogens","year":"2019","cit":2,"pfa":"\"","psa":"Mirela Praisler","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2992653021","eid":"W2992653021"},{"id":"paper-w2766794551","cat":"papers","name":"Hallucinogen Persisting Perception Disorder Following Therapeutic Ketamine: A Case Report","year":"2017","cit":2,"pfa":"Carl Salzman","psa":"Henry David Abraham","ptype":"article","src":"https://openalex.org/W2766794551","eid":"W2766794551"},{"id":"paper-w4252576606","cat":"papers","name":"DERIVED TRAIL MAKING TEST INDICES IN A SAMPLE OF HALLUCINOGEN ABUSERS: DEMOGRAPHIC EFFECTS","year":"2002","cit":2,"pfa":"Arthur MacNeill Horton","psa":"Charles Roberts","ptype":"article","src":"https://openalex.org/W4252576606","eid":"W4252576606"},{"id":"paper-w4307429831","cat":"papers","name":"Complexities of psychedelics for therapeutic use in obesity and eating disorders","year":"2022","cit":2,"pfa":"Amy Claire Reichelt","ptype":"article","src":"https://openalex.org/W4307429831","eid":"W4307429831"},{"id":"paper-w4286750283","cat":"papers","name":"The modern clinical use of hallucinogens. What can we learn from the natural product research?","year":"2022","cit":2,"pfa":"Genís Oña","psa":"José Carlos Bouso","ptype":"article","src":"https://openalex.org/W4286750283","eid":"W4286750283"},{"id":"paper-w4401814972","cat":"papers","name":"Chemistry/structural biology of psychedelic drugs and their receptor(s)","year":"2024","cit":2,"pfa":"Ryan H. Gumpper","psa":"David E. Nichols","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4401814972","eid":"W4401814972"},{"id":"paper-w3091349815","cat":"papers","name":"MOTOR INFLUENCE RESEARCH OF HYDROGEN MICRODOSES ON THE DIESEL MIDGET OF TOXICITY INDICATORS","year":"2019","cit":2,"pfa":"А. М. Лєвтєров","psa":"V.M. Bgantsev","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3091349815","eid":"W3091349815"},{"id":"paper-w3209825092","cat":"papers","name":"Phenomenology for Psychedelic Researchers: A Review of Current Methods & Practices","year":"2021","cit":2,"pfa":"Alan Houot","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W3209825092","eid":"W3209825092"},{"id":"paper-w4416033814","cat":"papers","name":"HALLUCINOGEN: Benchmarking Hallucination in Implicit Reasoning within Large Vision Language Models","year":"2025","cit":2,"pfa":"Ashish Seth","psa":"Chirag Agarwal","ptype":"conference-paper","src":"https://openalex.org/W4416033814","eid":"W4416033814"},{"id":"paper-w4394857578","cat":"papers","name":"Increases in EEG Alpha Power and Beta Power Following a VR Psychedelic Journey","year":"2024","cit":2,"pfa":"Sonny Mattek","topics":["Addiction","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4394857578","eid":"W4394857578"},{"id":"paper-w2938637013","cat":"papers","name":"What can we learn from the psychedelic renaissance","year":"2018","cit":2,"pfa":"Max Daly","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2938637013","eid":"W2938637013"},{"id":"paper-w3031716105","cat":"papers","name":"Early and Contemporary Human Neuroimaging Studies of Serotonergic Psychedelics","year":"2020","cit":2,"pfa":"Enzo Tagliazucchi","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W3031716105","eid":"W3031716105"},{"id":"paper-w2429392037","cat":"papers","name":"Hallucinogens Acting at 5-HT Receptors: Toward a Mechanistic Understanding at Atomic Resolution","year":"1994","cit":2,"pfa":"Harel Weinstein","psa":"Juan A. Bahesteros","topics":["Mechanism & neuroscience"],"ptype":"dataset","src":"https://openalex.org/W2429392037","eid":"W2429392037"},{"id":"paper-w4406320360","cat":"papers","name":"The Soma Question: Interrogating the History of Psychedelics with Sanskrit Mantras","year":"2025","cit":2,"pfa":"Finnian M. M. Gerety","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4406320360","eid":"W4406320360"},{"id":"paper-w3130443982","cat":"papers","name":"Cerebrum: Modelling the Mind through Psychedelic and Playful Environments","year":"2020","cit":2,"pfa":"Jonathan Lovell","ptype":"article","src":"https://openalex.org/W3130443982","eid":"W3130443982"},{"id":"paper-w4400364503","cat":"papers","name":"The Therapeutic Potential of Psychedelics on Reducing Rumination: A Mini-Review","year":"2024","cit":2,"pfa":"Banan Ramarushton","psa":"Linda M. Thompson","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"review","src":"https://openalex.org/W4400364503","eid":"W4400364503"},{"id":"paper-w4413521552","cat":"papers","name":"The tricky economics of subsidising psychedelics for mental health therapy","year":"2023","cit":2,"pfa":"Cathy Mihalopoulos","psa":"Christopher J. Langmead","ptype":"other","src":"https://openalex.org/W4413521552","eid":"W4413521552"},{"id":"paper-w4380625327","cat":"papers","name":"How psychedelic drugs achieve their potent health benefits","year":"2023","cit":2,"pfa":"Sara Reardon","ptype":"other","src":"https://openalex.org/W4380625327","eid":"W4380625327"},{"id":"paper-w4388532936","cat":"papers","name":"Lime microdosing: A new liming strategy for increased productivity in acid soils","year":"2023","cit":2,"pfa":"Sampson Agyin‐Birikorang","psa":"Haruna Waku Dauda","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4388532936","eid":"W4388532936"},{"id":"paper-w4385684312","cat":"papers","name":"Chasing the Numinous: Hungry Ghosts in the Shadow of the Psychedelic Renaissance","year":"2023","cit":2,"pfa":"Helge Michael Osterhold","psa":"Gisele Fernandes‐Osterhold","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4385684312","eid":"W4385684312"},{"id":"paper-w4406325103","cat":"papers","name":"Narrative Hermeneutics and Bioethics: Understanding the Psychedelic Value Changes","year":"2025","cit":2,"pfa":"Juuso Kähönen","psa":"Joona Räsänen","topics":["Policy & ethics"],"ptype":"editorial","src":"https://openalex.org/W4406325103","eid":"W4406325103"},{"id":"paper-w2177774878","cat":"papers","name":"Observation concerning the effects of medetomidine-microdose on midazolam-ketamine induced anesthesia in dogs.","year":"2011","cit":2,"pfa":"Florin Ioan Beteg","psa":"L. Hodiş","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2177774878","eid":"W2177774878"},{"id":"paper-w2511765214","cat":"papers","name":"Entoptic Phenomena in Audio: Categories of Psychedelic Electroacoustic Composition","year":"2016","cit":2,"pfa":"Jonathan Weinel","ptype":"article","src":"https://openalex.org/W2511765214","eid":"W2511765214"},{"id":"paper-w2250087391","cat":"papers","name":"Progressive Rock and Psychedelic Coding in the Work of Jimi Hendri","year":"2000","cit":2,"pfa":"Sheila Whiteley","ptype":"article","src":"https://openalex.org/W2250087391","eid":"W2250087391"},{"id":"paper-w2422442693","cat":"papers","name":"Psychedelic Drug Activity: Electronic, Steric and Biochemical Correlates","year":"1970","cit":2,"pfa":"Solomon H. Snyder","ptype":"book-chapter","src":"https://openalex.org/W2422442693","eid":"W2422442693"},{"id":"paper-w4214891682","cat":"papers","name":"The Dionysian Primate: Goethe, Nietzsche, Jung and Psychedelic Neuroscience","year":"2022","cit":2,"pfa":"Gary Clark","topics":["Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W4214891682","eid":"W4214891682"},{"id":"paper-w181323868","cat":"papers","name":"[A \"no-bleeding\" substitute hormone treatment with an oral microdose progesterone. A prospective multicenter study].","year":"1994","cit":2,"pfa":"J Y Gillet","psa":"E Philippe","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W181323868","eid":"W181323868"},{"id":"paper-w2331059897","cat":"papers","name":"Current markers of the Athlete Blood Passport do not flag microdose EPO doping","year":"2012","cit":2,"pfa":"Roy Jesse Shephard","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2331059897","eid":"W2331059897"},{"id":"paper-w3151549825","cat":"papers","name":"Epidemiology of hospitalizations with hallucinogen use disorder: a 17-year U.S. National study","year":"2021","cit":2,"pfa":"Jasvinder A. Singh","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W3151549825","eid":"W3151549825"},{"id":"paper-w4408235814","cat":"papers","name":"From controversy to curiosity: A qualitative exploration of societal perceptions of psychedelics","year":"2025","cit":2,"pfa":"Kerem Kemal Soylemez","psa":"Joanne Marie Lusher","ptype":"article","src":"https://openalex.org/W4408235814","eid":"W4408235814"},{"id":"paper-w4413982774","cat":"papers","name":"Are Psychedelic Agents Ready for Prime Time as Stand-Alone Treatments?","year":"2025","cit":2,"pfa":"Cláudio N. Soares","ptype":"article","src":"https://openalex.org/W4413982774","eid":"W4413982774"},{"id":"paper-w4402464197","cat":"papers","name":"Psychedelic LSD activates neurotrophic signal but fails to stimulate neural stem cells","year":"2024","cit":2,"pfa":"Xiaoxu Dong","psa":"Shichao Huang","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4402464197","eid":"W4402464197"},{"id":"paper-w131748824","cat":"papers","name":"Connecting, diverging, and reconnecting: Putting the psi back into psychedelic research","year":"2010","cit":2,"pfa":"David P. Luke","ptype":"conference-paper","src":"https://openalex.org/W131748824","eid":"W131748824"},{"id":"paper-w4200475628","cat":"papers","name":"No evidence that LSD microdosing affects recall or the balance between distracter resistance and updating","year":"2021","cit":2,"pfa":"Sean James Fallon","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4200475628","eid":"W4200475628"},{"id":"paper-w4415210931","cat":"papers","name":"Addressing US Demand for Psychedelic Medicines in the Face of Scientific Uncertainty","year":"2025","cit":2,"pfa":"Holly Fernandez Lynch","psa":"Alison Bateman-House","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4415210931","eid":"W4415210931"},{"id":"paper-w4392406062","cat":"papers","name":"The prototypical hallucinogen LSD produces rapid antidepressant effects via 5-HT2B receptor activation","year":"2024","cit":2,"pfa":"Amel Bouloufa","psa":"Nasser Haddjeri","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4392406062","eid":"W4392406062"},{"id":"paper-w4385801825","cat":"papers","name":"Rational Design, Synthesis, and Characterization of a Solid Δ9-Tetrahydrocannabinol Nanoformulation Suitable for “Microdosing” Applications","year":"2023","cit":2,"pfa":"Abhinandan Banerjee","psa":"John Frederick Trant","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4385801825","eid":"W4385801825"},{"id":"paper-w4408507667","cat":"papers","name":"Therapeutic and Structural Dimensions in Psychiatric Prescribing: Bridging Psychedelics and Antidepressants","year":"2025","cit":2,"pfa":"Christopher W. T. Miller","psa":"Zofia Kozak","topics":["Depression","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4408507667","eid":"W4408507667"},{"id":"paper-w4396676941","cat":"papers","name":"Integrating Psychedelics into Digital Health: A New Horizon in Mental Wellness","year":"2024","cit":2,"pfa":"Brenda K. Wiederhold","ptype":"article","src":"https://openalex.org/W4396676941","eid":"W4396676941"},{"id":"paper-w3018656868","cat":"papers","name":"A global workspace, evolution-based model of the effect of psychedelics on consciousness.","year":"2020","cit":2,"pfa":"Bjørn Grinde","psa":"Lowan Han Stewart","ptype":"article","src":"https://openalex.org/W3018656868","eid":"W3018656868"},{"id":"paper-w2209612569","cat":"papers","name":"Mini Review on Psychedelic Drugs: Illumination on the Hidden Aspects of Mind","year":"2013","cit":2,"pfa":"Atul Kaushik","psa":"Lemlem Hussien Salih","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2209612569","eid":"W2209612569"},{"id":"paper-w4409640045","cat":"papers","name":"A scoping review of the effects of serotonergic psychedelics on attitudes towards death","year":"2025","cit":2,"pfa":"Noah N T Barr","psa":"Sam G. Moreton","topics":["Addiction","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4409640045","eid":"W4409640045"},{"id":"paper-w161763958","cat":"papers","name":"[Recent data on the treatment of bovine hypodermyiasis using metrifonate (Neguvon) and ivermectin (Ivomec) in microdoses].","year":"1997","cit":2,"pfa":"J.L. Charbon","psa":"K. Pfister","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"other","src":"https://openalex.org/W161763958","eid":"W161763958"},{"id":"paper-w4406315597","cat":"papers","name":"Relationality in Psychedelic Facilitation Training Programs: The UC Berkeley Case","year":"2025","cit":2,"pfa":"Moana Meadow","topics":["Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4406315597","eid":"W4406315597"},{"id":"paper-w4413652561","cat":"papers","name":"LSD ‘microdosing’ is trending in Silicon Valley – but can it actually make you more creative?","year":"2017","cit":2,"pfa":"Barbara Jacquelyn Sahakian","psa":"George Savulich","topics":["Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W4413652561","eid":"W4413652561"},{"id":"paper-w4389056208","cat":"papers","name":"Nested hermeneutics: Mind at Large as a curated trope of psychedelic experience","year":"2023","cit":2,"pfa":"Adrian Webb","ptype":"article","src":"https://openalex.org/W4389056208","eid":"W4389056208"},{"id":"paper-w2029120193","cat":"papers","name":"GnRH antagonists and poor responders: is there hope after a failed microdose agonist flare cycle?","year":"2002","cit":2,"pfa":"Serena H. Chen","psa":"David B. Sable","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2029120193","eid":"W2029120193"},{"id":"paper-w4320519736","cat":"papers","name":"Psychedelic Forms - Ceramics and Physical Form in Conversation with Deep Learning","year":"2023","cit":2,"pfa":"Varvara Guljajeva","psa":"Mar Canet Solà","ptype":"conference-paper","src":"https://openalex.org/W4320519736","eid":"W4320519736"},{"id":"paper-w3016383562","cat":"papers","name":"Psychedelics to treat mental illness? Australian researchers are giving it a go","year":"2019","cit":2,"pfa":"Martin L Williams","psa":"Stephen Jason Bright","ptype":"other","src":"https://openalex.org/W3016383562","eid":"W3016383562"},{"id":"paper-w2563752423","cat":"papers","name":"Psychedelic Psychiatry: LSD from Clinic to Campus Erika Dyck","year":"2010","cit":2,"pfa":"Kenton Kroker","ptype":"article","src":"https://openalex.org/W2563752423","eid":"W2563752423"},{"id":"paper-w4313013399","cat":"papers","name":"Relational ethical challenges and best practices in psychedelic healing work","year":"2021","cit":2,"pfa":"William Brennan","psa":"Joseph G. Ponterotto","topics":["Policy & ethics"],"ptype":"dataset","src":"https://openalex.org/W4313013399","eid":"W4313013399"},{"id":"paper-w4383615407","cat":"papers","name":"Science, safety and education: Informing the psychedelic treatment of psychiatric disorders","year":"2023","cit":2,"pfa":"Allan Hunter Young","topics":["Safety & adverse events"],"ptype":"editorial","src":"https://openalex.org/W4383615407","eid":"W4383615407"},{"id":"paper-w4409185634","cat":"papers","name":"Comparing psychedelic and meditation experience reports with Natural Language Processing","year":"2025","cit":2,"pfa":"Konsta Kallio-Mannila","psa":"Jussi Jylkkä","topics":["Addiction","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4409185634","eid":"W4409185634"},{"id":"paper-w4417360312","cat":"papers","name":"Comparing psychedelic and meditation experience reports with natural language processing","year":"2025","cit":2,"pfa":"Konsta Kallio-Mannila","psa":"Jussi Jylkkä","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4417360312","eid":"W4417360312"},{"id":"paper-w2416946341","cat":"papers","name":"Specific pharmacological management of acute toxicity due to \"psychedelic\" drugs.","year":"1972","cit":2,"pfa":"Consroe Pf","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2416946341","eid":"W2416946341"},{"id":"paper-w3212027497","cat":"papers","name":"The Psychedelic Renaissance: Addressing Potential Adverse Effects in a Therapeutic Setting","year":"2021","cit":2,"pfa":"Robert B. Kargbo","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"editorial","src":"https://openalex.org/W3212027497","eid":"W3212027497"},{"id":"paper-w4409089625","cat":"papers","name":"Enhanced independence: De-biasing processes in psychedelic research and beyond","year":"2025","cit":2,"pfa":"Katherine Cheung","psa":"David B. Yaden","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4409089625","eid":"W4409089625"},{"id":"paper-w419423635","cat":"papers","name":"Off the wall : psychedelic rock posters from San Francisco","year":"2005","cit":2,"pfa":"Amélie Gastaut","psa":"Musée de l'affiche et de la publicité","ptype":"book","src":"https://openalex.org/W419423635","eid":"W419423635"},{"id":"paper-w172806403","cat":"papers","name":"5-MeO-DIPT, a Psychedelic Structurally Related to Psiloc(yb)in","year":"2009","cit":2,"pfa":"Enno Christian Kurt Freye","ptype":"book-chapter","src":"https://openalex.org/W172806403","eid":"W172806403"},{"id":"paper-w4385632837","cat":"papers","name":"Acid Scholarship: Timothy Leary and the Academic Background of Psychedelic Occulture","year":"2023","cit":2,"pfa":"Andrea Rota","ptype":"book-chapter","src":"https://openalex.org/W4385632837","eid":"W4385632837"},{"id":"paper-w2327727603","cat":"papers","name":"Pituitary suppression with a GnRHa short protocol in an alternate day schedule associated with rhCG microdoses","year":"2014","cit":2,"pfa":"Rosane S. Rodrigues","psa":"Edson Borges","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2327727603","eid":"W2327727603"},{"id":"paper-w2083148516","cat":"papers","name":"A randomized, prospective study of microdose leuprolide versus oocyte donation in poor response patients","year":"2003","cit":2,"pfa":"Laura S. Kanzepolsky","psa":"Ester Polak de Fried","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2083148516","eid":"W2083148516"},{"id":"paper-w1997329795","cat":"papers","name":"Microdose flare-up versus antagonist protocols for poor responder patients: a meta-analysis","year":"2010","cit":2,"pfa":"Ertuğ Kovanci","psa":"William E. Gibbons","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1997329795","eid":"W1997329795"},{"id":"paper-w4392773137","cat":"papers","name":"Buprenorphine microdosing regimen using transdermal buprenorphine patches to transition from methadone to buprenorphine","year":"2024","cit":2,"pfa":"Thileepan Naren","psa":"Dean Membrey","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4392773137","eid":"W4392773137"},{"id":"paper-w4416718471","cat":"papers","name":"Psychedelics in Multiple Sclerosis: Mechanisms, Challenges, and Prospects for Neuroimmune Modulation and Repair","year":"2025","cit":2,"pfa":"Ivan Anchesi","psa":"Giovanni Luca Cipriano","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4416718471","eid":"W4416718471"},{"id":"paper-w4414954923","cat":"papers","name":"Mind-Manifesting Hypnosis: Phenomenological Similarities and Differences in Hypnotic and Psychedelic Contexts","year":"2025","cit":2,"pfa":"Etzel Cardeña","ptype":"article","src":"https://openalex.org/W4414954923","eid":"W4414954923"},{"id":"paper-w4413442563","cat":"papers","name":"Acute Effects and Long-Term Neuropsychological Consequences of Classic Psychedelics Use","year":"2025","cit":2,"pfa":"Lukas Andreas Basedow","psa":"Thomas Riemer","ptype":"book-chapter","src":"https://openalex.org/W4413442563","eid":"W4413442563"},{"id":"paper-w4406334734","cat":"papers","name":"Psychedelics as moral bioenhancers: Protocol for a scoping review of ethical arguments for and against","year":"2025","cit":2,"pfa":"Samuel Streicher","psa":"Brian David Earp","topics":["Addiction","Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4406334734","eid":"W4406334734"},{"id":"paper-w4221055195","cat":"papers","name":"Drug companies are investing big in psychedelics, but can they engineer out the trip?","year":"2022","cit":2,"pfa":"Bethany A. Halford","ptype":"article","src":"https://openalex.org/W4221055195","eid":"W4221055195"},{"id":"paper-w4247586619","cat":"papers","name":"What is the optimum maximal gonadotropin dosage used in microdose flare-up cycles in poor responders?","year":"2007","cit":2,"pfa":"Murat Berkkanoğlu","psa":"K. Ozgur","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4247586619","eid":"W4247586619"},{"id":"paper-w4388496591","cat":"papers","name":"Psycholytic dosing or 'microdosing' of Amanita muscaria (red fly agaric) mushrooms—A retrospective case study","year":"2023","cit":2,"pfa":"Mika Turkia","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"preprint","src":"https://openalex.org/W4388496591","eid":"W4388496591"},{"id":"paper-w4410706194","cat":"papers","name":"Dissolving porcine and human microthrombi by short exposure to microdoses of alteplase in an in vitro model of microvascular obstruction","year":"2025","cit":2,"pfa":"Anastasia Milusev","psa":"Dominik Obrist","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4410706194","eid":"W4410706194"},{"id":"paper-w2402400024","cat":"papers","name":"[Screening and identification of stimulant and psychedelic drugs as acetyl-derivatives by GC-MS].","year":"2006","cit":2,"pfa":"M Szkutová","psa":"Marie Balı́ková","topics":["Addiction","Policy & ethics"],"ptype":"other","src":"https://openalex.org/W2402400024","eid":"W2402400024"},{"id":"paper-w4391404624","cat":"papers","name":"Study Finds Hundreds of Reddit Posts on “Trip-Killers” for Psychedelic Drugs","year":"2024","cit":2,"pfa":"Melissa Suran","ptype":"article","src":"https://openalex.org/W4391404624","eid":"W4391404624"},{"id":"paper-w4408685228","cat":"papers","name":"Hype or hope? The developing evidence base for psychedelic treatment of addiction disorders","year":"2025","cit":2,"pfa":"Emmert Roberts","topics":["Addiction"],"ptype":"editorial","src":"https://openalex.org/W4408685228","eid":"W4408685228"},{"id":"paper-w3213406768","cat":"papers","name":"The self-transcendent brain - a meta-analysis of functional neuroimaging on meditation and psychedelics","year":"2018","cit":2,"pfa":"T Krause","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"dissertation","src":"https://openalex.org/W3213406768","eid":"W3213406768"},{"id":"paper-w2613865780","cat":"papers","name":"Review of Psychedelic White: Goa Trance and the Viscosity of Race by Arun Saldanha","year":"2009","cit":2,"pfa":"Bruce Braun","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2613865780","eid":"W2613865780"},{"id":"paper-w4285179018","cat":"papers","name":"Altered Consciousness After Descartes: Whitehead’s Philosophy of Organism as Psychedelic Realism","year":"2022","cit":2,"pfa":"Matthew David Segall","ptype":"book-chapter","src":"https://openalex.org/W4285179018","eid":"W4285179018"},{"id":"paper-w4378652529","cat":"papers","name":"Facilitating real-life creative insight through psychedelic virtual reality","year":"2023","cit":2,"pfa":"Timo Siimon","psa":"Jaan Aru","topics":["Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4378652529","eid":"W4378652529"},{"id":"paper-w3012347809","cat":"papers","name":"Angel-Headed Hipsters: Psychedelic Militancy in Nineteen-Eighties North America","year":"2012","cit":2,"pfa":"James Greer","topics":["Policy & ethics"],"ptype":"other","src":"https://openalex.org/W3012347809","eid":"W3012347809"},{"id":"paper-w4409241067","cat":"papers","name":"Palliadelic: A neologism that refers to the use of psychedelics in hospice and palliative care settings","year":"2025","cit":2,"pfa":"Jaime Andrés Vinasco Barco","psa":"Ana Cláudia Mesquita Garcia","topics":["Addiction","Anxiety & end-of-life","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4409241067","eid":"W4409241067"},{"id":"paper-w3184344364","cat":"papers","name":"“Don’t Kill My Buzz, Man!” – Explaining the Criminalization of Psychedelic Drugs","year":"2021","cit":2,"pfa":"Conrad Sproul","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3184344364","eid":"W3184344364"},{"id":"paper-w4395466969","cat":"papers","name":"Psychotherapeutic Interventions in Clinical Trials of Psychedelics for the Treatment of Alcohol Use Disorder","year":"2024","cit":2,"pfa":"Ardavan Mohammad Aghaei","psa":"Anahita Bassir Nia","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4395466969","eid":"W4395466969"},{"id":"paper-w2149012095","cat":"papers","name":"Long-term effect of a continuous daily microdose of norgestrel on the genital organs and fertility of female rats","year":"1970","cit":2,"pfa":"A. Sen(Late)","psa":"Amiya Bhuson Kar","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2149012095","eid":"W2149012095"},{"id":"paper-w2946062730","cat":"papers","name":"The United States Print Media and its War on Psychedelic Research in the 1960s","year":"2019","cit":2,"pfa":"Jessica M Bracco","ptype":"article","src":"https://openalex.org/W2946062730","eid":"W2946062730"},{"id":"paper-w2886907233","cat":"papers","name":"A comparison of microdose flare versus antagonist protocol in poor responders chosen according to the Bologna criteria","year":"2017","cit":2,"pfa":"Neena Malhotra","psa":"Alka Kriplani","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2886907233","eid":"W2886907233"},{"id":"paper-w3094596368","cat":"papers","name":"Correction to: The effects of microdose LSD on time perception: a randomised, double-blind, placebo-controlled trial","year":"2020","cit":2,"pfa":"Steliana Yanakieva","psa":"Devin Blair Terhune","topics":["Dosing & pharmacology"],"ptype":"erratum","src":"https://openalex.org/W3094596368","eid":"W3094596368"},{"id":"paper-w944422429","cat":"papers","name":"“This Season’s People”: Stephen Gaskin, Psychedelic Religion, and a Community of Social Justice","year":"2015","cit":2,"pfa":"Morgan Shipley","ptype":"article","src":"https://openalex.org/W944422429","eid":"W944422429"},{"id":"paper-w1972944122","cat":"papers","name":"The effects of intracranial administration of hallucinogens on operant behavior in the rat. II. 2,5-Dimethoxy-4-methylamphetamine (DOM)","year":"1987","cit":2,"pfa":"David J. Mokler","psa":"Richard H. Rech","ptype":"article","src":"https://openalex.org/W1972944122","eid":"W1972944122"},{"id":"paper-w2756057209","cat":"papers","name":"Do (Ab)Users of Psychedelics Have Tendencies to Abuse High Authority? An Internet Snapshot Study","year":"2017","cit":2,"pfa":"Ahmed Al-Imam","psa":"Ban A. AbdulMajeed","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2756057209","eid":"W2756057209"},{"id":"paper-w4226225196","cat":"papers","name":"Signaling Snapshots of 5-HT 2BR Activated by the Prototypical Psychedelic LSD","year":"2022","cit":2,"pfa":"Can Cao","psa":"Bryan L. Roth","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4226225196","eid":"W4226225196"},{"id":"paper-w4417507819","cat":"papers","name":"Managing Psychological Challenges in the Subacute (“Afterglow”) Window of Psychedelic Drug Effects","year":"2025","cit":2,"pfa":"Ricarda Evens","psa":"Tomislav Majić","ptype":"book-chapter","src":"https://openalex.org/W4417507819","eid":"W4417507819"},{"id":"paper-w4378532979","cat":"papers","name":"Ton Steine Scherben: A Unique Hybrid of Psychedelic Rock and Battle Song","year":"2023","cit":2,"pfa":"David Robb","ptype":"article","src":"https://openalex.org/W4378532979","eid":"W4378532979"},{"id":"paper-w3107728923","cat":"papers","name":"Farmers' Soil Fertility Management in Niger and Opportunities for Improvements Through Mechanization, Microdosing, and Seed Coating","year":"2020","cit":2,"pfa":"Abdourahamane Issa M. Nourou","psa":"Jens B. Aune","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3107728923","eid":"W3107728923"},{"id":"paper-w235573706","cat":"papers","name":"Structure-activity relationships of hallucinogens: Design, synthesis, and pharmacological evaluation of a series of conformationally restricted phenethylamines","year":"1995","cit":2,"pfa":"Aaron P. Monte","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W235573706","eid":"W235573706"},{"id":"paper-w2327869036","cat":"papers","name":"Hallucinogen Persistent Perception Disorder Induced by New Psychoactive Substituted Phenethylamines; a Review with Illustrative Case","year":"2016","cit":2,"pfa":"Cornel N. Stanciu","psa":"Thomas M. Penders","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2327869036","eid":"W2327869036"},{"id":"paper-w142376288","cat":"papers","name":"Quality control of extemporaneously prepared microdose captopril capsules: weight variation versus content uniformity.","year":"1994","cit":2,"pfa":"Robert D. Colucci","psa":"L Glassner-Cohen","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W142376288","eid":"W142376288"},{"id":"paper-w1526813557","cat":"papers","name":"Microdosing Assessment to Evaluate Pharmacokinetics and Drug Metabolism Using Liquid Chromatography-Tandem Mass Spectrometry Technology","year":"2012","cit":2,"pfa":"Jinsong Ni","psa":"Josh Rowe","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W1526813557","eid":"W1526813557"},{"id":"paper-w1967952134","cat":"papers","name":"Psychotomimetic Plants. II","year":"1974","cit":2,"pfa":"Norman R. Farnsworth","ptype":"article","src":"https://openalex.org/W1967952134","eid":"W1967952134"},{"id":"paper-w2094037320","cat":"papers","name":"The Psychedelic Renaissance: Reassessing the Role of Psychedelic Drugs in 21st Century Psychiatry and Society By Ben Sessa. Muswell Hill Press. 2012. £16.95 (pb). 237 pp. ISBN: 9781908995009","year":"2013","cit":2,"pfa":"Mark Bolstridge","ptype":"book-review","src":"https://openalex.org/W2094037320","eid":"W2094037320"},{"id":"paper-w4389329838","cat":"papers","name":"If Everything Is Psychedelic, Then Nothing Is: A Response to O'Donnell et al. and Lepow et al.","year":"2023","cit":2,"pfa":"David E. Nichols","psa":"Charles David Nichols","ptype":"article","src":"https://openalex.org/W4389329838","eid":"W4389329838"},{"id":"paper-w354456107","cat":"papers","name":"Psychedelic horizons : Snow White, immune system, multistate mind, enlarging education","year":"2006","cit":2,"pfa":"Thomas B. Roberts","ptype":"book","src":"https://openalex.org/W354456107","eid":"W354456107"},{"id":"paper-w2172248122","cat":"papers","name":"Efficacy of a New Agonist-Antagonist Protocol Compared To Microdose Flare-up in Poor Responder IVF Patients","year":"2005","cit":2,"pfa":"Halit Fırat Erden","psa":"Mustafa Bahçeci","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2172248122","eid":"W2172248122"},{"id":"paper-w7151767047","cat":"papers","name":"Extended difficulties after psychedelic experiences: Prevalence and associations in a global, multilingual sample","year":"2026","cit":2,"pfa":"C. Robinson Oliver","psa":"Philippe Lucas","ptype":"preprint","src":"https://openalex.org/W7151767047","eid":"W7151767047"},{"id":"paper-w4407820913","cat":"papers","name":"A Review of the Food and Drug Administration Pipeline and Proposed California Legislation on Medicinal Psychedelics","year":"2025","cit":2,"pfa":"Jack R Watson","psa":"Jailene Lazaro Serrano","topics":["PTSD & trauma","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4407820913","eid":"W4407820913"},{"id":"paper-w2092573635","cat":"papers","name":"Microdose gonadotropin-releasing hormone agonist in the absence of exogenous gonadotropins is not sufficient to induce multiple follicle development","year":"2010","cit":2,"pfa":"Karine Chung","psa":"Richard J. Paulson","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2092573635","eid":"W2092573635"},{"id":"paper-w4406593575","cat":"papers","name":"Tripping in the Happiest Country of the World – Use Values of Psychedelics According to Finnish Users","year":"2025","cit":2,"pfa":"Mika Tsupari","psa":"Tuukka Tammi","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4406593575","eid":"W4406593575"},{"id":"paper-w2039368263","cat":"papers","name":"The Abuse of Psychotomimetic Drugs","year":"1971","cit":2,"pfa":"William A. Frosch","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2039368263","eid":"W2039368263"},{"id":"paper-w4223580264","cat":"papers","name":"Relief for Grief: Report from a Psychedelic Retreat for Bereaved Parents in Jamaica (ODS9)","year":"2022","cit":2,"pfa":"Chris Adrian","psa":"Dingle Spence","ptype":"article","src":"https://openalex.org/W4223580264","eid":"W4223580264"},{"id":"paper-w4291317262","cat":"papers","name":"Microdose d'ivermectine chez la vache laitière: concentrations plasmatiques et résidus dans le lait","year":"1994","cit":2,"pfa":"M. Alvinerie","psa":"Pierre L. Toutain","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4291317262","eid":"W4291317262"},{"id":"paper-w4234449414","cat":"papers","name":"Hallucinogen Actions on 5-HT Receptors Reveal Distinct Mechanisms of Activation and Signaling by G Protein-Coupled Receptors","year":"2008","cit":2,"pfa":"Harel Weinstein","topics":["Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W4234449414","eid":"W4234449414"},{"id":"paper-w2888623950","cat":"papers","name":"What Neuroimaging of the Psychedelic State Tells Us about the Mind-Body Problem","year":"2016","cit":2,"pfa":"Bernardo Kastrup","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2888623950","eid":"W2888623950"},{"id":"paper-w2962618840","cat":"papers","name":"KOMUNIKASI INTERPERSONAL DALAM KELOMPOK MAHASISWA MENGENAI GAYA PSYCHEDELIC DI BALI","year":"2019","cit":2,"pfa":"Nuning Indah Pratiwi","psa":"Kadek Adyatna Wedananta","ptype":"article","src":"https://openalex.org/W2962618840","eid":"W2962618840"},{"id":"paper-w4399055736","cat":"papers","name":"Non-hallucinogenic psychedelic psychotherapy: Decreasing risk and increasing access, or missing the point?","year":"2024","cit":2,"pfa":"Joanna Pashdag","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4399055736","eid":"W4399055736"},{"id":"paper-w4387047335","cat":"papers","name":"Decision-Making around Psychedelics for Depression and Anxiety: a Model Based on Online Discussions","year":"2023","cit":2,"pfa":"David T. Kryszajtys","psa":"Carol Strıke","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4387047335","eid":"W4387047335"},{"id":"paper-w4294733080","cat":"papers","name":"Comparative Pharmacology and Circuit-Level Models of the Effects of Psychedelic Drugs on the Human Brain","year":"2022","cit":2,"pfa":"Frederick Streeter Barrett","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4294733080","eid":"W4294733080"},{"id":"paper-w4390542756","cat":"papers","name":"Capturing Synergy Holistically in Psychedelic Clinical Trials: Assessing Processes in Addition to Outcomes","year":"2024","cit":2,"pfa":"Terence H. W. Ching","psa":"Sarah Shnayder","ptype":"article","src":"https://openalex.org/W4390542756","eid":"W4390542756"},{"id":"paper-w7155625268","cat":"papers","name":"Media hype regarding psychedelic treatments for depression and PTSD from 2017 to 2024","year":"2026","cit":2,"pfa":"Audrey G. Evers","psa":"Gabriela Kattan Khazanov","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7155625268","eid":"W7155625268"},{"id":"paper-w2403264757","cat":"papers","name":"A Review of the Research and Theological Implications of the Use of Psychedelic Drugs with Terminal Cancer Patients","year":"1977","cit":2,"pfa":"Betty L. Phifer","topics":["Anxiety & end-of-life","Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2403264757","eid":"W2403264757"},{"id":"paper-w4414140407","cat":"papers","name":"A scoping review of variations in psychedelic interventions for psychological suffering associated with the end of life","year":"2025","cit":2,"pfa":"Sarah Kratina","psa":"Brian R. Rush","topics":["Addiction","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4414140407","eid":"W4414140407"},{"id":"paper-w4237557840","cat":"papers","name":"Psychotomimetic Drugs","year":"2006","cit":2,"ptype":"book-chapter","src":"https://openalex.org/W4237557840","eid":"W4237557840"},{"id":"paper-w4389315264","cat":"papers","name":"Use of intravenous buprenorphine microdosing to initiate medication for opioid use disorder in a patient with co-occurring pain: case report","year":"2023","cit":2,"pfa":"Alia Bodnar","psa":"Rosalyn Walker Stewart","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4389315264","eid":"W4389315264"},{"id":"paper-w4415464450","cat":"papers","name":"Altered Rationality? Integrating Psychedelic Experiences Into Rational Thinking Through the Critical Anchor Approach","year":"2025","cit":2,"pfa":"Lucas F. Borkel","psa":"Luis Alberto Henríquez‐Hernández","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4415464450","eid":"W4415464450"},{"id":"paper-w4406325068","cat":"papers","name":"Psychedelics and Psychotherapy: What Can be Learned from a Historical Analysis of General Anesthesia and Surgery?","year":"2025","cit":2,"pfa":"Christopher S. Stauffer","topics":["Safety & adverse events","Therapy practice","Policy & ethics"],"ptype":"editorial","src":"https://openalex.org/W4406325068","eid":"W4406325068"},{"id":"paper-w4393384738","cat":"papers","name":"The psychedelic, DOI, increases dopamine release in nucleus accumbens to predictable rewards and reward cues","year":"2024","cit":2,"pfa":"David Alexander Martin","psa":"Donna J. Calu","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4393384738","eid":"W4393384738"},{"id":"paper-w2944207263","cat":"papers","name":"Improving traditional leafy vegetables production through water use efficiency and fertilizer microdosing technology in Benin Republic","year":"2019","cit":2,"pfa":"G. Esaïe Kpadonou","psa":"A.J. Djenontin","topics":["Dosing & pharmacology"],"ptype":"conference-paper","src":"https://openalex.org/W2944207263","eid":"W2944207263"},{"id":"paper-w4404488835","cat":"papers","name":"The Reporting of Setting in Psychedelic Clinical Trials (ReSPCT) Guidelines: An international Delphi consensus study","year":"2024","cit":2,"pfa":"Chloé Pronovost-Morgan","psa":"Leor Roseman","ptype":"preprint","src":"https://openalex.org/W4404488835","eid":"W4404488835"},{"id":"paper-w4408230190","cat":"papers","name":"Societal Trends and Opportunities in the Aftermath of the Nova Psychedelic Trance Rave, Through Lilla and Benjamin","year":"2025","cit":2,"pfa":"Demian Halperin","psa":"Guy Simon","topics":["PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4408230190","eid":"W4408230190"},{"id":"paper-w2051658793","cat":"papers","name":"Folk Revival Roots Still Evident in 1990s Recordings of San Francisco Psychedelic Veterans","year":"2001","cit":2,"pfa":"Craig Morrison","ptype":"article","src":"https://openalex.org/W2051658793","eid":"W2051658793"},{"id":"paper-w4399500467","cat":"papers","name":"Development of a sensitive LC-MS/MS assay to support human microdose study for an oral agonist of the GLP-1 receptor","year":"2024","cit":2,"pfa":"Eugene P. Kadar","psa":"Gregory S. Steeno","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4399500467","eid":"W4399500467"},{"id":"paper-w4409248810","cat":"papers","name":"From Stigma to Support: “Black-Owned” Labels and Expertise Stereotypes in Cannabis and Psychedelics Markets","year":"2025","cit":2,"pfa":"Chethana Achar","psa":"Keyaira Lock","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4409248810","eid":"W4409248810"},{"id":"paper-w7140135983","cat":"papers","name":"How to set up a psychedelic study: Unique considerations for research involving human participants","year":"2026","cit":2,"pfa":"Marcus J. Glennon","psa":"Anjali Bhat","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7140135983","eid":"W7140135983"},{"id":"paper-w786339294","cat":"papers","name":"The democratic surround: multimedia & American liberalism from World War II to the psychedelic sixties","year":"2014","cit":2,"ptype":"book-review","src":"https://openalex.org/W786339294","eid":"W786339294"},{"id":"paper-w4254428361","cat":"papers","name":"Psychotomimetic Drugs","year":"2008","cit":2,"pfa":"George K. Aghajanian","ptype":"reference-entry","src":"https://openalex.org/W4254428361","eid":"W4254428361"},{"id":"paper-w4416604992","cat":"papers","name":"Psychedelics in the age of reproducibility: Reflections on aura, set and setting and the medicalization of mystical-type experiences","year":"2025","cit":2,"pfa":"Guy Simon","psa":"Demian Halperin","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4416604992","eid":"W4416604992"},{"id":"paper-w3106974713","cat":"papers","name":"“Culture and psychedelic psychotherapy: Ethnic and racial themes from three black women therapists”","year":"2021","cit":2,"pfa":"Anne Vallely","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W3106974713","eid":"W3106974713"},{"id":"paper-w3210287605","cat":"papers","name":"INFLUENCE OF MICRODOSE OF FATTY ACIDS OF CITRULLUS COLOCYNTHIS EXTRACT ON LIPOPROTEIDS OF RAT BLOOD WITH DIABETES MELLITUS TYPE 1","year":"2017","cit":2,"pfa":"Oksana Kryvosheyeva","psa":"Л.В. Натрус","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3210287605","eid":"W3210287605"},{"id":"paper-w4412552713","cat":"papers","name":"Psychedelics and New Materialism: Challenging the Science–Spirituality Binary and the Onto-Epistemological Order of Modernity","year":"2025","cit":2,"pfa":"Mateo Sánchez Petrement","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4412552713","eid":"W4412552713"},{"id":"paper-w4413644327","cat":"papers","name":"Appraisal of the validity of preclinical investigations to predict the efficacy of psychedelic drugs as fast-acting antidepressants","year":"2025","cit":2,"pfa":"S. Clare Stanford","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4413644327","eid":"W4413644327"},{"id":"paper-w4408154583","cat":"papers","name":"Adverse Effects and Safety of Antidepressants and Psychedelics for Depression in Cancer: A Systematic Review of Randomized Controlled Trials","year":"2025","cit":2,"pfa":"Renan Massanobu Maekawa","psa":"RAFAEL GUIMARÃES DOS SANTOS","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W4408154583","eid":"W4408154583"},{"id":"paper-w4414291946","cat":"papers","name":"In Silico Characterization of Bromo‐ DragonFLY Binding to the 5‐ HT 2A Receptor: Molecular Insights Into a Potent Designer Psychedelic","year":"2025","cit":2,"pfa":"Shamoon Tariq","psa":"Zaheer Ul‐Haq","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4414291946","eid":"W4414291946"},{"id":"paper-w2032569920","cat":"papers","name":"Late initiation of gonadotrophin administration after microdose flare up increases response in poor responders – a randomized prospective study","year":"2007","cit":2,"pfa":"Guven Gunaydin","psa":"Onur Karabacak","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2032569920","eid":"W2032569920"},{"id":"paper-w4412707997","cat":"papers","name":"Treatment of depressive and negative symptoms in individuals with schizoaffective disorders using serotoninergic psychedelics: a case report","year":"2025","cit":2,"pfa":"Michel Sabé","psa":"Matthias Kirschner","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4412707997","eid":"W4412707997"},{"id":"paper-w4395479311","cat":"papers","name":"Feasibility and effectiveness study of applying a hallucinogen harm reduction and integration model to a mindfulness thinking intervention using virtual reality: A randomized controlled trial","year":"2024","cit":2,"pfa":"Yanying Chen","psa":"Duo Li","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4395479311","eid":"W4395479311"},{"id":"paper-w2422470285","cat":"papers","name":"Psychotomimetics and their abuse.","year":"1968","cit":2,"pfa":"Der Marderosian A","ptype":"article","src":"https://openalex.org/W2422470285","eid":"W2422470285"},{"id":"paper-w4413798260","cat":"papers","name":"Psychedelics, Harm Reduction, and Life's Big Questions: Making Sense of Spirituality and Religion After the Journey","year":"2025","cit":2,"pfa":"Lisa L. Gezon","psa":"Kenton Bartlett","topics":["Safety & adverse events","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4413798260","eid":"W4413798260"},{"id":"paper-w4410317247","cat":"papers","name":"Practitioner perspectives on extended difficulties and optimal support strategies following psychedelic experiences: A qualitative analysis","year":"2025","cit":2,"pfa":"Eirini K. Argyri","psa":"Celia J. A. Morgan","ptype":"preprint","src":"https://openalex.org/W4410317247","eid":"W4410317247"},{"id":"paper-w1970798618","cat":"papers","name":"S.07.02 In vivo measurements of brain serotonergic markers and analysis of drug use profiles among recreational ecstasy and hallucinogen users","year":"2011","cit":2,"pfa":"David Erritzøe","psa":"Gitte M. Knudsen","ptype":"article","src":"https://openalex.org/W1970798618","eid":"W1970798618"},{"id":"paper-w4223456429","cat":"papers","name":"Can the revival of serotonergic psychedelic drugs as treatments for mental disorders help to characterize their risks and benefits?","year":"2022","cit":2,"pfa":"Muhammad Ishrat Husain","psa":"Benoit H. Mulsant","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"editorial","src":"https://openalex.org/W4223456429","eid":"W4223456429"},{"id":"paper-w3130935817","cat":"papers","name":"A simple data post-processing method for axial peaks free 2D PSYCHEDELIC NMR spectra","year":"2021","cit":2,"pfa":"Xi Dong","psa":"Yanqin Lin","ptype":"article","src":"https://openalex.org/W3130935817","eid":"W3130935817"},{"id":"paper-w2277202705","cat":"papers","name":"Microdose flare-up vs. flexible-multidose GnRH antagonist protocols for poor responder patients who underwent ICSI","year":"2014","cit":2,"pfa":"İbrahim Esinler","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2277202705","eid":"W2277202705"},{"id":"paper-w4414124587","cat":"papers","name":"From Policy to Perception: Do Public Views on UK Drug Policy Shape Attitudes Toward Psychedelics?","year":"2025","cit":2,"pfa":"Katie Dickson","psa":"Joseph Lloyd Davies","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4414124587","eid":"W4414124587"},{"id":"paper-w3138992037","cat":"papers","name":"Microdose protocol stereoradiography has similar reliability to standard low-dose protocol during concurrent Sanders skeletal maturity staging","year":"2021","cit":2,"pfa":"Cynthia V. Nguyen","psa":"Robert H. Cho","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3138992037","eid":"W3138992037"},{"id":"paper-w403426362","cat":"papers","name":"Psychotomimetic Effects of Opioids","year":"1991","cit":2,"pfa":"Andreas F. H. Pfeiffer","topics":["Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W403426362","eid":"W403426362"},{"id":"paper-w4367601937","cat":"papers","name":"Treatment Issues Related to the Use of Psychedelics, Trichotillomania, Social Anxiety Disorder, Schizophrenia, and Opioid Use Disorder","year":"2023","cit":2,"pfa":"Ned H. Kalin","topics":["Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4367601937","eid":"W4367601937"},{"id":"paper-w3030048481","cat":"papers","name":"Evaluation of Renal Anionic Secretion Following Living-donor and Deceased-donor Renal Transplantation: A Clinical Pharmacokinetic Study of Cefoxitin Microdosing","year":"2020","cit":2,"pfa":"Hari Varun Kalluri","psa":"Raman Venkataramanan","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3030048481","eid":"W3030048481"},{"id":"paper-w2417182087","cat":"papers","name":"Are there any psychotherapeutic or psychotomimetic drugs?","year":"1958","cit":2,"pfa":"Murray E. Jarvik","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2417182087","eid":"W2417182087"},{"id":"paper-w4378965787","cat":"papers","name":"The Varieties of Psychedelic Expertise in 1960s Canada: The Psychiatrists behind the Addiction Research Foundation’s Study of LSD Therapy","year":"2023","cit":2,"pfa":"Andrew Jones","topics":["Addiction","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4378965787","eid":"W4378965787"},{"id":"paper-w4404674988","cat":"papers","name":"Survey of Massachusetts peer recovery coaches’ attitudes toward the use of psychedelics to treat substance use disorders","year":"2024","cit":2,"pfa":"Veronica Szpak","psa":"Joji Suzuki","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4404674988","eid":"W4404674988"},{"id":"paper-w4407941930","cat":"papers","name":"Bridging Psychedelic VR and BCI: Enhancing User Experience through Adaptive EEG-Guided Neural Modulation","year":"2025","cit":2,"pfa":"Leon Lange","psa":"Ying Choon Wu","topics":["Mechanism & neuroscience"],"ptype":"conference-paper","src":"https://openalex.org/W4407941930","eid":"W4407941930"},{"id":"paper-w3158924784","cat":"papers","name":"IVF Outcomes of Microdose Flare-up, GnRH Antagonist and Long Protocols in Patients Having a Poor Ovarian Response in the First Treatment Cycle","year":"2021","cit":2,"pfa":"Hassan Mumtaz","psa":"Aamir Ghazanfar","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3158924784","eid":"W3158924784"},{"id":"paper-w2023735156","cat":"papers","name":"Abstract 1183: Phase 0 microdosing trial quantitating DNA adduct formation to identify platinum chemosensitivity: from bench to bedside.","year":"2013","cit":2,"pfa":"Chong-xian Pan","psa":"Paul T. Henderson","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W2023735156","eid":"W2023735156"},{"id":"paper-w4311957183","cat":"papers","name":"Micro-dose, macro-impact: Leveraging psychedelics in frontline healthcare workers during the COVID-19 pandemic","year":"2022","cit":2,"pfa":"Andre Atoian","psa":"Duraiyah Thangathurai","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4311957183","eid":"W4311957183"},{"id":"paper-w4406546334","cat":"papers","name":"Persistent large-scale changes in alternative splicing in prefrontal cortical neuron types following psychedelic exposure","year":"2025","cit":2,"pfa":"Yungyi Hsiao","psa":"Andrea M. Gomez","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4406546334","eid":"W4406546334"},{"id":"paper-w4235600801","cat":"papers","name":"Turn on, Tune in, and Drop out: Predictors of Attrition in a Prospective Observational Cohort Study on Psychedelic Use (Preprint)","year":"2020","cit":2,"pfa":"Sebastian Hübner","psa":"Hannes Kettner","topics":["Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4235600801","eid":"W4235600801"},{"id":"paper-w4392472112","cat":"papers","name":"Cultural Divergence in Psychedelic Use among Medical Students: An ESPAD-Adapted Survey among Poles and Iraqis","year":"2024","cit":2,"pfa":"Ahmed Al-Imam","psa":"Michał Michalak","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4392472112","eid":"W4392472112"},{"id":"paper-w3017019933","cat":"papers","name":"Development and validation of an LC-MS/MS method for the quantification of imatinib and imatinib-d8 in human plasma for the support of an absolute bioavailability microdose trial","year":"2020","cit":2,"pfa":"Jeroen Roosendaal","psa":"Jos H. Beijnen","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3017019933","eid":"W3017019933"},{"id":"paper-w121617652","cat":"papers","name":"Mapping the binding site of the 5-HT2A receptor using mutagenesis and ligand libraries: Insights into the molecular actions of psychedelics","year":"2012","cit":2,"pfa":"John D. McCorvy","topics":["Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W121617652","eid":"W121617652"},{"id":"paper-w2218143743","cat":"papers","name":"Quantitation of anacetrapib, stable-isotope labeled-anacetrapib (microdose), and four metabolites in human plasma using liquid chromatography tandem mass spectrometry","year":"2015","cit":2,"pfa":"C.M. Chavez-Eng","psa":"Eric Woolf","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2218143743","eid":"W2218143743"},{"id":"paper-w4406170234","cat":"papers","name":"Notes from the Field: Severe Health Outcomes Linked to Consumption of Mushroom-Based Psychoactive Microdosing Products — Arizona, June–October 2024","year":"2025","cit":2,"pfa":"Heather M. Walker","psa":"Shane Brady","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4406170234","eid":"W4406170234"},{"id":"paper-w4297520094","cat":"papers","name":"Classic and dissociative psychedelics induce similar hyper-synchronous states in the cognitive-limbic cortex-basal ganglia system","year":"2022","cit":2,"pfa":"Ivani Brys","psa":"Pär Halje","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4297520094","eid":"W4297520094"},{"id":"paper-w4413377100","cat":"papers","name":"The experience of recalled trauma during psychedelic experiences and perceived links to subsequent extended difficulties: A mixed-methods study","year":"2025","cit":2,"pfa":"Guy Simon","psa":"Oliver C. Robinson","topics":["PTSD & trauma"],"ptype":"preprint","src":"https://openalex.org/W4413377100","eid":"W4413377100"},{"id":"paper-w4390459583","cat":"papers","name":"Pharmaco-Analysis of Psychedelics—Philo-Fictions about New Materialism, Quantum Mechanics, Information Science, and the Philosophy of Immanence","year":"2023","cit":2,"pfa":"Stefan Paulus","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4390459583","eid":"W4390459583"},{"id":"paper-w7154976854","cat":"papers","name":"A Single Dose of a Psychedelic Drug Repairs Prefrontal Cortex Synaptic Physiology in a Mouse Model of Prenatal Alcohol Exposure","year":"2026","cit":2,"pfa":"Tyler G. Ekins","psa":"Omar J. Ahmed","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7154976854","eid":"W7154976854"},{"id":"paper-w4240505962","cat":"papers","name":"Naturalistic use of psychedelics is related to emotional reactivity and self-consciousness: the mediating role of ego-dissolution and mystical experiences","year":"2021","cit":2,"pfa":"Paweł Orlowski","psa":"Michał Bola","topics":["Addiction"],"ptype":"preprint","src":"https://openalex.org/W4240505962","eid":"W4240505962"},{"id":"paper-w4386915153","cat":"papers","name":"Tripping outside the lines: lessons from observational studies of combination psychedelic use beyond regulated clinical contexts","year":"2023","cit":2,"pfa":"Sarah Kratina","psa":"Leah M. Mayo","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4386915153","eid":"W4386915153"},{"id":"paper-w4410093034","cat":"papers","name":"Pictorial representation of illness and self measure (PRISM): A putative transdiagnostic tool for evaluating therapeutic effects of psychedelic treatments","year":"2025","cit":2,"pfa":"Niloufar Pouyan","psa":"Kevin F. Boehnke","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4410093034","eid":"W4410093034"},{"id":"paper-w179380202","cat":"papers","name":"The Prevention of the Psychotomimetic Effects of Ketamine","year":"1973","cit":2,"pfa":"Francis F. Foldes","ptype":"book-chapter","src":"https://openalex.org/W179380202","eid":"W179380202"},{"id":"paper-w2410307416","cat":"papers","name":"Mechanism of action of psychotomimetic drugs.","year":"1975","cit":2,"pfa":"Leo G. Abood","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2410307416","eid":"W2410307416"},{"id":"paper-w4406451748","cat":"papers","name":"Self‐reported experiences and perspectives on using psychedelics to manage opioid use among participants of two Reddit communities","year":"2025","cit":2,"pfa":"Noa Krawczyk","psa":"Meredith C. Meacham","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4406451748","eid":"W4406451748"},{"id":"paper-w4392379877","cat":"papers","name":"The Relationship Between Changes in Mindfulness and Subsequent Changes in Well-Being Following Psychedelic Use: Prospective Cohort Study","year":"2024","cit":2,"pfa":"Grant M. Jones","psa":"Hannes Kettner","ptype":"article","src":"https://openalex.org/W4392379877","eid":"W4392379877"},{"id":"paper-w4415282943","cat":"papers","name":"A need to replenish essential lithium microdoses in epilepsy suggested by clinical and epidemiological studies on lithium as a factor for preventing impulsive behavior, suicide, stress disorders","year":"2025","cit":2,"pfa":"Ivan Yu. Torshin","psa":"Ольга Алексеевна Громова","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4415282943","eid":"W4415282943"},{"id":"paper-w2022667425","cat":"papers","name":"An oral contraceptive (OCP) microdose flare leuprolide acetate (LA) stimulation protocol is useful for poor prognosis patients undergoing in vitro fertilization (IVF)","year":"2002","cit":2,"pfa":"A Sanghvi","psa":"Lewis C. Krey","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2022667425","eid":"W2022667425"},{"id":"paper-w4399522857","cat":"papers","name":"Editorial: Down the rabbit hole – the psychological and neural mechanisms of psychedelic compounds and their use in treating mental health and medical conditions","year":"2024","cit":2,"pfa":"Leehe Peled‐Avron","psa":"Joshua D. Woolley","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"editorial","src":"https://openalex.org/W4399522857","eid":"W4399522857"},{"id":"paper-w4292231510","cat":"papers","name":"Changing attitudes to psychedelic drug assisted therapy: The induction of empathy to enhance community support for innovative interventions in mental health","year":"2022","cit":2,"pfa":"Corey Botansky","psa":"John Michael Innes","topics":["PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4292231510","eid":"W4292231510"},{"id":"paper-w7131799589","cat":"papers","name":"Measuring the Content of Visual Hallucinations Induced by Psychedelics and Stroboscopic Light: The Six-Dimensional Visual Hallucination Questionnaire (6D-VHQ)","year":"2026","cit":2,"pfa":"Trevor Hewitt","psa":"David J. Schwartzman","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7131799589","eid":"W7131799589"},{"id":"paper-w7162530369","cat":"papers","name":"Serotonin Transporter Blockade Reduces the Psychedelic-Like Effects of 4-Methoxy- N -methyl- N -isopropyltryptamine and Related Analogs","year":"2026","cit":2,"pfa":"Grant C. Glatfelter","psa":"Michael H. Baumann","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7162530369","eid":"W7162530369"},{"id":"paper-w2954965916","cat":"papers","name":"Abstract 4136: Direct intratumoral microdosing via the CIVO® platform reveals anti-tumor immune responses induced by the SUMO inhibitor TAK-981","year":"2019","cit":2,"pfa":"Beryl A. Hatton","psa":"Richard A. Klinghoffer","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W2954965916","eid":"W2954965916"},{"id":"paper-w2005099016","cat":"papers","name":"From Psychedelic Data Visualization to Hypothesis: All-At-Once Contemplation of Vast Amounts of Information From the National Burn Repository","year":"2008","cit":2,"pfa":"James C. Jeng","psa":"Bart Phillips","ptype":"article","src":"https://openalex.org/W2005099016","eid":"W2005099016"},{"id":"paper-w2405167529","cat":"papers","name":"The effect of psychotomimetic drugs on interferon production.","year":"1973","cit":2,"pfa":"Lefkowitz Ss","psa":"William F. Geber","ptype":"article","src":"https://openalex.org/W2405167529","eid":"W2405167529"},{"id":"paper-w2413839749","cat":"papers","name":"To Fathom Hell or Soar Angelic By Ben Sessa Psychedelic Press. 2015. £8.99 (pb). 312 pp. ISBN 9780992808839","year":"2016","cit":2,"pfa":"Stephen G. Potts","topics":["PTSD & trauma","Mechanism & neuroscience","Policy & ethics"],"ptype":"book-review","src":"https://openalex.org/W2413839749","eid":"W2413839749"},{"id":"paper-w7125529536","cat":"papers","name":"Modulators of altered states of consciousness across psychedelic, dissociative, and entactogen use: A retrospective naturalistic study using the 5D-ASC","year":"2026","cit":2,"pfa":"B. Romeo","psa":"Amine Benyamina","ptype":"article","src":"https://openalex.org/W7125529536","eid":"W7125529536"},{"id":"paper-w3022238476","cat":"papers","name":"Psychotomimetic Agent BZ (3-Quinuclidinyl Benzilate)","year":"2015","cit":2,"pfa":"Josef Fusek","psa":"Daniel Jun","ptype":"book-chapter","src":"https://openalex.org/W3022238476","eid":"W3022238476"},{"id":"paper-w7134047403","cat":"papers","name":"Fentanyl, Methamphetamine and Polysubstance Use Differentially Affect Locomotor Sensitisation and Social Behaviour in Rats: Psychedelic Treatment Reverses Social Deficits","year":"2026","cit":2,"pfa":"Leah M. Salinsky","psa":"Susan M. Ferguson","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7134047403","eid":"W7134047403"},{"id":"paper-w2009309458","cat":"papers","name":"EFFECT OF PSYCHOTOMIMETIC AGENTS ON SEX RATIO ?","year":"1970","cit":2,"pfa":"JoanM. Healy","psa":"PatriciaL. VAN HOUTEN.","ptype":"article","src":"https://openalex.org/W2009309458","eid":"W2009309458"},{"id":"paper-w2798671562","cat":"papers","name":"Crystal Vibes feat. Ott: A psychedelic musical virtual reality experience utilising the full-body vibrotactile haptic synesthesia suit","year":"2017","cit":2,"pfa":"Benjamin Outram","psa":"Tetsuya Mizuguchi","ptype":"conference-paper","src":"https://openalex.org/W2798671562","eid":"W2798671562"},{"id":"paper-w1999362523","cat":"papers","name":"A combined accelerator mass spectrometry/positron emission tomography microdose study to assess the plasma and brain tissue pharmacokinetics of 11C- and 14C-labelled verapamil in healthy volunteers","year":"2008","cit":2,"pfa":"Claudia Christina Wagner","psa":"Oliver Langer","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1999362523","eid":"W1999362523"},{"id":"paper-w1985760280","cat":"papers","name":"Comparison of GnRH-Agonist Microdose Flare-up Protocol and Flexible Multiple Dose Antagonistic Protocol in Poor Responder Patients Undergoing Intracytoplasmic Sperm Injection Cycle","year":"2013","cit":2,"pfa":"Semih Zeki Uludağ","psa":"Yılmaz Şahin","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1985760280","eid":"W1985760280"},{"id":"paper-w2040908785","cat":"papers","name":"Microdose GnRH agonist flare-up versus flexible GnRH antagonist protocol in poor responders undergoing in-vitro-fertilization (IVF) cycles: a randomized controlled trial","year":"2013","cit":2,"pfa":"Neena Malhotra","psa":"Nilanchali Singh","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2040908785","eid":"W2040908785"},{"id":"paper-w2491357249","cat":"papers","name":"Psychedelic Drugs Reconsidered. By Lester Grinspoon and James B. Bakalar. New York: Basic Books, 1979. 343 pp. $15.95 cloth","year":"1981","cit":2,"pfa":"Anthony J. Vattano","ptype":"article","src":"https://openalex.org/W2491357249","eid":"W2491357249"},{"id":"paper-w3211736253","cat":"papers","name":"Unique Effects of Sedatives, Dissociatives, Psychedelics, Stimulants, and Cannabinoids on Episodic Memory: A Review and Reanalysis of Acute Drug Effects on Recollection, Familiarity, and Metamemory","year":"2021","cit":2,"pfa":"Manoj K. Doss","topics":["Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W3211736253","eid":"W3211736253"},{"id":"paper-w4415914742","cat":"papers","name":"The 4-alkyl chain length of 2,5-dimethoxyamphetamines differentially affects in vitro serotonin receptor actions versus in vivo psychedelic-like effects","year":"2025","cit":2,"pfa":"Dino Luethi","psa":"Deborah Rudin","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4415914742","eid":"W4415914742"},{"id":"paper-w4408933762","cat":"papers","name":"Serotonin Transporter Activity Modulates the Psychedelic-Like Effects of 4-methoxy-N-methyl-N-isopropyltryptamine and Related Analogs in Mice (Abstract ID: 166221)","year":"2025","cit":2,"pfa":"Grant C. Glatfelter","psa":"Michael H. Baumann","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4408933762","eid":"W4408933762"},{"id":"paper-w42224279","cat":"papers","name":"COMPARATIVE NEUROPHYSIOLOGICAL STUDIES OF PSYCHOTOMIMETIC N-DIMETHYLAMINES AND N-DIETHYLAMINES AND THEIR NON-PSYCHOTOMIMETIC CONGENERS DEVOID OF THE N-DIMETHYL OR N-DIETHYL CONFIGURATIONS","year":"1967","cit":2,"pfa":"Harold E. Himwich","ptype":"book-chapter","src":"https://openalex.org/W42224279","eid":"W42224279"},{"id":"paper-w2319799672","cat":"papers","name":"Comparison of Anticholinergic Potency to Psychotomimetic Action of Glycolate Esters","year":"1967","cit":2,"pfa":"V.C. Lipman","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2319799672","eid":"W2319799672"},{"id":"paper-w3141742206","cat":"papers","name":"[Phencyclidine (PCP): a psychotomimetic drug. Case report and review of literature].","year":"1983","cit":2,"pfa":"S R G Stodieck","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3141742206","eid":"W3141742206"},{"id":"paper-w118141583","cat":"papers","name":"Drug Metabolism: Review of Principles and the Fate of One-Ring Psychotomimetics","year":"1978","cit":2,"pfa":"Neal Castagnoli","topics":["Reviews & meta-analyses"],"ptype":"book-chapter","src":"https://openalex.org/W118141583","eid":"W118141583"},{"id":"paper-w2581771264","cat":"papers","name":"Reply to: Ketamine and Psychosis History: Antidepressant Efficacy and Psychotomimetic Effects Postinfusion","year":"2017","cit":2,"pfa":"Carolina Medeiros da Frota Ribeiro","psa":"Robert B. Ostroff","topics":["Depression"],"ptype":"letter","src":"https://openalex.org/W2581771264","eid":"W2581771264"},{"id":"paper-w2185451265","cat":"papers","name":"Observations on central nervous system structures following the administration of a psychotomimetic substance.","year":"1979","cit":2,"pfa":"Milena Kemali","psa":"DARGUT KEMALI","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2185451265","eid":"W2185451265"},{"id":"paper-w1980564006","cat":"papers","name":"S.04.01 Diverse psychotomimetics act through a common signaling pathway","year":"2004","cit":2,"pfa":"Per Svenningsson","psa":"Paul Greengard","ptype":"article","src":"https://openalex.org/W1980564006","eid":"W1980564006"},{"id":"paper-w2515563716","cat":"papers","name":"The Psychedelic Policy Quagmire: Health, Law, Freedom, and Society Edited by J. Harold Ellens and Thomas B. Roberts ABC-CLIO, 2015, $73.00, hb, 423 pp. ISBN 9781440839702","year":"2017","cit":2,"pfa":"Adam G. Van Hagen","topics":["Policy & ethics"],"ptype":"book-review","src":"https://openalex.org/W2515563716","eid":"W2515563716"},{"id":"paper-w2229648160","cat":"papers","name":"The Influences of the Standard Prefrontal Lobotomy Operation on Hallucinatory Phenomena Associated with Psychotomimetic Drugs","year":"1970","cit":2,"pfa":"Jeni Holden","psa":"T.M. Itil","ptype":"book-chapter","src":"https://openalex.org/W2229648160","eid":"W2229648160"},{"id":"paper-w2402867257","cat":"papers","name":"Comparison of phencyclidine and related substances with various indole, phenethylamine, and other psychotomimetics.","year":"1986","cit":2,"pfa":"Domino Ef","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2402867257","eid":"W2402867257"},{"id":"paper-w2415334800","cat":"papers","name":"Rasd2 Modulates Psychotomimetic Drug Effects in Mice and Schizophrenia-related Phenotypes in Humans","year":"2015","cit":2,"pfa":"Daniela Vitucci","psa":"Alessandro Usiello","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2415334800","eid":"W2415334800"},{"id":"paper-w2475722520","cat":"papers","name":"COMPUTER ANALYSIS OF HIPPOCAMPAL EEG ACTIVITY AND IMPEDANCE IN APPROACH LEARNING: EFFECTS OF PSYCHOTOMIMETIC AND HALLUCINOGENIC DRUGS","year":"1965","cit":2,"pfa":"W. ROSS ADEY","ptype":"book-chapter","src":"https://openalex.org/W2475722520","eid":"W2475722520"},{"id":"paper-w4245109894","cat":"papers","name":"The psychotomimetic drugs D‐amphetamine and phencyclidine release calcitonin gene‐related peptide in the limbic forebrain of the rat","year":"1996","cit":2,"pfa":"A.A. Mathé","psa":"T.H. Svensson","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4245109894","eid":"W4245109894"},{"id":"paper-w1963808691","cat":"papers","name":"THE PSYCHOTOMIMETIC DRUGS D-AMPHETAMINE AND PHENCYCLIDINE RELEASE CALCITONIN GENE-RELATED PEPTIDE IN THE LIMBIC FOREBRAIN OF THE RAT","year":"1996","cit":2,"pfa":"REMY S MAUREL","psa":"VRY J DE","ptype":"conference-abstract","src":"https://openalex.org/W1963808691","eid":"W1963808691"},{"id":"paper-w2083065836","cat":"papers","name":"REDUCTION OF PSYCHOTOMIMETIC SIDE EFFECTS OF KETALAR (KETAMINE) BY ROHYPNOL (FLUNITRAZEPAM). A RANDOMIZED, DOUBLE-BLIND TRIAL","year":"1977","cit":2,"pfa":"I Freuchen","psa":"Birgit Ohrt Mikkelsen","ptype":"article","src":"https://openalex.org/W2083065836","eid":"W2083065836"},{"id":"paper-w2012910116","cat":"papers","name":"Specific effects by the psychotomimetic drugsd-amphetamine and phencyclidine on the performance of an aversely motivated successive visual discrimination in the rat","year":"1992","cit":2,"pfa":"S. Ahlenius","psa":"Torgny H. Svensson","ptype":"article","src":"https://openalex.org/W2012910116","eid":"W2012910116"},{"id":"paper-w2418370772","cat":"papers","name":"[Effect of diazepam on cardio-vascular and psychotomimetic action of ketamine administered as continuous intravenous drip. Double-blind study (author's transl)].","year":"1981","cit":2,"pfa":"T Pedersen","psa":"J Hicquet","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2418370772","eid":"W2418370772"},{"id":"paper-w2400319933","cat":"papers","name":"Comments on Cooper et al.’s review on strategies to mitigate dissociative and psychotomimetic effects from ketamine when used as a fast-acting antidepressant","year":"2016","cit":2,"pfa":"Paul Glue","psa":"Philip Bowden Mitchell","topics":["Depression","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2400319933","eid":"W2400319933"},{"id":"paper-w4367050535","cat":"papers","name":"Light Shining within the “Dark” Classics: A Perspective on Entheogenic Compounds","year":"2023","cit":2,"pfa":"Khalyd J. Clay","psa":"Jacob M. Hooker","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4367050535","eid":"W4367050535"},{"id":"paper-w2002141289","cat":"papers","name":"Handbook of Experimental Pharmacology, Vol. 55/Part 3: Psychotropic Agents (Vol.55 in 3 parts). Part. 3: Alcohol and Psychotomimetics, Psychotropic Effects of Central Acting Drugs, herausgeg. von F. Hoffmeister und G. St","year":"1983","cit":2,"pfa":"H. P. Büch","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2002141289","eid":"W2002141289"},{"id":"paper-w2982618147","cat":"papers","name":"The entheogenic origins of Mormonism: A working hypothesis","year":"2019","cit":2,"pfa":"Robert Beckstead","psa":"Michael Winkelman","ptype":"article","src":"https://openalex.org/W2982618147","eid":"W2982618147"},{"id":"paper-w4413967144","cat":"papers","name":"Molecular dynamics study of differential effects of serotonin-2A-receptor (5-HT2AR) modulators","year":"2025","cit":2,"pfa":"Jordy Peeters","psa":"Kenno Vanommeslaeghe","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4413967144","eid":"W4413967144"},{"id":"paper-w2555975330","cat":"papers","name":"Drug Induced Psychosis or Schizophrenia?","year":"2016","cit":2,"pfa":"Massimo Carlo Mauri","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2555975330","eid":"W2555975330"},{"id":"paper-w4402600853","cat":"papers","name":"Demographic, Mental Health, and Substance Use Correlates of Self-Described Medicinal Use, Recreational Use, and Non-Use of Hallucinogenic Drugs","year":"2024","cit":2,"pfa":"Sophie G. Coelho","psa":"Jeffrey D. Wardell","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4402600853","eid":"W4402600853"},{"id":"paper-w438962745","cat":"papers","name":"LSD: Problems Connected with Its Use, Misuse, and Abuse in the United States","year":"1966","cit":2,"pfa":"Max Rinkel","ptype":"book-chapter","src":"https://openalex.org/W438962745","eid":"W438962745"},{"id":"paper-w2892163574","cat":"papers","name":"Italian Progressive Rock as Indigenous Psychedelia","year":"2018","cit":2,"pfa":"Scott B. Montgomery","ptype":"article","src":"https://openalex.org/W2892163574","eid":"W2892163574"},{"id":"paper-w2149343277","cat":"papers","name":"Uso de microdosis de aloe vera L. en el asma bronquial","year":"2009","cit":2,"pfa":"Judit Rodríguez Pérez","psa":"Guillermo Ferrer Murgas","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2149343277","eid":"W2149343277"},{"id":"paper-w4405212493","cat":"papers","name":"Trends of Brain Stimulation Research in Substance Use Disorder: A Review of ClinicalTrials.gov Registered Trials and Their Publications","year":"2024","cit":2,"pfa":"Tathagata Biswas","psa":"Arpit Parmar","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4405212493","eid":"W4405212493"},{"id":"paper-w4416587114","cat":"papers","name":"DMT-Induced Shifts in Criticality Correlate with Self-Dissolution","year":"2025","cit":2,"pfa":"Mona Irrmischer","psa":"Christopher B. Timmermann","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4416587114","eid":"W4416587114"},{"id":"paper-w2951269628","cat":"papers","name":"ChemInform Abstract: STRUCTURE‐ACTIVITY RELATIONSHIPS OF THE CYCLOALKYL RING OF PHENCYCLIDINE","year":"1982","cit":2,"pfa":"Roy L. McQuinn","psa":"Tsung‐Ping Su","ptype":"article","src":"https://openalex.org/W2951269628","eid":"W2951269628"},{"id":"paper-w7167596963","cat":"papers","name":"Turning Toward Addiction - Understanding the Desire, Holding the Reality, and Letting Go of the Parts That Don't Belong","year":"2026","cit":2,"pfa":"Jamison Johsnon","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7167596963","eid":"W7167596963"},{"id":"paper-w4389830724","cat":"papers","name":"Substance‐Related and Addictive Disorders","year":"2016","cit":2,"pfa":"Lourie W Reichenberg","psa":"Linda Seligman","topics":["Addiction"],"ptype":"other","src":"https://openalex.org/W4389830724","eid":"W4389830724"},{"id":"paper-w654766082","cat":"papers","name":"Assessment and Treatment of Chemical Dependency","year":"2001","cit":2,"pfa":"Gennaro A. Ottomanelli","topics":["Addiction"],"ptype":"book","src":"https://openalex.org/W654766082","eid":"W654766082"},{"id":"paper-w2321845006","cat":"papers","name":"Phase 0 clinical trials and post-marketed re-evaluation of clinical safety in injection of traditional Chinese medicine","year":"2011","cit":2,"pfa":"Wei Xu","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2321845006","eid":"W2321845006"},{"id":"paper-w2790754858","cat":"papers","name":"The re-emergence of hallucinogenic research","year":"2018","cit":2,"pfa":"Matthew J. Begola","psa":"Jonathan S. Dowben","topics":["PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2790754858","eid":"W2790754858"},{"id":"paper-w4245560481","cat":"papers","name":"Harmaline","year":"1977","cit":2,"pfa":"Alexander T. Shulgin","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4245560481","eid":"W4245560481"},{"id":"paper-w4389832520","cat":"papers","name":"Which substances pose the greatest risk of substance use disorder after controlling for polysubstance use?","year":"2023","cit":2,"pfa":"Nolan Brian Gooding","psa":"Robert John Williams","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4389832520","eid":"W4389832520"},{"id":"paper-w2060468075","cat":"papers","name":"The Therapeutic Community Phenomeonon","year":"1975","cit":2,"pfa":"Peter G. Bourne","psa":"Ann S. Ramsey","ptype":"article","src":"https://openalex.org/W2060468075","eid":"W2060468075"},{"id":"paper-w2059504294","cat":"papers","name":"Chronic Ocular Symptoms Following the Use of Hallucinogenic Agents","year":"1972","cit":2,"pfa":"Alan C. Raine","ptype":"article","src":"https://openalex.org/W2059504294","eid":"W2059504294"},{"id":"paper-w1992898313","cat":"papers","name":"Reflections on LSD – Ten Years Later","year":"1978","cit":2,"pfa":"Ralph Metzner","ptype":"article","src":"https://openalex.org/W1992898313","eid":"W1992898313"},{"id":"paper-w2123970820","cat":"papers","name":"Psychomimesis: LSD and Disability Immersion Experiences of Schizophrenia","year":"2012","cit":2,"pfa":"Elizabeth J. Donaldson","ptype":"article","src":"https://openalex.org/W2123970820","eid":"W2123970820"},{"id":"paper-w2077150542","cat":"papers","name":"Issues for Inpatient Treatment of Chronic PCP Abuse","year":"1980","cit":2,"pfa":"Arthur Bolter","ptype":"article","src":"https://openalex.org/W2077150542","eid":"W2077150542"},{"id":"paper-w1994179899","cat":"papers","name":"Theoretical and Clinical Approaches to the Treatment of Drug Addiction","year":"1975","cit":2,"pfa":"G. G. Deangelis","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1994179899","eid":"W1994179899"},{"id":"paper-w4414495471","cat":"papers","name":"Discovery of Highly Selective 5-HT2A Agonists Using Structure-Guided Design","year":"2025","cit":2,"pfa":"Tyler G. Fenske","psa":"John D. McCorvy","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4414495471","eid":"W4414495471"},{"id":"paper-w1965343801","cat":"papers","name":"Approaches to Drug Abuse Prevention and Treatment in Rural Areas","year":"1974","cit":2,"pfa":"Peter G. Bourne","ptype":"article","src":"https://openalex.org/W1965343801","eid":"W1965343801"},{"id":"paper-w1969703802","cat":"papers","name":"The Role of Urine Testing in Heroin Treatment Programs","year":"1971","cit":2,"pfa":"G. G. Deangelis","ptype":"article","src":"https://openalex.org/W1969703802","eid":"W1969703802"},{"id":"paper-w3127235042","cat":"papers","name":"Behavioral effects of sub-anesthetic ketamine in a go/no-go task","year":"2021","cit":2,"pfa":"André Sevenius Nilsen","psa":"Johan Frederik Storm","topics":["Anxiety & end-of-life","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3127235042","eid":"W3127235042"},{"id":"paper-w2047733147","cat":"papers","name":"Preliminary Observations on the Organizational Context of Treatment for Female and Male Heroin Abusers","year":"1978","cit":2,"pfa":"Beth Glover Reed","psa":"Suzanne Gelber Rinaldo","ptype":"article","src":"https://openalex.org/W2047733147","eid":"W2047733147"},{"id":"paper-w2013155941","cat":"papers","name":"Introduction to the Problem of Heroin Addiction in America","year":"1971","cit":2,"pfa":"John C. Kramer","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2013155941","eid":"W2013155941"},{"id":"paper-w2139035314","cat":"papers","name":"New Potential Hazard Regarding Use of Marijuana – Treatment of Plants with Liquid Fertilizers","year":"1976","cit":2,"pfa":"Norman R. Farnsworth","psa":"Geoffrey A. Cordell","ptype":"article","src":"https://openalex.org/W2139035314","eid":"W2139035314"},{"id":"paper-w2025506583","cat":"papers","name":"The Heroin Addict 1n a Therapeutic Community for Adolescents: A Cultural “Rip-Off”","year":"1971","cit":2,"pfa":"Sheil Salasnek","psa":"Fariborz Amini","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2025506583","eid":"W2025506583"},{"id":"paper-w4409806525","cat":"papers","name":"Investigations Into the Urinary Metabolite Elimination Profile of the Selective Androgen Receptor Modulator S‐23 in Studies Mimicking Contaminated Product Ingestion for Doping Control Purposes","year":"2025","cit":2,"pfa":"Hana Alhalabi","psa":"Mario Thevis","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4409806525","eid":"W4409806525"},{"id":"paper-w3118462045","cat":"papers","name":"Clinical evolution of patients with schizophrenia associated with addictive disorders","year":"2020","cit":2,"pfa":"Andreea Sălcudean","psa":"Madalina Gherman","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W3118462045","eid":"W3118462045"},{"id":"paper-w4416092809","cat":"papers","name":"Frameless intraputaminal delivery of gene therapy with eladocagene exuparvovec in patients with aromatic L-amino acid decarboxylase deficiency: safe and efficient results","year":"2025","cit":2,"pfa":"Roni Mai","psa":"Svetlana V. Mikhaylova","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4416092809","eid":"W4416092809"},{"id":"paper-w2797302693","cat":"papers","name":"LSD increases social adaptation to opinions similar to one's own","year":"2019","cit":2,"pfa":"Katrin H. Preller","psa":"Franz X. Vollenweider","ptype":"article","src":"https://openalex.org/W2797302693","eid":"W2797302693"},{"id":"paper-w2411385527","cat":"papers","name":"[Changes in hemostasis and vagal tonus in healthy individuals and patients with facial neuropathy by micro-dose heparin stimulation of nasal receptors].","year":"1997","cit":2,"pfa":"I V Uryvaev","psa":"V V Sergeev","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2411385527","eid":"W2411385527"},{"id":"paper-w1792368396","cat":"papers","name":"Symbolic self-expression in drug addiction.","year":"1980","cit":2,"pfa":"A Marinow","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1792368396","eid":"W1792368396"},{"id":"paper-w2410305125","cat":"papers","name":"Complications of super-selective subarachnoid anesthesia (SSA) with hyperbaric bupivacaine: experiences with 355 patients in general and orthopaedic surgery.","year":"1997","cit":2,"pfa":"G B Pappalardo","psa":"Diego P. C. Beltrutti","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2410305125","eid":"W2410305125"},{"id":"paper-w1935368327","cat":"papers","name":"Physiological and Therapeutic Aspects of Shamanistic Healing","year":"1990","cit":2,"pfa":"Michael Winkelman","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1935368327","eid":"W1935368327"},{"id":"paper-w2993950341","cat":"papers","name":"[Identification in drug addiction].","year":"1975","cit":2,"pfa":"A J Charles-Nicolas","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2993950341","eid":"W2993950341"},{"id":"paper-w4401761786","cat":"papers","name":"Psychiatric Care Consultation Via Anti-anxiety Technology","year":"2023","cit":2,"pfa":"Hasan Alkhudairi","psa":"Mohammed Alkarni","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4401761786","eid":"W4401761786"},{"id":"paper-w2415363205","cat":"papers","name":"[Dependence on anticholinergics among schizophrenics. Iatrogenic disease or self-medication?].","year":"1992","cit":2,"pfa":"L Chamorro García","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2415363205","eid":"W2415363205"},{"id":"paper-w2497234847","cat":"papers","name":"Chapter 7. Substance Use Disorders","year":"2014","cit":2,"pfa":"Patcho N. Santiago","topics":["Addiction","Reviews & meta-analyses","Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W2497234847","eid":"W2497234847"},{"id":"paper-w2971058775","cat":"papers","name":"The Rolling Stones in 1968: In Defense of Lingering Psychedelia","year":"2019","cit":2,"pfa":"John Covach","ptype":"book-chapter","src":"https://openalex.org/W2971058775","eid":"W2971058775"},{"id":"paper-w3028059713","cat":"papers","name":"Menopausal Therapy: Modern View of the Problem","year":"2020","cit":2,"pfa":"Селихова Марина Сергеевна","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3028059713","eid":"W3028059713"},{"id":"paper-w2038444186","cat":"papers","name":"Radiosynthesis and in vitro evaluation of the 5HT2 receptor ligand [N-11C-methyl]-1-[2,5-dimethoxy-4-iodophenyl]-2-methylaminopropane for PET","year":"2004","cit":2,"pfa":"Joern Schmaljohann","psa":"Daniela Gündisch","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2038444186","eid":"W2038444186"},{"id":"paper-w2979918838","cat":"papers","name":"Analysis of online information available for treatment of depression","year":"2019","cit":2,"pfa":"Zachary Clarke","psa":"Pietro Ghezzi","topics":["Depression","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W2979918838","eid":"W2979918838"},{"id":"paper-w2083996592","cat":"papers","name":"LSD and Schizophrenia","year":"1984","cit":2,"pfa":"KARL E.C. WEAVER","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2083996592","eid":"W2083996592"},{"id":"paper-w2505317405","cat":"papers","name":"Application of Reverse Microdialysis in Neuropharmacological Studies","year":"2012","cit":2,"pfa":"Christián Höcht","psa":"Carlos Alberto Taira","topics":["Depression","Addiction","Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W2505317405","eid":"W2505317405"},{"id":"paper-w4392403926","cat":"papers","name":"AI as an Always-available Oncologist: A Vision for AI-optimized Cancer Therapy Based on Real-time Adaptive Dosing at the Patient Level","year":"2024","cit":2,"pfa":"Luis García‐Valiña","psa":"Gabriel Kalweit","topics":["Anxiety & end-of-life","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4392403926","eid":"W4392403926"},{"id":"paper-w4400026162","cat":"papers","name":"Bespoke library docking for 5-HT2A receptor agonists with antidepressant activity","year":"2024","cit":2,"pfa":"B.K. Shoichet","psa":"Autumn Q. Wetsel","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4400026162","eid":"W4400026162"},{"id":"paper-w4412708184","cat":"papers","name":"Psychoactive substances: novel molecular insights and therapeutic potential for Alzheimer's disease","year":"2025","cit":2,"pfa":"Chong-Lei Fu","psa":"Guichang Zou","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4412708184","eid":"W4412708184"},{"id":"paper-w4411903113","cat":"papers","name":"Multimodal Neuroimaging for the PK/PD Profile of NLX-204: A Biased 5-HT1A Receptor Agonist","year":"2025","cit":2,"pfa":"Violette Richin","psa":"Luc Zimmer","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4411903113","eid":"W4411903113"},{"id":"paper-w2408936119","cat":"papers","name":"Trajectory of Psychopharmacology : The role of the clinician and Industry.","year":"2003","cit":2,"pfa":"David Healy","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2408936119","eid":"W2408936119"},{"id":"paper-w3091606296","cat":"papers","name":"Acute Toxicity Related to 25G-NBOMe Use: An Internet High.","year":"2017","cit":2,"pfa":"Chloe Brooks","psa":"JOHN P. MIELL","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3091606296","eid":"W3091606296"},{"id":"paper-w181171937","cat":"papers","name":"Drug addiction among adolescents.","year":"1984","cit":2,"pfa":"Carlos Augusto Amaral Dias","psa":"F. Fouto Pólvora","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W181171937","eid":"W181171937"},{"id":"paper-w2346767428","cat":"papers","name":"Bioavailability of the hedgehog pathway inhibitor GDC-0449 in a phase I pharmacokinetic (PK) study in healthy female subjects.","year":"2010","cit":2,"pfa":"R. A. Graham","psa":"B L Lum","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W2346767428","eid":"W2346767428"},{"id":"paper-w4313201251","cat":"papers","name":"Effect of HTL0045725, a selective agonist of the orphan receptor GPR52, on kinase and transcription factor phosphorylation in striatal neurons","year":"2022","cit":2,"pfa":"Eugenia Sergeev","psa":"C.P. MacSweeney","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4313201251","eid":"W4313201251"},{"id":"paper-w2102180598","cat":"papers","name":"Enzyme‐amplified receptor assay screening test for chlorpromazine, trifluoperazine, and phencyclidine","year":"1990","cit":2,"pfa":"Susan F. Hallowell","psa":"Garry A. R Echnitz","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2102180598","eid":"W2102180598"},{"id":"paper-w1982709480","cat":"papers","name":"A brief history and motivation of an entheogenic chemist","year":"2007","cit":2,"pfa":"Casey Hardison","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1982709480","eid":"W1982709480"},{"id":"paper-w1876401404","cat":"papers","name":"De la psicodelia a las cortinas del siglo XXI","year":"2012","cit":2,"pfa":"Manuel Collado Arpía","ptype":"dissertation","src":"https://openalex.org/W1876401404","eid":"W1876401404"},{"id":"paper-w4237261256","cat":"papers","name":"Evidence-Based Treatments for Alcohol and Drug Abuse","year":"2012","cit":2,"pfa":"Paul M.G. Emmelkamp","psa":"Ellen Vedel","topics":["Addiction","Dosing & pharmacology"],"ptype":"book","src":"https://openalex.org/W4237261256","eid":"W4237261256"},{"id":"paper-w432028239","cat":"papers","name":"Effects of burns and vasoactive drugs on human skin : Clinical and Experimental studies using microdialysis","year":"2010","cit":2,"pfa":"Anders Samuelsson","topics":["PTSD & trauma","Addiction","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W432028239","eid":"W432028239"},{"id":"paper-w3040748147","cat":"papers","name":"Analysis of Behavior With Features of Addiction and Primary Prevention for Full-time Students at Masaryk University","year":"2015","cit":2,"pfa":"Petr Kachlík","topics":["Depression","Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3040748147","eid":"W3040748147"},{"id":"paper-w4205950337","cat":"papers","name":"Comprehensive method for the detection and quantification of drugs of abuse in urine by liquid chromatography mass spectrometry in a drug rehabilitation clinical setting","year":"2021","cit":2,"pfa":"Abuelgasim Elrasheed A. Alhassan","psa":"Hamad Al Ghafri","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4205950337","eid":"W4205950337"},{"id":"paper-w4417079703","cat":"papers","name":"From the gut to the brain: Potential novel avenues for IBD treatment via serotonergic pathways","year":"2025","cit":2,"pfa":"Sara Ibgui","psa":"Simon W. F. Milling","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4417079703","eid":"W4417079703"},{"id":"paper-w2504431126","cat":"papers","name":"Understanding Differences Between Heroin and Other Drug Users Among Individuals Entering Treatment","year":"2016","cit":2,"pfa":"Elizabeth B. Perkins","psa":"Lisa Michele Shannon","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2504431126","eid":"W2504431126"},{"id":"paper-w4411731502","cat":"papers","name":"Advancing translational neurotherapeutics: Bridging pharmacy, psychiatry, and neurology for precision brain disorder management","year":"2025","cit":2,"pfa":"Dushad Ram","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4411731502","eid":"W4411731502"},{"id":"paper-w2758119406","cat":"papers","name":"Pharmacology and Literature Review Based on Related Death and Non-Fatal Case Reports of the Benzofurans and Benzodifurans Designer Drugs","year":"2018","cit":2,"pfa":"Bernardino Barceló Martín","psa":"Isabel Gomila","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2758119406","eid":"W2758119406"},{"id":"paper-w2343161930","cat":"papers","name":"[Psychiatry and brua].","year":"2013","cit":2,"pfa":"Blom Jd","psa":"Trevor van Gellecum","topics":["Addiction"],"ptype":"other","src":"https://openalex.org/W2343161930","eid":"W2343161930"},{"id":"paper-w2223773519","cat":"papers","name":"Safety evaluation of Chinese medicine on tumor therapy","year":"2013","cit":2,"pfa":"Rui Liu","psa":"Jie Li","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2223773519","eid":"W2223773519"},{"id":"paper-w4416387150","cat":"papers","name":"Further Insights Into the Metabolism of LGD‐4033 in Human Urine. Part 2. A New Minor Metabolite With Antagonistic Activity on the Androgen Receptor Can Indicate Recent Substance Intake","year":"2025","cit":2,"pfa":"Yiannis S. Angelis","psa":"Emmanuel N. Pitsinos","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4416387150","eid":"W4416387150"},{"id":"paper-w4401185516","cat":"papers","name":"Deciphering the Causality between Gut Microbiota Dysbiosis and Poisoning by Narcotics and Psychodysleptics: A Mendelian Randomization Analysis","year":"2024","cit":2,"pfa":"Ning Wang","psa":"Zhenbo Su","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4401185516","eid":"W4401185516"},{"id":"paper-w4407002294","cat":"papers","name":"A cohort-based assessment of drug use trends during the COVID-19 pandemic: relationship with mood and sociodemographic factors in Brazil","year":"2025","cit":2,"pfa":"Núbia Heidrich","psa":"Helena M.T. Barros","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4407002294","eid":"W4407002294"},{"id":"paper-w4231318687","cat":"papers","name":"A Twin Study of Personality and Illicit Drug Use and Abuse/Dependence","year":"2004","cit":2,"pfa":"Arpana Agrawal","psa":"Kenneth S. Kendler","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4231318687","eid":"W4231318687"},{"id":"paper-w3179797897","cat":"papers","name":"Pharmacological assistance for psychotherapy","year":"2021","cit":2,"pfa":"Jessica Lochtenberg","psa":"Matthew W. Johnson","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3179797897","eid":"W3179797897"},{"id":"paper-w4394606051","cat":"papers","name":"Neurodegenerative Diseases: from the First CNS Drugs to New Treatments in Discovery (A Review)","year":"2024","cit":2,"pfa":"Jean‐Louis Kraus","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4394606051","eid":"W4394606051"},{"id":"paper-w3016538019","cat":"papers","name":"Elucidating Anti‐Inflammatory SAR at the 5‐HT 2A Receptor","year":"2020","cit":2,"pfa":"Gerald Bernard Billac","psa":"Charles David Nichols","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"conference-abstract","src":"https://openalex.org/W3016538019","eid":"W3016538019"},{"id":"paper-w4381987410","cat":"papers","name":"Fractional spinal anesthesia and systemic hemodynamics in frail elderly hip fracture patients","year":"2023","cit":2,"pfa":"Fredrik Olsen","psa":"Bengt Nellgård","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4381987410","eid":"W4381987410"},{"id":"paper-w4407782110","cat":"papers","name":"Building virtual patients for training mental health professionals","year":"2025","cit":2,"pfa":"Patrick C. Staples","psa":"Robert F. Dougherty","topics":["Mechanism & neuroscience","Reviews & meta-analyses","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4407782110","eid":"W4407782110"},{"id":"paper-w4401115607","cat":"papers","name":"Youth and young adult knowledge of and access to opioid harm reduction policies and interventions in North Carolina","year":"2024","cit":2,"pfa":"Kathleen L. Egan","psa":"Scott D. Rhodes","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4401115607","eid":"W4401115607"},{"id":"paper-w4298845857","cat":"papers","name":"A direct interaction of PSD-95 with 5-HT2A serotonin receptors regulates receptor trafficking and signal transduction","year":"2020","cit":2,"pfa":"Z. Xia","psa":"B.A. Compton-Toth","topics":["Depression","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4298845857","eid":"W4298845857"},{"id":"paper-w4295900174","cat":"papers","name":"Comparing immediate‐ and delayed‐onset posttraumatic stress disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions–III (NESARC‐III)","year":"2022","cit":2,"pfa":"Zoe Bourgault","psa":"Ahmed Nabeel Hassan","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4295900174","eid":"W4295900174"},{"id":"paper-w4394017106","cat":"papers","name":"Could immunotherapy be a hope for addiction treatment?","year":"2024","cit":2,"pfa":"Maria Carolina Machado da Silva","psa":"Amanda Della Giustina","topics":["Addiction","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4394017106","eid":"W4394017106"},{"id":"paper-w205004671","cat":"papers","name":"[Phencyclidine, a drug which induces psychosis: its neuropharmacological actions].","year":"1984","cit":2,"pfa":"Toshitaka NABESHIMA","psa":"Tsutomu Kameyama","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W205004671","eid":"W205004671"},{"id":"paper-w7118493661","cat":"papers","name":"Discordance Between Online Information and Male Hypogonadism Clinical Guidelines: A Global Multilingual Content Analysis","year":"2025","cit":2,"pfa":"Bonnie Grant","psa":"Channa Nalin Jayasena","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7118493661","eid":"W7118493661"},{"id":"paper-w2286030185","cat":"papers","name":"An open-label positron emission tomography (PET) study to investigate and quantify brain and tumor penetration of carbon-11 labeled lapatinib in patients with HER2-overexpressing (HER2+) advanced or metastatic breast can","year":"2011","cit":2,"pfa":"R. Charles Coombes","psa":"A. Saleem","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W2286030185","eid":"W2286030185"},{"id":"paper-w7141028515","cat":"papers","name":"Neuroimaging insights from Wistar-Kyoto rats under chronic mild stress: morphological and metabolic brain correlates of treatment-resistant depression","year":"2026","cit":2,"pfa":"Gianmauro Palombelli","psa":"Canese Rossella","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7141028515","eid":"W7141028515"},{"id":"paper-w4391820317","cat":"papers","name":"Considering New and Emerging Treatment Strategies for Depression: Beyond STAR*D and the Monoamines","year":"2024","cit":2,"pfa":"Lynne Alison McInnes","psa":"Tobias F. Marton","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4391820317","eid":"W4391820317"},{"id":"paper-w4405133584","cat":"papers","name":"Discovery of the closest free-living relative of the domesticated “magic mushroom” Psilocybe cubensis in Africa","year":"2024","cit":2,"pfa":"Alexander  James Bradshaw","psa":"Bryn T. M. Dentinger","ptype":"preprint","src":"https://openalex.org/W4405133584","eid":"W4405133584"},{"id":"paper-w2047624770","cat":"papers","name":"Ghodse's Drugs and Addictive Behaviour","year":"2010","cit":2,"pfa":"J. Wilford","topics":["Addiction","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2047624770","eid":"W2047624770"},{"id":"paper-w4237276167","cat":"papers","name":"LSD intoxication","year":"1985","cit":2,"pfa":"Suman Wason","ptype":"article","src":"https://openalex.org/W4237276167","eid":"W4237276167"},{"id":"paper-w7160084630","cat":"papers","name":"The End of the Game: Peter Green and the blues of psychosis","year":"2026","cit":2,"pfa":"Guido Nosari","psa":"Gianluca Giovanna","topics":["Addiction","Anxiety & end-of-life","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7160084630","eid":"W7160084630"},{"id":"paper-w4231515863","cat":"papers","name":"Treatment Episode Data Set -- Admissions (TEDS-A) -- Concatenated, 1992 to 2009","year":"2009","cit":2,"pfa":"United States Department Of Health And Human Services. Substance Abuse And…","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W4231515863","eid":"W4231515863"},{"id":"paper-w3111608069","cat":"papers","name":"Microdosage de buprénorphine-naloxone","year":"2020","cit":2,"pfa":"Radhika Marwah","psa":"Zack J Dumont","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3111608069","eid":"W3111608069"},{"id":"paper-w4235614448","cat":"papers","name":"Fashion in Post-Independence India","year":"2010","cit":2,"pfa":"Laila Tyabji","ptype":"reference-entry","src":"https://openalex.org/W4235614448","eid":"W4235614448"},{"id":"paper-w2898497175","cat":"papers","name":"Comparing Husbands’ Addiction in Women With and Without Exposure to Domestic Violence","year":"2018","cit":2,"pfa":"Mona Rahnavardi","psa":"Arezoo Shayan","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2898497175","eid":"W2898497175"},{"id":"paper-w4313200331","cat":"papers","name":"Treatment efficacy and effectiveness in adults with major depressive disorder and childhood trauma history: a comprehensive meta-analysis","year":"2022","cit":2,"pfa":"Erika Kuzminskaite","psa":"C H Vinkers","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4313200331","eid":"W4313200331"},{"id":"paper-w4402764321","cat":"papers","name":"Assessing the magnitude of mental health and substance use comorbidity among young adults in East Africa: a systematic review, 2024","year":"2024","cit":2,"pfa":"Kalkidan Worku Mitiku","psa":"Samuel Derbie Habtegiorgis","topics":["Depression","Addiction","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4402764321","eid":"W4402764321"},{"id":"paper-w2896224633","cat":"papers","name":"Extraordinary Rapid Wound Healing Time in Diabetic patients treated with Microburst Insulin Infusion","year":"2018","cit":2,"topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2896224633","eid":"W2896224633"},{"id":"paper-w4415094267","cat":"papers","name":"Advancing our understanding of schizophrenia: insights from recent research, emerging therapies, and future directions","year":"2025","cit":2,"pfa":"Tolutope Adebimpe Oso","psa":"Don Eliseo Lucero‐Prisno","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4415094267","eid":"W4415094267"},{"id":"paper-w3128819170","cat":"papers","name":"Pharmacological treatments for PTSD: where are we in 2020?","year":"2021","cit":2,"pfa":"Éric Bui","topics":["Depression","PTSD & trauma","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3128819170","eid":"W3128819170"},{"id":"paper-w4214887043","cat":"papers","name":"Treatment Episode Data Set -- Discharges (TEDS-D), 2008","year":"2011","cit":2,"pfa":"United States Department of Health and Human Services. Substance Abuse and…","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W4214887043","eid":"W4214887043"},{"id":"paper-w4236857183","cat":"papers","name":"Ketamine Addiction","year":"2018","cit":2,"pfa":"Hua Jun Liang","psa":"Wai Kwong Tang","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4236857183","eid":"W4236857183"},{"id":"paper-w4389227593","cat":"papers","name":"Abstract C024: Trial in progress: Phase 1 study of BAL0891 as monotherapy and in combination with chemotherapy in patients with advanced solid tumors","year":"2023","cit":2,"pfa":"Shivaani Kummar","psa":"Sun Young Rha","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W4389227593","eid":"W4389227593"},{"id":"paper-w2801306456","cat":"papers","name":"0007 Multiple-Ascending-Dose Study Of ACT-541468, A Novel Dual Orexin Receptor Antagonist: Characterization Of Its Multiple-Dose Pharmacokinetics, Pharmacodynamics, Safety, And Tolerability","year":"2018","cit":2,"pfa":"Clemens Muehlan","psa":"Jasper Dingemanse","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W2801306456","eid":"W2801306456"},{"id":"paper-w3196106332","cat":"papers","name":"Drugs of Abuse: How Clinical Pharmacology Brings Clarity to the Shadows","year":"2021","cit":2,"pfa":"Anne N. Nafziger","psa":"Charles Michael White","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3196106332","eid":"W3196106332"},{"id":"paper-w2090868835","cat":"papers","name":"IPRONIAZID THERAPY OF PSORIASIS","year":"1959","cit":2,"pfa":"Victor H. Witten","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2090868835","eid":"W2090868835"},{"id":"paper-w2800944288","cat":"papers","name":"0008 Night-Time Administration Of ACT-541468, A Novel Dual Orexin Receptor Antagonist: Characterization Of Its Pharmacokinetics, Next-Day Residual Effects, Safety, And Tolerability","year":"2018","cit":2,"pfa":"Clemens Muehlan","psa":"Jasper Dingemanse","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W2800944288","eid":"W2800944288"},{"id":"paper-w4390045444","cat":"papers","name":"A preclinical model of THC edibles that produces high-dose cannabimimetic responses","year":"2023","cit":2,"pfa":"Anthony English","psa":"Benjamin Bruce Land","topics":["Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4390045444","eid":"W4390045444"},{"id":"paper-w2061060332","cat":"papers","name":"Mimetics Hostilis : An Assemblage of Law, Psychiatry, and Chemical Artifice","year":"2008","cit":2,"pfa":"Richard Glen Boire","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2061060332","eid":"W2061060332"},{"id":"paper-w4404528710","cat":"papers","name":"Advancements in NMDA Receptor-Targeted Antidepressants: From d -Cycloserine Discovery to Preclinical Efficacy of Lu AF90103","year":"2024","cit":2,"pfa":"Erhad Ascic","psa":"John Paul Kilburn","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4404528710","eid":"W4404528710"},{"id":"paper-w4412464044","cat":"papers","name":"Microdosimetry calculations in situ for clinically relevant photon sources and their correlation with the early DNA damage response","year":"2025","cit":2,"pfa":"Mirta Dumančić","psa":"Shirin Abbasinejad Enger","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4412464044","eid":"W4412464044"},{"id":"paper-w4386220300","cat":"papers","name":"Utilization of Ketamine for Major Depression","year":"2023","cit":2,"pfa":"Ryan Dao","psa":"Amit Aggarwal","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4386220300","eid":"W4386220300"},{"id":"paper-w2552444708","cat":"papers","name":"S-ketamine for the treatment of depression","year":"2015","cit":2,"pfa":"Kaija Järventausta","psa":"Esa V. J. Leinonen","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2552444708","eid":"W2552444708"},{"id":"paper-w2969447047","cat":"papers","name":"Development of a Self-Administered Questionnaire to Detect Psychosis at High Altitude: The HAPSY Questionnaire","year":"2019","cit":2,"pfa":"Katharina Hüfner","psa":"Barbara Sperner‐Unterweger","ptype":"article","src":"https://openalex.org/W2969447047","eid":"W2969447047"},{"id":"paper-w3177370350","cat":"papers","name":"β‐arrestins mediate rapid 5‐HT2A receptor endocytosis to regulate intensity and duration of signaling","year":"2019","cit":2,"pfa":"Daniel Eric Felsing","psa":"John Allen","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3177370350","eid":"W3177370350"},{"id":"paper-w2996908182","cat":"papers","name":"Corticosterone as a potential confounding factor in delineating mechanisms underlying ketamine’s rapid antidepressant actions","year":"2019","cit":2,"pfa":"Lauren Wegman‐Points","psa":"Li‐Lian Yuan","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W2996908182","eid":"W2996908182"},{"id":"paper-w2967381719","cat":"papers","name":"Association of extent of cannabis use and psychotic like intoxication experiences in a multi-national sample of First Episode Psychosis patients and controls","year":"2019","cit":2,"pfa":"Musa Basseer Sami","psa":"Marta Di Forti","ptype":"preprint","src":"https://openalex.org/W2967381719","eid":"W2967381719"},{"id":"paper-w122338163","cat":"papers","name":"[Alcohol and substance dependence].","year":"2012","cit":2,"pfa":"Hideto Tsuchida","psa":"Kenji Fukui","topics":["Addiction","Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W122338163","eid":"W122338163"},{"id":"paper-w4415606557","cat":"papers","name":"TREK-1 channel blockade mediates the antidepressant-like effects of hydroxynorketamine","year":"2025","cit":2,"pfa":"Yingcai Song","psa":"Zhiqiang Liu","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4415606557","eid":"W4415606557"},{"id":"paper-w956903267","cat":"papers","name":"New Approaches to Treatment of Schizophrenia by Enhancing N-methyl-D-aspartate Neurotransmission","year":"2008","cit":2,"pfa":"Guochuan Emil Tsai","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W956903267","eid":"W956903267"},{"id":"paper-w4403527945","cat":"papers","name":"Dizocilpine derivatives as neuroprotective NMDA receptor antagonists without psychomimetic side effects","year":"2024","cit":2,"pfa":"Jan Konecny","psa":"Martin Hořák","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4403527945","eid":"W4403527945"},{"id":"paper-w4207083256","cat":"papers","name":"Pseudothrombocytopenia in a patient with bipolar type 2 disorder on lurasidone","year":"2022","cit":2,"pfa":"Kasturi Atmaram Sakhardande","psa":"Shyam Sundar Arumugham","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4207083256","eid":"W4207083256"},{"id":"paper-w4310122222","cat":"papers","name":"Ketamine: Linking NMDA receptor hypofunction, gamma oscillations and psychosis (commentary on Qin et al., 2022)","year":"2022","cit":2,"pfa":"Thomas James Reilly","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4310122222","eid":"W4310122222"},{"id":"paper-w4415078822","cat":"papers","name":"Intrathecal Anesthesia With Ketamine","year":"1998","cit":2,"pfa":"Chris Hawksworth","psa":"Mick G. Serpell","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4415078822","eid":"W4415078822"},{"id":"paper-w1573823513","cat":"papers","name":"Opioid Kappa Receptor Selective Agonist TRK-820 (Nalfurafine Hydrochloride)","year":"2012","cit":2,"pfa":"H. Fujii","psa":"Hiroshi Nagase","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W1573823513","eid":"W1573823513"},{"id":"paper-w3126850941","cat":"papers","name":"Phencyclidine-induced psychosis causes hypersynchronization and disruption of connectivity within prefrontal-hippocampal circuits that is rescued by antipsychotic drugs","year":"2021","cit":2,"pfa":"Cristina Delgado-Sallent","psa":"Maria Victoria Puig","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W3126850941","eid":"W3126850941"},{"id":"paper-w7119121683","cat":"papers","name":"A novel, experimental design to assess rapid antidepressant action: Results from a phase 1b randomized trial of NV-5138","year":"2026","cit":2,"pfa":"Steven D. Targum","psa":"Randall Owen","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7119121683","eid":"W7119121683"},{"id":"paper-w4300473569","cat":"papers","name":"Typical and atypical antipsychotic drug effects on locomotor hyperactivity and deficits in sensorimotor gating in a genetic model of NMDA receptor hypofunction","year":"2020","cit":2,"pfa":"B KOLLER","psa":"J LIEBERMAN","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4300473569","eid":"W4300473569"},{"id":"paper-w2783547364","cat":"papers","name":"Comparison of Anesthetic Properties of Ketofol (Ketamine with Propofol) and Propofol in Minor Surgical Procedures","year":"2018","cit":2,"pfa":"Shambhu Bahadur Karki","psa":"Kanak Khanal","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2783547364","eid":"W2783547364"},{"id":"paper-w4414761157","cat":"papers","name":"Cannabidiol reverses depression-like behaviors by enhancing hippocampal synaptic plasticity in rats with chronic restraint stress","year":"2025","cit":2,"pfa":"Jutamas Ruanpang","psa":"Narawut Pakaprot","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4414761157","eid":"W4414761157"},{"id":"paper-w2049956130","cat":"papers","name":"(142) Oral efficacy of S-norketamine in preclinical rodent pain models","year":"2008","cit":2,"pfa":"J. Holtman","psa":"Elzbieta P. Wala","ptype":"article","src":"https://openalex.org/W2049956130","eid":"W2049956130"},{"id":"paper-w4221090510","cat":"papers","name":"32 Effect of Oral Ketamine on Analgesia During Burn Wound Care","year":"2022","cit":2,"pfa":"Jill Rozynski","psa":"Arek J Wiktor","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W4221090510","eid":"W4221090510"},{"id":"paper-w2070558723","cat":"papers","name":"Amphetamines: Addiction to a Non-Addicting Drug*","year":"1971","cit":2,"pfa":"J. Griffith","psa":"J. Oates","topics":["Addiction","Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2070558723","eid":"W2070558723"},{"id":"paper-w3106627685","cat":"papers","name":"Ketamine for Chronic Non-Cancer Pain: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines [Internet]","year":"2020","cit":2,"pfa":"Khai Trieu Tran","psa":"Suzanne McCormack","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"review","src":"https://openalex.org/W3106627685","eid":"W3106627685"},{"id":"paper-w1592026891","cat":"papers","name":"Schizophrenia and nitric oxide. Deficits in information processing investigated in animal models","year":"2004","cit":2,"pfa":"Daniel Klamer","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W1592026891","eid":"W1592026891"},{"id":"paper-w4316143238","cat":"papers","name":"Clinical trials of novel psychotropic agents: some caveats","year":"2023","cit":2,"pfa":"Bernard A. Fischer","psa":"Tiffany R. Farchione","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4316143238","eid":"W4316143238"},{"id":"paper-w3115061627","cat":"papers","name":"The structure of acute chemical poisoning in patients with HIV infection in the emergency hospital","year":"2018","cit":2,"pfa":"М.М. Поцхверия","psa":"Mikhail A. Godkov","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3115061627","eid":"W3115061627"},{"id":"paper-w4391177466","cat":"papers","name":"Mental health and well-being for the prevention of substance use disorders","year":"2024","cit":2,"pfa":"Jayant Mahadevan","psa":"Vivek Benegal","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4391177466","eid":"W4391177466"},{"id":"paper-w4256546433","cat":"papers","name":"Synthesis of Esketamine","year":"2019","cit":2,"pfa":"Philip Kocienski","topics":["Mechanism & neuroscience"],"ptype":"editorial","src":"https://openalex.org/W4256546433","eid":"W4256546433"},{"id":"paper-w4362634650","cat":"papers","name":"Intranasal esketamine: A primer","year":"2023","cit":2,"pfa":"Maxwell Zachary Price","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4362634650","eid":"W4362634650"},{"id":"paper-w3217235043","cat":"papers","name":"Recommendations for the Usage of Ketamine and Esketamine","year":"2021","cit":2,"pfa":"Victor I. Reus","ptype":"article","src":"https://openalex.org/W3217235043","eid":"W3217235043"},{"id":"paper-w7126085050","cat":"papers","name":"Prophylactic esketamine to reduce postpartum depression in primiparae","year":"2026","cit":2,"pfa":"Tiantian Chu","psa":"Feng Gao","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7126085050","eid":"W7126085050"},{"id":"paper-w4225284588","cat":"papers","name":"Intranasal esketamine for depression: Not so special K","year":"2022","cit":2,"pfa":"Stephen J. Rosenman","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4225284588","eid":"W4225284588"},{"id":"paper-w4413107753","cat":"papers","name":"Salt-inducible kinase 1 and CREB-regulated transcription co-activator 1 in the paraventricular nucleus participate in the antidepressant-like mechanism of (2R, 6R)-hydroxynorketamine and (2S, 6S)-hydroxynorketamine in mi","year":"2025","cit":2,"pfa":"Jun-Jie Qian","psa":"Huahao Fan","topics":["Depression","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4413107753","eid":"W4413107753"},{"id":"paper-w4229887139","cat":"papers","name":"ICER issues final reports on esketamine and siponimod","year":"2019","cit":2,"ptype":"article","src":"https://openalex.org/W4229887139","eid":"W4229887139"},{"id":"paper-w2981426087","cat":"papers","name":"Esketamine Prevents Treatment-Resistant Depression Relapse","year":"2019","cit":2,"pfa":"Anita Slomski","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2981426087","eid":"W2981426087"},{"id":"paper-w3214916195","cat":"papers","name":"New drugs in psychiatry - cariprazine, lurasidone, esketamine","year":"2021","cit":2,"pfa":"Kinga Pożarowska","psa":"Jolanta Masiak","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3214916195","eid":"W3214916195"},{"id":"paper-w7134115908","cat":"papers","name":"Effective doses of esketamine oral or esketamine intranasal for the prevention of preoperative anxiety in pediatric patients: A randomized double-blind dose-finding trial","year":"2026","cit":2,"pfa":"Hongfei Xiong","psa":"Rongliang Xue","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7134115908","eid":"W7134115908"},{"id":"paper-w2802174580","cat":"papers","name":"Adjunctive Intranasal Esketamine in Treatment-Resistant Depression—Reply","year":"2018","cit":2,"pfa":"Ella Daly","psa":"Jaskaran B. Singh","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2802174580","eid":"W2802174580"},{"id":"paper-w4322742900","cat":"papers","name":"Acute Suicidal Ideation in the Context of Esketamine Maintenance Therapy","year":"2023","cit":2,"pfa":"Fletcher M Bell","ptype":"article","src":"https://openalex.org/W4322742900","eid":"W4322742900"},{"id":"paper-w4200178061","cat":"papers","name":"New drug: Esketamine hydrochloride for treatment-resistant depression","year":"2021","cit":2,"topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4200178061","eid":"W4200178061"},{"id":"paper-w4379137533","cat":"papers","name":"Clinical anesthetic effect of esketamine on children undergoing tonsillectomy","year":"2023","cit":2,"pfa":"Siqu Xiang","psa":"Chuanjin Li","ptype":"article","src":"https://openalex.org/W4379137533","eid":"W4379137533"},{"id":"paper-w3007812988","cat":"papers","name":"Approval of esketamine for treatment-resistant depression – Author's reply","year":"2020","cit":2,"pfa":"Erick H. Turner","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W3007812988","eid":"W3007812988"},{"id":"paper-w4294957939","cat":"papers","name":"Esketamine: NICE’s appraisal was unfair, appeal panel rules","year":"2022","cit":2,"pfa":"Ingrid Torjesen","ptype":"article","src":"https://openalex.org/W4294957939","eid":"W4294957939"},{"id":"paper-w4408134958","cat":"papers","name":"The impact of esketamine on cardiac function in patients undergoing anesthesia","year":"2025","cit":2,"pfa":"Edward Sun","psa":"Jingping Wang","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4408134958","eid":"W4408134958"},{"id":"paper-w4304776738","cat":"papers","name":"Esketamine following transcranial magnetic stimulation for treatment resistant depression","year":"2022","cit":2,"pfa":"Aliaa Al-Sabbagh","psa":"Mhd Khaled Bowarshi","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4304776738","eid":"W4304776738"},{"id":"paper-w4416455281","cat":"papers","name":"Application of esketamine during emergency care: current status and perspectives","year":"2025","cit":2,"pfa":"Yiwen Wan","psa":"Mi Li","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4416455281","eid":"W4416455281"},{"id":"paper-w4414491363","cat":"papers","name":"Esketamine in bipolar depression: Are we overlooking critical subgroups and dosing details?","year":"2025","cit":2,"pfa":"Yuqing You","psa":"Weifeng Yao","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4414491363","eid":"W4414491363"},{"id":"paper-w3112614985","cat":"papers","name":"Heterogeneous trajectory of depressive symptoms after repeated subcutaneous esketamine injections","year":"2020","cit":2,"pfa":"Matheus Ghossain Barbosa","psa":"Andrea Parolin Jackowski","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3112614985","eid":"W3112614985"},{"id":"paper-w4387729342","cat":"papers","name":"Esketamine More Effective Than Quetiapine for Hard-to-Treat Depression","year":"2023","cit":2,"pfa":"Emily N. Harris","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4387729342","eid":"W4387729342"},{"id":"paper-w4412702016","cat":"papers","name":"Effects of Esketamine Combined With Remimazolam Tosylate on Hemodynamics During Cardiovascular Anesthesia","year":"2025","cit":2,"pfa":"Lei Xi","psa":"Zhenzhen Jiang","ptype":"article","src":"https://openalex.org/W4412702016","eid":"W4412702016"},{"id":"paper-w4399219900","cat":"papers","name":"Increasing the bioavailability of oral esketamine by a single dose of cobicistat: A case study","year":"2024","cit":2,"pfa":"Cornelis F. Vos","psa":"Henricus Gerardus Ruhé","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4399219900","eid":"W4399219900"},{"id":"paper-w7126087735","cat":"papers","name":"Combining Intranasal Esketamine and Electroconvulsive Therapy in Severe Treatment‑Resistant Depression","year":"2026","cit":2,"pfa":"Sergi López-Rodríguez","psa":"Mikel Urretavizcaya","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7126087735","eid":"W7126087735"},{"id":"paper-w4386860469","cat":"papers","name":"Anosmia and ageusia after intravenous esketamine and propofol-based general anesthesia","year":"2023","cit":2,"pfa":"Cunjin Wang","psa":"Ju Gao","ptype":"article","src":"https://openalex.org/W4386860469","eid":"W4386860469"},{"id":"paper-w4410709202","cat":"papers","name":"Acute effects of intranasal esketamine application on thalamic structures in healthy individuals","year":"2025","cit":2,"pfa":"Benjamin Spurny‐Dworak","psa":"Rupert R. Lanzenberger","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4410709202","eid":"W4410709202"},{"id":"paper-w4309270107","cat":"papers","name":"(2R,6R)-Hydroxynorketamine restores postsynaptic localization of AMPAR in the prelimbic cortex to provide sustained pain relief","year":"2022","cit":2,"pfa":"Tingting JIN","psa":"Xiaodong Liu","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4309270107","eid":"W4309270107"},{"id":"paper-w4225141088","cat":"papers","name":"Pronounced Regional Variation in Esketamine and Ketamine Prescribing to US Medicaid Patients","year":"2022","cit":2,"pfa":"Alexia G. Aguilar","psa":"Brian J. Piper","topics":["Depression","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4225141088","eid":"W4225141088"},{"id":"paper-w4411617400","cat":"papers","name":"Racial-Ethnic Disparities in Ketamine and Esketamine Therapy for Major Depressive Disorder","year":"2025","cit":2,"pfa":"Michael Liu","psa":"Keming Gao","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4411617400","eid":"W4411617400"},{"id":"paper-w4409689187","cat":"papers","name":"Investigating the Mechanisms of Esketamine in Treating Propofol-Induced Cognitive Impairment in Elderly Rats","year":"2025","cit":2,"pfa":"Jieru Zhang","psa":"Leyan Qiao","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4409689187","eid":"W4409689187"},{"id":"paper-w4408457926","cat":"papers","name":"Person-centred care during treatment with nasal esketamine — a qualitative study","year":"2025","cit":2,"pfa":"Lina Klysing","psa":"Katrin Häggström Westberg","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4408457926","eid":"W4408457926"},{"id":"paper-w4413699385","cat":"papers","name":"Esketamine use in real-world clinical practice in patients with treatment-resistant depression","year":"2025","cit":2,"pfa":"Ismaël Conejero","psa":"Memind Group","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4413699385","eid":"W4413699385"},{"id":"paper-w4283579199","cat":"papers","name":"Clinical Application of Esketamine Hydrochloride in Children with Emergence Agitation under Sevoflurane Anesthesia","year":"2022","cit":2,"pfa":"Zhaoxia Wu","psa":"Wen Xianjie","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4283579199","eid":"W4283579199"},{"id":"paper-w4387799272","cat":"papers","name":"The Impact of Esketamine Combined with Dexmedetomidine on Laparoscopic Gallbladder Surgery: A Randomized Controlled Trial.","year":"2024","cit":2,"pfa":"Fanyan Hu","psa":"Yajun Liu","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4387799272","eid":"W4387799272"},{"id":"paper-w4398780864","cat":"papers","name":"Adding esketamine to lamotrigine to treat major depression: Combinatorial synergism, augmentation, or neither?","year":"2024","cit":2,"pfa":"Gin S. Malhi","psa":"Erica Bell","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4398780864","eid":"W4398780864"},{"id":"paper-w4414710993","cat":"papers","name":"Comment on Esketamine Treatment for Depression in Adults: A PRISMA Systematic Review and Meta-Analysis","year":"2025","cit":2,"pfa":"Carla M. Canuso","psa":"Wayne Curtis Drevets","topics":["Depression","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4414710993","eid":"W4414710993"},{"id":"paper-w4414160770","cat":"papers","name":"Effect of esketamine and etomidate anesthesia on neuroplasticity in electroconvulsive therapy for treatment-resistant depression","year":"2025","cit":2,"pfa":"Guoguang Zhao","psa":"Yi-Wei Zhang","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4414160770","eid":"W4414160770"},{"id":"paper-w4292411707","cat":"papers","name":"Repeated intravenous esketamine treatment in patients with ECT-resistant major depressive disorder","year":"2022","cit":2,"pfa":"A. Safai Pour","psa":"M.S. van Noorden","topics":["Depression","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4292411707","eid":"W4292411707"},{"id":"paper-w4410198110","cat":"papers","name":"The effect of esketamine on perioperative anxiety and depressive symptoms in patients undergoing total hysterectomy","year":"2025","cit":2,"pfa":"Jinfeng Ding","psa":"Qimin Yu","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4410198110","eid":"W4410198110"},{"id":"paper-w4413477145","cat":"papers","name":"Esketamine as an Epidural Adjuvant for Postoperative Analgesia in Gynecological Malignancy Surgery: A Randomized Trial","year":"2025","cit":2,"pfa":"Huanyu Luo","psa":"Jun Zhang","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4413477145","eid":"W4413477145"},{"id":"paper-w4401334453","cat":"papers","name":"Esketamine infusion therapy: A promising alternative in the treatment of chronic endometriosis-associated pain","year":"2024","cit":2,"pfa":"Rozemarijn de Koning","psa":"Andries R. H. Twijnstra","topics":["Depression","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4401334453","eid":"W4401334453"},{"id":"paper-w4404549987","cat":"papers","name":"Paradoxical Depressive Response to Intranasal Esketamine in Treatment-Resistant Depression: A Case Series","year":"2024","cit":2,"pfa":"José Alfonso Ontiveros-Sánchez de la Barquera","psa":"Grecia Alejandra Perez Jalomo","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4404549987","eid":"W4404549987"},{"id":"paper-w4405815941","cat":"papers","name":"Effect of subanesthetic dose of esketamine on early postoperative depression in elderly patients with Sarcopenia","year":"2024","cit":2,"pfa":"Yuru Fang","psa":"Yiqiao Wang","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4405815941","eid":"W4405815941"},{"id":"paper-w4200486892","cat":"papers","name":"P.0391 Ultra-resistant major depression: treatment with in-esketamine on compassionate use","year":"2021","cit":2,"pfa":"Ana Isabel de Santiago-Díaz","psa":"Jesús Artal-Simón","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4200486892","eid":"W4200486892"},{"id":"paper-w4389537903","cat":"papers","name":"Effect of Esketamine Applied in Fiberoptic Bronchoscopy on Negative Postoperative Behavioral Changes of Children","year":"2023","cit":2,"pfa":"Yu Zhang","psa":"Li Li","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4389537903","eid":"W4389537903"},{"id":"paper-w4415211385","cat":"papers","name":"Esketamine Nasal Spray for Treatment-Resistant Bipolar II Depression: A Case Report","year":"2025","cit":2,"pfa":"Hong-Ci Lin","psa":"Cheng‐Ho Chang","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4415211385","eid":"W4415211385"},{"id":"paper-w4410591613","cat":"papers","name":"Effect of subclinical esketamine on NLRP3 and cognitive dysfunction in elderly ischemic stroke patients","year":"2025","cit":2,"pfa":"Lang Wang","psa":"Jianping Zhang","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4410591613","eid":"W4410591613"},{"id":"paper-w4410036211","cat":"papers","name":"Auto-Induction in Oral Esketamine Treatment for Treatment-Resistant Depression: An Exploratory Study","year":"2025","cit":2,"pfa":"Jolien K. E. Veraart","psa":"Daan Johannes Touw","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4410036211","eid":"W4410036211"},{"id":"paper-w4413814332","cat":"papers","name":"Evaluating the combination of esketamine and propofol in procedural analgesia/sedation: a systematic review and meta-analysis","year":"2025","cit":2,"pfa":"Kumar Akash","psa":"Palwasha S Chaudhry","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W4413814332","eid":"W4413814332"},{"id":"paper-w2999577301","cat":"papers","name":"Correction to: Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial","year":"2020","cit":2,"pfa":"Sanne Y. Smith-Apeldoorn","psa":"Robert A. Schoevers","topics":["Depression"],"ptype":"erratum","src":"https://openalex.org/W2999577301","eid":"W2999577301"},{"id":"paper-w4411253391","cat":"papers","name":"Behavioral and biochemical changes associated with the analgesic effects of (2R,6R)-hydroxynorketamine alone and in combination with meloxicam following disk puncture in mice","year":"2025","cit":2,"pfa":"Vaskar Das","psa":"Robert J. McCarthy","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4411253391","eid":"W4411253391"},{"id":"paper-w4416192077","cat":"papers","name":"The Impact of Intranasal Esketamine on Emergence Agitation in Children Undergoing Adenotonsillectomy: A Randomized Controlled Study","year":"2025","cit":2,"pfa":"Jiajia Li","psa":"Kaiming Yuan","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4416192077","eid":"W4416192077"},{"id":"paper-w4412513572","cat":"papers","name":"Insomnia and Esketamine Add-On Therapy to Antidepressant Therapy in Patients with Treatment-Resistant Depression—A Pilot Study","year":"2025","cit":2,"pfa":"Daniel Szawarnoga","psa":"Marek Krzystanek","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4412513572","eid":"W4412513572"},{"id":"paper-w4405925718","cat":"papers","name":"Efficacy of esketamine for chronic post-thoracotomy pain: protocol for a systematic review and meta-analysis","year":"2024","cit":2,"pfa":"Juan Shu","psa":"Ye Yuan","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4405925718","eid":"W4405925718"},{"id":"paper-w4409481942","cat":"papers","name":"Association between major cardiovascular events and esketamine: A disproportionality analysis in the WHO pharmacovigilance database","year":"2025","cit":2,"pfa":"Tanguy Taillefer de Laportalière","psa":"François Montastruc","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4409481942","eid":"W4409481942"},{"id":"paper-w4412848594","cat":"papers","name":"Predictors of Esketamine Response in Treatment-Resistant Depression: The Role of Temperament and Cumulative Treatment Resistance","year":"2025","cit":2,"pfa":"Riccardo Guglielmo","psa":"Gianluca Serafini","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4412848594","eid":"W4412848594"},{"id":"paper-w4313330160","cat":"papers","name":"Effect of subanesthetic dose of esketamine on postoperative rehabilitation in elderly patients undergoing hip arthroplasty","year":"2022","cit":2,"pfa":"Menghang Min","psa":"Wenqi Xin","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4313330160","eid":"W4313330160"},{"id":"paper-w4412708647","cat":"papers","name":"Esketamine for Preventing Catheter-Related Bladder Discomfort After Ureteroscopic Lithotripsy: A Randomized Controlled Trial","year":"2025","cit":2,"pfa":"Zhaoli Wang","psa":"Tao Luo","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4412708647","eid":"W4412708647"},{"id":"paper-w4416122264","cat":"papers","name":"The hemodynamic effects of esketamine-based opioid-free anesthesia in laparoscopic hepatectomy: a randomized clinical trial","year":"2025","cit":2,"pfa":"Yiting Yao","psa":"Chun Yang","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4416122264","eid":"W4416122264"},{"id":"paper-w4410370543","cat":"papers","name":"Low-dose Esketamine combined with Propofol in microscopic pediatric strabismus surgery: a randomized controlled study","year":"2025","cit":2,"pfa":"Yaping Shen","psa":"Zhentao Sun","topics":["Safety & adverse events","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4410370543","eid":"W4410370543"},{"id":"paper-w4412086777","cat":"papers","name":"A Global Population-Based Study on the Association Between Ketamine and Esketamine With Suicidality Using WHO VigiBase","year":"2025","cit":2,"pfa":"Moiz Lakhani","psa":"Roger S. McIntyre","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4412086777","eid":"W4412086777"},{"id":"paper-w4398221260","cat":"papers","name":"Intravenous infusion with esketamine rapidly alleviates refractory somatic symptom disorder: A case report","year":"2024","cit":2,"pfa":"Shikai Wang","psa":"Huanxin Chen","ptype":"article","src":"https://openalex.org/W4398221260","eid":"W4398221260"},{"id":"paper-w4409242601","cat":"papers","name":"The Potential Influence of Associated Antidepressants on the Pharmacokinetic Profile of Esketamine in Patients Affected by Treatment-resistant Depression","year":"2025","cit":2,"pfa":"Marika Alborghetti","psa":"Sergio De Filippis","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4409242601","eid":"W4409242601"},{"id":"paper-w4390703000","cat":"papers","name":"Retracted: The Clinical Application of Remimazolam Benzenesulfonate Combined with Esketamine Intravenous Anesthesia in Endoscopic Retrograde Cholangiopancreatography","year":"2024","cit":2,"pfa":"BioMed Research International","ptype":"article","src":"https://openalex.org/W4390703000","eid":"W4390703000"},{"id":"paper-w7136109009","cat":"papers","name":"The effect of esketamine on emergence delirium or agitation in children after anesthesia-a systematic review and meta-analysis","year":"2026","cit":2,"pfa":"Wei Yang","psa":"He Huang","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7136109009","eid":"W7136109009"},{"id":"paper-w4412710773","cat":"papers","name":"Esketamine modulates cerebral function variations between S1 and BLA in rats with chronic pain and anxiety","year":"2025","cit":2,"pfa":"Yuanyuan Fang","psa":"Zongze Zhang","topics":["Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4412710773","eid":"W4412710773"},{"id":"paper-w4414263445","cat":"papers","name":"Intravenous Ketamine Followed by Intranasal Esketamine in 2 Subsequent Treatment-resistant Depressive Episodes: Insights From a Case Series","year":"2025","cit":2,"pfa":"Matteo Carminati","psa":"Raffaella Zanardi","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4414263445","eid":"W4414263445"},{"id":"paper-w4254469451","cat":"papers","name":"P.164 Safety and pharmacokinetic study of inhaled Esketamine after a multiple dose in healthy volunteers","year":"2019","cit":2,"pfa":"Sylwia Janowska","psa":"Maciej Wieczorek","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4254469451","eid":"W4254469451"},{"id":"paper-w4414375154","cat":"papers","name":"Ketamine/esketamine in the treatment of depression with comorbid borderline personality disorder or traits: A systematic review of effectiveness","year":"2025","cit":2,"pfa":"Emma Scott","psa":"Carla Meurk","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4414375154","eid":"W4414375154"},{"id":"paper-w4400158658","cat":"papers","name":"Combination of intranasal dexmedetomidine and intravenous esketamine for the sedation of pediatric patients undergoing cardiac magnetic resonance imaging","year":"2024","cit":2,"pfa":"Min Diao","psa":"Jieshu Zhou","ptype":"article","src":"https://openalex.org/W4400158658","eid":"W4400158658"},{"id":"paper-w7117491748","cat":"papers","name":"Effectiveness of Intranasal Esketamine on Suicidal Ideation and Depressive Symptoms in Patients with Treatment-Resistant Depression: A Longitudinal Study","year":"2025","cit":2,"pfa":"Matteo Leonardi","psa":"Bernardo Maria Dell’Osso","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7117491748","eid":"W7117491748"},{"id":"paper-w7138190794","cat":"papers","name":"Intranasal esketamine: real-world clinical practice in treatment-resistant depression and factors associated with treatment response","year":"2026","cit":2,"pfa":"B. Baune","psa":"Erhan Kavakbasi","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7138190794","eid":"W7138190794"},{"id":"paper-w2974898166","cat":"papers","name":"In treatment-resistant depression, adding esketamine nasal spray to an oral antidepressant improved symptoms at 28 days","year":"2019","cit":2,"pfa":"Hemraj Pal","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2974898166","eid":"W2974898166"},{"id":"paper-w4415381430","cat":"papers","name":"Rebuilding the atrophied brain: 6-month nasal esketamine therapy expands key frontal and hippocampal regions and reduces serum neurofilament levels in patients with major depressive disorder. A proof-of-concept study of","year":"2025","cit":2,"pfa":"Ana Rodríguez Lorente","psa":"Juan Antonio García-Carmona","topics":["Depression","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4415381430","eid":"W4415381430"},{"id":"paper-w4416716017","cat":"papers","name":"Real-world evaluation of change in depressive symptoms among patients with treatment-resistant depression treated with esketamine","year":"2025","cit":2,"pfa":"Carl D. Marci","psa":"Manish K. Jha","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4416716017","eid":"W4416716017"},{"id":"paper-w4410595763","cat":"papers","name":"Comparative Sedative Effects of Esketamine and Dexmedetomidine Versus Dexmedetomidine Alone in Patients Undergoing Spinal Tumor Surgery","year":"2025","cit":2,"pfa":"Chuanyan Lin","psa":"Jianlin Wang","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4410595763","eid":"W4410595763"},{"id":"paper-w4414785172","cat":"papers","name":"Hemorrhagic cystitis induced by intravenous esketamine in the treatment of new-onset refractory status epilepticus in children: a case report","year":"2025","cit":2,"pfa":"Jin-Meng Ding","psa":"Yao Liu","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4414785172","eid":"W4414785172"},{"id":"paper-w7117461952","cat":"papers","name":"Esketamine as an opioid-sparing adjuvant for epidural labour analgesia: a randomised, double-blind trial evaluating postpartum depression","year":"2025","cit":2,"pfa":"Yi-ying Zhang","psa":"Yugang Diao","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7117461952","eid":"W7117461952"},{"id":"paper-w4417362249","cat":"papers","name":"Prospective Dose-Finding of Esketamine for Suppressing Cervical Dilation Response in Ambulatory Hysteroscopy Under Monitored Anesthesia Care","year":"2025","cit":2,"pfa":"Lijuan Yan","psa":"Bin Yong Yang","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4417362249","eid":"W4417362249"},{"id":"paper-w4416676650","cat":"papers","name":"Adjunctive esketamine in propofol-based sedation for gastrointestinal endoscopy: a systematic review and meta-analysis of randomized trials","year":"2025","cit":2,"pfa":"Jiazheng Qi","psa":"Xu Zhao","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4416676650","eid":"W4416676650"},{"id":"paper-w4376116105","cat":"papers","name":"Intra-nasal esketamine induced psychotic disorder in a post COVID-19 major depressive episode: A case report","year":"2023","cit":2,"pfa":"Julie Tang","psa":"Matthieu Gasnier","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4376116105","eid":"W4376116105"},{"id":"paper-w4406064826","cat":"papers","name":"Esketamine-mediated alleviation of electroconvulsive shock-induced memory impairment is associated with the regulation of mGluR5 in depressive-like rats","year":"2025","cit":2,"pfa":"Yiwei Shen","psa":"Su Min","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4406064826","eid":"W4406064826"},{"id":"paper-w4388598942","cat":"papers","name":"Alleviating morphine-induced itching while sustaining its analgesic efficacy: Esketamine as a potential co-administrating choice","year":"2023","cit":2,"pfa":"Tong Cheng","psa":"Xiaqing Ma","ptype":"article","src":"https://openalex.org/W4388598942","eid":"W4388598942"},{"id":"paper-w3013816627","cat":"papers","name":"Pitfalls of Cost-Effectiveness Analysis in Practice: A TRD Case Example in the United States with Esketamine Versus Oral Antidepressants","year":"2020","cit":2,"pfa":"Swapna U. Karkare","psa":"Beth Barber","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W3013816627","eid":"W3013816627"},{"id":"paper-w4399706951","cat":"papers","name":"SA29 Motivations and Barriers for Psychiatric Practice Adoption of Esketamine Nasal Spray for Treatment-Resistant Depression in the United States","year":"2024","cit":2,"pfa":"Madeline Brendle","psa":"DC Malone","topics":["Depression"],"ptype":"conference-abstract","src":"https://openalex.org/W4399706951","eid":"W4399706951"},{"id":"paper-w4417233369","cat":"papers","name":"Effects of Subanesthetic Esketamine on Postoperative Sleep Quality Through EEG Analysis in Breast Cancer Patients: A Randomized Clinical Trial","year":"2025","cit":2,"pfa":"Yuening Zhan","psa":"Lingfei Wang","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4417233369","eid":"W4417233369"},{"id":"paper-w4416841165","cat":"papers","name":"Efficacy and safety of esketamine for pain control after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials","year":"2025","cit":2,"pfa":"Tingyu Jiang","psa":"Rui Zhi Zhao","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4416841165","eid":"W4416841165"},{"id":"paper-w4408398263","cat":"papers","name":"Effects of esketamine infusion on tourniquet-induced hypertension in patients undergoing below-knee orthopedic surgery: protocol for a randomized controlled trial","year":"2025","cit":2,"pfa":"Kai Jiang","psa":"Ke Peng","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4408398263","eid":"W4408398263"},{"id":"paper-w4409406614","cat":"papers","name":"Effects of esketamine–sufentanil for patient-controlled intravenous analgesia in women following cesarean section: A randomized clinical trial","year":"2025","cit":2,"pfa":"Yanping Zhao","psa":"Jiaming Fan","topics":["Depression","Anxiety & end-of-life","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4409406614","eid":"W4409406614"},{"id":"paper-w4411227986","cat":"papers","name":"The pattern of dissociative symptoms differs between post-traumatic stress disorder and first esketamine administration for treatment-resistant depression","year":"2025","cit":2,"pfa":"David J. G. Williamson","psa":"J. Douglas Bremner","topics":["Depression","PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4411227986","eid":"W4411227986"},{"id":"paper-w3208880129","cat":"papers","name":"Patterns of use, clinical efficacy, safety and tolerability of Ketamine and Esketamine in treatment-resistant depression: Towards registry‐based surveillance systems","year":"2021","cit":2,"pfa":"Álvaro López‐Díaz","psa":"Diego Vega","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3208880129","eid":"W3208880129"},{"id":"paper-w7147293267","cat":"papers","name":"Trauma re-experiencing episodes during esketamine treatment in patients with treatment-resistant depression and comorbid PTSD: a retrospective case series","year":"2026","cit":2,"pfa":"Maud Rothärmel","psa":"Lucie Berkovitch","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7147293267","eid":"W7147293267"},{"id":"paper-w4223443187","cat":"papers","name":"Ketamine and its metabolite 2R,6R-hydroxynorketamine promote ocular dominance plasticity and release TRKB from inhibitory control without changing perineuronal nets enwrapping parvalbumin interneurons","year":"2022","cit":2,"pfa":"Cecilia Cannarozzo","psa":"Eero Ċastrén","topics":["Depression","Mechanism & neuroscience","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4223443187","eid":"W4223443187"},{"id":"paper-w7139132317","cat":"papers","name":"Ketamine/esketamine for preventing rebound pain after peripheral nerve block: a systematic review and meta-analysis of randomized controlled trials","year":"2026","cit":2,"pfa":"Lanhua ZHONG","psa":"Hongbiao YANG","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W7139132317","eid":"W7139132317"},{"id":"paper-w7127280836","cat":"papers","name":"ED95 of Ciprofol Combined with Esketamine or Sufentanil in Elderly Patients Undergoing Endoscopic Submucosal Dissection: A Dose-Finding and Randomized Controlled Trial","year":"2026","cit":2,"pfa":"Xiaoxue Qin","psa":"Ilyar Mamtili","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7127280836","eid":"W7127280836"},{"id":"paper-w4400894206","cat":"papers","name":"Understanding profiles of patients with treatment-resistant depression by stringency of health plan prior authorization criteria for approval of esketamine nasal spray","year":"2024","cit":2,"pfa":"Lisa Harding","psa":"Kruti Joshi","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4400894206","eid":"W4400894206"},{"id":"paper-w7172312253","cat":"papers","name":"Esketamine versus dexmedetomidine for oxygenation and postoperative quality of recovery in thoracoscopic surgery: a randomized, double-blind, non-inferiority controlled trial","year":"2026","cit":2,"pfa":"Rui Feng","psa":"Jinqiao Qian","ptype":"article","src":"https://openalex.org/W7172312253","eid":"W7172312253"},{"id":"paper-w4414063034","cat":"papers","name":"A New Era for Esketamine in Managing Treatment-Resistant Depression: A Systematic Review of Its Use From Adjunct to First-Line Therapy","year":"2025","cit":2,"pfa":"Bhavya","psa":"Balakrishnan Sadasivam","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W4414063034","eid":"W4414063034"},{"id":"paper-w4367296967","cat":"papers","name":"Effects of Anesthesia Changes During Maintenance ECT: A Longitudinal Comparison of Seizure Quality Under Anesthesia Using Propofol/Esketamine Versus Methohexital","year":"2023","cit":2,"pfa":"Isabel Methfessel","psa":"Michael Belz","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4367296967","eid":"W4367296967"},{"id":"paper-w7133207197","cat":"papers","name":"Non-inferiority, comparative effectiveness study of intravenous ketamine v. intranasal esketamine for treatment-resistant depression: The EQUIVALENCE trial protocol","year":"2026","cit":2,"pfa":"Samuel T. Wilkinson","psa":"Gerard Sanacora","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7133207197","eid":"W7133207197"},{"id":"paper-w4412473626","cat":"papers","name":"[Clinical efficacy of sub-anesthetic doses of esketamine in providing perioperative anesthesia and analgesia for elderly patients with gastrointestinal tumors in plateau areas].","year":"2025","cit":2,"pfa":"Jun Tang","psa":"J La","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4412473626","eid":"W4412473626"},{"id":"paper-w4413201178","cat":"papers","name":"Intranasal Esketamine Premedication Reduces Sevoflurane Requirements During Laryngeal Mask Airway Insertion in Pediatric Patients: A Randomized Controlled Trial","year":"2025","cit":2,"pfa":"Chenxia Xu","psa":"Bin Qian","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4413201178","eid":"W4413201178"},{"id":"paper-w4411893153","cat":"papers","name":"Combination of dexmedetomidine and esketamine for postoperative nausea and vomiting in patients undergoing laparoscopic surgery: study protocol for a prospective, randomized, controlled trial","year":"2025","cit":2,"pfa":"Ying Zhou","psa":"Chao Zhang","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4411893153","eid":"W4411893153"},{"id":"paper-w4304776731","cat":"papers","name":"Comparison of ketamine infusion, intranasal esketamine spray and repetitive Transcranial Magnetic Stimulation (rTMS) for treatment-resistant depression at a suburban tertiary clinic","year":"2022","cit":2,"pfa":"Maria Cristina Davila","psa":"Ann M. Manzardo","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4304776731","eid":"W4304776731"},{"id":"paper-w4410765332","cat":"papers","name":"Combination of Ropivacaine Hydrochloride and Esketamine for Thoracic Paravertebral Block on Pain and Postoperative Recovery of Patients Undergoing Radical Resection Surgery for Lung Cancer","year":"2025","cit":2,"pfa":"Qun Yang","psa":"Li-Dong Zheng","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4410765332","eid":"W4410765332"},{"id":"paper-w4382657034","cat":"papers","name":"Effect of Single Intravenous Injection of Esketamine on Postpartum Depression after Labor Analgesia and Potential Mechanisms: A Randomized, Double-blinded Controlled Trial","year":"2023","cit":2,"pfa":"Bin Ling","psa":"Wei Wang","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4382657034","eid":"W4382657034"},{"id":"paper-w4417332183","cat":"papers","name":"The Effect of Opioid-Free Anesthesia with Esketamine on Postoperative Cognitive Dysfunction in Elderly Patients Undergoing Thoracoscopic Surgery: A Prospective, Randomized, Controlled Trial","year":"2025","cit":2,"pfa":"Yuening Zhan","psa":"Lingfei Wang","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4417332183","eid":"W4417332183"},{"id":"paper-w7131110904","cat":"papers","name":"Multiple peripheral inflammatory markers in adolescents with major depressive disorder treated with repeated esketamine infusions: results from a randomized controlled trial","year":"2026","cit":2,"pfa":"Xiaofeng Lan","psa":"Yanling Zhou","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7131110904","eid":"W7131110904"},{"id":"paper-w4405010266","cat":"papers","name":"Effect of esketamine on postoperative quality of recovery in patients undergoing arthroscopic rotator cuff repair: protocol for a prospective, randomized, double-blind study","year":"2024","cit":2,"pfa":"Qirong Sun","psa":"Leng Zhou","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4405010266","eid":"W4405010266"},{"id":"paper-w4238685659","cat":"papers","name":"P.607 Esketamine nasal spray for rapid reduction of major depressive disorder symptoms in patients at imminent risk for suicide: ASPIRE-2 study","year":"2019","cit":2,"pfa":"D. Ionescu","psa":"H.K. Manji","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4238685659","eid":"W4238685659"},{"id":"paper-w4386337211","cat":"papers","name":"The application of iliac fascia space block combined with esketamine intravenous general anesthesia in PFNA surgery of the elderly: A prospective, single-center, controlled trial","year":"2023","cit":2,"pfa":"Xuandong Jia","psa":"Maitao Zhou","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4386337211","eid":"W4386337211"},{"id":"paper-w4409444970","cat":"papers","name":"Electroconvulsive Therapy, Ketamine, and Esketamine in a Patient with Major Depressive Disorder and Multiple Comorbidities: A Case Report over 10-year Treatment from Adolescence to Adulthood","year":"2025","cit":2,"pfa":"Keming Gao","psa":"Margret A. Musso","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4409444970","eid":"W4409444970"},{"id":"paper-w7125577630","cat":"papers","name":"Modulating tonic NMDA receptor currents: mechanistic insights into ketamine, esketamine, and dextromethorphan for major depressive disorder and implications for the discovery and development of investigational agents","year":"2026","cit":2,"pfa":"Gia Han Le","psa":"Roger S. McIntyre","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7125577630","eid":"W7125577630"},{"id":"paper-w7125523482","cat":"papers","name":"Long-term effectiveness and side-effects of intranasal esketamine in treatment-resistant depression: real-world, single-arm study of over 100 sessions","year":"2026","cit":2,"pfa":"Nawfel Ayad","psa":"Syed Fahad Javaid","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7125523482","eid":"W7125523482"},{"id":"paper-w7124570066","cat":"papers","name":"Intranasal esketamine plus dexmedetomidine versus dexmedetomidine alone for emergence delirium in pediatric patients: a systematic review and meta-analysis of randomized controlled trials","year":"2026","cit":2,"pfa":"Yanni Wang","psa":"Hao Yao","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W7124570066","eid":"W7124570066"},{"id":"paper-w4416408356","cat":"papers","name":"Effects of esketamine combined with dexmedetomidine on oxidative stress and lung function during one-lung ventilation in patients with mild to moderate COPD undergoing thoracoscopic surgery","year":"2025","cit":2,"pfa":"Xiaoqi Zhang","psa":"Zhi-yuan Chen","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4416408356","eid":"W4416408356"},{"id":"paper-w4249867908","cat":"papers","name":"P.323 Esketamine nasal spray for rapid reduction of major depressive disorder symptoms in patients at imminent risk for suicide: aspire-1 study","year":"2019","cit":2,"pfa":"D.J. Fu","psa":"H.K. Manji","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4249867908","eid":"W4249867908"},{"id":"paper-w4412355865","cat":"papers","name":"Esketamine prevents carboprost-induced adverse reactions during cesarean section under combined spinal-epidural anesthesia: a double-blind, randomized trial","year":"2025","cit":2,"pfa":"Feng Zhou","psa":"Yue Tian","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4412355865","eid":"W4412355865"},{"id":"paper-w4413137546","cat":"papers","name":"Intraoperative low-dose esketamine on postoperative quality of recovery in patients undergoing open gynecologic surgery: a double-blinded, parallel-group, placebo- controlled trial","year":"2025","cit":2,"pfa":"Zhi-Yu Geng","psa":"Hui-Cheng Song","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4413137546","eid":"W4413137546"},{"id":"paper-w7138862667","cat":"papers","name":"Effect of Remimazolam or Propofol Combined With Esketamine on Anesthesia and Early Perioperative Neurocognitive Disorders in Patients Undergoing Thoracoscopic Partial Lung Resection: A Randomized Clinical Trial","year":"2026","cit":2,"pfa":"Wen Yuan","psa":"Jiang Shen","ptype":"article","src":"https://openalex.org/W7138862667","eid":"W7138862667"},{"id":"paper-w4414371088","cat":"papers","name":"Intraoperative Opioid-Free Anesthesia with Dexmedetomidine and Esketamine Versus Conventional General Anesthesia in Laparoscopic Cholecystectomy at 3,600 m: A Randomized Trial on Hemodynamic Stability and Postoperative R","year":"2025","cit":2,"pfa":"Ke Tu","psa":"Mingming Zhang","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4414371088","eid":"W4414371088"},{"id":"paper-w4416973180","cat":"papers","name":"Effects of Esketamine-Dexmedetomidine Combination on Immediate Postprocedural Oxygenation Index in Severe Pneumonia Patients Undergoing Bedside Fiberoptic Bronchoscopic Sputum Aspiration: A Prospective Randomised Control","year":"2025","cit":2,"pfa":"Yongbin Wang","psa":"Lu Zhang","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4416973180","eid":"W4416973180"},{"id":"paper-w2911671116","cat":"papers","name":"Esketamine nasal spray combined with an oral antidepressant for relapse prevention in treatment-resistant depression: results of a double-blind, randomized withdrawal, multicenter study (sustain-1)","year":"2019","cit":2,"pfa":"Ella Daly","psa":"Jaskaran B. Singh","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2911671116","eid":"W2911671116"},{"id":"paper-w4415148817","cat":"papers","name":"Effect of esketamine vs sufentanil adjunct to propofol deep sedation on the incidence of oxygen-desaturation in elderly patients undergoing urologic surgeries: a randomized, double-blind, controlled trial","year":"2025","cit":2,"pfa":"Si-Qi Hao","psa":"Xin Luo","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4415148817","eid":"W4415148817"},{"id":"paper-w4402837677","cat":"papers","name":"Efficacy and safety of esketamine hydrochloride adjunct to sufentanil in non-surgical patients under mechanical ventilation in the ICU (SENSATION trial): protocol for a multicentre, single-blind, randomised controlled tr","year":"2024","cit":2,"pfa":"Yi Long","psa":"Lu Ke","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4402837677","eid":"W4402837677"},{"id":"paper-w4410100363","cat":"papers","name":"Comparison Between Low-Dose Esketamine and Dexmedetomidine on Postoperative Recovery Quality Among Patients Undergoing Humeral Trauma Surgery in Interscalene Brachial Plexus Block: A Randomized, Double-Blind, Controlled","year":"2025","cit":2,"pfa":"Jiao Chen","psa":"Liwei Wang","topics":["PTSD & trauma","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4410100363","eid":"W4410100363"},{"id":"paper-w4405384888","cat":"papers","name":"Effect of different modes of administration of esketamine combined with supraclavicular brachial plexus block on the incidence of rebound pain after upper limb fracture surgery: study protocol for a single-centre, double","year":"2024","cit":2,"pfa":"Wencai Jiang","psa":"Yukai Zhou","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4405384888","eid":"W4405384888"},{"id":"paper-w4383315274","cat":"papers","name":"Esketamine Nasal Spray Improves Rate and Time to Remission Versus Quetiapine Extended Release in Subgroups of Patients With Treatment Resistant Depression and Two or Three Plus Prior Treatment Failures: Results From ESCA","year":"2023","cit":2,"pfa":"Allan Hunter Young","psa":"Yordan Godinov","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4383315274","eid":"W4383315274"},{"id":"paper-w4385683962","cat":"papers","name":"Ketamine Metabolites-waiting in the Wings as Therapeutic Candidate for Depression?","year":"2023","cit":2,"pfa":"Ming Tatt Lee","psa":"Yu‐Cheng Ho","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4385683962","eid":"W4385683962"},{"id":"paper-w4407532111","cat":"papers","name":"Identification of Key Genes in Esketamine’s Therapeutic Effects on Perioperative Neurocognitive Disorders via Transcriptome Sequencing","year":"2025","cit":2,"pfa":"Wen Hu","psa":"Xiaohua Zou","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4407532111","eid":"W4407532111"},{"id":"paper-w7128691174","cat":"papers","name":"The effect of glutamatergic modulators on sleep behavior and architecture in depressive disorders: A systematic review","year":"2026","cit":2,"pfa":"Kyle Valentino","psa":"Roger S. McIntyre","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7128691174","eid":"W7128691174"},{"id":"paper-w7133505539","cat":"papers","name":"Ketamine as an NMDA-modulating therapy in bipolar disorder: rationale and evidence","year":"2026","cit":2,"pfa":"Robert Queissner","psa":"EZ Reininghaus","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7133505539","eid":"W7133505539"},{"id":"paper-w7169670881","cat":"papers","name":"Role of perioperative ketamine on the incidence of rebound pain after regional nerve block in the adult surgical population: A systematic review and meta-analysis of randomised controlled trials","year":"2026","cit":2,"pfa":"Jeetinder Kaur Makkar","psa":"Narinder Pal Singh","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7169670881","eid":"W7169670881"},{"id":"paper-w4283216397","cat":"papers","name":"Effect of perioperative continuous infusion of S-ketamine on the quality of postoperative recovery of patients undergoing modified radical mastectomy: a randomized controlled trial","year":"2022","cit":2,"pfa":"Ke yao Zhang","psa":"Fang Gao","topics":["Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4283216397","eid":"W4283216397"},{"id":"paper-w4363673272","cat":"papers","name":"516. Metabolomic Biomarkers for (R, S)-Ketamine and (S)-Ketamine in Treatment-Resistant Depression and Healthy Controls: A Systematic Review","year":"2023","cit":2,"pfa":"Balwinder Singh","psa":"Gustavo C. Medeiros","topics":["Depression","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4363673272","eid":"W4363673272"},{"id":"paper-w4415335458","cat":"papers","name":"An Implementation Science Assessment of Intranasal Esketamine’s Limited Integration into Mainstream Psychiatric Treatment","year":"2025","cit":2,"pfa":"Benjamin Anderson","psa":"Megan A. O’Grady","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4415335458","eid":"W4415335458"},{"id":"paper-w4414718082","cat":"papers","name":"Rapid-acting NMDA and GABAergic Modulators in Mood Disorders: From Synaptic Mechanisms to Clinical Practice","year":"2025","cit":2,"pfa":"Alessandro Serretti","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4414718082","eid":"W4414718082"},{"id":"paper-w7165796403","cat":"papers","name":"Oral Prolonged-Release Ketamine for Treatment-Resistant Depression","year":"2026","cit":2,"pfa":"Martin Walter","psa":"Hans Eriksson","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7165796403","eid":"W7165796403"},{"id":"paper-w4207078860","cat":"papers","name":"Experimenter sex modulates mouse biobehavioural and pharmacological responses","year":"2022","cit":2,"pfa":"Polymnia Georgiou","psa":"Todd D. Gould","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4207078860","eid":"W4207078860"},{"id":"paper-w4408977685","cat":"papers","name":"Prophylactic Ketamine: Current Knowledge and Future Directions","year":"2025","cit":2,"pfa":"Astrid M. Cardona-Acosta","psa":"Eric M. Parise","ptype":"article","src":"https://openalex.org/W4408977685","eid":"W4408977685"},{"id":"paper-w4413003949","cat":"papers","name":"Beyond Anesthesia: Ketamine’s Expanding Role in Chronic Pain and Psychiatric Disorders","year":"2025","cit":2,"pfa":"Christopher Zaki","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4413003949","eid":"W4413003949"},{"id":"paper-w4399113713","cat":"papers","name":"Depression: Managing Resistance and Partial Response to Treatment.","year":"2024","cit":2,"pfa":"Heidi L Gaddey","psa":"Amol Naik","topics":["Depression","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4399113713","eid":"W4399113713"},{"id":"paper-w2325159142","cat":"papers","name":"Odds and Ends in Psychopharmacology From the Past 10 Years","year":"2015","cit":2,"pfa":"Robert H. Howland","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2325159142","eid":"W2325159142"},{"id":"paper-w3180227335","cat":"papers","name":"The risk of a blood pressure increase during treatment with selected psychotropic drugs","year":"2022","cit":2,"pfa":"Monika Romańczyk","psa":"Marek Krzystanek","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3180227335","eid":"W3180227335"},{"id":"paper-w4416147337","cat":"papers","name":"Caution Is Warranted in Prescribing Ketamine for Mental Health","year":"2025","cit":2,"pfa":"Katherine Drabiak","ptype":"article","src":"https://openalex.org/W4416147337","eid":"W4416147337"},{"id":"paper-w7123580851","cat":"papers","name":"Current treatment options for perinatal depression","year":"2026","cit":2,"pfa":"Ashley L. Clark","psa":"Alison M. Reminick","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7123580851","eid":"W7123580851"},{"id":"paper-w4323925110","cat":"papers","name":"Playing with a full dex of cards: Treatment resistant depression with suicidality responds to inpatient dextromethorphan therapy","year":"2023","cit":2,"pfa":"Itamar Shapira","psa":"Brandon Scott Pruett","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4323925110","eid":"W4323925110"},{"id":"paper-w4407184492","cat":"papers","name":"Efficacy and safety of S-ketamine in pain management for breast cancer patients undergoing modified radical mastectomy: a meta-analysis of randomized controlled trials","year":"2025","cit":2,"pfa":"Bilal Abu-Hussein","psa":"Ibrahim Gamal","topics":["Anxiety & end-of-life","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4407184492","eid":"W4407184492"},{"id":"paper-w7117293297","cat":"papers","name":"Patients’ Voices on Ketamine for Treatment-Resistant Depression: A Narrative Review of Qualitative Perspectives","year":"2025","cit":2,"pfa":"Michał Walaszek","psa":"Zofia Kachlik","topics":["Depression","Reviews & meta-analyses","Therapy practice"],"ptype":"review","src":"https://openalex.org/W7117293297","eid":"W7117293297"},{"id":"paper-w7133121322","cat":"papers","name":"Progress, potential and pitfalls of ketamine as a treatment for depression","year":"2026","cit":2,"pfa":"Diana K. Orsini","psa":"Joshua Daniel Rosenblat","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7133121322","eid":"W7133121322"},{"id":"paper-w4408579657","cat":"papers","name":"Chiral analysis of ketamine enantiomers in human urine and hair: Application to authentic cases of ketamine use","year":"2025","cit":2,"pfa":"Zhen Zhang","psa":"Xin Wang","ptype":"article","src":"https://openalex.org/W4408579657","eid":"W4408579657"},{"id":"paper-w7124848444","cat":"papers","name":"Next-Step Treatment Options for Treatment-Resistant Depression","year":"2026","cit":2,"pfa":"Matheus G. Marques","psa":"Balwinder Singh","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7124848444","eid":"W7124848444"},{"id":"paper-w4413169119","cat":"papers","name":"Impact of Remimazolam on Postoperative Delirium in Elderly Non-Cardiac Surgery Patients Admitted to the ICU: A Retrospective Propensity Score Matched Study","year":"2025","cit":2,"pfa":"Zeifei Zhu","psa":"Hongwei Wang","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4413169119","eid":"W4413169119"},{"id":"paper-w4405527912","cat":"papers","name":"Treatment Advances in Perinatal Depression: Innovations and Promising Approaches","year":"2024","cit":2,"pfa":"Kathleen A Kendall-Tackett","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4405527912","eid":"W4405527912"},{"id":"paper-w4413403773","cat":"papers","name":"Appetite measures as correlates of clinical response in mood disorders treated with ketamine: systematic review","year":"2025","cit":2,"pfa":"Jakub Słupski","psa":"Wiesław Jerzy Cubała","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W4413403773","eid":"W4413403773"},{"id":"paper-w4389167221","cat":"papers","name":"Individual Prediction of Optimal Treatment Allocation Between Electroconvulsive Therapy or Ketamine using the Personalized Advantage Index","year":"2023","cit":2,"pfa":"Benjamin Wade","psa":"Michael Henry","ptype":"preprint","src":"https://openalex.org/W4389167221","eid":"W4389167221"},{"id":"paper-w4400921181","cat":"papers","name":"Correction: A meta-analysis of the effects of ketamine on suicidal ideation in depression patients","year":"2024","cit":2,"pfa":"ZuoYao Shen","psa":"Weihua Yue","topics":["Depression","Reviews & meta-analyses"],"ptype":"erratum","src":"https://openalex.org/W4400921181","eid":"W4400921181"},{"id":"paper-w4412699687","cat":"papers","name":"Effect of opioid-free anaesthesia on postoperative delirium in elderly patients undergoing gastrointestinal surgery: study protocol for a single-centre, prospective, randomized controlled trial","year":"2025","cit":2,"pfa":"Yuehan Du","psa":"Yongtao Sun","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4412699687","eid":"W4412699687"},{"id":"paper-w4403720970","cat":"papers","name":"S4399 Ketamine-Induced Liver Injury (KILI) From Recreational Use: A Rare Phenomenon","year":"2024","cit":2,"pfa":"Nicole M. Anastasio","psa":"Rishabh Sachdev","topics":["Depression","Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W4403720970","eid":"W4403720970"},{"id":"paper-w4405629282","cat":"papers","name":"Mapping the Use of Ketamine in Treatment-Resistant Depression and Other Psychiatric Disorders: A Scoping Review of Practice Patterns, Efficacy, and Patient Demographic Trends","year":"2024","cit":2,"pfa":"Amna Aslam","psa":"Burton Jared Tabaac","topics":["Depression","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4405629282","eid":"W4405629282"},{"id":"paper-w4386626206","cat":"papers","name":"Using Interventional Pharmacoeconomic Clinical Trials and Outcomes-Based Contracts to Repurpose Generic Drugs with Cost-Savings","year":"2023","cit":2,"pfa":"Savva Kerdemelidis","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"conference-paper","src":"https://openalex.org/W4386626206","eid":"W4386626206"},{"id":"paper-w2901143452","cat":"papers","name":"On Razor's edge: Managing analgosedation during severe anti-NMDA receptor encephalitis","year":"2018","cit":2,"pfa":"Sarah Jesse","psa":"Jan Lewerenz","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2901143452","eid":"W2901143452"},{"id":"paper-w4403185868","cat":"papers","name":"Ketamine reverses chronic stress-induced behavioral changes via Ca 2+ -permeable AMPA receptors in mice","year":"2024","cit":2,"pfa":"Joshua C. Flowers","psa":"Seonil Kim","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W4403185868","eid":"W4403185868"},{"id":"paper-w2215483323","cat":"papers","name":"Purification of Serotonin- and LSD-binding Proteins from Synaptic Membranes","year":"1974","cit":2,"pfa":"E. Mehl","psa":"L. Weber","topics":["Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W2215483323","eid":"W2215483323"},{"id":"paper-w4242041769","cat":"papers","name":"Quasi-atomistic Receptor Surrogates for the 5-HT2A Receptor: A 3D-QSAR Study on Hallucinogenic Substances","year":"1999","cit":2,"pfa":"Meike Schulze‐Alexandru","psa":"Angelo Vedani","topics":["Addiction","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4242041769","eid":"W4242041769"},{"id":"paper-w63477395","cat":"papers","name":"Serotonin Receptor Subtypes: Exploiting their Therapeutic Potential","year":"1995","cit":2,"pfa":"José Manuel Palacios","topics":["Depression","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W63477395","eid":"W63477395"},{"id":"paper-w4383301604","cat":"papers","name":"Addressing the Current Knowledge and Gaps in Research Surrounding Lysergic Acid Diethylamide (LSD), Psilocybin, and Psilocin in Rodent Models","year":"2023","cit":1,"pfa":"Udoka C. Ezeaka","psa":"Robert B. Laprairie","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4383301604","eid":"W4383301604"},{"id":"paper-w4412793773","cat":"papers","name":"Synthesis of Psilocin, Psilocybin and 5‐MeO‐DMT Succinate, All Labelled With Carbon‐14 at the Indole 2‐Position","year":"2025","cit":1,"pfa":"Rodney Brown","psa":"Balasubramaniam Upeandran","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4412793773","eid":"W4412793773"},{"id":"paper-w4233625316","cat":"papers","name":"The Exploration of Naturalistically used Ayahuasca and 5-MeO-DMT","year":"2020","cit":1,"pfa":"Uthaug Malin Vedøy","ptype":"dissertation","src":"https://openalex.org/W4233625316","eid":"W4233625316"},{"id":"paper-w2305287955","cat":"papers","name":"Mescaline and lysergic acid diethylamide: therapeutic implications of the drug-induced state.","year":"1969","cit":1,"pfa":"Herman C.B. Denber","ptype":"article","src":"https://openalex.org/W2305287955","eid":"W2305287955"},{"id":"paper-w4246234634","cat":"papers","name":"Lysergic Acid Diethylamide","year":"1966","cit":1,"pfa":"S. E. Browne","ptype":"article","src":"https://openalex.org/W4246234634","eid":"W4246234634"},{"id":"paper-w2417439189","cat":"papers","name":"[The action of mescaline and lysergic acid diethylamide (LSD-25) on the behavior of the guinea pig].","year":"1969","cit":1,"pfa":"Joseph Sivadjian","ptype":"article","src":"https://openalex.org/W2417439189","eid":"W2417439189"},{"id":"paper-w2970300820","cat":"papers","name":"Lysergic acid diethylamide.","year":"2011","cit":1,"topics":["Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W2970300820","eid":"W2970300820"},{"id":"paper-w1000016935","cat":"papers","name":"Lysergic acid diethylamide (LSD)","year":"2005","cit":1,"pfa":"Shinichi Suzuki","ptype":"book-chapter","src":"https://openalex.org/W1000016935","eid":"W1000016935"},{"id":"paper-w2522570519","cat":"papers","name":"Lysergic acid diethylamide: LSD","year":"2001","cit":1,"pfa":"Raymond Seidler","ptype":"article","src":"https://openalex.org/W2522570519","eid":"W2522570519"},{"id":"paper-w2413036803","cat":"papers","name":"Lysergic acid diethylamide: a review.","year":"1959","cit":1,"pfa":"I D Yalom","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2413036803","eid":"W2413036803"},{"id":"paper-w4361829396","cat":"papers","name":"LSD (lysergic acid diethylamide)","year":"2023","cit":1,"pfa":"Cory C. Howard","psa":"Christine M. Stork","ptype":"reference-entry","src":"https://openalex.org/W4361829396","eid":"W4361829396"},{"id":"paper-w2400946138","cat":"papers","name":"[Inhibition of human serum-pseudocholinesterase by lysergic acid diethylamide and 2-bromo-lysergic acid diethylamide].","year":"1956","cit":1,"pfa":"K. Zehnder","psa":"A Cerletti","ptype":"article","src":"https://openalex.org/W2400946138","eid":"W2400946138"},{"id":"paper-w4214496590","cat":"papers","name":"Current Concepts: Lysergic Acid Diethylamide","year":"1968","cit":1,"pfa":"M E G","ptype":"article","src":"https://openalex.org/W4214496590","eid":"W4214496590"},{"id":"paper-w2493857327","cat":"papers","name":"Lysergic Acid Diethylamide and Mystical Experiences","year":"2016","cit":1,"pfa":"Michael Lyvers","ptype":"book-chapter","src":"https://openalex.org/W2493857327","eid":"W2493857327"},{"id":"paper-w2725305729","cat":"papers","name":"On the relationship between ibogaine and noribogaine","year":"2017","cit":1,"pfa":"Luke Yip","psa":"Jou‐Fang Deng","ptype":"article","src":"https://openalex.org/W2725305729","eid":"W2725305729"},{"id":"paper-w2802138776","cat":"papers","name":"A Case of Fetishism Treated with Lysergic Acid Diethylamide","year":"1960","cit":1,"pfa":"Donald G. Langsley","ptype":"article","src":"https://openalex.org/W2802138776","eid":"W2802138776"},{"id":"paper-w3004231054","cat":"papers","name":"Lysergic Acid Diethylamide (LSD, Entactogen) Toxicity","year":"2020","cit":1,"pfa":"Maximo Baquiran","psa":"Yasir Al Khalili","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3004231054","eid":"W3004231054"},{"id":"paper-w2406513003","cat":"papers","name":"[Studies on the mechanism of lysergic acid diethylamide. I].","year":"1953","cit":1,"pfa":"O H ARNOLD","psa":"H HOFF","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2406513003","eid":"W2406513003"},{"id":"paper-w2273853520","cat":"papers","name":"The fluorometric determination of lysergic acid diethylamide and ergonovine.","year":"1958","cit":1,"pfa":"E S BOYD","ptype":"article","src":"https://openalex.org/W2273853520","eid":"W2273853520"},{"id":"paper-w2795998653","cat":"papers","name":"The pharmacology of d-Lysergic acid diethylamide (LSD)","year":"2017","cit":1,"pfa":"Patrick C. Dolder","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W2795998653","eid":"W2795998653"},{"id":"paper-w3142997366","cat":"papers","name":"[The effect of lysergic acid diethylamide on memory in mice].","year":"1976","cit":1,"pfa":"S R Chaplygina","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"other","src":"https://openalex.org/W3142997366","eid":"W3142997366"},{"id":"paper-w2408994829","cat":"papers","name":"[Model psychoses and lysergic acid diethylamide treatment].","year":"1961","cit":1,"pfa":"E Geert-Jörgensen","ptype":"article","src":"https://openalex.org/W2408994829","eid":"W2408994829"},{"id":"paper-w4361245315","cat":"papers","name":"Lysergic acid diethylamide: In search of the wonder drug","year":"2023","cit":1,"pfa":"Mihai Avram","psa":"Stefan Borgwardt","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"book-chapter","src":"https://openalex.org/W4361245315","eid":"W4361245315"},{"id":"paper-w2405502013","cat":"papers","name":"Lysergic acid diethylamide, chlorpromazine and maze performance.","year":"1970","cit":1,"pfa":"Edward T. Uyeno","ptype":"article","src":"https://openalex.org/W2405502013","eid":"W2405502013"},{"id":"paper-w2790421624","cat":"papers","name":"A Brief Review of Chemistry and Pharmacology of Lysergic Acid Diethylamide","year":"2017","cit":1,"pfa":"Sagar U. Jadhav","psa":"Ajinkya M. Thanekar","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2790421624","eid":"W2790421624"},{"id":"paper-w2991653726","cat":"papers","name":"Erythema Multiforme Major Induced by Lysergic Acid Diethylamide","year":"2019","cit":1,"pfa":"Sik Yeng Chan","psa":"Christine Soon","ptype":"article","src":"https://openalex.org/W2991653726","eid":"W2991653726"},{"id":"paper-w4230327171","cat":"papers","name":"Editorial: Peyote (mescaline) and human chromosomes","year":"1975","cit":1,"pfa":"A. D. Bloom","ptype":"editorial","src":"https://openalex.org/W4230327171","eid":"W4230327171"},{"id":"paper-w2416637842","cat":"papers","name":"Some effects of lysergic acid diethylamide on barbiturate anesthesia.","year":"1957","cit":1,"pfa":"R. M. Burton","psa":"A Goldin","ptype":"article","src":"https://openalex.org/W2416637842","eid":"W2416637842"},{"id":"paper-w2413681883","cat":"papers","name":"The effects of lysergic acid diethylamide II: intraocular pressure.","year":"1965","cit":1,"pfa":"Audrey R. Holliday","psa":"T Sigurdson","ptype":"article","src":"https://openalex.org/W2413681883","eid":"W2413681883"},{"id":"paper-w176588036","cat":"papers","name":"Thin Layer Chromatography of Lysergic Acid Diethylamide (LSD), N,N Dimethyl Tryptamine (DMT), Methylene Dioxyphenyl Isopropylamine (STP), and Ibogaine","year":"1970","cit":1,"pfa":"Bernard Newman","psa":"Arnold Dihrberg","ptype":"article","src":"https://openalex.org/W176588036","eid":"W176588036"},{"id":"paper-w2410275226","cat":"papers","name":"Some CNS electrophysiologic effects of serotonin and lysergic acid diethylamide.","year":"1960","cit":1,"pfa":"Gunn Cg","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2410275226","eid":"W2410275226"},{"id":"paper-w4307851940","cat":"papers","name":"Lysergic Acid Diethylamide Alters the Effects of Brain Stimulation in Rodents","year":"2022","cit":1,"pfa":"Lucas L. Dwiel","psa":"Wilder T. Doucette","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W4307851940","eid":"W4307851940"},{"id":"paper-w3117287842","cat":"papers","name":"Overdose Toxic Effect of Hallucinogenic Drug: Lysergic Acid Diethylamide","year":"2018","cit":1,"pfa":"Rohit Kumar Verma","psa":"Rajeev Kumar","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3117287842","eid":"W3117287842"},{"id":"paper-w943929924","cat":"papers","name":"Studies on Screening Test for Lysergic Acid Diethylamide by Test Paper","year":"1970","cit":1,"pfa":"Tetsukichi Niwaguchi","psa":"Takako Inoue","ptype":"article","src":"https://openalex.org/W943929924","eid":"W943929924"},{"id":"paper-w2532423344","cat":"papers","name":"The metabolic fate of lysergic acid diethylamide (LSD) in laboratory animals","year":"1975","cit":1,"pfa":"Zahid Hussain Siddik","ptype":"dissertation","src":"https://openalex.org/W2532423344","eid":"W2532423344"},{"id":"paper-w2064273720","cat":"papers","name":"Effects of Lysergic Acid Diethylamide on the Nesting Behaviour of Male Pigeons","year":"1963","cit":1,"pfa":"EFREM ROSEN","psa":"Anthony J. Iovino","ptype":"article","src":"https://openalex.org/W2064273720","eid":"W2064273720"},{"id":"paper-w2420705740","cat":"papers","name":"Lysergic acid diethylamide and sexual dominance behavior of the male rat.","year":"1967","cit":1,"pfa":"Edward T. Uyeno","ptype":"article","src":"https://openalex.org/W2420705740","eid":"W2420705740"},{"id":"paper-w2047287170","cat":"papers","name":"Lysergic acid diethylamide (LSD) and tryptamine analogs as potential psychotomimetics","year":"1968","cit":1,"pfa":"Kenneth J. Liska","psa":"Edward D. Purich","ptype":"article","src":"https://openalex.org/W2047287170","eid":"W2047287170"},{"id":"paper-w7208779324","cat":"papers","name":"The role of nutrition in psychedelics clinical trials: Key considerations and recommendations for 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT)","year":"2026","cit":1,"pfa":"Agnieszka Mechlińska","psa":"Wiesław Jerzy Cubała","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7208779324","eid":"W7208779324"},{"id":"paper-w2963327546","cat":"papers","name":"Book Review: Lysergic Acid Diethylamide (LSD) in the Treatment of Alcoholism","year":"1968","cit":1,"pfa":"C. M. B. Pare","topics":["Addiction","Reviews & meta-analyses"],"ptype":"book-review","src":"https://openalex.org/W2963327546","eid":"W2963327546"},{"id":"paper-w2317257373","cat":"papers","name":"Fluorescent Spectra of Lysergic Acid Diethylamide: Observations on a Gastric Extract","year":"1973","cit":1,"pfa":"Rudolph G. Mueller","psa":"Gordon E. Lang","ptype":"article","src":"https://openalex.org/W2317257373","eid":"W2317257373"},{"id":"paper-w3025477244","cat":"papers","name":"Suppression of lysergic acid diethylamide (LSD) effects in pregnant rats.","year":"1972","cit":1,"pfa":"John R. Bergen","ptype":"article","src":"https://openalex.org/W3025477244","eid":"W3025477244"},{"id":"paper-w2413424810","cat":"papers","name":"[Action of lysergic acid diethylamide on the operant conditioning activity of rats].","year":"1965","cit":1,"pfa":"Luigi Molinengo","ptype":"article","src":"https://openalex.org/W2413424810","eid":"W2413424810"},{"id":"paper-w4411164509","cat":"papers","name":"Effect of Liner Properties on the Analysis of Lysergic Acid Diethylamide (LSD) Analogs","year":"2025","cit":1,"pfa":"Sarah A. Shuda","topics":["Addiction"],"ptype":"preprint","src":"https://openalex.org/W4411164509","eid":"W4411164509"},{"id":"paper-w4414401025","cat":"papers","name":"Effect of liner properties on the analysis of lysergic acid diethylamide ( LSD ) analogs","year":"2025","cit":1,"pfa":"Sarah A. Shuda","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4414401025","eid":"W4414401025"},{"id":"paper-w4249047703","cat":"papers","name":"Some Clinical and Social Aspects of Lysergic Acid Diethylamide: Part I","year":"1972","cit":1,"pfa":"David B. Sarwer","ptype":"article","src":"https://openalex.org/W4249047703","eid":"W4249047703"},{"id":"paper-w2414630964","cat":"papers","name":"Antagonism of d-lysergic acid diethylamide and mescaline by 1-methyl-1, 2, 5, 6-tetrahydropyridine-N, N-diethyl-carboxamide (THPC).","year":"1975","cit":1,"pfa":"Dyer Dc","psa":"Morin Rd","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2414630964","eid":"W2414630964"},{"id":"paper-w2340121246","cat":"papers","name":"Immunochemical detection of lysergic acid diethylamide using a photochemically linked immunogen","year":"2009","cit":1,"pfa":"Sarah Kerrigan","topics":["Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W2340121246","eid":"W2340121246"},{"id":"paper-w2431833135","cat":"papers","name":"[Pharmacological influencing of pyrogenic and lysergic acid diethylamide-induced fever in rabbits].","year":"1957","cit":1,"pfa":"E Eichenberger","psa":"B Friolet","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2431833135","eid":"W2431833135"},{"id":"paper-w2415034068","cat":"papers","name":"[Effect of lysergic acid diethylamide (LSD) and urethane on the function of a sympathetic ganglion].","year":"1957","cit":1,"pfa":"H Broghammer","psa":"Heinz Schaefer","ptype":"article","src":"https://openalex.org/W2415034068","eid":"W2415034068"},{"id":"paper-w1998524311","cat":"papers","name":"A Case of Early Paranoiad Psychosis Treated by Lysergic Acid Diethylamide (L.S.D.)","year":"2010","cit":1,"pfa":"A. Joyce Martin","ptype":"article","src":"https://openalex.org/W1998524311","eid":"W1998524311"},{"id":"paper-w2412259398","cat":"papers","name":"[Action of lysergic acid diethylamide (LSD-25) upon conditioning and sweating].","year":"1970","cit":1,"pfa":"Joseph Sivadjian","ptype":"article","src":"https://openalex.org/W2412259398","eid":"W2412259398"},{"id":"paper-w2413669148","cat":"papers","name":"[The effect of lysergic acid diethylamide (LSD) on the rat cortex. A quantitative autoradiographic study].","year":"1977","cit":1,"pfa":"Gatzke Hd","topics":["Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W2413669148","eid":"W2413669148"},{"id":"paper-w2045353932","cat":"papers","name":"THE BLOCKING EFFECT OF BENACTYZINE HYDROCHLORIDE ON A BEHAVIOUR DISTURBANCE INDUCED WITH LYSERGIC ACID DIETHYLAMIDE","year":"1959","cit":1,"pfa":"Peter H. Glow","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2045353932","eid":"W2045353932"},{"id":"paper-w2551773998","cat":"papers","name":"Basics of the medical use of ayahuasca: physiology of dimethyltryptamine.","year":"2018","cit":1,"pfa":"Ede Frecska","psa":"Móré Csaba","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2551773998","eid":"W2551773998"},{"id":"paper-w2992429495","cat":"papers","name":"[Characteristics of the development of model psychosis in rats in intracerebral administration of lysergic acid diethylamide].","year":"1983","cit":1,"pfa":"Krendal' Fp","psa":"A N Kudrin","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2992429495","eid":"W2992429495"},{"id":"paper-w4307860447","cat":"papers","name":"The effect of lysergic acid diethylamide (LSD) on whole-brain functional and effective connectivity","year":"2022","cit":1,"pfa":"Peter Bedford","psa":"Andreea Oliviana Diaconescu","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4307860447","eid":"W4307860447"},{"id":"paper-w4389078476","cat":"papers","name":"From Bwiti to Ibogaine and Back: A Transnational History of Tabernanthe iboga","year":"2023","cit":1,"pfa":"Julien Bonhomme","ptype":"book-chapter","src":"https://openalex.org/W4389078476","eid":"W4389078476"},{"id":"paper-w2029145166","cat":"papers","name":"Effects of Lysergic Acid Diethylamide (LSD) on Cortical Sensory Evoked Potentials in the Cat","year":"1959","cit":1,"pfa":"Th. W. Langfitt","psa":"Louis A. Finney","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2029145166","eid":"W2029145166"},{"id":"paper-w2404328545","cat":"papers","name":"[Experimental psychoses and psychiatric use of lysergic acid diethylamide; review of foreign literature].","year":"1959","cit":1,"pfa":"Banshchikov Vm","psa":"Stoliarov Gv","topics":["Reviews & meta-analyses"],"ptype":"other","src":"https://openalex.org/W2404328545","eid":"W2404328545"},{"id":"paper-w2523230554","cat":"papers","name":"Psilocybin, LSD, Mescaline and drug-induced synesthesia","year":"2016","cit":1,"pfa":"Dimitria Electra Gatzia","psa":"Berit “Brit” Brogaard","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2523230554","eid":"W2523230554"},{"id":"paper-w4376140901","cat":"papers","name":"Lysergic acid diethylamide stimulates cardiac human H 2 histamine receptors","year":"2023","cit":1,"pfa":"Ulrich Gergs","psa":"Joachim Neumann","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4376140901","eid":"W4376140901"},{"id":"paper-w2415610413","cat":"papers","name":"[Experimental action of lysergic acid diethylamide (LSD 25) on the leukocytes of the monkey Papio papio].","year":"1971","cit":1,"pfa":"Jacques Ruffié","psa":"Jean J Grozdea","ptype":"article","src":"https://openalex.org/W2415610413","eid":"W2415610413"},{"id":"paper-w2415178976","cat":"papers","name":"[Further contribution on the pharmacology of D-lysergic acid diethylamide; the effect of LSD on circulatory reflexes].","year":"1958","cit":1,"pfa":"Hans Weidmann","psa":"A Cerletti","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2415178976","eid":"W2415178976"},{"id":"paper-w1978380815","cat":"papers","name":"ASSAY OF LYSERGIC ACID DIETHYLAMIDE AND ITS PASSAGE FROM BLOOD INTO THE PERFUSED CEREBRAL VENTRICLES","year":"1960","cit":1,"pfa":"MIROSLAV DRAŠKOCI","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1978380815","eid":"W1978380815"},{"id":"paper-w2414776371","cat":"papers","name":"[Contribution to the differentiation of the pyretogenic actions of lipopolysaccharide pyrogen & D-lysergic acid diethylamide (LSD)].","year":"1959","cit":1,"pfa":"Hannes Benedikt Stähelin","psa":"Max Taeschler","ptype":"article","src":"https://openalex.org/W2414776371","eid":"W2414776371"},{"id":"paper-w2302160541","cat":"papers","name":"[Effects on the rabbit EEG of chronic or acute poisoning by lysergic acid diethylamide (LSD-25)].","year":"1957","cit":1,"pfa":"R PIERRE","ptype":"article","src":"https://openalex.org/W2302160541","eid":"W2302160541"},{"id":"paper-w2336474382","cat":"papers","name":"Occurrence of psilocybin and psilocin in certain Gonocybe and Psilocybe species.","year":"1962","cit":1,"pfa":"ROBERT G. BENEDICT","psa":"Varro E. Tyler","ptype":"article","src":"https://openalex.org/W2336474382","eid":"W2336474382"},{"id":"paper-w2414887332","cat":"papers","name":"[Dual effect of lysergic acid diethylamide on uterine contractions induced by 5-hydroxytryptamine (serotonin)].","year":"1956","cit":1,"pfa":"J Delay","psa":"J Thuillier","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2414887332","eid":"W2414887332"},{"id":"paper-w2398093020","cat":"papers","name":"Displacement of specific serotonin and lysergic acid diethylamide binding by Ergalgin, a new antiserotonin drug.","year":"1980","cit":1,"pfa":"W Oelszner","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2398093020","eid":"W2398093020"},{"id":"paper-w4414674246","cat":"papers","name":"Neural effects and phenomenology of nondual meditation and 5-MeO-DMT in an expert meditation practitioner","year":"2025","cit":1,"pfa":"Christopher B. Timmermann","psa":"Antoine Lutz","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4414674246","eid":"W4414674246"},{"id":"paper-w1982520479","cat":"papers","name":"Lysergic Acid Diethylamide (LSD 25): XXXXI The Use of LSD as an Adjunct to Psychotherapy: Fact and Fiction","year":"1973","cit":1,"pfa":"Harold A. Abramson","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W1982520479","eid":"W1982520479"},{"id":"paper-w2409594505","cat":"papers","name":"[Square test in determination of concentration of attention in experimental psychosis induced by lysergic acid diethylamide (LSD-25)].","year":"1958","cit":1,"pfa":"E Horácková","psa":"M Vojtĕchovský","ptype":"article","src":"https://openalex.org/W2409594505","eid":"W2409594505"},{"id":"paper-w4229925288","cat":"papers","name":"The influence of D-lysergic acid diethylamide (LSD) on the response properties of cells in the cat lateral geniculate nucleus","year":"1972","cit":1,"ptype":"article","src":"https://openalex.org/W4229925288","eid":"W4229925288"},{"id":"paper-w2170825939","cat":"papers","name":"Polymorphe Modifikationen und Solvate von Psilocin und Psilocybin","year":"1976","cit":1,"pfa":"Maria Kuhnert‐Brandstätter","psa":"Wolfgang Heindl","ptype":"article","src":"https://openalex.org/W2170825939","eid":"W2170825939"},{"id":"paper-w1795584722","cat":"papers","name":"[The effect of lysergic acid diethylamide on the ganglion cells. 1. Working hypothesis and ribonucleic acid bases in the hippocampus].","year":"1967","cit":1,"pfa":"V NEUHOFF","ptype":"article","src":"https://openalex.org/W1795584722","eid":"W1795584722"},{"id":"paper-w2055262130","cat":"papers","name":"Naloxone and propranolol inhibit the disruption of the hippocampal theta waves induced by d-lysergic acid diethylamide in the rabbit","year":"1986","cit":1,"pfa":"E. Ortolani","psa":"Sergio Palazzesi","ptype":"article","src":"https://openalex.org/W2055262130","eid":"W2055262130"},{"id":"paper-w4363672856","cat":"papers","name":"105. Intranasal 5-MeO-DMT: Safety, PK and Effect on Altered States of Consciousness in Healthy Volunteers","year":"2023","cit":1,"pfa":"James Rucker","psa":"Frank Wiegand","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4363672856","eid":"W4363672856"},{"id":"paper-w2745721751","cat":"papers","name":"Ayahuasca characterization, metabolism in humans, and relevance to endogenous N,N-dimethyltryptamines","year":"2012","cit":1,"pfa":"Ethan H. McIlhenny","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W2745721751","eid":"W2745721751"},{"id":"paper-w2401912051","cat":"papers","name":"[[ffects of high doses of d-lysergic acid diethylamide on the respiration, blood circulation and central sympathicus tone of cats].","year":"1968","cit":1,"pfa":"Georg Tauberger","psa":"O R KLIMMER","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2401912051","eid":"W2401912051"},{"id":"paper-w4399441838","cat":"papers","name":"5-MeO-DMT in the complete resolution of the consequences of chronic, severe sexual abuse in early childhood—a retrospective case study","year":"2024","cit":1,"pfa":"Mika Turkia","topics":["PTSD & trauma","Addiction","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4399441838","eid":"W4399441838"},{"id":"paper-w2946624803","cat":"papers","name":"Effects of the hallucinogenic drugs mescaline, phencyclidine and psilocybin on zebrafish behavior and physiology","year":"2012","cit":1,"pfa":"Evan J. Kyzar","psa":"Allan V. Kalueff","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2946624803","eid":"W2946624803"},{"id":"paper-w4415482210","cat":"papers","name":"Reactivations Associated with the Use of 5-MeO-DMT Among Spanish-Speaking Individuals: Prevalence, Predictors, and Emotional Valence","year":"2025","cit":1,"pfa":"Ana María Ortiz Bernal","psa":"Alan K. Davis","ptype":"article","src":"https://openalex.org/W4415482210","eid":"W4415482210"},{"id":"paper-w2419360150","cat":"papers","name":"[The effect of intravenous administration of lysergic acid diethylamide to pregnant rabbits on the concentration of serotonin, histamine and acetylcholine in mother and fetus].","year":"1975","cit":1,"pfa":"Iu M Zhabin","psa":"Urazaeva Zv","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2419360150","eid":"W2419360150"},{"id":"paper-w7131373365","cat":"papers","name":"SSRIs, Psilocybin, MDMA, and Disease Modeling: Strategies to Advance PTSD Treatment","year":"2026","cit":1,"pfa":"Momoko Ishii","psa":"Mark Zervas","topics":["PTSD & trauma","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7131373365","eid":"W7131373365"},{"id":"paper-w7162685456","cat":"papers","name":"Rapid and Sensitive Detection of Psilocybin and Psilocin in Urine by Surface‐Enhanced Raman Spectroscopy","year":"2026","cit":1,"pfa":"Lin Wei","psa":"Yuanyuan Li","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7162685456","eid":"W7162685456"},{"id":"paper-w4379377784","cat":"papers","name":"5-MeO-DMT induces sleep-like LFP spectral signatures in the hippocampus and prefrontal cortex of awake rats","year":"2023","cit":1,"pfa":"Annie da Costa Souza","psa":"Sidarta Tollendal Gomes Ribeiro","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4379377784","eid":"W4379377784"},{"id":"paper-w2460586709","cat":"papers","name":"STUDIES IN THE METABOLISM OF BRAIN PROTEINS. II. EFFECT OF CHLORPROMAZINE AND LYSERGIC ACID DIETHYLAMIDE ON THE TURNOVER RATE OF RAT BRAIN PROTEINS.","year":"1963","cit":1,"pfa":"Piha Rs","psa":"Oja Ss","ptype":"article","src":"https://openalex.org/W2460586709","eid":"W2460586709"},{"id":"paper-w3089863787","cat":"papers","name":"Drugs in therapy. LSD, MDMA, marijuana, psilocybin, designer drugs and its potential in modern medicine.","year":"2020","cit":1,"pfa":"Agata Tadeja","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W3089863787","eid":"W3089863787"},{"id":"paper-w7128030169","cat":"papers","name":"Cardiac Consequences Associated with Psychedelic Use: A Systematic Review of Lysergic Acid Diethylamide, 3,4-Methylenedioxymethamphetamine, and 5-Hydroxytryptamine 2B-Mediated Valvular Heart Disease","year":"2026","cit":1,"pfa":"Tianyi Xu","psa":"Roger S. McIntyre","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7128030169","eid":"W7128030169"},{"id":"paper-w4248384380","cat":"papers","name":"A Single Administration of the Atypical Psychedelic Ibogaine or its Metabolite Noribogaine Induces an Antidepressant-like Effect in Rats","year":"2020","cit":1,"pfa":"Paola María Rodríguez","psa":"Ignacio Carrera","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4248384380","eid":"W4248384380"},{"id":"paper-w4413977795","cat":"papers","name":"A randomised placebo-controlled study of the effects of lysergic acid diethylamide microdosing (15 μg) on pain perception in healthy volunteers","year":"2025","cit":1,"pfa":"Mauro Cavarra","psa":"Johannes Gerardus Ramaekers","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4413977795","eid":"W4413977795"},{"id":"paper-w2279166229","cat":"papers","name":"Iboga (Tabernanthe iboga)","year":"2004","cit":1,"pfa":"T.A. Mahop","psa":"T.C.H. Sunderland","ptype":"article","src":"https://openalex.org/W2279166229","eid":"W2279166229"},{"id":"paper-w2025603836","cat":"papers","name":"Preliminary Studies of the Distribution and Fate of 82 Br-labelled 2-brom-D-Lysergic Acid Diethylamide (BOL) in the Human Body","year":"2008","cit":1,"pfa":"D.A. Kalbhen","psa":"T.W. Sargent","ptype":"article","src":"https://openalex.org/W2025603836","eid":"W2025603836"},{"id":"paper-w1938749845","cat":"papers","name":"PENGARUH LYSERGIC ACID DIETHYLAMIDE YANG TERDAPAT PADA LEM EHA-BOND TERHADAP KUALITAS SPERMATOZOA WISTAR JANTAN (Rattus norvegicus)","year":"2015","cit":1,"pfa":"Alfred Budiono","psa":"Lusiana Satiawati","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1938749845","eid":"W1938749845"},{"id":"paper-w4412784617","cat":"papers","name":"In vitro metabolic fate of 1-[3-(trimethylsilyl)propanoyl] lysergic acid diethylamide (1S-LSD), a silicon-containing LSD analog","year":"2025","cit":1,"pfa":"Yuki Azuma","psa":"Takahiro Doi","ptype":"article","src":"https://openalex.org/W4412784617","eid":"W4412784617"},{"id":"paper-w4412098269","cat":"papers","name":"Effects of Psilocin and Psilocybin on Human 5-HT4 Serotonin and H2 Histamine Receptors in Perfused Hearts of Transgenic Mice","year":"2025","cit":1,"pfa":"Pauline Braekow","psa":"Ulrich Gergs","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4412098269","eid":"W4412098269"},{"id":"paper-w2313364157","cat":"papers","name":"Lysergic Acid Diethylamide (LSD-25) and Gamma Amino Butyric Acid (GABA) Interaction on Spontaneous Potentials and the Evoked Response in the Avian Tectum","year":"1973","cit":1,"pfa":"Norman W. Scholes","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2313364157","eid":"W2313364157"},{"id":"paper-w7169528335","cat":"papers","name":"Interoceptive effects of N1-substituted lysergamides in rats: Role of agonist affinity at 5-hydroxytryptamine receptors and in vivo metabolism to lysergic acid diethylamide","year":"2026","cit":1,"pfa":"Michael D. Berquist","psa":"William E. Fantegrossi","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7169528335","eid":"W7169528335"},{"id":"paper-w4400508380","cat":"papers","name":"Author Correction: 5-MeO-DMT induces sleep-like LFP spectral signatures in the hippocampus and prefrontal cortex of awake rats","year":"2024","cit":1,"pfa":"Annie C. Souza","psa":"Sidarta Tollendal Gomes Ribeiro","topics":["Mechanism & neuroscience"],"ptype":"erratum","src":"https://openalex.org/W4400508380","eid":"W4400508380"},{"id":"paper-w7128674161","cat":"papers","name":"Attitudes and perceptions of Portuguese mental health professionals on the therapeutic use of psilocybin and methylenedioxymethamphetamine (MDMA).","year":"2026","cit":1,"pfa":"Jorge Encantado","psa":"Pedro J. Teixeira","ptype":"article","src":"https://openalex.org/W7128674161","eid":"W7128674161"},{"id":"paper-w2417621506","cat":"papers","name":"[Comparative study of the psychopathological effects of lysergic acid ethylamide, (L. A. E. 32) & lysergic acid diethylamide, (L. S. D. 25) in neurotics].","year":"2000","cit":1,"pfa":"Franco Giberti","psa":"Gregoretti","ptype":"article","src":"https://openalex.org/W2417621506","eid":"W2417621506"},{"id":"paper-w4283792050","cat":"papers","name":"The Neuroimaging Documentation of Psychedelic Drugs’ Effect on the Brain: dmt, lsd, Psilocybin, and Ibogaine as Examples: A Mini Review","year":"2022","cit":1,"pfa":"Abdulwahab F Alahmari","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4283792050","eid":"W4283792050"},{"id":"paper-w2087500592","cat":"papers","name":"Light chain peptide secreted by rabbit antibody producing and murine MOPC 315 myeloma cells in the presence of d-lysergic acid diethylamide (LSD)","year":"1975","cit":1,"pfa":"Edward W. Voss","psa":"Nancy E. Cobb","ptype":"article","src":"https://openalex.org/W2087500592","eid":"W2087500592"},{"id":"paper-w4200030895","cat":"papers","name":"P.0294 Lysergic acid diethylamide acutely reduces intermittent ethanol intake without observable effects on sucrose consumption of intracranial stimulation reward in mice","year":"2021","cit":1,"pfa":"Lauri V. Elsilä","psa":"Esa R. Korpi","ptype":"article","src":"https://openalex.org/W4200030895","eid":"W4200030895"},{"id":"paper-w4242689983","cat":"papers","name":"Iboga Root. (Tabernanthe Iboga, Baill.)","year":"1895","cit":1,"ptype":"article","src":"https://openalex.org/W4242689983","eid":"W4242689983"},{"id":"paper-w7134115639","cat":"papers","name":"Beyond the toad's kiss: Mapping acute 5-MeO-DMT effects on brain connectivity across sex and dose using awake rat neuroimaging","year":"2026","cit":1,"pfa":"Noah Cavallaro","psa":"Craig F. Ferris","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7134115639","eid":"W7134115639"},{"id":"paper-w4385332854","cat":"papers","name":"Noribogaine effects on wakefulness and sleep","year":"2023","cit":1,"pfa":"Juan Pedro Castro‐Nin","psa":"Joaqúın González","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4385332854","eid":"W4385332854"},{"id":"paper-w4290970327","cat":"papers","name":"MESCALINE.","year":"1963","cit":1,"pfa":"N NEFF","psa":"George V. Rossi","ptype":"article","src":"https://openalex.org/W4290970327","eid":"W4290970327"},{"id":"paper-w4413453224","cat":"papers","name":"Development of a physiologically based pharmacokinetic model of N,N-dimethyltryptamine, harmine, and their interactions from ayahuasca in rats and humans","year":"2025","cit":1,"pfa":"Naphat Wittayakarn","psa":"Manupat Lohitnavy","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4413453224","eid":"W4413453224"},{"id":"paper-w4317241495","cat":"papers","name":"Direct Quantitation of Psilocybin and Psilocin by One-Dimensional 1H and 31P qNMR in a revived Greek specimen of Psilocybe cyanescens","year":"2022","cit":1,"pfa":"Prokopios Magiatis","psa":"Zacharoula Gonou‐Zagou","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4317241495","eid":"W4317241495"},{"id":"paper-w1965006104","cat":"papers","name":"N-(Hydroxymethyl)ibogaine","year":"2008","cit":1,"pfa":"Raoudha Mezghani Jarraya","psa":"Mohamed Damak","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1965006104","eid":"W1965006104"},{"id":"paper-w4361245253","cat":"papers","name":"Ibogaine: Ibogaine therapy as a method of care treatment for opioid dependence","year":"2023","cit":1,"pfa":"Deborah C. Mash","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W4361245253","eid":"W4361245253"},{"id":"paper-w2485897613","cat":"papers","name":"The Mescaline Psychosis: I. Pharmacological Aspects of Mescaline.","year":"1958","cit":1,"pfa":"Wolfram Block","topics":["Dosing & pharmacology"],"ptype":"conference-paper","src":"https://openalex.org/W2485897613","eid":"W2485897613"},{"id":"paper-w2768431969","cat":"papers","name":"Peyote and Peyotism","year":"1986","cit":1,"pfa":"Brian P. Akers","ptype":"article","src":"https://openalex.org/W2768431969","eid":"W2768431969"},{"id":"paper-w7117570900","cat":"papers","name":"Distinguishing 4- vs 5-Hydroxy- N , N -Dimethyltryptamine (Psilocin vs Bufotenine) Using Hydrogen–Deuterium Back-Exchange","year":"2025","cit":1,"pfa":"Michael W. Christopher","psa":"Timothy J. Garrett","ptype":"article","src":"https://openalex.org/W7117570900","eid":"W7117570900"},{"id":"paper-w3087343135","cat":"papers","name":"Chlorpromazine and mescaline.","year":"1956","cit":1,"pfa":"Herman C.B. Denber","ptype":"article","src":"https://openalex.org/W3087343135","eid":"W3087343135"},{"id":"paper-w4322587278","cat":"papers","name":"The Peyote Effect","year":"2019","cit":1,"pfa":"Alexander Dawson","topics":["Policy & ethics"],"ptype":"book","src":"https://openalex.org/W4322587278","eid":"W4322587278"},{"id":"paper-w1975140267","cat":"papers","name":"S.26.02 MDMA facilitated treatment of PTSD","year":"2007","cit":1,"pfa":"Michael C. Mithoefer","topics":["PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W1975140267","eid":"W1975140267"},{"id":"paper-w2416502345","cat":"papers","name":"[The effect of alkaloids from Tabernanthe iboga H. Bn. on the response of isolated organs to catecholamines and the possible role of calcium exchange. Case of Ibogaine].","year":"1977","cit":1,"pfa":"G Valette","psa":"Leclair Mf","ptype":"other","src":"https://openalex.org/W2416502345","eid":"W2416502345"},{"id":"paper-w4236902352","cat":"papers","name":"The Peyote Cult","year":"1952","cit":1,"pfa":"John Collier","ptype":"article","src":"https://openalex.org/W4236902352","eid":"W4236902352"},{"id":"paper-w3108648059","cat":"papers","name":"P.227 Psilocybin induces resting-state functional connectivity changes, which correlate with plasma psilocin levels and psychedelic experience","year":"2020","cit":1,"pfa":"Martin Korsbak Madsen","psa":"Patrick M. Fisher","ptype":"article","src":"https://openalex.org/W3108648059","eid":"W3108648059"},{"id":"paper-w4245979586","cat":"papers","name":"Peyote Ceremony","year":"2013","cit":1,"pfa":"Richard W. Voss","psa":"Robert Prue","ptype":"reference-entry","src":"https://openalex.org/W4245979586","eid":"W4245979586"},{"id":"paper-w7127452089","cat":"papers","name":"MDMA and Psilocybin Regulate Oligodendrocyte-Lineage Cell Numbers and Anxiety-Like Behaviors in a Rat Model of Fear","year":"2026","cit":1,"pfa":"Mehmet Bostancıklıoğlu","psa":"Ebru Temiz","topics":["Anxiety & end-of-life","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7127452089","eid":"W7127452089"},{"id":"paper-w2411265255","cat":"papers","name":"The pharmacology of peyote.","year":"1959","cit":1,"pfa":"F E KELSEY","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2411265255","eid":"W2411265255"},{"id":"paper-w4361245264","cat":"papers","name":"Psilocybin","year":"2023","cit":1,"pfa":"James Rucker","psa":"David Erritzøe","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W4361245264","eid":"W4361245264"},{"id":"paper-w7164759173","cat":"papers","name":"Genome-based optimization of psilocybin and N,N-dimethyltryptamine biosynthetic pathways in E. coli using CRISPR-associated transposases","year":"2026","cit":1,"pfa":"Zachary N Abrahms","psa":"J. Andrew Jones","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W7164759173","eid":"W7164759173"},{"id":"paper-w2742185519","cat":"papers","name":"Peyote — the divine cactus","year":"1981","cit":1,"pfa":"Richard Evans Schultes","ptype":"book-review","src":"https://openalex.org/W2742185519","eid":"W2742185519"},{"id":"paper-w857685142","cat":"papers","name":"A Note on Cheyenne Peyote","year":"1938","cit":1,"pfa":"John M. Goggin","ptype":"article","src":"https://openalex.org/W857685142","eid":"W857685142"},{"id":"paper-w2484938925","cat":"papers","name":"The Mescaline Psychosis: II. Clinical Considerations of the Mescaline-Induced State.","year":"1958","cit":1,"pfa":"Herman C.B. Denber","ptype":"conference-paper","src":"https://openalex.org/W2484938925","eid":"W2484938925"},{"id":"paper-w4399976871","cat":"papers","name":"On the quest for mescaline","year":"2024","cit":1,"pfa":"Francesco Zamberlan","ptype":"article","src":"https://openalex.org/W4399976871","eid":"W4399976871"},{"id":"paper-w4391617318","cat":"papers","name":"Ibogaine therapy in TBI","year":"2024","cit":1,"pfa":"Leonie Welberg","ptype":"article","src":"https://openalex.org/W4391617318","eid":"W4391617318"},{"id":"paper-w2322560516","cat":"papers","name":"Peyote religion — A history","year":"1989","cit":1,"pfa":"Richard Evans Schultes","ptype":"book-review","src":"https://openalex.org/W2322560516","eid":"W2322560516"},{"id":"paper-w2422995822","cat":"papers","name":"Studies with mescaline.","year":"1964","cit":1,"pfa":"Herman C.B. Denber","ptype":"article","src":"https://openalex.org/W2422995822","eid":"W2422995822"},{"id":"paper-w2087871723","cat":"papers","name":"Drugs of Hallucination: The Uses and Misuses of Lysergic Acid Diethylamide. By Sidney Cohen. Foreword by John Rowan Wilson. London: Martin Secker & Warburg. 1965. Pp. 268. Price 30s.","year":"1966","cit":1,"pfa":"Jacqui T.C. Robinson","ptype":"article","src":"https://openalex.org/W2087871723","eid":"W2087871723"},{"id":"paper-w7163126953","cat":"papers","name":"Thirty Years of Ibogaine Research","year":"2026","cit":1,"pfa":"Ewen Kervadec","psa":"Bruno Roméo","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7163126953","eid":"W7163126953"},{"id":"paper-w4243591231","cat":"papers","name":"Psilocybin","year":"2015","cit":1,"ptype":"book-chapter","src":"https://openalex.org/W4243591231","eid":"W4243591231"},{"id":"paper-w1966899268","cat":"papers","name":"Behavioral disinhibition by mescaline","year":"1976","cit":1,"pfa":"Brooks Carder","psa":"Rosalie Shall-Way Cheng","ptype":"article","src":"https://openalex.org/W1966899268","eid":"W1966899268"},{"id":"paper-w2314751204","cat":"papers","name":"Mescaline, Madness and Mysticism","year":"1967","cit":1,"pfa":"Albert S. Moraczewski","ptype":"article","src":"https://openalex.org/W2314751204","eid":"W2314751204"},{"id":"paper-w7212114860","cat":"papers","name":"Psilocybin","year":"2026","cit":1,"pfa":"Joshua Daniel Rosenblat","psa":"M. Ishrat Husain","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7212114860","eid":"W7212114860"},{"id":"paper-w1997878971","cat":"papers","name":"Peyote Is Not a Drug of Addiction","year":"1960","cit":1,"pfa":"David W. Maurer","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1997878971","eid":"W1997878971"},{"id":"paper-w4287514936","cat":"papers","name":"Ayahuasca on Trial","year":"2022","cit":1,"pfa":"Sara V. Press","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4287514936","eid":"W4287514936"},{"id":"paper-w2091988537","cat":"papers","name":"Effects by Ibogaine on the Dopamine Transporter","year":"2011","cit":1,"pfa":"Walter Sandtner","psa":"Harald H. Sitte","ptype":"article","src":"https://openalex.org/W2091988537","eid":"W2091988537"},{"id":"paper-w4401695832","cat":"papers","name":"Plant drugs: Transcending the mescaline biosynthesis","year":"2024","cit":1,"pfa":"Vincent Courdavault","psa":"Nicolas Papon","ptype":"article","src":"https://openalex.org/W4401695832","eid":"W4401695832"},{"id":"paper-w7117974624","cat":"papers","name":"Ayahuasca and ‘Shamanism’","year":"2025","cit":1,"pfa":"Richard G. Alexander","ptype":"book-chapter","src":"https://openalex.org/W7117974624","eid":"W7117974624"},{"id":"paper-w2943388424","cat":"papers","name":"100 years of mescaline","year":"2019","cit":1,"pfa":"Mike Jay","ptype":"article","src":"https://openalex.org/W2943388424","eid":"W2943388424"},{"id":"paper-w4312977390","cat":"papers","name":"Salvinorin A for Stroke Rescue Purposes","year":"2022","cit":1,"pfa":"Grothusen John","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4312977390","eid":"W4312977390"},{"id":"paper-w4248963816","cat":"papers","name":"MDMA","year":"2017","cit":1,"pfa":"Leo Hermle","psa":"Felix Schuldt","ptype":"book-chapter","src":"https://openalex.org/W4248963816","eid":"W4248963816"},{"id":"paper-w2437301874","cat":"papers","name":"[Injurious effects of mescaline].","year":"1954","cit":1,"pfa":"Hildebrand Teirich","ptype":"article","src":"https://openalex.org/W2437301874","eid":"W2437301874"},{"id":"paper-w7162668019","cat":"papers","name":"Blinding integrity in psychedelic research: Evidence from a comparative randomized controlled trial of psilocybin, MDMA, and methylphenidate in healthy volunteers","year":"2026","cit":1,"pfa":"L. Belinger","psa":"K.H. Preller","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7162668019","eid":"W7162668019"},{"id":"paper-w611889393","cat":"papers","name":"Ayahuasca and Globalization","year":"2011","cit":1,"pfa":"Jesse Hudson","topics":["Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W611889393","eid":"W611889393"},{"id":"paper-w2328391951","cat":"papers","name":"Ponca Peyote Songs","year":"1974","cit":1,"pfa":"Sandra Beloff","psa":"Tony Isaacs","ptype":"article","src":"https://openalex.org/W2328391951","eid":"W2328391951"},{"id":"paper-w400035557","cat":"papers","name":"Ayahuasca and shamanism","year":"2002","cit":1,"pfa":"Michael Taussig","psa":"Peter Lamborn Wilson","ptype":"book","src":"https://openalex.org/W400035557","eid":"W400035557"},{"id":"paper-w2416316836","cat":"papers","name":"[Oscillopolarographic behavior of mescaline].","year":"1956","cit":1,"pfa":"D Kaláb","ptype":"article","src":"https://openalex.org/W2416316836","eid":"W2416316836"},{"id":"paper-w2479750663","cat":"papers","name":"Peyote Way Church of God","year":"2005","cit":1,"pfa":"Bernadette. Rigal-Collard","ptype":"book","src":"https://openalex.org/W2479750663","eid":"W2479750663"},{"id":"paper-w2393318122","cat":"papers","name":"Treatment of heroin dependence with ibogaine","year":"2016","cit":1,"pfa":"Arnt Schellekens","psa":"Maarten Belgers","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2393318122","eid":"W2393318122"},{"id":"paper-w1973841185","cat":"papers","name":"Confirmation of the NMR assignments of salvinorin A","year":"2007","cit":1,"pfa":"Thomas Anthony Munro","ptype":"article","src":"https://openalex.org/W1973841185","eid":"W1973841185"},{"id":"paper-w4319315555","cat":"papers","name":"Transpersonal Intersubjectivity in Ibogaine Experiences: Three cases","year":"2023","cit":1,"pfa":"Jonathan E. Dickinson","ptype":"article","src":"https://openalex.org/W4319315555","eid":"W4319315555"},{"id":"paper-w3109167753","cat":"papers","name":"Persistent Tinnitus after Inhaled N,N-dimethyltryptamine (DMT)","year":"2020","cit":1,"pfa":"Heba Diab","psa":"Benjamin Malcolm","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3109167753","eid":"W3109167753"},{"id":"paper-w2058197524","cat":"papers","name":"Crystal data for some mescaline salts","year":"1974","cit":1,"pfa":"Stephen R. Ernst","psa":"F. William Cagle","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2058197524","eid":"W2058197524"},{"id":"paper-w585745139","cat":"papers","name":"The peyote ritual : visions and descriptions","year":"1957","cit":1,"pfa":"Monroe Tsatoke","ptype":"book","src":"https://openalex.org/W585745139","eid":"W585745139"},{"id":"paper-w2409216208","cat":"papers","name":"Synthesis of iboga alkaloids and related compounds.","year":"1969","cit":1,"pfa":"Augustine Rl","ptype":"article","src":"https://openalex.org/W2409216208","eid":"W2409216208"},{"id":"paper-w4245625216","cat":"papers","name":"Psilocybin for depression","year":"2015","cit":1,"pfa":"Robin Lester Carhart-Harris","topics":["Depression"],"ptype":"dataset","src":"https://openalex.org/W4245625216","eid":"W4245625216"},{"id":"paper-w4297872378","cat":"papers","name":"Psilocybin as a healer","year":"2022","cit":1,"pfa":"Kavita Golia","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4297872378","eid":"W4297872378"},{"id":"paper-w1479861617","cat":"papers","name":"Validation of an ultra performance liquid chromatography tandem mass spectrometry (UPLC™/MS/MS) method for forensic toxicological analysis : confirmation and quantitation of lysergic acid diethylamide (LSD) and its conge","year":"2006","cit":1,"pfa":"Angela Chung","topics":["Addiction"],"ptype":"dissertation","src":"https://openalex.org/W1479861617","eid":"W1479861617"},{"id":"paper-w4255993148","cat":"papers","name":"A note concerning the numbering of iboga alkaloids","year":"2001","cit":1,"ptype":"book-chapter","src":"https://openalex.org/W4255993148","eid":"W4255993148"},{"id":"paper-w2930392998","cat":"papers","name":"MDMA and Ecstasy","year":"2002","cit":1,"pfa":"Gerald Valentine","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W2930392998","eid":"W2930392998"},{"id":"paper-w4322495974","cat":"papers","name":"Ayahuasca and Freedom of Religion in Australia","year":"2023","cit":1,"pfa":"Amar Dhall","psa":"Manav Satija","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"book-chapter","src":"https://openalex.org/W4322495974","eid":"W4322495974"},{"id":"paper-w2050255385","cat":"papers","name":"Mescaline: Apotheosis of ‘The devil’s root’","year":"1955","cit":1,"pfa":"John Pearson","psa":"Kenneth Dewhurst","ptype":"article","src":"https://openalex.org/W2050255385","eid":"W2050255385"},{"id":"paper-w2315862938","cat":"papers","name":"An Oto-Omaha Peyote Ritual","year":"1956","cit":1,"pfa":"James H. Howard","ptype":"article","src":"https://openalex.org/W2315862938","eid":"W2315862938"},{"id":"paper-w1988400555","cat":"papers","name":"Peyote and the Arizona Court Decision","year":"1961","cit":1,"pfa":"Omer C. Stewart","psa":"Bernard E. Gorton","ptype":"article","src":"https://openalex.org/W1988400555","eid":"W1988400555"},{"id":"paper-w7212188604","cat":"papers","name":"What Is Psilocybin?","year":"2026","cit":1,"pfa":"Kristin L. Walter","ptype":"article","src":"https://openalex.org/W7212188604","eid":"W7212188604"},{"id":"paper-w2604781830","cat":"papers","name":"Intoxicación por ayahuasca","year":"2017","cit":1,"pfa":"RAFAEL GUIMARÃES DOS SANTOS","psa":"Jaime E. C. Hallak","ptype":"article","src":"https://openalex.org/W2604781830","eid":"W2604781830"},{"id":"paper-w1027911095","cat":"papers","name":"Analysis of psilocin in Polish hallucinogenic mushrooms","year":"1998","cit":1,"pfa":"Mansi Kala","psa":"Roman Stanaszek","ptype":"article","src":"https://openalex.org/W1027911095","eid":"W1027911095"},{"id":"paper-w2895496663","cat":"papers","name":"Ibogaine: History, Pharmacology, Spirituality, & Clinical Data","year":"2018","cit":1,"pfa":"Benjamin Shapiro","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W2895496663","eid":"W2895496663"},{"id":"paper-w1982090824","cat":"papers","name":"Peyote Use: A Case Report","year":"1972","cit":1,"pfa":"Morton L. Wadsworth","ptype":"article","src":"https://openalex.org/W1982090824","eid":"W1982090824"},{"id":"paper-w2957423022","cat":"papers","name":"La cultura del peyote","year":"2018","cit":1,"pfa":"Luis Gerardo Bernal Guzmán","ptype":"article","src":"https://openalex.org/W2957423022","eid":"W2957423022"},{"id":"paper-w4412100010","cat":"papers","name":"The Medial Prefrontal Cortex Modulates Psychedelic-like Effects of Psilocin","year":"2025","cit":1,"pfa":"Miyuan Zhang","psa":"Xiaohui Wang","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4412100010","eid":"W4412100010"},{"id":"paper-w4280488840","cat":"papers","name":"The role of extracellular serotonin and MDMA in the sensitizing effects of MDMA","year":"2022","cit":1,"pfa":"Ross van de Wetering","psa":"Susan Schenk","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4280488840","eid":"W4280488840"},{"id":"paper-w3023940490","cat":"papers","name":"The paradox of iboga: intoxication by a natural detoxification remedy.","year":"2019","cit":1,"pfa":"José-Manuel Matamoros-Castillo","psa":"Lorenzo Livianos‐Aldana","ptype":"article","src":"https://openalex.org/W3023940490","eid":"W3023940490"},{"id":"paper-w58659136","cat":"papers","name":"Ecstasy/MDMA","year":"2013","cit":1,"pfa":"Danielle E. Ramo","psa":"Jeffrey T. Parsons","ptype":"book-chapter","src":"https://openalex.org/W58659136","eid":"W58659136"},{"id":"paper-w4405678445","cat":"papers","name":"ALSUntangled #77: Psilocybin","year":"2024","cit":1,"pfa":"Bhavya Bakshi","psa":"Richard Stanley Bedlack","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4405678445","eid":"W4405678445"},{"id":"paper-w2413392192","cat":"papers","name":"Mescaline and homoveratrylamine as discriminative stimuli in rats.","year":"1975","cit":1,"pfa":"O F Bueno","ptype":"article","src":"https://openalex.org/W2413392192","eid":"W2413392192"},{"id":"paper-w4411530230","cat":"papers","name":"Wixárika Mara’akate: Healing with the Powers of Peyote","year":"2025","cit":1,"pfa":"Stacy B. Schaefer","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W4411530230","eid":"W4411530230"},{"id":"paper-w4404852047","cat":"papers","name":"Hair analysis to document ayahuasca consumption by LC-MS/MS","year":"2024","cit":1,"pfa":"Nadia Arbouche","psa":"Pascal Kintz","ptype":"article","src":"https://openalex.org/W4404852047","eid":"W4404852047"},{"id":"paper-w2031781055","cat":"papers","name":"Peyote—the divine plant of certain Indian tribes","year":"1933","cit":1,"pfa":"John Thomas Lloyd","ptype":"article","src":"https://openalex.org/W2031781055","eid":"W2031781055"},{"id":"paper-w2051346345","cat":"papers","name":"Binding of Mescaline with Subcellular Fractions upon Incubation of Brain Cortex Slices with [ 14 C] Mescaline","year":"2008","cit":1,"pfa":"R. K. Datta","psa":"J. J. Ghosh","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2051346345","eid":"W2051346345"},{"id":"paper-w2034369837","cat":"papers","name":"H-D Exchange of Psilocin and Its Analogs","year":"1999","cit":1,"pfa":"Haruhisa Shirahama","psa":"Kimiko Hashimoto","ptype":"article","src":"https://openalex.org/W2034369837","eid":"W2034369837"},{"id":"paper-w1978578403","cat":"papers","name":"Unusual hemiacetal structure derived from Salvinorin A","year":"2008","cit":1,"pfa":"Paulo Batista de Carvalho","psa":"Mitchell A. Avery","ptype":"article","src":"https://openalex.org/W1978578403","eid":"W1978578403"},{"id":"paper-w2086832371","cat":"papers","name":"Voget's Review of The Peyote Religion: A Comment","year":"1969","cit":1,"pfa":"Joseph G. Jorgensen","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2086832371","eid":"W2086832371"},{"id":"paper-w4413107582","cat":"papers","name":"Noribogaine altered intrinsic properties of thalamocortical neurons in a sex-dependent manner","year":"2025","cit":1,"pfa":"Sofía Villalba","psa":"Verónica Bisagno","ptype":"article","src":"https://openalex.org/W4413107582","eid":"W4413107582"},{"id":"paper-w4387211134","cat":"papers","name":"Ibogaine as a Treatment For Alcohol Use Disorder: a Preclinical Investigation","year":"2023","cit":1,"pfa":"Sarah Falkenhaug","topics":["Addiction","Dosing & pharmacology","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W4387211134","eid":"W4387211134"},{"id":"paper-w4213221063","cat":"papers","name":"Hallucinations of Neutrality in the Oregon Peyote Case","year":"1991","cit":1,"pfa":"Harry F. Tepker","ptype":"article","src":"https://openalex.org/W4213221063","eid":"W4213221063"},{"id":"paper-w1541007787","cat":"papers","name":"Chapter 4 The Iboga and Voacanga Alkaloids","year":"1968","cit":1,"pfa":"W. I. Taylor","ptype":"book-chapter","src":"https://openalex.org/W1541007787","eid":"W1541007787"},{"id":"paper-w4307276612","cat":"papers","name":"Acute Mescaline Intoxication Followed by Catatonia","year":"2022","cit":1,"pfa":"Din Duraković","psa":"Dalibor Karlović","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4307276612","eid":"W4307276612"},{"id":"paper-w2465602408","cat":"papers","name":"[Psilocybin, a new hallucinogen].","year":"1960","cit":1,"pfa":"Jiri Roubicek","psa":"S Drvota","ptype":"article","src":"https://openalex.org/W2465602408","eid":"W2465602408"},{"id":"paper-w4382701324","cat":"papers","name":"Psilocybin (Magic Mushrooms)","year":"2023","cit":1,"pfa":"Neha Singh","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4382701324","eid":"W4382701324"},{"id":"paper-w2183334665","cat":"papers","name":"Ayahuasca: From Ethnobotany to Pharmacology","year":"2012","cit":1,"pfa":"José Guilherme","psa":"Sudhanshu Tiwari","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2183334665","eid":"W2183334665"},{"id":"paper-w2064614132","cat":"papers","name":"Peyote, the Narcotic Mescal Button of the Indians","year":"1922","cit":1,"pfa":"William Edwin Safford","ptype":"article","src":"https://openalex.org/W2064614132","eid":"W2064614132"},{"id":"paper-w4387448101","cat":"papers","name":"The Introduction of Peyote into Pharmaceutical and Pharmacological Frameworks","year":"2023","cit":1,"pfa":"Mary Magnuson","psa":"Lucas Richert","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4387448101","eid":"W4387448101"},{"id":"paper-w2435547312","cat":"papers","name":"[Elimination of N,N-dimethyltryptamine by urine].","year":"1993","cit":1,"pfa":"N Spatz","psa":"F Brengio","ptype":"other","src":"https://openalex.org/W2435547312","eid":"W2435547312"},{"id":"paper-w2331777477","cat":"papers","name":"Cardiac Arrest after Ibogaine Ingestion","year":"2013","cit":1,"pfa":"L. Vlaanderen","ptype":"article","src":"https://openalex.org/W2331777477","eid":"W2331777477"},{"id":"paper-w1531413447","cat":"papers","name":"Neuer Zugang zu den Iboga-Alkaloiden","year":"1999","cit":1,"pfa":"Christine Frauenfelder","ptype":"dissertation","src":"https://openalex.org/W1531413447","eid":"W1531413447"},{"id":"paper-w2002739267","cat":"papers","name":"People of the Peyote: Huichol Indian History, Religion, and Survival:People of the Peyote: Huichol Indian History, Religion, and Survival.","year":"1997","cit":1,"pfa":"Maury Hutcheson","ptype":"article","src":"https://openalex.org/W2002739267","eid":"W2002739267"},{"id":"paper-w2089172118","cat":"papers","name":"Ayahuasca ‐ Liane der Geister","year":"1985","cit":1,"pfa":"Dagmar Eigner","psa":"Dieter Scholz","ptype":"article","src":"https://openalex.org/W2089172118","eid":"W2089172118"},{"id":"paper-w188296719","cat":"papers","name":"PSILOCYBIN AND SPIRITUAL EXPERIENCE","year":"2009","cit":1,"pfa":"Kevin Sean Bunch","psa":"Kevin Sean Bunch","ptype":"article","src":"https://openalex.org/W188296719","eid":"W188296719"},{"id":"paper-w2415589703","cat":"papers","name":"[Ibogaine--the substance for treatment of toxicomania. Neurochemical and pharmacological action].","year":"2004","cit":1,"pfa":"Saulius Kazlauskas","psa":"Audrius Sveikata","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2415589703","eid":"W2415589703"},{"id":"paper-w2767733316","cat":"papers","name":"The MDMA-neurotoxicity controversy","year":"1992","cit":1,"pfa":"RN Walsh","psa":"Mitchell B. Liester","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2767733316","eid":"W2767733316"},{"id":"paper-w4225399213","cat":"papers","name":"Receptor binding profiles and behavioral effects of psilocybin analogs","year":"2022","cit":1,"pfa":"Grant C. Glatfelter","psa":"Michael H. Baumann","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4225399213","eid":"W4225399213"},{"id":"paper-w1032106296","cat":"papers","name":"Noribogaine is a Mixed Agonist/Antagonist Opioid Ligand with Profound Functional Selectivity","year":"2015","cit":1,"pfa":"Émeline L. Maillet","psa":"Deborah C. Mash","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1032106296","eid":"W1032106296"},{"id":"paper-w191867349","cat":"papers","name":"Historia del MDMA","year":"2001","cit":1,"pfa":"Gaspar Fraga","ptype":"article","src":"https://openalex.org/W191867349","eid":"W191867349"},{"id":"paper-w2103271377","cat":"papers","name":"Methaemoglobinemia Induced by MDMA?","year":"2011","cit":1,"pfa":"Liese Lieve Willemien Verhaert","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2103271377","eid":"W2103271377"},{"id":"paper-w2416191683","cat":"papers","name":"[Mescaline in mental patients; clinical verifications].","year":"1956","cit":1,"pfa":"Jean-Christian Delay","psa":"M ROPERT","ptype":"article","src":"https://openalex.org/W2416191683","eid":"W2416191683"},{"id":"paper-w3004787526","cat":"papers","name":"Phenomenological analysis of experiences of ayahuasca","year":"2020","cit":1,"pfa":"Tom John Wolff","ptype":"book-chapter","src":"https://openalex.org/W3004787526","eid":"W3004787526"},{"id":"paper-w3004901972","cat":"papers","name":"Research about DMT and ayahuasca","year":"2020","cit":1,"pfa":"Tom John Wolff","ptype":"book-chapter","src":"https://openalex.org/W3004901972","eid":"W3004901972"},{"id":"paper-w2587594470","cat":"papers","name":"Psychological effects of MDMA","year":"2016","cit":1,"pfa":"Monika J. Wieliczko","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W2587594470","eid":"W2587594470"},{"id":"paper-w1968266425","cat":"papers","name":"A contemporary view of MDMA","year":"2006","cit":1,"pfa":"Richard De La Garza","psa":"Klaus A. Miczek","ptype":"article","src":"https://openalex.org/W1968266425","eid":"W1968266425"},{"id":"paper-w4384939486","cat":"papers","name":"MDMA as a Dance Drug","year":"2023","cit":1,"pfa":"Torsten Passie","topics":["Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W4384939486","eid":"W4384939486"},{"id":"paper-w2244982853","cat":"papers","name":"Peyote vs. the state: religious freedom on trial","year":"2009","cit":1,"ptype":"book-review","src":"https://openalex.org/W2244982853","eid":"W2244982853"},{"id":"paper-w4324284874","cat":"papers","name":"The Evolution and Ecology of Psilocybin in Nature","year":"2023","cit":1,"pfa":"Matthew J. Meyer","psa":"Jason C. Slot","ptype":"preprint","src":"https://openalex.org/W4324284874","eid":"W4324284874"},{"id":"paper-w2394684358","cat":"papers","name":"[Studies on hallucinogens. 3. Synthesis of psilocin (author's transl)].","year":"1973","cit":1,"pfa":"M Ono","psa":"Kazuo Takahashi","ptype":"article","src":"https://openalex.org/W2394684358","eid":"W2394684358"},{"id":"paper-w2049449922","cat":"papers","name":"Human‐Peyote Interaction in South Texas","year":"2000","cit":1,"pfa":"Servando Z. Hinojosa","ptype":"article","src":"https://openalex.org/W2049449922","eid":"W2049449922"},{"id":"paper-w4407346398","cat":"papers","name":"The Trouble With Psychedelic Cacti: Conflicting Meanings of San Pedro and Peyote","year":"2025","cit":1,"pfa":"Liam B. Engel","psa":"Mitchell Low","ptype":"article","src":"https://openalex.org/W4407346398","eid":"W4407346398"},{"id":"paper-w2320700219","cat":"papers","name":"A Monograph of a Peyote Singer: Asa Primeaux, Sr.","year":"1991","cit":1,"pfa":"Elizabeth Cook-Lynn","ptype":"article","src":"https://openalex.org/W2320700219","eid":"W2320700219"},{"id":"paper-w4250898819","cat":"papers","name":"Peyote Button Induces Religious Fervor","year":"1930","cit":1,"ptype":"article","src":"https://openalex.org/W4250898819","eid":"W4250898819"},{"id":"paper-w94741121","cat":"papers","name":"Proceedings: The uptake of mescaline by rat brain synaptosomes.","year":"1975","cit":1,"pfa":"Paul Bevan","ptype":"article","src":"https://openalex.org/W94741121","eid":"W94741121"},{"id":"paper-w4244458923","cat":"papers","name":"Dimethyltryptamine, a do-it-yourself hallucinogenic drug","year":"1967","cit":1,"pfa":"D. R. Rubin","ptype":"article","src":"https://openalex.org/W4244458923","eid":"W4244458923"},{"id":"paper-w4200200081","cat":"papers","name":"MDMA and mouth ulcers","year":"2021","cit":1,"pfa":"Yen Ming Lin","ptype":"article","src":"https://openalex.org/W4200200081","eid":"W4200200081"},{"id":"paper-w4245166304","cat":"papers","name":"The Peyote Controversy and the Demise of the Society of American Indians","year":"2013","cit":1,"pfa":"Thomas C. Maroukis","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4245166304","eid":"W4245166304"},{"id":"paper-w4242166461","cat":"papers","name":"Conditions for the Spread of the Peyote Cult in North America","year":"1982","cit":1,"ptype":"book-chapter","src":"https://openalex.org/W4242166461","eid":"W4242166461"},{"id":"paper-w2003438044","cat":"papers","name":"Naltrexone inhibits the subjective effects of salvinorin-A in humans","year":"2014","cit":1,"pfa":"Marta Valle","psa":"Jordi Riba","ptype":"article","src":"https://openalex.org/W2003438044","eid":"W2003438044"},{"id":"paper-w2008536133","cat":"papers","name":"134 The effect of mescaline on the optic evoked potential","year":"1961","cit":1,"pfa":"John Smythies","psa":"C.K. Levy","ptype":"article","src":"https://openalex.org/W2008536133","eid":"W2008536133"},{"id":"paper-w4214505356","cat":"papers","name":"MDMA (Ecstasy) Abuse","year":"2004","cit":1,"ptype":"dataset","src":"https://openalex.org/W4214505356","eid":"W4214505356"},{"id":"paper-w4291291098","cat":"papers","name":"Chemical composition of Ayahuasca seized in Poland","year":"2022","cit":1,"pfa":"Bogumiła Byrska","psa":"Roman Stanaszek","ptype":"article","src":"https://openalex.org/W4291291098","eid":"W4291291098"},{"id":"paper-w2305326982","cat":"papers","name":"QUELQUES ASPECTS ANALYTIQUES DE LA MESCALINE","year":"1990","cit":1,"pfa":"Marco Conti","psa":"F. Doillon","ptype":"article","src":"https://openalex.org/W2305326982","eid":"W2305326982"},{"id":"paper-w4409802142","cat":"papers","name":"AYAHUASCA E O INEFÁVEL","year":"2025","cit":1,"pfa":"Francisco Prosdocimi","psa":"María Carolina Pacini","ptype":"article","src":"https://openalex.org/W4409802142","eid":"W4409802142"},{"id":"paper-w2553907370","cat":"papers","name":"Consideration of Ayahuasca for the Treatment of Posttraumatic Stress Disorder","year":"2012","cit":1,"pfa":"Jessica L. Nielson","psa":"Julie D. Megler","topics":["PTSD & trauma","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2553907370","eid":"W2553907370"},{"id":"paper-w625354243","cat":"papers","name":"El peyote : estudio sobre el uso del peyote, entre las tribus huicholes, coras, tepehuanes y tarahumaras","year":"1965","cit":1,"pfa":"Isabel Gandola","ptype":"article","src":"https://openalex.org/W625354243","eid":"W625354243"},{"id":"paper-w4313201263","cat":"papers","name":"Rats hallucinate in a similar manner to humans after psilocin","year":"2022","cit":1,"pfa":"Čestmír Vejmola","psa":"Tomáš Páleníček","ptype":"article","src":"https://openalex.org/W4313201263","eid":"W4313201263"},{"id":"paper-w2335284717","cat":"papers","name":"Supplementary Material on the Life of John Wilson, \"The Revealer of Peyote\"","year":"1973","cit":1,"pfa":"John Wilson","psa":"Melburn D. Thurman","ptype":"supplementary-materials","src":"https://openalex.org/W2335284717","eid":"W2335284717"},{"id":"paper-w2781600636","cat":"papers","name":"The shifting journey of ayahuasca in diaspora Introduction","year":"2017","cit":1,"pfa":"Beatriz Caiuby Labate","psa":"Alex K. Gearin","ptype":"article","src":"https://openalex.org/W2781600636","eid":"W2781600636"},{"id":"paper-w7168380418","cat":"papers","name":"Synthesis and Biological Evaluation of O6C-Salvinorin Alkyne Probes","year":"2026","cit":1,"pfa":"Etienne Cotter","psa":"Ryan A. Shenvi","ptype":"article","src":"https://openalex.org/W7168380418","eid":"W7168380418"},{"id":"paper-w4386519663","cat":"papers","name":"Pharmacology and Therapeutic Effects of Psilocybin","year":"2023","cit":1,"pfa":"Xuehan Du","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4386519663","eid":"W4386519663"},{"id":"paper-w4401815070","cat":"papers","name":"The role of psilocybin in depressive disorders","year":"2024","cit":1,"pfa":"Jadwiga S. Najib","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4401815070","eid":"W4401815070"},{"id":"paper-w3217607417","cat":"papers","name":"Psilocybin steps closer to credibility","year":"2021","cit":1,"pfa":"Sam Wong","ptype":"article","src":"https://openalex.org/W3217607417","eid":"W3217607417"},{"id":"paper-w2505953778","cat":"papers","name":"Analysis of Salvinorin A in urine using microextraction in packed syringe and","year":"2013","cit":1,"pfa":"Ivo Moreno","psa":"Mário Barroso","ptype":"article","src":"https://openalex.org/W2505953778","eid":"W2505953778"},{"id":"paper-w587542226","cat":"papers","name":"Ayahuasca, religión y medicina : etnobotánica","year":"1970","cit":1,"pfa":"Plutarco Naranjo","ptype":"book","src":"https://openalex.org/W587542226","eid":"W587542226"},{"id":"paper-w2466170586","cat":"papers","name":"Prolongation of the disappearance of mescaline-14C by SKF 525-A.","year":"1973","cit":1,"pfa":"Shah Ns","psa":"Gibson Br","ptype":"article","src":"https://openalex.org/W2466170586","eid":"W2466170586"},{"id":"paper-w3173209673","cat":"papers","name":"Psilocybin: the magic medicine for depression?","year":"2021","cit":1,"pfa":"Amber Elyse Corrigan","psa":"Lydia Shackshaft","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3173209673","eid":"W3173209673"},{"id":"paper-w2789827160","cat":"papers","name":"MDMA (Ecstasy, Molly) Intoxication","year":"2018","cit":1,"pfa":"Julien J. Cavanagh","psa":"Teresa Y. Smith","ptype":"book-chapter","src":"https://openalex.org/W2789827160","eid":"W2789827160"},{"id":"paper-w2768648024","cat":"papers","name":"Ayahuasca enhances creative divergent thinking","year":"2016","cit":1,"pfa":"Kim P. C. Kuypers","psa":"Johannes Gerardus Ramaekers","ptype":"article","src":"https://openalex.org/W2768648024","eid":"W2768648024"},{"id":"paper-w2900920051","cat":"papers","name":"APPROXEMATE MOLECULAR ELECTROSTATIC POTENTIALS OF PROTONATED MESCALINE ANALOGUES","year":"1984","cit":1,"pfa":"Juan Gómez Jeria","psa":"J. I. Rodríguez Gatica","ptype":"article","src":"https://openalex.org/W2900920051","eid":"W2900920051"},{"id":"paper-w4409601789","cat":"papers","name":"Not Losing Momentum: Cross-Sectional Insights into Ibogaine Clinical Trials","year":"2025","cit":1,"pfa":"Damian Świeczkowski","psa":"Wiesław Jerzy Cubała","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4409601789","eid":"W4409601789"},{"id":"paper-w2414430235","cat":"papers","name":"[Constituents of seeds of Tabernanthe iboga Baillon. I. Alkaloids].","year":"1975","cit":1,"pfa":"Robert Goutarel","psa":"Christine Miet","ptype":"other","src":"https://openalex.org/W2414430235","eid":"W2414430235"},{"id":"paper-w1984686363","cat":"papers","name":"Peyote and the Yankton Sioux: The Life and Times of Sam Necklace","year":"2006","cit":1,"pfa":"Joel W. Martin","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1984686363","eid":"W1984686363"},{"id":"paper-w2081828346","cat":"papers","name":"Pursuit of Ecstasy: The MDMA Experience","year":"1994","cit":1,"pfa":"Steve Heilig","ptype":"article","src":"https://openalex.org/W2081828346","eid":"W2081828346"},{"id":"paper-w27418406","cat":"papers","name":"Las cartas de la ayahuasca","year":"2006","cit":1,"pfa":"Willian S. Burroughs","psa":"Allen Ginsberg","ptype":"article","src":"https://openalex.org/W27418406","eid":"W27418406"},{"id":"paper-w125444262","cat":"papers","name":"Ayahuasca 'shipiba' para la globalización","year":"2005","cit":1,"pfa":"Carlos Suárez","ptype":"article","src":"https://openalex.org/W125444262","eid":"W125444262"},{"id":"paper-w568624605","cat":"papers","name":"The Shaman & Ayahuasca: Journeys To Sacred Realms","year":"2011","cit":1,"pfa":"Don José Campos","psa":"Geraldine Overton","ptype":"book","src":"https://openalex.org/W568624605","eid":"W568624605"},{"id":"paper-w4392771317","cat":"papers","name":"Psilocybin and the Development of Serotonin Toxicity","year":"2024","cit":1,"pfa":"Avisha D Amarnani","psa":"Ritika Baweja","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4392771317","eid":"W4392771317"},{"id":"paper-w200253248","cat":"papers","name":"Cocaine, Methamphetamine, MDMA, and Heroin","year":"2014","cit":1,"pfa":"Ethan Oliver Bryson","ptype":"book-chapter","src":"https://openalex.org/W200253248","eid":"W200253248"},{"id":"paper-w1715176235","cat":"papers","name":"Ayahuasca e Recuperação de Pessoas em Situação de Rua [Ayahuasca and recovery of people on the streets]","year":"2013","cit":1,"pfa":"Bruno Ramos Gomes","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1715176235","eid":"W1715176235"},{"id":"paper-w4398166673","cat":"papers","name":"Pain Relief: Unique Derivatives of Ibogaine Alleviate Both Acute and Chronic Pain Symptoms","year":"2024","cit":1,"pfa":"Sanjit Dey","psa":"Surajit Sinha","topics":["Addiction","Anxiety & end-of-life","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4398166673","eid":"W4398166673"},{"id":"paper-w4233381127","cat":"papers","name":"Ayahuasca in the English courts: legal entanglements with the jungle vine","year":"2016","cit":1,"pfa":"CHARLOTTE WALSH","topics":["Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W4233381127","eid":"W4233381127"},{"id":"paper-w3004978668","cat":"papers","name":"Motivational structure for the ingestion of ayahuasca in the Internet","year":"2020","cit":1,"pfa":"Tom John Wolff","ptype":"book-chapter","src":"https://openalex.org/W3004978668","eid":"W3004978668"},{"id":"paper-w4394611632","cat":"papers","name":"MDMA (3,4-methylenedioxy-methamphetamine)","year":"2024","cit":1,"pfa":"Jayalakshmi Krishnan","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"book-chapter","src":"https://openalex.org/W4394611632","eid":"W4394611632"},{"id":"paper-w4253955651","cat":"papers","name":"Facts About MDMA (Ecstasy)","year":"1999","cit":1,"ptype":"dataset","src":"https://openalex.org/W4253955651","eid":"W4253955651"},{"id":"paper-w4412939048","cat":"papers","name":"Therapeutic and legal aspects of psilocybin in cancer-related depression","year":"2025","cit":1,"pfa":"Małgorzata Wierzbicka","psa":"Joanna Rymaszewska","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4412939048","eid":"W4412939048"},{"id":"paper-w1998705227","cat":"papers","name":"N,N-dimethyltryptamine like substance in rat brain","year":"1973","cit":1,"pfa":"B. Heller","psa":"Hugo Spatz","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1998705227","eid":"W1998705227"},{"id":"paper-w3111556480","cat":"papers","name":"‘Ecstasy’ (MDMA) and Visuospatial Processing","year":"2020","cit":1,"pfa":"Philip N. Murphy","psa":"Janice Bartholomew","topics":["Reviews & meta-analyses"],"ptype":"book-chapter","src":"https://openalex.org/W3111556480","eid":"W3111556480"},{"id":"paper-w4249819321","cat":"papers","name":"Neuroimaging of MDMA-Induced Neurotoxicity","year":"2003","cit":1,"pfa":"Una D. McCann","psa":"George A. Ricaurte","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W4249819321","eid":"W4249819321"},{"id":"paper-w4396748354","cat":"papers","name":"[MDMA-assisted therapy for PTSD].","year":"2024","cit":1,"pfa":"Helga Thorarinsdottir","psa":"Engilbert Sigurðsson","topics":["PTSD & trauma","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4396748354","eid":"W4396748354"},{"id":"paper-w4408313816","cat":"papers","name":"Psilocybin: revealing the enigmas of a revolutionary fungi","year":"2025","cit":1,"pfa":"RM Moosa-Battey","ptype":"article","src":"https://openalex.org/W4408313816","eid":"W4408313816"},{"id":"paper-w4392032046","cat":"papers","name":"Why Peyote Must Be Valued as Biocultural Patrimony of Mexico","year":"2016","cit":1,"pfa":"Mauricio Genet GuzmanChavez","ptype":"other","src":"https://openalex.org/W4392032046","eid":"W4392032046"},{"id":"paper-w4251175821","cat":"papers","name":"A Divergent Enantioselective Total Synthesis of Post‐Iboga Indole Alkaloids","year":"2020","cit":1,"pfa":"Jie Zhou","psa":"Fu‐She Han","ptype":"article","src":"https://openalex.org/W4251175821","eid":"W4251175821"},{"id":"paper-w3200562860","cat":"papers","name":"Psilocin Derivatives as Serotonergic Psychedelic Agents for the Treatment of CNS Disorders","year":"2021","cit":1,"pfa":"Robert B. Kargbo","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3200562860","eid":"W3200562860"},{"id":"paper-w2951609302","cat":"papers","name":"The Iboga Alkaloids and Their Role as Precursors of Antineoplastic Bisindole Catharanthus Alkaloids","year":"2003","cit":1,"pfa":"Richard J. Sundberg","psa":"Stanton Q. Smith","ptype":"article","src":"https://openalex.org/W2951609302","eid":"W2951609302"},{"id":"paper-w4387617056","cat":"papers","name":"Repurposing of recreational drugs: will these new ‘medicines’ (e.g., psychedelics, psilocybin, cannabinoids, LSD, MDMA, ketamine) deliver short- or longer-term benefits for those with depressive or other mood disorders?","year":"2023","cit":1,"pfa":"Ian Bernard Hickie","psa":"F. Markus Leweke","topics":["Depression","Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4387617056","eid":"W4387617056"},{"id":"paper-w2497401408","cat":"papers","name":"Genetics of Ecstasy (MDMA) Use","year":"2013","cit":1,"pfa":"Rafael de la Torre","psa":"Ricardo Pardo","ptype":"book-chapter","src":"https://openalex.org/W2497401408","eid":"W2497401408"},{"id":"paper-w1964975463","cat":"papers","name":"Amfetamines including MDMA (Ecstasy)","year":"2007","cit":1,"pfa":"Allister Vale","ptype":"article","src":"https://openalex.org/W1964975463","eid":"W1964975463"},{"id":"paper-w2460647329","cat":"papers","name":"Studies on the mechanisms of learning. I. Mescaline and the catecholamine hypothesis.","year":"1973","cit":1,"pfa":"J GARCIA RAMOS","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2460647329","eid":"W2460647329"},{"id":"paper-w4407274929","cat":"papers","name":"Psilocybin alters visual contextual computations","year":"2025","cit":1,"pfa":"Marco Aqil","psa":"Serge Olaf Dumoulin","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4407274929","eid":"W4407274929"},{"id":"paper-w4241235231","cat":"papers","name":"A climate for change: ICEERS and the challenges of the globalization of ayahuasca","year":"2016","cit":1,"pfa":"BENJAMIN K. DE LOENEN, ÒSCAR PARÉS FRANQUERO, AND","topics":["Addiction","Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W4241235231","eid":"W4241235231"},{"id":"paper-w7152588850","cat":"papers","name":"Dissociating the Hallucinogenic and Neuroplastic Effects of Psilocybin","year":"2026","cit":1,"pfa":"Jacob J. Baker","psa":"Yi Zuo","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7152588850","eid":"W7152588850"},{"id":"paper-w2995080235","cat":"papers","name":"Underlying mechanism of psilocybin induced psychosis","year":"1974","cit":1,"pfa":"Jan Kolařík","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2995080235","eid":"W2995080235"},{"id":"paper-w4245916842","cat":"papers","name":"Ibogaine attenuates morphine-induced conditioned place preference.","year":"1995","cit":1,"pfa":"Linda A. Parker","psa":"Tracey Luxton","ptype":"article","src":"https://openalex.org/W4245916842","eid":"W4245916842"},{"id":"paper-w4323045205","cat":"papers","name":"Ayahuasca in Western society and the metacognitive counselling approach","year":"2023","cit":1,"pfa":"Atsuko Kawakami","psa":"Masako Suzuki","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4323045205","eid":"W4323045205"},{"id":"paper-w2553755138","cat":"papers","name":"Ayahuasca, schamanische Trance und Santo Daime","year":"2016","cit":1,"pfa":"Gerhard Mayer","ptype":"book-chapter","src":"https://openalex.org/W2553755138","eid":"W2553755138"},{"id":"paper-w4414123038","cat":"papers","name":"Active Constituents of Psilocybin Mushroom Edibles","year":"2025","cit":1,"pfa":"Richard Bruce van Breemen","psa":"Jonathan Ferguson","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4414123038","eid":"W4414123038"},{"id":"paper-w4206257616","cat":"papers","name":"AYAHUASCA: FITOCOMPOSTOS, ETNOFARMACOLOGIA E POTENCIAL TERAPÊUTICO","year":"2022","cit":1,"pfa":"Kátia Thaís Fernandes Gurgel","psa":"Luanne Eugênia Nunes","ptype":"book-chapter","src":"https://openalex.org/W4206257616","eid":"W4206257616"},{"id":"paper-w1535040220","cat":"papers","name":"Word of Wisdom and Peyote: The Diversity of Interpretations, Part One","year":"1994","cit":1,"pfa":"Thomas Murphy","topics":["Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W1535040220","eid":"W1535040220"},{"id":"paper-w830494879","cat":"papers","name":"Peyote Cult on the Goshiute Reservation at Deep Creek, Utah","year":"1940","cit":1,"pfa":"Alden Hayes","ptype":"article","src":"https://openalex.org/W830494879","eid":"W830494879"},{"id":"paper-w4240895145","cat":"papers","name":"Preliminary Efficacy and Safety of Ibogaine in the Treatment of Methadone Detoxification","year":"2019","cit":1,"topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4240895145","eid":"W4240895145"},{"id":"paper-w1838292307","cat":"papers","name":"MDMA and Other “Club Drugs”","year":"2007","cit":1,"pfa":"María Isabel Colado","psa":"A. Richard Green","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W1838292307","eid":"W1838292307"},{"id":"paper-w4390034545","cat":"papers","name":"A institucionalização do uso da ayahuasca no Brasil","year":"2023","cit":1,"pfa":"Igor Fernandes Antunes","psa":"Paulo Santos de Almeida","ptype":"article","src":"https://openalex.org/W4390034545","eid":"W4390034545"},{"id":"paper-w7138881137","cat":"papers","name":"Enlightenment in a Pill—Testing the Efficacy of Psilocybin","year":"2026","cit":1,"pfa":"James I. Hudson","psa":"Harrison Graham Pope","topics":["Depression","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7138881137","eid":"W7138881137"},{"id":"paper-w2417211987","cat":"papers","name":"[Salvinorin A and related diterpenes--biological activity and potential therapeutic uses].","year":"2012","cit":1,"pfa":"Justyna Piekielna‐Ciesielska","psa":"Anna Janecka","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2417211987","eid":"W2417211987"},{"id":"paper-w2415327861","cat":"papers","name":"[Effect of mescaline on cerebral cholinesterases and on exploratory behavior in rats].","year":"1979","cit":1,"pfa":"E Torre","psa":"M Torre","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2415327861","eid":"W2415327861"},{"id":"paper-w3035015751","cat":"papers","name":"Ayahuasca Use Throughout Time: A Literature Review","year":"2020","cit":1,"pfa":"Gabriella Richardson","topics":["Reviews & meta-analyses","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W3035015751","eid":"W3035015751"},{"id":"paper-w4396937684","cat":"papers","name":"Psilocybin as a new way for depression treatment","year":"2024","cit":1,"pfa":"Mateusz Pawlicki","psa":"Wiktoria Wilanowska","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4396937684","eid":"W4396937684"},{"id":"paper-w7130340064","cat":"papers","name":"Effects of Psilocybin and Select Pharmaceutical Interactions","year":"2026","cit":1,"pfa":"Jordan McDowell","psa":"Jean-Vital Yambayamba","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7130340064","eid":"W7130340064"},{"id":"paper-w4313151943","cat":"papers","name":"3,4-Methylenedioxymethamphetamine (MDMA) and Synaptic Dopamine","year":"2022","cit":1,"pfa":"Francesca Romana Rizzo","psa":"Nicola Biagio Mercuri","ptype":"book-chapter","src":"https://openalex.org/W4313151943","eid":"W4313151943"},{"id":"paper-w4399645755","cat":"papers","name":"Therapeutic Implications of Psilocybin in the Wake of Decriminalization","year":"2024","cit":1,"pfa":"Nikola Lash","psa":"Eman Tadros","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4399645755","eid":"W4399645755"},{"id":"paper-w7144140681","cat":"papers","name":"Oxa-noribogaine reduces alcohol drinking through aversion learning and by altering glutamatergic activity in the mPFC","year":"2026","cit":1,"pfa":"Marcus W. Meinhardt","psa":"Angela Beeson","topics":["Addiction"],"ptype":"preprint","src":"https://openalex.org/W7144140681","eid":"W7144140681"},{"id":"paper-w20877979","cat":"papers","name":"MDMA and serotonin: based on two cases.","year":"2005","cit":1,"pfa":"Ignacio García Cabeza","psa":"Celso Arango","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W20877979","eid":"W20877979"},{"id":"paper-w4283368914","cat":"papers","name":"Natural language signatures of psilocybin microdosing","year":"2022","cit":1,"pfa":"Camila Sanz","psa":"Enzo Tagliazucchi","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4283368914","eid":"W4283368914"},{"id":"paper-w4233287131","cat":"papers","name":"Investigación terapéutica con MDMA («éxtasis»)","year":"2003","cit":1,"pfa":"José Carlos Bouso","psa":"Gregorio Gómez-Jarabo","ptype":"article","src":"https://openalex.org/W4233287131","eid":"W4233287131"},{"id":"paper-w2019334979","cat":"papers","name":"Investigación terapéutica con MDMA («éxtasis»)","year":"2003","cit":1,"pfa":"José Carlos Bouso","psa":"Gregorio Gómez-Jarabo","ptype":"article","src":"https://openalex.org/W2019334979","eid":"W2019334979"},{"id":"paper-w2078085512","cat":"papers","name":"Psilocybin - eine neue psychotrope Substanz","year":"1959","cit":1,"pfa":"W. de Borr","ptype":"article","src":"https://openalex.org/W2078085512","eid":"W2078085512"},{"id":"paper-w4232014298","cat":"papers","name":"Nootropic Candidates Inhibit Head-Twitches Induced by Mescaline in Mice","year":"1992","cit":1,"pfa":"Tsuneyuki Yamamoto","psa":"Showa Ueki","ptype":"article","src":"https://openalex.org/W4232014298","eid":"W4232014298"},{"id":"paper-w2903414378","cat":"papers","name":"Neuropsychological effect on long-term Ayahuasca use","year":"2022","cit":1,"pfa":"Tiffany D Tucker","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2903414378","eid":"W2903414378"},{"id":"paper-w2419246159","cat":"papers","name":"Effects of LSD-25 and mescaline on the electroplax of the electric eel","year":"1971","cit":1,"pfa":"GD Webb","psa":"DA Farquharson","ptype":"article","src":"https://openalex.org/W2419246159","eid":"W2419246159"},{"id":"paper-w2070680036","cat":"papers","name":"New Compounds: Structural Analogs Related to Asarone and Mescaline","year":"1970","cit":1,"pfa":"B. S. R. Murty","psa":"Ross Macpherson BAXTER","ptype":"article","src":"https://openalex.org/W2070680036","eid":"W2070680036"},{"id":"paper-w565585179","cat":"papers","name":"The Battle for the Legality and Legitimacy of Ayahuasca Religions in Brazil","year":"2012","cit":1,"pfa":"Jennifer N. Ross","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W565585179","eid":"W565585179"},{"id":"paper-w1858159396","cat":"papers","name":"La ayahuasca te da tu arte","year":"2014","cit":1,"pfa":"Paolo Del Aguila","ptype":"article","src":"https://openalex.org/W1858159396","eid":"W1858159396"},{"id":"paper-w4248458065","cat":"papers","name":"Ayahuasca, schamanische Trance und Santo Daime","year":"2016","cit":1,"pfa":"Gerhard Mayer","ptype":"book-chapter","src":"https://openalex.org/W4248458065","eid":"W4248458065"},{"id":"paper-w598553088","cat":"papers","name":"Hultkrantz, Å. 1997. The Attraction of Peyote: An Inquiry into the Basic","year":"2001","cit":1,"pfa":"Mikael Kurkiala","ptype":"article","src":"https://openalex.org/W598553088","eid":"W598553088"},{"id":"paper-w4302362420","cat":"papers","name":"Psilocybin: a revolution in psychedelic medicines in the US?","year":"2022","cit":1,"pfa":"Joanne Silberner","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4302362420","eid":"W4302362420"},{"id":"paper-w2490597912","cat":"papers","name":"MDMA (Ecstasy) and Gene Expression in the Brain","year":"2016","cit":1,"pfa":"Noèlia Fernàndez‐Castillo","psa":"Bru Cormand","ptype":"book-chapter","src":"https://openalex.org/W2490597912","eid":"W2490597912"},{"id":"paper-w4246470594","cat":"papers","name":"Healing with plant intelligence: A report from Ayahuasca","year":"2010","cit":1,"pfa":"Richard J. Doyle","ptype":"dataset","src":"https://openalex.org/W4246470594","eid":"W4246470594"},{"id":"paper-w597086537","cat":"papers","name":"The University of the Forest: Plant Spirits in Ayahuasca Shamanism","year":"2012","cit":1,"pfa":"Horner, Chip","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W597086537","eid":"W597086537"},{"id":"paper-w2941853691","cat":"papers","name":"Interference of metoprolol with amphetamines and MDMA immunoassays","year":"2019","cit":1,"pfa":"Marion Leclercq","psa":"Laurence Labat","ptype":"article","src":"https://openalex.org/W2941853691","eid":"W2941853691"},{"id":"paper-w4408244562","cat":"papers","name":"Risk communication about high‐dose MDMA: Impact of a hypothetical drug alert on future MDMA use","year":"2025","cit":1,"pfa":"Joel Keygan","psa":"Amy Peacock","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4408244562","eid":"W4408244562"},{"id":"paper-w4320474901","cat":"papers","name":"Iboga-type alkaloids from the leaves of Tabernaemontana penduliflora (Apocynaceae)","year":"2023","cit":1,"pfa":"Alexis Bienvenue Nama","psa":"Hartmut Laatsch","ptype":"article","src":"https://openalex.org/W4320474901","eid":"W4320474901"},{"id":"paper-w4393210231","cat":"papers","name":"Comprehensive computational insights on the conformations, electronic properties and binding mechanism of mescaline: A hallucinogenic molecule","year":"2024","cit":1,"pfa":"Poonam Bhadoria","psa":"V. Ramanathan","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4393210231","eid":"W4393210231"},{"id":"paper-w2467927725","cat":"papers","name":"Mescaline hydrochloride effects on the endocrine activity of male albino mice.","year":"1968","cit":1,"pfa":"Weltman As","psa":"R Schwartz","ptype":"article","src":"https://openalex.org/W2467927725","eid":"W2467927725"},{"id":"paper-w3016275922","cat":"papers","name":"Intrinsic Motivations and Perceived Benefits of U.S. Males for Taking Dimethyltryptamine","year":"2020","cit":1,"pfa":"Timothy Raymond Kazmarek","ptype":"dissertation","src":"https://openalex.org/W3016275922","eid":"W3016275922"},{"id":"paper-w1987031943","cat":"papers","name":"Effects of N, N-dimethyltryptamine on intracranial self-stimulation in the rat","year":"1973","cit":1,"pfa":"Alexander J. Rosen","psa":"Kenneth L. Kubos","ptype":"article","src":"https://openalex.org/W1987031943","eid":"W1987031943"},{"id":"paper-w4312996666","cat":"papers","name":"The Biology of Nitric Oxide Signaling and MDMA","year":"2022","cit":1,"pfa":"María Pilar García-Pardo","psa":"M.A. Aguilar","ptype":"book-chapter","src":"https://openalex.org/W4312996666","eid":"W4312996666"},{"id":"paper-w3094625811","cat":"papers","name":"Ayahuasca: perigos inerentes ao seu consumo","year":"2019","cit":1,"pfa":"Raquel Cônsul Lourenço","ptype":"article","src":"https://openalex.org/W3094625811","eid":"W3094625811"},{"id":"paper-w4399023496","cat":"papers","name":"Psilocybin Therapy for Depression: A Review of Current Molecular Knowledge","year":"2024","cit":1,"pfa":"Marcha C. T. Verheijen","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4399023496","eid":"W4399023496"},{"id":"paper-w4212954018","cat":"papers","name":"Psilocybin in the treatment of obsessive-compulsive disorder: What do we know so far?","year":"2021","cit":1,"pfa":"Nelson Descalço","psa":"Guilherme Luiz Guimaraes Borges","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4212954018","eid":"W4212954018"},{"id":"paper-w4309566260","cat":"papers","name":"A Rare Case of MDMA-Induced Hyponatremia","year":"2022","cit":1,"pfa":"Caroline G. Dorsen","psa":"Madeleine M. Lloyd","ptype":"article","src":"https://openalex.org/W4309566260","eid":"W4309566260"},{"id":"paper-w4234275321","cat":"papers","name":"Bristol Imperial MDMA in Alcoholism Study","year":"2019","cit":1,"topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4234275321","eid":"W4234275321"},{"id":"paper-w2328454126","cat":"papers","name":"MDMA keeps severe stress at bay","year":"2012","cit":1,"pfa":"Arran Frood","ptype":"article","src":"https://openalex.org/W2328454126","eid":"W2328454126"},{"id":"paper-w7141436917","cat":"papers","name":"Author response: Psilocin fosters neuroplasticity in iPSC-derived human cortical neurons","year":"2026","cit":1,"pfa":"Målin Schmidt","psa":"Philipp Koch","topics":["Mechanism & neuroscience"],"ptype":"peer-review","src":"https://openalex.org/W7141436917","eid":"W7141436917"},{"id":"paper-w2089475647","cat":"papers","name":"The Peyote Religion Among the Navaho. D avid F. A berle","year":"1968","cit":1,"pfa":"Fred W. Voget","ptype":"article","src":"https://openalex.org/W2089475647","eid":"W2089475647"},{"id":"paper-w2085147695","cat":"papers","name":"Effect of chronic treatment with mescaline upon tissue levels of the drug","year":"1973","cit":1,"pfa":"Vimala H. Sethy","psa":"Jerrold C. Winter","ptype":"article","src":"https://openalex.org/W2085147695","eid":"W2085147695"},{"id":"paper-w4402267105","cat":"papers","name":"Unmasking bias and MDMA-assisted therapy","year":"2024","cit":1,"pfa":"Balázs Szigeti","topics":["PTSD & trauma"],"ptype":"preprint","src":"https://openalex.org/W4402267105","eid":"W4402267105"},{"id":"paper-w7134840335","cat":"papers","name":"VeronicaMaki-Marttunen/Psilocybin-shapes-propagation-of-brain-activity: Mäki-Marttunen-Psilocybin-shapes-propagation-of-brain-activity","year":"2026","cit":1,"pfa":"Veronica Mäki-Marttunen","topics":["Mechanism & neuroscience"],"ptype":"software","src":"https://openalex.org/W7134840335","eid":"W7134840335"},{"id":"paper-w2955590079","cat":"papers","name":"06 - CASE-REPORT OF A ‘TEA CEREMONY’ WITH AYAHUASCA: AN EMOTIONAL ROLLERCOASTER","year":"2019","cit":1,"pfa":"Matheus H. L. Arts","psa":"Sergei I. Petrykiv","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"other","src":"https://openalex.org/W2955590079","eid":"W2955590079"},{"id":"paper-w4312435470","cat":"papers","name":"Psilocybin and Magic Mushrooms: Patterns of Abuse and Consequences of Recreational Misuse","year":"2022","cit":1,"pfa":"Andreia Machado Brito-da-Costa","psa":"Ricardo Jorge Dinis‐Oliveira","ptype":"book-chapter","src":"https://openalex.org/W4312435470","eid":"W4312435470"},{"id":"paper-w3091539953","cat":"papers","name":"Wait for the Science Before Widespread Use of Psilocybin","year":"2020","cit":1,"pfa":"Nicole H. Cirino","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"other","src":"https://openalex.org/W3091539953","eid":"W3091539953"},{"id":"paper-w2312635619","cat":"papers","name":"Daimismo, la comunión con la ayahuasca","year":"1997","cit":1,"pfa":"Jules Marshall","ptype":"article","src":"https://openalex.org/W2312635619","eid":"W2312635619"},{"id":"paper-w2904395274","cat":"papers","name":"“Men,” “shaman,” and “ayahuasca” as overlapping clichés in the Peruvian vegetalismo","year":"2018","cit":1,"pfa":"Ana Gretel Echazú Böschemeier","psa":"Carl Kevin Carew","topics":["Reviews & meta-analyses"],"ptype":"book-chapter","src":"https://openalex.org/W2904395274","eid":"W2904395274"},{"id":"paper-w1505950674","cat":"papers","name":"Propagación in vitro de peyote (Lophophora williamsii (Lemaire) Coulter)","year":"1997","cit":1,"pfa":"Juan Gerardo Ortiz Montiel","psa":"R Alcántara García","ptype":"article","src":"https://openalex.org/W1505950674","eid":"W1505950674"},{"id":"paper-w4392290679","cat":"papers","name":"A Student Experiment in Pharmacognosy: Biosynthesis of Mescaline in the Cactus Trichocereus pachanoi","year":"1976","cit":1,"pfa":"Jan G. Bruhn","psa":"Jan Lundström","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4392290679","eid":"W4392290679"},{"id":"paper-w2483299668","cat":"papers","name":"Neurobiology of 3,4-Methylenedioxymethamphetamine (MDMA, or \"\"Ecstasy\"\")","year":"2007","cit":1,"pfa":"Michael H. Baumann","psa":"Richard Eric Rothman","ptype":"book-chapter","src":"https://openalex.org/W2483299668","eid":"W2483299668"},{"id":"paper-w2479785193","cat":"papers","name":"Salvinorin A: Example of a Non-Alkaloidal Bioactive Opioid from a Plant Source","year":"2014","cit":1,"pfa":"Robert B. Raffa","topics":["Addiction","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W2479785193","eid":"W2479785193"},{"id":"paper-w2951574054","cat":"papers","name":"Asymmetric Synthesis of Salvinorin A (I), a Potent ϰ Opioid Receptor Agonist.","year":"2007","cit":1,"pfa":"Jonathan R. Scheerer","psa":"David Albert Evans","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2951574054","eid":"W2951574054"},{"id":"paper-w2893809943","cat":"papers","name":"Freizeitgebrauch von LSD und Psilocybin-Pilzen","year":"2018","cit":1,"pfa":"Susanna Prepeliczay","ptype":"book-chapter","src":"https://openalex.org/W2893809943","eid":"W2893809943"},{"id":"paper-w4200545220","cat":"papers","name":"P.0623 The clinical relevance of the pharmacokinetics of psilocybin","year":"2021","cit":1,"pfa":"A. Andreiev","psa":"Pierre S. Chue","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4200545220","eid":"W4200545220"},{"id":"paper-w4415742444","cat":"papers","name":"Psilocybin use in bipolar disorder: A comprehensive review","year":"2025","cit":1,"pfa":"André Do","psa":"Charlène Thauvin","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4415742444","eid":"W4415742444"},{"id":"paper-w4401461934","cat":"papers","name":"Resurrecting Ancestral Familial Health: A Role for Psilocybin?","year":"2024","cit":1,"pfa":"Ashley Glowiak","topics":["PTSD & trauma","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4401461934","eid":"W4401461934"},{"id":"paper-w7128841011","cat":"papers","name":"Electrophysiological effects of psilocybin co-administered with midazolam","year":"2026","cit":1,"pfa":"Michael H. Sutherland","psa":"Matthew I. Banks","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7128841011","eid":"W7128841011"},{"id":"paper-w4410847086","cat":"papers","name":"Divergent Effects of Psilocybin for 2 Patients Participating in a Psilocybin-assisted Cognitive Behavioral Therapy Trial for Major Depressive Disorder","year":"2025","cit":1,"pfa":"Marc J. Weintraub","psa":"Jessica Kay Jeffrey","topics":["Depression","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4410847086","eid":"W4410847086"},{"id":"paper-w7117359786","cat":"papers","name":"Psilocybin-induced modulation of visual salience processing","year":"2025","cit":1,"pfa":"Stephanie L. Muller","psa":"Enzo Tagliazucchi","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7117359786","eid":"W7117359786"},{"id":"paper-w4379380077","cat":"papers","name":"LSD and Ayahuasca in Argentina: The Pioneering Work of a Psychoanalyst in the 1950s","year":"2023","cit":1,"pfa":"Zoë Dubus","ptype":"article","src":"https://openalex.org/W4379380077","eid":"W4379380077"},{"id":"paper-w4285177793","cat":"papers","name":"3,4-Methylenedioxymethamphetamine (MDMA) and Synaptic Dopamine","year":"2022","cit":1,"pfa":"Francesca Romana Rizzo","psa":"Nicola Biagio Mercuri","ptype":"book-chapter","src":"https://openalex.org/W4285177793","eid":"W4285177793"},{"id":"paper-w3101784265","cat":"papers","name":"Study finds ayahuasca administration associated with antidepressant effects","year":"2015","cit":1,"pfa":"RAFAEL GUIMARÃES DOS SANTOS","psa":"Jaime E. C. Hallak","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W3101784265","eid":"W3101784265"},{"id":"paper-w4412529549","cat":"papers","name":"Psilocybin as a psychophysical adaptogen in chronic pain rehabilitation","year":"2025","cit":1,"pfa":"Nicholas P. Cherup","psa":"Patrick H. Finan","ptype":"article","src":"https://openalex.org/W4412529549","eid":"W4412529549"},{"id":"paper-w2551216332","cat":"papers","name":"PSILOCYBIN RESEARCH AT JOHNS HOPKINS: A 2014 REPORT","year":"2014","cit":1,"pfa":"Robert L. Jesse","psa":"Roland R. Griffi","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2551216332","eid":"W2551216332"},{"id":"paper-w2924407885","cat":"papers","name":"Salvinorin A effect on rats when tested in a bioassay based on Hall's open field test","year":"2006","cit":1,"pfa":"Sharon Sibel Bolle","psa":"Daniel J. Siebert","ptype":"article","src":"https://openalex.org/W2924407885","eid":"W2924407885"},{"id":"paper-w4254523323","cat":"papers","name":"Prophylactic Effects of Psilocybin on Chronic Cluster Headache","year":"2020","cit":1,"ptype":"article","src":"https://openalex.org/W4254523323","eid":"W4254523323"},{"id":"paper-w4417150183","cat":"papers","name":"N, N-Dimethyltryptamine and harmine formulation shifts metastable topography sequences in the cortex","year":"2025","cit":1,"pfa":"Maria Niedernhuber","psa":"Helena Aicher","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4417150183","eid":"W4417150183"},{"id":"paper-w2900060045","cat":"papers","name":"What Psilocybin Taught Me About Dying","year":"2018","cit":1,"pfa":"Anthony L. Back","ptype":"article","src":"https://openalex.org/W2900060045","eid":"W2900060045"},{"id":"paper-w3127548368","cat":"papers","name":"[Treatment with psilocybin: applications for patients with psychiatric disorders].","year":"2021","cit":1,"pfa":"Joost J. Breeksema","psa":"Robert A. Schoevers","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3127548368","eid":"W3127548368"},{"id":"paper-w4403412814","cat":"papers","name":"Expanding the Therapeutic Horizons of Psilocybin in Mental Health","year":"2024","cit":1,"pfa":"Robert B. Kargbo","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"editorial","src":"https://openalex.org/W4403412814","eid":"W4403412814"},{"id":"paper-w2062751755","cat":"papers","name":"Effect of Mescaline HCl on Resistance of Male Mice to Histamine Stress","year":"1970","cit":1,"pfa":"A. Stanley Weltman","psa":"Leroy Johnson","ptype":"article","src":"https://openalex.org/W2062751755","eid":"W2062751755"},{"id":"paper-w1984513710","cat":"papers","name":"Recreational MDMA users at risk of sleep apnea","year":"2010","cit":1,"pfa":"Eleanor Beal","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1984513710","eid":"W1984513710"},{"id":"paper-w1590277901","cat":"papers","name":"Knowledges of the ayahuasca and educational processes in the holy daime's religion","year":"2012","cit":1,"pfa":"Maria Betânia Barbosa Albuquerque","ptype":"article","src":"https://openalex.org/W1590277901","eid":"W1590277901"},{"id":"paper-w4386281321","cat":"papers","name":"CHEMISTRY OF AYAHUASCA: A DIDACTIC APPROACH TO TEACH FUNCTIONAL GROUPS","year":"2023","cit":1,"pfa":"Mateus Miranda","psa":"Lucas Soares de Jesus","ptype":"book-chapter","src":"https://openalex.org/W4386281321","eid":"W4386281321"},{"id":"paper-w4387821741","cat":"papers","name":"Investigations On Psilocybin And Its Analogs In Certain Fungi.","year":"1967","cit":1,"pfa":"Leung, Albert Yuk-sing","ptype":"dissertation","src":"https://openalex.org/W4387821741","eid":"W4387821741"},{"id":"paper-w2971463272","cat":"papers","name":"Oxidative Decorations of the Salvinorin A Backbone: Characterization of Salvia divinorum Cytochrome P450s","year":"2019","cit":1,"pfa":"Iris Ngo","topics":["Addiction","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W2971463272","eid":"W2971463272"},{"id":"paper-w2148508082","cat":"papers","name":"Peyote in the Kitchen: Gendered Identities and Imperial Domesticity in Edna Ferber's Cimarron","year":"2012","cit":1,"pfa":"Amanda J. Zink","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2148508082","eid":"W2148508082"},{"id":"paper-w4394566662","cat":"papers","name":"Psychotic Symptoms Following Ayahuasca Use in a Ceremonial Setting","year":"2024","cit":1,"pfa":"Alfonso Martínez Torres","psa":"Jorge Gómez-Arnau Ramírez","ptype":"article","src":"https://openalex.org/W4394566662","eid":"W4394566662"},{"id":"paper-w2626717340","cat":"papers","name":"Peyote and the Psychedelics: 20th Century Perceptions of the Religious Use of Psychoactive Substances","year":"2013","cit":1,"pfa":"Joshua Rager","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2626717340","eid":"W2626717340"},{"id":"paper-w2049347896","cat":"papers","name":"Use of Ayahuasca among Rubber Tappers of the Upper Juruá","year":"2008","cit":1,"pfa":"Mariana Ciavatta Pantoja","psa":"Osmildo Silva da Conceição","ptype":"article","src":"https://openalex.org/W2049347896","eid":"W2049347896"},{"id":"paper-w2747103694","cat":"papers","name":"Sintomatologia psicótica e ayahuasca: relato de caso","year":"2016","cit":1,"pfa":"Thaísa Silva Gios","psa":"Elie Leal de Barros Calfat","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2747103694","eid":"W2747103694"},{"id":"paper-w2960225694","cat":"papers","name":"The effects of MDMA on brain: An in vivo study in rats","year":"2018","cit":1,"pfa":"Fatin Haniza Zakaria","psa":"Wan Amir Nizam Wan Ahmad","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2960225694","eid":"W2960225694"},{"id":"paper-w4254088312","cat":"papers","name":"Acutely Administered MDMA Effect on Memories Measure","year":"2014","cit":1,"pfa":"Robin Lester Carhart-Harris","psa":"David John Nutt","ptype":"dataset","src":"https://openalex.org/W4254088312","eid":"W4254088312"},{"id":"paper-w4407274968","cat":"papers","name":"Dissociable effects of LSD and MDMA on striato-cortical connectivity in healthy subjects","year":"2025","cit":1,"pfa":"Natalie Ertl","psa":"Matthew B. Wall","topics":["PTSD & trauma","Addiction","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4407274968","eid":"W4407274968"},{"id":"paper-w2240047563","cat":"papers","name":"La mescaline chez les malades mentaux; constatations cliniques.","year":"1956","cit":1,"pfa":"J Delay","psa":"M Ropert","ptype":"article","src":"https://openalex.org/W2240047563","eid":"W2240047563"},{"id":"paper-w4402220147","cat":"papers","name":"Disorders due to Substance Use: Hallucinogens and MDMA-Related Substances","year":"2024","cit":1,"pfa":"Sandeep Manel Nayak","psa":"Matthew W. Johnson","topics":["Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W4402220147","eid":"W4402220147"},{"id":"paper-w598914828","cat":"papers","name":"Cellular and molecular mechanisms of drugs of abuse : cocaine, ibogaine, and substituted amphetamines","year":"1996","cit":1,"pfa":"Syed F. Ali","psa":"康夫 高橋","topics":["Mechanism & neuroscience"],"ptype":"book","src":"https://openalex.org/W598914828","eid":"W598914828"},{"id":"paper-w4205505429","cat":"papers","name":"The Role of Serotonin in MDMA Self-administration in Rats","year":"2014","cit":1,"pfa":"Sarah Bradbury","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W4205505429","eid":"W4205505429"},{"id":"paper-w4397049643","cat":"papers","name":"The influence of psilocybin on subconscious and conscious emotional learning","year":"2024","cit":1,"pfa":"Andrea F. Casanova","psa":"Franz X. Vollenweider","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4397049643","eid":"W4397049643"},{"id":"paper-w4409445284","cat":"papers","name":"Psilocin alleviates acute itch in mice: possible involvement of 5-HT2A receptors and kynurenine pathway","year":"2025","cit":1,"pfa":"Arya Afrooghe","psa":"Ahmad Reza Dehpour","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4409445284","eid":"W4409445284"},{"id":"paper-w3049320550","cat":"papers","name":"What Psilocybin Taught Me, One Year Later","year":"2020","cit":1,"pfa":"Anthony L. Back","ptype":"article","src":"https://openalex.org/W3049320550","eid":"W3049320550"},{"id":"paper-w2367554523","cat":"papers","name":"Forensic Identification of Ecstasy(MDMA) by Pattern Recognition","year":"2005","cit":1,"pfa":"Wu Guo","ptype":"article","src":"https://openalex.org/W2367554523","eid":"W2367554523"},{"id":"paper-w2740185291","cat":"papers","name":"Recreational Use of Ecstasy (MDMA) and Hippocampal Memory","year":"2016","cit":1,"pfa":"Christian Montag","psa":"Benjamin Becker","ptype":"book-chapter","src":"https://openalex.org/W2740185291","eid":"W2740185291"},{"id":"paper-w2403823650","cat":"papers","name":"[N,N-dimethyltryptamine: first comparative results. Preliminary communication].","year":"1975","cit":1,"pfa":"O H ARNOLD","topics":["Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W2403823650","eid":"W2403823650"},{"id":"paper-w2441893184","cat":"papers","name":"Alteration of the facilitatory effect of mescaline by pretreatment with alpha-methyl-p-tyrosine.","year":"1980","cit":1,"pfa":"David A. Gorelick","psa":"WagnerH. Bridger","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2441893184","eid":"W2441893184"},{"id":"paper-w4402485221","cat":"papers","name":"Back to the drawing board for Lykos' MDMA therapy","year":"2024","cit":1,"pfa":"Alison Knopf","topics":["PTSD & trauma","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4402485221","eid":"W4402485221"},{"id":"paper-w4313041021","cat":"papers","name":"Drug and MDMA Interactions Implications for Public Health","year":"2022","cit":1,"pfa":"Esther Papaseit","psa":"Clara Pérez‐Mañá","ptype":"book-chapter","src":"https://openalex.org/W4313041021","eid":"W4313041021"},{"id":"paper-w1206634835","cat":"papers","name":"Oxidation of MDMA in urine after exposure to bleach","year":"2011","cit":1,"pfa":"AQ Pham","psa":"M.E. Dawson","ptype":"conference-paper","src":"https://openalex.org/W1206634835","eid":"W1206634835"},{"id":"paper-w4380081955","cat":"papers","name":"The DEA report on ayahuasca risks: “Science” in service of prohibition?","year":"2023","cit":1,"pfa":"Beatriz Caiuby Labate","psa":"Sidarta Tollendal Gomes Ribeiro","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4380081955","eid":"W4380081955"},{"id":"paper-w1885015988","cat":"papers","name":"Self-reported impulsivity and 'ecstasy' (MDMA) use","year":"2005","cit":1,"pfa":"Georgia Butler","psa":"Kylie Harrison","ptype":"conference-paper","src":"https://openalex.org/W1885015988","eid":"W1885015988"},{"id":"paper-w4388263672","cat":"papers","name":"Evolution and Diversification of Carboxylesterase-like [4+2] Cyclases in Aspidosperma and Iboga Alkaloid Biosynthesis","year":"2023","cit":1,"pfa":"Matthew D. DeMars","psa":"Sarah Ellen O'Connor","topics":["Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4388263672","eid":"W4388263672"},{"id":"paper-w1971026055","cat":"papers","name":"Editorial note: MDMA-induced dopamine neurotoxicity","year":"2004","cit":1,"pfa":"David M. Warburton","topics":["Safety & adverse events"],"ptype":"editorial","src":"https://openalex.org/W1971026055","eid":"W1971026055"},{"id":"paper-w2912771843","cat":"papers","name":"What is the evidence for psychobiological harm from the use of ‘ecstasy’ (MDMA)?","year":"2018","cit":1,"pfa":"Carl Alexander Roberts","psa":"Catharine Montgomery","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"book-chapter","src":"https://openalex.org/W2912771843","eid":"W2912771843"},{"id":"paper-w4312431589","cat":"papers","name":"Life-Threatening 3,4‐Methylenedioxyamphetamine (MDMA) Usage","year":"2022","cit":1,"pfa":"Francis Kin Chiu Chu","ptype":"book-chapter","src":"https://openalex.org/W4312431589","eid":"W4312431589"},{"id":"paper-w2468913498","cat":"papers","name":"MDMA and Glutamate: Implications for Hippocampal GABAergic Neurotoxicity","year":"2016","cit":1,"pfa":"Courtney Huff","topics":["Safety & adverse events","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2468913498","eid":"W2468913498"},{"id":"paper-w4402270940","cat":"papers","name":"Usage of Psilocybin to Treat Huntington's Disease: A Research Protocol","year":"2024","cit":1,"pfa":"Cynthia Duan","psa":"Emma Yuan","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4402270940","eid":"W4402270940"},{"id":"paper-w1573988400","cat":"papers","name":"The internationalisation of ayahuasca, edited by Beatriz C. Lebate and Henrik Jungaberle","year":"2013","cit":1,"pfa":"Judith A. Aldridge","topics":["Policy & ethics"],"ptype":"book-review","src":"https://openalex.org/W1573988400","eid":"W1573988400"},{"id":"paper-w4390119370","cat":"papers","name":"Disorders due to Substance Use: Hallucinogens and MDMA-Related Substances","year":"2023","cit":1,"pfa":"Sandeep Manel Nayak","psa":"Matthew W. Johnson","topics":["Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W4390119370","eid":"W4390119370"},{"id":"paper-w2084363645","cat":"papers","name":"Pipe, Bible, and Peyote among the Oglala Lakota: A Study in Religious Identity","year":"2000","cit":1,"pfa":"Greg Johnson","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2084363645","eid":"W2084363645"},{"id":"paper-w4391147144","cat":"papers","name":"Psychedelic Mushrooms: The Use of Psilocybin in the Treatment of Mental Disorders","year":"2024","cit":1,"pfa":"Correa RMS","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4391147144","eid":"W4391147144"},{"id":"paper-w4401710078","cat":"papers","name":"Christ returns from the jungle: Ayahuasca religion as mystical healing","year":"2024","cit":1,"pfa":"Bonnie Glass‐Coffin","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4401710078","eid":"W4401710078"},{"id":"paper-w4389616335","cat":"papers","name":"MDMA-assisted therapy for borderline personality disorder","year":"2023","cit":1,"pfa":"Ann M. Inouye","psa":"Lianne T. Philhower","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4389616335","eid":"W4389616335"},{"id":"paper-w4281736251","cat":"papers","name":"Neuropharmacological analysis of the anti-addictive and therapeutic effects of psilocybin","year":"2022","cit":1,"pfa":"Anthony Principe","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4281736251","eid":"W4281736251"},{"id":"paper-w4403401432","cat":"papers","name":"Psilocybin-assisted psychotherapy as an ‘anti-distressant’ with multidimensional properties","year":"2024","cit":1,"pfa":"Danica E. Johnson","psa":"Joshua Daniel Rosenblat","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4403401432","eid":"W4403401432"},{"id":"paper-w2995721006","cat":"papers","name":"Ayahuasca no tratamento da farmacodependência à cocaína: possíveis intervenções terapêuticas?","year":"2019","cit":1,"pfa":"Vítor Bruno","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"dissertation","src":"https://openalex.org/W2995721006","eid":"W2995721006"},{"id":"paper-w2395557430","cat":"papers","name":"[Influencing of heart rhythm by injection of mescaline into the lateral cerebral ventricle of some mammals].","year":"1970","cit":1,"pfa":"Erich Lehr","psa":"Gottfried Werner","ptype":"article","src":"https://openalex.org/W2395557430","eid":"W2395557430"},{"id":"paper-w4307605245","cat":"papers","name":"Serotonergic antidepressant use is associated with weaker psilocybin effects","year":"2022","cit":1,"pfa":"Natalie Gukasyan","psa":"Sandeep Manel Nayak","topics":["Depression","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4307605245","eid":"W4307605245"},{"id":"paper-w3042578857","cat":"papers","name":"Correlation of mescaline concentrations in Lophophora williamsii (Cactaceae) with rib numbers and diameter of crown (U.S.A.)","year":"2020","cit":1,"pfa":"Richard Newbold","psa":"Martin Terry","ptype":"article","src":"https://openalex.org/W3042578857","eid":"W3042578857"},{"id":"paper-w2372252615","cat":"papers","name":"Study on DFT of the Structure and Property of MDMA Molecule","year":"2006","cit":1,"pfa":"Heping Jiang","ptype":"article","src":"https://openalex.org/W2372252615","eid":"W2372252615"},{"id":"paper-w2797914777","cat":"papers","name":"Narrative therapy-assisted psilocybin use for treatment of depression","year":"2017","cit":1,"pfa":"Carlyn Delavan","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2797914777","eid":"W2797914777"},{"id":"paper-w2512494613","cat":"papers","name":"Ritual Ayahuasca use and health: an interview with Jacques Mabit","year":"2011","cit":1,"pfa":"Beatriz Caiuby Labate","psa":"Henrik Jungaberle","ptype":"article","src":"https://openalex.org/W2512494613","eid":"W2512494613"},{"id":"paper-w2316104796","cat":"papers","name":"New C(2)-sulfonyl ester-type Salvinorin A ligands to the kappa-opioid receptor","year":"2015","cit":1,"pfa":"Prabhakar Reddy Polepally","psa":"JK Zjawiony","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2316104796","eid":"W2316104796"},{"id":"paper-w2613367118","cat":"papers","name":"An exploratory study of the short-term effects of Ibogaine treatment on drug addicts","year":"2013","cit":1,"pfa":"Anwar Jeewa","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2613367118","eid":"W2613367118"},{"id":"paper-w4388261558","cat":"papers","name":"Group Format Psilocybin-Assisted Therapy: Commentary on the HOPE trial (HOPE: a pilot study of psilocybin-enhanced group psychotherapy in patients with cancer)","year":"2022","cit":1,"pfa":"Benjamin R. Lewis","psa":"Anna Catherine Beck","topics":["Anxiety & end-of-life","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4388261558","eid":"W4388261558"},{"id":"paper-w1972336978","cat":"papers","name":"Mescaline‐Spikes and Amino Acids in the Cortex of Cats Pretreated with Caffeine and Pentetrazol","year":"1970","cit":1,"pfa":"C Pintilie","psa":"E Crighel","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1972336978","eid":"W1972336978"},{"id":"paper-w4283763711","cat":"papers","name":"A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for Depression","year":"2022","cit":1,"pfa":"Sandeep Manel Nayak","psa":"Robin Lester Carhart-Harris","topics":["Depression","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4283763711","eid":"W4283763711"},{"id":"paper-w4400167794","cat":"papers","name":"Up-to-Date on clinical and preclinical studies of psilocybin therapy","year":"2024","cit":1,"pfa":"Daisuke Ibi","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4400167794","eid":"W4400167794"},{"id":"paper-w2560324909","cat":"papers","name":"Ayahuasca under International law: The santo Daime churche in the Netherlands","year":"2011","cit":1,"pfa":"Adèle van der Plas","ptype":"article","src":"https://openalex.org/W2560324909","eid":"W2560324909"},{"id":"paper-w7125257065","cat":"papers","name":"Psilocin mediates long-term synaptic depression in the prelimbic cortex through 5-HT2A receptor-independent mechanisms","year":"2026","cit":1,"pfa":"Ana Domi","psa":"Louise Adermark","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7125257065","eid":"W7125257065"},{"id":"paper-w3128320403","cat":"papers","name":"Valvular heart disease associated with MDMA abuse.","year":"2007","cit":1,"pfa":"Steven Droogmans","ptype":"article","src":"https://openalex.org/W3128320403","eid":"W3128320403"},{"id":"paper-w166310718","cat":"papers","name":"Preliminary geologic map of the Peyote Point Quadrangle, Big Horn County, Montana","year":"1986","cit":1,"pfa":"S.S. Agard","ptype":"report","src":"https://openalex.org/W166310718","eid":"W166310718"},{"id":"paper-w602179044","cat":"papers","name":"Synthesis of Molecular Probes for Exploring the Human Consciousness, 5-HT7 Ligands and Salvinorins","year":"2005","cit":1,"pfa":"Pär Holmberg","topics":["Addiction","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W602179044","eid":"W602179044"},{"id":"paper-w2025480985","cat":"papers","name":"P.1.c.057 Human psychopharmacology of the kappa opioid agonist salvinorin A","year":"2010","cit":1,"pfa":"Matthew W. Johnson","psa":"Roland R. Griffiths","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2025480985","eid":"W2025480985"},{"id":"paper-w1968121519","cat":"papers","name":"Effect of Mescaline on Nicotinamide Adenine Dinucleotide Synthesis in the Central Nervous System","year":"1968","cit":1,"pfa":"Glenn D. Appelt","psa":"Robert G. S. Brown","ptype":"article","src":"https://openalex.org/W1968121519","eid":"W1968121519"},{"id":"paper-w4400745472","cat":"papers","name":"CURRENT STATE OF PSILOCYBIN-ASSISTED THERAPY IN MOOD DISORDERS","year":"2024","cit":1,"pfa":"Astrid Kaiserman","psa":"Charles Kornreich","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4400745472","eid":"W4400745472"},{"id":"paper-w2517629982","cat":"papers","name":"Foreword: Ayahuasca and the coming transformation of the international drug control system","year":"2011","cit":1,"pfa":"Charles D. Kaplan","ptype":"article","src":"https://openalex.org/W2517629982","eid":"W2517629982"},{"id":"paper-w4408197223","cat":"papers","name":"Risks of using psilocybin in treatment of treatment-resistant depression","year":"2025","cit":1,"pfa":"Michał Orzechowski","psa":"Karolina Kalinowska","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4408197223","eid":"W4408197223"},{"id":"paper-w2285784062","cat":"papers","name":"Prales vizí : ayahuasca, amazonská spiritualita a tradice Santo Daime.","year":"2007","cit":1,"pfa":"Alex Polari de Alverga","ptype":"article","src":"https://openalex.org/W2285784062","eid":"W2285784062"},{"id":"paper-w3047213868","cat":"papers","name":"Psilocybin-Assisted Psychotherapy: Treating Depression and Anxiety with Mushrooms","year":"2020","cit":1,"pfa":"Sofia Beck","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"other","src":"https://openalex.org/W3047213868","eid":"W3047213868"},{"id":"paper-w2097222940","cat":"papers","name":"Psilocybin Mushrooms of the World: an identification guide. Paul Stamets.","year":"2010","cit":1,"pfa":"Guy A. Rutter","ptype":"article","src":"https://openalex.org/W2097222940","eid":"W2097222940"},{"id":"paper-w4391051065","cat":"papers","name":"Psilocybin biphasically modulates cortical and behavioral activity in mice","year":"2024","cit":1,"pfa":"Adam T. Brockett","psa":"Nikolas A. Francis","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4391051065","eid":"W4391051065"},{"id":"paper-w2467635997","cat":"papers","name":"EEG changes after psilocybin in organic brain lesions.","year":"1971","cit":1,"pfa":"J Kolarĩk","ptype":"article","src":"https://openalex.org/W2467635997","eid":"W2467635997"},{"id":"paper-w7128690117","cat":"papers","name":"Psilocybin for Treatment-Resistant OCD: A Randomised Controlled Trial","year":"2026","cit":1,"pfa":"Benjamin Kelmendi","psa":"Christopher Pittenger","topics":["Depression"],"ptype":"preprint","src":"https://openalex.org/W7128690117","eid":"W7128690117"},{"id":"paper-w4323924646","cat":"papers","name":"Ayahuasca in the treatment of bipolar disorder with psychotic features–A retrospective case study","year":"2023","cit":1,"pfa":"Mika Turkia","topics":["PTSD & trauma","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4323924646","eid":"W4323924646"},{"id":"paper-w7153282894","cat":"papers","name":"Sex-specific increased reactivity of the PVT and prolonged PVT→CeA circuit engagement following psilocin administration","year":"2026","cit":1,"pfa":"D. P. Effinger","psa":"Melissa A. Herman","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7153282894","eid":"W7153282894"},{"id":"paper-w4401821604","cat":"papers","name":"Identifying Three Psilocybin Use Patterns by Frequency and Quantity","year":"2024","cit":1,"pfa":"Bethany A. Gray","psa":"Mark A. Prince","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4401821604","eid":"W4401821604"},{"id":"paper-w4401189692","cat":"papers","name":"MDMA Therapy for PTSD: Inching Closer to—or Farther From—Approval?","year":"2024","cit":1,"pfa":"Leigh Davitian","topics":["Depression","PTSD & trauma","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4401189692","eid":"W4401189692"},{"id":"paper-w3135529309","cat":"papers","name":"Renal Responses Produced by the Central Microinjection of Salvinorin A and B in conscious Rats","year":"2018","cit":1,"pfa":"Cynthia E. Franklin","psa":"Helmut B. Gottlieb","topics":["Addiction","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3135529309","eid":"W3135529309"},{"id":"paper-w2323481416","cat":"papers","name":"New vobasinyl-iboga bisindole alkaloids with antiparasitic activities from Muntafara sessilifolia","year":"2011","cit":1,"pfa":"Marion Girardot","psa":"Lengo Mambu","ptype":"article","src":"https://openalex.org/W2323481416","eid":"W2323481416"},{"id":"paper-w4400324748","cat":"papers","name":"The role of ayahuasca in cell viability and oxidative stress in gastric adenocarcinoma cell line","year":"2024","cit":1,"pfa":"Joana Gonçalves","psa":"Ana Paula Duarte","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4400324748","eid":"W4400324748"},{"id":"paper-w7130929835","cat":"papers","name":"Opioid Receptors in Psychedelia: Indirect Serotonergic Modulation of Direct KOR Activation by Salvinorin A","year":"2026","cit":1,"pfa":"Maximiliano Ganado","psa":"Moisés Rubio‐Osornio","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7130929835","eid":"W7130929835"},{"id":"paper-w7140124542","cat":"papers","name":"Comparative genome analysis provides a foundation for defining salvinorin A biosynthesis in Salvia divinorum","year":"2026","cit":1,"pfa":"Haixiu Li","psa":"Evangelos C. Tatsis","topics":["Depression","Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7140124542","eid":"W7140124542"},{"id":"paper-w3212509400","cat":"papers","name":"e use of ayahuasca among rubber tappers of the Alto Juruá","year":"2016","cit":1,"pfa":"Domingos Bernardo Sá","psa":"Matthew Meyer","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W3212509400","eid":"W3212509400"},{"id":"paper-w3111393997","cat":"papers","name":"The Neurobiological Mechanisms Underpinning MDMA and Impaired Psychological Functioning","year":"2020","cit":1,"pfa":"Catharine Montgomery","psa":"Carl Alexander Roberts","topics":["Mechanism & neuroscience","Reviews & meta-analyses","Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W3111393997","eid":"W3111393997"},{"id":"paper-w7124248974","cat":"papers","name":"Psilocybin for Treatment-Resistant OCD: A Randomized Controlled Trial","year":"2026","cit":1,"pfa":"Benjamin Kelmendi","psa":"Christopher Pittenger","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7124248974","eid":"W7124248974"},{"id":"paper-w2949174412","cat":"papers","name":"MDMA impairs response to water intake in healthy volunteers","year":"2015","cit":1,"pfa":"Matthew J. Baggott","psa":"Kathleen J. Garrison","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W2949174412","eid":"W2949174412"},{"id":"paper-w2291040552","cat":"papers","name":"Letter in response to “MDMA-induced angioedema treated with icatibant”","year":"2016","cit":1,"pfa":"Richard Gentry Wilkerson","psa":"Bryan D. Hayes","ptype":"article","src":"https://openalex.org/W2291040552","eid":"W2291040552"},{"id":"paper-w3162646616","cat":"papers","name":"Designer drugs, date rape drugs, LSD, volatiles, magic mushroom, and peyote cactus abuse","year":"2021","cit":1,"pfa":"Amitava Dasgupta","psa":"Amer Wahed","ptype":"book-chapter","src":"https://openalex.org/W3162646616","eid":"W3162646616"},{"id":"paper-w2525623692","cat":"papers","name":"El uso de la Ayahuasca en la Amazonia","year":"2010","cit":1,"pfa":"Edwin Trujillo Trujillo","psa":"William Trujillo","ptype":"article","src":"https://openalex.org/W2525623692","eid":"W2525623692"},{"id":"paper-w597100860","cat":"papers","name":"Seeing the Unseen:Personal Reflections on Ayahuasca Use Among the Shuar Indians","year":"1995","cit":1,"pfa":"Marie Perruchon","ptype":"article","src":"https://openalex.org/W597100860","eid":"W597100860"},{"id":"paper-w4409280591","cat":"papers","name":"181. Rapid, Sustained and Meaningful Antidepressant Effect of Intranasal BPL-003 (5-Methoxy-N,N-Dimethyltryptamine) in Treatment-Resistant Patients","year":"2025","cit":1,"pfa":"Fiona Dunbar","psa":"Claire Roberts","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4409280591","eid":"W4409280591"},{"id":"paper-w4414295539","cat":"papers","name":"Extraction and Characterization of N,N-Dimethyltryptamine from Mimosa tenuiflora: A Multivariate Approach","year":"2025","cit":1,"pfa":"Lucas Cordeiro de Oliveira","psa":"Suédina Maria de Lima Silva","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4414295539","eid":"W4414295539"},{"id":"paper-w3046965231","cat":"papers","name":"Ayahuasca Lodges in the Peruvian Amazon: A Valid Alternative for Ethno-development?","year":"2020","cit":1,"pfa":"Ana Gretel Echazú Böschemeier","psa":"María Eugenia Flores","ptype":"book-chapter","src":"https://openalex.org/W3046965231","eid":"W3046965231"},{"id":"paper-w4385830392","cat":"papers","name":"Major depressive disorder diagnosis from electroencephalogram data and potential treatment with dimethyltryptamine","year":"2023","cit":1,"pfa":"Sushmit JAHAN","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4385830392","eid":"W4385830392"},{"id":"paper-w1531461050","cat":"papers","name":"Chapter 7 Changes in gene expression and signal transduction following ibogaine treatment","year":"2001","cit":1,"pfa":"Emmanuel Shan Onaivi","psa":"Syed F. Ali","ptype":"book-chapter","src":"https://openalex.org/W1531461050","eid":"W1531461050"},{"id":"paper-w4412674828","cat":"papers","name":"Global Increases in Brain Glucose Metabolism Following Acute N,N-Dimethyltryptamine and Harmine Administration in Healthy Volunteers: An [¹⁸F]FDG-PET Study","year":"2025","cit":1,"pfa":"Klemens Egger","psa":"Paul D. Cumming","topics":["Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4412674828","eid":"W4412674828"},{"id":"paper-w2004804627","cat":"papers","name":"Mescaline: Its effects on learning rate and dopamine metabolism in goldfish (Carassius auratus)","year":"1976","cit":1,"pfa":"E. A. Zeller","psa":"R. R. Moody","ptype":"article","src":"https://openalex.org/W2004804627","eid":"W2004804627"},{"id":"paper-w2403292044","cat":"papers","name":"[Clinical experiences with psilocybin Sandoz (CY 39 Sandoz)].","year":"1961","cit":1,"pfa":"M. Sercl","psa":"O. Jaros","ptype":"article","src":"https://openalex.org/W2403292044","eid":"W2403292044"},{"id":"paper-w2601880600","cat":"papers","name":"The action of MDMA ('ecstacy') on neurohypophysial hormone release in vitro","year":"2000","cit":1,"pfa":"John K. Fallon","psa":"David Cowan","ptype":"article","src":"https://openalex.org/W2601880600","eid":"W2601880600"},{"id":"paper-w4403782949","cat":"papers","name":"Detection of MDMA using Rectangular Microstrip Patch Antenna","year":"2022","cit":1,"pfa":"Dewan Shahriar Shawon","psa":"Amit Khan and Dr. Md. Nurunnabi Mollah","ptype":"article","src":"https://openalex.org/W4403782949","eid":"W4403782949"},{"id":"paper-w2432174244","cat":"papers","name":"[Pharmacological studies on hallucinogens. I. 2. Investigation of the general pharmacological action of mescaline].","year":"1962","cit":1,"pfa":"E Hoshikawa","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2432174244","eid":"W2432174244"},{"id":"paper-w4410990611","cat":"papers","name":"Towards \"unmakable\" psychedelics: SAR exploration of psilocin analogs obtained by a HATU-mediated amide coupling strategy","year":"2025","cit":1,"pfa":"Judith Stirn","psa":"Christian D. P. Klein","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4410990611","eid":"W4410990611"},{"id":"paper-w4400575107","cat":"papers","name":"Developing Core Consensus Measures for Assessment of Psilocybin Services","year":"2024","cit":1,"pfa":"Philip Todd Korthuis","psa":"Christopher S. Stauffer","ptype":"article","src":"https://openalex.org/W4400575107","eid":"W4400575107"},{"id":"paper-w7129297531","cat":"papers","name":"Participant Experiences of Therapeutic Touch in Psilocybin‐Assisted Therapy","year":"2026","cit":1,"pfa":"Rachel Ham","psa":"Paul Liknaitzky","topics":["Safety & adverse events","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7129297531","eid":"W7129297531"},{"id":"paper-w4294919918","cat":"papers","name":"An MDMA cluster and the utility of illicit drug blood sampling","year":"2022","cit":1,"pfa":"Andrew Kozman","psa":"Daniel M Fatovich","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4294919918","eid":"W4294919918"},{"id":"paper-w4393224895","cat":"papers","name":"Identification of Precursors of MDMA in Unknown Substances in Sri Lanka","year":"2024","cit":1,"pfa":"Vajira Suranji Jayasekera","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4393224895","eid":"W4393224895"},{"id":"paper-w2969705340","cat":"papers","name":"Sobre Alexander S. Dawson, The Peyote Effect. From the Inquisition to the War on Drugs","year":"2019","cit":1,"pfa":"Ricardo Pérez Montfort","ptype":"article","src":"https://openalex.org/W2969705340","eid":"W2969705340"},{"id":"paper-w4401972979","cat":"papers","name":"Psilocybin, moralization and psychotherapy: a scoping review and a case report","year":"2024","cit":1,"pfa":"Emiliano Loria","psa":"Ambra D’Imperio","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4401972979","eid":"W4401972979"},{"id":"paper-w4404448166","cat":"papers","name":"Psilocybin Fungi Unveiled: Morphological Characteristics and Pharmacological Potentials","year":"2024","cit":1,"pfa":"Raj Nashikkar","psa":"Rajendra Patil","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4404448166","eid":"W4404448166"},{"id":"paper-w7148419316","cat":"papers","name":"Data from: Psilocin fosters neuroplasticity in iPSC-derived human cortical neurons","year":"2026","cit":1,"pfa":"Målin Schmidt","psa":"Philipp Koch","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dataset","src":"https://openalex.org/W7148419316","eid":"W7148419316"},{"id":"paper-w4384826415","cat":"papers","name":"Psilocybin Therapy for Major Depressive Disorder: A Systematic Review","year":"2023","cit":1,"pfa":"Kaden Venugopal","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W4384826415","eid":"W4384826415"},{"id":"paper-w3120019829","cat":"papers","name":"Angioedema by MDMA mediated by bradykinin. Role of icatibant acetate","year":"2020","cit":1,"pfa":"Francesc del Baño","psa":"F. Escolano","ptype":"article","src":"https://openalex.org/W3120019829","eid":"W3120019829"},{"id":"paper-w2965507512","cat":"papers","name":"3,4-Methylenedioxy-Methamphetamine (MDMA, Ecstasy, Molly) Toxicity","year":"2019","cit":1,"pfa":"Rick Figurasin","psa":"Nicole J. Maguire","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2965507512","eid":"W2965507512"},{"id":"paper-w4409225938","cat":"papers","name":"Peyote Poisoning Mimicking Autoimmune Encephalitis with Polyneuropathy: A Case Report (P7-3.008)","year":"2025","cit":1,"pfa":"Guangming Zhu","psa":"Tanya P. Lin","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4409225938","eid":"W4409225938"},{"id":"paper-w4390224086","cat":"papers","name":"Safety pharmacology of acute psilocybin administration in healthy participants","year":"2023","cit":1,"pfa":"Isabelle Straumann","psa":"Matthias E. Liechti","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4390224086","eid":"W4390224086"},{"id":"paper-w2335834295","cat":"papers","name":"Immediate and persistent effects of Salvinorin A on the kappa opioid receptor in rodents, monitored in vivo with pet","year":"2015","cit":1,"pfa":"Michael S. Placzek","psa":"Jacob M. Hooker","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2335834295","eid":"W2335834295"},{"id":"paper-w2511532223","cat":"papers","name":"Question-based Drug Development for psilocybin – Authors' reply","year":"2016","cit":1,"pfa":"Robin Lester Carhart-Harris","psa":"David Nutt","ptype":"letter","src":"https://openalex.org/W2511532223","eid":"W2511532223"},{"id":"paper-w3212256162","cat":"papers","name":"Effects of psilocybin-assisted therapy on treatment-resistant depression","year":"2021","cit":1,"pfa":"A. Fraga","psa":"A. Moutinho","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3212256162","eid":"W3212256162"},{"id":"paper-w4407407526","cat":"papers","name":"Akzeptanz psilocybin-assistierter Therapie in den deutschsprachigen Ländern","year":"2025","cit":1,"pfa":"Nina Hartter","psa":"Henrik Jungaberle","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4407407526","eid":"W4407407526"},{"id":"paper-w1812289792","cat":"papers","name":"Neuroimagen y neurotoxicidad inducida por MDMA (éxtasis)","year":"2003","cit":1,"pfa":"Una D. McCann","psa":"George A. Ricaurte","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1812289792","eid":"W1812289792"},{"id":"paper-w111303214","cat":"papers","name":"Neurochemical and neuroanatomic effects of 3,4-methylenedioxymethamphetamine (MDMA) in rats","year":"1986","cit":1,"pfa":"Robert M. Virus","psa":"Lewis S. Seiden","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W111303214","eid":"W111303214"},{"id":"paper-w4246189440","cat":"papers","name":"Long-Term Neuropsychiatric Consequences of \"Ecstasy\" (MDMA): A Review","year":"2002","cit":1,"pfa":"A. G. Montoya","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4246189440","eid":"W4246189440"},{"id":"paper-w2560631034","cat":"papers","name":"FDA approves MDMA Phase 3 trials for PTSD","year":"2016","cit":1,"pfa":"Alison Knopf","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W2560631034","eid":"W2560631034"},{"id":"paper-w4363674917","cat":"papers","name":"Acute liver failure after MDMA (Ecstasy) intoxication","year":"2023","cit":1,"pfa":"Markéta Nowaková","psa":"Jan Pavlíček","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4363674917","eid":"W4363674917"},{"id":"paper-w2009956147","cat":"papers","name":"Consistency of psilocybin induced changes in the minnesota multiphasic personality inventory","year":"1965","cit":1,"pfa":"MARTIN H. KEELER","psa":"Edward F. Doehne","ptype":"article","src":"https://openalex.org/W2009956147","eid":"W2009956147"},{"id":"paper-w2469063932","cat":"papers","name":"[Note apropos of the diagnostic and therapeutic use of hallucinogenic drugs (mescaline, L.S.D.25)].","year":"1962","cit":1,"pfa":"R Lanter","psa":"M ROTH","ptype":"article","src":"https://openalex.org/W2469063932","eid":"W2469063932"},{"id":"paper-w7153722761","cat":"papers","name":"Efficacy of N, N-dimethyltryptamine (DMT) psychedelic therapy for substance misuse: A systematic review and meta-analysis","year":"2026","cit":1,"pfa":"L. M. Wallace","psa":"Khushi Mittal","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W7153722761","eid":"W7153722761"},{"id":"paper-w650107454","cat":"papers","name":"Ayahuasca: farmacología, efectos agudos, potencial terapéutico y rituales","year":"2015","cit":1,"pfa":"Marta Aliño","psa":"Raúl Espert","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W650107454","eid":"W650107454"},{"id":"paper-w7155191260","cat":"papers","name":"Prevalence and Correlates of Past-Year Psilocybin Use in the United States","year":"2026","cit":1,"pfa":"Kevin H. Yang","psa":"Joseph J. Palamar","ptype":"article","src":"https://openalex.org/W7155191260","eid":"W7155191260"},{"id":"paper-w2916754836","cat":"papers","name":"Farmacologie en toxicologie van MDMA, deel 2","year":"2007","cit":1,"pfa":"Henk van Wilgenburg","ptype":"article","src":"https://openalex.org/W2916754836","eid":"W2916754836"},{"id":"paper-w4416416307","cat":"papers","name":"Mystical experiences during magnesium-Ibogaine are associated with improvements in PTSD symptoms in veterans","year":"2025","cit":1,"pfa":"Randi E. Brown","psa":"Nolan Williams","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4416416307","eid":"W4416416307"},{"id":"paper-w2507791720","cat":"papers","name":"Pipe, Bible, and Peyote Among the Oglala Lakota: A Study in Religious Identity.Paul B. Steinmetz","year":"1991","cit":1,"pfa":"J. D. Y. Peel","ptype":"article","src":"https://openalex.org/W2507791720","eid":"W2507791720"},{"id":"paper-w2896816276","cat":"papers","name":"BIOTRANSFORMASI MDMA (ECSTASY) STUDI PADA PENYALAHGUNAAN ECSTASY","year":"1999","cit":1,"pfa":"Fasich","ptype":"other","src":"https://openalex.org/W2896816276","eid":"W2896816276"},{"id":"paper-w4392950146","cat":"papers","name":"Synthesis of Iso-Dimethyltryptamines and Biological Analysis in a Model of Light-Induced Retinal Degeneration","year":"2024","cit":1,"pfa":"Ethan J. Pazur","psa":"Peter Wipf","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4392950146","eid":"W4392950146"},{"id":"paper-w2074391500","cat":"papers","name":"Behavioural differences in methylenedioxymethamphetamine (MDMA) enantiomers induced neurotoxicity","year":"2002","cit":1,"pfa":"Zsuzsanna Gyarmati","psa":"Zsuzsanna Fürst","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2074391500","eid":"W2074391500"},{"id":"paper-w4415526653","cat":"papers","name":"Iboga‐Indole Alkaloids as Potential Plasmodial Inhibitors: Identification, Biosynthesis, and Molecular Docking Studies","year":"2025","cit":1,"pfa":"Smith Borakaeyabe Babiaka","psa":"Michel Frédérich","ptype":"article","src":"https://openalex.org/W4415526653","eid":"W4415526653"},{"id":"paper-w2521986852","cat":"papers","name":"RAPID IDENTIFICATION OF ECSTASY (MDMA) AND METHAMPHETAMINE BY COLOR TESTS","year":"2016","cit":1,"pfa":"Alireza Khajeamiri","ptype":"article","src":"https://openalex.org/W2521986852","eid":"W2521986852"},{"id":"paper-w2433761789","cat":"papers","name":"The comparative behavioral effects of N,N-dimethyltryptamine and N,N-diethyltryptamine in primate dyads.","year":"1983","cit":1,"pfa":"W J Heinze","psa":"J M Davis","ptype":"article","src":"https://openalex.org/W2433761789","eid":"W2433761789"},{"id":"paper-w2416533328","cat":"papers","name":"THE ENZYMATIC OXIDATIVE DEAMINATION AND EFFECT ON CAT BEHAVIOR MESCALINE AND STRUCTURALLY-RELATED BETA-PHENETHYLAMINES.","year":"1964","cit":1,"pfa":"Leland C. Clark","psa":"Morin Rd","ptype":"article","src":"https://openalex.org/W2416533328","eid":"W2416533328"},{"id":"paper-w2063877348","cat":"papers","name":"Farmacologie en toxicologie van MDMA, deel 1","year":"2007","cit":1,"pfa":"Henk van Wilgenburg","ptype":"article","src":"https://openalex.org/W2063877348","eid":"W2063877348"},{"id":"paper-w4393011156","cat":"papers","name":"Synthesis of Iso-Dimethyltryptamines and Biological Analysis in a Model of Light-Induced Retinal Degeneration","year":"2024","cit":1,"pfa":"Ethan J. Pazur","psa":"Peter Wipf","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4393011156","eid":"W4393011156"},{"id":"paper-w74911118","cat":"papers","name":"Effect of MDMA-Like Drugs on CNS Neuropeptide Systems","year":"1990","cit":1,"pfa":"Glen R. Hanson","psa":"James W. Gibb","ptype":"book-chapter","src":"https://openalex.org/W74911118","eid":"W74911118"},{"id":"paper-w4307998958","cat":"papers","name":"Solving an Old Puzzle: Elucidation and Evaluation of the Binding Mode of Salvinorin A at the Kappa Opioid Receptor","year":"2022","cit":1,"pfa":"Kristina Puls","psa":"Gerhard Wolber","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4307998958","eid":"W4307998958"},{"id":"paper-w4392988832","cat":"papers","name":"Understanding The Religious Import Of Mystical States Of Consciousness Facilitated By Psilocybin","year":"2015","cit":1,"pfa":"William A. Richards","topics":["Therapy practice"],"ptype":"other","src":"https://openalex.org/W4392988832","eid":"W4392988832"},{"id":"paper-w4379882985","cat":"papers","name":"Effects of ayahuasca on gratitude and relationships with nature: An open-label, naturalistic study","year":"2023","cit":1,"pfa":"Jacob S. Aday","psa":"Christopher C. Davoli","ptype":"preprint","src":"https://openalex.org/W4379882985","eid":"W4379882985"},{"id":"paper-w7138877198","cat":"papers","name":"Psilocybin retail stores in Canada: Changes in availability, commercialization, and geographic distribution","year":"2026","cit":1,"pfa":"Jenna Matsukubo","psa":"Daniel Thomas Myran","ptype":"article","src":"https://openalex.org/W7138877198","eid":"W7138877198"},{"id":"paper-w7132820053","cat":"papers","name":"Appearance of necrotizing sialometaplasia temporarily associated with MDMA consumption","year":"2026","cit":1,"pfa":"E. Plaza-Matos","psa":"Javier Alberdi‐Navarro","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7132820053","eid":"W7132820053"},{"id":"paper-w7155108619","cat":"papers","name":"R -MDDMA is a Safer Analogue of MDMA with Therapeutic Potential","year":"2026","cit":1,"pfa":"Maxemiliano V. Vargas","psa":"David E. Olson","topics":["Depression","PTSD & trauma","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7155108619","eid":"W7155108619"},{"id":"paper-w7129385481","cat":"papers","name":"Rebuttal to “Questioning the recovery of dissociated traumatic memories under psilocybin”","year":"2026","cit":1,"pfa":"Stephanie Knatz Peck","psa":"Timothy D. Brewerton","topics":["PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7129385481","eid":"W7129385481"},{"id":"paper-w2904976048","cat":"papers","name":"A critical review of the literature on the diaspora of Brazilian ayahuasca religions 1","year":"2018","cit":1,"pfa":"Beatriz Caiuby Labate","psa":"Glauber Loures de Assis","topics":["Reviews & meta-analyses","Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W2904976048","eid":"W2904976048"},{"id":"paper-w3027223150","cat":"papers","name":"Etude du métabolisme de mescalines fluorées par Pieris brassicae (Insecte, Lépidoptère)","year":"1977","cit":1,"pfa":"G. Aranda","psa":"M. Vuillaume","ptype":"article","src":"https://openalex.org/W3027223150","eid":"W3027223150"},{"id":"paper-w7124834361","cat":"papers","name":"AYAHUASCA: O PROCESSO DE PRODUÇÃO EM CONTEXTOS MODERNOS","year":"2026","cit":1,"pfa":"Renato Lemes Peixoto","ptype":"book-chapter","src":"https://openalex.org/W7124834361","eid":"W7124834361"},{"id":"paper-w4400607327","cat":"papers","name":"Historical Perspectives and Pharmacodynamic Actions of the Magic Mushroom (Psilocybin) for Future Global Healthcare","year":"2024","cit":1,"pfa":"Bennett Lange","psa":"Muralikrishnan Dhanasekaran","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4400607327","eid":"W4400607327"},{"id":"paper-w2315138165","cat":"papers","name":"ChemInform Abstract: STRUCTURE AND ABSOLUTE CONFIGURATION OF (+)‐CORONARIDINE HYDROBROMIDE, A COMMENT ON THE ABSOLUTE CONFIGURATION OF THE IBOGA ALKALOIDS","year":"1973","cit":1,"pfa":"J. P. KUTNEY","psa":"Chunhua Wei","ptype":"article","src":"https://openalex.org/W2315138165","eid":"W2315138165"},{"id":"paper-w2337908566","cat":"papers","name":"Characteristics and predictors of ecstasy (MDMA) use during college","year":"2008","cit":1,"pfa":"Elaine Hatala","ptype":"dissertation","src":"https://openalex.org/W2337908566","eid":"W2337908566"},{"id":"paper-w7149936927","cat":"papers","name":"Catatonia Associated With First-Time Psilocybin Exposure: A Case Report","year":"2026","cit":1,"pfa":"Jasbir Singh","psa":"Pranathi Mruthyunjaya","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7149936927","eid":"W7149936927"},{"id":"paper-w2468531928","cat":"papers","name":"My Experience as a Guide in the Johns Hopkins Psilocybin Research Project","year":"2014","cit":1,"pfa":"Mary P Cosimano","ptype":"article","src":"https://openalex.org/W2468531928","eid":"W2468531928"},{"id":"paper-w4400729637","cat":"papers","name":"Your brain on shrooms — how psilocybin resets neural networks","year":"2024","cit":1,"pfa":"Max Kozlov","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4400729637","eid":"W4400729637"},{"id":"paper-w2099968430","cat":"papers","name":"Are Females More Sensitive to MDMA-Related Discriminative Stimuli?","year":"2011","cit":1,"pfa":"Jillian Helen Broadbear","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2099968430","eid":"W2099968430"},{"id":"paper-w4390025393","cat":"papers","name":"Flies on ’Shrooms: Studying the Psychotherapeutic Potential of Psilocybin using Drosophila","year":"2023","cit":1,"pfa":"Nicoletta Faraone","topics":["Addiction","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4390025393","eid":"W4390025393"},{"id":"paper-w4401920727","cat":"papers","name":"Improving Access to Psilocybin-Assisted Therapy: Barriers, Challenges, and Recommendations","year":"2024","cit":1,"pfa":"V. Tsang","psa":"C. Roney","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4401920727","eid":"W4401920727"},{"id":"paper-w4416407616","cat":"papers","name":"Psilocybin and Chronic Pain: A New Perspective for Future Pain Therapists?","year":"2025","cit":1,"pfa":"Silvia Natoli","psa":"Shigeki Yamaguchi","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4416407616","eid":"W4416407616"},{"id":"paper-w4387521317","cat":"papers","name":"Psilocybin, Depression, and Synaptogenesis: Insights into the Field’s Past, Present, and Future","year":"2023","cit":1,"pfa":"Anna C. Douglas","psa":"Fenn Suter","topics":["Depression","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4387521317","eid":"W4387521317"},{"id":"paper-w4409956273","cat":"papers","name":"Clarifying the legal landscape of psilocybin regulation: A medico-legal perspective","year":"2025","cit":1,"pfa":"Octavian Victor Brinzei","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4409956273","eid":"W4409956273"},{"id":"paper-w7131868995","cat":"papers","name":"Psilocybin for psychiatric disorders: History, clinical trials, neuroimaging, and regulations","year":"2026","cit":1,"pfa":"Kengo Yonezawa","psa":"Hideaki Tani","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7131868995","eid":"W7131868995"},{"id":"paper-w4412043599","cat":"papers","name":"Behavioural and pharmacological evaluation of the psilocybin analogue baeocystin in Wistar rats","year":"2025","cit":1,"pfa":"Hynek Danda","psa":"Martin Kuchař","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4412043599","eid":"W4412043599"},{"id":"paper-w1557475187","cat":"papers","name":"DETEKSI PSILOCIN URIN PADA MENCIT SWISS WEBSTER TERHADAP PEMBERIAN JAMUR PSILOCYBE CUBENSIS DOSIS BERTINGKAT.","year":"2013","cit":1,"pfa":"Mochamad Muntaha","psa":"Tuntas Dhanardhono","ptype":"article","src":"https://openalex.org/W1557475187","eid":"W1557475187"},{"id":"paper-w7140163094","cat":"papers","name":"Ibogaine is associated with reorganization of high-beta brain networks in veterans with post-traumatic stress disorder","year":"2026","cit":1,"pfa":"Kenneth Shinozuka","psa":"Cammie Rolle","topics":["PTSD & trauma","Addiction","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7140163094","eid":"W7140163094"},{"id":"paper-w7154685724","cat":"papers","name":"Psilocybin reshapes cortical inhibition through selective interneuron recruitment","year":"2026","cit":1,"pfa":"Pasha A. Davoudian","psa":"Alex C. Kwan","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7154685724","eid":"W7154685724"},{"id":"paper-w2794555859","cat":"papers","name":"A Review of A Culture’s Catalyst: Historical Encounters with Peyote and the Native American Church in Canada","year":"2017","cit":1,"pfa":"Feeney, Kevin","topics":["Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W2794555859","eid":"W2794555859"},{"id":"paper-w4289714531","cat":"papers","name":"Skepticism About Recent Evidence that Psilocybin Opens Depressed Minds","year":"2022","cit":1,"pfa":"Manoj K. Doss","psa":"Philip Robert Corlett","topics":["Depression"],"ptype":"preprint","src":"https://openalex.org/W4289714531","eid":"W4289714531"},{"id":"paper-w2408804395","cat":"papers","name":"[EFFECT OF PSILOCYBIN ON THE CLINICAL AND ELECTROENCEPHALOGRAPHIC PICTURE IN ORGANIC CNS LESIONS].","year":"1963","cit":1,"pfa":"Brooke Hopkins Dubansky","psa":"M Vyhnánková","ptype":"article","src":"https://openalex.org/W2408804395","eid":"W2408804395"},{"id":"paper-w4406131830","cat":"papers","name":"Psilocybin induces sex- and context-specific recruitment of the stress axis","year":"2025","cit":1,"pfa":"Sarah G. Cook","psa":"Gergely F. Turi","ptype":"preprint","src":"https://openalex.org/W4406131830","eid":"W4406131830"},{"id":"paper-w4410141094","cat":"papers","name":"Psilocybin Induces Sex- and Context-Specific Recruitment of the Stress Axis","year":"2025","cit":1,"pfa":"Sarah G. Cook","psa":"Gergely F. Turi","ptype":"preprint","src":"https://openalex.org/W4410141094","eid":"W4410141094"},{"id":"paper-w7167587921","cat":"papers","name":"Psilocybin therapy for adult females with anorexia nervosa: pilot study","year":"2026","cit":1,"pfa":"Hannah M. Douglass","psa":"Robin Lester Carhart-Harris","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7167587921","eid":"W7167587921"},{"id":"paper-w2346012242","cat":"papers","name":"Comparative phenomenology of psilocybin experiences in research and non-research settings","year":"2015","cit":1,"pfa":"Theresa M. Carbonaro","psa":"Roland R. Griffiths","ptype":"article","src":"https://openalex.org/W2346012242","eid":"W2346012242"},{"id":"paper-w4400873947","cat":"papers","name":"Síndrome serotoninérgico inducido por ayahuasca: a propósito de un caso","year":"2024","cit":1,"pfa":"Laura Ortega-Muñoz","psa":"Julián Benítez M.","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4400873947","eid":"W4400873947"},{"id":"paper-w4390222073","cat":"papers","name":"Safety, pharmacokinetics and pharmacodynamics of n,n-dimethyltryptamine administered as intravenous infusion in healthy smokers","year":"2023","cit":1,"pfa":"K. Van Der Heijden","psa":"Gabriël E. Jacobs","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4390222073","eid":"W4390222073"},{"id":"paper-w4387308393","cat":"papers","name":"Expectancy effects cannot be neglected in MDMA-assisted therapy research","year":"2023","cit":1,"pfa":"L. Jacob Flameling","psa":"Michiel van Elk","topics":["PTSD & trauma"],"ptype":"preprint","src":"https://openalex.org/W4387308393","eid":"W4387308393"},{"id":"paper-w4231988813","cat":"papers","name":"Sleep apnea in young abstinent recreational MDMA (“ecstasy”) consumers","year":"2011","cit":1,"pfa":"Una D. McCann","psa":"George A. Ricaurte","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4231988813","eid":"W4231988813"},{"id":"paper-w2335059432","cat":"papers","name":"Determination of the Organic Compounds in Synthetic Tablets Containing MDMA (Ecstasy)","year":"2014","cit":1,"pfa":"Taner Bora","psa":"Hasan Aydin","ptype":"article","src":"https://openalex.org/W2335059432","eid":"W2335059432"},{"id":"paper-w7193702","cat":"papers","name":"Behavioral Effects of 5, 7-DHT and MDMA Treatment in Rats","year":"1990","cit":1,"pfa":"Stanley A. Lorens","psa":"Margaret E. Hamilton","ptype":"book-chapter","src":"https://openalex.org/W7193702","eid":"W7193702"},{"id":"paper-w2010392188","cat":"papers","name":"Biosynthesis of Salvinorin A: Overexpression and Biochemical Characterization of Carboxy Methyltransferase from EST of Salvia divinorum Glands","year":"2009","cit":1,"pfa":"LM Kutrzeba","psa":"FE Dayan","topics":["Addiction","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2010392188","eid":"W2010392188"},{"id":"paper-w4400948033","cat":"papers","name":"Molecular insights into the modulation of the 5HT 2A receptor by serotonin, psilocin, and the G protein subunit Gqα","year":"2024","cit":1,"pfa":"Niklas Viohl","psa":"Himanshu Khandelia","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4400948033","eid":"W4400948033"},{"id":"paper-w4414273257","cat":"papers","name":"Severe Rhabdomyolysis With Stage 3 Acute Kidney Injury After Ayahuasca Use Managed Without Renal Replacement Therapy: A Case Report","year":"2025","cit":1,"pfa":"Arya Kermanshah","psa":"Ivet T. Cordoba Torres","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4414273257","eid":"W4414273257"},{"id":"paper-w2384744211","cat":"papers","name":"Nondestructive Determination of MDMA and MA in Ecstasy by Near Infrared Spectroscopy","year":"2007","cit":1,"pfa":"Bingren Xiang","ptype":"article","src":"https://openalex.org/W2384744211","eid":"W2384744211"},{"id":"paper-w4396849828","cat":"papers","name":"Psilocybin-induced anxiolytic effects supported by transient elevation of corticosterone","year":"2024","cit":1,"pfa":"N. Jones","psa":"Cody J. Wenthur","ptype":"article","src":"https://openalex.org/W4396849828","eid":"W4396849828"},{"id":"paper-w2041168136","cat":"papers","name":"Confirmation of Amphetamines, MDA and MDMA in Urine by a Simple HPLC Method","year":"1993","cit":1,"pfa":"Dinesh K. Talwar","psa":"Michael J. Stewart","ptype":"article","src":"https://openalex.org/W2041168136","eid":"W2041168136"},{"id":"paper-w4212989698","cat":"papers","name":"Neurovascular Uncoupling: Multimodal Imaging Delineates the Acute Effects of MDMA","year":"2022","cit":1,"pfa":"Tudor M. Ionescu","psa":"Kristina Herfert","topics":["PTSD & trauma","Addiction","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4212989698","eid":"W4212989698"},{"id":"paper-w7127637324","cat":"papers","name":"Ibogaine: Therapeutic Potential, Cardiac Safety, and Translational Perspectives in the Treatment of Substance Use Disorders—A Scoping Review","year":"2026","cit":1,"pfa":"Monica Patrícia Esperança","psa":"María G. Campos","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7127637324","eid":"W7127637324"},{"id":"paper-w2049888627","cat":"papers","name":"Longitudinal outcomes of MDMA (Ecstasy)-exposed infants in the United Kingdom","year":"2014","cit":1,"pfa":"Lynn T. Singer","psa":"Andrew C. Parrott","ptype":"article","src":"https://openalex.org/W2049888627","eid":"W2049888627"},{"id":"paper-w4414261976","cat":"papers","name":"Oral health effects of ecstasy (MDMA) and methamphetamine: a narrative review","year":"2025","cit":1,"pfa":"Lily-Rose Newell","psa":"Sylvie Boisramé","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4414261976","eid":"W4414261976"},{"id":"paper-w4404539705","cat":"papers","name":"The Age of The Onanya - regarding the spread of ayahuasca use throughout the Ucayali basin","year":"2023","cit":1,"pfa":"Carlos Suárez-Álvarez","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4404539705","eid":"W4404539705"},{"id":"paper-w2363910346","cat":"papers","name":"Identification of amphetamine and 3,4-methylenedioxymethamphetamine (MDMA) in plasma by TLC scanning","year":"2003","cit":1,"pfa":"Yujin Wang","ptype":"article","src":"https://openalex.org/W2363910346","eid":"W2363910346"},{"id":"paper-w4403969632","cat":"papers","name":"Ayahuasca-Inspired DMT/HAR Formulation Reduces Brain Differentiation Between Self and Other Faces","year":"2024","cit":1,"pfa":"Dila Suay","psa":"Davide Bottari","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4403969632","eid":"W4403969632"},{"id":"paper-w7161714083","cat":"papers","name":"Implementing psilocybin-assisted therapy in palliative care settings: A survey of stakeholders","year":"2026","cit":1,"pfa":"Louis Plourde","psa":"Michel Dorval","topics":["Anxiety & end-of-life","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7161714083","eid":"W7161714083"},{"id":"paper-w2067201783","cat":"papers","name":"Deteriorating Cost-Benefit Ratios for Ecstasy/MDMA with Repeated Usage","year":"2011","cit":1,"pfa":"A. O’Sullivan","ptype":"article","src":"https://openalex.org/W2067201783","eid":"W2067201783"},{"id":"paper-w4387955459","cat":"papers","name":"Adapting the Safe Consumption Site Model for Patient-Procured MDMA","year":"2023","cit":1,"pfa":"Shannon Dames","ptype":"article","src":"https://openalex.org/W4387955459","eid":"W4387955459"},{"id":"paper-w2403738004","cat":"papers","name":"[A preliminary study on the mechanism of neurotoxicity of MDMA--oxidative stress harm].","year":"2006","cit":1,"pfa":"Su‐Xia Li","psa":"Mingsheng Huang","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W2403738004","eid":"W2403738004"},{"id":"paper-w4402716580","cat":"papers","name":"Acute psilocybin and ketanserin effects on cerebral blood flow: 5-HT2AR neuromodulation in healthy humans","year":"2024","cit":1,"pfa":"Kristian Larsen","psa":"Patrick M. Fisher","topics":["Depression","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4402716580","eid":"W4402716580"},{"id":"paper-w324767899","cat":"papers","name":"Endocrine and neurochemical effects of S(+) and R(‐)‐MDMA in rhesus macaques","year":"2009","cit":1,"pfa":"Kevin Sean Murnane","psa":"Leonard Lee Howell","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W324767899","eid":"W324767899"},{"id":"paper-w329200959","cat":"papers","name":"Influence of marijuana and ecstasy (MDMA) on cognitive function and driving performance","year":"2004","cit":1,"pfa":"C. T. J. Lamers","topics":["Addiction","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W329200959","eid":"W329200959"},{"id":"paper-w2257347386","cat":"papers","name":"MDMA: Stress regulation, cortisol, 5-HTTLPR and COMT polymorphisms","year":"2006","cit":1,"pfa":"E M Tsapakis","psa":"Katherine Jean Aitchison","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2257347386","eid":"W2257347386"},{"id":"paper-w2576901979","cat":"papers","name":"MDMA e seus metabolitos : efeito vascular e toxicidade","year":"2014","cit":1,"pfa":"Maria Inês Simões da Silva Travassos Pimentel","ptype":"dissertation","src":"https://openalex.org/W2576901979","eid":"W2576901979"},{"id":"paper-w4408278967","cat":"papers","name":"Special issue on “Ketamine, MDMA, and psychedelics in the treatment of neuropsychiatric disorders”","year":"2025","cit":1,"pfa":"Kenji Hashimoto","psa":"Jichun Zhang","ptype":"editorial","src":"https://openalex.org/W4408278967","eid":"W4408278967"},{"id":"paper-w4211040017","cat":"papers","name":"Correction to: Administration of N,N‑dimethyltryptamine (DMT) in psychedelic therapeutics and research and the study of endogenous DMT","year":"2022","cit":1,"pfa":"Steven A. Barker","ptype":"erratum","src":"https://openalex.org/W4211040017","eid":"W4211040017"},{"id":"paper-w4378880364","cat":"papers","name":"Ego Birth: Measure 109, The NMHA, and Forward Movement in the Nascent Psilocybin Industry","year":"2023","cit":1,"pfa":"Andrew M. Robie","ptype":"preprint","src":"https://openalex.org/W4378880364","eid":"W4378880364"},{"id":"paper-w3101434061","cat":"papers","name":"The Synthesis and Chemical Profiling of 3,4-Methylene-Dioxymethamphetamine (MDMA) and Analogues","year":"2020","cit":1,"pfa":"Erin Heather","ptype":"dissertation","src":"https://openalex.org/W3101434061","eid":"W3101434061"},{"id":"paper-w4405061673","cat":"papers","name":"Chapter 4. MDMA-Assisted Psychotherapy for Posttraumatic Stress Disorder","year":"2018","cit":1,"topics":["PTSD & trauma","Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W4405061673","eid":"W4405061673"},{"id":"paper-w4409382109","cat":"papers","name":"A survey of tryptamines in southern African Senegalia and Vachellia reveals N,N-dimethyltryptamine in Senegalia ataxacantha","year":"2025","cit":1,"pfa":"Nicholas John Sadgrove","psa":"B.-E. Van Wyk","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4409382109","eid":"W4409382109"},{"id":"paper-w1998044228","cat":"papers","name":"Characterization of challenging experiences (i.e., bad trips) after ingesting psilocybin","year":"2014","cit":1,"pfa":"Matthew P. Bradstreet","psa":"Roland R. Griffiths","ptype":"article","src":"https://openalex.org/W1998044228","eid":"W1998044228"},{"id":"paper-w4206790817","cat":"papers","name":"Caffeine and MDMA (ecstasy) exacerbate ER stress triggered by hyperthermia","year":"2022","cit":1,"pfa":"Kathleen A. Trychta","psa":"Brandon K. Harvey","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4206790817","eid":"W4206790817"},{"id":"paper-w4224242407","cat":"papers","name":"Correction to: MDMA and memory, addiction, and depression: dose-effect analysis","year":"2022","cit":1,"pfa":"Madeline M. Pantoni","psa":"Stephan Anagnostaras","topics":["Depression","Addiction","Dosing & pharmacology"],"ptype":"erratum","src":"https://openalex.org/W4224242407","eid":"W4224242407"},{"id":"paper-w3080137050","cat":"papers","name":"Cation-π interaction of N,N-Dimethyltryptamine in hydrochloric acid solution characteristic to gastric acid","year":"2015","cit":1,"pfa":"Andrej Vidak","psa":"Vladimir Dananić","ptype":"article","src":"https://openalex.org/W3080137050","eid":"W3080137050"},{"id":"paper-w1571951885","cat":"papers","name":"Synthesis and pharmacological evaluation of fluorinated hallucinogenic tryptamine analogs and thienopyrrole bioisosteres of {\\it N,N/}-dimethyltryptamine","year":"1997","cit":1,"pfa":"Joseph B. Blair","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1571951885","eid":"W1571951885"},{"id":"paper-w2990161919","cat":"papers","name":"Labate, Beatriz Caiuby, and Edward MacRae (eds.): Ayahuasca, Ritual, and Religion in Brazil","year":"2012","cit":1,"pfa":"Bettina E. Schmidt","ptype":"article","src":"https://openalex.org/W2990161919","eid":"W2990161919"},{"id":"paper-w7163670700","cat":"papers","name":"Comparative medico-legal frameworks for psilocybin regulation: A March 2026 update","year":"2026","cit":1,"pfa":"Octavian Victor Brinzei","topics":["Policy & ethics"],"ptype":"editorial","src":"https://openalex.org/W7163670700","eid":"W7163670700"},{"id":"paper-w4409333610","cat":"papers","name":"Targeting Phantom Pain with Psilocybin: Toward Integration with Adaptive Sensory Technologies","year":"2025","cit":1,"pfa":"Robert B. Kargbo","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"editorial","src":"https://openalex.org/W4409333610","eid":"W4409333610"},{"id":"paper-w7134277123","cat":"papers","name":"Computational evaluation of aluminum and zinc doped C20 fullerenes as advanced sensors for the detection of the narcotic dimethyltryptamine","year":"2026","cit":1,"pfa":"Saad M. Alshahrani","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7134277123","eid":"W7134277123"},{"id":"paper-w4391810224","cat":"papers","name":"New evidence for flexible psilocybin dosing in patients with treatment-resistant depression","year":"2024","cit":1,"pfa":"Scott T. Aaronson","psa":"Zofia Kozak","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4391810224","eid":"W4391810224"},{"id":"paper-w4288059636","cat":"papers","name":"Ayahuasca and its interaction with the sigma-1 receptor: a potential treatment for COVID-19","year":"2022","cit":1,"pfa":"Guillermo Saúl Escobar Cornejo","psa":"Luis Fernando Ramos Vargas","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4288059636","eid":"W4288059636"},{"id":"paper-w3176443033","cat":"papers","name":"Psilocybin for Treating Psychiatric Disorders: Is it a Psychonaut Legend or a Promising Therapeutic Perspective?","year":"2021","cit":1,"pfa":"Maurizio Coppola","psa":"Raffaella Mondola","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W3176443033","eid":"W3176443033"},{"id":"paper-w4247147096","cat":"papers","name":"Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease","year":"2019","cit":1,"topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4247147096","eid":"W4247147096"},{"id":"paper-w4403733782","cat":"papers","name":"Psilocybin Reduces Grooming in the SAPAP3 Knockout Mouse Model of Compulsive Behaviour","year":"2024","cit":1,"pfa":"James J Gattuso","psa":"Thibault Renoir","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4403733782","eid":"W4403733782"},{"id":"paper-w7154915262","cat":"papers","name":"Psilocybin restores behavioral and neuroplastic deficits induced by chronic stress in rats","year":"2026","cit":1,"pfa":"Agnieszka Bysiek","psa":"Krystyna Gołembiowska","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7154915262","eid":"W7154915262"},{"id":"paper-w7143489717","cat":"papers","name":"Therapist Manual for Psilocybin-Assisted Therapy of Treatment-Resistant Major Depression","year":"2026","cit":1,"pfa":"Michael Koslowski","psa":"Lea Julia Mertens","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"report","src":"https://openalex.org/W7143489717","eid":"W7143489717"},{"id":"paper-w7128743161","cat":"papers","name":"Examining the effects of psilocybin-assisted psychotherapy on anhedonia in treatment-resistant depression","year":"2026","cit":1,"pfa":"Erica S. Kaczmarek","psa":"Joshua Daniel Rosenblat","topics":["Depression","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7128743161","eid":"W7128743161"},{"id":"paper-w4200395175","cat":"papers","name":"Daily briefing: Largest trial shows psilocybin is effective to treat depression","year":"2021","cit":1,"pfa":"Flora Graham","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4200395175","eid":"W4200395175"},{"id":"paper-w2415599107","cat":"papers","name":"Physiological concomitants of mescaline intoxication; a study of the effects upon normal subjects tested with submaximal doses.","year":"2003","cit":1,"pfa":"G A FEIGEN","psa":"Alles Ga","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2415599107","eid":"W2415599107"},{"id":"paper-w4399579797","cat":"papers","name":"Purging to Cleanse: A Qualitative Study of Ayahuasca Healing at a Drug Treatment Center in Peru","year":"2024","cit":1,"pfa":"Svět Lustig Vijay","psa":"Matteo Politi","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4399579797","eid":"W4399579797"},{"id":"paper-w7128392736","cat":"papers","name":"Preliminary effects of ayahuasca on mental and physical health: A systematic review of prospective studies","year":"2026","cit":1,"pfa":"Michael J. Haupt","psa":"Jacob S. Aday","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W7128392736","eid":"W7128392736"},{"id":"paper-w292126143","cat":"papers","name":"Possible uses of psilocybin and muscarin alkaloids in the chemotaxonomy of Inocybe (Fr.)Fr.","year":"1990","cit":1,"pfa":"L. S. Gurevich","psa":"E. L. Nezdoiminogo","ptype":"article","src":"https://openalex.org/W292126143","eid":"W292126143"},{"id":"paper-w4392948774","cat":"papers","name":"Psilocybin for the treatment of posttraumatic stress disorder: A magic to treat a harmony of illusions?","year":"2024","cit":1,"pfa":"Rakesh Khanna","topics":["PTSD & trauma","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4392948774","eid":"W4392948774"},{"id":"paper-w4417148678","cat":"papers","name":"The Relationship Between Participant Pretreatment Clinical Presentation and the Quality of Psilocybin Experience","year":"2025","cit":1,"pfa":"Namik Kirlić","psa":"Guy M. Goodwin","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4417148678","eid":"W4417148678"},{"id":"paper-w4413121052","cat":"papers","name":"Psilocybin triggers an activity-dependent rewiring of large-scale cortical networks","year":"2025","cit":1,"pfa":"Quan Jiang","psa":"Alex C. Kwan","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4413121052","eid":"W4413121052"},{"id":"paper-w2244684686","cat":"papers","name":"De la mandrágora al peyote. Plantas brujeriles en España y América","year":"2015","cit":1,"pfa":"Cecilia López Ridaura","ptype":"article","src":"https://openalex.org/W2244684686","eid":"W2244684686"},{"id":"paper-w2078461046","cat":"papers","name":"Lições da ayahuasca na AEUDV pernambucana DOI: 10.5007/1984-8951.2010v11n98p525","year":"2010","cit":1,"pfa":"Wagner Lins Lira","ptype":"article","src":"https://openalex.org/W2078461046","eid":"W2078461046"},{"id":"paper-w4411530308","cat":"papers","name":"Ayahuasca Ritual and Spiritual Practices for Substance Abuse Rehabilitation: the Takiwasi Model and Experience","year":"2025","cit":1,"pfa":"Jacques Mabit","psa":"Matteo Politi","topics":["Addiction","Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W4411530308","eid":"W4411530308"},{"id":"paper-w2770681623","cat":"papers","name":"3. « Un cas de toxicomanie par le peyote » : un enseignement inédit d’Henri Ellenberger","year":"2017","cit":1,"pfa":"HENRI F. ELLENBERGER","ptype":"book-chapter","src":"https://openalex.org/W2770681623","eid":"W2770681623"},{"id":"paper-w3157248359","cat":"papers","name":"Oregon's Pioneering Effort to Enact State Law to Allow Access to Psilocybin","year":"2020","cit":1,"pfa":"James D. Tucker","topics":["Depression","Anxiety & end-of-life","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W3157248359","eid":"W3157248359"},{"id":"paper-w2091308204","cat":"papers","name":"Osmoregulatory Mechanisms Differentiate MDMA-Associated Hyponatremia from Psychogenic Polydipsia","year":"2014","cit":1,"pfa":"Amir Kazory","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2091308204","eid":"W2091308204"},{"id":"paper-w4293181154","cat":"papers","name":"DNA damage in zebrafish larvae induced by exposure to MDMA: preliminary data","year":"2022","cit":1,"pfa":"Ondina Ribeiro","psa":"João Soares Carrola","ptype":"article","src":"https://openalex.org/W4293181154","eid":"W4293181154"},{"id":"paper-w1000868307","cat":"papers","name":"Ayahuasca-seremonier i Europa : søramerikansk sjamanisme i vestlig, nyreligiøs kontekst","year":"2010","cit":1,"pfa":"Bård Kjøge Rønning","ptype":"dissertation","src":"https://openalex.org/W1000868307","eid":"W1000868307"},{"id":"paper-w2786527446","cat":"papers","name":"Correction to: Current Perspective on MDMA-Assisted Psychotherapy for Posttraumatic Stress Disorder","year":"2018","cit":1,"pfa":"Sascha B. Thal","psa":"Miriam J.J. Lommen","topics":["PTSD & trauma","Therapy practice"],"ptype":"erratum","src":"https://openalex.org/W2786527446","eid":"W2786527446"},{"id":"paper-w2101202003","cat":"papers","name":"3,4-Methylenedioxymethamphetamine (MDMA) Induced Hyperthermia-The Role of Pro-Inflammatory Cytokines","year":"2011","cit":1,"pfa":"Abdallah Salem","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2101202003","eid":"W2101202003"},{"id":"paper-w4311073601","cat":"papers","name":"Evidências sobre os efeitos antidepressivos da Ayahuasca: uma revisão integrativa","year":"2022","cit":1,"pfa":"Ana Karoline Pontes da Silva","psa":"Natasha Silva","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4311073601","eid":"W4311073601"},{"id":"paper-w7127390507","cat":"papers","name":"LSD, champignons hallucinogènes, ayahuasca… contre la tentation d’un « exceptionnalisme psychédélique »","year":"2026","cit":1,"pfa":"Zoë Dubus","ptype":"other","src":"https://openalex.org/W7127390507","eid":"W7127390507"},{"id":"paper-w7203781486","cat":"papers","name":"Safety and Mental Health Outcomes of Oregon State-Regulated Psilocybin Services","year":"2026","cit":1,"pfa":"Philip Todd Korthuis","psa":"Adrianne R. Wilson‐Poe","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7203781486","eid":"W7203781486"},{"id":"paper-w2099505437","cat":"papers","name":"Decrease in use of ecstasy/MDMA: findings from the DUMA program","year":"2012","cit":1,"pfa":"Josh Sweeney","psa":"Sarah Macgregor","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2099505437","eid":"W2099505437"},{"id":"paper-w2545659549","cat":"papers","name":"Effects of ecstasy on autobiographical memories: implications for MDMA assisted psychotherapy","year":"2016","cit":1,"pfa":"H. Valerie Curran","psa":"David Nutt","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2545659549","eid":"W2545659549"},{"id":"paper-w2264556700","cat":"papers","name":"The differential effects of MDMA (ecstasy) use on executive and memory processes","year":"2017","cit":1,"pfa":"Catharine Montgomery","topics":["Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W2264556700","eid":"W2264556700"},{"id":"paper-w4413070968","cat":"papers","name":"Representaciones sociales de la salud mental en consumidores de Ayahuasca","year":"2025","cit":1,"pfa":"Fiorella Salazar Calderon","ptype":"dissertation","src":"https://openalex.org/W4413070968","eid":"W4413070968"},{"id":"paper-w2243020375","cat":"papers","name":"Imagens de cura: Ayahuasca, imaginação, saúde e doença na Barquinha","year":"2012","cit":1,"pfa":"Marcelo Simão Mercante","ptype":"article","src":"https://openalex.org/W2243020375","eid":"W2243020375"},{"id":"paper-w2397043754","cat":"papers","name":"[Studies on psilocybin, a hallucinogenic drug from the Mexican mushroom Psilocybe mexicana].","year":"1959","cit":1,"pfa":"F.A. Gnirss","ptype":"article","src":"https://openalex.org/W2397043754","eid":"W2397043754"},{"id":"paper-w2087050998","cat":"papers","name":"Chronic phenytoin and the stereotyped motor response induced by 5-methoxy-N,N-dimethyltryptamine in rats","year":"1985","cit":1,"pfa":"Robert Lalonde","psa":"M.I. Botez","ptype":"article","src":"https://openalex.org/W2087050998","eid":"W2087050998"},{"id":"paper-w1974841512","cat":"papers","name":"The Contribution of Ecstasy Dependence and Stress to Ecstasy/MDMA-Related Psychiatric Symptoms","year":"2011","cit":1,"pfa":"Raffaella Margherita Milani","ptype":"article","src":"https://openalex.org/W1974841512","eid":"W1974841512"},{"id":"paper-w4285521545","cat":"papers","name":"Aspectos históricos, jurídicos y culturales en torno al consumo de peyote en México","year":"2021","cit":1,"pfa":"Tláloc Humberto Mata-Zamor Tláloc Humberto Mata-Zamor","ptype":"article","src":"https://openalex.org/W4285521545","eid":"W4285521545"},{"id":"paper-w2801387544","cat":"papers","name":"The Next Chapter: MDMA-Assisted Psychotherapy for Chronic Treatment-Resistant PTSD","year":"2018","cit":1,"pfa":"Aaron S. Wolfgang","psa":"Sean L. Wilkes","topics":["Depression","PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2801387544","eid":"W2801387544"},{"id":"paper-w4411642243","cat":"papers","name":"Psilocybin Modulates TPJ Effective Connectivity during Out-of-Body Experiences","year":"2025","cit":1,"pfa":"Devon Stoliker","psa":"Adeel Razi","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4411642243","eid":"W4411642243"},{"id":"paper-w4416592848","cat":"papers","name":"Advancing treatment paradigms: the role of psilocybin in managing major depressive disorder","year":"2025","cit":1,"pfa":"Sana Rasheed","psa":"Abedin Samadi","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4416592848","eid":"W4416592848"},{"id":"paper-w4323912303","cat":"papers","name":"\"Toxic Encephalopathy following Methamphetamine, MDMA, and Marijuana Intoxication: A Case Report\"","year":"2022","cit":1,"pfa":"Stephen B. Howell","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4323912303","eid":"W4323912303"},{"id":"paper-w7117540352","cat":"papers","name":"Psilocybin Production With Genetically Modified Aspergillus nidulans Under Pressurized Conditions","year":"2025","cit":1,"pfa":"Sophie Weiser","psa":"Lars Regestein","ptype":"article","src":"https://openalex.org/W7117540352","eid":"W7117540352"},{"id":"paper-w1857561786","cat":"papers","name":"THERAPEUTIC MDMA (ECSTASY) & THE FEDERAL GOVERNMENT: A CLOUDY PAST & A HOPEFUL FUTURE","year":"2000","cit":1,"pfa":"Donald D. Lewis","topics":["Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1857561786","eid":"W1857561786"},{"id":"paper-w2174128864","cat":"papers","name":"Effect of vitamin C on 3,4 metoylenedioxymethamphetamine (MDMA) induced nephrotoxicity in rat.","year":"2010","cit":1,"pfa":"Massumeh Ahmadizadeh","psa":"J. Sharafee","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2174128864","eid":"W2174128864"},{"id":"paper-w4406667242","cat":"papers","name":"Experiential dimension of psilocybin-assisted therapy training: Necessity or hindrance to wider accessibility?","year":"2025","cit":1,"pfa":"Louis Plourde","psa":"Michel Dorval","topics":["Safety & adverse events","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4406667242","eid":"W4406667242"},{"id":"paper-w7165521934","cat":"papers","name":"Non-adherence to registration further undermines the methodologically weak Stanford University Magnesium-Ibogaine Study","year":"2026","cit":1,"pfa":"Dennis M. Gorman","ptype":"article","src":"https://openalex.org/W7165521934","eid":"W7165521934"},{"id":"paper-w4405966560","cat":"papers","name":"Psilocybin causes sex, time, and dose dependent alterations in brain signaling pathways","year":"2024","cit":1,"pfa":"J. Hudson Barnett","psa":"John Denis Fryer","topics":["Depression","PTSD & trauma","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4405966560","eid":"W4405966560"},{"id":"paper-w4409867324","cat":"papers","name":"Psilocybin Has No Analgesic Properties in Multiple Mouse Models of Acute and Chronic Pain","year":"2025","cit":1,"pfa":"Nicholas Gregory","psa":"Boris Dov Heifets","ptype":"article","src":"https://openalex.org/W4409867324","eid":"W4409867324"},{"id":"paper-w2910921484","cat":"papers","name":"Is MDMA-Assisted Psychotherapy an Effective Treatment for Posttraumatic Stress Disorder (PTSD)?","year":"2017","cit":1,"pfa":"Joey Rudd","topics":["PTSD & trauma","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2910921484","eid":"W2910921484"},{"id":"paper-w4407031458","cat":"papers","name":"1670: THE COST OF EUPHORIA: A CASE OF REFRACTORY SHOCK FROM MDMA TOXICITY","year":"2025","cit":1,"pfa":"Benjamin J. Pomy","psa":"Danielle L Davison","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4407031458","eid":"W4407031458"},{"id":"paper-w2152343762","cat":"papers","name":"Effects of ±3,4-Methylenedioxymethamphetamine (MDMA) Administration on Social Emotional Processing in Humans","year":"2011","cit":1,"pfa":"Gillinder Bedi","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2152343762","eid":"W2152343762"},{"id":"paper-w847918829","cat":"papers","name":"Patterns and Trends of MDMA Use and Sexual Risk Behavior in Central Ohio","year":"2001","cit":1,"pfa":"Robert Gideon Carlson","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W847918829","eid":"W847918829"},{"id":"paper-w4294202109","cat":"papers","name":"Therapeutic use of ayahuasca: a review of the evidence of its use in approaching depressive disorders","year":"2022","cit":1,"pfa":"Giovanni Caniçali Simões","psa":"R. Silva","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4294202109","eid":"W4294202109"},{"id":"paper-w4328054033","cat":"papers","name":"Psychedelische Therapie mit Psilocybin und Psychotherapie – Wo stehen wir?","year":"2023","cit":1,"pfa":"Anne Karow","topics":["Depression","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4328054033","eid":"W4328054033"},{"id":"paper-w7164885752","cat":"papers","name":"Distinct brain responses to psilocybin and escitalopram in depression captured by the Fluctuation-Dissipation Theorem","year":"2026","cit":1,"pfa":"Paulina Clara Dagnino","psa":"Gustavo Deco","topics":["Depression","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7164885752","eid":"W7164885752"},{"id":"paper-w1531274512","cat":"papers","name":"Ecstasy (MDMA) and its Relationship with Self- Report Depression, Anxiety and Schizotypy","year":"2010","cit":1,"pfa":"Lisa Wood","psa":"Barkus Emma","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W1531274512","eid":"W1531274512"},{"id":"paper-w4307184367","cat":"papers","name":"From neuroplasticity to psychoplasticity: Psilocybin may reverse personality disorders and political fanaticism","year":"2022","cit":1,"pfa":"Henry A. Nasrallah","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4307184367","eid":"W4307184367"},{"id":"paper-w4417435950","cat":"papers","name":"Doped C20 fullerenes as a new generation of efficient nanosorbents and nanosensors for rapid detection of dimethyltryptamine in drug detection","year":"2025","cit":1,"pfa":"Tareq Nafea Alharby","psa":"Jowaher Alanazi","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4417435950","eid":"W4417435950"},{"id":"paper-w798407066","cat":"papers","name":"Activity and Enzyme Kinetics of Human UDP-Glucuronosyltransferases : Studies of Psilocin Glucuronidation and the Effects of Albumin on the Enzyme Kinetic Mechanism","year":"2013","cit":1,"pfa":"Nenad Manevski","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W798407066","eid":"W798407066"},{"id":"paper-w2616590768","cat":"papers","name":"„Ecstasy” (MDMA): Pharmakologie, Toxikologie und Behandlung der akuten Intoxikation","year":"2004","cit":1,"pfa":"Matthias E. Liechti","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2616590768","eid":"W2616590768"},{"id":"paper-w2980960965","cat":"papers","name":"An investigation of the reinforcing effects of MDMA in rats trained to self-administer heroin","year":"2019","cit":1,"pfa":"Sharon L. Smith","psa":"David J. Heal","ptype":"article","src":"https://openalex.org/W2980960965","eid":"W2980960965"},{"id":"paper-w4226476783","cat":"papers","name":"Effects of MDMA on the development of Zebrafish (Danio rerio) embryos - preliminary data","year":"2022","cit":1,"pfa":"Nadine Peixoto","psa":"João Soares Carrola","ptype":"article","src":"https://openalex.org/W4226476783","eid":"W4226476783"},{"id":"paper-w4414072190","cat":"papers","name":"Psychological and neuropsychological effects of MDMA use during adolescence: a structured review","year":"2025","cit":1,"pfa":"Rocco Miazzi","psa":"Claudio Terranova","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4414072190","eid":"W4414072190"},{"id":"paper-w1981096261","cat":"papers","name":"Aggression attenuates psychomotor stimulant effects of d-amphetamine, MDMA and PCP","year":"1990","cit":1,"pfa":"Margaret Haney","psa":"Klaus A. Miczek","ptype":"article","src":"https://openalex.org/W1981096261","eid":"W1981096261"},{"id":"paper-w4409294824","cat":"papers","name":"431. Higher Intensity of Mystical Experience Following Magnesium-Ibogaine is Associated With Larger Decreases in PTSD Severity","year":"2025","cit":1,"pfa":"Randi E. Brown","psa":"Nolan Williams","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4409294824","eid":"W4409294824"},{"id":"paper-w4417193378","cat":"papers","name":"Real-World Psilocybin Therapy for Treatment-Resistant Depression: A Retrospective Observational Study","year":"2026","cit":1,"pfa":"Johannes Jungwirth","psa":"Sebastian Olbrich","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4417193378","eid":"W4417193378"},{"id":"paper-w2044303938","cat":"papers","name":"Neurons in the Dorsomedial Hypothalamus Mediate Physiologic Effects of MDMA in Anesthetized Rats","year":"2005","cit":1,"pfa":"Daniel E. Rusyniak","ptype":"conference-abstract","src":"https://openalex.org/W2044303938","eid":"W2044303938"},{"id":"paper-w4253697929","cat":"papers","name":"AYAHUASCA, THE HEALING VINE by MARLENE DOBKIN DE Rios. Mimeograph. 25 pp","year":"1970","cit":1,"ptype":"book-review","src":"https://openalex.org/W4253697929","eid":"W4253697929"},{"id":"paper-w4390541426","cat":"papers","name":"Exploring Psilocybin as a Tool for Studying Parkinsonism-Related Psychosis: A Narrative Review Supplemented with a Computational Approach","year":"2024","cit":1,"pfa":"Asja Čampara","psa":"Dženan Kovačić","topics":["Reviews & meta-analyses"],"ptype":"conference-paper","src":"https://openalex.org/W4390541426","eid":"W4390541426"},{"id":"paper-w4253655594","cat":"papers","name":"Erratum: Exposure to the Selective κ-Opioid Receptor Agonist Salvinorin A Modulates the Behavioral and Molecular Effects of Cocaine in Rats","year":"2008","cit":1,"pfa":"Elena H. Chartoff","psa":"William A. Carlezon","topics":["Addiction","Mechanism & neuroscience"],"ptype":"erratum","src":"https://openalex.org/W4253655594","eid":"W4253655594"},{"id":"paper-w2181660086","cat":"papers","name":"Investigating a Century-Long Hole in History: The Untold Story of Ayahuasca From 1755-1865","year":"2015","cit":1,"pfa":"Justin P. Williams","ptype":"dissertation","src":"https://openalex.org/W2181660086","eid":"W2181660086"},{"id":"paper-w4412819218","cat":"papers","name":"The Impact of Communicating the Benefits and Safety of Psilocybin on Policy Support: a Survey Based Experiment","year":"2025","cit":1,"pfa":"Karla Hitchins","psa":"James P. Reynolds","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4412819218","eid":"W4412819218"},{"id":"paper-w7155167159","cat":"papers","name":"Structural plasticity and enhanced fear extinction following psilocybin in chronically stressed mice","year":"2026","cit":1,"pfa":"Cory A. Knox","psa":"Alex C. Kwan","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7155167159","eid":"W7155167159"},{"id":"paper-w1990143094","cat":"papers","name":"ChemInform Abstract: Intramolecular Diels—Alder/Tsuji Allylation Assembly of the Functionalized trans‐Decalin (I) of Salvinorin A (II).","year":"2008","cit":1,"pfa":"Aaron C. Burns","psa":"Craig J. Forsyth","ptype":"article","src":"https://openalex.org/W1990143094","eid":"W1990143094"},{"id":"paper-w2053156304","cat":"papers","name":"Interactions between specific parameters of MDMA use and cognitive and psychopathological measures","year":"2014","cit":1,"pfa":"Daniel R. Wagner","psa":"Jörg Daumann","ptype":"article","src":"https://openalex.org/W2053156304","eid":"W2053156304"},{"id":"paper-w4411500561","cat":"papers","name":"The Emerging Use of Psilocybin in Adult Populations with Alcohol Use Disorder: A Scoping Review","year":"2025","cit":1,"pfa":"Danial Daroui","psa":"Sergio Amedeo Terracina","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4411500561","eid":"W4411500561"},{"id":"paper-w4415185432","cat":"papers","name":"The first applications of mescaline in psychiatry: The case of Madame Louise Françoise R. and its contemporary relevance","year":"2025","cit":1,"pfa":"Marion Hendrickx","psa":"Emmanuel Drouin","ptype":"article","src":"https://openalex.org/W4415185432","eid":"W4415185432"},{"id":"paper-w7153973756","cat":"papers","name":"Psilocybin for Treatment of Prolonged Grief Disorder: An Open-Label Feasibility Study Protocol","year":"2026","cit":1,"pfa":"J. Morgan Penberthy","psa":"Jonathan Singer","topics":["PTSD & trauma","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7153973756","eid":"W7153973756"},{"id":"paper-w4411885403","cat":"papers","name":"Psilocybin Use in an Intercollegiate Athlete with Persisting Symptoms After Concussion: A Case Report","year":"2025","cit":1,"pfa":"David Wyndham Lawrence","psa":"Michael G. Hutchison","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4411885403","eid":"W4411885403"},{"id":"paper-w4390816609","cat":"papers","name":"Enhanced visual contrast suppression during peak psilocybin effects: A psychophysical study","year":"2024","cit":1,"pfa":"Link Ray Swanson","psa":"Michael‐Paul Schallmo","topics":["Depression","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4390816609","eid":"W4390816609"},{"id":"paper-w7204809087","cat":"papers","name":"Pharmacokinetics, pharmacodynamics and safety of N,N -dimethyltryptamine administered intravenously in healthy smoking and non-smoking volunteers","year":"2026","cit":1,"pfa":"Katelijne V. van der Heijden","psa":"Gabriël E. Jacobs","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7204809087","eid":"W7204809087"},{"id":"paper-w4375947624","cat":"papers","name":"Psilocybin targets a common molecular mechanism for cognitive impairment and increased craving in alcoholism","year":"2023","cit":1,"pfa":"Marcus W. Meinhardt","psa":"Wolfgang H. Sommer","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4375947624","eid":"W4375947624"},{"id":"paper-w2730375455","cat":"papers","name":"Floresta manifesta: arte e imagens da ayahuasca em contextos urbanos brasileiros","year":"2016","cit":1,"pfa":"Gabrielle Dal Molin","ptype":"dissertation","src":"https://openalex.org/W2730375455","eid":"W2730375455"},{"id":"paper-w4410874041","cat":"papers","name":"Patients’ Attitudes Toward Hallucinogenic and Non-Hallucinogenic Psilocybin for Mental Health Treatment","year":"2025","cit":1,"pfa":"Araam Abboud","psa":"Danielle M. Gainer","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4410874041","eid":"W4410874041"},{"id":"paper-w4413368779","cat":"papers","name":"Resilience and Brain Changes in Long‐Term Ayahuasca Users: Insights From Psychometric and fMRI Pattern Recognition","year":"2025","cit":1,"pfa":"Lucas Rego Ramos","psa":"Tiago Arruda Sanchez","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4413368779","eid":"W4413368779"},{"id":"paper-w4415464487","cat":"papers","name":"Home-based psilocybin-assisted therapy for a patient with advanced cancer: A case report","year":"2025","cit":1,"pfa":"Houman Farzin","psa":"Nicolas Garel","topics":["Depression","Anxiety & end-of-life","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4415464487","eid":"W4415464487"},{"id":"paper-w4407319816","cat":"papers","name":"CORRECTION: Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis","year":"2025","cit":1,"pfa":"British Medical Journal Publishing Group","topics":["Depression","Reviews & meta-analyses"],"ptype":"erratum","src":"https://openalex.org/W4407319816","eid":"W4407319816"},{"id":"paper-w3038760066","cat":"papers","name":"Compreensão de Sentidos Atribuídos à Ayahuasca: Percursos Terapêuticos do Uso Ritualístico","year":"2020","cit":1,"pfa":"Jaqueline Tavares de ASSISI","psa":"Maria Inês Gandolfo Conceição","topics":["Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3038760066","eid":"W3038760066"},{"id":"paper-w4411176443","cat":"papers","name":"Psilocybin-Assisted Therapy Increases Self-Compassion in Patients with Alcohol Use Disorder","year":"2025","cit":1,"pfa":"Gabrielle Agin-Liebes","psa":"Michael P. Bogenschutz","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4411176443","eid":"W4411176443"},{"id":"paper-w1992531256","cat":"papers","name":"485. MDMA (“ecstasy”) effects on sensorimotor gating after selective pretreatments in humans","year":"2000","cit":1,"pfa":"Matthias E. Liechti","psa":"F.X. Vollenweider","ptype":"article","src":"https://openalex.org/W1992531256","eid":"W1992531256"},{"id":"paper-w1932051062","cat":"papers","name":"Personalidad, psicopatología y rendimiento neuropsicológico de los consumidores rituales de ayahuasca","year":"2012","cit":1,"pfa":"Bouso Saiz","psa":"José Carlos","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W1932051062","eid":"W1932051062"},{"id":"paper-w7118000985","cat":"papers","name":"The effects of psilocybin on time perception in humans: A comparative analysis of subjective and objective measures","year":"2026","cit":1,"pfa":"Petr Scholle","psa":"Tomáš Páleníček","ptype":"article","src":"https://openalex.org/W7118000985","eid":"W7118000985"},{"id":"paper-w1820732776","cat":"papers","name":"Jíkuri sepawa'ame (la \" raspa de peyote\"): una danza de curación en la sierra Tarahumara","year":"2009","cit":1,"pfa":"Carlo Bonfiglioli","ptype":"article","src":"https://openalex.org/W1820732776","eid":"W1820732776"},{"id":"paper-w4413539461","cat":"papers","name":"‘Authentic’ ayahuasca rituals sought by tourists often ignore Indigenous practices and spiritual grounding","year":"2024","cit":1,"pfa":"Pardis Mahdavi","ptype":"other","src":"https://openalex.org/W4413539461","eid":"W4413539461"},{"id":"paper-w4384663115","cat":"papers","name":"Personality Change in a Trial of Psilocybin Therapy vs Escitalopram Treatment for Depression – CORRIGENDUM","year":"2023","cit":1,"pfa":"Brandon Weiss","psa":"David Erritzøe","topics":["Depression"],"ptype":"erratum","src":"https://openalex.org/W4384663115","eid":"W4384663115"},{"id":"paper-w2153649102","cat":"papers","name":"population based study childhood and use of MDMA: prospective, Symptoms of anxiety and depression in","year":"2006","cit":1,"pfa":"Anja C. Huizink","psa":"Frank C. Verhulst","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2153649102","eid":"W2153649102"},{"id":"paper-w2541043966","cat":"papers","name":"Low-dose MDMA increases responses to psychosocial stress in healthy human volunteers","year":"2016","cit":1,"pfa":"Anya K. Bershad","psa":"Jacob A. Seiden","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2541043966","eid":"W2541043966"},{"id":"paper-w7130340412","cat":"papers","name":"Predicting drug–drug interactions between ayahuasca alkaloids and SSRIs using physiologically based pharmacokinetic modeling","year":"2026","cit":1,"pfa":"Gabriella de Souza Gomes Ribeiro","psa":"Tânia Marcourakis","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7130340412","eid":"W7130340412"},{"id":"paper-w7162316452","cat":"papers","name":"Psilocybin modulates social behaviour in male and female mice in a time-dependent manner","year":"2026","cit":1,"pfa":"Sheida Shadani","psa":"Claire J. Foldi","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7162316452","eid":"W7162316452"},{"id":"paper-w2797676293","cat":"papers","name":"Statute Prohibiting Use of Peyote Unconstitutional as Applied to Religious Users: Freedom of Religion. Constitutional Law. Narcotics","year":"1965","cit":1,"pfa":"H. Paul Breslin","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2797676293","eid":"W2797676293"},{"id":"paper-w4414613808","cat":"papers","name":"Psilocybin inhibits formalin-induced nociception through 5-hydroxytryptamine 2A receptor in rats","year":"2025","cit":1,"pfa":"Saadet Inan","psa":"Stephanie E. Daws","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4414613808","eid":"W4414613808"},{"id":"paper-w4415820910","cat":"papers","name":"Psilocybin-assisted therapy for demoralisation in hospice patients: feasibility, safety and preliminary efficacy","year":"2025","cit":1,"pfa":"Yvan Beaussant","psa":"James A. Tulsky","topics":["Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4415820910","eid":"W4415820910"},{"id":"paper-w4395102419","cat":"papers","name":"Psilocybin in the treatment of generalized anxiety disorder (GAD), alcoholism and smoking: a literature review","year":"2023","cit":1,"pfa":"Fabiano F. da Silva","psa":"Pierre Teodósio Félix","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4395102419","eid":"W4395102419"},{"id":"paper-w2768347162","cat":"papers","name":"Etnografitti: arte e ayahuasca na zona norte do Rio de Janeiro","year":"2017","cit":1,"pfa":"Gabrielle Dal Molin","ptype":"article","src":"https://openalex.org/W2768347162","eid":"W2768347162"},{"id":"paper-w4236031986","cat":"papers","name":"O USO RITUALISTÍCO E FARMACOLÓGICO DA AYAHUASCA: UMA REVISÃO DE LITERATURA","year":"2020","cit":1,"pfa":"Cicero Jerfesson Ferreira Silva","psa":"Alyne Oliveira Correia","topics":["Depression","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4236031986","eid":"W4236031986"},{"id":"paper-w7131407394","cat":"papers","name":"Advancing cancer neuroscience through stress modulation: Interdisciplinary potential of psilocybin and ketamine","year":"2026","cit":1,"pfa":"Alan C. Courtes","psa":"Rodrigo Machado‐Vieira","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7131407394","eid":"W7131407394"},{"id":"paper-w4416252417","cat":"papers","name":"Pharmacodynamic effects and plasma pharmacokinetics of N, N-dimethyltryptamine after intranasal versus subcutaneous administration in male rats","year":"2025","cit":1,"pfa":"Michael H. Baumann","psa":"Jacqueline L. von Salm","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4416252417","eid":"W4416252417"},{"id":"paper-w4235103517","cat":"papers","name":"Psychological Effects of Methylenedioxymethamphetamine (MDMA) When Administered to Healthy Volunteers (MT-2)","year":"2019","cit":1,"ptype":"article","src":"https://openalex.org/W4235103517","eid":"W4235103517"},{"id":"paper-w4399877880","cat":"papers","name":"Psilocybin Therapy for Depression and Anxiety in Parkinson's Disease: An Open-Label Pilot Trial","year":"2024","cit":1,"pfa":"Ellen  R. Bradley","psa":"Joshua D. Woolley","topics":["Depression","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W4399877880","eid":"W4399877880"},{"id":"paper-w2019004312","cat":"papers","name":"A single neurotoxic dose of MDMA decreases BDNF expression in the frontoparietal cortex but not in the hippocampus","year":"2009","cit":1,"pfa":"Szilvia Vas","psa":"György Bagdy","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2019004312","eid":"W2019004312"},{"id":"paper-w1525755079","cat":"papers","name":"Dependência, recuperação e o tratamento através da ayahuasca: definições e indefinições","year":"2013","cit":1,"pfa":"Marcelo Simão Mercante","ptype":"article","src":"https://openalex.org/W1525755079","eid":"W1525755079"},{"id":"paper-w4411178240","cat":"papers","name":"Cantos xamânicos Huni Kuin: cerimônias de ayahuasca, cosmologias e pontes entre mundos","year":"2025","cit":1,"pfa":"Leonardo Bomfim","ptype":"article","src":"https://openalex.org/W4411178240","eid":"W4411178240"},{"id":"paper-w4390223843","cat":"papers","name":"Psilocybin as a treatment for anorexia nervosa: 6-week and 3-month follow-up results","year":"2023","cit":1,"pfa":"Hannah M. Douglass","psa":"Robin Lester Carhart-Harris","ptype":"article","src":"https://openalex.org/W4390223843","eid":"W4390223843"},{"id":"paper-w4417459862","cat":"papers","name":"Psilocybin-assisted therapy for individuals with palliative care needs: A systematic review of safety and efficacy","year":"2025","cit":1,"pfa":"Rita S. Matos","psa":"Sara Diogo Gonçalves","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W4417459862","eid":"W4417459862"},{"id":"paper-w2615962745","cat":"papers","name":"Desenvolvimento de método para determinação de alcaloides indólicos em amostras de ayahuasca","year":"2016","cit":1,"pfa":"Mônica C. Santos","topics":["Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W2615962745","eid":"W2615962745"},{"id":"paper-w3008830597","cat":"papers","name":"The Effect of Curcumin on Functional and Structural Alterations of the Liver in Rats after MDMA Consumption","year":"2019","cit":1,"pfa":"Naser Khalaji","psa":"Mohammad Hassan Khadem Ansari","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3008830597","eid":"W3008830597"},{"id":"paper-w4312219828","cat":"papers","name":"High dose shock therapy with LSD and mescaline: the experiments of a French doctor on two homosexual adolescents in the 1960s","year":"2022","cit":1,"pfa":"Zoë Dubus","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W4312219828","eid":"W4312219828"},{"id":"paper-w2125330882","cat":"papers","name":"Signal-Averaged Electrocardiogram in Physically Healthy, Chronic 3,4-Methylenedioxymethamphetamine (MDMA) Users","year":"2008","cit":1,"pfa":"Praveen Kanneganti","psa":"David A. Gorelick","ptype":"article","src":"https://openalex.org/W2125330882","eid":"W2125330882"},{"id":"paper-w4405855206","cat":"papers","name":"MDMA as well as amphetamine and alcohol increase feelings of social closeness in healthy adults","year":"2024","cit":1,"pfa":"Harriet de Wit","psa":"Hanna M. Molla","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4405855206","eid":"W4405855206"},{"id":"paper-w2038933722","cat":"papers","name":"Low Hospital Admission Rates Following MDMA (Ecstasy) Intake in Essen (Germany)","year":"2007","cit":1,"pfa":"Norbert Scherbaum","psa":"Cornelius Wurthmann","ptype":"article","src":"https://openalex.org/W2038933722","eid":"W2038933722"},{"id":"paper-w2025940882","cat":"papers","name":"RETRACTED ARTICLE: Experimental and theoretical study of functionalized diterpenoids of salvinorin A type and molecular factors contributing to their selectivity to κ-opioid receptors","year":"2013","cit":1,"pfa":"Bojidarka B. Ivanova","psa":"Michael Spiteller","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2025940882","eid":"W2025940882"},{"id":"paper-w3082064415","cat":"papers","name":"PERCEPÇÃO SUBJETIVA DE UMA USUÁRIA DO CHÁ DE AYAHUASCA - ESTUDO DE CASO","year":"2020","cit":1,"pfa":"Caroline de Oliveira Lima","psa":"Vania Rodríguez","ptype":"article","src":"https://openalex.org/W3082064415","eid":"W3082064415"},{"id":"paper-w2149003461","cat":"papers","name":"Effect of Extraction Procedure and Gas Chromatography Temperature Program on Discrimination of MDMA Exhibits","year":"2013","cit":1,"pfa":"Karlie M. McManaman","psa":"Ruth Smith","ptype":"article","src":"https://openalex.org/W2149003461","eid":"W2149003461"},{"id":"paper-w3197754443","cat":"papers","name":"Three regulatory compliant test systems show no signs of MDMA-related genotoxicity","year":"2021","cit":1,"pfa":"Isaac V. Cohen","psa":"Berra Yazar‐Klosinski","topics":["PTSD & trauma","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3197754443","eid":"W3197754443"},{"id":"paper-w7164300604","cat":"papers","name":"“I even saw four deer grazing”: online-offline entanglements in the psilocybin pluriverse","year":"2026","cit":1,"pfa":"Michał Wanke","psa":"Piotr Siuda","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7164300604","eid":"W7164300604"},{"id":"paper-w4401871079","cat":"papers","name":"3,4-Methylenedioxymethamphetamine (MDMA) consumption in Aotearoa New Zealand: A quantitative survey exploration","year":"2024","cit":1,"pfa":"Jai Whelan","psa":"Ryan D. Ward","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4401871079","eid":"W4401871079"},{"id":"paper-w3161980303","cat":"papers","name":"Da Amazônia para o mundo: Ayahuasca, Xamanismo e o renascimento cultural Yawanawa","year":"2021","cit":1,"pfa":"V. BOMFIM","ptype":"book","src":"https://openalex.org/W3161980303","eid":"W3161980303"},{"id":"paper-w4409897324","cat":"papers","name":"Therapeutic Effects of Low-Dose Psilocybin in Depression and Other Mental Disorders: A Systematic Review","year":"2025","cit":1,"pfa":"Shakila Meshkat","psa":"Venkat Bhat","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W4409897324","eid":"W4409897324"},{"id":"paper-w4407426246","cat":"papers","name":"Sex Differences in Religious Beliefs Before and After an Entity Encounter During an Ayahuasca Experience","year":"2025","cit":1,"pfa":"Yitong Xin","psa":"Alan K. Davis","ptype":"article","src":"https://openalex.org/W4407426246","eid":"W4407426246"},{"id":"paper-w4407426955","cat":"papers","name":"Social Workers’ Attitudes and Beliefs about MDMA-Assisted Therapy for Adolescents with PTSD","year":"2025","cit":1,"pfa":"Maha N. Mian","psa":"Stacey B. Armstrong","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4407426955","eid":"W4407426955"},{"id":"paper-w125995102","cat":"papers","name":"Alarma social por el consumo de MDMA (Metilendioximetanfetamina) en España","year":"1995","cit":1,"pfa":"Rafael Garrido-Lestache","psa":"Gracia Barco Escobar","ptype":"article","src":"https://openalex.org/W125995102","eid":"W125995102"},{"id":"paper-w2609724700","cat":"papers","name":"High ambient temperature facilitates the acquisition of 3,4-methylenedioxymethamphetamine (MDMA) self-administration","year":"2017","cit":1,"pfa":"Shawn M. Aarde","psa":"Michael A. Taffe","topics":["Therapy practice","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W2609724700","eid":"W2609724700"},{"id":"paper-w4210650651","cat":"papers","name":"Animal Study Finds Effects on Behavior, Brain Chemistry of Prenatal MDMA Exposure","year":"2004","cit":1,"pfa":"Betsy Earp","ptype":"dataset","src":"https://openalex.org/W4210650651","eid":"W4210650651"},{"id":"paper-w2241021250","cat":"papers","name":"Primeiro perfil do usuário de \"êxtase\" (MDMA) em São Paulo","year":"2000","cit":1,"pfa":"Stella Pereira de Almeida","topics":["Depression"],"ptype":"dissertation","src":"https://openalex.org/W2241021250","eid":"W2241021250"},{"id":"paper-w3089848183","cat":"papers","name":"O uso da ayahuasca no tratamento da dependência química: uma revisão integrativa brasileira","year":"2020","cit":1,"pfa":"Leonardo Ferreira de Souza","psa":"Alberto Mesaque Martins","ptype":"article","src":"https://openalex.org/W3089848183","eid":"W3089848183"},{"id":"paper-w4399723683","cat":"papers","name":"How Does Psilocybin Therapy Work? an Exploration of Experiential Avoidance as a Putative Mechanism of Change","year":"2024","cit":1,"pfa":"Richard J. Zeifman","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W4399723683","eid":"W4399723683"},{"id":"paper-w2044213898","cat":"papers","name":"P15 THE EFFECT OF MDMA AND MDE ON L-DOPA-INDUCED DYSKINESIA IN PARKINSONIAN RATS","year":"2006","cit":1,"pfa":"J. Lauks","psa":"Werner Schmidt","topics":["Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W2044213898","eid":"W2044213898"},{"id":"paper-w4416827227","cat":"papers","name":"A meta-analytic analysis of the acute effects of MDMA on empathy and emotion recognition in humans","year":"2025","cit":1,"pfa":"Leehe Peled‐Avron","psa":"Joshua D. Woolley","topics":["PTSD & trauma","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4416827227","eid":"W4416827227"},{"id":"paper-w4403702429","cat":"papers","name":"5-HT 2C receptors in the nucleus accumbens constrain the rewarding effects of MDMA","year":"2024","cit":1,"pfa":"Matthew B. Pomrenze","psa":"Boris Dov Heifets","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4403702429","eid":"W4403702429"},{"id":"paper-w4408054844","cat":"papers","name":"Tū Wairua: Development of an Indigenous Rongoā Māori Approach to Healing with Psilocybin Containing Mushrooms","year":"2025","cit":1,"pfa":"Anna-Leigh Hodge","psa":"Patrick McHugh","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4408054844","eid":"W4408054844"},{"id":"paper-w7118595574","cat":"papers","name":"Pharmacological Management of Anxiety in End‐of‐Life Care: A Systematic Review of Benzodiazepines, Opioids, and Psilocybin","year":"2026","cit":1,"pfa":"Brunno Freitas da Costa","psa":"Daniel Pagnin","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W7118595574","eid":"W7118595574"},{"id":"paper-w2302873818","cat":"papers","name":"S. B. Schaefer & P. T. Fürst, eds., People of the Peyote. Huichol Indian History, Religion and Survival","year":"1998","cit":1,"pfa":"Anath Ariel de Vidas","ptype":"article","src":"https://openalex.org/W2302873818","eid":"W2302873818"},{"id":"paper-w4386509618","cat":"papers","name":"Optimized infusion rates for N,N‐dimethyltryptamine to achieve a target psychedelic intensity based on a modeling and simulation framework","year":"2023","cit":1,"pfa":"Emma Eckernäs","psa":"Michael Ashton","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4386509618","eid":"W4386509618"},{"id":"paper-w4415288704","cat":"papers","name":"Psilocybin alleviates high-glucose and high-lipid-induced skin aging in BJ5Ta fibroblasts","year":"2025","cit":1,"pfa":"Farzaneh Norouzkhani","psa":"Igor Kovalchuk","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4415288704","eid":"W4415288704"},{"id":"paper-w47281711","cat":"papers","name":"MDMA (Extasis). Una droga de diseño de alta toxicidad potencial","year":"1994","cit":1,"pfa":"Pedro Luis Lorenzo","ptype":"article","src":"https://openalex.org/W47281711","eid":"W47281711"},{"id":"paper-w4405660466","cat":"papers","name":"Investigational COMP360 psilocybin treatment for treatment-resistant depression: assessing altered states of consciousness","year":"2024","cit":1,"pfa":"N. Hewitt","psa":"Guy M. Goodwin","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4405660466","eid":"W4405660466"},{"id":"paper-w4400295306","cat":"papers","name":"Bridging Psilocybin-Induced Changes in the Brain’s Dynamic Functional Connectome With an Individual’s Subjective Experience","year":"2024","cit":1,"pfa":"S. Parker Singleton","psa":"Amy F. Kuceyeski","ptype":"article","src":"https://openalex.org/W4400295306","eid":"W4400295306"},{"id":"paper-w4412872234","cat":"papers","name":"Epigenome-wide association study of psilocybin-induced methylome changes in alcohol use disorder","year":"2026","cit":1,"pfa":"Marvin M. Urban","psa":"Marcus W. Meinhardt","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4412872234","eid":"W4412872234"},{"id":"paper-w4405661082","cat":"papers","name":"Exploration of MDMA-assisted therapy for major depressive disorder: a proof of principle study","year":"2024","cit":1,"pfa":"Tor-Morten Kvam","psa":"Ole A. Andreassen","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4405661082","eid":"W4405661082"},{"id":"paper-w4398222499","cat":"papers","name":"3, 4‐methylenedioxymethamphetamine (MDMA)‐assisted psychotherapy: what the pharmacist needs to know","year":"2024","cit":1,"pfa":"Alexander T. Gallo","psa":"Paul Bernard Fitzgerald","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4398222499","eid":"W4398222499"},{"id":"paper-w4403283802","cat":"papers","name":"Rapidly Trading Down Depression's 3 Pillars to 5HT3-Receptors Through ECT or Psilocybin?","year":"2024","cit":1,"pfa":"Gottfried R S Treviranus","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4403283802","eid":"W4403283802"},{"id":"paper-w1973488223","cat":"papers","name":"Validation of a HPLC–FLD/PDA method for the quantification of MDMA and MDA in human plasma","year":"2008","cit":1,"pfa":"Béla Kiss","psa":"Felicia Loghin","ptype":"article","src":"https://openalex.org/W1973488223","eid":"W1973488223"},{"id":"paper-w4399431880","cat":"papers","name":"Validation of the Swiss Psychedelic Side Effects Inventory: Standardized assessment of adverse effects in studies of psychedelics and MDMA","year":"2024","cit":1,"pfa":"Abigail E. Calder","psa":"Gregor Hasler","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4399431880","eid":"W4399431880"},{"id":"paper-w4328052806","cat":"papers","name":"The Unique Neural Signature of Your Trip: Functional Connectome Fingerprints of Subjective Psilocybin Experience","year":"2023","cit":1,"pfa":"Hanna M. Tolle","psa":"Enrico Amico","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4328052806","eid":"W4328052806"},{"id":"paper-w4402902766","cat":"papers","name":"Material and immaterial designs: The patrimonialization of the Shipibo-Conibo kene designs and of the traditional use of ayahuasca in Peru","year":"2012","cit":1,"pfa":"Luisa Elvira Belaúnde","ptype":"article","src":"https://openalex.org/W4402902766","eid":"W4402902766"},{"id":"paper-w4319316533","cat":"papers","name":"Ayahuasca and personality. A systematic review and meta-analysis of cross-sectional studies with long-term participants ( Ayahuasca y personalidad. Revisión sistemática y metaanálisis de estudios transversales con partic","year":"2023","cit":1,"pfa":"Ismael Apud","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4319316533","eid":"W4319316533"},{"id":"paper-w7160917606","cat":"papers","name":"Ethical Complexities and Best Practices in Informed Consent Processes for Psilocybin Services: A Qualitative Study","year":"2026","cit":1,"pfa":"Christina Chwyl","psa":"Jason B. Luoma","topics":["Safety & adverse events","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7160917606","eid":"W7160917606"},{"id":"paper-w2442780575","cat":"papers","name":"[Clinical and toxicological evaluation of fatal poisoning with amphetamine derivative--MDMA, ecstasy (3,4-methylenedioxymethamphetamine)].","year":"2004","cit":1,"pfa":"Magdalena Łukasik‐Głębocka","psa":"Janusz Kołowski","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2442780575","eid":"W2442780575"},{"id":"paper-w2091739658","cat":"papers","name":"Twelve month outcomes of methylenedioxymethamphetamine (MDMA), polydrug exposed infants in the United Kingdom","year":"2012","cit":1,"pfa":"Lynn T. Singer","psa":"Andrew C. Parrott","ptype":"article","src":"https://openalex.org/W2091739658","eid":"W2091739658"},{"id":"paper-w4380987212","cat":"papers","name":"Sentidos y vivencias relacionados con el uso recreativo de MDMA (Éxtasis)","year":"2023","cit":1,"pfa":"Leticia Aszkinas Browarski","psa":"Juan Enrique Fernández","ptype":"article","src":"https://openalex.org/W4380987212","eid":"W4380987212"},{"id":"paper-w3194848852","cat":"papers","name":"Use of alternative therapy with Psilocybin in oncologic patients with depression and/or anxiety disorders - integrative review","year":"2021","cit":1,"pfa":"Frederico Marques Silveira","psa":"Douglas Reis Abdalla","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3194848852","eid":"W3194848852"},{"id":"paper-w2188734940","cat":"papers","name":"Working memory de®cits in current and previous users of MDMA (`ecstasy')","year":"2000","cit":1,"pfa":"Michelle Wareing","psa":"Philip N. Murphy","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2188734940","eid":"W2188734940"},{"id":"paper-w4400574805","cat":"papers","name":"Sex Differences Are Associated With Perceived Changes in Baseline and Post-Acute Religious Beliefs Among Ayahuasca Users","year":"2024","cit":1,"pfa":"Yitong Xin","psa":"Alan K. Davis","ptype":"article","src":"https://openalex.org/W4400574805","eid":"W4400574805"},{"id":"paper-w2005806539","cat":"papers","name":"Age differences in (±)3,4-methylenedioxymethamphetamine (MDMA)-induced conditioned taste aversions and monoaminergic activity","year":"2014","cit":1,"pfa":"Jennifer L. Cobuzzi","psa":"Anthony Lee Riley","ptype":"article","src":"https://openalex.org/W2005806539","eid":"W2005806539"},{"id":"paper-w4411530241","cat":"papers","name":"Santo Daime Ethnopsychiatry: Psychotherapy and Spiritual Care Implications of a Global Ayahuasca Healing Tradition from Amazonia","year":"2025","cit":1,"pfa":"Marc G. Blainey","topics":["Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W4411530241","eid":"W4411530241"},{"id":"paper-w7133517857","cat":"papers","name":"Serotonergic modulation of cortical gamma synchronization: right-lateralized psilocin effects on 40 Hz auditory steady-state responses in rats","year":"2026","cit":1,"pfa":"Inga Griškova-Bulanova","psa":"Tomáš Páleníček","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7133517857","eid":"W7133517857"},{"id":"paper-w4283164971","cat":"papers","name":"Frontispiece: Enlightening the “Spirit Molecule”: Photomodulation of the 5‐HT2A Receptor by a Light‐Controllable N,N‐Dimethyltryptamine Derivative","year":"2022","cit":1,"pfa":"Hubert Gerwe","psa":"Michael W. Decker","topics":["Mechanism & neuroscience"],"ptype":"paratext","src":"https://openalex.org/W4283164971","eid":"W4283164971"},{"id":"paper-w4315829760","cat":"papers","name":"CORRESPONDENCERegistration and deregistrationCaution in MDMA reportingStrategic PlanCoding systemOversightWho are the oppressors?Two questions about money","year":"1997","cit":1,"pfa":"Craig Newnes","psa":"John W. Rowe","ptype":"letter","src":"https://openalex.org/W4315829760","eid":"W4315829760"},{"id":"paper-w746482882","cat":"papers","name":"From Demonic Agency to Divine Presence: A Study of Human-Entity Relations at an Ayahuasca Treatment Centre","year":"2015","cit":1,"pfa":"Christoffer Stuveback","topics":["Addiction"],"ptype":"other","src":"https://openalex.org/W746482882","eid":"W746482882"},{"id":"paper-w3159723459","cat":"papers","name":"Altered Prediction-Error Processing May Underlie Psilocybin-Induced Changes in Self-Processing","year":"2021","cit":1,"pfa":"Katrin H. Preller","ptype":"article","src":"https://openalex.org/W3159723459","eid":"W3159723459"},{"id":"paper-w7133199113","cat":"papers","name":"We Licked the Toads so You Don’t Have to: A Comprehensive Analysis of the Chemical Syntheses of the Classical Psychedelics Bufotenin(e) and 5‐Methoxy‐ N , N ‐Dimethyltryptamine","year":"2026","cit":1,"pfa":"Anton A. Homon","psa":"John Frederick Trant","topics":["Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7133199113","eid":"W7133199113"},{"id":"paper-w4399487178","cat":"papers","name":"Therapeutic Potential of Fungally Derived Psilocybin Extract in Morphine-Dependent Mice: A Research Protocol","year":"2024","cit":1,"pfa":"Linda Nguyen","psa":"Adam Gaisinsky","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4399487178","eid":"W4399487178"},{"id":"paper-w4408310815","cat":"papers","name":"MDMA-Assisted Therapy for Complex-Post-Traumatic Stress Disorder: Toward a neurocognitive account","year":"2025","cit":1,"pfa":"Philip Gerrans","psa":"Lena Oestreich","topics":["PTSD & trauma","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4408310815","eid":"W4408310815"},{"id":"paper-w2091455334","cat":"papers","name":"ChemInform Abstract: OXIDATIVE CYCLIZATION OF NB‐DIMETHYLTRYPTAMINE, 3‐INDOLEPROPANOL, AND 3‐INDOLEPROPANETHIOL WTH N‐BROMO‐ OR N‐CHLOROSUCCINIMIDE","year":"1976","cit":1,"pfa":"Tohru Hino","psa":"M. NAKAGAWA","ptype":"article","src":"https://openalex.org/W2091455334","eid":"W2091455334"},{"id":"paper-w1528403742","cat":"papers","name":"Misérable miracle : la mescaline : avec quarante-huit dessins et documents manuscrits originaux de l'auteur","year":"1972","cit":1,"pfa":"Henri Michaux","ptype":"book","src":"https://openalex.org/W1528403742","eid":"W1528403742"},{"id":"paper-w2032849769","cat":"papers","name":"LES DERNIERS ADORATEURS DU PEYOTL Last Worshippers of Peyote) by MARINO BENZI. Paris: Editions Gallimard, 1972. (In French.)","year":"1973","cit":1,"pfa":"Wolfgang G. Jilek","ptype":"article","src":"https://openalex.org/W2032849769","eid":"W2032849769"},{"id":"paper-w7128711323","cat":"papers","name":"Trends in toxicological findings and drug seizures of MDMA in New Zealand from 2010 to 2022","year":"2026","cit":1,"pfa":"Thomas J. Sheehan","psa":"Helen Poulsen","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7128711323","eid":"W7128711323"},{"id":"paper-w4395010892","cat":"papers","name":"Psilocybin reduces functional connectivity and the encoding of spatial information by neurons in mouse retrosplenial cortex","year":"2024","cit":1,"pfa":"Victorita E. Ivan","psa":"Aaron J. Gruber","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4395010892","eid":"W4395010892"},{"id":"paper-w2408557445","cat":"papers","name":"Peripheral tissue distribution, brain distribution, metabolism, placental transfer, & fetal distribution of mescaline- 14 C in monkeys.","year":"1972","cit":1,"pfa":"Taska Rj","ptype":"article","src":"https://openalex.org/W2408557445","eid":"W2408557445"},{"id":"paper-w2278685372","cat":"papers","name":"Role of muscarinic and non-MDMA receptors in area tempestas for focally-evoked status epilepticus","year":"1993","cit":1,"pfa":"Alfonso Antonio Vincenzo Tortorella","psa":"Karen Gale","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2278685372","eid":"W2278685372"},{"id":"paper-w7158867625","cat":"papers","name":"The consequences of MDMA use are not easily disentangled from other drug use or lifestyle factors","year":"2026","cit":1,"pfa":"Lukas Andreas Basedow","ptype":"article","src":"https://openalex.org/W7158867625","eid":"W7158867625"},{"id":"paper-w2981676820","cat":"papers","name":"شناسایی سریع اکستاسی(MDMA) و متآمفتامین با استفاده از تستهای رنگی","year":"2016","cit":1,"pfa":"علیرضا خواجه امیری","ptype":"article","src":"https://openalex.org/W2981676820","eid":"W2981676820"},{"id":"paper-w4402381719","cat":"papers","name":"MDMA (“Ecstasy”) abuse leading to delayed onset rhabdomyolysis: A case report and literature review","year":"2024","cit":1,"pfa":"Swotantra Gautam","psa":"Tasnuva Anindita H. Mahmud","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4402381719","eid":"W4402381719"},{"id":"paper-w7130514665","cat":"papers","name":"Identification and Analysis of Lysergic Acid Diethylamide Analogs, 4‐Benzoyl‐ N,N ‐Diethyl‐7‐Methyl‐4,6,6a,7,8,9‐Hexahydroindolo[4,3‐ fg ]quinoline‐9‐Carboxamide (1Bz‐LSD) and N , N ‐Diethyl‐7‐Methyl‐4‐(4‐(Trimethylsilyl","year":"2026","cit":1,"pfa":"Rie Tanaka","psa":"Ruri Kikura‐Hanajiri","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7130514665","eid":"W7130514665"},{"id":"paper-w7118121099","cat":"papers","name":"Meaning and Purpose Therapy Modified for Psilocybin (P-MaP): A Treatment Model for Palliative Care Patients","year":"2025","cit":1,"pfa":"Philip S. Garrity","psa":"Jason M. Thompson","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7118121099","eid":"W7118121099"},{"id":"paper-w7140297251","cat":"papers","name":"Psilocybin shapes the slow, global propagation of brain activity over the cortical layout of 5HT2a receptors","year":"2026","cit":1,"pfa":"Veronica Mäki-Marttunen","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7140297251","eid":"W7140297251"},{"id":"paper-w7154020626","cat":"papers","name":"Single exposure to Ayahuasca reverses chronic stress effects on sociability, anxiety, cortisol, and BDNF in zebrafish","year":"2026","cit":1,"pfa":"Guilherme Lodetti","psa":"Eduardo Pacheco Rico","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7154020626","eid":"W7154020626"},{"id":"paper-w4205878830","cat":"papers","name":"Treatment of PTSD with MDMA as a method of counteracting the incidence of suicide. A discussion in the context of Polish law","year":"2021","cit":1,"pfa":"Konrad Burdziak","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4205878830","eid":"W4205878830"},{"id":"paper-w3129595723","cat":"papers","name":"Correction: Simão, A.Y., et al. Evaluation of the Cytotoxicity of Ayahuasca Beverages. Molecules 2020, 25, 5594","year":"2021","cit":1,"pfa":"Ana Y. Simão","psa":"Eugénia Gallardo","topics":["Safety & adverse events"],"ptype":"erratum","src":"https://openalex.org/W3129595723","eid":"W3129595723"},{"id":"paper-w7127440111","cat":"papers","name":"Psilocybin exerts differential effects on social behavior and inflammation in mice in contexts of activity-based anorexia","year":"2026","cit":1,"pfa":"Sheida Shadani","psa":"Claire J. Foldi","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7127440111","eid":"W7127440111"},{"id":"paper-w4413373076","cat":"papers","name":"The Potential Economic and Public Health Impact of MDMA‐Assisted Group Therapy for PTSD in Ukraine","year":"2025","cit":1,"pfa":"Elliot A. Marseille","psa":"Oleh Orlov","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4413373076","eid":"W4413373076"},{"id":"paper-w4313200338","cat":"papers","name":"A phase 1/2 trial of a vaporized 5-Methoxy-N,N-Dimethyltryptamine formulation, in patients with treatment-resistant depression","year":"2022","cit":1,"pfa":"Johannes T. Reckweg","psa":"Johannes Gerardus Ramaekers","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4313200338","eid":"W4313200338"},{"id":"paper-w1964972809","cat":"papers","name":"Potentiation of 5‐methoxy‐n,n‐dimethyltryptamine‐induced head‐twitches by diazepam: Evidence for involvement of adenosine uptake inhibition","year":"1993","cit":1,"pfa":"Paul C. Moser","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1964972809","eid":"W1964972809"},{"id":"paper-w4385838842","cat":"papers","name":"use of 3,4-Methylenedioxymethamphetamine (MDMA) in the treatment of Post-Traumatic Stress Disorder (PTSD) - review","year":"2023","cit":1,"pfa":"Karol Womperski","psa":"Magdalena OSUCH","topics":["PTSD & trauma","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4385838842","eid":"W4385838842"},{"id":"paper-w230498267","cat":"papers","name":"Neurotransporters at the Juncture of Drug Action: Role in Programmed Cell Death, and Toxicity of Abused MDMA","year":"1997","cit":1,"pfa":"Rabi Simantov","topics":["Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W230498267","eid":"W230498267"},{"id":"paper-w2409536169","cat":"papers","name":"[Effect of psilocybin on the behavior of normal mice & waltzing mice; comparison with lysergic acid monoethylamide & diethylamide].","year":"1959","cit":1,"pfa":"Jean-Christian Delay","psa":"M Durandin","ptype":"article","src":"https://openalex.org/W2409536169","eid":"W2409536169"},{"id":"paper-w7203789443","cat":"papers","name":"Brain-wide reconfiguration of burst firing by psilocybin reveals 5-HT2A-dependent circuit dynamics","year":"2026","cit":1,"pfa":"Davide Momi","psa":"Irene Rembado","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7203789443","eid":"W7203789443"},{"id":"paper-w4281945458","cat":"papers","name":"Avaliação do potencial farmacológico de chá de ayahuasca no manejo da ansiedade e depressão","year":"2022","cit":1,"pfa":"Maria Eduarda Kegler Ramos","psa":"Luciano de Oliveira Siqueira","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4281945458","eid":"W4281945458"},{"id":"paper-w4392112022","cat":"papers","name":"Recreational MDMA doses do not elicit hepatotoxicity in HepG2 spheroids under normo- and hyperthermia","year":"2024","cit":1,"pfa":"Alessandra Mara de Oliveira","psa":"Daniel Junqueira Dorta","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4392112022","eid":"W4392112022"},{"id":"paper-w4409088799","cat":"papers","name":"Successful treatment of intractable MDMA adverse reactions using acupuncture and traditional Chinese medicine","year":"2025","cit":1,"pfa":"Hope G. Kronman","psa":"Jeffrey R. Guss","topics":["Anxiety & end-of-life","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4409088799","eid":"W4409088799"},{"id":"paper-w4362734001","cat":"papers","name":"118. Does Psilocybin Change Synaptic Vesicular Density in the Brains of Patients With Mild Cognitive Impairment?","year":"2023","cit":1,"pfa":"Aron Amaev","psa":"Philip Gerretsen","ptype":"article","src":"https://openalex.org/W4362734001","eid":"W4362734001"},{"id":"paper-w7117145281","cat":"papers","name":"A Randomised, Triple-Blind, Dose-Finding Study of the Impact of Psilocybin on Motor Function in Healthy Participants","year":"2025","cit":1,"pfa":"Chiranth Bhagavan","psa":"Richard Kanaan","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7117145281","eid":"W7117145281"},{"id":"paper-w2903234159","cat":"papers","name":"Science, medicine, spirituality and ayahuasca in Catalonia. Understanding ritual healing in the treatment of addictions from an interdisciplinary perspective","year":"2017","cit":1,"pfa":"Ismael Apud","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2903234159","eid":"W2903234159"},{"id":"paper-w4415071340","cat":"papers","name":"Resonance-enhanced deep-UV Raman spectroscopy for MDMA identification in colored ecstasy tablets","year":"2025","cit":1,"pfa":"Lars Jasperse","psa":"Ruben F. Kranenburg","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4415071340","eid":"W4415071340"},{"id":"paper-w4402544142","cat":"papers","name":"The unpaved road of ayahuasca, a psychoactive brew, as a treatment for neuropathic pain: A review of mechanistic insights and clinical prospects","year":"2024","cit":1,"pfa":"Bianca Castro dos Santos","psa":"Rosana L. Pagano","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4402544142","eid":"W4402544142"},{"id":"paper-w4412665012","cat":"papers","name":"Personal Psychedelic Experience as a Training Qualification for Facilitators: A Thematic Analysis of Qualitative Interviews with Psilocybin Experts","year":"2024","cit":1,"pfa":"Jason B. Luoma","psa":"Philip Todd Korthuis","topics":["Safety & adverse events","Therapy practice","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4412665012","eid":"W4412665012"},{"id":"paper-w4403170713","cat":"papers","name":"Qualitative Research on Psilocybin-Assisted Psychotherapy for the Treatment of Mental Health Disorders: A Scoping Review Protocol","year":"2024","cit":1,"pfa":"Jennifer Pincombe","psa":"Susan Lee Rossell","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4403170713","eid":"W4403170713"},{"id":"paper-w4406970759","cat":"papers","name":"Psilocybin-Assisted Psychotherapy for Methamphetamine Use Disorder: A Pilot Open-Label Safety and Feasibility Study","year":"2025","cit":1,"pfa":"Elizabeth Knock","psa":"Jonathan Brett","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4406970759","eid":"W4406970759"},{"id":"paper-w4401815262","cat":"papers","name":"Single-Dose Psilocybin Therapy for Alcohol Use Disorder: Pharmacokinetics, Feasibility, Safety, and Efficacy in an Open-Label Study","year":"2024","cit":1,"pfa":"Mathias Ebbesen Jensen","psa":"Anders Fink‐Jensen","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4401815262","eid":"W4401815262"},{"id":"paper-w2562746980","cat":"papers","name":"When the party is over….: Investigating the effects of alcohol, THC and MDMA on simulator driving performance","year":"2014","cit":1,"pfa":"Janet L. Veldstra","topics":["Addiction"],"ptype":"dissertation","src":"https://openalex.org/W2562746980","eid":"W2562746980"},{"id":"paper-w2492925530","cat":"papers","name":"Avaliacao neuropsicologica de adolescentes que consomem cha de Ayahuasca em contexto ritual religioso","year":"2003","cit":1,"pfa":"Evelyn Doering da Silveira","ptype":"article","src":"https://openalex.org/W2492925530","eid":"W2492925530"},{"id":"paper-w4414395171","cat":"papers","name":"Unterschiedliche Reaktionen und Enzyme in der Psilocybin‐ Biosynthese bei Inocybe‐ und Psilocybe ‐Pilzen","year":"2025","cit":1,"pfa":"Tim Schäfer","psa":"Dirk Hoffmeister","ptype":"article","src":"https://openalex.org/W4414395171","eid":"W4414395171"},{"id":"paper-w4378982345","cat":"papers","name":"Liquid light: ayahuasca spirituality and the Santo Daime tradition Liquid light: ayahuasca spirituality and the Santo Daime tradition , by G. William Barnard, New York, NY, Colombia University Press, 2022, 384 pp., $35 (","year":"2023","cit":1,"pfa":"A.F.M. van der Braak","ptype":"book-review","src":"https://openalex.org/W4378982345","eid":"W4378982345"},{"id":"paper-w4387575351","cat":"papers","name":"Psilocybin-assisted neurofeedback for the improvement of executive functions: a randomised semi-naturalistic-lab feasibility study","year":"2023","cit":1,"pfa":"Stefanie Enriquez‐Geppert","psa":"Morten Peter Lietz","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4387575351","eid":"W4387575351"},{"id":"paper-w7127964914","cat":"papers","name":"Calcium Activation Mechanism of a Noncanonical Aromatic L-Amino Acid Decarboxylase from Psilocybin Mushroom","year":"2026","cit":1,"pfa":"Erin. E. Reynolds","psa":"Jing‐Ke Weng","topics":["Mechanism & neuroscience"],"ptype":"dataset","src":"https://openalex.org/W7127964914","eid":"W7127964914"},{"id":"paper-w2280496024","cat":"papers","name":"EFFECT OF PENTOXIFYLLINE ON HISTOMORPHOLOGICAL CHANGES OF KIDNEY AFTER ECSTASY (MDMA) ADMINISTRATION IN MALE WISTAR RAT.","year":"2014","cit":1,"pfa":"Ashoori Barmchi Alieh","psa":"Shabnam Movassaghi","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2280496024","eid":"W2280496024"},{"id":"paper-w2622313412","cat":"papers","name":"A Six-month Prospective Evaluation Of Personality Traits, Psychiatric Symptoms And Quality Of Life In Ayahuasca-naïve Subjects","year":"2009","cit":1,"pfa":"Barbosa P.C.R.","psa":"Rick J. Strassman","ptype":"article","src":"https://openalex.org/W2622313412","eid":"W2622313412"},{"id":"paper-w4390003124","cat":"papers","name":"Usos da ayahuasca e discursos sobre transtornos mentais na imprensa brasileira 1960-2010","year":"2023","cit":1,"pfa":"Vinícius Maurício de Lima","ptype":"article","src":"https://openalex.org/W4390003124","eid":"W4390003124"},{"id":"paper-w4417054521","cat":"papers","name":"The 3,4-methylenedioxymethamphetamine (MDMA) reduces prosocial behavior in the social preference test in male and female rats","year":"2025","cit":1,"pfa":"Daniel Alejandro Palacios-Lagunas","psa":"Miguel Pérez de la Mora","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4417054521","eid":"W4417054521"},{"id":"paper-w4318613872","cat":"papers","name":"Validated Portable Device for the Qualitative and Quantitative Electrochemical Detection of Mdma Ready for On-Site Use","year":"2023","cit":1,"pfa":"Robin Van Echelpoel","psa":"Karolien De Wael","ptype":"preprint","src":"https://openalex.org/W4318613872","eid":"W4318613872"},{"id":"paper-w4394793620","cat":"papers","name":"Neurotoxicidade associada ao uso de mdma (3-4 metilenodioximetanfetamina): uma revisão integrativa","year":"2024","cit":1,"pfa":"Pedro Henrique Figueiredo Souza e Silva","psa":"Mariana Chaves Cabral Alvarenga","ptype":"article","src":"https://openalex.org/W4394793620","eid":"W4394793620"},{"id":"paper-w2517373597","cat":"papers","name":"B-56Investigation of Personality Change Following MDMA-Assisted Psychotherapy for Post Traumatic Stress Disorder","year":"2016","cit":1,"pfa":"Michael Wagner","psa":"Rick Doblin","topics":["Depression","PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2517373597","eid":"W2517373597"},{"id":"paper-w2545855757","cat":"papers","name":"Psilocybin-induced decrease in amygdala-putamen coupling during an event-related face discrimination task","year":"2016","cit":1,"pfa":"Oliver R. Grimm","psa":"F.X. Vollenweider","ptype":"article","src":"https://openalex.org/W2545855757","eid":"W2545855757"},{"id":"paper-w4408953403","cat":"papers","name":"BIOLOGICAL ACTIVITY OF PSILOCYBIN EXTRACTS FROM THE FRUITING BODIES OF PSILOCYBE CUBENSIS ANTIOXIDANT AND ANTIMICROBIAL POTENTIAL","year":"2025","cit":1,"pfa":"Shimal Yonuis Abdulhadi","psa":"Sanabel A. Abd Almajeed","ptype":"article","src":"https://openalex.org/W4408953403","eid":"W4408953403"},{"id":"paper-w4251781708","cat":"papers","name":"C-(4,5,6-Trimethoxyindan-1-yl)methanamine: A Mescaline Analogue Designed Using a Homology Model of the 5-HT2A Receptor.","year":"2006","cit":1,"pfa":"Thomas H. McLean","psa":"David E. Nichols","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4251781708","eid":"W4251781708"},{"id":"paper-w4405397191","cat":"papers","name":"Short- and long-term reconfiguration of rat prefrontal cortical networks following single doses of psilocybin","year":"2024","cit":1,"pfa":"Ross J. Purple","psa":"Matthew W. Jones","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4405397191","eid":"W4405397191"},{"id":"paper-w4250372175","cat":"papers","name":"P.644 Ayahuasca-induced mania as first presentation of bipolar disorder: A clinical case and literature review","year":"2019","cit":1,"pfa":"Luís Afonso Fernandes","psa":"Nuno Borja Santos","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4250372175","eid":"W4250372175"},{"id":"paper-w2588916038","cat":"papers","name":"Ecología del falso peyote (Ariocarpus fissuratus) en la Reserva Ecológica Municipal Sierra y Cañón de Jimulco","year":"2016","cit":1,"pfa":"Celso Manuel Valencia Castro","psa":"Norma Margarita De la Fuente Salcido","ptype":"article","src":"https://openalex.org/W2588916038","eid":"W2588916038"},{"id":"paper-w4304631554","cat":"papers","name":"19.4 Pediatric Study Plan Agreed Upon With the FDA for the Use of MDMA for PTSD in Children and Adolescents","year":"2022","cit":1,"pfa":"Berra Yazar‐Klosinski","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4304631554","eid":"W4304631554"},{"id":"paper-w4411279727","cat":"papers","name":"Naturalistic Psilocybin Use Increases Mind Perception but not Atheist-Believer status: A Prospective Longitudinal Study","year":"2023","cit":1,"pfa":"Sandeep Manel Nayak","psa":"David B. Yaden","ptype":"preprint","src":"https://openalex.org/W4411279727","eid":"W4411279727"},{"id":"paper-w4387538640","cat":"papers","name":"Corrigendum: Ceremonial ayahuasca in amazonian retreats—mental health and epigenetic outcomes from a six-month naturalistic study","year":"2023","cit":1,"pfa":"Simon Ruffell","psa":"Celia J. A. Morgan","ptype":"erratum","src":"https://openalex.org/W4387538640","eid":"W4387538640"},{"id":"paper-w4414827451","cat":"papers","name":"The psychoactive compound ibogaine sex-dependently alters the firing rate and afterhyperpolarization of Ih-negative neurons in the mouse ventral tegmental area","year":"2025","cit":1,"pfa":"Jannik Nicklas Eliasen","psa":"Kristi A. Kohlmeier","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4414827451","eid":"W4414827451"},{"id":"paper-w2063814176","cat":"papers","name":"Acute and subchronic effects of MDMA (“ecstasy”) on anxiety in the “elevated plus maze test” in male mice","year":"2000","cit":1,"pfa":"E. Maldonado","psa":"D. Beltrán","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2063814176","eid":"W2063814176"},{"id":"paper-w3148434394","cat":"papers","name":"Tzíman y Lahax: el peyote y el toloache como advocaciones culturales para la región Huasteca, México","year":"2017","cit":1,"pfa":"Joaquín Muñoz Mendoza","ptype":"article","src":"https://openalex.org/W3148434394","eid":"W3148434394"},{"id":"paper-w7161840607","cat":"papers","name":"Brain-MGF: Multimodal Graph Fusion Network for EEG-FMRI Brain Connectivity Analysis Under Psilocybin","year":"2026","cit":1,"pfa":"Sin-Yee Yap","psa":"Chee‐Ming Ting","topics":["Mechanism & neuroscience"],"ptype":"conference-paper","src":"https://openalex.org/W7161840607","eid":"W7161840607"},{"id":"paper-w1974291759","cat":"papers","name":"Factors contributing to the enhancement of MDMA-induced 5-HT depletion by ethanol: a reply to Byron and Cassel","year":"2007","cit":1,"pfa":"Esther O’Shea","psa":"María Isabel Colado","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1974291759","eid":"W1974291759"},{"id":"paper-w7134072318","cat":"papers","name":"Psilocybin Treatment as an Adjunct to Cognitive Behavioral Therapy for Eating Disorders: Therapeutic Rationale & Considerations for Protocol Development","year":"2026","cit":1,"pfa":"Elena Koning","psa":"Aaron R. Keshen","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7134072318","eid":"W7134072318"},{"id":"paper-w7125924088","cat":"papers","name":"The therapeutic potential of ayahuasca in depression, generalized anxiety, and substance use disorders: modulation of the depressive burden in a longitudinal study","year":"2026","cit":1,"pfa":"Gláucio Silva Camargos","psa":"Gerardo Maria de Araújo Filho","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7125924088","eid":"W7125924088"},{"id":"paper-w4413975997","cat":"papers","name":"Comparative effects of ayahuasca and breathwork on self-reported cognitive flexibility, emotion regulation, positive affect, and sleep quality","year":"2025","cit":1,"pfa":"Giordano Novak Rossi","psa":"Kim P. C. Kuypers","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4413975997","eid":"W4413975997"},{"id":"paper-w262099440","cat":"papers","name":"Release of (/sup 3/H)-monoamines from superfused rat striatal slices by methylenedioxymethamphetamine (MDMA)","year":"1986","cit":1,"pfa":"Jennifer A. Levin","psa":"Walter M. Lovenberg","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W262099440","eid":"W262099440"},{"id":"paper-w7126380743","cat":"papers","name":"Ayahuasca enhances functional connectivity in the third visual pathway and mirror neuron networks: a crossover, multiple-dose functional MRI study","year":"2026","cit":1,"pfa":"Carla Soares","psa":"Miguel Castelo‐Branco","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7126380743","eid":"W7126380743"},{"id":"paper-w4416593366","cat":"papers","name":"Negative affective bias in depression following treatment with psilocybin or escitalopram – a secondary analysis from a randomized trial","year":"2025","cit":1,"pfa":"Marieke Martens","psa":"Catherine J. Harmer","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4416593366","eid":"W4416593366"},{"id":"paper-w2542326290","cat":"papers","name":"Bidirectional relations between MDMA and social context: crosstalk between drug response and social interaction","year":"2016","cit":1,"pfa":"Harriet de Wit","ptype":"article","src":"https://openalex.org/W2542326290","eid":"W2542326290"},{"id":"paper-w4413138173","cat":"papers","name":"The effect of MDMA administration on oxytocin concentration levels: systematic review and a multilevel meta-analysis in humans","year":"2025","cit":1,"pfa":"Anna Vaslavski","psa":"Leehe Peled‐Avron","topics":["Dosing & pharmacology","Reviews & meta-analyses","Therapy practice"],"ptype":"review","src":"https://openalex.org/W4413138173","eid":"W4413138173"},{"id":"paper-w2407357053","cat":"papers","name":"[RESEARCH CONCERNING THE PHARMACOLOGIC CHARACTERIZATION AND DIFFERENTIATION OF HALLUCINOGENIC DRUGS (INDOLE DERIVATES AND MESCALINE, NALORPHINE, CENTRAL ANTICHOLINERGIC AGENTS, PHENCYCLIDINE)].","year":"1996","cit":1,"pfa":"Jean-Noël Jacob","psa":"Christiane Barthélemy","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2407357053","eid":"W2407357053"},{"id":"paper-w4379388132","cat":"papers","name":"ID: 212703 Augmenting rTMS With Psilocybin-Assisted Psychotherapy (PAP) for PTSD: A Proof-of-Concept Study Design","year":"2023","cit":1,"pfa":"Basant Pradhan","psa":"Anthony L. Rostain","topics":["PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4379388132","eid":"W4379388132"},{"id":"paper-w4412368847","cat":"papers","name":"Brain-epigenome wide association study (BEWAS) on the effects of two emerging psychedelics: ketamine & MDMA","year":"2025","cit":1,"pfa":"Moira G. Semple","psa":"Candace R. Lewis","topics":["PTSD & trauma","Mechanism & neuroscience","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4412368847","eid":"W4412368847"},{"id":"paper-w3013950128","cat":"papers","name":"Aspectos (de)colonialidade e epistemologia ecológica com ênfase no não Humano (Ayahuasca): discursos e emancipação","year":"2020","cit":1,"pfa":"Gleibson do Nascimento Silva","psa":"João Batista Santiago Ramos","ptype":"article","src":"https://openalex.org/W3013950128","eid":"W3013950128"},{"id":"paper-w4401290980","cat":"papers","name":"Fmrfamide Mitigated MDMA (3, 4- Methylenedioxymethamphetamine)/Tramadol-Induced Testicular Toxicity in Wistar Rat","year":"2024","cit":1,"pfa":"Adebola O. Adetunji","psa":"Goodness O. Olatinwo","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4401290980","eid":"W4401290980"},{"id":"paper-w2573384919","cat":"papers","name":"MDMA increases affiliative behaviors and vocalizations in nonhuman primates in a 5-HT2A receptor-dependent manner","year":"2017","cit":1,"pfa":"Elizabeth G. Pitts","psa":"Leonard Lee Howell","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2573384919","eid":"W2573384919"},{"id":"paper-w2945042302","cat":"papers","name":"Psychedelic Movement: Healing Trauma through MDMA (3,4-Methylenedioxymethamphetamine)-Assisted Authentic Movement Psychotherapy","year":"2017","cit":1,"pfa":"Lyndsay Pixler","topics":["PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2945042302","eid":"W2945042302"},{"id":"paper-w7127639818","cat":"papers","name":"Practical Guidelines for Supportive Touch in Psychedelic-Assisted and MDMA-Assisted Therapy: A Model for Practitioners and Researchers","year":"2026","cit":1,"pfa":"Jason B. Luoma","psa":"Mary K. Lear","ptype":"article","src":"https://openalex.org/W7127639818","eid":"W7127639818"},{"id":"paper-w4402666007","cat":"papers","name":"Rave gone wrong: MDMA- induced medical emergency at electrical daisy carnival. A case report","year":"2024","cit":1,"pfa":"Charissa Alo","psa":"Mutsumi John Kioka","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4402666007","eid":"W4402666007"},{"id":"paper-w4413284161","cat":"papers","name":"164. PSILOCYBIN DURING THE POSTPARTUM PERIOD INDUCES LONG-LASTING ADVERSE EFFECTS IN BOTH MOTHERS AND OFFSPRING","year":"2025","cit":1,"pfa":"Cassandra J. Hatzipantelis","psa":"Danielle S. Stolzenberg","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4413284161","eid":"W4413284161"},{"id":"paper-w4414258408","cat":"papers","name":"Supporting Meaningful Choices: A Decision Aid for Individuals Facing Existential Distress and Considering Psilocybin-Assisted Therapy","year":"2025","cit":1,"pfa":"Ariane Bélanger","psa":"Michel Dorval","topics":["Anxiety & end-of-life","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4414258408","eid":"W4414258408"},{"id":"paper-w2521372162","cat":"papers","name":"The effect of adrenalectomy on MDMA-induced dopamine release in the striatum as measured by in vivo microdialysis and depletion of serotonin","year":"1992","cit":1,"pfa":"J. Frank Nash","psa":"M T Lowy","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2521372162","eid":"W2521372162"},{"id":"paper-w2607418276","cat":"papers","name":"Self-Reported Physical, Affective and Somatic Effects of Ecstasy (MDMA): An Observational Study of Recreational Users","year":"2017","cit":1,"pfa":"S. Fuit","psa":"Joris C. Verster","ptype":"article","src":"https://openalex.org/W2607418276","eid":"W2607418276"},{"id":"paper-w4396646332","cat":"papers","name":"Navigating Treatment Challenges: A Case Study on Refractory Psychosis in a Chronic MDMA (3,4-Methylenedioxymethamphetamine) User","year":"2024","cit":1,"pfa":"Melissa N Litenski","psa":"Jose Cruz","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4396646332","eid":"W4396646332"},{"id":"paper-w7117646156","cat":"papers","name":"A Nature-Themed Video Intervention Increases Nature Relatedness in Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder","year":"2025","cit":1,"pfa":"Rhianna Rich","psa":"Keith G. Heinzerling","topics":["Addiction","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7117646156","eid":"W7117646156"},{"id":"paper-w2474460864","cat":"papers","name":"[Pharmacological studies of hallucinogens. Report 3. II. Pharmacological studies of influence of psilocybin on the central nervous system].","year":"1968","cit":1,"pfa":"Masahiro HORIBE","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2474460864","eid":"W2474460864"},{"id":"paper-w1992620656","cat":"papers","name":"Determination of 3,4-Methylenedioxymethamphetamine (MDMA) and 3,4-Methylenedioxyamphetamine (MDA) in Urine by High Performance Liquid Chromatography","year":"2009","cit":1,"pfa":"Marcelo Carvalho Lasmar","psa":"Edna Maria Alvarez Leite","ptype":"article","src":"https://openalex.org/W1992620656","eid":"W1992620656"},{"id":"paper-w3083681028","cat":"papers","name":"Identifikasi dan Determinasi MDMA dalam Sampel Urine dengan Metode Kromatografi Lapis Tipis","year":"2020","cit":1,"pfa":"Desak Putu Ayu Suariyani","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3083681028","eid":"W3083681028"},{"id":"paper-w7128718542","cat":"papers","name":"Therapeutic effects of psilocybin in major depressive disorder: a systematic review and meta-analysis exploring dose effects","year":"2026","cit":1,"pfa":"Ziping He","psa":"J. Yan","topics":["Depression","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7128718542","eid":"W7128718542"},{"id":"paper-w2760527422","cat":"papers","name":"ENTRE O SACRAMENTO E O NARCÓTICO: ANALISANDO DISCURSOS DE DESLEGITIMAÇÃO DOS SABERES DA AYAHUASCA","year":"2017","cit":1,"pfa":"Camila de Pieri Benedito","ptype":"article","src":"https://openalex.org/W2760527422","eid":"W2760527422"},{"id":"paper-w1570488277","cat":"papers","name":"Current Research on the Human Experience of Spirituality Following the Ingestion of ‘Magic’ Psilocybin Mushrooms: An Annotated Bibliography for Social Workers and Other Health Care Professionals","year":"2010","cit":1,"pfa":"Rose Jade","ptype":"preprint","src":"https://openalex.org/W1570488277","eid":"W1570488277"},{"id":"paper-w2058850018","cat":"papers","name":"059 — (PRO0041) Adolescent mice are more vulnerable than adults to the rewarding effects of ecstasy (MDMA)","year":"2014","cit":1,"pfa":"Roberta Procópio‐Souza","psa":"Roberto Frussa‐Filho","ptype":"article","src":"https://openalex.org/W2058850018","eid":"W2058850018"},{"id":"paper-w2254736772","cat":"papers","name":"MDMA self-administration fails to alter the behavioral response to 5-HT1A and 5-HT1B agonists","year":"2016","cit":1,"pfa":"Dane Aronsen","psa":"Susan Schenk","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2254736772","eid":"W2254736772"},{"id":"paper-w4417527707","cat":"papers","name":"Acute 3,4-Methylenedioxymethamphetamine (MDMA) Toxicity Leading to Fulminant Hepatic Failure and Emergency Liver Transplantation","year":"2025","cit":1,"pfa":"Maria E Batista","psa":"Nuno Germano","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4417527707","eid":"W4417527707"},{"id":"paper-w3180250310","cat":"papers","name":"User perceptions of long-term costs and benefits of MDMA use: Findings from a large online sample","year":"2021","cit":1,"pfa":"James W. B. Elsey","psa":"Anouk Fieten","topics":["Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W3180250310","eid":"W3180250310"},{"id":"paper-w2065483334","cat":"papers","name":"MDMA (“ECSTASY”) suppresses innate IFN-gamma production and signalling, and inhibits MHC II expression on APCs","year":"2006","cit":1,"pfa":"Nathan Boyle","psa":"T.J. Connor","ptype":"article","src":"https://openalex.org/W2065483334","eid":"W2065483334"},{"id":"paper-w2797535687","cat":"papers","name":"SLC6A4 binding site and acute prosocial effects of (+/-)-3,4-methylendioxymethamphetamine (MDMA) are evolutionarily conserved in Octopus bimaculoides","year":"2018","cit":1,"pfa":"Eric Edsinger","psa":"Gül Dölen","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W2797535687","eid":"W2797535687"},{"id":"paper-w2159966087","cat":"papers","name":"ChemInform Abstract: Improved Fischer Indole Reaction for the Preparation of N,N‐ Dimethyltryptamines: Synthesis of L‐695,894, a Potent 5‐HT1D Receptor Agonist.","year":"1994","cit":1,"pfa":"Chienhung Billy Chen","psa":"Paul J. Reider","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2159966087","eid":"W2159966087"},{"id":"paper-w4391527354","cat":"papers","name":"MDMA-assisted dialectical behavioral therapy for borderline personality disorder: A qualitative study of mental health clinicians","year":"2024","cit":1,"pfa":"Ann M. Inouye","psa":"Lianne T. Philhower","topics":["Depression","PTSD & trauma","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4391527354","eid":"W4391527354"},{"id":"paper-w4377088482","cat":"papers","name":"Psilocybin-gestützte Therapie von Depression, Angst und Suchtstörungen: Neurobiologische Grundlagen und klinische Anwendung","year":"2023","cit":1,"pfa":"Anna Lasch","psa":"Andreas Walther","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4377088482","eid":"W4377088482"},{"id":"paper-w3089341399","cat":"papers","name":"Plantas de poder: o uso da ayahuasca no Centro de Unificação Rosa Azul (CURA), Pará-Brasil","year":"2020","cit":1,"pfa":"Ulliane de Oliveira Mesquita","psa":"Manoel Ribeiro de Moraes","ptype":"article","src":"https://openalex.org/W3089341399","eid":"W3089341399"},{"id":"paper-w2177402012","cat":"papers","name":"A qualitative study into the protective factors of non-MDMA users who attend trance parties in South Africa","year":"2015","cit":1,"pfa":"Nicole May","psa":"Rizwana Roomaney","ptype":"article","src":"https://openalex.org/W2177402012","eid":"W2177402012"},{"id":"paper-w1919728297","cat":"papers","name":"To Find Our Life: The Peyote Hunt of the Huichols of Mexico. Filmed in 1968/69 and produced in 1969 by P eter T. F urst","year":"1970","cit":1,"pfa":"Weston La Barre","ptype":"article","src":"https://openalex.org/W1919728297","eid":"W1919728297"},{"id":"paper-w300320788","cat":"papers","name":"Update on the MDMA-Assisted Psychotherapy Study for Treatment-Resistant Anxiety Disorders Secondary to Advanced Stage Cancer","year":"2007","cit":1,"pfa":"John H. Halpern","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W300320788","eid":"W300320788"},{"id":"paper-w2921510883","cat":"papers","name":"Erratum to: Abuse potential of methylenedioxymethamphetamine (MDMA) and its derivatives in zebrafish: role of serotonin 5HT2-type receptors","year":"2016","cit":1,"pfa":"Luisa Ponzoni","psa":"Mariaelvina Sala","topics":["Mechanism & neuroscience"],"ptype":"erratum","src":"https://openalex.org/W2921510883","eid":"W2921510883"},{"id":"paper-w3111972030","cat":"papers","name":"A Systematic Literature Review of the Potential Therapeutic Effects of Ayahuasca Tea Prepared From the Use of Banisteriopsis Caapi and Psychotria Viridis","year":"2020","cit":1,"pfa":"Adriane Cordeiro Trevisani","psa":"Daniela Dib Gonçalves","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W3111972030","eid":"W3111972030"},{"id":"paper-w2033812997","cat":"papers","name":"The Role of Serotonin in Low Level Visual Processes, as Revealed by Using an “Ecstasy” (MDMA)-Based Research Model","year":"2011","cit":1,"pfa":"John Brown","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2033812997","eid":"W2033812997"},{"id":"paper-w2748041029","cat":"papers","name":"BIOANALISIS 3,4 - METHYLENEDIOXYMETAMPHETAMINE (MDMA) DAN BENTUK METABOLITNYA DI DALAM URIN HEWAN COBA KELINCI","year":"2005","cit":1,"pfa":"Magdalena Sri Handajani","ptype":"dissertation","src":"https://openalex.org/W2748041029","eid":"W2748041029"},{"id":"paper-w2604298405","cat":"papers","name":"A questão da legitimidade e da legalidade dos usos contemporâneos da ayahuasca: Um estudo de caso","year":"2013","cit":1,"pfa":"Tiago Coutinho","topics":["Addiction","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2604298405","eid":"W2604298405"},{"id":"paper-w3168971330","cat":"papers","name":"Usos terapéuticos de sustancias prohibidas: LSD, MDMA, THC, GHB, DMT, psilocybina y mescalina","year":"2013","cit":1,"pfa":"Ingrid Tartakowsky López","ptype":"article","src":"https://openalex.org/W3168971330","eid":"W3168971330"},{"id":"paper-w4311809225","cat":"papers","name":"INTOLERÂNCIA RELIGIOSA: UM ESTUDO SOBRE A UTILIZAÇÃO POLÊMICA DA AYAHUASCA, CHÁ XAMÂNICO MILENAR, NOS RITUAIS DAIMISTAS","year":"2022","cit":1,"pfa":"Ronaldo Emiliano de Miranda","ptype":"book-chapter","src":"https://openalex.org/W4311809225","eid":"W4311809225"},{"id":"paper-w2604031109","cat":"papers","name":"3,4-methylenedioxy-methamphetamine(MDMA)-induced Increases in Hippocampal Glutamate Concentrations and Its Impact on the Dentate Gyrus","year":"2016","cit":1,"pfa":"Collins, Stuart A","ptype":"article","src":"https://openalex.org/W2604031109","eid":"W2604031109"},{"id":"paper-w7132842830","cat":"papers","name":"A phase 2 uncontrolled, open-label study of intranasal BPL-003 (5-methoxy- N,N -dimethyltryptamine) in patients with treatment-resistant depression","year":"2026","cit":1,"pfa":"Claire Roberts","psa":"James Rucker","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7132842830","eid":"W7132842830"},{"id":"paper-w2070208051","cat":"papers","name":"Editorial: Preface and Overview Second International MDMA ‘Ecstasy’ Conference in Australasia: Monash University, Melbourne, Australia","year":"2011","cit":1,"pfa":"Jillian Helen Broadbear","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"editorial","src":"https://openalex.org/W2070208051","eid":"W2070208051"},{"id":"paper-w3210319121","cat":"papers","name":"Re-opening the Body Schema to a Shared Temporality:A Phenomenological Investigation into the Therapeutic Potential of Psilocybin-Assisted Therapy for Depression","year":"2020","cit":1,"pfa":"Raymond Cacciatore","topics":["Depression"],"ptype":"dissertation","src":"https://openalex.org/W3210319121","eid":"W3210319121"},{"id":"paper-w7154396122","cat":"papers","name":"A phase 1 study of a second experience with Group Retreat Psilocybin Therapy for partial responders after a first experience","year":"2026","cit":1,"pfa":"Anthony L. Back","psa":"Joseph Whinney","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7154396122","eid":"W7154396122"},{"id":"paper-w2257279549","cat":"papers","name":"The effect of MDMA and pentoxifylline drug on bad/bcl-xl gene dosage expression changes on rat liver","year":"2015","cit":1,"pfa":"Mitra Behroozaghdam","psa":"Shabnam Movaseghi","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2257279549","eid":"W2257279549"},{"id":"paper-w7129539813","cat":"papers","name":"Sense-Making Around Psilocybin in UK Women Experiencing Cancer-Related Existential Distress: An Interpretative Phenomenological Analysis","year":"2026","cit":1,"pfa":"Zaynab Khan","psa":"Verity Wainwright","topics":["Depression","Anxiety & end-of-life","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7129539813","eid":"W7129539813"},{"id":"paper-w2626774587","cat":"papers","name":"IMAGENS MENTAIS ESPONTÂNEAS: Mente, Alma, Corpo e Processos Visionários durante o uso ritual de Ayahuasca","year":"2016","cit":1,"pfa":"Marcelo Simão Mercante","ptype":"article","src":"https://openalex.org/W2626774587","eid":"W2626774587"},{"id":"paper-w4200007802","cat":"papers","name":"P.0729 Highlights of psychedelic history and current research on psilocybin application for treatment of depression – a comprehensive literature review","year":"2021","cit":1,"pfa":"Sara Penedos","psa":"A. Gamito","topics":["Depression","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4200007802","eid":"W4200007802"},{"id":"paper-w4386252864","cat":"papers","name":"MDMA-Based Psychotherapy in Treatment-Resistant Post-traumatic Stress Disorder (PTSD): A Brief Overview of Current Evidence","year":"2023","cit":1,"pfa":"Kainat Riaz","psa":"Domenico De Berardis","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W4386252864","eid":"W4386252864"},{"id":"paper-w2581460705","cat":"papers","name":"Evaluación del estado de conservación del peyote queretano Lophophora diffusa Croizat (Bravo), cactácea endémica del desierto Querétaro-Hidalguense, México","year":"2012","cit":1,"pfa":"Omar Díaz Segura","psa":"Erasmo Vázquez Díaz","ptype":"article","src":"https://openalex.org/W2581460705","eid":"W2581460705"},{"id":"paper-w4247531980","cat":"papers","name":"Developing a new national MDMA policy: Results of a multi-decision multi-criterion decision analysis (MD-MCDA)","year":"2020","cit":1,"pfa":"Jan van Amsterdam","psa":"Wim van den Brink","topics":["Safety & adverse events","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4247531980","eid":"W4247531980"},{"id":"paper-w4402730825","cat":"papers","name":"Psilocybin legalization in the United States and psychological reactance: A test of evidence uncertainty, controlling language, and an ambiguous call to action.","year":"2024","cit":1,"pfa":"Brian L. Quick","psa":"Brenda Davis Koester","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4402730825","eid":"W4402730825"},{"id":"paper-w4253631453","cat":"papers","name":"Simulated Driving and Attention of Repeat Users of MDMA and THC Compared with THC Users and Non-Drug-Using Controls","year":"2006","cit":1,"pfa":"C. T. J. Lamers","psa":"Jan G. Ramaekers","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4253631453","eid":"W4253631453"},{"id":"paper-w1982794823","cat":"papers","name":"Sex-differences in the pharmacokinetics of 3,4-methylenedioxymethamphetamine (MDMA) and its metabolite 3,4-methylenedioxyamphetamine (MDA) in Sprague–Dawley rats","year":"2009","cit":1,"pfa":"Julien Fonsart","psa":"Xavier Declèves","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1982794823","eid":"W1982794823"},{"id":"paper-w4406126712","cat":"papers","name":"Opto-Electrochemical Sensing of MDMA Molecule Through a Nanoarchitecture Formed Quantum Dots (QDs) Modified Aptasensor","year":"2024","cit":1,"ptype":"article","src":"https://openalex.org/W4406126712","eid":"W4406126712"},{"id":"paper-w2607536026","cat":"papers","name":"O uso da Ayahuasca e a experiência de transformação, alívio e cura, na União do Vegetal (UDV)","year":"2008","cit":1,"pfa":"Gabriela Santos Ricciardi","topics":["Depression"],"ptype":"dissertation","src":"https://openalex.org/W2607536026","eid":"W2607536026"},{"id":"paper-w2004161939","cat":"papers","name":"Memory, cognition, mood and impulsivity in current and former users of MDMA (ecstasy): testing the serotonergic neurotoxicity deficit hypothesis","year":"2003","cit":1,"pfa":"Michael Lyvers","psa":"J Bradnam","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2004161939","eid":"W2004161939"},{"id":"paper-w2328453904","cat":"papers","name":"In Vivo Imaging of Cerebral Serotonin Transporter and Serotonin2A Receptor Binding in 3,4-Methylenedioxymethamphetamine (MDMA or “Ecstasy”) and Hallucinogen Users","year":"2012","cit":1,"pfa":"P.F. Buckley","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2328453904","eid":"W2328453904"},{"id":"paper-w4402973566","cat":"papers","name":"Psilocybin prevents habituation to familiar stimuli and preserves sensitivity to sound following repeated stimulation in mouse primary auditory cortex","year":"2024","cit":1,"pfa":"Conor P. Lane","psa":"Etienne de Villers‐Sidani","topics":["Addiction","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4402973566","eid":"W4402973566"},{"id":"paper-w4405621816","cat":"papers","name":"Rapid antidepressant effect of intranasal BPL-003 (5-methoxy-N,N-dimethyltryptamine) in treatment-resistant patients: a phase 2a open label study","year":"2024","cit":1,"pfa":"C. Roberts","psa":"James Rucker","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4405621816","eid":"W4405621816"},{"id":"paper-w4250614801","cat":"papers","name":"APPLICATION OF TRANSCEREBRAL, WEAK (1 MICROT) COMPLEX MAGNETIC FIELDS AND MYSTICAL EXPERIENCES: ARE THEY GENERATED BY FIELD-INDUCED DIMETHYLTRYPTAMINE RELEASE FROM THE PINEAL ORGAN?","year":"2003","cit":1,"pfa":"Dianne Hill","ptype":"article","src":"https://openalex.org/W4250614801","eid":"W4250614801"},{"id":"paper-w2976097695","cat":"papers","name":"Xamanismo e enteogenia ameríndia: A ayahuasca e outras “plantas de poder” em contextos indigenistas e vegetalistas amazônicos","year":"2019","cit":1,"pfa":"Wagner Lins Lira","ptype":"article","src":"https://openalex.org/W2976097695","eid":"W2976097695"},{"id":"paper-w4381282948","cat":"papers","name":"Getting In Touch with Touch: The Importance of Studying Touch in MDMA-Assisted Therapy and the Development of a New Self-Report Measure","year":"2023","cit":1,"pfa":"Jason B. Luoma","psa":"Christopher S. Stauffer","topics":["Reviews & meta-analyses","Therapy practice","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4381282948","eid":"W4381282948"},{"id":"paper-w4403448677","cat":"papers","name":"The Second Methylation in Psilocybin Biosynthesis Is Enabled by a Hydrogen Bonding Network Extending into the Secondary Sphere Surrounding the Methyltransferase Active Site","year":"2024","cit":1,"pfa":"Jesse D. Hudspeth","psa":"Sebastiaan Werten","ptype":"article","src":"https://openalex.org/W4403448677","eid":"W4403448677"},{"id":"paper-w4408529433","cat":"papers","name":"A Modern Overview of the Potential Therapeutic Effects of Psilocybin in the Treatment of Depressive Disorders, Treatment-Resistant Depression, and End-of-Life Distress","year":"2025","cit":1,"pfa":"Fejzic Dino","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4408529433","eid":"W4408529433"},{"id":"paper-w2111548404","cat":"papers","name":"Estasi della mediazione. Il consumo di MDMA e la trasformazione dei suoi setting d'assunzione","year":"2007","cit":1,"pfa":"Luca Mori","ptype":"article","src":"https://openalex.org/W2111548404","eid":"W2111548404"},{"id":"paper-w1563717827","cat":"papers","name":"Observações do não-observável: breve relato sobre o I Encontro “Ayahuasca e o Tratamento da Dependência”","year":"2011","cit":1,"pfa":"Katerina Volcov","psa":"Marcelo Simão Mercante","ptype":"article","src":"https://openalex.org/W1563717827","eid":"W1563717827"},{"id":"paper-w4313200620","cat":"papers","name":"The efficacy of COMP360 psilocybin therapy in treatment-resistant depression: exploratory results from a phase IIb randomised controlled trial","year":"2022","cit":1,"pfa":"G M Goodwin","psa":"E. Malievskaia","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4313200620","eid":"W4313200620"},{"id":"paper-w4400773118","cat":"papers","name":"Critical review of 3,4-methylenedioxymethamphetamine (MDMA)-assisted therapy for posttraumatic stress disorder: Unanswered questions and future directions","year":"2024","cit":1,"pfa":"Alex Hood","psa":"Gary R. Elkins","topics":["PTSD & trauma","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4400773118","eid":"W4400773118"},{"id":"paper-w2095435382","cat":"papers","name":"Sprague–Dawley rats display metabolism-mediated sex differences in the acute toxicity of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)","year":"2008","cit":1,"pfa":"Julien Fonsart","psa":"Florence Noble","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2095435382","eid":"W2095435382"},{"id":"paper-w4415616586","cat":"papers","name":"Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) therapy for patients with advanced cancer: protocol for a multi-method feasibility trial","year":"2025","cit":1,"pfa":"Candice Richardson","psa":"Sarah Hales","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4415616586","eid":"W4415616586"},{"id":"paper-w4368362458","cat":"papers","name":"Corrigendum to ‘Psilocybin induces spatially constrained alterations in thalamic functional organizaton and connectivity’: Neuroimage 2022 Oct 15;260:119434","year":"2023","cit":1,"pfa":"Andrew Gaddis","psa":"Frederick Streeter Barrett","topics":["Mechanism & neuroscience"],"ptype":"erratum","src":"https://openalex.org/W4368362458","eid":"W4368362458"},{"id":"paper-w4410226659","cat":"papers","name":"A new insight into ayahuasca’s adverse effects: Reanalysis and perspectives on its mediating role in mental health from the Global Ayahuasca Survey (GAS)","year":"2025","cit":1,"pfa":"Óscar Andión","psa":"Daniel Perkins","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4410226659","eid":"W4410226659"},{"id":"paper-w4285595695","cat":"papers","name":"Effect of psilocybin on marble-burying in ICR mice: Role of 5-HT1A receptors and implications for the treatment of obsessive-compulsive disorder","year":"2022","cit":1,"pfa":"Sandeep Singh","psa":"Tzuri Lifschytz","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4285595695","eid":"W4285595695"},{"id":"paper-w3215406571","cat":"papers","name":"Garcina Kola neuroprotective effects on the prefrontal cortex cyto-architecture of MDMA-induced neuroinflammation in male Wistar rats model","year":"2021","cit":1,"pfa":"John Afees Olanrewaju","psa":"Fabiyi Sunday Oluseyi","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3215406571","eid":"W3215406571"},{"id":"paper-w4399722371","cat":"papers","name":"Comparing Cannabis Use Motivations and Dependence Across Regular Cannabis Users Who Have or Have Not Recently Used Psilocybin","year":"2024","cit":1,"pfa":"Madeline Stanger","psa":"Carillon J. Skrzynski","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4399722371","eid":"W4399722371"},{"id":"paper-w7130592715","cat":"papers","name":"Preliminary analysis of ayahuasca-induced anatomical alterations in the somatosensory cortex of juvenile non-human primates (Callithrix jacchus) subjected to chronic stress","year":"2026","cit":1,"pfa":"Luiz Roberto Fernandes Pereira","psa":"Expedito Silva do Nascimento Júnior","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7130592715","eid":"W7130592715"},{"id":"paper-w3164068611","cat":"papers","name":"Consommation de MDMA dans un contexte de « binge drinking » : à propos d’un cas non mortel","year":"2021","cit":1,"pfa":"Arezki Khaled Boukerma","psa":"Laurence Labat","ptype":"article","src":"https://openalex.org/W3164068611","eid":"W3164068611"},{"id":"paper-w2889817961","cat":"papers","name":"ANALISIS SENYAWA HALUSINOGEN DALAM MINUMAN MAGIC MUSHROOM (Psilocybin baeocystis) YANG BEREDAR DI KAWASAN KUTA-BALI","year":"2018","cit":1,"pfa":"N. M. Uaniti","psa":"S. A. Sari","ptype":"article","src":"https://openalex.org/W2889817961","eid":"W2889817961"},{"id":"paper-w4400577130","cat":"papers","name":"Psilocybin mushrooms and public health in Brazil: a low-risk adverse event profile calls for evidence-based regulatory discussions","year":"2024","cit":1,"pfa":"Marcel Nogueira","psa":"Leonardo Zanella Marques","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4400577130","eid":"W4400577130"},{"id":"paper-w1988548574","cat":"papers","name":"Amphetamines and 3,4-methylendioxymetamphetamine (MDMA): evaluation of KIMS (kinetic interaction of microparticles in solution) assay at two cut-off levels","year":"2004","cit":1,"pfa":"Lucio Marchioro","psa":"Mario Plebani","ptype":"article","src":"https://openalex.org/W1988548574","eid":"W1988548574"},{"id":"paper-w2130775826","cat":"papers","name":"Research Proposal Protocol Number: I-OA3 Study Title: Observational study of the long-term efficacy of ibogaine- assisted treatment in participants with opiate addiction","year":"2010","cit":1,"pfa":"Principal Investigator","psa":"Meg Jordan","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2130775826","eid":"W2130775826"},{"id":"paper-w4390451746","cat":"papers","name":"False positive ecstasy (MDMA) urine drug screening test results due to bupropion use: A case report","year":"2023","cit":1,"pfa":"Selin Acar","psa":"Yusuf Cem Kaplan","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W4390451746","eid":"W4390451746"},{"id":"paper-w4383825616","cat":"papers","name":"Reports by explorers and travelers and the first scientific studies on ayahuasca (dating from 1850 to 1950) within the current debate on the “psychedelic renaissance”","year":"2023","cit":1,"pfa":"Vinícius Maurício de Lima","psa":"Maria Gabriela Silva Martins da Cunha Marinho","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4383825616","eid":"W4383825616"},{"id":"paper-w4230242885","cat":"papers","name":"APPLICATION OF TRANSCEREBRAL, WEAK (1 MICROT) COMPLEX MAGNETIC FIELDS AND MYSTICAL EXPERIENCES: ARE THEY GENERATED BY FIELD-INDUCED DIMETHYLTRYPTAMINE RELEASE FROM THE PINEAL ORGAN?","year":"2003","cit":1,"pfa":"Dianne Hill","ptype":"article","src":"https://openalex.org/W4230242885","eid":"W4230242885"},{"id":"paper-w4392694325","cat":"papers","name":"Para una historia crítica del yajé y el ayahuasca: la hipótesis de Gow a la luz del yajé","year":"2024","cit":1,"pfa":"Pedro Musalem Nazar","ptype":"article","src":"https://openalex.org/W4392694325","eid":"W4392694325"},{"id":"paper-w7134987872","cat":"papers","name":"Journeying into Right Relations: Scientists Turn to Psilocybin to Shift Psychological Burdens of Global Environmental Change and Find Transformational Pathways Forward","year":"2026","cit":1,"pfa":"David J. Wrathall","psa":"Associates*","topics":["Anxiety & end-of-life","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7134987872","eid":"W7134987872"},{"id":"paper-w2060193513","cat":"papers","name":"P.6.c.014 Acute and chronic effects of MDMA on hippocampal cell fate markers in adolescent and adult rats","year":"2014","cit":1,"pfa":"Rubén García‐Cabrerizo","psa":"María Julia García-Fuster","ptype":"article","src":"https://openalex.org/W2060193513","eid":"W2060193513"},{"id":"paper-w4239863655","cat":"papers","name":"Barbara G. Meyerhoff, Peyote hunt. The sacred journey of the Huichol Indians, Ithaca and London, Cornell University Press, 1974, 8vo, pp. 285, illus., £8.20.","year":"1976","cit":1,"ptype":"book-review","src":"https://openalex.org/W4239863655","eid":"W4239863655"},{"id":"paper-w7130603925","cat":"papers","name":"Prospective real-world evidence of mental health outcomes following supervised psilocybin services within Oregon’s state-regulated model","year":"2026","cit":1,"pfa":"Amanda Gow","psa":"Jennie N Davis","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7130603925","eid":"W7130603925"},{"id":"paper-w7118016834","cat":"papers","name":"The efficacy of intranasal BPL-003 (5-methoxy-N,N-dimethyltryptamine) on anhedonia in patients with treatment resistant depression: a phase 2a open label study","year":"2026","cit":1,"pfa":"C. Hindocha","psa":"C. Roberts","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7118016834","eid":"W7118016834"},{"id":"paper-w7135015953","cat":"papers","name":"Balancing Innovation and Evidence: Reflections on Structured Protocols in MDMA-Assisted Therapy Versus a Principle-Guided, Patient-Directed Approach","year":"2026","cit":1,"pfa":"Amy Lehrner","psa":"Rachel Yehuda","topics":["PTSD & trauma","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7135015953","eid":"W7135015953"},{"id":"paper-w7164582898","cat":"papers","name":"Psilocybin restores behavior and 5-HT2A signaling while reducing microglial density after chronic traumatic brain injury in rats","year":"2026","cit":1,"pfa":"Josh Allen","psa":"Sandy R. Shultz","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7164582898","eid":"W7164582898"},{"id":"paper-w4403458382","cat":"papers","name":"Unveil the toxicity induced on early life stages of zebrafish (Danio rerio) exposed to 3,4-methylenedioxymethamphetamine (MDMA) and its enantiomers","year":"2024","cit":1,"pfa":"Ondina Ribeiro","psa":"João Soares Carrola","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4403458382","eid":"W4403458382"},{"id":"paper-w4394709884","cat":"papers","name":"Terapia assistida com 3,4-metilenodioximetanfetamina (MDMA) para o tratamento da ansiedade social em adultos autistas","year":"2024","cit":1,"pfa":"Jéssica de Sá Azevedo","psa":"Aline da Silva Guerra","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4394709884","eid":"W4394709884"},{"id":"paper-w4413998553","cat":"papers","name":"Nitrous Oxide Sourcing, Use and Harms: Insights From Australians Who Use Ecstasy/MDMA and Other Illicit Stimulants","year":"2025","cit":1,"pfa":"Jodie Grigg","psa":"Rachel Sutherland","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4413998553","eid":"W4413998553"},{"id":"paper-w7203734031","cat":"papers","name":"Level of Preparedness to Use Psilocybin Among Individuals Seeking Psychedelic Risk Reduction: A retrospective study of a pilot psychiatric consultation service","year":"2026","cit":1,"pfa":"Harland V. Harrison","psa":"Ximena A. Levander","topics":["PTSD & trauma","Safety & adverse events","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7203734031","eid":"W7203734031"},{"id":"paper-w4393869265","cat":"papers","name":"300 Psilocybin-induced changes in neural reactivity to alcohol and emotional cues in patients with alcohol use disorder: An fMRI pilot study","year":"2024","cit":1,"pfa":"Broc A. Pagni","psa":"Michael P. Bogenschutz","topics":["Addiction","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4393869265","eid":"W4393869265"},{"id":"paper-w4416549169","cat":"papers","name":"Cognitive outcomes following psilocybin-assisted therapy in treatment-resistant depression: A post-hoc analysis of a randomized, waitlist-controlled trial","year":"2025","cit":1,"pfa":"Danica E. Johnson","psa":"Joshua Daniel Rosenblat","topics":["Depression","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4416549169","eid":"W4416549169"},{"id":"paper-w4416953526","cat":"papers","name":"Using Insights from a Study of Psilocybin with Clergy to Advance Research on Psychedelics, Spirituality, and the Sacred: Commentary on Griffiths et al. (2025)","year":"2025","cit":1,"pfa":"Roman Palitsky","psa":"George H. Grant","ptype":"article","src":"https://openalex.org/W4416953526","eid":"W4416953526"},{"id":"paper-w7160037543","cat":"papers","name":"Does Psychological Flexibility Correlate with Mystical Experiences: A Machine Learning Approach Including State of Surrender, Near-Death Experiences, and Psilocybin Consumption","year":"2026","cit":1,"pfa":"Dylan Briggs","psa":"David R. Perkins","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W7160037543","eid":"W7160037543"},{"id":"paper-w7141250802","cat":"papers","name":"MDMA alters fear extinction, and reduces alcohol consumption in inbred alcohol preferring iP rats but not outbred Wistar rats","year":"2026","cit":1,"pfa":"Kade L. Huckstep","psa":"Leigh C. Walker","topics":["PTSD & trauma","Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7141250802","eid":"W7141250802"},{"id":"paper-w1816826634","cat":"papers","name":"Recreational ecstasy (MDMA) use is associated with increases in risk-taking and self-report scores for impulsiveness, venturesomeness and novelty-seeking","year":"2001","cit":1,"pfa":"GK Butler","psa":"Amj Montgomery","topics":["Safety & adverse events"],"ptype":"conference-paper","src":"https://openalex.org/W1816826634","eid":"W1816826634"},{"id":"paper-w2255752991","cat":"papers","name":"RECHERCHES CONCERNANT LA CARACT'ERISATION ET LA DIFF'ERENCIATION PHARMACOLOGIQUES DES DROGUES HALLUCINOG'ENES (D'ERIV'ES INDOLIQUES ET MESCALINE, NALORPHINE, ANTICHOLINERGIQUES CENTRAUX, PHENCYCLIDINE)","year":"1964","cit":1,"pfa":"Jean-Noël Jacob","psa":"Charles-Emmanuel Barthélémy","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2255752991","eid":"W2255752991"},{"id":"paper-w3204086223","cat":"papers","name":"Amitriptyline Accelerates SERT Binding Recovery Rate in MDMA-Induced Rat Model: In Vivo 4-[18F]-ADAM PET Imaging","year":"2021","cit":1,"pfa":"Skye Hsin‐Hsien Yeh","psa":"Kuo‐Hsing Ma","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W3204086223","eid":"W3204086223"},{"id":"paper-w4396235155","cat":"papers","name":"1. Psilocybin and 4-Bromo-2,5-Dimethoxyphenethylamine (2C-B) at Encoding Distort Episodic Familiarity and Positively Bias Emotional Metamemory","year":"2024","cit":1,"pfa":"Manoj K. Doss","psa":"Jan G. Ramaekers","ptype":"article","src":"https://openalex.org/W4396235155","eid":"W4396235155"},{"id":"paper-w4292528313","cat":"papers","name":"Virada maníaca induzida por Ayahuasca em um homem com transtorno bipolar: relato de caso com revisão de literatura","year":"2018","cit":1,"pfa":"André Botelho Oliveira","psa":"José Ricardo Pinto de Abreu","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4292528313","eid":"W4292528313"},{"id":"paper-w7171980656","cat":"papers","name":"Effects of an international ceremonial ayahuasca retreat on the diversity and community composition of the human gut microbiome: A preliminary observational single-arm pre-post study","year":"2026","cit":1,"pfa":"Lyanna R. Kessler","psa":"Christopher A. Lowry","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7171980656","eid":"W7171980656"},{"id":"paper-w2051778190","cat":"papers","name":"P.6.057 Effects of 2A receptor challenge by psilocybin on cognitive performance and neuroendocrine measures in healthy humans: A serotonin model of psychosis","year":"2003","cit":1,"pfa":"Felix Hasler","psa":"F.X. Vollenweider","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2051778190","eid":"W2051778190"},{"id":"paper-w4379647684","cat":"papers","name":"Cardioprotective Potential of the Ethanol and Water Extracts of Four Psilocybin Mushrooms on Angiotensin II-Induced Hypertrophy and Oxidative Stress on H9C2 Cardiomyocytes","year":"2023","cit":1,"pfa":"Sanah Malomile Nkadimeng","psa":"Jacobus Nicolaas Eloff","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4379647684","eid":"W4379647684"},{"id":"paper-w4410925857","cat":"papers","name":"There’s More Than One Way to Bring Health Back: Divergent Effects of Psilocybin and Escitalopram Treatment on Emotional Brain Function in Depression","year":"2025","cit":1,"pfa":"Gregory A. Fonzo","psa":"Charles B. Nemeroff","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4410925857","eid":"W4410925857"},{"id":"paper-w4390346011","cat":"papers","name":"Engaging Mood Brain Circuits with Psilocybin (EMBRACE): a study protocol for a randomized, proof-of-principle, placebo-controlled and crossover, neuroimaging trial in depression","year":"2023","cit":1,"pfa":"Joshua M. Poulin","psa":"Sean M. Nestor","topics":["Depression","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4390346011","eid":"W4390346011"},{"id":"paper-w1545631612","cat":"papers","name":"A Arte Visionária e a Ayahuasca: Representações Visuais de Espirais e Vórtices Inspiradas nos Estados Não Ordinários de Consciência (ENOC)","year":"2009","cit":1,"pfa":"José Eliézer Mikosz","ptype":"article","src":"https://openalex.org/W1545631612","eid":"W1545631612"},{"id":"paper-w4403503718","cat":"papers","name":"Therapeutic Potential of Psychedelic Compounds for Substance Use Disorders","year":"2024","cit":1,"pfa":"Tamara Valdez","psa":"Mary G. Hornick","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4403503718","eid":"W4403503718"},{"id":"paper-w4383825614","cat":"papers","name":"Relatos de exploradores e viajantes e primeiras pesquisas científicas com a ayahuasca, 1850-1950, no debate atual sobre o “renascimento psicodélico”","year":"2023","cit":1,"pfa":"Vinícius Maurício de Lima","psa":"Maria Gabriela Silva Martins da Cunha Marinho","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4383825614","eid":"W4383825614"},{"id":"paper-w4226376633","cat":"papers","name":"MDMA (3,4-methylenedioxy-methamphetamine) and cannabis intake resulting in multiple organ failure, hypoglycemia, disseminated intravascular coagulation (DIC), and methemoglobinemia","year":"2021","cit":1,"pfa":"Emel Altıntaş","psa":"Başak Bayram","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4226376633","eid":"W4226376633"},{"id":"paper-w2487494214","cat":"papers","name":"In the Magic Land of Peyote. By Fernando Benitez. Translated by John Upton. ([Texas Pan American Series] Austin: University of Texas Press, 1975. Pp. xxvii, 198. $9.75.)","year":"1976","cit":1,"pfa":"Joseph L. Zentner","ptype":"book-review","src":"https://openalex.org/W2487494214","eid":"W2487494214"},{"id":"paper-w7116873484","cat":"papers","name":"Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Anxiety and Depression: A Rite of Passage Facilitation Model for a Phase 1/2 Study","year":"2025","cit":1,"pfa":"Anthony L. Back","psa":"Leslie Lazar Thorn","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7116873484","eid":"W7116873484"},{"id":"paper-w2291109557","cat":"papers","name":"Wirkung von Halluzinogenen(Cyclazocin und Psilocybin) auf das Verhalten von Ratten im Offen-Feld und Wohn-Labyrinth","year":"1982","cit":1,"pfa":"Roland Looser","ptype":"dissertation","src":"https://openalex.org/W2291109557","eid":"W2291109557"},{"id":"paper-w7169664384","cat":"papers","name":"Psilocybin produces amplified acute responses and sex-specific long-term increases in sensorimotor gating in the mGlu5 knockout mouse model of schizophrenia","year":"2026","cit":1,"pfa":"James J Gattuso","psa":"Thibault Renoir","topics":["Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7169664384","eid":"W7169664384"},{"id":"paper-w7129015437","cat":"papers","name":"Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trial","year":"2026","cit":1,"pfa":"Zeina Beidas","psa":"Rotem Petranker","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7129015437","eid":"W7129015437"},{"id":"paper-w4323519203","cat":"papers","name":"Os benefícios do uso da ayahuasca como ferramenta alternativa ao tratamento convencional da depressão: uma revisão de literatura","year":"2023","cit":1,"pfa":"Bruna Letícia Martins","psa":"Bruna Karoline Lima Piazera","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4323519203","eid":"W4323519203"},{"id":"paper-w2085458633","cat":"papers","name":"Commentary on: Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance by Griffiths et al.","year":"2006","cit":1,"pfa":"Herbert D. Kleber","ptype":"editorial","src":"https://openalex.org/W2085458633","eid":"W2085458633"},{"id":"paper-w1980331413","cat":"papers","name":"Commentary on: Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance by Griffiths et al.","year":"2006","cit":1,"pfa":"Charles Roberts Schuster","ptype":"editorial","src":"https://openalex.org/W1980331413","eid":"W1980331413"},{"id":"paper-w1506534692","cat":"papers","name":"Presencia de \"Extasis\" (MDMA), \"Love drug\" (MDA) y metabolitos de la cocaina en una muestra biológica","year":"2001","cit":1,"pfa":"Daniel J. T. Mirson","psa":"Otmaro Enrique Roses","ptype":"article","src":"https://openalex.org/W1506534692","eid":"W1506534692"},{"id":"paper-w2352707104","cat":"papers","name":"Determination of amphetamine, methamphetamine, MDA and MDMA in urine samples by solid-phase microextraction and gas chromatography-mass spectrometry in selected ion monitoring","year":"2005","cit":1,"pfa":"Zengping Huang","ptype":"article","src":"https://openalex.org/W2352707104","eid":"W2352707104"},{"id":"paper-w2314258448","cat":"papers","name":"Low concentration mixtures of MDMA and its major human metabolites induce significant toxicity to liver cells, both at physiological and hyperthermic conditions","year":"2013","cit":1,"pfa":"Diana Dias da Silva","psa":"Helena Carmo","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2314258448","eid":"W2314258448"},{"id":"paper-w2049518189","cat":"papers","name":"Adenosine A2a receptors activate Nuclear Factor-Kappa B (NF-κB) in rat hippocampus after exposure to different doses of MDMA","year":"2014","cit":1,"pfa":"Fatemeh Kermanian","psa":"Hossein Haghir","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2049518189","eid":"W2049518189"},{"id":"paper-w2744723302","cat":"papers","name":"Mending Invisible Wounds: The Efficacy and Legality of MDMA-Assisted Psychotherapy in United States' Veterans Suffering with Post-Traumatic Stress Disorder.","year":"2016","cit":1,"pfa":"Jonathan Perry","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2744723302","eid":"W2744723302"},{"id":"paper-w4320492846","cat":"papers","name":"Aromatic Bromination Abolishes Deficits in Visuospatial Learning Induced by MDMA (“Ecstasy”) in Rats While Preserving the Ability to Increase LTP in the Prefrontal Cortex","year":"2023","cit":1,"pfa":"Patricio Sáez‐Briones","psa":"Alejandro Hernández","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4320492846","eid":"W4320492846"},{"id":"paper-w4323924721","cat":"papers","name":"MDMA, Internal Family Systems therapy, and the Minnesota model in the resolution of C-PTSD-induced alcohol and diazepam addiction—A retrospective case study","year":"2023","cit":1,"pfa":"Mika Turkia","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"preprint","src":"https://openalex.org/W4323924721","eid":"W4323924721"},{"id":"paper-w4406669498","cat":"papers","name":"Trends in alcohol, MDMA, methylamphetamine and THC in injured and deceased motor vehicle drivers and motorcyclists over a decade (2010–2019) in Victoria, Australia","year":"2025","cit":1,"pfa":"Jennifer Schumann","psa":"Joanna F. Dipnall","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4406669498","eid":"W4406669498"},{"id":"paper-w2564707390","cat":"papers","name":"Efecto de la ingestión de Banisteriopsis caapi y Psychotria viridis ‘Binomio ayahuasca’ en el hipocampo del cerebro de ratas","year":"2016","cit":1,"pfa":"Américo J. Castro","psa":"José Raez","ptype":"article","src":"https://openalex.org/W2564707390","eid":"W2564707390"},{"id":"paper-w2139706929","cat":"papers","name":"The Internationalization of Ayahuasca, Beatriz C.Labate and HenrikJungaberle, eds. Zurich Switzerland, Lit Verlag, 2011. 446pp. ISBN 978‐3‐643‐90148‐4, $69.95.","year":"2013","cit":1,"pfa":"Peter Benson","ptype":"book-review","src":"https://openalex.org/W2139706929","eid":"W2139706929"},{"id":"paper-w258272311","cat":"papers","name":"A Phase 1 Placebo-Controlled, Double-Blind Crossover Study to Assess Psychological Effects of MDMA when Administered to Healthy Volunteers SPONSOR","year":"2009","cit":1,"pfa":"Sponsor Designee","psa":"Valerie Mojeiko","ptype":"article","src":"https://openalex.org/W258272311","eid":"W258272311"},{"id":"paper-w3091818102","cat":"papers","name":"Ritualized Peyote Use Can Facilitate Mental Health, Social Solidarity, and Cultural Survival: A Case Study of the Religious and Mystical Experiences in the Wixárika People of the Sierra Madre Occidental","year":"2020","cit":1,"pfa":"Nathan William Luce","topics":["Anxiety & end-of-life","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W3091818102","eid":"W3091818102"},{"id":"paper-w4220974303","cat":"papers","name":"Comment and Response: (Lugo-Radillo & Cortez-Lopez, 2020) Long-Term Amelioration of OCD Symptoms in a Patient with Chronic Consumption of Psilocybin-Containing Mushrooms","year":"2022","cit":1,"pfa":"Ciarán Martin Fitzpatrick","psa":"Joseph R. Guydish","ptype":"article","src":"https://openalex.org/W4220974303","eid":"W4220974303"},{"id":"paper-w2780289599","cat":"papers","name":"O uso ritual da Ayahuasca e práticas de conservação florestal em paisagens fragmentadas de Rondônia: um reconhecimento com classificação GEOBIA","year":"2017","cit":1,"pfa":"Julien Marius Reis Thévenin","psa":"Edson Luís Piroli","ptype":"article","src":"https://openalex.org/W2780289599","eid":"W2780289599"},{"id":"paper-w7162570449","cat":"papers","name":"Long-Term Efficacy of Psilocybin with Adjunct Psychotherapy in Treatment-Resistant Major Depression: 6- and 12-Month Naturalistic Follow-Up of a Phase 2b Trial","year":"2026","cit":1,"pfa":"Lea Julia Mertens","psa":"Gerhard Gründer","topics":["Depression","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7162570449","eid":"W7162570449"},{"id":"paper-w2298798326","cat":"papers","name":"[Entactogenic drugs \"ecstasy\" (MDMA), \"eve\" (MDE) and other ring-substituted methamphetamine derivatives. A new class of substances among illegal designer drugs?].","year":"1997","cit":1,"pfa":"Felix Tretter","topics":["Addiction","Policy & ethics"],"ptype":"letter","src":"https://openalex.org/W2298798326","eid":"W2298798326"},{"id":"paper-w2030919454","cat":"papers","name":"Local cerebral metabolic response to 8-OH-DPAT in Dark Agouti rats is altered by prior exposure to 3, 4, -methylenedioxymethamphetamine (MDMA)","year":"2005","cit":1,"pfa":"Linda Ferrington","psa":"Paul A. Kelly","ptype":"conference-abstract","src":"https://openalex.org/W2030919454","eid":"W2030919454"},{"id":"paper-w2948477203","cat":"papers","name":"Avaliação do potencial antidepressivo da ayahuasca em ratos : comportamento, quantificação de monoaminas e do fator neurotrófico derivado do cérebro (BDNF)","year":"2018","cit":1,"pfa":"Camila Schoueri Colaço","topics":["Depression"],"ptype":"dissertation","src":"https://openalex.org/W2948477203","eid":"W2948477203"},{"id":"paper-w3184814794","cat":"papers","name":"Tres caminos posibles: una ausencia, una marca tipográfica y un evento fortuito: El peyote y otras hierbas en la materia médica (siglos XVI-XVII)","year":"2014","cit":1,"pfa":"Angélica Morales Sarabia","ptype":"article","src":"https://openalex.org/W3184814794","eid":"W3184814794"},{"id":"paper-w4414955208","cat":"papers","name":"“To Have the Encounter with Our Own Finiteness in that Existential Way”: Descriptions of Existential Experience in Patients with Cancer and Major Depression Participating in Psilocybin-Assisted Group Therapy","year":"2025","cit":1,"pfa":"Elise C. Tarbi","psa":"Yvan Beaussant","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4414955208","eid":"W4414955208"},{"id":"paper-w2140545410","cat":"papers","name":"STUDY OF THERAPEUTIC AND HISTOPATHOLOGIC EFFECTS OF CORN SILK'S AQUEOUS AND METANOLIC EXTRACT AGAINST DOSAGE INDUCED BY MDMA IN ISOLATED RAT LIVER PERFUSION SYSTEM","year":"2014","cit":1,"pfa":"Mohammad Yasin Karami","psa":"Noorolhoda Karami","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2140545410","eid":"W2140545410"},{"id":"paper-w4283768051","cat":"papers","name":"Efetividade do tratamento de transtorno de estresse pós-traumático com MDMA: uma revisão sistemática de estudos clínicos randomizados","year":"2022","cit":1,"pfa":"Emilly Vasconcelos Borges Fontes","psa":"Luiz Felipe Chaves Carvalho","ptype":"article","src":"https://openalex.org/W4283768051","eid":"W4283768051"},{"id":"paper-w4405917494","cat":"papers","name":"Repeated low doses of psilocybin reduces perceived symptom severity of obsessive-compulsive disorder, but fails to restore cognitive flexibility: A case study of identical twins","year":"2024","cit":1,"pfa":"Sivert Drange","psa":"Mikael Palner","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4405917494","eid":"W4405917494"},{"id":"paper-w2801685345","cat":"papers","name":"Tempo subjetivo de participantes com estados alterados da consciência em função de uso da bebida Ayahuasca em rituais xamânicos envolvendo música","year":"2018","cit":1,"pfa":"Ana Paula Silva Campagnoli","ptype":"dissertation","src":"https://openalex.org/W2801685345","eid":"W2801685345"},{"id":"paper-w4404229023","cat":"papers","name":"Música, Memória, Religião e Ayahuasca: A Musicalidade na Origem e na Preservação dos Ensinos Religiosos no Passado e em Religiões Ayahuasqueiras no Presente","year":"2023","cit":1,"pfa":"Clóvis Ecco","psa":"João Paulo Reis Braga","ptype":"article","src":"https://openalex.org/W4404229023","eid":"W4404229023"},{"id":"paper-w4384695020","cat":"papers","name":"Administration effects of four psilocybin mushroom extracts on serotonin levels and endothelial nitric oxide synthase activity levels in vivo and in vitro after one hour","year":"2023","cit":1,"pfa":"Sanah Malomile Nkadimeng","psa":"Jacobus Nicolaas Eloff","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4384695020","eid":"W4384695020"},{"id":"paper-w4255060588","cat":"papers","name":"Dual, Postsynaptic 5-HT2B Antagonist and 5-HT1A Agonist Approach to the Treatment of METH/MDMA Addiction and Related Problems. Part 2. Proof of Concept.","year":"2014","cit":1,"topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4255060588","eid":"W4255060588"},{"id":"paper-w3112125654","cat":"papers","name":"The impact of 3,4-methylendioxymetamphetamine (MDMA) abstinence on seeking behavior and the expression of the D2-like and mGlu5 receptors in the rat brain using saturation binding analyses.","year":"2020","cit":1,"pfa":"Małgorzata Frankowska","psa":"Małgorzata Filip","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3112125654","eid":"W3112125654"},{"id":"paper-w4251827558","cat":"papers","name":"Testimony Before the Subcommittee on Criminal Justice, Drug Policy and Human Resources , Committee on Government Reform, United States House of Representatives - Research on MDMA","year":"2002","cit":1,"pfa":"Glen R. Hanson","topics":["Policy & ethics"],"ptype":"dataset","src":"https://openalex.org/W4251827558","eid":"W4251827558"},{"id":"paper-w1636570251","cat":"papers","name":"Efeitos da ingestão de Ayahuasca em estados psicométricos relacionados ao pánico, ansiedade e depressão em membros do culto do Santo Daime","year":"2006","cit":1,"pfa":"RAFAEL GUIMARÃES DOS SANTOS","topics":["Depression"],"ptype":"dissertation","src":"https://openalex.org/W1636570251","eid":"W1636570251"},{"id":"paper-w2067478231","cat":"papers","name":"MERCANTE, Marcelo S. Imagens de cura: Ayahuasca, imaginação, saúde e doença da Barquinha. Rio de Janeiro: Editora FIOCRUZ, 2012. 322 p.","year":"2013","cit":1,"pfa":"Luciane Ferreira de Melo","ptype":"article","src":"https://openalex.org/W2067478231","eid":"W2067478231"},{"id":"paper-w2592575989","cat":"papers","name":"Enquête sur la consommation de MDMA (ecstasy) dans la population homosexuelle masculine française en 2016 : un retour en force","year":"2017","cit":1,"pfa":"Andrew Laurin","psa":"Matéi Marinescu","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2592575989","eid":"W2592575989"},{"id":"paper-w2552283646","cat":"papers","name":"Een onderzoek naar de effecten van MDMA (Ecstasy) op cognitieve en psychometrische functies, rijgedrag in de simulator, en consequenties voor de verkeersveiligheid","year":"2000","cit":1,"pfa":"Dick de Waard","psa":"Wolfgang Julius Riedel","ptype":"book","src":"https://openalex.org/W2552283646","eid":"W2552283646"},{"id":"paper-w4239672867","cat":"papers","name":"Chronic exposure to MDMA ( Ecstasy ) Induces DNA Damage , Impairs Functional Antioxidant Cellular Defenses , Enhances the Lipid Peroxidation Process and Alters Testes Histopathology in Male Rat","year":"2013","cit":1,"pfa":"Nadia Gamal Zaki","psa":"Laila Abdel Kawy","ptype":"article","src":"https://openalex.org/W4239672867","eid":"W4239672867"},{"id":"paper-w1996470464","cat":"papers","name":"MDMA (“Ecstasy”) suppresses the innate IFN-g response, and inhibits MHC class II and co-stimulatory molecule expression on antigen presenting cells: A role for IL-10?","year":"2006","cit":1,"pfa":"Noreen T. Boyle","psa":"Thomas J. Connor","ptype":"article","src":"https://openalex.org/W1996470464","eid":"W1996470464"},{"id":"paper-w2065668546","cat":"papers","name":"Retraction notice to “MDMA- and p-chlorophenylalanine-induced reduction in 5-HT concentrations: Effects on serotonin transporter densities” [Eur. J. Pharmacol. 453 (2002) 239–244]","year":"2006","cit":1,"pfa":"Brendon Phillip Boot","psa":"George A. Ricaurte","topics":["Mechanism & neuroscience"],"ptype":"retraction","src":"https://openalex.org/W2065668546","eid":"W2065668546"},{"id":"paper-w2329615882","cat":"papers","name":"P.1.g.005 Serotonergic modulation of emotion processing by the mixed 5-HT1A/2A receptor agonist psilocybin reduces amygdala activation to negative stimuli – a pharmacological fMRI study","year":"2014","cit":1,"pfa":"Rainer Krähenmann","psa":"F.X. Vollenweider","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2329615882","eid":"W2329615882"},{"id":"paper-w4411575009","cat":"papers","name":"Use of Psychedelic Agents in Older Adults with Treatment-Resistant Major Depressive Disorder: What the Evidence Shows","year":"2025","cit":1,"pfa":"Lou Vinarcsik","psa":"George Thomas Grossberg","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4411575009","eid":"W4411575009"},{"id":"paper-w4378651338","cat":"papers","name":"Mass Casualty Incidentsfrom HallucinogenicAgents: LSD, Other Indoles,and Phenylethylamine Derivatives","year":"2023","cit":1,"pfa":"Axel J. Adams","psa":"Fiona E. Gallahue","ptype":"book-chapter","src":"https://openalex.org/W4378651338","eid":"W4378651338"},{"id":"paper-w4416624841","cat":"papers","name":"3,4‐Methylenedioxymethamphetamine (MDMA) does not induce robust psychomotor activation and 50‐kHz ultrasonic vocalisations in tryptophan hydroxylase 2 (Tph2) ‐deficient rats lacking serotonin in the central nervous syste","year":"2025","cit":1,"pfa":"Tianhua Wang","psa":"Markus Wöhr","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4416624841","eid":"W4416624841"},{"id":"paper-w4410375514","cat":"papers","name":"The Analysis of Hallucinogenic Drugs from Plants and Fungi","year":"2025","cit":1,"pfa":"Michael D. Cole","psa":"Agatha Grela","ptype":"book-chapter","src":"https://openalex.org/W4410375514","eid":"W4410375514"},{"id":"paper-w2024256150","cat":"papers","name":"ChemInform Abstract: Synthesis and Pharmacological Examination of 1‐(3‐Methoxy‐4‐methylphenyl)‐2‐aminopropane and 5‐Methoxy‐6‐methyl‐2‐aminoindan: Similarities to 3,4‐(Methylenedioxy)methamphetamine (MDMA).","year":"1991","cit":1,"pfa":"Michael P. Johnson","psa":"David E. Nichols","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2024256150","eid":"W2024256150"},{"id":"paper-w2753274960","cat":"papers","name":"A correlative analysis of mystical experiences and lasting symptom improvement from MDMA-assisted psychotherapy for treatment-resistant PTSD : a project based upon an investigation sponsored by Multidisciplinary Associat","year":"2017","cit":1,"pfa":"Michiko Mitsunaga-Whitten","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"dissertation","src":"https://openalex.org/W2753274960","eid":"W2753274960"},{"id":"paper-w2616636618","cat":"papers","name":"Retraction Note to: Gene expression analysis indicates CB1 receptor upregulation in the hippocampus and neurotoxic effects in the frontal cortex 3 weeks after single-dose MDMA administration in Dark Agouti rats","year":"2016","cit":1,"pfa":"Péter Petschner","psa":"György Bagdy","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"retraction","src":"https://openalex.org/W2616636618","eid":"W2616636618"},{"id":"paper-w4407387126","cat":"papers","name":"PSILOCYBIN MITIGATES BEHAVIORAL DESPAIR AND COGNITIVE RECOGNITION IMPAIRMENTS BY REGULATING THE HYPOTHALAMIC- PITUITARY-ADRENAL (HPA) AXIS VIA THE BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) SIGNALING PATHWAY MEDIATED BY TH","year":"2025","cit":1,"pfa":"Zitong Wang","psa":"Xin‐Min Li","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4407387126","eid":"W4407387126"},{"id":"paper-w157128501","cat":"papers","name":"Qué son las drogas de síntesis: el éxtasis (MDMA) y otras drogas sintéticas : cómo pueden afectar al organismo : la cultura \"rave\" y la música electrónica","year":"2003","cit":1,"pfa":"José Carlos Bouso","ptype":"article","src":"https://openalex.org/W157128501","eid":"W157128501"},{"id":"paper-w4233414967","cat":"papers","name":"Plant and Fungal Hallucinogens as Toxic and Therapeutic Agents","year":"2015","cit":1,"pfa":"E.A. Carlini","psa":"Lucas Oliveira Maia","ptype":"book-chapter","src":"https://openalex.org/W4233414967","eid":"W4233414967"},{"id":"paper-w4414039441","cat":"papers","name":"Blunted psychedelic drug effects in older adults","year":"2025","cit":1,"pfa":"Jacob S. Aday","psa":"Kevin F. Boehnke","topics":["Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4414039441","eid":"W4414039441"},{"id":"paper-w4385669388","cat":"papers","name":"Improvement in Depression Symptoms Measured by Montgomery-Åsberg Depression Rating Scale and Quick Inventory of Depressive Symptomatology-Self Rated Items after Randomised Double-blind COMP360 Psilocybin Therapy for Trea","year":"2023","cit":1,"pfa":"Guy M. Goodwin","psa":"E. Malievskaia","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4385669388","eid":"W4385669388"},{"id":"paper-w4413965372","cat":"papers","name":"Blunted psychedelic drug effects in older adults","year":"2025","cit":1,"pfa":"Jacob S. Aday","psa":"Kevin F. Boehnke","topics":["Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4413965372","eid":"W4413965372"},{"id":"paper-w7139925630","cat":"papers","name":"When I use a word . . . The psychedelic mind’s eye","year":"2026","cit":1,"pfa":"J K Aronson","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7139925630","eid":"W7139925630"},{"id":"paper-w4412641880","cat":"papers","name":"Psychedelics, Spirituality, and Fundamentalism: A Brain Network Approach to Cognitive Flexibility and Rigidity","year":"2025","cit":1,"pfa":"Anjian Yang","psa":"Xiaohui Wang","topics":["Mechanism & neuroscience"],"ptype":"editorial","src":"https://openalex.org/W4412641880","eid":"W4412641880"},{"id":"paper-w2936870808","cat":"papers","name":"LSD and the Law: A Framework for Policy Making","year":"1970","cit":1,"pfa":"Stephen D. Ford","topics":["Dosing & pharmacology","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2936870808","eid":"W2936870808"},{"id":"paper-w2342025668","cat":"papers","name":"El Cuerpo Extasiado: Experiencia y Percepción del Cuerpo en Usuarios de MDMA en el contexto de la \"Cultura Electrónica\" de la Ciudad de Santiago de Chile","year":"2004","cit":1,"pfa":"Christian Matus Madrid","ptype":"article","src":"https://openalex.org/W2342025668","eid":"W2342025668"},{"id":"paper-w4254506988","cat":"papers","name":"Stroke and Adverse Effects on The Immune and Cardiovascular Systems: The Danger of the Rise and Use of Psychedelic Drugs for Depression and PTSD","year":"2021","cit":1,"topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4254506988","eid":"W4254506988"},{"id":"paper-w4400219530","cat":"papers","name":"IS PSYCHEDELIC TREATMENT OF MENTAL HEALTH DISORDERS READY FOR PRIME TIME?","year":"2024","cit":1,"pfa":"Nauman Ashraf","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4400219530","eid":"W4400219530"},{"id":"paper-w4401452387","cat":"papers","name":"Effects of serotonergic psychedelics on synaptogenesis and immediate early genes expression - comparison with ketamine, fluoxetine and lithium","year":"2024","cit":1,"pfa":"Yana Vella","psa":"Tomáš Páleníček","topics":["Depression","Mechanism & neuroscience","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4401452387","eid":"W4401452387"},{"id":"paper-w4384468334","cat":"papers","name":"Psychedelic medicines","year":"2023","cit":1,"pfa":"Matthew Piggott","psa":"Peter J. Duggan","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4384468334","eid":"W4384468334"},{"id":"paper-w7119482083","cat":"papers","name":"The impact of drug control on wider research: Psychedelic mushroom exploration","year":"2026","cit":1,"pfa":"Samuel Lasham","psa":"Rhys Ponton","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7119482083","eid":"W7119482083"},{"id":"paper-w3135459718","cat":"papers","name":"Therapeutic Potential of Psychedelics in Treatment of Psychiatric Disorders, Part 2","year":"2021","cit":1,"pfa":"Avinash Hosanagar","psa":"Rajiv Radhakrishnan","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W3135459718","eid":"W3135459718"},{"id":"paper-w3195303159","cat":"papers","name":"Psychedelics and psychiatric disorders: A emerging role","year":"2021","cit":1,"pfa":"Clayton Peixoto","psa":"H. Medeiros","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W3195303159","eid":"W3195303159"},{"id":"paper-w4409663182","cat":"papers","name":"Exploring the perceived usefulness of integration support after naturalistic psychedelic experiences in people concerned about their substance use: A survey","year":"2025","cit":1,"pfa":"Sophie van der Helder","psa":"Jonathan Brett","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4409663182","eid":"W4409663182"},{"id":"paper-w4413629699","cat":"papers","name":"The effects of psychedelics on neuroplasticity: A review of current research and the possibility of therapeutic application in psychiatry","year":"2025","cit":1,"pfa":"Mile Jevtić","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4413629699","eid":"W4413629699"},{"id":"paper-w4403268454","cat":"papers","name":"The association between study design and antidepressant effects in psychedelic-assisted therapy: A meta-analysis","year":"2024","cit":1,"pfa":"Jia-Ru Li","psa":"Tien‐Wei Hsu","topics":["Depression","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4403268454","eid":"W4403268454"},{"id":"paper-w4414181599","cat":"papers","name":"Reporting of psychotherapeutic methods in psychedelic treatments: on the road to ethical, professional and regulatory oversight","year":"2025","cit":1,"pfa":"A.J. Oliveira-Maia","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4414181599","eid":"W4414181599"},{"id":"paper-w2087888448","cat":"papers","name":"Psychedelics, Glutamate, and Neuroimaging Studies","year":"2014","cit":1,"pfa":"RAFAEL GUIMARÃES DOS SANTOS","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2087888448","eid":"W2087888448"},{"id":"paper-w2054313770","cat":"papers","name":"Ascorbic acid antagonizes the behavioural effects of LSD in cats","year":"1985","cit":1,"pfa":"Michael E. Trulson","psa":"Leslie J Henderson","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2054313770","eid":"W2054313770"},{"id":"paper-w4388421437","cat":"papers","name":"The Potential Therapeutic Benefits and Safety of Psychedelics in the Treatment of Mental Health Conditions: A Systematic Review","year":"2023","cit":1,"pfa":"7450 Summit Cir, Davison, MI 48423","psa":"Sarah Naher","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W4388421437","eid":"W4388421437"},{"id":"paper-w2897634901","cat":"papers","name":"1.13 Microdosing of Hallucinogens Among College Students: Frequency, Correlates, and Consequences","year":"2018","cit":1,"pfa":"Nicole Fossos‐Wong","psa":"Irene Markman Geisner","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2897634901","eid":"W2897634901"},{"id":"paper-w4385677413","cat":"papers","name":"Psychedelic Drug Treatments","year":"2016","cit":1,"pfa":"Ben Sessa","psa":"Eileen Worthley","topics":["Depression","PTSD & trauma"],"ptype":"book","src":"https://openalex.org/W4385677413","eid":"W4385677413"},{"id":"paper-w4405711320","cat":"papers","name":"Brain dynamics of classical psychedelics show paradoxical hierarchical flattening with increased complexity","year":"2024","cit":1,"pfa":"Jakub Vohryzek","psa":"Yonatan Sanz Perl","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4405711320","eid":"W4405711320"},{"id":"paper-w74223113","cat":"papers","name":"Clandestine Operations: Synthetic Methods, Hazards, and Safety","year":"2011","cit":1,"pfa":"JaVed I. Khan","psa":"Donnell R. Christian","topics":["Safety & adverse events","Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W74223113","eid":"W74223113"},{"id":"paper-w7163887510","cat":"papers","name":"Short- and Long-Acting Psychedelics: Structure–Activity Relationships, Pharmacology, and Implications for Neuropsychiatric Therapeutics","year":"2026","cit":1,"pfa":"Anoushka Bhat","psa":"Samuel Obeng","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7163887510","eid":"W7163887510"},{"id":"paper-w4408960032","cat":"papers","name":"Do undergraduates’ views of psychedelics relate to the context for psychedelic use?","year":"2025","cit":1,"pfa":"Dan Petrovitch","psa":"Andrew K. Littlefield","topics":["Safety & adverse events","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4408960032","eid":"W4408960032"},{"id":"paper-w7133953253","cat":"papers","name":"Efficacy and risks of psychedelics in the treatment of posttraumatic stress disorder: A systematic review","year":"2026","cit":1,"pfa":"Jennifer E. Thomas","psa":"Joshua Caballero","topics":["PTSD & trauma","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7133953253","eid":"W7133953253"},{"id":"paper-w4237312525","cat":"papers","name":"A Neuropharmacological Investigation on Hallucinogenic Drugs. Laboratory Results versus Clinical Trials","year":"1964","cit":1,"pfa":"Vincenzo G. Longo","psa":"Daniel Bovet","topics":["Dosing & pharmacology"],"ptype":"conference-paper","src":"https://openalex.org/W4237312525","eid":"W4237312525"},{"id":"paper-w4406224088","cat":"papers","name":"Exploring Therapeutic Potentials and Pathways of Psychedelics in Alzheimer’s Disease‐Related Dementia","year":"2024","cit":1,"pfa":"Jitendra Kumar Sinha","psa":"Manchala Raghunath","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4406224088","eid":"W4406224088"},{"id":"paper-w4405530937","cat":"papers","name":"Psychedelic Therapeutics for Adolescents: Ethics, Safety, Opportunities, and Equipoise","year":"2024","cit":1,"pfa":"Paul E. Croarkin","psa":"Ming‐Fen Ho","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4405530937","eid":"W4405530937"},{"id":"paper-w4407426725","cat":"papers","name":"Hallucinogen-Persisting Perception Disorder in a 16-Year-Old Adolescent","year":"2025","cit":1,"pfa":"Anna Mori-Kreiner","psa":"Meelie Bordoloi","topics":["Depression","Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4407426725","eid":"W4407426725"},{"id":"paper-w4312160354","cat":"papers","name":"Progress and Puzzles in Psychedelic Therapy","year":"2022","cit":1,"pfa":"Harriet de Wit","ptype":"article","src":"https://openalex.org/W4312160354","eid":"W4312160354"},{"id":"paper-w4408813813","cat":"papers","name":"Comparing Antidepressant Effects of Psilocybin-Assisted Psychotherapy in Individuals That Were Unmedicated at Initial Screening Versus Individuals Discontinuing Medications for Study Participation: Comparaison des effets","year":"2025","cit":1,"pfa":"Noah Chisamore","psa":"Joshua Daniel Rosenblat","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4408813813","eid":"W4408813813"},{"id":"paper-w4411463860","cat":"papers","name":"Molecular, haemodynamic and functional effects of LSD in the human brain","year":"2025","cit":1,"pfa":"Drummond E-Wen McCulloch","psa":"Gitte M. Knudsen","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4411463860","eid":"W4411463860"},{"id":"paper-w2288535203","cat":"papers","name":"The Birth of Psychedelic Literature: Drug Writing and the rise of LSD Therapy 1954 – 1964","year":"2012","cit":1,"pfa":"Robert Dickins","topics":["Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W2288535203","eid":"W2288535203"},{"id":"paper-w4312905304","cat":"papers","name":"Fungal Hallucinogens: Chemistry, Synthesis, Behavior, Toxicity and Detection Methods in Forensic Perspective","year":"2022","cit":1,"pfa":"Merlin Kirubakarababu","psa":"Arputharaj Samson Nesaraj","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4312905304","eid":"W4312905304"},{"id":"paper-w4416715662","cat":"papers","name":"A Mesoscale Framework for Psychedelic Drug Action in the Human Brain","year":"2025","cit":1,"pfa":"Rui Dai","psa":"George A. Mashour","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4416715662","eid":"W4416715662"},{"id":"paper-w4232572547","cat":"papers","name":"Hallucinogens","year":"2016","cit":1,"pfa":"Michael F. Weaver","ptype":"reference-entry","src":"https://openalex.org/W4232572547","eid":"W4232572547"},{"id":"paper-w7150989008","cat":"papers","name":"Psychedelic Therapies for Comorbid Major Depressive Disorder and Chronic Pain: A Review of Putative Mechanisms of Action","year":"2026","cit":1,"pfa":"Jordana Kazdan","psa":"M. Ishrat Husain","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7150989008","eid":"W7150989008"},{"id":"paper-w2943541377","cat":"papers","name":"A letter reporting a case of fatal ventricular dysrhythmia associated with the LSD analog AL-LAD","year":"2019","cit":1,"pfa":"Adam Blumenberg","psa":"Robert G. Hendrickson","ptype":"article","src":"https://openalex.org/W2943541377","eid":"W2943541377"},{"id":"paper-w4387492993","cat":"papers","name":"Psychedelics as Therapeutics: Research Advances and Implications for Practice","year":"2023","cit":1,"pfa":"Kevin Michael Gray","psa":"Paul E. Croarkin","ptype":"article","src":"https://openalex.org/W4387492993","eid":"W4387492993"},{"id":"paper-w3089464605","cat":"papers","name":"After more than sixty years we are still unclear whether LSD has a place in clinical psychiatry","year":"2020","cit":1,"pfa":"Arthur Saniotis","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3089464605","eid":"W3089464605"},{"id":"paper-w7146946836","cat":"papers","name":"Classic psychedelics in obsessive–compulsive disorder: a circuit-based framework","year":"2026","cit":1,"pfa":"Saif S. Ali","psa":"Karl G. Sieg","ptype":"article","src":"https://openalex.org/W7146946836","eid":"W7146946836"},{"id":"paper-w2608686536","cat":"papers","name":"951. Changes in Resting-State Global Brain Connectivity in LSD-Induced Altered States of Consciousness are Attributable to the 5-HT2A Receptor","year":"2017","cit":1,"pfa":"Katrin H. Preller","psa":"Alan Anticevic","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2608686536","eid":"W2608686536"},{"id":"paper-w4402025857","cat":"papers","name":"Psychedelics, Psychedelic-Assisted Therapy and Employees’ Wellbeing","year":"2024","cit":1,"pfa":"Charlotte Smith","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4402025857","eid":"W4402025857"},{"id":"paper-w4414606986","cat":"papers","name":"Of shrub, cactus, vine and toad: psychedelic species of conservation concern","year":"2025","cit":1,"pfa":"Anna O. Ermakova","psa":"Sam Gandy","topics":["Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4414606986","eid":"W4414606986"},{"id":"paper-w3133423484","cat":"papers","name":"Ayahuasca’s Religious Diaspora in the Wake of the Doctrine of Discovery","year":"2020","cit":1,"pfa":"Roger K. Green","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3133423484","eid":"W3133423484"},{"id":"paper-w4292379720","cat":"papers","name":"Delix Therapeutics : psychedelics without the trip","year":"2022","cit":1,"pfa":"Ken Garber","ptype":"article","src":"https://openalex.org/W4292379720","eid":"W4292379720"},{"id":"paper-w7118003672","cat":"papers","name":"Snapshot IP 1 Detection Following 5-HT 2 A Receptor Stimulation in the Mouse Brain","year":"2026","cit":1,"pfa":"Mario de la Fuente Revenga","psa":"Javier González‐Maeso","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7118003672","eid":"W7118003672"},{"id":"paper-w4313585872","cat":"papers","name":"Editorial: Old and new psychoactive substances: Pharmacology and potential applications","year":"2023","cit":1,"pfa":"Felix P. Mayer","psa":"Harald H. Sitte","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"editorial","src":"https://openalex.org/W4313585872","eid":"W4313585872"},{"id":"paper-w4403607589","cat":"papers","name":"Brazilian Psychedelic Science and the Frontiers of Psychiatry","year":"2024","cit":1,"pfa":"Dráulio Barros de Araújo","psa":"Sidarta Tollendal Gomes Ribeiro","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4403607589","eid":"W4403607589"},{"id":"paper-w4211249082","cat":"papers","name":"Hallucinogens","year":"2017","cit":1,"pfa":"Curtis P. Snook","ptype":"book-chapter","src":"https://openalex.org/W4211249082","eid":"W4211249082"},{"id":"paper-w4211031612","cat":"papers","name":"Indole Hallucinogens","year":"2016","cit":1,"pfa":"Curtis P. Snook","ptype":"book-chapter","src":"https://openalex.org/W4211031612","eid":"W4211031612"},{"id":"paper-w4408068665","cat":"papers","name":"Therapeutic Potential of Psychedelics for Treating Anosmia: An Investigation of Online Accounts","year":"2025","cit":1,"pfa":"Alexsandra Kovacevich","psa":"Brian Scott Barnett","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4408068665","eid":"W4408068665"},{"id":"paper-w2912596249","cat":"papers","name":"Intercultural, intermolecular: An ethnobotanical examination of the potential therapeutic value of LSD for the treatment of depression","year":"2019","cit":1,"pfa":"Karsten Fatur","topics":["Depression","Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2912596249","eid":"W2912596249"},{"id":"paper-w4319788497","cat":"papers","name":"Characterization of the Binding Poses of Classical and Photoswitchable Psychedelics Interacting with 5-HT2AR","year":"2023","cit":1,"pfa":"Vito Federico Palmisano","psa":"Juan José Nogueira","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4319788497","eid":"W4319788497"},{"id":"paper-w4416941966","cat":"papers","name":"Psychedelics for the Treatment of Substance Use Disorders","year":"2025","cit":1,"pfa":"Johannes Klaus","psa":"Anil Batra","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4416941966","eid":"W4416941966"},{"id":"paper-w2039280285","cat":"papers","name":"The Role of the Laboratory in the Diagnosis of LSD and Ecstasy Psychosis","year":"1994","cit":1,"pfa":"Robert L. DuPont","psa":"Karl Verebey","ptype":"article","src":"https://openalex.org/W2039280285","eid":"W2039280285"},{"id":"paper-w7155059059","cat":"papers","name":"Serotonergic Polypharmacology of 2-Halogenated Tryptamines","year":"2026","cit":1,"pfa":"Jeanine Yacoub","psa":"Jacqueline L. von Salm","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7155059059","eid":"W7155059059"},{"id":"paper-w4383187259","cat":"papers","name":"Daily briefing: Australia will be first to prescribe these psychedelics as medicines","year":"2023","cit":1,"pfa":"Flora Graham","ptype":"article","src":"https://openalex.org/W4383187259","eid":"W4383187259"},{"id":"paper-w2474650918","cat":"papers","name":"[Effect of blockade of the dopamine, serotonin and cholinergic receptors on opioid modification of habituation in the visual cortex of the turtle].","year":"1988","cit":1,"pfa":"A S Pivovarov","psa":"Izmest'ev Vi","topics":["Addiction","Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W2474650918","eid":"W2474650918"},{"id":"paper-w4399467429","cat":"papers","name":"Determination of hallucinogenic active substances of Ephedra distachya L., a cosmopolitan plant species, by GC-MS Method","year":"2024","cit":1,"pfa":"Handan Uysal","psa":"Mehmet İnce","topics":["Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4399467429","eid":"W4399467429"},{"id":"paper-w4324309729","cat":"papers","name":"Mush Room for Improving Therapeutic Approaches in Psychiatry","year":"2023","cit":1,"pfa":"Piet H. van der Graaf","topics":["Depression","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"editorial","src":"https://openalex.org/W4324309729","eid":"W4324309729"},{"id":"paper-w4399755773","cat":"papers","name":"Increased 5-HT 2A receptor signalling efficacy differentiates serotonergic psychedelics from non-psychedelics","year":"2024","cit":1,"pfa":"Aurelija Ippolito","psa":"Trevor Sharp","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4399755773","eid":"W4399755773"},{"id":"paper-w4243650533","cat":"papers","name":"LSD: 1967","year":"1968","cit":1,"pfa":"Glin Bennet","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4243650533","eid":"W4243650533"},{"id":"paper-w4391067287","cat":"papers","name":"Pharmacotherapy of Psychological Disorders Using Psychedelic Drugs: A Treatise for Psychiatrists","year":"2024","cit":1,"pfa":"Payal Ghosh","psa":"Debjeet Sur","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4391067287","eid":"W4391067287"},{"id":"paper-w7124532178","cat":"papers","name":"Psychedelics distinctly alter brain entropy and complexity compared to psychostimulants","year":"2026","cit":1,"pfa":"Kristian Larsen","psa":"Mihai Avram","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7124532178","eid":"W7124532178"},{"id":"paper-w2591911787","cat":"papers","name":"The Social Construction of Technology: The Case of LSD","year":"1995","cit":1,"pfa":"Robyn Lisa Hohauser","ptype":"dissertation","src":"https://openalex.org/W2591911787","eid":"W2591911787"},{"id":"paper-w1976507548","cat":"papers","name":"Psychedelic Agents and Mysticism","year":"1971","cit":1,"pfa":"Albert S. Moraczewski","ptype":"article","src":"https://openalex.org/W1976507548","eid":"W1976507548"},{"id":"paper-w4212795947","cat":"papers","name":"Psychotherapeutic and neurobiological processes associated with ayahuasca’s mental health and wellbeing outcomes: a proposed model and implications for therapeutic use","year":"2022","cit":1,"pfa":"Daniel Perkins","psa":"Jerome J. Sarris","topics":["Safety & adverse events","Reviews & meta-analyses","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4212795947","eid":"W4212795947"},{"id":"paper-w2413232515","cat":"papers","name":"The airline passenger undergoing withdrawal or overdose from narcotics or other drugs.","year":"1985","cit":1,"pfa":"Lyman Jl","psa":"Möhler","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W2413232515","eid":"W2413232515"},{"id":"paper-w4388364196","cat":"papers","name":"THE AYAHUASCA’S PSYCHEDELIC COMPONENT DMT POTENTIATES NEURITOGENESIS IN PC12 CELLS","year":"2023","cit":1,"pfa":"Mariana Pazos","psa":"Giselle Prunell","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W4388364196","eid":"W4388364196"},{"id":"paper-w4385561725","cat":"papers","name":"Plant Poisons, Hallucinogens, and Traditional Medicines","year":"2023","cit":1,"pfa":"Jeffrey K Aronson","ptype":"book-chapter","src":"https://openalex.org/W4385561725","eid":"W4385561725"},{"id":"paper-w3003307608","cat":"papers","name":"Matthew Oram, The Trials of Psychedelic Therapy: LSD Psychotherapy in America","year":"2020","cit":1,"pfa":"M L Draper","topics":["Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3003307608","eid":"W3003307608"},{"id":"paper-w7163656829","cat":"papers","name":"A cross-national comparison of nonmedical and medical use of psychedelic drugs in the international cannabis policy study","year":"2026","cit":1,"pfa":"Myfanwy Graham","psa":"David G. Hammond","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7163656829","eid":"W7163656829"},{"id":"paper-w7167101970","cat":"papers","name":"Surprising Variability in Tryptamine Profiles of Psilocybe cubensis Fruiting Bodies: Inter- and Intra-Strain Differences Across 14 Strains Cultivated Under Controlled Conditions","year":"2026","cit":1,"pfa":"Amiel Sharchaton","psa":"Eyal Kurzbaum","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7167101970","eid":"W7167101970"},{"id":"paper-w4294188985","cat":"papers","name":"Therapeutic potential of serotoninergic psychedelic substances in the treatment of Obsessive Compulsive Disorder","year":"2022","cit":1,"pfa":"Jaime Pereira Rodrigues","psa":"Luiz Vicente Ribeiro","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4294188985","eid":"W4294188985"},{"id":"paper-w4388247691","cat":"papers","name":"Commentary on Keyes and Patrick: Changes in psychedelic use in the United States may require changes in our narrative of psychedelic harms","year":"2023","cit":1,"pfa":"Celia J. A. Morgan","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"editorial","src":"https://openalex.org/W4388247691","eid":"W4388247691"},{"id":"paper-w4307008613","cat":"papers","name":"Sacred Plants and Mental Health in Latin America","year":"2019","cit":1,"pfa":"Oscar Espin","psa":"European Institute for Multidisciplinary Studies on Human Rights and Science -…","ptype":"article","src":"https://openalex.org/W4307008613","eid":"W4307008613"},{"id":"paper-w2013668848","cat":"papers","name":"The effect of LSD on the surface of neuroepithelial cells","year":"1977","cit":1,"pfa":"Paul-Emil Messier","ptype":"article","src":"https://openalex.org/W2013668848","eid":"W2013668848"},{"id":"paper-w2509166377","cat":"papers","name":"Pharmacology of novel psychoactive substances","year":"2016","cit":1,"pfa":"Anna Rickli","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W2509166377","eid":"W2509166377"},{"id":"paper-w4299512296","cat":"papers","name":"Neural correlates of the LSD experience revealed by multimodal neuroimaging","year":"2020","cit":1,"pfa":"Peter John Hellyer","psa":"David E. Nichols","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4299512296","eid":"W4299512296"},{"id":"paper-w4378348830","cat":"papers","name":"Editorial: Pharmacology of new psychoactive substances","year":"2023","cit":1,"pfa":"Kabirullah Lutfy","psa":"Nissar A. Darmani","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"editorial","src":"https://openalex.org/W4378348830","eid":"W4378348830"},{"id":"paper-w2017989155","cat":"papers","name":"Psychosis, Psychiatry, And Homicide","year":"1972","cit":1,"pfa":"Myron H. Marshall","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2017989155","eid":"W2017989155"},{"id":"paper-w7164930745","cat":"papers","name":"Expectations and Motivations for Participation in Clinical Trials Utilizing Psychedelics for Treatment‐Resistant Depression: A Qualitative Study","year":"2026","cit":1,"pfa":"Christopher J. Poppe","psa":"Dimitris Repantis","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7164930745","eid":"W7164930745"},{"id":"paper-w4410543882","cat":"papers","name":"Elevated Endogenous Psychedelic Bufotenine in the Urine of Patients Diagnosed With a Mental Illness: A Systematic Review","year":"2025","cit":1,"pfa":"Alistair J Clarke","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4410543882","eid":"W4410543882"},{"id":"paper-w150208414","cat":"papers","name":"Cholinergic Mechanisms in Mental Illness: Anticholinergic Hallucinogens","year":"1966","cit":1,"pfa":"Max Fink","topics":["Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W150208414","eid":"W150208414"},{"id":"paper-w2184921858","cat":"papers","name":"Anticholinergic toxicity after the ingestion of serotonergic 'magic mushrooms'","year":"2012","cit":1,"pfa":"Jacomien Aleman","psa":"Eric J. F. Franssen","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2184921858","eid":"W2184921858"},{"id":"paper-w4413416230","cat":"papers","name":"DMT and harmala alkaloids: an exploratory study of oral Acacia based formulations in healthy volunteers","year":"2025","cit":1,"pfa":"Yvonne Ann Bonomo","psa":"Jerome J. Sarris","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4413416230","eid":"W4413416230"},{"id":"paper-w4400573130","cat":"papers","name":"New-Onset Seizures in an Adolescent Following Use of LSD while on Low-Dose Lithium Therapy: A Case Study.","year":"2024","cit":1,"pfa":"Cole Edwards","psa":"Vivek Raj Anand","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4400573130","eid":"W4400573130"},{"id":"paper-w3174346467","cat":"papers","name":"3D‐based analyses of pharmacological modulation of zebrafish locomotion","year":"2011","cit":1,"pfa":"Jonathan Cachat","psa":"Allan V. Kalueff","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3174346467","eid":"W3174346467"},{"id":"paper-w7119167790","cat":"papers","name":"The Effect of Magic Mushroom ( Psilocybe azurescens ) on Social Interaction, Anxiety‐ and Depressive‐Like Behaviors in Male Rats; the Role of Neuroinflammation, Oxidative Stress, and Neurotrophic Factors","year":"2026","cit":1,"pfa":"Hediye Moghadam","psa":"Neda Valian","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7119167790","eid":"W7119167790"},{"id":"paper-w7152461820","cat":"papers","name":"Dorsal Raphe Revisited: A Systems Neuroscience Lens on Psychedelic Drug Action","year":"2026","cit":1,"pfa":"Alex C. Kwan","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7152461820","eid":"W7152461820"},{"id":"paper-w4393255782","cat":"papers","name":"Could the medicalization of psychedelics lead to the next generation of antidepressants?","year":"2024","cit":1,"pfa":"Peter J. Duggan","psa":"Scott R. Walker","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4393255782","eid":"W4393255782"},{"id":"paper-w2188401801","cat":"papers","name":"Effect of BOL on the LSD-induced alteration of flicker discrimination in the rat.","year":"1972","cit":1,"pfa":"M D Schechter","psa":"Winter Jc","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2188401801","eid":"W2188401801"},{"id":"paper-w4401859341","cat":"papers","name":"A Systematic Review of Participant Diversity in Psychedelic-Assisted Psychotherapy Trials","year":"2024","cit":1,"pfa":"Stephanie L. Haft","psa":"Joshua Woolley","topics":["Reviews & meta-analyses","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4401859341","eid":"W4401859341"},{"id":"paper-w2006114906","cat":"papers","name":"LSD and Chromosomes","year":"1970","cit":1,"pfa":"Etan Markowitz","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2006114906","eid":"W2006114906"},{"id":"paper-w4240942482","cat":"papers","name":"LSD: The Search","year":"1966","cit":1,"topics":["Addiction","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4240942482","eid":"W4240942482"},{"id":"paper-w2919408042","cat":"papers","name":"Animal models of schizophrenia","year":"2018","cit":1,"pfa":"GORDON S. CLARIDGE","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W2919408042","eid":"W2919408042"},{"id":"paper-w4415159952","cat":"papers","name":"Intravenous Administration of Serotonergic Psychedelics Produce Short-lasting Changes in Sleep-Wake Behavior and High Gamma Functional Connectivity in Rats","year":"2025","cit":1,"pfa":"Nicholas Kolbman","psa":"Dinesh Pal","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4415159952","eid":"W4415159952"},{"id":"paper-w4309420223","cat":"papers","name":"The future of hallucination research: Can hallucinogens and psychedelic drugs teach us anything?","year":"2022","cit":1,"pfa":"Flavie Waters","ptype":"article","src":"https://openalex.org/W4309420223","eid":"W4309420223"},{"id":"paper-w4249590091","cat":"papers","name":"Data justify further research on potential of psychedelics in treating psychiatric disorders","year":"2020","cit":1,"topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4249590091","eid":"W4249590091"},{"id":"paper-w4312628818","cat":"papers","name":"Pharmacological Action of LSD","year":"2022","cit":1,"pfa":"Monika Herian","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W4312628818","eid":"W4312628818"},{"id":"paper-w7129286008","cat":"papers","name":"Psychedelic‐ and Substance‐Assisted Therapies in Global Mental Health: Bridging Cultures, Evidence, and Access","year":"2026","cit":1,"pfa":"Simon Halm","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7129286008","eid":"W7129286008"},{"id":"paper-w2135361228","cat":"papers","name":"Changes in the mitochondrial electron transport chain (ETC) enzyme activities, ultra structure and motility of the sperms of lysergic acid (LSD ) users","year":"2005","cit":1,"pfa":"Wafaa Ibrahem","psa":"Mona El-Gohary","ptype":"article","src":"https://openalex.org/W2135361228","eid":"W2135361228"},{"id":"paper-w4285256578","cat":"papers","name":"Pharmacological Action of LSD","year":"2022","cit":1,"pfa":"Monika Herian","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W4285256578","eid":"W4285256578"},{"id":"paper-w7117295770","cat":"papers","name":"Knowledge, perceptions, and use of psychedelics for mental health among autistic adults: An online survey","year":"2025","cit":1,"pfa":"Sahba Afsharnia","psa":"Hsiang‐Yuan Lin","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7117295770","eid":"W7117295770"},{"id":"paper-w4391394309","cat":"papers","name":"LSD Modulates Proteins Involved in Cell Proteostasis, Energy Metabolism and Neuroplasticity in Human Cerebral Organoids","year":"2024","cit":1,"pfa":"Marcelo N. Costa","psa":"Stevens Kastrup Rehen","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4391394309","eid":"W4391394309"},{"id":"paper-w4412121766","cat":"papers","name":"Fatalities following DMT use: two case reports and a review of the literature","year":"2025","cit":1,"pfa":"Jade Pullen","psa":"Caroline S. Copeland","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4412121766","eid":"W4412121766"},{"id":"paper-w3118990308","cat":"papers","name":"Increased sensitivity to strong perturbations in a whole-brain model of LSD","year":"2021","cit":1,"pfa":"Beatrice Jobst","psa":"Gustavo Deco","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W3118990308","eid":"W3118990308"},{"id":"paper-w4405267603","cat":"papers","name":"The Effects of Psychedelic Microdosing on Mental Health: A Systematic Review","year":"2024","cit":1,"pfa":"David F. Lo","psa":"Don D. Shamilov","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"review","src":"https://openalex.org/W4405267603","eid":"W4405267603"},{"id":"paper-w4377029512","cat":"papers","name":"The serotonergic psychedelic N,N-Dipropyltryptamine prevents seizures in a mouse model of fragile X syndrome via an apparent non-serotonergic mechanism","year":"2023","cit":1,"pfa":"Richa Tyagi","psa":"Clinton Ernest Canal","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4377029512","eid":"W4377029512"},{"id":"paper-w4409078245","cat":"papers","name":"Recreational Drugs Addiction, Withdrawal and its Impact on the body: A Literature Review","year":"2025","cit":1,"pfa":"Mustafa Zaman","psa":"Datta Pentapati","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4409078245","eid":"W4409078245"},{"id":"paper-w7128431906","cat":"papers","name":"Rural–urban disparities in access to interventional psychiatry treatments among U.S. Department of Veterans Affairs patients.","year":"2026","cit":1,"pfa":"Brian R. Shiner","psa":"Bradley Vincent Watts","topics":["Depression","PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7128431906","eid":"W7128431906"},{"id":"paper-w2105275451","cat":"papers","name":"Hallucinogens induce a specific barcode of phosphorylation on the serotonin2A receptor that underlies a weaker receptor desensitization and internalization","year":"2014","cit":1,"topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2105275451","eid":"W2105275451"},{"id":"paper-w4281685776","cat":"papers","name":"Psychedelic Psychiatry","year":"2022","cit":1,"pfa":"Neil Harjai","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4281685776","eid":"W4281685776"},{"id":"paper-w2057582260","cat":"papers","name":"Adolescent and Young Adult Psychedelic Drug Abuse: An Overview.","year":"1968","cit":1,"pfa":"William F. Kiely","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2057582260","eid":"W2057582260"},{"id":"paper-w4387225253","cat":"papers","name":"Medical Use of Cannabinoids and Psychedelic Compounds","year":"2023","cit":1,"pfa":"Antonio Inserra","psa":"Gabriella Gobbi","ptype":"book-chapter","src":"https://openalex.org/W4387225253","eid":"W4387225253"},{"id":"paper-w4387463278","cat":"papers","name":"DOSE DEPENDENT EFFECTS OF TWO POLYMERIC MATERIALS AND SIMILARITIES WITH CERTAIN DRUGS","year":"2023","cit":1,"pfa":"Alexandra Săvucă","psa":"Mircea Nicoară","topics":["Addiction","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4387463278","eid":"W4387463278"},{"id":"paper-w4387216276","cat":"papers","name":"Hallucinogen-Induced Persisting Perception Disorder: A Case Report","year":"2023","cit":1,"pfa":"Javairia Ayyub","psa":"Luciano Tamayo","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4387216276","eid":"W4387216276"},{"id":"paper-w7164660865","cat":"papers","name":"Characterizing non-hallucinogenic psychedelics beyond the head twitch response: phenotypic fingerprinting of lisuride and LSD","year":"2026","cit":1,"pfa":"Jillian L. King","psa":"Scott M. Thompson","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7164660865","eid":"W7164660865"},{"id":"paper-w4316662395","cat":"papers","name":"Journey To The Centre Of The Mind: Psychedelic Treatment of Mental Health in Aotearoa","year":"2023","cit":1,"pfa":"Daisy Lutyens","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W4316662395","eid":"W4316662395"},{"id":"paper-w4409638055","cat":"papers","name":"Less is more? Antidepressant effects of short-acting psychedelics","year":"2025","cit":1,"pfa":"Johannes Gerardus Ramaekers","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4409638055","eid":"W4409638055"},{"id":"paper-w4408177956","cat":"papers","name":"Vermont Primary Care Provider Perspectives on Psychedelics — A Cross-Sectional Study","year":"2025","cit":1,"pfa":"Josephine Yalovitser","psa":"Charles D. MacLean","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4408177956","eid":"W4408177956"},{"id":"paper-w4220817243","cat":"papers","name":"Elective surgery for acute pain in patients with substance use disorder: lessons learned at a rural neurosurgical center. Patient series","year":"2022","cit":1,"pfa":"Christopher S. Ferari","psa":"Cara L. Sedney","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4220817243","eid":"W4220817243"},{"id":"paper-w3147930394","cat":"papers","name":"The Return of Psychedelics: Still Time to Prevent Tragedy","year":"2021","cit":1,"pfa":"Stanley N. Caroff","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W3147930394","eid":"W3147930394"},{"id":"paper-w1605920837","cat":"papers","name":"A Review on Medicinal Plants Used in Animal Models and Clinical Trials concerning Drug Addiction","year":"2009","cit":1,"pfa":"Saeed Kianbakht","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1605920837","eid":"W1605920837"},{"id":"paper-w4385324763","cat":"papers","name":"Med Check: FDA, Anti-Amyloid Beta Vaccine, Clinical Trials of Psychedelics, and Lumryz","year":"2023","cit":1,"pfa":"Terri D’Arrigo","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4385324763","eid":"W4385324763"},{"id":"paper-w4411530242","cat":"papers","name":"From “Poison” to Sacrament: Spiritual and Therapeutic Use of Amanita muscaria in the 21st Century","year":"2025","cit":1,"pfa":"Kevin Feeney","psa":"Tristan T. Kallweit","topics":["Safety & adverse events","Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W4411530242","eid":"W4411530242"},{"id":"paper-w4294189072","cat":"papers","name":"Does LSD Have Any Therapeutical Value In Mental Disorders? A Non-Systemic Review","year":"2022","cit":1,"pfa":"L. Silva","psa":"L. Bravo","topics":["Addiction","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4294189072","eid":"W4294189072"},{"id":"paper-w1535201276","cat":"papers","name":"Hallucinogens Activate a Specific Population of Neurons in the Cortex","year":"2015","cit":1,"pfa":"David Alexander Martin","psa":"Charles David Nichols","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1535201276","eid":"W1535201276"},{"id":"paper-w2025565431","cat":"papers","name":"Platelet serotonin 5‐HT2Areceptor binding in patients with carcinoid tumor","year":"2004","cit":1,"pfa":"Olav Spigset","psa":"Tom Mjörndal","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2025565431","eid":"W2025565431"},{"id":"paper-w7154601486","cat":"papers","name":"Psycholytic Therapy Using LSD: a Realist Review","year":"2026","cit":1,"pfa":"Hamish Grime","psa":"Eugenia Drini","topics":["PTSD & trauma","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7154601486","eid":"W7154601486"},{"id":"paper-w634711028","cat":"papers","name":"Clinical and Forensic Drug Toxicology","year":"2001","cit":1,"pfa":"Wolfgang Thormann","psa":"Jitka Caslavska","topics":["Depression","Safety & adverse events","Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W634711028","eid":"W634711028"},{"id":"paper-w3005275362","cat":"papers","name":"Historical approaches on DMT","year":"2020","cit":1,"pfa":"Tom John Wolff","ptype":"book-chapter","src":"https://openalex.org/W3005275362","eid":"W3005275362"},{"id":"paper-w3089499004","cat":"papers","name":"Psihotropna biljna vrsta Salvia divinorum Epl. & Jativa - izvor najpotentnijeg halucinogena u prirodi","year":"2010","cit":1,"pfa":"Darija Šarić","psa":"Zdravko Lacković","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3089499004","eid":"W3089499004"},{"id":"paper-w3206310222","cat":"papers","name":"Therapeutic use of psychedelic drugs in depression disorders","year":"2021","cit":1,"pfa":"Miguel Trigo","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3206310222","eid":"W3206310222"},{"id":"paper-w7124865986","cat":"papers","name":"Evaluation of 1cp-LSD for Enhancing Welfare in Shelter Dogs: A Randomized Blind Trial with Ethological Intervention","year":"2026","cit":1,"pfa":"Elisa Hernández‐Álvarez","psa":"Luis Alberto Henríquez-Hernández","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7124865986","eid":"W7124865986"},{"id":"paper-w7126067744","cat":"papers","name":"LSD Reconfigures Cortical Dynamics Through Faster Brain Rhythms and Increased Fractal Dimension","year":"2026","cit":1,"pfa":"Venkatesh Subramani","psa":"Karim Jerbi","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7126067744","eid":"W7126067744"},{"id":"paper-w2804939359","cat":"papers","name":"Right coronary anomaly in a patient with myocarditis and cardiac arrest: a case report","year":"2018","cit":1,"pfa":"Lisa Oberli","psa":"Bettina Heidecker","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2804939359","eid":"W2804939359"},{"id":"paper-w2904188803","cat":"papers","name":"Ayahuasca’s influence on gay identity 1","year":"2018","cit":1,"pfa":"Clancy Cavnar","topics":["Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W2904188803","eid":"W2904188803"},{"id":"paper-w4410112263","cat":"papers","name":"A protocol for a scoping review of variations among psychedelic interventions for psychological suffering associated with the end-of-life","year":"2025","cit":1,"pfa":"Sarah Kratina","psa":"Brian R. Rush","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4410112263","eid":"W4410112263"},{"id":"paper-w4282000","cat":"papers","name":"Preparation of neoclerodane diterpenes as probes for the opioid receptor system","year":"2010","cit":1,"pfa":"Anthony Lozama","psa":"Michael W. Duffel","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W4282000","eid":"W4282000"},{"id":"paper-w1853535074","cat":"papers","name":"Have a safe trip: An investigation of rituals and sanctions surrounding LSD use","year":"1997","cit":1,"pfa":"David Wellbourne-Wood","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1853535074","eid":"W1853535074"},{"id":"paper-w4415916146","cat":"papers","name":"Advances and Challenges in LSD Detection: Analytical Techniques, Matrix Selection, and Validation Gaps in Forensic Toxicology","year":"2025","cit":1,"pfa":"Diksha Thakur","psa":"Ajay Kumar","topics":["Reviews & meta-analyses","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4415916146","eid":"W4415916146"},{"id":"paper-w4405660721","cat":"papers","name":"Effects of serotonin agonists LSD and 25CN-NBOH on conditioned place preference and on synaptic plasticity of VTA dopamine neurons in mice","year":"2024","cit":1,"pfa":"Lauri V. Elsilä","psa":"Esa R. Korpi","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4405660721","eid":"W4405660721"},{"id":"paper-w2888247161","cat":"papers","name":"Chapter 19. Alcohol and Other Substance Use Disorders","year":"2018","cit":1,"pfa":"Thomas R. Kosten","psa":"Richard De La Garza","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"book-chapter","src":"https://openalex.org/W2888247161","eid":"W2888247161"},{"id":"paper-w1520525240","cat":"papers","name":"Investigating the Effects of Novel Kappa Opioid Receptor Agonists on the Dopamine Transporter","year":"2011","cit":1,"pfa":"Bridget Simonson","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W1520525240","eid":"W1520525240"},{"id":"paper-w4248275852","cat":"papers","name":"N-tert-butyl-alpha-phenylnitrone protects against 3,4-methylenedioxymethamphetamine-induced depletion of serotonin in rats","year":"1999","cit":1,"pfa":"S.Y. Yeh","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4248275852","eid":"W4248275852"},{"id":"paper-w4206444809","cat":"papers","name":"The \"Angel Dust\" States: Phencyclidine Toxicity","year":"1979","cit":1,"pfa":"Sidney Cohen","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4206444809","eid":"W4206444809"},{"id":"paper-w1522866645","cat":"papers","name":"The Role Of Sertonin And Vesicular Monoamine Transporters In The Adverse Responses To Methylenedioxymethamphetamine","year":"2014","cit":1,"pfa":"Lucina Eridna Lizarraga-Zazueta","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W1522866645","eid":"W1522866645"},{"id":"paper-w4392794286","cat":"papers","name":"Psychedelic drugs and the law: What’s next?","year":"2024","cit":1,"pfa":"Ben Seal","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4392794286","eid":"W4392794286"},{"id":"paper-w1896744198","cat":"papers","name":"The ‘Vines of the Self’: An assessment of entheogenic shamanic tourism in light of modern identity","year":"2011","cit":1,"pfa":"Henrike Prudon","ptype":"article","src":"https://openalex.org/W1896744198","eid":"W1896744198"},{"id":"paper-w2022644297","cat":"papers","name":"Inescapable shock alters mescaline's disruption of active avoidance acquisition","year":"1981","cit":1,"pfa":"Judith L. Gibbons","psa":"Wagner H. Bridger","ptype":"article","src":"https://openalex.org/W2022644297","eid":"W2022644297"},{"id":"paper-w4300764035","cat":"papers","name":"Comments on \"The ketamine model of the near-death experience: A central role for the N-methyl-D-aspartate receptor\".","year":"1997","cit":1,"pfa":"Bianchi, Antonio","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4300764035","eid":"W4300764035"},{"id":"paper-w2401120782","cat":"papers","name":"Independent Regulation of Receptor-Mediated Cell Depolarization and Adenylate Cyclase by 5-Hydroxytryptamine (Serotonin) in Neuroblastoma Hybrid Cells","year":"1979","cit":1,"pfa":"John MacDermot","psa":"Haruhiro Higashida","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2401120782","eid":"W2401120782"},{"id":"paper-w4398236849","cat":"papers","name":"N-tert-butoxycarbonyl-methylenedioxymethamphetamine, an methylenedioxymethamphetamine derivative, exhibits rewarding and reinforcing effects by increasing dopamine levels.","year":"2024","cit":1,"pfa":"Dong‐Hyun Youn","psa":"Sun-Ok Choi","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4398236849","eid":"W4398236849"},{"id":"paper-w2765872633","cat":"papers","name":"Entheogenesis and Entheogenic Employment of Harmal","year":"2017","cit":1,"pfa":"Ephraim Shmaya Lansky","psa":"Helena Maaria Paavilainen","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W2765872633","eid":"W2765872633"},{"id":"paper-w1541687620","cat":"papers","name":"Pineal Gland, DMT & Altered State of Consciousness","year":"2013","cit":1,"pfa":"Iona Miller","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1541687620","eid":"W1541687620"},{"id":"paper-w4405966203","cat":"papers","name":"The Role of the Dorsolateral Prefrontal Cortex in Ego Dissolution and Emotional Arousal During the Psychedelic State","year":"2024","cit":1,"pfa":"Clayton R. Coleman","psa":"Robin Lester Carhart-Harris","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4405966203","eid":"W4405966203"},{"id":"paper-w2405668407","cat":"papers","name":"Review Article Pineal Gland, DMT & Altered State of Consciousness","year":"2013","cit":1,"pfa":"Iona Miller","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2405668407","eid":"W2405668407"},{"id":"paper-w7162760053","cat":"papers","name":"Structural characterization of kappa-opioid receptor dimer in complex with two G proteins","year":"2026","cit":1,"pfa":"Y ZHAO","psa":"Youwen Zhuang","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7162760053","eid":"W7162760053"},{"id":"paper-w4414300374","cat":"papers","name":"The empathogen 3,4-methylenedioxymethamphetamine, but not methamphetamine, increases feelings of global trust","year":"2025","cit":1,"pfa":"Ramona L. Martinez","psa":"Sonja Lyubomirsky","ptype":"article","src":"https://openalex.org/W4414300374","eid":"W4414300374"},{"id":"paper-w7147332300","cat":"papers","name":"Mystical dynamics: renewal, luminous light, and ego disintegration as key features associated with mystical oneness—a psychometric analysis using the PES100 in controlled psychedelic studies","year":"2026","cit":1,"pfa":"Kurt Stocker","psa":"Matthias E. Liechti","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7147332300","eid":"W7147332300"},{"id":"paper-w1545825968","cat":"papers","name":"Investigation of Natural Product Scaffolds for the Development of Opioid Receptor Ligands","year":"2012","cit":1,"pfa":"Katherine Marie Smith","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W1545825968","eid":"W1545825968"},{"id":"paper-w4411530456","cat":"papers","name":"Healing in the Native American Church: Ritual Psychopharmacology and Therapeutic Narrative","year":"2025","cit":1,"pfa":"Joseph D. Calabrese","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W4411530456","eid":"W4411530456"},{"id":"paper-w4412196801","cat":"papers","name":"A systematic review and narrative summary of the therapeutic potential of classic serotonergic psychedelics for smoking cessation and reduction","year":"2025","cit":1,"pfa":"Dillon L Glenn","psa":"Rick S. Zimmerman","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W4412196801","eid":"W4412196801"},{"id":"paper-w2421168908","cat":"papers","name":"[Recent abuse of 3,4-methylenedioxymethamphetamine (\"yaoto-wang\", \"ecstasy\")].","year":"2002","cit":1,"pfa":"Yuki Satsumi","topics":["Safety & adverse events","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2421168908","eid":"W2421168908"},{"id":"paper-w4416732672","cat":"papers","name":"Knocking at the Doors of Perception: Relating LSD Effects on Low‐Frequency Fluctuations and Regional Homogeneity to Receptor Densities in fMRI","year":"2025","cit":1,"pfa":"Paolo La‐Torraca‐Vittori","psa":"Stefano Damiani","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4416732672","eid":"W4416732672"},{"id":"paper-w2068288736","cat":"papers","name":"Panic disorder due to ingestion of single dose ecstasy","year":"2005","cit":1,"pfa":"Ümit Başar Semiz","psa":"Servet Ebrinç","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2068288736","eid":"W2068288736"},{"id":"paper-w4384939492","cat":"papers","name":"The Toxicity Debate","year":"2023","cit":1,"pfa":"Torsten Passie","topics":["Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W4384939492","eid":"W4384939492"},{"id":"paper-w3169076037","cat":"papers","name":"Behandeling met psilocybine","year":"2021","cit":1,"pfa":"Joost J. Breeksema","psa":"Robert A. Schoevers","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3169076037","eid":"W3169076037"},{"id":"paper-w4386593692","cat":"papers","name":"Psychedelic Drug Therapy for Mental Disorders?","year":"2023","cit":1,"pfa":"John R. Rossiter","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4386593692","eid":"W4386593692"},{"id":"paper-w4412097474","cat":"papers","name":"Exploring Jordanian Physicians’ and Medical Students’ Perspectives on Ketamine and Psychedelic-Assisted Therapies: An Insight from the Middle East","year":"2025","cit":1,"pfa":"Khalid Ahmed","psa":"Zaid Al Kayed","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4412097474","eid":"W4412097474"},{"id":"paper-w7161692886","cat":"papers","name":"From trials to clinics: investigators’ perspectives on translating psychedelic research into clinical care","year":"2026","cit":1,"pfa":"Joshua Mitchell","psa":"Amy L. McGuire","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7161692886","eid":"W7161692886"},{"id":"paper-w3170753518","cat":"papers","name":"Proteomic changes induced by harmine in human brain organoids reveal signaling pathways related to neuroprotection","year":"2021","cit":1,"pfa":"Karina Karmirian","psa":"Stevens Kastrup Rehen","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W3170753518","eid":"W3170753518"},{"id":"paper-w4411230618","cat":"papers","name":"Post-traumatic stress disorder in psychedelic research","year":"2025","cit":1,"pfa":"Tijmen Bostoen","psa":"Robert A. Schoevers","topics":["PTSD & trauma"],"ptype":"book-chapter","src":"https://openalex.org/W4411230618","eid":"W4411230618"},{"id":"paper-w3094340407","cat":"papers","name":"Healing with the Brew: Ayahuasca’s Reconfiguration of “Addiction”","year":"2021","cit":1,"pfa":"Piera Talin","topics":["Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W3094340407","eid":"W3094340407"},{"id":"paper-w291027640","cat":"papers","name":"3,4-methylenedioxyamphetamine upregulates p75 neurotrophin receptor protein expression in the rat brain.","year":"2012","cit":1,"pfa":"Chaomin Wang","psa":"Xue Wang","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W291027640","eid":"W291027640"},{"id":"paper-w1942057892","cat":"papers","name":"Neuropharmacological properties of the cathinones","year":"2015","cit":1,"pfa":"S.E. Shortall","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W1942057892","eid":"W1942057892"},{"id":"paper-w2898553167","cat":"papers","name":"RETRACTED ARTICLE: Long-term systemic administration with low dose of 3,4-methylenedioxymethamphetamine causes photoreceptor cell damage in CD1 mice","year":"2018","cit":1,"pfa":"Xiu-fang Lv","psa":"Hui Zhong","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2898553167","eid":"W2898553167"},{"id":"paper-w7140027232","cat":"papers","name":"“You can only take your clients as far as you’ve been yourself”: examining the intersections between psychedelic-assisted therapy, lived-living experience, and clinical practice","year":"2026","cit":1,"pfa":"Jordan J. Negrine","psa":"Timothy M. Piatkowski","topics":["Safety & adverse events","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7140027232","eid":"W7140027232"},{"id":"paper-w4416066823","cat":"papers","name":"Beyond Rhabdomyolysis: C3 Glomerulopathy in 3,4-Methylenedioxymethamphetamine-Induced Multiorgan Dysfunction","year":"2025","cit":1,"pfa":"Solabomi Oyeronke Ojeniyi","psa":"Suzanne M. Boyle","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4416066823","eid":"W4416066823"},{"id":"paper-w7130417929","cat":"papers","name":"Psychedelic-assisted psychotherapy: Clarifying the role of the \"psychotherapy\"","year":"2026","cit":1,"pfa":"Stefan Jerotić","psa":"Nađa P. Marić","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7130417929","eid":"W7130417929"},{"id":"paper-w568802808","cat":"papers","name":"Mirror of the soul : cultural psychiatry, moral socialization and the development of the self in the Native American Church","year":"2006","cit":1,"pfa":"Joseph Ii D. Calabrese","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W568802808","eid":"W568802808"},{"id":"paper-w4404864305","cat":"papers","name":"Neurochemical characterization of 5-HT 2A R partial agonists with simultaneous PET-MRI","year":"2024","cit":1,"pfa":"Frederick A. Bagdasarian","psa":"Hanne Demant Hansen","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4404864305","eid":"W4404864305"},{"id":"paper-w1902440942","cat":"papers","name":"The Ups and Downs of 3,4-Methylenedioxymethamphetamine: Linking Subjective Effects to Spontaneous Brain Function","year":"2015","cit":1,"pfa":"Harriet de Wit","psa":"K. Luan Phan","ptype":"article","src":"https://openalex.org/W1902440942","eid":"W1902440942"},{"id":"paper-w2284783780","cat":"papers","name":"[The morphofunctional changes in the internal organs in the modelling of poisonings by psilocybine-containing mushrooms].","year":"1999","cit":1,"pfa":"Babakhanian Rv","psa":"O D Iagmurov","ptype":"article","src":"https://openalex.org/W2284783780","eid":"W2284783780"},{"id":"paper-w7165643590","cat":"papers","name":"Blocking 5-HT2B receptors abolishes psilocybin’s efficacy in the rat forced swim test","year":"2026","cit":1,"pfa":"Lenka Seillier","psa":"Romana Šlamberová","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7165643590","eid":"W7165643590"},{"id":"paper-w4229000835","cat":"papers","name":"Making the Case for Psychedelics: Comparing Alternative Treatment Options for Depression","year":"2022","cit":1,"pfa":"Nicole Amavisca","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W4229000835","eid":"W4229000835"},{"id":"paper-w4411095478","cat":"papers","name":"Meditation and psychedelics facilitate similar types of mystical, psychological, and philosophical-existential insights predictive of wellbeing: A qualitative-quantitative approach","year":"2025","cit":1,"pfa":"Jussi Jylkkä","topics":["Addiction","Anxiety & end-of-life","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4411095478","eid":"W4411095478"},{"id":"paper-w4280523617","cat":"papers","name":"Herbal Resources in the medication of depression during pandemic COVID-19","year":"2022","cit":1,"pfa":"Izabela Bolesławska","psa":"Juliusz Przysławski","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4280523617","eid":"W4280523617"},{"id":"paper-w4385697107","cat":"papers","name":"Understanding the chemical language of the natural pharmacopeia: Whose hallucinogen is it anyway?","year":"2023","cit":1,"pfa":"Renee Maria Borges","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4385697107","eid":"W4385697107"},{"id":"paper-w4409460143","cat":"papers","name":"From efficacy to effectiveness: evaluating psychedelic randomised controlled trials for trustworthy evidence-based policy and practice.","year":"2024","cit":1,"pfa":"Eduardo Ekman Schenberg","topics":["Depression","PTSD & trauma","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4409460143","eid":"W4409460143"},{"id":"paper-w4404572655","cat":"papers","name":"Schizophrenia and Other Psychotic Disorders Among the Visually Impaired","year":"2024","cit":1,"pfa":"Kamand Abedi","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4404572655","eid":"W4404572655"},{"id":"paper-w2240548124","cat":"papers","name":"The role of serotonin in brain development and 3,4- methylenedioxymethamphetamine-induced cognitive deficits","year":"2009","cit":1,"pfa":"Tori L. Schaefer","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2240548124","eid":"W2240548124"},{"id":"paper-w4404014915","cat":"papers","name":"Pyramidal cell types and 5-HT 2A receptors are essential for psilocybin’s lasting drug action","year":"2024","cit":1,"pfa":"Ling-Xiao Shao","psa":"Alex C. Kwan","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4404014915","eid":"W4404014915"},{"id":"paper-w4214830215","cat":"papers","name":"The Role ofPsychedelics in Managing Anxiety, Depression, and Flashbacks of Individuals withPost-Traumatic Stress Disorder","year":"2022","cit":1,"pfa":"Reace L. Hammel","psa":"Sam Abraham","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4214830215","eid":"W4214830215"},{"id":"paper-w4394598680","cat":"papers","name":"Mushroom Therapy: Psilocybin’s Role in Treating Substance Use Disorders (P3-9.018)","year":"2024","cit":1,"pfa":"Tina Singh","psa":"Sadeepa Bulasthina","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4394598680","eid":"W4394598680"},{"id":"paper-w1982452669","cat":"papers","name":"3,4-Methylendioxymethamphetamin (Ecstasy): Wirkung, Gefahren und präklinische Therapie der akuten Intoxikation","year":"2000","cit":1,"pfa":"Stephan Halbig","psa":"P. Kessler","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1982452669","eid":"W1982452669"},{"id":"paper-w4410446221","cat":"papers","name":"Under Pressure: Stronger depressive symptoms are associated with more positive expectations towards experimental treatments","year":"2025","cit":1,"pfa":"Lukas Andreas Basedow","psa":"Cüneyt Yildiz","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4410446221","eid":"W4410446221"},{"id":"paper-w4410695397","cat":"papers","name":"Psilocybine dans le traitement d’une dépression résistante unipolaire : à propos d’un cas clinique","year":"2025","cit":1,"pfa":"Maroussia Dumenil","psa":"Wissam El‐Hage","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4410695397","eid":"W4410695397"},{"id":"paper-w2793401663","cat":"papers","name":"Jeremy Shaw's DMT","year":"2017","cit":1,"pfa":"Jennifer Fisher","topics":["PTSD & trauma","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2793401663","eid":"W2793401663"},{"id":"paper-w3034683357","cat":"papers","name":"Hallucinogen Abuse and Dependence","year":"2014","cit":1,"pfa":"John H. Halpern","psa":"Torsten Passie","ptype":"reference-entry","src":"https://openalex.org/W3034683357","eid":"W3034683357"},{"id":"paper-w2925750024","cat":"papers","name":"Research on Psychedelics Making a Comeback","year":"2007","cit":1,"pfa":"Walter A. Brown","ptype":"article","src":"https://openalex.org/W2925750024","eid":"W2925750024"},{"id":"paper-w4405082695","cat":"papers","name":"Psychedelic-assisted grief therapy: a mixed-method case study","year":"2024","cit":1,"pfa":"Pablo Sabucedo","psa":"Débora González","topics":["Anxiety & end-of-life","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4405082695","eid":"W4405082695"},{"id":"paper-w2982427347","cat":"papers","name":"Johns Hopkins Opens Research Center on Psychedelics","year":"2019","cit":1,"pfa":"Nick Zagorski","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W2982427347","eid":"W2982427347"},{"id":"paper-w2023541755","cat":"papers","name":"Parallel liquid/liquid extraction (LLE) and GC–MS determination of ketamine, 7-amino-clonazepam, temazepam, and tramadol with DRUID core substances","year":"2008","cit":1,"pfa":"László Institóris","psa":"Tibor Varga","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2023541755","eid":"W2023541755"},{"id":"paper-w4401920066","cat":"papers","name":"Older Adults in Psychedelic-Assisted Therapy Trials: A Systematic Review","year":"2024","cit":1,"pfa":"Lisa Bouchet","psa":"Yvan Beaussant","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"review","src":"https://openalex.org/W4401920066","eid":"W4401920066"},{"id":"paper-w4402964177","cat":"papers","name":"Manic Episode with Psychotic Features Associated with Salvia divinorum Use: A Case Report","year":"2024","cit":1,"pfa":"Ze-Yu Lin","psa":"Ming‐Chyi Huang","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4402964177","eid":"W4402964177"},{"id":"paper-w3212706503","cat":"papers","name":"O6C-20-nor-SalA is a stable and potent KOR agonist","year":"2017","cit":1,"pfa":"Ryan A. Shenvi","psa":"Laura Bohn","topics":["Addiction","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W3212706503","eid":"W3212706503"},{"id":"paper-w4396534398","cat":"papers","name":"243. Anesthesia as a Control for Blinding in Psychedelic Therapy","year":"2024","cit":1,"pfa":"Tuuli M. Hietamies","psa":"Boris Dov Heifets","ptype":"article","src":"https://openalex.org/W4396534398","eid":"W4396534398"},{"id":"paper-w4414845017","cat":"papers","name":"The effect of methamphetamine and 3,4-methylenedioxymethamphetamine on peripheral endocannabinoid concentrations: a study in healthy adults","year":"2025","cit":1,"pfa":"Ana Deutsch","psa":"Leah M. Mayo","ptype":"article","src":"https://openalex.org/W4414845017","eid":"W4414845017"},{"id":"paper-w1565129581","cat":"papers","name":"Effect of 3,4-methylenedioxymethamphetamine on pituitary-gonadal hormonized axis in immature male Rats","year":"2012","cit":1,"pfa":"L Jamshidpoor","psa":"H Kargar Jahroumi","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1565129581","eid":"W1565129581"},{"id":"paper-w4229443770","cat":"papers","name":"Probing the antidepressant action of psychedelics","year":"2022","cit":1,"pfa":"Katie Kingwell","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4229443770","eid":"W4229443770"},{"id":"paper-w4232045821","cat":"papers","name":"Flashbacks und anhaltende Wahrnehmungsstörungen nach Einnahme von serotonergen Halluzinogenen","year":"2016","cit":1,"pfa":"Tomislav Majić","psa":"Leo Hermle","ptype":"book-chapter","src":"https://openalex.org/W4232045821","eid":"W4232045821"},{"id":"paper-w4385497393","cat":"papers","name":"Psychedelic treatment for anorexia","year":"2023","cit":1,"pfa":"Sarah Crunkhorn","ptype":"article","src":"https://openalex.org/W4385497393","eid":"W4385497393"},{"id":"paper-w2805577811","cat":"papers","name":"Psychedelics as change agents in addiction and mood disorders.","year":"2017","cit":1,"pfa":"Albert Garcia‐Romeu","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2805577811","eid":"W2805577811"},{"id":"paper-w4299577300","cat":"papers","name":"[Ecstasy toxicity].","year":"2006","cit":1,"pfa":"Dagmara Ona Reingardienė","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W4299577300","eid":"W4299577300"},{"id":"paper-w3005500994","cat":"papers","name":"Ritual elements that influence psychedelic experiences","year":"2020","cit":1,"pfa":"Tom John Wolff","ptype":"book-chapter","src":"https://openalex.org/W3005500994","eid":"W3005500994"},{"id":"paper-w4240455675","cat":"papers","name":"Speed and ecstasy linked to depression in teenagers, especially if both are used","year":"2012","cit":1,"topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4240455675","eid":"W4240455675"},{"id":"paper-w302119878","cat":"papers","name":"Stereoselective aspects of hallucinogenic drug action and drug discrimination studies of entactogens","year":"1989","cit":1,"pfa":"Robert A. Oberlender","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W302119878","eid":"W302119878"},{"id":"paper-w2340411559","cat":"papers","name":"[Biomimetic electrochemical synthesis of quinol-thioether conjugates: their implication in the serotonergic neurotoxicity of amphetamine derivatives].","year":"2003","cit":1,"pfa":"Martine Largeron","psa":"Maurice‐Bernard Fleury","topics":["Safety & adverse events","Policy & ethics"],"ptype":"other","src":"https://openalex.org/W2340411559","eid":"W2340411559"},{"id":"paper-w7134107912","cat":"papers","name":"From renaissance to confluence: A call for paradigm shift in psychedelic studies","year":"2026","cit":1,"pfa":"Glauber Loures de Assis","psa":"Jacqueline Alves Rodrigues","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7134107912","eid":"W7134107912"},{"id":"paper-w7124752751","cat":"papers","name":"Insights from the psychedelic experience integration session: Verbatims differentiate 3-month abstinence in alcohol use disorder with depressive symptoms","year":"2026","cit":1,"pfa":"Maria Garcia Garcia","psa":"Amandine Luquiens","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7124752751","eid":"W7124752751"},{"id":"paper-w7135185290","cat":"papers","name":"Psychedelics for treatment of negative symptoms and depressive symptoms in schizophrenia spectrum disorder: A narrative review","year":"2026","cit":1,"pfa":"Michel Sabé","psa":"Joseph T. La Torre","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W7135185290","eid":"W7135185290"},{"id":"paper-w2800678235","cat":"papers","name":"Psychedelics, the Spiritual and Consciousness—an Evolving Confluence in the Cultural Stream","year":"2018","cit":1,"pfa":"Phil Wolfson","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2800678235","eid":"W2800678235"},{"id":"paper-w4381853198","cat":"papers","name":"The Manure Tour: Invasive Populations and Clandestine Cultivars Have Bottlenecked Magic Mushrooms Since Psilocybe cubensis Spread From Its Unknown Centre of Origin","year":"2023","cit":1,"pfa":"Alistair R. McTaggart","psa":"Timothy Yong James","ptype":"preprint","src":"https://openalex.org/W4381853198","eid":"W4381853198"},{"id":"paper-w2837630476","cat":"papers","name":"2018/7/6/curcumin-breast-cancer-therapeutic-agent-to-replace-allopathic-treatments-with-extensive-side-effects","year":"2018","cit":1,"pfa":"Chu Hsien Lim","psa":"Jack Bergman","topics":["Depression","Anxiety & end-of-life"],"ptype":"report","src":"https://openalex.org/W2837630476","eid":"W2837630476"},{"id":"paper-w3022418460","cat":"papers","name":"Non-drug altered states as psychedelic experiences","year":"2019","cit":1,"pfa":"David P. Luke","psa":"Gabriella Bergin-Cartwright","ptype":"article","src":"https://openalex.org/W3022418460","eid":"W3022418460"},{"id":"paper-w3004191036","cat":"papers","name":"Richard Alpert (Ram Dass): Harvard psychologist who experimented with psychedelic drugs and became one of America’s most prominent and respected spiritual leaders","year":"2020","cit":1,"pfa":"Rebecca Wallersteiner","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3004191036","eid":"W3004191036"},{"id":"paper-w2524945059","cat":"papers","name":"Studies on Ligands of the Kappa Opioid Receptor","year":"2016","cit":1,"pfa":"Kelly M. DiMattio","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W2524945059","eid":"W2524945059"},{"id":"paper-w2964502611","cat":"papers","name":"DEVELOPMENT AND VALIDATION OF 3,4-METHYLENEDIOXYMETHAMPHETAMINE ANALYSIS METHODS IN DRIED BLOOD SPOT SAMPLE USING GAS CHROMATOGRAPHY-MASS SPECTROMETRY","year":"2019","cit":1,"pfa":"Yahdiana Harahap","psa":"Kuswardani Kuswardani","ptype":"article","src":"https://openalex.org/W2964502611","eid":"W2964502611"},{"id":"paper-w4225289697","cat":"papers","name":"A preliminary acoustic study of Mandarin speech in drug addicts","year":"2022","cit":1,"pfa":"Puyang Geng","psa":"Shaopei Shi","topics":["Addiction"],"ptype":"conference-paper","src":"https://openalex.org/W4225289697","eid":"W4225289697"},{"id":"paper-w7125790828","cat":"papers","name":"Psychedelics in Focus: Clinical Trial Advancements, USFDA Breakthrough Designations, Innovative Approaches, Legal and Regulatory Aspects","year":"2026","cit":1,"pfa":"Gadekar Kailas Vijay","psa":"Saurabh Srivastava","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7125790828","eid":"W7125790828"},{"id":"paper-w4289261488","cat":"papers","name":"The last man takes LSD: Foucault and the end of revolution.MitchellDean and DanielZamoraVerso, 2021, 256 pp., $26.95 cloth. ISBN‐13: 978‐1‐83976‐139‐3; 978‐1‐83976‐140‐9 (ebook)","year":"2022","cit":1,"pfa":"Dennis Bryson","topics":["Policy & ethics"],"ptype":"book-review","src":"https://openalex.org/W4289261488","eid":"W4289261488"},{"id":"paper-w4403721028","cat":"papers","name":"Critical appraisal of evidence supporting prescription of psychedelics from clinic websites in Ontario, Canada","year":"2024","cit":1,"pfa":"K S Kim","psa":"Braden Gregory O’Neill","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4403721028","eid":"W4403721028"},{"id":"paper-w4400916365","cat":"papers","name":"Treatment-Related Fluctuation in Guillain-Barre Syndrome With the Acute Motor-Sensory Axonal Neuropathy (AMSAN) Variant: A Case Report","year":"2024","cit":1,"pfa":"Elliot Hernandez","psa":"Juan Carlos López‐Hernández","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4400916365","eid":"W4400916365"},{"id":"paper-w4238306111","cat":"papers","name":"Harmine stimulates neurogenesis of human neural cells in vitro","year":"2016","cit":1,"pfa":"Vanja Dakic","psa":"Stevens Kastrup Rehen","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4238306111","eid":"W4238306111"},{"id":"paper-w4393862547","cat":"papers","name":"A Review of Psychedelic-Assisted Psychotherapy for Cancer Patients with Emotional Distress","year":"2024","cit":1,"pfa":"Isaac Tourgeman","psa":"Brooks Peterson","topics":["Anxiety & end-of-life","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4393862547","eid":"W4393862547"},{"id":"paper-w4396223513","cat":"papers","name":"The identification of psychedelic compounds within Australian Acacia species","year":"2024","cit":1,"pfa":"L O’Grady","psa":"Lawrence D. Webb","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4396223513","eid":"W4396223513"},{"id":"paper-w2275360187","cat":"papers","name":"Neurotoxicity of ecstasy : causality, course, and clinical relevance","year":"2007","cit":1,"pfa":"Maartje M. L. de Win","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"other","src":"https://openalex.org/W2275360187","eid":"W2275360187"},{"id":"paper-w4415298825","cat":"papers","name":"Understanding ketamine subjective effects","year":"2025","cit":1,"pfa":"Albert Dahan","psa":"Marieke Niesters","ptype":"book-chapter","src":"https://openalex.org/W4415298825","eid":"W4415298825"},{"id":"paper-w7159826531","cat":"papers","name":"Effects of psychedelic use on authoritarian attitudes revisited","year":"2026","cit":1,"pfa":"Otto Simonsson","psa":"Robin Lester Carhart-Harris","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7159826531","eid":"W7159826531"},{"id":"paper-w4385732924","cat":"papers","name":"Analyse de flacons d’ayahuasca séculaires : détermination de la composition des substances actives après cent ans de conservation","year":"2023","cit":1,"pfa":"Nadia Arbouche","psa":"Pascal Kintz","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4385732924","eid":"W4385732924"},{"id":"paper-w2141194033","cat":"papers","name":"Pharmacologie et toxicologie cliniques de l'ecstasy","year":"2003","cit":1,"pfa":"Laurent Simon","psa":"François‐Régis Cousin","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2141194033","eid":"W2141194033"},{"id":"paper-w4411990411","cat":"papers","name":"Accurate and Interpretable Prediction of Antidepressant Treatment Response from Receptor-informed Neuroimaging","year":"2025","cit":1,"pfa":"Hanna M. Tolle","psa":"Pedro A. M. Mediano","topics":["Depression","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4411990411","eid":"W4411990411"},{"id":"paper-w4389731046","cat":"papers","name":"116: ELECTRIC DAISY CARNIVAL AND ASSOCIATED COMPLICATION RATES IN ICU PATIENTS: A CASE SERIES","year":"2023","cit":1,"pfa":"Claire Chen","psa":"ARTHUR OLIVER ROMERO","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4389731046","eid":"W4389731046"},{"id":"paper-w2898161302","cat":"papers","name":"Pharmacokinetic data of synthetic cathinones in female Sprague-Dawley rats","year":"2018","cit":1,"pfa":"Gregory G. Grecco","psa":"Jon E. Sprague","topics":["Dosing & pharmacology"],"ptype":"data-paper","src":"https://openalex.org/W2898161302","eid":"W2898161302"},{"id":"paper-w7160867854","cat":"papers","name":"Trials, trips, and tribulations: pathways for implementing psychedelic therapy in Ireland","year":"2026","cit":1,"pfa":"John Richard Kelly","psa":"Andrew Harkin","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7160867854","eid":"W7160867854"},{"id":"paper-w4249091375","cat":"papers","name":"EFFECTS OF VARIOUS SEROTONERGIC AGONISTS AND AN ANTAGONIST ON A NOCICEPTIVE REACTION IN MICE","year":"1982","cit":1,"pfa":"Krishnaswami Ramabadran","psa":"Joseph Jacob","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4249091375","eid":"W4249091375"},{"id":"paper-w4236540483","cat":"papers","name":"Halluzinogene","year":"2011","cit":1,"pfa":"Euphrosyne Gouzoulis‐Mayfrank","ptype":"book-chapter","src":"https://openalex.org/W4236540483","eid":"W4236540483"},{"id":"paper-w4210885134","cat":"papers","name":"Addictions","year":"2020","cit":1,"pfa":"Marc Vogel","psa":"Jean‐Bernard Daeppen","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4210885134","eid":"W4210885134"},{"id":"paper-w2186279475","cat":"papers","name":"A Note on the Docking of some Hallucinogens to the 5-HT2A Receptor","year":"2015","cit":1,"pfa":"Juan S. Gàmez-Jeria","psa":"Andrés Robles-Navarro","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2186279475","eid":"W2186279475"},{"id":"paper-w3116018344","cat":"papers","name":"Addressing the Interactions between Opioid Ligands and Their Receptors: Classic and Nonclassic Cases","year":"2012","cit":1,"pfa":"Fred Nyberg","topics":["Addiction","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W3116018344","eid":"W3116018344"},{"id":"paper-w7165879237","cat":"papers","name":"Integrating psychedelic-assisted psychotherapy into addiction care in the Czech Republic: Clinical evidence, safety, and regulatory developments","year":"2026","cit":1,"pfa":"Zuzana Postránecká","psa":"Tomáš Páleníček","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7165879237","eid":"W7165879237"},{"id":"paper-w2549036538","cat":"papers","name":"Differential effects of 3,4-methylenedioxymethamphetamine, methamphetamine, meta-Chlorophenylpiperazine, and scopolamine on behavioral repetition versus variation in rats","year":"2016","cit":1,"pfa":"Rebecca A. Olsen","psa":"David N. Harper","ptype":"article","src":"https://openalex.org/W2549036538","eid":"W2549036538"},{"id":"paper-w3162194943","cat":"papers","name":"Psychedelics and Health Behavior Change - Journal of Psychopharmacology (in press)","year":"2021","cit":1,"pfa":"Pedro J. Teixeira","psa":"Robin Lester Carhart-Harris","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W3162194943","eid":"W3162194943"},{"id":"paper-w7130518933","cat":"papers","name":"Ethical Complexities and Best Practices in Informed Consent for Psychedelic Services: A Qualitative Study on Expert Perspectives","year":"2026","cit":1,"pfa":"Christina Chwyl","psa":"Jason B. Luoma","topics":["Safety & adverse events","Therapy practice","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W7130518933","eid":"W7130518933"},{"id":"paper-w4399104684","cat":"papers","name":"Not all serotonergic psychedelics are alike - they induce distinct patterns of altered metabolic activity and connectivity","year":"2024","cit":1,"pfa":"Frederik Gudmundsen","psa":"Mikael Palner","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4399104684","eid":"W4399104684"},{"id":"paper-w2010414953","cat":"papers","name":"P03-202 - About A Case: Psychosis Due To Substance Abuse Exacerbated After Admnistration Of Bupropion","year":"2010","cit":1,"pfa":"D.C. de la Vega","psa":"Á. Arcenegui Calvo","topics":["Depression","Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2010414953","eid":"W2010414953"},{"id":"paper-w2346566950","cat":"papers","name":"25C-NBOMe as a New Hallucinogen","year":"2016","cit":1,"pfa":"Dariusz Zuba","psa":"Simon P Elliott","ptype":"book-chapter","src":"https://openalex.org/W2346566950","eid":"W2346566950"},{"id":"paper-w2283350201","cat":"papers","name":"Do Earlier Age of Initiation of Substance Use and Criminal Behavior Matter? Survey of Mental Health Problems among Taiwanese Male Juvenile Delinquents","year":"2013","cit":1,"pfa":"Kuo-Ping Li","psa":"Shuan Lee","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2283350201","eid":"W2283350201"},{"id":"paper-w4221036239","cat":"papers","name":"The mushroom, the frog, and the rainbow of desire: A participatory-psychedelic spiritual emergence.","year":"2022","cit":1,"pfa":"G. Lahood","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4221036239","eid":"W4221036239"},{"id":"paper-w1483262816","cat":"papers","name":"Use of conformationally-restricted analogues and homology modeling to provide insight into the nature of the 5-HT2A receptor agonist binding site","year":"2002","cit":1,"pfa":"James J. Chambers","topics":["Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W1483262816","eid":"W1483262816"},{"id":"paper-w2061275778","cat":"papers","name":"Psychedelic Drugs in Correctional Treatment","year":"1972","cit":1,"pfa":"D F Duncan","topics":["Addiction","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2061275778","eid":"W2061275778"},{"id":"paper-w4282828559","cat":"papers","name":"An Attempt to Establish a Placebo Effect in Rats With Psychopharmacological Agents.","year":"1963","cit":1,"pfa":"Black Jr, Charles Jackson","topics":["Addiction","Dosing & pharmacology","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W4282828559","eid":"W4282828559"},{"id":"paper-w28903795","cat":"papers","name":"Mu opioid receptor activation without arrestin‐interactions; a pharmacological approach.","year":"2007","cit":1,"pfa":"Laura Bohn","psa":"Thomas Edward Prisinzano","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W28903795","eid":"W28903795"},{"id":"paper-w4414042197","cat":"papers","name":"Media representation of methamphetamine-related deaths: Exploring links to public stigma and support for harm reduction","year":"2025","cit":1,"pfa":"Stephanie Kershaw","psa":"Cath Chapman","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4414042197","eid":"W4414042197"},{"id":"paper-w4224299982","cat":"papers","name":"Charismatic, Synchronous and Psychedelic Religious Experiences: A Personal Account","year":"2022","cit":1,"pfa":"Brian Claude Macallan","ptype":"article","src":"https://openalex.org/W4224299982","eid":"W4224299982"},{"id":"paper-w3211623679","cat":"papers","name":"Illicit recreational drugs and sleep : a systematic review covering cocaine, ecstasy, LSD and cannabis","year":"2008","cit":1,"pfa":"Thomas Schierenbeck","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W3211623679","eid":"W3211623679"},{"id":"paper-w4313200379","cat":"papers","name":"Adverse experiences resulting in emergency medical treatment seeking following the use of magic mushrooms","year":"2022","cit":1,"pfa":"E. Kopra","psa":"J.J. Rucker","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4313200379","eid":"W4313200379"},{"id":"paper-w3045982249","cat":"papers","name":"The psychotherapeutic use of psychedelics","year":"2020","cit":1,"pfa":"Niklas Serning","psa":"Nina Lyon","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W3045982249","eid":"W3045982249"},{"id":"paper-w4411824807","cat":"papers","name":"Increasing the Evaluation and Reporting Rigor of Psychotherapy Interventions in Treatments Involving Psychedelics","year":"2025","cit":1,"pfa":"Mathieu Fradet","topics":["Depression","Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4411824807","eid":"W4411824807"},{"id":"paper-w4394611794","cat":"papers","name":"Drug Addiction Mechanisms in the Brain","year":"2024","cit":1,"pfa":"Jayalakshmi Krishnan","topics":["Addiction","Mechanism & neuroscience"],"ptype":"book","src":"https://openalex.org/W4394611794","eid":"W4394611794"},{"id":"paper-w2315003531","cat":"papers","name":"The Use of Synthetic Cathinones and Tryptamines in a Psychiatric Population","year":"2013","cit":1,"pfa":"lhsan Salloum","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2315003531","eid":"W2315003531"},{"id":"paper-w2806717238","cat":"papers","name":"An Evaluation of Traditional and Non-Traditional Psychopharmacological Treatments for Major Depression","year":"2018","cit":1,"pfa":"M. C. Hernandez Sanchez","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2806717238","eid":"W2806717238"},{"id":"paper-w4411282536","cat":"papers","name":"Mycelium Growth and Development of Psilocybe spp. Mother Cultures on Agar-Based Media","year":"2025","cit":1,"pfa":"Marco Pepe","psa":"Andrew Maxwell Phineas Jones","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4411282536","eid":"W4411282536"},{"id":"paper-w2277018096","cat":"papers","name":"[Current situation of drug dependence and task against it].","year":"2010","cit":1,"pfa":"Nobuo Kiriike","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"other","src":"https://openalex.org/W2277018096","eid":"W2277018096"},{"id":"paper-w4388291087","cat":"papers","name":"Reducing Overdoses Among African American Individuals in Ohio: An Emerging Public Health Crisis","year":"2023","cit":1,"pfa":"Abby Beausir","psa":"Keith A. King","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4388291087","eid":"W4388291087"},{"id":"paper-w2940490591","cat":"papers","name":"Evaluation of the analytical performance of a HPLC-MS/MS method for determining ketamine and norketamine in real forensic hair samples. Reanalyzing a selection of positive cases with high resolution LC-MS for seeking oth","year":"2019","cit":1,"pfa":"José Manuel Matey","psa":"Gemma Montalvo","ptype":"article","src":"https://openalex.org/W2940490591","eid":"W2940490591"},{"id":"paper-w4395685698","cat":"papers","name":"Psychedelics: Recent Philosophical Discussions","year":"2024","cit":1,"pfa":"Chris Letheby","ptype":"book-chapter","src":"https://openalex.org/W4395685698","eid":"W4395685698"},{"id":"paper-w4390617478","cat":"papers","name":"Corrigendum to “Psychedelic therapy for depressive symptoms: A systematic review and meta-analysis”. [J. Affect. Disord., 322 (2023), 194–204]","year":"2024","cit":1,"pfa":"Kwonmok Ko","psa":"James Rucker","topics":["Depression","Reviews & meta-analyses"],"ptype":"erratum","src":"https://openalex.org/W4390617478","eid":"W4390617478"},{"id":"paper-w3023116735","cat":"papers","name":"P557 ‘Flux NZ’: an online national cohort investigating HIV, STI and drug-related practices among new zealand gay and bisexual men","year":"2019","cit":1,"pfa":"Peter J. W. Saxton","psa":"Garrett Prestage","topics":["Safety & adverse events"],"ptype":"conference-abstract","src":"https://openalex.org/W3023116735","eid":"W3023116735"},{"id":"paper-w2913005571","cat":"papers","name":"Danger! One Prick Can Cause Instant Death the Results of Chemical Testing for Pharmacological Activity in Ethnobotanical Objects","year":"2008","cit":1,"pfa":"Rose Kubiatowicz","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2913005571","eid":"W2913005571"},{"id":"paper-w4399781617","cat":"papers","name":"An Alternative Approach in the Treatment of Anxiety Disorders: Current Directions","year":"2024","cit":1,"pfa":"Zuzanna Antos","psa":"Napoleon Waszkiewicz","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4399781617","eid":"W4399781617"},{"id":"paper-w2038889744","cat":"papers","name":"Dosage des amphétamines dans les cheveux, la salive et les urines","year":"2005","cit":1,"pfa":"Christine Mary Moore","psa":"James R. Soares","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2038889744","eid":"W2038889744"},{"id":"paper-w4403798987","cat":"papers","name":"Current practice in pharmacological treatment of generalized anxiety disorder","year":"2024","cit":1,"pfa":"A.N. Useinova","psa":"D. S. Davydova","topics":["Anxiety & end-of-life","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4403798987","eid":"W4403798987"},{"id":"paper-w4211101806","cat":"papers","name":"Psychedelika","year":"2017","cit":1,"pfa":"Maximilian von Heyden","psa":"Henrik Jungaberle","ptype":"book-chapter","src":"https://openalex.org/W4211101806","eid":"W4211101806"},{"id":"paper-w4410133268","cat":"papers","name":"Editorial: Advances in understanding and treating post-traumatic stress disorder","year":"2025","cit":1,"pfa":"Jenny J. W. Liu","psa":"Nasser H. Kashou","topics":["PTSD & trauma","Addiction","Anxiety & end-of-life"],"ptype":"editorial","src":"https://openalex.org/W4410133268","eid":"W4410133268"},{"id":"paper-w4411035865","cat":"papers","name":"Leveraging psychedelic neuroscience to boost human creativity using artificial intelligence","year":"2025","cit":1,"pfa":"Brian M. Ross","topics":["Safety & adverse events","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4411035865","eid":"W4411035865"},{"id":"paper-w4410011321","cat":"papers","name":"A Comprehensive Meta-Analysis Investigating the Efficacy of Various Psychedelic Drugs for the Treatment of Substance Misuse","year":"2025","cit":1,"pfa":"Eve E. Keighley","psa":"Ahmed A. Moustafa","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4410011321","eid":"W4410011321"},{"id":"paper-w2388184031","cat":"papers","name":"ANALYSIS OF POLYDRUG ABUSE IN HEROIN ADDICTS","year":"2006","cit":1,"pfa":"Zou Lian","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2388184031","eid":"W2388184031"},{"id":"paper-w2791795903","cat":"papers","name":"Visual hallucinations and lifetime use of hallucinogen perception persisting disorder associated recreational drugs: results from a large online survey","year":"2018","cit":1,"pfa":"Mascha M.J. Linszen","psa":"Iris E. Sommer","ptype":"article","src":"https://openalex.org/W2791795903","eid":"W2791795903"},{"id":"paper-w4410051084","cat":"papers","name":"Clade III Synthases Add Cyclic and Linear Terpenoids to the Psilocybe Metabolome","year":"2025","cit":1,"pfa":"Nick Zschoche","psa":"Dirk Hoffmeister","ptype":"article","src":"https://openalex.org/W4410051084","eid":"W4410051084"},{"id":"paper-w4390649922","cat":"papers","name":"Psychedelic Agents as Potential Therapeutics for Obsessive Compulsive Disorder","year":"2022","cit":1,"pfa":"Josh Nagra","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4390649922","eid":"W4390649922"},{"id":"paper-w2754605292","cat":"papers","name":"Google Trends Analyses and Case Report: A Persistently Dilated Pupil in Psychedelics’ User","year":"2017","cit":1,"pfa":"Ahmed Al-Imam","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W2754605292","eid":"W2754605292"},{"id":"paper-w4399518556","cat":"papers","name":"Geschichte der Anwendung von Psychedelika","year":"2024","cit":1,"pfa":"Uwe Herwig","topics":["Depression","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4399518556","eid":"W4399518556"},{"id":"paper-w4385517336","cat":"papers","name":"Emerging Perspectives in Addiction Psychiatry","year":"2023","cit":1,"pfa":"Ayana Jordan","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4385517336","eid":"W4385517336"},{"id":"paper-w3166607623","cat":"papers","name":"Pharmahuasca Reduces ROS Production and inflammatory Gene Expression in the Brain in a Model of PTSD: Exploration by RNA Sequencing","year":"2021","cit":1,"pfa":"D. Parker Kelley","psa":"Joseph Francis","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W3166607623","eid":"W3166607623"},{"id":"paper-w4380231022","cat":"papers","name":"Ethnopsychiatry","year":"2020","cit":1,"pfa":"HENRI F. ELLENBERGER","topics":["Addiction"],"ptype":"book","src":"https://openalex.org/W4380231022","eid":"W4380231022"},{"id":"paper-w2510356263","cat":"papers","name":"FUNCTIONAL INTERACTION BETWEEN 5-HT1B AND 5-HT1A OR 5-HT2 RECEPTORS IN MICE","year":"1992","cit":1,"pfa":"Ewa Chojnacka-Wójcik","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2510356263","eid":"W2510356263"},{"id":"paper-w3137989440","cat":"papers","name":"A Rare Presentation of Anticholinergic Toxicity in a Young Patient Due to Over-The-Counter Cold Medicines","year":"2021","cit":1,"pfa":"Ahsum Khan","psa":"Jason C. Jacob","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3137989440","eid":"W3137989440"},{"id":"paper-w7159811468","cat":"papers","name":"5-HT 1A receptor blockade potentiates the subjective effects of DMT","year":"2026","cit":1,"pfa":"Zarmeen Zahid","psa":"Sandeep Manel Nayak","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7159811468","eid":"W7159811468"},{"id":"paper-w4411530336","cat":"papers","name":"Healing of the Thunderbolt and Nahua Entheogenic Medicine (Psilocybe aztecorum and Tagetes lucida)","year":"2025","cit":1,"pfa":"Osiris Sinuhé González Romero","psa":"María del Carmen Macuil García","topics":["Addiction","Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W4411530336","eid":"W4411530336"},{"id":"paper-w4396883286","cat":"papers","name":"Hanscarl Leuner und die Grundlagen der Psycholytischen Therapie","year":"2024","cit":1,"pfa":"Torsten Passie","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4396883286","eid":"W4396883286"},{"id":"paper-w1603694758","cat":"papers","name":"The Pharmacology of LSD: A Critical Review by AnnelieHintzen & TorstenPassieOxford, UK: Oxford University Press, 2010 ISBN 13: 9780199589821, 150 pp. Paperback. Price: US$59.95","year":"2013","cit":1,"pfa":"Matthew J. Baggott","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"book-review","src":"https://openalex.org/W1603694758","eid":"W1603694758"},{"id":"paper-w4311293132","cat":"papers","name":"Rumors of Psychedelics, Psychotropics and Related Derivatives in Vachellia and Senegalia in Contrast with Verified Records in Australian Acacia","year":"2022","cit":1,"pfa":"Nicholas John Sadgrove","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4311293132","eid":"W4311293132"},{"id":"paper-w2065052803","cat":"papers","name":"Inhibition of Human Monoamine Oxidase A and B by beta-Carboline Alkaloids: Structure Activity Relationship Analysis","year":"2010","cit":1,"pfa":"ND Chaurasiya","psa":"BL Tekwani","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2065052803","eid":"W2065052803"},{"id":"paper-w4416422349","cat":"papers","name":"Acute experiences and persisting psychological effects associated with an encapsulated DMT-harmala alkaloid combination: results of a phase 1 study","year":"2025","cit":1,"pfa":"Daniel Perkins","psa":"Jerome J. Sarris","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4416422349","eid":"W4416422349"},{"id":"paper-w4401430042","cat":"papers","name":"Jung, the Rebirth Motif and Psychedelics I: Documenting Jung’s Contact with the British Pioneers","year":"2024","cit":1,"pfa":"Ginny Hill","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4401430042","eid":"W4401430042"},{"id":"paper-w7148242223","cat":"papers","name":"Psychedelics as a potential treatment for borderline personality disorder: A narrative review","year":"2026","cit":1,"pfa":"Erin Artna","psa":"Saadia Sediqzadah","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W7148242223","eid":"W7148242223"},{"id":"paper-w4391345434","cat":"papers","name":"Intensity of Psychoactive Substance Use Affects the Occurrence of Prodromal Symptoms of Psychosis","year":"2024","cit":1,"pfa":"Gniewko Więckiewicz","psa":"Magdalena Kotlicka‐Antczak","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4391345434","eid":"W4391345434"},{"id":"paper-w4410042630","cat":"papers","name":"Recreational Ketamine Use among Individuals with Opioid Use Disorder: Demographics, Motivations, and Polysubstance Use","year":"2025","cit":1,"pfa":"Corinne L. Chandler","psa":"Matthew S. Ellis","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4410042630","eid":"W4410042630"},{"id":"paper-w3160742562","cat":"papers","name":"Somatostatin interneurons activated by 5-HT 2A receptor suppress slow oscillations in medial entorhinal cortex","year":"2020","cit":1,"pfa":"Roberto De Filippo","psa":"Dietmar Schmitz","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W3160742562","eid":"W3160742562"},{"id":"paper-w4387776779","cat":"papers","name":"Editorial: Psychedelics as treatments for substance use disorders: exploring therapeutic potential, risks, underlying mechanisms of action, and implementation challenges","year":"2023","cit":1,"pfa":"Brian Scott Barnett","psa":"Jeremy Weleff","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"editorial","src":"https://openalex.org/W4387776779","eid":"W4387776779"},{"id":"paper-w4247753590","cat":"papers","name":"Editorial: The behavioural pharmacology of oxytocin","year":"2016","cit":1,"topics":["Depression","PTSD & trauma","Addiction"],"ptype":"editorial","src":"https://openalex.org/W4247753590","eid":"W4247753590"},{"id":"paper-w7140117420","cat":"papers","name":"Integrated 5-HT 2A –TrkB and G protein signaling in serotonergic psychedelic responses","year":"2026","cit":1,"pfa":"Marco Taddei-Tardon","psa":"Juan F. López‐Giménez","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7140117420","eid":"W7140117420"},{"id":"paper-w4415299843","cat":"papers","name":"Contemplating versus having used psychedelics in bipolar disorder - What makes the difference?","year":"2025","cit":1,"pfa":"L. Vale","psa":"Thomas Daniel Meyer","ptype":"article","src":"https://openalex.org/W4415299843","eid":"W4415299843"},{"id":"paper-w4406824838","cat":"papers","name":"Methanol Leaf Extract of Voacanga Africana Protects Against Diethylnitrosamine and Carbon Tetrachloride-Induced Hepatotoxicity in Wistar Rats via Antioxidant and Anti-Inflammatory Activities","year":"2025","cit":1,"pfa":"Raphael S. Olatoye","psa":"Oluwatosin Adekunle Adaramoye","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4406824838","eid":"W4406824838"},{"id":"paper-w4413768842","cat":"papers","name":"Unsupervised Extractive Summarization of Psychedelic User Experience Reports","year":"2025","cit":1,"pfa":"Md. Shahidul Islam","psa":"Md Nahid Hasan","topics":["Addiction","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4413768842","eid":"W4413768842"},{"id":"paper-w7163158712","cat":"papers","name":"Assembly and comparative analysis of the first complete mitochondrial genome of Lophophora williamsii (Cactaceae)","year":"2026","cit":1,"pfa":"Xingliang Liu","psa":"Teng Zhang","ptype":"article","src":"https://openalex.org/W7163158712","eid":"W7163158712"},{"id":"paper-w2610440865","cat":"papers","name":"Coleópteros das famílias bostrichidae e curculionidae (Scolytinae) associados a Banisteriopsis caapi (Spruce ex Grisebach)","year":"2013","cit":1,"pfa":"Rebeca Cristina Pena","ptype":"dissertation","src":"https://openalex.org/W2610440865","eid":"W2610440865"},{"id":"paper-w581630826","cat":"papers","name":"To An Unknown God: Religious Freedom On Trial","year":"2001","cit":1,"pfa":"Garrett Epps","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W581630826","eid":"W581630826"},{"id":"paper-w2477643644","cat":"papers","name":"Mortality and drug overdose","year":"2006","cit":1,"pfa":"Shane G Darke","psa":"Richard Phillip Mattick","topics":["Addiction","Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W2477643644","eid":"W2477643644"},{"id":"paper-w4409057336","cat":"papers","name":"Dynamic medial parietal and hippocampal deactivations under DMT relate to sympathetic output and altered sense of time, space, and the self","year":"2025","cit":1,"pfa":"Lorenzo Pasquini","psa":"Christopher B. Timmermann","topics":["Safety & adverse events","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4409057336","eid":"W4409057336"},{"id":"paper-w4407947052","cat":"papers","name":"Setting the Stage for the Inner Journey: Unraveling the Interplay of Contextual Factors and the Intensity of Ego-Dissolution in Naturalistic Psychedelic Experiences","year":"2025","cit":1,"pfa":"Stanisław Adamczyk","psa":"Paweł Orlowski","topics":["Addiction","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4407947052","eid":"W4407947052"},{"id":"paper-w4417081284","cat":"papers","name":"The effect of dextromethorphan on reward-related behaviors: A systematic review of preclinical and clinical evidence","year":"2025","cit":1,"pfa":"Kayla M. Teopiz","psa":"Roger S. McIntyre","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W4417081284","eid":"W4417081284"},{"id":"paper-w4407092703","cat":"papers","name":"Improved LC-MS Detection of Opioids, Amphetamines, and Psychedelics Using TrEnDi","year":"2025","cit":1,"pfa":"Christian A. Rosales","psa":"Jeffrey C. Smith","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4407092703","eid":"W4407092703"},{"id":"paper-w4403655694","cat":"papers","name":"The Afterglow Inventory (AGI) – validation of a new instrument for measuring subacute effects of classic serotonergic psychedelics","year":"2024","cit":1,"pfa":"Tomislav Majić","psa":"Ricarda Evens","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4403655694","eid":"W4403655694"},{"id":"paper-w4413994097","cat":"papers","name":"Evaluating Psychedelics and Psychedelic Assisted Psychotherapies for Veterans Amidst Enthusiasm and Advertising Hype","year":"2025","cit":1,"pfa":"Louis A. Pagano","psa":"Timothy P. Pagano","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4413994097","eid":"W4413994097"},{"id":"paper-w3199274122","cat":"papers","name":"Is MDD the right target for early-stage psychedelic-assisted therapy trials?","year":"2021","cit":1,"pfa":"Benjamin R. Lewis","psa":"Kevin Byrne","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W3199274122","eid":"W3199274122"},{"id":"paper-w4293345164","cat":"papers","name":"Terapias alternativas/complementares como estratégia para o cuidado da equipe de enfermagem frente à depressão em contextos de crise: revisão integrativa","year":"2022","cit":1,"pfa":"Ana Beatriz Alves Amanai","psa":"Oswalcir Almeida de Azevedo","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4293345164","eid":"W4293345164"},{"id":"paper-w7117872436","cat":"papers","name":"The Therapeutic Role of Physical Activity in Epilepsy: Potential Mechanisms and Clinical Implications","year":"2025","cit":1,"pfa":"Li BaoFeng","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7117872436","eid":"W7117872436"},{"id":"paper-w4410981407","cat":"papers","name":"Fatal Carbamazepine Overdose in a Polysubstance User: Polydrug Use Alters the Clinical Presentation – Case Report","year":"2025","cit":1,"pfa":"Assia Yamoun","psa":"Sara Abdennour","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4410981407","eid":"W4410981407"},{"id":"paper-w4417136348","cat":"papers","name":"Dual Modulation of 5-HT 2A Receptors and SERT by α-Ethyltryptamine and Its Optical Isomers","year":"2025","cit":1,"pfa":"Justin M. Silverman","psa":"Javier González‐Maeso","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4417136348","eid":"W4417136348"},{"id":"paper-w4415564957","cat":"papers","name":"Provider perspectives on challenges in treatment during psychedelic therapy","year":"2025","cit":1,"pfa":"David A. Bender","psa":"Eric J. Lenze","ptype":"article","src":"https://openalex.org/W4415564957","eid":"W4415564957"},{"id":"paper-w3207699762","cat":"papers","name":"Trip Reports: Exploring the Experience of Psychedelic Intoxication","year":"2021","cit":1,"pfa":"Jonas Bååth","psa":"Johan Nordgren","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"book-chapter","src":"https://openalex.org/W3207699762","eid":"W3207699762"},{"id":"paper-w4255473423","cat":"papers","name":"Correction: Structural Characterization of a Therapeutic Anti-Methamphetamine Antibody Fragment: Oligomerization and Binding of Active Metabolites","year":"2014","cit":1,"pfa":"Eric C. Peterson","psa":"Kottayil I. Varughese","topics":["Dosing & pharmacology"],"ptype":"erratum","src":"https://openalex.org/W4255473423","eid":"W4255473423"},{"id":"paper-w4402529503","cat":"papers","name":"Drug overdose deaths during prison riots and mental states of prisoners: a case study","year":"2024","cit":1,"pfa":"Luca Tomassini","psa":"Roberto Scendoni","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4402529503","eid":"W4402529503"},{"id":"paper-w4317387711","cat":"papers","name":"Development and validation of a GC-MS method for determination of amphetamine-type stimulants and ketamine in human hair","year":"2023","cit":1,"pfa":"Tran Viet Hung","psa":"Nguyễn Đức Tuấn","ptype":"article","src":"https://openalex.org/W4317387711","eid":"W4317387711"},{"id":"paper-w2982719338","cat":"papers","name":"Break On Through: Radical Psychiatry and the American Counterculture","year":"2019","cit":1,"pfa":"Lucas Richert","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"book","src":"https://openalex.org/W2982719338","eid":"W2982719338"},{"id":"paper-w7204496971","cat":"papers","name":"The Role of Delusions in Homicides by Psychedelic-Intoxicated Offenders: A Mixed-Method Analysis","year":"2026","cit":1,"pfa":"Jesse J. Norris","ptype":"article","src":"https://openalex.org/W7204496971","eid":"W7204496971"},{"id":"paper-w4415179000","cat":"papers","name":"Psychedelic Drug Checking: Analytical and Strategic Challenges in Harm Reduction for Classic Psychedelics","year":"2025","cit":1,"pfa":"Tim Hirschfeld","psa":"Laura Alexandra Smit‐Rigter","topics":["Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W4415179000","eid":"W4415179000"},{"id":"paper-w4414167818","cat":"papers","name":"Dynamic myocardial injury and variable hallucination latency in Psilocybe keralensis poisoning: a molecularly confirmed case series from China","year":"2025","cit":1,"pfa":"Zhifan He","psa":"Jing Li","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4414167818","eid":"W4414167818"},{"id":"paper-w4392110490","cat":"papers","name":"Psychedelics as a treatment for patients with post-traumatic stress disorder (PTSD)","year":"2024","cit":1,"pfa":"Krzysztof Marcinkowski","psa":"Aleksandra Kublińska","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4392110490","eid":"W4392110490"},{"id":"paper-w4387476743","cat":"papers","name":"#35647 Alternative pharmacological approaches to chronic pain management","year":"2023","cit":1,"pfa":"Fernando Gómez","psa":"Ruth Higuera-Díaz","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"conference-paper","src":"https://openalex.org/W4387476743","eid":"W4387476743"},{"id":"paper-w2916664969","cat":"papers","name":"PS260. A Roadmap to Golden hour intervention for Posttraumatic Stress Disorder","year":"2016","cit":1,"pfa":"Eric H. G. J. M. Vermetten","psa":"Harm J. Krugers","topics":["PTSD & trauma","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W2916664969","eid":"W2916664969"},{"id":"paper-w7134928340","cat":"papers","name":"Exploring Colombian medicinal flora used in indigenous and campesino health systems for neuropsychiatric disorders and neuropharmacological potential: an ethnopharmacological review","year":"2026","cit":1,"pfa":"Katrin Brache","psa":"Mauricio Diazgranados","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7134928340","eid":"W7134928340"},{"id":"paper-w3171532156","cat":"papers","name":"An Encounter with the Other: A Thematic Analysis of Accounts of DMT Experiences from a Naturalistic Field Study","year":"2021","cit":1,"pfa":"Pascal Michael","psa":"Oliver C. Robinson","topics":["Mechanism & neuroscience","Reviews & meta-analyses","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W3171532156","eid":"W3171532156"},{"id":"paper-w3134754834","cat":"papers","name":"Managing Risk Environments: An Ethnographic Study of Club Drug Use and Harm Reduction in the EDM Scene","year":"2020","cit":1,"pfa":"Nicholas Matthew Cristiano","topics":["Safety & adverse events","Therapy practice","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W3134754834","eid":"W3134754834"},{"id":"paper-w7119143402","cat":"papers","name":"Psychoactive mushroom edibles: trends and toxicities reported to the United States National Poison Data System®, 2023–2024","year":"2026","cit":1,"pfa":"D. Jorgenson","psa":"Joshua B. Radke","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7119143402","eid":"W7119143402"},{"id":"paper-w3119294996","cat":"papers","name":"The rebirth of psychedelic psychiatry","year":"2021","cit":1,"pfa":"Brian James Holoyda","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3119294996","eid":"W3119294996"},{"id":"paper-w4413318962","cat":"papers","name":"Attitudes Toward Psychedelic-Assisted Therapies for Cancer-Related Psychosocial Symptoms: A Multi- Stakeholder Analysis","year":"2025","cit":1,"pfa":"Haley D.M. Schuman","psa":"Linda Ellen Carlson","topics":["Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W4413318962","eid":"W4413318962"},{"id":"paper-w7196955431","cat":"papers","name":"Microdosing psychedelics: What, why, when, and how often? Insights from an international survey of people who use psychedelics","year":"2026","cit":1,"pfa":"Rotem Petranker","psa":"Philippe Lucas","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7196955431","eid":"W7196955431"},{"id":"paper-w4390505712","cat":"papers","name":"Through the Looking Glass: Psychedelics As a Window into Mindfulness and Mind–Body Health","year":"2024","cit":1,"pfa":"Peter M. Wayne","psa":"Darshan H. Mehta","topics":["Dosing & pharmacology","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4390505712","eid":"W4390505712"},{"id":"paper-w3043468905","cat":"papers","name":"Psychedelics, Safety and Clinical Trial Design","year":"2020","cit":1,"pfa":"Ron Joseph Shore","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W3043468905","eid":"W3043468905"},{"id":"paper-w4414109595","cat":"papers","name":"Preoperative illicit drug screening among elective surgery patients in West Bank, Palestine: unveiling the hidden","year":"2025","cit":1,"pfa":"Jehad Zuhd","psa":"Basma Damiri","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4414109595","eid":"W4414109595"},{"id":"paper-w4396993500","cat":"papers","name":"An Ancient Mexican Mask Describes the Clinical Manifestations of Psychoactive Mushrooms, Including Hallucinations Millennia Ago.","year":"2022","cit":1,"pfa":"Ramin Afshari","psa":"Reza Afshari","ptype":"article","src":"https://openalex.org/W4396993500","eid":"W4396993500"},{"id":"paper-w2891580892","cat":"papers","name":"Substances of Abuse and Hallucinogenic Activity: The Serotoninergic Pathway - Focus on Classical Hallucinogens and Entactogens","year":"2018","cit":1,"pfa":"Matteo Lazzaretti","psa":"Paolo Brambilla","topics":["Addiction","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W2891580892","eid":"W2891580892"},{"id":"paper-w4313482781","cat":"papers","name":"Consciousness alterations in a cohort of young Swiss men: Associations with substance use and personality traits","year":"2023","cit":1,"pfa":"Marianthi Lousiana Deligianni","psa":"Nicolas Bertholet","topics":["Addiction","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4313482781","eid":"W4313482781"},{"id":"paper-w4414074484","cat":"papers","name":"Patterns of recreational substance use, help seeking and harm reduction among UK music festival attendees","year":"2025","cit":1,"pfa":"Chloe L. Rayner","psa":"Alex Lee Jones","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4414074484","eid":"W4414074484"},{"id":"paper-w3017205254","cat":"papers","name":"5‐HT 2 Receptor Activation Differentially Modulates Linker Histone Kinetics and Histone Deacetylase Activity","year":"2020","cit":1,"pfa":"Thomas Wayne Flanagan","psa":"Charles David Nichols","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W3017205254","eid":"W3017205254"},{"id":"paper-w4394913801","cat":"papers","name":"Palliative Care Provider Attitudes Toward Psychedelics: A Survey in an Integrated Health System","year":"2024","cit":1,"pfa":"John Le","psa":"Dov M. Shalman","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4394913801","eid":"W4394913801"},{"id":"paper-w4416010844","cat":"papers","name":"Comprehensive in vitro profiling of traditional and emerging stimulants at monoamine transporters and the 5HT2A receptor","year":"2025","cit":1,"pfa":"Dārta Štālberga","psa":"Henrik Gréen","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4416010844","eid":"W4416010844"},{"id":"paper-w7125605108","cat":"papers","name":"Clinical and inflammatory profiles in substance use disorder: gender, substance type, and comorbidity in a single-center cross-sectional study in Turkey","year":"2026","cit":1,"pfa":"Kader Semra Karataş","psa":"Merve Akkuş","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7125605108","eid":"W7125605108"},{"id":"paper-w2435651543","cat":"papers","name":"[Relevance of toxicological identification of narcotics in hair for maintenance therapy of opiate addicts].","year":"2003","cit":1,"pfa":"Beata Karakiewicz","psa":"Wojciech Piekoszewski","topics":["Addiction"],"ptype":"other","src":"https://openalex.org/W2435651543","eid":"W2435651543"},{"id":"paper-w4386903146","cat":"papers","name":"Psychedelic-Assisted Therapy and Meditative Experience as Factors of Personal Change","year":"2023","cit":1,"pfa":"Nadiia Omelchenko","psa":"Anton Kurapov","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4386903146","eid":"W4386903146"},{"id":"paper-w4415597226","cat":"papers","name":"Effect of the anti-inflammatory action of β-carbolines on SH-SY5Y cell line (human neuroblastoma) and modulation of TMPRSS11 and Furin receptors","year":"2024","cit":1,"pfa":"Laura Seixas Bianco","psa":"Roberta Sessa Stilhano","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W4415597226","eid":"W4415597226"},{"id":"paper-w4393030764","cat":"papers","name":"Psychedelic Renaissance: Evidence and Culture","year":"2024","cit":1,"pfa":"Adrian Preda","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"other","src":"https://openalex.org/W4393030764","eid":"W4393030764"},{"id":"paper-w4200335145","cat":"papers","name":"Measurement of Hemodynamic Parameters and Antidepressant Activity in Hypertensive Rats Following Two Weeks Consumption of Acacia Tortilis Leaves Extract","year":"2021","cit":1,"pfa":"Abdulhalim Salim Serafi","psa":"Zahir Hussain","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4200335145","eid":"W4200335145"},{"id":"paper-w4401919893","cat":"papers","name":"Prevalence of drug use and substance dependence among university students at the University of Girona","year":"2024","cit":1,"pfa":"Fran Calvo","psa":"Sílvia Font‐Mayolas","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4401919893","eid":"W4401919893"},{"id":"paper-w180175972","cat":"papers","name":"Applications of extractive-derivatization sample preparation in a clinical toxicology laboratory setting","year":"2009","cit":1,"pfa":"Adriaan A. S. Marais","ptype":"dissertation","src":"https://openalex.org/W180175972","eid":"W180175972"},{"id":"paper-w3135306123","cat":"papers","name":"Author response: Self-blinding citizen science to explore psychedelic microdosing","year":"2020","cit":1,"pfa":"Balázs Szigeti","psa":"David Erritzøe","topics":["Depression","Addiction","Dosing & pharmacology"],"ptype":"peer-review","src":"https://openalex.org/W3135306123","eid":"W3135306123"},{"id":"paper-w4377020197","cat":"papers","name":"The Synthetic Psychedelic 2,5-methoxy-4-iodoampheamine (DOI) Attenuates the Positive Appetitive and Reinforcing Effects of Methamphetamine","year":"2023","cit":1,"pfa":"Bo Jarrett Wood","psa":"Kevin Sean Murnane","ptype":"article","src":"https://openalex.org/W4377020197","eid":"W4377020197"},{"id":"paper-w4230780647","cat":"papers","name":"Drug Abuse Treatment Outcome Study (DATOS), 1991-1994: [United States]","year":"2000","cit":1,"pfa":"United States Department Of Health And Human Services. National Institutes Of…","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"dataset","src":"https://openalex.org/W4230780647","eid":"W4230780647"},{"id":"paper-w7134201237","cat":"papers","name":"Unusual experiences and early-onset psychosis associated to hallucinogen use in adolescents: a systematic review and meta-analysis","year":"2026","cit":1,"pfa":"Maite Armanino-Irigaray","psa":"Gonzalo Salazar de Pablo","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7134201237","eid":"W7134201237"},{"id":"paper-w4381737976","cat":"papers","name":"AMA Backs Making Overdose Reversal Meds Accessible in Schools","year":"2023","cit":1,"pfa":"Mark Moran","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4381737976","eid":"W4381737976"},{"id":"paper-w2257439892","cat":"papers","name":"Behavioural Pharmacology of Novel Kappa Opioid Compounds","year":"2011","cit":1,"pfa":"Aashish S. Morani","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W2257439892","eid":"W2257439892"},{"id":"paper-w1862893638","cat":"papers","name":"STIMULATING DEBATE IN THE FIELD OF ADDICTION","year":"2012","cit":1,"pfa":"Adrian Carter","psa":"John D. O’Sullivan","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1862893638","eid":"W1862893638"},{"id":"paper-w4402894874","cat":"papers","name":"Editorial: Dual disorders in addiction and mood disorders: comorbidity or specific diagnosis?","year":"2024","cit":1,"pfa":"Warren Logge","psa":"Cheng‐Fang Yen","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"editorial","src":"https://openalex.org/W4402894874","eid":"W4402894874"},{"id":"paper-w4382360046","cat":"papers","name":"Psychedelic Therapy Requires Enhanced Consent Discussions","year":"2023","cit":1,"pfa":"Nick Zagorski","topics":["PTSD & trauma","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4382360046","eid":"W4382360046"},{"id":"paper-w4403659215","cat":"papers","name":"Editorial: Biological and non-pharmacological treatments of obsessive-compulsive disorder and related disorders","year":"2024","cit":1,"pfa":"Renato de Filippis","psa":"Mohammadreza Shalbafan","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"editorial","src":"https://openalex.org/W4403659215","eid":"W4403659215"},{"id":"paper-w4405412696","cat":"papers","name":"Disentangling debate about therapeutic and recreational use of psychedelics","year":"2024","cit":1,"pfa":"Christina M. Andrews","psa":"John Marsden","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4405412696","eid":"W4405412696"},{"id":"paper-w4391337625","cat":"papers","name":"Productos y Hongos que contienen Psilocibina y Psilocina","year":"2024","cit":1,"pfa":"Yuri Carvajal","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4391337625","eid":"W4391337625"},{"id":"paper-w2606320611","cat":"papers","name":"Analyses capillaires d’un cas d’intoxication par la diphénidine et le 5-MeO-DALT fournissant des données sur les concentrations dans les cheveux de nombreux nouveaux produits de synthèse","year":"2017","cit":1,"pfa":"Jean‐François Wiart","psa":"Jean‐Michel Gaulier","ptype":"article","src":"https://openalex.org/W2606320611","eid":"W2606320611"},{"id":"paper-w4391959887","cat":"papers","name":"Introduction to the Special Section on Psychedelics Research and Treatment","year":"2024","cit":1,"pfa":"Dominic Sisti","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4391959887","eid":"W4391959887"},{"id":"paper-w7160830727","cat":"papers","name":"From Trials to Clinics: Considerations for Implementing Psychedelic‐Assisted Therapy Into Clinical Practice","year":"2026","cit":1,"pfa":"Jessie Kim","psa":"Cory R. Weissman","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7160830727","eid":"W7160830727"},{"id":"paper-w3216860842","cat":"papers","name":"Marijuana, Hallucinogen Use Reach Historic Levels Among Young Adults","year":"2021","cit":1,"pfa":"Linda M. Richmond","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3216860842","eid":"W3216860842"},{"id":"paper-w645106121","cat":"papers","name":"Adulterants and interpretive challenges in forensic science: effects on colorimetric spot tests for presumptive drug identification and adverse side effects in the body","year":"2014","cit":1,"pfa":"Daniel A. Cosby","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"dissertation","src":"https://openalex.org/W645106121","eid":"W645106121"},{"id":"paper-w3173761909","cat":"papers","name":"Neurocognition in stimulant addiction: commentary on Kendrick et al (2021)","year":"2021","cit":1,"pfa":"Trevor William Robbins","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3173761909","eid":"W3173761909"},{"id":"paper-w4407416217","cat":"papers","name":"Editorial: World No-Tobacco day: an ethnopharmacological perspective","year":"2025","cit":1,"pfa":"Arquimedes Gasparotto","psa":"Ilana Berlowitz","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"editorial","src":"https://openalex.org/W4407416217","eid":"W4407416217"},{"id":"paper-w2922352985","cat":"papers","name":"The behavioural pharmacology of stress-related disorders","year":"2019","cit":1,"pfa":"Paul Willner","psa":"Louk J. M. J. Vanderschuren","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W2922352985","eid":"W2922352985"},{"id":"paper-w4376117102","cat":"papers","name":"Decolonizing Psychedelic Therapy","year":"2023","cit":1,"pfa":"Danielle M. Herrera","topics":["PTSD & trauma","Therapy practice","Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W4376117102","eid":"W4376117102"},{"id":"paper-w4406915288","cat":"papers","name":"Psychedelic-Assisted EMDR Therapy","year":"2025","cit":1,"pfa":"Hannah Raine-Smith","psa":"Jocelyn Rose","topics":["PTSD & trauma","Safety & adverse events","Reviews & meta-analyses"],"ptype":"book","src":"https://openalex.org/W4406915288","eid":"W4406915288"},{"id":"paper-w4212805924","cat":"papers","name":"The phenomenology of psychedelic therapy","year":"2021","cit":1,"pfa":"Chris Letheby","topics":["Reviews & meta-analyses"],"ptype":"book-chapter","src":"https://openalex.org/W4212805924","eid":"W4212805924"},{"id":"paper-w4376116967","cat":"papers","name":"Psychedelic-Assisted Group Therapy","year":"2023","cit":1,"pfa":"Christopher S. Stauffer","psa":"Brian T. Anderson","topics":["Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W4376116967","eid":"W4376116967"},{"id":"paper-w7125648187","cat":"papers","name":"Ethics of Psychedelic-Assisted Psychotherapy","year":"2026","cit":1,"pfa":"Hana Abbasian","topics":["Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7125648187","eid":"W7125648187"},{"id":"paper-w4283330379","cat":"papers","name":"Psychedelic therapy for body dysmorphic disorder","year":"2022","cit":1,"pfa":"Shevaugn Johnson","psa":"Chris Letheby","topics":["Safety & adverse events","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4283330379","eid":"W4283330379"},{"id":"paper-w4296001781","cat":"papers","name":"Psychedelic-Assisted Psychotherapy: A Literature Review","year":"2022","cit":1,"pfa":"Meredith Victoria Welch","topics":["PTSD & trauma","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"dissertation","src":"https://openalex.org/W4296001781","eid":"W4296001781"},{"id":"paper-w4403402461","cat":"papers","name":"Delusional beliefs and psychedelic-assisted psychotherapy","year":"2024","cit":1,"pfa":"Elly Vintiadis","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4403402461","eid":"W4403402461"},{"id":"paper-w4236988010","cat":"papers","name":"Research Into Psychedelic Therapy Urged","year":"1975","cit":1,"pfa":"Stan Krippner","ptype":"dataset","src":"https://openalex.org/W4236988010","eid":"W4236988010"},{"id":"paper-w7152968254","cat":"papers","name":"Not a Standalone Treatment: Considerations for Psychedelic‐Assisted Therapy","year":"2026","cit":1,"pfa":"Sharon Murphy","psa":"Justine Ellis","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7152968254","eid":"W7152968254"},{"id":"paper-w4391541689","cat":"papers","name":"Psychedelic-assisted therapy to treat anxiety disorders","year":"2024","cit":1,"pfa":"Stephen Russell Naulls","psa":"Sarah Bunn","topics":["Anxiety & end-of-life"],"ptype":"report","src":"https://openalex.org/W4391541689","eid":"W4391541689"},{"id":"paper-w4409663564","cat":"papers","name":"Intentional Choices of Metaphors for Psychedelic-Assisted Therapy","year":"2025","cit":1,"pfa":"Mitch Earleywine","psa":"Joseph Anthony De Leo","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4409663564","eid":"W4409663564"},{"id":"paper-w4407381743","cat":"papers","name":"Suicide after psychedelic-assisted treatment in context","year":"2025","cit":1,"pfa":"Mitch Earleywine","psa":"Sarah Slabaugh","ptype":"article","src":"https://openalex.org/W4407381743","eid":"W4407381743"},{"id":"paper-w4387016648","cat":"papers","name":"How does psychedelic therapy work?","year":"2023","cit":1,"pfa":"Héloïse Athéa","ptype":"book-review","src":"https://openalex.org/W4387016648","eid":"W4387016648"},{"id":"paper-w4405219890","cat":"papers","name":"Ensuring Access to Psychedelic-Assisted Therapy in Rural Communities","year":"2024","cit":1,"pfa":"Olivia M. Dhaliwal","psa":"Brian Scott Barnett","topics":["PTSD & trauma","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4405219890","eid":"W4405219890"},{"id":"paper-w4380550513","cat":"papers","name":"Creating Greater Safety in Psychedelic-Assisted Therapy Spaces","year":"2023","cit":1,"pfa":"Maira Evelyn Clancy","topics":["Safety & adverse events","Therapy practice","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W4380550513","eid":"W4380550513"},{"id":"paper-w4412968084","cat":"papers","name":"Psychedelic-Assisted Therapy Training in the US: A Landscape Analysis","year":"2025","cit":1,"pfa":"Roman Palitsky","psa":"Gosia Sklodowska","topics":["Anxiety & end-of-life","Safety & adverse events","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4412968084","eid":"W4412968084"},{"id":"paper-w4410544773","cat":"papers","name":"Psychedelic-assisted psychotherapy: The need to monitor adverse events","year":"2025","cit":1,"pfa":"KRJ Schruers","psa":"Nicole K. Leibold","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"editorial","src":"https://openalex.org/W4410544773","eid":"W4410544773"},{"id":"paper-w7158452214","cat":"papers","name":"Therapist Rated Predictors of Response to Psychedelic Assisted Therapy","year":"2026","cit":1,"pfa":"Grace Viljoen","psa":"Antonia Bendau","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"dataset","src":"https://openalex.org/W7158452214","eid":"W7158452214"},{"id":"paper-w3160456289","cat":"papers","name":"Psychedelic‐assisted therapy considered ‘breakthrough’ treatment for PTSD","year":"2021","cit":1,"pfa":"Valerie A. Canady","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W3160456289","eid":"W3160456289"},{"id":"paper-w4415973273","cat":"papers","name":"Ethical reflexivity and relational presence in psychedelic-assisted psychotherapy","year":"2025","cit":1,"pfa":"Hana Abbasian","psa":"Joonbum Lim","topics":["Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4415973273","eid":"W4415973273"},{"id":"paper-w7128399032","cat":"papers","name":"Psychedelic-assisted psychotherapy: The Australian and general practice perspective","year":"2026","cit":1,"pfa":"Anthony Helman","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7128399032","eid":"W7128399032"},{"id":"paper-w4206090345","cat":"papers","name":"Simulating Psychedelic Therapy Through Mediated Reality","year":"2017","cit":1,"pfa":"Andrew Hillstead","topics":["PTSD & trauma","Addiction","Reviews & meta-analyses"],"ptype":"dissertation","src":"https://openalex.org/W4206090345","eid":"W4206090345"},{"id":"paper-w7134897220","cat":"papers","name":"Psychedelic therapy and postpartum depression: priorities and prospects","year":"2026","cit":1,"pfa":"Guillaume Thuery","psa":"John Richard Kelly","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7134897220","eid":"W7134897220"},{"id":"paper-w4405002138","cat":"papers","name":"Healing through the Body: The Potential Role of Daoist Meditation in Psychedelic Therapy","year":"2024","cit":1,"pfa":"Kenneth Shinozuka","psa":"Leor Roseman","topics":["Depression","PTSD & trauma","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4405002138","eid":"W4405002138"},{"id":"paper-w4391543697","cat":"papers","name":"Nursing in psychedelic-assisted psychotherapy: new opportunities and future prospects","year":"2024","cit":1,"pfa":"Leonie Milner","psa":"Annie Mithoefer","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4391543697","eid":"W4391543697"},{"id":"paper-w4412525475","cat":"papers","name":"Radiation therapy patients’ interest in psychedelic-assisted therapy: results of a survey","year":"2025","cit":1,"pfa":"Jino Park","psa":"Jeremy P. Harris","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4412525475","eid":"W4412525475"},{"id":"paper-w4411307347","cat":"papers","name":"Psychedelic-Assisted Groups in the U.S.: A Culturally Responsive Counseling Approach","year":"2025","cit":1,"pfa":"Isaac Burt","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4411307347","eid":"W4411307347"},{"id":"paper-w4394946171","cat":"papers","name":"Bringing Psychedelic-Assisted Therapy from Psychiatry to Palliative Care","year":"2024","cit":1,"pfa":"Stacy M. Fischer","psa":"Yvan Beaussant","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4394946171","eid":"W4394946171"},{"id":"paper-w4405854366","cat":"papers","name":"Rural‐urban divide in risk perception of LSD: Implications for psychedelic‐assisted therapy","year":"2024","cit":1,"pfa":"Melissa Bradley","psa":"Peter S. Hendricks","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4405854366","eid":"W4405854366"},{"id":"paper-w4414261535","cat":"papers","name":"Psychedelic-Assisted Therapy in Palliative Care—Insights from an International Workshop","year":"2025","cit":1,"pfa":"Anna Schuldt","psa":"David Blum","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4414261535","eid":"W4414261535"},{"id":"paper-w4411140816","cat":"papers","name":"Protecting Patient Autonomy in Psychedelic-Assisted Psychotherapy: A Nursing Ethics Perspective","year":"2025","cit":1,"pfa":"Jennifer Tustison","psa":"Kristen R. Choi","topics":["Addiction","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4411140816","eid":"W4411140816"},{"id":"paper-w4410157526","cat":"papers","name":"Plant-based theatre: Drama therapy assists psychedelic-assisted therapy","year":"2025","cit":1,"pfa":"Brett Alters","ptype":"article","src":"https://openalex.org/W4410157526","eid":"W4410157526"},{"id":"paper-w4413270810","cat":"papers","name":"Neutral attitude toward the utilization of psychedelic therapy for depression in the United Kingdom population","year":"2025","cit":1,"pfa":"Liam O. Jarvis","psa":"Brandon Weiss","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4413270810","eid":"W4413270810"},{"id":"paper-w4389614167","cat":"papers","name":"Boundaries or boundlessness? Toward knowledge co-creation in psychedelic-assisted therapy","year":"2023","cit":1,"pfa":"David Clements","ptype":"article","src":"https://openalex.org/W4389614167","eid":"W4389614167"},{"id":"paper-w4407954021","cat":"papers","name":"Evidence-Based Therapy Models in a New Age of Psychedelic-Assisted Psychotherapy","year":"2025","cit":1,"pfa":"Adith V. Ram","psa":"Eric A. Storch","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4407954021","eid":"W4407954021"},{"id":"paper-w4410906688","cat":"papers","name":"Psychedelic-assisted therapy, metacognition, and the problem of integration: a tri-phasic approach","year":"2025","cit":1,"pfa":"Tra-ill Dowie","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4410906688","eid":"W4410906688"},{"id":"paper-w4406347674","cat":"papers","name":"Qualitative Analysis of Views of Psychedelic-Assisted Therapy in Low-Income, Urban, Black Americans","year":"2025","cit":1,"pfa":"Sierra Elizabeth Carter","psa":"Jessica L. Maples‐Keller","topics":["Depression","PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4406347674","eid":"W4406347674"},{"id":"paper-w4221010387","cat":"papers","name":"Psychedelic-assisted psychotherapy for existential suffering: Facilitating self-transcendence at the end of life.","year":"2022","cit":1,"pfa":"K. O. St. Arnaud","topics":["Addiction","Anxiety & end-of-life","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4221010387","eid":"W4221010387"},{"id":"paper-w4416096710","cat":"papers","name":"Corrigendum to “Psychedelic Assisted Therapy as a Complex Intervention: Implications for clinical trial design”","year":"2025","cit":1,"ptype":"erratum","src":"https://openalex.org/W4416096710","eid":"W4416096710"},{"id":"paper-w7197010344","cat":"papers","name":"Methodological fragmentation and integration priorities in psychedelic-assisted therapy assessment: a scoping review","year":"2026","cit":1,"pfa":"Maria Laura Mele","psa":"Stefano Federici","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7197010344","eid":"W7197010344"},{"id":"paper-w7131788183","cat":"papers","name":"Spiritual wellbeing in psychedelic-assisted therapy with palliative care populations: An analysis of outcome measures","year":"2026","cit":1,"pfa":"Stephen Lewis","topics":["Depression","Anxiety & end-of-life","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7131788183","eid":"W7131788183"},{"id":"paper-w4407422777","cat":"papers","name":"Cultural Humility and Psychedelics: A Framework Analysis of Psychedelic-Assisted Therapy Manuals and Practice Guidelines","year":"2025","cit":1,"pfa":"Ayanna K. Bell","psa":"Christopher S. Stauffer","ptype":"preprint","src":"https://openalex.org/W4407422777","eid":"W4407422777"},{"id":"paper-w7157177745","cat":"papers","name":"Spiritual transformation in psychedelic-assisted palliative care: Implications for existential and postmodern counseling practice","year":"2026","cit":1,"pfa":"Shopyan Jepri Kurniawan","psa":"Agus Supriyanto","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7157177745","eid":"W7157177745"},{"id":"paper-w4416276088","cat":"papers","name":"Supporting desistance from crime: The promise of psychedelic-assisted therapy in correctional and reentry contexts","year":"2025","cit":1,"pfa":"Tereza Dleštíková","ptype":"article","src":"https://openalex.org/W4416276088","eid":"W4416276088"},{"id":"paper-w4402140706","cat":"papers","name":"Examining the influence of team-based learning on medical students’ comprehension and attitudes regarding psychedelic therapies","year":"2024","cit":1,"pfa":"Shiven Chaudhry","psa":"Burton Jared Tabaac","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4402140706","eid":"W4402140706"},{"id":"paper-w3155147014","cat":"papers","name":"Psychedelic Therapy: Diplomatic Re-compositions of Life/Non-life, the Living and the Dead","year":"2021","cit":1,"pfa":"Harish Naraindas","topics":["Therapy practice"],"ptype":"other","src":"https://openalex.org/W3155147014","eid":"W3155147014"},{"id":"paper-w2964743607","cat":"papers","name":"Book Review: Oram, Matthew, The Trials of Psychedelic Therapy: LSD Psychotherapy in America","year":"2019","cit":1,"pfa":"Danielle M. Giffort","topics":["Reviews & meta-analyses","Therapy practice"],"ptype":"book-review","src":"https://openalex.org/W2964743607","eid":"W2964743607"},{"id":"paper-w7147451707","cat":"papers","name":"Attitudes toward psychedelic therapy among medical and nursing students: A cross-sectional survey study","year":"2026","cit":1,"pfa":"Diego Castellano-Ramírez","psa":"Luis Alberto Henríquez-Hernández","topics":["Safety & adverse events","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7147451707","eid":"W7147451707"},{"id":"paper-w4382918469","cat":"papers","name":"Re The prescription of psychedelic therapies in Australia and New Zealand: A brief survey of psychiatrists","year":"2023","cit":1,"pfa":"Graham W Mellsop","psa":"Peter Ellis","ptype":"article","src":"https://openalex.org/W4382918469","eid":"W4382918469"},{"id":"paper-w3174273228","cat":"papers","name":"Palliative care: is it time for health professionals to talk openly about psychedelic therapy?","year":"2021","cit":1,"pfa":"Emma Presern","topics":["Addiction","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3174273228","eid":"W3174273228"},{"id":"paper-w7126048364","cat":"papers","name":"Brief report: Ketamine‐assisted “bridge therapy” for opioid tapering in complex cases","year":"2026","cit":1,"pfa":"Mariana Calora Quintino de Oliveira","psa":"João Mauricio Castaldelli-Maia","topics":["Depression","Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7126048364","eid":"W7126048364"},{"id":"paper-w7128199367","cat":"papers","name":"Effectiveness of ketamine-assisted psychotherapy as a treatment for treatment-resistant depression: a systematic review","year":"2026","cit":1,"pfa":"Rebecca J Simpson","psa":"Mário F. Juruena","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W7128199367","eid":"W7128199367"},{"id":"paper-w4415283387","cat":"papers","name":"Ketamine-Assisted Therapy Outcomes for First Responders With Comorbid Mental Health Diagnoses","year":"2025","cit":1,"pfa":"Vivian W. L. Tsang","psa":"Pamela Kryskow","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4415283387","eid":"W4415283387"},{"id":"paper-w4220687839","cat":"papers","name":"Can psychedelic-assisted psychotherapy play a role in enhancing motivation to change in addiction treatment settings?","year":"2022","cit":1,"pfa":"Mark Kang","psa":"Elena Argento","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4220687839","eid":"W4220687839"},{"id":"paper-w4413975935","cat":"papers","name":"Assessing readiness for implementation of psychedelic-assisted mental health therapy, in low- and middle-income countries","year":"2025","cit":1,"pfa":"Kevin Lam","psa":"Elliot A. Marseille","topics":["Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4413975935","eid":"W4413975935"},{"id":"paper-w4405091810","cat":"papers","name":"Theorizing that Psychedelic Assisted Therapy May Play a Role in the Treatment of Trauma-Induced Personality Disorders.","year":"2024","cit":1,"pfa":"Gianni Martire","psa":"Kenneth Blum","topics":["PTSD & trauma","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4405091810","eid":"W4405091810"},{"id":"paper-w4416439259","cat":"papers","name":"The ethical use of therapeutic touch in psychedelic-assisted therapy: a qualitative study of researcher perspectives and experiences","year":"2025","cit":1,"pfa":"Diana McHerron","psa":"John Gardner","topics":["Dosing & pharmacology","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4416439259","eid":"W4416439259"},{"id":"paper-w4401920850","cat":"papers","name":"Psychedelic-assisted Therapy Training: Firsthand Experience of Non-Ordinary States of Consciousness in the Development of Competence","year":"2024","cit":1,"pfa":"Shannon Dames","psa":"V. Tsang","topics":["Safety & adverse events","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4401920850","eid":"W4401920850"},{"id":"paper-w4417179081","cat":"papers","name":"The Psychedelic Frontier: A Cross-Specialty Review of Healthcare Providers' Attitudes on Psychedelic-Assisted Therapy in the US","year":"2025","cit":1,"pfa":"Stefan Sampy","psa":"Rohan Sampy","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4417179081","eid":"W4417179081"},{"id":"paper-w7118848680","cat":"papers","name":"From Adults to Adolescents: Bridging Scientific Potential and Evidence-Based Paths for Psychedelic-Assisted Interventions","year":"2026","cit":1,"pfa":"Mayank Gupta","psa":"Priyal Khurana","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7118848680","eid":"W7118848680"},{"id":"paper-w3164853567","cat":"papers","name":"Correction to Set and Setting: A Randomized Study of Different Musical Genres in Supporting Psychedelic Therapy","year":"2021","cit":1,"pfa":"Justin C. Strickland","psa":"Matthew W. Johnson","topics":["Therapy practice"],"ptype":"erratum","src":"https://openalex.org/W3164853567","eid":"W3164853567"},{"id":"paper-w4413865636","cat":"papers","name":"Unfolding States of Mind: A Dissociative-Psychedelic Model of Ketamine-Assisted Psychotherapy in Palliative Care","year":"2025","cit":1,"pfa":"Alessandro Gonçalves Campolina","psa":"Marco Aurélio Tuena de Oliveira","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4413865636","eid":"W4413865636"},{"id":"paper-w2391754990","cat":"papers","name":"The Ketamine Assists Morphine with Subcutaneous Micro-infection to Cure the Pain of the Later Period Cancer","year":"2005","cit":1,"pfa":"Xiaorong Wang","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2391754990","eid":"W2391754990"},{"id":"paper-w4223594531","cat":"papers","name":"Sitting with Suffering, Sitting with Humanity: In the Common Ground of Emerging Psychedelic-Assisted Therapies and Palliative Care (FR208)","year":"2022","cit":1,"pfa":"Alden Doerner Rinaldi","psa":"Dingle Spence","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4223594531","eid":"W4223594531"},{"id":"paper-w7163050690","cat":"papers","name":"A Missing Voice? Peer Support Workers’ Perceptions of Psychedelic‐Assisted Therapy in Australia: A Cross‐Sectional Survey","year":"2026","cit":1,"pfa":"Aloysius Amos Lau","psa":"Sarah J. Catchlove","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7163050690","eid":"W7163050690"},{"id":"paper-w4412084250","cat":"papers","name":"Request for Correction of an Article Focused Bodywork as Facilitated Communication: Cautionary Perspectives on Touch in Psychedelic Therapy","year":"2025","cit":1,"pfa":"Veronika Gold","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4412084250","eid":"W4412084250"},{"id":"paper-w4393164509","cat":"papers","name":"Producing Altered States of Consciousness, Reducing Substance Misuse: A Review of Psychedelic-Assisted Psychotherapy, Transcendental Meditation and Hypnotherapy","year":"2024","cit":1,"pfa":"Agnieszka D. Sekula","psa":"Paul Liknaitzky","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4393164509","eid":"W4393164509"},{"id":"paper-w4413975908","cat":"papers","name":"Exploring barriers and opportunities for Black, Indigenous, and People of Color (BIPOC) therapists in psychedelic-assisted therapy: A qualitative study","year":"2025","cit":1,"pfa":"Yvan Beaussant","psa":"Manish Agrawal","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4413975908","eid":"W4413975908"},{"id":"paper-w4320879242","cat":"papers","name":"A Retrospective Study to Determine the Impact of Psychedelic Therapy for Dimensional Measures of Wellness: A Qualitative Analysis of Response Data","year":"2023","cit":1,"pfa":"Victoria Di Virgilio","psa":"Gaurav Gupta","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4320879242","eid":"W4320879242"},{"id":"paper-w4401056680","cat":"papers","name":"Taking the potential harms of psychedelic-assisted therapy seriously: How do we prevent or mitigate the risks to vulnerable patients?","year":"2024","cit":1,"pfa":"Sharon R. Sznitman","psa":"Kali Tal","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4401056680","eid":"W4401056680"},{"id":"paper-w7124417581","cat":"papers","name":"Barriers and Access to Care for Firefighters With Posttraumatic Stress Disorder Seeking Ketamine-Assisted Therapy: A Qualitative Study","year":"2026","cit":1,"pfa":"Vivian W. L. Tsang","psa":"Pamela Kryskow","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W7124417581","eid":"W7124417581"},{"id":"paper-w4200206543","cat":"papers","name":"Corrigendum: Ketamine-assisted psychotherapy for trauma-exposed patients in an outpatient setting: A clinical chart review study","year":"2021","cit":1,"pfa":"Alan K. Davis","psa":"Yitong Xin","topics":["PTSD & trauma","Reviews & meta-analyses","Therapy practice"],"ptype":"erratum","src":"https://openalex.org/W4200206543","eid":"W4200206543"},{"id":"paper-w4409623575","cat":"papers","name":"Ketamine-Assisted Group Therapy for Work-Related Stress in First Responders and Frontline Health Care Workers","year":"2025","cit":1,"pfa":"Luke Flynn","psa":"Scott Shannon","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4409623575","eid":"W4409623575"},{"id":"paper-w4385670282","cat":"papers","name":"Safety and Tolerability of Intramuscular and Sublingual Ketamine for Psychiatric Treatment in the Roots to Thrive Ketamine Assisted Therapy Program","year":"2023","cit":1,"pfa":"Vivian W. L. Tsang","psa":"Pamela Kryskow","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4385670282","eid":"W4385670282"},{"id":"paper-w3001979862","cat":"papers","name":"An Agenda of Psychedelic-Assisted Therapy Research in Seriously Ill Patients: Highlights from the Harvard Radcliffe Institute Exploratory Seminar (FR405)","year":"2020","cit":1,"pfa":"Yvan Beaussant","psa":"Justin J. Sanders","ptype":"article","src":"https://openalex.org/W3001979862","eid":"W3001979862"},{"id":"paper-w4408007707","cat":"papers","name":"Ketamine-Assisted Psychotherapy for Generalized Anxiety Disorder: A Comprehensive Case Report with Integrated Neurophysiological Imaging Using Magnetoencephalography","year":"2025","cit":1,"pfa":"Jacob Cohen","psa":"Benjamin Thomas Dunkley","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4408007707","eid":"W4408007707"},{"id":"paper-w7125413465","cat":"papers","name":"Ketamine-assisted group psychotherapy integrating cognitive processing therapy to address identity-based trauma: a pilot study","year":"2026","cit":1,"pfa":"Jae M. Sevelius","psa":"Talea M. Cornelius","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7125413465","eid":"W7125413465"},{"id":"paper-w4402227853","cat":"papers","name":"A Cross-Sectional Survey Investigating Māori and Non-Māori Cancer Patients’ Views on Psychedelic-Assisted Therapy in Aotearoa New Zealand","year":"2024","cit":1,"pfa":"Georgia Best","psa":"Lisa Reynolds","topics":["Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4402227853","eid":"W4402227853"},{"id":"paper-w4407327812","cat":"papers","name":"Protocol of an open-label safety and feasibility pilot study of ketamine-assisted psychotherapy for methamphetamine use disorder (the KAPPA trial)","year":"2025","cit":1,"pfa":"Kathryn Fletcher","psa":"Brendan Clifford","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4407327812","eid":"W4407327812"},{"id":"paper-w4403435312","cat":"papers","name":"Systematic Review of the Effect of Psychedelic-Assisted Therapy on Attitudes Toward Death, Life, and Spirituality on Symptoms of Distress, Depression, and/or Anxiety in Patients with Life-Threatening Illness","year":"2024","cit":1,"pfa":"Thivya Turner","psa":"Paul Glue","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W4403435312","eid":"W4403435312"},{"id":"paper-w7141801946","cat":"papers","name":"A scoping review of mystical-type experiences and mood symptom outcomes in psychedelic therapy clinical trials: comparing life-threatening disease and depressive populations","year":"2026","cit":1,"pfa":"Ana Deutsch","psa":"Leah M. Mayo","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7141801946","eid":"W7141801946"},{"id":"paper-w4416416382","cat":"papers","name":"Does number of dosing sessions and type of adjunctive psychotherapy affect outcomes in psychedelic-assisted-psychotherapy for depressive disorders and anxiety disorders? A systematic review and meta-analysis","year":"2025","cit":1,"pfa":"Tomas Lindegaard","psa":"Anton Käll","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W4416416382","eid":"W4416416382"},{"id":"paper-w2956213771","cat":"papers","name":"The Trials of Psychedelic Therapy: LSD Psychotherapy in America By Matthew Oram Johns Hopkins University Press. 2018. 288 pp. £33.30 (hb). ISBN 9781421426204","year":"2019","cit":1,"pfa":"Ben Sessa","topics":["Therapy practice"],"ptype":"book-review","src":"https://openalex.org/W2956213771","eid":"W2956213771"},{"id":"paper-w4416160807","cat":"papers","name":"Virtual reality and psychedelics: new perspectives and new possibilities in the treatment of alcohol use disorder","year":"2025","cit":1,"pfa":"Scott C. Matthews","psa":"Anahita Bassir Nia","topics":["Addiction","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4416160807","eid":"W4416160807"},{"id":"paper-w4410791644","cat":"papers","name":"Attitudes of U.S. Muslims Toward Psychedelics","year":"2025","cit":1,"pfa":"Syed F. Rab","psa":"Ali John Zarrabi","ptype":"article","src":"https://openalex.org/W4410791644","eid":"W4410791644"},{"id":"paper-w7124463736","cat":"papers","name":"AI-generated virtual psychedelics bridge digital and therapeutic frontiers in mental health research","year":"2026","cit":1,"pfa":"Giuseppe Riva","psa":"Antonino Greco","ptype":"article","src":"https://openalex.org/W7124463736","eid":"W7124463736"},{"id":"paper-w4415680812","cat":"papers","name":"Meaning and Psychedelics in Palliative Care: A Narrative Review","year":"2025","cit":1,"pfa":"William B. Alexander","psa":"Amy Allen Case","topics":["Anxiety & end-of-life","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4415680812","eid":"W4415680812"},{"id":"paper-w7130609587","cat":"papers","name":"Psychedelics, Harm Reduction, and Ethical Care","year":"2026","cit":1,"pfa":"Mia Sarno","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7130609587","eid":"W7130609587"},{"id":"paper-w4281392311","cat":"papers","name":"Book Symposium: Philosophy of Psychedelics","year":"2022","cit":1,"pfa":"Chiara Caporuscio","psa":"Sascha Benjamin Fink","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4281392311","eid":"W4281392311"},{"id":"paper-w7203925300","cat":"papers","name":"Tales of the unexpected: psychedelic trial design solutions","year":"2026","cit":1,"pfa":"Robin Lester Carhart-Harris","psa":"Jennifer Mitchell","topics":["Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W7203925300","eid":"W7203925300"},{"id":"paper-w4414807407","cat":"papers","name":"On psychedelic liberalism and mad trust: towards varieties of willing in extreme experiences","year":"2025","cit":1,"pfa":"Tehseen N. Noorani","ptype":"article","src":"https://openalex.org/W4414807407","eid":"W4414807407"},{"id":"paper-w4321791612","cat":"papers","name":"Psychoanalysis and Psychedelic Psychotherapy – A New Modern Synthesis?","year":"2023","cit":1,"pfa":"Gita Vaid","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W4321791612","eid":"W4321791612"},{"id":"paper-w3006418307","cat":"papers","name":"Sustained Opioid Cessation Following Rapid Opioid Detoxification with Ketamine Infusion Therapy in Veterans a Preliminary Study","year":"2019","cit":1,"pfa":"all J Malchow","psa":"Ashley P Yost","topics":["Addiction","Anxiety & end-of-life","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3006418307","eid":"W3006418307"},{"id":"paper-w4413819344","cat":"papers","name":"What Can Critical Humanities Contribute to Psychedelic Research? A Naturalist Approach to Interdisciplinary Integration","year":"2025","cit":1,"pfa":"Oliver Thorndike","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4413819344","eid":"W4413819344"},{"id":"paper-w4409334177","cat":"papers","name":"Reducing Cardiovascular Side Effects of DMT Using Beta-Blockers","year":"2025","cit":1,"pfa":"Robert B. Kargbo","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"editorial","src":"https://openalex.org/W4409334177","eid":"W4409334177"},{"id":"paper-w7116754160","cat":"papers","name":"Exploring Access to Psychedelics Among Canadian Veterans: Pathways, Barriers, and Perceptions","year":"2025","cit":1,"pfa":"Luis E. Contreras","psa":"Leah M. Mayo","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7116754160","eid":"W7116754160"},{"id":"paper-w4363675013","cat":"papers","name":"148. Glial Mechanisms Underlying the Effects of Psychedelics on Mood Behaviors of Mice","year":"2023","cit":1,"pfa":"Mee Jung Ko","psa":"Daniela Kaufer","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4363675013","eid":"W4363675013"},{"id":"paper-w7124983645","cat":"papers","name":"Unequal Healing: Gender, Psychedelics, and the Burden of Care","year":"2026","cit":1,"pfa":"Sean M. Viña","ptype":"article","src":"https://openalex.org/W7124983645","eid":"W7124983645"},{"id":"paper-w4402655898","cat":"papers","name":"Introduction: philosophy and psychedelic psychiatry","year":"2024","cit":1,"pfa":"Chris Letheby","psa":"Philip Gerrans","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"book-chapter","src":"https://openalex.org/W4402655898","eid":"W4402655898"},{"id":"paper-w4255744664","cat":"papers","name":"Psychedelic drug research will increase globally","year":"2021","cit":1,"topics":["Depression","PTSD & trauma","Addiction"],"ptype":"other","src":"https://openalex.org/W4255744664","eid":"W4255744664"},{"id":"paper-w4414551527","cat":"papers","name":"The Use of Psychedelics in Couples Therapy","year":"2025","cit":1,"pfa":"Alan M. Groveman","ptype":"book-chapter","src":"https://openalex.org/W4414551527","eid":"W4414551527"},{"id":"paper-w4405880478","cat":"papers","name":"Commentary: A framework for assessment of adverse events in psychedelic research","year":"2024","cit":1,"pfa":"Katherine Cheung","psa":"David B. Yaden","topics":["Anxiety & end-of-life","Safety & adverse events","Reviews & meta-analyses"],"ptype":"editorial","src":"https://openalex.org/W4405880478","eid":"W4405880478"},{"id":"paper-w4417255337","cat":"papers","name":"Looking Up at the Stars from the Middle of the Lake: Dare We Speak of Spirit? A Model of Psychedelic Consciousness for Psychoanalysis","year":"2025","cit":1,"pfa":"David Raniere","ptype":"article","src":"https://openalex.org/W4417255337","eid":"W4417255337"},{"id":"paper-w4400763780","cat":"papers","name":"Integrating Psychedelics into Groupwork: A Culturally Responsive Model for the Counseling Profession","year":"2024","cit":1,"pfa":"Isaac Burt","topics":["PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4400763780","eid":"W4400763780"},{"id":"paper-w4410217055","cat":"papers","name":"[Interventional psychiatric procedures and novel substances for the treatment of affective disorders: An overview and outlook].","year":"2025","cit":1,"pfa":"Tobias Bracht","psa":"Niklaus Denier","topics":["Depression","Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4410217055","eid":"W4410217055"},{"id":"paper-w4410862998","cat":"papers","name":"New Horizons in Post-Traumatic Stress Disorder Treatment: From Current Status to the Future","year":"2025","cit":1,"pfa":"Alişan Burak Yaşar","topics":["PTSD & trauma","Reviews & meta-analyses","Therapy practice"],"ptype":"editorial","src":"https://openalex.org/W4410862998","eid":"W4410862998"},{"id":"paper-w4213391130","cat":"papers","name":"On the need for a natural philosophy of psychedelics","year":"2021","cit":1,"pfa":"Chris Letheby","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"book-chapter","src":"https://openalex.org/W4213391130","eid":"W4213391130"},{"id":"paper-w4404286078","cat":"papers","name":"Exploring the therapeutic potential of psychedelics: Fear extinction mechanisms and amygdala modulation","year":"2024","cit":1,"pfa":"Thomas J. Kelly","psa":"Qing-song Liu","topics":["PTSD & trauma","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4404286078","eid":"W4404286078"},{"id":"paper-w7134902434","cat":"papers","name":"Toward a framework for psychedelic clinical trials in adolescents","year":"2026","cit":1,"pfa":"Christine K. Moore","psa":"Philippe Auby","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7134902434","eid":"W7134902434"},{"id":"paper-w4390839760","cat":"papers","name":"Therapeutic dissociation: From non-ordinary states to psychological transformation","year":"2024","cit":1,"pfa":"Joshua Clingo","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"preprint","src":"https://openalex.org/W4390839760","eid":"W4390839760"},{"id":"paper-w4405053273","cat":"papers","name":"The taming of the shrooms. Understanding current discursive struggles over the psychedelic in the light of their historical antecedents","year":"2024","cit":1,"pfa":"Thomas Slunecko","ptype":"article","src":"https://openalex.org/W4405053273","eid":"W4405053273"},{"id":"paper-w7132840876","cat":"papers","name":"Psychedelics and the Extracellular Matrix: Rewiring Neuroplasticity and Metaplasticity for Next-Generation Psychiatric Therapies","year":"2026","cit":1,"pfa":"Jin Zhang","psa":"Xiaohui Wang","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7132840876","eid":"W7132840876"},{"id":"paper-w4402748461","cat":"papers","name":"Psychotherapy in the Third Millennium - Cross-Cutting Themes and Proposals for Reflection","year":"2024","cit":1,"pfa":"Federico Durbano","psa":"Barbara Marchesi","topics":["Therapy practice"],"ptype":"book","src":"https://openalex.org/W4402748461","eid":"W4402748461"},{"id":"paper-w4407263176","cat":"papers","name":"Mental disorder and its treatment as a transformative experience","year":"2025","cit":1,"pfa":"Daniel Villiger","topics":["Depression","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4407263176","eid":"W4407263176"},{"id":"paper-w4378800466","cat":"papers","name":"Microbiome: The Next Frontier in Psychedelic Renaissance","year":"2023","cit":1,"pfa":"Robert B. Kargbo","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4378800466","eid":"W4378800466"},{"id":"paper-w4410146315","cat":"papers","name":"Harnessing psychedelics for treating posttraumatic stress disorder: Does the science support all the hype?","year":"2025","cit":1,"pfa":"Mark C. Creamer","psa":"Paula P. Schnurr","topics":["PTSD & trauma","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4410146315","eid":"W4410146315"},{"id":"paper-w4414397832","cat":"papers","name":"The collective lie in ketamine therapy: a call to realign clinical practice with neurobiology","year":"2025","cit":1,"pfa":"Charles Miller","psa":"Anna McCurdy","topics":["Safety & adverse events","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4414397832","eid":"W4414397832"},{"id":"paper-w4390111852","cat":"papers","name":"Psychedelic integration and transformation","year":"2023","cit":1,"pfa":"Jorge Branco","topics":["Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4390111852","eid":"W4390111852"},{"id":"paper-w4409728096","cat":"papers","name":"Exploring the importance of bodyset for the psychedelic experience and beyond","year":"2025","cit":1,"pfa":"Malin Vedøy Uthaug","psa":"Johannes Gerardus Ramaekers","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4409728096","eid":"W4409728096"},{"id":"paper-w4412168531","cat":"papers","name":"The Use of Psychedelics for Grief Following Death due to Advanced Illness: A Scoping Review","year":"2025","cit":1,"pfa":"Daniel Rosenbaum","psa":"Sarah Hales","topics":["Safety & adverse events","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4412168531","eid":"W4412168531"},{"id":"paper-w1982196148","cat":"papers","name":"2179 – Psychedelic Drugs In Psychotherapy. a Revival?","year":"2013","cit":1,"pfa":"V.M. Barrau-Alonso","psa":"Ramón Gracia-Marco","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1982196148","eid":"W1982196148"},{"id":"paper-w7140215872","cat":"papers","name":"When the therapist hallucinates: AI, psychedelics, and the risks of unsupervised digital mental health care","year":"2026","cit":1,"pfa":"Michael R. MacIntyre","topics":["Safety & adverse events","Therapy practice","Policy & ethics"],"ptype":"editorial","src":"https://openalex.org/W7140215872","eid":"W7140215872"},{"id":"paper-w4415757841","cat":"papers","name":"Antidepressant medications: a comprehensive review of efficacy, safety, and future directions","year":"2025","cit":1,"pfa":"Neelam Shah","psa":"Pankaj K. Singhal","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4415757841","eid":"W4415757841"},{"id":"paper-w4383498853","cat":"papers","name":"Lasting dynamic effects of the psychedelic 2,5-dimethoxy-4-iodoamphetamine ((±)-DOI) on cognitive flexibility","year":"2023","cit":1,"pfa":"Merima Šabanović","psa":"David M. Bannerman","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W4383498853","eid":"W4383498853"},{"id":"paper-w4414738251","cat":"papers","name":"Treatment Expectation is the Strongest Predictor of Willingness to Participate in Psychedelic Clinical Trials","year":"2025","cit":1,"pfa":"Anna Paige Payton","psa":"Pilleriin Sikka","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4414738251","eid":"W4414738251"},{"id":"paper-w4413971278","cat":"papers","name":"Evolving Psychotherapeutic Approaches for PTSD: Beyond the Fear-Based Model.","year":"2025","cit":1,"pfa":"Lisa Burback","psa":"Eric H. G. J. M. Vermetten","topics":["PTSD & trauma","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4413971278","eid":"W4413971278"},{"id":"paper-w7167518606","cat":"papers","name":"Disrupted self-referential processing and empathy-based interventions in mental disorders: neural mechanisms, cognitive biases, and therapeutic integration","year":"2026","cit":1,"pfa":"Siqintu","psa":"Temuqile","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7167518606","eid":"W7167518606"},{"id":"paper-w4410444259","cat":"papers","name":"Turning online to tune in: Psychedelic information seeking in an era of renewed psychedelic curiosity","year":"2025","cit":1,"pfa":"Oskar Enghoff","psa":"Morten Hesse","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4410444259","eid":"W4410444259"},{"id":"paper-w7167802990","cat":"papers","name":"Psychedelics in Mental Health: Opportunities and Challenges","year":"2026","cit":1,"pfa":"Lena Oestreich","psa":"Nathalie M. Rieser","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"editorial","src":"https://openalex.org/W7167802990","eid":"W7167802990"},{"id":"paper-w4407046297","cat":"papers","name":"Pilot study of a CBT-based intervention for promoting spiritual experience among men in residential addiction treatment","year":"2025","cit":1,"pfa":"John Calvin Chatlos","psa":"Michelle Zechner","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4407046297","eid":"W4407046297"},{"id":"paper-w7162625730","cat":"papers","name":"From Altered States to Well-Being: A Mechanistic Model about Acceptance and Experiential Avoidance in High Ventilation Breathwork","year":"2026","cit":1,"pfa":"Lena Erdmann","psa":"Michael A. Rapp","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W7162625730","eid":"W7162625730"},{"id":"paper-w7116801445","cat":"papers","name":"Ceremonial Psychedelic Experiences and Changes in Mental Health Outcomes in Those with Adverse Childhood Experiences","year":"2025","cit":1,"pfa":"Maryam Mehmood","psa":"Richard J. Zeifman","topics":["Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7116801445","eid":"W7116801445"},{"id":"paper-w7129021116","cat":"papers","name":"The psychoactive effects of repeated ketamine infusions and their mechanistic role in the treatment of alcohol use disorder: Secondary analysis of a randomised controlled trial","year":"2026","cit":1,"pfa":"Cassie Bloy","psa":"Will Lawn","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7129021116","eid":"W7129021116"},{"id":"paper-w4312211142","cat":"papers","name":"Neural Correlates of the DEEPP (Anti-suicidal Response to Ketamine in Treatment-Resistant Bipolar Depression) Study: Protocol for a Pilot, Open-Label Clinical Trial","year":"2022","cit":1,"pfa":"Yuliya Knyahnytska","psa":"Daniel M. Blumberger","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4312211142","eid":"W4312211142"},{"id":"paper-w4404998117","cat":"papers","name":"Guideline on the Use of Intravenous Ketamine for Procedural Sedation in the Children’s Emergency Department: A Quality Improvement Project","year":"2024","cit":1,"pfa":"Samuel I Udo","psa":"Joshua Lyon","topics":["Safety & adverse events","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4404998117","eid":"W4404998117"},{"id":"paper-w7134978803","cat":"papers","name":"Understanding Relationship between Mystical Experiences and Yoga-based Personality Traits in Meditators, Patients with Psychosis, and Psychedelic Users: A Cross-sectional Study","year":"2026","cit":1,"pfa":"Gokul Raj","psa":"Hemant Bhargav","topics":["Addiction","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7134978803","eid":"W7134978803"},{"id":"paper-w4384270455","cat":"papers","name":"A multidisciplinary approach to Mental Health and Consciousness Studies","year":"2023","cit":1,"pfa":"Diego González-Rodriguez","topics":["Safety & adverse events","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4384270455","eid":"W4384270455"},{"id":"paper-w4312077747","cat":"papers","name":"APA Task Force Reviews Digital Tools for Mental Health Care","year":"2022","cit":1,"pfa":"Nick Zagorski","topics":["PTSD & trauma","Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4312077747","eid":"W4312077747"},{"id":"paper-w4321602509","cat":"papers","name":"Psychedelic medicine and the clinical application of hallucinogens","year":"2023","cit":1,"pfa":"eClinicalMedicine","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4321602509","eid":"W4321602509"},{"id":"paper-w3165682268","cat":"papers","name":"Psychedelic Properties of Peganum Harmala: Macrodose and Microdose Reports","year":"2020","cit":1,"pfa":"Michael Doty","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3165682268","eid":"W3165682268"},{"id":"paper-w2063429827","cat":"papers","name":"Hallucinogens: A Reader Zig Zag Zen: Buddhism and Psychedelics","year":"2002","cit":1,"pfa":"Steve Heilig","ptype":"article","src":"https://openalex.org/W2063429827","eid":"W2063429827"},{"id":"paper-w4386602243","cat":"papers","name":"Microdosing psychedelics: The segregation of spiritual and scientific narratives within the r/microdosing online community","year":"2023","cit":1,"pfa":"Ioana Andreea Pop","psa":"Hannah Kottmann","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4386602243","eid":"W4386602243"},{"id":"paper-w4212882523","cat":"papers","name":"Hallucinogens","year":"2010","cit":1,"pfa":"Michael H. Bloch","psa":"Subhash C. Pandey","ptype":"reference-entry","src":"https://openalex.org/W4212882523","eid":"W4212882523"},{"id":"paper-w4304110305","cat":"papers","name":"What we know so far about microdosing psychedelics","year":"2022","cit":1,"pfa":"Vince Polito","topics":["Dosing & pharmacology"],"ptype":"report","src":"https://openalex.org/W4304110305","eid":"W4304110305"},{"id":"paper-w4389504535","cat":"papers","name":"ENTHEOGENS AND RITUAL","year":"2023","cit":1,"pfa":"Igor Kudrya","ptype":"article","src":"https://openalex.org/W4389504535","eid":"W4389504535"},{"id":"paper-w4385040984","cat":"papers","name":"entheogen, n.","year":"2023","cit":1,"ptype":"reference-entry","src":"https://openalex.org/W4385040984","eid":"W4385040984"},{"id":"paper-w4232309156","cat":"papers","name":"Hallucinogens","year":"1993","cit":1,"pfa":"Mark J. Werner","ptype":"article","src":"https://openalex.org/W4232309156","eid":"W4232309156"},{"id":"paper-w4240468372","cat":"papers","name":"Hallucinogens","year":"2015","cit":1,"pfa":"D. Hank Ellison","psa":"Olaf Drummer","ptype":"book-chapter","src":"https://openalex.org/W4240468372","eid":"W4240468372"},{"id":"paper-w4308221264","cat":"papers","name":"Hallucinogens","year":"2022","cit":1,"pfa":"Morgan Alonzo","psa":"Shanlin Fu","ptype":"reference-entry","src":"https://openalex.org/W4308221264","eid":"W4308221264"},{"id":"paper-w2403093360","cat":"papers","name":"THE USE OF HALLUCINOGENIC, PSYCHOTOMIMETIC, PSYCHEDELIC DRUGS IN NORTH CAROLINA.","year":"1963","cit":1,"pfa":"Keeler Mh","ptype":"article","src":"https://openalex.org/W2403093360","eid":"W2403093360"},{"id":"paper-w4403232082","cat":"papers","name":"Wine in India and Other Substances An Anthropology of ‘Entheogens’","year":"2024","cit":1,"pfa":"Stefano Beggiora","topics":["Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W4403232082","eid":"W4403232082"},{"id":"paper-w3021138053","cat":"papers","name":"Hallucinogens","year":"2013","cit":1,"pfa":"Silvia Saboia Martins","psa":"Carla L. Storr","ptype":"book-chapter","src":"https://openalex.org/W3021138053","eid":"W3021138053"},{"id":"paper-w4417026469","cat":"papers","name":"Flashbacks, Hallucinogen Persisting Perception Disorder (HPPD), and Reactivations Following the Use of Classic Psychedelics: Classification and Therapeutic Management","year":"2025","cit":1,"pfa":"Marija Franka Žuljević","psa":"Tomislav Majić","ptype":"book-chapter","src":"https://openalex.org/W4417026469","eid":"W4417026469"},{"id":"paper-w2592275976","cat":"papers","name":"Microdosing of Scents","year":"2017","cit":1,"pfa":"Martin Richter","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W2592275976","eid":"W2592275976"},{"id":"paper-w2469079329","cat":"papers","name":"[Pharmacology of hallucinogens].","year":"1971","cit":1,"pfa":"Peter Gaudenz Waser","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2469079329","eid":"W2469079329"},{"id":"paper-w4388520221","cat":"papers","name":"Hallucinating hallucinogens","year":"2023","cit":1,"pfa":"Michael A. Skinnider","ptype":"article","src":"https://openalex.org/W4388520221","eid":"W4388520221"},{"id":"paper-w4253013386","cat":"papers","name":"HALLUCINOGEN AND TERATOGEN?","year":"1967","cit":1,"ptype":"article","src":"https://openalex.org/W4253013386","eid":"W4253013386"},{"id":"paper-w2470795413","cat":"papers","name":"The biochemistry of hallucinogens.","year":"1958","cit":1,"pfa":"Ábel Lajtha","ptype":"article","src":"https://openalex.org/W2470795413","eid":"W2470795413"},{"id":"paper-w4377029651","cat":"papers","name":"β-Arrestins Mediate Rapid 5-HT2A Receptor Endocytosis to Control the Efficacy and Kinetics of Serotonin and Psychedelic Hallucinogen Signaling","year":"2023","cit":1,"pfa":"Hudson Smith","psa":"John Allen","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4377029651","eid":"W4377029651"},{"id":"paper-w4254684441","cat":"papers","name":"Microdose mammography","year":"1976","cit":1,"pfa":"M. B. Hermel","psa":"Morton G. Murdock","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4254684441","eid":"W4254684441"},{"id":"paper-w4290619627","cat":"papers","name":"[Hallucinogen abuse].","year":"1970","cit":1,"pfa":"J Angst","ptype":"article","src":"https://openalex.org/W4290619627","eid":"W4290619627"},{"id":"paper-w4256300521","cat":"papers","name":"Profitable Hallucinogens","year":"1996","cit":1,"pfa":"Marc Edelman","ptype":"article","src":"https://openalex.org/W4256300521","eid":"W4256300521"},{"id":"paper-w4415054852","cat":"papers","name":"Daily self-assessment within a regimen of microdosing indicates enhanced psychological functioning on microdosing days relative to non-microdosing days","year":"2025","cit":1,"pfa":"Michelle St. Pierre","psa":"Zach Walsh","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4415054852","eid":"W4415054852"},{"id":"paper-w4391839665","cat":"papers","name":"Perioperative considerations for patients exposed to hallucinogens","year":"2024","cit":1,"pfa":"Trent D. Emerick","psa":"Doug Ririe","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4391839665","eid":"W4391839665"},{"id":"paper-w1516331763","cat":"papers","name":"Hallucinogens and Related Drugs","year":"1989","cit":1,"pfa":"Marc Alan Schuckit","ptype":"book-chapter","src":"https://openalex.org/W1516331763","eid":"W1516331763"},{"id":"paper-w2799228143","cat":"papers","name":"Psychoactive Sacramentals: Essays on Entheogens and Religion","year":"2001","cit":1,"pfa":"Albert Hofmann","psa":"Stanislav Grof","ptype":"book","src":"https://openalex.org/W2799228143","eid":"W2799228143"},{"id":"paper-w4235024325","cat":"papers","name":"Microdosing may be all in the mind","year":"2021","cit":1,"pfa":"Drugs","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4235024325","eid":"W4235024325"},{"id":"paper-w2433468828","cat":"papers","name":"[A psychiatrist's autoexperiment with hallucinogens].","year":"1966","cit":1,"pfa":"M Vojtĕchovský","ptype":"article","src":"https://openalex.org/W2433468828","eid":"W2433468828"},{"id":"paper-w4292082524","cat":"papers","name":"Reviving the study of hallucinogens.","year":"2006","cit":1,"ptype":"article","src":"https://openalex.org/W4292082524","eid":"W4292082524"},{"id":"paper-w4409505229","cat":"papers","name":"Psychedelics","year":"2025","cit":1,"pfa":"Erika Dyck","ptype":"reference-entry","src":"https://openalex.org/W4409505229","eid":"W4409505229"},{"id":"paper-w2519480189","cat":"papers","name":"Microdose Pharmacokinetic Study","year":"2004","cit":1,"pfa":"HIDEYO NOGUCHI","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2519480189","eid":"W2519480189"},{"id":"paper-w4206924609","cat":"papers","name":"psychedelic","year":"2022","cit":1,"ptype":"reference-entry","src":"https://openalex.org/W4206924609","eid":"W4206924609"},{"id":"paper-w2786791513","cat":"papers","name":"Diverging Roads For Microdosing","year":"2013","cit":1,"pfa":"Celia Henry Arnaud","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W2786791513","eid":"W2786791513"},{"id":"paper-w2749270716","cat":"papers","name":"Chapter 4 Hallucinogens","year":"2000","cit":1,"ptype":"book-chapter","src":"https://openalex.org/W2749270716","eid":"W2749270716"},{"id":"paper-w2040721537","cat":"papers","name":"Hybrid microdosing system","year":"1998","cit":1,"pfa":"Nam‐Trung Nguyen","psa":"Thomas Geßner","topics":["Dosing & pharmacology"],"ptype":"conference-paper","src":"https://openalex.org/W2040721537","eid":"W2040721537"},{"id":"paper-w2014368796","cat":"papers","name":"Hallucinogens in the United States: A Diagnostic Evaluation","year":"1977","cit":1,"pfa":"Patricia J. Cleckner","ptype":"article","src":"https://openalex.org/W2014368796","eid":"W2014368796"},{"id":"paper-w4246160585","cat":"papers","name":"Tripping the light fantastic: the phenomenon of the hallucinogens","year":"2016","cit":1,"pfa":"Ilana Belle Glass","ptype":"book-chapter","src":"https://openalex.org/W4246160585","eid":"W4246160585"},{"id":"paper-w2419409705","cat":"papers","name":"[PRACTICAL EXPERIENCES WITH HALLUCINOGENS IN PSYCHOTHERAPY].","year":"1963","cit":1,"pfa":"Milan Hausner","psa":"V DOLEZAL","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2419409705","eid":"W2419409705"},{"id":"paper-w2427284235","cat":"papers","name":"A note on epistemic organization and hallucinogens.","year":"1974","cit":1,"pfa":"A J Marsella","psa":"Douglass R. Price-Williams","ptype":"article","src":"https://openalex.org/W2427284235","eid":"W2427284235"},{"id":"paper-w2410668149","cat":"papers","name":"Identification of Analogs of the Hallucinogen Cyclohexamine","year":"1979","cit":1,"pfa":"Keith Bailey","psa":"Donald Legault","ptype":"article","src":"https://openalex.org/W2410668149","eid":"W2410668149"},{"id":"paper-w2054121390","cat":"papers","name":"Hallucinogens: Cross-cultural Perspectives","year":"1985","cit":1,"pfa":"Richard Evans Schultes","ptype":"article","src":"https://openalex.org/W2054121390","eid":"W2054121390"},{"id":"paper-w2435330677","cat":"papers","name":"[Beyond hallucinogens: the case of Solange].","year":"1973","cit":1,"pfa":"Paul Jonckheere","ptype":"article","src":"https://openalex.org/W2435330677","eid":"W2435330677"},{"id":"paper-w4241442768","cat":"papers","name":"Metates and Hallucinogens in Costa Rica","year":"1991","cit":1,"pfa":"Ursula Jones","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4241442768","eid":"W4241442768"},{"id":"paper-w4384559710","cat":"papers","name":"The history of psychedelics and why psychedelic stories matter","year":"2023","cit":1,"pfa":"Erika Dyck","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4384559710","eid":"W4384559710"},{"id":"paper-w2478510463","cat":"papers","name":"BIOSYNTHESIS AND ACTION OF HALLUCINOGENS IN MAMMALS","year":"1978","cit":1,"pfa":"Arnold J. Friedhoff","ptype":"book-chapter","src":"https://openalex.org/W2478510463","eid":"W2478510463"},{"id":"paper-w4414798451","cat":"papers","name":"Exploring the effects of microdosing on health behaviour change","year":"2025","cit":1,"pfa":"Luisa Prochazkova","psa":"Pedro J. Teixeira","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4414798451","eid":"W4414798451"},{"id":"paper-w2143528523","cat":"papers","name":"INTERACTION OF HALLUCINOGENS WITH OTHER DRUGS","year":"1976","cit":1,"pfa":"Stephen Szára","ptype":"article","src":"https://openalex.org/W2143528523","eid":"W2143528523"},{"id":"paper-w4241640588","cat":"papers","name":"Psychedelic Drugs","year":"1970","cit":1,"pfa":"Sidney Cohen","ptype":"article","src":"https://openalex.org/W4241640588","eid":"W4241640588"},{"id":"paper-w2340092369","cat":"papers","name":"The Psychedelics and Religion","year":"2010","cit":1,"pfa":"Walter Houston Clark","ptype":"article","src":"https://openalex.org/W2340092369","eid":"W2340092369"},{"id":"paper-w4404286293","cat":"papers","name":"Psychedelics: The Journal of Psychedelic and Psychoactive Drug Research – Charting a new course in psychedelic science","year":"2024","cit":1,"pfa":"Júlio Licinio","ptype":"article","src":"https://openalex.org/W4404286293","eid":"W4404286293"},{"id":"paper-w3080277805","cat":"papers","name":"[Psychedelics and psychiatry].","year":"2020","cit":1,"pfa":"Joost J. Breeksema","psa":"Willem Johan van den Brink","ptype":"editorial","src":"https://openalex.org/W3080277805","eid":"W3080277805"},{"id":"paper-w4301703639","cat":"papers","name":"[Psychedelic drugs].","year":"1968","cit":1,"pfa":"Pieter C. Kuiper","ptype":"article","src":"https://openalex.org/W4301703639","eid":"W4301703639"},{"id":"paper-w1971310631","cat":"papers","name":"The Psychedelic Reader","year":"1966","cit":1,"pfa":"Sidney Cohen","ptype":"article","src":"https://openalex.org/W1971310631","eid":"W1971310631"},{"id":"paper-w2473798243","cat":"papers","name":"[The use of hallucinogens in folkloric psychiatry].","year":"1976","cit":1,"pfa":"Chiappe Costa M","ptype":"other","src":"https://openalex.org/W2473798243","eid":"W2473798243"},{"id":"paper-w2469996843","cat":"papers","name":"Hallucinogens and dominance behavior of the rat.","year":"1967","cit":1,"pfa":"Edward T. Uyeno","ptype":"article","src":"https://openalex.org/W2469996843","eid":"W2469996843"},{"id":"paper-w4205565988","cat":"papers","name":"Psychedelic vision","year":"2013","cit":1,"pfa":"Orit Halpern","ptype":"article","src":"https://openalex.org/W4205565988","eid":"W4205565988"},{"id":"paper-w4406314461","cat":"papers","name":"Psychedelic Atmospherics","year":"2025","cit":1,"pfa":"Alex K. Gearin","ptype":"article","src":"https://openalex.org/W4406314461","eid":"W4406314461"},{"id":"paper-w2889114949","cat":"papers","name":"The Psychedelic Furs","year":"2003","cit":1,"pfa":"Dave Thompson","ptype":"book","src":"https://openalex.org/W2889114949","eid":"W2889114949"},{"id":"paper-w4319344660","cat":"papers","name":"Willingness to participate in entheogen use research in naturalistic settings","year":"2023","cit":1,"pfa":"Riley D. Kirk","psa":"Stephen Dahmer","topics":["Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4319344660","eid":"W4319344660"},{"id":"paper-w2500954562","cat":"papers","name":"ANALYSIS OF HALLUCINOGENS BY MEANS OF PAVLOVIAN CONDITIONING","year":"1978","cit":1,"pfa":"Isidore Gormezano","psa":"John A. Harvey","ptype":"book-chapter","src":"https://openalex.org/W2500954562","eid":"W2500954562"},{"id":"paper-w3096341211","cat":"papers","name":"Screening/Spot/Colour test of hallucinogens","year":"2020","cit":1,"pfa":"A K Jaiswal","psa":"M Gupta","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3096341211","eid":"W3096341211"},{"id":"paper-w4387397524","cat":"papers","name":"Pharmacists and psychedelic medicine","year":"2023","cit":1,"pfa":"Kelan L. H. Thomas","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4387397524","eid":"W4387397524"},{"id":"paper-w4312945751","cat":"papers","name":"The Varieties of Psychedelic Law","year":"2022","cit":1,"pfa":"Mason Marks","ptype":"preprint","src":"https://openalex.org/W4312945751","eid":"W4312945751"},{"id":"paper-w4412848755","cat":"papers","name":"Becoming a Psychedelic User: Reflections on Howard Becker and the (Future) Sociology of Psychedelics","year":"2025","cit":1,"pfa":"Jarrett Robert Rose","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4412848755","eid":"W4412848755"},{"id":"paper-w377737240","cat":"papers","name":"Pharmacological Studies of hallucinogens, Report II","year":"1964","cit":1,"pfa":"Meitetsu MATSUOKA","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W377737240","eid":"W377737240"},{"id":"paper-w4362692475","cat":"papers","name":"Legal Limitations Associated with Microdosing Buprenorphine","year":"2023","cit":1,"pfa":"Barbara Andraka‐Christou","psa":"Natasha S. Mendoza","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"editorial","src":"https://openalex.org/W4362692475","eid":"W4362692475"},{"id":"paper-w4231967124","cat":"papers","name":"Humphry Osmond: The Psychedelic Psychiatrist","year":"2016","cit":1,"topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4231967124","eid":"W4231967124"},{"id":"paper-w2416552985","cat":"papers","name":"Metabolism of hallucinogens in brain and other tissues.","year":"1975","cit":1,"pfa":"Ho Bt","ptype":"article","src":"https://openalex.org/W2416552985","eid":"W2416552985"},{"id":"paper-w4380087750","cat":"papers","name":"Psychedelic New York","year":"2023","cit":1,"pfa":"Chris Elcock","ptype":"book","src":"https://openalex.org/W4380087750","eid":"W4380087750"},{"id":"paper-w2220133845","cat":"papers","name":"[Continuous microdoses of chloramadinone during lactation].","year":"1970","cit":1,"pfa":"C González","topics":["Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W2220133845","eid":"W2220133845"},{"id":"paper-w2896392545","cat":"papers","name":"Indole Hallucinogens Derived from Tryptophan","year":"1967","cit":1,"pfa":"Abram Hoffer","psa":"H Osmond","ptype":"book-chapter","src":"https://openalex.org/W2896392545","eid":"W2896392545"},{"id":"paper-w4245970180","cat":"papers","name":"The psychedelic plague and polypsychotropia","year":"1971","cit":1,"pfa":"Patrick T. Donlon","ptype":"article","src":"https://openalex.org/W4245970180","eid":"W4245970180"},{"id":"paper-w7165616676","cat":"papers","name":"Medical Complications of Psychedelics","year":"2026","cit":1,"pfa":"Franklin King","psa":"Theodore A. Stern","ptype":"article","src":"https://openalex.org/W7165616676","eid":"W7165616676"},{"id":"paper-w4384834745","cat":"papers","name":"Psychedelic New York","year":"2023","cit":1,"pfa":"Chris Elcock","ptype":"book","src":"https://openalex.org/W4384834745","eid":"W4384834745"},{"id":"paper-w4391942630","cat":"papers","name":"Empowerment at the Heart of Psychedelic Care","year":"2024","cit":1,"pfa":"Fanny Charrasse","psa":"Nicolas Marquis","topics":["Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W4391942630","eid":"W4391942630"},{"id":"paper-w4249104292","cat":"papers","name":"Psychedelic liquid crystals","year":"2003","cit":1,"ptype":"article","src":"https://openalex.org/W4249104292","eid":"W4249104292"},{"id":"paper-w2317158468","cat":"papers","name":"Book Review: The Botany and Chemistry of Hallucinogens","year":"1974","cit":1,"pfa":"Stanley S. Brown","topics":["Reviews & meta-analyses"],"ptype":"book-review","src":"https://openalex.org/W2317158468","eid":"W2317158468"},{"id":"paper-w4244267376","cat":"papers","name":"Psychedelics: Drugs in rehab","year":"2005","cit":1,"pfa":"Steven Kotler","ptype":"dataset","src":"https://openalex.org/W4244267376","eid":"W4244267376"},{"id":"paper-w4281696700","cat":"papers","name":"Psychedelics and Religious Experiences","year":"2022","cit":1,"pfa":"Patrick McNamara","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"book-chapter","src":"https://openalex.org/W4281696700","eid":"W4281696700"},{"id":"paper-w3092258780","cat":"papers","name":"Psychedelics and Mental Health","year":"2020","cit":1,"pfa":"Angelica Milla","ptype":"article","src":"https://openalex.org/W3092258780","eid":"W3092258780"},{"id":"paper-w4384855430","cat":"papers","name":"psychedelic, n. & adj.","year":"2023","cit":1,"ptype":"reference-entry","src":"https://openalex.org/W4384855430","eid":"W4384855430"},{"id":"paper-w3005202325","cat":"papers","name":"Phenomenology of psychedelic experiences","year":"2020","cit":1,"pfa":"Tom John Wolff","ptype":"book-chapter","src":"https://openalex.org/W3005202325","eid":"W3005202325"},{"id":"paper-w7161118969","cat":"papers","name":"Psychedelics: after the renaissance","year":"2026","cit":1,"pfa":"The Lancet","ptype":"article","src":"https://openalex.org/W7161118969","eid":"W7161118969"},{"id":"paper-w7160187508","cat":"papers","name":"Psychedelic Harm Reduction","year":"2026","cit":1,"topics":["Safety & adverse events"],"ptype":"book","src":"https://openalex.org/W7160187508","eid":"W7160187508"},{"id":"paper-w4415667709","cat":"papers","name":"Overmystifying the Psychedelic Experience","year":"2025","cit":1,"pfa":"Jack D. C. Dahan","psa":"Karel W.F. Scheepstra","ptype":"article","src":"https://openalex.org/W4415667709","eid":"W4415667709"},{"id":"paper-w4409180911","cat":"papers","name":"Deeper Learning with Psychedelics","year":"2024","cit":1,"pfa":"David J. Blacker","ptype":"book","src":"https://openalex.org/W4409180911","eid":"W4409180911"},{"id":"paper-w2978274411","cat":"papers","name":"The How and Why of Psychedelics","year":"2019","cit":1,"pfa":"Tony Jinks","ptype":"book-chapter","src":"https://openalex.org/W2978274411","eid":"W2978274411"},{"id":"paper-w2119196379","cat":"papers","name":"General, Applied, and Theoretical: Visionary Vine: Psychedelic Healing in the Peruvian Amazon. Marlene Dobkin de Rios. Flesh of the Gods: The Ritual Use of Hallucinogens. Peter T. Furst, ed","year":"1976","cit":1,"pfa":"Arthur J. Rubel","ptype":"article","src":"https://openalex.org/W2119196379","eid":"W2119196379"},{"id":"paper-w2521260884","cat":"papers","name":"2. The Psychedelic Revolution","year":"2016","cit":1,"pfa":"Douglas Osto","ptype":"book-chapter","src":"https://openalex.org/W2521260884","eid":"W2521260884"},{"id":"paper-w2158631644","cat":"papers","name":"A role for psychedelics in psychiatry?","year":"2005","cit":1,"pfa":"N. Crowley","ptype":"article","src":"https://openalex.org/W2158631644","eid":"W2158631644"},{"id":"paper-w122530030","cat":"papers","name":"Microdose: The New Drug Development Approach","year":"2012","cit":1,"pfa":"T.C. Perestrelo","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W122530030","eid":"W122530030"},{"id":"paper-w2501093119","cat":"papers","name":"Microdose GnRH for the Stimulation of Low Responders","year":"2003","cit":1,"pfa":"CAM Jansen","psa":"K.E. Tucker","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W2501093119","eid":"W2501093119"},{"id":"paper-w186487301","cat":"papers","name":"Evaluating the Therapeutic Utility of Hallucinogens for Substance Use Disorders","year":"2014","cit":1,"pfa":"Elias Dakwar","topics":["Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W186487301","eid":"W186487301"},{"id":"paper-w4392988239","cat":"papers","name":"Continuing History Of Psychedelics In Medical Practices: The Renaissance Of Psychedelic Medical Research","year":"2015","cit":1,"pfa":"Ben Sessa","ptype":"other","src":"https://openalex.org/W4392988239","eid":"W4392988239"},{"id":"paper-w2412598407","cat":"papers","name":"[Do hallucinogens cause chromosomal defects and abnormalities?].","year":"1973","cit":1,"pfa":"Paul Eberlé","ptype":"article","src":"https://openalex.org/W2412598407","eid":"W2412598407"},{"id":"paper-w4367834666","cat":"papers","name":"Marketing pitches of ‘magic mushrooms’ and ‘psychedelics’ mask that psychotomimetics use exposes those vulnerable to serious adverse effects","year":"2023","cit":1,"pfa":"Alain Braillon","psa":"Florian Naudet","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4367834666","eid":"W4367834666"},{"id":"paper-w2410914829","cat":"papers","name":"Autoradiographic Approaches to Studying Hallucinogens or Other Drugs","year":"1994","cit":1,"pfa":"N M Appel","topics":["Mechanism & neuroscience"],"ptype":"dataset","src":"https://openalex.org/W2410914829","eid":"W2410914829"},{"id":"paper-w197226115","cat":"papers","name":"The Use of the Genus Virola as a Hallucinogen In South America","year":"1999","cit":1,"pfa":"Miller","psa":"Randall G. Terry","ptype":"article","src":"https://openalex.org/W197226115","eid":"W197226115"},{"id":"paper-w1985625185","cat":"papers","name":"Indolamine Hallucinogens as Mao Inhibitor Agents–Theoretical Approach","year":"1983","cit":1,"pfa":"Yaacov Brandys","psa":"Shlomo Yehuda","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1985625185","eid":"W1985625185"},{"id":"paper-w4411245211","cat":"papers","name":"Microdosing: Knowledge Distillation for GAN Based Compression","year":"2021","cit":1,"pfa":"Leonhard Helminger","psa":"Christopher Schroers","topics":["Dosing & pharmacology"],"ptype":"conference-paper","src":"https://openalex.org/W4411245211","eid":"W4411245211"},{"id":"paper-w2079970958","cat":"papers","name":"ADOLESCENT TRANSITION AND THE USE OF HALLUCINOGENS: A SUBCULTURAL ANALYSIS","year":"1998","cit":1,"pfa":"Shelley G. MacDonald","psa":"Gary Winship","ptype":"article","src":"https://openalex.org/W2079970958","eid":"W2079970958"},{"id":"paper-w2325238226","cat":"papers","name":"Impact of Microdose Clinical Trials in the Preclinical Stage","year":"2014","cit":1,"pfa":"Soonih Kim","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2325238226","eid":"W2325238226"},{"id":"paper-w2243728794","cat":"papers","name":"[Use of hallucinogens by young people: psychosocial aspects].","year":"1969","cit":1,"pfa":"J. Robertson Unwin","ptype":"article","src":"https://openalex.org/W2243728794","eid":"W2243728794"},{"id":"paper-w2379137021","cat":"papers","name":"Concerning the Hallucinogens for Shamanic Ecstasy in Ancient China","year":"2005","cit":1,"pfa":"Jichao Wang","ptype":"article","src":"https://openalex.org/W2379137021","eid":"W2379137021"},{"id":"paper-w2064387295","cat":"papers","name":"Catnip and Related Psychedelic Compounds","year":"1969","cit":1,"pfa":"Vincent dePaul Lynch","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2064387295","eid":"W2064387295"},{"id":"paper-w4407936589","cat":"papers","name":"Public priorities in psychedelics research","year":"2025","cit":1,"pfa":"Maria Bălăeţ","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4407936589","eid":"W4407936589"},{"id":"paper-w4381191356","cat":"papers","name":"Unpicking the antidepressant actions of psychedelics","year":"2023","cit":1,"pfa":"Katherine M. Whalley","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4381191356","eid":"W4381191356"},{"id":"paper-w4241197718","cat":"papers","name":"Whatever happened to Psychedelic Research?","year":"1975","cit":1,"pfa":"Jules Asher","ptype":"dataset","src":"https://openalex.org/W4241197718","eid":"W4241197718"},{"id":"paper-w4406565829","cat":"papers","name":"Psychedelics and the Future Evolution of Humanity","year":"2025","cit":1,"pfa":"Michael Winkelman","ptype":"preprint","src":"https://openalex.org/W4406565829","eid":"W4406565829"},{"id":"paper-w4390014289","cat":"papers","name":"On the ambiguity of psychedelic awe in China","year":"2023","cit":1,"pfa":"Alex K. Gearin","topics":["Anxiety & end-of-life","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4390014289","eid":"W4390014289"},{"id":"paper-w4387972070","cat":"papers","name":"What is at stake in the psychedelic renaissance?","year":"2023","cit":1,"pfa":"Erika Dyck","ptype":"article","src":"https://openalex.org/W4387972070","eid":"W4387972070"},{"id":"paper-w1992402430","cat":"papers","name":"The Psychedelic Experience: High Adolescence","year":"1972","cit":1,"pfa":"John A. Chunko","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1992402430","eid":"W1992402430"},{"id":"paper-w7134963603","cat":"papers","name":"Advancing the Field of Psychedelic Epidemiology","year":"2026","cit":1,"pfa":"Otto Simonsson","psa":"David B. Yaden","ptype":"article","src":"https://openalex.org/W7134963603","eid":"W7134963603"},{"id":"paper-w2773631280","cat":"papers","name":"[Classic psychedelic drugs and their potential therapeutic effect].","year":"2017","cit":1,"pfa":"Michael Bayat","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2773631280","eid":"W2773631280"},{"id":"paper-w2336960643","cat":"papers","name":"5. Microdose Clinical Study for Drug Development","year":"2009","cit":1,"pfa":"Kazuya Maeda","psa":"Yuichi Sugiyama","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2336960643","eid":"W2336960643"},{"id":"paper-w2505284120","cat":"papers","name":"The Varieties of Psychedelic Lab Experience","year":"2012","cit":1,"pfa":"Nicolas Langlitz","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W2505284120","eid":"W2505284120"},{"id":"paper-w7126171657","cat":"papers","name":"Psychedelics for the management of symptoms of traumatic brain injury: Findings from the global psychedelic survey","year":"2026","cit":1,"pfa":"Baeleigh VanderZwaag","psa":"Philippe Lucas","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W7126171657","eid":"W7126171657"},{"id":"paper-w2076642413","cat":"papers","name":"Utility of a microdose study for drug discovery and development","year":"2013","cit":1,"pfa":"Yoshiyuki Yamaura","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2076642413","eid":"W2076642413"},{"id":"paper-w4394932105","cat":"papers","name":"3D Microfluidic Channel Development for a Microdosing System","year":"2024","cit":1,"pfa":"Ana C. Romo-Cardenas","psa":"Faruk Fonthal","topics":["Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4394932105","eid":"W4394932105"},{"id":"paper-w7128374616","cat":"papers","name":"Exploring the interface of meditation and psychedelics: A qualitative analysis of experienced practitioners’ perspectives on psychedelic preparation","year":"2026","cit":1,"pfa":"Mia Riedel","psa":"Matthew D. Sacchet","topics":["Safety & adverse events","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7128374616","eid":"W7128374616"},{"id":"paper-w4396232056","cat":"papers","name":"A media ecology perspective on psychedelics","year":"2024","cit":1,"pfa":"Ido Hartogsohn","ptype":"article","src":"https://openalex.org/W4396232056","eid":"W4396232056"},{"id":"paper-w4376646569","cat":"papers","name":"Psychedelics for treating chronic pain","year":"2023","cit":1,"pfa":"Alaa A Abd-Elsayed","psa":"Christopher J. Gilligan","ptype":"article","src":"https://openalex.org/W4376646569","eid":"W4376646569"},{"id":"paper-w2098708284","cat":"papers","name":"The Long-Term Effects of Psychedelics","year":"1968","cit":1,"pfa":"Wilson Van Dusen","psa":"Ralph Metzner","ptype":"article","src":"https://openalex.org/W2098708284","eid":"W2098708284"},{"id":"paper-w4406325533","cat":"papers","name":"Psychedelic Ethics Beside Institutions","year":"2025","cit":1,"pfa":"Kai River Blevins","topics":["Safety & adverse events","Policy & ethics"],"ptype":"editorial","src":"https://openalex.org/W4406325533","eid":"W4406325533"},{"id":"paper-w2894883791","cat":"papers","name":"Psychedelics and the media in the Visegrad countries","year":"2018","cit":1,"pfa":"Orsolya Feher","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2894883791","eid":"W2894883791"},{"id":"paper-w2292881999","cat":"papers","name":"Psychedelic Drug Use by Adolescents","year":"1968","cit":1,"pfa":"Burt Shachter","ptype":"article","src":"https://openalex.org/W2292881999","eid":"W2292881999"},{"id":"paper-w2913940472","cat":"papers","name":"Medical Possibilities for Psychedelic Drugs","year":"1995","cit":1,"pfa":"Paula Kurtzweil","ptype":"dataset","src":"https://openalex.org/W2913940472","eid":"W2913940472"},{"id":"paper-w4415242203","cat":"papers","name":"The promise of psychedelic medicine in psychiatry","year":"2025","cit":1,"pfa":"Natalie Healey","ptype":"other","src":"https://openalex.org/W4415242203","eid":"W4415242203"},{"id":"paper-w4230097096","cat":"papers","name":"Research on psychedelics makes a comeback","year":"2010","cit":1,"pfa":"A. Novotney","ptype":"dataset","src":"https://openalex.org/W4230097096","eid":"W4230097096"},{"id":"paper-w3034895927","cat":"papers","name":"Psychedelic Unselfing and Moral Perception : A Philosophical Account of the Change of Values Induced by Psychedelic Experiences","year":"2020","cit":1,"pfa":"Juuso Kähönen","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3034895927","eid":"W3034895927"},{"id":"paper-w2415073973","cat":"papers","name":"The influence of anticholinergic hallucinogens on spontaneous and conditioned behaviour in rats.","year":"1971","cit":1,"pfa":"J Kabeš","psa":"Z Fink","ptype":"article","src":"https://openalex.org/W2415073973","eid":"W2415073973"},{"id":"paper-w2188464364","cat":"papers","name":"Datura Metel L: Analgesic or Hallucinogen? \"Sharo\" Pespective","year":"2014","cit":1,"pfa":"Babalola Samuel Adeola","psa":"Michael Obinna Okpara","ptype":"article","src":"https://openalex.org/W2188464364","eid":"W2188464364"},{"id":"paper-w4285302559","cat":"papers","name":"A Cultural History of Psychedelics in the US","year":"2022","cit":1,"pfa":"Kyle Buller","psa":"Lenny Gibson","ptype":"book-chapter","src":"https://openalex.org/W4285302559","eid":"W4285302559"},{"id":"paper-w2028749357","cat":"papers","name":"PSYCHEDELICS: A TEST CASE FOR THE LIBERTARIAN","year":"1981","cit":1,"pfa":"E. J. Mishan","ptype":"article","src":"https://openalex.org/W2028749357","eid":"W2028749357"},{"id":"paper-w4405425063","cat":"papers","name":"Psychosomadelics: The case for renaming psychedelics","year":"2024","cit":1,"pfa":"Felix Scholkmann","psa":"Peter Sjöstedt-Hughes","topics":["Addiction"],"ptype":"preprint","src":"https://openalex.org/W4405425063","eid":"W4405425063"},{"id":"paper-w7117980054","cat":"papers","name":"Theories of Psychedelic Drug Use","year":"2025","cit":1,"pfa":"Richard G. Alexander","ptype":"book-chapter","src":"https://openalex.org/W7117980054","eid":"W7117980054"},{"id":"paper-w2410112629","cat":"papers","name":"[Result of the application of microdoses of gamma-rays in the breeding of birds].","year":"1960","cit":1,"pfa":"I G KOSTIN","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2410112629","eid":"W2410112629"},{"id":"paper-w2418646010","cat":"papers","name":"[Anomalies of the waking state under the effect of psychodysleptics (hallucinogens)].","year":"1969","cit":1,"pfa":"Arlette Rougeul","ptype":"article","src":"https://openalex.org/W2418646010","eid":"W2418646010"},{"id":"paper-w2422565952","cat":"papers","name":"History of the Psychedelic Drug Experience","year":"1968","cit":1,"pfa":"Winston Mahabir","ptype":"article","src":"https://openalex.org/W2422565952","eid":"W2422565952"},{"id":"paper-w4415116672","cat":"papers","name":"Psychedelic Mystical Experiences Are Authentic","year":"2025","cit":1,"pfa":"Hans Van Eyghen","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4415116672","eid":"W4415116672"},{"id":"paper-w4401216584","cat":"papers","name":"Psychedelic Christianity: Commentary and reply","year":"2024","cit":1,"pfa":"Michael Winkelman","psa":"Hunt Priest","ptype":"article","src":"https://openalex.org/W4401216584","eid":"W4401216584"},{"id":"paper-w4416861172","cat":"papers","name":"Psychedelic research – Going global","year":"2025","cit":1,"pfa":"David J. Heal","psa":"Jack E. Henningfield","topics":["Dosing & pharmacology","Reviews & meta-analyses","Policy & ethics"],"ptype":"editorial","src":"https://openalex.org/W4416861172","eid":"W4416861172"},{"id":"paper-w1988462250","cat":"papers","name":"Nanoscale psychedelics produced by ferrofluids","year":"2012","cit":1,"pfa":"Jacob Aron","ptype":"article","src":"https://openalex.org/W1988462250","eid":"W1988462250"},{"id":"paper-w4406358237","cat":"papers","name":"Intersections with Indigeneity in Psychedelic Buddhism","year":"2025","cit":1,"pfa":"Colin H. Simonds","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4406358237","eid":"W4406358237"},{"id":"paper-w3195763756","cat":"papers","name":"Drug Addictions, Hallucinogens and Shamanism: the View from Anthropology","year":"2001","cit":1,"pfa":"Tim Batchelder","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W3195763756","eid":"W3195763756"},{"id":"paper-w4405105135","cat":"papers","name":"Locomotor and discriminative stimulus effects of NBOH hallucinogens in rodents","year":"2024","cit":1,"pfa":"Daaniyal D. Munir","psa":"Michael J. Forster","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4405105135","eid":"W4405105135"},{"id":"paper-w2602674072","cat":"papers","name":"The serotonin-like actions of some hallucinogens on a molluscan heart","year":"1973","cit":1,"pfa":"John H. Welsh","psa":"Lois D. Arnold","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2602674072","eid":"W2602674072"},{"id":"paper-w7125903910","cat":"papers","name":"Understanding Symptom Modulating Factors of Post-Psychedelic Complications Following the Use of Classic Psychedelics or Entactogens.","year":"2026","cit":1,"pfa":"Bente Lubahn","psa":"Tomislav Majić","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7125903910","eid":"W7125903910"},{"id":"paper-w4415703427","cat":"papers","name":"Psychedelics as Non-Specific Amplifiers","year":"2025","cit":1,"pfa":"Anastasia Ruban","psa":"Michiel van Elk","topics":["Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4415703427","eid":"W4415703427"},{"id":"paper-w4403275107","cat":"papers","name":"Microdosing Odors in Virtual Reality for Psychophysiological Stress Training","year":"2024","cit":1,"pfa":"Daniel Anheuer","psa":"Cornelia Küsel","topics":["Safety & adverse events","Dosing & pharmacology","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4403275107","eid":"W4403275107"},{"id":"paper-w4210583398","cat":"papers","name":"Evaluation of Entheogens Used in Shamanic Rituals in the Concept of History of Medicine: Traditional Review","year":"2022","cit":1,"pfa":"İlkim KARAKAPICI","psa":"Müge Demir","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4210583398","eid":"W4210583398"},{"id":"paper-w4406324617","cat":"papers","name":"Identity-Based Decisional Capacity and Psychedelic Treatments: Furthering the Case Against Psychedelic Ethical Exceptionalism","year":"2025","cit":1,"pfa":"Shen Pan","psa":"David S. Wendler","topics":["Addiction","Policy & ethics"],"ptype":"editorial","src":"https://openalex.org/W4406324617","eid":"W4406324617"},{"id":"paper-w4231167018","cat":"papers","name":"SEROTONERGIC RECEPTOR SUBTYPES AND HALLUCINOGEN-INDUCED STIMULUS CONTROL","year":"1998","cit":1,"pfa":"Jerrold C. Winter","psa":"R.A. Rabin","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4231167018","eid":"W4231167018"},{"id":"paper-w3101150220","cat":"papers","name":"STATE-DEPENDENT LEARNING (DISSOCIATION OF LEARNING) WITH HALLUCINOGENS IN RATS","year":"1973","cit":1,"pfa":"Katsushi Yamada","psa":"Showa Ueki","ptype":"article","src":"https://openalex.org/W3101150220","eid":"W3101150220"},{"id":"paper-w1557329164","cat":"papers","name":"Deceptive argumentation against diagnostic microdosing of anticancer drugs","year":"2014","cit":1,"pfa":"Dirk Theile","psa":"Gerd Mikus","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1557329164","eid":"W1557329164"},{"id":"paper-w4407182767","cat":"papers","name":"Sleep-administered ketamine/psychedelics: A streamlined strategy to address two challenges in research on ketamine and psychedelics","year":"2025","cit":1,"pfa":"Shokouh Arjmand","psa":"Gregers Wegener","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4407182767","eid":"W4407182767"},{"id":"paper-w1256068780","cat":"papers","name":"[Microdose clinical trial--impact of PET molecular imaging].","year":"2010","cit":1,"pfa":"Tsuneo Yano","psa":"Yasuyoshi Watanabe","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W1256068780","eid":"W1256068780"},{"id":"paper-w3189235389","cat":"papers","name":"Probing the Future of Psychedelics for Mental Health","year":"2021","cit":1,"pfa":"Summer E. Allen","ptype":"article","src":"https://openalex.org/W3189235389","eid":"W3189235389"},{"id":"paper-w2417620549","cat":"papers","name":"[Hallucinogens used by Indians of the Amazone Basin and upper Orinoco].","year":"1965","cit":1,"pfa":"Marini-Bettòlo Gb","psa":"Montalvo Eg","ptype":"article","src":"https://openalex.org/W2417620549","eid":"W2417620549"},{"id":"paper-w4242751358","cat":"papers","name":"SEROTONERGIC RECEPTOR SUBTYPES AND HALLUCINOGEN-INDUCED STIMULUS CONTROL","year":"1998","cit":1,"pfa":"Jerrold C. Winter","psa":"R.A. Rabin","topics":["Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W4242751358","eid":"W4242751358"},{"id":"paper-w1995580459","cat":"papers","name":"Ketamine Use in a Burn Center: Hallucinogen or Debridement Facilitator?","year":"1986","cit":1,"pfa":"Suzanne E. Martinez","psa":"Marlene Dobkin de Ríos","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W1995580459","eid":"W1995580459"},{"id":"paper-w4386686220","cat":"papers","name":"Psychedelic Treatment of Disruptive Personality Patterns","year":"2019","cit":1,"pfa":"Petr Winkler","psa":"Rita Kočárová","ptype":"other","src":"https://openalex.org/W4386686220","eid":"W4386686220"},{"id":"paper-w4401179160","cat":"papers","name":"Considering Alternatives to Prohibiting Psychedelic Drugs","year":"2024","cit":1,"pfa":"Priest, Michelle","psa":"Ramchand, Rajeev","topics":["Addiction","Policy & ethics"],"ptype":"book","src":"https://openalex.org/W4401179160","eid":"W4401179160"},{"id":"paper-w7118684792","cat":"papers","name":"Psychedelic Drugs Rediscovered—In Silico Study of Potential Fetal Exposure to Analogues of Psychedelic Drugs During Pregnancy","year":"2026","cit":1,"pfa":"Anna W. Sobańska","psa":"Elżbieta Brzezińska","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7118684792","eid":"W7118684792"},{"id":"paper-w63646277","cat":"papers","name":"Microdosing: Pharmacokinetic and Metabolism Data Early in the Drug Development Process","year":"2011","cit":1,"pfa":"Graham Lappin","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W63646277","eid":"W63646277"},{"id":"paper-w4409242788","cat":"papers","name":"Psychedelics Move Toward Mainstream Medicine","year":"2025","cit":1,"pfa":"Charles B. Nemeroff","psa":"Gregory A. Fonzo","ptype":"article","src":"https://openalex.org/W4409242788","eid":"W4409242788"},{"id":"paper-w4404622884","cat":"papers","name":"Psychedelics' Uncertain Risks: A Reply to Myran et al.","year":"2024","cit":1,"pfa":"Haley Maria Dourron","psa":"Peter S. Hendricks","topics":["Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4404622884","eid":"W4404622884"},{"id":"paper-w4230015584","cat":"papers","name":"Intratumoral Microdosing of TAK-981 in Head and Neck Cancer","year":"2019","cit":1,"topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4230015584","eid":"W4230015584"},{"id":"paper-w3137547746","cat":"papers","name":"Cognition Enhancers, Psychostimulants, and Psychedelic Drugs","year":"2021","cit":1,"pfa":"Vimala Ananthy","ptype":"book-chapter","src":"https://openalex.org/W3137547746","eid":"W3137547746"},{"id":"paper-w4391818433","cat":"papers","name":"Validation of the Imperial Psychedelic Predictor Scale","year":"2024","cit":1,"pfa":"Michael Angyus","psa":"Robin Lester Carhart-Harris","topics":["Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4391818433","eid":"W4391818433"},{"id":"paper-w2014558299","cat":"papers","name":"Psychedelic sciences writ small and large","year":"2013","cit":1,"pfa":"Michelle Corbin","ptype":"article","src":"https://openalex.org/W2014558299","eid":"W2014558299"},{"id":"paper-w136657716","cat":"papers","name":"Artificial Paradises: Baudelaire and the Psychedelic Experience","year":"2016","cit":1,"pfa":"Catherine B. Osborn","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W136657716","eid":"W136657716"},{"id":"paper-w4412090611","cat":"papers","name":"The Ethics of Set and Setting in Psychedelic Psychotherapy","year":"2025","cit":1,"pfa":"Kyle Patch","psa":"William Smith","topics":["Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4412090611","eid":"W4412090611"},{"id":"paper-w2159159435","cat":"papers","name":"Better Outcomes Using Microdose of Recombinant Human Chrorionic Gonadotropin (r-hCG Microdose) to Support Ovarian Folliculogenesis in Good Prognosis Patients","year":"2005","cit":1,"pfa":"Edson Borges","psa":"Assumpto Iaconelli","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2159159435","eid":"W2159159435"},{"id":"paper-w4293373959","cat":"papers","name":"The Link Between Marijuana and Hallucinogen Use Among US Adolescents","year":"2022","cit":1,"pfa":"Saral R. Desai","psa":"Adela Gerolemou","ptype":"article","src":"https://openalex.org/W4293373959","eid":"W4293373959"},{"id":"paper-w4412149443","cat":"papers","name":"The promises and perils of the psychedelic turn in psychiatry","year":"2025","cit":1,"pfa":"Elly Vintiadis","ptype":"editorial","src":"https://openalex.org/W4412149443","eid":"W4412149443"},{"id":"paper-w3082421314","cat":"papers","name":"Are Psychedelics Something New in Teaching Psychopharmacology?","year":"2020","cit":1,"pfa":"Alan K. Louie","psa":"Adam M. Brenner","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3082421314","eid":"W3082421314"},{"id":"paper-w4407230150","cat":"papers","name":"Social Worker Attitudes towards Psychedelics","year":"2025","cit":1,"pfa":"Eva Nowakowski-Sims","psa":"Joshua Holzworth","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4407230150","eid":"W4407230150"},{"id":"paper-w2254040331","cat":"papers","name":"Pituitary-Adrenal Responsiveness During Microdose Norethindrone Therapy","year":"1972","cit":1,"pfa":"R. Nuran Turksoy","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2254040331","eid":"W2254040331"},{"id":"paper-w4396521782","cat":"papers","name":"Psychedelics in medicine - a call for educational action","year":"2024","cit":1,"pfa":"Daniel Shane","psa":"Sabrina Akhtar","ptype":"article","src":"https://openalex.org/W4396521782","eid":"W4396521782"},{"id":"paper-w4234543403","cat":"papers","name":"Psychedelic, Baby: An Interview with Pipilotti Rist","year":"2000","cit":1,"pfa":"Jane Harris","ptype":"article","src":"https://openalex.org/W4234543403","eid":"W4234543403"},{"id":"paper-w4402897700","cat":"papers","name":"What Ceremony Does to Psychedelics: On the Importance of Applying Integrated Theories of Ritual Value Generation to Psychedelic Studies","year":"2024","cit":1,"pfa":"Mark Juhan Schunemann","topics":["Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4402897700","eid":"W4402897700"},{"id":"paper-w4392988260","cat":"papers","name":"Psychedelics As a Practice of Truth: A Foucauldian Argument","year":"2015","cit":1,"pfa":"Pieter Stokkink","ptype":"other","src":"https://openalex.org/W4392988260","eid":"W4392988260"},{"id":"paper-w4414402578","cat":"papers","name":"Intersections of Psychedelics, Mystical Experiences, and Hypnosis","year":"2025","cit":1,"pfa":"Gary R. Elkins","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4414402578","eid":"W4414402578"},{"id":"paper-w2563816003","cat":"papers","name":"Can Science Validate the Psychedelic Experience","year":"2007","cit":1,"pfa":"C. W. Hayes","ptype":"article","src":"https://openalex.org/W2563816003","eid":"W2563816003"},{"id":"paper-w4403649650","cat":"papers","name":"Suggestions effects in psychedelics: Confounds and opportunities","year":"2024","cit":1,"pfa":"Madeline Victore Stein","psa":"Devin Blair Terhune","topics":["Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4403649650","eid":"W4403649650"},{"id":"paper-w7127945671","cat":"papers","name":"Toward Greater Diversity in Psychedelic Science","year":"2026","cit":1,"pfa":"Marcus Hughes","ptype":"article","src":"https://openalex.org/W7127945671","eid":"W7127945671"},{"id":"paper-w4411917730","cat":"papers","name":"The Psychedelic Media Exposure Questionnaire: The development and validation of a new scale assessing psychedelic-related media exposure","year":"2025","cit":1,"pfa":"Andrea W.M. Evers","psa":"Boris Dov Heifets","topics":["Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4411917730","eid":"W4411917730"},{"id":"paper-w4406168681","cat":"papers","name":"Could psychedelics be useful in the treatment of patients with personality disorder? A case report of psychotherapy with concomitant use of psychedelics","year":"2025","cit":1,"pfa":"Martin Blay","psa":"Mario Speranza","topics":["Depression","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4406168681","eid":"W4406168681"},{"id":"paper-w4383823314","cat":"papers","name":"A new mechanism of psychedelic action in mice","year":"2023","cit":1,"pfa":"Ioannis Bakoyiannis","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4383823314","eid":"W4383823314"},{"id":"paper-w4365792721","cat":"papers","name":"Integrating Psychedelic Experiences Through Touch","year":"2022","cit":1,"pfa":"James Salomons","ptype":"article","src":"https://openalex.org/W4365792721","eid":"W4365792721"},{"id":"paper-w2081604338","cat":"papers","name":"The Psychedelic Environment: A New Psychological Phenomonon*","year":"1969","cit":1,"pfa":"John L. Haer","ptype":"article","src":"https://openalex.org/W2081604338","eid":"W2081604338"},{"id":"paper-w4386441034","cat":"papers","name":"Psychedelics reopening windows of development in mice","year":"2023","cit":1,"pfa":"Antonia Eisenkoeck","ptype":"article","src":"https://openalex.org/W4386441034","eid":"W4386441034"},{"id":"paper-w2113132087","cat":"papers","name":"TPT NOTES: The Psychedelic Student-Getter","year":"1969","cit":1,"pfa":"William R. Franklin","ptype":"article","src":"https://openalex.org/W2113132087","eid":"W2113132087"},{"id":"paper-w7128428910","cat":"papers","name":"Predicting Nurses’ Views on Decriminalization of Psychedelics","year":"2025","cit":1,"pfa":"Carolyn M. Porta","psa":"Caroline G. Dorsen","topics":["Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7128428910","eid":"W7128428910"},{"id":"paper-w4412634367","cat":"papers","name":"Characterising the clinical associations of hallucinogen persisting perceptual disorder: a retrospective cohort study","year":"2025","cit":1,"pfa":"Matthew Butler","psa":"Thomas Arthur Pollak","ptype":"preprint","src":"https://openalex.org/W4412634367","eid":"W4412634367"},{"id":"paper-w2405786045","cat":"papers","name":"[Experimental psychoses induced by sleep deprivation and hallucinogens in abstaining alcoholics].","year":"1969","cit":1,"pfa":"M Vojtĕchovský","psa":"V Hort","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2405786045","eid":"W2405786045"},{"id":"paper-w2009979225","cat":"papers","name":"DFT-based QSAR and Action Mechanism of Phenylalkylamine and Tryptamine Hallucinogens","year":"2011","cit":1,"pfa":"Shaofei Zhang","psa":"Suli Cheng","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2009979225","eid":"W2009979225"},{"id":"paper-w2123486664","cat":"papers","name":"Why to use subarachnoid microdoses of morphine chlor. In cancer pain","year":"1984","cit":1,"pfa":"Matossi R.M. LʼOrsa","psa":"M Delpero","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2123486664","eid":"W2123486664"},{"id":"paper-w2591019472","cat":"papers","name":"A phase 0 microdosing trial to identify chemoresistance in bladder cancer.","year":"2011","cit":1,"pfa":"Chong-xian Pan","psa":"Paul T. Henderson","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W2591019472","eid":"W2591019472"},{"id":"paper-w4320035662","cat":"papers","name":"Reconsidering Context in Psychedelic Research: Rituals as Ancient Libraries of Knowledge","year":"2023","cit":1,"pfa":"Heather Lutz","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4320035662","eid":"W4320035662"},{"id":"paper-w4411181627","cat":"papers","name":"Considerations on the Construction, Timing, and Consequences of the Psychedelic Renaissance","year":"2025","cit":1,"pfa":"Cindy Brooks Dollar","ptype":"article","src":"https://openalex.org/W4411181627","eid":"W4411181627"},{"id":"paper-w7162809350","cat":"papers","name":"A landscape analysis of psychedelic facilitation training in the US","year":"2026","cit":1,"pfa":"Roman Palitsky","psa":"Gosia Sklodowska","topics":["Anxiety & end-of-life","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7162809350","eid":"W7162809350"},{"id":"paper-w2169706278","cat":"papers","name":"Reply of the Authors: Microdose flare versus antagonist for poor responders","year":"2010","cit":1,"pfa":"Aygül Demi̇rol","psa":"Timur Gürgan","topics":["Dosing & pharmacology"],"ptype":"letter","src":"https://openalex.org/W2169706278","eid":"W2169706278"},{"id":"paper-w4281793970","cat":"papers","name":"Ketamine Psychedelic and Antinociceptive Effects Are Connected: Erratum","year":"2022","cit":1,"ptype":"erratum","src":"https://openalex.org/W4281793970","eid":"W4281793970"},{"id":"paper-w4390059279","cat":"papers","name":"Psychedelic Healing: A Historical, Empirical, and Personal Account","year":"2023","cit":1,"pfa":"Robert Swoap","ptype":"article","src":"https://openalex.org/W4390059279","eid":"W4390059279"},{"id":"paper-w3111614812","cat":"papers","name":"Psychedelics re-engineered for potential use in the clinic","year":"2020","cit":1,"pfa":"Gabriela Manzano-Nieves","psa":"Conor M. Liston","ptype":"article","src":"https://openalex.org/W3111614812","eid":"W3111614812"},{"id":"paper-w4396795576","cat":"papers","name":"Psychedelic Medicine Is Coming. The Law Isn't Ready","year":"2019","cit":1,"pfa":"Matt Lamkin","ptype":"article","src":"https://openalex.org/W4396795576","eid":"W4396795576"},{"id":"paper-w4391123086","cat":"papers","name":"As Psychedelic Research Advances, Can Youth Benefit?","year":"2024","cit":1,"pfa":"Katie O’Connor","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4391123086","eid":"W4391123086"},{"id":"paper-w4393118247","cat":"papers","name":"FDA gives breakthrough designation for psychedelic treatment","year":"2024","cit":1,"pfa":"Valerie A. Canady","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4393118247","eid":"W4393118247"},{"id":"paper-w3203226628","cat":"papers","name":"Psychedelic Therapeutic: Potential Treatment for Headache Disorders","year":"2021","cit":1,"pfa":"Robert B. Kargbo","topics":["Mechanism & neuroscience"],"ptype":"editorial","src":"https://openalex.org/W3203226628","eid":"W3203226628"},{"id":"paper-w4409117745","cat":"papers","name":"Webbed Attachments: Psychedelic Lessons from the Multiverse","year":"2025","cit":1,"pfa":"Ramzi Fawaz","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4409117745","eid":"W4409117745"},{"id":"paper-w4294018087","cat":"papers","name":"Exploring Psychedelics and Entactogens as Treatments for Psychiatric Disorders","year":"2022","cit":1,"pfa":"Forum on Neuroscience and Nervous System Disorders","psa":"National Academies of Sciences, Engineering, and Medicine","ptype":"book","src":"https://openalex.org/W4294018087","eid":"W4294018087"},{"id":"paper-w4404600785","cat":"papers","name":"Correction: Neural mechanisms of psychedelic visual imagery","year":"2024","cit":1,"pfa":"Devon Stoliker","psa":"Adeel Razi","topics":["Mechanism & neuroscience"],"ptype":"erratum","src":"https://openalex.org/W4404600785","eid":"W4404600785"},{"id":"paper-w4414329824","cat":"papers","name":"Psychedelic Integration and Spiritual Growth in a Christian Context","year":"2025","cit":1,"pfa":"Ron Cole‐Turner","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4414329824","eid":"W4414329824"},{"id":"paper-w3003761233","cat":"papers","name":"Psychedelic mysteries of the feminine: Creativity, ecstasy, healing","year":"2019","cit":1,"pfa":"Maria Papaspyrou","psa":"David P. Luke","ptype":"article","src":"https://openalex.org/W3003761233","eid":"W3003761233"},{"id":"paper-w2417004481","cat":"papers","name":"[Problem of microdoses in chemistry and biology (growth substances as activators of catalytic systems].","year":"2004","cit":1,"pfa":"Zubovich Ia","psa":"N I KOBOZEV","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2417004481","eid":"W2417004481"},{"id":"paper-w1486166366","cat":"papers","name":"Communicating the Unspeakable: Linguistic Phenomena in the Psychedelic Sphere","year":"2011","cit":1,"pfa":"Diana Reed Slattery","topics":["Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W1486166366","eid":"W1486166366"},{"id":"paper-w4405614242","cat":"papers","name":"Can psychedelics improve well-being in autism?","year":"2024","cit":1,"pfa":"Rachel Nuwer","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4405614242","eid":"W4405614242"},{"id":"paper-w2904796010","cat":"papers","name":"The culture(s) of narcissism: simultaneity and the psychedelic sixties","year":"2018","cit":1,"pfa":"Justin Lorentzen","ptype":"book-chapter","src":"https://openalex.org/W2904796010","eid":"W2904796010"},{"id":"paper-w4408724359","cat":"papers","name":"Current U.S. Approaches to Studying Psychedelic Medicines Compared to Psychedelics Use Among Indigenous Groups: What Are We Missing?","year":"2025","cit":1,"pfa":"Michael A. Cirillo","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4408724359","eid":"W4408724359"},{"id":"paper-w4298143042","cat":"papers","name":"The next bet for cerebral aneurysms treatment: Psychedelics","year":"2022","cit":1,"pfa":"Mustafa Ismail","psa":"Norberto O. Andaluz","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4298143042","eid":"W4298143042"},{"id":"paper-w4390402630","cat":"papers","name":"Psychedemia: Charting the future of interdisciplinary Psychedelic Studies","year":"2023","cit":1,"pfa":"Neşe Devenot","psa":"Alan K. Davis","topics":["Dosing & pharmacology","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4390402630","eid":"W4390402630"},{"id":"paper-w7139992084","cat":"papers","name":"An Existential Approach to Integrating Challenging Psychedelic Experiences","year":"2023","cit":1,"pfa":"Andrew Carnahan","topics":["Anxiety & end-of-life","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7139992084","eid":"W7139992084"},{"id":"paper-w2953754683","cat":"papers","name":"Psychedelics As A New Anti‐Inflammatory Therapeutic For Atherosclerosis","year":"2017","cit":1,"pfa":"Charles David Nichols","psa":"Thomas Wayne Flanagan","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2953754683","eid":"W2953754683"},{"id":"paper-w3097556944","cat":"papers","name":"Corrigendum: Psychedelics as a Treatment for Alzheimer's Disease Dementia","year":"2020","cit":1,"pfa":"Simon Jones","psa":"Allison O’Kelly","ptype":"erratum","src":"https://openalex.org/W3097556944","eid":"W3097556944"},{"id":"paper-w2616585552","cat":"papers","name":"Psychedelics and the Spiritual Path – critical voices and considerations","year":"2016","cit":1,"pfa":"Elliot David Cohen","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2616585552","eid":"W2616585552"},{"id":"paper-w3042225060","cat":"papers","name":"Psychedelics; Intention and attitude amongst the general public","year":"2020","cit":1,"pfa":"Karan Karthik Raju","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W3042225060","eid":"W3042225060"},{"id":"paper-w4415956909","cat":"papers","name":"Can psychedelic experiences induce religious credences?","year":"2025","cit":1,"pfa":"Michiel van Elk","ptype":"editorial","src":"https://openalex.org/W4415956909","eid":"W4415956909"},{"id":"paper-w4398213931","cat":"papers","name":"How Psychedelics Can Increase Moral Concern","year":"2024","cit":1,"pfa":"Danica Dillion","psa":"Kurt J. Gray","topics":["Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W4398213931","eid":"W4398213931"},{"id":"paper-w45794279","cat":"papers","name":"SIMILAR EFFECTS OF INDOLEAMINE AND PHENYLETHYLAMINE HALLUCINOGENS ON DORSAL AND MEDIAN RAPHE NEURONS","year":"1979","cit":1,"pfa":"Mark A. Geyer","psa":"Arnold J. Mandell","ptype":"book-chapter","src":"https://openalex.org/W45794279","eid":"W45794279"},{"id":"paper-w2137957230","cat":"papers","name":"Women with small ovarian volume and microdose GnRH agonist protocol","year":"2001","cit":1,"pfa":"Nahed Hammadieh","psa":"B. Ola","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2137957230","eid":"W2137957230"},{"id":"paper-w4412109728","cat":"papers","name":"Electrophysiological Mechanisms of Psychedelic Drugs: A Systematic Review","year":"2025","cit":1,"pfa":"Javier Hidalgo Jiménez","psa":"Jaan Aru","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4412109728","eid":"W4412109728"},{"id":"paper-w4299306439","cat":"papers","name":"Quantitative structure activity relationships of analgesics, narcotic antagonists, and hallucinogens: introduction.","year":"1978","cit":1,"ptype":"article","src":"https://openalex.org/W4299306439","eid":"W4299306439"},{"id":"paper-w4409716539","cat":"papers","name":"Psychedelic Affective Maps for New Ecological Futures","year":"2025","cit":1,"pfa":"Lana Cook","ptype":"article","src":"https://openalex.org/W4409716539","eid":"W4409716539"},{"id":"paper-w4214809928","cat":"papers","name":"A Long Trip into the Universe: Psychedelics and Space Travel","year":"2022","cit":1,"pfa":"Leonard B. Lerer","psa":"Jeet Chandrakant Varia","ptype":"preprint","src":"https://openalex.org/W4214809928","eid":"W4214809928"},{"id":"paper-w3080091993","cat":"papers","name":"[Effectivity of psychedelics in the treatment of psychiatric disorders; introduction].","year":"2020","cit":1,"pfa":"Willem Johan van den Brink","psa":"Joost J. Breeksema","ptype":"article","src":"https://openalex.org/W3080091993","eid":"W3080091993"},{"id":"paper-w4391117128","cat":"papers","name":"Buprenorphine Induction Using Microdosing for the Management of Opioid Use Disorder in Pregnancy","year":"2024","cit":1,"pfa":"Neil B. Patel","psa":"Barbara V. Parilla","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4391117128","eid":"W4391117128"},{"id":"paper-w4411921790","cat":"papers","name":"Health-related behavioral changes following the use of psychedelics in naturalistic settings","year":"2025","cit":1,"pfa":"Pedro J. Teixeira","psa":"Charles L. Raison","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4411921790","eid":"W4411921790"},{"id":"paper-w4416274681","cat":"papers","name":"A Descriptive Study of Hallucinogen and Inhalant Detoxification Admissions From 2006 to 2022","year":"2025","cit":1,"pfa":"Gail S. Geiger","psa":"Orrin D. Ware","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4416274681","eid":"W4416274681"},{"id":"paper-w4401979559","cat":"papers","name":"Phase 0 trials/ Intra-Target-Microdosing (ITM) and the lung: a review","year":"2024","cit":1,"pfa":"Tom Michael Quinn","psa":"Kevin Dhaliwal","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4401979559","eid":"W4401979559"},{"id":"paper-w4413578228","cat":"papers","name":"Another Round? What really happens when you microdose alcohol","year":"2021","cit":1,"pfa":"Harry R. Sumnall","topics":["Addiction","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W4413578228","eid":"W4413578228"},{"id":"paper-w2411253120","cat":"papers","name":"[Autoradiographic studies on the distribution pattern of neuroleptics, antidepressives and hallucinogens in rat brain].","year":"1969","cit":1,"pfa":"A Hopf","psa":"H Eckert","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2411253120","eid":"W2411253120"},{"id":"paper-w2077526265","cat":"papers","name":"The threshold action of microdoses of mercuric chloride on the activity of diastase in the hydrolysis of starch","year":"1949","cit":1,"pfa":"William Edgar Boyd","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2077526265","eid":"W2077526265"},{"id":"paper-w2589591999","cat":"papers","name":"Phase 0 microdose trial to identify chemoresistance in lung and bladder cancer.","year":"2010","cit":1,"pfa":"Paul T. Henderson","psa":"C. Pan","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W2589591999","eid":"W2589591999"},{"id":"paper-w2403840502","cat":"papers","name":"[Effect of thyroxin microdoses on oxygen consumption in normal and in thyroidectomized and hypophysectomized rats].","year":"1951","cit":1,"pfa":"L Balogh","psa":"G Mestyãn","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2403840502","eid":"W2403840502"},{"id":"paper-w2895505659","cat":"papers","name":"Printable medicines: A Microdosing Device for the Production of Personalized Oral Dosage Forms","year":"2011","cit":1,"pfa":"Christine Voura","psa":"A. Zimmer","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2895505659","eid":"W2895505659"},{"id":"paper-w2511634092","cat":"papers","name":"323 A clinical pharmacokinetic microdosing study of docetaxel with Japanese cancer patients","year":"2015","cit":1,"pfa":"K.I. Fujita","psa":"Yuka Sasaki","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2511634092","eid":"W2511634092"},{"id":"paper-w2494935124","cat":"papers","name":"Calculated Microdose Spectra for Intermediate Energy Neutrons (1 to 100 keV)","year":"1983","cit":1,"pfa":"I.A.M. Al-Affan","psa":"D.E. Watt","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2494935124","eid":"W2494935124"},{"id":"paper-w7159618274","cat":"papers","name":"A critical review of brain entropy as a biomarker of the psychedelic state","year":"2026","cit":1,"pfa":"Bruno Moses","psa":"Enzo Tagliazucchi","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7159618274","eid":"W7159618274"},{"id":"paper-w4406325229","cat":"papers","name":"Equipoise and Personal Experience: Maintaining Objectivity in Psychedelic Research","year":"2025","cit":1,"pfa":"Katrina DeBonis","psa":"Thomas B. Strouse","topics":["Therapy practice","Policy & ethics"],"ptype":"editorial","src":"https://openalex.org/W4406325229","eid":"W4406325229"},{"id":"paper-w4412414278","cat":"papers","name":"The impact of a psychedelic drug on olfactory search behavior by mice","year":"2026","cit":1,"pfa":"Amanda C. Welch","psa":"Matthew C. Smear","ptype":"article","src":"https://openalex.org/W4412414278","eid":"W4412414278"},{"id":"paper-w2049848117","cat":"papers","name":"Effect of Continuous Local Microdose Norethisterone Enanthate on the Epididymis of Adult Rat","year":"2009","cit":1,"pfa":"U.K. Srivastava","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2049848117","eid":"W2049848117"},{"id":"paper-w2126118974","cat":"papers","name":"Stochastic Threshold Microdose Model for Cell Killing by Insoluble Metallic Nanomaterial Particles","year":"2010","cit":1,"pfa":"Bobby R. Scott","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2126118974","eid":"W2126118974"},{"id":"paper-w269317652","cat":"papers","name":"Ship, Captain, and Crew in Education: Reflections on a Psychedelic Experience.","year":"1971","cit":1,"pfa":"Sidney P. Marland","ptype":"article","src":"https://openalex.org/W269317652","eid":"W269317652"},{"id":"paper-w4406778664","cat":"papers","name":"Experimental Test of Perceptions of Psychedelics by Therapeutic and Recreational Use","year":"2025","cit":1,"pfa":"Mackenzie T. Kiniry","psa":"Benjamin O. Ladd","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4406778664","eid":"W4406778664"},{"id":"paper-w7118818009","cat":"papers","name":"A critical review of brain entropy as a biomarker of the psychedelic state","year":"2026","cit":1,"pfa":"Bruno Moses","psa":"Enzo Tagliazucchi","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7118818009","eid":"W7118818009"},{"id":"paper-w3012151079","cat":"papers","name":"The Psychedelic Reinterpretation of Corpus Christi by Philip K. Dick","year":"2020","cit":1,"pfa":"Bogdan Trocha","ptype":"article","src":"https://openalex.org/W3012151079","eid":"W3012151079"},{"id":"paper-w2753898440","cat":"papers","name":"The Witches' Ointment: The Secret History of Psychedelic Magic by Thomas Hatsis","year":"2017","cit":1,"pfa":"Michael Ostling","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2753898440","eid":"W2753898440"},{"id":"paper-w4409761586","cat":"papers","name":"Dynamic VR Modulation with EEG Feedback for Psychedelic Simulation","year":"2025","cit":1,"pfa":"Leon Lange","psa":"Ying Choon Wu","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"conference-paper","src":"https://openalex.org/W4409761586","eid":"W4409761586"},{"id":"paper-w2044140919","cat":"papers","name":"The metaphysical combat with death in the terminally ill and the psychedelic trail","year":"2014","cit":1,"pfa":"Varsha Dutta","ptype":"article","src":"https://openalex.org/W2044140919","eid":"W2044140919"},{"id":"paper-w4205466085","cat":"papers","name":"Psychedelic Perception in Queer-Feminist Reading and Writing (as Performance)","year":"2021","cit":1,"pfa":"Deni Li","ptype":"article","src":"https://openalex.org/W4205466085","eid":"W4205466085"},{"id":"paper-w4413548177","cat":"papers","name":"Could psychedelics help us resolve the climate crisis?","year":"2020","cit":1,"pfa":"Matthew Adams","ptype":"other","src":"https://openalex.org/W4413548177","eid":"W4413548177"},{"id":"paper-w4389078438","cat":"papers","name":"Psychedelics, Political Radicalism, and Transnational Acid-Anarchism in the 1970s","year":"2023","cit":1,"pfa":"Hallam Roffey","ptype":"book-chapter","src":"https://openalex.org/W4389078438","eid":"W4389078438"},{"id":"paper-w8714905","cat":"papers","name":"Spirituality in the Laboratory: Negotiating the politics of knowledge in the psychedelic sciences","year":"2010","cit":1,"pfa":"Michelle Corbin","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W8714905","eid":"W8714905"},{"id":"paper-w2166615377","cat":"papers","name":"Erika Dyck, Psychedelic Psychiatry: LSD on the Canadian Prairies","year":"2015","cit":1,"pfa":"Eli Oda Sheiner","ptype":"book-review","src":"https://openalex.org/W2166615377","eid":"W2166615377"},{"id":"paper-w4414806378","cat":"papers","name":"Different realities: Symbolic boundaries and psychedelic drug use","year":"2025","cit":1,"pfa":"Emily Wagner","psa":"Jacob H. Erickson","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4414806378","eid":"W4414806378"},{"id":"paper-w4377242023","cat":"papers","name":"UC Berkeley Students’ Psychedelic Experiences: A Qualitative Analysis","year":"2023","cit":1,"pfa":"Dylan Earp","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4377242023","eid":"W4377242023"},{"id":"paper-w4414487013","cat":"papers","name":"Placebo Effects in the Treatment of Depression—Implications for the Psychedelic Renaissance","year":"2025","cit":1,"pfa":"Mina Ansari","psa":"Gerard Sanacora","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4414487013","eid":"W4414487013"},{"id":"paper-w7143279405","cat":"papers","name":"Should People With a History of Psychosis Be Included in Psychedelic Research?","year":"2026","cit":1,"pfa":"Khaleel Rajwani","ptype":"article","src":"https://openalex.org/W7143279405","eid":"W7143279405"},{"id":"paper-w409856190","cat":"papers","name":"Captazione tiroidea nel bambino con una microdose di131I (0,1 µc)","year":"1971","cit":1,"pfa":"GIORGIO GIOVANNELLI","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W409856190","eid":"W409856190"},{"id":"paper-w4403847912","cat":"papers","name":"Microdosing of alteplase leads to thrombolysis in an in vitro flow model of cardiac microvascular obstruction","year":"2024","cit":1,"pfa":"Anastasia Milusev","psa":"Dominik Obrist","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4403847912","eid":"W4403847912"},{"id":"paper-w4240321562","cat":"papers","name":"Quantitative EEG study of serotonergic hallucinogens in rats – the relationship of brain activity and behavior","year":"2016","cit":1,"pfa":"Čestmír Vejmola","ptype":"other","src":"https://openalex.org/W4240321562","eid":"W4240321562"},{"id":"paper-w4389057275","cat":"papers","name":"Association of Hallucinogen Persisting Perception Disorder with Trait Neuroticism and Mental Health Symptoms","year":"2023","cit":1,"pfa":"Morgan Hadley","psa":"James M. Stone","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4389057275","eid":"W4389057275"},{"id":"paper-w4389395580","cat":"papers","name":"The Age of Aquarius revisited: implications of a new psychedelic era","year":"2023","cit":1,"pfa":"Lawrence H. Price","ptype":"article","src":"https://openalex.org/W4389395580","eid":"W4389395580"},{"id":"paper-w4293078370","cat":"papers","name":"Mysticizing medicine: Incorporating nondualism into the training of psychedelic guides","year":"2022","cit":1,"pfa":"Valeria McCarroll","topics":["PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4293078370","eid":"W4293078370"},{"id":"paper-w2007717526","cat":"papers","name":"Impact of NEDO Project on Microdosing Clinical Studies: Toward the eIND Study in Japan","year":"2011","cit":1,"pfa":"Shinji Yamashita","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2007717526","eid":"W2007717526"},{"id":"paper-w2091469054","cat":"papers","name":"Introduction of microdoses of germanium and indium dopants into the bulk and surface layers of semiconductor materials","year":"2008","cit":1,"pfa":"А. П. Леушина","psa":"E. V. Zyablitseva","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2091469054","eid":"W2091469054"},{"id":"paper-w4403840352","cat":"papers","name":"Phenomenology of Mystical Psychedelic Experiences: The Case of Existential Anxiety","year":"2024","cit":1,"pfa":"Erik Kuravsky","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4403840352","eid":"W4403840352"},{"id":"paper-w4412749263","cat":"papers","name":"Social Value Communication Amidst the \"Hype\" of Psychedelic Research","year":"2025","cit":1,"pfa":"Caleigh Propes","psa":"Katherine Cheung","topics":["Safety & adverse events"],"ptype":"editorial","src":"https://openalex.org/W4412749263","eid":"W4412749263"},{"id":"paper-w4408683189","cat":"papers","name":"Islam and Psychedelics: An Essay on the Issues of Permissibility and Medical Utility","year":"2025","cit":1,"pfa":"Haroon Asghar","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4408683189","eid":"W4408683189"},{"id":"paper-w4403403515","cat":"papers","name":"Epistemic Character Change: Psychedelic Experiences as a Case Study","year":"2024","cit":1,"pfa":"Noam Tiran","ptype":"book-chapter","src":"https://openalex.org/W4403403515","eid":"W4403403515"},{"id":"paper-w4407415684","cat":"papers","name":"Comparative Frameworks for a Human Rights-Based Approach to Psychedelics","year":"2025","cit":1,"pfa":"Dustin N. Sharp","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4407415684","eid":"W4407415684"},{"id":"paper-w4235073527","cat":"papers","name":"Potentized microdoses of cadmium reduce the lethal effect of this heavy metal in amphibian embryos","year":"1997","cit":1,"topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4235073527","eid":"W4235073527"},{"id":"paper-w146097202","cat":"papers","name":"Drugs and American youth. A psychiatrist looks at the psychedelic generation.","year":"1969","cit":1,"pfa":"Klee Gd","ptype":"article","src":"https://openalex.org/W146097202","eid":"W146097202"},{"id":"paper-w4245537639","cat":"papers","name":"Goatrance Travelers: Psychedelic Trance and Its Seasoned Progeny","year":"2013","cit":1,"pfa":"Graham St John","topics":["Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W4245537639","eid":"W4245537639"},{"id":"paper-w7163713917","cat":"papers","name":"Micro Doses, Macro Potential? Considerations for Microdosing Tirzepatide in Multi‐Dose Pens","year":"2026","cit":1,"pfa":"Abigail B. Lodrigues","psa":"Anne M. Komé","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7163713917","eid":"W7163713917"},{"id":"paper-w2573399041","cat":"papers","name":"Further Studies on Microdose Intravenous Heparin in the Prevention of Postoperative Deep Vein Thrombosis","year":"1987","cit":1,"pfa":"David Negus","psa":"Anne Friedgood","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2573399041","eid":"W2573399041"},{"id":"paper-w2898085758","cat":"papers","name":"The Use of Imaging, Biomonitoring and Microdosing in Human Volunteers to Improve Safety Assessments and Clinical Development","year":"2018","cit":1,"pfa":"Tal Burt","psa":"Robert D. Combes","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W2898085758","eid":"W2898085758"},{"id":"paper-w2172099148","cat":"papers","name":"Erratum to: High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens","year":"2013","cit":1,"pfa":"Chad J. Reissig","psa":"Roland R. Griffiths","topics":["Dosing & pharmacology"],"ptype":"erratum","src":"https://openalex.org/W2172099148","eid":"W2172099148"},{"id":"paper-w4415381801","cat":"papers","name":"Psychedelic Use and Intimacy: A Systematic Review of Experimental and Naturalistic Research","year":"2025","cit":1,"pfa":"Anna Bradford","psa":"Rachel E. Dinero","topics":["Anxiety & end-of-life","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4415381801","eid":"W4415381801"},{"id":"paper-w2412560684","cat":"papers","name":"[Survey on the use of psychodysleptics (hallucinogens) in the collages and universities of the Province of Quebec. I. Questionnaire used].","year":"1968","cit":1,"pfa":"Simone Radouco-Thomas","psa":"Corneille Radouco-Thomas","ptype":"article","src":"https://openalex.org/W2412560684","eid":"W2412560684"},{"id":"paper-w1998606291","cat":"papers","name":"Abstract LB-403: A Phase 0 microdosing clinical trial to identify chemoresistance","year":"2011","cit":1,"pfa":"Chong-xian Pan","psa":"Paul T. Henderson","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W1998606291","eid":"W1998606291"},{"id":"paper-w4292836445","cat":"papers","name":"Correction: Chronic pain and psychedelics: a review and proposed mechanism of action","year":"2022","cit":1,"topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"erratum","src":"https://openalex.org/W4292836445","eid":"W4292836445"},{"id":"paper-w4399941385","cat":"papers","name":"The way of O: phenomenology of psychedelic use and the path to ultimate reality","year":"2024","cit":1,"pfa":"Christopher W. T. Miller","ptype":"article","src":"https://openalex.org/W4399941385","eid":"W4399941385"},{"id":"paper-w3164539589","cat":"papers","name":"Psychedelic Medicine: Past, Present, Future (elective course syllabus)","year":"2020","cit":1,"pfa":"William L. Prueitt","psa":"Jordan Sloshower","topics":["Addiction","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W3164539589","eid":"W3164539589"},{"id":"paper-w307553342","cat":"papers","name":"Observation concerning the effects of medetomidine-microdose on diazepam-ketamine induced anesthesia in dogs.","year":"2010","cit":1,"pfa":"Florin Ioan Beteg","psa":"A. Krupaci","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W307553342","eid":"W307553342"},{"id":"paper-w4394165438","cat":"papers","name":"Classic Psychedelics as a Psychotherapeutic Aid in the Treatment of Stimulant Use Disorder","year":"2021","cit":1,"pfa":"Shevaugn Johnson","psa":"Quentin C. Black","topics":["Addiction","Therapy practice"],"ptype":"dataset","src":"https://openalex.org/W4394165438","eid":"W4394165438"},{"id":"paper-w4381949879","cat":"papers","name":"Report finds psychedelic helpline may avert harmful outcomes","year":"2023","cit":1,"pfa":"Valerie A. Canady","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4381949879","eid":"W4381949879"},{"id":"paper-w2235509787","cat":"papers","name":"The Rip Van Winkle Science: Credibility Struggles in the \"Psychedelic Renaissance\"","year":"2015","cit":1,"pfa":"Danielle M. Giffort","topics":["Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W2235509787","eid":"W2235509787"},{"id":"paper-w4408331757","cat":"papers","name":"Innovative Approaches in Psychedelics, AI, and Communication: A Multi-Domain Perspective","year":"2025","cit":1,"pfa":"Robert B. Kargbo","ptype":"editorial","src":"https://openalex.org/W4408331757","eid":"W4408331757"},{"id":"paper-w4220767337","cat":"papers","name":"Effects of Fertilizer Microdosing on Yield and Nitrogen Use Efficiency of Green Amaranth (Amaranthusviridis)","year":"2022","cit":1,"pfa":"O. B. Kuye","psa":"Idowu M. K","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4220767337","eid":"W4220767337"},{"id":"paper-w4387306391","cat":"papers","name":"Exploring Regulatory Frameworks For Psychedelic Services To Treat Mental Illnesses","year":"2023","cit":1,"pfa":"Varun\n    Saraswathula","psa":"Molly\n    Candon","topics":["Policy & ethics"],"ptype":"dataset","src":"https://openalex.org/W4387306391","eid":"W4387306391"},{"id":"paper-w4406755891","cat":"papers","name":"Integrating Artificial Intelligence and Digital Innovations in Psychedelic and Brain Therapeutics","year":"2025","cit":1,"pfa":"Robert B. Kargbo","ptype":"editorial","src":"https://openalex.org/W4406755891","eid":"W4406755891"},{"id":"paper-w3108990871","cat":"papers","name":"Images of Native Americans in Rick Griffin's Early Psychedelic Posters","year":"2020","cit":1,"pfa":"Michael Parke‐Taylor","ptype":"article","src":"https://openalex.org/W3108990871","eid":"W3108990871"},{"id":"paper-w4390223054","cat":"papers","name":"Effects of psychedelics on induced pluripotent stem cells — derived neurons","year":"2023","cit":1,"pfa":"D. Reyes","psa":"Deepak P. Srivastava","ptype":"article","src":"https://openalex.org/W4390223054","eid":"W4390223054"},{"id":"paper-w4409811758","cat":"papers","name":"Exploring Factors Affecting Psychological Flexibility After Psychedelic Experiences","year":"2025","cit":1,"pfa":"Bruno Roméo","psa":"Amine Benyamina","ptype":"article","src":"https://openalex.org/W4409811758","eid":"W4409811758"},{"id":"paper-w4213290141","cat":"papers","name":"Correction to “On the Relationship between Classic Psychedelics and Suicidality: A Systematic Review”","year":"2022","cit":1,"pfa":"Richard J. Zeifman","psa":"Cory R. Weissman","topics":["Reviews & meta-analyses"],"ptype":"erratum","src":"https://openalex.org/W4213290141","eid":"W4213290141"},{"id":"paper-w4413188926","cat":"papers","name":"Hypoxia, Psychedelics, and Terminal Lucidity: A Perspective on Neuroplasticity and Neuropsychiatric Disorders","year":"2025","cit":1,"pfa":"Junjie Zhang","psa":"Xiaohui Wang","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4413188926","eid":"W4413188926"},{"id":"paper-w2067275383","cat":"papers","name":"Student Psychedelic Drug Use—An Evaluation by Student Drug Users","year":"1969","cit":1,"pfa":"Malcolm B. Bowers","ptype":"article","src":"https://openalex.org/W2067275383","eid":"W2067275383"},{"id":"paper-w2888408683","cat":"papers","name":"Yes, Make Psychedelics Legally Available, but Don’t Forget the Risks","year":"2018","cit":1,"pfa":"John Horgan","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2888408683","eid":"W2888408683"},{"id":"paper-w4400026030","cat":"papers","name":"5-HT2ASNPs Alter the Pharmacological Signaling of Potentially Therapeutic Psychedelics","year":"2024","cit":1,"pfa":"Slocum S.T","psa":"Jain M.K","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4400026030","eid":"W4400026030"},{"id":"paper-w4406326827","cat":"papers","name":"Exceptional Stigma: Parallels Between Marginalized Groups and Psychedelic Medicine","year":"2025","cit":1,"pfa":"Susan Lee","psa":"Lisa Campo-Engelstein","ptype":"editorial","src":"https://openalex.org/W4406326827","eid":"W4406326827"},{"id":"paper-w4414260069","cat":"papers","name":"Psychedelic Resurgence, Spirituality and Psychological Disorders: Epistemological and Clinical Implications","year":"2025","cit":1,"pfa":"Ana Sofia Machado Ferreira","psa":"Enrico Facco","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4414260069","eid":"W4414260069"},{"id":"paper-w4200051477","cat":"papers","name":"Los Jaivas: Toward a Decolonial Attitude in Chilean Psychedelic Rock","year":"2021","cit":1,"pfa":"Israel Holas Allimant","psa":"Sergio Holas","ptype":"article","src":"https://openalex.org/W4200051477","eid":"W4200051477"},{"id":"paper-w7117549486","cat":"papers","name":"From Science to Pleasure: Justifications of the Use of Classic Psychedelics in Finland","year":"2025","cit":1,"pfa":"Mika Tsupari","psa":"Aleksi Hupli","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7117549486","eid":"W7117549486"},{"id":"paper-w2890694325","cat":"papers","name":"Psychedelic Territories: Exile and Sonorities in Caetano Veloso and Gilberto Gil","year":"2018","cit":1,"pfa":"Luiza Bittencourt","psa":"Rafael Lage","ptype":"article","src":"https://openalex.org/W2890694325","eid":"W2890694325"},{"id":"paper-w2415515696","cat":"papers","name":"[Rapid microdose 14C-urea breath test for detection of Helicobacter pylori infection].","year":"1998","cit":1,"pfa":"An-ren Kuang","psa":"Q Ouyang","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2415515696","eid":"W2415515696"},{"id":"paper-w4405490291","cat":"papers","name":"Could psychedelic drugs improve the mental health of autistic people?","year":"2024","cit":1,"ptype":"dataset","src":"https://openalex.org/W4405490291","eid":"W4405490291"},{"id":"paper-w4386029191","cat":"papers","name":"Trends in Hallucinogen-associated Emergency Department Visits and Hospitalizations in California from 2016–2021","year":"2023","cit":1,"pfa":"Steven Tate","psa":"Anna Lembke","topics":["Addiction","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4386029191","eid":"W4386029191"},{"id":"paper-w1491743036","cat":"papers","name":"A Longitudinal History of Self-Transformation: Psychedelics, Spirituality, Activism and Transformation","year":"2011","cit":1,"pfa":"Phil Wolfson","ptype":"article","src":"https://openalex.org/W1491743036","eid":"W1491743036"},{"id":"paper-w7153988786","cat":"papers","name":"Psychedelics Are Still Not Ethically Exceptional: Rebutting Recent Claims of Uniqueness","year":"2026","cit":1,"pfa":"Brian David Earp","psa":"David B. Yaden","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7153988786","eid":"W7153988786"},{"id":"paper-w4416031648","cat":"papers","name":"Feeling groovy? The present and future of psychedelic research in palliative care","year":"2025","cit":1,"pfa":"Justin J. Sanders","psa":"Yvan Beaussant","topics":["Anxiety & end-of-life"],"ptype":"editorial","src":"https://openalex.org/W4416031648","eid":"W4416031648"},{"id":"paper-w7165143026","cat":"papers","name":"Lowlands Science 2023: A virtual reality (VR) psychedelic experience","year":"2023","cit":1,"pfa":"Josephine Marschall","psa":"Michiel van Elk","ptype":"preprint","src":"https://openalex.org/W7165143026","eid":"W7165143026"},{"id":"paper-w4406320912","cat":"papers","name":"With Best Intention: Psychedelic Intention-Setting Rituals as Rites of Sacralization","year":"2025","cit":1,"pfa":"Jeffrey A. Breau","ptype":"article","src":"https://openalex.org/W4406320912","eid":"W4406320912"},{"id":"paper-w1979704869","cat":"papers","name":"Microdose GnRH agonist flare protocol results in lower incidence of chromosome aneuploid blastocysts","year":"2011","cit":1,"pfa":"William B. Schoolcraft","psa":"J. Stevens","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1979704869","eid":"W1979704869"},{"id":"paper-w4402383814","cat":"papers","name":"Exploring the Role of Psychedelic Experiences on Wellbeing and Symptoms of Disordered Eating","year":"2024","cit":1,"pfa":"Nadine Loh","psa":"David P. Luke","topics":["Depression","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4402383814","eid":"W4402383814"},{"id":"paper-w4402656168","cat":"papers","name":"The psychedelic experience: a new perspective, a new attitude towards the world","year":"2024","cit":1,"pfa":"Virginia Ballesteros","topics":["Depression","Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W4402656168","eid":"W4402656168"},{"id":"paper-w2006426390","cat":"papers","name":"On the Potential Utility of Nitrous Oxide In Psychedelic Psychotherapy: A Pilot Study","year":"1978","cit":1,"pfa":"John Rhead","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2006426390","eid":"W2006426390"},{"id":"paper-w4402529552","cat":"papers","name":"The serotonergic psychedelic DOI impairs deviance detection in the auditory cortex","year":"2024","cit":1,"pfa":"Max Horrocks","psa":"Santiago Jaramillo","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4402529552","eid":"W4402529552"},{"id":"paper-w4406326746","cat":"papers","name":"Psychedelics in a Deregulated Policy Climate: What Might 2025 Bring?","year":"2025","cit":1,"pfa":"Lori Bruce","topics":["Policy & ethics"],"ptype":"editorial","src":"https://openalex.org/W4406326746","eid":"W4406326746"},{"id":"paper-w2285962882","cat":"papers","name":"Integrated fertiliser microdosing and organic manure to adapt to climate variability and change in Northern Benin","year":"2015","cit":1,"pfa":"Gbènoukpo Pierre Tovihoudji","psa":"Charles Louis Bielders","topics":["Dosing & pharmacology"],"ptype":"conference-paper","src":"https://openalex.org/W2285962882","eid":"W2285962882"},{"id":"paper-w4409716557","cat":"papers","name":"Psychedelics under Catastrophe: Reflections on the October 7 Rave Massacre","year":"2025","cit":1,"pfa":"Arun Saldanha","ptype":"article","src":"https://openalex.org/W4409716557","eid":"W4409716557"},{"id":"paper-w2412032031","cat":"papers","name":"[Studies on hallucinogens. IV. Synthesis of 2,5-dimethoxy-4-methylamphetamine (STP) (author's transl)].","year":"1973","cit":1,"pfa":"M Ono","psa":"Kazuo Takahashi","ptype":"other","src":"https://openalex.org/W2412032031","eid":"W2412032031"},{"id":"paper-w4407781426","cat":"papers","name":"Psychedelic Codes and Close Listening to South Korean Fiction, 1971 – 1989","year":"2025","cit":1,"pfa":"Ethan Waddell","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4407781426","eid":"W4407781426"},{"id":"paper-w4415246877","cat":"papers","name":"Translation and validation of the psychedelic Challenging Experience Questionnaire (CEQ) to Brazilian Portuguese.","year":"2025","cit":1,"pfa":"Eduardo Ekman Schenberg","psa":"Peter S. Hendricks","ptype":"article","src":"https://openalex.org/W4415246877","eid":"W4415246877"},{"id":"paper-w4416948154","cat":"papers","name":"Patent Highlights at the Frontier of Neuroscience: From Molecular Targets to Psychedelic Neurotherapeutics","year":"2025","cit":1,"pfa":"Ram W. Sabnis","psa":"Robert B. Kargbo","ptype":"editorial","src":"https://openalex.org/W4416948154","eid":"W4416948154"},{"id":"paper-w248892959","cat":"papers","name":"A Microdosing Study to Assess the Oral Absorption of ^ C-EM 1421 in Healthy Male Subjects","year":"2007","cit":1,"pfa":"Lloyd Stevens","psa":"Marcia L. Gaido","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W248892959","eid":"W248892959"},{"id":"paper-w2377661778","cat":"papers","name":"Analysis on Time-Effect Relationship about Anti-Fatigue of Microdose Sodium Salicylate in Mice","year":"2008","cit":1,"pfa":"Yuxiang An","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2377661778","eid":"W2377661778"},{"id":"paper-w2389696696","cat":"papers","name":"Establishment of an Animal Model of Human Erythroleukemia in NOD/SCID Mice Using Microdose K562 Cells","year":"2005","cit":1,"pfa":"Shao-Liang Huang","psa":"Sun Yat-sen","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2389696696","eid":"W2389696696"},{"id":"paper-w2539077620","cat":"papers","name":"Treatment of the orbicularis oculi muscle’s lower portion with microdoses of botulinum toxin: a 300 cases series","year":"2016","cit":1,"pfa":"Guilherme Bueno de Oliveira","psa":"Bárbara Maria Tarraf Moreira","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2539077620","eid":"W2539077620"},{"id":"paper-w4400004367","cat":"papers","name":"Psychedelic 5-HT2A Receptor Agonism Alters Neurovascular Coupling in Mice","year":"2024","cit":1,"pfa":"Jonah A. Padawer-Curry","psa":"Adam Q. Bauer","topics":["Mechanism & neuroscience"],"ptype":"conference-paper","src":"https://openalex.org/W4400004367","eid":"W4400004367"},{"id":"paper-w2994839435","cat":"papers","name":"Psychedelic Mystery Traditions: Spirit Plants, Magical Practices and Ecstatic States","year":"2019","cit":1,"pfa":"Roy Vickery","ptype":"article","src":"https://openalex.org/W2994839435","eid":"W2994839435"},{"id":"paper-w4413951246","cat":"papers","name":"Psychedelic training program development: lessons from the evolution of the EMBARK program","year":"2025","cit":1,"pfa":"Bill Brennan","psa":"Alex R. Kelman","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4413951246","eid":"W4413951246"},{"id":"paper-w2405363067","cat":"papers","name":"[A new North American species of Psilocybe hallucinogen: Psilocybe quebecensis G. Ola'h and R. Heim].","year":"1967","cit":1,"pfa":"Ola'h Gm","psa":"R Heim","ptype":"article","src":"https://openalex.org/W2405363067","eid":"W2405363067"},{"id":"paper-w2584691187","cat":"papers","name":"Integrating microdosing of fertilizers with biological control agents for maize production in the Eastern Cape, South Africa.","year":"2015","cit":1,"pfa":"Bongani Petros Kubheka","topics":["Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W2584691187","eid":"W2584691187"},{"id":"paper-w4200396261","cat":"papers","name":"Reduced precision underwrites ego dissolution and therapeutic outcomes under psychedelics","year":"2021","cit":1,"pfa":"Devon Stoliker","psa":"Adeel Razi","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4200396261","eid":"W4200396261"},{"id":"paper-w4361303332","cat":"papers","name":"Contribution of serotonin 5-HT2A receptor to antidepressant effect of serotonergic psychedelics","year":"2023","cit":1,"pfa":"Daisuke Ibi","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4361303332","eid":"W4361303332"},{"id":"paper-w2995379616","cat":"papers","name":"Evolutionary algorithm applied for improving the accuracy of the automated detection of psychedelic amphetamines","year":"2018","cit":1,"pfa":"\"","psa":"Mirela Praisler","ptype":"article","src":"https://openalex.org/W2995379616","eid":"W2995379616"},{"id":"paper-w2157630768","cat":"papers","name":"Comparing a Microdose Flare to a GnRH Antagonist Protocol for Poor Responder Patients Undergoing In-Vitro Fertilization","year":"2005","cit":1,"pfa":"Jackie Hollett-Caines","psa":"Basim F. Abu-Rafea","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2157630768","eid":"W2157630768"},{"id":"paper-w2904614023","cat":"papers","name":"The beatles’ psycheclassical synthesis: Psychedelic classicism and classical psychedelia in Sgt. Pepper","year":"2018","cit":1,"pfa":"Naphtali Wagner","ptype":"book-chapter","src":"https://openalex.org/W2904614023","eid":"W2904614023"},{"id":"paper-w4390476599","cat":"papers","name":"Reproducing the Psychedelic Experience: “One of the 5 Most Meaningful Experiences in Life”?","year":"2023","cit":1,"pfa":"Petri Kajonius","psa":"David Sjöström","ptype":"preprint","src":"https://openalex.org/W4390476599","eid":"W4390476599"},{"id":"paper-w4405531064","cat":"papers","name":"Psychedelic Therapeutics for Adolescents: Ethics, Safety, Opportunities, and Equipoise—Authors' Reply","year":"2024","cit":1,"pfa":"Jessica Kay Jeffrey","psa":"Charles S. Grob","topics":["Safety & adverse events","Policy & ethics"],"ptype":"letter","src":"https://openalex.org/W4405531064","eid":"W4405531064"},{"id":"paper-w4399360948","cat":"papers","name":"Psychedelics and Older Adults: What Do They Do Compared to Younger People?","year":"2024","cit":1,"pfa":"Philip D. Harvey","ptype":"article","src":"https://openalex.org/W4399360948","eid":"W4399360948"},{"id":"paper-w3091478385","cat":"papers","name":"Microdosing of para-amino-hippuric acid in the blood and urine, studied with a view to determining the clearance of this substance.","year":"2008","cit":1,"pfa":"J HAMBURGER","psa":"Ryckewaert","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3091478385","eid":"W3091478385"},{"id":"paper-w2043649157","cat":"papers","name":"Effective interception with the levonorgestrel-20-IUD contrarily to WHO advocated Lng-2-microdose IUD","year":"1988","cit":1,"pfa":"A.A. Haspels","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2043649157","eid":"W2043649157"},{"id":"paper-w4235587307","cat":"papers","name":"Leary, Timothy (1920-1996), clinical psychologist and psychedelic drug guru","year":"2001","cit":1,"pfa":"Bruce L. Janoff","ptype":"reference-entry","src":"https://openalex.org/W4235587307","eid":"W4235587307"},{"id":"paper-w4379378207","cat":"papers","name":"Psychedelic-inspired drugs could relieve depression without causing hallucinations","year":"2023","cit":1,"topics":["Depression"],"ptype":"dataset","src":"https://openalex.org/W4379378207","eid":"W4379378207"},{"id":"paper-w2252989655","cat":"papers","name":"Design of a phase 0 microdosing trial for correlation of platinum-induced DNA damage to chemotherapy outcomes","year":"2009","cit":1,"pfa":"C. Pan","psa":"Paul T. Henderson","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W2252989655","eid":"W2252989655"},{"id":"paper-w7154628120","cat":"papers","name":"The Emerging Neurobiology of Psychedelics: Critical Periods, Metaplasticity, and Extracellular Matrix Remodeling","year":"2026","cit":1,"pfa":"Gül Dölen","psa":"Makenzie L. Wilkinson","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"review","src":"https://openalex.org/W7154628120","eid":"W7154628120"},{"id":"paper-w1488632330","cat":"papers","name":"Facing Our Dragons: Spiritual Activism, Psychedelic Mysticism and the Pursuit of Opposition","year":"2006","cit":1,"pfa":"Michelle Corbin","ptype":"article","src":"https://openalex.org/W1488632330","eid":"W1488632330"},{"id":"paper-w4413061936","cat":"papers","name":"Applying the EU Regulatory Framework to Determine the Benefit–Risk Profile of Psychedelics","year":"2025","cit":1,"pfa":"Kate Browne","psa":"Steffen Thirstrup","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"editorial","src":"https://openalex.org/W4413061936","eid":"W4413061936"},{"id":"paper-w4415219138","cat":"papers","name":"The impact of the serotonergic psychedelic DOI on active vision in freely moving mice","year":"2025","cit":1,"pfa":"Rolf J. Skyberg","psa":"Cristopher M. Niell","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4415219138","eid":"W4415219138"},{"id":"paper-w4406232233","cat":"papers","name":"LOS ALUCINÓGENOS: SU HISTORIA, ANTROPOLOGÍA, QUÍMICA Y FARMACOLOGÍA - THE HALLUCINOGENS: THEIR HISTORY, ANTHROPOLOGY, CHEMISTRY AND PHARMACOLOGY","year":"2010","cit":1,"pfa":"MANUEL MARTÍNEZ HERRERA","psa":"JOSE ML. RODRÍGUEZ","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4406232233","eid":"W4406232233"},{"id":"paper-w4406325416","cat":"papers","name":"Measuring and Understanding the Meaning of Exceptionalism to Bolster Ethics Oversight of Psychedelics Research","year":"2025","cit":1,"pfa":"Naomi Scheinerman","psa":"Claire M. Erickson","topics":["Policy & ethics"],"ptype":"editorial","src":"https://openalex.org/W4406325416","eid":"W4406325416"},{"id":"paper-w4299650378","cat":"papers","name":"WHITE HAND SOCIETY: THE PSYCHEDELIC PARTNERSHIP OF TIMOTHY LEARY AND ALLEN GINSBERG","year":"2011","cit":1,"pfa":"William Lawlor","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4299650378","eid":"W4299650378"},{"id":"paper-w7127889326","cat":"papers","name":"The impact of microdosed plyometric training on speed and explosive abilities of football players during the pre-season","year":"2026","cit":1,"pfa":"Marián Škorik","psa":"Michal Hrubý","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7127889326","eid":"W7127889326"},{"id":"paper-w4241394956","cat":"papers","name":"Overcoming the traumatic through the psychedelic in One Flew over the Cuckoo’s Nest","year":"2016","cit":1,"topics":["PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4241394956","eid":"W4241394956"},{"id":"paper-w3003712797","cat":"papers","name":"The Great God Pan is Not Dead – A. N. Whitehead and the Psychedelic Mode of Perception","year":"2017","cit":1,"pfa":"Peter Sjöstedt-H.","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W3003712797","eid":"W3003712797"},{"id":"paper-w2911974566","cat":"papers","name":"Radical Trips: Exploring the Political Dimension and Context of the 1960s Psychedelic Poster","year":"2019","cit":1,"pfa":"Scott B. Montgomery","ptype":"article","src":"https://openalex.org/W2911974566","eid":"W2911974566"},{"id":"paper-w4399399801","cat":"papers","name":"Psychedelics and Global Wellness Industries and Change in Associated Strategies in International Business","year":"2024","cit":1,"pfa":"Kavita Sharma","psa":"Tarun Kumar Makhija","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4399399801","eid":"W4399399801"},{"id":"paper-w4410835160","cat":"papers","name":"Psychological Effects Related to Psychedelic Substance Use in the Previous 12 Months","year":"2025","cit":1,"pfa":"Jacqueline A. Williams","psa":"Philip N. Murphy","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4410835160","eid":"W4410835160"},{"id":"paper-w4416668227","cat":"papers","name":"Exploring practitioners’ perceptions of health behavior changes associated with psychedelic experiences","year":"2025","cit":1,"pfa":"Laura Lopes de Carvalho","psa":"Pedro J. Teixeira","topics":["Addiction","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4416668227","eid":"W4416668227"},{"id":"paper-w4285113557","cat":"papers","name":"Journeying in the realm of the Unconscious: Carl Jung’s Liber Novus and the Psychedelic Experience","year":"2022","cit":1,"pfa":"Johanna Sopanen","ptype":"book-chapter","src":"https://openalex.org/W4285113557","eid":"W4285113557"},{"id":"paper-w2013704338","cat":"papers","name":"Very Low Dose Luteal Lupron and Microdose Lupron Flare Offer Comparable Outcomes in Poor Responders","year":"2000","cit":1,"pfa":"R. Kaufmann","psa":"Grant W. Patton","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2013704338","eid":"W2013704338"},{"id":"paper-w2053178605","cat":"papers","name":"PS-128 The Ethics Of Microdosing Studies In Children: The Experience Of The Era-net Priomedchild Project Pamper","year":"2014","cit":1,"pfa":"Francis P. Crawley","psa":"R. Colin Garner","topics":["Dosing & pharmacology","Reviews & meta-analyses","Policy & ethics"],"ptype":"conference-paper","src":"https://openalex.org/W2053178605","eid":"W2053178605"},{"id":"paper-w4283739315","cat":"papers","name":"Narrative therapy in psychedelic harm reduction: Supporting safety, agency and meaning-making","year":"2022","cit":1,"pfa":"Blake Johns","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4283739315","eid":"W4283739315"},{"id":"paper-w2072026086","cat":"papers","name":"SLCO1B1 polymorphisms affect atorvastatin pharmacokinetics and cholesterol-lowering effects in patients with hypercholesterolemia in a microdosing approach","year":"2013","cit":1,"pfa":"Kanazawa Kajinami","psa":"N. Fukizawa","topics":["Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W2072026086","eid":"W2072026086"},{"id":"paper-w2518024113","cat":"papers","name":"P.1.013 Synthetic hallucinogen 5-methoxy-N,N-diisopropyltryptamine and its action in the rat brain","year":"2016","cit":1,"pfa":"Karolina Noworyta","psa":"Krystyna Gołembiowska","ptype":"article","src":"https://openalex.org/W2518024113","eid":"W2518024113"},{"id":"paper-w4392405996","cat":"papers","name":"Exploring the potential of synergistic psychedelic – NMDAr modulator treatment for refractory neuropsychiatric disorders","year":"2024","cit":1,"pfa":"Tom Ben-Tal","psa":"Bernard Lerer","ptype":"article","src":"https://openalex.org/W4392405996","eid":"W4392405996"},{"id":"paper-w4322489082","cat":"papers","name":"The classic psychedelic DOI induces a persistent desynchronized state in medial prefrontal cortex","year":"2023","cit":1,"pfa":"Randall J. Olson","psa":"Atheir I. Abbas","topics":["Depression","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4322489082","eid":"W4322489082"},{"id":"paper-w4403746278","cat":"papers","name":"Neural Correlates of Psychedelic, Sleep, and Sedated States Support Global Theories of Consciousness","year":"2024","cit":1,"pfa":"Rui Dai","psa":"George A. Mashour","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4403746278","eid":"W4403746278"},{"id":"paper-w4361004400","cat":"papers","name":"Rational design, synthesis, and characterization of a solid Δ9-tetrahydrocannabinol (THC) nanoformulation suitable for “microdosing” applications","year":"2023","cit":1,"pfa":"Abhinandan Banerjee","psa":"John Frederick Trant","topics":["Addiction","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4361004400","eid":"W4361004400"},{"id":"paper-w4393026242","cat":"papers","name":"You Have A Constitutional Right To Psychedelics: Academic Freedom, Personal Conscience, And Psychotechnologies","year":"2015","cit":1,"pfa":"Thomas B. Roberts","ptype":"other","src":"https://openalex.org/W4393026242","eid":"W4393026242"},{"id":"paper-w4399646075","cat":"papers","name":"God on Psychedelics: Tripping Across the Rubble of Old-time Religion, by Don Lattin","year":"2024","cit":1,"pfa":"Connor M. Ritchie","ptype":"article","src":"https://openalex.org/W4399646075","eid":"W4399646075"},{"id":"paper-w4410463397","cat":"papers","name":"Knowledge and attitudes about the use of psychedelic drugs among psychiatric professionals in Korea","year":"2025","cit":1,"pfa":"Won-Seok Choi","psa":"Duk‐In Jon","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4410463397","eid":"W4410463397"},{"id":"paper-w4383218363","cat":"papers","name":"Critique of “Changed Substance Use After Psychedelic Experiences Among Individuals in Canada”","year":"2023","cit":1,"pfa":"Harshita Seal","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4383218363","eid":"W4383218363"},{"id":"paper-w4361211278","cat":"papers","name":"Corrigendum: Three naturally-occurring psychedelics and their significance in the treatment of mental health disorders","year":"2023","cit":1,"pfa":"Nataliya S. Vorobyeva","psa":"Alena A. Kozlova","ptype":"erratum","src":"https://openalex.org/W4361211278","eid":"W4361211278"},{"id":"paper-w4285094891","cat":"papers","name":"Review of The Path of the Serpent, Volume 1: Psychedelics and the Neuropsychology of Gnosis by Hereward Tilton","year":"2022","cit":1,"pfa":"Gary Clark","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4285094891","eid":"W4285094891"},{"id":"paper-w7165782449","cat":"papers","name":"\"Digital pain relief\" or \"digital hallucinogen\": a study on the impact mechanism of short video usage intensity on loneliness","year":"2026","cit":1,"pfa":"Yirui Zhang","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7165782449","eid":"W7165782449"},{"id":"paper-w4414301067","cat":"papers","name":"Psychedelics for major depression—From controlled research settings into broader clinical use","year":"2025","cit":1,"pfa":"Mihai Avram","psa":"Stefan Borgwardt","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4414301067","eid":"W4414301067"},{"id":"paper-w2762594992","cat":"papers","name":"‘A critique of culture’: Alan Watts, psychedelic Buddhism, and religious play in postwar America","year":"2017","cit":1,"pfa":"Morgan Shipley","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2762594992","eid":"W2762594992"},{"id":"paper-w2288099635","cat":"papers","name":"Psychedelic Fears. Drug Use as an Emotional Practice in West Germany around 1970","year":"2016","cit":1,"pfa":"Florian Schleking","ptype":"article","src":"https://openalex.org/W2288099635","eid":"W2288099635"},{"id":"paper-w2275945590","cat":"papers","name":"Supernatural revelation via hallucinogens in initiation, spirit-possession, and jurisprudence: a Southern African problem-solving mechanism","year":"1973","cit":1,"pfa":"Thomas F. Johnston","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2275945590","eid":"W2275945590"},{"id":"paper-w4411087740","cat":"papers","name":"Modeling the hallucinatory effects of classical psychedelics in terms of replay-dependent plasticity mechanisms","year":"2025","cit":1,"pfa":"Colin Bredenberg","psa":"Guillaume Lajoie","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4411087740","eid":"W4411087740"},{"id":"paper-w4220966597","cat":"papers","name":"Corrigendum: Psychedelic Mushrooms in the USA: Knowledge, Patterns of Use, and Association With Health Outcomes","year":"2022","cit":1,"pfa":"Richard Matzopoulos","psa":"Leonard B. Lerer","ptype":"erratum","src":"https://openalex.org/W4220966597","eid":"W4220966597"},{"id":"paper-w596703971","cat":"papers","name":"The Children of nuggets: the definitive guide to \"psychedelic sixties\" punk rock on compilation albums","year":"1990","cit":1,"ptype":"book-review","src":"https://openalex.org/W596703971","eid":"W596703971"},{"id":"paper-w4381891855","cat":"papers","name":"Psychedelic Marxism: The Ecstatic States of the Body in the White Panther Party around 1970","year":"2023","cit":1,"pfa":"Kristoff Kerl","ptype":"article","src":"https://openalex.org/W4381891855","eid":"W4381891855"},{"id":"paper-w4285550978","cat":"papers","name":"Ido Hartogsohn, American Trip: Set, Setting, and the Psychedelic Experience in the Twentieth Century","year":"2021","cit":1,"pfa":"Chris Elcock","ptype":"article","src":"https://openalex.org/W4285550978","eid":"W4285550978"},{"id":"paper-w7138923029","cat":"papers","name":"Leveraging molecular dynamics simulations to study psychedelics and their receptors in future drug development","year":"2026","cit":1,"pfa":"Cong Zhang","psa":"Xiaohui Wang","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7138923029","eid":"W7138923029"},{"id":"paper-w4251750945","cat":"papers","name":"“Psychedelic” Drugs as Means to Mystical Experience: Aldous Huxley versus Indian Reality","year":"2001","cit":1,"pfa":"Albrecht Wezler","ptype":"book-chapter","src":"https://openalex.org/W4251750945","eid":"W4251750945"},{"id":"paper-w2398378212","cat":"papers","name":"Knowledge as an emotional and intellectual realization of the unconscious. Gnosiology, Psychedelic Drugs and Prenatal Experiences*","year":"2000","cit":1,"pfa":"Zephyros Kafkalides","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2398378212","eid":"W2398378212"},{"id":"paper-w7172491304","cat":"papers","name":"Environmental and Endogenous Psychedelics as Adaptive Plasticity Modulators: An Integrative Systems Biology Framework","year":"2026","cit":1,"pfa":"Kaya Genc","psa":"James Franciscus Barkell","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7172491304","eid":"W7172491304"},{"id":"paper-w1994206018","cat":"papers","name":"Altérations rénales et hépatiques chez des rats albinos traités par microdoses de NaF","year":"1961","cit":1,"pfa":"S. Fiorentini","psa":"F. Di Blasi","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1994206018","eid":"W1994206018"},{"id":"paper-w4401521492","cat":"papers","name":"A clinical research perspective on the regulation of medical and non‐medical use of psychedelic drugs","year":"2024","cit":1,"pfa":"Michael P. Bogenschutz","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4401521492","eid":"W4401521492"},{"id":"paper-w7125502419","cat":"papers","name":"Bridging ancient substances and modern psychiatry: the role of classic psychedelics in depression treatment","year":"2026","cit":1,"pfa":"Guilherme Lodetti","psa":"Eduardo Pacheco Rico","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W7125502419","eid":"W7125502419"},{"id":"paper-w2126619183","cat":"papers","name":"IVF Success Rates in Patients With an Elevated Baseline FSH (> 10 mIU/ml): Antagonist vs. Microdose Flare","year":"2005","cit":1,"pfa":"David A. Ryley","psa":"Michael M. Alper","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2126619183","eid":"W2126619183"},{"id":"paper-w4387607417","cat":"papers","name":"Psychedelic 5-HT2A receptor agonism: neuronal signatures and altered neurovascular coupling.","year":"2023","cit":1,"pfa":"Adam Q. Bauer","psa":"Joshua S. Siegel","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4387607417","eid":"W4387607417"},{"id":"paper-w4414290827","cat":"papers","name":"Modeling Whole-Body Dynamic PET Microdosing Data to Predict the Whole-Body Pharmacokinetics of Glyburide in Humans","year":"2025","cit":1,"pfa":"Léa Comin","psa":"Emmanuelle Comets","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4414290827","eid":"W4414290827"},{"id":"paper-w2755058137","cat":"papers","name":"Let’s Go Out For A Day Trip? Perspectives of Psychedelics (Ab)Users on the Safety of Acid (LSD) Tripping in Public Places","year":"2017","cit":1,"pfa":"Ahmed Al-Imam","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2755058137","eid":"W2755058137"},{"id":"paper-w7120919592","cat":"papers","name":"Response of different soybean varieties to phosphorus fertilizer microdosing and rhizobium inoculation in the sub-humid zone of Northern Benin","year":"2025","cit":1,"pfa":"Kamarou‐Dine Seydou","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7120919592","eid":"W7120919592"},{"id":"paper-w4249997227","cat":"papers","name":"Folk Revival Roots Still Evident in 1990s Recordings of San Francisco Psychedelic Veterans","year":"2001","cit":1,"pfa":"Craig Morrison","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4249997227","eid":"W4249997227"},{"id":"paper-w4390403892","cat":"papers","name":"Naturalistic use of psychedelics does not modulate processing of self-related stimuli (but it might modulate attentional mechanisms): an event-related potentials study comparing non-users and experienced users of classic","year":"2023","cit":1,"pfa":"Paweł Orlowski","psa":"Michał Bola","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4390403892","eid":"W4390403892"},{"id":"paper-w4233223151","cat":"papers","name":"Psychotomimetic Drugs","year":"1972","cit":1,"pfa":"Richard I. Shader","ptype":"article","src":"https://openalex.org/W4233223151","eid":"W4233223151"},{"id":"paper-w4382193269","cat":"papers","name":"EFFECTS OF MICRODOSE FERTILIZATION ON SANIO MILLET (Pennisetum glaucum (L.) R. Br) IN LOW CASAMANCE (SOUTHERN SENEGAL)","year":"2023","cit":1,"pfa":"Adama Tounkara","psa":"Daouda Ngom","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4382193269","eid":"W4382193269"},{"id":"paper-w1973540207","cat":"papers","name":"Toward a rational approach to psychedelics: The controversy over popular use from a clinical viewpoint","year":"1970","cit":1,"pfa":"A. A. Weech","psa":"Richard E. Bibb","ptype":"article","src":"https://openalex.org/W1973540207","eid":"W1973540207"},{"id":"paper-w7125957137","cat":"papers","name":"Prevalence, types, and demographic characteristics associated with major life changes following psychedelic use","year":"2026","cit":1,"pfa":"Nicholas A. Carlisle","psa":"Peter S. Hendricks","topics":["Addiction","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7125957137","eid":"W7125957137"},{"id":"paper-w3187723278","cat":"papers","name":"Successful rotation from long-acting full agonist opioids to sublingual buprenorphine/naloxone using a microdosing approach","year":"2021","cit":1,"pfa":"MBBS René C. Vytialingam","psa":"MBBS Richard O’Regan","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3187723278","eid":"W3187723278"},{"id":"paper-w7155644248","cat":"papers","name":"Reopening developmental windows: Social play, safety, autonomic flexibility, and the therapeutic potential of psychedelics","year":"2026","cit":1,"pfa":"Karam Radwan","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7155644248","eid":"W7155644248"},{"id":"paper-w4402612544","cat":"papers","name":"The anxiolytic-like effect of the alkaloid fraction of the psychedelic plant Mimosa tenuiflora (Willd.) Poir","year":"2024","cit":1,"pfa":"Jady Vitória Barjud Pereira Ferreira","psa":"Maurício Pires de Moura do Amaral","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4402612544","eid":"W4402612544"},{"id":"paper-w4413597629","cat":"papers","name":"Manipulating light can induce psychedelic experiences – and scientists aren’t quite sure why","year":"2022","cit":1,"pfa":"Matthew MacKisack","psa":"Reshanne Reeder","ptype":"other","src":"https://openalex.org/W4413597629","eid":"W4413597629"},{"id":"paper-w3020890889","cat":"papers","name":"Psychotomimetic Indolealkylamines","year":"1998","cit":1,"pfa":"Karel Valter","psa":"Philippe Arrizabalaga","ptype":"book-chapter","src":"https://openalex.org/W3020890889","eid":"W3020890889"},{"id":"paper-w4386252601","cat":"papers","name":"Psychedelics and Artificial Intelligence: Integrating AI-Powered Analysis in Phenomenological Mental Health Studies","year":"2023","cit":1,"pfa":"Diego González-Rodriguez","psa":"Marta Perez-Carmona","ptype":"preprint","src":"https://openalex.org/W4386252601","eid":"W4386252601"},{"id":"paper-w4404043457","cat":"papers","name":"Does the Perception of Risk Associated with Psychedelics Use Differ in Physicians According to Their Belief of Effectiveness?","year":"2024","cit":1,"pfa":"A. Bezo","psa":"M. Hermand","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4404043457","eid":"W4404043457"},{"id":"paper-w4389078511","cat":"papers","name":"From Rubber Adulterant to Ceremonial Psychedelic: Voacanga africana in the Transnational Imagination, 1894–2018","year":"2023","cit":1,"pfa":"Timothy Vilgiate","ptype":"book-chapter","src":"https://openalex.org/W4389078511","eid":"W4389078511"},{"id":"paper-w2891468875","cat":"papers","name":"Multidrug analyses in cancer patients via intratumoral microdosing with CIVO: A microinjection technology for phase 0 drug investigation.","year":"2018","cit":1,"pfa":"Richard A. Klinghoffer","psa":"Seth M. Pollack","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W2891468875","eid":"W2891468875"},{"id":"paper-w4412896905","cat":"papers","name":"Relief from Chronic Neuropathic Pain with Ketamine but Increased Burden of Psychedelic Adverse Effects?","year":"2025","cit":1,"pfa":"José Eduardo Guimarães Pereira","psa":"Sabine Himmelseher","topics":["Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W4412896905","eid":"W4412896905"},{"id":"paper-w4367186429","cat":"papers","name":"Psychedelic Concentrations of Nitrous Oxide Reduce Functional Differentiation in Frontoparietal and Somatomotor Cortical Networks","year":"2023","cit":1,"pfa":"Rui Dai","psa":"George A. Mashour","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4367186429","eid":"W4367186429"},{"id":"paper-w4404038347","cat":"papers","name":"How Should We Expand Access to Psychedelics While Maintaining an Environment of Peace and Safety?","year":"2024","cit":1,"pfa":"Zachary J. Verne","psa":"Jeffrey  Zabinski","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4404038347","eid":"W4404038347"},{"id":"paper-w7117580003","cat":"papers","name":"Through acid psychiatry to acid communism. Psychedelic renaissance in psychiatry as a chance for a paradigm shift","year":"2025","cit":1,"pfa":"Radosław Stupak","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7117580003","eid":"W7117580003"},{"id":"paper-w4404080173","cat":"papers","name":"Proteomic analysis of psychedelic mushroom isolate and exploring potential antimicrobial peptides against bacteria","year":"2024","cit":1,"pfa":"Balakrishnan Karthiyayini","psa":"Dhanasekaran Dharumadurai","ptype":"article","src":"https://openalex.org/W4404080173","eid":"W4404080173"},{"id":"paper-w4396222451","cat":"papers","name":"Dissolving the Self, Embracing the Earth: A Philosophical Exploration of Psychedelics, Self-Transcendence, and Environmental Connection","year":"2024","cit":1,"pfa":"Muzamil Hussain","topics":["Addiction","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4396222451","eid":"W4396222451"},{"id":"paper-w3020939832","cat":"papers","name":"Psychotomimetic Agents","year":"1968","cit":1,"pfa":"John A. Scigliano","ptype":"article","src":"https://openalex.org/W3020939832","eid":"W3020939832"},{"id":"paper-w2324236610","cat":"papers","name":"Dayglo Koans and Spiritual Renewal: 1960s Psychedelic Rock Concert Posters and the Broadening of American Spirituality","year":"2004","cit":1,"pfa":"Kevin M. Moist","ptype":"article","src":"https://openalex.org/W2324236610","eid":"W2324236610"},{"id":"paper-w2606922881","cat":"papers","name":"The Value of Area Under the Curve Analysis as an Outcome Measure in the Assessment of a Continuous Microdosing Fluocinolone Acetonide Implant (ILUVIEN®)","year":"2017","cit":1,"pfa":"Sepehr Bahadorani","psa":"Michael A. Singer","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2606922881","eid":"W2606922881"},{"id":"paper-w4392783823","cat":"papers","name":"Impact of Microdosing Practices on Technical Efficiency: An Analysis Accounting for Selection Bias Among Smallholder Maize Farmers in Burkina Faso","year":"2024","cit":1,"pfa":"Didier Sawadogo","psa":"Asres Elias","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4392783823","eid":"W4392783823"},{"id":"paper-w612974127","cat":"papers","name":"Artialisation et ontogenèse des lieux contemporains : étude du courant musical \"psychedelic trance\"","year":"2006","cit":1,"pfa":"Éric Boutouyrie","topics":["Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W612974127","eid":"W612974127"},{"id":"paper-w2394939394","cat":"papers","name":"The Adventures of Acidman : Psychedelics and the Evolution of Consciousness in Science Fiction and Superhero Comics from the 1960s Onward","year":"2015","cit":1,"pfa":"Ian Stuart Garlington","ptype":"dissertation","src":"https://openalex.org/W2394939394","eid":"W2394939394"},{"id":"paper-w7162128405","cat":"papers","name":"Intention-Setting Among Recreational Psychedelic Users: Associated Acute Effects and Changes in Well-Being","year":"2026","cit":1,"pfa":"Fiona Low","psa":"Mitch Earleywine","ptype":"article","src":"https://openalex.org/W7162128405","eid":"W7162128405"},{"id":"paper-w2023281734","cat":"papers","name":"Combining luteal estradiol patch and GnRH antagonist suppression with co-flare and microdose flare stimulation for IVF in poor responders","year":"2010","cit":1,"pfa":"Jia Huang","psa":"Zev Rosenwaks","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2023281734","eid":"W2023281734"},{"id":"paper-w4366983256","cat":"papers","name":"Barriers and Facilitators to the Equitable Access of Psychedelic Medical Care and Research in Alzheimer’s Disease and Related Dementias","year":"2023","cit":1,"pfa":"Kaila A. Rudolph","topics":["Therapy practice"],"ptype":"editorial","src":"https://openalex.org/W4366983256","eid":"W4366983256"},{"id":"paper-w2050864404","cat":"papers","name":"The Intracranial Injection of Drugs in Goldfish. II: Preliminary Report on Behavior of Serotonin as a Potential Hallucinogen when Injected Intracranially and Intraabdominally","year":"1980","cit":1,"pfa":"Harold A. Abramson","psa":"A. Rolo","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2050864404","eid":"W2050864404"},{"id":"paper-w4410452378","cat":"papers","name":"Retraction: The effect of psychedelics on the level of brain-derived neurotrophic factor: A systematic review and meta-analysis","year":"2025","cit":1,"topics":["Reviews & meta-analyses"],"ptype":"retraction","src":"https://openalex.org/W4410452378","eid":"W4410452378"},{"id":"paper-w4381054163","cat":"papers","name":"Correction to: Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review","year":"2023","cit":1,"pfa":"Nina Schimmers","psa":"Robert A. Schoevers","topics":["Depression","Anxiety & end-of-life","Reviews & meta-analyses"],"ptype":"erratum","src":"https://openalex.org/W4381054163","eid":"W4381054163"},{"id":"paper-w2991089481","cat":"papers","name":"Lessons from the Psychedelic Community in Supporting People through Acute Psychosis: A Grounded Theory Study","year":"2019","cit":1,"pfa":"Emily Shah","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2991089481","eid":"W2991089481"},{"id":"paper-w7130306539","cat":"papers","name":"Cannabis and Psychedelics Among U.S. Young Adults: Use, Messaging Exposure, Perceptions, and Legalization Support","year":"2026","cit":1,"pfa":"Carla J. Berg","psa":"Y. Tony Yang","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7130306539","eid":"W7130306539"},{"id":"paper-w654497233","cat":"papers","name":"Psychedelic Rock : Drogenkult und Spiritualität in der psychedelischen Rockmusik und ihre musikpädagogische Reflexion","year":"2003","cit":1,"pfa":"Herbert Hopfgartner","ptype":"article","src":"https://openalex.org/W654497233","eid":"W654497233"},{"id":"paper-w4408187296","cat":"papers","name":"Self‐treatment with psychedelic substances for health and wellbeing in Aotearoa New Zealand: an exploratory descriptive study","year":"2025","cit":1,"pfa":"Chris Arnison","psa":"John H. Shaver","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4408187296","eid":"W4408187296"},{"id":"paper-w2951443282","cat":"papers","name":"ChemInform Abstract: ISOMERIC CYCLOPROPYL RING‐METHYLATED HOMOLOGS OF TRANS‐2‐(2,5‐DIMETHOXY‐4‐METHYLPHENYL)CYCLOPROPYLAMINE, AN HALLUCINOGEN ANALOG","year":"1982","cit":1,"pfa":"James N. Jacob","psa":"David E. Nichols","ptype":"article","src":"https://openalex.org/W2951443282","eid":"W2951443282"},{"id":"paper-w4411473088","cat":"papers","name":"Comment on Komé et al. One Size Does Not Fit All: Understanding Microdosing Semaglutide for Diabetes in Multidose Pens","year":"2025","cit":1,"pfa":"Cristina Tejera Pérez","topics":["Dosing & pharmacology"],"ptype":"letter","src":"https://openalex.org/W4411473088","eid":"W4411473088"},{"id":"paper-w4404630978","cat":"papers","name":"Processing of self-related thoughts in experienced users of classic psychedelics: A source localisation EEG study","year":"2024","cit":1,"pfa":"Anastasia Ruban","psa":"Aneta Brzezicka","ptype":"article","src":"https://openalex.org/W4404630978","eid":"W4404630978"},{"id":"paper-w4380203940","cat":"papers","name":"Sublingual buprenorphine-naloxone microdosing protocol to wean and explant intrathecal drug delivery systems for chronic non-cancer pain","year":"2023","cit":1,"pfa":"Vanessa Choi Yin Wong","psa":"Vishal P. Varshney","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4380203940","eid":"W4380203940"},{"id":"paper-w2911421883","cat":"papers","name":"The prototypical hallucinogen LSD suppresses rat dorsal raphe serotonergic neuronal activity through 5-HT1A and 5-HT2B receptors","year":"2019","cit":1,"pfa":"Sarah Delcourte","psa":"Nasser Haddjeri","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2911421883","eid":"W2911421883"},{"id":"paper-w4403808994","cat":"papers","name":"Microdosing of a kappa opioid receptor agonist within proximal nucleus accumbens shell microstructures revealing opposing behavioral outcomes","year":"2024","cit":1,"pfa":"Erin B. Rousseau","psa":"Elena H. Chartoff","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4403808994","eid":"W4403808994"},{"id":"paper-w2965516351","cat":"papers","name":"Addicted to Drug Control: The History of American Drug Prohibition and its Consequences for Modern Psychedelic Medicine","year":"2019","cit":1,"pfa":"Seth McDowell","topics":["Addiction","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W2965516351","eid":"W2965516351"},{"id":"paper-w4387402980","cat":"papers","name":"Reverse engineering therapeutic mechanisms of ketamine and Psychedelics: Insights from Translational Oncology for Research in Psychiatry","year":"2023","cit":1,"pfa":"Elizabeth E. Klettke","psa":"Gregory H. Jones","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4387402980","eid":"W4387402980"},{"id":"paper-w4407293242","cat":"papers","name":"Effects of Microdose Fertilizers and Irrigation Depth on Onion ( Allium cepa L. ) Growth Under Drip Irrigation in Northern Ethiopia","year":"2025","cit":1,"pfa":"Aemro Wale","psa":"Gashaw Beza","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4407293242","eid":"W4407293242"},{"id":"paper-w2943993657","cat":"papers","name":"Correction to: New Psychoactive Substances (NPS), Psychedelic Experiences and Dissociation: Clinical and Clinical Pharmacological Issues","year":"2019","cit":1,"pfa":"Fabrizio Schifano","psa":"Alessandro Emiliano Vento","topics":["Addiction","Dosing & pharmacology"],"ptype":"erratum","src":"https://openalex.org/W2943993657","eid":"W2943993657"},{"id":"paper-w3185020882","cat":"papers","name":"\"I Am that Very Witch\": Gender, Genre, Psychedelics, and Abjection in the 2010s \"Witch\" Horror Cycle","year":"2021","cit":1,"pfa":"Payton Alexa McCarty-Simas","ptype":"article","src":"https://openalex.org/W3185020882","eid":"W3185020882"},{"id":"paper-w2738349749","cat":"papers","name":"Scaling-up and -out of fertilizer microdosing and \"warrantage\" or inventory credit system to improve food security and farmers´ income in West Africa","year":"2007","cit":1,"pfa":"Ramadjita Tabo","psa":"Koala, Saidou","topics":["Dosing & pharmacology"],"ptype":"conference-paper","src":"https://openalex.org/W2738349749","eid":"W2738349749"},{"id":"paper-w7128511153","cat":"papers","name":"Making sense of desperation for treatment in decisions to use psychedelics for depression and anxiety: A qualitative Subreddit study anticipating clinical challenges","year":"2026","cit":1,"pfa":"David T. Kryszajtys","psa":"Jacqueline L. Bender","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7128511153","eid":"W7128511153"},{"id":"paper-w7134888175","cat":"papers","name":"Fear and Loathing in the United Nations: The Establishment of International Control of Psychedelics Through the 1971 Convention on Psychotropic Substances","year":"2026","cit":1,"pfa":"Måns Bergkvist","psa":"Bjorn Helge Johnson","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7134888175","eid":"W7134888175"},{"id":"paper-w268976549","cat":"papers","name":"CALCULATION OF PRIMARY ENERGY TRANSFER AND EFFECTIVE INACTIVATION CROSS SECTION OF BIOLOGICAL TARGETS FOR HEAVY CHARGED PARTICLES BASED ON MICRODOSE CONCEPT.","year":"1969","cit":1,"pfa":"Takao Numakunai","psa":"N. Oda","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W268976549","eid":"W268976549"},{"id":"paper-w4410956694","cat":"papers","name":"Hallucinogen Use and Associated Illicit Drug Use and Prescription Drug Misuse Among Adults in the USA: Results from a National Survey","year":"2025","cit":1,"pfa":"Yen‐Han Lee","psa":"Yen‐Chang Chang","ptype":"article","src":"https://openalex.org/W4410956694","eid":"W4410956694"},{"id":"paper-w999704416","cat":"papers","name":"Hallucinogen Persisting Perception Disorder (HPPD) After Marijuana Consumption: Clinical And In-vitro Evidence Of Cannabinoid (CB) Receptors In RPE Cells","year":"2011","cit":1,"pfa":"Ditta Zobor","psa":"Eberhart Zrenner","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W999704416","eid":"W999704416"},{"id":"paper-w7129080714","cat":"papers","name":"Fertiliser Microdosing and Organic Amendments as an Integrated Soil Fertility Management Strategy: Evidence From On‐Farm Sorghum Trials in Burkina Faso","year":"2026","cit":1,"pfa":"Yacouba Ouédraogo","psa":"Charles Louis Bielders","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7129080714","eid":"W7129080714"},{"id":"paper-w7122520569","cat":"papers","name":"Psychedelic 5-HT2A agonist increases spontaneous and evoked 5-Hz oscillations in visual and retrosplenial cortex","year":"2026","cit":1,"pfa":"Callum M. White","psa":"Dirk Jancke","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7122520569","eid":"W7122520569"},{"id":"paper-w4404286069","cat":"papers","name":"Peripheral signals, central questions: Examining the relationship between psychedelics and brain-derived neurotrophic factor (BDNF)","year":"2024","cit":1,"pfa":"Vivek Seelamneni","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4404286069","eid":"W4404286069"},{"id":"paper-w4226236336","cat":"papers","name":"Revisiting Forbidden Drugs: Chemical and Pharmacological Perspectives Over Psychedelic Indoleamines and Entactogens as Promising Therapeutic Agents","year":"2022","cit":1,"pfa":"João Pedro Evangelista Ferreira","psa":"Airton Vicente Pereira","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4226236336","eid":"W4226236336"},{"id":"paper-w4415505005","cat":"papers","name":"Associations between psychedelic use and adverse outcomes in substance use disorders: a real-world EHR-based cohort study","year":"2025","cit":1,"pfa":"Fares Qeadan","psa":"Paul D. Thielking","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4415505005","eid":"W4415505005"},{"id":"paper-w4409920380","cat":"papers","name":"Adolescent Psychedelic Use and Mental Health Is Associated with User Personality: A Representative National Study on Drug Use","year":"2025","cit":1,"pfa":"David K. Sjöström","psa":"Petri Kajonius","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4409920380","eid":"W4409920380"},{"id":"paper-w2740683281","cat":"papers","name":"Early versus long-term changes in visual acuity (VA) with continuous 0.2 µg/day fluocinolone acetonide (FAc) microdosing","year":"2017","cit":1,"pfa":"Vishak J. John","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2740683281","eid":"W2740683281"},{"id":"paper-w4404038408","cat":"papers","name":"How Should Clinicians Share Decision Making With Patients Interested in Using Psychedelics to Feel Psychologically Safe?","year":"2024","cit":1,"pfa":"Jennifer C. Jones","psa":"Aisha Mohammed","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4404038408","eid":"W4404038408"},{"id":"paper-w4412065820","cat":"papers","name":"Psychedelic 5-HT2A agonist increases spontaneous and evoked 5-Hz oscillations in visual and retrosplenial cortex","year":"2025","cit":1,"pfa":"Callum M White","psa":"Dirk Jancke","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4412065820","eid":"W4412065820"},{"id":"paper-w2895495292","cat":"papers","name":"The comparison of microdose flare up and flexible antagonist protocols in poor responders undergoing IVF treatment: A prospective randomized controlled trial","year":"2018","cit":1,"pfa":"Serdinç Özdoğan","psa":"Ümit Göktolga","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2895495292","eid":"W2895495292"},{"id":"paper-w3029022272","cat":"papers","name":"Potential of reduced agricultural lime application rates to increase yield and profitability of maize through microdosing in central Malawi - A short note","year":"2020","cit":1,"pfa":"Lolani Martin","psa":"H. Kabambe Vernon","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3029022272","eid":"W3029022272"},{"id":"paper-w1971457722","cat":"papers","name":"Changes in the electric characteristics of the inner surface of Escherichia coli cytoplasmic membrane after the binding of microdoses of copper to its outer surface","year":"2006","cit":1,"pfa":"L. A. Volodina","psa":"D. Sh. Burbaev","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1971457722","eid":"W1971457722"},{"id":"paper-w2011442021","cat":"papers","name":"Age specific pregnancy outcome in pure FSH versus FSH/LH stimulation for IVF in women with ovarian resistance on a microdose-agonist protocol","year":"2002","cit":1,"pfa":"Norbert Gleicher","psa":"A Videli","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2011442021","eid":"W2011442021"},{"id":"paper-w2165675607","cat":"papers","name":"Outcome of microdose and antagonist protocols in poor responder patients: comparison with long protocol cycles with incidentally had low number of oocytes in IVF","year":"2013","cit":1,"pfa":"Mehmet Erdem","psa":"Nuray Bozkurt","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2165675607","eid":"W2165675607"},{"id":"paper-w2944327644","cat":"papers","name":"Rapid screening of nine unradiolabeled candidate compounds as PET brain imaging agents using cassette-wave microdosing and LC-MS/MS","year":"2019","cit":1,"pfa":"Mingyue Sun","psa":"Jinping Qiao","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2944327644","eid":"W2944327644"},{"id":"paper-w4243729403","cat":"papers","name":"CNS stimulants and psychotomimetic drugs","year":"2012","cit":1,"pfa":"H P Rang","psa":"G Henderson","ptype":"book-chapter","src":"https://openalex.org/W4243729403","eid":"W4243729403"},{"id":"paper-w3124465050","cat":"papers","name":"Molecular-Scale Studies of Phosphorus Speciation and Transformation in Manure-Amended and Microdose-Fertilized Indigenous Vegetable Production Systems of Nigeria and Benin Republic","year":"2019","cit":1,"pfa":"Gourango Kar","psa":"Derek Peak","topics":["Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W3124465050","eid":"W3124465050"},{"id":"paper-w4414163110","cat":"papers","name":"Exploring the potential psychological predictors associated with changes in depression, anxiety, and well-being following naturalistic psychedelic use","year":"2025","cit":1,"pfa":"Felipe M. Herrmann","psa":"Hannes Kettner","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4414163110","eid":"W4414163110"},{"id":"paper-w2913476995","cat":"papers","name":"Erika Dyck. Psychedelic Psychiatry: LSD From Clinic To Campus. Baltimore: Johns Hopkins University Press, 2008.","year":"2010","cit":1,"pfa":"Suzanne Taylor","ptype":"book-review","src":"https://openalex.org/W2913476995","eid":"W2913476995"},{"id":"paper-w4416069807","cat":"papers","name":"GMP production of [68Ga]Ga-ATH001, a tracer targeting the platelet-derived growth factor receptor beta (PDGFRβ) for a microdose trial in humans","year":"2025","cit":1,"pfa":"Mélodie Ferrat","psa":"Thuy B. Tran","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4416069807","eid":"W4416069807"},{"id":"paper-w4391521612","cat":"papers","name":"Processing of self-related thoughts in experienced users of classic psychedelics and non-users: a source localisation EEG study","year":"2024","cit":1,"pfa":"Anastasia Ruban","psa":"Aneta Brzezicka","topics":["Addiction"],"ptype":"preprint","src":"https://openalex.org/W4391521612","eid":"W4391521612"},{"id":"paper-w2045406999","cat":"papers","name":"Stimulation of the young poor responder: our experience with luteal estradiol/GnRH antagonist suppression versus a standard protocol (OCP microdose lupron)","year":"2008","cit":1,"pfa":"S.M. Shastri","psa":"Zev Rosenwaks","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2045406999","eid":"W2045406999"},{"id":"paper-w4414579014","cat":"papers","name":"Determination and Confirmation of Psychedelic and Psychoactive Compounds in Botanical Materials by UPLC-ESI-MS/MS: Single-Laboratory Validation","year":"2025","cit":1,"pfa":"Torey French","psa":"Sidney Sudberg","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4414579014","eid":"W4414579014"},{"id":"paper-w7160316194","cat":"papers","name":"Response to: Swieczkowski D, Kwaśny A, Cubała WJ. Regulatory context for protocol amendments and public reporting in psychedelic trials","year":"2026","cit":1,"pfa":"Marija Franka Žuljević","psa":"Diana Gujinović","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7160316194","eid":"W7160316194"},{"id":"paper-w3164003221","cat":"papers","name":"A Phase 0 Microdosing PET/CT Study Using O-[18F]Fluoromethyl-d-Tyrosine in Normal Human Brain and Brain Tumor","year":"2021","cit":1,"pfa":"Hansol Moon","psa":"Sang Moo Lim","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3164003221","eid":"W3164003221"},{"id":"paper-w2416396226","cat":"papers","name":"[Changes in the electrical characteristics of the internal surface of cytoplasmic membrane of bacteria Escherichia coli after the binding of microdoses of copper ions by its external surface].","year":"2006","cit":1,"pfa":"L A Volodina","psa":"D Sh Burbaev","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2416396226","eid":"W2416396226"},{"id":"paper-w4400686993","cat":"papers","name":"Chronos vs Kairos - The Perception of Time in Near-Death Experiences, Mystical States of Consciousness, and Psychedelic-Induced States of Consciousness","year":"2024","cit":1,"pfa":"Mitchell B. Liester","topics":["Reviews & meta-analyses","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4400686993","eid":"W4400686993"},{"id":"paper-w4407067922","cat":"papers","name":"Exploring the Use of Psychedelic Drugs for Personal Growth and Mental Health Improvement: Early Qualitative Lessons From Focus Groups","year":"2025","cit":1,"pfa":"Jennifer S. Jewell","psa":"Andrew A. Monte","ptype":"article","src":"https://openalex.org/W4407067922","eid":"W4407067922"},{"id":"paper-w4404286465","cat":"papers","name":"Bernard Lerer: Pre-clinical, translational and clinical research focused on the use of psychedelic drugs and their derivatives to treat psychiatric disorders","year":"2024","cit":1,"pfa":"Bernard Lerer","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4404286465","eid":"W4404286465"},{"id":"paper-w4234212853","cat":"papers","name":"Supplemental Material for Changes in Self-Rumination and Self-Compassion Mediate the Effect of Psychedelic Experiences on Decreases in Depression, Anxiety, and Stress","year":"2021","cit":1,"topics":["Depression","Anxiety & end-of-life"],"ptype":"supplementary-materials","src":"https://openalex.org/W4234212853","eid":"W4234212853"},{"id":"paper-w4206948608","cat":"papers","name":"The SENSOR System: Using Standardized Data Entry and Dashboards for Review of Scientific Studies Using the Clinical Applications of Psychedelics as an Illustration","year":"2022","cit":1,"pfa":"Latifah Kamal","psa":"Gaurav Gupta","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4206948608","eid":"W4206948608"},{"id":"paper-w4406316139","cat":"papers","name":"The Legal Definition of Religion in the Context of Modern Religious Exercise with Psychedelics: Protection, Double Standards, and Potential Expansion under RFRA","year":"2025","cit":1,"pfa":"Allison Hoots","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4406316139","eid":"W4406316139"},{"id":"paper-w7130549565","cat":"papers","name":"Commentary on Schettino et al.: Distinguishing psychological support from psychotherapy in psychedelic medicine – Integrating intent and behavioral frameworks","year":"2026","cit":1,"pfa":"Michael Aaron Levine","psa":"Jérémie Richard","topics":["Therapy practice"],"ptype":"editorial","src":"https://openalex.org/W7130549565","eid":"W7130549565"},{"id":"paper-w4318714725","cat":"papers","name":"Pharmacokinetics of a microdosed cocktail of three direct oral anticoagulants in children with congenital heart defects: study protocol for a single-centre clinical trial (DOAC-Child)","year":"2023","cit":1,"pfa":"Simon A. Hermann","psa":"Victoria C. Ziesenitz","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4318714725","eid":"W4318714725"},{"id":"paper-w7169804046","cat":"papers","name":"Adolescent exposure to the psychedelic 25C-NBOMe in rats induces lasting competitive avoidance through disrupted hippocampal–prefrontal synchrony","year":"2026","cit":1,"pfa":"Zhi-Peng Yu","psa":"Haowei Shen","ptype":"article","src":"https://openalex.org/W7169804046","eid":"W7169804046"},{"id":"paper-w1677070416","cat":"papers","name":"Los alucinógenos y los teoremas de “Gating” en la acción psicofarmacológica alucinatoria y en la esquizofrenia/ The Hallucinogens and the Gating Theorems that explain Hallucinatory Psychopharmacology and Schizophrenia","year":"2008","cit":1,"pfa":"Carlos Manuel Quirce Balma","psa":"Roger P. Maickel","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1677070416","eid":"W1677070416"},{"id":"paper-w2083079402","cat":"papers","name":"Hicks, Richard E., and Fink, Paul J. (Eds.)Psychedelic Drugs.New York: Grune and Stratton, 1969. Pp. 249 + xiii","year":"1971","cit":1,"pfa":"Stanley Krippner","ptype":"article","src":"https://openalex.org/W2083079402","eid":"W2083079402"},{"id":"paper-w4417522448","cat":"papers","name":"Predicting Hallucinogen Use During Adolescence and Early Adulthood in Justice-Involved Youth Using the Dual Systems Model: Does Salience Vary Across the Life-Course?","year":"2025","cit":1,"pfa":"Thomas Walter Wojciechowski","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4417522448","eid":"W4417522448"},{"id":"paper-w7155629785","cat":"papers","name":"Field Notes From Inner Space: Global Psychedelic Survey Participants Report Health Benefits, Personal Growth, and Life Transformations","year":"2026","cit":1,"pfa":"Jill Robinson","psa":"Philippe Lucas","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7155629785","eid":"W7155629785"},{"id":"paper-w7117234154","cat":"papers","name":"Evaluating Nutrient Removal and Use Efficiency in Pearl Millet (Pennisetum glaucum L.) through Arbuscular Mycorrhizal Fungi Inoculation and Fertilizer Microdosing in Sahelian Sandy Soils","year":"2025","cit":1,"pfa":"Malick Ndiaye","psa":"Tahir Abdoulaye Diop","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7117234154","eid":"W7117234154"},{"id":"paper-w4416221484","cat":"papers","name":"The psychedelic phenethylamine 25C-NBF, a selective 5-HT2A agonist, shows psychoplastogenic properties and rapid antidepressant effects in male rodents","year":"2025","cit":1,"pfa":"Núria Nadal‐Gratacós","psa":"Raúl López‐Arnau","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4416221484","eid":"W4416221484"},{"id":"paper-w4412030977","cat":"papers","name":"Accept to change: Translation and validation of the Acceptance/Avoidance-Promoting Experiences Questionnaire (APEQ) in an international survey of Spanish-speaking psychedelic users","year":"2025","cit":1,"pfa":"Óscar Soto-Angona","psa":"Max Wolff","ptype":"article","src":"https://openalex.org/W4412030977","eid":"W4412030977"},{"id":"paper-w4414608888","cat":"papers","name":"Unveiling the pathways: The effects of mindfulness and recreational psychedelic experiences on well-being—The mediating roles of nondual awareness, prosociality, and meaning in life.","year":"2025","cit":1,"pfa":"Sebastian Ehmann","psa":"Michael J. Gawrysiak","ptype":"article","src":"https://openalex.org/W4414608888","eid":"W4414608888"},{"id":"paper-w7164900288","cat":"papers","name":"IARS Emery Brown Award 2026: Anesthetics and Serotonergic Psychedelics May Promote Therapeutic Neuroplasticity by Destabilizing Pathological Neuronal Circuitry","year":"2026","cit":1,"pfa":"Joseph Cichon","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7164900288","eid":"W7164900288"},{"id":"paper-w1963708388","cat":"papers","name":"Clinical Effects of Ovulation Induction With Recombinant FSH (rFSH) Supplemented With Recombinant LH (rLH) or Low-dose Recombinant HCG (rHCG) in the Midfollicular Phase in Microdose Cycles","year":"2005","cit":1,"pfa":"Murat Berkkanoğlu","psa":"K. Ozgur","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1963708388","eid":"W1963708388"},{"id":"paper-w2415804756","cat":"papers","name":"A comparison between r-LH and urinary supplements containing LH activity in patients undergoing the microdose GnRH agonist flare protocol for in-vitro fertilization: a pilot study.","year":"2016","cit":1,"pfa":"Tal Shavit","psa":"Michael Haim Dahan","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2415804756","eid":"W2415804756"},{"id":"paper-w1977415582","cat":"papers","name":"The Mystery of Manna: The Psychedelic Sacrament of the Bible Dan Merkur Rochester, VT: Park St. Press, 2000. v + 186 p","year":"2000","cit":1,"pfa":"Philip L. Tite","ptype":"article","src":"https://openalex.org/W1977415582","eid":"W1977415582"},{"id":"paper-w7163938654","cat":"papers","name":"Sustained Low-Dose Semaglutide Is Linked to Broad-Spectrum Cardiometabolic Benefits, and Better Tolerability Profile over Low-Dose Tirzepatide, Motivating Semaglutide Microdosing Studies","year":"2026","cit":1,"pfa":"Karthik Murugadoss","psa":"Venky Soundararajan","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7163938654","eid":"W7163938654"},{"id":"paper-w7136032199","cat":"papers","name":"Therapeutic-Like Context and Relational Support During Psychedelic Use Moderate Links Among Stress, Challenging Experiences, and Psychological Outcomes","year":"2026","cit":1,"pfa":"Aaron D. Cherniak","psa":"Max Wolff","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7136032199","eid":"W7136032199"},{"id":"paper-w2949220054","cat":"papers","name":"ChemInform Abstract: Synthesis und Evaluation of 2,3‐Dihydrobenzofuran Analogues of the Hallucinogen 1‐(2,5‐Dimethoxy‐4‐methylphenyl)‐2‐aminopropane: Drug Discrimination Studies in Rats.","year":"1986","cit":1,"pfa":"David E. Nichols","psa":"Robert M. Riggs","ptype":"article","src":"https://openalex.org/W2949220054","eid":"W2949220054"},{"id":"paper-w2021785474","cat":"papers","name":"The Interactions of Alcohol and Other Drugs Including Psychotomimetics","year":"1972","cit":1,"pfa":"Robert B. Forney","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2021785474","eid":"W2021785474"},{"id":"paper-w2418804852","cat":"papers","name":"Biochemical effects of psychotomimetic anticholinergic drugs.","year":"1972","cit":1,"pfa":"O'Neill Jj","psa":"Walker Jg","ptype":"article","src":"https://openalex.org/W2418804852","eid":"W2418804852"},{"id":"paper-w2416801395","cat":"papers","name":"Psychotomimetics. Chemical, pharmacological and clinical aspects.","year":"1961","cit":1,"pfa":"Alfred André Hofmann","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2416801395","eid":"W2416801395"},{"id":"paper-w4282980603","cat":"papers","name":"Abstract 620: Intratumoral microdosing via the CIVO® Platform reveals anti-tumor immune responses induced by the STING Agonist TAK-676 alone and in combination with chemotherapies","year":"2022","cit":1,"pfa":"Beryl A. Hatton","psa":"Neil B. Lineberry","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W4282980603","eid":"W4282980603"},{"id":"paper-w3016794509","cat":"papers","name":"Ketamine Induced Analgesia in Mice at Sub-psychotomimetic Dose","year":"2017","cit":1,"pfa":"Soliu Abiola Atunwa","psa":"Adegboyega Rotimi Owolabi","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3016794509","eid":"W3016794509"},{"id":"paper-w2406586568","cat":"papers","name":"[Contribution to the knowledge of hysteria based on the use of psychotomimetics].","year":"1998","cit":1,"pfa":"Franco Giberti","psa":"L Gregoretti","ptype":"article","src":"https://openalex.org/W2406586568","eid":"W2406586568"},{"id":"paper-w3160984586","cat":"papers","name":"Psychedelic Pasts—and Presents Ido Hartogsohn. American Trip: Set, Setting, and the Psychedelic Experience in the Twentieth Century. Cambridge: MIT Press, 2020. 432 pp. $35.00 Stephen Kinzer. Poisoner in Chief: Sidney Go","year":"2021","cit":1,"pfa":"Lucas Richert","topics":["Addiction","Dosing & pharmacology"],"ptype":"book-review","src":"https://openalex.org/W3160984586","eid":"W3160984586"},{"id":"paper-w2123824138","cat":"papers","name":"CENTRAL ACTIONS OF KETAMINE AND RELATED PSYCHOTOMIMETIC BENZOMORPHANS","year":"1984","cit":1,"pfa":"David Lodge","ptype":"article","src":"https://openalex.org/W2123824138","eid":"W2123824138"},{"id":"paper-w4281768015","cat":"papers","name":"How to Change Your Mind: What the New Science of Psychedelics Teaches Us About Consciousness, Dying, Addiction, Depression, and Transcendence by Michael Pollan","year":"2022","cit":1,"pfa":"Colm Harrington","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W4281768015","eid":"W4281768015"},{"id":"paper-w4398258119","cat":"papers","name":"Activity of prefrontal cortex serotonin 2A receptor expressing neurons is necessary for the head-twitch response of mice to psychedelic drug DOI in a sex-dependent manner","year":"2024","cit":1,"pfa":"Annika B. Ozols","psa":"Amelia L. Gallitano","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4398258119","eid":"W4398258119"},{"id":"paper-w4235271181","cat":"papers","name":"Acid revival: The psychedelic renaissance and the quest for medical legitimacyDanielle GiffortUniversity of Minnesota Press, 2020, 256 pp. $100.00 (cloth). ISBN 9781517906719; 9781517906726 (paper).","year":"2021","cit":1,"pfa":"Andrew Jones","ptype":"book-review","src":"https://openalex.org/W4235271181","eid":"W4235271181"},{"id":"paper-w2906945591","cat":"papers","name":"Epidemiologic Investigation of the Elderly Deaths Caused by Narcotic and Psychedelic Drug Abuse Complications Referred to the Legal Medicine Organization of Tehran, Iran During 2013 and 2014","year":"2019","cit":1,"pfa":"Seyed Saeed Hashemi Nazari","psa":"Forough Fallah-Noudehi","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2906945591","eid":"W2906945591"},{"id":"paper-w2903257329","cat":"papers","name":"How to Change Your Mind: The New Science of Psychedelics by Michael Pollan; Blue Dreams: The Science and the Story of the Drugs that Changed Our Minds by Lauren Slater","year":"2018","cit":1,"pfa":"Mike Jay","ptype":"article","src":"https://openalex.org/W2903257329","eid":"W2903257329"},{"id":"paper-w2468575104","cat":"papers","name":"[Number sets and hallucinogens and early paleolithic Moravian shaman-medicine men. An amulet from Predmost for pregnant women which bears a calculation of the time of the first movements of the child to the time of birth","year":"1986","cit":1,"pfa":"A Pokorný","ptype":"other","src":"https://openalex.org/W2468575104","eid":"W2468575104"},{"id":"paper-w3014212930","cat":"papers","name":"Impact De La Combinaison Regeneration Naturelle Assistee (Rna) Et Engrais En Microdose Sur La Productivite Du Mil (Pennisetum Glaucum (L.) R. Br.) Au Niger","year":"2020","cit":1,"pfa":"Abdou Maman Manssour","psa":"Alzouma Mayaki Zoubeirou","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3014212930","eid":"W3014212930"},{"id":"paper-w2949228138","cat":"papers","name":"ChemInform Abstract: STRUCTURE‐ACTIVITY RELATIONSHIPS IN PSYCHOTOMIMETIC PHENYLALKYLAMINES","year":"1975","cit":1,"pfa":"F.A.B. Aldous","psa":"K. J. Tutt","ptype":"article","src":"https://openalex.org/W2949228138","eid":"W2949228138"},{"id":"paper-w603591406","cat":"papers","name":"Alcohol and psychotomimetics, psychotropic effects of central acting drugs","year":"1982","cit":1,"pfa":"Leo G. Abood","psa":"Günther Stille","topics":["Addiction"],"ptype":"book","src":"https://openalex.org/W603591406","eid":"W603591406"},{"id":"paper-w1973860645","cat":"papers","name":"Gonadotropin Releasing Hormone (GnRH) antagonist versus Microdose GnRH agonist flare for in vitro fertilization (IVF) cycles in women 39 − 42 years old with normal Follicle Stimulating Hormone (FSH) levels","year":"2004","cit":1,"pfa":"Louis N. Weckstein","psa":"Kristen A. Ivani","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1973860645","eid":"W1973860645"},{"id":"paper-w4293090380","cat":"papers","name":"The acid room: The psychedelic trials and tribulations of Hollywood hospitalJesseDonaldson and ErikaDyckVancouver: Anvil Press, 2022. 160 pp. $15 soft. ISBN 978‐1‐77214‐186‐3","year":"2022","cit":1,"pfa":"Susan Lamb","ptype":"book-review","src":"https://openalex.org/W4293090380","eid":"W4293090380"},{"id":"paper-w300342297","cat":"papers","name":"Book Review: Gowan, John Curtis. Professor of Educational Psychology; California State University, Northridge. DEVELOPMENT OF THE PSYCHEDELIC INDIVIDUAL. 1974, 287 pages, paper, privately printed at $4","year":"1975","cit":1,"pfa":"Norma Jean Groth","topics":["Reviews & meta-analyses"],"ptype":"book-review","src":"https://openalex.org/W300342297","eid":"W300342297"},{"id":"paper-w4411162035","cat":"papers","name":"A Psychedelic Study of Select Stories in Padmavati the Harlot & Other Stories (Sebuah Studi Psikedelik tentang Cerita-Cerita Terpilih dalam Padmavati si Pelacur & Cerita-Cerita Lainnya)","year":"2025","cit":1,"pfa":"Vaishali Suyal","psa":"Nilofar Akhtar","ptype":"article","src":"https://openalex.org/W4411162035","eid":"W4411162035"},{"id":"paper-w2461162203","cat":"papers","name":"The effect of psychotomimetic drugs upon human chromosomes in tissue culture.","year":"1974","cit":1,"pfa":"Rendon Or","ptype":"article","src":"https://openalex.org/W2461162203","eid":"W2461162203"},{"id":"paper-w2949828705","cat":"papers","name":"ChemInform Abstract: SUBSTITUENT BRANCHING IN PHENETHYLAMINE‐TYPE HALLUCINOGENS: A COMPARISON OF 1‐(2,5‐DIMETHOXY‐4‐(2‐BUTYL)PHENYL)‐2‐AMINOPROPANE AND 1‐(2,5‐DIMETHOXY‐4‐(2‐METHYLPROPYL)PHENYL)‐2‐AMINOPROPANE","year":"1984","cit":1,"pfa":"Robert A. Oberlender","psa":"Joseph E. Zabik","ptype":"article","src":"https://openalex.org/W2949828705","eid":"W2949828705"},{"id":"paper-w4389033830","cat":"papers","name":"Psychedelics Produce Complex And Heterogeneous Transcriptional Responses In Diverse Cortical Cell Types In The Brain Of Rats As Determined By New Flow Cytometric Methods Allowing For Sorting Of Distinct Cell And Neuronal","year":"2016","cit":1,"pfa":"David Alexander Martin","psa":"Charles David Nichols","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4389033830","eid":"W4389033830"},{"id":"paper-w2510546091","cat":"papers","name":"Erika Dyck. Psychedelic Psychiatry: LSD from Clinic to Campus. xiii + 199 pp., illus., bibl., index. Baltimore: Johns Hopkins University Press, 2008. $35 (cloth).","year":"2009","cit":1,"pfa":"John Chynoweth Burnham","ptype":"book-review","src":"https://openalex.org/W2510546091","eid":"W2510546091"},{"id":"paper-w2441481104","cat":"papers","name":"EEG arousal sites of amphetamine and its psychotomimetic methoxy derivatives in rabbit brain.","year":"1971","cit":1,"pfa":"Maiko Fujimori","psa":"H E HIMWICH","ptype":"article","src":"https://openalex.org/W2441481104","eid":"W2441481104"},{"id":"paper-w4382896782","cat":"papers","name":"Essai de la combinaison des microdoses d’engrais minéraux avec le super Gro sur la productivité de la nouvelle variété biofortifiée du maïs UPN1 dans un sol sableux de Kinshasa.","year":"2022","cit":1,"pfa":"David NSIMBA Nsiku","psa":"Jean-Claude Lukombo Lukeba","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4382896782","eid":"W4382896782"},{"id":"paper-w4214829522","cat":"papers","name":"Ido Hartogsohn. American Trip: Set, Setting, and the Psychedelic Experience in the Twentieth Century. 432 pp., bibl., index. Cambridge, Mass./London: MIT Press, 2020. $35 (paper); ISBN 9780262539142.","year":"2022","cit":1,"pfa":"Alex Mold","ptype":"book-review","src":"https://openalex.org/W4214829522","eid":"W4214829522"},{"id":"paper-w4401550968","cat":"papers","name":"Safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and effects of intravenous (IV) and intramuscular (IM) dosing of SPL028 (deuterated DMT fumarate [a serotonergic psychedelic]) in healthy volunteers and","year":"2024","cit":1,"pfa":"Ezanul Wahab","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"dataset","src":"https://openalex.org/W4401550968","eid":"W4401550968"},{"id":"paper-w3160590297","cat":"papers","name":"Ido Hartogsohn, The American Trip: Set, Setting, and the Psychedelic Experience in the Twentieth Century Cambridge, MA: MIT Press, 2020. Pp. 432. ISBN: 978-0-2625-3914-2. $35.00 (paperback)","year":"2021","cit":1,"pfa":"Andrew Jones","ptype":"book-review","src":"https://openalex.org/W3160590297","eid":"W3160590297"},{"id":"paper-w3010632036","cat":"papers","name":"Effet De La Combinaison Régénération Naturelle Assistée (RNA) Et Microdose D’engrais Sur La Production Du Mil (Pennisetum Glaucum (L.) R.Br) Dans Les Zones Agro-Écologiques Du Centre-Sud Du Niger","year":"2020","cit":1,"pfa":"Zounon Christian Serge Félix","psa":"Ambouta Karimou","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3010632036","eid":"W3010632036"},{"id":"paper-w2076889729","cat":"papers","name":"Crystallographic characterization of the first reported crystalline form of the potent hallucinogen (R)-2-amino-1-(8-bromobenzo[1,2-b;5,4-b′]difuran-4-yl)propane or `bromodragonfly': the 1:1 anhydrous proton-transfer com","year":"2010","cit":1,"pfa":"Graham S. T. Smith","psa":"Sue E. Boyd","ptype":"article","src":"https://openalex.org/W2076889729","eid":"W2076889729"},{"id":"paper-w3197351506","cat":"papers","name":"Danielle Giffort. Acid Revival: The Psychedelic Renaissance and the Quest for Medical Legitimacy. xiv + 240 pp., bibl., index. Minneapolis/London: University of Minnesota Press, 2020. $25 (paper); ISBN 9781517906726. Clo","year":"2021","cit":1,"pfa":"Kim Hewitt","ptype":"book-review","src":"https://openalex.org/W3197351506","eid":"W3197351506"},{"id":"paper-w3196229157","cat":"papers","name":"Do adolescents and adults differ in the acute subjective, psychotomimetic, and memory-impairing effects of cannabis?","year":"2021","cit":1,"pfa":"Will Lawn","psa":"Matthew B. Wall","ptype":"preprint","src":"https://openalex.org/W3196229157","eid":"W3196229157"},{"id":"paper-w2954525284","cat":"papers","name":"How to change your mind: What the new science of psychedelics teaches us about consciousness, dying, addiction, depression, and transcendence By M.Pollan, (Ed.) New York, NY: Penguin Press, 2018. US$19.04. ISBN: 97815942","year":"2019","cit":1,"pfa":"Erika Dyck","topics":["Depression","Addiction"],"ptype":"book-review","src":"https://openalex.org/W2954525284","eid":"W2954525284"},{"id":"paper-w2402621548","cat":"papers","name":"[Study of the neurologic and psychopathologic effects of a new drug with psychotomimetic action (JB-329 or Ditran) in depressed patients].","year":"1998","cit":1,"pfa":"Franco Giberti","psa":"R. Rossi","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2402621548","eid":"W2402621548"},{"id":"paper-w2317859393","cat":"papers","name":"The effect of serotonergic lesions in the medial prefrontal cortex on psychotomimetic drug-induced locomotor hyperactivity and prepulse inhibition in rats","year":"2011","cit":1,"pfa":"Snezana Kusljic","psa":"den van","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2317859393","eid":"W2317859393"},{"id":"paper-w2408634771","cat":"papers","name":"[Clinical, EEG & ECG study of a new psychotomimetic drug: the methyl ester of phenyl-piperidyl-acetic acid (ritalin)].","year":"1958","cit":1,"pfa":"Levi Pg","psa":"L SINISI","ptype":"article","src":"https://openalex.org/W2408634771","eid":"W2408634771"},{"id":"paper-w4249345633","cat":"papers","name":"CORRECTION TO “METABOLISM OF THE PSYCHOTOMIMETIC TRYPTAMINE DERIVATIVE 5-METHOXY-N,N-DIISOPROPYLTRYPTAMINE IN HUMANS: IDENTIFICATION AND QUANTIFICATION OF ITS URINARY METABOLITES”","year":"2006","cit":1,"ptype":"erratum","src":"https://openalex.org/W4249345633","eid":"W4249345633"},{"id":"paper-w2949211791","cat":"papers","name":"ChemInform Abstract: CHEMICAL CONVERSION OF THE PSYCHOTOMIMETIC AMINE 1‐(2,5‐DIMETHOXY‐4‐METHYLPHENYL)‐2‐AMINOPROPANE TO 5‐HYDROXY‐2,6‐DIMETHYLINDOLE","year":"1974","cit":1,"pfa":"Jonathan S. Zweig","psa":"Neal Castagnoli","ptype":"article","src":"https://openalex.org/W2949211791","eid":"W2949211791"},{"id":"paper-w4223954559","cat":"papers","name":"Improving Medication Adherence in Convalscent Psychiatric Out-Patients Exposed to Psychotomimetic Medications in South-West, Nigeria: The Role of Medication Literacy and `Therapeutic Relationships.","year":"2022","cit":1,"pfa":"Dennis Uba Donald","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4223954559","eid":"W4223954559"},{"id":"paper-w3186250615","cat":"papers","name":"Women’s Imaging 2015 Breast Imaging Vol.10 Part 1 ターニングポイントを迎えた乳がん検診の現状と展望 III 乳がん画像診断技術の最新動向 1.デジタルマンモグラフィの最新技術動向 3)フォトンカウンティング技術・MicroDose SI(フィリップスエレクトロニクスジャパン)","year":"2015","cit":1,"pfa":"長屋重幸","psa":"黒田勝哉","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3186250615","eid":"W3186250615"},{"id":"paper-w3010396106","cat":"papers","name":"Cynthia Carson Bisbee; Paul Bisbee; Erika Dyck; Patrick Farrell; James Sexton; James W. Spisak (Editors). Psychedelic Prophets: The Letters of Aldous Huxley and Humphry Osmond. (McGill-Queen’s/Associated Medical Services","year":"2020","cit":1,"pfa":"Alex Mold","ptype":"book-review","src":"https://openalex.org/W3010396106","eid":"W3010396106"},{"id":"paper-w2054423253","cat":"papers","name":"R & D for LSD?","year":"1997","cit":1,"pfa":"Michael Farrell","ptype":"article","src":"https://openalex.org/W2054423253","eid":"W2054423253"},{"id":"paper-w6663923","cat":"papers","name":"EUPHOROHALLUCINOGENS - TOWARD A BEHAVIORAL MODEL","year":"1978","cit":1,"pfa":"Mark A. Geyer","psa":"Arnold J. Mandell","ptype":"book-chapter","src":"https://openalex.org/W6663923","eid":"W6663923"},{"id":"paper-w4413139817","cat":"papers","name":"Hallucinogenic drug use and depression, psychological distress and suicidality among disabled adults in the US","year":"2025","cit":1,"pfa":"Samantha M Ross-Cypcar","psa":"Jeanette M. Garcia","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4413139817","eid":"W4413139817"},{"id":"paper-w4388189271","cat":"papers","name":"ACD856, a Novel Positive Allosteric Modulator of Trk-receptors, Single Ascending Doses in Healthy Subjects: Safety and Pharmacokinetics","year":"2023","cit":1,"pfa":"Boel Nilsson","psa":"Märta Segerdahl","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4388189271","eid":"W4388189271"},{"id":"paper-w2464652208","cat":"papers","name":"Aplicación de microdosis de ozono en pacientes portadores de dolor o daños neurológicos. Reporte de 67 casos","year":"2016","cit":1,"pfa":"Froylán Alvarado Güémez","psa":"Gastón Mora de la Cruz","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2464652208","eid":"W2464652208"},{"id":"paper-w1990210775","cat":"papers","name":"Aggression and the Chronic Use of LSD","year":"1970","cit":1,"pfa":"K. H. Blacker","ptype":"article","src":"https://openalex.org/W1990210775","eid":"W1990210775"},{"id":"paper-w7161007765","cat":"papers","name":"N -Benzyl-Tryptamine Derivatives as Serotonin 5-HT 2 Receptor Ligands: Synthesis and Structure-Affinity/Activity Relationships","year":"2026","cit":1,"pfa":"Darío Martínez-Afani","psa":"Bruce K. Cassels","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7161007765","eid":"W7161007765"},{"id":"paper-w4387796999","cat":"papers","name":"Well-Being","year":"2023","cit":1,"pfa":"Aidan Lyon","ptype":"book-chapter","src":"https://openalex.org/W4387796999","eid":"W4387796999"},{"id":"paper-w4379878150","cat":"papers","name":"Repeated application of luteal phase oestradiol/GnRH antagonist priming increases IVF success for poor ovarian reserve patients","year":"2023","cit":1,"pfa":"Temel Ceyhan","psa":"Cem Korkmaz","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4379878150","eid":"W4379878150"},{"id":"paper-w4389078522","cat":"papers","name":"From Psychiatric Clinics to Magical Center: LSD in the Netherlands","year":"2023","cit":1,"pfa":"Stephen Snelders","topics":["PTSD & trauma","Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W4389078522","eid":"W4389078522"},{"id":"paper-w2755868395","cat":"papers","name":"Mystical mobilities and entheogenic Latin America","year":"2017","cit":1,"pfa":"Guillermo Giucci","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2755868395","eid":"W2755868395"},{"id":"paper-w2399504610","cat":"papers","name":"[Clinical evaluation of CNS drugs with PET].","year":"2009","cit":1,"pfa":"Akihiro Takano","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2399504610","eid":"W2399504610"},{"id":"paper-w1546316315","cat":"papers","name":"Pharmacological Therapeutics for Detoxification in Addictive Disorders","year":"2010","cit":1,"pfa":"Firas Kobeissy","psa":"Mark S. Gold","topics":["Addiction","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W1546316315","eid":"W1546316315"},{"id":"paper-w3022565942","cat":"papers","name":"Do Acute Experiences During Ketamine Infusions Influence its Antidepressant Effects?","year":"2020","cit":1,"pfa":"Maximillian S. Greenwald","psa":"Carlos A. Zarate","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W3022565942","eid":"W3022565942"},{"id":"paper-w4415428469","cat":"papers","name":"Self-treatment of psychiatric conditions using ketamine: Patterns, characteristics, and retrospective insights","year":"2025","cit":1,"pfa":"Gabrielle A. Smith","psa":"Cheneal Puljević","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4415428469","eid":"W4415428469"},{"id":"paper-w3110811009","cat":"papers","name":"Predicting high-risk behaviors based on associating with delinquent peers, depression, and problem solving","year":"2019","cit":1,"pfa":"Michael Bakhshesh Boroujrni","psa":"Sepideh Farajpour Niri","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3110811009","eid":"W3110811009"},{"id":"paper-w2411163695","cat":"papers","name":"[Pre-Columbian indigenous psychopharmacology].","year":"1978","cit":1,"pfa":"E Jiménez-Olivares","topics":["Depression","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"other","src":"https://openalex.org/W2411163695","eid":"W2411163695"},{"id":"paper-w7124310066","cat":"papers","name":"Whole-Body Dynamic PET Imaging of Half-Life Extended Variable Domains of Heavy Chain-Only Antibodies: Beyond Blood Pharmacokinetics","year":"2026","cit":1,"pfa":"E. Marchal","psa":"Nicolas Tournier","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7124310066","eid":"W7124310066"},{"id":"paper-w2154339694","cat":"papers","name":"Mental Health Treatment and Heroin Addiction","year":"1978","cit":1,"pfa":"Phillip E. Jacobs","psa":"A. Lurie","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2154339694","eid":"W2154339694"},{"id":"paper-w2000788076","cat":"papers","name":"The Therapeutic Implications of Poetry Writing: A Methodology","year":"1976","cit":1,"pfa":"Neil Baldwin","ptype":"article","src":"https://openalex.org/W2000788076","eid":"W2000788076"},{"id":"paper-w2965334476","cat":"papers","name":"An investigation into serotonergic and environmental interventions against depression in a simulated delayed reward paradigm","year":"2019","cit":1,"pfa":"Bernd Porr","psa":"Alex William Trew","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2965334476","eid":"W2965334476"},{"id":"paper-w2093169992","cat":"papers","name":"Medical Model or Medical Metaphor: The Impact of Third Party Payments on Drug Treatment Programs","year":"1976","cit":1,"pfa":"Arthur Stickgold","ptype":"article","src":"https://openalex.org/W2093169992","eid":"W2093169992"},{"id":"paper-w2920876494","cat":"papers","name":"An investigation into serotonergic and environmental interventions against depression in a simulated delayed reward paradigm","year":"2019","cit":1,"pfa":"Bernd Porr","psa":"Alice Miller","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W2920876494","eid":"W2920876494"},{"id":"paper-w2107422799","cat":"papers","name":"Treatment of Acute Hallucinogenic Drug Toxicity: Specific Pharmacological Intervention","year":"1973","cit":1,"pfa":"Paul F. Consroe","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2107422799","eid":"W2107422799"},{"id":"paper-w2007440474","cat":"papers","name":"Training Techniques for Physicians in the Diagnosis and Treatment of Amphetamine Abuse","year":"1978","cit":1,"pfa":"John N. Chappel","psa":"Millicent E. Buxton","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2007440474","eid":"W2007440474"},{"id":"paper-w2182731939","cat":"papers","name":"LAS PLANTAS Y LOS HONGOS ALUCINÓGENOS: REFLEXIONES PRELIMINARES SOBRE SU ROL EN LA EVOLUCIÓN HUMANA HALLUCINOGENIC PLANTS AND MUSHROOMS: PRELIMINARY REFLECTIONS ON THEIR ROLE IN HUMAN EVOLUTION","year":"2012","cit":1,"pfa":"José Manuel Rodríguez Arce","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2182731939","eid":"W2182731939"},{"id":"paper-w2036443997","cat":"papers","name":"Possible Rationale for Differential Chemotherapy of Depression In Humans: A Review of the Biogenic Amine Hypothesis Part I","year":"1976","cit":1,"pfa":"Kenneth Blum","psa":"Sanford Futterman","topics":["Depression","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2036443997","eid":"W2036443997"},{"id":"paper-w4389671612","cat":"papers","name":"Perceptual Modifying Compounds and Their Potential Therapeutic Applications in Neuropsychiatric Disorders","year":"2023","cit":1,"pfa":"Robert B. Kargbo","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"editorial","src":"https://openalex.org/W4389671612","eid":"W4389671612"},{"id":"paper-w2086535550","cat":"papers","name":"Charcoal Hemoperfusion: A Method for Removing PCP from the Blood and Body in Overdose Cases","year":"1980","cit":1,"pfa":"Raymond J. Lipicky","psa":"Freda Jacobsen","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2086535550","eid":"W2086535550"},{"id":"paper-w3031170992","cat":"papers","name":"0243 Community-Level Daytime Sleepiness and Substance Use: Implications of Sleep Time and Mental Health","year":"2020","cit":1,"pfa":"W Khader","psa":"Michael A. Grandner","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"conference-abstract","src":"https://openalex.org/W3031170992","eid":"W3031170992"},{"id":"paper-w2030056272","cat":"papers","name":"Documents on Police Bureaucracy's Conspiracy Against Human Rights of Opiate Addicts and Constitutional Rights of Medical Profession Causing Mass Breakdown of Urban Law and Order","year":"1971","cit":1,"pfa":"Allen Ginsberg","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2030056272","eid":"W2030056272"},{"id":"paper-w4403079254","cat":"papers","name":"The Optejet Technology Minimizes Preservative-Mediated Cytotoxicity of Conjunctival Epithelial Cells Treated with Latanoprost In Vitro","year":"2024","cit":1,"pfa":"Ayesha Sultan","psa":"Pedram Hamrah","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4403079254","eid":"W4403079254"},{"id":"paper-w3174303139","cat":"papers","name":"The 4 Position of 5‐HT 2A Structural Agonists Imparts the Anti‐Inflammatory Propensity Responsible for Reducing Airway Hyperrresponsiveness in Allergic Asthma","year":"2018","cit":1,"pfa":"Thomas Wayne Flanagan","psa":"Charles David Nichols","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3174303139","eid":"W3174303139"},{"id":"paper-w4205848387","cat":"papers","name":"Przez kwasową psychiatrię do kwasowego komunizmu. Renesans psychodeliczny w psychiatrii jako szansa na zmianę paradygmatu","year":"2021","cit":1,"pfa":"Radosław Stupak","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4205848387","eid":"W4205848387"},{"id":"paper-w4389858437","cat":"papers","name":"Treatment of fertile age patients with benign breast tumors","year":"2015","cit":1,"pfa":"Vladimir Ye. Karasjov","psa":"О. В. Леонов","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4389858437","eid":"W4389858437"},{"id":"paper-w2479080292","cat":"papers","name":"Ethnopharmacology in Central and South America","year":"2015","cit":1,"pfa":"Salvador Cañigueral","psa":"Jaume Sanz‐Biset","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"other","src":"https://openalex.org/W2479080292","eid":"W2479080292"},{"id":"paper-w7117361968","cat":"papers","name":"Challenges of enrolling participants with alcohol and opioid use disorders in the emergency department for clinical trials of ketamine: The experience from two randomized controlled trials","year":"2025","cit":1,"pfa":"PR Chai","psa":"Joji Suzuki","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7117361968","eid":"W7117361968"},{"id":"paper-w2115346729","cat":"papers","name":"Alter Ego Representations in San Agustin Monolithic Sculptures: Possible Plant Hallucinogenic Influences","year":"2009","cit":1,"pfa":"Marlene Dobkin de Ríos","ptype":"article","src":"https://openalex.org/W2115346729","eid":"W2115346729"},{"id":"paper-w1972089952","cat":"papers","name":"SUBSTANCE ABUSE AND ARRESTS Variations in Pretreatment Arrests of Clients in Drug Treatment Programs","year":"1981","cit":1,"pfa":"B. K. SINGH","psa":"George W. Joe","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1972089952","eid":"W1972089952"},{"id":"paper-w4409281706","cat":"papers","name":"An Innovative Cream Improves Signs and Symptoms of Dermatoporosis in Patients Aged 65 and Over","year":"2025","cit":1,"pfa":"Alan David Widgerow","psa":"Matthew Meckfessel","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4409281706","eid":"W4409281706"},{"id":"paper-w2770920009","cat":"papers","name":"LSD, Caffeine and Cholera: Possible Causes of Schizophrenia","year":"2017","cit":1,"pfa":"Paul T E Cusack","ptype":"article","src":"https://openalex.org/W2770920009","eid":"W2770920009"},{"id":"paper-w2524713119","cat":"papers","name":"[INFLUENCE OF STIMULATION PROTOCOL ON MATURITY AND MORPHOLOGICAL FEATURES OF OOCYTES IN PATIENTS WITH LOW OVARIAN RESERVE: STUDY OF 72 IVF/ICSI TREATMENT CYCLES].","year":"2016","cit":1,"pfa":"Ingilizova","psa":"С. А. Иванов","topics":["Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W2524713119","eid":"W2524713119"},{"id":"paper-w3206878357","cat":"papers","name":"The hallucinogenic serotonin 2A receptor agonist, DOI, promotes CREB-dependent gene expression of specific plasticity-associated genes in the rodent neocortex","year":"2021","cit":1,"pfa":"Lynette A. Desouza","psa":"Vidita A. Vaidya","topics":["Depression","Mechanism & neuroscience","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W3206878357","eid":"W3206878357"},{"id":"paper-w2419562985","cat":"papers","name":"[Therapeutic management of ovarian dystrophy and insufficiency in abortion disorders: recent data].","year":"2000","cit":1,"pfa":"Jean Marie Antoine","psa":"S. Uzan","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W2419562985","eid":"W2419562985"},{"id":"paper-w2070927723","cat":"papers","name":"Determination of quality factors by microdosimetry","year":"1987","cit":1,"pfa":"I.A.M. Al-Affan","psa":"D.E. Watt","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2070927723","eid":"W2070927723"},{"id":"paper-w7127444930","cat":"papers","name":"The Effect of Ecopipam on the Pharmacokinetics of Concomitant Medications","year":"2026","cit":1,"pfa":"Virginia D. Schmith","psa":"Stephen P. Wanaski","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7127444930","eid":"W7127444930"},{"id":"paper-w72177","cat":"papers","name":"Uncommon adverse effects of commonly abused illicit drugs.","year":"2013","cit":1,"pfa":"Dale A. Patterson","psa":"Adam Houghton","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"editorial","src":"https://openalex.org/W72177","eid":"W72177"},{"id":"paper-w4394606863","cat":"papers","name":"Cannabis use and dependence among festival attendees: results from the French OCTOPUS survey","year":"2024","cit":1,"pfa":"Sarah Chaaban","psa":"Caroline Victorri‐Vigneau","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4394606863","eid":"W4394606863"},{"id":"paper-w4308285398","cat":"papers","name":"Farmers perceptions of fertilizer micro-dosing adoption and continued use in Burkina Faso","year":"2022","cit":1,"pfa":"Mamadou Sanogo","psa":"Charles Louis Bielders","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4308285398","eid":"W4308285398"},{"id":"paper-w2241786326","cat":"papers","name":"Psicodelia y mística","year":"2024","cit":1,"pfa":"Ana Iribas Rudín","topics":["Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W2241786326","eid":"W2241786326"},{"id":"paper-w4206427717","cat":"papers","name":"Ketamine infusion therapy in treatment-resistant depression","year":"2021","cit":1,"pfa":"Τheodosios Ε Christodoulakis","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W4206427717","eid":"W4206427717"},{"id":"paper-w4404551767","cat":"papers","name":"Safety and cognitive pharmacodynamics following dose escalations with 3-methylmethcathinone (3-MMC): a first in human, designer drug study","year":"2024","cit":1,"pfa":"Jan G. Ramaekers","psa":"Eef Lien Theunissen","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4404551767","eid":"W4404551767"},{"id":"paper-w4403309998","cat":"papers","name":"Mindful Organisations: Cultivating Well-being, Performance, and Leadership in the Modern Workplace","year":"2024","cit":1,"pfa":"Mary C. Smith","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4403309998","eid":"W4403309998"},{"id":"paper-w4392371422","cat":"papers","name":"Above the Sea of Fog: Dietary and Lifestyle Interventions for the Treatment of Depression","year":"2024","cit":1,"pfa":"Matthew T. J. Halma","psa":"Paul Ellis Marik","topics":["Depression","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4392371422","eid":"W4392371422"},{"id":"paper-w4411530374","cat":"papers","name":"Conclusions: Comparisons of Contemporary Entheogenic Healing","year":"2025","cit":1,"pfa":"Michael J. Winkelman","topics":["Addiction","Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W4411530374","eid":"W4411530374"},{"id":"paper-w4286298417","cat":"papers","name":"New strategies for multimodal analgesia in patients with high-risk geriatric cancer in perioperative period.","year":"2022","cit":1,"pfa":"Sergey V. Tumanyan","psa":"Natalia N. Popova","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"conference-abstract","src":"https://openalex.org/W4286298417","eid":"W4286298417"},{"id":"paper-w2954300764","cat":"papers","name":"Theoretical Biochemical Mechanisms for Drug Dependence","year":"2019","cit":1,"pfa":"Doris H. Clouet","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W2954300764","eid":"W2954300764"},{"id":"paper-w4416387325","cat":"papers","name":"Receptor interaction profiles of 4-alkoxy-2,6-dimethoxyphenethylamines (Ψ derivatives) and related amphetamines","year":"2025","cit":1,"pfa":"Karolina E. Kolaczynska","psa":"Dino Luethi","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4416387325","eid":"W4416387325"},{"id":"paper-w4294911947","cat":"papers","name":"Ketamine With Psychotherapy for the Treatment of Depression","year":"2022","cit":1,"pfa":"Fernando Espí Forcén","psa":"Maren Nyer","topics":["Depression","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4294911947","eid":"W4294911947"},{"id":"paper-w4388047943","cat":"papers","name":"722 Evaluation of the effects of pembrolizumab alone and in combination(s) with MDSC-targeting agents MK-0482 and MK-4830 on the native cancer patient TME via functional spatial profiling (CIVO®)","year":"2023","cit":1,"pfa":"Kenneth R. Gundle","psa":"Richard A. Klinghoffer","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W4388047943","eid":"W4388047943"},{"id":"paper-w4413284223","cat":"papers","name":"97. NEURAL AND BEHAVIORAL EVIDENCE FROM REINFORCEMENT LEARNING CONVERGE IN SUPPORT OF RELAXED BELIEFS UNDER LSD","year":"2025","cit":1,"pfa":"Jonathan W. Kanen","psa":"Hanneke E.M. den Ouden","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"conference-abstract","src":"https://openalex.org/W4413284223","eid":"W4413284223"},{"id":"paper-w4200495736","cat":"papers","name":"Addictions and Substance Misuse","year":"2021","cit":1,"topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W4200495736","eid":"W4200495736"},{"id":"paper-w3007060162","cat":"papers","name":"COMPARATIVE EFFICACY OF HORMONAL DRUGS FOR THE PREPARATION OF THE ENDOMETRIUM FOR ABLATION IN PREMENOPAUSAL PATIENTS","year":"2019","cit":1,"pfa":"Sergey P. Sinchikhin","psa":"Lusine V. Stepanyan","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3007060162","eid":"W3007060162"},{"id":"paper-w3164073396","cat":"papers","name":"Substance Use Disorder","year":"2021","cit":1,"pfa":"Azmi R. Jahan","psa":"Douglas M. Burgess","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W3164073396","eid":"W3164073396"},{"id":"paper-w2277085964","cat":"papers","name":"The patient exhibiting episodic violent behavior.","year":"1983","cit":1,"pfa":"R E Anstett","psa":"L Wood","ptype":"article","src":"https://openalex.org/W2277085964","eid":"W2277085964"},{"id":"paper-w2435779074","cat":"papers","name":"[Comorbidity of substance abuse and psychosis. Results of a multicenter study ].","year":"2009","cit":1,"pfa":"Balázs Matuszka","psa":"József Gerevich","topics":["Addiction"],"ptype":"other","src":"https://openalex.org/W2435779074","eid":"W2435779074"},{"id":"paper-w3212616677","cat":"papers","name":"555 A high-throughput in situ screen to identify synergistic combinations of immune-oncology drugs with targeted and cytotoxic agents in a patient-derived humanized mouse model of renal cancer","year":"2021","cit":1,"pfa":"Oliver H. Jonas","psa":"Julia B. Schüler","topics":["Anxiety & end-of-life","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"conference-abstract","src":"https://openalex.org/W3212616677","eid":"W3212616677"},{"id":"paper-w2411613097","cat":"papers","name":"[Preparations for peripheral and segmental level protection of the patient in the system of general anesthesia and postoperative analgesia].","year":"2003","cit":1,"pfa":"Osipova Na","psa":"E V Bogdanova","topics":["PTSD & trauma","Addiction","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W2411613097","eid":"W2411613097"},{"id":"paper-w3010950912","cat":"papers","name":"[Research on hallucinogenic drugs used in Shaman religious activities].","year":"2017","cit":1,"pfa":"Xiaoyang Fang","psa":"B Yuan","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3010950912","eid":"W3010950912"},{"id":"paper-w4249895049","cat":"papers","name":"Drug Abuse Treatment Outcome Study--Adolescent (DATOS-A), 1993-1995: [United States]","year":"2004","cit":1,"pfa":"United States Department Of Health And Human Services. National Institutes Of…","topics":["Depression","Addiction","Therapy practice"],"ptype":"dataset","src":"https://openalex.org/W4249895049","eid":"W4249895049"},{"id":"paper-w3169885128","cat":"papers","name":"Acute Experiences During Infusions Cause Extra-Pharmacological Antidepressant Effects in Ketamine Treatment: Evidence From Randomized, Placebo-Controlled Trials","year":"2021","cit":1,"pfa":"Maximillian S. Greenwald","psa":"Carlos A. Zarate","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3169885128","eid":"W3169885128"},{"id":"paper-w2428809933","cat":"papers","name":"[Multimodal approach to postoperative analgesia in patients with neuropathic pain].","year":"2009","cit":1,"pfa":"A P Nikolaev","psa":"Svetlov Va","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2428809933","eid":"W2428809933"},{"id":"paper-w4403819762","cat":"papers","name":"A Modern View of Placebo Interventions: From Comparative Clinical Trials to Novel Therapies to Quantum Tunnelling","year":"2024","cit":1,"pfa":"Sarfaraz K. Niazi","topics":["Addiction","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4403819762","eid":"W4403819762"},{"id":"paper-w4324134526","cat":"papers","name":"Use of freshly amputated human limbs for pre-clinical evaluation of molecular-targeted fluorescent probes","year":"2023","cit":1,"pfa":"Logan M. Bateman","psa":"Eric R. Henderson","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"conference-paper","src":"https://openalex.org/W4324134526","eid":"W4324134526"},{"id":"paper-w2708531663","cat":"papers","name":"Differences in substance abuse patterns: multiple drug abuse alone versus schizophrenia with multiple drug abuse","year":"2001","cit":1,"pfa":"M. Lammertink","psa":"Ralf Pukrop","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2708531663","eid":"W2708531663"},{"id":"paper-w2224140085","cat":"papers","name":"Pathology-Important Advances in Clinical Medicine: Hepatitis-delta-Agent.","year":"1984","cit":1,"pfa":"S Govindarajan","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2224140085","eid":"W2224140085"},{"id":"paper-w2154149263","cat":"papers","name":"Multimodal Sensory Distortions in Postpartum Exacerbation of Schizophrenia","year":"2013","cit":1,"pfa":"Urvakhsh Meherwan Mehta","psa":"Jagadisha Thirthalli","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2154149263","eid":"W2154149263"},{"id":"paper-w4206157162","cat":"papers","name":"National Health Interview Survey, 1991: Drug and Alcohol Use Supplement","year":"1993","cit":1,"pfa":"United States Department Of Health And Human Services. Centers For Disease…","topics":["Addiction","Policy & ethics"],"ptype":"dataset","src":"https://openalex.org/W4206157162","eid":"W4206157162"},{"id":"paper-w3008174326","cat":"papers","name":"Sleep deprivation rapidly upregulates serotonin 2A receptor expression via the immediate early gene Egr3","year":"2019","cit":1,"pfa":"X. Zhao","psa":"Amelia L. Gallitano","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W3008174326","eid":"W3008174326"},{"id":"paper-w4236108640","cat":"papers","name":"A Coaxial Double Cylindrical TEPC for the Microdosimetry of Selected Neutron Energy Bands in Mixed Fields of Fast Neutrons","year":"1990","cit":1,"pfa":"E.B. Saion","psa":"P. Colautti","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4236108640","eid":"W4236108640"},{"id":"paper-w2898890072","cat":"papers","name":"Effect of zaï and micro dose on root biomass and the grain and straw yield so sorghum at Tangaye in the North region in Burkina Faso","year":"2018","cit":1,"pfa":"Albert Barro","psa":"Clarisse Pulchérie Kondombo","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2898890072","eid":"W2898890072"},{"id":"paper-w2944375218","cat":"papers","name":"Intensive ketamine use for multiple years: A case report","year":"2014","cit":1,"pfa":"James X. Liu","psa":"Stephen Ross","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2944375218","eid":"W2944375218"},{"id":"paper-w4414181480","cat":"papers","name":"MM120 (lysergide) in a controlled clinical setting: treatment of generalized anxiety disorder without co-occurring psychotherapeutic intervention","year":"2025","cit":1,"pfa":"Sarah M. Karas","psa":"Todd M. Solomon","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4414181480","eid":"W4414181480"},{"id":"paper-w4400781725","cat":"papers","name":"Personality vulnerabilities and adverse event reporting in phase 1 clinical studies","year":"2024","cit":1,"pfa":"Joanna Skommer","psa":"Thomas M. Polasek","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4400781725","eid":"W4400781725"},{"id":"paper-w4404085731","cat":"papers","name":"Exploring the role of genetic factors in personality disorders among women with heroin dependence","year":"2024","cit":1,"pfa":"Kadir Uludağ","psa":"Min Zhao","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4404085731","eid":"W4404085731"},{"id":"paper-w2418280601","cat":"papers","name":"Dependent opioid users assessed for methadone treatment in Otago: patterns of drug use.","year":"1997","cit":1,"pfa":"Dore Gm","psa":"Niven Be","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2418280601","eid":"W2418280601"},{"id":"paper-w4200163322","cat":"papers","name":"Development of an MRI-Compatible Nasal Drug Delivery Method for Probing Nicotine Addiction Dynamics","year":"2021","cit":1,"pfa":"Rajat Kumar","psa":"Helmut H. Strey","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4200163322","eid":"W4200163322"},{"id":"paper-w4387875303","cat":"papers","name":"Simultaneously determination of fine particle dose of vilanterol and fluticasone furoate for dry powder inhaler (DPI) by utilizing gradient elution in chromatography system","year":"2023","cit":1,"pfa":"Ewelina Szalek","psa":"Paweł Szymański","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4387875303","eid":"W4387875303"},{"id":"paper-w4396974705","cat":"papers","name":"Mood Disorders: Therapeutic Challenges in the Medically Ill Patient","year":"2024","cit":1,"pfa":"Peter A. Shapiro","psa":"Chineze Worthington","topics":["Depression","Anxiety & end-of-life"],"ptype":"book-chapter","src":"https://openalex.org/W4396974705","eid":"W4396974705"},{"id":"paper-w7131778166","cat":"papers","name":"Opioid Agonist Therapy for Fentanyl-Related Opioid Use Disorder: A Systematic Review","year":"2026","cit":1,"pfa":"Austin Daniel Solak","psa":"Christopher J. Byrne","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W7131778166","eid":"W7131778166"},{"id":"paper-w4412721552","cat":"papers","name":"Discovery of Rapid-Acting, Orally Available Antidepressants by Activating TrkB Signaling","year":"2025","cit":1,"pfa":"Xu Cheng","psa":"Wei Cui","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4412721552","eid":"W4412721552"},{"id":"paper-w4416824199","cat":"papers","name":"Patterns and Determinants of Polystimulant Use Among Patients Seeking Treatment for Stimulant Use Disorders","year":"2025","cit":1,"pfa":"Éric Janssen","psa":"Stanislas Spilka","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4416824199","eid":"W4416824199"},{"id":"paper-w3160317715","cat":"papers","name":"From hallucinations to synaesthesia: a circular inference account of unimodal and multimodal erroneous percepts in clinical and drug-induced psychosis","year":"2021","cit":1,"pfa":"Pantelis Leptourgos","psa":"Renaud Jardri","topics":["Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W3160317715","eid":"W3160317715"},{"id":"paper-w2513537219","cat":"papers","name":"A report from the 167th American Psychiatric Association Annual Meeting","year":"2014","cit":1,"pfa":"Xavier Rabasseda","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2513537219","eid":"W2513537219"},{"id":"paper-w4406430361","cat":"papers","name":"Wirkmechanismen antidepressiver Pharmakotherapie: Gehirn und Psyche – Körper und Umwelt","year":"2025","cit":1,"pfa":"Moritz Spangemacher","psa":"Gerhard Gründer","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4406430361","eid":"W4406430361"},{"id":"paper-w2913767900","cat":"papers","name":"Orexin 2 Receptor Antagonists from Prefrontal Cortical Circuitry to Rodent Behavioral Screens","year":"2019","cit":1,"pfa":"Gerard J. Marek","psa":"Mark J. Benvenga","topics":["Depression","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W2913767900","eid":"W2913767900"},{"id":"paper-w4364303471","cat":"papers","name":"The Central Mechanisms by which illicit drugs lead to addiction","year":"2022","cit":1,"pfa":"Riya Ubeja","psa":"Caroline C. Szujewski","topics":["Addiction","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4364303471","eid":"W4364303471"},{"id":"paper-w2022800443","cat":"papers","name":"Are patients with panic disorder respiratory subtype more vulnerable to tobacco, alcohol or illicit drug use?","year":"2013","cit":1,"pfa":"Rafael C. R. Freire","psa":"Antônio Egídio Nardi","topics":["Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2022800443","eid":"W2022800443"},{"id":"paper-w4376543538","cat":"papers","name":"Baroque Pop and Psychedelia: Bachian Pastness, Prestige, and Hybridity","year":"2023","cit":1,"pfa":"Thomas A. Cressy","ptype":"article","src":"https://openalex.org/W4376543538","eid":"W4376543538"},{"id":"paper-w4411812798","cat":"papers","name":"THE PROBLEM OF LEGALIZED USE OF FLY AGARICS AND DIAGNOSIS BASED ON THE RESULTS OF CLINICAL LABORATORY DIAGNOSTICS (LITERATURE REVIEW)","year":"2025","cit":1,"pfa":"E. A. Evdokimova","psa":"O Yu Strelova","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4411812798","eid":"W4411812798"},{"id":"paper-w4400496797","cat":"papers","name":"Demographic and Clinical Profile of Persons with Substance Abuse Disorder Attending Happy Life Psychological Services Islamabad, Pakistan","year":"2024","cit":1,"pfa":"Naveed Sultan","psa":"Anam Saher","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4400496797","eid":"W4400496797"},{"id":"paper-w4280488999","cat":"papers","name":"Ketamine for Chronic Pain","year":"2022","cit":1,"pfa":"Çiğdem Yıldırım Güçlü","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W4280488999","eid":"W4280488999"},{"id":"paper-w842559590","cat":"papers","name":"Coleridge's \"Kubla Khan\":Creation of Genius or Addiction?","year":"2006","cit":1,"pfa":"Karen E. Mahar","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W842559590","eid":"W842559590"},{"id":"paper-w4315797253","cat":"papers","name":"Slow Panic? The Regulation of Salvia Divinorum in Canada, 1991-2019","year":"2023","cit":1,"pfa":"Jeff Yaremko","psa":"Kevin Walby","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4315797253","eid":"W4315797253"},{"id":"paper-w4412044594","cat":"papers","name":"Bi-directional AI Framework for Differentiate Psychiatric Disorders and Predicting Symptoms from Drug-Induced Neurotoxicity","year":"2025","cit":1,"pfa":"Mutaz Khaled Yousef Abdel Wahed","psa":"Salma Abdel Wahed","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4412044594","eid":"W4412044594"},{"id":"paper-w3198862472","cat":"papers","name":"Evaluation of the Subchronic Toxicity of Seed Extract of Datura Metel Linn in Rats: A Psychoactive Substance","year":"2021","cit":1,"pfa":"T. G. Okereke","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3198862472","eid":"W3198862472"},{"id":"paper-w7128516183","cat":"papers","name":"Ketamine combined with psychotherapy for treatment-resistant depression: Real-world outcomes and the role of subjective experience","year":"2026","cit":1,"pfa":"Rebeca Cohen","psa":"Pedro Castro-Rodrigues","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7128516183","eid":"W7128516183"},{"id":"paper-w2105033037","cat":"papers","name":"P01-346-Current priorities of investigation of mental health of growing generation","year":"2011","cit":1,"pfa":"V.Y.A. Semke","topics":["Safety & adverse events","Dosing & pharmacology","Therapy practice"],"ptype":"conference-abstract","src":"https://openalex.org/W2105033037","eid":"W2105033037"},{"id":"paper-w4404855228","cat":"papers","name":"Serotonin Inhibition of Claustrum Projection Neurons: Ionic Mechanism, Receptor Subtypes and Consequences for Claustrum Computation","year":"2024","cit":1,"pfa":"Kelly L.L. Wong","psa":"George J. Augustine","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4404855228","eid":"W4404855228"},{"id":"paper-w4321782566","cat":"papers","name":"Fractional spinal anesthesia and systemic hemodynamics in frail elderly hip fracture patients","year":"2023","cit":1,"pfa":"Fredrik Olsen","psa":"Bengt Nellgård","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4321782566","eid":"W4321782566"},{"id":"paper-w4389344560","cat":"papers","name":"Psychopharmacology: Examine the Emerging Pharmaceutical Treatments for Mental Health Conditions and their Effectiveness Compared to Traditional Medication","year":"2023","cit":1,"pfa":"7450 Summit Cir, Davison, MI 48423","psa":"Sarah Alnaher","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4389344560","eid":"W4389344560"},{"id":"paper-w4200524724","cat":"papers","name":"P.0078 Inflammatory cytokine plasma levels correlation with MADRS score in patients with treatment-resistant major depression after dry-powder inhaled esketamine administration","year":"2021","cit":1,"pfa":"Mikołaj Matłoka","psa":"Jerzy Pieczykolan","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4200524724","eid":"W4200524724"},{"id":"paper-w2046012357","cat":"papers","name":"SU‐FF‐I‐36: Average Glandular Dose with Sectra MDM in Routine Mammography Screening","year":"2005","cit":1,"pfa":"Bengt Hemdal","psa":"M Olsson","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2046012357","eid":"W2046012357"},{"id":"paper-w7167284270","cat":"papers","name":"Mitochondrial-inflammation crosstalk in major depressive disorder: molecular mechanisms and therapeutic implications","year":"2026","cit":1,"pfa":"Yu Wang","psa":"Tianmei Si","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7167284270","eid":"W7167284270"},{"id":"paper-w1575092402","cat":"papers","name":"Case Files Psychiatry","year":"2006","cit":1,"pfa":"Eugene C. Toy","psa":"Debra Lee Klamen","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W1575092402","eid":"W1575092402"},{"id":"paper-w2059832591","cat":"papers","name":"2210 – A Phase Ii Randomized, Double-blind, Placebo-controlled Trial Of Glyx-13 For The Rapid Treatment Of Major Depressive Disorder Using Central Ratings","year":"2013","cit":1,"pfa":"Danielle Popp","psa":"Michael J. Detke","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2059832591","eid":"W2059832591"},{"id":"paper-w4407671586","cat":"papers","name":"Increased Risks of Major Cardiac Adverse Events in Stimulant Use Disorder as Compared With Other Substance Use Disorders: A Propensity-score Matching Cohort Study","year":"2025","cit":1,"pfa":"Nicolas Garel","psa":"Anna Lembke","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4407671586","eid":"W4407671586"},{"id":"paper-w4416589507","cat":"papers","name":"Harmaline Impairs Prepulse Inhibition through 5-HT₂A Receptor Activation: Evidence for a Serotonergic Mechanism of Action","year":"2025","cit":1,"pfa":"Hasan Enes Kurnaz","psa":"Tayfun I. Uzbay","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4416589507","eid":"W4416589507"},{"id":"paper-w2096284002","cat":"papers","name":"Evaluation of the effects of therapeutic hypothermia and cardiac arrest on specific cytochrome P450 isoform activity","year":"2011","cit":1,"pfa":"Jiangquan Zhou","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W2096284002","eid":"W2096284002"},{"id":"paper-w2182328610","cat":"papers","name":"Process Psychotherapy: Holotropic Breathwork and Alfred North Whitehead","year":"2014","cit":1,"pfa":"Lenny Gibson","psa":"Respiración Holotrópica","topics":["Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2182328610","eid":"W2182328610"},{"id":"paper-w4413300519","cat":"papers","name":"Recent Advances in the Treatment of OCD","year":"2025","cit":1,"pfa":"Anirudh Bakam","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4413300519","eid":"W4413300519"},{"id":"paper-w7108456065","cat":"papers","name":"Have you tried switching it off and on again? Mechanisms and therapeutic prospects of resetting homeostatic set points in medicine and neuropsychiatry","year":"2025","cit":1,"pfa":"Thomas Pollak","psa":"Mark J Edwards","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7108456065","eid":"W7108456065"},{"id":"paper-w4402333075","cat":"papers","name":"KETAMINE: Neural- and network-level changes","year":"2024","cit":1,"pfa":"Vishal Bharmauria","psa":"Stéphane Molotchnikoff","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4402333075","eid":"W4402333075"},{"id":"paper-w7139972475","cat":"papers","name":"Detecting neuroplastic effects induced by ketamine in healthy human subjects: A multimodal approach","year":"2026","cit":1,"pfa":"Claudio Agnorelli","psa":"David Erritzøe","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7139972475","eid":"W7139972475"},{"id":"paper-w2803551774","cat":"papers","name":"SP740ASSESSMENT OF THE EFFECT OF DRUG FORMULATION ON THE EXTENT OF THE PHARMACOKINETIC INTERACTION BETWEEN VORICONAZOLE AND TACROLIMUS","year":"2018","cit":1,"pfa":"Christian Ott","psa":"David Czock","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2803551774","eid":"W2803551774"},{"id":"paper-w4409799529","cat":"papers","name":"A systematic study of changes in monoamine neurotransmitters in the rat brain following acute administration of alpha-methyltryptamine (AMT), 5-methoxy-alpha-methyltryptamine (5-MeO-AMT) and 5-methoxy-N,N-diisopropyltryp","year":"2025","cit":1,"pfa":"Kaixi Li","psa":"Peng Hui Xu","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4409799529","eid":"W4409799529"},{"id":"paper-w7140310917","cat":"papers","name":"Ketamine Use in Self-Described Therapeutic Contexts: A Thematic Analysis of Reddit Posts","year":"2026","cit":1,"pfa":"Jared Kendrick","psa":"Pravesh Sharma","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7140310917","eid":"W7140310917"},{"id":"paper-w4392959637","cat":"papers","name":"Review on Clinical Perspective of Multiple Substance use Disorder and its Ayurvedic Management","year":"2024","cit":1,"pfa":"K Dhanya","psa":"M Jithesh","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4392959637","eid":"W4392959637"},{"id":"paper-w3028323836","cat":"papers","name":"Features of ambulatory and stationary treatment of patients with endometriosis","year":"2020","cit":1,"pfa":"Т. А. Обоскалова","psa":"Irina I. Astryuhina","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3028323836","eid":"W3028323836"},{"id":"paper-w4402335415","cat":"papers","name":"THE MULTIFACETED BURDEN OF DEPRESSION: EXPLORING CAUSES, SYMPTOMS, AND TREATMENTS","year":"2024","cit":1,"pfa":"Navinder Singh","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4402335415","eid":"W4402335415"},{"id":"paper-w4380715039","cat":"papers","name":"Abstract 13403: Substance Use is Associated With an Increased Risk for Hospital Readmission and Mortality in Patients With Heart Failure","year":"2022","cit":1,"pfa":"Samantha L Yeung","psa":"Tien M. H. Ng","topics":["Addiction","Safety & adverse events"],"ptype":"conference-abstract","src":"https://openalex.org/W4380715039","eid":"W4380715039"},{"id":"paper-w4414753099","cat":"papers","name":"Naltrexone in the Treatment of Ketamine Use Disorders: A Case Report and Literature Review","year":"2025","cit":1,"pfa":"Rishi Verma","psa":"Irene Guerrini","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4414753099","eid":"W4414753099"},{"id":"paper-w7132851986","cat":"papers","name":"Links between cannabinoid hyperemesis syndrome symptoms and drug use, mental health problems, antisocial behavior, and personality in a national survey of adults in the United States","year":"2026","cit":1,"pfa":"Brian M. Hicks","psa":"Mark Andrew Ilgen","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7132851986","eid":"W7132851986"},{"id":"paper-w4410265877","cat":"papers","name":"A review of the complex intersection between religion, spirituality, and harm reduction","year":"2025","cit":1,"pfa":"Jessica Van Denend","psa":"Gabriela Garcia‐Vassallo","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4410265877","eid":"W4410265877"},{"id":"paper-w4385728646","cat":"papers","name":"Ligand-Free Signaling of G Protein Coupled Receptors: Physiology, Pharmacology, and Genetics","year":"2023","cit":1,"pfa":"Wolfgang Sadée","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4385728646","eid":"W4385728646"},{"id":"paper-w4416833645","cat":"papers","name":"Characteristics of Youth With Recent Substance Use With and Without Substance Use Disorder Presenting for Primary Mental Healthcare in Australia: Baseline Findings From the INTEGRATE Trial","year":"2025","cit":1,"pfa":"Elaheh Ahounbar","psa":"Gillinder Bedi","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4416833645","eid":"W4416833645"},{"id":"paper-w4408242399","cat":"papers","name":"Fine-tuning of dopamine receptor signaling with aripiprazole counteracts ketamine’s dissociative action, but not its antidepressant effect","year":"2025","cit":1,"pfa":"Daiki Nakatsuka","psa":"Toshiya Murai","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4408242399","eid":"W4408242399"},{"id":"paper-w2991589087","cat":"papers","name":"[Current and future pharmacotherapy of severe psychiatric disorders].","year":"2019","cit":1,"pfa":"Eva Češková","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2991589087","eid":"W2991589087"},{"id":"paper-w4390201357","cat":"papers","name":"Lithium carbonate treatment decrease neuroinflammation and ameliorates long‐term memory in a Down syndrome animal model","year":"2023","cit":1,"pfa":"Larissa Estessi de Souza","psa":"Daniele de Paula Faria","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4390201357","eid":"W4390201357"},{"id":"paper-w2980559638","cat":"papers","name":"POSTOPERATIVE PNEUMONIA: PREVENTION AND TREATMENT IN URGENT ABDOMINAL SURGERY","year":"2018","cit":1,"pfa":"Д А Абдуллоев","psa":"Khayyam Shukhratovich Shaymardanov","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2980559638","eid":"W2980559638"},{"id":"paper-w7117304115","cat":"papers","name":"Decoding the Self: Single‐Trial Prediction of Self‐Boundary Meditation States From Magnetoencephalography Recordings","year":"2025","cit":1,"pfa":"Henrik Röhr","psa":"Marieke K. van Vugt","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7117304115","eid":"W7117304115"},{"id":"paper-w250457050","cat":"papers","name":"An intervention study to prevent gastric cancer by micro-selenium and large dose of allitridum","year":"2004","cit":1,"pfa":"李颢","psa":"谢晓燕","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W250457050","eid":"W250457050"},{"id":"paper-w2802960060","cat":"papers","name":"Abstract TMP51: Nationwide Estimates of Opioid Abuse in Young Stroke Patients","year":"2018","cit":1,"pfa":"Hari Kishan Reddy Indupuru","psa":"Farhaan Vahidy","topics":["Addiction","Safety & adverse events"],"ptype":"conference-abstract","src":"https://openalex.org/W2802960060","eid":"W2802960060"},{"id":"paper-w2938641406","cat":"papers","name":"O3.4. DOES CANNABIS INDUCE PSYCHOSIS BY ALTERING GLUTAMATE SIGNALING IN THE STRIATUM?","year":"2019","cit":1,"pfa":"Marco Colizzi","psa":"Sagnik Bhattacharyya","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2938641406","eid":"W2938641406"},{"id":"paper-w4410043463","cat":"papers","name":"Attitudes and Perceptions of Portuguese Psychiatrists and Psychologists on the Clinical Use of Ketamine","year":"2025","cit":1,"pfa":"Pedro M.P.C. Mota","psa":"Pedro J. Teixeira","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4410043463","eid":"W4410043463"},{"id":"paper-w4323354406","cat":"papers","name":"Psychoactive supplements: What to tell patients","year":"2023","cit":1,"pfa":"Marija Markovic","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4323354406","eid":"W4323354406"},{"id":"paper-w4224943684","cat":"papers","name":"Conditioned anti-immobility by ketamine: A comparison to escitalopram and bupropion.","year":"2022","cit":1,"pfa":"Brett Melanson","psa":"Francesco Leri","topics":["Depression","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4224943684","eid":"W4224943684"},{"id":"paper-w7139913325","cat":"papers","name":"N -Benzyl-tryptamine Derivatives as Serotonin 5-HT 2A Receptor (5-HT 2A R) Agonists: Focus on Different In Vitro 5-HT 2A R Activity Profiles","year":"2026","cit":1,"pfa":"Eline Pottie","psa":"Christophe Pol Stove","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7139913325","eid":"W7139913325"},{"id":"paper-w4206436381","cat":"papers","name":"Treatment Episode Data Set -- Admissions (TEDS-A), 2003","year":"2005","cit":1,"pfa":"United States Department of Health and Human Services. Substance Abuse and…","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W4206436381","eid":"W4206436381"},{"id":"paper-w2911092056","cat":"papers","name":"Treatment Episode Data Set -- Admissions (TEDS-A), 1999","year":"2002","cit":1,"pfa":"United States Department of Health and Human Services. Substance Abuse and…","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W2911092056","eid":"W2911092056"},{"id":"paper-w4214744314","cat":"papers","name":"Treatment Episode Data Set -- Admissions (TEDS-A), 2006","year":"2008","cit":1,"pfa":"United States Department Of Health And Human Services. Substance Abuse And…","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W4214744314","eid":"W4214744314"},{"id":"paper-w2910751198","cat":"papers","name":"Treatment Episode Data Set -- Admissions (TEDS-A), 1993","year":"1997","cit":1,"pfa":"United States Department of Health and Human Services. Substance Abuse and…","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W2910751198","eid":"W2910751198"},{"id":"paper-w7131666821","cat":"papers","name":"Acute and long-term psychiatric consequences of synthetic cannabinoids and related novel psychoactive substances: A systematic review","year":"2026","cit":1,"pfa":"Valerio Ricci","psa":"Giuseppe Maina","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7131666821","eid":"W7131666821"},{"id":"paper-w4206837103","cat":"papers","name":"Treatment Episode Data Set -- Admissions (TEDS-A), 2006","year":"2008","cit":1,"pfa":"United States Department Of Health And Human Services. Substance Abuse And…","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W4206837103","eid":"W4206837103"},{"id":"paper-w7164205844","cat":"papers","name":"An exploratory study of breathwork-induced altered states of consciousness in experienced practitioners: the airways to alteration (A2A) trial","year":"2026","cit":1,"pfa":"Guy W. Fincham","psa":"Alessandro Colasanti","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7164205844","eid":"W7164205844"},{"id":"paper-w1491920159","cat":"papers","name":"Microsystems manufacturing technologies for pharmaceutical toxicity testing","year":"2013","cit":1,"pfa":"Niall P. Macdonald","topics":["Safety & adverse events","Dosing & pharmacology","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W1491920159","eid":"W1491920159"},{"id":"paper-w4205838279","cat":"papers","name":"Diagnosis and management of patients with hyperandrogenism in early reproductive age","year":"2021","cit":1,"pfa":"Khashchenko E.P. Khashchenko","psa":"Elena V. Uvarova","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4205838279","eid":"W4205838279"},{"id":"paper-w4409517453","cat":"papers","name":"Case Report: Challenges of insulin and sulfonylurea dosing in an extremely premature infant for the management of KCNJ11-associated neonatal diabetes mellitus","year":"2025","cit":1,"pfa":"Ishan R Perera","psa":"Melissa D. Garganta","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4409517453","eid":"W4409517453"},{"id":"paper-w752967841","cat":"papers","name":"Pituitary suppression with GnRH agonist on alternate days: can costs, effectiveness and comfort be brought together?","year":"2011","cit":1,"pfa":"Luiz Guilherme Louzada Maldonado","psa":"Edson Borges","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W752967841","eid":"W752967841"},{"id":"paper-w4417176088","cat":"papers","name":"Mental Health, Well-Being, and Meditative Development: A Phenomenological Study of Advanced Meditators","year":"2026","cit":1,"pfa":"Sebastian Ehmann","psa":"Matthew D. Sacchet","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4417176088","eid":"W4417176088"},{"id":"paper-w3211109281","cat":"papers","name":"Predictable Biomarkers for Rapid-Acting Antidepressant Response to Ketamine","year":"2021","cit":1,"pfa":"Yunfei Tan","psa":"Kenji Hashimoto","topics":["Depression"],"ptype":"book-chapter","src":"https://openalex.org/W3211109281","eid":"W3211109281"},{"id":"paper-w3084402826","cat":"papers","name":"Substance Abuse Treatment and Its Implications on Science and Society","year":"2020","cit":1,"pfa":"David Christopher A","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3084402826","eid":"W3084402826"},{"id":"paper-w2790182746","cat":"papers","name":"05-qEEG predictors of response to antidepressive treatment with ketamine","year":"2018","cit":1,"pfa":"Martin Brunovský","psa":"Cyril Höschl","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2790182746","eid":"W2790182746"},{"id":"paper-w3115020298","cat":"papers","name":"Alcoholism, Drug Addiction, and the Road to Recovery","year":"2014","cit":1,"pfa":"Barry Stimmel","psa":"Barry Stimmel","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"book","src":"https://openalex.org/W3115020298","eid":"W3115020298"},{"id":"paper-w4306319841","cat":"papers","name":"Impact of cannabis use in patients with implantable cardiac defibrillators admitted with acute heart failure: a national perspective","year":"2022","cit":1,"pfa":"Don Mathew","psa":"Prabhjot Singh Bedi","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W4306319841","eid":"W4306319841"},{"id":"paper-w2917491849","cat":"papers","name":"Treatment Episode Data Set -- Discharges (TEDS-D), 2009","year":"2012","cit":1,"pfa":"United States Department of Health and Human Services. Substance Abuse and…","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W2917491849","eid":"W2917491849"},{"id":"paper-w2916645917","cat":"papers","name":"Treatment Episode Data Set -- Discharges (TEDS-D), 2006","year":"2009","cit":1,"pfa":"United States Department of Health and Human Services. Substance Abuse and…","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W2916645917","eid":"W2916645917"},{"id":"paper-w2413846947","cat":"papers","name":"[A study on the pharmacological action of phencyclidine].","year":"1993","cit":1,"pfa":"Tetsuro Ohmori","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W2413846947","eid":"W2413846947"},{"id":"paper-w2915666246","cat":"papers","name":"Treatment Episode Data Set -- Discharges (TEDS-D), 2008","year":"2011","cit":1,"pfa":"United States Department Of Health And Human Services. Substance Abuse And…","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W2915666246","eid":"W2915666246"},{"id":"paper-w4411706411","cat":"papers","name":"PolDrugs 2025: results of the third edition of the nationwide study on psychoactive substance use in the context of psychiatry and harm reduction","year":"2025","cit":1,"pfa":"Julia Marek","psa":"Gniewko Więckiewicz","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4411706411","eid":"W4411706411"},{"id":"paper-w4366979629","cat":"papers","name":"Interventional Psychiatry Comes of Age: How Do We Define the Practice?","year":"2023","cit":1,"pfa":"Richard A. Bermudes","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4366979629","eid":"W4366979629"},{"id":"paper-w4415123476","cat":"papers","name":"Childhood Maltreatment and Risk for Illicit Substance Use: Evidence for Mid-Adolescence as a Sensitive Exposure Period","year":"2025","cit":1,"pfa":"Alaptagin Khan","psa":"Martin H. Teicher","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4415123476","eid":"W4415123476"},{"id":"paper-w4247925650","cat":"papers","name":"Treatment Episode Data Set -- Discharges (TEDS-D) -- Concatenated, 2006 to 2008","year":"2011","cit":1,"pfa":"United States Department Of Health And Human Services. Substance Abuse And…","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W4247925650","eid":"W4247925650"},{"id":"paper-w4381681747","cat":"papers","name":"P-396 Modified Flare/GnRH antagonist protocol versus GnRH antagonist protocol in oocyte cryopreservation cycles","year":"2023","cit":1,"pfa":"Alon Kedem","psa":"Ariel Hourvitz","topics":["Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W4381681747","eid":"W4381681747"},{"id":"paper-w4388362803","cat":"papers","name":"CANNABIDIOL HAS THERAPEUTIC POTENTIAL FOR MYOFASCIAL PAIN IN FEMALE AND MALE PARKINSONIAN RATS","year":"2023","cit":1,"pfa":"Airam Nicole Vivanco-Estela","psa":"Glauce Crivelaro Nascimento","ptype":"article","src":"https://openalex.org/W4388362803","eid":"W4388362803"},{"id":"paper-w4402000888","cat":"papers","name":"Tolerability of multiphasic and monophasic combined hormonal contraceptives patients with uterine fibroids","year":"2024","cit":1,"pfa":"Natalia V. Aganezova","psa":"M.M. Buryak","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4402000888","eid":"W4402000888"},{"id":"paper-w4389957331","cat":"papers","name":"Abstract 18434: Amanita Muscaria and Pantherina Withdrawal as a Cause of Lone Atrial Fibrillation","year":"2023","cit":1,"pfa":"Alejandro Cruz Ponce","psa":"Chase Contino","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W4389957331","eid":"W4389957331"},{"id":"paper-w7128797130","cat":"papers","name":"Postoperative neurocognitive disorders, delirium, and the ketamine conundrum","year":"2026","cit":1,"pfa":"David W. Hewson","psa":"Iain Keith Moppett","ptype":"article","src":"https://openalex.org/W7128797130","eid":"W7128797130"},{"id":"paper-w4403776125","cat":"papers","name":"The therapeutic potential of cannabidiol in neuropsychiatric and neurodegenerative disorders","year":"2024","cit":1,"pfa":"Sâmia R.L. Joca","psa":"Francisco Silveira Guimarães","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4403776125","eid":"W4403776125"},{"id":"paper-w1535147254","cat":"papers","name":"The Forensic Pharmacology of Drugs of Abuse","year":"2003","cit":1,"pfa":"Robert James Flanagan","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1535147254","eid":"W1535147254"},{"id":"paper-w3145496010","cat":"papers","name":"Comparison of Water Pipes vs Other Modes of Cannabis Consumption and Subsequent Illicit Drug Use in a Longitudinal Cohort of Young Swiss Men","year":"2021","cit":1,"pfa":"Dai-Hua Tsai","psa":"Meichun Mohler‐Kuo","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3145496010","eid":"W3145496010"},{"id":"paper-w4387751977","cat":"papers","name":"S3755 Ketamine Uropathy: A Seed to Innumerable Hepatic Abscesses","year":"2023","cit":1,"pfa":"Nirali Sheth","psa":"Joel Baum","topics":["Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W4387751977","eid":"W4387751977"},{"id":"paper-w4389078430","cat":"papers","name":"Milan Hausner, the Sadská Clinic, and The Fate of LSD Psychotherapy in Communist Czechoslovakia","year":"2023","cit":1,"pfa":"Ross Crockford","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W4389078430","eid":"W4389078430"},{"id":"paper-w4387731042","cat":"papers","name":"Immediate and Long-Term Electrophysiological Biomarkers of Antidepressant Behavioral Effects After Subanesthetic Ketamine and Medial Prefrontal Cortex Deep Brain Stimulation Treatment","year":"2023","cit":1,"pfa":"Matthew Bergosh","psa":"Darrin Jason Lee","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4387731042","eid":"W4387731042"},{"id":"paper-w7127090968","cat":"papers","name":"Inflammatory models of depression in rodents and humans","year":"2026","cit":1,"pfa":"Dmitrii Markov","psa":"Oleg V. Dolotov","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7127090968","eid":"W7127090968"},{"id":"paper-w4297546141","cat":"papers","name":"Substance Use Disorders and Risk of Cardiovascular and Cerebrovascular Disease: Analysis of the Nationwide Inpatient Sample Database","year":"2022","cit":1,"pfa":"Harshil Patel","psa":"Marcel Zughaib","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4297546141","eid":"W4297546141"},{"id":"paper-w1924478058","cat":"papers","name":"Principles of Forensic Toxicology. Barry Levine, ed. Washington, DC: American Association for Clinical Chemistry, 1999, 394 pp., $49.00. ISBN 1-890889-07-7.","year":"1999","cit":1,"pfa":"Salvador F. Sena","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"book-review","src":"https://openalex.org/W1924478058","eid":"W1924478058"},{"id":"paper-w3004721580","cat":"papers","name":"Elucidating Anti‐Inflammatory Signaling Paradigm at the 5‐HT 2A Receptor","year":"2019","cit":1,"pfa":"Gerald Bernard Billac","psa":"Charles David Nichols","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3004721580","eid":"W3004721580"},{"id":"paper-w7127579907","cat":"papers","name":"AZD0780, a novel, oral PCSK9 inhibitor with properties allowing for broad use, food-intake independency and co-administration with other lipid lowering therapies","year":"2025","cit":1,"pfa":"April Barbour","psa":"Jaya Birgitte Rosenmeier","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7127579907","eid":"W7127579907"},{"id":"paper-w4292170380","cat":"papers","name":"Region-Specific Enhancement of c-fos Expression by Combined Treatment With NMDA Receptor Agonists and Antagonists With Antidepressant Potential","year":"2022","cit":1,"pfa":"Andrei-Nicolae Vasilescu","psa":"Peter Gass","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4292170380","eid":"W4292170380"},{"id":"paper-w2311583572","cat":"papers","name":"Cannabis use and psychiatric disorders","year":"2007","cit":1,"pfa":"Baba Awoye Issa","topics":["Addiction","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2311583572","eid":"W2311583572"},{"id":"paper-w4380369412","cat":"papers","name":"Intravenous Ketamine-induced Affective Switch in a Patient of Major Depressive Disorder with Suicidal Ideation: A Case Report","year":"2022","cit":1,"pfa":"Akanksha Varshney","psa":"Suhail Ahmad Azmi","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4380369412","eid":"W4380369412"},{"id":"paper-w4416088090","cat":"papers","name":"580 Phase 1 study of mitotic checkpoint inhibitor BAL0891 in combination with tislelizumab (anti-PD-1 antibody) in patients with advanced solid tumors","year":"2025","cit":1,"pfa":"Sujin Lee","psa":"Sun Young Rha","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W4416088090","eid":"W4416088090"},{"id":"paper-w7128171835","cat":"papers","name":"Links between Cannabinoid Hyperemesis Syndrome and drug use, mental health problems, antisocial behavior, and personality in a national survey of adults in the United States","year":"2026","cit":1,"pfa":"Brian M. Hicks","psa":"Mark Andrew Ilgen","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W7128171835","eid":"W7128171835"},{"id":"paper-w4310009816","cat":"papers","name":"A preclinical model of THC edibles that produces high-dose cannabimimetic responses","year":"2022","cit":1,"pfa":"Anthony English","psa":"Benjamin Bruce Land","topics":["Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4310009816","eid":"W4310009816"},{"id":"paper-w4396587311","cat":"papers","name":"Abstract PO5-27-06: Development of TTX-MC138, a First-In-Class miRNA-10b-Targeted Therapeutic Against Metastatic Cancers of Diverse Primary Disease Origins","year":"2024","cit":1,"pfa":"Zdravka O. Medarova","psa":"Susan Duggan","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W4396587311","eid":"W4396587311"},{"id":"paper-w2921477620","cat":"papers","name":"17 D2 Receptor Partial Agonists in Dual Disorders: Use of Aripiprazole in Psychotic Disorder and Comorbid Substance Use Disorder","year":"2019","cit":1,"pfa":"Daniel Hernández Huerta","psa":"Rocío Torralba Viorreta","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2921477620","eid":"W2921477620"},{"id":"paper-w2980201505","cat":"papers","name":"3110 A Case of Reflux Esophagitis Mimicking Globus Sensation in a Patient With Cannabis Abuse","year":"2019","cit":1,"pfa":"Charudatta Wankhade","psa":"Kaleem M. Rizvon","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2980201505","eid":"W2980201505"},{"id":"paper-w4392376694","cat":"papers","name":"Abstract A011: An implantable microdevice to interrogate responses to therapy in ovarian cancer","year":"2024","cit":1,"pfa":"Elizabeth H. Stover","psa":"Oliver H. Jonas","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W4392376694","eid":"W4392376694"},{"id":"paper-w3009934304","cat":"papers","name":"Effects of Adjunctive Ketamine Intravenous Infusion in Taiwanese Patients with Treatment-Resistant Depression: Antidepression, Antisuicidality, BDNF Val66Met, and Brain Imaging","year":"2020","cit":1,"pfa":"Mu‐Hong Chen","psa":"Tung‐Ping Su","topics":["Depression"],"ptype":"book-chapter","src":"https://openalex.org/W3009934304","eid":"W3009934304"},{"id":"paper-w7162560783","cat":"papers","name":"State-specific inhibition of NMDA receptors by memantine provides insight into NMDAR channel blocker tolerability","year":"2026","cit":1,"pfa":"Matthew B. Phillips","psa":"Jon W. Johnson","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7162560783","eid":"W7162560783"},{"id":"paper-w2413988782","cat":"papers","name":"[Effects of NMDA and metabotropic glutamate receptors antagonists in working memory task in rats].","year":"2009","cit":1,"pfa":"Iu A Novitskaia","psa":"Anton Bespalov","topics":["Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W2413988782","eid":"W2413988782"},{"id":"paper-w2398969848","cat":"papers","name":"[Evaluation of antipsychotic and relative drugs using disruption of prepulse inhibition as an animal model for schizophrenia].","year":"2008","cit":1,"pfa":"Katsuya Suemaru","psa":"Hiroaki Araki","topics":["Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W2398969848","eid":"W2398969848"},{"id":"paper-w1819598161","cat":"papers","name":"Quantification Methods for Clinical Studies in Nuclear Medicine - Applications in AMS, PET/CT and SPECT/CT","year":"2013","cit":1,"pfa":"Marie Sydoff","topics":["Safety & adverse events","Dosing & pharmacology","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W1819598161","eid":"W1819598161"},{"id":"paper-w7165944468","cat":"papers","name":"Pharmacokinetics and pharmacodynamics of orally administered S-ketamine in healthy participants","year":"2026","cit":1,"pfa":"Joost van Mechelen","psa":"Gabriël E. Jacobs","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7165944468","eid":"W7165944468"},{"id":"paper-w2913307695","cat":"papers","name":"For First-Episode Psychosis, Psychiatrists Should Behave like Cardiologists: Starting a Long-Acting Injectable Antipsychotic Soon after a First Psychotic Episode Can Prevent a More Destructive Second Episode","year":"2017","cit":1,"pfa":"Henry A. Nasrallah","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2913307695","eid":"W2913307695"},{"id":"paper-w2401911587","cat":"papers","name":"[NMDA-type glutamate receptor and schizophrenia].","year":"2013","cit":1,"pfa":"Toru Nishikawa","psa":"Sayuri Ishiwata","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"other","src":"https://openalex.org/W2401911587","eid":"W2401911587"},{"id":"paper-w2118730289","cat":"papers","name":"Effects of the M4 muscarinic receptor positive allosteric modulator VU0467154 on cognition and pyramidal cell firing properties in layer V of the mPFC (845.9)","year":"2014","cit":1,"pfa":"Michael D. Grannan","psa":"Carrie K. Jones","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2118730289","eid":"W2118730289"},{"id":"paper-w4412637201","cat":"papers","name":"High-frequency oscillations in the mammalian brain after ketamine and other NMDA receptor antagonists","year":"2025","cit":1,"pfa":"Mark Jeremy Hunt","psa":"Jacek Wróbel","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4412637201","eid":"W4412637201"},{"id":"paper-w2008909820","cat":"papers","name":"D2 dopamine receptor binding before and after treatment of major depression measured by single photon emission computed tomography","year":"1996","cit":1,"pfa":"Ansgar Klimke","psa":"Wolfgang Gäebel","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2008909820","eid":"W2008909820"},{"id":"paper-w7136185528","cat":"papers","name":"Ketamine for negative and depressive symptoms in schizophrenia: the evidence so far","year":"2026","cit":1,"pfa":"C.M. Diendorfer","psa":"Matthäus Willeit","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7136185528","eid":"W7136185528"},{"id":"paper-w7114895956","cat":"papers","name":"Medical Marijuana and Treatment Personalization: The Role of Genetics and Epigenetics in Response to THC and CBD","year":"2025","cit":1,"pfa":"Małgorzata Kalak","psa":"Tomasz Kalak","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7114895956","eid":"W7114895956"},{"id":"paper-w2032131153","cat":"papers","name":".SIGMA.-Ligands for new therapeutic drugs.","year":"1994","cit":1,"pfa":"Makoto Muramatsu","psa":"Makoto Tanaka","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2032131153","eid":"W2032131153"},{"id":"paper-w74513860","cat":"papers","name":"NMDA Antagonist-Induced Neurotoxicity and Psychosis","year":"2002","cit":1,"pfa":"Kevin Noguchi","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"book-chapter","src":"https://openalex.org/W74513860","eid":"W74513860"},{"id":"paper-w4413015590","cat":"papers","name":"Mechanism of antidepressant action of ketamine and differences between its two enantiomers","year":"2025","cit":1,"pfa":"Junbiao Zhan","psa":"Zhongyuan Xia","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4413015590","eid":"W4413015590"},{"id":"paper-w1997281213","cat":"papers","name":"Reply to: Rapid antidepressant effects and abuse liability of ketamine","year":"2014","cit":1,"pfa":"Todd M. Hillhouse","psa":"S. Stevens Negus","topics":["Depression"],"ptype":"letter","src":"https://openalex.org/W1997281213","eid":"W1997281213"},{"id":"paper-w2090688627","cat":"papers","name":"New Approaches to Treatment of Schizophrenia by Enhancing N-methyl- d -aspartate Neurotransmission","year":"2007","cit":1,"pfa":"Guochuan Emil Tsai","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2090688627","eid":"W2090688627"},{"id":"paper-w4386012686","cat":"papers","name":"Now I know my CBDs; cases of psychiatric admissions after delta-8-tetrahydrocannabinol (delta-8-THC, Δ⁸-THC) product usage","year":"2023","cit":1,"pfa":"Matthew J. Johnson","psa":"Andrew Malanga","topics":["Safety & adverse events","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4386012686","eid":"W4386012686"},{"id":"paper-w4310484185","cat":"papers","name":"Psychiatric outcomes following ketamine administration for orthopedic surgical anesthesia","year":"2022","cit":1,"pfa":"Alec E. Mansour","psa":"Daniel S. Saks","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4310484185","eid":"W4310484185"},{"id":"paper-w2035213629","cat":"papers","name":"The Ketamine Challenge: When Practice Leaps Ahead of Science","year":"2015","cit":1,"pfa":"Jeffrey Alan Lieberman","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2035213629","eid":"W2035213629"},{"id":"paper-w3083015017","cat":"papers","name":"A randomized comparative study of two different concentrations of ketamine and propofol combination in upper gastrointestinal endoscopy procedures","year":"2020","cit":1,"pfa":"hosni salem","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3083015017","eid":"W3083015017"},{"id":"paper-w7124445187","cat":"papers","name":"Negative allosteric modulation of α5-GABA A receptors engages dynamic cortical glutamatergic and GABAergic mechanisms underlying adaptive behavior in mice","year":"2026","cit":1,"pfa":"Fernanda Daher","psa":"Manoela V. Fogaça","topics":["Depression","Mechanism & neuroscience","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7124445187","eid":"W7124445187"},{"id":"paper-w2741795282","cat":"papers","name":"64 lH-Imidazol-l-y1)-7-nitro-2,3( lH,4H)-quinoxalinedione Hydrochloride (YMSOK) and Related Compounds: Structure-Activity Relationships for the AMPA-Type Non-NMDA Receptor","year":"1994","cit":1,"pfa":"Junya Ohmori","psa":"Kiyoshi Murase","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2741795282","eid":"W2741795282"},{"id":"paper-w2041260321","cat":"papers","name":"Pharmacotherapies for Treatment of Opioid Dependence","year":"1992","cit":1,"pfa":"Frank J. Vocci","psa":"Heinz Sorer","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2041260321","eid":"W2041260321"},{"id":"paper-w2149703248","cat":"papers","name":"Drug use, mortality and outcomes among drug users in the general population and in methadone maintenance treatment","year":"2011","cit":1,"pfa":"Ingrid Davstad","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2149703248","eid":"W2149703248"},{"id":"paper-w2018655449","cat":"papers","name":"The \"Clever Hans\" Phenomenon in Animal Models of Schizophrenia, or Homology as an Important Factor in Comparing Behavioral Functions Across Species","year":"1991","cit":1,"pfa":"Sven Ahlénius","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2018655449","eid":"W2018655449"},{"id":"paper-w2061542812","cat":"papers","name":"Discovering Addiction: The Science and Politics of Substance Abuse Research (review)","year":"2009","cit":1,"pfa":"Howard I. Kushner","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2061542812","eid":"W2061542812"},{"id":"paper-w4206120907","cat":"papers","name":"Break on Through: Radical Psychiatry and the American Counterculture by Lucas Richert","year":"2021","cit":1,"pfa":"Wendy Kline","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4206120907","eid":"W4206120907"},{"id":"paper-w4412732716","cat":"papers","name":"NMDA receptor antagonist induced c-Fos expression in the medial entorhinal cortex during postnatal development","year":"2025","cit":1,"pfa":"Feng Liang","psa":"Robert K. Naumann","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4412732716","eid":"W4412732716"},{"id":"paper-w1968003439","cat":"papers","name":"Most Drug Abusers Believe They Don’t Need Treatment","year":"2003","cit":1,"pfa":"Eve Bender","topics":["Addiction","Anxiety & end-of-life","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1968003439","eid":"W1968003439"},{"id":"paper-w4407387204","cat":"papers","name":"ADIPONECTIN ELICITS RAPID-ANTIDEPRESSANT EFFECTS IN CHRONICALLY STRESSED MICE IN ASSOCIATION WITH INCREASED GLUTAMATERGIC ACTIVITY IN THE MPFC","year":"2025","cit":1,"pfa":"Douglas Affonso Formolo","psa":"Suk‐Yu Yau","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4407387204","eid":"W4407387204"},{"id":"paper-w2182402980","cat":"papers","name":"KETAMINE FOR DEPRESSION: AN OLD DRUG WITH A NEW INDICATION","year":"2014","cit":1,"pfa":"Chiara Schepisi","psa":"Paolo Nencini","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2182402980","eid":"W2182402980"},{"id":"paper-w1583348479","cat":"papers","name":"Cognition and social behaviour in schizophrenia: An animal model investigating the potential role of nitric oxide","year":"2007","cit":1,"pfa":"Caroline Wass","topics":["Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W1583348479","eid":"W1583348479"},{"id":"paper-w2162865128","cat":"papers","name":"Neonatal viral brain infection and the development of prepulse inhibition: A neurodevelopmental model of schizophrenia","year":"2003","cit":1,"pfa":"Teemu Aitta‐aho","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2162865128","eid":"W2162865128"},{"id":"paper-w2144721965","cat":"papers","name":"Labeling in vivo of sigma receptors in mouse brain with [3H]‐(+)‐SKF 10,047: Effects of phencyclidine, (+)‐ and (−)‐N‐allylnormetazocine, and other drugs","year":"1991","cit":1,"pfa":"Robert M. Ferris","psa":"Phillip A. Topham","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2144721965","eid":"W2144721965"},{"id":"paper-w391500828","cat":"papers","name":"Schizophrenia : pathophysiological mechanisms : proceedings of the Nobel Symposium 111 on Schizophrenia, held in Stockholm, Sweden on October 1-3, 1998","year":"2000","cit":1,"pfa":"Göran Sedvall","psa":"Lars Y. Terenius","topics":["Safety & adverse events","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W391500828","eid":"W391500828"},{"id":"paper-w4283378761","cat":"papers","name":"The show must go on. Reply to “Distinct functions of S-ketamine and R-ketamine in mediating biobehavioral processes of drug dependency: comments on Bonaventura et al” by Insop Shim","year":"2022","cit":1,"pfa":"Jordi Bonaventura","psa":"Michael Michaelides","ptype":"article","src":"https://openalex.org/W4283378761","eid":"W4283378761"},{"id":"paper-w2320072034","cat":"papers","name":"Journal Scan: Benzodiazepines Reduce Ketamine-Related Emergence Reactions in Adults","year":"2011","cit":1,"pfa":"Matthew A. Waxman","psa":"Luis M. Lovato","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2320072034","eid":"W2320072034"},{"id":"paper-w94705570","cat":"papers","name":"NEUROPEPTIDE Y (NPY) AND GLUTAMATE TRANSPORTER (GLAST) IN BEHAVIORAL MODELS OF PSYCHIATRIC DISORDERS","year":"2008","cit":1,"pfa":"Rose‐Marie Karlsson","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"dissertation","src":"https://openalex.org/W94705570","eid":"W94705570"},{"id":"paper-w1529418912","cat":"papers","name":"Therapeutic Communications for Health Professionals","year":"1999","cit":1,"pfa":"Carol D. Tamparo","psa":"Wilburta Q. Lindh","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"book","src":"https://openalex.org/W1529418912","eid":"W1529418912"},{"id":"paper-w4391443953","cat":"papers","name":"Precipitated Withdrawal: What Next?","year":"2024","cit":1,"pfa":"Anthony Spadaro","psa":"Jeanmarie Perrone","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4391443953","eid":"W4391443953"},{"id":"paper-w2284270714","cat":"papers","name":"Glutamate: New Hope for Schizophrenia Treatment: Research on Glutamatergic Dyfunction May Lead to Therapies Targeting Negative and Cognitive Symptoms","year":"2011","cit":1,"pfa":"Joshua T. Kantrowitz","psa":"Daniel C. Javitt","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2284270714","eid":"W2284270714"},{"id":"paper-w7161307675","cat":"papers","name":"The dysconnection hypothesis of schizophrenia: a 30‐year update","year":"2026","cit":1,"pfa":"Karl John Friston","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7161307675","eid":"W7161307675"},{"id":"paper-w1572299820","cat":"papers","name":"Cannabinoids: Forensic Toxicology and Therapeutics","year":"2011","cit":1,"pfa":"Helena M.","psa":"Flávio Reis","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"book-chapter","src":"https://openalex.org/W1572299820","eid":"W1572299820"},{"id":"paper-w1491791435","cat":"papers","name":"Prepulse inhibition of acoustic startle in the rat. An animal model of schizophrenia","year":"1999","cit":1,"pfa":"Jianhua Zhang","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W1491791435","eid":"W1491791435"},{"id":"paper-w2167990804","cat":"papers","name":"Book of the Month: The Creation of Psychopharmacology","year":"2002","cit":1,"pfa":"Allan W. Beveridge","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2167990804","eid":"W2167990804"},{"id":"paper-w4238100713","cat":"papers","name":"The structure of acute chemical poisoning in patients with HIV infection in the emergency hospital","year":"2018","cit":1,"pfa":"М.М. Поцхверия","psa":"Mikhail A. Godkov","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4238100713","eid":"W4238100713"},{"id":"paper-w4403219500","cat":"papers","name":"Editorial: International day of happiness: happiness and wellbeing in the age of climate catastrophe","year":"2024","cit":1,"pfa":"Andrew Haddon Kemp","psa":"Panu Pihkala","topics":["Anxiety & end-of-life","Safety & adverse events","Therapy practice"],"ptype":"editorial","src":"https://openalex.org/W4403219500","eid":"W4403219500"},{"id":"paper-w4285119620","cat":"papers","name":"Efficacy and Safety of Repeated Subcutaneous Ketamine Injections for Treatment Resistant Depression - The KADS Study: A Randomised, Double-Blind, Comparator-Controlled Trial","year":"2022","cit":1,"pfa":"Colleen K A Loo","psa":"Anthony J. Rodgers","topics":["Depression","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4285119620","eid":"W4285119620"},{"id":"paper-w4248621753","cat":"papers","name":"Esketamine","year":"2020","cit":1,"pfa":"Stephen M. Stahl","ptype":"other","src":"https://openalex.org/W4248621753","eid":"W4248621753"},{"id":"paper-w4387411972","cat":"papers","name":"Spravato (Esketamine)","year":"2023","cit":1,"pfa":"V. Nirosha","psa":"V. Gayathri","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W4387411972","eid":"W4387411972"},{"id":"paper-w4414383152","cat":"papers","name":"Ketamine and Esketamine","year":"2025","cit":1,"pfa":"Samuel T. Wilkinson","psa":"Taeho Greg Rhee","ptype":"article","src":"https://openalex.org/W4414383152","eid":"W4414383152"},{"id":"paper-w4403902254","cat":"papers","name":"Progress in the Clinical Application of Esketamine","year":"2024","cit":1,"pfa":"宇 乔","ptype":"article","src":"https://openalex.org/W4403902254","eid":"W4403902254"},{"id":"paper-w7125493960","cat":"papers","name":"Esketamine in bipolar depression: Unreproducible data","year":"2026","cit":1,"pfa":"Liang-Chun Wang","psa":"Joshua Wang","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7125493960","eid":"W7125493960"},{"id":"paper-w4404211668","cat":"papers","name":"Esketamine-Induced Dissociation: A Case Report","year":"2024","cit":1,"pfa":"Jake Scarcella","psa":"Thomas L. Schwartz","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4404211668","eid":"W4404211668"},{"id":"paper-w4206978697","cat":"papers","name":"Esketamine for treatment-resistant depression in adults","year":"2022","cit":1,"pfa":"Chiara Gastaldon","psa":"Corrado Barbui","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4206978697","eid":"W4206978697"},{"id":"paper-w3208105066","cat":"papers","name":"(2R,6R)-Hydroxynorketamine, A Metabolite of Ketamine: The Antidepressant Actions and the Mechanisms","year":"2021","cit":1,"pfa":"Kenichi Fukumoto","psa":"Ronald S. Duman","topics":["Depression","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W3208105066","eid":"W3208105066"},{"id":"paper-w3186960871","cat":"papers","name":"Intranasal esketamine and the dawn of precision psychiatry","year":"2021","cit":1,"pfa":"Devon Watts","psa":"Flávio Pereira Kapczinski","ptype":"article","src":"https://openalex.org/W3186960871","eid":"W3186960871"},{"id":"paper-w4375816927","cat":"papers","name":"Medication for Depression: Monoamine Enhancers and Esketamine (Antidepressants)","year":"2023","cit":1,"pfa":"Seon‐Cheol Park","psa":"Winston Wu‐Dien Shen","topics":["Depression"],"ptype":"book-chapter","src":"https://openalex.org/W4375816927","eid":"W4375816927"},{"id":"paper-w4294201735","cat":"papers","name":"Clinical efficacy and tolerability of Esketamine: a case series","year":"2022","cit":1,"pfa":"Carolina Passani","psa":"Cristina Colombo","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4294201735","eid":"W4294201735"},{"id":"paper-w4413423770","cat":"papers","name":"Esketamine in Geriatric Depression and Pseudodementia: A Case Study","year":"2025","cit":1,"pfa":"Filippo Mazzoni","psa":"Miriam Olivola","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4413423770","eid":"W4413423770"},{"id":"paper-w7163384652","cat":"papers","name":"Prophylactic esketamine to reduce postpartum depression in primiparae","year":"2026","cit":1,"pfa":"Weijia Du","psa":"Zhiqiang Liu","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7163384652","eid":"W7163384652"},{"id":"paper-w4410753027","cat":"papers","name":"Esketamine treatment: advances in personalized clinical monitoring","year":"2025","cit":1,"pfa":"Ingrid Tonhajzerová","psa":"Igor Ondrejka","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4410753027","eid":"W4410753027"},{"id":"paper-w7142611232","cat":"papers","name":"Clinical applications of esketamine: Current status and future perspectives","year":"2026","cit":1,"pfa":"Hui Li","psa":"Yuenong Zhang","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7142611232","eid":"W7142611232"},{"id":"paper-w3081034088","cat":"papers","name":"Fairness and Protection for the Vulnerable: Lessons from Esketamine","year":"2020","cit":1,"pfa":"Gin S. Malhi","psa":"Julian Savulescu","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3081034088","eid":"W3081034088"},{"id":"paper-w4415659097","cat":"papers","name":"Racemic Ketamine vs Esketamine in Treatment-Resistant Depression","year":"2025","cit":1,"pfa":"Yunfei Tan","psa":"Kenji Hashimoto","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4415659097","eid":"W4415659097"},{"id":"paper-w3027212309","cat":"papers","name":"Esketamine nasal spray for treatment‐resistant depression","year":"2020","cit":1,"pfa":"Steve Chaplin","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3027212309","eid":"W3027212309"},{"id":"paper-w4415494603","cat":"papers","name":"Esketamine for Treatment-Resistant Depression in Pakistan: A Promising Strategy","year":"2025","cit":1,"pfa":"Moomal Memon","psa":"Muhammad Momin Khan","topics":["Depression","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4415494603","eid":"W4415494603"},{"id":"paper-w4200314999","cat":"papers","name":"P.0899 Pilot study of the neurocognitive effects of arketamine in treatment-resistant depression and bipolar depression","year":"2021","cit":1,"pfa":"Breno Souza‐Marques","psa":"Lucas C. Quarantini","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4200314999","eid":"W4200314999"},{"id":"paper-w4403046839","cat":"papers","name":"Challenges for esketamine nasal spray in China: use and management","year":"2024","cit":1,"pfa":"Jianhong Wu","psa":"Zhenhe Zhou","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4403046839","eid":"W4403046839"},{"id":"paper-w7131231411","cat":"papers","name":"Compatibility and stability of ciprofol with different concentrations of remifentanil or esketamine","year":"2026","cit":1,"pfa":"Xi Cheng","psa":"Fuchao Chen","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7131231411","eid":"W7131231411"},{"id":"paper-w4400007691","cat":"papers","name":"Intranasal esketamine and manic symptoms: A disproportionality analysis in EudraVigilance","year":"2024","cit":1,"pfa":"Vladimir Akhrimenko","psa":"Unax Lertxundi","ptype":"article","src":"https://openalex.org/W4400007691","eid":"W4400007691"},{"id":"paper-w4398780513","cat":"papers","name":"The optimal esketamine dosage for perioperative depression: A meta-regression","year":"2024","cit":1,"pfa":"I‐Wen Chen","psa":"Kuo‐Chuan Hung","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4398780513","eid":"W4398780513"},{"id":"paper-w4391211527","cat":"papers","name":"Esketamine in the Treatment of Depression with Co-Morbid Anorexia Nervosa","year":"2024","cit":1,"pfa":"Philip A. P. M. Gorwood","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4391211527","eid":"W4391211527"},{"id":"paper-w2607926272","cat":"papers","name":"790. Ketamine Exerts NMDAR Inhibition-Independent Antidepressant Actions via Its Hydroxynorketamine Metabolites","year":"2017","cit":1,"pfa":"Panos Zanos","psa":"Todd D. Gould","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2607926272","eid":"W2607926272"},{"id":"paper-w4414111168","cat":"papers","name":"Safety of Esketamine Nasal Spray Is Consistent With Clinical Reports","year":"2025","cit":1,"pfa":"Mark Moran","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4414111168","eid":"W4414111168"},{"id":"paper-w4390547870","cat":"papers","name":"Esketamine Nasal Spray versus Quetiapine for Resistant Depression","year":"2024","cit":1,"pfa":"Mark Abie Horowitz","psa":"Florian Naudet","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4390547870","eid":"W4390547870"},{"id":"paper-w7127284762","cat":"papers","name":"Are the current safety measures for the treatment of depression with esketamine sufficient?","year":"2026","cit":1,"pfa":"Kyle Valentino","psa":"Roger S. McIntyre","topics":["Depression","Safety & adverse events"],"ptype":"editorial","src":"https://openalex.org/W7127284762","eid":"W7127284762"},{"id":"paper-w4401919621","cat":"papers","name":"“Esketamine” in Borderline Personality Disorder: focud on suicide ideation","year":"2024","cit":1,"pfa":"Miriam Olivola","psa":"Natascia Brondino","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4401919621","eid":"W4401919621"},{"id":"paper-w3217001861","cat":"papers","name":"How effective are ketamine or esketamine in treatment-resistant depression?","year":"2021","cit":1,"pfa":"Nikhila Veluri","psa":"Zeeshan Mansuri","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3217001861","eid":"W3217001861"},{"id":"paper-w4388423827","cat":"papers","name":"Use of esketamine and propofol combination for reducing hypotension risk","year":"2023","cit":1,"pfa":"I‐Wen Chen","psa":"Kuo‐Chuan Hung","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4388423827","eid":"W4388423827"},{"id":"paper-w7166578209","cat":"papers","name":"Patient-centred education for ketamine and esketamine therapies in mood disorders","year":"2026","cit":1,"pfa":"Zofia Kachlik","psa":"Michał Walaszek","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7166578209","eid":"W7166578209"},{"id":"paper-w2797661793","cat":"papers","name":"188. Common Neurotransmission Recruited in Ketamine and (2R,6R)-Hydroxynorketamine-Induced Sustained Antidepressant Effects","year":"2018","cit":1,"pfa":"Alain Michel Gardier","psa":"Christine Ann Denny","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2797661793","eid":"W2797661793"},{"id":"paper-w3042907150","cat":"papers","name":"P199 - HILIC UPLC-MS/MS methods for the assessment of hydroxynorketamines pharmacokinetics in mouse plasma and brain","year":"2020","cit":1,"pfa":"Amy Q. Wang","psa":"Xin Xu","topics":["Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W3042907150","eid":"W3042907150"},{"id":"paper-w4401906815","cat":"papers","name":"Neurocognitive changes in a patient receiving esketamine for treatment-resistant depression","year":"2024","cit":1,"pfa":"Carolyn F. Kundert","psa":"Muaid Ithman","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4401906815","eid":"W4401906815"},{"id":"paper-w4285818746","cat":"papers","name":"Research Progress on the Effects of Ketamine and Esketamine on Perioperative Neurocognitive Function","year":"2022","cit":1,"pfa":"萌 崔","ptype":"article","src":"https://openalex.org/W4285818746","eid":"W4285818746"},{"id":"paper-w7166155528","cat":"papers","name":"Pain control or brain protection: which mechanism defines esketamine?","year":"2026","cit":1,"pfa":"Lu Jin","psa":"Qian Gao","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7166155528","eid":"W7166155528"},{"id":"paper-w3095261702","cat":"papers","name":"Esketamine: the first glutamatergic drug for the management of treatment- resistant depression","year":"2020","cit":1,"pfa":"Laura Musazzi","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3095261702","eid":"W3095261702"},{"id":"paper-w7147550206","cat":"papers","name":"Esketamine Nasal Spray: Mechanism of Action, Clinical, and Translational Science","year":"2026","cit":1,"pfa":"Matthijs W. van Hoogdalem","psa":"Peter Zannikos","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7147550206","eid":"W7147550206"},{"id":"paper-w7117995447","cat":"papers","name":"Maintaining clinical improvement with intranasal esketamine in treatment resistant depression","year":"2026","cit":1,"pfa":"J.E. Mesones Peral","psa":"E. Sáez Fuentes","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7117995447","eid":"W7117995447"},{"id":"paper-w4321373948","cat":"papers","name":"The parable of the Therapeutic Goods Administration approval of esketamine (Spravato) in Australia","year":"2023","cit":1,"pfa":"William Lugg","topics":["Safety & adverse events","Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4321373948","eid":"W4321373948"},{"id":"paper-w4251646734","cat":"papers","name":"Common neurotransmission recruited in (R,S)-ketamine and (2R,6R)-hydroxynorketamine-induced sustained antidepressant-like effects","year":"2017","cit":1,"pfa":"Thu Ha Pham","topics":["Depression"],"ptype":"other","src":"https://openalex.org/W4251646734","eid":"W4251646734"},{"id":"paper-w7203456133","cat":"papers","name":"Patient selection and safety of lidocaine–esketamine analgesia after hepatectomy","year":"2026","cit":1,"pfa":"Haiyue Yu","psa":"Hang Lyu","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7203456133","eid":"W7203456133"},{"id":"paper-w4416819241","cat":"papers","name":"Esketamine in Treatment-Resistant Depression and Suicidal Ideation: A Systematic Review","year":"2025","cit":1,"pfa":"Natalia Dudziak","psa":"Patrycja Gągałka","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W4416819241","eid":"W4416819241"},{"id":"paper-w4379966756","cat":"papers","name":"Giovanni Martinotti: Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine and bipolar × unipolar treatment resistant depression","year":"2023","cit":1,"pfa":"Maria Ana Sousa Gonçalves","psa":"Fábio Gomes de Matos e Souza","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4379966756","eid":"W4379966756"},{"id":"paper-w4407998476","cat":"papers","name":"The role of esketamine in persistent long COVID with predominant psychiatric manifestations","year":"2025","cit":1,"pfa":"Ina Bozic","psa":"Lucie Bartova","ptype":"article","src":"https://openalex.org/W4407998476","eid":"W4407998476"},{"id":"paper-w4404173495","cat":"papers","name":"Perioperative esketamine administration on depression: A systematic review and meta-analysis","year":"2024","cit":1,"pfa":"Yonghui Shen","psa":"Wanwen Li","topics":["Depression","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4404173495","eid":"W4404173495"},{"id":"paper-w4402939058","cat":"papers","name":"Statewide Ketamine and Esketamine Prescribing Trends in Rhode Island, 2017-2023.","year":"2024","cit":1,"pfa":"Taylor J Paiva","psa":"Rachel Wightman","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4402939058","eid":"W4402939058"},{"id":"paper-w4406254568","cat":"papers","name":"Effectiveness of Esketamine as a Treatment for Depression: A Real-World Survey of Disease Improvement","year":"2024","cit":1,"pfa":"Amanda Teeple","psa":"Manish Jha","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4406254568","eid":"W4406254568"},{"id":"paper-w4401651948","cat":"papers","name":"Determining postoperative benefits of intravenous lidocaine and esketamine following thyroidectomy","year":"2024","cit":1,"pfa":"Danfeng Wang","psa":"Fu‐Shan Xue","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4401651948","eid":"W4401651948"},{"id":"paper-w4413406832","cat":"papers","name":"(2R,6R)-hydroxynorketamine reverses mechanical and thermal pain hypersensitivity produced by the chemotherapeutic agent oxaliplatin in rats","year":"2025","cit":1,"pfa":"Maria Campanile","psa":"Caroline A. Browne","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4413406832","eid":"W4413406832"},{"id":"paper-w4401920065","cat":"papers","name":"Intranasal esketamine efficacy as a treatment for treatment-resistant depression, case series","year":"2024","cit":1,"pfa":"C. Delgado Marmisa","psa":"B. Jiménez-Fernández","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4401920065","eid":"W4401920065"},{"id":"paper-w7119019593","cat":"papers","name":"Comparison of rTMS and esketamine for treatment-resistant depression: A target trial emulation","year":"2026","cit":1,"pfa":"J. F. Chen","psa":"Chih-Sung Liang","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7119019593","eid":"W7119019593"},{"id":"paper-w4409217239","cat":"papers","name":"Progress of Clinical Application of Esketamine in Abdominal Tumor Surgery in Elderly Patients","year":"2025","cit":1,"pfa":"Jin-Xi Xie","psa":"Li-Wen Zhou","ptype":"article","src":"https://openalex.org/W4409217239","eid":"W4409217239"},{"id":"paper-w4411717643","cat":"papers","name":"THERAPEUTIC PROTOCOLS USING KETAMINE AND ESKETAMINE FOR DEPRESSIVE DISORDERS: A SYSTEMATIC REVIEW","year":"2023","cit":1,"pfa":"JULIA MURIEL KUTNO FREIND","topics":["Depression","Reviews & meta-analyses"],"ptype":"dissertation","src":"https://openalex.org/W4411717643","eid":"W4411717643"},{"id":"paper-w4294200383","cat":"papers","name":"The cognitive effects of esketamine: what do we know so far?","year":"2022","cit":1,"pfa":"M. Barbosa","psa":"Roberta D’nyra Almeida Sousa Guedes","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4294200383","eid":"W4294200383"},{"id":"paper-w7159591619","cat":"papers","name":"A comprehensive review of the clinical progress of esketamine: From anesthesia to antidepressant therapy","year":"2026","cit":1,"pfa":"Hai-Lin Hu","psa":"Ping-Xia Xie","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7159591619","eid":"W7159591619"},{"id":"paper-w4393187771","cat":"papers","name":"Effectiveness of ketamine and esketamine in preventing postpartum depression: A trial sequential analysis","year":"2024","cit":1,"pfa":"I‐Wen Chen","psa":"Kuo‐Chuan Hung","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4393187771","eid":"W4393187771"},{"id":"paper-w4402207450","cat":"papers","name":"[Treatment of New Daily Persistent Headache With Esketamine: Report of One Case].","year":"2024","cit":1,"pfa":"Li Zhang","psa":"Zhao Dong","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4402207450","eid":"W4402207450"},{"id":"paper-w4412896663","cat":"papers","name":"Racemic Ketamine and Esketamine for Treatment of Refractory and Super-Refractory Status Epilepticus","year":"2025","cit":1,"pfa":"Mohamed ElSayed","psa":"Islam Mohammad Shehata","ptype":"book-chapter","src":"https://openalex.org/W4412896663","eid":"W4412896663"},{"id":"paper-w4412896642","cat":"papers","name":"How About Esketamine for Sedation of Critically Ill COVID-19 Patients?","year":"2025","cit":1,"pfa":"Sabine Himmelseher","psa":"Helmut Trimmel","ptype":"book-chapter","src":"https://openalex.org/W4412896642","eid":"W4412896642"},{"id":"paper-w4407151764","cat":"papers","name":"Dezocine versus esketamine as postoperative analgesia in women undergoing cesarean section","year":"2025","cit":1,"pfa":"Wei Qiao","psa":"Xiaoxiao Zhang","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4407151764","eid":"W4407151764"},{"id":"paper-w4393324241","cat":"papers","name":"Research Progress on the Effect of Esketamine on Postoperative Cognitive Dysfunction in Elderly Patients","year":"2024","cit":1,"pfa":"学雪 张","ptype":"article","src":"https://openalex.org/W4393324241","eid":"W4393324241"},{"id":"paper-w4415958658","cat":"papers","name":"Efficacy and Tolerability of Esketamine Augmented With Dextromethorphan/Bupropion for Treatment-Resistant Depression","year":"2025","cit":1,"pfa":"Joshua C. Eloge","psa":"John Zajecka","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4415958658","eid":"W4415958658"},{"id":"paper-w4415992646","cat":"papers","name":"Esketamine for Postoperative Depressive Symptoms: Considerations for Broader Perioperative Practice [Letter]","year":"2025","cit":1,"pfa":"Louise Matthewson","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4415992646","eid":"W4415992646"},{"id":"paper-w3192324935","cat":"papers","name":"Which are the demographic and clinical characteristics of patients who respond to subcutaneous esketamine?","year":"2021","cit":1,"pfa":"João Pedro de Oliveira Morais da Costa","psa":"Fábio Gomes de Matos e Souza","ptype":"article","src":"https://openalex.org/W3192324935","eid":"W3192324935"},{"id":"paper-w4411102602","cat":"papers","name":"Comparative study of dexmedetomidine and esketamine in elderly patients undergoing percutaneous vertebroplasty","year":"2025","cit":1,"ptype":"article","src":"https://openalex.org/W4411102602","eid":"W4411102602"},{"id":"paper-w4389475316","cat":"papers","name":"( 2R,6R )-hydroxynorketamine facilitates extinction and prevents emotional impairment and stress-induced reinstatement in morphine abstinent mice","year":"2023","cit":1,"pfa":"Andria Michael","psa":"Panos Zanos","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W4389475316","eid":"W4389475316"},{"id":"paper-w4400790874","cat":"papers","name":"Use of intranasal esketamine in the treatment of treatment-resistant depression: A case report","year":"2024","cit":1,"pfa":"Stefan Jerotić","psa":"Milan B. Latas","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4400790874","eid":"W4400790874"},{"id":"paper-w4411661421","cat":"papers","name":"Research trends in esketamine for depression over the past decade: a bibliometric analysis","year":"2025","cit":1,"pfa":"Baozhou Zhang","psa":"Junping Chen","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4411661421","eid":"W4411661421"},{"id":"paper-w4295978349","cat":"papers","name":"Study on the Clinical Anesthesia of Esketamine Combined with Propofol in Endoscopic Retrograde Cholangiopancreatography","year":"2022","cit":1,"pfa":"<p>Lingyuan Zeng, Yang Xiao, Dezhan Li, Kun Zhang</p>","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4295978349","eid":"W4295978349"},{"id":"paper-w7166017556","cat":"papers","name":"Methodological considerations for lidocaine with low‐dose esketamine analgesia after hepatectomy","year":"2026","cit":1,"pfa":"Minghui Tong","psa":"Tongtong Ma","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7166017556","eid":"W7166017556"},{"id":"paper-w2995143403","cat":"papers","name":"PMH16 LONG-TERM COST-EFFECTIVENESS OF ESKETAMINE FOR THE TREATMENT OF TREATMENT-RESISTANT DEPRESSION","year":"2019","cit":1,"pfa":"Daniel R. Touchette","psa":"David M. Rind","topics":["Depression"],"ptype":"conference-abstract","src":"https://openalex.org/W2995143403","eid":"W2995143403"},{"id":"paper-w4415517827","cat":"papers","name":"Ketamine/esketamine treatment for resistant depression in children and adolescents: a PRISMA systematic review","year":"2025","cit":1,"pfa":"Konstantinos Ν. Fountoulakis","psa":"Alan F. Schatzberg","topics":["Depression","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4415517827","eid":"W4415517827"},{"id":"paper-w7135072892","cat":"papers","name":"Perioperative Ketamine and Esketamine for Enhanced Recovery After Surgery (ERAS): A Systematic Review","year":"2026","cit":1,"pfa":"Muhan Xu","psa":"Jijun Xu","topics":["Depression","Addiction","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W7135072892","eid":"W7135072892"},{"id":"paper-w4406254543","cat":"papers","name":"Cost Efficiency of Esketamine Nasal Spray Versus Quetiapine for Treatment Resistant Depression","year":"2024","cit":1,"pfa":"Kristin Clemens","psa":"Kruti Joshi","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4406254543","eid":"W4406254543"},{"id":"paper-w4403052404","cat":"papers","name":"Esketamine in postoperative recovery: Reliable for negative emotional relief, ambiguous for cognitive function","year":"2024","cit":1,"pfa":"Mingzhen Wang","psa":"Rui Dong","ptype":"article","src":"https://openalex.org/W4403052404","eid":"W4403052404"},{"id":"paper-w4226180336","cat":"papers","name":"The probability of response after each subcutaneous injection of esketamine in treatment-resistant depression","year":"2021","cit":1,"pfa":"Victor Augusto Rodovalho Fava","psa":"Hugo Cogo‐Moreira","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4226180336","eid":"W4226180336"},{"id":"paper-w4406796275","cat":"papers","name":"Oral Esketamine as Alternative for Maintenance Electroconvulsive Therapy in Patients With Treatment-Resistant Depression","year":"2025","cit":1,"pfa":"Daniël T. Coerts","psa":"Sjoerd M. van Belkum","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4406796275","eid":"W4406796275"},{"id":"paper-w4400875871","cat":"papers","name":"The Dopaminergic Effects of Esketamine are Mediated by a Dual Mechanism Involving Glutamate and Opioid Receptors","year":"2024","cit":1,"pfa":"Arianna Rizzo","psa":"Jordi Bonaventura","topics":["Addiction","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4400875871","eid":"W4400875871"},{"id":"paper-w4403901545","cat":"papers","name":"Merits and demerits of administering esketamine in preventing postpartum depression following cesarean section","year":"2024","cit":1,"pfa":"Takahiko Nagamine","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4403901545","eid":"W4403901545"},{"id":"paper-w7154382444","cat":"papers","name":"Use of Ketamine and Esketamine in the Pediatric Population: Current Evidence and Clinical Applications","year":"2026","cit":1,"pfa":"Thomas Kun Pak","psa":"Emine Rabia Ayvaci","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7154382444","eid":"W7154382444"},{"id":"paper-w4416850311","cat":"papers","name":"The impact of intraoperative esketamine infusion on postoperative sleep in patients undergoing general surgery","year":"2025","cit":1,"pfa":"Meiling Zhang","psa":"Qing Ji","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4416850311","eid":"W4416850311"},{"id":"paper-w4414179851","cat":"papers","name":"Intranasal esketamine in treatment-resistant depression: Descriptive study of our clinical experience","year":"2025","cit":1,"pfa":"E. Abalde García","psa":"José M. Diez","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"conference-abstract","src":"https://openalex.org/W4414179851","eid":"W4414179851"},{"id":"paper-w4307746006","cat":"papers","name":"Effect of esketamine on opioid consumption and postoperative pain in thyroidectomy: a randomized controlled trial","year":"2022","cit":1,"pfa":"Penglei Wang","psa":"Yun Lin WU","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4307746006","eid":"W4307746006"},{"id":"paper-w7130375109","cat":"papers","name":"Sex differences in placebo and antidepressant response to intranasal esketamine for treatment-resistant depression","year":"2026","cit":1,"pfa":"Marie Huc","psa":"Argel Aguilar‐Valles","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7130375109","eid":"W7130375109"},{"id":"paper-w4416265920","cat":"papers","name":"Effects of different doses of esketamine combined with propofol on gastrointestinal endoscopy in elderly patients","year":"2025","cit":1,"pfa":"Xin Ni","psa":"Yijun Zhu","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4416265920","eid":"W4416265920"},{"id":"paper-w4386187190","cat":"papers","name":"Mechanism of Antidepressant Action of (2R,6R)-6-Hydroxynorketamine (HNK) and Its Compounds: Insights from Proteomic Analysis","year":"2023","cit":1,"pfa":"Chaohui Zhen","psa":"Zhen Tan","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4386187190","eid":"W4386187190"},{"id":"paper-w4408065732","cat":"papers","name":"Esketamine induces embryonic and cardiac malformation through regulating the nkx2.5 and gata4 in zebrafish","year":"2025","cit":1,"pfa":"Shuang Li","psa":"Jiancheng Tang","topics":["Depression","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4408065732","eid":"W4408065732"},{"id":"paper-w3081917463","cat":"papers","name":"Rapid acting antidepressant (2R,6R)-hydroxynorketamine (HNK) targets glucocorticoid receptor signaling: a longitudinal cerebrospinal fluid proteome study","year":"2020","cit":1,"pfa":"David P. Herzog","psa":"Marianne B. Müller","topics":["Depression","Mechanism & neuroscience","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W3081917463","eid":"W3081917463"},{"id":"paper-w7160018894","cat":"papers","name":"Cognitive Behavioral Therapy Following Esketamine for Major Depression and Suicidal Ideation for Relapse Prevention","year":"2026","cit":1,"pfa":"Samuel T. Wilkinson","psa":"TG Rhee","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7160018894","eid":"W7160018894"},{"id":"paper-w4413117620","cat":"papers","name":"The Early Effects of Esketamine on the Tumor Metastatic Microenvironment in Postoperative Lung Cancer Patients","year":"2025","cit":1,"pfa":"Yong Wang","psa":"Huiqun Jia","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4413117620","eid":"W4413117620"},{"id":"paper-w7154597166","cat":"papers","name":"Ketamine and Esketamine in Obsessive–Compulsive Disorder: A Scoping Review of Clinical and Mechanistic Evidence","year":"2026","cit":1,"pfa":"Maria Marmureanu","psa":"Mirela Manea","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7154597166","eid":"W7154597166"},{"id":"paper-w4391697939","cat":"papers","name":"Clinical application of esketamine-induced mild sedation technique in outpatient oral surgery","year":"2023","cit":1,"pfa":"Zhijun Xin","psa":"Meiling Yao","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4391697939","eid":"W4391697939"},{"id":"paper-w4409016575","cat":"papers","name":"Safety Profile and Suicidality Associated with Use of Esketamine in the Treatment of Major Depressive Disorder","year":"2025","cit":1,"pfa":"Ilaria Ammendolia","psa":"Fabrizio Calapai","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4409016575","eid":"W4409016575"},{"id":"paper-w4414670722","cat":"papers","name":"Research Progress on the Efficacy of Esketamine Adjuvant Combined with Ropivacaine in Brachial Plexus Block","year":"2025","cit":1,"pfa":"羽彤 杨","ptype":"article","src":"https://openalex.org/W4414670722","eid":"W4414670722"},{"id":"paper-w2963279472","cat":"papers","name":"Ovarian hormones mediate the prophylactic efficacy of ( R,S )-ketamine and (2 R ,6 R )-hydroxynorketamine in female mice","year":"2019","cit":1,"pfa":"Briana K. Chen","psa":"Christine Ann Denny","topics":["Depression","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W2963279472","eid":"W2963279472"},{"id":"paper-w7128167387","cat":"papers","name":"A comprehensive review and meta-analysis on the safety and efficacy of esketamine for emerging delirium in elderly patients","year":"2026","cit":1,"pfa":"Yanping E. Lu","psa":"Shan Ou","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7128167387","eid":"W7128167387"},{"id":"paper-w4410120048","cat":"papers","name":"Determining Opioid-Sparing Efficacy of Intraoperative Esketamine After Laparoscopic Gynecological Surgery [Letter]","year":"2025","cit":1,"pfa":"Xiaoying Chen","psa":"Fu‐Shan Xue","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4410120048","eid":"W4410120048"},{"id":"paper-w4416871801","cat":"papers","name":"Intraoperative Esketamine and Postpartum Depression Among Women With Cesarean Delivery: A Randomized Clinical Trial","year":"2025","cit":1,"pfa":"Li Ren","psa":"G Wu","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4416871801","eid":"W4416871801"},{"id":"paper-w4402675384","cat":"papers","name":"Esketamine-Induced acute transient psychotic episode in treatment-resistant depression: A case report","year":"2024","cit":1,"pfa":"Özgür Değirmenci","psa":"Ali Saffet Gönül","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4402675384","eid":"W4402675384"},{"id":"paper-w7162288479","cat":"papers","name":"Neurodevelopmental and behavioral effects of early-life esketamine hydrochloride exposure in zebrafish (Danio rerio)","year":"2026","cit":1,"pfa":"Shukai Zheng","psa":"Wenlong Huang","ptype":"article","src":"https://openalex.org/W7162288479","eid":"W7162288479"},{"id":"paper-w7135211236","cat":"papers","name":"Comparative safety of esketamine in procedural sedation and analgesia: a systematic review and network meta-analysis","year":"2026","cit":1,"pfa":"Baraah T. Abu AlSel","psa":"Yehia Nabil","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W7135211236","eid":"W7135211236"},{"id":"paper-w7118368060","cat":"papers","name":"Esketamine effect on remifentanil-induced depression of the acute hypoxic ventilatory response: a volunteer study","year":"2026","cit":1,"pfa":"Jimmy J. Arévalo","psa":"Rutger M. van der Schrier","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7118368060","eid":"W7118368060"},{"id":"paper-w7140285060","cat":"papers","name":"Esketamine And Postoperative Cognitive Dysfunction In Aged Mice: Role Of The SIRT3/AMPK/MTOR Pathway","year":"2026","cit":1,"pfa":"Yunfei Wang","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7140285060","eid":"W7140285060"},{"id":"paper-w4404646016","cat":"papers","name":"First experiences with esketamine nasal spray in patients with moderate and severe treatment-resistant depression","year":"2024","cit":1,"pfa":"J.M. García","psa":"José Enrique Romero Baca","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4404646016","eid":"W4404646016"},{"id":"paper-w4385266641","cat":"papers","name":"Retracted: A Study on the Preventive Effect of Esketamine on Postpartum Depression (PPD) after Cesarean Section","year":"2023","cit":1,"pfa":"Computational and Mathematical Methods in Medicine","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4385266641","eid":"W4385266641"},{"id":"paper-w4399567850","cat":"papers","name":"Perioperative Use of Esketamine for the Prevention of Postpartum Depression after Cesarean Section: A Meta-Analysis","year":"2024","cit":1,"pfa":"Yanhong Li","psa":"Jun Zhou","topics":["Depression","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4399567850","eid":"W4399567850"},{"id":"paper-w4410390905","cat":"papers","name":"Effects of esketamine on postoperative depression in breast cancer patients: A systematic review and meta-analysis","year":"2025","cit":1,"pfa":"Linli He","psa":"Yonghong Lu","topics":["Depression","Anxiety & end-of-life","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4410390905","eid":"W4410390905"},{"id":"paper-w4406254602","cat":"papers","name":"Ketamine and Esketamine Use for Mood Disorders with Psychosis: A Systematic Review of Dissociative and Psychotic Symptoms","year":"2024","cit":1,"pfa":"Renzo Costa","psa":"Muhammad Zaidi","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4406254602","eid":"W4406254602"},{"id":"paper-w4414711053","cat":"papers","name":"Esketamine Treatment for Depression in Adults: Response to Price et al. and Canuso et al.","year":"2025","cit":1,"pfa":"Konstantinos Ν. Fountoulakis","psa":"Alan F. Schatzberg","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4414711053","eid":"W4414711053"},{"id":"paper-w3209637377","cat":"papers","name":"Esketamine in patient with treatment resistant depression: Outcome of the temporary authorization for use programme in France","year":"2021","cit":1,"pfa":"E. Gaudre Wattinne","psa":"Sophie Bouju","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3209637377","eid":"W3209637377"},{"id":"paper-w4417520455","cat":"papers","name":"Esketamine relieves postoperative depression and pain indicators in patients undergoing laparoscopic total hysterectomy","year":"2025","cit":1,"pfa":"Jun Jing","psa":"Yuanhai Li","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4417520455","eid":"W4417520455"},{"id":"paper-w4412896853","cat":"papers","name":"Comparing Intravenous Racemic Ketamine and Intranasal Esketamine for Treatment-Resistant Depression: A Clinical Dilemma","year":"2025","cit":1,"pfa":"Balwinder Singh","psa":"Simon Kung","topics":["Depression"],"ptype":"book-chapter","src":"https://openalex.org/W4412896853","eid":"W4412896853"},{"id":"paper-w2954667187","cat":"papers","name":"PMH14 COST EFFICIENCY OF ESKETAMINE NASAL SPRAY VERSUS STANDARD OF CARE FOR TREATMENT RESISTANT DEPRESSION","year":"2019","cit":1,"pfa":"Urvi S. Desai","psa":"John J. Sheehan","topics":["Depression"],"ptype":"conference-abstract","src":"https://openalex.org/W2954667187","eid":"W2954667187"},{"id":"paper-w4401790654","cat":"papers","name":"Comparison Between Esketamine and Alfentanil for Hysteroscopy: A Prospective, Double-Blind, Randomized Controlled Trial [Letter]","year":"2024","cit":1,"pfa":"Guanyu Yang","ptype":"article","src":"https://openalex.org/W4401790654","eid":"W4401790654"},{"id":"paper-w7133540888","cat":"papers","name":"Esketamine Alleviates Postoperative Cognitive Dysfunction via Rock2/Add1 Signaling Pathway in Aged Mice","year":"2026","cit":1,"pfa":"Chang Xu","psa":"Xinli Ni","ptype":"article","src":"https://openalex.org/W7133540888","eid":"W7133540888"},{"id":"paper-w7117959330","cat":"papers","name":"Benefits, challenges, and future recommendations of prescribing esketamine for patients diagnosed with depression. A scoping review","year":"2026","cit":1,"pfa":"Mohammed Qutishat","psa":"Mohammed Albalushi","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7117959330","eid":"W7117959330"},{"id":"paper-w4309159919","cat":"papers","name":"Comment on “Efficacy and Safety of Subcutaneous Esketamine in the Treatment of Suicidality in Major Depressive Disorder and Bipolar Depression”","year":"2022","cit":1,"pfa":"Alina Wilkowska","psa":"Wiesław Jerzy Cubała","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4309159919","eid":"W4309159919"},{"id":"paper-w4412746040","cat":"papers","name":"Letter to the Editor: Toward personalized, evidence-based medicine for the use of esketamine in treatment-resistant depression","year":"2025","cit":1,"pfa":"Yassine Benhaddouch","psa":"Adil El Ammouri","topics":["Depression"],"ptype":"letter","src":"https://openalex.org/W4412746040","eid":"W4412746040"},{"id":"paper-w3123152751","cat":"papers","name":"Letter to the editor - Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis","year":"2021","cit":1,"pfa":"Breno Souza‐Marques","psa":"Lucas C. Quarantini","topics":["Depression","Reviews & meta-analyses"],"ptype":"letter","src":"https://openalex.org/W3123152751","eid":"W3123152751"},{"id":"paper-w7134182731","cat":"papers","name":"Intranasal esketamine for treatment-resistant depression: real-world effectiveness in electroconvulsive therapy non-responders","year":"2026","cit":1,"pfa":"Rocío Gómez-Juanes","psa":"Mauro Garcı́a-Toro","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7134182731","eid":"W7134182731"},{"id":"paper-w4412896692","cat":"papers","name":"Intranasal Esketamine for Management of Treatment-Resistant Depression: Evidence of Efficacy and Safety and Use in Clinical Practice","year":"2025","cit":1,"pfa":"Ludovic Samalin","psa":"Pierre‐Michel Llorca","topics":["Depression","Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W4412896692","eid":"W4412896692"},{"id":"paper-w3159642342","cat":"papers","name":"Letter to the Editor: Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis","year":"2021","cit":1,"pfa":"Joakim Ekstrand","topics":["Depression","Reviews & meta-analyses"],"ptype":"letter","src":"https://openalex.org/W3159642342","eid":"W3159642342"},{"id":"paper-w4313204027","cat":"papers","name":"Extended applications the subcutaneous esketamine for major depression with suicidal ideation in autism traits—Case report","year":"2022","cit":1,"pfa":"Ana Paula Anzolin","psa":"Marcia Kauer‐Sant’Anna","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4313204027","eid":"W4313204027"},{"id":"paper-w7117464665","cat":"papers","name":"Network pharmacology of cellular targets in major depressive disorder and differential mechanisms of fluoxetine, ketamine and esketamine","year":"2025","cit":1,"pfa":"Silvia Tapia‐González","psa":"George Emilio Barreto","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7117464665","eid":"W7117464665"},{"id":"paper-w4411127553","cat":"papers","name":"Increased Kcnq2 in the hippocampal contributes to esketamine-induced long-term cognitive dysfunction in neonatal mice","year":"2025","cit":1,"pfa":"Junjie Zhang","psa":"Ying Xu","ptype":"article","src":"https://openalex.org/W4411127553","eid":"W4411127553"},{"id":"paper-w4245481595","cat":"papers","name":"P.327 Withdrawal symptom assessment in an esketamine safety study in patients with treatment-resistant depression","year":"2019","cit":1,"pfa":"Leah E. Aluisio","psa":"Jaskaran B. Singh","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4245481595","eid":"W4245481595"},{"id":"paper-w7160233598","cat":"papers","name":"Pilot study on esketamine response in treatment-resistant depression: impact of pharmacogenetic, clinical, and demographic variables","year":"2026","cit":1,"pfa":"Michaela Krivosova","psa":"Massimo Clerici","topics":["Depression","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7160233598","eid":"W7160233598"},{"id":"paper-w4416593293","cat":"papers","name":"Esketamine prevents postoperative sleep disturbance in patients with preoperative sleep disorders: a role for oral microbiota","year":"2025","cit":1,"pfa":"Xin-Yu Li","psa":"Jianjun Yang","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4416593293","eid":"W4416593293"},{"id":"paper-w4399142999","cat":"papers","name":"Efficacy of intravenous esketamine in reducing suicidal ideation and major depressive symptoms: A real-world evidence study","year":"2024","cit":1,"pfa":"Tiago Gil","psa":"T.C. Bonetti","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4399142999","eid":"W4399142999"},{"id":"paper-w4412508098","cat":"papers","name":"Esketamine mitigates endotoxin-induced acute lung injury by suppressing caspase-11-driven pyroptosis","year":"2025","cit":1,"pfa":"Yunfei Bao","psa":"Jianling Li","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4412508098","eid":"W4412508098"},{"id":"paper-w4413969521","cat":"papers","name":"Case Report: Intranasal esketamine combined with a form of generative artificial intelligence in the management of treatment-resistant depression","year":"2025","cit":1,"pfa":"Alexandre Fraichot","psa":"Hélène Richard-Lepouriel","topics":["Depression","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4413969521","eid":"W4413969521"},{"id":"paper-w4415435160","cat":"papers","name":"Comparison of Esketamine and Propofol for Prehospital Emergency Anaesthesia in Patients With Traumatic Brain Injury—A Retrospective Observational Study","year":"2025","cit":1,"pfa":"Juri Laamanen","psa":"Jouni O. Nurmi","topics":["PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4415435160","eid":"W4415435160"},{"id":"paper-w4415141923","cat":"papers","name":"Improvements in health-related quality of life with esketamine nasal spray versus quetiapine extended release","year":"2025","cit":1,"pfa":"Andreas Reif","psa":"Eduard Vieta","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4415141923","eid":"W4415141923"},{"id":"paper-w4413385792","cat":"papers","name":"Effects of ketamine and esketamine on death, suicidal behaviour, and suicidal ideation in psychiatric disorders: A systematic review and meta-analysis","year":"2025","cit":1,"pfa":"Martin Plöderl","psa":"Joanna Moncrieff","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4413385792","eid":"W4413385792"},{"id":"paper-w4387745798","cat":"papers","name":"Intranasal esketamine as tool for rapid cycling bipolar disorder: A case report of successful mood stabilization","year":"2023","cit":1,"pfa":"Giacomo d’Andrea","psa":"Giovanni Martinotti","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4387745798","eid":"W4387745798"},{"id":"paper-w4402519236","cat":"papers","name":"Comparison Between Esketamine and Alfentanil for Hysteroscopy: A Prospective, Double-Blind, Randomized Controlled Trial [Response to Letter]","year":"2024","cit":1,"pfa":"Mengcao Weng","psa":"Yue Bo Jin","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4402519236","eid":"W4402519236"},{"id":"paper-w7125427315","cat":"papers","name":"Real-world comparison of intranasal racemic ketamine and esketamine in treatment-resistant depression: A retrospective observational study","year":"2026","cit":1,"pfa":"Jan Sarlon","psa":"Undine Emmi Lang","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7125427315","eid":"W7125427315"},{"id":"paper-w4416261310","cat":"papers","name":"Esketamine combined with sertraline for brain altered regional homogeneity in patients with major depressive disorder: A preliminary study","year":"2025","cit":1,"pfa":"Xiang Liu","psa":"Guangyao Wu","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4416261310","eid":"W4416261310"},{"id":"paper-w4406254594","cat":"papers","name":"Role of External Factors in the Severity of Dissociation Experienced by Treatment- Resistant Depression Patients Following Esketamine Administration","year":"2024","cit":1,"pfa":"Maria M. Vento-Correa","psa":"Gil Abramovici","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4406254594","eid":"W4406254594"},{"id":"paper-w4410215233","cat":"papers","name":"Esketamine combined with low-dose propofol induction strategy for category-1 cesarean section: a case series","year":"2025","cit":1,"pfa":"Guang-Qiu Zhu","psa":"Wan-Lan Mou","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4410215233","eid":"W4410215233"},{"id":"paper-w7117355092","cat":"papers","name":"The Emerging Role of Ketamine and Esketamine in the Concurrent Management of Pain and Depression in Cancer Patients: Evidence and Implications for Practice","year":"2025","cit":1,"pfa":"Shannon Moriarty","psa":"Kathleen Mary Frey","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7117355092","eid":"W7117355092"},{"id":"paper-w4254503879","cat":"papers","name":"P.033 Managing esketamine treatment frequency toward successful outcomes: Analysis of phase 3 data","year":"2019","cit":1,"pfa":"M. Nijs","psa":"Allitia DiBernardo","ptype":"article","src":"https://openalex.org/W4254503879","eid":"W4254503879"},{"id":"paper-w7127106044","cat":"papers","name":"Esketamine attenuates bone cancer pain by suppressing MAPK signaling and glial activation in the spinal dorsal horn of rats","year":"2026","cit":1,"pfa":"Liang Cheng","psa":"Huadong Ni","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7127106044","eid":"W7127106044"},{"id":"paper-w4415299253","cat":"papers","name":"Esketamine attenuates hemodynamic oscillations during anesthesia induction in elderly gastrointestinal surgical patients: a randomized trial","year":"2025","cit":1,"pfa":"C.-Y. Zhang","psa":"Hanbing Wang","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4415299253","eid":"W4415299253"},{"id":"paper-w4409329407","cat":"papers","name":"Ascorbic Acid and Esketamine for Mental Disorders in Women with Miscarriage: A Randomized Controlled Double-Blind Trial Protocol","year":"2025","cit":1,"pfa":"Zhaojuan Ke","psa":"Linya Deng","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4409329407","eid":"W4409329407"},{"id":"paper-w7153128647","cat":"papers","name":"Sustained effectiveness and safety of esketamine for major depressive disorder: a target trial simulation of real-world data","year":"2026","cit":1,"pfa":"Ting-Hui Liu","psa":"Chih-Cheng Lai","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7153128647","eid":"W7153128647"},{"id":"paper-w4403174835","cat":"papers","name":"Efficacy and safety of propofol in combination with different esketamine doses for anesthesia during loop electrosurgical excision procedure","year":"2024","cit":1,"topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4403174835","eid":"W4403174835"},{"id":"paper-w4417431704","cat":"papers","name":"Case Report: A possible association between significant dissociations after esketamine treatment and histrionic personality disorder","year":"2025","cit":1,"pfa":"Veronika Savica","psa":"Māris Taube","topics":["Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4417431704","eid":"W4417431704"},{"id":"paper-w4414179780","cat":"papers","name":"Real world clinical practice, efficacy and safety of esketamine nasal spray in MDD patients: the French ELLIPSE study","year":"2025","cit":1,"pfa":"Pierre‐Michel Llorca","psa":"J. Dupin","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4414179780","eid":"W4414179780"},{"id":"paper-w4404778695","cat":"papers","name":"P22: Comparative Analysis of Efficacy of Intravenous Ketamine and Intranasal Esketamine in Treatment-Resistant Depression across Age Groups","year":"2024","cit":1,"pfa":"Charles J. Hutchison","psa":"Patricio Riva‐Posse","topics":["Depression"],"ptype":"conference-abstract","src":"https://openalex.org/W4404778695","eid":"W4404778695"},{"id":"paper-w4416276621","cat":"papers","name":"Treatment-Resistant Depression: Esketamine Is Promising, but Personalized Medicine Including Pharmacogenetic Testing Should Come First","year":"2025","cit":1,"pfa":"Andrej Belančić","psa":"Rossana Roncato","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4416276621","eid":"W4416276621"},{"id":"paper-w7117901082","cat":"papers","name":"Transcriptional Signatures of Mitochondrial Metabolism Predict Esketamine-Induced rACC Structural Changes in Adolescent Major Depression","year":"2025","cit":1,"pfa":"Yanling Zhou","psa":"Yuping Ning","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7117901082","eid":"W7117901082"},{"id":"paper-w7161446339","cat":"papers","name":"Clinical Predictors of Antidepressant Effects of Ketamine and Esketamine in Treatment-Resistant Unipolar and Bipolar Depression: A Systematic Review","year":"2026","cit":1,"pfa":"Omer A. Syed","psa":"Peter Giacobbe","topics":["Depression","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7161446339","eid":"W7161446339"},{"id":"paper-w4415918182","cat":"papers","name":"Efficacy and Safety of Esketamine–Lidocaine for Anesthesia Induction in Elderly Patients Undergoing Elective Surgery: A Randomized Controlled Trial","year":"2025","cit":1,"pfa":"Jinhui Xu","psa":"Yaqi Li","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4415918182","eid":"W4415918182"},{"id":"paper-w4405637173","cat":"papers","name":"Longitudinal efficacy of esketamine treatment on depression, anxiety, and anhedonic severity in patients with treatment resistant depression: preliminary study","year":"2024","cit":1,"pfa":"Elssa Toumeh","psa":"Martin A. Katzman","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4405637173","eid":"W4405637173"},{"id":"paper-w4407419059","cat":"papers","name":"EXPLORING VORTIOXETINE COMBINATION WITH INTRANASAL ESKETAMINE: A PROMISING ALTERNATIVE TO SSRI/SNRI - INSIGHTS FROM THE REAL-ESK STUDY","year":"2025","cit":1,"pfa":"Clara Cavallotto","psa":"Giovanni Martinotti","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4407419059","eid":"W4407419059"},{"id":"paper-w4411902638","cat":"papers","name":"Efficacy and safety of esketamine hydrochloride injection at different dosages for patients undergoing radical thyroidectomy for thyroid cancer: a randomized trial","year":"2025","cit":1,"pfa":"Yihuan Luo","psa":"Fang Hua","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4411902638","eid":"W4411902638"},{"id":"paper-w4416128012","cat":"papers","name":"Efficacy and safety of esketamine in patients undergoing painless gastrointestinal endoscopy: a systematic review and meta-analysis of randomized controlled trials","year":"2025","cit":1,"pfa":"Qi Zhang","psa":"Qinghui Wang","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4416128012","eid":"W4416128012"},{"id":"paper-w4417335129","cat":"papers","name":"Esketamine Protects the Blood–Brain Barrier Against Sepsis‐Associated Brain Injury by Regulating the BDNF/TrkB Pathway","year":"2025","cit":1,"pfa":"Weiqin Wei","psa":"Jialing Lu","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4417335129","eid":"W4417335129"},{"id":"paper-w7127086144","cat":"papers","name":"Comparative Effectiveness of Single-Dose Epidural Esketamine versus Hydromorphone in Thoracic and Upper Abdominal Surgery: A Randomized Trial","year":"2026","cit":1,"pfa":"Yuejiao Song","psa":"Chao Liang","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7127086144","eid":"W7127086144"},{"id":"paper-w7160491966","cat":"papers","name":"Effect of aerosol inhalation of esketamine on postoperative sore throat in patients undergoing thoracoscopic radical resection of lung cancer","year":"2026","cit":1,"pfa":"Zhaoxia Yan","psa":"YOU Wenjing","topics":["Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7160491966","eid":"W7160491966"},{"id":"paper-w4367043605","cat":"papers","name":"Repeated doses of subcutaneous esketamine in patients with treatment-resistant depression: Case series in a general hospital in Southern Brazil","year":"2023","cit":1,"pfa":"Márcia Surdo Pereira","psa":"Luciane Nascimento Cruz","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4367043605","eid":"W4367043605"},{"id":"paper-w7165685224","cat":"papers","name":"Esketamine improves postoperative sleep quality in thoracic surgery patients with preoperative sleep disturbance: a randomized controlled trial","year":"2026","cit":1,"pfa":"Xingyu Wang","psa":"Huiyu Luo","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7165685224","eid":"W7165685224"},{"id":"paper-w2922338092","cat":"papers","name":"POST HOC ANALYSES OF ESKETAMINE NASAL SPRAY PLUS AN ORAL ANTIDEPRESSANT IN ELDERLY PATIENTS WITH TREATMENT-RESISTANT DEPRESSION","year":"2019","cit":1,"pfa":"Rachel Ochs-Ross","psa":"Jaskaran B. Singh","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2922338092","eid":"W2922338092"},{"id":"paper-w3019520766","cat":"papers","name":"149 Evaluation of Individual Items on the PHQ-9 and SDS in Patients with Treatment-Resistant Depression Treated with Esketamine Nasal Spray","year":"2020","cit":1,"pfa":"Lysbeth L. Floden","psa":"Jaskaran B. Singh","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3019520766","eid":"W3019520766"},{"id":"paper-w4406254608","cat":"papers","name":"Change in Depressive Symptoms Following Esketamine Initiation among Patients with Treatment-Resistant Depression in a Real-World Setting","year":"2024","cit":1,"pfa":"Carl D. Marci","psa":"Kruti Joshi","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4406254608","eid":"W4406254608"},{"id":"paper-w4414223758","cat":"papers","name":"Low-dose esketamine combined with remimazolam as an ideal anesthetic regimen for pediatric bronchoscopy: A synergistic approach to safety and efficacy","year":"2025","cit":1,"pfa":"Yilin Zhao","psa":"Xue Zhang","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4414223758","eid":"W4414223758"},{"id":"paper-w7135078392","cat":"papers","name":"Fast-acting approaches for treatment-resistant depression: real-world comparative effectiveness of Intranasal Esketamine versus accelerated rTMS","year":"2026","cit":1,"pfa":"Michele Prato","psa":"Zanardi Raffaella","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7135078392","eid":"W7135078392"},{"id":"paper-w4405140934","cat":"papers","name":"Esketamine infusion as treatment for chronic endometriosis-associated pain? Study protocol for a randomized controlled trial (EASYlight-study)","year":"2024","cit":1,"pfa":"Rozemarijn de Koning","psa":"Andries R. H. Twijnstra","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W4405140934","eid":"W4405140934"},{"id":"paper-w4415382745","cat":"papers","name":"Esketamine versus sufentanil as analgesics for sedation during painless gastrointestinal endoscopy: a double-blinded randomized controlled trial","year":"2025","cit":1,"pfa":"Tingting Li","psa":"Xiao Wang","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4415382745","eid":"W4415382745"},{"id":"paper-w4409281355","cat":"papers","name":"196. Lamotrigine is Not Associated With Differential Clinical Outcomes in a Real-World Sample of Patients With Unipolar Depression Receiving Ketamine/Esketamine","year":"2025","cit":1,"pfa":"Mia C Santucci","psa":"Samuel T. Wilkinson","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4409281355","eid":"W4409281355"},{"id":"paper-w4414497341","cat":"papers","name":"Efficacy and Safety of Esketamine Nasal Spray in Treatment-Resistant Depression: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","year":"2025","cit":1,"pfa":"Bhaskara Gowthami","psa":"Rakhshanda Khan","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4414497341","eid":"W4414497341"},{"id":"paper-w4200302445","cat":"papers","name":"P.0685 Safety assessment of esketamine administration via dry powder inhaler in patients with treatment-resistant bipolar depression","year":"2021","cit":1,"pfa":"Maciej Wieczorek","psa":"Piotr Gałecki","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4200302445","eid":"W4200302445"},{"id":"paper-w4406114000","cat":"papers","name":"Intranasal Esketamine for Treating Inpatients with Borderline Personality Disorder and Comorbid Treatment-Resistant Depression – a Retrospective Chart Review Study","year":"2025","cit":1,"pfa":"Hannah Tramontano","psa":"Mohamed Wagdy ElSayed","topics":["Depression","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4406114000","eid":"W4406114000"},{"id":"paper-w3134641785","cat":"papers","name":"Effect of esketamine nasal spray on cognition in patients with treatment-resistant depression: results from five phase-3 studies","year":"2019","cit":1,"pfa":"Robert M. Morrison","psa":"Husseini K. Manji","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W3134641785","eid":"W3134641785"},{"id":"paper-w7196946442","cat":"papers","name":"Effects of Esketamine on Emergence Delirium in Children Undergoing Sevoflurane Anesthesia: A Systematic Review, Meta‐Analysis, and Trial Sequential Analysis","year":"2026","cit":1,"pfa":"Munder Lateiresh","psa":"Muhammed Elhadi","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7196946442","eid":"W7196946442"},{"id":"paper-w4414000333","cat":"papers","name":"Effect of Esketamine and Etomidate on Postoperative Cognitive Function in Elderly Patients Undergoing Painless retain-->Bronchoscopy: A Randomized Controlled Trial","year":"2025","cit":1,"pfa":"Xiaofeng Xu","psa":"Ligang Shan","ptype":"article","src":"https://openalex.org/W4414000333","eid":"W4414000333"},{"id":"paper-w7139995483","cat":"papers","name":"Esketamine nasal spray for treatment-resistant depression: A retrospective multicenter real-world cohort study on effectiveness and suicidal outcomes","year":"2026","cit":1,"pfa":"J. García-Jiménez","psa":"J.E. Mesones Peral","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7139995483","eid":"W7139995483"},{"id":"paper-w7131790135","cat":"papers","name":"Mental health professionals’ perspective on the use of esketamine in treatment-resistant depression and their motivation to adopt it: a Saudi cross-sectional study","year":"2026","cit":1,"pfa":"Ahmad H. Almadani","psa":"Saleh A. Alghamdi","topics":["Depression","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7131790135","eid":"W7131790135"},{"id":"paper-w7125593243","cat":"papers","name":"Effects of esketamine on postoperative pain, anxiety, depression, sleep, and inflammation in pregnancies undergoing cesarean section: A randomized controlled trial","year":"2026","cit":1,"pfa":"Yijun Wang","psa":"Junhua Zhang","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7125593243","eid":"W7125593243"},{"id":"paper-w4200416962","cat":"papers","name":"P.0224 Dosing regimen overview of treatment-resistant depression patients treated with esketamine: eskale study interim analysis","year":"2021","cit":1,"pfa":"Ludovic Samalin","psa":"Sophie Bouju","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4200416962","eid":"W4200416962"},{"id":"paper-w4410408292","cat":"papers","name":"Effect of Subanesthetic Dose of Esketamine on Liver Function Following Microvascular Reconstruction for Head and Neck Cancer: A Randomized Controlled Trial","year":"2025","cit":1,"pfa":"Xue-Li Lv","psa":"Yingchun Dong","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4410408292","eid":"W4410408292"},{"id":"paper-w4415447268","cat":"papers","name":"Esketamine relieves depressive-like behaviors in MPTP-induced Parkinson disease mice via GPR109A-dependent reduction of neuroinflammation","year":"2025","cit":1,"pfa":"Shu Wang","psa":"Chen Wang","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4415447268","eid":"W4415447268"},{"id":"paper-w4387128964","cat":"papers","name":"Oral esketamine in patients with treatment-resistant depression: a double-blind, randomized, placebo-controlled trial with open-label extension","year":"2023","cit":1,"pfa":"Sanne Y. Smith-Apeldoorn","psa":"Robert A. Schoevers","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4387128964","eid":"W4387128964"},{"id":"paper-w4410946858","cat":"papers","name":"Cardiovascular Effects of Non-Selective Monoamine Oxidase Inhibitors and Intranasal Esketamine Combination in Depression – A Quasi-Experimental Design with Bayesian Analyses","year":"2025","cit":1,"pfa":"Ludovic C. Dormegny-Jeanjean","psa":"Clément de Crespin de Billy","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4410946858","eid":"W4410946858"},{"id":"paper-w4415622958","cat":"papers","name":"Effect of esketamine as an adjuvant of ropivacaine on the efficacy of supraclavicular brachial plexus block in radius fracture surgery: a randomized controlled trial","year":"2025","cit":1,"pfa":"Ju LIU","psa":"Yun Wu","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4415622958","eid":"W4415622958"},{"id":"paper-w7164925394","cat":"papers","name":"Intranasal esketamine in treatment-resistant depression with and without comorbid borderline personality disorder: A multicenter real-world longitudinal study","year":"2026","cit":1,"pfa":"Filippo Mazzoni","psa":"Miriam Olivola","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7164925394","eid":"W7164925394"},{"id":"paper-w4414393676","cat":"papers","name":"Development of HPLC-MS/MS Method for Simultaneous Detection of Esketamine and Norketamine: Application to Pharmacokinetics Drug Interactions Affected by Dexmedetomidine","year":"2025","cit":1,"pfa":"Wei Min Zhou","psa":"Xiangjun Qiu","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4414393676","eid":"W4414393676"},{"id":"paper-w4389791581","cat":"papers","name":"Effect and mechanism of a subanesthetic dose of esketamine on postoperative neurocognitive disorders through the regulating of the TLR4/NF-κB pathway in microglia","year":"2023","cit":1,"pfa":"Yang Zhang","psa":"Xiuhong Wang","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4389791581","eid":"W4389791581"},{"id":"paper-w4393006027","cat":"papers","name":"4CPS-174 Nasal esketamine use for mayor depressive disorder, from a third-level hospital to peripheral mental centres","year":"2024","cit":1,"pfa":"Iñigo Sánchez Monasterio","psa":"S Arostegi","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"conference-paper","src":"https://openalex.org/W4393006027","eid":"W4393006027"},{"id":"paper-w4410867369","cat":"papers","name":"Effect of esketamine on postinduction hypotension in elderly patients undergoing elective noncardiac surgery: a secondary analysis of a randomized clinical trial","year":"2025","cit":1,"pfa":"Yuan Zhang","psa":"Qingtao Meng","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4410867369","eid":"W4410867369"},{"id":"paper-w4413030985","cat":"papers","name":"Effects of Esketamine on Post-Partum Depression in Patients With Different Personality Types Undergoing Caesarean Section: Randomised Controlled Trial","year":"2025","cit":1,"pfa":"Mei Luo","psa":"Xiaobin Wang","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4413030985","eid":"W4413030985"},{"id":"paper-w4405628728","cat":"papers","name":"Navigating Treatment-Resistant Major Depressive Disorder With Suicidal Ideation: Exploring the Efficacy of Spravato (Esketamine) in an 86-Year-Old Male","year":"2024","cit":1,"pfa":"Aarman P Jivraj","psa":"Annupriya Itteera","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4405628728","eid":"W4405628728"},{"id":"paper-w7152527390","cat":"papers","name":"Efficacy and Safety of Ketamine or Esketamine versus Fentanyl-Class Opioids as Adjuncts to Propofol for Gastrointestinal Endoscopy: A Systematic Review and Meta-Analysis","year":"2026","cit":1,"pfa":"Kiran Inam","psa":"Erum Noon","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W7152527390","eid":"W7152527390"},{"id":"paper-w7155720969","cat":"papers","name":"Repeated intranasal esketamine augmentation in treatment-resistant obsessive-compulsive disorder with comorbid major depressive disorder: a prospective case series","year":"2026","cit":1,"pfa":"Sergi López-Rodríguez","psa":"Mª del Pino Alonso","topics":["Depression","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7155720969","eid":"W7155720969"},{"id":"paper-w3011875610","cat":"papers","name":"Ketamine/esketamine: Putative Mechanisms of Action: Details of How These Agents Produce Rapid Antidepressant Effects Have Been Misrepresented","year":"2020","cit":1,"pfa":"John J. Miller","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3011875610","eid":"W3011875610"},{"id":"paper-w4404370328","cat":"papers","name":"The impact of esketamine combined with butorphanol on postoperative analgesia and maternal psychological status after cesarean section: A randomized controlled study","year":"2024","cit":1,"pfa":"Siqi Ma","psa":"Ran Ran","topics":["Depression","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4404370328","eid":"W4404370328"},{"id":"paper-w7155071441","cat":"papers","name":"Intranasal esketamine in treatment-resistant depression: long-term dosing patterns and clinical outcomes in a 5-year observational study","year":"2026","cit":1,"pfa":"Alessandro Cuomo","psa":"Andrea M. Fagiolini","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7155071441","eid":"W7155071441"},{"id":"paper-w4313388271","cat":"papers","name":"Esketamine combined with sevoflurane anaesthesia for transurethral resection of the prostate in ankylosing spondylitis with severe thoracolumbar kyphoscoliosis: a case report and literature review","year":"2022","cit":1,"pfa":"Xiaoling Gu","psa":"Dekun Yin","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4313388271","eid":"W4313388271"},{"id":"paper-w7140194545","cat":"papers","name":"Effect of Intraoperative Low-Dose Esketamine on Postoperative High-Sensitivity Troponin T in Elderly Patients Undergoing Ivor Lewis Esophagectomy","year":"2026","cit":1,"pfa":"Zhou Hai","psa":"Liwei Wang","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7140194545","eid":"W7140194545"},{"id":"paper-w4390223531","cat":"papers","name":"Remission/response with esketamine nasal spray versus quetiapine extended release in treatment resistant depression using the Patient Health Questionnaire","year":"2023","cit":1,"pfa":"Allan Hunter Young","psa":"Yordan Godinov","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4390223531","eid":"W4390223531"},{"id":"paper-w4313410982","cat":"papers","name":"The effects of opioid-free anesthesia with dexmedetomidine and esketamine on postoperative anesthetic-related complications for hip surgery in the elderly – a randomized controlled trial","year":"2022","cit":1,"pfa":"Qiuping Ye","psa":"Yun Lin WU","topics":["Addiction","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4313410982","eid":"W4313410982"},{"id":"paper-w7162207443","cat":"papers","name":"Early suicidal ideation change and suicidality-associated emergency department utilization after ketamine or esketamine treatment in treatment-resistant depression","year":"2026","cit":1,"pfa":"Liliana Patarroyo-Rodríguez","psa":"Balwinder Singh","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7162207443","eid":"W7162207443"},{"id":"paper-w4415085400","cat":"papers","name":"Esketamine infusion for the prevention of tourniquet‐induced intra‐operative hypertension during below‐knee orthopaedic surgery: a randomised controlled trial","year":"2025","cit":1,"pfa":"Kai Jiang","psa":"Ke Peng","ptype":"article","src":"https://openalex.org/W4415085400","eid":"W4415085400"},{"id":"paper-w4414489513","cat":"papers","name":"Effect of intraoperative low-dose esketamine on postoperative quality of recovery in patients undergoing laparotomy for gynecologic malignancy: a randomized controlled trial","year":"2025","cit":1,"pfa":"Zhi-Yu Geng","psa":"Hui-Cheng Song","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4414489513","eid":"W4414489513"},{"id":"paper-w7160433882","cat":"papers","name":"Esketamine-led opioid-free anaesthesia reduces postoperative pulmonary complications in bariatric surgery patients: a prospective randomized controlled trial","year":"2026","cit":1,"pfa":"He-Liang Sun","psa":"Chun Yang","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7160433882","eid":"W7160433882"},{"id":"paper-w4414865933","cat":"papers","name":"The effect of esketamine on perioperative neurocognitive dysfunction in elderly patients undergoing gastrointestinal tumor surgery: a randomized double-blind controlled study","year":"2025","cit":1,"pfa":"Xiaoyan Ma","psa":"Wenli Yu","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4414865933","eid":"W4414865933"},{"id":"paper-w4414913955","cat":"papers","name":"Efficacy of Different Doses of Remimazolam Tosilate Combined with Esketamine in Painless Abortion Patients: A Prospective, Double-Blind, Randomized Controlled Trial","year":"2025","cit":1,"pfa":"Jiejuan Chen","psa":"Hui Li","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4414913955","eid":"W4414913955"},{"id":"paper-w7133199396","cat":"papers","name":"Effects of Intraoperative Esketamine–Dexmedetomidine Combination on Postpartum Depressive Symptoms and Neuropsychiatric Events Following Cesarean Delivery: A Randomized Controlled Trial","year":"2026","cit":1,"pfa":"Meng-Meng Li","psa":"Pan-Pan Fang","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7133199396","eid":"W7133199396"},{"id":"paper-w4390223970","cat":"papers","name":"Long-term safety and maintenance of response with esketamine nasal spray in treatment-resistant depression – final results of the SUSTAIN-3 study","year":"2023","cit":1,"pfa":"Allan Hunter Young","psa":"Dong‐Jing Fu","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4390223970","eid":"W4390223970"},{"id":"paper-w7117990822","cat":"papers","name":"Beyond acute response: long-term (102±86 weeks) treatment with esketamine in complex treatment-resistant depression in the real-world","year":"2026","cit":1,"pfa":"S. Pardossi","psa":"Alessandro Cuomo","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7117990822","eid":"W7117990822"},{"id":"paper-w4410753351","cat":"papers","name":"Fentanyl or esketamine for traumatic pain (FORE-PAIN) trial: study protocol for a double-blind multi-arm randomized non-inferiority trial","year":"2025","cit":1,"pfa":"Midas N. de Grunt","psa":"Robert P. Weenink","topics":["PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4410753351","eid":"W4410753351"},{"id":"paper-w4210536681","cat":"papers","name":"Antidepressant Effect of Prolonged Twice-Weekly Intranasal Esketamine Treatments after Nonresponse to Electroconvulsive Therapy in a Patient with Treatment-Resistant Depression","year":"2022","cit":1,"pfa":"Audrey G. Evers","psa":"Manish K. Jha","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4210536681","eid":"W4210536681"},{"id":"paper-w4417327632","cat":"papers","name":"Opioid-free anesthesia with esketamine combined with interpectoral plane block and pectoralis-serratus plane blocks in radical mastectomy: a randomized controlled trial","year":"2025","cit":1,"pfa":"Wenping Ding","psa":"Liwei Wang","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4417327632","eid":"W4417327632"},{"id":"paper-w4410265467","cat":"papers","name":"The Effect of Esketamine as an Adjuvant for Adductor Canal Block on Postoperative Pain in Patients Undergoing Arthroscopic Knee Surgery: A Randomized Controlled Trial","year":"2025","cit":1,"pfa":"Shilei Zhao","psa":"Yingjie Sun","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4410265467","eid":"W4410265467"},{"id":"paper-w4409987340","cat":"papers","name":"Esketamine Reduces Lung Injury Caused by Limb Ischemia-Reperfusion by Regulating Oxidative Stress via the TLR4/NF-κB/NLRP3 Pathway","year":"2025","cit":1,"pfa":"Meng Wang","psa":"Heng Wen","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4409987340","eid":"W4409987340"},{"id":"paper-w7128424409","cat":"papers","name":"Effect of subanesthetic dose esketamine on anxiety and depression in patients with breast cancer after surgery: a randomized controlled, double-blind study","year":"2026","cit":1,"pfa":"Song-Yuan Liu","psa":"Ming-Qiang Zhao","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7128424409","eid":"W7128424409"},{"id":"paper-w4408133401","cat":"papers","name":"Effect of Subanesthetic Dose of Esketamine Infusion on Postoperative Sleep Disturbance in Elderly Undergoing Laparoscopic Gastrointestinal Surgery：protocol for a randomized controlled trial（RCT）","year":"2025","cit":1,"pfa":"Rongrong Li","psa":"Xingying He","topics":["Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4408133401","eid":"W4408133401"},{"id":"paper-w4388047238","cat":"papers","name":"Correction: Analysis of the efficacy of subclinical doses of esketamine in combination with propofol in non-intubated general anesthesia procedures - a systematic review and meta-analysis","year":"2023","cit":1,"pfa":"Haoming Chen","psa":"Peng Li","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"erratum","src":"https://openalex.org/W4388047238","eid":"W4388047238"},{"id":"paper-w4296356673","cat":"papers","name":"Possible Use of Minocycline in Adjunction to Intranasal Esketamine for the Management of Difficult to Treat Depression following Extensive Pharmacogenomic Testing: Two Case Reports","year":"2022","cit":1,"pfa":"Matteo Marcatili","psa":"Massimo Clerici","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4296356673","eid":"W4296356673"},{"id":"paper-w2608091502","cat":"papers","name":"74. PERSEVERE: A Study of Esketamine for the Reduction of the Symptoms of Major Depressive Disorder, including Suicidal Ideation, in Subjects Assessed to Be at Imminent Risk for Suicide","year":"2017","cit":1,"pfa":"Carla M. Canuso","psa":"Wayne Curtis Drevets","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2608091502","eid":"W2608091502"},{"id":"paper-w4390521412","cat":"papers","name":"The effect of esketamine on perioperative neurocognitive dysfunction in elderly patients who underwent gastrointestinal tumor surgery: a randomized double-blind controlled study","year":"2024","cit":1,"pfa":"Xiaoyan Ma","psa":"Lirong Yang","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4390521412","eid":"W4390521412"},{"id":"paper-w4401921394","cat":"papers","name":"How adults with treatment resistant depression experience their first esketamine nasal spray treatment? Preliminary results from a French qualitative study","year":"2024","cit":1,"pfa":"Émilie Manolios","psa":"Anne Révah‐Levy","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4401921394","eid":"W4401921394"},{"id":"paper-w4200494134","cat":"papers","name":"P.0230 Compassionate use of esketamine nasal spray in patients ≥65 years old with treatment-resistant depression: a descriptive multicenter study","year":"2021","cit":1,"pfa":"Alejandro Fuertes-Sáiz","psa":"R. Mora-Marín","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4200494134","eid":"W4200494134"},{"id":"paper-w7131269059","cat":"papers","name":"Comparative effectiveness and safety of esketamine versus injectable racemic ketamine and oral antidepressants for major depressive disorder: A population-based target trial emulation","year":"2026","cit":1,"pfa":"Ching-Hua Julie Lee","psa":"Kevin Sheng-Kai Ma","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7131269059","eid":"W7131269059"},{"id":"paper-w4414179853","cat":"papers","name":"Esketamine Nasal Spray in the Treatment of Depression: A Comprehensive Analysis of its Efficacy and Safety in 107 Patients of Sulwan Psychiatric Hospital in Kingdom of Bahrain","year":"2025","cit":1,"pfa":"A. M. Al Hamada","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4414179853","eid":"W4414179853"},{"id":"paper-w4361010721","cat":"papers","name":"Effects of the Different Doses of Esketamine on Postoperative Quality of Recovery in Patients Undergoing Modified Radical Mastectomy: A Randomized, Double-Blind, Controlled Trial [Letter]","year":"2023","cit":1,"pfa":"Yi Cheng","psa":"Chengwen Li","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4361010721","eid":"W4361010721"},{"id":"paper-w4414474043","cat":"papers","name":"Medicaid Coverage of Esketamine and Ketamine Therapies: Cross-Sectional Policy Analysis Across 51 Jurisdictions and 165 Coverage Entities (August 2025)","year":"2025","cit":1,"pfa":"Michael Alvear","topics":["Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4414474043","eid":"W4414474043"},{"id":"paper-w7123338917","cat":"papers","name":"Comparison of the Effective Dose 90 (ED90) and Clinical Outcomes of Fentanyl Versus Esketamine for Analgesia in Hysteroscopy: A Two-Part, Randomized, Double-Blind Trial","year":"2026","cit":1,"pfa":"Jun Du","psa":"Xiarong Qin","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7123338917","eid":"W7123338917"},{"id":"paper-w7167284368","cat":"papers","name":"Intranasal esketamine plus oral antidepressant for treatment-resistant depression: acute induction and maintenance relapse-prevention outcomes in a systematic review and meta-analysis","year":"2026","cit":1,"pfa":"Jingqiang Xie","psa":"Mingyue Sun","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7167284368","eid":"W7167284368"},{"id":"paper-w4366293964","cat":"papers","name":"Effects of the Different Doses of Esketamine on Postoperative Quality of Recovery in Patients Undergoing Modified Radical Mastectomy: A Randomized, Double-Blind, Controlled Trial [Response to Letter]","year":"2023","cit":1,"pfa":"Min Zhu","psa":"Xitong Yu","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4366293964","eid":"W4366293964"},{"id":"paper-w4200149577","cat":"papers","name":"P.0226 Indirect comparison estimating the benefit of esketamine compared to distinct real-world treatment strategies for treatment resistant depression in general psychiatry","year":"2021","cit":1,"pfa":"B. Rive","psa":"Joachim Morrens","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4200149577","eid":"W4200149577"},{"id":"paper-w4311483333","cat":"papers","name":"CO151 Estimating the Benefit of Esketamine Nasal Spray Versus Real-World Treatment on Patient-Reported Functional Remission: Results From the Iceberg Study","year":"2022","cit":1,"pfa":"Albino Jorge Oliveira-Maia","psa":"Siobhán Mulhern-Haughey","ptype":"conference-abstract","src":"https://openalex.org/W4311483333","eid":"W4311483333"},{"id":"paper-w4408163759","cat":"papers","name":"Effect of esketamine on postoperative sleep disturbance in patients undergoing spinal surgery: a study protocol for a randomised, double-blinded, placebo-controlled clinical trial","year":"2025","cit":1,"pfa":"Minyu Jian","psa":"Huiwen Wang","topics":["Depression","Anxiety & end-of-life","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4408163759","eid":"W4408163759"},{"id":"paper-w4406588954","cat":"papers","name":"Mental Health-Related Disability Days and Costs Among Patients with Treatment-Resistant Depression Initiated on Esketamine Nasal Spray and Conventional Therapies in the USA","year":"2025","cit":1,"pfa":"Manish K. Jha","psa":"Kruti Joshi","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4406588954","eid":"W4406588954"},{"id":"paper-w4414263463","cat":"papers","name":"Assessment of patient-reported depression severity in subpopulation of ESCAPE-TRD study: esketamine nasal spray versus quetiapine extended release for treatment-resistant depression","year":"2025","cit":1,"pfa":"Kristin Clemens","psa":"Yordan Godinov","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4414263463","eid":"W4414263463"},{"id":"paper-w4391537522","cat":"papers","name":"Effective dose of propofol combined with intravenous esketamine for smooth flexible laryngeal mask airway insertion in two distinct age groups of preschool children","year":"2024","cit":1,"pfa":"Bin Zhang","psa":"Junxia Wang","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4391537522","eid":"W4391537522"},{"id":"paper-w4392639222","cat":"papers","name":"Single intravenous subanesthetic dose of esketamine failed to relieve postoperative pain in obese patients undergoing bariatric surgery: a randomized controlled clinical trial","year":"2024","cit":1,"pfa":"Tao Hu","psa":"Qiang Fu","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4392639222","eid":"W4392639222"},{"id":"paper-w7125816176","cat":"papers","name":"Esketamine-Based Opioid-Free versus Opioid-Based Anesthesia for Recovery Quality After Laparoscopic Transabdominal Preperitoneal Repair: A Randomized Noninferiority Trial","year":"2026","cit":1,"pfa":"Huan Liu","psa":"Lijian Chen","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7125816176","eid":"W7125816176"},{"id":"paper-w4414086429","cat":"papers","name":"Safety and efficacy evaluation of low-dose of esketamine combined with propofol for painless gastroscopy: a single-center, randomized, double-blind, parallel controlled clinical trial","year":"2025","cit":1,"pfa":"Rong-sen Gu","psa":"Yong-Fa Zhang","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4414086429","eid":"W4414086429"},{"id":"paper-w4200490033","cat":"papers","name":"P.0225 Indirect comparison estimating the benefit of esketamine compared to real-world treatment of treatment resistant depression in general psychiatry: preliminary analysis","year":"2021","cit":1,"pfa":"Joachim Morrens","psa":"B. Rive","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4200490033","eid":"W4200490033"},{"id":"paper-w4411977711","cat":"papers","name":"[Esketamine Alleviates Postoperative Depressive Symptoms in Frail Elderly Patients Undergoing Thoracoscopic Radical Resection of Lung Cancer: A Randomized Double-Blind Controlled Trial].","year":"2025","cit":1,"pfa":"Congli Zhang","psa":"Li Ren","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4411977711","eid":"W4411977711"},{"id":"paper-w4409898824","cat":"papers","name":"Effect of pretreatment with low-dose Esketamine on the Propofol requirements and the onset time of cisatracurium during the induction of general anesthesia: a prospective, randomized, double-blinded trial","year":"2025","cit":1,"pfa":"Rui An","psa":"Longhui Cao","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4409898824","eid":"W4409898824"},{"id":"paper-w4382048836","cat":"papers","name":"A comparative study of Esketamine-Dexmedetomidine and Sufentanil-Dexmedetomidine for sedation and analgesia in lung tumor percutaneous radiofrequency ablation(PRFA):A randomized double-blind clinical trial","year":"2023","cit":1,"pfa":"Zhonglan Lin","psa":"S. Li","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4382048836","eid":"W4382048836"},{"id":"paper-w3201920714","cat":"papers","name":"Opioid-Free General Anesthesia with Dexmedetomidine-Esketamine-Lidocaine Versus Opioid-Based General Anesthesia with Sufentanil-Remifentanil for Breast Benign Patients Undergoing Lumpectomy","year":"2021","cit":1,"pfa":"Xiali Qian","psa":"Xiang Wang","topics":["Addiction","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W3201920714","eid":"W3201920714"},{"id":"paper-w4414089366","cat":"papers","name":"Real-world esketamine treatment for treatment-resistant depression: an analysis of comorbid post-traumatic stress disorder, comorbid anxiety disorder and line of therapy subgroups","year":"2025","cit":1,"pfa":"Malcolm Hopwood","psa":"Ian Bernard Hickie","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4414089366","eid":"W4414089366"},{"id":"paper-w4362664991","cat":"papers","name":"Effect of esketamine-based opioid-sparing anesthesia strategy on postoperative pain and recovery quality in patients undergoing total laparoscopic hysterectomy : a randomized controlled trail","year":"2023","cit":1,"pfa":"Jialei Liu","psa":"Yan Li","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4362664991","eid":"W4362664991"},{"id":"paper-w4387679887","cat":"papers","name":"Effects of different doses of esketamine on hemodynamic indexes, pain stress indexes, and VAS scores in patients with benign ovarian tumors undergoing laparoscopic resection induced by remifentanil","year":"2023","cit":1,"topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4387679887","eid":"W4387679887"},{"id":"paper-w7131412731","cat":"papers","name":"Adverse drug events and toxicological mechanisms of esketamine: a study based on US Food and Drug Administration Adverse Event Reporting System and network toxicology analysis","year":"2026","cit":1,"pfa":"Lu Wang","psa":"Xiaodan Lai","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7131412731","eid":"W7131412731"},{"id":"paper-w7115730199","cat":"papers","name":"Effects of Intravenous Subanesthetic-Dose Esketamine on Early Postoperative Pain in Elderly Patients Undergoing Thoracoscopic Lung Surgery: A Randomized Double-Blind Controlled Trial","year":"2025","cit":1,"pfa":"Haishu Zhao","psa":"Lidong Zhang","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7115730199","eid":"W7115730199"},{"id":"paper-w7162677085","cat":"papers","name":"The esketamine-based multimodal low-opioid anaesthesia improves quality of recovery in elderly patients undergoing radical lung cancer surgery: a randomized controlled trial","year":"2026","cit":1,"pfa":"Zhou Hai","psa":"Liwei Wang","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7162677085","eid":"W7162677085"},{"id":"paper-w4414281236","cat":"papers","name":"Esketamine versus fentanyl as adjuncts to hepatic hilar nerve block for ambulatory percutaneous liver tumor ablation focusing on respiratory safety: protocol for a randomized controlled trial","year":"2025","cit":1,"pfa":"Xiao Wang","psa":"Bin Yang","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4414281236","eid":"W4414281236"},{"id":"paper-w4416932631","cat":"papers","name":"Cheung’s Regimen Series: Successful Conversion From One Dose of Esketamine to a Low-Cost Oral Ketamine-Class Glutamatergic Regimen in Treatment-Resistant Depression and OCD","year":"2025","cit":1,"pfa":"Ngo Cheung","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4416932631","eid":"W4416932631"},{"id":"paper-w7127042379","cat":"papers","name":"Effectiveness of intranasal esketamine in the treatment of patients with treatment-resistant depression: an observational study based on data collected in a Spravato treatment program at the Institute of Living, Hartford","year":"2026","cit":1,"pfa":"Benjamin Anderson","psa":"Grace Chan","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7127042379","eid":"W7127042379"},{"id":"paper-w7164513376","cat":"papers","name":"Comment on “Effect of Remimazolam or Propofol Combined With Esketamine on Anesthesia and Early Perioperative Neurocognitive Disorders in Patients Undergoing Thoracoscopic Partial Lung Resection: A Randomized Clinical Tri","year":"2026","cit":1,"pfa":"Shobana Chandrasekar","psa":"Umesh Kumar","ptype":"article","src":"https://openalex.org/W7164513376","eid":"W7164513376"},{"id":"paper-w7150862889","cat":"papers","name":"The effect of esketamine as adjuvant to ropivacaine for unilateral paravertebral block on postoperative pain and sensitization in adult patients undergoing video-assisted thoracoscopic surgery: a randomized clinical tria","year":"2026","cit":1,"pfa":"Na Yang","psa":"Lihua Peng","ptype":"article","src":"https://openalex.org/W7150862889","eid":"W7150862889"},{"id":"paper-w7152482636","cat":"papers","name":"Esketamine/dexmedetomidine-based opioid-free anesthesia modulates perioperative neuro-inflammatory biomarkers and enhances postoperative cognitive recovery in patients undergoing total laparoscopic hysterectomy","year":"2026","cit":1,"pfa":"Guohua LI","psa":"Xiao LI","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7152482636","eid":"W7152482636"},{"id":"paper-w7118133686","cat":"papers","name":"Intravenous Esketamine Versus Erector Spinae Plane Block for Postoperative Recovery Quality Following Video-Assisted Thoracoscopic Surgery: A Randomized Controlled Non-Inferiority Trial","year":"2026","cit":1,"pfa":"Zhili Liu","psa":"LiDong Zhang","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7118133686","eid":"W7118133686"},{"id":"paper-w4413071397","cat":"papers","name":"Efficacy and safety of esketamine for treatment resistant depression: registered report for a Systematic Review with an Individual Patient Data Meta-analysis of Randomized, Double-Blind, Placebo-Controlled Trials","year":"2025","cit":1,"pfa":"Florian Naudet","psa":"Ioana A. Cristea","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4413071397","eid":"W4413071397"},{"id":"paper-w4409838769","cat":"papers","name":"Impact of Medical Comorbidities on Ketamine and Esketamine Treatment Effectiveness for Posttraumatic Stress Disorder and Depression: A Clinical Outcomes Analysis from the VA San Diego Healthcare System","year":"2025","cit":1,"pfa":"Sijia Zhang","psa":"Miranda Francoeur Koloski","topics":["Depression","PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4409838769","eid":"W4409838769"},{"id":"paper-w4386753005","cat":"papers","name":"Corrigendum to “Comparing fast-acting interventions for treatment-resistant depression: An explorative study of accelerated HF-rTMS versus intranasal esketamine” [Brain Stimul 16 (2023)]","year":"2023","cit":1,"pfa":"Mauro Pettorruso","psa":"Luca Carlone","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"erratum","src":"https://openalex.org/W4386753005","eid":"W4386753005"},{"id":"paper-w7204631035","cat":"papers","name":"Esketamine-based treatment, depression-specific metacognitive training, and their combination in treatment-resistant depression: 6-month trajectories of depressive symptoms and rumination in a multicenter observational s","year":"2026","cit":1,"pfa":"Vassilis Martiadis","psa":"Bernardo Maria Dell’Osso","topics":["Depression","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7204631035","eid":"W7204631035"},{"id":"paper-w4394615485","cat":"papers","name":"The efficacy of nasal administration of esketamine in patients having moderate-to-severe pain after preoperative CT-guided needle localization: a randomized, double-blind, placebo-controlled trial","year":"2024","cit":1,"pfa":"Jiangning Xu","psa":"Yuwei Qiu","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4394615485","eid":"W4394615485"},{"id":"paper-w4283524279","cat":"papers","name":"EE51 Cost-Effectiveness of Esketamine Nasal Spray Compared to Intravenous Ketamine for Patients with Treatment-Resistant Depression in the US Utilizing Clinical Trial Efficacy and Real-World Effectiveness Estimates","year":"2022","cit":1,"pfa":"Madeline Brendle","psa":"DC Malone","topics":["Depression"],"ptype":"conference-abstract","src":"https://openalex.org/W4283524279","eid":"W4283524279"},{"id":"paper-w7134066680","cat":"papers","name":"Brain functional network correlates and predictors of the perioperative antidepressant effect of esketamine in breast cancer patients: a double-blind randomized controlled trial using resting-state fMRI and graph theory","year":"2026","cit":1,"pfa":"Huimin Zhu","psa":"Yongqiang Yu","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7134066680","eid":"W7134066680"},{"id":"paper-w4408890485","cat":"papers","name":"Notice of Retraction. Xu LL, et al. Efficacy and Safety of Esketamine for Supplemental Analgesia During Elective Cesarean Delivery: A Randomized Clinical Trial. JAMA Netw Open. 2023;6(4):e239321.","year":"2025","cit":1,"pfa":"Xinzhong Chen","psa":"Dong‐Xin Wang","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4408890485","eid":"W4408890485"},{"id":"paper-w4385669018","cat":"papers","name":"A 28-Day, Randomized, Controlled, Single-Blind, Phase 2 Study in Treatment-Resistant Major Depressive Disorder (TRD) Patients Receiving Intranasal Esketamine Comparing Addition of Almond Therapy TM with Treatment-as-Usua","year":"2023","cit":1,"pfa":"Pierre S. Chue","psa":"James Chue","topics":["Depression","PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4385669018","eid":"W4385669018"},{"id":"paper-w7154173194","cat":"papers","name":"Pleiotropic modulation of the gut-brain-lung axis by ketamine and its enantiomers","year":"2026","cit":1,"pfa":"Xinyu Zhao","psa":"Jiancheng Zhang","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7154173194","eid":"W7154173194"},{"id":"paper-w7160400165","cat":"papers","name":"Effects of ketamine on sleep and circadian rhythmicity in major depressive disorder and bipolar disorder: A systematic review","year":"2026","cit":1,"pfa":"Rutger Boesjes","psa":"Jens H. van Dalfsen","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7160400165","eid":"W7160400165"},{"id":"paper-w3006608799","cat":"papers","name":"NIMH Director to Discuss Advances in Treating Major Depression","year":"2020","cit":1,"pfa":"Nick Zagorski","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3006608799","eid":"W3006608799"},{"id":"paper-w4411326384","cat":"papers","name":"Rapid treatment center for depression in China: constructive reflections and transnational implications","year":"2025","cit":1,"pfa":"Zhan-Ming Shi","psa":"Wei Zheng","topics":["Depression","Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4411326384","eid":"W4411326384"},{"id":"paper-w4206582804","cat":"papers","name":"The role of ketamine in the treatment of treatment-resistant bipolar depression","year":"2021","cit":1,"pfa":"Grigorios N. Karakatsoulis","psa":"Konstantinos Ν. Fountoulakis","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4206582804","eid":"W4206582804"},{"id":"paper-w4413956758","cat":"papers","name":"Insights Into the Effects of Ketamine on the Opioid System","year":"2025","cit":1,"pfa":"Charles F. Zorumski","psa":"Steven J. Mennerick","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4413956758","eid":"W4413956758"},{"id":"paper-w4405425161","cat":"papers","name":"Emerging medications in psychiatry: Transforming the treatment landscape for depression and psychosis in Parkinson’s disease","year":"2024","cit":1,"pfa":"Brijesh Saran","psa":"Rohit Bhagat","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4405425161","eid":"W4405425161"},{"id":"paper-w4412761256","cat":"papers","name":"Exploring Esketamine’s Therapeutic Role for Perinatal Depression via TASK-1 Tandem Pore Potassium Channels","year":"2025","cit":1,"pfa":"Lin Zhu","psa":"Fengrui Yang","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4412761256","eid":"W4412761256"},{"id":"paper-w7161052462","cat":"papers","name":"Ketamin und Esketamin bei der therapieresistenten Depression","year":"2026","cit":1,"pfa":"Cornelius Schüle","psa":"Helena Victoria Rogg","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7161052462","eid":"W7161052462"},{"id":"paper-w4389158697","cat":"papers","name":"Financement de la psychiatrie en France, la question des médicaments onéreux : exemple de l’Esketamine dans l’épisode dépressif caractérisé résistant","year":"2023","cit":1,"pfa":"Tanguy Taillefer de Laportalière","psa":"Blandine Juillard‐Condat","ptype":"article","src":"https://openalex.org/W4389158697","eid":"W4389158697"},{"id":"paper-w4401919879","cat":"papers","name":"“It was all yellow” first patient with resistant depresion treated with esketamina","year":"2024","cit":1,"pfa":"M. J. Mateos Sexmero","psa":"Óscar Martín-Santiago","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4401919879","eid":"W4401919879"},{"id":"paper-w4409737227","cat":"papers","name":"Ketamine-Occasioned Mystical Experience in Veterans with Treatment-Resistant Depression: A Retrospective Exploratory Analysis","year":"2025","cit":1,"pfa":"Kush V. Bhatt","psa":"Andrew W. Bismark","topics":["Depression","PTSD & trauma","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4409737227","eid":"W4409737227"},{"id":"paper-w3116292025","cat":"papers","name":"Effects of Discontinuation of Drugs Used for Augmentation Therapy on Treatment Outcomes in Depression: A Systematic Review and Meta-analysis","year":"2020","cit":1,"pfa":"Hideo Kato","psa":"Hiroyuki Uchida","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W3116292025","eid":"W3116292025"},{"id":"paper-w4415168309","cat":"papers","name":"(Es)ketamine as a treatment for depressive episodes with psychotic features: systematic review","year":"2025","cit":1,"pfa":"Henrique Castro Santos","psa":"Mário F. Juruena","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4415168309","eid":"W4415168309"},{"id":"paper-w4311065952","cat":"papers","name":"Editorial: The development of biomarkers in psychiatry","year":"2022","cit":1,"pfa":"Takashi Nakano","psa":"Shin‐ichi Kano","topics":["Depression"],"ptype":"editorial","src":"https://openalex.org/W4311065952","eid":"W4311065952"},{"id":"paper-w4394762178","cat":"papers","name":"The Effectiveness of Low-dose Esmketamine Versus Remifentanil Adjunct to Propofol for Sedation in Patients Undergoing Radiofrequency Thermocoagulation for Trigeminal Neuralgia.","year":"2024","cit":1,"pfa":"An Xie","psa":"Xianjie Zhang","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4394762178","eid":"W4394762178"},{"id":"paper-w3046873086","cat":"papers","name":"Corrigendum: Allopregnanolone, the Neuromodulator Turned Therapeutic Agent: Thank You, Next?","year":"2020","cit":1,"pfa":"Graziano Pinna","topics":["Depression","Mechanism & neuroscience"],"ptype":"erratum","src":"https://openalex.org/W3046873086","eid":"W3046873086"},{"id":"paper-w4399220472","cat":"papers","name":"Glutamate concentrations related to depression and mania symptoms in patients with G raves' disease: A 1 H ‐magnetic resonance spectroscopy study","year":"2024","cit":1,"pfa":"Shih‐Hsien Lin","psa":"Yen Kuang Yang","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4399220472","eid":"W4399220472"},{"id":"paper-w4391017154","cat":"papers","name":"S(+)-ketamin: Review of pharmacological properties and use in clinical practice (S(+)-ketamin: Pharmacology and clinical use)","year":"2023","cit":1,"pfa":"Dragan Turanjanin","psa":"Biljana G. Draskovic","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4391017154","eid":"W4391017154"},{"id":"paper-w4416809617","cat":"papers","name":"Assessment and management of major depressive disorder in adults","year":"2025","cit":1,"pfa":"Pauline Stoltzner","psa":"Cameron Duncan","topics":["Depression","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4416809617","eid":"W4416809617"},{"id":"paper-w7127606161","cat":"papers","name":"Estimated preventive dose of racemic ketamine for shivering and pruritus prophylaxis in cesarean delivery: a Monte Carlo simulation guided network meta-analysis","year":"2026","cit":1,"pfa":"Wei-Long Wang","psa":"Zhen-feng Zhou","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7127606161","eid":"W7127606161"},{"id":"paper-w3131309205","cat":"papers","name":"[About the use of ketamine in emergency psychiatric settings].","year":"2021","cit":1,"pfa":"Ioannis N. Sergentanis","psa":"Julia Ambrosetti","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3131309205","eid":"W3131309205"},{"id":"paper-w7165787475","cat":"papers","name":"Evaluating the abuse liability of ketamine in the treatment of mood disorders: A systematic review","year":"2026","cit":1,"pfa":"Shreya Vasudeva","psa":"Joshua Daniel Rosenblat","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W7165787475","eid":"W7165787475"},{"id":"paper-w4415706383","cat":"papers","name":"A Systematic Review of the Effects of N-Methyl-D-Aspartate Receptor Antagonists on Pancreatic Islets","year":"2025","cit":1,"pfa":"Sabrina Wong","psa":"Roger S. McIntyre","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W4415706383","eid":"W4415706383"},{"id":"paper-w7141340560","cat":"papers","name":"2025 in Review: FDA Approvals, Practice Guidelines, and Label Changes in Psychiatry","year":"2025","cit":1,"pfa":"Sebastián Malleza","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"report","src":"https://openalex.org/W7141340560","eid":"W7141340560"},{"id":"paper-w7170711498","cat":"papers","name":"The impact of different intervention methods (anesthetic adjuvant drugs, anesthetic techniques, and non-pharmacological interventions) on postoperative cognitive function in patients undergoing cardiac surgery: a systema","year":"2026","cit":1,"pfa":"Jiao Xue","psa":"Yi Qiu","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7170711498","eid":"W7170711498"},{"id":"paper-w4414639546","cat":"papers","name":"Procedural Sedation and Analgesia with Spontaneous Ventilation Outside the Operating Room in Non-emergency Scenarios and Ketamine","year":"2025","cit":1,"pfa":"Soumya Sarkar","topics":["Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W4414639546","eid":"W4414639546"},{"id":"paper-w4321481233","cat":"papers","name":"Reconstruction of TrkB complex assemblies and localizing antidepressant targets using Artificial Intelligence","year":"2023","cit":1,"pfa":"Xufu Xiang","psa":"Fuzhen Xia","topics":["Depression","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4321481233","eid":"W4321481233"},{"id":"paper-w4402784183","cat":"papers","name":"SAL0114: a novel deuterated dextromethorphan-bupropion combination with improved antidepressant efficacy and safety profile","year":"2024","cit":1,"pfa":"Ying Xiao","psa":"J M Wu","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4402784183","eid":"W4402784183"},{"id":"paper-w7134829485","cat":"papers","name":"Effect of ketamine on reward processing in depressive disorders: a systematic review of neuroimaging studies","year":"2026","cit":1,"pfa":"Halima Faisal","psa":"Roger S. McIntyre","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7134829485","eid":"W7134829485"},{"id":"paper-w4408084897","cat":"papers","name":"Modulation of negative affective biases in male rats may predict the rapid and sustained antidepressant effects of different NMDA antagonists","year":"2025","cit":1,"pfa":"Justyna K. Hinchcliffe","psa":"Emma S J Robinson","topics":["Depression","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4408084897","eid":"W4408084897"},{"id":"paper-w4407369015","cat":"papers","name":"Intersections of Anesthesiology and Psychiatry: Reply","year":"2025","cit":1,"pfa":"Connor T. A. Brenna","psa":"Beverley Anne Orser","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4407369015","eid":"W4407369015"},{"id":"paper-w4398763083","cat":"papers","name":"Moving Forward with Ketamine Therapy: Ensuring Safety, Efficacy, and Accessibility in Depression Treatment","year":"2024","cit":1,"pfa":"Julienne DeSanto","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W4398763083","eid":"W4398763083"},{"id":"paper-w4210949761","cat":"papers","name":"Ketamine and Other Glutamate Receptor Antagonists As Fast-Actin","year":"2022","cit":1,"pfa":"Mu‐Hong Chen","psa":"Shih‐Jen Tsai","topics":["Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W4210949761","eid":"W4210949761"},{"id":"paper-w4363643565","cat":"papers","name":"Mood and Anxiety Disorders: Suicide.","year":"2023","cit":1,"pfa":"Ashley Wilk","psa":"Shannon Smith","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4363643565","eid":"W4363643565"},{"id":"paper-w7129630226","cat":"papers","name":"Advances in antidepressant pharmacotherapy: phase 3 evidence and clinical perspectives","year":"2026","cit":1,"pfa":"Alessandro Cuomo","psa":"Andrea M. Fagiolini","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7129630226","eid":"W7129630226"},{"id":"paper-w4403422988","cat":"papers","name":"Toward Enhanced Methodological Rigor: Addressing Limitations in the Comparative Analysis of Probiotics and Antidepressants for Major Depressive Disorder Management","year":"2024","cit":1,"pfa":"Sérgio André de Souza Júnior","psa":"Fábio Gomes de Matos e Souza","topics":["Depression","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4403422988","eid":"W4403422988"},{"id":"paper-w4385669333","cat":"papers","name":"A Review of the Metabolism and Relevance to Form and Formulation of Ketamine","year":"2023","cit":1,"pfa":"Pierre S. Chue","psa":"M. Tate","topics":["Depression","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4385669333","eid":"W4385669333"},{"id":"paper-w7126028671","cat":"papers","name":"Promotion of lung cancer growth via glutamate ionotropic receptor N-methyl-D-aspartate-type subunit 2D (GRIN2D)","year":"2026","cit":1,"pfa":"Yun‐Luo Lv","psa":"Hongguang Bao","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7126028671","eid":"W7126028671"},{"id":"paper-w4416422317","cat":"papers","name":"The Role of Physical Activity in the Management of Treatment-Resistant Depression: Evidence and Future Directions","year":"2025","cit":1,"pfa":"Justyna Klonowska","psa":"Maria Izabela Sroka","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4416422317","eid":"W4416422317"},{"id":"paper-w7126122686","cat":"papers","name":"Effects of nine sedative-analgesic combinations on fatigue after gastrointestinal endoscopy: a randomized controlled 3 × 3 factorial trial protocol","year":"2026","cit":1,"pfa":"Lei Huang","psa":"Ke Peng","ptype":"article","src":"https://openalex.org/W7126122686","eid":"W7126122686"},{"id":"paper-w7128438758","cat":"papers","name":"Effect of total intravenous opioid-free anesthesia on quality of recovery following gynecological laparoscopy: protocol for a multicenter, randomized, double-blind, controlled trial","year":"2026","cit":1,"pfa":"T. Wu","psa":"Fuhai Ji","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7128438758","eid":"W7128438758"},{"id":"paper-w7151344104","cat":"papers","name":"Clinical correlates of anhedonia non-response to ketamine in treatment-resistant depression","year":"2026","cit":1,"pfa":"Michał Walaszek","psa":"Aleksander Kwaśny","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7151344104","eid":"W7151344104"},{"id":"paper-w4398771410","cat":"papers","name":"Assessment of postoperative pain in children following sclerotherapy of vascular malformations: a retrospective single centre cohort study","year":"2024","cit":1,"pfa":"Cees Klein Tank","psa":"Ignacio Malagon","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4398771410","eid":"W4398771410"},{"id":"paper-w4408517461","cat":"papers","name":"Endoscopy Sedation Challenges in Patients With Hepatic Encephalopathy: A Focused Review on Propofol and Selective Use of Benzodiazepines","year":"2025","cit":1,"pfa":"Miruna V. Moraru","psa":"Ion Fulga","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4408517461","eid":"W4408517461"},{"id":"paper-w4391338716","cat":"papers","name":"Comparison of Three Intravenous Sedation Techniques Used for Extracting Mandibular Third Molars in Dental Patients","year":"2024","cit":1,"pfa":"Zhijun Xin","psa":"Zhuojun Hu","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4391338716","eid":"W4391338716"},{"id":"paper-w4414179970","cat":"papers","name":"Is there a risk of addiction to ketamine during the treatment of depression? A systematic review of available literature","year":"2025","cit":1,"pfa":"Gianmarco Ingrosso","psa":"Mário F. Juruena","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W4414179970","eid":"W4414179970"},{"id":"paper-w3189668723","cat":"papers","name":"The Substantiality of the Neuroplasticity Hypothesis of Major Depressive Disorder: The Prospective Use of Ketamine-Like Drugs as Antidepressants","year":"2020","cit":1,"pfa":"Roma A. Kankaria","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3189668723","eid":"W3189668723"},{"id":"paper-w7170037304","cat":"papers","name":"Effect of opioid-free anesthesia on postoperative recovery in elderly patients undergoing laparoscopic abdominal surgery: a randomized controlled trial","year":"2026","cit":1,"pfa":"Qiucheng Zhao","psa":"Xiaoyu Xu","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7170037304","eid":"W7170037304"},{"id":"paper-w7154498117","cat":"papers","name":"Intranasal administration in modulating depressive-like behavior and reconstructing treatment paradigms through neuroinflammation and neurotrophic pathways","year":"2026","cit":1,"pfa":"Juan An","psa":"Yuanming Pan","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7154498117","eid":"W7154498117"},{"id":"paper-w2955270561","cat":"papers","name":"Neuromodulation Interventions: ECT and rTMS – Work-Up, Preparation, and Posttreatment Care + Ketamine in Inpatient Psychiatry","year":"2019","cit":1,"pfa":"Lisa McMurray","psa":"Barbara Deren","ptype":"book-chapter","src":"https://openalex.org/W2955270561","eid":"W2955270561"},{"id":"paper-w2948690994","cat":"papers","name":"Rapid-acting antidepressants : Shared neuropharmacological mechanisms","year":"2019","cit":1,"pfa":"Samuel Kohtala","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W2948690994","eid":"W2948690994"},{"id":"paper-w4414180909","cat":"papers","name":"Typical clinical manifestations of anxiety and depression in patients with medical illness and general notions about their treatment","year":"2025","cit":1,"pfa":"Lucie Bartova","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4414180909","eid":"W4414180909"},{"id":"paper-w4401919390","cat":"papers","name":"Ketamine in the treatment of obsessive-compulsive disorder – a case report and literature review","year":"2024","cit":1,"pfa":"Isabel Palma","psa":"R. Moreira","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4401919390","eid":"W4401919390"},{"id":"paper-w4414586509","cat":"papers","name":"Remimazolam for intravenous anaesthesia in children: reassessing the dose‐onset relationship","year":"2025","cit":1,"pfa":"Yi Zhang","psa":"Xiaofeng Lei","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4414586509","eid":"W4414586509"},{"id":"paper-w7170090510","cat":"papers","name":"Editorial: Treatment resistant depression: epidemiology, clinic, burden and treatment, volume II","year":"2026","cit":1,"pfa":"Vassilis Martiadis","psa":"Andrea Fiorillo","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"editorial","src":"https://openalex.org/W7170090510","eid":"W7170090510"},{"id":"paper-w4377234089","cat":"papers","name":"Unsubstantiated use of Selective serotonin reuptake inhibitors as an alternative for the treatment of depression","year":"2023","cit":1,"pfa":"Syeda Shahnoor","psa":"Che Mbali Valentina Sih","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4377234089","eid":"W4377234089"},{"id":"paper-w4316143370","cat":"papers","name":"Key considerations for clinical trials in psychopharmacology","year":"2023","cit":1,"pfa":"Carlos A. Zarate","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4316143370","eid":"W4316143370"},{"id":"paper-w2315225108","cat":"papers","name":"First Evidence-Based Tinnitus Guideline Shines Light on Treatment","year":"2014","cit":1,"pfa":"Janelle Weaver","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2315225108","eid":"W2315225108"},{"id":"paper-w2028653157","cat":"papers","name":"α‐Flupenthixyl chloride: Binding profile to dopaminergic, serotonergic, adrenergic, and cholinergic neuro‐receptors","year":"1988","cit":1,"pfa":"Randall B. Murphy","psa":"Laurence R. Meyerson","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2028653157","eid":"W2028653157"},{"id":"paper-w2473498779","cat":"papers","name":"Participation of serotonin in development of morphine dependence in mice and rats.","year":"1981","cit":1,"pfa":"Alicja Kruszewska","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2473498779","eid":"W2473498779"},{"id":"paper-w7134986171","cat":"papers","name":"Reduced peripheral serotonin levels in women with multiple sclerosis: associations with underweight status, treatment duration, and use of interferon beta 1a","year":"2026","cit":1,"pfa":"Gilberto Pérez‐Sánchez","psa":"Lenin Pavón","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7134986171","eid":"W7134986171"},{"id":"paper-w7214752259","cat":"papers","name":"Adverse Health Outcomes of Psilocybin, LSD, MDMA, Ibogaine, and 5-MeO-DMT","year":"2026","cit":0,"pfa":"Otto Simonsson","psa":"Peter S. Hendricks","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7214752259","eid":"W7214752259"},{"id":"paper-w4399305171","cat":"papers","name":"Psilocybin, peyote, mescaline, and lysergic acid diethylamide (LSD) use in a nationally representative population by cancer history.","year":"2024","cit":0,"pfa":"Amrit Baral","psa":"Denise Christina Vidot","topics":["Anxiety & end-of-life","Policy & ethics"],"ptype":"conference-abstract","src":"https://openalex.org/W4399305171","eid":"W4399305171"},{"id":"paper-w4229788395","cat":"papers","name":"Lysergic Acid Diethylamide and Mescaline","year":"2014","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W4229788395","eid":"W4229788395"},{"id":"paper-w4386481052","cat":"papers","name":"P05-02: Assessment of the CYP450 inhibitory activity of psilocybin, psilocin, LSD, 5-MeO-DMT and mescaline: An in vitro study","year":"2023","cit":0,"pfa":"A. M. Costa","psa":"D. Dias-da-Silva","ptype":"article","src":"https://openalex.org/W4386481052","eid":"W4386481052"},{"id":"paper-w2417045896","cat":"papers","name":"[Mescaline, lysergic acid diethylamide (LSD 25) & menstruation].","year":"1957","cit":0,"pfa":"E V Salerno","psa":"A Tallaferro","ptype":"article","src":"https://openalex.org/W2417045896","eid":"W2417045896"},{"id":"paper-w4411530237","cat":"papers","name":"Treating War Trauma with Ibogaine and 5-MEO-DMT","year":"2025","cit":0,"pfa":"Martin Polanco","psa":"Mia Black","topics":["PTSD & trauma","Safety & adverse events","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W4411530237","eid":"W4411530237"},{"id":"paper-w2781085211","cat":"papers","name":"Tolerance, antagonism and the relation between D-lysergic acid diethylamide and mescaline","year":"1958","cit":0,"pfa":"George K. Aghajanian","ptype":"article","src":"https://openalex.org/W2781085211","eid":"W2781085211"},{"id":"paper-w2594385044","cat":"papers","name":"Comparison of Mescaline and Lysergic Acid Diethylamide Effects on Lymphocyte Function in Vitro","year":"1978","cit":0,"pfa":"Daniel L. Sissors","ptype":"article","src":"https://openalex.org/W2594385044","eid":"W2594385044"},{"id":"paper-w4389914926","cat":"papers","name":"Ibogaine and Noribogaine","year":"2023","cit":0,"pfa":"Deborah C. Mash","psa":"Michael Karukin","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W4389914926","eid":"W4389914926"},{"id":"paper-w4220990109","cat":"papers","name":"Reply to: 5‐MeO‐DMT has not been found in traditional ayahuasca preparations and the combination of 5‐MeO‐DMT with MAOIs is dangerous","year":"2022","cit":0,"pfa":"Edward James","psa":"Ben Sessa","ptype":"letter","src":"https://openalex.org/W4220990109","eid":"W4220990109"},{"id":"paper-w2476720085","cat":"papers","name":"Psilocybin and Mescaline","year":"2014","cit":0,"pfa":"Paul May","psa":"S. A. Cotton","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W2476720085","eid":"W2476720085"},{"id":"paper-w4410860686","cat":"papers","name":"5-MeO-DMT","year":"2025","cit":0,"pfa":"Angelica Ukaigwe","psa":"S. Vinod Kumar","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"book-chapter","src":"https://openalex.org/W4410860686","eid":"W4410860686"},{"id":"paper-w4240918002","cat":"papers","name":"Congenital Malformations Induced by Mescaline, Lysergic Acid Diethylamide, and Bromolysergic Acid in the Hamster","year":"1968","cit":0,"topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4240918002","eid":"W4240918002"},{"id":"paper-w7132432859","cat":"papers","name":"Pharmacokinetics of ibogaine and noribogaine","year":"2013","cit":0,"pfa":"Asta Kubilienė","psa":"Leonid Ivanov","topics":["Dosing & pharmacology"],"ptype":"conference-paper","src":"https://openalex.org/W7132432859","eid":"W7132432859"},{"id":"paper-w7132606580","cat":"papers","name":"Toxicity of lysergic acid diethylamide","year":"2008","cit":0,"pfa":"Virginija Stasiukynienė","psa":"Armida Augutienė","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7132606580","eid":"W7132606580"},{"id":"paper-w2516163755","cat":"papers","name":"D ‐lysergic Acid Diethylamide","year":"2007","cit":0,"ptype":"reference-entry","src":"https://openalex.org/W2516163755","eid":"W2516163755"},{"id":"paper-w3022106080","cat":"papers","name":"LSD (Lysergic Acid Diethylamide)","year":"2005","cit":0,"pfa":"Christopher P. Holstege","ptype":"reference-entry","src":"https://openalex.org/W3022106080","eid":"W3022106080"},{"id":"paper-w4416948668","cat":"papers","name":"Psilocybin and Psilocin","year":"2000","cit":0,"pfa":"John C.M. Brust","ptype":"book-chapter","src":"https://openalex.org/W4416948668","eid":"W4416948668"},{"id":"paper-w4415328671","cat":"papers","name":"Influence of administration setting on the pharmacological effects of the psychedelics dimethyltryptamine (DMT) and 5-methoxy-dimethyltryptamine (5-MeO-DMT)","year":"2025","cit":0,"pfa":"Romain Hacquet","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W4415328671","eid":"W4415328671"},{"id":"paper-w3023138512","cat":"papers","name":"LSD (Lysergic Acid Diethylamide)","year":"2003","cit":0,"pfa":"Ludmila A. Kryzhanovskaya","psa":"Catherine A. Leslie","ptype":"reference-entry","src":"https://openalex.org/W3023138512","eid":"W3023138512"},{"id":"paper-w4300802768","cat":"papers","name":"D ‐Lysergic Acid Diethylamide","year":"2004","cit":0,"ptype":"other","src":"https://openalex.org/W4300802768","eid":"W4300802768"},{"id":"paper-w4254334746","cat":"papers","name":"A Demand for Clarity Regarding a Case Report on the Ingestion of 5-Methoxy-N, N-Dimethyltryptamine (5-MeO-DMT) in an Ayahuasca Preparation: Reply","year":"2006","cit":0,"pfa":"J. H. Sklerov","psa":"David R. Fowler","ptype":"article","src":"https://openalex.org/W4254334746","eid":"W4254334746"},{"id":"paper-w3087322820","cat":"papers","name":"Lysergic acid diethylamide in psychiatry.","year":"1956","cit":0,"pfa":"M BERTHIAUME","ptype":"article","src":"https://openalex.org/W3087322820","eid":"W3087322820"},{"id":"paper-w3120466448","cat":"papers","name":"Lysergic acid diethylamide (LSD)","year":"2019","cit":0,"pfa":"Snezha Zlateva","psa":"Gabriela Krasimirova Kehayova","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3120466448","eid":"W3120466448"},{"id":"paper-w4394619341","cat":"papers","name":"LSD (Lysergic Acid Diethylamide)","year":"2024","cit":0,"pfa":"Jayalakshmi Krishnan","topics":["Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W4394619341","eid":"W4394619341"},{"id":"paper-w7211940536","cat":"papers","name":"Deconstruction of lysergic acid diethylamide","year":"2026","cit":0,"pfa":"Andrian G. Basargin","psa":"David E. Olson","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7211940536","eid":"W7211940536"},{"id":"paper-w2416395504","cat":"papers","name":"Cytological effects of lysergic acid diethylamide.","year":"1983","cit":0,"pfa":"Herman C.B. Denber","ptype":"letter","src":"https://openalex.org/W2416395504","eid":"W2416395504"},{"id":"paper-w2409113001","cat":"papers","name":"[Synthesis of (+)-lysergic acid diethylamide tartrate].","year":"1984","cit":0,"pfa":"Zhang Cz","psa":"J Zhou","ptype":"other","src":"https://openalex.org/W2409113001","eid":"W2409113001"},{"id":"paper-w2034685710","cat":"papers","name":"Synthesis of analogs of lysergic acid diethylamide","year":"1972","cit":0,"pfa":"I. L. Kotlyarevskii","psa":"L. A. Mal'kova","ptype":"article","src":"https://openalex.org/W2034685710","eid":"W2034685710"},{"id":"paper-w4233175474","cat":"papers","name":"D ‐Lysergic Acid Diethylamide Tartrate","year":"2004","cit":0,"ptype":"other","src":"https://openalex.org/W4233175474","eid":"W4233175474"},{"id":"paper-w7120814113","cat":"papers","name":"Lysergic acid diethylamide (LSD) and N,N-dimethyltryptamine (DMT) as peroxidases substrates: a possible metabolization pathway","year":"2008","cit":0,"pfa":"Melissa Medrano Gomes","ptype":"dissertation","src":"https://openalex.org/W7120814113","eid":"W7120814113"},{"id":"paper-w4237502759","cat":"papers","name":"Lysergic Acid Diethylamide and Ego Functions","year":"1963","cit":0,"ptype":"article","src":"https://openalex.org/W4237502759","eid":"W4237502759"},{"id":"paper-w2395591310","cat":"papers","name":"Aquarius redux--lysergic acid diethylamide.","year":"1985","cit":0,"pfa":"Mack Rb","ptype":"article","src":"https://openalex.org/W2395591310","eid":"W2395591310"},{"id":"paper-w2414674895","cat":"papers","name":"[Synthesis of lysergic acid diethylamide (LSD)].","year":"1970","cit":0,"pfa":"Goro Urakubo","psa":"Y Kido","ptype":"article","src":"https://openalex.org/W2414674895","eid":"W2414674895"},{"id":"paper-w4297241025","cat":"papers","name":"LSD (Lysergic acid diethylamide) (c)","year":"2011","cit":0,"topics":["Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W4297241025","eid":"W4297241025"},{"id":"paper-w4399852020","cat":"papers","name":"Rapid and prolonged antidepressant and antianxiety effects of psilocybin, lysergic acid diethylamide, ayahuasca, and 3, 4-methylenedioxy-methamphetamine. A systematic review and meta-analysis of randomized controlled tri","year":"2024","cit":0,"pfa":"Dimy Fluyau","psa":"Neelambika Revadigar","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W4399852020","eid":"W4399852020"},{"id":"paper-w2441835618","cat":"papers","name":"[Lysergic acid diethylamide. A clinical and psychological study].","year":"1963","cit":0,"pfa":"C E BRATTEMO","psa":"B Lassenius","ptype":"article","src":"https://openalex.org/W2441835618","eid":"W2441835618"},{"id":"paper-w2501131357","cat":"papers","name":"Drug Abuse, Lysergic Acid Diethylamide (LSD)","year":"2011","cit":0,"pfa":"Eric Gewirtz","ptype":"book-chapter","src":"https://openalex.org/W2501131357","eid":"W2501131357"},{"id":"paper-w3007067410","cat":"papers","name":"Lysergic Acid Diethylamide: Review and Collaborative Study","year":"1968","cit":0,"pfa":"James M Look","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3007067410","eid":"W3007067410"},{"id":"paper-w2416236821","cat":"papers","name":"[Psychiatric complications in the misuse of lysergic acid diethylamide].","year":"1968","cit":0,"pfa":"E Geert-Jörgensen","psa":"Mogens Hertz","ptype":"article","src":"https://openalex.org/W2416236821","eid":"W2416236821"},{"id":"paper-w7205727604","cat":"papers","name":"Adverse events of DMT, 5-MeO-DMT, and ayahuasca according to the setting of administration: A systematic review","year":"2025","cit":0,"pfa":"Romain Hacquet","psa":"A. Roussin","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7205727604","eid":"W7205727604"},{"id":"paper-w7144218147","cat":"papers","name":"In-silico toxicity study of tryptamine, psilocin, psilocybin, N,N-dimethyltryptamine, 5’-methoxy-N,N-dimethyltryptamine and O-acetylpsilocin","year":"2026","cit":0,"pfa":"Kamil Jurowski","psa":"Maciej Noga","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7144218147","eid":"W7144218147"},{"id":"paper-w4378533175","cat":"papers","name":"Exploring Psychedelic Potential: Comparative Acute Effects of Mescaline, Lysergic Acid Diethylamide, and Psilocybin in a Groundbreaking Double-Blind, Placebo-Controlled Cross-Over Study on Healthy Participants","year":"2023","cit":0,"pfa":"HQ Teach","ptype":"report","src":"https://openalex.org/W4378533175","eid":"W4378533175"},{"id":"paper-w7151689979","cat":"papers","name":"Distribusion of ibogaine and noribogaine in mice organs","year":"2011","cit":0,"pfa":"Mindaugas Marksa","ptype":"dissertation","src":"https://openalex.org/W7151689979","eid":"W7151689979"},{"id":"paper-w2423075631","cat":"papers","name":"Lysergic Acid Diethylamide (LSD) in the Treatment of Alcoholism","year":"1968","cit":0,"pfa":"C. M. B. Pare","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2423075631","eid":"W2423075631"},{"id":"paper-w2402589966","cat":"papers","name":"[Antagonists of lysergic acid diethylamide (literature review)].","year":"1972","cit":0,"pfa":"O N Davydova","psa":"A N Kudrin","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2402589966","eid":"W2402589966"},{"id":"paper-w7204488455","cat":"papers","name":"A dominant frontoparietal beta oscillatory brain state in the days after psilocybin and 5-MeO-DMT","year":"2026","cit":0,"pfa":"Chloe L. West","psa":"Jordan P. Hamm","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7204488455","eid":"W7204488455"},{"id":"paper-w2464373303","cat":"papers","name":"[Influence of mescaline and of lysergic acid diethylamide (LSD-25) on the development of primary and secondary conditioned avoidance reflexes in rats].","year":"1959","cit":0,"pfa":"Giulio Maffii","ptype":"article","src":"https://openalex.org/W2464373303","eid":"W2464373303"},{"id":"paper-w2417541633","cat":"papers","name":"[Search for lysergic acid diethylamide (LSD) antagonists].","year":"1972","cit":0,"pfa":"O N Davydova","psa":"A N Kudrin","ptype":"article","src":"https://openalex.org/W2417541633","eid":"W2417541633"},{"id":"paper-w2437684252","cat":"papers","name":"[Drugs in psychochemical warfare; lysergic acid diethylamide].","year":"1961","cit":0,"pfa":"Slawomir Rump","ptype":"article","src":"https://openalex.org/W2437684252","eid":"W2437684252"},{"id":"paper-w4399392687","cat":"papers","name":"The mechanism of hallucinations caused by lysergic acid diethylamide","year":"2024","cit":0,"pfa":"Chaoyi Fan","psa":"Shaohuan Yu","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4399392687","eid":"W4399392687"},{"id":"paper-w2808610030","cat":"papers","name":"Lysergic Acid Diethylamide (LSD) and the “Hallucinogenic” Drugs","year":"1967","cit":0,"pfa":"A. J. Smith","ptype":"article","src":"https://openalex.org/W2808610030","eid":"W2808610030"},{"id":"paper-w2419099544","cat":"papers","name":"[Rapid detection of LSD (lysergic acid diethylamide)].","year":"1972","cit":0,"pfa":"Rene Hackel","psa":"Gerhard A. Müller","ptype":"article","src":"https://openalex.org/W2419099544","eid":"W2419099544"},{"id":"paper-w2411057895","cat":"papers","name":"[Lysergic acid diethylamide and psychiatry. General introduction].","year":"1960","cit":0,"pfa":"Durand Vj","ptype":"article","src":"https://openalex.org/W2411057895","eid":"W2411057895"},{"id":"paper-w4235696713","cat":"papers","name":"Effects of ibogaine and noribogaine on phosphoinositide hydrolysis","year":"1996","cit":0,"pfa":"R.A. Rabin","ptype":"article","src":"https://openalex.org/W4235696713","eid":"W4235696713"},{"id":"paper-w4232528792","cat":"papers","name":"Health Concerns: Lysergic Acid Diethylamide (LSD)","year":"2009","cit":0,"ptype":"dataset","src":"https://openalex.org/W4232528792","eid":"W4232528792"},{"id":"paper-w4255360392","cat":"papers","name":"Differential Behavioral Responsivity to d-Lysergic Acid Diethylamide","year":"1963","cit":0,"ptype":"article","src":"https://openalex.org/W4255360392","eid":"W4255360392"},{"id":"paper-w2360360950","cat":"papers","name":"The Analytical Research Of Lysergic Acid Diethylamide And The Metabolite In The Urine","year":"2006","cit":0,"pfa":"Jiang He","ptype":"article","src":"https://openalex.org/W2360360950","eid":"W2360360950"},{"id":"paper-w4415487588","cat":"papers","name":"Psychedelic Therapy: A Primer for Primary Care Clinicians—5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT)","year":"2025","cit":0,"pfa":"Burton Jared Tabaac","psa":"Owen S. Muir","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4415487588","eid":"W4415487588"},{"id":"paper-w3037203699","cat":"papers","name":"Case reports involving the use of lysergic acid diethylamide","year":"2020","cit":0,"pfa":"Diane M. Boland","ptype":"book-chapter","src":"https://openalex.org/W3037203699","eid":"W3037203699"},{"id":"paper-w2383865469","cat":"papers","name":"EFFECT OF LYSERGIC ACID DIETHYLAMIDE ON LIP-ACUPUNCTURE ANALGESIA","year":"1979","cit":0,"pfa":"Yin Q","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2383865469","eid":"W2383865469"},{"id":"paper-w7132507149","cat":"papers","name":"Study of acute toxicity of ibogaine and noribogaine","year":"2008","cit":0,"pfa":"Asta Kubilienė","psa":"Almantas Ražukas","topics":["Safety & adverse events"],"ptype":"conference-paper","src":"https://openalex.org/W7132507149","eid":"W7132507149"},{"id":"paper-w4298290112","cat":"papers","name":"d‐Lysergic Acid Diethylamide 478‐94‐4","year":"2012","cit":0,"pfa":"Leuthold, Joshua","ptype":"other","src":"https://openalex.org/W4298290112","eid":"W4298290112"},{"id":"paper-w2399525793","cat":"papers","name":"Lysergic acid diethylamide and chromosome damage--its controversy.","year":"1972","cit":0,"pfa":"C.H. Carter","psa":"Josephine M. Connolly","ptype":"article","src":"https://openalex.org/W2399525793","eid":"W2399525793"},{"id":"paper-w2431922516","cat":"papers","name":"[Case of allergy to lysergides (derivatives of lysergic acid diethylamide)].","year":"1973","cit":0,"pfa":"C Nava","ptype":"article","src":"https://openalex.org/W2431922516","eid":"W2431922516"},{"id":"paper-w3171912028","cat":"papers","name":"A Systemic Investigations on the Medicinal User of Lysergic Acid Diethylamide","year":"2021","cit":0,"pfa":"Foster, Kayla","psa":"Pascale, Luke","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"dissertation","src":"https://openalex.org/W3171912028","eid":"W3171912028"},{"id":"paper-w2761382515","cat":"papers","name":"Studies of Fluorometric Assay Procedures for Lysergic Acid Diethylamide","year":"1972","cit":0,"pfa":"Peter J. Kasvinsky","ptype":"article","src":"https://openalex.org/W2761382515","eid":"W2761382515"},{"id":"paper-w4411393752","cat":"papers","name":"Lysergic Acid Diethylamide extends lifespan in Caenorhabditis elegans","year":"2025","cit":0,"pfa":"Beatriz de Sá Carrilho","psa":"Stevens Kastrup Rehen","topics":["Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4411393752","eid":"W4411393752"},{"id":"paper-w2418350283","cat":"papers","name":"[Experimental psychoses induced by lysergic acid diethylamide (LSD)].","year":"1957","cit":0,"pfa":"J Irányi","psa":"Rosa Frater","ptype":"article","src":"https://openalex.org/W2418350283","eid":"W2418350283"},{"id":"paper-w2418023963","cat":"papers","name":"[Effect of mexamine on central effects of lysergic acid diethylamide].","year":"1968","cit":0,"pfa":"G I Mil'shteĭn","ptype":"article","src":"https://openalex.org/W2418023963","eid":"W2418023963"},{"id":"paper-w2411389925","cat":"papers","name":"Lysergic acid diethylamide. What are its therapeutic possibilities?","year":"1998","cit":0,"pfa":"George D. Woodward","ptype":"article","src":"https://openalex.org/W2411389925","eid":"W2411389925"},{"id":"paper-w7202085926","cat":"papers","name":"The impact of fluoxetine on the aversive effects of lysergic acid diethylamide.","year":"2026","cit":0,"pfa":"Rachel Crupi","psa":"Anthony L. Riley","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7202085926","eid":"W7202085926"},{"id":"paper-w2419450747","cat":"papers","name":"[The influence of iprazid and reserpine on the effect of lysergic acid diethylamide].","year":"1966","cit":0,"pfa":"Stoliarov Gv","ptype":"article","src":"https://openalex.org/W2419450747","eid":"W2419450747"},{"id":"paper-w2280663928","cat":"papers","name":"[Some psychotoxicological problems exemplified by lysergic acid diethylamide].","year":"1975","cit":0,"pfa":"J Kocur","ptype":"other","src":"https://openalex.org/W2280663928","eid":"W2280663928"},{"id":"paper-w3092650153","cat":"papers","name":"A critical analysis of lysergic acid diethylamide in the present light!","year":"2020","cit":0,"pfa":"M Baskaran","psa":"A Jayasudha","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3092650153","eid":"W3092650153"},{"id":"paper-w2399751775","cat":"papers","name":"[Contribution to the study on the central effect of lysergic acid diethylamide].","year":"1998","cit":0,"pfa":"Eugeniusz Miętkiewski","psa":"E Lichota","ptype":"article","src":"https://openalex.org/W2399751775","eid":"W2399751775"},{"id":"paper-w3193184489","cat":"papers","name":"Lizerginės rūgšties dietilamido toksiškumas = Toxicity of lysergic acid diethylamide","year":"2008","cit":0,"pfa":"Virginija Stasiukynienė","psa":"Armida Augutienė","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3193184489","eid":"W3193184489"},{"id":"paper-w4242832342","cat":"papers","name":"d‐Lysergic Acid Diethylamide Tartrate 478‐94‐4","year":"2012","cit":0,"ptype":"other","src":"https://openalex.org/W4242832342","eid":"W4242832342"},{"id":"paper-w2032793588","cat":"papers","name":"Persistent Palinopsia Following Ingestion of Lysergic Acid Diethylamide (LSD)","year":"1996","cit":0,"pfa":"Lyn A. Sedwick","ptype":"article","src":"https://openalex.org/W2032793588","eid":"W2032793588"},{"id":"paper-w2921774532","cat":"papers","name":"The Distribution of Lysergic Acid Diethylamide ([3H]LSD) in the Rat","year":"1975","cit":0,"pfa":"J. Singh","psa":"David J. Back","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2921774532","eid":"W2921774532"},{"id":"paper-w2417665350","cat":"papers","name":"[Analogies between schizophrenic diseases and lysergic acid diethylamide psychoses].","year":"1958","cit":0,"pfa":"Oldrich Vinar","ptype":"article","src":"https://openalex.org/W2417665350","eid":"W2417665350"},{"id":"paper-w7132150057","cat":"papers","name":"Pharmacokinetic properties of Ibogaine and Noribogaine in plasma of mice","year":"2013","cit":0,"pfa":"Asta Kubilienė","psa":"Leonid Ivanov","topics":["Dosing & pharmacology"],"ptype":"conference-paper","src":"https://openalex.org/W7132150057","eid":"W7132150057"},{"id":"paper-w2434765017","cat":"papers","name":"[Spectrophotometric determination of lysergic acid diethylamide in salts and animal blood].","year":"1970","cit":0,"pfa":"Nekrasov Vi","psa":"O N Davydova","ptype":"article","src":"https://openalex.org/W2434765017","eid":"W2434765017"},{"id":"paper-w7108207127","cat":"papers","name":"A Cryo_EM structure of 5_HT1A complex with 5-Meo-DMT","year":"2024","cit":0,"pfa":"Q. Yuan","psa":"S. Li","ptype":"dataset","src":"https://openalex.org/W7108207127","eid":"W7108207127"},{"id":"paper-w4292502425","cat":"papers","name":"Ibogaine and Noribogaine : Structural Analysis and Stability Studies. Use of LC-MS to determine alkaloid Contents of the Root of Tabernanthe Iboga","year":"2007","cit":0,"pfa":"V. Kontrimaviciute","psa":"F.M.M. Bressolle","ptype":"article","src":"https://openalex.org/W4292502425","eid":"W4292502425"},{"id":"paper-w2409695857","cat":"papers","name":"The CNS action of d-lysergic acid diethylamide (L.S.D.-25).","year":"1953","cit":0,"pfa":"R SMITH","ptype":"article","src":"https://openalex.org/W2409695857","eid":"W2409695857"},{"id":"paper-w2578932334","cat":"papers","name":"Probable Presence of d-Lysergic Acid Diethylamide in Toxoplasma Infections.","year":"1956","cit":0,"pfa":"Gerardo Varela","psa":"J Torroella","ptype":"article","src":"https://openalex.org/W2578932334","eid":"W2578932334"},{"id":"paper-w2423724084","cat":"papers","name":"[Serotonin and D-lysergic acid diethylamide receptors in the mammalian brain].","year":"1981","cit":0,"pfa":"Tatyana Ivanovna Vlasova","psa":"Kirzon Mv","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2423724084","eid":"W2423724084"},{"id":"paper-w2437732482","cat":"papers","name":"[Data on the symptomatology of lysergic acid diethylamide induced experimental psychosis].","year":"1957","cit":0,"pfa":"J Irányi","psa":"Rosa Frater","ptype":"article","src":"https://openalex.org/W2437732482","eid":"W2437732482"},{"id":"paper-w2414463148","cat":"papers","name":"[Change in complex forms of conditioned reflexes caused by the application of lysergic acid diethylamide (LSD) and mescaline to the cortical ends of the auditory and visual analyzers].","year":"1971","cit":0,"pfa":"L A Alekseeva","ptype":"article","src":"https://openalex.org/W2414463148","eid":"W2414463148"},{"id":"paper-w2247010607","cat":"papers","name":"Lysergic acid diethylamide. Adverse reactions and use in experimental therapy.","year":"1967","cit":0,"pfa":"Keeler Mh","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2247010607","eid":"W2247010607"},{"id":"paper-w2407166143","cat":"papers","name":"Effect of lysergic acid diethylamide on oestrus cycle and offspring in rats.","year":"1974","cit":0,"pfa":"Sam","psa":"T Joseph","ptype":"article","src":"https://openalex.org/W2407166143","eid":"W2407166143"},{"id":"paper-w2024991199","cat":"papers","name":"Circulatory effects of d-lysergic acid diethylamide (LSD-25)","year":"1964","cit":0,"pfa":"OVE HASSLER","ptype":"article","src":"https://openalex.org/W2024991199","eid":"W2024991199"},{"id":"paper-w2730094777","cat":"papers","name":"RAPHE-SPINAL SYMPATHO-INHIBITION ANTAGONIZED BY LYSERGIC-ACID DIETHYLAMIDE","year":"1981","cit":0,"pfa":"COOTE, JH","psa":"GILBEY, MP","ptype":"article","src":"https://openalex.org/W2730094777","eid":"W2730094777"},{"id":"paper-w2496309506","cat":"papers","name":"The LSD-Psychosis: III. Lysergic Acid Diethylamide and Related Compounds.","year":"1958","cit":0,"pfa":"Albert Hofmann","ptype":"conference-paper","src":"https://openalex.org/W2496309506","eid":"W2496309506"},{"id":"paper-w4238495397","cat":"papers","name":"The Effects of d-Lysergic Acid Diethylamide Upon Group Interaction","year":"1963","cit":0,"ptype":"article","src":"https://openalex.org/W4238495397","eid":"W4238495397"},{"id":"paper-w2244416290","cat":"papers","name":"Lysergic Acid Diethylamide (L.S.D.) overdose complicated by Mendelson's Syndrome","year":"1968","cit":0,"pfa":"Shoukoufe Hamzepour","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2244416290","eid":"W2244416290"},{"id":"paper-w2604395083","cat":"papers","name":"Molecule of the Month: Psilocybin and Mescaline","year":"1999","cit":0,"pfa":"Paul William May","ptype":"article","src":"https://openalex.org/W2604395083","eid":"W2604395083"},{"id":"paper-w4281400613","cat":"papers","name":"Incilius alvarius cell-based synthesis of 5-MeO-DMT","year":"2022","cit":0,"pfa":"Leonard B. Lerer","psa":"Bernard Lerer","ptype":"preprint","src":"https://openalex.org/W4281400613","eid":"W4281400613"},{"id":"paper-w4250555247","cat":"papers","name":"Drug Fact Sheet: Peyote and Mescaline","year":"2012","cit":0,"ptype":"dataset","src":"https://openalex.org/W4250555247","eid":"W4250555247"},{"id":"paper-w3153158704","cat":"papers","name":"The Effects of Chronic Lysergic Acid Diethylamide Exposure and Withdrawal in Zebrafish","year":"2020","cit":0,"pfa":"Jessica Kumar","topics":["Addiction","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3153158704","eid":"W3153158704"},{"id":"paper-w2413046151","cat":"papers","name":"[The effect of lysergic acid diethylamide on the hypotensive effects of dopamine and adrenalin].","year":"1958","cit":0,"pfa":"Oleh Hornykiewicz","psa":"H. Obenaus","ptype":"article","src":"https://openalex.org/W2413046151","eid":"W2413046151"},{"id":"paper-w4231473015","cat":"papers","name":"2‐Bromo‐d‐Lysergic Acid Diethylamide 478‐84‐2","year":"2012","cit":0,"ptype":"other","src":"https://openalex.org/W4231473015","eid":"W4231473015"},{"id":"paper-w4410123538","cat":"papers","name":"Vigilance state dissociation induced by 5-MeO DMT in mice","year":"2025","cit":0,"pfa":"Benjamin J. B. Bréant","psa":"Vladyslav V. Vyazovskiy","ptype":"preprint","src":"https://openalex.org/W4410123538","eid":"W4410123538"},{"id":"paper-w7166071774","cat":"papers","name":"EE127 A REVIEW OF HEALTH ECONOMIC ANALYSES OF PSILOCYBIN, MIDOMAFETAMINE(MDMA), AND KETAMINE-BASED TREATMENTS FOR MENTAL HEALTH CARE","year":"2026","cit":0,"pfa":"Matthew Sidovar","psa":"Lucinda Orsini","topics":["Reviews & meta-analyses"],"ptype":"conference-abstract","src":"https://openalex.org/W7166071774","eid":"W7166071774"},{"id":"paper-w2465436885","cat":"papers","name":"[Psychopathological changes demonstrated in lysergic acid diethylamide intoxication in chronic schizophrenics].","year":"1959","cit":0,"pfa":"J Irányi","ptype":"article","src":"https://openalex.org/W2465436885","eid":"W2465436885"},{"id":"paper-w2413673431","cat":"papers","name":"[D-Lysergic acid diethylamide (LSD). 2. Clinical aspects].","year":"1960","cit":0,"pfa":"S Grof","psa":"Zdenek Votava","ptype":"article","src":"https://openalex.org/W2413673431","eid":"W2413673431"},{"id":"paper-w3015480559","cat":"papers","name":"Smuggling of the Dimethyltryptamine Drug in the Ayahuasca Drink","year":"2019","cit":0,"pfa":"Marat R. Potashov","ptype":"article","src":"https://openalex.org/W3015480559","eid":"W3015480559"},{"id":"paper-w2007168594","cat":"papers","name":"P.2.017 The hallucinogen 5-methoxy-N, N-dimethyltryptamine (5-MeO-DMT) disrupts cortical function: reversal by antipsychotic drugs","year":"2013","cit":0,"pfa":"Maurizio S. Riga","psa":"Pau Celada","ptype":"article","src":"https://openalex.org/W2007168594","eid":"W2007168594"},{"id":"paper-w2411681254","cat":"papers","name":"[On the mechanism of lysergic acid diethylamide (LSD) action on the central nervous system].","year":"1967","cit":0,"pfa":"Anokhina Ip","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2411681254","eid":"W2411681254"},{"id":"paper-w4401745769","cat":"papers","name":"8.1. Biosynthesis of mescaline and other peyote alkaloids","year":"1972","cit":0,"pfa":"J. Lundström","psa":"Stig Agurell","ptype":"conference-paper","src":"https://openalex.org/W4401745769","eid":"W4401745769"},{"id":"paper-w2406187143","cat":"papers","name":"[THE EFFECT OF D-LYSERGIC ACID DIETHYLAMIDE ON HIGHER NERVOUS ACTIVITY IN MONKEYS].","year":"1996","cit":0,"pfa":"Lagutina Ni","psa":"Norkina Ln","ptype":"article","src":"https://openalex.org/W2406187143","eid":"W2406187143"},{"id":"paper-w2289416799","cat":"papers","name":"Crayfish Aggression after Injections of 5-hydroxytryptamine and Lysergic Acid Diethylamide","year":"2016","cit":0,"pfa":"Ryan Colabella","ptype":"article","src":"https://openalex.org/W2289416799","eid":"W2289416799"},{"id":"paper-w4242912398","cat":"papers","name":"ChemInform Abstract: LUMINESCENCE CHARACTERISTICS OF LYSERGIC ACID DIETHYLAMIDE AND RELATED ERGOLINES","year":"1973","cit":0,"pfa":"A. J. Bowd","psa":"James H. Turnbull","ptype":"article","src":"https://openalex.org/W4242912398","eid":"W4242912398"},{"id":"paper-w2080571120","cat":"papers","name":"Problems in an Unconscious Patient Who Had Taken Lysergic Acid Diethylamide","year":"1968","cit":0,"pfa":"Ruth Clayton","ptype":"article","src":"https://openalex.org/W2080571120","eid":"W2080571120"},{"id":"paper-w4235601236","cat":"papers","name":"Effects of lysergic acid diethylamide (LSD-25) on retention performance of weanlings","year":"1969","cit":0,"pfa":"Edward T. Uyeno","ptype":"dataset","src":"https://openalex.org/W4235601236","eid":"W4235601236"},{"id":"paper-w2416486840","cat":"papers","name":"[ON THE EFFECT OF LYSERGIC ACID DIETHYLAMIDE ON SOME FORMS OF BEHAVIOR IN MICE AND RATS].","year":"1996","cit":0,"pfa":"G I Mil'shteĭn","psa":"K A Laricheva","ptype":"article","src":"https://openalex.org/W2416486840","eid":"W2416486840"},{"id":"paper-w2259309299","cat":"papers","name":"[Effects of serotonin, phenothiazine derivatives, steroids, and tranquilizing agents on the electroencephalogram of rabbits poisoned by lysergic acid diethylamide. I. Action on chronic lysergic acid diethylamide poisonin","year":"1957","cit":0,"pfa":"R PIERRE","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2259309299","eid":"W2259309299"},{"id":"paper-w3185532090","cat":"papers","name":"CASE REPORT OF RECREATIONAL LYSERGIC-ACID-DIETHYLAMIDE (LSD) USE IN MALAYSIA","year":"2018","cit":0,"pfa":"Mohammad Farris Iman Leong Bin Abdullah","psa":"B. Vicknasingam Kasinather","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3185532090","eid":"W3185532090"},{"id":"paper-w2004284345","cat":"papers","name":"Qualitative analysis of lysergic acid diethylamide by means of the 10-hydroxy derivative","year":"1973","cit":0,"pfa":"Marvin A. Brooks","psa":"Lucius D’Arconte","ptype":"article","src":"https://openalex.org/W2004284345","eid":"W2004284345"},{"id":"paper-w2012612305","cat":"papers","name":"Factors Affecting the Analysis of Illicit Lysergic Acid Diethylamide (LSD) Preparations","year":"1974","cit":0,"pfa":"Richard N. Smith","ptype":"article","src":"https://openalex.org/W2012612305","eid":"W2012612305"},{"id":"paper-w2407436150","cat":"papers","name":"Lysergic acid diethylamide: no gross or microscopic effect on the developing chick embryo.","year":"1974","cit":0,"pfa":"Bargman Gj","psa":"L I GARDNER","ptype":"article","src":"https://openalex.org/W2407436150","eid":"W2407436150"},{"id":"paper-w7135677355","cat":"papers","name":"Phenomenology of 5-MeO-DMT and connection with aspects of mental health","year":"2023","cit":0,"pfa":"Miroslav Živnůstka","topics":["Addiction"],"ptype":"dissertation","src":"https://openalex.org/W7135677355","eid":"W7135677355"},{"id":"paper-w4210292260","cat":"papers","name":"2‐Bromo‐ d ‐Lysergic Acid Diethylamide 478‐84‐2","year":"2004","cit":0,"ptype":"other","src":"https://openalex.org/W4210292260","eid":"W4210292260"},{"id":"paper-w3146921727","cat":"papers","name":"[The effect of lysergic acid diethylamide on the permeability of the blood-brain barrier in rats].","year":"1967","cit":0,"pfa":"M Ia Maĭzelis","ptype":"article","src":"https://openalex.org/W3146921727","eid":"W3146921727"},{"id":"paper-w4249751534","cat":"papers","name":"EFFECT OF LYSERGIC ACID DIETHYLAMIDE (LSD-25) ON MORPHINE INDUCED BRADYCARDIA","year":"1967","cit":0,"pfa":"B.P. JAJU","psa":"G.P. Gupta","ptype":"article","src":"https://openalex.org/W4249751534","eid":"W4249751534"},{"id":"paper-w2233606408","cat":"papers","name":"Effects of lysergic acid diethylamide (LSD25) on short-term memory in cat.","year":"1970","cit":0,"pfa":"M Sterescu-Volanschi","psa":"R. Floru","ptype":"article","src":"https://openalex.org/W2233606408","eid":"W2233606408"},{"id":"paper-w7204880821","cat":"papers","name":"Inhalable Psychedelic 5-MeO-DMT Shows Promise in Treatment-Resistant Depression","year":"2026","cit":0,"pfa":"Saghir Ali","psa":"Jia Zhou","topics":["Depression","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7204880821","eid":"W7204880821"},{"id":"paper-w2394521875","cat":"papers","name":"[Effect of d-lysergic acid diethylamide and 5-hydroxytryptamine on spinal reflex].","year":"1957","cit":0,"pfa":"Hans Weidmann","ptype":"article","src":"https://openalex.org/W2394521875","eid":"W2394521875"},{"id":"paper-w2269934049","cat":"papers","name":"Mapping of the hallucinogen 5-Meo-DMT in living porcine brain","year":"2006","cit":0,"pfa":"Kasper Tholstrup Pedersen","psa":"Svend Borup Jensen","ptype":"conference-paper","src":"https://openalex.org/W2269934049","eid":"W2269934049"},{"id":"paper-w2057409393","cat":"papers","name":"EFFECT OF LYSERGIC ACID DIETHYLAMIDE (LSD-25) ON MORPHINE INDUCED BRADYCARDIA","year":"1967","cit":0,"pfa":"B.P. JAJU","psa":"G.P. Gupta","ptype":"article","src":"https://openalex.org/W2057409393","eid":"W2057409393"},{"id":"paper-w2004264643","cat":"papers","name":"Effect of lysergic acid diethylamide on permeability of the tissue-blood barriers in rats","year":"1967","cit":0,"pfa":"M. Ya. Maizelis","ptype":"article","src":"https://openalex.org/W2004264643","eid":"W2004264643"},{"id":"paper-w2414189790","cat":"papers","name":"[The effect of lysergic acid diethylamide on the permeability of the blood-brain barrier in rats].","year":"1967","cit":0,"pfa":"Maĭzelis MIa","ptype":"article","src":"https://openalex.org/W2414189790","eid":"W2414189790"},{"id":"paper-w7162135614","cat":"papers","name":"The effects of lysergic acid diethylamide (LSD-25) on perception with stabilized images.","year":"1963","cit":0,"pfa":"Bruno Kohn","topics":["Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W7162135614","eid":"W7162135614"},{"id":"paper-w1513150942","cat":"papers","name":"Actions of lysergic acid diethylamide (LSD) on the copulatory response in female rats","year":"1976","cit":0,"pfa":"Mona Eliasson","ptype":"article","src":"https://openalex.org/W1513150942","eid":"W1513150942"},{"id":"paper-w3091404831","cat":"papers","name":"Of the physiological action of iboga, Tabernanthe iboga H. Bn., And of ibogaine; effect on muscle chronaxis.","year":"1949","cit":0,"pfa":"R Paris","psa":"C Vairel","ptype":"article","src":"https://openalex.org/W3091404831","eid":"W3091404831"},{"id":"paper-w7204358294","cat":"papers","name":"Catalogue of the literature on Delysid-D-lysergic acid diethylamide or LSD 25.","cit":0,"pfa":"Sandoz Pharmaceuticals.\n    http://id.loc.gov/authorities/names/n84205088","ptype":"article","src":"https://openalex.org/W7204358294","eid":"W7204358294"},{"id":"paper-w7211873921","cat":"papers","name":"Exploratory Insights into 5-MeO-DMT Experiences on Reddit: A Thematic Analysis","year":"2026","cit":0,"pfa":"Damian Świeczkowski","psa":"Wiesław Jerzy Cubała","topics":["Safety & adverse events","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7211873921","eid":"W7211873921"},{"id":"paper-w1604179272","cat":"papers","name":"Psiconáutica católica 22: 5-meo-dmt y pharmepéna","year":"2003","cit":0,"pfa":"Jonathan Ott","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1604179272","eid":"W1604179272"},{"id":"paper-w4411530260","cat":"papers","name":"5-MEO-DMT: a Controversial Part of a Contemporary Psychedelic Scene","year":"2025","cit":0,"pfa":"Rita Kočárová","psa":"Michaela Plevková","ptype":"book-chapter","src":"https://openalex.org/W4411530260","eid":"W4411530260"},{"id":"paper-w7172178241","cat":"papers","name":"The effects of lysergic acid diethylamide (LSD-25) on perception with stabilized images.","year":"1963","cit":0,"pfa":"Bruno Kohn","ptype":"dissertation","src":"https://openalex.org/W7172178241","eid":"W7172178241"},{"id":"paper-w2406656261","cat":"papers","name":"[EFFECT OF NICOTINIC ACID ON EXPERIMENTAL PSYCHOSES INDUCED WITH LYSERGIC ACID DIETHYLAMIDE].","year":"1964","cit":0,"pfa":"Ivanova Ra","psa":"Fanchenko Nd","ptype":"article","src":"https://openalex.org/W2406656261","eid":"W2406656261"},{"id":"paper-w2633195416","cat":"papers","name":"Mapping of the hallucinogen 5-Meo-DMT in living pig brain","year":"2006","cit":0,"pfa":"Kasper Tholstrup Pedersen","psa":"Svend Borup Jensen","ptype":"conference-paper","src":"https://openalex.org/W2633195416","eid":"W2633195416"},{"id":"paper-w2771921141","cat":"papers","name":"Effects of D-Lysergic Acid Diethylamide on Rabbit Antibody Biosynthesis in Vitro","year":"1974","cit":0,"pfa":"Jeffrey L. Winkelhake","ptype":"article","src":"https://openalex.org/W2771921141","eid":"W2771921141"},{"id":"paper-w3134206454","cat":"papers","name":"Anxiogenic Effects of Lysergic Acid Diethylamide in Adult Sprague-Dawley Rats","year":"2020","cit":0,"pfa":"Catherine M. Conway","ptype":"dissertation","src":"https://openalex.org/W3134206454","eid":"W3134206454"},{"id":"paper-w3160552502","cat":"papers","name":"Influence of repeated doses on accumulation of ibogaine and noribogaine in organs of mice","year":"2014","cit":0,"pfa":"Asta Kubilienė","psa":"Leonid L Ivanov","topics":["Dosing & pharmacology"],"ptype":"conference-paper","src":"https://openalex.org/W3160552502","eid":"W3160552502"},{"id":"paper-w3048620298","cat":"papers","name":"A New Spectrophotometric Method for the Determination of Psilocin and Psilocybin","year":"2017","cit":0,"pfa":"Krishna Lavanya","psa":"T.R. Baggi","ptype":"article","src":"https://openalex.org/W3048620298","eid":"W3048620298"},{"id":"paper-w2783120370","cat":"papers","name":"The action of D-lysergic acid diethylamide and 5-hydroxytryptamine on spinal reflexes of the cat","year":"1957","cit":0,"pfa":"Hans Weidmann","psa":"A Cerletti","ptype":"article","src":"https://openalex.org/W2783120370","eid":"W2783120370"},{"id":"paper-w2419086281","cat":"papers","name":"[Age-related aspects of the psychic reactions of oligophrenics to the administration of lysergic acid diethylamide].","year":"1965","cit":0,"pfa":"M Achkova","ptype":"article","src":"https://openalex.org/W2419086281","eid":"W2419086281"},{"id":"paper-w4393878918","cat":"papers","name":"Elucidation of the mescaline biosynthesis in peyote (L. williamsii) - Dataset","year":"2023","cit":0,"pfa":"Jacinta L. Watkins","psa":"Peter J. Facchini","ptype":"dataset","src":"https://openalex.org/W4393878918","eid":"W4393878918"},{"id":"paper-w2051668039","cat":"papers","name":"Effect of D-lysergic acid diethylamide on striatal choline acetyltransferase activity in the rat","year":"1979","cit":0,"pfa":"Yu-Wah Wong","psa":"Ram K. Mishra","ptype":"article","src":"https://openalex.org/W2051668039","eid":"W2051668039"},{"id":"paper-w4410218949","cat":"papers","name":"Pharmacokinetics (PK) of psilocybin and psilocin in plasma following intravenous administration of psilocin and oral administration of psilocybin to male beagle dogs","year":"2025","cit":0,"pfa":"Inés de Lannoy","psa":"Joseph A. Araujo","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4410218949","eid":"W4410218949"},{"id":"paper-w2442990021","cat":"papers","name":"[Probable existence of D-lysergic acid diethylamide in infections caused by Toxoplasma gondii].","year":"1956","cit":0,"pfa":"Gerardo Varela","psa":"J Torroella","ptype":"article","src":"https://openalex.org/W2442990021","eid":"W2442990021"},{"id":"paper-w2413383041","cat":"papers","name":"[Effect of lysergic acid diethylamide on the monoamine content of some midbrain and hypothalamic nuclei].","year":"1970","cit":0,"pfa":"N A Khristoliubova","ptype":"article","src":"https://openalex.org/W2413383041","eid":"W2413383041"},{"id":"paper-w2994410021","cat":"papers","name":"[Effect of lysergic acid diethylamide on the activity of single neurons of some cerebral regions].","year":"1971","cit":0,"pfa":"Bondarenko Tt","ptype":"article","src":"https://openalex.org/W2994410021","eid":"W2994410021"},{"id":"paper-w4401572463","cat":"papers","name":"Acute Effects of Psilocybin and Salvinorin-A on Functional Connectivity","year":"2024","cit":0,"pfa":"Frederick A. Bagdasarian","psa":"Hsiao‐Ying Wey","topics":["Addiction","Mechanism & neuroscience"],"ptype":"conference-paper","src":"https://openalex.org/W4401572463","eid":"W4401572463"},{"id":"paper-w2415714997","cat":"papers","name":"[Effects of serotonin and lysergic acid diethylamide (LSD 25) on excitability of nervous centers].","year":"1957","cit":0,"pfa":"Paul Chauchard","psa":"Henriette Mazoué","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2415714997","eid":"W2415714997"},{"id":"paper-w4390223155","cat":"papers","name":"Lysergic acid diethylamide-induced modification in the functional connectivity of distinct thalamic subfields","year":"2023","cit":0,"pfa":"Stefano Delli Pizzi","psa":"Stefano Luca Sensi","ptype":"article","src":"https://openalex.org/W4390223155","eid":"W4390223155"},{"id":"paper-w4405635777","cat":"papers","name":"Pharmacokinetics and pharmacodynamics of sublingual microdosed lysergic acid diethylamide in healthy adult volunteers","year":"2024","cit":0,"pfa":"R. Murphy","psa":"Rachael L. Sumner","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4405635777","eid":"W4405635777"},{"id":"paper-w2467739287","cat":"papers","name":"[Acetylcholine content of rat brain structures following administration of lysergic acid diethylamide].","year":"1972","cit":0,"pfa":"J Kabeš","psa":"Josef Fusek","ptype":"article","src":"https://openalex.org/W2467739287","eid":"W2467739287"},{"id":"paper-w3083436265","cat":"papers","name":"The Exploration of Naturalistically used Ayahuasca and 5-MeO-DMT : An assessment of their respective Sub-acute and Long-Term effects on Mental Health Related Variables","year":"2020","cit":0,"pfa":"Malin Vedøy Uthaug","topics":["Depression","Anxiety & end-of-life"],"ptype":"dissertation","src":"https://openalex.org/W3083436265","eid":"W3083436265"},{"id":"paper-w2415431238","cat":"papers","name":"The influence of selective temporal lobe damage on behavior and the response to lysergic acid diethylamide.","year":"1971","cit":0,"pfa":"Wood Cd","ptype":"article","src":"https://openalex.org/W2415431238","eid":"W2415431238"},{"id":"paper-w4235356471","cat":"papers","name":"LSD, Mescaline, Psilocybin, and other Psychedelic Drugs","year":"2017","cit":0,"pfa":"Theodore X. Barber","ptype":"book-chapter","src":"https://openalex.org/W4235356471","eid":"W4235356471"},{"id":"paper-w2292174366","cat":"papers","name":"A critique of selected research concerning effects of lysergic acid diethylamide (L.S.D. -25)","year":"1968","cit":0,"pfa":"Bernice Vivian Boustani","ptype":"dissertation","src":"https://openalex.org/W2292174366","eid":"W2292174366"},{"id":"paper-w4253665065","cat":"papers","name":"Comparative Acute Effects of LSD, Psilocybin and Mescaline","year":"2020","cit":0,"ptype":"article","src":"https://openalex.org/W4253665065","eid":"W4253665065"},{"id":"paper-w7120419906","cat":"papers","name":"Development of voltammetric methods and a paper-bases electrode for analysis of Lysergic Acid Diethylamide (LSD)","year":"2020","cit":0,"pfa":"Maria Fernanda Muzetti Ribeiro","topics":["Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7120419906","eid":"W7120419906"},{"id":"paper-w2594125979","cat":"papers","name":"Interactions of Lysergic Acid Diethylamide and a Lysergyl Metabolic Derivative With Anti-Drug Antibodies","year":"1974","cit":0,"pfa":"Dennis E. Lopatin","ptype":"article","src":"https://openalex.org/W2594125979","eid":"W2594125979"},{"id":"paper-w2406328045","cat":"papers","name":"[Action of lysergic acid diethylamide (L.S.D.) on enzymatic activity of Papio papio leukocytes].","year":"1970","cit":0,"pfa":"Jean J Grozdea","psa":"C. Bouloux","ptype":"article","src":"https://openalex.org/W2406328045","eid":"W2406328045"},{"id":"paper-w2413874448","cat":"papers","name":"[The anticholinergic effect of lysergic acid diethylamide on the isolated jejunum and isolated atria of rats].","year":"1973","cit":0,"pfa":"Josef Fusek","psa":"Z Fink","ptype":"article","src":"https://openalex.org/W2413874448","eid":"W2413874448"},{"id":"paper-w2801855509","cat":"papers","name":"Some Test Findings Associated with Susceptibility to Psychosis Induced by Lysergic Acid Diethylamide","year":"1962","cit":0,"pfa":"Floyd K. Garetz","ptype":"article","src":"https://openalex.org/W2801855509","eid":"W2801855509"},{"id":"paper-w2261451138","cat":"papers","name":"[Psychomotor effects in acute and chronic poisoning with amine derivatives of lysergic acid diethylamide].","year":"1959","cit":0,"pfa":"Giuseppe Tonini","psa":"G Missere","ptype":"article","src":"https://openalex.org/W2261451138","eid":"W2261451138"},{"id":"paper-w2416980751","cat":"papers","name":"[THERAPEUTIC USE OF D-LYSERGIC ACID DIETHYLAMIDE (DELYSIDE OR LSD-25) IN PSYCHONEUROSES].","year":"1963","cit":0,"pfa":"A Kafkalidis","ptype":"article","src":"https://openalex.org/W2416980751","eid":"W2416980751"},{"id":"paper-w4393429806","cat":"papers","name":"Elucidation of the mescaline biosynthesis in peyote (L. williamsii) - Dataset","year":"2023","cit":0,"pfa":"Jacinta L. Watkins","psa":"Peter J. Facchini","ptype":"dataset","src":"https://openalex.org/W4393429806","eid":"W4393429806"},{"id":"paper-w7162789710","cat":"papers","name":"Lysergic acid diethylamide reverses aging- and neurodegeneration-associated brain transcriptional programs","year":"2026","cit":0,"pfa":"Aurora Savino","psa":"Francesco Iorio","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7162789710","eid":"W7162789710"},{"id":"paper-w4200236734","cat":"papers","name":"P.0624 Lysergic acid diethylamide: re-opening the doors of perception and an encounter with psychosis","year":"2021","cit":0,"pfa":"S. Jesus","psa":"R. Silva","ptype":"article","src":"https://openalex.org/W4200236734","eid":"W4200236734"},{"id":"paper-w4244855400","cat":"papers","name":"ChemInform Abstract: STUDIES OF LYSERGIC ACID DIETHYLAMIDE AND RELATED COMPOUNDS. PART 8. STRUCTURAL IDENTIFICATION OF NEW METABOLITES OF LYSERGIC ACID DIETHYLAMIDE OBTAINED BY MICROBIAL TRANSFORMATION USING STREPTOMYCES","year":"1980","cit":0,"pfa":"Hisashi Ishii","psa":"M. HAYASHI","ptype":"article","src":"https://openalex.org/W4244855400","eid":"W4244855400"},{"id":"paper-w7132582907","cat":"papers","name":"Investigation into pharmacokinetic properties of active alkaloid ibogaine and its metabolite noribogaine","year":"2017","cit":0,"pfa":"Asta Kubilienė","psa":"Leonid Ivanov","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7132582907","eid":"W7132582907"},{"id":"paper-w2418971334","cat":"papers","name":"[Lysergic acid diethylamide (LSD-25) test and psychotropic therapy: electroencephalographic study].","year":"1965","cit":0,"pfa":"P Borenstein","psa":"C Olivenstein","ptype":"article","src":"https://openalex.org/W2418971334","eid":"W2418971334"},{"id":"paper-w7133035081","cat":"papers","name":"Lysergic Acid Diethylamide Modulation of Motor Seizures and Hippocampal and Cortical Oscillatory Rhythms","year":"2025","cit":0,"pfa":"Brenden Samuel Rabinovitch","ptype":"dissertation","src":"https://openalex.org/W7133035081","eid":"W7133035081"},{"id":"paper-w2297141617","cat":"papers","name":"[Effects of experimental lysergic acid diethylamide poisoning in 2 cases of visual anosognosia].","year":"1956","cit":0,"pfa":"G Alemà","psa":"G Donini","ptype":"article","src":"https://openalex.org/W2297141617","eid":"W2297141617"},{"id":"paper-w7172310531","cat":"papers","name":"Psychological change processes in alcohol use disorder: A qualitative study of 5‐methoxy‐ N , N ‐dimethyltryptamine (5‐MeO‐DMT) with cognitive behavioural therapy","year":"2026","cit":0,"pfa":"Mathieu Seynaeve","psa":"John Marsden","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7172310531","eid":"W7172310531"},{"id":"paper-w4390222421","cat":"papers","name":"Increased fractional anisotropy after lysergic acid diethylamide therapy for major depression","year":"2023","cit":0,"pfa":"Mihai Avram","psa":"Stefan Borgwardt","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4390222421","eid":"W4390222421"},{"id":"paper-w7116082846","cat":"papers","name":"Lysergic acid diethylamide pretreatment prolongs brain-stimulation induced neural activity changes","year":"2025","cit":0,"pfa":"Lucas L. Dwiel","psa":"Wilder T. Doucette","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7116082846","eid":"W7116082846"},{"id":"paper-w4416070182","cat":"papers","name":"Participant Experiences of Microdosed Lysergic Acid Diethylamide in a 6-Week Randomised Controlled Trial","year":"2025","cit":0,"pfa":"Robin J. Murphy","psa":"Suresh D Muthukumaraswamy","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4416070182","eid":"W4416070182"},{"id":"paper-w189423342","cat":"papers","name":"Ayahuasca et Iboga: secte et néo-chamanisme","year":"2008","cit":0,"pfa":"Anne-Françoise Collart","ptype":"conference-paper","src":"https://openalex.org/W189423342","eid":"W189423342"},{"id":"paper-w2417068510","cat":"papers","name":"[Use of lysergic acid diethylamide in psychoneuroses; preliminary observations and principles of diagnostic and therapeutic evaluation].","year":"2002","cit":0,"pfa":"Franco Giberti","psa":"Giuseppe Boeri","ptype":"article","src":"https://openalex.org/W2417068510","eid":"W2417068510"},{"id":"paper-w2947282787","cat":"papers","name":"Use of MDMA & Psilocybin in the Treatment of PTSD","year":"2019","cit":0,"pfa":"Camden Grant-Howard","psa":"Joel S. Steele","topics":["PTSD & trauma","Policy & ethics"],"ptype":"conference-paper","src":"https://openalex.org/W2947282787","eid":"W2947282787"},{"id":"paper-w2419055267","cat":"papers","name":"[Effect of hydroxyzine hydrochloride on psychotoxic symptoms of lysergic acid diethylamide in normal human subjects].","year":"2002","cit":0,"pfa":"CA Loeb","psa":"Franco Giberti","ptype":"article","src":"https://openalex.org/W2419055267","eid":"W2419055267"},{"id":"paper-w633615862","cat":"papers","name":"Ibogaine (iboga tabernanthe) as a potential anti-addictive treatment in the pipeline : a short communication","year":"2014","cit":0,"pfa":"Mohamed Nazar","psa":"Nor Ilyani","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W633615862","eid":"W633615862"},{"id":"paper-w4378378339","cat":"papers","name":"THE EFFICACY OF LYSERGIC ACID DIETHYLAMIDE FOR PSYCHOLOGICAL ASSISTED THERAPY: SYSTEMATIC REVIEW AND METAANALYSIS OF RANDOMIZED CONTROLLED TRIALS","year":"2023","cit":0,"pfa":"Dimple Gupta","psa":"Gorish Gupta","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4378378339","eid":"W4378378339"},{"id":"paper-w7162206559","cat":"papers","name":"Speech markers of psychological change following a psychedelic 5-MeO-DMT retreat","year":"2026","cit":0,"pfa":"Joanna Kuc","psa":"Jeremy I Skipper","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W7162206559","eid":"W7162206559"},{"id":"paper-w2784349684","cat":"papers","name":"HPLC/DAD analysis of psilocin and psilocybin in psilocybe cubensis","year":"2007","cit":0,"pfa":"Veniero Gambaro","psa":"CM Pecoraro","ptype":"article","src":"https://openalex.org/W2784349684","eid":"W2784349684"},{"id":"paper-w4378737975","cat":"papers","name":"THE EFFICACY OF LYSERGIC ACID DIETHYLAMIDE FOR PSYCHOLOGICAL ASSISTED THERAPY: SYSTEMATIC REVIEW AND METAANALYSIS OF RANDOMIZED CONTROLLED TRIALS","year":"2023","cit":0,"pfa":"Dimple Gupta","psa":"Gorish Gupta","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W4378737975","eid":"W4378737975"},{"id":"paper-w7161958908","cat":"papers","name":"Lysergic acid diethylamide pretreatment prolongs brain-stimulation induced neural activity changes","year":"2026","cit":0,"pfa":"Lucas L. Dwiel","psa":"Wilder T. Doucette","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7161958908","eid":"W7161958908"},{"id":"paper-w2401591434","cat":"papers","name":"[The effect of lysergic acid diethylamide (LSD-25) on the ERG of cold and warm blooded animals].","year":"1962","cit":0,"pfa":"W Mueller-Limmroth","psa":"H HARTMANN","ptype":"article","src":"https://openalex.org/W2401591434","eid":"W2401591434"},{"id":"paper-w7111917089","cat":"papers","name":"Registered Clinical Trials Investigating Lysergic Acid Diethylamide (LSD) in Healthy and Psychiatric Populations","year":"2023","cit":0,"pfa":"Paul Seli","psa":"Laura Kate Jackson","topics":["Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7111917089","eid":"W7111917089"},{"id":"paper-w1412161719","cat":"papers","name":"Differential effects of subcortical lysergic acid diethylamide and serotonin on visual cortical evoked potentials","year":"1977","cit":0,"pfa":"Jean R Strahlendorf","psa":"Roger T. Malseed","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1412161719","eid":"W1412161719"},{"id":"paper-w405878751","cat":"papers","name":"Lysergic Acid Diethylamide(LSD)の合成について","year":"1970","cit":0,"pfa":"五郎 浦久保","ptype":"article","src":"https://openalex.org/W405878751","eid":"W405878751"},{"id":"paper-w3176105942","cat":"papers","name":"Effects of two weeks exposure of ibogaine and noribogaine on mouse organs : morphologic evaluation","year":"2012","cit":0,"pfa":"Asta Kubilienė","psa":"Alius Pockevičius","topics":["Addiction","Dosing & pharmacology"],"ptype":"conference-paper","src":"https://openalex.org/W3176105942","eid":"W3176105942"},{"id":"paper-w2015092996","cat":"papers","name":"Some physiological characteristics of the effect of lysergic acid diethylamide on the sensorimotor area of the cerebral cortex","year":"1966","cit":0,"pfa":"V. F. Meshman","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2015092996","eid":"W2015092996"},{"id":"paper-w2416927770","cat":"papers","name":"[The susceptibility of the conditioned motor escape reaction in rats to noradrenalin, serotonin and lysergic acid diethylamide].","year":"1963","cit":0,"pfa":"Joachim Schmidt","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2416927770","eid":"W2416927770"},{"id":"paper-w2053876354","cat":"papers","name":"Effect of lysergic acid diethylamide (LSD) on monoamine content in some nuclei of the mesencephalon and hypothalamus","year":"1970","cit":0,"pfa":"N. A. Khristolyubova","ptype":"article","src":"https://openalex.org/W2053876354","eid":"W2053876354"},{"id":"paper-w1496256426","cat":"papers","name":"Noribogaine: An active metabolite of the indole alkaloid ibogaine as an anti-addiction pharmacotherapy","year":"2000","cit":0,"pfa":"John P. Pablo","topics":["Addiction"],"ptype":"dissertation","src":"https://openalex.org/W1496256426","eid":"W1496256426"},{"id":"paper-w2412395452","cat":"papers","name":"[Research on the problem of schizophrenia using radiocarbon-labeled lysergic acid diethylamide & succinic acid].","year":"1958","cit":0,"pfa":"O H ARNOLD","psa":"H Leupold-Lowenthal","ptype":"article","src":"https://openalex.org/W2412395452","eid":"W2412395452"},{"id":"paper-w3048428495","cat":"papers","name":"The Effects of Low Dose Lysergic Acid Diethylamide Administration in a Rodent Model of Delay Discounting","year":"2020","cit":0,"pfa":"Robert Köhler","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3048428495","eid":"W3048428495"},{"id":"paper-w4360584888","cat":"papers","name":"Peyote","year":"2023","cit":0,"pfa":"Christine M. Stork","ptype":"reference-entry","src":"https://openalex.org/W4360584888","eid":"W4360584888"},{"id":"paper-w4412056134","cat":"papers","name":"Lysergic Acid Diethylamide (LSD) and the Heart: Exploring the Potential Impacts of LSD on Cardiovascular Function","year":"2025","cit":0,"pfa":"Akshita Suleria","psa":"Tanveer Ahamad Shaik","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4412056134","eid":"W4412056134"},{"id":"paper-w4240805006","cat":"papers","name":"Separation of D-lysergic acid diethylamide derivatives using micellar electrokinetic capillary chromatography","year":"2000","cit":0,"pfa":"M. Nebojsa Djordjevic","psa":"Fabrice Houdiere","ptype":"article","src":"https://openalex.org/W4240805006","eid":"W4240805006"},{"id":"paper-w4409418234","cat":"papers","name":"A Toad Less Traveled: Should 5-MeO-DMT Have a Role in Treating Depression?","year":"2025","cit":0,"pfa":"Caroline Hayes","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4409418234","eid":"W4409418234"},{"id":"paper-w2952378764","cat":"papers","name":"ChemInform Abstract: LYSERGIC ACID DIETHYLAMIDE. PHOTOELECTRON IONIZATION POTENTIALS AS INDICES OF BEHAVIORAL ACTIVITY","year":"1978","cit":0,"pfa":"Linda N. Domelsmith","psa":"K. N. Houk","ptype":"article","src":"https://openalex.org/W2952378764","eid":"W2952378764"},{"id":"paper-w7119476178","cat":"papers","name":"5-MeO-DMT Use in Humans: A Scoping Review of Peer-Reviewed Research","year":"2026","cit":0,"pfa":"Michael Esposito","psa":"Rafael Lancelotta","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W7119476178","eid":"W7119476178"},{"id":"paper-w2416343766","cat":"papers","name":"[Lysergic acid diethylamide. 3. Practical and theoretical problems in administration of LSD to human subjects].","year":"1960","cit":0,"pfa":"S Grof","psa":"Zdenek Votava","ptype":"article","src":"https://openalex.org/W2416343766","eid":"W2416343766"},{"id":"paper-w1987706759","cat":"papers","name":"Nifedipine prevents neurochemical and cognitive changes induced by chronic lysergic acid diethylamide in rodents","year":"1997","cit":0,"pfa":"J Vetulani","psa":"Lucyna Antkiewicz‐Michaluk","ptype":"article","src":"https://openalex.org/W1987706759","eid":"W1987706759"},{"id":"paper-w7171780897","cat":"papers","name":"GAS CHROMATOGRAPHIC METHOD DEVELOPMENT AND VALIDATION FOR QUANTITATIVE ANALYSIS OF LYSERGIC ACID DIETHYLAMIDE IN ILLICIT PREPARATIONS","year":"2026","cit":0,"pfa":"Kandhagatla Saisneha1*, Dr. Madireddy Mamata2, Ragipati Suneetha3, Donthula…","ptype":"article","src":"https://openalex.org/W7171780897","eid":"W7171780897"},{"id":"paper-w2908609250","cat":"papers","name":"An investigation of social cognition using psilocybin and MDMA","year":"2017","cit":0,"pfa":"Anthony S. Gabay","ptype":"dissertation","src":"https://openalex.org/W2908609250","eid":"W2908609250"},{"id":"paper-w2266433428","cat":"papers","name":"THE MICROSYNTHESIS OF $sup 82$Br-LABELLED 2-BROM-D-LYSERGIC ACID DIETHYLAMIDE (BOL)","year":"1963","cit":0,"pfa":"D.A. Kalbhen","ptype":"article","src":"https://openalex.org/W2266433428","eid":"W2266433428"},{"id":"paper-w2417338066","cat":"papers","name":"[A histoenzymatic study of cerebral and internal organ tissues following prolonged administration of lysergic acid diethylamide].","year":"1973","cit":0,"pfa":"Matveev Vp","psa":"E Kh Chudina","ptype":"article","src":"https://openalex.org/W2417338066","eid":"W2417338066"},{"id":"paper-w4386409757","cat":"papers","name":"Acute effects of psilocybin, LSD, mescaline found to be similar","year":"2023","cit":0,"ptype":"article","src":"https://openalex.org/W4386409757","eid":"W4386409757"},{"id":"paper-w2402604749","cat":"papers","name":"The frog neuron Nissl substance, nucleus, and nucleolus after intravenous injection of lysergic acid diethylamide.","year":"1982","cit":0,"pfa":"Milena Kemali","psa":"DARGUT KEMALI","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2402604749","eid":"W2402604749"},{"id":"paper-w4293079604","cat":"papers","name":"JOHANNESBURG ௹ (+2781) 341 4602௹ ₳ PURE IBOGA POWDER IN JOHANNESBURG // IBOGA SEEDS IN JOHANNESBURG // IBOGAINE HCL FOR SALE IN HOHANNESBURG ///","year":"2022","cit":0,"pfa":"Nicole","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4293079604","eid":"W4293079604"},{"id":"paper-w7135700160","cat":"papers","name":"Voltammetric Determination of Psilocin and Psilocybin at Carbon-fiber PLA Electrode","year":"2022","cit":0,"pfa":"Marta Choińska-Mlynarczyk","ptype":"conference-paper","src":"https://openalex.org/W7135700160","eid":"W7135700160"},{"id":"paper-w7132218444","cat":"papers","name":"Ibogaine and noribogaine distribution in the organs of mice by liquid chromatography and solid phase extraction","year":"2010","cit":0,"pfa":"Asta Kubilienė","psa":"Leonid Ivanov","ptype":"conference-paper","src":"https://openalex.org/W7132218444","eid":"W7132218444"},{"id":"paper-w4390271499","cat":"papers","name":"Psychedelic Therapy: A Primer for Primary Care Clinicians – Part II. Lysergic acid diethylamide (LSD)","year":"2023","cit":0,"pfa":"Bryce David Beutler","psa":"Owen S. Muir","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W4390271499","eid":"W4390271499"},{"id":"paper-w2394318175","cat":"papers","name":"EFFECTS OF LIP-ACUPUNCTURE AND LYSERGIC ACID DIETHYLAMIDE(LSD)ON DORSAL RAPHE UNIT ACTIVITY IN RATS","year":"1983","cit":0,"pfa":"Fengjun Gu","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2394318175","eid":"W2394318175"},{"id":"paper-w4411666638","cat":"papers","name":"Fear as medicine: A mixed-methods analysis of 5-MeO-DMT, mental health, and intergenerational healing","year":"2025","cit":0,"pfa":"Jeffrey S. Overall","topics":["PTSD & trauma","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4411666638","eid":"W4411666638"},{"id":"paper-w113082877","cat":"papers","name":"The effects of lysergic acid diethylamide (LSD-25) on the physiology and morphology of rabbit sperm maintained in vitro","year":"1970","cit":0,"pfa":"Washington, Pauline Baxter","ptype":"article","src":"https://openalex.org/W113082877","eid":"W113082877"},{"id":"paper-w2059035176","cat":"papers","name":"B31 3,4-METHYLENEDIOXYMETHAPMHETAMINE (MDMA) AND 4-OH-DIMETHYLTRYPTAMINE (PSILOCIN) INTERACTION IN RATS: BEHAVIORAL STUDY ON PREPULSE INHIBITION OF ACOUSTIC STARTLE REACTION AND ON LOCOMOTION","year":"2005","cit":0,"pfa":"Tomáš Páleníček","psa":"Martin Votava","topics":["Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W2059035176","eid":"W2059035176"},{"id":"paper-w7171829354","cat":"papers","name":"GAS CHROMATOGRAPHIC METHOD DEVELOPMENT AND VALIDATION FOR QUANTITATIVE ANALYSIS OF LYSERGIC ACID DIETHYLAMIDE IN ILLICIT PREPARATIONS","year":"2026","cit":0,"pfa":"Kandhagatla Saisneha1*, Dr. Madireddy Mamata2, Ragipati Suneetha3, Donthula…","ptype":"article","src":"https://openalex.org/W7171829354","eid":"W7171829354"},{"id":"paper-w4411975641","cat":"papers","name":"Policies on the Control of Lysergic Acid Diethylamide (LSD) Chemicals in Glues to Prevent LSD Chemical Abuse","year":"2025","cit":0,"topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4411975641","eid":"W4411975641"},{"id":"paper-w7135193244","cat":"papers","name":"Fabricated ancestrality: The Sonoran Desert toad, psychedelic globalization, and the ecological politics of 5-MeO-DMT","year":"2026","cit":0,"pfa":"A.M Ortiz Bernal","psa":"A.K. Davis","topics":["Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7135193244","eid":"W7135193244"},{"id":"paper-w7167939980","cat":"papers","name":"An integrated living dataset of psilocybin and psilocin publications, preprints, and trial records","year":"2026","cit":0,"pfa":"Christopher B. Germann","topics":["Reviews & meta-analyses"],"ptype":"dataset","src":"https://openalex.org/W7167939980","eid":"W7167939980"},{"id":"paper-w2411811253","cat":"papers","name":"[Interaction of the effects of lysergic acid diethylamide and aminazine at the level of individual neurons of the midbrain reticular formation].","year":"1972","cit":0,"pfa":"Bondarenko Tt","ptype":"article","src":"https://openalex.org/W2411811253","eid":"W2411811253"},{"id":"paper-w1580847710","cat":"papers","name":"Peyote [Lophophora williamsii(Lem. Ex Salm‐Dyck) Coult.] and Mescaline","year":"2012","cit":0,"pfa":"Donald G. Barceloux","topics":["Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W1580847710","eid":"W1580847710"},{"id":"paper-w2463432675","cat":"papers","name":"[Histoenzymatic study of the brain tissue and internal organs of experimental animals with a single administration of lysergic acid diethylamide].","year":"1972","cit":0,"pfa":"E Kh Chudina","ptype":"article","src":"https://openalex.org/W2463432675","eid":"W2463432675"},{"id":"paper-w7165151622","cat":"papers","name":"Acute and post-acute neurobehavioral responses to lysergic acid diethylamide in healthy subjects: a randomized controlled study","year":"2026","cit":0,"pfa":"Abigail E. Calder","psa":"Gregor Hasler","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7165151622","eid":"W7165151622"},{"id":"paper-w7160918234","cat":"papers","name":"Iboga and ayahuasca and its effects on narcissism, conspicuous consumption, and compulsive consumption","year":"2026","cit":0,"pfa":"Ash Zareian","ptype":"dataset","src":"https://openalex.org/W7160918234","eid":"W7160918234"},{"id":"paper-w7168154779","cat":"papers","name":"An integrated living dataset of psilocybin and psilocin publications, preprints, and trial records","year":"2026","cit":0,"pfa":"Christopher B. Germann","topics":["Reviews & meta-analyses"],"ptype":"dataset","src":"https://openalex.org/W7168154779","eid":"W7168154779"},{"id":"paper-w7170188387","cat":"papers","name":"5-MeO-DMT induces NEIL3-independent acute cell proliferation in the adult dentate gyrus","year":"2026","cit":0,"pfa":"Rafael Vitor Lima da Cruz","psa":"Thiago C. Moulin","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7170188387","eid":"W7170188387"},{"id":"paper-w2897203573","cat":"papers","name":"A single dose of 5-MeO-DMT stimulates adult neurogenesis in mouse dentate gyrus","year":"2018","cit":0,"pfa":"Rafael Vitor Lima da Cruz","topics":["Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W2897203573","eid":"W2897203573"},{"id":"paper-w2921915039","cat":"papers","name":"Thin layer Chromatography of Ibogaine from plant extract of Tabernanthe iboga.","year":"2015","cit":0,"pfa":"Shweta Rangari","psa":"M. Sonwane .","ptype":"article","src":"https://openalex.org/W2921915039","eid":"W2921915039"},{"id":"paper-w4390222453","cat":"papers","name":"Influence of the context of administration in the anxiolytic and antidepressant-like effects of the psychedelic 5-MeO-DMT","year":"2023","cit":0,"pfa":"Romain Hacquet","psa":"Bruno Pierre Guiard","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4390222453","eid":"W4390222453"},{"id":"paper-w4414670666","cat":"papers","name":"Neural effects and phenomenology of nondual meditation and 5-MeO-DMT in an expert meditation practitioner","year":"2025","cit":0,"pfa":"Christopher B. Timmermann","psa":"Antoine Lutz","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4414670666","eid":"W4414670666"},{"id":"paper-w4287178788","cat":"papers","name":"JOHANNESBURG ௹ +2778 278 2201 ௹ ₳ PURE IBOGA POWDER IN JOHANNESBURG // IBOGA SEEDS IN JOHANNESBURG // IBOGAINE HCL FOR SALE IN HOHANNESBURG ///","year":"2021","cit":0,"pfa":"Nicole","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4287178788","eid":"W4287178788"},{"id":"paper-w2902934564","cat":"papers","name":"RETRACTED: Long-term systemic treatment with lysergic acid diethylamide causes retinal damage in CD1 mice","year":"2018","cit":0,"pfa":"Huaiyan Jiang","psa":"Huaqing Xu","ptype":"article","src":"https://openalex.org/W2902934564","eid":"W2902934564"},{"id":"paper-w7160962403","cat":"papers","name":"Iboga and ayahuasca and its effects on narcissism, conspicuous consumption, and compulsive consumption","year":"2026","cit":0,"pfa":"Ash Zareian","ptype":"dataset","src":"https://openalex.org/W7160962403","eid":"W7160962403"},{"id":"paper-w7203918935","cat":"papers","name":"Low-dose lysergic acid diethylamide alters subjective visual perception but not visual contrast surround suppression","year":"2026","cit":0,"pfa":"Lucca Jaeckel","psa":"Philipp Sterzer","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7203918935","eid":"W7203918935"},{"id":"paper-w2416705340","cat":"papers","name":"[II. Tree-drawing test in application to the study of lysergic acid diethylamide-induced psychopathological changes in schizophrenics].","year":"1958","cit":0,"pfa":"G Gomirato","psa":"E Pascal","ptype":"article","src":"https://openalex.org/W2416705340","eid":"W2416705340"},{"id":"paper-w2768061300","cat":"papers","name":"Psilocybin and Mescaline - Molecule of the Month October 1999 [Archived version]","year":"2017","cit":0,"pfa":"Paul William May","ptype":"other","src":"https://openalex.org/W2768061300","eid":"W2768061300"},{"id":"paper-w2415180966","cat":"papers","name":"[Effects of 5-hydroxy tryptamin (serotonin) and lysergic acid diethylamide (LSD) on the pituitary-adrenal cortex system].","year":"1956","cit":0,"pfa":"STEVAN MILKOVIĆ","psa":"Zlatko Supek","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2415180966","eid":"W2415180966"},{"id":"paper-w4250137043","cat":"papers","name":"Faculty Opinions recommendation of Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials.","year":"2012","cit":0,"pfa":"Bryon H. Adinoff","topics":["Addiction","Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4250137043","eid":"W4250137043"},{"id":"paper-w2405014737","cat":"papers","name":"[Lesions of the central nervous system in Carassius auratus caused by serotonin and the protective action of lysergic acid diethylamide].","year":"1956","cit":0,"pfa":"Adolfo Brusa","psa":"U Sacchi","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2405014737","eid":"W2405014737"},{"id":"paper-w4390222118","cat":"papers","name":"Lysergic acid diethylamide for depression — a randomized, double-blind, low dose-controlled phase ii trial","year":"2023","cit":0,"pfa":"Felix Müller","psa":"Matthias E. Liechti","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4390222118","eid":"W4390222118"},{"id":"paper-w4407387006","cat":"papers","name":"BEHAVIORAL AND ELECTROPHYSIOLOGICAL EFFECTS OF LYSERGIC ACID DIETHYLAMIDE (LSD) IN A MOUSE MODEL OF ALCOHOL USE DISORDER (AUD)","year":"2025","cit":0,"pfa":"Danilo De Gregorio","psa":"Margherita Spadaccini","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W4407387006","eid":"W4407387006"},{"id":"paper-w2301738458","cat":"papers","name":"[Gas chromatography-mass spectrometry in the study of illegal mescaline/dimethyltryptamine--laboratory findings].","year":"1981","cit":0,"pfa":"Werner Gielsdorf","psa":"K Allin","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2301738458","eid":"W2301738458"},{"id":"paper-w2395681081","cat":"papers","name":"[Noxious effects of various drugs and medicaments on the genetic material. II. The problem of lysergic acid diethylamide (LSD)].","year":"1971","cit":0,"pfa":"S Armendares","ptype":"article","src":"https://openalex.org/W2395681081","eid":"W2395681081"},{"id":"paper-w4407075805","cat":"papers","name":"Prevalence of Use of Psilocybin and MDMA in Multiple US Cities","year":"2025","cit":0,"pfa":"Tamara A. Millay","psa":"Linda Bauer Cottler","ptype":"article","src":"https://openalex.org/W4407075805","eid":"W4407075805"},{"id":"paper-w3087644955","cat":"papers","name":"Personality Differences Among Long-Term Users, Short-Term Users, & Nonusers of Lysergic Acid Diethylamide","year":"1977","cit":0,"pfa":"Wayne A. Fuller","ptype":"dissertation","src":"https://openalex.org/W3087644955","eid":"W3087644955"},{"id":"paper-w7211988400","cat":"papers","name":"720. Unraveling anxiolytic and anti-addictive properties of lysergic acid diethylamide in a model of alcohol use disorder","year":"2026","cit":0,"pfa":"T Solomon","psa":"J. Freedman","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"conference-abstract","src":"https://openalex.org/W7211988400","eid":"W7211988400"},{"id":"paper-w7117986947","cat":"papers","name":"Lysergic acid diethylamide modulates hippocampal and cortical local field potential oscillatory rhythms in male mice","year":"2026","cit":0,"pfa":"Brenden Samuel Rabinovitch","psa":"Peter Louis Carlen","ptype":"article","src":"https://openalex.org/W7117986947","eid":"W7117986947"},{"id":"paper-w7117627746","cat":"papers","name":"Past-Year Lysergic Acid Diethylamide Use in United States Sexual Minorities from 2015 to 2019","year":"2025","cit":0,"pfa":"Brian Scott Barnett","psa":"Jeremy Weleff","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7117627746","eid":"W7117627746"},{"id":"paper-w3209180968","cat":"papers","name":"Psilocybin and Mescaline - Molecule of the Month October 1999 [Archived version]","year":"2017","cit":0,"pfa":"Paul William May","ptype":"article","src":"https://openalex.org/W3209180968","eid":"W3209180968"},{"id":"paper-w7212048878","cat":"papers","name":"515. Influence of the context of administration on 5-MeO-DMT-promoted antidepressant-like effects and neuroplasticity","year":"2026","cit":0,"pfa":"Romain Hacquet","psa":"Bruno Pierre Guiard","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7212048878","eid":"W7212048878"},{"id":"paper-w7130947183","cat":"papers","name":"Psilocin glucuronide in whole blood: a stable and useful biomarker of psilocybin intake","year":"2026","cit":0,"pfa":"Marianne Skov‐Skov Bergh","psa":"Åse Marit Leere Øiestad","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W7130947183","eid":"W7130947183"},{"id":"paper-w2912604483","cat":"papers","name":"Interaction between effects of lysergic acid diethylamide and chlorpromazine at the single neuron level in the mesencephalic reticular formation","year":"1972","cit":0,"pfa":"T. T. Bondarenko","ptype":"article","src":"https://openalex.org/W2912604483","eid":"W2912604483"},{"id":"paper-w4252210958","cat":"papers","name":"RETRACTION NOTICE: Long-term systemic treatment with lysergic acid diethylamide causes retinal damage in CD1 mice","year":"2019","cit":0,"ptype":"retraction","src":"https://openalex.org/W4252210958","eid":"W4252210958"},{"id":"paper-w2440217932","cat":"papers","name":"Is 2-bromo-D-lysergic acid diethylamide (BOL) an allosteric antagonist of serotonergic receptors in rabbit atria?","year":"1988","cit":0,"pfa":"Z Xu","psa":"R E Purdy","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2440217932","eid":"W2440217932"},{"id":"paper-w2945277871","cat":"papers","name":"Generation of monoclonal antibodies for on-site analysis of psilocin and psilocybin in hallucinogenic mushrooms","year":"2019","cit":0,"pfa":"Izumi Morita","psa":"N. Kobayashi","ptype":"article","src":"https://openalex.org/W2945277871","eid":"W2945277871"},{"id":"paper-w2409200961","cat":"papers","name":"[Effect of lysergic acid diethylamide on monoamino-oxidase activity of the liver, kidney & brain in the presence of 5-hydroxytryptamine].","year":"1956","cit":0,"pfa":"L DE GIUSEPPE","psa":"B CASTELLI","ptype":"article","src":"https://openalex.org/W2409200961","eid":"W2409200961"},{"id":"paper-w7153834657","cat":"papers","name":"Trifecta Study Post-registration - An Observational Study Evaluating the Impact of Ibogaine-Magnesium, 5-MeO-DMT, Magnetic e-Resonance Therapy, and Hormone Replacement Therapy in Special Operations Forces Combat Veterans","year":"2026","cit":0,"pfa":"Brandon Weiss","psa":"Kathryn M. Pate","topics":["Depression","PTSD & trauma"],"ptype":"other","src":"https://openalex.org/W7153834657","eid":"W7153834657"},{"id":"paper-w4413273277","cat":"papers","name":"Lysergic acid diethylamide modulates hippocampal and cortical local field potential oscillatory rhythms in male mice","year":"2025","cit":0,"pfa":"Brenden Samuel Rabinovitch","psa":"Peter Louis Carlen","topics":["Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4413273277","eid":"W4413273277"},{"id":"paper-w4362733972","cat":"papers","name":"332. 5-MeO-DMT Modifies Innate Behaviors and Promotes Structural Neural Plasticity in Mice","year":"2023","cit":0,"pfa":"Sarah Jefferson","psa":"Alex C. Kwan","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4362733972","eid":"W4362733972"},{"id":"paper-w4394740932","cat":"papers","name":"Molecular Docking, MM-GBSA, and Molecular Dynamics Approach: 5-MeO-DMT Analogues as Potential Antidepressants.","year":"2023","cit":0,"pfa":"Rajagopal Kalirajan","psa":"Islam Rezaul","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4394740932","eid":"W4394740932"},{"id":"paper-w7140229882","cat":"papers","name":"Intranasal 5-MeO-DMT Concomitant with SSRI for Treatment-Resistant Depression: A Proof-of-Concept Trial","year":"2026","cit":0,"pfa":"Mathieu Seynaeve","psa":"Claire Roberts","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7140229882","eid":"W7140229882"},{"id":"paper-w4417427963","cat":"papers","name":"Lysergic acid diethylamide-derived excitatory/inhibitory ratio change enhances global synchrony in functional brain dynamics","year":"2025","cit":0,"pfa":"Lingyu Zhang","psa":"Tianzi Jiang","topics":["Safety & adverse events","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4417427963","eid":"W4417427963"},{"id":"paper-w4254795274","cat":"papers","name":"The role of the serotonin 2A receptor in the fabric and modulation of personal meaning in lysergic acid diethylamide (LSD)-induced states","year":"2016","cit":0,"pfa":"Katrin H. Preller","topics":["Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W4254795274","eid":"W4254795274"},{"id":"paper-w4405637682","cat":"papers","name":"An open-label prospective 12-month follow-up of lysergic acid diethylamide-assisted therapy in patients with anxiety","year":"2024","cit":0,"pfa":"Friederike Holze","psa":"Matthias E. Liechti","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4405637682","eid":"W4405637682"},{"id":"paper-w4240619081","cat":"papers","name":"Faculty Opinions recommendation of Lysergic acid diethylamide (LSD) promotes social behavior through mTORC1 in the excitatory neurotransmission.","year":"2021","cit":0,"pfa":"Thomas Knöpfel","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"peer-review","src":"https://openalex.org/W4240619081","eid":"W4240619081"},{"id":"paper-w7168015730","cat":"papers","name":"A source-preserving living dataset of psilocybin and psilocin publications, preprints, and trial records","year":"2026","cit":0,"pfa":"Christopher B. Germann","ptype":"dataset","src":"https://openalex.org/W7168015730","eid":"W7168015730"},{"id":"paper-w4388831828","cat":"papers","name":"Molecular Docking, MM-GBSA, and Molecular Dynamics Approach: 5-MeO-DMT Analogues as Potential Antidepressants","year":"2023","cit":0,"pfa":"Rajagopal, Kalirajan","psa":"Islam, Md. Rezaul","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4388831828","eid":"W4388831828"},{"id":"paper-w2409451958","cat":"papers","name":"[Comparative study of the effects of lysergic acid diethylamide (LSD25) and of lysergic acid bromodiethylamide (BOL148) on short-term memory].","year":"1972","cit":0,"pfa":"M Sterescu-Volanschi","ptype":"article","src":"https://openalex.org/W2409451958","eid":"W2409451958"},{"id":"paper-w2594720947","cat":"papers","name":"The Screening of Mushrooms Found in Trinidad to Determine the Presence of the Psychoactive Substances Psilocin and Psilocybin","year":"2007","cit":0,"pfa":"Louis Garraway","psa":"Rean Maharaj","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2594720947","eid":"W2594720947"},{"id":"paper-w7133804101","cat":"papers","name":"Psilocybin and Ibogaine in Cocaine‐Seeking: Extinction Enhancement Without Relapse Prevention","year":"2026","cit":0,"pfa":"Isis Koutrouli","psa":"Tomáš Páleníček","topics":["Addiction","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7133804101","eid":"W7133804101"},{"id":"paper-w2951731548","cat":"papers","name":"ChemInform Abstract: STUDIES ON LYSERGIC ACID DIETHYLAMIDE AND RELATED COMPOUNDS PART 3, INPROVEMENT OF AMIDATION OF LYSERGIC ACID","year":"1974","cit":0,"pfa":"Y. NAKAHARA","psa":"Tetsukichi Niwaguchi","ptype":"article","src":"https://openalex.org/W2951731548","eid":"W2951731548"},{"id":"paper-w2422177167","cat":"papers","name":"[Influence exerted by adreno- and sympatholytic agents on changes of primary responses in the visual cortex induced by lysergic acid diethylamide].","year":"1966","cit":0,"pfa":"S Ia Arbuzov","psa":"Frolov Sf","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2422177167","eid":"W2422177167"},{"id":"paper-w2408995029","cat":"papers","name":"Incorporation of 14-C-labelled amino acids into the proteins of the liver. Effect of chlorpromazine, meprobamate and lysergic acid diethylamide.","year":"1963","cit":0,"pfa":"Piha Rs","psa":"Oja Ss","ptype":"article","src":"https://openalex.org/W2408995029","eid":"W2408995029"},{"id":"paper-w2778452110","cat":"papers","name":"Brain levels of 5-Hydroxytryptamine (Serotonin) after acute and chronic administration of Lysergic acid Diethylamide (LSD-25)","year":"1959","cit":0,"pfa":"Robert Lyle Fisher","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2778452110","eid":"W2778452110"},{"id":"paper-w1557317385","cat":"papers","name":"Enzymatic modification of d-lysergic acid diethylamide (lsd) by rabbit lymphoid cells and murine mopc 315 plasmacytoma cells.","year":"1975","cit":0,"pfa":"Edward W. Voss","psa":"Nancy E. Cobb","ptype":"article","src":"https://openalex.org/W1557317385","eid":"W1557317385"},{"id":"paper-w7114213779","cat":"papers","name":"Reactivations Associated with the Use of 5-MeO-DMT Among Spanish-Speaking Individuals: Prevalence, Predictors, and Emotional Valence","year":"2025","cit":0,"pfa":"Ortiz Bernal, AM","psa":"Davis, AK","ptype":"article","src":"https://openalex.org/W7114213779","eid":"W7114213779"},{"id":"paper-w2950054465","cat":"papers","name":"ChemInform Abstract: STUDIES ON LYSERGIC ACID DIETHYLAMIDE AND RELATED COMPOUNDS. V. SYNTHESES OF DIHYDROLYSERGIC ACID DIETHYLAMIDES AND RELATED COMPOUNDS","year":"1978","cit":0,"pfa":"Y. NAKAHARA","psa":"Hisashi Ishii","ptype":"article","src":"https://openalex.org/W2950054465","eid":"W2950054465"},{"id":"paper-w7120787687","cat":"papers","name":"Rewarding Effects of the Psychedelics Ayahuasca and Psilocybin in the Conditioned Place Preference Paradigm","year":"2025","cit":0,"pfa":"Vítor Bruno","topics":["Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7120787687","eid":"W7120787687"},{"id":"paper-w7168051061","cat":"papers","name":"A source-preserving living dataset of psilocybin and psilocin publications, preprints, and trial records","year":"2026","cit":0,"pfa":"Christopher B. Germann","topics":["Reviews & meta-analyses"],"ptype":"dataset","src":"https://openalex.org/W7168051061","eid":"W7168051061"},{"id":"paper-w7204737036","cat":"papers","name":"A randomized crossover trial comparing the acute physiological and psychological effects of botanical formulations of oral psilocybin, oral psilocin, and sublingual psilocin","year":"2026","cit":0,"pfa":"Marlene L. Tai","psa":"Joshua D. Woolley","topics":["Safety & adverse events","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7204737036","eid":"W7204737036"},{"id":"paper-w157609518","cat":"papers","name":"[Preliminary electron microscopy studies on the limbic system of Rana esculenta during chronic treatment with lysergic acid diethylamide].","year":"1975","cit":0,"pfa":"Milena Kemali","psa":"DARGUT KEMALI","ptype":"other","src":"https://openalex.org/W157609518","eid":"W157609518"},{"id":"paper-w7159932638","cat":"papers","name":"Attunement as Leadership: Council Practice and Low-Dose 5-MeO-DMT as Transdisciplinary Pathways to Transformative Leadership","year":"2026","cit":0,"pfa":"Azul Delgrasso","psa":"Jay Monger","topics":["Safety & adverse events","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7159932638","eid":"W7159932638"},{"id":"paper-w7167895031","cat":"papers","name":"A source-preserving living dataset of psilocybin and psilocin publications, preprints, and trial records","year":"2026","cit":0,"pfa":"Christopher B. Germann","ptype":"dataset","src":"https://openalex.org/W7167895031","eid":"W7167895031"},{"id":"paper-w7168043686","cat":"papers","name":"A source-preserving living dataset of psilocybin and psilocin publications, preprints, and trial records","year":"2026","cit":0,"pfa":"Christopher B. Germann","ptype":"dataset","src":"https://openalex.org/W7168043686","eid":"W7168043686"},{"id":"paper-w7168015054","cat":"papers","name":"A source-preserving living dataset of psilocybin and psilocin publications, preprints, and trial records","year":"2026","cit":0,"pfa":"Christopher B. Germann","ptype":"dataset","src":"https://openalex.org/W7168015054","eid":"W7168015054"},{"id":"paper-w7164035518","cat":"papers","name":"Corrigendum to “From Prohibited to Prescribed: The Rescheduling of MDMA and Psilocybin in Australia”","year":"2026","cit":0,"ptype":"erratum","src":"https://openalex.org/W7164035518","eid":"W7164035518"},{"id":"paper-w7126079054","cat":"papers","name":"The Intersection of EEG and Oculometry: Insights from 5-MeO-DMT-Induced Effects on Sleep and Brain States","year":"2026","cit":0,"pfa":"B.J.-B. Bréant","psa":"V.V. Vyazovskiy","ptype":"article","src":"https://openalex.org/W7126079054","eid":"W7126079054"},{"id":"paper-w4413237112","cat":"papers","name":"Lysergic acid diethylamide inhibits status epilepticus and mortality in a mouse model of acute kainic acid-induced motor seizures","year":"2025","cit":0,"pfa":"Brenden Samuel Rabinovitch","psa":"Peter Louis Carlen","ptype":"article","src":"https://openalex.org/W4413237112","eid":"W4413237112"},{"id":"paper-w7212063617","cat":"papers","name":"188. A single high-dose acute injection of 5-MeO-DMT reverses stress-induced anhedonia in rats","year":"2026","cit":0,"pfa":"S Socolow","psa":"Gabriella Gobbi","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7212063617","eid":"W7212063617"},{"id":"paper-w7202299274","cat":"papers","name":"Preclinical Comparison of DMT and 5-MeO-DMT Reveals Behavioral Dissociation, Distinct TrkB Activation and Differential Plasticity Profiles","year":"2026","cit":0,"pfa":"Orr Shahar","psa":"Bernard Lerer","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7202299274","eid":"W7202299274"},{"id":"paper-w7211999847","cat":"papers","name":"Acute lysergic acid diethylamide induces a time-dependent shift toward hippocampal control of default mode network reorganization","year":"2026","cit":0,"pfa":"Fahd François Hilal","psa":"Md Taufiq Nasseef","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7211999847","eid":"W7211999847"},{"id":"paper-w2394585453","cat":"papers","name":"[Biochemical concept of experimental psychoses. I. Effects of lysergic acid diethylamide on humoral balance and on cerebral metabolism in the rabbit in vivo].","year":"1957","cit":0,"pfa":"J Cahn","psa":"Buret Jp","ptype":"article","src":"https://openalex.org/W2394585453","eid":"W2394585453"},{"id":"paper-w7128522737","cat":"papers","name":"Vaporizable Formulation of 5-MeO-DMT and THCV as Prophylactic or Therapeutic Agent for Treatment-Resistant Depression (TRD) and Anxiety Disorders","year":"2026","cit":0,"pfa":"Philippe Henry","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7128522737","eid":"W7128522737"},{"id":"paper-w7168022350","cat":"papers","name":"A source-preserving living dataset of psilocybin and psilocin publications, preprints, and trial records","year":"2026","cit":0,"pfa":"Christopher B. Germann","topics":["Reviews & meta-analyses"],"ptype":"dataset","src":"https://openalex.org/W7168022350","eid":"W7168022350"},{"id":"paper-w2289521170","cat":"papers","name":"Peyote and related alkaloids. Structure and synthesis of some new Krebs cycle conjugates of mescaline.","year":"1970","cit":0,"pfa":"G. J. KAPADIA","psa":"Henry Marshall Fales","ptype":"article","src":"https://openalex.org/W2289521170","eid":"W2289521170"},{"id":"paper-w7118009596","cat":"papers","name":"Mismatch between psilocybin-induced head-twitch behaviour and psilocin brain levels in mice","year":"2026","cit":0,"pfa":"F. Sellitti","psa":"Linda D. Simmler","ptype":"article","src":"https://openalex.org/W7118009596","eid":"W7118009596"},{"id":"paper-w609696539","cat":"papers","name":"D-Lysergic Acid Diethylamide(LSD25)による実験的精神障害","year":"1958","cit":0,"pfa":"俊実 石橋","ptype":"article","src":"https://openalex.org/W609696539","eid":"W609696539"},{"id":"paper-w4392523932","cat":"papers","name":"MDMA and Mescaline; What do We Know About Psychedelics and Their Potential Uses?","year":"2024","cit":0,"pfa":"Ammar G. Almorsy","psa":"Larissa L. Loukianova","ptype":"book-chapter","src":"https://openalex.org/W4392523932","eid":"W4392523932"},{"id":"paper-w4241628477","cat":"papers","name":"S.17.02 Lysergic acid diethylamide reverses anxious-like behaviour and modulates serotonergic neurotransmission in a chronic stress model","year":"2019","cit":0,"pfa":"D. De Gregorio","psa":"Gabriella Gobbi","ptype":"article","src":"https://openalex.org/W4241628477","eid":"W4241628477"},{"id":"paper-w7117984165","cat":"papers","name":"Hallucinogen persisting perception disorder in adolescence: a complex case of lysergic acid diethylamide-induced visual disturbances with trauma-associated exacerbation","year":"2026","cit":0,"pfa":"A. Fernandez Ribas","psa":"M. Paduraru","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7117984165","eid":"W7117984165"},{"id":"paper-w4295279548","cat":"papers","name":"P03-20 Ayahuasca and N,N-dimethyltryptamine (DMT): Toxicokinetics, toxicodynamics, and biological effects","year":"2022","cit":0,"pfa":"Áurea Madureira-Carvalho","psa":"Ricardo Jorge Dinis‐Oliveira","ptype":"article","src":"https://openalex.org/W4295279548","eid":"W4295279548"},{"id":"paper-w4408850776","cat":"papers","name":"Psilocybin and Psilocin Regulate Microglial Immunomodulation and Support Neuroplasticity Via Serotonergic and Ahr Signaling","year":"2025","cit":0,"pfa":"Salma Laabi","psa":"Victor  M. Jimenez Jr","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4408850776","eid":"W4408850776"},{"id":"paper-w7165820534","cat":"papers","name":"The forensic identification of N,N-Dimethyltryptamine in plant species commonly used in the preparation of ayahuasca","year":"2025","cit":0,"pfa":"Megan Rebecca Dunkle","ptype":"dissertation","src":"https://openalex.org/W7165820534","eid":"W7165820534"},{"id":"paper-w4230348939","cat":"papers","name":"Faculty Opinions recommendation of Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases.","year":"2014","cit":0,"pfa":"Dave Nichols","topics":["Anxiety & end-of-life","Safety & adverse events","Therapy practice"],"ptype":"peer-review","src":"https://openalex.org/W4230348939","eid":"W4230348939"},{"id":"paper-w7160927212","cat":"papers","name":"Cytochrome P450 Inhibition by Psilocybin and Psilocin: A Combined Molecular Dynamics and Enzymatic Screening Study","year":"2026","cit":0,"pfa":"Andreia Machado Brito-da-Costa","psa":"Diana Dias da Silva","ptype":"article","src":"https://openalex.org/W7160927212","eid":"W7160927212"},{"id":"paper-w4404398481","cat":"papers","name":"Psychedelic Therapy: A Primer for Primary Care Clinicians—N,N-Dimethyltryptamine and Ayahuasca: Erratum","year":"2024","cit":0,"ptype":"erratum","src":"https://openalex.org/W4404398481","eid":"W4404398481"},{"id":"paper-w7206025556","cat":"papers","name":"The prototypical hallucinogen lysergic acid diethylamide produces rapid antidepressant-like effects via 5-HT2B receptor activation in rats.","year":"2024","cit":0,"pfa":"Amel Bouloufa","psa":"Nasser Haddjeri","topics":["Depression","Mechanism & neuroscience"],"ptype":"conference-paper","src":"https://openalex.org/W7206025556","eid":"W7206025556"},{"id":"paper-w4413572055","cat":"papers","name":"Why the TGA should reschedule MDMA and psilocybin for the treatment of mental illness","year":"2021","cit":0,"pfa":"Sarah-Catherine Rodan","psa":"Samuel D. Banister","ptype":"other","src":"https://openalex.org/W4413572055","eid":"W4413572055"},{"id":"paper-w4389033926","cat":"papers","name":"Lysergic Acid Diethylamide (LSD) Modulates Circadian Activity Behavior And The Expression Level of Circadian Genes in Drosophila melanogaster in Both Sexes","year":"2016","cit":0,"pfa":"Kelly Jean Sherman","psa":"Charles David Nichols","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4389033926","eid":"W4389033926"},{"id":"paper-w2031313386","cat":"papers","name":"Enzyme capable of modifying d-lysergic acid diethylamide (LSD) in rabbit lymphoid cells and murine MOPC 315 myeloma cells","year":"1974","cit":0,"pfa":"Edward W. Voss","psa":"Nancy E. Cobb","ptype":"article","src":"https://openalex.org/W2031313386","eid":"W2031313386"},{"id":"paper-w7162504159","cat":"papers","name":"Therapeutic properties of ayahuasca component N,N-Dimethyltryptamine in a pre-clinical model of Parkinson's disease","year":"2026","cit":0,"pfa":"Javier Calleja‐Conde","psa":"Jose Angel Morales-Garcia","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7162504159","eid":"W7162504159"},{"id":"paper-w4413284771","cat":"papers","name":"661. A SINGLE DOSE OF LYSERGIC ACID DIETHYLAMIDE (LSD) REDUCES ALCOHOL CONSUMPTION AND REVERTS DOPAMINERGIC (DA) DISFUNCTION IN MALE MICE","year":"2025","cit":0,"pfa":"I Esquivel","psa":"Danilo De Gregorio","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4413284771","eid":"W4413284771"},{"id":"paper-w2434720526","cat":"papers","name":"[High affinity binding of 5-hydroxytryptamine to some membrane preparations from cattle brain. Relationship to lysergic acid diethylamide (LSD)].","year":"1977","cit":0,"pfa":"G. Fillion","psa":"J. Jacob","ptype":"other","src":"https://openalex.org/W2434720526","eid":"W2434720526"},{"id":"paper-w2582483187","cat":"papers","name":"PENERAPAN SANKSI BAGI PENGGUNA LSD (LYSERGIC ACID DIETHYLAMIDE) MENURUT UNDANG-UNDANG NOMOR 35 TAHUN 2009 TENTANG NARKOTIKA","year":"2015","cit":0,"pfa":"Bima Panca Putra","psa":"Npm. ........","ptype":"dissertation","src":"https://openalex.org/W2582483187","eid":"W2582483187"},{"id":"paper-w3108330716","cat":"papers","name":"P.668 Lysergic acid diethylamide (LSD) modulates social behavior and neuronal activity of pyramidal neurons in the medial prefrontal cortex","year":"2020","cit":0,"pfa":"Antonio Inserra","psa":"Gabriella Gobbi","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3108330716","eid":"W3108330716"},{"id":"paper-w2490168900","cat":"papers","name":"EFFECT OF LYSERGIC ACID DIETHYLAMIDE (LSD) AND ITS BROMO DERIVATIVE (BOL) ON THE CONTRACTIONS OF ISOLATED RAT UTERUS ELICITED BY DIFFERENT SUBSTANCES","year":"1978","cit":0,"pfa":"MIROSLAV DRAŠKOCI","psa":"S.K. Krstić","topics":["Addiction"],"ptype":"conference-abstract","src":"https://openalex.org/W2490168900","eid":"W2490168900"},{"id":"paper-w7117895209","cat":"papers","name":"Neural Signatures of Lysergic Acid Diethylamide–Induced Subjective Experience Identified via Connectome-Based Predictive Modeling: analysis code","year":"2026","cit":0,"pfa":"Olivia M. F. Rapp","psa":"David Bohnert","topics":["Mechanism & neuroscience"],"ptype":"software","src":"https://openalex.org/W7117895209","eid":"W7117895209"},{"id":"paper-w3205112733","cat":"papers","name":"Non-Traditional Psychotherapy Techniques: An Assessment of the Value of MDMA, Psilocybin and LSD.","year":"2021","cit":0,"pfa":"Madison Hagood","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W3205112733","eid":"W3205112733"},{"id":"paper-w4410702676","cat":"papers","name":"Psilocin","year":"2025","cit":0,"pfa":"T Arndt","ptype":"book-chapter","src":"https://openalex.org/W4410702676","eid":"W4410702676"},{"id":"paper-w2791528259","cat":"papers","name":"Mesencephalic raphe nuclei regulation of afferent input to the lateral geniculate : dependence upon endogenous serotonin and antagonism by lysergic acid diethylamide","year":"1974","cit":0,"pfa":"David Russell Humpherys","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W2791528259","eid":"W2791528259"},{"id":"paper-w7212163068","cat":"papers","name":"Neural Signatures of Lysergic Acid Diethylamide–Induced Subjective Experience Identified via Connectome-Based Predictive Modeling: analysis code","year":"2026","cit":0,"pfa":"Olivia M. F. Rapp","psa":"David Bohnert","topics":["Mechanism & neuroscience"],"ptype":"software","src":"https://openalex.org/W7212163068","eid":"W7212163068"},{"id":"paper-w7166881515","cat":"papers","name":"Meskalin / Mescaline","year":"2026","cit":0,"pfa":"Schüller Thomas","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7166881515","eid":"W7166881515"},{"id":"paper-w4391298347","cat":"papers","name":"Psychedelic dabbling: The fleeting exploration of mescaline, LSD, and psilocybin by French medicine in the 20th century","year":"2023","cit":0,"pfa":"Zoë Dubus","psa":"Vincent Verroust","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4391298347","eid":"W4391298347"},{"id":"paper-w2417407333","cat":"papers","name":"[Nuclear anomalies appearing after phytohemagglutinin stimulation at the level of baboon Papio papio lymphocytes submitted to lysergic acid diethylamide (L.S.D.) injection].","year":"1970","cit":0,"pfa":"Jacques Ruffié","psa":"J Ducos","ptype":"article","src":"https://openalex.org/W2417407333","eid":"W2417407333"},{"id":"paper-w7166847786","cat":"papers","name":"Meskalin / Mescaline","year":"2026","cit":0,"pfa":"Schüller Thomas","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7166847786","eid":"W7166847786"},{"id":"paper-w2950793211","cat":"papers","name":"MOTIVASI PENYALAHGUNAAN LEM PEREKAT YANG MENGANDUNG LYSERGIC ACID DIETHYLAMIDE PADA REMAJA MENURUT KAJIAN MODEL SISTEM PERILAKU JOHNSON","year":"2019","cit":0,"pfa":"Rahel A. Kululu","psa":"Andi Buanasari","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2950793211","eid":"W2950793211"},{"id":"paper-w2320160775","cat":"papers","name":"σ2-Receptor mediates spinal monosynaptic reflex depressant effects of 5-MeO-DMT, a hallucinogenic DMT analog, in rats","year":"2010","cit":0,"pfa":"Shohei Yamamoto","psa":"Hideki Ono","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2320160775","eid":"W2320160775"},{"id":"paper-w4245176755","cat":"papers","name":"Psilocin","year":"2007","cit":0,"ptype":"reference-entry","src":"https://openalex.org/W4245176755","eid":"W4245176755"},{"id":"paper-w4249155057","cat":"papers","name":"Ibogaine","year":"2018","cit":0,"ptype":"article","src":"https://openalex.org/W4249155057","eid":"W4249155057"},{"id":"paper-w4394475207","cat":"papers","name":"Dataset: Effects of ketamine optical isomers, psilocybin, psilocin and norpsilocin on time estimation and cognition in rats","year":"2021","cit":0,"pfa":"Piotr Popik","psa":"Joanna Gołębiowska","ptype":"dataset","src":"https://openalex.org/W4394475207","eid":"W4394475207"},{"id":"paper-w2420324434","cat":"papers","name":"[Blockade of dextran-anuria in water deprived rats through the serotonin antagonists lysergic acid diethylamide and 1-methyl-lysergic acid butanolamide].","year":"1967","cit":0,"pfa":"J Táborský","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2420324434","eid":"W2420324434"},{"id":"paper-w7117971173","cat":"papers","name":"Psilocybin and ibogaine as therapeutic candidates for cocaine addiction: Insights from a rat self-administration model","year":"2026","cit":0,"pfa":"I.R.A. Koutrouli","psa":"Tomáš Páleníček","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7117971173","eid":"W7117971173"},{"id":"paper-w4417245537","cat":"papers","name":"Psilocybin and MDMA in Couples Therapy: Investigating Treatment for Substance Use Disorders and Codependency","year":"2025","cit":0,"pfa":"Samuel Hosford","psa":"Heather Austin-Robillard","topics":["PTSD & trauma","Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4417245537","eid":"W4417245537"},{"id":"paper-w4393715746","cat":"papers","name":"Long-COVID Symptoms Improved after MDMA and Psilocybin Therapy: a case report","year":"2024","cit":0,"pfa":"Harman Chopra","psa":"Joel P Castellanos","ptype":"preprint","src":"https://openalex.org/W4393715746","eid":"W4393715746"},{"id":"paper-w4416948795","cat":"papers","name":"Mescaline","year":"2000","cit":0,"pfa":"John C M Brust","topics":["Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W4416948795","eid":"W4416948795"},{"id":"paper-w4410860617","cat":"papers","name":"Mescaline","year":"2025","cit":0,"pfa":"Abby L’Heureux","psa":"Erika Dyck","topics":["Addiction","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W4410860617","eid":"W4410860617"},{"id":"paper-w2472142467","cat":"papers","name":"[Effects of 5-hydroxytryptamine (5HT), D-lysergic acid diethylamide (LSD 25), phenobarbital, nembutal, and two derivatives of phenothiazine on cerebral metabolism in vivo].","year":"1957","cit":0,"pfa":"J Cahn","psa":"Buret Jp","ptype":"article","src":"https://openalex.org/W2472142467","eid":"W2472142467"},{"id":"paper-w2399588739","cat":"papers","name":"[Effect of vagotomy and lysergic acid diethylamide (LSD) on ulcerogenic action of phenylbutazone and reserpine in rats with regard to the role of 5-hydroxytryptamine (author's transl)].","year":"1977","cit":0,"pfa":"A Kohút","psa":"Andrej Nicák","ptype":"article","src":"https://openalex.org/W2399588739","eid":"W2399588739"},{"id":"paper-w4384519750","cat":"papers","name":"Mescaline","year":"2023","cit":0,"pfa":"Timothy J. Wiegand","ptype":"reference-entry","src":"https://openalex.org/W4384519750","eid":"W4384519750"},{"id":"paper-w202332923","cat":"papers","name":"Primera Jornada de Diálogos entre Medicinas: (Iboga, hoja de coca, San Pedro, ayahuasca)","year":"2009","cit":0,"pfa":"Federico Paz","ptype":"article","src":"https://openalex.org/W202332923","eid":"W202332923"},{"id":"paper-w2503618471","cat":"papers","name":"DIFFERENCES IN BINDING OF 3H 5-HYDROXYTRYPTAMINE (5-HT) AND 3H LYSERGIC ACID DIETHYLAMIDE (LSD) TO SPECIFIC SEROTONINERGIC SITES IN SYNAPTOSOMAL MEMBRANE PREPARATIONS","year":"1978","cit":0,"pfa":"G. Fillion","psa":"J. Jacob","topics":["Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W2503618471","eid":"W2503618471"},{"id":"paper-w4237564249","cat":"papers","name":"Mescaline","year":"2014","cit":0,"pfa":"J.D. Slothower","psa":"T.J. Wiegand","ptype":"reference-entry","src":"https://openalex.org/W4237564249","eid":"W4237564249"},{"id":"paper-w4410860630","cat":"papers","name":"Ibogaine","year":"2025","cit":0,"pfa":"Carlee Fountaine","psa":"Tobias Erny","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W4410860630","eid":"W4410860630"},{"id":"paper-w2411183322","cat":"papers","name":"[Experimental study of the effect of large doses of lysergic acid diethylamide (LSD 25) on lymphocytic reactivity with phytohemagglutinin and on baboon (Papio papio) karyotype].","year":"1972","cit":0,"pfa":"Jacques Ruffié","psa":"Jean J Grozdea","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2411183322","eid":"W2411183322"},{"id":"paper-w2891458222","cat":"papers","name":"“STAIRWAY TO HEAVEN”: LYSERGIC ACID DIETHYLAMIDE (LSD) AND ALCOHOLICS ANONYMOUS (AA) AS A THERAPY FOR PROBLEM DRINKING IN MIDTWENTIETH CENTURY SASKATCHEWAN, 1953-1968","year":"2018","cit":0,"pfa":"Michael James Christopher Lyons","topics":["Addiction","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W2891458222","eid":"W2891458222"},{"id":"paper-w4390271928","cat":"papers","name":"Psychedelic Therapy: A Primer for Primary Care Clinicians – Part III. N,N-dimethyltryptamine (DMT) and Ayahuasca","year":"2023","cit":0,"pfa":"Kenneth Shinozuka","psa":"Owen S. Muir","topics":["Depression","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4390271928","eid":"W4390271928"},{"id":"paper-w4243992361","cat":"papers","name":"Faculty Opinions recommendation of Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects.","year":"2021","cit":0,"pfa":"Linda A. Parker","topics":["Dosing & pharmacology"],"ptype":"peer-review","src":"https://openalex.org/W4243992361","eid":"W4243992361"},{"id":"paper-w4407827351","cat":"papers","name":"Correction: Clinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post‑Hoc Analysis","year":"2025","cit":0,"pfa":"Marije E. Otto","psa":"J. G. Coen van Hasselt","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"erratum","src":"https://openalex.org/W4407827351","eid":"W4407827351"},{"id":"paper-w4254291291","cat":"papers","name":"Psilocin","year":"2019","cit":0,"pfa":"Axel M. Gressner","psa":"Torsten Arndt","ptype":"book-chapter","src":"https://openalex.org/W4254291291","eid":"W4254291291"},{"id":"paper-w2950567313","cat":"papers","name":"ChemInform Abstract: STUDIES ON LYSERGIC ACID DIETHYLAMIDE AND RELATED COMPOUNDS. IV. SYNTHESES OF F VARIOUS AMIDE DERIVATIVES OF NORLYSERGIC ACID AND RELATED COMPOUNDS","year":"1976","cit":0,"pfa":"Tetsukichi Niwaguchi","psa":"Hisashi Ishii","ptype":"article","src":"https://openalex.org/W2950567313","eid":"W2950567313"},{"id":"paper-w4249710185","cat":"papers","name":"Ibogaine","year":"2009","cit":0,"pfa":"&NA;","ptype":"article","src":"https://openalex.org/W4249710185","eid":"W4249710185"},{"id":"paper-w4249139328","cat":"papers","name":"Iboga","year":"2010","cit":0,"pfa":"Angelika Prentner","ptype":"book-chapter","src":"https://openalex.org/W4249139328","eid":"W4249139328"},{"id":"paper-w2302418544","cat":"papers","name":"The zebrafish (Danio rerio) as a highly sensitive tool for screening hallucinogenic drug action: Lessons from mescaline and salvinorin A","cit":0,"pfa":"Collins, Christopher J.","topics":["Addiction","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W2302418544","eid":"W2302418544"},{"id":"paper-w4390223345","cat":"papers","name":"Phase 1 study results on the effects of 5-MeO-DMT benzoate on facial emotion processing in psychedelic-naïve healthy subjects","year":"2023","cit":0,"pfa":"Asad Malik","psa":"C. Roberts","ptype":"article","src":"https://openalex.org/W4390223345","eid":"W4390223345"},{"id":"paper-w2951668562","cat":"papers","name":"ChemInform Abstract: PEYOTE AND RELATED ALKALOIDS PART 16, SYNTHESIS OF 3,4,5‐TRIMETHOXYPHENYLALANIN, AN AMINO ACID ANALOG OF MESCALINE","year":"1974","cit":0,"pfa":"Manohar L. Sethi","psa":"G. J. KAPADIA","ptype":"article","src":"https://openalex.org/W2951668562","eid":"W2951668562"},{"id":"paper-w4253706562","cat":"papers","name":"Peyote","year":"2007","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W4253706562","eid":"W4253706562"},{"id":"paper-w4255033226","cat":"papers","name":"Mescaline","year":"2006","cit":0,"ptype":"reference-entry","src":"https://openalex.org/W4255033226","eid":"W4255033226"},{"id":"paper-w4416193258","cat":"papers","name":"Comparative Efficacy of Psilocybin and MDMA in PTSD Treatment: A Systematic Review of Long-Term Outcomes","year":"2025","cit":0,"pfa":"Presley Aspen","psa":"Jennifer Mitchell","topics":["PTSD & trauma","Addiction","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4416193258","eid":"W4416193258"},{"id":"paper-w4234100041","cat":"papers","name":"Mescaline*","year":"2005","cit":0,"pfa":"Christopher P. Holstege","ptype":"reference-entry","src":"https://openalex.org/W4234100041","eid":"W4234100041"},{"id":"paper-w4242695934","cat":"papers","name":"Peyote","year":"2012","cit":0,"pfa":"Peter N. Jones","ptype":"reference-entry","src":"https://openalex.org/W4242695934","eid":"W4242695934"},{"id":"paper-w4249354501","cat":"papers","name":"Ibogaine","year":"2012","cit":0,"pfa":"&NA;","ptype":"article","src":"https://openalex.org/W4249354501","eid":"W4249354501"},{"id":"paper-w1487904120","cat":"papers","name":"Platelet Serotonin (5-HT)2A Receptor Binding Sites in Affective Disorders: A Quantitative Receptor Autoradiographic Study with [ 125I ] Lysergic Acid Diethylamide","year":"1998","cit":0,"pfa":"Tsujimura Toru","psa":"Masaki Hayashida","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1487904120","eid":"W1487904120"},{"id":"paper-w4244099642","cat":"papers","name":"Peyote","year":"2008","cit":0,"pfa":"Richard T. Schaefer","ptype":"reference-entry","src":"https://openalex.org/W4244099642","eid":"W4244099642"},{"id":"paper-w7198383219","cat":"papers","name":"Could Toad Venom Inhalation Cure a Suffering Mind? : A Literature Review on the Long-term Effects of 5-MeO-DMT on Mental Health","year":"2023","cit":0,"pfa":"Ville Salmensuu","topics":["PTSD & trauma","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7198383219","eid":"W7198383219"},{"id":"paper-w4416150213","cat":"papers","name":"Dimethyltryptamine and harmine, components of ayahuasca, prevented cocaine-induced apoptosis in SH-SY5Y human neuroblastoma cells","year":"2025","cit":0,"pfa":"Gabriela Salles","psa":"Raphael Caio Tamborelli Garcia","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4416150213","eid":"W4416150213"},{"id":"paper-w4299412662","cat":"papers","name":"hERG Blockade by Iboga Alkaloids","year":"2020","cit":0,"pfa":"N. Liu","psa":"Fowler, S.J.","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4299412662","eid":"W4299412662"},{"id":"paper-w4400575417","cat":"papers","name":"Involvement of 5-HT2A and 5-HT1A Receptors in the Pharmacological Effects of 5-MeO-DMT Analogs in Male C57BL/6J Mice","year":"2024","cit":0,"pfa":"Grant C. Glatfelter","psa":"Michael H. Baumann","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4400575417","eid":"W4400575417"},{"id":"paper-w4407076385","cat":"papers","name":"International Drug Policy Study Trends With Psychedelic Drugs: A Spotlight on Psilocybin, LSD, and MDMA","year":"2025","cit":0,"pfa":"Myfanwy Graham","psa":"David G. Hammond","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4407076385","eid":"W4407076385"},{"id":"paper-w4244833252","cat":"papers","name":"Ibogaine","year":"2018","cit":0,"ptype":"article","src":"https://openalex.org/W4244833252","eid":"W4244833252"},{"id":"paper-w4307040962","cat":"papers","name":"Ibogaine","year":"2022","cit":0,"ptype":"article","src":"https://openalex.org/W4307040962","eid":"W4307040962"},{"id":"paper-w4206400717","cat":"papers","name":"Ibogaine","year":"1998","cit":0,"pfa":"Jacqueline C. Wootton","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4206400717","eid":"W4206400717"},{"id":"paper-w4235024160","cat":"papers","name":"Ibogaine","year":"2013","cit":0,"ptype":"article","src":"https://openalex.org/W4235024160","eid":"W4235024160"},{"id":"paper-w4393037878","cat":"papers","name":"Problems of Qualification of Trafficking in Plants and Plant Parts Containing Psychoactive Substances and Mushrooms Containing Psilocybin and (or) Psilocin","year":"2024","cit":0,"pfa":"Aleksandr V. Kulikov","psa":"Ilya Yu. Zheleznyak","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4393037878","eid":"W4393037878"},{"id":"paper-w2487894849","cat":"papers","name":"IBOGAINE, TABERNANTHINE AND MESCALINE ON MECHANICAL RESPONSES OF RAT ISOLATED PORTAL VEIN. INFLUENCE OF CALCIUM AMOUNT VARIATIONS IN THE MILIEU","year":"1978","cit":0,"pfa":"G Valette","psa":"Leclair Mf","ptype":"conference-abstract","src":"https://openalex.org/W2487894849","eid":"W2487894849"},{"id":"paper-w7212056415","cat":"papers","name":"805. Rapid Antidepressant-Like Effects of 5-MeO-DMT Require Both 5-HT 1A and 5-HT 2A Receptors","year":"2026","cit":0,"pfa":"B Richardson","psa":"Gabriella Gobbi","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W7212056415","eid":"W7212056415"},{"id":"paper-w7129735452","cat":"papers","name":"In Vitro Metabolism of 1‐Benzoyl‐Lysergic Acid Diethylamide (1Bz‐LSD) and Identification of a Deethylated Metabolite (1Bz‐LAE) Using a Synthesized Reference Standard","year":"2026","cit":0,"pfa":"Yuki Azuma","psa":"Takahiro Doi","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7129735452","eid":"W7129735452"},{"id":"paper-w4240074514","cat":"papers","name":"Iboga","year":"2007","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W4240074514","eid":"W4240074514"},{"id":"paper-w4238214599","cat":"papers","name":"Ibogaine","year":"2017","cit":0,"ptype":"article","src":"https://openalex.org/W4238214599","eid":"W4238214599"},{"id":"paper-w4241496310","cat":"papers","name":"Peyote","year":"2007","cit":0,"ptype":"reference-entry","src":"https://openalex.org/W4241496310","eid":"W4241496310"},{"id":"paper-w4205309930","cat":"papers","name":"Peyote*","year":"2005","cit":0,"pfa":"Amanda Lofton","ptype":"reference-entry","src":"https://openalex.org/W4205309930","eid":"W4205309930"},{"id":"paper-w4241543584","cat":"papers","name":"Peyote","year":"2009","cit":0,"pfa":"Paul Finkelman","psa":"Tim Alan Garrison","ptype":"reference-entry","src":"https://openalex.org/W4241543584","eid":"W4241543584"},{"id":"paper-w7166860331","cat":"papers","name":"DMT und Ayahuasca / DMT and Ayahuasca","year":"2026","cit":0,"pfa":"Schüller Thomas","ptype":"article","src":"https://openalex.org/W7166860331","eid":"W7166860331"},{"id":"paper-w764129845","cat":"papers","name":"Electroencephalographic and behavioral effects of 4-phosphoryloxy N, N-dimethyltryptamine (psilocybin) on the New Zealand albino rabbit","year":"1977","cit":0,"pfa":"James Edward Guest","ptype":"dissertation","src":"https://openalex.org/W764129845","eid":"W764129845"},{"id":"paper-w4236129297","cat":"papers","name":"Iboga","year":"1956","cit":0,"ptype":"article","src":"https://openalex.org/W4236129297","eid":"W4236129297"},{"id":"paper-w948601357","cat":"papers","name":"El alucinógeno 5-MeO-DMT reduce las oscilaciones lentas (<4Hz) en corteza prefrontal. Reversión por fármacos antipsicóticos","year":"2011","cit":0,"pfa":"Maurizio S. Riga","psa":"Pau Celada","ptype":"article","src":"https://openalex.org/W948601357","eid":"W948601357"},{"id":"paper-w4249580749","cat":"papers","name":"Ibogaine","year":"2014","cit":0,"ptype":"article","src":"https://openalex.org/W4249580749","eid":"W4249580749"},{"id":"paper-w4249576151","cat":"papers","name":"Ibogaine","year":"2016","cit":0,"pfa":"Jason Jalil","ptype":"reference-entry","src":"https://openalex.org/W4249576151","eid":"W4249576151"},{"id":"paper-w4248401247","cat":"papers","name":"Dimethyltryptamine","year":"2006","cit":0,"ptype":"reference-entry","src":"https://openalex.org/W4248401247","eid":"W4248401247"},{"id":"paper-w2296203535","cat":"papers","name":"Platelet serotonin (5-HT)2A receptor binding sites in affective disorders : a quantitative receptor autoradiographic study with [125I]lysergic acid diethylamide","year":"1999","cit":0,"pfa":"辻村徹","topics":["Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W2296203535","eid":"W2296203535"},{"id":"paper-w2463186299","cat":"papers","name":"[Influence of serotonin, phenothiazine derivatives, steroids and tranquilizing agents on electroencephalography of rabbits intoxicated by lysergic acid diethylamide. II. Action on the arousal reaction produced by LSD].","year":"1957","cit":0,"pfa":"R PIERRE","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2463186299","eid":"W2463186299"},{"id":"paper-w4255472420","cat":"papers","name":"Mescaline","year":"2007","cit":0,"ptype":"reference-entry","src":"https://openalex.org/W4255472420","eid":"W4255472420"},{"id":"paper-w4391281514","cat":"papers","name":"Peyote","year":"2024","cit":0,"pfa":"Alexander Dawson","ptype":"reference-entry","src":"https://openalex.org/W4391281514","eid":"W4391281514"},{"id":"paper-w4401785710","cat":"papers","name":"Mescaline","year":"2024","cit":0,"ptype":"reference-entry","src":"https://openalex.org/W4401785710","eid":"W4401785710"},{"id":"paper-w4240514970","cat":"papers","name":"Mescaline","year":"2015","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W4240514970","eid":"W4240514970"},{"id":"paper-w4413457503","cat":"papers","name":"Neuroimaging Documentation of Psychedelic Drugs Effect on the Brain: DMT, LSD, Psilocybin, and Ibogaine as Examples: A Mini Review","year":"2022","cit":0,"topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4413457503","eid":"W4413457503"},{"id":"paper-w4417363285","cat":"papers","name":"Advances in Psychedelic Therapeutics: Multimodal Iboga Analogs, EEG-Guided Psilocybin Dosing, and Optimized Harmine–DMT Formulations","year":"2025","cit":0,"pfa":"Anna C. Renner","psa":"Robert B. Kargbo","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"editorial","src":"https://openalex.org/W4417363285","eid":"W4417363285"},{"id":"paper-w635636315","cat":"papers","name":"Lysergic acid diethylamide(LSD)の試験紙による簡易検出法について","year":"1970","cit":0,"pfa":"徹吉 丹羽口","ptype":"article","src":"https://openalex.org/W635636315","eid":"W635636315"},{"id":"paper-w4232941022","cat":"papers","name":"Ibogaine","year":"2013","cit":0,"ptype":"article","src":"https://openalex.org/W4232941022","eid":"W4232941022"},{"id":"paper-w4251607167","cat":"papers","name":"Ibogaine","year":"2018","cit":0,"ptype":"article","src":"https://openalex.org/W4251607167","eid":"W4251607167"},{"id":"paper-w4236676798","cat":"papers","name":"Dimethyltryptamine","year":"2007","cit":0,"pfa":"Stephen Erhorn","ptype":"book-chapter","src":"https://openalex.org/W4236676798","eid":"W4236676798"},{"id":"paper-w4236603302","cat":"papers","name":"Dimethyltryptamine","year":"2015","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W4236603302","eid":"W4236603302"},{"id":"paper-w4361245242","cat":"papers","name":"Ayahuasca","year":"2023","cit":0,"pfa":"Daniel Perkins","psa":"Jerome J. Sarris","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"book-chapter","src":"https://openalex.org/W4361245242","eid":"W4361245242"},{"id":"paper-w4411170776","cat":"papers","name":"« Ayahuasca sans ayahuasca »","year":"2025","cit":0,"pfa":"José López Sánchez","psa":"Silvia Mesturini Cappo","ptype":"article","src":"https://openalex.org/W4411170776","eid":"W4411170776"},{"id":"paper-w2413596989","cat":"papers","name":"[Contribution to a biochemical concept of experimental psychoses. VIII. Effect of iproniazid (marsilid), desoxyephedrine (pervitin) & lysergic acid diethylamide on blood & cerebral metabolism in the conscious rabbit].","year":"1958","cit":0,"pfa":"J Cahn","psa":"Y BRETON","ptype":"article","src":"https://openalex.org/W2413596989","eid":"W2413596989"},{"id":"paper-w4237429696","cat":"papers","name":"Ibogaine","year":"2013","cit":0,"ptype":"article","src":"https://openalex.org/W4237429696","eid":"W4237429696"},{"id":"paper-w4243027998","cat":"papers","name":"Peyote","year":"2020","cit":0,"pfa":"Virgil Zeigler‐Hill","psa":"Todd K. Shackelford","ptype":"reference-entry","src":"https://openalex.org/W4243027998","eid":"W4243027998"},{"id":"paper-w7166567380","cat":"papers","name":"MDMA and psilocybin therapy rules have been relaxed. Here’s what might happen next","year":"2026","cit":0,"pfa":"Thileepan Naren","psa":"Myfanwy Graham","ptype":"other","src":"https://openalex.org/W7166567380","eid":"W7166567380"},{"id":"paper-w4250906982","cat":"papers","name":"Ibogaine","year":"2014","cit":0,"ptype":"article","src":"https://openalex.org/W4250906982","eid":"W4250906982"},{"id":"paper-w4242368688","cat":"papers","name":"Ibogaine","year":"2020","cit":0,"ptype":"article","src":"https://openalex.org/W4242368688","eid":"W4242368688"},{"id":"paper-w7162833360","cat":"papers","name":"Investigating Visually Induced Long-Term Potentiation and Peripheral BDNF as Biomarkers of Plasticity Changes in Major Depressive Disorder Following Repeated Microdosing with Lysergic Acid Diethylamide","year":"2026","cit":0,"pfa":"Boglarka Varga","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7162833360","eid":"W7162833360"},{"id":"paper-w4246620885","cat":"papers","name":"Ibogaine overdose","year":"2015","cit":0,"topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4246620885","eid":"W4246620885"},{"id":"paper-w4295279481","cat":"papers","name":"P03-18 Simultaneous detection and quantification of psilocybin and psilocin by gas chromatography coupled to mass spectrometry (GC-MS)","year":"2022","cit":0,"pfa":"Andreia Machado Brito-da-Costa","psa":"Diana Dias da Silva","ptype":"article","src":"https://openalex.org/W4295279481","eid":"W4295279481"},{"id":"paper-w4230791422","cat":"papers","name":"Ibogaine","year":"2021","cit":0,"ptype":"article","src":"https://openalex.org/W4230791422","eid":"W4230791422"},{"id":"paper-w4302201434","cat":"papers","name":"Mescaline.","year":"1972","cit":0,"pfa":"R K Olney","ptype":"article","src":"https://openalex.org/W4302201434","eid":"W4302201434"},{"id":"paper-w4254512367","cat":"papers","name":"Ibogaine","year":"2018","cit":0,"ptype":"article","src":"https://openalex.org/W4254512367","eid":"W4254512367"},{"id":"paper-w4236131761","cat":"papers","name":"Mescaline","year":"2020","cit":0,"pfa":"Virgil Zeigler-Hill","psa":"Todd K. Shackelford","ptype":"reference-entry","src":"https://openalex.org/W4236131761","eid":"W4236131761"},{"id":"paper-w4405636234","cat":"papers","name":"Pharmacological characterization of psilocin affinity towards different 5-HT receptors and receptor regulation after psilocybin administration in pigs","year":"2024","cit":0,"pfa":"E. Kolesnik","psa":"Hanne Demant Hansen","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4405636234","eid":"W4405636234"},{"id":"paper-w4205205626","cat":"papers","name":"Peyote","year":"2012","cit":0,"ptype":"reference-entry","src":"https://openalex.org/W4205205626","eid":"W4205205626"},{"id":"paper-w7213370563","cat":"papers","name":"Psilocybin and ayahuasca in treatment-resistant depression: clinical evidence, methodological constraints and ethical challenges: a narrative review","year":"2026","cit":0,"pfa":"Serena Chiara Civardi","psa":"Miriam Olivola","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7213370563","eid":"W7213370563"},{"id":"paper-w7167607963","cat":"papers","name":"α2-Adrenergic receptor modulates 5-HT2A-mediated behavioral effects of MDMA and psilocybin in mice","year":"2026","cit":0,"pfa":"Axel Fogaça Rosado","psa":"Alfred P. Kaye","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7167607963","eid":"W7167607963"},{"id":"paper-w4233360779","cat":"papers","name":"Ibogaine","year":"2013","cit":0,"ptype":"article","src":"https://openalex.org/W4233360779","eid":"W4233360779"},{"id":"paper-w4384866365","cat":"papers","name":"psilocin, n.","year":"2023","cit":0,"ptype":"reference-entry","src":"https://openalex.org/W4384866365","eid":"W4384866365"},{"id":"paper-w3117155932","cat":"papers","name":"Biosynthesis of salvinorin A","year":"2020","cit":0,"pfa":"Elena Ostrozhenkova","ptype":"conference-paper","src":"https://openalex.org/W3117155932","eid":"W3117155932"},{"id":"paper-w2161173481","cat":"papers","name":"A Study of Peyote","year":"1968","cit":0,"pfa":"Louann McLain","ptype":"article","src":"https://openalex.org/W2161173481","eid":"W2161173481"},{"id":"paper-w4254119432","cat":"papers","name":"Iboga — Alkaloide","year":"1964","cit":0,"pfa":"Manfred Hesse","ptype":"book-chapter","src":"https://openalex.org/W4254119432","eid":"W4254119432"},{"id":"paper-w4408085457","cat":"papers","name":"Is the mere absence of dimethyltryptamine in hair evidence of ayahuasca non-exposure? Development of an LC-MS/MS method for the comprehensive quantification of β-carbolines and tryptamines in hair","year":"2025","cit":0,"pfa":"Nadia Arbouche","psa":"Pascal Kintz","ptype":"article","src":"https://openalex.org/W4408085457","eid":"W4408085457"},{"id":"paper-w4245265343","cat":"papers","name":"Psilocybin","year":"2018","cit":0,"pfa":"C. Vidal","psa":"W.-R. Külpmann","ptype":"book-chapter","src":"https://openalex.org/W4245265343","eid":"W4245265343"},{"id":"paper-w4231913784","cat":"papers","name":"Mescaline.","year":"1973","cit":0,"pfa":"National Clearinghouse for Drug Abuse Information, Rockville, MD","ptype":"dataset","src":"https://openalex.org/W4231913784","eid":"W4231913784"},{"id":"paper-w982134632","cat":"papers","name":"Antipsychotic drugs reverse the disruption in prefrontal cortex function produced by the serotonergic hallucinogen 5-Methoxy-N,N-Dimethyltriptamine (5-MeO-DMT)","year":"2012","cit":0,"pfa":"Pau Celada","psa":"Francesc Artigas","topics":["Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W982134632","eid":"W982134632"},{"id":"paper-w7141839089","cat":"papers","name":"Effects of Psychedelics Lysergic Acid Diethylamide and R (–)-2,5-Dimethoxy-4-Iodoamphetamine on Oral Opioid Consumption and Naloxone-Precipitated Withdrawal in Male C57Bl/6J Mice","year":"2026","cit":0,"pfa":"Levi Neal","psa":"William E. Fantegrossi","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7141839089","eid":"W7141839089"},{"id":"paper-w2291571846","cat":"papers","name":"Lysergic Acid Diethylamide(LSD25)による実験的精神障碍時の脳波所見","year":"1959","cit":0,"pfa":"宏一郎 白橋","ptype":"dissertation","src":"https://openalex.org/W2291571846","eid":"W2291571846"},{"id":"paper-w4251597211","cat":"papers","name":"Chocolate Mescaline","year":"2020","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W4251597211","eid":"W4251597211"},{"id":"paper-w4205719215","cat":"papers","name":"Peyote Ceremony","year":"2009","cit":0,"pfa":"Richard W. Voss","psa":"Robert Prue","ptype":"reference-entry","src":"https://openalex.org/W4205719215","eid":"W4205719215"},{"id":"paper-w4413793753","cat":"papers","name":"Peyote Songs","year":"2013","cit":0,"ptype":"reference-entry","src":"https://openalex.org/W4413793753","eid":"W4413793753"},{"id":"paper-w4410860704","cat":"papers","name":"Ayahuasca","year":"2025","cit":0,"pfa":"Anjna Chauhan","psa":"S. Vinod Kumar","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W4410860704","eid":"W4410860704"},{"id":"paper-w2254218420","cat":"papers","name":"The determination of the formation of the carpophores and sclerotia in culture of Psilocybe mexicana Heim, a Mexican, hallucinogenic agaric, and the demonstration of the presence of psilocybin and psilocin.","year":"1958","cit":0,"pfa":"Richard R. Heim","psa":"Roger Cailleux","ptype":"article","src":"https://openalex.org/W2254218420","eid":"W2254218420"},{"id":"paper-w4245869734","cat":"papers","name":"Peyote","year":"2010","cit":0,"pfa":"Angelika Prentner","ptype":"book-chapter","src":"https://openalex.org/W4245869734","eid":"W4245869734"},{"id":"paper-w7166876974","cat":"papers","name":"DMT und Ayahuasca / DMT and Ayahuasca","year":"2026","cit":0,"pfa":"Schüller Thomas","ptype":"article","src":"https://openalex.org/W7166876974","eid":"W7166876974"},{"id":"paper-w4408376371","cat":"papers","name":"PSYCHEDELIC PHARMACOLOGY IN PSYCHIATRY: THE MECHANISMS AND THERAPEUTIC POTENTIAL OF PSILOCYBIN, MDMA, AND LSD IN MENTAL HEALTH DISORDERS","year":"2025","cit":0,"pfa":"Dr Hafiz Shafique Ahmad","psa":"Usman Ul Haq","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4408376371","eid":"W4408376371"},{"id":"paper-w7105889485","cat":"papers","name":"[RESEARCH PROTOCOL] Evaluation of Interpersonal Perceptual Content Synchrony in Induced Altered States of Consciousness (Lysergic Acid Diethylamide - LSD): A High-Fidelity, Short-Duration Study.","year":"2025","cit":0,"pfa":"Brandon Tavares Machado","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7105889485","eid":"W7105889485"},{"id":"paper-w4246946458","cat":"papers","name":"Peyote Ceremony","year":"2012","cit":0,"ptype":"reference-entry","src":"https://openalex.org/W4246946458","eid":"W4246946458"},{"id":"paper-w4395051157","cat":"papers","name":"The Peyote Road","year":"2024","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W4395051157","eid":"W4395051157"},{"id":"paper-w4242662787","cat":"papers","name":"Peyote Religion","year":"2020","cit":0,"pfa":"Richard W. Voss","psa":"Robert Prue","ptype":"reference-entry","src":"https://openalex.org/W4242662787","eid":"W4242662787"},{"id":"paper-w4312826865","cat":"papers","name":"Tabernanthe iboga","year":"2019","cit":0,"pfa":"CABI","ptype":"dataset","src":"https://openalex.org/W4312826865","eid":"W4312826865"},{"id":"paper-w4230132243","cat":"papers","name":"Ibogaine overdose","year":"2020","cit":0,"topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4230132243","eid":"W4230132243"},{"id":"paper-w4234014119","cat":"papers","name":"Ibogaine overdose","year":"2015","cit":0,"topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4234014119","eid":"W4234014119"},{"id":"paper-w4223570461","cat":"papers","name":"Faculty Opinions recommendation of Repeated lysergic acid diethylamide (LSD) reverses stress-induced anxiety-like behavior, cortical synaptogenesis deficits and serotonergic neurotransmission decline.","year":"2022","cit":0,"pfa":"Harriet de Wit","topics":["Anxiety & end-of-life"],"ptype":"peer-review","src":"https://openalex.org/W4223570461","eid":"W4223570461"},{"id":"paper-w3039795292","cat":"papers","name":"Mescaline Addiction and Treatment | Mescaline Side Effects","year":"2017","cit":0,"pfa":"Mark Adams","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W3039795292","eid":"W3039795292"},{"id":"paper-w7152709192","cat":"papers","name":"Influence du contexte d'administration sur les effets pharmacologiques des psychédéliques diméthyltryptamine (DMT) et 5-méthoxy-diméthyltryptamine (5-MeO-DMT)","year":"2025","cit":0,"pfa":"Romain Hacquet","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7152709192","eid":"W7152709192"},{"id":"paper-w7134124833","cat":"papers","name":"Noribogaine CNS Drug Design Analysis","year":"2025","cit":0,"pfa":"Robert Likic","psa":"Ana Špljarić","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"dataset","src":"https://openalex.org/W7134124833","eid":"W7134124833"},{"id":"paper-w4249188778","cat":"papers","name":"Peyote drum","year":"2014","cit":0,"pfa":"David P. McAllester","ptype":"reference-entry","src":"https://openalex.org/W4249188778","eid":"W4249188778"},{"id":"paper-w4246436478","cat":"papers","name":"Haloperidol/ibogaine","year":"2015","cit":0,"ptype":"article","src":"https://openalex.org/W4246436478","eid":"W4246436478"},{"id":"paper-w2978178425","cat":"papers","name":"The Peyote Ceremony","year":"2013","cit":0,"pfa":"Joseph D. Calabrese","ptype":"book-chapter","src":"https://openalex.org/W2978178425","eid":"W2978178425"},{"id":"paper-w2029649801","cat":"papers","name":"Synthesis of Salvinorin A","year":"2007","cit":0,"pfa":"Jonathan R. Scheerer","psa":"David Albert Evans","topics":["Addiction","Mechanism & neuroscience"],"ptype":"editorial","src":"https://openalex.org/W2029649801","eid":"W2029649801"},{"id":"paper-w3139973346","cat":"papers","name":"Ibogaine and addiction","year":"2013","cit":0,"pfa":"Roman Paškulin","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W3139973346","eid":"W3139973346"},{"id":"paper-w7125802797","cat":"papers","name":"A dispersive liquid–liquid microextraction method for the determination of ayahuasca alkaloids (N,N-dimethyltryptamine and β-carbolines) in human hair","year":"2026","cit":0,"pfa":"Fabiana Pereira Santos","psa":"Maurı́cio Yonamine","ptype":"article","src":"https://openalex.org/W7125802797","eid":"W7125802797"},{"id":"paper-w7171448148","cat":"papers","name":"MDMA and Psilocybin-Assisted Therapy in Australia: Early Real-World Prescribing, Safety Monitoring and Regulatory Developments","year":"2026","cit":0,"pfa":"Octavian Victor Brinzei","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W7171448148","eid":"W7171448148"},{"id":"paper-w4245571256","cat":"papers","name":"Iboga-Alkaloide","year":"1968","cit":0,"pfa":"Manfred Hesse","ptype":"book-chapter","src":"https://openalex.org/W4245571256","eid":"W4245571256"},{"id":"paper-w4385098465","cat":"papers","name":"ibogaine, n.","year":"2023","cit":0,"ptype":"reference-entry","src":"https://openalex.org/W4385098465","eid":"W4385098465"},{"id":"paper-w7167910493","cat":"papers","name":"Advancing Next-Generation Psychedelic Therapeutics through Selective 5-HT2A Activation, Precision Aerosol Delivery, and Optimized 5-MeO-DMT Treatment Paradigms","year":"2026","cit":0,"pfa":"Anna C. Renner","psa":"Robert B. Kargbo","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"editorial","src":"https://openalex.org/W7167910493","eid":"W7167910493"},{"id":"paper-w4387482738","cat":"papers","name":"The Struggle for Peyote","year":"2016","cit":0,"pfa":"Fannie Kahan","ptype":"book-chapter","src":"https://openalex.org/W4387482738","eid":"W4387482738"},{"id":"paper-w2274881989","cat":"papers","name":"[Mescaline and psychotherapy].","year":"1966","cit":0,"pfa":"DANIELLE M. TURNS","psa":"Herman C.B. Denber","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2274881989","eid":"W2274881989"},{"id":"paper-w4318330615","cat":"papers","name":"Peyote and Amphetamines","year":"2009","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W4318330615","eid":"W4318330615"},{"id":"paper-w4235379749","cat":"papers","name":"Peyote Religion","year":"2009","cit":0,"pfa":"Richard W. Voss","psa":"Robert Prue","ptype":"reference-entry","src":"https://openalex.org/W4235379749","eid":"W4235379749"},{"id":"paper-w4390222148","cat":"papers","name":"Neurodynamics of empathy and prosociality following serotonergic stimulation with an ayahuasca analogue containing N,N-dimethyltryptamine and harmine in a randomised controlled trial","year":"2023","cit":0,"pfa":"Helena Aicher","psa":"Milan Scheidegger","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4390222148","eid":"W4390222148"},{"id":"paper-w2269625584","cat":"papers","name":"Lysergic Acid Diethylamide及び関連化合物の代謝産物の化学的研究","year":"1976","cit":0,"pfa":"雄二 中原","ptype":"dissertation","src":"https://openalex.org/W2269625584","eid":"W2269625584"},{"id":"paper-w4253210348","cat":"papers","name":"Botany of Peyote","year":"1996","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W4253210348","eid":"W4253210348"},{"id":"paper-w2971032480","cat":"papers","name":"The Peyote Cult","year":"2008","cit":0,"pfa":"Paul Radin","psa":"Paul Radin","ptype":"book","src":"https://openalex.org/W2971032480","eid":"W2971032480"},{"id":"paper-w2596648162","cat":"papers","name":"Pszichedelikumok és kvázi-pszichedelikumok a modern kutatások tükrében: orvosi kannabisz, MDMA, szalvinorin A, ibogain és ayahuasca","year":"2015","cit":0,"pfa":"Attila Szabó","psa":"Zoltán Brys","ptype":"article","src":"https://openalex.org/W2596648162","eid":"W2596648162"},{"id":"paper-w4230097603","cat":"papers","name":"Peyote Rituals","year":"2006","cit":0,"pfa":"H. James Birx","ptype":"reference-entry","src":"https://openalex.org/W4230097603","eid":"W4230097603"},{"id":"paper-w4234494356","cat":"papers","name":"Peyote-Kult","year":"2015","cit":0,"pfa":"Elio Masferrer","ptype":"reference-entry","src":"https://openalex.org/W4234494356","eid":"W4234494356"},{"id":"paper-w4240737312","cat":"papers","name":"Ibogaine abuse","year":"2014","cit":0,"ptype":"article","src":"https://openalex.org/W4240737312","eid":"W4240737312"},{"id":"paper-w4244847447","cat":"papers","name":"Peyote rattle","year":"2016","cit":0,"pfa":"David P. McAllester","ptype":"reference-entry","src":"https://openalex.org/W4244847447","eid":"W4244847447"},{"id":"paper-w4251937244","cat":"papers","name":"Peyote Woman","year":"2016","cit":0,"pfa":"James Treat","ptype":"article","src":"https://openalex.org/W4251937244","eid":"W4251937244"},{"id":"paper-w4394359198","cat":"papers","name":"With-ayahuasca","year":"2022","cit":0,"pfa":"Caroline L. Alves","ptype":"dataset","src":"https://openalex.org/W4394359198","eid":"W4394359198"},{"id":"paper-w7116943670","cat":"papers","name":"Ayahuasca","year":"2025","cit":0,"pfa":"Larissa Carneiro","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7116943670","eid":"W7116943670"},{"id":"paper-w4290979953","cat":"papers","name":"[Ayahuasca].","year":"1998","cit":0,"pfa":"De Alvarez De Toledo","ptype":"article","src":"https://openalex.org/W4290979953","eid":"W4290979953"},{"id":"paper-w586155906","cat":"papers","name":"d-lysergic acid diethylamide投与時の家兎脳の電子顕微鏡学的研究","year":"1969","cit":0,"pfa":"正毅 吉田","ptype":"dissertation","src":"https://openalex.org/W586155906","eid":"W586155906"},{"id":"paper-w7113029112","cat":"papers","name":"Taking a Trip into Nature’s Medicine Cabinet: A Country Comparison of Efforts to Reschedule Psilocybin and MDMA for Therapeutic Use","year":"2025","cit":0,"pfa":"Jones, Ariyah","ptype":"article","src":"https://openalex.org/W7113029112","eid":"W7113029112"},{"id":"paper-w7212087255","cat":"papers","name":"475. Psilocin pharmacokinetics and exposure-response relationships in Japanese patients with treatment-resistant depression receiving psilocybin therapy: an open-label study","year":"2026","cit":0,"pfa":"K Kusudo","psa":"H Uchida","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7212087255","eid":"W7212087255"},{"id":"paper-w4394477190","cat":"papers","name":"No-ayahuasca","year":"2022","cit":0,"pfa":"Caroline L. Alves","ptype":"dataset","src":"https://openalex.org/W4394477190","eid":"W4394477190"},{"id":"paper-w4242305733","cat":"papers","name":"MDMA","year":"2007","cit":0,"pfa":"Anthony J. Baucum","psa":"Annette E. Fleckenstein","ptype":"book-chapter","src":"https://openalex.org/W4242305733","eid":"W4242305733"},{"id":"paper-w4235019956","cat":"papers","name":"Peyote drum","year":"2016","cit":0,"pfa":"David P. McAllester","psa":"J. Richard Haefer","ptype":"reference-entry","src":"https://openalex.org/W4235019956","eid":"W4235019956"},{"id":"paper-w7155634218","cat":"papers","name":"Acute Effects of 4-Bromo-2,5-Dimethoxyphenethylamine (2C-B) Compared With Psilocybin and MDMA in Healthy Participants","year":"2026","cit":0,"pfa":"Friederike Holze","psa":"Matthias E. Liechti","ptype":"article","src":"https://openalex.org/W7155634218","eid":"W7155634218"},{"id":"paper-w4230945015","cat":"papers","name":"Chemístry of Peyote","year":"1996","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W4230945015","eid":"W4230945015"},{"id":"paper-w4253100639","cat":"papers","name":"Peyote Religion","year":"2012","cit":0,"ptype":"reference-entry","src":"https://openalex.org/W4253100639","eid":"W4253100639"},{"id":"paper-w4231437453","cat":"papers","name":"Ibogaine overdose","year":"2016","cit":0,"topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4231437453","eid":"W4231437453"},{"id":"paper-w4297241149","cat":"papers","name":"Mescaline (c)","year":"2011","cit":0,"topics":["Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W4297241149","eid":"W4297241149"},{"id":"paper-w4234435473","cat":"papers","name":"Taming ibogaine","year":"2020","cit":0,"pfa":"Bethany A. Halford","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"other","src":"https://openalex.org/W4234435473","eid":"W4234435473"},{"id":"paper-w2414330180","cat":"papers","name":"A Sunday with mescaline.","year":"1959","cit":0,"pfa":"P B SMITH","ptype":"article","src":"https://openalex.org/W2414330180","eid":"W2414330180"},{"id":"paper-w7204580494","cat":"papers","name":"Development of a Physiologically Based Pharmacokinetic/Pharmacodynamic Model of Psilocybin/Psilocin from Psilocybe cubensis (Magic Mushroom) in Treatment-Resistant Depression","year":"2026","cit":0,"pfa":"Nilubon Thaoboonruang","psa":"Manupat Lohitnavy","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7204580494","eid":"W7204580494"},{"id":"paper-w4230047094","cat":"papers","name":"In vitrostudies on metabolism of salvinorin A","year":"2009","cit":0,"pfa":"Lukasz M. Kutrzeba","psa":"Jordan Kordian Zjawiony","ptype":"article","src":"https://openalex.org/W4230047094","eid":"W4230047094"},{"id":"paper-w4246362238","cat":"papers","name":"Peyote Hunt.","year":"1975","cit":0,"pfa":"Sherri Cavan","psa":"Barbara G. Myerhoff","ptype":"article","src":"https://openalex.org/W4246362238","eid":"W4246362238"},{"id":"paper-w4255780046","cat":"papers","name":"Peyote rattle","year":"2014","cit":0,"pfa":"Mary Riemer-Weller","ptype":"reference-entry","src":"https://openalex.org/W4255780046","eid":"W4255780046"},{"id":"paper-w1604392214","cat":"papers","name":"Geologia Estructural del Anticlinal Peyotes (IN SPANISH), Sturctural Geology of The Peyotes Anticline","year":"1952","cit":0,"pfa":"Teodoro Diaz","ptype":"article","src":"https://openalex.org/W1604392214","eid":"W1604392214"},{"id":"paper-w4214568415","cat":"papers","name":"Peyote Intoxication","year":"1927","cit":0,"pfa":"P. P.","ptype":"article","src":"https://openalex.org/W4214568415","eid":"W4214568415"},{"id":"paper-w4243971300","cat":"papers","name":"Ayahuasca","year":"2020","cit":0,"pfa":"Virgil Zeigler-Hill","psa":"Todd K. Shackelford","ptype":"reference-entry","src":"https://openalex.org/W4243971300","eid":"W4243971300"},{"id":"paper-w4406757780","cat":"papers","name":"Tabernanthe iboga Baill. Apocynaceae","year":"2025","cit":0,"pfa":"Emmanuel Muhumuza","psa":"Godwin Anywar","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W4406757780","eid":"W4406757780"},{"id":"paper-w2332903567","cat":"papers","name":"Pharmacognosy of Ayahuasca","year":"2011","cit":0,"pfa":"LJ Standish","psa":"SA Barker","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2332903567","eid":"W2332903567"},{"id":"paper-w4320517554","cat":"papers","name":"Peyote Queen","year":"1965","cit":0,"ptype":"other","src":"https://openalex.org/W4320517554","eid":"W4320517554"},{"id":"paper-w4232063587","cat":"papers","name":"Pharmacoloģy of Peyote","year":"1996","cit":0,"topics":["Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W4232063587","eid":"W4232063587"},{"id":"paper-w4241162818","cat":"papers","name":"Peyote Ceremoníes","year":"1996","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W4241162818","eid":"W4241162818"},{"id":"paper-w4384752683","cat":"papers","name":"mescaline, n.","year":"2023","cit":0,"ptype":"reference-entry","src":"https://openalex.org/W4384752683","eid":"W4384752683"},{"id":"paper-w7104529227","cat":"papers","name":"Ibogaine: An Update","year":"2023","cit":0,"pfa":"Sameš, Dalibor","ptype":"article","src":"https://openalex.org/W7104529227","eid":"W7104529227"},{"id":"paper-w4235853802","cat":"papers","name":"Ayahuasca","year":"2020","cit":0,"pfa":"Raquel Consul","psa":"María G. Campos","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W4235853802","eid":"W4235853802"},{"id":"paper-w2610577155","cat":"papers","name":"The hallucinogen 5-MeO-DMT simultaneously alters oscillatory activity in prefrontal and visual cortex: regionally-selective reversal by risperidone and 5-HT1A-R receptor blockade","year":"2016","cit":0,"pfa":"Pau Celada","psa":"Francesc Artigas","topics":["Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W2610577155","eid":"W2610577155"},{"id":"paper-w4240237969","cat":"papers","name":"Iboga alkaloid stereochemistry confirmed","year":"1967","cit":0,"topics":["Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W4240237969","eid":"W4240237969"},{"id":"paper-w7204483735","cat":"papers","name":"Synthesis and Analytical Characterization of 1‐(1,2‐Dimethylcyclobutane‐1‐Carbonyl)‐Lysergic Acid Diethylamide (1D‐LSD) and Differentiation From 1‐(Thiophene‐2‐Carbonyl)‐LSD (1T‐LSD)","year":"2026","cit":0,"pfa":"Yuki Okada","psa":"Masanobu Uchiyama","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7204483735","eid":"W7204483735"},{"id":"paper-w2789987702","cat":"papers","name":"Lysergic Acid Diethylamideおよび関連化合物の代謝産物の化学的研究","year":"1976","cit":0,"pfa":"雄二 中原","ptype":"dissertation","src":"https://openalex.org/W2789987702","eid":"W2789987702"},{"id":"paper-w4232614564","cat":"papers","name":"Peyote Religion","year":"2013","cit":0,"pfa":"Richard W. Voss","psa":"Robert Prue","ptype":"reference-entry","src":"https://openalex.org/W4232614564","eid":"W4232614564"},{"id":"paper-w4384865997","cat":"papers","name":"peyote, n.","year":"2023","cit":0,"ptype":"reference-entry","src":"https://openalex.org/W4384865997","eid":"W4384865997"},{"id":"paper-w3012020243","cat":"papers","name":"The Peyote Cult","year":"1961","cit":0,"pfa":"Omer C. Stewart","ptype":"article","src":"https://openalex.org/W3012020243","eid":"W3012020243"},{"id":"paper-w4319075102","cat":"papers","name":"PEYOTE FRONTIER","year":"2023","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W4319075102","eid":"W4319075102"},{"id":"paper-w7213623885","cat":"papers","name":"Psilocybin","year":"2026","cit":0,"ptype":"article","src":"https://openalex.org/W7213623885","eid":"W7213623885"},{"id":"paper-w4391978673","cat":"papers","name":"Ayahuasca","year":"2011","cit":0,"ptype":"other","src":"https://openalex.org/W4391978673","eid":"W4391978673"},{"id":"paper-w3004104242","cat":"papers","name":"Development of a Microcrystal Test For The Detection of Psilocin","year":"2019","cit":0,"pfa":"Jacqueline Davila (7976654)","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W3004104242","eid":"W3004104242"},{"id":"paper-w4414759679","cat":"papers","name":"Consistency of protocol and safety data reporting in clinical trial registrations and corresponding publications of interventions involving MDMA and psilocybin","year":"2025","cit":0,"pfa":"Marija Franka Žuljević","psa":"Diana Gujinović","topics":["Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4414759679","eid":"W4414759679"},{"id":"paper-w3082052599","cat":"papers","name":"Clinical and forensic aspects of ibogaine","year":"2020","cit":0,"pfa":"Ana Catarina Freitas Belo","topics":["Addiction","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W3082052599","eid":"W3082052599"},{"id":"paper-w2001269415","cat":"papers","name":"Ibogaine ‐ poison or panacea?","year":"2004","cit":0,"pfa":"Gary E. Hayes","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2001269415","eid":"W2001269415"},{"id":"paper-w2581029732","cat":"papers","name":"Chapter 7. Peyote","year":"2016","cit":0,"pfa":"Dan Choffnes","ptype":"book-chapter","src":"https://openalex.org/W2581029732","eid":"W2581029732"},{"id":"paper-w4395063098","cat":"papers","name":"PSILOCYBIN","year":"2024","cit":0,"pfa":"Brad Necyk","ptype":"book-chapter","src":"https://openalex.org/W4395063098","eid":"W4395063098"},{"id":"paper-w4247128208","cat":"papers","name":"Peyote ín Mexíco","year":"1996","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W4247128208","eid":"W4247128208"},{"id":"paper-w4312534256","cat":"papers","name":"Mushrooms, psilocybin","year":"2022","cit":0,"pfa":"Milad Tavassoli","psa":"Ramin Rezaee","ptype":"reference-entry","src":"https://openalex.org/W4312534256","eid":"W4312534256"},{"id":"paper-w4241528206","cat":"papers","name":"Psilocybin","year":"2020","cit":0,"pfa":"Virgil Zeigler‐Hill","psa":"Todd K. Shackelford","ptype":"reference-entry","src":"https://openalex.org/W4241528206","eid":"W4241528206"},{"id":"paper-w2007219990","cat":"papers","name":"Peyote: The Divine Cactus","year":"1981","cit":0,"pfa":"Joseph L. Zentner","ptype":"article","src":"https://openalex.org/W2007219990","eid":"W2007219990"},{"id":"paper-w4287167964","cat":"papers","name":"IN DURBAN @ +27782782201 IBOGAIN HCL FOR SALE IN DURBAN , IBOGA CAPSULES , IBOGA ROOT BARKS AND POWDER FO SALE IN DURBAN","year":"2021","cit":0,"pfa":"Nicole","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4287167964","eid":"W4287167964"},{"id":"paper-w4414592477","cat":"papers","name":"Mindset Over Molecule: Comparing Self-Transcendent and Mystical Experiences Across Recreational Psilocybin, MDMA, and Cannabis Use","year":"2025","cit":0,"pfa":"Christina Chwyl","psa":"Jason B. Luoma","ptype":"preprint","src":"https://openalex.org/W4414592477","eid":"W4414592477"},{"id":"paper-w4244126237","cat":"papers","name":"Peyote Cult","year":"2014","cit":0,"pfa":"Elio Masferrer","ptype":"dataset","src":"https://openalex.org/W4244126237","eid":"W4244126237"},{"id":"paper-w2562850345","cat":"papers","name":"The Timeline of Peyote","year":"2016","cit":0,"pfa":"Eric Edelson","ptype":"article","src":"https://openalex.org/W2562850345","eid":"W2562850345"},{"id":"paper-w4231033334","cat":"papers","name":"Peyote Ceremony","year":"2020","cit":0,"pfa":"Richard W. Voss","psa":"Robert Prue","ptype":"reference-entry","src":"https://openalex.org/W4231033334","eid":"W4231033334"},{"id":"paper-w4403305546","cat":"papers","name":"Allaying the fears: Midomafetamine with therapy is a medicine","year":"2024","cit":0,"pfa":"David John Nutt","psa":"Anne Katrin Schlag","ptype":"editorial","src":"https://openalex.org/W4403305546","eid":"W4403305546"},{"id":"paper-w7119469464","cat":"papers","name":"Psilocybin","year":"2025","cit":0,"ptype":"article","src":"https://openalex.org/W7119469464","eid":"W7119469464"},{"id":"paper-w7125195175","cat":"papers","name":"Mindset over molecule: comparing self-transcendent and mystical experiences across recreational psilocybin, MDMA, and cannabis use","year":"2026","cit":0,"pfa":"Christina Chwyl","psa":"Jason B. Luoma","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7125195175","eid":"W7125195175"},{"id":"paper-w2588034139","cat":"papers","name":"Ibogaine and addiction","year":"2013","cit":0,"pfa":"TRoman Paskulin","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2588034139","eid":"W2588034139"},{"id":"paper-w4391771677","cat":"papers","name":"Noribogaine effects on wakefulness and sleep","year":"2024","cit":0,"pfa":"J.P. Castro","psa":"Joaqúın González","ptype":"article","src":"https://openalex.org/W4391771677","eid":"W4391771677"},{"id":"paper-w2796185666","cat":"papers","name":"Salvinorin interaction with the cannabinoid system","year":"2008","cit":0,"pfa":"Cinzia Guidali","psa":"Tiziana Rubino","ptype":"article","src":"https://openalex.org/W2796185666","eid":"W2796185666"},{"id":"paper-w4401813485","cat":"papers","name":"Psilocybin may be as effective as escitalopram in treating depression, study suggests","year":"2024","cit":0,"topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4401813485","eid":"W4401813485"},{"id":"paper-w7148586112","cat":"papers","name":"Tabernanthe iboga Baill.","year":"2026","cit":0,"pfa":"Royal Botanic Garden Edinburgh","ptype":"dataset","src":"https://openalex.org/W7148586112","eid":"W7148586112"},{"id":"paper-w4242145229","cat":"papers","name":"Leģal Aspects of Peyote","year":"1996","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W4242145229","eid":"W4242145229"},{"id":"paper-w4247574399","cat":"papers","name":"Ibogaine neurotoxic in rodents.","year":"1993","cit":0,"pfa":"&NA;","ptype":"article","src":"https://openalex.org/W4247574399","eid":"W4247574399"},{"id":"paper-w4233146192","cat":"papers","name":"DIMETHYLTRYPTAMINE AND PSYCHOSIS","year":"1974","cit":0,"ptype":"article","src":"https://openalex.org/W4233146192","eid":"W4233146192"},{"id":"paper-w4383220557","cat":"papers","name":"Mushroom, Psilocybin","year":"2023","cit":0,"pfa":"Timothy J. Wiegand","ptype":"reference-entry","src":"https://openalex.org/W4383220557","eid":"W4383220557"},{"id":"paper-w4210353217","cat":"papers","name":"Ibogaine/various drugs","year":"2012","cit":0,"pfa":"&NA;","ptype":"article","src":"https://openalex.org/W4210353217","eid":"W4210353217"},{"id":"paper-w4242389606","cat":"papers","name":"Psilocybin","year":"2016","cit":0,"pfa":"Andrew Hund","ptype":"reference-entry","src":"https://openalex.org/W4242389606","eid":"W4242389606"},{"id":"paper-w4404640461","cat":"papers","name":"Psilocybin","year":"2024","cit":0,"ptype":"article","src":"https://openalex.org/W4404640461","eid":"W4404640461"},{"id":"paper-w904861741","cat":"papers","name":"Justification of Legalized Peyote","year":"2009","cit":0,"pfa":"Faith Roncoroni","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W904861741","eid":"W904861741"},{"id":"paper-w4290847766","cat":"papers","name":"[PSILOCYBIN].","year":"1960","cit":0,"ptype":"article","src":"https://openalex.org/W4290847766","eid":"W4290847766"},{"id":"paper-w4412377523","cat":"papers","name":"Psilocybin","year":"2025","cit":0,"ptype":"article","src":"https://openalex.org/W4412377523","eid":"W4412377523"},{"id":"paper-w3006918587","cat":"papers","name":"In the Magic Land of Peyote","year":"1976","cit":0,"pfa":"THOMAS B. HINTON","ptype":"article","src":"https://openalex.org/W3006918587","eid":"W3006918587"},{"id":"paper-w7167596473","cat":"papers","name":"XÂY DỰNG PHƯƠNG PHÁP ĐỊNH LƯỢNG PSILOCIN VÀ PSILOCYBIN TRONG HUYẾT TƯƠNG NGƯỜI BẰNG LC-MS/MS","year":"2026","cit":0,"pfa":"Trần Nguyên Hà","psa":"Vu Ngan Binh","ptype":"article","src":"https://openalex.org/W7167596473","eid":"W7167596473"},{"id":"paper-w4401787743","cat":"papers","name":"Psilocybin","year":"2024","cit":0,"ptype":"reference-entry","src":"https://openalex.org/W4401787743","eid":"W4401787743"},{"id":"paper-w2947028796","cat":"papers","name":"The Effects of LSD and Psilocin on Anxiety-Related Behaviours in Zebrafish","year":"2017","cit":0,"pfa":"Anne Walley","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2947028796","eid":"W2947028796"},{"id":"paper-w7154071906","cat":"papers","name":"Ayahuasca Çayı Nedir? Ayahuasca Çayı Neden Tehlikeli?","year":"2026","cit":0,"topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7154071906","eid":"W7154071906"},{"id":"paper-w4307470650","cat":"papers","name":"One. Peyote frontier","year":"2022","cit":0,"pfa":"Thomas Crow","ptype":"book-chapter","src":"https://openalex.org/W4307470650","eid":"W4307470650"},{"id":"paper-w2952691126","cat":"papers","name":"A Facile Method for the Preparation of Deuterium Labeled Salvinorin A: Synthesis of [2,2,2‐2H3]‐Salvinorin A.","year":"2005","cit":0,"pfa":"Kevin Joseph Tidgewell","psa":"Thomas Edward Prisinzano","ptype":"article","src":"https://openalex.org/W2952691126","eid":"W2952691126"},{"id":"paper-w4254420490","cat":"papers","name":"MDMA","year":"2000","cit":0,"pfa":"Gerhard Stumm","psa":"Univ.-Prof. Dr. Alfred Pritz","ptype":"book-chapter","src":"https://openalex.org/W4254420490","eid":"W4254420490"},{"id":"paper-w7203571612","cat":"papers","name":"Psilocybin","year":"2026","cit":0,"pfa":"Jennifer E. Thomas","psa":"Juhi Saxena","ptype":"book-chapter","src":"https://openalex.org/W7203571612","eid":"W7203571612"},{"id":"paper-w4253462461","cat":"papers","name":"Psilocybin occupancy of brain serotonin 2A receptors correlates with psilocin levels and subjective experience: a [11C]Cimbi-36 PET study in humans","year":"2018","cit":0,"pfa":"Patrick M. Fisher","psa":"Gitte M. Knudsen","topics":["Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W4253462461","eid":"W4253462461"},{"id":"paper-w2396969269","cat":"papers","name":"[Isolation of oxymescaline and mescaline].","year":"1952","cit":0,"pfa":"Alfred Dornow","psa":"G Petsch","ptype":"article","src":"https://openalex.org/W2396969269","eid":"W2396969269"},{"id":"paper-w2791689520","cat":"papers","name":"Texas Peyote Culture","year":"2018","cit":0,"pfa":"Kevin Feeney","ptype":"article","src":"https://openalex.org/W2791689520","eid":"W2791689520"},{"id":"paper-w3206624536","cat":"papers","name":"6.3 CURRENT RESEARCH ON PSILOCYBIN TREATMENT ON END-OF-LIFE ANXIETY AND MDMA TREATMENT OF SOCIAL ANXIETY IN AUTISM SPECTRUM DISORDER","year":"2021","cit":0,"pfa":"Charles S. Grob","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3206624536","eid":"W3206624536"},{"id":"paper-w4300090699","cat":"papers","name":"Editorial: Dimethyltryptamine and psychosis.","year":"1974","cit":0,"ptype":"editorial","src":"https://openalex.org/W4300090699","eid":"W4300090699"},{"id":"paper-w4384939491","cat":"papers","name":"MDMA and the Military","year":"2023","cit":0,"pfa":"Torsten Passie","topics":["Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W4384939491","eid":"W4384939491"},{"id":"paper-w2314440309","cat":"papers","name":"Cheyenne Peyote Songs","year":"1977","cit":0,"pfa":"David P. McAllester","ptype":"article","src":"https://openalex.org/W2314440309","eid":"W2314440309"},{"id":"paper-w156569773","cat":"papers","name":"Peyote en casa","year":"1999","cit":0,"pfa":"Joaquim Tarinas","psa":"Julio Mogrovejo","ptype":"article","src":"https://openalex.org/W156569773","eid":"W156569773"},{"id":"paper-w4361245257","cat":"papers","name":"MDMA","year":"2023","cit":0,"pfa":"Michael C. Mithoefer","psa":"David E. Presti","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"book-chapter","src":"https://openalex.org/W4361245257","eid":"W4361245257"},{"id":"paper-w4410433343","cat":"papers","name":"Psilocybin","year":"2025","cit":0,"pfa":"Helga Peter","psa":"Jan Giso Peter","ptype":"book-chapter","src":"https://openalex.org/W4410433343","eid":"W4410433343"},{"id":"paper-w4407031608","cat":"papers","name":"Antipsychotics and Mescaline Disposition","year":"1974","cit":0,"pfa":"K.C. L.","ptype":"article","src":"https://openalex.org/W4407031608","eid":"W4407031608"},{"id":"paper-w2328654550","cat":"papers","name":"The Kiowa Peyote Meeting","year":"1975","cit":0,"pfa":"James H. Howard","psa":"HARRY H. SMITH","ptype":"article","src":"https://openalex.org/W2328654550","eid":"W2328654550"},{"id":"paper-w1528527760","cat":"papers","name":"Ibogaine (Tabernanthe ibogaBaill.)","year":"2012","cit":0,"pfa":"Donald G. Barceloux","topics":["Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W1528527760","eid":"W1528527760"},{"id":"paper-w7214241914","cat":"papers","name":"Effect of Peyote on Human Chromosomes","year":"1975","cit":0,"pfa":"David Dorrance","ptype":"article","src":"https://openalex.org/W7214241914","eid":"W7214241914"},{"id":"paper-w4300552542","cat":"papers","name":"Psilocybin.","year":"1972","cit":0,"pfa":"D Mulkey","ptype":"article","src":"https://openalex.org/W4300552542","eid":"W4300552542"},{"id":"paper-w7160664972","cat":"papers","name":"Preclinical evaluation of psilocybin and related compounds: Inhibition of cytochrome P450 isoforms","year":"2026","cit":0,"pfa":"Mariana Silva‐Carvalho","psa":"Diana Dias-da-Silva","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7160664972","eid":"W7160664972"},{"id":"paper-w7162185233","cat":"papers","name":"Psilocybin","year":"2026","cit":0,"ptype":"article","src":"https://openalex.org/W7162185233","eid":"W7162185233"},{"id":"paper-w4206069913","cat":"papers","name":"MDMA","year":"2006","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W4206069913","eid":"W4206069913"},{"id":"paper-w4316114806","cat":"papers","name":"Psilocybin","year":"2023","cit":0,"ptype":"article","src":"https://openalex.org/W4316114806","eid":"W4316114806"},{"id":"paper-w4240058282","cat":"papers","name":"Psilocybin","year":"2007","cit":0,"ptype":"reference-entry","src":"https://openalex.org/W4240058282","eid":"W4240058282"},{"id":"paper-w7162514711","cat":"papers","name":"Ayahuasca / yagé","year":"2025","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W7162514711","eid":"W7162514711"},{"id":"paper-w4322495897","cat":"papers","name":"Ayahuasca in Uruguay","year":"2023","cit":0,"pfa":"Juan Scuro","psa":"Sebastián Torterola","topics":["Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W4322495897","eid":"W4322495897"},{"id":"paper-w7117974763","cat":"papers","name":"Ayahuasca on Stage","year":"2025","cit":0,"pfa":"Richard G. Alexander","ptype":"book-chapter","src":"https://openalex.org/W7117974763","eid":"W7117974763"},{"id":"paper-w7148845918","cat":"papers","name":"Tabernanthe iboga Baill.","year":"2026","cit":0,"pfa":"Royal Botanic Garden Edinburgh","ptype":"dataset","src":"https://openalex.org/W7148845918","eid":"W7148845918"},{"id":"paper-w7203671592","cat":"papers","name":"Mescaline vs. Muskellunge","year":"1966","cit":0,"pfa":"Charles L. Todd","ptype":"article","src":"https://openalex.org/W7203671592","eid":"W7203671592"},{"id":"paper-w1500226011","cat":"papers","name":"Mescaliner - Willow Spree","year":"2012","cit":0,"pfa":"Andy Brown","ptype":"article","src":"https://openalex.org/W1500226011","eid":"W1500226011"},{"id":"paper-w4243656111","cat":"papers","name":"The Feminization of Ayahuasca","year":"2009","cit":0,"pfa":"Evgenia Fotiou","ptype":"dataset","src":"https://openalex.org/W4243656111","eid":"W4243656111"},{"id":"paper-w4414241298","cat":"papers","name":"ayahuasca, n.","year":"2025","cit":0,"ptype":"reference-entry","src":"https://openalex.org/W4414241298","eid":"W4414241298"},{"id":"paper-w4399265178","cat":"papers","name":"Fear and Loathing about Ibogaine","year":"2024","cit":0,"pfa":"Leon Gussow","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4399265178","eid":"W4399265178"},{"id":"paper-w2969420234","cat":"papers","name":"To the Roots: Me, My Brother, Heroin and Iboga","year":"2019","cit":0,"pfa":"Sagit Mezamer","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2969420234","eid":"W2969420234"},{"id":"paper-w4245377477","cat":"papers","name":"Diazepam/methadone/Tabernanthe iboga","year":"2014","cit":0,"ptype":"article","src":"https://openalex.org/W4245377477","eid":"W4245377477"},{"id":"paper-w4254760097","cat":"papers","name":"DMT und Ayahuasca","year":"2021","cit":0,"topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4254760097","eid":"W4254760097"},{"id":"paper-w4232614984","cat":"papers","name":"MDMA","year":"2006","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W4232614984","eid":"W4232614984"},{"id":"paper-w4239248494","cat":"papers","name":"Psilocybin","year":"2019","cit":0,"pfa":"C. Vidal","psa":"W.-R. Külpmann","ptype":"book-chapter","src":"https://openalex.org/W4239248494","eid":"W4239248494"},{"id":"paper-w4410860622","cat":"papers","name":"Psilocybin","year":"2025","cit":0,"pfa":"Jessi Humphreys","psa":"Charles S. Grob","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"book-chapter","src":"https://openalex.org/W4410860622","eid":"W4410860622"},{"id":"paper-w2410112020","cat":"papers","name":"In reply – on the toxicity of ibogaine","year":"2016","cit":0,"pfa":"Tibor M. Brunt","psa":"Ruud P. W. Litjens","topics":["Safety & adverse events"],"ptype":"letter","src":"https://openalex.org/W2410112020","eid":"W2410112020"},{"id":"paper-w4410860573","cat":"papers","name":"MDMA","year":"2025","cit":0,"pfa":"Elisha D. Waldman","psa":"Mark Bates","topics":["PTSD & trauma","Anxiety & end-of-life","Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W4410860573","eid":"W4410860573"},{"id":"paper-w7163021326","cat":"papers","name":"Blinding integrity in psychedelic research: Evidence from a comparative randomized controlled trial of psilocybin, MDMA, and methylphenidate in healthy volunteers.","year":"2026","cit":0,"pfa":"L. Belinger","psa":"Katrin H. Preller","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7163021326","eid":"W7163021326"},{"id":"paper-w4245168509","cat":"papers","name":"MDMA","year":"2008","cit":0,"pfa":"Sandra McPherson","psa":"Errol B. Yudko","ptype":"book-chapter","src":"https://openalex.org/W4245168509","eid":"W4245168509"},{"id":"paper-w782405312","cat":"papers","name":"Songs of the Peyote Women","year":"2011","cit":0,"pfa":"Santa Fe Galloway","ptype":"article","src":"https://openalex.org/W782405312","eid":"W782405312"},{"id":"paper-w2376749703","cat":"papers","name":"MDMA DISTRIBUTION IN MDMA-EXPOSED RABBITS","year":"2009","cit":0,"pfa":"Kou Bing","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2376749703","eid":"W2376749703"},{"id":"paper-w4405284238","cat":"papers","name":"Ayahuasca and Religious Freedom","year":"2024","cit":0,"pfa":"Andrew C. Michaels","ptype":"preprint","src":"https://openalex.org/W4405284238","eid":"W4405284238"},{"id":"paper-w4249543376","cat":"papers","name":"MDMA*","year":"2004","cit":0,"pfa":"Neil Shear","psa":"Jerome Z. Litt","ptype":"book-chapter","src":"https://openalex.org/W4249543376","eid":"W4249543376"},{"id":"paper-w7150743081","cat":"papers","name":"Psilocybin and Other Psychedelic Compounds","year":"2026","cit":0,"pfa":"Siena M Madsen","psa":"J Andrew Jones","ptype":"book-chapter","src":"https://openalex.org/W7150743081","eid":"W7150743081"},{"id":"paper-w4210357595","cat":"papers","name":"MESCALINE IN PSYCHIATRIC RESEARCH","year":"1936","cit":0,"ptype":"article","src":"https://openalex.org/W4210357595","eid":"W4210357595"},{"id":"paper-w4300919194","cat":"papers","name":"MDMA.","year":"2001","cit":0,"ptype":"article","src":"https://openalex.org/W4300919194","eid":"W4300919194"},{"id":"paper-w4246129478","cat":"papers","name":"Ayahuasca Variations","year":"2015","cit":0,"pfa":"William L. Benzon","ptype":"preprint","src":"https://openalex.org/W4246129478","eid":"W4246129478"},{"id":"paper-w7137441458","cat":"papers","name":"Ayahuasca/ Cipó","cit":0,"ptype":"article","src":"https://openalex.org/W7137441458","eid":"W7137441458"},{"id":"paper-w4236714497","cat":"papers","name":"Ayahuasca intoxication","year":"2017","cit":0,"pfa":"RAFAEL GUIMARÃES DOS SANTOS","psa":"Jaime E. C. Hallak","ptype":"article","src":"https://openalex.org/W4236714497","eid":"W4236714497"},{"id":"paper-w4237547041","cat":"papers","name":"Ayahuasca tourism","year":"2020","cit":0,"pfa":"Tom John Wolff","ptype":"book-chapter","src":"https://openalex.org/W4237547041","eid":"W4237547041"},{"id":"paper-w4408563353","cat":"papers","name":"Revisiting Ayahuasca","year":"2025","cit":0,"pfa":"Jasleen Kaur","psa":"Vania Modesto‐Lowe","ptype":"article","src":"https://openalex.org/W4408563353","eid":"W4408563353"},{"id":"paper-w4243899818","cat":"papers","name":"The Peyote User’s Experíence","year":"1996","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W4243899818","eid":"W4243899818"},{"id":"paper-w4249924005","cat":"papers","name":"MDMA","year":"2008","cit":0,"ptype":"reference-entry","src":"https://openalex.org/W4249924005","eid":"W4249924005"},{"id":"paper-w7137435516","cat":"papers","name":"Explanation of Ayahuasca","cit":0,"ptype":"article","src":"https://openalex.org/W7137435516","eid":"W7137435516"},{"id":"paper-w4242646545","cat":"papers","name":"MDMA","year":"2003","cit":0,"pfa":"Sandra B. McPherson","psa":"Errol Yudko","topics":["Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W4242646545","eid":"W4242646545"},{"id":"paper-w4246980746","cat":"papers","name":"Mdma","year":"2003","cit":0,"pfa":"Errol B. Yudko","ptype":"book-chapter","src":"https://openalex.org/W4246980746","eid":"W4246980746"},{"id":"paper-w615721426","cat":"papers","name":"Salvinorin B Derivatives, EOM and MOM Substitue for the Discriminative Stimulus Effects of Salvinorin A","year":"2009","cit":0,"pfa":"M. Melissa Peet","ptype":"article","src":"https://openalex.org/W615721426","eid":"W615721426"},{"id":"paper-w4251174513","cat":"papers","name":"Ayahuasca-Liane","year":"2007","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W4251174513","eid":"W4251174513"},{"id":"paper-w2518260844","cat":"papers","name":"The Peyote Cult.Weston La Barre","year":"1939","cit":0,"pfa":"Ruth Shonle Cavan","ptype":"book-review","src":"https://openalex.org/W2518260844","eid":"W2518260844"},{"id":"paper-w4401780580","cat":"papers","name":"MDMA","year":"2024","cit":0,"ptype":"reference-entry","src":"https://openalex.org/W4401780580","eid":"W4401780580"},{"id":"paper-w4409938199","cat":"papers","name":"Reimagining Ayahuasca","year":"2023","cit":0,"ptype":"other","src":"https://openalex.org/W4409938199","eid":"W4409938199"},{"id":"paper-w4239165322","cat":"papers","name":"Ayahuasca-Liane","year":"2010","cit":0,"pfa":"Angelika Prentner","ptype":"book-chapter","src":"https://openalex.org/W4239165322","eid":"W4239165322"},{"id":"paper-w7155603806","cat":"papers","name":"Treatment of major depressive disorder and treatment resistant depression with 5-MeO-DMT: Impact of 25 years of non-traditional public scientific communication and education on clinical development and commercialization","year":"2026","cit":0,"pfa":"Juliet Meccia","psa":"Mark Seelig","topics":["Depression","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7155603806","eid":"W7155603806"},{"id":"paper-w4231139209","cat":"papers","name":"Medícínal Use of Peyote","year":"1996","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W4231139209","eid":"W4231139209"},{"id":"paper-w2935885320","cat":"papers","name":"The Peyote Cult (Plains)","year":"2015","cit":0,"pfa":"Paul Radin","ptype":"article","src":"https://openalex.org/W2935885320","eid":"W2935885320"},{"id":"paper-w4367680169","cat":"papers","name":"The Ayahuasca Voices","year":"2023","cit":0,"pfa":"Guillermo Giucci","psa":"Sebastián Torterola","ptype":"book-chapter","src":"https://openalex.org/W4367680169","eid":"W4367680169"},{"id":"paper-w2331057994","cat":"papers","name":"Comanche Peyote Songs","year":"1971","cit":0,"pfa":"David P. McAllester","psa":"Tony Isaacs","ptype":"article","src":"https://openalex.org/W2331057994","eid":"W2331057994"},{"id":"paper-w4236152048","cat":"papers","name":"Ayahuasca intoxication","year":"2017","cit":0,"pfa":"Bernat de Pablo Márquez","psa":"Beatriz Dietl Gómez-Luengo","ptype":"article","src":"https://openalex.org/W4236152048","eid":"W4236152048"},{"id":"paper-w4245201596","cat":"papers","name":"MDMA","year":"2016","cit":0,"pfa":"Leo Hermle","psa":"Felix Schuldt","ptype":"book-chapter","src":"https://openalex.org/W4245201596","eid":"W4245201596"},{"id":"paper-w2340735380","cat":"papers","name":"Analysis of N-hydroxy-MDMA and MDMA","year":"2009","cit":0,"pfa":"敬次 榎本","psa":"順司 渡瀬","ptype":"article","src":"https://openalex.org/W2340735380","eid":"W2340735380"},{"id":"paper-w7161281550","cat":"papers","name":"Pre-registered hERG QSAR Predictions for Coronaridine and Oxa-noribogaine","year":"2026","cit":0,"pfa":"Vincent Couey","ptype":"preprint","src":"https://openalex.org/W7161281550","eid":"W7161281550"},{"id":"paper-w4251960581","cat":"papers","name":"MDMA","year":"2010","cit":0,"pfa":"Michael M. Morgan","psa":"MALCOLM H. LADER","ptype":"reference-entry","src":"https://openalex.org/W4251960581","eid":"W4251960581"},{"id":"paper-w4414907947","cat":"papers","name":"Attitudes Towards Psilocybin: A General Population’s Opinions on Psilocybin and Psilocybin-Assisted Therapies","year":"2025","cit":0,"pfa":"Madison M. H. Simounet","psa":"Joy Drinnon","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4414907947","eid":"W4414907947"},{"id":"paper-w2883795660","cat":"papers","name":"Experiences of opioid detoxification using ibogaine in various treatment settings: Exploring ibogaine users’ motivations, understanding of risks, and effects of ibogaine treatment","year":"2018","cit":0,"pfa":"Jamie David Walker","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W2883795660","eid":"W2883795660"},{"id":"paper-w4234642991","cat":"papers","name":"Mescaline 54‐04‐6","year":"2012","cit":0,"ptype":"other","src":"https://openalex.org/W4234642991","eid":"W4234642991"},{"id":"paper-w1823476772","cat":"papers","name":"Synthesis of Heterocyclic Analogues of Salvinorin A","year":"2006","cit":0,"pfa":"Anthony Lozama","psa":"Thomas Edward Prisinzano","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1823476772","eid":"W1823476772"},{"id":"paper-w2728988362","cat":"papers","name":"Synthetic Work Towards Salvinorin A","year":"2015","cit":0,"pfa":"Patrick Walker Timmons","ptype":"dissertation","src":"https://openalex.org/W2728988362","eid":"W2728988362"},{"id":"paper-w4411294344","cat":"papers","name":"Escitalopram/psilocybin","year":"2025","cit":0,"ptype":"article","src":"https://openalex.org/W4411294344","eid":"W4411294344"},{"id":"paper-w1596635659","cat":"papers","name":"Peyote, \"Multiculturalism,\" and the Caricature of the West","year":"1991","cit":0,"pfa":"Robert G. Natelson","ptype":"article","src":"https://openalex.org/W1596635659","eid":"W1596635659"},{"id":"paper-w2330370511","cat":"papers","name":"Ayahuasca A Proving","year":"2013","cit":0,"pfa":"Chetna Shukla","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2330370511","eid":"W2330370511"},{"id":"paper-w2333309990","cat":"papers","name":"In the Magic Land of Peyote","year":"1974","cit":0,"pfa":"Omer C. Stewart","psa":"Marino Benzi","ptype":"article","src":"https://openalex.org/W2333309990","eid":"W2333309990"},{"id":"paper-w4406968051","cat":"papers","name":"Of Hyperthermia, Rodenticides, and Ibogaine Toxicity","year":"2025","cit":0,"pfa":"Leon Gussow","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4406968051","eid":"W4406968051"},{"id":"paper-w250449244","cat":"papers","name":"Ibogaine, Psychedelic Molecule with Anti-Addictive Properties","year":"2009","cit":0,"pfa":"Enno Christian Kurt Freye","topics":["Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W250449244","eid":"W250449244"},{"id":"paper-w4239999694","cat":"papers","name":"Peyote ín the Uníted States","year":"1996","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W4239999694","eid":"W4239999694"},{"id":"paper-w1987793900","cat":"papers","name":"ChemInform Abstract: A New Synthesis of Psilocin","year":"1999","cit":0,"pfa":"Hideki Sakagami","psa":"Kunio Ogasawara","ptype":"article","src":"https://openalex.org/W1987793900","eid":"W1987793900"},{"id":"paper-w189186210","cat":"papers","name":"Iboga: una ventana a la oportunidad","year":"2009","cit":0,"pfa":"Federico Paz","psa":"BENJAMIN DE LOENEN","ptype":"article","src":"https://openalex.org/W189186210","eid":"W189186210"},{"id":"paper-w1565513986","cat":"papers","name":"Peyote and Native American Culture","year":"1998","cit":0,"pfa":"Jennifer Majchrzak","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1565513986","eid":"W1565513986"},{"id":"paper-w2407161871","cat":"papers","name":"[Psychopathology & mescaline intoxication].","year":"1951","cit":0,"pfa":"Van Den Berg Jh","ptype":"article","src":"https://openalex.org/W2407161871","eid":"W2407161871"},{"id":"paper-w77070489","cat":"papers","name":"Pharmacology of Ecstasy (MDMA)","year":"2009","cit":0,"pfa":"Enno Christian Kurt Freye","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W77070489","eid":"W77070489"},{"id":"paper-w4254035272","cat":"papers","name":"Tabernanthe Iboga– Typha latifolia","year":"1958","cit":0,"pfa":"Heinz A. Hoppe","ptype":"book-chapter","src":"https://openalex.org/W4254035272","eid":"W4254035272"},{"id":"paper-w4205138453","cat":"papers","name":"Ibogaine in the Treatment of Opiate Addiction","year":"2009","cit":0,"pfa":"John Harrison","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W4205138453","eid":"W4205138453"},{"id":"paper-w2283333369","cat":"papers","name":"The origin of the Kiowa peyote religion","year":"1991","cit":0,"pfa":"Daniel A. Hickerson","ptype":"dissertation","src":"https://openalex.org/W2283333369","eid":"W2283333369"},{"id":"paper-w4255462981","cat":"papers","name":"MDMA","year":"2011","cit":0,"pfa":"Ari Kalechstein","psa":"James J. Mahoney","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W4255462981","eid":"W4255462981"},{"id":"paper-w4411530359","cat":"papers","name":"Ibogaine as a Tool in the Process of Overcoming Drug Addiction","year":"2025","cit":0,"pfa":"Bruno Ramos Gomes","psa":"Bruno Rasmussen Chaves","topics":["Addiction","Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W4411530359","eid":"W4411530359"},{"id":"paper-w7168160520","cat":"papers","name":"magnetismo del peyote","year":"2026","cit":0,"pfa":"Stacy B. Schaefer","ptype":"article","src":"https://openalex.org/W7168160520","eid":"W7168160520"},{"id":"paper-w7170134733","cat":"papers","name":"No evidence for deleterious effects of psilocybin and MDMA on working memory or related neurophysiological activity in a non-clinical population: An uncontrolled exploratory study","year":"2026","cit":0,"pfa":"Neil Wayne Bailey","psa":"Paul Bernard Fitzgerald","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7170134733","eid":"W7170134733"},{"id":"paper-w7132608787","cat":"papers","name":"N,N-Dimethyltryptamine","year":"2020","cit":0,"pfa":"Kamile YÜCEL","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W7132608787","eid":"W7132608787"},{"id":"paper-w2405900477","cat":"papers","name":"The synthesis of analogs of mescaline","year":"1944","cit":0,"pfa":"Harry K. Iwamoto","ptype":"dissertation","src":"https://openalex.org/W2405900477","eid":"W2405900477"},{"id":"paper-w2234831374","cat":"papers","name":"Chlorpromazine et mescaline.","year":"1956","cit":0,"pfa":"Herman C.B. Denber","ptype":"article","src":"https://openalex.org/W2234831374","eid":"W2234831374"},{"id":"paper-w7113507172","cat":"papers","name":"Psilocybin and Aging","year":"2025","cit":0,"pfa":"Leonard Lerer","topics":["Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7113507172","eid":"W7113507172"},{"id":"paper-w3096712663","cat":"papers","name":"Salvinorin A 83729‐01‐5","year":"2012","cit":0,"ptype":"other","src":"https://openalex.org/W3096712663","eid":"W3096712663"},{"id":"paper-w4236210370","cat":"papers","name":"S.05.05 Ibogaine therapy","year":"2005","cit":0,"ptype":"article","src":"https://openalex.org/W4236210370","eid":"W4236210370"},{"id":"paper-w88455472","cat":"papers","name":"Glazed Peyote Crème Brûlée","year":"2012","cit":0,"pfa":"Paul Chicharo","ptype":"article","src":"https://openalex.org/W88455472","eid":"W88455472"},{"id":"paper-w4396540254","cat":"papers","name":"Peyote Meeting at the Medicine Bulls’","year":"2024","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W4396540254","eid":"W4396540254"},{"id":"paper-w7104549742","cat":"papers","name":"Salvinorin A: beyond partial synthesis","year":"2023","cit":0,"pfa":"Munro, Thomas","ptype":"article","src":"https://openalex.org/W7104549742","eid":"W7104549742"},{"id":"paper-w7164705863","cat":"papers","name":"Quapaw Tribe's Use of Peyote","year":"1971","cit":0,"pfa":"Velma Nieberding","ptype":"other","src":"https://openalex.org/W7164705863","eid":"W7164705863"},{"id":"paper-w2201525173","cat":"papers","name":"Sartre, Mescaline and the Thing with the Crabs","year":"2010","cit":0,"pfa":"Jessica Au","ptype":"article","src":"https://openalex.org/W2201525173","eid":"W2201525173"},{"id":"paper-w4251585712","cat":"papers","name":"Ayahuasca Tales","year":"2004","cit":0,"pfa":"Stanley Krippner","ptype":"dataset","src":"https://openalex.org/W4251585712","eid":"W4251585712"},{"id":"paper-w7214252549","cat":"papers","name":"Psilocybin in oncological care","year":"2026","cit":0,"pfa":"Eliška Létalová","topics":["Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W7214252549","eid":"W7214252549"},{"id":"paper-w1869200651","cat":"papers","name":"Ayahuasca Weaving Destinies","year":"2012","cit":0,"pfa":"Juan Álvaro Echeverri","ptype":"article","src":"https://openalex.org/W1869200651","eid":"W1869200651"},{"id":"paper-w7135718649","cat":"papers","name":"Metabolism and physiological effects of dimethyltryptamine","year":"2016","cit":0,"pfa":"Petr Matouš","ptype":"dissertation","src":"https://openalex.org/W7135718649","eid":"W7135718649"},{"id":"paper-w4233458372","cat":"papers","name":"22 Psilocybin","year":"2005","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W4233458372","eid":"W4233458372"},{"id":"paper-w4384886996","cat":"papers","name":"psilocybin, n.","year":"2023","cit":0,"ptype":"reference-entry","src":"https://openalex.org/W4384886996","eid":"W4384886996"},{"id":"paper-w7207021399","cat":"papers","name":"Performance y Ayahuasca","year":"2023","cit":0,"pfa":"Sandra Julieth Gallo Ramírez","ptype":"dissertation","src":"https://openalex.org/W7207021399","eid":"W7207021399"},{"id":"paper-w2625330141","cat":"papers","name":"Cattle, Deer, Corn and Peyote","year":"2009","cit":0,"pfa":"Frédéric Saumade","ptype":"article","src":"https://openalex.org/W2625330141","eid":"W2625330141"},{"id":"paper-w7171952631","cat":"papers","name":"Dimethyltryptamine and the Recursive Reorganization of Consciousness","year":"2026","cit":0,"pfa":"Clement Paulus","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"book","src":"https://openalex.org/W7171952631","eid":"W7171952631"},{"id":"paper-w4387482583","cat":"papers","name":"Peyote Ceremony and Jungian Archetypes","year":"2016","cit":0,"pfa":"Teodoro Weckowicz","ptype":"book-chapter","src":"https://openalex.org/W4387482583","eid":"W4387482583"},{"id":"paper-w2409016123","cat":"papers","name":"Intermediary metabolism of mescaline analogs.","year":"1969","cit":0,"pfa":"A R Martin","ptype":"article","src":"https://openalex.org/W2409016123","eid":"W2409016123"},{"id":"paper-w1543046648","cat":"papers","name":"Perlongher y ayahuasca","year":"2013","cit":0,"pfa":"Federico San Juan","ptype":"article","src":"https://openalex.org/W1543046648","eid":"W1543046648"},{"id":"paper-w4403931804","cat":"papers","name":"Escitalopram/Psilocybin","year":"2024","cit":0,"ptype":"article","src":"https://openalex.org/W4403931804","eid":"W4403931804"},{"id":"paper-w2622396005","cat":"papers","name":"Development of presumptive macroscopic, microscopic, and colorimetric tests for Salvia divinorum, salvinorin A, and salvinorin B","year":"2012","cit":0,"pfa":"Keri Lyn LaBelle","ptype":"dissertation","src":"https://openalex.org/W2622396005","eid":"W2622396005"},{"id":"paper-w4408422024","cat":"papers","name":"Panini and Psilocybin","year":"2024","cit":0,"pfa":"Bridget Verhaaren","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4408422024","eid":"W4408422024"},{"id":"paper-w2906815202","cat":"papers","name":"Transformative Psychopharmacology: the Case of 5-Methoxy-N,N-Dimethyltryptamine","year":"2019","cit":0,"pfa":"Jan M. Keppel Hesselink","psa":"Jan M. Keppel Hesselink","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2906815202","eid":"W2906815202"},{"id":"paper-w4402811408","cat":"papers","name":"Ayahuasca-Tourismus in Südamerika","year":"2024","cit":0,"pfa":"Tom John Wolff","ptype":"book-chapter","src":"https://openalex.org/W4402811408","eid":"W4402811408"},{"id":"paper-w337430016","cat":"papers","name":"Peyotes y San Pedro","year":"2007","cit":0,"pfa":"Pedro Caldentey","ptype":"article","src":"https://openalex.org/W337430016","eid":"W337430016"},{"id":"paper-w2460153949","cat":"papers","name":"[\"Clinical and basic research with mescaline\"].","year":"1965","cit":0,"pfa":"Herman C.B. Denber","ptype":"article","src":"https://openalex.org/W2460153949","eid":"W2460153949"},{"id":"paper-w2886913742","cat":"papers","name":"Toward the Origins of Peyote Beadwork","year":"2018","cit":0,"pfa":"Gerald R. Hubbell","ptype":"dissertation","src":"https://openalex.org/W2886913742","eid":"W2886913742"},{"id":"paper-w2492354367","cat":"papers","name":"[The potential use of ayahuasca in psychiatry].","year":"2016","cit":0,"pfa":"Ede Frecska","psa":"Kovacs Attila","topics":["Safety & adverse events","Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2492354367","eid":"W2492354367"},{"id":"paper-w4287169077","cat":"papers","name":"௹ +2778 278 2201 ௹ ₳SUPERIOR QUALITY IBOGA ROOTBARKS FOR SALE**IBOGAIN FOR SALE ** IBOGA POWDER FOR SALE IN PRETORIA , CAPE TOWN , DURBAN , MPUMALANGA","year":"2021","cit":0,"pfa":"Nicole","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4287169077","eid":"W4287169077"},{"id":"paper-w2595254473","cat":"papers","name":"Construction of the Carbon Skeleton of Salvinorin A","year":"2011","cit":0,"pfa":"Sean C. Butler","ptype":"article","src":"https://openalex.org/W2595254473","eid":"W2595254473"},{"id":"paper-w7162382897","cat":"papers","name":"Psilocybin for Anxiety","year":"2026","cit":0,"pfa":"Mikael Palner","topics":["Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W7162382897","eid":"W7162382897"},{"id":"paper-w4205269177","cat":"papers","name":"Psilocybin in the news","year":"2020","cit":0,"ptype":"article","src":"https://openalex.org/W4205269177","eid":"W4205269177"},{"id":"paper-w4416564511","cat":"papers","name":"Psilocybin Therapy","year":"2025","cit":0,"pfa":"Gabriel Bennett","ptype":"book","src":"https://openalex.org/W4416564511","eid":"W4416564511"},{"id":"paper-w2739638311","cat":"papers","name":"LAS PROPIEDADES FARMACOCINÉTICAS DEL AYAHUASCA THE PHARMACOLOGICAL PROPERTIES OF AYAHUASCA","year":"2015","cit":0,"pfa":"Guillermo Saúl","psa":"Escobar Cornejo","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2739638311","eid":"W2739638311"},{"id":"paper-w4300935594","cat":"papers","name":"Las propiedades farmacocinéticas del ayahuasca / The pharmacological properties of ayahuasca","year":"2015","cit":0,"pfa":"Guillermo Saúl Escobar Cornejo","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4300935594","eid":"W4300935594"},{"id":"paper-w3097356923","cat":"papers","name":"Psilocybin for Depression","year":"2020","cit":0,"pfa":"Steven L. Dubovsky","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3097356923","eid":"W3097356923"},{"id":"paper-w2792069862","cat":"papers","name":"Peyote a Církev Původních Američanů","year":"2015","cit":0,"pfa":"Alice Heider","ptype":"dissertation","src":"https://openalex.org/W2792069862","eid":"W2792069862"},{"id":"paper-w2060082529","cat":"papers","name":"ChemInform Abstract: Structure of Ibogaine.","year":"1993","cit":0,"pfa":"Manuel Soriano-García","ptype":"article","src":"https://openalex.org/W2060082529","eid":"W2060082529"},{"id":"paper-w3128797214","cat":"papers","name":"The Peyote Case: A Return to Reynolds","year":"2021","cit":0,"pfa":"Theresa Cook","ptype":"article","src":"https://openalex.org/W3128797214","eid":"W3128797214"},{"id":"paper-w4410768922","cat":"papers","name":"Mulatas Incorporate Peyote and Patle","year":"2025","cit":0,"pfa":"Martin Austin Nesvig","ptype":"book-chapter","src":"https://openalex.org/W4410768922","eid":"W4410768922"},{"id":"paper-w3120598547","cat":"papers","name":"Dimethyltryptamine, methyltryptamine, hallucinations and metals","year":"2021","cit":0,"pfa":"Elena L. Paley","ptype":"book-chapter","src":"https://openalex.org/W3120598547","eid":"W3120598547"},{"id":"paper-w3177483530","cat":"papers","name":"Studies towards the total synthesis of salvinorin A","year":"2021","cit":0,"pfa":"Ylva E. Bergman","ptype":"dissertation","src":"https://openalex.org/W3177483530","eid":"W3177483530"},{"id":"paper-w2609897552","cat":"papers","name":"Ayahuasca: Friend or Foe?","year":"2016","cit":0,"pfa":"Gerard I. Fernando","ptype":"article","src":"https://openalex.org/W2609897552","eid":"W2609897552"},{"id":"paper-w4403727448","cat":"papers","name":"Is the stereoisomer R-MDMA a safer version of MDMA?","year":"2024","cit":0,"pfa":"Gillinder Bedi","topics":["PTSD & trauma","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4403727448","eid":"W4403727448"},{"id":"paper-w7170043150","cat":"papers","name":"MEDITAÇÃO COM AYAHUASCA: AYAHUASCA COMO CATALISADOR DO ESTADO MEDITATIVO","year":"2022","cit":0,"pfa":"R J G F Oliveira","ptype":"dissertation","src":"https://openalex.org/W7170043150","eid":"W7170043150"},{"id":"paper-w7134864764","cat":"papers","name":"Mdma afvist","year":"2024","cit":0,"pfa":"Kristian Hvidtfelt; id_orcid 0000-0002-6192-400X Nielsen","ptype":"other","src":"https://openalex.org/W7134864764","eid":"W7134864764"},{"id":"paper-w7113198795","cat":"papers","name":"Psilocybin Attitudes","year":"2024","cit":0,"pfa":"Joy Drinnon","ptype":"preprint","src":"https://openalex.org/W7113198795","eid":"W7113198795"},{"id":"paper-w1385730","cat":"papers","name":"Ayahuasca y salud","year":"2013","cit":0,"pfa":"Beatriz Caiuby Labate","psa":"José Carlos Bouso","ptype":"article","src":"https://openalex.org/W1385730","eid":"W1385730"},{"id":"paper-w2347049565","cat":"papers","name":"The 1918 U.S. Congressional Hearings on Peyote","year":"2006","cit":0,"pfa":"Lee D. Baker","ptype":"article","src":"https://openalex.org/W2347049565","eid":"W2347049565"},{"id":"paper-w4249846171","cat":"papers","name":"Ecstasy (MDMA)","year":"2010","cit":0,"pfa":"Lakshman Delgoda Karalliedde","psa":"Janaka Karalliedde","ptype":"book-chapter","src":"https://openalex.org/W4249846171","eid":"W4249846171"},{"id":"paper-w7141743772","cat":"papers","name":"MDMA in PTSD","year":"2019","cit":0,"topics":["PTSD & trauma","Dosing & pharmacology","Therapy practice"],"ptype":"report","src":"https://openalex.org/W7141743772","eid":"W7141743772"},{"id":"paper-w746790760","cat":"papers","name":"Top-Eye, The Peyote Man","year":"2006","cit":0,"pfa":"Jim Puder","ptype":"article","src":"https://openalex.org/W746790760","eid":"W746790760"},{"id":"paper-w7147097346","cat":"papers","name":"Ayahuasca and Its Main Component N,N-Dimethyltryptamine (DMT) for the Treatment of Mental Disorders: Mechanisms of Action, Clinical Studies, and Tools to Explore the Human Mind","year":"2026","cit":0,"pfa":"Alice Melani","psa":"Marco Scarselli","topics":["Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W7147097346","eid":"W7147097346"},{"id":"paper-w261670809","cat":"papers","name":"Duro Peyote, en concierto.","year":"2011","cit":0,"pfa":"Javier Puebla","ptype":"article","src":"https://openalex.org/W261670809","eid":"W261670809"},{"id":"paper-w7132139936","cat":"papers","name":"Ekstazis (MDMA)","year":"2010","cit":0,"pfa":"Dagmara Ona Reingardienė","ptype":"conference-paper","src":"https://openalex.org/W7132139936","eid":"W7132139936"},{"id":"paper-w7171993596","cat":"papers","name":"Dimethyltryptamine and the Recursive Reorganization of Consciousness","year":"2026","cit":0,"pfa":"Clement Paulus","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"book","src":"https://openalex.org/W7171993596","eid":"W7171993596"},{"id":"paper-w4244801690","cat":"papers","name":"Mescaline 54‐04‐6","year":"2004","cit":0,"ptype":"other","src":"https://openalex.org/W4244801690","eid":"W4244801690"},{"id":"paper-w4414507205","cat":"papers","name":"Peyote Use and Religious Freedom","year":"2005","cit":0,"ptype":"other","src":"https://openalex.org/W4414507205","eid":"W4414507205"},{"id":"paper-w7141318516","cat":"papers","name":"Psilocybin for Depression","year":"2018","cit":0,"topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"report","src":"https://openalex.org/W7141318516","eid":"W7141318516"},{"id":"paper-w4292635634","cat":"papers","name":"Psilocybin administration","year":"2022","cit":0,"pfa":"George Winter","ptype":"article","src":"https://openalex.org/W4292635634","eid":"W4292635634"},{"id":"paper-w4242567378","cat":"papers","name":"Perspectives on Ayahuasca healing","year":"2010","cit":0,"pfa":"Evgenia Fotiou","ptype":"dataset","src":"https://openalex.org/W4242567378","eid":"W4242567378"},{"id":"paper-w2945508398","cat":"papers","name":"Biosynthesis of an Anti-Addiction Agent from the Iboga Plant","year":"2019","cit":0,"pfa":"Scott C. Farrow","psa":"Sarah Ellen O'Connor","topics":["Addiction"],"ptype":"preprint","src":"https://openalex.org/W2945508398","eid":"W2945508398"},{"id":"paper-w4247312022","cat":"papers","name":"Mushrooms, Psilocybin","year":"2005","cit":0,"pfa":"Anthony S. Manoguerra","ptype":"reference-entry","src":"https://openalex.org/W4247312022","eid":"W4247312022"},{"id":"paper-w7204470900","cat":"papers","name":"Challenging Psychedelic Experiences Across DMT, Psilocybin, MDMA, and Ketamine: A Thematic Analysis of User Reports with Exploratory Human-LLM Concordance Analysis","year":"2026","cit":0,"pfa":"Holly Hepburn","topics":["Addiction"],"ptype":"dissertation","src":"https://openalex.org/W7204470900","eid":"W7204470900"},{"id":"paper-w4392988831","cat":"papers","name":"Ayahuasca and The Vines of Politics","year":"2015","cit":0,"pfa":"Danny Nemu","ptype":"other","src":"https://openalex.org/W4392988831","eid":"W4392988831"},{"id":"paper-w207881627","cat":"papers","name":"13 IBOGA ALKALOIDSの合成研究 : dl-Ibogamine,dl-Epiibogamine dl-Ibogaine,dl-Epiibogaine,dl-Tabernanthine,dl-Epitabernanthineの全合成","year":"1969","cit":0,"pfa":"義雄 伴","psa":"武 大石","ptype":"article","src":"https://openalex.org/W207881627","eid":"W207881627"},{"id":"paper-w4926973","cat":"papers","name":"Sanación con ayahuasca","year":"2007","cit":0,"pfa":"Jerónimo Pérez","ptype":"article","src":"https://openalex.org/W4926973","eid":"W4926973"},{"id":"paper-w4391198345","cat":"papers","name":"Globalization and the Future of Ayahuasca","year":"2008","cit":0,"ptype":"other","src":"https://openalex.org/W4391198345","eid":"W4391198345"},{"id":"paper-w4306177051","cat":"papers","name":"Psilocybin treatment for AUD: Promise in new study","year":"2022","cit":0,"pfa":"Alison Knopf","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4306177051","eid":"W4306177051"},{"id":"paper-w4391198622","cat":"papers","name":"Native Use of Ayahuasca","year":"2008","cit":0,"ptype":"other","src":"https://openalex.org/W4391198622","eid":"W4391198622"},{"id":"paper-w1502844089","cat":"papers","name":"AYAHUASCA – ASPECTOS BOTÂNICOS E FARMACOLÓGICOS AYAHUASCA – BOTANICAL AND PHARMACOLOGICAL ASPECTS","year":"2009","cit":0,"pfa":"Guilherme Balarde Martinez","psa":"Celi de Paula Silva","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1502844089","eid":"W1502844089"},{"id":"paper-w4321207593","cat":"papers","name":"More on psilocybin","year":"2023","cit":0,"pfa":"Aryan Sarparast","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4321207593","eid":"W4321207593"},{"id":"paper-w7170090006","cat":"papers","name":"MEDITAÇÃO COM AYAHUASCA: AYAHUASCA COMO CATALISADOR DO ESTADO MEDITATIVO","year":"2022","cit":0,"pfa":"R J G F Oliveira","ptype":"dissertation","src":"https://openalex.org/W7170090006","eid":"W7170090006"},{"id":"paper-w139084921","cat":"papers","name":"Ayahuasca para principiantes","year":"2014","cit":0,"pfa":"Pedro Musalem Nazar","ptype":"article","src":"https://openalex.org/W139084921","eid":"W139084921"},{"id":"paper-w7160868912","cat":"papers","name":"MDMA and Grief","year":"2024","cit":0,"pfa":"Graham, G. Scott","topics":["PTSD & trauma","Therapy practice"],"ptype":"book","src":"https://openalex.org/W7160868912","eid":"W7160868912"},{"id":"paper-w4247110712","cat":"papers","name":"Methylenedioxymethamphetamine (MDMA)","year":"2015","cit":0,"pfa":"Iain S. McGregor","psa":"Murray R. Thompson","ptype":"reference-entry","src":"https://openalex.org/W4247110712","eid":"W4247110712"},{"id":"paper-w7206895845","cat":"papers","name":"The history of MDMA","year":"2023","cit":0,"pfa":"Passie, Torsten 1961-","psa":"Dennis, Andrew","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7206895845","eid":"W7206895845"},{"id":"paper-w2735964692","cat":"papers","name":"Mescaline and Hindu mystical experience","year":"1975","cit":0,"pfa":"Arvind Sharma","ptype":"article","src":"https://openalex.org/W2735964692","eid":"W2735964692"},{"id":"paper-w2439160425","cat":"papers","name":"[ELECTROGRAPHIC PECULIARITIES IN MESCALINE INTOXICATION].","year":"1996","cit":0,"pfa":"R Spiazzi","ptype":"article","src":"https://openalex.org/W2439160425","eid":"W2439160425"},{"id":"paper-w106464650","cat":"papers","name":"MDMA and LSD","year":"2012","cit":0,"pfa":"Andrew C. Parrott","ptype":"book-chapter","src":"https://openalex.org/W106464650","eid":"W106464650"},{"id":"paper-w3171799642","cat":"papers","name":"Peyote Religion/Native American Church","year":"2021","cit":0,"pfa":"Jeanette Lynne Weaskus","ptype":"other","src":"https://openalex.org/W3171799642","eid":"W3171799642"},{"id":"paper-w4388558516","cat":"papers","name":"PEYOTE POEM, PART I","year":"2023","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W4388558516","eid":"W4388558516"},{"id":"paper-w2970781131","cat":"papers","name":"Ayahuasca Weaving Destinies","year":"2010","cit":0,"pfa":"Jimmy Weiskopf","ptype":"book","src":"https://openalex.org/W2970781131","eid":"W2970781131"},{"id":"paper-w2810224821","cat":"papers","name":"Ayahuasca: A Way to the balance","year":"2016","cit":0,"pfa":"Rita Barreto de Sales Oliveira","ptype":"article","src":"https://openalex.org/W2810224821","eid":"W2810224821"},{"id":"paper-w4300891446","cat":"papers","name":"[MDMA--\"ecstasy\"].","year":"1996","cit":0,"pfa":"W Keup","ptype":"article","src":"https://openalex.org/W4300891446","eid":"W4300891446"},{"id":"paper-w2396676165","cat":"papers","name":"[Some analytical aspects of mescaline].","year":"1990","cit":0,"pfa":"Marc Conti","psa":"Alain Viala","ptype":"other","src":"https://openalex.org/W2396676165","eid":"W2396676165"},{"id":"paper-w3029543757","cat":"papers","name":"Etnofarmacologia de Ayahuasca","year":"2017","cit":0,"pfa":"Catarina Dorisa Azevedo da Silva","ptype":"dissertation","src":"https://openalex.org/W3029543757","eid":"W3029543757"},{"id":"paper-w4393178759","cat":"papers","name":"DMT und Ayahuasca","year":"2024","cit":0,"pfa":"Norbert Scherbaum","ptype":"book-chapter","src":"https://openalex.org/W4393178759","eid":"W4393178759"},{"id":"paper-w4390078127","cat":"papers","name":"22 The Effect of Ibogaine on Cognitive Functioning","year":"2023","cit":0,"pfa":"Kirsten N. Cherian","psa":"Nolan Williams","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4390078127","eid":"W4390078127"},{"id":"paper-w197423744","cat":"papers","name":"Pharmacokinetics of MDMA","year":"2009","cit":0,"pfa":"Enno Christian Kurt Freye","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W197423744","eid":"W197423744"},{"id":"paper-w3133755313","cat":"papers","name":"Ayahuasca, the vine of the soul","year":"2019","cit":0,"pfa":"Nathalie Dubois","ptype":"conference-paper","src":"https://openalex.org/W3133755313","eid":"W3133755313"},{"id":"paper-w2784183836","cat":"papers","name":"The Peyote cult of the Delaware Indians","year":"1956","cit":0,"pfa":"William W. Newcomb","ptype":"article","src":"https://openalex.org/W2784183836","eid":"W2784183836"},{"id":"paper-w4236834465","cat":"papers","name":"Ayahuasca: The visionary brew","year":"2012","cit":0,"pfa":"Brigitte Mars","ptype":"dataset","src":"https://openalex.org/W4236834465","eid":"W4236834465"},{"id":"paper-w2491664890","cat":"papers","name":"Psychobiology of MDMA","year":"2009","cit":0,"topics":["Depression","Policy & ethics"],"ptype":"book","src":"https://openalex.org/W2491664890","eid":"W2491664890"},{"id":"paper-w4410858532","cat":"papers","name":"The History of MDMA","year":"2025","cit":0,"pfa":"Zoë Dubus","ptype":"book-review","src":"https://openalex.org/W4410858532","eid":"W4410858532"},{"id":"paper-w4256310739","cat":"papers","name":"MDMA (Ecstasy)","year":"2013","cit":0,"ptype":"dataset","src":"https://openalex.org/W4256310739","eid":"W4256310739"},{"id":"paper-w7160822291","cat":"papers","name":"MDMA and Grief","year":"2024","cit":0,"pfa":"Graham, G. Scott","topics":["PTSD & trauma","Therapy practice"],"ptype":"book","src":"https://openalex.org/W7160822291","eid":"W7160822291"},{"id":"paper-w2288531980","cat":"papers","name":"W. La Barre, The peyote cult","year":"1967","cit":0,"pfa":"Arlette Frigout","ptype":"article","src":"https://openalex.org/W2288531980","eid":"W2288531980"},{"id":"paper-w7201928820","cat":"papers","name":"The therapeutic potentials of Ayahuasca","year":"2026","cit":0,"pfa":"Aníta Ösp Gunnlaugsdóttir","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7201928820","eid":"W7201928820"},{"id":"paper-w2562125620","cat":"papers","name":"[Ibogaine - structure, influence on human body, clinical relevance].","year":"2016","cit":0,"pfa":"Zygmunt Zdrojewicz","psa":"Natalia Olszak","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2562125620","eid":"W2562125620"},{"id":"paper-w951069498","cat":"papers","name":"A Mass Fragmentographic Method for the Determination of Mescaline in Biological Fluids","year":"1978","cit":0,"pfa":"Carlos Van Peteghem","psa":"Aubin M. Heyndrickx","ptype":"book-chapter","src":"https://openalex.org/W951069498","eid":"W951069498"},{"id":"paper-w7119378049","cat":"papers","name":"Ayahuasca Mamancuma merci beaucoup : diversification and internationalization of Peruvian ayahuasca vegetalismo","year":"2011","cit":0,"pfa":"Beatriz Caiuby Labate","ptype":"dissertation","src":"https://openalex.org/W7119378049","eid":"W7119378049"},{"id":"paper-w7160437300","cat":"papers","name":": The History of MDMA","year":"2026","cit":0,"pfa":"Peder Clark","ptype":"article","src":"https://openalex.org/W7160437300","eid":"W7160437300"},{"id":"paper-w7135607127","cat":"papers","name":"The Ayahuasca Subculture in Prague","year":"2013","cit":0,"pfa":"Kateřina Petružálková","ptype":"dissertation","src":"https://openalex.org/W7135607127","eid":"W7135607127"},{"id":"paper-w7199408400","cat":"papers","name":"The psychopharmacology of MDMA","year":"2010","cit":0,"pfa":"MR Thompson","psa":"IS McGregor","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"book-chapter","src":"https://openalex.org/W7199408400","eid":"W7199408400"},{"id":"paper-w3112498640","cat":"papers","name":"Novelty of Ayahuasca Scale","year":"2020","cit":0,"pfa":"Brianna R. Altman","psa":"Mitch Earleywine","ptype":"dataset","src":"https://openalex.org/W3112498640","eid":"W3112498640"},{"id":"paper-w4246094923","cat":"papers","name":"Mescaline Sulfate 5967‐42‐0","year":"2004","cit":0,"ptype":"other","src":"https://openalex.org/W4246094923","eid":"W4246094923"},{"id":"paper-w4243817126","cat":"papers","name":"Mescaline and Shock-Induced Aggression in Rats","year":"1973","cit":0,"pfa":"Robert J. Sbordone","psa":"Brooks Carder","ptype":"dataset","src":"https://openalex.org/W4243817126","eid":"W4243817126"},{"id":"paper-w7110699440","cat":"papers","name":"Professor Stefan Szuman's mescaline visions","year":"2024","cit":0,"pfa":"Wójcikiewicz, Józef","psa":"Kwiatkowska-Wójcikiewicz, Violetta","ptype":"book-chapter","src":"https://openalex.org/W7110699440","eid":"W7110699440"},{"id":"paper-w4312237963","cat":"papers","name":"Ayahuasca comes to the city!","year":"2022","cit":0,"pfa":"Jimmy Weiskopf","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4312237963","eid":"W4312237963"},{"id":"paper-w7116676253","cat":"papers","name":"Otherwise Ayahuasca Expressions. Ritual Reinvention and Social Change in Ayahuasca Rituals","year":"2025","cit":0,"pfa":"Piera Talin","ptype":"article","src":"https://openalex.org/W7116676253","eid":"W7116676253"},{"id":"paper-w2477602830","cat":"papers","name":"Substitutes of MDMA","year":"1998","cit":0,"pfa":"Karel Valter","psa":"Philippe Arrizabalaga","ptype":"book-chapter","src":"https://openalex.org/W2477602830","eid":"W2477602830"},{"id":"paper-w4240092507","cat":"papers","name":"MDMA (Ecstasy)","year":"2016","cit":0,"pfa":"Susan P. Robbins","psa":"Luz M. Alquicira","ptype":"reference-entry","src":"https://openalex.org/W4240092507","eid":"W4240092507"},{"id":"paper-w2906090347","cat":"papers","name":"Ayahuasca, você conhece?","year":"2016","cit":0,"pfa":"Afrânio Patrocínio de Andrade","ptype":"article","src":"https://openalex.org/W2906090347","eid":"W2906090347"},{"id":"paper-w7135581701","cat":"papers","name":"Ibogaine and its potential use in the treatment of drug addiction","year":"2025","cit":0,"pfa":"Hubert Kobr","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W7135581701","eid":"W7135581701"},{"id":"paper-w4229599295","cat":"papers","name":"Methylenedioxymethamphetamine (MDMA)","year":"2010","cit":0,"pfa":"Michael M. Morgan","psa":"MALCOLM H. LADER","ptype":"reference-entry","src":"https://openalex.org/W4229599295","eid":"W4229599295"},{"id":"paper-w3141743116","cat":"papers","name":"Discriminative Stimulus Effects of Atypical Hallucinogen Salvinorin A, and Semi-Synthetic Analogs, Salvinorin B Methoxymethyl (MOM) and Salvinorin B Ethoxymethyl (EOM) Ethers","year":"2009","cit":0,"pfa":"Bryan A. Killinger","ptype":"article","src":"https://openalex.org/W3141743116","eid":"W3141743116"},{"id":"paper-w4416759409","cat":"papers","name":"Ayahuasca e religiosidade","year":"2025","cit":0,"pfa":"Aldemir Inácio de Azevedo","psa":"Cláudia Mirella Pereira Ramos","ptype":"article","src":"https://openalex.org/W4416759409","eid":"W4416759409"},{"id":"paper-w2764372655","cat":"papers","name":"Mescaline-induced changes of brain-cortex ribosomes. Effect of mescaline on the stability of brain-cortex ribosomes","year":"1970","cit":0,"topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2764372655","eid":"W2764372655"},{"id":"paper-w3117982672","cat":"papers","name":"Chemical submission by “ayahuasca”","year":"2021","cit":0,"pfa":"Cesáreo Fernández Alonso","psa":"Andrés E. Santiago Sáez","ptype":"article","src":"https://openalex.org/W3117982672","eid":"W3117982672"},{"id":"paper-w4396883278","cat":"papers","name":"MDMA-gestützte Therapie","year":"2024","cit":0,"pfa":"Laura Bechtold","psa":"Dimitris Repantis","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4396883278","eid":"W4396883278"},{"id":"paper-w135867038","cat":"papers","name":"STRUCTURE–ACTIVITY RELATIONSHIPS OF MESCALINE","year":"1967","cit":0,"pfa":"John Smythies","psa":"Elizabeth A. Sykes","ptype":"book-chapter","src":"https://openalex.org/W135867038","eid":"W135867038"},{"id":"paper-w7135944885","cat":"papers","name":"Therapeutic potential of ibogaine in treating addiction","year":"2023","cit":0,"pfa":"Selma de Donnová","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"dissertation","src":"https://openalex.org/W7135944885","eid":"W7135944885"},{"id":"paper-w7212142559","cat":"papers","name":"QT Prolongation With Methadone, Donepezil, and Ibogaine","year":"2026","cit":0,"pfa":"Scott R. Beach","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"report","src":"https://openalex.org/W7212142559","eid":"W7212142559"},{"id":"paper-w7112010788","cat":"papers","name":"Ayahuasca : rito sincretista","year":"2024","cit":0,"pfa":"Pasajes Martínez, Joan Manuel","ptype":"dissertation","src":"https://openalex.org/W7112010788","eid":"W7112010788"},{"id":"paper-w2803359249","cat":"papers","name":"Interpreting the Narrative of Peyote Woman","year":"2009","cit":0,"pfa":"Benjamín Calvo Pérez","ptype":"book","src":"https://openalex.org/W2803359249","eid":"W2803359249"},{"id":"paper-w2508038528","cat":"papers","name":"The Peyote Religion. J. S. Slotkin","year":"1957","cit":0,"pfa":"Charles Henry Long","ptype":"book-review","src":"https://openalex.org/W2508038528","eid":"W2508038528"},{"id":"paper-w4415503904","cat":"papers","name":"MDMA (“Ecstasy”)","year":"2025","cit":0,"pfa":"Marcello Cherchi","ptype":"book-chapter","src":"https://openalex.org/W4415503904","eid":"W4415503904"},{"id":"paper-w4250705785","cat":"papers","name":"Ayahuasca Religious Movements","year":"2012","cit":0,"pfa":"Mark Juergensmeyer","psa":"Wade Clark Roof","ptype":"reference-entry","src":"https://openalex.org/W4250705785","eid":"W4250705785"},{"id":"paper-w2273763389","cat":"papers","name":"Human pharmacology of Ayahuasca","year":"2015","cit":0,"pfa":"Crina Lorena Ghimbasan","psa":"Nuria María Vivas Sabido","topics":["Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W2273763389","eid":"W2273763389"},{"id":"paper-w2201851578","cat":"papers","name":"Ibogaine: Suppressed Addiction Cure or Just Hype?","year":"2015","cit":0,"pfa":"Scott W Stern","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2201851578","eid":"W2201851578"},{"id":"paper-w7168291882","cat":"papers","name":"[Research Progress on Mescaline and Its Analogues].","year":"2026","cit":0,"pfa":"Ruidi Shen","psa":"Zhenhua Qian","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7168291882","eid":"W7168291882"},{"id":"paper-w2396112466","cat":"papers","name":"[Interactions of morphine and mescaline with cerebral proteins].","year":"1957","cit":0,"pfa":"P Dessi","psa":"A M GIANNI","ptype":"article","src":"https://openalex.org/W2396112466","eid":"W2396112466"},{"id":"paper-w2182268062","cat":"papers","name":"Consultorio legal: Ayahuasca","year":"2015","cit":0,"pfa":"Pedro Caldentey","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2182268062","eid":"W2182268062"},{"id":"paper-w4236370556","cat":"papers","name":"ALSUntangled 40: Ayahuasca","year":"2017","cit":0,"pfa":"The ALSUntangled Group","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4236370556","eid":"W4236370556"},{"id":"paper-w7133115053","cat":"papers","name":"The international ayahuasca community","year":"2021","cit":0,"pfa":"Alhena Caicedo Fernández","psa":"Sofía Lara Largo","ptype":"article","src":"https://openalex.org/W7133115053","eid":"W7133115053"},{"id":"paper-w3005562396","cat":"papers","name":"Ayahuasca Religions of Brazil","year":"2016","cit":0,"pfa":"Andrew Dawson","ptype":"article","src":"https://openalex.org/W3005562396","eid":"W3005562396"},{"id":"paper-w2622191140","cat":"papers","name":"MDMA and Glutamate","year":"2016","cit":0,"pfa":"John H. Anneken","psa":"Gary A. Gudelsky","ptype":"book-chapter","src":"https://openalex.org/W2622191140","eid":"W2622191140"},{"id":"paper-w4387482465","cat":"papers","name":"Peyote: A Sacrament by Medical Prescription","year":"2016","cit":0,"pfa":"Abram Hoffer","psa":"Humphry Osmond","ptype":"book-chapter","src":"https://openalex.org/W4387482465","eid":"W4387482465"},{"id":"paper-w4244080198","cat":"papers","name":"MDMA (Ecstasy)","year":"2004","cit":0,"pfa":"White House Office of National Drug Control Policy","ptype":"dataset","src":"https://openalex.org/W4244080198","eid":"W4244080198"},{"id":"paper-w4404812606","cat":"papers","name":"II. The Peyote Trial of 1914","year":"1952","cit":0,"pfa":"J. S. Slotkin","ptype":"book-chapter","src":"https://openalex.org/W4404812606","eid":"W4404812606"},{"id":"paper-w2945785529","cat":"papers","name":"Peyoteism and the Origins of Caddo Religious Thought","year":"2014","cit":0,"pfa":"Robert Casr","ptype":"article","src":"https://openalex.org/W2945785529","eid":"W2945785529"},{"id":"paper-w2320433608","cat":"papers","name":"The Peyote Book: A Study of Native Medicine","year":"1991","cit":0,"pfa":"Joseph B. Herring","psa":"Silvester J. Brito","ptype":"article","src":"https://openalex.org/W2320433608","eid":"W2320433608"},{"id":"paper-w4232163185","cat":"papers","name":"MDMA: Pharmacokinetics","year":"2016","cit":0,"pfa":"Mag Farr","psa":"Rafael de la Torre","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W4232163185","eid":"W4232163185"},{"id":"paper-w4406757002","cat":"papers","name":"False Peyote (Lophophora diffusa (Croizat) Bravo Cactaceae)","year":"2025","cit":0,"pfa":"Ehsan Ali","psa":"Ume Laila","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W4406757002","eid":"W4406757002"},{"id":"paper-w2403733683","cat":"papers","name":"Ibogaine: proceedings of the First International Conference.","year":"2001","cit":0,"pfa":"Herbert D. Kleber","ptype":"article","src":"https://openalex.org/W2403733683","eid":"W2403733683"},{"id":"paper-w4251650474","cat":"papers","name":"Drug, peyote, haled into French court","year":"1929","cit":0,"pfa":"Science Service","ptype":"article","src":"https://openalex.org/W4251650474","eid":"W4251650474"},{"id":"paper-w2566427683","cat":"papers","name":"7 STUDIES ON THE SYNTHESIS OF ASPIDOSPERMA AND IBOGA ALKALOIDS","year":"1966","cit":0,"pfa":"Yoshio Ban","psa":"Ikuo Iijima","ptype":"article","src":"https://openalex.org/W2566427683","eid":"W2566427683"},{"id":"paper-w4253084210","cat":"papers","name":"Subjective Effects of Salvinorin A: Sacred and Profane","year":"2009","cit":0,"pfa":"Peter H. Addy","ptype":"dataset","src":"https://openalex.org/W4253084210","eid":"W4253084210"},{"id":"paper-w753067063","cat":"papers","name":"Salvinorin A: Fragment Synthesis and Modeling Studies","year":"2009","cit":0,"pfa":"Donna L. McGovern","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W753067063","eid":"W753067063"},{"id":"paper-w2405299376","cat":"papers","name":"[Mexican hallucinogenic plants (peyote and hallucinogen fungi)].","year":"1966","cit":0,"pfa":"Pérez Cirera R","ptype":"article","src":"https://openalex.org/W2405299376","eid":"W2405299376"},{"id":"paper-w1995872529","cat":"papers","name":"Salvinorin B as a Putative Biosynthetic Precursor of Salvinorin A. Study on O-Acetyltransferasein Glandular Trichomes Isolated from Salviadivinorium","year":"2008","cit":0,"pfa":"LM Kutrzeba","psa":"FE Dayan","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1995872529","eid":"W1995872529"},{"id":"paper-w2597617416","cat":"papers","name":"Pone Miinun; Nepi / Enseñanza de Chamán; Ayahuasca / Shaman Training; Ayahuasca","year":"2003","cit":0,"pfa":"Pone","psa":"Alfonso Aguavil Calazacón","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2597617416","eid":"W2597617416"},{"id":"paper-w4247801520","cat":"papers","name":"MDMA (Methylendioxymethamphetamin)","year":"2019","cit":0,"pfa":"Axel M. Gressner","psa":"Torsten Arndt","ptype":"book-chapter","src":"https://openalex.org/W4247801520","eid":"W4247801520"},{"id":"paper-w1971520173","cat":"papers","name":"Ecstasy (MDMA): Mood effects in recreational polydrug users","year":"1996","cit":0,"pfa":"Andrew C. Parrott","ptype":"article","src":"https://openalex.org/W1971520173","eid":"W1971520173"},{"id":"paper-w2376003009","cat":"papers","name":"Synthesis of N,N-Dimethyltryptamine Derivative","year":"2002","cit":0,"pfa":"Liu De-chen","ptype":"article","src":"https://openalex.org/W2376003009","eid":"W2376003009"},{"id":"paper-w2417852485","cat":"papers","name":"Effect of mescaline on an innate behaviour of mice.","year":"1979","cit":0,"pfa":"L Altomani","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2417852485","eid":"W2417852485"},{"id":"paper-w4233025644","cat":"papers","name":"How the Names are Changed on the Peyote Journey","year":"2019","cit":0,"pfa":"Ramón Medina Silva","ptype":"conference-paper","src":"https://openalex.org/W4233025644","eid":"W4233025644"},{"id":"paper-w4385500708","cat":"papers","name":"Critical Analysis of the Total Synthesis of Salvinorin A","year":"2023","cit":0,"pfa":"AJ Martin","ptype":"preprint","src":"https://openalex.org/W4385500708","eid":"W4385500708"},{"id":"paper-w4304110272","cat":"papers","name":"Taking psilocybin for science","year":"2022","cit":0,"pfa":"Devon Stoliker","psa":"Adeel Razi","ptype":"report","src":"https://openalex.org/W4304110272","eid":"W4304110272"},{"id":"paper-w7135491743","cat":"papers","name":"Psilocybin: the mechanism of action and therapeutic potential","year":"2023","cit":0,"pfa":"Tímea Mintálová","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"dissertation","src":"https://openalex.org/W7135491743","eid":"W7135491743"},{"id":"paper-w7161120874","cat":"papers","name":"Ep. 2533: Can Ibogaine Really Reset Addiction?","year":"2026","cit":0,"pfa":"Daniel Rosehill","psa":"Chatterbox TTS","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"other","src":"https://openalex.org/W7161120874","eid":"W7161120874"},{"id":"paper-w7166622614","cat":"papers","name":"Templated from Sexual identity moderation of associations between lifetime MDMA/ecstasy and psilocybin use and mental health outcomes in NSDUH 2015–2019","year":"2026","cit":0,"pfa":"Maya Seale","ptype":"preprint","src":"https://openalex.org/W7166622614","eid":"W7166622614"},{"id":"paper-w2943130965","cat":"papers","name":"A SYSTEMATIC REVIEW OF RESEARCH ON N,N-DIMETHYLTRYPTAMINE","year":"2017","cit":0,"pfa":"Denitsa M. Hristova","psa":"M. Zhelyazkova-Savova","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W2943130965","eid":"W2943130965"},{"id":"paper-w761878229","cat":"papers","name":"Binding specificities for mescaline of anti-mescaline antibodies and mitochondrial-synaptosomal subcellular fractions of rat brain","year":"1976","cit":0,"pfa":"Sidney H. Schnoll","ptype":"article","src":"https://openalex.org/W761878229","eid":"W761878229"},{"id":"paper-w2103348509","cat":"papers","name":"Effects of ibogaine on neurohormones and neurotransmitter systems in rat","year":"1996","cit":0,"pfa":"Syed F. Ali","psa":"Michael H. Baumann","ptype":"article","src":"https://openalex.org/W2103348509","eid":"W2103348509"},{"id":"paper-w7163670685","cat":"papers","name":"Ibogaine in the Vet Brain: Changes in Brain Metabolism and Connectivity After Ibogaine Administration in Veterans With Traumatic Brain Injury","year":"2026","cit":0,"pfa":"Gregory A. Fonzo","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W7163670685","eid":"W7163670685"},{"id":"paper-w59331255","cat":"papers","name":"Desierto, peyote y una hormiga","year":"2001","cit":0,"pfa":"Titi Trigo","ptype":"article","src":"https://openalex.org/W59331255","eid":"W59331255"},{"id":"paper-w2915689780","cat":"papers","name":"4 DMT und Ayahuasca","year":"2016","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W2915689780","eid":"W2915689780"},{"id":"paper-w2809520799","cat":"papers","name":"Ayahuasca: Путь к балансу","year":"2016","cit":0,"pfa":"Rita Barreto de Sales Oliveira","ptype":"article","src":"https://openalex.org/W2809520799","eid":"W2809520799"},{"id":"paper-w4386849553","cat":"papers","name":"Medicalisation of Ayahuasca as a Depression Treatment","year":"2023","cit":0,"pfa":"Elena Gomel Cordeiro","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W4386849553","eid":"W4386849553"},{"id":"paper-w2198172106","cat":"papers","name":"Selective Modification of the Furan Ring of Salvinorin A","year":"2007","cit":0,"pfa":"N. Han","psa":"Thomas Edward Prisinzano","ptype":"article","src":"https://openalex.org/W2198172106","eid":"W2198172106"},{"id":"paper-w4411166780","cat":"papers","name":"Psilocybin bei Alkoholkonsumstörung","year":"2025","cit":0,"ptype":"article","src":"https://openalex.org/W4411166780","eid":"W4411166780"},{"id":"paper-w2146496306","cat":"papers","name":"Mescaline : la religion du peyotl","year":"2004","cit":0,"pfa":"Pascal Kintz","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2146496306","eid":"W2146496306"},{"id":"paper-w2806004487","cat":"papers","name":"Modifications to the Synthesis of the Salvinorin A Carbon Skeleton","year":"2016","cit":0,"pfa":"Jerry Casbohm","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2806004487","eid":"W2806004487"},{"id":"paper-w4243527041","cat":"papers","name":"Chapter 15 Pagan Ceremonies and Peyote","year":"2001","cit":0,"pfa":"Robert Zingg","ptype":"book-chapter","src":"https://openalex.org/W4243527041","eid":"W4243527041"},{"id":"paper-w7141456584","cat":"papers","name":"Experimental Treatments: Psilocybin","year":"2018","cit":0,"topics":["Mechanism & neuroscience"],"ptype":"report","src":"https://openalex.org/W7141456584","eid":"W7141456584"},{"id":"paper-w7133308154","cat":"papers","name":"Synthesis and Characterization of Psilocybin Metabolites and Deuterated Analogs","year":"2026","cit":0,"pfa":"Samuel E. Williamson","psa":"Alexander M. Sherwood","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7133308154","eid":"W7133308154"},{"id":"paper-w2025262863","cat":"papers","name":"Catharanthinol and Dihydrocatharanthinol: Two Iboga‐Class Alkaloids.","year":"2005","cit":0,"pfa":"Lionel Moisan","psa":"P. Thuéry","ptype":"article","src":"https://openalex.org/W2025262863","eid":"W2025262863"},{"id":"paper-w7148779483","cat":"papers","name":"Psilocybin and human longevity","year":"2026","cit":0,"pfa":"Leonard B. Lerer","topics":["Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7148779483","eid":"W7148779483"},{"id":"paper-w2425757767","cat":"papers","name":"[Titration of the total alkaloids in the roots of Tabernanthe iboga].","year":"1959","cit":0,"pfa":"G Ghielmetti","psa":"C Mela","ptype":"article","src":"https://openalex.org/W2425757767","eid":"W2425757767"},{"id":"paper-w3093826296","cat":"papers","name":"Psilocybin and LSD in the Treatment of Depression and Anxiety","year":"2020","cit":0,"pfa":"Marcus Allgulin","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"dissertation","src":"https://openalex.org/W3093826296","eid":"W3093826296"},{"id":"paper-w2339511681","cat":"papers","name":"5. Hyperbolic: Divining Ayahuasca","year":"2011","cit":0,"topics":["Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W2339511681","eid":"W2339511681"},{"id":"paper-w1024241441","cat":"papers","name":"Una cura de ayahuasca","year":"2004","cit":0,"pfa":"Iván Carrasco Montesinos","ptype":"article","src":"https://openalex.org/W1024241441","eid":"W1024241441"},{"id":"paper-w4388302445","cat":"papers","name":"The remarkable reimagining of psilocybin","year":"2023","cit":0,"pfa":"Crist N. Filer","ptype":"article","src":"https://openalex.org/W4388302445","eid":"W4388302445"},{"id":"paper-w4308932276","cat":"papers","name":"Chlorothiazide/paracetamol/psilocybin","year":"2022","cit":0,"ptype":"article","src":"https://openalex.org/W4308932276","eid":"W4308932276"},{"id":"paper-w4400673781","cat":"papers","name":"Psilocybin and other Psychedelics","year":"2024","cit":0,"pfa":"Alfred P. Kaye","psa":"Christopher Pittenger","ptype":"book-chapter","src":"https://openalex.org/W4400673781","eid":"W4400673781"},{"id":"paper-w7167695901","cat":"papers","name":"Entourage-Psilocybin-Ganzpilz","year":"2026","cit":0,"pfa":"Schüller Thomas","ptype":"article","src":"https://openalex.org/W7167695901","eid":"W7167695901"},{"id":"paper-w4310033164","cat":"papers","name":"Mode of action of psilocybin","year":"2022","cit":0,"pfa":"Marten Dooper","ptype":"conference-paper","src":"https://openalex.org/W4310033164","eid":"W4310033164"},{"id":"paper-w4413313077","cat":"papers","name":"AYAHUASCA E SAÚDE MENTAL","year":"2025","cit":0,"pfa":"Pedro Ygor Café Paes Lira","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4413313077","eid":"W4413313077"},{"id":"paper-w7162554003","cat":"papers","name":"Studies on enzymatic hydrolysis of psilocin- O -glucuronide for screening of psilocin in human urine by liquid chromatography–triple quadrupole tandem mass spectrometry","year":"2026","cit":0,"pfa":"David A Barajas","psa":"Pucheng Ke","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7162554003","eid":"W7162554003"},{"id":"paper-w4416016336","cat":"papers","name":"Psilocybin bei Alkoholkonsumstörung","year":"2025","cit":0,"ptype":"article","src":"https://openalex.org/W4416016336","eid":"W4416016336"},{"id":"paper-w7215056171","cat":"papers","name":"Embeddedness under psilocybin","year":"2026","cit":0,"pfa":"Henrietta Howells","ptype":"article","src":"https://openalex.org/W7215056171","eid":"W7215056171"},{"id":"paper-w7198794859","cat":"papers","name":"Psilocybin as a Treatment for Depression","year":"2025","cit":0,"pfa":"Arif Ersegün Kahraman","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7198794859","eid":"W7198794859"},{"id":"paper-w7111691777","cat":"papers","name":"Psilocybin and self-stigma","year":"2025","cit":0,"pfa":"Graeme Knibb","ptype":"preprint","src":"https://openalex.org/W7111691777","eid":"W7111691777"},{"id":"paper-w3048778283","cat":"papers","name":"Binding Interactions of Psilocin and Serotonin in the 5-HT2A Receptor","year":"2020","cit":0,"pfa":"Katie R. Barnes","psa":"Stephanie N. Lewis","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3048778283","eid":"W3048778283"},{"id":"paper-w7167724603","cat":"papers","name":"Entourage-Psilocybin-Ganzpilz","year":"2026","cit":0,"pfa":"Schüller Thomas","ptype":"article","src":"https://openalex.org/W7167724603","eid":"W7167724603"},{"id":"paper-w2784473684","cat":"papers","name":"Iconography : Treatment of heroin dependence with ibogaine","year":"2016","cit":0,"pfa":"Arnt Schellekens","psa":"Maarten Belgers","ptype":"article","src":"https://openalex.org/W2784473684","eid":"W2784473684"},{"id":"paper-w4401271157","cat":"papers","name":"The Peyote Religion and the Native American Church","year":"2002","cit":0,"ptype":"other","src":"https://openalex.org/W4401271157","eid":"W4401271157"},{"id":"paper-w2414798892","cat":"papers","name":"A study of alkoxycarbonium ions related to mescaline.","year":"1969","cit":0,"pfa":"A I Popov","ptype":"article","src":"https://openalex.org/W2414798892","eid":"W2414798892"},{"id":"paper-w84774327","cat":"papers","name":"La mil caras del peyote","year":"2000","cit":0,"pfa":"Julio Mogrovejo","ptype":"article","src":"https://openalex.org/W84774327","eid":"W84774327"},{"id":"paper-w4246199056","cat":"papers","name":"Psilocybin Fast Facts","year":"2003","cit":0,"ptype":"dataset","src":"https://openalex.org/W4246199056","eid":"W4246199056"},{"id":"paper-w4416537015","cat":"papers","name":"Psychotrophic Compounds from Psilocybin Mushrooms","year":"2025","cit":0,"pfa":"Supriya Sharma","psa":"Rajshree Karanwal","ptype":"book-chapter","src":"https://openalex.org/W4416537015","eid":"W4416537015"},{"id":"paper-w4402989512","cat":"papers","name":"Voltammetric Detection of MDMA","year":"2024","cit":0,"pfa":"Bruna Coldibeli","psa":"Elen Romão Sartori","topics":["Addiction","Reviews & meta-analyses"],"ptype":"conference-paper","src":"https://openalex.org/W4402989512","eid":"W4402989512"},{"id":"paper-w52121689","cat":"papers","name":"Neuroimaging of MDMA-Induced Neurotoxicity","year":"2002","cit":0,"pfa":"Una D. McCann","psa":"George A. Ricaurte","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W52121689","eid":"W52121689"},{"id":"paper-w1980534275","cat":"papers","name":"Brazilian Literature on Ayahuasca Religions","year":"2008","cit":0,"pfa":"Beatriz Caiuby Labate","ptype":"article","src":"https://openalex.org/W1980534275","eid":"W1980534275"},{"id":"paper-w3194396335","cat":"papers","name":"The Effect of Psilocybin on Personality","year":"2021","cit":0,"pfa":"Ravital LaBua","topics":["Safety & adverse events","Therapy practice","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W3194396335","eid":"W3194396335"},{"id":"paper-w4392731896","cat":"papers","name":"Psilocybin gegen Depressionen","year":"2024","cit":0,"pfa":"Thomas Müller","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4392731896","eid":"W4392731896"},{"id":"paper-w7141215514","cat":"papers","name":"Psilocin fosters neuroplasticity in iPSC-derived human cortical neurons","year":"2026","cit":0,"pfa":"Målin Schmidt","psa":"P J Koch","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7141215514","eid":"W7141215514"},{"id":"paper-w7134863413","cat":"papers","name":"Ibogaine analogues in the human Serotonin Transporter","year":"2012","cit":0,"pfa":"Henriette Bjerregaard","psa":"Steffen Sinning","topics":["Mechanism & neuroscience"],"ptype":"conference-paper","src":"https://openalex.org/W7134863413","eid":"W7134863413"},{"id":"paper-w7140303704","cat":"papers","name":"Psilocybin: Chemical Foundations and Emerging Therapeutic Potential","year":"2026","cit":0,"pfa":"Shivaputra A. Patil","psa":"Holly C. Hunsberger","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7140303704","eid":"W7140303704"},{"id":"paper-w2528468170","cat":"papers","name":"Occasional MDMA Substitutes","year":"1998","cit":0,"pfa":"Karel Valter","psa":"Philippe Arrizabalaga","ptype":"book-chapter","src":"https://openalex.org/W2528468170","eid":"W2528468170"},{"id":"paper-w2639821851","cat":"papers","name":"INFINITOS ICAROS CON AYAHUASCA","year":"2016","cit":0,"pfa":"Ronald Rivera Cachique","ptype":"article","src":"https://openalex.org/W2639821851","eid":"W2639821851"},{"id":"paper-w2320515691","cat":"papers","name":"ISDN2012_0285: Cellular mechanisms of salvinorin A action in vivo","year":"2012","cit":0,"pfa":"Prem Narayan Yadav","psa":"Bryan L. Roth","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2320515691","eid":"W2320515691"},{"id":"paper-w4384939543","cat":"papers","name":"History of the Names of MDMA","year":"2023","cit":0,"pfa":"Torsten Passie","ptype":"reference-entry","src":"https://openalex.org/W4384939543","eid":"W4384939543"},{"id":"paper-w4254078353","cat":"papers","name":"Effects of ibogaine on neurohormones and neurotransmitter systems in rat.","year":"1996","cit":0,"pfa":"S Ali","ptype":"article","src":"https://openalex.org/W4254078353","eid":"W4254078353"},{"id":"paper-w7124277691","cat":"papers","name":"Ibogaine for Opioid Use Disorder: An Unrecognized Risk","year":"2026","cit":0,"pfa":"Dale Terasaki","psa":"Andrew A. Monte","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7124277691","eid":"W7124277691"},{"id":"paper-w4387809126","cat":"papers","name":"AYAHUASCA POSSUI EFEITO ANTIDEPRESSIVO?","year":"2023","cit":0,"pfa":"Jocimar Rodrigues de Oliveira Júnior","topics":["Depression"],"ptype":"book-chapter","src":"https://openalex.org/W4387809126","eid":"W4387809126"},{"id":"paper-w3043281529","cat":"papers","name":"MDMA (“Ecstasy”) for PTSD.","year":"2020","cit":0,"pfa":"Robert W. Motta","topics":["PTSD & trauma"],"ptype":"book-chapter","src":"https://openalex.org/W3043281529","eid":"W3043281529"},{"id":"paper-w2233346157","cat":"papers","name":"Psilocybin in psychiatry, and beyond.","year":"1961","cit":0,"pfa":"Richard R. Heim","ptype":"article","src":"https://openalex.org/W2233346157","eid":"W2233346157"},{"id":"paper-w4398919164","cat":"papers","name":"Acute Biphasic effects of ayahuasca","year":"2015","cit":0,"pfa":"Eduardo Ekman Schenberg","topics":["Reviews & meta-analyses"],"ptype":"dataset","src":"https://openalex.org/W4398919164","eid":"W4398919164"},{"id":"paper-w3190727609","cat":"papers","name":"Religiões ayahuasqueiras [Ayahuasca religions]","year":"2005","cit":0,"pfa":"Beatriz Caiuby Labate","psa":"Sandra Goulart","ptype":"article","src":"https://openalex.org/W3190727609","eid":"W3190727609"},{"id":"paper-w3134311722","cat":"papers","name":"Ayahuasca: drug, sacrament of medicijn?","year":"2020","cit":0,"pfa":"A.F.M. van der Braak","ptype":"article","src":"https://openalex.org/W3134311722","eid":"W3134311722"},{"id":"paper-w4409938257","cat":"papers","name":"Making Sense of Ayahuasca in the West","year":"2023","cit":0,"ptype":"other","src":"https://openalex.org/W4409938257","eid":"W4409938257"},{"id":"paper-w425566483","cat":"papers","name":"Lysergic Acid Diethylamideおよび関連化合物に関する研究(第3報)Lysergic Acidのアミド化の改良","year":"1974","cit":0,"pfa":"雄二 中原","psa":"徹吉 丹羽口","ptype":"article","src":"https://openalex.org/W425566483","eid":"W425566483"},{"id":"paper-w2801964021","cat":"papers","name":"The Emerging MDMA Pandemic","year":"2018","cit":0,"pfa":"Suprakash Chaudhury","ptype":"article","src":"https://openalex.org/W2801964021","eid":"W2801964021"},{"id":"paper-w4250551019","cat":"papers","name":"Report series: Psilocybin","year":"1973","cit":0,"ptype":"dataset","src":"https://openalex.org/W4250551019","eid":"W4250551019"},{"id":"paper-w2492615284","cat":"papers","name":"Psilocybin and Peak Experiences","year":"2016","cit":0,"pfa":"Jennifer A. Lyke","ptype":"book-chapter","src":"https://openalex.org/W2492615284","eid":"W2492615284"},{"id":"paper-w4322495954","cat":"papers","name":"A Defense Expert Witness on Ayahuasca","year":"2023","cit":0,"pfa":"Beatriz Caiuby Labate","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W4322495954","eid":"W4322495954"},{"id":"paper-w7215164222","cat":"papers","name":"Ayahuasca rituaalne kasutamine Eestis","year":"2019","cit":0,"pfa":"Helle Kaasik","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7215164222","eid":"W7215164222"},{"id":"paper-w4388078393","cat":"papers","name":"A Structural Typology of Ayahuasca Visualizations","year":"2002","cit":0,"pfa":"Benny Shanon","topics":["Reviews & meta-analyses"],"ptype":"book-chapter","src":"https://openalex.org/W4388078393","eid":"W4388078393"},{"id":"paper-w7139061033","cat":"papers","name":"Ayahuasca and Public Health III: Health Status of a Sample of Ayahuasca Ceremony Attenders in Portugal","year":"2026","cit":0,"pfa":"Pedro J. Teixeira","psa":"Maja Kohek","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7139061033","eid":"W7139061033"},{"id":"paper-w2784485362","cat":"papers","name":"@@112049@@ : Treatment of heroin dependence with ibogaine","year":"2016","cit":0,"pfa":"Arnt Schellekens","psa":"Maarten Belgers","ptype":"article","src":"https://openalex.org/W2784485362","eid":"W2784485362"},{"id":"paper-w4242531776","cat":"papers","name":"4 DMT und Ayahuasca","year":"2019","cit":0,"pfa":"Norbert Scherbaum","ptype":"book-chapter","src":"https://openalex.org/W4242531776","eid":"W4242531776"},{"id":"paper-w2409800832","cat":"papers","name":"[Pharmacopsychiatric observations with psilocybin].","year":"1962","cit":0,"pfa":"L GREGORETTI","psa":"C Sinisi","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2409800832","eid":"W2409800832"},{"id":"paper-w7129675453","cat":"papers","name":"Psilocin fosters neuroplasticity in iPSC-derived human cortical neurons","year":"2026","cit":0,"pfa":"Målin Schmidt","psa":"P J Koch","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W7129675453","eid":"W7129675453"},{"id":"paper-w4415209745","cat":"papers","name":"Ayahuasca: Pharmacological Composition and Potential Benefits","year":"2025","cit":0,"pfa":"Raj Nashikkar","psa":"Rajendra Patil","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4415209745","eid":"W4415209745"},{"id":"paper-w2906947562","cat":"papers","name":"MDMA and its Derivatives","year":"1998","cit":0,"pfa":"Karel Valter","psa":"Philippe Arrizabalaga","ptype":"book-chapter","src":"https://openalex.org/W2906947562","eid":"W2906947562"},{"id":"paper-w2530995236","cat":"papers","name":"The psilocybin producer's guide","year":"1976","cit":0,"pfa":"A. Gottlieb","ptype":"article","src":"https://openalex.org/W2530995236","eid":"W2530995236"},{"id":"paper-w4391469842","cat":"papers","name":"Effect of psilocybin on pain","year":"2024","cit":0,"pfa":"Alexandra Le Bras","ptype":"article","src":"https://openalex.org/W4391469842","eid":"W4391469842"},{"id":"paper-w3201864382","cat":"papers","name":"Ekstazy (MDMA) toksiškumas","year":"2005","cit":0,"pfa":"Dagmara Ona Reingardienė","ptype":"conference-paper","src":"https://openalex.org/W3201864382","eid":"W3201864382"},{"id":"paper-w834093156","cat":"papers","name":"Changing Perspective on MDMA","year":"2015","cit":0,"pfa":"Chloe Boden","topics":["PTSD & trauma","Policy & ethics"],"ptype":"conference-paper","src":"https://openalex.org/W834093156","eid":"W834093156"},{"id":"paper-w3089327765","cat":"papers","name":"The Peyote Effect: From the Inquisition to the War on Drugs","year":"2020","cit":0,"pfa":"Robert C. Fuller","ptype":"article","src":"https://openalex.org/W3089327765","eid":"W3089327765"},{"id":"paper-w886581181","cat":"papers","name":"Essai de culture du Tabernanthe iboga Baill.","year":"1962","cit":0,"pfa":"A. G. B. Bouquet","psa":"Henri Botton","ptype":"article","src":"https://openalex.org/W886581181","eid":"W886581181"},{"id":"paper-w7133315817","cat":"papers","name":"Functional validation of enzymes in Salvinorin A biosynthesis - LCMS data.","year":"2026","cit":0,"pfa":"Evangelos Tatsis","ptype":"dataset","src":"https://openalex.org/W7133315817","eid":"W7133315817"},{"id":"paper-w4386455034","cat":"papers","name":"Sintomatologia psicótica e ayahuasca","year":"2016","cit":0,"pfa":"Analice de Paula Gigliotti","psa":"Elie Leal de Barros Calfat","ptype":"article","src":"https://openalex.org/W4386455034","eid":"W4386455034"},{"id":"paper-w2936838778","cat":"papers","name":"Chamanes, ayahuasca y sanación","year":"2018","cit":0,"pfa":"Santiago López-Pavillard","ptype":"article","src":"https://openalex.org/W2936838778","eid":"W2936838778"},{"id":"paper-w7120528971","cat":"papers","name":"The setting questionnaire for the Ayahuasca experience","year":"2021","cit":0,"pfa":"Alexandre Augusto de Deus Pontual","ptype":"dissertation","src":"https://openalex.org/W7120528971","eid":"W7120528971"},{"id":"paper-w947026182","cat":"papers","name":"Non-Native Ayahuasca Use","year":"2011","cit":0,"pfa":"Danylo Kosovych","topics":["PTSD & trauma"],"ptype":"dissertation","src":"https://openalex.org/W947026182","eid":"W947026182"},{"id":"paper-w2001680361","cat":"papers","name":"MDMA and Impulsivity: A Review","year":"2008","cit":0,"pfa":"Casey R. Guillot","topics":["Mechanism & neuroscience","Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2001680361","eid":"W2001680361"},{"id":"paper-w2569324349","cat":"papers","name":"Ayahuasca: la sentencia definitiva","year":"2016","cit":0,"pfa":"Pedro Caldentey","ptype":"article","src":"https://openalex.org/W2569324349","eid":"W2569324349"},{"id":"paper-w4404812607","cat":"papers","name":"VII. The Peyote Ritual among the Menomini","year":"1952","cit":0,"pfa":"J. S. Slotkin","ptype":"book-chapter","src":"https://openalex.org/W4404812607","eid":"W4404812607"},{"id":"paper-w4404812802","cat":"papers","name":"V. How Peyote is Obtained by the Menomini","year":"1952","cit":0,"pfa":"J. S. Slotkin","ptype":"book-chapter","src":"https://openalex.org/W4404812802","eid":"W4404812802"},{"id":"paper-w2147657002","cat":"papers","name":"Jikuri, the Tarahumara Peyote Cult: An Interpretation","year":"1992","cit":0,"pfa":"Alfonso Paredes","psa":"Fructuoso Irigoyen-Rascón","ptype":"book-chapter","src":"https://openalex.org/W2147657002","eid":"W2147657002"},{"id":"paper-w2157099350","cat":"papers","name":": The Peyote Cult . Weston La Barre.","year":"1939","cit":0,"pfa":"MORRIS EDWARD OPLER","ptype":"article","src":"https://openalex.org/W2157099350","eid":"W2157099350"},{"id":"paper-w2168204022","cat":"papers","name":"The Peyote Road: A Text in Search of a Context","year":"1995","cit":0,"pfa":"Wiluam K. Powers","ptype":"article","src":"https://openalex.org/W2168204022","eid":"W2168204022"},{"id":"paper-w187624499","cat":"papers","name":"Peyote, tesoro de los huicholes","year":"2006","cit":0,"pfa":"Carlos Omar Rodríguez Suárez","ptype":"article","src":"https://openalex.org/W187624499","eid":"W187624499"},{"id":"paper-w4403363152","cat":"papers","name":"“Peyote: Wild Experience, Wild Consciousness”","year":"2024","cit":0,"pfa":"Peggy Pacini","ptype":"conference-paper","src":"https://openalex.org/W4403363152","eid":"W4403363152"},{"id":"paper-w2398695177","cat":"papers","name":"[Suppression by chlorpromazine of uterine contractions induced by mescaline].","year":"1956","cit":0,"pfa":"J Thuillier","ptype":"article","src":"https://openalex.org/W2398695177","eid":"W2398695177"},{"id":"paper-w7140035285","cat":"papers","name":"IbogaineVault: A Structured Evidence Map for Ibogaine Science","year":"2026","cit":0,"pfa":"Philip Kagalovsky","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"software","src":"https://openalex.org/W7140035285","eid":"W7140035285"},{"id":"paper-w4414057900","cat":"papers","name":"5HT2AR-miniGq heterotrimer in complex with a psychedelic psilocin","year":"2025","cit":0,"pfa":"M. Cao","psa":"X. Ji","ptype":"dataset","src":"https://openalex.org/W4414057900","eid":"W4414057900"},{"id":"paper-w2325655132","cat":"papers","name":"Implications of Court Decisions on Peyote for the Users of LSD","year":"1969","cit":0,"pfa":"B. F. Simmons","ptype":"article","src":"https://openalex.org/W2325655132","eid":"W2325655132"},{"id":"paper-w2951081203","cat":"papers","name":"ChemInform Abstract: CONFORMATIONALLY CONSTRAINED ANALOGS OF MESCALINE","year":"1975","cit":0,"pfa":"Robert J. Wolters","psa":"N. S. TANNER","ptype":"article","src":"https://openalex.org/W2951081203","eid":"W2951081203"},{"id":"paper-w4416808309","cat":"papers","name":"Subtle Energies in Ayahuasca Healing","year":"2025","cit":0,"pfa":"Wouter J. Hanegraaff","ptype":"book-chapter","src":"https://openalex.org/W4416808309","eid":"W4416808309"},{"id":"paper-w4251335494","cat":"papers","name":"Ayahuasca and the construction of a healing tradition","year":"2010","cit":0,"pfa":"Erik W. Davis","ptype":"dataset","src":"https://openalex.org/W4251335494","eid":"W4251335494"},{"id":"paper-w7130318722","cat":"papers","name":"Psilocybin Precision Functional Mapping (data from Psilocybin desynchronizes the human brain)","year":"2026","cit":0,"pfa":"S. Subramanian","psa":"et al.","ptype":"dataset","src":"https://openalex.org/W7130318722","eid":"W7130318722"},{"id":"paper-w7134229554","cat":"papers","name":"The long roots of ibogaine: A journey from plant to pharmaceutical","year":"2026","cit":0,"pfa":"Genís Oña","psa":"Sidsel Marie","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7134229554","eid":"W7134229554"},{"id":"paper-w4244936841","cat":"papers","name":"Multiple drugs/MDMA","year":"2011","cit":0,"pfa":"&NA;","ptype":"article","src":"https://openalex.org/W4244936841","eid":"W4244936841"},{"id":"paper-w4285547893","cat":"papers","name":"Setting Questionnaire for the Ayahuasca Experience","year":"2021","cit":0,"pfa":"Alexandre Augusto de Deus Pontual","psa":"Clarissa Mendonça Corradi-Webster","ptype":"dataset","src":"https://openalex.org/W4285547893","eid":"W4285547893"},{"id":"paper-w4409938296","cat":"papers","name":"Facing Gaia Through Ayahuasca","year":"2023","cit":0,"ptype":"other","src":"https://openalex.org/W4409938296","eid":"W4409938296"},{"id":"paper-w4234420004","cat":"papers","name":"Ayahuasca Mamancuma merci beaucoup","year":"2011","cit":0,"pfa":"Beatriz Caiuby Labate","ptype":"dissertation","src":"https://openalex.org/W4234420004","eid":"W4234420004"},{"id":"paper-w4416285937","cat":"papers","name":"Is there more to magic mushrooms than psilocybin?","year":"2025","cit":0,"pfa":"special to C EN Mara Johnson-Groh","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W4416285937","eid":"W4416285937"},{"id":"paper-w2181934872","cat":"papers","name":"Ayahuasca: il vino dell'anima","year":"2015","cit":0,"pfa":"Andrea Ossato","psa":"Matteo Marti","ptype":"article","src":"https://openalex.org/W2181934872","eid":"W2181934872"},{"id":"paper-w7161138818","cat":"papers","name":"Ep. 2533: Can Ibogaine Really Reset Addiction?","year":"2026","cit":0,"pfa":"Daniel Rosehill","psa":"Chatterbox TTS","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"other","src":"https://openalex.org/W7161138818","eid":"W7161138818"},{"id":"paper-w7140724976","cat":"papers","name":"Detection of Psilocybin Mushroom Analogs in Chocolate","year":"2009","cit":0,"pfa":"Brandon Huskins","psa":"Christopher R. Dockery","ptype":"article","src":"https://openalex.org/W7140724976","eid":"W7140724976"},{"id":"paper-w20695560","cat":"papers","name":"Risk assessment of MDMA","year":"2013","cit":0,"pfa":"L.B. van Engelen","topics":["Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W20695560","eid":"W20695560"},{"id":"paper-w4245497147","cat":"papers","name":"Mescaline Hydrochloride 832‐92‐8","year":"2004","cit":0,"ptype":"other","src":"https://openalex.org/W4245497147","eid":"W4245497147"},{"id":"paper-w4297241112","cat":"papers","name":"MDMA (Methylenedioxymethamfetamine) (c)","year":"2011","cit":0,"topics":["Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W4297241112","eid":"W4297241112"},{"id":"paper-w4392156286","cat":"papers","name":"Psychedelic-Assisted Therapy: Ayahuasca","year":"2024","cit":0,"pfa":"Bruce Ecker","psa":"Laurel Hulley","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W4392156286","eid":"W4392156286"},{"id":"paper-w3206691099","cat":"papers","name":"Ayahuasca. Vocabulario Controlado SEDRONAR","year":"2015","cit":0,"pfa":"Biblioteca Sedronar","ptype":"article","src":"https://openalex.org/W3206691099","eid":"W3206691099"},{"id":"paper-w4309969484","cat":"papers","name":"Ayahuasca Self Consciousness and Mysticism","year":"2022","cit":0,"pfa":"Robson Savoldi","psa":"Antônio Roazzi","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4309969484","eid":"W4309969484"},{"id":"paper-w7143404446","cat":"papers","name":"The Ethnopharmacological Use of Mescaline for Psychiatric Disorders: A Systematic Review","year":"2026","cit":0,"pfa":"Jonathan Shaw","psa":"Robert G. Bota","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W7143404446","eid":"W7143404446"},{"id":"paper-w2443690230","cat":"papers","name":"Eesti ayahuasca tarvitajate psüühika","year":"2016","cit":0,"pfa":"Helle Kaasik","topics":["Depression","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W2443690230","eid":"W2443690230"},{"id":"paper-w3096636258","cat":"papers","name":"Utilidades terapéuticas del ayahuasca","year":"2020","cit":0,"pfa":"R. Pinilla","psa":"Andrea Sotillos","topics":["Addiction","Mechanism & neuroscience"],"ptype":"conference-paper","src":"https://openalex.org/W3096636258","eid":"W3096636258"},{"id":"paper-w4322496032","cat":"papers","name":"Regulating Ayahuasca in the United Kingdom","year":"2023","cit":0,"pfa":"Charlotte Walsh","topics":["Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W4322496032","eid":"W4322496032"},{"id":"paper-w2570975898","cat":"papers","name":"The effects of mescaline analogues on the operant behaviour of rats","year":"1967","cit":0,"pfa":"Victor S. Johnston","ptype":"dissertation","src":"https://openalex.org/W2570975898","eid":"W2570975898"},{"id":"paper-w4241222515","cat":"papers","name":"MARAVIROC MARIHUANA MDMA","year":"2014","cit":0,"pfa":"Neil Shear","ptype":"book-chapter","src":"https://openalex.org/W4241222515","eid":"W4241222515"},{"id":"paper-w2614271452","cat":"papers","name":"Ayahuasca Visions in the Peruvian Amazon","year":"2016","cit":0,"pfa":"Greg Batchelder","ptype":"article","src":"https://openalex.org/W2614271452","eid":"W2614271452"},{"id":"paper-w837594239","cat":"papers","name":"The study of reactions involved in the synthesis of mescaline","year":"1951","cit":0,"pfa":"CATHERINE B. GAIRAUD","ptype":"dissertation","src":"https://openalex.org/W837594239","eid":"W837594239"},{"id":"paper-w2488626130","cat":"papers","name":"5 DMT und Ayahuasca","year":"2005","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W2488626130","eid":"W2488626130"},{"id":"paper-w4377191632","cat":"papers","name":"Where Will buy legal iboga online Be 1 Year From Now?","year":"2023","cit":0,"pfa":"genielforxkzw","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4377191632","eid":"W4377191632"},{"id":"paper-w2362796272","cat":"papers","name":"(MDMA): current perspectives","year":"2013","cit":0,"pfa":"Jerrold S. Meyer","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W2362796272","eid":"W2362796272"},{"id":"paper-w4245432198","cat":"papers","name":"Methylenedioxy metamphetamine (MDMA)","year":"2012","cit":0,"pfa":"Frank C. Mooren","psa":"Boris Schmitz","ptype":"reference-entry","src":"https://openalex.org/W4245432198","eid":"W4245432198"},{"id":"paper-w4242970228","cat":"papers","name":"Mescaline Sulfate 5967‐42‐0","year":"2012","cit":0,"ptype":"other","src":"https://openalex.org/W4242970228","eid":"W4242970228"},{"id":"paper-w2990030903","cat":"papers","name":"Kummels, Ingrid: Land, Nahrung und Peyote","year":"2009","cit":0,"pfa":"Bettina E. Schmidt","ptype":"article","src":"https://openalex.org/W2990030903","eid":"W2990030903"},{"id":"paper-w3215848701","cat":"papers","name":"Response to Luz & Mash on cardiac toxicity of ibogaine","year":"2021","cit":0,"pfa":"Arnt Schellekens","psa":"Robbert‐Jan Verkes","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3215848701","eid":"W3215848701"},{"id":"paper-w7150914311","cat":"papers","name":"IbogaineVault: A Structured Evidence Map for Ibogaine Science","year":"2026","cit":0,"pfa":"Philip Kagalovsky","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"software","src":"https://openalex.org/W7150914311","eid":"W7150914311"},{"id":"paper-w7129337774","cat":"papers","name":"Ayahuasca: Between Cognition and Culture","year":"2020","cit":0,"pfa":"Ismael Apud Pelaez","ptype":"book","src":"https://openalex.org/W7129337774","eid":"W7129337774"},{"id":"paper-w7202114562","cat":"papers","name":"Psilocybin Precision Functional Mapping (data from Psilocybin desynchronizes the human brain)","year":"2026","cit":0,"pfa":"S. Subramanian","psa":"et al.","ptype":"dataset","src":"https://openalex.org/W7202114562","eid":"W7202114562"},{"id":"paper-w2588892896","cat":"papers","name":"Different effects of MDMA or methamphetamine on aggressivity in mice repeatedly pretreated by MDMA","year":"2006","cit":0,"pfa":"Karel Šlais","psa":"Alexandra Šulcová","ptype":"article","src":"https://openalex.org/W2588892896","eid":"W2588892896"},{"id":"paper-w4384939510","cat":"papers","name":"The Early History of MDMA","year":"2023","cit":0,"pfa":"Torsten Passie","ptype":"book-chapter","src":"https://openalex.org/W4384939510","eid":"W4384939510"},{"id":"paper-w2725555998","cat":"papers","name":"Amada’s Blessings from the Peyote Gardens of South Texas","year":"2017","cit":0,"pfa":"Sarah Dees","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2725555998","eid":"W2725555998"},{"id":"paper-w3024057501","cat":"papers","name":"Fatal MDMA intoxication","year":"1999","cit":0,"pfa":"Sir—J A Henry","psa":"I R Hill","ptype":"article","src":"https://openalex.org/W3024057501","eid":"W3024057501"},{"id":"paper-w3110554755","cat":"papers","name":"Ayahuasca, Capitalism and the New Age","year":"2020","cit":0,"pfa":"Daniela M. Peluso","ptype":"other","src":"https://openalex.org/W3110554755","eid":"W3110554755"},{"id":"paper-w7135526863","cat":"papers","name":"Capillary electrophoresis of psilocybin in hallucinogenic mushrooms","year":"1998","cit":0,"pfa":"Stig Pedersen-Bjergaard","psa":"Knut Einar Rasmussen","ptype":"article","src":"https://openalex.org/W7135526863","eid":"W7135526863"},{"id":"paper-w1970882472","cat":"papers","name":"EFFECT OF MESCALINE ON RESPIRATION OF CEREBRAL TISSUE","year":"1960","cit":0,"pfa":"Tatsuya Tsunoda","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1970882472","eid":"W1970882472"},{"id":"paper-w2591148014","cat":"papers","name":"L'ecstasy (metilendiossimetilamfetamina, MDMA)","year":"2008","cit":0,"pfa":"Pier Francesco Mannaioni","psa":"Guido Mannaioni","ptype":"article","src":"https://openalex.org/W2591148014","eid":"W2591148014"},{"id":"paper-w2360606585","cat":"papers","name":"The Study of MDMA Toxicity","year":"2004","cit":0,"pfa":"Weihong Kuang","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2360606585","eid":"W2360606585"},{"id":"paper-w7112765046","cat":"papers","name":"Ecstasy eller MDMA","year":"2020","cit":0,"pfa":"Hesse, Morten; id_orcid 0000-0002-6849-6554","ptype":"book-chapter","src":"https://openalex.org/W7112765046","eid":"W7112765046"},{"id":"paper-w2805483056","cat":"papers","name":"A synthetic approach to the iboga alkaloids : a new synthesis of isoquinuclidines /","year":"1964","cit":0,"pfa":"Cornelius Kendall Wilkins","ptype":"article","src":"https://openalex.org/W2805483056","eid":"W2805483056"},{"id":"paper-w7130327698","cat":"papers","name":"Psilocybin Precision Functional Mapping (data from Psilocybin desynchronizes the human brain)","year":"2026","cit":0,"pfa":"S. Subramanian","psa":"et al.","ptype":"dataset","src":"https://openalex.org/W7130327698","eid":"W7130327698"},{"id":"paper-w4390270939","cat":"papers","name":"Psychedelic Therapy: A Primer for Primary Care Clinicians – Part V. Ibogaine","year":"2023","cit":0,"pfa":"Kirsten N. Cherian","psa":"Owen S. Muir","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"preprint","src":"https://openalex.org/W4390270939","eid":"W4390270939"},{"id":"paper-w7120712561","cat":"papers","name":"Pharmacokinetic studies of ayahuasca alkaloids","year":"2010","cit":0,"pfa":"Ana Paula Salum Pires","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7120712561","eid":"W7120712561"},{"id":"paper-w3080381951","cat":"papers","name":"Chapter Ten. 1971: Peyote Outlawed in Mexico","year":"2019","cit":0,"pfa":"Alexander Dawson","ptype":"article","src":"https://openalex.org/W3080381951","eid":"W3080381951"},{"id":"paper-w4253403259","cat":"papers","name":"The Peyote Controversy and the Demise of the Society of American Indians","year":"2013","cit":0,"pfa":"Thomas C. Maroukis","ptype":"article","src":"https://openalex.org/W4253403259","eid":"W4253403259"},{"id":"paper-w7115310314","cat":"papers","name":"Explanation of the Ayahuasca ritual and song","cit":0,"ptype":"article","src":"https://openalex.org/W7115310314","eid":"W7115310314"},{"id":"paper-w7120468110","cat":"papers","name":"The use of ayahuasca in the dependence of crack","year":"2013","cit":0,"pfa":"Joselaine Ida da [UNIFESP] Cruz","ptype":"dissertation","src":"https://openalex.org/W7120468110","eid":"W7120468110"},{"id":"paper-w3174579905","cat":"papers","name":"Exploration of Salvinorin A for the Development of Pain and Addiction Therapies","year":"2017","cit":0,"pfa":"Rachel S. Crowley","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W3174579905","eid":"W3174579905"},{"id":"paper-w2997929346","cat":"papers","name":"Ibogaine as an alternative and efficacious treatment for heroin addiction","year":"2012","cit":0,"pfa":"N K Amadon","psa":"Andrew M. Roecker","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2997929346","eid":"W2997929346"},{"id":"paper-w7151844175","cat":"papers","name":"IbogaineVault: A Structured Evidence Map for Ibogaine Science","year":"2026","cit":0,"pfa":"Philip Kagalovsky","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"software","src":"https://openalex.org/W7151844175","eid":"W7151844175"},{"id":"paper-w2414051624","cat":"papers","name":"Some notes on peyote (Lophophora williamsii).","year":"1958","cit":0,"pfa":"Kloesel Lg","ptype":"article","src":"https://openalex.org/W2414051624","eid":"W2414051624"},{"id":"paper-w4387482558","cat":"papers","name":"Peyote—A Culture’s Catalyst The Eternal Search","year":"2016","cit":0,"pfa":"Fannie Kahan","ptype":"book-chapter","src":"https://openalex.org/W4387482558","eid":"W4387482558"},{"id":"paper-w7140058002","cat":"papers","name":"IbogaineVault: A Structured Evidence Map for Ibogaine Science","year":"2026","cit":0,"pfa":"Philip Kagalovsky","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"software","src":"https://openalex.org/W7140058002","eid":"W7140058002"},{"id":"paper-w3114320607","cat":"papers","name":"Ibogaine inspires potential neuropsychiatric treatment","year":"2020","cit":0,"pfa":"Bethany A. Halford","ptype":"article","src":"https://openalex.org/W3114320607","eid":"W3114320607"},{"id":"paper-w2792526501","cat":"papers","name":"Ibogaine offers an alternative approach for treating opiate addiction","year":"2018","cit":0,"pfa":"Christopher Sivert Nielsen","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W2792526501","eid":"W2792526501"},{"id":"paper-w2057303908","cat":"papers","name":"Ayahuasca: Human Consciousness and the Spirits of Nature Ayahuasca Reader: Encounters with the Amazon's Sacred Vine","year":"2002","cit":0,"pfa":"Steve Heilig","ptype":"article","src":"https://openalex.org/W2057303908","eid":"W2057303908"},{"id":"paper-w2188937407","cat":"papers","name":"Intoxication mortelle à l'iboga : quantification de l'ibogaïne et de l'ibogamine dans des racines d'iboga et dans des prélèvements post-mortem par CPG-SM/SM Fatal intoxication after taking iboga: GC-MS/MS determination o","year":"2012","cit":0,"pfa":"Cédric Mazoyer","psa":"Yvan Gaillard","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2188937407","eid":"W2188937407"},{"id":"paper-w4382203673","cat":"papers","name":"Psilocybin decelerates cellular senescence","year":"2023","cit":0,"pfa":"Louise Hecker","psa":"Ali Zarrabi","ptype":"preprint","src":"https://openalex.org/W4382203673","eid":"W4382203673"},{"id":"paper-w4399592945","cat":"papers","name":"Psychoactive Drug MDMA","year":"2024","cit":0,"pfa":"Amit Prasad Rath","topics":["PTSD & trauma","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4399592945","eid":"W4399592945"},{"id":"paper-w2010118115","cat":"papers","name":"Kliniske erfaringer med psilocybin","year":"1963","cit":0,"pfa":"Ketty Kjærbye Kristensen","ptype":"article","src":"https://openalex.org/W2010118115","eid":"W2010118115"},{"id":"paper-w1156866806","cat":"papers","name":"Characterization of Noribogaine at nAChRs and Effect on Nicotine Self‐Administration in Rats","year":"2015","cit":0,"pfa":"Émeline L. Maillet","psa":"Deborah C. Mash","topics":["Addiction","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1156866806","eid":"W1156866806"},{"id":"paper-w4252137134","cat":"papers","name":"Mescaline Hydrochloride 832‐92‐8","year":"2012","cit":0,"ptype":"other","src":"https://openalex.org/W4252137134","eid":"W4252137134"},{"id":"paper-w7165199227","cat":"papers","name":"DESI-MSI-Based Multi-Organ Distribution Mapping of Psilocin in Zebrafish","year":"2026","cit":0,"pfa":"Mengxuan Dong","psa":"Chen Wang","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7165199227","eid":"W7165199227"},{"id":"paper-w3174190725","cat":"papers","name":"Synthetic studies on the iboga alkaloids targeting voacangines","year":"2021","cit":0,"pfa":"Shun Oyadomari","ptype":"article","src":"https://openalex.org/W3174190725","eid":"W3174190725"},{"id":"paper-w4407960790","cat":"papers","name":"Open MDMA: A Comprehensive Narrative Review and Practical Guide for the Therapeutic use of MDMA","year":"2025","cit":0,"pfa":"Mark Groeneveld","psa":"Thomas Harper","topics":["PTSD & trauma","Anxiety & end-of-life","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4407960790","eid":"W4407960790"},{"id":"paper-w2496324710","cat":"papers","name":"Die MDMA-Architektur","year":"1993","cit":0,"pfa":"Michael Rupprecht","ptype":"book-chapter","src":"https://openalex.org/W2496324710","eid":"W2496324710"},{"id":"paper-w4281613779","cat":"papers","name":"How dangerous is MDMA?","year":"2022","cit":0,"pfa":"Joachim Frost","ptype":"article","src":"https://openalex.org/W4281613779","eid":"W4281613779"},{"id":"paper-w4322584611","cat":"papers","name":"Chapter Ten. 1971: Peyote Outlawed in Mexico","year":"2019","cit":0,"pfa":"Alexander S. Dawson","ptype":"book-chapter","src":"https://openalex.org/W4322584611","eid":"W4322584611"},{"id":"paper-w2013494745","cat":"papers","name":"The effect of desipramine on the uptake of mescaline by cortical synaptosomes","year":"1977","cit":0,"pfa":"Paul Bevan","psa":"E. Szabadi","ptype":"article","src":"https://openalex.org/W2013494745","eid":"W2013494745"},{"id":"paper-w7140101865","cat":"papers","name":"IbogaineVault: A Structured Evidence Map for Ibogaine Science","year":"2026","cit":0,"pfa":"Philip Kagalovsky","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"software","src":"https://openalex.org/W7140101865","eid":"W7140101865"},{"id":"paper-w3004273005","cat":"papers","name":"The Peyote Effect: From the Inquisition to the War on Drugs","year":"2020","cit":0,"pfa":"Michele McArdle Stephens","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3004273005","eid":"W3004273005"},{"id":"paper-w4410650945","cat":"papers","name":"Comments on the Psychological Effects of Mescaline and Allied Drugs","year":"2012","cit":0,"ptype":"other","src":"https://openalex.org/W4410650945","eid":"W4410650945"},{"id":"paper-w7147176516","cat":"papers","name":"IbogaineVault: A Structured Evidence Map for Ibogaine Science","year":"2026","cit":0,"pfa":"Philip Kagalovsky","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"software","src":"https://openalex.org/W7147176516","eid":"W7147176516"},{"id":"paper-w1583919213","cat":"papers","name":"Ethnology: The Peyote Cult. Weston La Barre","year":"1977","cit":0,"pfa":"Omer C. Stewart","ptype":"article","src":"https://openalex.org/W1583919213","eid":"W1583919213"},{"id":"paper-w2413840159","cat":"papers","name":"[Effect of dimethyltryptamine (DMT) on the electroencephalogram of normal individuals].","year":"1958","cit":0,"pfa":"Ferenc Kajtor","ptype":"article","src":"https://openalex.org/W2413840159","eid":"W2413840159"},{"id":"paper-w4392109171","cat":"papers","name":"Peyote and the Department of Energy Access Authorization Criteria","year":"2002","cit":0,"pfa":"Phillip Kannan","psa":"USDOE Office of Nonproliferation and National Security (NN)","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"report","src":"https://openalex.org/W4392109171","eid":"W4392109171"},{"id":"paper-w7130651199","cat":"papers","name":"Psychedelic Therapy: A Primer for Primary Care Clinicians—5-Methoxy-N,N-Dimethyltryptamine","year":"2026","cit":0,"pfa":"Burton Jared Tabaac","psa":"Owen S. Muir","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7130651199","eid":"W7130651199"},{"id":"paper-w4298008970","cat":"papers","name":"Salvinorin A: A potent naturally occurring nonnitrogenous κ opioid selective agonist","year":"2020","cit":0,"pfa":"K. Baner","psa":"R.B. Rothman","topics":["Addiction","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4298008970","eid":"W4298008970"},{"id":"paper-w7166650553","cat":"papers","name":"Psilocin as a Broad Inhibitor of CYP450 Enzymes: Integrated In Vitro and In Silico Evidence","year":"2026","cit":0,"pfa":"Diana Silva","psa":"Sérgio F. Sousa","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7166650553","eid":"W7166650553"},{"id":"paper-w2764703144","cat":"papers","name":"Mescaline-induced changes of brain-cortex ribosomes. Effect of mescaline on the hydrogen-bonded structure of ribonucleic acid of brain-cortex ribosomes","year":"1970","cit":0,"topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2764703144","eid":"W2764703144"},{"id":"paper-w7141528910","cat":"papers","name":"The Use of MDMA for PTSD","year":"2018","cit":0,"topics":["PTSD & trauma","Mechanism & neuroscience"],"ptype":"report","src":"https://openalex.org/W7141528910","eid":"W7141528910"},{"id":"paper-w4286466512","cat":"papers","name":"Amphetamine, Methylamphetamine and MDMA","year":"2022","cit":0,"topics":["Addiction","Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W4286466512","eid":"W4286466512"},{"id":"paper-w1992608127","cat":"papers","name":"529 The hallucinogen psilocybin increases prepulse inhibition of the startle reflex in healthy humans","year":"1998","cit":0,"pfa":"Euphrosyne Gouzoulis‐Mayfrank","psa":"M.A. Geyer","ptype":"article","src":"https://openalex.org/W1992608127","eid":"W1992608127"},{"id":"paper-w2410957113","cat":"papers","name":"[Two auto-observations of experimental mescaline intoxication].","year":"1956","cit":0,"pfa":"Jean-Christian Delay","psa":"M ROPERT","ptype":"article","src":"https://openalex.org/W2410957113","eid":"W2410957113"},{"id":"paper-w7126348724","cat":"papers","name":"Noribogaine altered intrinsic properties of thalamocortical neurons in a sex-dependent manner","year":"2025","cit":0,"pfa":"María Sofía Villalba","psa":"Verónica Bisagno","ptype":"article","src":"https://openalex.org/W7126348724","eid":"W7126348724"},{"id":"paper-w117505175","cat":"papers","name":"Evaluation of MDPV and Mephedrone in Rats Trained to Discriminate MDMA or a MDMA-Amphetamine Mixture","year":"2014","cit":0,"pfa":"Eric L. Harvey","psa":"Jennifer L. Walters","ptype":"article","src":"https://openalex.org/W117505175","eid":"W117505175"},{"id":"paper-w2409253064","cat":"papers","name":"[Preparation of some alpha-disubstituted derivatives of mescaline].","year":"1961","cit":0,"pfa":"G Schwachhofer","psa":"Jean Chopin","ptype":"article","src":"https://openalex.org/W2409253064","eid":"W2409253064"},{"id":"paper-w4294189693","cat":"papers","name":"Possible Therapeutics Effects of Ayahuasca, a Psychedelic Compound","year":"2022","cit":0,"pfa":"L. Silva","psa":"L. Bravo","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4294189693","eid":"W4294189693"},{"id":"paper-w4390006951","cat":"papers","name":"Application of psilocybin in mental health disorders","year":"2023","cit":0,"pfa":"Jingxuan Chen","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4390006951","eid":"W4390006951"},{"id":"paper-w2327085285","cat":"papers","name":"Ayahuasca en los lugares comunes","year":"2015","cit":0,"pfa":"Carlos Suárez","ptype":"article","src":"https://openalex.org/W2327085285","eid":"W2327085285"},{"id":"paper-w3164580831","cat":"papers","name":"Terapéutica del Peyote y la Mescalina (","year":"1987","cit":0,"pfa":"A. Ma Carmona i Cornet","psa":"María Perera Bonay","ptype":"article","src":"https://openalex.org/W3164580831","eid":"W3164580831"},{"id":"paper-w2952869982","cat":"papers","name":"ChemInform Abstract: SYNTHESIS OF POTENTIAL MESCALINE ANTAGONISTS","year":"1977","cit":0,"pfa":"F. JUN. DESANTIS","psa":"Karl A. Nieforth","ptype":"article","src":"https://openalex.org/W2952869982","eid":"W2952869982"},{"id":"paper-w2769902477","cat":"papers","name":"Joe Blackbear’S Story of the Origin Of the Peyote Religion","year":"1963","cit":0,"pfa":"Charles S. Brant","ptype":"article","src":"https://openalex.org/W2769902477","eid":"W2769902477"},{"id":"paper-w2562623068","cat":"papers","name":"Behavioural effects of mescaline and some of its analogues","year":"1970","cit":0,"pfa":"Elizabeth A. Sykes","topics":["Depression","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"dissertation","src":"https://openalex.org/W2562623068","eid":"W2562623068"},{"id":"paper-w7118011230","cat":"papers","name":"Acute effects of mescaline on emotional and cognitive empathy","year":"2026","cit":0,"pfa":"A. Klaiber","psa":"Y. Schmid","ptype":"article","src":"https://openalex.org/W7118011230","eid":"W7118011230"},{"id":"paper-w2407763473","cat":"papers","name":"[Neighbors of the Huichol Indians under the influence of mescaline].","year":"1971","cit":0,"pfa":"M Benzi","ptype":"article","src":"https://openalex.org/W2407763473","eid":"W2407763473"},{"id":"paper-w2413403342","cat":"papers","name":"[Effect of mescaline on the serotoninergic system of the rat brain].","year":"1976","cit":0,"pfa":"M Torre","psa":"Filippo Bogetto","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2413403342","eid":"W2413403342"},{"id":"paper-w77234043","cat":"papers","name":"Ayahuasca, una realidad en expansión","year":"2009","cit":0,"pfa":"Borja De Miguel","ptype":"article","src":"https://openalex.org/W77234043","eid":"W77234043"},{"id":"paper-w4394954332","cat":"papers","name":"Uso da ayahuasca no tratamento da depressão","year":"2021","cit":0,"pfa":"Robenilson Diniz Alves","psa":"Joezilda Sousa Silvestre","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4394954332","eid":"W4394954332"},{"id":"paper-w2809922301","cat":"papers","name":"Ayahuasca: Un modo per l'equilibrio","year":"2016","cit":0,"pfa":"Rita Barreto de Sales Oliveira","ptype":"article","src":"https://openalex.org/W2809922301","eid":"W2809922301"},{"id":"paper-w4412402208","cat":"papers","name":"AYAHUASCA E SAÚDE: O USO DA AYAHUASCA COMO TERAPIA ALTERNATIVA NA DEPRESSÃO.","year":"2025","cit":0,"pfa":"Andressa Maria Ferreira Carneiro","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4412402208","eid":"W4412402208"},{"id":"paper-w1574964055","cat":"papers","name":"Antropología simétrica y procesos de curación con ayahuasca Symmetric anthropology and healing processes with ayahuasca","year":"2014","cit":0,"pfa":"Mauricio Genet Guzmán Chávez","ptype":"article","src":"https://openalex.org/W1574964055","eid":"W1574964055"},{"id":"paper-w4398774678","cat":"papers","name":"Open MDMA: An Open Source Framework and Practical Guide for the Therapeutic use of MDMA","year":"2024","cit":0,"pfa":"Mark Groeneveld","psa":"Thomas Harper","topics":["PTSD & trauma","Anxiety & end-of-life","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4398774678","eid":"W4398774678"},{"id":"paper-w3194236679","cat":"papers","name":"Mit Psilocybin gegen Depression","year":"2021","cit":0,"pfa":"Markus Weih","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W3194236679","eid":"W3194236679"},{"id":"paper-w135126470","cat":"papers","name":"Detenciones ilegales por recibir ayahuasca","year":"2011","cit":0,"pfa":"José Carlos Bouso","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W135126470","eid":"W135126470"},{"id":"paper-w4249676079","cat":"papers","name":"Confusion over psilocybin toxicity","year":"1982","cit":0,"topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4249676079","eid":"W4249676079"},{"id":"paper-w2885676282","cat":"papers","name":"Ayahuasca: proprietà farmacologiche e tossicologiche","year":"2017","cit":0,"pfa":"Salma El Fettach","ptype":"article","src":"https://openalex.org/W2885676282","eid":"W2885676282"},{"id":"paper-w7119019149","cat":"papers","name":"Psilocin fosters neuroplasticity in iPSC-derived human cortical neurons","year":"2026","cit":0,"pfa":"Philipp Koch","psa":"Georg Köhr","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7119019149","eid":"W7119019149"},{"id":"paper-w4322765821","cat":"papers","name":"Wirkt Psilocybin nachhaltig antidepressiv?","year":"2023","cit":0,"pfa":"Lea Julia Mertens","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4322765821","eid":"W4322765821"},{"id":"paper-w7110662772","cat":"papers","name":"Could psilocin rescue chronic, stress-accelerated, transcriptional aging in brain?","year":"2025","cit":0,"pfa":"Craig, Danny R","psa":"Blalock, Eric M.","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7110662772","eid":"W7110662772"},{"id":"paper-w4386807386","cat":"papers","name":"Electrical Spiking of Psilocybin Fungi","year":"2023","cit":0,"pfa":"Antoni Gandía","psa":"Andrew Adamatzky","ptype":"book-chapter","src":"https://openalex.org/W4386807386","eid":"W4386807386"},{"id":"paper-w4313425551","cat":"papers","name":"Translational research investigating psilocybin","year":"2023","cit":0,"pfa":"Manon M.J. van den Berg","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W4313425551","eid":"W4313425551"},{"id":"paper-w4414850748","cat":"papers","name":"Psilocybin in the Treatment of Mental Disorders","year":"2024","cit":0,"pfa":"Doğancan Sönmez","psa":"Aslı Enzel Koç","ptype":"article","src":"https://openalex.org/W4414850748","eid":"W4414850748"},{"id":"paper-w7127267022","cat":"papers","name":"Ayahuasca, el bejuco el espíritu","year":"2026","cit":0,"pfa":"Lahiri Zuleta Moreno","ptype":"article","src":"https://openalex.org/W7127267022","eid":"W7127267022"},{"id":"paper-w7117884858","cat":"papers","name":"The Peyote Road: Uncovering the History of a Sacred Journey","year":"2026","cit":0,"pfa":"Reanna Daniels","psa":"Erika Dyck","ptype":"article","src":"https://openalex.org/W7117884858","eid":"W7117884858"},{"id":"paper-w2409963775","cat":"papers","name":"[Lysergic acid amides & mescaline in psychodiagnosis & psychotherapy].","year":"1957","cit":0,"pfa":"Gian Paolo Tonini","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2409963775","eid":"W2409963775"},{"id":"paper-w2411343754","cat":"papers","name":"[Autoradiography studies on the distribution of 3H-mescaline in mammals].","year":"1969","cit":0,"pfa":"E Lehr","psa":"Grazyna Werner","ptype":"article","src":"https://openalex.org/W2411343754","eid":"W2411343754"},{"id":"paper-w7203528416","cat":"papers","name":"Psilocybin and Psilocybin-Mushroom Safety: An Evidence-Based White Paper on Toxicity, Dependence, Mortality, and Risk Context","year":"2026","cit":0,"pfa":"Marcos Lago","psa":"Mariana Cerveira","topics":["PTSD & trauma","Addiction","Anxiety & end-of-life"],"ptype":"report","src":"https://openalex.org/W7203528416","eid":"W7203528416"},{"id":"paper-w7203555387","cat":"papers","name":"Psilocybin and Psilocybin-Mushroom Safety: An Evidence-Based White Paper on Toxicity, Dependence, Mortality, and Risk Context","year":"2026","cit":0,"pfa":"Marcos Lago","psa":"Mariana Cerveira","topics":["PTSD & trauma","Addiction","Anxiety & end-of-life"],"ptype":"report","src":"https://openalex.org/W7203555387","eid":"W7203555387"},{"id":"paper-w4299647817","cat":"papers","name":"Psilocybin, Its History and Pharmacology.","year":"1960","cit":0,"topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4299647817","eid":"W4299647817"},{"id":"paper-w2343077858","cat":"papers","name":"Las propiedades farmacocinéticas del Ayahuasca","year":"2015","cit":0,"pfa":"Escobar Cornejo","psa":"Guillermo Saúl","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2343077858","eid":"W2343077858"},{"id":"paper-w2924868903","cat":"papers","name":"Ayahuasca e redução do tabagismo","year":"2018","cit":0,"pfa":"Carolina Marcolino Massarentti","psa":"Dimitri Daldegan‐Bueno","ptype":"article","src":"https://openalex.org/W2924868903","eid":"W2924868903"},{"id":"paper-w7112553641","cat":"papers","name":"Predictors of Acute Experience in Ceremonial Ayahuasca","year":"2022","cit":0,"pfa":"Brandon Weiss","psa":"Gabrielle Agin-Liebes","ptype":"preprint","src":"https://openalex.org/W7112553641","eid":"W7112553641"},{"id":"paper-w4394478955","cat":"papers","name":"Use of Coconut Charcoal and Menthone-Thiosemicarbazone Polymer as Solid Phase Materials for the Determination of N,N-Dimethyltryptamine, Harmine, Harmaline, Harmalol, and Tetrahydroharmine in Ayahuasca Beverage by Liquid","year":"2019","cit":0,"pfa":"Sandro Navickiene","psa":"Alain Gaujac","topics":["Safety & adverse events"],"ptype":"dataset","src":"https://openalex.org/W4394478955","eid":"W4394478955"},{"id":"paper-w3209525250","cat":"papers","name":"Rapid quantification of Psilocybin with reversed-phase HPLC and single-wavelength detection","year":"2021","cit":0,"pfa":"Alexzander Samuelsson","psa":"Markus Roggen","ptype":"preprint","src":"https://openalex.org/W3209525250","eid":"W3209525250"},{"id":"paper-w4387880074","cat":"papers","name":"Is psilocybin effective for treatment of depression?","year":"2023","cit":0,"pfa":"Lucia Carbajal","psa":"Joseph Nelson","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4387880074","eid":"W4387880074"},{"id":"paper-w4414554064","cat":"papers","name":"The Ghosts of Ayahuasca: Conceptual Limits and Spectral Residues","year":"2025","cit":0,"pfa":"Jacob W. Glazier","psa":"S. Jo O'Donnell","ptype":"article","src":"https://openalex.org/W4414554064","eid":"W4414554064"},{"id":"paper-w4415041566","cat":"papers","name":"Questions and Concerns About MDMA-Assisted Therapy (MDMA-AT) in Veterans with PTSD Symptoms","year":"2025","cit":0,"pfa":"Mitch Earleywine","psa":"Stacey L. Farmer","topics":["PTSD & trauma","Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4415041566","eid":"W4415041566"},{"id":"paper-w7211873425","cat":"papers","name":"Who Is Reached by Supervised Psilocybin Services? Oregon Services Versus National Psilocybin Use","year":"2026","cit":0,"pfa":"Gabriel P. A. Costa","psa":"João Paulo De Aquino","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W7211873425","eid":"W7211873425"},{"id":"paper-w1922775193","cat":"papers","name":"Psilocybin (experiments and subjective criticism).","year":"1960","cit":0,"pfa":"Henri Michaux","ptype":"article","src":"https://openalex.org/W1922775193","eid":"W1922775193"},{"id":"paper-w7132166878","cat":"papers","name":"The potential use of psilocybin in psychiatry","year":"2023","cit":0,"pfa":"Kamilė Žalkauskaitė","psa":"Vilius Ogenskas","ptype":"article","src":"https://openalex.org/W7132166878","eid":"W7132166878"},{"id":"paper-w4402233221","cat":"papers","name":"The Therapeutic Potential of Psilocybin for Depression","year":"2024","cit":0,"pfa":"Tessa Bo Watford","topics":["Depression","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4402233221","eid":"W4402233221"},{"id":"paper-w7133332018","cat":"papers","name":"Functional validation of enzymes in Salvinorin A biosynthesis - LCMS data.","year":"2026","cit":0,"pfa":"Evangelos Tatsis","ptype":"dataset","src":"https://openalex.org/W7133332018","eid":"W7133332018"},{"id":"paper-w4221159545","cat":"papers","name":"[Psilocybin compared with escitalopram for depression].","year":"2022","cit":0,"pfa":"Jurriaan F. M. Strous","topics":["Depression","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4221159545","eid":"W4221159545"},{"id":"paper-w3012767919","cat":"papers","name":"Effects of psilocin on the striatal monoamine contents in mice and rats","year":"2020","cit":0,"pfa":"Maho Hirasawa","ptype":"article","src":"https://openalex.org/W3012767919","eid":"W3012767919"},{"id":"paper-w4229804140","cat":"papers","name":"A Case of Death Due to Ibogaine Use for Heroin Addiction","year":"2013","cit":0,"pfa":"Shwan Jalal","psa":"Raymond Hilu","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4229804140","eid":"W4229804140"},{"id":"paper-w4410326153","cat":"papers","name":"Discovery of Iboga-Derived Ligands for the Sigma-2 Receptor","year":"2025","cit":0,"pfa":"Alexander J. Hughes","psa":"Steven D. Townsend","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4410326153","eid":"W4410326153"},{"id":"paper-w7124304422","cat":"papers","name":"Acute psilocybin effects on CBF and ICA diameter","year":"2026","cit":0,"pfa":"Kristian Larsen","topics":["Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W7124304422","eid":"W7124304422"},{"id":"paper-w4323921578","cat":"papers","name":"Patternizing Psilocybin in Logic Space","year":"2023","cit":0,"pfa":"Parker Emmerson","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4323921578","eid":"W4323921578"},{"id":"paper-w7129484021","cat":"papers","name":"eLife Assessment: Psilocin fosters neuroplasticity in iPSC-derived human cortical neurons","year":"2026","cit":0,"pfa":"Mariano Soiza‐Reilly","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"peer-review","src":"https://openalex.org/W7129484021","eid":"W7129484021"},{"id":"paper-w7161898772","cat":"papers","name":"Symptom-level antidepressant response to psilocybin: exploratory outcomes comparing psilocybin treatment to niacin","year":"2026","cit":0,"pfa":"E. Lopez","psa":"N. Edvall","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7161898772","eid":"W7161898772"},{"id":"paper-w7112206954","cat":"papers","name":"Kentucky Should Reconsider Funding Ibogaine Research","year":"2025","cit":0,"pfa":"Hall, Lucas","ptype":"article","src":"https://openalex.org/W7112206954","eid":"W7112206954"},{"id":"paper-w7160265280","cat":"papers","name":"IbogaineVault: A Structured Evidence Map for Ibogaine Science","year":"2026","cit":0,"pfa":"Philip Kagalovsky","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"software","src":"https://openalex.org/W7160265280","eid":"W7160265280"},{"id":"paper-w2954776469","cat":"papers","name":"Plan de negocio Ayahuasca Pub","year":"2018","cit":0,"pfa":"Janeth Laiche Bardales","ptype":"dissertation","src":"https://openalex.org/W2954776469","eid":"W2954776469"},{"id":"paper-w2376386801","cat":"papers","name":"Spirituality and tourism impacts: The Ayahuasca experience","year":"2014","cit":0,"pfa":"Girish Prayag","psa":"Julien Fontaine","ptype":"article","src":"https://openalex.org/W2376386801","eid":"W2376386801"},{"id":"paper-w4320405533","cat":"papers","name":"The effect of MDMA self-administration on MDMA-produced hyperactivity and c-fos expression","year":"2016","cit":0,"pfa":"Natasha Bukholt","topics":["Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W4320405533","eid":"W4320405533"},{"id":"paper-w4240190199","cat":"papers","name":"FUNCTIONAL CONSEQUENCES OF MDMA NEUROTOXICITY","year":"1998","cit":0,"pfa":"G.A. Ricaurte","psa":"U. McCann","topics":["Anxiety & end-of-life","Safety & adverse events"],"ptype":"conference-abstract","src":"https://openalex.org/W4240190199","eid":"W4240190199"},{"id":"paper-w4384835068","cat":"papers","name":"Psilocybin-based mushrooms and usage","year":"2023","cit":0,"pfa":"Dunn Harmony","psa":"D Michael","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4384835068","eid":"W4384835068"},{"id":"paper-w4412885037","cat":"papers","name":"Psilocybin-assisted treatment of depression","year":"2025","cit":0,"pfa":"Barbara Anna Zapalska","psa":"Artur Galus","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4412885037","eid":"W4412885037"},{"id":"paper-w7154870114","cat":"papers","name":"Ayahuasca and its expansion in Brazil: The cosmogonical principles of the three major ayahuasca religions in the state of Pernambuco","year":"2020","cit":0,"pfa":"José Arturo Costa Escobar","psa":"Robson Savoldi","ptype":"article","src":"https://openalex.org/W7154870114","eid":"W7154870114"},{"id":"paper-w2157086194","cat":"papers","name":"The Synthesis and Pharmacological Evaluation of Salvinorin A Analogues as Opioid Receptor Probes","year":"2011","cit":0,"pfa":"Kimberly M. Lovell","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W2157086194","eid":"W2157086194"},{"id":"paper-w2410834479","cat":"papers","name":"[Antagonism and synergism of mescaline at the level of smooth muscles].","year":"1967","cit":0,"pfa":"Y. Ruckebusch","psa":"M Roche","ptype":"article","src":"https://openalex.org/W2410834479","eid":"W2410834479"},{"id":"paper-w4254659184","cat":"papers","name":"Swiss Psilocybin and US Dollars","year":"2012","cit":0,"pfa":"Nicolas Langlitz","topics":["Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W4254659184","eid":"W4254659184"},{"id":"paper-w4205725397","cat":"papers","name":"Psilocybin as a treatment for anorexia nervosa","year":"2021","cit":0,"pfa":"Meg J. Spriggs","ptype":"dataset","src":"https://openalex.org/W4205725397","eid":"W4205725397"},{"id":"paper-w1572789773","cat":"papers","name":"O USO RITUAL DA AYAHUASCA","year":"2003","cit":0,"pfa":"Montagut Mejía","psa":"Claudia María","ptype":"article","src":"https://openalex.org/W1572789773","eid":"W1572789773"},{"id":"paper-w319692000","cat":"papers","name":"El multiverso de la ayahuasca","year":"2014","cit":0,"pfa":"Fernando Pardo","ptype":"article","src":"https://openalex.org/W319692000","eid":"W319692000"},{"id":"paper-w7115185088","cat":"papers","name":"Review of: Peyote Hunt: The Sacred Journey of the Huichol Indians","year":"1975","cit":0,"pfa":"Grimes, Joseph E.","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7115185088","eid":"W7115185088"},{"id":"paper-w4411538319","cat":"papers","name":"AYAHUASCA E OUTRAS PLANTAS MEDICINAIS","year":"2024","cit":0,"pfa":"Rejane Nunes","psa":"Ludmilla Emília Martins Costa","ptype":"article","src":"https://openalex.org/W4411538319","eid":"W4411538319"},{"id":"paper-w4408691039","cat":"papers","name":"SUBJECTIVE EXPERIENCES OF AYAHUASCA NAIVE USERS","year":"2025","cit":0,"pfa":"Lucas Villar Magalhães da Cruz","topics":["Depression"],"ptype":"dissertation","src":"https://openalex.org/W4408691039","eid":"W4408691039"},{"id":"paper-w4411157331","cat":"papers","name":"Psilocybin and hallucinogenic mushrooms – ERRATUM","year":"2025","cit":0,"pfa":"Mathieu Fradet","psa":"Trisha M Suppes","ptype":"erratum","src":"https://openalex.org/W4411157331","eid":"W4411157331"},{"id":"paper-w4311834218","cat":"papers","name":"A PLANTA AYAHUASCA NO TRATAMENTO DA DEPRESSÃO","year":"2022","cit":0,"pfa":"Mariana Beatriz Gomes De Abreu","psa":"Hilana Maria Braga Fernandes Abreu","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4311834218","eid":"W4311834218"},{"id":"paper-w4411131922","cat":"papers","name":"Ayahuasca revisited. Case studies & observations","year":"2025","cit":0,"pfa":"Mika Turkia","ptype":"preprint","src":"https://openalex.org/W4411131922","eid":"W4411131922"},{"id":"paper-w4411151145","cat":"papers","name":"The impact of psilocybin on the loneliness epidemic","year":"2023","cit":0,"pfa":"Seema Sharma","psa":"Kristine Marie Jacquin","ptype":"dataset","src":"https://openalex.org/W4411151145","eid":"W4411151145"},{"id":"paper-w7167250009","cat":"papers","name":"Psilocybin helps woman with Alzheimer's","year":"2026","cit":0,"pfa":"Mattha Busby","ptype":"article","src":"https://openalex.org/W7167250009","eid":"W7167250009"},{"id":"paper-w2779503474","cat":"papers","name":"El peyote, los indios y nosotros","year":"1982","cit":0,"pfa":"A Pinto","ptype":"article","src":"https://openalex.org/W2779503474","eid":"W2779503474"},{"id":"paper-w2086175456","cat":"papers","name":"Peyote: The Divine Cactus. Edward F. Anderson","year":"1982","cit":0,"pfa":"N. Ross Crumrine","ptype":"article","src":"https://openalex.org/W2086175456","eid":"W2086175456"},{"id":"paper-w2405353950","cat":"papers","name":"Basic Neuropharmachological Research on Ibogaine as a Potential Therapy for Drug Addiction","year":"2014","cit":0,"pfa":"Blaž Svetic","psa":"Maja Bresjanac","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2405353950","eid":"W2405353950"},{"id":"paper-w1508384205","cat":"papers","name":"Effect of ibogaine on morphine: Induced modifications of palatability","year":"1995","cit":0,"pfa":"Hardy J. Rideout","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1508384205","eid":"W1508384205"},{"id":"paper-w2416977697","cat":"papers","name":"Identification of time intervals under LSD25 and mescaline.","year":"1977","cit":0,"pfa":"Leon Mitrani","psa":"S Yanev","ptype":"article","src":"https://openalex.org/W2416977697","eid":"W2416977697"},{"id":"paper-w1038636543","cat":"papers","name":"Iquitos: centro del mundo ayahuasca","year":"2004","cit":0,"pfa":"Christian Rätsch","ptype":"article","src":"https://openalex.org/W1038636543","eid":"W1038636543"},{"id":"paper-w7165736251","cat":"papers","name":"Development and validation of a UPLC-MS/MS method for real-time neuropharmacokinetic monitoring of iboga alkaloids in rat brain","year":"2026","cit":0,"pfa":"Scot McIntosh","psa":"Scott E. Hemby","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7165736251","eid":"W7165736251"},{"id":"paper-w4232468031","cat":"papers","name":"Towards a cognitive-psychological study of Ayahuasca","year":"1997","cit":0,"pfa":"Benny Shanon","ptype":"dataset","src":"https://openalex.org/W4232468031","eid":"W4232468031"},{"id":"paper-w4309988851","cat":"papers","name":"LAS PROPIEDADES FARMACOCINÉTICAS DEL AYAHUASCA","year":"2015","cit":0,"pfa":"Guillermo Saúl Escobar Cornejo","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4309988851","eid":"W4309988851"},{"id":"paper-w2318743847","cat":"papers","name":"ChemInform Abstract: NEUER ZUGANG ZU PSILOCIN‐DERIVATEN","year":"1974","cit":0,"pfa":"C. Germain","psa":"J. BOURDAIS","ptype":"article","src":"https://openalex.org/W2318743847","eid":"W2318743847"},{"id":"paper-w7124249212","cat":"papers","name":"Acute psilocybin effects on CBF and ICA diameter","year":"2026","cit":0,"pfa":"Kristian Larsen","topics":["Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W7124249212","eid":"W7124249212"},{"id":"paper-w2530721503","cat":"papers","name":"Investigations Of Salvinorin A: Synthetic Isolation, Quantification, And In Vivo Characteristics","year":"2013","cit":0,"pfa":"Michael Caspers","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W2530721503","eid":"W2530721503"},{"id":"paper-w1726887533","cat":"papers","name":"De Peyote-cultus der Noordamerikaansche Indianen. Slot","year":"1935","cit":0,"pfa":"A. N. J. den Hollander","ptype":"article","src":"https://openalex.org/W1726887533","eid":"W1726887533"},{"id":"paper-w2396977172","cat":"papers","name":"Enzyme Immunoassay for Salvinorin A (a Main Component in Salvia divinorum)","year":"2016","cit":0,"pfa":"Hiroyuki Tanaka","psa":"Satoshi Morimoto","ptype":"book-chapter","src":"https://openalex.org/W2396977172","eid":"W2396977172"},{"id":"paper-w1591471583","cat":"papers","name":"Review of Peyote: The Divine Cactus by Edward F. Anderson","year":"1997","cit":0,"pfa":"Daniel J. Gelo","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1591471583","eid":"W1591471583"},{"id":"paper-w2952810114","cat":"papers","name":"ChemInform Abstract: Progress in the Synthesis of Iboga‐alkaloids and Their Congeners","year":"2012","cit":0,"pfa":"Goutam Kumar Jana","psa":"Surajit Sinha","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2952810114","eid":"W2952810114"},{"id":"paper-w2139105709","cat":"papers","name":"Identification and characterization of diterpene synthases in the salvinorin A biosynthetic pathway","year":"2012","cit":0,"pfa":"Rod Mitchell","topics":["Addiction","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W2139105709","eid":"W2139105709"},{"id":"paper-w4415611515","cat":"papers","name":"Evaluation of bioisosteric 6,5-fused heterocyclic salvinorin A analogues","year":"2025","cit":0,"pfa":"Ashlyn Standley","psa":"Adam W. Keasling","ptype":"article","src":"https://openalex.org/W4415611515","eid":"W4415611515"},{"id":"paper-w2040268350","cat":"papers","name":"Do the neuroprotective effects of adolescent MDMA pretreatment on a subsequent MDMA binge generalize to methamphetamine?","year":"2009","cit":0,"pfa":"Christina S. Henderson","psa":"Jerrold S. Meyer","ptype":"article","src":"https://openalex.org/W2040268350","eid":"W2040268350"},{"id":"paper-w3126244391","cat":"papers","name":"Correction to: Ayahuasca as a Candidate Therapy for PTSD","year":"2020","cit":0,"pfa":"Jessica L. Nielson","psa":"Julie D. Megler","topics":["PTSD & trauma"],"ptype":"erratum","src":"https://openalex.org/W3126244391","eid":"W3126244391"},{"id":"paper-w2997403725","cat":"papers","name":"Ritual Discourse in Contemporary Ayahuasca Rituals","year":"2018","cit":0,"pfa":"Evgenia Fotiou","ptype":"article","src":"https://openalex.org/W2997403725","eid":"W2997403725"},{"id":"paper-w3082563060","cat":"papers","name":"Psilocybin Can Diminish Depression","year":"2020","cit":0,"pfa":"Teresa Kay Jones","psa":"Steven Lippmann","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W3082563060","eid":"W3082563060"},{"id":"paper-w4312953170","cat":"papers","name":"Psilocybin: a psychedelic alternative to antidepressants?","year":"2022","cit":0,"topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4312953170","eid":"W4312953170"},{"id":"paper-w2516746124","cat":"papers","name":"The effect of MDMA self-administration on MDMA-produced hyperactivity and c-fos expression","year":"2016","cit":0,"pfa":"Natasha Bukholt","topics":["Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W2516746124","eid":"W2516746124"},{"id":"paper-w4210584970","cat":"papers","name":"The Peyote Effect: From the Inquisition to the War on Drugs","year":"2020","cit":0,"pfa":"Kevin Feeney","ptype":"article","src":"https://openalex.org/W4210584970","eid":"W4210584970"},{"id":"paper-w2808783774","cat":"papers","name":"Ayahuasca: Un camino al equilibrio","year":"2016","cit":0,"pfa":"Rita Barreto de Sales Oliveira","ptype":"article","src":"https://openalex.org/W2808783774","eid":"W2808783774"},{"id":"paper-w4239882938","cat":"papers","name":"Erratum: Internet method for the extraction of N,N-dimethyltryptamine from Mimosa hostilis roots: Does it really extract dimethyltryptamine?","year":"2020","cit":0,"pfa":"Giordano Novak Rossi","psa":"RAFAEL GUIMARÃES DOS SANTOS","ptype":"erratum","src":"https://openalex.org/W4239882938","eid":"W4239882938"},{"id":"paper-w4244284197","cat":"papers","name":"The Healing Power of the Icaros: An Analysis of Ayahuasca","year":"2009","cit":0,"pfa":"Susana Bustos","ptype":"dataset","src":"https://openalex.org/W4244284197","eid":"W4244284197"},{"id":"paper-w2304223062","cat":"papers","name":"El viaje de la Ayahuasca","year":"2012","cit":0,"pfa":"Jamil Revelo Chiriboga","topics":["Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W2304223062","eid":"W2304223062"},{"id":"paper-w3201191016","cat":"papers","name":"Ibogaine affects the redox status in rat heart","year":"2016","cit":0,"pfa":"Nikola Tatalović","psa":"Duško P. Blagojević","ptype":"article","src":"https://openalex.org/W3201191016","eid":"W3201191016"},{"id":"paper-w7119089270","cat":"papers","name":"Ibogaine for the treatment of Parkinson's disease: A case report","year":"2026","cit":0,"pfa":"Tobias Erny","psa":"Geoff Noller","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7119089270","eid":"W7119089270"},{"id":"paper-w4235980706","cat":"papers","name":"Exploring the side effect profile of 16-Ethynyl Salvinorin A","year":"2019","cit":0,"pfa":"Stephen George Mathew","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"dissertation","src":"https://openalex.org/W4235980706","eid":"W4235980706"},{"id":"paper-w4417457936","cat":"papers","name":"Ibogaine: Revisiting an Ancient Alkaloid for Modern Opioid Dependence","year":"2025","cit":0,"pfa":"Markus D Moore","psa":"Saeed K Alzghari","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"editorial","src":"https://openalex.org/W4417457936","eid":"W4417457936"},{"id":"paper-w4249624092","cat":"papers","name":"Psilocybin vs escitalopram for depression","year":"2018","cit":0,"pfa":"Bruna Giribaldi","topics":["Depression"],"ptype":"dataset","src":"https://openalex.org/W4249624092","eid":"W4249624092"},{"id":"paper-w7106325502","cat":"papers","name":"Structural Basis for Psilocybin Biosynthesis","year":"2025","cit":0,"pfa":"Zhu, Xudong","ptype":"dataset","src":"https://openalex.org/W7106325502","eid":"W7106325502"},{"id":"paper-w4205176454","cat":"papers","name":"ChemInform Abstract: CONFORMATIONALLY CONSTRAINED ANALOGS OF MESCALINE. II","year":"1976","cit":0,"pfa":"Robert J. Wolters","psa":"N. S. TANNER","ptype":"article","src":"https://openalex.org/W4205176454","eid":"W4205176454"},{"id":"paper-w4416618184","cat":"papers","name":"Peer Review Report For: Development of a physiologically based pharmacokinetic (PBPK) model of psilocybin and psilocin from magic mushroom in rats and humans [version 1; peer review: 1 approved with reservations, 1 not a","year":"2021","cit":0,"pfa":"Quoc Ba Tran","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4416618184","eid":"W4416618184"},{"id":"paper-w7172100937","cat":"papers","name":"Psilocybin for Fear of Cancer Recurrence","year":"2026","cit":0,"pfa":"Matthew Cho","psa":"Sarah Hales","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7172100937","eid":"W7172100937"},{"id":"paper-w1973779228","cat":"papers","name":"De gevolgen van MDMA","year":"2014","cit":0,"pfa":"Nienke van den Tempel-Vorstenburg","ptype":"article","src":"https://openalex.org/W1973779228","eid":"W1973779228"},{"id":"paper-w4240484856","cat":"papers","name":"Ayahuasca enhances creative divergent thinking","year":"2016","cit":0,"pfa":"Kim P. C. Kuypers","ptype":"other","src":"https://openalex.org/W4240484856","eid":"W4240484856"},{"id":"paper-w7165534430","cat":"papers","name":"Regulating Psilocybin as Food, Not Drugs","year":"2026","cit":0,"pfa":"Julia S. Etkin","psa":"Vincent Joralemon","topics":["Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W7165534430","eid":"W7165534430"},{"id":"paper-w4290972699","cat":"papers","name":"[PSILOCYBIN, a new psychotropic substance].","year":"1959","cit":0,"topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4290972699","eid":"W4290972699"},{"id":"paper-w2981873322","cat":"papers","name":"Modified E. coli pump out psilocybin","year":"2019","cit":0,"pfa":"Megha Satyanarayana","topics":["Depression"],"ptype":"other","src":"https://openalex.org/W2981873322","eid":"W2981873322"},{"id":"paper-w2810654546","cat":"papers","name":"Ayahuasca : Une façon de l’équilibre","year":"2016","cit":0,"pfa":"Rita Barreto de Sales Oliveira","ptype":"article","src":"https://openalex.org/W2810654546","eid":"W2810654546"},{"id":"paper-w2176345400","cat":"papers","name":"Synthesis of Salvinorin A Analogues and Isolation of Methyl Barbascoate","year":"2006","cit":0,"pfa":"Joaquı́n Del Rı́o","psa":"Thomas Edward Prisinzano","ptype":"article","src":"https://openalex.org/W2176345400","eid":"W2176345400"},{"id":"paper-w2950413763","cat":"papers","name":"ChemInform Abstract: BETA‐CHLOROETHYLAMINES RELATED TO MESCALINE","year":"1973","cit":0,"pfa":"P. D. COOPER","ptype":"article","src":"https://openalex.org/W2950413763","eid":"W2950413763"},{"id":"paper-w7117990902","cat":"papers","name":"Acute effects of MDMA, MDA and their prodrugs lysine-MDMA and lysine-MDA in healthy participants","year":"2026","cit":0,"pfa":"I. Straumann","psa":"M.E. Liechti","ptype":"article","src":"https://openalex.org/W7117990902","eid":"W7117990902"},{"id":"paper-w2890819288","cat":"papers","name":"Effects of MDMA on social cognition","year":"2016","cit":0,"pfa":"Matthias E. Liechti","psa":"C.M. Hysek","ptype":"article","src":"https://openalex.org/W2890819288","eid":"W2890819288"},{"id":"paper-w2409003579","cat":"papers","name":"[Iproniazid-mescaline antagonism evaluated with the method of conditioned reflexes].","year":"1961","cit":0,"pfa":"Goldwurm Gf","psa":"E Gualandri","ptype":"article","src":"https://openalex.org/W2409003579","eid":"W2409003579"},{"id":"paper-w4386978376","cat":"papers","name":"Endogenous Biosynthesis and Neural Correlates of N,N-dimethyltryptamine","year":"2023","cit":0,"pfa":"Nicolas G. Glynos","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W4386978376","eid":"W4386978376"},{"id":"paper-w7165265490","cat":"papers","name":"The Holy Inquisition and the Genesis of Seventeenth-Century Peyote Banning","year":"2025","cit":0,"pfa":"Osiris González Romero","ptype":"article","src":"https://openalex.org/W7165265490","eid":"W7165265490"},{"id":"paper-w3004048484","cat":"papers","name":"Regaining Religious Power Along the Peyote Way Road","year":"2019","cit":0,"pfa":"Alana McKnight","ptype":"article","src":"https://openalex.org/W3004048484","eid":"W3004048484"},{"id":"paper-w2234894659","cat":"papers","name":"Symmetric anthropology and healing processes with ayahuasca","year":"2014","cit":0,"pfa":"Guzmán Chávez","psa":"Mauricio Genet","ptype":"article","src":"https://openalex.org/W2234894659","eid":"W2234894659"},{"id":"paper-w2620271073","cat":"papers","name":"Characterization of ibogaine analogs on the hα3β4 nicotinic acetylcholine receptor.","year":"2012","cit":0,"pfa":"Jordan M. Ross","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2620271073","eid":"W2620271073"},{"id":"paper-w2068205273","cat":"papers","name":"Central antagonism of tyramine-induced systemic hypotension by mescaline","year":"1977","cit":0,"pfa":"Jean R Strahlendorf","psa":"Frederick J. Goldstein","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2068205273","eid":"W2068205273"},{"id":"paper-w4246488346","cat":"papers","name":"Intimacy in the healing function of Ayahuasca Icaros","year":"2010","cit":0,"pfa":"Susana Bustos","ptype":"dataset","src":"https://openalex.org/W4246488346","eid":"W4246488346"},{"id":"paper-w2031232972","cat":"papers","name":"Psilocybin Results Inspire Researchers","year":"2007","cit":0,"pfa":"TIMOTHY F. KIRN","ptype":"article","src":"https://openalex.org/W2031232972","eid":"W2031232972"},{"id":"paper-w4401117899","cat":"papers","name":"How psilocybin affects the brain","year":"2024","cit":0,"pfa":"Karen O’Leary","ptype":"article","src":"https://openalex.org/W4401117899","eid":"W4401117899"},{"id":"paper-w4402347011","cat":"papers","name":"Einmalig Psilocybin: antidepressive Effekte","year":"2024","cit":0,"pfa":"Arnim Quante","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4402347011","eid":"W4402347011"},{"id":"paper-w4386869262","cat":"papers","name":"Psilocybin for Dementia Prevention: Could Treating Major Depression with Psilocybin Alter the Neurodegenerative Disease Trajectory?","year":"2023","cit":0,"pfa":"Zarah R. Haniff","psa":"Sandrine Thuret","topics":["Depression"],"ptype":"preprint","src":"https://openalex.org/W4386869262","eid":"W4386869262"},{"id":"paper-w7214730919","cat":"papers","name":"Worsening of Depression and Anxiety With Psilocybin","year":"2026","cit":0,"pfa":"S. Nassir Ghaemi","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7214730919","eid":"W7214730919"},{"id":"paper-w4303197755","cat":"papers","name":"‘Ecstasy’: MDMA (3,4-Methylenedioxy-N-Methylamphetamine), MDMA Analogues and Drugs with Similar Effects","year":"2022","cit":0,"pfa":"Dima Abdulrahim","psa":"Owen Bowden‐Jones","topics":["Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W4303197755","eid":"W4303197755"},{"id":"paper-w2794402642","cat":"papers","name":"De viaje espiritual con ayahuasca","year":"2018","cit":0,"pfa":"Katharina Müller","ptype":"article","src":"https://openalex.org/W2794402642","eid":"W2794402642"},{"id":"paper-w4378421346","cat":"papers","name":"AYAHUASCA, EL ALUCINÓGENO DE MODA","year":"2023","cit":0,"topics":["Policy & ethics"],"ptype":"conference-paper","src":"https://openalex.org/W4378421346","eid":"W4378421346"},{"id":"paper-w7137391484","cat":"papers","name":"MDMA, le nouveau Prozac ?","year":"2024","cit":0,"pfa":"Nastasia Hadjadji","psa":"Olivia Blanc","ptype":"article","src":"https://openalex.org/W7137391484","eid":"W7137391484"},{"id":"paper-w7120640387","cat":"papers","name":"Evaluation of the neurotoxic effects of ayahuasca tea","year":"2012","cit":0,"pfa":"Alex Roberto Melgar Figueroa","topics":["Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W7120640387","eid":"W7120640387"},{"id":"paper-w4317889733","cat":"papers","name":"Ayahuasca zur sanften Psychedelika-Therapie","year":"2023","cit":0,"pfa":"Thomas Müller","ptype":"article","src":"https://openalex.org/W4317889733","eid":"W4317889733"},{"id":"paper-w4294326210","cat":"papers","name":"Interplay of hydrogen bonding in deciding the conformers of psilocin: Computational insights","year":"2022","cit":0,"pfa":"Poonam Bhadoria","psa":"V. Ramanathan","ptype":"preprint","src":"https://openalex.org/W4294326210","eid":"W4294326210"},{"id":"paper-w7112804795","cat":"papers","name":"Ayahuasca: Imagen de un saber","year":"1995","cit":0,"pfa":"Lasso Mejía, Javier","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W7112804795","eid":"W7112804795"},{"id":"paper-w7120647506","cat":"papers","name":"Discourses on the religious use of psychoactive Ayahuasca","year":"2013","cit":0,"pfa":"Paulo Alves Bueno","ptype":"dissertation","src":"https://openalex.org/W7120647506","eid":"W7120647506"},{"id":"paper-w2491550606","cat":"papers","name":"Chapter-55 Ecstasy (MDMA)","year":"2005","cit":0,"pfa":"Arjun Mehta","ptype":"book-chapter","src":"https://openalex.org/W2491550606","eid":"W2491550606"},{"id":"paper-w2242977939","cat":"papers","name":"Is there an ecstasy (MDMA) dependence syndrome","year":"2010","cit":0,"pfa":"Louisa J Degenhardt","psa":"Libby Topp","ptype":"article","src":"https://openalex.org/W2242977939","eid":"W2242977939"},{"id":"paper-w2029085840","cat":"papers","name":"179 The neuro-psychophysiology of MDMA","year":"1998","cit":0,"pfa":"A. Klugman","psa":"John H Gruzelier","ptype":"article","src":"https://openalex.org/W2029085840","eid":"W2029085840"},{"id":"paper-w2201463559","cat":"papers","name":"Asymmetric studies towards the synthesis of trifluoromethyl isostatine and salvinorin A","year":"2017","cit":0,"pfa":"Horsfall, Luke","ptype":"dissertation","src":"https://openalex.org/W2201463559","eid":"W2201463559"},{"id":"paper-w7204198038","cat":"papers","name":"Salvinorin A in humans: A systematic review of pharmacokinetics, pharmacodynamics, and safety","year":"2026","cit":0,"pfa":"Wolfgang Emanuel Zürrer","psa":"Benjamin Victor Ineichen","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W7204198038","eid":"W7204198038"},{"id":"paper-w7113200799","cat":"papers","name":"Redox-mediated mechanisms of ibogaine pharmacological effects on female rats","year":"2024","cit":0,"pfa":"Tatalović, Nikola","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7113200799","eid":"W7113200799"},{"id":"paper-w2431827229","cat":"papers","name":"[Vegetative and humoral modifications caused by mescalinic shock].","year":"1956","cit":0,"pfa":"Jean-Christian Delay","psa":"M ROPERT","ptype":"article","src":"https://openalex.org/W2431827229","eid":"W2431827229"},{"id":"paper-w7135965531","cat":"papers","name":"The effect of psilocybin on memory consolidation in rats","year":"2022","cit":0,"pfa":"Kembe Chona","topics":["Depression","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W7135965531","eid":"W7135965531"},{"id":"paper-w4241632045","cat":"papers","name":"Interaction between Bupropion and MDMA","year":"2015","cit":0,"ptype":"article","src":"https://openalex.org/W4241632045","eid":"W4241632045"},{"id":"paper-w2650609862","cat":"papers","name":"Mojitos, MDMA och marijuana","year":"2016","cit":0,"pfa":"Axel Hammarén","ptype":"article","src":"https://openalex.org/W2650609862","eid":"W2650609862"},{"id":"paper-w4413673460","cat":"papers","name":"Is psychiatry ready for medical MDMA?","year":"2018","cit":0,"pfa":"Gillinder Bedi","ptype":"other","src":"https://openalex.org/W4413673460","eid":"W4413673460"},{"id":"paper-w2627038138","cat":"papers","name":"[Review of] Silvester J. Brito. The Way of a Peyote Roadman","year":"1991","cit":0,"pfa":"D. C. Cole","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2627038138","eid":"W2627038138"},{"id":"paper-w4205395135","cat":"papers","name":"Tourists and Charlatans: Ayahuasca Shamanism in Transition","year":"2010","cit":0,"pfa":"Joshua Homan","ptype":"dataset","src":"https://openalex.org/W4205395135","eid":"W4205395135"},{"id":"paper-w4243657297","cat":"papers","name":"The translation of Ayahuasca into a depression and anxiety therapy","year":"2010","cit":0,"pfa":"Brian Anderson","topics":["Depression","Anxiety & end-of-life"],"ptype":"dataset","src":"https://openalex.org/W4243657297","eid":"W4243657297"},{"id":"paper-w7133402590","cat":"papers","name":"Ayahuasca as a therapeutic resource?: a scoping review","year":"2022","cit":0,"pfa":"Eder Medeiros Rêgo","topics":["Depression","Reviews & meta-analyses","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W7133402590","eid":"W7133402590"},{"id":"paper-w4390403949","cat":"papers","name":"AYAHUASCA NO TRATAMENTO DE DEPRESSÃO RESISTENTE","year":"2023","cit":0,"pfa":"Nicolly Medeiros ANTUNES","psa":"Luciane Dalarmi","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4390403949","eid":"W4390403949"},{"id":"paper-w2516614311","cat":"papers","name":"Question-based Drug Development for psilocybin","year":"2016","cit":0,"pfa":"Francis M. Dijkstra","psa":"Adam F. Cohen","ptype":"article","src":"https://openalex.org/W2516614311","eid":"W2516614311"},{"id":"paper-w3082700463","cat":"papers","name":"Design and Development of Salvinorin-Based Ligands for Opioid Receptors","year":"2019","cit":0,"pfa":"Nicholas S. Akins","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3082700463","eid":"W3082700463"},{"id":"paper-w7131903600","cat":"papers","name":"Functional validation of enzymes in Salvinorin A biosynthesis - LCMS data.","year":"2026","cit":0,"pfa":"Evangelos Tatsis","ptype":"dataset","src":"https://openalex.org/W7131903600","eid":"W7131903600"},{"id":"paper-w2271039139","cat":"papers","name":"[Male uses a gourd to pick up peyote, Rejogochi.]","year":"2012","cit":0,"pfa":"Luis. Verplancken","ptype":"article","src":"https://openalex.org/W2271039139","eid":"W2271039139"},{"id":"paper-w2122220403","cat":"papers","name":"Serotonergic neurotoxicity — the example MDMA","year":"2006","cit":0,"pfa":"Andrea G. Ludolph","psa":"Albert Christian Ludolph","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W2122220403","eid":"W2122220403"},{"id":"paper-w3157599119","cat":"papers","name":"Stimulant Drugs: MDMA and Drugs with Similar Effects","year":"2020","cit":0,"pfa":"Owen Bowden‐Jones","psa":"Dima Abdulrahim","ptype":"book-chapter","src":"https://openalex.org/W3157599119","eid":"W3157599119"},{"id":"paper-w304930435","cat":"papers","name":"Peyote: Narcotic or Medicine? (3/9/00)","year":"2000","cit":0,"pfa":"Harlan McKosato","ptype":"article","src":"https://openalex.org/W304930435","eid":"W304930435"},{"id":"paper-w7200364906","cat":"papers","name":"Exploring the relationship between personality traits, attitudes toward psilocybin use, and motivations for using psilocybin","year":"2025","cit":0,"pfa":"Molly Mifsud","psa":"Jill Robinson","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7200364906","eid":"W7200364906"},{"id":"paper-w2541305473","cat":"papers","name":"Recent insights into the psychopharmacology of MDMA","year":"2016","cit":0,"pfa":"David Nutt","psa":"H. Valerie Curran","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2541305473","eid":"W2541305473"},{"id":"paper-w7165394708","cat":"papers","name":"The FDA Backdoor to MDMA Rescheduling","year":"2026","cit":0,"pfa":"Vincent Joralemon","ptype":"preprint","src":"https://openalex.org/W7165394708","eid":"W7165394708"},{"id":"paper-w4412450068","cat":"papers","name":"Ayahuasca, Pain, and Inflammation: A Systematic Review of Preclinical Studies","year":"2025","cit":0,"pfa":"Bianca Villanova","psa":"RAFAEL GUIMARÃES DOS SANTOS","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4412450068","eid":"W4412450068"},{"id":"paper-w171815620","cat":"papers","name":"Transferring Patterns: From Twill to Peyote Stitch","year":"2009","cit":0,"pfa":"Eva Knoll","ptype":"article","src":"https://openalex.org/W171815620","eid":"W171815620"},{"id":"paper-w3129628288","cat":"papers","name":"Tabernanthalog, an Ibogaine Analogue for Treatment of Addiction and Depression","year":"2021","cit":0,"pfa":"Dirk H. Trauner","psa":"Andrej Shemet","topics":["Depression","Addiction"],"ptype":"editorial","src":"https://openalex.org/W3129628288","eid":"W3129628288"},{"id":"paper-w4286466266","cat":"papers","name":"An Unusual Case of MDMA Manufacture","year":"2022","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W4286466266","eid":"W4286466266"},{"id":"paper-w2991145769","cat":"papers","name":"Synthesis of types II and III post-iboga alkaloids","year":"2019","cit":0,"pfa":"Sikwang Seong","psa":"Sunkyu Han","ptype":"book-chapter","src":"https://openalex.org/W2991145769","eid":"W2991145769"},{"id":"paper-w4414181428","cat":"papers","name":"Ayahuasca and debut of psychosis, description of a clinical case","year":"2025","cit":0,"pfa":"E. E. Morales Castellano","psa":"A. M. Morales Rivero","topics":["Safety & adverse events","Reviews & meta-analyses","Policy & ethics"],"ptype":"conference-abstract","src":"https://openalex.org/W4414181428","eid":"W4414181428"},{"id":"paper-w3135890157","cat":"papers","name":"Structure of the alpha-beta hydrolase CorS from Tabernathe iboga","year":"2019","cit":0,"pfa":"Scott C. Farrow","psa":"Sarah Ellen O'Connor","ptype":"dataset","src":"https://openalex.org/W3135890157","eid":"W3135890157"},{"id":"paper-w2997901721","cat":"papers","name":"Effects of ibogaine treatment on redox homeostasis and energy metabolism in rat","year":"2019","cit":0,"pfa":"Nikola Tatalović","psa":"Duško P. Blagojević","topics":["Addiction","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2997901721","eid":"W2997901721"},{"id":"paper-w4244383026","cat":"papers","name":"Drug Facts: MDMA (\"Ecstasy\")","year":"2012","cit":0,"ptype":"dataset","src":"https://openalex.org/W4244383026","eid":"W4244383026"},{"id":"paper-w7172388876","cat":"papers","name":"Stimulants: Cocaine, Amphetamines, and MDMA","year":"2026","cit":0,"pfa":"Martha S. Rosenthal","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W7172388876","eid":"W7172388876"},{"id":"paper-w3176176594","cat":"papers","name":"Discriminative stimulus effects of hallucinogens and psychostimulants in S(+)‐MDMA, and R(−)‐MDMA trained mice","year":"2008","cit":0,"pfa":"Kevin Sean Murnane","psa":"William E. Fantegrossi","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W3176176594","eid":"W3176176594"},{"id":"paper-w198906773","cat":"papers","name":"Viaje a través de la ayahuasca","year":"2004","cit":0,"pfa":"Gabriela Wiener","ptype":"article","src":"https://openalex.org/W198906773","eid":"W198906773"},{"id":"paper-w2912263563","cat":"papers","name":"6.10. Otras sustancias. 6.10.1. Ayahuasca","year":"2006","cit":0,"pfa":"Jordi Riba Serrano","psa":"M. Barbanoj","ptype":"article","src":"https://openalex.org/W2912263563","eid":"W2912263563"},{"id":"paper-w134172492","cat":"papers","name":"III. El turismo de \"ayahuasca\"","year":"2010","cit":0,"pfa":"Jonathan Ott","ptype":"article","src":"https://openalex.org/W134172492","eid":"W134172492"},{"id":"paper-w7120364047","cat":"papers","name":"Effects of ayahuasca on emotional memory in rats","year":"2012","cit":0,"pfa":"Daiana Aparecida Kruchelski da Silva","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7120364047","eid":"W7120364047"},{"id":"paper-w2248831517","cat":"papers","name":"Thematic analysis of N.N-Dimethyltryptamine-induced experiences","year":"2008","cit":0,"pfa":"Christopher Cott","psa":"Adam J. Rock","ptype":"dataset","src":"https://openalex.org/W2248831517","eid":"W2248831517"},{"id":"paper-w4403436697","cat":"papers","name":"Inhaled Dimethyltryptamine (DMT): Use Patterns and Predictors of Consumption Frequency","year":"2024","cit":0,"pfa":"Jamie E. Parnes","psa":"Mitch Earleywine","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4403436697","eid":"W4403436697"},{"id":"paper-w2027471678","cat":"papers","name":"FUNCTIONAL CONSEQUENCES OF MDMA NEUROTOXICITY","year":"1998","cit":0,"pfa":"G.A. Ricaurte","psa":"U. McCann","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2027471678","eid":"W2027471678"},{"id":"paper-w7208630026","cat":"papers","name":"Structures of the Alkaloids of Indole -type : Ibogaine and Related Bases.","year":"1961","cit":0,"pfa":"Kazuo Ito","psa":"Kazuo Ito","ptype":"article","src":"https://openalex.org/W7208630026","eid":"W7208630026"},{"id":"paper-w4382682570","cat":"papers","name":"Humphry Osmond’s Statement on Peyote, 5 November 1955","year":"2018","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W4382682570","eid":"W4382682570"},{"id":"paper-w2434820453","cat":"papers","name":"Dendritic action potentials induced by mescaline in the cat's cortex.","year":"1971","cit":0,"pfa":"Ramos Jg","psa":"Ortiz Hr","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2434820453","eid":"W2434820453"},{"id":"paper-w4417416245","cat":"papers","name":"Is ibogaine treatment durable? 12-month follow-up of magnesium–ibogaine therapy (MISTIC) in Special Operations Veterans with traumatic brain injuries","year":"2025","cit":0,"pfa":"Camarin E. Rolle","psa":"Ian H. Kratter","topics":["PTSD & trauma"],"ptype":"preprint","src":"https://openalex.org/W4417416245","eid":"W4417416245"},{"id":"paper-w3007722816","cat":"papers","name":"Mescaline: A Global History of the First Psychedelic by Mike Jay","year":"2020","cit":0,"pfa":"Emily Witt","ptype":"article","src":"https://openalex.org/W3007722816","eid":"W3007722816"},{"id":"paper-w2948551984","cat":"papers","name":"Exploring the side effect profile of 16-Ethynyl Salvinorin A","year":"2019","cit":0,"pfa":"Stephen George Mathew","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"dissertation","src":"https://openalex.org/W2948551984","eid":"W2948551984"},{"id":"paper-w4236540430","cat":"papers","name":"First Peyote (Deer) Journey Brings the Sun to the Sky","year":"2004","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W4236540430","eid":"W4236540430"},{"id":"paper-w7212432134","cat":"papers","name":"Implications of Potential US FDA Approval of Psychedelics or Psychedelic-Adjacents Such as Ibogaine for Pharmacy in Japan","year":"2026","cit":0,"pfa":"Robert B. Raffa","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7212432134","eid":"W7212432134"},{"id":"paper-w4416564509","cat":"papers","name":"Therapeutic Benefits of Psilocybin in Treating Depression","year":"2025","cit":0,"pfa":"Gabriel Bennett","topics":["Depression"],"ptype":"book-chapter","src":"https://openalex.org/W4416564509","eid":"W4416564509"},{"id":"paper-w4252337779","cat":"papers","name":"FUNCTIONAL CONSEQUENCES OF MDMA NEUROTOXICITY","year":"1998","cit":0,"pfa":"G.A. Ricaurte","psa":"U. D. McCann","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4252337779","eid":"W4252337779"},{"id":"paper-w4413731937","cat":"papers","name":"How does MDMA kill?","year":"2019","cit":0,"pfa":"Nicole Lee","ptype":"other","src":"https://openalex.org/W4413731937","eid":"W4413731937"},{"id":"paper-w3155039880","cat":"papers","name":"MDMA Policy Think Tank","year":"2020","cit":0,"pfa":"Gjalt-Jorn Peters","topics":["Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W3155039880","eid":"W3155039880"},{"id":"paper-w7135123844","cat":"papers","name":"Oregon's Emerging Psilocybin Services Workforce: A Survey of the First Legal Psilocybin Facilitators and Their Training Programs","year":"2026","cit":0,"pfa":"Jason B. Luoma","psa":"Philip Todd Korthuis","topics":["PTSD & trauma","Reviews & meta-analyses","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7135123844","eid":"W7135123844"},{"id":"paper-w2233780261","cat":"papers","name":"Ibogaine may help drug addicts live the 'never again'.","year":"2006","cit":0,"pfa":"Chris Bateman","topics":["Addiction"],"ptype":"other","src":"https://openalex.org/W2233780261","eid":"W2233780261"},{"id":"paper-w2253094669","cat":"papers","name":"Glutamate and MDMA Neurobehavioral Toxicity","year":"2012","cit":0,"pfa":"John H. Anneken","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2253094669","eid":"W2253094669"},{"id":"paper-w3009709363","cat":"papers","name":"Phytochemical Characterisation and Effects of the Native Plant Tabernanthe iboga in Models of Diabetes","year":"2019","cit":0,"pfa":"Bayissi Bading-Taïka","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W3009709363","eid":"W3009709363"},{"id":"paper-w2041226737","cat":"papers","name":"The Complications of 'Ecstasy' (MDMA)-Reply","year":"1988","cit":0,"pfa":"John Osterloh","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2041226737","eid":"W2041226737"},{"id":"paper-w2956143010","cat":"papers","name":"MDMA-Assisted Psychotherapy for PTSD","year":"2019","cit":0,"pfa":"Martim Marinheira Dias Sampaio Monteiro","topics":["PTSD & trauma","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W2956143010","eid":"W2956143010"},{"id":"paper-w1598089406","cat":"papers","name":"3,4-Methylenedioxymethamphetamine (MDMA, \"Ecstasy\") : studies on MDMA metabolism and pharmacokinetics in humans and squirrel monkeys","year":"2009","cit":0,"pfa":"Melanie Müller","topics":["Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W1598089406","eid":"W1598089406"},{"id":"paper-w4408109544","cat":"papers","name":"eLife Assessment: Psilocin fosters neuroplasticity in iPSC-derived human cortical neurons","year":"2025","cit":0,"pfa":"Mariano Soiza‐Reilly","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"peer-review","src":"https://openalex.org/W4408109544","eid":"W4408109544"},{"id":"paper-w871283064","cat":"papers","name":"The influence of psilocin and phenylethylamine on the energy metabolism in the rat heart","year":"2003","cit":0,"pfa":"Anna Machoy‐Mokrzyńska","psa":"Dariusz Chlubek","ptype":"article","src":"https://openalex.org/W871283064","eid":"W871283064"},{"id":"paper-w3182683552","cat":"papers","name":"Sintomatologia psicótica e ayahuasca: relato de caso","year":"2016","cit":0,"pfa":"Thaísa Silva Gios","psa":"Elie Leal de Barros Calfat","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3182683552","eid":"W3182683552"},{"id":"paper-w4408108930","cat":"papers","name":"Author response: Psilocin fosters neuroplasticity in iPSC-derived human cortical neurons","year":"2025","cit":0,"pfa":"Målin Schmidt","psa":"Philipp Koch","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"peer-review","src":"https://openalex.org/W4408108930","eid":"W4408108930"},{"id":"paper-w7148252741","cat":"papers","name":"The Efficacy and Safety of Ibogaine Treatment for Substance Use Disorders - A Narrative Review","year":"2026","cit":0,"pfa":"Milena Majchrzyk","psa":"Anna Malczyk","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7148252741","eid":"W7148252741"},{"id":"paper-w2274813561","cat":"papers","name":"Psychedelic Zebrafish: the effects of LSD and MDMA on zebrafish behavior and physiology","year":"2015","cit":0,"pfa":"Jonathan Cachat","topics":["Dosing & pharmacology"],"ptype":"dataset","src":"https://openalex.org/W2274813561","eid":"W2274813561"},{"id":"paper-w7104565720","cat":"papers","name":"Psilocin esters – An investigation of synthetic feasibility, chemical, and metabolic stability","year":"2023","cit":0,"pfa":"Eklund, Julia","ptype":"article","src":"https://openalex.org/W7104565720","eid":"W7104565720"},{"id":"paper-w2759333658","cat":"papers","name":"Methamphetamine or MDMA pretreatment effects subsequent methamphetamine self-administration and MDMA-induced reinstatement in rats","year":"2005","cit":0,"pfa":"Iain S. McGregor","psa":"Jennifer L. Cornish","ptype":"article","src":"https://openalex.org/W2759333658","eid":"W2759333658"},{"id":"paper-w4409657794","cat":"papers","name":"A Quick Ibogaine Synthesis Amenable to Late-Stage Diversification","year":"2025","cit":0,"pfa":"Dirk Trauner","psa":"Daniel W. Zuschlag","topics":["Addiction"],"ptype":"editorial","src":"https://openalex.org/W4409657794","eid":"W4409657794"},{"id":"paper-w3100203081","cat":"papers","name":"Methylenedioxymethamphetamine (MDMA)a.k.a. Ecstasy","year":"2020","cit":0,"pfa":"Jerrold C. Winter","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W3100203081","eid":"W3100203081"},{"id":"paper-w2467710284","cat":"papers","name":"[Pharmacology of psychodysleptic drugs. Research on the mechanism of action of mescaline].","year":"1969","cit":0,"pfa":"C Pintilie","psa":"E Crighel","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2467710284","eid":"W2467710284"},{"id":"paper-w2498915051","cat":"papers","name":"Peyote, ever virgin: A case of religious hybridism in Mexico","year":"2016","cit":0,"pfa":"Martin Nesvig","ptype":"article","src":"https://openalex.org/W2498915051","eid":"W2498915051"},{"id":"paper-w7139458458","cat":"papers","name":"Review of Peyote: The Divine Cactus by Edward F. Anderson","year":"1997","cit":0,"pfa":"Daniel J. Gelo","topics":["Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7139458458","eid":"W7139458458"},{"id":"paper-w2943010415","cat":"papers","name":"Review: The Way of a Peyote Roadman by Silvester J. Brito","year":"1991","cit":0,"pfa":"D. C. Cole","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2943010415","eid":"W2943010415"},{"id":"paper-w402219485","cat":"papers","name":"11C-Labeled Dimethyltryptamine: A New Radiopharmaceutical for the Brain Imaging","year":"1983","cit":0,"pfa":"Kazuhiko Yanai","psa":"Ren Iwata","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W402219485","eid":"W402219485"},{"id":"paper-w4410261085","cat":"papers","name":"The effect of MDMA on the anterior pituitary","year":"2025","cit":0,"pfa":"Sara-Jessica Camerin","psa":"Mirjam Christ‐Crain","ptype":"conference-abstract","src":"https://openalex.org/W4410261085","eid":"W4410261085"},{"id":"paper-w7129265901","cat":"papers","name":"Author response: Psilocin fosters neuroplasticity in iPSC-derived human cortical neurons","year":"2026","cit":0,"pfa":"Målin Schmidt","psa":"Philipp Koch","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"peer-review","src":"https://openalex.org/W7129265901","eid":"W7129265901"},{"id":"paper-w4400959793","cat":"papers","name":"PTSD Treatment: An Inquiry into the Promising Potential of Psilocybin","year":"2024","cit":0,"pfa":"Ibrahim Lanre Folorunsho","psa":"Gibson Anugwom","topics":["PTSD & trauma","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4400959793","eid":"W4400959793"},{"id":"paper-w7202277007","cat":"papers","name":"Is ibogaine treatment durable? 12-month follow-up of magnesium–ibogaine therapy (MISTIC) in special operations veterans with traumatic brain injuries","year":"2026","cit":0,"pfa":"Afik Faerman","psa":"Nolan Williams","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7202277007","eid":"W7202277007"},{"id":"paper-w4380887031","cat":"papers","name":"Touch and play—'spiritual attacks' in ayahuasca ceremonies","year":"2023","cit":0,"pfa":"Mika Turkia","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4380887031","eid":"W4380887031"},{"id":"paper-w2938214599","cat":"papers","name":"Pursuit of ecstasy: The MDMA experience","year":"1997","cit":0,"pfa":"Philip Gatter","ptype":"article","src":"https://openalex.org/W2938214599","eid":"W2938214599"},{"id":"paper-w145289191","cat":"papers","name":"O Uso Ritual Da Ayahuasca (Book)","year":"2004","cit":0,"pfa":"Peter Gow","ptype":"article","src":"https://openalex.org/W145289191","eid":"W145289191"},{"id":"paper-w307006550","cat":"papers","name":"Cuando la ayahuasca es un negocio","year":"2015","cit":0,"pfa":"Carlos Suárez","ptype":"article","src":"https://openalex.org/W307006550","eid":"W307006550"},{"id":"paper-w7208039752","cat":"papers","name":"Development of LC-MS/MS and Nanodiamond-Assisted MALDI Approaches for the Analysis of Psilocin and Related Psychoactive Compounds","year":"2026","cit":0,"pfa":"Amir Khajavinia","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"dissertation","src":"https://openalex.org/W7208039752","eid":"W7208039752"},{"id":"paper-w4386484873","cat":"papers","name":"Psilocybin Use in Palliative Care #464","year":"2023","cit":0,"pfa":"Mark D. Sims","psa":"John Hendrick","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4386484873","eid":"W4386484873"},{"id":"paper-w4399432513","cat":"papers","name":"FDA advisory committee rejects MDMA application for PTSD, but…","year":"2024","cit":0,"pfa":"Alison Knopf","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4399432513","eid":"W4399432513"},{"id":"paper-w2405544379","cat":"papers","name":"[Serotonin metabolism in experimental psilocybin psychosis].","year":"1961","cit":0,"pfa":"V VITEK","psa":"S Grof","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2405544379","eid":"W2405544379"},{"id":"paper-w7201888578","cat":"papers","name":"A psilocybin project for feminist new materialism","year":"2017","cit":0,"pfa":"Bianka Haitham Halaseh","ptype":"dissertation","src":"https://openalex.org/W7201888578","eid":"W7201888578"},{"id":"paper-w4416725176","cat":"papers","name":"A streamlined synthesis of 5-methoxy- N,N -dimethyltryptamine, bufotenin, and bufotenin prodrugs from melatonin","year":"2026","cit":0,"pfa":"Anton A. Homon","psa":"John Frederick Trant","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4416725176","eid":"W4416725176"},{"id":"paper-w4248335596","cat":"papers","name":"Amanda's blessings from the Peyote gardens of South Texas","year":"2012","cit":0,"pfa":"Stacy B. Schaefer","ptype":"dataset","src":"https://openalex.org/W4248335596","eid":"W4248335596"},{"id":"paper-w3168028697","cat":"papers","name":"Effects of the putative antidepressant psilocin on the lipid‐raft proteome and lipid‐raft signaling","year":"2021","cit":0,"pfa":"Nicolas B. Senese","psa":"Mark M. Rasenick","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3168028697","eid":"W3168028697"},{"id":"paper-w4391277213","cat":"papers","name":"The Therapeutic Effect and Potential Application of Psilocybin","year":"2023","cit":0,"pfa":"Tianran Liu","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4391277213","eid":"W4391277213"},{"id":"paper-w4407973865","cat":"papers","name":"Explore the effect of psilocybin on depression and anxiety","year":"2025","cit":0,"pfa":"Yutong Song","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4407973865","eid":"W4407973865"},{"id":"paper-w4312562942","cat":"papers","name":"The Higher Powers: Fred M. Smith and the Peyote Ceremonies","year":"1995","cit":0,"pfa":"Shelby M. Barnes","ptype":"article","src":"https://openalex.org/W4312562942","eid":"W4312562942"},{"id":"paper-w7166567909","cat":"papers","name":"A Critical Evaluation of the Hypothesis that N,N-Dimethyltryptamine Maintains Neuroplasticity","year":"2026","cit":0,"pfa":"Ramiro Solis","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7166567909","eid":"W7166567909"},{"id":"paper-w2191745453","cat":"papers","name":"Kappa Opioid Receptor Ligands Derived from Salvinorin A","year":"2008","cit":0,"pfa":"Denise S. Simpson","psa":"Thomas Edward Prisinzano","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2191745453","eid":"W2191745453"},{"id":"paper-w7167056787","cat":"papers","name":"Sexual identity as a moderator of associations between lifetime MDMA/ecstasy or psilocybin use and mental health outcomes: An exploratory analysis of a nationally representative sample using NSDUH 2015–2019","year":"2026","cit":0,"pfa":"Maya Seale","ptype":"preprint","src":"https://openalex.org/W7167056787","eid":"W7167056787"},{"id":"paper-w4294495202","cat":"papers","name":"Mike Jay, Mescaline: A Global History of the First Psychedelic","year":"2020","cit":0,"pfa":"Evan Bonney","ptype":"article","src":"https://openalex.org/W4294495202","eid":"W4294495202"},{"id":"paper-w2969274807","cat":"papers","name":"Oklahoma-narárachi: paisajes del camino del peyote","year":"2010","cit":0,"pfa":"Francisco Cabanzo","ptype":"article","src":"https://openalex.org/W2969274807","eid":"W2969274807"},{"id":"paper-w7135870731","cat":"papers","name":"Ayahuasca neo-shamanic habitus in Czech Republic or what one has to do for becoming an ayahuasca neo-shaman","year":"2020","cit":0,"pfa":"Natanael Herrmann","ptype":"dissertation","src":"https://openalex.org/W7135870731","eid":"W7135870731"},{"id":"paper-w3201802469","cat":"papers","name":"Ontology and inequality: coca, ayahuasca and the historical agency.","year":"2016","cit":0,"pfa":"María Eugenia Flores","psa":"Ana Gretel Echazú Böschemeier","ptype":"article","src":"https://openalex.org/W3201802469","eid":"W3201802469"},{"id":"paper-w4415322579","cat":"papers","name":"On Drugs and Cults: The Ayahuasca Ban in France","year":"2025","cit":0,"pfa":"Henrique Fernandes Antunes","ptype":"book-chapter","src":"https://openalex.org/W4415322579","eid":"W4415322579"},{"id":"paper-w161574035","cat":"papers","name":"Aspectos terapéuticos de la mandrágora y la iboga","year":"2010","cit":0,"pfa":"Federico Paz","psa":"Roman Paškulin","ptype":"article","src":"https://openalex.org/W161574035","eid":"W161574035"},{"id":"paper-w7116796442","cat":"papers","name":"Towards the Total Synthesis of Salvinorin A: An Access to Decalones by Rearrangements of Epoxyazulenes","year":"2025","cit":0,"pfa":"Tamer Kocakaya","topics":["Addiction","Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W7116796442","eid":"W7116796442"},{"id":"paper-w7161986694","cat":"papers","name":"Observability and pharmacological calibration in psychoactive ethnobotany: ceremony duration, admixture selection, and the discovery of ayahuasca","year":"2026","cit":0,"pfa":"Elliot Allan","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7161986694","eid":"W7161986694"},{"id":"paper-w4416779935","cat":"papers","name":"Neurobiological and Therapeutic Potential of Psilocybin in Psychiatric Disorders","year":"2025","cit":0,"pfa":"Loganathan M","psa":"Mohamed Safir Ali","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4416779935","eid":"W4416779935"},{"id":"paper-w2416573070","cat":"papers","name":"[Acute toxicity of mescaline sulfate and antidotism of sodium succinate].","year":"1950","cit":0,"pfa":"J Delay","psa":"J Thuillier","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2416573070","eid":"W2416573070"},{"id":"paper-w1978878583","cat":"papers","name":"Ibogaine Stimulates Ionic Currents Mediated by Serotonin Transporter","year":"2010","cit":0,"pfa":"Wei Zhang","psa":"Gary Rudnick","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1978878583","eid":"W1978878583"},{"id":"paper-w2488263670","cat":"papers","name":"2. Swiss Psilocybin and US Dollars","year":"2019","cit":0,"pfa":"Nicolas Langlitz","ptype":"book-chapter","src":"https://openalex.org/W2488263670","eid":"W2488263670"},{"id":"paper-w4412265451","cat":"papers","name":"Kan psilocybin forbedre vores moral?","year":"2022","cit":0,"pfa":"Lange, Victor","psa":"Marie, Sidsel","ptype":"article","src":"https://openalex.org/W4412265451","eid":"W4412265451"},{"id":"paper-w4411986809","cat":"papers","name":"Psilocybin bei schwerer behandlungsresistenter Depression","year":"2025","cit":0,"topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4411986809","eid":"W4411986809"},{"id":"paper-w4413888032","cat":"papers","name":"PSYCHEDELICS IN PSYCHIATRY - OVERVIEW OF PSILOCYBIN RESEARCH","year":"2025","cit":0,"pfa":"Anna Blazhkova","psa":"Ewa Szczęsna","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4413888032","eid":"W4413888032"},{"id":"paper-w7147129341","cat":"papers","name":"Psilocybin: Wirksam, aber kein Wundermittel","year":"2026","cit":0,"pfa":"Helena Pichler","ptype":"article","src":"https://openalex.org/W7147129341","eid":"W7147129341"},{"id":"paper-w7166640155","cat":"papers","name":"Chronic psilocin microdosing produces limited behavioral effects and does not enhance neurogenesis in rats","year":"2026","cit":0,"pfa":"Lucie Olejníková Ladislavová","psa":"Tomáš Páleníček","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7166640155","eid":"W7166640155"},{"id":"paper-w1661076285","cat":"papers","name":"TRANSFERENCE PHENOMENA IN THE URBAN RITUAL OF TAKES OF AYAHUASCA","year":"2012","cit":0,"pfa":"Martha Isabel Córdoba","psa":"Juan Manuel Saa","ptype":"article","src":"https://openalex.org/W1661076285","eid":"W1661076285"},{"id":"paper-w4408058270","cat":"papers","name":"Development of Bioisosteric Iboga -alkaloids as Antinociceptive and Anxiolytic Agents with Neuroprotective Effects","year":"2025","cit":0,"pfa":"Abhishek Gupta","psa":"Surajit Sinha","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4408058270","eid":"W4408058270"},{"id":"paper-w4394121500","cat":"papers","name":"Psychedelic Zebrafish: the effects of LSD and MDMA on zebrafish behavior and physiology","year":"2015","cit":0,"pfa":"Jonathan Cachat","topics":["Dosing & pharmacology"],"ptype":"dataset","src":"https://openalex.org/W4394121500","eid":"W4394121500"},{"id":"paper-w4285612797","cat":"papers","name":"Unravelling a New Conformer of Psilocin Through Computational Methods","year":"2022","cit":0,"pfa":"Poonam Bhadoria","psa":"V. Ramanathan","ptype":"preprint","src":"https://openalex.org/W4285612797","eid":"W4285612797"},{"id":"paper-w2439914299","cat":"papers","name":"[USE OF PSILOCYBIN AS A DIAGNOSTIC TEST IN NEUROLOGY].","year":"1964","cit":0,"pfa":"Brooke Hopkins Dubansky","ptype":"article","src":"https://openalex.org/W2439914299","eid":"W2439914299"},{"id":"paper-w4412054280","cat":"papers","name":"Explore the effect of psilocybin on depression and anxiety","year":"2025","cit":0,"pfa":"Yutong Song","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4412054280","eid":"W4412054280"},{"id":"paper-w2777231772","cat":"papers","name":"Äiti Ayahuasca: Ayahuascalla tuotetun kokemuksen fenomenologiaa","year":"2017","cit":0,"pfa":"Aatu Poutanen","ptype":"dissertation","src":"https://openalex.org/W2777231772","eid":"W2777231772"},{"id":"paper-w2321568737","cat":"papers","name":"The Supreme Court, Peyote, and Minority Religions: Zero Tolerance","year":"1991","cit":0,"pfa":"Russel Lawrence Barsh","ptype":"article","src":"https://openalex.org/W2321568737","eid":"W2321568737"},{"id":"paper-w113126382","cat":"papers","name":"Sting y su viaje de ayahuasca","year":"2004","cit":0,"pfa":"Jordi Soler","ptype":"article","src":"https://openalex.org/W113126382","eid":"W113126382"},{"id":"paper-w4386013106","cat":"papers","name":"Psilocybin und Funktionalität bei Depression","year":"2023","cit":0,"pfa":"Moritz Spangemacher","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4386013106","eid":"W4386013106"},{"id":"paper-w2886320779","cat":"papers","name":"Aplicações psicológicas e psiquiátricas da Ayahuasca","year":"2016","cit":0,"pfa":"José Miguel Graça Pereira Palma","ptype":"dissertation","src":"https://openalex.org/W2886320779","eid":"W2886320779"},{"id":"paper-w3013039061","cat":"papers","name":"Studies on asymmetric syntheses of Iboga type indole alkaloids, voacangines and chippiines","year":"2020","cit":0,"pfa":"Shunsuke Takano","ptype":"article","src":"https://openalex.org/W3013039061","eid":"W3013039061"},{"id":"paper-w35755256","cat":"papers","name":"Ayahuasca y nuevas religiones mistéricas americanas","year":"2002","cit":0,"pfa":"Josep Maria Fericgla","ptype":"article","src":"https://openalex.org/W35755256","eid":"W35755256"},{"id":"paper-w2258077143","cat":"papers","name":"MDMA (\"Ecstasy\") and Brain Damage","year":"1998","cit":0,"pfa":"Brian Jarman","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2258077143","eid":"W2258077143"},{"id":"paper-w4233154861","cat":"papers","name":"MDMA TV: turn on, tune in","year":"2012","cit":0,"ptype":"article","src":"https://openalex.org/W4233154861","eid":"W4233154861"},{"id":"paper-w7126007757","cat":"papers","name":"La mescaline : évolution de la perception huxleyienne et intérêt thérapeutique moderne","year":"2025","cit":0,"pfa":"Pablo Garcia Lopez","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"dissertation","src":"https://openalex.org/W7126007757","eid":"W7126007757"},{"id":"paper-w1593581669","cat":"papers","name":"Effects of analgesics on the mescaline scratch response in mice. Abstr.","year":"1960","cit":0,"pfa":"Russell F. Krueger","psa":"Green, D M","ptype":"article","src":"https://openalex.org/W1593581669","eid":"W1593581669"},{"id":"paper-w4294993183","cat":"papers","name":"Three-decade research development of ibogaine use for the treatment of substance-related disorders: a bibliometric analysis","year":"2022","cit":0,"pfa":"Maria Helha Fernandes-Nascimento","psa":"Yuan‐Pang Wang","topics":["Addiction"],"ptype":"preprint","src":"https://openalex.org/W4294993183","eid":"W4294993183"},{"id":"paper-w4393593704","cat":"papers","name":"Psilocybin zur Behandlung depressiver Erkrankungen","year":"2024","cit":0,"pfa":"Henning Hintzsche","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4393593704","eid":"W4393593704"},{"id":"paper-w36529299","cat":"papers","name":"Effect of psilocybin on decision-making and motivation in the healthy rat.","year":"2023","cit":0,"pfa":"Brianna F Roberts","psa":"Matthew S McMurray","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W36529299","eid":"W36529299"},{"id":"paper-w2415775399","cat":"papers","name":"Mescaline and reactivity to foot shock--a dose response study.","year":"1981","cit":0,"pfa":"M. Leifer","psa":"Bridger Wh","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2415775399","eid":"W2415775399"},{"id":"paper-w33528649","cat":"papers","name":"Viaje por la tierra mágica del Peyote","year":"1999","cit":0,"pfa":"Joaquim Tarinas","ptype":"article","src":"https://openalex.org/W33528649","eid":"W33528649"},{"id":"paper-w4394401349","cat":"papers","name":"Psychedelic Clinical Studies - Bibliometric Dataset","year":"2021","cit":0,"pfa":"Jeremy Weleff","psa":"Brian Scott Barnett","ptype":"dataset","src":"https://openalex.org/W4394401349","eid":"W4394401349"},{"id":"paper-w3211151501","cat":"papers","name":"[Analysis of Dimethyltryptamine in Captured Suspicious Substances：Three Case Reports].","year":"2021","cit":0,"pfa":"J L Xu","psa":"Chunfang Ni","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W3211151501","eid":"W3211151501"},{"id":"paper-w4295004963","cat":"papers","name":"Psilocybin therapy reduces heavy drinking","year":"2022","cit":0,"pfa":"Karen O’Leary","ptype":"article","src":"https://openalex.org/W4295004963","eid":"W4295004963"},{"id":"paper-w7112419589","cat":"papers","name":"Salience, sensemaking, and setting in psilocybin microdosing","year":"2025","cit":0,"pfa":"Oblak, Aleš","psa":"Bon, Jurij","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7112419589","eid":"W7112419589"},{"id":"paper-w4237700656","cat":"papers","name":"MDMA (Ecstasy) Fast Facts","year":"2003","cit":0,"ptype":"dataset","src":"https://openalex.org/W4237700656","eid":"W4237700656"},{"id":"paper-w4245491510","cat":"papers","name":"Psilocybin shows potential as treatment for depression","year":"2016","cit":0,"topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4245491510","eid":"W4245491510"},{"id":"paper-w4240848632","cat":"papers","name":"Repeat Dosing of Psilocybin in Migraine Headache","year":"2020","cit":0,"topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4240848632","eid":"W4240848632"},{"id":"paper-w4406986871","cat":"papers","name":"Psilocybin for Depression and Anxiety in Cancer Patients","year":"2025","cit":0,"pfa":"Tammie E. Quest","psa":"Ali John Zarrabi","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W4406986871","eid":"W4406986871"},{"id":"paper-w4384835076","cat":"papers","name":"Psilocybin-Based Breakthroughs in Natural Medicine","year":"2023","cit":0,"pfa":"Dunn Harmony","psa":"Michael John Dochniak","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4384835076","eid":"W4384835076"},{"id":"paper-w4390750384","cat":"papers","name":"Psilocybin virker godt mot depresjon","year":"2024","cit":0,"pfa":"Jørgen Østensjø","ptype":"article","src":"https://openalex.org/W4390750384","eid":"W4390750384"},{"id":"paper-w4401200580","cat":"papers","name":"Treating Anxiety and Depression With Psilocybin Therapy.","year":"2024","cit":0,"pfa":"Amanda Paige Hanstein","psa":"Chance Felchlin","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4401200580","eid":"W4401200580"},{"id":"paper-w4250360815","cat":"papers","name":"Psilocybin: Antidepressive, Anxiolytic and Antiaddictive Effects","year":"2018","cit":0,"pfa":"Carolina Machado","topics":["Depression","Addiction"],"ptype":"other","src":"https://openalex.org/W4250360815","eid":"W4250360815"},{"id":"paper-w4401172233","cat":"papers","name":"Psilocybin desynchronization persists in the human brain","year":"2024","cit":0,"pfa":"Jake Rogers","ptype":"article","src":"https://openalex.org/W4401172233","eid":"W4401172233"},{"id":"paper-w7163695947","cat":"papers","name":"Motivation-based subtypes of psilocybin microdosers","year":"2026","cit":0,"pfa":"Ethan Klukas","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7163695947","eid":"W7163695947"},{"id":"paper-w7125431792","cat":"papers","name":"Is psilocybin only effective as part of psychotherapy?","year":"2026","cit":0,"pfa":"Tripdatabase","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W7125431792","eid":"W7125431792"},{"id":"paper-w7125369813","cat":"papers","name":"Is psilocybin only effective as part of psychotherapy?","year":"2026","cit":0,"pfa":"Tripdatabase","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W7125369813","eid":"W7125369813"},{"id":"paper-w7118002886","cat":"papers","name":"Behavioral and neuronal effects of psilocybin in mice","year":"2026","cit":0,"pfa":"C. Weber","psa":"Linda D. Simmler","ptype":"article","src":"https://openalex.org/W7118002886","eid":"W7118002886"},{"id":"paper-w7167494430","cat":"papers","name":"Synthetic Drugs and Behavioural Addictions: LSD, MDMA and Digital Toxicity","year":"2026","cit":0,"pfa":"Sharda More-Pol","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W7167494430","eid":"W7167494430"},{"id":"paper-w7166746595","cat":"papers","name":"Investigating the impact of serotonergic psychedelic drugs, MDMA and ketamine on social cognition in psychiatric disorders: A scoping review","year":"2026","cit":0,"pfa":"Sarah Ann Smith","psa":"Yanbo Zhang","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7166746595","eid":"W7166746595"},{"id":"paper-w4285292638","cat":"papers","name":"Conformational Analysis of Psilocybin: A Computational Approach","year":"2022","cit":0,"pfa":"Poonam Bhadoria","psa":"V. Ramanathan","ptype":"preprint","src":"https://openalex.org/W4285292638","eid":"W4285292638"},{"id":"paper-w7127040761","cat":"papers","name":"Psilocybin wirkt bei therapieresistenter Depression","year":"2026","cit":0,"pfa":"Thomas Müller","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7127040761","eid":"W7127040761"},{"id":"paper-w7141653385","cat":"papers","name":"Advancements in Treating Psychiatric Disorders With Psilocybin","year":"2024","cit":0,"pfa":"David A. Gorelick","topics":["Depression","Safety & adverse events","Therapy practice"],"ptype":"report","src":"https://openalex.org/W7141653385","eid":"W7141653385"},{"id":"paper-w4401229628","cat":"papers","name":"Precipitous Increases in Psilocybin Exposure in Youths","year":"2024","cit":0,"topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4401229628","eid":"W4401229628"},{"id":"paper-w4365151023","cat":"papers","name":"Phase I psilocybin safety trial","year":"2023","cit":0,"pfa":"Jennifer Bennett","topics":["Safety & adverse events"],"ptype":"dataset","src":"https://openalex.org/W4365151023","eid":"W4365151023"},{"id":"paper-w4387081757","cat":"papers","name":"Psilocybin kann offenbar Depressionen lindern","year":"2023","cit":0,"pfa":"Thomas Müller","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4387081757","eid":"W4387081757"},{"id":"paper-w3091928111","cat":"papers","name":"Ayahuasca Weaving Destinies, de Jimmy Weiskopf","year":"2012","cit":0,"pfa":"Juan Álvaro Echeverri","ptype":"article","src":"https://openalex.org/W3091928111","eid":"W3091928111"},{"id":"paper-w7135357796","cat":"papers","name":"The Effects of Psilocybin on Depression and Anxiety: A Review","year":"2025","cit":0,"pfa":"Hannah Joy Eliason","topics":["Depression","Anxiety & end-of-life","Reviews & meta-analyses"],"ptype":"dissertation","src":"https://openalex.org/W7135357796","eid":"W7135357796"},{"id":"paper-w4393210403","cat":"papers","name":"MedCheck; Psilocybin, Roluperidone, Latozinemab, Lacosamide","year":"2024","cit":0,"pfa":"Terri D’Arrigo","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4393210403","eid":"W4393210403"},{"id":"paper-w4248672862","cat":"papers","name":"Psilocybin shows potential as treatment for depression","year":"2016","cit":0,"topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4248672862","eid":"W4248672862"},{"id":"paper-w4362597408","cat":"papers","name":"Psilocybin zeigt Wirkung bei Depression","year":"2023","cit":0,"pfa":"Lea Julia Mertens","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4362597408","eid":"W4362597408"},{"id":"paper-w7120522636","cat":"papers","name":"Temporal perception in the ritual use of ayahuasca and snuff","year":"2025","cit":0,"pfa":"Ana Paula Silva Campagnoli","topics":["Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7120522636","eid":"W7120522636"},{"id":"paper-w2897747917","cat":"papers","name":"Total Synthesis of Salvinorin A via an IMDA-Tsuji Allylation Strategy","year":"2016","cit":0,"pfa":"Nathan J. Line","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2897747917","eid":"W2897747917"},{"id":"paper-w2417841453","cat":"papers","name":"[Studies on hallucinogens. V. Synthesis of psilocybin].","year":"1974","cit":0,"pfa":"M Ono","psa":"Tadao Inoue","ptype":"article","src":"https://openalex.org/W2417841453","eid":"W2417841453"},{"id":"paper-w2333493931","cat":"papers","name":"PSILOCYBIN STUDIES TURN A NEW LEAF","year":"2006","cit":0,"pfa":"Ivan Amato","topics":["Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W2333493931","eid":"W2333493931"},{"id":"paper-w7215523952","cat":"papers","name":"Psilocybin-Assisted Therapy as a Treatment for Depression","year":"2021","cit":0,"pfa":"Amelia Hamilton","topics":["Depression","Anxiety & end-of-life","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7215523952","eid":"W7215523952"},{"id":"paper-w4392762389","cat":"papers","name":"Peyote Shrines, Remembrance, and Ritual Surrogacy in South Texas","year":"2024","cit":0,"pfa":"Servando Z. Hinojosa","ptype":"article","src":"https://openalex.org/W4392762389","eid":"W4392762389"},{"id":"paper-w3149000809","cat":"papers","name":"Dimethyltryptamine（DMT）：a biochemical Swiss Army knife in neuroinflammation and neuroprotection？","year":"2016","cit":0,"pfa":"Attila","psa":"Frecska","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3149000809","eid":"W3149000809"},{"id":"paper-w1852370208","cat":"papers","name":"Does the First Amendment Accommodate the Religious Use of Peyote","year":"1987","cit":0,"pfa":"Nell Jessup Newton","ptype":"article","src":"https://openalex.org/W1852370208","eid":"W1852370208"},{"id":"paper-w7112093162","cat":"papers","name":"The therapeutic potential of Salvinorin A: a systematic review of preclinical and clinical studies","year":"2025","cit":0,"pfa":"Benjamin Victor Ineichen","psa":"Wolfgang Emanuel Zürrer","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W7112093162","eid":"W7112093162"},{"id":"paper-w2416610281","cat":"papers","name":"Investigation of the psycho-chemical basis of visual hallucinations produced by mescaline.","year":"1947","cit":0,"pfa":"Koren Salomon","psa":"Beverly Wescott Gabrio","ptype":"article","src":"https://openalex.org/W2416610281","eid":"W2416610281"},{"id":"paper-w2405295971","cat":"papers","name":"[Molecular biological approach to psychiatric problems using studies with mescaline].","year":"1968","cit":0,"pfa":"Herman C.B. Denber","psa":"David N. Teller","ptype":"article","src":"https://openalex.org/W2405295971","eid":"W2405295971"},{"id":"paper-w4408212909","cat":"papers","name":"Microcrystal Tests for the Identification of Illicit Drugs: Phencyclidine, Pseudoephedrine, and Psilocin","year":"2019","cit":0,"pfa":"Kelly M. Brinsko","psa":"Sebastian B. Sparenga","ptype":"article","src":"https://openalex.org/W4408212909","eid":"W4408212909"},{"id":"paper-w4255701151","cat":"papers","name":"LSD und Psilocybin als Selbstmedikation","year":"2020","cit":0,"topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4255701151","eid":"W4255701151"},{"id":"paper-w2956046898","cat":"papers","name":"The Potential of Psilocybin Administration in Terminal Cancer Patients","year":"2019","cit":0,"pfa":"Richard Simoneaux","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2956046898","eid":"W2956046898"},{"id":"paper-w4244294450","cat":"papers","name":"Health Concerns: Psilocybin (Magic Mushrooms)","year":"2009","cit":0,"ptype":"dataset","src":"https://openalex.org/W4244294450","eid":"W4244294450"},{"id":"paper-w2424510833","cat":"papers","name":"[Auto-experimentation with LSD-25 and psilocybin].","year":"1963","cit":0,"pfa":"A Calanca","ptype":"article","src":"https://openalex.org/W2424510833","eid":"W2424510833"},{"id":"paper-w7167594697","cat":"papers","name":"Beyond Enthusiasm: Ayahuasca and the Future of Depression Research","year":"2026","cit":0,"pfa":"Alberto Souza Sá Filho","psa":"Sergio Eduardo de Carvalho Machado","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7167594697","eid":"W7167594697"},{"id":"paper-w4242289263","cat":"papers","name":"The Circulation of Ayahuasca: Shamanic Tourism and Its Effects","year":"2010","cit":0,"pfa":"Evgenia Fotiou","ptype":"dataset","src":"https://openalex.org/W4242289263","eid":"W4242289263"},{"id":"paper-w4375871014","cat":"papers","name":"USO DA AYAHUASCA NO TRATAMENTO DA DEPRESSÃO","year":"2021","cit":0,"pfa":"Robenilson Diniz Alves","psa":"Joezilda Sousa Silvestre","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4375871014","eid":"W4375871014"},{"id":"paper-w2936772948","cat":"papers","name":"Psilocybin to Manage Cancer-Related Depression","year":"2016","cit":0,"pfa":"Bobby Lazzara","topics":["Depression","Anxiety & end-of-life","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2936772948","eid":"W2936772948"},{"id":"paper-w4230515641","cat":"papers","name":"Transcendental experiences with ayahuasca among Western users","year":"2008","cit":0,"pfa":"Evgenia Fotiou","ptype":"dataset","src":"https://openalex.org/W4230515641","eid":"W4230515641"},{"id":"paper-w2345877143","cat":"papers","name":"Surrendering to the Vine of the Soul: Ayahuasca Shamanism as a Logotherapy","year":"2016","cit":0,"pfa":"Rayo Gomez","psa":"Maria Lúcia Bueno Coelho de Paula","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2345877143","eid":"W2345877143"},{"id":"paper-w7120603274","cat":"papers","name":"Ayahuasca teacher: Cartography of the subjectivation processes of ayahuasqueiros","year":"2023","cit":0,"pfa":"Marina Pontes de Miranda Soares de Souza","ptype":"dissertation","src":"https://openalex.org/W7120603274","eid":"W7120603274"},{"id":"paper-w2429963531","cat":"papers","name":"[Action of mescaline on noradrenaline and dopamine levels in the rat brain].","year":"1977","cit":0,"pfa":"Mónica Padilla‐de la Torre","psa":"M Fassio","ptype":"article","src":"https://openalex.org/W2429963531","eid":"W2429963531"},{"id":"paper-w2766340631","cat":"papers","name":"Can Psilocybin Treat Severe Depression","year":"2017","cit":0,"pfa":"Barbara Geller","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2766340631","eid":"W2766340631"},{"id":"paper-w7153842460","cat":"papers","name":"Observability and pharmacological calibration in psychoactive ethnobotany: ceremony duration, admixture selection, and the discovery of ayahuasca","year":"2026","cit":0,"pfa":"Elliot Allan","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7153842460","eid":"W7153842460"},{"id":"paper-w4416941969","cat":"papers","name":"Psilocybin-assistierte Gruppenpsychotherapie bei Abhängigkeitserkrankungen","year":"2025","cit":0,"pfa":"Alexander Wopfner","psa":"Leila Maria Soravia","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4416941969","eid":"W4416941969"},{"id":"paper-w7202272719","cat":"papers","name":"The mechanism debate in psilocybin therapy for depression","year":"2026","cit":0,"pfa":"eBioMedicine","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7202272719","eid":"W7202272719"},{"id":"paper-w4406756190","cat":"papers","name":"Peyote (Lophophora williamsii (Lem. ex J.F. Cels) J.M. Coult.- Cactaceae)","year":"2025","cit":0,"pfa":"Viktória Lilla Balázs","psa":"Eszter Csikós","topics":["Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W4406756190","eid":"W4406756190"},{"id":"paper-w2579027576","cat":"papers","name":"Unidos por la ayahuasca: acuerdos y desencuentros en la II Conferencia Mundial de la Ayahuasca","year":"2016","cit":0,"pfa":"Miguel Castejón","ptype":"article","src":"https://openalex.org/W2579027576","eid":"W2579027576"},{"id":"paper-w2106289722","cat":"papers","name":"The Antipodes of the Mind: Charting the Phenomenology of the Ayahuasca Experience","year":"2003","cit":0,"pfa":"Steve Heilig","ptype":"article","src":"https://openalex.org/W2106289722","eid":"W2106289722"},{"id":"paper-w2797547028","cat":"papers","name":"Effect of Ayahuasca Rituals on Perception of Gay Identity","year":"2013","cit":0,"pfa":"Clancy Cavnar","ptype":"dataset","src":"https://openalex.org/W2797547028","eid":"W2797547028"},{"id":"paper-w2897551891","cat":"papers","name":"Etnografía visual fotográfica sobre la Ayahuasca.","year":"2018","cit":0,"pfa":"Cazar Vaca","psa":"Cynthia Karina","ptype":"dissertation","src":"https://openalex.org/W2897551891","eid":"W2897551891"},{"id":"paper-w2944097791","cat":"papers","name":"Contribution à l'étude de Tabernanthe Iboga H. Bn","year":"2007","cit":0,"pfa":"Loïc Sanner","psa":"Dominique Mattar","topics":["Addiction"],"ptype":"dissertation","src":"https://openalex.org/W2944097791","eid":"W2944097791"},{"id":"paper-w7212078508","cat":"papers","name":"828. Psilocin attenuates polyinosinic:polycytidylic acid (Poly I:C)-indued interferon responses in human peripheral blood mononuclear cells","year":"2026","cit":0,"pfa":"Christopher Sheridan","psa":"Andrew Harkin","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7212078508","eid":"W7212078508"},{"id":"paper-w2340344751","cat":"papers","name":"MDMA May Be Neurotoxic to Dopamine Neurons","year":"2002","cit":0,"pfa":"Charles B. Nemeroff","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2340344751","eid":"W2340344751"},{"id":"paper-w4406201383","cat":"papers","name":"Is MDMA an effective treatment for patients with PTSD?","year":"2025","cit":0,"pfa":"Allison Strauss","psa":"David Songco","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4406201383","eid":"W4406201383"},{"id":"paper-w4411400117","cat":"papers","name":"La ayahuasca como flosofía de vida","year":"2016","cit":0,"pfa":"Felipe Vásquez Sepúlveda","ptype":"article","src":"https://openalex.org/W4411400117","eid":"W4411400117"},{"id":"paper-w7212269178","cat":"papers","name":"Psilocybin may stop nerve damage","year":"2026","cit":0,"pfa":"Carissa Wong","ptype":"article","src":"https://openalex.org/W7212269178","eid":"W7212269178"},{"id":"paper-w7202198439","cat":"papers","name":"The Australian Ayahuasca Dietero Networks: Culture, Community, and Practices","year":"2026","cit":0,"pfa":"Alana Roy","psa":"Monica Jane Barratt","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7202198439","eid":"W7202198439"},{"id":"paper-w4416624308","cat":"papers","name":"Peer Review Report For: Development of a physiologically based pharmacokinetic (PBPK) model of psilocybin and psilocin from magic mushroom in rats and humans [version 1; peer review: 1 approved with reservations, 1 not a","year":"2021","cit":0,"pfa":"Michael W. Dzierlenga","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4416624308","eid":"W4416624308"},{"id":"paper-w2739639322","cat":"papers","name":"Neurochemical andbehavioural interactions between ibogaine andnicotine intherat","year":"1996","cit":0,"pfa":"M. E. M. Benwell","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2739639322","eid":"W2739639322"},{"id":"paper-w7155446220","cat":"papers","name":"Correction to: Ibogaine for the treatment of Parkinson's disease: A case report","year":"2026","cit":0,"pfa":"Tobias Erny","psa":"Geoff Noller","ptype":"erratum","src":"https://openalex.org/W7155446220","eid":"W7155446220"},{"id":"paper-w7164172685","cat":"papers","name":"Clinical and non-clinical use of MDMA","year":"2026","cit":0,"pfa":"Tor-Morten Kvam","psa":"Ole A. Andreassen","ptype":"article","src":"https://openalex.org/W7164172685","eid":"W7164172685"},{"id":"paper-w4391329406","cat":"papers","name":"Psilocybin-assisted psychotherapy for cancer patients","year":"2024","cit":0,"pfa":"Houman Farzin","topics":["Anxiety & end-of-life","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4391329406","eid":"W4391329406"},{"id":"paper-w7168102549","cat":"papers","name":"Psilocybin-induced behavioral and cellular effects","year":"2026","cit":0,"pfa":"Albert M. Dong","psa":"Xiaojie Huang","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7168102549","eid":"W7168102549"},{"id":"paper-w7172404737","cat":"papers","name":"MDMA and Gene Regulation: A Literature Review","year":"2026","cit":0,"pfa":"James Tran","psa":"Rebecca Jean Ryznar","topics":["Reviews & meta-analyses","Policy & ethics"],"ptype":"conference-abstract","src":"https://openalex.org/W7172404737","eid":"W7172404737"},{"id":"paper-w4238717967","cat":"papers","name":"MDMA/Ecstasy - A Drug With Complex Consequences","year":"2001","cit":0,"pfa":"Alan I. Leshner","ptype":"dataset","src":"https://openalex.org/W4238717967","eid":"W4238717967"},{"id":"paper-w2335888876","cat":"papers","name":"Tolerance to MDMA-induced serotonergic neurotoxicity","year":"2010","cit":0,"pfa":"Nirmal Bhide","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2335888876","eid":"W2335888876"},{"id":"paper-w2498563021","cat":"papers","name":"Mitochondrial Trails in the Neurotoxic Mechanisms of MDMA","year":"2016","cit":0,"pfa":"Daniel José Barbosa","psa":"Félix Dias Carvalho","topics":["Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W2498563021","eid":"W2498563021"},{"id":"paper-w7106112194","cat":"papers","name":"Meta-Analysis of MDMA on Mental Illness","year":"2025","cit":0,"pfa":"Tyler Owen","psa":"Nicholas Borgogna","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W7106112194","eid":"W7106112194"},{"id":"paper-w2414025687","cat":"papers","name":"[Dynamics of brain protein amide groups in mescaline epileptogenic focus].","year":"1969","cit":0,"pfa":"N Mison-Krigel'","psa":"G Badiu","ptype":"article","src":"https://openalex.org/W2414025687","eid":"W2414025687"},{"id":"paper-w4408108952","cat":"papers","name":"Reviewer #2 (Public review): Psilocin fosters neuroplasticity in iPSC-derived human cortical neurons","year":"2025","cit":0,"pfa":"Malin Schmidt","psa":"Philipp Koch","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"peer-review","src":"https://openalex.org/W4408108952","eid":"W4408108952"},{"id":"paper-w3103604892","cat":"papers","name":"„MDMA: efekty kliniczne i toksykologia”","year":"2017","cit":0,"pfa":"Jakub Szlachetka","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3103604892","eid":"W3103604892"},{"id":"paper-w2794078048","cat":"papers","name":"A Culture's Catalyst: Historical Encounters with Peyote and the Native American Church in Canada by Fannie Kahan","year":"2018","cit":0,"pfa":"Stacy B. Schaefer","psa":"Professor Emerita","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2794078048","eid":"W2794078048"},{"id":"paper-w4253178213","cat":"papers","name":"MDMA-induced angioedema treated with icatibant","year":"2016","cit":0,"pfa":"August Supervía","psa":"Francisco del Baño","ptype":"article","src":"https://openalex.org/W4253178213","eid":"W4253178213"},{"id":"paper-w7163107762","cat":"papers","name":"Motivation-based subtypes of psilocybin microdosers","year":"2026","cit":0,"pfa":"Ethan Klukas","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7163107762","eid":"W7163107762"},{"id":"paper-w4409654230","cat":"papers","name":"Open MDMA: An Evidence-Based Mixed-Methods Review, Theoretical Framework, and Manual for MDMA Therapy","year":"2025","cit":0,"pfa":"Mark Groeneveld","psa":"Thomas Harper","topics":["PTSD & trauma","Safety & adverse events","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4409654230","eid":"W4409654230"},{"id":"paper-w2469802172","cat":"papers","name":"[Similarities and dissimilarities of experimental psychoses caused by LSD-25 and mescaline].","year":"1960","cit":0,"pfa":"M Vojtĕchovský","psa":"S Grof","ptype":"article","src":"https://openalex.org/W2469802172","eid":"W2469802172"},{"id":"paper-w4411530349","cat":"papers","name":"Treating Childhood Trauma through Psilocybin","year":"2025","cit":0,"pfa":"Bénédicte Mannix","psa":"Michael Winkelman","topics":["PTSD & trauma","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W4411530349","eid":"W4411530349"},{"id":"paper-w2618833921","cat":"papers","name":"Exploring MDMA and its therapeutic potential","year":"2012","cit":0,"pfa":"Michael Christian","topics":["PTSD & trauma","Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2618833921","eid":"W2618833921"},{"id":"paper-w832595298","cat":"papers","name":"Annotation de Notes sur la prise de mescaline","year":"2010","cit":0,"pfa":"Juliette Simont","psa":"Gilles Philippe","ptype":"book-chapter","src":"https://openalex.org/W832595298","eid":"W832595298"},{"id":"paper-w2364260700","cat":"papers","name":"THE NEUROTOXICITY AND SERT mRNA EXPRESSION OF MDMA","year":"2004","cit":0,"pfa":"Xue Wang","topics":["Safety & adverse events","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2364260700","eid":"W2364260700"},{"id":"paper-w1543016373","cat":"papers","name":"The effects of ayahuasca on psi: a preliminary study in South America","year":"2010","cit":0,"pfa":"David P. Luke","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W1543016373","eid":"W1543016373"},{"id":"paper-w2414799282","cat":"papers","name":"[On the pharmacologic action of Thabernante Iboga. Collective review and clinical contribution].","year":"1965","cit":0,"pfa":"B Milani","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2414799282","eid":"W2414799282"},{"id":"paper-w4413518997","cat":"papers","name":"Ayahuasca: just how safe is this psychoactive brew?","year":"2022","cit":0,"pfa":"Colin Davidson","ptype":"other","src":"https://openalex.org/W4413518997","eid":"W4413518997"},{"id":"paper-w4223937577","cat":"papers","name":"Inca sacrifice victims were given ayahuasca","year":"2022","cit":0,"ptype":"article","src":"https://openalex.org/W4223937577","eid":"W4223937577"},{"id":"paper-w7120849154","cat":"papers","name":"Tryptamine and dimethyltryptamine on melanomas: biosynthesis, metabolism and antitumor activity","year":"2012","cit":0,"pfa":"Janine Baptista Coimbra","ptype":"dissertation","src":"https://openalex.org/W7120849154","eid":"W7120849154"},{"id":"paper-w4405635967","cat":"papers","name":"Safety pharmacology of acute mescaline administration in healthy participants","year":"2024","cit":0,"pfa":"Aaron Klaiber","psa":"Matthias E. Liechti","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4405635967","eid":"W4405635967"},{"id":"paper-w4299986379","cat":"papers","name":"Role of kappa-opioid receptors in the effects of salvinorin A and ketamine on attention in rats","year":"2020","cit":0,"pfa":"Bruce M. Cohen","psa":"Bryan L. Roth","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4299986379","eid":"W4299986379"},{"id":"paper-w7126357595","cat":"papers","name":"Ibogaine for the treatment of opioid dependence: From mechanisms of action to clinical efficacy","year":"2024","cit":0,"pfa":"Genís Oña Esteve","topics":["Addiction","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W7126357595","eid":"W7126357595"},{"id":"paper-w2597743545","cat":"papers","name":"Effects of Ayahuasca on an animal model of Ethanol addiction","year":"2015","cit":0,"pfa":"Las F Berro","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2597743545","eid":"W2597743545"},{"id":"paper-w7143282109","cat":"papers","name":"Dataset: Registered Clinical Trials of Ayahuasca and DMT","year":"2026","cit":0,"pfa":"Thiago C. Moulin","ptype":"dataset","src":"https://openalex.org/W7143282109","eid":"W7143282109"},{"id":"paper-w7139132619","cat":"papers","name":"Raman Activity Investigation and Utilization of Psilocybin","year":"2026","cit":0,"pfa":"Mingyu Sun","psa":"Liang Tong","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7139132619","eid":"W7139132619"},{"id":"paper-w2334408114","cat":"papers","name":"ChemInform Abstract: REGIO‐ UND STEREOSPEZIFISCHE MODELLE DER BIOSYNTH. VON INDOLALKALOIDEN, PROLOG UND KOMMENTAR, CORYNANTHE/STRYCHNOS‐IBOGA‐, CORYNANTHE‐ASPIDOSPERMA‐, ASPIDOSPERMA‐IBOGA‐BEZIEHUNG","year":"1973","cit":0,"pfa":"A. Ian Scott","psa":"C. C. Wei","ptype":"article","src":"https://openalex.org/W2334408114","eid":"W2334408114"},{"id":"paper-w2595822141","cat":"papers","name":"MDMA ADMINISTRATION AFFECTS COGNITION IN THE RAT","year":"2006","cit":0,"pfa":"Jessica A. Able","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2595822141","eid":"W2595822141"},{"id":"paper-w7132589380","cat":"papers","name":"Mirties dėl Ekstazio (MDMA) perdozavimo","year":"2010","cit":0,"pfa":"Dagmara Ona Reingardienė","psa":"Povilas Ūzas","ptype":"conference-paper","src":"https://openalex.org/W7132589380","eid":"W7132589380"},{"id":"paper-w4388309700","cat":"papers","name":"Coca et ayahuasca, une même destinée?","year":"2018","cit":0,"pfa":"Jacques Mabit","ptype":"article","src":"https://openalex.org/W4388309700","eid":"W4388309700"},{"id":"paper-w7120324295","cat":"papers","name":"Anomalous experiences with ayahuasca and DMT: a psychosocial analysis","year":"2024","cit":0,"pfa":"R Perreira dos Santos","ptype":"dissertation","src":"https://openalex.org/W7120324295","eid":"W7120324295"},{"id":"paper-w7130713779","cat":"papers","name":"Ayahuasca, DMT, and Mental Health: A Current Review of Scientific Studies","year":"2026","cit":0,"pfa":"Dráulio B. Araújo","psa":"Fernanda Palhano-Fontes","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7130713779","eid":"W7130713779"},{"id":"paper-w2961947623","cat":"papers","name":"Os Saberes da Ayahuasca na Barquinha","year":"2017","cit":0,"pfa":"Rita Barreto de Sales Oliveira","ptype":"article","src":"https://openalex.org/W2961947623","eid":"W2961947623"},{"id":"paper-w4409472916","cat":"papers","name":"Potenciais da Ayahuasca na Saúde Mental","year":"2025","cit":0,"pfa":"Renan de Oliveira Monteiro","psa":"Graciana de Sousa Lopes","ptype":"book-chapter","src":"https://openalex.org/W4409472916","eid":"W4409472916"},{"id":"paper-w2422204147","cat":"papers","name":"[Action of amphetamine on mescaline inhibition of conditioned reflexes in the rat].","year":"1998","cit":0,"pfa":"Goldwurm Gf","psa":"E Gualandri","ptype":"article","src":"https://openalex.org/W2422204147","eid":"W2422204147"},{"id":"paper-w7198050137","cat":"papers","name":"MDMA-assisted psychotherapy for the treatment of PTSD","year":"2022","cit":0,"pfa":"David Mazor","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7198050137","eid":"W7198050137"},{"id":"paper-w1576239838","cat":"papers","name":"Designing a Model of the Ayahuasca Experience : A Phenomenological Study","year":"2010","cit":0,"pfa":"Anette Kjellgren","psa":"Torsten Norlander","ptype":"article","src":"https://openalex.org/W1576239838","eid":"W1576239838"},{"id":"paper-w7157516610","cat":"papers","name":"Philosophical elements for understanding the healing effects \"ayahuasca\"","year":"2012","cit":0,"pfa":"Milton Briceño Bueno","ptype":"article","src":"https://openalex.org/W7157516610","eid":"W7157516610"},{"id":"paper-w4416386276","cat":"papers","name":"Unmixing the psychedelic connectome: Brain network traits of psilocybin","year":"2026","cit":0,"pfa":"Krishna Prasad Bhavaraju","psa":"Enrico Amico","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4416386276","eid":"W4416386276"},{"id":"paper-w4318212900","cat":"papers","name":"Psilocybin-Assisted Psychotherapy in Palliative Care","year":"2022","cit":0,"pfa":"Stephen Ross","psa":"Anthony P. Bossis","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W4318212900","eid":"W4318212900"},{"id":"paper-w7132113077","cat":"papers","name":"The Treatment of Obsessive Compulsive Disorder with Psilocybin","year":"2023","cit":0,"pfa":"İpek Duygu Özdemir","psa":"Hacı Ahmet Kılıç","ptype":"conference-paper","src":"https://openalex.org/W7132113077","eid":"W7132113077"},{"id":"paper-w7118127068","cat":"papers","name":"Psilocybin and Bipolar Depression: Promise and Prudence","year":"2026","cit":0,"pfa":"Matheus G. Marques","psa":"Balwinder Singh","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7118127068","eid":"W7118127068"},{"id":"paper-w99965482","cat":"papers","name":"Ayahuasca, una receta con múltiples aplicaciones","year":"2009","cit":0,"pfa":"Borja De Miguel","ptype":"article","src":"https://openalex.org/W99965482","eid":"W99965482"},{"id":"paper-w7128675830","cat":"papers","name":"MDMA: effects on sleep and the circadian system","year":"2017","cit":0,"pfa":"Rowan P. Ogeil","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7128675830","eid":"W7128675830"},{"id":"paper-w572509175","cat":"papers","name":"Rock crystals & peyote dreams: explorations in the Huichol universe","year":"2007","cit":0,"topics":["Therapy practice"],"ptype":"book-review","src":"https://openalex.org/W572509175","eid":"W572509175"},{"id":"paper-w2320232422","cat":"papers","name":"Absolute configuration of iboga-type alklaoids from Ervatamia officinalis","year":"2014","cit":0,"pfa":"Zhang Xq","psa":"CT Che","ptype":"article","src":"https://openalex.org/W2320232422","eid":"W2320232422"},{"id":"paper-w4363673733","cat":"papers","name":"MDMA-Therapy for Trauma Related Disorders","year":"2023","cit":0,"pfa":"Jennifer Mitchell","psa":"Berra Yazar‐Klosinski","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4363673733","eid":"W4363673733"},{"id":"paper-w1035192066","cat":"papers","name":"MDMA (éxtasis): potencial del abuso","year":"1998","cit":0,"pfa":"Emilio Sanchéz Hervás","psa":"Vicente Tomás Gradolí","ptype":"article","src":"https://openalex.org/W1035192066","eid":"W1035192066"},{"id":"paper-w2407253116","cat":"papers","name":"[Psychological aspects of MDMA (ecstasy) users].","year":"2003","cit":0,"pfa":"Isabelle Varescon","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"other","src":"https://openalex.org/W2407253116","eid":"W2407253116"},{"id":"paper-w2352374252","cat":"papers","name":"Postmortem redistribution of MDMA and its mechanisms","year":"2005","cit":0,"pfa":"Yingyuan Wang","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2352374252","eid":"W2352374252"},{"id":"paper-w2734897895","cat":"papers","name":"Apresentação - E se um viajante numa sessão de ayahuasca: jornadas interdisciplinares de ayahuasca e saúde","year":"2017","cit":0,"pfa":"Ana Letícia de Fiori","psa":"Marcelo Simão Mercante","ptype":"article","src":"https://openalex.org/W2734897895","eid":"W2734897895"},{"id":"paper-w3162599402","cat":"papers","name":"Ayahuasca-Tourismus in Peru: Motivationen und subjektive Bedeutungen bei Teilnehmern von Ayahuasca-Retreats im oberen Amazonasgebiet","year":"2021","cit":0,"pfa":"Tom John Wolff","ptype":"article","src":"https://openalex.org/W3162599402","eid":"W3162599402"},{"id":"paper-w7117534874","cat":"papers","name":"Unexpected Detection of Psilocybin in a 100 mg Tramadol Tablet: A Forensic Case Report","year":"2025","cit":0,"pfa":"Amin Reihani","psa":"Fatemeh Shaki","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7117534874","eid":"W7117534874"},{"id":"paper-w4200337583","cat":"papers","name":"P.0006 BDNF levels in blood serum and plasma of MDMA users and MDMA-naïve controls","year":"2021","cit":0,"pfa":"Serena Stamatakos","psa":"Boris B. Quednow","ptype":"article","src":"https://openalex.org/W4200337583","eid":"W4200337583"},{"id":"paper-w4388870661","cat":"papers","name":"News Brief: MDMA therapy for PTSD.","year":"2023","cit":0,"topics":["PTSD & trauma","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4388870661","eid":"W4388870661"},{"id":"paper-w2586324323","cat":"papers","name":"What is the difference between Ecstasy and MDMA","year":"2016","cit":0,"pfa":"Alexandra Turner","topics":["Addiction","Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W2586324323","eid":"W2586324323"},{"id":"paper-w4206634053","cat":"papers","name":"ΔFosB: A Molecular Mechanism of MDMA Dependence","year":"2017","cit":0,"pfa":"Jason Foote","topics":["Addiction","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W4206634053","eid":"W4206634053"},{"id":"paper-w4401694907","cat":"papers","name":"FDA ixnays MDMA, papers retracted","year":"2024","cit":0,"pfa":"Sarah Braner","topics":["PTSD & trauma","Safety & adverse events","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W4401694907","eid":"W4401694907"},{"id":"paper-w4405636605","cat":"papers","name":"Acute effects of individual R- and S-MDMA enantiomer administration compared with racemic (±)-MDMA in healthy participants","year":"2024","cit":0,"pfa":"Isabelle Straumann","psa":"Matthias E. Liechti","ptype":"article","src":"https://openalex.org/W4405636605","eid":"W4405636605"},{"id":"paper-w7204023876","cat":"papers","name":"Characterizing Psilocybin Use Motivations and Effects Among Older Adults Accessing State-Regulated Psilocybin Services","year":"2026","cit":0,"pfa":"Ximena A. Levander","psa":"Benjamin H. Han","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7204023876","eid":"W7204023876"},{"id":"paper-w4205475045","cat":"papers","name":"Extractivism in Iquitos: From Rubber to Ayahuasca Literature","year":"2021","cit":0,"pfa":"Amanda M. Smith","ptype":"book-chapter","src":"https://openalex.org/W4205475045","eid":"W4205475045"},{"id":"paper-w4286354963","cat":"papers","name":"Potenciales terapéuticos del peyote entre no indígenas en México","year":"2022","cit":0,"pfa":"Mauricio Genet Guzmán Chávez","psa":"José Noyola Cherpitel","ptype":"article","src":"https://openalex.org/W4286354963","eid":"W4286354963"},{"id":"paper-w7130345003","cat":"papers","name":"Regulatory ambiguity and governance challenges for psilocybin mushrooms in Brazil","year":"2026","cit":0,"pfa":"Marcel Nogueira","psa":"Daniel Cardoso Rodrigues","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7130345003","eid":"W7130345003"},{"id":"paper-w2077958291","cat":"papers","name":"Book Review: Peyote vs. The State: Religious Freedom on Trial","year":"2011","cit":0,"pfa":"Shyam K. Sriram","topics":["Reviews & meta-analyses"],"ptype":"book-review","src":"https://openalex.org/W2077958291","eid":"W2077958291"},{"id":"paper-w7141189300","cat":"papers","name":"Trial of Psilocybin vs Escitalopram for Depression","year":"2021","cit":0,"topics":["Depression"],"ptype":"report","src":"https://openalex.org/W7141189300","eid":"W7141189300"},{"id":"paper-w7128724266","cat":"papers","name":"MDMA: effects on sleep and the circadian system","year":"2017","cit":0,"pfa":"Rowan P. Ogeil","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7128724266","eid":"W7128724266"},{"id":"paper-w7111566676","cat":"papers","name":"Aotearoa MDMA Use and Users Survey","year":"2024","cit":0,"pfa":"Ryan Ward","psa":"Geoff Noller","ptype":"preprint","src":"https://openalex.org/W7111566676","eid":"W7111566676"},{"id":"paper-w4413965579","cat":"papers","name":"Unmasking bias and MDMA-assisted therapy","year":"2025","cit":0,"pfa":"Balázs Szigeti","psa":"Joshua D. Woolley","topics":["PTSD & trauma"],"ptype":"preprint","src":"https://openalex.org/W4413965579","eid":"W4413965579"},{"id":"paper-w7132825580","cat":"papers","name":"Psychedelic Therapy: A Primer for Primary Care Clinicians—Mescaline","year":"2026","cit":0,"pfa":"Burton Jared Tabaac","psa":"Owen S. Muir","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7132825580","eid":"W7132825580"},{"id":"paper-w7164906744","cat":"papers","name":"Psychedelic Therapy: A Primer for Primary Care Clinicians—Mescaline","year":"2026","cit":0,"pfa":"Burton Jared Tabaac","psa":"Owen S. Muir","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7164906744","eid":"W7164906744"},{"id":"paper-w3120720742","cat":"papers","name":"Neurobiology of 3,4-Methylenedioxymethamphetamine (MDMA, or “Ecstasy”)","year":"2007","cit":0,"pfa":"Steven B. Karch Ffflm","ptype":"article","src":"https://openalex.org/W3120720742","eid":"W3120720742"},{"id":"paper-w2473893484","cat":"papers","name":"[Action of psilocybin on the excitability of the nerve centers].","year":"1961","cit":0,"pfa":"Paul Chauchard","psa":"Henriette Mazoué","ptype":"article","src":"https://openalex.org/W2473893484","eid":"W2473893484"},{"id":"paper-w7108443677","cat":"papers","name":"Psilocybin-assistierte Gruppenpsychotherapie bei Abhängigkeitserkrankungen","year":"2025","cit":0,"pfa":"Wopfner, Alexander","psa":"Soravia, Leila M.","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W7108443677","eid":"W7108443677"},{"id":"paper-w2757371907","cat":"papers","name":"La ayahuasca, una planta de poder","year":"2017","cit":0,"pfa":"Diario El Tiempo","ptype":"article","src":"https://openalex.org/W2757371907","eid":"W2757371907"},{"id":"paper-w815379561","cat":"papers","name":"Notice pour Notes sur la prise de mescaline","year":"2010","cit":0,"pfa":"Juliette Simont","psa":"Gilles Philippe","ptype":"book-chapter","src":"https://openalex.org/W815379561","eid":"W815379561"},{"id":"paper-w7134244645","cat":"papers","name":"Enchanted consciousness revisited – Ayahuasca visualizations and Sartre's ideas on hallucination","year":"2026","cit":0,"pfa":"Lajos Horváth","ptype":"article","src":"https://openalex.org/W7134244645","eid":"W7134244645"},{"id":"paper-w2622036093","cat":"papers","name":"Synthesis of Iboga Alkaloids Using Cascade Cyclisation, Nitrone Cycloaddition","year":"2017","cit":0,"pfa":"Ziad T. I. Alkayar","ptype":"dissertation","src":"https://openalex.org/W2622036093","eid":"W2622036093"},{"id":"paper-w7134849729","cat":"papers","name":"VeronicaMaki-Marttunen/Psilocybin-shapes-propagation-of-brain-activity: Mäki-Marttunen-Psilocybin-shapes-propagation-of-brain-activity","year":"2026","cit":0,"pfa":"Veronica Mäki-Marttunen","topics":["Mechanism & neuroscience"],"ptype":"software","src":"https://openalex.org/W7134849729","eid":"W7134849729"},{"id":"paper-w101731910","cat":"papers","name":"La ayahuasca fortificada de Jatun Sacha","year":"2006","cit":0,"pfa":"Jonathan Ott","ptype":"article","src":"https://openalex.org/W101731910","eid":"W101731910"},{"id":"paper-w2808790563","cat":"papers","name":"Ayahuasca: Ein Weg, um das Gleichgewicht","year":"2016","cit":0,"pfa":"Rita Flávia Miranda de Oliveira","ptype":"article","src":"https://openalex.org/W2808790563","eid":"W2808790563"},{"id":"paper-w2915052643","cat":"papers","name":"Sexual Seduction in Ayahuasca Shaman and Participants Interactions","year":"2018","cit":0,"pfa":"Daniela M. Peluso","ptype":"other","src":"https://openalex.org/W2915052643","eid":"W2915052643"},{"id":"paper-w4312681917","cat":"papers","name":"Evidências do efeito terapêutico da ayahuasca","year":"2021","cit":0,"pfa":"Fernanda Palhano-Fontes","psa":"Dráulio Barros de Araújo","ptype":"book-chapter","src":"https://openalex.org/W4312681917","eid":"W4312681917"},{"id":"paper-w2363906621","cat":"papers","name":"DISTRIBUTION OF MDMA IN ACUTE POISONED RATS","year":"2005","cit":0,"pfa":"Yingyuan Wang","ptype":"article","src":"https://openalex.org/W2363906621","eid":"W2363906621"},{"id":"paper-w2995589546","cat":"papers","name":"The Behavioral and Brain Effects of MDMA (Ecstasy)","year":"2006","cit":0,"pfa":"Jessica Shields","ptype":"article","src":"https://openalex.org/W2995589546","eid":"W2995589546"},{"id":"paper-w2809267625","cat":"papers","name":"Ayahuasca: Um Caminho para o Equilíbrio","year":"2016","cit":0,"pfa":"Rita Barreto de Sales Oliveira","psa":"Renilda Gonçalves do Amaral","ptype":"article","src":"https://openalex.org/W2809267625","eid":"W2809267625"},{"id":"paper-w2776953135","cat":"papers","name":"Ecstasy (MDMA) and other designer drugs","year":"2013","cit":0,"pfa":"Ronald L. Cowan","psa":"Todd B. Monroe","ptype":"book-chapter","src":"https://openalex.org/W2776953135","eid":"W2776953135"},{"id":"paper-w3004169626","cat":"papers","name":"MDMA could be approved to treat PTSD","year":"2020","cit":0,"pfa":"Christine Blank","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W3004169626","eid":"W3004169626"},{"id":"paper-w7166650499","cat":"papers","name":"Secret Amazon species may be new source of ibogaine for addiction treatment","year":"2026","cit":0,"pfa":"Jenny Gonzales","topics":["Addiction"],"ptype":"other","src":"https://openalex.org/W7166650499","eid":"W7166650499"},{"id":"paper-w2410280740","cat":"papers","name":"[Two cases of \"Ecstasy (MDMA)\" poisoning].","year":"2003","cit":0,"pfa":"Takao Chishiro","psa":"Shun-ichiro Kiuchi","ptype":"article","src":"https://openalex.org/W2410280740","eid":"W2410280740"},{"id":"paper-w1527165796","cat":"papers","name":"Substance‐Related Disorders: Hallucinogens and MDMA","year":"2006","cit":0,"pfa":"Michael B. First","psa":"Allan Tasman","topics":["Addiction"],"ptype":"other","src":"https://openalex.org/W1527165796","eid":"W1527165796"},{"id":"paper-w7213945218","cat":"papers","name":"EFFICACY AND SAFETY OF PSILOCYBIN IN TREATMENT-RESISTANT DEPRESSION: A REVIEW","year":"2026","cit":0,"pfa":"Mateusz Gawin","psa":"Aleksandra Golec","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7213945218","eid":"W7213945218"},{"id":"paper-w7132296799","cat":"papers","name":"Mirtis nuo ekstazio (MDMA) perdozavimo","year":"2010","cit":0,"pfa":"Dagmara Ona Reingardienė","ptype":"article","src":"https://openalex.org/W7132296799","eid":"W7132296799"},{"id":"paper-w2149648847","cat":"papers","name":"Dependência, recuperação e o tratamento através da ayahuasca: definições e indefinições Dependency, recuperation and the treatment through ayahuasca: definitions and indefinitions","year":"2013","cit":0,"pfa":"Marcelo Simão Mercante","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2149648847","eid":"W2149648847"},{"id":"paper-w4412648561","cat":"papers","name":"Efficient Acyloxymethylation of Psilocin and Other Tryptamines Yielding ACOM Prodrugs for Psychedelic‐Assisted Therapy","year":"2025","cit":0,"pfa":"Judith Stirn","psa":"Christian D. P. Klein","ptype":"article","src":"https://openalex.org/W4412648561","eid":"W4412648561"},{"id":"paper-w2019156800","cat":"papers","name":"Substituted Iboga -alkaloids and their model receptor interactions – Theoretical and experimental studies","year":"2012","cit":0,"pfa":"Bojidarka B. Ivanova","psa":"Michael Spiteller","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2019156800","eid":"W2019156800"},{"id":"paper-w4414410007","cat":"papers","name":"Recent advances in the total synthesis of type III post-Iboga alkaloids","year":"2025","cit":0,"pfa":"Xian-Yue Zhang","psa":"Guang Li","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4414410007","eid":"W4414410007"},{"id":"paper-w2044417205","cat":"papers","name":"The kappa agonist, salvinorin A, punishes remifentanil and cocaine self-administration in monkeys","year":"2014","cit":0,"pfa":"Kevin B. Freeman","psa":"William L. Woolverton","ptype":"article","src":"https://openalex.org/W2044417205","eid":"W2044417205"},{"id":"paper-w4241741659","cat":"papers","name":"Drug Fact Sheet: Ecstasy or MDMA","year":"2012","cit":0,"ptype":"dataset","src":"https://openalex.org/W4241741659","eid":"W4241741659"},{"id":"paper-w2277958568","cat":"papers","name":"Effects of MDMA (ecstasy) on the limbic system","year":"2005","cit":0,"pfa":"Ian J. Tamburini","psa":"Antonio Paparelli","ptype":"conference-paper","src":"https://openalex.org/W2277958568","eid":"W2277958568"},{"id":"paper-w7127606273","cat":"papers","name":"THE PSYCHEDELIC RENAISSANCE: A SYSTEMATIC REVIEW OF PSILOCYBIN AND LSD IN THE TREATMENT OF PSYCHIATRIC DISORDERS","year":"2026","cit":0,"pfa":"Jakub Klepacz","psa":"Zuzanna Dobrakowska","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"review","src":"https://openalex.org/W7127606273","eid":"W7127606273"},{"id":"paper-w2141233825","cat":"papers","name":"Salvinorin: Uyuşturucu Madde Kapsamına Alınan Yeni Psiko-Stimülan Madde","year":"2013","cit":0,"pfa":"Faruk Aşıcıoğlu","psa":"Latif Ilhan","ptype":"article","src":"https://openalex.org/W2141233825","eid":"W2141233825"},{"id":"paper-w7128621865","cat":"papers","name":"Neural Correlates of Ibogaine: Evidence From Functional Neuroimaging of Military Veterans","year":"2026","cit":0,"pfa":"Malvika Sridhar","psa":"Nolan Williams","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7128621865","eid":"W7128621865"},{"id":"paper-w4238422512","cat":"papers","name":"4‐Hydroxy‐ N , N ‐Dimethyltryptamine 520‐53‐6","year":"2004","cit":0,"ptype":"other","src":"https://openalex.org/W4238422512","eid":"W4238422512"},{"id":"paper-w3034821272","cat":"papers","name":"Constitutional Law: The Peyote Decision: A Restriction upon All Religions?","year":"1991","cit":0,"pfa":"Brett D. Brewer","ptype":"article","src":"https://openalex.org/W3034821272","eid":"W3034821272"},{"id":"paper-w2978861836","cat":"papers","name":"The indole alkaloid ibogaine and its mechanism of KV11.1 channel block","year":"2013","cit":0,"pfa":"Patrick Thurner","topics":["Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W2978861836","eid":"W2978861836"},{"id":"paper-w7165792934","cat":"papers","name":"A Critical Evaluation of the Hypothesis that N,N-Dimethyltryptamine Maintains Neuroplasticity","year":"2026","cit":0,"pfa":"Ramiro Solis","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7165792934","eid":"W7165792934"},{"id":"paper-w1529367833","cat":"papers","name":"Molly: The Not So Convincing Truth of MDMA","year":"2013","cit":0,"pfa":"Alison Cromer","ptype":"article","src":"https://openalex.org/W1529367833","eid":"W1529367833"},{"id":"paper-w4389449947","cat":"papers","name":"Mononeuritis multiplex secondary to MDMA (4041)","year":"2020","cit":0,"pfa":"Shameer Rafee","psa":"Niall Tubridy","ptype":"article","src":"https://openalex.org/W4389449947","eid":"W4389449947"},{"id":"paper-w12439179","cat":"papers","name":"Implications of MDMA use for mental health","year":"1998","cit":0,"pfa":"Suzanne L. Verheyden","psa":"H. Valerie Curran","ptype":"conference-paper","src":"https://openalex.org/W12439179","eid":"W12439179"},{"id":"paper-w4238665724","cat":"papers","name":"Pipe, Bible, and Peyote among the Lakota: A Study in Religious Identity","year":"1992","cit":0,"pfa":"Timothy A. Zwink","psa":"Paul B. Steinmetz","ptype":"article","src":"https://openalex.org/W4238665724","eid":"W4238665724"},{"id":"paper-w2017441208","cat":"papers","name":"Profound Hypoglycemia With MDMA (Ecstasy) Intoxication","year":"2014","cit":0,"pfa":"Perliveh Carrera","psa":"Vivek Iyer","ptype":"article","src":"https://openalex.org/W2017441208","eid":"W2017441208"},{"id":"paper-w3188397360","cat":"papers","name":"Informe Técnico sobre la Ayahuasca 2017","year":"2017","cit":0,"pfa":"José Carlos Bouso","psa":"Beatriz Caiuby Labate","ptype":"article","src":"https://openalex.org/W3188397360","eid":"W3188397360"},{"id":"paper-w7161613006","cat":"papers","name":"A ayahuasca na literatura, uma pequena historiografia","year":"2026","cit":0,"pfa":"Eunice Coelho da Conceição","psa":"Clarides Henrich de Barba","ptype":"article","src":"https://openalex.org/W7161613006","eid":"W7161613006"},{"id":"paper-w2242039006","cat":"papers","name":"MDMA pharmacology in humans and serotonergic effects","year":"2013","cit":0,"pfa":"Yubero Lahoz","psa":"Samanta","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W2242039006","eid":"W2242039006"},{"id":"paper-w7104286544","cat":"papers","name":"Tips and Recommendations for The Ingestion of Psilocybin: An Introduction to Community-Based Public Health Guidance for Lower Risk Psilocybin Use","year":"2023","cit":0,"pfa":"Grewal, Ashmita","psa":"Card, Kiffer G.","topics":["Safety & adverse events","Policy & ethics"],"ptype":"report","src":"https://openalex.org/W7104286544","eid":"W7104286544"},{"id":"paper-w4387447479","cat":"papers","name":"Mike Jay,Mescaline: A Global History of the First Psychedelic","year":"2023","cit":0,"pfa":"Erika Dyck","ptype":"article","src":"https://openalex.org/W4387447479","eid":"W4387447479"},{"id":"paper-w1181815541","cat":"papers","name":"Differential Effects of Methylenedioxypyrovalerone (MDPV) and Mephedrone in Rats Trained to Discriminate MDMA or a D-Amphetamine+MDMA Mixture","year":"2015","cit":0,"pfa":"Eric L. Harvey","ptype":"article","src":"https://openalex.org/W1181815541","eid":"W1181815541"},{"id":"paper-w3204470817","cat":"papers","name":"Ayahuasca by Javier Regueiro Health, Mind & Body","year":"2017","cit":0,"pfa":"Javier Regueiro","ptype":"article","src":"https://openalex.org/W3204470817","eid":"W3204470817"},{"id":"paper-w7159692375","cat":"papers","name":"Exploring the Relationship Between Aphantasia and Dimethyltryptamine Levels in Cerebrospinal Fluid","year":"2026","cit":0,"pfa":"J. Martin Strangeweather","ptype":"other","src":"https://openalex.org/W7159692375","eid":"W7159692375"},{"id":"paper-w2945332","cat":"papers","name":"Health Beliefs in a sample of MDMA users.","year":"2008","cit":0,"pfa":"Kirstie Soar","psa":"Jacqui Rodgers","ptype":"conference-paper","src":"https://openalex.org/W2945332","eid":"W2945332"},{"id":"paper-w2847200657","cat":"papers","name":"ΔFosB: A Molecular Mechanism of MDMA Dependence","year":"2017","cit":0,"pfa":"Jason Foote","topics":["Addiction","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W2847200657","eid":"W2847200657"},{"id":"paper-w2923029727","cat":"papers","name":"Enantioselective disposition of MDMA in Maltese users.","year":"2004","cit":0,"pfa":"Michael Sammut","psa":"Carmel Sammut","ptype":"dissertation","src":"https://openalex.org/W2923029727","eid":"W2923029727"},{"id":"paper-w4206460635","cat":"papers","name":"ΔFosB: A Molecular Mechanism of MDMA Dependence","year":"2017","cit":0,"pfa":"Jason Foote","topics":["Addiction","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W4206460635","eid":"W4206460635"},{"id":"paper-w2972778784","cat":"papers","name":"Neuropsychopharmacological Investigations of MDMA/Cocaine Combinations","year":"2007","cit":0,"pfa":"Panos","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2972778784","eid":"W2972778784"},{"id":"paper-w4240944924","cat":"papers","name":"MDMA (\"Ecstasy\") and the Frontal Executive System","year":"2013","cit":0,"pfa":"Konstantine K. Zakzanis","psa":"Arija Birze","ptype":"dataset","src":"https://openalex.org/W4240944924","eid":"W4240944924"},{"id":"paper-w2581967712","cat":"papers","name":"Pharmacology and neurotoxicity of 3,4-methylenedioxymethamphetamine (MDMA).","year":"2016","cit":0,"pfa":"Joep Titulaer","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W2581967712","eid":"W2581967712"},{"id":"paper-w4226205119","cat":"papers","name":"The Biology of Nitric Oxide Signaling and MDMA","year":"2022","cit":0,"pfa":"María Pilar García-Pardo","psa":"M.A. Aguilar","ptype":"book-chapter","src":"https://openalex.org/W4226205119","eid":"W4226205119"},{"id":"paper-w3179398278","cat":"papers","name":"Ecstasy (MDMA) toksiškumas : [elektroninis išteklius]","year":"2004","cit":0,"pfa":"Dagmara Ona Reingardienė","psa":"Jolita Vilčinskaitė","ptype":"conference-paper","src":"https://openalex.org/W3179398278","eid":"W3179398278"},{"id":"paper-w2187344673","cat":"papers","name":"MDMA und andere moderne Designerdrogen","year":"2011","cit":0,"pfa":"Euphrosyne Gouzoulis‐Mayfrank","ptype":"book-chapter","src":"https://openalex.org/W2187344673","eid":"W2187344673"},{"id":"paper-w3034722429","cat":"papers","name":"MDMA, Psychedelika, NPS, Amphetamin und andere Substanzen","year":"2020","cit":0,"pfa":"Rainer Biesinger","psa":"Max Klute","ptype":"book-chapter","src":"https://openalex.org/W3034722429","eid":"W3034722429"},{"id":"paper-w7211904270","cat":"papers","name":"BrainSymphony Reveals Psilocybin-Induced Network Reorganization","year":"2026","cit":0,"pfa":"M. Amin Khajehnejad","psa":"Adeel Razi","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"conference-paper","src":"https://openalex.org/W7211904270","eid":"W7211904270"},{"id":"paper-w2608977707","cat":"papers","name":"Studies on Mescaline XXII: Subcellular Effects of Different Blocking Agents","year":"1972","cit":0,"pfa":"Michel J. A. Denber","ptype":"article","src":"https://openalex.org/W2608977707","eid":"W2608977707"},{"id":"paper-w2258155765","cat":"papers","name":"MDMA or ecstasy: neuropsychobiological and health aspects","year":"2008","cit":0,"pfa":"Parrott, Andrew C.","psa":"Raimondo Bruno","ptype":"conference-paper","src":"https://openalex.org/W2258155765","eid":"W2258155765"},{"id":"paper-w2417452719","cat":"papers","name":"Behavioural effects of N-(3,4,5-trimethoxyphenylethyl)aziridine--a mescaline derivative.","year":"1989","cit":0,"pfa":"Marie Koupilová","psa":"V Hrdina","ptype":"article","src":"https://openalex.org/W2417452719","eid":"W2417452719"},{"id":"paper-w2771962068","cat":"papers","name":"Aporphines - MDMA Antagonists and AChE Inhibitors","year":"2014","cit":0,"pfa":"Stevan Pecic","topics":["Mechanism & neuroscience"],"ptype":"book","src":"https://openalex.org/W2771962068","eid":"W2771962068"},{"id":"paper-w2586734830","cat":"papers","name":"MDMA: effects on sleep and the circadian system","year":"2017","cit":0,"pfa":"Rowan P. Ogeil","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W2586734830","eid":"W2586734830"},{"id":"paper-w3048437492","cat":"papers","name":"Psilocybin im Dorsch Lexikon der Psychologie","year":"2021","cit":0,"pfa":"Michael Paulzen","ptype":"article","src":"https://openalex.org/W3048437492","eid":"W3048437492"},{"id":"paper-w7160944523","cat":"papers","name":"Characterization Of Peyote Hybird Lophophora williamsii var Jourdaniana Through Genomic Analysis And Molecular Studies","year":"2026","cit":0,"pfa":"Ginny Li","topics":["Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W7160944523","eid":"W7160944523"},{"id":"paper-w2093180824","cat":"papers","name":"Case of a false positive MDMA and methamphetamine","year":"2012","cit":0,"pfa":"Zulfikaral H. Verjee","psa":"David Colantonio","ptype":"article","src":"https://openalex.org/W2093180824","eid":"W2093180824"},{"id":"paper-w7117893079","cat":"papers","name":"Expectancy and Hope in MDMA-Assisted Therapy","year":"2026","cit":0,"pfa":"Jamie Beachy","psa":"Wael Garas","ptype":"article","src":"https://openalex.org/W7117893079","eid":"W7117893079"},{"id":"paper-w4415031436","cat":"papers","name":"Stabilizing Psilocybin Pharmacology and Tuning Safety with Atypical Antipsychotic Cotherapy","year":"2025","cit":0,"pfa":"Anna C. Renner","psa":"Robert B. Kargbo","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"editorial","src":"https://openalex.org/W4415031436","eid":"W4415031436"},{"id":"paper-w1981527786","cat":"papers","name":"Performance Enhancement and Adverse Consequences of MDMA","year":"2006","cit":0,"pfa":"Firas Kobeissy","psa":"Mark S. Gold","topics":["Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W1981527786","eid":"W1981527786"},{"id":"paper-w2514958130","cat":"papers","name":"El eterno retorno a la MDMA","year":"2016","cit":0,"pfa":"Alejo Alberdi","ptype":"article","src":"https://openalex.org/W2514958130","eid":"W2514958130"},{"id":"paper-w7162662445","cat":"papers","name":"Psilocybin-induced neurocardiogenic syncope: a case report","year":"2026","cit":0,"pfa":"Mazen A. Atiq","psa":"Ceyda Sayalı","topics":["Anxiety & end-of-life","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7162662445","eid":"W7162662445"},{"id":"paper-w4254672547","cat":"papers","name":"Psilocybin-assisted Psychotherapy for Opioid Use Disorder","year":"2019","cit":0,"topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4254672547","eid":"W4254672547"},{"id":"paper-w1981991721","cat":"papers","name":"S30.02 Behavioural pharmacology of MDMA in nonhumans","year":"2000","cit":0,"pfa":"Chris Ellyn Johanson","topics":["Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W1981991721","eid":"W1981991721"},{"id":"paper-w182148630","cat":"papers","name":"[MDMA (ecstasy): neuroendocrine and behavioral features].","year":"2002","cit":0,"pfa":"Gilberto Gerra","psa":"Teodora Macchia","topics":["Addiction","Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W182148630","eid":"W182148630"},{"id":"paper-w4301769412","cat":"papers","name":"3,4-methylenedioxymethamphetamine (MDMA): current perspectives","year":"2013","cit":0,"pfa":"Meyer JS","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4301769412","eid":"W4301769412"},{"id":"paper-w7204501308","cat":"papers","name":"Say Yes to Drugs: Rescheduling Ibogaine from Schedule I","year":"2026","cit":0,"pfa":"Autumn Zierman","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7204501308","eid":"W7204501308"},{"id":"paper-w2952655837","cat":"papers","name":"ChemInform Abstract: Total Synthesis of the Hallucinogenic Neoclerodane Diterpenoid Salvinorin A.","year":"2008","cit":0,"pfa":"Masato Nozawa","psa":"Hisahiro Hagiwara","ptype":"article","src":"https://openalex.org/W2952655837","eid":"W2952655837"},{"id":"paper-w634639696","cat":"papers","name":"Die Peyote-Religion nordamerikanischer Indianer : eine kulturanthropologische Interpretation","year":"1975","cit":0,"pfa":"Peter R. Gerber","ptype":"book","src":"https://openalex.org/W634639696","eid":"W634639696"},{"id":"paper-w2403682867","cat":"papers","name":"[Pharmacological studies on hallucinogens. I. 3. Bibliographical study of mescaline].","year":"1962","cit":0,"pfa":"E Hoshikawa","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2403682867","eid":"W2403682867"},{"id":"paper-w1521939502","cat":"papers","name":"A mechanistic insight into MDMA-mediated hepatotoxicity","year":"2011","cit":0,"pfa":"I. Antolino Lobo","topics":["Safety & adverse events","Mechanism & neuroscience","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W1521939502","eid":"W1521939502"},{"id":"paper-w2082940209","cat":"papers","name":"MDMA and the psychopharmacology of presynaptic serotonin releasers","year":"1991","cit":0,"pfa":"Mark A. Geyer","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2082940209","eid":"W2082940209"},{"id":"paper-w2096107795","cat":"papers","name":"The Breakdown of Mescaline and Mescaline-like Substances in the Organism. (Z. Physiol. Chem., vol. ccxxxviii, pp. 14–22, 1936.) Slotta, K. H., and Müller, J.","year":"1936","cit":0,"pfa":"Arthur Wayland Dox","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2096107795","eid":"W2096107795"},{"id":"paper-w4412823749","cat":"papers","name":"Ayahuasca-Induced Serotonin Syndrome: Risks, Mechanisms, and Clinical Considerations","year":"2025","cit":0,"pfa":"M. Laura Isabella Ortega","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W4412823749","eid":"W4412823749"},{"id":"paper-w2051130600","cat":"papers","name":"Corrigendum to “Reductive Heck coupling: an efficient approach toward the iboga alkaloids. Synthesis of ibogamine, epiibogamine, and iboga analogs” [Tetrahedron Lett. 53 (2012) 1671–1674]","year":"2012","cit":0,"pfa":"Goutam Kumar Jana","psa":"Surajit Sinha","ptype":"erratum","src":"https://openalex.org/W2051130600","eid":"W2051130600"},{"id":"paper-w3197892625","cat":"papers","name":"Investigation of the in vitro antimicrobial activity of an extract of ayahuasca tea.","year":"2013","cit":0,"pfa":"Benjamin Lima","psa":"ARTHUR FERREIRA COELHO","ptype":"article","src":"https://openalex.org/W3197892625","eid":"W3197892625"},{"id":"paper-w3091667890","cat":"papers","name":"The Ayahuasca Experience: A Phenomenological Study of Tourists in Iquitos, Peru","year":"2020","cit":0,"pfa":"Jesse Wasson","ptype":"other","src":"https://openalex.org/W3091667890","eid":"W3091667890"},{"id":"paper-w7163032277","cat":"papers","name":"Zeg je JA tegen MDMA?!","year":"2026","cit":0,"pfa":"A.T. (Anne) Steenbakkers","psa":"R.J.H. (Rob) Gilsing","ptype":"dataset","src":"https://openalex.org/W7163032277","eid":"W7163032277"},{"id":"paper-w4399638721","cat":"papers","name":"MDMA: Mathijs Deen's Miscellaneous Auxiliaries","year":"2024","cit":0,"pfa":"Mathijs Deen","ptype":"dataset","src":"https://openalex.org/W4399638721","eid":"W4399638721"},{"id":"paper-w1973519796","cat":"papers","name":"Religious Freedom and Obedience to the Law: Communion, Wine, Kosher Slaughterhouses, and Peyote","year":"2000","cit":0,"pfa":"Lane V. Sunderland","ptype":"article","src":"https://openalex.org/W1973519796","eid":"W1973519796"},{"id":"paper-w7213645470","cat":"papers","name":"A brief perturbation. A broad transcriptional signature: psilocin human-neuron transcriptomics","year":"2026","cit":0,"pfa":"Christopher B. Germann","topics":["Mechanism & neuroscience"],"ptype":"software","src":"https://openalex.org/W7213645470","eid":"W7213645470"},{"id":"paper-w4301495377","cat":"papers","name":"Convenient synthesis and in vitro pharmacological activity of 2-thioanalogs of salvinorin A and B","year":"2020","cit":0,"pfa":"Jordan Kordian Zjawiony","psa":"Yan, Feng","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4301495377","eid":"W4301495377"},{"id":"paper-w4408108951","cat":"papers","name":"Reviewer #1 (Public review): Psilocin fosters neuroplasticity in iPSC-derived human cortical neurons","year":"2025","cit":0,"pfa":"Malin Schmidt","psa":"Philipp Koch","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"peer-review","src":"https://openalex.org/W4408108951","eid":"W4408108951"},{"id":"paper-w167865194","cat":"papers","name":"Telepathine (ayahuasca) and psychic ability: field research in South America","year":"2009","cit":0,"pfa":"David P. Luke","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W167865194","eid":"W167865194"},{"id":"paper-w9967280","cat":"papers","name":"Huxley, Crowley y el peyote de las cinco","year":"2012","cit":0,"pfa":"Alejo Alberdi","ptype":"article","src":"https://openalex.org/W9967280","eid":"W9967280"},{"id":"paper-w4321448955","cat":"papers","name":"A Question of Dose and Context: LSD, Peyote and Chemical Interactions, Human Variation, and Interpretation","year":"2022","cit":0,"pfa":"Niccolo Caldararo","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W4321448955","eid":"W4321448955"},{"id":"paper-w776818025","cat":"papers","name":"Beiträge zur Konstitutionsaufklärung von Iboga-Alkaloiden und Biflorin","year":"1955","cit":0,"pfa":"Mathys, Frédéric","ptype":"dissertation","src":"https://openalex.org/W776818025","eid":"W776818025"},{"id":"paper-w4213302776","cat":"papers","name":"Tales of ayahuasca: An open forum on sacred plant experiences","year":"2012","cit":0,"pfa":"Bethe Hagens","psa":"Steve Beyer","ptype":"dataset","src":"https://openalex.org/W4213302776","eid":"W4213302776"},{"id":"paper-w7199794686","cat":"papers","name":"Psilocybin as a treatment for psychiatric disorders: a review of the literature","year":"2024","cit":0,"pfa":"Verneri Pellinen","topics":["PTSD & trauma","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7199794686","eid":"W7199794686"},{"id":"paper-w7163080073","cat":"papers","name":"Zeg je JA tegen MDMA?!","year":"2026","cit":0,"pfa":"A.T. (Anne) Steenbakkers","psa":"R.J.H. (Rob) Gilsing","ptype":"dataset","src":"https://openalex.org/W7163080073","eid":"W7163080073"},{"id":"paper-w7204944454","cat":"papers","name":"M.D.’s Protest Control of MDMA","year":"1985","cit":0,"ptype":"article","src":"https://openalex.org/W7204944454","eid":"W7204944454"},{"id":"paper-w3081809294","cat":"papers","name":"Psilocybin-assisted therapy and depression - a systematic review","year":"2020","cit":0,"pfa":"Rui Pedro Leal Andrade","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"dissertation","src":"https://openalex.org/W3081809294","eid":"W3081809294"},{"id":"paper-w4313001717","cat":"papers","name":"Psilocybin may be effective for treatment-resistant depression","year":"2022","cit":0,"topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4313001717","eid":"W4313001717"},{"id":"paper-w7145610319","cat":"papers","name":"A five-step synthesis of psilocin from indole-3-carbaldehyde","year":"1998","cit":0,"pfa":"Fumio Yamada","psa":"Masanori Somei","ptype":"article","src":"https://openalex.org/W7145610319","eid":"W7145610319"},{"id":"paper-w2070221671","cat":"papers","name":"Música e Ayahuasca em duas religiões brasileiras","year":"2013","cit":0,"pfa":"Lucas Kastrup F. Rehen","ptype":"article","src":"https://openalex.org/W2070221671","eid":"W2070221671"},{"id":"paper-w4417330592","cat":"papers","name":"Future Ayahuasca Care Spaces: An Experimental Speculative Exercise","year":"2025","cit":0,"pfa":"Pietro Benedito","psa":"Piera Talin","ptype":"article","src":"https://openalex.org/W4417330592","eid":"W4417330592"},{"id":"paper-w7129497565","cat":"papers","name":"Reviewer #2 (Public review): Psilocin fosters neuroplasticity in iPSC-derived human cortical neurons","year":"2026","cit":0,"pfa":"Målin Schmidt","psa":"Philipp Koch","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"peer-review","src":"https://openalex.org/W7129497565","eid":"W7129497565"},{"id":"paper-w7135615651","cat":"papers","name":"Ayahuasca Ceremonies: Motivation and Impacts on Participants' Mental Health","year":"2025","cit":0,"pfa":"Anna Šepsová","topics":["Addiction","Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W7135615651","eid":"W7135615651"},{"id":"paper-w2398926917","cat":"papers","name":"[The place of psilocybin among other psychotropic substances].","year":"1959","cit":0,"pfa":"W Ruemmele","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2398926917","eid":"W2398926917"},{"id":"paper-w1988622343","cat":"papers","name":"Effect of clozapine and molindone on plasma and brain levels of mescaline in mice","year":"1984","cit":0,"pfa":"Nandkumar S. Shah","psa":"O.D. Gulati","ptype":"article","src":"https://openalex.org/W1988622343","eid":"W1988622343"},{"id":"paper-w405968400","cat":"papers","name":"\"The spirit of ayahuasca\" : de kognitiva grunderna i erfarenheten av substansen ayahuasca: en fältstudie genomförd i Pisac, Peru","year":"2010","cit":0,"pfa":"Johan Wallner","topics":["Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W405968400","eid":"W405968400"},{"id":"paper-w1503744476","cat":"papers","name":"Estudos de farmacocinética dos alcalóides da ayahuasca","year":"2011","cit":0,"pfa":"Ana Paula Salum Pires","topics":["Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W1503744476","eid":"W1503744476"},{"id":"paper-w4386626688","cat":"papers","name":"Is Taking Peyote Protected Religious Practice? Employment Division v. Smith","year":"2017","cit":0,"ptype":"other","src":"https://openalex.org/W4386626688","eid":"W4386626688"},{"id":"paper-w3089864842","cat":"papers","name":"An unexpected vasodilator, mescaline; experiences made in Dachau in July 1944.","year":"1949","cit":0,"pfa":"Chaumerliac","psa":"ROCHE","ptype":"article","src":"https://openalex.org/W3089864842","eid":"W3089864842"},{"id":"paper-w7104261660","cat":"papers","name":"Tips and Recommendations for The Ingestion of Psilocybin: An Introduction to Community-Based Public Health Guidance for Lower Risk Psilocybin Use","year":"2023","cit":0,"pfa":"Grewal, Ashmita","psa":"Card, Kiffer G.","topics":["Safety & adverse events","Policy & ethics"],"ptype":"report","src":"https://openalex.org/W7104261660","eid":"W7104261660"},{"id":"paper-w201084006","cat":"papers","name":"II De \"ayahuasca\" a 'farmahuasca y anahuasca","year":"2010","cit":0,"pfa":"Jonathan Ott","ptype":"article","src":"https://openalex.org/W201084006","eid":"W201084006"},{"id":"paper-w7131423057","cat":"papers","name":"Von Ayahuasca bis Critical Global Health","year":"2024","cit":0,"pfa":"Peter van Eeuwijk","ptype":"article","src":"https://openalex.org/W7131423057","eid":"W7131423057"},{"id":"paper-w7162120513","cat":"papers","name":"Ayahuasca and Fibromyalgia: Promising Mechanisms, Missing Evidence: A Mini-review","year":"2026","cit":0,"pfa":"Jozelio Freire de Carvalho","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7162120513","eid":"W7162120513"},{"id":"paper-w2993525666","cat":"papers","name":"Dimethyltryptamine (DMT) - Molecule of the Month September 2019 [Archived version]","year":"2019","cit":0,"pfa":"Paul William May","ptype":"other","src":"https://openalex.org/W2993525666","eid":"W2993525666"},{"id":"paper-w3162343488","cat":"papers","name":"Jiculi Ba-Ba (Estudio etnográfico sobre el peyote)","year":"1948","cit":0,"pfa":"Francisco Rojas González","ptype":"article","src":"https://openalex.org/W3162343488","eid":"W3162343488"},{"id":"paper-w2023481257","cat":"papers","name":"Copper(II) complexes and basic properties of N,N-dimethyltryptamine","year":"1979","cit":0,"pfa":"Harold C. Nelson","psa":"George W. Watt","ptype":"article","src":"https://openalex.org/W2023481257","eid":"W2023481257"},{"id":"paper-w7155504500","cat":"papers","name":"Trump orders ibogaine and other psychedelics on fast track at FDA","year":"2026","cit":0,"pfa":"Alison Knopf","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7155504500","eid":"W7155504500"},{"id":"paper-w7127191842","cat":"papers","name":"local reifnement of 5HT2AR-miniGq heterotrimer in complex with a psychedelic psilocin","year":"2026","cit":0,"pfa":"L. Tang","psa":"S. Wang","ptype":"dataset","src":"https://openalex.org/W7127191842","eid":"W7127191842"},{"id":"paper-w423080137","cat":"papers","name":"C-13-1 The Biosynthesis of Ibogaine(Alkaloids and alkaloid biosynthesis)","year":"1964","cit":0,"pfa":"Edward Leete","psa":"Mikio Yamazaki","ptype":"conference-paper","src":"https://openalex.org/W423080137","eid":"W423080137"},{"id":"paper-w2737748355","cat":"papers","name":"Why the Ayahuasca? On the Internationalization of a Native American Ritual Practice","year":"2011","cit":0,"pfa":"Anne‐Marie Losonczy","psa":"Silvia Mesturini Cappo","ptype":"article","src":"https://openalex.org/W2737748355","eid":"W2737748355"},{"id":"paper-w4322584617","cat":"papers","name":"Chapter One. 1887: Dr. John Briggs Eats Some Peyote","year":"2019","cit":0,"pfa":"Alexander S. Dawson","ptype":"book-chapter","src":"https://openalex.org/W4322584617","eid":"W4322584617"},{"id":"paper-w7126403964","cat":"papers","name":"Psilocybin-Induced Neuroplasticity and Sustained Antidepressant Effects","year":"2026","cit":0,"pfa":"Anna Maria Komarczewska","psa":"Michał Pietrasz","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7126403964","eid":"W7126403964"},{"id":"paper-w4252759495","cat":"papers","name":"Psilocybin zur Behandlung der therapieresistenten Depression","year":"2016","cit":0,"topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4252759495","eid":"W4252759495"},{"id":"paper-w7155435080","cat":"papers","name":"Wherefore the Magic? The Evolutionary Role of Psilocybin in Nature","year":"2026","cit":0,"pfa":"Kirsty J. Matthews Nicholass","psa":"J. S. Ellis","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7155435080","eid":"W7155435080"},{"id":"paper-w2335880166","cat":"papers","name":"Interaction of ibogaine with human a3b4 nicotinic receptors in different conformational states","year":"2012","cit":0,"pfa":"Ilana Emert","psa":"Hugo Rubén Arias","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2335880166","eid":"W2335880166"},{"id":"paper-w2950794665","cat":"papers","name":"ChemInform Abstract: New Iboga‐Type Alkaloids from Ervatamia hainanensis.","year":"2016","cit":0,"pfa":"Zhi‐Wen Liu","psa":"Wen‐Cai Ye","ptype":"article","src":"https://openalex.org/W2950794665","eid":"W2950794665"},{"id":"paper-w778311201","cat":"papers","name":"Salvinorin A Fails to Attenuate Cocaine Discrimination in Male Sprague-Dawley Rats","year":"2010","cit":0,"pfa":"Amanda R. Austin","ptype":"article","src":"https://openalex.org/W778311201","eid":"W778311201"},{"id":"paper-w7213654132","cat":"papers","name":"A brief perturbation. A broad transcriptional signature: psilocin human-neuron transcriptomics","year":"2026","cit":0,"pfa":"Christopher B. Germann","topics":["Mechanism & neuroscience"],"ptype":"software","src":"https://openalex.org/W7213654132","eid":"W7213654132"},{"id":"paper-w2308684454","cat":"papers","name":"Molecular mechanisms by which salvinorin A binds to and activates the κ-opioid receptor.","year":"2008","cit":0,"pfa":"Feng Yan","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2308684454","eid":"W2308684454"},{"id":"paper-w7162118002","cat":"papers","name":"Exploring the Use of Ibogaine in Opioid Recovery: Insights from Lived Experience","year":"2026","cit":0,"pfa":"Jamie David Walker","psa":"Bruno Hamish Unger","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7162118002","eid":"W7162118002"},{"id":"paper-w3026266826","cat":"papers","name":"Psilocybin as a treatment for psychiatric disorders : a systematic review","year":"2018","cit":0,"pfa":"Henrique Castro Santos","topics":["Depression","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W3026266826","eid":"W3026266826"},{"id":"paper-w4206128298","cat":"papers","name":"Caracterização da ayahuasca usando espectrometria de massas","year":"2018","cit":0,"pfa":"Rita de Cassia Zacardi de Souza","ptype":"dissertation","src":"https://openalex.org/W4206128298","eid":"W4206128298"},{"id":"paper-w4206966198","cat":"papers","name":"c‐Fos Responses Produced by the Central Microinjection of Salvinorin A in Conscious Rats","year":"2019","cit":0,"pfa":"Aboozar B. Ali","psa":"Helmut B. Gottlieb","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4206966198","eid":"W4206966198"},{"id":"paper-w3163422255","cat":"papers","name":"The use of psilocybin in the treatment of depression and anxiety disorders","year":"2019","cit":0,"pfa":"Karjala, Anni","topics":["Depression","Anxiety & end-of-life"],"ptype":"dissertation","src":"https://openalex.org/W3163422255","eid":"W3163422255"},{"id":"paper-w7125428177","cat":"papers","name":"Does psilocybin help with mental health conditions?","year":"2026","cit":0,"pfa":"Tripdatabase","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7125428177","eid":"W7125428177"},{"id":"paper-w7211914641","cat":"papers","name":"BrainSymphony Reveals Psilocybin-Induced Network Reorganization","year":"2026","cit":0,"pfa":"M. Amin Khajehnejad","psa":"Adeel Razi","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"conference-paper","src":"https://openalex.org/W7211914641","eid":"W7211914641"},{"id":"paper-w2284025252","cat":"papers","name":"A social and cultural history of the federal prohibition of psilocybin","year":"2007","cit":0,"pfa":"Colin Wark","ptype":"dissertation","src":"https://openalex.org/W2284025252","eid":"W2284025252"},{"id":"paper-w4402811861","cat":"papers","name":"Freizeitgebrauch von LSD und Psilocybin-Pilzen","year":"2024","cit":0,"pfa":"Susanna Prepeliczay","ptype":"book-chapter","src":"https://openalex.org/W4402811861","eid":"W4402811861"},{"id":"paper-w7171361377","cat":"papers","name":"Evaluating psilocybin for the management of depression: a literature review","year":"2026","cit":0,"pfa":"Rachel Sinclair","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7171361377","eid":"W7171361377"},{"id":"paper-w2738784859","cat":"papers","name":"Peyote and Ghouls in the Night: Justice Scalia's Religion Clause Minimalism","year":"2017","cit":0,"pfa":"John D. Inazu","ptype":"article","src":"https://openalex.org/W2738784859","eid":"W2738784859"},{"id":"paper-w4392637815","cat":"papers","name":"Psilocybin poisoning from Psilocybe argentipes ingestion","year":"2024","cit":0,"pfa":"Hiroshi Ito","psa":"Daiki Kobayashi","ptype":"article","src":"https://openalex.org/W4392637815","eid":"W4392637815"},{"id":"paper-w4401697859","cat":"papers","name":"Cannabis and Psilocybin: Insurance Reimbursement, Legalization, and Rescheduling","year":"2024","cit":0,"pfa":"Elena Markos","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4401697859","eid":"W4401697859"},{"id":"paper-w4415552656","cat":"papers","name":"Electrophysiological effects of psilocybin co-administered with midazolam","year":"2025","cit":0,"pfa":"Michael H. Sutherland","psa":"Matthew I. Banks","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4415552656","eid":"W4415552656"},{"id":"paper-w7204754170","cat":"papers","name":"Can psilocybin help a patient with chronic depression?","year":"2026","cit":0,"pfa":"Tripdatabase","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7204754170","eid":"W7204754170"},{"id":"paper-w4376602238","cat":"papers","name":"Psychedelic Sensationalism: An Analysis of the Schedule Classification of Psilocybin","year":"2023","cit":0,"pfa":"Elisabeth Wood","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4376602238","eid":"W4376602238"},{"id":"paper-w7119396643","cat":"papers","name":"Strange forces : a psychoanalytic contribution to the visual effect of ayahuasca","year":"2024","cit":0,"pfa":"Rodolfo Olivieri","ptype":"dissertation","src":"https://openalex.org/W7119396643","eid":"W7119396643"},{"id":"paper-w37088594","cat":"papers","name":"Shuracpamba, el peyote y el Fuego de Itzachilatan","year":"2002","cit":0,"pfa":"Iván Carrasco Montesinos","ptype":"article","src":"https://openalex.org/W37088594","eid":"W37088594"},{"id":"paper-w2006198155","cat":"papers","name":"LSD‐25, MESCALINE INDUCED PSYCHOSIS AND CATECHOL AMINE METABOLISM","year":"1959","cit":0,"pfa":"Kenji Sakamoto","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2006198155","eid":"W2006198155"},{"id":"paper-w4403659615","cat":"papers","name":"The Action on Psilocybin in Neural Plasticity, Brain Reorganization and Cognitive Enhancement","year":"2024","cit":0,"pfa":"Carlos Henrique Marchiori","psa":"Klebert de Paula Malheiros","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4403659615","eid":"W4403659615"},{"id":"paper-w4318965036","cat":"papers","name":"The psychedelic renaissance: can psilocybin possibly combat depression?","year":"2022","cit":0,"pfa":"Hamna Raheel","psa":"Omer Ahmed Shaikh","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4318965036","eid":"W4318965036"},{"id":"paper-w7159575086","cat":"papers","name":"Exploring the Relationship Between Aphantasia and Dimethyltryptamine Levels in Cerebrospinal Fluid","year":"2026","cit":0,"pfa":"J. Martin Strangeweather","ptype":"other","src":"https://openalex.org/W7159575086","eid":"W7159575086"},{"id":"paper-w4295990945","cat":"papers","name":"P03-21 Magic mushrooms and psilocybin: pharmacokinetics, pharmacodynamics, and clinical applications","year":"2022","cit":0,"pfa":"Diana Dias da Silva","psa":"Áurea Madureira-Carvalho","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4295990945","eid":"W4295990945"},{"id":"paper-w7133499596","cat":"papers","name":"Inhibition of cortico-amygdala projections underlies affective bias modification by psilocybin","year":"2026","cit":0,"pfa":"Matthew D. B. Claydon","psa":"Emma S J Robinson","topics":["Depression","Mechanism & neuroscience","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W7133499596","eid":"W7133499596"},{"id":"paper-w2914411651","cat":"papers","name":"Ibogaine Binds Human Serotonin Transporter in Multiple Functional States","year":"2019","cit":0,"pfa":"Zhiyu Zhao","psa":"Emad Tajkhorshid","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2914411651","eid":"W2914411651"},{"id":"paper-w7116119509","cat":"papers","name":"Wherefore the magic? The evolutionary role of psilocybin in nature","year":"2025","cit":0,"pfa":"K.J Matthews Nicholass","psa":"J.S Ellis","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7116119509","eid":"W7116119509"},{"id":"paper-w7172221053","cat":"papers","name":"Beading with Algorithms: Cellular Automata in Peyote Stitch by Gwen Fisher and Roger Antonsen","year":"2026","cit":0,"pfa":"Jane Hawkins","ptype":"article","src":"https://openalex.org/W7172221053","eid":"W7172221053"},{"id":"paper-w4396801934","cat":"papers","name":"Liquid light: Ayahuasca spirituality and the Santo Daime tradition","year":"2024","cit":0,"pfa":"Bonnie Glass‐Coffin","ptype":"article","src":"https://openalex.org/W4396801934","eid":"W4396801934"},{"id":"paper-w145599822","cat":"papers","name":"Reasoning deficits in ecstasy (MDMA) users","year":"2005","cit":0,"pfa":"John E. Fisk","psa":"Philip N. Murphy","ptype":"article","src":"https://openalex.org/W145599822","eid":"W145599822"},{"id":"paper-w2555582383","cat":"papers","name":"MDMA induces oxytocin release in humans","year":"2008","cit":0,"pfa":"Glenn Dumont","psa":"Robbert‐Jan Verkes","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2555582383","eid":"W2555582383"},{"id":"paper-w4313201121","cat":"papers","name":"Neurochemical properties of psilocybin in comparison to ketamine in vivo","year":"2022","cit":0,"pfa":"A. Wojtas","psa":"Krystyna Gołembiowska","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4313201121","eid":"W4313201121"},{"id":"paper-w7161909266","cat":"papers","name":"The effect of psilocybin on serotonergic activity and social behaviour","year":"2023","cit":0,"pfa":"Michael Pileggi","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7161909266","eid":"W7161909266"},{"id":"paper-w4400574686","cat":"papers","name":"Physiological Effects of Psilocybin, Psilacetin, and DOI in Rats","year":"2024","cit":0,"pfa":"Shelby A. McGriff","psa":"Michael Baumann","ptype":"article","src":"https://openalex.org/W4400574686","eid":"W4400574686"},{"id":"paper-w2198564413","cat":"papers","name":"Effects of psilocybin on the human brain functional network","year":"2013","cit":0,"pfa":"Weissbart Hugo","ptype":"dissertation","src":"https://openalex.org/W2198564413","eid":"W2198564413"},{"id":"paper-w4391885116","cat":"papers","name":"NIDA: Psilocybin mushroom seizures rose significantly","year":"2024","cit":0,"pfa":"Alison Knopf","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4391885116","eid":"W4391885116"},{"id":"paper-w2966957352","cat":"papers","name":"The Peyote Effect from the Inquisition to the War on Drugs. By Alexander S. Dawson","year":"2019","cit":0,"pfa":"Brittany Edmoundson","ptype":"article","src":"https://openalex.org/W2966957352","eid":"W2966957352"},{"id":"paper-w7132625809","cat":"papers","name":"Efficacy of psilocybin on suicidal ideation. A systematic review","year":"2023","cit":0,"pfa":"Kamilė Žalkauskaitė","psa":"Jonas Fugalis","topics":["Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7132625809","eid":"W7132625809"},{"id":"paper-w3091996077","cat":"papers","name":"Psychedelics: A Window To Mental Illness; Psilocybin And Depression","year":"2020","cit":0,"pfa":"Kiomary Rivera Quintana","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W3091996077","eid":"W3091996077"},{"id":"paper-w7204764098","cat":"papers","name":"Can psilocybin help a patient with chronic depression?","year":"2026","cit":0,"pfa":"Tripdatabase","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7204764098","eid":"W7204764098"},{"id":"paper-w4415747429","cat":"papers","name":"Dissociable effects of LSD and MDMA on striato-cortical connectivity in healthy subjects","year":"2025","cit":0,"pfa":"Natalie Ertl","psa":"Matthew B. Wall","topics":["PTSD & trauma","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4415747429","eid":"W4415747429"},{"id":"paper-w4313199409","cat":"papers","name":"The role of psilocybin in memory consolidation in the animal model","year":"2022","cit":0,"pfa":"K. Šíchová","psa":"T. Páleníček","ptype":"article","src":"https://openalex.org/W4313199409","eid":"W4313199409"},{"id":"paper-w7162755829","cat":"papers","name":"Psilocybin shows rapid relief for depression symptoms","year":"2026","cit":0,"pfa":"Valerie A. Canady","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7162755829","eid":"W7162755829"},{"id":"paper-w2788048110","cat":"papers","name":"Religious Revitalization among the Kiowas: The Ghost Dance, Peyote, and Christianity","year":"2018","cit":0,"pfa":"Benjamin R. Kracht","ptype":"article","src":"https://openalex.org/W2788048110","eid":"W2788048110"},{"id":"paper-w2419892193","cat":"papers","name":"[AUTO-OBSERVATION OF 2 EXPERIMENTAL INTOXICATIONS WITH PSILOCYBIN].","year":"1963","cit":0,"pfa":"C Wiart","ptype":"article","src":"https://openalex.org/W2419892193","eid":"W2419892193"},{"id":"paper-w2955416807","cat":"papers","name":"A SYSTEMATIC REVIEW OF PSILOCYBIN IN THE TREATMENT OF DEPRESSION AND ANXIETY","year":"2019","cit":0,"pfa":"Jihun Lyu","psa":"Trisha M Suppes","topics":["Depression","Anxiety & end-of-life","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2955416807","eid":"W2955416807"},{"id":"paper-w3172202809","cat":"papers","name":"Reseña del documental Huicholes: los últimos guardianes del peyote","year":"2015","cit":0,"pfa":"Universidad de Guadalajara","psa":"Alan Rodríguez","ptype":"article","src":"https://openalex.org/W3172202809","eid":"W3172202809"},{"id":"paper-w2408424309","cat":"papers","name":"EEG and cerebral blood flow following cortical application of strychnine and mescaline.","year":"1969","cit":0,"pfa":"D Tchavdarow","ptype":"article","src":"https://openalex.org/W2408424309","eid":"W2408424309"},{"id":"paper-w4294891482","cat":"papers","name":"A AYAHUASCA NO SANTO DAIME : UMA TRAJETÓRIA DE RESSIGNIFICAÇÃO","year":"2022","cit":0,"pfa":"Nicole Silva Loss","psa":"Alex de Souza Siqueira","ptype":"book-chapter","src":"https://openalex.org/W4294891482","eid":"W4294891482"},{"id":"paper-w7120358306","cat":"papers","name":"Ayahuasca in the treatment of cocaine addiction: possible therapeutic interventions?","year":"2019","cit":0,"pfa":"Vítor Bruno","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W7120358306","eid":"W7120358306"},{"id":"paper-w4404470718","cat":"papers","name":"Intact neurophysiological markers of death denial in ayahuasca veterans","year":"2024","cit":0,"pfa":"Yair Dor‐Ziderman","psa":"Aviva Berkovich‐Ohana","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4404470718","eid":"W4404470718"},{"id":"paper-w7202362192","cat":"papers","name":"Ayahuasca and Salvia divinorum as contrasting modes of consciousness reorganization: Implications for psychedelic-assisted psychotherapy","year":"2026","cit":0,"pfa":"Brian M. Ross","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7202362192","eid":"W7202362192"},{"id":"paper-w4297691226","cat":"papers","name":"Depression: Psilocybin etwas besser als Escitalopram","year":"2022","cit":0,"topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4297691226","eid":"W4297691226"},{"id":"paper-w4385669209","cat":"papers","name":"Psilocybin as an antidepressant strategy - a review of safety aspects","year":"2023","cit":0,"pfa":"René Zeiss","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4385669209","eid":"W4385669209"},{"id":"paper-w3045370936","cat":"papers","name":"THE POTENTIAL THERAPEUTIC VALUE OF PSILOCYBIN : In Relation to Depression","year":"2019","cit":0,"pfa":"Isabella Stendahl","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"dissertation","src":"https://openalex.org/W3045370936","eid":"W3045370936"},{"id":"paper-w4400083626","cat":"papers","name":"Review identifies factors associated with response to psilocybin","year":"2024","cit":0,"topics":["Depression","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4400083626","eid":"W4400083626"},{"id":"paper-w7125399434","cat":"papers","name":"Does psilocybin help with mental health conditions?","year":"2026","cit":0,"pfa":"Tripdatabase","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7125399434","eid":"W7125399434"},{"id":"paper-w7110564344","cat":"papers","name":"Psilocybin Treatment for Refractory Depression: A Clinical Review","year":"2026","cit":0,"pfa":"Jensen, Hailey A","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7110564344","eid":"W7110564344"},{"id":"paper-w3137482844","cat":"papers","name":"Religious Revitalization among the Kiowas: The Ghost Dance, Peyote, and Christianity","year":"2021","cit":0,"pfa":"Christina Gish Hill","ptype":"article","src":"https://openalex.org/W3137482844","eid":"W3137482844"},{"id":"paper-w2768574057","cat":"papers","name":"Mescaline 55, Edith Boissonnas, Henri Michaux, Jean Paulhan","year":"2014","cit":0,"pfa":"Muriel Pic","ptype":"book","src":"https://openalex.org/W2768574057","eid":"W2768574057"},{"id":"paper-w3079400006","cat":"papers","name":"50 Mescaline + Universe in Disenchantment = Tim Maia Racional? (1974)","year":"2019","cit":0,"ptype":"other","src":"https://openalex.org/W3079400006","eid":"W3079400006"},{"id":"paper-w7165982862","cat":"papers","name":"Biopiracy and epistemic exclusion: a decolonial analysis of the ayahuasca case","year":"2026","cit":0,"pfa":"Yeraldin Osorno Vallejo","topics":["Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W7165982862","eid":"W7165982862"},{"id":"paper-w4401309147","cat":"papers","name":"Overview Of Review (OoR) on PSILOCYBIN in Psychiatric Disorders","year":"2024","cit":0,"pfa":"Pierfelice Cutrufelli","psa":"Maria Salvina Signorelli","topics":["Reviews & meta-analyses"],"ptype":"report","src":"https://openalex.org/W4401309147","eid":"W4401309147"},{"id":"paper-w4394813412","cat":"papers","name":"Acute adverse effects of psilocybin in therapeutic use","year":"2024","cit":0,"pfa":"Steve Chaplin","topics":["Safety & adverse events"],"ptype":"dataset","src":"https://openalex.org/W4394813412","eid":"W4394813412"},{"id":"paper-w4223588025","cat":"papers","name":"Psylocybin and Psilocin as new tools to fight depression: an overview of the Pharmacodynamic and pharmacokinetic mechanisms","year":"2022","cit":0,"pfa":"Sofia Lemos Martins","psa":"Diana Dias da Silva","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4223588025","eid":"W4223588025"},{"id":"paper-w2491880492","cat":"papers","name":"ENZYMIC PATTERN CHANGES IN CAT NEOCORTEX PRODUCED BY MESCALINE EPILEPTOGENIC FOCUS","year":"1969","cit":0,"pfa":"NELLA MISON-CRIGHEL","psa":"G Badiu","topics":["Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W2491880492","eid":"W2491880492"},{"id":"paper-w4406364712","cat":"papers","name":"Age- and estrous-dependent effects of psilocybin in rats","year":"2025","cit":0,"pfa":"Alexia L. Zylko","psa":"MS McMurray","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4406364712","eid":"W4406364712"},{"id":"paper-w4322496053","cat":"papers","name":"A Genealogy of the Ayahuasca Cultural Heritage Registration Process in Brazil","year":"2023","cit":0,"pfa":"Beatriz Caiuby Labate","psa":"Glauber Loures de Assis","ptype":"book-chapter","src":"https://openalex.org/W4322496053","eid":"W4322496053"},{"id":"paper-w4377191928","cat":"papers","name":"15 Secretly Funny People Working in buy pure ibogaine online","year":"2023","cit":0,"pfa":"brittaforbxtl","ptype":"article","src":"https://openalex.org/W4377191928","eid":"W4377191928"},{"id":"paper-w7140144240","cat":"papers","name":"Dynamic Functional Brain Networks after Ayahuasca Ingestion","year":"2026","cit":0,"pfa":"Thaise G. L. de O. Toutain","psa":"C. Thielemann","topics":["Policy & ethics"],"ptype":"other","src":"https://openalex.org/W7140144240","eid":"W7140144240"},{"id":"paper-w4415901143","cat":"papers","name":"A Thematic Analysis of the Subjective Effects and Phenomenology of Ibogaine Administered in a Clinical Setting","year":"2025","cit":0,"pfa":"Joseph T. La Torre","psa":"Nathan B. Sackett","ptype":"preprint","src":"https://openalex.org/W4415901143","eid":"W4415901143"},{"id":"paper-w1676905061","cat":"papers","name":"Social/Cultural Anthropology: Peyote Religion: A History. Omer C. Stewart.","year":"1988","cit":0,"pfa":"Roland M. Wagner","ptype":"article","src":"https://openalex.org/W1676905061","eid":"W1676905061"},{"id":"paper-w3105352906","cat":"papers","name":"2 Quanah Parker: Die Peyote-Religion der Comanche-Indianer","year":"2020","cit":0,"pfa":"Michael Stausberg","ptype":"book-chapter","src":"https://openalex.org/W3105352906","eid":"W3105352906"},{"id":"paper-w2403660163","cat":"papers","name":"Interaction of N,N-dimethyltryptamine with central neuroaminergic receptor blocking agents.","year":"1979","cit":0,"pfa":"Quock Rm","psa":"Stephen F. Small","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2403660163","eid":"W2403660163"},{"id":"paper-w7133003130","cat":"papers","name":"In a time of ilinx: An interpretation of an Ayahuasca experience by a japanese anthropologist","year":"2014","cit":0,"pfa":"Makoto Yamamoto","ptype":"article","src":"https://openalex.org/W7133003130","eid":"W7133003130"},{"id":"paper-w7165933516","cat":"papers","name":"EXPANSÃO GLOBAL DA AYAHUASCA E SAÚDE MENTAL","year":"2026","cit":0,"pfa":"Leonardo Tondato Mello","psa":"Janaína Liz Aquino","ptype":"article","src":"https://openalex.org/W7165933516","eid":"W7165933516"},{"id":"paper-w7120763325","cat":"papers","name":"Effects of N, N-Dimethyltryptamine on the phenotype and diathesis of a mice model of depression","year":"2023","cit":0,"pfa":"Rafael Vitor Lima da Cruz","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W7120763325","eid":"W7120763325"},{"id":"paper-w2416798344","cat":"papers","name":"[Effects of serotonin, 5-hydroxy-N,N-dimethyltryptamine and 5-methoxy-N,N-dimethyltryptamine on the synaptosomal Mg(Na,K)-ATPase from rat brain].","year":"1978","cit":0,"pfa":"Ralf Uebelhack","psa":"R Fehlinger","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2416798344","eid":"W2416798344"},{"id":"paper-w7120006010","cat":"papers","name":"Behavioral changes over time following ayahuasca exposure in zebrafish","year":"2017","cit":0,"pfa":"Robson Savoldi","psa":"Ana Carolina Luchiari","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7120006010","eid":"W7120006010"},{"id":"paper-w1479952978","cat":"papers","name":"Serotonergic Neurotoxicity and Depression Following MDMA Administration","year":"2010","cit":0,"pfa":"Ann Catherine Frisse","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1479952978","eid":"W1479952978"},{"id":"paper-w1973867654","cat":"papers","name":"S.23.04 Effects of MDMA on mood and memory","year":"2011","cit":0,"pfa":"Kim P. C. Kuypers","psa":"Johannes Gerardus Ramaekers","ptype":"article","src":"https://openalex.org/W1973867654","eid":"W1973867654"},{"id":"paper-w7118009135","cat":"papers","name":"Preclinical evaluation of psilocybin as an anti-inflammatory agent","year":"2026","cit":0,"pfa":"N. Martínez-Álvarez","psa":"J.E. Ortega","ptype":"article","src":"https://openalex.org/W7118009135","eid":"W7118009135"},{"id":"paper-w7201834409","cat":"papers","name":"Feasibility and Tolerability of Psilocybin for Phantom Limb Pain","year":"2026","cit":0,"pfa":"Jon G. Dean","psa":"Adam L. Halberstadt","ptype":"article","src":"https://openalex.org/W7201834409","eid":"W7201834409"},{"id":"paper-w4417453981","cat":"papers","name":"Psilocybin reporting in media (PRiMe) for the treatment of depression","year":"2025","cit":0,"pfa":"Gurjot Brar","psa":"John Richard Kelly","topics":["Depression","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4417453981","eid":"W4417453981"},{"id":"paper-w7203831721","cat":"papers","name":"Psilocybin lengthens hippocampal sharp wave ripples","year":"2026","cit":0,"pfa":"İlknur Kayıkçıoğlu Bozkır","psa":"Nathaniel R. Kinsky","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7203831721","eid":"W7203831721"},{"id":"paper-w7139838719","cat":"papers","name":"Developing Translational Methods for Unlocking the Psychopharmacology of Psilocybin","cit":0,"pfa":"Dasha Anderson","topics":["Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7139838719","eid":"W7139838719"},{"id":"paper-w2512391617","cat":"papers","name":"Clinical Potential for Use of LSD and MDMA in Treatment of Trauma Healing Highs: the Clinical Potential for the Use of Lysergic Acid Diethylmide (lsd-25) and 3,4-Methylenedioxy-methamphetamine (MDMA) in the Treatment of","year":"2015","cit":0,"pfa":"Cory Arthurs","topics":["PTSD & trauma","Addiction","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W2512391617","eid":"W2512391617"},{"id":"paper-w2410730067","cat":"papers","name":"[Psilocybin: prospects of its use in clinical psychiatry].","year":"1963","cit":0,"pfa":"Toscano Aguilar M","ptype":"article","src":"https://openalex.org/W2410730067","eid":"W2410730067"},{"id":"paper-w4409280771","cat":"papers","name":"58. Acute Behavioral Effects of Psilocybin and Its Pharmacokinetics in Nonhuman Primates","year":"2025","cit":0,"pfa":"Ashton Barber","psa":"Ned H. Kalin","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4409280771","eid":"W4409280771"},{"id":"paper-w7214202074","cat":"papers","name":"Unveiling ayahuasca: Comprehensive Study of Botanical and Chemical Diversity","year":"2026","cit":0,"pfa":"Yurani Carolina Saavedra-Saenz","psa":"Regina Célia de Oliveira","ptype":"article","src":"https://openalex.org/W7214202074","eid":"W7214202074"},{"id":"paper-w3080825938","cat":"papers","name":"Predicting the Efficacy of Psilocybin in Treating Mental Health and Addiction","year":"2020","cit":0,"pfa":"Courtney Ledford","topics":["Addiction","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3080825938","eid":"W3080825938"},{"id":"paper-w2547975558","cat":"papers","name":"Methodological studies of the microelectrophoretic technique, with special reference to the pharmacology of mescaline","year":"1974","cit":0,"pfa":"C. M. Bradshaw","topics":["Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W2547975558","eid":"W2547975558"},{"id":"paper-w4402764277","cat":"papers","name":"AEs reported after use of psychedelics such as psilocybin","year":"2024","cit":0,"ptype":"article","src":"https://openalex.org/W4402764277","eid":"W4402764277"},{"id":"paper-w2355230731","cat":"papers","name":"POSTMORTEM REDISTRIBUTION OF MDMA IN ACUTE POISONED RATS","year":"2005","cit":0,"pfa":"Yingyuan Wang","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2355230731","eid":"W2355230731"},{"id":"paper-w2504720268","cat":"papers","name":"Neuropharmacology of Ecstasy (MDMA) and Other Designer Drugs","year":"2013","cit":0,"pfa":"Jörg Daumann","psa":"Euphrosyne Gouzoulis‐Mayfrank","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W2504720268","eid":"W2504720268"},{"id":"paper-w7165744991","cat":"papers","name":"A Critical Evaluation of the Hypothesis that N,N-Dimethyltryptamine Maintains Neuroplasticity","year":"2026","cit":0,"pfa":"Ramiro Solis","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7165744991","eid":"W7165744991"},{"id":"paper-w4386728495","cat":"papers","name":"Stereoselective Robinson Annulation Enables Access to Potent and Selective Salvinorin Analogs","year":"2023","cit":0,"pfa":"Dirk H. Trauner","psa":"Tongil Ko","ptype":"editorial","src":"https://openalex.org/W4386728495","eid":"W4386728495"},{"id":"paper-w2412856493","cat":"papers","name":"[Studies on hallucinogens. I. Synthesis of mescaline sulfate (author's transl)].","year":"1973","cit":0,"pfa":"M Ono","psa":"Kazuo Takahashi","ptype":"other","src":"https://openalex.org/W2412856493","eid":"W2412856493"},{"id":"paper-w3126805599","cat":"papers","name":"25. Cannabis et autres toxiques (LSD, mescaline, amphétamine…)","year":"2019","cit":0,"pfa":"Olivier Cottencin","psa":"Alain Dervaux","ptype":"article","src":"https://openalex.org/W3126805599","eid":"W3126805599"},{"id":"paper-w7119421799","cat":"papers","name":"Inorganic characterization of Ayahuasca and evaluation of its psychotherapeutic potential","year":"2018","cit":0,"pfa":"Ivanilce Cristina Guimarães","topics":["Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W7119421799","eid":"W7119421799"},{"id":"paper-w1747028747","cat":"papers","name":"Into an Ilinx Time : An Interpretation of an Ayahuasca Experience by a Japanese Anthropologist","year":"2014","cit":0,"pfa":"Makoto Yamamoto","ptype":"article","src":"https://openalex.org/W1747028747","eid":"W1747028747"},{"id":"paper-w7162020464","cat":"papers","name":"Psychedelics in context: Mapping the adaptation of an ayahuasca religion in Canada","year":"2015","cit":0,"pfa":"Eli Oda Sheiner","topics":["Addiction"],"ptype":"dissertation","src":"https://openalex.org/W7162020464","eid":"W7162020464"},{"id":"paper-w2774909456","cat":"papers","name":"MDMA Advances Another Step As Tool to Treat PTSD","year":"2017","cit":0,"pfa":"Richard B. Karel","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W2774909456","eid":"W2774909456"},{"id":"paper-w2172077797","cat":"papers","name":"(+/-)-3,4-methylenedioxymethamphetamine (MDMA, \"Ecstasy\") Investigator's Brochure","year":"2007","cit":0,"pfa":"Lisa Jerome","ptype":"article","src":"https://openalex.org/W2172077797","eid":"W2172077797"},{"id":"paper-w4409547958","cat":"papers","name":"Exploring the therapeutic convergence of meditation, psychedelics, and MDMA","year":"2025","cit":0,"pfa":"Jacob T. Dines","topics":["Depression","PTSD & trauma","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4409547958","eid":"W4409547958"},{"id":"paper-w4410302326","cat":"papers","name":"Psilocybin-induced modulation of visual salience processing","year":"2025","cit":0,"pfa":"Stephanie L. Muller","psa":"Enzo Tagliazucchi","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4410302326","eid":"W4410302326"},{"id":"paper-w3012672514","cat":"papers","name":"Vision Quest: Examining Ayahuasca in Kentucky, implications for Counseling","year":"2020","cit":0,"pfa":"Angela C Spiers EdD Lpcc-S Ncc","psa":"Jacob Hurd","ptype":"article","src":"https://openalex.org/W3012672514","eid":"W3012672514"},{"id":"paper-w4415995652","cat":"papers","name":"CHAMANISMO Y NEOBARROSO: POÉTICA DE LA AYAHUASCA","year":"2019","cit":0,"pfa":"Enrique Flores","ptype":"article","src":"https://openalex.org/W4415995652","eid":"W4415995652"},{"id":"paper-w2475089707","cat":"papers","name":"MDMA and Learning: Effects of Acute and Neurotoxic Exposure","year":"1998","cit":0,"pfa":"Thomas P. Byrne","topics":["Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W2475089707","eid":"W2475089707"},{"id":"paper-w4385727456","cat":"papers","name":"Salvaging Salvinorin: From Hallucinogen to Potential Therapeutic through Chemical Synthesis","year":"2023","cit":0,"pfa":"Bhawyanth Duvvuru","psa":"Myles W. Smith","topics":["Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W4385727456","eid":"W4385727456"},{"id":"paper-w4241442837","cat":"papers","name":"Errata: People of the Peyote: Huichol Indian History, Religion, and Survival","year":"1998","cit":0,"ptype":"book-review","src":"https://openalex.org/W4241442837","eid":"W4241442837"},{"id":"paper-w3004462621","cat":"papers","name":"A.S. Dawson, The Peyote Effect: From the Inquisition to the War on Drugs","year":"2019","cit":0,"pfa":"Elaine Carey","ptype":"article","src":"https://openalex.org/W3004462621","eid":"W3004462621"},{"id":"paper-w7105158933","cat":"papers","name":"The translational potential of salvinorin A: systematic review and meta-analysis of preclinical studies","year":"2025","cit":0,"pfa":"Wettstein, Lionel","psa":"Ineichen, Benjamin Victor","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W7105158933","eid":"W7105158933"},{"id":"paper-w7129483113","cat":"papers","name":"Reviewer #1 (Public review): Psilocin fosters neuroplasticity in iPSC-derived human cortical neurons","year":"2026","cit":0,"pfa":"Målin Schmidt","psa":"Philipp Koch","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"peer-review","src":"https://openalex.org/W7129483113","eid":"W7129483113"},{"id":"paper-w2908135816","cat":"papers","name":"Application of Gold(I) Catalysis in the Synthesis of Bridged Carbocycles, (±)-Magellanine and (±)-Salvinorin A","year":"2018","cit":0,"pfa":"Philippe McGee","topics":["Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W2908135816","eid":"W2908135816"},{"id":"paper-w4403867180","cat":"papers","name":"Why the Native American Church of North America Opposes Decriminalization of Peyote","year":"2024","cit":0,"pfa":"Nanea Renteria","topics":["Policy & ethics"],"ptype":"other","src":"https://openalex.org/W4403867180","eid":"W4403867180"},{"id":"paper-w1973066322","cat":"papers","name":"REVIEW: \"The Antipodes of the Mind: Charting the Phenomenology of the Ayahuasca Experience\"","year":"2004","cit":0,"pfa":"Ralph W. Hood","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1973066322","eid":"W1973066322"},{"id":"paper-w4377191642","cat":"papers","name":"14 Businesses Doing a Great Job at buy ibogaine online 2023","year":"2023","cit":0,"pfa":"hafgarforlkbs","ptype":"article","src":"https://openalex.org/W4377191642","eid":"W4377191642"},{"id":"paper-w4299380556","cat":"papers","name":"Synthesis and biological evaluation of new salvinorin A analogues incorporating natural amino acids","year":"2020","cit":0,"pfa":"Bryan L. Roth","psa":"Yan, Feng","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4299380556","eid":"W4299380556"},{"id":"paper-w2949096314","cat":"papers","name":"Convenient Synthesis and in vitro Pharmacological Activity of 2‐Thioanalogues of Salvinorins A and B.","year":"2007","cit":0,"pfa":"R. V. Bikbulatov","psa":"Jordan Kordian Zjawiony","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2949096314","eid":"W2949096314"},{"id":"paper-w4390613979","cat":"papers","name":"Usikker effekt av psilocybin ved anoreksi","year":"2024","cit":0,"pfa":"Haakon B. Benestad","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4390613979","eid":"W4390613979"},{"id":"paper-w4394381307","cat":"papers","name":"Ayahuasca: what mental health professionals need to know","year":"2017","cit":0,"pfa":"RAFAEL GUIMARÃES DOS SANTOS","psa":"Jaime E. C. Hallak","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"dataset","src":"https://openalex.org/W4394381307","eid":"W4394381307"},{"id":"paper-w4394948902","cat":"papers","name":":Liquid Light: Ayahuasca Spirituality and the Santo Daime Tradition","year":"2024","cit":0,"pfa":"Kelly E. Hayes","ptype":"article","src":"https://openalex.org/W4394948902","eid":"W4394948902"},{"id":"paper-w7130630306","cat":"papers","name":"Intentions to use Psilocybin in a Mental Health Context","year":"2026","cit":0,"pfa":"Brian P. Meier","ptype":"preprint","src":"https://openalex.org/W7130630306","eid":"W7130630306"},{"id":"paper-w1548572502","cat":"papers","name":"Avaliação dos efeitos neurotóxicos do chá ayahuasca","year":"2012","cit":0,"pfa":"Alex Roberto Melgar Figueroa","ptype":"dissertation","src":"https://openalex.org/W1548572502","eid":"W1548572502"},{"id":"paper-w7120540283","cat":"papers","name":"Legal protection of practices and specific territorialities to ayahuasca comunities","year":"2023","cit":0,"pfa":"Marcus Vinícius Santana Teles","topics":["Safety & adverse events","Reviews & meta-analyses","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W7120540283","eid":"W7120540283"},{"id":"paper-w2021809102","cat":"papers","name":"3H-metaraminol releasing action of mescaline from rat hypothalamus in vitro","year":"1977","cit":0,"pfa":"O.D. Gulati","psa":"Nandkumar S. Shah","ptype":"article","src":"https://openalex.org/W2021809102","eid":"W2021809102"},{"id":"paper-w7124704426","cat":"papers","name":"The translational potential of salvinorin A: systematic review and meta-analysis of preclinical studies","year":"2025","cit":0,"pfa":"Wolfgang Emanuel Zürrer","psa":"Benjamin Victor Ineichen","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W7124704426","eid":"W7124704426"},{"id":"paper-w4240254648","cat":"papers","name":"Drug tourism or cultural healing? Ayahuasca journeys in Amazonia","year":"2003","cit":0,"pfa":"Michael Winkelman","ptype":"dataset","src":"https://openalex.org/W4240254648","eid":"W4240254648"},{"id":"paper-w7205279647","cat":"papers","name":"‘Ayahuasca is not a psychedelic’ – centring Indigenous forms of knowledge in research","year":"2024","cit":0,"pfa":"Emilia Sanabria","ptype":"other","src":"https://openalex.org/W7205279647","eid":"W7205279647"},{"id":"paper-w7135310306","cat":"papers","name":"Challenges in Evaluating MDMA-Assisted Therapy in Palliative Care","year":"2025","cit":0,"pfa":"DB Menkes","psa":"P Glue","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"conference-paper","src":"https://openalex.org/W7135310306","eid":"W7135310306"},{"id":"paper-w2737685828","cat":"papers","name":"Residual effects of MDMA on mood and cognitive function","year":"1997","cit":0,"pfa":"H. Valerie Curran","psa":"Charles, C","ptype":"conference-paper","src":"https://openalex.org/W2737685828","eid":"W2737685828"},{"id":"paper-w2623481990","cat":"papers","name":"A medicinal chemistry investigation of 3,4-Methylenedioxymethamphetamine (MDMA)","year":"2011","cit":0,"pfa":"Katie D. Lewis","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W2623481990","eid":"W2623481990"},{"id":"paper-w4405282280","cat":"papers","name":"MDMA-Assisted Therapy for Posttraumatic Stress Disorder","year":"2024","cit":0,"pfa":"Dimitri Perivoliotis","topics":["PTSD & trauma"],"ptype":"reference-entry","src":"https://openalex.org/W4405282280","eid":"W4405282280"},{"id":"paper-w4297945457","cat":"papers","name":"Salvinorin A analogues PR-37 and PR-38 attenuate compound 48/80-induced itch responses in mice: Salvinorin A analogues PR-37 and PR-38 in pruritus","year":"2020","cit":0,"pfa":"A. Fabisiak","psa":"J. K. Zjawiony","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4297945457","eid":"W4297945457"},{"id":"paper-w7133060937","cat":"papers","name":"The Biochemistry of Psilocybin & Its Metabolism in the Human Body","year":"2022","cit":0,"pfa":"Samuel Soriano","ptype":"other","src":"https://openalex.org/W7133060937","eid":"W7133060937"},{"id":"paper-w4413814943","cat":"papers","name":"Effects of ayahuasca in preclinical studies with animals: a systematic review","year":"2025","cit":0,"pfa":"André Walsh-Monteiro","psa":"Janari da Silva Pedroso","topics":["Depression","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4413814943","eid":"W4413814943"},{"id":"paper-w7110582841","cat":"papers","name":"MDMA for PTSD: Systematic Review & Meta-Analysis","year":"2019","cit":0,"pfa":"Anees Bahji","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W7110582841","eid":"W7110582841"},{"id":"paper-w4387365319","cat":"papers","name":"ISOLATION OF THE COMPOUND MDMA FOR APPLICATION AS A REFERENCE MATERIAL","year":"2023","cit":0,"pfa":"Clebson de Jesus Macrino","psa":"Álvaro Cunha Neto","ptype":"article","src":"https://openalex.org/W4387365319","eid":"W4387365319"},{"id":"paper-w7140100941","cat":"papers","name":"Dynamic Functional Brain Networks after Ayahuasca Ingestion","year":"2026","cit":0,"pfa":"Thaise G. L. de O. Toutain","psa":"C. Thielemann","topics":["Policy & ethics"],"ptype":"other","src":"https://openalex.org/W7140100941","eid":"W7140100941"},{"id":"paper-w7204379177","cat":"papers","name":"Biological characteristics, mechanism of action and potential use of psilocybin mushrooms","year":"2026","cit":0,"pfa":"Rok Rituper","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7204379177","eid":"W7204379177"},{"id":"paper-w3004543004","cat":"papers","name":"Ritual transfer, ayahuasca and the pursuit of altered consciousness in the West","year":"2015","cit":0,"pfa":"Daniel Perkins","psa":"Violeta Schubert","ptype":"article","src":"https://openalex.org/W3004543004","eid":"W3004543004"},{"id":"paper-w7198705683","cat":"papers","name":"Ayahuasca and the sacred Feminine: the dimension of healing in the circle of women","year":"2023","cit":0,"pfa":"Suevelin Cintia dos [UNIFESP] Santos","ptype":"dissertation","src":"https://openalex.org/W7198705683","eid":"W7198705683"},{"id":"paper-w4415322570","cat":"papers","name":"Who’s Heritage Is It? The Patrimonialization of the Religious Use of Ayahuasca in Brazil","year":"2025","cit":0,"pfa":"Henrique Fernandes Antunes","ptype":"book-chapter","src":"https://openalex.org/W4415322570","eid":"W4415322570"},{"id":"paper-w2076103806","cat":"papers","name":"ChemInform Abstract: Palladium‐Catalyzed Synthesis of Tryptamines and Tryptamine Homologues: Synthesis of Psilocin.","year":"2010","cit":0,"pfa":"Chunmei Hu","psa":"Yanxing Jia","ptype":"article","src":"https://openalex.org/W2076103806","eid":"W2076103806"},{"id":"paper-w4406404120","cat":"papers","name":"Applications of MDMA in Modern Medicine - A Literature Review","year":"2025","cit":0,"pfa":"Wiktoria Podlasiewicz","psa":"Maria Golińska","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4406404120","eid":"W4406404120"},{"id":"paper-w4385645939","cat":"papers","name":"use of psilocybin in the treatment of psychiatric disorders – review","year":"2023","cit":0,"pfa":"Justyna Woźniak","psa":"Magdalena OSUCH","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4385645939","eid":"W4385645939"},{"id":"paper-w7135904591","cat":"papers","name":"Studium mechanismů účinku nové syntetické drogy 2C-B v animálním modelu a srovnání s účinky rozšířených psychotropních látek (LSD, MDMA, psilocin a mezkalin) ::možná rizika užívání, implikace pro prevenci a léčbu intoxik","year":"2009","cit":0,"pfa":"Tomáš Páleníček","psa":"Psychiatrické centrum Praha","topics":["Mechanism & neuroscience"],"ptype":"report","src":"https://openalex.org/W7135904591","eid":"W7135904591"},{"id":"paper-w7135995791","cat":"papers","name":"The effects of psilocybin assisted therapy on analytical rumination.","year":"2023","cit":0,"pfa":"Max Vykoukal","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W7135995791","eid":"W7135995791"},{"id":"paper-w7125977079","cat":"papers","name":"Possible Effects of MDMA on Vehicle Driving Competencies","year":"2026","cit":0,"pfa":"Samuel Hubočan","psa":"Matúš Madleňák","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7125977079","eid":"W7125977079"},{"id":"paper-w4312194249","cat":"papers","name":"Depression Improves Following Single Dose of Psilocybin","year":"2022","cit":0,"pfa":"Nick Zagorski","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4312194249","eid":"W4312194249"},{"id":"paper-w7155199454","cat":"papers","name":"Psilocybin as an alternative to conventional treatments: A systematic review","year":"2026","cit":0,"pfa":"Deivid Antonio Cahuasqui-Mendoza","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W7155199454","eid":"W7155199454"},{"id":"paper-w2394361757","cat":"papers","name":"AN ANALYSIS OF THE PERSONALITY CHARACTERISTICS OF 135 MDMA ABUSERS","year":"2004","cit":0,"pfa":"Chen Li","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2394361757","eid":"W2394361757"},{"id":"paper-w7120727056","cat":"papers","name":"Development of method for determination of indole alkaloids in ayahuasca samples","year":"2016","cit":0,"pfa":"Mônica C. Santos","ptype":"dissertation","src":"https://openalex.org/W7120727056","eid":"W7120727056"},{"id":"paper-w4231255259","cat":"papers","name":"Executive dysfunction in abstinent MDMA (Ecstasy) users","year":"2000","cit":0,"pfa":"K. Zakzanis","psa":"A. Birze","ptype":"article","src":"https://openalex.org/W4231255259","eid":"W4231255259"},{"id":"paper-w7198574735","cat":"papers","name":"The efficacy and psychological safety of MDMA-assisted psychotherapy","year":"2017","cit":0,"pfa":"Teo Piitulainen","topics":["PTSD & trauma","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7198574735","eid":"W7198574735"},{"id":"paper-w2415550419","cat":"papers","name":"[Comparative action of mescaline, LSD 25 and yageine on the central temperature of the rat].","year":"1998","cit":0,"pfa":"J Delphaut","psa":"M LANZA","ptype":"article","src":"https://openalex.org/W2415550419","eid":"W2415550419"},{"id":"paper-w7165804891","cat":"papers","name":"A Critical Evaluation of the Hypothesis that N,N-Dimethyltryptamine has Endogenous Functions","year":"2026","cit":0,"pfa":"Ramiro Solis","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7165804891","eid":"W7165804891"},{"id":"paper-w2910076473","cat":"papers","name":"Experimental toxicity of mdma (ecstasy) in reproduction and development","year":"2011","cit":0,"pfa":"Marta Barenys Espadaler","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2910076473","eid":"W2910076473"},{"id":"paper-w2907837006","cat":"papers","name":"La ayahuasca bajo los ojos del mundo","year":"2019","cit":0,"pfa":"Guillermo Saúl Escobar Cornejo","psa":"Luis Fernando Ramos Vargas","ptype":"article","src":"https://openalex.org/W2907837006","eid":"W2907837006"},{"id":"paper-w4312322002","cat":"papers","name":"VIAJES DE AYAHUASCA DESDE LA REPÚBLICA CHECA","year":"2020","cit":0,"pfa":"Miroslav Horák","psa":"Slavia Salinas","ptype":"book-chapter","src":"https://openalex.org/W4312322002","eid":"W4312322002"},{"id":"paper-w2980790891","cat":"papers","name":"The Peyote Effect: From the Inquisition to the War on Drugs ‐ by Dawson, Alexander S.","year":"2019","cit":0,"pfa":"Stacy B. Schaefer","ptype":"article","src":"https://openalex.org/W2980790891","eid":"W2980790891"},{"id":"paper-w7132901416","cat":"papers","name":"A Study of the Inhibitory and Pharmacological Chaperone Effects of Bupropion and Ibogaine on Monoamine Transporters","year":"2025","cit":0,"pfa":"Erin Q. Williams","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7132901416","eid":"W7132901416"},{"id":"paper-w2039494863","cat":"papers","name":"Peyote Hunt: The Sacred Journey of the Huichol Indians. BARBARA G. MYERHOFF","year":"1975","cit":0,"pfa":"Joseph E. Grimes","ptype":"article","src":"https://openalex.org/W2039494863","eid":"W2039494863"},{"id":"paper-w4399675440","cat":"papers","name":"Reaction mixed over FDA committee rejection of MDMA therapy for PTSD","year":"2024","cit":0,"pfa":"Valerie A. Canady","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4399675440","eid":"W4399675440"},{"id":"paper-w4396849919","cat":"papers","name":"The Classical Psychedelic Psilocybin Mitigates Oxycodone Withdrawal","year":"2024","cit":0,"pfa":"Mohamad Imad Damaj","psa":"Belle Buzzi","ptype":"article","src":"https://openalex.org/W4396849919","eid":"W4396849919"},{"id":"paper-w4411494238","cat":"papers","name":"Political Attitudes towards the Legalization of Cannabis and Psilocybin","year":"2025","cit":0,"pfa":"Emma Cinotti","topics":["Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4411494238","eid":"W4411494238"},{"id":"paper-w3165647036","cat":"papers","name":"A Literature Review: The Efficacy of MDMA-Assisted Psychotherapy","year":"2017","cit":0,"pfa":"Olivia Tsai","topics":["PTSD & trauma","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3165647036","eid":"W3165647036"},{"id":"paper-w4394762471","cat":"papers","name":"Toxicokinetics of MDMA and Its Metabolite MDA in Rats.","year":"2024","cit":0,"pfa":"Weiguang Yu","psa":"Keming Yun","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4394762471","eid":"W4394762471"},{"id":"paper-w4383112754","cat":"papers","name":"Recurrent cerebral intraparenchymal hemorrhage after ayahuasca consumption: a case report","year":"2023","cit":0,"pfa":"Caroline Darold Vieira","psa":"Millene Camilo Rodrigues","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W4383112754","eid":"W4383112754"},{"id":"paper-w107776995","cat":"papers","name":"MDMA (\"Ecstasy\") in Tiermodellen des Morbus Parkinson","year":"2004","cit":0,"pfa":"Heike B. Lebsanft","ptype":"dissertation","src":"https://openalex.org/W107776995","eid":"W107776995"},{"id":"paper-w3101181456","cat":"papers","name":"OS POTENCIAIS TERAPÊUTICOS DA AYAHUASCA NA DEPRESSÃO","year":"2020","cit":0,"pfa":"Veronica Candaten Furini","psa":"Ícaro Bonamigo Gaspodini","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3101181456","eid":"W3101181456"},{"id":"paper-w7126174439","cat":"papers","name":"5-Methoxy-N,N-Dimethyltryptamine: Functional Safety Pharmacology and Video-EEG Assessment of a Short-Acting Serotonergic Psychedelic in Beagle Canines","year":"2026","cit":0,"pfa":"Amir Lotfi","psa":"Simon Authier","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7126174439","eid":"W7126174439"},{"id":"paper-w7132932548","cat":"papers","name":"MDMA-avusteinen psykoterapia traumaperäisen stressihäiriön hoidossa","year":"2025","cit":0,"pfa":"Samu Kivirauma","topics":["PTSD & trauma"],"ptype":"dissertation","src":"https://openalex.org/W7132932548","eid":"W7132932548"},{"id":"paper-w4231652584","cat":"papers","name":"Recreational MDMA (Ecstasy) use and serotonergic neurotoxicity","year":"1999","cit":0,"topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4231652584","eid":"W4231652584"},{"id":"paper-w2043572008","cat":"papers","name":"Gender differences in the psychotropic effects of MDMA (“Ecstasy”)","year":"2001","cit":0,"pfa":"Matthias E. Liechti","psa":"Franz X. Vollenweider","ptype":"article","src":"https://openalex.org/W2043572008","eid":"W2043572008"},{"id":"paper-w7112143294","cat":"papers","name":"Decoding subjective experience clusters from neural features in breathwork and N,N-Dimethyltryptamine","year":"2025","cit":0,"pfa":"Evan Lewis-Healey","psa":"Enzo Tagliazucchi","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7112143294","eid":"W7112143294"},{"id":"paper-w4300937876","cat":"papers","name":"Kappa-opioid receptor-selective dicarboxylic ester-derived salvinorin A ligands","year":"2020","cit":0,"pfa":"Eyal Vardy","psa":"Prabhakar Reddy Polepally","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4300937876","eid":"W4300937876"},{"id":"paper-w4239346396","cat":"papers","name":"4‐Hydroxy‐N,N‐Dimethyltryptamine 520‐53‐6","year":"2012","cit":0,"ptype":"other","src":"https://openalex.org/W4239346396","eid":"W4239346396"},{"id":"paper-w2796716581","cat":"papers","name":"Relationships among performance on simulated tasks of decision-making, positive outcome expectancies for MDMA, and age of first MDMA use","year":"2005","cit":0,"pfa":"Scott M. Patterson","topics":["Addiction"],"ptype":"dissertation","src":"https://openalex.org/W2796716581","eid":"W2796716581"},{"id":"paper-w2938178243","cat":"papers","name":"Does MDMA Have a Role in Clinical Psychiatry","year":"2011","cit":0,"pfa":"Michael C. Mithoefer","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2938178243","eid":"W2938178243"},{"id":"paper-w2978720071","cat":"papers","name":"Visuospatial memory impairments in users of MDMA (‘ecstasy’)","year":"2003","cit":0,"pfa":"M. Wareing","psa":"Philip N. Murphy","ptype":"conference-paper","src":"https://openalex.org/W2978720071","eid":"W2978720071"},{"id":"paper-w1605466255","cat":"papers","name":"MDMA : binge use and functional outcomes in the rat","year":"2009","cit":0,"pfa":"Ratchanee Rodsiri","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W1605466255","eid":"W1605466255"},{"id":"paper-w2607644592","cat":"papers","name":"ChemInform Abstract: SYNTHESIS OF CERTAIN MESCALINE DERIVATIVES FOR PHARMACOLOGICAL STUDY","year":"1979","cit":0,"pfa":"Azza M. Kadry","psa":"Mohamed E. Khalifa","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2607644592","eid":"W2607644592"},{"id":"paper-w3007326117","cat":"papers","name":"Potential benefits and risks of MDMA-use in psychoteraphy","year":"2004","cit":0,"pfa":"Kateřina Němcová","topics":["Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W3007326117","eid":"W3007326117"},{"id":"paper-w563211119","cat":"papers","name":"In vitro studies on the neurotoxic effects of MDMA (ecstasy)","year":"2013","cit":0,"pfa":"Andréas Forsblad","ptype":"article","src":"https://openalex.org/W563211119","eid":"W563211119"},{"id":"paper-w1485819609","cat":"papers","name":"The Role of Serotonin in MDMA Self-administration in Rats","year":"2014","cit":0,"pfa":"Sarah Bradbury","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W1485819609","eid":"W1485819609"},{"id":"paper-w2365991940","cat":"papers","name":"Increased cortical excitability in human MDMA users","year":"2015","cit":0,"pfa":"Ronald L. Cowan","psa":"David Harold Zald","ptype":"article","src":"https://openalex.org/W2365991940","eid":"W2365991940"},{"id":"paper-w4381296164","cat":"papers","name":"Potencial antidepressivo da Ayahuasca: uma revisão integrativa","year":"2023","cit":0,"pfa":"Mayara Cecile Nascimento Oliveira","psa":"Mirian Graciela da Silva Stiebbe Salvadori","topics":["Depression"],"ptype":"book-chapter","src":"https://openalex.org/W4381296164","eid":"W4381296164"},{"id":"paper-w3166318926","cat":"papers","name":"1376: PLASMAPHERESIS FOR TREATMENT OF MDMA-INDUCED RHABDOMYOLYSIS","year":"2017","cit":0,"pfa":"Audrey Sue Cruz","psa":"Saba Hamiduzzaman","ptype":"article","src":"https://openalex.org/W3166318926","eid":"W3166318926"},{"id":"paper-w4401214899","cat":"papers","name":"Understanding Neuroplasticity Induced by TrYptamines (UNITy): the effects of dimethyltryptamine (DMT) on drinking","year":"2024","cit":0,"pfa":"Ravi Das","psa":"Gregory M. Cooper","topics":["Mechanism & neuroscience"],"ptype":"dataset","src":"https://openalex.org/W4401214899","eid":"W4401214899"},{"id":"paper-w2531395519","cat":"papers","name":"Ayahuasca, een potentiële therapeutische tool voor verslaving","year":"2016","cit":0,"pfa":"T. van Wijck","ptype":"dissertation","src":"https://openalex.org/W2531395519","eid":"W2531395519"},{"id":"paper-w188782316","cat":"papers","name":"Salvinorin A Establishes Conditioned Place Aversion in Male Sprague-Dawley Rats","year":"2009","cit":0,"pfa":"Sheryl L. Walker","ptype":"article","src":"https://openalex.org/W188782316","eid":"W188782316"},{"id":"paper-w2784854558","cat":"papers","name":"Manchettes peyote & Cie : 10 créations féminissimes / Stéphanie Le Roux","year":"2017","cit":0,"pfa":"Stéphanie Le Roux","psa":"créatrice de bijoux en perles","ptype":"article","src":"https://openalex.org/W2784854558","eid":"W2784854558"},{"id":"paper-w2326514360","cat":"papers","name":"Review: Peyote vs. the State: Religious Freedom on Trial, by Garrett Epps","year":"2010","cit":0,"pfa":"Eric Michael Mazur","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2326514360","eid":"W2326514360"},{"id":"paper-w2314841369","cat":"papers","name":"Book Review: The Peyote Road: Religious Freedom and the Native American Church","year":"2011","cit":0,"pfa":"Randy S. Woodley","topics":["Reviews & meta-analyses"],"ptype":"book-review","src":"https://openalex.org/W2314841369","eid":"W2314841369"},{"id":"paper-w2023373507","cat":"papers","name":"Peyote y kieri en Nayar de Miguel Ángel Menéndez","year":"2012","cit":0,"pfa":"Edmer Calero del Mar","ptype":"article","src":"https://openalex.org/W2023373507","eid":"W2023373507"},{"id":"paper-w165956027","cat":"papers","name":"The Perrymander, Polarization, and Peyote v. Section 2 of the Voting Rights Act","year":"2013","cit":0,"pfa":"Rosemarie Unite","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W165956027","eid":"W165956027"},{"id":"paper-w7156084607","cat":"papers","name":"[CB01 ] — \"Willie Peyote - Elegia Sabauda\" Streaming-ITA in Alta Definizione","year":"2026","cit":0,"pfa":"pusing ndase","topics":["Policy & ethics"],"ptype":"report","src":"https://openalex.org/W7156084607","eid":"W7156084607"},{"id":"paper-w7198099204","cat":"papers","name":"Az ayahuasca orvosi alkalmazásának alapjai: a dimetiltriptamin szomatofiziológiája","year":"2016","cit":0,"pfa":"Ede Frecska","psa":"E. Csaba Móré","ptype":"article","src":"https://openalex.org/W7198099204","eid":"W7198099204"},{"id":"paper-w1578866464","cat":"papers","name":"Substance Abuse: Hallucinogen‐ and MDMA‐Related Disorders","year":"2006","cit":0,"topics":["Addiction"],"ptype":"other","src":"https://openalex.org/W1578866464","eid":"W1578866464"},{"id":"paper-w4378649792","cat":"papers","name":"Central Basis For MDMA (ecstasy) Induced Hyponatremia","year":"2023","cit":0,"pfa":"Joshua C. Wyrosdic","psa":"Charles W. Bourque","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4378649792","eid":"W4378649792"},{"id":"paper-w4413621053","cat":"papers","name":"Ayahuasca: the shamanic brew that produces out-of-body experiences","year":"2016","cit":0,"pfa":"Andrew Dawson","ptype":"other","src":"https://openalex.org/W4413621053","eid":"W4413621053"},{"id":"paper-w4394226994","cat":"papers","name":"Influence of Environmental Factors and Cultural Methods on the Content of N,N-Dimethyltryptamine in Psychotriaviridis (Rubiaceae)","year":"2018","cit":0,"pfa":"André D. Cavalcante","psa":"Sidney Augusto Vieira Filho","ptype":"dataset","src":"https://openalex.org/W4394226994","eid":"W4394226994"},{"id":"paper-w4239148208","cat":"papers","name":"Ausdrucksphänomenologie der Modellpsychosen (Psilocybin); pp. 85–100","year":"2008","cit":0,"pfa":"H. Heimann","ptype":"article","src":"https://openalex.org/W4239148208","eid":"W4239148208"},{"id":"paper-w7113627528","cat":"papers","name":"Neurological & Cognitive Effects of Psilocybin-Assisted Therapy for Fibromyalgia","year":"2023","cit":0,"pfa":"Haley Dourron","ptype":"preprint","src":"https://openalex.org/W7113627528","eid":"W7113627528"},{"id":"paper-w4407796960","cat":"papers","name":"BROAD SPECTRUM OF THERAPEUTIC PROPERTIES OF PSILOCYBIN: A LITERATURE REVIEW","year":"2025","cit":0,"pfa":"Julia Wójcik","psa":"Maksymilian Janeczek","topics":["PTSD & trauma","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4407796960","eid":"W4407796960"},{"id":"paper-w4404556355","cat":"papers","name":"Psilocybin-unterstützte Psychotherapie reduziert Ängste und Depressionen","year":"2024","cit":0,"pfa":"Lamia Özgör","topics":["Depression","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4404556355","eid":"W4404556355"},{"id":"paper-w4245050823","cat":"papers","name":"MDMA may yet have a therapeutic role","year":"1992","cit":0,"pfa":"&NA;","ptype":"article","src":"https://openalex.org/W4245050823","eid":"W4245050823"},{"id":"paper-w972029458","cat":"papers","name":"Stereoselective separation of MDMA enantiomers in sewage water","year":"2013","cit":0,"pfa":"Erik Emke","psa":"Pim de Voogt","ptype":"article","src":"https://openalex.org/W972029458","eid":"W972029458"},{"id":"paper-w2077804070","cat":"papers","name":"Executive dysfunction in abstinent MDMA (Ecstasy) users","year":"2000","cit":0,"pfa":"Konstantine K. Zakzanis","ptype":"article","src":"https://openalex.org/W2077804070","eid":"W2077804070"},{"id":"paper-w569683322","cat":"papers","name":"Syllogistic reasoning reasoning in MDMA (Ecstasy) users","year":"2003","cit":0,"pfa":"Catharine Montgomery","psa":"Philip N. Murphy","ptype":"conference-paper","src":"https://openalex.org/W569683322","eid":"W569683322"},{"id":"paper-w4385669474","cat":"papers","name":"Knocking on the Doors of Perception: the role of psilocybin in substance use disorder treatment","year":"2023","cit":0,"pfa":"Roxanny Tenório de Sousa","psa":"N. Cunha","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4385669474","eid":"W4385669474"},{"id":"paper-w239991644","cat":"papers","name":"N, N-Dimethyltryptamine and Biological Reductive Accounts for Religious and Spiritual Experiences","year":"2014","cit":0,"pfa":"Shaun A. Smith","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W239991644","eid":"W239991644"},{"id":"paper-w7165615259","cat":"papers","name":"Impact of CYP2D6 Polymorphisms on the Pharmacokinetics of N,N-Dimethyltryptamine and Harmine via PBPK Modeling and Simulation","year":"2026","cit":0,"pfa":"Gabriella de Souza Gomes Ribeiro","psa":"Tânia Marcourakis","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7165615259","eid":"W7165615259"},{"id":"paper-w4226186521","cat":"papers","name":"Drug and MDMA Interactions Implications for Public Health","year":"2022","cit":0,"pfa":"Esther Papaseit","psa":"Clara Pérez‐Mañá","ptype":"book-chapter","src":"https://openalex.org/W4226186521","eid":"W4226186521"},{"id":"paper-w2555303978","cat":"papers","name":"Notes on Taber-nanthe iboga, Cassia occidentalis and Combretum micranthum in Spanish Guinea.","year":"1943","cit":0,"pfa":"M. L. Gómez-moreno","ptype":"article","src":"https://openalex.org/W2555303978","eid":"W2555303978"},{"id":"paper-w2312465101","cat":"papers","name":"Rock Crystals and Peyote Dreams: Explorations in the Huichol Universe. Peter T. Furst","year":"2008","cit":0,"pfa":"Hope MacLean","ptype":"book-review","src":"https://openalex.org/W2312465101","eid":"W2312465101"},{"id":"paper-w7135304883","cat":"papers","name":"Ways to increase the efficiency of using the human resources of the consulting company LLC \"Peyote\"","year":"2021","cit":0,"pfa":"М.О. Гаврилова","ptype":"dissertation","src":"https://openalex.org/W7135304883","eid":"W7135304883"},{"id":"paper-w4200425394","cat":"papers","name":"P.0858 Psilocin induces perceptual alterations in rats: visual discrimination study","year":"2021","cit":0,"pfa":"Čestmír Vejmola","psa":"Tomáš Páleníček","ptype":"article","src":"https://openalex.org/W4200425394","eid":"W4200425394"},{"id":"paper-w2319105970","cat":"papers","name":"ChemInform Abstract: ALKALOIDS PART 30, CHIROPTICAL INVESTIGATIONS ON THE IBOGA AND VOACANGA ALKALOIDS","year":"1974","cit":0,"pfa":"K. Bláha","psa":"Jan Trojánek","ptype":"article","src":"https://openalex.org/W2319105970","eid":"W2319105970"},{"id":"paper-w1881538112","cat":"papers","name":"Synthetic Modifications of the Furan Ring of Salvinorin A, a Neoclerodane Diterpene from Salvia divinorum","year":"2006","cit":0,"pfa":"Denise S. Simpson","psa":"Thomas Edward Prisinzano","ptype":"article","src":"https://openalex.org/W1881538112","eid":"W1881538112"},{"id":"paper-w2914350141","cat":"papers","name":"Synthesis and in vitro Pharmacological Studies of New C(2) Modified Salvinorin A Analogues.","year":"2006","cit":0,"pfa":"Bruce M. Cohen","psa":"et al. et al.","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2914350141","eid":"W2914350141"},{"id":"paper-w2965296886","cat":"papers","name":"8-Epi-Salvinorin B: Crystal Structure and Affinity at the K Opioid Receptor","year":"2011","cit":0,"pfa":"Harold H. Trimm","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W2965296886","eid":"W2965296886"},{"id":"paper-w4408925922","cat":"papers","name":"Ayahuasca in the treatment of the consequences of chronic childhood sexual abuse in a religious community","year":"2025","cit":0,"pfa":"Mika Turkia","topics":["Depression","PTSD & trauma","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4408925922","eid":"W4408925922"},{"id":"paper-w2951084960","cat":"papers","name":"ChemInform Abstract: Ecstasy: 3,4‐Methylenedioxymethamphetamine (MDMA).","year":"1998","cit":0,"pfa":"Bruce H. Morimoto","psa":"Bart E. Kahr","ptype":"article","src":"https://openalex.org/W2951084960","eid":"W2951084960"},{"id":"paper-w3085627189","cat":"papers","name":"MDMA-Alcohol interactions: effects on activity and thermoregulation","year":"2005","cit":0,"pfa":"Byron Jones","psa":"Hélène Jeltsch‐David","topics":["Addiction","Policy & ethics"],"ptype":"conference-paper","src":"https://openalex.org/W3085627189","eid":"W3085627189"},{"id":"paper-w4250252236","cat":"papers","name":"Stanford Reward Circuits of the Brain Study - MDMA","year":"2019","cit":0,"ptype":"article","src":"https://openalex.org/W4250252236","eid":"W4250252236"},{"id":"paper-w4394855195","cat":"papers","name":"Bioisosteric analogs of MDMA with improved pharmacological profile","year":"2024","cit":0,"pfa":"Ana Sofia Alberto‐Silva","psa":"Harald H. Sitte","topics":["PTSD & trauma","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4394855195","eid":"W4394855195"},{"id":"paper-w1606652061","cat":"papers","name":"Längsschnitt-Untersuchung der Neurotoxizität von MDMA","year":"2005","cit":0,"pfa":"Johann-Ulrich Geck","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1606652061","eid":"W1606652061"},{"id":"paper-w7156768113","cat":"papers","name":"Mechanistic and Methodological Insights in Research on Psychedelics and MDMA","year":"2026","cit":0,"pfa":"L. Belinger","topics":["Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W7156768113","eid":"W7156768113"},{"id":"paper-w183794533","cat":"papers","name":"Future perspectives: Psychlogical research on MDMA ('ecstasy')","year":"1998","cit":0,"pfa":"H. Valerie Curran","ptype":"conference-paper","src":"https://openalex.org/W183794533","eid":"W183794533"},{"id":"paper-w2945171975","cat":"papers","name":"PT693. BRAIN SPECT IN ALCOHOL, COCAINE AND MDMA","year":"2016","cit":0,"pfa":"Enrique Galli","psa":"Enrique Galli Jr.","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W2945171975","eid":"W2945171975"},{"id":"paper-w4226031080","cat":"papers","name":"Life-Threatening 3,4‐Methylenedioxyamphetamine (MDMA) Usage","year":"2022","cit":0,"pfa":"Francis Kin Chiu Chu","ptype":"book-chapter","src":"https://openalex.org/W4226031080","eid":"W4226031080"},{"id":"paper-w4232526860","cat":"papers","name":"Cardiovascular Effects of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)","year":"2000","cit":0,"ptype":"article","src":"https://openalex.org/W4232526860","eid":"W4232526860"},{"id":"paper-w4255416318","cat":"papers","name":"Changing your mind: Methamphetamine and MDMA in the brain","year":"2008","cit":0,"pfa":"Bertha Kalifon Madras","ptype":"dataset","src":"https://openalex.org/W4255416318","eid":"W4255416318"},{"id":"paper-w1166415737","cat":"papers","name":"Trauma Innovations: MDMA as a Treatment Intervention for PTSD","year":"2015","cit":0,"pfa":"Anthony Christian","psa":"Terra Sorg","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W1166415737","eid":"W1166415737"},{"id":"paper-w7103882109","cat":"papers","name":"Neuroimaging in moderate MDMA use: A systematic review","year":"2016","cit":0,"pfa":"Mueller, Felix","psa":"Borgwardt, Stefan","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7103882109","eid":"W7103882109"},{"id":"paper-w3038815947","cat":"papers","name":"Scoping Review Protocol: Mapping Psilocybin Animal Research","year":"2020","cit":0,"pfa":"Ron Joseph Shore","psa":"Craig E. Goldie","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"other","src":"https://openalex.org/W3038815947","eid":"W3038815947"},{"id":"paper-w4229637288","cat":"papers","name":"Psychedelic Drugs and Personality","year":"2020","cit":0,"pfa":"James W. B. Elsey","psa":"Linos Vossoughi","ptype":"reference-entry","src":"https://openalex.org/W4229637288","eid":"W4229637288"},{"id":"paper-w7127544596","cat":"papers","name":"A mood disorder episode with an onset under chronic cannabis consumption and accompanied with psychotic features immediately after N, N-Dimethyltryptamine (DMT) use: a case report","year":"2011","cit":0,"pfa":"Guliz Ozgen","psa":"Ahmet Türkcan","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7127544596","eid":"W7127544596"},{"id":"paper-w3096517713","cat":"papers","name":"Ayahuasca, ¿cura o enfermedad? A propósito de un caso.","year":"2020","cit":0,"pfa":"Julia Fábrega Ruz","psa":"Sheila Santiago González","topics":["PTSD & trauma"],"ptype":"conference-paper","src":"https://openalex.org/W3096517713","eid":"W3096517713"},{"id":"paper-w4244535738","cat":"papers","name":"Behavioral Effects and Pharmacokinetics of MDMA (Ecstasy) in Baboons","year":"2013","cit":0,"topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4244535738","eid":"W4244535738"},{"id":"paper-w2050425444","cat":"papers","name":"Neuroehavioral outcomes of infants exposed prenatally to MDMA","year":"2008","cit":0,"pfa":"Lynn T. Singer","psa":"Sarah E. Fulton","ptype":"article","src":"https://openalex.org/W2050425444","eid":"W2050425444"},{"id":"paper-w2372716753","cat":"papers","name":"The Mediation Dispute mechanism of Akhond (MDMA) in Ningxia","year":"2011","cit":0,"pfa":"Yi Jun","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2372716753","eid":"W2372716753"},{"id":"paper-w4385433848","cat":"papers","name":"MDMA-Assisted Therapy for Treatment of PTSD and Beyond","year":"2023","cit":0,"topics":["PTSD & trauma","Reviews & meta-analyses"],"ptype":"book","src":"https://openalex.org/W4385433848","eid":"W4385433848"},{"id":"paper-w7112526608","cat":"papers","name":"Defining Neo-Shamanic Practices Involving Dimethyltryptamine (DMT) from Shamans’ Perceptions on Transcendence and Transformation","year":"2023","cit":0,"pfa":"Moreno, Ivan Dario","ptype":"dissertation","src":"https://openalex.org/W7112526608","eid":"W7112526608"},{"id":"paper-w2373524522","cat":"papers","name":"New Achievements in the Analysis of the Chemical Elements in MDMA","year":"2002","cit":0,"pfa":"Chen Nin","psa":"Jianhua Zhang","ptype":"article","src":"https://openalex.org/W2373524522","eid":"W2373524522"},{"id":"paper-w3047299866","cat":"papers","name":"Safety pharmacology and pharmacogenetics of 3,4-methylenedioxymethamphetamine (MDMA)","year":"2020","cit":0,"pfa":"Patrick Vizeli","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W3047299866","eid":"W3047299866"},{"id":"paper-w4396858032","cat":"papers","name":"Common side effects of MDMA-assisted psychotherapy","year":"2024","cit":0,"pfa":"Conor H. Murray","topics":["PTSD & trauma","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4396858032","eid":"W4396858032"},{"id":"paper-w7171492689","cat":"papers","name":"High-sensitivity immunochromatographic assay based on time-resolved fluorescence microspheres for the simultaneous detection of mescaline and LSD in hair","year":"2026","cit":0,"pfa":"Moying Yang","psa":"Mengxiang Su","ptype":"article","src":"https://openalex.org/W7171492689","eid":"W7171492689"},{"id":"paper-w2611964476","cat":"papers","name":"Future perspectives for psychological research with MDMA ('ecstasy').","year":"1997","cit":0,"pfa":"H. Valerie Curran","ptype":"conference-paper","src":"https://openalex.org/W2611964476","eid":"W2611964476"},{"id":"paper-w597205060","cat":"papers","name":"EFFECTS OF MDMA (ECSTASY) ON DRIVING PERFORMANCE AND COGNITION","year":"2002","cit":0,"pfa":"Johannes Gerardus Ramaekers","topics":["Addiction","Policy & ethics"],"ptype":"conference-paper","src":"https://openalex.org/W597205060","eid":"W597205060"},{"id":"paper-w7115279659","cat":"papers","name":"Recreative use of MDMA and quality of romantic relationships","year":"2020","cit":0,"pfa":"Špan, Ema","topics":["Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7115279659","eid":"W7115279659"},{"id":"paper-w4406886559","cat":"papers","name":"A Uhplc-(Esi)Ms/Ms Method for the Determination of the Psychedelic Secondary Metabolite Mescaline in San Pedro (Trichocereus Spp.) and its Applicability for Screening Mescaline in Other Cacti Varieties","year":"2025","cit":0,"pfa":"Pragna Gaur","psa":"Mitchell Low","ptype":"preprint","src":"https://openalex.org/W4406886559","eid":"W4406886559"},{"id":"paper-w7127231335","cat":"papers","name":"Psilocybin Mushrooms: Identifying the Profile of the Most Likely Users","year":"2025","cit":0,"pfa":"Gale Wohlfarth","ptype":"conference-paper","src":"https://openalex.org/W7127231335","eid":"W7127231335"},{"id":"paper-w7172275487","cat":"papers","name":"Trial suggests effectiveness of psilocybin for cocaine use disorder","year":"2026","cit":0,"topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7172275487","eid":"W7172275487"},{"id":"paper-w37847962","cat":"papers","name":"Stereoselective effects of MDMA on inhibition of monoamine uptake","year":"1986","cit":0,"pfa":"Thomas Steele","psa":"George K. W. Yim","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W37847962","eid":"W37847962"},{"id":"paper-w8574817","cat":"papers","name":"Assessment of the Discriminative Stimulus Effects and Time Courses of Salvinorin A and Two Synthetic Salvinorin B Derivatives, Methoxylmethyl (MOM) and Ethoxymethyl (EOM), Ethers in Rats Trained To Discriminate U69,593","year":"2012","cit":0,"pfa":"Lisa M. Bell","ptype":"article","src":"https://openalex.org/W8574817","eid":"W8574817"},{"id":"paper-w1573612464","cat":"papers","name":"The effect of mescaline on activity and emotional defaecation in seven inbred strains of mice.","year":"1974","cit":0,"pfa":"Ian E. Lush","ptype":"article","src":"https://openalex.org/W1573612464","eid":"W1573612464"},{"id":"paper-w3197136185","cat":"papers","name":"Binocular rivalry perceptual memory in schizophrenia and in acute ayahuasca administration","year":"2021","cit":0,"pfa":"Keith D. White","psa":"Ede Frecska","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3197136185","eid":"W3197136185"},{"id":"paper-w4205154030","cat":"papers","name":"The Role of Serotonin in MDMA Self-administration in Rats","year":"2014","cit":0,"pfa":"Sarah Bradbury","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W4205154030","eid":"W4205154030"},{"id":"paper-w4248440035","cat":"papers","name":"MDMA may yet have a therapeutic role","year":"1992","cit":0,"pfa":"&NA;","ptype":"article","src":"https://openalex.org/W4248440035","eid":"W4248440035"},{"id":"paper-w7120422831","cat":"papers","name":"Caracterização pré-clínica das propriedades antinociceptivas da ayahuasca","year":"2023","cit":0,"pfa":"Pedro Santana Sales Lauria","ptype":"dissertation","src":"https://openalex.org/W7120422831","eid":"W7120422831"},{"id":"paper-w2605698679","cat":"papers","name":"ChemInform Abstract: INDOLE 22. MITT. INDOLSYNTH., ANWENDUNG AUF PSILOCIN","year":"1970","cit":0,"pfa":"Marc Julia","psa":"YVES ROBERT PASCAL","ptype":"article","src":"https://openalex.org/W2605698679","eid":"W2605698679"},{"id":"paper-w7213668581","cat":"papers","name":"A brief perturbation. A broad transcriptional signature: psilocin human-neuron transcriptomics","year":"2026","cit":0,"pfa":"Christopher B. Germann","topics":["Mechanism & neuroscience"],"ptype":"software","src":"https://openalex.org/W7213668581","eid":"W7213668581"},{"id":"paper-w2511814781","cat":"papers","name":"Psychonautic uses of \"Ayahuasca\" and its analogues: Panæa or Outré entertainment?","year":"2011","cit":0,"pfa":"Jonathan Ott","ptype":"article","src":"https://openalex.org/W2511814781","eid":"W2511814781"},{"id":"paper-w4298423023","cat":"papers","name":"Antropología simétrica y procesos de curación con ayahuasca","year":"2014","cit":0,"pfa":"Mauricio Genet Guzmán Chávez","ptype":"article","src":"https://openalex.org/W4298423023","eid":"W4298423023"},{"id":"paper-w4410757245","cat":"papers","name":"Corrigendum to “The Trouble With Psychedelic Cacti: Conflicting Meanings of San Pedro and Peyote”","year":"2025","cit":0,"ptype":"erratum","src":"https://openalex.org/W4410757245","eid":"W4410757245"},{"id":"paper-w7165183330","cat":"papers","name":"Koshering Psychedelics: Ayahuasca in the Ultra-Orthodox (Haredi) Jewish World","year":"2026","cit":0,"pfa":"Jonathan David","psa":"Leor Roseman","ptype":"preprint","src":"https://openalex.org/W7165183330","eid":"W7165183330"},{"id":"paper-w1514100437","cat":"papers","name":"Ecstasy: Actions of the 107th Congress to Control MDMA","year":"2002","cit":0,"pfa":"Mark Eddy","ptype":"article","src":"https://openalex.org/W1514100437","eid":"W1514100437"},{"id":"paper-w2760919341","cat":"papers","name":"MDMA efficacy in treating treatment resistant PTSD","year":"2016","cit":0,"pfa":"Brandon Lipin","topics":["Depression","PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W2760919341","eid":"W2760919341"},{"id":"paper-w2991908323","cat":"papers","name":"AYAHUASCA: UM SAGRADO SELVAGEM QUE BASTIDE NÃO CONHECEU","year":"2019","cit":0,"pfa":"Drance Elias da Silva","psa":"João Paulo Reis Braga","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2991908323","eid":"W2991908323"},{"id":"paper-w4232661967","cat":"papers","name":"2‐Methyl‐5‐Methoxy‐N‐Dimethyltryptamine 67292‐68‐6","year":"2012","cit":0,"ptype":"other","src":"https://openalex.org/W4232661967","eid":"W4232661967"},{"id":"paper-w7166510824","cat":"papers","name":"A Critical Evaluation of the Hypothesis that N,N-Dimethyltryptamine has Endogenous Functions","year":"2026","cit":0,"pfa":"Ramiro Solis","ptype":"preprint","src":"https://openalex.org/W7166510824","eid":"W7166510824"},{"id":"paper-w2173909728","cat":"papers","name":"Toxicomanie : ecstasy, mda, mdma et mdea","year":"2010","cit":0,"pfa":"Bourrillon Antoine","ptype":"article","src":"https://openalex.org/W2173909728","eid":"W2173909728"},{"id":"paper-w7141020531","cat":"papers","name":"eLife Assessment: Psilocin fosters neuroplasticity in iPSC-derived human cortical neurons","year":"2026","cit":0,"pfa":"Mariano Soiza‐Reilly","topics":["Mechanism & neuroscience"],"ptype":"peer-review","src":"https://openalex.org/W7141020531","eid":"W7141020531"},{"id":"paper-w7154188867","cat":"papers","name":"Psilocybin acutely reduces low-frequency BOLD power and frequency-specific connectivity","year":"2026","cit":0,"pfa":"Anders S. Olsen","psa":"Patrick M. Fisher","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7154188867","eid":"W7154188867"},{"id":"paper-w7204240548","cat":"papers","name":"Endogenous Dimethyltryptamine Reconsidered: A Constraint-Based Trace Amine Ensemble Model","year":"2026","cit":0,"pfa":"Lester H. LaCombe II","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7204240548","eid":"W7204240548"},{"id":"paper-w2408218114","cat":"papers","name":"N-(3,4,5-trimethoxyphenylethyl)-aziridine--a mescaline derivative: interaction with cholinesterases in vitro.","year":"1989","cit":0,"pfa":"J Patocka","psa":"J. Zámocký","ptype":"article","src":"https://openalex.org/W2408218114","eid":"W2408218114"},{"id":"paper-w7167865695","cat":"papers","name":"Psychedelics and Ibogaine “Pain Medications” at the Pharmacy Counter: Implications for Pharmacy Practice","year":"2026","cit":0,"pfa":"Frank Breve","psa":"Robert B. Raffa","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7167865695","eid":"W7167865695"},{"id":"paper-w2955212346","cat":"papers","name":"Os conhecimentos da ayahuasca na união do vegetal","year":"2019","cit":0,"pfa":"Rita Barreto de Sales Oliveira","ptype":"article","src":"https://openalex.org/W2955212346","eid":"W2955212346"},{"id":"paper-w4380205679","cat":"papers","name":"“A Case of Peyote Drug Addiction”: Unpublished Course Notes by Henri Ellenberger","year":"2020","cit":0,"pfa":"HENRI F. ELLENBERGER","topics":["Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W4380205679","eid":"W4380205679"},{"id":"paper-w2896107760","cat":"papers","name":"MDMA Makes Octopuses Friendlier And More Social","year":"2018","cit":0,"pfa":"Alexander Bolano","ptype":"article","src":"https://openalex.org/W2896107760","eid":"W2896107760"},{"id":"paper-w2416993437","cat":"papers","name":"[Quantitative evaluation of the action of drugs on vestibular function. III. Neurotoxicity of mescaline].","year":"1953","cit":0,"pfa":"A Crema","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2416993437","eid":"W2416993437"},{"id":"paper-w2002635183","cat":"papers","name":"Synthesis and in vitro characterization of new salvinorin a analogs incorporating natural amino acids","year":"2011","cit":0,"pfa":"Jakub Fichna","psa":"Jordan Kordian Zjawiony","ptype":"article","src":"https://openalex.org/W2002635183","eid":"W2002635183"},{"id":"paper-w2972047756","cat":"papers","name":"Design and Development of Chemically and Biologically Stable Salvinorin-Based Ligands for Opioid Receptors","year":"2019","cit":0,"pfa":"Tanner Neilson","topics":["Addiction","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W2972047756","eid":"W2972047756"},{"id":"paper-w7162447643","cat":"papers","name":"Psychedelics and Mental Health: Psilocybin and Depression. A Sistematic Review","year":"2026","cit":0,"pfa":"Marta Gómez Álvarez","psa":"Víctor Echeverry‐Alzate","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7162447643","eid":"W7162447643"},{"id":"paper-w2897006173","cat":"papers","name":"Efeitos da ayahuasca na memoria emocional de ratos","year":"2012","cit":0,"pfa":"Daiana Aparecida da Silva","ptype":"article","src":"https://openalex.org/W2897006173","eid":"W2897006173"},{"id":"paper-w2611805600","cat":"papers","name":"Metamorphosis: a comparative analysis of ayahuasca healing in Amazonia and Australia 1","year":"2013","cit":0,"pfa":"Alex K. Gearin","ptype":"article","src":"https://openalex.org/W2611805600","eid":"W2611805600"},{"id":"paper-w2478385450","cat":"papers","name":"Effects of MDMA on an active avoidance paradigm in mice","year":"2003","cit":0,"pfa":"A. Cabrero","psa":"Rafaël Maldonado","ptype":"article","src":"https://openalex.org/W2478385450","eid":"W2478385450"},{"id":"paper-w2507591961","cat":"papers","name":"Consequences of ± 3,4-methylenedioxymethamphetamine (MDMA) administration in the rat","year":"2006","cit":0,"pfa":"Megan M. W. Straiko","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2507591961","eid":"W2507591961"},{"id":"paper-w7212062177","cat":"papers","name":"706. Neurobiology of MDMA and mechanisms in trauma recovery","year":"2026","cit":0,"pfa":"U Schmidt","topics":["PTSD & trauma","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7212062177","eid":"W7212062177"},{"id":"paper-w2885691941","cat":"papers","name":"DISCURSOS SOBRE O USO RELIGIOSO DO PSICOATIVO AYAHUASCA","year":"2013","cit":0,"pfa":"Paulo Alves Bueno","ptype":"dissertation","src":"https://openalex.org/W2885691941","eid":"W2885691941"},{"id":"paper-w7171863228","cat":"papers","name":"One Dose of Psilocybin May Alter Brain Structure","year":"2026","cit":0,"pfa":"Richard B. Karel","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7171863228","eid":"W7171863228"},{"id":"paper-w3156738831","cat":"papers","name":"Ayahuasca as a Versatile Therapeutic Agent: From Molecules to Metacognition and Back","year":"2021","cit":0,"pfa":"Marta Valle","psa":"Jordi Riba","ptype":"book-chapter","src":"https://openalex.org/W3156738831","eid":"W3156738831"},{"id":"paper-w2952346551","cat":"papers","name":"ChemInform Abstract: Analogues of the Iboga Alkaloids. Synthesis and Reactions of (.+‐.)‐15‐ Oxo‐20‐deethylcoronaridine Derivatives.","year":"1987","cit":0,"pfa":"Richard J. Sundberg","psa":"Avanthi M. Fernando","ptype":"article","src":"https://openalex.org/W2952346551","eid":"W2952346551"},{"id":"paper-w2908170115","cat":"papers","name":"Upplevelser av möten med Ayahuasca - själens lian","year":"2008","cit":0,"pfa":"Anders Eriksson","ptype":"article","src":"https://openalex.org/W2908170115","eid":"W2908170115"},{"id":"paper-w4408888199","cat":"papers","name":"Participant experiences of therapeutic touch in psilocybin-assisted therapy","year":"2025","cit":0,"pfa":"Rachel Ham","psa":"Adrian Carter","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4408888199","eid":"W4408888199"},{"id":"paper-w7127649333","cat":"papers","name":"Retraction: Acute psilocybin increased cortical activities in rats","year":"2026","cit":0,"pfa":"Frontiers Editorial Office","ptype":"retraction","src":"https://openalex.org/W7127649333","eid":"W7127649333"},{"id":"paper-w4237780708","cat":"papers","name":"Faculty Opinions recommendation of The mechanistic basis for noncompetitive ibogaine inhibition of serotonin and dopamine transporters.","year":"2013","cit":0,"pfa":"Shimon Schuldiner","topics":["Mechanism & neuroscience"],"ptype":"peer-review","src":"https://openalex.org/W4237780708","eid":"W4237780708"},{"id":"paper-w4312355123","cat":"papers","name":"Heteroaromatic Salvinorin a Analogue (P-3l) Elicits Antinociceptive and Anxiolytic-Like Effects","year":"2022","cit":0,"pfa":"Caroline V. L. Moreira","psa":"James Oluwagbamigbe Fajemiroye","ptype":"preprint","src":"https://openalex.org/W4312355123","eid":"W4312355123"},{"id":"paper-w1995748681","cat":"papers","name":"Longitudinal study of psychiatric comorbidity in MDMA users","year":"2002","cit":0,"pfa":"Jose Maria Gines","psa":"Rafael de la Torre","ptype":"article","src":"https://openalex.org/W1995748681","eid":"W1995748681"},{"id":"paper-w4394155470","cat":"papers","name":"Pre-clinical interaction of ayahuasca, a brew used in spiritual movements, with morphine and propofol","year":"2018","cit":0,"pfa":"Júlia Movilla Pires","psa":"E.A. Carlini","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"dataset","src":"https://openalex.org/W4394155470","eid":"W4394155470"},{"id":"paper-w2582234767","cat":"papers","name":"Book Review: Peyote and the Yankton Sioux: The Life and Times of Sam Necklace","year":"2006","cit":0,"pfa":"Randy S. Woodley","topics":["Reviews & meta-analyses"],"ptype":"book-review","src":"https://openalex.org/W2582234767","eid":"W2582234767"},{"id":"paper-w4367310358","cat":"papers","name":"Moved by Another Life: Altered Sentience and Historical Poiesis in the Peyote Craze","year":"2023","cit":0,"pfa":"Sylvie Boulette","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4367310358","eid":"W4367310358"},{"id":"paper-w4408266781","cat":"papers","name":"Direct effects of psilocybin on serotonin receptors regulate lipid accumulation in hepatic cells and adipocytes","year":"2025","cit":0,"pfa":"ANGELO SIGNOR","psa":"S. De Martin","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4408266781","eid":"W4408266781"},{"id":"paper-w7202360095","cat":"papers","name":"Ibogaine as a double-edged sword: Developmental cardiotoxicity and neurobehavioral alterations in zebrafish","year":"2026","cit":0,"pfa":"Alessandra Mara de Oliveira","psa":"Danielle Palma de Oliveira","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7202360095","eid":"W7202360095"},{"id":"paper-w4414123080","cat":"papers","name":"Behavioural investigations of psilocybin in non-human animals 1962–2021: A scoping review","year":"2025","cit":0,"pfa":"Ron Joseph Shore","psa":"Éric C. Dumont","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4414123080","eid":"W4414123080"},{"id":"paper-w267451597","cat":"papers","name":"Iquitos: meca de la ayahuasca: Benigno es bueno","year":"2014","cit":0,"pfa":"Carlos Suárez","ptype":"article","src":"https://openalex.org/W267451597","eid":"W267451597"},{"id":"paper-w4410327917","cat":"papers","name":"AYAHUASCA COMO ALTERNATIVA DE TRATAMENTO NA DEPRESSÃO RESISTENTE","year":"2025","cit":0,"pfa":"Isabella Carvalho Lopes Avellar","psa":"Petra Wagner Ciscato","topics":["Depression"],"ptype":"book-chapter","src":"https://openalex.org/W4410327917","eid":"W4410327917"},{"id":"paper-w2936534570","cat":"papers","name":"Ayahuasca aka the vine of the soul as a potential new treatment for depression","year":"2018","cit":0,"pfa":"pMaya G Liester","psa":"Mitchell B Liesterp","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2936534570","eid":"W2936534570"},{"id":"paper-w4394164013","cat":"papers","name":"Ayahuasca and Public Health II. Supporting information 2: Database","year":"2022","cit":0,"pfa":"Maja Kohek","psa":"Miguel Ángel Alcázar‐Córcoles","ptype":"dataset","src":"https://openalex.org/W4394164013","eid":"W4394164013"},{"id":"paper-w7167634769","cat":"papers","name":"Perception, Cognition and Ayahuasca A Multidimensional Analysis of Alter States of Consciousness","year":"2024","cit":0,"pfa":"Dila Suay","topics":["Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W7167634769","eid":"W7167634769"},{"id":"paper-w2898353767","cat":"papers","name":"The Nature of memory impairment in recreational MDMA-users : enduring encoding dysfunction in current and two-year abstinent MDMA-users","year":"2001","cit":0,"pfa":"Kate Hall","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W2898353767","eid":"W2898353767"},{"id":"paper-w2895288817","cat":"papers","name":"The frontiers of psychedelic therapy: psilocybin as a new treatment option","year":"2015","cit":0,"pfa":"Pedro Miguel Sá Machado","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W2895288817","eid":"W2895288817"},{"id":"paper-w4401907376","cat":"papers","name":"Insights into the efficacy of psilocybin in treating depression and other disorders","year":"2024","cit":0,"pfa":"Sarah Jane Palmer","topics":["Depression"],"ptype":"editorial","src":"https://openalex.org/W4401907376","eid":"W4401907376"},{"id":"paper-w2766747524","cat":"papers","name":"Visual Perception and Imagery Adaptation effects modulated by Ayahuasca","year":"2014","cit":0,"pfa":"Katia Andrade","psa":"Dráulio Barros de Araújo","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2766747524","eid":"W2766747524"},{"id":"paper-w4412724384","cat":"papers","name":"Open MDMA: An Evidence-Based Synthesis, Theory, and Manual for MDMA Therapy Based on Predictive Processing, Complex Systems, and the Defense Cascade","year":"2025","cit":0,"pfa":"Mark Groeneveld","psa":"Thomas Harper","topics":["PTSD & trauma","Safety & adverse events","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4412724384","eid":"W4412724384"},{"id":"paper-w4392410062","cat":"papers","name":"Access to new chiral building blocks towards the synthesis of salvinorin A analogues and bioactive terpenes","year":"2017","cit":0,"pfa":"Lucie Schiavo","ptype":"dissertation","src":"https://openalex.org/W4392410062","eid":"W4392410062"},{"id":"paper-w108440860","cat":"papers","name":"Ayahuasca: saber y poder desde la selva shipibo","year":"2004","cit":0,"pfa":"Pablo Friedländer","ptype":"article","src":"https://openalex.org/W108440860","eid":"W108440860"},{"id":"paper-w2615796204","cat":"papers","name":"Fear No Spirits: A Pilgrim’s Journey through the Brazilian Churches of Ayahuasca","year":"2005","cit":0,"pfa":"Robert Tindall","ptype":"article","src":"https://openalex.org/W2615796204","eid":"W2615796204"},{"id":"paper-w2292665101","cat":"papers","name":"Las visiones de la ayahuasca, en la vestimenta","year":"2016","cit":0,"pfa":"Diario El Comercio","ptype":"article","src":"https://openalex.org/W2292665101","eid":"W2292665101"},{"id":"paper-w4387615831","cat":"papers","name":"Christ returns from the jungle. ayahuasca religion as mystical healing","year":"2023","cit":0,"pfa":"Stefano Bigliardi","ptype":"book-review","src":"https://openalex.org/W4387615831","eid":"W4387615831"},{"id":"paper-w4310033611","cat":"papers","name":"Antidepressant properties of psilocybin might be related to changes in sleep","year":"2022","cit":0,"pfa":"Marten Dooper","topics":["Depression"],"ptype":"conference-paper","src":"https://openalex.org/W4310033611","eid":"W4310033611"},{"id":"paper-w4415757045","cat":"papers","name":"Ketamine and psilocybin for athletes: A therapeutic breakthrough or a slippery slope?","year":"2025","cit":0,"pfa":"Thomas Zandonai","psa":"Ornella Corazza","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4415757045","eid":"W4415757045"},{"id":"paper-w4231952833","cat":"papers","name":"10-step Synthesis of 20-nor-Salvinorin A by Dynamic Strategic Bond Analysis","year":"2017","cit":0,"pfa":"Jeremy J. Roach","psa":"Ryan A. Shenvi","topics":["Addiction","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4231952833","eid":"W4231952833"},{"id":"paper-w3080389600","cat":"papers","name":"Chapter One. 1887: Dr. John Briggs Eats Some Peyote","year":"2019","cit":0,"pfa":"Alexander Dawson","ptype":"article","src":"https://openalex.org/W3080389600","eid":"W3080389600"},{"id":"paper-w2892368126","cat":"papers","name":"Neurobiology of psilocybin in the context of its potential therapeutic use","year":"2015","cit":0,"pfa":"Filip Tylš","ptype":"article","src":"https://openalex.org/W2892368126","eid":"W2892368126"},{"id":"paper-w3013419105","cat":"papers","name":"Long-Term Analysis of Psilocybin in Cancer Patients With Distress","year":"2020","cit":0,"pfa":"Richard Simoneaux","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3013419105","eid":"W3013419105"},{"id":"paper-w4396797833","cat":"papers","name":"Calls to Poison Centers Involving Psilocybin Rising in Youth","year":"2024","cit":0,"pfa":"Terri D’Arrigo","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4396797833","eid":"W4396797833"},{"id":"paper-w7208807862","cat":"papers","name":"Psilocybin as an emerging anxiolytic: mechanisms, evidence, and open questions","year":"2026","cit":0,"pfa":"Gerasimos Konstantinou","psa":"Stefan M. Kloiber","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7208807862","eid":"W7208807862"},{"id":"paper-w4386469766","cat":"papers","name":"EVALUATION OF THE THERAPEUTIC NEUROTOXIC EFFECTS OF THE USE OF AYAHUASCA BY DEPRESSIVE PATIENTS","year":"2023","cit":0,"pfa":"Catarina Rodrigues Damasceno Murucci","psa":"Cassius de Souza","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4386469766","eid":"W4386469766"},{"id":"paper-w4408712131","cat":"papers","name":"Participant experiences of therapeutic touch in psilocybin-assisted therapy","year":"2025","cit":0,"pfa":"Rachel Ham","psa":"Paul Liknaitzky","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4408712131","eid":"W4408712131"},{"id":"paper-w7117257845","cat":"papers","name":"Magic mushrooms and mood: exploring Psilocybin as a depression treatment","year":"2025","cit":0,"pfa":"M. Haseeb Ul Rasool","psa":"Muhammad Imam","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7117257845","eid":"W7117257845"},{"id":"paper-w7120447062","cat":"papers","name":"Individual contribution of single MDMA enantiomers of 3,4- methylenedioxymetamphetamine (MDMA) compared to racemic mixture in liver, kidney and striatal rats toxicity","year":"2012","cit":0,"pfa":"G Bosio","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7120447062","eid":"W7120447062"},{"id":"paper-w4250790111","cat":"papers","name":"Psychedelic Drugs and Personality","year":"2018","cit":0,"pfa":"James W. B. Elsey","psa":"Linos Vossoughi","ptype":"reference-entry","src":"https://openalex.org/W4250790111","eid":"W4250790111"},{"id":"paper-w4412702075","cat":"papers","name":"Effects of psilocybin and related compounds on neuroprotection in human stroke","year":"2025","cit":0,"pfa":"Ruslan Rust","ptype":"report","src":"https://openalex.org/W4412702075","eid":"W4412702075"},{"id":"paper-w7155456556","cat":"papers","name":"Effectiveness of Psilocybin in Treatment-Resistant Depression: A Systematic Review","year":"2026","cit":0,"pfa":"Roberta Matulevičiūtė","psa":"Gintarė Šiaudikytė","topics":["Depression","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7155456556","eid":"W7155456556"},{"id":"paper-w1020248353","cat":"papers","name":"Behavioural changes in rats exposed to perinatal MDMA","year":"2005","cit":0,"pfa":"Susanna Gyarmati","psa":"S Furts","ptype":"article","src":"https://openalex.org/W1020248353","eid":"W1020248353"},{"id":"paper-w2899418011","cat":"papers","name":"Elucidate the Neurotoxic Effects of MDMA & its analogues","year":"2014","cit":0,"pfa":"Senthilkumar S. Karuppagounder","psa":"Muralikrishnan Dhanasekaran","ptype":"article","src":"https://openalex.org/W2899418011","eid":"W2899418011"},{"id":"paper-w2409552543","cat":"papers","name":"A possible mechanism for the antischizophrenic action of chlorpromazine: inhibition of the formation of dimethyltryptamine by chlorpromazine metabolites.","year":"1974","cit":0,"pfa":"N. Narasimhachari","psa":"Lin Rl","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2409552543","eid":"W2409552543"},{"id":"paper-w4417514861","cat":"papers","name":"Alternative therapy for neurological and psychiatric disorders using psilocybin","year":"2025","cit":0,"pfa":"Henrique Tofoli Vieira Machado","psa":"Gabriella Assink de Castro","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"conference-abstract","src":"https://openalex.org/W4417514861","eid":"W4417514861"},{"id":"paper-w7126444817","cat":"papers","name":"The Use of Psilocybin in the Treatment of Depressive Disorders: A Narrative Review","year":"2026","cit":0,"pfa":"Lukasz Siwek","psa":"Paulina Wróblewska","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W7126444817","eid":"W7126444817"},{"id":"paper-w7203911426","cat":"papers","name":"The trials of translating psilocybin treatment from research to practice","year":"2026","cit":0,"pfa":"Liliana Galindo","psa":"Benjamin J. G. Illingworth","ptype":"article","src":"https://openalex.org/W7203911426","eid":"W7203911426"},{"id":"paper-w4200460234","cat":"papers","name":"P.0553 Effect of chronic microdosing of psilocin on cell proliferation and behavior in rats","year":"2021","cit":0,"pfa":"Lucie Olejníková","psa":"Tomáš Páleníček","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4200460234","eid":"W4200460234"},{"id":"paper-w4234124331","cat":"papers","name":"Clinical and Mechanistic Effects of Psilocybin in Alcohol Addicted Patients","year":"2019","cit":0,"topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4234124331","eid":"W4234124331"},{"id":"paper-w7170078939","cat":"papers","name":"The “dark magic mushroom” co-produces amatoxins and psilocybin","year":"2026","cit":0,"pfa":"Andrew R. Kunik","psa":"Matthew Edward Smith","ptype":"preprint","src":"https://openalex.org/W7170078939","eid":"W7170078939"},{"id":"paper-w2184971394","cat":"papers","name":"N,N-Dimethyltryptamine Production inPhalaris aquatica Seedlings MATHEMATICAL MODEL FOR ITSSYNTHESIS","year":"1988","cit":0,"pfa":"Joseph P. G. Mack","psa":"Dawn P. Mulvena","ptype":"article","src":"https://openalex.org/W2184971394","eid":"W2184971394"},{"id":"paper-w7155204523","cat":"papers","name":"US speeds up research into mind-altering drugs — including mysterious ‘ibogaine’","year":"2026","cit":0,"pfa":"Max Kozlov","ptype":"other","src":"https://openalex.org/W7155204523","eid":"W7155204523"},{"id":"paper-w2412792034","cat":"papers","name":"[Methochlopramide and reagents of the central nervous system (mescaline, tryptamine, morphine, tremorine, nicotine)].","year":"1966","cit":0,"pfa":"C Laville","psa":"J Margarit","ptype":"article","src":"https://openalex.org/W2412792034","eid":"W2412792034"},{"id":"paper-w4406664194","cat":"papers","name":"Peyote: Neurochemistry, Psychological Effects, Cultural Aspects, Religious Perspectives, and Legality","year":"2025","cit":0,"pfa":"Emma David","psa":"H. Russell Searight","topics":["Policy & ethics"],"ptype":"reference-entry","src":"https://openalex.org/W4406664194","eid":"W4406664194"},{"id":"paper-w2810389180","cat":"papers","name":"Development of an analytical method for determination and identification of mescaline in plant and biological material","year":"2017","cit":0,"pfa":"Lucie Skácelová","ptype":"article","src":"https://openalex.org/W2810389180","eid":"W2810389180"},{"id":"paper-w2950711844","cat":"papers","name":"ChemInform Abstract: Dihydrobenzofuran Analogues of Hallucinogens. Part 4. Mescaline Derivatives.","year":"1998","cit":0,"pfa":"Aaron P. Monte","psa":"David E. Nichols","ptype":"article","src":"https://openalex.org/W2950711844","eid":"W2950711844"},{"id":"paper-w7113035064","cat":"papers","name":"A qualitative study about treatment of substance abuse with the natural remedy Ibogaine","year":"2010","cit":0,"pfa":"Andersson, Sofie","psa":"Angefred, Kristina","topics":["Addiction"],"ptype":"dissertation","src":"https://openalex.org/W7113035064","eid":"W7113035064"},{"id":"paper-w7167725754","cat":"papers","name":"Psychedelics and Ibogaine “Pain Medications” at the Pharmacy Counter: Implications for Pharmacy Practice","year":"2026","cit":0,"pfa":"Frank Breve","psa":"Robert B. Raffa","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7167725754","eid":"W7167725754"},{"id":"paper-w7204238876","cat":"papers","name":"Endogenous Dimethyltryptamine Reconsidered: A Constraint-Based Trace Amine Ensemble Model","year":"2026","cit":0,"pfa":"Lester H. LaCombe II","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7204238876","eid":"W7204238876"},{"id":"paper-w4409030909","cat":"papers","name":"Corrigendum: Ayahuasca-induced personal death experiences: prevalence, characteristics, and impact on attitudes toward death, life, and the environment","year":"2025","cit":0,"pfa":"Jonathan David","psa":"Aviva Berkovich‐Ohana","ptype":"erratum","src":"https://openalex.org/W4409030909","eid":"W4409030909"},{"id":"paper-w7171931510","cat":"papers","name":"Cardiovascular safety of psilocybin in psychiatric practice: a narrative review","year":"2026","cit":0,"pfa":"Łukasz Szarpak","psa":"Wiesław Jerzy Cubała","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7171931510","eid":"W7171931510"},{"id":"paper-w2404898033","cat":"papers","name":"[ACTION OF CHLORPROMAZINE AND PSILOCYBIN ON THE TELENCEPHALIC AROUSAL REACTION OF A DIPNOAN].","year":"1964","cit":0,"pfa":"R Godet","psa":"J Bert","ptype":"article","src":"https://openalex.org/W2404898033","eid":"W2404898033"},{"id":"paper-w7164245578","cat":"papers","name":"Linking Psilocybin Biosynthesis to Antimicrobial and Larvicidal Activity in Psilocybe cubensis","year":"2026","cit":0,"pfa":"August Schanno","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7164245578","eid":"W7164245578"},{"id":"paper-w7201840591","cat":"papers","name":"Single-crystal structure determination of psilocybin after dehydration","year":"2026","cit":0,"pfa":"Sonya K. Emmett","psa":"Stephen A. Moggach","ptype":"article","src":"https://openalex.org/W7201840591","eid":"W7201840591"},{"id":"paper-w3150452335","cat":"papers","name":"Psilocybin Use in the Future Psychiatric Practice: A Comprehensive Review","year":"2019","cit":0,"pfa":"Anthony Ceman","topics":["Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W3150452335","eid":"W3150452335"},{"id":"paper-w4401380403","cat":"papers","name":"Efficacy of Psilocybin in the Treatment of Substance and Alcohol Use Disorders","year":"2024","cit":0,"pfa":"Hanna Brancaccio","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"conference-paper","src":"https://openalex.org/W4401380403","eid":"W4401380403"},{"id":"paper-w7119426820","cat":"papers","name":"The brew and the settings : the experience of being in psychoterapy and participating in ayahuasca rituals","year":"2018","cit":0,"pfa":"Ana Carolina Simão","ptype":"dissertation","src":"https://openalex.org/W7119426820","eid":"W7119426820"},{"id":"paper-w7119407556","cat":"papers","name":"Opportunities for improving spiritual centers for the development of ayahuasca tourism in Pucallpa","year":"2025","cit":0,"pfa":"Alexandra Martinez Matamoros","psa":"Yanire Sarai Davila Uriarte","ptype":"dissertation","src":"https://openalex.org/W7119407556","eid":"W7119407556"},{"id":"paper-w7166059922","cat":"papers","name":"Global pressure on ayahuasca threatens Amazonian plants and knowledge systems","year":"2026","cit":0,"pfa":"Carlos Minuano","ptype":"other","src":"https://openalex.org/W7166059922","eid":"W7166059922"},{"id":"paper-w4415200851","cat":"papers","name":"A percepção temporal no uso ritual da ayahuasca e rapé","year":"2025","cit":0,"pfa":"Ana Paula Silva Campagnoli","ptype":"dissertation","src":"https://openalex.org/W4415200851","eid":"W4415200851"},{"id":"paper-w4394156530","cat":"papers","name":"Ayahuasca and Public Health II. Supporting information 2: Database","year":"2022","cit":0,"pfa":"Maja Kohek","psa":"Miguel Ángel Alcázar‐Córcoles","ptype":"dataset","src":"https://openalex.org/W4394156530","eid":"W4394156530"},{"id":"paper-w4249566955","cat":"papers","name":"Out of the jungle and onto the couch: Integrating Ayahuasca into psychoanalytic treatment","year":"2010","cit":0,"pfa":"Stephen Trichter","ptype":"dataset","src":"https://openalex.org/W4249566955","eid":"W4249566955"},{"id":"paper-w2463824988","cat":"papers","name":"[The psychomimetic effects of LSD and psilocybin in the clinical exploration of the personality].","year":"1963","cit":0,"pfa":"Aldaheff Bw","ptype":"article","src":"https://openalex.org/W2463824988","eid":"W2463824988"},{"id":"paper-w1983955647","cat":"papers","name":"The Peyote Road: Religious Freedom and the Native American Church by Thomas C. Maroukis (review)","year":"2013","cit":0,"pfa":"William M. Clements","topics":["Anxiety & end-of-life","Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1983955647","eid":"W1983955647"},{"id":"paper-w69749986","cat":"papers","name":"Breaking the Habit; An Evaluation of Ibogaine as a Viable Treatment for Opioid Dependence and Withdrawal","year":"2014","cit":0,"pfa":"M.A. Styles","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W69749986","eid":"W69749986"},{"id":"paper-w4312206785","cat":"papers","name":"High dose of psilocybin effective for treatment‐resistant depression","year":"2022","cit":0,"topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4312206785","eid":"W4312206785"},{"id":"paper-w3035195363","cat":"papers","name":"Scoping Review Protocol: Mapping Psilocybin Therapy Research","year":"2020","cit":0,"pfa":"Ron Joseph Shore","psa":"Craig E. Goldie","topics":["Reviews & meta-analyses"],"ptype":"other","src":"https://openalex.org/W3035195363","eid":"W3035195363"},{"id":"paper-w4392283305","cat":"papers","name":"Corrigendum to: Indigenous psilocybin mushroom practices: An annotated bibliography","year":"2024","cit":0,"pfa":"Nicholas Spiers","psa":"Nidia Olvera","ptype":"erratum","src":"https://openalex.org/W4392283305","eid":"W4392283305"},{"id":"paper-w4243758738","cat":"papers","name":"0159 Acute Effects of 3,4-methylenedioxymethamphetamine (MDMA) And R(−)MDMA on Actigraphy-based Daytime Activity and Sleep Parameters in Rhesus Monkeys","year":"2018","cit":0,"pfa":"Lais Fernanda Berro","psa":"Leonard Lee Howell","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4243758738","eid":"W4243758738"},{"id":"paper-w4300060754","cat":"papers","name":"Psilocybin for depression and anxiety associated with life-threatening illnesses","year":"2020","cit":0,"pfa":"B.L. Roth","psa":"J.D. McCorvy","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4300060754","eid":"W4300060754"},{"id":"paper-w4401865239","cat":"papers","name":"Refractory CRPS pain treated with psilocybin: a case report","year":"2024","cit":0,"pfa":"David S. Jevotovsky","psa":"Joel P Castellanos","topics":["Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4401865239","eid":"W4401865239"},{"id":"paper-w2462307363","cat":"papers","name":"[PSYCHOMIMETIC SUBSTANCES. (CONTRIBUTION TO THE CLINICAL PSYCHOPATHOLOGICAL STUDY OF PSILOCYBIN)].","year":"1963","cit":0,"pfa":"Giorgio Sogliani","psa":"G M Buoso","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2462307363","eid":"W2462307363"},{"id":"paper-w4245208197","cat":"papers","name":"Study: Psilocybin enhances therapy in patients with major depression","year":"2021","cit":0,"topics":["Depression","Anxiety & end-of-life","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4245208197","eid":"W4245208197"},{"id":"paper-w3202550363","cat":"papers","name":"Psilocybin: Next to treat depression, OCD and nicotine addiction","year":"2021","cit":0,"pfa":"Alison Knopf","topics":["Depression","Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3202550363","eid":"W3202550363"},{"id":"paper-w4416717006","cat":"papers","name":"Psilocybin reduces comorbid chronic pain and depression in mice","year":"2025","cit":0,"pfa":"Jorge Ferreira","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4416717006","eid":"W4416717006"},{"id":"paper-w4200447646","cat":"papers","name":"P.0620 Psilocybin as a treatment of addictions: a review of the literature","year":"2021","cit":0,"pfa":"Melissa Alfafar","psa":"Felipe De Pontes","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4200447646","eid":"W4200447646"},{"id":"paper-w1603999042","cat":"papers","name":"Formation en Ethnopharmacologie appliquée Promotion \"Ayahuasca\" septembre 1999","year":"2002","cit":0,"pfa":"Guy Lesoeurs","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W1603999042","eid":"W1603999042"},{"id":"paper-w2607260594","cat":"papers","name":"Is Ayahuasca a Potential Ethnic Plant for the Treatment of ParkinsonâÂÂs Disease?","year":"2017","cit":0,"pfa":"Juan Perucho","psa":"Marı́a José Casarejos","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2607260594","eid":"W2607260594"},{"id":"paper-w2965249736","cat":"papers","name":"Review: The Tawny One: Soma, Haoma, Ayahuasca by Matthew Clark","year":"2019","cit":0,"pfa":"Chris Elcock","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2965249736","eid":"W2965249736"},{"id":"paper-w7134237830","cat":"papers","name":"Effects of ayahuasca on neuropsychological performance and social cognition: A systematic review","year":"2026","cit":0,"pfa":"Caio Cesar de Paula","psa":"RAFAEL GUIMARÃES DOS SANTOS","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7134237830","eid":"W7134237830"},{"id":"paper-w7154491146","cat":"papers","name":"Sleep Blinding Psilocybin, a feasibility study: Examining if participants can tell if they received psilocybin or a placebo when medication is given to act in sleep","year":"2026","cit":0,"pfa":"Raphael Paul Rifkin-Zybutz","ptype":"dataset","src":"https://openalex.org/W7154491146","eid":"W7154491146"},{"id":"paper-w4406756885","cat":"papers","name":"Ayahuasca (Banisteriopsis caapi (Spruce ex Griseb.) Morton Malpighiaceae)","year":"2025","cit":0,"pfa":"Noureddine Chaachouay","psa":"Lahcen Zidane","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W4406756885","eid":"W4406756885"},{"id":"paper-w7125645280","cat":"papers","name":"Ayahuasca reverses ischemic stroke-induced neuroinflammation and oxidative stress","year":"2025","cit":0,"pfa":"Larissa da Silva Joaquim","psa":"Rafael Mariano de Bitencourt","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W7125645280","eid":"W7125645280"},{"id":"paper-w2415857118","cat":"papers","name":"[OUR CLINICAL EXPERIENCE WITH A NEW PHARMACOLOGICAL PREPARATION PSILOCYBIN].","year":"1963","cit":0,"pfa":"D Dordević","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2415857118","eid":"W2415857118"},{"id":"paper-w4412327862","cat":"papers","name":"Klassiske psykedeliske stoffer - inkl. psilocybin og LSD","year":"2020","cit":0,"pfa":"Morten Hesse","ptype":"book-chapter","src":"https://openalex.org/W4412327862","eid":"W4412327862"},{"id":"paper-w4415055785","cat":"papers","name":"Control group improvement lower in psilocybin trials for depression","year":"2025","cit":0,"topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4415055785","eid":"W4415055785"},{"id":"paper-w4407068569","cat":"papers","name":"Oregon’s Emerging Psilocybin Services Workforce: An Environmental Scan","year":"2025","cit":0,"pfa":"Kellie Pertl","psa":"Philip Todd Korthuis","ptype":"article","src":"https://openalex.org/W4407068569","eid":"W4407068569"},{"id":"paper-w4388850907","cat":"papers","name":"Psilocybin therapy to reduce depression following a terminal diagnosis","year":"2023","cit":0,"pfa":"Elizabeth Boudreau","psa":"Krissa Orlowski","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4388850907","eid":"W4388850907"},{"id":"paper-w3164081616","cat":"papers","name":"Unmet need in depression: Psilocybin, a breakthrough treatment option","year":"2021","cit":0,"pfa":"Yogesh Kumar Chahar","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3164081616","eid":"W3164081616"},{"id":"paper-w7106800949","cat":"papers","name":"Akzeptanz psilocybin-assistierter Therapie in den deutschsprachigen Ländern","year":"2025","cit":0,"pfa":"Hartter, Nina","psa":"Jungaberle, Henrik","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W7106800949","eid":"W7106800949"},{"id":"paper-w4414179982","cat":"papers","name":"Psilocybin: Systematic review of its use in the treatment of depression","year":"2025","cit":0,"pfa":"Pilar Andrés-Olivera","psa":"B. Arribas-Simón","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W4414179982","eid":"W4414179982"},{"id":"paper-w4398165704","cat":"papers","name":"Effect of Intravenous Delivery of N,N Dimethyltryptamine on Sleep-Wake States in Rat","year":"2024","cit":0,"pfa":"Rachel Summerfield","psa":"Dinesh Pal","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4398165704","eid":"W4398165704"},{"id":"paper-w7165746513","cat":"papers","name":"A Critical Evaluation of the Hypothesis that N,N-Dimethyltryptamine has Endogenous Functions","year":"2026","cit":0,"pfa":"Ramiro Solis","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7165746513","eid":"W7165746513"},{"id":"paper-w2951228407","cat":"papers","name":"ChemInform Abstract: STUDIES ON SEVERAL 7‐SUBSTITUTED N,N‐DIMETHYLTRYPTAMINES","year":"1981","cit":0,"pfa":"Richard A. Glennon","psa":"John A. Rosecrans","ptype":"article","src":"https://openalex.org/W2951228407","eid":"W2951228407"},{"id":"paper-w7110545371","cat":"papers","name":"Psilocybin unterstützte Psychotherapie zur Behandlung depressiver Erkrankungen","year":"2025","cit":0,"pfa":"Schulz, Julian Vincent","topics":["Depression","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W7110545371","eid":"W7110545371"},{"id":"paper-w7165504588","cat":"papers","name":"Expectancy Effects in Naturalistic Psilocybin Use in a Dutch Smartshop","year":"2026","cit":0,"pfa":"Michiel van Elk","psa":"Hannah Friedrich","topics":["Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W7165504588","eid":"W7165504588"},{"id":"paper-w4414175451","cat":"papers","name":"Reappraisal of the hype and hope offered by psilocybin treatment of depression","year":"2025","cit":0,"pfa":"Ben Beaglehole","psa":"Jenni Manuel","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4414175451","eid":"W4414175451"},{"id":"paper-w4409054606","cat":"papers","name":"Changes in Brain Structure and Age in Veterans With TBI After Treatment With Magnesium-Ibogaine","year":"2025","cit":0,"pfa":"Maheen M. Adamson","ptype":"article","src":"https://openalex.org/W4409054606","eid":"W4409054606"},{"id":"paper-w7162773192","cat":"papers","name":"Bases ecológicas para la conservación del peyote queretano en México","year":"2026","cit":0,"pfa":"Humberto Romero-Jiménez","psa":"Pablito Marcelo López-Serrano","ptype":"article","src":"https://openalex.org/W7162773192","eid":"W7162773192"},{"id":"paper-w2948557694","cat":"papers","name":"MDMA-induced neurotoxicity: neurochemestry, EEG & histopathology.","year":"2004","cit":0,"pfa":"Francesco Fornai","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2948557694","eid":"W2948557694"},{"id":"paper-w2222609130","cat":"papers","name":"Does MDMA impair inhibitory executive functioning","year":"2008","cit":0,"pfa":"P. Murphy","psa":"Catharine Montgomery","ptype":"conference-paper","src":"https://openalex.org/W2222609130","eid":"W2222609130"},{"id":"paper-w3173033642","cat":"papers","name":"El nudo gordiano del MDMA (Éxtasis)","year":"2021","cit":0,"pfa":"Juan Enrique Fernández Romar","psa":"Leticia Aszkinas Browarsk","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3173033642","eid":"W3173033642"},{"id":"paper-w4394249365","cat":"papers","name":"Ayahuasca and Public Health II. Supporting information 2: Database","year":"2022","cit":0,"pfa":"Maja Kohek","psa":"Miguel Ángel Alcázar‐Córcoles","ptype":"dataset","src":"https://openalex.org/W4394249365","eid":"W4394249365"},{"id":"paper-w4234222167","cat":"papers","name":"Psilocybin and Quantum Change in Attitude and Behavior: Treatment Implications","year":"2010","cit":0,"pfa":"Roland R. Griffiths","psa":"Matthew W. Johnson","ptype":"dataset","src":"https://openalex.org/W4234222167","eid":"W4234222167"},{"id":"paper-w7205494802","cat":"papers","name":"Psilocybin Production With Genetically Modified Under Pressurized Conditions","year":"2025","cit":0,"pfa":"Sophie Weiser","psa":"Lars Regestein","ptype":"article","src":"https://openalex.org/W7205494802","eid":"W7205494802"},{"id":"paper-w3016902642","cat":"papers","name":"c‐Fos Responses Produced by the Central Microinjection of Salvinorin B in Conscious Rats","year":"2020","cit":0,"pfa":"Aboozar B. Ali","psa":"Gottlieb B. Helmut","topics":["Addiction","Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W3016902642","eid":"W3016902642"},{"id":"paper-w7154872659","cat":"papers","name":"Oregon's Psilocybin Services: A Summary and Public Health Commentary.","year":"2026","cit":0,"pfa":"Cassidy R. LoParco","psa":"Carla J Berg","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7154872659","eid":"W7154872659"},{"id":"paper-w2601172397","cat":"papers","name":"The effect of metabolites of MDMA (ecstasy) on vasopressin release in vitro.","year":"2001","cit":0,"pfa":"Mary L. Forsling","psa":"David Cowan","ptype":"article","src":"https://openalex.org/W2601172397","eid":"W2601172397"},{"id":"paper-w7133090070","cat":"papers","name":"Psilocybin: Historical and pharmacological perspective and current authorized research","year":"2009","cit":0,"pfa":"David Serrano Hurtado","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7133090070","eid":"W7133090070"},{"id":"paper-w4396793982","cat":"papers","name":"Psilocybin Therapy May Work as Well as Common Antidepressant","year":"2021","cit":0,"pfa":"Zoe Cormier","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4396793982","eid":"W4396793982"},{"id":"paper-w2746202855","cat":"papers","name":"10-step Synthesis of 20-nor-Salvinorin A by Dynamic Strategic Bond Analysis","year":"2017","cit":0,"pfa":"Jeremy J. Roach","psa":"Ryan A. Shenvi","topics":["Addiction","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W2746202855","eid":"W2746202855"},{"id":"paper-w4409088113","cat":"papers","name":"Pharmacology and Chemistry of Collybolide, Salvinorin A, and Mitragynine: Natural Product-Based Pain Therapeutics","year":"2025","cit":0,"pfa":"Uzman Khan","psa":"Ayesha Aslam","topics":["Dosing & pharmacology"],"ptype":"dataset","src":"https://openalex.org/W4409088113","eid":"W4409088113"},{"id":"paper-w2431997414","cat":"papers","name":"[Effect of psychodysleptics (LSD and mescaline) on the nymphal diapauses of Pieris brassicae (Lepidoptera Pieridae)].","year":"1972","cit":0,"pfa":"M. Vuillaume","psa":"Jacqueline Seugé","ptype":"article","src":"https://openalex.org/W2431997414","eid":"W2431997414"},{"id":"paper-w4389566642","cat":"papers","name":"CHIẾT XUẤT PSILOCIN TỪ NẤM THỨC THẦN LÀM NGUYÊN LIỆU THIẾT LẬP CHUẨN","year":"2023","cit":0,"pfa":"Nguyên Hà Trần","psa":"Nguyễn Xuân Trường","ptype":"article","src":"https://openalex.org/W4389566642","eid":"W4389566642"},{"id":"paper-w829577229","cat":"papers","name":"An evaluation of the purported anti-craving effects of ibogaine, and comparative studies employing harmaline","year":"1989","cit":0,"pfa":"Michael Gintowt","topics":["Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W829577229","eid":"W829577229"},{"id":"paper-w4407387063","cat":"papers","name":"EFFECT OF ACUTE PSILOCYBIN ON THERMAL AND NEUROPATHIC PAIN IN RODENTS","year":"2025","cit":0,"pfa":"Martha-Lopez Canul","psa":"Gabriella Gobbi","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4407387063","eid":"W4407387063"},{"id":"paper-w4411163945","cat":"papers","name":"Is there mush-room to improve the environmental sustainability of psilocybin production?","year":"2025","cit":0,"pfa":"Luke Lanham","psa":"James Robert Falconer","topics":["Depression","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4411163945","eid":"W4411163945"},{"id":"paper-w7119152842","cat":"papers","name":"Psilocybin shapes neural plasticity in selective brain networks","year":"2026","cit":0,"pfa":"Siân Lewis","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7119152842","eid":"W7119152842"},{"id":"paper-w7160532923","cat":"papers","name":"Psilocybin for PTSD with or without Psychotherapy: A Pilot study of safety and efficacy outcomes – The first characterization of nightmare burden in PTSD following psilocybin administration","year":"2026","cit":0,"pfa":"Zarmeen Zahid","psa":"Sandeep Manel Nayak","topics":["PTSD & trauma","Safety & adverse events","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7160532923","eid":"W7160532923"},{"id":"paper-w2598547342","cat":"papers","name":"Holotropic Medicine, Stan Grof’s Influence on MDMA Research","year":"2014","cit":0,"pfa":"Michael C. Mithoefer","psa":"Annie Mithoefer","topics":["PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2598547342","eid":"W2598547342"},{"id":"paper-w4404554571","cat":"papers","name":"Behavioural Effects of High Doses of Psilocybin in Female Rats","year":"2024","cit":0,"pfa":"Larissa Rocha","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W4404554571","eid":"W4404554571"},{"id":"paper-w3137635019","cat":"papers","name":"Psicoestimulantes : cocaína, anfetamina, MDMA, metilxantinas y nicotina","year":"2012","cit":0,"pfa":"Diego Redolar Ripoll","ptype":"article","src":"https://openalex.org/W3137635019","eid":"W3137635019"},{"id":"paper-w2577571642","cat":"papers","name":"Influences of social stress in the rewarding effects of mdma and alcohol","year":"2015","cit":0,"pfa":"García Pardo","psa":"María Pilar","topics":["Addiction","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2577571642","eid":"W2577571642"},{"id":"paper-w2971180952","cat":"papers","name":"Methylenedioxymethamphetamine (MDMA) Overdose at Rave Parties, a Case Series","year":"2019","cit":0,"pfa":"Kia Nikoomanesh","psa":"Sarkis Arabian","topics":["Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W2971180952","eid":"W2971180952"},{"id":"paper-w4389611461","cat":"papers","name":"Kültürel Miras ile Uyuşturucu Madde Tartışmaları Arasında Ayahuasca","year":"2023","cit":0,"pfa":"Nadide Şahin","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4389611461","eid":"W4389611461"},{"id":"paper-w4410345144","cat":"papers","name":"Relatos do uso terapêutico do chá de Ayahuasca","year":"2025","cit":0,"pfa":"Eliza Maria Bonot","psa":"Mariana Pereira de Souza Goldim","ptype":"article","src":"https://openalex.org/W4410345144","eid":"W4410345144"},{"id":"paper-w2985015069","cat":"papers","name":"Perfil de compostos fenólicos e alcaloides da ayahuasca","year":"2018","cit":0,"pfa":"Júlia Krentkovski Menna Barreto","ptype":"dissertation","src":"https://openalex.org/W2985015069","eid":"W2985015069"},{"id":"paper-w2966518464","cat":"papers","name":"CHÁ DA AYAHUASCA: UMA REVISÃO DOS ASPECTOS TOXICOLÓGICOS","year":"2017","cit":0,"pfa":"Rosane Andrade Cezaro","psa":"Heber Amilcar Martins","ptype":"article","src":"https://openalex.org/W2966518464","eid":"W2966518464"},{"id":"paper-w7135868658","cat":"papers","name":"Organized experience with ayahuasca in the Czech Republic from the perspective of users","year":"2024","cit":0,"pfa":"Veronika Chvostová","topics":["Addiction","Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W7135868658","eid":"W7135868658"},{"id":"paper-w4286714051","cat":"papers","name":"La Native American Church, l'anthropologie états-unienne et le peyote","year":"2021","cit":0,"pfa":"Thomas Grillot","ptype":"article","src":"https://openalex.org/W4286714051","eid":"W4286714051"},{"id":"paper-w4394317592","cat":"papers","name":"A Validated NMR Approach for MDMA Quantification in Ecstasy Tablets","year":"2018","cit":0,"pfa":"Nathália Siqueira Almeida","psa":"Aline Oliveira","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W4394317592","eid":"W4394317592"},{"id":"paper-w4385669353","cat":"papers","name":"The therapeutic potential of psilocybin in depression resistant to psychotropic drugs","year":"2023","cit":0,"pfa":"J. Ramirez Gonzalez","psa":"E. Miranda Ruiz","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4385669353","eid":"W4385669353"},{"id":"paper-w7196940780","cat":"papers","name":"Mapping excitatory synaptic plasticity evoked by single-dose psilocybin in mice","year":"2026","cit":0,"pfa":"Ziming Li","psa":"Linda D. Simmler","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7196940780","eid":"W7196940780"},{"id":"paper-w2395290981","cat":"papers","name":"[Initial results of the action of psilocybin in a group of psychiatric patients].","year":"1998","cit":0,"pfa":"Reda Gc","psa":"Luigi Cancrini","ptype":"article","src":"https://openalex.org/W2395290981","eid":"W2395290981"},{"id":"paper-w7124268562","cat":"papers","name":"Psilocybin-Therapie vorteilhaft für Stimmungsstörungen von Parkinsonkranken","year":"2026","cit":0,"topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7124268562","eid":"W7124268562"},{"id":"paper-w4289781881","cat":"papers","name":"Med Check: Psilocybin for OCD, Nuplazid Vote, and More","year":"2022","cit":0,"pfa":"Terri D’Arrigo","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4289781881","eid":"W4289781881"},{"id":"paper-w4387616208","cat":"papers","name":"Assessing Metro Vancouver Residents’ Knowledge and Opinions of Psilocybin","year":"2023","cit":0,"pfa":"Payman Baharmand","psa":"Amardeep Kambo","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4387616208","eid":"W4387616208"},{"id":"paper-w4396688147","cat":"papers","name":"The Psilocybin Connection: Psychedelics, the Transformation of Consciousness, and Evolution on the Planet","year":"2024","cit":0,"pfa":"Barri Babow","ptype":"article","src":"https://openalex.org/W4396688147","eid":"W4396688147"},{"id":"paper-w4247289982","cat":"papers","name":"MDMA modifies active avoidance learning and recall in mice","year":"2008","cit":0,"pfa":"José Manuel Trigo","psa":"Patricia Robledo","ptype":"article","src":"https://openalex.org/W4247289982","eid":"W4247289982"},{"id":"paper-w7112455977","cat":"papers","name":"Iboga‐Indole Alkaloids as Potential Plasmodial Inhibitors: Identification, Biosynthesis, and Molecular Docking Studies","year":"2025","cit":0,"pfa":"Joel Loveridge","ptype":"article","src":"https://openalex.org/W7112455977","eid":"W7112455977"},{"id":"paper-w4415774856","cat":"papers","name":"La patrimonialización del uso de ayahuasca en Perú","year":"2025","cit":0,"pfa":"Kinga Kowalczyk","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4415774856","eid":"W4415774856"},{"id":"paper-w2801570862","cat":"papers","name":"Giovanni Lattanzi’s Reinvented Toltecs, Science, and Dislocution: Critical Discussion of the Monograph Kambo and Iboga (2016)","year":"2018","cit":0,"pfa":"Stefano Bigliardi","ptype":"article","src":"https://openalex.org/W2801570862","eid":"W2801570862"},{"id":"paper-w2760676887","cat":"papers","name":"O uso da ayahuasca na dependência do crack","year":"2013","cit":0,"pfa":"Joselaine Ida da Cruz","ptype":"article","src":"https://openalex.org/W2760676887","eid":"W2760676887"},{"id":"paper-w4407946697","cat":"papers","name":"Open MDMA: An Evidence-Based Synthesis, Theory, and Manual for MDMA Therapy Based on Memory Reconsolidation, Complex Systems, and the Defense Cascade","year":"2024","cit":0,"pfa":"Mark Groeneveld","psa":"Thomas Harper","topics":["Safety & adverse events","Mechanism & neuroscience","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4407946697","eid":"W4407946697"},{"id":"paper-w2565904641","cat":"papers","name":"Amada’s Blessings from the Peyote Gardens of South Texas by Stacy B. Schaefer","year":"2016","cit":0,"pfa":"Teresa Palomo Acosta","topics":["Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2565904641","eid":"W2565904641"},{"id":"paper-w2414748387","cat":"papers","name":"BEM-ESTAR SUBJETIVO E QUALIDADE DE VIDA EM ADEPTOS DE AYAHUASCA BIENESTAR SUBJETIVO Y CALIDAD DE VIDA DE LOS SEGUIDORES DE LA AYAHUASCA SUBJECTIVE WELL-BEING AND QUALITY OF LIFE FOR FOLLOWERS OF AYAHUASCA","year":"2014","cit":0,"pfa":"Cleber Lizardo de Assis","psa":"Tenório Lins","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2414748387","eid":"W2414748387"},{"id":"paper-w17011483","cat":"papers","name":"The effect of metabolites of MDMA ('ecstasy') on the release of vasopressin in vitro","year":"2001","cit":0,"pfa":"Mary L. Forsling","psa":"David Cowan","ptype":"article","src":"https://openalex.org/W17011483","eid":"W17011483"},{"id":"paper-w2804362033","cat":"papers","name":"MDMA-Facilitated Psychotherapy for Chronic PTSD: A Pilot Study","year":"2018","cit":0,"pfa":"Peter Roy‐Byrne","topics":["PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2804362033","eid":"W2804362033"},{"id":"paper-w4246818956","cat":"papers","name":"Caiuby Labate Beatriz and Henrik Jungaberle (eds), The internationalization of ayahuasca","year":"2013","cit":0,"pfa":"David Dupuis","ptype":"article","src":"https://openalex.org/W4246818956","eid":"W4246818956"},{"id":"paper-w2726675387","cat":"papers","name":"A ayahuasca como locus mediterraneus da América do Sul","year":"2015","cit":0,"pfa":"Janaína Alexandra Capistrano da Costa","topics":["Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W2726675387","eid":"W2726675387"},{"id":"paper-w4389985589","cat":"papers","name":"Is there credible evidence to assert psilocybin-assisted therapy for depression?","year":"2023","cit":0,"pfa":"Guilherme Nobre Nogueira","psa":"Luísa Weber Bisol","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4389985589","eid":"W4389985589"},{"id":"paper-w7129082326","cat":"papers","name":"The Effects of Educational Materials on Knowledge and Attitudes Toward Psilocybin","year":"2025","cit":0,"pfa":"Lindsey Elise Wade","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W7129082326","eid":"W7129082326"},{"id":"paper-w4402730334","cat":"papers","name":"Psilocybin for Alcohol Use Disorder (AUD): a systematic review","year":"2024","cit":0,"pfa":"shuai wang","psa":"Zushen Wang","topics":["Addiction","Reviews & meta-analyses"],"ptype":"report","src":"https://openalex.org/W4402730334","eid":"W4402730334"},{"id":"paper-w4413834957","cat":"papers","name":"Psilocybin-occasioned Mystical-Type Experiences and Mental Wellness","year":"2025","cit":0,"pfa":"Romesha Uduwawela","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"dissertation","src":"https://openalex.org/W4413834957","eid":"W4413834957"},{"id":"paper-w7136253679","cat":"papers","name":"Explainable AI framework for psilocybin depression treatment optimization","year":"2026","cit":0,"pfa":"Akey Sungheetha","psa":"P. D. Mahendhiran","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7136253679","eid":"W7136253679"},{"id":"paper-w7159562383","cat":"papers","name":"Cardiovascular safety of ibogaine in adults: a systematic review of the clinical evidence, 1990–2026","year":"2026","cit":0,"pfa":"Kadir Singer","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7159562383","eid":"W7159562383"},{"id":"paper-w2201071940","cat":"papers","name":"Aspects psychologiques des consommateurs de MDMA (ecstasy)","year":"2003","cit":0,"pfa":"Isabelle Varescon","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2201071940","eid":"W2201071940"},{"id":"paper-w2078937482","cat":"papers","name":"MDMA ('Ecstasy') impairs categorization of brief fearful expressions","year":"2010","cit":0,"pfa":"Matthew J. Baggott","psa":"John E. Mendelson","ptype":"article","src":"https://openalex.org/W2078937482","eid":"W2078937482"},{"id":"paper-w4214562531","cat":"papers","name":"Ayahuasca -- Bridging Worlds: Exploring Indigenous Practices for Modern Applications","year":"2009","cit":0,"pfa":"Stephen Trichter","ptype":"dataset","src":"https://openalex.org/W4214562531","eid":"W4214562531"},{"id":"paper-w7135921348","cat":"papers","name":"The meaning of 3,4-Methylenedioxymethamphetamine (MDMA) use in romantic relationships","year":"2020","cit":0,"pfa":"Hana Tenglerová","topics":["Addiction","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W7135921348","eid":"W7135921348"},{"id":"paper-w4414499628","cat":"papers","name":"MDMA no tratamento de Transtornos Depressivos: revisão sistemática","year":"2025","cit":0,"pfa":"Vinícius Nascimento Cavalcante da Silva","psa":"Sandra Regina Mota Ortiz","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4414499628","eid":"W4414499628"},{"id":"paper-w7172475920","cat":"papers","name":"When the Vine Speaks: Ayahuasca-Induced Voices and the Boundaries of Hallucination","cit":0,"pfa":"David Dupuis","psa":"Charles Fernyhough","ptype":"article","src":"https://openalex.org/W7172475920","eid":"W7172475920"},{"id":"paper-w4310033391","cat":"papers","name":"Fast and sustained effect of 2 administrations of psilocybin on depression","year":"2022","cit":0,"pfa":"Marten Dooper","topics":["Depression"],"ptype":"conference-paper","src":"https://openalex.org/W4310033391","eid":"W4310033391"},{"id":"paper-w4412955867","cat":"papers","name":"Evaluating Psilocybin as a Treatment for Neuropsychiatric Symptoms in Parkinson’s Disease","year":"2025","cit":0,"pfa":"Nayiri Barton","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4412955867","eid":"W4412955867"},{"id":"paper-w292012046","cat":"papers","name":"Análogos de la Ayahuasca: El enteógeno de Pangea","year":"2000","cit":0,"pfa":"Joaquim Tarinas","ptype":"article","src":"https://openalex.org/W292012046","eid":"W292012046"},{"id":"paper-w1978147043","cat":"papers","name":"A Hallucinogenic Tea, Laced with Controversy: Ayahuasca in the Amazon and the United States","year":"2011","cit":0,"pfa":"David P. Luke","ptype":"article","src":"https://openalex.org/W1978147043","eid":"W1978147043"},{"id":"paper-w4394692398","cat":"papers","name":"Iboga e Ibogaína no Brasil: Uso contemporâneo de uma planta ancestral","year":"2024","cit":0,"pfa":"GOMES B.R.","psa":"OBAME L.E.","ptype":"book","src":"https://openalex.org/W4394692398","eid":"W4394692398"},{"id":"paper-w4414597646","cat":"papers","name":"FDA publicly releases MDMA rejection letter; MAPS vows to press forward","year":"2025","cit":0,"pfa":"Valerie A. Canady","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4414597646","eid":"W4414597646"},{"id":"paper-w2330507919","cat":"papers","name":"Washo-Peyote Songs; Songs of the American Indian Native Church-Peyotist","year":"1976","cit":0,"pfa":"Charlotte Heth","psa":"Warren L. D'Azevedo","ptype":"article","src":"https://openalex.org/W2330507919","eid":"W2330507919"},{"id":"paper-w188407748","cat":"papers","name":"What Should Christians Take from the Native American Church Peyote Ceremony","year":"2011","cit":0,"pfa":"Brian Rajcok","ptype":"conference-paper","src":"https://openalex.org/W188407748","eid":"W188407748"},{"id":"paper-w2190832525","cat":"papers","name":"Synthesis of Open-Ring Analogues of Salvinorin A, a Hallucinogenic Opioid from Salvia divinorum","year":"2007","cit":0,"pfa":"Matthew D. Schmidt","psa":"Thomas Edward Prisinzano","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2190832525","eid":"W2190832525"},{"id":"paper-w4230492997","cat":"papers","name":"Psilocybin Treatment in Advanced-Stage Cancer Patients With Anxiety","year":"2010","cit":0,"pfa":"Charles S. Grob","topics":["Anxiety & end-of-life"],"ptype":"dataset","src":"https://openalex.org/W4230492997","eid":"W4230492997"},{"id":"paper-w4416589905","cat":"papers","name":"Open MDMA: An Evidence-Based Synthesis, Theory, and Manual for MDMA Therapy Based on Predictive Processing, Complex Systems, and the Defense Cascade","year":"2025","cit":0,"pfa":"Mark Groeneveld","psa":"Thomas Harper","topics":["PTSD & trauma","Safety & adverse events","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4416589905","eid":"W4416589905"},{"id":"paper-w2064076974","cat":"papers","name":"MDMA: Neurohormonal, Neurocognitive, and Psychobiological Aspects of Recreational Ecstasy","year":"2009","cit":0,"pfa":"Andrew C. Parrott","psa":"Andrew B Scholey","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2064076974","eid":"W2064076974"},{"id":"paper-w4394133219","cat":"papers","name":"Ayahuasca and Public Health II. Supporting information 2: Database","year":"2022","cit":0,"pfa":"Maja Kohek","psa":"Miguel Ángel Alcázar‐Córcoles","ptype":"dataset","src":"https://openalex.org/W4394133219","eid":"W4394133219"},{"id":"paper-w2285922437","cat":"papers","name":"La espiritualidad navajo y el movimiento pan-indio del peyote","year":"2002","cit":0,"pfa":"Antje Mannaerts","ptype":"article","src":"https://openalex.org/W2285922437","eid":"W2285922437"},{"id":"paper-w7120538154","cat":"papers","name":"Effect of chronic administration of ayahuasca in preclinical models of memory and anxiety","year":"2013","cit":0,"pfa":"Vanessa Manchim Favaro","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7120538154","eid":"W7120538154"},{"id":"paper-w7120453742","cat":"papers","name":"Research with Ayahuasca in psychology: a literature review of its therapeutic potential","year":"2020","cit":0,"pfa":"Sofia Azevêdo De Araújo","psa":"Daniely Ildegardes Brito Tatmatsu","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7120453742","eid":"W7120453742"},{"id":"paper-w4240323261","cat":"papers","name":"Elucidating the Cellular Effects of MDMA on the Serotonin Transporter (SERT)","year":"2012","cit":0,"pfa":"A. Holley","topics":["Depression","Mechanism & neuroscience","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W4240323261","eid":"W4240323261"},{"id":"paper-w1536694270","cat":"papers","name":"The role of norephinephrine in the pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, \"ecstasy\")","year":"2013","cit":0,"pfa":"Cédric M. Hysek","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W1536694270","eid":"W1536694270"},{"id":"paper-w7139823517","cat":"papers","name":"Analogues of MDMA for modulating SERT, DAT, and / or NET activity","year":"2023","cit":0,"pfa":"Glenn A. Pullella","psa":"Matthew Piggott","ptype":"other","src":"https://openalex.org/W7139823517","eid":"W7139823517"},{"id":"paper-w7115166480","cat":"papers","name":"Psilocybin and Neuroplasticity: Mechanisms, Therapeutic Potential, and Future Directions","year":"2025","cit":0,"pfa":"S. Fereydouni","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7115166480","eid":"W7115166480"},{"id":"paper-w1798577550","cat":"papers","name":"Antropología simétrica y procesos de curación con ayahuasca","year":"2014","cit":0,"pfa":"Guzmán Chávez","psa":"Mauricio Genet","ptype":"article","src":"https://openalex.org/W1798577550","eid":"W1798577550"},{"id":"paper-w7213259618","cat":"papers","name":"Evaluation of the carcinogenic potential of ayahuasca employing the epithelial tumor test in Drosophila melanogaster","year":"2025","cit":0,"pfa":"Alexandre Azenha Alves de Rezende","psa":"Luciana Karen Calábria","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7213259618","eid":"W7213259618"},{"id":"paper-w27799036","cat":"papers","name":"Dihydroergot誘導体,および, Lysergic Acid Diethylamide(LSD-25)にかんする臨床的,ならびに,実験的研究,とくに,その脳波的観察","year":"1958","cit":0,"pfa":"和夫 石川","ptype":"article","src":"https://openalex.org/W27799036","eid":"W27799036"},{"id":"paper-w2952084109","cat":"papers","name":"ChemInform Abstract: SULFUR ANALOGUES OF PSYCHOTOMIMETIC AGENTS. MONOTHIO ANALOGS OF MESCALINE AND ISOMESCALINE","year":"1982","cit":0,"pfa":"Peyton Jacob","psa":"Alexander T. Shulgin","ptype":"article","src":"https://openalex.org/W2952084109","eid":"W2952084109"},{"id":"paper-w2972627392","cat":"papers","name":"Význam kaktusu peyote v každodenním životě, umění a náboženství Indiánů Huichol","year":"2017","cit":0,"pfa":"Adéla Ščurková","ptype":"dissertation","src":"https://openalex.org/W2972627392","eid":"W2972627392"},{"id":"paper-w7112648137","cat":"papers","name":"In Search of: A Federal Safe Harbor for State Legalization of Psilocybin","year":"2023","cit":0,"pfa":"Tucker, Kathryn L.","psa":"Morris, Ebony","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7112648137","eid":"W7112648137"},{"id":"paper-w4408154898","cat":"papers","name":"Psilocybin therapy might help frontline pandemic workers","year":"2025","cit":0,"topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4408154898","eid":"W4408154898"},{"id":"paper-w7203871494","cat":"papers","name":"JAMA study examines Oregon's psilocybin services model","year":"2026","cit":0,"pfa":"Valerie A. Canady","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7203871494","eid":"W7203871494"},{"id":"paper-w2288987096","cat":"papers","name":"AYAHUASCA E A INFLUÊNCIA NA CRIAÇÃO DE ÍNCARO: ESTÓRIAS DAQUELE QUE VOOU The Influence of Ayahuasca for Creating Íncaro: Stories of One Who Flew","year":"2014","cit":0,"pfa":"Matheus Moura Silva","ptype":"article","src":"https://openalex.org/W2288987096","eid":"W2288987096"},{"id":"paper-w7127554350","cat":"papers","name":"Highs and Lows: A Multi-Method Investigation of MDMA and Mental Health","year":"2026","cit":0,"pfa":"Zachary Charles Maxwell Bryant","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"dissertation","src":"https://openalex.org/W7127554350","eid":"W7127554350"},{"id":"paper-w4399308390","cat":"papers","name":"Plant dehydration, alkaloid concentration, and cytotoxicity on ayahuasca traditional tea","year":"2024","cit":0,"pfa":"Ordilena Ferreira de Miranda","psa":"Mary Ann Foglio","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4399308390","eid":"W4399308390"},{"id":"paper-w4409499108","cat":"papers","name":"Ayahuasca Retreats: The Role of Awe and Mystical Experiences in Well-Being","year":"2025","cit":0,"pfa":"Brant R. Maclean","psa":"Lee Kannis‐Dymand","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4409499108","eid":"W4409499108"},{"id":"paper-w2166278508","cat":"papers","name":"MDMA-assisted Psychotherapy in people with Posttraumatic Stress Disorder","year":"2009","cit":0,"pfa":"Principal Investigator","psa":"Moshe Kotler","topics":["PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2166278508","eid":"W2166278508"},{"id":"paper-w2510344285","cat":"papers","name":"MDMA: El regreso de la droga proscrita","year":"2016","cit":0,"pfa":"Iker Puente","ptype":"article","src":"https://openalex.org/W2510344285","eid":"W2510344285"},{"id":"paper-w3083741926","cat":"papers","name":"The Therapeutic Potential of Psilocybin and 3,4-Methylenedioxymethamphetamine in the Treatment of Depression and Post-Traumatic Stress Disorder","year":"2020","cit":0,"pfa":"Sofia Gyllvik","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"dissertation","src":"https://openalex.org/W3083741926","eid":"W3083741926"},{"id":"paper-w7204184442","cat":"papers","name":"Observability and pharmacological calibration in psychoactive ethnobotany: Admixture selection and the discovery of Ayahuasca","year":"2026","cit":0,"pfa":"Elliot Allan","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7204184442","eid":"W7204184442"},{"id":"paper-w2388999451","cat":"papers","name":"NVESTIGATION OF ABUSE PATTERNS AND PSYCHOLOGICALEFFECTS OF MIXTURE OF MA AND MDMA","year":"2000","cit":0,"pfa":"Zhang Daming","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2388999451","eid":"W2388999451"},{"id":"paper-w7131628565","cat":"papers","name":"Riding the Octo-High: MDMA and Sociality in Octopus Bimaculoids","year":"2026","cit":0,"pfa":"Kelsey Sanders","ptype":"article","src":"https://openalex.org/W7131628565","eid":"W7131628565"},{"id":"paper-w7115036998","cat":"papers","name":"EFFECTS OF ADRENALECTOMY ON THE GUT MICROBIOME AND HYPERTHERMIA INDUCED BY MDMA","cit":0,"pfa":"Usanova Saodat Turayevna","ptype":"article","src":"https://openalex.org/W7115036998","eid":"W7115036998"},{"id":"paper-w2247684133","cat":"papers","name":"Affective disturbance in currently abstinent MDMA (ecstasy) users","year":"2003","cit":0,"pfa":"Jonathan Paul Roiser","psa":"Barbara Jacquelyn Sahakian","ptype":"conference-paper","src":"https://openalex.org/W2247684133","eid":"W2247684133"},{"id":"paper-w2205994835","cat":"papers","name":"The influence of hyperthermia on the vascular effects of MDMA and its metabolites","year":"2015","cit":0,"pfa":"Diogo A. Fonseca","psa":"Maria Dulce Cotrim","ptype":"article","src":"https://openalex.org/W2205994835","eid":"W2205994835"},{"id":"paper-w2900303394","cat":"papers","name":"Use of MDMA in the treatment of Post-traumatic Stress Disorder","year":"2018","cit":0,"pfa":"Júlia Molina Trullàs","topics":["PTSD & trauma"],"ptype":"dissertation","src":"https://openalex.org/W2900303394","eid":"W2900303394"},{"id":"paper-w3120177426","cat":"papers","name":"Historia MDMA (ecstasy) ― od syntezy po teraźniejszość","year":"2021","cit":0,"pfa":"Gniewko Więckiewicz","psa":"Robert Pudło","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W3120177426","eid":"W3120177426"},{"id":"paper-w4399878524","cat":"papers","name":"Review for \"Bioisosteric analogs of MDMA : Improving the pharmacological profile?\"","year":"2023","cit":0,"topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4399878524","eid":"W4399878524"},{"id":"paper-w7135518662","cat":"papers","name":"Ecstasy (MDMA) m.v.-et fænomen i retsmedicinen?","year":"1999","cit":0,"pfa":"Sys Stybe Johansen","psa":"Irene Breum Müller","ptype":"article","src":"https://openalex.org/W7135518662","eid":"W7135518662"},{"id":"paper-w7135183130","cat":"papers","name":"A Few Lessons to Draw from Ayahuasca About the Knowledge of Togetherness","year":"2026","cit":0,"pfa":"Philippe Hert","ptype":"other","src":"https://openalex.org/W7135183130","eid":"W7135183130"},{"id":"paper-w7163602133","cat":"papers","name":"Enzymatic–Nonenzymatic Cellular Antioxidant Defense Systems Response and Immunohistochemical Detection of MDMA, VMAT2, HSP70, and Apoptosis as Biomarkers for MDMA (Ecstasy) Neurotoxicity","year":"2010","cit":0,"pfa":"Riezzo I","psa":"Vittorio Fineschi","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7163602133","eid":"W7163602133"},{"id":"paper-w4396946528","cat":"papers","name":"Utilisation de micro-prélèvements volumétriques dans une situation d’autopsie : à propos d’un cas d’intoxication à la 5-methoxy-dimethyltryptamine","year":"2024","cit":0,"pfa":"Laurène Dufayet","psa":"Pascal Houzé","ptype":"article","src":"https://openalex.org/W4396946528","eid":"W4396946528"},{"id":"paper-w4388836729","cat":"papers","name":"Can ayahuasca reduce inattention, hyperactivity and impulsivity? A pilot study","year":"2023","cit":0,"pfa":"WaiFung Tsang","psa":"Jack Hollingdale","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4388836729","eid":"W4388836729"},{"id":"paper-w651960227","cat":"papers","name":"The effects of MDMA (Ecstasy) and cannabis on working memory function","year":"2003","cit":0,"pfa":"Wareing, M.","psa":"Jeni Fisk","ptype":"article","src":"https://openalex.org/W651960227","eid":"W651960227"},{"id":"paper-w4256371459","cat":"papers","name":"Consumption of MDMA : a survey in the french male homosexual population","year":"2018","cit":0,"pfa":"Matei Marinescu","ptype":"other","src":"https://openalex.org/W4256371459","eid":"W4256371459"},{"id":"paper-w4391090918","cat":"papers","name":"Med Check: NDA for MDMA-Assisted Therapy and More","year":"2024","cit":0,"pfa":"Terri D’Arrigo","topics":["PTSD & trauma","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4391090918","eid":"W4391090918"},{"id":"paper-w4403729239","cat":"papers","name":"FDA Denies Approval of MDMA-Assisted Therapy for PTSD","year":"2024","cit":0,"pfa":"Karen M. Roush","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4403729239","eid":"W4403729239"},{"id":"paper-w4391332040","cat":"papers","name":"Therapeutic potential of N,N-dimethyltryptamine in the treatment of psychiatric and neurodegenerative disorders","year":"2023","cit":0,"pfa":"Jakub Schimmelpfennig","psa":"Kamila Jankowiak-Siuda","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4391332040","eid":"W4391332040"},{"id":"paper-w7170094419","cat":"papers","name":"In silico insights into the adsorption and detection of dimethyltryptamine on metal doped C20 fullerene","year":"2026","cit":0,"pfa":"Abdulrahman Sumayli","psa":"Jawaher Abdullah Alamoudi","ptype":"article","src":"https://openalex.org/W7170094419","eid":"W7170094419"},{"id":"paper-w4254480100","cat":"papers","name":"A new approach methodology (NAM) for the prediction of (nor)ibogaine-induced cardiotoxicity in humans_suppl","year":"2021","cit":0,"pfa":"Miaoying Shi","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4254480100","eid":"W4254480100"},{"id":"paper-w1869441845","cat":"papers","name":"Proceedings: Comparison of the effects of mescaline, noradrenaline and 5-hydroxytryptamine on single cortical neurones.","year":"1974","cit":0,"pfa":"Paul Bevan","psa":"E. Szabadi","ptype":"article","src":"https://openalex.org/W1869441845","eid":"W1869441845"},{"id":"paper-w1842874463","cat":"papers","name":"Preparation of Ring D Modified Analogues of Salvinorin A and Evaluation of Their Activity at Opioid Receptors","year":"2006","cit":0,"pfa":"Denise S. Simpson","psa":"Thomas Edward Prisinzano","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1842874463","eid":"W1842874463"},{"id":"paper-w1995110346","cat":"papers","name":"13C- and 2H-Labeled Deoxyxylulose as a Tool in Study of Kinetics and Mechanism of Salvinorin A Biosynthesis","year":"2008","cit":0,"pfa":"LM Kutrzeba","psa":"JK Zjawiony","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1995110346","eid":"W1995110346"},{"id":"paper-w133107103","cat":"papers","name":"Review of Pipe, Bible, and Peyote among the Oglala Sioux: A Study in Religious Identity","year":"1992","cit":0,"pfa":"Elizabeth S. Grobsmith","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W133107103","eid":"W133107103"},{"id":"paper-w4243634130","cat":"papers","name":"ChemInform Abstract: CRYSTAL STRUCTURES OF THE TEONANACATL HALLUCINOGENS PART 2, PSILOCIN C12H15N2O","year":"1974","cit":0,"pfa":"Trevor James Petcher","psa":"Hans Peter Weber","ptype":"article","src":"https://openalex.org/W4243634130","eid":"W4243634130"},{"id":"paper-w4399560207","cat":"papers","name":"THU-285 Lownonpsychedelic dosed of psilocybin for the therapy of MASLD","year":"2024","cit":0,"pfa":"Martina Colognesi","psa":"Sara De Martin","topics":["Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W4399560207","eid":"W4399560207"},{"id":"paper-w2941902070","cat":"papers","name":"La paradoja del iboga: intoxicación por un remedio natural de desintoxicación","year":"2019","cit":0,"pfa":"JM Matamoros-Castillo","psa":"L Livianos-Aldana","ptype":"article","src":"https://openalex.org/W2941902070","eid":"W2941902070"},{"id":"paper-w2043215253","cat":"papers","name":"Éxtasis (MDMA): estudios neurobiológicos en el laboratorio","year":"2008","cit":0,"pfa":"María Isabel Colado","ptype":"article","src":"https://openalex.org/W2043215253","eid":"W2043215253"},{"id":"paper-w4205978858","cat":"papers","name":"Methamphetamine, MDMA use increases risk for depressive symptoms","year":"2012","cit":0,"topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4205978858","eid":"W4205978858"},{"id":"paper-w4411488394","cat":"papers","name":"New iboga-type indole alkaloids with anti-glioma activity from Tabernaemontana pachysiphon","year":"2025","cit":0,"pfa":"Wen Yuan Gao","psa":"Caifeng Ding","ptype":"article","src":"https://openalex.org/W4411488394","eid":"W4411488394"},{"id":"paper-w2401820901","cat":"papers","name":"Behavioral and rewarding effects of methylone, an analog of MDMA in mice","year":"2011","cit":0,"pfa":"眞紀 宮澤","ptype":"dissertation","src":"https://openalex.org/W2401820901","eid":"W2401820901"},{"id":"paper-w4407244073","cat":"papers","name":"MDMA and the Brain: A Short Review on the Role of Neurotransmitters in Neurotoxicit","year":"2020","cit":0,"pfa":"Nor Suliana Mustafa","psa":"Rashidi Ahmad","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4407244073","eid":"W4407244073"},{"id":"paper-w205330384","cat":"papers","name":"I. El 'Yajé' o \"ayahuasca\" en la realidad","year":"2010","cit":0,"pfa":"Jonathan Ott","ptype":"article","src":"https://openalex.org/W205330384","eid":"W205330384"},{"id":"paper-w2198358978","cat":"papers","name":"El Ritual de la Ayahuasca en Zamora Chinchipe","year":"2014","cit":0,"pfa":"Isidro Marín Gutiérrez","ptype":"article","src":"https://openalex.org/W2198358978","eid":"W2198358978"},{"id":"paper-w4415719438","cat":"papers","name":"Ayahuasca prevents the reinstatement of cocaine-induced rewarding effects in C57Bl/6 mice","year":"2025","cit":0,"pfa":"Vítor Bruno","psa":"Tânia Marcourakis","ptype":"article","src":"https://openalex.org/W4415719438","eid":"W4415719438"},{"id":"paper-w4234457737","cat":"papers","name":"S.28.02 MDMA as a model of 5-HT dysfunction","year":"2005","cit":0,"topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4234457737","eid":"W4234457737"},{"id":"paper-w1617046359","cat":"papers","name":"Behavioural and Neurochemical Consequences of MDMA Self-Administration in Rats","year":"2012","cit":0,"pfa":"Do, Jennifer","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W1617046359","eid":"W1617046359"},{"id":"paper-w3124248923","cat":"papers","name":"An Examination of Federal Sentencing Guidelines’ Treatment of MDMA (“Ecstacy”)","year":"2014","cit":0,"pfa":"Alyssa C. Hennig","ptype":"article","src":"https://openalex.org/W3124248923","eid":"W3124248923"},{"id":"paper-w4231011738","cat":"papers","name":"Mice in Ecstasy: Advanced Animal Models in the Study of MDMA","year":"2010","cit":0,"pfa":"Christophe Pol Stove","psa":"Willy E. Lambert","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4231011738","eid":"W4231011738"},{"id":"paper-w1861711127","cat":"papers","name":"fNIRS responses to cognitive stress in chronic MDMA users","year":"2013","cit":0,"pfa":"Catherine Montgomery","psa":"Mark A Wetherell","ptype":"conference-paper","src":"https://openalex.org/W1861711127","eid":"W1861711127"},{"id":"paper-w2547621444","cat":"papers","name":"The Use of Cyproheptadine and Dantrolene in Prolonged MDMA-Induced Hyperthermia","year":"2015","cit":0,"pfa":"Victoria Su","psa":"British Columbia","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2547621444","eid":"W2547621444"},{"id":"paper-w4399878523","cat":"papers","name":"Review for \"Bioisosteric analogs of MDMA : Improving the pharmacological profile?\"","year":"2023","cit":0,"topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4399878523","eid":"W4399878523"},{"id":"paper-w7162826770","cat":"papers","name":"SAMATI: Social Anxiety and MDMA-Assisted Therapy Investigation","year":"2026","cit":0,"pfa":"Christina Chwyl","psa":"Mary K. Lear","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7162826770","eid":"W7162826770"},{"id":"paper-w4412063351","cat":"papers","name":"Equitable access to psilocybin-assisted psychotherapy in New Zealand","year":"2025","cit":0,"pfa":"Cameron James Lacey","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4412063351","eid":"W4412063351"},{"id":"paper-w2924097675","cat":"papers","name":"Clinical and Medical Management of Conditions Caused by MDMA or ‘Ecstasy’","year":"2018","cit":0,"pfa":"Andrew C. Parrott","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W2924097675","eid":"W2924097675"},{"id":"paper-w3172549027","cat":"papers","name":"Efficacy of MDMA-Assisted Psychotherapy in the Treatment of Chronic PTSD","year":"2020","cit":0,"pfa":"A. Rand Coleman","psa":"Nicole Blixt","topics":["Depression","PTSD & trauma","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3172549027","eid":"W3172549027"},{"id":"paper-w2978184393","cat":"papers","name":"Anti-methamphetamine single chain Fv in complex with MDMA","year":"2009","cit":0,"pfa":"Reha Celikel","psa":"Kottayil I. Varughese","ptype":"dataset","src":"https://openalex.org/W2978184393","eid":"W2978184393"},{"id":"paper-w2940727853","cat":"papers","name":"Antidepressant-like effects of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy).","year":"2010","cit":0,"pfa":"Irina Majumder","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W2940727853","eid":"W2940727853"},{"id":"paper-w2978880272","cat":"papers","name":"Study on the Properties of POE reinforced with the in-situ prepared MDMA","year":"2010","cit":0,"pfa":"Qiu Gui-xue","ptype":"article","src":"https://openalex.org/W2978880272","eid":"W2978880272"},{"id":"paper-w4413610941","cat":"papers","name":"The real promise of LSD, MDMA and mushrooms for medical science","year":"2018","cit":0,"pfa":"Erika Dyck","ptype":"other","src":"https://openalex.org/W4413610941","eid":"W4413610941"},{"id":"paper-w3211121356","cat":"papers","name":"MDMA, PTSD and the amygdala: Promising approach for treating SUDs","year":"2021","cit":0,"pfa":"Alison Knopf","topics":["PTSD & trauma","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3211121356","eid":"W3211121356"},{"id":"paper-w4366958553","cat":"papers","name":"Company on brink takes psilocybin to trial for fragile X syndrome","year":"2023","cit":0,"pfa":"Peter Hess","ptype":"article","src":"https://openalex.org/W4366958553","eid":"W4366958553"},{"id":"paper-w3034540991","cat":"papers","name":"Determination of the main compounds of Ayahuasca and the study of their cytotoxicity in dopaminergic neurons","year":"2019","cit":0,"pfa":"Ana Aysa da Rocha Simão","topics":["Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W3034540991","eid":"W3034540991"},{"id":"paper-w4394239839","cat":"papers","name":"Ayahuasca and Public Health II. Supporting information 2: Database","year":"2022","cit":0,"pfa":"Maja Kohek","psa":"Miguel Ángel Alcázar‐Córcoles","ptype":"dataset","src":"https://openalex.org/W4394239839","eid":"W4394239839"},{"id":"paper-w2992716242","cat":"papers","name":"e development of Brazilian public policies on the religious use of Ayahuasca","year":"2016","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W2992716242","eid":"W2992716242"},{"id":"paper-w7214327777","cat":"papers","name":"Psychosis associated with ayahuasca: A narrative review of traditional use, vulnerability, and case evidence","year":"2026","cit":0,"pfa":"Julio Torales","psa":"Antonio Ventriglio","topics":["PTSD & trauma","Safety & adverse events","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W7214327777","eid":"W7214327777"},{"id":"paper-w3112808793","cat":"papers","name":"Estudio químico de la Liana Ayahuasca (Banisteriopis caapi)","year":"2002","cit":0,"pfa":"Víctor Reyna Pinedo","psa":"Tania Sánchez Ramirez","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3112808793","eid":"W3112808793"},{"id":"paper-w184319933","cat":"papers","name":"THE EFFECTS OF PARTICIPATION IN AYAHUASCA RITUALS ON GAYS ’ AND LESBIANS ’ SELF PERCEPTION","year":"2011","cit":0,"pfa":"Clancy Cavnar","ptype":"article","src":"https://openalex.org/W184319933","eid":"W184319933"},{"id":"paper-w4413719756","cat":"papers","name":"Can Ayahuasca, the ‘sacred plant’ of the Amazon, help addiction and depression?","year":"2016","cit":0,"pfa":"RAFAEL GUIMARÃES DOS SANTOS","topics":["Depression","Addiction"],"ptype":"other","src":"https://openalex.org/W4413719756","eid":"W4413719756"},{"id":"paper-w7120856985","cat":"papers","name":"Regulations on the use of psychoactive substances for religious purposes: the case of ayahuasca","year":"2010","cit":0,"pfa":"Andréa Depieri de Albuquerque Reginato","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7120856985","eid":"W7120856985"},{"id":"paper-w2579431816","cat":"papers","name":"NEUROPHYSIOLOGICAL CORRELATES OF ECSTASY/MDMA USE ON EXECUTIVE FUNCTIONING","year":"2016","cit":0,"pfa":"Carl Alexander Roberts","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W2579431816","eid":"W2579431816"},{"id":"paper-w4205591723","cat":"papers","name":"Effect of repeated MDMA exposure on rat brain and behaviour","year":"2020","cit":0,"pfa":"Ross van de Wetering","topics":["Addiction","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W4205591723","eid":"W4205591723"},{"id":"paper-w4406306371","cat":"papers","name":"Preclinical characterizations of the effects of MDMA as a candidate prohedonic medication","year":"2023","cit":0,"pfa":"Kayleigh S. LaMalfa","psa":"Brian D. Kangas","ptype":"dataset","src":"https://openalex.org/W4406306371","eid":"W4406306371"},{"id":"paper-w7128116767","cat":"papers","name":"MDMA as an adjuvant in the psychoterapy of post-traumatic stress disorder","year":"2023","cit":0,"pfa":"Xabier Olalde Soloeta","topics":["PTSD & trauma","Mechanism & neuroscience","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W7128116767","eid":"W7128116767"},{"id":"paper-w7120345038","cat":"papers","name":"Pharmacological evaluation of the possible effect of anti-alcohol ayahuasca in mice","year":"2009","cit":0,"pfa":"Bruno Gianfratti","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W7120345038","eid":"W7120345038"},{"id":"paper-w7128601444","cat":"papers","name":"RESENHA CRÍTICA DA OBRA VISÕES MULTIDISCIPLINARES DA AYAHUASCA","year":"2026","cit":0,"pfa":"Julia Dias Milani","ptype":"article","src":"https://openalex.org/W7128601444","eid":"W7128601444"},{"id":"paper-w4403710977","cat":"papers","name":"Increased reactivity of the paraventricular nucleus of the hypothalamus and decreased threat responding in male rats following psilocin administration","year":"2024","cit":0,"pfa":"Mott, Sarah E.","psa":"Sema G. Quadir","ptype":"article","src":"https://openalex.org/W4403710977","eid":"W4403710977"},{"id":"paper-w2322968673","cat":"papers","name":"The Peyote Road: Religious Freedom and the Native American Church. By Thomas C. Maroukis","year":"2011","cit":0,"pfa":"T. Tinker","ptype":"article","src":"https://openalex.org/W2322968673","eid":"W2322968673"},{"id":"paper-w4237499240","cat":"papers","name":"Behavioural and Neurochemical Consequences of MDMA Self-Administration in Rats","year":"2012","cit":0,"pfa":"Do, Jennifer","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W4237499240","eid":"W4237499240"},{"id":"paper-w3031546020","cat":"papers","name":"Adherence Rating in MDMA-Assisted Psychotherapy for PTSD Research","year":"2016","cit":0,"pfa":"Justin Forman","topics":["PTSD & trauma","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W3031546020","eid":"W3031546020"},{"id":"paper-w4408525915","cat":"papers","name":"MDMA disrupts alcohol memory reconsolidation and attenuates relapse","year":"2025","cit":0,"pfa":"Y. De Picciotto","psa":"S. Barak","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4408525915","eid":"W4408525915"},{"id":"paper-w2952807918","cat":"papers","name":"SAR of Psilocybin Analogues: Discovery of a Selective 5‐HT2C Agonist.","year":"2005","cit":0,"pfa":"Howard Sard","psa":"Louis Shuster","ptype":"article","src":"https://openalex.org/W2952807918","eid":"W2952807918"},{"id":"paper-w4327497830","cat":"papers","name":"Therapeutic mechanism of psilocybin in the treatment of depression and other psychiatric disorders.","year":"2023","cit":0,"pfa":"O. Shahar","psa":"Bernard Lerer","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4327497830","eid":"W4327497830"},{"id":"paper-w7135865598","cat":"papers","name":"Ritual use of peyote hallucinogen: the comparation of its usage among the Tarahumaras and Huicholes","year":"2014","cit":0,"pfa":"Klára Sztymonová","ptype":"dissertation","src":"https://openalex.org/W7135865598","eid":"W7135865598"},{"id":"paper-w2352827919","cat":"papers","name":"PERSONALITY DIFFERENCE BETWEEN MDMA ABUSERS AND HEROIN ABUSERS","year":"2002","cit":0,"pfa":"Zhu Yuezheng","ptype":"article","src":"https://openalex.org/W2352827919","eid":"W2352827919"},{"id":"paper-w2604639035","cat":"papers","name":"Development of clinical protocol for Ibogaine administration as anti addictive treatment in opioid addiction","year":"2016","cit":0,"pfa":"Syed Mohd Syahmi Syed Mohmad Paudzi","psa":"Ramli Musa","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2604639035","eid":"W2604639035"},{"id":"paper-w2592206987","cat":"papers","name":"Ayahuasca (Banisteriopsis spp. and admixtures): Appropriation and globalization of a sacred NTFP","year":"2002","cit":0,"pfa":"Miguel N. Alexiades","ptype":"book-chapter","src":"https://openalex.org/W2592206987","eid":"W2592206987"},{"id":"paper-w7161377665","cat":"papers","name":"Ayahuasca use and improvements in suicidal behavior: An exploratory qualitative study","year":"2026","cit":0,"pfa":"Nádia Valéria Moreira Santos","psa":"Paulo Rogério Morais","ptype":"article","src":"https://openalex.org/W7161377665","eid":"W7161377665"},{"id":"paper-w2792511928","cat":"papers","name":"Effect of MDMA administration on eye redox system in rat","year":"2005","cit":0,"pfa":"Lucia Micheli","psa":"Simone Pannini","ptype":"conference-paper","src":"https://openalex.org/W2792511928","eid":"W2792511928"},{"id":"paper-w3080738447","cat":"papers","name":"Effect of repeated MDMA exposure on rat brain and behaviour","year":"2020","cit":0,"pfa":"Ross van de Wetering","topics":["Addiction","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W3080738447","eid":"W3080738447"},{"id":"paper-w2286462458","cat":"papers","name":"MDMA (ecstasy) neurotoxicity estends beyond the basal ganglia","year":"2003","cit":0,"pfa":"Francesco Fornai","psa":"Antonio Paparelli","topics":["Safety & adverse events"],"ptype":"conference-paper","src":"https://openalex.org/W2286462458","eid":"W2286462458"},{"id":"paper-w4206208481","cat":"papers","name":"(CASO CLÍNICO) UN MAL VIAJE CON AYAHUASCA: A PROPÓSITO DE UN CASO","year":"2021","cit":0,"topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"conference-paper","src":"https://openalex.org/W4206208481","eid":"W4206208481"},{"id":"paper-w2979385243","cat":"papers","name":"Review: The Peyote Effect: From the Inquisition to the War on Drugs by Alexander S. Dawson","year":"2019","cit":0,"pfa":"Thomas C. Maroukis","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2979385243","eid":"W2979385243"},{"id":"paper-w2037942995","cat":"papers","name":"Effects of mescaline and 2, 5-dimethoxy-4-methylphenethylamine on sleeping time in mice","year":"1970","cit":0,"pfa":"Beng T. Ho","psa":"Jen‐Tzaw Huang","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2037942995","eid":"W2037942995"},{"id":"paper-w2540878495","cat":"papers","name":"Effects of modafinil on MDMA-induced spatial memory impairment","year":"2016","cit":0,"pfa":"Reyhaneh Shariatmadari","ptype":"article","src":"https://openalex.org/W2540878495","eid":"W2540878495"},{"id":"paper-w3131386026","cat":"papers","name":"MDMA‐assisted psychotherapy reduces PTSD symptom severity","year":"2021","cit":0,"pfa":"Valerie A. Canady","topics":["PTSD & trauma","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3131386026","eid":"W3131386026"},{"id":"paper-w4416698816","cat":"papers","name":"MDMA-INDUCED THROMBOTIC THROMBOCYTOPENIC PURPURA IN IMMONOCOMPETENT ADULT","year":"2025","cit":0,"pfa":"CLARA KEUM","psa":"ADAM KANDIL","ptype":"article","src":"https://openalex.org/W4416698816","eid":"W4416698816"},{"id":"paper-w4231315938","cat":"papers","name":"Behavioral memory impairment in abstinent MDMA (Ecstasy) users","year":"2000","cit":0,"pfa":"K. Zakzanis","psa":"A. Silverberg","ptype":"article","src":"https://openalex.org/W4231315938","eid":"W4231315938"},{"id":"paper-w2580402176","cat":"papers","name":"Discriminative Stimulus Properties of MDMA: The Role of Serotonin and Dopamine","year":"2016","cit":0,"pfa":"Jeremy Webster","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W2580402176","eid":"W2580402176"},{"id":"paper-w3033088402","cat":"papers","name":"MDMA-assisted psychotherapy for posttraumatic stress disorder: An overview","year":"2020","cit":0,"pfa":"Fiona Judith Bachoroski","topics":["PTSD & trauma","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3033088402","eid":"W3033088402"},{"id":"paper-w7167090085","cat":"papers","name":"MiSAM opposes bill giving $50 million in opioid settlement funds to ibogaine research","year":"2026","cit":0,"pfa":"Alison Knopf","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7167090085","eid":"W7167090085"},{"id":"paper-w7110395006","cat":"papers","name":"Psilocybin rewires specific mouse cortical networks in lasting ways","year":"2025","cit":0,"pfa":"Siddhant Pusdekar","ptype":"article","src":"https://openalex.org/W7110395006","eid":"W7110395006"},{"id":"paper-w4413421199","cat":"papers","name":"Context-dependent structurally informed effective connectivity under psilocybin","year":"2025","cit":0,"pfa":"Matthew D. Greaves","psa":"Adeel Razi","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4413421199","eid":"W4413421199"},{"id":"paper-w4386410207","cat":"papers","name":"Psilocybin, escitalopram have comparable effects on personality in patients with depression","year":"2023","cit":0,"topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4386410207","eid":"W4386410207"},{"id":"paper-w4412941980","cat":"papers","name":"Response to emotional stimuli weaker in SSRI users compared with psilocybin","year":"2025","cit":0,"topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4412941980","eid":"W4412941980"},{"id":"paper-w7208657947","cat":"papers","name":"A qualitative investigation into the naturalistic use of psilocybin to treat psychosomatic concerns","year":"2026","cit":0,"pfa":"AJ Macbeth","ptype":"dissertation","src":"https://openalex.org/W7208657947","eid":"W7208657947"},{"id":"paper-w2000818920","cat":"papers","name":"MDMA research leaves ravers far from ecstatic","year":"2002","cit":0,"pfa":"James Butcher","ptype":"article","src":"https://openalex.org/W2000818920","eid":"W2000818920"},{"id":"paper-w4224250451","cat":"papers","name":"MDMA effects on Daphnia magna morphophysiology: preliminary data","year":"2022","cit":0,"pfa":"Ana Rita Fernandes Miranda da Costa","psa":"Cláudia Maria Rosa Ribeiro","ptype":"article","src":"https://openalex.org/W4224250451","eid":"W4224250451"},{"id":"paper-w4366687337","cat":"papers","name":"LSD et MDMA en combinaison (Candy Flip)","year":"2023","cit":0,"pfa":"Pierre Poloméni","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4366687337","eid":"W4366687337"},{"id":"paper-w2161052866","cat":"papers","name":"MDMA, Love, Mourning and Melancholy. Experiences of Psychological “Compression”","year":"2013","cit":0,"pfa":"Finian Fallon","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W2161052866","eid":"W2161052866"},{"id":"paper-w4399878662","cat":"papers","name":"Review for \"Bioisosteric analogs of MDMA : Improving the pharmacological profile?\"","year":"2024","cit":0,"topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4399878662","eid":"W4399878662"},{"id":"paper-w4409434810","cat":"papers","name":"Ketamine, MDMA, and psychedelics: Emerging therapeutics in mental health","year":"2025","cit":0,"pfa":"Anand Lingeswaran","ptype":"article","src":"https://openalex.org/W4409434810","eid":"W4409434810"},{"id":"paper-w4313200261","cat":"papers","name":"Neurochemical and behavioural characterisation of the psychedelic 5HT2AR agonist psilocybin in mice","year":"2022","cit":0,"pfa":"Ines Erkizia-Santamaría","psa":"J.E. Ortega","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4313200261","eid":"W4313200261"},{"id":"paper-w2597042372","cat":"papers","name":"MDMA-Induced Serotonin Neurotoxicity Linked with Memory Impairment","year":"1999","cit":0,"pfa":"Gabriel F. Tucker","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2597042372","eid":"W2597042372"},{"id":"paper-w2118214081","cat":"papers","name":"Piracetam increases methamphetamine and MDMA behavioral effects in mice","year":"2009","cit":0,"pfa":"Alexandra Šulcová","ptype":"article","src":"https://openalex.org/W2118214081","eid":"W2118214081"},{"id":"paper-w364250703","cat":"papers","name":"The effects of ecstasy (MDMA) and cannabis use on executive functioning","year":"2006","cit":0,"pfa":"Philip N. Murphy","psa":"M. Wareing","ptype":"article","src":"https://openalex.org/W364250703","eid":"W364250703"},{"id":"paper-w3121772493","cat":"papers","name":"JOP826594_supplemental_material – Supplemental material for Greater empathy in MDMA users","year":"2019","cit":0,"pfa":"Molly Carlyle","psa":"Celia J. A. Morgan","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W3121772493","eid":"W3121772493"},{"id":"paper-w3048251129","cat":"papers","name":"Bead tapestry patterns peyote gold $20 coin by augustus saint gaudens dice","year":"2016","cit":0,"pfa":"georgia grisolia","ptype":"book","src":"https://openalex.org/W3048251129","eid":"W3048251129"},{"id":"paper-w2472570236","cat":"papers","name":"[MDMA (Ecstasy). A designer drug with high toxicity potential].","year":"1994","cit":0,"pfa":"Fernández Pl","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2472570236","eid":"W2472570236"},{"id":"paper-w4291291492","cat":"papers","name":"Human methylone, MDMA and metabolites’ plasma concentrations by a new LC-MS/MS method after controlled administration of methylone and MDMA","year":"2022","cit":0,"pfa":"Alfredo Fabrizio Lo Faro","psa":"Francesco Paolo Busardò","ptype":"article","src":"https://openalex.org/W4291291492","eid":"W4291291492"},{"id":"paper-w7169849703","cat":"papers","name":"Reconstituting a two-step pathway for N,N-dimethyltryptamine (DMT) biosynthesis in bacteria","year":"2026","cit":0,"pfa":"Lucas Henrique Junges","psa":"Marcelo Müller‐Santos","ptype":"article","src":"https://openalex.org/W7169849703","eid":"W7169849703"},{"id":"paper-w4414195129","cat":"papers","name":"Did the vilca/tobacco snuff combination at Chavín aim for an “ayahuasca effect”?","year":"2025","cit":0,"pfa":"Peter Whitridge","ptype":"article","src":"https://openalex.org/W4414195129","eid":"W4414195129"},{"id":"paper-w2184829120","cat":"papers","name":"Keywords Ecstasy, fenfluramine, impulsivity, MDMA, neurotoxicity, serotonin.","year":"2011","cit":0,"pfa":"Michael Lyvers","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2184829120","eid":"W2184829120"},{"id":"paper-w7133686892","cat":"papers","name":"Development and optimization of a reliable HPLC-MS method for the identification of Tabernanthe iboga and its differentiation from toxic look-alikes","year":"2026","cit":0,"pfa":"Kateřina Knížková","psa":"Martin Kuchař","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"conference-paper","src":"https://openalex.org/W7133686892","eid":"W7133686892"},{"id":"paper-w7139865835","cat":"papers","name":"Agony of the ecstacy: Report of five cases of MDMA smuggling","year":"2005","cit":0,"pfa":"Vincent Low","psa":"EK Dillon","ptype":"review","src":"https://openalex.org/W7139865835","eid":"W7139865835"},{"id":"paper-w2115798448","cat":"papers","name":"Neurobiological mechanisms involved in MDMA-Seeking behaviour and relapse","year":"2010","cit":0,"pfa":"María Juliana Orejarena","topics":["Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W2115798448","eid":"W2115798448"},{"id":"paper-w7126179801","cat":"papers","name":"Empathic Behavioral Substrates Altered by MDMA and Their Therapeutic Consequences","year":"2026","cit":0,"pfa":"Makaela Weeda","psa":"Ákos Babiczky","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7126179801","eid":"W7126179801"},{"id":"paper-w2350210789","cat":"papers","name":"The effect on anxious mood of rats of acute toxicity of MDMA","year":"2006","cit":0,"pfa":"Jing Li","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2350210789","eid":"W2350210789"},{"id":"paper-w3177342698","cat":"papers","name":"Phenotypic differences in behavioral response of mice to MDMA (′ecstasy′)","year":"2006","cit":0,"pfa":"Twum Ampofo Ansah","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3177342698","eid":"W3177342698"},{"id":"paper-w4246117378","cat":"papers","name":"Podcast: MDMA and the malleable mind, and keeping skin young","year":"2019","cit":0,"ptype":"article","src":"https://openalex.org/W4246117378","eid":"W4246117378"},{"id":"paper-w7164646534","cat":"papers","name":"Blinding, Expectancy, and the Active Placebo Paradox in MDMA Research","year":"2026","cit":0,"pfa":"Mitch Earleywine","psa":"Quinn Allen","ptype":"article","src":"https://openalex.org/W7164646534","eid":"W7164646534"},{"id":"paper-w2013544977","cat":"papers","name":"ChemInform Abstract: Dippinines A—D, New Iboga‐Derived Indole Alkaloids from Tabernaemontana.","year":"2002","cit":0,"pfa":"Toh‐Seok Kam","psa":"Kooi‐Mow Sim","ptype":"article","src":"https://openalex.org/W2013544977","eid":"W2013544977"},{"id":"paper-w4412763777","cat":"papers","name":"NeuroAlchemy: Unveiling Cognitive and Neural Plasticity Through Weekly DMT and Ayahuasca","year":"2025","cit":0,"pfa":"Thomas Hatzilabrou","topics":["Mechanism & neuroscience"],"ptype":"report","src":"https://openalex.org/W4412763777","eid":"W4412763777"},{"id":"paper-w2967246776","cat":"papers","name":"Religious Revitalization among the Kiowa: The Ghost Dance, Peyote, and Christianity by Benjamin R. Kracht","year":"2019","cit":0,"pfa":"Dennis Wiedman","topics":["Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2967246776","eid":"W2967246776"},{"id":"paper-w2951363651","cat":"papers","name":"Synthesis of the 3‐(3,4,5‐Trimethoxyphenyl)pyrrolidine (V): A New Conformationally Constrained Mescaline Analogue.","year":"2007","cit":0,"pfa":"Ricardo de L. Barreto","psa":"Carlos Roque Duarte Correira","ptype":"article","src":"https://openalex.org/W2951363651","eid":"W2951363651"},{"id":"paper-w3025278056","cat":"papers","name":"Studies of Salvinorin-Based Antagonists to Elucidate Pertinent Interactions for Kappa Opioid Receptor Antagonism","year":"2020","cit":0,"pfa":"Madeline Keane","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3025278056","eid":"W3025278056"},{"id":"paper-w2182721190","cat":"papers","name":"Involvement of the cannabinoid receptor type-1 (CB1) on Salvinorin-A-induced emotional response in rats","year":"2007","cit":0,"pfa":"Valeria Capurro","psa":"Sala Mariaelvina","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2182721190","eid":"W2182721190"},{"id":"paper-w2903210187","cat":"papers","name":"Detection of ibogaine in body fluids[DETECTION DE L'IBOGAINE DANS LES LIQUIDES ORGANIQUES]","year":"1976","cit":0,"pfa":"Elisabetta Bertol","psa":"Rino Froldi","ptype":"article","src":"https://openalex.org/W2903210187","eid":"W2903210187"},{"id":"paper-w4246962837","cat":"papers","name":"Psilocybin therapy appears as effective as escitalopram, small study finds","year":"2021","cit":0,"topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4246962837","eid":"W4246962837"},{"id":"paper-w7122985359","cat":"papers","name":"MDMA and LSD increase odds of substance-related disorders","year":"2026","cit":0,"topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7122985359","eid":"W7122985359"},{"id":"paper-w2413158991","cat":"papers","name":"A quantum chemical investigation of the pi-electronic structure of the hallucinogenic N,N-dimethyltryptamines.","year":"1974","cit":0,"pfa":"Richard A. Glennon","ptype":"article","src":"https://openalex.org/W2413158991","eid":"W2413158991"},{"id":"paper-w4226014501","cat":"papers","name":"Quantum Chemical Study of the Hydrolysis of Oxidized Endogenous Psychedelic N,N-Dimethyltryptamine","year":"2022","cit":0,"pfa":"Károly Kubicskó","psa":"Ödön Farkas","ptype":"preprint","src":"https://openalex.org/W4226014501","eid":"W4226014501"},{"id":"paper-w4283316495","cat":"papers","name":"Quantum chemical study of the hydrolysis of oxidized endogenous psychedelic N,N-dimethyltryptamine","year":"2022","cit":0,"pfa":"Károly Kubicskó","psa":"Ödön Farkas","ptype":"article","src":"https://openalex.org/W4283316495","eid":"W4283316495"},{"id":"paper-w2740313961","cat":"papers","name":"Original Investigations Differences in Tolerance to Mescaline Produced by Peripheral and Direct Central Administration","year":"1971","cit":0,"pfa":"H. A. Tilsoi","psa":"S. B. Sfa","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2740313961","eid":"W2740313961"},{"id":"paper-w162329795","cat":"papers","name":"Iboga, la tierra de los muertos y un rosario por las noches","year":"2002","cit":0,"pfa":"Vera Leheman","ptype":"article","src":"https://openalex.org/W162329795","eid":"W162329795"},{"id":"paper-w4245186737","cat":"papers","name":"MDMA could enhance psychotherapy outcomes in people with PTSD","year":"2018","cit":0,"topics":["PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4245186737","eid":"W4245186737"},{"id":"paper-w355754303","cat":"papers","name":"MDMA alters the response of the circadian clock to a serotonin agonist","year":"2000","cit":0,"pfa":"Stephany M. Biello","psa":"Richard Ian Dafters","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W355754303","eid":"W355754303"},{"id":"paper-w3006687252","cat":"papers","name":"Methamphetamine and MDMA behavioural effects are reinforced bypiracetam in mice","year":"2009","cit":0,"pfa":"Karel Šlais","psa":"Alexandra Šulcová","ptype":"article","src":"https://openalex.org/W3006687252","eid":"W3006687252"},{"id":"paper-w1510058165","cat":"papers","name":"Metanfetamina vendida como MDMA (3,4-metilendioximetanfetamina, éxtasis)","year":"2013","cit":0,"pfa":"Fernando Caudevilla Gálligo","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1510058165","eid":"W1510058165"},{"id":"paper-w2035787385","cat":"papers","name":"Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans","year":"2013","cit":0,"pfa":"April Rolle","psa":"Robert S. Hoffman","topics":["Safety & adverse events","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2035787385","eid":"W2035787385"},{"id":"paper-w4401454556","cat":"papers","name":"Experiências anômalas com ayahuasca e DMT: uma leitura psicossocial","year":"2024","cit":0,"pfa":"Ricardo Assarice dos Santos","ptype":"dissertation","src":"https://openalex.org/W4401454556","eid":"W4401454556"},{"id":"paper-w2407431128","cat":"papers","name":"[Preliminary aspects of the pharmaco-psychiatric study of the ayahuasca and its active principle].","year":"1962","cit":0,"pfa":"Oscar Ríos","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2407431128","eid":"W2407431128"},{"id":"paper-w7212120408","cat":"papers","name":"Multilevel Mechanisms and Clinical Efficacy of Psilocybin in Depression Treatment: A Systematic Review","year":"2026","cit":0,"pfa":"Xizhen Zhang","psa":"Sheng Wei","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W7212120408","eid":"W7212120408"},{"id":"paper-w4237519030","cat":"papers","name":"Donepezil in MDMA Users: A Potential Treatment? A Case Study","year":"2003","cit":0,"pfa":"Diana Jovanovski","ptype":"dataset","src":"https://openalex.org/W4237519030","eid":"W4237519030"},{"id":"paper-w7204910411","cat":"papers","name":"El uso de MDMA para el TEPT","year":"2018","cit":0,"pfa":"Mercedes Guaia Memita Guaia","topics":["Mechanism & neuroscience"],"ptype":"report","src":"https://openalex.org/W7204910411","eid":"W7204910411"},{"id":"paper-w2771523803","cat":"papers","name":"Methylenedioxymethamphetamine (MDMA)-induced toxic leukoencephalopathy: a case report","year":"2017","cit":0,"pfa":"Haitham Salem","psa":"Antônio Lúcio Teixeira","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2771523803","eid":"W2771523803"},{"id":"paper-w2056891709","cat":"papers","name":"Behavioral memory impairment in abstinent MDMA (Ecstasy) users","year":"2000","cit":0,"pfa":"Konstantine K. Zakzanis","ptype":"article","src":"https://openalex.org/W2056891709","eid":"W2056891709"},{"id":"paper-w2190392141","cat":"papers","name":"MDMA : réduction des risques en milieu festif","year":"2015","cit":0,"pfa":"Thomas Lalanne","ptype":"article","src":"https://openalex.org/W2190392141","eid":"W2190392141"},{"id":"paper-w7167343159","cat":"papers","name":"Toward a nuanced framework for the medical development of ibogaine and its analogues and derivatives: implications for psychopharmacology","year":"2026","cit":0,"pfa":"Christopher D. Verrico","psa":"Ramiro Salas","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7167343159","eid":"W7167343159"},{"id":"paper-w356377530","cat":"papers","name":"Iboga Alkaloidsの全合成 (天然物化学'68)","year":"1968","cit":0,"pfa":"亘 永田","ptype":"article","src":"https://openalex.org/W356377530","eid":"W356377530"},{"id":"paper-w2949140957","cat":"papers","name":"ChemInform Abstract: CARBON‐13 NMR SPECTROSCOPY OF NATURALLY OCCURRING SUBSTANCES. XLV. IBOGA ALKALOIDS","year":"1977","cit":0,"pfa":"Ernest Wenkert","psa":"Maria Iracema Lacerda Machado Madruga","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2949140957","eid":"W2949140957"},{"id":"paper-w4414657180","cat":"papers","name":"Considering Psilocybin Legalization: Insights for New York and Other Jurisdictions","year":"2025","cit":0,"pfa":"Kilmer, Beau","topics":["Policy & ethics"],"ptype":"book","src":"https://openalex.org/W4414657180","eid":"W4414657180"},{"id":"paper-w7211918960","cat":"papers","name":"P31-17 Psilocin as a Broad CYP450 Inhibitor: Evidence from Enzymatic Assays and Molecular Dynamics","year":"2026","cit":0,"pfa":"D. Dias da Silva","psa":"S.F. Sousa","ptype":"article","src":"https://openalex.org/W7211918960","eid":"W7211918960"},{"id":"paper-w2289089661","cat":"papers","name":"Formas de Pensar a Ayahuasca: Internet Viabilizando a Construção de Novas","year":"2011","cit":0,"pfa":"Carlos García","psa":"Duarte de Lanna","ptype":"article","src":"https://openalex.org/W2289089661","eid":"W2289089661"},{"id":"paper-w3088435629","cat":"papers","name":"Effects of psilocybin on time perception and temporal control of behaviour in humans","year":"2007","cit":0,"pfa":"Marc Wittmann","psa":"Franz X. Vollenweider","ptype":"article","src":"https://openalex.org/W3088435629","eid":"W3088435629"},{"id":"paper-w3005367189","cat":"papers","name":"Psilocybin may help cancer patients with depression and anxiety for years","year":"2020","cit":0,"pfa":"Laura Sanders","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3005367189","eid":"W3005367189"},{"id":"paper-w2752994995","cat":"papers","name":"Os sentidos da experiência com a ayahuasca : uma leitura fenomenológica","year":"2011","cit":0,"pfa":"Filipe Starling Loureiro Franca","ptype":"dissertation","src":"https://openalex.org/W2752994995","eid":"W2752994995"},{"id":"paper-w4313203493","cat":"papers","name":"Ayahuasca e as pesquisas relacionadas ao contexto religioso: revisão integrativa","year":"2022","cit":0,"pfa":"Thalyta Mariany Rêgo Lopes Ueno","psa":"Alex Martins","ptype":"article","src":"https://openalex.org/W4313203493","eid":"W4313203493"},{"id":"paper-w4385669433","cat":"papers","name":"Possible psychotic episode after repeated ayahuasca intake: a case report","year":"2023","cit":0,"pfa":"E. Prades Marin","psa":"P. Sánchez Díez","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4385669433","eid":"W4385669433"},{"id":"paper-w4404059677","cat":"papers","name":"Could Ayahuasca Communities Play a Role in the Compassionate Communities Movement?: A Commentary","year":"2024","cit":0,"pfa":"Débora González","psa":"José Carlos Bouso","ptype":"article","src":"https://openalex.org/W4404059677","eid":"W4404059677"},{"id":"paper-w2240538941","cat":"papers","name":"16. Ayahuasca contra violencia: estudio de caso de asesinato","year":"2013","cit":0,"pfa":"Ede Frecska","ptype":"article","src":"https://openalex.org/W2240538941","eid":"W2240538941"},{"id":"paper-w7118465147","cat":"papers","name":"Revisiting trauma through altered states: The potential of ayahuasca-assisted therapy","year":"2026","cit":0,"pfa":"Gazaal Zahedi","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W7118465147","eid":"W7118465147"},{"id":"paper-w7140714281","cat":"papers","name":"Anti-nociceptive effect of psilocybin in a preclinical model of neuropathic pain","year":"2026","cit":0,"pfa":"Maria Maiarù","ptype":"dataset","src":"https://openalex.org/W7140714281","eid":"W7140714281"},{"id":"paper-w2911948015","cat":"papers","name":"Consumption of MDMA: A survey in the French male homosexual population","year":"2019","cit":0,"pfa":"Andrew Laurin","psa":"Y. Bescond","ptype":"article","src":"https://openalex.org/W2911948015","eid":"W2911948015"},{"id":"paper-w1978425017","cat":"papers","name":"Cannabis and MDMA abuse Continues to Incline Among Adoelescents","year":"2009","cit":0,"pfa":"S. Vucetic-Arsic","psa":"J. Daragan-Saveljic","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1978425017","eid":"W1978425017"},{"id":"paper-w3016415830","cat":"papers","name":"MDMA and Pavlovian Fear Memory: Dose‐Effect Analysis","year":"2019","cit":0,"pfa":"Madeline M. Pantoni","psa":"Stephan Anagnostaras","topics":["PTSD & trauma","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3016415830","eid":"W3016415830"},{"id":"paper-w4386946264","cat":"papers","name":"MDMA expected to get US approval as therapy for PTSD","year":"2023","cit":0,"pfa":"Jason Arunn Murugesu","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4386946264","eid":"W4386946264"},{"id":"paper-w825829637","cat":"papers","name":"An Examination of Federal Sentencing Guidelines' Treatment of MDMA ('Ecstasy')","year":"2014","cit":0,"pfa":"Alyssa C. Hennig","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W825829637","eid":"W825829637"},{"id":"paper-w4401919790","cat":"papers","name":"Motives for MDMA Use: A Comparative Study with Alcohol and Cannabis","year":"2024","cit":0,"pfa":"DANIELE FABIO ZULLINO","psa":"Gabriel Thorens","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4401919790","eid":"W4401919790"},{"id":"paper-w2057919525","cat":"papers","name":"B61 MDMA ATTENUATES THC WITHDRAWAL SYNDROME IN MICE","year":"2005","cit":0,"pfa":"Clara Touriño","psa":"Olga Valverde","ptype":"conference-abstract","src":"https://openalex.org/W2057919525","eid":"W2057919525"},{"id":"paper-w2335044593","cat":"papers","name":"Effects of MDMA and methylphenidate on steroid levels in healthy humans","year":"2013","cit":0,"pfa":"Julia Seibert","psa":"Alex Odermatt","ptype":"article","src":"https://openalex.org/W2335044593","eid":"W2335044593"},{"id":"paper-w4249533081","cat":"papers","name":"Trial of psilocybin does not show major difference from antidepressant","year":"2021","cit":0,"topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4249533081","eid":"W4249533081"},{"id":"paper-w7105986457","cat":"papers","name":"Collective Voices of Healing: Psilocybin Discourse and Meaning-Making on Reddit","year":"2025","cit":0,"pfa":"Gevorgyan, Natalya","psa":"Gevorgyan, Narek","topics":["Depression","PTSD & trauma","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7105986457","eid":"W7105986457"},{"id":"paper-w7138979953","cat":"papers","name":"Optimization of Psilocybin Extraction from Psilocybe cubensis Mushrooms and Characterization of the Fungal Extract","year":"2026","cit":0,"pfa":"Mateus Araújo da Luz","psa":"Maria C. M. Torres","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7138979953","eid":"W7138979953"},{"id":"paper-w3215794758","cat":"papers","name":"Researchers hope psilocybin could improve quit rates for smokers","year":"2021","cit":0,"pfa":"Gary A. Enos","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W3215794758","eid":"W3215794758"},{"id":"paper-w4414761184","cat":"papers","name":"Legal and Regulatory Barriers to Medical Psilocybin Use: An International Overview","year":"2025","cit":0,"pfa":"Mohamad Chweikh","topics":["Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4414761184","eid":"W4414761184"},{"id":"paper-w7160417548","cat":"papers","name":"Case series of psilocybin self-medication for spinal cord injury","year":"2026","cit":0,"pfa":"Robin Sandell","psa":"Robin Lester Carhart-Harris","ptype":"preprint","src":"https://openalex.org/W7160417548","eid":"W7160417548"},{"id":"paper-w2501418529","cat":"papers","name":"TOMIANCRA DEVELOPMENT TO THE ANTINOCICEPTIVE ACTION OP MESCALINE INTRAVEN= TRICULARLY INJECTED INTO THE RABBIT","year":"1977","cit":0,"pfa":"P. C. Braga","psa":"Angela Santagostino","ptype":"conference-abstract","src":"https://openalex.org/W2501418529","eid":"W2501418529"},{"id":"paper-w7164529693","cat":"papers","name":"Physarum-Mediated Biofeedback Rehabilitation: A Bio-Hybrid Framework for Ibogaine-Assisted Neural Recovery","year":"2026","cit":0,"pfa":"Saeid Ghiasi","topics":["PTSD & trauma","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7164529693","eid":"W7164529693"},{"id":"paper-w2055183248","cat":"papers","name":"INCREASED ANXIETY AND DEPRESSION ASSOCIATED WITH MDMA (ECSTASY) USE","year":"1999","cit":0,"pfa":"Anthony M. J. Montgomery","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W2055183248","eid":"W2055183248"},{"id":"paper-w2610328047","cat":"papers","name":"Pneumomediastinum as a complication of MDMA (3,4-methylenedioxymetamfetamine, Ecstasy) ingestion","year":"2016","cit":0,"pfa":"Suleiman Ezoubi","psa":"W. Stephen Waring","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2610328047","eid":"W2610328047"},{"id":"paper-w4237726049","cat":"papers","name":"Effects of modafinil on MDMA-induced spatial memory impairment","year":"2016","cit":0,"pfa":"Rayhaneh Shariatmadari","ptype":"other","src":"https://openalex.org/W4237726049","eid":"W4237726049"},{"id":"paper-w3080569875","cat":"papers","name":"[Three forms of Dionysus: recreational, medical and religious use of ayahuasca].","year":"2020","cit":0,"pfa":"A.F.M. van der Braak","ptype":"article","src":"https://openalex.org/W3080569875","eid":"W3080569875"},{"id":"paper-w2336849002","cat":"papers","name":"Something Old or Something New? Indian Peyote Churches And the Cultural Logic of Authenticity 1","year":"2002","cit":0,"pfa":"Matthew Meyer","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2336849002","eid":"W2336849002"},{"id":"paper-w7110975881","cat":"papers","name":"Clinical pharmacokinetics of N,N-dimethyltryptamine (DMT): a systematic review and post-hoc analysis","year":"2025","cit":0,"pfa":"Heijden, K.V. van der","psa":"Jacobs, G.","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7110975881","eid":"W7110975881"},{"id":"paper-w4408334427","cat":"papers","name":"“Plants Don’t Have a Culture to Appropriate”: Accounting for Accusations of Cultural Appropriation of Peyote Ceremonies","year":"2025","cit":0,"pfa":"Heith Copes","psa":"Peter S. Hendricks","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4408334427","eid":"W4408334427"},{"id":"paper-w2318828559","cat":"papers","name":"ChemInform Abstract: SYNTH. DES SCHWEFELANALOGEN VON PSILOCIN UND EINIGEN VERWANDTEN VERBINDUNGEN","year":"1973","cit":0,"pfa":"N. B. Chapman","psa":"Thomas Sutton","ptype":"article","src":"https://openalex.org/W2318828559","eid":"W2318828559"},{"id":"paper-w4417437388","cat":"papers","name":"Which Psychotherapy Model Should be Used in Psilocybin Treatment for Depression?","year":"2025","cit":0,"pfa":"Elena Koning","psa":"Elisa M. Brietzke","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4417437388","eid":"W4417437388"},{"id":"paper-w7141025975","cat":"papers","name":"Psilocybin Attenuates Cortical Representations of Aversion in the Mouse Auditory Cortex","year":"2026","cit":0,"pfa":"James D. Johnson","psa":"Zheng Li","topics":["PTSD & trauma","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7141025975","eid":"W7141025975"},{"id":"paper-w2285064619","cat":"papers","name":"Cardiovascular and Renal Responses Produced by the Central Microinjection of Salvinorin A in Ketamine/Xylaxine‐Anesthetized Rats","year":"2009","cit":0,"pfa":"Helmut B. Gottlieb","psa":"JT Cunningham","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2285064619","eid":"W2285064619"},{"id":"paper-w1584567406","cat":"papers","name":"Abuse of Magic Mushrooms, Peyote Cactus, Khat, and Solvents: No Readily Available Laboratory Tests","year":"2012","cit":0,"pfa":"Amitava Dasgupta","ptype":"other","src":"https://openalex.org/W1584567406","eid":"W1584567406"},{"id":"paper-w7125925661","cat":"papers","name":"Improving access to psilocybin-assisted therapy: barriers, challenges, and recommendations","year":"2026","cit":0,"pfa":"Vivian W. L. Tsang","psa":"Shannon Dames","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7125925661","eid":"W7125925661"},{"id":"paper-w1531997442","cat":"papers","name":"Elucidating the Cellular Effects of MDMA on the Serotonin Transporter (SERT)","year":"2012","cit":0,"pfa":"A. Holley","topics":["Depression","Mechanism & neuroscience","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W1531997442","eid":"W1531997442"},{"id":"paper-w4239099847","cat":"papers","name":"Club Drugs (MDMA/Ecstasy, Rohypnol, GHB, Ketamine)","year":"2013","cit":0,"pfa":"White House Office of National Drug Control Policy","ptype":"dataset","src":"https://openalex.org/W4239099847","eid":"W4239099847"},{"id":"paper-w7128701623","cat":"papers","name":"Neurorestorative properties of ibogaine: linking multi-receptor affinities to remyelination and metabolic restoration","year":"2026","cit":0,"pfa":"Tanya Calvey","psa":"STEVEN J. SHOPTAW","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7128701623","eid":"W7128701623"},{"id":"paper-w4401276469","cat":"papers","name":"Psilocybin - A Drug to be Considered for the Treatment of Anxiety and Depression in Cancer Patients","year":"2024","cit":0,"pfa":"Velumani Suresh","psa":"Ramachandran Balaraman","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4401276469","eid":"W4401276469"},{"id":"paper-w7117975833","cat":"papers","name":"Perceptions of Psilocybin-Assisted Psychotherapy and Standard Interventions for Nicotine Cessation","year":"2026","cit":0,"pfa":"Philip Kamilar-Britt","psa":"Mitch Earleywine","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W7117975833","eid":"W7117975833"},{"id":"paper-w238600660","cat":"papers","name":"Ecstasy: Legislative Proposals in the 107th Congress to Control MDMA","year":"2003","cit":0,"pfa":"Mark Eddy","ptype":"article","src":"https://openalex.org/W238600660","eid":"W238600660"},{"id":"paper-w3032794299","cat":"papers","name":"The effect on anxious mood of rats of acute toxicity of MDMA","year":"2006","cit":0,"pfa":"李素霞","psa":"黄明生","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3032794299","eid":"W3032794299"},{"id":"paper-w4233041482","cat":"papers","name":"o ‐Phosphoryl‐4‐Hydroxy‐ N , N ‐Dimethyltryptamine 520‐52‐5","year":"2004","cit":0,"ptype":"other","src":"https://openalex.org/W4233041482","eid":"W4233041482"},{"id":"paper-w7171924130","cat":"papers","name":"Beyond psilocybin: Do magic mushroom preparations contain other compounds with pharmacological effects?","year":"2026","cit":0,"pfa":"Samuel Lasham","psa":"Rhys Ponton","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7171924130","eid":"W7171924130"},{"id":"paper-w3193030430","cat":"papers","name":"The effects of psilocybin microdosing on perception: a double-blind controlled study","year":"2019","cit":0,"pfa":"Michiel van Elk","psa":"Pascal Lempe","topics":["Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W3193030430","eid":"W3193030430"},{"id":"paper-w7154988296","cat":"papers","name":"Sustained Effects of Low-to-Moderate Doses of Psilocybin on Brain Connectivity","year":"2026","cit":0,"pfa":"Chiranth Bhagavan","psa":"Richard Kanaan","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7154988296","eid":"W7154988296"},{"id":"paper-w7170080395","cat":"papers","name":"Psilocybin as serotonergic therapy in epilepsy: Narrative review of potentials and limitations","year":"2026","cit":0,"pfa":"Miguel Benjamín Cervera-Sánchez","psa":"Christian Padilla-Cabezutd","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W7170080395","eid":"W7170080395"},{"id":"paper-w4250377597","cat":"papers","name":"MDMA and Pavlovian Fear Memory: Dose‐Effect Analysis","year":"2020","cit":0,"pfa":"Madeline M. Pantoni","psa":"Stephan Anagnostaras","topics":["PTSD & trauma","Anxiety & end-of-life","Safety & adverse events"],"ptype":"conference-abstract","src":"https://openalex.org/W4250377597","eid":"W4250377597"},{"id":"paper-w4406147548","cat":"papers","name":"A Psilocybin Experience Gone Wrong: The Importance of Psychedelic Assisted Psychotherapy","year":"2025","cit":0,"pfa":"Fernando Espí Forcén","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4406147548","eid":"W4406147548"},{"id":"paper-w2596133640","cat":"papers","name":"Escutar interpretações e interpretar: memórias do \"Povo da Ayahuasca\"","year":"2016","cit":0,"pfa":"Gerson Rodrigues de Albuquerque","ptype":"article","src":"https://openalex.org/W2596133640","eid":"W2596133640"},{"id":"paper-w3020543541","cat":"papers","name":"Assessment of the mechanism of neurotoxicity of 3,4-methylenedioxy methamphetamine (MDMA)","year":"1988","cit":0,"pfa":"Thomas Steele","topics":["Safety & adverse events","Mechanism & neuroscience","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W3020543541","eid":"W3020543541"},{"id":"paper-w7204807964","cat":"papers","name":"Beyond the empathogen label: the social-affective profile of MDMA","year":"2026","cit":0,"pfa":"Makaela Weeda","psa":"Ákos Babiczky","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7204807964","eid":"W7204807964"},{"id":"paper-w7119287155","cat":"papers","name":"Os efeitos da Ayahuasca em modelo animal de depressão","year":"2018","cit":0,"pfa":"Janaína Xavier da Silveira","topics":["Depression"],"ptype":"dissertation","src":"https://openalex.org/W7119287155","eid":"W7119287155"},{"id":"paper-w7214403881","cat":"papers","name":"Single-Dose Ayahuasca for Depressive and Anxiety Symptoms Associated With Cancer Diagnosis","year":"2026","cit":0,"pfa":"Renan Massanobu Maekawa","psa":"RAFAEL GUIMARÃES DOS SANTOS","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7214403881","eid":"W7214403881"},{"id":"paper-w2560048772","cat":"papers","name":"Uso ritualístico da ayahuasca : percursos terapêuticos, saúde e espiritualidade","year":"2016","cit":0,"pfa":"Jaqueline Tavares de Assis","ptype":"dissertation","src":"https://openalex.org/W2560048772","eid":"W2560048772"},{"id":"paper-w4226427970","cat":"papers","name":"USO DA AYAHUASCA NO TRATAMENTO DA DEPRESSÃO: UMA REVISÃO LITERÁRIA","year":"2022","cit":0,"pfa":"Robenilson Diniz Alves","psa":"José Jorde Canuto da Silva","topics":["Depression"],"ptype":"book-chapter","src":"https://openalex.org/W4226427970","eid":"W4226427970"},{"id":"paper-w7154318405","cat":"papers","name":"Development of Bioisosteres of Iboga Alkaloids: A Step-Economical Synthesis to Enhance the Antinociceptive and Anxiolytic Activity with Neuroprotective Effects","year":"2026","cit":0,"pfa":"Abhishek Gupta","psa":"Surajit Sinha","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7154318405","eid":"W7154318405"},{"id":"paper-w2310864213","cat":"papers","name":"Psilocybin, an active psychotropic material from the Mexican hallucinogenic fungus.","year":"1958","cit":0,"pfa":"Alfred André Hofmann","psa":"H. Kobel","ptype":"article","src":"https://openalex.org/W2310864213","eid":"W2310864213"},{"id":"paper-w7164239928","cat":"papers","name":"Categorizing Key Elements of Interpersonal Grounding in Psilocybin-Assisted Therapy","year":"2026","cit":0,"pfa":"Julia Hart","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"other","src":"https://openalex.org/W7164239928","eid":"W7164239928"},{"id":"paper-w7163847115","cat":"papers","name":"EFFECT OF PSILOCYBIN ON PERSISTENT AVERSIVE SIGNALING ACROSS THE CINGULATE CORTEX","year":"2025","cit":0,"pfa":"Sophie Rogers","topics":["Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W7163847115","eid":"W7163847115"},{"id":"paper-w7162551404","cat":"papers","name":"Catatonia Associated With First-Time Psilocybin Exposure: A Case Report","year":"2026","cit":0,"pfa":"Jasbir Singh","psa":"Pranathi Mruthyunjaya","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7162551404","eid":"W7162551404"},{"id":"paper-w2940926707","cat":"papers","name":"Wild type human serotonin transporter in complex with 15B8 Fab bound to ibogaine in occluded conformation","year":"2018","cit":0,"pfa":"Jonathan A. Coleman","psa":"Eric Gouaux","topics":["Mechanism & neuroscience"],"ptype":"dataset","src":"https://openalex.org/W2940926707","eid":"W2940926707"},{"id":"paper-w4414270284","cat":"papers","name":"Território e Xamanismo no Instituto Céu da Ayahuasca (Marabá-PA)","year":"2025","cit":0,"pfa":"Roberta Cruz Correia","psa":"Jeronimo Silva e Silva","ptype":"book-chapter","src":"https://openalex.org/W4414270284","eid":"W4414270284"},{"id":"paper-w4411735765","cat":"papers","name":"Ayahuasca and the Unified Integrative Model of Medicine: A Path to Healing and Spiritual Transformation","year":"2025","cit":0,"pfa":"Nader Butto","topics":["PTSD & trauma","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4411735765","eid":"W4411735765"},{"id":"paper-w4313199668","cat":"papers","name":"The effect of psilocybin and sleep manipulation on neuroplasticity and sleep architecture in rats","year":"2022","cit":0,"pfa":"Lucie Olejníková","psa":"Tomáš Páleníček","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4313199668","eid":"W4313199668"},{"id":"paper-w7132167095","cat":"papers","name":"Cardiovascular effects of a hallucinogenic agent (psilocybin) – presentation of a clinical case","year":"2023","cit":0,"pfa":"Augustė Railaitė","psa":"Giedrė Bakšytė","topics":["Safety & adverse events"],"ptype":"conference-paper","src":"https://openalex.org/W7132167095","eid":"W7132167095"},{"id":"paper-w4402851343","cat":"papers","name":"A clinical trial of 5 mg psilocybin plus psychological support vs 25 mg psilocybin plus psychological support in adults with generalised anxiety disorder","year":"2024","cit":0,"pfa":"Clare Knight","psa":"Mallika Punukollu","topics":["Anxiety & end-of-life"],"ptype":"dataset","src":"https://openalex.org/W4402851343","eid":"W4402851343"},{"id":"paper-w7204002261","cat":"papers","name":"Distinct response of resting-state brain networks to psilocybin in autism","year":"2026","cit":0,"pfa":"Tobias P. Whelan","psa":"Grainne Mary McAlonan","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7204002261","eid":"W7204002261"},{"id":"paper-w7148332219","cat":"papers","name":"Psilocybin Attenuates Cortical Representations of Aversion in the Mouse Auditory Cortex","year":"2026","cit":0,"pfa":"James Johnson","topics":["Mechanism & neuroscience"],"ptype":"dataset","src":"https://openalex.org/W7148332219","eid":"W7148332219"},{"id":"paper-w7208821196","cat":"papers","name":"HORMONAL MODULATION OF PSILOCYBIN RESPONSIVITY ACROSS THE FEMALE REPRODUCTIVE LIFESPAN","year":"2026","cit":0,"pfa":"Katarzyna Pawłucka","psa":"Martyna Więcławek","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7208821196","eid":"W7208821196"},{"id":"paper-w249515812","cat":"papers","name":"Differential Effects of Sex on the Attenuation of d-amphetamine-induced Hyperlocomotor Activity by Salvinorin A in Rats","year":"2013","cit":0,"pfa":"M. Melissa Peet","ptype":"article","src":"https://openalex.org/W249515812","eid":"W249515812"},{"id":"paper-w3042032199","cat":"papers","name":"Religious Revitalization Among the Kiowas: The Ghost Dance, Peyote, and Christianity . By Benjamin R. Kracht","year":"2020","cit":0,"pfa":"Jennifer Graber","ptype":"article","src":"https://openalex.org/W3042032199","eid":"W3042032199"},{"id":"paper-w7200407946","cat":"papers","name":"Search strategy for rapid review of psilocybin for treatment-resistant depression","year":"2024","cit":0,"pfa":"Caroline Currie","psa":"Valentina Mărginean","topics":["Depression","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7200407946","eid":"W7200407946"},{"id":"paper-w3184447009","cat":"papers","name":"Psilocybin-Assisted Therapy: A Double-Blind Randomized Controlled Trial","year":"2019","cit":0,"pfa":"Katherine Gruppo","ptype":"article","src":"https://openalex.org/W3184447009","eid":"W3184447009"},{"id":"paper-w2104246914","cat":"papers","name":"An application of Ricoeur's hermeneutic theory: Configuations of the shamanic in contemporary ayahuasca narratives","year":"2013","cit":0,"pfa":"Matthew Koczkur","ptype":"dissertation","src":"https://openalex.org/W2104246914","eid":"W2104246914"},{"id":"paper-w4417255521","cat":"papers","name":"Network Rerouting Under Ayahuasca: Temporally and Hemisphere-Resolved EEG Connectomics","year":"2025","cit":0,"pfa":"Caroline L. Alves","psa":"Dráulio Barros de Araújo","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4417255521","eid":"W4417255521"},{"id":"paper-w7169797894","cat":"papers","name":"Sustained abstinence in severe ketamine use disorder following ibogaine treatment case report","year":"2026","cit":0,"pfa":"Sergio R Pérez Rosal","psa":"Markus Backmund","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7169797894","eid":"W7169797894"},{"id":"paper-w4413284724","cat":"papers","name":"597. ARE SIDE EFFECTS NECESSARY FOR ANTIDEPRESSIVE TREATMENT: THE PSILOCYBIN EXPERIENCE","year":"2025","cit":0,"pfa":"Siegfried Kasper","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W4413284724","eid":"W4413284724"},{"id":"paper-w1552887584","cat":"papers","name":"Ayahuasca- \"själens dryck\" : En intervjustudie utifrån svenska deltagares perspektiv om valet att använda sig av Ayahuasca samt hur erfarenheten påverkat dem.","year":"2014","cit":0,"pfa":"Bodil Anderson","ptype":"dissertation","src":"https://openalex.org/W1552887584","eid":"W1552887584"},{"id":"paper-w4377091976","cat":"papers","name":"A força da espiritualidade na saúde: O uso da Ayahuasca","year":"2023","cit":0,"pfa":"Kelly Caroline Andrade","psa":"Emyr Hiago Bellaver","topics":["Depression"],"ptype":"book-chapter","src":"https://openalex.org/W4377091976","eid":"W4377091976"},{"id":"paper-w7197325687","cat":"papers","name":"Perceptions of Psychedelics: University Students' Attitudes and Motives for Psilocybin Use","year":"2024","cit":0,"pfa":"Shayla Frinton","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7197325687","eid":"W7197325687"},{"id":"paper-w7106018746","cat":"papers","name":"Collective Voices of Healing: Psilocybin Discourse and Meaning-Making on Reddit","year":"2025","cit":0,"pfa":"Gevorgyan, Natalya","psa":"Gevorgyan, Narek","topics":["Depression","PTSD & trauma","Reviews & meta-analyses"],"ptype":"report","src":"https://openalex.org/W7106018746","eid":"W7106018746"},{"id":"paper-w7133186796","cat":"papers","name":"A Randomized Controlled Trial of Psilocybin for the Treatment of Obsessive-Compulsive Disorder","year":"2026","cit":0,"pfa":"Katja Ehrmann","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W7133186796","eid":"W7133186796"},{"id":"paper-w7111643881","cat":"papers","name":"Transformative work - Individual pursuits of self-improvement in collective Ayahuasca ceremonies","year":"2025","cit":0,"pfa":"Petersen, Margit Anne; id_orcid 0000-0002-9145-6745","ptype":"book-chapter","src":"https://openalex.org/W7111643881","eid":"W7111643881"},{"id":"paper-w4416097430","cat":"papers","name":"Intact neurophysiological markers of death denial in long-term ayahuasca users","year":"2025","cit":0,"pfa":"Yair Dor‐Ziderman","psa":"Aviva Berkovich‐Ohana","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4416097430","eid":"W4416097430"},{"id":"paper-w7141125275","cat":"papers","name":"Microdosing With Psilocybin Mushrooms: A Double-Blind Placebo-Controlled Study","year":"2022","cit":0,"pfa":"James Phelps","topics":["Dosing & pharmacology"],"ptype":"report","src":"https://openalex.org/W7141125275","eid":"W7141125275"},{"id":"paper-w4317889950","cat":"papers","name":"Going on Trial: Arbaclofen reboot; cell implants; psilocybin microdoses","year":"2023","cit":0,"pfa":"Peter Hess","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4317889950","eid":"W4317889950"},{"id":"paper-w4399225856","cat":"papers","name":"Using Psilocybin Therapy for treating end of life distress trial","year":"2023","cit":0,"pfa":"Margaret Ross","psa":"Justin L. Dwyer","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4399225856","eid":"W4399225856"},{"id":"paper-w7166853822","cat":"papers","name":"The relevance of the 5HT2A–mGlu2 heterodimer in explaining the clinical ambivalence of psilocybin","year":"2026","cit":0,"pfa":"Guillermo Saúl Escobar Cornejo","psa":"Fernando P. Cárdenas","ptype":"article","src":"https://openalex.org/W7166853822","eid":"W7166853822"},{"id":"paper-w7165437838","cat":"papers","name":"Evaluating the therapeutic and ethical dimensions of psilocybin for major depressive disorder","year":"2025","cit":0,"pfa":"Girija Bhatnagar","topics":["Depression","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W7165437838","eid":"W7165437838"},{"id":"paper-w7160471612","cat":"papers","name":"The effects of psilocybin microdosing on perception: a double-blind controlled study","year":"2021","cit":0,"pfa":"Josephine Marschall","psa":"Michiel van Elk","topics":["Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7160471612","eid":"W7160471612"},{"id":"paper-w7158598212","cat":"papers","name":"Psilocybin and Irritable Bowel Syndrome: A Scoping Review of the Existing Evidence","year":"2026","cit":0,"pfa":"Saeed, Muhammad Osama","topics":["Reviews & meta-analyses"],"ptype":"other","src":"https://openalex.org/W7158598212","eid":"W7158598212"},{"id":"paper-w4413284594","cat":"papers","name":"476. ACUTE AND CHRONIC PSILOCYBIN IN MOUSE MODELS OF PSYCHIATRIC DISORDERS","year":"2025","cit":0,"pfa":"Thibault Renoir","psa":"Anthony John Hannan","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4413284594","eid":"W4413284594"},{"id":"paper-w7163680882","cat":"papers","name":"Developing Methods for Observing Awe Narration in Psilocybin-Assisted Therapy","year":"2026","cit":0,"pfa":"Elise C. Tarbi","psa":"Emily Manetta","topics":["Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7163680882","eid":"W7163680882"},{"id":"paper-w4412700952","cat":"papers","name":"La geopolítica del peyote en México y el suroeste de EE. UU","year":"2024","cit":0,"pfa":"Osiris Sinuhé González Romero","ptype":"article","src":"https://openalex.org/W4412700952","eid":"W4412700952"},{"id":"paper-w2396811648","cat":"papers","name":"Psilocybin as an Inducer of Ego Death and Similar Experiences of Religious Provenance","year":"2016","cit":0,"pfa":"Katarzyna Stebelska","psa":"Krzysztof Łabuz","ptype":"book-chapter","src":"https://openalex.org/W2396811648","eid":"W2396811648"},{"id":"paper-w7162787347","cat":"papers","name":"Psilocybin shows mixed results for patients with treatment‐resistant depression","year":"2026","cit":0,"topics":["Depression","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7162787347","eid":"W7162787347"},{"id":"paper-w4327809071","cat":"papers","name":"AYAHUASCA: INTERAÇÃO NEUROFARMACOLOGICA, ESTADO DE CONSCIÊNCIA E USO RITUALÍSTICO.","year":"2022","cit":0,"pfa":"RAIANE KELLY GOMES OLIVEIRA","psa":"Natássia Albuquerque Ribeiro","ptype":"conference-paper","src":"https://openalex.org/W4327809071","eid":"W4327809071"},{"id":"paper-w4416985266","cat":"papers","name":"Predicting and exploring ayahuasca effects: Perception, mind-wandering, and EEG oscillations","year":"2025","cit":0,"pfa":"Natan Silva-Costa","psa":"Isabel Wießner","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4416985266","eid":"W4416985266"},{"id":"paper-w7164845889","cat":"papers","name":"Psilocybin and Mental Health Outcomes: Scoping Review with ☸SAIMSARA","year":"2026","cit":0,"pfa":"SAIMSARA","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7164845889","eid":"W7164845889"},{"id":"paper-w4409838180","cat":"papers","name":"University Students’ Motives for Psilocybin Use: A Mixed-Methods Analysis","year":"2025","cit":0,"pfa":"Shayla Frinton","psa":"Jill Oliver Robinson","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4409838180","eid":"W4409838180"},{"id":"paper-w7211943708","cat":"papers","name":"Daily briefing: Psilocybin blocks side-effect of chemotherapy in mice","year":"2026","cit":0,"pfa":"Flora Graham","ptype":"article","src":"https://openalex.org/W7211943708","eid":"W7211943708"},{"id":"paper-w7167787527","cat":"papers","name":"Therapeutic potential of psilocybin in the pharmacological treatment of obsessive-compulsive disorder: a scoping review protocol.","year":"2026","cit":0,"pfa":"Raul Edison Luna Lazo","psa":"Roberto Pontarolo","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7167787527","eid":"W7167787527"},{"id":"paper-w7114816897","cat":"papers","name":"Population pharmacokinetic-pharmacodynamic modeling of co-administered N,N-dimethyltryptamine and harmine in healthy subjects","year":"2025","cit":0,"pfa":"Äbelö, Angela","psa":"Scheidegger, Milan","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7114816897","eid":"W7114816897"},{"id":"paper-w7155871864","cat":"papers","name":"Guarda [CB01] Willie Peyote - Elegia Sabauda In Streaming ita Senza Registrazione","year":"2026","cit":0,"pfa":"pusing ndase","topics":["Policy & ethics"],"ptype":"report","src":"https://openalex.org/W7155871864","eid":"W7155871864"},{"id":"paper-w7171574916","cat":"papers","name":"Protective Role of Dimethyltryptamine in Preserving Donor Heart Function in a Heterotopic Rat Transplantation Model","year":"2026","cit":0,"pfa":"Máté Csonka","psa":"Kálmán Benke","ptype":"preprint","src":"https://openalex.org/W7171574916","eid":"W7171574916"},{"id":"paper-w4395032120","cat":"papers","name":"MedCheck: Psilocybin for Depression, LSD for Anxiety, Donanemab, LSD, and More","year":"2024","cit":0,"pfa":"Terri D’Arrigo","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4395032120","eid":"W4395032120"},{"id":"paper-w4409945764","cat":"papers","name":"Psilocybin‐assisted therapy shows range of benefits in cancer patients","year":"2025","cit":0,"topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4409945764","eid":"W4409945764"},{"id":"paper-w1546811553","cat":"papers","name":"The effects of psilocybin and lycergic acid on the extinction of avoidance behavior in rats.","year":"1961","cit":0,"pfa":"Jacoby, John Eric","ptype":"article","src":"https://openalex.org/W1546811553","eid":"W1546811553"},{"id":"paper-w7199110388","cat":"papers","name":"The theory and practice of psilocybin assisted psychotherapy : an intervention design checklist","year":"2018","cit":0,"pfa":"Volodymyr Mykhalevych","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W7199110388","eid":"W7199110388"},{"id":"paper-w7154799735","cat":"papers","name":"‘Fostering a cosmic connection: The experience of couples taking psilocybin together.’","year":"2025","cit":0,"pfa":"S. Rihm","topics":["Safety & adverse events","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W7154799735","eid":"W7154799735"},{"id":"paper-w7160948350","cat":"papers","name":"Observability and pharmacological calibration in psychoactive ethnobotany: ceremony duration, admixture selection, and the discovery of ayahuasca","year":"2026","cit":0,"pfa":"Elliot Allan","topics":["Addiction","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7160948350","eid":"W7160948350"},{"id":"paper-w2965064462","cat":"papers","name":"The future role of PMHNP in MDMA-assisted psychotherapy for PTSD","year":"2019","cit":0,"pfa":"pCraig Lavinp","topics":["PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2965064462","eid":"W2965064462"},{"id":"paper-w7132982825","cat":"papers","name":"MDMA-avusteinen psykoterapia hoitoresistentin traumaperäisen stressihäiriön hoidossa","year":"2021","cit":0,"pfa":"Oskari Ventilä","psa":"Antti Hupli","topics":["PTSD & trauma"],"ptype":"review","src":"https://openalex.org/W7132982825","eid":"W7132982825"},{"id":"paper-w151021061","cat":"papers","name":"Ayahuasca: una bebida entre la persecución y el reconocimiento","year":"2009","cit":0,"pfa":"Borja De Miguel","ptype":"article","src":"https://openalex.org/W151021061","eid":"W151021061"},{"id":"paper-w7215515790","cat":"papers","name":"Psychedelic Ayahuasca induced persistent genomewide DNA methylation changes in humans","year":"2026","cit":0,"pfa":"Romain Hacquet","psa":"Francois-Xavier Ricaut","ptype":"conference-paper","src":"https://openalex.org/W7215515790","eid":"W7215515790"},{"id":"paper-w7165741598","cat":"papers","name":"Activité biologique de 9 alcaloïdes indoliques de type Iboga sur les cellules L1210","year":"1985","cit":0,"pfa":"Yahya Yachaoui","topics":["Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W7165741598","eid":"W7165741598"},{"id":"paper-w4399852572","cat":"papers","name":"Ayahuasca: da abordagem religiosa/cultural às suas aplicações farmacêuticas","year":"2023","cit":0,"pfa":"Bruno Ayron de Souza Aguiar","psa":"Vanessa Costa Souza Paz","ptype":"book-chapter","src":"https://openalex.org/W4399852572","eid":"W4399852572"},{"id":"paper-w4387361294","cat":"papers","name":"Psilocybin shows promising results in subjects continuing to use an antidepressant","year":"2023","cit":0,"topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4387361294","eid":"W4387361294"},{"id":"paper-w4400323479","cat":"papers","name":"Psilocybin in the Management of Substance Use Disorders: A Summary of Current Evidence","year":"2024","cit":0,"pfa":"Hussein El Bourji","psa":"Samer El Hayek","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4400323479","eid":"W4400323479"},{"id":"paper-w4376275182","cat":"papers","name":"Exposure therapy under psilocybin for general anxiety disorder and claustrophobia","year":"2023","cit":0,"pfa":"Gabriel Thorens","psa":"DANIELE FABIO ZULLINO","topics":["Depression","Anxiety & end-of-life","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4376275182","eid":"W4376275182"},{"id":"paper-w4213047290","cat":"papers","name":"Faculty Opinions recommendation of Trial of Psilocybin versus Escitalopram for Depression.","year":"2021","cit":0,"pfa":"Dave Nichols","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"peer-review","src":"https://openalex.org/W4213047290","eid":"W4213047290"},{"id":"paper-w7112145062","cat":"papers","name":"Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study","year":"2022","cit":0,"pfa":"Fiachra O'Higgins","psa":"Enzo Tagliazucchi","topics":["Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7112145062","eid":"W7112145062"},{"id":"paper-w4405635994","cat":"papers","name":"Neural effects of psilocybin-treatment in patients with treatment-resistant depression","year":"2024","cit":0,"pfa":"C. Schmitz","psa":"Gerhard Gründer","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4405635994","eid":"W4405635994"},{"id":"paper-w4394936295","cat":"papers","name":"Depressionen: Remission durch Psilocybin bei laufender SSRI-Therapie","year":"2024","cit":0,"topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4394936295","eid":"W4394936295"},{"id":"paper-w4404801372","cat":"papers","name":"Synergistic Behavioral and Neuroplastic Effects of Psilocybin-NMDAR Modulator Administration","year":"2024","cit":0,"pfa":"Tom Ben-Tal","psa":"Bernard Lerer","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4404801372","eid":"W4404801372"},{"id":"paper-w3136780439","cat":"papers","name":"Ontwikkeling van een rationeel nationaal MDMA-beleid met behulp van multi-decision multi-criterion decision analyse : Denktank MDMA beleid","year":"2020","cit":0,"pfa":"Jan van Amsterdam","psa":"Gjalt-Jorn Peters","ptype":"report","src":"https://openalex.org/W3136780439","eid":"W3136780439"},{"id":"paper-w2290888781","cat":"papers","name":"PRIMEIRO PERFIL DO USUÁRIO DE \"ÊXTASE\" (MDMA) EM","year":"2000","cit":0,"pfa":"Stella Pereira de Almeida","psa":"São Paulo","ptype":"article","src":"https://openalex.org/W2290888781","eid":"W2290888781"},{"id":"paper-w4394372533","cat":"papers","name":"An ontogenic study of the behavioral effects of chronic intermittent exposure to ayahuasca in mice","year":"2019","cit":0,"pfa":"N.F. Correa-Netto","psa":"Alessandra Linardi","topics":["Anxiety & end-of-life","Safety & adverse events"],"ptype":"dataset","src":"https://openalex.org/W4394372533","eid":"W4394372533"},{"id":"paper-w7143494435","cat":"papers","name":"Ayahuasca experiences in Uruguay: An interpretative phenomenological analysis of Neovegetalismo and Santo Daime","year":"2026","cit":0,"pfa":"Ismael Apud","psa":"Ignacio Carrera","ptype":"article","src":"https://openalex.org/W7143494435","eid":"W7143494435"},{"id":"paper-w7125693386","cat":"papers","name":"Design, Synthesis, and Pharmacokinetic Profiling of Fluorinated Reversible N -Alkyl Carbamate Derivatives of Psilocin for Sub-Hallucinogenic Brain Exposure","year":"2026","cit":0,"pfa":"Marco Banzato","psa":"Andrea Mattarei","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7125693386","eid":"W7125693386"},{"id":"paper-w7167943183","cat":"papers","name":"Proliferative Effects of the Psychedelic N,N -Dimethyltryptamine (DMT) in Human Neural Stem Cells","year":"2026","cit":0,"pfa":"José Alexandre Salerno","psa":"Stevens Kastrup Rehen","topics":["Depression","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7167943183","eid":"W7167943183"},{"id":"paper-w7158986634","cat":"papers","name":"Multimodal brain, autonomic and phenomenological data for the acute effects of N,N-dimethyltryptamine (DMT)","year":"2026","cit":0,"pfa":"Tomás Ariel D’Amelio","psa":"Enzo Tagliazucchi","topics":["Dosing & pharmacology"],"ptype":"dataset","src":"https://openalex.org/W7158986634","eid":"W7158986634"},{"id":"paper-w7119318174","cat":"papers","name":"Characterization of ayahuasca by mass spectrometry : quantification of active principles and fingerprinting analysis","year":"2018","cit":0,"pfa":"Souza, Rita de Cassia Zacardi de, 1977-","ptype":"dissertation","src":"https://openalex.org/W7119318174","eid":"W7119318174"},{"id":"paper-w4214650046","cat":"papers","name":"LA AYAHUASCA COMO NUEVO HORIZONTE TERAPÉUTICO EN TRASTORNOS PSIQUIÁTRICOS","year":"2021","cit":0,"topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"conference-paper","src":"https://openalex.org/W4214650046","eid":"W4214650046"},{"id":"paper-w3014376722","cat":"papers","name":"Behavioural, biochemical and neurocytoarchitechural impact of MDMA in male adolescent mice","year":"1970","cit":0,"pfa":"B.J Oloruntola","psa":"Philemon Dauda Shallie","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3014376722","eid":"W3014376722"},{"id":"paper-w4237466552","cat":"papers","name":"MDMA Petitions FDA to Stop Reprocessing of Single-Use Devices","year":"1999","cit":0,"ptype":"article","src":"https://openalex.org/W4237466552","eid":"W4237466552"},{"id":"paper-w2086412842","cat":"papers","name":"MDMA modulates spontaneous firing of subthalamic nucleus neurons in vitro","year":"2014","cit":0,"pfa":"Luise Liebig","psa":"Harald Hentschke","ptype":"article","src":"https://openalex.org/W2086412842","eid":"W2086412842"},{"id":"paper-w630014310","cat":"papers","name":"Word fluency deficits among users of MDMA (ecstasy)","year":"2004","cit":0,"pfa":"Catharine Montgomery","psa":"Russell Newcombe","ptype":"conference-paper","src":"https://openalex.org/W630014310","eid":"W630014310"},{"id":"paper-w4206536493","cat":"papers","name":"Effect of repeated MDMA exposure on rat brain and behaviour","year":"2020","cit":0,"pfa":"Ross van de Wetering","topics":["Addiction","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W4206536493","eid":"W4206536493"},{"id":"paper-w4408533963","cat":"papers","name":"Industry considers concerns about masking in MDMA trials","year":"2025","cit":0,"pfa":"Alison Knopf","ptype":"article","src":"https://openalex.org/W4408533963","eid":"W4408533963"},{"id":"paper-w4399287156","cat":"papers","name":"The Role of Ayahuasca in Colorectal Adenocarcinoma Cell Survival, Proliferation and Oxidative Stress","year":"2024","cit":0,"pfa":"Joana Gonçalves","psa":"Ana Paula Duarte","topics":["Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4399287156","eid":"W4399287156"},{"id":"paper-w3214562118","cat":"papers","name":"The effects of Ayahuasca on psychopathical symptoms and quality of life in an Austrian and German sample","year":"2017","cit":0,"pfa":"Julia Lubawinski","ptype":"dissertation","src":"https://openalex.org/W3214562118","eid":"W3214562118"},{"id":"paper-w790935986","cat":"papers","name":"Owning Ayahuasca: The Role of a Medicinal Plant in Colonial Bioprospecting and Contemporary Conservation","year":"2010","cit":0,"pfa":"Elizabeth Dankenbring","ptype":"article","src":"https://openalex.org/W790935986","eid":"W790935986"},{"id":"paper-w4405708480","cat":"papers","name":"POTENCIAIS TERAPÊUTICOS DA AYAHUASCA NO TRATAMENTO DE ANSIEDADE E DEPRESSÃO","year":"2024","cit":0,"pfa":"BRUNNA LIMA DOS SANTOS","topics":["Depression"],"ptype":"conference-paper","src":"https://openalex.org/W4405708480","eid":"W4405708480"},{"id":"paper-w2343603397","cat":"papers","name":"Ayahuasca, qualidade de vida e a esperança de adictos em recuperação: relatos de caso Ayahuasca, quality of life and the hope in recovering of addicts: case reports","year":"2015","cit":0,"pfa":"Dias de Jesus Júnior","psa":"Manfredo Barata Almeida da Fonseca","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2343603397","eid":"W2343603397"},{"id":"paper-w4409677032","cat":"papers","name":"Therapeutic Potential of Psilocybin-Assisted Therapy in Hospice and Palliative Care","year":"2025","cit":0,"pfa":"Ana Cláudia Mesquita Garcia","topics":["Addiction","Anxiety & end-of-life","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4409677032","eid":"W4409677032"},{"id":"paper-w4409945649","cat":"papers","name":"Trial finds psilocybin improves symptoms in treatment‐resistant depression","year":"2025","cit":0,"topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4409945649","eid":"W4409945649"},{"id":"paper-w2762853060","cat":"papers","name":"Pathways through MDMA use : a qualitative life story study","year":"2016","cit":0,"pfa":"Ghazaleh Sharifimonfared","topics":["Safety & adverse events","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W2762853060","eid":"W2762853060"},{"id":"paper-w4254013502","cat":"papers","name":"Determination of the Organic Compounds in Synthetic Tablets Containing MDMA (Ecstasy)","year":"2014","cit":0,"pfa":"Taner Bora","psa":"Hasan Aydin","ptype":"article","src":"https://openalex.org/W4254013502","eid":"W4254013502"},{"id":"paper-w4231403717","cat":"papers","name":"Effects of SERT Inhibition on the Subjective Response to Psilocybin in Healthy Subjects","year":"2019","cit":0,"ptype":"article","src":"https://openalex.org/W4231403717","eid":"W4231403717"},{"id":"paper-w7115809035","cat":"papers","name":"Fungi for the Mind: Exploring the role of suggestion in psilocybin assisted therapy","year":"2025","cit":0,"pfa":"Clare, Susan","topics":["Therapy practice","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W7115809035","eid":"W7115809035"},{"id":"paper-w4396883294","cat":"papers","name":"Fallbeispiele zur Therapie der rezidivierenden Depression mit Psilocybin","year":"2024","cit":0,"pfa":"Eva Maria Schindowski","psa":"Franz X. Vollenweider","topics":["Depression","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4396883294","eid":"W4396883294"},{"id":"paper-w4231945730","cat":"papers","name":"P.839 Modelling the acute temporal dynamics of psilocybin psychoactive effects; relation to brain serotonin 2a receptor levels","year":"2019","cit":0,"pfa":"Dea Siggaard Stenbæk","psa":"Patrick M. Fisher","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4231945730","eid":"W4231945730"},{"id":"paper-w7120651875","cat":"papers","name":"Quantification of MDMA in ecstasy samples by gas chromatography (GC/NPD)","year":"2004","cit":0,"pfa":"Silvio Fernandes Lapachinske","ptype":"dissertation","src":"https://openalex.org/W7120651875","eid":"W7120651875"},{"id":"paper-w4399878739","cat":"papers","name":"Decision letter for \"Bioisosteric analogs of MDMA : Improving the pharmacological profile?\"","year":"2023","cit":0,"topics":["Dosing & pharmacology"],"ptype":"peer-review","src":"https://openalex.org/W4399878739","eid":"W4399878739"},{"id":"paper-w2946900823","cat":"papers","name":"Evaluation of the therapeutic potential of ayahuasca in the treatment of alcohol dependence in an experimental model","year":"2018","cit":0,"pfa":"pLuciana M Nollip","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2946900823","eid":"W2946900823"},{"id":"paper-w7202302784","cat":"papers","name":"Investigating the Effects of Psilocybin on Cognitive Flexibility in Touchscreen and Naturalistic Variations of the Probabilistic Reversal Learning Task","year":"2026","cit":0,"pfa":"Dasha Anderson","psa":"Emma S J Robinson","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7202302784","eid":"W7202302784"},{"id":"paper-w3159947973","cat":"papers","name":"The therapeutic potential of ayahuasca and other serotonergic hallucinogens in the treatment of social anxiety.","year":"2018","cit":0,"pfa":"RAFAEL GUIMARÃES DOS SANTOS","psa":"Jaime E. C. Hallak","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3159947973","eid":"W3159947973"},{"id":"paper-w4415354984","cat":"papers","name":"Psychedelic-induced behavioral and developmental effects on zebrafish: a systematic review","year":"2025","cit":0,"pfa":"Arthur L. de Oliveira","psa":"Jaime E. C. Hallak","topics":["Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4415354984","eid":"W4415354984"},{"id":"paper-w2002157804","cat":"papers","name":"The kappa receptor agonist salvinorin A suppresses phasic dopamine signaling and motivation for food reward","year":"2010","cit":0,"pfa":"Stephanie R. Ebner","psa":"Mitchell F. Roitman","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2002157804","eid":"W2002157804"},{"id":"paper-w7117461912","cat":"papers","name":"Psilocybin as a Serotonergic Therapy in Epilepsy: Narrative Review of Therapeutic Potentials and Seizure Risks","year":"2025","cit":0,"pfa":"Miguel Benjamín Cervera-Sánchez","psa":"Christian Padilla-Cabezutd","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7117461912","eid":"W7117461912"},{"id":"paper-w4244831103","cat":"papers","name":"MDMA (\"Ecstasy\") Impairs Memory 2 Years Following Use","year":"2006","cit":0,"ptype":"dataset","src":"https://openalex.org/W4244831103","eid":"W4244831103"},{"id":"paper-w2526075679","cat":"papers","name":"Reducción de riesgos en el consumo de MDMA","year":"2013","cit":0,"pfa":"Ricardo Caparrós Casado","psa":"Maite Ugarte","ptype":"article","src":"https://openalex.org/W2526075679","eid":"W2526075679"},{"id":"paper-w2980898617","cat":"papers","name":"Herbetovering van de wereld. De ontologische subversiviteit van de ayahuasca-ervaring: Lezing over de filosofische aspecten van ayahuasca voor Radboud Reflects","year":"2019","cit":0,"pfa":"P. Lemmens","ptype":"conference-paper","src":"https://openalex.org/W2980898617","eid":"W2980898617"},{"id":"paper-w2401678850","cat":"papers","name":"Increasing MDMA Use Among College Students: The Agony of Ecstasy","year":"2002","cit":0,"pfa":"Susan M. Jay","ptype":"article","src":"https://openalex.org/W2401678850","eid":"W2401678850"},{"id":"paper-w2046847856","cat":"papers","name":"Pathology, Toxicology, Cause, and Manner of Death in MDMA-related Fatalities","year":"2002","cit":0,"pfa":"Mandakini Mansukh Patel","ptype":"article","src":"https://openalex.org/W2046847856","eid":"W2046847856"},{"id":"paper-w4414124411","cat":"papers","name":"Correction: Therapeutic and legal aspects of psilocybin in cancer-related depression","year":"2025","cit":0,"pfa":"Małgorzata Wierzbicka","psa":"Joanna Rymaszewska","topics":["Depression","Anxiety & end-of-life","Policy & ethics"],"ptype":"erratum","src":"https://openalex.org/W4414124411","eid":"W4414124411"},{"id":"paper-w7152631097","cat":"papers","name":"Efficacy of psilocybin on death anxiety in terminal patients: a narrative review","year":"2025","cit":0,"pfa":"Morris Lintong Barimbing","psa":"Made Edwin Sridana","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W7152631097","eid":"W7152631097"},{"id":"paper-w3183331325","cat":"papers","name":"THE ETHICS OF PSYCHEDELIC MEDICINE: A CASE FOR THE RECLASSIFICATION OF PSILOCYBIN FOR THERAPEUTIC PURPOSES","year":"2021","cit":0,"pfa":"Akansh Hans","topics":["Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W3183331325","eid":"W3183331325"},{"id":"paper-w4413513275","cat":"papers","name":"Exploring Psychotherapeutic Benefits of Psilocybin and Psychedelics In Controlled Medical Settings","year":"2024","cit":0,"pfa":"Arman Fard","psa":"Allison Cohen","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4413513275","eid":"W4413513275"},{"id":"paper-w4407077022","cat":"papers","name":"Clinical Trial Comparing Psilocybin to Nicotine Patch for Tobacco Addiction","year":"2025","cit":0,"pfa":"Matthew Johnson","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4407077022","eid":"W4407077022"},{"id":"paper-w4390241461","cat":"papers","name":"Pharmacodynamics of SPL026 (N,N-Dimethyltryptamine fumarate) with supportive therapy in patients with major depressive disorder","year":"2023","cit":0,"pfa":"Ellen James","psa":"Tiffanie A. Benway","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4390241461","eid":"W4390241461"},{"id":"paper-w3011973688","cat":"papers","name":"Use of ‘Ecstasy/MDMA’ resulting in emergency medical treatment in Australia","year":"2019","cit":0,"pfa":"Monica Jane Barratt","psa":"ADAM R. WINSTOCK","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3011973688","eid":"W3011973688"},{"id":"paper-w7203928864","cat":"papers","name":"Complex Fatal Self-Harm Under Psilocybin Intoxication: Suicidal Manner of Death or Not?","year":"2026","cit":0,"pfa":"Caleb Labonté","psa":"Alfredo Eugene Walker","topics":["Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7203928864","eid":"W7203928864"},{"id":"paper-w2208180116","cat":"papers","name":"Preparation of Ring D Modified Analogues of Salvinorin A, A Kappa Opioid Agonist from Salvia divinorum","year":"2006","cit":0,"pfa":"Denise S. Simpson","psa":"Thomas Edward Prisinzano","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2208180116","eid":"W2208180116"},{"id":"paper-w58285331","cat":"papers","name":"[Analysis of MDMA and its metabolites in urine by GC and GC/MS].","year":"1998","cit":0,"pfa":"M Shen","psa":"Bo Jiang","topics":["Addiction"],"ptype":"other","src":"https://openalex.org/W58285331","eid":"W58285331"},{"id":"paper-w2489879782","cat":"papers","name":"The Behavioral Effects of MDMA in Humans Under Controlled Laboratory Conditions","year":"2016","cit":0,"pfa":"Matthew G. Kirkpatrick","psa":"Carl L. Hart","ptype":"book-chapter","src":"https://openalex.org/W2489879782","eid":"W2489879782"},{"id":"paper-w2339979262","cat":"papers","name":"El consumo urbano de ayahuasca: sentidos, prácticas y subjetividad","year":"2014","cit":0,"pfa":"Juan Camilo Medina","psa":"Andrés Caicedo","ptype":"article","src":"https://openalex.org/W2339979262","eid":"W2339979262"},{"id":"paper-w7134881560","cat":"papers","name":"Jungle Brew and Depression:Molecular Pharmacology of Ayahuasca Alkaloids on Monoamine Transporter Systems","year":"2017","cit":0,"pfa":"Steffen Sinning","psa":"Aviaja Elisabeth Lund","topics":["Depression","Dosing & pharmacology"],"ptype":"conference-paper","src":"https://openalex.org/W7134881560","eid":"W7134881560"},{"id":"paper-w4394200826","cat":"papers","name":"Behavioral characterization of ayahuasca treatment on Wistar rats in the open field test","year":"2023","cit":0,"pfa":"Cid Pinheiro Farias","psa":"Hudson W. de Carvalho","topics":["Anxiety & end-of-life"],"ptype":"dataset","src":"https://openalex.org/W4394200826","eid":"W4394200826"},{"id":"paper-w4404068601","cat":"papers","name":"Spirituality, Drugs, and Tourism: Tourists' and Shamans' Experiences of Ayahuasca in Iquitos, Peru","year":"2024","cit":0,"pfa":"Girish Prayag","psa":"Julien Fontaine","ptype":"book-chapter","src":"https://openalex.org/W4404068601","eid":"W4404068601"},{"id":"paper-w7166436628","cat":"papers","name":"Phase 1 trial suggests benefit of psilocybin in OCD treatment","year":"2026","cit":0,"topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7166436628","eid":"W7166436628"},{"id":"paper-w2790441287","cat":"papers","name":"Resistenza indigena e globalizzazione nelle pratiche rituali della ayahuasca","year":"2008","cit":0,"pfa":"Riccardo Badini","ptype":"conference-paper","src":"https://openalex.org/W2790441287","eid":"W2790441287"},{"id":"paper-w2273716994","cat":"papers","name":"Prefacio: La ayahuasca en la encrucijada de los saberes","year":"2013","cit":0,"pfa":"Renato Sztutman","ptype":"article","src":"https://openalex.org/W2273716994","eid":"W2273716994"},{"id":"paper-w2407761195","cat":"papers","name":"[Peyote alkaloids in the therapy of autonomic neurological conditions & especially in rheumatic heart disease & presenile states].","year":"1958","cit":0,"pfa":"M WAHL","ptype":"article","src":"https://openalex.org/W2407761195","eid":"W2407761195"},{"id":"paper-w7120903997","cat":"papers","name":"The use of ibogaine in the management of drug dependence in Brazil : a one year qualitative follow-up study","year":"2021","cit":0,"pfa":"Bruno Ramos Gomes","ptype":"dissertation","src":"https://openalex.org/W7120903997","eid":"W7120903997"},{"id":"paper-w2492627523","cat":"papers","name":"ACCUMULATION OF 3H-DOPAMINE FORMED FROM 14H-DOPA: II. EFFECT OF N'N-DIMETHYLTRYPTAMINE","year":"1977","cit":0,"pfa":"P. C. Waldmeier","psa":"L. Maître","ptype":"conference-abstract","src":"https://openalex.org/W2492627523","eid":"W2492627523"},{"id":"paper-w4241326213","cat":"papers","name":"Faculty Opinions recommendation of Serotonin transporter-ibogaine complexes illuminate mechanisms of inhibition and transport.","year":"2019","cit":0,"pfa":"Gary Rudnick","psa":"Steffen Sinning","topics":["Mechanism & neuroscience"],"ptype":"peer-review","src":"https://openalex.org/W4241326213","eid":"W4241326213"},{"id":"paper-w4416041037","cat":"papers","name":"Intoxication Associated with Ayahuasca Consumption, Characterization, and Comparative Analysis of the Beverage's Components: A Case Report","year":"2025","cit":0,"pfa":"Edgar Antonio Estrella-Parra","psa":"Francisco Javier Alarcón-Aguilar","ptype":"article","src":"https://openalex.org/W4416041037","eid":"W4416041037"},{"id":"paper-w7116104340","cat":"papers","name":"From fungi to pharmacy: Applied technologies in psilocybin production and its therapeutic applications","year":"2025","cit":0,"pfa":"Qinqing Chen","psa":"Bai-Xiong Chen","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7116104340","eid":"W7116104340"},{"id":"paper-w2410654324","cat":"papers","name":"[Clinical and physiological study of mescaline sulfate- and lysergic acid-induced reactions in mental disorders].","year":"1956","cit":0,"pfa":"R Laricchia","psa":"Zapparoli Gc","ptype":"article","src":"https://openalex.org/W2410654324","eid":"W2410654324"},{"id":"paper-w4406243180","cat":"papers","name":"Study finds encouraging results in psilocybin treatment for TRD patients","year":"2025","cit":0,"pfa":"Valerie A. Canady","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4406243180","eid":"W4406243180"},{"id":"paper-w7160906477","cat":"papers","name":"Efficacy and Safety of a Single Dose of Psilocybin for Chronic Suicidal Ideation","year":"2026","cit":0,"pfa":"Andrew van der Vaart","psa":"Scott T. Aaronson","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7160906477","eid":"W7160906477"},{"id":"paper-w4250196558","cat":"papers","name":"O‐Phosphoryl‐4‐Hydroxy‐N,N‐Dimethyltryptamine 520‐52‐5","year":"2012","cit":0,"ptype":"other","src":"https://openalex.org/W4250196558","eid":"W4250196558"},{"id":"paper-w4308501745","cat":"papers","name":"Psilocybin‐assisted therapy reduces heavy drinking in patients with AUD","year":"2022","cit":0,"topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4308501745","eid":"W4308501745"},{"id":"paper-w4416922186","cat":"papers","name":"Psilocybin and Death Anxiety: A Dual-Mechanism Approach to Existential Distress","year":"2025","cit":0,"pfa":"A.B.J. Swain","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"dissertation","src":"https://openalex.org/W4416922186","eid":"W4416922186"},{"id":"paper-w4247462151","cat":"papers","name":"Ecstasy (MDMA) Reduces Working Memory and Anxiety in Adolescent Rats","year":"2003","cit":0,"pfa":"Brian J. Piper","topics":["Anxiety & end-of-life"],"ptype":"dataset","src":"https://openalex.org/W4247462151","eid":"W4247462151"},{"id":"paper-w1497640193","cat":"papers","name":"The role of dopamine D3 receptors in MDMA-induced behavioral sensitization","year":"2004","cit":0,"pfa":"Corey D Jones","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1497640193","eid":"W1497640193"},{"id":"paper-w4229501624","cat":"papers","name":"MDMA May Reduce Gray Matter in Key Brain Regions","year":"2005","cit":0,"ptype":"dataset","src":"https://openalex.org/W4229501624","eid":"W4229501624"},{"id":"paper-w1613079666","cat":"papers","name":"Abuso de Ecstasy (MDMA) e Efeitos no Sistema Imunológico","year":"2015","cit":0,"pfa":"Talita Chinellato dos Santos","psa":"Vitória Profito Olivato","ptype":"article","src":"https://openalex.org/W1613079666","eid":"W1613079666"},{"id":"paper-w3189477428","cat":"papers","name":"Elaboração de escala avaliativa do setting no uso de ayahuasca","year":"2021","cit":0,"pfa":"Alexandre Augusto de Deus Pontual","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"dissertation","src":"https://openalex.org/W3189477428","eid":"W3189477428"},{"id":"paper-w7135975793","cat":"papers","name":"Ayahuasca ceremonies carried out in Prague and how the participants valuate them","year":"2015","cit":0,"pfa":"Veronika Ava","ptype":"dissertation","src":"https://openalex.org/W7135975793","eid":"W7135975793"},{"id":"paper-w2439144067","cat":"papers","name":"The neurocognitive, neuropharmacological and mood effects of +3,4 methylenedioxymethamphetamine (MDMA, \"Ecstacy\").","year":"2006","cit":0,"pfa":"Rosa Hoshi","topics":["Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W2439144067","eid":"W2439144067"},{"id":"paper-w2588674465","cat":"papers","name":"MDMA pre-treatment cross-sensitizes to methamphetaminestimulatory effects in mice","year":"2006","cit":0,"pfa":"Jana Kučerová","psa":"Alexandra Šulcová","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2588674465","eid":"W2588674465"},{"id":"paper-w2414300463","cat":"papers","name":"[Effect of mescaline on the RNA and protein content of cortical neurons and their glial cell-satellites].","year":"1973","cit":0,"pfa":"Ts S Tencheva","psa":"Pevzner Lz","ptype":"article","src":"https://openalex.org/W2414300463","eid":"W2414300463"},{"id":"paper-w4383550128","cat":"papers","name":"Psychoactive substances in psychotherapy - A vision for the future? – A systematic review on Psilocybin","year":"2023","cit":0,"pfa":"Jenny Tetem","psa":"Tim Julian Möller","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W4383550128","eid":"W4383550128"},{"id":"paper-w4392453921","cat":"papers","name":"Neuroimaging features of psilocybin-induced toxic-metabolic encephalopathy in an adolescent","year":"2024","cit":0,"pfa":"Clarice Ho","psa":"John Ross Crawford","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4392453921","eid":"W4392453921"},{"id":"paper-w7163363441","cat":"papers","name":"Clinical improvement following an integrative iboga microdosing protocol in post-concussive and hypoxic brain injury syndromes: a case series","year":"2026","cit":0,"pfa":"Burton Jared Tabaac","psa":"Teresa Yung","topics":["PTSD & trauma","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7163363441","eid":"W7163363441"},{"id":"paper-w7125929049","cat":"papers","name":"PSILOCYBIN IN PSYCHIATRIC PRACTICE AND PSYCHEDELIC-ASSISTED THERAPY FOR TREATMENT-RESISTANT DEPRESSION","year":"2026","cit":0,"pfa":"Łukasz Deska","psa":"Julia Wawerska","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7125929049","eid":"W7125929049"},{"id":"paper-w4405637013","cat":"papers","name":"Psilocybin vs Escitalopram for depression: 6-month follow-up","year":"2024","cit":0,"pfa":"T. Barba","psa":"Robin Lester Carhart-Harris","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4405637013","eid":"W4405637013"},{"id":"paper-w4323038969","cat":"papers","name":"WHEN THE PARTY IS OVER: SEVERE MDMA-INDUCED DILATED CARDIOMYOPATHY","year":"2023","cit":0,"pfa":"JOSEPH TENG","psa":"Radha S. Gopalan","ptype":"article","src":"https://openalex.org/W4323038969","eid":"W4323038969"},{"id":"paper-w400436762","cat":"papers","name":"Ayahuasca : mitos, leyendas y relatos de la Amazonía peruana","year":"1980","cit":0,"pfa":"Arturo Burga Freitas","ptype":"book","src":"https://openalex.org/W400436762","eid":"W400436762"},{"id":"paper-w2247063236","cat":"papers","name":"Farmacopea sagrada: proceso, rito y horizonte de la Ayahuasca","year":"2012","cit":0,"pfa":"Rosario Hernández Catalán","psa":"Rubén Figaredo Fernández","ptype":"article","src":"https://openalex.org/W2247063236","eid":"W2247063236"},{"id":"paper-w4415174747","cat":"papers","name":"Global Ayahuasca: Wondrous Visions and Modern Worlds. By Alex K. Gearin","year":"2025","cit":0,"pfa":"Daniela M. Peluso","ptype":"article","src":"https://openalex.org/W4415174747","eid":"W4415174747"},{"id":"paper-w4381492495","cat":"papers","name":"Visualizing drug actions on dendrites: psilocybin and other classic psychedelics","year":"2023","cit":0,"pfa":"Ling-Xiao Shao","psa":"Alex C. Kwan","topics":["Mechanism & neuroscience"],"ptype":"conference-paper","src":"https://openalex.org/W4381492495","eid":"W4381492495"},{"id":"paper-w7214993179","cat":"papers","name":"An Observational Study on the Effects of Psilocybin Truffle Use in a Retreat Setting","year":"2026","cit":0,"pfa":"Hüseyin Beyköylü","psa":"Michiel van Elk","topics":["Policy & ethics"],"ptype":"dataset","src":"https://openalex.org/W7214993179","eid":"W7214993179"},{"id":"paper-w7165340605","cat":"papers","name":"Psilocybin for Major Depressive Disorder: A Systematic Review of Clinical Evidence","year":"2026","cit":0,"pfa":"Etienne Louis Pacheco","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7165340605","eid":"W7165340605"},{"id":"paper-w2006677582","cat":"papers","name":"MDMA-users in a specialised adolescent psychiatric out-patient service","year":"1998","cit":0,"pfa":"Oliver Bilke","psa":"U Knölker","topics":["Addiction"],"ptype":"conference-abstract","src":"https://openalex.org/W2006677582","eid":"W2006677582"},{"id":"paper-w4386959224","cat":"papers","name":"New research finds MDMA effective in treating severe PTSD","year":"2023","cit":0,"pfa":"Valerie A. Canady","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4386959224","eid":"W4386959224"},{"id":"paper-w4409324289","cat":"papers","name":"MDMA-Assisted Psychotherapy Phase 3 Trial Publication Retractions","year":"2025","cit":0,"pfa":"Burton Jared Tabaac","psa":"Kenneth Shinozuka","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4409324289","eid":"W4409324289"},{"id":"paper-w4388431292","cat":"papers","name":"TERAPIAS PSICODÉLICAS NO TRATAMENTO DE TRANSTORNOS MENTAIS: A TRAJETÓRIA DAS PESQUISAS COM A AYAHUASCA","year":"2022","cit":0,"pfa":"Helio Júnior Henrique de Siqueira","psa":"Alcione de Oliveira dos Santo","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4388431292","eid":"W4388431292"},{"id":"paper-w1585354708","cat":"papers","name":"Mdma and Methamphetamine: An Investigation of a Neurochemical and Behavioral Cross-Tolerance in the Rat","year":"2023","cit":0,"pfa":"Christina S. Henderson","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W1585354708","eid":"W1585354708"},{"id":"paper-w7162811075","cat":"papers","name":"VA launches MDMA‐assisted mental health therapy trial","year":"2026","cit":0,"pfa":"Valerie A. Canady","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7162811075","eid":"W7162811075"},{"id":"paper-w2683608198","cat":"papers","name":"A dose-response study of ecstasy (MDMA) on the porcine serotonin system","year":"2005","cit":0,"pfa":"Aage Kristian Olsen Alstrup","psa":"Paul D. Cumming","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"conference-paper","src":"https://openalex.org/W2683608198","eid":"W2683608198"},{"id":"paper-w7214973963","cat":"papers","name":"Correction: Sustained abstinence in severe ketamine use disorder following ibogaine treatment case report","year":"2026","cit":0,"pfa":"Sergio R Pérez Rosal","psa":"Markus Backmund","topics":["Addiction"],"ptype":"erratum","src":"https://openalex.org/W7214973963","eid":"W7214973963"},{"id":"paper-w7160842206","cat":"papers","name":"Observability and pharmacological calibration in psychoactive ethnobotany: ceremony duration, admixture selection, and the discovery of ayahuasca","year":"2026","cit":0,"pfa":"Elliot Allan","topics":["Addiction","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7160842206","eid":"W7160842206"},{"id":"paper-w655499358","cat":"papers","name":"[Review of T. C. Maroukis, Peyote and the Yankton Sioux: The life and times of Sam Necklace]","year":"2005","cit":0,"pfa":"Ray Bucko","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W655499358","eid":"W655499358"},{"id":"paper-w1475212338","cat":"papers","name":"Effects of 3,4-methylenedioxymethamphetamine (MDMA) on cholinergic neurons in the rat brain.","year":"2005","cit":0,"pfa":"Sunila G Nair","ptype":"article","src":"https://openalex.org/W1475212338","eid":"W1475212338"},{"id":"paper-w2047070095","cat":"papers","name":"Ethanol increases MDMA toxicity to primary rat hepatocyte cultures","year":"2008","cit":0,"pfa":"Helena Pontes","psa":"Maria de Lourdes Bastos","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2047070095","eid":"W2047070095"},{"id":"paper-w4415165609","cat":"papers","name":"Associations between MDMA/ecstasy, classic psychedelics, and suicidality in adolescents","year":"2023","cit":0,"pfa":"Grant M. Jones","ptype":"dataset","src":"https://openalex.org/W4415165609","eid":"W4415165609"},{"id":"paper-w2909664045","cat":"papers","name":"A Culture's Catalyst: Historical Encounters with Peyote and the Native American Church in Canada by Fannie Kahan","year":"2018","cit":0,"pfa":"Alexander Dawson","ptype":"article","src":"https://openalex.org/W2909664045","eid":"W2909664045"},{"id":"paper-w2950792268","cat":"papers","name":"ChemInform Abstract: LIPOPHILICITY AND SEROTONIN AGONIST ACTIVITY IN A SERIES OF 4‐SUBSTITUTED MESCALINE ANALOGS","year":"1977","cit":0,"pfa":"David E. Nichols","psa":"D. C. Dyer","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2950792268","eid":"W2950792268"},{"id":"paper-w2409058397","cat":"papers","name":"Effect of mescaline on glutamic acid decarboxylase and gaba-oxoglutarate transferase activities of rat brain.","year":"1971","cit":0,"pfa":"A Mukherjee","psa":"Khosa Rl","ptype":"article","src":"https://openalex.org/W2409058397","eid":"W2409058397"},{"id":"paper-w2611009174","cat":"papers","name":"Review: Amada’s Blessings from the Peyote Gardens of South Texas by Stacy B. Schaefer","year":"2017","cit":0,"pfa":"Alexander Dawson","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2611009174","eid":"W2611009174"},{"id":"paper-w7164542370","cat":"papers","name":"Physarum-Mediated Biofeedback Rehabilitation: A Bio-Hybrid Framework for Ibogaine-Assisted Neural Recovery","year":"2026","cit":0,"pfa":"Saeid Ghiasi","topics":["PTSD & trauma","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7164542370","eid":"W7164542370"},{"id":"paper-w2327378684","cat":"papers","name":"ChemInform Abstract: BENZO(B)THIOPHENE DERIVATIVES PART 19, THE SULFUR ISOSTERES OF PSILOCIN AND RELATED ISOMERS","year":"1973","cit":0,"pfa":"Ernest E. Campaigne","psa":"R. B. ROGERS","ptype":"article","src":"https://openalex.org/W2327378684","eid":"W2327378684"},{"id":"paper-w2501121888","cat":"papers","name":"3,4-Methylenedioxymethamphetamine (MDMA, Ecstacy) neurotoxicity : role of thioether adducts.","year":"2003","cit":0,"pfa":"Neil Easton","topics":["Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W2501121888","eid":"W2501121888"},{"id":"paper-w4411328555","cat":"papers","name":"Forensic Toxicology Analysis of MDMA (Methylenedioxymethamphetamine): A Systematic Literature Review","year":"2025","cit":0,"pfa":"Mohammad Anrico Putra Pratama","psa":"Ayudia Pratiwi","topics":["Anxiety & end-of-life","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4411328555","eid":"W4411328555"},{"id":"paper-w7160303426","cat":"papers","name":"Psilocybin and Psilocybe cubensis extract exhibit divergent behavioural and toxicological effects in rats","year":"2026","cit":0,"pfa":"Diana Dias da Silva","psa":"Áurea Madureira-Carvalho","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7160303426","eid":"W7160303426"},{"id":"paper-w2287730541","cat":"papers","name":"Effects of combined exposure to MDMA and loud noise on myocardial structure","year":"2001","cit":0,"pfa":"Marco Gesi","psa":"Antonio Paparelli","ptype":"conference-paper","src":"https://openalex.org/W2287730541","eid":"W2287730541"},{"id":"paper-w595827342","cat":"papers","name":"THE INFLUENCE OF MDMA ON COGNITION AND PSYCHOMOTOR FUNCTION, AND THE IMPORTANCE FOR DRIVING CAPACITY","year":"2002","cit":0,"pfa":"C. T. J. Lamers","psa":"Wim J. Riedel","topics":["Addiction","Dosing & pharmacology"],"ptype":"conference-paper","src":"https://openalex.org/W595827342","eid":"W595827342"},{"id":"paper-w3211547399","cat":"papers","name":"Metabolomics approach in the investigation of hepatic metabolic changes caused by MDMA","year":"2019","cit":0,"pfa":"Ana Margarida Araújo","psa":"Paula Guedes de Pinho","ptype":"conference-paper","src":"https://openalex.org/W3211547399","eid":"W3211547399"},{"id":"paper-w7117533224","cat":"papers","name":"USO DA AYAHUASCA NO BRASIL: UMA ANÁLISE DE UMA DÉCADA","year":"2025","cit":0,"pfa":"Marcos Lorran Paranhos Leão","psa":"Estácio Amaro da Silva Júnior","topics":["Depression","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7117533224","eid":"W7117533224"},{"id":"paper-w2955107217","cat":"papers","name":"RELIGIÃO E EDUCAÇÃO: OS SABERES DA AYAHUASCA NO SANTO DAIME","year":"2011","cit":0,"pfa":"Maria Betânia Barbosa Albuquerque","ptype":"article","src":"https://openalex.org/W2955107217","eid":"W2955107217"},{"id":"paper-w2605160726","cat":"papers","name":"Behaviorální účinky MDMA u myší v konfliktních sociálníchinterakcích","year":"2006","cit":0,"pfa":"Karel Šlais","psa":"Alexandra Šulcová","ptype":"article","src":"https://openalex.org/W2605160726","eid":"W2605160726"},{"id":"paper-w7141768332","cat":"papers","name":"MDMA-Assisted Psychotherapy for Posttraumatic Stress Disorder: The Devil Is in the Detail","year":"2022","cit":0,"pfa":"James Phelps","topics":["PTSD & trauma","Reviews & meta-analyses","Therapy practice"],"ptype":"report","src":"https://openalex.org/W7141768332","eid":"W7141768332"},{"id":"paper-w7129027409","cat":"papers","name":"Microfluidic Platform for On-site Simultaneous Analysis of Ketamine and MDMA in Urine","year":"2026","cit":0,"pfa":"Seulgi Lee","psa":"Heesun Chung","ptype":"article","src":"https://openalex.org/W7129027409","eid":"W7129027409"},{"id":"paper-w7162775771","cat":"papers","name":"A spatiotemporal gating hypothesis for psilocybin plasticity: reconciling the 5-HT₂A-TrkB mechanistic paradox","year":"2026","cit":0,"pfa":"Gang Pei","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7162775771","eid":"W7162775771"},{"id":"paper-w1595254093","cat":"papers","name":"Cerebral oedema after MDMA (“ecstasy”) and unrestricted water intake","year":"1996","cit":0,"pfa":"S M Matthai","psa":"J A Sills","ptype":"article","src":"https://openalex.org/W1595254093","eid":"W1595254093"},{"id":"paper-w7120719555","cat":"papers","name":"Five year follow-up of a group of ecstasy (MDMA) users","year":"2009","cit":0,"pfa":"Murilo Campos Battisti","topics":["Addiction"],"ptype":"dissertation","src":"https://openalex.org/W7120719555","eid":"W7120719555"},{"id":"paper-w4200083165","cat":"papers","name":"P.0298 Evaluation of the acute mechanism of action of psilocybin in mice","year":"2021","cit":0,"pfa":"Ines Erkizia-Santamaría","psa":"Jorge Emilio Ortega","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4200083165","eid":"W4200083165"},{"id":"paper-w7213893685","cat":"papers","name":"Prior trauma shapes the effects of psilocybin on stress sensitization in mice","year":"2026","cit":0,"pfa":"Sophia R. Ottofaro","psa":"Javier González‐Maeso","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W7213893685","eid":"W7213893685"},{"id":"paper-w4411461721","cat":"papers","name":"Psilocybin as a Tool in the Management of Palliative Care: An Historical, Pharmacological and Clinical Approach","year":"2025","cit":0,"pfa":"Andrés David Turizo Smith","psa":"Diana Milena Berrío Cuartas","topics":["Addiction","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4411461721","eid":"W4411461721"},{"id":"paper-w7143463961","cat":"papers","name":"Therapist Manual for Psilocybin-Assisted Therapy of Treatment-Resistant Major Depression","year":"2026","cit":0,"pfa":"Michael Koslowski","psa":"Lea Julia Mertens","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"report","src":"https://openalex.org/W7143463961","eid":"W7143463961"},{"id":"paper-w7155193588","cat":"papers","name":"Distinct Modulatory Effects on Affective Biases by Different Serotonergic Psychedelics and MDMA in Male Rats: Possible Implications for Antidepressant Effects","year":"2026","cit":0,"pfa":"Justyna K. Hinchcliffe","psa":"Emma S. J. Robinson","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7155193588","eid":"W7155193588"},{"id":"paper-w2331065731","cat":"papers","name":"Review: The Peyote Road: Religious Freedom and the Native American Church, by Thomas C. Maroukis","year":"2011","cit":0,"pfa":"Tìsa Wenger","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2331065731","eid":"W2331065731"},{"id":"paper-w4408544636","cat":"papers","name":"Entity and environment relationships in psychedelic experiences resulting from inhalation of N,N-dimethyltryptamine","year":"2025","cit":0,"pfa":"Stephen Kagan","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4408544636","eid":"W4408544636"},{"id":"paper-w3104596844","cat":"papers","name":"Presynaptic effect of 5-methoxy-N,N-dimethyltryptamine on the isolated guinea-pig vas deferens","year":"1986","cit":0,"pfa":"Soichi Yoshida","psa":"Tetsurō Kuga","ptype":"article","src":"https://openalex.org/W3104596844","eid":"W3104596844"},{"id":"paper-w4412253619","cat":"papers","name":"Exploring moral bio-enhancement through psilocybin facilitated prosocial effects","year":"2021","cit":0,"pfa":"Lange, Victor","psa":"Marie, Sidsel","topics":["Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4412253619","eid":"W4412253619"},{"id":"paper-w2245845742","cat":"papers","name":"Exportación de ayahuasca en fundas de infusión hacia Estados Unidos","year":"2012","cit":0,"pfa":"Quelal Zapata","psa":"Verónica Gabriela","ptype":"dissertation","src":"https://openalex.org/W2245845742","eid":"W2245845742"},{"id":"paper-w7154598108","cat":"papers","name":"Protective Role of Dimethyltryptamine in Preserving Donor Cardiac Function in a Heterotopic Rat Transplantation Model","year":"2026","cit":0,"pfa":"K. Benke","psa":"T. Radovits","ptype":"article","src":"https://openalex.org/W7154598108","eid":"W7154598108"},{"id":"paper-w157569351","cat":"papers","name":"Users’ perceptions of the effects of MDMA (ecstasy): A factor analytic study","year":"2001","cit":0,"pfa":"P. Murphy","psa":"J. Fisk","ptype":"article","src":"https://openalex.org/W157569351","eid":"W157569351"},{"id":"paper-w4252739537","cat":"papers","name":"A Behavioural Analysis of Serotonergic Functional Status Following MDMA Exposure","year":"2006","cit":0,"pfa":"Brennan, Katie","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W4252739537","eid":"W4252739537"},{"id":"paper-w4400181442","cat":"papers","name":"MDMA (3,4-methylenedioxymethamphetamine) modulation of tactile sensory information processing","year":"2007","cit":0,"pfa":"Melanie Alexander Starr","psa":"Barry D. Waterhouse","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W4400181442","eid":"W4400181442"},{"id":"paper-w2735541580","cat":"papers","name":"Oppioidi, MDMA, marijuana e l’immunosoppressione : quale rilevanza clinica?","year":"2011","cit":0,"pfa":"Paola Sacerdote","psa":"Alberto Emilio Panerai","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2735541580","eid":"W2735541580"},{"id":"paper-w7161546257","cat":"papers","name":"C29-12 Psilocybin Treatment Could Improve Outcomes for Age-associated Lung Diseases","year":"2026","cit":0,"pfa":"Louise Hecker","psa":"K Kato","topics":["Addiction","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7161546257","eid":"W7161546257"},{"id":"paper-w7147647790","cat":"papers","name":"Replication Data for: The magic of mushrooms: Psilocybin influences behaviour in the mangrove rivulus, Kryptolebias marmoratus","year":"2026","cit":0,"pfa":"Dayna Forsyth","psa":"Suzanne Currie","topics":["Dosing & pharmacology"],"ptype":"dataset","src":"https://openalex.org/W7147647790","eid":"W7147647790"},{"id":"paper-w7160877206","cat":"papers","name":"Observability and pharmacological calibration in psychoactive ethnobotany: ceremony duration, admixture selection, and the discovery of ayahuasca","year":"2026","cit":0,"pfa":"Elliot Allan","topics":["Addiction","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7160877206","eid":"W7160877206"},{"id":"paper-w7214069198","cat":"papers","name":"Ethnopharmacological and Pharmacological Insights into Ayahuasca: Experimental Evidence, Toxicological Perspectives, and Emerging Biomedical Applications","year":"2026","cit":0,"pfa":"Emilly V. Souza","psa":"Jerusa M. Oliveira","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7214069198","eid":"W7214069198"},{"id":"paper-w2900034783","cat":"papers","name":"Modulation of serotonin-mediated intracellular signalling by 3,4-methylendioxymetamphetamine (MDMA).","year":"2002","cit":0,"pfa":"Maria Letizia Trincavelli","psa":"Gino Giannaccini","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2900034783","eid":"W2900034783"},{"id":"paper-w2345738794","cat":"papers","name":"The Effect of Social Anxiety on Acute Responses to the Drug MDMA (Ecstasy","year":"2016","cit":0,"pfa":"Kasey S. Cervantes","topics":["Anxiety & end-of-life","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2345738794","eid":"W2345738794"},{"id":"paper-w4245117638","cat":"papers","name":"Tolerance to the Behavioural and Neurochemical Effects of MDMA Following Repeated Exposure","year":"2009","cit":0,"pfa":"Karen L. Jones","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W4245117638","eid":"W4245117638"},{"id":"paper-w7204852149","cat":"papers","name":"Differential effects of psilocybin derivatives on fentanyl-induced conditioned place preference in male and female mice","year":"2026","cit":0,"pfa":"Tiffini N. Lovell","psa":"Ana‐Clara Bobadilla","topics":["Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7204852149","eid":"W7204852149"},{"id":"paper-w2541838945","cat":"papers","name":"Psilocybin-induced psychosis in humans and in rats − translational quantitative EEG study","year":"2016","cit":0,"pfa":"Filip Tylš","psa":"Tomáš Páleníček","ptype":"article","src":"https://openalex.org/W2541838945","eid":"W2541838945"},{"id":"paper-w7214516758","cat":"papers","name":"Assessing the effect of psilocybin, a serotonin 5ht2 agonist, in oc-spectrum disorders","year":"2026","cit":0,"pfa":"Stephan Ludewig","topics":["Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W7214516758","eid":"W7214516758"},{"id":"paper-w4388023533","cat":"papers","name":"Single dose of psilocybin improves depressive symptoms in Phase 2 study","year":"2023","cit":0,"topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4388023533","eid":"W4388023533"},{"id":"paper-w4413468564","cat":"papers","name":"Therapeutic Divergence in 5-HT2A Agonism: Psilocybin and Phenalkylamines for Demoralization Syndrome","year":"2025","cit":0,"pfa":"Robert B. Kargbo","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"editorial","src":"https://openalex.org/W4413468564","eid":"W4413468564"},{"id":"paper-w4415610859","cat":"papers","name":"Understanding psilocybin mushrooms and aiding in setting standards for a burgeoning industry in Jamaica","year":"2025","cit":0,"pfa":"Rupika Delgoda","psa":"Shemar Daniel","ptype":"article","src":"https://openalex.org/W4415610859","eid":"W4415610859"},{"id":"paper-w80010474","cat":"papers","name":"Wheel running behavior and thermoregulation in mice: effects of MDMA and methamphetamine","year":"2010","cit":0,"pfa":"William E. Fantegrossi","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W80010474","eid":"W80010474"},{"id":"paper-w7120809098","cat":"papers","name":"The meaning of ritualized use of ayahuasca in the treatment of homeless users in a group in São Paulo","year":"2011","cit":0,"pfa":"Bruno Ramos Gomes","ptype":"dissertation","src":"https://openalex.org/W7120809098","eid":"W7120809098"},{"id":"paper-w2013702596","cat":"papers","name":"The pharmacological and toxicological effects of a single oral administration of MDMA in the rat","year":"1996","cit":0,"pfa":"Ian de Souza","psa":"Brian E. Leonard","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2013702596","eid":"W2013702596"},{"id":"paper-w3175705310","cat":"papers","name":"MDMA‐mediated cardiac toxicity is associated with increased oxidative stress","year":"2008","cit":0,"pfa":"Sylvia K Shenouda","psa":"Kurt James Varner","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3175705310","eid":"W3175705310"},{"id":"paper-w4246813072","cat":"papers","name":"Faculty Opinions recommendation of Effect of Iboga alkaloids on µ-opioid receptor-coupled G protein activation.","year":"2013","cit":0,"pfa":"Roland Seifert","topics":["Addiction","Mechanism & neuroscience"],"ptype":"peer-review","src":"https://openalex.org/W4246813072","eid":"W4246813072"},{"id":"paper-w4399878525","cat":"papers","name":"Author response for \"Bioisosteric analogs of MDMA : Improving the pharmacological profile?\"","year":"2024","cit":0,"pfa":"Ana Sofia Alberto‐Silva","psa":"Harald H. Sitte","topics":["Dosing & pharmacology"],"ptype":"peer-review","src":"https://openalex.org/W4399878525","eid":"W4399878525"},{"id":"paper-w2472436152","cat":"papers","name":"Ayahuasca contra la violencia: Estudio de un caso de asesinato","year":"2013","cit":0,"pfa":"Ede Frecska","ptype":"book-chapter","src":"https://openalex.org/W2472436152","eid":"W2472436152"},{"id":"paper-w7112567012","cat":"papers","name":"Drugs concept for criminal law purposes: The case os ayahuasca drink in Spain","year":"2025","cit":0,"pfa":"Díaz Cortés, Lina Mariola","topics":["Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W7112567012","eid":"W7112567012"},{"id":"paper-w4310919998","cat":"papers","name":"OS POTENCIAIS TERAPÊUTICOS DA AYAHUASCA NO TRATAMENTO DE DEPRESSÃO E ANSIEDADE","year":"2022","cit":0,"pfa":"Josemeire Coimbra De Oliveira","psa":"Keylla dos Santos Pádua","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4310919998","eid":"W4310919998"},{"id":"paper-w1590842705","cat":"papers","name":"Aberle df. The peyote religion among the navahos. Usa, university of oklahoma press, norman and london, 1991","year":"1994","cit":0,"pfa":"I Gomez Gil","ptype":"article","src":"https://openalex.org/W1590842705","eid":"W1590842705"},{"id":"paper-w4413731756","cat":"papers","name":"MDMA makes people more cooperative but only with those they trust","year":"2018","cit":0,"pfa":"Anthony S. Gabay","ptype":"other","src":"https://openalex.org/W4413731756","eid":"W4413731756"},{"id":"paper-w4390223482","cat":"papers","name":"MM-402 demonstrates better efficacy than S(+)-3,4-MDMA or (±)-3,4-MDMA in Fmr1 knockout mice, an animal model of autism spectrum disorder","year":"2023","cit":0,"pfa":"Gennady N. Smagin","psa":"Ranee Barrow","ptype":"conference-abstract","src":"https://openalex.org/W4390223482","eid":"W4390223482"},{"id":"paper-w2996439622","cat":"papers","name":"AYAHUASCA: COMMERCE ÉQUITABLE FOR THE EMPOWERMENT AND PROTECTION OF INDIGENOUS PEOPLE’S INTELLECTUAL PROPERTY RIGHTS","year":"2019","cit":0,"pfa":"Marta Carolina Giménez Pereira","psa":"Samantha Albuquerque de Mello","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W2996439622","eid":"W2996439622"},{"id":"paper-w4399140068","cat":"papers","name":"The Long Road Toward Equitable MDMA Treatment in the United States","year":"2024","cit":0,"pfa":"Zofia Kozak","psa":"Scott T. Aaronson","ptype":"article","src":"https://openalex.org/W4399140068","eid":"W4399140068"},{"id":"paper-w4230306355","cat":"papers","name":"Study Suggests Cognitive Deficits in MDMA-Only Drug Abusers","year":"2005","cit":0,"pfa":"Robin Eisner","ptype":"dataset","src":"https://openalex.org/W4230306355","eid":"W4230306355"},{"id":"paper-w2037484027","cat":"papers","name":"S.16.02 Rewarding properties of MDMA – behaviour and underlying mechanisms","year":"2007","cit":0,"pfa":"Patricia Robledo","psa":"R. Maldonado","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2037484027","eid":"W2037484027"},{"id":"paper-w1037900862","cat":"papers","name":"Behavioral and biochemical effects of acutely administered MDMA in animal models","year":"2014","cit":0,"pfa":"Barbara Budzyńska","psa":"Grażyna Biała","ptype":"article","src":"https://openalex.org/W1037900862","eid":"W1037900862"},{"id":"paper-w7151618443","cat":"papers","name":"CBD and it's addictive properties in relation to MDMA and LSD malformation","year":"2026","cit":0,"pfa":"Spr R Marshall","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7151618443","eid":"W7151618443"},{"id":"paper-w4240774599","cat":"papers","name":"The role of dopamine D₂ receptor mechanisms in the development of MDMA sensitisation","year":"2016","cit":0,"pfa":"Ross van de Wetering","topics":["Addiction","Mechanism & neuroscience","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W4240774599","eid":"W4240774599"},{"id":"paper-w4360614329","cat":"papers","name":"Lifetime prevalence of ecstasy/MDMA use (hbsc.ch - Standard table)","year":"2023","cit":0,"ptype":"dataset","src":"https://openalex.org/W4360614329","eid":"W4360614329"},{"id":"paper-w1499360210","cat":"papers","name":"Tolerance to the Behavioural and Neurochemical Effects of MDMA Following Repeated Exposure","year":"2009","cit":0,"pfa":"Karen L. Jones","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W1499360210","eid":"W1499360210"},{"id":"paper-w2796619886","cat":"papers","name":"Ecstasy/MDMA Perceived Risk by Late Adolescents and Early Adults","year":"2017","cit":0,"pfa":"Uriel E Salas","psa":"LaVelle Hendricks","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2796619886","eid":"W2796619886"},{"id":"paper-w2593275669","cat":"papers","name":"Executive functioning of cognition and emotion in chronic MDMA (ecstasy) users","year":"2009","cit":0,"pfa":"Gloria M.P. Roberts","topics":["Addiction"],"ptype":"dissertation","src":"https://openalex.org/W2593275669","eid":"W2593275669"},{"id":"paper-w4312291948","cat":"papers","name":"Unfinished Business: Revisiting the Drug Conversion Tables and Their Treatment of MDMA","year":"2022","cit":0,"pfa":"Jonathan Perez-Reyzin","psa":"Ismail L. Ali","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4312291948","eid":"W4312291948"},{"id":"paper-w2331860919","cat":"papers","name":"Reply: MDMA and the Loss of Reinforcement in Fantegrossi et al (2004)","year":"2004","cit":0,"pfa":"William E. Fantegrossi","psa":"George A. Ricaurte","ptype":"letter","src":"https://openalex.org/W2331860919","eid":"W2331860919"},{"id":"paper-w2324961421","cat":"papers","name":"3,4-Methylenedioxymethamphetamine (MDMA) administration induces alterations in rat electroretinogram","year":"2009","cit":0,"pfa":"Ambrosio Antonio","ptype":"article","src":"https://openalex.org/W2324961421","eid":"W2324961421"},{"id":"paper-w3164461708","cat":"papers","name":"Indigene Medizin im ärztlichen Umfeld Kolumbiens - ayahuasca-Rituale in der Großstadt","year":"2015","cit":0,"pfa":"Heiner Dörfler","ptype":"dissertation","src":"https://openalex.org/W3164461708","eid":"W3164461708"},{"id":"paper-w4408164935","cat":"papers","name":"EFEITOS DO USO DE AYAHUASCA NAS FUNÇÕES EXECUTIVAS DE RELIGIOSOS","year":"2024","cit":0,"pfa":"Bruno Rodrigues dos Santos","psa":"A.C.G. Santos","ptype":"conference-paper","src":"https://openalex.org/W4408164935","eid":"W4408164935"},{"id":"paper-w2329902558","cat":"papers","name":"ChemInform Abstract: ALKALOIDE 154. MITT. UMWANDLUNGEN DER IBOGA‐ALKALOIDE VOACANGIN UND CONOPHARYNGIN","year":"1975","cit":0,"pfa":"Yutaka Morita","psa":"Hans Schmid","ptype":"article","src":"https://openalex.org/W2329902558","eid":"W2329902558"},{"id":"paper-w2952529001","cat":"papers","name":"ChemInform Abstract: Efficient Access to the Core of the Strychnos, Aspidosperma and Iboga Alkaloids. A Short Synthesis of Norfluorocurarine.","year":"2009","cit":0,"pfa":"David B. C. Martin","psa":"Christopher D. Vanderwal","ptype":"article","src":"https://openalex.org/W2952529001","eid":"W2952529001"},{"id":"paper-w4225010514","cat":"papers","name":"P388. Open Label Psilocybin Administration in Severely Treatment Resistant Depression","year":"2022","cit":0,"pfa":"Scott Aaronson","psa":"Trisha M Suppes","topics":["Depression"],"ptype":"conference-abstract","src":"https://openalex.org/W4225010514","eid":"W4225010514"},{"id":"paper-w4210421718","cat":"papers","name":"NIDA's Latest Research Report Focuses on MDMA (Ecstasy) Abuse","year":"2005","cit":0,"ptype":"dataset","src":"https://openalex.org/W4210421718","eid":"W4210421718"},{"id":"paper-w3081826458","cat":"papers","name":"‘Molly’ cases: MDMA ODs, bad batch or another compound?","year":"2015","cit":0,"pfa":"Alison Knopf","ptype":"article","src":"https://openalex.org/W3081826458","eid":"W3081826458"},{"id":"paper-w2966324159","cat":"papers","name":"Molecular Characterization of the Opioid Receptors: Design, Development, and Preclinical Evaluation of Salvinorin A-Based Molecular Probes.","year":"2017","cit":0,"pfa":"Adam W. Keasling","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2966324159","eid":"W2966324159"},{"id":"paper-w2785740636","cat":"papers","name":"Effects of combined exposure to MDMA loud noise on myocardial structure","year":"2001","cit":0,"pfa":"Marco Gesi","psa":"Antonio Paparelli","ptype":"article","src":"https://openalex.org/W2785740636","eid":"W2785740636"},{"id":"paper-w2284235690","cat":"papers","name":"Caffeine potentiation of 3,4-methylenedioxymethamphetamine (MDMA) toxicity: role of age","year":"2011","cit":0,"pfa":"Lucia Frau","psa":"Micaela Morelli","topics":["Safety & adverse events"],"ptype":"conference-paper","src":"https://openalex.org/W2284235690","eid":"W2284235690"},{"id":"paper-w3111762938","cat":"papers","name":"Avaliação ecotoxicológica do MDMA e derivados – Estudo QSAR","year":"2019","cit":0,"pfa":"Joao Magina","ptype":"dissertation","src":"https://openalex.org/W3111762938","eid":"W3111762938"},{"id":"paper-w2053981139","cat":"papers","name":"The Peyote Road: Religious Freedom and the Native American Church by Thomas C. Maroukis (review)","year":"2014","cit":0,"pfa":"Joshua M. Young","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2053981139","eid":"W2053981139"},{"id":"paper-w7144817217","cat":"papers","name":"Effects of MDA and MDMA on in vivo binding of ^3H-Paroxetine in the brain","year":"1991","cit":0,"pfa":"謙二 橋本","psa":"毅 五郎丸","ptype":"article","src":"https://openalex.org/W7144817217","eid":"W7144817217"},{"id":"paper-w2247262725","cat":"papers","name":"Critical care nurses' knowledge of the effects of MDMA : a pilot study","year":"2005","cit":0,"pfa":"Vanessa Brotto","psa":"G. Lee","ptype":"conference-paper","src":"https://openalex.org/W2247262725","eid":"W2247262725"},{"id":"paper-w2186634771","cat":"papers","name":"Solid-Phase Extraction of MDMA, MDA and MDEA in Urine and analysis","year":"2012","cit":0,"pfa":"Serge Auger","psa":"David Dubé","ptype":"article","src":"https://openalex.org/W2186634771","eid":"W2186634771"},{"id":"paper-w2589126096","cat":"papers","name":"STEREOSPECIFIC EFFECTS OF MDMA ON OXYTOCIN ACTIVITY AND OXYTOCIN-DEPENDENT BEHAVIOR","year":"2017","cit":0,"pfa":"Karly N. Hampshire","ptype":"article","src":"https://openalex.org/W2589126096","eid":"W2589126096"},{"id":"paper-w3149549263","cat":"papers","name":"3,4-methylenedioxymethamphetamine (MDMA)-induced macular haemorrhage: A case report","year":"2021","cit":0,"pfa":"Nebojša Đogatović","psa":"Bojan Kozomara","ptype":"article","src":"https://openalex.org/W3149549263","eid":"W3149549263"},{"id":"paper-w4242159886","cat":"papers","name":"Safety and Efficacy of 3,4-Methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy for PTSD","year":"2010","cit":0,"pfa":"Michael C. Mithoeffer","psa":"Rick Doblin","topics":["PTSD & trauma","Safety & adverse events","Therapy practice"],"ptype":"dataset","src":"https://openalex.org/W4242159886","eid":"W4242159886"},{"id":"paper-w4399878945","cat":"papers","name":"Decision letter for \"Bioisosteric analogs of MDMA : Improving the pharmacological profile?\"","year":"2024","cit":0,"topics":["Dosing & pharmacology"],"ptype":"peer-review","src":"https://openalex.org/W4399878945","eid":"W4399878945"},{"id":"paper-w4239074899","cat":"papers","name":"The pharmacological and toxicological effects of a single oral administration of MDMA in the rat","year":"1996","cit":0,"pfa":"Ian de Souza","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4239074899","eid":"W4239074899"},{"id":"paper-w2067979615","cat":"papers","name":"INTRAVENOUS SELF-ADMINISTRATION OF MDMA AND ITS STEREOISOMERS BY RHESUS MONKEYS","year":"1999","cit":0,"pfa":"William E. Fantegrossi","topics":["Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W2067979615","eid":"W2067979615"},{"id":"paper-w15283339","cat":"papers","name":"The effects of cannabis ‘ecstasy’ (MDMA) and IQ on visuospatial memory performance.","year":"2007","cit":0,"pfa":"Philip N. Murphy","psa":"Philip G. Erwin","ptype":"article","src":"https://openalex.org/W15283339","eid":"W15283339"},{"id":"paper-w7128940574","cat":"papers","name":"MDMA and Psychosocial Change in Autistic Adults: Implications for Mental Health","year":"2025","cit":0,"pfa":"Layla Witham","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7128940574","eid":"W7128940574"},{"id":"paper-w2405985326","cat":"papers","name":"[Analysis of the interaction of peripheral serotonin antagonists with tryptamine and N,N-dimethyltryptamine on rabbit electrocorticograms].","year":"1972","cit":0,"pfa":"Fediaeva-Basova Lp","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2405985326","eid":"W2405985326"},{"id":"paper-w2884464716","cat":"papers","name":"A Culture's Catalyst: Historical Encounters with Peyote and the Native American Church of Canada by Fannie Kahan","year":"2018","cit":0,"pfa":"Thomas C. Maroukis","ptype":"book-review","src":"https://openalex.org/W2884464716","eid":"W2884464716"},{"id":"paper-w7165743755","cat":"papers","name":"Endogenous N,N-Dimethyltryptamine as a Rigid Mechanical Anchor and Thermodynamic Buffer During Apoptotic Transition","year":"2026","cit":0,"pfa":"Enkhamgalan Nasanjargal","ptype":"article","src":"https://openalex.org/W7165743755","eid":"W7165743755"},{"id":"paper-w7167232614","cat":"papers","name":"Estimated Health and Economic Outcomes of Medically Monitored Ibogaine for Opioid Use Disorder in the United States","year":"2026","cit":0,"pfa":"T Wagner","psa":"Hannah J. Goodman","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W7167232614","eid":"W7167232614"},{"id":"paper-w2116967801","cat":"papers","name":"The role of alpha-methyldopamine thioethers in the serotonergic neurotoxicity of MDA and MDMA","year":"2004","cit":0,"pfa":"Douglas C. Jones","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W2116967801","eid":"W2116967801"},{"id":"paper-w2380338962","cat":"papers","name":"Determination of MDA and MDMA by TFA Derivatization-GC/MS/MS","year":"2009","cit":0,"pfa":"Yu Xiao","ptype":"article","src":"https://openalex.org/W2380338962","eid":"W2380338962"},{"id":"paper-w7141113210","cat":"papers","name":"Reviewer #1 (Public review): Psilocin fosters neuroplasticity in iPSC-derived human cortical neurons","year":"2026","cit":0,"topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W7141113210","eid":"W7141113210"},{"id":"paper-w7141627935","cat":"papers","name":"Reviewer #2 (Public review): Psilocin fosters neuroplasticity in iPSC-derived human cortical neurons","year":"2026","cit":0,"topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W7141627935","eid":"W7141627935"},{"id":"paper-w2971040370","cat":"papers","name":"Peyote, onto-política y território: hacia una práctica política de afectos compartidos","year":"2019","cit":0,"pfa":"Oscar-Felipe Reyna-Jimenez","ptype":"article","src":"https://openalex.org/W2971040370","eid":"W2971040370"},{"id":"paper-w2966575169","cat":"papers","name":"Peyote and ololiuhqui in the medical texts of New Spain and their circulation in Spain during the 16th and 17th centuries","year":"2019","cit":0,"pfa":"Angélica Morales-Sarabia","ptype":"book-chapter","src":"https://openalex.org/W2966575169","eid":"W2966575169"},{"id":"paper-w4386091224","cat":"papers","name":"A quantitative textual analysis of the subjective effects of ayahuasca in naive users with and without depression","year":"2023","cit":0,"pfa":"Lucas Villar Magalhães da Cruz","psa":"Daniel C. Mograbi","topics":["Depression"],"ptype":"preprint","src":"https://openalex.org/W4386091224","eid":"W4386091224"},{"id":"paper-w4251653432","cat":"papers","name":"MDMA Use May Increase Risk for Cardiac Valve Disease","year":"2003","cit":0,"pfa":"Arnold Mann","topics":["Safety & adverse events"],"ptype":"dataset","src":"https://openalex.org/W4251653432","eid":"W4251653432"},{"id":"paper-w2384904424","cat":"papers","name":"Study on the neuron apoptosis and the expression of cytochrome C induced by MDMA","year":"2004","cit":0,"pfa":"Xueli Sun","ptype":"article","src":"https://openalex.org/W2384904424","eid":"W2384904424"},{"id":"paper-w3000307202","cat":"papers","name":"Addictions à l'alcool, caféine, cannabis, hallucinogènes et MDMA","year":"2019","cit":0,"pfa":"L Maëlle","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W3000307202","eid":"W3000307202"},{"id":"paper-w3009296931","cat":"papers","name":"MDMA-Assisted Psychotherapy Facilitates Post-Traumatic Growth in PTSD","year":"2020","cit":0,"pfa":"Joel Yager","topics":["PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3009296931","eid":"W3009296931"},{"id":"paper-w4241807024","cat":"papers","name":"Assessment of the Reinforcing Properties of Orally Administered MDMA ('Ecstasy') in Rats","year":"2010","cit":0,"pfa":"Lincoln S. Hely","topics":["Addiction","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W4241807024","eid":"W4241807024"},{"id":"paper-w2803049244","cat":"papers","name":"MDMA-Assisted Psychotherapy for Posttraumatic Stress Disorder: A Review of the Literature","year":"2018","cit":0,"pfa":"Erin M. Solomon","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2803049244","eid":"W2803049244"},{"id":"paper-w4313200870","cat":"papers","name":"Effects of psilocybin in relative and global cerebral blood flow and behavioural correlates","year":"2022","cit":0,"pfa":"Nathalie M. Rieser","psa":"Katrin H. Preller","ptype":"article","src":"https://openalex.org/W4313200870","eid":"W4313200870"},{"id":"paper-w7124314724","cat":"papers","name":"LSD and psilocybin effects on cerebral blood flow and global functional connectivity","year":"2026","cit":0,"pfa":"Kristian Larsen","ptype":"other","src":"https://openalex.org/W7124314724","eid":"W7124314724"},{"id":"paper-w7212010788","cat":"papers","name":"469. The serotonin 5-HT2A agonist psilocybin in the treatment of neuropathic pain","year":"2026","cit":0,"pfa":"Ella Nield","psa":"Gabriella Gobbi","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7212010788","eid":"W7212010788"},{"id":"paper-w4413893315","cat":"papers","name":"Psilocybin-Assisted Psychotherapy for Chronic Somatoform Pain Disorder: A Case Report","year":"2025","cit":0,"pfa":"M Mercier","psa":"Louise E. Penzenstadler","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4413893315","eid":"W4413893315"},{"id":"paper-w7162222410","cat":"papers","name":"Psilocybin-Assisted Therapy in the Management of Anxiety and Depression Among Cancer Patients","year":"2026","cit":0,"pfa":"Caleb Lemus","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7162222410","eid":"W7162222410"},{"id":"paper-w7165502204","cat":"papers","name":"Church leaders attending a psilocybin retreat: Experiences and effects on faith development","year":"2026","cit":0,"pfa":"Michiel van Elk","psa":"Josephine Marschall","ptype":"preprint","src":"https://openalex.org/W7165502204","eid":"W7165502204"},{"id":"paper-w7202271098","cat":"papers","name":"Exploring the In Vitro Effect of Psilocybin on the Composition and Metabolic Activity of Gut Microbiota in Individuals with Severe Anxiety","year":"2026","cit":0,"pfa":"Mateus Kawata Salgaço","psa":"Kátia Sivieri","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7202271098","eid":"W7202271098"},{"id":"paper-w1601980153","cat":"papers","name":"Evidence for impaired information processing efficiency among MDMA users","year":"2003","cit":0,"pfa":"M. Wareing","psa":"Catharine Montgomery","ptype":"article","src":"https://openalex.org/W1601980153","eid":"W1601980153"},{"id":"paper-w4390222496","cat":"papers","name":"Acute effects of MDMA and LSD co-administration in healthy participants","year":"2023","cit":0,"pfa":"Isabelle Straumann","psa":"Matthias E. Liechti","ptype":"article","src":"https://openalex.org/W4390222496","eid":"W4390222496"},{"id":"paper-w2781683654","cat":"papers","name":"Time Course of Neuronal Damage and Recovery Induced by Mdma (Ecstasy)","year":"2010","cit":0,"pfa":"Eszter Kirilly","ptype":"book","src":"https://openalex.org/W2781683654","eid":"W2781683654"},{"id":"paper-w2508466490","cat":"papers","name":"The role of dopamine D₂ receptor mechanisms in the development of MDMA sensitisation","year":"2016","cit":0,"pfa":"Ross van de Wetering","topics":["Addiction","Mechanism & neuroscience","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W2508466490","eid":"W2508466490"},{"id":"paper-w4229611068","cat":"papers","name":"The effect of Ecstasy/MDMA use on psychiatric symptoms in recreational users","year":"2018","cit":0,"pfa":"Talitha C. Ford","psa":"Amie C. Hayley","ptype":"other","src":"https://openalex.org/W4229611068","eid":"W4229611068"},{"id":"paper-w2736299606","cat":"papers","name":"The neuropharmacological, cognitive and mood effects of ±3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy')","year":"2006","cit":0,"pfa":"Rosa Hoshi","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W2736299606","eid":"W2736299606"},{"id":"paper-w2287697494","cat":"papers","name":"Synergistic action of MDMA on serotonin and dopamine release in living brain","year":"2007","cit":0,"pfa":"Søren Dinesen Østergaard","psa":"Svend Borup Jensen","topics":["Mechanism & neuroscience"],"ptype":"conference-paper","src":"https://openalex.org/W2287697494","eid":"W2287697494"},{"id":"paper-w3082282509","cat":"papers","name":"Conducting PTSD clinical trials on a Schedule I drug: MDMA","year":"2016","cit":0,"pfa":"Alison Knopf","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W3082282509","eid":"W3082282509"},{"id":"paper-w4247568406","cat":"papers","name":"MDMA-Assisted Psychotherapy in Veterans With Combat-Related, Refractory PTSD","year":"2020","cit":0,"topics":["PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4247568406","eid":"W4247568406"},{"id":"paper-w4416917008","cat":"papers","name":"Next-Generation MDMA Analogue SDMA: Pharmacological and Metabolic Insights","year":"2025","cit":0,"pfa":"Nina Kastner","psa":"Harald H. Sitte","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4416917008","eid":"W4416917008"},{"id":"paper-w4395066932","cat":"papers","name":"Anxiolytic behavior accompanied by the alteration of the intestinal bacteriome during psilocybin treatment","year":"2023","cit":0,"pfa":"Emese Prandovszky","psa":"Robert H. Yolken","ptype":"article","src":"https://openalex.org/W4395066932","eid":"W4395066932"},{"id":"paper-w4416022508","cat":"papers","name":"Ketamine and Psilocybin Differentially Impact Sensory Learning During the Mismatch Negativity","year":"2025","cit":0,"pfa":"Shona G. Allohverdi","psa":"Andreea Oliviana Diaconescu","topics":["Depression","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4416022508","eid":"W4416022508"},{"id":"paper-w4417165392","cat":"papers","name":"Psilocybin in Alcohol Use Disorder Maintains Abstinence Efficacy: A Scoping Review","year":"2025","cit":0,"pfa":"Jacques Suspène","psa":"Raphaël Serreau","topics":["Addiction","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4417165392","eid":"W4417165392"},{"id":"paper-w7167826623","cat":"papers","name":"Sex-specific outcomes of developmental stress and psilocybin intervention on the brain and behavior","year":"2026","cit":0,"pfa":"Sowmya V. Narayan","topics":["Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W7167826623","eid":"W7167826623"},{"id":"paper-w2425650218","cat":"papers","name":"[Psychopsychic correlations under the effect of psycholytics (LSD, psilocybin and similar drugs)].","year":"1961","cit":0,"pfa":"Heinz Holfeld","ptype":"article","src":"https://openalex.org/W2425650218","eid":"W2425650218"},{"id":"paper-w4413284885","cat":"papers","name":"564. TOWARD AN UNDERSTANDING OF THE THERAPEUTICALLY RELEVANT MECHANISMS OF PSILOCYBIN FOR ANOREXIA NERVOSA","year":"2025","cit":0,"pfa":"Claire J. Foldi","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"conference-abstract","src":"https://openalex.org/W4413284885","eid":"W4413284885"},{"id":"paper-w7166826008","cat":"papers","name":"Delta Expression Encoder — Model Checkpoints (psilocybin transcriptional response, v1.0.0)","year":"2026","cit":0,"pfa":"Sai Jayakumar","topics":["Therapy practice"],"ptype":"software","src":"https://openalex.org/W7166826008","eid":"W7166826008"},{"id":"paper-w3025200592","cat":"papers","name":"Prevalencia del uso de MDMA (éxtasis) y neurotoxicidad","year":"2002","cit":0,"pfa":"Ingmar H. A. Franken","ptype":"article","src":"https://openalex.org/W3025200592","eid":"W3025200592"},{"id":"paper-w2894945509","cat":"papers","name":"Biological Reasons for the Neurotoxic Effects of MDMA (‘Ecstasy’) on the Developing Fetus","year":"2015","cit":0,"pfa":"Leah Schneeweiss","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2894945509","eid":"W2894945509"},{"id":"paper-w3047601216","cat":"papers","name":"Lysergsyradietylamid (LSD) och psilocybin vid depression och ångestsjukdom : En litteraturstudie om effekter och biverkningar av LSD- och psilocybin-assisterad psykoterapi","year":"2017","cit":0,"pfa":"Natalie Engström","topics":["Depression"],"ptype":"dissertation","src":"https://openalex.org/W3047601216","eid":"W3047601216"},{"id":"paper-w4412924598","cat":"papers","name":"Ayahuasca prevents the reinstatement of cocaine-induced rewarding effects in C57Bl/6 mice","year":"2025","cit":0,"pfa":"Vítor Bruno","psa":"Tânia Marcourakis","ptype":"preprint","src":"https://openalex.org/W4412924598","eid":"W4412924598"},{"id":"paper-w2338721102","cat":"papers","name":"AYAHUASCA COM POTÊNCIAL FARMACOLÓGICO, TOXICOLÓGICO E POSSÍVEIS APLICAÇÕES NA TERAPÊUTICA","year":"2016","cit":0,"pfa":"Bianca Menezes Torres","psa":"Cleide Barbieri de Souza","ptype":"article","src":"https://openalex.org/W2338721102","eid":"W2338721102"},{"id":"paper-w4388431533","cat":"papers","name":"O USO DA AYAHUASCA COMO TERAPIA ALTERNATIVA PARA ADICTOS QUÍMICOS","year":"2022","cit":0,"pfa":"Amábile Castro da Silva","psa":"Antônio Cipriano Gurgel do Amaral Neto","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4388431533","eid":"W4388431533"},{"id":"paper-w4415193543","cat":"papers","name":"Shamans’ gardens: sites of creative equivocation between Indigenous and internationalized ayahuasca shamanism","year":"2025","cit":0,"pfa":"Françoise Barbira-Freedman","psa":"Stephen P Hugh-Jones","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4415193543","eid":"W4415193543"},{"id":"paper-w2972287955","cat":"papers","name":"CLINAL GEOGRAPHIC VARIATION IN MESCALINE CONCENTRATION AMONG TEXAS POPULATIONS OF LOPHOPHORA WILLIAMSII (CACTACEAE)","year":"2011","cit":0,"pfa":"Hulsey, Diana","psa":"Terry, Martin","ptype":"article","src":"https://openalex.org/W2972287955","eid":"W2972287955"},{"id":"paper-w4402512871","cat":"papers","name":"A chromosome level reference genome of Diviners sage (Salvia divinorum) provides insight into salvinorin A biosynthesis","year":"2024","cit":0,"pfa":"Scott A. Ford","psa":"Michael A. Phillips","topics":["PTSD & trauma","Addiction","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4402512871","eid":"W4402512871"},{"id":"paper-w7130653344","cat":"papers","name":"Salvinorin A alleviates Idiopathic pulmonary fibrosis by inhibiting M2 macrophage polarization and macrophage-to-myofibroblast transition","year":"2026","cit":0,"pfa":"Xu Li","psa":"Shudong Yang","ptype":"preprint","src":"https://openalex.org/W7130653344","eid":"W7130653344"},{"id":"paper-w2528974877","cat":"papers","name":"Análise de alcaloides e metais pesados presentes no chá de Ayahuasca.","year":"2016","cit":0,"pfa":"Caroline Godois","ptype":"article","src":"https://openalex.org/W2528974877","eid":"W2528974877"},{"id":"paper-w4253876649","cat":"papers","name":"Psilocybin-induced psychosis in humans and in rats – translational quantitative EEG study","year":"2016","cit":0,"pfa":"Filip Tylš","ptype":"other","src":"https://openalex.org/W4253876649","eid":"W4253876649"},{"id":"paper-w4223465507","cat":"papers","name":"The Therapeutic Efficacy of Psilocybin in a Preclinical Model of Depressive- and Anxiety-Like Symptomology","year":"2022","cit":0,"pfa":"Henry Chafee","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"dissertation","src":"https://openalex.org/W4223465507","eid":"W4223465507"},{"id":"paper-w4416340750","cat":"papers","name":"Psilocybin Experiential Therapist Training: Insights from a World-First Study","year":"2025","cit":0,"pfa":"Georgia Ioakimidis-MacDougall","psa":"Paul Liknaitzky","topics":["Safety & adverse events","Dosing & pharmacology","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4416340750","eid":"W4416340750"},{"id":"paper-w7152716917","cat":"papers","name":"Psilocybin mushrooms are going mainstream, but scientific research and regulation lag behind","year":"2026","cit":0,"pfa":"Hollis C. Karoly","psa":"Kent E. Hutchison","topics":["Policy & ethics"],"ptype":"other","src":"https://openalex.org/W7152716917","eid":"W7152716917"},{"id":"paper-w7160313400","cat":"papers","name":"Impact of psilocybin and Psilocybe cubensis extract on gut microbiota in Wistar Han rats","year":"2026","cit":0,"pfa":"Francisco Sacadura","psa":"Diana Dias da Silva","ptype":"article","src":"https://openalex.org/W7160313400","eid":"W7160313400"},{"id":"paper-w4390271459","cat":"papers","name":"Psychedelic Therapy: A Primer for Primary Care Clinicians – Part IV. Psilocybin","year":"2023","cit":0,"pfa":"Burton Jared Tabaac","psa":"Owen S. Muir","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W4390271459","eid":"W4390271459"},{"id":"paper-w7155687836","cat":"papers","name":"Medscape Now! Psilocybin-Assisted Therapy: A Clinical Primer forHealthcare Providers","year":"2026","cit":0,"pfa":"Nasir Mustafa","ptype":"article","src":"https://openalex.org/W7155687836","eid":"W7155687836"},{"id":"paper-w4385880634","cat":"papers","name":"Review: Liquid Light: Ayahuasca Spirituality and the Santo Daime Tradition, by G. William Barnard","year":"2023","cit":0,"pfa":"Tarryl Janik","topics":["Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4385880634","eid":"W4385880634"},{"id":"paper-w7215079204","cat":"papers","name":"The New Mexico Medical Psilocybin Act and current trends in the United States psychedelic policy","year":"2026","cit":0,"pfa":"Diego Borbón","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7215079204","eid":"W7215079204"},{"id":"paper-w4287163089","cat":"papers","name":"Assessment of environmental condition and drying process of the plants on the concentration of alkaloids and cytotoxicity of traditional Ayahuasca Tea","year":"2021","cit":0,"pfa":"Miranda Ordilena Ferreira de","psa":"Foglio Mary Ann","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4287163089","eid":"W4287163089"},{"id":"paper-w2316178925","cat":"papers","name":"High affinity C(2)-thiocarbonate and thioacetate-type salvinorin A ligands to the kappa-opioid receptor","year":"2015","cit":0,"pfa":"Prabhakar Reddy Polepally","psa":"JK Zjawiony","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2316178925","eid":"W2316178925"},{"id":"paper-w7155629252","cat":"papers","name":"382. Differential Effects of MDMA and Methamphetamine on Reward and Punishment Sensitivity","year":"2026","cit":0,"pfa":"Madeline Carlson","psa":"Justin Riddle","ptype":"article","src":"https://openalex.org/W7155629252","eid":"W7155629252"},{"id":"paper-w2757848385","cat":"papers","name":"MDMA-evoked competition between [11C]raclopride and endogenous dopamine","year":"2003","cit":0,"pfa":"Pedro Rosa‐Neto","psa":"Paul D. Cumming","ptype":"conference-paper","src":"https://openalex.org/W2757848385","eid":"W2757848385"},{"id":"paper-w2093452322","cat":"papers","name":"Acute and Long-Term Behavioural Effects of MDMA in Adolescent Rats","year":"2011","cit":0,"pfa":"Esther Remmelink","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2093452322","eid":"W2093452322"},{"id":"paper-w3048508498","cat":"papers","name":"3,4-Methylendioxymethamphetamin (MDMA) im Dorsch Lexikon der Psychologie","year":"2016","cit":0,"pfa":"Wilhelm Janke","psa":"R. Küffner","ptype":"article","src":"https://openalex.org/W3048508498","eid":"W3048508498"},{"id":"paper-w3207187692","cat":"papers","name":"[The development of a rational national MDMA policy and its relevance for psychiatry].","year":"2021","cit":0,"pfa":"Jan van Amsterdam","psa":"Willem Johan van den Brink","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3207187692","eid":"W3207187692"},{"id":"paper-w2043049110","cat":"papers","name":"An investigation into the power of IRMS to discriminate batches of MDMA by synthetic route","year":"2010","cit":0,"pfa":"Hilary A. S. Buchanan","psa":"Helen F. Kemp","ptype":"article","src":"https://openalex.org/W2043049110","eid":"W2043049110"},{"id":"paper-w4409816996","cat":"papers","name":"Ayahuasca as Liquid Divinity: An Ontological Approach by André van der Braak (review)","year":"2025","cit":0,"pfa":"Tarryl Janik","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4409816996","eid":"W4409816996"},{"id":"paper-w7213432225","cat":"papers","name":"POTENCIAL TERAPÊUTICO DA AYAHUASCA NO MANEJO DO ALCOOLISMO: UMA REVISÃO INTEGRATIVA","year":"2026","cit":0,"pfa":"Alberto Vaughon Jennings Neto","psa":"Wladimir Albuquerque d’Alva Filho","ptype":"book-chapter","src":"https://openalex.org/W7213432225","eid":"W7213432225"},{"id":"paper-w4233891051","cat":"papers","name":"The Many Faces of MDMA Use Challenge Drug Abuse Prevention","year":"2001","cit":0,"pfa":"Robert Mathias","ptype":"dataset","src":"https://openalex.org/W4233891051","eid":"W4233891051"},{"id":"paper-w4400325014","cat":"papers","name":"3,4-Methylenedioxymethamphetamine (MDMA)-induced anxiety disorder in a young female","year":"2024","cit":0,"pfa":"Sudip S. Mukherjee","psa":"Suprakash Chaudhury","topics":["PTSD & trauma","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4400325014","eid":"W4400325014"},{"id":"paper-w7128420803","cat":"papers","name":"N,N-dimethyltryptamine (DMT) is neither formed nor retained in serotonin terminals in the rat brain","year":"2026","cit":0,"pfa":"Mikael Palner","psa":"Paul D. Cumming","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7128420803","eid":"W7128420803"},{"id":"paper-w4409400324","cat":"papers","name":"Psilocybin as a Tool in the Management of Palliative Care: An Historical, Pharmacological, and Clinical Approach","year":"2025","cit":0,"pfa":"Andrés David Turizo Smith","psa":"Diana Milena Berrío Cuartas","topics":["Addiction","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4409400324","eid":"W4409400324"},{"id":"paper-w770135244","cat":"papers","name":"Peyote and related alkaloids. XII. Structure and synthesis of peyoglunal, a new cactus β-phenethyl-pyrrole.","year":"1970","cit":0,"pfa":"G. J. KAPADIA","ptype":"article","src":"https://openalex.org/W770135244","eid":"W770135244"},{"id":"paper-w2784901956","cat":"papers","name":"Review: A Culture’s Catalyst: Historical Encounters with Peyote and the Native American Church in Canada by Fannie Kahan","year":"2018","cit":0,"pfa":"Tìsa Wenger","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2784901956","eid":"W2784901956"},{"id":"paper-w4385702384","cat":"papers","name":"Is peyote Lophophora diffusa (Croizat) Bravo (Cactaceae) a species destined for extinction? A population dynamics approach","year":"2023","cit":0,"pfa":"Omar Díaz‐Segura","psa":"Erika Arroyo‐Pérez","topics":["Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4385702384","eid":"W4385702384"},{"id":"paper-w7106223303","cat":"papers","name":"Meditation, psychedelics, and brain connectivity: A randomized controlled resting-state fMRI study of N,N-dimethyltryptamine and harmine in a meditation retreat","year":"2025","cit":0,"pfa":"Egger, Klemens","psa":"Scheidegger, Milan","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7106223303","eid":"W7106223303"},{"id":"paper-w4416079942","cat":"papers","name":"The Psychedelic Psilocin Suppresses Activity of Central Amygdala Corticotropin-Releasing Factor Receptor 1 Neurons and Decreases Ethanol Drinking in Female Mice","year":"2025","cit":0,"pfa":"Sarah N. Magee","psa":"Melissa A. Herman","topics":["Addiction","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4416079942","eid":"W4416079942"},{"id":"paper-w7162798090","cat":"papers","name":"Effects of psilocybin on sleep quality and brain microstructure in chronic cluster headache","year":"2026","cit":0,"pfa":"Kristoffer Brendstrup‐Brix","psa":"Martin K. Madsen","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7162798090","eid":"W7162798090"},{"id":"paper-w1988022653","cat":"papers","name":"Beta-adrenergic blocking agents as potent antagonists of mescaline-induced contractions in the rat uterus","year":"1976","cit":0,"pfa":"R. Jaques","ptype":"article","src":"https://openalex.org/W1988022653","eid":"W1988022653"},{"id":"paper-w7165624128","cat":"papers","name":"Synthesis and Biological Evaluation of 4-Bromo- N,N- dimethyltryptamine (4-Br-DMT): A Synthetic Building Block for Future Analog Development","year":"2026","cit":0,"pfa":"Elena Bray","psa":"Jacqueline L. von Salm","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7165624128","eid":"W7165624128"},{"id":"paper-w7158789841","cat":"papers","name":"Multimodal brain, autonomic and phenomenological data for the acute effects of N,N-dimethyltryptamine (DMT)","year":"2026","cit":0,"pfa":"Tomás Ariel D’Amelio","psa":"Enzo Tagliazucchi","topics":["Dosing & pharmacology"],"ptype":"dataset","src":"https://openalex.org/W7158789841","eid":"W7158789841"},{"id":"paper-w4250168646","cat":"papers","name":"ChemInform Abstract: SALVINORIN, A NEW TRANS‐NEOCLERODANE DITERPENE FROM SALVIA DIVINORUM (LABIATAE)","year":"1983","cit":0,"pfa":"A. Ortega","psa":"Percy S. Manchand","ptype":"article","src":"https://openalex.org/W4250168646","eid":"W4250168646"},{"id":"paper-w653771940","cat":"papers","name":"Misérable miracle : la mescaline : avec 48 gravures hors texte de l'auteur","year":"1956","cit":0,"pfa":"Henri Michaux","ptype":"book","src":"https://openalex.org/W653771940","eid":"W653771940"},{"id":"paper-w2945811376","cat":"papers","name":"Caracterização inorgânica da Ayahuasca e avaliação do seu potencial psicoterapêutico","year":"2018","cit":0,"pfa":"Ivanilce Cristina Guimarães","ptype":"dissertation","src":"https://openalex.org/W2945811376","eid":"W2945811376"},{"id":"paper-w3087307445","cat":"papers","name":"[Ayahuasca in the Netherlands: what the doctor should know about its side effects].","year":"2020","cit":0,"pfa":"A van den Berg","psa":"Pieter Roel Tuinman","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3087307445","eid":"W3087307445"},{"id":"paper-w4400575688","cat":"papers","name":"AYAHUASCA SELF-ADMINISTRATION USING A TWO-BOTTLE CHOICE PROCEDURE IN MALE MICE","year":"2024","cit":0,"pfa":"Yasmim A. Serra","psa":"Eduardo Marinho","ptype":"article","src":"https://openalex.org/W4400575688","eid":"W4400575688"},{"id":"paper-w7129063358","cat":"papers","name":"Lectotypification and neotypification of names related to Banisteriopsis caapi (Malpighiaceae): a contribution to understanding of Ayahuasca","year":"2026","cit":0,"pfa":"RANIELY MIRANDA DE SOUZA","psa":"Regina Célia de Oliveira","ptype":"dataset","src":"https://openalex.org/W7129063358","eid":"W7129063358"},{"id":"paper-w7155600655","cat":"papers","name":"Global Ayahuasca: Wondrous Visions and Modern Worlds by Alex K. Gearin (review)","year":"2026","cit":0,"pfa":"Tarryl Janik","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7155600655","eid":"W7155600655"},{"id":"paper-w2978144567","cat":"papers","name":"Usages urbains et transculturels de la plante psychoactive amazonienne ayahuasca","year":"2011","cit":0,"pfa":"Clara De bisschop","ptype":"article","src":"https://openalex.org/W2978144567","eid":"W2978144567"},{"id":"paper-w2077493950","cat":"papers","name":"Evidence for rapid sensitization to the stimulant effects of MDMA in adolescent rats","year":"2010","cit":0,"pfa":"Jerrold S. Meyer","psa":"Brian J. Piper","ptype":"article","src":"https://openalex.org/W2077493950","eid":"W2077493950"},{"id":"paper-w7196933009","cat":"papers","name":"Portable 3D-printed system for on-site MDMA electrochemical detection","year":"2026","cit":0,"pfa":"Elisa D. Bottelli","psa":"Charles S. Henry","ptype":"article","src":"https://openalex.org/W7196933009","eid":"W7196933009"},{"id":"paper-w7120679538","cat":"papers","name":"The use of Ayahuasca as a public problem: a comparison between the cases of Brazil and the United States","year":"2019","cit":0,"pfa":"Henrique Fernandes Antunes","ptype":"dissertation","src":"https://openalex.org/W7120679538","eid":"W7120679538"},{"id":"paper-w1965548601","cat":"papers","name":"Effects of the hallucinogenic 5-HT2A agonist psilocybin on object completion in humans","year":"2008","cit":0,"pfa":"F.X. Vollenweider","psa":"Michael Kometer","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1965548601","eid":"W1965548601"},{"id":"paper-w7208809041","cat":"papers","name":"Psilocybin-induced changes in electroencephalography link acute and long-term effects","year":"2026","cit":0,"pfa":"Marek Nikolič","psa":"Tomáš Páleníček","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7208809041","eid":"W7208809041"},{"id":"paper-w7214153504","cat":"papers","name":"Psilocybin for Treatment-Resistant Major Depression: Efficacy, Safety and Therapeutic Mechanisms","year":"2026","cit":0,"pfa":"Lea Julia Mertens","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7214153504","eid":"W7214153504"},{"id":"paper-w4388362849","cat":"papers","name":"CROSS-SPECIES EVIDENCE FOR PSILOCIN-INDUCED VISUAL HALLUCINATIONS: RATS PERCEIVE QUALITATIVELY SIMILAR CHANGES AS HUMANS","year":"2023","cit":0,"pfa":"Čestmír Vejmola","psa":"Tomáš Páleníček","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4388362849","eid":"W4388362849"},{"id":"paper-w1971197907","cat":"papers","name":"105 Mdma (ECSTASY) Causes Neurodegeneration in the Developing Rat Brain","year":"2005","cit":0,"pfa":"Mark Dzietko","psa":"Ursula Felderhoff‐Mueser","ptype":"article","src":"https://openalex.org/W1971197907","eid":"W1971197907"},{"id":"paper-w4236745729","cat":"papers","name":"Psilocybin induces aberrant prediction error processing for tactile mismatch responses","year":"2018","cit":0,"pfa":"Patricia Duerler","psa":"Katrin H. Preller","ptype":"other","src":"https://openalex.org/W4236745729","eid":"W4236745729"},{"id":"paper-w3081187027","cat":"papers","name":"[From Adam to ecstacy; legal use of MDMA in the 1970s and 1980s].","year":"2020","cit":0,"pfa":"Gemma Blok","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3081187027","eid":"W3081187027"},{"id":"paper-w4221097544","cat":"papers","name":"Comparison of subjective, autonomic, and endocrine effects of LSD and psilocybin in healthy subjects","year":"2022","cit":0,"pfa":"Friederike Holze","psa":"Matthias E. Liechti","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4221097544","eid":"W4221097544"},{"id":"paper-w4400574683","cat":"papers","name":"Lifetime Depression and Psilocybin Mushroom Use in U.S. Adults, 2008–2019","year":"2024","cit":0,"pfa":"Lauren Renee Gorfinkel","psa":"Deborah S. Hasin","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4400574683","eid":"W4400574683"},{"id":"paper-w2514978295","cat":"papers","name":"The new brazilian law on drug and the religious uses of Ayahuasca: Legal and Anthropological aspects","year":"2011","cit":0,"pfa":"Luciana Boiteux","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2514978295","eid":"W2514978295"},{"id":"paper-w828518597","cat":"papers","name":"Noot bij: EHRM 6 mei 2014, EHRC, 2014, 246 (Ayahuasca)","year":"2014","cit":0,"pfa":"J.L.W. Broeksteeg","ptype":"other","src":"https://openalex.org/W828518597","eid":"W828518597"},{"id":"paper-w7120363338","cat":"papers","name":"Cartographies of the unconscious in comics: ayahuasca, holotropic breathing and lucid dreams as creative processes","year":"2018","cit":0,"pfa":"Matheus Moura Silva","ptype":"dissertation","src":"https://openalex.org/W7120363338","eid":"W7120363338"},{"id":"paper-w7207678137","cat":"papers","name":"Safety, pharmacokinetics, and pharmacodynamics of intravenously administered deuterated N,N -dimethyltryptamine (CYB004) in healthy volunteers","year":"2026","cit":0,"pfa":"Katelijne V. van der Heijden","psa":"Amir Inamdar","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7207678137","eid":"W7207678137"},{"id":"paper-w4400574532","cat":"papers","name":"Differing Approaches to Investigating the Therapeutic Efficacy of Psilocybin Across Diverse Indications","year":"2024","cit":0,"pfa":"Ryan K. Lanier","psa":"Judy Ashworth","ptype":"article","src":"https://openalex.org/W4400574532","eid":"W4400574532"},{"id":"paper-w7118013054","cat":"papers","name":"Electrical brain changes following psilocybin administration in sprague-dawley rats","year":"2026","cit":0,"pfa":"B Richardson","psa":"Gabriella Gobbi","ptype":"article","src":"https://openalex.org/W7118013054","eid":"W7118013054"},{"id":"paper-w7167347191","cat":"papers","name":"Single Ayahuasca administration attenuates alcohol relapse and associated behavioral, neurochemical, and oxidative alterations in rats","year":"2026","cit":0,"pfa":"Guilherme Lodetti","psa":"Eduardo Pacheco Rico","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7167347191","eid":"W7167347191"},{"id":"paper-w4412155832","cat":"papers","name":"Psilocybin treatment extends cellular lifespan and improves survival of aged mice","year":"2025","cit":0,"pfa":"Cristian Coarfa","psa":"Kosuke Kato","ptype":"report","src":"https://openalex.org/W4412155832","eid":"W4412155832"},{"id":"paper-w7155636348","cat":"papers","name":"Profiling the Cell-Type Specific Effects of Psilocybin in Medial Prefrontal Cortexh","year":"2026","cit":0,"pfa":"Heike Schuler","psa":"Rosemary C. Bagot","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7155636348","eid":"W7155636348"},{"id":"paper-w2286475310","cat":"papers","name":"Effects of a Beta3‐Adrenergic Antagonist on the Hyperthermic Response to MDMA in mice","year":"2008","cit":0,"pfa":"James R. Docherty","psa":"Sotiria Bexis","topics":["Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W2286475310","eid":"W2286475310"},{"id":"paper-w4234071731","cat":"papers","name":"The role of dopamine D1 receptors in MDMA-induced memory impairments","year":"2020","cit":0,"pfa":"Hanna Squire","psa":"David J. Harper","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4234071731","eid":"W4234071731"},{"id":"paper-w4391332049","cat":"papers","name":"MDMA-assisted psychotherapy in the treatment of PTSD in adults – literature review","year":"2023","cit":0,"pfa":"Monika Nowak","psa":"Michał Gebuza","topics":["PTSD & trauma","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4391332049","eid":"W4391332049"},{"id":"paper-w7129014706","cat":"papers","name":"MDMA-Assisted Therapy for PTSD: Neuroplastic Change or Psychotherapeutic Catalyst?","year":"2026","cit":0,"pfa":"Aidan Butler","psa":"Robert McCullumsmith","topics":["PTSD & trauma","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7129014706","eid":"W7129014706"},{"id":"paper-w7160853298","cat":"papers","name":"Safety and Efficacy of Psilocybin in the Management of Treatment-Resistant Depression: A Systematic Review","year":"2026","cit":0,"pfa":"Chloë K Walters","psa":"Lefa Julius Lerotholi","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7160853298","eid":"W7160853298"},{"id":"paper-w2414768694","cat":"papers","name":"[COMPARISON OF PSYCHOPHARMACA LSD-25, BOL-148 AND PSILOCYBIN IN CLINICAL PRACTICE].","year":"1963","cit":0,"pfa":"B Kandić","psa":"D Dordević","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2414768694","eid":"W2414768694"},{"id":"paper-w7162235135","cat":"papers","name":"Psilocybin for Treatment-Resistant Depression: A Comprehensive Review of Mechanisms and Therapeutic Potential","year":"2026","cit":0,"pfa":"Dallas T Mason","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7162235135","eid":"W7162235135"},{"id":"paper-w2071294183","cat":"papers","name":"ChemInform Abstract: Chemistry of Indoles. Part 88. A Five‐Step Synthesis of Psilocin from Indole‐3‐carbaldehyde.","year":"1999","cit":0,"pfa":"Fumio Yamada","psa":"Masanori Somei","ptype":"article","src":"https://openalex.org/W2071294183","eid":"W2071294183"},{"id":"paper-w7204024343","cat":"papers","name":"The Neurochemical Crucible Hypothesis: Psilocybin as the Missing Catalyst for Human Cognitive Evolution","year":"2026","cit":0,"pfa":"Jonahon Howitz","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7204024343","eid":"W7204024343"},{"id":"paper-w7127179276","cat":"papers","name":"Psilocybin or Nicotine Patch for Smoking Cessation: A Pilot Randomized Clinical Trial","year":"2026","cit":0,"pfa":"Matthew Johnson","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"dataset","src":"https://openalex.org/W7127179276","eid":"W7127179276"},{"id":"paper-w7127409271","cat":"papers","name":"Spatiotemporal mapping of brain organisation following the administration of 2C-B and psilocybin","year":"2026","cit":0,"pfa":"Pablo Mallaroni","psa":"Johannes Gerardus Ramaekers","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7127409271","eid":"W7127409271"},{"id":"paper-w7133076000","cat":"papers","name":"Efficacy of psilocybin as a psychotherapeutic adjunct in patients with post-traumatic stress disorder","year":"2025","cit":0,"pfa":"David Felipe Perez Lozano","psa":"Andres Camilo Arenas Riveros","topics":["PTSD & trauma","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W7133076000","eid":"W7133076000"},{"id":"paper-w7160524592","cat":"papers","name":"Neural correlates of insight on psilocybin: a within-subjects, healthy volunteer study","year":"2026","cit":0,"pfa":"Lorenzo Pasquini","psa":"Robin Lester Carhart-Harris","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7160524592","eid":"W7160524592"},{"id":"paper-w7160185913","cat":"papers","name":"Role of Psychological support in sustaining Antidepressants effects in Psilocybin - Assisted Clinical","year":"2026","cit":0,"pfa":"Gyandev Gupta","psa":"Ravina Yadav","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7160185913","eid":"W7160185913"},{"id":"paper-w7162075570","cat":"papers","name":"Prevalence and Correlates of Past-Year Psilocybin Use in the U.S., 2024, USA","year":"2026","cit":0,"pfa":"R Andrew Yockey","psa":"Rachel Hoopsick","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7162075570","eid":"W7162075570"},{"id":"paper-w2277373111","cat":"papers","name":"Efectos de la ayahuasca para personas que nunca han tomado","year":"2015","cit":0,"pfa":"Josep Maria Fericgla","ptype":"article","src":"https://openalex.org/W2277373111","eid":"W2277373111"},{"id":"paper-w2912928498","cat":"papers","name":"Psilocybin induces aberrant prediction error processing for tactile mismatch responses","year":"2019","cit":0,"pfa":"P. Dürler","ptype":"article","src":"https://openalex.org/W2912928498","eid":"W2912928498"},{"id":"paper-w4408545862","cat":"papers","name":"Use of Psilocybin in the Treatment of Mental Disorders: Systematic Review of Clinal Trials","year":"2024","cit":0,"pfa":"Danielle B Rodrigues","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"review","src":"https://openalex.org/W4408545862","eid":"W4408545862"},{"id":"paper-w4415976738","cat":"papers","name":"Metaanalyse: Wirksamkeit und Sicherheit von Psilocybin bei Major Depressionen","year":"2025","cit":0,"topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4415976738","eid":"W4415976738"},{"id":"paper-w7124234941","cat":"papers","name":"Supplementary Materials for Psilocybin for Treatment-Resistant OCD: A Randomized Controlled Trial","year":"2026","cit":0,"pfa":"Gabrielle Agin-Liebes","topics":["Depression"],"ptype":"preprint","src":"https://openalex.org/W7124234941","eid":"W7124234941"},{"id":"paper-w7166813502","cat":"papers","name":"Delta Expression Encoder — Model Checkpoints (psilocybin transcriptional response, v1.0.0)","year":"2026","cit":0,"pfa":"Sai Jayakumar","topics":["Therapy practice"],"ptype":"software","src":"https://openalex.org/W7166813502","eid":"W7166813502"},{"id":"paper-w7125915297","cat":"papers","name":"Neuroprotective Effect of Psilocybin Zebrafish Poster Basic Clinical Neuroscience 2025","year":"2025","cit":0,"pfa":"Mersedeh Shamsedin","ptype":"article","src":"https://openalex.org/W7125915297","eid":"W7125915297"},{"id":"paper-w7205023569","cat":"papers","name":"Macro- and microdoses of psilocybin for therapeutic use in mental health and pain disorders","year":"2025","cit":0,"pfa":"Luis Ernesto Acosta","psa":"Nicolás Lavagnino","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7205023569","eid":"W7205023569"},{"id":"paper-w4403684433","cat":"papers","name":"Government-funded trial will test psilocybin as treatment for opioid use disorder","year":"2024","cit":0,"topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4403684433","eid":"W4403684433"},{"id":"paper-w4403787979","cat":"papers","name":"Review for \"Substrate recognition by the 4‐hydroxytryptamine kinase PsiK in psilocybin biosynthesis\"","year":"2024","cit":0,"topics":["Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4403787979","eid":"W4403787979"},{"id":"paper-w4406591022","cat":"papers","name":"Therapieresistente Depression: Studie zur Psilocybin-augmentierten Psychotherapie nicht erfolgreich","year":"2025","cit":0,"pfa":"Friederike Klein","topics":["Depression","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4406591022","eid":"W4406591022"},{"id":"paper-w4304633208","cat":"papers","name":"19.3 Psilocybin-Assisted Therapy for MDD: Current Evidence and Clinical Considerations","year":"2022","cit":0,"pfa":"Natalie Gukasyan","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4304633208","eid":"W4304633208"},{"id":"paper-w7162213705","cat":"papers","name":"The effects of psilocybin on prefrontal-cortical-dependent cognitive and behavioral processes in mice","year":"2023","cit":0,"pfa":"Juliet Meccia","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W7162213705","eid":"W7162213705"},{"id":"paper-w7118604966","cat":"papers","name":"Salvinorin A Attenuates Subarachnoid Hemorrhage by Suppressing JNK/NF-κB-Mediated Neuroinflammation and Preserving Synaptic Integrity","year":"2026","cit":0,"pfa":"Lei Guo","psa":"See PDF","ptype":"preprint","src":"https://openalex.org/W7118604966","eid":"W7118604966"},{"id":"paper-w2973229723","cat":"papers","name":"Peyote and Religious Freedom: How Legal Discourse, Race, and Identity Shape Religion for American Indians","year":"2019","cit":0,"pfa":"Amanda Dominique","topics":["Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W2973229723","eid":"W2973229723"},{"id":"paper-w4214861337","cat":"papers","name":"Alleviation of Cocaine Withdrawal and Pertinent Interactions between Salvinorin-based Antagonists and Kappa Opioid Receptor","year":"2022","cit":0,"pfa":"Nicholas S. Akins","psa":"Hoang V. Le","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W4214861337","eid":"W4214861337"},{"id":"paper-w7211874353","cat":"papers","name":"P06-08 Clinical and Analytical Toxicology of Ibogaine in Substance Use Disorders: Real-World Evidence","year":"2026","cit":0,"pfa":"M.P. Esperanca","psa":"M.G.R. Campos","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7211874353","eid":"W7211874353"},{"id":"paper-w7165781739","cat":"papers","name":"Endogenous N,N-Dimethyltryptamine as a Rigid Mechanical Anchor and Thermodynamic Buffer During Apoptotic Transition","year":"2026","cit":0,"pfa":"Enkhamgalan Nasanjargal","ptype":"article","src":"https://openalex.org/W7165781739","eid":"W7165781739"},{"id":"paper-w7120401803","cat":"papers","name":"Investigation of ß- carbolines alkaloids, tryptamine present in Ayahuasca (Santo Daime) in samples of sweat","year":"2014","cit":0,"pfa":"Lidiane Silva Tavares","topics":["Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W7120401803","eid":"W7120401803"},{"id":"paper-w4400874597","cat":"papers","name":"Psychedelics in the Battle Against Itch: Unmasking the Antipruritic Potential of Psilocin Via 5-Ht2a Receptors and Kynurenine Pathway","year":"2024","cit":0,"pfa":"Arya Afrooghe","psa":"Ahmad Reza Dehpour","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4400874597","eid":"W4400874597"},{"id":"paper-w2287494031","cat":"papers","name":"MDMA(Ecstasy) neurotoxicity in vivo and in vitro: a morphological and biochemical study","year":"2004","cit":0,"pfa":"Marco Gesi","psa":"Antonio Paparelli","topics":["Safety & adverse events"],"ptype":"conference-paper","src":"https://openalex.org/W2287494031","eid":"W2287494031"},{"id":"paper-w2911908342","cat":"papers","name":"The effect of Ecstasy/MDMA use on psychiatric symptoms in recreational users","year":"2019","cit":0,"pfa":"Oliver Zwalf","psa":"Luke A. Downey","ptype":"article","src":"https://openalex.org/W2911908342","eid":"W2911908342"},{"id":"paper-w2955393335","cat":"papers","name":"These fungi drug cicadas with psilocybin or amphetamine to make them mate nonstop","year":"2019","cit":0,"pfa":"Tina Hesman Saey","ptype":"article","src":"https://openalex.org/W2955393335","eid":"W2955393335"},{"id":"paper-w7103881202","cat":"papers","name":"Severe Rhabdomyolysis and Acute Kidney Injury Following Ayahuasca‐Related Trauma: A Case Report","year":"2025","cit":0,"pfa":"American Medical Association 2025","psa":"Bedi, Ashmeet","topics":["PTSD & trauma","Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W7103881202","eid":"W7103881202"},{"id":"paper-w4241639320","cat":"papers","name":"Review of Drugs and Phantasy: The Effects of LSD, Psilocybin, and Sernyl on College Students.","year":"1966","cit":0,"topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4241639320","eid":"W4241639320"},{"id":"paper-w7155616142","cat":"papers","name":"Psilocybin use among Basotho healers and non-healers in southern Africa","year":"2026","cit":0,"pfa":"Eli Stark-Elster","psa":"Manvir Singh","topics":["Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7155616142","eid":"W7155616142"},{"id":"paper-w7167637338","cat":"papers","name":"CSF galanin and noradrenaline downregulation by psilocybin therapy in major depressive disorder","year":"2026","cit":0,"pfa":"Wojciech Pasławski","psa":"Per Svenningsson","topics":["Depression","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7167637338","eid":"W7167637338"},{"id":"paper-w4411105944","cat":"papers","name":"Correction: Dissociable effects of psilocybin and escitalopram for depression on processing of musical surprises","year":"2025","cit":0,"pfa":"Rebecca Harding","psa":"Leor Roseman","topics":["Depression","Mechanism & neuroscience"],"ptype":"erratum","src":"https://openalex.org/W4411105944","eid":"W4411105944"},{"id":"paper-w7203743152","cat":"papers","name":"The subtle science: a systematic review of psilocybin magic mushroom and truffle microdosing","year":"2026","cit":0,"pfa":"Jeni Page","psa":"Elizabeth Lorenzo","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W7203743152","eid":"W7203743152"},{"id":"paper-w4394351526","cat":"papers","name":"Chronic intermittent exposure to ayahuasca during aging does not affect memory in mice","year":"2019","cit":0,"pfa":"N.F. Correa-Netto","psa":"Alessandra Linardi","topics":["Anxiety & end-of-life"],"ptype":"dataset","src":"https://openalex.org/W4394351526","eid":"W4394351526"},{"id":"paper-w7197751028","cat":"papers","name":"Efeitos da ayahuasca sobre os processos da memória de medo","year":"2024","cit":0,"pfa":"Alana Sueli dos Santos","ptype":"article","src":"https://openalex.org/W7197751028","eid":"W7197751028"},{"id":"paper-w4404957432","cat":"papers","name":"O uso do chá alucinógeno Ayahuasca no tratamento da dor crônica","year":"2024","cit":0,"pfa":"Ana Beatriz Pereira de Souza","topics":["Depression","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W4404957432","eid":"W4404957432"},{"id":"paper-w2911249940","cat":"papers","name":"Cancer at the Dinner Table: Experiences of Psilocybin-Assisted Psychotherapy for the Treatment of Cancer-Related Psychological Distress","year":"2018","cit":0,"pfa":"Thomas Cody Swift","topics":["Anxiety & end-of-life","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2911249940","eid":"W2911249940"},{"id":"paper-w7212069685","cat":"papers","name":"Craving Reduction and Smoking Outcomes in Psilocybin-Assisted and Standard Cessation Care","year":"2026","cit":0,"pfa":"Lisbeth Strandberg","psa":"Nora Saether","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7212069685","eid":"W7212069685"},{"id":"paper-w4407323133","cat":"papers","name":"Psilocybin and self actualization: Preliminary findings from a randomized controlled trial","year":"2023","cit":0,"pfa":"Hadi Zaki","psa":"Albert Garcia‐Romeu","ptype":"dataset","src":"https://openalex.org/W4407323133","eid":"W4407323133"},{"id":"paper-w7213670168","cat":"papers","name":"Perceptions and Attitudes on Psilocybin-Assisted Therapy among Underrepresented People with Cancer","year":"2026","cit":0,"pfa":"Megan Miller","psa":"Yvan Beaussaunt","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7213670168","eid":"W7213670168"},{"id":"paper-w7164387819","cat":"papers","name":"Pharmacokinetic and pharmacodynamic rational for expanding the therapeutic landscape of psilocybin beyond depression","year":"2026","cit":0,"pfa":"Jessica Mingardi","psa":"F. Bifari","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7164387819","eid":"W7164387819"},{"id":"paper-w7213600212","cat":"papers","name":"Supporting data for “The dark magic mushroom\" co-produces amatoxins and psilocybin","year":"2026","cit":0,"pfa":"Andrew R. Kunik","ptype":"preprint","src":"https://openalex.org/W7213600212","eid":"W7213600212"},{"id":"paper-w2529393177","cat":"papers","name":"Peyote and related alkaloids part 17 synthesis of new derivatives related to the cactus alkaloids","year":"1972","cit":0,"pfa":"G. J. KAPADIA","psa":"B.K. Chowdhury","ptype":"article","src":"https://openalex.org/W2529393177","eid":"W2529393177"},{"id":"paper-w3034813153","cat":"papers","name":"Weekly Dose: ayahuasca, a cautionary tale for tourists eager to try this shamanic brew","year":"2017","cit":0,"pfa":"Stephen Jason Bright","psa":"David G. E. Caldicott","topics":["Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W3034813153","eid":"W3034813153"},{"id":"paper-w3176772765","cat":"papers","name":"Ayahuasca en el Ecuador: Entre la tradición y la polémica","year":"2017","cit":0,"pfa":"Marilyn Peñafiel","psa":"Paola Isis Montes de Oca Vega","ptype":"article","src":"https://openalex.org/W3176772765","eid":"W3176772765"},{"id":"paper-w7115336446","cat":"papers","name":"Diálogo Iconoclasta e IA - Matemática, Ayahuasca, Filosofia, Teologia e Metafísica","year":"2025","cit":0,"pfa":"Gentil Lopes da Silva","ptype":"preprint","src":"https://openalex.org/W7115336446","eid":"W7115336446"},{"id":"paper-w4415322590","cat":"papers","name":"The Road from Drug to Religion and Culture: The Regulation of the Religious Use of Ayahuasca in Brazil","year":"2025","cit":0,"pfa":"Henrique Fernandes Antunes","topics":["Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W4415322590","eid":"W4415322590"},{"id":"paper-w7208690063","cat":"papers","name":"Los Huicholes : y su mundo sagrado del peyote ( Los profesores tienen la palabra)","year":"2002","cit":0,"pfa":"ヘオルヒナ ロメロ","psa":"Georgina Romero","ptype":"article","src":"https://openalex.org/W7208690063","eid":"W7208690063"},{"id":"paper-w2418181999","cat":"papers","name":"MEMO ON THE RELIGIOUS IMPLICATIONS OF THE CONSCIOUSNESS-CHANGING DRUGS (LSD, Mescalin, Psilocybin)","year":"2016","cit":0,"pfa":"Joseph Havens","ptype":"article","src":"https://openalex.org/W2418181999","eid":"W2418181999"},{"id":"paper-w7203885761","cat":"papers","name":"The Use of Psilocybin for Managing Refractory Behavioral Health Conditions: A Narrative Review","year":"2026","cit":0,"pfa":"Rachel N Clark","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"review","src":"https://openalex.org/W7203885761","eid":"W7203885761"},{"id":"paper-w7165669171","cat":"papers","name":"Salvinorin A Alleviates Bleomycin-Induced Pulmonary Fibrosis by Inhibiting M2 Macrophage Polarization and Macrophage-to-Myofibroblast Transition","year":"2026","cit":0,"pfa":"LW Xu","psa":"Shudong Yang","ptype":"article","src":"https://openalex.org/W7165669171","eid":"W7165669171"},{"id":"paper-w2276591123","cat":"papers","name":"Ayahuasca e Recuperação de Pessoas em Situação de Rua I","year":"2013","cit":0,"pfa":"Bruno Ramos Gomes","ptype":"article","src":"https://openalex.org/W2276591123","eid":"W2276591123"},{"id":"paper-w4399073787","cat":"papers","name":"Ayahuasca nas causas e sintomas da depressão: uma revisão narrativa","year":"2024","cit":0,"pfa":"Mariah Caroline Charafeddine Dias","psa":"Rafael Mariano de Bitencourt","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4399073787","eid":"W4399073787"},{"id":"paper-w7120635304","cat":"papers","name":"Drugs, religion and culture: a mapping of public controversy concerning the use of ayahuasca in Brazil","year":"2012","cit":0,"pfa":"Henrique Fernandes Antunes","ptype":"dissertation","src":"https://openalex.org/W7120635304","eid":"W7120635304"},{"id":"paper-w4280526204","cat":"papers","name":"A critique of: Skepticism About Recent Evidence that Psilocybin Opens Depressed Minds","year":"2022","cit":0,"pfa":"Robin Lester Carhart-Harris","psa":"David John Nutt","topics":["Depression"],"ptype":"preprint","src":"https://openalex.org/W4280526204","eid":"W4280526204"},{"id":"paper-w2295496510","cat":"papers","name":"Effecten van 3,4-methyleendioxymetamfetamine (MDMA, 'ecstasy', xtc) en analogen","year":"2005","cit":0,"pfa":"Els De Letter","ptype":"book-chapter","src":"https://openalex.org/W2295496510","eid":"W2295496510"},{"id":"paper-w7132747903","cat":"papers","name":"MDMA vartojimo ypatumų sąsajos su empatiškumu tarp jaunų žmonių","year":"2024","cit":0,"pfa":"Šarūnas Janušas","psa":"Aušra Norė","topics":["Mechanism & neuroscience"],"ptype":"conference-paper","src":"https://openalex.org/W7132747903","eid":"W7132747903"},{"id":"paper-w7155051634","cat":"papers","name":"Comparative Medico-Legal Frameworks for Psilocybin Regulation: A March 2026 Update","year":"2026","cit":0,"pfa":"Octavian Victor Brinzei","topics":["Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W7155051634","eid":"W7155051634"},{"id":"paper-w7160889537","cat":"papers","name":"Demoralization in Psilocybin-Assisted Therapy for Advanced Cancer: An Exploratory Network Analysis","year":"2026","cit":0,"pfa":"Austin Mallard","psa":"Stacy M. Fischer","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7160889537","eid":"W7160889537"},{"id":"paper-w4244101164","cat":"papers","name":"ChemInform Abstract: BENZO(B)THIOPHENE DERIVATIVES PART 21, ON THE PROOF OF STRUCTURE OF THE SULFUR ISOSTERE OF PSILOCIN","year":"1974","cit":0,"pfa":"Ernest E. Campaigne","psa":"R. B. ROGERS","ptype":"article","src":"https://openalex.org/W4244101164","eid":"W4244101164"},{"id":"paper-w4389995095","cat":"papers","name":"PRODUÇÃO CIENTÍFICA SOBRE A AYAHUASCA NA WEB OF SCIENCE: UMA ANÁLISE BIBLIOMÉTRICA","year":"2023","cit":0,"pfa":"Herta Maria de Açucena do Nascimento Soeiro","ptype":"article","src":"https://openalex.org/W4389995095","eid":"W4389995095"},{"id":"paper-w4244053470","cat":"papers","name":"Tabernanthe iboga: Botanic Gardens Conservation International (BGCI) & IUCN SSC Global Tree Specialist Group","year":"2018","cit":0,"pfa":"IUCN","ptype":"reference-entry","src":"https://openalex.org/W4244053470","eid":"W4244053470"},{"id":"paper-w4249657165","cat":"papers","name":"Genotoxicity Study of Illegal Drug MDMA and Its Nitroso Derivative N-MDMA by Micronucleus and Chromosomal Aberration Tests using Chinese Hamster Lung Fibroblast Cell Line","year":"2007","cit":0,"pfa":"Hayato Yoshioka","psa":"Ryo TAKAGI","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4249657165","eid":"W4249657165"},{"id":"paper-w2081969179","cat":"papers","name":"Use of MDMA (“Ecstasy”) and Its homologues among German university freshmen","year":"1999","cit":0,"pfa":"Kathleen G. Schonauer","psa":"Andreas Erfurth","ptype":"article","src":"https://openalex.org/W2081969179","eid":"W2081969179"},{"id":"paper-w3135538552","cat":"papers","name":"MDMA-gerelateerde sterfgevallen onderzocht door het Nederlands Forensisch Instituut","year":"2017","cit":0,"pfa":"A. Vreeker","psa":"Lusthof, K.","ptype":"book","src":"https://openalex.org/W3135538552","eid":"W3135538552"},{"id":"paper-w4388100014","cat":"papers","name":"OS EFEITOS DA AYAHUASCA NO TRATAMENTO TERAPÊUTICO DA ANSIEDADE E DEPRESSÃO","year":"2023","cit":0,"pfa":"Roberto Carlos Gonçalves de Carvalho","psa":"Fabiano Lacerda Carvalho","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4388100014","eid":"W4388100014"},{"id":"paper-w7117149684","cat":"papers","name":"Psilocybin, Spirituality, and the Potential for Personal Transformation: Commentary on Effects of Psilocybin on Religious and Spiritual Attitudes and Behaviors in Clergy from Various Major World Religions by Griffiths et","year":"2025","cit":0,"pfa":"Kenneth I. Pargäment","ptype":"editorial","src":"https://openalex.org/W7117149684","eid":"W7117149684"},{"id":"paper-w7213965271","cat":"papers","name":"Acute psilocybin or ethocybin leads to a sustained increase in Pavlovian aversion memory in male mice","year":"2026","cit":0,"pfa":"David Ernst Hogg","psa":"Christopher Robert Pryce","topics":["Depression","PTSD & trauma","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7213965271","eid":"W7213965271"},{"id":"paper-w1995571313","cat":"papers","name":"ChemInform Abstract: Highly Oxygenated Diterpenoids Associated to the Central Nervous System: Syntheses of Salvinorin and Forskolin","year":"2010","cit":0,"pfa":"Hisahiro Hagiwara","psa":"Masato Nozawa","ptype":"article","src":"https://openalex.org/W1995571313","eid":"W1995571313"},{"id":"paper-w3200752577","cat":"papers","name":"Treating Major Depression Disorder with Psychedelics: A Potential Therapeutic Application for Psilocybin?","year":"2021","cit":0,"pfa":"Gonçalo Cotovio","psa":"Albino Jorge Oliveira-Maia","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W3200752577","eid":"W3200752577"},{"id":"paper-w3156337608","cat":"papers","name":"A Case Report of an Individual's Experience Participating in a Traditional Costa Rican Ayahuasca Ceremony.","year":"2020","cit":0,"pfa":"George T. Naratadam","psa":"Safeer Shah","ptype":"article","src":"https://openalex.org/W3156337608","eid":"W3156337608"},{"id":"paper-w2781892791","cat":"papers","name":"Entrevista a Josep Mª. Fericgla: Ayahuasca, chamanismo y estados de conciencia","year":"2017","cit":0,"pfa":"Ampa Pérez","ptype":"editorial","src":"https://openalex.org/W2781892791","eid":"W2781892791"},{"id":"paper-w3158162564","cat":"papers","name":"Current trends in the use of Ayahuasca, sacred plant medicine from the Amazon basin","year":"2019","cit":0,"pfa":"pFrancesca Morgantep","ptype":"article","src":"https://openalex.org/W3158162564","eid":"W3158162564"},{"id":"paper-w7124441443","cat":"papers","name":"Time-resolved Neural and Experience Dynamics of Medium- and High-dose N,N-Dimethyltryptamine (DMT).","year":"2026","cit":0,"pfa":"Evan Lewis-Healey","psa":"Tristán Bekinschtein","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7124441443","eid":"W7124441443"},{"id":"paper-w2217453902","cat":"papers","name":"Recent Advances in the Total Synthesis of Ring-Opened Analogues of the Kappa Opioid Receptor Agonist Salvinorin A","year":"2007","cit":0,"pfa":"Matthew D. Schmidt","psa":"Thomas Edward Prisinzano","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2217453902","eid":"W2217453902"},{"id":"paper-w7208474552","cat":"papers","name":"Perlen weben Schritt für Schritt Perlenschmuck selber machen mit der Peyote-Technik","cit":0,"pfa":"Lisa Santiuste Iñurrieta","psa":"Stiebner Verlag","ptype":"article","src":"https://openalex.org/W7208474552","eid":"W7208474552"},{"id":"paper-w2444534869","cat":"papers","name":"[Electrical rhythms of the brain following administration of mescaline and lysergic acid (LSD 25) in mental disorders].","year":"1955","cit":0,"pfa":"I Sanguineti","psa":"R Laricchia","ptype":"article","src":"https://openalex.org/W2444534869","eid":"W2444534869"},{"id":"paper-w3096572865","cat":"papers","name":"Meetings with Mother Ayahuasca: The effects of the spiritual experience on mental processes and physiological responses","year":"2020","cit":0,"pfa":"Linus Pettersson","psa":"Hamoar Hadi Hamasaleh Karim","topics":["Depression","Addiction","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W3096572865","eid":"W3096572865"},{"id":"paper-w7135159330","cat":"papers","name":"N , N -dimethyltryptamine mitigates experimental stroke by stabilizing the blood-brain barrier and reducing neuroinflammation","year":"2025","cit":0,"pfa":"J Laszlo","psa":"Sándor Nardai","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7135159330","eid":"W7135159330"},{"id":"paper-w3036698796","cat":"papers","name":"Hallucinogenic Mushrooms Including Chemical Hallucinogens: Bufotenin and Psilocybin; a Select Bibliography.","year":"1975","cit":0,"pfa":"Sybil H. Bullock","ptype":"article","src":"https://openalex.org/W3036698796","eid":"W3036698796"},{"id":"paper-w4402894145","cat":"papers","name":"Ketamine and Psilocybin Differentially Impact Sensory Learning During the Mismatch Negativity","year":"2024","cit":0,"pfa":"Shona G. Allohverdi","psa":"Andreea Oliviana Diaconescu","ptype":"preprint","src":"https://openalex.org/W4402894145","eid":"W4402894145"},{"id":"paper-w2106739373","cat":"papers","name":"Patterns and settings of 3,4-methylenedioxymethamphetamine (MDMA) use at dance parties in Japan","year":"2014","cit":0,"pfa":"Takuya Shimane","psa":"Masahiko Funada","ptype":"article","src":"https://openalex.org/W2106739373","eid":"W2106739373"},{"id":"paper-w2516980118","cat":"papers","name":"The influence of MDMA (100 mg) and alcohol (0.5 ‰) on simulated driving performance","year":"2010","cit":0,"pfa":"Janna Veldstra","psa":"Karel Brookhuis","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2516980118","eid":"W2516980118"},{"id":"paper-w7164454896","cat":"papers","name":"The effects of a low psilocybin dose on mood and social behavior at a social event.","year":"2026","cit":0,"pfa":"Michiel van Elk","psa":"Josephine Marschall","topics":["Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7164454896","eid":"W7164454896"},{"id":"paper-w2587795892","cat":"papers","name":"Gender differences in effects of MDMA, cannabinoid agonist andtheir combinations in mice","year":"2006","cit":0,"pfa":"Jana Kučerová","psa":"Alexandra Šulcová","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2587795892","eid":"W2587795892"},{"id":"paper-w4414552632","cat":"papers","name":"Recreational MDMA use in Norway: results from an internet convenience sample","year":"2025","cit":0,"pfa":"Cato Grønnerød","psa":"Tor-Morten Kvam","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4414552632","eid":"W4414552632"},{"id":"paper-w7117974449","cat":"papers","name":"Balancing expectations: a systematic review of potential active placebos for MDMA research","year":"2026","cit":0,"pfa":"A. Noar","psa":"M. Bloomfield","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7117974449","eid":"W7117974449"},{"id":"paper-w4390223492","cat":"papers","name":"Intranasal 5-methoxy-N,N-dimethyltryptamine safety, pharmacokinetics and psychedelic effects in healthy volunteers","year":"2023","cit":0,"pfa":"C. Roberts","psa":"F. Wiegand","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4390223492","eid":"W4390223492"},{"id":"paper-w7128645657","cat":"papers","name":"Personality, not cognition, distinguishes chronic ayahuasca and cannabis users from non-users","year":"2026","cit":0,"pfa":"José Carlos Bouso","psa":"Jordi Riba","ptype":"article","src":"https://openalex.org/W7128645657","eid":"W7128645657"},{"id":"paper-w7167203144","cat":"papers","name":"Estimated Health and Economic Outcomes of Medically Monitored Ibogaine for Opioid Use Disorder in the United States","year":"2026","cit":0,"pfa":"T Wagner","psa":"Gaetano Lardieri","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W7167203144","eid":"W7167203144"},{"id":"paper-w4288059639","cat":"papers","name":"Ayahuasca and its interaction with the sigma-1 receptor: a potential treatment for COVID-19","year":"2022","cit":0,"pfa":"Guillermo Saúl Escobar Cornejo","psa":"Luis Fernando Ramos Vargas","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4288059639","eid":"W4288059639"},{"id":"paper-w7112788432","cat":"papers","name":"Beyond psilocybin: A scoping review of other psychedelics as emerging treatment in psychiatry","year":"2022","cit":0,"pfa":"Ishrat Husain","psa":"Nicholas Fabiano","topics":["Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7112788432","eid":"W7112788432"},{"id":"paper-w7140078436","cat":"papers","name":"Messiah Drift and the Phenomenology of Psilocybin: Cross-Kingdom Neurotransmitter Interception and Clinical Integration","year":"2025","cit":0,"pfa":"C.S. Tarpley","psa":"ClearBridge Policy & Ethics Consortium","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7140078436","eid":"W7140078436"},{"id":"paper-w569190612","cat":"papers","name":"Neurocognitive deficits in current and abstinent MDMA and cannabis users (Invited Paper)","year":"2008","cit":0,"pfa":"M. Wareing","psa":"Philip N. Murphy","ptype":"article","src":"https://openalex.org/W569190612","eid":"W569190612"},{"id":"paper-w4246771744","cat":"papers","name":"The role of Dopamine in the Sensitised Locomotor Activating Effects of Methylenedioxymethamphetamine (MDMA) in Rats","year":"2009","cit":0,"pfa":"Dave Gittings","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W4246771744","eid":"W4246771744"},{"id":"paper-w2128248443","cat":"papers","name":"Psychiatric Aspects Of MDMA (3,4-Methylenedioxymethamphetamine): The ‘Diathesis-Stress’ Explanatory Model","year":"2011","cit":0,"pfa":"Andrew C. Parrott","ptype":"article","src":"https://openalex.org/W2128248443","eid":"W2128248443"},{"id":"paper-w4399658894","cat":"papers","name":"LSD-Forschung: Positive Effekte durch zeitgleiche Einnahme von MDMA?","year":"2024","cit":0,"topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4399658894","eid":"W4399658894"},{"id":"paper-w4281400661","cat":"papers","name":"Psilocybin-Assisted Therapy Found to Improve Depression, Offer Other Benefits","year":"2022","cit":0,"pfa":"Richard B. Karel","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4281400661","eid":"W4281400661"},{"id":"paper-w7154344405","cat":"papers","name":"Therapeutic Potential of Psilocybin in Psychiatric Disorders: Mechanisms, Efficacy, and Clinical Implications","year":"2026","cit":0,"pfa":"Shakila Meshkat","psa":"Venkat Bhat","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7154344405","eid":"W7154344405"},{"id":"paper-w7171550005","cat":"papers","name":"Identifying factors that contribute to the behavioral effects of psilocybin in preclinical mouse models","year":"2026","cit":0,"pfa":"Sixtine Fleury","psa":"Katherine M. Nautiyal","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7171550005","eid":"W7171550005"},{"id":"paper-w7159010255","cat":"papers","name":"Datasets used for Honours thesis : Fishy trip or trippy fish? Larval zebrafish as a model for ayahuasca pharmacotherapy","year":"2026","cit":0,"pfa":"Alexia Walker","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"dataset","src":"https://openalex.org/W7159010255","eid":"W7159010255"},{"id":"paper-w2994852584","cat":"papers","name":"MDMA (ecstasy) increases the aquaporin 2 expression in lithium diabetes insipidus","year":"2012","cit":0,"pfa":"Ana Carolina de Bragança","psa":"Antônio J. Magaldi","ptype":"article","src":"https://openalex.org/W2994852584","eid":"W2994852584"},{"id":"paper-w2498321909","cat":"papers","name":"The role of 5-HT1A and 5-HT1B receptors in MDMA self-administration","year":"2016","cit":0,"pfa":"Dane Aronsen","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W2498321909","eid":"W2498321909"},{"id":"paper-w197170190","cat":"papers","name":"Effects of strain on MDMA (“ecstasy”)‐induced locomotor hyperactivity and sensitization in mice","year":"2008","cit":0,"pfa":"Twum Ampofo Ansah","psa":"Tultul Nayyar","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W197170190","eid":"W197170190"},{"id":"paper-w2319953317","cat":"papers","name":"Effects of MDMA-induced serotonergic damage on hippocampal theta activity in rats","year":"2010","cit":0,"pfa":"Bagdy György","ptype":"article","src":"https://openalex.org/W2319953317","eid":"W2319953317"},{"id":"paper-w2560610216","cat":"papers","name":"Caffeine exacerbates the toxicity of 3,4 methylenedioxymethamphetamine (MDMA, Ecstasy ) : a role for dopamine","year":"2010","cit":0,"pfa":"Natacha Vanattou‐Saïfoudine","topics":["Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W2560610216","eid":"W2560610216"},{"id":"paper-w7134268385","cat":"papers","name":"MDMA enhances prefrontal plasticity and representational drift during fear extinction","year":"2026","cit":0,"pfa":"Nitzan Geva","psa":"Alfred P. Kaye","topics":["Addiction","Mechanism & neuroscience","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7134268385","eid":"W7134268385"},{"id":"paper-w7204861982","cat":"papers","name":"Global Ayahuasca: Wondrous Visions and Modern Worlds GearinAlex K. 2024. Global Ayahuasca: Wondrous Visions and Modern Worlds. Stanford, CA: Stanford University Press. 260 pp. ISBN: 9781503636576.","year":"2026","cit":0,"pfa":"Joanna Kempner","ptype":"book-review","src":"https://openalex.org/W7204861982","eid":"W7204861982"},{"id":"paper-w7107960201","cat":"papers","name":"Meditation, psychedelics, and brain connectivity: A randomized controlled resting-state fMRI study of N,N-dimethyltryptamine and harmine in a meditation retreat","year":"2025","cit":0,"pfa":"Egger, Klemens","psa":"Scheidegger, Milan","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7107960201","eid":"W7107960201"},{"id":"paper-w4413284274","cat":"papers","name":"205. SYNERGISTIC BEHAVIORAL AND NEUROPLASTIC EFFECTS OF PSILOCYBIN-NMDAR MODULATOR ADMINISTRATION","year":"2025","cit":0,"pfa":"Bernard Lerer","psa":"Uriel Heresco‐Levy","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4413284274","eid":"W4413284274"},{"id":"paper-w2565462123","cat":"papers","name":"Efforts of Native Americans to Make the Consumption of Peyote for Religious Purposes Legal in the United States of America","year":"2015","cit":0,"pfa":"Anna Drwal","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2565462123","eid":"W2565462123"},{"id":"paper-w4390222133","cat":"papers","name":"Electrophysiological study of visual and auditory processing in psilocin-induced hallucinations: exploring evoked potentials and 5-HT2A receptor involvement","year":"2023","cit":0,"pfa":"Čestmír Vejmola","psa":"Tomáš Páleníček","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4390222133","eid":"W4390222133"},{"id":"paper-w2316472144","cat":"papers","name":"ChemInform Abstract: DIE BESTIMMUNG DER ABSOLUTEN KONFIG. DER IBOGA‐ UND VOACANGA‐ALKALOIDE DURCH OPTISCHE VERFAHREN","year":"1972","cit":0,"pfa":"K. Bláha","psa":"Jan Trojánek","ptype":"article","src":"https://openalex.org/W2316472144","eid":"W2316472144"},{"id":"paper-w4387494383","cat":"papers","name":"6.3 Psilocybin Therapy for the Treatment of Young Adults With Anorexia Nervosa: State of the Research","year":"2023","cit":0,"pfa":"Amanda E. Downey","ptype":"article","src":"https://openalex.org/W4387494383","eid":"W4387494383"},{"id":"paper-w7127898831","cat":"papers","name":"Activity-Dependent Neural Rewiring by Psilocybin: A Monosynaptic Rabies Virus Tracing Study","year":"2026","cit":0,"pfa":"Zen Revista","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7127898831","eid":"W7127898831"},{"id":"paper-w4392379407","cat":"papers","name":"Patients with bipolar II disorder benefit from single dose of psilocybin","year":"2024","cit":0,"topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4392379407","eid":"W4392379407"},{"id":"paper-w2949657343","cat":"papers","name":"ChemInform Abstract: Chemical and Enzymatic Oxidative Coupling of 5‐Hydroxy‐N,N‐dimethyltryptamine with Amines.","year":"1987","cit":0,"pfa":"Fabienne Babin","psa":"Huynh Dinh Tam","ptype":"article","src":"https://openalex.org/W2949657343","eid":"W2949657343"},{"id":"paper-w3020875138","cat":"papers","name":"A fatal case of myocardial damage due to misuse of the “designer drug” MDMA","year":"2010","cit":0,"pfa":"Rie Sano","psa":"Hideaki Itoh","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3020875138","eid":"W3020875138"},{"id":"paper-w2508583288","cat":"papers","name":"Self-reported physical, affective and somatic effects of ecstasy (MDMA) use","year":"2015","cit":0,"pfa":"S. Fuit","psa":"Joris C. Verster","ptype":"article","src":"https://openalex.org/W2508583288","eid":"W2508583288"},{"id":"paper-w7125272559","cat":"papers","name":"Hypersensitivity to serotonin reuptake inhibitors induced by MDMA: two clinical cases","year":"2025","cit":0,"pfa":"D Antonini","psa":"C Point","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7125272559","eid":"W7125272559"},{"id":"paper-w4251924499","cat":"papers","name":"ChemInform Abstract: SULFUR ANALOGS OF PSYCHOTOMIMETIC AGENTS. 30. ETHYL HOMOLOGS OF MESCALINE AND D THEIR MONOTHIOANALOGS","year":"1984","cit":0,"pfa":"Peyton Jacob","psa":"Alexander T. Shulgin","ptype":"article","src":"https://openalex.org/W4251924499","eid":"W4251924499"},{"id":"paper-w3101968285","cat":"papers","name":"Hallucinogens: Magic Mushrooms, Ayahuasca, Mescal Buttons, and Dr. Hofmann’s Problem Child","year":"2020","cit":0,"pfa":"Jerrold C. Winter","topics":["Addiction","Dosing & pharmacology","Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W3101968285","eid":"W3101968285"},{"id":"paper-w2316995198","cat":"papers","name":"ChemInform Abstract: ALKALOIDS. 156. TRANSFORMATION OF THE IBOGA ALKALOID VOACANGINE INTO VOAKETONE, A DERIVATIVE OF β‐CARBOLINE","year":"1976","cit":0,"pfa":"Yutaka Morita","psa":"Hans Schmid","ptype":"article","src":"https://openalex.org/W2316995198","eid":"W2316995198"},{"id":"paper-w2950141538","cat":"papers","name":"ChemInform Abstract: SYNTHESIS AND ACTION ON THE CENTRAL NERVOUS SYSTEM OF MESCALINE ANALOGS CONTAINING PIPERAZINE OR HOMOPIPERAZINE RINGS","year":"1983","cit":0,"pfa":"M. W. MAJCHRZAK","psa":"Konrad Kowalczyk","ptype":"article","src":"https://openalex.org/W2950141538","eid":"W2950141538"},{"id":"paper-w4415343657","cat":"papers","name":"Psilocybin in Alcohol Use Disorder Maintains Abstinence Efficacity: A Scoping Review","year":"2025","cit":0,"pfa":"Jacques Suspène","psa":"Raphaël Serreau","topics":["Addiction","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4415343657","eid":"W4415343657"},{"id":"paper-w7124310451","cat":"papers","name":"LSD and psilocybin effects on cerebral blood flow and global functional connectivity","year":"2026","cit":0,"pfa":"Kristian Larsen","ptype":"other","src":"https://openalex.org/W7124310451","eid":"W7124310451"},{"id":"paper-w4388041191","cat":"papers","name":"Tabernathe Iboga como coadjuvante no tratamento homeopático do craving, na síndrome da dependência química","year":"2023","cit":0,"pfa":"Adilson Martinghi","psa":"Natalia Rubio Claret Pereira","ptype":"book-chapter","src":"https://openalex.org/W4388041191","eid":"W4388041191"},{"id":"paper-w4410993855","cat":"papers","name":"In vitro assessment of psilocin for CYP-dependent drug-drug interaction potential using rapid luminescent assays","year":"2025","cit":0,"pfa":"James J. Cali","ptype":"article","src":"https://openalex.org/W4410993855","eid":"W4410993855"},{"id":"paper-w7214906093","cat":"papers","name":"Stroboscopic light stimulation as a controllable probe of the psilocybin state: a mechanistic framework and a falsifiable prediction","year":"2026","cit":0,"pfa":"Kacper Żełabowski","psa":"Adam Hamed","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7214906093","eid":"W7214906093"},{"id":"paper-w2185479318","cat":"papers","name":"Ecstasy (MDMA) and its Relationship with Self- Report Depression, Anxiety and Schizotypy Éxtasis (MDMA) y su relación con la depresión, ansiedad y esquizotipia autoinformadas","year":"2010","cit":0,"pfa":"Lisa Wood","psa":"Emma Barkus","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2185479318","eid":"W2185479318"},{"id":"paper-w4251489428","cat":"papers","name":"Faculty Opinions recommendation of Thermoregulatory effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans.","year":"2005","cit":0,"pfa":"William Walter Blessing","topics":["Policy & ethics"],"ptype":"peer-review","src":"https://openalex.org/W4251489428","eid":"W4251489428"},{"id":"paper-w2511538228","cat":"papers","name":"Studies on the acute and long-term effects of MDMA (3, 4- methylenedioxymethamphetamine).","year":"2006","cit":0,"pfa":"Kathryn S. Saadat","ptype":"dissertation","src":"https://openalex.org/W2511538228","eid":"W2511538228"},{"id":"paper-w4416541077","cat":"papers","name":"Psilocybin in Alcohol Use Disorder Maintains Abstinence Efficacy: A Scoping Review","year":"2025","cit":0,"pfa":"Jacques Suspène","psa":"Raphaël Serreau","topics":["Addiction","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4416541077","eid":"W4416541077"},{"id":"paper-w4390223994","cat":"papers","name":"Olfactory hallucination due to MDMA use: a very rare case report","year":"2023","cit":0,"pfa":"Eylül Yeral","psa":"Filiz Kulacaoğlu","ptype":"article","src":"https://openalex.org/W4390223994","eid":"W4390223994"},{"id":"paper-w4407325982","cat":"papers","name":"Stare substancje, nowe terapieczyli MDMA w terapii zaburzeń psychicznych","year":"2024","cit":0,"pfa":"Agnieszka Bysiek","topics":["PTSD & trauma","Anxiety & end-of-life","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4407325982","eid":"W4407325982"},{"id":"paper-w2082960650","cat":"papers","name":"P.4.022 The impact of serotonin system modulation on behavior and quantitative EEG in an animal model of psychosis induced by psilocin","year":"2014","cit":0,"pfa":"Filip Tylš","psa":"Jiřı́ Horáček","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2082960650","eid":"W2082960650"},{"id":"paper-w2777932697","cat":"papers","name":"Beeldvormend onderzoek naar de mogelijke neurotoxiciteit van ecstacy (MDMA)","year":"2002","cit":0,"pfa":"Liesbeth Reneman","psa":"Gerard J. den Heeten","topics":["Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W2777932697","eid":"W2777932697"},{"id":"paper-w4244872644","cat":"papers","name":"Phase 3 trial suggests benefit of MDMA‐assisted therapy for PTSD","year":"2021","cit":0,"topics":["PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4244872644","eid":"W4244872644"},{"id":"paper-w4396751431","cat":"papers","name":"One Night of Fun, One Lifetime of Effects: MDMA and Sympathomimetic Syndrome","year":"2024","cit":0,"pfa":"Mustafa Tolga Özdal","psa":"Halil Kaya","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4396751431","eid":"W4396751431"},{"id":"paper-w7158613817","cat":"papers","name":"Datasets used for Honours thesis : Fishy trip or trippy fish? Larval zebrafish as a model for ayahuasca pharmacotherapy","year":"2026","cit":0,"pfa":"Alexia Walker","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"dataset","src":"https://openalex.org/W7158613817","eid":"W7158613817"},{"id":"paper-w7168083930","cat":"papers","name":"Serum inflammatory marker predictors of psilocybin response in treatment resistant depression","year":"2026","cit":0,"pfa":"Luke Baxter","topics":["Depression","Addiction","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7168083930","eid":"W7168083930"},{"id":"paper-w3045947598","cat":"papers","name":"Význam zkušenosti s 3,4-methylendioxymethamfetaminem (MDMA) v partnerském vztahu","year":"2020","cit":0,"pfa":"Hana Tenglerová","ptype":"dissertation","src":"https://openalex.org/W3045947598","eid":"W3045947598"},{"id":"paper-w7113598477","cat":"papers","name":"Potential uses and therapeutic effects of 3,4-methylenedioxymethamphetamine (MDMA): systematic review","year":"2024","cit":0,"pfa":"Teixeira, Jéssica","psa":"Pinho, Cláudia","topics":["Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7113598477","eid":"W7113598477"},{"id":"paper-w1955397708","cat":"papers","name":"Efectos conductuales del MDMA (\"éxtasis\") en animales de experimentación","year":"2001","cit":0,"pfa":"EF Maldonado","psa":"JF Navarro","ptype":"article","src":"https://openalex.org/W1955397708","eid":"W1955397708"},{"id":"paper-w2368082742","cat":"papers","name":"MDMA (3,4-methylenedioxy-methamphetamine)on mouse testicular tissue damage of DNA","year":"2013","cit":0,"pfa":"Yaxi Li","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2368082742","eid":"W2368082742"},{"id":"paper-w2576794785","cat":"papers","name":"Les implications politiques de la techno et du MDMA","year":"2001","cit":0,"pfa":"Vandenberghe, F.","ptype":"article","src":"https://openalex.org/W2576794785","eid":"W2576794785"},{"id":"paper-w3194316799","cat":"papers","name":"Caffeine, Nicotine and MDMA Effects on Retina suggestive of Potential Functional Consequences","year":"2021","cit":0,"pfa":"Joshua Owolabi","psa":"Philip O. Ogunnaike","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3194316799","eid":"W3194316799"},{"id":"paper-w2071979126","cat":"papers","name":"P.1.c.040 MDMA induces oxytocin release in humans","year":"2008","cit":0,"pfa":"Glenn Dumont","psa":"Robbert‐Jan Verkes","ptype":"article","src":"https://openalex.org/W2071979126","eid":"W2071979126"},{"id":"paper-w7105642565","cat":"papers","name":"Changes in Psychoemotional Processes Following MDMA-Assisted Therapy for Anorexia Nervosa","year":"2025","cit":0,"pfa":"Burmester, Victoria","psa":"Galindo, Liliana","topics":["Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W7105642565","eid":"W7105642565"},{"id":"paper-w4412150107","cat":"papers","name":"Treatment with LSD and psilocybin at the department of psychiatry at Frederiksberg Hospital in Denmark from 1960 to 1973: an analysis of 324 cases","year":"2025","cit":0,"pfa":"Jens Larsen","psa":"Søren Dinesen Østergaard","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4412150107","eid":"W4412150107"},{"id":"paper-w7208787084","cat":"papers","name":"Psilocybin, From Ancestral Use to Therapeutic Potential: A Multidimensional Review of Its Pharmacological Basis and Current Perspectives","year":"2026","cit":0,"pfa":"José Norberto Vásquez-Bonilla","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7208787084","eid":"W7208787084"},{"id":"paper-w7151958593","cat":"papers","name":"Evaluation of a facilitator training program in a randomized controlled trial of psilocybin treatment for depression","year":"2026","cit":0,"pfa":"Nikita Sanati Morel","psa":"Maria Beckman","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7151958593","eid":"W7151958593"},{"id":"paper-w7120811242","cat":"papers","name":"Ayahuasca no tratamento da farmacodependência ao etanol em camundongos: possível intervenção terapêutica?","year":"2019","cit":0,"pfa":"Carolina Aparecida de Faria Almeida","ptype":"dissertation","src":"https://openalex.org/W7120811242","eid":"W7120811242"},{"id":"paper-w4321480656","cat":"papers","name":"Lectotypification and neotypification of names related to Banisteriopsis caapi (Malpighiaceae): a contribution to understanding of Ayahuasca","year":"2023","cit":0,"pfa":"RANIELY MIRANDA DE SOUZA","psa":"Regina Célia de Oliveira","ptype":"article","src":"https://openalex.org/W4321480656","eid":"W4321480656"},{"id":"paper-w3013309544","cat":"papers","name":"MDMA attenuates phase shifts of the circadian clock to the GABAB agonist baclofen","year":"2004","cit":0,"pfa":"Rognvald Blance","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W3013309544","eid":"W3013309544"},{"id":"paper-w4394710916","cat":"papers","name":"Intoxicación severa por 3,4-metilendioximetanfetamina (MDMA). Reporte de caso","year":"2024","cit":0,"pfa":"Jaisson Eluceeb Cetina Estepa","psa":"Onofre Casas Castro","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4394710916","eid":"W4394710916"},{"id":"paper-w2779861893","cat":"papers","name":"Symptomatische Hyponatriämie nach Methylendioxy-N-methylamphetamin-Einnahme (MDMA, Ecstasy)","year":"2017","cit":0,"pfa":"Nikolai Stahr","psa":"Dawid Leander Staudacher","ptype":"article","src":"https://openalex.org/W2779861893","eid":"W2779861893"},{"id":"paper-w99757846","cat":"papers","name":"Ayahuasca: expresión de animismo vegetal en la medicina tradicional amazónica","year":"1995","cit":0,"pfa":"Sinforiano Rodríguez Doldán","ptype":"article","src":"https://openalex.org/W99757846","eid":"W99757846"},{"id":"paper-w4251664270","cat":"papers","name":"Review: Ayahuasca, Ritual and Religion in Brazil, by Beatriz Caiuby Labate and Edward MacRae","year":"2013","cit":0,"pfa":"Patricia Barker Lerch","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4251664270","eid":"W4251664270"},{"id":"paper-w4391338385","cat":"papers","name":"Genotoxic and mutagenic evaluation of Ayahuasca in peripheral blood and bone marrow of Mus musculus.","year":"2024","cit":0,"pfa":"Patrícia Feitosa","psa":"Fabrício Pires de Moura do Amaral","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4391338385","eid":"W4391338385"},{"id":"paper-w7214961676","cat":"papers","name":"Estimated Health and Economic Outcomes of Medically Monitored Ibogaine for Opioid Use Disorder in the United States","year":"2026","cit":0,"pfa":"T Wagner","psa":"Gaetano Lardieri","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W7214961676","eid":"W7214961676"},{"id":"paper-w7215033844","cat":"papers","name":"Gabon, home to the medicinal plant behind ibogaine, wants a fairer share of its global boom","year":"2026","cit":0,"pfa":"Molly Helfend","ptype":"other","src":"https://openalex.org/W7215033844","eid":"W7215033844"},{"id":"paper-w4407760123","cat":"papers","name":"Among Psychedelics, Only Psilocybin Has Demonstrated Benefit to Treat Depression.","year":"2025","cit":0,"pfa":"Allen F. Shaughnessy","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4407760123","eid":"W4407760123"},{"id":"paper-w7143470547","cat":"papers","name":"The Impact of State-Regulated Psilocybin Services on Pain in the OPEN Longitudinal Cohort","year":"2026","cit":0,"pfa":"Adie Wilson-Poe","psa":"Kevin F. Boehnke","topics":["Depression","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W7143470547","eid":"W7143470547"},{"id":"paper-w1779979466","cat":"papers","name":"CENTRAL AND SOUTH AMERICA: Der Peyote‐Kult: Entstehung und Verbreitung. M artin G usinde","year":"1940","cit":0,"pfa":"Marvin K. Opler","ptype":"article","src":"https://openalex.org/W1779979466","eid":"W1779979466"},{"id":"paper-w4387861581","cat":"papers","name":"Side-effects of MDMA-assisted Psychotherapy: A Systematic Review and Meta-analysis","year":"2023","cit":0,"pfa":"Julia Colcott","psa":"Gillinder Bedi","topics":["Safety & adverse events","Reviews & meta-analyses","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4387861581","eid":"W4387861581"},{"id":"paper-w3036592951","cat":"papers","name":"Toxicidad asociada al abuso de MDMA y otras anfetaminas","year":"2018","cit":0,"pfa":"Daniel Arévalo Tomillo","topics":["Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W3036592951","eid":"W3036592951"},{"id":"paper-w2890497054","cat":"papers","name":"Young adults in Ireland are taking more MDMA and cannabis than they used to.","year":"2018","cit":0,"pfa":"Cormac Fitzgerald","ptype":"article","src":"https://openalex.org/W2890497054","eid":"W2890497054"},{"id":"paper-w7131678567","cat":"papers","name":"Medical Marijuana? More Like Medical MDMA: Party Drugs and PTSD","year":"2026","cit":0,"pfa":"Aruni Areti","psa":"Jackson Savage","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W7131678567","eid":"W7131678567"},{"id":"paper-w7171942087","cat":"papers","name":"Exploring Attitudes Toward MDMA-Assisted Therapy in Mental Health Care","year":"2026","cit":0,"pfa":"Agnieszka Mechlińska","psa":"Wiesław Jerzy Cubała","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7171942087","eid":"W7171942087"},{"id":"paper-w2320883233","cat":"papers","name":"Isolation and quantification of alkaloids from Tetrapterys mucronata - a plant used in the ayahuasca preparation","year":"2013","cit":0,"pfa":"MF Queiroz","psa":"Jean‐Luc Wolfender","ptype":"article","src":"https://openalex.org/W2320883233","eid":"W2320883233"},{"id":"paper-w4416889747","cat":"papers","name":"Hepatite autoimune induzida por chá de Ayahuasca: relato de caso","year":"2025","cit":0,"pfa":"Stella Bianchini Borges","psa":"Ana Flávia Carrijo Chiovato","ptype":"article","src":"https://openalex.org/W4416889747","eid":"W4416889747"},{"id":"paper-w2763009559","cat":"papers","name":"A performance e os estados alternativos de consciência nos rituais da ayahuasca","year":"2017","cit":0,"pfa":"Gabrielle Dal Molin","ptype":"article","src":"https://openalex.org/W2763009559","eid":"W2763009559"},{"id":"paper-w7120878645","cat":"papers","name":"Development of a method based on green analytical chemistry for foreign ayahuasca active components in hair","year":"2023","cit":0,"pfa":"Fabiana Maria da Conceição dos Santos","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W7120878645","eid":"W7120878645"},{"id":"paper-w7165698909","cat":"papers","name":"Ayahuasca rituals among ultra-Orthodox (Haredi) Jews: context, phenomenology, changes, and negotiations","year":"2026","cit":0,"pfa":"Aviva Berkovich‐Ohana","psa":"Michael Fine","ptype":"preprint","src":"https://openalex.org/W7165698909","eid":"W7165698909"},{"id":"paper-w4385336292","cat":"papers","name":"Psychedelic drug psilocybin shows promise treating anorexia in early trials","year":"2023","cit":0,"pfa":"Grace Wade","ptype":"article","src":"https://openalex.org/W4385336292","eid":"W4385336292"},{"id":"paper-w7127070576","cat":"papers","name":"Neurocognitive effects of psilocybin: A systematic and comprehensive review of neuroimaging studies in humans","year":"2025","cit":0,"pfa":"Lucie Berkovitch","psa":"Raphaël Gaillard","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7127070576","eid":"W7127070576"},{"id":"paper-w7204021951","cat":"papers","name":"The Neurochemical Crucible Hypothesis: Psilocybin as the Missing Catalyst for Human Cognitive Evolution","year":"2026","cit":0,"pfa":"Jonahon Howitz","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7204021951","eid":"W7204021951"},{"id":"paper-w7214562824","cat":"papers","name":"Assessing the effect of psilocybin, a serotonin 5ht2 agonist, in oc-spectrum disorders","year":"2026","cit":0,"pfa":"Stephan Ludewig","topics":["Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W7214562824","eid":"W7214562824"},{"id":"paper-w633244232","cat":"papers","name":"Analytical studies on MDMA and its related compounds in biomaterials by HPLC methods","year":"2008","cit":0,"pfa":"心一 中村","ptype":"article","src":"https://openalex.org/W633244232","eid":"W633244232"},{"id":"paper-w4237775358","cat":"papers","name":"Effects of the Inhibition of Serotonin Reuptake on the Acquisition and Reinstatement of MDMA-Induced CPP","year":"2013","cit":0,"pfa":"José Miñarro","psa":"M.A. Aguilar","topics":["Mechanism & neuroscience"],"ptype":"dataset","src":"https://openalex.org/W4237775358","eid":"W4237775358"},{"id":"paper-w4312267131","cat":"papers","name":"Cosmic and Comic: Jocosity and creativity as strategies to turn off boundaries in a Ayahuasca Religion in The Netherlands","year":"2010","cit":0,"pfa":"Alberto Groisman","ptype":"article","src":"https://openalex.org/W4312267131","eid":"W4312267131"},{"id":"paper-w7116785765","cat":"papers","name":"Psilocybin modulates social behaviour in male and female mice in a time-dependent manner","year":"2025","cit":0,"pfa":"Sheida Shadani","psa":"Claire J. Foldi","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7116785765","eid":"W7116785765"},{"id":"paper-w7131204672","cat":"papers","name":"Making Sense After Psilocybin: Integration, Identity, and Gendered Storylines in Written Accounts.","year":"2026","cit":0,"pfa":"Olivia Ward","topics":["Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7131204672","eid":"W7131204672"},{"id":"paper-w7131816493","cat":"papers","name":"THE EFFECT OF PSILOCYBIN AND EUGENOL ON LIPOPOLYSACCHARIDE INDUCED INFLAMMATION IN SMALL AND LARGE INTESTINE OF MICE","year":"2026","cit":0,"pfa":"Zeinab Asghari, Gregory Robinson, Marta Gerasymchuk, Esmaeel Ghasemi Gojani,…","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7131816493","eid":"W7131816493"},{"id":"paper-w7160738229","cat":"papers","name":"The Right to 'Trip:' Navigating Psilocybin-Assisted Psychotherapy Under the Right to Try Pathway","year":"2025","cit":0,"pfa":"Caitlyn S. Greenspun","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7160738229","eid":"W7160738229"},{"id":"paper-w7129028447","cat":"papers","name":"Psilocybin-assisted cognitive behavioral therapy for major depressive disorder: A pilot trial","year":"2026","cit":0,"pfa":"Marc J. Weintraub","psa":"David J. Miklowitz","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7129028447","eid":"W7129028447"},{"id":"paper-w7166830239","cat":"papers","name":"Past-Year Psilocybin and Alcohol Co-Use: Associations With Mental Health Symptoms","year":"2026","cit":0,"pfa":"Haley M Hummel","psa":"Anita Cservenka","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7166830239","eid":"W7166830239"},{"id":"paper-w2307866119","cat":"papers","name":"Genotoxicity study of illegal drug MDMA and its nitroso derivative N-MDMA by micronucleus and chromosomal aberration tests using Chinese hamster lung fibroblast cell line","year":"2007","cit":0,"pfa":"早戸 吉岡","topics":["Safety & adverse events","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W2307866119","eid":"W2307866119"},{"id":"paper-w1854739598","cat":"papers","name":"5. El peyote y su uso ritual entre los indios de Nayarit (1907)","year":"2005","cit":0,"pfa":"Léon Diguet","ptype":"book-chapter","src":"https://openalex.org/W1854739598","eid":"W1854739598"},{"id":"paper-w4253309438","cat":"papers","name":"Ecstasy (MDMA) May Enhance Effectiveness of Exposure Therapy in the Treatment of PTSD","year":"2009","cit":0,"topics":["PTSD & trauma"],"ptype":"dataset","src":"https://openalex.org/W4253309438","eid":"W4253309438"},{"id":"paper-w4389395547","cat":"papers","name":"MDMA‐assisted therapy for PTSD reduced symptoms in Phase 3 trial","year":"2023","cit":0,"topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4389395547","eid":"W4389395547"},{"id":"paper-w3098110402","cat":"papers","name":"GC/FID cihazı ile kantitatif mdma analizi metot validasyonu","year":"2016","cit":0,"pfa":"Mesut Şahin","ptype":"dissertation","src":"https://openalex.org/W3098110402","eid":"W3098110402"},{"id":"paper-w4391132609","cat":"papers","name":"Med Check: MDMA-Assisted Therapy, OTC Fentanyl Test, and More","year":"2024","cit":0,"pfa":"Nick Zagorski","psa":"Terri D’Arrigo","topics":["PTSD & trauma","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4391132609","eid":"W4391132609"},{"id":"paper-w4408525889","cat":"papers","name":"Functional connectivity changes after a meditation retreat including administration of an ayahuasca-inspired formulation","year":"2025","cit":0,"pfa":"K. Egger","psa":"Milan Scheidegger","ptype":"article","src":"https://openalex.org/W4408525889","eid":"W4408525889"},{"id":"paper-w4298044738","cat":"papers","name":"Michael acceptor approach to the design of new salvinorin A-based high affinity ligands for the kappa-opioid receptor","year":"2020","cit":0,"pfa":"Eyal Vardy","psa":"Vincent Setola","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4298044738","eid":"W4298044738"},{"id":"paper-w7214221655","cat":"papers","name":"Psychedelic Research Database: Journals, Articles & Preprints","year":"2026","cit":0,"pfa":"Gabriella Gatto","psa":"Jonah Stabinski","topics":["Reviews & meta-analyses"],"ptype":"dataset","src":"https://openalex.org/W7214221655","eid":"W7214221655"},{"id":"paper-w4389721551","cat":"papers","name":"WINE OF SOULS: HOW THE USE OF AYAHUASCA CAN IMPACT ON THE QUALITY OF LIFE IN THE LIGHT OF NEUROPSYCHOLOGY","year":"2023","cit":0,"pfa":"Vinícius Eduardo Damacena","psa":"Natalie de Castro Almeida","ptype":"article","src":"https://openalex.org/W4389721551","eid":"W4389721551"},{"id":"paper-w7214626104","cat":"papers","name":"Spiral brain dynamics track the temporal unfolding of subjective intensity during the N,N-dimethyltryptamine experience","year":"2026","cit":0,"pfa":"Gabriela Sawicka","psa":"Gustavo Deco","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7214626104","eid":"W7214626104"},{"id":"paper-w3030860289","cat":"papers","name":"The effects of the long-term neurotoxicity of MDMA on spatial learning and memory function","year":"2006","cit":0,"pfa":"李素霞","psa":"黄明生","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3030860289","eid":"W3030860289"},{"id":"paper-w7120381727","cat":"papers","name":"Development of electrochemical sensors for voltammetric detection of MDMA in samples of forensic interest","year":"2016","cit":0,"pfa":"Maraine Catarina Tadini","topics":["Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W7120381727","eid":"W7120381727"},{"id":"paper-w2114785463","cat":"papers","name":"Ayahuasca, Autoconsciência e Bem-Estar Psicológico: Um Estudo Sobre a (In)Congruência Religiosa","year":"2014","cit":0,"pfa":"Alfredo Pereira","psa":"Francisco Carlos Barbosa dos Santos","ptype":"dissertation","src":"https://openalex.org/W2114785463","eid":"W2114785463"},{"id":"paper-w4402911694","cat":"papers","name":"MDMA modulates human sensorimotor cortical pathways during gentle touch","year":"2024","cit":0,"pfa":"Hanna M. Molla","psa":"India Morrison","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4402911694","eid":"W4402911694"},{"id":"paper-w2416382154","cat":"papers","name":"[On the determination of homologous amines in biologic substrates. 2. Determination of N,N-dimethyltryptamine in blood and urine].","year":"1965","cit":0,"pfa":"H Gross","psa":"Fr. Franzen","ptype":"article","src":"https://openalex.org/W2416382154","eid":"W2416382154"},{"id":"paper-w114235380","cat":"papers","name":"Discriminative stimulus effects of MDMA and its enantiomers in mice: pharmacokinetic considerations","year":"2009","cit":0,"pfa":"William E. Fantegrossi","psa":"Raphael De La Torre","topics":["Addiction","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W114235380","eid":"W114235380"},{"id":"paper-w2202244349","cat":"papers","name":"MDMA (Ecstasy) Induces Egr-1 Expression and Inhibits Neuronal Differentiation","year":"2011","cit":0,"pfa":"Ji‐Hae Lee","psa":"Seunghoon Lee","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2202244349","eid":"W2202244349"},{"id":"paper-w2938217067","cat":"papers","name":"MDMA-relaterte dødsfall i Norge i perioden 2000-2017","year":"2018","cit":0,"pfa":"Anna Sofie Myklevold Kallevik","ptype":"dissertation","src":"https://openalex.org/W2938217067","eid":"W2938217067"},{"id":"paper-w2912871689","cat":"papers","name":"Protective effect of thymoquinone on the MDMA induced serotonin depletion in the brain of rats","year":"2018","cit":0,"pfa":"Rashidi Ahmadp","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2912871689","eid":"W2912871689"},{"id":"paper-w7165381821","cat":"papers","name":"Semantic confusion between “MD” and MDMA in Indian Addiction Psychiatry Practice","year":"2026","cit":0,"pfa":"Ashok Seervi","psa":"Indraja Sharma","topics":["Addiction","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7165381821","eid":"W7165381821"},{"id":"paper-w2917416446","cat":"papers","name":"Persistent neurochemical effects of orally administered methylenedioxymethamphetamine mdma in rats and monkeys","year":"1989","cit":0,"pfa":"Syed F. Ali","psa":"William Slikker","ptype":"article","src":"https://openalex.org/W2917416446","eid":"W2917416446"},{"id":"paper-w2599195694","cat":"papers","name":"Review of Listening Into the Heart of Things-on MDMA and LSD by Samuel Widmer (1989)","year":"2016","cit":0,"pfa":"Michael Richard Starks","topics":["Anxiety & end-of-life","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2599195694","eid":"W2599195694"},{"id":"paper-w7160415716","cat":"papers","name":"Ecstasy (MDMA) for social anxiety in autism: a specialized application of empathogen therapy","year":"2026","cit":0,"pfa":"Mahnoor Sheikh","psa":"Jaber Hamad Jaber Amin","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7160415716","eid":"W7160415716"},{"id":"paper-w2530666485","cat":"papers","name":"Efeitos Cardiovasculares, Renais e Hepáticos Produzidos pela Administração Crônica de Ayahuasca em Ratos Hipertensos/Cardiovascular, Renal and Hepatic Effects Produced by Chronic Administration of Ayahuasca in Hypertensi","year":"1970","cit":0,"pfa":"Aline Cunha Santos","psa":"Nilo César do Vale Baracho","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2530666485","eid":"W2530666485"},{"id":"paper-w2241546218","cat":"papers","name":"Farmacología y toxicidad de la 3,4-metilendioximetamfetamina (MDMA, éxtasis)","year":"2004","cit":0,"pfa":"Norberto Aguirre García","ptype":"article","src":"https://openalex.org/W2241546218","eid":"W2241546218"},{"id":"paper-w4413508188","cat":"papers","name":"Latest trials confirm the benefits of MDMA – the drug in ecstasy – for treating PTSD","year":"2021","cit":0,"pfa":"Charles Michael White","psa":"Adrián Vladimir Hernández","topics":["PTSD & trauma"],"ptype":"other","src":"https://openalex.org/W4413508188","eid":"W4413508188"},{"id":"paper-w4415151518","cat":"papers","name":"MDMA in Psychiatry: From PTSD to emerging indications, safety, and future directions","year":"2025","cit":0,"pfa":"Mingming Zhao","psa":"Kenji Hashimoto","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4415151518","eid":"W4415151518"},{"id":"paper-w7155615487","cat":"papers","name":"Sex-Specific Effects of Psilocin on Paraventricular Nucleus of the Thalamus (PVT) Circuitry and Threat Responding Behavior in Male and Female Rats","year":"2026","cit":0,"pfa":"Melissa A. Herman","ptype":"article","src":"https://openalex.org/W7155615487","eid":"W7155615487"},{"id":"paper-w4313199447","cat":"papers","name":"A phase 1, dose-ranging trial to assess the safety and psychoactive effects of a vaporized 5-methoxy-N,N-dimethyltryptamine formulation in healthy volunteers","year":"2022","cit":0,"pfa":"Johannes T. Reckweg","psa":"Johannes Gerardus Ramaekers","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4313199447","eid":"W4313199447"},{"id":"paper-w4397000224","cat":"papers","name":"Spina bifida; MDMA effects in a mouse model of autism; maternal autoantibodies","year":"2024","cit":0,"pfa":"Jill U. Adams","ptype":"article","src":"https://openalex.org/W4397000224","eid":"W4397000224"},{"id":"paper-w1923504080","cat":"papers","name":"Ayahuasca: la liana delle anime tra New Age e tradizione indigena","year":"2007","cit":0,"pfa":"M. Cristina Cesàro","ptype":"article","src":"https://openalex.org/W1923504080","eid":"W1923504080"},{"id":"paper-w4233308302","cat":"papers","name":"MDMA in two dose strengths shows effectiveness in reducing PTSD symptoms","year":"2018","cit":0,"topics":["PTSD & trauma","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4233308302","eid":"W4233308302"},{"id":"paper-w2045673409","cat":"papers","name":"Sex differences of MDMA metabolism in squirrel monkeys: A comparison to findings in humans","year":"2014","cit":0,"pfa":"Melanie Mueller","psa":"G.A. Ricaurte","ptype":"article","src":"https://openalex.org/W2045673409","eid":"W2045673409"},{"id":"paper-w93827237","cat":"papers","name":"Health related beliefs and behaviours of MDMA (‘Ecstasy’) users in the UK and the US","year":"2001","cit":0,"pfa":"M. Wareing","psa":"John E. Fisk","ptype":"article","src":"https://openalex.org/W93827237","eid":"W93827237"},{"id":"paper-w151715019","cat":"papers","name":"Collecte de MDMA pure (100 %) dans la région Aquitaine","year":"2009","cit":0,"pfa":"Dispositif Sintes","ptype":"article","src":"https://openalex.org/W151715019","eid":"W151715019"},{"id":"paper-w1972028575","cat":"papers","name":"Morbidity in a Population of Low-Income, Female Users of MDMA and Other Drugs","year":"2009","cit":0,"pfa":"Z. Helen Wu","psa":"Linda Bauer Cottler","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W1972028575","eid":"W1972028575"},{"id":"paper-w4401490398","cat":"papers","name":"The Promise of MDMA in the Future Treatment of Severe Post-Traumatic Stress Disorder","year":"2024","cit":0,"pfa":"Mia Panin","psa":"Jason Abercrombie","topics":["PTSD & trauma","Anxiety & end-of-life","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4401490398","eid":"W4401490398"},{"id":"paper-w2245271388","cat":"papers","name":"14. Farmacología de la ayahuasca: investigaciones con voluntarios mediante ensayos clínicos","year":"2013","cit":0,"pfa":"Jordi Riba","psa":"M.J. Barbanoj","ptype":"article","src":"https://openalex.org/W2245271388","eid":"W2245271388"},{"id":"paper-w4366307171","cat":"papers","name":"EFEITOS DA ASSOCIAÇÃO DA IBOGAÍNA E DA AYAHUASCA NA DEPENDÊNCIA ETÍLICA","year":"2023","cit":0,"pfa":"Fernanda Leticia dos Santos Matta","psa":"Marystela Fávero De Oliveira Cardoso","ptype":"conference-paper","src":"https://openalex.org/W4366307171","eid":"W4366307171"},{"id":"paper-w4236000634","cat":"papers","name":"e treatment and handling of substance dependence with ayahuasca: re°ections on current and future research","year":"2016","cit":0,"topics":["Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W4236000634","eid":"W4236000634"},{"id":"paper-w4240559153","cat":"papers","name":"MDMA: Research Areas Needing More Emphasis (PA-04-152)","year":"2005","cit":0,"ptype":"dataset","src":"https://openalex.org/W4240559153","eid":"W4240559153"},{"id":"paper-w2410838658","cat":"papers","name":"[Urinary excretion of bufotenin, N,N-dimethyltryptamine and 3,4-dimethoxyphenylethylamine and the clinical picture of mental disorders].","year":"1978","cit":0,"pfa":"H Matsumoto","psa":"I Pietruszewska","ptype":"other","src":"https://openalex.org/W2410838658","eid":"W2410838658"},{"id":"paper-w7160898827","cat":"papers","name":"Psilocybin in Older Adults: Therapeutic Opportunities in Inflammation-Driven Disorders of Aging—From Depression to Neurodegeneration","year":"2026","cit":0,"pfa":"Marta Jóźwiak-Bębenista","psa":"Edward Kowalczyk","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7160898827","eid":"W7160898827"},{"id":"paper-w2912083460","cat":"papers","name":"The development of a questionnaire to measure MDMA outcome expectancies : the ecstacy expectancy questionnaire","year":"2002","cit":0,"pfa":"Maria M. Scoda","ptype":"dissertation","src":"https://openalex.org/W2912083460","eid":"W2912083460"},{"id":"paper-w4293181149","cat":"papers","name":"Behavioural effects of MDMA on Zebrafish (Danio Rerio) Larvae: preliminary data","year":"2022","cit":0,"pfa":"Ana Rita Cruz","psa":"João Soares Carrola","ptype":"article","src":"https://openalex.org/W4293181149","eid":"W4293181149"},{"id":"paper-w7167635383","cat":"papers","name":"What are the risks of serotonin syndrome when using MDMA and SSRIs together?","year":"2026","cit":0,"pfa":"Tripdatabase","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7167635383","eid":"W7167635383"},{"id":"paper-w327145112","cat":"papers","name":"Zur Identifizierung von Psilocin, einem psychotropen Inhaltstoff mexikanischer Rauschpilze der Gattungen Psilocybe und Stropharia","year":"1960","cit":0,"pfa":"K. S�llner","ptype":"article","src":"https://openalex.org/W327145112","eid":"W327145112"},{"id":"paper-w2745172305","cat":"papers","name":"The acute cognitive and subjective effects of MDMA both alone and in combination with alcohol","year":"2005","cit":0,"pfa":"H. Valerie Curran","psa":"Henry, JA","topics":["Addiction"],"ptype":"conference-paper","src":"https://openalex.org/W2745172305","eid":"W2745172305"},{"id":"paper-w2473266436","cat":"papers","name":"The effect of ecstasy (MDMA) on components of impulsivity: A study controlling for cannabis use","year":"2009","cit":0,"pfa":"Lark Peart","psa":"Raimondo Bruno","ptype":"article","src":"https://openalex.org/W2473266436","eid":"W2473266436"},{"id":"paper-w7168040909","cat":"papers","name":"Brain-targeted epigenetic effects of two emerging psychoplastogens: ketamine & MDMA","year":"2026","cit":0,"pfa":"Moira G. Semple","psa":"Candace R. Lewis","topics":["PTSD & trauma","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7168040909","eid":"W7168040909"},{"id":"paper-w2580672850","cat":"papers","name":"Efeito vascular da MDMA e seus metabolitos em hipertermia","year":"2012","cit":0,"pfa":"Ana Filipa da Cunha Travasso Guerra","ptype":"dissertation","src":"https://openalex.org/W2580672850","eid":"W2580672850"},{"id":"paper-w7133557299","cat":"papers","name":"Correction to “Next-Generation MDMA Analogue SDMA: Pharmacological and Metabolic Insights”","year":"2026","cit":0,"pfa":"Nina Kastner","psa":"Harald H. Sitte","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"erratum","src":"https://openalex.org/W7133557299","eid":"W7133557299"},{"id":"paper-w7158817556","cat":"papers","name":"Datasets sued for Honours thesis : Fishy trip or trippy fish? Larval zebrafish as a model for ayahuasca pharmacotherapy","year":"2026","cit":0,"pfa":"Alexia Walker","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"dataset","src":"https://openalex.org/W7158817556","eid":"W7158817556"},{"id":"paper-w7115903725","cat":"papers","name":"Ibogaine induces juvenile-like plasticity and modulates functional and structural regulators of plasticity in the adult mouse visual cortex","year":"2025","cit":0,"pfa":"Alejo Acuña","psa":"Francesco M. Rossi","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W7115903725","eid":"W7115903725"},{"id":"paper-w7141080424","cat":"papers","name":"Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial","year":"2021","cit":0,"topics":["Depression"],"ptype":"report","src":"https://openalex.org/W7141080424","eid":"W7141080424"},{"id":"paper-w7154837372","cat":"papers","name":"Evaluation of a facilitator training program in a randomized controlled trial of psilocybin treatment for depression","year":"2026","cit":0,"pfa":"Nikita Sanati Morel","psa":"Maria Beckman","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W7154837372","eid":"W7154837372"},{"id":"paper-w568617714","cat":"papers","name":"Acute ecstasy ('MDMA') administration affects the processing of fearful facial expressions","year":"2004","cit":0,"pfa":"Rosa Hoshi","psa":"H. Valerie Curran","ptype":"conference-paper","src":"https://openalex.org/W568617714","eid":"W568617714"},{"id":"paper-w2543763213","cat":"papers","name":"Cytochrome 2D6 function moderates the pharmacokinetics and pharmacodynamics of MDMA in healthy subjects","year":"2016","cit":0,"pfa":"Yasmin Schmid","psa":"Matthias E. Liechti","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2543763213","eid":"W2543763213"},{"id":"paper-w7211920101","cat":"papers","name":"P02-09 Dobutamine cross-reactivity with MDMA immunoassay in a postmortem case","year":"2026","cit":0,"pfa":"I. Kolli","psa":"S. Kaddour","ptype":"article","src":"https://openalex.org/W7211920101","eid":"W7211920101"},{"id":"paper-w4412832134","cat":"papers","name":"Disintegration of Default Mode: Functional MRI Insights Into N,N-Dimethyltryptamine (DMT), Consciousness, and Subcortical Connectivity.","year":"2025","cit":0,"pfa":"Amy Avakian","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4412832134","eid":"W4412832134"},{"id":"paper-w7166665532","cat":"papers","name":"Contribution of the Serotonin 5‐ HT 2A Receptor to the Therapeutic Effect of Psilocin on Social Behavior Deficits in Mice Repeatedly Exposed to Social Defeat Stress","year":"2026","cit":0,"pfa":"Daisuke Ibi","psa":"Masayuki Hiramatsu","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7166665532","eid":"W7166665532"},{"id":"paper-w4391058681","cat":"papers","name":"Uso de ayahuasca en psicoterapia. Un estudio cualitativo en Londres Inglaterra","year":"2005","cit":0,"pfa":"Manuel Villaescusa","ptype":"article","src":"https://openalex.org/W4391058681","eid":"W4391058681"},{"id":"paper-w4366263162","cat":"papers","name":"A UTILIZAÇÃO DA AYAHUASCA NO TRATAMENTO DE PERTURBAÇÕES PSIQUIÁTRICAS: UMA REVISÃO DA LITERATURA","year":"2023","cit":0,"pfa":"João Maria de Bragança Vasconcelos Vilas Boas","topics":["Depression","PTSD & trauma","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4366263162","eid":"W4366263162"},{"id":"paper-w7167617731","cat":"papers","name":"What are the risks of serotonin syndrome when using MDMA and SSRIs together?","year":"2026","cit":0,"pfa":"Tripdatabase","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7167617731","eid":"W7167617731"},{"id":"paper-w2786480486","cat":"papers","name":"Isolation of a Potent Naturally Occurring Hallucinogen, Salvinorin A, from Salvia divinorum and Investigation of Its Photo-degradation","year":"2018","cit":0,"pfa":"Luann Wong","psa":"Takayuki Shibamoto","ptype":"article","src":"https://openalex.org/W2786480486","eid":"W2786480486"},{"id":"paper-w2972227073","cat":"papers","name":"Analogues of MDMA/'Ecstasy' as potential anti-neoplastics in non-Hodgkin's lymphoma","year":"2008","cit":0,"pfa":"AM Wasik","psa":"Matthew Piggott","ptype":"conference-paper","src":"https://openalex.org/W2972227073","eid":"W2972227073"},{"id":"paper-w2914447875","cat":"papers","name":"O chá e os settings : a experiência de estar em psicoterapia e fazer uso ritual da ayahuasca = The brew and the settings: the experience of being in psychoterapy and participating in ayahuasca rituals","year":"2018","cit":0,"pfa":"Ana Carolina Simão","ptype":"dissertation","src":"https://openalex.org/W2914447875","eid":"W2914447875"},{"id":"paper-w655873778","cat":"papers","name":"Tryptophan depletion and cognitive function in regular and ex-users of MDMA ('ecstasy')","year":"2000","cit":0,"pfa":"SL Verheyden","psa":"H. Valerie Curran","ptype":"article","src":"https://openalex.org/W655873778","eid":"W655873778"},{"id":"paper-w2529960789","cat":"papers","name":"The long-term effects of MDMA on behaviour and serotonergic receptor function in the rat.","year":"2003","cit":0,"pfa":"E Bull","topics":["Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W2529960789","eid":"W2529960789"},{"id":"paper-w2388286670","cat":"papers","name":"The effects of the long-term neurotoxicity of MDMA on spatial learning and memory function","year":"2006","cit":0,"pfa":"Xue Wang","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2388286670","eid":"W2388286670"},{"id":"paper-w4410466142","cat":"papers","name":"Correction to: Incremental efficacy systematic review and meta-analysis of psilocybin-for-depression RCTs","year":"2025","cit":0,"pfa":"Nicholas C. Borgogna","psa":"Benjamin David Hill","topics":["Depression","Reviews & meta-analyses"],"ptype":"erratum","src":"https://openalex.org/W4410466142","eid":"W4410466142"},{"id":"paper-w7117474774","cat":"papers","name":"BoneAmanita v5.6: Metabolic Intelligence, Cosmic Topology, and the Psilocybin Architecture of Generative Text","year":"2025","cit":0,"pfa":"James Taylor","psa":"Andrew Edmark","topics":["PTSD & trauma"],"ptype":"report","src":"https://openalex.org/W7117474774","eid":"W7117474774"},{"id":"paper-w4252610774","cat":"papers","name":"Faculty Opinions recommendation of Exploratory Controlled Study of the Migraine-Suppressing Effects of Psilocybin.","year":"2021","cit":0,"pfa":"Michael A. Rogawski","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"peer-review","src":"https://openalex.org/W4252610774","eid":"W4252610774"},{"id":"paper-w4389633978","cat":"papers","name":"The Comparative Therapeutic Effects of Psilocybin Treatment and Antidepressant Medications in Adults Diagnosed with Depression","year":"2023","cit":0,"pfa":"Nassar Melchor","topics":["Depression"],"ptype":"other","src":"https://openalex.org/W4389633978","eid":"W4389633978"},{"id":"paper-w7139605333","cat":"papers","name":"Clinical use of psilocybin in mental disorders:: a bibliometric analysis in Scopus and Web of Science","year":"2025","cit":0,"pfa":"Jimmy Nicolas Hernandez Herrera","psa":"Marian Daniela Guio Sierra","ptype":"article","src":"https://openalex.org/W7139605333","eid":"W7139605333"},{"id":"paper-w7170086547","cat":"papers","name":"Longitudinal neural and psychological changes following psilocybin under compassion imagery priming","year":"2026","cit":0,"pfa":"Carla Pallavicini","psa":"Enzo Tagliazucchi","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7170086547","eid":"W7170086547"},{"id":"paper-w7212027750","cat":"papers","name":"433. Psilocybin reveals diverse antidepressant efficacies across different preclinical models of depression","year":"2026","cit":0,"pfa":"Z Wang","psa":"G Russo","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W7212027750","eid":"W7212027750"},{"id":"paper-w2956152755","cat":"papers","name":"Users' explanations of their psychoactive substance use, with a particular focus on MDMA (Ecstasy)","year":"1999","cit":0,"pfa":"Sarah Zetler","topics":["Addiction"],"ptype":"dissertation","src":"https://openalex.org/W2956152755","eid":"W2956152755"},{"id":"paper-w2365336283","cat":"papers","name":"Determination of MDA and MDMA in Human Blood by Microwave Extraction-Gas Chromatography","year":"2009","cit":0,"pfa":"Ji Wang","ptype":"article","src":"https://openalex.org/W2365336283","eid":"W2365336283"},{"id":"paper-w7132044879","cat":"papers","name":"Associations Between Characteristics of MDMA Use and Empathy Among Young People","year":"2024","cit":0,"pfa":"Šarūnas Janušas","psa":"Aušra Norė","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7132044879","eid":"W7132044879"},{"id":"paper-w7214165553","cat":"papers","name":"Psychedelic Research Database: Journals, Articles & Preprints","year":"2026","cit":0,"pfa":"Gabriella Gatto","psa":"Jonah Stabinski","topics":["Reviews & meta-analyses"],"ptype":"dataset","src":"https://openalex.org/W7214165553","eid":"W7214165553"},{"id":"paper-w2888462715","cat":"papers","name":"Réseaux moléculaires en toxicologie médico-légale: application à une suspicion d’intoxication à Tabernanthe iboga","year":"2018","cit":0,"pfa":"Sophie Allard","psa":"Tristan Gicquel","ptype":"article","src":"https://openalex.org/W2888462715","eid":"W2888462715"},{"id":"paper-w4393116130","cat":"papers","name":"MDMA enhances early visual processing for salient socio-emotional stimuli.","year":"2024","cit":0,"pfa":"Connor J. Haggarty","psa":"Harriet de Wit","topics":["Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4393116130","eid":"W4393116130"},{"id":"paper-w4249825526","cat":"papers","name":"Prenatal exposure to methylenedioxymethamphetamine (MDMA) produces behavioral but not neurochemical changes in offspring","year":"1990","cit":0,"pfa":"Developmental Toxicology","ptype":"article","src":"https://openalex.org/W4249825526","eid":"W4249825526"},{"id":"paper-w4284891105","cat":"papers","name":"AÇÕES SINÉRGICAS ENTRE OS COMPONENTES DO CHÁ DE AYAHUASCA E ANTIDEPRESSIVOS","year":"2022","cit":0,"pfa":"Sueli Mendonça Netto","psa":"Orlando Vieira de Sousa","topics":["Depression"],"ptype":"book-chapter","src":"https://openalex.org/W4284891105","eid":"W4284891105"},{"id":"paper-w1548840457","cat":"papers","name":"Effects of Ganglioside GM1 on MDMA-Induced Serotonergic Neurotoxicity in the Rat Brain","year":"1995","cit":0,"pfa":"Robert L. Dunbar","topics":["Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W1548840457","eid":"W1548840457"},{"id":"paper-w7214008942","cat":"papers","name":"Psilocybin may help the brain recover from concussion, new study shows","year":"2026","cit":0,"pfa":"Argel Valles","ptype":"other","src":"https://openalex.org/W7214008942","eid":"W7214008942"},{"id":"paper-w7130380078","cat":"papers","name":"N,N-dimethyltryptamine (DMT) is neither formed nor retained in serotonin terminals in the rat brain.","year":"2026","cit":0,"pfa":"Mikael Palner","psa":"Paul D. Cumming","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7130380078","eid":"W7130380078"},{"id":"paper-w2189546749","cat":"papers","name":"Amnésie antérograde consécutive à l'absorption de MDMA et d'alcool : à propos d'un cas Anterograde amnesia following MDMA and alcohol absorption: report of a case","year":"2012","cit":0,"pfa":"Caroline Sastre","psa":"Anne‐Laure Pélissier‐Alicot","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2189546749","eid":"W2189546749"},{"id":"paper-w7160576007","cat":"papers","name":"\"Characterization of the Effects and Mechanism of Action of Psilocybin in a Genetic Model of Autism Spectrum Disorder\"","year":"2026","cit":0,"pfa":"Fabrizio Ascone","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W7160576007","eid":"W7160576007"},{"id":"paper-w7120649860","cat":"papers","name":"Study of the indoleamine 2,3-dioxygenase inhibitory action by tryptamine (TRY) and N,N-dimethyltryptamine (DMT)","year":"2012","cit":0,"pfa":"Melissa Cavalheiro Tourino","ptype":"dissertation","src":"https://openalex.org/W7120649860","eid":"W7120649860"},{"id":"paper-w3212679347","cat":"papers","name":"Sensitive and Selective Detection of N,N-Dimethyltryptamine with Molecularly Imprinted Polymer Coupled with Electrogenerated Chemiluminescence","year":"2021","cit":0,"pfa":"Wujian Miao","psa":"Karl J. Wallace","ptype":"conference-abstract","src":"https://openalex.org/W3212679347","eid":"W3212679347"},{"id":"paper-w7213971027","cat":"papers","name":"N,N-Dimethyltryptamine and harmine formulation alters transient EEG topography sequences near the peak of the psychedelic state","year":"2026","cit":0,"pfa":"Maria Niedernhuber","psa":"Helena Aicher","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7213971027","eid":"W7213971027"},{"id":"paper-w4412772962","cat":"papers","name":"Meditation, Psychedelics, and Brain Connectivity: A Randomised Controlled Resting-State fMRI Study of N,N -Dimethyltryptamine and Harmine in a Meditation Retreat","year":"2025","cit":0,"pfa":"Klemens Egger","psa":"Milan Scheidegger","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4412772962","eid":"W4412772962"},{"id":"paper-w3024716072","cat":"papers","name":"Mystical experiences of the Ayahuasca consumption – the Brazilian Santo Daime doctrine and European neo-shamanism","year":"2020","cit":0,"pfa":"Giselle Mânica","topics":["Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W3024716072","eid":"W3024716072"},{"id":"paper-w7201938091","cat":"papers","name":"The Diversity of Yajé (a.k.a. Ayahuasca) & Other Spiritual Plants Among the A'i (a.k.a. Cofán).","year":"2021","cit":0,"pfa":"David Felipe Rodriguez Mora","ptype":"article","src":"https://openalex.org/W7201938091","eid":"W7201938091"},{"id":"paper-w4220813099","cat":"papers","name":"An Exploration of the Aberrant Perceptions Experienced by Westerners in the Peruvian Amazon Amid Shipibo Ayahuasca Practices","year":"2022","cit":0,"pfa":"Agnes Dudek","ptype":"article","src":"https://openalex.org/W4220813099","eid":"W4220813099"},{"id":"paper-w3143574083","cat":"papers","name":"Efeitos da Ayahuasca em medidas psicométricas de pânico, ansiedade e desesperança","year":"2009","cit":0,"pfa":"RAFAEL GUIMARÃES DOS SANTOS","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3143574083","eid":"W3143574083"},{"id":"paper-w897164256","cat":"papers","name":"Pluralismo, Direito e Ayahuasca: autodeterminação e legitimação do poder no mundo desencantado.","year":"2013","cit":0,"pfa":"Jair Araújo Facundes","ptype":"dissertation","src":"https://openalex.org/W897164256","eid":"W897164256"},{"id":"paper-w7112336983","cat":"papers","name":"Modulation of rat prefrontal cortical network activity following single doses of psilocybin","year":"2025","cit":0,"pfa":"Ross Purple","topics":["Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7112336983","eid":"W7112336983"},{"id":"paper-w7126188296","cat":"papers","name":"An open-label pilot study of psilocybin-assisted therapy for binge eating disorder","year":"2026","cit":0,"pfa":"Jesse Dallery","psa":"Beverlee Loeser","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"other","src":"https://openalex.org/W7126188296","eid":"W7126188296"},{"id":"paper-w7169884822","cat":"papers","name":"Therapeutic Potential of Psilocybin in Alcohol and Opioid Use Disorders: A Promising Role for Psychedelics","year":"2026","cit":0,"pfa":"Elmira Zolali","psa":"Samuel Obeng","topics":["Addiction"],"ptype":"editorial","src":"https://openalex.org/W7169884822","eid":"W7169884822"},{"id":"paper-w4200393290","cat":"papers","name":"P.0353 Study protocol: psilocybin as a treatment for anorexia nervosa: a pilot study","year":"2021","cit":0,"pfa":"Hannah M. Douglass","psa":"Robin Lester Carhart-Harris","ptype":"article","src":"https://openalex.org/W4200393290","eid":"W4200393290"},{"id":"paper-w4413238195","cat":"papers","name":"The 5-HT1B Autoreceptor's Role in Emotional Processing in Relation to Acute Psilocybin Experiences","year":"2025","cit":0,"pfa":"Max Malinak","psa":"Katelynne Beach","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4413238195","eid":"W4413238195"},{"id":"paper-w2582186487","cat":"papers","name":"ARDS and Severe Symptomatic Hyponatremia Associated with MDMA Use. A Case Report","year":"2016","cit":0,"pfa":"Heinrich David Fan","psa":"Laura E. Meinke","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2582186487","eid":"W2582186487"},{"id":"paper-w920396234","cat":"papers","name":"Non-Medical Use of Pharmaceutical Opioids Among MDMA Users in Ohio","year":"2008","cit":0,"pfa":"Raminta Daniulaityte","psa":"Jichuan Wang","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W920396234","eid":"W920396234"},{"id":"paper-w2323904186","cat":"papers","name":"An ab initio study on 3,4-methylenedioxymethamphetamine, MDMA (ecstasy) and its derivatives","year":"2016","cit":0,"pfa":"Zahra Fallah Ebrahimi","ptype":"article","src":"https://openalex.org/W2323904186","eid":"W2323904186"},{"id":"paper-w2077545776","cat":"papers","name":"P.2.06 MDMA modifies active avoidance learning and recall in mice","year":"2008","cit":0,"pfa":"J.M. Trigo-Díaz","psa":"Patricia Robledo","ptype":"article","src":"https://openalex.org/W2077545776","eid":"W2077545776"},{"id":"paper-w4248515736","cat":"papers","name":"The role of 5-HT1A and 5-HT1B receptors in MDMA self-administration","year":"2016","cit":0,"pfa":"Dane Aronsen","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W4248515736","eid":"W4248515736"},{"id":"paper-w7115172671","cat":"papers","name":"Field Quantification of MDMA in Seized Samples Using Portable NIR Spectroscopy","year":"2025","cit":0,"pfa":"B. Jurásek","psa":"M. Kuchař","ptype":"article","src":"https://openalex.org/W7115172671","eid":"W7115172671"},{"id":"paper-w2922450363","cat":"papers","name":"Totalsynthese von Lingzhiol via radikalischer Cyclisierung sowie Studien zur Synthese der Kernstruktur von Salvinorin A","year":"2018","cit":0,"pfa":"Lea-Marina Mehl","ptype":"dissertation","src":"https://openalex.org/W2922450363","eid":"W2922450363"},{"id":"paper-w7154897588","cat":"papers","name":"Psilocybin in Older Adults: Therapeutic Opportunities in Inflammation-Driven Disorders of Aging—From Depression to Neurodegeneration","year":"2026","cit":0,"pfa":"Marta Jóźwiak-Bębenista","psa":"Edward Kowalczyk","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W7154897588","eid":"W7154897588"},{"id":"paper-w4380608686","cat":"papers","name":"The Expressive Forms of Amazonian Indigenous Peoples and Ayahuasca: the Huni Kuin and other Pano groups","year":"2023","cit":0,"pfa":"Sandra Lucia Goulart","ptype":"article","src":"https://openalex.org/W4380608686","eid":"W4380608686"},{"id":"paper-w2796263057","cat":"papers","name":"Long-term effects of 3,4- Methylenedioxymethamphetamine (MDMA) on serotonergic and dopaminergic functioning","year":"2003","cit":0,"pfa":"Jodi Lynn Kohutek","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2796263057","eid":"W2796263057"},{"id":"paper-w4245948861","cat":"papers","name":"Cytochrome 2D6 function moderates the pharmacokinetics and pharmacodynamics of MDMA in healthy subjects","year":"2016","cit":0,"pfa":"Patrick Vizeli","topics":["Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W4245948861","eid":"W4245948861"},{"id":"paper-w4293152572","cat":"papers","name":"Présentation de deux cas d’intoxication mortelle à la MDMA","year":"2022","cit":0,"pfa":"Marie Martin Fabritius","psa":"Wolfgang Weinmann","ptype":"article","src":"https://openalex.org/W4293152572","eid":"W4293152572"},{"id":"paper-w4387171824","cat":"papers","name":"POSIBLES ETIOLOGÍAS A DESCARTAR ANTES DE DIAGNOSTICAR FALSO POSITIVO MDMA.","year":"2023","cit":0,"pfa":"BELÉN GONZÁLEZ","psa":"ANA ROSA SÁNCHEZ","ptype":"conference-paper","src":"https://openalex.org/W4387171824","eid":"W4387171824"},{"id":"paper-w7128516111","cat":"papers","name":"Lifetime MDMA use and associations with meaning in life in the context of childhood trauma","year":"2026","cit":0,"pfa":"Michelle Olofsson","psa":"Alexander V. Lebedev","topics":["PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7128516111","eid":"W7128516111"},{"id":"paper-w6820407","cat":"papers","name":"La verdad es amarga: Preparación tradicional del Peyote. La madre de la mescalina","year":"1999","cit":0,"pfa":"Enric Dagà","psa":"Julio Mogrovejo","ptype":"article","src":"https://openalex.org/W6820407","eid":"W6820407"},{"id":"paper-w4313199337","cat":"papers","name":"Acute change in functional brain entropy following psilocybin administration in healthy volunteers","year":"2022","cit":0,"pfa":"Drummond E-Wen McCulloch","psa":"Patrick M. Fisher","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4313199337","eid":"W4313199337"},{"id":"paper-w7166080670","cat":"papers","name":"The therapeutic potential and mechanisms of action of psilocybin-assisted therapy in anorexia nervosa treatment","year":"2024","cit":0,"pfa":"Hannah Douglass","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7166080670","eid":"W7166080670"},{"id":"paper-w7122630135","cat":"papers","name":"Intentions, Spirituality, Set, and Setting Are Associated with Mystical Experiences in Psilocybin-Assisted Therapy","year":"2026","cit":0,"pfa":"Kelsey T. Laird","psa":"Keith G. Heinzerling","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7122630135","eid":"W7122630135"},{"id":"paper-w7213868964","cat":"papers","name":"Curious about Psilocybin? Prevalence and correlates of interest among adults with chronic pain.","year":"2026","cit":0,"pfa":"Carolyn M. L. Crawford","psa":"Susan Holtzman","topics":["Depression"],"ptype":"preprint","src":"https://openalex.org/W7213868964","eid":"W7213868964"},{"id":"paper-w2172073277","cat":"papers","name":"The anti-addiction drug ibogaine inhibits cardiac ion channels: a study to assess the drug’s proarrhythmic potential","year":"2012","cit":0,"pfa":"Xaver Koenig","psa":"Karlheinz Hilber","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2172073277","eid":"W2172073277"},{"id":"paper-w7203465601","cat":"papers","name":"F25. COMPARING PSILOCYBIN-ASSISTED THERAPY AND SSRIS IN THE TREATMENT OF LATE-LIFE DEPRESSION","year":"2026","cit":0,"pfa":"Talia Lall","psa":"Juan Espinosa","topics":["Depression"],"ptype":"conference-abstract","src":"https://openalex.org/W7203465601","eid":"W7203465601"},{"id":"paper-w3204395089","cat":"papers","name":"Ibogaine Modifies GDNF, BDNF and NGF Expression in Brain Regions Involved in Mesocorticolimbic and Nigral Dopaminergic Circuits","year":"2018","cit":0,"pfa":"Soledad Marton","psa":"Ignacio Carrera","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W3204395089","eid":"W3204395089"},{"id":"paper-w7120867581","cat":"papers","name":"Efeitos da ayahuasca sobre a extinção de memórias aversivas contextuais em ratos","year":"2023","cit":0,"pfa":"Werle, Isabel","ptype":"dissertation","src":"https://openalex.org/W7120867581","eid":"W7120867581"},{"id":"paper-w7215041491","cat":"papers","name":"Psychedelic Experience and Metaphysical Belief Change: Preliminary Findings from Ayahuasca Ceremonies in Peru","year":"2026","cit":0,"pfa":"Raluca BilacoRusu","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7215041491","eid":"W7215041491"},{"id":"paper-w4414149661","cat":"papers","name":"We may know why psilocybin helps treat mental health conditions","year":"2025","cit":0,"pfa":"Chris Simms","ptype":"article","src":"https://openalex.org/W4414149661","eid":"W4414149661"},{"id":"paper-w4417293081","cat":"papers","name":"Analysis of Serotonin in Caenorhabditis Elegans Subjected to Micro-Dosing with Psilocybin| Iris Publishers","year":"2025","cit":0,"pfa":"Douglas B Craig","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4417293081","eid":"W4417293081"},{"id":"paper-w2572518171","cat":"papers","name":"Dopaminergic mediation of the discriminative stimulus effects of three cathinone analogs of MDMA","year":"2017","cit":0,"pfa":"Sean B. Dolan","psa":"Michael B. Gatch","ptype":"article","src":"https://openalex.org/W2572518171","eid":"W2572518171"},{"id":"paper-w4408975325","cat":"papers","name":"Psilocybin‐assisted therapy leads to personality shifts in patients with alcohol use disorder","year":"2025","cit":0,"topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4408975325","eid":"W4408975325"},{"id":"paper-w4415974900","cat":"papers","name":"A single dose of psilocybin alleviates chronic pain and associated anxiety and depression in mice","year":"2025","cit":0,"pfa":"AccessScience Editors","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"dataset","src":"https://openalex.org/W4415974900","eid":"W4415974900"},{"id":"paper-w7125652025","cat":"papers","name":"The Evaluation of the Efficacy and Safety of the Use of Psilocybin in the Treatment of Adults with Treatment-Resistant Depression","year":"2026","cit":0,"pfa":"Rishika Scott","psa":"James Smith","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7125652025","eid":"W7125652025"},{"id":"paper-w7214985354","cat":"papers","name":"Analysis code for: An Observational Study on the Effects of Psilocybin Truffle Use in a Retreat Setting","year":"2026","cit":0,"pfa":"Hüseyin Beyköylü","psa":"Michiel van Elk","topics":["Policy & ethics"],"ptype":"software","src":"https://openalex.org/W7214985354","eid":"W7214985354"},{"id":"paper-w7128020141","cat":"papers","name":"Activity-Dependent Neural Rewiring: Mechanisms of Psilocybin-Induced Cortical Network Reorganization","year":"2026","cit":0,"pfa":"Zen Revista","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7128020141","eid":"W7128020141"},{"id":"paper-w4389484742","cat":"papers","name":"Single dose of psilocybin alleviates treatment-resistant depression in bipolar II depression","year":"2023","cit":0,"pfa":"Steve Chaplin","topics":["Depression","Dosing & pharmacology"],"ptype":"dataset","src":"https://openalex.org/W4389484742","eid":"W4389484742"},{"id":"paper-w4409280291","cat":"papers","name":"595. Psilocybin-Assisted Therapy for Relapse Prevention in Alcohol Use Disorder: A RCT","year":"2025","cit":0,"pfa":"Nathalie M. Rieser","psa":"Katrin H. Preller","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4409280291","eid":"W4409280291"},{"id":"paper-w4298189580","cat":"papers","name":"CoMFA analyses of C-2 position Salvinorin A analogs at the kappa-opioid receptor provides insights into epimer selectivity","year":"2020","cit":0,"pfa":"Donna L. McGovern","psa":"Bryan L. Roth","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4298189580","eid":"W4298189580"},{"id":"paper-w2009136789","cat":"papers","name":"κ-opioid and cannabinoid-1 receptors mediate anti-inflammatory and antinociceptive effect of salvinorin a on experimental colitis in mice","year":"2011","cit":0,"pfa":"Jakub Fichna","psa":"Martin Storr","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2009136789","eid":"W2009136789"},{"id":"paper-w2596192470","cat":"papers","name":"An investigation of the acute and longer-term effects of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy')","year":"2001","cit":0,"pfa":"Annis O. Mechan","ptype":"dissertation","src":"https://openalex.org/W2596192470","eid":"W2596192470"},{"id":"paper-w593700767","cat":"papers","name":"The effects of MDMA (Ecstasy) and cannabis on global measures of working memory functioning","year":"2002","cit":0,"pfa":"M. Wareing","psa":"Philip N. Murphy","ptype":"conference-paper","src":"https://openalex.org/W593700767","eid":"W593700767"},{"id":"paper-w2016989689","cat":"papers","name":"MDMA‐ and METH‐induced neurotoxicity in mice: sensitization and desensitization to psychostimulants effects","year":"2002","cit":0,"pfa":"Syed F. Ali","psa":"Yossef Itzhak","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2016989689","eid":"W2016989689"},{"id":"paper-w791853398","cat":"papers","name":"Problematic and non-problematic ecstasy (MDMA) usage : cognitive and psychopathological aspects","year":"2005","cit":0,"pfa":"Kirstie Soar","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W791853398","eid":"W791853398"},{"id":"paper-w4394768468","cat":"papers","name":"PSYCHEDELIC PSILOCYBIN-ASSISTED THERAPY REDUCES DEPRESSIVE SYMPTOMS IN ADULTS WITH CANCER AND DEPRESSION","year":"2024","cit":0,"topics":["Depression","Anxiety & end-of-life","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4394768468","eid":"W4394768468"},{"id":"paper-w7128047664","cat":"papers","name":"Activity-Dependent Neural Rewiring: Mechanisms of Psilocybin-Induced Cortical Network Reorganization","year":"2026","cit":0,"pfa":"Zen Revista","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7128047664","eid":"W7128047664"},{"id":"paper-w4406885597","cat":"papers","name":"Review for \"Molecular insights into the modulation of the 5 HT 2 A receptor by serotonin, psilocin, and the G protein subunit Gqα\"","year":"2024","cit":0,"topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4406885597","eid":"W4406885597"},{"id":"paper-w4396850546","cat":"papers","name":"Inhibition of cytochrome P450 3A4 enzyme activity by alkaloid psilocin from magic mushrooms: potential for drug interactions","year":"2024","cit":0,"pfa":"Lavonne Wilson","psa":"Rupika Delgoda","ptype":"article","src":"https://openalex.org/W4396850546","eid":"W4396850546"},{"id":"paper-w4230540335","cat":"papers","name":"Dinámica poblacional de Lophophora diffusa \"peyote\" (Cactaceae) en una localidad del Estado de Querétaro","year":"2013","cit":0,"pfa":"Omar Díaz Segura","ptype":"dissertation","src":"https://openalex.org/W4230540335","eid":"W4230540335"},{"id":"paper-w4406885598","cat":"papers","name":"Review for \"Molecular insights into the modulation of the 5 HT 2 A receptor by serotonin, psilocin, and the G protein subunit Gqα\"","year":"2024","cit":0,"topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4406885598","eid":"W4406885598"},{"id":"paper-w4407897905","cat":"papers","name":"The Impact of Communicating the Benefits and Safety of Psilocybin on Policy Support: A Survey Based Experiment.","year":"2025","cit":0,"pfa":"Karla Hitchins","psa":"James Reynolds","topics":["Safety & adverse events","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4407897905","eid":"W4407897905"},{"id":"paper-w7140105589","cat":"papers","name":"Psilocybin, Lp(a), CAC, Niere und Darmkrebs – Evidenz-Quickies KW 12","year":"2026","cit":0,"pfa":"Denis Nößler","topics":["Depression","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7140105589","eid":"W7140105589"},{"id":"paper-w7160910785","cat":"papers","name":"Rapid-acting interventions in treatment-resistant depression – a comparative review of esketamine and psilocybin","year":"2026","cit":0,"pfa":"Bartłomiej Kosiarski","psa":"Paulina Biedroń","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7160910785","eid":"W7160910785"},{"id":"paper-w7204528136","cat":"papers","name":"Oregon’s state-regulated psilocybin services: Early real-world safety signals","year":"2026","cit":0,"pfa":"Jason B. Luoma","psa":"Philip Todd Korthuis","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7204528136","eid":"W7204528136"},{"id":"paper-w4411677348","cat":"papers","name":"Set and Setting in Psilocybin-Assisted Therapy: A Qualitative Study of Patients with Cancer and Depression","year":"2025","cit":0,"pfa":"Yvan Beaussant","psa":"Manish Agrawal","topics":["Depression","Anxiety & end-of-life","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4411677348","eid":"W4411677348"},{"id":"paper-w4416994935","cat":"papers","name":"Qualitative Research on Psilocybin-Assisted Psychotherapy for the Treatment of Mental Disorders: A Scoping Review","year":"2025","cit":0,"pfa":"Jennifer Pincombe","psa":"Susan Lee Rossell","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4416994935","eid":"W4416994935"},{"id":"paper-w4229686695","cat":"papers","name":"Recreational MDMA (\"Ecstasy\") Users Exhibit Deficits in Episodic Prospective Memory","year":"2003","cit":0,"pfa":"Donald Young","ptype":"dataset","src":"https://openalex.org/W4229686695","eid":"W4229686695"},{"id":"paper-w2738185014","cat":"papers","name":"Cognitive and subjective effects of the acute MDMA both alone and in combination with alcohol.","year":"2007","cit":0,"pfa":"H. Valerie Curran","psa":"Julie D. Henry","topics":["Addiction"],"ptype":"conference-paper","src":"https://openalex.org/W2738185014","eid":"W2738185014"},{"id":"paper-w4386951632","cat":"papers","name":"MDMA-Assisted Therapy for PTSD Shows Promise for Patients of Diverse Backgrounds","year":"2023","cit":0,"topics":["Depression","PTSD & trauma","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4386951632","eid":"W4386951632"},{"id":"paper-w7148444670","cat":"papers","name":"EDNA Report 2026 Q1: Emergency department presentations with MDMA exposure","year":"2026","cit":0,"pfa":"Courtney Weber","psa":"Jennifer L. Smith","topics":["Safety & adverse events"],"ptype":"other","src":"https://openalex.org/W7148444670","eid":"W7148444670"},{"id":"paper-w4386210471","cat":"papers","name":"Intravenous psilocybin administration attenuates mechanical hypersensitivity in a rat model of chronic pain","year":"2023","cit":0,"pfa":"Nicholas Kolbman","psa":"Dinesh Pal","ptype":"preprint","src":"https://openalex.org/W4386210471","eid":"W4386210471"},{"id":"paper-w4407933975","cat":"papers","name":"Uncovering the dynamics of psilocybin in human neural pain circuits with intracranial neural recordings","year":"2025","cit":0,"pfa":"Tess L. Veuthey","psa":"Prasad R. Shirvalkar","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4407933975","eid":"W4407933975"},{"id":"paper-w7166436963","cat":"papers","name":"Psilocybin reduces fear memory and restores neuroplasticity in the hippocampus and medial prefrontal cortex","year":"2026","cit":0,"pfa":"Y J Du","psa":"Liming Zhang","topics":["Depression","PTSD & trauma","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7166436963","eid":"W7166436963"},{"id":"paper-w4397017186","cat":"papers","name":"Methodological issues undermine evidence about adverse effects of psilocybin-assisted psychotherapy","year":"2024","cit":0,"pfa":"Jonathon Marinis","psa":"Gillinder Bedi","topics":["Safety & adverse events","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4397017186","eid":"W4397017186"},{"id":"paper-w2323041304","cat":"papers","name":"ChemInform Abstract: STUDY OF THE SYNTHESIS OF ISOSTERIC SULFUR PSILOCINS AND SOME 4‐HYDROXYBENZ(B)THIOPHENE DERIVATIVES","year":"1978","cit":0,"pfa":"Richard Neidlein","psa":"C. Gehringer","ptype":"article","src":"https://openalex.org/W2323041304","eid":"W2323041304"},{"id":"paper-w2122304248","cat":"papers","name":"Mescaline Intoxication [Meskalinrausch]. (Brit. Journ. of Med. Psych., May, 1929.) Buchanan, D. N.","year":"1930","cit":0,"pfa":"Gerald W. T. H. Fleming","ptype":"article","src":"https://openalex.org/W2122304248","eid":"W2122304248"},{"id":"paper-w4408526135","cat":"papers","name":"Effects of escitalopram and psilocybin therapy on mesolimbic resting-state functional connectivity in depression","year":"2025","cit":0,"pfa":"R. Harding","psa":"Robin Lester Carhart-Harris","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4408526135","eid":"W4408526135"},{"id":"paper-w4390222176","cat":"papers","name":"A multi-metric evaluation of psilocybin effects on functional brain entropy in healthy volunteers","year":"2023","cit":0,"pfa":"Drummond E-Wen McCulloch","psa":"Patrick M. Fisher","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4390222176","eid":"W4390222176"},{"id":"paper-w7169560954","cat":"papers","name":"Publication bias in randomized trials of psilocybin for depression: a Robust Bayesian Meta-Analysis","year":"2026","cit":0,"pfa":"Çağrı ÖZKURT","topics":["Depression","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7169560954","eid":"W7169560954"},{"id":"paper-w4408266844","cat":"papers","name":"Beneficial effect of the combination psilocybin-semaglutide in a murine model of Steatotic Liver Disease","year":"2025","cit":0,"pfa":"Martina Colognesi","psa":"Sara De Martin","ptype":"article","src":"https://openalex.org/W4408266844","eid":"W4408266844"},{"id":"paper-w2765225346","cat":"papers","name":"Economic Evaluation Of Ayahuasca Treatment For Substance Use Disorder (SUD) Patients In A Peruvian Centre","year":"2017","cit":0,"pfa":"Isotta Triulzi","psa":"Giuseppe Turchetti","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2765225346","eid":"W2765225346"},{"id":"paper-w4417352086","cat":"papers","name":"O Rio e a Floresta: articulações Huni kuin — Rio de Janeiro-Ayahuasca","year":"2019","cit":0,"pfa":"Maicon Fecher","psa":"Elizabeth de Paula Pissolato","ptype":"article","src":"https://openalex.org/W4417352086","eid":"W4417352086"},{"id":"paper-w7117995674","cat":"papers","name":"Temporal effects of a single oral dose of psilocybin on plasma circulating miRNAs in humans","year":"2026","cit":0,"pfa":"A. O'shea","psa":"M. Verheijen","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7117995674","eid":"W7117995674"},{"id":"paper-w7130337407","cat":"papers","name":"Psilocybin-assisted psychotherapy for psycho-existential distress in advanced cancer: a narrative review","year":"2026","cit":0,"pfa":"L. Magnani","psa":"Alessandra Costanza","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W7130337407","eid":"W7130337407"},{"id":"paper-w7166796269","cat":"papers","name":"Convergent biosynthesis of psilocybin in an ectomycorrhizal lineage: is the psychoactive end-product the selected trait?","year":"2026","cit":0,"pfa":"Mellica Askari","psa":"Varun Surapaneni","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7166796269","eid":"W7166796269"},{"id":"paper-w7215108221","cat":"papers","name":"Oregon’s State-Regulated Psilocybin Services: Early Real-World Safety Signals","year":"2026","cit":0,"pfa":"Jason B. Luoma","psa":"Philip Todd Korthuis","topics":["Safety & adverse events","Therapy practice","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W7215108221","eid":"W7215108221"},{"id":"paper-w4413526070","cat":"papers","name":"Psilocybin shows promise for treating eating disorders, but more controlled research is needed","year":"2023","cit":0,"pfa":"Elena PhD","ptype":"other","src":"https://openalex.org/W4413526070","eid":"W4413526070"},{"id":"paper-w2623104575","cat":"papers","name":"La ayahuasca y otras drogas en el tratamiento de adicciones a sustancias","year":"2016","cit":0,"pfa":"Héctor Pastor Pardo","ptype":"dissertation","src":"https://openalex.org/W2623104575","eid":"W2623104575"},{"id":"paper-w7203453263","cat":"papers","name":"Ayahuasca rituals among ultra-Orthodox (Haredi) Jews: context, phenomenology, changes, and negotiations","year":"2026","cit":0,"pfa":"Jonathan David","psa":"Leor Roseman","ptype":"preprint","src":"https://openalex.org/W7203453263","eid":"W7203453263"},{"id":"paper-w2556968325","cat":"papers","name":"Neurokognition, Hirnfunktion und Psychopathologie bei beginnenden MDMA- und Amphetaminkonsumenten","year":"2012","cit":0,"pfa":"Daniel R. Wagner","ptype":"dissertation","src":"https://openalex.org/W2556968325","eid":"W2556968325"},{"id":"paper-w7170705432","cat":"papers","name":"MDMA as an early post-trauma intervention in a translational animal model of PTSD","year":"2026","cit":0,"pfa":"Omer Baruch","psa":"Hagit Cohen","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W7170705432","eid":"W7170705432"},{"id":"paper-w2800438070","cat":"papers","name":"Céu do Mapiá: Social Organization and the Role of Ayahuasca in the Amazonian Santo Daime Community","year":"2018","cit":0,"pfa":"Nikola Bulajic","topics":["Addiction","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W2800438070","eid":"W2800438070"},{"id":"paper-w4414621182","cat":"papers","name":"Acute suicidal behavior following ayahuasca ingestion in a clinical trial setting: a case report","year":"2025","cit":0,"pfa":"José Augusto Silva Reis","psa":"RAFAEL GUIMARÃES DOS SANTOS","ptype":"article","src":"https://openalex.org/W4414621182","eid":"W4414621182"},{"id":"paper-w4417171111","cat":"papers","name":"Review of: \"Psilocybin in Alcohol Use Disorder Maintains Abstinence Efficacy: A Scoping Review\"","year":"2025","cit":0,"pfa":"Leonard B. Lerer","topics":["Addiction","Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4417171111","eid":"W4417171111"},{"id":"paper-w7116757415","cat":"papers","name":"A Naturalistic Study on the Combined Neural and Psychological Effects of Psilocybin and Compassion Focused Imagery","year":"2025","cit":0,"pfa":"Carla Pallavicini","psa":"Enzo Tagliazucchi","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7116757415","eid":"W7116757415"},{"id":"paper-w4205935196","cat":"papers","name":"Uso ritual da ayahuasca durante o tratamento de doenças físicas graves","year":"2020","cit":0,"pfa":"Lucas Oliveira Maia","ptype":"dissertation","src":"https://openalex.org/W4205935196","eid":"W4205935196"},{"id":"paper-w4413555036","cat":"papers","name":"Sapos y ayahuasca: la naturaleza es el mayor camello del planeta","year":"2020","cit":0,"pfa":"Francisco Castro","ptype":"other","src":"https://openalex.org/W4413555036","eid":"W4413555036"},{"id":"paper-w3087011623","cat":"papers","name":"Ayahuasca in de polder Wat een dokter moet weten over de bijwerkingen","year":"2020","cit":0,"pfa":"A van den Berg","psa":"Pieter Roel Tuinman","ptype":"article","src":"https://openalex.org/W3087011623","eid":"W3087011623"},{"id":"paper-w7161800164","cat":"papers","name":"Cost-Effectiveness of Psilocybin-Assisted Therapy (PAT) for Patients with Treatment-Resistant Depression","year":"2026","cit":0,"pfa":"Yosr Ziadi","psa":"Taehwan Park","topics":["Depression"],"ptype":"preprint","src":"https://openalex.org/W7161800164","eid":"W7161800164"},{"id":"paper-w7124833468","cat":"papers","name":"Early response to psilocybin in adults with treatment-resistant depression as a predictor for antidepressant efficacy","year":"2026","cit":0,"pfa":"Zoe Doyle","psa":"Joshua Daniel Rosenblat","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7124833468","eid":"W7124833468"},{"id":"paper-w4416420447","cat":"papers","name":"Interactions between psilocybin, LSD, and serotonergic antidepressants: A qualitative analysis of user reports","year":"2025","cit":0,"pfa":"Holly Hepburn","psa":"Jiun Youn","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4416420447","eid":"W4416420447"},{"id":"paper-w2417569014","cat":"papers","name":"[Influence of LSD and 5-methyoxy-N,N,-dimethyltryptamine on the RNA synthesis in the cell nuclei of rat's brain].","year":"1979","cit":0,"pfa":"Ralf Uebelhack","psa":"K Seidel","ptype":"other","src":"https://openalex.org/W2417569014","eid":"W2417569014"},{"id":"paper-w4247874294","cat":"papers","name":"Ibogaine Modifies GDNF, BDNF and NGF Expression in Brain Regions Involved in Mesocorticolimbic and Nigral Dopaminergic Circuits","year":"2018","cit":0,"pfa":"Soledad Marton","psa":"Ignacio Carrera","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4247874294","eid":"W4247874294"},{"id":"paper-w2951671927","cat":"papers","name":"ChemInform Abstract: SEROTONIN RECEPTOR BINDING AFFINITIES OF SEVERAL HALLUCINOGENIC PHENYLALKYLAMINE AND N,N‐DIMETHYLTRYPTAMINE ANALOGS","year":"1978","cit":0,"pfa":"Richard A. Glennon","psa":"Elizabeth C. Mack","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2951671927","eid":"W2951671927"},{"id":"paper-w7118088356","cat":"papers","name":"Daily Administration of Psilocin Mucate (L-130) Produces a Favorable Safety Profile and Anxiolytic Effects in Rodents Exposed to Chronic Unpredictable Mild Stress","year":"2026","cit":0,"pfa":"Frederick D. Sancilio","psa":"Lyl Tomlinson","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7118088356","eid":"W7118088356"},{"id":"paper-w7165491654","cat":"papers","name":"Ayahuasca rituals among ultra-Orthodox (Haredi) Jews: context, phenomenology, changes, and negotiations","year":"2026","cit":0,"pfa":"Jonathan David","psa":"Leor Roseman","ptype":"preprint","src":"https://openalex.org/W7165491654","eid":"W7165491654"},{"id":"paper-w4405531629","cat":"papers","name":"Psilocybin Microdosing for Anxiety Relief in Young Adults: A Comparative Review of Emerging Evidence","year":"2024","cit":0,"pfa":"Kanwal Shabir","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4405531629","eid":"W4405531629"},{"id":"paper-w4410886448","cat":"papers","name":"Converging pathways: shared brain circuitry engaged by monoaminergic antidepressants, ketamine and psilocybin","year":"2025","cit":0,"pfa":"K Sunny Joseph","psa":"Pavel Osten","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4410886448","eid":"W4410886448"},{"id":"paper-w7128760314","cat":"papers","name":"Psilocybin and Animal Testing: Charting an End to the Use of Animals in Drug Development Research","year":"2026","cit":0,"pfa":"Amanda Elyse","ptype":"preprint","src":"https://openalex.org/W7128760314","eid":"W7128760314"},{"id":"paper-w7160160464","cat":"papers","name":"Acute Cardiovascular Effects of Psilocybin: A Pooled Analysis of 14 Studies with Safety Recommendations","year":"2026","cit":0,"pfa":"Sandeep Manel Nayak","psa":"Frederick Streeter Barrett","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7160160464","eid":"W7160160464"},{"id":"paper-w4406885593","cat":"papers","name":"Decision letter for \"Molecular insights into the modulation of the 5 HT 2 A receptor by serotonin, psilocin, and the G protein subunit Gqα\"","year":"2024","cit":0,"topics":["Mechanism & neuroscience"],"ptype":"peer-review","src":"https://openalex.org/W4406885593","eid":"W4406885593"},{"id":"paper-w205270860","cat":"papers","name":"Ayahuasca. Der Pfad südamerikanischer Schamanen zur Heilung und Auflösung von Schmerzen","year":"2007","cit":0,"pfa":"C. Kobau","ptype":"book-chapter","src":"https://openalex.org/W205270860","eid":"W205270860"},{"id":"paper-w2528025450","cat":"papers","name":"Ayahuasca, um enigma contemporâneo: produção científica do uso terapêutico do chá","year":"2016","cit":0,"pfa":"Amanda Castelan Felipe","ptype":"article","src":"https://openalex.org/W2528025450","eid":"W2528025450"},{"id":"paper-w4409416792","cat":"papers","name":"Psilocybin alters the circulating metabolomic profile in both non-clinical and clinical models","year":"2024","cit":0,"pfa":"Emese Prandovszky O’Donnell","psa":"Robert H. Yolken","ptype":"article","src":"https://openalex.org/W4409416792","eid":"W4409416792"},{"id":"paper-w7164901517","cat":"papers","name":"Mystical States & Psilocybin. From Dissociation Towards Association: A Conversational Model Discussion","year":"2025","cit":0,"pfa":"Toby A. Clark","ptype":"article","src":"https://openalex.org/W7164901517","eid":"W7164901517"},{"id":"paper-w7162031316","cat":"papers","name":"PsiConnect: Multimodal Neuroimaging of Context-Dependent Brain and Behaviour Dynamics under Psilocybin","year":"2026","cit":0,"pfa":"Leonardo Novelli","psa":"Adeel Razi","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"data-paper","src":"https://openalex.org/W7162031316","eid":"W7162031316"},{"id":"paper-w4367666053","cat":"papers","name":"Going on Trial: Serotonin drug; psilocybin phase 2; placebo response data","year":"2023","cit":0,"pfa":"Peter Hess","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4367666053","eid":"W4367666053"},{"id":"paper-w4244750555","cat":"papers","name":"Faculty Opinions recommendation of The near-death experience: a cerebellar method to protect body and soul-lessons from the Iboga healing ceremony in Gabon.","year":"2008","cit":0,"pfa":"Kent C. Berridge","ptype":"peer-review","src":"https://openalex.org/W4244750555","eid":"W4244750555"},{"id":"paper-w7164618","cat":"papers","name":"The role of Dopamine in the Sensitised Locomotor Activating Effects of Methylenedioxymethamphetamine (MDMA) in Rats","year":"2009","cit":0,"pfa":"Dave Gittings","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7164618","eid":"W7164618"},{"id":"paper-w7125948288","cat":"papers","name":"Psilocybin and the Evolutionary Significance of Altered Neural States: Interaction-Based Perspectives Beyond Deterrence Models","year":"2026","cit":0,"pfa":"Philip Rebensburg","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7125948288","eid":"W7125948288"},{"id":"paper-w4412864820","cat":"papers","name":"Title: the use of ayahuasca in the investigation of serious criminal offenses (felonies): a scientific and legal analysis","year":"2025","cit":0,"pfa":"K. Shyshkarov","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4412864820","eid":"W4412864820"},{"id":"paper-w4405738311","cat":"papers","name":"Narrative review of psilocybin, an important psychoactive substance with potential peri-anesthetic implications","year":"2024","cit":0,"pfa":"George Tewfik","psa":"Dorisanne O. Adaralegbe","topics":["Addiction","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4405738311","eid":"W4405738311"},{"id":"paper-w1994931715","cat":"papers","name":"S30.04 Functional brain imaging after acute and chronic exposure to MDMA (“ecstasy”)","year":"2000","cit":0,"pfa":"Alex Gamma","psa":"F.X. Vollenweider","ptype":"conference-abstract","src":"https://openalex.org/W1994931715","eid":"W1994931715"},{"id":"paper-w4394766421","cat":"papers","name":"Letter to the Editor: Will Psilocybin-Assisted Therapy Reduce the Incidence of Medical Assistance in Dying?","year":"2024","cit":0,"pfa":"Matthew Cho","psa":"Sarah Hales","ptype":"letter","src":"https://openalex.org/W4394766421","eid":"W4394766421"},{"id":"paper-w7140209027","cat":"papers","name":"Psilocybin-containing mushrooms as a prospective therapeutic for Parkinson’s disease. Pre-clinical study","year":"2025","cit":0,"pfa":"Elisabete Godinho de Oliveira","ptype":"dissertation","src":"https://openalex.org/W7140209027","eid":"W7140209027"},{"id":"paper-w4415611545","cat":"papers","name":"Optimization of a green method for quantifying harmine in Banisteriopsis caapi stems used in the preparation of ayahuasca","year":"2025","cit":0,"pfa":"Geslane Custódio","psa":"Cristiano Soleo Funari","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4415611545","eid":"W4415611545"},{"id":"paper-w7154843286","cat":"papers","name":"Evaluation of a facilitator training program in a randomized controlled trial of psilocybin treatment for depression","year":"2026","cit":0,"pfa":"Nikita Sanati Morel","psa":"Maria Beckman","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W7154843286","eid":"W7154843286"},{"id":"paper-w2080723431","cat":"papers","name":"S38-02 - Recreational MDMA ‘Ecstasy’: Psychiatric Aspects and the Diathesis Stress Model","year":"2010","cit":0,"pfa":"Andrew Parrott","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2080723431","eid":"W2080723431"},{"id":"paper-w2263643428","cat":"papers","name":"THE EFFECT OF GLUTATHIONE ON NEPHROTOXICITY, INDUCED FROM 3, 4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA) IN MICE","year":"2012","cit":0,"pfa":"Masoumeh Ahmadizadeh","psa":"Asma Siavashpour","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2263643428","eid":"W2263643428"},{"id":"paper-w2774658527","cat":"papers","name":"Symptoms and correlates of emergency medical treatment following the use of MDMA (2014-2016)","year":"2017","cit":0,"pfa":"Larissa Jasmine Maier","psa":"ADAM R. WINSTOCK","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2774658527","eid":"W2774658527"},{"id":"paper-w7162854068","cat":"papers","name":"An exploratory persistent-homology analysis of resting-state fMRI functional connectivity under Ayahuasca","year":"2026","cit":0,"pfa":"Tales C. dos Santos","psa":"Fernando A. N. Santos","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7162854068","eid":"W7162854068"},{"id":"paper-w2524682491","cat":"papers","name":"Neurobiological substrates involved in the behavioural alterations induced by MDMA and THC administration in mice","year":"2015","cit":0,"pfa":"Viñals Álvarez","psa":"Xavier","topics":["Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W2524682491","eid":"W2524682491"},{"id":"paper-w4417497243","cat":"papers","name":"Effects of LSD and Psilocybin on Heart Rate in Patients Receiving Psychedelic Treatment for Depressive and Anxiety Disorders: A Retrospective Observational Study","year":"2025","cit":0,"pfa":"Mylène Cheng","psa":"Louise E. Penzenstadler","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4417497243","eid":"W4417497243"},{"id":"paper-w4403787992","cat":"papers","name":"Decision letter for \"Substrate recognition by the 4‐hydroxytryptamine kinase PsiK in psilocybin biosynthesis\"","year":"2024","cit":0,"ptype":"peer-review","src":"https://openalex.org/W4403787992","eid":"W4403787992"},{"id":"paper-w7162785692","cat":"papers","name":"Effect of psilocybin-assisted psychotherapy on anxiety symptoms: A systematic review and meta-analysis","year":"2026","cit":0,"pfa":"Alex Hood","psa":"Gary R. Elkins","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"review","src":"https://openalex.org/W7162785692","eid":"W7162785692"},{"id":"paper-w7197002658","cat":"papers","name":"Correspondence: “Breaking the chains of depression: A systematic review and meta-analysis of psilocybin therapy”","year":"2026","cit":0,"pfa":"Nils Hörnqvist","topics":["Depression","Reviews & meta-analyses"],"ptype":"letter","src":"https://openalex.org/W7197002658","eid":"W7197002658"},{"id":"paper-w2891195100","cat":"papers","name":"Progress toward the Development of a \"Catch/Release\" Strategy for Isolating Salvinorin A, From Plant Materails Including Microwave Promotion","year":"2017","cit":0,"pfa":"Douglas L. Armstrong","psa":"Logan T. Smith","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2891195100","eid":"W2891195100"},{"id":"paper-w3105416800","cat":"papers","name":"Electroencephalographic Effects of Δ9-Tetrahydrocannabinol, LSD-25, Mescaline and 2,5-Dimethoxy-4-Methylamphetamine in the Rabbits","year":"1972","cit":0,"pfa":"Shigenori Watanabe","psa":"Showa Ueki","ptype":"article","src":"https://openalex.org/W3105416800","eid":"W3105416800"},{"id":"paper-w51225147","cat":"papers","name":"Miazal, donde la ayahuasca y la brujería corren por las venas","year":"2003","cit":0,"pfa":"Iván Carrasco Montesinos","ptype":"article","src":"https://openalex.org/W51225147","eid":"W51225147"},{"id":"paper-w4405190124","cat":"papers","name":"Sustentabilidade, ayahuasca e manejo: análise das técnicas, normas e reflexos socioambientais","year":"2023","cit":0,"pfa":"Igor Fernandes Antunes","ptype":"dissertation","src":"https://openalex.org/W4405190124","eid":"W4405190124"},{"id":"paper-w7170191431","cat":"papers","name":"Psicodélico presente na ayahuasca pode ajudar o cérebro a produzir novos neurônios","year":"2026","cit":0,"pfa":"Stevens Rehen","psa":"José Alexandre Salerno","ptype":"other","src":"https://openalex.org/W7170191431","eid":"W7170191431"},{"id":"paper-w4214824040","cat":"papers","name":"Persisting decreases in state and trait anxiety post-psilocybin: A naturalistic, observational study among retreat attendees","year":"2022","cit":0,"pfa":"Maggie Kiraga","psa":"Natasha Leigh Mason","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4214824040","eid":"W4214824040"},{"id":"paper-w4399282447","cat":"papers","name":"Psilocybin with Acceptance and Commitment Therapy (ACT) for the Treatment of Social Anxiety Disorder (SAD)","year":"2024","cit":0,"pfa":"Aspen Allred","topics":["Anxiety & end-of-life","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W4399282447","eid":"W4399282447"},{"id":"paper-w7127925138","cat":"papers","name":"Activity-Dependent Neural Rewiring by Psilocybin: A Monosynaptic Rabies Virus Tracing Study","year":"2026","cit":0,"pfa":"Zen Revista","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7127925138","eid":"W7127925138"},{"id":"paper-w4233868422","cat":"papers","name":"EFFECT OF ONCE WEEKLY TREATMENT WITH MDMA ON SCHEDULE-CONTROLLED BEHAVIOR AND LOCOMOTOR ACTIVITY","year":"1998","cit":0,"pfa":"M. E. Branson","psa":"M. C. Newland","ptype":"conference-abstract","src":"https://openalex.org/W4233868422","eid":"W4233868422"},{"id":"paper-w2342762302","cat":"papers","name":"Contribution to the study of the mechanisms of action and neuropsychopharmacological effects of MDMA and new β-ketoamphetamines","year":"2016","cit":0,"pfa":"Andrés-Michael Ciudad Roberts","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W2342762302","eid":"W2342762302"},{"id":"paper-w3094552061","cat":"papers","name":"Avaliação farmacológica do possível efeito anti-álcool da ayahuasca em camundongos","year":"2009","cit":0,"pfa":"Bruno Gianfratti","ptype":"dissertation","src":"https://openalex.org/W3094552061","eid":"W3094552061"},{"id":"paper-w2951367171","cat":"papers","name":"Uso terapéutico del MDMA para el Trastorno de estrés postraumático","year":"2018","cit":0,"pfa":"Mateu Socias Ramis","ptype":"dissertation","src":"https://openalex.org/W2951367171","eid":"W2951367171"},{"id":"paper-w7112402883","cat":"papers","name":"Supplementary Materials: Psilocybin Increases Self-Compassion in Patients with Alcohol Use Disorder","year":"2025","cit":0,"pfa":"Gabrielle Agin-Liebes","topics":["Addiction"],"ptype":"preprint","src":"https://openalex.org/W7112402883","eid":"W7112402883"},{"id":"paper-w4413284931","cat":"papers","name":"229. PSILOCYBIN WITH PSYCHOTHERAPEUTIC SUPPORT FOR TREATMENT-RESISTANT DEPRESSION: A PILOT CLINICAL TRIAL","year":"2025","cit":0,"pfa":"S Meikle","psa":"Susan Lee Rossell","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4413284931","eid":"W4413284931"},{"id":"paper-w7128687814","cat":"papers","name":"Correction: The serotonin 1B receptor is required for some of the behavioral effects of psilocybin in mice","year":"2026","cit":0,"pfa":"Sixtine Fleury","psa":"Katherine M. Nautiyal","topics":["Depression","Mechanism & neuroscience"],"ptype":"erratum","src":"https://openalex.org/W7128687814","eid":"W7128687814"},{"id":"paper-w2810459822","cat":"papers","name":"Ayahuasca Weaving Destinies Jimmy Weiskopf Bogotá: sin editorial 2010, 557 páginas","year":"2012","cit":0,"pfa":"Juan Álvaro Echeverri","ptype":"book-review","src":"https://openalex.org/W2810459822","eid":"W2810459822"},{"id":"paper-w7213984035","cat":"papers","name":"“She Told Me So”: Psychoanalytic Perspectives on the Plant Third and the Messages from Ayahuasca","year":"2026","cit":0,"pfa":"Rodolfo Olivieri","psa":"Luís Fernando Tófoli","topics":["Safety & adverse events","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7213984035","eid":"W7213984035"},{"id":"paper-w2172044675","cat":"papers","name":"Perlongher y ayahuasca : La antropología como una forma bastarda de realismo","year":"2012","cit":0,"pfa":"Federico San Juan","ptype":"conference-paper","src":"https://openalex.org/W2172044675","eid":"W2172044675"},{"id":"paper-w4406885605","cat":"papers","name":"Review for \"Molecular insights into the modulation of the 5 HT 2 A receptor by serotonin, psilocin, and the G protein subunit Gqα\"","year":"2024","cit":0,"topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4406885605","eid":"W4406885605"},{"id":"paper-w2164435036","cat":"papers","name":"El error de Ricaurte: la neurotoxicidad del MDMA a revisión","year":"2003","cit":0,"pfa":"José Carlos Bouso","ptype":"article","src":"https://openalex.org/W2164435036","eid":"W2164435036"},{"id":"paper-w2166913751","cat":"papers","name":"MDMA-evoked changes in 11C-raclopride and 11C-NMSP binding potentials.","year":"2003","cit":0,"pfa":"Pedro Rosa‐Neto","psa":"Paul D. Cumming","ptype":"other","src":"https://openalex.org/W2166913751","eid":"W2166913751"},{"id":"paper-w2440857928","cat":"papers","name":"[Pharmacological effect and therapeutic properties of two tropical African plants: Tabernanthe Iboga H. Baillon and Tabernanthe Mannii Stapf].","year":"1956","cit":0,"pfa":"P F Robiola","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2440857928","eid":"W2440857928"},{"id":"paper-w4406885603","cat":"papers","name":"Review for \"Molecular insights into the modulation of the 5 HT 2 A receptor by serotonin, psilocin, and the G protein subunit Gqα\"","year":"2024","cit":0,"topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4406885603","eid":"W4406885603"},{"id":"paper-w7161021476","cat":"papers","name":"Architecture-Specific Failure Modes in hERG QSAR Predictions for Iboga Alkaloids: A Within-Family Empirical Test of the Binding-vs-Blockade Limitation","year":"2026","cit":0,"pfa":"Vincent Wesley Couey","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7161021476","eid":"W7161021476"},{"id":"paper-w7117316334","cat":"papers","name":"Indoles as Molecular Growth Instructions: Psilocybin as Conserved Morphogenetic Signal from Deep Ancestry to Neural Execution","year":"2026","cit":0,"pfa":"C.S. Tarpley","psa":"ClearBridge Policy & Ethics Consortium","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7117316334","eid":"W7117316334"},{"id":"paper-w3202004327","cat":"papers","name":"Psilocybin Mushroom Handbook by L. G Nicholas & Kerry Ogame Social Science","year":"2006","cit":0,"pfa":"L. G Nicholas Kerry Ogame","ptype":"article","src":"https://openalex.org/W3202004327","eid":"W3202004327"},{"id":"paper-w7169831819","cat":"papers","name":"Psilocybin asymmetrically modulates outcome-based choice and cortical processing under uncertainty","year":"2026","cit":0,"pfa":"David S. Jacobs","psa":"Bita Moghaddam","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7169831819","eid":"W7169831819"},{"id":"paper-w2980905361","cat":"papers","name":"THE AGONY AND THE ECSTASY: MDMA INDUCED HYPERTHERMIA, ACUTE LIVER INJURY, DIC, AND RHABDOMYOLYSIS","year":"2019","cit":0,"pfa":"Caroline Dooley","psa":"Keith M. Rose","ptype":"article","src":"https://openalex.org/W2980905361","eid":"W2980905361"},{"id":"paper-w4401444658","cat":"papers","name":"Caffeine, Nicotine and Mdma Effects on the Brain Hippocampal Formation of Juvenile Experiential Models","year":"2024","cit":0,"pfa":"Lola Adeola Adelakin","psa":"Joshua Owolabi","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4401444658","eid":"W4401444658"},{"id":"paper-w7170168404","cat":"papers","name":"Estimating Cardiac 5-HT2B Safety Margins for Repeated Low-Dose Psilocybin Using an Exposure–Response Model","year":"2026","cit":0,"pfa":"William J. Tyler","psa":"Michael B. McDonnell","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7170168404","eid":"W7170168404"},{"id":"paper-w2073482625","cat":"papers","name":"The effects of MDMA on neutrophil activity and leukocyte distribution are not mediated by beta2-adrenergic receptor","year":"2010","cit":0,"pfa":"V. Ferraz-de-Paula","psa":"João Palermo‐Neto","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2073482625","eid":"W2073482625"},{"id":"paper-w4413284268","cat":"papers","name":"694. INVESTIGATING THE POTENTIAL OF PSILOCYBIN FOR COMPULSIVE EATING IN A RAT MODEL OF BINGE EATING","year":"2025","cit":0,"pfa":"Nicolo Fabila","psa":"Robyn M. Brown","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4413284268","eid":"W4413284268"},{"id":"paper-w7142062999","cat":"papers","name":"Associations Between Psilocybin Use Motives and Cognitive, Affective, and Behavioural Self-Stigma","year":"2026","cit":0,"pfa":"Graeme Knibb","psa":"Carl Alexander Roberts","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7142062999","eid":"W7142062999"},{"id":"paper-w7160533237","cat":"papers","name":"Pilot Results for Psilocybin-Assisted Psychotherapy for Cocaine Use Disorder—A Critical Appraisal","year":"2026","cit":0,"pfa":"Erin Elizabeth Bonar","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7160533237","eid":"W7160533237"},{"id":"paper-w7130720501","cat":"papers","name":"Divergent effects of ketamine and psilocybin on EEG power spectral density in a mismatch negativity paradigm","year":"2026","cit":0,"pfa":"Milad Soltanzadeh","psa":"Andreea Oliviana Diaconescu","ptype":"article","src":"https://openalex.org/W7130720501","eid":"W7130720501"},{"id":"paper-w2005948412","cat":"papers","name":"Salvinorin A modulates the neurotransmitters release from different mouse brain areas through presynaptic metabotropic receptors activation","year":"2008","cit":0,"pfa":"Mario Marchi","psa":"Anna Pittaluga","topics":["Addiction","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2005948412","eid":"W2005948412"},{"id":"paper-w2019689374","cat":"papers","name":"S35 ROLE OF MICROGLIA AND CYTOKINES IN MDMA-INDUCED LONG-TERM NEUROTOXICITY","year":"2005","cit":0,"pfa":"M. Isabel Colado","topics":["Safety & adverse events"],"ptype":"conference-abstract","src":"https://openalex.org/W2019689374","eid":"W2019689374"},{"id":"paper-w2782480197","cat":"papers","name":"Enantiômeros e mistura racêmica de MDMA: efeitos no estresse oxidativo","year":"2015","cit":0,"pfa":"Graziela Costa Bósio Mariúba","ptype":"book","src":"https://openalex.org/W2782480197","eid":"W2782480197"},{"id":"paper-w2623516164","cat":"papers","name":"MDMA use among young Irish adults rising – drugs report.","year":"2017","cit":0,"pfa":"A. Philip McMahon","ptype":"article","src":"https://openalex.org/W2623516164","eid":"W2623516164"},{"id":"paper-w2901995656","cat":"papers","name":"The role played by oxidative stress and hyperthermia in the cardiotoxicity of MDMA combined with BZP","year":"2018","cit":0,"pfa":"Sara Cristina Oliveira da Silva","topics":["Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W2901995656","eid":"W2901995656"},{"id":"paper-w2952596825","cat":"papers","name":"ChemInform Abstract: Synthetic Studies and Pharmacological Evaluations on the MDMA (“Ecstasy”) Antagonist Nantenine.","year":"2010","cit":0,"pfa":"Onica LeGendre","psa":"Wayne Wesley Harding","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2952596825","eid":"W2952596825"},{"id":"paper-w3097696375","cat":"papers","name":"Ayahuasca: riesgos y beneficios de una droga cada vez más extendida.","year":"2020","cit":0,"pfa":"Miguel García Jiménez","psa":"Alejandro Martínez Rico","topics":["PTSD & trauma","Mechanism & neuroscience"],"ptype":"conference-paper","src":"https://openalex.org/W3097696375","eid":"W3097696375"},{"id":"paper-w7204149889","cat":"papers","name":"Exploring Ayahuasca Multitarget Potential in Neuropsychiatric Disorders: Integrated Insights Towards Drug Discovery","year":"2026","cit":0,"pfa":"John Ihayi Ogbu","psa":"James Oluwagbamigbe Fajemiroye","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7204149889","eid":"W7204149889"},{"id":"paper-w4388366064","cat":"papers","name":"UNRAVELLING THE ROLE OF 5-HT2AR ACTIVATION IN THE LONG-LASTING BEHAVIORAL EFFECTS OF PSILOCYBIN","year":"2023","cit":0,"pfa":"Chloé Galipeau","psa":"Ana Maria Sebastião","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4388366064","eid":"W4388366064"},{"id":"paper-w4407914947","cat":"papers","name":"The Impact of Communicating the Benefits and Safety of Psilocybin on Policy Support: A Survey Based Experiment.","year":"2025","cit":0,"pfa":"Karla Hitchins","psa":"James Reynolds","topics":["Safety & adverse events","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4407914947","eid":"W4407914947"},{"id":"paper-w7128821525","cat":"papers","name":"Messiah Drift and the Phenomenology of Psilocybin: Cross-Kingdom Neurotransmitter Interception and Clinical Integration","year":"2025","cit":0,"pfa":"C.S. Tarpley","psa":"ClearBridge Policy & Ethics Consortium","topics":["Mechanism & neuroscience","Therapy practice","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W7128821525","eid":"W7128821525"},{"id":"paper-w7140227436","cat":"papers","name":"Psilocybin Reshapes Anterior Cingulate Network Neuropathic Topology to Reduce Chronic Pain","year":"2026","cit":0,"pfa":"Gregory F. Corder","psa":"Corinna Oswell","ptype":"article","src":"https://openalex.org/W7140227436","eid":"W7140227436"},{"id":"paper-w7160487085","cat":"papers","name":"The magic of mushrooms: psilocybin influences behavior in the mangrove rivulus fish, Kryptolebias marmoratus","year":"2026","cit":0,"pfa":"Dayna Forsyth","psa":"Suzanne Currie","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7160487085","eid":"W7160487085"},{"id":"paper-w4417176534","cat":"papers","name":"Acute Blockade of the Serotonin Transporter With Low Doses of Escitalopram Does Not Alter the Behavioural Responses to Acute Psilocybin","year":"2025","cit":0,"pfa":"Nina Kleditzsch","psa":"Thibault Renoir","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4417176534","eid":"W4417176534"},{"id":"paper-w7155399545","cat":"papers","name":"Ayahuasca Therapy: Possible Reduction of Suicidal Ideation in Treatment-Resistant Depression – A Systematic Review","year":"2026","cit":0,"pfa":"Brayan Jonas Mano‐Sousa","psa":"Joaquim Maurício Duarte‐Almeida","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7155399545","eid":"W7155399545"},{"id":"paper-w4411581573","cat":"papers","name":"The Clinical Applications of Psilocybin Therapies and Post-COVID Syndrome: A Comprehensive Narrative Review","year":"2025","cit":0,"pfa":"A Mathew","psa":"Sagar Kamprath","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"review","src":"https://openalex.org/W4411581573","eid":"W4411581573"},{"id":"paper-w7117292388","cat":"papers","name":"Messiah Drift and the Phenomenology of Psilocybin: Cross-Kingdom Neurotransmitter Interception and Clinical Integration","year":"2025","cit":0,"pfa":"C.S. Tarpley","topics":["Mechanism & neuroscience","Therapy practice","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W7117292388","eid":"W7117292388"},{"id":"paper-w7166654132","cat":"papers","name":"Adverse Events after Naturalistic Psilocybin Use: Analysis from the PUNS Study","year":"2026","cit":0,"pfa":"Roman Palitsky","psa":"Petr Šupa","topics":["Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W7166654132","eid":"W7166654132"},{"id":"paper-w7160557567","cat":"papers","name":"265 Self-reported rates of psilocybin use in North Florida, 2012 to present","year":"2026","cit":0,"pfa":"Tamara A. Millay","psa":"Linda Cottler","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7160557567","eid":"W7160557567"},{"id":"paper-w2594517726","cat":"papers","name":"Cytochrome P450 polymorphisms moderate pharmacokinetics and pharmacodynamic effects of MDMA in healthy subjects","year":"2017","cit":0,"pfa":"Patrick Vizeli","psa":"Matthias E. Liechti","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2594517726","eid":"W2594517726"},{"id":"paper-w7162225828","cat":"papers","name":"The Use of Psilocybin for Managing Refractory Behavioral Health Conditions: A New and Promising Approach","year":"2026","cit":0,"pfa":"Rachel N Clark","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7162225828","eid":"W7162225828"},{"id":"paper-w3119198755","cat":"papers","name":"Psychoactive effects and toxicity of tryptamine, N-methyltryptamine (NMT), and N, N-dimethyltryptamine (DMT): quantification methods","year":"2021","cit":0,"pfa":"Elena L. Paley","topics":["Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W3119198755","eid":"W3119198755"},{"id":"paper-w4413284688","cat":"papers","name":"426. THE MGLUR2/3 ANTAGONIST ENHANCES THE BEHAVIORAL AND CELLULAR ANTIDEPRESSANT-LIKE EFFECTS OF PSILOCYBIN AND SCOPOLAMINE","year":"2025","cit":0,"pfa":"Yana Babii","psa":"Andrzej Pilc","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W4413284688","eid":"W4413284688"},{"id":"paper-w4396829929","cat":"papers","name":"Effects of Ayahuasca on Ethanol-Conditioned Place Preference and ΔFosB Expression in the Nucleus Accumbens in Mice","year":"2024","cit":0,"pfa":"Victor Distefano Wiltenburg","psa":"Fúlvio Rieli Mendes","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4396829929","eid":"W4396829929"},{"id":"paper-w4238661024","cat":"papers","name":"The dynamics of healing and creativity during Ayahuasca shamanic journeys: Toward a neuroscience--human sciences model","year":"2010","cit":0,"pfa":"Frank Echenhofer","ptype":"dataset","src":"https://openalex.org/W4238661024","eid":"W4238661024"},{"id":"paper-w4200392979","cat":"papers","name":"P.0321 Ayahuasca as a rescue treatment in depressive patients resistant to pharmacological treatment: a systematic review","year":"2021","cit":0,"pfa":"C. López Morillo","psa":"E. Sánchez Martínez","topics":["Depression","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4200392979","eid":"W4200392979"},{"id":"paper-w4409073082","cat":"papers","name":"Corrigendum: Ayahuasca-assisted meaning reconstruction therapy for grief: a non-randomized clinical trial protocol","year":"2025","cit":0,"pfa":"Pablo Sabucedo","psa":"Débora González","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"erratum","src":"https://openalex.org/W4409073082","eid":"W4409073082"},{"id":"paper-w2506390520","cat":"papers","name":"Drug-seeking following extinction of MDMA self- administration: Role of dopamine and serotonin","year":"2015","cit":0,"pfa":"Susan Schenk","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2506390520","eid":"W2506390520"},{"id":"paper-w7125836890","cat":"papers","name":"Long-Term Follow-Up of MDMA-Assisted Therapy for Major Depressive Disorder","year":"2025","cit":0,"topics":["Depression"],"ptype":"conference-paper","src":"https://openalex.org/W7125836890","eid":"W7125836890"},{"id":"paper-w7112547341","cat":"papers","name":"Psilocybin administration leads to a recurrent high integrated and low segregated brain pattern","year":"2023","cit":0,"pfa":"Mortaheb, Sepehr","psa":"Demertzi, Athina","topics":["Reviews & meta-analyses"],"ptype":"conference-abstract","src":"https://openalex.org/W7112547341","eid":"W7112547341"},{"id":"paper-w4416999810","cat":"papers","name":"Review of: \"Psilocybin in Alcohol Use Disorder Maintains Abstinence Efficacy: A Scoping Review\"","year":"2025","cit":0,"pfa":"Anees Bahji","topics":["Addiction","Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4416999810","eid":"W4416999810"},{"id":"paper-w4409001595","cat":"papers","name":"Effects of a single dose of psilocybin on diet-induced weight loss in obese mice","year":"2026","cit":0,"pfa":"Ryan J. Keenan","psa":"Michael Alexander Cowley","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4409001595","eid":"W4409001595"},{"id":"paper-w7162100098","cat":"papers","name":"A single dose of psilocybin eased depression symptoms for months, our study found","year":"2026","cit":0,"pfa":"Hampus Yngwe","psa":"J O Lundberg","topics":["Depression","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W7162100098","eid":"W7162100098"},{"id":"paper-w2790171984","cat":"papers","name":"Norepinephrine loss enhances MDMA toxicity and formation of ubiquitin positive striatal whorls","year":"2001","cit":0,"pfa":"Francesco Fornai","psa":"Antonio Paparelli","topics":["Safety & adverse events"],"ptype":"conference-paper","src":"https://openalex.org/W2790171984","eid":"W2790171984"},{"id":"paper-w2474286866","cat":"papers","name":"The pharmacology of MDMA and methylphenidate, as revealed by immediate-early gene expression in rat brain.","year":"2005","cit":0,"pfa":"J. Aston","topics":["Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W2474286866","eid":"W2474286866"},{"id":"paper-w4413720155","cat":"papers","name":"The MDMA being used to treat trauma is different from the street drug Ecstasy","year":"2016","cit":0,"pfa":"Joseph J. Palamar","topics":["PTSD & trauma"],"ptype":"other","src":"https://openalex.org/W4413720155","eid":"W4413720155"},{"id":"paper-w7120607791","cat":"papers","name":"Biochemical, cellular and histological effects on Crassostrea gasar exposed to 3,4-methylenedioxymethamphetamine (MDMA)","year":"2024","cit":0,"pfa":"Érico Barzan de Mattos Amaral","ptype":"dissertation","src":"https://openalex.org/W7120607791","eid":"W7120607791"},{"id":"paper-w7162007475","cat":"papers","name":"Mescaline Alters Cerebellar Function, Global Connectivity, and Frequency-Selective Acoustic Gating: A BOLD fMRI Study in Awake Rats","year":"2026","cit":0,"pfa":"Noah Cavallaro","psa":"Craig F. Ferris","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7162007475","eid":"W7162007475"},{"id":"paper-w2615076145","cat":"papers","name":"Sagrado e o feminino: as mulheres e suas vicissitudes no consumo da ayahuasca","year":"2017","cit":0,"pfa":"Natássia Henriques Daldegan Bueno","ptype":"article","src":"https://openalex.org/W2615076145","eid":"W2615076145"},{"id":"paper-w7120806073","cat":"papers","name":"Ayahuasca e self : relações entre autoconsciência, misticismo e dissolução do eu","year":"2022","cit":0,"pfa":"Robson Savoldi","topics":["Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7120806073","eid":"W7120806073"},{"id":"paper-w4405621732","cat":"papers","name":"Evaluation of the long-term cognitive effects of psilocybin in a chronic stress mouse model","year":"2024","cit":0,"pfa":"Nerea Martínez-Álvarez","psa":"J.E. Ortega","ptype":"article","src":"https://openalex.org/W4405621732","eid":"W4405621732"},{"id":"paper-w4413284794","cat":"papers","name":"363. DIFFERENTIAL EFFECTS OF PSILOCYBIN AND LISURIDE ON SEROTONIN AND DOPAMINE NEURONAL ACTIVITY AND BEHAVIOR","year":"2025","cit":0,"pfa":"B Richardson","psa":"Gabriella Gobbi","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4413284794","eid":"W4413284794"},{"id":"paper-w7213292509","cat":"papers","name":"5-HT2A receptor activation is dispensable for psilocybin-induced fear extinction and neuroplasticity in mice","year":"2026","cit":0,"pfa":"Yingjie Du","psa":"Guyan Wang","topics":["Mechanism & neuroscience","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7213292509","eid":"W7213292509"},{"id":"paper-w7119334938","cat":"papers","name":"A institucionalização do uso da ayahuasca no Brasil: práticas, estigmas e políticas públicas","year":"2023","cit":0,"pfa":"Almeida, Paulo Santos de","ptype":"article","src":"https://openalex.org/W7119334938","eid":"W7119334938"},{"id":"paper-w4395066859","cat":"papers","name":"Ayahuasca-based psychedelic-assisted therapy for PTSD and its effects on the microbiome: A discovery cohort","year":"2023","cit":0,"pfa":"Lyanna R. Kessler","psa":"Christopher A. Lowry","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4395066859","eid":"W4395066859"},{"id":"paper-w806316479","cat":"papers","name":"The prosocial effects of oxytocin, vasopressin and 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') in laboratory rats","year":"2014","cit":0,"pfa":"Linnet Ramos","topics":["PTSD & trauma","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W806316479","eid":"W806316479"},{"id":"paper-w2191438066","cat":"papers","name":"The Internationalization of Ayahuasca. Vol. 16 of the series Performances: Intercultural Studies on Ritual, Play and Theatre","year":"2012","cit":0,"pfa":"John R. Baker","ptype":"article","src":"https://openalex.org/W2191438066","eid":"W2191438066"},{"id":"paper-w7214851892","cat":"papers","name":"Experiencias de sanación emocional: relatos subjetivos en contextos rituales de ayahuasca.","year":"2026","cit":0,"pfa":"Juan José Yasnó Gallego","ptype":"dissertation","src":"https://openalex.org/W7214851892","eid":"W7214851892"},{"id":"paper-w4254910040","cat":"papers","name":"ChemInform Abstract: CRYSTAL STRUCTURES OF THE TEONANACATL HALLUCINOGENS PART 1, PSILOCYBIN C12H17N2O4O","year":"1974","cit":0,"pfa":"Hans Peter Weber","psa":"Trevor James Petcher","ptype":"article","src":"https://openalex.org/W4254910040","eid":"W4254910040"},{"id":"paper-w7127054291","cat":"papers","name":"Review of: \"Psilocybin in Alcohol Use Disorder Maintains Abstinence Efficacy: A Scoping Review\"","year":"2026","cit":0,"pfa":"Carlton J. Spotswood","topics":["Addiction","Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W7127054291","eid":"W7127054291"},{"id":"paper-w7131870859","cat":"papers","name":"THE EFFECT OF PSILOCYBIN AND EUGENOL ON LIPOPOLYSACCHARIDE INDUCED INFLAMMATION IN SMALL AND LARGE INTESTINE OF MICE","year":"2026","cit":0,"pfa":"Zeinab Asghari, Gregory Robinson, Marta Gerasymchuk, Esmaeel Ghasemi Gojani,…","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7131870859","eid":"W7131870859"},{"id":"paper-w7172261546","cat":"papers","name":"Safety and Efficacy of Psilocybin During Anticancer Treatment: A Phase II Trial Secondary Analysis","year":"2026","cit":0,"pfa":"Daniel A. Schaefer","psa":"Yvan Beaussant","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7172261546","eid":"W7172261546"},{"id":"paper-w2585773692","cat":"papers","name":"Los Huicholes--y su mundo sagrado del peyote (ESPECIAL: Los profesores tienen la palabra)","year":"2002","cit":0,"pfa":"Georgina Pérez Romero","ptype":"article","src":"https://openalex.org/W2585773692","eid":"W2585773692"},{"id":"paper-w7165444878","cat":"papers","name":"Indoles as Molecular Growth Instructions: Psilocybin as Conserved Morphogenetic Signal from Deep Ancestry to Neural Execution","year":"2026","cit":0,"pfa":"C.S. Tarpley","psa":"ClearBridge Policy & Ethics Consortium","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7165444878","eid":"W7165444878"},{"id":"paper-w7172487620","cat":"papers","name":"Cost-Effectiveness of Medically Monitored Ibogaine for Opioid Use Disorder in Tennessee: A State-Specific Semi-Markov Analysis","year":"2026","cit":0,"pfa":"T Wagner","psa":"KD Adams","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7172487620","eid":"W7172487620"},{"id":"paper-w7154730086","cat":"papers","name":"Ibogaine induces juvenile-like plasticity and modulates functional and structural regulators of plasticity in the adult mouse visual cortex","year":"2026","cit":0,"pfa":"Alejo Acuña","psa":"Francesco Rossi","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7154730086","eid":"W7154730086"},{"id":"paper-w7213536713","cat":"papers","name":"A Case of Acute Mania and Rhabdomyolysis Associated With Long-Term, Daily Psilocybin Use","year":"2026","cit":0,"pfa":"Drew A. Wells","psa":"Katharyn Walker","ptype":"article","src":"https://openalex.org/W7213536713","eid":"W7213536713"},{"id":"paper-w2037327917","cat":"papers","name":"RG-007 Male germ cell-mediated transgenerational effect of ecstasy (MDMA)","year":"2008","cit":0,"pfa":"Jy Yang","psa":"GS Rhee","ptype":"conference-abstract","src":"https://openalex.org/W2037327917","eid":"W2037327917"},{"id":"paper-w7139461572","cat":"papers","name":"Impact of a serotonergic lesion on parkinsonian symptomatology : multiple approaches in the MPTP-MDMA monkey","year":"2015","cit":0,"pfa":"Maude Beaudoin","topics":["Addiction","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W7139461572","eid":"W7139461572"},{"id":"paper-w4214926937","cat":"papers","name":"Correction to “Cognitive Effects of MDMA in Laboratory Animals: A Systematic Review Focusing on Dose”","year":"2021","cit":0,"topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"erratum","src":"https://openalex.org/W4214926937","eid":"W4214926937"},{"id":"paper-w7165120489","cat":"papers","name":"Protocol for a qualitative mechanistic study of MDMA with a sample of psychoanalytic psychotherapists: A phenomenological investigation","year":"2026","cit":0,"pfa":"Elisa Liberati","psa":"Sunjeev K. Kamboj","topics":["PTSD & trauma","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7165120489","eid":"W7165120489"},{"id":"paper-w7126262825","cat":"papers","name":"An open-label pilot study of psilocybin-assisted therapy for binge eating disorder","year":"2026","cit":0,"pfa":"Jesse Dallery","psa":"Beverlee Loeser","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"other","src":"https://openalex.org/W7126262825","eid":"W7126262825"},{"id":"paper-w4407268731","cat":"papers","name":"O USO FITOTERÁPICO DA AYAHUASCA NO TRATAMENTO DE TRANSTORNOS MENTAIS: UMA REVISÃO BIBLIOGRÁFICA","year":"2025","cit":0,"pfa":"Lavynia Ferreira Nunes","psa":"José Walter Lima Prado","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4407268731","eid":"W4407268731"},{"id":"paper-w1556623874","cat":"papers","name":"Biossocialidades e o valor terapêutico da ayahuasca per se em dois centros da alta amazônia peruana/ Biosocialities and the therapeutic value of ayahuasca per se at two healing centers on the peruvian amazon","year":"2013","cit":0,"pfa":"Ana Gretel Echazú Böschemeier","ptype":"article","src":"https://openalex.org/W1556623874","eid":"W1556623874"},{"id":"paper-w7144977025","cat":"papers","name":"Reversal of Acute Effects of 3,4-Methylenedioxymethamphetamine (MDMA) in Rat Brain by 1-Piperonylpiperazine","year":"1993","cit":0,"pfa":"謙二 橋本","psa":"毅 五郎丸","ptype":"article","src":"https://openalex.org/W7144977025","eid":"W7144977025"},{"id":"paper-w2503759011","cat":"papers","name":"La MDMA (ecstasy) : contextes d’utilisation et conséquences de la consommation.","year":"2003","cit":0,"pfa":"Isabelle Varescon","ptype":"article","src":"https://openalex.org/W2503759011","eid":"W2503759011"},{"id":"paper-w7112797148","cat":"papers","name":"A Study on the Knowledge Related to Risky Behaviors and Condom Use among MDMA Arrestees","year":"2004","cit":0,"pfa":"鄭淑心","psa":"Shu-Shin Cheng","topics":["Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W7112797148","eid":"W7112797148"},{"id":"paper-w7133401664","cat":"papers","name":"Preliminary Findings From An Ongoing Survey On Self-Administered Psilocybin Microdosing Practices And Effects","year":"2026","cit":0,"pfa":"Kim Pc Kuypers","topics":["Dosing & pharmacology"],"ptype":"conference-paper","src":"https://openalex.org/W7133401664","eid":"W7133401664"},{"id":"paper-w2612480473","cat":"papers","name":"Êxtase (3,4- Metilenodioximetanfetamina - MDMA): uma abordagem epidemiológica, clínica e toxicológica.","year":"2006","cit":0,"pfa":"Glauco Luis Frare","ptype":"article","src":"https://openalex.org/W2612480473","eid":"W2612480473"},{"id":"paper-w4253675982","cat":"papers","name":"THE AGONY AND THE ECSTASY: MDMA-INDUCED HYPERTHERMIA, ACUTE LIVER INJURY, DIC, AND RHABDOMYOLYSIS","year":"2020","cit":0,"pfa":"Caroline Dooley","ptype":"other","src":"https://openalex.org/W4253675982","eid":"W4253675982"},{"id":"paper-w2163900503","cat":"papers","name":"Changes in stereotyped behaviour following acute or repeated methylenedioxy-methamphetamine (MDMA) treatment","year":"2007","cit":0,"pfa":"Susanna Szelényi","psa":"Susanna Fürst","ptype":"article","src":"https://openalex.org/W2163900503","eid":"W2163900503"},{"id":"paper-w3015040338","cat":"papers","name":"HPLC method for the detection of N,N-dimethyltryptamine (DMT) metabolites and cytotoxicity on glioma and neuron cell lines","year":"2011","cit":0,"pfa":"Janine Baptista Coimbra","psa":"Ana Čampa","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3015040338","eid":"W3015040338"},{"id":"paper-w1976363202","cat":"papers","name":"The role of serotonin 2A and 2C receptors in tryptamine hallucinogens N,N-dimethyltryptamine and N,N-diisopropyltryptamine","year":"2014","cit":0,"pfa":"Theresa M. Carbonaro","psa":"Michael B. Gatch","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1976363202","eid":"W1976363202"},{"id":"paper-w658337147","cat":"papers","name":"Salvinorin A: pharmacology, therapeutic potential and structural considerations of a unique non-nitrogenous selective k-opioid receptor agonist, and active component of the sage Salvia divinorum.","year":"2014","cit":0,"pfa":"A. Ciaffoni","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W658337147","eid":"W658337147"},{"id":"paper-w3104886605","cat":"papers","name":"Suppressive effect of mitragynine on 5-methoxy-N,N-dimethyltryptamine-induced head twitch responses in mice.","year":"1996","cit":0,"pfa":"Kinzo Matsumoto","psa":"Hiroshi Watanabe","ptype":"article","src":"https://openalex.org/W3104886605","eid":"W3104886605"},{"id":"paper-w4416983687","cat":"papers","name":"Review of: \"Psilocybin in Alcohol Use Disorder Maintains Abstinence Efficacy: A Scoping Review\"","year":"2025","cit":0,"pfa":"Virtudes Pérez‐Jover","topics":["Addiction","Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4416983687","eid":"W4416983687"},{"id":"paper-w7202131492","cat":"papers","name":"Could Psilocybin Be the Key to Treating Anorexia? -Breaking the Mind's Most Stubborn Loop","year":"2026","cit":0,"pfa":"Ijaz Durrani","ptype":"article","src":"https://openalex.org/W7202131492","eid":"W7202131492"},{"id":"paper-w7204763598","cat":"papers","name":"Psilocybin-Assisted Therapy for Alcohol Use Disorder: A Systematic Review of Clinical Evidence","year":"2026","cit":0,"pfa":"Laura Schäffert","psa":"­Human‐Friedrich Unterrainer","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7204763598","eid":"W7204763598"},{"id":"paper-w7120680121","cat":"papers","name":"Effects of N, N-dimethyltryptamine (DMT) in a model of corticosterone-induced resistant depression: investigation of the influence of sex","year":"2024","cit":0,"pfa":"Dino Cesar da Silva Clemente","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7120680121","eid":"W7120680121"},{"id":"paper-w7139928481","cat":"papers","name":"Cardiac Morphology During Predictable Drug-Induced QT Prolongation: An Educational Review with an Ibogaine Case Example","year":"2026","cit":0,"pfa":"Mark D. Nicolas","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7139928481","eid":"W7139928481"},{"id":"paper-w4311571920","cat":"papers","name":"A MENSAGEM QUE VEM DA FLORESTA: UM BREVE LEVANTAMENTO DOS SABERES DA AYAHUASCA","year":"2022","cit":0,"pfa":"Miguel Firmeza Bezerra","psa":"Juliana Abonizio","ptype":"book-chapter","src":"https://openalex.org/W4311571920","eid":"W4311571920"},{"id":"paper-w7132887284","cat":"papers","name":"Materialidades, sentidos y saberes: una experiencia de expansión de consciencia con ayahuasca","year":"2024","cit":0,"pfa":"Eva Machado Hernandez","ptype":"dissertation","src":"https://openalex.org/W7132887284","eid":"W7132887284"},{"id":"paper-w3100001462","cat":"papers","name":"Rapid formation and disappearance of the MDMA metabolite, 3,4-dihydroxymethamphetamine by rat liver microsomes.","year":"1991","cit":0,"pfa":"Masayuki Hiramatsu","psa":"Arthur K. Cho","ptype":"article","src":"https://openalex.org/W3100001462","eid":"W3100001462"},{"id":"paper-w4389019141","cat":"papers","name":"Regulation of Goal‐directed Action Selection by Cocaine, MDMA, and Orbitofrontal BDNF‐trkB","year":"2017","cit":0,"pfa":"Elizabeth G. Pitts","psa":"Shannon L. Gourley","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4389019141","eid":"W4389019141"},{"id":"paper-w7118589987","cat":"papers","name":"Dataset for: A Naturalistic Study on the Combined Neural and Psychological Effects of Psilocybin and Compassion Focused Imagery","year":"2026","cit":0,"pfa":"Carla Pallavicini","topics":["Mechanism & neuroscience"],"ptype":"dataset","src":"https://openalex.org/W7118589987","eid":"W7118589987"},{"id":"paper-w67765788","cat":"papers","name":"La implicaciones políticas de la música tecno y el MDMA","year":"2001","cit":0,"pfa":"Frédéric Vandenberghe","ptype":"article","src":"https://openalex.org/W67765788","eid":"W67765788"},{"id":"paper-w1787337687","cat":"papers","name":"Presence of N,N-Dimethyl-3,4-Methylenedioxyamphetamine(MDDM) in a fatal MDMA-overdose","year":"2003","cit":0,"pfa":"Marie-Paule L. A. Bouche","psa":"Jan Van Bocxlaer","topics":["Dosing & pharmacology"],"ptype":"conference-paper","src":"https://openalex.org/W1787337687","eid":"W1787337687"},{"id":"paper-w3029431704","cat":"papers","name":"The relation of behavior style and pscychological defensive mechanism with 3,4-methyIenedioxymethamphetamine(MDMA)addicts","year":"2007","cit":0,"pfa":"赵素华","psa":"王玲芝","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3029431704","eid":"W3029431704"},{"id":"paper-w4253020793","cat":"papers","name":"The Effects of Acute and Binge 3,4-methylenedioxymethamphetamine (MDMA) Exposure on Learning and Memory in Rats","year":"2010","cit":0,"pfa":"Charlotte Jane Kay","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W4253020793","eid":"W4253020793"},{"id":"paper-w2275194715","cat":"papers","name":"Paradoxical negative mood changes following 100MG: acute MDMA in a laboratory study","year":"2011","cit":0,"pfa":"Andrew C. Parrott","psa":"Con K. K. Stough","ptype":"article","src":"https://openalex.org/W2275194715","eid":"W2275194715"},{"id":"paper-w2240343974","cat":"papers","name":"20. Cambios en el perfil de valores tras una experienca con ayahuasca","year":"2013","cit":0,"pfa":"Josep Maria Fericgla","ptype":"article","src":"https://openalex.org/W2240343974","eid":"W2240343974"},{"id":"paper-w2970497316","cat":"papers","name":"Assessment of the Stimulus Properties of MDA and MDMA Stereoisomers in a LSD-Saline-Amphetamine Discrimination","year":"1996","cit":0,"pfa":"Michele Taylor","ptype":"article","src":"https://openalex.org/W2970497316","eid":"W2970497316"},{"id":"paper-w4404285144","cat":"papers","name":"Psilocybin-assisted psychotherapy: Advancements, challenges, and future directions for treating resistant depression","year":"2024","cit":0,"pfa":"Rodolfo Myronn de Melo Rodrigues","topics":["Depression","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4404285144","eid":"W4404285144"},{"id":"paper-w4401484380","cat":"papers","name":"Vers une utilisation thérapeutique encadrée de la MDMA outre-Atlantique ?","year":"2024","cit":0,"pfa":"Anne-Solène Naudon","ptype":"article","src":"https://openalex.org/W4401484380","eid":"W4401484380"},{"id":"paper-w4406886066","cat":"papers","name":"Decision letter for \"Molecular insights into the modulation of the 5 HT 2 A receptor by serotonin, psilocin, and the G protein subunit Gqα\"","year":"2024","cit":0,"topics":["Mechanism & neuroscience"],"ptype":"peer-review","src":"https://openalex.org/W4406886066","eid":"W4406886066"},{"id":"paper-w1965319128","cat":"papers","name":"S.23.05 MDMA and other party drugs: neural and social effects in rodents","year":"2011","cit":0,"pfa":"Iain S. McGregor","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1965319128","eid":"W1965319128"},{"id":"paper-w4388774585","cat":"papers","name":"Role of Microglia in 3, 4 Methylenedioxymethamphetamine (MDMA) -Induced Neurotoxicity: A Mini Review","year":"2023","cit":0,"pfa":"Nor Suliana Mustafa","psa":"Nelbon Giloi","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4388774585","eid":"W4388774585"},{"id":"paper-w7202278187","cat":"papers","name":"Direct anti-inflammatory actions of N,N -dimethyltryptamine on microglia are revealed by proteomic profiling and receptor pharmacology","year":"2026","cit":0,"pfa":"István Pesti","psa":"Eszter Farkas","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7202278187","eid":"W7202278187"},{"id":"paper-w3046456529","cat":"papers","name":"Von Ayahuasca bis Critical Global Health. Wandel und Beständigkeit in der medizinethnologischen Lehre","year":"2020","cit":0,"pfa":"Peter van Eeuwijk","ptype":"article","src":"https://openalex.org/W3046456529","eid":"W3046456529"},{"id":"paper-w7163616085","cat":"papers","name":"Examining the Pre-Columbian Use of Psychotropic Plants in the South American Andes: Tobacco, Coca, and Ayahuasca","year":"2026","cit":0,"pfa":"Jalayne Allison","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7163616085","eid":"W7163616085"},{"id":"paper-w2026959543","cat":"papers","name":"B113 PARADOXICAL SLEEP DEPRIVATION POTENTIATES ???ECSTASY??? (MDMA)-INDUCED LOCOMOTOR STIMULATION","year":"2005","cit":0,"pfa":"Mariana Bendlin Calzavara","psa":"Roberto Frussa‐Filho","ptype":"conference-abstract","src":"https://openalex.org/W2026959543","eid":"W2026959543"},{"id":"paper-w4395058813","cat":"papers","name":"Ayahuasca e saúde mental: efeitos do seu uso associado a casos de depressão","year":"2023","cit":0,"pfa":"Lucas Daniel dos Santos","psa":"Wallisten Passos Garcia","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4395058813","eid":"W4395058813"},{"id":"paper-w4241364743","cat":"papers","name":"EFFECT OF ONCE WEEKLY TREATMENT WITH MDMA ON SCHEDULE-CONTROLLED BEHAVIOR AND LOCOMOTOR ACTIVITY","year":"1998","cit":0,"pfa":"M. E. Branson","psa":"M. C. Newland","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4241364743","eid":"W4241364743"},{"id":"paper-w2047547215","cat":"papers","name":"528 Neurotoxicity of MDMA and intensity dependence of auditory evoked dipole source activity","year":"1998","cit":0,"pfa":"Frank Tuchtenhagen","psa":"Euphrosyne Gouzoulis‐Mayfrank","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2047547215","eid":"W2047547215"},{"id":"paper-w51847422","cat":"papers","name":"A Comparison of Repeated MDMA- and AMPH-Produced Centre and Periphery Activity and the Underlying Neuroadaptations","year":"2010","cit":0,"pfa":"Sarah Bradbury","topics":["Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W51847422","eid":"W51847422"},{"id":"paper-w2324322792","cat":"papers","name":"Autoradiographische Untersuchungen zur Verteilung von 3H-Mescalin bei Säugetieren / Autoradiographic Investigations with Mescaline in Mammals","year":"1969","cit":0,"pfa":"E. Lehr","psa":"Gottfried Werner","ptype":"book-chapter","src":"https://openalex.org/W2324322792","eid":"W2324322792"},{"id":"paper-w7163160532","cat":"papers","name":"Time to embrace the whole: considering the replacement of psilocybin with Psilocybe spp. in psychedelic research and therapy","year":"2026","cit":0,"pfa":"Genís Oña","psa":"Óscar Soto-Angona","topics":["Depression","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7163160532","eid":"W7163160532"},{"id":"paper-w4413516706","cat":"papers","name":"Parents of teens, here’s what you really need to know about MDMA","year":"2019","cit":0,"pfa":"Jarryd Bartle","psa":"Paula Ross","ptype":"other","src":"https://openalex.org/W4413516706","eid":"W4413516706"},{"id":"paper-w4401966325","cat":"papers","name":"Multi-Dimensional Multiple Access (MDMA) Scheme Provisioning in 6G Wireless Networks","year":"2024","cit":0,"pfa":"Ishwarlal Rathod","psa":"Ankit Saxena","ptype":"article","src":"https://openalex.org/W4401966325","eid":"W4401966325"},{"id":"paper-w2053416910","cat":"papers","name":"P.6.d.024 Serotonergic challenge of memory functions in MDMA users","year":"2010","cit":0,"pfa":"Katrin H. Preller","psa":"Boris B. Quednow","ptype":"article","src":"https://openalex.org/W2053416910","eid":"W2053416910"},{"id":"paper-w2275010739","cat":"papers","name":"Long term effects of MDMA administration in rats during early and late adolescence.","year":"2011","cit":0,"pfa":"Olga V. Kolyaduke","topics":["Anxiety & end-of-life","Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W2275010739","eid":"W2275010739"},{"id":"paper-w2592884967","cat":"papers","name":"Does repeated treatment with MDMA sensitize to its effects onagonistic behaviour in mice","year":"2005","cit":0,"pfa":"Karel Šlais","psa":"Alexandra Šulcová","ptype":"article","src":"https://openalex.org/W2592884967","eid":"W2592884967"},{"id":"paper-w185557450","cat":"papers","name":"Interactions entre MDMA et éthanol : effets comportementaux, physiologiques et pharmacologiques","year":"2009","cit":0,"pfa":"Sami Ben Hamida","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W185557450","eid":"W185557450"},{"id":"paper-w4245646270","cat":"papers","name":"A Comparison of Repeated MDMA- and AMPH-Produced Centre and Periphery Activity and the Underlying Neuroadaptations","year":"2010","cit":0,"pfa":"Sarah Bradbury","topics":["Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W4245646270","eid":"W4245646270"},{"id":"paper-w4394318338","cat":"papers","name":"Salvinorin A preserves cerebral pial artery autoregulation after forebrain ischemia via the PI3K/AKT/cGMP pathway","year":"2018","cit":0,"pfa":"Haiping Dong","psa":"Z.H. Wang","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"dataset","src":"https://openalex.org/W4394318338","eid":"W4394318338"},{"id":"paper-w2075713477","cat":"papers","name":"MDMA (drug)–drug interactions influence CYP3A4 expression via PXR-mediator","year":"2010","cit":0,"pfa":"I. Antolino Lobo","psa":"Majorie B.M. van Duursen","ptype":"article","src":"https://openalex.org/W2075713477","eid":"W2075713477"},{"id":"paper-w2991530871","cat":"papers","name":"Hill, Thomas W.: Native American Drinking. Life Styles, Alcohol Use, Drunken Comportment, and the Peyote Religion","year":"2016","cit":0,"pfa":"Roland S. Moore","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2991530871","eid":"W2991530871"},{"id":"paper-w2739300490","cat":"papers","name":"The role of sensation seeking and social cognitions in explaining polydrug use in MDMA users","year":"2009","cit":0,"pfa":"Hendrik Boer","psa":"Marcel E. Pieterse","ptype":"other","src":"https://openalex.org/W2739300490","eid":"W2739300490"},{"id":"paper-w1663177614","cat":"papers","name":"The Effects of Acute and Binge 3,4-methylenedioxymethamphetamine (MDMA) Exposure on Learning and Memory in Rats","year":"2010","cit":0,"pfa":"Charlotte Jane Kay","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W1663177614","eid":"W1663177614"},{"id":"paper-w2223392398","cat":"papers","name":"Rapid determination of MDMA and its three metabolites: Application in ex vivo studies","year":"2012","cit":0,"pfa":"Bardia Jamali","psa":"Mohammad Reza Rouini","ptype":"article","src":"https://openalex.org/W2223392398","eid":"W2223392398"},{"id":"paper-w991502007","cat":"papers","name":"Effects of 3,4‐Methylenedioxypyrovalerone (MDPV) and 3,4‐Methylenedioxymethamphetamine (MDMA) on Place Conditioning in Mice","year":"2015","cit":0,"pfa":"Brenda M. Gannon","psa":"William E. Fantegrossi","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W991502007","eid":"W991502007"},{"id":"paper-w7170033321","cat":"papers","name":"MDMA restores cortico-accumbal signaling and rescues autism-related social deficits.","year":"2026","cit":0,"pfa":"Pierre Llorach","psa":"J J Walsh","ptype":"dataset","src":"https://openalex.org/W7170033321","eid":"W7170033321"},{"id":"paper-w4383092630","cat":"papers","name":"Ayahuasca, coronavirus y transformación: la perspectiva espiritual de la organización Inner Mastery","year":"2023","cit":0,"pfa":"Luis Santamaría del Río","ptype":"article","src":"https://openalex.org/W4383092630","eid":"W4383092630"},{"id":"paper-w2605955728","cat":"papers","name":"Thermoregulatory, behavioural and neurochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related stimulant drugs.","year":"2010","cit":0,"pfa":"Emily Joy Jaehne","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W2605955728","eid":"W2605955728"},{"id":"paper-w2610712443","cat":"papers","name":"Manifestações orais associadas ao consumo da droga de abuso MDMA","year":"2016","cit":0,"pfa":"Mafalda Nuñez Teixeira de Oliveira","ptype":"dissertation","src":"https://openalex.org/W2610712443","eid":"W2610712443"},{"id":"paper-w7212236792","cat":"papers","name":"Therapeutic Alliance and Perceived Closeness in MDMA-Assisted Therapy for Social Anxiety Disorder","year":"2026","cit":0,"pfa":"Joseph M. Diehl","psa":"Jason B. Luoma","topics":["Anxiety & end-of-life","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7212236792","eid":"W7212236792"},{"id":"paper-w7162751456","cat":"papers","name":"Single‐dose psilocybin with CBT more effective than nicotine patch for smoking cessation","year":"2026","cit":0,"topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7162751456","eid":"W7162751456"},{"id":"paper-w2784657008","cat":"papers","name":"Lower Lip Erosion anTemporomandibuar Joint Pain Due to the Pure MDMA Intake","year":"2017","cit":0,"pfa":"V Vučićević Boras","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2784657008","eid":"W2784657008"},{"id":"paper-w4411272698","cat":"papers","name":"Fatal ecstasy (MDMA) intoxication with extreme hyperpyrexia, rhabdomyolysis, and disseminated intravascular coagulopathy","year":"2025","cit":0,"pfa":"M Mynář","psa":"Z. Turek","ptype":"article","src":"https://openalex.org/W4411272698","eid":"W4411272698"},{"id":"paper-w4399723236","cat":"papers","name":"How Does Psilocybin Therapy Work? an Exploration of Experiential Avoidance as a Putative Mechanism of Change","year":"2024","cit":0,"pfa":"Richard J. Zeifman","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W4399723236","eid":"W4399723236"},{"id":"paper-w7160172090","cat":"papers","name":"Sa1731 A PILOT STUDY OF OPEN-LABEL PSILOCYBIN-ASSISTED THERAPY IN TREATMENT-REFRACTORY IBS","year":"2026","cit":0,"pfa":"Erin Mauney","psa":"Franklin King","ptype":"conference-abstract","src":"https://openalex.org/W7160172090","eid":"W7160172090"},{"id":"paper-w7167885640","cat":"papers","name":"Psilocybin selectively rescues cognitive flexibility impairments caused by aberrant prefrontal error signaling","year":"2026","cit":0,"pfa":"Christine Junhui Liu","psa":"Vikaas Singh Sohal","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7167885640","eid":"W7167885640"},{"id":"paper-w2461159830","cat":"papers","name":"[Effects of mescaline and lysergide on the mechanical responses of isolated organs of the rat to catecholamines and the role of calcium transfers in these phenomena].","year":"1978","cit":0,"pfa":"G Valette","psa":"Leclair Mf","ptype":"other","src":"https://openalex.org/W2461159830","eid":"W2461159830"},{"id":"paper-w7160381304","cat":"papers","name":"ABSTRACT NUMBER: ESOC2026YS125 DIMETHYLTRYPTAMINE INHIBITS SPREADING DEPOLARISATION IN BRAIN SLICES OF SIGMA-1 RECEPTORKNOCKOUT MICE","year":"2026","cit":0,"pfa":"Anna Zsigmond","psa":"Eszter Farkas","topics":["Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W7160381304","eid":"W7160381304"},{"id":"paper-w3012315032","cat":"papers","name":"MDMA: What 150,000 users of MDMA from 5 years of the Global Drug Survey can tell us about changing patterns of use and risk, user preference and harm reduction","year":"2019","cit":0,"pfa":"Ahnjili Zhuparris","psa":"Jason Ferris","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3012315032","eid":"W3012315032"},{"id":"paper-w2747817868","cat":"papers","name":"Neuroprotective effect and mechanism of Salvinorin A on the injury of oxygen-glucose deprivation in cortical neurons of rats by primary culture","year":"2016","cit":0,"pfa":"Wu Guangxi","psa":"Su Diansan","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2747817868","eid":"W2747817868"},{"id":"paper-w7165484318","cat":"papers","name":"Indoles as Molecular Growth Instructions: Psilocybin as Conserved Morphogenetic Signal from Deep Ancestry to Neural Execution","year":"2026","cit":0,"pfa":"C.S. Tarpley","psa":"ClearBridge Policy & Ethics Consortium","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7165484318","eid":"W7165484318"},{"id":"paper-w2802665075","cat":"papers","name":"Efectos farmacológicos de la 3,4 metilendioximetanfetamina (mdma, éxtasis) en humanos","year":"1999","cit":0,"pfa":"Marta Mas Garcia","ptype":"article","src":"https://openalex.org/W2802665075","eid":"W2802665075"},{"id":"paper-w366283769","cat":"papers","name":"Self-reported psychological effects of Ecstasy/MDMA use: An overview of internet studies.","year":"2008","cit":0,"pfa":"Andrew B Scholey","psa":"Daniel B. Kennedy","ptype":"article","src":"https://openalex.org/W366283769","eid":"W366283769"},{"id":"paper-w2902311680","cat":"papers","name":"Salvia divinorum e seus efeitos biológicos: “A critical review on the toxicity of Salvia divinorum and its major constituent Salvinorin A”","year":"2015","cit":0,"pfa":"Sara Domingos","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"dissertation","src":"https://openalex.org/W2902311680","eid":"W2902311680"},{"id":"paper-w769893775","cat":"papers","name":"Depressive Symptomatik und gesundheitsbezogene Lebensqualität bei MDMA-KonsumentInnen im Freizeitbereich","year":"2014","cit":0,"pfa":"David Jäckle","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W769893775","eid":"W769893775"},{"id":"paper-w2302170302","cat":"papers","name":"Relationships between MDMA induced increases in extracellular glucose, glycogenolysis in brain and hyperthermia","year":"2008","cit":0,"pfa":"Rashida Pachmerhiwala","ptype":"article","src":"https://openalex.org/W2302170302","eid":"W2302170302"},{"id":"paper-w4400067594","cat":"papers","name":"USO DE MDMA PARA O TRANSTORNO DO ESTRESSE PÓS-TRAUMÁTICO","year":"2024","cit":0,"pfa":"Letícia Rodrigues Vasconcelos","psa":"Marcos Vinícius Milki","ptype":"conference-paper","src":"https://openalex.org/W4400067594","eid":"W4400067594"},{"id":"paper-w2361753049","cat":"papers","name":"Flavone Glycoside Antagonizes Psilocybin-Induced Toxicity by Reducing Oxidative Stress in Rats Model","year":"2012","cit":0,"pfa":"LI Yu-bai","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2361753049","eid":"W2361753049"},{"id":"paper-w1965353955","cat":"papers","name":"MDMA (Ecstasy)-abuse in young adults — Is there a risk profile for severe psychiatric disorders?","year":"1996","cit":0,"pfa":"Oliver Bilke","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1965353955","eid":"W1965353955"},{"id":"paper-w4405021032","cat":"papers","name":"Correction to Posttraumatic Growth fter MDMA‐Assisted Psychotherapy for Posttraumatic Stress Disorder","year":"2024","cit":0,"topics":["PTSD & trauma","Dosing & pharmacology","Therapy practice"],"ptype":"erratum","src":"https://openalex.org/W4405021032","eid":"W4405021032"},{"id":"paper-w7116737777","cat":"papers","name":"Preadministration of Lorazepam Negates the Long-Term Antidepressant-Like Effects of Psilocybin in Male Wistar Kyoto Rats","year":"2025","cit":0,"pfa":"Sophie Woodruff","psa":"Charles David Nichols","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7116737777","eid":"W7116737777"},{"id":"paper-w2292538141","cat":"papers","name":"Lack of alpha1b-adrenergic receptors protects against epileptic seizures and MDMA sensitization","year":"2006","cit":0,"pfa":"Chiara Pizzanelli","psa":"Antonio Paparelli","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2292538141","eid":"W2292538141"},{"id":"paper-w1993160351","cat":"papers","name":"P.6.c.001 Cortisol levels and MDMA-induced memory impairment","year":"2010","cit":0,"pfa":"Kim P. C. Kuypers","psa":"Johannes Gerardus Ramaekers","ptype":"article","src":"https://openalex.org/W1993160351","eid":"W1993160351"},{"id":"paper-w4409281322","cat":"papers","name":"186. Assessing Cognitive Outcomes in Treatment-Resistant Depression Following Psilocybin-Assisted Psychotherapy","year":"2025","cit":0,"pfa":"Danica E. Johnson","psa":"Joshua Daniel Rosenblat","topics":["Depression","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4409281322","eid":"W4409281322"},{"id":"paper-w4417291690","cat":"papers","name":"Regional specificity of the cingulate cortex thickness association with the intensity of psilocybin experience: a replication study","year":"2025","cit":0,"pfa":"David Greguš","psa":"Jiřı́ Horáček","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4417291690","eid":"W4417291690"},{"id":"paper-w7160062019","cat":"papers","name":"Sa1731 A PILOT STUDY OF OPEN-LABEL PSILOCYBIN-ASSISTED THERAPY IN TREATMENT-REFRACTORY IBS","year":"2026","cit":0,"pfa":"Erin Mauney","psa":"Franklin King","ptype":"conference-abstract","src":"https://openalex.org/W7160062019","eid":"W7160062019"},{"id":"paper-w4391986091","cat":"papers","name":"AYAHUASCA EM MANAUS: CONTRIBUIÇÕES AO DEBATE SOBRE ATENÇÃO PSICOSSOCIAL E SAÚDE MENTAL","year":"2024","cit":0,"pfa":"Marisa Melo de Souza","psa":"Alex Martins","ptype":"conference-paper","src":"https://openalex.org/W4391986091","eid":"W4391986091"},{"id":"paper-w7165773689","cat":"papers","name":"Da floresta para a cidade: Guardiões Huni Kuin e seus rituais com \\\"ayahuasca\\\"","year":"2025","cit":0,"pfa":"Libna Pires Gomes","ptype":"dissertation","src":"https://openalex.org/W7165773689","eid":"W7165773689"},{"id":"paper-w2162671088","cat":"papers","name":"MDMA use is associated with lower gray matter volume in widespread cortical regions","year":"2014","cit":0,"pfa":"Andrew J. Dornan","psa":"Ronald L. Cowan","ptype":"article","src":"https://openalex.org/W2162671088","eid":"W2162671088"},{"id":"paper-w7163173144","cat":"papers","name":"Market approval and the right to health: a human rights perspective on MDMA-assisted therapy","year":"2026","cit":0,"pfa":"Christoph Bublitz","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7163173144","eid":"W7163173144"},{"id":"paper-w3093263156","cat":"papers","name":"INQUÉRITOS POLICIAIS SOBRE APREENSÕES DE AYAHUASCA: AS AMBIVALÊNCIAS DA LEGISLAÇÃO E DA TRADIÇÃO","year":"2020","cit":0,"pfa":"Fabiana Lima Agapejev Andrade","ptype":"article","src":"https://openalex.org/W3093263156","eid":"W3093263156"},{"id":"paper-w4319069481","cat":"papers","name":"Review: Christ Returns from the Jungle: Ayahuasca Religion as Mystical Healing, by Marc G. Blainey","year":"2023","cit":0,"pfa":"Kelly E. Hayes","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4319069481","eid":"W4319069481"},{"id":"paper-w4405062707","cat":"papers","name":"Ayahuasca, etnofarmacologia e usos no tratamento do transtorno de ansiedade: uma revisão sistemática","year":"2024","cit":0,"pfa":"Francy Gizella Marroquin Rincon","psa":"Josana de Castro Peixoto","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4405062707","eid":"W4405062707"},{"id":"paper-w2407160168","cat":"papers","name":"[Effect of L-glutamate and succinate on oxygen consumption of the cat cerebral cortex in epileptogenic foci induced by mescaline].","year":"1965","cit":0,"pfa":"C Pintilie","psa":"NELLA MISON-CRIGHEL","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2407160168","eid":"W2407160168"},{"id":"paper-w2793919554","cat":"papers","name":"O uso da ayahuasca no tratamento da dependência de substâncias: um estudo exploratório","year":"2014","cit":0,"pfa":"Hortênsia Isabela Santos Vieira","ptype":"dissertation","src":"https://openalex.org/W2793919554","eid":"W2793919554"},{"id":"paper-w2755129482","cat":"papers","name":"A mixed-methodological analysis into Ayahuasca users from Western society; Parapsychological and transpersonal psychological perspectives","year":"2017","cit":0,"pfa":"Johnny Ryan","psa":"Lesley-Ann Smith","ptype":"conference-paper","src":"https://openalex.org/W2755129482","eid":"W2755129482"},{"id":"paper-w4403448301","cat":"papers","name":"As mudanças psicológicas promovidas pela ayahuasca em participantes iniciantes: um estudo observacional longitudinal","year":"2024","cit":0,"pfa":"Vitória Pereira de Menezes","psa":"Rafael Mariano de Bitencourt","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4403448301","eid":"W4403448301"},{"id":"paper-w7215431055","cat":"papers","name":"Ayahuasca y Salud. Beatriz Caiuby Labate y José Carlos Bouso (Eds.), 2013.","year":"2014","cit":0,"pfa":"Juan Scuro","ptype":"book-review","src":"https://openalex.org/W7215431055","eid":"W7215431055"},{"id":"paper-w7119436817","cat":"papers","name":"A complex perspective on the ritualistic use of Ayahuasca among individuals with a history of problematic use of psychoactive substances","year":"2017","cit":0,"pfa":"Rebeca Trindade Rocha Mohr","topics":["Addiction"],"ptype":"dissertation","src":"https://openalex.org/W7119436817","eid":"W7119436817"},{"id":"paper-w7162883762","cat":"papers","name":"Salvinorin A exerts antiepileptic effects by regulating PINK1/Parkin-mediated mitophagy in the hippocampus of pilocarpine-induced chronic epileptic mice","year":"2026","cit":0,"pfa":"CAI Jiheng","psa":"JI Miaojin","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7162883762","eid":"W7162883762"},{"id":"paper-w2602770722","cat":"papers","name":"MDMA decreases sociability and aggression and increases anxietyin mouse model of agonistic behaviour","year":"2009","cit":0,"pfa":"Karel Šlais","psa":"Alexandra Šulcová","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2602770722","eid":"W2602770722"},{"id":"paper-w1971995971","cat":"papers","name":"Evaluation of the oxidative damage induced by MDMA and its metabolites in rat brain synaptosomes","year":"2010","cit":0,"pfa":"Daniel José Barbosa","psa":"Félix Dias Carvalho","ptype":"article","src":"https://openalex.org/W1971995971","eid":"W1971995971"},{"id":"paper-w2732913998","cat":"papers","name":"3,4-methylenedioxymethamphetamine (MDMA): pharmacology, toxicology, usage patterns, and neurological effects in humans","year":"2014","cit":0,"pfa":"Alexander I. Helfand","topics":["PTSD & trauma","Safety & adverse events","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W2732913998","eid":"W2732913998"},{"id":"paper-w2405610048","cat":"papers","name":"[Studies on hallucinogens. II. Synthesis of N,N-dimethyltryptamine (DMT) and its related compounds (author's transl)].","year":"1973","cit":0,"pfa":"M Ono","psa":"Kazuo Takahashi","ptype":"other","src":"https://openalex.org/W2405610048","eid":"W2405610048"},{"id":"paper-w7165791243","cat":"papers","name":"The Architecture of Ego Dissolution: A Mechanical-First Evaluation of N,N-Dimethyltryptamine at the Sigma-1 and 5-HT2A Interfaces","year":"2026","cit":0,"pfa":"Enkhamgalan Nasanjargal","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7165791243","eid":"W7165791243"},{"id":"paper-w4406885604","cat":"papers","name":"Author response for \"Molecular insights into the modulation of the 5 HT 2 A receptor by serotonin, psilocin, and the G protein subunit Gqα\"","year":"2024","cit":0,"pfa":"Niklas Viohl","psa":"Himanshu Khandelia","topics":["Mechanism & neuroscience"],"ptype":"peer-review","src":"https://openalex.org/W4406885604","eid":"W4406885604"},{"id":"paper-w7164889349","cat":"papers","name":"MDMA-induced CYP2D6 inhibition: concentration-dependent variability using dextromethorphan as a probe","year":"2026","cit":0,"pfa":"Faezeh Ahmadi","psa":"Yalda H. Ardakani","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7164889349","eid":"W7164889349"},{"id":"paper-w2005086389","cat":"papers","name":"S30.03 Subjective and reinforcing effects of MDMA and mCPP compared to d-amphetamine in humans","year":"2000","cit":0,"pfa":"Manuel E. Tancer","psa":"Chris Ellyn Johanson","ptype":"conference-abstract","src":"https://openalex.org/W2005086389","eid":"W2005086389"},{"id":"paper-w2390490840","cat":"papers","name":"EFFECT OF ELECTRONIC ACUPUNCTURE ON REGIONAL BLOOD FLOW AND CEREBRAL FUNCTION IN MDMA ABUSERS","year":"2002","cit":0,"pfa":"Shi Yu","ptype":"article","src":"https://openalex.org/W2390490840","eid":"W2390490840"},{"id":"paper-w7213916889","cat":"papers","name":"Pharmacokinetics and safety of a modified‐release psilocybin formulation: A SAD Phase I trial in normal‐weight and overweight/obese participants","year":"2026","cit":0,"pfa":"Anna Signor","psa":"Sara De Martin","topics":["Safety & adverse events","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7213916889","eid":"W7213916889"},{"id":"paper-w7215292617","cat":"papers","name":"Anomalística e o sentido de quase morte no uso de ayahuasca na terapêutica","year":"2021","cit":0,"pfa":"Alessandro Gonçalves Campolina","ptype":"article","src":"https://openalex.org/W7215292617","eid":"W7215292617"},{"id":"paper-w7110263788","cat":"papers","name":"RAPIDLY TRADING DOWN DEPRESSION'S 3 PILLARS TO 5HT3-RECEPTORS THROUGH ECT OR PSILOCYBIN?","year":"2024","cit":0,"pfa":"R.S. Treviranus, Gottfried","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7110263788","eid":"W7110263788"},{"id":"paper-w4404131022","cat":"papers","name":"Tū Wairua: Development of an Indigenous Rongoā Māori Approach to Healing with Psilocybin Containing Mushrooms","year":"2024","cit":0,"pfa":"Anna-Leigh Hodge","psa":"Patrick McHugh","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4404131022","eid":"W4404131022"},{"id":"paper-w4252915453","cat":"papers","name":"P.228 The polypharmacological profile of psilocybin and potential behavioural effects of very low doses","year":"2019","cit":0,"pfa":"K. Kiilerich","psa":"Mikael Palner","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4252915453","eid":"W4252915453"},{"id":"paper-w2518976886","cat":"papers","name":"Estudio químico de la Liana Ayahuasca (Banisteriopsis Caapi Spruse Ex. Grisebach Morton)","year":"2001","cit":0,"pfa":"Sánchez Ramírez","psa":"Tania Yenny","ptype":"dissertation","src":"https://openalex.org/W2518976886","eid":"W2518976886"},{"id":"paper-w3034434416","cat":"papers","name":"O uso ritual da ayahuasca, Beatriz Caiuby Labate y Wladimyr Sena (comps.)","year":"2003","cit":0,"pfa":"Claudia María Montagut Mejía","ptype":"article","src":"https://openalex.org/W3034434416","eid":"W3034434416"},{"id":"paper-w2738357218","cat":"papers","name":"A regulação/regulamentação da ayahuasca como fluidez entre o religioso e o político","year":"2017","cit":0,"pfa":"Janaína Alexandra Capistrano da Costa","ptype":"article","src":"https://openalex.org/W2738357218","eid":"W2738357218"},{"id":"paper-w4401958212","cat":"papers","name":"Religious Freedom and the Global Regulation of Ayahuasca ed. by Beatriz Caiuby Labate and Clancy Cavnar (review)","year":"2024","cit":0,"topics":["Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4401958212","eid":"W4401958212"},{"id":"paper-w2345195472","cat":"papers","name":"BENEFÍCIOS A SAÚDE OCASIONADOS PELA INGESTÃO DA AYAHUASCA: CONTEXTO SOCIAL E AÇÃO NEUROPSICOLÓGICA, FISIOIMUNOLÓGICA, MICROBIOLÓGICA E PARASITÁRIA Health benefits of ayahuasca in take: social context and neuropsychologic","year":"2014","cit":0,"pfa":"Oliveira Meneguetti","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2345195472","eid":"W2345195472"},{"id":"paper-w2005668164","cat":"papers","name":"ChemInform Abstract: Synthesis of Iboga Alkaloids by Pd‐Catalyzed Heteroannulation of 2‐Iodoaniline with an Internal Alkyne as the Key Step.","year":"2010","cit":0,"pfa":"Goutam Kumar Jana","psa":"Surajit Sinha","ptype":"article","src":"https://openalex.org/W2005668164","eid":"W2005668164"},{"id":"paper-w7111485189","cat":"papers","name":"(54095) An observational pre-post study evaluating safety of a naturally occurring psychoactive compound of the tabernanthe iboga plant.","year":"2024","cit":0,"pfa":"Kirsten Cherian","psa":"John Coetzee","topics":["Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W7111485189","eid":"W7111485189"},{"id":"paper-w4407619146","cat":"papers","name":"Esse quam Videre: Critical Reflections on the Use of Psilocybin as an Adjuvant in Psychedelic-Assisted Psychotherapy","year":"2025","cit":0,"pfa":"Fábio Nogueira Pereira","psa":"Kelly De Souza Ventura","topics":["Reviews & meta-analyses","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4407619146","eid":"W4407619146"},{"id":"paper-w7125697704","cat":"papers","name":"The therapeutic efficacy of psilocybin in major depressive disorder: A review of recent clinical and mechanistic evidence","year":"2026","cit":0,"pfa":"Fernando Mora López","psa":"Daniela Consumi Cordero","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7125697704","eid":"W7125697704"},{"id":"paper-w4415950082","cat":"papers","name":"Correction: Acute and long-term effects of psilocybin on energy balance and feeding behavior in mice","year":"2025","cit":0,"pfa":"Nicole Fadahunsi","psa":"Christoffer Clemmensen","ptype":"erratum","src":"https://openalex.org/W4415950082","eid":"W4415950082"},{"id":"paper-w7204201502","cat":"papers","name":"Psilocybin collapses visual change detection and drives cortical dynamics toward a state of surprise","year":"2026","cit":0,"pfa":"Roberto De Filippo","psa":"Torben Ott","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7204201502","eid":"W7204201502"},{"id":"paper-w1508250878","cat":"papers","name":"Neuroadaptive Changes in5-HT1A Autoreceptor SensitivityFollowing High-Dose MDMA Treatment","year":"2011","cit":0,"pfa":"Simon David Fisher","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1508250878","eid":"W1508250878"},{"id":"paper-w2508421625","cat":"papers","name":"Locality and the Moral Inequality of MDMA Users in Taiwan: A Case of a Newly Democratized Country","year":"2014","cit":0,"pfa":"Ming-Feng Liu","ptype":"article","src":"https://openalex.org/W2508421625","eid":"W2508421625"},{"id":"paper-w7212002983","cat":"papers","name":"717. Clinical trials, ethical dimensions, and the pathway of MDMA-assisted therapy in PTSD","year":"2026","cit":0,"pfa":"Christopher J. Poppe","psa":"Dimitris Repantis","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7212002983","eid":"W7212002983"},{"id":"paper-w3008167184","cat":"papers","name":"The dose-response effect of MDMA (\"Ecstasy\") treatment on the serotonin system in the porcine brain","year":"2005","cit":0,"pfa":"Aage Kristian Olsen Alstrup","psa":"Paul D. Cumming","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"conference-paper","src":"https://openalex.org/W3008167184","eid":"W3008167184"},{"id":"paper-w2607223289","cat":"papers","name":"The electrophysiological effects of MDMA \"ecstasy\" on dopamine neurons of the ventral tegmental area in the rat","year":"1987","cit":0,"pfa":"B. Cummings","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W2607223289","eid":"W2607223289"},{"id":"paper-w4380538698","cat":"papers","name":"The Science of MDMA & Its Therapeutic Uses: Benefits & Risks | Huberman Lab Podcast","year":"2023","cit":0,"pfa":"Sikandar Shah","topics":["Safety & adverse events"],"ptype":"report","src":"https://openalex.org/W4380538698","eid":"W4380538698"},{"id":"paper-w4399757050","cat":"papers","name":"The Conceptual Framework for the Therapeutic Approach used in Phase 3 Trials of MDMA-AT for PTSD","year":"2024","cit":0,"pfa":"Kelley C. O’Donnell","psa":"Marcela Ot’alora G.","topics":["PTSD & trauma","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4399757050","eid":"W4399757050"},{"id":"paper-w7170067140","cat":"papers","name":"MDMA restores cortico-accumbal signaling and rescues autism-related social deficits.","year":"2026","cit":0,"pfa":"Pierre Llorach","psa":"J J Walsh","ptype":"dataset","src":"https://openalex.org/W7170067140","eid":"W7170067140"},{"id":"paper-w2292607036","cat":"papers","name":"Norepinephrine loss enhances MDMA toxicity and formation of ubiquitine positive striatal whorls.","year":"2001","cit":0,"pfa":"Francesco Fornai","psa":"Antonio Paparelli","topics":["Safety & adverse events"],"ptype":"conference-paper","src":"https://openalex.org/W2292607036","eid":"W2292607036"},{"id":"paper-w2295201677","cat":"papers","name":"Morphological adaptations in the brain motive circuit induced by 3,4‐methylenedioxymethamphetamine (MDMA; ecstasy)","year":"2010","cit":0,"pfa":"Kevin T. Ball","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2295201677","eid":"W2295201677"},{"id":"paper-w4362517777","cat":"papers","name":"Neural correlates of the personality factor openness before and after psilocybin-therapy to depressed patients","year":"2019","cit":0,"pfa":"Manca Peskar","topics":["Depression","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W4362517777","eid":"W4362517777"},{"id":"paper-w4388182594","cat":"papers","name":"High-Performance Liquid Chromatography Analysis of Psilocybin-Containing Mushrooms: Key Considerations and Insights","year":"2023","cit":0,"pfa":"Dom Annunziato","ptype":"report","src":"https://openalex.org/W4388182594","eid":"W4388182594"},{"id":"paper-w7213296936","cat":"papers","name":"A machine learning framework for psilocybin-facilitated retraining in treatment-resistant obsessive-compulsive disorder","year":"2026","cit":0,"pfa":"Randi Addington","topics":["Depression","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W7213296936","eid":"W7213296936"},{"id":"paper-w7166591939","cat":"papers","name":"Consumo recreativo de MDMA: un estudio sobre jóvenes en España","year":"2026","cit":0,"pfa":"Diego Fernández Piedra","psa":"Jordi Navarro-López","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7166591939","eid":"W7166591939"},{"id":"paper-w7126262449","cat":"papers","name":"Combined Neuroprotective Effects of N,N‐Dimethyltryptamine and Ventral Root Reimplantation Following Spinal Root Avulsion in Rats","year":"2026","cit":0,"pfa":"Paola Andrea Caro Aponte","psa":"Alexandre Leite Rodrigues de Oliveira","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7126262449","eid":"W7126262449"},{"id":"paper-w7116780285","cat":"papers","name":"A qualitative analysis of participant expectations and experiences of psilocybin‐assisted psychotherapy for methamphetamine use disorder","year":"2025","cit":0,"pfa":"Jonathan Brett","psa":"Sebastian Job","topics":["Addiction","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7116780285","eid":"W7116780285"},{"id":"paper-w7164845361","cat":"papers","name":"Psilocybin-Assisted Therapy for Common Mental Health Disorders and their Comorbid Presentations: A Scoping Review","year":"2026","cit":0,"pfa":"Nandita Jowaheer","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W7164845361","eid":"W7164845361"},{"id":"paper-w2760838737","cat":"papers","name":"Peyote by Alice Marriott and Carol K. Rachlin, and: The Magic World: American Indian Songs and Poems by William Brandon","year":"1971","cit":0,"pfa":"Paul N. Pavich","ptype":"article","src":"https://openalex.org/W2760838737","eid":"W2760838737"},{"id":"paper-w4406885602","cat":"papers","name":"Review for \"Molecular insights into the modulation of the 5 HT 2 A receptor by serotonin, psilocin, and the G protein subunit Gqα\"","year":"2024","cit":0,"topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4406885602","eid":"W4406885602"},{"id":"paper-w4414341779","cat":"papers","name":"Evolution and Comparative Analysis of Clinical Trials on Psilocybin in the Treatment of Psychopathologies: Trends in the EU and the US","year":"2025","cit":0,"pfa":"Anastasia Calin","psa":"Andreia Corciovă","topics":["Safety & adverse events","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4414341779","eid":"W4414341779"},{"id":"paper-w7128590135","cat":"papers","name":"Mystical but not challenging experiences predict symptom improvement after psilocybin for treatment-resistant OCD","year":"2026","cit":0,"pfa":"Sarah Shnayder","psa":"Thomas Adams","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7128590135","eid":"W7128590135"},{"id":"paper-w7127217117","cat":"papers","name":"An Evaluation of Therapeutic Harm Reduction and Psilocybin-Assisted Therapy Within Oregon's Measure 109","year":"2025","cit":0,"pfa":"Bodhi Norton","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7127217117","eid":"W7127217117"},{"id":"paper-w2413725492","cat":"papers","name":"[Extraction of serotonin, bufotenin, 5-methoxytryptamine and 5-methoxy-N,N-dimethyltryptamine and their fluorometric determination with o-phthaldialdehyde].","year":"1980","cit":0,"pfa":"Werner Kitzrow","psa":"K Seidel","topics":["Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W2413725492","eid":"W2413725492"},{"id":"paper-w3101603169","cat":"papers","name":"Mikrodosering av lysergsyradietylamid och psilocybin och dess effekter på psykisk hälsa","year":"2018","cit":0,"pfa":"Anisha Lela Larsson","topics":["Depression","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W3101603169","eid":"W3101603169"},{"id":"paper-w4417387420","cat":"papers","name":"Exploring Determinants of Psilocybin Acceptance as an Alternative Modality for Major Depressive Disorder: A Pilot Study","year":"2025","cit":0,"pfa":"Shannon Antoine-Hardy","psa":"D’Elia Bonilla","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4417387420","eid":"W4417387420"},{"id":"paper-w7172096098","cat":"papers","name":"Antinociceptive effect of N,N-dimethyltryptamine (DMT) involving serotonergic, opioidergic, cannabinoidergic, and nitrergic systems in PGE2-induced hyperalgesia in rats","year":"2026","cit":0,"pfa":"Flávia Cristina de Sousa Fonseca","psa":"Igor Dimitri Gama Duarte","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7172096098","eid":"W7172096098"},{"id":"paper-w4394687929","cat":"papers","name":"Treating Bipolar Depression Using Psilocybin—Validity Threats Regarding Efficacy and Safety—Reply","year":"2024","cit":0,"pfa":"Scott T. Aaronson","psa":"Harold A. Sackeïm","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4394687929","eid":"W4394687929"},{"id":"paper-w7112200146","cat":"papers","name":"Magic mushrooms, friend or foe: deciphering the singular subjective experience with psilocybin in portuguese population","year":"2025","cit":0,"pfa":"Hurevich, Maryia","topics":["Anxiety & end-of-life"],"ptype":"dissertation","src":"https://openalex.org/W7112200146","eid":"W7112200146"},{"id":"paper-w4410279628","cat":"papers","name":"Mycelial Conceptions of Being and Well-Being: Reconciling Paradigmatic Tensions in Psilocybin Healing Spaces","year":"2025","cit":0,"pfa":"Camila Itzel Espinosa-Short","ptype":"preprint","src":"https://openalex.org/W4410279628","eid":"W4410279628"},{"id":"paper-w7160609961","cat":"papers","name":"1080 Psilocybin Elicits Non-Linear Night to Night Changes in Sleep Spectral Power","year":"2026","cit":0,"pfa":"Matthew Reid","psa":"Frederick Streeter Barrett","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7160609961","eid":"W7160609961"},{"id":"paper-w7162805790","cat":"papers","name":"A systematic review of the pharmacokinetics of classical serotonergic psychedelic compounds in healthy adult subjects","year":"2026","cit":0,"pfa":"Elliot Hampsey","psa":"James Rucker","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7162805790","eid":"W7162805790"},{"id":"paper-w4401540486","cat":"papers","name":"Avaliação histológica cerebral em ratos expostos a ayahuasca por via dérmica e oral","year":"2024","cit":0,"pfa":"Luca Silva Facciolo","psa":"Ana Rosa Crisci","ptype":"conference-paper","src":"https://openalex.org/W4401540486","eid":"W4401540486"},{"id":"paper-w1999873288","cat":"papers","name":"EFFECT OF ONCE WEEKLY TREATMENT WITH MDMA ON SCHEDULE-CONTROLLED BEHAVIOR AND LOCOMOTOR ACTIVITY","year":"1998","cit":0,"pfa":"M. E. Branson","psa":"M. Christopher Newland","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1999873288","eid":"W1999873288"},{"id":"paper-w4415165669","cat":"papers","name":"Examining associations between MDMA/ecstasy and classic psychedelic use and social impairment","year":"2023","cit":0,"pfa":"Grant M. Jones","psa":"Erica Wang","ptype":"dataset","src":"https://openalex.org/W4415165669","eid":"W4415165669"},{"id":"paper-w7203920834","cat":"papers","name":"El uso Inadecuado de la ayahuasca y sus impactos en la salud","year":"2026","cit":0,"pfa":"Azul Monserrathe Illicachi-Erazo","psa":"David Alejandro Toapanta-Amores","ptype":"article","src":"https://openalex.org/W7203920834","eid":"W7203920834"},{"id":"paper-w7202129853","cat":"papers","name":"Psilocybin Restores Spatial Memory but Not Fronto-Hippocampal Synchrony in a Rat Model of Alzheimer's Disease","year":"2026","cit":0,"pfa":"Mersedeh Shamsedin","ptype":"dataset","src":"https://openalex.org/W7202129853","eid":"W7202129853"},{"id":"paper-w4408043503","cat":"papers","name":"Tū Wairua: Development of an Indigenous Rongoā Māori Approach to Healing with Psilocybin Containing Mushrooms","year":"2024","cit":0,"pfa":"Anna-Leigh Hodge","psa":"Patrick McHugh","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4408043503","eid":"W4408043503"},{"id":"paper-w7161007383","cat":"papers","name":"Psilocybin-Assisted Therapy for Adolescent Anorexia Nervosa: Clinical Considerations and Emerging Models of Care","year":"2026","cit":0,"pfa":"Jamarie A. Geller","psa":"Natalie Gukasyan","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7161007383","eid":"W7161007383"},{"id":"paper-w7166194446","cat":"papers","name":"EE341 COST-EFFECTIVENESS OF PSILOCYBIN-ASSISTED THERAPY (PAT) FOR PATIENTS WITH TREATMENT-RESISTANT DEPRESSION","year":"2026","cit":0,"pfa":"Yosr Ziadi","psa":"Taehwan Park","topics":["Depression"],"ptype":"conference-abstract","src":"https://openalex.org/W7166194446","eid":"W7166194446"},{"id":"paper-w7168134125","cat":"papers","name":"Reporting practices in psilocybin-assisted therapy trials for depression: A descriptive review and temporal overview","year":"2026","cit":0,"pfa":"Nils Hörnqvist","topics":["Depression","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7168134125","eid":"W7168134125"},{"id":"paper-w4390439845","cat":"papers","name":"Psilocybin - new remedy for patients with psychiatric disorders? Critical analysis of the current state of knowledge","year":"2023","cit":0,"pfa":"Karolina Wąsik","psa":"Magda Wojtuś","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4390439845","eid":"W4390439845"},{"id":"paper-w4412399445","cat":"papers","name":"Efficacy of Chronic Non-Psychedelic Psilocybin on Visual Recovery in a Mouse Model of Occipital Stroke","year":"2025","cit":0,"pfa":"Sofia Nasini","psa":"Stefano Comai","ptype":"preprint","src":"https://openalex.org/W4412399445","eid":"W4412399445"},{"id":"paper-w7133332779","cat":"papers","name":"An Evaluation of Therapeutic Harm Reduction and Psilocybin-Assisted Therapy Within Oregon's Measure 109","year":"2025","cit":0,"pfa":"Bodhi Norton","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W7133332779","eid":"W7133332779"},{"id":"paper-w4248710528","cat":"papers","name":"Annual Survey Shows Teen Smoking Down, Rise in MDMA Use Slowing","year":"2002","cit":0,"topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W4248710528","eid":"W4248710528"},{"id":"paper-w2752244276","cat":"papers","name":"Comparative neuropharmacology of the substituted amphetamines: p-methoxyamphetamine (PMA) & 3,4-methylenedioxymethamphetamine (MDMA)","year":"2008","cit":0,"pfa":"Paul D. Callaghan","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2752244276","eid":"W2752244276"},{"id":"paper-w2038771038","cat":"papers","name":"Effects of age of exposure to 3,4-methylenedioxymethamphetamine (MDMA) in rats on later learning and behavior","year":"2010","cit":0,"pfa":"Charles V. Vorhees","psa":"Michael T. Williams","ptype":"article","src":"https://openalex.org/W2038771038","eid":"W2038771038"},{"id":"paper-w1580800840","cat":"papers","name":"Effects of Chronic Administration of THC on MDMA-Induced Physiological, Behavioral, and Neurochemical Alterations","year":"2021","cit":0,"pfa":"Erica Shen","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W1580800840","eid":"W1580800840"},{"id":"paper-w4401869708","cat":"papers","name":"MDMA Abuse Leading to Delayed Onset Rhabdomyolysis: A Case Report and Literature Review","year":"2024","cit":0,"pfa":"Swotantra Gautam","psa":"Tasnuva Anindita H. Mahmud","topics":["Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4401869708","eid":"W4401869708"},{"id":"paper-w4200520319","cat":"papers","name":"Between Prohibitionism and Religious Freedom: The Legal Disputes Concerning an Ayahuasca Church and the United States Government","year":"2021","cit":0,"pfa":"Henrique Fernandes Antunes","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4200520319","eid":"W4200520319"},{"id":"paper-w4401418692","cat":"papers","name":"Letter to editor regarding “Psilocybin-assisted therapy for depression: A systematic review and meta-analysis”","year":"2024","cit":0,"pfa":"Xin Yang","psa":"Weihong Kuang","topics":["Depression","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4401418692","eid":"W4401418692"},{"id":"paper-w7118235548","cat":"papers","name":"Dataset for: A Naturalistic Study on the Combined Neural and Psychological Effects of Psilocybin and Compassion Focused Imagery","year":"2026","cit":0,"pfa":"Carla Pallavicini","topics":["Mechanism & neuroscience"],"ptype":"dataset","src":"https://openalex.org/W7118235548","eid":"W7118235548"},{"id":"paper-w7202025674","cat":"papers","name":"Severe Serotonin Syndrome With Acute Respiratory Failure Following Ayahuasca and Dextromethorphan Use: A Case Report","year":"2026","cit":0,"pfa":"Sean Pack","psa":"Yahya Ahmad","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7202025674","eid":"W7202025674"},{"id":"paper-w7153433221","cat":"papers","name":"Psychological Support in Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder: A Scoping Review Protocol","year":"2026","cit":0,"pfa":"Amin Nazmuddin Mohammadi","psa":"Christine Wekerle","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W7153433221","eid":"W7153433221"},{"id":"paper-w7111578110","cat":"papers","name":"PRISMA-ScR Protocol: Psilocybin therapy for demoralization in patients with terminal illness, a scoping review","year":"2025","cit":0,"pfa":"Jennifer Docherty","psa":"Lorraine Li","topics":["Depression","Anxiety & end-of-life","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7111578110","eid":"W7111578110"},{"id":"paper-w3093226098","cat":"papers","name":"Ayahuasca : aspectos gerais e toxicológicos e análise do uso ritualístico no Distrito Federal","year":"2019","cit":0,"pfa":"Iane Azevedo Lopes","ptype":"article","src":"https://openalex.org/W3093226098","eid":"W3093226098"},{"id":"paper-w2021655305","cat":"papers","name":"Toxicological and psychological profile of MDMA (ecstasy) abusers and non-abusers in military conscripts","year":"1998","cit":0,"pfa":"Pilar Alejandra Sáiz","psa":"Julio Bobes","ptype":"article","src":"https://openalex.org/W2021655305","eid":"W2021655305"},{"id":"paper-w7135217732","cat":"papers","name":"Investigating the Role of Self-Compassion in MDMA-Assisted Therapy for Social Anxiety Disorder","year":"2026","cit":0,"pfa":"Christina Chwyl","psa":"Jason Luoma","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7135217732","eid":"W7135217732"},{"id":"paper-w4313360924","cat":"papers","name":"Ayahuasca: N, N-dimetiltriptamina (DMT) una Herramienta Psicodélica con Posibles Propiedades Psicoplastogénicas","year":"2022","cit":0,"pfa":"Fernando Alcino Da Silva Ponciano","psa":"Heulália Teodora Cerqueira Gonçalves","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4313360924","eid":"W4313360924"},{"id":"paper-w4404267255","cat":"papers","name":"Chapter Six. Convergent Therapies in Peru’s Amazon: Enriching Mental Wellness through Ayahuasca and Psychotherapy","year":"2019","cit":0,"pfa":"Ronnie Shepard","psa":"Shir Lerman Ginzburg","topics":["Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W4404267255","eid":"W4404267255"},{"id":"paper-w2626087292","cat":"papers","name":"Realidades expandidas: Influências da tecnologia no transe religioso - estudo de caso sobre ayahuasca","year":"2014","cit":0,"pfa":"Welliton Moraes","ptype":"dissertation","src":"https://openalex.org/W2626087292","eid":"W2626087292"},{"id":"paper-w4409891327","cat":"papers","name":"POTENCIAL TERAPÊUTICO DA AYAHUASCA COMO INTERVENÇÃO NOS TRANSTORNOS PSIQUIÁTRICOS: UMA REVISÃO SISTEMÁTICA","year":"2025","cit":0,"pfa":"Yasmine Jurdi Jasserand","psa":"Leandro Fajardo","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4409891327","eid":"W4409891327"},{"id":"paper-w7166512842","cat":"papers","name":"Global increases in brain glucose metabolism following acute N,N-dimethyltryptamine and harmine administration in healthy volunteers: A randomised [¹⁸F]FDG-PET study","year":"2026","cit":0,"pfa":"Klemens Egger","psa":"Paul D. Cumming","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7166512842","eid":"W7166512842"},{"id":"paper-w2950107656","cat":"papers","name":"ChemInform Abstract: A Simple Synthesis of 5‐Amino‐3‐(2‐dimethylaminoethyl)indole (5‐Amino‐ N,N‐dimethyltryptamine).","year":"1993","cit":0,"pfa":"John E. Macor","psa":"Kevin Ryan","ptype":"article","src":"https://openalex.org/W2950107656","eid":"W2950107656"},{"id":"paper-w7203571519","cat":"papers","name":"A Matrix-Reduced Whole-Plant Approach to Ayahuasca Preparation: Co-Extraction of Banisteriopsis caapi and Psychotria viridis","year":"2026","cit":0,"pfa":"Elias Rubenstein","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7203571519","eid":"W7203571519"},{"id":"paper-w7120474837","cat":"papers","name":"Metabolomic profiling of serum from patients with treatment-resistant depression (TRD) under ayahuasca treatment","year":"2023","cit":0,"pfa":"Luidy Darllan Barbosa","topics":["Depression"],"ptype":"dissertation","src":"https://openalex.org/W7120474837","eid":"W7120474837"},{"id":"paper-w4415230118","cat":"papers","name":"Um chá entre a ciência e a fé : histórias de ayahuasca e de cura","year":"2024","cit":0,"pfa":"Renato Brocchi","psa":"Blotta, Vitor Souza Lima","topics":["Depression","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W4415230118","eid":"W4415230118"},{"id":"paper-w4408043720","cat":"papers","name":"Tū Wairua: Development of an Indigenous Rongoā Māori Approach to Healing with Psilocybin Containing Mushrooms","year":"2025","cit":0,"pfa":"Anna-Leigh Hodge","psa":"Patrick McHugh","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4408043720","eid":"W4408043720"},{"id":"paper-w7124978464","cat":"papers","name":"Insights into psilocybin use among people with bipolar disorder: A thematic analysis of Reddit posts","year":"2026","cit":0,"pfa":"Laura Mills","psa":"Sean P. Carruthers","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7124978464","eid":"W7124978464"},{"id":"paper-w7155091271","cat":"papers","name":"Efficacy and Safety of Psilocybin-Assisted Therapy for Depression: A Meta-Analysis of Randomised Controlled Trials","year":"2026","cit":0,"pfa":"Siti N. Rusdhy","psa":"Devira Ayu Wulandari","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7155091271","eid":"W7155091271"},{"id":"paper-w7163740386","cat":"papers","name":"Retreat-based Investigation of Survivor Experiences with Psilocybin (Project RISE): Primary Outcomes Paper","year":"2026","cit":0,"pfa":"Christina Chwyl","psa":"Mary K. Lear","topics":["Depression","Anxiety & end-of-life","Therapy practice"],"ptype":"other","src":"https://openalex.org/W7163740386","eid":"W7163740386"},{"id":"paper-w7126233234","cat":"papers","name":"Review for \"COMBINED NEUROPROTECTIVE EFFECTS OF N, N DIMETHYLTRYPTAMINE AND VENTRAL ROOT REIMPLANTATION FOLLOWING SPINAL ROOT AVULSION IN RATS\"","year":"2025","cit":0,"topics":["Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W7126233234","eid":"W7126233234"},{"id":"paper-w4312591137","cat":"papers","name":"PV-037 - LA AYAHUASCA, UN VIAJE POCO PLACENTERO. A PROPÓSITO DE UN CASO.","year":"2022","cit":0,"ptype":"conference-paper","src":"https://openalex.org/W4312591137","eid":"W4312591137"},{"id":"paper-w4406886042","cat":"papers","name":"Decision letter for \"Molecular insights into the modulation of the 5 HT 2 A receptor by serotonin, psilocin, and the G protein subunit Gqα\"","year":"2024","cit":0,"topics":["Mechanism & neuroscience"],"ptype":"peer-review","src":"https://openalex.org/W4406886042","eid":"W4406886042"},{"id":"paper-w4253493775","cat":"papers","name":"Low-dose MDMA increases responses to psychosocial stress in healthy human volunteers","year":"2016","cit":0,"pfa":"Anya K. Bershad","topics":["Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W4253493775","eid":"W4253493775"},{"id":"paper-w4411691379","cat":"papers","name":"We licked the frogs so you don’t have to: A comprehensive history and analysis of the chemical syntheses of the classical psychedelics Bufotenin(e) and 5-methoxy-N,N-dimethyltryptamine","year":"2025","cit":0,"pfa":"Anton A. Homon","psa":"John Frederick Trant","topics":["Reviews & meta-analyses","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4411691379","eid":"W4411691379"},{"id":"paper-w4407262905","cat":"papers","name":"O USO FITOTERÁPICO DA AYAHUASCA NO TRATAMENTO DE TRANSTORNOS MENTAIS: UMA REVISÃO BIBLIOGRÁFICA","year":"2025","cit":0,"pfa":"Lavynia Ferreira Nunes","psa":"José Walter Lima Prado","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4407262905","eid":"W4407262905"},{"id":"paper-w7161946609","cat":"papers","name":"The acute and long-term effects of a single dose of psilocybin on neuroplasticity in mouse auditory cortex","year":"2025","cit":0,"pfa":"Lane, Conor","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7161946609","eid":"W7161946609"},{"id":"paper-w577363290","cat":"papers","name":"Hirsch, Mais und Peyote in der Konzeption der Huichol : Ursprung und Transformation eines Symbol-Komplexes","year":"1988","cit":0,"pfa":"Christina Hell","ptype":"book","src":"https://openalex.org/W577363290","eid":"W577363290"},{"id":"paper-w7169560877","cat":"papers","name":"Psilocybin bei Depression: Systematisches Review und Meta-Analyse zur antidepressiven Wirksamkeit","year":"2026","cit":0,"pfa":"Nele Böhm","psa":"Frank Euteneuer","topics":["Depression","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7169560877","eid":"W7169560877"},{"id":"paper-w7212010331","cat":"papers","name":"701. Efficacy and safety of COMP360 psilocybin therapy in anorexia nervosa: a proof-of-concept study","year":"2026","cit":0,"pfa":"G M Goodwin","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7212010331","eid":"W7212010331"},{"id":"paper-w4385934552","cat":"papers","name":"Synthetic Studies Toward the Marine Alkaloid Convolutindole a, a Structurally Remarkable Derivative of the Hallucinogen N,N-Dimethyltryptamine (Dmt)","year":"2023","cit":0,"pfa":"Jonathan Sperry","psa":"Yihan Yu","ptype":"preprint","src":"https://openalex.org/W4385934552","eid":"W4385934552"},{"id":"paper-w7165769223","cat":"papers","name":"The Architecture of Ego Dissolution: A Mechanical-First Evaluation of N,N-Dimethyltryptamine at the Sigma-1 and 5-HT2A Interfaces","year":"2026","cit":0,"pfa":"Enkhamgalan Nasanjargal","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7165769223","eid":"W7165769223"},{"id":"paper-w3106384608","cat":"papers","name":"Effects of 5-HT receptor antagonists and starvation on 5-methoxy-N,N-dimethyltryptamine-induced behaviour in mice","year":"1987","cit":0,"pfa":"Yumi Sugimoto","psa":"Kazuyoshi Horisaka","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3106384608","eid":"W3106384608"},{"id":"paper-w7137616373","cat":"papers","name":"Survey Study of Challenging and Mystical Experiences After Consuming Psilocybin Mushrooms in New Zealand","year":"2023","cit":0,"pfa":"Zixuan (Jonathan) Zong","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W7137616373","eid":"W7137616373"},{"id":"paper-w4405621760","cat":"papers","name":"Insights into the serotonergic mechanisms of psilocybin-induced improvements in anorexia-like behaviour in female rats","year":"2024","cit":0,"pfa":"Kyna‐Anne Conn","psa":"Claire J. Foldi","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4405621760","eid":"W4405621760"},{"id":"paper-w7165030356","cat":"papers","name":"“I even saw four deer grazing”: online-offline entanglements in the psilocybin pluriverse","year":"2026","cit":0,"pfa":"Michał Wanke","psa":"Piotr Siuda","topics":["Safety & adverse events","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W7165030356","eid":"W7165030356"},{"id":"paper-w7169736387","cat":"papers","name":"Psilocybin bei Depression: Systematisches Review und Meta-Analyse zur antidepressiven Wirksamkeit","year":"2026","cit":0,"pfa":"Frank Euteneuer","psa":"Nele Böhm","topics":["Depression","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7169736387","eid":"W7169736387"},{"id":"paper-w1525399315","cat":"papers","name":"Interacciones neuroquímicas y comportamentales entre 3,4-metilenodioximetanfetamina (MDMA) y etanol: implicación en la neurotoxicidad de MDMA y en el consumo de etanol en roedores","year":"2011","cit":0,"pfa":"María Izco Gaviria","topics":["Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W1525399315","eid":"W1525399315"},{"id":"paper-w2380409666","cat":"papers","name":"An experimental study on mechanism of damage to primarily cultured cortical neurons by MDMA in neonate mice","year":"2006","cit":0,"pfa":"Liying Ji","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2380409666","eid":"W2380409666"},{"id":"paper-w1994090718","cat":"papers","name":"Evaluation of the neurodevelopmental effects of MDMA (ecstasy) with the ‘Neurosphere Assay’: An in vitro test for developmental neurotoxicity","year":"2012","cit":0,"pfa":"Marta Barenys","psa":"Ellen Fritsche","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1994090718","eid":"W1994090718"},{"id":"paper-w4248542476","cat":"papers","name":"REAGUDIZACIÓN PSICÓTICA ASOCIADA AL CONSUMO DE MDMA: A PROPÓSITO DE UN CASO","year":"2021","cit":0,"topics":["Mechanism & neuroscience"],"ptype":"conference-paper","src":"https://openalex.org/W4248542476","eid":"W4248542476"},{"id":"paper-w7196952050","cat":"papers","name":"The occurrence and potential role of mystical experiences in MDMA-assisted therapy for PTSD: A secondary analysis","year":"2026","cit":0,"pfa":"Tijmen Bostoen","psa":"Erik J. Giltay","topics":["PTSD & trauma","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7196952050","eid":"W7196952050"},{"id":"paper-w7127938652","cat":"papers","name":"India’s Unique Legal Framework for Psilocybin Mushroom Research: An Unprecedented Opportunity in Psychiatric Therapeutics","year":"2026","cit":0,"pfa":"Ashlyn Tom","psa":"SureshBada Math","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7127938652","eid":"W7127938652"},{"id":"paper-w7161606725","cat":"papers","name":"Corrigendum to: “Psilocybin in the real world: Regulatory, ethical, and operational challenges in Australia’s clinical landscape”","year":"2026","cit":0,"topics":["Policy & ethics"],"ptype":"erratum","src":"https://openalex.org/W7161606725","eid":"W7161606725"},{"id":"paper-w7153258409","cat":"papers","name":"Microcrystal Tests for the Identification of Illicit Drugs: Heroin, Hydrocodone, Hydromorphone, MDMA, Methadone, and Methylphenidate","year":"2017","cit":0,"pfa":"Kelly M. Brinsko","psa":"Sebastian B. Sparenga","ptype":"article","src":"https://openalex.org/W7153258409","eid":"W7153258409"},{"id":"paper-w4292375951","cat":"papers","name":"On the Disbalance and Impairment of Serotonin Heteroreceptor Complexes in the Rat Brain After MDMA and Hallucinogens Administration","year":"2022","cit":0,"pfa":"Kjell Fuxé","psa":"Dasiel O. Borroto‐Escuela","topics":["Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W4292375951","eid":"W4292375951"},{"id":"paper-w2167243431","cat":"papers","name":"The K appa Opioid Agonist, Salvinorin A, Att enuates Locomotor Effec ts of Morphine but not Morphine-Induced Conditioned Place Preference","year":"2012","cit":0,"pfa":"Stacy Dianne Engebretson","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2167243431","eid":"W2167243431"},{"id":"paper-w7165032301","cat":"papers","name":"Community engagement as a foundation for implementation research for group psilocybin assisted therapy in New Mexico","year":"2026","cit":0,"pfa":"Lawrence Leeman","psa":"Janet Page‐Reeves","topics":["PTSD & trauma","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7165032301","eid":"W7165032301"},{"id":"paper-w604475018","cat":"papers","name":"Saberes de ayahuasca y procesos educativos en la religión de Santo Daime","year":"2012","cit":0,"pfa":"Maria Betânia Barbosa Albuquerque","ptype":"article","src":"https://openalex.org/W604475018","eid":"W604475018"},{"id":"paper-w3161021141","cat":"papers","name":"Anomalística e o sentido de quase morte no uso de ayahuasca na terapêutica","year":"2019","cit":0,"pfa":"Alessandro Gonçalves Campolina","ptype":"article","src":"https://openalex.org/W3161021141","eid":"W3161021141"},{"id":"paper-w7159871245","cat":"papers","name":"El estatuto legal internacional de la ayahuasca: una aproximación jurídica y antropológica","year":"2026","cit":0,"pfa":"Francisco Javier Esteban Guinea","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7159871245","eid":"W7159871245"},{"id":"paper-w2557597038","cat":"papers","name":"From MDMA to Lady Gaga: Expertise and Contribution Behavior of Editing Communities on Wikipedia","year":"2016","cit":0,"pfa":"Louis Dijkstra","psa":"Lisa Jenny Krieg","ptype":"conference-paper","src":"https://openalex.org/W2557597038","eid":"W2557597038"},{"id":"paper-w4413513288","cat":"papers","name":"PTSD and psychoactive drugs: MDMA treatment shows potential, but others lack evidence","year":"2020","cit":0,"pfa":"Tracey Varker","topics":["PTSD & trauma"],"ptype":"other","src":"https://openalex.org/W4413513288","eid":"W4413513288"},{"id":"paper-w2243495459","cat":"papers","name":"Mood and cognitive effects of MDMA: Mid-week low after week-end high","year":"1997","cit":0,"pfa":"H. Valerie Curran","psa":"RA Travill","ptype":"conference-paper","src":"https://openalex.org/W2243495459","eid":"W2243495459"},{"id":"paper-w128805799","cat":"papers","name":"Efectos neurotóxicos del MDMA en el sistema límbico de la rata","year":"2007","cit":0,"pfa":"María del Mar Arroyo Jiménez","psa":"Ana María Insausti Serrano","ptype":"article","src":"https://openalex.org/W128805799","eid":"W128805799"},{"id":"paper-w4302085657","cat":"papers","name":"The Neurochemistry of Drugs of Abuse: Cocaine, Ibogaine, and Substituted Amphetamines. Proceedings of a meeting. Hamilton, Bermuda, July 16-18, 1997.","year":"1998","cit":0,"ptype":"article","src":"https://openalex.org/W4302085657","eid":"W4302085657"},{"id":"paper-w1561040937","cat":"papers","name":"Droga, religião e cultura: um mapeamento da controvérsia pública sobre a ayahuasca no Brasil","year":"2012","cit":0,"pfa":"Henrique Fernandes Antunes","topics":["Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W1561040937","eid":"W1561040937"},{"id":"paper-w4400575547","cat":"papers","name":"SPONTANEOUS CHANGES IN CIGARETTE SMOKING FOLLOWING PSILOCYBIN-ASSISTED TREATMENT FOR ALCOHOL USE DISORDER","year":"2024","cit":0,"pfa":"Broc A. Pagni","psa":"Michael P. Bogenschutz","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4400575547","eid":"W4400575547"},{"id":"paper-w4402002981","cat":"papers","name":"Behavioral pharmacology of mescaline - the role of serotonin 5-HT2A, 5-HT2B, 5-HT2C and 5-HT1A receptors","year":"2024","cit":0,"pfa":"Lucie Olejníková","psa":"Tomáš Páleníček","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4402002981","eid":"W4402002981"},{"id":"paper-w7140107616","cat":"papers","name":"Inflammatory biomarker outcomes associated with MDMA-assisted therapy: an open-label exploratory study","year":"2026","cit":0,"pfa":"Jenna E. Kachmarik","psa":"Christopher S. Stauffer","topics":["PTSD & trauma","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7140107616","eid":"W7140107616"},{"id":"paper-w7213915339","cat":"papers","name":"Methylenedioxymethamphetamine (MDMA)‐related fatal poisoning in Australia, 2016 to 2025: Trends, characteristics and toxicology","year":"2026","cit":0,"pfa":"Shane G Darke","psa":"Amy Peacock","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7213915339","eid":"W7213915339"},{"id":"paper-w1969009821","cat":"papers","name":"S33 MDMA, METHAMPHETAMINE AND THEIR COMBINATION: COMPARISON OF LONG-TERM BEHAVIOURAL AND NEURAL EFFECTS IN RATS","year":"2005","cit":0,"pfa":"Iain S. McGregor","psa":"Glenn E. Hunt","topics":["Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W1969009821","eid":"W1969009821"},{"id":"paper-w4394236288","cat":"papers","name":"MDMA-facilitated cognitive-behavioural conjoint therapy for posttraumatic stress disorder: an uncontrolled trial","year":"2020","cit":0,"pfa":"Candice M. Monson","psa":"Michael C. Mithoefer","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"dataset","src":"https://openalex.org/W4394236288","eid":"W4394236288"},{"id":"paper-w7125699554","cat":"papers","name":"The therapeutic efficacy of psilocybin in major depressive disorder: A review of recent clinical and mechanistic evidence","year":"2026","cit":0,"pfa":"Fernando Mora López","psa":"Daniela Consumi Cordero","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7125699554","eid":"W7125699554"},{"id":"paper-w4382399403","cat":"papers","name":"Faculty Opinions recommendation of Increased global integration in the brain after psilocybin therapy for depression.","year":"2023","cit":0,"pfa":"Branko Aleksić","topics":["Depression","Therapy practice"],"ptype":"peer-review","src":"https://openalex.org/W4382399403","eid":"W4382399403"},{"id":"paper-w4388363773","cat":"papers","name":"PSILOCYBIN EXERTS ANTIDEPRESSANT EFFECTS IN A CHRONIC UNPREDICTABLE MILD STRESS (CUMS) ANIMAL MODEL","year":"2023","cit":0,"pfa":"Ines Erkizia-Santamaría","psa":"Jorge Emilio Ortega","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4388363773","eid":"W4388363773"},{"id":"paper-w7214513136","cat":"papers","name":"Study of the effects of chronic stress and the rapid-acting antidepressant psilocybin in primary murine microglia","year":"2026","cit":0,"pfa":"B. Brusa","psa":"J. Mingardi","topics":["Depression"],"ptype":"conference-paper","src":"https://openalex.org/W7214513136","eid":"W7214513136"},{"id":"paper-w7214988771","cat":"papers","name":"Derived results and figures for: An Observational Study on the Effects of Psilocybin Truffle Use in a Retreat Setting","year":"2026","cit":0,"pfa":"Hüseyin Beyköylü","psa":"Michiel van Elk","topics":["Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W7214988771","eid":"W7214988771"},{"id":"paper-w2913876692","cat":"papers","name":"Fitoterapia en procesos de deshabituación a drogas de abuso. Tabernanthe iboga. Perfil toxicológico y perfil terapéutico.","year":"2016","cit":0,"pfa":"Tania Prieto Alfaro","psa":"Hugo Sánchez Jiménez","ptype":"dissertation","src":"https://openalex.org/W2913876692","eid":"W2913876692"},{"id":"paper-w222445803","cat":"papers","name":"Efecto del selenio en dieta sobre la neurotoxicidad inducida por MDMA («éxtasis») en cerebro de ratón Effect of dietary selenium on MDMA («ecstasy»)-induced neurotoxicity in brain mouse","year":"2004","cit":0,"pfa":"Violeta Sánchez Sánchez","psa":"Camarero Jiménez","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W222445803","eid":"W222445803"},{"id":"paper-w7147554266","cat":"papers","name":"Psilocybin and Emotional Breakthough: An Umbrella Review and Theoretical Integration [SCIENTIFIC V5.0 - Q1 HIGH-IMPACT]","year":"2026","cit":0,"pfa":"Juan Moises de la Serna","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7147554266","eid":"W7147554266"},{"id":"paper-w2941694194","cat":"papers","name":"Cryo-EM Structure of the wild-type human serotonin transporter in complex with ibogaine and 15B8 Fab in the inward conformation","year":"2018","cit":0,"pfa":"Dongxue Yang","psa":"Eric Gouaux","topics":["Mechanism & neuroscience"],"ptype":"dataset","src":"https://openalex.org/W2941694194","eid":"W2941694194"},{"id":"paper-w1510988856","cat":"papers","name":"Consumo de MDMA (éxtasis: análisis de un caso de politoxicomanía","year":"1998","cit":0,"pfa":"Emilio Sanchéz Hervás","psa":"Vicente Tomás Gradolí","ptype":"article","src":"https://openalex.org/W1510988856","eid":"W1510988856"},{"id":"paper-w90089258","cat":"papers","name":"Gender differences in initiation and expression of behavioural sensitization to MDMA (ecstasy) effects in mice","year":"2005","cit":0,"pfa":"Jana Kučerová","psa":"Alexandra Šulcová","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W90089258","eid":"W90089258"},{"id":"paper-w7164820747","cat":"papers","name":"Efficacy of Psilocybin-Assisted Therapy in Major Depressive Disorder: A Systematic Review and Meta-Analysis","year":"2026","cit":0,"pfa":"Angel Labra-Lorenzana","psa":"Christian Gabriel Toledo-Lozano","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W7164820747","eid":"W7164820747"},{"id":"paper-w7170175039","cat":"papers","name":"Psilocybin Restores Spatial Memory but Not Fronto-Hippocampal Synchrony in a Rat Model of Alzheimer's Disease","year":"2026","cit":0,"pfa":"Mersedeh Shamsedin","ptype":"dataset","src":"https://openalex.org/W7170175039","eid":"W7170175039"},{"id":"paper-w7213987315","cat":"papers","name":"Exploring the Therapeutic Potential of Psilocybin: A Comprehensive Review of Clinical Trial Evidence and Implications for Rescheduling","year":"2026","cit":0,"pfa":"Fatemeh Abolhasani","psa":"Mohammad Shabani","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7213987315","eid":"W7213987315"},{"id":"paper-w2784533002","cat":"papers","name":"Suicide Ideation in Female Juvenile Offenders with a History of 3,4-Methylenedioxymethamphetamine (MDMA or 'Ecstasy') Consumption","year":"2017","cit":0,"pfa":"Torrance Stephens","ptype":"article","src":"https://openalex.org/W2784533002","eid":"W2784533002"},{"id":"paper-w3094290147","cat":"papers","name":"S2548 MDMA-Induced Rapidly Progressive Multiorgan Failure: A Rare Case of Full Recovery","year":"2020","cit":0,"pfa":"Cheng-Hung Tai","psa":"Aakash Aggarwal","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W3094290147","eid":"W3094290147"},{"id":"paper-w3110226252","cat":"papers","name":"Mike Jay, Mescaline: A Global History of the First Psychedelic. London and New Haven, CT: Yale University Press, 2019.","year":"2020","cit":0,"pfa":"James Edward Pugh","ptype":"book-review","src":"https://openalex.org/W3110226252","eid":"W3110226252"},{"id":"paper-w7119316388","cat":"papers","name":"Pharmacological screening of ayahuasca in tumor cells culture, nociception and anxiety (Banisteriopsis caapi and Psychotria viridis)","year":"2013","cit":0,"pfa":"Mariana Cecchetto Figueiredo","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7119316388","eid":"W7119316388"},{"id":"paper-w2025673771","cat":"papers","name":"S34 LONG-TERM CHANGES IN SEROTONERGIC FUNCTION FOLLOWING MDMA ADMINISTRATION TO ADOLESCENT RATS","year":"2005","cit":0,"pfa":"Kevin C.F. Fone","psa":"Peter H. Hutson","ptype":"conference-abstract","src":"https://openalex.org/W2025673771","eid":"W2025673771"},{"id":"paper-w7170169664","cat":"papers","name":"Psilocybin restores spatial memory but not fronto-hippocampal synchrony in a rat model of Alzheimer's disease","year":"2026","cit":0,"pfa":"Mersedeh Shamsedin","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7170169664","eid":"W7170169664"},{"id":"paper-w3198906313","cat":"papers","name":"The effect of the substituted amphetamines, 2.4-methylenedioxymethamphetamine (MDMA) and P-methoxyamphetamine (PMA), on platelet aggregation","year":"2001","cit":0,"pfa":"A.J. Sluggett","psa":"John V. Lloyd","ptype":"article","src":"https://openalex.org/W3198906313","eid":"W3198906313"},{"id":"paper-w1991403222","cat":"papers","name":"Search for the critical period in rats neonatally treated with 3,4-(±)-methylenedioxymethamphetamine (MDMA): Effects on behavior","year":"2009","cit":0,"pfa":"Charles Voorhees","psa":"Michael J. Williams","ptype":"article","src":"https://openalex.org/W1991403222","eid":"W1991403222"},{"id":"paper-w4406885600","cat":"papers","name":"Author response for \"Molecular insights into the modulation of the 5 HT 2 A receptor by serotonin, psilocin, and the G protein subunit Gqα\"","year":"2024","cit":0,"pfa":"Niklas Viohl","psa":"Himanshu Khandelia","topics":["Mechanism & neuroscience"],"ptype":"peer-review","src":"https://openalex.org/W4406885600","eid":"W4406885600"},{"id":"paper-w4386294662","cat":"papers","name":"Safety, blood levels and effects of N,N-dimethyltryptamine [DMT (SPL026)] in healthy participants and participants with major depressive disorder","year":"2023","cit":0,"pfa":"David Erritzøe","topics":["Depression","Safety & adverse events"],"ptype":"dataset","src":"https://openalex.org/W4386294662","eid":"W4386294662"},{"id":"paper-w192244456","cat":"papers","name":"Adolescent 3,4-methylenedioxymethamphetamine (MDMA or ‘ecstasy’) exposure in rats: Behavioral, neurochemical, and pharmocokinetic activity","year":"2007","cit":0,"pfa":"Brian J. Piper","topics":["Addiction","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W192244456","eid":"W192244456"},{"id":"paper-w4405020853","cat":"papers","name":"Expression of Concern: Posttraumatic Growth After MDMA‐Assisted Psychotherapy for Posttraumatic Stress Disorder","year":"2024","cit":0,"topics":["PTSD & trauma","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4405020853","eid":"W4405020853"},{"id":"paper-w7154503970","cat":"papers","name":"Psilocybin use in Puerto Rico: Patterns, motivations, and personality correlates from an online survey","year":"2026","cit":0,"pfa":"JC Rodriguez","psa":"Cruz M. Nazario","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7154503970","eid":"W7154503970"},{"id":"paper-w2796241797","cat":"papers","name":"Navigating intimacy with ecstasy: The emotional, spatial and boundaried dynamics of couples’ MDMA experiences","year":"2017","cit":0,"pfa":"Katie Anderson","topics":["Safety & adverse events","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W2796241797","eid":"W2796241797"},{"id":"paper-w4234960766","cat":"papers","name":"A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD II","year":"2019","cit":0,"topics":["PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4234960766","eid":"W4234960766"},{"id":"paper-w4413549988","cat":"papers","name":"MDMA-assisted couples therapy: How a psychedelic is enhancing intimacy and healing PTSD","year":"2019","cit":0,"pfa":"Anne Wagner","topics":["PTSD & trauma"],"ptype":"other","src":"https://openalex.org/W4413549988","eid":"W4413549988"},{"id":"paper-w7105674428","cat":"papers","name":"MDMA-Assisted Therapy for Anorexia Nervosa: Preliminary Evidence of Safety, Tolerability, and Effectiveness","year":"2025","cit":0,"pfa":"Jamarie Geller","psa":"Dahlgren, Camilla Lindvall","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"other","src":"https://openalex.org/W7105674428","eid":"W7105674428"},{"id":"paper-w7202360555","cat":"papers","name":"Psychologists’ attitudes towards the use of MDMA in therapy may be shaped by personal experiences","year":"2026","cit":0,"pfa":"Rita I. Csákó","psa":"David Cullen","topics":["PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7202360555","eid":"W7202360555"},{"id":"paper-w4241253658","cat":"papers","name":"Faculty Opinions recommendation of Dynamical exploration of the repertoire of brain networks at rest is modulated by psilocybin.","year":"2019","cit":0,"pfa":"Lutz Jäncke","ptype":"peer-review","src":"https://openalex.org/W4241253658","eid":"W4241253658"},{"id":"paper-w7164003040","cat":"papers","name":"PSILOCYBIN AS AN ADJUNCTIVE TREATMENT FOR DEPRESSION AND PSYCHOLOGICAL DISTRESS IN ONCOLOGY: CURRENT EVIDENCE AND CLINICAL IMPLICATIONS","year":"2026","cit":0,"pfa":"Anna Maria Komarczewska","psa":"Anna Lubomska","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7164003040","eid":"W7164003040"},{"id":"paper-w4241772725","cat":"papers","name":"MDMA-induced hyperactivity in rats is due to serotonin release acting on 5HT-1B receptors","year":"1991","cit":0,"pfa":"Mark A. Geyer","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4241772725","eid":"W4241772725"},{"id":"paper-w4291291524","cat":"papers","name":"Finding CYP2D6 activity biomarkers by correlating MDMA pharmacokinetic parameters to untargeted metabolomics data","year":"2022","cit":0,"pfa":"Yannick Wartmann","psa":"Andrea Eva Steuer","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4291291524","eid":"W4291291524"},{"id":"paper-w3121348693","cat":"papers","name":"Analysis of Newspaper Coverage of Psilocybin from January 1, 1989 to December 31, 2019","year":"2020","cit":0,"pfa":"Dax Oliver","topics":["Safety & adverse events","Policy & ethics"],"ptype":"other","src":"https://openalex.org/W3121348693","eid":"W3121348693"},{"id":"paper-w2767052081","cat":"papers","name":"Os efeitos antidepressivos da ayahuasca, suas bases neurais e relação com a experiência psicodélica","year":"2017","cit":0,"pfa":"Fernanda Palhano Xavier de Fontes","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W2767052081","eid":"W2767052081"},{"id":"paper-w7201869551","cat":"papers","name":"Relationship Between Ayahuasca Use and Cotard Syndrome: Is the Subjective Experience of Death a Potential Capacity of the Human Psyche?","year":"2026","cit":0,"pfa":"Elena María Martínez Gijón","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7201869551","eid":"W7201869551"},{"id":"paper-w3034776394","cat":"papers","name":"Ayahuascans helande kraft : En kvalitativ studie av utövares upplevelser av arbetet med ayahuasca","year":"2019","cit":0,"pfa":"Hanna Zäther","psa":"Emilia Stålnacke","ptype":"dissertation","src":"https://openalex.org/W3034776394","eid":"W3034776394"},{"id":"paper-w4319151550","cat":"papers","name":"Notas sobre o uso de ayahuasca e peiote no Mexico: um campo enteogeno emergente","year":"2022","cit":0,"pfa":"Maurício Guzmán","psa":"Beatriz Caiuby Labate","ptype":"book-chapter","src":"https://openalex.org/W4319151550","eid":"W4319151550"},{"id":"paper-w4409281909","cat":"papers","name":"630. Synthetic Psilocybin (COMP 360) for Chronic Active Suicidal Ideation: An Open-Label Study","year":"2025","cit":0,"pfa":"Scott Aaronson","psa":"Andrew van der Vaart","ptype":"article","src":"https://openalex.org/W4409281909","eid":"W4409281909"},{"id":"paper-w2204364241","cat":"papers","name":"Ayahuasca: Propagating a Plant Teacher to Heal the World (A Guideline for Future Greenhouse Production of Psychotria viridis)","year":"2015","cit":0,"pfa":"Jack Kuderko","topics":["Policy & ethics"],"ptype":"report","src":"https://openalex.org/W2204364241","eid":"W2204364241"},{"id":"paper-w3024575951","cat":"papers","name":"Efectos subjetivos de la MDMA (“éxtasis”) sobre la función sexual humana","year":"2001","cit":0,"pfa":"Zvi Zemishlany","psa":"Abraham Weizman","ptype":"article","src":"https://openalex.org/W3024575951","eid":"W3024575951"},{"id":"paper-w7119425642","cat":"papers","name":"A six-month prospective evaluation of mental heath follow-up in new Ayahuasca religious users","year":"2008","cit":0,"pfa":"Paulo César Ribeiro Barbosa","ptype":"dissertation","src":"https://openalex.org/W7119425642","eid":"W7119425642"},{"id":"paper-w4416277430","cat":"papers","name":"92. Mushrooms and Mania: Differentiating Psilocybin-Induced Mania From First-Break Bipolar Mania","year":"2025","cit":0,"pfa":"Tyler D. McGehee","psa":"Alan M. Langlieb","ptype":"article","src":"https://openalex.org/W4416277430","eid":"W4416277430"},{"id":"paper-w4414474014","cat":"papers","name":"A trial to investigate if psilocybin therapy is effective in improving outcomes for people with opioid use disorder","year":"2025","cit":0,"pfa":"David Erritzøe","psa":"David Nutt","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W4414474014","eid":"W4414474014"},{"id":"paper-w7120641925","cat":"papers","name":"Application of the lipidomic approach in the investigation of the treatment of major depression with ayahuasca in patients resistant to conventional antidepressants","year":"2024","cit":0,"pfa":"Santos, Emerson Andrade Ferreira dos, 1990-","topics":["Depression"],"ptype":"dissertation","src":"https://openalex.org/W7120641925","eid":"W7120641925"},{"id":"paper-w7214965520","cat":"papers","name":"Ayahuasca treatment reduces 50-kHz ultrasonic vocalizations and modifies mesocorticolimbic monoamine neurochemistry in rats","year":"2026","cit":0,"pfa":"Camila Pasquini de Souza","psa":"Cristina Aparecida Jark Stern","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7214965520","eid":"W7214965520"},{"id":"paper-w2314706420","cat":"papers","name":"ChemInform Abstract: CHEMIE DES INDOLS 4. MITT. SYNTH. IN DER IBOGA‐REIHE 1. MITT. (D,1)‐DESAETHYLIBOGAMIN","year":"1973","cit":0,"pfa":"Peter Rosenmund","psa":"Rainer Frische","ptype":"article","src":"https://openalex.org/W2314706420","eid":"W2314706420"},{"id":"paper-w7144866806","cat":"papers","name":"Metabolism and excretion of 3,4-methylenedioxymethamphetamine (MDMA) enantiomers in rats using 15N-labeled tracer","year":"2012","cit":0,"pfa":"毅 五郎丸","psa":"景子 中村","ptype":"article","src":"https://openalex.org/W7144866806","eid":"W7144866806"},{"id":"paper-w2979485330","cat":"papers","name":"Subchronic 3, 4-methylenedioximethamphetamine (mdma) reverts anxiety induced by chronic mild stress","year":"2013","cit":0,"pfa":"Laura Alejandra Rubio León","psa":"Fernando Cardenas P.","topics":["Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2979485330","eid":"W2979485330"},{"id":"paper-w2249176557","cat":"papers","name":"Automated quantitative semantic analysis of speech discriminates acute effects of +/- 3,4-MDMA and methamphetamine","year":"2013","cit":0,"pfa":"Gillinder Bedi","psa":"Harriet de Wit","ptype":"article","src":"https://openalex.org/W2249176557","eid":"W2249176557"},{"id":"paper-w4378374471","cat":"papers","name":"EFICACIA DEL MDMA EN EL TRASTORNO POR ESTRÉS POSTRAUMÁTICO. REVISIÓN BIBLIOGRÁFICA.","year":"2023","cit":0,"topics":["Policy & ethics"],"ptype":"conference-paper","src":"https://openalex.org/W4378374471","eid":"W4378374471"},{"id":"paper-w4401593579","cat":"papers","name":"Benefícios da psicoterapia assistida por MDMA para pacientes diagnosticados com TEPT","year":"2024","cit":0,"pfa":"Gustavo Souza Fioroti","psa":"Fábio Nogueira Pereira","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4401593579","eid":"W4401593579"},{"id":"paper-w7156685738","cat":"papers","name":"Trends in toxicological findings and drug seizures of MDMA in New Zealand from 2010 to 2022","year":"2026","cit":0,"pfa":"Sheehan, Thomas J.","psa":"Helen Poulsen","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7156685738","eid":"W7156685738"},{"id":"paper-w7212182612","cat":"papers","name":"Prior ayahuasca experience is associated with improved mental health: observational data from ritualistic settings","year":"2026","cit":0,"pfa":"Lucas Villar Magalhães da Cruz","psa":"Daniel C. Mograbi","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7212182612","eid":"W7212182612"},{"id":"paper-w7161558607","cat":"papers","name":"B48-13 Severe Serotonin Syndrome With Acute Respiratory Failure Following Ayahuasca and Dextromethorphan Use: A Case Report","year":"2026","cit":0,"pfa":"Sean Pack","psa":"Yahya Ahmad","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7161558607","eid":"W7161558607"},{"id":"paper-w634401837","cat":"papers","name":"Part I.: Approaches to syntheses of iboga alkaloids ; part II.: Structure of dynamic 1, 2-nonadiene-y-yne","year":"1971","cit":0,"pfa":"A. Whitehead","ptype":"book","src":"https://openalex.org/W634401837","eid":"W634401837"},{"id":"paper-w2055416098","cat":"papers","name":"Serotonin Transporter Concentration is Decreased in Cerebral Cortex but not in Striatum of Chronic MDMA (ecstasy) Users","year":"2009","cit":0,"pfa":"Stephen J. Kish","psa":"Sylvain Houle","topics":["PTSD & trauma","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2055416098","eid":"W2055416098"},{"id":"paper-w4413492228","cat":"papers","name":"Psilocybin legislation is helping psychedelic drugs make a comeback – a drug researcher explains the challenges they face","year":"2024","cit":0,"pfa":"Benjamin Y. Fong","ptype":"other","src":"https://openalex.org/W4413492228","eid":"W4413492228"},{"id":"paper-w4409294360","cat":"papers","name":"458. Microdoses of Psilocybin Combined With Eugenol are Absorbed and Induce Unique Cerebellar Gene Expression","year":"2025","cit":0,"pfa":"Chuck T. Chen","psa":"Richard Paul Bazinet","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4409294360","eid":"W4409294360"},{"id":"paper-w4416141312","cat":"papers","name":"CNSC-36. PSILOCYBIN INDUCES SUSTAINED GLIOMA GROWTH THROUGH SEROTONERGIC AND TRKB PATHWAYS","year":"2025","cit":0,"pfa":"Richard Drexler","psa":"Michelle Monje","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4416141312","eid":"W4416141312"},{"id":"paper-w2287146675","cat":"papers","name":"7. Los niños de la Reina - ayahuasca y embarazo: un informe preliminar","year":"2013","cit":0,"pfa":"Marlo Eakes Meyer","psa":"Matthew D. S. Meyer","ptype":"article","src":"https://openalex.org/W2287146675","eid":"W2287146675"},{"id":"paper-w2900487171","cat":"papers","name":"Estudo etnográfico: Potencial psicoterápico do uso ritual da Ayahuasca em contextos neoxamânicos","year":"2018","cit":0,"pfa":"Odair Almeida da Silva","ptype":"article","src":"https://openalex.org/W2900487171","eid":"W2900487171"},{"id":"paper-w4404649361","cat":"papers","name":"RELIGIOUS FREEDOM AND TRANSNATIONALIZATION: The regulation of Brazilian ayahuasca religions under United States and Netherlands jurisdiction","year":"2019","cit":0,"pfa":"Cezar Augusto Dranka","psa":"Melissa Martins Casagrande","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4404649361","eid":"W4404649361"},{"id":"paper-w2101175006","cat":"papers","name":"EFFECT OF MEDIUM-TERM INJECTION OF MDMA ON THE ANXIETY OF MALE RAT WITH PLUS MAZE TEST","year":"2012","cit":0,"pfa":"Mehrdad Jahanshahi","psa":"F Seid Hosseini","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2101175006","eid":"W2101175006"},{"id":"paper-w2170112232","cat":"papers","name":"P-46 * DEPLETION OF OREXIN AFFECTS THE DISCRIMINATIVE STIMULUS AND REWARDING EFFECTS OF MDMA IN MICE","year":"2014","cit":0,"pfa":"Naoki Uzawa","psa":"Tsutomu Suzuki","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"conference-abstract","src":"https://openalex.org/W2170112232","eid":"W2170112232"},{"id":"paper-w7171336301","cat":"papers","name":"MDMA and Rave Parties: Intentional and Impulsive Patterns of Use and Users' Harm Reduction Strategies","year":"2026","cit":0,"pfa":"Kateřina Randová","topics":["Safety & adverse events","Dosing & pharmacology","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W7171336301","eid":"W7171336301"},{"id":"paper-w2227282062","cat":"papers","name":"Geschlechtsunterschiede der Auswirkungen von 3,4- Methylendioxymethamphetamin (MDMA, Ecstasy) auf kognitive Leistungen","year":"2005","cit":0,"pfa":"Holger Hauspurg","ptype":"article","src":"https://openalex.org/W2227282062","eid":"W2227282062"},{"id":"paper-w7208690860","cat":"papers","name":"Psilocybinによる実験的精神障害","year":"1966","cit":0,"pfa":"正名 内田","ptype":"other","src":"https://openalex.org/W7208690860","eid":"W7208690860"},{"id":"paper-w7113160508","cat":"papers","name":"A brain pattern of high integration and low segregation is recurrently observed after psilocybin administration","year":"2022","cit":0,"pfa":"Mortaheb, Sepehr","psa":"Demertzi, Athina","topics":["Reviews & meta-analyses","Therapy practice"],"ptype":"conference-paper","src":"https://openalex.org/W7113160508","eid":"W7113160508"},{"id":"paper-w7156860364","cat":"papers","name":"Trends in toxicological findings and drug seizures of MDMA in New Zealand from 2010 to 2022","year":"2026","cit":0,"pfa":"Sheehan, Thomas J.","psa":"Helen Poulsen","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7156860364","eid":"W7156860364"},{"id":"paper-w7168029453","cat":"papers","name":"Changes in trauma symptoms of discrimination after MDMA-assisted psychotherapy for posttraumatic stress disorder","year":"2026","cit":0,"pfa":"Monnica T. Williams","psa":"Sergio R Pérez Rosal","topics":["PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7168029453","eid":"W7168029453"},{"id":"paper-w7202331231","cat":"papers","name":"Evaluating the Therapeutic Effects of Ayahuasca: A Naturalistic Longitudinal Study on Alcohol Use, Mental Wellbeing, and the Mystical Experience","year":"2026","cit":0,"pfa":"Camille Curran King","topics":["Addiction"],"ptype":"dissertation","src":"https://openalex.org/W7202331231","eid":"W7202331231"},{"id":"paper-w4414493987","cat":"papers","name":"Regional Specificity of the Cingulate Cortex Thickness Association with the Intensity of Psilocybin Experience: A Replication Study","year":"2025","cit":0,"pfa":"David Greguš","psa":"Jiřı́ Horáček","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4414493987","eid":"W4414493987"},{"id":"paper-w7128759568","cat":"papers","name":"Mystical but Not Challenging Experiences Predict Symptom Improvement After Psilocybin for Treatment-Resistant OCD","year":"2026","cit":0,"pfa":"Gabrielle Agin-Liebes","psa":"Jamila Hokanson","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W7128759568","eid":"W7128759568"},{"id":"paper-w7166295254","cat":"papers","name":"Divergent changes in perturbation-induced brain reconfiguration following depression treatment with psilocybin and escitalopram","year":"2026","cit":0,"pfa":"Paulina Clara Dagnino","psa":"Gustavo Deco","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7166295254","eid":"W7166295254"},{"id":"paper-w7213540649","cat":"papers","name":"An Open-Label, Dose-Escalation Trial of Psilocybin-Assisted Therapy for Bipolar II Depression","year":"2026","cit":0,"pfa":"Amanda E. Downey","psa":"Josh D. Woolley","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7213540649","eid":"W7213540649"},{"id":"paper-w7113788846","cat":"papers","name":"Psychedelic integration – An open window for development : A scoping review on the role of integration in psilocybin-assisted therapy","year":"2023","cit":0,"pfa":"Berglund, Marcus","psa":"Ajemark, Simon","topics":["Reviews & meta-analyses","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W7113788846","eid":"W7113788846"},{"id":"paper-w4248688903","cat":"papers","name":"Comparison of Methamphetamine and MDMA Extended Access Self-administration: Acquisition, Maintenance, and Response Patterns","year":"2020","cit":0,"pfa":"Alex Maan","topics":["Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W4248688903","eid":"W4248688903"},{"id":"paper-w7160621769","cat":"papers","name":"0408 Insomnia Severity Differences by Psilocybin, LSD, and DMT Use Status Among Young Adult Daily Cannabis Consumers in the Herbal Heart Study","year":"2026","cit":0,"pfa":"Denise Vidot","psa":"Girardin Jean‐Louis","topics":["Safety & adverse events"],"ptype":"conference-abstract","src":"https://openalex.org/W7160621769","eid":"W7160621769"},{"id":"paper-w4402740515","cat":"papers","name":"Premorbid Characteristics of the SAPAP3-Mouse Model of Obsessive-Compulsive Disorder: Behavior, Neuroplasticity, and Psilocybin Treatment","year":"2024","cit":0,"pfa":"Michal Lazar","psa":"Bernard Lerer","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4402740515","eid":"W4402740515"},{"id":"paper-w4414083069","cat":"papers","name":"MDMA-assisted Acceptance and Commitment Therapy for Posttraumatic Stress Disorder: Rationale for a New Approach","year":"2025","cit":0,"pfa":"Mathew Herbert","psa":"Joshua Woolley","topics":["PTSD & trauma","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4414083069","eid":"W4414083069"},{"id":"paper-w7117532351","cat":"papers","name":"Exploring MDMA assisted therapy in eating disorders: mechanisms, clinical evidence, and future directions","year":"2025","cit":0,"pfa":"Michael A Harkhoe","psa":"Eric H. G. J. M. Vermetten","topics":["PTSD & trauma","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7117532351","eid":"W7117532351"},{"id":"paper-w7166843546","cat":"papers","name":"Characterizing Integration Sessions and Predictors of Integration Engagement Within Oregon’s State-Regulated Psilocybin Services","year":"2026","cit":0,"pfa":"Christina Chwyl","psa":"Devin Gregoire","topics":["Safety & adverse events","Therapy practice","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W7166843546","eid":"W7166843546"},{"id":"paper-w7167262029","cat":"papers","name":"Trajectories of psychedelic-assisted change: An observational study of a psilocybin retreat program followed by psychotherapeutic interventions","year":"2026","cit":0,"pfa":"Henry J. Whitfield","psa":"Kim P. C. Kuypers","topics":["Depression","Anxiety & end-of-life","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7167262029","eid":"W7167262029"},{"id":"paper-w2590204533","cat":"papers","name":"Rozdíly v účinnosti MDMA při aktuním a chronickém podávání umyších samců a samic","year":"2008","cit":0,"pfa":"Jana Kučerová","psa":"Alexandra Šulcová","ptype":"article","src":"https://openalex.org/W2590204533","eid":"W2590204533"},{"id":"paper-w2406264398","cat":"papers","name":"Mais-peyote-hjort : kosmologi opprettholdt gjennom resiprositets handlinger i ritualer : en studie av urbefolkningen Huichol","year":"2007","cit":0,"pfa":"Håkon Rokseth","ptype":"dissertation","src":"https://openalex.org/W2406264398","eid":"W2406264398"},{"id":"paper-w2592345831","cat":"papers","name":"Fannie Kahan, Erika Dyck (ed), A Culture’s Catalyst: Historical Encounters with Peyote and the Native American Church in Canada","year":"2017","cit":0,"pfa":"NANCY D. CAMPBELL","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2592345831","eid":"W2592345831"},{"id":"paper-w7212248664","cat":"papers","name":"Control, Support, and Context: Distinguishing Cultic Coercion, Religiosity, and Ritual Ayahuasca Use in Research on Substance Use","year":"2026","cit":0,"pfa":"Mohnish Shende","topics":["Addiction"],"ptype":"preprint","src":"https://openalex.org/W7212248664","eid":"W7212248664"},{"id":"paper-w7201842027","cat":"papers","name":"Relationship Between Ayahuasca Use and Cotard Syndrome: Is the Subjective Experience of Death a Potential Capacity of the Human Psyche?","year":"2026","cit":0,"pfa":"Elena María Martínez Gijón","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7201842027","eid":"W7201842027"},{"id":"paper-w2759817465","cat":"papers","name":"Serotonin 5-HT4 receptors in the nucleus accumbens are involved in the appetite suppressant effects of MDMA","year":"2009","cit":0,"pfa":"Heather Francis","psa":"Jennifer L. Cornish","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2759817465","eid":"W2759817465"},{"id":"paper-w2622619714","cat":"papers","name":"Estradiol and MDMA affect the susceptibility and immune response to genital herpes and genital herpes immunization","year":"2009","cit":0,"pfa":"Jeffry W. Pennock","ptype":"dissertation","src":"https://openalex.org/W2622619714","eid":"W2622619714"},{"id":"paper-w2518106551","cat":"papers","name":"MDMA と methylphenidate の感覚効果の相違","year":"2015","cit":0,"pfa":"鈴木 勉","psa":"森友久","ptype":"article","src":"https://openalex.org/W2518106551","eid":"W2518106551"},{"id":"paper-w7124725494","cat":"papers","name":"The Potential of MDMA-Assisted Psychotherapy in the Treatment of Post-Traumatic Stress Disorder: An Integrative Review","year":"2022","cit":0,"pfa":"Delyone de Paula Canedo Filho","topics":["PTSD & trauma","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7124725494","eid":"W7124725494"},{"id":"paper-w4400275305","cat":"papers","name":"Avaliação metabolômica do soro sanguíneo de pacientes com depressão refratária tratados com ayahuasca","year":"2023","cit":0,"pfa":"Luidy Darllan Barbosa","topics":["Depression"],"ptype":"dissertation","src":"https://openalex.org/W4400275305","eid":"W4400275305"},{"id":"paper-w3192054945","cat":"papers","name":"Terapias asistidas con Ayahuasca en el tratamiento de usos problemáticos de sustancias psicoactivas","year":"2020","cit":0,"pfa":"Alejandra Meikle","ptype":"article","src":"https://openalex.org/W3192054945","eid":"W3192054945"},{"id":"paper-w3036409757","cat":"papers","name":"Efeitos agudos e subagudos de dose única de Ayahuasca no reconhecimento de expressões faciais","year":"2020","cit":0,"pfa":"Juliana Mendes Rocha","topics":["Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W3036409757","eid":"W3036409757"},{"id":"paper-w30022929","cat":"papers","name":"Metabolites of 3,4‐Methylenedioxymethamphetamine (MDMA) produce apoptosis in adult left ventricular myocytes (ALVM)","year":"2007","cit":0,"pfa":"Sylvia K Shenouda","psa":"Kurt James Varner","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W30022929","eid":"W30022929"},{"id":"paper-w7166018605","cat":"papers","name":"Global increases in brain glucose metabolism following acute N,N-dimethyltryptamine and harmine administration in healthy volunteers: A randomised [$_{18}$F]FDG-PET study","year":"2026","cit":0,"pfa":"Klemens Egger","psa":"Paul D. Cumming","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7166018605","eid":"W7166018605"},{"id":"paper-w4251266862","cat":"papers","name":"P.3.06 Cannabis co-administration potentiates MDMA effects on temperature and heart rate","year":"2009","cit":0,"pfa":"Glenn Dumont","psa":"R. J. Verkes","ptype":"article","src":"https://openalex.org/W4251266862","eid":"W4251266862"},{"id":"paper-w4252109553","cat":"papers","name":"Book Reviews : Lysergic Acid Diethylamide (LSD) in the Treatment of Alcoholism: an investigation of its effects on drinking behaviour personality structure and social functioning by Reginald G. Smart, PH.D., Thomas Storm","year":"1969","cit":0,"topics":["Addiction","Reviews & meta-analyses"],"ptype":"book-review","src":"https://openalex.org/W4252109553","eid":"W4252109553"},{"id":"paper-w4226332855","cat":"papers","name":"Neuroadaptive Changes in 5-HT1A Autoreceptor Sensitivity Following High-Dose MDMA Treatment","year":"2011","cit":0,"pfa":"Simon David Fisher","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W4226332855","eid":"W4226332855"},{"id":"paper-w2318296573","cat":"papers","name":"P.6.d.012 Effects of methylphenidate and MDMA (ecstasy) on appraisal of erotic stimuli","year":"2014","cit":0,"pfa":"Yasmin Schmid","psa":"Matthias E. Liechti","ptype":"article","src":"https://openalex.org/W2318296573","eid":"W2318296573"},{"id":"paper-w7106416769","cat":"papers","name":"The DMT Antenna Hypothesis: Endogenous N,N-Dimethyltryptamine as the Molecular Substrate for the Subjective \"I Am\" Across Living Systems","year":"2025","cit":0,"pfa":"Swygert, John","ptype":"article","src":"https://openalex.org/W7106416769","eid":"W7106416769"},{"id":"paper-w81191673","cat":"papers","name":"Verantwortlichkeit eines Arztes für Einnahme von MDMA bei einer Psycholyse-Behandlung","year":"2011","cit":0,"pfa":"BGH","ptype":"article","src":"https://openalex.org/W81191673","eid":"W81191673"},{"id":"paper-w2981973827","cat":"papers","name":"Mescaline en de lijntjes van je broek: Een essay over aandacht, belevenissen en ervaringen","year":"2018","cit":0,"pfa":"Gijs van Maanen","ptype":"other","src":"https://openalex.org/W2981973827","eid":"W2981973827"},{"id":"paper-w4416197013","cat":"papers","name":"MDMA como facilitador terapêutico: o impacto na reintegração de experiências traumáticas","year":"2025","cit":0,"pfa":"Maria Eduarda Mesquita Gonsalves","psa":"Maurício Cupello Peixoto","ptype":"article","src":"https://openalex.org/W4416197013","eid":"W4416197013"},{"id":"paper-w3166299915","cat":"papers","name":"MDMA (3,4-methylenedioxymethamphetamine) nitrate – an atypical salt form or a new trend in the drug market?","year":"2017","cit":0,"pfa":"Robert Bachliński","psa":"Małgorzata Galarda","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W3166299915","eid":"W3166299915"},{"id":"paper-w3160830488","cat":"papers","name":"Visions from other worlds: Western Esotericism, UFO beliefs and conspiracy theories in New Age ayahuasca groups","year":"2021","cit":0,"pfa":"Ricardo Assarice dos Santos","psa":"Leornardo Breno Martins","ptype":"article","src":"https://openalex.org/W3160830488","eid":"W3160830488"},{"id":"paper-w1510609850","cat":"papers","name":"The Effects of Repeated Administration of Varying Doses of MDMA on the Expression of Sexual Behavior in the Male Rat","year":"1991","cit":0,"pfa":"William M. Struthers","psa":"Faculty Advisor Dornan","topics":["Dosing & pharmacology"],"ptype":"conference-paper","src":"https://openalex.org/W1510609850","eid":"W1510609850"},{"id":"paper-w1976327521","cat":"papers","name":"Intoxicación aguda por MDMA: manejo inicial en el servicio de urgencias","year":"2006","cit":0,"pfa":"J. Lloret","ptype":"article","src":"https://openalex.org/W1976327521","eid":"W1976327521"},{"id":"paper-w2613163470","cat":"papers","name":"Wheel running increases hyperthermia and mortality rate following 3,4-methylenedioxymethamphetamine (MDMA) in rats","year":"2017","cit":0,"pfa":"Michael A. Taffe","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W2613163470","eid":"W2613163470"},{"id":"paper-w4403618851","cat":"papers","name":"OTFS-MDMA: An Elastic Multi-Domain Resource Utilization Mechanism for High Mobility Scenarios","year":"2024","cit":0,"pfa":"Chen, Jie","psa":"Hanzo, Lajos","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4403618851","eid":"W4403618851"},{"id":"paper-w400121666","cat":"papers","name":"Speed and efficiency of information processing as a basis for working memory deficits in users of ‘ecstasy’ (MDMA)","year":"2006","cit":0,"pfa":"M. Wareing","psa":"Melanie Chandler","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W400121666","eid":"W400121666"},{"id":"paper-w4392405987","cat":"papers","name":"Is it dopamine or serotonin?: Contrasting social cognition and aggression between chronic MDMA and methamphetamine users","year":"2024","cit":0,"pfa":"Amelie Zacher","psa":"Boris B. Quednow","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4392405987","eid":"W4392405987"},{"id":"paper-w7119384936","cat":"papers","name":"Benefícios da psicoterapia assistida por MDMA para pacientes diagnosticados com TEP","year":"2025","cit":0,"pfa":"Gustavo Souza Fioroti","psa":"Fabio de Barros Pereira","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7119384936","eid":"W7119384936"},{"id":"paper-w2941475287","cat":"papers","name":"Cryo-EM structure of the ts2-active human serotonin transporter in complex with 15B8 Fab and 8B6 ScFv bound to ibogaine","year":"2018","cit":0,"pfa":"Jonathan A. Coleman","psa":"Eric Gouaux","topics":["Mechanism & neuroscience"],"ptype":"dataset","src":"https://openalex.org/W2941475287","eid":"W2941475287"},{"id":"paper-w7106342846","cat":"papers","name":"Additional NMR data for: A streamlined synthesis of 5-methoxy-N,N-dimethyltryptamine, bufotenin, and bufotenin prodrugs from melatonin","year":"2025","cit":0,"pfa":"Homon, Anton","psa":"Pourian, Elham","ptype":"dataset","src":"https://openalex.org/W7106342846","eid":"W7106342846"},{"id":"paper-w7163070014","cat":"papers","name":"Global increases in brain glucose metabolism following acute N,N-dimethyltryptamine and harmine administration in healthy volunteers: A randomized [ 18 F]FDG-PET study","year":"2026","cit":0,"pfa":"Klemens Egger","psa":"Paul D. Cumming","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7163070014","eid":"W7163070014"},{"id":"paper-w4403152120","cat":"papers","name":"Review for \"Psilocybin reduces functional correlation and the encoding of spatial information by neurons in mouse retrosplenial cortex\"","year":"2024","cit":0,"topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4403152120","eid":"W4403152120"},{"id":"paper-w7146996951","cat":"papers","name":"Psilocybin as a potential countermeasure to Toxoplasma gondii-induced behavioral modification: A hypothesis and proposed research framework","year":"2026","cit":0,"pfa":"Griffiths Hamilton","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7146996951","eid":"W7146996951"},{"id":"paper-w3021977779","cat":"papers","name":"The Efficacy of Psilocybin Compared to Selective Serotonin Reuptake Inhibitors in the Treatment of Adults with Major Depressive Disorder","year":"2020","cit":0,"pfa":"Krista Worden","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3021977779","eid":"W3021977779"},{"id":"paper-w4392405867","cat":"papers","name":"Exploring the molecular basis of treatment-resistant depression: Discoveries from a rat model and psilocybin therapy","year":"2024","cit":0,"pfa":"Agata Korlatowicz","psa":"Agata Faron‐Górecka","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4392405867","eid":"W4392405867"},{"id":"paper-w4386783048","cat":"papers","name":"Potential of Natural Products to Modulate Microglial Phenotypes in 3, 4 Methylenedioxymethamphetamine (MDMA) Neurotoxicity","year":"2023","cit":0,"pfa":"Nor Suliana Mustafa","psa":"Liyana Hazwani Mohd Adnan","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4386783048","eid":"W4386783048"},{"id":"paper-w7139630507","cat":"papers","name":"Profiling the effects of Naltrexone, Ketamine, and MDMA on behaviour and brain neurophysiology in alcohol- drinking rats","cit":0,"pfa":"Isabel E Faulkner","topics":["Addiction"],"ptype":"other","src":"https://openalex.org/W7139630507","eid":"W7139630507"},{"id":"paper-w2018421527","cat":"papers","name":"A THREE-LEVER DRUG DISCRIMINATION PROCEDURE DIFFERENTIATES THE STIMULUS PROPERTIES OF MDMA AND d-AMPHETAMINE","year":"1999","cit":0,"pfa":"Amy Goodwin","topics":["Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W2018421527","eid":"W2018421527"},{"id":"paper-w1043838831","cat":"papers","name":"Perceived effects of MDMA (Ecstasy) use: a factor analytic study of users' self-reports","year":"2004","cit":0,"pfa":"M. Wareing","psa":"J. Fisk","ptype":"conference-paper","src":"https://openalex.org/W1043838831","eid":"W1043838831"},{"id":"paper-w1982551280","cat":"papers","name":"Prospective Study Finds Brain Damage from Short-Term, Low-Dose MDMA","year":"2008","cit":0,"pfa":"RICHARD ROBINSON","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1982551280","eid":"W1982551280"},{"id":"paper-w1926126291","cat":"papers","name":"Simultaneous [99mTc]-TRODAT-1 and [123I]-ADAM brain SPECT in MDMA-treated monkeys","year":"2010","cit":0,"pfa":"Cheng‐Yi Cheng","psa":"Wen‐Sheng Huang","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1926126291","eid":"W1926126291"},{"id":"paper-w2243653081","cat":"papers","name":"How does ecstasy/MDMA use affect the visual system, and does it really matter?","year":"2011","cit":0,"pfa":"Raimondo Bruno","psa":"Georgia Murphy","ptype":"article","src":"https://openalex.org/W2243653081","eid":"W2243653081"},{"id":"paper-w2319069610","cat":"papers","name":"Adolescent MDMA Exposure Diminishes the Physiological, Behavioral, and Neurotoxic Consequences of a Subsequent Methamphetamine Binge","year":"2014","cit":0,"pfa":"Christina S. Henderson","psa":"Jerrold S. Meyer","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2319069610","eid":"W2319069610"},{"id":"paper-w4376625831","cat":"papers","name":"3,4-Methylenedioxymethamphetamine (MDMA) - Assisted psychotherapy for treatment of posttraumatic stress disorder: Literature review","year":"2020","cit":0,"pfa":"Tiberiu Constantin Ionescu","psa":"Cătălina Tudose","topics":["PTSD & trauma","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4376625831","eid":"W4376625831"},{"id":"paper-w4396741965","cat":"papers","name":"Copeptin and oxytocin in MDMA-induced hyponatremia:incidence and severity, mechanisms of action, and the effect of fluid restriction","year":"2024","cit":0,"pfa":"Cihan Atila","psa":"Mirjam Christ‐Crain","topics":["Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W4396741965","eid":"W4396741965"},{"id":"paper-w4399269846","cat":"papers","name":"Effects of the Combination of Caffeine, Nicotine, and 3,4 Methylenedioxymethamphetamine (MDMA) on the Hippocampus of Experimental Wistar Rats","year":"2024","cit":0,"pfa":"Adetunji O. Adebola","psa":"Ajibade T. Pricilla","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4399269846","eid":"W4399269846"},{"id":"paper-w2909355169","cat":"papers","name":"Regional and dose-dependent effects of MDMA (ecstasy) on MAP kinases and NO signaling in rat brain","year":"2003","cit":0,"pfa":"Wessinger Wd","psa":"Svetlana V. Kiosseva","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2909355169","eid":"W2909355169"},{"id":"paper-w2183711185","cat":"papers","name":"EFFECTS OF 3,4-~IOXY-- AMINE (MDMA) ON ANXIETY IN MICE TESTED IN THE LIGHT-DARK BOX","year":"2000","cit":0,"pfa":"E. Maldonado","psa":"José Francisco Navarro","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2183711185","eid":"W2183711185"},{"id":"paper-w4292484119","cat":"papers","name":"Effects of 3,4-Methylendioxymethamphetamine (MDMA, Ecstasy) on dopamine transmission in the nucleus accumbens shell and core","year":"2005","cit":0,"pfa":"C. Cadoni","psa":"G. Di Chiara","ptype":"article","src":"https://openalex.org/W4292484119","eid":"W4292484119"},{"id":"paper-w7162411864","cat":"papers","name":"Serotonine transporter imaging in MDMA or hallucinogenic drug users and non using controls Data","year":"2026","cit":0,"pfa":"David Erritzøe","psa":"Klaus K. Holst","topics":["Mechanism & neuroscience"],"ptype":"dataset","src":"https://openalex.org/W7162411864","eid":"W7162411864"},{"id":"paper-w4412100552","cat":"papers","name":"Validation Method of 3,4-Methylenedioxymethamphetamine (MDMA) Analysis Using Gas Chromatography Mass Spectroscopy","year":"2025","cit":0,"pfa":"Muhammad Taufik","psa":"Andriayani Andriayani","ptype":"article","src":"https://openalex.org/W4412100552","eid":"W4412100552"},{"id":"paper-w2134321935","cat":"papers","name":"Beeldvormend onderzoek naar de mogelijke neurotoxiciteit van ecstasy (MDMA) (Hfdst 6)","year":"2003","cit":0,"pfa":"Liesbeth Reneman","psa":"J. van Weeghel","topics":["Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W2134321935","eid":"W2134321935"},{"id":"paper-w2292582188","cat":"papers","name":"Der Einfluss fluorsubstituierter MDMA-Derivate auf die motorische Parkinsonsymptomatik von Ratten","year":"2015","cit":0,"pfa":"Katrin Gittinger","topics":["Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W2292582188","eid":"W2292582188"},{"id":"paper-w2915486823","cat":"papers","name":"A portfolio of research work including an interpretative phenomenological analysis of MDMA assisted psychotherapy for PTSD.","year":"2018","cit":0,"pfa":"Michelle Ruger","topics":["PTSD & trauma","Anxiety & end-of-life","Reviews & meta-analyses"],"ptype":"dissertation","src":"https://openalex.org/W2915486823","eid":"W2915486823"},{"id":"paper-w4225989004","cat":"papers","name":"The gluco-regulatory effects of 3,4- Methylenedioxymethamphetamine (MDMA): A controlled n-of-2 self-experimentation","year":"2021","cit":0,"pfa":"Harriet A. Carroll","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4225989004","eid":"W4225989004"},{"id":"paper-w7154492819","cat":"papers","name":"Machine learning recovers folk classification of Banisteriopsis caapi from herbarium leaves an ayahuasca liana","year":"2026","cit":0,"pfa":"Scheila Cristina Biazatti","psa":"Regina Célia de Oliveira","ptype":"article","src":"https://openalex.org/W7154492819","eid":"W7154492819"},{"id":"paper-w4394897232","cat":"papers","name":"AYAHUASCA: DAS DIFERENTES DESIGNAÇÕES NA MÍDIA BRASILEIRA À PRODUÇÃO E CIRCULAÇÃO DE SENTIDOS","year":"2024","cit":0,"pfa":"H. OLIVEIRA","psa":"M. I. SOUZA","ptype":"book-chapter","src":"https://openalex.org/W4394897232","eid":"W4394897232"},{"id":"paper-w4403152367","cat":"papers","name":"Review for \"Psilocybin reduces functional correlation and the encoding of spatial information by neurons in mouse retrosplenial cortex\"","year":"2024","cit":0,"topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4403152367","eid":"W4403152367"},{"id":"paper-w2492480615","cat":"papers","name":"Avaliação toxicológica da ayahuasca em ratos Wistar : comportamento e toxicidade reprodutiva em machos","year":"2016","cit":0,"pfa":"Alana de Fátima Andrade Santos","ptype":"dissertation","src":"https://openalex.org/W2492480615","eid":"W2492480615"},{"id":"paper-w4406385685","cat":"papers","name":"O relatório da DEA sobre os riscos da ayahuasca: a “ciência” a serviço do proibicionismo?","year":"2024","cit":0,"pfa":"Beatriz Caiuby Labate","psa":"Sidarta Tollendal Gomes Ribeiro","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4406385685","eid":"W4406385685"},{"id":"paper-w4298292794","cat":"papers","name":"Effects of 3,4 methylhenedioxymethamphetamine (MDMA)-Ethanol associations on locomotor activity and body temperature in rats","year":"2005","cit":0,"pfa":"Jean‐Christophe Cassel","psa":"Jones, Byron","ptype":"conference-paper","src":"https://openalex.org/W4298292794","eid":"W4298292794"},{"id":"paper-w1965584686","cat":"papers","name":"S.07.05 Cannabis co-administration potentiates MDMA effects on temperature and heart rate","year":"2009","cit":0,"pfa":"Glenn Dumont","psa":"Robbert‐Jan Verkes","ptype":"article","src":"https://openalex.org/W1965584686","eid":"W1965584686"},{"id":"paper-w3048841939","cat":"papers","name":"Influência da ayahuasca na resolução de problemas por uma nova cadeia de respostas","year":"2019","cit":0,"pfa":"de Araújo","psa":"Sofia Azevêdo","ptype":"article","src":"https://openalex.org/W3048841939","eid":"W3048841939"},{"id":"paper-w4400117077","cat":"papers","name":"\"Vine of the Soul\": The Potential of Ayahuasca for Reducing Depression, Anxiety, and Stress among Ceremony Participants and the Role of Rumination","year":"2024","cit":0,"pfa":"Banan Ramarushton","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W4400117077","eid":"W4400117077"},{"id":"paper-w4385619100","cat":"papers","name":"New Study Reveals Long-Term Effects of MDMA on the Brain’s Glutamate-Glutamine Complex","year":"2023","cit":0,"pfa":"Apochi Obed Okwoli","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4385619100","eid":"W4385619100"},{"id":"paper-w4390533105","cat":"papers","name":"A rapid scoping review of harm reduction strategies for ecstasy (MDMA) users in recreational settings","year":"2024","cit":0,"pfa":"Deborah J. Edwards","psa":"Jane Harden","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4390533105","eid":"W4390533105"},{"id":"paper-w7160698256","cat":"papers","name":"Baseline Resilience as a Predictor of Ayahuasca Acute Effects and Moderator of the Relationship between Acute Effects and Psychospiritual Outcomes","year":"2026","cit":0,"pfa":"Yitong Xin","psa":"Mo Yee Lee","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W7160698256","eid":"W7160698256"},{"id":"paper-w4226119087","cat":"papers","name":"Neuroadaptive Changes in 5-HT1A Autoreceptor Sensitivity Following High-Dose MDMA Treatment","year":"2011","cit":0,"pfa":"Simon David Fisher","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W4226119087","eid":"W4226119087"},{"id":"paper-w4400575079","cat":"papers","name":"Differences in Acute and Enduring Effects of MDMA vs. Classic Psychedelics in People With Eating Disorders","year":"2024","cit":0,"pfa":"Natalie Gukasyan","psa":"Roland R. Griffiths","ptype":"article","src":"https://openalex.org/W4400575079","eid":"W4400575079"},{"id":"paper-w4226056732","cat":"papers","name":"Validation and exploratory application of a simple, rapid and economical procedure (MESQ) for the quantification of mescaline in fresh cactus tissue and aqueous cactus extracts","year":"2022","cit":0,"pfa":"Van Der Sypt Frederick A.P.","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4226056732","eid":"W4226056732"},{"id":"paper-w4390593108","cat":"papers","name":"Review for \"Psilocybin as a lead candidate molecule in preclinical therapeutic studies of psychiatric disorders: A systematic review\"","year":"2023","cit":0,"topics":["Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4390593108","eid":"W4390593108"},{"id":"paper-w7202314872","cat":"papers","name":"Real-world use, safety, and mental health efficacy of regulated psilocybin services in Oregon and Colorado","year":"2026","cit":0,"pfa":"Scott M. Thompson","psa":"Niko Skievaski","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7202314872","eid":"W7202314872"},{"id":"paper-w4413538287","cat":"papers","name":"We now know what a brain looks like on psilocybin – but what does that tell us?","year":"2024","cit":0,"pfa":"Michiel van Elk","ptype":"other","src":"https://openalex.org/W4413538287","eid":"W4413538287"},{"id":"paper-w2938534989","cat":"papers","name":"Caracterização da ayahuasca usando espectrometria de massas : quantificação de princípios ativos e fingerprinting","year":"2018","cit":0,"pfa":"Rita de Cassia Zacardi de Souza","ptype":"article","src":"https://openalex.org/W2938534989","eid":"W2938534989"},{"id":"paper-w2971527215","cat":"papers","name":"A Three-Choice Drug Discrimination Procedure Differentiates the Stimulus Effects of d-Amphetamine and MDMA","year":"1999","cit":0,"pfa":"Amy Goodwin","ptype":"article","src":"https://openalex.org/W2971527215","eid":"W2971527215"},{"id":"paper-w2740049673","cat":"papers","name":"MDMA Increases Excitability in the Dentate Gyrus: Role of 5HT2A Receptor Induced PGE2 Signaling","year":"2016","cit":0,"pfa":"Stuart A. Collins","psa":"Bryan K. Yamamoto","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2740049673","eid":"W2740049673"},{"id":"paper-w3034396399","cat":"papers","name":"Comparison of Methamphetamine and MDMA Extended Access Self-administration: Acquisition, Maintenance, and Response Patterns","year":"2020","cit":0,"pfa":"Alex Maan","topics":["Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W3034396399","eid":"W3034396399"},{"id":"paper-w2597573673","cat":"papers","name":"ANÁLISE DO DOCUMENTÁRIO “O ACRE EXISTE”: AYAHUASCA COMO ELEMENTO DE REPRESENTAÇÃO DO ESTADO","year":"2016","cit":0,"pfa":"Leandra Beatriz Haerdrich Cunha","ptype":"article","src":"https://openalex.org/W2597573673","eid":"W2597573673"},{"id":"paper-w2283006308","cat":"papers","name":"11. Efectos a largo plazo sobre la salud mental del consumo ritual de ayahuasca","year":"2013","cit":0,"pfa":"José Carlos Bouso","psa":"Gregorio Gómez-Jarabo García","ptype":"article","src":"https://openalex.org/W2283006308","eid":"W2283006308"},{"id":"paper-w7120511509","cat":"papers","name":"Development of analytical methods for the determination of ayahuasca alkaloids in different matrices applying green analytical chemistry strategies","year":"2020","cit":0,"pfa":"Gabriela de Oliveira Silveira","topics":["Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W7120511509","eid":"W7120511509"},{"id":"paper-w4387861142","cat":"papers","name":"Development of the MDMA-Assisted Psychotherapy Side Effects Tool (M-SET): a Delphi study","year":"2026","cit":0,"pfa":"Julia Colcott","psa":"Gillinder Bedi","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4387861142","eid":"W4387861142"},{"id":"paper-w7171519526","cat":"papers","name":"Feasibility, safety and preliminary effects of ibogaine in patients with moderate and severe alcohol use disorder: a pilot, open-label study","year":"2026","cit":0,"pfa":"Juliana Mendes Rocha","psa":"RAFAEL GUIMARÃES DOS SANTOS","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7171519526","eid":"W7171519526"},{"id":"paper-w7126191588","cat":"papers","name":"Review for \"COMBINED NEUROPROTECTIVE EFFECTS OF N, N DIMETHYLTRYPTAMINE AND VENTRAL ROOT REIMPLANTATION FOLLOWING SPINAL ROOT AVULSION IN RATS\"","year":"2025","cit":0,"topics":["Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W7126191588","eid":"W7126191588"},{"id":"paper-w7106236900","cat":"papers","name":"The DMT Antenna Hypothesis: Endogenous N,N-Dimethyltryptamine as the Molecular Substrate for the Subjective \"I Am\" Across Living Systems","year":"2025","cit":0,"pfa":"Swygert, John","ptype":"article","src":"https://openalex.org/W7106236900","eid":"W7106236900"},{"id":"paper-w2029122328","cat":"papers","name":"P.6.065 MDMA-evoked changes in [11C]raclopride and [11C]NMSP binding potentials","year":"2003","cit":0,"pfa":"Pedro Rosa‐Neto","psa":"Paul D. Cumming","ptype":"article","src":"https://openalex.org/W2029122328","eid":"W2029122328"},{"id":"paper-w2026884369","cat":"papers","name":"A104 ANTI-AGGRESSIVE AND ANXIOGENIC EFFECTS OF MDMA IN AGGRESSIVE AND TIMID SINGLY HOUSED MICE","year":"2005","cit":0,"pfa":"Karel Šlais","psa":"Alexandra Šulcová","topics":["Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W2026884369","eid":"W2026884369"},{"id":"paper-w2310465856","cat":"papers","name":"THE ROLE OF AGONIST OF A2A ADENOSINE RECEPTORS ON NEUROTOXICITY OF MDMA (ECSTASY PILL) ON RAT’S HIPPOCAMPUS","year":"2011","cit":0,"pfa":"Farzaneh Mohammadzadeh","psa":"M Solimani","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2310465856","eid":"W2310465856"},{"id":"paper-w3212745693","cat":"papers","name":"Decreased Serotonin Release Capacity and Altered 5-Ht2A Receptor Density in MDMA Users","year":"2013","cit":0,"pfa":"Boris B. Quednow","psa":"Franz X. Vollenweider","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3212745693","eid":"W3212745693"},{"id":"paper-w2246185275","cat":"papers","name":"Increased Creatinine Kinase Levels due to MDMA use without Myoglobinuria and Renal Failure","year":"2015","cit":0,"pfa":"Nilüfer Eldeş","psa":"Yılmaz Yüksel","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2246185275","eid":"W2246185275"},{"id":"paper-w4313399943","cat":"papers","name":"On the Disbalance and Impairment of Serotonin Heteroreceptor Complexes in the Rat Brain After MDMA and Hallucinogens Administration","year":"2022","cit":0,"pfa":"Kjell Fuxé","psa":"Dasiel O. Borroto‐Escuela","topics":["Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W4313399943","eid":"W4313399943"},{"id":"paper-w2949406511","cat":"papers","name":"ChemInform Abstract: COMPARISON OF SOLUTION CONFORMATIONAL PREFERENCES FOR THE HALLUCINOGENS BUFOTENIN AND PSILOCIN USING 360‐MHZ PROTON NMR SPECTROSCOPY","year":"1981","cit":0,"pfa":"Gerald P. Migliaccio","psa":"David E. Nichols","ptype":"article","src":"https://openalex.org/W2949406511","eid":"W2949406511"},{"id":"paper-w7204564544","cat":"papers","name":"Biphasic Hierarchical Reorganization and Riemannian Connectomic Plasticity: A Longitudinal Precision Functional Mapping Study of Psilocybin","year":"2026","cit":0,"pfa":"Luna da Silva Nascimento","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7204564544","eid":"W7204564544"},{"id":"paper-w7143313855","cat":"papers","name":"Effects of psilocybin and related compounds on cerebroprotection during ischemic stroke (Stage 1 Registered Report)","year":"2026","cit":0,"pfa":"Ruslan Rust","psa":"Patrick Lyden","ptype":"report","src":"https://openalex.org/W7143313855","eid":"W7143313855"},{"id":"paper-w1863492705","cat":"papers","name":"Evidence of dysregulated basal functioning of the hypothalamic-pituitary-adrenal (HPA) axis in MDMA users","year":"2011","cit":0,"pfa":"Mark A Wetherell","psa":"Catherine Montgomery","topics":["Policy & ethics"],"ptype":"conference-paper","src":"https://openalex.org/W1863492705","eid":"W1863492705"},{"id":"paper-w7106311766","cat":"papers","name":"The DMT Antenna Hypothesis: Endogenous N,N-Dimethyltryptamine as the Molecular Substrate for the Subjective \"I Am\" Across Living Systems","year":"2025","cit":0,"pfa":"Swygert, John","ptype":"article","src":"https://openalex.org/W7106311766","eid":"W7106311766"},{"id":"paper-w3204852451","cat":"papers","name":"Análise quantitativa do relato dos efeitos agudos da ayahuasca em voluntários saudáveis","year":"2021","cit":0,"pfa":"Júlia da Silva Xavier","ptype":"dissertation","src":"https://openalex.org/W3204852451","eid":"W3204852451"},{"id":"paper-w7125456452","cat":"papers","name":"La Ayahuasca como recurso educativo: integración de saberes ancestrales y educación contemporánea","year":"2026","cit":0,"pfa":"Rogger Mauricio Silva Herrera","psa":"María del Rosario Vivar Sarmiento","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W7125456452","eid":"W7125456452"},{"id":"paper-w4378374321","cat":"papers","name":"NEUROTRANSMISIÓN ASOCIADA A MDMA E IMPLICACIÓN EN LA CLÍNICA, ¿HASTA DÓNDE SABEMOS?","year":"2023","cit":0,"topics":["Policy & ethics"],"ptype":"conference-paper","src":"https://openalex.org/W4378374321","eid":"W4378374321"},{"id":"paper-w2613330620","cat":"papers","name":"\"Flipping the Switch\": Connective Effect of Psilocybin Mushrooms Help Hospice Patients Enjoy End of Life","year":"2017","cit":0,"pfa":"Walden, Thomas","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2613330620","eid":"W2613330620"},{"id":"paper-w7149606263","cat":"papers","name":"Real-world evidence of patients who received psilocybin through Canada’s Special Access Program","year":"2026","cit":0,"pfa":"Jennifer Docherty","ptype":"other","src":"https://openalex.org/W7149606263","eid":"W7149606263"},{"id":"paper-w7161753513","cat":"papers","name":"Effects of low-dose psilocybin on EEG markers of sensory processing in autistic and non-autistic adults","year":"2026","cit":0,"pfa":"O. Ollari","psa":"G.M. McAlonan","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7161753513","eid":"W7161753513"},{"id":"paper-w4403152244","cat":"papers","name":"Review for \"Psilocybin reduces functional correlation and the encoding of spatial information by neurons in mouse retrosplenial cortex\"","year":"2024","cit":0,"topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4403152244","eid":"W4403152244"},{"id":"paper-w7110645337","cat":"papers","name":"Rebalancing the depressed brain: a wholebrain computational study on the effects of external perturbations in psilocybin and escitalopram treatments","year":"2024","cit":0,"pfa":"Marcel Socoro Garrigosa","topics":["Depression"],"ptype":"dissertation","src":"https://openalex.org/W7110645337","eid":"W7110645337"},{"id":"paper-w7131652481","cat":"papers","name":"MedCheck: FDA Reviews NDA for Narcolepsy Drug, Green-Lights Psilocybin Trial for PTSD, and More","year":"2026","cit":0,"pfa":"Linda M. Richmond","topics":["PTSD & trauma","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7131652481","eid":"W7131652481"},{"id":"paper-w7126263788","cat":"papers","name":"Decision letter for \"COMBINED NEUROPROTECTIVE EFFECTS OF N, N DIMETHYLTRYPTAMINE AND VENTRAL ROOT REIMPLANTATION FOLLOWING SPINAL ROOT AVULSION IN RATS\"","year":"2025","cit":0,"ptype":"peer-review","src":"https://openalex.org/W7126263788","eid":"W7126263788"},{"id":"paper-w2351825259","cat":"papers","name":"Studies on the 3,4-methylenedioxymethamphetamine (MDMA)-induced dysregulation of energy metabolism and its neurochemical consequences","year":"2005","cit":0,"pfa":"Altaf S. Darvesh","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2351825259","eid":"W2351825259"},{"id":"paper-w7128551744","cat":"papers","name":"MDMA-assisted therapy as a treatment for major depressive disorder: proof of principle study – CORRIGENDUM","year":"2026","cit":0,"pfa":"Tor-Morten Kvam","psa":"Ole A. Andreassen","topics":["Depression"],"ptype":"erratum","src":"https://openalex.org/W7128551744","eid":"W7128551744"},{"id":"paper-w4405637298","cat":"papers","name":"Changes in positive and negative affect in participants with treatment-resistant depression following COMP360 psilocybin treatment","year":"2024","cit":0,"pfa":"M.B. Young","psa":"Guy M. Goodwin","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4405637298","eid":"W4405637298"},{"id":"paper-w7204153785","cat":"papers","name":"Toward an Optimal Framework for Psilocybin Regulation: A Comparison of State Regulatory Approaches Across Key Dimensions","year":"2026","cit":0,"pfa":"Daliya Saadoon","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7204153785","eid":"W7204153785"},{"id":"paper-w2316926542","cat":"papers","name":"ChemInform Abstract: STABLE CARBONIUM IONS FROM BETA‐ARYLALKYL DERIVATIVES IN SBF5‐SO2 PART 2, IONS RELATED TO MESCALINE","year":"1974","cit":0,"pfa":"James A. Manner","psa":"Brian G. Ramsey","ptype":"article","src":"https://openalex.org/W2316926542","eid":"W2316926542"},{"id":"paper-w1979533818","cat":"papers","name":"Separation and quantitation of enantiomers of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) by gas chromatography","year":"1992","cit":0,"pfa":"Kathleen Hegadoren","psa":"Ronald T. Coutts","ptype":"article","src":"https://openalex.org/W1979533818","eid":"W1979533818"},{"id":"paper-w7111493651","cat":"papers","name":"Inappropriate antidiuretic hormone secretion and extreme rises in creatinine kinase following MDMA ingestion","year":"1995","cit":0,"pfa":"Satchell, SC","psa":"Connaughton, M","ptype":"article","src":"https://openalex.org/W7111493651","eid":"W7111493651"},{"id":"paper-w1963702417","cat":"papers","name":"S.23.01 Effects of MDMA on sociability and neural response to social threat and social reward","year":"2011","cit":0,"pfa":"Harriet de Wit","psa":"M. Kirkpatrick","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1963702417","eid":"W1963702417"},{"id":"paper-w4417475351","cat":"papers","name":"Exploring Psilocybin-Assisted Schema Therapy: A Conceptual Framework for Potential Therapeutic Synergies in Personality Disorders","year":"2026","cit":0,"pfa":"Alberto Barbieri","topics":["Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4417475351","eid":"W4417475351"},{"id":"paper-w7163364624","cat":"papers","name":"Bringing Psilocybin-Assisted Therapy to Palliative Oncology: Early Lessons from Real-World Implementation","year":"2026","cit":0,"pfa":"Michel Dorval","psa":"Jason R. Guertin","topics":["Anxiety & end-of-life","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7163364624","eid":"W7163364624"},{"id":"paper-w7168259606","cat":"papers","name":"Changes in neuroticism and values after naturalistic use of psychedelics and MDMA: A prospective survey study","year":"2026","cit":0,"pfa":"Abigail E. Calder","psa":"Gregor Hasler","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7168259606","eid":"W7168259606"},{"id":"paper-w4247283781","cat":"papers","name":"Psilocybin-induced decrease in amygdala-putamen coupling during an event-related face discrimination task","year":"2016","cit":0,"pfa":"Oliver R. Grimm","ptype":"other","src":"https://openalex.org/W4247283781","eid":"W4247283781"},{"id":"paper-w7204489102","cat":"papers","name":"Psilocybin enhances sociability only in altered behavioural state and does not need an awake experience to be effective","year":"2026","cit":0,"pfa":"Chenchen Song","psa":"Thomas Knöpfel","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7204489102","eid":"W7204489102"},{"id":"paper-w7213525747","cat":"papers","name":"Psilocybin for Depressive and Anxiety Disorders (2022–2026): Hybrid Bibliometric Analysis and Systematic Review (CRIBADO)","year":"2026","cit":0,"pfa":"Andrea Estefanía Aranda Rosas","psa":"Miguel Á. Trejo-Rodríguez","topics":["Depression","Anxiety & end-of-life","Reviews & meta-analyses"],"ptype":"other","src":"https://openalex.org/W7213525747","eid":"W7213525747"},{"id":"paper-w7206188240","cat":"papers","name":"A response to the letter to editor: Breaking the chains of depression: A systematic review and meta-analysis of psilocybin therapy","year":"2026","cit":0,"pfa":"Faheem Ahmed Khan","psa":"Siriporn Chuchawankul","topics":["Depression","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7206188240","eid":"W7206188240"},{"id":"paper-w7162677920","cat":"papers","name":"E8‑Based Neurochemical Simulation Accelerates Psilocybin Therapy for Cocaine Addiction — E8 Intelligence Research","year":"2026","cit":0,"pfa":"Andrew Stewart Caldin","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7162677920","eid":"W7162677920"},{"id":"paper-w7162669868","cat":"papers","name":"E8‑Based Neurochemical Simulation Accelerates Psilocybin Therapy for Cocaine Addiction — E8 Intelligence Research","year":"2026","cit":0,"pfa":"Andrew Stewart Caldin","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7162669868","eid":"W7162669868"},{"id":"paper-w2791069814","cat":"papers","name":"Nuevas aportaciones al mecanismo neurotóxico de la 3,4-metilendioximentanfetamina (MDMA, «éxtasis»)","year":"2001","cit":0,"pfa":"Isabel Hervías","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2791069814","eid":"W2791069814"},{"id":"paper-w7108221923","cat":"papers","name":"Short- and long-term modulation of rat prefrontal cortical activity following single doses of psilocybin","year":"2025","cit":0,"pfa":"Purple, Ross J.","psa":"Jones, Matthew W.","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7108221923","eid":"W7108221923"},{"id":"paper-w4407067985","cat":"papers","name":"Lifetime Psilocybin Use and Opioid Use Disorder in Pregnant and Non-Pregnant Women of Reproductive Age","year":"2025","cit":0,"pfa":"Amanda L. Elmore","psa":"Mirine Richey","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4407067985","eid":"W4407067985"},{"id":"paper-w4413284317","cat":"papers","name":"620. IDENTIFICATION OF BLOOD BIOMARKERS OF PSILOCYBIN-ASSISTED THERAPY TREATMENT RESPONSE FOR GENERALISED ANXIETY DISORDER","year":"2025","cit":0,"pfa":"A Gibbons","psa":"Suresh Sundram","topics":["Anxiety & end-of-life","Safety & adverse events"],"ptype":"conference-abstract","src":"https://openalex.org/W4413284317","eid":"W4413284317"},{"id":"paper-w67261116","cat":"papers","name":"Ayahuasca: Tradición, nuevas aplicaciones y futuro: V Jornadas Internacionales sobre Enteógenos en Barcelona","year":"2002","cit":0,"pfa":"José T. Gállego","ptype":"article","src":"https://openalex.org/W67261116","eid":"W67261116"},{"id":"paper-w3110447307","cat":"papers","name":"Genetische und biochemische Grundlage der Indolalkaloidbildung in Basidiomyceten und biotechnologische Produktion des Psilocybins","year":"2020","cit":0,"pfa":"Janis Fricke","ptype":"dissertation","src":"https://openalex.org/W3110447307","eid":"W3110447307"},{"id":"paper-w7204911593","cat":"papers","name":"Daily Psilocybin Microdosing as a Receptor-Adaptation Paradigm: A Testable 5-HT2A Down-Regulation Hypothesis","year":"2026","cit":0,"pfa":"Andrea Vittorini","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7204911593","eid":"W7204911593"},{"id":"paper-w2606454784","cat":"papers","name":"ChemInform Abstract: CHLORIERTE 2‐HYDROXY‐ UND 2‐METHOXY‐PHENOXYAETHYLAMINE, ANALOGA VON PSILOCYBIN","year":"1971","cit":0,"pfa":"Marc Julià","psa":"JOEL DE ROSNAY","ptype":"article","src":"https://openalex.org/W2606454784","eid":"W2606454784"},{"id":"paper-w7124770112","cat":"papers","name":"The Effect of Psilocybin on Cortical Neural Dynamics, Sleep-Wake Behavior, and Persistent Pain in a Rat Model","year":"2025","cit":0,"pfa":"Nicholas Kolbman","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"dissertation","src":"https://openalex.org/W7124770112","eid":"W7124770112"},{"id":"paper-w7147601482","cat":"papers","name":"Psilocybin and Emotional Breakthough: An Umbrella Review and Theoretical Integration [SCIENTIFIC V5.0 - Q1 HIGH-IMPACT]","year":"2026","cit":0,"pfa":"Juan Moises de la Serna","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7147601482","eid":"W7147601482"},{"id":"paper-w4409857782","cat":"papers","name":"Calcium Activation Mechanism of a Noncanonical Aromatic L-Amino Acid Decarboxylase from Psilocybin Mushroom","year":"2025","cit":0,"pfa":"Yi Wang","psa":"Jing‐Ke Weng","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4409857782","eid":"W4409857782"},{"id":"paper-w7167496298","cat":"papers","name":"The need for another tool: Australian healthcare professionals on the use of psilocybin for existential distress in people with cancer","year":"2026","cit":0,"pfa":"Hannah Adler","psa":"S Grant","topics":["Anxiety & end-of-life","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7167496298","eid":"W7167496298"},{"id":"paper-w7212073939","cat":"papers","name":"444. In depth behavioral phenotyping of sex-dependent consequences of maternal separation in mice and effects of psilocybin","year":"2026","cit":0,"pfa":"J. Mingardi","psa":"L Musazzi","topics":["PTSD & trauma","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7212073939","eid":"W7212073939"},{"id":"paper-w4417203101","cat":"papers","name":"Age and Cannabis Co-Use Are Associated with Differences in Experience and Perceived Benefits of Psilocybin: A Retrospective Study","year":"2026","cit":0,"pfa":"Jake Hooper","psa":"Kent E. Hutchison","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4417203101","eid":"W4417203101"},{"id":"paper-w7126271361","cat":"papers","name":"Review for \"COMBINED NEUROPROTECTIVE EFFECTS OF N, N DIMETHYLTRYPTAMINE AND VENTRAL ROOT REIMPLANTATION FOLLOWING SPINAL ROOT AVULSION IN RATS\"","year":"2025","cit":0,"topics":["Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W7126271361","eid":"W7126271361"},{"id":"paper-w4408294173","cat":"papers","name":"Revealing Changes in Linear and Nonlinear Functional Connectivity After Psilocybin and Escitalopram Treatment in Patients with Depression","year":"2025","cit":0,"pfa":"Shaun K.L. Quah","psa":"Manish Saggar","topics":["Depression","Mechanism & neuroscience","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4408294173","eid":"W4408294173"},{"id":"paper-w7155487356","cat":"papers","name":"“Large-Scale and Local Functional Connectivity Changes Following Psilocybin Administration in Methamphetamine Use Disorder","year":"2026","cit":0,"pfa":"Joga Chaganti","psa":"Jonathan Brett","topics":["Addiction","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7155487356","eid":"W7155487356"},{"id":"paper-w7112012766","cat":"papers","name":"Impact of modulating hippocampal dentate gyrus adult-born cells in the context of depression and Psilocybin treatment","year":"2024","cit":0,"pfa":"Ferraz, Ana Luísa Marques","topics":["Depression"],"ptype":"dissertation","src":"https://openalex.org/W7112012766","eid":"W7112012766"},{"id":"paper-w7211927759","cat":"papers","name":"Psilocybin for Depressive and Anxiety Disorders (2022–2026): Hybrid Bibliometric Analysis and Systematic Review (CRIBADO)","year":"2026","cit":0,"pfa":"Andrea Estefanía Aranda Rosas","psa":"Miguel Á. Trejo-Rodríguez","topics":["Depression","Anxiety & end-of-life","Reviews & meta-analyses"],"ptype":"other","src":"https://openalex.org/W7211927759","eid":"W7211927759"},{"id":"paper-w4248543520","cat":"papers","name":"P.188 Long-term effects of psilocybin on cerebral serotonin 2A receptor levels and personality","year":"2019","cit":0,"pfa":"Mie Madsen","psa":"Gitte M. Knudsen","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4248543520","eid":"W4248543520"},{"id":"paper-w4413541602","cat":"papers","name":"Does psilocybin really provide long-term relief from depression, as new study suggests?","year":"2024","cit":0,"pfa":"Johan Lundberg","psa":"Guusje Haver","topics":["Depression"],"ptype":"other","src":"https://openalex.org/W4413541602","eid":"W4413541602"},{"id":"paper-w4223612605","cat":"papers","name":"Plausible Mechanism in Prevention/Reversal of Oral Psychosomatic Disorders vis-à-vis Endogenous Secretion of N, N-Dimethyltryptamine","year":"2022","cit":0,"pfa":"Khalil Ibrahim Assiri","psa":"Abdullah Alqarni","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4223612605","eid":"W4223612605"},{"id":"paper-w4233398028","cat":"papers","name":"Suppression of 5-methoxy-N,N-dimethyltryptamine(5-MeODHT)-induced head twitches in hyperammonemic state of mice","year":"1992","cit":0,"pfa":"Takao Shimizu","psa":"Takeo Fukuda","ptype":"article","src":"https://openalex.org/W4233398028","eid":"W4233398028"},{"id":"paper-w4417172012","cat":"papers","name":"Gut–Mind Interactions in Psychedelic Healing: A Case Study Assessing the Effects of Huachuma and Ayahuasca on the Mind and Microbiome","year":"2025","cit":0,"pfa":"Payton Follestad","psa":"Heather L. Zwickey","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4417172012","eid":"W4417172012"},{"id":"paper-w4403152368","cat":"papers","name":"Review for \"Psilocybin reduces functional correlation and the encoding of spatial information by neurons in mouse retrosplenial cortex\"","year":"2024","cit":0,"topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4403152368","eid":"W4403152368"},{"id":"paper-w7117234728","cat":"papers","name":"Data: Evolution and horizontal transfer of the psilocybin biosynthetic gene cluster drive the diversification of magic mushrooms","year":"2025","cit":0,"pfa":"Fei Liu","topics":["Therapy practice","Policy & ethics"],"ptype":"dataset","src":"https://openalex.org/W7117234728","eid":"W7117234728"},{"id":"paper-w7148684203","cat":"papers","name":"Neural Entropy and Cognitive Flexibility: A Research Agenda for Psilocybin-Assisted Therapy [FUTURE DIRECTIONS v1.0]","year":"2026","cit":0,"pfa":"Juan Moisés de la Serna","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7148684203","eid":"W7148684203"},{"id":"paper-w7117124167","cat":"papers","name":"Recommendations and Consensus Statements on Psilocybin-Assisted Psychotherapy (PAP) for Depression: A Rapid Review and Thematic Analysis","year":"2025","cit":0,"pfa":"Aimee Freeburn","psa":"Simon Bell","topics":["Depression","Reviews & meta-analyses","Therapy practice"],"ptype":"other","src":"https://openalex.org/W7117124167","eid":"W7117124167"},{"id":"paper-w3003482269","cat":"papers","name":"P.324 Acute effects of psilocybin on glutamate concentration levels, functional connectivity and subjective state","year":"2020","cit":0,"pfa":"Natasha Leigh Mason","psa":"Johannes Gerardus Ramaekers","ptype":"article","src":"https://openalex.org/W3003482269","eid":"W3003482269"},{"id":"paper-w3161341351","cat":"papers","name":"‘Is There Magic in These Mushrooms?’ Discussing Current Psychiatric Treatment Options, and the Potential of Psilocybin Mushrooms in the Future of Such Treatments","year":"2021","cit":0,"pfa":"Sasha Faichuk","ptype":"article","src":"https://openalex.org/W3161341351","eid":"W3161341351"},{"id":"paper-w7204891799","cat":"papers","name":"Beyond Efficacy Signals: Regulatory, Methodological, and Translational Challenges in Clinical Research on Ketamine and Psilocybin in Psychiatry","year":"2026","cit":0,"pfa":"Damian Świeczkowski","psa":"Wiesław Jerzy Cubała","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7204891799","eid":"W7204891799"},{"id":"paper-w7204928610","cat":"papers","name":"Daily Psilocybin Microdosing as a Receptor-Adaptation Paradigm: A Testable 5-HT2A Down-Regulation Hypothesis","year":"2026","cit":0,"pfa":"Andrea Vittorini","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7204928610","eid":"W7204928610"},{"id":"paper-w7106005943","cat":"papers","name":"Cost-Effectiveness of Psilocybin-Assisted Therapy versus Standard of Care for Patients with Treatment-Resistant Depression","year":"2025","cit":0,"pfa":"Yosr Ziadi","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7106005943","eid":"W7106005943"},{"id":"paper-w7164519137","cat":"papers","name":"EEG microstate dynamics during psilocybin intoxication relate to acute experience and persisting psychological changes","year":"2026","cit":0,"pfa":"Nikola Jajcay","psa":"Tomáš Páleníček","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7164519137","eid":"W7164519137"},{"id":"paper-w7204873279","cat":"papers","name":"Surrender, disidentification, and reappraisal: a qualitative comparison of psilocybin responders and non-responders in treatment-resistant OCD","year":"2026","cit":0,"pfa":"Gabrielle Agin-Liebes","psa":"Benjamin Kelmendi","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7204873279","eid":"W7204873279"},{"id":"paper-w2607318479","cat":"papers","name":"ChemInform Abstract: AUFTRETEN DES PSYCHOTOMIMETISCHEN AGENS PSILOCYBIN IN DEM AUSTRALISCHEN BLAETTERPILZ PSILOCYBE SUBAERUGINOSA","year":"1970","cit":0,"pfa":"J. PICKER","psa":"R. W. RICKARDS","ptype":"article","src":"https://openalex.org/W2607318479","eid":"W2607318479"},{"id":"paper-w7163564850","cat":"papers","name":"Correction to: Preliminary Evidence of Sleep Improvements Following Psilocybin Administration, and their Involvement in Antidepressant Therapeutic Action","year":"2026","cit":0,"pfa":"Matthew J. Reid","psa":"Robin Lester Carhart-Harris","topics":["Depression"],"ptype":"erratum","src":"https://openalex.org/W7163564850","eid":"W7163564850"},{"id":"paper-w4390824805","cat":"papers","name":"MicroRNAs underlying the antidepressant effect of psilocybin – Establishing an nCounter pipeline for microRNA-quantification in the pig brain","year":"2024","cit":0,"pfa":"Erik Kaadt","psa":"Betina Elfving","topics":["Depression"],"ptype":"preprint","src":"https://openalex.org/W4390824805","eid":"W4390824805"},{"id":"paper-w3020595643","cat":"papers","name":"Investigations into the mechanism by which 3,4-methylenedioxymethamphetamine (MDMA) induces degeneration of selective serotonergic terminals","year":"1994","cit":0,"pfa":"Jon E. Sprague","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W3020595643","eid":"W3020595643"},{"id":"paper-w4230665912","cat":"papers","name":"Faculty Opinions recommendation of Neural correlates of MDMA (\"Ecstasy\")-induced social interaction in rats.","year":"2008","cit":0,"pfa":"Harriet de Wit","psa":"Gillinder Bedi","topics":["Mechanism & neuroscience"],"ptype":"peer-review","src":"https://openalex.org/W4230665912","eid":"W4230665912"},{"id":"paper-w1946405112","cat":"papers","name":"Effects of auditory and thermal stimuli on 3,4 -methylenedioxymethamphetamine (MDMA) -induced neurochemical and behavioral responses","year":"2009","cit":0,"pfa":"Allison A. Feduccia","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1946405112","eid":"W1946405112"},{"id":"paper-w4402361333","cat":"papers","name":"Too big to fail? Comparing effect sizes of MDMA assisted therapy to unmasking bias","year":"2024","cit":0,"pfa":"Balázs Szigeti","psa":"Joshua D. Woolley","topics":["PTSD & trauma"],"ptype":"preprint","src":"https://openalex.org/W4402361333","eid":"W4402361333"},{"id":"paper-w2335873470","cat":"papers","name":"CRECIMIENTO DE PLANTAS REGENERADAS IN VITRO DE PEYOTE (Lophophora diffusa CROIZAT (BRAVO) EN MEZCLA DE SUSTRATOS AGRÍCOLAS","year":"2016","cit":0,"pfa":"S.L.F Sánchez","psa":"Estefana Alvarado Bárcenas","ptype":"article","src":"https://openalex.org/W2335873470","eid":"W2335873470"},{"id":"paper-w7135493464","cat":"papers","name":"Koma-ulykke burde være undgået: ekspert advarer mod ayahuasca ceremonier i ukyndige hænder","year":"2020","cit":0,"pfa":"Jesper Andreasen T.","ptype":"article","src":"https://openalex.org/W7135493464","eid":"W7135493464"},{"id":"paper-w7153852731","cat":"papers","name":"Data and code for: Cultural computation in psychoactive traditions: ceremony-pharmacokinetic calibration, admixture selection, and the discovery of ayahuasca","year":"2026","cit":0,"pfa":"Elliot Allan","topics":["Dosing & pharmacology"],"ptype":"dataset","src":"https://openalex.org/W7153852731","eid":"W7153852731"},{"id":"paper-w2913021657","cat":"papers","name":"P.2.23 MDMA self-administration is abolished in serotonin transporter knock-out mice","year":"2007","cit":0,"pfa":"J.M. Trigo-Díaz","psa":"R. Maldonado","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2913021657","eid":"W2913021657"},{"id":"paper-w1783204555","cat":"papers","name":"Ayahuasca, qualidade de vida e a esperança de adictos em recuperação: relatos de caso","year":"2015","cit":0,"pfa":"Tenes Dias de Jesus Júnior","psa":"Dilson Henrique Ramos Evangelista","ptype":"article","src":"https://openalex.org/W1783204555","eid":"W1783204555"},{"id":"paper-w7211985602","cat":"papers","name":"A Transformer-Based Delta Expression Encoder for Psilocybin Transcriptional Response: Architecture, Representations, and Biological Validation","year":"2026","cit":0,"pfa":"Sai Jayakumar","topics":["Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W7211985602","eid":"W7211985602"},{"id":"paper-w4390222237","cat":"papers","name":"Change in whole blood BDNF after escitalopram or psilocybin intervention in patients with depression and healthy controls","year":"2023","cit":0,"pfa":"Miriam L. Navarro","psa":"Gitte M. Knudsen","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4390222237","eid":"W4390222237"},{"id":"paper-w4403152381","cat":"papers","name":"Review for \"Psilocybin reduces functional correlation and the encoding of spatial information by neurons in mouse retrosplenial cortex\"","year":"2024","cit":0,"topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4403152381","eid":"W4403152381"},{"id":"paper-w4402559755","cat":"papers","name":"Exploring U.K. cancer doctors’ attitudes toward psilocybin-assisted psychotherapy for cancer-related distress","year":"2024","cit":0,"pfa":"Shane Mageean","psa":"Sara Jane Tai","topics":["Anxiety & end-of-life","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4402559755","eid":"W4402559755"},{"id":"paper-w2268481641","cat":"papers","name":"El uso terapéutico de la ayahuasca en la rehabilitación de presidiarios en Brasil","year":"2015","cit":0,"pfa":"RAFAEL GUIMARÃES DOS SANTOS","ptype":"article","src":"https://openalex.org/W2268481641","eid":"W2268481641"},{"id":"paper-w3116894059","cat":"papers","name":"The psychedelic compound psilocybin may ‘reset’ the brain to help manage treatment-resistant major depression","year":"2019","cit":0,"pfa":"Robin Lester Carhart-Harris","psa":"David John Nutt","topics":["Depression"],"ptype":"preprint","src":"https://openalex.org/W3116894059","eid":"W3116894059"},{"id":"paper-w7141776293","cat":"papers","name":"Real-world evidence of patients who received psilocybin through Canada’s Special Access Program","year":"2026","cit":0,"pfa":"Jennifer Docherty","ptype":"preprint","src":"https://openalex.org/W7141776293","eid":"W7141776293"},{"id":"paper-w7215065028","cat":"papers","name":"Reduced egocentricity after psilocybin in patients with alcohol use disorder: a pilot randomized controlled trial","year":"2026","cit":0,"pfa":"Henryk Bukowski","psa":"Amandine Luquiens","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7215065028","eid":"W7215065028"},{"id":"paper-w7120495349","cat":"papers","name":"Pharmacological effects of the main active compounds of ayahuasca on anxious type behaviors and memory in zebrafish (Danio rerio)","year":"2023","cit":0,"pfa":"Hector David Quinones Vargas","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"dissertation","src":"https://openalex.org/W7120495349","eid":"W7120495349"},{"id":"paper-w3092247482","cat":"papers","name":"Psilocybin as an Effective Treatment for Patients with Life-Threatening Cancer and Psychological Distress: A Critically Appraised Topic","year":"2020","cit":0,"pfa":"Callie Munson","psa":"Elyse Sunshine","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3092247482","eid":"W3092247482"},{"id":"paper-w4410069603","cat":"papers","name":"Mycelial Conceptions of Being and Well-Being: Reconciling Paradigmatic Tensions Within Psilocybin Healing Spaces","year":"2025","cit":0,"pfa":"Camila Itzel Espinosa-Short","ptype":"preprint","src":"https://openalex.org/W4410069603","eid":"W4410069603"},{"id":"paper-w7202138867","cat":"papers","name":"Temporal effects of a single oral dose of psilocybin on plasma circulating miRNAs in healthy young adults","year":"2026","cit":0,"pfa":"Aedan O'Shea","psa":"Julian Krauskopf","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W7202138867","eid":"W7202138867"},{"id":"paper-w4401734470","cat":"papers","name":"Current Trends in Psychedelic Science: Integrating Modified Lysergic Acid Derivatives and Psilocybin in Modern Medicine","year":"2024","cit":0,"pfa":"Robert B. Kargbo","topics":["Dosing & pharmacology"],"ptype":"editorial","src":"https://openalex.org/W4401734470","eid":"W4401734470"},{"id":"paper-w4402898466","cat":"papers","name":"Psilocybin-induzierte mystische Erfahrungen in subjektiven Berichten: Ein Scoping Review mit qualitativer Inhaltsanalyse.","year":"2024","cit":0,"pfa":"Anna Graue","psa":"Lisa Emily Richter","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4402898466","eid":"W4402898466"},{"id":"paper-w7162471438","cat":"papers","name":"Psilocybin induces stereotyped movements and reduces defensive responding in planarians through 5-hydroxytryptamine mechanisms","year":"2026","cit":0,"pfa":"Razeen J Akbar","psa":"Scott M. Rawls","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7162471438","eid":"W7162471438"},{"id":"paper-w7168253338","cat":"papers","name":"Psilocybin-Assisted Early Palliative Care for Demoralization and Chronic Pain: An Open-Label Pilot Study","year":"2026","cit":0,"pfa":"Ali John Zarrabi","psa":"Boadie Waid Dunlop","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7168253338","eid":"W7168253338"},{"id":"paper-w578194167","cat":"papers","name":"GC-MS Studies on Methoxymethylene- Substituted Phenethylamines Related to MDA, MDMA, MDEA and MDMMA","year":"2012","cit":0,"pfa":"Yu Ning","ptype":"dissertation","src":"https://openalex.org/W578194167","eid":"W578194167"},{"id":"paper-w4414394838","cat":"papers","name":"The fatal consequences of chemsex, as exemplified by MDMA and sildenafil poisoning (“sexstasy”) from Upper Silesia","year":"2025","cit":0,"pfa":"Rafał Skowronek","ptype":"article","src":"https://openalex.org/W4414394838","eid":"W4414394838"},{"id":"paper-w3202165123","cat":"papers","name":"Reseña de \"O uso ritualda ayahuasca\".B. C. Labate e W. S. Araujo","year":"2003","cit":0,"pfa":"Edmundo Marcelo Mendes Pereira","ptype":"article","src":"https://openalex.org/W3202165123","eid":"W3202165123"},{"id":"paper-w3098668686","cat":"papers","name":"O uso da ayahuasca em rituais religiosos como patrimônio cultural imaterial do Brasil","year":"2016","cit":0,"pfa":"Cecília Grangeiro y Martin","ptype":"article","src":"https://openalex.org/W3098668686","eid":"W3098668686"},{"id":"paper-w4417429371","cat":"papers","name":"The Santo Daime without Daime Tactics, Agency, and Ritual Change in Ayahuasca Religions under Prohibition in Italy","year":"2025","cit":0,"pfa":"Piera Talin","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4417429371","eid":"W4417429371"},{"id":"paper-w2342704411","cat":"papers","name":"CONSTITUIÇÃO E PLURALISMO: A PROTEÇÃO DO USO RITUAL DA AYAHUASCA (DAIME) PELA LIBERDADE RELIGIOSA","year":"2014","cit":0,"pfa":"Jair Araújo Facundes","ptype":"article","src":"https://openalex.org/W2342704411","eid":"W2342704411"},{"id":"paper-w7215190692","cat":"papers","name":"DOCUMENTOS: PAÍSES BAJOS - HIGH COURT - SENTENCIA - Prohibición de importar ayahuasca con fines religiosos","year":"2023","cit":0,"pfa":"Equipo Editorial- Boletín Jurídico Observatorio de libertad religiosa de…","ptype":"article","src":"https://openalex.org/W7215190692","eid":"W7215190692"},{"id":"paper-w3103633987","cat":"papers","name":"Pre- and post-synaptic effects of 5-hydroxytryptamine and 5-methoxy-N, N-dimethyltryptamine in the guinea-pig vas deferens","year":"1984","cit":0,"pfa":"Soichi Yoshida","psa":"Tetsurō Kuga","ptype":"article","src":"https://openalex.org/W3103633987","eid":"W3103633987"},{"id":"paper-w7120824100","cat":"papers","name":"Omics approaches in analysis of samples with associated traditional knowledge : Ayahuasca and Psychotria viridis leaves Ruiz & Pav","year":"2024","cit":0,"pfa":"Taynara Simão Matos","ptype":"dissertation","src":"https://openalex.org/W7120824100","eid":"W7120824100"},{"id":"paper-w4408220578","cat":"papers","name":"Ayahuasca Mitigates Morphological Cortical Alterations in Juvenile Non-human Primates Following Chronic Stress Exposure","year":"2025","cit":0,"pfa":"Expedito do Nascimento Júnior","psa":"Nicole Galvao Coelho","ptype":"preprint","src":"https://openalex.org/W4408220578","eid":"W4408220578"},{"id":"paper-w4403272071","cat":"papers","name":"Does psilocybin reduce symptoms of depression in adults with major depressive disorder or life-threatening cancer?","year":"2024","cit":0,"pfa":"Morgan Justin","psa":"Kerry Watrin","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4403272071","eid":"W4403272071"},{"id":"paper-w7162242232","cat":"papers","name":"From therapeutic promise to evidentiary discipline: Reassessing MDMA‐assisted psychotherapy for posttraumatic stress disorder","year":"2026","cit":0,"pfa":"Kadek Suhardita","psa":"Agung Slamet Kusmanto","topics":["PTSD & trauma","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7162242232","eid":"W7162242232"},{"id":"paper-w7148801419","cat":"papers","name":"Neural Entropy and Cognitive Flexibility: A Research Agenda for Psilocybin-Assisted Therapy [FUTURE DIRECTIONS v1.0]","year":"2026","cit":0,"pfa":"Juan Moisés de la Serna","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7148801419","eid":"W7148801419"},{"id":"paper-w7204481116","cat":"papers","name":"“Am I a candidate for magic mushrooms?” A mystery shopper study of Oregon psilocybin service centers","year":"2026","cit":0,"pfa":"Danielle R. Adams","psa":"Kevin Young Xu","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7204481116","eid":"W7204481116"},{"id":"paper-w2031616537","cat":"papers","name":"P.6.d.011 Gender differences in effects of MDMA, cannabinoid agonist and their combinations in mice","year":"2006","cit":0,"pfa":"Jana Kučerová","psa":"Alexandra Šulcová","ptype":"article","src":"https://openalex.org/W2031616537","eid":"W2031616537"},{"id":"paper-w2527227617","cat":"papers","name":"Bracelets peyote : le kit : techniques, modèles, perles et fils / Agnès Delage-Calvet ; photographies de Richard Boutin","year":"2015","cit":0,"pfa":"Agnès Delage-Calvet","psa":"Richard Boutin","ptype":"article","src":"https://openalex.org/W2527227617","eid":"W2527227617"},{"id":"paper-w2784709717","cat":"papers","name":"MDMA and mephedrone: current psychobiological models of ‘Ecstasy’ and ‘m-cat’, and future human research needs.","year":"1970","cit":0,"pfa":"Andrew Parrott","ptype":"article","src":"https://openalex.org/W2784709717","eid":"W2784709717"},{"id":"paper-w2299820308","cat":"papers","name":"Comparison of extraction procedures for the extraction of organic impurities from seized 3,4-methylenedioxymethamphetamine (MDMA) tablets","year":"2009","cit":0,"pfa":"Meisinger, Sarah Christine","ptype":"dissertation","src":"https://openalex.org/W2299820308","eid":"W2299820308"},{"id":"paper-w4390593118","cat":"papers","name":"Review for \"Psilocybin as a lead candidate molecule in preclinical therapeutic studies of psychiatric disorders: A systematic review\"","year":"2023","cit":0,"topics":["Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4390593118","eid":"W4390593118"},{"id":"paper-w7142651643","cat":"papers","name":"Effects of psilocybin and related compounds on cerebroprotection during ischemic stroke (Stage 1 Registered Report)","year":"2026","cit":0,"pfa":"Ruslan Rust","psa":"Patrick Lyden","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"report","src":"https://openalex.org/W7142651643","eid":"W7142651643"},{"id":"paper-w7126208532","cat":"papers","name":"Decision letter for \"COMBINED NEUROPROTECTIVE EFFECTS OF N, N DIMETHYLTRYPTAMINE AND VENTRAL ROOT REIMPLANTATION FOLLOWING SPINAL ROOT AVULSION IN RATS\"","year":"2026","cit":0,"ptype":"peer-review","src":"https://openalex.org/W7126208532","eid":"W7126208532"},{"id":"paper-w3143980515","cat":"papers","name":"6,5-Fused Ring, C2-Salvinorin Ester, Dual Kappa and Mu Opioid Receptor Agonists as Analgesics Devoid of Anxiogenic Effects","year":"2021","cit":0,"pfa":"Nicholas S. Akins","psa":"Hoang V. Le","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W3143980515","eid":"W3143980515"},{"id":"paper-w7126162539","cat":"papers","name":"Decision letter for \"COMBINED NEUROPROTECTIVE EFFECTS OF N, N DIMETHYLTRYPTAMINE AND VENTRAL ROOT REIMPLANTATION FOLLOWING SPINAL ROOT AVULSION IN RATS\"","year":"2025","cit":0,"ptype":"peer-review","src":"https://openalex.org/W7126162539","eid":"W7126162539"},{"id":"paper-w4412846525","cat":"papers","name":"Symbiotic Ally: An overview of ayahuasca research in mental health and how new technology can bridge gaps","year":"2025","cit":0,"pfa":"Sean T. Manion","ptype":"report","src":"https://openalex.org/W4412846525","eid":"W4412846525"},{"id":"paper-w7213658873","cat":"papers","name":"Single ayahuasca administration mitigates long-term behavioral and neurochemical effects of early-life stress in rats","year":"2026","cit":0,"pfa":"Guilherme Lodetti","psa":"Eduardo Pacheco Rico","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7213658873","eid":"W7213658873"},{"id":"paper-w2044082601","cat":"papers","name":"Age modulates the long-term but not the acute effects of the serotonergic neurotoxicant 3,4-methvlenedioxymeth-amphetamine (MDMA)","year":"1995","cit":0,"pfa":"Harry W. Broening","ptype":"article","src":"https://openalex.org/W2044082601","eid":"W2044082601"},{"id":"paper-w4390592736","cat":"papers","name":"Decision letter for \"Psilocybin as a lead candidate molecule in preclinical therapeutic studies of psychiatric disorders: A systematic review\"","year":"2023","cit":0,"topics":["Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4390592736","eid":"W4390592736"},{"id":"paper-w3007062767","cat":"papers","name":"Angioedema por MDMA mediado por bradiquinina. Papel del acetato de icatibant","year":"2020","cit":0,"pfa":"Francesc del Baño","psa":"F. Escolano","ptype":"article","src":"https://openalex.org/W3007062767","eid":"W3007062767"},{"id":"paper-w4287141354","cat":"papers","name":"The gluco-regulatory effects of 3,4- Methylenedioxymethamphetamine (MDMA): A controlled n-of-2 self-experimentation","year":"2021","cit":0,"pfa":"Harriet A. Carroll","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4287141354","eid":"W4287141354"},{"id":"paper-w7104468878","cat":"papers","name":"MDMA-Assisted Internal Family Systems Therapy for Eating Disorders: An Observational Pilot Study","year":"2025","cit":0,"pfa":"Tahseen, Ahmed","psa":"Burmester, Victoria","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"other","src":"https://openalex.org/W7104468878","eid":"W7104468878"},{"id":"paper-w7145939202","cat":"papers","name":"MDMA induces cardiac contractile dysfunction through autophagy upregulation and lysosome destabilization in rats.","cit":0,"pfa":"元三 竹村","topics":["Policy & ethics"],"ptype":"other","src":"https://openalex.org/W7145939202","eid":"W7145939202"},{"id":"paper-w2168990123","cat":"papers","name":"Farmacología clínica de la Metilenodioximetanfetamina (MDMA, éxtasis) tras su administración a dosis repetidas","year":"2001","cit":0,"pfa":"Àngels Tomillero Alemany","ptype":"dissertation","src":"https://openalex.org/W2168990123","eid":"W2168990123"},{"id":"paper-w4220743600","cat":"papers","name":"Investigating cue-reactivity as biomarker for treatment success in psilocybin-assisted therapy for alcohol use disorder","year":"2022","cit":0,"pfa":"Nathalie M. Rieser","psa":"Katrin H. Preller","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4220743600","eid":"W4220743600"},{"id":"paper-w7127978410","cat":"papers","name":"Calcium Activation Mechanism of a Noncanonical Aromatic L-Amino Acid Decarboxylase from Psilocybin Mushroom","year":"2026","cit":0,"pfa":"Erin. E. Reynolds","psa":"Jing‐Ke Weng","topics":["Mechanism & neuroscience"],"ptype":"dataset","src":"https://openalex.org/W7127978410","eid":"W7127978410"},{"id":"paper-w4388090409","cat":"papers","name":"Chili Drugs: Methylenedioxymethamphetamine (MDMA), Gamma Hydroxybutyrate (GHB), Ketamine, and Agents Taken in Similar Patterns","year":"2004","cit":0,"pfa":"Gail D. Winger","psa":"Frederick G Hofmann","topics":["Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W4388090409","eid":"W4388090409"},{"id":"paper-w7214395583","cat":"papers","name":"No lasting effects of moderate doses of MDMA (Ecstasy) on memory performance and mood states in healthy humans","year":"2026","cit":0,"pfa":"Stephan Ludewig","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7214395583","eid":"W7214395583"},{"id":"paper-w4394434489","cat":"papers","name":"Psychedelics for treatment resistant depression: are they game changers?","year":"2023","cit":0,"pfa":"Michail Kalfas","psa":"Allan Hunter Young","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"dataset","src":"https://openalex.org/W4394434489","eid":"W4394434489"},{"id":"paper-w2899209583","cat":"papers","name":"A imunidade tributária de imóveis destinados ao plantio dos vegetais que compõem chá Ayahuasca","year":"2011","cit":0,"pfa":"João Paulo de Abreu Peçanha Lós","ptype":"article","src":"https://openalex.org/W2899209583","eid":"W2899209583"},{"id":"paper-w1805153526","cat":"papers","name":"Marcelo S. Mercante. Imagens de cura: Ayahuasca, imaginação, saúde e doença na Barquinha","year":"2013","cit":0,"pfa":"Alvaro Antonio Russo Júnior","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1805153526","eid":"W1805153526"},{"id":"paper-w7119329513","cat":"papers","name":"Música no neoxamanismo de ayahuasca: as cerimônias da Sétima Lua e do Voo da Águia","year":"2017","cit":0,"pfa":"Christian Alberto Weik","ptype":"dissertation","src":"https://openalex.org/W7119329513","eid":"W7119329513"},{"id":"paper-w4206712105","cat":"papers","name":"EL BOOM DE LA AYAHUASCA. A PROPÓSITO DE UN CASO. A PROPÓSITO DE UN CASO","year":"2021","cit":0,"topics":["Mechanism & neuroscience"],"ptype":"conference-paper","src":"https://openalex.org/W4206712105","eid":"W4206712105"},{"id":"paper-w7172285065","cat":"papers","name":"Efeito do tratamento do extrato bruto de ayahuasca em cultura de astrócitos humanos","year":"2026","cit":0,"pfa":"Rebecca Rodrigues","ptype":"dissertation","src":"https://openalex.org/W7172285065","eid":"W7172285065"},{"id":"paper-w7117961846","cat":"papers","name":"Relationship between cardiovascular effects and psychedelic experiences under psilocybin in patients with treatment-resistant depression","year":"2026","cit":0,"pfa":"L. Puhl","psa":"Moritz Spangemacher","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7117961846","eid":"W7117961846"},{"id":"paper-w2249217438","cat":"papers","name":"19. Experiencia de un tratamiento con ayahuasca para las drogodependencias en al amazonia brasileña","year":"2013","cit":0,"pfa":"Xavier Fernández Berges","psa":"Josep María Fábregas","ptype":"article","src":"https://openalex.org/W2249217438","eid":"W2249217438"},{"id":"paper-w3100554197","cat":"papers","name":"Effect of TRH, 5-HTP and 5-methoxy-N,N-dimethyltryptamine on spinal reflexes in 5,6-dihydroxytryptamine-treated rats","year":"1986","cit":0,"pfa":"Nobuo Nagano","psa":"Hideomi Fukuda","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3100554197","eid":"W3100554197"},{"id":"paper-w7161827243","cat":"papers","name":"Self-reported benefits and harms of microdosing with natural psilocybin: preliminary results from a naturalistic study","year":"2026","cit":0,"pfa":"Iva Totomanova","psa":"K.P.C. Kuypers","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7161827243","eid":"W7161827243"},{"id":"paper-w4410522192","cat":"papers","name":"A pilot study investigating naturally occurring dimethyltryptamine (DMT) and related psychoactive substances in Western Australian Acacia (Fabaceae: Mimosoideae)","year":"2025","cit":0,"pfa":"Richard Donovan","psa":"Kelly Anne Shepherd","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4410522192","eid":"W4410522192"},{"id":"paper-w4233342960","cat":"papers","name":"Genetic deletion of Rhes increases susceptibility to the neuroinflammatory and dopaminergic neurotoxic effects of 3,4-methylenedioxymethamphetamine (MDMA)","year":"2018","cit":0,"pfa":"Micaela Morelli","psa":"Giulia Costa","ptype":"other","src":"https://openalex.org/W4233342960","eid":"W4233342960"},{"id":"paper-w2491960373","cat":"papers","name":"DIFFERENCES BETWEEN AMINE OXIDASES DEAMINATING THE STRUCTURALLY RELATED 3:4:5 - TRIMETHOXYPHENETHYLAMINE (MESCALINE) AND 3:4 - DIMETHOXYPHENETHYLAMINE","year":"1966","cit":0,"pfa":"Zsuzsanna Huszti","ptype":"book-chapter","src":"https://openalex.org/W2491960373","eid":"W2491960373"},{"id":"paper-w7147675091","cat":"papers","name":"S-MDMA: Sensitivity-Aware Model Division Multiple Access for Satellite–Ground Semantic Communication","year":"2026","cit":0,"pfa":"Cao Hui","psa":"Ping Zhang","ptype":"article","src":"https://openalex.org/W7147675091","eid":"W7147675091"},{"id":"paper-w7125878391","cat":"papers","name":"S-MDMA: Sensitivity-Aware Model Division Multiple Access for Satellite-Ground Semantic Communication","year":"2026","cit":0,"pfa":"Hui Cao","psa":"Ping Zhang","ptype":"preprint","src":"https://openalex.org/W7125878391","eid":"W7125878391"},{"id":"paper-w4390576894","cat":"papers","name":"Review for \"Psilocybin as a lead candidate molecule in preclinical therapeutic studies of psychiatric disorders: A systematic review\"","year":"2023","cit":0,"topics":["Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4390576894","eid":"W4390576894"},{"id":"paper-w1977899830","cat":"papers","name":"Psychological effects of MDMA (“Ecstasy”) after pretreatment with selective neuroreceptor ligands in healthy volunteers","year":"2000","cit":0,"pfa":"Matthias E. Liechti","psa":"F.X. Vollenweider","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1977899830","eid":"W1977899830"},{"id":"paper-w2948591492","cat":"papers","name":"Neuronal inclusions and DNA damage associated with nigrostriatal dopamine denervation following MDMA (ecstasy)","year":"2003","cit":0,"pfa":"Michela Ferrucci","psa":"Antonio Paparelli","ptype":"conference-paper","src":"https://openalex.org/W2948591492","eid":"W2948591492"},{"id":"paper-w3010623932","cat":"papers","name":"Increased heat production by brown adipose tissue contributes to MDMA-elicited hyperthermia in rats","year":"2006","cit":0,"pfa":"Youichirou Ootsuka","psa":"William Walter Blessing","ptype":"article","src":"https://openalex.org/W3010623932","eid":"W3010623932"},{"id":"paper-w4415357511","cat":"papers","name":"Evaluating the efficacy and safety of MDMA for the treatment of Post Traumatic Stress Disorder: a systematic review","year":"2025","cit":0,"pfa":"Megha Kodancha","psa":"Sten Kajitani","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"review","src":"https://openalex.org/W4415357511","eid":"W4415357511"},{"id":"paper-w7117234978","cat":"papers","name":"Data: Evolution and horizontal transfer of the psilocybin biosynthetic gene cluster drive the diversification of magic mushrooms","year":"2025","cit":0,"pfa":"Fei Liu","topics":["Therapy practice","Policy & ethics"],"ptype":"dataset","src":"https://openalex.org/W7117234978","eid":"W7117234978"},{"id":"paper-w2729689153","cat":"papers","name":"Aportes para un debate sobre la regulación de la ayahuasca en el Uruguay","year":"2015","cit":0,"pfa":"Juan Scuro","psa":"Ismael Apud","ptype":"article","src":"https://openalex.org/W2729689153","eid":"W2729689153"},{"id":"paper-w7116777647","cat":"papers","name":"Psilocybin Treatment as an Adjunct to Cognitive Behavioral Therapy for Eating Disorders: Therapeutic Rationale & Considerations for Protocol Development","year":"2025","cit":0,"pfa":"Elena Koning","psa":"Aaron R. Keshen","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7116777647","eid":"W7116777647"},{"id":"paper-w7160848043","cat":"papers","name":"Prohedonic Effects of Psilocybin (COMP360) in a Touchscreen-Based Rodent Probabilistic Reward Task (Abstract ID: 227883)","year":"2026","cit":0,"pfa":"Kayleigh LaMalfa","psa":"Brian Kangas","ptype":"article","src":"https://openalex.org/W7160848043","eid":"W7160848043"},{"id":"paper-w7211946027","cat":"papers","name":"Psilocybin for Depressive and Anxiety Disorders (2022–2026): Hybrid Bibliometric Analysis and Systematic Review (protocol fase)","year":"2026","cit":0,"pfa":"Andrea Estefanía Aranda Rosas","psa":"Miguel Á. Trejo-Rodríguez","topics":["Depression","Anxiety & end-of-life","Reviews & meta-analyses"],"ptype":"other","src":"https://openalex.org/W7211946027","eid":"W7211946027"},{"id":"paper-w3048078595","cat":"papers","name":"Pesquisas com Ayahuasca na Psicologia: Uma revisão de literatura sobre o potencial terapêutico","year":"2020","cit":0,"pfa":"Sofia Azevêdo De Araújo","psa":"Daniely Ildegardes Brito Tatmatsu","ptype":"article","src":"https://openalex.org/W3048078595","eid":"W3048078595"},{"id":"paper-w7163014936","cat":"papers","name":"De la selva amazónica al laboratorio: el potencial de la ayahuasca contra el párkinson","year":"2026","cit":0,"pfa":"J de la Torre García","ptype":"other","src":"https://openalex.org/W7163014936","eid":"W7163014936"},{"id":"paper-w3152497442","cat":"papers","name":"Efectos terapéuticos de la ayahuasca en la salud mental: revisión exploratoria de literatura","year":"2020","cit":0,"pfa":"Laura Stefanny Martínez Coral","ptype":"dissertation","src":"https://openalex.org/W3152497442","eid":"W3152497442"},{"id":"paper-w4312335739","cat":"papers","name":"PV-071 - CRUZANDO AL OTRO LADO: UN CASO DE PSICOSIS INDUCIDA POR AYAHUASCA","year":"2022","cit":0,"ptype":"conference-abstract","src":"https://openalex.org/W4312335739","eid":"W4312335739"},{"id":"paper-w2122443494","cat":"papers","name":"Ecstasy: The Complete Guide. A Comprehensive Look at the Risks and Benefits of MDMA Ecstasy and the Rise of the Chemical Generation","year":"2002","cit":0,"pfa":"Steve Heilig","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2122443494","eid":"W2122443494"},{"id":"paper-w2947859700","cat":"papers","name":"Long-term behavioural effects of the âLegal Highâ MDMA alternative 5-IAI in adolescent rats","year":"2019","cit":0,"pfa":"David M. Compton","psa":"Jordan M Sossong","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2947859700","eid":"W2947859700"},{"id":"paper-w4403152500","cat":"papers","name":"Review for \"Psilocybin reduces functional correlation and the encoding of spatial information by neurons in mouse retrosplenial cortex\"","year":"2024","cit":0,"topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4403152500","eid":"W4403152500"},{"id":"paper-w1990735940","cat":"papers","name":"Toxicology and Pharmacology of Mescaline. (Rass. ter. pat. clin., vol. vi, pp. 577–94, 1934) De Nito, G.","year":"1937","cit":0,"pfa":"James C. Munch","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1990735940","eid":"W1990735940"},{"id":"paper-w7126185123","cat":"papers","name":"Author response for \"COMBINED NEUROPROTECTIVE EFFECTS OF N, N DIMETHYLTRYPTAMINE AND VENTRAL ROOT REIMPLANTATION FOLLOWING SPINAL ROOT AVULSION IN RATS\"","year":"2025","cit":0,"pfa":"Paola Andrea Caro Aponte","psa":"Alexandre Leite Rodrigues de Oliveira","ptype":"peer-review","src":"https://openalex.org/W7126185123","eid":"W7126185123"},{"id":"paper-w7126255286","cat":"papers","name":"Author response for \"COMBINED NEUROPROTECTIVE EFFECTS OF N, N DIMETHYLTRYPTAMINE AND VENTRAL ROOT REIMPLANTATION FOLLOWING SPINAL ROOT AVULSION IN RATS\"","year":"2026","cit":0,"pfa":"Paola Andrea Caro Aponte","psa":"Alexandre Leite Rodrigues de Oliveira","ptype":"peer-review","src":"https://openalex.org/W7126255286","eid":"W7126255286"},{"id":"paper-w2107856688","cat":"papers","name":"Short and long-term effects of MDMA exposure in rodents : physiological, behavioral and neurochemical responses","year":"2006","cit":0,"pfa":"Maria Elena Reveron","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2107856688","eid":"W2107856688"},{"id":"paper-w2058490839","cat":"papers","name":"MDMA (Ecstasy)-induced liver toxicity in a HepG2 and immune cell co-culture model","year":"2011","cit":0,"pfa":"Irene Antolino-Lobo","psa":"Majorie B.M. van Duursen","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2058490839","eid":"W2058490839"},{"id":"paper-w7165163474","cat":"papers","name":"Chemical Conversations: Linguistic Markers of Authenticity, Emotionality and Prosocial Behavior Under MDMA Influence","year":"2025","cit":0,"pfa":"Deeksha Handa","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W7165163474","eid":"W7165163474"},{"id":"paper-w7171627278","cat":"papers","name":"Psilocybin-containing mushroom-assisted psychotherapy is associated with sustained psychological and somatic improvements: two case studies from Jamaica","year":"2026","cit":0,"pfa":"Caitlyn Hanna Sams","psa":"Winston De La Haye","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7171627278","eid":"W7171627278"},{"id":"paper-w7120066215","cat":"papers","name":"Practical Guidelines for Supportive Touch in Psychedelic-Assisted and MDMA-Assisted Therapy: A Model for Practitioners and Researchers","year":"2026","cit":0,"pfa":"Jason B. Luoma","psa":"Kati M. Lear","topics":["Safety & adverse events","Therapy practice","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W7120066215","eid":"W7120066215"},{"id":"paper-w7212087722","cat":"papers","name":"Memory deficits of MDMA users are linked to cortical thinning related to 5-HT receptor densities","year":"2026","cit":0,"pfa":"Rebecca C. Coray","psa":"Boris B.; https://orcid.org/0000-0001-7933-2865 Quednow","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7212087722","eid":"W7212087722"},{"id":"paper-w4390576913","cat":"papers","name":"Review for \"Psilocybin as a lead candidate molecule in preclinical therapeutic studies of psychiatric disorders: A systematic review\"","year":"2023","cit":0,"topics":["Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4390576913","eid":"W4390576913"},{"id":"paper-w7148336161","cat":"papers","name":"Psilocybin and Emotional Breakthough: An Umbrella Review and Theoretical Integration [SCIENTIFIC V5.0 - Q1 HIGH-IMPACT]","year":"2026","cit":0,"pfa":"Juan Moises de la Serna","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7148336161","eid":"W7148336161"},{"id":"paper-w4403152472","cat":"papers","name":"Decision letter for \"Psilocybin reduces functional correlation and the encoding of spatial information by neurons in mouse retrosplenial cortex\"","year":"2024","cit":0,"topics":["Mechanism & neuroscience"],"ptype":"peer-review","src":"https://openalex.org/W4403152472","eid":"W4403152472"},{"id":"paper-w7118071268","cat":"papers","name":"The one that abstained: Psilocybe fuscofulva genome suggests two recent origins of the psilocybin gene cluster in Psilocybe","year":"2026","cit":0,"pfa":"Jason C. Slot","psa":"Ian M. Bollinger","topics":["Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W7118071268","eid":"W7118071268"},{"id":"paper-w7169607828","cat":"papers","name":"Quantifying psilocybin exposure in a natural product–based retreat setting: An observational field method for dose measurement","year":"2026","cit":0,"pfa":"Sergio Pérez Rosal","psa":"Sonya C. Faber","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7169607828","eid":"W7169607828"},{"id":"paper-w7160836527","cat":"papers","name":"Pure psilocybin reduces reward-associated preference while mushroom extract shows transient exploratory effects in rats","year":"2026","cit":0,"pfa":"Andreia Machado Brito-da-Costa","psa":"Diana Dias da Silva","ptype":"article","src":"https://openalex.org/W7160836527","eid":"W7160836527"},{"id":"paper-w7161826543","cat":"papers","name":"Dynamic response of intrinsic connectivity networks to low-dose psilocybin during face matching in autistic adults","year":"2026","cit":0,"pfa":"Y. Ge","psa":"Dafnis Batallé","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7161826543","eid":"W7161826543"},{"id":"paper-w7214527256","cat":"papers","name":"Additional file 1 of Evaluation of a facilitator training program in a randomized controlled trial of psilocybin treatment for depression","year":"2026","cit":0,"pfa":"Nikita Morel","psa":"Maria Beckman","topics":["Depression","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7214527256","eid":"W7214527256"},{"id":"paper-w7166779507","cat":"papers","name":"Study Protocol for “Exploring the safety and therapeutic potential of psilocybin in the treatment of anorexia nervosa in adolescents and young adults”","year":"2026","cit":0,"pfa":"David K. Sjöström","psa":"Pouya Movahed","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7166779507","eid":"W7166779507"},{"id":"paper-w4382702512","cat":"papers","name":"Exploration and Practice of First-class Specialty Construction of MDMA Under the Background of “Double 10000 Plan”","year":"2023","cit":0,"pfa":"Xifeng Liang","psa":"Weihong Sun","ptype":"conference-paper","src":"https://openalex.org/W4382702512","eid":"W4382702512"},{"id":"paper-w3006434407","cat":"papers","name":"Beyond the Self and Back: Neural Mechanisms and Behavioral Imprints of a Psilocybin-Induced Alteration of Self-Experience","year":"2020","cit":0,"pfa":"Lukasz Smigielski","topics":["Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W3006434407","eid":"W3006434407"},{"id":"paper-w7212067573","cat":"papers","name":"263. Feasibility of psilocybin treatment in Japanese patients with treatment-resistant depression: an open-label study","year":"2026","cit":0,"pfa":"K Yonezawa","psa":"H Uchida","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7212067573","eid":"W7212067573"},{"id":"paper-w4308964657","cat":"papers","name":"Public Interest in Psilocybin and Psychedelic Therapy in the Context of the COVID-19 Pandemic: Google Trends Analysis (Preprint)","year":"2022","cit":0,"pfa":"George Danias","psa":"Jacob M. Appel","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W4308964657","eid":"W4308964657"},{"id":"paper-w4413502406","cat":"papers","name":"Editorial for “Resilience and Brain Changes in Long‐Term Ayahuasca Users: Insights From Psychometric and fMRI Pattern Recognition”","year":"2025","cit":0,"pfa":"Niels Bergsland","topics":["Mechanism & neuroscience"],"ptype":"editorial","src":"https://openalex.org/W4413502406","eid":"W4413502406"},{"id":"paper-w7214205397","cat":"papers","name":"The effects of recreational MDMA ('ecstasy') on skills learning, memory, sleep and the memory consolidation function of sleep","year":"2010","cit":0,"pfa":"Mark Blagrove","ptype":"dataset","src":"https://openalex.org/W7214205397","eid":"W7214205397"},{"id":"paper-w3168063229","cat":"papers","name":"Addressing the Implicit Impacts of Sexual Trauma: An Exploration of Somatic Experiencing as an Adjunct to Psilocybin-Assisted Therapy","year":"2021","cit":0,"pfa":"Despina Stratidakis","topics":["PTSD & trauma","Safety & adverse events","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W3168063229","eid":"W3168063229"},{"id":"paper-w7114940363","cat":"papers","name":"Age and cannabis co-use are associated with differences in experience and perceived benefits of psilocybin: a retrospective study","year":"2025","cit":0,"pfa":"Sarah Williams","psa":"Kent Hutchison","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W7114940363","eid":"W7114940363"},{"id":"paper-w7160694792","cat":"papers","name":"Psilocybin-Assisted Therapy in Depressive Disorders: Efficacy, Safety, and Persistence of Clinical Effects — A Narrative Review","year":"2026","cit":0,"pfa":"Kinga Zachar","psa":"Jędrzej Czmyr","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W7160694792","eid":"W7160694792"},{"id":"paper-w1988080100","cat":"papers","name":"A106 LONG-LASTING CONSEQUENCES OF ADOLESCENT EXPOSURE TO MDMA ON MORPHINE-INDUCED REWARD IN ADULT MICE","year":"2005","cit":0,"pfa":"Marta Rodríguez‐Arias","psa":"J. Mi aro","ptype":"conference-abstract","src":"https://openalex.org/W1988080100","eid":"W1988080100"},{"id":"paper-w3193894304","cat":"papers","name":"Risks of driving when affected by cannabis, MDMA (ecstasy) and methamphetamine and the deterrence of such behaviour: a literature review","year":"2020","cit":0,"pfa":"W J Frith","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W3193894304","eid":"W3193894304"},{"id":"paper-w4225293819","cat":"papers","name":"3,4‐methylenedioxymethamphetamine (MDMA) stimulates activation of TAAR1 and subsequent neurotransmitter transporter internalization in serotonin neurons","year":"2022","cit":0,"pfa":"Suzanne M. Underhill","psa":"Susan Amara","topics":["PTSD & trauma","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4225293819","eid":"W4225293819"},{"id":"paper-w7147427279","cat":"papers","name":"MDMA-assisted therapy for PTSD and substance use disorders: A scoping review of feasibility and future directions","year":"2026","cit":0,"pfa":"Teun L. Meijer","psa":"Wiebren Markus","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7147427279","eid":"W7147427279"},{"id":"paper-w7167014213","cat":"papers","name":"Psilocybin as a Transdiagnostic Treatment for Eating Disorders and Comorbid Psychopathology: Implications for Clinical Nosology and Research Directions","year":"2026","cit":0,"pfa":"Elena Koning","psa":"Aaron R. Keshen","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7167014213","eid":"W7167014213"},{"id":"paper-w7212279061","cat":"papers","name":"Psilocybin and Chronic Neuropathic and Centralized Pain: Converging Mechanisms in Central Sensitization, Neuroplasticity, and Network Organization","year":"2026","cit":0,"pfa":"Marina Seixas Studart e Neves","psa":"Howard Lopes Ribeiro","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7212279061","eid":"W7212279061"},{"id":"paper-w2234437640","cat":"papers","name":"Prospective memory problems in recreational MDMA users: relationship to dancing and feeling hot when on ecstasy","year":"2005","cit":0,"pfa":"Parrott, A. C.","psa":"Scholey, A. B.","ptype":"article","src":"https://openalex.org/W2234437640","eid":"W2234437640"},{"id":"paper-w3157228730","cat":"papers","name":"EFFECTS OF 3,4-METHYLENDIOXY-N-METHYLAMPHETAMINE (MDMA, ‘ECSTASY’) ADMINISTRATION ON THE DYNORPHINERGIC SYSTEM IN THE RAT BRAIN.","year":"2005","cit":0,"pfa":"Manuela Di Benedetto","psa":"Patrizia Romualdi","ptype":"conference-paper","src":"https://openalex.org/W3157228730","eid":"W3157228730"},{"id":"paper-w2014110347","cat":"papers","name":"P.6.d.015 MDMA self-administration is abolished in serotonin transporter knockout mice","year":"2006","cit":0,"pfa":"José-Luis Díaz","psa":"R. Maldonado","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2014110347","eid":"W2014110347"},{"id":"paper-w2500234450","cat":"papers","name":"Serotonin receptor and neuronal nitric oxide synthase expression in the rat brain : implications for MDMA toxicity.","year":"2010","cit":0,"pfa":"Cheung Ny","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W2500234450","eid":"W2500234450"},{"id":"paper-w4387733243","cat":"papers","name":"S3635 Exploring Hepatic Consequences of Chronic MDMA Consumption: A Clinical Case Study and Histopathological Analysis","year":"2023","cit":0,"pfa":"Philip Bouchette","psa":"James Morris","ptype":"conference-abstract","src":"https://openalex.org/W4387733243","eid":"W4387733243"},{"id":"paper-w7140139596","cat":"papers","name":"Memory deficits of MDMA users are linked to cortical thinning related to 5-HT receptor densities","year":"2026","cit":0,"pfa":"Rebecca C. Coray","psa":"Boris B. Quednow","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7140139596","eid":"W7140139596"},{"id":"paper-w7162165421","cat":"papers","name":"Associations between the Frequency and Interval of Methylenedioxymethamphetamine (MDMA) Use and Depressiveness and Anxiety Among Young People","year":"2026","cit":0,"pfa":"Šarūnas Janušas","topics":["Depression","Anxiety & end-of-life"],"ptype":"dissertation","src":"https://openalex.org/W7162165421","eid":"W7162165421"},{"id":"paper-w1993527206","cat":"papers","name":"P6.d.014 MDMA self-administration is abolished in 5-HT2A receptor knockout mice","year":"2009","cit":0,"pfa":"María Juliana Orejarena","psa":"Patricia Robledo","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1993527206","eid":"W1993527206"},{"id":"paper-w3172086505","cat":"papers","name":"Presentation of Psychosis Subsequent to Penile Injection of MDMA in a 60-year-old Patient-A Case Report","year":"2021","cit":0,"pfa":"Ana Lilian Reyes","psa":"Tessy Korah","ptype":"preprint","src":"https://openalex.org/W3172086505","eid":"W3172086505"},{"id":"paper-w7135500032","cat":"papers","name":"A Death-Changing Experience: A Qualitative Investigation of Patient and Carer Experiences Following MDMA-Assisted Psychotherapy","year":"2024","cit":0,"pfa":"Cynthia Lucia Brumder","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W7135500032","eid":"W7135500032"},{"id":"paper-w4230624128","cat":"papers","name":"Corrigendum: Metabolite Profiling of Anti‐Addictive Alkaloids from Four Mexican Tabernaemontana Species and the Entheogenic African Shrub Tabernanthe iboga (Apocynaceae)","year":"2019","cit":0,"pfa":"Felix Krengel","psa":"Ricardo Reyes‐Chilpa","topics":["Addiction"],"ptype":"erratum","src":"https://openalex.org/W4230624128","eid":"W4230624128"},{"id":"paper-w4416347625","cat":"papers","name":"Effects of psilocybin and related compounds on cerebroprotection during ischemic stroke (Stage 1 Registered Report)","year":"2025","cit":0,"pfa":"Ruslan Rust","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"report","src":"https://openalex.org/W4416347625","eid":"W4416347625"},{"id":"paper-w7154693788","cat":"papers","name":"Neural Entropy and Cognitive Flexibility: A Research Agenda for Psilocybin-Assisted Therapy [FUTURE DIRECTIONS v1.0]","year":"2026","cit":0,"pfa":"Juan Moisés de la Serna","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7154693788","eid":"W7154693788"},{"id":"paper-w7204531450","cat":"papers","name":"Biphasic Hierarchical Reorganization and Riemannian Connectomic Plasticity: A Longitudinal Precision Functional Mapping Study of Psilocybin","year":"2026","cit":0,"pfa":"Luna da Silva Nascimento","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7204531450","eid":"W7204531450"},{"id":"paper-w7126235573","cat":"papers","name":"Review for \"COMBINED NEUROPROTECTIVE EFFECTS OF N, N DIMETHYLTRYPTAMINE AND VENTRAL ROOT REIMPLANTATION FOLLOWING SPINAL ROOT AVULSION IN RATS\"","year":"2025","cit":0,"topics":["Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W7126235573","eid":"W7126235573"},{"id":"paper-w2738739695","cat":"papers","name":"Principios activos naturales con accion alucinogena : vi ibogaina su presencia en tabernanthe iboga baill h bn (apocynaceae)","year":"1985","cit":0,"pfa":"Eloy L. Mandrile","psa":"Graciela Bongiorno de Pfirter","ptype":"article","src":"https://openalex.org/W2738739695","eid":"W2738739695"},{"id":"paper-w4231447017","cat":"papers","name":"Faculty Opinions recommendation of Dynamic Strategic Bond Analysis Yields a Ten-Step Synthesis of 20-nor-Salvinorin A, a Potent κ-OR Agonist.","year":"2018","cit":0,"pfa":"Bryan L. Roth","ptype":"peer-review","src":"https://openalex.org/W4231447017","eid":"W4231447017"},{"id":"paper-w2891506492","cat":"papers","name":"MDMA (\"Ecstasy\") Abuse and High-Risk Sexual Behaviors among 169 Gay and Bisexual Men","year":"2000","cit":0,"pfa":"Alexander S. McKay","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2891506492","eid":"W2891506492"},{"id":"paper-w4394480808","cat":"papers","name":"Additional file 4: of De novo sequencing and analysis of Lophophora williamsii transcriptome, and searching for putative genes involved in mescaline biosynthesis","year":"2015","cit":0,"pfa":"Enrique Ibarra‐Laclette","psa":"Luís Herrera‐Estrella","ptype":"dataset","src":"https://openalex.org/W4394480808","eid":"W4394480808"},{"id":"paper-w2511376618","cat":"papers","name":"Effects of Ecstasy (MDMA) on the brain uptake of ¹¹C(+)McN-5652 studied by positron emission tomography","year":"2000","cit":0,"pfa":"Pascale M. Gucker","ptype":"dissertation","src":"https://openalex.org/W2511376618","eid":"W2511376618"},{"id":"paper-w3159936694","cat":"papers","name":"Geçmişte Kannabis ve MDMA Birlikte Kullanımının Subklinik Psikotik Semptomlar Üzerindeki Ek Etkisi","year":"2017","cit":0,"pfa":"Berker Duman","psa":"Bora Başkak","ptype":"article","src":"https://openalex.org/W3159936694","eid":"W3159936694"},{"id":"paper-w2233295993","cat":"papers","name":"Serotonin 5-HT 2C receptors: Role in (+)-MDMA sensitization and distribution in the ventral tegmental area","year":"2005","cit":0,"pfa":"Marcy J. Bubar","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2233295993","eid":"W2233295993"},{"id":"paper-w4375837504","cat":"papers","name":"The Role of Trait Impulsivity and Novelty-Seeking as Predisposing Factors to the Acquisition and Reinstatement of MDMA Self-Administration","year":"2013","cit":0,"pfa":"Judith Bird","topics":["Safety & adverse events","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W4375837504","eid":"W4375837504"},{"id":"paper-w2560268253","cat":"papers","name":"Determining the purity of ecstasy (MDMA): strategies utilized by recreational ecstasy users in Victoria, British Columbia","year":"2016","cit":0,"pfa":"Melanie Callas","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W2560268253","eid":"W2560268253"},{"id":"paper-w4412578699","cat":"papers","name":"Evaluation of Two Spectroscopic Techniques to Estimate the MDMA Dose of Ecstasy‐Like Tablets, an On‐Site Approach","year":"2025","cit":0,"pfa":"Natalie Meert","psa":"Joy Eliaerts","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4412578699","eid":"W4412578699"},{"id":"paper-w7117995658","cat":"papers","name":"Psilocybin during the postpartum period induces long-lasting adverse effects in both mothers and offspring- dataset","year":"2025","cit":0,"pfa":"Danielle S. Stolzenberg","topics":["Safety & adverse events"],"ptype":"dataset","src":"https://openalex.org/W7117995658","eid":"W7117995658"},{"id":"paper-w2120957003","cat":"papers","name":"Perseveration of Response Sequences as a Mechanism Underlying 3,4-Methylenedioxymethamphetamine (MDMA or ‘Ecstasy’) Induced Memory Impairments","year":"2013","cit":0,"pfa":"David N. Harper","topics":["Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W2120957003","eid":"W2120957003"},{"id":"paper-w1481959452","cat":"papers","name":"Intramolecular Diels–Alder/Tsuji Allylation assembly of the functionalized trans-Decalin of Salvinorin A and sea lamprey migratory pheromone structure activity relationship studies.","year":"2010","cit":0,"pfa":"Aaron C. Burns","ptype":"dissertation","src":"https://openalex.org/W1481959452","eid":"W1481959452"},{"id":"paper-w7161263389","cat":"papers","name":"Psicoterapia auxiliada por MDMA como tratamento do transtorno de estresse pós-traumático","year":"2022","cit":0,"pfa":"Davi Mello Castanheira","psa":"Andréa da Silva Torrão","ptype":"dissertation","src":"https://openalex.org/W7161263389","eid":"W7161263389"},{"id":"paper-w7120578306","cat":"papers","name":"Evaluation of possible interactions between cannabidiol and ayahuasca in healthy volunteers: A randomized, double-blind, placebo-controlled study","year":"2020","cit":0,"pfa":"Giordano Novak Rossi","topics":["Depression"],"ptype":"dissertation","src":"https://openalex.org/W7120578306","eid":"W7120578306"},{"id":"paper-w2156462773","cat":"papers","name":"A Hallucinogenic Tea, Laced with Controversy: Ayahuasca in the Amazon and the United States. by Marlene Dobkin de Rios and Roger Rumrrill","year":"2010","cit":0,"pfa":"John R. Baker","ptype":"article","src":"https://openalex.org/W2156462773","eid":"W2156462773"},{"id":"paper-w2292181283","cat":"papers","name":"AYAHUASCA Y AUTO-COMPASIÓN: UN ESTUDIO CUANTITATIVO EN LA IGLESIA DEL SANTO DAIME EN","year":"2014","cit":0,"pfa":"Santiago de Chile","ptype":"article","src":"https://openalex.org/W2292181283","eid":"W2292181283"},{"id":"paper-w1978363642","cat":"papers","name":"In vitro studies on the neurotoxic effects of piperazine-derived designer drugs and 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”)","year":"2013","cit":0,"pfa":"Dina Popova","psa":"Stig O. P. Jacobsson","ptype":"article","src":"https://openalex.org/W1978363642","eid":"W1978363642"},{"id":"paper-w4414027372","cat":"papers","name":"A biopsychosocial model of MDMA-assisted therapy in application: Dyadic One Session Treatment for specific phobia","year":"2025","cit":0,"pfa":"Nicholas J. Ahari","psa":"Gregory A. Fonzo","topics":["PTSD & trauma","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4414027372","eid":"W4414027372"},{"id":"paper-w7127642270","cat":"papers","name":"Memory deficits of MDMA users are linked to cortical thinning related to 5-HT receptor densities","year":"2026","cit":0,"pfa":"Rebecca C. Coray","psa":"Boris B. Quednow","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7127642270","eid":"W7127642270"},{"id":"paper-w7106713382","cat":"papers","name":"Endogenous N,N-Dimethyltryptamine and Sigma-1 Receptor Modulation as Enhancers of Neural-Substrate Coherence in the Swygert Theory of Everything AO (TSTOEAO)","year":"2025","cit":0,"pfa":"Swygert, John","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7106713382","eid":"W7106713382"},{"id":"paper-w1907000484","cat":"papers","name":"The Effect of Ecstasy (MDMA) on the Number of Ovary Follicles and Hormonal Axis of Pituitary-Gonadal in Immature Rats","year":"2013","cit":0,"pfa":"Zahra Allaeian","psa":"Ali Reza Alaeyan Jahromi","ptype":"article","src":"https://openalex.org/W1907000484","eid":"W1907000484"},{"id":"paper-w2507593649","cat":"papers","name":"Behavioural and Neurochemical Effects of Acute (±) 3,4 methylenedioxymethamphetamine (MDMA) in the Dopamine D1 Receptor Mutant Rat","year":"2016","cit":0,"pfa":"Hanna Squire","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"dissertation","src":"https://openalex.org/W2507593649","eid":"W2507593649"},{"id":"paper-w7124842340","cat":"papers","name":"MDMA Enantiomers: an Exploration into 5-HT2AR Necessity in Non-Hallucinogen Induced Frontal Cortex Plasticity","year":"2025","cit":0,"pfa":"Maya Gaines-Smith","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7124842340","eid":"W7124842340"},{"id":"paper-w7125663418","cat":"papers","name":"The Universal Law of Machine Intelligence: Machine Decision-Making Ability (MDMA) Across Technological Eras","year":"2026","cit":0,"pfa":"Muhammad Rashid","topics":["Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7125663418","eid":"W7125663418"},{"id":"paper-w14673567","cat":"papers","name":"DNA damage and ubiquitinated neuronal inclusions in the substantia nigra and striatum of mice following MDMA (ecstasy).","year":"2004","cit":0,"pfa":"田中 真理","psa":"A Paparelli","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W14673567","eid":"W14673567"},{"id":"paper-w4410617502","cat":"papers","name":"Aus dem Nähkästchen: Praxiseinblicke in die Traumatherapie mit MDMA in Australien und der Schweiz","year":"2025","cit":0,"pfa":"Eva Gallacher","psa":"Andrea Jesser","topics":["PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4410617502","eid":"W4410617502"},{"id":"paper-w7125638300","cat":"papers","name":"The Universal Law of Machine Intelligence: Machine Decision-Making Ability (MDMA) Across Technological Eras","year":"2026","cit":0,"pfa":"Muhammad Rashid","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W7125638300","eid":"W7125638300"},{"id":"paper-w314528670","cat":"papers","name":"The Correlation between the Communication of the Health Risks of Ecstasy (MDMA) and the Drug's Use among College Students.","year":"2001","cit":0,"pfa":"Brian Campe","psa":"Michael W. Parsons","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W314528670","eid":"W314528670"},{"id":"paper-w4390270869","cat":"papers","name":"Psychedelic Therapy: A Primer for Primary Care Clinicians – Part VI. 3,4-methylenedioxy-methamphetamine (MDMA)","year":"2023","cit":0,"pfa":"Kenneth Shinozuka","psa":"Owen S. Muir","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"preprint","src":"https://openalex.org/W4390270869","eid":"W4390270869"},{"id":"paper-w4396753902","cat":"papers","name":"Oxytocin, Not Vasopressin, Mediates High Incidence of MDMA-Induced Hyponatremia - A Complication Preventable by Fluid Restriction","year":"2024","cit":0,"pfa":"Cihan Atila","psa":"Mirjam Christ‐Crain","ptype":"preprint","src":"https://openalex.org/W4396753902","eid":"W4396753902"},{"id":"paper-w7202295320","cat":"papers","name":"MDMA-Enhanced Exposure Therapy Reverses PTSD-Like Features In a Learned Helplessness Mouse Model","year":"2026","cit":0,"pfa":"Orr Shahar","psa":"Bernard Lerer","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W7202295320","eid":"W7202295320"},{"id":"paper-w4407076043","cat":"papers","name":"Source Localized Auditory Erp Sensory and Preattentive Correlates of Psilocybin-Induced Ego-Dissolution Related Effects","year":"2025","cit":0,"pfa":"Destiny Carbello","psa":"Tomáš Páleníček","ptype":"article","src":"https://openalex.org/W4407076043","eid":"W4407076043"},{"id":"paper-w7127080333","cat":"papers","name":"Psilocybin-assisted therapy for relapse prevention in alcohol use disorder: a phase 2 randomized clinical trial","year":"2025","cit":0,"pfa":"Nathalie M. Rieser","psa":"Katrin H. Preller","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7127080333","eid":"W7127080333"},{"id":"paper-w7118005328","cat":"papers","name":"The impact of COMP360 psilocybin on anhedonia: post-hoc analyses from a phase IIb randomised controlled trial","year":"2026","cit":0,"pfa":"L. Marwood","psa":"G M Goodwin","ptype":"article","src":"https://openalex.org/W7118005328","eid":"W7118005328"},{"id":"paper-w7202205998","cat":"papers","name":"Psilocybin for depressive and anxiety disorders (2022-2026): bibliometric arm of a hybrid bibliometric and meta-analytic study","year":"2026","cit":0,"pfa":"Andrea Estefania Aranda-Rosas","psa":"Miguel Á. Trejo-Rodríguez","topics":["Depression","Anxiety & end-of-life"],"ptype":"software","src":"https://openalex.org/W7202205998","eid":"W7202205998"},{"id":"paper-w7106783440","cat":"papers","name":"Brain-MGF: Multimodal Graph Fusion Network for EEG-fMRI Brain Connectivity Analysis Under Psilocybin","year":"2025","cit":0,"pfa":"Yap, Sin-Yee","psa":"Ting, Chee-Ming","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7106783440","eid":"W7106783440"},{"id":"paper-w7163510976","cat":"papers","name":"Changes in anxiety, quality of life, and functioning following psilocybin-assisted therapy in veterans with treatment-resistant depression","year":"2026","cit":0,"pfa":"Carlton M. Kelly","psa":"Trisha Suppes","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7163510976","eid":"W7163510976"},{"id":"paper-w4255462369","cat":"papers","name":"Protective Effects of Atorvastatin and Rosuvastatin on 3,4-methylenedioxymethamphetamine (MDMA)-Induced Spatial Learning and Memory Impairment","year":"2021","cit":0,"pfa":"Majid Eslami","psa":"Ruhollah Mirjani","topics":["Safety & adverse events","Therapy practice","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4255462369","eid":"W4255462369"},{"id":"paper-w7151461819","cat":"papers","name":"MDMA-Assisted Therapy for Veterans with PTSD and Alcohol Use Disorders: Considerations for Randomized Controlled Trials","year":"2026","cit":0,"pfa":"Christy Capone","psa":"Erica M. Eaton","topics":["PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7151461819","eid":"W7151461819"},{"id":"paper-w4253019647","cat":"papers","name":"ChemInform Abstract: DIELS‐ALDER ADDUCTS OF 1‐BENZENESULFONYLINDOLE‐2‐ACRYLATES AND 1‐(ALKOXYCARBONYL)‐1,2‐DIHYDROPYRIDINES. INTERMEDIATES FOR SYNTHESIS OF IBOGA ALKALOID ANALOGS","year":"1982","cit":0,"pfa":"Richard J. Sundberg","psa":"Jonathan D. Bloom","ptype":"article","src":"https://openalex.org/W4253019647","eid":"W4253019647"},{"id":"paper-w2891090720","cat":"papers","name":"Benzylpiperazine (BZP) additively increases Methylenedioxymethamphetamine (MDMA) cardiotoxicity in H9c2 cells, an effect potentiatted by hyperthermia","year":"2018","cit":0,"pfa":"Félix Dias Carvalho","psa":"D.D.D. Silva","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2891090720","eid":"W2891090720"},{"id":"paper-w7108463159","cat":"papers","name":"Terapias psicodélicas (psilocibina, mdma) en el tratamiento del trastorno de estrés postraumático","year":"2025","cit":0,"pfa":"Autor independiente, Ecuador","psa":"Jhon Bryan Paca Aucancela","topics":["PTSD & trauma","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7108463159","eid":"W7108463159"},{"id":"paper-w3081791018","cat":"papers","name":"Efeito da administração crônica de ayahuasca em modelos pré-clínicos de memória e ansiedade","year":"2013","cit":0,"pfa":"Vanessa Manchim Favaro","ptype":"dissertation","src":"https://openalex.org/W3081791018","eid":"W3081791018"},{"id":"paper-w3029442794","cat":"papers","name":"Uso ritual da ayahuasca durante o tratamento de doenças físicas graves: um estudo qualitativo","year":"2020","cit":0,"pfa":"Maia LSM","ptype":"dissertation","src":"https://openalex.org/W3029442794","eid":"W3029442794"},{"id":"paper-w4416324639","cat":"papers","name":"A qualitative study of long-term members of ayahuasca spiritual communities in the United States: Motivations, practices, experiences and beliefs","year":"2025","cit":0,"pfa":"Joseph T. La Torre","psa":"Nathan B. Sackett","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4416324639","eid":"W4416324639"},{"id":"paper-w7119563908","cat":"papers","name":"Paper: \"Psilocybin as a Potential Countermeasure to Toxoplasma gondii-Induced Behavioral Modification: A Hypothesis and Proposed Research Framework\"","year":"2026","cit":0,"pfa":"Griffiths Hamilton","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7119563908","eid":"W7119563908"},{"id":"paper-w7153198387","cat":"papers","name":"Observing the mind under psychedelics: conceptual metaphors used following four once-weekly macrodoses of psilocybin","year":"2026","cit":0,"pfa":"Eric Rundquist","psa":"Jennifer Mitchell","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7153198387","eid":"W7153198387"},{"id":"paper-w4389116135","cat":"papers","name":"Performance Analysis of MDMA-Based Cooperative MRC Networks with Relays in Dissimilar Rayleigh Fading Channels","year":"2023","cit":0,"pfa":"Lei Teng","psa":"Xiaodong Xu","ptype":"preprint","src":"https://openalex.org/W4389116135","eid":"W4389116135"},{"id":"paper-w1971959128","cat":"papers","name":"519 Quantitative EEG reveals changes in human brain function associated with MDMA (“ecstasy”) use","year":"1998","cit":0,"pfa":"Richard Ian Dafters","psa":"Caroline Bouquet","ptype":"article","src":"https://openalex.org/W1971959128","eid":"W1971959128"},{"id":"paper-w2590020572","cat":"papers","name":"Rozdíly působení MDMA a metamfetaminu na sociabilitu agresivních myší v modelu sociálních interakcí","year":"2010","cit":0,"pfa":"Alena Máchalová","psa":"Alexandra Šulcová","ptype":"article","src":"https://openalex.org/W2590020572","eid":"W2590020572"},{"id":"paper-w7213877811","cat":"papers","name":"A Randomized, Double-Blind, Placebo-Controlled Single-Ascending-Dose Study to Identify a Subperceptual Dose of Psilocybin in Healthy Adults","year":"2026","cit":0,"pfa":"Naama Levy‐Cooperman","psa":"Michael B. McDonnell","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7213877811","eid":"W7213877811"},{"id":"paper-w7128732952","cat":"papers","name":"The Axis Mundi Hypothesis: Endogenous N,N-Dimethyltryptamine as a Neurobiological Bridge Between Conscious and Subconscious Processing - An Integrative Theoretical Framework","year":"2026","cit":0,"pfa":"Mihai Alexandru","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W7128732952","eid":"W7128732952"},{"id":"paper-w7213907444","cat":"papers","name":"Toxicokinetics and analytical toxicology of four N, N-dimethyltryptamine derivatives studied in human in vitro systems and in vivo by means of zebrafish embryos","year":"2026","cit":0,"pfa":"Gloria Daziani","psa":"Markus R. Meyer","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7213907444","eid":"W7213907444"},{"id":"paper-w86670234","cat":"papers","name":"REGULAMENTAÇÃO DE USO DE SUBSTÂNCIA PSICOATIVA PARA USO RELIGIOSO: O CASO DA AYAHUASCA","year":"2010","cit":0,"pfa":"Andréa Depieri de Albuquerque Reginato","ptype":"article","src":"https://openalex.org/W86670234","eid":"W86670234"},{"id":"paper-w294651873","cat":"papers","name":"Methamphetamine and MDMA (3,4-methylenedioxymethamphetamine) Induce Apoptosis in Both Human Serotonergic and Dopaminergic Cell Lines","year":"2003","cit":0,"pfa":"Kyu‐Bong Kim","psa":"Sun Hee Lee","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W294651873","eid":"W294651873"},{"id":"paper-w4396781706","cat":"papers","name":"Efeitos do uso da Ayahuasca utilizada em Cerimônias religiosas sobre aspectos emocionais dos participantes","year":"2024","cit":0,"pfa":"Felipe Teixeira","ptype":"article","src":"https://openalex.org/W4396781706","eid":"W4396781706"},{"id":"paper-w7155066504","cat":"papers","name":"The efficacy and safety of psilocybin-assisted therapy for major depressive disorder: a meta-analytic review of clinical outcomes","year":"2026","cit":0,"pfa":"Mohsen Khosravi","psa":"Massimo Tusconi","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7155066504","eid":"W7155066504"},{"id":"paper-w7161252142","cat":"papers","name":"Reply: The consequences of MDMA use are not easily disentangled from other drug use or lifestyle factors","year":"2026","cit":0,"pfa":"Boris B. Quednow","psa":"Rebecca C. Coray","ptype":"letter","src":"https://openalex.org/W7161252142","eid":"W7161252142"},{"id":"paper-w2915160336","cat":"papers","name":"A simple and fast UPLC-MS/MS method for the determination of DMT and harmala alkaloids in ayahuasca tea and vegetal samples","year":"2018","cit":0,"pfa":"Gabriela de Oliveira Silveira","psa":"Maurı́cio Yonamine","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2915160336","eid":"W2915160336"},{"id":"paper-w3136118965","cat":"papers","name":"Evidências do efeito antidepressivo rápido da Ayahuasca em um modelo animal de depressão maior","year":"2021","cit":0,"pfa":"Francisco Cid Coelho Pinto","topics":["Depression","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W3136118965","eid":"W3136118965"},{"id":"paper-w7167875807","cat":"papers","name":"Efeitos do uso de cetamina e ayahuasca na memória em ratos adultos e idosos","year":"2025","cit":0,"pfa":"Marina da Silva Medeiros","ptype":"conference-abstract","src":"https://openalex.org/W7167875807","eid":"W7167875807"},{"id":"paper-w2073463153","cat":"papers","name":"P.1.36 Caffeine exacerbates MDMA “Ecstasy”-induced hyperthermia: a role for dopamine D1 receptors","year":"2008","cit":0,"pfa":"Natacha Vanattou‐Saïfoudine","psa":"Andrew Harkin","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2073463153","eid":"W2073463153"},{"id":"paper-w2307540581","cat":"papers","name":"Optimization of a microwave-assisted extraction procedure for the extraction of organic impurities from seized MDMA tablets","year":"2009","cit":0,"pfa":"Joiner, Patricia Jean","ptype":"dissertation","src":"https://openalex.org/W2307540581","eid":"W2307540581"},{"id":"paper-w2045598172","cat":"papers","name":"P.6.d.001 The effects of MDMA pre-treatment on behavioural responses to mephedrone in the rat","year":"2012","cit":0,"pfa":"S.E. Shortall","psa":"Madeleine V. King","ptype":"article","src":"https://openalex.org/W2045598172","eid":"W2045598172"},{"id":"paper-w1989290128","cat":"papers","name":"P8 THE ANTIPARKINSONIAN ACTIONS OF MDMA IN RATS: ROLE OF SEROTONIN TRANSPORTERS AND 5-HT(1A)-RECEPTORS.","year":"2006","cit":0,"pfa":"Artur Mayerhofer","psa":"M. H pkes","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1989290128","eid":"W1989290128"},{"id":"paper-w1483669241","cat":"papers","name":"Alcohol and ecstasy (MDMA‐3,4‐methylenedioxymethamphetamine) overdose as a reason for acute hepatitis with gall bladder inflammation","year":"2009","cit":0,"pfa":"Tomasz Mikuła","psa":"Alicja Wiercińska‐Drapało","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1483669241","eid":"W1483669241"},{"id":"paper-w2415877572","cat":"papers","name":"The Connection Between MDMA (ecstasy/molly) Use and Sexual Risk Taking: Implications for HIV Prevention","year":"2014","cit":0,"pfa":"Khary K. Rigg","topics":["Safety & adverse events"],"ptype":"conference-paper","src":"https://openalex.org/W2415877572","eid":"W2415877572"},{"id":"paper-w4387073788","cat":"papers","name":"From the party to the therapy – MDMA as an alternative for the existing methods of Post-traumatic Stress Disorder treatment","year":"2023","cit":0,"pfa":"Wiktoria Bojarska","psa":"Bartosz Burda","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4387073788","eid":"W4387073788"},{"id":"paper-w7126241584","cat":"papers","name":"Additional file 1 of An open-label pilot study of psilocybin-assisted therapy for binge eating disorder","year":"2026","cit":0,"pfa":"Jesse Dallery","psa":"Beverlee Loeser","ptype":"article","src":"https://openalex.org/W7126241584","eid":"W7126241584"},{"id":"paper-w4237153576","cat":"papers","name":"Two Kinds of Modification by 5-Methoxy-N,N-Dimethyltryptamine of Contractile Responses to Electrical Stimulation of Isolated Guinea-Pig Vas Deferens","year":"1987","cit":0,"pfa":"Soichi Yoshida","psa":"Tetsurō Kuga","ptype":"article","src":"https://openalex.org/W4237153576","eid":"W4237153576"},{"id":"paper-w2062874531","cat":"papers","name":"High-throughput determination of methamphetamine, MDMA and MDA from human plasma by LC/MS/MS","year":"2008","cit":0,"pfa":"Laurian Vlase","psa":"Sorin Emilian Leucuta","ptype":"article","src":"https://openalex.org/W2062874531","eid":"W2062874531"},{"id":"paper-w4363647760","cat":"papers","name":"O PAPEL DO HINÁRIO NOS RITUAIS DE AYAHUASCA: UMA ANÁLISE NA PERSPECTIVA DE BARDIN","year":"2023","cit":0,"pfa":"Rita Barreto de Sales Oliveira","ptype":"book-chapter","src":"https://openalex.org/W4363647760","eid":"W4363647760"},{"id":"paper-w3166939445","cat":"papers","name":"Usos de plantas sagradas y sus regulaciones: el caso de la ayahuasca en Uruguay","year":"2019","cit":0,"pfa":"Juan Scuro","ptype":"article","src":"https://openalex.org/W3166939445","eid":"W3166939445"},{"id":"paper-w758209705","cat":"papers","name":"From Polygamy to Peyote: What is the Proper Role of Religion in American Political Decision-Making? (Review of Religion in Politics, by Michael J. Perry)","year":"1999","cit":0,"pfa":"J. Nathan Jensen","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W758209705","eid":"W758209705"},{"id":"paper-w4403152357","cat":"papers","name":"Author response for \"Psilocybin reduces functional correlation and the encoding of spatial information by neurons in mouse retrosplenial cortex\"","year":"2024","cit":0,"pfa":"Victorita E. Ivan","psa":"Aaron J. Gruber","topics":["Mechanism & neuroscience"],"ptype":"peer-review","src":"https://openalex.org/W4403152357","eid":"W4403152357"},{"id":"paper-w3203456384","cat":"papers","name":"Religion in Indian Life: The Peyote Religion among the Navaho . David F. Aberle. Aldine, Chicago, 1966. 480 pp., illus. $10.","year":"1967","cit":0,"pfa":"Alice Marriott","ptype":"article","src":"https://openalex.org/W3203456384","eid":"W3203456384"},{"id":"paper-w2253974454","cat":"papers","name":"Acute effects of MDMA (“Ecstasy”) on neurotransmission in the central nervous system: G protein activated pathways.","year":"2002","cit":0,"pfa":"Andrea Pirone","psa":"Ortenzio Fabiani","ptype":"conference-paper","src":"https://openalex.org/W2253974454","eid":"W2253974454"},{"id":"paper-w2593596851","cat":"papers","name":"Seguimento por cinco anos de uma amostra de usuários de ecstasy (MDMA)","year":"2009","cit":0,"pfa":"Murilo Campos Battisti","ptype":"dissertation","src":"https://openalex.org/W2593596851","eid":"W2593596851"},{"id":"paper-w3150870043","cat":"papers","name":"Prenatal exposure to 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) has lasting consequences on neural development and behavior.","year":"2010","cit":0,"pfa":"Thompson","topics":["Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W3150870043","eid":"W3150870043"},{"id":"paper-w2739924984","cat":"papers","name":"Vpeljava postopkov in vitro razmnoževanja in tvorbe koreninskih skupkov pri vrsti Tabernanthe iboga (L.) Nutt. ter analiza vsebnosti ibogaina","year":"2017","cit":0,"pfa":"Janja Homar","topics":["Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W2739924984","eid":"W2739924984"},{"id":"paper-w7139023279","cat":"papers","name":"Psychedelic drug MDMA could help treat PTSD – but there’s a reason it’s not widely available","year":"2026","cit":0,"pfa":"Tracey Varker","psa":"Meaghan O'Donnell","topics":["PTSD & trauma"],"ptype":"other","src":"https://openalex.org/W7139023279","eid":"W7139023279"},{"id":"paper-w4294085942","cat":"papers","name":"The Combined Psychoactive Effects of Caffeine, Nicotine and MDMA on the Prefrontal Cortex of Juvenile Male Wistar Rats","year":"2022","cit":0,"pfa":"Victor C. Ogbolu","psa":"Joshua Owolabi","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4294085942","eid":"W4294085942"},{"id":"paper-w7214384718","cat":"papers","name":"No lasting effects of moderate doses of MDMA (Ecstasy) on memory performance and mood states in healthy humans","year":"2026","cit":0,"pfa":"Stephan Ludewig","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7214384718","eid":"W7214384718"},{"id":"paper-w2889134612","cat":"papers","name":"'They're asking about MDMA, LSD and cocaine': Keeping people drug-safe at Electric Picnic.","year":"2018","cit":0,"pfa":"Hayley Halpin","ptype":"article","src":"https://openalex.org/W2889134612","eid":"W2889134612"},{"id":"paper-w4221025030","cat":"papers","name":"Therapy combined with MDMA is effective in treating severe PTSD, phase III trial results suggest","year":"2022","cit":0,"topics":["PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4221025030","eid":"W4221025030"},{"id":"paper-w7165400959","cat":"papers","name":"Indoles as Molecular Growth Instructions: Psilocybin as Conserved Morphogenetic Signal from Deep Ancestry to Neural Execution","year":"2026","cit":0,"pfa":"C.S. Tarpley","psa":"ClearBridge Policy & Ethics Consortium","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"preprint","src":"https://openalex.org/W7165400959","eid":"W7165400959"},{"id":"paper-w7166854327","cat":"papers","name":"Modeled Long‐Term Effects of Psilocybin on Dynamic Activity and Effective Connectivity of Fronto‐Striatal‐Thalamic Circuits","year":"2026","cit":0,"pfa":"Lorenzo Pasquini","psa":"Gustavo Deco","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7166854327","eid":"W7166854327"},{"id":"paper-w1150859444","cat":"papers","name":"Irish recreational drug users reveal cocaine and MDMA use – and talk ‘mystery white powders’.","year":"2015","cit":0,"pfa":"Orla Ryan","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1150859444","eid":"W1150859444"},{"id":"paper-w4395037534","cat":"papers","name":"Author Correction: Psilocybin enhances insightfulness in meditation: a perspective on the global topology of brain imaging during meditation","year":"2024","cit":0,"pfa":"Berit Singer","psa":"Milan Scheidegger","ptype":"erratum","src":"https://openalex.org/W4395037534","eid":"W4395037534"},{"id":"paper-w7127545051","cat":"papers","name":"The role of Oceanic boundlessness in psilocybin-assisted therapy in patients with treatment-resistant depression: Exploring its relationship with connectedness to nature.","year":"2026","cit":0,"pfa":"Samuel Seymour","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W7127545051","eid":"W7127545051"},{"id":"paper-w4405640893","cat":"papers","name":"AYAHUASCA E PSICOLOGIA: A CONEXÃO ENTRE O CHÁ SAGRADO DA AMAZÔNIA E A TERAPIA MODERNA","year":"2024","cit":0,"pfa":"L. L. SILVA","ptype":"book-chapter","src":"https://openalex.org/W4405640893","eid":"W4405640893"},{"id":"paper-w4391973452","cat":"papers","name":"ATENÇÃO PSICOSSOCIAL: PERCEPÇÕES RELIGIOSAS E MOTIVAÇÕES DE USUÁRIOS DE AYAHUASCA EM MANAUS – AM","year":"2024","cit":0,"pfa":"Marisa Melo de Souza","psa":"Alex Martins","ptype":"conference-paper","src":"https://openalex.org/W4391973452","eid":"W4391973452"},{"id":"paper-w4327638648","cat":"papers","name":"Evaluación del muro de visualización implementado con Chromium en el Cluster Peyote del LCI-ITVer","year":"2016","cit":0,"pfa":"Abelardo Rodríguez-León","psa":"J. C. Prince Avelino","ptype":"article","src":"https://openalex.org/W4327638648","eid":"W4327638648"},{"id":"paper-w2783265398","cat":"papers","name":"No difference in 5-HT transporter densities in individuals who stopped using MDMA as compared to controls","year":"2000","cit":0,"pfa":"Liesbeth Reneman","psa":"Jan Booij","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2783265398","eid":"W2783265398"},{"id":"paper-w7125780776","cat":"papers","name":"S-MDMA: Sensitivity-Aware Model Division Multiple Access for Satellite-Ground Semantic Communication","year":"2026","cit":0,"pfa":"Hui Cao","psa":"Ping Zhang","ptype":"preprint","src":"https://openalex.org/W7125780776","eid":"W7125780776"},{"id":"paper-w2497061174","cat":"papers","name":"The use of combined telemetry and microdialysis techniques to assess 3,4- methylenedioxymethamphetamine (MDMA, ‘Ecstasy’) effects in rats.","year":"2015","cit":0,"pfa":"Intan Sofia Omar","topics":["Safety & adverse events","Mechanism & neuroscience","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W2497061174","eid":"W2497061174"},{"id":"paper-w4405021184","cat":"papers","name":"Correction to Sleep Quality Improvements After MDMA‐Assisted Psychotherapy for the Treatment of Posttraumatic Stress Disorder","year":"2024","cit":0,"topics":["PTSD & trauma","Dosing & pharmacology","Therapy practice"],"ptype":"erratum","src":"https://openalex.org/W4405021184","eid":"W4405021184"},{"id":"paper-w7105737618","cat":"papers","name":"Monitoring the Misuse Potential of MDMA and Other Substances in Clinical Trials: A Systematic Review of Methodological Approaches","year":"2025","cit":0,"pfa":"Lewis Nunez Severino","psa":"Carolina L. Haass-Koffler","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"preprint","src":"https://openalex.org/W7105737618","eid":"W7105737618"},{"id":"paper-w7213460784","cat":"papers","name":"Psilocybin restores social novelty investigation in male SAPAP3 knockout mice and engages prefrontal–hippocampal circuitry","year":"2026","cit":0,"pfa":"James J Gattuso","psa":"Thibault Renoir","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7213460784","eid":"W7213460784"},{"id":"paper-w7214424921","cat":"papers","name":"Systematic study of Panaeolus (Agaricales, Galeropsidaceae) sensu lato and psilocybin-producing traits of species from China","year":"2026","cit":0,"pfa":"Mao-Qiang He","psa":"Rui-Lin Zhao","topics":["Reviews & meta-analyses"],"ptype":"dataset","src":"https://openalex.org/W7214424921","eid":"W7214424921"},{"id":"paper-w2945887815","cat":"papers","name":"Acerca del uso ritual de las drogas como derecho humano: el caso del peyote en México","year":"2019","cit":0,"pfa":"Pamela Ruiz Flores López","ptype":"article","src":"https://openalex.org/W2945887815","eid":"W2945887815"},{"id":"paper-w7165129048","cat":"papers","name":"Sex-Specific Effects of Psilocybin Versus Escitalopram on Anxiety and Anhedonia: A Bayesian Reanalysis of Antidepressant Treatment Outcomes","year":"2026","cit":0,"pfa":"Aline Frick","psa":"Robin Lester Carhart-Harris","topics":["Depression","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W7165129048","eid":"W7165129048"},{"id":"paper-w4394123648","cat":"papers","name":"Additional file 9: of De novo sequencing and analysis of Lophophora williamsii transcriptome, and searching for putative genes involved in mescaline biosynthesis","year":"2015","cit":0,"pfa":"Enrique Ibarra‐Laclette","psa":"Luís Herrera‐Estrella","ptype":"dataset","src":"https://openalex.org/W4394123648","eid":"W4394123648"},{"id":"paper-w4405637267","cat":"papers","name":"Blinding in psychedelic studies: comparison of placebo and sub-perceptual dose of intranasal 5-Methoxy-N,N-dimethyltryptamine in healthy volunteers","year":"2024","cit":0,"pfa":"Chandni N Hindocha","psa":"C. Roberts","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4405637267","eid":"W4405637267"},{"id":"paper-w4407387224","cat":"papers","name":"N,N-DIMETHYLTRYPTAMINE, A NATURAL HALLUCINOGEN, AMELIORATES ALZHEIMER’ S DISEASE BY RESTORING NEURONAL SIGMA-1 RECEPTOR- MEDIATED ENDOPLASMIC RETICULUM-MITOCHONDRIA CROSSTALK","year":"2025","cit":0,"pfa":"Dan Cheng","psa":"Zhang‐Jin Zhang","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4407387224","eid":"W4407387224"},{"id":"paper-w2268466571","cat":"papers","name":"MERCANTE, Marcelo S. 2012. Imagens de Cura: Ayahuasca, imaginação, saúde e doença na Barquinha","year":"2013","cit":0,"pfa":"Ana Gretel Echazú Böschemeier","ptype":"article","src":"https://openalex.org/W2268466571","eid":"W2268466571"},{"id":"paper-w7163353038","cat":"papers","name":"A scoping review of ayahuasca-assisted therapy for Indigenous people living with addictions: gaps, lessons learned and policy implications","year":"2026","cit":0,"pfa":"Marion Maar","psa":"Carol Eshkakogan","topics":["Addiction","Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7163353038","eid":"W7163353038"},{"id":"paper-w65066320","cat":"papers","name":"Prenatal exposure to 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) has lasting consequences on neural development and behavior","year":"2010","cit":0,"pfa":"Valerie B. Thompson","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W65066320","eid":"W65066320"},{"id":"paper-w4403152379","cat":"papers","name":"Decision letter for \"Psilocybin reduces functional correlation and the encoding of spatial information by neurons in mouse retrosplenial cortex\"","year":"2024","cit":0,"topics":["Mechanism & neuroscience"],"ptype":"peer-review","src":"https://openalex.org/W4403152379","eid":"W4403152379"},{"id":"paper-w7126211216","cat":"papers","name":"Additional file 2 of An open-label pilot study of psilocybin-assisted therapy for binge eating disorder","year":"2026","cit":0,"pfa":"Jesse Dallery","psa":"Beverlee Loeser","ptype":"article","src":"https://openalex.org/W7126211216","eid":"W7126211216"},{"id":"paper-w3168868344","cat":"papers","name":"[Comment to article 'Altered Vision : Ayahuasca Shamanism and Sensory Individualism' / Alex K. Gearin and Oscar Calavia S]","year":"2021","cit":0,"pfa":"Pirjo Kristiina Virtanen","ptype":"article","src":"https://openalex.org/W3168868344","eid":"W3168868344"},{"id":"paper-w4399193551","cat":"papers","name":"Transfer Learning Between fMRI-Based Predictors of Treatment Outcome with Psilocybin and Escitalopram in Patients with Major Depression","year":"2024","cit":0,"pfa":"Débora Copa","psa":"Enzo Tagliazucchi","topics":["Depression","Mechanism & neuroscience"],"ptype":"conference-paper","src":"https://openalex.org/W4399193551","eid":"W4399193551"},{"id":"paper-w4407387345","cat":"papers","name":"BEHAVIORAL PHENOTYPING AND METABOLOMIC COMPARISON OF CHEMICALLY SYNTHESIZED PSILOCYBIN AND PSYCHEDELIC MUSHROOM EXTRACT IN A ZEBRAFISH DEPRESSION MODEL","year":"2025","cit":0,"pfa":"Leonard B. Lerer","psa":"Bernard Lerer","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W4407387345","eid":"W4407387345"},{"id":"paper-w7106648726","cat":"papers","name":"Brain-MGF: Multimodal Graph Fusion Network for EEG-fMRI Brain Connectivity Analysis Under Psilocybin","year":"2025","cit":0,"pfa":"Yap, Sin-Yee","psa":"Ting, Chee-Ming","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7106648726","eid":"W7106648726"},{"id":"paper-w7161565162","cat":"papers","name":"Appetite for change: How nutritional state and ventral striatal dopamine shape psilocybin effects on cognitive flexibility","year":"2026","cit":0,"pfa":"Kyna Conn","psa":"Claire J. Foldi","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7161565162","eid":"W7161565162"},{"id":"paper-w4409999287","cat":"papers","name":"Psilocybin-gestützte Therapie von Depression, Angst und Suchtstörungen: Neurobiologische Grundlagen und klinische Anwendung","year":"2025","cit":0,"pfa":"Anna Lasch","psa":"Andreas Walther","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4409999287","eid":"W4409999287"},{"id":"paper-w4400358126","cat":"papers","name":"O uso terapêutico da Ayahuasca no transtorno de ansiedade generalizada: uma revisão sistemática da literatura","year":"2024","cit":0,"pfa":"Meyson Santos Silva","psa":"Jéssica Shâmea Borges e Silva","ptype":"article","src":"https://openalex.org/W4400358126","eid":"W4400358126"},{"id":"paper-w4388363682","cat":"papers","name":"DOES THE PHENOMENOLOGY OF THE PSILOCYBIN EXPERIENCE PREDICT LONG-TERM EFFECTS ON MOOD AND WELL-BEING IN HEALTHY VOLUNTEERS?","year":"2023","cit":0,"pfa":"Tomáš Páleníček","psa":"Martin Brunovský","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4388363682","eid":"W4388363682"},{"id":"paper-w4413285103","cat":"papers","name":"317. PSILOCYBIN DOES NOT INDUCE CONDITIONED PLACE PREFERENCE, BUT MODIFIES BEHAVIORAL PATTERNS IN SPRAGUE-DAWLEY RATS","year":"2025","cit":0,"pfa":"V Bruno","psa":"Gabriella Gobbi","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4413285103","eid":"W4413285103"},{"id":"paper-w7117235785","cat":"papers","name":"Psilocybin Maintains Better Brain Function in an Alzheimer’s Disease Model with Reduced Neuroinflammation and Improved Hippocampal Neurogenesis","year":"2025","cit":0,"pfa":"Leelavathi Narayana Madhu","psa":"Ashok Kumar Shetty","topics":["Depression","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7117235785","eid":"W7117235785"},{"id":"paper-w7126230928","cat":"papers","name":"Additional file 2 of An open-label pilot study of psilocybin-assisted therapy for binge eating disorder","year":"2026","cit":0,"pfa":"Jesse Dallery","psa":"Beverlee Loeser","ptype":"article","src":"https://openalex.org/W7126230928","eid":"W7126230928"},{"id":"paper-w7203667278","cat":"papers","name":"\"BaZi Birth-Chart Favorability and Psychological Growth Following Ayahuasca Ceremonies: A Pre-Registered Retrospective Correlational Study","year":"2026","cit":0,"pfa":"Fabrizio Dimitri Boris Beverina","topics":["Safety & adverse events","Reviews & meta-analyses","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7203667278","eid":"W7203667278"},{"id":"paper-w3136952438","cat":"papers","name":"Sartre et l'expérimentation de la mescaline dans le contexte de la psychopathologie française des années 1930","year":"2021","cit":0,"pfa":"Gautier Dassonneville","topics":["Addiction"],"ptype":"other","src":"https://openalex.org/W3136952438","eid":"W3136952438"},{"id":"paper-w3043257560","cat":"papers","name":"Desenmascarar lo \"alternativo\" : empresarios de sí y la búsqueda de ayahuasca en la Amazonía","year":"2020","cit":0,"pfa":"Nicolás Botero Correal","ptype":"dissertation","src":"https://openalex.org/W3043257560","eid":"W3043257560"},{"id":"paper-w7163319741","cat":"papers","name":"A scoping review of ayahuasca-assisted therapy for Indigenous people living with addictions: gaps, lessons learned and policy implications","year":"2026","cit":0,"pfa":"Marion Maar","psa":"Carol Eshkakogan","topics":["Addiction","Reviews & meta-analyses","Therapy practice"],"ptype":"dataset","src":"https://openalex.org/W7163319741","eid":"W7163319741"},{"id":"paper-w7117973888","cat":"papers","name":"Psilocybin during the postpartum period induces long-lasting adverse effects in both mothers and offspring- dataset","year":"2025","cit":0,"pfa":"Danielle S. Stolzenberg","topics":["Safety & adverse events"],"ptype":"dataset","src":"https://openalex.org/W7117973888","eid":"W7117973888"},{"id":"paper-w7213933930","cat":"papers","name":"Reply: The consequences of MDMA use are not easily disentangled from other drug use or lifestyle factors","year":"2026","cit":0,"pfa":"Boris B. Quednow","psa":"Rebecca C. Coray","ptype":"article","src":"https://openalex.org/W7213933930","eid":"W7213933930"},{"id":"paper-w4313201140","cat":"papers","name":"Acute psilocybin and ketanserin effects on cerebral blood flow: 5-HT2AR neuromodulatory effects in healthy humans","year":"2022","cit":0,"pfa":"K. Larsen","psa":"Patrick M. Fisher","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4313201140","eid":"W4313201140"},{"id":"paper-w4390576889","cat":"papers","name":"Decision letter for \"Psilocybin as a lead candidate molecule in preclinical therapeutic studies of psychiatric disorders: A systematic review\"","year":"2023","cit":0,"topics":["Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4390576889","eid":"W4390576889"},{"id":"paper-w7202191340","cat":"papers","name":"Psilocybin-associated microRNA changes in the pig brain: Establishing an nCounter pipeline for cross-species microRNA quantification","year":"2026","cit":0,"pfa":"Erik Kaadt","psa":"Betina Elfving","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7202191340","eid":"W7202191340"},{"id":"paper-w7211936605","cat":"papers","name":"A Two-Threshold Model of Psilocybin Response Explains Variability in Psychedelic-Assisted Therapy for Treatment-Resistant Depression","year":"2026","cit":0,"pfa":"Jesús Isaac Castillo Sánchez","topics":["Depression"],"ptype":"preprint","src":"https://openalex.org/W7211936605","eid":"W7211936605"},{"id":"paper-w31736357","cat":"papers","name":"Ultrastructural alteration of cortical serotonergic fibers after MDMA (ecstasy) treatment in Dark Agouti rat","year":"2009","cit":0,"pfa":"Bagdy György","ptype":"article","src":"https://openalex.org/W31736357","eid":"W31736357"},{"id":"paper-w2614574376","cat":"papers","name":"Motivationen und Morphologie des Freizeitgebrauchs von Psychedelika (LSD, Psilocybin-Pilze) : eine qualitative Interviewstudie","year":"2016","cit":0,"pfa":"Susanna Prepeliczay","ptype":"article","src":"https://openalex.org/W2614574376","eid":"W2614574376"},{"id":"paper-w7160494262","cat":"papers","name":"361 Effect of intravenous psilocybin on mechanical hypersensitivity in a rat model of reserpine-induced chronic centralized pain","year":"2026","cit":0,"pfa":"Emma Huels","psa":"Dinesh Pal","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7160494262","eid":"W7160494262"},{"id":"paper-w7126159137","cat":"papers","name":"Enhancing mindfulness and compassion through an ayahuasca-inspired formulation containing N,N-DMT and harmine: A randomized controlled trial in healthy subjects","year":"2025","cit":0,"pfa":"Helena Aicher","psa":"Milan Scheidegger","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7126159137","eid":"W7126159137"},{"id":"paper-w4234723109","cat":"papers","name":"P.6.028 Does repeated treatment with MDMA sensitize to its effects on agonistic behaviour in mice?","year":"2005","cit":0,"ptype":"article","src":"https://openalex.org/W4234723109","eid":"W4234723109"},{"id":"paper-w3135788091","cat":"papers","name":"Does MDMA-Assisted Psychotherapy Result in Symptom Improvement in Adults with Posttraumatic Stress Disorder (PTSD)?","year":"2020","cit":0,"pfa":"Nicole Ulrick","topics":["PTSD & trauma","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3135788091","eid":"W3135788091"},{"id":"paper-w4395959578","cat":"papers","name":"378. Neural Circuit Delineation of (±)-3,4-methylenedioxymethamphetamine (MDMA)-evoked Sociability and Fear Memory Deficits","year":"2024","cit":0,"pfa":"Austen Casey","psa":"Boris Dov Heifets","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4395959578","eid":"W4395959578"},{"id":"paper-w7153539587","cat":"papers","name":"Effects of MDMA treatment and cessation on sexual behaviour and testicular functions in male sprague-dawley rats","year":"2026","cit":0,"pfa":"O.O. Obembe","psa":"R.E. Akhigbe","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7153539587","eid":"W7153539587"},{"id":"paper-w4403257475","cat":"papers","name":"Cardiac Histomorphological Alterations in Adult Wistar Rats Following Exposure to 3,4- Methylenedioxymethamphetamine (MDMA) Pills","year":"2024","cit":0,"pfa":"Idehen I.C.","psa":"Iyevhobu Kenneth Oshiokhayamhe","ptype":"article","src":"https://openalex.org/W4403257475","eid":"W4403257475"},{"id":"paper-w7125708655","cat":"papers","name":"The Universal Law of Machine Intelligence: Machine Decision-Making Ability (MDMA) Across Technological Eras","year":"2026","cit":0,"pfa":"Muhammad Rashid","topics":["Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7125708655","eid":"W7125708655"},{"id":"paper-w3106412487","cat":"papers","name":"Linguagens artísticas e o uso da ayahuasca: povos indígenas Huni Kuin e Shipibo Konibo","year":"2020","cit":0,"pfa":"Larissa Alves Medrado Aguiar","ptype":"article","src":"https://openalex.org/W3106412487","eid":"W3106412487"},{"id":"paper-w7163694045","cat":"papers","name":"Prenatal stress, excitatory-inhibitory imbalance, and ADHD risk: a hypothesis-driven perspective on psilocybin-induced neuroplasticity","year":"2026","cit":0,"pfa":"Samaneh Ahmadian-Moghadam","psa":"Ehsan Saboory","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7163694045","eid":"W7163694045"},{"id":"paper-w7141273400","cat":"papers","name":"AI-Powered Prediction of Psilocybin Production from Microscopy Images of Aspergillus nidulans in Stirred-Tank Reactors","year":"2026","cit":0,"pfa":"Parastoo Akbarimoghaddam","psa":"Marc Thilo Figge","ptype":"dataset","src":"https://openalex.org/W7141273400","eid":"W7141273400"},{"id":"paper-w4250324256","cat":"papers","name":"MDMA (\"ecstasy\") administration provokes changes in the temporal and sequential structure of the agonistic behaviour in male mice","year":"2000","cit":0,"pfa":"E. Maldonado","psa":"J. F. Navarro","ptype":"dataset","src":"https://openalex.org/W4250324256","eid":"W4250324256"},{"id":"paper-w4411003099","cat":"papers","name":"MDMA-Assisted Treatment for PTSD, Anxiety, and Depression: A Visualized Literature Analysis over 30 Years","year":"2025","cit":0,"pfa":"Jinlong Zhang","psa":"Jie Yan","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4411003099","eid":"W4411003099"},{"id":"paper-w7159905393","cat":"papers","name":"Efeito do uso prolongado de cetamina e ayahuasca na memória ao longo do envelhecimento","year":"2025","cit":0,"pfa":"Vitória Malikovski Castello","ptype":"conference-abstract","src":"https://openalex.org/W7159905393","eid":"W7159905393"},{"id":"paper-w4311684896","cat":"papers","name":"Faculty Opinions recommendation of Psilocybin mitigates the cognitive deficits observed in a rat model of Fragile X syndrome.","year":"2022","cit":0,"pfa":"Randi Jenssen Hagerman","ptype":"peer-review","src":"https://openalex.org/W4311684896","eid":"W4311684896"},{"id":"paper-w4254670845","cat":"papers","name":"Faculty Opinions recommendation of Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study.","year":"2016","cit":0,"pfa":"Rainer Spanagel","topics":["Depression"],"ptype":"peer-review","src":"https://openalex.org/W4254670845","eid":"W4254670845"},{"id":"paper-w4390592860","cat":"papers","name":"Author response for \"Psilocybin as a lead candidate molecule in preclinical therapeutic studies of psychiatric disorders: A systematic review\"","year":"2023","cit":0,"pfa":"James J Gattuso","psa":"Thibault Renoir","topics":["Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4390592860","eid":"W4390592860"},{"id":"paper-w7134964970","cat":"papers","name":"Impact of formulation variables on the quality attributes of psilocybin-loaded oral thin films for early-phase development","year":"2026","cit":0,"pfa":"Vorawut Wongumpornpinit","psa":"Raimar Löebenberg","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7134964970","eid":"W7134964970"},{"id":"paper-w7126212517","cat":"papers","name":"Additional file 1 of An open-label pilot study of psilocybin-assisted therapy for binge eating disorder","year":"2026","cit":0,"pfa":"Jesse Dallery","psa":"Beverlee Loeser","ptype":"article","src":"https://openalex.org/W7126212517","eid":"W7126212517"},{"id":"paper-w7124985959","cat":"papers","name":"Effects of psilocybin and chronic mild stress on microglial activation in rat spinal cord: an ex vivo analysis","year":"2026","cit":0,"pfa":"Piotr Olejnik","psa":"Kaja Kasarełło","ptype":"article","src":"https://openalex.org/W7124985959","eid":"W7124985959"},{"id":"paper-w7172078146","cat":"papers","name":"Shrooming Ahead: How the U.S. is Marching Toward Psilocybin Legalization and What Other Countries May Learn","year":"2026","cit":0,"pfa":"Titus Scheid","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7172078146","eid":"W7172078146"},{"id":"paper-w7204464270","cat":"papers","name":"Longitudinal changes in depressive symptoms following naturalistic ayahuasca use: A prospective cohort study in Las Vegas, Nevada","year":"2026","cit":0,"pfa":"Krista Whitley","psa":"Kristina Domanski","topics":["Depression"],"ptype":"preprint","src":"https://openalex.org/W7204464270","eid":"W7204464270"},{"id":"paper-w4390593572","cat":"papers","name":"Decision letter for \"Psilocybin as a lead candidate molecule in preclinical therapeutic studies of psychiatric disorders: A systematic review\"","year":"2023","cit":0,"topics":["Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4390593572","eid":"W4390593572"},{"id":"paper-w4229984640","cat":"papers","name":"ChemInform Abstract: PSILOCIN ANALOGS. 1. SYNTHESIS OF 3‐(2‐(DIALKYLAMINO)ETHYL)‐ AND 3‐(2‐(CYCLOALKYLAMINO)ETHYL)INDOL‐4‐OLS","year":"1977","cit":0,"pfa":"David B. Repke","psa":"Dallas K. Bates","ptype":"article","src":"https://openalex.org/W4229984640","eid":"W4229984640"},{"id":"paper-w4407387447","cat":"papers","name":"ASSOCIATIONS BETWEEN ESCITALOPRAM AND PSILOCYBIN THERAPY AND BRAIN RESTING-STATE FUNCTIONAL CONNECTIVITY IN MAJOR DEPRESSIVE DISORDER","year":"2025","cit":0,"pfa":"Rebecca Harding","psa":"Rayyan R. Zafar","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4407387447","eid":"W4407387447"},{"id":"paper-w4412490624","cat":"papers","name":"Correction to “Acceptability of psilocybin‐assisted group therapy in patients with cancer and major depressive disorder: Qualitative analysis”","year":"2025","cit":0,"topics":["Depression","Anxiety & end-of-life"],"ptype":"erratum","src":"https://openalex.org/W4412490624","eid":"W4412490624"},{"id":"paper-w7125573025","cat":"papers","name":"A stranger in a strange land: negotiating supernatural 'fact' and 'fiction' within visions and hallucinations in non-traditional ayahuasca churches","year":"2025","cit":0,"pfa":"Andrew Dean","psa":"Rajindra K. Puri","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7125573025","eid":"W7125573025"},{"id":"paper-w7130833121","cat":"papers","name":"Increased cortical thickness and decreased brain age among special operations veterans with blast TBI after a magnesium-ibogaine protocol","year":"2026","cit":0,"pfa":"Andrew D. Geoly","psa":"Nolan Williams","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7130833121","eid":"W7130833121"},{"id":"paper-w4247029755","cat":"papers","name":"Faculty Opinions recommendation of The hallucinogenic herb Salvia divinorum and its active ingredient salvinorin A inhibit enteric cholinergic transmission in the guinea-pig ileum.","year":"2006","cit":0,"pfa":"Jackie D. Wood","ptype":"peer-review","src":"https://openalex.org/W4247029755","eid":"W4247029755"},{"id":"paper-w4413284549","cat":"papers","name":"631. PSILOCYBIN AND KETANSERIN VS RTMS IN TREATMENT-RESISTANT DEPRESSION: ENHANCING TOLERABILITY BY MITIGATING PSYCHEDELIC EFFECTS","year":"2025","cit":0,"pfa":"Giovanni Martinotti","psa":"Mauro Pettorruso","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W4413284549","eid":"W4413284549"},{"id":"paper-w7154825459","cat":"papers","name":"Additional file 1 of Evaluation of a facilitator training program in a randomized controlled trial of psilocybin treatment for depression","year":"2026","cit":0,"pfa":"Nikita Sanati Morel","psa":"Maria Beckman","topics":["Depression","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7154825459","eid":"W7154825459"},{"id":"paper-w7214038418","cat":"papers","name":"Data from: 5-HT2ARs in layer 5 pyramidal neurons mediate the neuroplastic but not the hallucinogenic effects of psilocybin","year":"2026","cit":0,"pfa":"Baker, Jacob","psa":"Yi Zuo","topics":["Mechanism & neuroscience"],"ptype":"dataset","src":"https://openalex.org/W7214038418","eid":"W7214038418"},{"id":"paper-w4400575216","cat":"papers","name":"Acute Psychedelic Effects and Clinical Outcomes are Associated With Therapeutic Alliance Among Participants Receiving Psilocybin Therapy","year":"2024","cit":0,"pfa":"Alan K. Davis","psa":"Roland R. Griffiths","ptype":"article","src":"https://openalex.org/W4400575216","eid":"W4400575216"},{"id":"paper-w4417034603","cat":"papers","name":"Griffiths et al.’s Study of Psilocybin with Religious Professionals: A Theological Response from a Christian Perspective","year":"2025","cit":0,"pfa":"Joseph Lorenz","psa":"Bryan McCarthy","topics":["Safety & adverse events"],"ptype":"editorial","src":"https://openalex.org/W4417034603","eid":"W4417034603"},{"id":"paper-w2125847506","cat":"papers","name":"ChemInform Abstract: Modified Ibogaine Fragments: Synthesis and Preliminary Pharmacological Characterization of 3‐Ethyl‐5‐phenyl‐1,2,3,4,5,6‐hexahydroazepino[4,5‐b]benzothiophenes.","year":"1999","cit":0,"pfa":"Simon M. N. Efange","psa":"Quinjie Ouyang","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2125847506","eid":"W2125847506"},{"id":"paper-w4251721784","cat":"papers","name":"P.2.083 Long term effects of 3,4-Methylenedioxy-methamphetamine (MDMA) on serotoninergic neurotransmission in mice","year":"2005","cit":0,"topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4251721784","eid":"W4251721784"},{"id":"paper-w4404033579","cat":"papers","name":"Preliminary safety and effectiveness of psilocybin-assisted therapy in adults with fibromyalgia: An open-label, pilot clinical trial","year":"2024","cit":0,"pfa":"Jacob S. Aday","psa":"Kevin F. Boehnke","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4404033579","eid":"W4404033579"},{"id":"paper-w4408935843","cat":"papers","name":"Evaluating the Influence of CYP450 Enzyme Inducers on the Efficacy of Psilocybin as a Treatment for Neuropsychiatric Disorders (Abstract ID: 167358)","year":"2025","cit":0,"pfa":"Elmira Zolali","psa":"Samuel Obeng","ptype":"article","src":"https://openalex.org/W4408935843","eid":"W4408935843"},{"id":"paper-w4391138711","cat":"papers","name":"Desenvolvimento de método baseado em Toxicologia Analítica Verde para determinação dos componentes ativos da ayahuasca em cabelo","year":"2023","cit":0,"pfa":"Fabiana Pereira Santos","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W4391138711","eid":"W4391138711"},{"id":"paper-w7128533889","cat":"papers","name":"Representing mental images and immaterial processes in VR. A new materialist reading of Manic VR and Ayahuasca – Kosmik Journey","year":"2026","cit":0,"pfa":"Desiree Foerster","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7128533889","eid":"W7128533889"},{"id":"paper-w4254600485","cat":"papers","name":"Faculty Opinions recommendation of Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial.","year":"2020","cit":0,"pfa":"Dave Nichols","topics":["Depression"],"ptype":"peer-review","src":"https://openalex.org/W4254600485","eid":"W4254600485"},{"id":"paper-w7163900033","cat":"papers","name":"Revealing shortcomings in the assessment of psilocybin effects on OCD-related symptoms in preclinical and clinical studies: A systematic review","year":"2026","cit":0,"pfa":"Marzieh Jalalian-Javadpour","psa":"Salar Vaseghi","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"review","src":"https://openalex.org/W7163900033","eid":"W7163900033"},{"id":"paper-w7161761100","cat":"papers","name":"MDMA-Assisted Therapy Randomized Controlled Trial Incremental Effects Systematic Review and Meta-Analysis","year":"2026","cit":0,"pfa":"Nicholas C. Borgogna","psa":"Benjamin David Hill","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W7161761100","eid":"W7161761100"},{"id":"paper-w4399126541","cat":"papers","name":"AS PLANTAS DE PODER NO FIM DO NOVO MUNDO: INTERLOCUÇÕES ENTRE LEGALIZAÇÃO, CONSERVAÇÃO E SABERES TRADICIONAIS ASSOCIADOS À AYAHUASCA","year":"2024","cit":0,"pfa":"Luana Lopes Souto Maior","psa":"Raquel Giffoni Pinto","topics":["Policy & ethics"],"ptype":"conference-paper","src":"https://openalex.org/W4399126541","eid":"W4399126541"},{"id":"paper-w7124744927","cat":"papers","name":"Systematic study of Panaeolus (Agaricales, Galeropsidaceae) sensu lato and psilocybin-producing traits of species from China","year":"2026","cit":0,"pfa":"Mao-Qiang He","psa":"Rui-Lin Zhao","topics":["Reviews & meta-analyses"],"ptype":"dataset","src":"https://openalex.org/W7124744927","eid":"W7124744927"},{"id":"paper-w2330583829","cat":"papers","name":"ChemInform Abstract: CHEMIE DES INDOLS 5. MITT. SYNTH. IN DER IBOGA‐REIHE 2. MITT. 8‐OXO‐DESAETHYLIBOGAIN UND DESAETHYLISOIBOGAIN","year":"1973","cit":0,"pfa":"Peter Rosenmund","psa":"Rainer Frische","ptype":"article","src":"https://openalex.org/W2330583829","eid":"W2330583829"},{"id":"paper-w7115770299","cat":"papers","name":"Supplementary material for: Regional specificity of the cingulate cortex thickness association with the intensity of psilocybin experience: a replication study","year":"2025","cit":0,"pfa":"Gregus, David","psa":"Horacek, Jiri","topics":["Mechanism & neuroscience"],"ptype":"supplementary-materials","src":"https://openalex.org/W7115770299","eid":"W7115770299"},{"id":"paper-w7202142995","cat":"papers","name":"Psilocybin acutely dissociates cognitive and affective empathy, with empathic concern predicting persisting positive psychological effects","year":"2026","cit":0,"pfa":"Natasha Leigh Mason","psa":"Johannes Gerardus Ramaekers","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7202142995","eid":"W7202142995"},{"id":"paper-w7171563745","cat":"papers","name":"Sustaining engagement: how research participation supports integration and retention in oregon’s state-regulated psilocybin services","year":"2026","cit":0,"pfa":"Megan Cheslock","topics":["Reviews & meta-analyses","Therapy practice","Policy & ethics"],"ptype":"other","src":"https://openalex.org/W7171563745","eid":"W7171563745"},{"id":"paper-w7204167115","cat":"papers","name":"Beyond head-twitch response: Acute psilocybin affects spontaneous behaviors in rats in a dose-dependent manner","year":"2026","cit":0,"pfa":"Praachi Tiwari","psa":"Elise M. Weerts","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7204167115","eid":"W7204167115"},{"id":"paper-w2499999505","cat":"papers","name":"O uso da Ayahuasca no contexto urbano: um lugar entre o tradicional e o moderno.","year":"2013","cit":0,"pfa":"Fábio Eduardo Celant","ptype":"dissertation","src":"https://openalex.org/W2499999505","eid":"W2499999505"},{"id":"paper-w2800829760","cat":"papers","name":"Perfil conductual de mdma (éxtasis) en modelos animales de agresión y ansiedad","year":"2000","cit":0,"pfa":"E. Maldonado","ptype":"article","src":"https://openalex.org/W2800829760","eid":"W2800829760"},{"id":"paper-w2610855172","cat":"papers","name":"Effects of MDMA (\"ecstasy\") on dopaminergic radioligand binding in rat striatum - a combined PET/autoradiographic study","year":"2007","cit":0,"pfa":"Søren Dinesen Østergaard","psa":"Paul D. Cumming","ptype":"conference-paper","src":"https://openalex.org/W2610855172","eid":"W2610855172"},{"id":"paper-w406237426","cat":"papers","name":"Executive Working Memory Deficits in Abstinent Ecstasy/MDMA Users: A Critical Review (Keynote Presentation)","year":"2008","cit":0,"pfa":"P. Murphy","psa":"Catharine Montgomery","topics":["Reviews & meta-analyses"],"ptype":"conference-paper","src":"https://openalex.org/W406237426","eid":"W406237426"},{"id":"paper-w7118011913","cat":"papers","name":"Low dose psilocybin differentially alters resting-state network connectivity in autistic and non-autistic people","year":"2026","cit":0,"pfa":"T.P. Whelan","psa":"G.M. McAlonan","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7118011913","eid":"W7118011913"},{"id":"paper-w330194263","cat":"papers","name":"Estudio de la apoptosis inducida por la mdma. En células hepáticas de rata","year":"2002","cit":0,"pfa":"Cristina Montiel‐Duarte","ptype":"dissertation","src":"https://openalex.org/W330194263","eid":"W330194263"},{"id":"paper-w3084944872","cat":"papers","name":"Ethanol, 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and their combination: long-term behavioral, neurochemical and neuropharmacological effects in the rat","year":"2005","cit":0,"pfa":"Jean‐Christophe Cassel","psa":"Rolf Jackisch","topics":["Dosing & pharmacology"],"ptype":"conference-paper","src":"https://openalex.org/W3084944872","eid":"W3084944872"},{"id":"paper-w1501909134","cat":"papers","name":"The acute and long-term effects of 3,4-methylenedioxymethamphetamine (MDMA; 'ecstasy') upon cerebral and cerebrovascular serotonergic processes","year":"2004","cit":0,"pfa":"Linda Ferrington","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W1501909134","eid":"W1501909134"},{"id":"paper-w4210967656","cat":"papers","name":"Faculty Opinions recommendation of Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo.","year":"2021","cit":0,"pfa":"Joël Bockaert","topics":["Mechanism & neuroscience"],"ptype":"peer-review","src":"https://openalex.org/W4210967656","eid":"W4210967656"},{"id":"paper-w4200432780","cat":"papers","name":"P.0593 Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals","year":"2021","cit":0,"pfa":"Drummond E-Wen McCulloch","psa":"Patrick M. Fisher","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4200432780","eid":"W4200432780"},{"id":"paper-w2386471769","cat":"papers","name":"Analytical Methods for Determination of MDMA and MDA in Urine by Acyl Derivatization and Gas Chromatography with Nitrogen-Phosphorous Detection","year":"2007","cit":0,"pfa":"Hui Song","ptype":"article","src":"https://openalex.org/W2386471769","eid":"W2386471769"},{"id":"paper-w4390576864","cat":"papers","name":"Author response for \"Psilocybin as a lead candidate molecule in preclinical therapeutic studies of psychiatric disorders: A systematic review\"","year":"2023","cit":0,"pfa":"James J Gattuso","psa":"Thibault Renoir","topics":["Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4390576864","eid":"W4390576864"},{"id":"paper-w7141360090","cat":"papers","name":"AI-Powered Prediction of Psilocybin Production from Microscopy Images of Aspergillus nidulans in Stirred-Tank Reactors","year":"2026","cit":0,"pfa":"Parastoo Akbarimoghaddam","psa":"Marc Thilo Figge","ptype":"dataset","src":"https://openalex.org/W7141360090","eid":"W7141360090"},{"id":"paper-w7171554840","cat":"papers","name":"Long- term administration of low doses of psilocybin causes epigenetic changes in the rat medial prefrontal cortex","year":"2026","cit":0,"pfa":"Agnieszka Wawrzczak‐Bargieła","psa":"Marzena Maćkowiak","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7171554840","eid":"W7171554840"},{"id":"paper-w7213707071","cat":"papers","name":"Explorando os efeitos da ayahuasca sobre o comportamento alimentar em camundongos em compulsão alimentar","year":"2026","cit":0,"pfa":"Cristian Ferreira Corona","ptype":"article","src":"https://openalex.org/W7213707071","eid":"W7213707071"},{"id":"paper-w2552744428","cat":"papers","name":"A comparison of MDMA (Ecstasy) and 3,4-methylenedioxymethcathinone (Methylone) in their acute behavioural effects and development of tolerance in rats","year":"2016","cit":0,"pfa":"Mark L. Davidson","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W2552744428","eid":"W2552744428"},{"id":"paper-w4220941856","cat":"papers","name":"Biotic interactions prior to seed dispersal determine recruitment probability of peyote (Lophophora diffusa, Cactaceae), a threatened species pollinator-dependent","year":"2022","cit":0,"pfa":"María Isabel Briseño-Sánchez","psa":"María C. Mandujano","ptype":"preprint","src":"https://openalex.org/W4220941856","eid":"W4220941856"},{"id":"paper-w3047172457","cat":"papers","name":"Simultaneous determination of amphetamine (AM), methamphetamine (MA), methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) by GC/MS in Hair","year":"2001","cit":0,"pfa":"J.S. Lee","psa":"Young-Chan Yoo","ptype":"article","src":"https://openalex.org/W3047172457","eid":"W3047172457"},{"id":"paper-w1981007334","cat":"papers","name":"De langetermijngevolgen van mdma-gebruik op het serotonerge systeem, het werkgeheugen en impulsiviteit","year":"2009","cit":0,"pfa":"Jeroen Heijden","ptype":"article","src":"https://openalex.org/W1981007334","eid":"W1981007334"},{"id":"paper-w305965607","cat":"papers","name":"Estudo exploratório sobre o sentido da experiência subjectiva com a ayahuasca através do método fenomenológico","year":"2014","cit":0,"pfa":"Campos, Andreia Vanessa Mateus","ptype":"dissertation","src":"https://openalex.org/W305965607","eid":"W305965607"},{"id":"paper-w2902196301","cat":"papers","name":"O cipó, a folha e o apuro: visões e imagens de uma etnografia da ayahuasca","year":"2018","cit":0,"pfa":"Rafael Hupsel Palomo Garcia","topics":["Addiction"],"ptype":"dissertation","src":"https://openalex.org/W2902196301","eid":"W2902196301"},{"id":"paper-w2971745984","cat":"papers","name":"ETNOFARMACOLOGIA, AYAHUASCA, E AS POSSIBILIDADES TERAPÊUTICAS PARA O USO ABUSIVO DE ÁLCOOL E OUTRAS DROGAS","year":"2019","cit":0,"pfa":"Rodrigo Scalabrin","psa":"Lincoln Costa Valença","ptype":"book-chapter","src":"https://openalex.org/W2971745984","eid":"W2971745984"},{"id":"paper-w7148459901","cat":"papers","name":"Psilocybin and Emotional Breakthrough: A Comprehensive Umbrella Review and Theoretical Integration [SCIENTIFIC V7.0 - Q1 HIGH-IMPACT]","year":"2026","cit":0,"pfa":"Juan Moises de la Serna","topics":["Reviews & meta-analyses","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7148459901","eid":"W7148459901"},{"id":"paper-w2045437420","cat":"papers","name":"Two kinds of modification by 5-methoxy-N,N-dimethyltryptamine of contractile responses to electrical stimulation of isolated guinea-pig vas deferens.","year":"1987","cit":0,"pfa":"Soichi Yoshida","psa":"Tetsurō Kuga","ptype":"article","src":"https://openalex.org/W2045437420","eid":"W2045437420"},{"id":"paper-w7167497412","cat":"papers","name":"A nondirective physical and psychological support protocol for inhaled N,N-Dimethyltryptamine (DMT): A qualitative evaluation of safety, comfort, and integration in a clinical setting.","year":"2026","cit":0,"pfa":"Handersson Barros","psa":"Dráulio Barros de Araújo","topics":["Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7167497412","eid":"W7167497412"},{"id":"paper-w4242625924","cat":"papers","name":"The Role of Trait Impulsivity and Novelty-Seeking as Predisposing Factors to the Acquisition and Reinstatement of MDMA Self-Administration","year":"2013","cit":0,"pfa":"Judith Bird","topics":["Safety & adverse events","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W4242625924","eid":"W4242625924"},{"id":"paper-w2899012999","cat":"papers","name":"System Capacity and Convergence Rate Evaluation for Downlink Power Control in 5G MDMA Cellular Systems","year":"2018","cit":0,"pfa":"Wei‐Han Hsiao","psa":"Chia-Chi Huang","ptype":"conference-paper","src":"https://openalex.org/W2899012999","eid":"W2899012999"},{"id":"paper-w7160419075","cat":"papers","name":"Glutathione as a Potential Neuroprotectant Against MDMA-Induced Oxidative Stress, Neuroinflammation, and Apoptosis in the Rat Brain","year":"2026","cit":0,"pfa":"Oyedayo Phillips Akano","psa":"Ayodeji Folorunsho Ajayi","ptype":"article","src":"https://openalex.org/W7160419075","eid":"W7160419075"},{"id":"paper-w4405636616","cat":"papers","name":"Clinical pharmacokinetics of N,N-dimethyltryptamine: a systematic review and post-hoc analysis to guide future clinical studies for neuropsychiatric indications","year":"2024","cit":0,"pfa":"K. Van Der Heijden","psa":"G. Jacobs","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4405636616","eid":"W4405636616"},{"id":"paper-w7212445696","cat":"papers","name":"Psilocybin for Depressive and Anxiety Disorders (2022–2026): Hybrid Bibliometric Analysis and Systematic Review (protocol phase)","year":"2026","cit":0,"pfa":"Andrea Estefanía Aranda Rosas","psa":"Miguel Á. Trejo-Rodríguez","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"other","src":"https://openalex.org/W7212445696","eid":"W7212445696"},{"id":"paper-w1015080330","cat":"papers","name":"摇头丸（MDMA）的危害及其分析检验","year":"2006","cit":0,"pfa":"秦总根","ptype":"article","src":"https://openalex.org/W1015080330","eid":"W1015080330"},{"id":"paper-w4387295290","cat":"papers","name":"Microneedle array-based electrochemical sensor functionalized with nanomaterials for the highly sensitive monitoring of MDMA in interstitial fluid","year":"2023","cit":0,"pfa":"Ana-Maria Drăgan","psa":"Karolien De Wael","ptype":"article","src":"https://openalex.org/W4387295290","eid":"W4387295290"},{"id":"paper-w7213307049","cat":"papers","name":"Differential alterations in peripheral tryptophan pathways in methamphetamine versus MDMA users are linked to their contrasting psychiatric symptoms","year":"2026","cit":0,"pfa":"Francesco Bavato","psa":"Boris B. Quednow","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7213307049","eid":"W7213307049"},{"id":"paper-w2073690096","cat":"papers","name":"Molecular biological analyses of the augmentation of 5-HT release by sustained MDMA in organotypic raphe slice culture","year":"2009","cit":0,"pfa":"Kazuki Nagayasu","psa":"Shuji Kaneko","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2073690096","eid":"W2073690096"},{"id":"paper-w4380786958","cat":"papers","name":"A rapid scoping review of self-initiated harm reduction strategies for ecstasy (MDMA) users in recreational settings","year":"2023","cit":0,"pfa":"Deborah J. Edwards","psa":"Jane Harden","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4380786958","eid":"W4380786958"},{"id":"paper-w7212270090","cat":"papers","name":"Active deep dive therapy (ADDT): A theoretically grounded model for MDMA-facilitated free-associative psychotherapy","year":"2026","cit":0,"pfa":"Olivier Le Bon","topics":["Depression","Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7212270090","eid":"W7212270090"},{"id":"paper-w7126129743","cat":"papers","name":"A case series of ibogaine toxicity reported to the United Kingdom National Poisons Information Service (NPIS) over a 10-year period","cit":0,"pfa":"Edwards EP","psa":"Coulson JM","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7126129743","eid":"W7126129743"},{"id":"paper-w3107142764","cat":"papers","name":"The Peyote Dance. Soundwalk Collective with Patti Smith. Brighton, England: Bella Union, 2019. MP3 $7.92, CD $14.98, vinyl $25.98.","year":"2020","cit":0,"pfa":"Branislav Jakovljević","ptype":"article","src":"https://openalex.org/W3107142764","eid":"W3107142764"},{"id":"paper-w2520343789","cat":"papers","name":"Alterations in brain mGluR5 and D2 receptor density during MDMA abstinence in different living conditions in rats","year":"2015","cit":0,"pfa":"Małgorzata Frankowska","psa":"Małgorzata Filip","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2520343789","eid":"W2520343789"},{"id":"paper-w2762897777","cat":"papers","name":"Pumpkin Seed Point by Frank Waters, and: The Peyote Religion Among the Navaho by David F. Aberle, and: The Arapaho Way by Althea Bass","year":"1969","cit":0,"pfa":"Thomas J. Lyon","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2762897777","eid":"W2762897777"},{"id":"paper-w1486538390","cat":"papers","name":"La ayahuasca: una planta amazónica para tratar las adicciones: Entrevista con Josep Maria Fàbregas, psiquiatra","year":"2003","cit":0,"pfa":"Pablo Friedländer","ptype":"article","src":"https://openalex.org/W1486538390","eid":"W1486538390"},{"id":"paper-w857716123","cat":"papers","name":"Estudo do efeito da ayahuasca sobre a agressividade de ratos submetidos ao estresse por contenção","year":"2011","cit":0,"pfa":"Marcos Coutinho da Silva","ptype":"article","src":"https://openalex.org/W857716123","eid":"W857716123"},{"id":"paper-w7163358433","cat":"papers","name":"A scoping review of ayahuasca-assisted therapy for Indigenous people living with addictions: gaps, lessons learned and policy implications","year":"2026","cit":0,"pfa":"Marion Maar","psa":"Carol Eshkakogan","topics":["Addiction","Reviews & meta-analyses","Therapy practice"],"ptype":"dataset","src":"https://openalex.org/W7163358433","eid":"W7163358433"},{"id":"paper-w4405233054","cat":"papers","name":"Die subakuten Effekte des Psilocybin auf Persönlichkeit, Achtsamkeit und die Auflösung des Selbst","year":"2024","cit":0,"pfa":"Albert Lehr","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W4405233054","eid":"W4405233054"},{"id":"paper-w4413608041","cat":"papers","name":"How cannabis and psilocybin might help some of the 50 million Americans who are experiencing chronic pain","year":"2024","cit":0,"pfa":"Kevin F. Boehnke","ptype":"other","src":"https://openalex.org/W4413608041","eid":"W4413608041"},{"id":"paper-w2728938858","cat":"papers","name":"Reinvenções e controvérsias: a necessidade da tradição e as disputas em torno da regulamentação da ayahuasca","year":"2017","cit":0,"pfa":"Henrique Fernandes Antunes","ptype":"article","src":"https://openalex.org/W2728938858","eid":"W2728938858"},{"id":"paper-w7119247568","cat":"papers","name":"Teceduras do cipó: uma cartografia das controvérsias da patrimonialização da ayahuasca no Brasil (2008-2019)","year":"2022","cit":0,"pfa":"Maíra de Oliveira Dias","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"dissertation","src":"https://openalex.org/W7119247568","eid":"W7119247568"},{"id":"paper-w2950660687","cat":"papers","name":"Study molecular of interaction between N,N-dimethyltryptamine analogs (DMT) with 5-HT1A and 5-HT1B receptors, associated in neuronal alterations","year":"2019","cit":0,"pfa":"Hilder Mercado-la Peira","psa":"Karick Jotty","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"other","src":"https://openalex.org/W2950660687","eid":"W2950660687"},{"id":"paper-w144660763","cat":"papers","name":"The effects of MDMA on circadian parameters: rates of re-entrainment, phase shifts to triazolam and histological findings","year":"2003","cit":0,"pfa":"Maria Gardani","psa":"Stephany M. Biello","ptype":"article","src":"https://openalex.org/W144660763","eid":"W144660763"},{"id":"paper-w4407169454","cat":"papers","name":"Efectos positivos en el ámbito social de la administración controlada de MDMA","year":"2023","cit":0,"pfa":"Universidad de Cartagena","psa":"Ariel Enrique Pastrana Arias","topics":["Mechanism & neuroscience"],"ptype":"report","src":"https://openalex.org/W4407169454","eid":"W4407169454"},{"id":"paper-w7154853940","cat":"papers","name":"Additional file 1 of Evaluation of a facilitator training program in a randomized controlled trial of psilocybin treatment for depression","year":"2026","cit":0,"pfa":"Nikita Sanati Morel","psa":"Maria Beckman","topics":["Depression","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7154853940","eid":"W7154853940"},{"id":"paper-w7160842269","cat":"papers","name":"Effects of Psilocybin on Attentional Set-Shifting Following Chronic Unpredictable Stress in Rats (Abstract ID: 231339)","year":"2026","cit":0,"pfa":"Joseph J. Hennessey","psa":"John D. McCorvy","ptype":"article","src":"https://openalex.org/W7160842269","eid":"W7160842269"},{"id":"paper-w7148540443","cat":"papers","name":"Psilocybin and Emotional Breakthrough: A Comprehensive Umbrella Review and Theoretical Integration [SCIENTIFIC V7.0 - Q1 HIGH-IMPACT]","year":"2026","cit":0,"pfa":"Juan Moises de la Serna","topics":["Reviews & meta-analyses","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7148540443","eid":"W7148540443"},{"id":"paper-w7117320272","cat":"papers","name":"Replication Data for: Calcium Activation Mechanism of a Noncanonical Aromatic L-Amino Acid Decarboxylase from Psilocybin Mushroom","year":"2025","cit":0,"pfa":"Tianjie LI","topics":["Mechanism & neuroscience"],"ptype":"dataset","src":"https://openalex.org/W7117320272","eid":"W7117320272"},{"id":"paper-w7215342456","cat":"papers","name":"UNA MIRADA A LA MERCANTILIZACIÓN DE LA AYAHUASCA EN IQUITOS, PERÚ, DESDE LA ECOLOGÍA POLÍTICA LATINOAMERICANA","year":"2018","cit":0,"pfa":"Duván Rivera Arcila","ptype":"article","src":"https://openalex.org/W7215342456","eid":"W7215342456"},{"id":"paper-w7160642056","cat":"papers","name":"Characterizing Resting-State Brain Dynamics with Frequency-Resolved EEG Microstates: Parallel Analyses of Psilocybin Microdosing and Acute Inhaled DMT","year":"2026","cit":0,"pfa":"Povilas Tarailis","psa":"Inga Griškova-Bulanova","topics":["Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7160642056","eid":"W7160642056"},{"id":"paper-w2201591268","cat":"papers","name":"Alterações da default mode network provocadas pela ingestão de Ayahuasca investigadas por Ressonância Magnética Funcional","year":"2012","cit":0,"pfa":"Fernanda Palhano Xavier de Fontes","topics":["Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W2201591268","eid":"W2201591268"},{"id":"paper-w4296598215","cat":"papers","name":"Clinical profiles of first-time drug offenders in Taipei City: Comparison of methamphetamine, MDMA, and marijuana users","year":"2022","cit":0,"pfa":"Lian‐Yu Chen","psa":"Ming‐Chyi Huang","topics":["Addiction","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4296598215","eid":"W4296598215"},{"id":"paper-w4233055748","cat":"papers","name":"Faculty Opinions recommendation of Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo.","year":"2021","cit":0,"pfa":"Bryan L. Roth","topics":["Mechanism & neuroscience"],"ptype":"peer-review","src":"https://openalex.org/W4233055748","eid":"W4233055748"},{"id":"paper-w4411279155","cat":"papers","name":"Shame, guilt and psychedelic experience: Results from a prospective, longitudinal survey of real-world psilocybin use","year":"2023","cit":0,"pfa":"David S. Mathai","psa":"Albert Garcia‐Romeu","ptype":"preprint","src":"https://openalex.org/W4411279155","eid":"W4411279155"},{"id":"paper-w4414021563","cat":"papers","name":"Correction: Short- and long-term modulation of rat prefrontal cortical activity following single doses of psilocybin","year":"2025","cit":0,"pfa":"Ross J. Purple","psa":"Matthew W. Jones","topics":["Dosing & pharmacology"],"ptype":"erratum","src":"https://openalex.org/W4414021563","eid":"W4414021563"},{"id":"paper-w3040528574","cat":"papers","name":"Motivaciones de los consumidores de ayahuasca en 2018. Locales y viajeros en los países amazónicos","year":"2019","cit":0,"pfa":"Mireia Puerto Pous","ptype":"dissertation","src":"https://openalex.org/W3040528574","eid":"W3040528574"},{"id":"paper-w2036124429","cat":"papers","name":"Experimental Catatonia by Means of Derivatives of Mescaline and Adrenaline. (Proc. Acad. Sci. Amsterdam, vol. xxxvii, p. 562, 1934.) Noteboom, L.","year":"1935","cit":0,"pfa":"C. W. SONDERN","ptype":"article","src":"https://openalex.org/W2036124429","eid":"W2036124429"},{"id":"paper-w7167297843","cat":"papers","name":"An act relating to the establishment of a consortium to conduct United States Food and Drug Administration's drug development clinical trials with ibogaine to secure the administration's approval of the medication's use","year":"2025","cit":0,"pfa":"Texas. Legislature. Senate.","topics":["Addiction"],"ptype":"other","src":"https://openalex.org/W7167297843","eid":"W7167297843"},{"id":"paper-w7167714648","cat":"papers","name":"Rapid Isolation and High-Purity Characterization of N, N-Dimethyltryptamine from Mimosa tenuiflora for Analytical Standard Development and Regulatory Insight","year":"2026","cit":0,"pfa":"Zhang Ming","topics":["Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W7167714648","eid":"W7167714648"},{"id":"paper-w7128730579","cat":"papers","name":"The Axis Mundi Hypothesis: Endogenous N,N-Dimethyltryptamine as a Neurobiological Bridge Between Conscious and Subconscious Processing - An Integrative Theoretical Framework","year":"2026","cit":0,"pfa":"Mihai Alexandru","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W7128730579","eid":"W7128730579"},{"id":"paper-w4242892403","cat":"papers","name":"Two kinds of modification by 5-methoxy-N,N-dimethyltryptamine of contractile responses to electrical stimulation of the isolated guinea-pig vas deferens","year":"1987","cit":0,"pfa":"Soichi Yoshida","psa":"Tetsurō Kuga","ptype":"article","src":"https://openalex.org/W4242892403","eid":"W4242892403"},{"id":"paper-w2011606860","cat":"papers","name":"METHYLENEDIOXYAMPHETAMINE (MDA) AND METHYLENEDIOXYMETHAMPHETAMINE (MDMA OR ECSTASY) EXTERNAL QUALITY ASSESSMENT IN URINE DRUG TEST SCREENING.","year":"1999","cit":0,"pfa":"Tommaso Trenti","psa":"E Sternieri","ptype":"article","src":"https://openalex.org/W2011606860","eid":"W2011606860"},{"id":"paper-w4363678421","cat":"papers","name":"43. Acute Effects of MDMA on Intrinsic Functional Connectomes Associated With Altered States of Consciousness and Defensiveness","year":"2023","cit":0,"pfa":"Xue Zhang","psa":"Leanne Maree Williams","ptype":"article","src":"https://openalex.org/W4363678421","eid":"W4363678421"},{"id":"paper-w7129103660","cat":"papers","name":"Systematic study of Panaeolus (Agaricales, Galeropsidaceae) sensu lato and psilocybin-producing traits of species from China","year":"2026","cit":0,"pfa":"Mao-Qiang He","psa":"Rui-Lin Zhao","topics":["Reviews & meta-analyses"],"ptype":"dataset","src":"https://openalex.org/W7129103660","eid":"W7129103660"},{"id":"paper-w4234299529","cat":"papers","name":"'Like a hug from everyone who loves you' — how MDMA could help patients with trauma","year":"2018","cit":0,"topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4234299529","eid":"W4234299529"},{"id":"paper-w3011007254","cat":"papers","name":"Do cryptomarkets users differ in reporting emergency medical treatment following MDMA, LSD and cocaine use?","year":"2020","cit":0,"pfa":"Leigh Coney","psa":"ADAM R. WINSTOCK","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3011007254","eid":"W3011007254"},{"id":"paper-w7160871683","cat":"papers","name":"Effects of Deuteration or Fluorination of MDMA-Like Empathogen Compounds on Monoamine Transporter Activities (Abstract ID: 228967)","year":"2026","cit":0,"pfa":"Michael R. Baumann","psa":"Nicholas V. Cozzi","ptype":"article","src":"https://openalex.org/W7160871683","eid":"W7160871683"},{"id":"paper-w2286900580","cat":"papers","name":"MDMA (ecstasy) induce inclusi neuronali e danno al DNA nel sistema nigro-striatale","year":"2003","cit":0,"pfa":"Michela Ferrucci","psa":"Francesco Fornai","ptype":"conference-paper","src":"https://openalex.org/W2286900580","eid":"W2286900580"},{"id":"paper-w1513700057","cat":"papers","name":"La Influència de l'estereroquímica en el metabolisme de la 3,4-metilendioximetamfetamina (MDMA, èxtasi)","year":"2004","cit":0,"pfa":"Pizarro Lozano","psa":"Ma Nieves","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W1513700057","eid":"W1513700057"},{"id":"paper-w396896482","cat":"papers","name":"Mécanismes sérotoninergiques sous-tendant les effets de la MDMA (\"ecstasy\") chez la souris","year":"2008","cit":0,"pfa":"Thibault Renoir","topics":["Depression","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W396896482","eid":"W396896482"},{"id":"paper-w2911387821","cat":"papers","name":"P.2.08 Increased sensitivity to Δ9-tetrahydrocannabinol and MDMA reward after exposure to nicotine in mice and zebrafish","year":"2019","cit":0,"pfa":"Luca Ponzoni","psa":"Mariaelvina Sala","ptype":"article","src":"https://openalex.org/W2911387821","eid":"W2911387821"},{"id":"paper-w4362734364","cat":"papers","name":"44. Acute Effects of MDMA on Negative Affective Brain Circuit Function: A Randomized Controlled Mechanistic Trial","year":"2023","cit":0,"pfa":"Laura M. Hack","psa":"Leanne Maree Williams","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4362734364","eid":"W4362734364"},{"id":"paper-w4241757883","cat":"papers","name":"Anxiety of Death and Dying: Treatment With Psilocybin-Assisted Psychotherapy and the New York University Phase II Study","year":"2011","cit":0,"pfa":"Alexander Belser","psa":"Krystallia Kalliontzi","topics":["Anxiety & end-of-life","Therapy practice"],"ptype":"dataset","src":"https://openalex.org/W4241757883","eid":"W4241757883"},{"id":"paper-w4242587462","cat":"papers","name":"Fetal mesencephalic cells exposed to MDMA (ecstasy) enhance dopamine cell survival and neurite outgrowth in vitro","year":"2006","cit":0,"pfa":"D.L. Choi","psa":"J.W. Lipton","ptype":"article","src":"https://openalex.org/W4242587462","eid":"W4242587462"},{"id":"paper-w2261669131","cat":"papers","name":"Implicación del sistema serotoninérgico y dopaminérgico en los efectos reforzantes de la MDMA","year":"2012","cit":0,"pfa":"Concepción Roger Sánchez","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2261669131","eid":"W2261669131"},{"id":"paper-w1975152269","cat":"papers","name":"Critical Issues in Cross-sectional Research Studies of Human Ecstasy (MDMA) Users: A Response to Krebs and Johansen","year":"2012","cit":0,"pfa":"Ronald L. Cowan","ptype":"article","src":"https://openalex.org/W1975152269","eid":"W1975152269"},{"id":"paper-w4230204339","cat":"papers","name":"The possible role of neuroglycan C in neural network recovery after MDMA treatment in dark Agouti rats","year":"2016","cit":0,"pfa":"Kristóf Pintér","topics":["Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W4230204339","eid":"W4230204339"},{"id":"paper-w2996936153","cat":"papers","name":"Caffeine, nicotine and mdma effects on retinal morphology, rhodopsin and gfap expressions suggest potential functional consequences","year":"2019","cit":0,"pfa":"Joshua Owolabi","psa":"Oluseyi Sunday Fabiyi","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2996936153","eid":"W2996936153"},{"id":"paper-w4415238267","cat":"papers","name":"Psilocybin exerts differential effects on social behaviour and inflammation in mice in contexts of activity-based anorexia (ABA)","year":"2025","cit":0,"pfa":"Sheida Shadani","psa":"Claire J. Foldi","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4415238267","eid":"W4415238267"},{"id":"paper-w7115676814","cat":"papers","name":"Supplementary material for: Regional specificity of the cingulate cortex thickness association with the intensity of psilocybin experience: a replication study","year":"2025","cit":0,"pfa":"Gregus, David","psa":"Horacek, Jiri","topics":["Mechanism & neuroscience"],"ptype":"supplementary-materials","src":"https://openalex.org/W7115676814","eid":"W7115676814"},{"id":"paper-w7131123653","cat":"papers","name":"Safety and Efficacy of Microdosing Psilocybin over 8 Weeks for Major Depressive Disorder: A Randomized Clinical Trial","year":"2026","cit":0,"pfa":"Rotem Petranker","psa":"Adam Blackman","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7131123653","eid":"W7131123653"},{"id":"paper-w1879275478","cat":"papers","name":"The most frequent psychopathology related to the use of 3,4-methylenedioxymethamphetamine (MDMA) of medical help seekers: causality or coincidence?","year":"2011","cit":0,"pfa":"Mercedes Lovrečić","psa":"Barbara Lovrečić","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1879275478","eid":"W1879275478"},{"id":"paper-w2389869807","cat":"papers","name":"A comparison study of the detection of MDMA in urine between liquid chromatography mass spectrometry and colloidal gold strip","year":"2012","cit":0,"pfa":"Mingjin Huang","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2389869807","eid":"W2389869807"},{"id":"paper-w7203821322","cat":"papers","name":"Arte Visionario con San Pedro y Ayahuasca en Ecuador, en diálogo con el mundo Kichwa","year":"2026","cit":0,"pfa":"Susan Elizabeth Rocha","topics":["Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7203821322","eid":"W7203821322"},{"id":"paper-w4401328895","cat":"papers","name":"A Systematic and Meta-Analytic Review on Psilocybin and 3,4-Methylenedioxymethamphetamine in the Treatment of Mental Illnesses: Effects of Dosage, Psychotherapeutic Support, and Antidepressant Use on Treatment Efficacy","year":"2024","cit":0,"pfa":"Lena Oestreich","psa":"Stephen Parker","topics":["Depression","Reviews & meta-analyses","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4401328895","eid":"W4401328895"},{"id":"paper-w7135781980","cat":"papers","name":"Sexuální rozdíly v účincích 3,4-methylendioxymetamfetaminu ( MDMA ) na kognitivní funkce, neurogenezi a farmakokinetické parametry","year":"2012","cit":0,"pfa":"Věra Valešová","psa":"Psychiatrické centrum Praha","ptype":"report","src":"https://openalex.org/W7135781980","eid":"W7135781980"},{"id":"paper-w4408963307","cat":"papers","name":"CARDIOVASCULAR OUTCOMES OF PATIENTS HOSPITALIZED FOR HALLUCINOGEN OVERDOSE: A COMPARATIVE ANALYSIS OF LSD, CANNABIS, MDMA, AND OTHER HALLUCINOGENS","year":"2025","cit":0,"pfa":"Acile Nahlawi","psa":"Franklin King","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4408963307","eid":"W4408963307"},{"id":"paper-w2974975564","cat":"papers","name":"Azotan MDMA (3,4-metylenodioksymetamfetaminy) – nietypowa postać soli czy nowy trend na rynku narkotyków?","year":"2017","cit":0,"pfa":"Robert Bachliński","psa":"Małgorzata Galarda","ptype":"article","src":"https://openalex.org/W2974975564","eid":"W2974975564"},{"id":"paper-w7169723435","cat":"papers","name":"A randomized, double-blind, placebo-controlled single-ascending-dose study to identify a non-hallucinogenic dose of psilocybin in healthy adults","year":"2026","cit":0,"pfa":"Naama Levy‐Cooperman","psa":"Michael B. McDonnell","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7169723435","eid":"W7169723435"},{"id":"paper-w2607057367","cat":"papers","name":"ChemInform Abstract: PEYOTE UND VERWANDTE ALKALOIDE 14. MITT. MESCALOXYLSAEURE UND MESCALORUVINSAEURE, NEUARTIGE AMINOSAEURE‐ANALOGA VON MESCALIN","year":"1972","cit":0,"pfa":"G. J. KAPADIA","psa":"G. S. R. Subba Rao","ptype":"article","src":"https://openalex.org/W2607057367","eid":"W2607057367"},{"id":"paper-w2023738910","cat":"papers","name":"P.6.d.012 MDMA pre-treatment cross-sensitizes to methamphetamine stimulatory effects in mice","year":"2006","cit":0,"pfa":"Jana Kučerová","psa":"Alexandra Šulcová","ptype":"article","src":"https://openalex.org/W2023738910","eid":"W2023738910"},{"id":"paper-w2092034029","cat":"papers","name":"P.6.c.004 Sex -differences in the effects of MDMA (ecstasy) on plasma copeptin in healthy subjects","year":"2011","cit":0,"pfa":"C.M. Hysek","psa":"Matthias E. Liechti","ptype":"article","src":"https://openalex.org/W2092034029","eid":"W2092034029"},{"id":"paper-w4394261285","cat":"papers","name":"User perceptions of long-term costs and benefits of MDMA use: findings from a large online sample","year":"2023","cit":0,"pfa":"James W. B. Elsey","psa":"Anouk Fieten","topics":["Safety & adverse events"],"ptype":"dataset","src":"https://openalex.org/W4394261285","eid":"W4394261285"},{"id":"paper-w652233659","cat":"papers","name":"A-5 EFFECT OF 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA) ON STEREOTYPED BEHAVIORS AND NEUROTRANSMITTER RELEASE INTO RAT BRAIN DIALYSATE IN VIVO","year":"1990","cit":0,"pfa":"Kunio Kawashima","psa":"Akira Takanaka","ptype":"article","src":"https://openalex.org/W652233659","eid":"W652233659"},{"id":"paper-w2280469273","cat":"papers","name":"Perinatal lead exposure sensitizes rats to the rewarding effects of cocaine, but not cocaine/3,4-methylenedioxymethamphetamine(MDMA) combinations","year":"2013","cit":0,"pfa":"Aaron L. Cardon","ptype":"dissertation","src":"https://openalex.org/W2280469273","eid":"W2280469273"},{"id":"paper-w4400575360","cat":"papers","name":"Acute Effects of Oral 3,4-Methylenedioxymethamphetamine (MDMA) and Delta-9-Tetrahydrocannabinol (THC) on Intrinsic Functional Connectivity","year":"2024","cit":0,"pfa":"Tonisha E. Kearney-Ramos","psa":"Gillinder Bedi","ptype":"article","src":"https://openalex.org/W4400575360","eid":"W4400575360"},{"id":"paper-w4404995259","cat":"papers","name":"Integrated Heterogeneous Service Provisioning: Unifying Beyond-Communication Capabilities with MDMA in 6G and Future Wireless Networks","year":"2024","cit":0,"pfa":"Pengyi Jia","psa":"Robert Schober","topics":["Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4404995259","eid":"W4404995259"},{"id":"paper-w4413139245","cat":"papers","name":"The Mechanism of Calcium Handling Proteins and NF-κB in Calcium Dyshomeostasis of Cardiomyocytes Caused by Acute MDMA Exposure.","year":"2025","cit":0,"pfa":"Rongshuai Wang","psa":"Liang Liu","topics":["Safety & adverse events","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4413139245","eid":"W4413139245"},{"id":"paper-w2941241840","cat":"papers","name":"Implicación de los radicales libres en la neurodegeneración inducida por 3,4-metilenodioximetanfetamina (MDMA)","year":"1998","cit":0,"pfa":"María Esther O'shea Gaya","topics":["Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W2941241840","eid":"W2941241840"},{"id":"paper-w2371315873","cat":"papers","name":"Rapid simultaneous determination of amphetamine,methamphetamine MDA and MDMA in urine using HS/SPME and GC/MS","year":"2007","cit":0,"pfa":"Pan Zhi-wen","ptype":"article","src":"https://openalex.org/W2371315873","eid":"W2371315873"},{"id":"paper-w7106646833","cat":"papers","name":"Endogenous N,N-Dimethyltryptamine and Sigma-1 Receptor Modulation as Enhancers of Neural-Substrate Coherence in the Swygert Theory of Everything AO (TSTOEAO)","year":"2025","cit":0,"pfa":"Swygert, John","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7106646833","eid":"W7106646833"},{"id":"paper-w4238006562","cat":"papers","name":"No effect of MDMA (ecstasy) on cell death and 5-HT2A receptor density in organotypic rat hippocampal cultures","year":"2004","cit":0,"pfa":"M SVEEN","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4238006562","eid":"W4238006562"},{"id":"paper-w4417187604","cat":"papers","name":"MDMA-assisted psychotherapy in major depression: critical considerations for clinical translation: commentary, Ai et al","year":"2025","cit":0,"pfa":"Yingtong Ai","psa":"Xiumei Hou","topics":["Depression","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4417187604","eid":"W4417187604"},{"id":"paper-w2797007220","cat":"papers","name":"“Washo Peyote Songs.” Alan P. Merriam and Warren L. d'Azevedo. (American Anthropologist, Vol 59, No. 4, pp. 615–641, 1957.)","year":"1960","cit":0,"pfa":"F. B.","ptype":"article","src":"https://openalex.org/W2797007220","eid":"W2797007220"},{"id":"paper-w7167485400","cat":"papers","name":"MDMA-assisted PTSD and Alcohol Therapy Trial (MPATHY): study protocol for a double-blind, randomised, controlled outpatient trial of MDMA-assisted integrated exposure-based therapy for comorbid post-traumatic stress diso","year":"2026","cit":0,"pfa":"Kirsten C. Morley","psa":"Paul Haber","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7167485400","eid":"W7167485400"},{"id":"paper-w2061147949","cat":"papers","name":"P.1.e.017 The functional brain correlates of the psychedelic state: an arterial spin labelling study with psilocybin","year":"2011","cit":0,"pfa":"Robin Lester Carhart-Harris","psa":"David Nutt","ptype":"article","src":"https://openalex.org/W2061147949","eid":"W2061147949"},{"id":"paper-w4416229038","cat":"papers","name":"Qualitative insights into psilocybin and LSD experiences: Enhanced connection and emotion processing reported by Spanish-speaking survey respondents","year":"2025","cit":0,"pfa":"Meghan A. DellaCrosse","psa":"Alan K. Davis","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4416229038","eid":"W4416229038"},{"id":"paper-w7118005769","cat":"papers","name":"Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE): Results of a randomized active placebo-controlled trial","year":"2026","cit":0,"pfa":"L. Mertens","psa":"G. Gründer","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7118005769","eid":"W7118005769"},{"id":"paper-w176738511","cat":"papers","name":"Ayahuasca y Sanpedro: Estados alterados de conciencia y Teoría de sistemas. Una aproximación a su estudio","year":"2013","cit":0,"pfa":"Alberto Butler","ptype":"article","src":"https://openalex.org/W176738511","eid":"W176738511"},{"id":"paper-w2062542326","cat":"papers","name":"Enantiomeric analysis of MDMA (Ecstasy) in plasma and urine by capillary gc: A preliminary investigation of the stereoselective disposition in man","year":"1998","cit":0,"pfa":"John K. Fallon","psa":"J.A. Henry","ptype":"conference-abstract","src":"https://openalex.org/W2062542326","eid":"W2062542326"},{"id":"paper-w2545622145","cat":"papers","name":"The possible role of neuroglycan C in neural network recovery after MDMA treatment in dark Agouti rats","year":"2016","cit":0,"pfa":"K. Pintér","psa":"György Bagdy","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2545622145","eid":"W2545622145"},{"id":"paper-w7116367742","cat":"papers","name":"Acute Subjective Effects of MDMA-Assisted Therapy in Anorexia Nervosa and Associations with Changes in Eating Disorder Symptoms","year":"2025","cit":0,"pfa":"Victoria Burmester","psa":"Miriam Kaiyo","ptype":"other","src":"https://openalex.org/W7116367742","eid":"W7116367742"},{"id":"paper-w7169098728","cat":"papers","name":"Silence is golden: Documenting the speech production of participants and support providers in psilocybin administration sessions for the treatment of post-traumatic stress disorder","year":"2026","cit":0,"pfa":"Robert F. Dougherty","psa":"Guy M. Goodwin","topics":["PTSD & trauma","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7169098728","eid":"W7169098728"},{"id":"paper-w2315089999","cat":"papers","name":"Barquinha: Religião ayahuasqueira, afro-brasileira ou afro-amazônica? / Barquinha: ayahuasca, Afro-Brazilian or Afro-Amazonian religion?","year":"2015","cit":0,"pfa":"Marcelo Simão Mercante","ptype":"article","src":"https://openalex.org/W2315089999","eid":"W2315089999"},{"id":"paper-w7208796954","cat":"papers","name":"Avaliação dos efeitos antidepressivos da ayahuasca em um modelo animal de depressão induzida por LPS : estudo comparativo de ayahuasca, DMT e fluoxetina em ratos Wistar utilizando o teste comportamental do campo aberto","year":"2026","cit":0,"pfa":"Guilherme Antônio Dias Carvalho","topics":["Depression"],"ptype":"dissertation","src":"https://openalex.org/W7208796954","eid":"W7208796954"},{"id":"paper-w7165660151","cat":"papers","name":"Aumenta el consumo de MDMA entre los jóvenes para socializar: ¿qué peligros esconde?","year":"2026","cit":0,"pfa":"Juan López-Morales","psa":"Anabel López","ptype":"other","src":"https://openalex.org/W7165660151","eid":"W7165660151"},{"id":"paper-w2011298810","cat":"papers","name":"Mescaline and Depersonalization. (Journ. Neur. and Psychopath., vol. xvi, p. 193, Jan., 1936.) Guttmann, E., and Maclay, W. S.","year":"1936","cit":0,"pfa":"Gerald W. T. H. Fleming","ptype":"article","src":"https://openalex.org/W2011298810","eid":"W2011298810"},{"id":"paper-w2193814848","cat":"papers","name":"Abordaje antropológico del consumo de tres substancias psicoactivas: el alcohol, la coca y la ayahuasca","year":"2012","cit":0,"pfa":"Sinforiano Rodríguez Doldán","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2193814848","eid":"W2193814848"},{"id":"paper-w7135439481","cat":"papers","name":"Simultaneous Polysubstance Use and Serotonin Transporter and 2A Receptor Binding Among Human Mdma and Hallucinogen Users","year":"2010","cit":0,"pfa":"D. Erritzoe","psa":"G. M. Knudsen","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7135439481","eid":"W7135439481"},{"id":"paper-w7161249182","cat":"papers","name":"Understanding How Trait Negative Emotionality (NEM) Influences Social Connectedness and Responses to ± 3,4-Methylenedioxymethamphetamine (MDMA)","year":"2026","cit":0,"pfa":"Ruiyan Hu","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7161249182","eid":"W7161249182"},{"id":"paper-w7139242489","cat":"papers","name":"Rapid glucose and lactate changes in blood and brain by intravenous 3,4-methylenedioxymethamphetamine (MDMA, \"Ecstasy\") in awake rats","year":"2005","cit":0,"pfa":"Jan Bert Gramsbergen","psa":"P. Cumming","ptype":"conference-paper","src":"https://openalex.org/W7139242489","eid":"W7139242489"},{"id":"paper-w2317612531","cat":"papers","name":"Effective Neuroprotection of Acetyl-L-Carnitine over MDMA-Induced Serotonin loss in the Adoloscent Rat Brain","year":"2009","cit":0,"pfa":"Teresa Summavielle","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2317612531","eid":"W2317612531"},{"id":"paper-w4413348976","cat":"papers","name":"Eutylone History Selectively Impacts the Affective Properties of Cocaine, Mdma, and Eutylone in Female Sprague-Dawley Rats","year":"2025","cit":0,"pfa":"Negar Ghasem Ardabili","psa":"Anthony Lee Riley","ptype":"preprint","src":"https://openalex.org/W4413348976","eid":"W4413348976"},{"id":"paper-w7151601243","cat":"papers","name":"The impact of antidepressant use on MDMA fatalities: A matched case-control study using a post-mortem database","year":"2026","cit":0,"pfa":"Kirsten L. Rock","psa":"Caroline S. Copeland","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7151601243","eid":"W7151601243"},{"id":"paper-w7202254245","cat":"papers","name":"Psilocybin-Assisted Therapy in Psychiatry: A Narrative Clinical Review of Mechanisms, Therapeutic Applications, and Emerging Evidence (2025–2026)","year":"2026","cit":0,"pfa":"Teodora Anghel","psa":"Iuliana-Anamaria Trăilă","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7202254245","eid":"W7202254245"},{"id":"paper-w2802908478","cat":"papers","name":"Cartografias do inconsciente em quadrinhos: ayahuasca, respiração holotrópica e sonhos lúcidos como processos criativos","year":"2018","cit":0,"pfa":"Matheus Moura Silva","ptype":"dissertation","src":"https://openalex.org/W2802908478","eid":"W2802908478"},{"id":"paper-w4389560846","cat":"papers","name":"CONHECIMENTO DOS PROFISSIONAIS ENFERMEIROS ACERCA DOS EFEITOS OCASIONADOS PELO USO DO CHÁ DE AYAHUASCA","year":"2023","cit":0,"pfa":"Luis Felipe Biora Comim","psa":"Adriana de Oliveira Christoff","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4389560846","eid":"W4389560846"},{"id":"paper-w7168266726","cat":"papers","name":"PSILOCYBIN IN THE TREATMENT OF DEPRESSIVE DISORDERS: CLINICAL EVIDENCE AND ITS POTENTIAL TO ADDRESS THE GLOBAL MENTAL HEALTH CRISIS - A REVIEW","year":"2026","cit":0,"pfa":"A. P. M. Los","psa":"Gabriela Płodzień","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7168266726","eid":"W7168266726"},{"id":"paper-w7165120276","cat":"papers","name":"Understanding How Trait Negative Emotionality (NEM) Influences Social Connectedness and Responses to ± 3,4-Methylenedioxymethamphetamine (MDMA)","year":"2026","cit":0,"pfa":"Ruiyan Hu","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7165120276","eid":"W7165120276"},{"id":"paper-w4417258517","cat":"papers","name":"COMPARATIVE EFFICACY AND ACCEPTABILITY OF PSILOCYBIN-KETAMINE AND TYPICAL ANTIDEPRESSANTS FOR MAJOR DEPRESSIVE DISORDER MANAGEMENT: A NETWORK META-ANALYSIS","year":"2025","cit":0,"pfa":"Paulo Henrique Rodrigues e Rodrigues","psa":"R. Silva","topics":["Depression","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4417258517","eid":"W4417258517"},{"id":"paper-w7160707086","cat":"papers","name":"Effects of Psilocybin Treatment on Cognitive Effort Avoidance in Major Depressive Disorder and Co-Occurring Alcohol Use Disorder","year":"2026","cit":0,"pfa":"Ceyda Sayalı","psa":"Frederick Streeter Barrett","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W7160707086","eid":"W7160707086"},{"id":"paper-w2311983553","cat":"papers","name":"Quantitation of amphetamine, methamphetamine, MDA, MDMA and MDEA in saliva with a Q-TOF LC/MS/MS system","year":"2001","cit":0,"pfa":"Karine M. Clauwaert","psa":"Emilie Van den Eeckhout","ptype":"conference-paper","src":"https://openalex.org/W2311983553","eid":"W2311983553"},{"id":"paper-w7171987341","cat":"papers","name":"MDMA-Assisted Psychotherapy for Cluster B Personality Disorders: A Narrative Review of This Translational Framework for Relational Healing","year":"2026","cit":0,"pfa":"M. Rocha","psa":"Sreenivas Dutt Gunturu","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W7171987341","eid":"W7171987341"},{"id":"paper-w2791682168","cat":"papers","name":"Le evidenze isto-patologiche e tossicologiche nella intossicazione mortale da MDMA e MDEA","year":"1999","cit":0,"pfa":"Fabio Centini","psa":"Vittorio Fineschi","ptype":"article","src":"https://openalex.org/W2791682168","eid":"W2791682168"},{"id":"paper-w2069267573","cat":"papers","name":"S(+)MDMA and 5-HT Evoke Dissimilar Ionic Currents in Human Serotonin Transporter-Expressing Cells","year":"2013","cit":0,"pfa":"Vanessa Cabra","psa":"José Miguel Eltit","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2069267573","eid":"W2069267573"},{"id":"paper-w3127728600","cat":"papers","name":"Synthesis and characterization of MDMA and development of field-deployable methods for its detection and quantification within Ecstasy tablets","year":"2026","cit":0,"pfa":"Jannat Hena Hussain","topics":["Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W3127728600","eid":"W3127728600"},{"id":"paper-w7163017615","cat":"papers","name":"COMBINATION OF PSILOCYBIN AND COGNITIVE BEHAVIORAL THERAPY IMPROVES OXYTOCIN LEVELS AND DEPRESSIVE SYMPTOMS IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER","year":"2026","cit":0,"pfa":"Mahvash Khan","psa":"Muhammad Ismail Bhatti","topics":["Depression","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7163017615","eid":"W7163017615"},{"id":"paper-w7124469617","cat":"papers","name":"Psilocybin rapidly, but not immediately, reverses reward learning deficits in a durable manner in an inflammatory rat model of depressive symptoms","year":"2026","cit":0,"pfa":"Justyna K. Hinchcliffe","psa":"Emma S. J. Robinson","topics":["Depression","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7124469617","eid":"W7124469617"},{"id":"paper-w7170158035","cat":"papers","name":"Reporting Quality in Randomized Controlled Trials Evaluating Psilocybin-Assisted Therapy for Major Depressive Disorder: A Systematic Review","year":"2026","cit":0,"pfa":"Aman Hemani","topics":["Depression","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7170158035","eid":"W7170158035"},{"id":"paper-w3082923741","cat":"papers","name":"Self-reported physical, affective and somatic effects of ecstasy (MDMA) use: An observational study of recreational users","year":"2015","cit":0,"pfa":"S. Fuit","psa":"Joris C. Verster","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W3082923741","eid":"W3082923741"},{"id":"paper-w7139120683","cat":"papers","name":"A neurocognitive account of complex PTSD: self-modelling, affective dysregulation, and implications for MDMA-assisted and targeted psychotherapies","year":"2026","cit":0,"pfa":"Philip Gerrans","psa":"Lena Oestreich","topics":["PTSD & trauma","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7139120683","eid":"W7139120683"},{"id":"paper-w2118844237","cat":"papers","name":"Ecstasy (MDMA) use is associated with risk-taking and increased self-report scores for impulsiveness, and novelty-seeking","year":"2001","cit":0,"pfa":"Georgia Butler","psa":"Anthony M. J. Montgomery","topics":["Safety & adverse events"],"ptype":"conference-paper","src":"https://openalex.org/W2118844237","eid":"W2118844237"},{"id":"paper-w3094231904","cat":"papers","name":"Zinc Protects against MDMA-Induced Apoptosis of Sertoli Cells in Mouse via Attenuation of Caspase-3.","year":"2020","cit":0,"pfa":"Nadia Hossein-Zadeh","psa":"Mahdieh Nasirzadeh","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3094231904","eid":"W3094231904"},{"id":"paper-w7204742570","cat":"papers","name":"Effects of MDMA-Assisted Therapy on Depressive Symptoms in Posttraumatic Stress Disorder: A Systematic Review and Meta-Analysis","year":"2026","cit":0,"pfa":"Nils Hörnqvist","topics":["Depression","PTSD & trauma","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7204742570","eid":"W7204742570"},{"id":"paper-w4363673412","cat":"papers","name":"Behavioral Mechanisms Underlying the Therapeutic Effects of MDMA: Evidence From Laboratory Studies in Healthy Human Volunteers","year":"2023","cit":0,"pfa":"Anya K. Bershad","psa":"Harriet de Wit","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4363673412","eid":"W4363673412"},{"id":"paper-w4405088523","cat":"papers","name":"Integrated Heterogeneous Service Provisioning: Unifying Beyond-Communication Capabilities with MDMA in 6G and Future Wireless Networks","year":"2024","cit":0,"pfa":"Pengyi Jia","psa":"Robert Schober","topics":["Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4405088523","eid":"W4405088523"},{"id":"paper-w4414005071","cat":"papers","name":"Utilizing In Vivo and Imaginal Exposure in the Context of MDMA-Assisted Therapy for Social Anxiety Disorder: A Case Report","year":"2025","cit":0,"pfa":"Jason B. Luoma","psa":"Brian C. Pilecki","topics":["Anxiety & end-of-life","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4414005071","eid":"W4414005071"},{"id":"paper-w610037821","cat":"papers","name":"Modificacion de la tradicion : Supervivencia de la tradicion huichola por la vision del peyote y los ritos","year":"2002","cit":0,"pfa":"靖人 山森","ptype":"dissertation","src":"https://openalex.org/W610037821","eid":"W610037821"},{"id":"paper-w747052031","cat":"papers","name":"Etablissement du texte inédit de Notes sur la prise de mescaline (1935) d’après le manuscrit de Sartre","year":"2010","cit":0,"pfa":"Juliette Simont","psa":"Gilles Philippe","ptype":"book-chapter","src":"https://openalex.org/W747052031","eid":"W747052031"},{"id":"paper-w4251307964","cat":"papers","name":"Two Kinds of Modification by 5-Methoxy-N,N-Dimethyltryptamine of Contractile Responses to Electrical Stimulation of Isolated Guinea-Pig Vas Deferens","year":"1987","cit":0,"pfa":"Soichi Yoshida","psa":"Tetsurō Kuga","ptype":"article","src":"https://openalex.org/W4251307964","eid":"W4251307964"},{"id":"paper-w4294163566","cat":"papers","name":"A legalidade do uso da Ayahuasca: o acesso ao chá por praticantes fora das religiões tradicionais","year":"2022","cit":0,"pfa":"Gerson Lima Gervázio","psa":"Vinícius Pinheiro Marques","topics":["Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W4294163566","eid":"W4294163566"},{"id":"paper-w4298041565","cat":"papers","name":"Cellular and Molecular Mechanisms of Drugs of Abuse: Cocaine, Ibogaine, and Substituted Amphetamines. Proceedings of a conference. Niigata City, Japan, June 29-30, 1995.","year":"1996","cit":0,"topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4298041565","eid":"W4298041565"},{"id":"paper-w2009160432","cat":"papers","name":"P.2.028 Active and passive MDMA (‘ecstasy’) intake induces differential transcriptional changes in the mouse brain","year":"2011","cit":0,"pfa":"María Juliana Orejarena","psa":"Bru Cormand","ptype":"article","src":"https://openalex.org/W2009160432","eid":"W2009160432"},{"id":"paper-w2517645473","cat":"papers","name":"S.25.02 Effects of MDMA on self-referent encoding and personal memories: implications for its use in PTSD","year":"2015","cit":0,"pfa":"H. Valerie Curran","psa":"Bart Ferguson","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W2517645473","eid":"W2517645473"},{"id":"paper-w7163654209","cat":"papers","name":"MDMA-Assisted Therapy for Social Anxiety Disorder: A Randomized, Open-label, Wait-list Controlled Trial","year":"2026","cit":0,"pfa":"Jason B. Luoma","psa":"Christopher Stauffer","topics":["Anxiety & end-of-life","Safety & adverse events","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7163654209","eid":"W7163654209"},{"id":"paper-w613899379","cat":"papers","name":"3,4-methylenedioxymethamphetamine (MDMA, 揺頭丸, エクスタシー)の乱用の現状","year":"2002","cit":0,"pfa":"由貴 西村","ptype":"article","src":"https://openalex.org/W613899379","eid":"W613899379"},{"id":"paper-w7128561393","cat":"papers","name":"Psychoactive Synthetic Adulterants in Tablets Sold as MDMA after the COVID-19 Pandemic: Implications for Central Effects","year":"2026","cit":0,"pfa":"Amira Guirguis","ptype":"article","src":"https://openalex.org/W7128561393","eid":"W7128561393"},{"id":"paper-w7165026243","cat":"papers","name":"Indication-stratified mortality risk of ibogaine treatment under contemporary safety protocols: a multisite analysis of 19,071 patients and updated systematic review of fatalities","year":"2026","cit":0,"pfa":"Martijn Arns","psa":"Joseph Barsuglia","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7165026243","eid":"W7165026243"},{"id":"paper-w1488647789","cat":"papers","name":"Reseña de \"O USO RITUAL DA AYAHUASCA\" de BEATRIZ CAIUBY LABATE, WLADIMYR SENA ARAÚJO (COMPS.)","year":"2003","cit":0,"pfa":"Claudia María Montagut Mejía","ptype":"article","src":"https://openalex.org/W1488647789","eid":"W1488647789"},{"id":"paper-w2119140552","cat":"papers","name":"A Ayahuasca como um veículo para a expansão da consciência: uma experiência na busca da transformação pessoal","year":"2005","cit":0,"pfa":"Zélia Regina Corrêa Tavares","ptype":"dissertation","src":"https://openalex.org/W2119140552","eid":"W2119140552"},{"id":"paper-w3172004891","cat":"papers","name":"Ayahuasca e experiências religiosa e cultural entre indígenas da floresta amazônica e nawas das cidades","year":"2021","cit":0,"pfa":"Bruno Eduardo Freitas Honorato","psa":"Luiz Alex Silva Saraiva","ptype":"article","src":"https://openalex.org/W3172004891","eid":"W3172004891"},{"id":"paper-w3046009319","cat":"papers","name":"Efecto de la administración cronica de mdma sobre el aprendizaje y la memoria","year":"2010","cit":0,"pfa":"Arias Cavieres","psa":"Carolina Alejandra","ptype":"dissertation","src":"https://openalex.org/W3046009319","eid":"W3046009319"},{"id":"paper-w4413539598","cat":"papers","name":"FDA rejects MDMA-assisted therapy for PTSD treatment – a drug researcher explains the challenges psychedelics face","year":"2024","cit":0,"pfa":"Benjamin Y. Fong","topics":["PTSD & trauma"],"ptype":"other","src":"https://openalex.org/W4413539598","eid":"W4413539598"},{"id":"paper-w7203871668","cat":"papers","name":"MDMA-Assisted Therapy for Neuropathic Pain: Mechanisms, Evidence, and the Case for Dedicated Clinical Trials: A Narrative Review","year":"2026","cit":0,"pfa":"Ivan Temprado-Ordiaz","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W7203871668","eid":"W7203871668"},{"id":"paper-w7201959206","cat":"papers","name":"Psychedelic Mycology in Goa, India: A Review of the Environmental, Economic, and Regulatory Case for Sustainable Development of Psilocybin-Containing Fungi","year":"2026","cit":0,"pfa":"Shruti Malik","topics":["Reviews & meta-analyses","Policy & ethics"],"ptype":"other","src":"https://openalex.org/W7201959206","eid":"W7201959206"},{"id":"paper-w381684116","cat":"papers","name":"The highs and lows of drugs use: acute effects of cannabis, cocaine and MDMA on impulsivity, cognition and subjective experience","year":"2014","cit":0,"pfa":"Janelle H. P. van Wel","ptype":"dissertation","src":"https://openalex.org/W381684116","eid":"W381684116"},{"id":"paper-w4402919728","cat":"papers","name":"Comprehensive Analysis of 42 Psilocybin-Producing Fungi Variants Reveals Diverse Secondary Metabolites with Vast Therapeutic Potential","year":"2024","cit":0,"pfa":"Jonathan A. Cohen","psa":"David Meiri","ptype":"preprint","src":"https://openalex.org/W4402919728","eid":"W4402919728"},{"id":"paper-w2411112222","cat":"papers","name":"[Action of LSD and 5-methoxy-N,N-dimethyltryptamine on the high affinity uptake of [3H]-serotonin by isolated rat brain synaptosomes].","year":"1978","cit":0,"pfa":"Ralf Uebelhack","psa":"K Seidel","topics":["Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W2411112222","eid":"W2411112222"},{"id":"paper-w3200547222","cat":"papers","name":"Temperamento dos adeptos do uso ritual da Ayahuasca do Centro Luz Divina, Piedade – SP, Brasil.","year":"2021","cit":0,"pfa":"Arilton Martins Fonseca","psa":"Eliana Rodrigues","ptype":"article","src":"https://openalex.org/W3200547222","eid":"W3200547222"},{"id":"paper-w2040751821","cat":"papers","name":"ChemInform Abstract: The Chemistry of Indoles. Part 109. Synthetic Studies of Psilocin Analogues Having Either a Formyl Group or Bromine Atom at the 5‐ or 7‐Position.","year":"2002","cit":0,"pfa":"Fumio Yamada","psa":"Masanori Somei","ptype":"article","src":"https://openalex.org/W2040751821","eid":"W2040751821"},{"id":"paper-w4394480152","cat":"papers","name":"Additional file 3: Table S1. of De novo sequencing and analysis of Lophophora williamsii transcriptome, and searching for putative genes involved in mescaline biosynthesis","year":"2015","cit":0,"pfa":"Enrique Ibarra‐Laclette","psa":"Luís Herrera‐Estrella","ptype":"dataset","src":"https://openalex.org/W4394480152","eid":"W4394480152"},{"id":"paper-w3167608887","cat":"papers","name":"Culturas de la Iboga: perspectivas sobre el Bwiti de los funcionarios españoles en Guinea Ecuatorial durante el período franquista","year":"2020","cit":0,"pfa":"Jesús Sánchez Azañedo","ptype":"article","src":"https://openalex.org/W3167608887","eid":"W3167608887"},{"id":"paper-w7166641777","cat":"papers","name":"Psilocybin-assisted therapy for major depressive disorder: implications for clinical effectiveness, health economics, and regulatory decision-making","year":"2026","cit":0,"pfa":"C Faria","psa":"João José Sousa","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7166641777","eid":"W7166641777"},{"id":"paper-w2003286542","cat":"papers","name":"A124 MDMA-INDUCED LONG-TERM 5-HT1A RECEPTOR MODIFICATION IN MICE RAPHE DORSAL NUCLEUS","year":"2005","cit":0,"pfa":"Thibault Renoir","psa":"Laurence Lanfumey","topics":["Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W2003286542","eid":"W2003286542"},{"id":"paper-w2983327269","cat":"papers","name":"Individuals with Hyperthyroidism are More Susceptible to having a Serious Serotonin Syndrome Following MDMA (Ecstasy) Administration in Rats.","year":"2018","cit":0,"pfa":"Ibrahim M. Shokry","psa":"Rui Tao","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2983327269","eid":"W2983327269"},{"id":"paper-w2607498828","cat":"papers","name":"ChemInform Abstract: ALLGEMEINE METHODEN FUER SYNTH. VON INDOLALKALOIDEN 8. MITT. VERSUCH DER DARST. VON VERBINDUNGEN DER IBOGA‐VOACANGA‐REIHE","year":"1970","cit":0,"pfa":"Ernest Wenkert","psa":"GD Reynolds","ptype":"article","src":"https://openalex.org/W2607498828","eid":"W2607498828"},{"id":"paper-w4389435114","cat":"papers","name":"Supplemental Material for Ayahuasca in the Treatment of Posttraumatic Stress Disorder: Mixed-Methods Case Series Evaluation in Military Combat Veterans","year":"2023","cit":0,"topics":["PTSD & trauma"],"ptype":"supplementary-materials","src":"https://openalex.org/W4389435114","eid":"W4389435114"},{"id":"paper-w1494045394","cat":"papers","name":"Interacció farmacològica entre la 3.4-Metilendioximetamfetamina (MDMA, Èxtasi) i la paroxetina en humans","year":"2004","cit":0,"pfa":"Mireia Segura Agulló","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W1494045394","eid":"W1494045394"},{"id":"paper-w2520375729","cat":"papers","name":"Pharmacogenetic mechanisms (COMT and hSERT) modulating deleterious effects of MDMA and cannabis on cognitive performance in drug users","year":"2011","cit":0,"pfa":"Elisabet Cuyàs Navarro","topics":["Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W2520375729","eid":"W2520375729"},{"id":"paper-w7203901482","cat":"papers","name":"MDMA-Assisted Therapy for Neuropathic Pain: Mechanisms, Evidence, and the Case for Dedicated Clinical Trials: A Narrative Review","year":"2026","cit":0,"pfa":"Ivan Temprado-Ordiaz","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W7203901482","eid":"W7203901482"},{"id":"paper-w7134088710","cat":"papers","name":"MDMA-assisted psychotherapy in major depression: critical considerations for clinical translation: commentary, Kvam et al","year":"2026","cit":0,"pfa":"Tor-Morten Kvam","psa":"Ole A. Andreassen","topics":["Depression","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7134088710","eid":"W7134088710"},{"id":"paper-w7120692223","cat":"papers","name":"Ação neuroprotetora da ayahuasca no córtex pré-frontal de saguis (Callithrix jacchus) induzidos a um estado depressivo","year":"2023","cit":0,"pfa":"Lílian Andrade Carlos de Mendonça Batista","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W7120692223","eid":"W7120692223"},{"id":"paper-w4234653258","cat":"papers","name":"Faculty Opinions recommendation of Chronic, Intermittent Microdoses of the Psychedelic N,N-Dimethyltryptamine (DMT) Produce Positive Effects on Mood and Anxiety in Rodents.","year":"2020","cit":0,"pfa":"Eric Hollander","psa":"Genoveva Uzunova","topics":["Anxiety & end-of-life","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4234653258","eid":"W4234653258"},{"id":"paper-w4406385680","cat":"papers","name":"Entre saberes tradicionais, ciência e proibicionismo: contribuições da antropologia para a legitimação do uso da ayahuasca","year":"2024","cit":0,"pfa":"Henrique Fernandes Antunes","psa":"Beatriz Caiuby Labate","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4406385680","eid":"W4406385680"},{"id":"paper-w7155155213","cat":"papers","name":"Psilocybin-Assisted Therapy for Mood Disorders: A Comparative Literature Review of Australia, the United States, the United Kingdom, and Canada","year":"2026","cit":0,"pfa":"Jorge Oliveira","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7155155213","eid":"W7155155213"},{"id":"paper-w7120749331","cat":"papers","name":"Effects of N-methyl-3,4-methylenedioxymethamphetamine (MDMA-Ecstasy) on behavioral, neuroendocrines, and neutrophils activity parameters in mice","year":"2007","cit":0,"pfa":"Viviane Mendonça de Paula","topics":["Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7120749331","eid":"W7120749331"},{"id":"paper-w4390653206","cat":"papers","name":"TEOR DE MDMA EM AMOSTRAS TIPO ECSTASY APREENDIDAS NO ESTADO DE MINAS GERAIS, BRASIL","year":"2023","cit":0,"pfa":"Artur Diniz","psa":"Pablo Alves Marinho","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4390653206","eid":"W4390653206"},{"id":"paper-w4407825638","cat":"papers","name":"Development of an Australian Clinical Practice Guideline on methylenedioxymethamphetamine (MDMA)-assisted Psychotherapy for Post-traumatic Stress Disorder","year":"2025","cit":0,"pfa":"Alene Sze Jing Yong","psa":"J. Simon Bell","topics":["PTSD & trauma","Safety & adverse events","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4407825638","eid":"W4407825638"},{"id":"paper-w2244976725","cat":"papers","name":"2. Dormido, borracho, alucinando: estados corporales alterados a través de la ayahuasca en al amazonia peruana","year":"2013","cit":0,"pfa":"Peter Gowan","ptype":"article","src":"https://openalex.org/W2244976725","eid":"W2244976725"},{"id":"paper-w3139018829","cat":"papers","name":"As etapas da produção audiovisual como ferramenta de divulgação científica sobre a Ayahuasca e seus aspectos etnobotânicos","year":"2021","cit":0,"pfa":"Jussara Suzano Bento","ptype":"article","src":"https://openalex.org/W3139018829","eid":"W3139018829"},{"id":"paper-w7212038726","cat":"papers","name":"Psilocybin selectively suppresses novelty-induced grooming via 5-HT2B receptors: A microstructure analysis in Wistar rats","year":"2026","cit":0,"pfa":"Alexandre Seillier","psa":"Lenka Seillier","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7212038726","eid":"W7212038726"},{"id":"paper-w7131639414","cat":"papers","name":"Calcium activation mechanism of a noncanonical aromatic L-amino acid decarboxylase from psilocybin mushroom Psilocybe cubensis","year":"2026","cit":0,"pfa":"Tianjie Li","psa":"Yi Wang","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7131639414","eid":"W7131639414"},{"id":"paper-w7204955117","cat":"papers","name":"Factors Associated with Intentions to Use Psilocybin for Mental Health in Relation to Psychotherapy, Psychiatric Medications, and Natural/Synthetic Options","year":"2026","cit":0,"pfa":"Brian P. Meier","psa":"Matthew W. Johnson","topics":["Depression","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7204955117","eid":"W7204955117"},{"id":"paper-w7214550502","cat":"papers","name":"Psilocybin Microdosing Schedules, 5-HT2A Adaptation, and the Age-Dependent Cortical State: From Intermittent to Continuous Exposure","year":"2026","cit":0,"pfa":"Andrea Vittorini","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7214550502","eid":"W7214550502"},{"id":"paper-w7134916537","cat":"papers","name":"Enhancing cGMP signaling with psilocybin reduces head twitch and restructures the synaptic proteome while maintaining antidepressant response","year":"2026","cit":0,"pfa":"Gabriele Floris","psa":"Alfred P. Kaye","topics":["Depression","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7134916537","eid":"W7134916537"},{"id":"paper-w3196545686","cat":"papers","name":"THEORIES AND MAJOR HYPOTHESES IN ETHNOBOTANY: CULTURAL KEYSTONE SPECIES, UTILITARIAN REDUNDANCY, ETHNOBOTANY OF THE SHIPIBO-KONIBO, AND EFFECTS OF HARVEST ON AYAHUASCA","year":"2019","cit":0,"pfa":"Michael A. Coe","topics":["Reviews & meta-analyses","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W3196545686","eid":"W3196545686"},{"id":"paper-w7201967556","cat":"papers","name":"Psychedelic Mycology in Goa, India: A Review of the Environmental, Economic, and Regulatory Case for Sustainable Development of Psilocybin-Containing Fungi","year":"2026","cit":0,"pfa":"Shruti Malik","topics":["Reviews & meta-analyses","Policy & ethics"],"ptype":"other","src":"https://openalex.org/W7201967556","eid":"W7201967556"},{"id":"paper-w7211991627","cat":"papers","name":"643. A mechanism-informed clinical trial of psilocybin-assisted therapy for opioid use disorder: rationale and neurobiological framework","year":"2026","cit":0,"pfa":"O Mallon","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7211991627","eid":"W7211991627"},{"id":"paper-w7154114794","cat":"papers","name":"An Open-Label Study of Single-Dose Psilocybin for Borderline Personality Disorder With Co-Occurring Major Depressive Disorder","year":"2026","cit":0,"pfa":"Jon Edgar Grant","psa":"Dustin Ehsan","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7154114794","eid":"W7154114794"},{"id":"paper-w2048544586","cat":"papers","name":"Fetal mesencephalic cells exposed to MDMA (Ecstasy) enhance dopamine cell survival and neurite outgrowth in vitro","year":"2006","cit":0,"pfa":"Jack W. Lipton","psa":"Timothy J. Collier","ptype":"article","src":"https://openalex.org/W2048544586","eid":"W2048544586"},{"id":"paper-w111026355","cat":"papers","name":"The Effects of he Hallucinogenic Serotonin 1A/2A Agonist, Psilocybin, on Binocular Rivalry and Visual Contrast Detection Thresholds","year":"2004","cit":0,"pfa":"Olivia L. Carter","psa":"John Douglas Pettigrew","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W111026355","eid":"W111026355"},{"id":"paper-w4413761657","cat":"papers","name":"Differential alterations in peripheral tryptophan pathways in methamphetamine versus MDMA users are linked to their contrasting psychiatric symptoms","year":"2026","cit":0,"pfa":"Francesco Bavato","psa":"Boris B. Quednow","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4413761657","eid":"W4413761657"},{"id":"paper-w4376129001","cat":"papers","name":"How Psilocybin Can Rewire Our Brain, Its Therapeutic Benefits & Its Risks | Huberman Lab Podcast","year":"2023","cit":0,"pfa":"Sikandar Shah","topics":["Safety & adverse events"],"ptype":"report","src":"https://openalex.org/W4376129001","eid":"W4376129001"},{"id":"paper-w7214993352","cat":"papers","name":"MedCheck: Drugmakers Advance Psilocybin, Oral Pregnanolone for MDD, Plus FDA Approves Pediatric Tourette's Drug, and More","year":"2026","cit":0,"pfa":"Linda M. Richmond","topics":["Depression"],"ptype":"other","src":"https://openalex.org/W7214993352","eid":"W7214993352"},{"id":"paper-w4413284521","cat":"papers","name":"519. PSILOCYBIN ASSISTED PSYCHOTHERAPY FOR OBSESSIVE COMPULSIVE DISORDER, BODY DYSMORPHIC DISORDER, AND ANOREXIA NERVOSA: STUDY PROTOCOL","year":"2025","cit":0,"pfa":"N Acevdo","psa":"Susan Lee Rossell","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4413284521","eid":"W4413284521"},{"id":"paper-w4417207699","cat":"papers","name":"Review for \"Acute blockade of the serotonin transporter with low doses of escitalopram does not alter the behavioural responses to acute psilocybin\"","year":"2025","cit":0,"topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4417207699","eid":"W4417207699"},{"id":"paper-w2515600213","cat":"papers","name":"βk-amphetamines: Neurotoxicity triggered by methylone and MDPV in undifferentiated and differentiated SH-SY5Y cells and comparison to MDMA","year":"2016","cit":0,"pfa":"Maria João Valente","psa":"Márcia C. Carvalho","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2515600213","eid":"W2515600213"},{"id":"paper-w7161961757","cat":"papers","name":"Differential alterations in peripheral tryptophan pathways in methamphetamine versus MDMA users are linked to their contrasting psychiatric symptoms","year":"2026","cit":0,"pfa":"Francesco Bavato","psa":"Boris B.; https://orcid.org/0000-0001-7933-2865 Quednow","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7161961757","eid":"W7161961757"},{"id":"paper-w4313249676","cat":"papers","name":"Producción científica en Scopus sobre el uso de ayahuasca en la salud humana: Estudio Bibliométrico","year":"2022","cit":0,"pfa":"Kary Gonzales-Dávila","psa":"Alejandra Bussalleu","ptype":"article","src":"https://openalex.org/W4313249676","eid":"W4313249676"},{"id":"paper-w2068268272","cat":"papers","name":"No lasting psycho-physiological effects of a single dose of MDMA (“Ecstasy”) in controlled conditions in healthy human volunteers","year":"2001","cit":0,"pfa":"Matthias E. Liechti","psa":"F.X. Vollenweider","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2068268272","eid":"W2068268272"},{"id":"paper-w7207083186","cat":"papers","name":"MDLLIN : documental sonoro sobre el consumo de MDMA en la ciudad de Medellín","year":"2023","cit":0,"pfa":"Laura Almanza López","ptype":"dissertation","src":"https://openalex.org/W7207083186","eid":"W7207083186"},{"id":"paper-w7166742321","cat":"papers","name":"MDMA-Assisted Psychotherapy for Treatment-Resistant PTSD: A Scoping Review of Efficacy, Mechanisms, and Long-Term Outcomes","year":"2026","cit":0,"pfa":"Colter Romo","psa":"Jacquelyn D. Waller","topics":["Depression","PTSD & trauma","Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W7166742321","eid":"W7166742321"},{"id":"paper-w4417207729","cat":"papers","name":"Review for \"Acute blockade of the serotonin transporter with low doses of escitalopram does not alter the behavioural responses to acute psilocybin\"","year":"2025","cit":0,"topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4417207729","eid":"W4417207729"},{"id":"paper-w3183560864","cat":"papers","name":"\"It kind of polishes all your flaws away\": long-term experiences with psilocybin mushrooms and the influence of set and setting","year":"2021","cit":0,"pfa":"Danielle Nicole Daniel","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W3183560864","eid":"W3183560864"},{"id":"paper-w4417207696","cat":"papers","name":"Review for \"Acute blockade of the serotonin transporter with low doses of escitalopram does not alter the behavioural responses to acute psilocybin\"","year":"2025","cit":0,"topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4417207696","eid":"W4417207696"},{"id":"paper-w7214556818","cat":"papers","name":"Psilocybin Microdosing Schedules, 5-HT2A Adaptation, and the Age-Dependent Cortical State: From Intermittent to Continuous Exposure","year":"2026","cit":0,"pfa":"Andrea Vittorini","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7214556818","eid":"W7214556818"},{"id":"paper-w4414304737","cat":"papers","name":"Inhaled N,N-Dimethyltryptamine Diminishes Connectivity between the Ventral Tegmental Area and the Nucleus Accumbens : relevance to pathologies of mesolimbic and mesocortical pathways","year":"2025","cit":0,"pfa":"Gisela Lima","psa":"Miguel Castelo-Branco","ptype":"preprint","src":"https://openalex.org/W4414304737","eid":"W4414304737"},{"id":"paper-w7163199668","cat":"papers","name":"How Deliberate Metaphors Enable New Ways of Conceiving the Self After Psilocybin-Induced Ego Dissolution Experiences","year":"2026","cit":0,"pfa":"Diego Monasterio López","topics":["Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W7163199668","eid":"W7163199668"},{"id":"paper-w2289364849","cat":"papers","name":"REMÉDIO CASEIRO, ORÁCULO, DROGA, ERVA DOS BRUXOS: AQUÉM DA LEGITIMAÇÃO DA AYAHUASCA PELA VIA TERAPÊUTICO-ESPIRITUAL","year":"2014","cit":0,"pfa":"Ana Gretel Echazú Böschemeier","ptype":"article","src":"https://openalex.org/W2289364849","eid":"W2289364849"},{"id":"paper-w2284812320","cat":"papers","name":"Investigação de alcaloides ß-carbolinas, Triptaminas presentes na Ayahuasca (Santo Daime) em amostras de suor","year":"2014","cit":0,"pfa":"Lidiane Silva Tavares","ptype":"dissertation","src":"https://openalex.org/W2284812320","eid":"W2284812320"},{"id":"paper-w7203674465","cat":"papers","name":"Psilocybin-assisted psychotherapy for substance use disorders as a complex intervention: A systematic review of efficacy, mechanisms and psychotherapeutic frameworks","year":"2026","cit":0,"pfa":"Lana Strika-Bruneau","psa":"Bruno Roméo","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W7203674465","eid":"W7203674465"},{"id":"paper-w4405021687","cat":"papers","name":"Expression of Concern: Sleep Quality Improvements After MDMA‐Assisted Psychotherapy for the Treatment of Posttraumatic Stress Disorder","year":"2024","cit":0,"topics":["PTSD & trauma","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4405021687","eid":"W4405021687"},{"id":"paper-w2613473023","cat":"papers","name":"Recommended Methods for the Detection and Assay of Lysergide (LSD), Phencyclidine (PCP), Psilocybin and Methaqualone in biological Specimens (multiauthored manual)","year":"1999","cit":0,"pfa":"Franco Tagliaro","ptype":"article","src":"https://openalex.org/W2613473023","eid":"W2613473023"},{"id":"paper-w2958844344","cat":"papers","name":"Uso da ayahuasca : fundamentos e limites da criminalização do tráfico de drogas em sociedades multirreligiosas","year":"2019","cit":0,"pfa":"Rafael Ferreira Vianna","topics":["Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W2958844344","eid":"W2958844344"},{"id":"paper-w2579220271","cat":"papers","name":"Kappa opioid receptor agonist 16-ethynyl salvinorin a attenuates the rewarding effects of cocaine in the progressive ratio model in rats with fewer side-effects","year":"2017","cit":0,"pfa":"Bronwyn Maree Kivell","psa":"Thomas Edward Prisinzano","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2579220271","eid":"W2579220271"},{"id":"paper-w7213023931","cat":"papers","name":"Botanical Context Biasing for Experience-Dependent Neuroplasticity: A Two-Timescale Hypothesis of Directional Reinforcement During Psilocybin-Induced Plasticity","year":"2026","cit":0,"pfa":"Robinson, Shaun","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7213023931","eid":"W7213023931"},{"id":"paper-w4416054783","cat":"papers","name":"Estudio de la bebida ancestral ayahuasca (Banisteriopsis CAAPI) para la elaboración de un menú gastronómico","year":"2025","cit":0,"pfa":"Daniel Santiago Rivera-Rosero","psa":"Tannia Cristina Poveda-Morales","ptype":"article","src":"https://openalex.org/W4416054783","eid":"W4416054783"},{"id":"paper-w7118396332","cat":"papers","name":"La representación de la ayahuasca en los relatos polacos disponibles en Internet. Una aproximación introductoria","year":"2025","cit":0,"pfa":"Anna Zaczkiewicz","ptype":"article","src":"https://openalex.org/W7118396332","eid":"W7118396332"},{"id":"paper-w4410129529","cat":"papers","name":"Psilocybin Mitigates Behavioral Despair and Cognitive Impairment in Treatment-resistant Depression Model using Wistar Kyoto Rats","year":"2025","cit":0,"pfa":"Zitong Wang","psa":"Yanbo Zhang","topics":["Depression"],"ptype":"preprint","src":"https://openalex.org/W4410129529","eid":"W4410129529"},{"id":"paper-w1924906414","cat":"papers","name":"Combinatiegebruik bij party-bezoekers : inzicht in gebruikspatronen, psychologische determinanten en verwachtingen van MDMA-(combi)gebruikers","year":"2008","cit":0,"pfa":"N. van der Meer","topics":["Addiction"],"ptype":"dissertation","src":"https://openalex.org/W1924906414","eid":"W1924906414"},{"id":"paper-w2065032701","cat":"papers","name":"p.1.i.005 Long-term functional effects on circadian rhythm caused by a single MDMA treatment","year":"2010","cit":0,"pfa":"Zita Kátai","psa":"György Bagdy","ptype":"article","src":"https://openalex.org/W2065032701","eid":"W2065032701"},{"id":"paper-w4405636529","cat":"papers","name":"Serotonergic plasticity beyond the brain? Contrasting effects of chronic MDMA vs. methamphetamine use on peripheral serotonin pathways","year":"2024","cit":0,"pfa":"Francesco Bavato","psa":"Boris B. Quednow","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4405636529","eid":"W4405636529"},{"id":"paper-w4417207731","cat":"papers","name":"Review for \"Acute blockade of the serotonin transporter with low doses of escitalopram does not alter the behavioural responses to acute psilocybin\"","year":"2025","cit":0,"topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4417207731","eid":"W4417207731"},{"id":"paper-w2403235383","cat":"papers","name":"Psychopharmacological effects of +-3, 4-methylenedioxymetamphetamine (MDMA, 'Ecstacy') : mood and cognitive function in current and ex-users.","year":"2001","cit":0,"pfa":"Suzanne L. Verheyden","topics":["Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W2403235383","eid":"W2403235383"},{"id":"paper-w4247486405","cat":"papers","name":"Erratum to: Exploring functional data analysis and wavelet principal component analysis on ecstasy (MDMA) wastewater data","year":"2017","cit":0,"pfa":"Stefania Salvatore","psa":"Jo Røislien","ptype":"erratum","src":"https://openalex.org/W4247486405","eid":"W4247486405"},{"id":"paper-w7125582213","cat":"papers","name":"Ayahuasca pretreatment prevents sepsis-induced anxiety-like behavior, neuroinflammation, and oxidative stress, and increases brain-derived neurotrophic factor","year":"2025","cit":0,"pfa":"Lara Rodrigues da Rosa","psa":"Rafael Mariano de Bitencourt","topics":["Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"conference-paper","src":"https://openalex.org/W7125582213","eid":"W7125582213"},{"id":"paper-w7213995300","cat":"papers","name":"Enigmas que se inventam quando a ayahuasca e a clínica se encontram: “Fale de mim para os acadêmicos”","year":"2025","cit":0,"pfa":"Lucas Conforti Protti","ptype":"dissertation","src":"https://openalex.org/W7213995300","eid":"W7213995300"},{"id":"paper-w7212022485","cat":"papers","name":"354. Effects of psilocybin treatment on cognitive function in Japanese patients with treatment-resistant depression: an open-label study","year":"2026","cit":0,"pfa":"S Tomiyama","psa":"H Uchida","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W7212022485","eid":"W7212022485"},{"id":"paper-w4416607013","cat":"papers","name":"Peer Review Report For: A whole genome atlas of 81 Psilocybe genomes as a resource for psilocybin production. [version 1; peer review: 1 not approved]","year":"2021","cit":0,"pfa":"Kevin Judd McKernan","psa":"Stephen McLaughlin","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4416607013","eid":"W4416607013"},{"id":"paper-w2278906451","cat":"papers","name":"A new model of limbic epilepsy: MDMA (ecstasy) leads to persistent EEG changes and seizures facilitation in mice","year":"2004","cit":0,"pfa":"Chiara Pizzanelli","psa":"Francesco Fornai","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2278906451","eid":"W2278906451"},{"id":"paper-w2792922769","cat":"papers","name":"Faculty Opinions recommendation of Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression.","year":"2018","cit":0,"pfa":"Dave Nichols","topics":["Depression"],"ptype":"peer-review","src":"https://openalex.org/W2792922769","eid":"W2792922769"},{"id":"paper-w3017236858","cat":"papers","name":"Antibody Gene Therapy Mitigates Adverse Immunological Effects of 3,4‐Methylenedioxymethamphetamine (MDMA) in Male BALB/c Mice","year":"2020","cit":0,"pfa":"Caleb Bolden","psa":"Eric Charles Peterson","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W3017236858","eid":"W3017236858"},{"id":"paper-w7213667211","cat":"papers","name":"Oportunidades de mejora de los centros espirituales para el desarrollo del turismo de ayahuasca en Pucallpa","year":"2025","cit":0,"pfa":"Alexandra Martinez Matamoros","psa":"Yanire Sarai Davila Uriarte","topics":["Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W7213667211","eid":"W7213667211"},{"id":"paper-w4403242772","cat":"papers","name":"Ayahuasca as liquid divinity: An ontological approach By André van der Braak, Lanham: Lexington Books. 2023. 229 pp.","year":"2024","cit":0,"pfa":"Shana Harris","topics":["Therapy practice"],"ptype":"book-review","src":"https://openalex.org/W4403242772","eid":"W4403242772"},{"id":"paper-w4297846694","cat":"papers","name":"Effect of psilocybin on marble-burying in ICR mice: Role of 5-HT1A receptors and implications for the treatment of obsessive-compulsive disorder","year":"2022","cit":0,"pfa":"Bernard Lerer","psa":"Tzuri Lifschytz","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4297846694","eid":"W4297846694"},{"id":"paper-w4390223307","cat":"papers","name":"Effect of co-administration of low doses of psilocybin and mGluR2/3 antagonist LY341495 in chronic restraint stress model of depression","year":"2023","cit":0,"pfa":"Agata Machaczka","psa":"Andrzej Pilc","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4390223307","eid":"W4390223307"},{"id":"paper-w4405050323","cat":"papers","name":"Review for \"Randomized Controlled Trials of Psilocybin‐Assisted Therapy in the Treatment of Major Depressive Disorder: Systematic Review and Meta‐Analysis\"","year":"2024","cit":0,"topics":["Depression","Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4405050323","eid":"W4405050323"},{"id":"paper-w7155010953","cat":"papers","name":"Symmetrical Global Mental Health (Sym-GMH): Ayahuasca and shipibo traditional medicine for lasting changes in personality and quality of life","year":"2026","cit":0,"pfa":"José Carlos Bouso","psa":"Débora González","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7155010953","eid":"W7155010953"},{"id":"paper-w7165127045","cat":"papers","name":"Psilocybin-assisted therapy in treatment-resistant depression: rapid remission, uncertain durability, and the next phase of clinical evidence","year":"2026","cit":0,"pfa":"Astrit Sabani","psa":"Adnan Khatak","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7165127045","eid":"W7165127045"},{"id":"paper-w7117318443","cat":"papers","name":"Psilocybin decreases reward-seeking behavior accompanied by increased activity of parvalbumin neurons with perineuronal nets in the medial prefrontal cortex","year":"2025","cit":0,"pfa":"Jenna Houff","psa":"Alberto Del Arco","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7117318443","eid":"W7117318443"},{"id":"paper-w4409955030","cat":"papers","name":"Ayahuasca Shifts Brain Dynamics Toward Higher Entropy: Persistent Elevation of Ising Temperature Correlates with Acute Subjective Effects","year":"2025","cit":0,"pfa":"Rodrigo M. Cabral-Carvalho","psa":"João Ricardo Sato","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4409955030","eid":"W4409955030"},{"id":"paper-w7205092489","cat":"papers","name":"Yagé, ayahuasca, caapi et leur alcaloïde : télépathine ou yagéine / par Ém. Perrot et Raymond Hamet","year":"1927","cit":0,"pfa":"Émile (1867-1951). Auteur du texte Perrot","psa":"Raymond de Capoue (1330?-1399). Auteur du texte","ptype":"book","src":"https://openalex.org/W7205092489","eid":"W7205092489"},{"id":"paper-w1480594431","cat":"papers","name":"Problematizando uma hibridização: significação e ressignificação do uso da Ayahuasca, ou: quem está colonizando quem?","year":"2010","cit":0,"pfa":"Jacques Henri Maurice Gauthier","ptype":"article","src":"https://openalex.org/W1480594431","eid":"W1480594431"},{"id":"paper-w27283168","cat":"papers","name":"Daño hepático producido por la droga de abuso éxtasis (mdma) a corto y largo plazo","year":"1998","cit":0,"pfa":"Guadalupe Beitia Berrotarán","ptype":"dissertation","src":"https://openalex.org/W27283168","eid":"W27283168"},{"id":"paper-w1986667278","cat":"papers","name":"S31 BEHAVIORAL AND NEURAL ADAPTATIONS DURING WITHDRAWAL FROM A NON-NEUROTOXIC REGIMEN OF (+)-3,4-METHYLENEDIOXYMETHAMPHETAMINE [(+)-MDMA; ECSTASY]","year":"2005","cit":0,"pfa":"Kathryn A. Cunningham","psa":"Michaël Thomas","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W1986667278","eid":"W1986667278"},{"id":"paper-w4253243406","cat":"papers","name":"Erratum to: MDMA administration during adolescence exacerbates MPTP-induced cognitive impairment and neuroinflammation in the hippocampus and prefrontal cortex","year":"2014","cit":0,"pfa":"Giulia Costa","psa":"Micaela Morelli","topics":["Mechanism & neuroscience"],"ptype":"erratum","src":"https://openalex.org/W4253243406","eid":"W4253243406"},{"id":"paper-w2916372466","cat":"papers","name":"Chiral separation of the enantiomers of ephedrine, amphetamine, methamphetamine, MDA, MDMA, and phentermine in blood using LC-MS/MS","year":"2018","cit":0,"pfa":"Ashley Vallier","topics":["Addiction","Dosing & pharmacology","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W2916372466","eid":"W2916372466"},{"id":"paper-w4362734251","cat":"papers","name":"Brain-Wide Activity Mapping Reveals a Required Role for the Dorsal Endopiriform Nucleus in MDMA-Evoked Prosocial Behavior","year":"2023","cit":0,"pfa":"Boris Dov Heifets","psa":"Robert C. Malenka","ptype":"article","src":"https://openalex.org/W4362734251","eid":"W4362734251"},{"id":"paper-w4406217027","cat":"papers","name":"Supplemental Material for A Critical Evaluation of Psilocybin-Assisted Therapy Protocol Components From Clinical Trial Patients, Facilitators, and Caregivers","year":"2025","cit":0,"topics":["Therapy practice"],"ptype":"supplementary-materials","src":"https://openalex.org/W4406217027","eid":"W4406217027"},{"id":"paper-w7199233093","cat":"papers","name":"Avaliação dos efeitos da Ayahuasca sobre os processos de extinção e reconsolidação da memória de medo","year":"2024","cit":0,"pfa":"Aline Machado Gaspar","ptype":"article","src":"https://openalex.org/W7199233093","eid":"W7199233093"},{"id":"paper-w4393738534","cat":"papers","name":"Supplementary data for the article \"Ayahuasca Users in Estonia: Ceremonial Practices, Subjective Long-Term Effects, Mental Health and Quality of Life\"","year":"2020","cit":0,"pfa":"Helle Kaasik","psa":"Kairi Kreegipuu","ptype":"supplementary-materials","src":"https://openalex.org/W4393738534","eid":"W4393738534"},{"id":"paper-w2021740163","cat":"papers","name":"P.6.c.007 Brainstem raphe lesion in MDMA (ecstasy) users recorded on transcranial sonography (TCS)","year":"2011","cit":0,"pfa":"Mislav Budišić","psa":"Vida Demarin","ptype":"article","src":"https://openalex.org/W2021740163","eid":"W2021740163"},{"id":"paper-w7146210824","cat":"papers","name":"Psilocybin実験精神病の精神病理学的研究","year":"1965","cit":0,"pfa":"Akimitsu Miyoshi","ptype":"dissertation","src":"https://openalex.org/W7146210824","eid":"W7146210824"},{"id":"paper-w7141351298","cat":"papers","name":"When I use a word . . . Terminology of hallucinogenic agents","year":"2026","cit":0,"pfa":"J K Aronson","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7141351298","eid":"W7141351298"},{"id":"paper-w7139041963","cat":"papers","name":"New‐Onset Obsessive–Compulsive Symptoms After MDMA‐Assisted Psychotherapy in a Patient With Refractory PTSD: A Case Report","year":"2026","cit":0,"pfa":"Ridhi J. Vyas","psa":"Zelde Espinel","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7139041963","eid":"W7139041963"},{"id":"paper-w3089578341","cat":"papers","name":"Ethanol, 3,4 methylhenedioxymethamphetamine (MDMA, ecstasy) and their combination: long-term behavioural, neurochemical and neuropharmacological effects in the rat","year":"2005","cit":0,"pfa":"Jean‐Christophe Cassel","psa":"Rolf Jackisch","topics":["Dosing & pharmacology"],"ptype":"conference-paper","src":"https://openalex.org/W3089578341","eid":"W3089578341"},{"id":"paper-w4409280622","cat":"papers","name":"188. Mapping Psilocybin Therapy: A Systematic Review of Therapeutic Frameworks, Adaptations, and Standardization Across Contemporary Clinical Trials","year":"2025","cit":0,"pfa":"Mary E. Kittur","psa":"Ishrat M. Husain","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4409280622","eid":"W4409280622"},{"id":"paper-w4365139214","cat":"papers","name":"Implementación de un producto natural a partir de Ayahuasca (banisteriopsis caapi) en la sustitución de antidepresivos sintéticos","year":"2023","cit":0,"pfa":"Franklin Andrés Álvarez Cortez","psa":"Daicy Paola Arias Salazar","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4365139214","eid":"W4365139214"},{"id":"paper-w7114991502","cat":"papers","name":"Ayahuasca como adyuvante en el tratamiento de la depresión y la ansiedad: revisión de la literatura","year":"2025","cit":0,"pfa":"Haro Haro, Katherine Michelle","psa":"Freire Montesdeoca, Jessica Mariana","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7114991502","eid":"W7114991502"},{"id":"paper-w7114992283","cat":"papers","name":"Ayahuasca como adyuvante en el tratamiento de la depresión y la ansiedad: revisión de la literatura","year":"2025","cit":0,"pfa":"Haro Haro, Katherine Michelle","psa":"Freire Montesdeoca, Jessica Mariana","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7114992283","eid":"W7114992283"},{"id":"paper-w7201866252","cat":"papers","name":"Impact of Psilocybin on Motor Function in Healthy Participants: A Phase 1, Randomised, Triple-Blind, Dose-Finding Study","year":"2026","cit":0,"pfa":"Chiranth Bhagavan","psa":"Richard Kanaan","topics":["Safety & adverse events","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7201866252","eid":"W7201866252"},{"id":"paper-w7118329195","cat":"papers","name":"Eutylone history selectively impacts the rewarding and aversive effects of cocaine, MDMA, and eutylone in female Sprague-Dawley rats","year":"2026","cit":0,"pfa":"Negar Ghasem Ardabili","psa":"Anthony Lee Riley","ptype":"article","src":"https://openalex.org/W7118329195","eid":"W7118329195"},{"id":"paper-w7106656061","cat":"papers","name":"Endogenous N,N-Dimethyltryptamine and Sigma-1 Receptor Modulation as Enhancers of Neural-Substrate Coherence in the Swygert Theory of Everything AO (TSTOEAO)","year":"2025","cit":0,"pfa":"Swygert, John","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7106656061","eid":"W7106656061"},{"id":"paper-w7209963665","cat":"papers","name":"El uso ritual y profano del peyote, a través de los registros de la Inquisición de México. (s. XVI-XVII)","year":"2026","cit":0,"pfa":"A Barrera","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7209963665","eid":"W7209963665"},{"id":"paper-w7170067294","cat":"papers","name":"Dynamic Substates of the Default Mode Network Are Associated with Mystical Experiences and Clinical Outcomes after Magnesium-Ibogaine Treatment in Veterans with Traumatic Brain Injury","year":"2026","cit":0,"pfa":"Kenneth Shinozuka","psa":"Cammie Rolle","topics":["PTSD & trauma","Addiction","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7170067294","eid":"W7170067294"},{"id":"paper-w2304006269","cat":"papers","name":"Hyperfrontalität und Psychopathologie am Ketamin- und Psilocybin-Modell der Schizophrenie — Nachweis mit FDG-PET","year":"1995","cit":0,"pfa":"F.X. Vollenweider","psa":"Klaus Leonhard Leenders","ptype":"book-chapter","src":"https://openalex.org/W2304006269","eid":"W2304006269"},{"id":"paper-w4408525624","cat":"papers","name":"Long-term effects of single-dose psilocybin and psychedelic mushroom extract in the SAPAP3 model of OCD-like behavior","year":"2025","cit":0,"pfa":"Michal Brownstien","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4408525624","eid":"W4408525624"},{"id":"paper-w2168691145","cat":"papers","name":"De aanzet tot het gebruik van ecstasy (MDMA) onder adolescenten: Persoonlijkheids- en sociale predictoren","year":"2015","cit":0,"pfa":"D.J.G. Visser","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2168691145","eid":"W2168691145"},{"id":"paper-w4411954097","cat":"papers","name":"Exploring the Therapeutic Potential of Psilocybin and Ketamine in Major Depressive Disorder including Treatment-Resistant Depression: A Narrative Review","year":"2025","cit":0,"pfa":"Christian S. Skowron","psa":"Piotr Franciszek Kurzyna","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W4411954097","eid":"W4411954097"},{"id":"paper-w2436547401","cat":"papers","name":"Increased side-chain length confers a greater dopaminergic phenotype and increased reinforcing efficacy to cathinone analogs of MDMA","year":"2016","cit":0,"pfa":"Sean B. Dolan","psa":"Michael B. Gatch","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2436547401","eid":"W2436547401"},{"id":"paper-w3084296494","cat":"papers","name":"Evidence for the involvement of PAX4 transcription factor behind the chronic consequences of single-dose MDMA treatment in the rat hippocampus","year":"2018","cit":0,"pfa":"Péter Petschner","psa":"György Bagdy","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3084296494","eid":"W3084296494"},{"id":"paper-w3035589633","cat":"papers","name":"Evaluation drugs --Amphetamine, Methamphetamine and its derivative, 3, 4-methylenedioxymethamphetamine (MDMA) by Gas Chromatography -Mass Spectrometry","year":"2018","cit":0,"pfa":"黃美涵","psa":"王怡棻","ptype":"article","src":"https://openalex.org/W3035589633","eid":"W3035589633"},{"id":"paper-w18645122","cat":"papers","name":"Akut- und Langzeiteffekte von 3,4-Methylendioxymethamphetamin (MDMA, 'Ecstasy') in Tiermodellen der Sucht und Neurotoxizität","year":"2002","cit":0,"pfa":"Andreas Mayerhofer","ptype":"dissertation","src":"https://openalex.org/W18645122","eid":"W18645122"},{"id":"paper-w2321724181","cat":"papers","name":"From Bench to Bedside: Understanding the Science behind the Pharmacologic Management of MDMA- and other Sympathomimetic-Mediated Hyperthermia","year":"2011","cit":0,"pfa":"Matthew L. Banks","psa":"Jon E. Sprague","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2321724181","eid":"W2321724181"},{"id":"paper-w4406913696","cat":"papers","name":"Foreword: Ecstasy, Molly, MDMA: What health practitioners need to know about this common recreational drug","year":"2025","cit":0,"pfa":"Nancy Friedman","psa":"Ross Friedman","ptype":"article","src":"https://openalex.org/W4406913696","eid":"W4406913696"},{"id":"paper-w7143392773","cat":"papers","name":"A living systematic review, meta-analysis, and open data resource of trials of MDMA-assisted therapy for PTSD","year":"2026","cit":0,"pfa":"Brooke L. Sevchik","psa":"Theodore Daniel Satterthwaite","topics":["PTSD & trauma","Safety & adverse events","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7143392773","eid":"W7143392773"},{"id":"paper-w1984672465","cat":"papers","name":"S.04.02 5HT-transporter dependent effects of MDMA (“ecstasy”) on the 5HT-system and hippocampal cell proliferation in mice","year":"2007","cit":0,"pfa":"Thibault Renoir","psa":"Laurence Lanfumey","ptype":"article","src":"https://openalex.org/W1984672465","eid":"W1984672465"},{"id":"paper-w4412606037","cat":"papers","name":"LGBTQ+ Ayahuasca Retreat Experience is Associated with Benefits to Mental Health, Quality of Life, and Spiritual Well-being: A Prospective, Naturalistic Study","year":"2025","cit":0,"pfa":"Matthew X. Lowe","psa":"Heather Jackson","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"preprint","src":"https://openalex.org/W4412606037","eid":"W4412606037"},{"id":"paper-w4417207727","cat":"papers","name":"Decision letter for \"Acute blockade of the serotonin transporter with low doses of escitalopram does not alter the behavioural responses to acute psilocybin\"","year":"2025","cit":0,"topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"peer-review","src":"https://openalex.org/W4417207727","eid":"W4417207727"},{"id":"paper-w7171996200","cat":"papers","name":"One dose of Psilocybin modulates Brain Activity among Depressive patients : Preliminary Neuroimaging Results from the PSILODAC Study","year":"2026","cit":0,"pfa":"M. Pastre","psa":"I. Conejero","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7171996200","eid":"W7171996200"},{"id":"paper-w2166740942","cat":"papers","name":"Evaluating the effects of chronic MDMA abuses on cerebral metabolism using proton magnetic resonance spectroscopy (1H-MRS)","year":"2008","cit":0,"pfa":"Wei-Yin Liu","psa":"Woei‐Chyn Chu","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"conference-paper","src":"https://openalex.org/W2166740942","eid":"W2166740942"},{"id":"paper-w7214878603","cat":"papers","name":"Modelo multicomponente de la dinámica modal de aerosoles (MDMA) acoplado a contaminantes en fase gaseosa","year":"2017","cit":0,"pfa":"William Raúl Patiño González","ptype":"dissertation","src":"https://openalex.org/W7214878603","eid":"W7214878603"},{"id":"paper-w2725372175","cat":"papers","name":"Entropia de Shannon e propriedades topológicas de redes funcionais do cérebro humano sob efeito de Ayahuasca","year":"2015","cit":0,"pfa":"Aline Amabile Viol Barbosa","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W2725372175","eid":"W2725372175"},{"id":"paper-w2949997100","cat":"papers","name":"3,4-Methylendioxymethamphetamine (MDMA, ECSTASY) preferentially increases extracellular dopamine in the shell compared to the core of the rat nucleus accumbens","year":"2002","cit":0,"pfa":"Cristina Cadoni","psa":"G. Di Chiara","ptype":"article","src":"https://openalex.org/W2949997100","eid":"W2949997100"},{"id":"paper-w236340994","cat":"papers","name":"3,4—Methylenedioxymethamphetamine（MDMA） Abuse Markedly Inhibits Acetylcholinesterase Activity and Induces Severe Oxidative Damage and Liperoxidative Damage","year":"2003","cit":0,"pfa":"Jun-Fuzhou","psa":"Dong-Cai","ptype":"article","src":"https://openalex.org/W236340994","eid":"W236340994"},{"id":"paper-w2121728312","cat":"papers","name":"P.1.c.049 Alertness and electrocortical activity after (co-)administration of MDMA and THC in healthy volunteers","year":"2008","cit":0,"pfa":"Marieke M. Lansbergen","psa":"Robbert‐Jan Verkes","ptype":"article","src":"https://openalex.org/W2121728312","eid":"W2121728312"},{"id":"paper-w2763803316","cat":"papers","name":"合成麻薬(MDMA)の遺伝毒性について","year":"2006","cit":0,"pfa":"吉岡早戸","psa":"清水英佑","ptype":"article","src":"https://openalex.org/W2763803316","eid":"W2763803316"},{"id":"paper-w4239249785","cat":"papers","name":"Faculty Opinions recommendation of MDMA self-administration in rats: acquisition, progressive ratio responding and serotonin transporter binding.","year":"2009","cit":0,"pfa":"George A. Ricaurte","topics":["Mechanism & neuroscience"],"ptype":"peer-review","src":"https://openalex.org/W4239249785","eid":"W4239249785"},{"id":"paper-w7172417560","cat":"papers","name":"Integrated biomarker analysis of multi-organ effects following MDMA and alcohol co-consumption in Pakistan: A pilot study","year":"2026","cit":0,"pfa":"Anila Jaleel","psa":"Ghulam Farid","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7172417560","eid":"W7172417560"},{"id":"paper-w7106479126","cat":"papers","name":"Ayahuasca como adyuvante en el tratamiento de la depresión y la ansiedad: revisión de la literatura","year":"2025","cit":0,"pfa":"Haro Haro Katherine Michelle","psa":"Freire Montesdeoca Jessica Mariana","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7106479126","eid":"W7106479126"},{"id":"paper-w4405636342","cat":"papers","name":"Effects of psilocybin and sleep quality on brain water diffusivity and microstructure in healthy individuals and chronic cluster headache patients","year":"2024","cit":0,"pfa":"Kristoffer Brendstrup‐Brix","psa":"Martin Korsbak Madsen","ptype":"article","src":"https://openalex.org/W4405636342","eid":"W4405636342"},{"id":"paper-w41186508","cat":"papers","name":"Neurotoxicity of Methylenedioxymethamphetamine (MDMA; Ecstasy) and its Main Metabolites, on Rat Brain Mitochondria In Vitro and In Vivo - Behavioral Consequences","year":"2011","cit":0,"pfa":"Ema Luís Pereira Gomes Alves","topics":["Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W41186508","eid":"W41186508"},{"id":"paper-w7160379761","cat":"papers","name":"Variation in Problem Behaviors Due to History of MDMA or 'Ecstasy' Use among African American Female Juvenile Detainees","year":"2026","cit":0,"pfa":"Torrance Stephens","psa":"Christopher K. Bass","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7160379761","eid":"W7160379761"},{"id":"paper-w4405049631","cat":"papers","name":"Review for \"Randomized Controlled Trials of Psilocybin‐Assisted Therapy in the Treatment of Major Depressive Disorder: Systematic Review and Meta‐Analysis\"","year":"2024","cit":0,"topics":["Depression","Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4405049631","eid":"W4405049631"},{"id":"paper-w3156017280","cat":"papers","name":"When formulation procedures strongly matter: a case study of ayahuasca use in Centro Luz Divina, Piedade, São Paulo, Brazil","year":"2021","cit":0,"pfa":"Arilton Martins Fonseca","psa":"Eliana Rodrigues","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3156017280","eid":"W3156017280"},{"id":"paper-w4417207713","cat":"papers","name":"Author response for \"Acute blockade of the serotonin transporter with low doses of escitalopram does not alter the behavioural responses to acute psilocybin\"","year":"2025","cit":0,"pfa":"Nina Kleditzsch","psa":"Thibault Renoir","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"peer-review","src":"https://openalex.org/W4417207713","eid":"W4417207713"},{"id":"paper-w399449849","cat":"papers","name":"N,アルファ--ジメチル-3,4-(メチレンジオキシ)フェネチルアミン(MDMA)検出試薬の検討","year":"1991","cit":0,"pfa":"五生 武藤","ptype":"article","src":"https://openalex.org/W399449849","eid":"W399449849"},{"id":"paper-w2589007927","cat":"papers","name":"Methylenenedioxymethamphetamine (MDMA Ecstasy) suppresses the innate immune system : a critical role for the anti-inflammatory cytokine interleukin-10","year":"2007","cit":0,"pfa":"Noreen T. Boyle","ptype":"dissertation","src":"https://openalex.org/W2589007927","eid":"W2589007927"},{"id":"paper-w1553492970","cat":"papers","name":"Die neurotoxische Wirkung von MDMA auf das unreife Gehirn am Modell der neonatalen Ratte","year":"2009","cit":0,"pfa":"Juliane Klaus","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W1553492970","eid":"W1553492970"},{"id":"paper-w7161395252","cat":"papers","name":"Additional file 2: Figure S1. of De novo sequencing and analysis of Lophophora williamsii transcriptome, and searching for putative genes involved in mescaline biosynthesis","year":"2016","cit":0,"pfa":"Enrique Ibarra‐Laclette","psa":"Luís Herrera‐Estrella","ptype":"article","src":"https://openalex.org/W7161395252","eid":"W7161395252"},{"id":"paper-w7117999175","cat":"papers","name":"Global increases in brain glucose metabolism following acute N,N-dimethyltryptamine and harmine administration in healthy volunteers: An [18F]FDG-PET study","year":"2026","cit":0,"pfa":"K. Egger","psa":"Paul D. Cumming","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7117999175","eid":"W7117999175"},{"id":"paper-w1965926395","cat":"papers","name":"Increased responsiveness to cocaine-induced reward and psychomotor stimulation in mice exposed to methylphenidate and MDMA (“Ecstasy”) during adolescence","year":"2003","cit":0,"pfa":"Cindy N. Achat","psa":"Yossef Itzhak","ptype":"article","src":"https://openalex.org/W1965926395","eid":"W1965926395"},{"id":"paper-w7120604855","cat":"papers","name":"Neuroimmunological aspects of ecstasy (N-methyl-3,4-Methylenedioxymethamphetamine-MDMA) on lung inflammatory response in Balb/C mice.","year":"2010","cit":0,"pfa":"Daniel Stankevicius","topics":["Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W7120604855","eid":"W7120604855"},{"id":"paper-w3167275898","cat":"papers","name":"Effects of 3,4‐methylenedioxymethamphetamine (MDMA) and d‐methamphetamine on pro‐social behavior in drug‐naïve female nonhuman primates","year":"2021","cit":0,"pfa":"Alison G. P. Wakeford","psa":"Stephen John Kohut","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3167275898","eid":"W3167275898"},{"id":"paper-w2554413215","cat":"papers","name":"“It’s like shrooms times a million, plus aliens”: an interpretative phenomenological analysis of experiential accounts from recreational Ayahuasca users","year":"2015","cit":0,"pfa":"Johnny Ryan","psa":"Lesley-Ann Smith","ptype":"conference-paper","src":"https://openalex.org/W2554413215","eid":"W2554413215"},{"id":"paper-w4297065393","cat":"papers","name":"Pubescent Long-Evans male rats are more sensitive to a high dose of 3,4 methylhenedioxymethamphetamine (MDMA) than females","year":"2005","cit":0,"pfa":"Christian R. Kelche","psa":"Jean‐Christophe Cassel","topics":["Dosing & pharmacology"],"ptype":"conference-paper","src":"https://openalex.org/W4297065393","eid":"W4297065393"},{"id":"paper-w3140785010","cat":"papers","name":"Combined Effects of MDMA and Ethanol on Locomotor Activity and Place Conditioning in Male and Female Adolescent Sprague-Dawley Rats","year":"2014","cit":0,"pfa":"Keli A. Herr","ptype":"article","src":"https://openalex.org/W3140785010","eid":"W3140785010"},{"id":"paper-w2954178314","cat":"papers","name":"Modulação sérica do fator neurotrófico derivado do cérebro (BDNF) pela ayahuasca: contribuições para a depressão maior","year":"2019","cit":0,"pfa":"Raíssa Nóbrega de Almeida","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W2954178314","eid":"W2954178314"},{"id":"paper-w4400574241","cat":"papers","name":"Associations Between Harm Reduction Strategy Use and Acute Psychedelic Effects in Spanish Speakers who Used LSD or Psilocybin","year":"2024","cit":0,"pfa":"Rafael Lancelotta","psa":"Alan K. Davis","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4400574241","eid":"W4400574241"},{"id":"paper-w4400599881","cat":"papers","name":"Prevalence of Psilocybin and Cannabis Concurrent Use During the COVID-19 Pandemic: An Analysis of the COVID-19 Cannabis Health Study","year":"2024","cit":0,"pfa":"Denise Christina Vidot","psa":"Sarah Elizabeth Messiah","ptype":"article","src":"https://openalex.org/W4400599881","eid":"W4400599881"},{"id":"paper-w2949136839","cat":"papers","name":"ChemInform Abstract: An Improved Reaction Sequence for Electrophilic Cyclization of Methyl 6‐(2‐Indolyl)‐2‐azabicyclooct‐7‐ene‐6‐carboxylates to Iboga Alkaloid Analogs.","year":"1991","cit":0,"pfa":"Richard J. Sundberg","psa":"Kumar G. Gadamasetti","ptype":"article","src":"https://openalex.org/W2949136839","eid":"W2949136839"},{"id":"paper-w7212022242","cat":"papers","name":"562. Repeated psilocybin administration does not induce rewarding effects and increases ventral tegmental dopaminergic activity during withdrawal","year":"2026","cit":0,"pfa":"Vítor Bruno","psa":"Gabriella Gobbi","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"conference-abstract","src":"https://openalex.org/W7212022242","eid":"W7212022242"},{"id":"paper-w7120852146","cat":"papers","name":"Effect of ayahuasca beverage on the behavior of Wistar rats in the open field and elevated plus maze and on the expression of EAAC1 in the hippocampus and in the prefrontal cortex.","year":"2014","cit":0,"pfa":"Luana Gonçalves Zamarrenho","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7120852146","eid":"W7120852146"},{"id":"paper-w4406320676","cat":"papers","name":"Soul Quest Ayahuasca Church of Mother Earth v. The DEA: Religious Sincerity and Situational Adjustments in the Process of Defining a Church and a Plant","year":"2025","cit":0,"pfa":"Tarryl Janik","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4406320676","eid":"W4406320676"},{"id":"paper-w2319585220","cat":"papers","name":"ChemInform Abstract: BEITRAEGE ZUR CHEMIE DES INDOLS 7. MITT. SYNTHESEN IN DER IBOGA‐REIHE 3. MITT. IBOGAMIN, IBOGAIN UND EPIIBOGAMIN","year":"1975","cit":0,"pfa":"Peter Rosenmund","psa":"Rainer Frische","ptype":"article","src":"https://openalex.org/W2319585220","eid":"W2319585220"},{"id":"paper-w7163526764","cat":"papers","name":"Therapeutic Processes in Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression: A Qualitative Analysis of Allegorical Imagery, Insight, and (Dis)Connectedness","year":"2026","cit":0,"pfa":"Anja Vandersmissen","psa":"Rainer Krähenmann","topics":["Depression","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7163526764","eid":"W7163526764"},{"id":"paper-w7145512932","cat":"papers","name":"Prevention of drug priming- and cue-induced reinstatement of MDMA-seeking behaviors by the CB1 cannabinoid receptor antagonist AM251.","year":"2016","cit":0,"topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7145512932","eid":"W7145512932"},{"id":"paper-w2781936614","cat":"papers","name":"Contra la ansiedad social: entrevista con Alicia Danforth sobre la terapia MDMA para autistas","year":"2018","cit":0,"pfa":"André Langlois","ptype":"article","src":"https://openalex.org/W2781936614","eid":"W2781936614"},{"id":"paper-w7124174111","cat":"papers","name":"Severe 3,4-Methylenedioxymethamphetamine (MDMA)-Associated Rhabdomyolysis in Crohn’s Disease: Direct Toxicity and Inflammatory Susceptibility in the Absence of Hyperthermia","year":"2026","cit":0,"pfa":"Sebastian Hernandez Mejia","psa":"Ranwa Aldaker","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7124174111","eid":"W7124174111"},{"id":"paper-w7134972492","cat":"papers","name":"Psilocybin decreases preference for large rewards accompanied by increased activity of parvalbumin neurons with perineuronal nets in the medial prefrontal cortex.","year":"2026","cit":0,"pfa":"Jenna Houff","psa":"Alberto Del Arco","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dataset","src":"https://openalex.org/W7134972492","eid":"W7134972492"},{"id":"paper-w4417207734","cat":"papers","name":"Decision letter for \"Acute blockade of the serotonin transporter with low doses of escitalopram does not alter the behavioural responses to acute psilocybin\"","year":"2025","cit":0,"topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"peer-review","src":"https://openalex.org/W4417207734","eid":"W4417207734"},{"id":"paper-w4413016586","cat":"papers","name":"Psychedelics as treatment of alcohol use disorders: insights from preclinical models and comparison of the different psychedelics psilocybin, LSD and ketamine","year":"2025","cit":0,"pfa":"Mickaël Naassïla","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4413016586","eid":"W4413016586"},{"id":"paper-w7169758970","cat":"papers","name":"Learnings from a hybrid communities of practice group therapy model to support psilocybin-assisted therapy for patients with a terminal diagnosis","year":"2026","cit":0,"pfa":"Vivian W. L. Tsang","psa":"Shannon Dames","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7169758970","eid":"W7169758970"},{"id":"paper-w2949076500","cat":"papers","name":"ChemInform Abstract: Observations Concerning the Synthesis of Tryptamine Homologues and Branched Tryptamine Derivatives via the Borrowing Hydrogen Process: Synthesis of Psilocin, Bufotenin, and Serotonin.","year":"2016","cit":0,"pfa":"Silvia Bartolucci","psa":"Giovanni Piersanti","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2949076500","eid":"W2949076500"},{"id":"paper-w2186163496","cat":"papers","name":"3,4-Methylenedioxymethamphetamine (MDMA) Modulates Cortical and Limbic Brain Activity as Measured by (H 2 15 O)-PET in","year":"2000","cit":0,"pfa":"Alex Gamma","psa":"Franz X. Vollenweider","ptype":"article","src":"https://openalex.org/W2186163496","eid":"W2186163496"},{"id":"paper-w4400575521","cat":"papers","name":"Ayahuasca-Assisted Addiction Treatment in Peru: Results, Challenges, and Promises From a Multi-Year, Mixed-Methods Study at Takiwasi Center","year":"2024","cit":0,"pfa":"Olivia Marcus","psa":"Brian R. Rush","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4400575521","eid":"W4400575521"},{"id":"paper-w7213319889","cat":"papers","name":"To what extent is MDMA-assisted psychotherapy helping individuals with treatment-resistant post-traumatic stress disorder (PTSD)?","year":"2026","cit":0,"pfa":"Karen Coy","topics":["Depression","PTSD & trauma","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W7213319889","eid":"W7213319889"},{"id":"paper-w2250067133","cat":"papers","name":"13. El consumo de ayahuasca en el diván: beneficios y riesgos - entrevista con Evelyn Silveira","year":"2013","cit":0,"pfa":"Beatriz Caiuby Labate","psa":"Isabel Santana de Rose","ptype":"article","src":"https://openalex.org/W2250067133","eid":"W2250067133"},{"id":"paper-w2596690324","cat":"papers","name":"TENSÕES E (RE)INVENÇÕES DO RELIGIOSO NA MODERNIDADE: O caso das religiões da Ayahuasca no Brasil","year":"2015","cit":0,"pfa":"Victor Breno Farias Barrozo","ptype":"article","src":"https://openalex.org/W2596690324","eid":"W2596690324"},{"id":"paper-w7210058730","cat":"papers","name":"Implementación de un producto natural a partir de Ayahuasca (banisteriopsis caapi) en la sustitución de antidepresivos sintéticos","year":"2023","cit":0,"pfa":"Franklin Andrés Álvarez Cortez","psa":"Daicy Paola Arias Salazar","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7210058730","eid":"W7210058730"},{"id":"paper-w7204134572","cat":"papers","name":"Medical and Psychiatric Consultation for Patients Considering State-Regulated Psilocybin Services: A Risk-Reduction Model and Two Illustrative Cases","year":"2026","cit":0,"pfa":"MICHAEL SARVI","psa":"Aryan Sarparast","topics":["Safety & adverse events","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W7204134572","eid":"W7204134572"},{"id":"paper-w7118002543","cat":"papers","name":"Changes in wellbeing, self-compassion and alexithymia in a proof of principle trial with MDMA-assisted therapy for Major Depressive Disorder","year":"2026","cit":0,"pfa":"M. Berthold-Losleben","psa":"I. Goksøyr","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7118002543","eid":"W7118002543"},{"id":"paper-w2955149601","cat":"papers","name":"Efectos inmediatos y a largo plazo inducidos por 3,4-metilenodioximetanfetamina (mdma) en cerebro de ratón","year":"2003","cit":0,"pfa":"Jorge Camarero Jiménez","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2955149601","eid":"W2955149601"},{"id":"paper-w4403546941","cat":"papers","name":"Consumo de MDMA e LSD por jovens e adolescentes: efeitos nocivos para saúde mental","year":"2024","cit":0,"pfa":"Lucas Siqueira dos Santos","psa":"Layane Estefany Siqueira dos Santos","topics":["Depression","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4403546941","eid":"W4403546941"},{"id":"paper-w4378363917","cat":"papers","name":"DIREITO AO TRATAMENTO DA DEPENDÊNCIA QUÍMICA E DOENÇAS DECORRENTES COM O USO DO MEDICAMENTO NATURAL AYAHUASCA","year":"2023","cit":0,"pfa":"Laura Vitória Pavão Borges","psa":"Michele Segala Camargo","ptype":"book-chapter","src":"https://openalex.org/W4378363917","eid":"W4378363917"},{"id":"paper-w7169474870","cat":"papers","name":"Cross-cultural Attitudes Towards Using Ayahuasca as an Alternative Treatment for PTSD: A Comparative Study of Attitudes in the MENA Region and Western Countries.","year":"2026","cit":0,"pfa":"Abeer Manneh","topics":["PTSD & trauma","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W7169474870","eid":"W7169474870"},{"id":"paper-w3172470537","cat":"papers","name":"Antibody Gene Therapy Mitigates the immunosuppressive effects of 3,4‐Methylenedioxymethamphetamine (MDMA) in the periphery of Male BALB/c Mice","year":"2021","cit":0,"pfa":"Caleb Bolden","psa":"Eric Charles Peterson","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3172470537","eid":"W3172470537"},{"id":"paper-w1753216862","cat":"papers","name":"Selective impairments of executive function in young, female MDMA (\"Ecstasy\") users: Effects that are not attributable to concommitant cannabis use","year":"2006","cit":0,"pfa":"Philip Terry","psa":"Claire O’Brien","ptype":"conference-paper","src":"https://openalex.org/W1753216862","eid":"W1753216862"},{"id":"paper-w4406190715","cat":"papers","name":"IDENTIFICATION OF 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA) IN URINE SAMPLES USING GAS CHROMATOGRAPHY-MASS SPECTROMETRY (GC-MS) INSTRUMENT","year":"2024","cit":0,"pfa":"Maisari Utami","psa":"Eryani Ayu Meitasari","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4406190715","eid":"W4406190715"},{"id":"paper-w1969721484","cat":"papers","name":"S30.02 Effects of MDMA (ecstasy) on sensorimotor gating (prepulse inhibition) in humans after pretreatment with citalopram, haloperidol, or ketanserin","year":"2000","cit":0,"pfa":"F.X. Vollenweider","psa":"Daniel Hell","ptype":"conference-abstract","src":"https://openalex.org/W1969721484","eid":"W1969721484"},{"id":"paper-w7155418505","cat":"papers","name":"Protective effects of vitamin E and quercetin against MDMA-induced cardiac and hematological dysfunction in male wistar rats","year":"2026","cit":0,"pfa":"Ayodeji Folorunsho Ajayi","psa":"Oyedayo Phillips Akano","ptype":"article","src":"https://openalex.org/W7155418505","eid":"W7155418505"},{"id":"paper-w108478119","cat":"papers","name":"Platzpräferenz und Metabolismus von Enantiomeren der Party-Drogen MDMA und MDE bei der Ratte","year":"2002","cit":0,"pfa":"Anja Meyer","ptype":"dissertation","src":"https://openalex.org/W108478119","eid":"W108478119"},{"id":"paper-w2302641532","cat":"papers","name":"Immunohistochemical demonstration of the amphetamine derivatives 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) in human post-mortem tissues","year":"2003","cit":0,"pfa":"Els De Letter","psa":"Michel H A Piette","ptype":"article","src":"https://openalex.org/W2302641532","eid":"W2302641532"},{"id":"paper-w2945124306","cat":"papers","name":"Ayahuasca : potencial terapêutico na dependência ao álcool e atividade neural da proteína cFOS em modelo experimental","year":"2018","cit":0,"pfa":"Luciana Marangni Nolli","topics":["Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W2945124306","eid":"W2945124306"},{"id":"paper-w2557225161","cat":"papers","name":"Amada's Blessings from the Peyote Gardens of South Texas by Stacy B. Schaefer. Albuquerque: University of New Mexico Press, 2015. 272 pp.","year":"2016","cit":0,"pfa":"Stacey A. Schwartzkopf","ptype":"book-review","src":"https://openalex.org/W2557225161","eid":"W2557225161"},{"id":"paper-w2545101166","cat":"papers","name":"\"Quantificação de MDMA em amostras de ecstasy por cromatografia em fase gasosa (GC/NPD)\"","year":"2004","cit":0,"pfa":"Silvio Fernandes Lapachinske","ptype":"dissertation","src":"https://openalex.org/W2545101166","eid":"W2545101166"},{"id":"paper-w7212727830","cat":"papers","name":"Botanical Context Biasing for Experience-Dependent Neuroplasticity: A Two-Timescale Hypothesis of Directional Reinforcement During Psilocybin-Induced Plasticity","year":"2026","cit":0,"pfa":"Robinson, Shaun","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7212727830","eid":"W7212727830"},{"id":"paper-w4417207689","cat":"papers","name":"Author response for \"Acute blockade of the serotonin transporter with low doses of escitalopram does not alter the behavioural responses to acute psilocybin\"","year":"2025","cit":0,"pfa":"Nina Kleditzsch","psa":"Thibault Renoir","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"peer-review","src":"https://openalex.org/W4417207689","eid":"W4417207689"},{"id":"paper-w7124754252","cat":"papers","name":"Understanding Neuroplasticity Induced by Tryptamines (UNITy): Understanding Neuroplasticity Induced by Tryptamines: Rewiring Maladaptive Memories in Hazardous Drinking with Memory Reactivation and Dimethyltryptamine (DMT","year":"2025","cit":0,"pfa":"Natalia Fernandez‐Vinson","psa":"Shelan Ofori","topics":["Addiction","Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W7124754252","eid":"W7124754252"},{"id":"paper-w3137131474","cat":"papers","name":"Is Psilocybin an Effective Treatment to Reduce Depression and Anxiety in Cancer Patients with a Diagnosis of an Anxiety Disorder, Mood Disorder, And/Or Stress Disorder?","year":"2020","cit":0,"pfa":"Brooke Reichenbach","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3137131474","eid":"W3137131474"},{"id":"paper-w4389762368","cat":"papers","name":"Peak Experiences: Lessons Learned from a Feasibility Study of Psilocybin-assisted Therapy for Demoralization in Patients Receiving Hospice Care","year":"2023","cit":0,"pfa":"Roxanne Sholevar","ptype":"article","src":"https://openalex.org/W4389762368","eid":"W4389762368"},{"id":"paper-w4388951994","cat":"papers","name":"UNCOVERING THE UNTAPPED POTENTIAL OF PSILOCYBIN THERAPY IN ALLEVIATING CANCER-RELATED DEPRESSION: AN URGENT CALL TO RE-EVALUATE TREATMENT STRATEGIES.","year":"2023","cit":0,"pfa":"Huda Ahmed","psa":"Talal Arshad","topics":["Depression","Anxiety & end-of-life"],"ptype":"letter","src":"https://openalex.org/W4388951994","eid":"W4388951994"},{"id":"paper-w4409899284","cat":"papers","name":"Pictorial Representation of Illness and Self Measure: A Putative Transdiagnostic Tool for Evaluating Therapeutic Effects of Psilocybin-Assisted Therapy in Fibromyalgia","year":"2025","cit":0,"pfa":"Niloufar Pouyan","psa":"Steven E. Harte","ptype":"article","src":"https://openalex.org/W4409899284","eid":"W4409899284"},{"id":"paper-w7117301755","cat":"papers","name":"Safety, feasibility, and tolerability of psilocybin in older adults with amnestic MCI: Preliminary data from a SV2a PET imaging study","year":"2025","cit":0,"pfa":"Danielle Bukovsky","psa":"Philip Gerretsen","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7117301755","eid":"W7117301755"},{"id":"paper-w4416942450","cat":"papers","name":"Comment on: Effect of psilocybin therapy on suicidal ideation, attempts, and deaths in people with psychiatric diagnoses: a systematic review and meta-analysis","year":"2025","cit":0,"pfa":"Tiago Luís Gonçalves Neves Machado","psa":"João N. Costa","topics":["Reviews & meta-analyses"],"ptype":"letter","src":"https://openalex.org/W4416942450","eid":"W4416942450"},{"id":"paper-w2298315362","cat":"papers","name":"Bioprospección en el Ecuador : los casos de la Ayahuasca y el Convenio ESPOCH- Universidad de Illinois","year":"1997","cit":0,"pfa":"María Sol Bejarano","ptype":"article","src":"https://openalex.org/W2298315362","eid":"W2298315362"},{"id":"paper-w4405621752","cat":"papers","name":"Associations between behavioral and neuronal changes in self-referential processing following a single, moderate dose of psilocybin in depressed patients","year":"2024","cit":0,"pfa":"L. Belinger","psa":"Katrin H. Preller","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4405621752","eid":"W4405621752"},{"id":"paper-w7156276221","cat":"papers","name":"Processed Data - Single-nucleus transcriptomics reveals time-dependent and cell-type-specific effects of psilocybin on gene expression","year":"2026","cit":0,"pfa":"Clara Liao","psa":"Alex Kwan","ptype":"dataset","src":"https://openalex.org/W7156276221","eid":"W7156276221"},{"id":"paper-w7116954033","cat":"papers","name":"Conocimientos locales, prácticas y usos contemporáneos atribuidos a la ayahuasca en el noroeste de la Amazonia peruana","year":"2025","cit":0,"pfa":"E. Hanz Rodríguez-Cabrera","psa":"Angel Martin Rodriguez del Castillo","ptype":"article","src":"https://openalex.org/W7116954033","eid":"W7116954033"},{"id":"paper-w7140611633","cat":"papers","name":"Psilocybin in Neuropsychiatric Disorders: Seeking Valuable Evidence in History, Pure Science, Clinical Trials and Real-World Data (RWD)","year":"2026","cit":0,"pfa":"Piotr Skalski","psa":"Michał K. Owecki","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7140611633","eid":"W7140611633"},{"id":"paper-w7156193440","cat":"papers","name":"Processed Data - Single-nucleus transcriptomics reveals time-dependent and cell-type-specific effects of psilocybin on gene expression","year":"2026","cit":0,"pfa":"Clara Liao","psa":"Alex Kwan","ptype":"dataset","src":"https://openalex.org/W7156193440","eid":"W7156193440"},{"id":"paper-w7151392145","cat":"papers","name":"Neuroimmune Mechanisms Underlying MDMA-Assisted Therapy in Veterans with Comorbid Posttraumatic Stress Disorder and Alcohol Use Disorder","year":"2026","cit":0,"pfa":"Lewis Nunez Severino","psa":"Carolina L. Haass‐Koffler","topics":["PTSD & trauma","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7151392145","eid":"W7151392145"},{"id":"paper-w2791271620","cat":"papers","name":"Impact of genetic variability in the serotonin transporter, Tryptophan Hydroxylase-2, and Serotonin 2A Receptors on MDMA Use and Impulsivity","year":"2008","cit":0,"pfa":"Nidal J. Moukaddam","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2791271620","eid":"W2791271620"},{"id":"paper-w7204783214","cat":"papers","name":"Mit unserem MDMA-Modell für Applied Improv und High Performance Flexibility Führung zukunftsfähig gestalten","year":"2026","cit":0,"pfa":"Vaya Wieser-Weber","ptype":"book-chapter","src":"https://openalex.org/W7204783214","eid":"W7204783214"},{"id":"paper-w2767678669","cat":"papers","name":"Marknadsföring av ayahuasca : En kvalitativ explorativ studie om hur ayahuascaretreater skildrar den hallucinogena brygden på internet","year":"2017","cit":0,"pfa":"Elina Sälik","ptype":"book","src":"https://openalex.org/W2767678669","eid":"W2767678669"},{"id":"paper-w1518333037","cat":"papers","name":"The Effects of Acute Administration of the 5-HT Neurotoxin PCA on the Expression of Male Rat Copulatory Behavior: A Comparison with MDMA","year":"1992","cit":0,"pfa":"William M. Struthers","psa":"Faculty Advisor Dornan","topics":["Mechanism & neuroscience"],"ptype":"conference-paper","src":"https://openalex.org/W1518333037","eid":"W1518333037"},{"id":"paper-w4394105262","cat":"papers","name":"New insights on different response of MDMA-elicited serotonin syndrome and toxicity to systemic and intracranial administrations in the rat brain","year":"2016","cit":0,"pfa":"Rui Tao","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"dataset","src":"https://openalex.org/W4394105262","eid":"W4394105262"},{"id":"paper-w2793730161","cat":"papers","name":"Desenvolvimento de sensores eletroquímicos para a detecção voltamétrica de MDMA em amostras de interesse forense","year":"2016","cit":0,"pfa":"Maraine Catarina Tadini","ptype":"dissertation","src":"https://openalex.org/W2793730161","eid":"W2793730161"},{"id":"paper-w7120912697","cat":"papers","name":"Dried Spots associated to an LC-DAD method for the simultaneous determination of MDMA (ecstasy) and MDA in oral fluid samples","year":"2021","cit":0,"pfa":"Leandro Oka Duarte","ptype":"dissertation","src":"https://openalex.org/W7120912697","eid":"W7120912697"},{"id":"paper-w1534207233","cat":"papers","name":"Investigations into the neurochemical mechanisms underlying 3,4-methylenedioxymethamphetamine (MDMA)-induced neurotoxicity: Assessment of the role of GABA and the dopamine transporter","year":"2001","cit":0,"pfa":"Arthi Kanthasamy","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W1534207233","eid":"W1534207233"},{"id":"paper-w7166024284","cat":"papers","name":"Safety, Efficacy, and Blinding Integrity of Psilocybin-Assisted Therapy for Substance Use Disorders: A Systematic Review of Randomized Controlled Trials","year":"2026","cit":0,"pfa":"Max Courtney","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7166024284","eid":"W7166024284"},{"id":"paper-w7214797486","cat":"papers","name":"Psilocybin in psychiatry: Current clinical evidence, mechanisms of action and translational perspectives. A literature review based on PubMed-indexed studies","year":"2026","cit":0,"pfa":"Bartosz Nadolski","psa":"Ewa Gromniak-Haniecka","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7214797486","eid":"W7214797486"},{"id":"paper-w7137008636","cat":"papers","name":"Does severity of treatment resistance predict response to treatment with psilocybin in patients with depression? A secondary data analysis of the PsiDeR trial","year":"2026","cit":0,"pfa":"Anais Alachbili Chihab","psa":"James Rucker","topics":["Depression","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W7137008636","eid":"W7137008636"},{"id":"paper-w914038125","cat":"papers","name":"Appeasing the Mushroom Gods: A Foucauldian Discourse Analysis of Magic Mushroom Users' Constructions of Meanings Surrounding Psilocybin Mushroom Use","year":"2014","cit":0,"pfa":"James A. Thompson","topics":["Addiction"],"ptype":"dissertation","src":"https://openalex.org/W914038125","eid":"W914038125"},{"id":"paper-w7126417845","cat":"papers","name":"Regarding “The molecular mechanisms through which psilocybin prevents suicide: evidence from network pharmacology and molecular docking analyses”","year":"2026","cit":0,"pfa":"Jesper Langgaard Kristensen","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7126417845","eid":"W7126417845"},{"id":"paper-w4200326768","cat":"papers","name":"P.0421 Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) – study design, rationale and current status","year":"2021","cit":0,"pfa":"Lea Julia Mertens","psa":"Gerhard Gründer","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4200326768","eid":"W4200326768"},{"id":"paper-w2217238269","cat":"papers","name":"Repeated exposure to the 5-HT 1b/1a agonist, RU 24969, facilitates the acquisition of MDMA self-administration","year":"2015","cit":0,"pfa":"Dane Aronsen","psa":"Susan Schenk","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2217238269","eid":"W2217238269"},{"id":"paper-w7135245336","cat":"papers","name":"LGBTQ+ Ayahuasca Retreat Experience is Associated with Benefits to Mental Health, Quality of Life, and Spiritual Well-Being: A Prospective, Naturalistic Study","year":"2026","cit":0,"pfa":"Matthew X. Lowe","psa":"Heather Jackson","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7135245336","eid":"W7135245336"},{"id":"paper-w4411272926","cat":"papers","name":"LGBTQ+ Ayahuasca Retreat Experience is Associated with Benefits to Mental Health, Quality of Life, and Spiritual Well-being: A Prospective, Naturalistic Study","year":"2025","cit":0,"pfa":"Matthew X. Lowe","psa":"Heather Jackson","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"preprint","src":"https://openalex.org/W4411272926","eid":"W4411272926"},{"id":"paper-w7155621718","cat":"papers","name":"356. Psilocybin Therapy is Associated With Decreases in Markers of Mitochondrial Stress and Inflammation in an Open-Label Clinical Trial of Parkinson’s Disease","year":"2026","cit":0,"pfa":"Ellen Bradley","psa":"Aoife O’Donovan","ptype":"article","src":"https://openalex.org/W7155621718","eid":"W7155621718"},{"id":"paper-w7203458714","cat":"papers","name":"Subacute and long-term changes in cognitive functioning after administration of classic psychedelics, MDMA and ketamine: A systematic review of clinical and preclinical evidence","year":"2026","cit":0,"pfa":"Catherine Kelly","psa":"Kirsten C. Morley","topics":["Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7203458714","eid":"W7203458714"},{"id":"paper-w2073973949","cat":"papers","name":"LABATE, Beatriz C. & BOUSO, José C. 2013. Ayahuasca e salud. Barcelona: La Liebre de Marzo. 485 pp.","year":"2014","cit":0,"pfa":"Rosa Virgínia Melo","ptype":"book-review","src":"https://openalex.org/W2073973949","eid":"W2073973949"},{"id":"paper-w2001723459","cat":"papers","name":"Corrigendum to “Effects of MDMA on olfactory memory and reversal learning in rats” [Neurobiol. Learning Memory 114 (2014) 209–216]","year":"2015","cit":0,"pfa":"Andrew B. Hawkey","psa":"Mark Galizio","ptype":"erratum","src":"https://openalex.org/W2001723459","eid":"W2001723459"},{"id":"paper-w7211953305","cat":"papers","name":"MDMA-Assisted Therapy May Decrease PTSD Symptoms, Dissociation, Depression, and Functional Disability: A Systematic Review and Meta-Analysis","year":"2026","cit":0,"pfa":"Warwick Green","psa":"Luke R. Johnson","topics":["Depression","PTSD & trauma","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W7211953305","eid":"W7211953305"},{"id":"paper-w4417207691","cat":"papers","name":"Decision letter for \"Acute blockade of the serotonin transporter with low doses of escitalopram does not alter the behavioural responses to acute psilocybin\"","year":"2025","cit":0,"topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"peer-review","src":"https://openalex.org/W4417207691","eid":"W4417207691"},{"id":"paper-w898387203","cat":"papers","name":"Self-Reported Long-Term Adverse Consequences Associated with MDMA/Ecstasy use Among Young Adults in Ohio","year":"2003","cit":0,"pfa":"Robert Gideon Carlson","psa":"Jill Adair McCaughan","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W898387203","eid":"W898387203"},{"id":"paper-w4403670851","cat":"papers","name":"Psicoterapias assistidas por MDMA no tratamento do estresse pós-traumático em adultos: uma revisão integrativa","year":"2024","cit":0,"pfa":"Manuela Bahia Almeida da Franca","psa":"Sandra Regina Mota Ortiz","ptype":"article","src":"https://openalex.org/W4403670851","eid":"W4403670851"},{"id":"paper-w2188112978","cat":"papers","name":"Study Protocol Phase II clinical trial testing the safety and efficacy of 3,4- methylenedioxymethamphetamine (MDMA)-assisted psychotherapy in subjects","year":"2009","cit":0,"pfa":"Michael C. Mithoefer","topics":["Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2188112978","eid":"W2188112978"},{"id":"paper-w2078002695","cat":"papers","name":"P.1.c.022 Effects of 3,4-methylenedioxymethamphetamine (MDMA or ecstasy) on prosocial feelings and oxytocin plasma levels in humans","year":"2011","cit":0,"pfa":"C.M. Hysek","psa":"Matthias E. Liechti","ptype":"article","src":"https://openalex.org/W2078002695","eid":"W2078002695"},{"id":"paper-w4411273352","cat":"papers","name":"LGBTQ+ Ayahuasca Retreat Experience is Associated with Benefits to Mental Health, Quality of Life, and Spiritual Well-being: A Prospective, Naturalistic Study","year":"2025","cit":0,"pfa":"Matthew X. Lowe","psa":"Heather Jackson","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"preprint","src":"https://openalex.org/W4411273352","eid":"W4411273352"},{"id":"paper-w7125943988","cat":"papers","name":"Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non‑microdosing controls","year":"2022","cit":0,"pfa":"Joseph M. Rootman","psa":"Zach Walsh","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7125943988","eid":"W7125943988"},{"id":"paper-w4405050234","cat":"papers","name":"Review for \"Randomized Controlled Trials of Psilocybin‐Assisted Therapy in the Treatment of Major Depressive Disorder: Systematic Review and Meta‐Analysis\"","year":"2024","cit":0,"topics":["Depression","Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4405050234","eid":"W4405050234"},{"id":"paper-w7110043654","cat":"papers","name":"Extraction of N, N-dimethyltryptamine (DMT) from Mimosa tenuiflora, syn. Mimosa hostilis (Tepescohuite) using supercritical CO2 and study of its surface activity","year":"2025","cit":0,"pfa":"Arenas-Quevedo, Miguel Gonzalo","psa":"Gracia-Fadrique, Jesús","ptype":"article","src":"https://openalex.org/W7110043654","eid":"W7110043654"},{"id":"paper-w7165967962","cat":"papers","name":"Supplemental Material for A Nondirective Physical and Psychological Support Protocol for Inhaled N,N-Dimethyltryptamine (DMT): A Qualitative Evaluation of Safety, Comfort, and Integration in a Clinical Setting","year":"2026","cit":0,"topics":["Safety & adverse events","Therapy practice"],"ptype":"supplementary-materials","src":"https://openalex.org/W7165967962","eid":"W7165967962"},{"id":"paper-w2945065363","cat":"papers","name":"Perbandingan Metode Zero Suffix dan Metode MDMA (Maximum Divide Minimum Allotment) untuk menyelesaikan masalah transportasi","year":"2018","cit":0,"pfa":"Muhammad Iqbal Andian Permana","ptype":"dissertation","src":"https://openalex.org/W2945065363","eid":"W2945065363"},{"id":"paper-w7164018163","cat":"papers","name":"Semi-Quantitative Estimation of MDMA Tablet Dosage and Cocaine/Ketamine Purity Using a Simple to Operate Field-Portable Device","year":"2026","cit":0,"pfa":"Matthew Gardner","psa":"Christopher R. Pudney","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7164018163","eid":"W7164018163"},{"id":"paper-w2911409049","cat":"papers","name":"MRI Differentiates Anoxic Brain Injury from Liver Failure Associated Cerebral Edema in Ecstasy (MDMA) Toxicity","year":"2007","cit":0,"pfa":"Joshua E. Melson","psa":"Stanley M. Cohen","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2911409049","eid":"W2911409049"},{"id":"paper-w985891782","cat":"papers","name":"Follow-up em saude mental de pessoas que experimentam pela primeira vez a Ayahuasca em contexto religioso","year":"2008","cit":0,"pfa":"Paulo César Ribeiro Barbosa","ptype":"dissertation","src":"https://openalex.org/W985891782","eid":"W985891782"},{"id":"paper-w2755415836","cat":"papers","name":"“It’s like shrooms times a million, plus aliens”: an interpretative phenomenological analysis of experiential accounts from ayahuasca users in Britain","year":"2017","cit":0,"pfa":"Lesley-Ann Smith","psa":"Rachel E. Evenden","topics":["Therapy practice"],"ptype":"conference-paper","src":"https://openalex.org/W2755415836","eid":"W2755415836"},{"id":"paper-w7215069407","cat":"papers","name":"A narrativa sobre o Santo Daime e a Ayahuasca nos periódicos da região Norte entre 1980 e 1997:","year":"2025","cit":0,"pfa":"Herta Maria de Açucena do Nascimento Soeiro","psa":"Matheus Pangracio ITALIANO","ptype":"article","src":"https://openalex.org/W7215069407","eid":"W7215069407"},{"id":"paper-w7155700571","cat":"papers","name":"Ayahuasca and Cardiovascular Risk: A Hypothesis-Generating Paper Calling for Longitudinal Blood Pressure Monitoring and Formal Contraindications in Regular Ritual Consumers","year":"2026","cit":0,"pfa":"Jan Keppel Hesselink","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7155700571","eid":"W7155700571"},{"id":"paper-w7134904097","cat":"papers","name":"Psilocybin decreases preference for large rewards accompanied by increased activity of parvalbumin neurons with perineuronal nets in the medial prefrontal cortex.","year":"2026","cit":0,"pfa":"Jenna Houff","psa":"Alberto Del Arco","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dataset","src":"https://openalex.org/W7134904097","eid":"W7134904097"},{"id":"paper-w7202192981","cat":"papers","name":"An Open-Label Trial Protocol to Test Menstrual Cycle Effects and Tolerance to Low-Dose Psilocybin in Healthy Menstruating Persons.","year":"2026","cit":0,"pfa":"Farheen Mustak Kothiwala","psa":"Rachael L. Sumner","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7202192981","eid":"W7202192981"},{"id":"paper-w2522775160","cat":"papers","name":"MDMA（迷魂药）的神经精神毒性及治疗","year":"2005","cit":0,"pfa":"梁军成","ptype":"article","src":"https://openalex.org/W2522775160","eid":"W2522775160"},{"id":"paper-w48290084","cat":"papers","name":"セロトニン系乱用薬MDMA、5-Meo-DIPTの神経毒性","year":"2005","cit":0,"pfa":"陽太郎 沼知","psa":"一郎 曽良","ptype":"article","src":"https://openalex.org/W48290084","eid":"W48290084"},{"id":"paper-w2783850135","cat":"papers","name":"Correction to: Case Study and Performance Evaluation of MDMA–A Non-orthogonal Multiple Access Scheme for 5G Cellular Systems","year":"2018","cit":0,"pfa":"Wei‐Han Hsiao","psa":"Chia-Chi Huang","ptype":"erratum","src":"https://openalex.org/W2783850135","eid":"W2783850135"},{"id":"paper-w3091998316","cat":"papers","name":"El barroco en perspectiva o la religión de la Ayahuasca según el etrusco de La Habana","year":"2003","cit":0,"pfa":"Claudia Caísso","ptype":"article","src":"https://openalex.org/W3091998316","eid":"W3091998316"},{"id":"paper-w4393776508","cat":"papers","name":"Supplementary data for the article \"Ayahuasca Users in Estonia: Ceremonial Practices, Subjective Long-Term Effects, Mental Health and Quality of Life\"","year":"2020","cit":0,"pfa":"Helle Kaasik","psa":"Kairi Kreegipuu","ptype":"supplementary-materials","src":"https://openalex.org/W4393776508","eid":"W4393776508"},{"id":"paper-w4405050268","cat":"papers","name":"Decision letter for \"Randomized Controlled Trials of Psilocybin‐Assisted Therapy in the Treatment of Major Depressive Disorder: Systematic Review and Meta‐Analysis\"","year":"2024","cit":0,"topics":["Depression","Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4405050268","eid":"W4405050268"},{"id":"paper-w4409567580","cat":"papers","name":"Psychedelics are Bringing a new wind to the Pharmacopoeia","year":"2025","cit":0,"pfa":"Michel Bourin","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4409567580","eid":"W4409567580"},{"id":"paper-w4292308316","cat":"papers","name":"Christ Returns from the Jungle: Ayahuasca Religion as Mystical Healing. Marc G. Blainey, Albany: SUNY Press, 2021, 562 pp.","year":"2022","cit":0,"pfa":"Abou Farman","ptype":"book-review","src":"https://openalex.org/W4292308316","eid":"W4292308316"},{"id":"paper-w7120478887","cat":"papers","name":"Acute interactions obtained from ayahuasca tea when in association with drugs used in anesthetic procedures (propofol and morphine), observed in animal models","year":"2009","cit":0,"pfa":"Júlia Movilla [UNIFESP] Pires","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7120478887","eid":"W7120478887"},{"id":"paper-w4409281325","cat":"papers","name":"187. Changes in Symptoms of Anhedonia With Psilocybin-Assisted Psychotherapy: A Secondary Analysis of a Randomized Clinical Trial for Treatment-Resistant Depression","year":"2025","cit":0,"pfa":"Erica S. Kaczmarek","psa":"Joshua Daniel Rosenblat","topics":["Depression","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4409281325","eid":"W4409281325"},{"id":"paper-w7117566828","cat":"papers","name":"Assessing The Readiness of Psychiatrists in Louisiana to Incorporate Psilocybin into Clinical Practice—Lessons Learned from a State Underrepresented in Clinical Psychedelic Research","year":"2025","cit":0,"pfa":"Amanda Husein","psa":"Kevin Sean Murnane","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7117566828","eid":"W7117566828"},{"id":"paper-w7163132999","cat":"papers","name":"Review for \"Psilocybin decreases reward-seeking behavior accompanied by increased activity of parvalbumin neurons with perineuronal nets in the medial prefrontal cortex\"","year":"2026","cit":0,"topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W7163132999","eid":"W7163132999"},{"id":"paper-w7167640618","cat":"papers","name":"Making a case for using MDMA-assisted psychotherapy for borderline personality disorder and complex PTSD: a descriptive systematic review of the literature","year":"2026","cit":0,"pfa":"Karthika Kasiviswanathan","psa":"Jillian Helen Broadbear","topics":["PTSD & trauma","Safety & adverse events","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W7167640618","eid":"W7167640618"},{"id":"paper-w2891177251","cat":"papers","name":"Psychedelic revival: a mixed-methods analysis of recreational magic mushroom (psilocybin) use for transformational, micro-dosing and leisure purposes","year":"2018","cit":0,"pfa":"Lindsay Shaw","topics":["Addiction","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W2891177251","eid":"W2891177251"},{"id":"paper-w2398302433","cat":"papers","name":"Efeitos da MDMA (ECSTASY) sobre os recetores 5-HT1 na artéria mamária interna humana","year":"2015","cit":0,"pfa":"Ana Cristina Afonso Costa Teixeira","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2398302433","eid":"W2398302433"},{"id":"paper-w7161420786","cat":"papers","name":"Additional file 2: Figure S1. of De novo sequencing and analysis of Lophophora williamsii transcriptome, and searching for putative genes involved in mescaline biosynthesis","year":"2016","cit":0,"pfa":"Enrique Ibarra‐Laclette","psa":"Luís Herrera‐Estrella","ptype":"article","src":"https://openalex.org/W7161420786","eid":"W7161420786"},{"id":"paper-w392272887","cat":"papers","name":"幻覚剤に関する研究-5-Psilocybinの合成(ノ-ト)","year":"1974","cit":0,"pfa":"昌子 大野","ptype":"article","src":"https://openalex.org/W392272887","eid":"W392272887"},{"id":"paper-w4407418295","cat":"papers","name":"ANXIOLYTIC- AND PROCOGNITIVE-LIKE EFFECTS OF A 30-DAY CHRONIC TREATMENT WITH A LOW NON-PSYCHEDELIC DOSE OF PSILOCYBIN IN C57BL/6J MICE","year":"2025","cit":0,"pfa":"Sofia Nasini","psa":"Stefano Comai","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4407418295","eid":"W4407418295"},{"id":"paper-w7141271109","cat":"papers","name":"26-CCC-15854-ACC TALK ABOUT A BAD TRIP!: PSILOCYBIN USE WITH PRE-EXISTING CARDIOVASCULAR DISEASE, A CASE REPORT","year":"2026","cit":0,"pfa":"Christine Buchanan","ptype":"article","src":"https://openalex.org/W7141271109","eid":"W7141271109"},{"id":"paper-w2281469333","cat":"papers","name":"Ayahuasca y auto-compasión: Un estudio cuantitativo en la Iglesia del Santo Daime en Santiago de Chile","year":"2014","cit":0,"pfa":"Saavedra Medina","psa":"Carla Andréa","ptype":"dissertation","src":"https://openalex.org/W2281469333","eid":"W2281469333"},{"id":"paper-w4405635691","cat":"papers","name":"Heart-rate variability changes in veterans and non-veteran population exposed to ceremonial ayahuasca indexed using a non-invasive wearable device","year":"2024","cit":0,"pfa":"A. Wingert","psa":"William Keith Campbell","ptype":"article","src":"https://openalex.org/W4405635691","eid":"W4405635691"},{"id":"paper-w7161232051","cat":"papers","name":"Chá de ayahuasca ; uma revisão bibliográfica sobre o uso da bebida alucinógena na neuropsiquiatria e na neurociência","year":"2022","cit":0,"pfa":"Carolina Martins Cabrera","psa":"Maurício Yonamine","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W7161232051","eid":"W7161232051"},{"id":"paper-w7172481291","cat":"papers","name":"Prevalence of Potential Contraindications and Risk Factors Relevant to MDMA-Assisted Therapy Among U.S. Veterans with Posttraumatic Stress Disorder","year":"2026","cit":0,"pfa":"Catherine S. Hwang","psa":"Christopher S. Stauffer","topics":["PTSD & trauma","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7172481291","eid":"W7172481291"},{"id":"paper-w4390222110","cat":"papers","name":"Investigating changes in EEG entropy rate in response to psilocybin – a comparison of lempel ziv and state-space entropy rate measures","year":"2023","cit":0,"pfa":"Marek Nikolič","psa":"Tomáš Páleníček","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4390222110","eid":"W4390222110"},{"id":"paper-w7117144288","cat":"papers","name":"Effects of Psilocybin on Religious and Spiritual Attitudes and Behaviors in Clergy from Various Major World Religions, by Griffiths et al","year":"2025","cit":0,"pfa":"Harriet de Wit","ptype":"article","src":"https://openalex.org/W7117144288","eid":"W7117144288"},{"id":"paper-w4313200992","cat":"papers","name":"Differential effects of repeated treatment with DOI and psilocybin on the head-twitch response (HTR), locomotor activity and anxiety-like behaviour","year":"2022","cit":0,"pfa":"E. Stojek","psa":"Fionn Dunphy-Doherty","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4313200992","eid":"W4313200992"},{"id":"paper-w7163205006","cat":"papers","name":"Psilocybin Decreases Preference for Large Rewards Accompanied by Increased Activity of Parvalbumin Neurons With Perineuronal Nets in the Medial Prefrontal Cortex","year":"2026","cit":0,"pfa":"Jenna Houff","psa":"Alberto Del Arco","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7163205006","eid":"W7163205006"},{"id":"paper-w7164192013","cat":"papers","name":"Psilocybin-assisted Physiotherapy for Refractory Motor Functional Neurological Disorder: A Randomized Dose-comparison Pilot Study (P7-17.001)","year":"2026","cit":0,"pfa":"Alexander Bryson","psa":"Richard Kanaan","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7164192013","eid":"W7164192013"},{"id":"paper-w7206720911","cat":"papers","name":"Una visión sistémica y transversal de la ayahuasca a través de la etnografía, la psicología y la biología","year":"2012","cit":0,"pfa":"Víctor Daniel Uribe Valencia","topics":["Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W7206720911","eid":"W7206720911"},{"id":"paper-w4416301040","cat":"papers","name":"Standardization of Psilocybin Dosing in a Natural Product–Based Retreat Setting: A Practical Method for Dose Quantification and Adjustment Across Sessions","year":"2025","cit":0,"pfa":"Sergio Pérez Rosal","psa":"Sonya C. Faber","topics":["Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4416301040","eid":"W4416301040"},{"id":"paper-w2601501217","cat":"papers","name":"Dopamine receptors gene expression in male rat hippocampus after administration of MDMA (Ecstasy) [La Expresión Génica de Receptores de Dopamina en el Hipocampo de Ratas Macho Después de la Administración de MDMA (Éxtasi","year":"2015","cit":0,"pfa":"Simin Montazeri","psa":"Majid Shahbazi","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2601501217","eid":"W2601501217"},{"id":"paper-w2970698421","cat":"papers","name":"Caffeine potentiates 3,4 methylenedioxymethamphetamine (MDMA, ecstasy)-induced-glial activation: role of age and adenosine A1 and A2A receptors","year":"2010","cit":0,"pfa":"Micaela Morelli","psa":"Sandro Fenu","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2970698421","eid":"W2970698421"},{"id":"paper-w4409280673","cat":"papers","name":"166. Dynamic Mediodorsal Thalamus Activity Predicts and Reflects Longitudinal Treatment Outcomes in Psilocybin Therapy for Treatment-Resistant Depression","year":"2025","cit":0,"pfa":"Xue Zhang","psa":"Leanne Maree Williams","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4409280673","eid":"W4409280673"},{"id":"paper-w4391827590","cat":"papers","name":"Design, Simulation and Analysis of Multi-Dimensional Multiple Access (MDMA) Schemes Using MATLAB for Quality of Service (QoS) Enhancement","year":"2024","cit":0,"pfa":"Ishwarlal","psa":"Ankit Saxena","ptype":"article","src":"https://openalex.org/W4391827590","eid":"W4391827590"},{"id":"paper-w7136950700","cat":"papers","name":"Additional file 1: of Exploring functional data analysis and wavelet principal component analysis on ecstasy (MDMA) wastewater data","year":"2016","cit":0,"pfa":"Stefania Salvatore","psa":"Jo Røislien","ptype":"article","src":"https://openalex.org/W7136950700","eid":"W7136950700"},{"id":"paper-w3107263479","cat":"papers","name":"Ayahuasca, experiências e neoxamanismo: um estudo etnográfico junto ao Grupo Xamânico Caminho do Arco-Íris – Pelotas/RS","year":"2015","cit":0,"pfa":"Vinicius Schwochow Paiva","ptype":"dissertation","src":"https://openalex.org/W3107263479","eid":"W3107263479"},{"id":"paper-w2924251278","cat":"papers","name":"Os efeitos de terapias baseadas em mindfulness e doses de ayahuasca em traços de depressão e ansiedade","year":"2018","cit":0,"pfa":"Thamiris Botelho Ribeiro Conceição","topics":["Depression","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W2924251278","eid":"W2924251278"},{"id":"paper-w4310268653","cat":"papers","name":"Psicoterapia Assistida por MDMA: um Novo Paradigma no Tratamento da Perturbação de Stress Pós‐Traumático Resistente?","year":"2022","cit":0,"pfa":"Pedro M.P.C. Mota","psa":"Manuel João Quartilho","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4310268653","eid":"W4310268653"},{"id":"paper-w4324373669","cat":"papers","name":"New study investigates the impact of Amazonian ayahuasca retreats on veterans, assessing its effect on brainwaves, the genome, gut microbiome and mental health","year":"2023","cit":0,"pfa":"Simon Ruffell","ptype":"preprint","src":"https://openalex.org/W4324373669","eid":"W4324373669"},{"id":"paper-w4390222321","cat":"papers","name":"Withdrawal of antidepressants does not impact the efficacy of COMP360 psilocybin therapy: results from a phase IIb randomised controlled trial","year":"2023","cit":0,"pfa":"Guy M. Goodwin","psa":"J. Tsai","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4390222321","eid":"W4390222321"},{"id":"paper-w2590156794","cat":"papers","name":"Study of 3,4-Methylenedioxymethamphetamine (MDMA)-Induced Neurotoxicity in Rat Brain Using Specific In Vivo Binding of [^3H]6-Nitroquipazine","year":"1993","cit":0,"pfa":"謙二 橋本","psa":"Tsuyoshi Goromaru","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2590156794","eid":"W2590156794"},{"id":"paper-w2169860544","cat":"papers","name":"IDENTIFICAÇÃO E CARACTERIZAÇÃO DOS PRINCIPAIS ALCALOIDES DE BANISTERIOPSIS CAAPI E PSYCHOTRIA VIRIDIS, COMPONENTES DO CHÁ DE AYAHUASCA","year":"2015","cit":0,"pfa":"Danielly Joani Ullé","psa":"Júlia Luiza Ern","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2169860544","eid":"W2169860544"},{"id":"paper-w4399054727","cat":"papers","name":"Il consumo di ayahuasca per fini cultuali: il Santo Daime tra ordine pubblico sanitario e libertà religiosa","year":"2024","cit":0,"pfa":"Andrea Micciché","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4399054727","eid":"W4399054727"},{"id":"paper-w1584903048","cat":"papers","name":"Die Auswirkung von Wachstumsfaktoren auf das neonatale Gehirn am Beispiel Hyperoxie- und MDMA-induzierter Neurotoxizität","year":"2011","cit":0,"pfa":"Daniela Brait","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W1584903048","eid":"W1584903048"},{"id":"paper-w7120603628","cat":"papers","name":"Beliefs attributed to the option of not using MDMA (ecstasy): a qualitative study among non-users, experimental users and ex-users","year":"2011","cit":0,"pfa":"Maria Angélica de Castro Comis","ptype":"dissertation","src":"https://openalex.org/W7120603628","eid":"W7120603628"},{"id":"paper-w4416133211","cat":"papers","name":"A TERAPIA ASSISTIDA POR MDMA NO TRATAMENTO DE TRANSTORNO DE ESTRESSE PÓS-TRAUMÁTICO (TEPT) GRAVE E REFRATÁRIO","year":"2025","cit":0,"pfa":"Carla Karoline de Oliveira Salotti","psa":"Mariana Nunes Miranda Carasek da Rocha","topics":["PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4416133211","eid":"W4416133211"},{"id":"paper-w2083465712","cat":"papers","name":"P.6.d.008 Cannabinoid CB1 receptor modulation of the acute and semichronic effects of MDMA in locomotor activity in mice","year":"2007","cit":0,"pfa":"J.M. Oliva","psa":"Per Svenningsson","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2083465712","eid":"W2083465712"},{"id":"paper-w7128954846","cat":"papers","name":"Toxicometabolomics Characterization of Two N1-Sulfonated Dimethyltryptamine Derivatives in Zebrafish Larvae and Human Liver S9 Fractions Using Liquid Chromatography–High-Resolution Mass Spectrometry","year":"2026","cit":0,"pfa":"Prajwal Punnamraju","psa":"Markus R. Meyer","topics":["Addiction","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7128954846","eid":"W7128954846"},{"id":"paper-w7214521694","cat":"papers","name":"Letter to the Editor for “Evaluating Pharmacogenomic Prescription Data in the Military Health System”: Medication-Induced CYP2D6 Inhibition Reveals a Screening Gap in Proxy-Defined Ibogaine Candidates","year":"2026","cit":0,"pfa":"James Green","psa":"Barbara Tafuto","topics":["Safety & adverse events"],"ptype":"letter","src":"https://openalex.org/W7214521694","eid":"W7214521694"},{"id":"paper-w7214148138","cat":"papers","name":"Las personalidades del maíz en la mitología wixarika o cómo las mazorcas de los ancestros se transformaron en peyotes","year":"2014","cit":0,"pfa":"Héctor M. Medina Miranda","ptype":"article","src":"https://openalex.org/W7214148138","eid":"W7214148138"},{"id":"paper-w2537983899","cat":"papers","name":"'l'}ilN LAYER CHROMATOGRAPHY OF LYSERGIC ACID DE1'HYLAMIDE (LSD), N, N DI5&lflHYL TRYPTAMINE (DMT), MElSlYtENE DIONYL ISOPROPYLAMINE (STP), AND IBOGAINE","year":"2016","cit":0,"pfa":"Bernard Newman","psa":"Arnold Dihrberg","ptype":"article","src":"https://openalex.org/W2537983899","eid":"W2537983899"},{"id":"paper-w2919016188","cat":"papers","name":"Current Research: Analysis of ceramic vessel residues from the Washington Square Mound Site (41NA49) for evidence of peyote use by the Caddo in the 13th-15th centuries A.D.","year":"2019","cit":0,"pfa":"Timothy K. Perttula","psa":"Martin Terry","ptype":"article","src":"https://openalex.org/W2919016188","eid":"W2919016188"},{"id":"paper-w4408590287","cat":"papers","name":"Turismo místico y la práctica de ayahuasca: análisis del corredor turístico en Madre de Dios, 2021-2022","year":"2024","cit":0,"pfa":"Ana Delia Lazo-Suta","psa":"O. Zevallos","ptype":"article","src":"https://openalex.org/W4408590287","eid":"W4408590287"},{"id":"paper-w7208797577","cat":"papers","name":"Efeitos do chá de ayahuasca (Banisteriopsis caapi e Psychotria viridis) em modelos in vitro e in vivo de tumores","year":"2025","cit":0,"pfa":"Luciana Gueiros da Motta","ptype":"dissertation","src":"https://openalex.org/W7208797577","eid":"W7208797577"},{"id":"paper-w4412934844","cat":"papers","name":"Efeitos de dose única de ayahuasca em universitários com uso abusivo de álcool: um estudo simples-cego","year":"2025","cit":0,"pfa":"Lucas Silva Rodrigues","topics":["Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W4412934844","eid":"W4412934844"},{"id":"paper-w7212524858","cat":"papers","name":"Efeitos de quatro doses de ayahuasca ou escetamina na depressão maior: um estudo randomizado e duplo-cego","year":"2025","cit":0,"pfa":"Giordano Novak Rossi","topics":["Depression","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7212524858","eid":"W7212524858"},{"id":"paper-w7161575324","cat":"papers","name":"Correction to: Prospective examination of synthetic 5-methoxy-N, N-dimethyltryptamine inhalation: effects on salivary IL-6, cortisol levels, affect, and non-judgment","year":"2026","cit":0,"pfa":"Malin Vedøy Uthaug","psa":"Johannes Gerardus Ramaekers","ptype":"erratum","src":"https://openalex.org/W7161575324","eid":"W7161575324"},{"id":"paper-w2091717194","cat":"papers","name":"ChemInform Abstract: The Chemistry of Indoles. Part 71. Simple Syntheses of Lespedamine and 5‐Bromo‐N,N‐dimethyltryptamine Based on 1‐Hydroxyindole Chemistry.","year":"1995","cit":0,"pfa":"Masanori Somei","psa":"Yashikazu Fukui","ptype":"article","src":"https://openalex.org/W2091717194","eid":"W2091717194"},{"id":"paper-w7153244897","cat":"papers","name":"Press Release - Clinical Trial into Psilocybin Therapy for Psychological Distress in Palliative Care, PsyPal, Receives Medical Ethical Authorisation, with Conditions","year":"2024","cit":0,"pfa":"University Medical Center Groningen","topics":["Anxiety & end-of-life","Safety & adverse events","Policy & ethics"],"ptype":"other","src":"https://openalex.org/W7153244897","eid":"W7153244897"},{"id":"paper-w2768595227","cat":"papers","name":"Marcadores espectrais de eletroencefalografia observados durante os efeitos agudos da ayahuasca e sua relação com a experiência psicodélica","year":"2017","cit":0,"pfa":"Jéssica de Andrade Pessoa","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W2768595227","eid":"W2768595227"},{"id":"paper-w4285528346","cat":"papers","name":"Using Drugs to Treat Drug Dependence: Exploring the Use of MDMA-Assisted Psychotherapy for Individuals with PTSD and Concurrent Substance Use","year":"2021","cit":0,"pfa":"Brenda Tichler","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4285528346","eid":"W4285528346"},{"id":"paper-w2257929122","cat":"papers","name":"EVALUATION OF SERUMS LEVELS OF GLUCOSE, LIPIDS AND LIPOPROTEINS AFTER INDUCED 3, 4 METHYLENEDIOXYMETH AMPHETAMINE (MDMA, ECSTASY) IN DOG","year":"2008","cit":0,"pfa":"B Amou Oughli Tabrizi","psa":"Amir H. Zargarzadeh","ptype":"article","src":"https://openalex.org/W2257929122","eid":"W2257929122"},{"id":"paper-w2939113501","cat":"papers","name":"El peyote y la autodeterminación a lo largo de la frontera entre Estados Unidos y México: desde pátzcuaro hasta Avándaro","year":"2011","cit":0,"pfa":"Alexander Dawson","ptype":"article","src":"https://openalex.org/W2939113501","eid":"W2939113501"},{"id":"paper-w4231754343","cat":"papers","name":"Optimizing ALD HfO2 for Advanced Gate Stacks with Interspersed UV and Thermal Treatments- DADA and MDMA Variations, Combinations, and Optimization","year":"2011","cit":0,"pfa":"Robert D. Clark","psa":"Gert J. Leusink","ptype":"conference-abstract","src":"https://openalex.org/W4231754343","eid":"W4231754343"},{"id":"paper-w2432499966","cat":"papers","name":"[Mass spectrometry data of some metabolites of the amphetamine derivatives 3,4-(methylenedioxy) amphetamine (MDA) and 3,4-methylenedioxy)methylamphetamine (MDMA)].","year":"1996","cit":0,"pfa":"A M Verweij","ptype":"other","src":"https://openalex.org/W2432499966","eid":"W2432499966"},{"id":"paper-w4383102066","cat":"papers","name":"BENEFÍCIOS DO USO DOS PSICODÉLICOS CLÁSSICOS SEROTONINÉRGICOS, PSILOCIBINA E AYAHUASCA, NO TRATAMENTO DA DEPRESSÃO MAIOR: UMA REVISÃO INTEGRATIVA.","year":"2023","cit":0,"pfa":"Graziele Cristina Ignácio","psa":"Sandra Mota Ortiz","topics":["Depression","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W4383102066","eid":"W4383102066"},{"id":"paper-w7140251627","cat":"papers","name":"Psilocibina e MDMA: psichedelici ad uso terapeutico e come strumento di indagine delle attività mentali","year":"2026","cit":0,"pfa":"FABRIZIO BERTOZZI","topics":["Depression","PTSD & trauma","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W7140251627","eid":"W7140251627"},{"id":"paper-w1999157428","cat":"papers","name":"Chronic effects of methamphetamine, MDMA and 5-MeO-DiPT on raphe serotonergic neurons in rat organotypic mesencephalic slice culture","year":"2007","cit":0,"pfa":"Megumi Higuchi","psa":"Shuji Kaneko","ptype":"article","src":"https://openalex.org/W1999157428","eid":"W1999157428"},{"id":"paper-w7140802124","cat":"papers","name":"Safety and Efficacy of Psilocybin-Assisted Therapy for Alcohol Use Disorder: Open-Label Extension of a Phase II Randomized Controlled Trial","year":"2026","cit":0,"pfa":"Broc A. Pagni","psa":"Michael P. Bogenschutz","topics":["Addiction","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W7140802124","eid":"W7140802124"},{"id":"paper-w3135591988","cat":"papers","name":"Structure Based Drug Design towards Exploring Potential Anti-Psychotic and Anti-Depressant Activity of Possible Stiff Base of Psilocybin","year":"2019","cit":0,"pfa":"Krishna Kumar Varshney","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W3135591988","eid":"W3135591988"},{"id":"paper-w4407246147","cat":"papers","name":"Dose-dependent changes in global brain activity and functional connectivity following exposure to psilocybin: a BOLD MRI study in awake rats","year":"2025","cit":0,"pfa":"Evan Fuini","psa":"Craig F. Ferris","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4407246147","eid":"W4407246147"},{"id":"paper-w7214006381","cat":"papers","name":"Apomorphine and psilocybin to improve recovery from coma in the intensive care unit: protocol for a prospective, open-label, dose-escalation study","year":"2026","cit":0,"pfa":"Anna Kristina Eigenbrodt","psa":"Daniel Kondziella","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7214006381","eid":"W7214006381"},{"id":"paper-w2974596392","cat":"papers","name":"Estudio fenomenológico de experiencias psiquedélicas de personas que han participado en sesiones de Terapia con Ayahuasca","year":"2019","cit":0,"pfa":"Erik Hendrick Carpio","ptype":"article","src":"https://openalex.org/W2974596392","eid":"W2974596392"},{"id":"paper-w3017167477","cat":"papers","name":"ALTERAÇÕES NEUROPSICOLÓGICAS CAUSADAS PELA INGESTÃO DO CHÁ DA AYAHUASCA E A OBSERVAÇÃO DO EFEITO EM UM BEBÊ","year":"2020","cit":0,"pfa":"Dalila Maîte Rosa Sena","psa":"Gésica Borges Bergamini","ptype":"book-chapter","src":"https://openalex.org/W3017167477","eid":"W3017167477"},{"id":"paper-w7119389962","cat":"papers","name":"Perfil Comportamental e Toxicológico de Ratos Submetidos ao Modelo de Dependência Química ao Etanol Tratados com Ayahuasca","year":"2017","cit":0,"pfa":"Paula Pólvora Victoria","ptype":"dissertation","src":"https://openalex.org/W7119389962","eid":"W7119389962"},{"id":"paper-w2082196680","cat":"papers","name":"Mescaline Intoxication: A Personal Experience [l’ intossicazione mescalinica: Autoesperienze]. (Riv. Sper. di Fren., vol. Ivi, p. 42, March, 1932.) Ceroni, L.","year":"1933","cit":0,"pfa":"Gerald W. T. H. Fleming","ptype":"article","src":"https://openalex.org/W2082196680","eid":"W2082196680"},{"id":"paper-w7155204599","cat":"papers","name":"Toward a Biologically Plausible Account of Attention-Guided Neural Plasticity: A Theoretical Integration of the HCOS Framework with Neuroscientific Evidence on Psilocybin and Mindfulness","year":"2026","cit":0,"pfa":"Normand Jones","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7155204599","eid":"W7155204599"},{"id":"paper-w7215603531","cat":"papers","name":"ESPAÇOS RITUAIS DE INGESTÃO DA AYAHUASCA NO OESTE CATARINENSE: ESTUDO DE CASO DO ESPAÇO CÉU CAMINHOS DO AMOR","year":"2019","cit":0,"pfa":"Natália Aimée Barilli Concolatto","psa":"Jaisson Teixeira Lino","ptype":"article","src":"https://openalex.org/W7215603531","eid":"W7215603531"},{"id":"paper-w7120666958","cat":"papers","name":"Espaços rituais de ingestão da Ayahuasca no oeste catarinense: estudo de caso do espaço Céu Caminhos do Amor","year":"2022","cit":0,"pfa":"Jaisson Teixeira Lino","psa":"Natália Aimée Barilli Concolatto","ptype":"article","src":"https://openalex.org/W7120666958","eid":"W7120666958"},{"id":"paper-w2774100793","cat":"papers","name":"Labate, Beatriz Caiuby y Araujo, Wladimyr Sena. O uso ritual da Ayahuasca, Campinas: Mercado das Letras, 2002","year":"2003","cit":0,"pfa":"Marcelo Simão Mercante","ptype":"article","src":"https://openalex.org/W2774100793","eid":"W2774100793"},{"id":"paper-w1762620821","cat":"papers","name":"Toxicidade aguda, neurotoxicidade reprodutiva e embriotoxicidade do chá ayahuasca (Banisteriopsis caapi e Psychotria viridis) em ratas wistar","year":"2013","cit":0,"pfa":"Luciana Gueiros da Motta","ptype":"dissertation","src":"https://openalex.org/W1762620821","eid":"W1762620821"},{"id":"paper-w4413542986","cat":"papers","name":"Frustração psicodélica: os bastidores da tentativa fracassada de registro do MDMA como medicamento nos EUA","year":"2024","cit":0,"pfa":"Fabrício A. Pamplona","ptype":"other","src":"https://openalex.org/W4413542986","eid":"W4413542986"},{"id":"paper-w7212280327","cat":"papers","name":"MDMA administration reduces ethanol drinking and is associated with altered nociceptin and dynorphin system gene expression in alcohol-preferring rats","year":"2026","cit":0,"pfa":"Laura Rullo","psa":"Patrizia Romualdi","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7212280327","eid":"W7212280327"},{"id":"paper-w7213236102","cat":"papers","name":"Level of preparedness to use psilocybin among individuals seeking psychedelic risk reduction: a retrospective study of a pilot psychiatric consultation service","year":"2026","cit":0,"pfa":"Harland V. Harrison","psa":"Ximena A. Levander","topics":["PTSD & trauma","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7213236102","eid":"W7213236102"},{"id":"paper-w4407008238","cat":"papers","name":"Study Protocol for ‘PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity’","year":"2025","cit":0,"pfa":"Sorcha O'Connor","psa":"David Erritzøe","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4407008238","eid":"W4407008238"},{"id":"paper-w2902223301","cat":"papers","name":"Effects of 3,4-metylendioxymethamphetamine (MDMA, Ecstasy) on prefrontal cortical acetylcholine and accumbens shell and core dopamine transmission: a microdialysis study","year":"2001","cit":0,"pfa":"Paola Marrocu","psa":"G. Di Chiara","ptype":"article","src":"https://openalex.org/W2902223301","eid":"W2902223301"},{"id":"paper-w4293218261","cat":"papers","name":"Exploratory review of psilocybin usage and awareness amongst college students and potential consumer goods tradeoffs resulting from increased usage","year":"2022","cit":0,"pfa":"Russell J. Zwanka","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4293218261","eid":"W4293218261"},{"id":"paper-w4390222334","cat":"papers","name":"Behavioral effects of a 14-day repeated treatment with psilocybin at a low non-psychedelic dose: a preliminary study in C57BL/6J mice","year":"2023","cit":0,"pfa":"Sofia Nasini","psa":"Stefano Comai","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4390222334","eid":"W4390222334"},{"id":"paper-w7163217713","cat":"papers","name":"Review for \"Psilocybin decreases reward-seeking behavior accompanied by increased activity of parvalbumin neurons with perineuronal nets in the medial prefrontal cortex\"","year":"2026","cit":0,"topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W7163217713","eid":"W7163217713"},{"id":"paper-w3176350609","cat":"papers","name":"A concretização do direito fundamental à liberdade religiosa: política do reconhecimento e legalização do uso religioso da Ayahuasca","year":"2011","cit":0,"pfa":"Carlos Henrique De Aragao Cavalcante","topics":["Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W3176350609","eid":"W3176350609"},{"id":"paper-w7168165083","cat":"papers","name":"Acceptability and safety of two sequential doses of psilocybin in bipolar II depression: protocol for an open-label single-arm feasibility study","year":"2026","cit":0,"pfa":"Thomas Daniel Meyer","psa":"Jair C. Soares","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7168165083","eid":"W7168165083"},{"id":"paper-w4407068578","cat":"papers","name":"Eutylone Pre-Exposure Has No Impact on the Aversive Effects of Cocaine and MDMA: Implications of Its Hybrid Neurochemical Mechanisms of Action","year":"2025","cit":0,"pfa":"Nina Ardabili","psa":"Anthony Lee Riley","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4407068578","eid":"W4407068578"},{"id":"paper-w7135963883","cat":"papers","name":"Evaluation and validation of latent fingerprints as a non-invasive drug screening matrix for the detection of MDMA using lateral flow technology","cit":0,"pfa":"Caroline Pollard","ptype":"dissertation","src":"https://openalex.org/W7135963883","eid":"W7135963883"},{"id":"paper-w4402885470","cat":"papers","name":"Review for \"Direct photochemical intramolecular [4 + 2] cycloadditions of dehydrosecodine-type substrates for the synthesis of the iboga-type scaffold and divergent [2 + 2] cycloadditions employing micro-flow system\"","year":"2024","cit":0,"topics":["Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4402885470","eid":"W4402885470"},{"id":"paper-w2474385533","cat":"papers","name":"[Pharmacological studies of hallucinogens. Report 3. I. Bibliographical considerations of psilocybin, with special reference to its actions on the central nervous system].","year":"1968","cit":0,"pfa":"Masahiro HORIBE","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2474385533","eid":"W2474385533"},{"id":"paper-w4405050121","cat":"papers","name":"Author response for \"Randomized Controlled Trials of Psilocybin‐Assisted Therapy in the Treatment of Major Depressive Disorder: Systematic Review and Meta‐Analysis\"","year":"2024","cit":0,"pfa":"Vikas Menon","psa":"Chittaranjan Andrade","topics":["Depression","Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4405050121","eid":"W4405050121"},{"id":"paper-w7155189424","cat":"papers","name":"Toward a Biologically Plausible Account of Attention-Guided Neural Plasticity: A Theoretical Integration of the HCOS Framework with Neuroscientific Evidence on Psilocybin and Mindfulness","year":"2026","cit":0,"pfa":"Normand Jones","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7155189424","eid":"W7155189424"},{"id":"paper-w4417259674","cat":"papers","name":"EFEITOS DO USO RITUALÍSTICO E TERAPÊUTICO DA AYAHUASCA NO MANEJO DA DEPRESSÃO EM INDIVÍDUOS ADULTOS: UMA REVISÃO NARRATIVA","year":"2025","cit":0,"pfa":"Diogo da Conceição Silva","psa":"Anderson Scherer","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4417259674","eid":"W4417259674"},{"id":"paper-w4405049719","cat":"papers","name":"Decision letter for \"Randomized Controlled Trials of Psilocybin‐Assisted Therapy in the Treatment of Major Depressive Disorder: Systematic Review and Meta‐Analysis\"","year":"2024","cit":0,"topics":["Depression","Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4405049719","eid":"W4405049719"},{"id":"paper-w4381283161","cat":"papers","name":"Supplemental Material for Reports of Self-Compassion and Affect Regulation in Psilocybin-Assisted Therapy for Alcohol Use Disorder: An Interpretive Phenomenological Analysis","year":"2023","cit":0,"topics":["Addiction","Policy & ethics"],"ptype":"supplementary-materials","src":"https://openalex.org/W4381283161","eid":"W4381283161"},{"id":"paper-w3115828104","cat":"papers","name":"Ancestralidade e “cura” na/pela “medicina da floresta”: a importância da regulamentação do uso ritualístico da Ayahuasca no Brasil","year":"2019","cit":0,"pfa":"Nelson Rodrigues Tedesco","ptype":"article","src":"https://openalex.org/W3115828104","eid":"W3115828104"},{"id":"paper-w7167239267","cat":"papers","name":"Naturally Derived Psilocybin for Therapeutic Use: A Six-Criterion Framework for Evidence, Safety, and Benefit–Risk Considerations in Policy and Clinical Development","year":"2026","cit":0,"pfa":"Stefanie Enriquez‐Geppert","psa":"Vince Polito","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7167239267","eid":"W7167239267"},{"id":"paper-w2151459575","cat":"papers","name":"The Peyote Road: Religious Freedom and the Native American Church. By Thomas C.Maroukis. Norman: University of Oklahoma Press, 2010. Pp. xii + 281; maps, figures. $29.95.","year":"2013","cit":0,"pfa":"Natalie Avalos Cisneros","ptype":"book-review","src":"https://openalex.org/W2151459575","eid":"W2151459575"},{"id":"paper-w4236679868","cat":"papers","name":"Corrigendum: Four Weekly Ayahuasca Sessions Lead to Increases in “Acceptance” Capacities: A Comparison Study with a Standard 8-Week Mindfulness Training Program","year":"2021","cit":0,"pfa":"Joaquim Soler","psa":"Jordi Riba","topics":["Dosing & pharmacology","Therapy practice","Policy & ethics"],"ptype":"erratum","src":"https://openalex.org/W4236679868","eid":"W4236679868"},{"id":"paper-w4412512397","cat":"papers","name":"Transdiagnostic use of 3,4-methylenedioxymethamphetamine (MDMA)-assisted therapy to treat obsessive–compulsive disorder (OCD): commentary, Brakoulias and Rossell","year":"2025","cit":0,"pfa":"Vlasios Brakoulias","psa":"Susan Lee Rossell","ptype":"article","src":"https://openalex.org/W4412512397","eid":"W4412512397"},{"id":"paper-w7147638263","cat":"papers","name":"Impact d'une lésion sérotoninergique sur la symptomatologie parkinsonienne : approches multiples chez le singe MPTP-MDMA","year":"2015","cit":0,"pfa":"Maude Beaudoin","topics":["Addiction","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W7147638263","eid":"W7147638263"},{"id":"paper-w7214731733","cat":"papers","name":"MDMA administration attenuates hippocampal IL-β immunoreactivity and subsequent stress-enhanced fear learning: An animal model of PTSD","year":"2026","cit":0,"pfa":"Lydia O. Adams","psa":"Shveta V. Parekh","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W7214731733","eid":"W7214731733"},{"id":"paper-w4406299512","cat":"papers","name":"What are the benefits and harms of classical psychedelics (psilocybin and LSD) for treating anxiety, depression, and existential distress in people with life-threatening diseases?","year":"2025","cit":0,"pfa":"Amin Sharifan","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4406299512","eid":"W4406299512"},{"id":"paper-w2796320604","cat":"papers","name":"Effect of adenosine A1 and A2A antagonists on 3,4 methylenedioxymethamphetamine (MDMA)-induced neuroinflammation and dopamine neuron toxicity in mouse brain","year":"2011","cit":0,"pfa":"Amit Khairnar","psa":"Micaela Morelli","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2796320604","eid":"W2796320604"},{"id":"paper-w7136177215","cat":"papers","name":"Additional file 1: of Exploring functional data analysis and wavelet principal component analysis on ecstasy (MDMA) wastewater data","year":"2016","cit":0,"pfa":"Stefania Salvatore","psa":"Jo Røislien","ptype":"article","src":"https://openalex.org/W7136177215","eid":"W7136177215"},{"id":"paper-w4413892766","cat":"papers","name":"Development of MDMA analysis method in dried blood spot using gas chromatography mass spectrometry Quadrupole Time-of-Flight","year":"2025","cit":0,"pfa":"Aisyah Alifia Anjeli","psa":"Yuswardi Yuswardi","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4413892766","eid":"W4413892766"},{"id":"paper-w4405637305","cat":"papers","name":"Ayahuasca modulates socio-emotional brain circuits concomitantly with positive persisting behavioral effects – a cross-over multiple dosage fMRI study","year":"2024","cit":0,"pfa":"Carla Soares","psa":"Miguel Castelo‐Branco","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4405637305","eid":"W4405637305"},{"id":"paper-w593881080","cat":"papers","name":"Blut-Serum-Verteilung von MDMA und MDA - ein Vergleich von in vitro ermittelten Werten mit authentischem Probenmaterial","year":"2009","cit":0,"pfa":"Regine Garcia Boy","psa":"Gisela Skopp","ptype":"article","src":"https://openalex.org/W593881080","eid":"W593881080"},{"id":"paper-w4238862286","cat":"papers","name":"Faculty Opinions recommendation of Human pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) after repeated doses taken 2 h apart.","year":"2012","cit":0,"pfa":"Frédérique Servin","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"peer-review","src":"https://openalex.org/W4238862286","eid":"W4238862286"},{"id":"paper-w2739281133","cat":"papers","name":"MDMA-evoked changes in [11C]N-methyl-spiperone, [3H] raclopride and [3H] spiperone binding in 5,7 dihydrotryptamine hemilesioned rats","year":"2006","cit":0,"pfa":"Søren Dinesen Østergaard","psa":"Paul D. Cumming","ptype":"conference-paper","src":"https://openalex.org/W2739281133","eid":"W2739281133"},{"id":"paper-w7110155036","cat":"papers","name":"Extraction of N, N-dimethyltryptamine (DMT) from Mimosa tenuiflora, syn. Mimosa hostilis (Tepescohuite) using supercritical CO2 and study of its surface activity","year":"2025","cit":0,"pfa":"Arenas-Quevedo, Miguel Gonzalo","psa":"Gracia-Fadrique, Jesús","ptype":"article","src":"https://openalex.org/W7110155036","eid":"W7110155036"},{"id":"paper-w1966886737","cat":"papers","name":"Inconstancy of the Formal Structure of the Personality: Experimental Study of the Influence of Mescaline on the Rorschach Test. (Arch. of Neur. and Psychiat., July, 1932.) Wetham. F., and Bleuler, M.","year":"1933","cit":0,"pfa":"Gerald W. T. H. Fleming","ptype":"article","src":"https://openalex.org/W1966886737","eid":"W1966886737"},{"id":"paper-w4390241281","cat":"papers","name":"Acute neurovascular effects of psilocybin administration in healthy humans: Implications for cerebral blood flow measurements using arterial spin labelling","year":"2023","cit":0,"pfa":"K. Larsen","psa":"Patrick M. Fisher","ptype":"article","src":"https://openalex.org/W4390241281","eid":"W4390241281"},{"id":"paper-w7117964120","cat":"papers","name":"An open-label study of single-dose COMP360 psilocybin for post-traumatic stress disorder: safety, tolerability, and secondary efficacy outcomes","year":"2026","cit":0,"pfa":"N. Mcgowan","psa":"G. Goodwin","topics":["PTSD & trauma","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7117964120","eid":"W7117964120"},{"id":"paper-w4416646295","cat":"papers","name":"Peer Review Report For: A whole genome atlas of 81 Psilocybe genomes as a resource for psilocybin production. [version 2; peer review: 1 approved with reservations, 1 not approved]","year":"2024","cit":0,"pfa":"Kevin Judd McKernan","psa":"Stephen McLaughlin","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4416646295","eid":"W4416646295"},{"id":"paper-w2701739177","cat":"papers","name":"Estudo do perfil genotóxico, citotóxico, neurocomportamental e bioquímico da ayahuasca em ratos Wistar tratados com dose única","year":"2014","cit":0,"pfa":"Willian Melo","topics":["Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W2701739177","eid":"W2701739177"},{"id":"paper-w7112471464","cat":"papers","name":"Magic Mushrooms as Medicine: What the United States Can Learn from Jamaica’s Unregulated Psilocybin Industry as FDA Approval Nears","year":"2025","cit":0,"pfa":"Spohn, Kyle","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7112471464","eid":"W7112471464"},{"id":"paper-w199307055","cat":"papers","name":"Consumo de alcohol y éxtasis (MDMA) en adolescentes y variables psicosociales implicadas. Un análisis descriptivo","year":"2005","cit":0,"pfa":"Cecilia Peñacoba","psa":"Isabel Carretero","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W199307055","eid":"W199307055"},{"id":"paper-w2188769240","cat":"papers","name":"EFFECTS OF ACUTE AND CHRONIC TREATMENT WITH 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA) AND THE CANNABINOID RECEPTOR AGONIST WIN55,212-2 ON BEHAVIOUR AND COGNITION IN RATS","year":"2012","cit":0,"pfa":"Sybille Schulz","topics":["Addiction","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2188769240","eid":"W2188769240"},{"id":"paper-w7161429007","cat":"papers","name":"MacArthur Foundation 100&Change Grant Application: MDMA-Assisted Therapy for Post-Traumatic Stress Disorder in Australia 2024","year":"2026","cit":0,"pfa":"Octavian Victor Brinzei","topics":["PTSD & trauma","Reviews & meta-analyses","Therapy practice"],"ptype":"other","src":"https://openalex.org/W7161429007","eid":"W7161429007"},{"id":"paper-w7128497182","cat":"papers","name":"The effects of acute and repeated adolescent MDMA exposure on behavior, cognition, and the monoamine neurotransmitter systems: A review of human and pre-clinical research","year":"2026","cit":0,"pfa":"Kristin A. Felsch","psa":"Jessica A. Siegel","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7128497182","eid":"W7128497182"},{"id":"paper-w7132822523","cat":"papers","name":"Toxicometabolomics Characterization of Two N1-Sulfonated Dimethyltryptamine Derivatives in Zebrafish Larvae and Human Liver S9 Fractions Using Liquid Chromatography–High-Resolution Mass Spectrometry","year":"2026","cit":0,"pfa":"Prajwal Punnamraju","psa":"Markus R. Meyer","ptype":"other","src":"https://openalex.org/W7132822523","eid":"W7132822523"},{"id":"paper-w4401460000","cat":"papers","name":"Galactic transmissions from tantra bros, pu$$y priestesses, red-pilled starseeds, and ayahuasca girls: Decoding the pedagogies of conspiritual life coaching","year":"2024","cit":0,"pfa":"Sandro R. Barros","psa":"Jennifer A. Sandlin","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4401460000","eid":"W4401460000"},{"id":"paper-w2115668949","cat":"papers","name":"Interacciones farmacológicas entre la 3,4-Metilenodioximetanfetamina (MDMA, éxtasis) y el alcohol administrados a dosis únicas en humanos","year":"2002","cit":0,"pfa":"Cándido Hernández López","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2115668949","eid":"W2115668949"},{"id":"paper-w4394116407","cat":"papers","name":"Additional file 8: Alignment of HPP dioxygenase proteins. of De novo sequencing and analysis of Lophophora williamsii transcriptome, and searching for putative genes involved in mescaline biosynthesis","year":"2015","cit":0,"pfa":"Enrique Ibarra‐Laclette","psa":"Luís Herrera‐Estrella","ptype":"dataset","src":"https://openalex.org/W4394116407","eid":"W4394116407"},{"id":"paper-w4402885575","cat":"papers","name":"Decision letter for \"Direct photochemical intramolecular [4 + 2] cycloadditions of dehydrosecodine-type substrates for the synthesis of the iboga-type scaffold and divergent [2 + 2] cycloadditions employing micro-flow sy","year":"2024","cit":0,"ptype":"peer-review","src":"https://openalex.org/W4402885575","eid":"W4402885575"},{"id":"paper-w4378374577","cat":"papers","name":"IDENTIFICAR LA RELACIÓN DE PSICOSIS Y EL CONSUMO DE AYAHUASCA, LA DROGA \"ESPIRITUAL\". A PROPÓSITO DE UN CASO.","year":"2023","cit":0,"topics":["Policy & ethics"],"ptype":"conference-paper","src":"https://openalex.org/W4378374577","eid":"W4378374577"},{"id":"paper-w4253052095","cat":"papers","name":"Erratum 3, 4-Methylenedioxymeth-amphetamine (MDMA) Modulates Cortical and Limbic Brain Activity as Measured by [H215O]-PET in Healthy Humans","year":"2000","cit":0,"ptype":"erratum","src":"https://openalex.org/W4253052095","eid":"W4253052095"},{"id":"paper-w2184599249","cat":"papers","name":"Club Drugs: They're All the Rave: A Review of Use and Abuse: Effects of MDMA, Methamphetamine, and Gamma-Hydroxy-Butyrate (GHB) on Memory","year":"2005","cit":0,"pfa":"Firas Kobeissy","psa":"Steven N. Gold","topics":["PTSD & trauma","Addiction","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W2184599249","eid":"W2184599249"},{"id":"paper-w4408018934","cat":"papers","name":"Psilocybin Impairs Short-Term Cognitive Flexibility but Indicates Long-Term Benefits in a Rodent Three-Choice Reversal Learning Task","year":"2025","cit":0,"pfa":"Anton T Gregersen","psa":"Mikael Palner","topics":["Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4408018934","eid":"W4408018934"},{"id":"paper-w3015181829","cat":"papers","name":"症例から学ぶ急性中毒 29〔違法薬物〕MDMA","year":"2013","cit":0,"pfa":"冨岡譲二","ptype":"article","src":"https://openalex.org/W3015181829","eid":"W3015181829"},{"id":"paper-w7129630219","cat":"papers","name":"Mindfulness-Based Psilocybin-Assisted Therapy (MB-PAT) for cancer-related demoralization in Canada: the case for a hybrid group-based delivery model","year":"2026","cit":0,"pfa":"Christopher P. Albertyn","psa":"Linda Ellen Carlson","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7129630219","eid":"W7129630219"},{"id":"paper-w4416262057","cat":"papers","name":"Microdosing Psilocybin for Major Depressive Disorder: Study Protocol for a Phase II Double-Blind Placebo-Controlled Randomized Partial Crossover Trial","year":"2025","cit":0,"pfa":"Zeina Beidas","psa":"Rotem Petranker","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4416262057","eid":"W4416262057"},{"id":"paper-w7202201520","cat":"papers","name":"Psilocybin for Depressive and Anxiety Disorders in Working-Age Adults: A Systematic Review od controled trails with a Hybrid Bibliometric Analysis (2022 to 2026)","year":"2026","cit":0,"pfa":"Andrea Estefania Aranda-Rosas","psa":"Miguel Á. Trejo-Rodríguez","topics":["Depression","Anxiety & end-of-life","Reviews & meta-analyses"],"ptype":"software","src":"https://openalex.org/W7202201520","eid":"W7202201520"},{"id":"paper-w4409280654","cat":"papers","name":"13. Safety, Feasibility, and Tolerability of Psilocybin in Older Adults With Amnestic MCI: Preliminary Data From a SV2a PET Imaging Study","year":"2025","cit":0,"pfa":"Danielle Bukovsky","psa":"Philip Gerretsen","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4409280654","eid":"W4409280654"},{"id":"paper-w2788563881","cat":"papers","name":"MDMA Kullanımı Sonrası Miyoglobinüri ve Böbrek Yetmezliği Olmadan Kreatin Kinaz Yüksekliği Olan Bir Olgu Sunumu","year":"2012","cit":0,"pfa":"Nilüfer Eldeş","psa":"Yüksel Yılmaz","ptype":"article","src":"https://openalex.org/W2788563881","eid":"W2788563881"},{"id":"paper-w7136080842","cat":"papers","name":"Bioactivation and Metabolism of Amino Acid MDMA Prodrugs in Zebrafish Embryos, Human Liver S9, Whole Blood, and Microdosed Human Urine","year":"2026","cit":0,"pfa":"Simon K. Wellenberg","psa":"Markus R. Meyer","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7136080842","eid":"W7136080842"},{"id":"paper-w4256483648","cat":"papers","name":"Review Garrett Epps Peyote vs. the State: Religious Freedom on Trial. University of Oklahoma Press, Norman, 2009. Notes, index. 296 pages. $$19.95 paper.","year":"2010","cit":0,"topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4256483648","eid":"W4256483648"},{"id":"paper-w4390223380","cat":"papers","name":"The safety and efficacy of COMP360 psilocybin therapy in treatment-resistant depression: results from a long-term observational follow-up study","year":"2023","cit":0,"pfa":"Guy M. Goodwin","psa":"E. Malievskaia","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4390223380","eid":"W4390223380"},{"id":"paper-w4402885073","cat":"papers","name":"Review for \"Direct photochemical intramolecular [4 + 2] cycloadditions of dehydrosecodine-type substrates for the synthesis of the iboga-type scaffold and divergent [2 + 2] cycloadditions employing micro-flow system\"","year":"2024","cit":0,"topics":["Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4402885073","eid":"W4402885073"},{"id":"paper-w7153263780","cat":"papers","name":"Psilocybin elicits a conserved glucocorticoid-responsive gene signature across five 5-HT2A receptor-rich brain regions in rat","year":"2026","cit":0,"pfa":"Ashkan Veysi","psa":"Elias Eriksson","topics":["Depression","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7153263780","eid":"W7153263780"},{"id":"paper-w4410053350","cat":"papers","name":"Uso, experiencia y percepción de la ayahuasca como terapia psicológica alternativa en contextos urbanos en Guadalajara, Jalisco, México","year":"2024","cit":0,"pfa":"Alejandro Chávez Rodríguez","ptype":"book-chapter","src":"https://openalex.org/W4410053350","eid":"W4410053350"},{"id":"paper-w4402885559","cat":"papers","name":"Review for \"Direct photochemical intramolecular [4 + 2] cycloadditions of dehydrosecodine-type substrates for the synthesis of the iboga-type scaffold and divergent [2 + 2] cycloadditions employing micro-flow system\"","year":"2024","cit":0,"topics":["Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4402885559","eid":"W4402885559"},{"id":"paper-w4242991549","cat":"papers","name":"Open Label Multi-Site Study of Safety and Effects of MDMA-assisted Psychotherapy for Treatment of PTSD With Optional fMRI Sub-Study","year":"2019","cit":0,"topics":["PTSD & trauma","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4242991549","eid":"W4242991549"},{"id":"paper-w4236100978","cat":"papers","name":"VISIONS DES HUICHOLS SOUS L'EFFET DU PEYOTL (Peyote Hallucinations in the Huichol Indians) by MARINO BENZI. Hygiene Mentale no. 3 (1969): 61-97. (In French.)","year":"1971","cit":0,"ptype":"article","src":"https://openalex.org/W4236100978","eid":"W4236100978"},{"id":"paper-w77944008","cat":"papers","name":"A double-blind, placebo controlled study of the effect of the hallucinogenic 5-HT1A&2A agonist psilocybin on binocular rivalry rate and rhythmicity","year":"2003","cit":0,"pfa":"Olivia L. Carter","psa":"John Douglas Pettigrew","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W77944008","eid":"W77944008"},{"id":"paper-w7162520467","cat":"papers","name":"SAT-219 Hepatic 5-HT2B receptor antagonism mediates the anti-steatotic and antifibrotic effects of psilocybin in preclinical MASH models","year":"2026","cit":0,"pfa":"Anna Signor","psa":"Sara De Martin","topics":["Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W7162520467","eid":"W7162520467"},{"id":"paper-w3120327489","cat":"papers","name":"O fim da Ayahuasca? (pelo menos como conheci a bebida e seu uso nos anos 1980s): saberes e transformações","year":"2021","cit":0,"pfa":"Alberto Groisman","ptype":"article","src":"https://openalex.org/W3120327489","eid":"W3120327489"},{"id":"paper-w7166883336","cat":"papers","name":"Der gezüchtete psychoaktive Pilz als Fall der Zugangs-Reorganisation — mit dem komparativen Fall des Peyote.** Transdisziplinäre Monografie (Ausbaustufe). Zweisprachig **DE + EN**","year":"2026","cit":0,"pfa":"Schüller Thomas","ptype":"article","src":"https://openalex.org/W7166883336","eid":"W7166883336"},{"id":"paper-w2753613823","cat":"papers","name":"Memoria, rescate y transmisión de saberes ancestrales. Caso de estudio: la Ayahuasca en la Comunidad Shuar de Puyo","year":"2015","cit":0,"pfa":"Márquez Acevedo","psa":"Adriana Elizabeth","ptype":"dissertation","src":"https://openalex.org/W2753613823","eid":"W2753613823"},{"id":"paper-w7155645923","cat":"papers","name":"483. Acute Functional Brain Changes Associated With Psilocybin in Depression and Healthy Adults: A Systematic Review and Coordinate-Based Meta-Analysis","year":"2026","cit":0,"pfa":"Joshua M. Poulin","psa":"Sean M. Nestor","topics":["Depression","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7155645923","eid":"W7155645923"},{"id":"paper-w7166862257","cat":"papers","name":"Der gezüchtete psychoaktive Pilz als Fall der Zugangs-Reorganisation — mit dem komparativen Fall des Peyote.** Transdisziplinäre Monografie (Ausbaustufe). Zweisprachig **DE + EN**","year":"2026","cit":0,"pfa":"Schüller Thomas","ptype":"article","src":"https://openalex.org/W7166862257","eid":"W7166862257"},{"id":"paper-w4390223807","cat":"papers","name":"Psilocybin rescues depressive phenotype and modulates serotonin-2A and glucocorticoid receptor mRNA expression in brain cortex of a stress animal model","year":"2023","cit":0,"pfa":"Ines Erkizia-Santamaría","psa":"Jorge Emilio Ortega","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4390223807","eid":"W4390223807"},{"id":"paper-w2460986804","cat":"papers","name":"Interações agudas do chá de ayahuasca com agentes usados em anestesia (propofol e morfina), observadas em modelos animais","year":"2009","cit":0,"pfa":"Júlia Movilla Pires","ptype":"dissertation","src":"https://openalex.org/W2460986804","eid":"W2460986804"},{"id":"paper-w3083698863","cat":"papers","name":"Avaliação de risco no uso de ayahuasca em contexto religioso: os alcaloides harmânicos e seu efeito inibidor da monoaminoxidase","year":"2019","cit":0,"pfa":"Ícaro Durante","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3083698863","eid":"W3083698863"},{"id":"paper-w2968405750","cat":"papers","name":"Efectos inmediatos y a largo plazo inducidos por la administración intracerebral o sistémica de 3,4-metilenodioximentanfetamina (mdma)","year":"2000","cit":0,"pfa":"Blanca Esteban Barrios","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2968405750","eid":"W2968405750"},{"id":"paper-w1998070632","cat":"papers","name":"Impaired cognitive performance in drag-free recreational ecstasy (MDMA) users raises concern about neurotoxic brain damage","year":"1999","cit":0,"pfa":"Euphrosyne Gouzoulis‐Mayfrank","psa":"H. Sass","ptype":"article","src":"https://openalex.org/W1998070632","eid":"W1998070632"},{"id":"paper-w404838030","cat":"papers","name":"Comprehensive Analytical Procedures for the Unequivocal Determination of a Newly Encountered Drug “N-hydroxy-3,4-methylenedioxymethamphetamine (N-OH-MDMA)”","year":"2010","cit":0,"pfa":"Kei Zaitsu","psa":"Hitoshi Tsuchihashi","ptype":"article","src":"https://openalex.org/W404838030","eid":"W404838030"},{"id":"paper-w7198537671","cat":"papers","name":"Effects of extracted from kratom (Mitragyna speciosa (Korth.)Havil) reduced of withdrawal symptoms in MDMA-induced mice model","year":"2021","cit":0,"pfa":"กมลธร จินดาละออง","ptype":"dissertation","src":"https://openalex.org/W7198537671","eid":"W7198537671"},{"id":"paper-w7161536654","cat":"papers","name":"Amendment LXXVIII — Psychedelic and Cannabinoid Pharmacology as Phi Modulation: McCaul's Law Replicates Psilocybin and THC Therapeutic Effects Without Substances","year":"2026","cit":0,"pfa":"Justin McCaul","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7161536654","eid":"W7161536654"},{"id":"paper-w4245107766","cat":"papers","name":"Faculty Opinions recommendation of Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance.","year":"2006","cit":0,"pfa":"John E. Mendelson","ptype":"peer-review","src":"https://openalex.org/W4245107766","eid":"W4245107766"},{"id":"paper-w7153114652","cat":"papers","name":"Press Release - Clinical Trial into Psilocybin Therapy for Psychological Distress in Palliative Care, PsyPal, Receives Medical Ethical Authorisation, with Conditions","year":"2024","cit":0,"pfa":"University Medical Center Groningen","topics":["Anxiety & end-of-life","Safety & adverse events","Policy & ethics"],"ptype":"other","src":"https://openalex.org/W7153114652","eid":"W7153114652"},{"id":"paper-w4417115356","cat":"papers","name":"Extraction of N, N-dimethyltryptamine (DMT) from Mimosa tenuiflora, syn. Mimosa hostilis (Tepescohuite) using supercritical CO 2 and study of its surface activity","year":"2025","cit":0,"pfa":"Miguel Gonzalo Arenas-Quevedo","psa":"Jesús Gracia Fadrique","ptype":"article","src":"https://openalex.org/W4417115356","eid":"W4417115356"},{"id":"paper-w4392646730","cat":"papers","name":"Study Of Multi-Objective Linear Transportation Problem And Its Optimal Solution Using Maximum Divide And Minimum Allotment (MDMA) Method","year":"2023","cit":0,"pfa":"Anushaka Sharma","psa":"Rajpal Rajpal","ptype":"article","src":"https://openalex.org/W4392646730","eid":"W4392646730"},{"id":"paper-w7114939821","cat":"papers","name":"Investigating the effect of oxytocin and MDMA on social interaction and long-term memory in the rat test for social transmission of food preferences (STFP)","year":"2025","cit":0,"pfa":"Singh Kaur, Jaskirat","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W7114939821","eid":"W7114939821"},{"id":"paper-w7111580650","cat":"papers","name":"Evaluation of the quality of reporting of randomized clinical trials investigating psilocybin in depression between the years 2000 and 2024 using the CONSORT statement","year":"2024","cit":0,"pfa":"Μπαλαπανίδης-Παρίσης, Χρήστος-Νικηφόρος Δ.","psa":"Μπαλαπανίδης-Παρίσης, Χρήστος-Νικηφόρος Δ.","topics":["Depression"],"ptype":"dissertation","src":"https://openalex.org/W7111580650","eid":"W7111580650"},{"id":"paper-w2149762056","cat":"papers","name":"ISDN2014_0074: REMOVED: Effects of adenosine A2a receptor agonist and antagonist on hippocampal nuclear factor‐kB expression preceded by MDMA toxicity","year":"2015","cit":0,"pfa":"Mehdi Mehdizadeh","psa":"Hossein Haghir","topics":["Safety & adverse events","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2149762056","eid":"W2149762056"},{"id":"paper-w7155649331","cat":"papers","name":"619. Emerging Evidence for Ketamine and MDMA, Combined With Behavioral Interventions for Treatment-Resistant PTSD: Evidence From New Meta-Analyses","year":"2026","cit":0,"pfa":"Sanket B. Raut","psa":"Luke Johnson","topics":["Depression","PTSD & trauma","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7155649331","eid":"W7155649331"},{"id":"paper-w2331440821","cat":"papers","name":"ChemInform Abstract: PEYOTE UND VERWANDTE ALKALOIDE 15. MITT. O‐METHYL‐PEYOXYLSAEURE UND O‐METHYL‐PEYORUVINSAEURE, NEUE CYCLISCHE AMINOSAEURE‐ANALOGA VON MESCALIN","year":"1973","cit":0,"pfa":"G. J. KAPADIA","psa":"B.K. Chowdhury","ptype":"article","src":"https://openalex.org/W2331440821","eid":"W2331440821"},{"id":"paper-w4235525322","cat":"papers","name":"In the Magic Land of Peyote. By Fernando Benitez. Translated by John Upton. ([Texas Pan American Series] Austin: University of Texas Press, 1975. Pp. xxvii, 198. $9.75.)","year":"1976","cit":0,"pfa":"Joseph L. Zentner","ptype":"book-review","src":"https://openalex.org/W4235525322","eid":"W4235525322"},{"id":"paper-w7163093406","cat":"papers","name":"MDMA-Assisted Psychotherapy for Social Anxiety in Adults with Autistic Spectrum Disorder: A Randomized, Double-Blind, Placebo-Controlled Longitudinal Study","year":"2026","cit":0,"pfa":"Irina Dell'Orto","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7163093406","eid":"W7163093406"},{"id":"paper-w7154841588","cat":"papers","name":"Analysis Code and Results: Granger-Predictive Influence Pipeline Across Five Pharmacological fMRI Datasets (LSD, Psilocybin, DMT, Ketamine, Propofol)","year":"2026","cit":0,"pfa":"Ryan Malone","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dataset","src":"https://openalex.org/W7154841588","eid":"W7154841588"},{"id":"paper-w2994725115","cat":"papers","name":"Metabolomics in forensic toxicology : analytical considerations and evaluation of metabolic changes after controlled administration of 3,4-methylenediosy-methamphetamine (MDMA) to humans","year":"2018","cit":0,"pfa":"Martina I. Boxler","ptype":"dissertation","src":"https://openalex.org/W2994725115","eid":"W2994725115"},{"id":"paper-w7125463300","cat":"papers","name":"Terapia asistida con MDMA para el trastorno de estrés postraumático: una alternativa eficaz a los tratamientos convencionales","year":"2025","cit":0,"pfa":"Sheila Marzo Gascón","psa":"Marina Daiana Reguilón Romero","ptype":"dissertation","src":"https://openalex.org/W7125463300","eid":"W7125463300"},{"id":"paper-w7202074253","cat":"papers","name":"Intermittent Low-Dose MDMA for Neuroergonomic Optimization: A Systems Framework for Minimum Effective Functional Dosing, Harm Reduction, and Autonomous Integration","year":"2026","cit":0,"pfa":"Elias Rubenstein","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7202074253","eid":"W7202074253"},{"id":"paper-w7127054037","cat":"papers","name":"Experiences of Australian clinicians, researchers, and patients with MDMA-assisted psychotherapy for post-traumatic stress disorder: A framework-guided qualitative analysis","year":"2026","cit":0,"pfa":"Alene Sze Jing Yong","psa":"J. Simon Bell","topics":["PTSD & trauma","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7127054037","eid":"W7127054037"},{"id":"paper-w4402885487","cat":"papers","name":"Review for \"Direct photochemical intramolecular [4 + 2] cycloadditions of dehydrosecodine-type substrates for the synthesis of the iboga-type scaffold and divergent [2 + 2] cycloadditions employing micro-flow system\"","year":"2024","cit":0,"topics":["Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4402885487","eid":"W4402885487"},{"id":"paper-w4300758401","cat":"papers","name":"Study of the effect of 3, 4 methylenedioxymeth amphetamine (MDMA, Ecstasy) on the serumic levels of urea, creatinine, total protein and albumin in the dog","year":"2008","cit":0,"pfa":"Bahram Amouoghli-Tabrizi","psa":"Mehrdad Neshat","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4300758401","eid":"W4300758401"},{"id":"paper-w7124467716","cat":"papers","name":"Review of: Alex K. Gearin. Global Ayahuasca: Wondrous Visions and Modern Worlds. Stanford University Press 2024. P. 296. ISBN: 9781503636576","year":"2025","cit":0,"pfa":"Jenkins, Megan","topics":["Reviews & meta-analyses"],"ptype":"book-review","src":"https://openalex.org/W7124467716","eid":"W7124467716"},{"id":"paper-w7153173456","cat":"papers","name":"Corrigendum to Safety, tolerability and subjective effects of vaporized N, N-Dimethyltryptamine: A randomized double-blind clinical trial [European Neuropsychopharmacology 97 (2025) 16–27]","year":"2026","cit":0,"pfa":"Isabel Wießner","psa":"Fernanda Palhano-Fontes","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"erratum","src":"https://openalex.org/W7153173456","eid":"W7153173456"},{"id":"paper-w7164928395","cat":"papers","name":"Strong Alliance, Weak Conclusions: Comment on Goodwin et al. (2026) “The Role of Therapeutic Alliance in Psilocybin Treatment for Treatment-Resistant Depression”","year":"2026","cit":0,"pfa":"Max Wolff","psa":"Moritz Spangemacher","topics":["Depression","Therapy practice"],"ptype":"editorial","src":"https://openalex.org/W7164928395","eid":"W7164928395"},{"id":"paper-w7204237032","cat":"papers","name":"Pilot study comparing the effects of high dose THC to high dose psilocybin and placebo in the set and setting of a classic psychedelic therapy session","year":"2026","cit":0,"pfa":"Frederick Streeter Barrett","psa":"Ryan G. Vandrey","topics":["Safety & adverse events","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7204237032","eid":"W7204237032"},{"id":"paper-w4400982303","cat":"papers","name":"Correction to “Ayahuasca in the treatment of posttraumatic stress disorder: Mixed-methods case series evaluation in military combat veterans” by Weiss et al. (2023).","year":"2024","cit":0,"topics":["PTSD & trauma","Safety & adverse events"],"ptype":"erratum","src":"https://openalex.org/W4400982303","eid":"W4400982303"},{"id":"paper-w2485251098","cat":"papers","name":"250例苯丙胺类摇头丸（MDMA）滥用人群分析","year":"2004","cit":0,"pfa":"孙毅","psa":"张惠民","ptype":"article","src":"https://openalex.org/W2485251098","eid":"W2485251098"},{"id":"paper-w2242373640","cat":"papers","name":"The Relationships Among Life Stress, Attitude Toward MDMA (Ecstasy) Intake, and Leisure Participation of Students at Institutes of Technology in Taipei, Taiwan","year":"2008","cit":0,"pfa":"Wen-chieh Lei","ptype":"article","src":"https://openalex.org/W2242373640","eid":"W2242373640"},{"id":"paper-w2467762504","cat":"papers","name":"Behavioral sensitization following concurrent exposure to 4-methylmethcathinone (4-MMC) and 3,4-methylenedioxymethamphetamine (MDMA) in male Sprague-Dawley rats","year":"2016","cit":0,"pfa":"Trent A. Bullock","ptype":"article","src":"https://openalex.org/W2467762504","eid":"W2467762504"},{"id":"paper-w7143884623","cat":"papers","name":"Psychedelic exposure in pregnancy: a scoping review to inform perinatal drug safety and clinical counseling","year":"2026","cit":0,"pfa":"Ovie Martin Albert","psa":"Alexander Arthur","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7143884623","eid":"W7143884623"},{"id":"paper-w7168292428","cat":"papers","name":"Shurooms: The First Ethnomycological Study from Within the African Initiatory Tradition — Ewe, Soma, and the Ceremonial Architecture of Psilocybin Healing (N = 300+)","year":"2026","cit":0,"pfa":"Shumake, Robert S. (Ajarn Shaman Shu | Oluwo Jolaoso Osainbola, PhD | Shri…","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7168292428","eid":"W7168292428"},{"id":"paper-w7120800251","cat":"papers","name":"Estudo estereológico dos efeitos da ayahuasca na neuroanatomia do estriado de sagüis (Callithrix jacchus) em um modelo de depressão","year":"2024","cit":0,"pfa":"Wigínio Gabriel de Lira Bandeira","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7120800251","eid":"W7120800251"},{"id":"paper-w4205922985","cat":"papers","name":"Faculty Opinions recommendation of MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study.","year":"2021","cit":0,"pfa":"Bryan L. Roth","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"peer-review","src":"https://openalex.org/W4205922985","eid":"W4205922985"},{"id":"paper-w7207473640","cat":"papers","name":"The serotonin lesion induced by MDMA (Ecstasy) in non-human primate produces an acute anxiety disorder and a disturbance of fluoxetine therapeutic effects.","year":"2023","cit":0,"pfa":"Léon Tremblay","topics":["Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"conference-paper","src":"https://openalex.org/W7207473640","eid":"W7207473640"},{"id":"paper-w2017547872","cat":"papers","name":"P.1.h.027 MBDB, a recreational drug similar to MDMA, alters sequential structure of agonistic behaviour in male mice","year":"2013","cit":0,"pfa":"A.T. Muela","psa":"José Francisco Navarro","ptype":"article","src":"https://openalex.org/W2017547872","eid":"W2017547872"},{"id":"paper-w4226314472","cat":"papers","name":"Microevidence for microdosing with psilocybin mushrooms: a double-blind placebo-controlled study of subjective effects, behavior, creativity, perception, cognition, and brain activity","year":"2021","cit":0,"pfa":"Enzo Tagliazucchi","topics":["Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4226314472","eid":"W4226314472"},{"id":"paper-w2078488886","cat":"papers","name":"232 3,4, METHYLENEDIOXYAMPHETAMINE (MDA) AND 3,4, METHILENEDIOXYMETHAMFETAMINE (MDMA) DETERMINATION AFTER RAPID DERIVATIZATION WITH TRIFLUOROACETIC ACID BY HPLC AND GC/MS","year":"1997","cit":0,"pfa":"T Trenti","psa":"E. Stenieri","ptype":"article","src":"https://openalex.org/W2078488886","eid":"W2078488886"},{"id":"paper-w2066338958","cat":"papers","name":"WITHDRAWN: Prenatal exposure to MDMA induces sex-dependent and region-specific modifications in brain dopamine systems at adult age in the rat","year":"2008","cit":0,"pfa":"Emilie Heuland","psa":"Sylvie Chalon","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2066338958","eid":"W2066338958"},{"id":"paper-w7170173765","cat":"papers","name":"Bioactivation and Metabolism of Amino Acid MDMA Prodrugs in Zebrafish Embryos, Human Liver S9, Whole Blood, and Microdosed Human Urine","year":"2026","cit":0,"pfa":"Simon K. Wellenberg","psa":"Markus R. Meyer","topics":["Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W7170173765","eid":"W7170173765"},{"id":"paper-w2593742028","cat":"papers","name":"LABATE, Beatriz Caiuby; ARAÚJO, Wladimyr Sena (Org.). O uso ritual da ayahuasca. Campinas: Mercado das Letras, 2002. 686 p.","year":"2003","cit":0,"pfa":"Marcelo Simão Mercante","ptype":"article","src":"https://openalex.org/W2593742028","eid":"W2593742028"},{"id":"paper-w7213392699","cat":"papers","name":"Exploratory safety, tolerability, and feasibility of psilocybin-assisted psychotherapy for adults with co-occurring treatment-resistant depression and cluster B personality disorders","year":"2026","cit":0,"pfa":"Orly Lipsitz","psa":"Joshua Daniel Rosenblat","topics":["Depression","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7213392699","eid":"W7213392699"},{"id":"paper-w3022015276","cat":"papers","name":"ERP Correlates of Behavioural Inhibition during a Flanker Go/Nogo Task in Chronic Cannabis and MDMA-Cannabis Poly-drug Users","year":"2018","cit":0,"pfa":"Allison Jane Matthews","psa":"Caleb stone","ptype":"other","src":"https://openalex.org/W3022015276","eid":"W3022015276"},{"id":"paper-w4313138992","cat":"papers","name":"Saved from Ecstasy: A Multi-partite Intervention for First Time and Repeat Users of 3,4-methylenedioxymethamphetamine (MDMA) Within The LGBTQ+ Community","year":"2022","cit":0,"pfa":"Candice Carpenter","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4313138992","eid":"W4313138992"},{"id":"paper-w7214865469","cat":"papers","name":"Efectos del tratamiento crónico con MDMA, fluoxetina y amitriptilina sobre un modelo animal de depresión inducida","year":"2007","cit":0,"pfa":"Laura Andrea León Anhuamán","ptype":"dissertation","src":"https://openalex.org/W7214865469","eid":"W7214865469"},{"id":"paper-w2620943025","cat":"papers","name":"A natureza nos caminhos da ayahuasca: territorialidade, arranjos institucionais e aspectos fitogeográficos de conservação florestal na Amazônia (Rondônia/Brasil)","year":"2017","cit":0,"pfa":"Julien Marius Reis Thévenin","ptype":"dissertation","src":"https://openalex.org/W2620943025","eid":"W2620943025"},{"id":"paper-w7168306079","cat":"papers","name":"Shurooms: The First Ethnomycological Study from Within the African Initiatory Tradition — Ewe, Soma, and the Ceremonial Architecture of Psilocybin Healing (N = 300+)","year":"2026","cit":0,"pfa":"Shumake, Robert S. (Ajarn Shaman Shu | Oluwo Jolaoso Osainbola, PhD | Shri…","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7168306079","eid":"W7168306079"},{"id":"paper-w4402355654","cat":"papers","name":"Change in occupational burnout measures in emergency medical service workers after a psychedelic experience induced by a single self-administered dose of psilocybin mushrooms","year":"2024","cit":0,"pfa":"Ana Sofia Machado Ferreira","psa":"David P. Luke","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4402355654","eid":"W4402355654"},{"id":"paper-w7213404944","cat":"papers","name":"Data from Changes in self-related cognitive processes and depressive symptom severity following a single, moderate dose of psilocybin in depressed patients","year":"2026","cit":0,"pfa":"L. Belinger","psa":"Katrin H. Preller","topics":["Depression","Dosing & pharmacology"],"ptype":"dataset","src":"https://openalex.org/W7213404944","eid":"W7213404944"},{"id":"paper-w4402589360","cat":"papers","name":"ENTRE O SAGRADO E O URBANO: IMPACTO DO USO DA AYAHUASCA NA SUBJETIVIDADE DE PSICONAUTAS EM CONTEXTO URBANO","year":"2024","cit":0,"pfa":"Geovanna Matias Alves do Nascimento","psa":"Rodrigo Ramon Falconi Gomez","ptype":"article","src":"https://openalex.org/W4402589360","eid":"W4402589360"},{"id":"paper-w2900585118","cat":"papers","name":"Ligand-based drug design : I. conformational studies of GBR 12909 analogs as cocaine antagonists; II. 3d-QSAR studies of salvinorin a analogs as kappa opioid agonists","year":"2007","cit":0,"pfa":"Deepangi Pandit","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2900585118","eid":"W2900585118"},{"id":"paper-w2095032066","cat":"papers","name":"The acute effects of N-methyl-1(1,3-benzodioxol-5-YL)-2-propanamime (MDMA) on rat brain catecholamine levels","year":"1990","cit":0,"pfa":"J. M. Beaton","psa":"John A. Monti","ptype":"article","src":"https://openalex.org/W2095032066","eid":"W2095032066"},{"id":"paper-w2009438660","cat":"papers","name":"P.6.d.003 Ethological evaluation of the effects of MDEA, a recreational drug similar to MDMA, on anxiety in the elevated maze in mice","year":"2012","cit":0,"pfa":"A.T. Muela","psa":"José Francisco Navarro","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2009438660","eid":"W2009438660"},{"id":"paper-w7171862645","cat":"papers","name":"Mindfulness-Based Psilocybin-Assisted Therapy (MB-PAT) for cancer-related demoralization in Canada: The case for a hybrid group-based delivery model","year":"2026","cit":0,"pfa":"Christopher P. Albertyn","psa":"Linda Ellen Carlson","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7171862645","eid":"W7171862645"},{"id":"paper-w2071926494","cat":"papers","name":"The Oxidation of Mescaline and Certain other Amines. (Journ. Biol. Chem., vol. cxxiii, pp. 317-26, 1938.) Bernheim, F., and Bernheim, M. L. C.","year":"1938","cit":0,"pfa":"A. P. Lothrop","ptype":"article","src":"https://openalex.org/W2071926494","eid":"W2071926494"},{"id":"paper-w4394425027","cat":"papers","name":"Additional file 1: TrnL-trnF intergenic spacer. of De novo sequencing and analysis of Lophophora williamsii transcriptome, and searching for putative genes involved in mescaline biosynthesis","year":"2015","cit":0,"pfa":"Enrique Ibarra‐Laclette","psa":"Luís Herrera‐Estrella","ptype":"dataset","src":"https://openalex.org/W4394425027","eid":"W4394425027"},{"id":"paper-w7135267314","cat":"papers","name":"Caracterización y articulación del contenido en Facebook sobre las ceremonias de ayahuasca en Costa Rica (I semestre de 2017)","year":"2019","cit":0,"pfa":"Michael Méndez Arias","ptype":"dissertation","src":"https://openalex.org/W7135267314","eid":"W7135267314"},{"id":"paper-w7161256027","cat":"papers","name":"Strong alliance, weak conclusions: Comment on Goodwin et al. (2026) “The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression”","year":"2026","cit":0,"pfa":"Max Wolff","psa":"Moritz Spangemacher","topics":["Depression","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7161256027","eid":"W7161256027"},{"id":"paper-w7168279048","cat":"papers","name":"Shurooms: The First Ethnomycological Study from Within the African Initiatory Tradition — Ewe, Soma, and the Ceremonial Architecture of Psilocybin Healing (N = 300+)","year":"2026","cit":0,"pfa":"Shumake, Robert S. (Ajarn Shaman Shu | Oluwo Jolaoso Osainbola, PhD | Shri…","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7168279048","eid":"W7168279048"},{"id":"paper-w7168248929","cat":"papers","name":"Shurooms: The First Ethnomycological Study from Within the African Initiatory Tradition — Ewe, Soma, and the Ceremonial Architecture of Psilocybin Healing (N = 300+)","year":"2026","cit":0,"pfa":"Shumake, Robert S. (Ajarn Shaman Shu | Oluwo Jolaoso Osainbola, PhD | Shri…","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7168248929","eid":"W7168248929"},{"id":"paper-w2016965273","cat":"papers","name":"P.1.04 Serotonin transporter dependent effects of 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) on the serotoninergic system and hippocampal cell proliferation in mice","year":"2007","cit":0,"pfa":"Thibault Renoir","psa":"Laurence Lanfumey","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2016965273","eid":"W2016965273"},{"id":"paper-w2250544526","cat":"papers","name":"Does serotonin affect information processing speed? Examination through the use of an ecstasy (MDMA) using sample, controlling for cannabis use","year":"2009","cit":0,"pfa":"Antoine de Poorter","psa":"Raimondo Bruno","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2250544526","eid":"W2250544526"},{"id":"paper-w2061734881","cat":"papers","name":"P6.d.005 Ultrastructural alteration of cortical serotonergic fibers after MDMA (ecstasy) treatment using a new TpH2 antibody","year":"2009","cit":0,"pfa":"Csaba Ádori","psa":"G. Bagdyf","ptype":"article","src":"https://openalex.org/W2061734881","eid":"W2061734881"},{"id":"paper-w7136618798","cat":"papers","name":"Psilocybin-Assisted Therapy for Major Depressive Disorder versus Treatment-Resistant Depression: A Systematic Review Comparing Clinical Outcomes and Trial Methodology","year":"2026","cit":0,"pfa":"Tom Bielen","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7136618798","eid":"W7136618798"},{"id":"paper-w7163187674","cat":"papers","name":"Decision letter for \"Psilocybin decreases reward-seeking behavior accompanied by increased activity of parvalbumin neurons with perineuronal nets in the medial prefrontal cortex\"","year":"2026","cit":0,"topics":["Mechanism & neuroscience"],"ptype":"peer-review","src":"https://openalex.org/W7163187674","eid":"W7163187674"},{"id":"paper-w2053601532","cat":"papers","name":"Optical multidimensional multiple access(O-MDMA): a new concept for free-space laser communication based on photonic mixer devices","year":"2004","cit":0,"pfa":"Holger Heß","psa":"Rudolf Schwarte","ptype":"conference-paper","src":"https://openalex.org/W2053601532","eid":"W2053601532"},{"id":"paper-w2763716551","cat":"papers","name":"Estudo da alteracao na neurotransmissao aminoacidergica e monoaminergica no hipocampo, cortex e amigdala de ratos apos inGestão de ayahuasca","year":"2009","cit":0,"pfa":"Rafael Henrique da Cunha","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2763716551","eid":"W2763716551"},{"id":"paper-w2035892403","cat":"papers","name":"P.6.d.018 Ethological evaluation of the effects of MBDB, the alpha-ethyl homologue of MDMA, on anxiety in the elevated maze in mice","year":"2011","cit":0,"pfa":"A.T. Muela","psa":"José Francisco Navarro","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2035892403","eid":"W2035892403"},{"id":"paper-w4401921074","cat":"papers","name":"A Cohort Based Case Series: Learnings from an Iterative Group Therapy Model to Support Psilocybin-Assisted Therapy for Patients with a Terminal Diagnosis","year":"2024","cit":0,"pfa":"V. Tsang","topics":["Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4401921074","eid":"W4401921074"},{"id":"paper-w7117120976","cat":"papers","name":"Effects of Psilocybin on Religious and Spiritual Attitudes and Behaviors in Clergy from Various Major World Religions: The Great Promise of Psychedelics: Evolving Human Consciousness","year":"2025","cit":0,"pfa":"Tara Brach","ptype":"editorial","src":"https://openalex.org/W7117120976","eid":"W7117120976"},{"id":"paper-w167865521","cat":"papers","name":"Psiconáutica de la ayahuasca y sus análogos: ¿Una panacea para Pangea, un entretenimiento outré, o una simple droga?","year":"2010","cit":0,"pfa":"Jonathan Ott","ptype":"article","src":"https://openalex.org/W167865521","eid":"W167865521"},{"id":"paper-w4400575520","cat":"papers","name":"High Blood Pressure Among Psilocybin and Cannabis Consumers During the COVID-19 Pandemic: An Analysis of the COVID-19 Cannabis Health Study","year":"2024","cit":0,"pfa":"Denise Christina Vidot","psa":"Sarah Elizabeth Messiah","ptype":"article","src":"https://openalex.org/W4400575520","eid":"W4400575520"},{"id":"paper-w1942384798","cat":"papers","name":"Benefícios a Saúde Humana ocasionado pela ingestão da Ayahuasca: Contexto Social e sua ação Neuropsicológica, Fisioimunológica, Microbiológica e Parasitária","year":"2014","cit":0,"pfa":"Dionatas Ulises de Oliveira Meneguetti","psa":"Naila Fernanda Sbsczk Pereira Meneguetti","ptype":"article","src":"https://openalex.org/W1942384798","eid":"W1942384798"},{"id":"paper-w7138852397","cat":"papers","name":"Corrigendum “Withania somnifera influences MDMA-induced hyperthermic, cognitive, neurotoxic and neuroinflammatory effects in mice.” [Biomed. Pharmacother. 161 (2023) 114475]","year":"2026","cit":0,"pfa":"Giulia Costa","psa":"Micaela Morelli","topics":["Safety & adverse events"],"ptype":"erratum","src":"https://openalex.org/W7138852397","eid":"W7138852397"},{"id":"paper-w4407076188","cat":"papers","name":"Latent Class Analysis of Changes in Substance Use and Depressive Symptoms following Naturalistic Psilocybin Use: Results from a Prospective Longitudinal Survey","year":"2025","cit":0,"pfa":"Jérémie Richard","psa":"Albert Garcia‐Romeu","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W4407076188","eid":"W4407076188"},{"id":"paper-w2753791924","cat":"papers","name":"Cambios inducidos por MDMA sobre la actividad de las metaloproteinasas e integridad de la barrera hematoencefálica","year":"2016","cit":0,"pfa":"Mercedes Pérez Hernández","topics":["Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W2753791924","eid":"W2753791924"},{"id":"paper-w7161600093","cat":"papers","name":"Decision letter for \"N,N-Dimethyltryptamine (DMT) acutely exposed to mouse ventral tegmental area Ih-negative neurons alters the firing rate and conductance in a sex-dependent manner\"","year":"2026","cit":0,"ptype":"peer-review","src":"https://openalex.org/W7161600093","eid":"W7161600093"},{"id":"paper-w2935366230","cat":"papers","name":"Avaliação dos efeitos da ayahuasca nos parâmetros comportamentais de ratos submetidos ao modelo de neuroinflamação induzida por LPS","year":"2018","cit":0,"pfa":"Marina Goulart da Silva","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2935366230","eid":"W2935366230"},{"id":"paper-w7111532548","cat":"papers","name":"Amitriptyline accelerates SERT binding recovery in a rat 3,4-methylenedioxymethamphetamine (MDMA) model: in vivo 4-[18F]-ADAM PET imaging","year":"2022","cit":0,"pfa":"蔡季蓉","psa":"Chi-Jung Tsai, Chuang-Hsin Chiu, Yu-Yeh Kuo, Wen-Sheng Huang, Tsung-Hsun Yu,…","ptype":"article","src":"https://openalex.org/W7111532548","eid":"W7111532548"},{"id":"paper-w7163222270","cat":"papers","name":"MDMA-Assisted Psychotherapy for Social Anxiety in Adults with Autistic Spectrum Disorder: A Randomized, Double-Blind, Placebo-Controlled Longitudinal Study","year":"2026","cit":0,"pfa":"Irina Dell'Orto","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W7163222270","eid":"W7163222270"},{"id":"paper-w4394234982","cat":"papers","name":"Additional file 7: Alignment of αKG-dependent dioxigenase proteins. of De novo sequencing and analysis of Lophophora williamsii transcriptome, and searching for putative genes involved in mescaline biosynthesis","year":"2015","cit":0,"pfa":"Enrique Ibarra‐Laclette","psa":"Luís Herrera‐Estrella","ptype":"dataset","src":"https://openalex.org/W4394234982","eid":"W4394234982"},{"id":"paper-w4312627999","cat":"papers","name":"Liquid Chromatography–Tandem Mass Spectrometry Method for the Bioanalysis of N,N-Dimethyltryptamine (Dmt) and its Metabolites Dmt-N-Oxide and Indole-3-Acetic Acid in Human Plasma","year":"2022","cit":0,"pfa":"Dino Luethi","psa":"Urs Duthaler","ptype":"preprint","src":"https://openalex.org/W4312627999","eid":"W4312627999"},{"id":"paper-w7154847775","cat":"papers","name":"Analysis Code and Results: Granger-Predictive Influence Pipeline Across Five Pharmacological fMRI Datasets (LSD, Psilocybin, DMT, Ketamine, Propofol)","year":"2026","cit":0,"pfa":"Ryan Malone","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dataset","src":"https://openalex.org/W7154847775","eid":"W7154847775"},{"id":"paper-w4251739339","cat":"papers","name":"Faculty Opinions recommendation of Behavioral and neurochemical consequences of long-term intravenous self-administration of MDMA and its enantiomers by rhesus monkeys.","year":"2004","cit":0,"pfa":"Trevor William Robbins","ptype":"peer-review","src":"https://openalex.org/W4251739339","eid":"W4251739339"},{"id":"paper-w2061180870","cat":"papers","name":"P.1.d.007 Behavioural profile of MDEA, a recreational drug similar to MDMA, in agonistic encounters between male mice","year":"2011","cit":0,"pfa":"A.T. Muela","psa":"José Francisco Navarro","ptype":"article","src":"https://openalex.org/W2061180870","eid":"W2061180870"},{"id":"paper-w7129005970","cat":"papers","name":"Hallucinogenic Therapy in Alzheimer’s Disease targeting Mitochondria-Associated Membranes","year":"2026","cit":0,"pfa":"Fernando Minauro‐Sanmiguel","psa":"Héctor Vargas-Pérez","ptype":"article","src":"https://openalex.org/W7129005970","eid":"W7129005970"},{"id":"paper-w3112428243","cat":"papers","name":"Efeitos da administração repetida de ayahuasca no comportamento e na expressão de c-Fos em ratos expostos ao campo aberto","year":"2020","cit":0,"pfa":"Dimitri Henriques Daldegan-Bueno","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W3112428243","eid":"W3112428243"},{"id":"paper-w7117971009","cat":"papers","name":"Preliminary results from an ongoing naturalistic survey study investigating dose-finding practices and effects of self-administered small amounts of psilocybin","year":"2026","cit":0,"pfa":"Iva Totomanova","psa":"K.P.C. Kuypers","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7117971009","eid":"W7117971009"},{"id":"paper-w3159968412","cat":"papers","name":"SACRALIZAÇÃO DA NATUREZA E O USO RELIGIOSO DA AYAHUASCA: PERCEPÇÃO E ÉTICA AMBIENTAL DA FLORESTA AMAZÔNICA AOS CENTROS URBANOS","year":"2020","cit":0,"pfa":"Julien Marius Reis Thévenin","psa":"Carlos Teodoro José Hugueney Irigaray","ptype":"article","src":"https://openalex.org/W3159968412","eid":"W3159968412"},{"id":"paper-w7198945068","cat":"papers","name":"Wild Trips, Fake Shamans – and Responsible Tourism? : Ayahuasca journeys in different realities? How is responsibility of tourism displayed in the narratives of ayahuascatourists travelling to Colombian Amazonia?","year":"2024","cit":0,"pfa":"Kaisa Penttinen","ptype":"article","src":"https://openalex.org/W7198945068","eid":"W7198945068"},{"id":"paper-w7160855351","cat":"papers","name":"PDE4B Inhibition and Psilocybin as Promising Approaches for Treating Methamphetamine Use Disorder: Preclinical Evidence From Rat Models (Abstract ID: 232554)","year":"2026","cit":0,"pfa":"Sean A. Hayduk","psa":"Sara Jane Ward","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7160855351","eid":"W7160855351"},{"id":"paper-w7161606707","cat":"papers","name":"N,N‐Dimethyltryptamine ( DMT ) Acutely Exposed to Mouse Ventral Tegmental Area I h ‐Negative Neurons Alters the Firing Rate and Conductance in a Sex‐Dependent Manner","year":"2026","cit":0,"pfa":"Jannik Nicklas Eliasen","psa":"Kristi A. Kohlmeier","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7161606707","eid":"W7161606707"},{"id":"paper-w4399537175","cat":"papers","name":"WED-123 Female mice with cirrhosis are more prone to acute and chronic effects of psilocybin exposure without tolerance compared to male mice","year":"2024","cit":0,"pfa":"Jessica L. Maltman","psa":"Jasmohan Singh Bajaj","ptype":"conference-abstract","src":"https://openalex.org/W4399537175","eid":"W4399537175"},{"id":"paper-w7143351248","cat":"papers","name":"Strong alliance, weak conclusions: Comment on Goodwin et al. (2026) “The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression”","year":"2026","cit":0,"pfa":"Max Wolff","psa":"Moritz Spangemacher","topics":["Depression","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7143351248","eid":"W7143351248"},{"id":"paper-w3119681165","cat":"papers","name":"اثربخشی آموزش مبتنی بر تئوری برنامه ریزی شده در پیشگیری از سوء مصرف MDMA ( اکستازی ) در دانشجویان","year":"2011","cit":0,"pfa":"hamid allahverdipuor","ptype":"article","src":"https://openalex.org/W3119681165","eid":"W3119681165"},{"id":"paper-w7128530756","cat":"papers","name":"Antibiotic-induced Microbiome Depletion Selectively Reduces Baseline Hypothalamic Oxytocin Signaling without Affecting MDMA-induced Oxytocin Response in Rats","year":"2026","cit":0,"pfa":"Yong Yue","psa":"Kenji Hashimoto","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7128530756","eid":"W7128530756"},{"id":"paper-w7161309214","cat":"papers","name":"Uso terapêutico de mdma na psicoterapia assistida para o tratamento de transtorno de estresse pós-traumático (tept)","year":"2022","cit":0,"pfa":"Amanda Medeiros Furquim","psa":"Tania Marcourakis","topics":["Depression","PTSD & trauma","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W7161309214","eid":"W7161309214"},{"id":"paper-w7213409146","cat":"papers","name":"Data from Changes in self-related cognitive processes and depressive symptom severity following a single, moderate dose of psilocybin in depressed patients","year":"2026","cit":0,"pfa":"L. Belinger","psa":"Katrin H. Preller","topics":["Depression","Dosing & pharmacology"],"ptype":"dataset","src":"https://openalex.org/W7213409146","eid":"W7213409146"},{"id":"paper-w402181117","cat":"papers","name":"Etude comportementale et transcriptionnelle de la 3,4- méthylenedioxyméthamphétamine (MDMA) chez la souris : rôle de la protéine ERK","year":"2004","cit":0,"pfa":"Julie Salzmann","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W402181117","eid":"W402181117"},{"id":"paper-w2909725279","cat":"papers","name":"Huraches hacia Viracocha. retorno a lo sagrado: El ritual Huichol del Peyote en el desierto de San Luís de Potosí, México. una experiencia","year":"2002","cit":0,"pfa":"Martín Correa Urquiza","ptype":"article","src":"https://openalex.org/W2909725279","eid":"W2909725279"},{"id":"paper-w4402885558","cat":"papers","name":"Author response for \"Direct photochemical intramolecular [4 + 2] cycloadditions of dehydrosecodine-type substrates for the synthesis of the iboga-type scaffold and divergent [2 + 2] cycloadditions employing micro-flow sy","year":"2024","cit":0,"pfa":"Gavin Tay","psa":"Hiroki Oguri","ptype":"peer-review","src":"https://openalex.org/W4402885558","eid":"W4402885558"},{"id":"paper-w2323785551","cat":"papers","name":"Memory deficits and altered hippocampal function in ecstasy (MDMA) users: evidence from neuropsychological, functional imaging (fMRI) and MR-spectroscopy studies","year":"2004","cit":0,"pfa":"Euphrosyne Gouzoulis‐Mayfrank","psa":"Jörg Daumann","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2323785551","eid":"W2323785551"},{"id":"paper-w4255384278","cat":"papers","name":"Entheogens","year":"2020","cit":0,"pfa":"Katie Givens Kime","ptype":"reference-entry","src":"https://openalex.org/W4255384278","eid":"W4255384278"},{"id":"paper-w4392461352","cat":"papers","name":"(236) Does MDMA Have Treatment Potential in Sexual Dysfunction? A Systematic Review of Outcomes Across the Female and Male Sexual Response Cycles","year":"2024","cit":0,"pfa":"A Wexler","psa":"KARYN SCHLUNT EILBER","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4392461352","eid":"W4392461352"},{"id":"paper-w4394527500","cat":"papers","name":"Additional file 6: Alignment of PPO1-KFDV protein domain. of De novo sequencing and analysis of Lophophora williamsii transcriptome, and searching for putative genes involved in mescaline biosynthesis","year":"2015","cit":0,"pfa":"Enrique Ibarra‐Laclette","psa":"Luís Herrera‐Estrella","ptype":"dataset","src":"https://openalex.org/W4394527500","eid":"W4394527500"},{"id":"paper-w7161014612","cat":"papers","name":"Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trial – CORRIGENDUM","year":"2026","cit":0,"pfa":"Zeina Beidas","psa":"Rotem Petranker","topics":["Depression","Dosing & pharmacology"],"ptype":"erratum","src":"https://openalex.org/W7161014612","eid":"W7161014612"},{"id":"paper-w4406091874","cat":"papers","name":"Uso do MDMA (Ecstasy) em Sessões de Psicoterapia para o Tratamento do TEPT Crônico: um estudo bibliométrico","year":"2025","cit":0,"pfa":"Rachel Lais Brandão Viana","psa":"Maria Hosana Conceição","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4406091874","eid":"W4406091874"},{"id":"paper-w7161599871","cat":"papers","name":"Review for \"N,N-Dimethyltryptamine (DMT) acutely exposed to mouse ventral tegmental area Ih-negative neurons alters the firing rate and conductance in a sex-dependent manner\"","year":"2025","cit":0,"topics":["Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W7161599871","eid":"W7161599871"},{"id":"paper-w3011365279","cat":"papers","name":"Explorando manifestaciones de auto-compasión en usuarios regulares de Ayahuasca, miembros de la Iglesia del Santo Daime de Chile","year":"2015","cit":0,"pfa":"M Felipe Cardemil","psa":"Lorena Cristina","ptype":"dissertation","src":"https://openalex.org/W3011365279","eid":"W3011365279"},{"id":"paper-w7120835013","cat":"papers","name":"Investigação teórica da síntese de mdma a partir do safrol e estudo da atividade de anfetaminas via qsar","year":"2018","cit":0,"pfa":"Miony Carolina Cardoso COSTA","ptype":"dissertation","src":"https://openalex.org/W7120835013","eid":"W7120835013"},{"id":"paper-w7213430104","cat":"papers","name":"Supplementary material from \"Changes in self-related cognitive processes and depressive symptom severity following a single, moderate dose of psilocybin in depressed patients\"","year":"2026","cit":0,"pfa":"L. Belinger","psa":"Katrin H. Preller","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"supplementary-materials","src":"https://openalex.org/W7213430104","eid":"W7213430104"},{"id":"paper-w2607318859","cat":"papers","name":"ChemInform Abstract: TOTALSYNTH. VON INDOL‐ UND DIHYDROINDOL‐ALKALOIDEN 4. MITT. TOTALSYNTH. VON IBOGA‐ UND VINCA‐ALKALOIDEN 5. MITT. TOTALSYNTH. VON ASPIDOSPERMA‐ALKALOIDEN","year":"1970","cit":0,"pfa":"James Peter Kutney","psa":"Isidoros Vlattas","ptype":"article","src":"https://openalex.org/W2607318859","eid":"W2607318859"},{"id":"paper-w7169574930","cat":"papers","name":"Efeitos de dose única de ayahuasca em sintomas depressivos e ansiosos associados ao diagnóstico de câncer: um estudo simples-cego","year":"2026","cit":0,"pfa":"Renan Massanobu Maekawa","topics":["Depression","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7169574930","eid":"W7169574930"},{"id":"paper-w2802724655","cat":"papers","name":"Um olhar complexo sobre o uso ritualístico da Ayahuasca entre indivíduos com histórico de uso problemático de psicoativos","year":"2017","cit":0,"pfa":"Rebeca Trindade Rocha Mohr","ptype":"dissertation","src":"https://openalex.org/W2802724655","eid":"W2802724655"},{"id":"paper-w7141214793","cat":"papers","name":"Dose-dependent pharmacokinetics and acute effects of intravenous bolus N,N-dimethyltryptamine: double-blind, randomized versus open-label dose-escalation administration study in healthy participants","year":"2026","cit":0,"pfa":"Livio Erne","psa":"Severin B. Vogt","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7141214793","eid":"W7141214793"},{"id":"paper-w4394183676","cat":"papers","name":"Additional file 5: Alignment of Pyridoxal DeC protein domain. of De novo sequencing and analysis of Lophophora williamsii transcriptome, and searching for putative genes involved in mescaline biosynthesis","year":"2015","cit":0,"pfa":"Enrique Ibarra‐Laclette","psa":"Luís Herrera‐Estrella","ptype":"dataset","src":"https://openalex.org/W4394183676","eid":"W4394183676"},{"id":"paper-w2890856367","cat":"papers","name":"Omer C. Stewart. Peyote Religion: A History. (The Civilization of the American Indian Series, number 181.) Norman: University of Oklahoma Press. 1987. Pp. xvii, 454. $29.95","year":"1989","cit":0,"pfa":"Henry Warner Bowden","ptype":"book-review","src":"https://openalex.org/W2890856367","eid":"W2890856367"},{"id":"paper-w4410627499","cat":"papers","name":"A influência do contexto de uso sobre a experiência psicodélica e o potencial terapêutico da ayahuasca, uma revisão integrativa de literatura","year":"2025","cit":0,"pfa":"Alexandre Franca Barreto","psa":"Yanderson Marcos da Silva Ramos","ptype":"article","src":"https://openalex.org/W4410627499","eid":"W4410627499"},{"id":"paper-w4401475482","cat":"papers","name":"A cidade aberta ao Céu Xamânico: percurso de pesquisas e práticas ritualísticas no Instituto Xamânico Céu da Ayahuasca em Marabá, Pará","year":"2024","cit":0,"pfa":"Roberta Cruz Correia","psa":"Jerônimo da Silva e Silva","ptype":"article","src":"https://openalex.org/W4401475482","eid":"W4401475482"},{"id":"paper-w1839432818","cat":"papers","name":"Aspectos neuroimunológicos do ecstasy (N-metil-3,4-Metilenodioximetanfetamina-MDMA), na inflamação alérgica pulmonar em camundongos Balb/C.","year":"2010","cit":0,"pfa":"Daniel Stankevicius","ptype":"dissertation","src":"https://openalex.org/W1839432818","eid":"W1839432818"},{"id":"paper-w4285260947","cat":"papers","name":"Methylone Pre-Exposure Differentially Impacts the Aversive Effects of MDPV and MDMA in Male and Female Sprague-Dawley Rats: Implications for Abuse Vulnerability","year":"2022","cit":0,"pfa":"Hayley N. Manke","psa":"Anthony Lee Riley","ptype":"preprint","src":"https://openalex.org/W4285260947","eid":"W4285260947"},{"id":"paper-w874358152","cat":"papers","name":"MDMA（摇头丸）对小鼠LD50的测定及其毒性作用","year":"2005","cit":0,"pfa":"周丽萍","psa":"贺东生","ptype":"article","src":"https://openalex.org/W874358152","eid":"W874358152"},{"id":"paper-w3192556801","cat":"papers","name":"O USO DA AYAHUASCA/HOASCA EM CULTOS RELIGIOSOS E A SUA PROIBIÇÃO NA ESPANHA: RESTRIÇÕES ESTATAIS AO EXERCÍCIO DA LIBERDADE RELIGIOSA.","year":"2021","cit":0,"pfa":"Daniel França Jin Machado de Carvalho","ptype":"article","src":"https://openalex.org/W3192556801","eid":"W3192556801"},{"id":"paper-w7139416359","cat":"papers","name":"Worsening suicidal ideation and prolonged adverse event following psilocybin administration in a clinical setting: Case report and thematic analysis of one participant's experience","cit":0,"pfa":"Wahba M","psa":"McAllister-Williams RH","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7139416359","eid":"W7139416359"},{"id":"paper-w7213424377","cat":"papers","name":"Supplemental Material from Changes in self-related cognitive processes and depressive symptom severity following a single, moderate dose of psilocybin in depressed patients","year":"2026","cit":0,"pfa":"L. Belinger","psa":"Katrin H. Preller","topics":["Depression","Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W7213424377","eid":"W7213424377"},{"id":"paper-w4402885059","cat":"papers","name":"Decision letter for \"Direct photochemical intramolecular [4 + 2] cycloadditions of dehydrosecodine-type substrates for the synthesis of the iboga-type scaffold and divergent [2 + 2] cycloadditions employing micro-flow sy","year":"2024","cit":0,"ptype":"peer-review","src":"https://openalex.org/W4402885059","eid":"W4402885059"},{"id":"paper-w750753702","cat":"papers","name":"Oh ! Nos os sont revêtus d’un nouveau corps amoureux…: Ayahuasca, chamanisme et discours du corps chez les Ashéninka de l’Ucayali","year":"2007","cit":0,"pfa":"Marc Lenaerts","psa":"Pierre Petit","ptype":"book-chapter","src":"https://openalex.org/W750753702","eid":"W750753702"},{"id":"paper-w7212014919","cat":"papers","name":"429. Association between subjective experiences and symptom improvement following psilocybin therapy in Japanese patients with treatment-resistant depression: an open-label study","year":"2026","cit":0,"pfa":"L Harada","psa":"H Uchida","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W7212014919","eid":"W7212014919"},{"id":"paper-w4409281338","cat":"papers","name":"194. Improving Workplace and Psychosocial Function in Treatment-Resistant Depression: Exploratory Outcomes From an Open-Label Feasibility Trial of Psilocybin-Assisted Psychotherapy","year":"2025","cit":0,"pfa":"Orly Lipsitz","psa":"Joshua Daniel Rosenblat","topics":["Depression","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4409281338","eid":"W4409281338"},{"id":"paper-w4411369954","cat":"papers","name":"Neurotoxic and Neuroprotective Effects of Psychedelics in a Human Neuroblastoma Cell Model","year":"2025","cit":0,"pfa":"Andreia Machado Brito-da-Costa","psa":"Diana Dias-da-Silva","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4411369954","eid":"W4411369954"},{"id":"paper-w7161540448","cat":"papers","name":"Review for \"N,N-Dimethyltryptamine (DMT) acutely exposed to mouse ventral tegmental area Ih-negative neurons alters the firing rate and conductance in a sex-dependent manner\"","year":"2026","cit":0,"topics":["Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W7161540448","eid":"W7161540448"},{"id":"paper-w2186203201","cat":"papers","name":"Phase II dose-response pilot study of ±3,4-methylenedioxymethamphetamine (MDMA)- assisted psychotherapy in subjects with anxiety associated with advanced-stage cancer.","year":"2004","cit":0,"pfa":"John H. Halpern","psa":"Arthur J. Siegel","topics":["Anxiety & end-of-life","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2186203201","eid":"W2186203201"},{"id":"paper-w2175483263","cat":"papers","name":"Psicoterapia asistida con LSD, Psilocibina y MDMA. Descripciones realizadas por los terapeutas en torno a los procesos clínicos","year":"2014","cit":0,"pfa":"Ingrid Tartakowsky López","ptype":"dissertation","src":"https://openalex.org/W2175483263","eid":"W2175483263"},{"id":"paper-w7160819923","cat":"papers","name":"Toward a Comprehensive Profile of MDMA as a Candidate Therapeutic: The Role of the Dopamine-Serotonin Continuum in Prohedonic Efficacy and Abuse Liability (Abstract ID: 228563)","year":"2026","cit":0,"pfa":"Nicholas Bloom","psa":"Brian Kangas","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7160819923","eid":"W7160819923"},{"id":"paper-w4402599370","cat":"papers","name":"A study in healthy male volunteers to investigate how the test medicine COMP360 [14C]-psilocybin is taken up, broken down and removed from the body","year":"2024","cit":0,"pfa":"Zainab Alashe","psa":"Study Contact","ptype":"dataset","src":"https://openalex.org/W4402599370","eid":"W4402599370"},{"id":"paper-w7171854693","cat":"papers","name":"Safety, feasibility, and preliminary clinical outcomes of psilocybin-assisted therapy for veterans with severe, treatment-resistant PTSD: an open-label pilot clinical trial","year":"2026","cit":0,"pfa":"Stacey B. Armstrong","psa":"Alan K. Davis","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7171854693","eid":"W7171854693"},{"id":"paper-w7125776111","cat":"papers","name":"Facing Mortality Together: A Constructivist Grounded Theory Analysis of Group Psilocybin Therapy Among Older Long-Term AIDS Survivor Gay Men","year":"2026","cit":0,"pfa":"Hannah Whitmore","psa":"B L Anderson","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7125776111","eid":"W7125776111"},{"id":"paper-w7106330185","cat":"papers","name":"Psilocybin-Assisted Therapy for Trauma-Related Disorders: A Scoping Review of a Depression-Dominated Evidence Base with Implications for Intimate Partner Violence-Related PTSD","year":"2025","cit":0,"pfa":"Mackenzie Hancock","psa":"Shambhu Prasad Adhikari","topics":["Depression","PTSD & trauma","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7106330185","eid":"W7106330185"},{"id":"paper-w7163845881","cat":"papers","name":"The Therapeutic Alliance's Moderating Role on the Negative Relationship Between Dread of Ego Dissolution and Changes in Depression in Psilocybin-Assisted Therapy for Treatment-Resistant Depression.","year":"2026","cit":0,"pfa":"Petrina Chu","psa":"Tim Mantingh","topics":["Depression","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7163845881","eid":"W7163845881"},{"id":"paper-w7213417846","cat":"papers","name":"Supplemental Material from Changes in self-related cognitive processes and depressive symptom severity following a single, moderate dose of psilocybin in depressed patients","year":"2026","cit":0,"pfa":"L. Belinger","psa":"Katrin H. Preller","topics":["Depression","Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W7213417846","eid":"W7213417846"},{"id":"paper-w7103895099","cat":"papers","name":"Psilocybin-Assisted Therapy for Trauma-Related Disorders: A Scoping Review of a Depression-Dominated Evidence Base with Implications for Intimate Partner Violence-Related PTSD","year":"2025","cit":0,"pfa":"Shambhu Prasad Adhikari","psa":"Getz, Nicole","topics":["Depression","PTSD & trauma","Reviews & meta-analyses"],"ptype":"other","src":"https://openalex.org/W7103895099","eid":"W7103895099"},{"id":"paper-w7213425449","cat":"papers","name":"Supplementary material from \"Changes in self-related cognitive processes and depressive symptom severity following a single, moderate dose of psilocybin in depressed patients\"","year":"2026","cit":0,"pfa":"L. Belinger","psa":"Katrin H. Preller","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"supplementary-materials","src":"https://openalex.org/W7213425449","eid":"W7213425449"},{"id":"paper-w223355519","cat":"papers","name":"\"Mdea(3,4-metilendioxietanfetamina, \"\"eva\"\"): neurotoxicidad y efecto amnésico en rata. Estudio comparativo con mdma (3,4-metilendioximetanfetamina, \"\"éxtasis\"\")\"","year":"1998","cit":0,"pfa":"Meritxell Barrionuevo Madrid","topics":["Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W223355519","eid":"W223355519"},{"id":"paper-w4250798145","cat":"papers","name":"Erratum: Involvement of Inferior Parietal Lobules in Prospective Memory Impairment During Acute MDMA (Ecstasy) Intoxication: An Event-Related fMRI Study","year":"2009","cit":0,"pfa":"Johannes Gerardus Ramaekers","psa":"E Formisano","topics":["Mechanism & neuroscience"],"ptype":"erratum","src":"https://openalex.org/W4250798145","eid":"W4250798145"},{"id":"paper-w4409280220","cat":"papers","name":"323. Comparing Antidepressant Effects of Psilocybin-Assisted Psychotherapy in Individuals That Were Unmedicated at Initial Screening Versus Individuals Discontinuing Medications for Study Participation","year":"2025","cit":0,"pfa":"Noah Chisamore","psa":"Joshua Daniel Rosenblat","topics":["Depression","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4409280220","eid":"W4409280220"},{"id":"paper-w4294200176","cat":"papers","name":"MDMA-Assisted Therapy for Treatment-Resistant Posttraumatic Stress Disorder (PTSD) – One step further toward a patient-centered treatment pathway","year":"2022","cit":0,"pfa":"Sara Penedos","psa":"A. Gamito","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4294200176","eid":"W4294200176"},{"id":"paper-w2914117375","cat":"papers","name":"Efecto de la fluoxetina y del selenio frente a la neurotoxicidad inducida por 3,4-metilenodioximetanfetamina (mdma, éxtasis) en roedores","year":"2003","cit":0,"pfa":"Verónica Sánchez Sánchez","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2914117375","eid":"W2914117375"},{"id":"paper-w7165428374","cat":"papers","name":"MDMA-Assisted Therapy for Post-Traumatic Stress Disorder in Australia: Analysis of a Translational Public Health Proposal and Independent Multi-Stage Evaluation","year":"2026","cit":0,"pfa":"Octavian Victor Brinzei","topics":["PTSD & trauma"],"ptype":"preprint","src":"https://openalex.org/W7165428374","eid":"W7165428374"},{"id":"paper-w7204805636","cat":"papers","name":"Ayahuasca como precipitante de virada diagnóstica em paciente com Transtorno Bipolar: relato de caso de evolução para Transtorno Esquizoafetivo","year":"2026","cit":0,"pfa":"Ricardo Cavalari Dória","psa":"Bruno Andraus Ferreira","ptype":"article","src":"https://openalex.org/W7204805636","eid":"W7204805636"},{"id":"paper-w1505114896","cat":"papers","name":"Observações sobre usos diversos e diferentes formas de dependência: de um pronto-socorro espiritual que usa ayahuasca à cracolândia","year":"2013","cit":0,"pfa":"Roberta Costa","ptype":"article","src":"https://openalex.org/W1505114896","eid":"W1505114896"},{"id":"paper-w4416174264","cat":"papers","name":"Aplicação da abordagem lipidômica no estudo do tratamento do transtorno da depressão maior com ayahuasca em pacientes resistentes a antidepressivos convencionais","year":"2024","cit":0,"pfa":"Emerson Andrade Ferreira dos Santos","topics":["Depression"],"ptype":"dissertation","src":"https://openalex.org/W4416174264","eid":"W4416174264"},{"id":"paper-w4415054088","cat":"papers","name":"Corrigendum to “The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression” [Journal of Affective Disorders, Volume 372 (2025), Pages 523-532]","year":"2025","cit":0,"pfa":"Guy M. Goodwin","psa":"Ekaterina Malievskaia","topics":["Depression"],"ptype":"erratum","src":"https://openalex.org/W4415054088","eid":"W4415054088"},{"id":"paper-w7106583689","cat":"papers","name":"THE DMT–LASER INTERFERENCE PROTOCOL (Version 2): A Standardized, Open-Source Framework for Safe, Reproducible Investigation of Structured Visual Phenomena in Diffused Coherent Light Under N,N-Dimethyltryptamine","year":"2025","cit":0,"pfa":"Swygert, John","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7106583689","eid":"W7106583689"},{"id":"paper-w7106558260","cat":"papers","name":"THE DMT–LASER INTERFERENCE PROTOCOL (Version 2): A Standardized, Open-Source Framework for Safe, Reproducible Investigation of Structured Visual Phenomena in Diffused Coherent Light Under N,N-Dimethyltryptamine","year":"2025","cit":0,"pfa":"Swygert, John","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7106558260","eid":"W7106558260"},{"id":"paper-w1569712076","cat":"papers","name":"Causas de mortalidad individual del “falso peyote” Astrophytum asterias (cactaceae); una cactácea amenazada: el efecto de daño de herbivoría en poblaciones mexicanas","year":"2008","cit":0,"pfa":"José Guadalupe Martínez-Ávalos","psa":"Enrique Jurado","ptype":"article","src":"https://openalex.org/W1569712076","eid":"W1569712076"},{"id":"paper-w4400600406","cat":"papers","name":"Regional Differences of Self-Reported Past-12-month Marijuana, Psilocybin, and Cocaine Use: Results From NDEWS Rapid Street Reporting 2021-2022","year":"2024","cit":0,"pfa":"Nae Won","psa":"Linda Bauer Cottler","ptype":"article","src":"https://openalex.org/W4400600406","eid":"W4400600406"},{"id":"paper-w4212954050","cat":"papers","name":"Efficacy and safety results from the first pivotal phase 3 randomized controlled trial of mdma-assisted psychotherapy for treatment of severe chronic PTSD","year":"2021","cit":0,"pfa":"Bessel van der Kolk","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4212954050","eid":"W4212954050"},{"id":"paper-w7133302870","cat":"papers","name":"Dual-Pathway BDNF Upregulation via Timed Co-Administration of Sub-Perceptual Psilocybin with High-Intensity Resistance Exercise: A Proposed Method and Theoretical Framework","year":"2026","cit":0,"pfa":"Drake Sadosky","topics":["Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W7133302870","eid":"W7133302870"},{"id":"paper-w2572120885","cat":"papers","name":"Investigation of cerebral perfusion changes following MDMA Ecstasy administration in an animal model using bolus-tracking arterial spin labelling MRI","year":"2012","cit":0,"pfa":"Jennifer Rouine","topics":["Safety & adverse events","Mechanism & neuroscience","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W2572120885","eid":"W2572120885"},{"id":"paper-w3202248738","cat":"papers","name":"The therapeutical role of psychedelic drugs in treatment of mental disorders","year":"2021","cit":0,"pfa":"Dan Cătălin Oprea","psa":"Adrian Cantemir","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3202248738","eid":"W3202248738"},{"id":"paper-w3184431862","cat":"papers","name":"Evaluación de la función antibacteriana de las β-carbolinas extraídas de banisteriopsis caapi (ayahuasca) contra bacterias gram-positivas y negativas","year":"2021","cit":0,"pfa":"Cadena Ullauri","psa":"Santiago André","topics":["Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W3184431862","eid":"W3184431862"},{"id":"paper-w2004735969","cat":"papers","name":"P.1.c.001 Acute psychomotor, memory and subjective effects of MDMA and THC (co-) administration over time in healthy volunteers","year":"2010","cit":0,"pfa":"Glenn Dumont","psa":"Robbert‐Jan Verkes","ptype":"article","src":"https://openalex.org/W2004735969","eid":"W2004735969"},{"id":"paper-w2511463113","cat":"papers","name":"トリプタミン系ドラッグ5-methoxy-N,N-dimethyltryptamine投与によるマウス雄性生殖器系障害","year":"2009","cit":0,"pfa":"Kuniaki Tayama","psa":"小縣 昭夫","ptype":"article","src":"https://openalex.org/W2511463113","eid":"W2511463113"},{"id":"paper-w3046206836","cat":"papers","name":"Molecular docking and binding interaction between psychedelic drugs and human serum albumin","year":"2020","cit":0,"pfa":"Hossein Orcid Khastar","psa":"Moslem Jafarisani","ptype":"article","src":"https://openalex.org/W3046206836","eid":"W3046206836"},{"id":"paper-w4415044730","cat":"papers","name":"The Brinzei MDMA-PTSD Protocol: Addressing the Food and Drug Administration’s Breaking Blind Concerns with Precision Approaches to Post-Traumatic Stress Disorder Treatment","year":"2025","cit":0,"pfa":"Octavian Victor Brinzei","topics":["PTSD & trauma","Therapy practice","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4415044730","eid":"W4415044730"},{"id":"paper-w3128527072","cat":"papers","name":"Psicoactivos y entógenos naturales, al alcance de todos, al limíte de la ley: El consumo de Ayahuasca en nuestro país","year":"2020","cit":0,"pfa":"Marcos Quintero López","ptype":"article","src":"https://openalex.org/W3128527072","eid":"W3128527072"},{"id":"paper-w4245994075","cat":"papers","name":"ChemInform Abstract: PSILOCIN ANALOGS. PART 2. SYNTHESIS OF 3‐(2‐(DIALKYLAMINO)ETHYL)‐, 3‐(2‐(N‐METHYL‐N‐ALKYLAMINO)ETHYL)‐, AND 3‐(2‐(CYCLOALKYLAMINO)ETHYL)INDOL‐4‐OLS","year":"1981","cit":0,"pfa":"David B. Repke","psa":"Dallas K. Bates","ptype":"article","src":"https://openalex.org/W4245994075","eid":"W4245994075"},{"id":"paper-w3040761155","cat":"papers","name":"BASES CELULARES Y MOLECULARES DEL EFECTO DE MDMA (EXTASIS) SOBRE LA PLASTICIDAD SINAPTICA EN CORTEZA VISUAL E HIPOCAMPO","year":"2008","cit":0,"pfa":"Marc Leander Zeise Ssa","psa":"Claudio Antonio Acuna Castillo","ptype":"article","src":"https://openalex.org/W3040761155","eid":"W3040761155"},{"id":"paper-w7207791819","cat":"papers","name":"MassIVE MSV000103108 - Effect of drying methods on chemical profile, psilocybin content and acetylcholinesterase inhibitory activity of Psilocybe cubensis supported by molecular docking analysis","year":"2026","cit":0,"pfa":"Thomas Garzón","ptype":"dataset","src":"https://openalex.org/W7207791819","eid":"W7207791819"},{"id":"paper-w905877142","cat":"papers","name":"基于多相多址（MDMA）传输的低功耗无线局域网","year":"2004","cit":0,"pfa":"侯维岩","psa":"陈伯时","ptype":"article","src":"https://openalex.org/W905877142","eid":"W905877142"},{"id":"paper-w4399154387","cat":"papers","name":"Hallucinogens, dissociative drugs, and empathogens","year":"2024","cit":0,"topics":["Addiction","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W4399154387","eid":"W4399154387"},{"id":"paper-w2191032909","cat":"papers","name":"Labate, Beatriz C.; Araujo, Wladimir S. (Orgs.). O uso ritual da ayahuasca. Campinas: FAPESP/Mercado das Letras, 2002, 686 p","year":"2003","cit":0,"pfa":"Marco Tromboni","ptype":"article","src":"https://openalex.org/W2191032909","eid":"W2191032909"},{"id":"paper-w2959748050","cat":"papers","name":"Investigation of fatalities related to the use of 3,4-methylenedioxymethamphetamine (MDMA,\"Ecstasy\") and analogues : anatomo-pathological and thanato-toxicological approach / Els A. De Letter.","year":"2002","cit":0,"pfa":"Els De Letter","ptype":"dissertation","src":"https://openalex.org/W2959748050","eid":"W2959748050"},{"id":"paper-w3177795277","cat":"papers","name":"A new strategy for exploring the role of hyperthermia in MDMA-induced toxicity in primary mouse hepatic cells using GC-MS-based metabolomics","year":"2019","cit":0,"pfa":"Ana Margarida Araújo","psa":"Márcia C. Carvalho","topics":["Safety & adverse events"],"ptype":"conference-paper","src":"https://openalex.org/W3177795277","eid":"W3177795277"},{"id":"paper-w1978355507","cat":"papers","name":"P6.c.008 Pharmacogenetic modulation of neurocognitive deficits in MDMA users: The role of catechol-O-methyltransferase, serotonin transporter SERT and 5HT2A polymorphisms","year":"2009","cit":0,"pfa":"Ana Beatriz Fagundo","psa":"R. de la Torre","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1978355507","eid":"W1978355507"},{"id":"paper-w3203640860","cat":"papers","name":"Revaloración ancestral de la (banisteriopsis caapi) ayahuasca mediante la producción de plantones en la universidad nacional intercultural de la Amazonia","year":"2019","cit":0,"pfa":"Edwin Miranda Ruiz","psa":"Jherson Edu Sangama Bardales","ptype":"article","src":"https://openalex.org/W3203640860","eid":"W3203640860"},{"id":"paper-w4410883376","cat":"papers","name":"Publisher’s Note re: “Effects of Psilocybin on Religious and Spiritual Attitudes and Behaviors in Clergy from Various Major World Religions” (doi: 10.1089/psymed.2023.0044)","year":"2025","cit":0,"ptype":"article","src":"https://openalex.org/W4410883376","eid":"W4410883376"},{"id":"paper-w7112695483","cat":"papers","name":"Psilocybin-Assisted Therapy for Trauma-Related Disorders: A Scoping Review of a Depression-Dominated Evidence Base with Implications for Intimate Partner Violence-Related PTSD","year":"2025","cit":0,"pfa":"Nicole Getz","psa":"Shambhu Prasad Adhikari","topics":["Depression","PTSD & trauma","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7112695483","eid":"W7112695483"},{"id":"paper-w2096163010","cat":"papers","name":"ChemInform Abstract: Abbreviated Ibogaine Congeners. Synthesis and Reactions of Tropan‐3‐yl‐ 2‐ and ‐3‐indoles. Investigation of an Unusual Isomerization of 2‐ Substituted Indoles Using Computational and Spectroscopic Te","year":"1994","cit":0,"pfa":"David B. Repke","psa":"Erik H.F. Wong","ptype":"article","src":"https://openalex.org/W2096163010","eid":"W2096163010"},{"id":"paper-w1983202797","cat":"papers","name":"Action of Mescaline on the α-waves (Berger Rhythm) in Man. (Compt. Rend. Soc. Biol., vol. cxxiv, pp. 1296–9, 1937.) Chweitzer, A., Geblewicz, E., and Liberson, W.","year":"1937","cit":0,"pfa":"L. E. Gilson","ptype":"article","src":"https://openalex.org/W1983202797","eid":"W1983202797"},{"id":"paper-w4417477518","cat":"papers","name":"The Brinzei MDMA-PTSD Protocol: Addressing the Food and Drug Administration’s Breaking Blind Concerns with Precision Approaches to Post-Traumatic Stress Disorder Treatment","year":"2025","cit":0,"pfa":"Octavian Victor Brinzei","topics":["PTSD & trauma","Therapy practice","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4417477518","eid":"W4417477518"},{"id":"paper-w1508121057","cat":"papers","name":"Exploring the effects of 3-methyladenine against MDMA-induced serotonergic neurotoxicity in rat brain using 4-[18F]-ADAM/small animal PET","year":"2014","cit":0,"pfa":"I‐Hsun Li","psa":"Kuo‐Hsing Ma","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1508121057","eid":"W1508121057"},{"id":"paper-w2280546898","cat":"papers","name":"La perdita di norepinefrina aumenta ka tossicità da MDMA e la formazione di whorls striatali positivi per l'ubiquitina","year":"2002","cit":0,"pfa":"Francesco Fornai","psa":"A. Paparelli","ptype":"conference-paper","src":"https://openalex.org/W2280546898","eid":"W2280546898"},{"id":"paper-w2611983522","cat":"papers","name":"Alle tieners zeggen \"ja\" tegen MDMA- De invloed van humor op de effectiviteit van bedreigende voorlichting over partydrugs.","year":"2015","cit":0,"pfa":"I.M.J. van Hooft","ptype":"article","src":"https://openalex.org/W2611983522","eid":"W2611983522"},{"id":"paper-w4293237846","cat":"papers","name":"Use of Psilocybin for Improving Health-Related Outcomes and Mental State in Patients with Major Depressive Disorder: Protocol for a Living Systematic Review and Meta-Analysis (Preprint)","year":"2022","cit":0,"pfa":"John Michael Pederson","psa":"Alan K. Davis","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4293237846","eid":"W4293237846"},{"id":"paper-w185252264","cat":"papers","name":"Caractérisation d'échantillons de 3,4-méthylènedioxyméthamphétamine (MDMA) par analyse en chromatographie gazeuse - spectrométrie de masse des impuretés de synthèse","year":"2003","cit":0,"pfa":"Pascal Gimeno","ptype":"dissertation","src":"https://openalex.org/W185252264","eid":"W185252264"},{"id":"paper-w2337036935","cat":"papers","name":"Plan de negocios para la elaboración y exportación de bolsas de té a base de ayahuasca (Banisteriopsis Caapi) a los países bajos","year":"2015","cit":0,"pfa":"Melany Lorena Almeida Veintimilla","psa":"Diana Carolina Rivas Recalde","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"dissertation","src":"https://openalex.org/W2337036935","eid":"W2337036935"},{"id":"paper-w7136413906","cat":"papers","name":"HPLC–MS/MS stereoselective determination and quantification of MDMA and its phase-1 metabolite in human oral fluid samples: estimation of consumption time","year":"2026","cit":0,"pfa":"Aurora Balloni","psa":"Alfredo Fabrizio Lo Faro","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7136413906","eid":"W7136413906"},{"id":"paper-w2935406734","cat":"papers","name":"El estatuto legal de la ayahuasca en España : la relevancia penal de los comportamientos relacionados con su consumo y posesión","year":"2019","cit":0,"pfa":"Juan Ramón Muñoz Sánchez","psa":"Antonio Antonio","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2935406734","eid":"W2935406734"},{"id":"paper-w4393974706","cat":"papers","name":"SOME HEART BREAKS ARE WORSE THAN OTHERS: A RARE CASE OF MID-VENTRICULAR TAKOTSUBO CARDIOMYOPATHY RESULTING IN CARDIOGENIC SHOCK IN CONTEXT OF MDMA USE","year":"2024","cit":0,"pfa":"Uttsav B. Sandesara","psa":"Taiyeb M. Khumri","ptype":"article","src":"https://openalex.org/W4393974706","eid":"W4393974706"},{"id":"paper-w7160609640","cat":"papers","name":"1020 Long-term Impact of Psilocybin Administration on Sleep-Continuity via Wearable Sensor Time-series: Preliminary-results in Post-Treatment Lyme Disease","year":"2026","cit":0,"pfa":"Matthew Reid","psa":"Albert Garcia‐Romeu","topics":["Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W7160609640","eid":"W7160609640"},{"id":"paper-w7133347211","cat":"papers","name":"Dual-Pathway BDNF Upregulation via Timed Co-Administration of Sub-Perceptual Psilocybin with High-Intensity Resistance Exercise: A Proposed Method and Theoretical Framework","year":"2026","cit":0,"pfa":"Drake Sadosky","topics":["Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W7133347211","eid":"W7133347211"},{"id":"paper-w4248055189","cat":"papers","name":"P.609 Therapeutic mechanisms of psychedelic drugs: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression","year":"2019","cit":0,"pfa":"Laura Mertens","psa":"Robin Lester Carhart-Harris","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4248055189","eid":"W4248055189"},{"id":"paper-w2763485857","cat":"papers","name":"Plan de Negocios para la creación de la Hacienda Agro-turística \"Ayahuasca\" en el Cantón Limón, Provincia de Morona Santiago 2011","year":"2012","cit":0,"pfa":"Estrella Roldán","psa":"Laura Gabriela","ptype":"dissertation","src":"https://openalex.org/W2763485857","eid":"W2763485857"},{"id":"paper-w1976400758","cat":"papers","name":"P.1.c.014 MBDB, a recreational drug similar to MDMA, exhibits anxiogenic-like effects in mice tested in the elevated plus-maze","year":"2010","cit":0,"pfa":"A.T. Muela","psa":"José Francisco Navarro","ptype":"article","src":"https://openalex.org/W1976400758","eid":"W1976400758"},{"id":"paper-w7143506056","cat":"papers","name":"Effets de l'exposition prénatale au MDMA (« Ecstasy ») ou au méthylphénidate sur les systèmes dopaminergiques chez le rat adulte","year":"2009","cit":0,"pfa":"Emilie Heuland","ptype":"dissertation","src":"https://openalex.org/W7143506056","eid":"W7143506056"},{"id":"paper-w7112548280","cat":"papers","name":"Incidence de la MDMA sur la sphère oro-faciale et stratégies de prise en charge au cabinet dentaire","year":"2025","cit":0,"pfa":"Potin, Charlotte","ptype":"dissertation","src":"https://openalex.org/W7112548280","eid":"W7112548280"},{"id":"paper-w3203535261","cat":"papers","name":"GAMBARAN KARAKTERISTIK SOSIODEMOGRAFIK, TINGKAT PENGETAHUAN DAN POLA PENGGUNAAN JAMUR Psilocybin PADA MAHASISWA S1 UNIVERSITAS PADJAJARAN PERIODE AJAR 2010-2011","year":"2012","cit":0,"pfa":"Natasha Amalda Ediwan","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W3203535261","eid":"W3203535261"},{"id":"paper-w4405115904","cat":"papers","name":"Six Month Follow up of one of the First Patients to Complete MDMA-Assisted Therapy for PTSD Outside of Clinical Trials in Australia: Implications for Translating Clinical Research to Clinical Practice","year":"2024","cit":0,"pfa":"Monica Margaret Schweickle","psa":"Ted Cassidy","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4405115904","eid":"W4405115904"},{"id":"paper-w2793937530","cat":"papers","name":"Previous Exposure to MDMA Produces Long-Lasting Alteration in Limbic Brain Excitability Measured by EEG Spectrum Analysis, Brain Metabolism and Seizure Susceptibility","year":"2005","cit":0,"pfa":"Filippo Sean Giorgi","psa":"Francesco Fornai","ptype":"conference-paper","src":"https://openalex.org/W2793937530","eid":"W2793937530"},{"id":"paper-w2981449884","cat":"papers","name":"Perbandingan metode MDMA (Maximum Divide Minimum Allotment) dan metode Hanif Rafi untuk mendapatkan solusi optimal terhadap masalah transportasi","year":"2019","cit":0,"pfa":"Shelvia Shelvia","ptype":"dissertation","src":"https://openalex.org/W2981449884","eid":"W2981449884"},{"id":"paper-w4255244745","cat":"papers","name":"Correction to: Extinction training following cocaine or MDMA self-administration produces discrete changes in D2-like and mGlu5 receptor density in the rat brain","year":"2020","cit":0,"pfa":"Małgorzata Frankowska","psa":"Małgorzata Filip","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"erratum","src":"https://openalex.org/W4255244745","eid":"W4255244745"},{"id":"paper-w4405447055","cat":"papers","name":"PR012/#955 Psilocybin assisted psychotherapy for patients with ovarian caner: a subset analysis of a randomized, double-blind, placebo-controlled, phase II clinical trial","year":"2024","cit":0,"pfa":"Daniel Spinosa","psa":"Stephen Ross","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4405447055","eid":"W4405447055"},{"id":"paper-w2587560496","cat":"papers","name":"La MDMA y el LSD se venden mucho más puros que la cocaína, el speed y la ketamina","year":"2017","cit":0,"pfa":"Miguel Angel Castejón","ptype":"article","src":"https://openalex.org/W2587560496","eid":"W2587560496"},{"id":"paper-w7104014620","cat":"papers","name":"Mapa Simbólico das Mirações: um estudo das experiências de ampliação da consciência com o uso da Ayahuasca fundamentado na Psicologia Transpessoal","year":"2025","cit":0,"pfa":"Nobrega, Rafael dos Santos","ptype":"other","src":"https://openalex.org/W7104014620","eid":"W7104014620"},{"id":"paper-w3175547324","cat":"papers","name":"Neuropharmacology of 3,4‐methylenedioxymethamphetamine (MDMA, “ecstasy”) and its stereoisomers: a combined positron emission tomography and functional magnetic resonance imaging study in rhesus monkeys","year":"2011","cit":0,"pfa":"Kevin Sean Murnane","psa":"Leonard Lee Howell","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3175547324","eid":"W3175547324"},{"id":"paper-w3201936938","cat":"papers","name":"Dawson, Alexander S. The Peyote Effect. From the Inquisition to the War on Drugs. Oakland, California: University of California Press, 2018, 320 pp. ISBN 978-052-028-543-9","year":"2021","cit":0,"pfa":"Ricardo Pérez Montfort","ptype":"book-review","src":"https://openalex.org/W3201936938","eid":"W3201936938"},{"id":"paper-w7153638789","cat":"papers","name":"El Renacimiento de la Terapia Asistida con Psicodélicos: Potencial Terapéutico y Retos Éticos de la Psilocibina y el MDMA","year":"2026","cit":0,"pfa":"Juan Moisés de la Serna","ptype":"preprint","src":"https://openalex.org/W7153638789","eid":"W7153638789"},{"id":"paper-w7161952771","cat":"papers","name":"AVALIAÇÃO IN SÍLICO DAS POSSÍVEIS ATIVIDADES FARMACOLÓGICAS E TOXICOLÓGICAS DOS COMPOSTOS SECUNDÁRIOS QUE COMPÕEM A BEBIDA AYAHUASCA: BANISTERIOPSIS CAAPI E PSYCHOTRIA VIRIDIS","year":"2026","cit":0,"pfa":"Maysa Cruz Lima Feitosa","psa":"Joubert Aires de Sousa","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7161952771","eid":"W7161952771"},{"id":"paper-w3037017071","cat":"papers","name":"Occurrence and Risk Assessment of Illicit Drugs in Wastewater Treatment Plants’ influent and effluent in Halland County, Sweden: Cocaine, MDMA, Amphetamine, Methamphetamine, and Cannabis.","year":"2018","cit":0,"pfa":"Jamshid Ansari","topics":["Addiction","Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W3037017071","eid":"W3037017071"},{"id":"paper-w2123405884","cat":"papers","name":"Time-Perception in Mescaline Intoxication [La percezione del tempo nell’ ebbrezza mescalinica]. (Rass. di Studi Psichiat., vol. xxvi, p. 455, May-June, 1937.) Favilli, M.","year":"1938","cit":0,"pfa":"H. Wilfred Eddison","ptype":"article","src":"https://openalex.org/W2123405884","eid":"W2123405884"},{"id":"paper-w7161783985","cat":"papers","name":"Desenvolvimento de um método voltamétrico para detecção e quantificação de MDMA em comprimidos de ecstasy apreendidos pela polícia","year":"2022","cit":0,"pfa":"Larissa Ayumi Hisano Higuti","psa":"Marcelo Firmino de Oliveira","ptype":"dissertation","src":"https://openalex.org/W7161783985","eid":"W7161783985"},{"id":"paper-w3188666261","cat":"papers","name":"Avaliação das possíveis interações entre o canabidiol e a ayahuasca em voluntários saudáveis: um estudo randomizado, duplo-cego e controlado com placebo","year":"2020","cit":0,"pfa":"Giordano Novak Rossi","ptype":"dissertation","src":"https://openalex.org/W3188666261","eid":"W3188666261"},{"id":"paper-w1768703726","cat":"papers","name":"Estudio poblacional del falso peyote Astrophytum asterias (Zucc.) Lem. (Cactaceae) en una fracción del matorral espinoso tamaulipeco en Villagrán, Tamaulipas (por) Luis Rocha Domínguez","year":"1995","cit":0,"pfa":"Luis Rocha Domínguez","ptype":"article","src":"https://openalex.org/W1768703726","eid":"W1768703726"},{"id":"paper-w7167917748","cat":"papers","name":"Psychedelic-Assisted Psychosexual Therapy","year":"2026","cit":0,"pfa":"Lohani Noor","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W7167917748","eid":"W7167917748"},{"id":"paper-w613630528","cat":"papers","name":"カイウサギのDirect cortical responseにおよぼすmescalineおよびLSDの影響について","year":"1970","cit":0,"pfa":"士郎 栗山","ptype":"article","src":"https://openalex.org/W613630528","eid":"W613630528"},{"id":"paper-w7123362591","cat":"papers","name":"IMPLICACIONES PENALES DE LOS COMPORTAMIENTOS RELACIONADOS CON LA AYAHUASCA. ESTUDIO DEL OBJETO MATERIAL EN LOS “OTROS” DELITOS CONTRA LA SALUD PÚBLICA","year":"2026","cit":0,"pfa":"Antonio Martín Pardo","ptype":"article","src":"https://openalex.org/W7123362591","eid":"W7123362591"},{"id":"paper-w7133294566","cat":"papers","name":"Dual-Pathway BDNF Upregulation via Timed Co-Administration of Sub-Perceptual Psilocybin with High-Intensity Resistance Exercise: A Proposed Method and Theoretical Framework","year":"2026","cit":0,"pfa":"Drake Sadosky","topics":["Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W7133294566","eid":"W7133294566"},{"id":"paper-w7133305713","cat":"papers","name":"Dual-Pathway BDNF Upregulation via Timed Co-Administration of Sub-Perceptual Psilocybin with High-Intensity Resistance Exercise: A Proposed Method and Theoretical Framework","year":"2026","cit":0,"pfa":"Drake Sadosky","topics":["Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W7133305713","eid":"W7133305713"},{"id":"paper-w2969455299","cat":"papers","name":"Implicación de la temperatura en la neurodegeneración inducida por la 3,4-metilenodioxi-metanfetamina (mdma) y su neuro-protección farmacológica","year":"1999","cit":0,"pfa":"Raquel Granados Martin","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2969455299","eid":"W2969455299"},{"id":"paper-w3217373316","cat":"papers","name":"Role of Adenosine A1 and A2A receptors on 3,4-methylendioxymeth-amphetamine (MDMA, Ecstasy)-induced neurotoxicity, astroglia and microglia reactivity in mouse striatum and substantia nigra","year":"2010","cit":0,"pfa":"Amit Khairnar","psa":"Micaela Morelli","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3217373316","eid":"W3217373316"},{"id":"paper-w4412412056","cat":"papers","name":"Some Heart Breaks Are Worse Than Others: A Rare Case of Mid-Ventricular Takotsubo Cardiomyopathy Resulting in Cardiogenic Shock in the Context of MDMA Use.","year":"2025","cit":0,"pfa":"Ma'in Abumuhfouz","psa":"Mohammed Saghir","ptype":"preprint","src":"https://openalex.org/W4412412056","eid":"W4412412056"},{"id":"paper-w2419128942","cat":"papers","name":"The effect of inhibitors of protein synthesis to inhibit brain protein synthesis and prevent the hyperactivity and hyperpyrexia in rats produced by inhibition of monoamine oxidase and the administration of L-tryptophan o","year":"1972","cit":0,"pfa":"A. David Smith","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2419128942","eid":"W2419128942"},{"id":"paper-w2922792327","cat":"papers","name":"Crenças atribuídas à opção de não usar MDMA (ecstasy): estudo qualitativo entre não usuários, usuários experimentais e ex-usuários","year":"2011","cit":0,"pfa":"Maria Angélica de Castro Comis","ptype":"article","src":"https://openalex.org/W2922792327","eid":"W2922792327"},{"id":"paper-w7161402073","cat":"papers","name":"Mind Medicine Australia MacArthur Foundation 100&Change 2024 Grant Application for an MDMA-Assisted Therapy Public Health Proposal for Veterans and First Responders","year":"2026","cit":0,"pfa":"Octavian Victor Brinzei","psa":"Ilan Hayman","topics":["PTSD & trauma","Reviews & meta-analyses","Therapy practice"],"ptype":"other","src":"https://openalex.org/W7161402073","eid":"W7161402073"},{"id":"paper-w4412665454","cat":"papers","name":"Repeated low doses of psilocybin reduces perceived symptom severity of obsessive-compulsive disorder, but fails to restore cognitive flexibility: A case study of identical twins","year":"2025","cit":0,"pfa":"Mikael Palner","psa":"Benjamin Thomas Dunkley","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4412665454","eid":"W4412665454"},{"id":"paper-w2014473898","cat":"papers","name":"Abstracts and Reviews : Los Significados Del Uso De La Ayahuasca Entre Los Aborigenes Chama (Ese'Ejja) Del Oriente De Bolivia: Una Investigacion Transcultural (Cultural Meanings of the Use of Xono (Ayahuasca) Among the C","year":"1981","cit":0,"pfa":"G. Vega","topics":["Reviews & meta-analyses"],"ptype":"conference-abstract","src":"https://openalex.org/W2014473898","eid":"W2014473898"},{"id":"paper-w2955402799","cat":"papers","name":"Caiuby Labate, Beatriz; Cavnar, Clancy (eds.). Peyote. History, Tradition, Politics, and Conservation (foreword by James A. Baumland Stacy B. Schaefer). Santa Barbara: Praeger, 2016, 280 p","year":"2016","cit":0,"pfa":"David Lorente Fernández","ptype":"article","src":"https://openalex.org/W2955402799","eid":"W2955402799"},{"id":"paper-w7161395654","cat":"papers","name":"Mind Medicine Australia MacArthur Foundation 100&Change 2024 Grant Application for an MDMA-Assisted Therapy Public Health Proposal for Veterans and First Responders","year":"2026","cit":0,"pfa":"Octavian Victor Brinzei","topics":["PTSD & trauma","Reviews & meta-analyses","Therapy practice"],"ptype":"other","src":"https://openalex.org/W7161395654","eid":"W7161395654"},{"id":"paper-w4231583489","cat":"papers","name":"Faculty Opinions recommendation of Mephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5-HT levels in nucleus accumbens of awake rats.","year":"2016","cit":0,"pfa":"Leslie Lars Iversen","topics":["Mechanism & neuroscience"],"ptype":"peer-review","src":"https://openalex.org/W4231583489","eid":"W4231583489"},{"id":"paper-w3121238753","cat":"papers","name":"[Rezension von] Margrit Jütte: Reisende im Strom der Zeit. Zum Yajé (Ayahuasca) ‐ Gebrauch der kolumbianischen Cofán. (= Ethnologie/Anthropology, 64). (Münster, 2016)","year":"2020","cit":0,"pfa":"Roland Spliesgart","ptype":"article","src":"https://openalex.org/W3121238753","eid":"W3121238753"},{"id":"paper-w7104030278","cat":"papers","name":"Mapa Simbólico das Mirações: um estudo das experiências de ampliação da consciência com o uso da Ayahuasca fundamentado na Psicologia Transpessoal","year":"2025","cit":0,"pfa":"Nobrega, Rafael dos Santos","ptype":"other","src":"https://openalex.org/W7104030278","eid":"W7104030278"},{"id":"paper-w2407473001","cat":"papers","name":"Assessment N>e Discriminative Stimulus Effects of (±)-3,4-Methylenedioxymethamphetamine (MDMA, \"ecstasy\") and (+Lysergic Add Diethylamide (LSD) in a Three-Lever Drug Discrimination Procedure","year":"2002","cit":0,"pfa":"Amy Goodwin","ptype":"article","src":"https://openalex.org/W2407473001","eid":"W2407473001"},{"id":"paper-w2788499603","cat":"papers","name":"Dádiva e reciprocidade na confecção do Vegetal: O 'Feitio' da ayahuasca na sede do Centro Espiritualista Estrela Universal (CEEU) em Maceió (AL).","year":"2017","cit":0,"pfa":"Wagner Lins Lira","ptype":"dataset","src":"https://openalex.org/W2788499603","eid":"W2788499603"},{"id":"paper-w4384406290","cat":"papers","name":"LIQUID LIGHT: AYAHUASCA SPIRITUALITY AND THE SANTO DAIME TRADITION. By G. WilliamBarnard. New York: Columbia University Press, 2022. Pp. xvi + 364. Hardback, $140.00; Paperback, $35.00.","year":"2023","cit":0,"ptype":"book-review","src":"https://openalex.org/W4384406290","eid":"W4384406290"},{"id":"paper-w7167441488","cat":"papers","name":"Más allá del éxtasis : Mecanismos moleculares del MDMA y estrategias de alfabetización científica en plataformas digitales de consumo rápido","year":"2026","cit":0,"pfa":"Alberto de la Mata Gómez","psa":"Universitat Autònoma de Barcelona. Facultat de Biociències","topics":["Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W7167441488","eid":"W7167441488"},{"id":"paper-w7161397419","cat":"papers","name":"Mind Medicine Australia MacArthur Foundation 100&Change 2024 Registration Submission for an MDMA-Assisted Therapy Public Health Proposal for Veterans and First Responders","year":"2026","cit":0,"pfa":"Octavian Victor Brinzei","topics":["Depression","PTSD & trauma","Reviews & meta-analyses"],"ptype":"other","src":"https://openalex.org/W7161397419","eid":"W7161397419"},{"id":"paper-w7164743613","cat":"papers","name":"Los mercados de drogas en España vistos a través de un servicio de análisis de sustancias: MDMA, cocaína y tusi.","year":"2025","cit":0,"pfa":"Claudio Vidal Giné","psa":"Jordi Navarro López","ptype":"article","src":"https://openalex.org/W7164743613","eid":"W7164743613"},{"id":"paper-w2797125628","cat":"papers","name":"Revisitando a terminologia substance, set e setting: o exemplo dos festivais de música eletrônica e os ritos urbanos de consumo de ayahuasca","year":"2023","cit":0,"pfa":"Tiago Coutinho","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2797125628","eid":"W2797125628"},{"id":"paper-w2784939693","cat":"papers","name":"Short communication Gender differences in self-reported anxiety, depression, and somatization among ecstasy/MDMA polydrug users, alcohol/tobacco users, and nondrug users","year":"2004","cit":0,"pfa":"Raffaella Margherita Milani","psa":"Helen C Fox","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2784939693","eid":"W2784939693"},{"id":"paper-w3086842826","cat":"papers","name":"Entheogene Pilze: Welches Potential bietet die psychoaktive Substanz Psilocybin für die moderne Psychotherapie in Forschung und Praxis? / Sophie-Charlotte Alice Adler","year":"2018","cit":0,"pfa":"Sophie-Charlotte Alice Adler","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W3086842826","eid":"W3086842826"},{"id":"paper-w7153540481","cat":"papers","name":"El Renacimiento de la Terapia Asistida con Psicodélicos: Potencial Terapéutico y Retos Éticos de la Psilocibina y el MDMA","year":"2026","cit":0,"pfa":"Juan Moisés de la Serna","ptype":"preprint","src":"https://openalex.org/W7153540481","eid":"W7153540481"},{"id":"paper-w7160627143","cat":"papers","name":"Integrating the Mystical Experience Questionnaire Into a Broader Psychometric Framework: English Validation of the Psychedelic Experience Scale and Comparison of Psilocybin and LSD Sessions Across Two Controlled Settings","year":"2026","cit":0,"pfa":"Kurt Stocker","psa":"Matthias E. Liechti","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7160627143","eid":"W7160627143"},{"id":"paper-w405614280","cat":"papers","name":"Toxicité aiguë, métabolisme et pharmacocinétique de la 3,4-méthylènedioxyméthamphétamine (MDMA, ecstasy) : influence du sexe chez le rat Sprague-Dawley","year":"2008","cit":0,"pfa":"Julien Fonsart","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W405614280","eid":"W405614280"},{"id":"paper-w7106229490","cat":"papers","name":"Assessing the suitability of ‘mass loss analysis’ as a low cost, low technology test to approximate MDMA content in ecstasy tablets, using laboratory and field comparisons","year":"2025","cit":0,"pfa":"Mike Pascoe","psa":"Fiona Measham","ptype":"preprint","src":"https://openalex.org/W7106229490","eid":"W7106229490"},{"id":"paper-w2189387259","cat":"papers","name":"Maas, U. and Strubelt, S. (2006): Fatalities after taking ibogaine in addiction treatment could be related to sudden cardiac death caused by autonomic disfunction. Medical Hypotheses, 67:960-964","year":"2006","cit":0,"pfa":"Uwe Maas","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2189387259","eid":"W2189387259"},{"id":"paper-w2408738845","cat":"papers","name":"MERCANTE, Marcelo S. 2012. Imagens de Cura: Ayahuasca, imaginação, saúde e doença na Barquinha. Rio de Janeiro: Editora Fiocruz. 322 pp.","year":"2013","cit":0,"pfa":"Ana Gretel Echazú Böschemeier","ptype":"article","src":"https://openalex.org/W2408738845","eid":"W2408738845"},{"id":"paper-w3111439064","cat":"papers","name":"Alexander S. Dawson, The Peyote Effect: From the Inquisition to the War on Drugs (Oakland, CA: University of California Press, 2018), pp. x + 245, £70.00; $85.00, hb, £25.00; $29.95, pb.","year":"2020","cit":0,"pfa":"Stacey A. Schwartzkopf","ptype":"book-review","src":"https://openalex.org/W3111439064","eid":"W3111439064"},{"id":"paper-w7163373926","cat":"papers","name":"From Amygdala to Synapse: A Multimodal Longitudinal RCT of Psilocybin-Assisted Therapy for Major Depressive Disorder Integrating Neuroplasticity Biomarkers, Inflammatory Indices, and Acute Experiential Mediators","year":"2026","cit":0,"pfa":"Irina Dell'Orto","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7163373926","eid":"W7163373926"},{"id":"paper-w7155643158","cat":"papers","name":"6. Open-Label Extension of Psilocybin-Assisted Therapy in Patients With Alcohol Use Disorder: Continued Safety and Short-Term Efficacy Signal for Drinking, Craving, and Self-Efficacy","year":"2026","cit":0,"pfa":"Broc A. Pagni","psa":"Michael P. Bogenschutz","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7155643158","eid":"W7155643158"},{"id":"paper-w3115438969","cat":"papers","name":"When Sacred Plants Turn into Resources. Review of “Cull of Personality: Ayahuasca, Shamanism and the Death of the Healer” by Kevin Tucker Black, Black and Green Press: Denver 2019, 208 pages","year":"2020","cit":0,"pfa":"Zuzanna Sadowska","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3115438969","eid":"W3115438969"},{"id":"paper-w4412458529","cat":"papers","name":"Exploring Underrated Cardiotoxicity and Neurovascular Implications in a 13-Month-Old Infant Following Accidental MDMA Ingestion: A Case Report and 3-Month Follow-Up","year":"2025","cit":0,"pfa":"F. El Hachimi","psa":"Rachida Habbal","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4412458529","eid":"W4412458529"},{"id":"paper-w4237767959","cat":"papers","name":"EFECTOS DE LA NOMIFENSINA SOBRE LA INFLUENCIA DEL ESTRÉS SOCIAL EN LAS PROPIEDADES REFORZANTES DE LA MDMA O ÉXTASIS","year":"2021","cit":0,"ptype":"conference-paper","src":"https://openalex.org/W4237767959","eid":"W4237767959"},{"id":"paper-w7161172916","cat":"papers","name":"Low doses of psilocybin as adjunct pharmacological treatment to virtual reality exposure therapy for social anxiety disorder: A study protocol for a double-blind randomized controlled trial.","year":"2026","cit":0,"pfa":"Jacob Cohen","psa":"Mikael Palner","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7161172916","eid":"W7161172916"},{"id":"paper-w270448033","cat":"papers","name":"\"El circuito motivador y sus interconexiones en el fenómeno de sensibilización producido por la 3,4-metilendioximetanfetamina (mdma, \"\"éxtasis\"\") en rata\"","year":"2005","cit":0,"pfa":"María Ramos Masa","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W270448033","eid":"W270448033"},{"id":"paper-w3045884550","cat":"papers","name":"Carnaval de incienso y MDMA: un acercamiento desde la criminología cultural al fenómeno de los Raves y la semana santa","year":"2019","cit":0,"pfa":"Antonio Silva Esquinas","psa":"Jorge Ramiro Pérez Suárez","ptype":"article","src":"https://openalex.org/W3045884550","eid":"W3045884550"},{"id":"paper-w7162200738","cat":"papers","name":"Mind Medicine Australia MacArthur Foundation 100&Change 2024 Grant Application for an MDMA-Assisted Therapy Public Health Proposal for Veterans and First Responders","year":"2026","cit":0,"pfa":"Octavian Victor Brinzei","psa":"Ilan Hayman","topics":["PTSD & trauma","Reviews & meta-analyses","Therapy practice"],"ptype":"other","src":"https://openalex.org/W7162200738","eid":"W7162200738"},{"id":"paper-w4413794992","cat":"papers","name":"The relationship between 3,4‐methylenedioxymethamphetamine (MDMA) use in young adulthood and anxiety or depressive disorders in the mid‐30s: Findings from the Victorian Adolescent Health Cohort Study","year":"2025","cit":0,"pfa":"Zachary Bryant","psa":"Tim N Slade","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4413794992","eid":"W4413794992"},{"id":"paper-w2328790417","cat":"papers","name":"The Peyote Road: Religious Freedom and the Native American Church. By Thomas Constantine Maroukis. (Norman: University of Oklahoma Press, 2010. xii, 281 pp. $29.95, ISBN 978-0-8061-4109-1.)","year":"2010","cit":0,"pfa":"Christopher Vecsey","topics":["Addiction","Policy & ethics"],"ptype":"book-review","src":"https://openalex.org/W2328790417","eid":"W2328790417"},{"id":"paper-w4392162324","cat":"papers","name":"Safety, blood levels and effects of N,N-dimethyltryptamine [DMT (SPL026)] in healthy participants that have taken psychedelic substances before (Part A) and in healthy participants with little to no psychedelic experienc","year":"2024","cit":0,"pfa":"Adeep Puri","topics":["Addiction","Safety & adverse events"],"ptype":"dataset","src":"https://openalex.org/W4392162324","eid":"W4392162324"},{"id":"paper-w3019804613","cat":"papers","name":"De l'hallucination à l'image: les enjeux de la prise de mescaline par Sartre. Sartre et Merleau-Ponty face à la psychologie française des années 1930","year":"2020","cit":0,"pfa":"Gautier Dassonneville","ptype":"article","src":"https://openalex.org/W3019804613","eid":"W3019804613"},{"id":"paper-w2283879312","cat":"papers","name":"Un nuovo modello sperimentale di epilessia limbica: la sensitizzazione con MDMA (ecstasy) produce modificazioni persistenti EEG e crisi epilettiche","year":"2004","cit":0,"pfa":"Chiara Pizzanelli","psa":"Francesco Fornai","ptype":"conference-paper","src":"https://openalex.org/W2283879312","eid":"W2283879312"},{"id":"paper-w4249073722","cat":"papers","name":"Faculty Opinions recommendation of Mephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5-HT levels in nucleus accumbens of awake rats.","year":"2016","cit":0,"pfa":"Louis J. DeFelice","topics":["Mechanism & neuroscience"],"ptype":"peer-review","src":"https://openalex.org/W4249073722","eid":"W4249073722"},{"id":"paper-w7161423755","cat":"papers","name":"Mind Medicine Australia MacArthur Foundation 100&Change 2024 Registration Submission for an MDMA-Assisted Therapy Public Health Proposal for Veterans and First Responders","year":"2026","cit":0,"pfa":"Octavian Victor Brinzei","topics":["Depression","PTSD & trauma","Reviews & meta-analyses"],"ptype":"other","src":"https://openalex.org/W7161423755","eid":"W7161423755"},{"id":"paper-w2266203625","cat":"papers","name":"بررسی اثر میان مدت MDMA (اکستازی) بر اضطراب در موش سفید آزمایشگاهی بزرگ نر با استفاده از تست Plus Maze","year":"2012","cit":0,"pfa":"مهرداد جهانشاهی","psa":"فخرالسادات سیدحسینی","ptype":"article","src":"https://openalex.org/W2266203625","eid":"W2266203625"},{"id":"paper-w4394388977","cat":"papers","name":"Psychedelics for treatment resistant depression: are they game changers?","year":"2023","cit":0,"pfa":"Michail Kalfas","psa":"Allan Hunter Young","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"dataset","src":"https://openalex.org/W4394388977","eid":"W4394388977"},{"id":"paper-w4415935003","cat":"papers","name":"Assessing the suitability of ‘mass loss analysis’ as a low cost, low technology test to approximate MDMA content in ecstasy tablets, using laboratory and field comparisons","year":"2025","cit":0,"pfa":"Mike Pascoe","psa":"Fiona Catherine Measham","ptype":"preprint","src":"https://openalex.org/W4415935003","eid":"W4415935003"},{"id":"paper-w7131072867","cat":"papers","name":"Delayed psilocybin treatment after repeated mild traumatic brain injury recovers chronic behavioural deficits, reduces microglial density, and enhances hippocampal neurogenesis in rats","year":"2026","cit":0,"pfa":"Sandy R. Shultz","psa":"Stuart McDonald","topics":["PTSD & trauma"],"ptype":"preprint","src":"https://openalex.org/W7131072867","eid":"W7131072867"},{"id":"paper-w2952686596","cat":"papers","name":"Efectes de l’administració de MDMA sobre l’expressió de neurones en desenvolupament en l’hipocamp de rata en diferents etapes durant l’adolescència","year":"2018","cit":0,"pfa":"Llabrés Mas","psa":"Aina María","ptype":"dissertation","src":"https://openalex.org/W2952686596","eid":"W2952686596"},{"id":"paper-w7163520560","cat":"papers","name":"Comparison of acute effects of 3,4-methylenedioxymethamphetamine (MDMA) with and without a supplemental booster dose in healthy participants: a double-blind, randomized, placebo-controlled, crossover study","year":"2026","cit":0,"pfa":"Mélusine Humbert‐Droz","psa":"Lorenz Mueller","topics":["PTSD & trauma","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7163520560","eid":"W7163520560"},{"id":"paper-w2906087810","cat":"papers","name":"Mães do equilíbrio: prática religiosa e terapêutica em mulheres que [não] fazem uso da ayahuasca durante a gestação e parto em João Pessoa","year":"2017","cit":0,"pfa":"Mariana Pereira Gonsalves","ptype":"dissertation","src":"https://openalex.org/W2906087810","eid":"W2906087810"},{"id":"paper-w7155681870","cat":"papers","name":"Integrating the Mystical Experience Questionnaire Into a Broader Psychometric Framework: English Validation of the Psychedelic Experience Scale and Comparison of Psilocybin and LSD Sessions Across Two Controlled Settings","year":"2026","cit":0,"pfa":"Kurt Stocker","psa":"Matthias E. Liechti","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7155681870","eid":"W7155681870"},{"id":"paper-w2606032011","cat":"papers","name":"ChemInform Abstract: TOTALSYNTHESE VON INDOL‐ UND DIHYDROINDOL‐ALKALOIDEN 3. MITT. TRANSANNULARE CYCLISIERUNG VON CARBOMETHOXY‐DIHYDRO‐CLEAVAMIN UND CARBOMETHOXY‐CLEAVAMIN‐DERIVATEN, WEG ZU VINCA‐ UND IBOGA‐ALKALOIDEN","year":"1970","cit":0,"pfa":"James Peter Kutney","psa":"John R. Hadfield","ptype":"article","src":"https://openalex.org/W2606032011","eid":"W2606032011"},{"id":"paper-w7120408761","cat":"papers","name":"Estudio de motivaciones y experiencia en el uso de ayahuasca y otros compuestos en una región de triple frontera (Brasil-Paraguay-Argentina)","year":"2022","cit":0,"pfa":"Gisela Giombelli Decezere","ptype":"dissertation","src":"https://openalex.org/W7120408761","eid":"W7120408761"},{"id":"paper-w4238282112","cat":"papers","name":"EFECTOS DE LA NOMIFENSINA SOBRE LA INFLUENCIA DEL ESTRÉS SOCIAL EN LAS PROPIEDADES REFORZANTES DE LA MDMA O ÉXTASIS","year":"2021","cit":0,"ptype":"conference-paper","src":"https://openalex.org/W4238282112","eid":"W4238282112"},{"id":"paper-w7154736086","cat":"papers","name":"The entactogen MDMA (3,4-methylenedioxymethamphetamine, “Ecstasy”) disrupts helping behaviour while reinforcing electrophysiological indicators of potentially associated synaptic plasticity in male Sprague-Dawley rats","year":"2026","cit":0,"pfa":"Patricio Sáez‐Briones","psa":"Alejandro Hernández","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7154736086","eid":"W7154736086"},{"id":"paper-w7162035947","cat":"papers","name":"MMP-1 Safety and efficacy of MDMA-assisted therapy for Post-Traumatic Stress Disorder in Military Veterans and First Responders: a randomised waitlist-controlled clinical trial","year":"2026","cit":0,"pfa":"Paul Liknaitzky","psa":"Murat Yucel","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W7162035947","eid":"W7162035947"},{"id":"paper-w3011428474","cat":"papers","name":"La Estructura Neo-Colonial del Turismo Espiritual en el Perú: las percepciones locales de quien controla la mercantilización del ayahuasca en Cusco","year":"2019","cit":0,"pfa":"Andrea Aspajo","ptype":"article","src":"https://openalex.org/W3011428474","eid":"W3011428474"},{"id":"paper-w4407840828","cat":"papers","name":"Rede social de conhecimentos etnobotânicos da planta sagrada, cipó Mariri Banisteriopsis caapi (Spruce ex Grisebach), da floresta amazônica, componente do chá Ayahuasca","year":"2025","cit":0,"pfa":"Arielen Barreto de Carvalho","psa":"Carolina Joana da Silva","ptype":"article","src":"https://openalex.org/W4407840828","eid":"W4407840828"},{"id":"paper-w7120577053","cat":"papers","name":"Evaluation of the morphological, anatomical and phytochemical variation of Banisteriopsis caapi (Spruce ex Griseb.) C.V.Morton and Psychotria viridis Ruiz & Pav in different environments, content of alkaloids and cytotox","year":"2020","cit":0,"pfa":"Ordilena Ferreira de Miranda","topics":["Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W7120577053","eid":"W7120577053"},{"id":"paper-w4252700521","cat":"papers","name":"Faculty Opinions recommendation of Urinary excretion of the main metabolites of 3,4-methylenedioxymethamphetamine (MDMA), including the sulfate and glucuronide of 4-hydroxy-3-methoxymethamphetamine (HMMA), in humans and","year":"2008","cit":0,"pfa":"Gary O'Neal Rankin","ptype":"peer-review","src":"https://openalex.org/W4252700521","eid":"W4252700521"},{"id":"paper-w7168070234","cat":"papers","name":"La responsabilidad penal del guía por los eventuales daños derivados de la ingesta de ayahuasca en el curso de una ceremonia de consumo","year":"2026","cit":0,"pfa":"Antonio Martín Pardo","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7168070234","eid":"W7168070234"},{"id":"paper-w2753634683","cat":"papers","name":"Psychedelic rehabilitation for drug policy and trauma survivors : advancing mental health care by granting access to MDMA-assisted therapy for the treatment of post-traumatic stress disorder","year":"2016","cit":0,"pfa":"Lily Jarrett Pyle","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2753634683","eid":"W2753634683"},{"id":"paper-w2842691076","cat":"papers","name":"Tradição e modernidade no campo ayahuasqueiro: uma análise a partir dos processos de regulamentação e patrimonialização da ayahuasca no Brasil no período de 1985/2016.","year":"2016","cit":0,"pfa":"G. C. Barros","psa":"Geovânea Corrêa. Barros","ptype":"dissertation","src":"https://openalex.org/W2842691076","eid":"W2842691076"},{"id":"paper-w7115814492","cat":"papers","name":"Brujería capitalista y turistas pishtaco: Tensiones ocultas en torno al turismo de ayahuasca entre los shipibo de San Francisco (Amazonia peruana)","year":"2025","cit":0,"pfa":"Slaghenauffi, Doriane Sabine","topics":["Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7115814492","eid":"W7115814492"},{"id":"paper-w4393204641","cat":"papers","name":"André van der Braak, Ayahuasca as Liquid Divinity: An Ontological Approach. Studies in Comparative Philosophy and Religion (Lanham: Lexington Books 2023), ISBN 9781666906448, 240 pp., € 73.85.","year":"2024","cit":0,"pfa":"W. Stoker","ptype":"book-review","src":"https://openalex.org/W4393204641","eid":"W4393204641"},{"id":"paper-w4406815468","cat":"papers","name":"GLOBAL AYAHUASCA: WONDROUS VISIONS AND MODERN WORLDS. By Alex K.Gearin. Spiritual Phenomena. Stanford: Stanford University Press, 2024. Pp. xiv + 280. Hardback, $90.00; Paperback, $22.50.","year":"2024","cit":0,"pfa":"Elena Popov","topics":["Therapy practice","Policy & ethics"],"ptype":"book-review","src":"https://openalex.org/W4406815468","eid":"W4406815468"},{"id":"paper-w2326915565","cat":"papers","name":"Thomas Constantine Maroukis . The Peyote Road: Religious Freedom and the Native American Church . (The Civilization of the American Indian Series, number 265.) Norman : University of Oklahoma Press . 2010 . Pp. xii, 281.","year":"2011","cit":0,"pfa":"Michael F. Steltenkamp","topics":["Reviews & meta-analyses","Policy & ethics"],"ptype":"book-review","src":"https://openalex.org/W2326915565","eid":"W2326915565"},{"id":"paper-w7120855545","cat":"papers","name":"N-metyl-3,4 methylendioxymethamphetamine (MDMA Ecstasy) decreases innate immunity response and host resistence to Listeria monocytogenes: role for HPA axis and Sympathetic Nervous System","year":"2011","cit":0,"pfa":"Viviane Mendonça de Paula","topics":["Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7120855545","eid":"W7120855545"},{"id":"paper-w7214911931","cat":"papers","name":"USO DE AYAHUASCA EM BAIXAS DOSES EM CONTEXTO COMUNITÁRIO: ESTUDO NATURALÍSTICO LONGITUDINAL DE 45 DIAS SOBRE AUTORREGISTRO EMOCIONAL, ADESÃO E PRÁTICAS REFLEXIVAS","year":"2026","cit":0,"pfa":"Renato Lemes Peixoto","psa":"Lígia Freitas","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7214911931","eid":"W7214911931"},{"id":"paper-w7167062704","cat":"papers","name":"La responsabilidad penal del guía por los eventuales daños derivados de la ingesta de ayahuasca en el curso de una ceremonia de consumo","year":"2026","cit":0,"pfa":"Antonio Martín Pardo","ptype":"article","src":"https://openalex.org/W7167062704","eid":"W7167062704"},{"id":"paper-w2923943993","cat":"papers","name":"Efectos farmacológicos y farmacocinética de la 3,4-metilenodioximetanfetamina (mdma, éxtasis) a dosis múltiples y en diferentes intervalos de administración en humanos","year":"2004","cit":0,"pfa":"Ana María Peiró","ptype":"article","src":"https://openalex.org/W2923943993","eid":"W2923943993"},{"id":"paper-w7139987371","cat":"papers","name":"Baseline HRV predicts bidirectional treatment response in major depressive disorder: high-HRV patients respond better to psilocybin, low-HRV patients respond better to SSRIs","year":"2026","cit":0,"pfa":"de Souza, Gabriel Manhães","topics":["Depression"],"ptype":"preprint","src":"https://openalex.org/W7139987371","eid":"W7139987371"},{"id":"paper-w2896817321","cat":"papers","name":"La ayahuasca y su poder ancestral para el desarrollo del turismo místico y de salud en el distrito de Yarinacocha - región Ucayali.","year":"2018","cit":0,"pfa":"Neyra Luzuriaga","psa":"Kary Jannet","ptype":"dissertation","src":"https://openalex.org/W2896817321","eid":"W2896817321"},{"id":"paper-w357020078","cat":"papers","name":"「MDMA」等錠剤型麻薬の解説--薬物乱用防止のために","year":"2003","cit":0,"pfa":"純一 須藤","ptype":"article","src":"https://openalex.org/W357020078","eid":"W357020078"},{"id":"paper-w2105808550","cat":"papers","name":"Avaliação dos efeitos do N-metil-3,4 metilenodioximetanfetamina (MDMA - Ecstasy) sobre parâmetros comportamentais, neuroendócrinos e de atividade de neutrófilos em camundongos","year":"2007","cit":0,"pfa":"Viviane Ferraz de Paula","ptype":"dissertation","src":"https://openalex.org/W2105808550","eid":"W2105808550"},{"id":"paper-w7213637217","cat":"papers","name":"Encuesta sobre consumo de MDMA (ecstasy) en la población homosexual masculina francesa en 2016 en la que vuelve a irrumpir con fuerza","year":"2017","cit":0,"pfa":"Andrew Laurin","psa":"Matéi Marinescu","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7213637217","eid":"W7213637217"},{"id":"paper-w4390587973","cat":"papers","name":"Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder: Protocol for a Double-Blind, Randomized, Placebo-Controlled, 7-month Parallel-Group Phase II Superiority Trial","year":"2024","cit":0,"pfa":"Laetitia Vanderijst","psa":"Xavier Noël","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"preprint","src":"https://openalex.org/W4390587973","eid":"W4390587973"},{"id":"paper-w4403423787","cat":"papers","name":"Puerto de Cádiz (España): ruta para la provisión europea de fenetilaminas (MDMA) utilizadas en la producción de éxtasis para Sudamérica","year":"2023","cit":0,"pfa":"Jorge Saltos Luna","ptype":"article","src":"https://openalex.org/W4403423787","eid":"W4403423787"},{"id":"paper-w1797142744","cat":"papers","name":"Contribución de los estados modificados de conciencia facilitados por la experiencia con Ayahuasca en la rehabilitación de drogodependientes de la Comunidad Terapéutica Takiwasi","year":"2009","cit":0,"pfa":"Carrillo Aedo","psa":"Natalia Francisca","ptype":"dissertation","src":"https://openalex.org/W1797142744","eid":"W1797142744"},{"id":"paper-w4414162257","cat":"papers","name":"Corrigendum to “Chronic psilocybin administration increases sociability and alters the gut microbiome in male wild-type mice but not in a preclinical model of obsessive-compulsive disorder” [Neuropharmacology 279 (2025)","year":"2025","cit":0,"pfa":"James J Gattuso","psa":"Thibault Renoir","topics":["Dosing & pharmacology"],"ptype":"erratum","src":"https://openalex.org/W4414162257","eid":"W4414162257"},{"id":"paper-w7197678121","cat":"papers","name":"Ayahuasca como ferramenta terapêutica no tratamento do transtorno por uso de cocaína e crack: uma análise do uso com base em estudos clínicos","year":"2025","cit":0,"pfa":"Ana Paula Soares de Oliveira [UNIFESP] Braga","topics":["PTSD & trauma","Addiction"],"ptype":"dissertation","src":"https://openalex.org/W7197678121","eid":"W7197678121"},{"id":"paper-w7120717434","cat":"papers","name":"Avaliação estereológica dos efeitos da ayahuasca (Banisteriopsis caapi e Psychotria viridis) no córtex somatossensorial de saguis (Callithrix jacchus) juvenis induzidos ao transtorno depressivo maior","year":"2024","cit":0,"pfa":"Luiz Roberto Fernandes Pereira","topics":["Depression","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W7120717434","eid":"W7120717434"},{"id":"paper-w7161432171","cat":"papers","name":"Mind Medicine Australia MacArthur Foundation 100&Change 2024 Participatory Peer Review Results for an MDMA-Assisted Therapy Public Health Proposal for Veterans and First Responders","year":"2026","cit":0,"pfa":"Octavian Victor Brinzei","topics":["PTSD & trauma","Reviews & meta-analyses","Therapy practice"],"ptype":"other","src":"https://openalex.org/W7161432171","eid":"W7161432171"},{"id":"paper-w2996824728","cat":"papers","name":"Matthew Clark: The Tawny One: Soma, Haoma, and Ayahuasca. x, 285 pp. London and New York: Muswell Hill Press, 2017. ISBN 978 1 90899 522 3.","year":"2019","cit":0,"pfa":"Finnian M. M. Gerety","ptype":"book-review","src":"https://openalex.org/W2996824728","eid":"W2996824728"},{"id":"paper-w2483095989","cat":"papers","name":"Chapter 51. Hallucinogen-Related Disorders","year":"2014","cit":0,"pfa":"Robert N. Pechnick","psa":"Itai Danovitch","topics":["Addiction","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W2483095989","eid":"W2483095989"},{"id":"paper-w7161381592","cat":"papers","name":"Mind Medicine Australia MacArthur Foundation 100&Change 2024 Participatory Peer Review Results for an MDMA-Assisted Therapy Public Health Proposal for Veterans and First Responders","year":"2026","cit":0,"pfa":"Octavian Victor Brinzei","topics":["PTSD & trauma","Reviews & meta-analyses","Therapy practice"],"ptype":"other","src":"https://openalex.org/W7161381592","eid":"W7161381592"},{"id":"paper-w7162574591","cat":"papers","name":"Supplementary Material for: Long-Term Efficacy of Psilocybin with Adjunct Psychotherapy in Treatment-Resistant Major Depression (EPIsoDE): 6- and 12-Month Naturalistic Follow-Up of a Phase 2b Trial","year":"2026","cit":0,"pfa":"figshare admin karger","psa":"Gründer G.","topics":["Depression","Dosing & pharmacology","Therapy practice"],"ptype":"supplementary-materials","src":"https://openalex.org/W7162574591","eid":"W7162574591"},{"id":"paper-w647527141","cat":"papers","name":"Bebidas tóxicas de los indios del noroeste del Amazonas: el ayahuasca, el yajé, el huanto : estudio comparativo tóxico-fisiológico de una experiencia personal","year":"1965","cit":0,"pfa":"P. Reinburg","ptype":"book","src":"https://openalex.org/W647527141","eid":"W647527141"},{"id":"paper-w3170840804","cat":"papers","name":"Dried Spots associado com um método LC-DAD para determinação simultânea de MDMA (ecstasy) e MDA em amostras de fluído oral","year":"2021","cit":0,"pfa":"Leandro Oka Duarte","ptype":"dissertation","src":"https://openalex.org/W3170840804","eid":"W3170840804"},{"id":"paper-w4396610540","cat":"papers","name":"Correction to: A Bayesian Reanalysis of a Trial of Psilocybin Versus Escitalopram for Depression by Nayak, et al. Psychedelic Med 2023;1(1):18–26; doi: 10.1089/psymed.2022.0002","year":"2024","cit":0,"topics":["Depression"],"ptype":"erratum","src":"https://openalex.org/W4396610540","eid":"W4396610540"},{"id":"paper-w2626766575","cat":"papers","name":"Psychotropes et sociétés : étude à partir de l'usage rituel d'un hallucinogène naturel (Ayahuasca) dans le cadre de la médecine traditionnelle en Amazonie péruvienne","year":"2007","cit":0,"pfa":"Agnès Di Gennaro","topics":["Addiction"],"ptype":"dissertation","src":"https://openalex.org/W2626766575","eid":"W2626766575"},{"id":"paper-w4411422335","cat":"papers","name":"Meta-Analysis on Predatory Date-Rape Drugs: Pharmacodynamics and Counteractive Studies of Liquid Ecstasy-GHB (y-hydroxybutyrate) and Ecstasy (3, 4-methylenedioxy-N-methamphetamine, or MDMA)","year":"2025","cit":0,"pfa":"Rajat Ramesh Pithadia","psa":"Sheetal Rajan","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4411422335","eid":"W4411422335"},{"id":"paper-w2278046234","cat":"papers","name":"毛細管電泳螢光光譜法對尿液中低濃度毒品3,4-亞甲雙氧甲基安非他命（3,4-MDMA）與麥角二乙胺（LSD）之分析研究","year":"2001","cit":0,"pfa":"方晴","ptype":"article","src":"https://openalex.org/W2278046234","eid":"W2278046234"},{"id":"paper-w3210396326","cat":"papers","name":"POSTER 1 ¿Implication of C/EBPb in mitochondrial function and autophagy in in vitro models of Parkinson's Disease?POSTER 2 ¿DMT, compound found in the hallucinogenic tea ayahuasca, regulates adult neurogenesis?","year":"2020","cit":0,"pfa":"Ana Pérez Castillo","psa":"Jesús Alarcón-Gil","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3210396326","eid":"W3210396326"},{"id":"paper-w2810607074","cat":"papers","name":"Factors Associated with Intent to Use Condoms to Prevent Sexual TransmittedInfections (STIs) among African American Female Juvenile Detainees that Use 3,4-Methylenedioxymethamphetamine (MDMA or ‘Ecstasy’)","year":"2018","cit":0,"pfa":"Torrance Stephens","psa":"Aniya Allen","ptype":"article","src":"https://openalex.org/W2810607074","eid":"W2810607074"},{"id":"paper-w3167707683","cat":"papers","name":"Uporedna analiza patohistoloških promena u bubrezima i promena vrednosti biohemijskih parametara u krvi kod ljudi i pacova uzrokovanih 3,4-metilendioksimetamfetaminom (MDMA)","year":"2021","cit":0,"pfa":"Aleksić Ivan","ptype":"article","src":"https://openalex.org/W3167707683","eid":"W3167707683"},{"id":"paper-w4280634565","cat":"papers","name":"Forma-de-vida e pluralismo de oposição ao direito: as portas da justiça em Walter Benjamin, a rejeição franciscana ao direito no século XIV e a ayahuasca indígena","year":"2022","cit":0,"pfa":"João Paulo Salles Pinto","psa":"Leonel Severo Rocha","ptype":"article","src":"https://openalex.org/W4280634565","eid":"W4280634565"},{"id":"paper-w3041197944","cat":"papers","name":"Participacon de receptores ampa en el efecto de mdma (extasis) sobre la potenciación de larga duración (ltp) en rebanadas de hipocampo","year":"2010","cit":0,"pfa":"Loyola Arroyo","psa":"Sebastian Enrique","topics":["Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W3041197944","eid":"W3041197944"},{"id":"paper-w7110951638","cat":"papers","name":"IMPLICAÇÕES E INTERAÇÕES FARMACOLÓGICAS DA EXPOSIÇÃO À 3,4-METILENODIOXIMETANFETAMINA (MDMA) NA INTEGRIDADE FUNCIONAL DA BARREIRA HEMATOENCEFÁLICA: UMA REVISÃO SISTEMÁTICA DA LITERATURA","year":"2025","cit":0,"pfa":"Abel Anaquiry Oliveira","psa":"Rainara Cobos Rocha","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7110951638","eid":"W7110951638"},{"id":"paper-w4405087006","cat":"papers","name":"Comparative antidepressant effects and safety of intravenous racemic ketamine, psilocybin and theta burst stimulation for major depressive disorder: A systematic review and network meta‐analyses of randomized controlled","year":"2024","cit":0,"pfa":"Itsuki Terao","psa":"Wakako Kodama","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4405087006","eid":"W4405087006"},{"id":"paper-w7162575260","cat":"papers","name":"Supplementary Material for: Long-Term Efficacy of Psilocybin with Adjunct Psychotherapy in Treatment-Resistant Major Depression (EPIsoDE): 6- and 12-Month Naturalistic Follow-Up of a Phase 2b Trial","year":"2026","cit":0,"pfa":"figshare admin karger","psa":"Gründer G.","topics":["Depression","Dosing & pharmacology","Therapy practice"],"ptype":"supplementary-materials","src":"https://openalex.org/W7162575260","eid":"W7162575260"},{"id":"paper-w7120726606","cat":"papers","name":"Determination of 3,4-methylenedioxymethamphetamine (MDMA - Ecstasy), 3,4-methylenedioxyethylamphetamine (MDEA - Eve) and 3,4-methylenedioxyamphetamine (MDA) in biological fluids by high-performance liquid chromatography:","year":"2004","cit":0,"pfa":"José Luiz Da Costa","ptype":"dissertation","src":"https://openalex.org/W7120726606","eid":"W7120726606"},{"id":"paper-w4409860262","cat":"papers","name":"Zinc Mitigates MDMA-Prompted Apoptosis by Alteration of Cross Talk Among Bcl-2, Bax and P53 Genes Expression in Mouse Sertoli and Leydig Cell Lines","year":"2024","cit":0,"pfa":"Salar Mahmoudi-Nejad","psa":"Morteza Bagheri","ptype":"article","src":"https://openalex.org/W4409860262","eid":"W4409860262"},{"id":"paper-w572178244","cat":"papers","name":"1B2-6 外側膝状体キンドリングネコの光過敏性に対する5-Methoxy-N, N-dimethyltryptamineの抑制効果","year":"1990","cit":0,"pfa":"充彦 中村","psa":"宏 奥田","ptype":"article","src":"https://openalex.org/W572178244","eid":"W572178244"},{"id":"paper-w7161488342","cat":"papers","name":"Mind Medicine Australia MacArthur Foundation 100&Change 2024 Expert Panel Review Results for an MDMA-Assisted Therapy Public Health Proposal for Veterans and First Responders","year":"2026","cit":0,"pfa":"Octavian Victor Brinzei","topics":["Depression","PTSD & trauma","Reviews & meta-analyses"],"ptype":"other","src":"https://openalex.org/W7161488342","eid":"W7161488342"},{"id":"paper-w7167423873","cat":"papers","name":"EFICÁCIA COMPARATIVA DE PSICODÉLICOS (PSILOCIBINA E MDMA) NO TRATAMENTO DE TRANSTORNO DE ESTRESSE PÓS-TRAUMÁTICO E DEPRESSÃO RESISTENTE AO TRATAMENTO: REVISÃO SISTEMÁTICA","year":"2026","cit":0,"pfa":"Pedro Martins Rabelo","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7167423873","eid":"W7167423873"},{"id":"paper-w2904492760","cat":"papers","name":"\"Interleuquina-1beta (il-1beta) y activación glial en la hipertermia y neurotoxicidad inducidas por 3,4-metilendioximetanfetamina (MDMA, \"éxtasis\") en la rata\"","year":"2005","cit":0,"pfa":"Laura Orío Ortiz","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2904492760","eid":"W2904492760"},{"id":"paper-w7130712582","cat":"papers","name":"Additional file 1 of “I’ve learned that I’m open-minded to this possibility”: A qualitative study to evaluate the acceptability of a psilocybin-aided smoking cessation treatment for people with HIV who smoke","year":"2025","cit":0,"pfa":"Patricia A. Cioe","psa":"Sarah Dugal","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7130712582","eid":"W7130712582"},{"id":"paper-w3033135173","cat":"papers","name":"Estudio de los mecanismos de neurotoxicidad de la 3,4-metilendioximentanfetamina (mdma,\"extasis\") tras su administracion en rata: nuevas respuestas a antiguos interrogants","year":"2007","cit":0,"pfa":"Beatriz Goñi‐Allo","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W3033135173","eid":"W3033135173"},{"id":"paper-w4403248178","cat":"papers","name":"Plain Language Summary Publication: Low‐dose psilocybin in short‐lasting unilateral neuralgiform headache attacks: Results from an open‐label phase Ib ascending dose study","year":"2024","cit":0,"pfa":"James Rucker","psa":"Manjit Singh Matharu","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4403248178","eid":"W4403248178"},{"id":"paper-w4312082640","cat":"papers","name":"Addictovigilance de la MDMA (ecstasy) en France : l’émergence de « nouvelles substances » ne doit pas éclipser le suivi sanitaire des plus anciennes","year":"2022","cit":0,"pfa":"Reynald Le Boisselier","psa":"Véronique Savignat","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4312082640","eid":"W4312082640"},{"id":"paper-w7202137817","cat":"papers","name":"Potential Role of Psychedelics in the Treatment of Depressive Disorder","year":"2026","cit":0,"pfa":"Sheng‐Min Wang","psa":"Won-Myong Bahk","topics":["Depression"],"ptype":"book-chapter","src":"https://openalex.org/W7202137817","eid":"W7202137817"},{"id":"paper-w2613504112","cat":"papers","name":"Avaliação do potencial terapêutico da ayahuasca na diminuição do consumo de álcool utilizando o procedimento IA2BC (intermittent access to 2 bottle choice) em ratos Wistar","year":"2016","cit":0,"pfa":"Stefany Sousa Alves","ptype":"article","src":"https://openalex.org/W2613504112","eid":"W2613504112"},{"id":"paper-w412858925","cat":"papers","name":"摇头丸（MDMA）的危害及其对免疫系统影响的研究进展","year":"2009","cit":0,"pfa":"陈锐","psa":"黄英华","ptype":"article","src":"https://openalex.org/W412858925","eid":"W412858925"},{"id":"paper-w4416622804","cat":"papers","name":"Peer Review Report For: Over 30 million psychedelic users in the United States [version 1; peer review: 2 approved]","year":"2013","cit":0,"pfa":"Teri Suzanne Krebs","psa":"Pål-Ørjan Johansen","topics":["Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4416622804","eid":"W4416622804"},{"id":"paper-w2997553873","cat":"papers","name":"Implicación de la vía kinurenina en los efectos inmediatos y a largo plazo inducidos por 3,4-metilendioximetanfetamina (MDMA, éxtasis) en cerebro de rata","year":"2019","cit":0,"pfa":"Cristina Abuin Martinez","topics":["Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W2997553873","eid":"W2997553873"},{"id":"paper-w4390270927","cat":"papers","name":"Psychedelic Therapy: A Primer for Primary Care Clinicians – Part I. Historical Perspective and Overview","year":"2023","cit":0,"pfa":"Burton Jared Tabaac","psa":"Owen S. Muir","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W4390270927","eid":"W4390270927"},{"id":"paper-w2970926766","cat":"papers","name":"Modelo de interacción de los alcaloides n.n dimetiltriptamina y harmina presentes en el ayahuasca con el receptor 5ht y la enzima Monoamino Oxidasa en humanos","year":"2011","cit":0,"pfa":"Rafael Eduardo Malagón Bernal","psa":"Manuel Alejandro Fernández Navas","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2970926766","eid":"W2970926766"},{"id":"paper-w4413274662","cat":"papers","name":"Exploring the Therapeutic Potential of Ketamine and Psilocybin in Comparison to Current Treatment Regimens for Treatment-Resistant Depression, Mood Disorders, and Post-traumatic Stress Disorder in the Pediatric Populatio","year":"2025","cit":0,"pfa":"Brett G.M. Hughes","psa":"Sudhakar Pemminati","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"review","src":"https://openalex.org/W4413274662","eid":"W4413274662"},{"id":"paper-w4416631486","cat":"papers","name":"Peer Review Report For: Over 30 million psychedelic users in the United States [version 1; peer review: 2 approved]","year":"2013","cit":0,"pfa":"Teri Suzanne Krebs","psa":"Pål-Ørjan Johansen","topics":["Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4416631486","eid":"W4416631486"},{"id":"paper-w7161481970","cat":"papers","name":"Mind Medicine Australia MacArthur Foundation 100&Change 2024 Expert Panel Review Results for an MDMA-Assisted Therapy Public Health Proposal for Veterans and First Responders","year":"2026","cit":0,"pfa":"Octavian Victor Brinzei","topics":["Depression","PTSD & trauma","Reviews & meta-analyses"],"ptype":"other","src":"https://openalex.org/W7161481970","eid":"W7161481970"},{"id":"paper-w2911534466","cat":"papers","name":"Cambios inducidos por cocaína sobre la neurotoxicidad de 3,4-metilendioximetanfetamina (mdma)en ratón: implicación del estrés oxidativo y del transportador de dopamina","year":"2009","cit":0,"pfa":"Ines Peraile Muñoz","ptype":"article","src":"https://openalex.org/W2911534466","eid":"W2911534466"},{"id":"paper-w7166328922","cat":"papers","name":"The purpose of the psychosocial protocol in the psychedelic-assisted therapy: A scoping review","year":"2026","cit":0,"pfa":"Flavia Giaffone de Paiva Ferreira","psa":"Thiago Marques Fidalgo","topics":["Addiction","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7166328922","eid":"W7166328922"},{"id":"paper-w7110986535","cat":"papers","name":"Additional file 1 of “I’ve learned that I’m open-minded to this possibility”: A qualitative study to evaluate the acceptability of a psilocybin-aided smoking cessation treatment for people with HIV who smoke","year":"2025","cit":0,"pfa":"Cioe, Patricia A.","psa":"Dugal, Sarah","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7110986535","eid":"W7110986535"},{"id":"paper-w1517927433","cat":"papers","name":"Contribuição individual dos enatiômeros isolados da 3,4-metilenodioximetanfetamina (MDMA) comparativamente com a mistura racêmica no estresse oxidativo hepático, renal e estriatal de ratos","year":"2012","cit":0,"pfa":"G Bosio","ptype":"dissertation","src":"https://openalex.org/W1517927433","eid":"W1517927433"},{"id":"paper-w4400943191","cat":"papers","name":"Forma-de-vida e pluralismo de oposição ao direito: as portas da justiça em Walter Benjamin, a rejeição franciscana ao direito no século XIV e a ayahuasca indígena","year":"2024","cit":0,"pfa":"João Paulo Salles Pinto","psa":"Leonel Severo Rocha","ptype":"article","src":"https://openalex.org/W4400943191","eid":"W4400943191"},{"id":"paper-w103088737","cat":"papers","name":"[Curso de formación en drogodependencias para farmacéuticos. Módulo 3: Septiembre-Noviembre 2009] Tema 7. El éxtasis (MDMA) y las drogas de diseño","year":"2009","cit":0,"pfa":"Francisco Javier Lopez-Munoz","psa":"Marisa López Gironés","ptype":"article","src":"https://openalex.org/W103088737","eid":"W103088737"},{"id":"paper-w2156411495","cat":"papers","name":"The Peyote Road: Religious Freedom and the Native American Church. By Thomas C. Maroukis. The Civilization of the American Indian Series, vol. 265. Norman: University of Oklahoma Press, 2010. xii + 281 pp. $29.95 cloth;","year":"2013","cit":0,"pfa":"Michael David McNally","ptype":"book-review","src":"https://openalex.org/W2156411495","eid":"W2156411495"},{"id":"paper-w7199393076","cat":"papers","name":"Desenvolvimento biblioteca forense de novas substâncias psicoativas e avaliação da interação de ADB-BUTINACA, MDMA e N-etilpentilona com a albumina sérica humana","year":"2025","cit":0,"pfa":"Isabella Ferreira Melo","ptype":"article","src":"https://openalex.org/W7199393076","eid":"W7199393076"},{"id":"paper-w199238206","cat":"papers","name":"Evaluación neuroquímica y funcional de los adrenoceptores alfa2 tras la administración de mdma. Implicación en el desarrollo de conductas orales para funcionales","year":"2001","cit":0,"pfa":"Aurora Arrúe","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W199238206","eid":"W199238206"},{"id":"paper-w4283830504","cat":"papers","name":"PENGUJIAN SELEKTIVITAS UJI KOLORIMETRI ( FAST BLUE B SALT) UNTUK IDENTIFIKASI METAMFETAMINA (MA) DAN METILENDIOKSIMETAMFETAMINA (MDMA) DALAM URINE DENGAN TLC, HPTLC DAN GCMS","year":"2022","cit":0,"pfa":"Supiyani","psa":"Debora M. Hutagaol","ptype":"article","src":"https://openalex.org/W4283830504","eid":"W4283830504"},{"id":"paper-w7133048038","cat":"papers","name":"Modelo de interacción de los alcaloides n.n dimetiltriptamina y harmina presentes en el ayahuasca con el receptor 5ht y la enzima Monoamino Oxidasa en humanos","year":"2011","cit":0,"pfa":"Rafael Eduardo Malagón Bernal","psa":"Manuel Alejandro Fernández Navas","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W7133048038","eid":"W7133048038"},{"id":"paper-w2962784624","cat":"papers","name":"Comparación de la capacidad antioxidante de cuatro metabolitos secundarios presentes en la planta amazónica Banisteriopsis caapi (Ayahuasca) frente a la N-acetil cisteína, fármaco antioxidante comercial","year":"2018","cit":0,"pfa":"Bravo Bernal","psa":"F. Muzitano Michelle","ptype":"dissertation","src":"https://openalex.org/W2962784624","eid":"W2962784624"},{"id":"paper-w4386544759","cat":"papers","name":"Classic Psychedelics for the Treatment of Depressive Disorders: An Update for Psychiatrists in Training","year":"2023","cit":0,"pfa":"Lawrence Canale","psa":"Jeremy Weleff","topics":["Depression","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4386544759","eid":"W4386544759"},{"id":"paper-w7212008675","cat":"papers","name":"Avaliação dos efeitos de diferentes doses de ayahuasca na inteligência e memória verbal de voluntários saudáveis: um estudo duplo-cego, randomizado e controlado com placebo","year":"2026","cit":0,"pfa":"Caio Cesar de Paula","topics":["Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7212008675","eid":"W7212008675"},{"id":"paper-w2429480728","cat":"papers","name":"Desenvolvimento e validação de metodologias para quantificação de 3,4 metilenodioximetanfetamina (MDMA) em comprimidos de ecstasy por cromatografia gasosa e ressonância magnética nuclear","year":"2016","cit":0,"pfa":"Nathália Siqueira Almeida","ptype":"dissertation","src":"https://openalex.org/W2429480728","eid":"W2429480728"},{"id":"paper-w431299375","cat":"papers","name":"ニュースになった毒(7)芸能人をむしばむ薬物 覚醒剤,MDMA,コカイン","year":"2009","cit":0,"pfa":"祖健 杜","ptype":"article","src":"https://openalex.org/W431299375","eid":"W431299375"},{"id":"paper-w4390617706","cat":"papers","name":"Optimization of Enantioselective High-Performance Liquid Chromatography-Tandem Mass Spectrometry Method for the Quantitative Determination of 3,4-Methylenedioxy-Methamphetamine (Mdma) and its Phase-1 Metabolites in Human","year":"2024","cit":0,"pfa":"Giorgia Sprega","psa":"Bezhan Chankvetadze","ptype":"preprint","src":"https://openalex.org/W4390617706","eid":"W4390617706"},{"id":"paper-w4401286170","cat":"papers","name":"Erratum for Protective Effects of Vitamin E on Heart and Testis Histology Following MDMA (Ecstasy) Exposure in Mice [Int J High Risk Behav Addict. 2018; 8(4):e84212]","year":"2024","cit":0,"pfa":"Seyed Soran Ghafori","psa":"Tahmineh Peirouvi","topics":["Addiction","Safety & adverse events"],"ptype":"erratum","src":"https://openalex.org/W4401286170","eid":"W4401286170"},{"id":"paper-w3181672659","cat":"papers","name":"N-ヒドロキシ-3,4-メチレンジオキシメタンフェタミン(N-OH MDMA)の薬物依存性並びに細胞毒性の評価","year":"2010","cit":0,"pfa":"秋武義治","psa":"和田清","ptype":"article","src":"https://openalex.org/W3181672659","eid":"W3181672659"},{"id":"paper-w747434473","cat":"papers","name":"Identificação dos inibidores de acetilcolinesterase em Tetrapterys mucronata Cav. (Malpighiaceae) e comparação quali e quantitativa dos derivados triptamícos presentes na espécie em estudo e Ayahuasca","year":"2013","cit":0,"pfa":"Marcos Marçal Ferreira Queiroz","ptype":"dissertation","src":"https://openalex.org/W747434473","eid":"W747434473"},{"id":"paper-w368518071","cat":"papers","name":"PsilocybinおよびLSDの精神身体症状におよぼす影響-1-LSDに就て","year":"1970","cit":0,"pfa":"五郎 中村","ptype":"article","src":"https://openalex.org/W368518071","eid":"W368518071"},{"id":"paper-w2504482445","cat":"papers","name":"Hallucinogens and Dissociatives","year":"2015","cit":0,"pfa":"Darius A. Rastegar","psa":"Michael Fingerhood","ptype":"book-chapter","src":"https://openalex.org/W2504482445","eid":"W2504482445"},{"id":"paper-w7117084829","cat":"papers","name":"PsyNamic: A living systematic review of psychedelic therapy in psychiatric disorders","year":"2025","cit":0,"pfa":"Vera Bernhard","psa":"Drummond E-Wen McCulloch","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W7117084829","eid":"W7117084829"},{"id":"paper-w4391882048","cat":"papers","name":"Corrigendum: Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlis","year":"2024","cit":0,"pfa":"Terence H. W. Ching","psa":"Benjamin Kelmendi","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"erratum","src":"https://openalex.org/W4391882048","eid":"W4391882048"},{"id":"paper-w4411378476","cat":"papers","name":"“Diversity makes the richness of humanity”: The emergence and persistence of mental imagery after self-reported psilocybin truffles intake in an autistic woman with “blind imagination” (aphantasia): A 33-month retrospect","year":"2025","cit":0,"pfa":"Kevin Rebecchi","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4411378476","eid":"W4411378476"},{"id":"paper-w7163184043","cat":"papers","name":"The Therapeutic Alliance's Moderating Role on the Negative Relationship Between Dread of Ego Dissolution and Changes in Depression Symptom Severity in Psilocybin-Assisted Therapy for Treatment-Resistant Depression: A Sec","year":"2026","cit":0,"pfa":"Canyon Akromis","psa":"James Rucker","topics":["Depression","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7163184043","eid":"W7163184043"},{"id":"paper-w3008075240","cat":"papers","name":"Self-reported patterns of MDMA use and their related beliefs.: Symposium abstracts: Society for the Study of Addiction: from biology to sociology: evidence base and implementation strategies for alcohol, drugs and tobacc","year":"2000","cit":0,"pfa":"Michelle Wareing","psa":"John E. Fisk","topics":["Addiction"],"ptype":"conference-paper","src":"https://openalex.org/W3008075240","eid":"W3008075240"},{"id":"paper-w4255420596","cat":"papers","name":"Consumidores de «speed» (metanfetamina): un viaje de ida y vuelta entre el «éxtasis» (MDMA) y la cocaína. Algunos aspectos clínicos, preventivos y asistenciales","year":"2004","cit":0,"pfa":"Jordi Royo-Isach","psa":"Leonardo Jesús Panta Ruiz","ptype":"article","src":"https://openalex.org/W4255420596","eid":"W4255420596"},{"id":"paper-w4315881169","cat":"papers","name":"Anti-Inflammatory Effects of Four Psilocybin-Containing Magic Mushroom Water Extracts in vitro on 15-Lipoxygenase Activity and on Lipopolysaccharide-Induced Cyclooxygenase-2 and Inflammatory Cytokines in Human U937 Macro","year":"2021","cit":0,"pfa":"SM Nkadimeng","psa":"Eloff JN","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4315881169","eid":"W4315881169"},{"id":"paper-w2292941149","cat":"papers","name":"MDMA（3,4亚甲基二氧甲基苯丙胺）对小鼠睾丸组织DNA的损伤","year":"2013","cit":0,"pfa":"赵忠桂","psa":"李雅欣","ptype":"article","src":"https://openalex.org/W2292941149","eid":"W2292941149"},{"id":"paper-w4396508753","cat":"papers","name":"Safety, tolerability, pharmacokinetics, pharmacodynamics and exploratory efficacy of intravenous dosing of SPL026 drug product (N, N-dimethyltryptamine fumarate; DMT Fumarate [A Serotonergic Psychedelic]) alone or in com","year":"2024","cit":0,"pfa":"Neel Bhatt","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"dataset","src":"https://openalex.org/W4396508753","eid":"W4396508753"},{"id":"paper-w3195212628","cat":"papers","name":"A influência do consumo da Ayahuasca em contexto ritual na cognição, temperamento e religiosidade: uma comparação entre usuários experientes e iniciantes do Centro Luz Divina, Piedade – SP","year":"2021","cit":0,"pfa":"Arilton Martins Fonseca","ptype":"dissertation","src":"https://openalex.org/W3195212628","eid":"W3195212628"},{"id":"paper-w2328032702","cat":"papers","name":"THOMAS CONSTANTINE MAROUKIS. Peyote and the Yankton Sioux: The Life and Times of Sam Necklace. Foreword by LEONARD R. BRUGUIER. (The Civilization of the American Indian Series, number 249.) Norman: University of Oklahoma","year":"2006","cit":0,"pfa":"Christopher Vecsey","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"book-review","src":"https://openalex.org/W2328032702","eid":"W2328032702"},{"id":"paper-w201926632","cat":"papers","name":"Implicación de la molécula de adhesión ALCAM en el daño cerebral: modelo de daño neuronal mediante la administración de MDMA/éxtasis en rata","year":"2013","cit":0,"pfa":"Elia Moreno Cubero","psa":"M. D. Gutiérrez López","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W201926632","eid":"W201926632"},{"id":"paper-w4394316166","cat":"papers","name":"Data From: Coe, M. A.; Gaoue, O. G. 2023. Increased clonal growth in heavily harvested ecosystems failed to rescue ayahuasca lianas from decline in the Peruvian Amazon rainforest. Journal of Applied Ecology.","year":"2023","cit":0,"pfa":"Michael A. Coe","psa":"Orou G. Gaoue","ptype":"dataset","src":"https://openalex.org/W4394316166","eid":"W4394316166"},{"id":"paper-w7135439437","cat":"papers","name":"Chiral separation and quantification of R/S-amphetamine, R/S-metamphetamine, R/S-MDA, R/S-MDMA and R/S-MDEA in whole blood by GC-EI-MS","year":"2006","cit":0,"pfa":"Louise Nygaard Rasmussen","psa":"Sys Stybe Johansen","ptype":"article","src":"https://openalex.org/W7135439437","eid":"W7135439437"},{"id":"paper-w998499663","cat":"papers","name":"台灣市面上販售之Salvia divinorum及台灣原生種鼠尾草中迷幻成分salvinorin A之含量檢測及管理探討","year":"2012","cit":0,"pfa":"林柏翔","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W998499663","eid":"W998499663"},{"id":"paper-w2580213572","cat":"papers","name":"Mejoramiento de la Solubilidad Acuosa de la fracción alcaloidea de Banisteriopsis Caapi (ayahuasca), mediante el desarrollo de dispersiones sólidas in vitro, utilizando tres tipos de polímeros Hidrofílicos","year":"2014","cit":0,"pfa":"Rodríguez Vinueza","psa":"Valeria Isabel","ptype":"dissertation","src":"https://openalex.org/W2580213572","eid":"W2580213572"},{"id":"paper-w3194135934","cat":"papers","name":"Optimización del método de extracción de β-carbolinas a partir de banisteriopsis caapi (ayahuasca) y caracterización del extracto para su posterior aplicación en modelos celulares con fines terapéuticos","year":"2020","cit":0,"pfa":"Pérez Marvit","psa":"María José","topics":["Anxiety & end-of-life"],"ptype":"dissertation","src":"https://openalex.org/W3194135934","eid":"W3194135934"},{"id":"paper-w1917071227","cat":"papers","name":"Los países en desarrollo y la política de la OMC relativa a la protección de invenciones biotecnológicas estudio del caso de la patente otorgada a la ayahuasca ecuatoriana","year":"2005","cit":0,"pfa":"Juanita Casas Castrillón","ptype":"dissertation","src":"https://openalex.org/W1917071227","eid":"W1917071227"},{"id":"paper-w2808045861","cat":"papers","name":"Estudo do efeito agudo dos compostos ativos do chá de Ayahuasca (Banisteriopsis Caapi e Psychotria Viridi), em saguis (Callithrix jacchus) como modelo animal de depressão juvenil","year":"2017","cit":0,"pfa":"Flávia Santos da Silva","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W2808045861","eid":"W2808045861"},{"id":"paper-w2767418535","cat":"papers","name":"Literature review: Considerations for Psychedelic Research","year":"2013","cit":0,"pfa":"Charlesice Hawkins","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2767418535","eid":"W2767418535"},{"id":"paper-w2283436586","cat":"papers","name":"9. «Salud, riesgo y uso religioso» en disputas por el estatus legal del so de ayahuasca: implicaciones y desenlaces de procesos judiciales ocurridos en los Estados Unidos","year":"2013","cit":0,"pfa":"Alberto Groisman","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2283436586","eid":"W2283436586"},{"id":"paper-w1583657388","cat":"papers","name":"N-metil-3,4 metilenodioximetanfetamina (MDMA - Ecstasy) diminui a resposta imune inata e a resistência à Listeria monocytogenes: papel do eixo HPA e do sistema nervoso simpático","year":"2011","cit":0,"pfa":"Viviane Ferraz de Paula","ptype":"dissertation","src":"https://openalex.org/W1583657388","eid":"W1583657388"},{"id":"paper-w205643350","cat":"papers","name":"Effects of combined applications of ethanol and 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) in vitro and in vivo : Focus on presynaptic 5-HT1b auto- and heteroreceptors and their possible overexpression using HSV-1","year":"2007","cit":0,"pfa":"Céline Riegert","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W205643350","eid":"W205643350"},{"id":"paper-w7214405809","cat":"papers","name":"Bibliometric analysis of scientific production on **psilocybin, depression, and anxiety** published between 2022 and 2026, based on structured searches executed on **5 September 2026** in Web of Science Core Collection,","year":"2026","cit":0,"pfa":"Andrea Estefanía Aranda Rosas","psa":"Miguel Á. Trejo-Rodríguez","topics":["Depression","Anxiety & end-of-life"],"ptype":"dataset","src":"https://openalex.org/W7214405809","eid":"W7214405809"},{"id":"paper-w4416510573","cat":"papers","name":"Peer Review Report For: Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocol [version 1; peer review: 1 approved, 3 approved with reservat","year":"2024","cit":0,"pfa":"Lorenzo Pasquini","topics":["Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4416510573","eid":"W4416510573"},{"id":"paper-w2411488159","cat":"papers","name":"[Studies on the identification of psychotropic substances (VII). Preparation and various analytical data of standard references of some hallucinogens, 3,4-methylenedioxyamphetamine (MDA), 3,4- methylenedioxymethamphetami","year":"1990","cit":0,"pfa":"MOCHIHIKO SHIMAMINE","psa":"Y Nakahara","topics":["Addiction"],"ptype":"other","src":"https://openalex.org/W2411488159","eid":"W2411488159"},{"id":"paper-w2469847235","cat":"papers","name":"Relevancia del género y de algunos polimorfismos genéticos en los efectos agudos y la farmacocinética de la ±3,4-metilendioximetanfetamina (MDMA, \"éxtasis\") en humanos","year":"2012","cit":0,"pfa":"Ricardo Pardo Lozano","topics":["Addiction","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W2469847235","eid":"W2469847235"},{"id":"paper-w4416512185","cat":"papers","name":"Peer Review Report For: Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocol [version 1; peer review: 1 approved, 3 approved with reservat","year":"2024","cit":0,"pfa":"Rayyan R. Zafar","topics":["Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4416512185","eid":"W4416512185"},{"id":"paper-w4250693254","cat":"papers","name":"Local Parabiotic Changes in the Brain Produced by Mescaline Poisoning. (Arch. Sci. Biol. [U.S.S.R.], vol. xlii, Nos. 1, 2, pp. 147–74 [in English, p. 294], 1936.) Aleksandrovskii, A. B., Babskii, E. B., and Kryazhev, B.","year":"1938","cit":0,"pfa":"W. A. P.","ptype":"article","src":"https://openalex.org/W4250693254","eid":"W4250693254"},{"id":"paper-w2280980129","cat":"papers","name":"Identificacao de 3,4-metilenodioximetanfetamina (MDMA) e compostos relacionados por cromatografia em fase gasosa e espectrometria de massas em comprimidos de ecstasy apreendidos em Sao Paulo","year":"1998","cit":0,"pfa":"Ovandir A. Silva","psa":"Vera Eliza Domingues Reinhardt","ptype":"article","src":"https://openalex.org/W2280980129","eid":"W2280980129"},{"id":"paper-w4416514292","cat":"papers","name":"Peer Review Report For: Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocol [version 1; peer review: 1 approved, 3 approved with reservat","year":"2024","cit":0,"pfa":"Manoj K. Doss","topics":["Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4416514292","eid":"W4416514292"},{"id":"paper-w4416519363","cat":"papers","name":"Peer Review Report For: Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocol [version 2; peer review: 3 approved, 1 approved with reservat","year":"2025","cit":0,"pfa":"Manoj K. Doss","topics":["Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4416519363","eid":"W4416519363"},{"id":"paper-w3113949750","cat":"papers","name":"Efficacité de la RPP dans la détection de substances issues des familles du MDMA, des amphétamines et des hallucinogènes type 2CB recueillies en milieu festif.","year":"2007","cit":0,"pfa":"Pradeille J.-L.","psa":"Daulouede J.-P.","topics":["Addiction"],"ptype":"conference-paper","src":"https://openalex.org/W3113949750","eid":"W3113949750"},{"id":"paper-w4409891811","cat":"papers","name":"The Difference between an Entheogen and Synthetic Psychedelic","year":"2025","cit":0,"pfa":"Charmaine Husum","topics":["Addiction","Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W4409891811","eid":"W4409891811"},{"id":"paper-w7214326008","cat":"papers","name":"Bibliometric analysis of scientific production on **psilocybin, depression, and anxiety** published between 2022 and 2026, based on structured searches executed on **5 September 2026** in Web of Science Core Collection,","year":"2026","cit":0,"pfa":"Andrea Estefanía Aranda Rosas","psa":"Miguel Á. Trejo-Rodríguez","topics":["Depression","Anxiety & end-of-life"],"ptype":"dataset","src":"https://openalex.org/W7214326008","eid":"W7214326008"},{"id":"paper-w4366993430","cat":"papers","name":"A EXPERIÊNCIA TRANSFORMADORA DE UM ENFERMEIRO DE ESTRATÉGIA DE SAÚDE DA FAMÍLIA COM A MEDICINA DA FLORESTA AYAHUASCA E O FORTALECIMENTO DA HUMANIZAÇÃO EM SAÚDE EM SEU LOCAL DE TRABALHO","year":"2023","cit":0,"pfa":"Thiago Santos Monção","ptype":"conference-paper","src":"https://openalex.org/W4366993430","eid":"W4366993430"},{"id":"paper-w4394440810","cat":"papers","name":"Additional file 3: of Gene expression analysis indicates reduced memory and cognitive functions in the hippocampus and increase in synaptic reorganization in the frontal cortex 3 weeks after MDMA administration in Dark","year":"2018","cit":0,"pfa":"Péter Petschner","psa":"György Bagdy","topics":["Mechanism & neuroscience"],"ptype":"dataset","src":"https://openalex.org/W4394440810","eid":"W4394440810"},{"id":"paper-w7167073096","cat":"papers","name":"Policy Considerations for Psychedelics in Research and Medicine – What’s Next on the Schedule?","year":"2026","cit":0,"pfa":"Matthew A. Boehm","psa":"Oriana Mayorga","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7167073096","eid":"W7167073096"},{"id":"paper-w7212120531","cat":"papers","name":"Cardiac Arrhythmia Associated with Psychoactive Drugs: An analysis of the FDA Adverse Event Reporting System","year":"2026","cit":0,"pfa":"Mori Jacob Krantz","psa":"David Peter Kao","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7212120531","eid":"W7212120531"},{"id":"paper-w4416510782","cat":"papers","name":"Peer Review Report For: Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocol [version 1; peer review: 1 approved, 3 approved with reservat","year":"2024","cit":0,"pfa":"Manesh Girn","topics":["Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4416510782","eid":"W4416510782"},{"id":"paper-w4394134621","cat":"papers","name":"Additional file 2: of Gene expression analysis indicates reduced memory and cognitive functions in the hippocampus and increase in synaptic reorganization in the frontal cortex 3 weeks after MDMA administration in Dark","year":"2018","cit":0,"pfa":"Péter Petschner","psa":"György Bagdy","topics":["Mechanism & neuroscience"],"ptype":"dataset","src":"https://openalex.org/W4394134621","eid":"W4394134621"},{"id":"paper-w4416519411","cat":"papers","name":"Peer Review Report For: Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocol [version 2; peer review: 3 approved, 1 approved with reservat","year":"2025","cit":0,"pfa":"Manesh Girn","topics":["Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4416519411","eid":"W4416519411"},{"id":"paper-w7164399561","cat":"papers","name":"Tendências globais do uso dos psicodélicos clássicos (psilocibina, dimetiltriptamina-DMT/ayahuasca, dietilamida do ácido lisérgico-LSD e mescalina) no tratamento dos transtornos mentais: uma análise cientométrica e metan","year":"2026","cit":0,"pfa":"Maria Nascimento","ptype":"dissertation","src":"https://openalex.org/W7164399561","eid":"W7164399561"},{"id":"paper-w2279653621","cat":"papers","name":"Anthropological Psychoanalysis of ReligionThe Ghost Dance: Origins of Religion. Weston La BarreThey Shall Take up Serpents: Psychology of the Southern Snake-Handling Cult. Weston La BarreThe Human Animal. Weston La Barre","year":"1971","cit":0,"pfa":"Mac Linscott Ricketts","ptype":"article","src":"https://openalex.org/W2279653621","eid":"W2279653621"},{"id":"paper-w2316139973","cat":"papers","name":"Acute Co-Administration of the Cannabinoid Receptor Agonist WIN 55- 212,2 does not Influence 3,4-Methylenedioxymetamphetamine (MDMA)- Induced Effects on Effort-Based Decision Making, Locomotion, Food Intake and Body Temp","year":"2014","cit":0,"pfa":"Hayn L Gundelach J","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2316139973","eid":"W2316139973"},{"id":"paper-w4249935467","cat":"papers","name":"Hallucinogenic Drugs","year":"2020","cit":0,"pfa":"Katherine R. Bonson","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"reference-entry","src":"https://openalex.org/W4249935467","eid":"W4249935467"},{"id":"paper-w4394230219","cat":"papers","name":"Additional file 4: of Gene expression analysis indicates reduced memory and cognitive functions in the hippocampus and increase in synaptic reorganization in the frontal cortex 3 weeks after MDMA administration in Dark","year":"2018","cit":0,"pfa":"Péter Petschner","psa":"György Bagdy","topics":["Mechanism & neuroscience"],"ptype":"dataset","src":"https://openalex.org/W4394230219","eid":"W4394230219"},{"id":"paper-w4394210490","cat":"papers","name":"Additional file 5: of Gene expression analysis indicates reduced memory and cognitive functions in the hippocampus and increase in synaptic reorganization in the frontal cortex 3 weeks after MDMA administration in Dark","year":"2018","cit":0,"pfa":"Péter Petschner","psa":"György Bagdy","topics":["Mechanism & neuroscience"],"ptype":"dataset","src":"https://openalex.org/W4394210490","eid":"W4394210490"},{"id":"paper-w7120685400","cat":"papers","name":"Estudo do potencial efeito neuroprotetor do canabidiol e seus análogos, bem como do N,N-dimetiltriptamina e da harmina, componentes da ayahuasca, frente à neurotoxicidade induzida pelo etanol","year":"2024","cit":0,"pfa":"Carolina Aparecida de Faria Almeida","topics":["Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W7120685400","eid":"W7120685400"},{"id":"paper-w836981082","cat":"papers","name":"Influence de la religion iboga sur la medecine traditionnelle et les soins de sante au gabon. \"etude effectuee en milieu fang dans le cadre de la confrerie erindzi douma du district de ntoum\"","year":"1986","cit":0,"pfa":"Jerome Mba Bitome","ptype":"dissertation","src":"https://openalex.org/W836981082","eid":"W836981082"},{"id":"paper-w4234005803","cat":"papers","name":"Psychomimetic Drugs, Marijuana, and 5-HT Antagonists","year":"2019","cit":0,"pfa":"Oscar E. Prospero-Garcia","psa":"René Drucker-Colı́n","topics":["Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W4234005803","eid":"W4234005803"},{"id":"paper-w4392429639","cat":"papers","name":"Survey finds new users of psychedelics report unusual visual experiences","year":"2024","cit":0,"topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4392429639","eid":"W4392429639"},{"id":"paper-w4394560791","cat":"papers","name":"Additional file 1: of Gene expression analysis indicates reduced memory and cognitive functions in the hippocampus and increase in synaptic reorganization in the frontal cortex 3 weeks after MDMA administration in Dark","year":"2018","cit":0,"pfa":"Péter Petschner","psa":"György Bagdy","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"dataset","src":"https://openalex.org/W4394560791","eid":"W4394560791"},{"id":"paper-w418478528","cat":"papers","name":"15N標識トレーサによる3,4-methylenedioxymethamphetamine(MDMA)光学異性体のラットにおける体内挙動","year":"2011","cit":0,"pfa":"毅 五郎丸","psa":"一樹 向井","ptype":"article","src":"https://openalex.org/W418478528","eid":"W418478528"},{"id":"paper-w4402656163","cat":"papers","name":"Psychedelics: a window into perceptual processing","year":"2024","cit":0,"pfa":"Berit “Brit” Brogaard","psa":"Dimitria Electra Gatzia","topics":["Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W4402656163","eid":"W4402656163"},{"id":"paper-w1543741791","cat":"papers","name":"Efeito do chá de ayahuasca sobre o comportamento de ratos Wistar no campo aberto e labirinto em cruz elevado e sobre a expressão de EAAC1 no hipocampo e córtex pré-frontal","year":"2014","cit":0,"pfa":"Luana Gonçalves Zamarrenho","ptype":"dissertation","src":"https://openalex.org/W1543741791","eid":"W1543741791"},{"id":"paper-w366675050","cat":"papers","name":"催幻覚薬に関する薬理学的研究(第1報):第2篇 Mescalineの一般薬理作用の検索","year":"1962","cit":0,"pfa":"英夫 星川","ptype":"article","src":"https://openalex.org/W366675050","eid":"W366675050"},{"id":"paper-w374595111","cat":"papers","name":"長期隔離飼育ハツカネズミの体重,攻撃性,肝臓glycogen量に及ぼすeserine,mescaline,aldosteroneおよびmethamphetamineの影響","year":"1973","cit":0,"pfa":"光章 佐野","ptype":"dissertation","src":"https://openalex.org/W374595111","eid":"W374595111"},{"id":"paper-w4405676368","cat":"papers","name":"MEDICINA DO ESPORTE E DROGAS ESTIMULANTES DO SNC: A INFLUÊNCIA DO MDMA (ECSTASY) E DERIVADOS NO METABOLISMO HUMANO, DESEMPENHO FÍSICO E ANABÓLICO DE PRATICANTES DE TREINAMENTO DE FORÇA","year":"2024","cit":0,"pfa":"Edson Carlos Zaher Rosa","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4405676368","eid":"W4405676368"},{"id":"paper-w7140780066","cat":"papers","name":"Enabling Stabilization, Purification, and Handling of Highly Reactive Catechol Metabolites of MDMA: Synthesis of 3,4-Dihydroxyamphetamine (HHA) and 3,4-Dihydroxymethamphetamine (HHMA) as Certified Reference Standards Add","year":"2026","cit":0,"pfa":"David Vonlanthen","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7140780066","eid":"W7140780066"},{"id":"paper-w3164004836","cat":"papers","name":"A utilização terapêutica da psilocibina como coadjuvante no tratamento do transtorno depressivo maior: uma revisão narrativa de literatura / The therapeutic use of psilocybin as an adjunct in the treatment of major depre","year":"2021","cit":0,"pfa":"Fabiana Venancio Santana Silva","psa":"David Filipe de Santana","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3164004836","eid":"W3164004836"},{"id":"paper-w2330476449","cat":"papers","name":"螢光性液相層析法對尿液中amphetamine、methamphetamine、MDMA、MDA及MDEA之高感度分析研究","year":"2006","cit":0,"pfa":"李坤泰","ptype":"article","src":"https://openalex.org/W2330476449","eid":"W2330476449"},{"id":"paper-w2769133001","cat":"papers","name":"Corrigendum to “The external gate of the human and Drosophila serotonin transporters requires a basic/acidic amino acid pair for 3,4-methylenedioxymethamphetamine (MDMA) translocation and the induction of substrate efflu","year":"2017","cit":0,"pfa":"Natalie R. Sealover","psa":"Loren Keith Henry","topics":["Mechanism & neuroscience"],"ptype":"erratum","src":"https://openalex.org/W2769133001","eid":"W2769133001"},{"id":"paper-w4390049483","cat":"papers","name":"Corrigendum to “In utero exposure to dexamethasone causes a persistent and age-dependent exacerbation of the neurotoxic effects and glia activation induced by MDMA in dopaminergic brain regions of C57BL/6J mice” [NeuroTo","year":"2023","cit":0,"pfa":"Giulia Costa","psa":"Micaela Morelli","ptype":"erratum","src":"https://openalex.org/W4390049483","eid":"W4390049483"},{"id":"paper-w7140422128","cat":"papers","name":"Enabling Stabilization, Purification, and Handling of Highly Reactive Catechol Metabolites of MDMA: Synthesis of 3,4-Dihydroxyamphetamine (HHA) and 3,4-Dihydroxymethamphetamine (HHMA) as Certified Reference Standards Add","year":"2026","cit":0,"pfa":"David Vonlanthen","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7140422128","eid":"W7140422128"},{"id":"paper-w7133333618","cat":"papers","name":"A repeated low-dose regimen of MDMA has transient next-day effects on locomotor activity, anxiety-like behavior, and brain serotonin levels, with no effect on anhedonia-like behavior, in both female and male rats","year":"2026","cit":0,"pfa":"Ava M. Mac","psa":"Shane Alan Perrine","topics":["PTSD & trauma","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7133333618","eid":"W7133333618"},{"id":"paper-w258296071","cat":"papers","name":"精神分裂病者の病像とPsilocybin,LSD-25反応に関する精神病理学的研究","year":"1972","cit":0,"pfa":"襄 三隅","ptype":"article","src":"https://openalex.org/W258296071","eid":"W258296071"},{"id":"paper-w4412664681","cat":"papers","name":"Sociodemographic and mental-health characteristics of psychedelic-assisted therapy participants: Latent class analysis of a cross-sectional, purposive online sample","year":"2025","cit":0,"pfa":"Dan Petrovitch","psa":"Heather Austin-Robillard","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W4412664681","eid":"W4412664681"},{"id":"paper-w4390146184","cat":"papers","name":"WITHDRAWN: Corrigendum to “In utero exposure to dexamethasone causes a persistent and age-dependent exacerbation of the neurotoxic effects and glia activation induced by MDMA in dopaminergic brain regions of C57BL/6J mic","year":"2023","cit":0,"pfa":"Giulia Costa","psa":"Micaela Morelli","ptype":"erratum","src":"https://openalex.org/W4390146184","eid":"W4390146184"},{"id":"paper-w4413353820","cat":"papers","name":"Psilocybin-assisted psychotherapy, combined antipsychotic and antidepressant treatment for bipolar depression, duration of birth control pill use and risk of depression, handgrip strength and cognitive function, mood dis","year":"2025","cit":0,"pfa":"Harold George Koenig","topics":["Depression","Safety & adverse events","Therapy practice"],"ptype":"editorial","src":"https://openalex.org/W4413353820","eid":"W4413353820"},{"id":"paper-w2910249486","cat":"papers","name":"Implicacion de la interleuquina-1 beta en el precondicionamiento por exposicion a 3,4-metilenodioximetanfetamina (MDMA, \"extasis\") frente a la neurotoxicidad producida por la droga en el cerebro de rata","year":"2011","cit":0,"pfa":"Andrea Mayado Colino","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2910249486","eid":"W2910249486"},{"id":"paper-w4383645896","cat":"papers","name":"Une nouvelle prise en charge innovante dans le traitement des troubles de stress post-traumatique : la thérapie assistée par MDMA, approche historique et analyse des protocoles actuels","year":"2023","cit":0,"pfa":"Filippo Dellanoce","psa":"Thomas Rabeyron","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4383645896","eid":"W4383645896"},{"id":"paper-w2601901908","cat":"papers","name":"Ταυτοχρόνος προσδιορισμός των ναρκωτικών ουσιών GHB, GBL, 14BD, MDMA, MDEA, MDA, KET, nor-KET στα ούρα με τη μέθοδο της απευθείας έγχυσης και της φασματομετρίας μαζών","year":"2015","cit":0,"pfa":"Ελένη Κουρτέση","ptype":"dissertation","src":"https://openalex.org/W2601901908","eid":"W2601901908"},{"id":"paper-w4413938593","cat":"papers","name":"Reply to Gattuso et al.: “Comments on ‘Striking long-term beneficial effects of single-dose psilocybin and psychedelic mushroom extract in the SAPAP3 rodent model of OCD-like excessive self-grooming’ by Brownstien et al.","year":"2025","cit":0,"pfa":"Michal Brownstien","psa":"Bernard Lerer","topics":["Dosing & pharmacology"],"ptype":"letter","src":"https://openalex.org/W4413938593","eid":"W4413938593"},{"id":"paper-w4415859275","cat":"papers","name":"Psychedelics and Dissociative Substances","year":"2025","cit":0,"pfa":"Hesham Maged","topics":["Addiction"],"ptype":"preprint","src":"https://openalex.org/W4415859275","eid":"W4415859275"},{"id":"paper-w4399259513","cat":"papers","name":"From Venerable Cultural Practices to Modern Psychological Solutions: Enter Entheogens into Mainstream Medicine","year":"2024","cit":0,"pfa":"Nicholas A Kerna","psa":"Uzoamaka Nwokorie","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4399259513","eid":"W4399259513"},{"id":"paper-w7106552661","cat":"papers","name":"DMT as the Prototype of a New Class of Crisis-Linked Endogenous Consciousness Modulators (cECMs)","year":"2025","cit":0,"pfa":"Swygert, John","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7106552661","eid":"W7106552661"},{"id":"paper-w7213431810","cat":"papers","name":"US federal aggregate production quotas for psychedelic substances, 2013 to 2026","year":"2026","cit":0,"pfa":"H. Tamba","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W7213431810","eid":"W7213431810"},{"id":"paper-w7213435727","cat":"papers","name":"US federal aggregate production quotas for psychedelic substances, 2013 to 2026","year":"2026","cit":0,"pfa":"H. Tamba","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W7213435727","eid":"W7213435727"},{"id":"paper-w3163554890","cat":"papers","name":"3,4-Methylenedioxymethamphetamine(MDMA)による精神毒性発現における脳由来神経栄養因子(BDNF)の関与","year":"2012","cit":0,"pfa":"毛利彰宏","psa":"鍋島俊隆","ptype":"article","src":"https://openalex.org/W3163554890","eid":"W3163554890"},{"id":"paper-w3092846049","cat":"papers","name":"Plan de exportación de ayahuasca en fundas de infusión desde la Asociación de Productores de Plantas Medicinales, parroquia Yaruquíes, provincia de Chimborazo para el mercado de, Ámsterdam - Holanda en el periodo 2017.","year":"2017","cit":0,"pfa":"Ramírez Hernández","psa":"Armando Bocchio Rubén","ptype":"dissertation","src":"https://openalex.org/W3092846049","eid":"W3092846049"},{"id":"paper-w7166815336","cat":"papers","name":"Psychedelics: Historical Context, Emerging Science, and Future Clinical Frontiers","year":"2026","cit":0,"pfa":"Vipul Janardan","psa":"SK Mathur","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7166815336","eid":"W7166815336"},{"id":"paper-w3131002145","cat":"papers","name":"Avaliação da variação morfológica, anatômica e fitoquímica de >i /i< (Spruce ex Griseb.) C.v. Morton e >i /i< Ruiz & Pav em diferentes ambientes, teor de alcaloides e citotoxicidade do chá Ayahuasca","year":"2020","cit":0,"pfa":"Ordilena Ferreira de Miranda","ptype":"dissertation","src":"https://openalex.org/W3131002145","eid":"W3131002145"},{"id":"paper-w4220921172","cat":"papers","name":"Hallucinogens","year":"2022","cit":0,"pfa":"William E. Schreiber","topics":["Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W4220921172","eid":"W4220921172"},{"id":"paper-w7162942623","cat":"papers","name":"Classic psychedelics and personality: An updated systematic review","year":"2026","cit":0,"pfa":"Anna Beatriz Vicentini","psa":"RAFAEL GUIMARÃES DOS SANTOS","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7162942623","eid":"W7162942623"},{"id":"paper-w7213402923","cat":"papers","name":"US federal aggregate production quotas for psychedelic substances, 2013 to 2026","year":"2026","cit":0,"pfa":"H. Tamba","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W7213402923","eid":"W7213402923"},{"id":"paper-w7138924647","cat":"papers","name":"Estudo histopatológico de diferentes formas farmacêuticas e vias de administração do chá de ayahuasca, administrado em ratos machos Wistar e quantificação dos seus metabólitos por cromatografia gasosa acoplada a espectro","year":"2026","cit":0,"pfa":"Lara Amaral Santos","psa":"Wilson Roberto Malfará","ptype":"book-chapter","src":"https://openalex.org/W7138924647","eid":"W7138924647"},{"id":"paper-w4406628720","cat":"papers","name":"La ayahuasca como tema y recurso narrativo en dos novelas peruanas: \"Las tres mitades de Ino Moxo y otros brujos de la Amazonía y Puka Allpa. Viaje hacia la selva invisible\"","year":"2025","cit":0,"pfa":"Julio César Penenrey Navarro","ptype":"article","src":"https://openalex.org/W4406628720","eid":"W4406628720"},{"id":"paper-w7106527558","cat":"papers","name":"DMT as the Prototype of a New Class of Crisis-Linked Endogenous Consciousness Modulators (cECMs)","year":"2025","cit":0,"pfa":"Swygert, John","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7106527558","eid":"W7106527558"},{"id":"paper-w4254805538","cat":"papers","name":"Hallucinogens","year":"1996","cit":0,"pfa":"Peter D Bryson","topics":["Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W4254805538","eid":"W4254805538"},{"id":"paper-w2810693291","cat":"papers","name":"弱い電気魚Gymnotus carapoにおける攻撃行動及び妨害回避反応 3,4‐メチレンジオキシメタンフェタミン(MDMA)の影響","year":"1997","cit":0,"pfa":"Alberto Capurro","psa":"Omar Macadar","ptype":"article","src":"https://openalex.org/W2810693291","eid":"W2810693291"},{"id":"paper-w2330046804","cat":"papers","name":"ChemInform Abstract: Indolalkaloide. 102. Mitt. Zwei aus Blättern von Tabernanthe iboga Baillon und von T. subsessilis Stapf isolierte neue Typen von Indolalkaloiden, Ibophyllidin, abgeleitet von Nor‐21(+)‐Pandolan und I","year":"1977","cit":0,"pfa":"Françoise Khuong‐Huu","psa":"Robert Goutarel","ptype":"article","src":"https://openalex.org/W2330046804","eid":"W2330046804"},{"id":"paper-w7152399124","cat":"papers","name":"NIRA Formal Experimental Protocol Version 4.0 — Integrated Series Edition: Geometric Coherence Window Detection in Microtubule Architectures — Anesthesia Convergence, Multi-Agent Pharmacological Tuning, and High-Density","year":"2026","cit":0,"pfa":"Damon Sasser","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"report","src":"https://openalex.org/W7152399124","eid":"W7152399124"},{"id":"paper-w7167746766","cat":"papers","name":"[Psychedelics and pyschodelic-associated psychotherapies - Who is PAP for after all?]","year":"2025","cit":0,"pfa":"Noémi Papp","psa":"Xénia Gonda","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7167746766","eid":"W7167746766"},{"id":"paper-w2966924707","cat":"papers","name":"Implicación de la respuesta inflamatoria en la toxicidad inducida por 3,4-metilenodioximetanfetamina (mdma) en cerebro de rata y su modulación por el agonista del receptor cannabinoide cb2 jwh-015","year":"2011","cit":0,"pfa":"Elisa Torres Lorite","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2966924707","eid":"W2966924707"},{"id":"paper-w2307048980","cat":"papers","name":"Psiquiatria cultural do uso ritualizado de um alucinogeno no contexto urbano : uma investigação dos estados de consciencia induzidos pela ingestão da ayahuasca no Santo Daime e União do Vegetal em moradores de São Paulo","year":"2001","cit":0,"pfa":"Paulo César Ribeiro Barbosa","psa":"Paulo Dalgalarrondo","ptype":"dissertation","src":"https://openalex.org/W2307048980","eid":"W2307048980"},{"id":"paper-w2969284943","cat":"papers","name":"Patron de distribucion y persistencia de la neurotoxicidad dopaminergica inducida por 3,4-metilenodioximetanfetamina (MDMA o extasis) en raton: papel de los receptores dopaminergicos y su impacto en la memoria","year":"2008","cit":0,"pfa":"Noelia Granado Martinez","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2969284943","eid":"W2969284943"},{"id":"paper-w2272558141","cat":"papers","name":"PADRÕES DE USO E DEPENDÊNCIA DE DROGAS NA CULTURA RAVE BRASILEIRA ? O IMPACTO DO CONSUMO DE MDMA/ECSTASY EM USUÁRIOS DE PORTO ALEGRE ? DESCRIÇÃO E RESULTADOS DO ESTUDO PILOTO.","year":"2009","cit":0,"pfa":"Nino César Marchi","psa":"Lysa Remy e Tatiana Otto Stock","ptype":"conference-abstract","src":"https://openalex.org/W2272558141","eid":"W2272558141"},{"id":"paper-w7152445175","cat":"papers","name":"NIRA Formal Experimental Protocol Version 4.0 — Integrated Series Edition: Geometric Coherence Window Detection in Microtubule Architectures — Anesthesia Convergence, Multi-Agent Pharmacological Tuning, and High-Density","year":"2026","cit":0,"pfa":"Damon Sasser","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"report","src":"https://openalex.org/W7152445175","eid":"W7152445175"},{"id":"paper-w7172186803","cat":"papers","name":"Classic Serotonergic Psychedelics in the Treatment of Eating Disorders: A Scoping Review","year":"2026","cit":0,"pfa":"Luca Steardo","psa":"Annarita Vignapiano","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7172186803","eid":"W7172186803"},{"id":"paper-w7202241626","cat":"papers","name":"An Exploratory Bibliometric Analysis of Psychedelic-Assisted Therapy Research in Mental Health: Co-Authorship Networks and Keyword Trends (2019–2024)","year":"2026","cit":0,"pfa":"Ashvind N. Adkins Singh","psa":"B. D. Hill","ptype":"article","src":"https://openalex.org/W7202241626","eid":"W7202241626"},{"id":"paper-w7170992923","cat":"papers","name":"Psychedelic Drugs","year":"2026","cit":0,"topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7170992923","eid":"W7170992923"},{"id":"paper-w7204997530","cat":"papers","name":"PSYCHEDELICS AND ENTACTOGENS IN PSYCHIATRY: PHARMACOLOGY, CLINICAL TRIAL EVIDENCE, AND REGULATORY CONSIDERATIONS","year":"2025","cit":0,"pfa":"Ifeyinwa Adar Opoku","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7204997530","eid":"W7204997530"},{"id":"paper-w3035145741","cat":"papers","name":"The addiction drugs and hyponatremia","year":"2020","cit":0,"pfa":"Niranjan Prasad","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3035145741","eid":"W3035145741"},{"id":"paper-w7170998516","cat":"papers","name":"Psychedelic Drugs","year":"2026","cit":0,"pfa":"Federico Durbano","psa":"Marco Otto Toscano","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7170998516","eid":"W7170998516"},{"id":"paper-w4247292622","cat":"papers","name":"Hallucinogens and narcotics alarm public","year":"1970","cit":0,"ptype":"other","src":"https://openalex.org/W4247292622","eid":"W4247292622"},{"id":"paper-w7124312498","cat":"papers","name":"Contextualizing Violence Risk Associated With Hallucinogens","year":"2026","cit":0,"pfa":"Tyler A. Durns","psa":"Greg Iannuzzi","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7124312498","eid":"W7124312498"},{"id":"paper-w4400050300","cat":"papers","name":"Structure of a Hallucinogen-Activated Gq-Coupled 5-HT2A Serotonin Receptor","year":"2024","cit":0,"pfa":"Ouliana Panova","psa":"Alpay Burak Seven","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4400050300","eid":"W4400050300"},{"id":"paper-w7117327267","cat":"papers","name":"A Systematic Review of the efficacy, safety, and Tolerability of Psychedelics in the Treatment of post-traumatic Stress Disorder","year":"2025","cit":0,"pfa":"Manasicha Wongpaiboon","psa":"Maddison Vail","topics":["PTSD & trauma","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7117327267","eid":"W7117327267"},{"id":"paper-w2082801220","cat":"papers","name":"The relationship between personality and post traumatic stress disorder","year":"2002","cit":0,"pfa":"Farāmarz Sohrābi","topics":["PTSD & trauma","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2082801220","eid":"W2082801220"},{"id":"paper-w194271431","cat":"papers","name":"覚せい剤、大麻、MDMA (若者と薬物乱用--ドラッグの闇から守るために) -- (薬物乱用の理解)","year":"2010","cit":0,"pfa":"堯子 井上","ptype":"article","src":"https://openalex.org/W194271431","eid":"W194271431"},{"id":"paper-w4400034863","cat":"papers","name":"Molecular insights into psychedelic drug action","year":"2024","cit":0,"pfa":"Roth B.L","psa":"DiBerto J.F","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4400034863","eid":"W4400034863"},{"id":"paper-w7140999332","cat":"papers","name":"Exploring the World of Psychedelics: An Introduction","year":"2024","cit":0,"pfa":"Franklin King IV","topics":["Safety & adverse events"],"ptype":"report","src":"https://openalex.org/W7140999332","eid":"W7140999332"},{"id":"paper-w7164031094","cat":"papers","name":"The effects of psychedelics on attention-deficit and hyperactivity disorder – a systematic review","year":"2026","cit":0,"pfa":"Helerin Raikkerus","psa":"Jari Tiihonen","topics":["Depression","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7164031094","eid":"W7164031094"},{"id":"paper-w364136120","cat":"papers","name":"Long-Term IsolationによりStressを起こさせたMouseの体重Aggressivenessおよび脳Acetylcholine消費率の変動に及ぼすMescalineの効果","year":"1971","cit":0,"pfa":"Masayuki Horibe","ptype":"article","src":"https://openalex.org/W364136120","eid":"W364136120"},{"id":"paper-w4395017345","cat":"papers","name":"Psychedelics in psychiatry","year":"2024","cit":0,"pfa":"RAFAEL GUIMARÃES DOS SANTOS","psa":"Jaime E. C. Hallak","ptype":"book-chapter","src":"https://openalex.org/W4395017345","eid":"W4395017345"},{"id":"paper-w4394918793","cat":"papers","name":"Therapeutics Uses of Psychedelics in patients with psychiatric disorders A Systematic Review","year":"2024","cit":0,"pfa":"Sarosh Nawaz","psa":"Ann Kashmer Yu","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"review","src":"https://openalex.org/W4394918793","eid":"W4394918793"},{"id":"paper-w943158038","cat":"papers","name":"Informando sobre el éxtasis: un análisis de las noticias vertidas en el último mes sobre MDMA vistas desde una perspectiva científica, junto con una recomendaciones básicas para un uso más seguro","year":"2002","cit":0,"pfa":"José Carlos Bouso","ptype":"article","src":"https://openalex.org/W943158038","eid":"W943158038"},{"id":"paper-w7168359165","cat":"papers","name":"Sex-dependent effects of psychedelics: review of evidence from rodent models","year":"2026","cit":0,"pfa":"Rafał Marecki","psa":"Kacper Łukasiewicz","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7168359165","eid":"W7168359165"},{"id":"paper-w3126672385","cat":"papers","name":"Estudio bibliométrico de artículos científicos de psicología sobre el uso terapéutico del MDMA para el abordaje de estrés postraumático de la base de datos EBSCOhost en periodo de tiempo de 2010 - 2020","year":"2020","cit":0,"pfa":"Mariana Daniela Canales García","psa":"Alexia Noelia Zuzunaga Gutierrez","topics":["PTSD & trauma","Addiction","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W3126672385","eid":"W3126672385"},{"id":"paper-w2237679018","cat":"papers","name":"MDMA（3，4亚甲基二氧甲基苯丙胺）对小鼠睾丸细胞微核率及染色体畸变率的影响","year":"2015","cit":0,"pfa":"赵忠桂","psa":"周业成","ptype":"article","src":"https://openalex.org/W2237679018","eid":"W2237679018"},{"id":"paper-w4402228344","cat":"papers","name":"Psychedelic-assisted therapy: Magical thinking or a meaningful treatment for mental illness","year":"2024","cit":0,"pfa":"Megha Kodancha","topics":["PTSD & trauma","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4402228344","eid":"W4402228344"},{"id":"paper-w4207062049","cat":"papers","name":"Psychedelics hold promise for primary care research","year":"2022","cit":0,"pfa":"James Bailey Sanford","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4207062049","eid":"W4207062049"},{"id":"paper-w7106812958","cat":"papers","name":"Best practices for first psychedelic experiences: harm reduction advice from the psychedelic community","year":"2025","cit":0,"pfa":"Kruger, Daniel J.","psa":"Boehnke, Kevin F.","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"other","src":"https://openalex.org/W7106812958","eid":"W7106812958"},{"id":"paper-w7106836156","cat":"papers","name":"Best practices for first psychedelic experiences: harm reduction advice from the psychedelic community","year":"2025","cit":0,"pfa":"Kruger, Daniel J.","psa":"Boehnke, Kevin F.","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"other","src":"https://openalex.org/W7106836156","eid":"W7106836156"},{"id":"paper-w4414736657","cat":"papers","name":"Ethical challenges in the therapeutic application of classical psychedelics for pediatric health conditions: A comprehensive review","year":"2025","cit":0,"pfa":"Pinelopi Vlotinou","psa":"Aspasia Serdari","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4414736657","eid":"W4414736657"},{"id":"paper-w7165566978","cat":"papers","name":"Psychedelics and related compounds in cluster headache and migraine: a systematic review and meta-analysis v1","year":"2026","cit":0,"pfa":"Camille Racca","psa":"Cécilie Cordier","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7165566978","eid":"W7165566978"},{"id":"paper-w7172025972","cat":"papers","name":"Psychedelic Renaissance: A New Paradigm in Mental Health","year":"2026","cit":0,"pfa":"A. Matas Ochoa","psa":"I. D. Sacristán","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"conference-abstract","src":"https://openalex.org/W7172025972","eid":"W7172025972"},{"id":"paper-w2945669083","cat":"papers","name":"Nouve applicazione dell'elettroforesi capillare nelle scienze forensi: separazione chirale di efedrina, amfetamina, metamfetamina, e dei princiapli componenti dell'\"ecstasy\" [3,4-metilen-diossi-metamfetamina (mdma), 3,4-","year":"1998","cit":0,"pfa":"Franco Tagliaro","psa":"M. Marigo","ptype":"article","src":"https://openalex.org/W2945669083","eid":"W2945669083"},{"id":"paper-w2292522233","cat":"papers","name":"3,4-Methylendioxymethamphetamine(MDMA)による高体温に対するmirtazapine及びfluoxetineの効果と作用機序についての検討","year":"2013","cit":0,"pfa":"Makiko Kasai","ptype":"dissertation","src":"https://openalex.org/W2292522233","eid":"W2292522233"},{"id":"paper-w4414955224","cat":"papers","name":"Efficacy and Safety of Psychoactive Tryptamines in Addiction: A Systematic Review","year":"2025","cit":0,"pfa":"Pim B. van der Meer","psa":"Albert Batalla","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4414955224","eid":"W4414955224"},{"id":"paper-w7106830260","cat":"papers","name":"Psychotomimetic to Mind-Manifesting","year":"2021","cit":0,"pfa":"Szczech, Klaudia","topics":["Addiction","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7106830260","eid":"W7106830260"},{"id":"paper-w2899649489","cat":"papers","name":"El uso de MDMA como un tratamiento coadyuvante a la psicoterapia grupal enfocada en el desarrollo de habilidades sociales para tratar el déficit social en pacientes adultos con trastorno del espectro autista de alto func","year":"2018","cit":0,"pfa":"García Cacciò","psa":"Giancarlo Alberto","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W2899649489","eid":"W2899649489"},{"id":"paper-w4391026101","cat":"papers","name":"Psychedelics for mental health: a biochemical perspective","year":"2024","cit":0,"pfa":"Javier González‐Maeso","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4391026101","eid":"W4391026101"},{"id":"paper-w4413243451","cat":"papers","name":"Psychedelic Awakenings","year":"2025","cit":0,"pfa":"Gary Laderman","ptype":"book-chapter","src":"https://openalex.org/W4413243451","eid":"W4413243451"},{"id":"paper-w7204973641","cat":"papers","name":"Efficacy and Safety of Psychoactive Tryptamines in Addiction: A Systematic Review","year":"2026","cit":0,"pfa":"Pim B. van der Meer","psa":"Diagnostiek & Vroege Psychose Medisch","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7204973641","eid":"W7204973641"},{"id":"paper-w7160887689","cat":"papers","name":"From monotherapy to sequential models: An updated scoping review on ibogaine’s role in treatment for psychiatric disorders","year":"2026","cit":0,"pfa":"Pravesh Sharma","psa":"Douglas B. Matthews","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7160887689","eid":"W7160887689"},{"id":"paper-w7147113808","cat":"papers","name":"Psychedelics and Their Clinical Use","year":"2026","cit":0,"pfa":"Sajeeka Jeyakumar","psa":"Erick Messias","ptype":"book-chapter","src":"https://openalex.org/W7147113808","eid":"W7147113808"},{"id":"paper-w4413187934","cat":"papers","name":"Psychedelic agents for treatment-resistant depression","year":"2022","cit":0,"pfa":"Natalie Gukasyan","psa":"Roland R. Griffiths","topics":["Depression"],"ptype":"book-chapter","src":"https://openalex.org/W4413187934","eid":"W4413187934"},{"id":"paper-w3001867576","cat":"papers","name":"Psychedelic therapy: Fresh promise for mental health","year":"2020","cit":0,"pfa":"Heidi Bush","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W3001867576","eid":"W3001867576"},{"id":"paper-w260389174","cat":"papers","name":"催幻覚薬に関する薬理学的研究(第1報):第1篇 Mescalineの中枢神経機能,殊に精神機能に及ぼす影響の検索","year":"1962","cit":0,"pfa":"英夫 星川","ptype":"article","src":"https://openalex.org/W260389174","eid":"W260389174"},{"id":"paper-w4291018630","cat":"papers","name":"SP56 Psychedelic drugs and pain","year":"2022","cit":0,"pfa":"Martina Rekatsina","psa":"Varrassi G","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"conference-paper","src":"https://openalex.org/W4291018630","eid":"W4291018630"},{"id":"paper-w58365570","cat":"papers","name":"Pharmacokinetic and pharmacodynamic interactions of indolealkylamine drugs of abuse","year":"2012","cit":0,"pfa":"Ai‐Ming Yu","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W58365570","eid":"W58365570"},{"id":"paper-w7167887905","cat":"papers","name":"Epigenetic landscapes of classical psychedelics and ketamine: molecular mechanisms of long-lasting neuromodulation","year":"2026","cit":0,"pfa":"C T Lin","psa":"Xiaohui Wang","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7167887905","eid":"W7167887905"},{"id":"paper-w4415151524","cat":"papers","name":"Psychedelics in the context of stress and psychiatric disorders: A new horizon in mental health treatment","year":"2025","cit":0,"pfa":"Sha Jin","psa":"Xiaohui Wang","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4415151524","eid":"W4415151524"},{"id":"paper-w403836548","cat":"papers","name":"34)Psilocybin投与による情動の変化と血中17-CHCSの動態(精神生理)(第8回日本精神身体医学会総会)","year":"1967","cit":0,"pfa":"望 諏訪","psa":"耗三 伊藤","ptype":"article","src":"https://openalex.org/W403836548","eid":"W403836548"},{"id":"paper-w649728736","cat":"papers","name":"催幻覚薬に関する薬理学的研究(第3報):第1篇 Psilocybinの文献的考察ことに中枢作用について","year":"1968","cit":0,"pfa":"Masahiro HORIBE","ptype":"article","src":"https://openalex.org/W649728736","eid":"W649728736"},{"id":"paper-w4417099564","cat":"papers","name":"Psychedelics as neuroplasticity enhancers: Mechanisms, therapeutic applications, and translational challenges","year":"2025","cit":0,"pfa":"Taslim Uddin","psa":"Kanak Yadab Ghosh","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4417099564","eid":"W4417099564"},{"id":"paper-w4318591507","cat":"papers","name":"Plant Medicine Healing! Discovering the Roots of Psychedelic-Assisted Therapy in Mental Health","year":"2023","cit":0,"pfa":"Jennings Hernandez","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4318591507","eid":"W4318591507"},{"id":"paper-w4414740466","cat":"papers","name":"B-302 Psychedelics and Dissociative Anesthetics: Concentrations in Suspected Impaired Driving Investigations, 2024","year":"2025","cit":0,"pfa":"Stephanie Marco","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"conference-abstract","src":"https://openalex.org/W4414740466","eid":"W4414740466"},{"id":"paper-w7130694548","cat":"papers","name":"Lifetime psychedelic use and opioid use disorder severity in a National Survey: the roles of psychedelic type and mental health","year":"2026","cit":0,"pfa":"Sebastian Ehmann","psa":"John J. B. Allen","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7130694548","eid":"W7130694548"},{"id":"paper-w7215332719","cat":"papers","name":"CHILE. Corte de Apelaciones de Rancagua -Sentencia- Deja sin efecto medida de prohibición de acercamiento de padre con su hija. El padre alega que la madre de la menor participaría en culto \"religioso\" en el cual se cons","year":"2026","cit":0,"pfa":"Equipo Editorial- Boletín Jurídico Observatorio de libertad religiosa de…","ptype":"article","src":"https://openalex.org/W7215332719","eid":"W7215332719"},{"id":"paper-w4414705353","cat":"papers","name":"Gestational LSD exposure in mouse rapidly reaches embryonic CSF and is associated with altered choroid plexus signaling, cerebral cortical development, and offspring behavior","year":"2025","cit":0,"pfa":"Ya’el Courtney","psa":"Maria K. Lehtinen","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4414705353","eid":"W4414705353"},{"id":"paper-w4413875569","cat":"papers","name":"Therapeutic Potential of Psychedelics: Mechanisms, Applications, and Challenges","year":"2025","cit":0,"pfa":"Guilllermo Castaño-Perez","psa":"Sara Isabel Castaño-Ocampo","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W4413875569","eid":"W4413875569"},{"id":"paper-w387309760","cat":"papers","name":"縫線核含有中脳切片培養系におけるメタンフェタミン、MDMAおよび 5-MeO-DiPT 長期処置によるセロトニン神経への影響","year":"2007","cit":0,"pfa":"貴之 中川","ptype":"article","src":"https://openalex.org/W387309760","eid":"W387309760"},{"id":"paper-w4416771409","cat":"papers","name":"New treatments for OCD? Evidence for cannabinoids and psychedelics","year":"2025","cit":0,"pfa":"Michael Van Ameringen","psa":"Maryam Rahat","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4416771409","eid":"W4416771409"},{"id":"paper-w4386371105","cat":"papers","name":"Revisión sobre estudios del uso de microdosificación con alucinógenos que combinan técnicas psicoterapéuticas con administraciones de LSD, MDMA o Psilocibina, como complementos farmacológicos en psicopatologías crónicas,","year":"2023","cit":0,"pfa":"Aldo Chiquini","topics":["Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4386371105","eid":"W4386371105"},{"id":"paper-w7128008256","cat":"papers","name":"Challenges with clinical trial participants in studies with classical psychedelics: A position statement from the National Network of Depression Centers’ task group on psychedelics and related compounds","year":"2026","cit":0,"pfa":"Benjamin R. Lewis","psa":"Frederick Streeter Barrett","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7128008256","eid":"W7128008256"},{"id":"paper-w4415381295","cat":"papers","name":"Psychedelics and time: Exploring altered temporal perception and its implications for consciousness, neuroscience, and therapy","year":"2025","cit":0,"pfa":"Pu Jiang","psa":"Xiaohui Wang","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4415381295","eid":"W4415381295"},{"id":"paper-w7115587785","cat":"papers","name":"Psychedelic-Assisted Therapy (Pat): A New Frontier in Mental Health Treatment","year":"2025","cit":0,"pfa":"M. H. M. Wickramasekara","psa":"G. D. M. C. Gonapaladeniya","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7115587785","eid":"W7115587785"},{"id":"paper-w2424891639","cat":"papers","name":"非水相毛細管電泳/低溫螢光分析法對尿液中3,4-亞甲雙氧甲基安非他命(3,4-MDMA)之分析研究","year":"2000","cit":0,"pfa":"鍾裕霖","ptype":"article","src":"https://openalex.org/W2424891639","eid":"W2424891639"},{"id":"paper-w4385669428","cat":"papers","name":"The suitability of zebrafish (danio rerio) as an optimal organism to further investigate the associated schizophrenia-like phenotype","year":"2023","cit":0,"pfa":"Ilinca-Bianca Nita","psa":"Romeo Dobrin","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4385669428","eid":"W4385669428"},{"id":"paper-w4381744623","cat":"papers","name":"THE THERAPEUTIC POTENTIAL OF PSYCHEDELICS FOR MENTAL HEALTH DISORDERS: A REVIEW OF CURRENT EVIDENCE","year":"2023","cit":0,"pfa":"Chirag Ambaliya","psa":"Krupa Mukeshbhai Unadkat","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4381744623","eid":"W4381744623"},{"id":"paper-w7214204610","cat":"papers","name":"Sex Differences and Sex-Specific Effects of Classical Serotonergic Psychedelics in Humans: A Scoping Review","year":"2026","cit":0,"pfa":"Anna Graue","psa":"Lea Julia Mertens","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"other","src":"https://openalex.org/W7214204610","eid":"W7214204610"},{"id":"paper-w3017294991","cat":"papers","name":"Psychedelics for Psychiatric Disorders: More Research Needed","year":"2020","cit":0,"pfa":"Nick Zagorski","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W3017294991","eid":"W3017294991"},{"id":"paper-w7125960911","cat":"papers","name":"Brain Dynamics of Classical Psychedelics Show Paradoxical Hierarchical Flattening With Increased Complexity","year":"2026","cit":0,"pfa":"Jakub Vohryzek","psa":"Yonatan Sanz-Perl","ptype":"preprint","src":"https://openalex.org/W7125960911","eid":"W7125960911"},{"id":"paper-w7135481711","cat":"papers","name":"Relationship between psychedelic experience and selected psychological phenomena","year":"2024","cit":0,"pfa":"Rita Kočárová","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7135481711","eid":"W7135481711"},{"id":"paper-w7172414035","cat":"papers","name":"Hallucinogens","year":"2026","cit":0,"pfa":"Martha S. Rosenthal","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W7172414035","eid":"W7172414035"},{"id":"paper-w7151630586","cat":"papers","name":"Psychedelic-assisted pharmacotherapy: clinical applications and regulatory considerations","year":"2026","cit":0,"pfa":"Donatella Marazziti","psa":"Federico Mucci","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7151630586","eid":"W7151630586"},{"id":"paper-w7171812723","cat":"papers","name":"Near-Death Experience Phenomenology in Ketamine and Psychedelic Research: A Curated Literature Dataset","year":"2026","cit":0,"pfa":"Michael Alvear","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"dataset","src":"https://openalex.org/W7171812723","eid":"W7171812723"},{"id":"paper-w169161140","cat":"papers","name":"催幻覚成分を含む植物由来物質,アヤワスカ(Ayahuasca)の単回使用により精神病症状の再燃を来した中毒精神病の1例","year":"2010","cit":0,"pfa":"真我 江崎","psa":"隆志 五味渕","ptype":"article","src":"https://openalex.org/W169161140","eid":"W169161140"},{"id":"paper-w2766489148","cat":"papers","name":"The Development and Regulation of Psychedelic Medicines","year":"2017","cit":0,"pfa":"Jonathan Nash","topics":["Addiction","Policy & ethics"],"ptype":"conference-paper","src":"https://openalex.org/W2766489148","eid":"W2766489148"},{"id":"paper-w7169101018","cat":"papers","name":"The polypharmacology of psychedelics reveals multiple targets for potential therapeutics","year":"2026","cit":0,"pfa":"Carl‐Mikael Suomivuori","psa":"David E.I. Gloriam","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7169101018","eid":"W7169101018"},{"id":"paper-w7171768937","cat":"papers","name":"Near-Death Experience Phenomenology in Ketamine and Psychedelic Research: A Curated Literature Dataset","year":"2026","cit":0,"pfa":"Michael Alvear","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"dataset","src":"https://openalex.org/W7171768937","eid":"W7171768937"},{"id":"paper-w7136015439","cat":"papers","name":"EEG correlates of the effect of serotonergic hallucinogens in the rat","year":"2016","cit":0,"pfa":"Čestmír Vejmola","topics":["Addiction","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W7136015439","eid":"W7136015439"},{"id":"paper-w4396866346","cat":"papers","name":"Psychedelics Use and the Risk of Reduced Formal Mental Health Care","year":"2024","cit":0,"pfa":"Sean M. Viña","topics":["Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4396866346","eid":"W4396866346"},{"id":"paper-w7160059393","cat":"papers","name":"The Ecstasy of Gold in Neurodiversity: Focus on the Use of Psychedelics in Autism Spectrum Disorder","year":"2026","cit":0,"pfa":"Stefano Marini","psa":"Domenico De Berardis","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7160059393","eid":"W7160059393"},{"id":"paper-w4291291513","cat":"papers","name":"What once was old is new again: The emergence of traditional stimulants and hallucinogens in Miami-Dade County postmortem casework","year":"2022","cit":0,"pfa":"Elisa N. Shoff","psa":"Diane M. Boland","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4291291513","eid":"W4291291513"},{"id":"paper-w7141114387","cat":"papers","name":"Examining the Combined Use of Psychedelics and Psychiatric Drugs","year":"2024","cit":0,"topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"report","src":"https://openalex.org/W7141114387","eid":"W7141114387"},{"id":"paper-w2516130710","cat":"papers","name":"Mechanism of Lysergic Acid Diethylamid Antibody Biosynthesis (LSD/amino acid analogue/isoelectric focusing)","year":"2016","cit":0,"pfa":"Edward W. Voss","psa":"Jeffrey L. Winkelha","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2516130710","eid":"W2516130710"},{"id":"paper-w4407387174","cat":"papers","name":"BEHAVIORAL ANALYSES OF ANTIDEPRESSANT-LIKE EFFECT OF SEROTONERGIC PSYCHEDELICS IN MICE","year":"2025","cit":0,"pfa":"Daisuke Ibi","psa":"Masayuki Hiramatsu","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4407387174","eid":"W4407387174"},{"id":"paper-w196012317","cat":"papers","name":"Psychological and Psychiatric Consequences of Hallucinogens","year":"1998","cit":0,"pfa":"Richard B. Seymour","psa":"David Eugene Smith","ptype":"book-chapter","src":"https://openalex.org/W196012317","eid":"W196012317"},{"id":"paper-w4398250619","cat":"papers","name":"On serotonin, psychedelics, entactogens and psychoplastogens in depression, anxiety, post-traumatic stress, and related disorders.","year":"2024","cit":0,"pfa":"Daniël Hoyer","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W4398250619","eid":"W4398250619"},{"id":"paper-w4304631776","cat":"papers","name":"19.1 Renaissance in Psychedelic Research","year":"2022","cit":0,"pfa":"Christopher Pittenger","ptype":"article","src":"https://openalex.org/W4304631776","eid":"W4304631776"},{"id":"paper-w4410043539","cat":"papers","name":"Evaluating the Effectiveness of Psychedelic-Assisted Therapy in Treating Alcohol Use Disorders: A Review","year":"2025","cit":0,"pfa":"Ritika Jagdeep Shah","psa":"Ashish Sarangi","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4410043539","eid":"W4410043539"},{"id":"paper-w4400050497","cat":"papers","name":"The promises and perils of psychedelic pharmacology for psychiatry","year":"2024","cit":0,"pfa":"McClure-Begley T.D","psa":"Roth B.L","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4400050497","eid":"W4400050497"},{"id":"paper-w2369791076","cat":"papers","name":"依存性薬物3,4-Methylenedioxymethamphetamine(MDMA)による高体温に対する非定型抗精神病薬risperidoneの有効性とその作用機序についての検討","year":"2008","cit":0,"pfa":"勝利 塩田","ptype":"dissertation","src":"https://openalex.org/W2369791076","eid":"W2369791076"},{"id":"paper-w4417428835","cat":"papers","name":"Psychedelics in Psychiatry: New Treatment Paradigms or Addictive Treatment Strategies? A Narrative Review","year":"2025","cit":0,"pfa":"Marco Otto Toscano","psa":"Federico Durbano","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W4417428835","eid":"W4417428835"},{"id":"paper-w7212009255","cat":"papers","name":"Wayfinder Atlas: Global Psychedelic-Therapy Legality Tracker","year":"2026","cit":0,"pfa":"Sascha Mayr","topics":["Addiction","Policy & ethics"],"ptype":"dataset","src":"https://openalex.org/W7212009255","eid":"W7212009255"},{"id":"paper-w7167688192","cat":"papers","name":"Wayfinder Atlas: Global Psychedelic-Therapy Legality Tracker","year":"2026","cit":0,"pfa":"Sascha Mayr","topics":["Addiction","Policy & ethics"],"ptype":"dataset","src":"https://openalex.org/W7167688192","eid":"W7167688192"},{"id":"paper-w7127630015","cat":"papers","name":"A psychedelic research agenda? The quest for therapeutic and legal legitimacy","year":"2026","cit":0,"pfa":"Muireann Quigley","psa":"Matt Hayler","topics":["PTSD & trauma","Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W7127630015","eid":"W7127630015"},{"id":"paper-w4405141401","cat":"papers","name":"The Potential of Psilocybe Genus Fungi to Treat Depression and Some Addictions","year":"2022","cit":0,"pfa":"Vanessa Eveline VLAIC","psa":"Andreea ONA","topics":["Depression","Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4405141401","eid":"W4405141401"},{"id":"paper-w7167737036","cat":"papers","name":"Theta Atlas: Global Psychedelic-Therapy Legality Tracker","year":"2026","cit":0,"pfa":"Sascha Mayr","topics":["Addiction","Policy & ethics"],"ptype":"dataset","src":"https://openalex.org/W7167737036","eid":"W7167737036"},{"id":"paper-w7201847384","cat":"papers","name":"Theta Atlas: Global Psychedelic-Therapy Legality Tracker","year":"2026","cit":0,"pfa":"Sascha Mayr","topics":["Addiction","Policy & ethics"],"ptype":"dataset","src":"https://openalex.org/W7201847384","eid":"W7201847384"},{"id":"paper-w7125127809","cat":"papers","name":"The 3D-ASCr scale: A revalidation of the core dimensions of the Altered States of Consciousness Rating Scale 5D(11)-ASC for psychedelic research","year":"2026","cit":0,"pfa":"Kurt Stocker","psa":"Matthias E. Liechti","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7125127809","eid":"W7125127809"},{"id":"paper-w4205162910","cat":"papers","name":"Dictionary of organic compounds the constitution and physical and chemical properties of the principal carbon compounds and their derivatives, together with the relevant literature references. (In four volumes.) 2nd ed.","year":"1954","cit":0,"ptype":"book-review","src":"https://openalex.org/W4205162910","eid":"W4205162910"},{"id":"paper-w3131877907","cat":"papers","name":"Nutzen von Psychedelika in der Psychotherapie","year":"2020","cit":0,"pfa":"Andreas Broocks","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W3131877907","eid":"W3131877907"},{"id":"paper-w4405099283","cat":"papers","name":"The Potential of Psilocybe Genus Fungi to Treat Depression and Some Addictions","year":"2022","cit":0,"pfa":"Vanessa Eveline VLAIC","psa":"Andreea ONA","topics":["Depression","Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4405099283","eid":"W4405099283"},{"id":"paper-w4394936223","cat":"papers","name":"Für ein besseres Verständnis anhaltender Wahrnehmungsstörungen nach der Einnahme klassischer Psychedelika","year":"2024","cit":0,"pfa":"Stefan Borgwardt","psa":"Uwe Herwig","topics":["Depression","Therapy practice"],"ptype":"editorial","src":"https://openalex.org/W4394936223","eid":"W4394936223"},{"id":"paper-w4295138759","cat":"papers","name":"Reporting on Adverse Clinical Events","year":"2022","cit":0,"topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4295138759","eid":"W4295138759"},{"id":"paper-w4233828914","cat":"papers","name":"Psychopharmacology II: Psychedelic Drugs","year":"2017","cit":0,"pfa":"Frank Villafana","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"book-chapter","src":"https://openalex.org/W4233828914","eid":"W4233828914"},{"id":"paper-w4416229569","cat":"papers","name":"A Comparative Neurophenomenology of the Psychedelic State and Autism: Predictive Processing as a Unifying Lens","year":"2025","cit":0,"pfa":"William Roseby","psa":"Catriona Osborn Moar","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4416229569","eid":"W4416229569"},{"id":"paper-w7213457361","cat":"papers","name":"High ventilation breathwork as a non-pharmacological model for inducing psychedelic-like states: expert evaluations of therapeutic potential and risk","year":"2026","cit":0,"pfa":"Ulrike Lueken","psa":"Laura Stefanie Daedelow","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7213457361","eid":"W7213457361"},{"id":"paper-w7110568410","cat":"papers","name":"Efficacy of Psychedelics Therapy Across Psychiatric Disorders: An Umbrella Review of Meta-Analyses","year":"2025","cit":0,"pfa":"Lopez, Alissa A","psa":"Lopez-Alvarenga, Juan C","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7110568410","eid":"W7110568410"},{"id":"paper-w7166481212","cat":"papers","name":"Vaporized mebufotenin leads to improvement in treatment‐resistant depression","year":"2026","cit":0,"topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7166481212","eid":"W7166481212"},{"id":"paper-w7135100807","cat":"papers","name":"Strategic Neurodelivery of Psychedelic Compounds: Bridging Molecular Pharmacology with Therapeutic Innovation in CNS Disorders","year":"2026","cit":0,"pfa":"Shikha Baghel Chauhan","psa":"Indu Singh","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7135100807","eid":"W7135100807"},{"id":"paper-w7212026700","cat":"papers","name":"410. Comparative neurophysiological signatures of psychedelics, stimulants and anesthetics in rodent cortical activity","year":"2026","cit":0,"pfa":"B Richardson","psa":"Gabriella Gobbi","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7212026700","eid":"W7212026700"},{"id":"paper-w2030935930","cat":"papers","name":"CHROMOSOME ABNORMALITY IN OFFSPRING OF LSD USER. D TRISOMY WITH D/D TRANSLOCATION","year":"1970","cit":0,"pfa":"Lillian Y. F. Hsu","psa":"Kurt Hirschhorn","ptype":"article","src":"https://openalex.org/W2030935930","eid":"W2030935930"},{"id":"paper-w4413310980","cat":"papers","name":"Psychedelics’ Intoxicating Impact and Behavioural Dynamics","year":"2025","cit":0,"pfa":"Afshan Zeeshan Wasti","topics":["Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W4413310980","eid":"W4413310980"},{"id":"paper-w7171946191","cat":"papers","name":"A Molecule-Resolved Bibliometric Analysis of PubMed-Indexed Psychedelic Research (2015–2025): Volume, Temporal Trends, and Publication Types","year":"2026","cit":0,"pfa":"M. Pastuszak","psa":"Wiesław Jerzy Cubała","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7171946191","eid":"W7171946191"},{"id":"paper-w4415775208","cat":"papers","name":"Lifetime Psychedelic Use and Opioid Use Disorder Severity: Substance-Use Pattern Specific and Mental Health–Dependent Associations in a National Survey","year":"2025","cit":0,"pfa":"Sebastian Ehmann","psa":"John J. B. Allen","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4415775208","eid":"W4415775208"},{"id":"paper-w7204005858","cat":"papers","name":"Adverse Effect-Related Language in Recreational Psychedelic and non-Psychedelic Substance Experience Reports","year":"2026","cit":0,"pfa":"Adrian Hase","psa":"Gregor Hasler","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7204005858","eid":"W7204005858"},{"id":"paper-w2774369609","cat":"papers","name":"LSD and Freedom of Religion","year":"1966","cit":0,"pfa":"Lorraine A. Smith","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2774369609","eid":"W2774369609"},{"id":"paper-w4409833807","cat":"papers","name":"[Treatment with psychedelics : potential benefits in Parkinson's disease].","year":"2025","cit":0,"pfa":"Louise E. Penzenstadler","psa":"Vanessa Fleury","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"other","src":"https://openalex.org/W4409833807","eid":"W4409833807"},{"id":"paper-w2286548504","cat":"papers","name":"Differential regulation of serotonin 2A receptor responsiveness by agonist-directed interactions with beta-arrestin2","year":"2011","cit":0,"pfa":"Cullen L. Schmid","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2286548504","eid":"W2286548504"},{"id":"paper-w7112971088","cat":"papers","name":"Comparative Efficacy of Hallucinogens in Treating Mood Disorders Through a Meta-Analysis of Symptom Reduction, Dosage, and Duration","year":"2025","cit":0,"pfa":"Muniz, John Marco D.F.","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W7112971088","eid":"W7112971088"},{"id":"paper-w2949903776","cat":"papers","name":"Serotonin and the psychedelics","year":"2019","cit":0,"pfa":"Mitul Ashok Mehta","psa":"Mark David Tricklebank","topics":["Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W2949903776","eid":"W2949903776"},{"id":"paper-w7172008736","cat":"papers","name":"The Experience-Trajectory Framework: Substance-Specific Risk Stratification for Psychedelic Preparation and Aftercare Beyond Set and Setting","year":"2026","cit":0,"pfa":"Elias Rubenstein","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7172008736","eid":"W7172008736"},{"id":"paper-w3162353370","cat":"papers","name":"Behavioral and pharmacological characterization of 3,4-methylenedioxymethamphetamine, its enantiomers, and related compounds.","year":"2002","cit":0,"pfa":"William E. Fantegrossi","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W3162353370","eid":"W3162353370"},{"id":"paper-w2259747732","cat":"papers","name":"以毛細管電泳螢光光譜法對尿液及藥錠中3,4-亞甲雙氧甲基安非他命(3,4-MDMA)及相關濫用藥物光學異構物之分析研究","year":"2005","cit":0,"pfa":"黃鈺珊","ptype":"article","src":"https://openalex.org/W2259747732","eid":"W2259747732"},{"id":"paper-w633089920","cat":"papers","name":"Blood Levels of LSD 25 in Cat","year":"1955","cit":0,"pfa":"Julius Axelrod","ptype":"article","src":"https://openalex.org/W633089920","eid":"W633089920"},{"id":"paper-w7139912224","cat":"papers","name":"Psychedelics and Mental Health in Endurance Athletes: A Cross-Sectional Study in Brazil","year":"2026","cit":0,"pfa":"Marina A. M. Portes","psa":"Leandro Jose Bertoglio","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7139912224","eid":"W7139912224"},{"id":"paper-w54220930","cat":"papers","name":"LSD: An Analysis of the Literature Concerning its Use in the Therapy of Alcoholism","year":"1967","cit":0,"pfa":"Patti Lyddon","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W54220930","eid":"W54220930"},{"id":"paper-w7212073389","cat":"papers","name":"843. Not all who wander are lost – Might psychedelics alleviate neurodegeneration and depression in dementia?","year":"2026","cit":0,"pfa":"J.D. Vieira-Andrade","psa":"M Brito","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"conference-abstract","src":"https://openalex.org/W7212073389","eid":"W7212073389"},{"id":"paper-w7212070291","cat":"papers","name":"Psychedelic 4-AcO-DMT attenuated looming-induced freezing behaviors by activating PrL CaMKIIα neurons in mice","year":"2026","cit":0,"pfa":"Ke Xia","psa":"Haitao Yan","ptype":"article","src":"https://openalex.org/W7212070291","eid":"W7212070291"},{"id":"paper-w4414447517","cat":"papers","name":"Electrodynamics of the Psychedelic Experience","year":"2025","cit":0,"pfa":"Tamlyn Hunt","topics":["Addiction","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4414447517","eid":"W4414447517"},{"id":"paper-w7204668353","cat":"papers","name":"Microdosing Psychedelics: A Systematic Review of Human Studies and Registered Clinical Trials","year":"2025","cit":0,"pfa":"Arun Chinna‐Meyyappan","psa":"Joshua Rosenblat","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"review","src":"https://openalex.org/W7204668353","eid":"W7204668353"},{"id":"paper-w4392949566","cat":"papers","name":"Psychedelics: The New Kid on the Block","year":"2024","cit":0,"pfa":"Prosenjit Ghosh","psa":"Avinash Desousa","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4392949566","eid":"W4392949566"},{"id":"paper-w4412832634","cat":"papers","name":"Psychedelics‐Inspired Drug Discovery","year":"2025","cit":0,"pfa":"Alan Gibbs","psa":"Tanweer A. Khan","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"other","src":"https://openalex.org/W4412832634","eid":"W4412832634"},{"id":"paper-w4392799517","cat":"papers","name":"Scanning the new frontier of mental health: psychedelic brain imaging","year":"2024","cit":0,"pfa":"Natalie Ertl","psa":"Matthew B. Wall","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4392799517","eid":"W4392799517"},{"id":"paper-w4286648699","cat":"papers","name":"THE BENEFITS OF PSYCHEDELIC THERAPY FOR MENTAL HEALTH: EXPLORING PSYCHEDELICS","year":"2022","cit":0,"pfa":"Liliana Irizabal","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"report","src":"https://openalex.org/W4286648699","eid":"W4286648699"},{"id":"paper-w7118016845","cat":"papers","name":"Behavioral effects of psychedelic and non-psychedelic serotonin 2A receptor agonist drugs in pigs","year":"2026","cit":0,"pfa":"CA Madsen","psa":"G.M. Knudsen","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7118016845","eid":"W7118016845"},{"id":"paper-w4255075678","cat":"papers","name":"Hallucinogens","year":"1990","cit":0,"pfa":"H. Thomas Milhorn","ptype":"book-chapter","src":"https://openalex.org/W4255075678","eid":"W4255075678"},{"id":"paper-w4206397546","cat":"papers","name":"The Hallucinogens","year":"1968","cit":0,"pfa":"Samuel Henry Kraines","ptype":"article","src":"https://openalex.org/W4206397546","eid":"W4206397546"},{"id":"paper-w4241117630","cat":"papers","name":"Hallucinogens","year":"2011","cit":0,"pfa":"Michael John Weaver","ptype":"reference-entry","src":"https://openalex.org/W4241117630","eid":"W4241117630"},{"id":"paper-w4404119411","cat":"papers","name":"Review of trials finds psychedelics generally well‐tolerated","year":"2024","cit":0,"topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4404119411","eid":"W4404119411"},{"id":"paper-w232435412","cat":"papers","name":"The genus psilocybe","year":"1984","cit":0,"pfa":"Richard Evans Schultes","ptype":"book-review","src":"https://openalex.org/W232435412","eid":"W232435412"},{"id":"paper-w1589677194","cat":"papers","name":"Products from Catha edulis and Lophophora williamsii","year":"2003","cit":0,"pfa":"Michael Cole","ptype":"other","src":"https://openalex.org/W1589677194","eid":"W1589677194"},{"id":"paper-w4245971954","cat":"papers","name":"Hallucinogens","year":"2018","cit":0,"pfa":"Michael F. Weaver","ptype":"reference-entry","src":"https://openalex.org/W4245971954","eid":"W4245971954"},{"id":"paper-w4384523308","cat":"papers","name":"Leveraging psychedelic therapies for binge eating disorder","year":"2023","cit":0,"pfa":"Jim Gilligan","topics":["Safety & adverse events","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4384523308","eid":"W4384523308"},{"id":"paper-w4389613923","cat":"papers","name":"Studying classic psychedelics for the management of headache disorders: Considerations for Veterans","year":"2023","cit":0,"pfa":"Emmanuelle A. D. Schindler","psa":"Jason Jonathon Sico","topics":["PTSD & trauma","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4389613923","eid":"W4389613923"},{"id":"paper-w7204018301","cat":"papers","name":"STRUCTURALLY SIMPLIFIED ANALOGUES OF LSD FOR THE TREATMENT OF CNS DISORDERS","year":"2026","cit":0,"pfa":"Michael James; id_orcid 0000-0002-0359-732X Nutt","psa":"Scott Gordon; id_orcid 0000-0002-7537-247X Stewart","ptype":"other","src":"https://openalex.org/W7204018301","eid":"W7204018301"},{"id":"paper-w7172419785","cat":"papers","name":"Role of β-Arrestin2 Signaling in Neuropharmacological Effects of Psychedelic Drugs","year":"2026","cit":0,"pfa":"Aurelija Ippolito","psa":"Trevor Sharp","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7172419785","eid":"W7172419785"},{"id":"paper-w4214778046","cat":"papers","name":"G. Reichel-Dolmatoff: The Shaman and the Jaguar: A Study of Narcotic Drugs among the Indians of Colombia (Philadelphia, Temple University Press, 1975, $15.oo). Pp. xxi+280. - Fernando Benítez: In the Magic Land of Peyote","year":"1976","cit":0,"pfa":"Peter Rivière","ptype":"book-review","src":"https://openalex.org/W4214778046","eid":"W4214778046"},{"id":"paper-w4243488602","cat":"papers","name":"LSD","year":"2003","cit":0,"pfa":"Allister Vale","ptype":"article","src":"https://openalex.org/W4243488602","eid":"W4243488602"},{"id":"paper-w4379659828","cat":"papers","name":"Italian psychedelic therapies of the past century: An historical overview","year":"2023","cit":0,"pfa":"Adriana D’Arienzo","psa":"Giorgio Samorini","topics":["Depression","Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4379659828","eid":"W4379659828"},{"id":"paper-w4210441740","cat":"papers","name":"Tripping on Entropy: LSD in Pynchon’s The Crying of Lot 49","year":"2022","cit":0,"pfa":"Dylan M. Schellenberg","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4210441740","eid":"W4210441740"},{"id":"paper-w4401921810","cat":"papers","name":"Current situation regarding psychedelics and magic mushroom in Korea","year":"2024","cit":0,"pfa":"J. S. Seo","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4401921810","eid":"W4401921810"},{"id":"paper-w7152048949","cat":"papers","name":"NIRA Formal Experimental Protocol Version 3.0 — Geometric Coherence Window Detection in Microtubule Architectures: Multi-Agent Pharmacological Tuning with High-Density EEG","year":"2026","cit":0,"pfa":"Damon Sasser","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"report","src":"https://openalex.org/W7152048949","eid":"W7152048949"},{"id":"paper-w7151613196","cat":"papers","name":"Your brain on drugs: different psychedelics work in surprisingly similar ways","year":"2026","cit":0,"pfa":"Miryam Naddaf","ptype":"article","src":"https://openalex.org/W7151613196","eid":"W7151613196"},{"id":"paper-w4415749444","cat":"papers","name":"“It Fueled the Fire to Who I Am Now”: Exploring Motivations for Microdosing Psychedelics","year":"2025","cit":0,"pfa":"Blake Beaton","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4415749444","eid":"W4415749444"},{"id":"paper-w7152043013","cat":"papers","name":"NIRA Formal Experimental Protocol Version 3.0 — Geometric Coherence Window Detection in Microtubule Architectures: Multi-Agent Pharmacological Tuning with High-Density EEG","year":"2026","cit":0,"pfa":"Damon Sasser","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"report","src":"https://openalex.org/W7152043013","eid":"W7152043013"},{"id":"paper-w4367017439","cat":"papers","name":"Beckley raises funds for psychedelic drugs","year":"2021","cit":0,"pfa":"Ryan W. Cross","topics":["Depression","Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W4367017439","eid":"W4367017439"},{"id":"paper-w4256481672","cat":"papers","name":"Chemical Concepts of Psychosis: Proceedings of the Symposium on Chemical Concepts of Psychosis held at the Second International Congress of Psychiatry in Zurich, Switzerland, September 1 to 7, 1957","year":"1959","cit":0,"topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4256481672","eid":"W4256481672"},{"id":"paper-w3044551396","cat":"papers","name":"21 Psychedelic treatment of functional neurological disorder – a systematic review","year":"2020","cit":0,"pfa":"Matthew Butler","psa":"James Rucker","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W3044551396","eid":"W3044551396"},{"id":"paper-w4249500571","cat":"papers","name":"LSD","year":"2018","cit":0,"pfa":"C. Vidal","psa":"W.-R. Külpmann","ptype":"book-chapter","src":"https://openalex.org/W4249500571","eid":"W4249500571"},{"id":"paper-w4401151608","cat":"papers","name":"Expanding Mindscapes: A Global History of Psychedelics. By ErikaDyck, ChrisElcock (Eds.), Cambridge, MA: The MIT Press. 2023. ISBN: 9780262546935","year":"2024","cit":0,"pfa":"Peder Clark","topics":["Addiction","Dosing & pharmacology"],"ptype":"book-review","src":"https://openalex.org/W4401151608","eid":"W4401151608"},{"id":"paper-w7160276832","cat":"papers","name":"Investigating Psychedelic Tryptamines: Extraction and Quantification from Psilocybe Mushrooms","year":"2026","cit":0,"pfa":"Beatriz P. Senra","psa":"Carlos J. A. Ribeiro","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7160276832","eid":"W7160276832"},{"id":"paper-w4391033677","cat":"papers","name":"Corrigendum to: Introduction to the chemistry and pharmacology of psychedelic drugs","year":"2024","cit":0,"pfa":"Scott R. Walker","psa":"Peter J. Duggan","topics":["Dosing & pharmacology"],"ptype":"erratum","src":"https://openalex.org/W4391033677","eid":"W4391033677"},{"id":"paper-w7140165772","cat":"papers","name":"Modulating the Thermodynamics and Kinetics of Psychedelics at Serotonin Receptors via Terahertz Waves","year":"2026","cit":0,"pfa":"Cong Zhang","psa":"Xiaohui Wang","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7140165772","eid":"W7140165772"},{"id":"paper-w10441800","cat":"papers","name":"Entheogens as a bridge between paranormal and religious experience","year":"2008","cit":0,"pfa":"David P. Luke","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W10441800","eid":"W10441800"},{"id":"paper-w4391362024","cat":"papers","name":"Hallucinogens: Altering Reality or Helping?","year":"2024","cit":0,"pfa":"John Brick","topics":["Depression","PTSD & trauma","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W4391362024","eid":"W4391362024"},{"id":"paper-w3186838209","cat":"papers","name":"Decision letter: Transcriptomics-informed large-scale cortical model captures topography of pharmacological neuroimaging effects of LSD","year":"2021","cit":0,"topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"peer-review","src":"https://openalex.org/W3186838209","eid":"W3186838209"},{"id":"paper-w4220982704","cat":"papers","name":"Demystifying Psychedelic Treatments in Psychiatry: Is Ego Dissolution the Solution?","year":"2022","cit":0,"pfa":"Michael Avissar","psa":"Adrian Jacques H. Ambrose","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4220982704","eid":"W4220982704"},{"id":"paper-w7203784819","cat":"papers","name":"Klassische Halluzinogene in der Behandlung von Suchterkrankungen – Ein narrativer Überblick","year":"2026","cit":0,"pfa":"Yann David Kippe","psa":"Tomislav Majić","topics":["Mechanism & neuroscience","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7203784819","eid":"W7203784819"},{"id":"paper-w7143411647","cat":"papers","name":"Therapeutic Potential of Classical Psychedelics and NonHallucinogenic Psychoplastogens in Psychiatric Disorders","year":"2026","cit":0,"pfa":"Kenji Hashimoto","psa":"Mesut Çetin","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7143411647","eid":"W7143411647"},{"id":"paper-w2955619491","cat":"papers","name":"Hallucinogens, CNS Stimulants, And Cannabis","year":"2019","cit":0,"pfa":"Alexander T. Shulgin","topics":["Addiction","Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W2955619491","eid":"W2955619491"},{"id":"paper-w7160630756","cat":"papers","name":"Announcement of special issue: ‘Behavioural pharmacology of ketamine and psychedelic drugs’","year":"2026","cit":0,"pfa":"Bart A. Ellenbroek","psa":"Gernot Riedel","topics":["Depression","Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7160630756","eid":"W7160630756"},{"id":"paper-w4401639124","cat":"papers","name":"Much anticipated FDA decision about psychedelics for PTSD ends with denial","year":"2024","cit":0,"pfa":"Valerie A. Canady","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4401639124","eid":"W4401639124"},{"id":"paper-w4313199284","cat":"papers","name":"Investigation of the neural network responsible for antidepressant effect of serotonergic psychedelics","year":"2022","cit":0,"pfa":"Daisuke Ibi","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4313199284","eid":"W4313199284"},{"id":"paper-w4294091474","cat":"papers","name":"Potential Treatment for Obsessive-Compulsive Disorder","year":"2022","cit":0,"pfa":"Robert B. Kargbo","topics":["Mechanism & neuroscience"],"ptype":"editorial","src":"https://openalex.org/W4294091474","eid":"W4294091474"},{"id":"paper-w4410502978","cat":"papers","name":"0391 Racial/Ethnic Differences in Psychedelic Use and Sleep Satisfaction: Preliminary Findings from the Herbal Heart Study","year":"2025","cit":0,"pfa":"Denise Christina Vidot","psa":"Girardin Jean‐Louis","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W4410502978","eid":"W4410502978"},{"id":"paper-w7160650396","cat":"papers","name":"Psilocybe mushrooms: extraction, identification, and quantification of psychedelic tryptamines","year":"2026","cit":0,"pfa":"Beatriz P. Senra","psa":"Carlos J. A. Ribeiro","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7160650396","eid":"W7160650396"},{"id":"paper-w7211910813","cat":"papers","name":"“It’s a soul supplement”: an exploration of microdosing psychedelics through an in-depth interview with a user","year":"2026","cit":0,"pfa":"Dimitrios Liokaftos","topics":["Addiction","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7211910813","eid":"W7211910813"},{"id":"paper-w7213658706","cat":"papers","name":"Psychedelics and suicidality: A double-edged sword - risks, mechanisms, and moving forward","year":"2026","cit":0,"pfa":"Maia Mallevays","psa":"Lucie Berkovitch","topics":["Safety & adverse events","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7213658706","eid":"W7213658706"},{"id":"paper-w4294310361","cat":"papers","name":"Psychedelics’ binding depends on receptor mutations","year":"2022","cit":0,"pfa":"special to C EN Attabey Rodríguez Benítez","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"other","src":"https://openalex.org/W4294310361","eid":"W4294310361"},{"id":"paper-w7212293022","cat":"papers","name":"A suite of engineered mice for interrogating psychedelic drug actions","year":"2026","cit":0,"pfa":"Gavin P. Schmitz","psa":"Grégory Scherrer","ptype":"article","src":"https://openalex.org/W7212293022","eid":"W7212293022"},{"id":"paper-w4409891909","cat":"papers","name":"Is Ketamine a Psychedelic?","year":"2025","cit":0,"pfa":"Charmaine Husum","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W4409891909","eid":"W4409891909"},{"id":"paper-w7139121355","cat":"papers","name":"Psychological support in psychedelic-assisted therapy clinical trials: A systematic review","year":"2026","cit":0,"pfa":"Bonnie Brusky","psa":"M. Barrault","topics":["Safety & adverse events","Reviews & meta-analyses","Therapy practice"],"ptype":"review","src":"https://openalex.org/W7139121355","eid":"W7139121355"},{"id":"paper-w4410966395","cat":"papers","name":"Microdosing of LSD does not show efficacy in adults with ADHD","year":"2025","cit":0,"topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4410966395","eid":"W4410966395"},{"id":"paper-w4237304086","cat":"papers","name":"Hallucinogens and Phencyclidine","year":"2020","cit":0,"pfa":"Frank Lynn Iber","ptype":"book-chapter","src":"https://openalex.org/W4237304086","eid":"W4237304086"},{"id":"paper-w1968585467","cat":"papers","name":"The Hallucinogenic (LSD) Experience","year":"1972","cit":0,"pfa":"Robert J. Gregory","ptype":"article","src":"https://openalex.org/W1968585467","eid":"W1968585467"},{"id":"paper-w4211134923","cat":"papers","name":"Psychedelika","year":"2017","cit":0,"pfa":"Maximilian von Heyden","psa":"Henrik Jungaberle","ptype":"book-chapter","src":"https://openalex.org/W4211134923","eid":"W4211134923"},{"id":"paper-w4400574495","cat":"papers","name":"WORKSHOP: STANDARDS OF PSYCHEDELIC CARE: PEER & PROFESSIONAL PROVIDERS","year":"2024","cit":0,"pfa":"Brian Anderson","psa":"Jennifer Mitchell","ptype":"article","src":"https://openalex.org/W4400574495","eid":"W4400574495"},{"id":"paper-w7171626075","cat":"papers","name":"A Pseudo-Nonprofit Model for Psychedelic Clinical Trial Funding","year":"2026","cit":0,"pfa":"Vincent Joralemon","ptype":"preprint","src":"https://openalex.org/W7171626075","eid":"W7171626075"},{"id":"paper-w4387931054","cat":"papers","name":"LSD Use Increasing More Among People With Depression","year":"2023","cit":0,"pfa":"Emily M. Harris","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4387931054","eid":"W4387931054"},{"id":"paper-w4405854946","cat":"papers","name":"Microdosing Psychedelics as a Promising New Pharmacotherapeutic","year":"2024","cit":0,"pfa":"Kim P. C. Kuypers","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W4405854946","eid":"W4405854946"},{"id":"paper-w4416781274","cat":"papers","name":"Single dose of LSD formulation improves anxiety in Phase 2b trial","year":"2025","cit":0,"topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4416781274","eid":"W4416781274"},{"id":"paper-w4416409815","cat":"papers","name":"Exploring the first use of psychedelic macrodoses in Latin American adults: Sociodemographic profiles, consumption factors, and subjective experiences","year":"2025","cit":0,"pfa":"Óscar Véliz‐García","psa":"Marcos Domic‐Siede","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4416409815","eid":"W4416409815"},{"id":"paper-w4413920645","cat":"papers","name":"Therapeutic Effects of Psychedelics and their Non-Hallucinogenic Analogs on Depressive-Like Behaviour","year":"2025","cit":0,"pfa":"Kaylee Reid","psa":"Argel Aguilar‐Valles","topics":["Depression","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4413920645","eid":"W4413920645"},{"id":"paper-w4378610727","cat":"papers","name":"In healthy adults, microdosing of LSD produced transient effects on mood","year":"2023","cit":0,"topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4378610727","eid":"W4378610727"},{"id":"paper-w4233436690","cat":"papers","name":"T181. LSD Increases Social Adaptation to Opinions Similar to One’s Own","year":"2018","cit":0,"pfa":"Katrin H. Preller","psa":"Franz X. Vollenweider","ptype":"conference-abstract","src":"https://openalex.org/W4233436690","eid":"W4233436690"},{"id":"paper-w2973963851","cat":"papers","name":"The Psychedelic Altered State of Consciousness : An Assessment of the Current Status of Psychedelic Research","year":"2019","cit":0,"pfa":"Emma Christersson","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"dissertation","src":"https://openalex.org/W2973963851","eid":"W2973963851"},{"id":"paper-w7139876810","cat":"papers","name":"Hunter S. Thompson's Hallucinogenic Sub-Theme in Fear and Loathing in Las Vegas","year":"1985","cit":0,"pfa":"Denton Ketels","ptype":"article","src":"https://openalex.org/W7139876810","eid":"W7139876810"},{"id":"paper-w7160645977","cat":"papers","name":"Addiction as an Attachment Disorder","year":"2026","cit":0,"pfa":"Jeffrey D. Roth","psa":"Katie Washington Cole","topics":["Addiction","Therapy practice","Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W7160645977","eid":"W7160645977"},{"id":"paper-w7162782583","cat":"papers","name":"Psychedelic-induced hypomania and mania: a systematic review and meta-analysis","year":"2026","cit":0,"pfa":"Mickael Eskinazi","psa":"Michel Sabé","topics":["Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7162782583","eid":"W7162782583"},{"id":"paper-w7140928407","cat":"papers","name":"Classic psychedelic medicines for adolescent refractory mental health disease","year":"2026","cit":0,"pfa":"Aly Shah Aziz","topics":["Safety & adverse events","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7140928407","eid":"W7140928407"},{"id":"paper-w3173806178","cat":"papers","name":"The The hallucinogenic species of the Psilocybe genus on Cancer","year":"2018","cit":0,"pfa":"Belton Cadmael","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3173806178","eid":"W3173806178"},{"id":"paper-w4406259447","cat":"papers","name":"Unlocking the Therapeutic Potential of DMT’s: Molecular Modelling Insights into Nueropharmacological Mechanisms and Clinical Prospects","year":"2024","cit":0,"topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4406259447","eid":"W4406259447"},{"id":"paper-w7197014584","cat":"papers","name":"A suite of engineered mice for interrogating psychedelic drug actions","year":"2026","cit":0,"pfa":"Yi-Ting Chiu","psa":"B L Roth","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7197014584","eid":"W7197014584"},{"id":"paper-w4408687864","cat":"papers","name":"L’iboga. Un patrimoine naturel, culturel et national au service du monde","year":"2024","cit":0,"pfa":"Claire Versuela IDOMBA MBOUKOUABO","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4408687864","eid":"W4408687864"},{"id":"paper-w7170094955","cat":"papers","name":"Predictive Processing, Psychedelic Spirituality, and Neurophenomenology","year":"2026","cit":0,"pfa":"Julian Kiverstein","topics":["Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W7170094955","eid":"W7170094955"},{"id":"paper-w4406826637","cat":"papers","name":"L’iboga. Un patrimoine naturel,culturel et national au service du monde","year":"2024","cit":0,"pfa":"Claire Versuela IDOMBA MBOUKOUABO","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4406826637","eid":"W4406826637"},{"id":"paper-w2411719498","cat":"papers","name":"Social engineering and the structure activity relationships (SAR’s) of selected mind-altering compounds such as tryptamine and phenylethylamine derivatives","year":"2016","cit":0,"pfa":"Michael M. Knott","psa":"Harriet Knott","ptype":"article","src":"https://openalex.org/W2411719498","eid":"W2411719498"},{"id":"paper-w2291118456","cat":"papers","name":"Aspects of secondary metabolism in basidiomycetes: I. biological and biochemical studies on Psilocybe cubensis II. a survey of phenol-o-methyltransferase in species of Lentinus and Lentinellus","year":"2010","cit":0,"pfa":"Weiwei Wang","ptype":"dissertation","src":"https://openalex.org/W2291118456","eid":"W2291118456"},{"id":"paper-w4382360061","cat":"papers","name":"Experts Offer Tips on Talking With Patients About Psychedelics","year":"2023","cit":0,"pfa":"Terri D’Arrigo","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4382360061","eid":"W4382360061"},{"id":"paper-w4408069739","cat":"papers","name":"L’iboga. Un patrimoine naturel,culturel et national au service du monde","year":"2024","cit":0,"pfa":"Claire Versuela IDOMBA MBOUKOUABO","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4408069739","eid":"W4408069739"},{"id":"paper-w4390615352","cat":"papers","name":"Examining psychedelic drug action","year":"2024","cit":0,"pfa":"D. Dewran Koçak","psa":"Bryan L. Roth","ptype":"article","src":"https://openalex.org/W4390615352","eid":"W4390615352"},{"id":"paper-w4416516846","cat":"papers","name":"Peer Review Report For: Clinical Psychedelic Therapy Research Involving Adolescents: Protocol for a Scoping Review of Intervention Studies [version 1; peer review: 2 approved with reservations]","year":"2025","cit":0,"pfa":"Omer A. Syed","topics":["Addiction","Reviews & meta-analyses","Policy & ethics"],"ptype":"peer-review","src":"https://openalex.org/W4416516846","eid":"W4416516846"},{"id":"paper-w83385153","cat":"papers","name":"LSD-Like Flashbacks Associated with ECT.","year":"1987","cit":0,"pfa":"Mark J. Russ","psa":"James M. Gold","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W83385153","eid":"W83385153"},{"id":"paper-w4233045224","cat":"papers","name":"Catatonia LSD Induced?","year":"1995","cit":0,"pfa":"K. M. H. Perera","psa":"M. R. M. Pinto","ptype":"article","src":"https://openalex.org/W4233045224","eid":"W4233045224"},{"id":"paper-w4411066292","cat":"papers","name":"LSD","year":"2025","cit":0,"pfa":"Margaret Stark","psa":"Michael Scott-Ham","topics":["Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W4411066292","eid":"W4411066292"},{"id":"paper-w4362651511","cat":"papers","name":"LSD derivatives. Current legal status, MS spectrum analysis and an attempt to interpret decomposition of fragmentation pathways","year":"2021","cit":0,"pfa":"Wojciech Kotowski","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4362651511","eid":"W4362651511"},{"id":"paper-w7163899681","cat":"papers","name":"Psychedelics disrupt hierarchical cortical propagations in the default mode network of humans and mice","year":"2026","cit":0,"pfa":"Adam R. Pines","psa":"Leanne M. Williams","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7163899681","eid":"W7163899681"},{"id":"paper-w2287677097","cat":"papers","name":"FTOX031 Analysis of acid lysergic (LSD) in vitreous humor and oral fluid samples","year":"2012","cit":0,"pfa":"Mariana Dadalto Peres","psa":"Bruno Spinosa De Martinis","ptype":"article","src":"https://openalex.org/W2287677097","eid":"W2287677097"},{"id":"paper-w4231143703","cat":"papers","name":"Powerful Hallucinogens, Phencyclidine, and Ecstasy","year":"2014","cit":0,"pfa":"Barry Stimmel","psa":"Barry Stimmel","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"book-chapter","src":"https://openalex.org/W4231143703","eid":"W4231143703"},{"id":"paper-w7164999174","cat":"papers","name":"Anxiety-related platform in zebrafish (Danio rerio) larvae: An integrated analysis of behavioural and molecular assay in drug screening research","year":"2026","cit":0,"pfa":"Małgorzata Potoczna","psa":"Piotr Podlasz","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7164999174","eid":"W7164999174"},{"id":"paper-w7161947696","cat":"papers","name":"New Approach Methodologies and Open Access Tools Help Characterize Risks for DART , DNT , or Endocrine Effects From Exposure to Hallucinogens With Potential Pesticide Contaminants","year":"2026","cit":0,"pfa":"Marilyn Helen Silva","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7161947696","eid":"W7161947696"},{"id":"paper-w4409891782","cat":"papers","name":"Suicide and Psychedelics","year":"2025","cit":0,"pfa":"Charmaine Husum","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"book-chapter","src":"https://openalex.org/W4409891782","eid":"W4409891782"},{"id":"paper-w4391804622","cat":"papers","name":"Tryptamine Derivatives of Norpsilocin Induce Psychedelic-Like Responses in Mice","year":"2024","cit":0,"pfa":"Dirk H. Trauner","psa":"Kenny Calderon-Godinez","ptype":"editorial","src":"https://openalex.org/W4391804622","eid":"W4391804622"},{"id":"paper-w7212693934","cat":"papers","name":"Correlation of Ketamine and Classic Psychedelics with Pain-Related Neural Connectivity: A Scoping Review of Clinical Experiments on a Potential Therapeutic Target Concerning Ketamine and Classical Psychedelics Administra","year":"2026","cit":0,"pfa":"Vasileios Chytas","psa":"Dimitrios Chytas","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7212693934","eid":"W7212693934"},{"id":"paper-w2550063776","cat":"papers","name":"Stanislav Grof's Contributions to FDA Drug Development Research with Psychedelics","year":"2014","cit":0,"pfa":"Rick Doblin","topics":["PTSD & trauma","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2550063776","eid":"W2550063776"},{"id":"paper-w4396671169","cat":"papers","name":"Psychedelic Drugs: A Mind-expanding Hallucinogens","year":"2024","cit":0,"pfa":"Shreyasee Das","psa":"Rahul Shil","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4396671169","eid":"W4396671169"},{"id":"paper-w2930041115","cat":"papers","name":"Prescribing Substances of Abuse in Psychiatric Care","year":"2018","cit":0,"pfa":"Samuel R. Weber","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2930041115","eid":"W2930041115"},{"id":"paper-w4404711079","cat":"papers","name":"A contemporary analysis of the effects of neuroplasticity on well-being","year":"2024","cit":0,"topics":["Addiction","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4404711079","eid":"W4404711079"},{"id":"paper-w316320411","cat":"papers","name":"Synthesis and Chemistry of Lysergic Acid Derivatives. Part 1","year":"1964","cit":0,"pfa":"Thomas C. Simmons","psa":"Thomas F. Kolesar","ptype":"article","src":"https://openalex.org/W316320411","eid":"W316320411"},{"id":"paper-w4381856426","cat":"papers","name":"Hallucinogen-Persisting Perception Disorder (HPPD): A Teenage Boy with Hallucinations","year":"2023","cit":0,"pfa":"Christopher C. Glisson","ptype":"book-chapter","src":"https://openalex.org/W4381856426","eid":"W4381856426"},{"id":"paper-w7152078973","cat":"papers","name":"Altered States of Consciousness and the Subconscious Mind: A Comprehensive Comparative Review of Disciplines, Neurobiological Mechanisms, Clinical Applications, and Philosophical Frameworks — Including Life Between Lives","year":"2026","cit":0,"pfa":"Luis Miguel Gallardo","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W7152078973","eid":"W7152078973"},{"id":"paper-w7161641859","cat":"papers","name":"Understanding and Choosing Psychedelic Medicines","year":"2026","cit":0,"pfa":"Vanessa Bibliowicz","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W7161641859","eid":"W7161641859"},{"id":"paper-w2768830310","cat":"papers","name":"Sex Differences in Serotonergic and Dopaminergic Mediation of LSD Discrimination in Rats","year":"2017","cit":0,"pfa":"Keli A. Herr","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W2768830310","eid":"W2768830310"},{"id":"paper-w4408942378","cat":"papers","name":"Psychedelics","year":"2025","cit":0,"pfa":"Eric John Parkins","topics":["Mechanism & neuroscience","Therapy practice","Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W4408942378","eid":"W4408942378"},{"id":"paper-w7214040360","cat":"papers","name":"Peripheral Serotonin Signaling and 5-HT2B Modulation as Emerging Metabolic Targets in MASLD: Translational Evidence from Preclinical Models and Early Clinical Development","year":"2026","cit":0,"pfa":"Sara De Martin","psa":"Paolo Manfredi","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7214040360","eid":"W7214040360"},{"id":"paper-w4236736182","cat":"papers","name":"LSD","year":"2007","cit":0,"pfa":"Allister Vale","ptype":"article","src":"https://openalex.org/W4236736182","eid":"W4236736182"},{"id":"paper-w4409718193","cat":"papers","name":"Speech markers of psychedelic-induced psychological change","year":"2025","cit":0,"pfa":"Joanna Kuc","psa":"Jeremy I Skipper","topics":["Anxiety & end-of-life","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4409718193","eid":"W4409718193"},{"id":"paper-w2084673175","cat":"papers","name":"Characterization of specific binding sites labeled by [3H]LSD in coronal sections of paraformaldehyde-fixed rat brain","year":"1985","cit":0,"pfa":"Sheryl G. Beck","psa":"Efrain C. Azmitia","ptype":"article","src":"https://openalex.org/W2084673175","eid":"W2084673175"},{"id":"paper-w4399577191","cat":"papers","name":"Psychedelics’ Use as Medicine Hits Significant Roadblock","year":"2024","cit":0,"pfa":"Linda M. Richmond","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4399577191","eid":"W4399577191"},{"id":"paper-w7171702641","cat":"papers","name":"What Counts as a Psychedelic?","year":"2026","cit":0,"pfa":"Vincent Joralemon","ptype":"preprint","src":"https://openalex.org/W7171702641","eid":"W7171702641"},{"id":"paper-w2488174722","cat":"papers","name":"Chapter 53. Club Drug Addiction","year":"2014","cit":0,"pfa":"Michael Weaver","psa":"Sidney H. Schnoll","topics":["Addiction","Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W2488174722","eid":"W2488174722"},{"id":"paper-w3005878477","cat":"papers","name":"Psychedelics for alcohol use disorder: state of the research","year":"2020","cit":0,"pfa":"Talha Khan Burki","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W3005878477","eid":"W3005878477"},{"id":"paper-w2552889338","cat":"papers","name":"Effect of LSD-2 5 on Mitotic and Meiotic Chromosomes of Mice and Monkeys*","year":"1969","cit":0,"pfa":"M. P. de Valencia","psa":"Received July","ptype":"article","src":"https://openalex.org/W2552889338","eid":"W2552889338"},{"id":"paper-w2612851265","cat":"papers","name":"Les hallucinogènes dans la thérapie des addictions","year":"2014","cit":0,"pfa":"Robert Hämmig","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2612851265","eid":"W2612851265"},{"id":"paper-w7165692381","cat":"papers","name":"U.S. Veterans and Psychedelics: Prevalence of Use and Policy Preferences","year":"2026","cit":0,"pfa":"Michelle Priest","psa":"Beau Kilmer","topics":["Addiction","Policy & ethics"],"ptype":"book","src":"https://openalex.org/W7165692381","eid":"W7165692381"},{"id":"paper-w7111791024","cat":"papers","name":"Defining ‘psychedelic’","year":"2025","cit":0,"pfa":"Leor Roseman","psa":"Kyle Greenway","ptype":"preprint","src":"https://openalex.org/W7111791024","eid":"W7111791024"},{"id":"paper-w4402518921","cat":"papers","name":"Psychedelics","year":"2024","cit":0,"pfa":"G. Hussein Rassool","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W4402518921","eid":"W4402518921"},{"id":"paper-w4248916990","cat":"papers","name":"Lysergide","year":"1995","cit":0,"pfa":"John F. Wilson","ptype":"book-chapter","src":"https://openalex.org/W4248916990","eid":"W4248916990"},{"id":"paper-w7208800503","cat":"papers","name":"In vitro Transcriptomic Biomarker Discovery for Psychedelic Tryptamines and Its Applications for High-throughput Drug Screening Platform Development","year":"2025","cit":0,"pfa":"Wantao Xiao","topics":["Depression","PTSD & trauma","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W7208800503","eid":"W7208800503"},{"id":"paper-w4246183459","cat":"papers","name":"LSD — A Dangerous Drug","year":"1965","cit":0,"topics":["Addiction","Safety & adverse events"],"ptype":"editorial","src":"https://openalex.org/W4246183459","eid":"W4246183459"},{"id":"paper-w912640727","cat":"papers","name":"Ernst Jünger - eine Annäherung an Drogen - Medizinische Analyse seiner LSD-Versuche","year":"2012","cit":0,"pfa":"Corinna Maria Odilia Coenen","topics":["Addiction","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W912640727","eid":"W912640727"},{"id":"paper-w4205291617","cat":"papers","name":"Hallucinogens","year":"2006","cit":0,"pfa":"David L. Eldridge","psa":"Karin M. Hillenbrand","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4205291617","eid":"W4205291617"},{"id":"paper-w7202128756","cat":"papers","name":"Psychedelics and astrocytes: a hypothesis-driven perspective on neuro-glial integration, network plasticity, and neuroimmune reprogramming","year":"2026","cit":0,"pfa":"Xiaoshan Ke","psa":"Xiaohui Wang","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W7202128756","eid":"W7202128756"},{"id":"paper-w2725784961","cat":"papers","name":"The resurrection of psychedelic psychiatry and its role in addiction treatment","year":"2016","cit":0,"pfa":"Rachel Skocylas","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2725784961","eid":"W2725784961"},{"id":"paper-w2598386764","cat":"papers","name":"Bakunin and the Entheogenic Challenge to Atheism 1","year":"2016","cit":0,"pfa":"Sebastian Job","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2598386764","eid":"W2598386764"},{"id":"paper-w7125202165","cat":"papers","name":"U.S. Psychedelic Use and Microdosing in 2025: Insights from a Probability-Based and Nationally Representative Survey","year":"2026","cit":0,"pfa":"Michelle Priest","psa":"Claude Messan Setodji","topics":["Addiction","Dosing & pharmacology"],"ptype":"book","src":"https://openalex.org/W7125202165","eid":"W7125202165"},{"id":"paper-w2418608449","cat":"papers","name":"[Localization and functions of the D-neuron: significance in pathogenesis of schizophrenia].","year":"2013","cit":0,"pfa":"Keiko Ikemoto","topics":["Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W2418608449","eid":"W2418608449"},{"id":"paper-w1966297505","cat":"papers","name":"Psychosis, Psychiatry, And Homicide","year":"1972","cit":0,"pfa":"George S. Layne","ptype":"article","src":"https://openalex.org/W1966297505","eid":"W1966297505"},{"id":"paper-w7135709513","cat":"papers","name":"The electroencephalographic changes in animal serotonergic model of psychosis-the study of EEG connectivity in relation to behavior","year":"2017","cit":0,"pfa":"Filip Tylš","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7135709513","eid":"W7135709513"},{"id":"paper-w4249165125","cat":"papers","name":"Hallucinogen Persisting Perception Disorder","year":"2017","cit":0,"pfa":"John H. Halpern","topics":["Depression"],"ptype":"reference-entry","src":"https://openalex.org/W4249165125","eid":"W4249165125"},{"id":"paper-w4407119019","cat":"papers","name":"Sex-specific effects of psychedelic drug exposure on central amygdala reactivity and behavioral responding","year":"2025","cit":0,"pfa":"Sema G. Quadir","psa":"Meredith G Cone","ptype":"article","src":"https://openalex.org/W4407119019","eid":"W4407119019"},{"id":"paper-w2325113300","cat":"papers","name":"Studies on Inhibition of Human Serum Cholinesterase by Lysergic Acid and Clavine Alkaloids","year":"1969","cit":0,"pfa":"Tetsukichi Niwaguchi","psa":"Takako Inoue","ptype":"article","src":"https://openalex.org/W2325113300","eid":"W2325113300"},{"id":"paper-w4415932492","cat":"papers","name":"Classic psychedelics may treat depressive disorders, but more evidence and legislative changes are required","year":"2025","cit":0,"pfa":"Aisling McGuigan","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4415932492","eid":"W4415932492"},{"id":"paper-w2056577282","cat":"papers","name":"A preliminary study of THC-LSD interactions on rabbit EEG and behavior","year":"1981","cit":0,"pfa":"Parthena Martin","psa":"Paul F. Consroe","ptype":"article","src":"https://openalex.org/W2056577282","eid":"W2056577282"},{"id":"paper-w7204988578","cat":"papers","name":"Through the Looking-Glass: A Scoping Review of Psychological Mechanisms of Psychedelic-Assisted Therapy for Substance Use Disorders","year":"2026","cit":0,"pfa":"Kathryn Fletcher","psa":"Krista J. Siefried","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7204988578","eid":"W7204988578"},{"id":"paper-w4397013596","cat":"papers","name":"Psychedelic renaissance: A renewed focus on the clinical utility of hallucinogens","year":"2024","cit":0,"pfa":"Shunichiro Ikeda","psa":"Toshihiko Kinoshita","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4397013596","eid":"W4397013596"},{"id":"paper-w7162854889","cat":"papers","name":"A trip through the psychiatric use of psychedelics in Brazil: A scoping review","year":"2026","cit":0,"pfa":"Vinicius Ryu Kami","psa":"Thiago Henrique Roza","topics":["Depression","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7162854889","eid":"W7162854889"},{"id":"paper-w7171830787","cat":"papers","name":"Childhood trauma and psychological outcomes following psychedelic use: a scoping review","year":"2026","cit":0,"pfa":"Lorraine Li","psa":"James Rucker","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7171830787","eid":"W7171830787"},{"id":"paper-w7134171913","cat":"papers","name":"Public attitudes diverge sharply on legal use of psychedelics","year":"2026","cit":0,"pfa":"Valerie A. Canady","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7134171913","eid":"W7134171913"},{"id":"paper-w4387646369","cat":"papers","name":"The Theoretical Synthesis and in silico Modelling of Lysergic Acid Biscinnamylidene Amide from the Adduct Formation of d-Lysergic Acid Amide and Cinnamaldehyde","year":"2022","cit":0,"pfa":"Victor Chiruta","ptype":"article","src":"https://openalex.org/W4387646369","eid":"W4387646369"},{"id":"paper-w4210908417","cat":"papers","name":"Hallucinogen chemistry guides antidepressant drug discovery","year":"2022","cit":0,"pfa":"Bethany A. Halford","topics":["Depression","Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W4210908417","eid":"W4210908417"},{"id":"paper-w7127937073","cat":"papers","name":"The Effect of Psycholitics-Hallucinogens on Tonus and Concentrations of Vegetative Organs","year":"1975","cit":0,"pfa":"Seid Huković","psa":"Elvedina Zvizdić","ptype":"article","src":"https://openalex.org/W7127937073","eid":"W7127937073"},{"id":"paper-w4385669097","cat":"papers","name":"The Effects of Serotonergic Psychedelics on Neural Activity: A Meta-Analysis of Task-Based Functional Neuroimaging Studies","year":"2023","cit":0,"pfa":"J. H. Shepherd","psa":"C. H. Miller","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4385669097","eid":"W4385669097"},{"id":"paper-w7131122098","cat":"papers","name":"Hallucinations Induced by Psychoactive Drugs: Mechanisms, Consequences, and Therapeutic Interventions","year":"2026","cit":0,"topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7131122098","eid":"W7131122098"},{"id":"paper-w7135675278","cat":"papers","name":"Serotonergic hallucinogenes and their therapeutic use","year":"2021","cit":0,"pfa":"David Bouberl","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"dissertation","src":"https://openalex.org/W7135675278","eid":"W7135675278"},{"id":"paper-w2186582210","cat":"papers","name":"The Psychedelic Renaissance: Horizons, the Fifth Annual Conference on Psychedelic Research","year":"2016","cit":0,"pfa":"Michael Cooper","ptype":"article","src":"https://openalex.org/W2186582210","eid":"W2186582210"},{"id":"paper-w4415275464","cat":"papers","name":"Psychedelic compounds directly excite 5-HT2A layer V medial prefrontal cortex neurons through 5-HT2A Gq activation","year":"2025","cit":0,"pfa":"Gabriele Maria König","psa":"Mia L. Foglesong","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4415275464","eid":"W4415275464"},{"id":"paper-w7127047751","cat":"papers","name":"Can LLMs Get High? A Dual-Metric Framework for Evaluating Psychedelic Simulation and Safety in Large Language Models","year":"2026","cit":0,"pfa":"Ziv Ben‐Zion","psa":"Teddy Lazebnik","topics":["Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W7127047751","eid":"W7127047751"},{"id":"paper-w7131779461","cat":"papers","name":"Psychedelics and microglia in aging: unraveling the secret dialogue behind healthy aging, mental health, and neuroinflammation","year":"2026","cit":0,"pfa":"Antonio Inserra","psa":"Attila Jozsef Szabo","ptype":"book-chapter","src":"https://openalex.org/W7131779461","eid":"W7131779461"},{"id":"paper-w4403365464","cat":"papers","name":"A survey investigating United States federal grant submissions proposing to investigate therapeutic applications of psychedelics","year":"2024","cit":0,"pfa":"Brian Scott Barnett","ptype":"preprint","src":"https://openalex.org/W4403365464","eid":"W4403365464"},{"id":"paper-w2310190525","cat":"papers","name":"Acute health problems due to recreational drug use in patients presenting to an urban emergency department","year":"2015","cit":0,"pfa":"Evangelia Liakoni","psa":"Matthias E. Liechti","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2310190525","eid":"W2310190525"},{"id":"paper-w7167421772","cat":"papers","name":"Psychedelics and longevity: implications for lifespan, healthspan and functional aging","year":"2026","cit":0,"pfa":"Mark Haden","psa":"Kenneth W. Tupper","topics":["PTSD & trauma","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7167421772","eid":"W7167421772"},{"id":"paper-w2902673336","cat":"papers","name":"Exploration of Ayahuasca’s Mechanisms in the Treatment of Stimulant Use Disorder","year":"2018","cit":0,"pfa":"Aaron M. Eisen","psa":"W. S Griesar","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"conference-paper","src":"https://openalex.org/W2902673336","eid":"W2902673336"},{"id":"paper-w4407326530","cat":"papers","name":"DMT – psychodelik otwierający duszę","year":"2024","cit":0,"pfa":"Izabela Szpręgiel","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4407326530","eid":"W4407326530"},{"id":"paper-w4385335415","cat":"papers","name":"Correction: Ethical considerations in rapid and novel treatments in psychiatry","year":"2023","cit":0,"pfa":"Tobias Haeusermann","psa":"Winston Chiong","topics":["Policy & ethics"],"ptype":"erratum","src":"https://openalex.org/W4385335415","eid":"W4385335415"},{"id":"paper-w7160826166","cat":"papers","name":"LSD persistently disrupts affective pain processing","year":"2026","cit":0,"pfa":"Jared Plotkin","psa":"Jing Wang","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7160826166","eid":"W7160826166"},{"id":"paper-w4401686421","cat":"papers","name":"Computational Design of an Improved Photoswitchable Psychedelic Based on Light Absorption, Membrane Permeation and Protein Binding","year":"2024","cit":0,"pfa":"Vito Federico Palmisano","psa":"Juan José Nogueira","topics":["Depression","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4401686421","eid":"W4401686421"},{"id":"paper-w7214261051","cat":"papers","name":"Design, Synthesis, and Evaluation of Non-Competitive NMDA Receptor Antagonists and Serotonergic Agents for Neuropsychiatric and Metabolic Disorders","cit":0,"pfa":"MARCO BANZATO","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W7214261051","eid":"W7214261051"},{"id":"paper-w4230497734","cat":"papers","name":"3,4-Methylenedioxymethamphetamine","year":"2020","cit":0,"pfa":"National Cancer Institute","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"reference-entry","src":"https://openalex.org/W4230497734","eid":"W4230497734"},{"id":"paper-w4417407603","cat":"papers","name":"Molecular Diagnostics, Circuit-Calming Modulators, and Controlled Neuroplastogens: Emerging Strategies in Precision Neuropsychiatric Therapeutics","year":"2025","cit":0,"pfa":"Anna C. Renner","psa":"Robert B. Kargbo","topics":["PTSD & trauma","Mechanism & neuroscience"],"ptype":"editorial","src":"https://openalex.org/W4417407603","eid":"W4417407603"},{"id":"paper-w4382680172","cat":"papers","name":"FDA issues first draft guidance on psychedelic research","year":"2023","cit":0,"pfa":"Valerie A. Canady","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4382680172","eid":"W4382680172"},{"id":"paper-w4413381444","cat":"papers","name":"Perspectives on Trauma Treatment, Self-Management Strategies, and Attitudes Toward Psychedelic Therapies in Individuals with Psychological Trauma Symptoms","year":"2025","cit":0,"pfa":"Nadav Liam Modlin","psa":"James Rucker","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4413381444","eid":"W4413381444"},{"id":"paper-w4410178457","cat":"papers","name":"Psychedelic-assisted psychotherapy and its potential to manage demoralization: A brief exploration of an alternative approach to end of life care","year":"2025","cit":0,"pfa":"Jennifer Ai Ong","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4410178457","eid":"W4410178457"},{"id":"paper-w2437508402","cat":"papers","name":"Heat shock protein in mammalian I physiologically relevant increase in induced by D-lysergic acid diethyla: (hyperthermia/protein synthesis in vivo/cell-free translation)","year":"2016","cit":0,"pfa":"James W. Cosgrove","psa":"Ian R. Brown","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2437508402","eid":"W2437508402"},{"id":"paper-w7214154048","cat":"papers","name":"LSD and Chromosomes","year":"1969","cit":0,"pfa":"Joe‐Hin Tjio","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W7214154048","eid":"W7214154048"},{"id":"paper-w7162001787","cat":"papers","name":"IDENTIFYING THE NEUROPHYSIOLOGICAL MECHANISMS UNDERLYING THE POTENTIAL THERAPEUTIC EFFECTS OF PSYCHEDELIC COMPOUNDS","year":"2026","cit":0,"pfa":"Gavin P. Schmitz","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7162001787","eid":"W7162001787"},{"id":"paper-w4224935312","cat":"papers","name":"Psilocybe mexicana R. Heim – Mexikanischer Kahlkopf","year":"2022","cit":0,"pfa":"Antonia Kuhn","psa":"Matthias F. Melzig","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4224935312","eid":"W4224935312"},{"id":"paper-w4401579874","cat":"papers","name":"Computational Design of an Improved Photoswitchable Psychedelics Based on Light Absorption, Membrane Permeation and Protein Binding","year":"2024","cit":0,"pfa":"Vito Federico Palmisano","psa":"Juan José Nogueira","topics":["Depression","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4401579874","eid":"W4401579874"},{"id":"paper-w7164804665","cat":"papers","name":"Psychedelics and neuroanesthesia: A narrative review of converging mechanisms","year":"2026","cit":0,"pfa":"Kunal Kumar Sharma","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"review","src":"https://openalex.org/W7164804665","eid":"W7164804665"},{"id":"paper-w4417103562","cat":"papers","name":"Unlocking the power of tryptamine alkaloids in Psilocybe fungi: chemistry, mental health potential and legal challenges","year":"2025","cit":0,"pfa":"Mohammad Reza Mirzadeh","psa":"Jianhua Zhang","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4417103562","eid":"W4417103562"},{"id":"paper-w7171673667","cat":"papers","name":"Selling Psychedelics","year":"2025","cit":0,"pfa":"Vincent Joralemon","ptype":"preprint","src":"https://openalex.org/W7171673667","eid":"W7171673667"},{"id":"paper-w7166465028","cat":"papers","name":"Classical psychedelic microdosing, mood, and cognitive function: An umbrella review with narrative synthesis","year":"2026","cit":0,"pfa":"Yiğit Özaydın","psa":"Buket Canlan Ozaydin","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7166465028","eid":"W7166465028"},{"id":"paper-w157377883","cat":"papers","name":"Functional selectivity at the serotonin 2A receptor: differential signaling by serotonin and dimethylated tryptamines","year":"2010","cit":0,"pfa":"Cullen L. Schmid","psa":"Laura Bohn","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W157377883","eid":"W157377883"},{"id":"paper-w7167422156","cat":"papers","name":"Psilocybe Poisoning: Pathophysiology, Classification and Treatment. A Clinical Case Review","year":"2026","cit":0,"pfa":"Omar Azuara-Antonio","psa":"Lesly Idaliht Hernandez-Martinez","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7167422156","eid":"W7167422156"},{"id":"paper-w7165638399","cat":"papers","name":"Psychedelics and autism spectrum disorder: Mechanistic insights, translational evidence and ethical challenges","year":"2026","cit":0,"pfa":"Júlio César Claudino dos Santos","psa":"Cinara Ludvig Gonçalves","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7165638399","eid":"W7165638399"},{"id":"paper-w3012401750","cat":"papers","name":"Can Psychedelics Radically Change SUD Treatment?","year":"2020","cit":0,"pfa":"Katie O’Connor","topics":["PTSD & trauma","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3012401750","eid":"W3012401750"},{"id":"paper-w7117561192","cat":"papers","name":"Natural Hallucinogens in Clinical Studies: A Review of Therapeutic Efficacy and Methodological Limitations","year":"2025","cit":0,"pfa":"Ewa Niedzielska","psa":"Lucyna Pomierny-Chamioło","topics":["PTSD & trauma","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7117561192","eid":"W7117561192"},{"id":"paper-w4200050959","cat":"papers","name":"Announcement of two special issues: behavioural pharmacology of synaptopathies and psychedelic drugs","year":"2021","cit":0,"pfa":"Louk J. M. J. Vanderschuren","psa":"Bart A. Ellenbroek","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4200050959","eid":"W4200050959"},{"id":"paper-w7169523177","cat":"papers","name":"Psychedelic Therapies in the Management of Post-Traumatic Stress Disorder","year":"2026","cit":0,"pfa":"Jakub Maksymilian Bajer","psa":"Piotr Mrozek","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7169523177","eid":"W7169523177"},{"id":"paper-w3164939105","cat":"papers","name":"Psychedelics 2.0","year":"2020","cit":0,"pfa":"Russell C. Crandall","topics":["Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W3164939105","eid":"W3164939105"},{"id":"paper-w294073382","cat":"papers","name":"Book Review: The Harvard Psychedelic Club by Don Lattin","year":"2010","cit":0,"pfa":"Kenneth J. Weiss","topics":["Addiction","Reviews & meta-analyses","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W294073382","eid":"W294073382"},{"id":"paper-w7125526398","cat":"papers","name":"RAND: Microdosing surges as millions turned to psychedelics in 2025","year":"2026","cit":0,"pfa":"Valerie A. Canady","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7125526398","eid":"W7125526398"},{"id":"paper-w4205735637","cat":"papers","name":"The potential of psychedelic medicine – A personal account","year":"2022","cit":0,"pfa":"David Eugene Smith","ptype":"article","src":"https://openalex.org/W4205735637","eid":"W4205735637"},{"id":"paper-w1978519803","cat":"papers","name":"EPA-0137 – EEG power spectra and connectivity changes in animal serotonergic and glutamatergic models of psychosis – implications for treatment","year":"2014","cit":0,"pfa":"Tomáš Páleníček","psa":"Jiřı́ Horáček","topics":["Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W1978519803","eid":"W1978519803"},{"id":"paper-w4395111833","cat":"papers","name":"Do undergraduates’ views of psychedelics relate to the context for psychedelic use?","year":"2024","cit":0,"pfa":"Dan Petrovitch","psa":"Andrew K. Littlefield","topics":["Safety & adverse events","Dosing & pharmacology","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4395111833","eid":"W4395111833"},{"id":"paper-w4297846562","cat":"papers","name":"Intoxicaties met hallucinogenen","year":"2022","cit":0,"pfa":"Arnt Schellekens","psa":"Jurjen Justin Luykx","ptype":"book-chapter","src":"https://openalex.org/W4297846562","eid":"W4297846562"},{"id":"paper-w7151542227","cat":"papers","name":"Enhanced effect of the hallucinogen DOI in L-DOPA receptor Gpr143-deficient mice","year":"2026","cit":0,"pfa":"Daiki Masukawa","psa":"Yoshio Goshima","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7151542227","eid":"W7151542227"},{"id":"paper-w7171965348","cat":"papers","name":"MM120 (Lysergide) May Enhance Neuroplasticity by Post-Dose Upregulation of TrkB","year":"2026","cit":0,"pfa":"G. Smagin","psa":"J. Tripp","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7171965348","eid":"W7171965348"},{"id":"paper-w4306672654","cat":"papers","name":"Preparing for psychedelic therapies in Australia","year":"2022","cit":0,"pfa":"Paul Liknaitzky","topics":["Therapy practice"],"ptype":"report","src":"https://openalex.org/W4306672654","eid":"W4306672654"},{"id":"paper-w4304110275","cat":"papers","name":"Stigma in drug research holding back new therapies","year":"2022","cit":0,"pfa":"Malcolm Hopwood","topics":["Addiction"],"ptype":"report","src":"https://openalex.org/W4304110275","eid":"W4304110275"},{"id":"paper-w7111616188","cat":"papers","name":"Measuring and Enhancing Psychedelic Preparedness","year":"2025","cit":0,"pfa":"McAlpine, Rosalind G","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"dissertation","src":"https://openalex.org/W7111616188","eid":"W7111616188"},{"id":"paper-w4245451221","cat":"papers","name":"LSD","year":"2018","cit":0,"pfa":"GORDON S. CLARIDGE","ptype":"book-chapter","src":"https://openalex.org/W4245451221","eid":"W4245451221"},{"id":"paper-w4225966348","cat":"papers","name":"Why Now? Medicine, Media, and Mysticism in Past and Present American Thought on Psychedelic Drugs","year":"2022","cit":0,"pfa":"Aaron Roberts","ptype":"preprint","src":"https://openalex.org/W4225966348","eid":"W4225966348"},{"id":"paper-w2547382893","cat":"papers","name":"Effects of Caffeine Addiction","year":"2016","cit":0,"pfa":"Afreen","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2547382893","eid":"W2547382893"},{"id":"paper-w4363673488","cat":"papers","name":"Psychedelic Medicine: From Brain Science to Clinical Trials","year":"2023","cit":0,"pfa":"David Nutt","ptype":"article","src":"https://openalex.org/W4363673488","eid":"W4363673488"},{"id":"paper-w4239998439","cat":"papers","name":"Psychedelic Drugs.","year":"1970","cit":0,"pfa":"Leo E. Hollister","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4239998439","eid":"W4239998439"},{"id":"paper-w2767077566","cat":"papers","name":"Other Times I Can Barely See: The Effects of Hallucinogens on Vision and Attention - eScholarship","year":"2010","cit":0,"pfa":"Matthew J. Baggott","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2767077566","eid":"W2767077566"},{"id":"paper-w7161845170","cat":"papers","name":"DMT, Madness, and Healing: Psychosis Model, Therapy Model, and Their Relations to Mystical Experiences and Positive Emotionality","year":"2026","cit":0,"pfa":"Isabel Wießner","psa":"Draulio de Araujo","ptype":"preprint","src":"https://openalex.org/W7161845170","eid":"W7161845170"},{"id":"paper-w7148453101","cat":"papers","name":"Responsible Ceremonial Medicine: A Review of Current Evidence, Safety Protocols, and Ethical Considerations for Professional Practice","year":"2026","cit":0,"pfa":"Espinoza Patricio","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7148453101","eid":"W7148453101"},{"id":"paper-w4416981571","cat":"papers","name":"Ibogaine’s potential role in supporting reward system recovery across diagnostic boundaries","year":"2025","cit":0,"pfa":"Mark Nicolas","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4416981571","eid":"W4416981571"},{"id":"paper-w4402454696","cat":"papers","name":"Chemical Reactivity Parameters to Analyze Psychedelics: How Do We Explain the Potency of the Drugs?","year":"2024","cit":0,"pfa":"Ana Martı́nez","psa":"Diana Salvador-García","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4402454696","eid":"W4402454696"},{"id":"paper-w7213466340","cat":"papers","name":"Comparative Policy Analysis of Psychedelic Therapy Regulation in Australia, Brazil, and the USA","year":"2026","cit":0,"pfa":"A S Shikha","psa":"Dilip Maheshwari","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7213466340","eid":"W7213466340"},{"id":"paper-w319928026","cat":"papers","name":"Other Times I Can Barely See: The Effects of Hallucinogens on Vision and Attention","year":"2010","cit":0,"pfa":"Matthew J. Baggott","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W319928026","eid":"W319928026"},{"id":"paper-w3089232716","cat":"papers","name":"Crystal structure shows LSD bound to its receptor","year":"2020","cit":0,"pfa":"Ariana Remmel","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W3089232716","eid":"W3089232716"},{"id":"paper-w7148576656","cat":"papers","name":"Responsible Ceremonial Medicine: A Review of Current Evidence, Safety Protocols, and Ethical Considerations for Professional Practice","year":"2026","cit":0,"pfa":"Espinoza Patricio","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7148576656","eid":"W7148576656"},{"id":"paper-w4304787309","cat":"papers","name":"THE RENAISSANCE OF PSYCHEDELICS IN PSYCHIATRY: EVIDENCE, ETHICS, AND POTENTIAL IN MENTAL HEALTH TREATMENT FOR ADOLESCENTS","year":"2022","cit":0,"pfa":"Carol Vidal","psa":"Kevin Michael Gray","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4304787309","eid":"W4304787309"},{"id":"paper-w4399479356","cat":"papers","name":"Who believes psychedelic-assisted therapies work? Risky cannabis use and other factors are associated with positive treatment-outcome expectancies","year":"2024","cit":0,"pfa":"Dan Petrovitch","psa":"Andrew K. Littlefield","topics":["Addiction","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4399479356","eid":"W4399479356"},{"id":"paper-w3044365596","cat":"papers","name":"Molyneux on LSD","year":"2020","cit":0,"pfa":"Brian Glenney","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W3044365596","eid":"W3044365596"},{"id":"paper-w7169786207","cat":"papers","name":"Amendment LXXVIII — Psychedelic and Cannabinoid Pharmacology as Phi Modulation","year":"2026","cit":0,"pfa":"Justin McCaul","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"report","src":"https://openalex.org/W7169786207","eid":"W7169786207"},{"id":"paper-w7131239465","cat":"papers","name":"Public Opinion on Legalizing Psychedelics","year":"2026","cit":0,"pfa":"Ben Senator","psa":"Beau Kilmer","topics":["Addiction","Policy & ethics"],"ptype":"book","src":"https://openalex.org/W7131239465","eid":"W7131239465"},{"id":"paper-w4253228078","cat":"papers","name":"Method detects LSD in minute amounts","year":"1972","cit":0,"ptype":"other","src":"https://openalex.org/W4253228078","eid":"W4253228078"},{"id":"paper-w2916276122","cat":"papers","name":"Recalling of birth memories with LSD","year":"2018","cit":0,"pfa":"Roy Ridgway","psa":"Michael A. Crawford","ptype":"book-chapter","src":"https://openalex.org/W2916276122","eid":"W2916276122"},{"id":"paper-w4205632002","cat":"papers","name":"Neuropharmacology.","year":"1957","cit":0,"pfa":"Norman P. Goldstein","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4205632002","eid":"W4205632002"},{"id":"paper-w2948177903","cat":"papers","name":"Simulation of Molecular Stereoelectronic Mechanism for the Interaction of Hallucinogens and Indole Derivatives at 5-HT Receptors","year":"2018","cit":0,"pfa":"Harel Weinstein","psa":"A.P. Mazurek","topics":["Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W2948177903","eid":"W2948177903"},{"id":"paper-w3199714003","cat":"papers","name":"被覆しない毛管及びキラルセレクタとしての天然β-シクロデキストリンで被覆した毛管を用いた電気泳動による3,4-メチレンジオキシメタアンフェタミン(MDMA),3-4-メチレンジオキシアンフェタミン(MDA),3,4-メチレンジオキシエチルアンフェタミン(MDE),エフェドリン,アンフェタミン及びメタアンフェタミンの毛管電気泳動による同時キラル分離 尿及び毛髪の分析への予備的適用","year":"1998","cit":0,"pfa":"Franco Tagliaro","psa":"M. Marigo","ptype":"article","src":"https://openalex.org/W3199714003","eid":"W3199714003"},{"id":"paper-w2058081515","cat":"papers","name":"Homicide and LSD.","year":"1973","cit":0,"pfa":"Robert R. Klamt","ptype":"article","src":"https://openalex.org/W2058081515","eid":"W2058081515"},{"id":"paper-w7166698621","cat":"papers","name":"From Altered States to Altered Trajectories and From Molecules to Meaning: A Network Meta Analysis Mapping Comparative Efficacy of Psychedelic Assisted Therapies in Modern Psychiatry","year":"2026","cit":0,"pfa":"Gaurav Uppal","psa":"Khushboo Kansal","topics":["PTSD & trauma","Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7166698621","eid":"W7166698621"},{"id":"paper-w2513790806","cat":"papers","name":"Serotonin-Sensitive Adenylate Cyclase in r to the Serotonin Receptor: A Possible Sit( Acid Diethylamide","year":"2016","cit":0,"pfa":"James A. Nathanson","psa":"Paul Greengard","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2513790806","eid":"W2513790806"},{"id":"paper-w3205171128","cat":"papers","name":"6.2 OVERVIEW OF PSYCHEDELIC COMPOUNDS AND THEIR USE IN TREATMENT","year":"2021","cit":0,"pfa":"Matthew T. Keener","ptype":"article","src":"https://openalex.org/W3205171128","eid":"W3205171128"},{"id":"paper-w7125566383","cat":"papers","name":"[Role of psychedelics in psychiatry: a true therapeutic revolution or a trend?]","year":"2025","cit":0,"pfa":"Michel Sabé","psa":"Gabriel Thorens","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7125566383","eid":"W7125566383"},{"id":"paper-w4210612332","cat":"papers","name":"Psychedelic Drugs.","year":"1971","cit":0,"pfa":"Leo E. Hollister","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4210612332","eid":"W4210612332"},{"id":"paper-w2791063839","cat":"papers","name":"Taking Psychedelics Seriously (TH316)","year":"2018","cit":0,"pfa":"Ira Robert Byock","psa":"Charles S. Grob","ptype":"article","src":"https://openalex.org/W2791063839","eid":"W2791063839"},{"id":"paper-w100552415","cat":"papers","name":"Effects of the N343A mutation in TM6 of the human serotonin 5‐HT2A Receptor","year":"2006","cit":0,"pfa":"Michael R. Braden","psa":"David E. Nichols","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W100552415","eid":"W100552415"},{"id":"paper-w7212000760","cat":"papers","name":"452. Primary neuronal cultures to study neuroplastic effects of hallucinogen drugs","year":"2026","cit":0,"pfa":"Noemi Nicosia","psa":"L Musazzi","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7212000760","eid":"W7212000760"},{"id":"paper-w7141492019","cat":"papers","name":"The Mechanisms and Effects of Psychedelics","year":"2024","cit":0,"topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"report","src":"https://openalex.org/W7141492019","eid":"W7141492019"},{"id":"paper-w890687895","cat":"papers","name":"Ketamine and Phencyclidine","year":"2010","cit":0,"pfa":"Michael F. Weaver","psa":"Sidney H. Schnoll","ptype":"book-chapter","src":"https://openalex.org/W890687895","eid":"W890687895"},{"id":"paper-w7212604158","cat":"papers","name":"Effects of psychedelics on markers of neuroplasticity in humans","year":"2026","cit":0,"pfa":"Abigail E. Calder","topics":["Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W7212604158","eid":"W7212604158"},{"id":"paper-w7155193213","cat":"papers","name":"Classic psychedelic and cannabis use among U.S. cancer survivors aged ≥ 50 years: nationally representative estimates by cancer type/site","year":"2026","cit":0,"pfa":"Amrit Baral","psa":"Denise C Vidot","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7155193213","eid":"W7155193213"},{"id":"paper-w2756506476","cat":"papers","name":"Navigating Psychedelic Medicines through (Inter)national Regulation","year":"2017","cit":0,"pfa":"Jonathan Nash","topics":["Addiction","Policy & ethics"],"ptype":"conference-paper","src":"https://openalex.org/W2756506476","eid":"W2756506476"},{"id":"paper-w4400049151","cat":"papers","name":"Signaling snapshots of a serotonin receptor activated by the prototypical psychedelic LSD","year":"2024","cit":0,"pfa":"Xiangru Zhong","psa":"Robertson M.J","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4400049151","eid":"W4400049151"},{"id":"paper-w7169811185","cat":"papers","name":"Amendment LXXVIII — Psychedelic and Cannabinoid Pharmacology as Phi Modulation","year":"2026","cit":0,"pfa":"Justin McCaul","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"report","src":"https://openalex.org/W7169811185","eid":"W7169811185"},{"id":"paper-w2159041569","cat":"papers","name":"Time Foran RANZCP Committee for the Investigation of Psychedelic Therapies?","year":"1993","cit":0,"pfa":"Ron Morstyn","ptype":"article","src":"https://openalex.org/W2159041569","eid":"W2159041569"},{"id":"paper-w7161582854","cat":"papers","name":"ITU Tier 1+ #7: Psychiatric Information Theory (K_psych)","year":"2026","cit":0,"pfa":"Munehiro Terada","topics":["Depression","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W7161582854","eid":"W7161582854"},{"id":"paper-w4411148903","cat":"papers","name":"Interview with Allen Kalpin and Reiko Ikemoto-Joseph: psychedelics and ISTDP","year":"2025","cit":0,"pfa":"Thomas Hesslow","topics":["PTSD & trauma","Addiction","Therapy practice"],"ptype":"editorial","src":"https://openalex.org/W4411148903","eid":"W4411148903"},{"id":"paper-w2559867613","cat":"papers","name":"Effects of LSD on a visual discrimination between real and illusory stimuli by macaca mulatta","year":"1976","cit":0,"pfa":"Paulene Bunker Popek","topics":["Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W2559867613","eid":"W2559867613"},{"id":"paper-w4320041086","cat":"papers","name":"Mystical experience occasioned by non-medicinal embodied therapy And integration process for mental well-Being","year":"2022","cit":0,"pfa":"Bruce W. Meleski","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4320041086","eid":"W4320041086"},{"id":"paper-w4205637480","cat":"papers","name":"LSD THERAPY-NO HELP FOR ALCOHOLICS","year":"1969","cit":0,"topics":["Addiction","Anxiety & end-of-life"],"ptype":"other","src":"https://openalex.org/W4205637480","eid":"W4205637480"},{"id":"paper-w7130560736","cat":"papers","name":"Psychedelika und Entaktogene: Neue Hoffnung für therapieresistente Störungen?","year":"2026","cit":0,"pfa":"Dimitris Repantis","psa":"Tomislav Majić","topics":["PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7130560736","eid":"W7130560736"},{"id":"paper-w7161547594","cat":"papers","name":"ITU Tier 1+ #7: Psychiatric Information Theory (K_psych)","year":"2026","cit":0,"pfa":"Munehiro Terada","topics":["Depression","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W7161547594","eid":"W7161547594"},{"id":"paper-w3044110502","cat":"papers","name":"4 Psychedelics: therapeutic mechanisms","year":"2020","cit":0,"pfa":"Robin Lester Carhart-Harris","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3044110502","eid":"W3044110502"},{"id":"paper-w7135990936","cat":"papers","name":"The potential of psychedelics in the treatment of drug addiction in animal models.","year":"2022","cit":0,"pfa":"Barbara Mallarino","topics":["Addiction","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W7135990936","eid":"W7135990936"},{"id":"paper-w2402656243","cat":"papers","name":"Organicity measures following repeated LSD ingestion.","year":"1970","cit":0,"pfa":"McGlothlin Wh","psa":"Freedman Dx","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2402656243","eid":"W2402656243"},{"id":"paper-w4391786404","cat":"papers","name":"Pioneering Methods in Brain Optimization and Mental Health Treatment","year":"2024","cit":0,"pfa":"Robert B. Kargbo","topics":["Mechanism & neuroscience"],"ptype":"editorial","src":"https://openalex.org/W4391786404","eid":"W4391786404"},{"id":"paper-w4408907103","cat":"papers","name":"Existing evidence for the use of psychedelics in patients with cancer and other serious illness: A narrative review","year":"2025","cit":0,"pfa":"Jennifer L. Bires","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W4408907103","eid":"W4408907103"},{"id":"paper-w4240074231","cat":"papers","name":"Victorian Hallucinogens1","year":"2008","cit":0,"pfa":"Susan Zieger","ptype":"article","src":"https://openalex.org/W4240074231","eid":"W4240074231"},{"id":"paper-w7211993905","cat":"papers","name":"230. LSD microdosing for depression: hype or hope? A randomised controlled trial in major depressive disorder","year":"2026","cit":0,"pfa":"Carina Joy Donegan","psa":"S Muthukumaraswamy","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7211993905","eid":"W7211993905"},{"id":"paper-w2527594029","cat":"papers","name":"Impurity profiling and synthesis of precursors to the hallucinogenic amphetamine DOB","year":"2015","cit":0,"pfa":"Jonathan Quille","ptype":"dissertation","src":"https://openalex.org/W2527594029","eid":"W2527594029"},{"id":"paper-w4363648473","cat":"papers","name":"509. Meta-Analysis of Functional Neuroimaging Studies of the Effects of Serotonergic Psychedelics on Neural Activity","year":"2023","cit":0,"pfa":"Jonah H. Shepherd","psa":"Chris H. Miller","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4363648473","eid":"W4363648473"},{"id":"paper-w4390740243","cat":"papers","name":"Intoxication familiale involontaire avec une tablette de chocolat contenant du Psilocybe cubensis : une étude de cas","year":"2024","cit":0,"pfa":"Cécile Adamski","psa":"Magali Labadie","ptype":"article","src":"https://openalex.org/W4390740243","eid":"W4390740243"},{"id":"paper-w7138827229","cat":"papers","name":"Hallucinogens for Mood and Anxiety Disorders: A Critical Review of Psychedelic-Assisted Therapies","year":"2026","cit":0,"pfa":"Georgia Chlebek","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7138827229","eid":"W7138827229"},{"id":"paper-w409502468","cat":"papers","name":"Sensitive Analysis of LSD by Microscope/FTIR Using Pinpoint Condensation Technique","year":"1997","cit":0,"pfa":"宮沢 正","psa":"池田 昌彦","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W409502468","eid":"W409502468"},{"id":"paper-w2330563760","cat":"papers","name":"Analysis of the Smoke of Cigarettes Containing Salvia divinorum","year":"2014","cit":0,"pfa":"John L. Krstenansky","psa":"Miguel Muzzio","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2330563760","eid":"W2330563760"},{"id":"paper-w2768554200","cat":"papers","name":"\"Too Hot to Handle\": LSD, Medical Activism, and the Spring Grove Studies","year":"2017","cit":0,"pfa":"Lauren N Haslem","topics":["Addiction","Anxiety & end-of-life","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W2768554200","eid":"W2768554200"},{"id":"paper-w4225709710","cat":"papers","name":"Investigation of neuronal basis underlying antidepressant effect of serotonergic psychedelics","year":"2022","cit":0,"pfa":"Daisuke Ibi","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4225709710","eid":"W4225709710"},{"id":"paper-w4416119531","cat":"papers","name":"The shape of things to come-psychedelic assisted therapy and the role of the mental health nurse","year":"2025","cit":0,"pfa":"Carolyn Maile","ptype":"article","src":"https://openalex.org/W4416119531","eid":"W4416119531"},{"id":"paper-w4415038600","cat":"papers","name":"Transformations, Tensions, and Transgressions: Neuroethical Reflections on Psychedelic Therapies","year":"2025","cit":0,"pfa":"John Gardner","psa":"Adrian Carter","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4415038600","eid":"W4415038600"},{"id":"paper-w232737528","cat":"papers","name":"LSD, a Semisynthetic Psychedelic Drug","year":"2009","cit":0,"pfa":"Enno Christian Kurt Freye","ptype":"book-chapter","src":"https://openalex.org/W232737528","eid":"W232737528"},{"id":"paper-w4400575707","cat":"papers","name":"SYMPOSIUM: THE POTENTIAL OF PSYCHEDELIC THERAPIES FOR SUBSTANCE USE DISORDERS","year":"2024","cit":0,"pfa":"Albert Garcia‐Romeu","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4400575707","eid":"W4400575707"},{"id":"paper-w2090594862","cat":"papers","name":"Undoing Addiction In The Brain's Reward Sector","year":"2005","cit":0,"pfa":"SOPHIE L. ROVNER","topics":["Addiction"],"ptype":"other","src":"https://openalex.org/W2090594862","eid":"W2090594862"},{"id":"paper-w7203764494","cat":"papers","name":"The Timing of Plasticity: Beyond Synapses in Psychedelic Therapeutics","year":"2026","cit":0,"pfa":"Daniel J. Christoffel","psa":"Jessica J. Walsh","ptype":"article","src":"https://openalex.org/W7203764494","eid":"W7203764494"},{"id":"paper-w4239901044","cat":"papers","name":"Hallucinogens","year":"1971","cit":0,"pfa":"Stephen Szára","ptype":"book-chapter","src":"https://openalex.org/W4239901044","eid":"W4239901044"},{"id":"paper-w2062748619","cat":"papers","name":"VISUAL DEFECTS AND LSD","year":"1967","cit":0,"pfa":"D. M. Gordon","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2062748619","eid":"W2062748619"},{"id":"paper-w2319772829","cat":"papers","name":"Designer Hallucinogens","year":"2003","cit":0,"pfa":"Leon Gussow","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2319772829","eid":"W2319772829"},{"id":"paper-w4206786191","cat":"papers","name":"Hallucinogenic Drugs","year":"1989","cit":0,"pfa":"John Smythies","psa":"C. B. Ireland","ptype":"book-chapter","src":"https://openalex.org/W4206786191","eid":"W4206786191"},{"id":"paper-w4416818688","cat":"papers","name":"Micro-Messiahs: When Psychedelics and Politics Meet","year":"2025","cit":0,"pfa":"Leor Roseman","topics":["Anxiety & end-of-life","Safety & adverse events","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4416818688","eid":"W4416818688"},{"id":"paper-w4244543719","cat":"papers","name":"Hallucinogens","year":"2001","cit":0,"pfa":"Ken W. Day","psa":"Barry Hudson","topics":["Addiction","Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W4244543719","eid":"W4244543719"},{"id":"paper-w7162570051","cat":"papers","name":"Attitudes Toward Psychedelics and Psychedelic-Assisted Therapy (PAT) Among Mental Health Professionals in Poland and Their Associations with Cognitive, Epistemic, and Existential Factors","year":"2026","cit":0,"pfa":"Katarzyna Korsak","psa":"Paweł Holas","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"preprint","src":"https://openalex.org/W7162570051","eid":"W7162570051"},{"id":"paper-w4200447822","cat":"papers","name":"Quo Vadis? Plants of the Gods and Their Recently Discovered Therapeutic Applications","year":"2021","cit":0,"pfa":"Sarshar Shabnam Beydokhti","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"conference-paper","src":"https://openalex.org/W4200447822","eid":"W4200447822"},{"id":"paper-w7208826158","cat":"papers","name":"HANDBOOK OF ENTHEOGENIC HEALING. Edited by Michael J.Winkelman. Brill Handbooks on Contemporary Religion, 23. Brill, 2025. Pp. xxxii + 644. Hardback, €220.00.","year":"2026","cit":0,"pfa":"Andrej Kapcár","topics":["Addiction","Dosing & pharmacology","Therapy practice"],"ptype":"book-review","src":"https://openalex.org/W7208826158","eid":"W7208826158"},{"id":"paper-w4293317364","cat":"papers","name":"The Activities of the Multidisciplinary Association for Psychedelic Studies as an Example of Modern US Science Diplomacy","year":"2022","cit":0,"pfa":"Aleksandra S. Rogovtseva","topics":["PTSD & trauma","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4293317364","eid":"W4293317364"},{"id":"paper-w4306711279","cat":"papers","name":"Canonical and Non-Canonical Psychedelic Drugs Induce Common Network Changes in Human Cortex","year":"2022","cit":0,"pfa":"Rui Dai","psa":"George A. Mashour","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4306711279","eid":"W4306711279"},{"id":"paper-w4416903294","cat":"papers","name":"Micro-Messiahs: When Psychedelics and Politics Meet","year":"2025","cit":0,"pfa":"Leor Roseman","topics":["Anxiety & end-of-life","Safety & adverse events","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4416903294","eid":"W4416903294"},{"id":"paper-w4392135761","cat":"papers","name":"The Use of Classic Hallucinogens/Psychedelics in a Therapeutic Context: Healthcare Policy Opportunities and Challenges","year":"2021","cit":0,"pfa":"dos Santos RG","psa":"Jaime E. C. Hallak","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4392135761","eid":"W4392135761"},{"id":"paper-w7116755206","cat":"papers","name":"The genus Psilocybe in Italy","year":"2025","cit":0,"pfa":"Giuseppe Venturella","psa":"Maria Letizia Gargano","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7116755206","eid":"W7116755206"},{"id":"paper-w7214858042","cat":"papers","name":"PSYCHEDELIC-ASSISTED THERAPY FOR YOUTH AND WHAT WE KNOW FROM ADULT STUDIES","year":"2023","cit":0,"pfa":"Alicia FEDEWA","psa":"Amber WATSON","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7214858042","eid":"W7214858042"},{"id":"paper-w7135851627","cat":"papers","name":"Histomorphological, biochemical and behavioral profile of animal models of schizophrenia","year":"2015","cit":0,"pfa":"Kubešová, Anna","topics":["Addiction","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7135851627","eid":"W7135851627"},{"id":"paper-w7170779894","cat":"papers","name":"Time-dependent effects of rapid-acting antidepressants in iPSC-derived neurons from treatment-resistant depression and healthy volunteers","year":"2026","cit":0,"pfa":"Jenessa N. Johnston","psa":"Carlos A. Zarate","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7170779894","eid":"W7170779894"},{"id":"paper-w7130700378","cat":"papers","name":"Trends in first-time psychedelic and other hallucinogen use in the United States: Results from the National Survey on Drug Use and Health","year":"2026","cit":0,"pfa":"Juan Carlos C. Montoy","psa":"Brian T. Anderson","ptype":"article","src":"https://openalex.org/W7130700378","eid":"W7130700378"},{"id":"paper-w4225578345","cat":"papers","name":"Pharmacological Action of LSD","year":"2022","cit":0,"pfa":"Monika Herian","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W4225578345","eid":"W4225578345"},{"id":"paper-w7135542146","cat":"papers","name":"Psychedelics and mechanisms of their effect on the CNS","year":"2014","cit":0,"pfa":"Čestmír Vejmola","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7135542146","eid":"W7135542146"},{"id":"paper-w7138904487","cat":"papers","name":"Beyond the Genomic Storm: Evaluating Tabernanthalog as a Potential Scaffold for Silent Neuroplasticity and Broad-Spectrum Therapy","year":"2026","cit":0,"pfa":"Ivan Anchesi","psa":"Giovanni Luca Cipriano","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7138904487","eid":"W7138904487"},{"id":"paper-w3210294436","cat":"papers","name":"Treating addiction with psychedelics - are we waking up?","year":"2021","cit":0,"pfa":"Jackelyne Gabrielle Jesus de Miranda","psa":"A. Tarelho","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3210294436","eid":"W3210294436"},{"id":"paper-w2000027256","cat":"papers","name":"P.2.160 Blunted inhibition of return in humanhallucinogen models of psychosis","year":"2004","cit":0,"pfa":"Euphrosyne Gouzoulis‐Mayfrank","psa":"K. Stock","ptype":"article","src":"https://openalex.org/W2000027256","eid":"W2000027256"},{"id":"paper-w4411323002","cat":"papers","name":"LSD Restores Synaptic Plasticity in VTA of Morphine-Treated Mice and Disrupts Morphine-Conditioned Place Preference","year":"2025","cit":0,"pfa":"Michael Von Gunten","psa":"Jeffrey G. Edwards","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4411323002","eid":"W4411323002"},{"id":"paper-w4220835321","cat":"papers","name":"Rediscovering psychedelics","year":"2022","cit":0,"pfa":"Bethany A. Halford","topics":["Depression","PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4220835321","eid":"W4220835321"},{"id":"paper-w4411489518","cat":"papers","name":"Elucidating the Toxicity and Energetic Signatures of DMT and its Analogs at Serotonin Receptors: A Quantum Biochemistry-Guided Approach for Therapeutic Innovation and Human Potential","year":"2025","cit":0,"pfa":"Jonas Ivan Nobre Oliveira","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"report","src":"https://openalex.org/W4411489518","eid":"W4411489518"},{"id":"paper-w4389614071","cat":"papers","name":"A history and future of psychedelics: The case of the Canadian military","year":"2023","cit":0,"pfa":"Erika Dyck","psa":"Gregory P. Marchildon","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4389614071","eid":"W4389614071"},{"id":"paper-w7204881946","cat":"papers","name":"Examinando el uso combinado de psicodelicos y medicamentos psiquiatricos","year":"2024","cit":0,"pfa":"Mercedes Guaia Memita Guaia","topics":["Mechanism & neuroscience"],"ptype":"report","src":"https://openalex.org/W7204881946","eid":"W7204881946"},{"id":"paper-w4323924486","cat":"papers","name":"Understanding psychedelic 'mystical experience'—A case example","year":"2023","cit":0,"pfa":"Mika Turkia","topics":["PTSD & trauma"],"ptype":"preprint","src":"https://openalex.org/W4323924486","eid":"W4323924486"},{"id":"paper-w7135852327","cat":"papers","name":"Prospects of PTSD treatment in war veterans with psychadelic-assisted psychotherapy","year":"2023","cit":0,"pfa":"Timotej Štefánik","topics":["PTSD & trauma","Addiction","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W7135852327","eid":"W7135852327"},{"id":"paper-w3107470089","cat":"papers","name":"Hallucinogens as Therapeutic Agents: Past, Present, and Future","year":"2020","cit":0,"pfa":"Elena Vos","psa":"Toine Pieters","ptype":"book-chapter","src":"https://openalex.org/W3107470089","eid":"W3107470089"},{"id":"paper-w2790902361","cat":"papers","name":"Zeichnen unter Einfluss von Halluzinogenen","year":"2018","cit":0,"pfa":"W Ladisich","ptype":"article","src":"https://openalex.org/W2790902361","eid":"W2790902361"},{"id":"paper-w7129654448","cat":"papers","name":"Publisher Correction: Psychedelics elicit their effects by 5-HT2A receptor-mediated Gi signalling","year":"2026","cit":0,"pfa":"Zheng Xu","psa":"Zhenhua Shao","topics":["Mechanism & neuroscience"],"ptype":"erratum","src":"https://openalex.org/W7129654448","eid":"W7129654448"},{"id":"paper-w2409145052","cat":"papers","name":"A role for psychedelics in psychiatry?","year":"2005","cit":0,"pfa":"Gill Edwards","topics":["Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2409145052","eid":"W2409145052"},{"id":"paper-w4312273073","cat":"papers","name":"Hallucinogens as Therapeutic Agents: Past, Present, and Future","year":"2022","cit":0,"pfa":"Elena Vos","psa":"Toine Pieters","ptype":"book-chapter","src":"https://openalex.org/W4312273073","eid":"W4312273073"},{"id":"paper-w7204045731","cat":"papers","name":"The Strangest Drug Ever Studied: The Chemical Structure, History, and Enduring, Conjecturing Mystery of DMT","year":"2026","cit":0,"pfa":"Benjamin Pham","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7204045731","eid":"W7204045731"},{"id":"paper-w3193219878","cat":"papers","name":"Psychedelic Therapy Hits Another Milestone, But Caution Urged","year":"2021","cit":0,"pfa":"Nick Zagorski","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W3193219878","eid":"W3193219878"},{"id":"paper-w7117105451","cat":"papers","name":"The Neurophysiology of Enlightenment: Measured EEG Markers at 43 Hz and t=41 s","year":"2025","cit":0,"pfa":"Mihai Alexandru Bucurenciu","ptype":"article","src":"https://openalex.org/W7117105451","eid":"W7117105451"},{"id":"paper-w7164890397","cat":"papers","name":"Hallucinogen-Assisted Psychotherapy for Trauma Disorders: A Bionian Lens","year":"2026","cit":0,"pfa":"Christopher W. T. Miller","psa":"Zofia Kozak","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7164890397","eid":"W7164890397"},{"id":"paper-w7117109251","cat":"papers","name":"The Neurophysiology of Enlightenment: Measured EEG Markers at 43 Hz and t=41 s","year":"2025","cit":0,"pfa":"Mihai Alexandru Bucurenciu","ptype":"article","src":"https://openalex.org/W7117109251","eid":"W7117109251"},{"id":"paper-w7125801196","cat":"papers","name":"Psychedelics in psychiatric treatment: a literature review","year":"2026","cit":0,"pfa":"Adam Wolski","psa":"Katarzyna Więckowska","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7125801196","eid":"W7125801196"},{"id":"paper-w4408160714","cat":"papers","name":"The positive and negative performance outcomes of psychedelic use in healthy adults: A narrative systematic review","year":"2025","cit":0,"pfa":"K. H. Kelvin Ing","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4408160714","eid":"W4408160714"},{"id":"paper-w3178462483","cat":"papers","name":"Psychedelics: Comparing therapeutic uses and potential harms","year":"2021","cit":0,"pfa":"Rabeet Tariq","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W3178462483","eid":"W3178462483"},{"id":"paper-w2738451067","cat":"papers","name":"Preliminary Investigations on the Influence of Reserpine Therapy on Adrenocortical Function in Schizophrenia","year":"1956","cit":0,"pfa":"Kurze Mitteilungen","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2738451067","eid":"W2738451067"},{"id":"paper-w7124598490","cat":"papers","name":"Consciousness Field EFT (43 Hz): EEG Evidence from DMT Breakthrough & Meditation (N=35 Subjects)","year":"2026","cit":0,"pfa":"Mihai Alexandru Bucurenciu","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7124598490","eid":"W7124598490"},{"id":"paper-w4406946134","cat":"papers","name":"Psychiatric Treatments with Short-Duration Psychedelics and AI-Driven Behavioral Monitoring","year":"2025","cit":0,"pfa":"Robert B. Kargbo","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"editorial","src":"https://openalex.org/W4406946134","eid":"W4406946134"},{"id":"paper-w3133604748","cat":"papers","name":"Session on Psychedelics Sure to Be Enlightening","year":"2021","cit":0,"pfa":"Nick Zagorski","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W3133604748","eid":"W3133604748"},{"id":"paper-w4416941978","cat":"papers","name":"Positionspapier zu Psychedelika assistierter Therapie von Abhängigkeitserkrankungen der Schweizerischen Gesellschaft für Suchttherapie","year":"2025","cit":0,"pfa":"Alexander Wopfner","psa":"Louise E. Penzenstadler","topics":["Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4416941978","eid":"W4416941978"},{"id":"paper-w7120680358","cat":"papers","name":"Evidence of Ayahuasca's fast antidepressive effect in an animal model of greater depression","year":"2021","cit":0,"pfa":"Francisco Cid Coelho Pinto","topics":["Depression","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7120680358","eid":"W7120680358"},{"id":"paper-w7204042908","cat":"papers","name":"The Strangest Drug Ever Studied: The Chemical Structure, History, and Enduring, Conjecturing Mystery of DMT","year":"2026","cit":0,"pfa":"Benjamin Pham","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7204042908","eid":"W7204042908"},{"id":"paper-w1976825746","cat":"papers","name":"Mental Health Tribunals: Law, Practice and Procedure. By Jonathan Butler. Jordan Publishing. 2009. £65.00 (pb). 489 pp. ISBN: 9781846611391","year":"2010","cit":0,"pfa":"Richard Latham","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"book-review","src":"https://openalex.org/W1976825746","eid":"W1976825746"},{"id":"paper-w4415103344","cat":"papers","name":"Other Influential Psychiatric Diagnoses","year":"2025","cit":0,"pfa":"Jennifer L. Gaudiani","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"book-chapter","src":"https://openalex.org/W4415103344","eid":"W4415103344"},{"id":"paper-w7130376171","cat":"papers","name":"Consciousness Field EFT (43 Hz): EEG Evidence from DMT Breakthrough & Meditation (N=35 Subjects)","year":"2026","cit":0,"pfa":"Mihai Alexandru Bucurenciu","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7130376171","eid":"W7130376171"},{"id":"paper-w7162007156","cat":"papers","name":"Treatment-Resistant Depression in the 21st Century: A Scoping Review of Psychedelics and Neuromodulation in Transforming Care","year":"2026","cit":0,"pfa":"Khadija Kamene","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7162007156","eid":"W7162007156"},{"id":"paper-w4281617244","cat":"papers","name":"0841 Case Report: Can LSD be Associated with Chronic Exploding Head Syndrome?","year":"2022","cit":0,"pfa":"Feby Puravath Manikat","psa":"Clete A. Kushida","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4281617244","eid":"W4281617244"},{"id":"paper-w1600338357","cat":"papers","name":"Serotonin 5‐HT2 receptor activation prevents the development of allergic asthma: Physiology and functional selectivity (LB575)","year":"2014","cit":0,"pfa":"Charles David Nichols","psa":"Stephania A. Cormier","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1600338357","eid":"W1600338357"},{"id":"paper-w4396676081","cat":"papers","name":"Effects of Classical Psychedelics on Implicit and Explicit Emotional Empathy and Cognitive Empathy: A Meta-analysis of MET task","year":"2024","cit":0,"pfa":"Amit Olami","psa":"Leehe Peled‐Avron","topics":["Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4396676081","eid":"W4396676081"},{"id":"paper-w7161849392","cat":"papers","name":"Psychedelic-assisted therapy: a survey on the clinical methods of Swiss physicians","year":"2026","cit":0,"pfa":"Kristian Beichmann","psa":"Gregor Hasler","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7161849392","eid":"W7161849392"},{"id":"paper-w1788585400","cat":"papers","name":"Characterization and colorimetric analysis of semi-synthetic Salvia divinorum analogues","year":"2014","cit":0,"pfa":"Rhiannon Rae Carter","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W1788585400","eid":"W1788585400"},{"id":"paper-w4313343960","cat":"papers","name":"Mass Multiplication, Production Cost Analysis, and Marketing of Psilocybe Mushroom","year":"2023","cit":0,"pfa":"Boomika Nallaiyan","psa":"Dhanasekaran Dharumadurai","ptype":"book-chapter","src":"https://openalex.org/W4313343960","eid":"W4313343960"},{"id":"paper-w4399852713","cat":"papers","name":"Does LSD confer lasting psychological resilience? an investigation of naturalistic users experiencing job loss","year":"2024","cit":0,"pfa":"Benjamin A. Korman","ptype":"article","src":"https://openalex.org/W4399852713","eid":"W4399852713"},{"id":"paper-w4402225710","cat":"papers","name":"Medical Use of Cannabinoids and Psychedelic Compounds","year":"2024","cit":0,"pfa":"Antonio Inserra","psa":"Gabriella Gobbi","ptype":"book-chapter","src":"https://openalex.org/W4402225710","eid":"W4402225710"},{"id":"paper-w4413116433","cat":"papers","name":"Preparing Social Work for Psychedelic-Assisted Therapy","year":"2025","cit":0,"pfa":"HEIDI L. ALLEN","psa":"Brooke L Stott","topics":["Depression","PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4413116433","eid":"W4413116433"},{"id":"paper-w4394992735","cat":"papers","name":"The selective 5-HT 2A receptor agonist LPH-5 induces persistent and robust antidepressant-like effects in rodents","year":"2024","cit":0,"pfa":"Anders A. Jensen","psa":"Jesper Langgaard Kristensen","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4394992735","eid":"W4394992735"},{"id":"paper-w7110283060","cat":"papers","name":"Impact of Most Memorable Psychedelic Experience on Spiritual Beliefs Among USA Veterans and Their Partners","year":"2025","cit":0,"pfa":"Orion, Dylan","psa":"Kozyr, Lena","ptype":"other","src":"https://openalex.org/W7110283060","eid":"W7110283060"},{"id":"paper-w7166828055","cat":"papers","name":"Healthcare Providers’ Perspectives on Psychedelic-Assisted Therapies Across Clinical Contexts: “I Can Offer Medical Assistance in Dying, but I Can’t Prescribe Psychedelics”","year":"2026","cit":0,"pfa":"Haley D.M. Schuman","psa":"Linda Ellen Carlson","topics":["PTSD & trauma","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7166828055","eid":"W7166828055"},{"id":"paper-w7171942640","cat":"papers","name":"The therapeutic potential of psychedelic drugs: past, present, and future","year":"2026","cit":0,"pfa":"David Nutt","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7171942640","eid":"W7171942640"},{"id":"paper-w7212048060","cat":"papers","name":"846. Inconsistent trial risk-of-bias judgements across psychedelic-assisted psychotherapy systematic reviews","year":"2026","cit":0,"pfa":"Katarzyna Henke‐Ciążyńska","psa":"Bartosz Helfer","topics":["Safety & adverse events","Reviews & meta-analyses","Therapy practice"],"ptype":"review","src":"https://openalex.org/W7212048060","eid":"W7212048060"},{"id":"paper-w4401323570","cat":"papers","name":"Brain Connectivity Pattern Changes Associated With Psychedelic-Assisted Psychotherapy","year":"2024","cit":0,"pfa":"Prince Patel","psa":"Bhaumik Patel","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"conference-paper","src":"https://openalex.org/W4401323570","eid":"W4401323570"},{"id":"paper-w2616400231","cat":"papers","name":"Upotreba božanske kadulje (Salvia divinorum) i njeno fiziološko – biokemijsko djelovanje","year":"2014","cit":0,"pfa":"Lucija Ivić","topics":["Addiction","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W2616400231","eid":"W2616400231"},{"id":"paper-w4411214546","cat":"papers","name":"Stability-Guided Formulation of a Light-Sensitive D-LSD Capsule for Clinical Investigation","year":"2025","cit":0,"pfa":"Bernard Do","psa":"Philippe-Henri Secrétan","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4411214546","eid":"W4411214546"},{"id":"paper-w3215499144","cat":"papers","name":"HALLUCINOGENIC MUSHROOMS AND THEIR LEGAL STATUS IN TURKEY","year":"2017","cit":0,"pfa":"İlgaz Akata","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3215499144","eid":"W3215499144"},{"id":"paper-w2959642902","cat":"papers","name":"Personality and Attitude Measures: The Differences (and Lack Thereof) Between Marijuana Users, Psychedelic Users and Abstainers","year":"2008","cit":0,"pfa":"Rachel D. Hanson","ptype":"conference-paper","src":"https://openalex.org/W2959642902","eid":"W2959642902"},{"id":"paper-w3199098367","cat":"papers","name":"A novel method for predicting human cardiotoxicity without animal testing","year":"2021","cit":0,"pfa":"Miaoying Shi","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W3199098367","eid":"W3199098367"},{"id":"paper-w4392720916","cat":"papers","name":"Medical Use of Cannabinoids and Psychedelic Compounds","year":"2023","cit":0,"pfa":"Antonio Inserra","psa":"Gabriella Gobbi","ptype":"book-chapter","src":"https://openalex.org/W4392720916","eid":"W4392720916"},{"id":"paper-w2752662627","cat":"papers","name":"Desenvolvimento de métodos voltamétricos para a quantificação de LSD utilizando-se o eletrodo de pasta de carbono modificado com complexo de base de Schiff","year":"2016","cit":0,"pfa":"Maria Fernanda Muzetti Ribeiro","ptype":"dissertation","src":"https://openalex.org/W2752662627","eid":"W2752662627"},{"id":"paper-w7116864166","cat":"papers","name":"Psychedelics as a Therapeutic Opportunity or Threat: A Narrative Review","year":"2025","cit":0,"pfa":"Paweł Liszka","psa":"Jakub Brodowski","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"review","src":"https://openalex.org/W7116864166","eid":"W7116864166"},{"id":"paper-w7166078398","cat":"papers","name":"Micro-Messiahs and the Revolutionary Dynamics of Psychedelic Diffusion","year":"2026","cit":0,"pfa":"Leor Roseman","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7166078398","eid":"W7166078398"},{"id":"paper-w4416948816","cat":"papers","name":"Lysergide","year":"2000","cit":0,"pfa":"Arnold E. Merriam","topics":["Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W4416948816","eid":"W4416948816"},{"id":"paper-w4411736916","cat":"papers","name":"Australia’s psychedelic experiment: reflections from a psychiatrist clinical researcher","year":"2025","cit":0,"pfa":"Adam J. Bayes","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4411736916","eid":"W4411736916"},{"id":"paper-w4390618916","cat":"papers","name":"Potent psychedelic drug banishes PTSD, small study finds","year":"2024","cit":0,"pfa":"Max Kozlov","topics":["PTSD & trauma"],"ptype":"other","src":"https://openalex.org/W4390618916","eid":"W4390618916"},{"id":"paper-w2963767451","cat":"papers","name":"Biljne droge s halucinogenim i psihostimulirajućim učincima","year":"2019","cit":0,"pfa":"Željan Maleš","psa":"Tihana Vilović","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2963767451","eid":"W2963767451"},{"id":"paper-w4361839572","cat":"papers","name":"The Pharmacology of Scheduled Psychoactive Drugs","year":"2023","cit":0,"pfa":"R. H. Ettinger","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W4361839572","eid":"W4361839572"},{"id":"paper-w7171585406","cat":"papers","name":"Convergent neuroimmune signaling underlying rapid antidepressant response to ketamine and psychedelics","year":"2026","cit":0,"pfa":"Gregory H. Jones","psa":"Carlos A. Zarate","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7171585406","eid":"W7171585406"},{"id":"paper-w2493971310","cat":"papers","name":"Concepts of Addiction: The U.S. Experience","year":"1993","cit":0,"pfa":"David F. Musto","topics":["Addiction","Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W2493971310","eid":"W2493971310"},{"id":"paper-w7125357336","cat":"papers","name":"Impact of Most Memorable Psychedelic Experience on Spiritual Beliefs Among USA Veterans and Their Partners","year":"2026","cit":0,"pfa":"Irakli Kaloiani","psa":"Dylan Orion","ptype":"preprint","src":"https://openalex.org/W7125357336","eid":"W7125357336"},{"id":"paper-w7155691678","cat":"papers","name":"Psychedelics: Future Therapeutics in Major Depression?","year":"2026","cit":0,"pfa":"Berend Olivier","psa":"Jocelien D.A. Olivier","topics":["Depression"],"ptype":"book-chapter","src":"https://openalex.org/W7155691678","eid":"W7155691678"},{"id":"paper-w7133898398","cat":"papers","name":"LSD Relaxes Structural Constraints on Brain Dynamics: A Connectome Harmonic MEG Study","year":"2026","cit":0,"pfa":"Venkatesh Subramani","psa":"Nicolas Farrugia","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7133898398","eid":"W7133898398"},{"id":"paper-w2941699004","cat":"papers","name":"Unlearning to See: Linking the Perceptual and Clinical Effects of Psychedelic Drugs.","year":"2018","cit":0,"pfa":"Link Ray Swanson","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2941699004","eid":"W2941699004"},{"id":"paper-w2039158291","cat":"papers","name":"P-1285 - Delusions in schizophrenia interpreted as cognitive hallucinations according to a neurocomputational model of the thalamus","year":"2012","cit":0,"pfa":"Javier Ropero Peláez","psa":"S. Taniguchi","topics":["Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W2039158291","eid":"W2039158291"},{"id":"paper-w3161248517","cat":"papers","name":"Oral Health and Quality of Life of Addicts in Brazilian Population","year":"2021","cit":0,"pfa":"Marilisa Carneiro Leão Gabardo","psa":"Maria Ângela Naval Machado","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W3161248517","eid":"W3161248517"},{"id":"paper-w4400034812","cat":"papers","name":"LSD-stimulated behaviors in mice require β-arrestin 2 but not β-arrestin 1","year":"2024","cit":0,"pfa":"Roth B.L","psa":"R.M. Rodriguiz","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4400034812","eid":"W4400034812"},{"id":"paper-w7115197406","cat":"papers","name":"Psychedelic Assisted Psychotherapy (PAP): the Geneva University Hospital model","year":"2025","cit":0,"pfa":"F. Seragnoli","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7115197406","eid":"W7115197406"},{"id":"paper-w3160508650","cat":"papers","name":"Supporting the Patient on LSD Day","year":"2021","cit":0,"pfa":"Betsy Todd","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W3160508650","eid":"W3160508650"},{"id":"paper-w3005336267","cat":"papers","name":"Serotonergic Psychoactive Compounds as a Treatment for Addiction, Anxiety, and Depression: Their Efficacy and Legality","year":"2019","cit":0,"pfa":"William G. Crane","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3005336267","eid":"W3005336267"},{"id":"paper-w3164723073","cat":"papers","name":"Genetic deletion of β-arrestin 2 modulates LSD-stimulated behaviors in mice","year":"2021","cit":0,"pfa":"Ramona M. Rodriguiz","psa":"William C. Wetsel","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W3164723073","eid":"W3164723073"},{"id":"paper-w4412617219","cat":"papers","name":"Mécanismes d’action et perspectives thérapeutiques du LSD : état des lieux actuel","year":"2025","cit":0,"pfa":"Amel Bouloufa","psa":"Nasser Haddjeri","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4412617219","eid":"W4412617219"},{"id":"paper-w2005729499","cat":"papers","name":"BIOCHEMICAL ANOMALIES IN SCHIZOPHRENIA","year":"1959","cit":0,"pfa":"Paul W. Clough","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2005729499","eid":"W2005729499"},{"id":"paper-w7203747184","cat":"papers","name":"Tuning in together: LSD enhances inter-brain synchrony and felt connectedness in romantic couples","year":"2026","cit":0,"pfa":"Natasha Leigh Mason","psa":"Jan Ramaekers","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7203747184","eid":"W7203747184"},{"id":"paper-w4327724871","cat":"papers","name":"Perceived risk of LSD use in the United States from 2015-2019: Are Americans more realistically assessing LSD’s risks?","year":"2023","cit":0,"pfa":"Brian Scott Barnett","psa":"Jeremy Weleff","topics":["Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4327724871","eid":"W4327724871"},{"id":"paper-w7117768931","cat":"papers","name":"The helioscope effect: A new framework for evaluating trauma-related memory processing in psychedelic experiences","year":"2025","cit":0,"pfa":"Vincent J Diehl","psa":"Gregor Hasler","topics":["PTSD & trauma","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7117768931","eid":"W7117768931"},{"id":"paper-w4402799995","cat":"papers","name":"Distinct classes of antidepressants commonly act to shape pallidal structure and function in mice","year":"2024","cit":0,"pfa":"Yoshifumi Abe","psa":"Kenji F. Tanaka","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4402799995","eid":"W4402799995"},{"id":"paper-w2188369675","cat":"papers","name":"receptor was lost during mammalian evolution","year":"2001","cit":0,"pfa":"Régis Grailhe","psa":"Gregg W. Grabtree","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2188369675","eid":"W2188369675"},{"id":"paper-w4206066328","cat":"papers","name":"Hallucinogens","year":"1993","cit":0,"pfa":"Mark J. Werner","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4206066328","eid":"W4206066328"},{"id":"paper-w7212077546","cat":"papers","name":"477. Antidepressant action of short-acting psychedelics","year":"2026","cit":0,"pfa":"Jan Ramaekers","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7212077546","eid":"W7212077546"},{"id":"paper-w2754353458","cat":"papers","name":"Simplification of hallucinogen pays off","year":"2017","cit":0,"pfa":"Tien Nguyen","topics":["Addiction","Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W2754353458","eid":"W2754353458"},{"id":"paper-w7202215062","cat":"papers","name":"Psychedelic Therapy for Depression","year":"2026","cit":0,"pfa":"Saanvi Gutta","topics":["Depression","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7202215062","eid":"W7202215062"},{"id":"paper-w3158482202","cat":"papers","name":"Correction: Optimizing psychedelic compounds for neuropsychiatric therapy","year":"2021","cit":0,"pfa":"Scott M. Thompson","ptype":"erratum","src":"https://openalex.org/W3158482202","eid":"W3158482202"},{"id":"paper-w4221011057","cat":"papers","name":"Spatial Distribution Pattern and Interactions Facilitating of Lophophora Williamsii (Lem. Ex Salm-Dyck) J.M.Coult. (Cactaceae) in Tamaulipas, México","year":"2022","cit":0,"pfa":"Leandro Schwertner-Charão","psa":"Eduardo Osorio-Hernández","topics":["Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4221011057","eid":"W4221011057"},{"id":"paper-w7200761338","cat":"papers","name":"Lysergihapon dietyyliamidin addiktioon liittyvät käyttäytymisvaikutukset hiirissä : Tutkielma psykedeelien, addiktion ja hoitojen yhtymäkohdasta","year":"2025","cit":0,"pfa":"Lauri V. Elsilä","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W7200761338","eid":"W7200761338"},{"id":"paper-w2801862023","cat":"papers","name":"Peyote’s Race Problem","year":"2018","cit":0,"pfa":"Alexander Dawson","ptype":"book-chapter","src":"https://openalex.org/W2801862023","eid":"W2801862023"},{"id":"paper-w4294189495","cat":"papers","name":"Psychedelic Psychiatry","year":"2022","cit":0,"pfa":"David Nutt","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4294189495","eid":"W4294189495"},{"id":"paper-w4413910449","cat":"papers","name":"Toward Consensus in Psychedelic-Assisted Therapy","year":"2025","cit":0,"pfa":"Vania Modesto‐Lowe","psa":"Pa-C Margaret Chaplin","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4413910449","eid":"W4413910449"},{"id":"paper-w7202187378","cat":"papers","name":"Psychedelic Therapy for Depression","year":"2026","cit":0,"pfa":"Saanvi Gutta","topics":["Depression","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7202187378","eid":"W7202187378"},{"id":"paper-w4394436995","cat":"papers","name":"RawData_TandemLCMS_PsilocybinPsilacetin_Psilocin_PlasmaConcentrations","year":"2023","cit":0,"pfa":"Cody J. Wenthur","psa":"Molly C. Pellitteri-Hahn","ptype":"dataset","src":"https://openalex.org/W4394436995","eid":"W4394436995"},{"id":"paper-w2912060784","cat":"papers","name":"L'Ayahuasca : usages traditionnels, pratiques modernes et perspectives thérapeutiques d’une boisson hallucinogène","year":"2017","cit":0,"pfa":"Aude Le Floch","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2912060784","eid":"W2912060784"},{"id":"paper-w4404409947","cat":"papers","name":"Will Psychedelics Propel Your Career? Exploring the Potential Impact of Psychedelics on Work, Productivity and Well-Being","year":"2024","cit":0,"pfa":"Jonathan Westover","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4404409947","eid":"W4404409947"},{"id":"paper-w7115169718","cat":"papers","name":"Uncovering Psychedelics: From Neural Circuits to Therapeutic Applications","year":"2025","cit":0,"pfa":"A. Melani","psa":"M. Scarselli","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7115169718","eid":"W7115169718"},{"id":"paper-w4313495409","cat":"papers","name":"A pilot study of cerebral metabolism and serotonin 5-HT2A receptor occupancy in rats treated with the psychedelic tryptamine DMT in conjunction with the MAO inhibitor harmine","year":"2023","cit":0,"pfa":"Klemens Egger","psa":"Mikael Palner","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4313495409","eid":"W4313495409"},{"id":"paper-w7168180253","cat":"papers","name":"Combined DMT–harmine formulation reduces negative self-referential emotions during social self-evaluation: a randomized placebo-controlled trial in healthy volunteers","year":"2026","cit":0,"pfa":"Helena Aicher","psa":"Dario Dornbierer","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7168180253","eid":"W7168180253"},{"id":"paper-w7169810997","cat":"papers","name":"Combined DMT–harmine formulation reduces negative self-referential emotions during social self-evaluation: a randomized placebo-controlled trial in healthy volunteers","year":"2026","cit":0,"pfa":"Helena Aicher","psa":"Dario Dornbierer","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7169810997","eid":"W7169810997"},{"id":"paper-w4415276615","cat":"papers","name":"Psychedelics for the Treatment of Substance Use Disorder","year":"2025","cit":0,"pfa":"Berta Fumàs","psa":"Núria Nadal‐Gratacós","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W4415276615","eid":"W4415276615"},{"id":"paper-w3146194954","cat":"papers","name":"幻覚作用を示さないibogaine類縁体の開発／簡単な反応で質の高い化合物群を生み出すことができる？／有機アニオン性薬物の肝移行効率の定量的予測：血清アルブミンが鍵？／プロスタグランジン受容体拮抗薬は糖代謝を正常化して脳を若返らせる／新型コロナウイルス感染が疑われる患者への処方箋交付について／薬局におけるプレアボイド事例集積","year":"2021","cit":0,"pfa":"ファルマシア委員会","ptype":"article","src":"https://openalex.org/W3146194954","eid":"W3146194954"},{"id":"paper-w7147277536","cat":"papers","name":"Psychonstructor: A Scientific Framework for Analyzing Altered States of Consciousness, Clinical Risk, and Ethical Boundaries in Psychedelic Contexts","year":"2022","cit":0,"pfa":"Ally Delshad Tehrani","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"book","src":"https://openalex.org/W7147277536","eid":"W7147277536"},{"id":"paper-w7135805108","cat":"papers","name":"The explant cultures of Trichocereus pachanoi","year":"2015","cit":0,"pfa":"Petra Čabelková","ptype":"dissertation","src":"https://openalex.org/W7135805108","eid":"W7135805108"},{"id":"paper-w7171498862","cat":"papers","name":"Candidate Biomarkers of Bipolar Disorder Progression: Implications for Ketamine and Psychedelic Interventions","year":"2026","cit":0,"pfa":"Alina Wilkowska","psa":"Wiesław Jerzy Cubała","ptype":"article","src":"https://openalex.org/W7171498862","eid":"W7171498862"},{"id":"paper-w1745714","cat":"papers","name":"Dissociation of multiple effects of acute LSD on exploratory behavior in rats by ritanserin and propranolol.","year":"1991","cit":0,"pfa":"利明 白井","psa":"M A Geyer","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1745714","eid":"W1745714"},{"id":"paper-w2967565123","cat":"papers","name":"Molecular Targets of Psychedelics and Their Role in Behavioral Models of Hallucinogenic Action","year":"2019","cit":0,"pfa":"Hiba Vohra","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2967565123","eid":"W2967565123"},{"id":"paper-w7147394625","cat":"papers","name":"Psychonstructor: A Scientific Framework for Analyzing Altered States of Consciousness, Clinical Risk, and Ethical Boundaries in Psychedelic Contexts","year":"2022","cit":0,"pfa":"Ally Delshad Tehrani","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"book","src":"https://openalex.org/W7147394625","eid":"W7147394625"},{"id":"paper-w4225310586","cat":"papers","name":"Psychopathological descriptive model of hallucinogenic/psychedelic drugs effect in the treatment of depression and addictions","year":"2022","cit":0,"pfa":"Nestor Girala","topics":["Depression","Addiction","Reviews & meta-analyses"],"ptype":"other","src":"https://openalex.org/W4225310586","eid":"W4225310586"},{"id":"paper-w7131651397","cat":"papers","name":"It’s all about the relationship: The caregiver experience of supporting a person with advanced cancer going through an LSD microdosing trial","year":"2026","cit":0,"pfa":"Fiona Cottam","psa":"Lisa Reynolds","topics":["Anxiety & end-of-life","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7131651397","eid":"W7131651397"},{"id":"paper-w7135693922","cat":"papers","name":"Analysis of Psilocybe constituents I.","year":"2016","cit":0,"pfa":"Tereza Kobrlová","topics":["Addiction"],"ptype":"dissertation","src":"https://openalex.org/W7135693922","eid":"W7135693922"},{"id":"paper-w7207645866","cat":"papers","name":"Hallucinogen Persisting Perception Disorder in a Young Adult Case Report","year":"2026","cit":0,"pfa":"Sonali Notani","psa":"Ashley L. Weiss","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7207645866","eid":"W7207645866"},{"id":"paper-w7130838555","cat":"papers","name":"Psychedelic research and sexuality: opportunities and pitfalls","year":"2026","cit":0,"pfa":"Henderikus Knegtering","psa":"Symen Kornelis Spoelstra","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7130838555","eid":"W7130838555"},{"id":"paper-w7128237680","cat":"papers","name":"Beyond The Stigma: Psychedelics in The Fight Against Depression and PTSD","year":"2025","cit":0,"pfa":"Avrina Kartika Ririe","psa":"Hrishik Iqbal","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7128237680","eid":"W7128237680"},{"id":"paper-w4412664633","cat":"papers","name":"Exploring Public Sentiments of Psychedelics Versus Other Substances: A Reddit-Based Natural Language Processing Study","year":"2025","cit":0,"pfa":"Brandon-Joe Biba","psa":"Brian O'Shea","topics":["Addiction","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4412664633","eid":"W4412664633"},{"id":"paper-w1972162241","cat":"papers","name":"PW01-222 - Adolescents Using Hallucinogens Within A Religious Context: A Neuropsychological Assessment","year":"2010","cit":0,"pfa":"Evelyn Doering-Silveira","psa":"Dartiu Xavier da Silveira","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1972162241","eid":"W1972162241"},{"id":"paper-w4408214715","cat":"papers","name":"Exploring Public Sentiments of Psychedelics Versus Other Substances: A Reddit-Based Natural Language Processing Study","year":"2025","cit":0,"pfa":"Brandon-Joe Biba","psa":"Brian O'Shea","topics":["Addiction","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4408214715","eid":"W4408214715"},{"id":"paper-w4406161181","cat":"papers","name":"PSYCHEDELICS IN THE TREATMENT OF MENTAL DISORDERS","year":"2025","cit":0,"pfa":"Eduardo d’Avila Lins Lacerda","psa":"Paulo Heinrich Soares Bomtempo","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4406161181","eid":"W4406161181"},{"id":"paper-w4402677707","cat":"papers","name":"Dart-Hrms Analysis as a Screening Method for Hallucinogenic Mushrooms","year":"2024","cit":0,"pfa":"Vanessa Braga Galhego","psa":"Gabriela Vanini","ptype":"preprint","src":"https://openalex.org/W4402677707","eid":"W4402677707"},{"id":"paper-w2950987044","cat":"papers","name":"ChemInform Abstract: Tris‐N,N′,N′′‐(3′,4′,5′‐trimethoxyphenethyl)‐1,3,5‐hexahydrotriazine, a Methylenemescaline Trimer: Characterization and Selective Cyclization to Anhalinine Under Non‐Aqueous Conditions.","year":"1990","cit":0,"pfa":"Linda A. Chrisey","psa":"A. BROSSI","ptype":"article","src":"https://openalex.org/W2950987044","eid":"W2950987044"},{"id":"paper-w7164535985","cat":"papers","name":"A theoretical investigation of DMT metabolism and the formation of apotential biomarker","year":"2026","cit":0,"pfa":"Maria  Luiza Luiz Marçal","psa":"Luiz Antonio Sodre Costa","ptype":"preprint","src":"https://openalex.org/W7164535985","eid":"W7164535985"},{"id":"paper-w7166663063","cat":"papers","name":"Psychedelics in treatment-resistant depression: a comprehensive review of mechanisms, clinical evidence, and recommendations","year":"2026","cit":0,"pfa":"Cielo A. Estela-Fernández","psa":"Hossam Tharwat Ali","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7166663063","eid":"W7166663063"},{"id":"paper-w4366160746","cat":"papers","name":"Perceived risk of LSD use in the United States from 2015-2019: Are Americans assessing LSD’s risk profile more favorably?","year":"2023","cit":0,"pfa":"Brian Scott Barnett","psa":"Jeremy Weleff","topics":["Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4366160746","eid":"W4366160746"},{"id":"paper-w2005516824","cat":"papers","name":"Death and Disability in Drug Addiction and Abuse","year":"1967","cit":0,"pfa":"Henry Brill","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2005516824","eid":"W2005516824"},{"id":"paper-w7212181712","cat":"papers","name":"Psychedelics in the Future of Global Mental Healthcare","year":"2026","cit":0,"pfa":"Lily R. Aleksandrova","psa":"Michael Krausz","ptype":"book-chapter","src":"https://openalex.org/W7212181712","eid":"W7212181712"},{"id":"paper-w4417046156","cat":"papers","name":"m-DASC: Measuring Subjective Effects of Very Low Doses of Psychedelic Drugs","year":"2025","cit":0,"pfa":"Jonah Griffin-Stolbach","psa":"Harriet de Wit","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4417046156","eid":"W4417046156"},{"id":"paper-w7133043086","cat":"papers","name":"“With Face Uplifted and Bright Eyes”: LSD, Autism, and the Science of Emotional Connection in Postwar America","year":"2025","cit":0,"pfa":"Andrew Jones","ptype":"dissertation","src":"https://openalex.org/W7133043086","eid":"W7133043086"},{"id":"paper-w4395068156","cat":"papers","name":"Plant Medicine, Psychedelics and the Inner-Sciences of Mental Wellness: Implications for Healthy Longevity and Rejuvenation","year":"2024","cit":0,"pfa":"Jeffrey L. McNairy","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4395068156","eid":"W4395068156"},{"id":"paper-w2398026694","cat":"papers","name":"The Plant Salvia divinorum (Lamiaceae)—Chemistry and Pharmacology","year":"2016","cit":0,"pfa":"Adam W. Keasling","psa":"Jordan Kordian Zjawiony","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W2398026694","eid":"W2398026694"},{"id":"paper-w4412705571","cat":"papers","name":"Psychedelic Herbal Medicines: Exploring the Renaissance of a Therapeutic Frontier","year":"2025","cit":0,"pfa":"Gaurav Mude","psa":"Raghvendra Dubey","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4412705571","eid":"W4412705571"},{"id":"paper-w7138969525","cat":"papers","name":"Binaries, Multitudes, and Beyond: A Client-Authored Case Study in Psychedelic-Assisted Therapy, Artificial Intelligence, and Narrative Agency","year":"2026","cit":0,"pfa":"Mark A. Michaels","ptype":"preprint","src":"https://openalex.org/W7138969525","eid":"W7138969525"},{"id":"paper-w7171479310","cat":"papers","name":"Perceptual changes induced by psychedelics and their electrophysiological correlates in animal models","year":"2025","cit":0,"pfa":"Čestmír Vejmola","topics":["Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W7171479310","eid":"W7171479310"},{"id":"paper-w7119484008","cat":"papers","name":"Psychedelics in Practice: Science, Safety, and the Future of Healing","year":"2025","cit":0,"pfa":"Renee E. E. Ireland","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"conference-abstract","src":"https://openalex.org/W7119484008","eid":"W7119484008"},{"id":"paper-w7172314959","cat":"papers","name":"Where is the sweet spot for psychedelic-enhanced fear extinction? An integrative quantitative synthesis of dose–effect patterns in rodent models","year":"2026","cit":0,"pfa":"Isabel Werle","psa":"Leandro Jose Bertoglio","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7172314959","eid":"W7172314959"},{"id":"paper-w7160257271","cat":"papers","name":"Investigating Hypo‐Egoic Features: Ayahuasca's Psychedelic Path Versus Meditation's Mindful Journey","year":"2026","cit":0,"pfa":"María Arqueros","psa":"Juan Carlos Pascual","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7160257271","eid":"W7160257271"},{"id":"paper-w4414208490","cat":"papers","name":"Selective outcome reporting and non-reporting in trials of psychedelic drugs for mental disorders","year":"2025","cit":0,"pfa":"Ioana A. Cristea","psa":"A. Bonessio","topics":["Safety & adverse events","Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4414208490","eid":"W4414208490"},{"id":"paper-w185924985","cat":"papers","name":"Methylenedioxymethamphetamine-induced neurotoxicity: The role of hepatic enzymes cytochrome p450 2d6 and catechol-o-methyltransferase and contribution of microglia","year":"2013","cit":0,"pfa":"Joseph M. Herndon","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W185924985","eid":"W185924985"},{"id":"paper-w4294203067","cat":"papers","name":"Psychopathological descriptive model of hallucinogenic/psychedelic drugs effect in the treatment of depression and addictions","year":"2022","cit":0,"pfa":"Nestor Girala","topics":["Depression","Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4294203067","eid":"W4294203067"},{"id":"paper-w7214086238","cat":"papers","name":"Preclinical Anxiolytic- and Antidepressant-like Effects of α,α-Trehalose, a Bioactive Compound Identified in Psilocybe cubensis","year":"2026","cit":0,"pfa":"Aylín R. Tabal-Robles","psa":"Jesús Martín Torres-Valencia","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7214086238","eid":"W7214086238"},{"id":"paper-w7214168709","cat":"papers","name":"Prolonged Psychological Distress Following Recreational LSD Use in a Young Adult with Multiple Vulnerability Factors: A Case Report","year":"2026","cit":0,"pfa":"Giacomo d’Andrea","psa":"Mauro Pettorruso","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7214168709","eid":"W7214168709"},{"id":"paper-w4402945378","cat":"papers","name":"A Prospective Survey Study of Radiation Therapy Patient Interest in Psychedelic Research","year":"2024","cit":0,"pfa":"J. Park","psa":"Jeremy P. Harris","ptype":"article","src":"https://openalex.org/W4402945378","eid":"W4402945378"},{"id":"paper-w7213549664","cat":"papers","name":"Psychedelic Hormesis: LSD Activates Adaptive Stress Transcriptional Programs in the Prefrontal Cortex","year":"2026","cit":0,"pfa":"Aurora Savino","psa":"Valeria Poli","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W7213549664","eid":"W7213549664"},{"id":"paper-w4408352126","cat":"papers","name":"Psilocibina no Manejo da Depressão e Ansiedade: Uma Revisão Integrativa de Evidências Científicas","year":"2025","cit":0,"pfa":"Ana Paula Dalmagro","psa":"Michele Andrade","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4408352126","eid":"W4408352126"},{"id":"paper-w1584706860","cat":"papers","name":"Factors Underlying +/- 3, 4-Methylenedioxymethamphetamine Self Administration","year":"2007","cit":0,"pfa":"Evangelene Joy Kia Daniela","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W1584706860","eid":"W1584706860"},{"id":"paper-w7158128609","cat":"papers","name":"Evaluating the evidence for repressed memory recovery in psychedelic contexts","year":"2026","cit":0,"pfa":"Anne-Fiona Griesfeller","psa":"Henry Otgaar","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7158128609","eid":"W7158128609"},{"id":"paper-w4321448003","cat":"papers","name":"Factors Underlying +/- 3, 4-Methylenedioxymethamphetamine Self Administration","year":"2007","cit":0,"pfa":"Evangelene Joy Kia Daniela","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W4321448003","eid":"W4321448003"},{"id":"paper-w2089166055","cat":"papers","name":"Urinary excretion profiles ofN-hydroxy-3,4-methylenedioxymethamphetamine in rats","year":"2011","cit":0,"pfa":"Kenji Tsujikawa","psa":"Hiroyuki Inoue","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2089166055","eid":"W2089166055"},{"id":"paper-w4380667701","cat":"papers","name":"Protective Effects of N-Acetyl-L-cystein on 3,4-Methylene Dioxymethamphetamie-Induced Neurotoxicity in Cerebellum of Male Rats","year":"2011","cit":0,"pfa":"Sara Soleimani Asl","psa":"Mehdi Mehdizadeh","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4380667701","eid":"W4380667701"},{"id":"paper-w7170157446","cat":"papers","name":"Structural characterization of kappa-opioid receptor dimer in complex with two G proteins","year":"2026","cit":0,"pfa":"Yue Wang","psa":"Jianfeng Liu","topics":["Addiction","Mechanism & neuroscience"],"ptype":"dataset","src":"https://openalex.org/W7170157446","eid":"W7170157446"},{"id":"paper-w4416216533","cat":"papers","name":"Return of the lysergamides. Part IV: Analytical and pharmacological characterization of lysergic acid morpholide (LSM‐775)","year":"2025","cit":0,"pfa":"Jason V. Wallach","psa":"Brendan Twamley","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4416216533","eid":"W4416216533"},{"id":"paper-w4405045610","cat":"papers","name":"DART-HRMS analysis as a screening method for hallucinogenic mushrooms","year":"2024","cit":0,"pfa":"Vanessa Braga Galhego","psa":"Gabriela Vanini","ptype":"article","src":"https://openalex.org/W4405045610","eid":"W4405045610"},{"id":"paper-w4385542835","cat":"papers","name":"Simultaneous PET/fMRI of the Kappa Opioid Receptor System During Psychotropic Drug Challenge","year":"2023","cit":0,"pfa":"Frederick A. Bagdasarian","psa":"Hsiao‐Ying Wey","topics":["Addiction","Mechanism & neuroscience"],"ptype":"conference-paper","src":"https://openalex.org/W4385542835","eid":"W4385542835"},{"id":"paper-w7104933563","cat":"papers","name":"Psychedelics induced modulation of motor recovery after stroke","year":"2025","cit":0,"pfa":"Koschützke, Leif","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7104933563","eid":"W7104933563"},{"id":"paper-w7117996243","cat":"papers","name":"Conclusion: Psychedelic Shamans","year":"2025","cit":0,"pfa":"Richard G. Alexander","ptype":"book-chapter","src":"https://openalex.org/W7117996243","eid":"W7117996243"},{"id":"paper-w4402325321","cat":"papers","name":"P-43 Everybody’s talking: is PAT the new VAD? a narrative review of psychedelic assisted therapies for people facing life threatening illness","year":"2024","cit":0,"pfa":"Judith Lacey","psa":"Debra Scott","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"review","src":"https://openalex.org/W4402325321","eid":"W4402325321"},{"id":"paper-w7162627957","cat":"papers","name":"Innovative and legal significance of psychedelic-assisted therapy: novelties of international practice and implementation in Ukraine","year":"2026","cit":0,"pfa":"Oleksandr Mykhailichenko","topics":["PTSD & trauma","Safety & adverse events","Reviews & meta-analyses"],"ptype":"conference-paper","src":"https://openalex.org/W7162627957","eid":"W7162627957"},{"id":"paper-w2888514029","cat":"papers","name":"Hallucinogènes d’origine végétale","year":"2018","cit":0,"pfa":"G. Le Roux","ptype":"article","src":"https://openalex.org/W2888514029","eid":"W2888514029"},{"id":"paper-w11119588","cat":"papers","name":"Effect of adenosine receptors on 3, 4 methylene dioxy methamphetamine induced hyperthermic, neuroinflammatory and neurotoxic effects in mouse brain","year":"2010","cit":0,"pfa":"Amit Khairnar","topics":["Safety & adverse events","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W11119588","eid":"W11119588"},{"id":"paper-w7170186387","cat":"papers","name":"Structural characterization of kappa-opioid receptor dimer in complex with two G proteins","year":"2026","cit":0,"pfa":"Yue Wang","psa":"Jianfeng Liu","topics":["Addiction","Mechanism & neuroscience"],"ptype":"dataset","src":"https://openalex.org/W7170186387","eid":"W7170186387"},{"id":"paper-w4405322357","cat":"papers","name":"Differential in Vitro Activation Profiles for Psychedelic versus Non-psychedelic Ergolines at the 5-HT2A Receptor","year":"2024","cit":0,"pfa":"Eline Pottie","psa":"Christophe Pol Stove","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4405322357","eid":"W4405322357"},{"id":"paper-w7124072416","cat":"papers","name":"Reward-related neural activity after low doses of LSD in participants with depressed mood","year":"2026","cit":0,"pfa":"James E. Glazer","psa":"Harriet de Wit","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7124072416","eid":"W7124072416"},{"id":"paper-w2482093445","cat":"papers","name":"My self and I: The intimate and completely frank record of one woman's courageous experiment with psychiatry's newest drug LSD-25.","year":"1962","cit":0,"pfa":"Constance A. Newland","topics":["Anxiety & end-of-life","Therapy practice"],"ptype":"book","src":"https://openalex.org/W2482093445","eid":"W2482093445"},{"id":"paper-w4211239236","cat":"papers","name":"Geschichte der Psychedelika in der Medizin","year":"2017","cit":0,"pfa":"Ben Sessa","ptype":"book-chapter","src":"https://openalex.org/W4211239236","eid":"W4211239236"},{"id":"paper-w7162015011","cat":"papers","name":"Psychedelic psychotherapy and the cultural concept of the person","year":"2022","cit":0,"pfa":"Khaleel Rajwani","topics":["Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W7162015011","eid":"W7162015011"},{"id":"paper-w7215483580","cat":"papers","name":"The Role of Psychedelics in Treating Mental Health Disorders: A Mini-Review","year":"2025","cit":0,"pfa":"Ahed Jumah Alkhatib","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"review","src":"https://openalex.org/W7215483580","eid":"W7215483580"},{"id":"paper-w3012910213","cat":"papers","name":"Exogenous Ghrelin Could Not Ameliorate 3,4-methylenedioxymethamphetamine-induced Acute Liver Injury in The Rat: Involved Mechanisms.","year":"2020","cit":0,"pfa":"Ravieh Golchoobian","psa":"Hafseh Fanaei","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3012910213","eid":"W3012910213"},{"id":"paper-w2792140207","cat":"papers","name":"Sleep and drugs of abuse: an overview of preclinical research and new global trends","year":"2013","cit":0,"pfa":"Daniel Ninello Polesel","psa":"Mônica L. Andersen","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2792140207","eid":"W2792140207"},{"id":"paper-w7162630799","cat":"papers","name":"Innovative and legal significance of psychedelic-assisted therapy: novelties of international practice and implementation in Ukraine","year":"2026","cit":0,"pfa":"Oleksandr Mykhailichenko","topics":["PTSD & trauma","Safety & adverse events","Reviews & meta-analyses"],"ptype":"conference-paper","src":"https://openalex.org/W7162630799","eid":"W7162630799"},{"id":"paper-w7112896538","cat":"papers","name":"Hallucinogen Usage, Experiencing Mystical Phenomena, and Transformational Identity Change","year":"2025","cit":0,"pfa":"Hyder, Cameron","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W7112896538","eid":"W7112896538"},{"id":"paper-w2377186953","cat":"papers","name":"Neurotoxicity of 3,4-methylenedioxymethamphetamine and protection with vitamin C in rats","year":"2008","cit":0,"pfa":"Zhiyun Wang","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2377186953","eid":"W2377186953"},{"id":"paper-w4238954476","cat":"papers","name":"Comments on \"The ketamine model of the near-death experience: A central role for the N-methyl-D-aspartate receptor\".","year":"1997","cit":0,"pfa":"Bianchi","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4238954476","eid":"W4238954476"},{"id":"paper-w7137912392","cat":"papers","name":"Gabriella Gobbi: Embracing psychiatry from bench to bedside","year":"2026","cit":0,"pfa":"Gabriella Gobbi","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7137912392","eid":"W7137912392"},{"id":"paper-w7204171966","cat":"papers","name":"L'uomo metafisico - Sospensione del Weltbild e metamorfosi del mondo vissuto nell'esperienza mescalinica","year":"2026","cit":0,"pfa":"Kevin Rauter","ptype":"book","src":"https://openalex.org/W7204171966","eid":"W7204171966"},{"id":"paper-w4320403836","cat":"papers","name":"A Three-Way Drug Discrimination Study: A Role for DA-Mediated Effects in MDMA's Discriminative Cue Properties","year":"2012","cit":0,"pfa":"Anna-Lena Langen","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W4320403836","eid":"W4320403836"},{"id":"paper-w7204212101","cat":"papers","name":"L'uomo metafisico - Sospensione del Weltbild e metamorfosi del mondo vissuto nell'esperienza mescalinica","year":"2026","cit":0,"pfa":"Kevin Rauter","ptype":"dissertation","src":"https://openalex.org/W7204212101","eid":"W7204212101"},{"id":"paper-w4411556621","cat":"papers","name":"The Potential Neuroinflammatory Attenuation Effects of Thymoquinone against 3, 4-Methylenedioxymethamphetamine-Induced Microglial Activation in BV2 Mouse Cell Line","year":"2025","cit":0,"pfa":"Nor Suliana Mustafa","psa":"Liyana Hazwani Mohd Adnan","topics":["Safety & adverse events","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4411556621","eid":"W4411556621"},{"id":"paper-w2903037479","cat":"papers","name":"Chronic effects of 3,4-methylenedioxymethamphetamine on social and non-social cognition","year":"2017","cit":0,"pfa":"Michael D. Wunderli","ptype":"dissertation","src":"https://openalex.org/W2903037479","eid":"W2903037479"},{"id":"paper-w7154715066","cat":"papers","name":"A New Use for an Old Compound: Microdosing LSD to Reduce Fibromyalgia Symptoms","year":"2026","cit":0,"pfa":"Sara Melisa Arciniegas Ruiz","psa":"Hagit Eldar-Finkelman","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"conference-paper","src":"https://openalex.org/W7154715066","eid":"W7154715066"},{"id":"paper-w7149251645","cat":"papers","name":"3,4-Methylenedioxymethamphetamine: From Dangerous Party Drug to Potential Therapeutic Agent","year":"2026","cit":0,"pfa":"Magdalena Ostaszewska","psa":"Anna Malczyk","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7149251645","eid":"W7149251645"},{"id":"paper-w2771603125","cat":"papers","name":"„Terapia szokowa”, czyli agoniści receptor 5-HT2A w leczeniu depresji i lęku","year":"2017","cit":0,"pfa":"Joanna Stefaniuk","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2771603125","eid":"W2771603125"},{"id":"paper-w7169497006","cat":"papers","name":"Beyond Monoamines: Ketamine, Esketamine, and Classic Psychedelics in the Treatment of Depression","year":"2026","cit":0,"pfa":"Bartosz Niciński, Magdalena Kloc, Ewa Wiench, Natasza Millan, Aleksandra…","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7169497006","eid":"W7169497006"},{"id":"paper-w2510846214","cat":"papers","name":"NeuN Expression Alterations in the Hippocampus Following Ecstasy Treatment","year":"2016","cit":0,"pfa":"Fahimeh Ghasemi Moravej","psa":"Sara Soleimani Asl","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2510846214","eid":"W2510846214"},{"id":"paper-w1575708244","cat":"papers","name":"A Three-Way Drug Discrimination Study: A Role for DA-Mediated Effects in MDMA's Discriminative Cue Properties","year":"2012","cit":0,"pfa":"Anna-Lena Langen","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W1575708244","eid":"W1575708244"},{"id":"paper-w4405231848","cat":"papers","name":"Chronic pain education: past, present, and future of psychedelics for the management of chronic pain","year":"2024","cit":0,"pfa":"Christopher Louis Robinson","psa":"Trent D. Emerick","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4405231848","eid":"W4405231848"},{"id":"paper-w4394425548","cat":"papers","name":"Supplementary Material for: Acute Effects of 3,4-Methylenedioxymethamphetamine and Methylphenidate on Circulating Steroid Levels in Healthy Subjects","year":"2014","cit":0,"pfa":"Julia Seibert","psa":"Alex Odermatt","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4394425548","eid":"W4394425548"},{"id":"paper-w4393934981","cat":"papers","name":"THE CONNECTION BETWEEN THE INDIVIDUAL SUBJECTIVE WELL-BEING AND THE MYSTICAL EXPERIENCE PRODUCED BY THE USE OF PSYCHEDELICS","year":"2023","cit":0,"pfa":"Tetiana Kudrina","psa":"Kozlovska Anna","ptype":"article","src":"https://openalex.org/W4393934981","eid":"W4393934981"},{"id":"paper-w77221283","cat":"papers","name":"Pro‐social effects of 3,4‐methylenedioxymethamphetamine in mice","year":"2012","cit":0,"pfa":"Daniel W. Curry","psa":"Leonard Lee Howell","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W77221283","eid":"W77221283"},{"id":"paper-w4242685256","cat":"papers","name":"Examination of the action of 3,4‐methylenedioxymethamphetamine on rat A10 dopamine neurons","year":"1996","cit":0,"pfa":"Andrew N. Gifford","psa":"Charles R. Ashby","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4242685256","eid":"W4242685256"},{"id":"paper-w4235632304","cat":"papers","name":"Review of the book Ketamine: Dreams and realities, by K. Jansen","year":"2003","cit":0,"pfa":"Rick J. Strassman","topics":["Reviews & meta-analyses"],"ptype":"book-review","src":"https://openalex.org/W4235632304","eid":"W4235632304"},{"id":"paper-w2067927319","cat":"papers","name":"Biophotons, hallucinogens, and fluorescence","year":"2011","cit":0,"pfa":"F. Grass","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W2067927319","eid":"W2067927319"},{"id":"paper-w2061731266","cat":"papers","name":"Hyponatremic effect caused by 3,4-methylenedioxymethamphetamine (ecstasy) in rats: The role of metabolic bioactivation","year":"2009","cit":0,"pfa":"Helena Carmo","psa":"Maria de Lourdes Bastos","ptype":"article","src":"https://openalex.org/W2061731266","eid":"W2061731266"},{"id":"paper-w4403350818","cat":"papers","name":"Snapshot of 5-HT 2A receptor activation in the mouse brain via IP 1 detection","year":"2024","cit":0,"pfa":"Mario de la Fuente Revenga","psa":"Javier González‐Maeso","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4403350818","eid":"W4403350818"},{"id":"paper-w4377263811","cat":"papers","name":"Therapeutic effects of methimazole on 3,4-methylenedioxymethamphetamine-induced hyperthermia and serotonergic neurotoxicity","year":"2023","cit":0,"pfa":"I‐Hsun Li","psa":"Jui‐Hu Shih","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4377263811","eid":"W4377263811"},{"id":"paper-w7169604178","cat":"papers","name":"Beyond Monoamines: Ketamine, Esketamine, and Classic Psychedelics in the Treatment of Depression","year":"2026","cit":0,"pfa":"Bartosz Niciński, Magdalena Kloc, Ewa Wiench, Natasza Millan, Aleksandra…","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7169604178","eid":"W7169604178"},{"id":"paper-w3162329058","cat":"papers","name":"Untersuchungen zur Biosynthese von Indolalkaloiden aus den Basidiomyceten der Gattung Psilocybe","year":"2020","cit":0,"pfa":"Felix Blei","ptype":"dissertation","src":"https://openalex.org/W3162329058","eid":"W3162329058"},{"id":"paper-w1491213191","cat":"papers","name":"Investigations into the Potential for 3,4-methylenedioxymethamphetamine to Induce Neurotoxic Terminal Damage to Serotonergic Neurons","year":"2019","cit":0,"pfa":"Dominik K. Biezonski","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W1491213191","eid":"W1491213191"},{"id":"paper-w4245075433","cat":"papers","name":"Salvia divinorum","year":"2021","cit":0,"pfa":"Norbert Scherbaum","ptype":"article","src":"https://openalex.org/W4245075433","eid":"W4245075433"},{"id":"paper-w4394296720","cat":"papers","name":"Supplementary Material for: 3,4-Methylenedioxymethamphetamine (Ecstasy) Decreases Inflammation and Airway Reactivity in a Murine Model of Asthma","year":"2012","cit":0,"pfa":"D. Stankevicius","psa":"João Palermo‐Neto","topics":["Mechanism & neuroscience"],"ptype":"supplementary-materials","src":"https://openalex.org/W4394296720","eid":"W4394296720"},{"id":"paper-w3044010597","cat":"papers","name":"Persistent Psychosis with ‘Ecstasy’ Single Use","year":"2018","cit":0,"pfa":"Mariem Moalla","psa":"Jaweher Masmoudi","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3044010597","eid":"W3044010597"},{"id":"paper-w4386443224","cat":"papers","name":"Phytochemical and pharmacological profile of diviner's sage (Salvia divinorum Epling a jativa.)","year":"2023","cit":0,"pfa":"Chinnadurai Immanuel Selvaraj","psa":"Gadwal Shaik Nishat Anjum","topics":["Depression","Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W4386443224","eid":"W4386443224"},{"id":"paper-w3046649178","cat":"papers","name":"Psilocybin's effects on the brain and implications for depression treatment","year":"2020","cit":0,"pfa":"Katariina Sarajärvi","topics":["Depression"],"ptype":"dissertation","src":"https://openalex.org/W3046649178","eid":"W3046649178"},{"id":"paper-w4409897133","cat":"papers","name":"My fight to unlock cannabis and psychedelic drugs for use in medical research","year":"2025","cit":0,"pfa":"Robin Berghaus","ptype":"article","src":"https://openalex.org/W4409897133","eid":"W4409897133"},{"id":"paper-w2898535518","cat":"papers","name":"Everything old is new again: are psychedelic medicines poised to take mental health by storm?","year":"2018","cit":0,"pfa":"Charles L. Raison","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2898535518","eid":"W2898535518"},{"id":"paper-w2922983337","cat":"papers","name":"Persistent Psychosis with âEcstasyâ Single Use","year":"2018","cit":0,"pfa":"Mariem Moalla","psa":"Jaweher Masmoudi","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2922983337","eid":"W2922983337"},{"id":"paper-w4411873027","cat":"papers","name":"Prolonged hallucinogenic effects following Psilocybe cubensis ingestion: Case report","year":"2025","cit":0,"pfa":"Rodrigo A. Petter","psa":"Cinthia D. Gigliotti","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4411873027","eid":"W4411873027"},{"id":"paper-w2600447775","cat":"papers","name":"Ecstasy, anxiety and rat hippocampal astrocytes","year":"2013","cit":0,"pfa":"Mehrdad Jahanshahi","psa":"Fatemeh Seid-Hosseini","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2600447775","eid":"W2600447775"},{"id":"paper-w7135594899","cat":"papers","name":"Production of secondary metabolites in the explant cultures of Trichocereus pachanoi (Cactaceae)","year":"2016","cit":0,"pfa":"Lucie Urbanová","topics":["Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W7135594899","eid":"W7135594899"},{"id":"paper-w7151732093","cat":"papers","name":"Mystical dynamics: renewal, luminous light, and ego disintegration as key features associated with mystical oneness-a psychometric analysis using the PES100 in controlled psychedelic studies","year":"2026","cit":0,"pfa":"Kurt Stocker","psa":"Matthias E. Liechti","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7151732093","eid":"W7151732093"},{"id":"paper-w7164186919","cat":"papers","name":"DMT use in Cluster Headache: Interim Analysis of an International Survey (S23.003)","year":"2026","cit":0,"pfa":"Emmanuelle A. D. Schindler","psa":"Robert Wold","ptype":"article","src":"https://openalex.org/W7164186919","eid":"W7164186919"},{"id":"paper-w2008088658","cat":"papers","name":"Neuropeptide y protects retina neural cells from ecstasy‐induced neurotoxicity","year":"2007","cit":0,"pfa":"A. F. Ambrósio","psa":"Cláudia Cavadas","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W2008088658","eid":"W2008088658"},{"id":"paper-w4316928124","cat":"papers","name":"Dämpfer für die Psilocybintherapie","year":"2023","cit":0,"pfa":"Thomas Müller","ptype":"article","src":"https://openalex.org/W4316928124","eid":"W4316928124"},{"id":"paper-w4416948768","cat":"papers","name":"3,4-Methylenedioxymethamphetamine","year":"2000","cit":0,"pfa":"William Slikker","psa":"Herbert H. Schaumburg","topics":["Safety & adverse events","Dosing & pharmacology","Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W4416948768","eid":"W4416948768"},{"id":"paper-w7133363188","cat":"papers","name":"Self-nanoemulsifying drug delivery systems (SNEDDS) as psychotherapeutic couriers","year":"2026","cit":0,"pfa":"William Charles Hosie","psa":"John Frederick Trant","topics":["Depression","Addiction","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7133363188","eid":"W7133363188"},{"id":"paper-w3094103825","cat":"papers","name":"Effect of duloxetine acute treatment against 3, 4 methylenedioxymethamphetamine-induced cognitive impairment and memory deficiency in male rats","year":"2020","cit":0,"pfa":"Nasrin Hashemi Firouzi","psa":"Sara Soleimani Asl","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3094103825","eid":"W3094103825"},{"id":"paper-w7104738164","cat":"papers","name":"Psychedelic-Assisted Therapy: The Emerging Role of the Psychiatric-Mental Health Nurse","year":"2024","cit":0,"pfa":"Khalaud Naseeb Alhajry","psa":"Anwar Mehdaf Akash Alrowaly","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7104738164","eid":"W7104738164"},{"id":"paper-w4236484557","cat":"papers","name":"Morphological effects in the mouse myocardium after methylenedioxymethamphetamine administration combined with loud noise exposure","year":"2002","cit":0,"pfa":"Marco Gesi","psa":"Antonio Paparelli","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4236484557","eid":"W4236484557"},{"id":"paper-w7133349059","cat":"papers","name":"DMT microstates","year":"2026","cit":0,"pfa":"Maria Niedernhuber","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"dataset","src":"https://openalex.org/W7133349059","eid":"W7133349059"},{"id":"paper-w7203602128","cat":"papers","name":"Psychedelic Safety and Clinical Outcomes Across Exposure Patterns: A Structured Narrative Review","year":"2026","cit":0,"pfa":"Szabolcs Kéri","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"review","src":"https://openalex.org/W7203602128","eid":"W7203602128"},{"id":"paper-w7121233275","cat":"papers","name":"Effects of Serotonergic Psychedelics on Synaptic Function and Neuroplasticity","year":"2026","cit":0,"pfa":"Aneta Petrušková","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"dissertation","src":"https://openalex.org/W7121233275","eid":"W7121233275"},{"id":"paper-w4377246074","cat":"papers","name":"(058) Does Ecstasy Have Treatment Potential in Female Sexual Dysfunction? A Systematic Review of Effects on the Female Sexual Response Cycle","year":"2023","cit":0,"pfa":"Alexandra Dubinskaya","psa":"KARYN SCHLUNT EILBER","topics":["Mechanism & neuroscience","Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4377246074","eid":"W4377246074"},{"id":"paper-w4385658334","cat":"papers","name":"Psilocybin's Emerging Role in Combating Depressive Disorder","year":"2023","cit":0,"pfa":"Anna Jaremek","psa":"Paweł Gregorek","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4385658334","eid":"W4385658334"},{"id":"paper-w4402119279","cat":"papers","name":"Study of interfacial competitive distribution and synergistic permeation in nanofiltration separation of Salvia divinorum acids from the aqueous extract","year":"2024","cit":0,"pfa":"Yangyang Xu","psa":"Cunyu Li","ptype":"article","src":"https://openalex.org/W4402119279","eid":"W4402119279"},{"id":"paper-w1512465094","cat":"papers","name":"Clinical and toxicological significance of the involvement of the cytocrhome p450 system in the metabolism of 3,4-methylenedioxymethamphetamine","year":"2008","cit":0,"pfa":"Brian OʼMahony","topics":["Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W1512465094","eid":"W1512465094"},{"id":"paper-w2124501712","cat":"papers","name":"Dantrolene Use in 3,4-Methylenedioxymethamphetamine (“Ecstasy”)–Mediated Hyperthermia","year":"2004","cit":0,"pfa":"Marko Fiege","psa":"Jochen Schulte am Esch","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2124501712","eid":"W2124501712"},{"id":"paper-w3005636722","cat":"papers","name":"Ecstasy as Therapy","year":"2020","cit":0,"pfa":"Brian David Earp","psa":"Julian Savulescu","topics":["Safety & adverse events","Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W3005636722","eid":"W3005636722"},{"id":"paper-w4401690921","cat":"papers","name":"Tripping on Utopia: Margaret Mead, the Cold War, and the troubled birth of psychedelic science By BenjaminBreen. New York: Grand Central Publishing, 2024. 384 pp.","year":"2024","cit":0,"pfa":"Jim Weil","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"book-review","src":"https://openalex.org/W4401690921","eid":"W4401690921"},{"id":"paper-w7133331026","cat":"papers","name":"DMT microstates","year":"2026","cit":0,"pfa":"Maria Niedernhuber","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"dataset","src":"https://openalex.org/W7133331026","eid":"W7133331026"},{"id":"paper-w7110533292","cat":"papers","name":"Psilocybin’s Role in Major Depressive Disorder: A Scoping Review","year":"2024","cit":0,"pfa":"Barajas, Carlos","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7110533292","eid":"W7110533292"},{"id":"paper-w2058279255","cat":"papers","name":"Pharmacological evalution of cilostazol by thermograms of patients with chronic arterial occlusive disease","year":"1990","cit":0,"pfa":"Yasuharu Kitani","psa":"Tatsuya Fujita","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2058279255","eid":"W2058279255"},{"id":"paper-w7136056358","cat":"papers","name":"nwharbert8-ui/psychedelic-wj-architecture: Publication Release","year":"2026","cit":0,"pfa":"nwharbert8-ui","topics":["Mechanism & neuroscience"],"ptype":"software","src":"https://openalex.org/W7136056358","eid":"W7136056358"},{"id":"paper-w4294189615","cat":"papers","name":"Methylenedioxymethamphetamine-assisted Psychotherapy For Posttraumatic Stress Disorder: A Review","year":"2022","cit":0,"pfa":"J. Sá Couto","psa":"T. Ventura Gil","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4294189615","eid":"W4294189615"},{"id":"paper-w27144950","cat":"papers","name":"Phase II metabolism of 3,4-methylenedioxymethamphetamine : synthesis, analysis, and enantioselective in vitro and in vivo kinetics","year":"2011","cit":0,"pfa":"Andrea E. Schwaninger","topics":["Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W27144950","eid":"W27144950"},{"id":"paper-w3019468561","cat":"papers","name":"Pharmacological characterization of 3,4-methylenedioxymethamphetamine analogues: Corollaries to mechanisms of behavioral and neurotoxic activity","year":"1991","cit":0,"pfa":"Michael P. Johnson","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W3019468561","eid":"W3019468561"},{"id":"paper-w4414573954","cat":"papers","name":"Breaking the Stigma: Oncology Providers Weigh in on Psychedelic-Assisted Therapy","year":"2025","cit":0,"pfa":"Akul Munjal","psa":"Jeremy P. Harris","ptype":"article","src":"https://openalex.org/W4414573954","eid":"W4414573954"},{"id":"paper-w7125353692","cat":"papers","name":"Potentiel thérapeutique de la psilocybine dans la dépression résistante","year":"2025","cit":0,"pfa":"Estelle Samblanquat","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W7125353692","eid":"W7125353692"},{"id":"paper-w4405019156","cat":"papers","name":"Effects of 3,4‐methylenedioxymethamphetamine on neural activity in the nucleus accumbens of male mice engaged in social behavior","year":"2024","cit":0,"pfa":"Naoya Nishitani","psa":"Katsuyuki Kaneda","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4405019156","eid":"W4405019156"},{"id":"paper-w2548038812","cat":"papers","name":"Estudi dels efectes neuroplàstics i neurotòxics de l’MDMA en models experimentals d’alteracions del Sistema Nerviós Central","year":"2016","cit":0,"pfa":"Sònia Abad Florensa","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W2548038812","eid":"W2548038812"},{"id":"paper-w4411086044","cat":"papers","name":"Knocking at the Doors of Perception: Relating LSD Effects on Low-Frequency Fluctuations and Regional Homogeneity to Receptor Densities in fMRI","year":"2025","cit":0,"pfa":"Paolo La‐Torraca‐Vittori","psa":"Stefano Damiani","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4411086044","eid":"W4411086044"},{"id":"paper-w2946426983","cat":"papers","name":"Psychiatry Roundup: Tricks or Treatments?","year":"2016","cit":0,"pfa":"Laurie Martin","ptype":"article","src":"https://openalex.org/W2946426983","eid":"W2946426983"},{"id":"paper-w7214377222","cat":"papers","name":"Stress history determines psilocybin’s effects on fear extinction in male adolescent rats","year":"2026","cit":0,"pfa":"Elizabeth A Virakorn","psa":"Rick Richardson","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7214377222","eid":"W7214377222"},{"id":"paper-w4375930268","cat":"papers","name":"Methylenedioxymethamphetamine","year":"2023","cit":0,"pfa":"Matthew Robert Dernbach","ptype":"reference-entry","src":"https://openalex.org/W4375930268","eid":"W4375930268"},{"id":"paper-w2172931839","cat":"papers","name":"Psychosis and Catatonia after Dancing with a Dangerous Partner","year":"2015","cit":0,"pfa":"Surbhi Khanna","psa":"Pamila Herrington","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2172931839","eid":"W2172931839"},{"id":"paper-w4413284731","cat":"papers","name":"551. PSYCHEDELICS AND OCD: TRANSLATIONAL APPROACHES","year":"2025","cit":0,"pfa":"Bernard Lerer","psa":"Tzuri Lifschytz","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W4413284731","eid":"W4413284731"},{"id":"paper-w7162993318","cat":"papers","name":"Patient perceptions towards psychedelics for musculoskeletal pain: A cross-sectional survey","year":"2026","cit":0,"pfa":"Erica J. Li","psa":"Kim Madden","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7162993318","eid":"W7162993318"},{"id":"paper-w7126235935","cat":"papers","name":"Assessing the psyhophysiological effects of Happy Tea at a Microdose Together company social event","year":"2025","cit":0,"pfa":"Michiel van Elk","topics":["Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7126235935","eid":"W7126235935"},{"id":"paper-w7134128727","cat":"papers","name":"Psychedelic Assisted Therapy","year":"2026","cit":0,"pfa":"Nikolaos Fragkias","topics":["Depression","Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7134128727","eid":"W7134128727"},{"id":"paper-w4415077681","cat":"papers","name":"Psychedelika assistierte Therapie","year":"2025","cit":0,"pfa":"Heiner Dörfler","topics":["Depression","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4415077681","eid":"W4415077681"},{"id":"paper-w4396883252","cat":"papers","name":"Psychedelika in der Psychiatrie Nachlese der 1. Tagung der DGPFT e. V.","year":"2024","cit":0,"pfa":"Uwe Herwig","topics":["Depression","PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4396883252","eid":"W4396883252"},{"id":"paper-w7140219800","cat":"papers","name":"Epistemic Discovery, Psychedelic Drugs, and the First Amendment","year":"2026","cit":0,"pfa":"Jeremy K. Kessler","psa":"David E. Pozen","ptype":"preprint","src":"https://openalex.org/W7140219800","eid":"W7140219800"},{"id":"paper-w1435711203","cat":"papers","name":"Electrocardiographic examination of heart function in rats exposed to hallucinogens from Psilocybe mushrooms","year":"2003","cit":0,"pfa":"Krzysztof S. Borowiak","psa":"V Mikolajek","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1435711203","eid":"W1435711203"},{"id":"paper-w2328629560","cat":"papers","name":"“LSD and Competence” – A Case Report","year":"1973","cit":0,"pfa":"Wolfram Rieger","psa":"Kenneth A. Kessler","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2328629560","eid":"W2328629560"},{"id":"paper-w4409979900","cat":"papers","name":"Ellagic acid mitigates LSD-induced neurobehavioral disorders via pro-inflammatory pathway inhibition in Wistar rats","year":"2025","cit":0,"pfa":"Saiedeh Arabmoazzen","psa":"Fereshteh Badini","ptype":"article","src":"https://openalex.org/W4409979900","eid":"W4409979900"},{"id":"paper-w2737769353","cat":"papers","name":"Pharmacological Chaperones of the Dopamine Transporter: A Strategy for Increasing Function of Wild Type and Mutant Transporter","year":"2017","cit":0,"pfa":"Pieter Beerepoot","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W2737769353","eid":"W2737769353"},{"id":"paper-w4254888538","cat":"papers","name":"Psychedelic Hallucinogen","year":"2006","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W4254888538","eid":"W4254888538"},{"id":"paper-w2003167791","cat":"papers","name":"The acute and subchronic effect of 3,4-methylenedioxymethamphetamine on body temperature in rats","year":"2009","cit":0,"pfa":"Ivan Simić","psa":"Živorad Maličević","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2003167791","eid":"W2003167791"},{"id":"paper-w2512310917","cat":"papers","name":"Neurociencias y aplicaciones psicoterapéuticas en el renacimiento de la investigación con psicodélicos Neurosciences and psycotherapeutic applications in the psychedelic research renaissaince","year":"2014","cit":0,"pfa":"S Christopher Timmermann","topics":["PTSD & trauma","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2512310917","eid":"W2512310917"},{"id":"paper-w3038042529","cat":"papers","name":"A death involving extremely high levels of 3,4-methylenedioxymethamphetamine","year":"2020","cit":0,"pfa":"Leo Johnson","psa":"Uttam C Garg","ptype":"book-chapter","src":"https://openalex.org/W3038042529","eid":"W3038042529"},{"id":"paper-w4321017755","cat":"papers","name":"Psychedelics Legislation Gains Momentum","year":"2023","cit":0,"pfa":"Terri D’Arrigo","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4321017755","eid":"W4321017755"},{"id":"paper-w3088451382","cat":"papers","name":"Effect of 3,4-Methylenedioxymethamphetamine on Liver CYP2C19 Enzyme Activity in Isolated Perfused Rat Liver Using Omeprazole Probe","year":"2020","cit":0,"pfa":"Mohammad Reza Rouini","psa":"Yalda H. Ardakani","ptype":"article","src":"https://openalex.org/W3088451382","eid":"W3088451382"},{"id":"paper-w4413989179","cat":"papers","name":"Acute Reversible Toxic Leukoencephalopathy Associated with Ketamine and Ecstasy Intoxication: A Case Report from Vietnam","year":"2025","cit":0,"pfa":"Kim Nga Huynh","psa":"My Tra Ton Nu","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4413989179","eid":"W4413989179"},{"id":"paper-w7164940158","cat":"papers","name":"Psilocybin’s kinematic effect on manual dexterity","year":"2026","cit":0,"pfa":"Pierre Klintefors","psa":"Olivia L. Carter","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7164940158","eid":"W7164940158"},{"id":"paper-w299562239","cat":"papers","name":"An Exploration of the Relationships Between Body Image, Hair Removal, Pornography, and Women's Sexual Self-Efficacy","year":"2013","cit":0,"pfa":"Elissa Allen","ptype":"article","src":"https://openalex.org/W299562239","eid":"W299562239"},{"id":"paper-w4394675067","cat":"papers","name":"Erika Dyck and Chris Elcock (eds), Expanding Mindscapes: A Global History of Psychedelics","year":"2024","cit":0,"pfa":"Alexander Dawson","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4394675067","eid":"W4394675067"},{"id":"paper-w4416993041","cat":"papers","name":"What is it like to microdose LSD for depression? a thematic analysis of participant interviews from an open-label trial","year":"2025","cit":0,"pfa":"Carina Joy Donegan","psa":"Lisa Reynolds","topics":["Depression","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4416993041","eid":"W4416993041"},{"id":"paper-w7105794842","cat":"papers","name":"Forensic and pharmaceutical analysis of addictive morbidity because of the use of psychotropic psychoactive substances in Ukraine (retrospective aspect)","year":"2019","cit":0,"pfa":"V V, Jr. Shapovalov","psa":"V V Shapovalov","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7105794842","eid":"W7105794842"},{"id":"paper-w7105831843","cat":"papers","name":"5mC and 5hmC Detection Highlights How Psychedelics Affect Brain Epigenetic Patterns","year":"2025","cit":0,"pfa":"Bertocchi, Uri","psa":"Ebenstein, Yuval","topics":["Depression","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7105831843","eid":"W7105831843"},{"id":"paper-w7165390053","cat":"papers","name":"Effects of repeated low-dose LSD on neuropsychological functioning in adults with ADHD: a randomized placebo-controlled study","year":"2026","cit":0,"pfa":"E. C. H. M. Haijen-Bongers","psa":"K.P.C. Kuypers","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7165390053","eid":"W7165390053"},{"id":"paper-w4229970716","cat":"papers","name":"Psychedelic Hallucinogen","year":"2008","cit":0,"ptype":"reference-entry","src":"https://openalex.org/W4229970716","eid":"W4229970716"},{"id":"paper-w2094474569","cat":"papers","name":"P.6.c.013 Prodromal symptoms and neurocognitive profile of 3 groups of dependent drug users: cannabis, ketamine and cocaine","year":"2009","cit":0,"pfa":"C.A. Morgan","psa":"H. Valerie Curran","ptype":"article","src":"https://openalex.org/W2094474569","eid":"W2094474569"},{"id":"paper-w7134982311","cat":"papers","name":"Age moderates the relationship between psychedelics use and mental health in naturalistic settings","year":"2026","cit":0,"pfa":"Giammarco Di Gregorio","psa":"Marco Bocchio","ptype":"preprint","src":"https://openalex.org/W7134982311","eid":"W7134982311"},{"id":"paper-w7136075621","cat":"papers","name":"nwharbert8-ui/psychedelic-wj-architecture: Publication Release","year":"2026","cit":0,"pfa":"nwharbert8-ui","topics":["Mechanism & neuroscience"],"ptype":"software","src":"https://openalex.org/W7136075621","eid":"W7136075621"},{"id":"paper-w7165649073","cat":"papers","name":"How sex and environmental conditions shape psilocybin's effects on social and cognitive function in mice","year":"2026","cit":0,"pfa":"Sheida Shadani","ptype":"dissertation","src":"https://openalex.org/W7165649073","eid":"W7165649073"},{"id":"paper-w4206825820","cat":"papers","name":"Faculty Opinions recommendation of A non-hallucinogenic psychedelic analogue with therapeutic potential.","year":"2021","cit":0,"pfa":"Jason M. Crawford","psa":"Natavan Dudkina","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"peer-review","src":"https://openalex.org/W4206825820","eid":"W4206825820"},{"id":"paper-w2233808508","cat":"papers","name":"Triagem farmacológica em cultura de células tumorais, em modelos de nocicepção e de ansiedade (Banisteriopsis caapi e Psychotria viridis)","year":"2013","cit":0,"pfa":"Mariana Cecchetto Figueiredo","topics":["Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W2233808508","eid":"W2233808508"},{"id":"paper-w7128923372","cat":"papers","name":"Ischemia-Induced Neurodegeneration in Glaucoma: Mechanistic Insights and Translational Opportunities for Psychoplastogen-Based Therapies","year":"2026","cit":0,"pfa":"Petra Dolenec","psa":"Anja Harej","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7128923372","eid":"W7128923372"},{"id":"paper-w7163674173","cat":"papers","name":"The Role of the Basolateral and Central Amygdala During Heroin Withdrawal and 3,4-Methylenedioxymethamphetamine Administration","year":"2026","cit":0,"pfa":"Charlotte Rubin","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W7163674173","eid":"W7163674173"},{"id":"paper-w4409148237","cat":"papers","name":"Exploring psilocybin’s role in mental health and palliative medicine: a path to improved well-being","year":"2025","cit":0,"pfa":"María Alejandra Umbacia","psa":"Rosa‐Helena Bustos","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4409148237","eid":"W4409148237"},{"id":"paper-w4404747898","cat":"papers","name":"Neuroimaging of Serotonergic and Psychedelic Agonist Drug Challenges in Non-Human Primates","year":"2024","cit":0,"pfa":"Ande Bagdasarian","psa":"Hsiao‐Ying Wey","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"conference-paper","src":"https://openalex.org/W4404747898","eid":"W4404747898"},{"id":"paper-w2363992676","cat":"papers","name":"Can ecstasy treat the agony of PTSD?","year":"2016","cit":0,"pfa":"Michael C. Mithoefer","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"conference-abstract","src":"https://openalex.org/W2363992676","eid":"W2363992676"},{"id":"paper-w4401984788","cat":"papers","name":"The Birth of the Psychedelic Industry: Capitalizing on the Psychedelic Renaissance","year":"2024","cit":0,"pfa":"Minsu Yoo","psa":"Sofia Sakopoulos","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4401984788","eid":"W4401984788"},{"id":"paper-w237012388","cat":"papers","name":"Single—photon emission computed tomography imaging studies of dopamine transkporter availability in heroin and 3,4—methylenedioxymethamphetamine abusers","year":"2002","cit":0,"pfa":"ShiJ","psa":"JiaSW","ptype":"article","src":"https://openalex.org/W237012388","eid":"W237012388"},{"id":"paper-w7105859284","cat":"papers","name":"5mC and 5hmC Detection Highlights How Psychedelics Affect Brain Epigenetic Patterns","year":"2025","cit":0,"pfa":"Bertocchi, Uri","psa":"Ebenstein, Yuval","topics":["Depression","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7105859284","eid":"W7105859284"},{"id":"paper-w7128014083","cat":"papers","name":"Psychological Therapy Quantity and Depressive Symptom Reduction in Psychedelic-Assisted Therapy: A Systematic Review and Meta-Analysis.","year":"2026","cit":0,"pfa":"Florineth, Gianluca Andri","psa":"Soravia, Leila Maria","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7128014083","eid":"W7128014083"},{"id":"paper-w4294202139","cat":"papers","name":"Treating Catatonia: a Blind Spot of Psychiatry?","year":"2022","cit":0,"pfa":"Pavel Mohr","topics":["PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4294202139","eid":"W4294202139"},{"id":"paper-w4249728442","cat":"papers","name":"Psychedelic Hallucinogen","year":"2006","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W4249728442","eid":"W4249728442"},{"id":"paper-w7169800930","cat":"papers","name":"Psychedelic drug action at dendrites is gated by behavioral state and serotonin receptors","year":"2026","cit":0,"pfa":"Neil K. Savalia","psa":"Alex C. Kwan","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7169800930","eid":"W7169800930"},{"id":"paper-w7135624824","cat":"papers","name":"Psychedelic experience and the afterglow effect from the perspective of healthy volunteers in an experimental study: a qualitative analysis","year":"2021","cit":0,"pfa":"Agáta Červenková","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7135624824","eid":"W7135624824"},{"id":"paper-w4248666216","cat":"papers","name":"Magic mushrooms as a treatment for depression","year":"2017","cit":0,"topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4248666216","eid":"W4248666216"},{"id":"paper-w7165668082","cat":"papers","name":"How sex and environmental conditions shape psilocybin's effects on social and cognitive function in mice","year":"2026","cit":0,"pfa":"Sheida Shadani","ptype":"dissertation","src":"https://openalex.org/W7165668082","eid":"W7165668082"},{"id":"paper-w4413892760","cat":"papers","name":"Development of a 3,4-methylenedioxymethamphetamine analysis method in dried blood spot using ultra-high per-formance liquid chromatography quadrupole–Time of flight","year":"2025","cit":0,"pfa":"Nadya Ayu Anandita","psa":"Yuswardi Yuswardi","ptype":"article","src":"https://openalex.org/W4413892760","eid":"W4413892760"},{"id":"paper-w3176819182","cat":"papers","name":"Relation of Lsd, Ecstasy and Alcohol Used by Undergraduate Students","year":"2018","cit":0,"pfa":"Maria Clara Chaves Mendes","psa":"Ingrid Dragan Taricano","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3176819182","eid":"W3176819182"},{"id":"paper-w2886153694","cat":"papers","name":"Methylenedioxymethamphetamine Induced Neuro-Psychiatric Disorders: A Case Report from Southern India","year":"2018","cit":0,"pfa":"Nalakath Arakkal Uvais","ptype":"article","src":"https://openalex.org/W2886153694","eid":"W2886153694"},{"id":"paper-w2586747082","cat":"papers","name":"Súvislosti medzi variabilitou účinkov psilocybínu, osobnostnými charakteristikami a fenomenológiou intoxikácie u zdravých dobrovoľníkov","year":"2015","cit":0,"pfa":"Peter Zäch","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2586747082","eid":"W2586747082"},{"id":"paper-w7165130491","cat":"papers","name":"Psychedelic Use, Microdosing, Motives, and Information and Product Sources Among Young Adults in the United States","year":"2026","cit":0,"pfa":"Carla J. Berg","psa":"Y. Tony Yang","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7165130491","eid":"W7165130491"},{"id":"paper-w2326527620","cat":"papers","name":"Design And Synthesis Of Dual-Affinity Molecular Probes Targeting The Opioid Receptors","year":"2016","cit":0,"pfa":"AW Keasling","psa":"JK Zjawiony","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2326527620","eid":"W2326527620"},{"id":"paper-w7154992046","cat":"papers","name":"Psychedelics and Autism Therapy: A Review of Current Research and Future Directions","year":"2026","cit":0,"pfa":"Christopher S. Gondi","psa":"Lusine H. Demirkhanyan","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7154992046","eid":"W7154992046"},{"id":"paper-w7160597817","cat":"papers","name":"Exploring new avenues: Psychedelic‐assisted therapy for young people","year":"2026","cit":0,"pfa":"Ioanna Artemis Vamvakopoulou","psa":"M. Di Simplicio","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7160597817","eid":"W7160597817"},{"id":"paper-w4410126044","cat":"papers","name":"3,4-methylenedioxymethamphetamine induces reactive oxygen species-mediated autophagy and thioredoxin-interactive protein/nucleotide-binding domain, leucine-rich containing family, pyrin domain-containing-3 inflammasome a","year":"2025","cit":0,"pfa":"Shih‐Yu Lee","psa":"Chung-Hsing Li","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4410126044","eid":"W4410126044"},{"id":"paper-w2922115110","cat":"papers","name":"Toxicity of 3.4-Methylenedioxy-N-Methamphetamine","year":"2019","cit":0,"pfa":"Yağmur PAK","psa":"Terken Baydar","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2922115110","eid":"W2922115110"},{"id":"paper-w7126227261","cat":"papers","name":"Protecting patient autonomy in psychedelic-assisted psychotherapy: a nursing ethics perspective","year":"2026","cit":0,"pfa":"Aditi Kanwar","psa":"Pramod Kumar Ashaiya","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7126227261","eid":"W7126227261"},{"id":"paper-w7143442364","cat":"papers","name":"Unlocking ‘stuckness’ and catalysing change: A qualitative study of clinician and service leader perspectives on psychedelic‐assisted therapy for substance use and mental health problems","year":"2026","cit":0,"pfa":"Sarah J. Catchlove","psa":"Shalini Arunogiri","topics":["Depression","Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7143442364","eid":"W7143442364"},{"id":"paper-w7204114047","cat":"papers","name":"Age moderates the relationship between psychedelic use and mental health in naturalistic settings","year":"2026","cit":0,"pfa":"Giammarco Di Gregorio","psa":"Bocchio, Marco","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"dataset","src":"https://openalex.org/W7204114047","eid":"W7204114047"},{"id":"paper-w7126157028","cat":"papers","name":"Protecting patient autonomy in psychedelic-assisted psychotherapy: a nursing ethics perspective","year":"2026","cit":0,"pfa":"Aditi Kanwar","psa":"Pramod Kumar Ashaiya","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7126157028","eid":"W7126157028"},{"id":"paper-w7134135948","cat":"papers","name":"Psychedelic Assisted Therapy","year":"2026","cit":0,"pfa":"Nikolaos Fragkias","topics":["Depression","Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7134135948","eid":"W7134135948"},{"id":"paper-w3202318796","cat":"papers","name":"Self-Administration of entactogen psychostimulants dysregulates GABA and Kappa Opioid Receptor signaling in the central nucleus of the amygdala of female Wistar rats","year":"2021","cit":0,"pfa":"Sophia Khom","psa":"Michael A. Taffe","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W3202318796","eid":"W3202318796"},{"id":"paper-w4388443775","cat":"papers","name":"The G protein biased serotonin 5-HT2A receptor agonist lisuride exerts anti-depressant drug-like activities in mice","year":"2023","cit":0,"pfa":"Vladimir M. Pogorelov","psa":"Bryan L. Roth","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4388443775","eid":"W4388443775"},{"id":"paper-w7212021609","cat":"papers","name":"401. Prophylactic effects of LSD on inflammatory rodent model of depression","year":"2026","cit":0,"pfa":"Amel Bouloufa","psa":"Nasser Haddjeri","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7212021609","eid":"W7212021609"},{"id":"paper-w7135184973","cat":"papers","name":"The renaissance of research on psychedelics in child and adolescent psychopharmacology","year":"2026","cit":0,"pfa":"Marc‐Antoine Crocq","psa":"Philippe Auby","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7135184973","eid":"W7135184973"},{"id":"paper-w7204099123","cat":"papers","name":"Age moderates the relationship between psychedelic use and mental health in naturalistic settings","year":"2026","cit":0,"pfa":"Giammarco Di Gregorio","psa":"Marco Bocchio","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7204099123","eid":"W7204099123"},{"id":"paper-w2464700591","cat":"papers","name":"The Role of the Serotonin Transporter as a Genetic Risk Factor in the Development of Drug Addiction","year":"2016","cit":0,"pfa":"Bridget W. Brox","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"dissertation","src":"https://openalex.org/W2464700591","eid":"W2464700591"},{"id":"paper-w2003066676","cat":"papers","name":"98. Small molecule therapies for neurologic manifestations of LSD in humans","year":"2009","cit":0,"pfa":"Marc C. Patterson","ptype":"article","src":"https://openalex.org/W2003066676","eid":"W2003066676"},{"id":"paper-w4244092202","cat":"papers","name":"Psilocybine","year":"2020","cit":0,"pfa":"National Cancer Institute","topics":["Mechanism & neuroscience"],"ptype":"reference-entry","src":"https://openalex.org/W4244092202","eid":"W4244092202"},{"id":"paper-w4233416944","cat":"papers","name":"The Role of the Serotonin Transporter as a Genetic Risk Factor in the Development of Drug Addiction","year":"2016","cit":0,"pfa":"Brox, Bridget Williams","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"dissertation","src":"https://openalex.org/W4233416944","eid":"W4233416944"},{"id":"paper-w7135040486","cat":"papers","name":"Consent Without Continuity: Psychedelic-Assisted Therapy and the Structural Failure of Informed Consent Doctrine","year":"2026","cit":0,"pfa":"Michael Palmieri","ptype":"preprint","src":"https://openalex.org/W7135040486","eid":"W7135040486"},{"id":"paper-w7212014624","cat":"papers","name":"A national approach in a European context: Multidisciplinary and multiprofessional recommendations on the clinical use of psychedelic substances","year":"2026","cit":0,"pfa":"Carolina Seybert","psa":"Albino Jorge Oliveira-Maia","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7212014624","eid":"W7212014624"},{"id":"paper-w7117962834","cat":"papers","name":"The role of 5-HT2A receptors in sleep architecture and memory consolidation in the animal model","year":"2026","cit":0,"pfa":"K. Aleksič","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7117962834","eid":"W7117962834"},{"id":"paper-w4411724032","cat":"papers","name":"ANÁLISE TERAPÊUTICA DO USO DA PSILOCIBINA NO TRATAMENTO DA DEPRESSÃO RESISTENTE: UMA REVISÃO DE ENSAIOS CLÍNICOS RECENTES","year":"2025","cit":0,"pfa":"Gabriel Bispo do Carmo","psa":"João Henrique Neves Ferreira","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4411724032","eid":"W4411724032"},{"id":"paper-w3174798520","cat":"papers","name":"Antagonism of 5‐HT2A receptors attenuates the effects of amphetamine and 3,4‐methylenedioxymethamphetamine on wakefulness and dopamine overflow","year":"2012","cit":0,"pfa":"Kevin Sean Murnane","psa":"Leonard Lee Howell","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3174798520","eid":"W3174798520"},{"id":"paper-w2162779322","cat":"papers","name":"3, 4-methylenedioximethamphetamin reverses anxiety induced by chronic mild stress","year":"2013","cit":0,"pfa":"Laura Andrea León","psa":"Fernando P. Cárdenas","topics":["Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2162779322","eid":"W2162779322"},{"id":"paper-w573932598","cat":"papers","name":"Acute tryptophan depletion potentiates 3,4-methylenedioxymethamphetamine-induced cerebrovascular hyperperfusion in rats","year":"2010","cit":0,"pfa":"Eva van Donkelaar","psa":"Linda Ferrington","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W573932598","eid":"W573932598"},{"id":"paper-w7150383838","cat":"papers","name":"Do 5-HT2A receptor agonists reduce alcohol drinking in animal models: A Systematic Review","year":"2026","cit":0,"pfa":"Anni-Maija Talvio","psa":"Aamos Tappola","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W7150383838","eid":"W7150383838"},{"id":"paper-w7126320745","cat":"papers","name":"3,4-methylenedioxymethamphetamine-assisted psychotherapy for the treatment of posttraumatic stress disorder","year":"2023","cit":0,"pfa":"Thomas Kenneth Poullette","topics":["PTSD & trauma","Addiction","Anxiety & end-of-life"],"ptype":"dissertation","src":"https://openalex.org/W7126320745","eid":"W7126320745"},{"id":"paper-w7204908559","cat":"papers","name":"Psilocibina e neuroplasticidade: novas perspectivas terapêuticas para depressão resistente","year":"2026","cit":0,"pfa":"Leticia Almeida Castro","psa":"Cristiane Lyrio da Silva","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7204908559","eid":"W7204908559"},{"id":"paper-w2026688327","cat":"papers","name":"P.6.d.022 The role of serotonin and dopamine systems in the action of the psychedelic 4-bromo-2,5-dimethoxyphenylethylamine (2C-B)","year":"2010","cit":0,"pfa":"Tomáš Páleníček","psa":"Jiřı́ Horáček","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2026688327","eid":"W2026688327"},{"id":"paper-w4406003057","cat":"papers","name":"Perturbing whole-brain models of brain hierarchy: an application for depression following pharmacological treatment","year":"2025","cit":0,"pfa":"Marcel Socoro Garrigosa","psa":"Gustavo Deco","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4406003057","eid":"W4406003057"},{"id":"paper-w7201849956","cat":"papers","name":"A Novel Therapeutic Approach to Improving Quality of Life and Performance in Athletes and Other Patients with Cluster Headache","year":"2026","cit":0,"pfa":"Michał Lewczuk","psa":"Julia Chmielowiec","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7201849956","eid":"W7201849956"},{"id":"paper-w7135486067","cat":"papers","name":"The influence of set and setting on experiencing a challenging psychedelic experience","year":"2023","cit":0,"pfa":"Jana Jetelinová","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W7135486067","eid":"W7135486067"},{"id":"paper-w7212303504","cat":"papers","name":"Lifetime classic psychedelics use is associated with positive environmental attitudes and adopting a vegetarian diet","year":"2026","cit":0,"pfa":"Pedro J. Teixeira","psa":"Matthias Forstmann","ptype":"article","src":"https://openalex.org/W7212303504","eid":"W7212303504"},{"id":"paper-w7106021341","cat":"papers","name":"Modern Pharmacological Paradigms in the Treatment of Depression","year":"2025","cit":0,"pfa":"Shraddha Wasnik*, Dr. Shantilal Singune","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7106021341","eid":"W7106021341"},{"id":"paper-w3016871833","cat":"papers","name":"The Biased Kappa Opioid Receptor Agonist Nalfurafine Reduces the Reinforcing Properties of Oxycodone and Enhances Oxycodone‐Induced Spinal Anti‐Nociception","year":"2020","cit":0,"pfa":"Vincent Setola","psa":"David Peter Siderovski","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W3016871833","eid":"W3016871833"},{"id":"paper-w7165764267","cat":"papers","name":"Chemical ecology and convergent evolution of natural hallucinogens: From ecological defense to conserved neural targets","year":"2026","cit":0,"pfa":"Yibo Wang","psa":"Xiaohui Wang","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7165764267","eid":"W7165764267"},{"id":"paper-w7128905792","cat":"papers","name":"Peer-led drug checking in Chile: a case study of the country’s first harm reduction service at electronic music events","year":"2026","cit":0,"pfa":"Camilo Obregón","psa":"Javiera Navarrete","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7128905792","eid":"W7128905792"},{"id":"paper-w2913026945","cat":"papers","name":"Are psychedelics effective in treating anxiety associated with a lifethreatening disease","year":"2018","cit":0,"pfa":"Kayla Wilwohl","topics":["Anxiety & end-of-life","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2913026945","eid":"W2913026945"},{"id":"paper-w4390288436","cat":"papers","name":"Neuroprotective Effect of Pentoxifylline on 3,4-Methylenedioxymethamphetamine-Induced Apoptosis in CA1 Cells of Wistar Rat Hippocampus","year":"2019","cit":0,"pfa":"Zahra Nadia Sharifi","psa":"Sourena Jafari Semnani","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4390288436","eid":"W4390288436"},{"id":"paper-w7204453436","cat":"papers","name":"AMCP Market Insights: Optimizing managed care approaches to treatment-resistant depression","year":"2026","cit":0,"pfa":"Bridget M. Flavin","psa":"Michael H. Shannon","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7204453436","eid":"W7204453436"},{"id":"paper-w112431981","cat":"papers","name":"G‐protein alpha subunits differentially alter the conformation of kappa opioid receptor","year":"2007","cit":0,"pfa":"Feng Yan","psa":"Bryan L. Roth","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W112431981","eid":"W112431981"},{"id":"paper-w4313201433","cat":"papers","name":"Intravenous valproic acid for the treatment of inpatients with bipolar disorder experiencing manic or depressive episodes with mixed features","year":"2022","cit":0,"pfa":"P. Carmellini","psa":"Andrea M. Fagiolini","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4313201433","eid":"W4313201433"},{"id":"paper-w7106034639","cat":"papers","name":"Modern Pharmacological Paradigms in the Treatment of Depression","year":"2025","cit":0,"pfa":"Shraddha Wasnik*, Dr. Shantilal Singune","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7106034639","eid":"W7106034639"},{"id":"paper-w7171326350","cat":"papers","name":"The Right to Cognitive Travel: Psychedelic Experience and Freedom of Movement","year":"2026","cit":0,"pfa":"Dustin Marlan","ptype":"preprint","src":"https://openalex.org/W7171326350","eid":"W7171326350"},{"id":"paper-w7158690306","cat":"papers","name":"Characterizing psilocybin’s effects on nociception and thermoregulation in preclinical pain models","year":"2026","cit":0,"pfa":"Tyler Girard","psa":"Stanford University","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7158690306","eid":"W7158690306"},{"id":"paper-w7169564134","cat":"papers","name":"Screening and Supporting Spiritual Concerns in Psychedelic Assisted Therapy with Palliative Care Populations: A Narrative Review Pre-Registration","year":"2026","cit":0,"pfa":"Stephen P Lewis","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W7169564134","eid":"W7169564134"},{"id":"paper-w4412165380","cat":"papers","name":"The Effects of 3,4-Methylenedioxymethamphetamine on Reproductive Hormones, Organ Weight, and Fertility Outcomes in Female Wistar Rats","year":"2025","cit":0,"pfa":"Eferavware","psa":"Ezeuko","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4412165380","eid":"W4412165380"},{"id":"paper-w7160408431","cat":"papers","name":"Severe Hyponatremic Encephalopathy Induced by Unsupervised “Therapeutic” 3,4-Methylenedioxymethamphetamine Use in a 55-Year-Old Woman: A Diagnostic Pitfall","year":"2026","cit":0,"pfa":"Pierre-Henri Woitrin","psa":"Pascale Lievens","topics":["PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7160408431","eid":"W7160408431"},{"id":"paper-w7169542824","cat":"papers","name":"OPTICS: Opinions and Preferences for Treatments In Community Samples","year":"2026","cit":0,"pfa":"Christina Chwyl","psa":"Brian C. Pilecki","topics":["PTSD & trauma","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7169542824","eid":"W7169542824"},{"id":"paper-w4413284846","cat":"papers","name":"577. CLINICAL EVIDENCE AND APPLICATIONS OF PSYCHEDELICS FOR MENTAL ILLNESSES","year":"2025","cit":0,"pfa":"H Tani","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"conference-abstract","src":"https://openalex.org/W4413284846","eid":"W4413284846"},{"id":"paper-w7203458575","cat":"papers","name":"Truth about Hallucinogens","year":"2004","cit":0,"pfa":"Lori Widzinski","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7203458575","eid":"W7203458575"},{"id":"paper-w7143948441","cat":"papers","name":"Malpractice without a Baseline: Tort Liability and the Structural Paradoxes of Psychedelic-assisted Therapy","year":"2026","cit":0,"pfa":"Michael Palmieri","ptype":"preprint","src":"https://openalex.org/W7143948441","eid":"W7143948441"},{"id":"paper-w4414609853","cat":"papers","name":"Psychedelics Offer Healing and Ecological Remembrance for Marginalized Individuals Failed by U.S. Health Care","year":"2025","cit":0,"pfa":"Nicole I. Torres","topics":["PTSD & trauma","Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4414609853","eid":"W4414609853"},{"id":"paper-w422362947","cat":"papers","name":"Dödens lian som livlina : en religionspsykologisk studie av ayahuascaanvändning som religiös copingstrategi","year":"2013","cit":0,"pfa":"Pierre Durrani","ptype":"article","src":"https://openalex.org/W422362947","eid":"W422362947"},{"id":"paper-w7154493245","cat":"papers","name":"Psilocybin’s Kinematic Effect on Manual Dexterity","year":"2026","cit":0,"pfa":"Pierre Klintefors","psa":"Olivia L. Carter","ptype":"preprint","src":"https://openalex.org/W7154493245","eid":"W7154493245"},{"id":"paper-w2236584982","cat":"papers","name":"Flashbacks: Media representations of illicit hallucinogenic substance use in medical therapies before and after marijuana decriminalization","year":"2015","cit":0,"pfa":"Kembra Nicole Gerner","topics":["Addiction","Reviews & meta-analyses","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W2236584982","eid":"W2236584982"},{"id":"paper-w2592637059","cat":"papers","name":"Can 3,4,-methylenedioxymethamphetamine therapy be used to treat alcohol use disorder?","year":"2017","cit":0,"pfa":"Ben Sessa","topics":["PTSD & trauma","Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2592637059","eid":"W2592637059"},{"id":"paper-w2789672250","cat":"papers","name":"Metilendioximetanfetamina (éxtasis): efectos neurotóxicos e inducción de cambios adaptativos en los receptores 5-ht1a de cerebro de rata","year":"1996","cit":0,"pfa":"Norberto Aguirre García","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2789672250","eid":"W2789672250"},{"id":"paper-w2325449519","cat":"papers","name":"Salvia divinorum","year":"2006","cit":0,"pfa":"Leon Gussow","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2325449519","eid":"W2325449519"},{"id":"paper-w2316692859","cat":"papers","name":"Hallucinogenic amphetamines neurotoxicity in cultured hippocampal neurons","year":"2011","cit":0,"pfa":"S. da Costa Araújo","psa":"João Paulo Capela","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2316692859","eid":"W2316692859"},{"id":"paper-w7161154755","cat":"papers","name":"ITU and Psychiatry: A Single-Axiom View of K_brain Failures, Predictive Coding, Drug Mechanisms, and the 2026-2050 Roadmap","year":"2026","cit":0,"pfa":"Munehiro Terada","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W7161154755","eid":"W7161154755"},{"id":"paper-w4240227887","cat":"papers","name":"Performance Enhancement and Adverse Consequences ofMDMA","year":"2007","cit":0,"pfa":"Firas H. Kobeissy Meghan B. O'Donoghue Erin C. Golden Stephen F. Lamer Zhiqun…","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"book-chapter","src":"https://openalex.org/W4240227887","eid":"W4240227887"},{"id":"paper-w7135930193","cat":"papers","name":"Effects of Serotonergic Psychedelics on Synaptic Function and Neuroplasticity","year":"2025","cit":0,"pfa":"Aneta Petrušková","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"dissertation","src":"https://openalex.org/W7135930193","eid":"W7135930193"},{"id":"paper-w7208787575","cat":"papers","name":"Healing together: Results from a pilot trial of 3,4‐Methylenedioxymethamphetamine‐enhanced cognitive‐behavioral conjoint therapy for posttraumatic stress disorder","year":"2026","cit":0,"pfa":"Leslie A. Morland","psa":"Kayla C. Knopp","topics":["PTSD & trauma","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7208787575","eid":"W7208787575"},{"id":"paper-w7198789145","cat":"papers","name":"MDMA:n vaikutukset GABAergisissä soluissa hiiren amygdalassa","year":"2024","cit":0,"pfa":"Ronja Mandelin","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7198789145","eid":"W7198789145"},{"id":"paper-w1981680485","cat":"papers","name":"Ambient temperature impact on hepatocellular liver damage in rats following intake of 3,4-methylenedioxymethamphetamine","year":"2011","cit":0,"pfa":"Nadica Marinkovic","psa":"Jovan Dimitrijevic","ptype":"article","src":"https://openalex.org/W1981680485","eid":"W1981680485"},{"id":"paper-w4414071976","cat":"papers","name":"Psychedelics that Heal and Harm – Their Therapeutic and Recreational Use","year":"2025","cit":0,"pfa":"Faheema Aziz Wani","psa":"Irfan Ahmad Wani","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W4414071976","eid":"W4414071976"},{"id":"paper-w7147451430","cat":"papers","name":"Clinical Characteristics of Emergency Visits Related to Recreational Psychedelic Use","year":"2026","cit":0,"pfa":"Kush V. Bhatt","psa":"Dhakshin Ramanathan","topics":["Anxiety & end-of-life","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7147451430","eid":"W7147451430"},{"id":"paper-w4416564506","cat":"papers","name":"Current Research Limitations and Opportunities for Studying Psilocybin’s Therapeutic Benefits in Treating Depression","year":"2025","cit":0,"pfa":"Gabriel Bennett","topics":["Depression"],"ptype":"book-chapter","src":"https://openalex.org/W4416564506","eid":"W4416564506"},{"id":"paper-w7212030435","cat":"papers","name":"331. Rapid antidepressant effects of inhaled GH001 in treatment-resistant depression: results from a phase 2b, double-blind, randomized controlled trial with 6-month follow-up","year":"2026","cit":0,"pfa":"Wiesław Jerzy Cubała","psa":"B. Baune","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"conference-abstract","src":"https://openalex.org/W7212030435","eid":"W7212030435"},{"id":"paper-w7149298641","cat":"papers","name":"Psychedelic-Assisted Psychotherapy for TRD: An Umbrella Review [Clinical Psychology Topic 331]","year":"2026","cit":0,"pfa":"Juan Moises de la Serna","topics":["Mechanism & neuroscience","Reviews & meta-analyses","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7149298641","eid":"W7149298641"},{"id":"paper-w4403044193","cat":"papers","name":"From efficacy to effectiveness: evaluating psychedelic randomised controlled trials for trustworthy evidence-based policy and practice.","year":"2024","cit":0,"pfa":"Eduardo Ekman Schenberg","topics":["Depression","PTSD & trauma","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4403044193","eid":"W4403044193"},{"id":"paper-w4255422860","cat":"papers","name":"Psychedelia","year":"2016","cit":0,"pfa":"James Slauson","topics":["Addiction"],"ptype":"reference-entry","src":"https://openalex.org/W4255422860","eid":"W4255422860"},{"id":"paper-w7164151445","cat":"papers","name":"CNS Drugs Targeting the Neuropsychiatric and Cognitive Symptoms of Alzheimer’s Disease (P3-12.014)","year":"2026","cit":0,"pfa":"Aidan Butler","psa":"Elise K. Webber","ptype":"article","src":"https://openalex.org/W7164151445","eid":"W7164151445"},{"id":"paper-w7161142094","cat":"papers","name":"ITU and Psychiatry: A Single-Axiom View of K_brain Failures, Predictive Coding, Drug Mechanisms, and the 2026-2050 Roadmap","year":"2026","cit":0,"pfa":"Munehiro Terada","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W7161142094","eid":"W7161142094"},{"id":"paper-w7126129735","cat":"papers","name":"Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases","cit":0,"pfa":"Nathan H. Heller","psa":"Pantelis Leptourgos","topics":["Mechanism & neuroscience","Reviews & meta-analyses","Policy & ethics"],"ptype":"review","src":"https://openalex.org/W7126129735","eid":"W7126129735"},{"id":"paper-w7149479738","cat":"papers","name":"Psychedelic-Assisted Psychotherapy for TRD: An Umbrella Review [Clinical Psychology Topic 331]","year":"2026","cit":0,"pfa":"Juan Moises de la Serna","topics":["Mechanism & neuroscience","Reviews & meta-analyses","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7149479738","eid":"W7149479738"},{"id":"paper-w4312063969","cat":"papers","name":"LSD reduces anxiety symptoms in Phase 2 trial","year":"2022","cit":0,"topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4312063969","eid":"W4312063969"},{"id":"paper-w7202255093","cat":"papers","name":"Psychedelic integration beyond the verbal: participatory-imaginal processing as a hypothesis-generating therapeutic framework","year":"2026","cit":0,"pfa":"Anthony L. Back","psa":"Robert Bosnak","topics":["Anxiety & end-of-life","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7202255093","eid":"W7202255093"},{"id":"paper-w134856783","cat":"papers","name":"Acute, Repeated-Dose and Residual Effects of Amphetamines on Psychological Measures in Humans","year":"2014","cit":0,"pfa":"Allison Turza Bajger","topics":["Dosing & pharmacology","Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W134856783","eid":"W134856783"},{"id":"paper-w4413920565","cat":"papers","name":"The Psychedelic Reset: How Psychedelics May Reshape the Corticostriatal Circuit in Anorexia Nervosa","year":"2025","cit":0,"pfa":"Maham Khurram","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4413920565","eid":"W4413920565"},{"id":"paper-w7171560399","cat":"papers","name":"A Systematic Review of EEG Predictors and Correlates of Psilocybin’s Treatment in Depression","year":"2026","cit":0,"pfa":"Danial Beniameen","psa":"Armya Beniameen","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7171560399","eid":"W7171560399"},{"id":"paper-w4242085023","cat":"papers","name":"Reporting On Adverse Clinical Events","year":"2009","cit":0,"topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4242085023","eid":"W4242085023"},{"id":"paper-w4289021211","cat":"papers","name":"Preclinical Testing of Nalfurafine as an Opioid-sparing Adjuvant that Potentiates Analgesia by the Mu Opioid Receptor-targeting Agonist Morphine","year":"2022","cit":0,"pfa":"J. Aubé","psa":"T.E. Prisinzano","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4289021211","eid":"W4289021211"},{"id":"paper-w7160044142","cat":"papers","name":"A Systematic Review of MDMA’s Effects on Social Cognition in Placebo-Controlled Trials","year":"2026","cit":0,"pfa":"Victoria Burmester","psa":"Dasha Nicholls","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7160044142","eid":"W7160044142"},{"id":"paper-w3177177235","cat":"papers","name":"Psychedelic Assisted Therapy for Major Depressive Disorder: A Review","year":"2021","cit":0,"pfa":"Annie McCartney","psa":"Alexander De Foe","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W3177177235","eid":"W3177177235"},{"id":"paper-w4408961409","cat":"papers","name":"Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases","year":"2025","cit":0,"pfa":"Nathan H. Heller","psa":"Pantelis Leptourgos","topics":["Mechanism & neuroscience","Reviews & meta-analyses","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4408961409","eid":"W4408961409"},{"id":"paper-w4412441845","cat":"papers","name":"Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases","year":"2025","cit":0,"pfa":"Nathan H. Heller","psa":"Pantelis Leptourgos","topics":["Mechanism & neuroscience","Reviews & meta-analyses","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4412441845","eid":"W4412441845"},{"id":"paper-w4414314827","cat":"papers","name":"Effective connectivity of the human claustrum: Triple networks, subcortical circuits, and psychedelic modulation","year":"2025","cit":0,"pfa":"Navid Shams Masjedi","psa":"Adeel Razi","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4414314827","eid":"W4414314827"},{"id":"paper-w7131071120","cat":"papers","name":"metapsy-project/data-ptsd-mdmactr: Version 26.0.0","year":"2026","cit":0,"pfa":"Parker Singleton","psa":"Brooke L. Sevchik","topics":["PTSD & trauma","Safety & adverse events"],"ptype":"software","src":"https://openalex.org/W7131071120","eid":"W7131071120"},{"id":"paper-w7131097867","cat":"papers","name":"metapsy-project/data-ptsd-mdmactr: Version 26.0.1","year":"2026","cit":0,"pfa":"Parker Singleton","psa":"Mathias Harrer","topics":["PTSD & trauma","Safety & adverse events"],"ptype":"software","src":"https://openalex.org/W7131097867","eid":"W7131097867"},{"id":"paper-w7201350117","cat":"papers","name":"mGlu2/3-reseptorien antagonismin vaikutus MDMA:n paikkapreferenssiin ja lokomotoriikkaan","year":"2024","cit":0,"pfa":"Jevi Lenius","topics":["PTSD & trauma","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7201350117","eid":"W7201350117"},{"id":"paper-w4214524060","cat":"papers","name":"Reporting on Adverse Clinical Events","year":"2011","cit":0,"topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4214524060","eid":"W4214524060"},{"id":"paper-w2928707018","cat":"papers","name":"Clinical relevance of verbal memory impairment in polydrug Ecstasy users: A pooled data analysis","year":"2015","cit":0,"pfa":"Kim P. C. Kuypers","psa":"Johannes Gerardus Ramaekers","ptype":"dataset","src":"https://openalex.org/W2928707018","eid":"W2928707018"},{"id":"paper-w7120715543","cat":"papers","name":"The regulation of ayahuasca's religious use in Brazil: a sociological review of Brazilian drug legislation after the 1960s in accordance with international guidelines","year":"2018","cit":0,"pfa":"Jânio de Oliveira Silva Júnior","topics":["Reviews & meta-analyses","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W7120715543","eid":"W7120715543"},{"id":"paper-w4410905439","cat":"papers","name":"Effects of intravenous propofol combined with opioids on euphoria in patients undergoing painless gastrointestinal endoscopy: protocol for a randomized double-blind placebo-controlled trial","year":"2025","cit":0,"pfa":"Youjia Yu","psa":"Chuntao Ma","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4410905439","eid":"W4410905439"},{"id":"paper-w4407513670","cat":"papers","name":"Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases","year":"2025","cit":0,"pfa":"Nathan H. Heller","psa":"Pantelis Leptourgos","topics":["Mechanism & neuroscience","Reviews & meta-analyses","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4407513670","eid":"W4407513670"},{"id":"paper-w4415014334","cat":"papers","name":"Toward Precision Psychedelic Therapies: Chemical, Computational, and Neuromodulatory Innovations","year":"2025","cit":0,"pfa":"Anna C. Renner","psa":"Robert B. Kargbo","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"editorial","src":"https://openalex.org/W4415014334","eid":"W4415014334"},{"id":"paper-w7140882833","cat":"papers","name":"metapsy-project/data-ptsd-mdmactr: Version 26.0.1","year":"2026","cit":0,"pfa":"Parker Singleton","psa":"Mathias Harrer","topics":["PTSD & trauma","Safety & adverse events"],"ptype":"software","src":"https://openalex.org/W7140882833","eid":"W7140882833"},{"id":"paper-w3152773548","cat":"papers","name":"The PACT Model: Improving Outcomes in the Treatment of PTSD","year":"2021","cit":0,"pfa":"Veronika Larova","psa":"Heather Frederick","topics":["PTSD & trauma","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3152773548","eid":"W3152773548"},{"id":"paper-w4415045798","cat":"papers","name":"Psilocybin’s effect on human brain synaptic plasticity","year":"2025","cit":0,"pfa":"Gitte M. Knudsen","psa":"Claus Svarer","ptype":"preprint","src":"https://openalex.org/W4415045798","eid":"W4415045798"},{"id":"paper-w2350480170","cat":"papers","name":"Identification of Main Components and some Impurities in 3,4-Methylenedioxymethamphetamine by GC/MS","year":"2004","cit":0,"pfa":"Wu Guo","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2350480170","eid":"W2350480170"},{"id":"paper-w2977944874","cat":"papers","name":"Cognitive consequences of 3,4-methylenedioxymethamphetamine use","year":"2019","cit":0,"pfa":"Catharine Montgomery","psa":"Carl Alexander Roberts","ptype":"book-chapter","src":"https://openalex.org/W2977944874","eid":"W2977944874"},{"id":"paper-w7115249255","cat":"papers","name":"Vem äger själens ranka? : Ayahuascaturism utifrån tre dokumentärer","year":"2021","cit":0,"pfa":"Andersson, Tove","ptype":"dissertation","src":"https://openalex.org/W7115249255","eid":"W7115249255"},{"id":"paper-w7214154195","cat":"papers","name":"Temporal structure tunes the psychedelic experience","year":"2026","cit":0,"pfa":"Jake Rogers","ptype":"article","src":"https://openalex.org/W7214154195","eid":"W7214154195"},{"id":"paper-w7132817380","cat":"papers","name":"Comprehensive study into psychostimulant photocatalytic removal using immobilized TiO2: Performance, transformation products, and environmental safety","year":"2026","cit":0,"pfa":"Tereza Maříková","psa":"Jiřı́ Rathouský","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7132817380","eid":"W7132817380"},{"id":"paper-w4415322527","cat":"papers","name":"Ayahuasca’s Path in the United States: The RFRA and the Sincere Exercise of Religion","year":"2025","cit":0,"pfa":"Henrique Fernandes Antunes","ptype":"book-chapter","src":"https://openalex.org/W4415322527","eid":"W4415322527"},{"id":"paper-w7212235105","cat":"papers","name":"A Systematic Review of MDMA’s Effects on Social Cognition in Placebo-Controlled Trials","year":"2026","cit":0,"pfa":"Victoria Burmester","psa":"Dasha Nicholls","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7212235105","eid":"W7212235105"},{"id":"paper-w4406756675","cat":"papers","name":"Diviner's Sage (Salvia divinorum Epling & Játiva Lamiaceae)","year":"2025","cit":0,"pfa":"Mai M. Younis","psa":"Abdel Nasser B. Singab","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W4406756675","eid":"W4406756675"},{"id":"paper-w7200887802","cat":"papers","name":"Classic psychedelics in the treatment of depression: mechanisms of action and the role of therapy","year":"2022","cit":0,"pfa":"Ellen Saikku","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7200887802","eid":"W7200887802"},{"id":"paper-w7162517758","cat":"papers","name":"Which medication is effective in treating anhedonia associated with bipolar depression?","year":"2026","cit":0,"pfa":"Tripdatabase","topics":["Depression","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7162517758","eid":"W7162517758"},{"id":"paper-w4245522750","cat":"papers","name":"Hallucinogen Abuse and Dependence","year":"2010","cit":0,"pfa":"Michael H. Bloch","psa":"Subhash C. Pandey","ptype":"reference-entry","src":"https://openalex.org/W4245522750","eid":"W4245522750"},{"id":"paper-w4417094071","cat":"papers","name":"Disengaged: A systematic review of community engagement in psychedelic-assisted therapy research","year":"2025","cit":0,"pfa":"Mallet R. Reid","psa":"Jacob S. Aday","topics":["Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4417094071","eid":"W4417094071"},{"id":"paper-w7168366556","cat":"papers","name":"Psilocybin’s effect on human brain synaptic plasticity","year":"2026","cit":0,"pfa":"Annette Johansen","psa":"Gitte M. Knudsen","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7168366556","eid":"W7168366556"},{"id":"paper-w2600440177","cat":"papers","name":"5-Hydroxytryptamine receptors in rat cerebrum","year":"1985","cit":0,"pfa":"Christine M. Brown","psa":"Roger Lewis Whiting","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2600440177","eid":"W2600440177"},{"id":"paper-w4402860749","cat":"papers","name":"Psychedelic Social Psychology","year":"2024","cit":0,"pfa":"Tanya K. Vannoy","psa":"Sonja Lyubomirsky","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W4402860749","eid":"W4402860749"},{"id":"paper-w2030108485","cat":"papers","name":"Pseudohypoparathyroidism, Cimetidine, and Neurologic Toxicity","year":"1983","cit":0,"pfa":"Alan R. Rushton","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2030108485","eid":"W2030108485"},{"id":"paper-w4306758344","cat":"papers","name":"Klassieke psychedelica als behandeling voor depressie: waar staan we vandaag?","year":"2022","cit":0,"pfa":"F. Slechten","psa":"M. De Hert","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4306758344","eid":"W4306758344"},{"id":"paper-w7132975307","cat":"papers","name":"Predictors of the Antidepressant Effects of Ketamine and Psychedelic Substances","year":"2025","cit":0,"pfa":"Omer A. Syed","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W7132975307","eid":"W7132975307"},{"id":"paper-w7162548132","cat":"papers","name":"Which medication is effective in treating anhedonia associated with bipolar depression?","year":"2026","cit":0,"pfa":"Tripdatabase","topics":["Depression","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7162548132","eid":"W7162548132"},{"id":"paper-w7203744950","cat":"papers","name":"Psychedelics tune the brain to the environment","year":"2026","cit":0,"pfa":"Stefan Borgwardt","psa":"Mihai Avram","ptype":"article","src":"https://openalex.org/W7203744950","eid":"W7203744950"},{"id":"paper-w7209844554","cat":"papers","name":"Psychopharmacology (2004) 173:310–317 DOI 10.1007/s00213-003-1765-7","year":"2014","cit":0,"topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7209844554","eid":"W7209844554"},{"id":"paper-w7213297049","cat":"papers","name":"EP991 - ECE_1551 - Reduced empathy and impaired emotion recognition in patients with arginine vasopressin deficiency","year":"2026","cit":0,"pfa":"Liv-Helen Lang","psa":"Mirjam Christ‐Crain","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W7213297049","eid":"W7213297049"},{"id":"paper-w2939054662","cat":"papers","name":"F55. CLINICAL OUTCOMES ASSOCIATED WITH ILLICIT SUBSTANCE USE IN FIRST EPISODE PSYCHOSIS (FEP): A TEXT MINING STUDY OF ELECTRONIC HEALTH RECORDS","year":"2019","cit":0,"pfa":"Rashmi Patel","psa":"Philip K. McGuire","topics":["Addiction","Safety & adverse events"],"ptype":"conference-abstract","src":"https://openalex.org/W2939054662","eid":"W2939054662"},{"id":"paper-w4414975365","cat":"papers","name":"Real-world use of classic and non-classic psychedelics in Hispanic/Latino adults with Obsessive-Compulsive Disorder: International findings from the LATINO Study.","year":"2025","cit":0,"pfa":"Vanessa Zavala Cruz","psa":"Renee M Frederick","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4414975365","eid":"W4414975365"},{"id":"paper-w4416088647","cat":"papers","name":"Engineering the Next Generation of Psychedelic Therapeutics through Serotonergic Precision and Pharmacokinetic Control","year":"2025","cit":0,"pfa":"Anna C. Renner","psa":"Robert B. Kargbo","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"editorial","src":"https://openalex.org/W4416088647","eid":"W4416088647"},{"id":"paper-w4407101752","cat":"papers","name":"Histomorphological findings in the brain of adult Wistar rats exposed to the ecstasy Pill; 3, 4 methylenedioxymethamphetamine","year":"2024","cit":0,"pfa":"I C Idehen","psa":"Iyevhobu Kenneth Oshiokhayamhe","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4407101752","eid":"W4407101752"},{"id":"paper-w2300591169","cat":"papers","name":"Interaction of tricyclic antidepressants with the ha3β4 nicotinic receptor","year":"2010","cit":0,"pfa":"Ali H. Ahmad","psa":"Hugo Rubén Arias","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2300591169","eid":"W2300591169"},{"id":"paper-w7141010691","cat":"papers","name":"Torsades de Pointes: Impact of Antidepressants and Antipsychotics","year":"2025","cit":0,"pfa":"Scott R. Beach","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"report","src":"https://openalex.org/W7141010691","eid":"W7141010691"},{"id":"paper-w4414144426","cat":"papers","name":"Sociodemographic and mental-health characteristics of psychedelic-assisted therapy participants: Latent class analysis of a cross-sectional, purposive online sample","year":"2025","cit":0,"pfa":"Dan Petrovitch","psa":"Heather Austin-Robillard","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4414144426","eid":"W4414144426"},{"id":"paper-w1977816893","cat":"papers","name":"Study Suggests Hallucinogen May Be Personality Changer","year":"2011","cit":0,"pfa":"Joan Arehart-Treichel","ptype":"article","src":"https://openalex.org/W1977816893","eid":"W1977816893"},{"id":"paper-w4286379140","cat":"papers","name":"The Role of Serotonin in the Development of Psychiatric Disorders: Studies on Drug Dependence and Anxiety-like Behaviour Following the Genetic Reduction of the Serotonin Transporter","year":"2015","cit":0,"pfa":"Alana Oakly","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W4286379140","eid":"W4286379140"},{"id":"paper-w4401727521","cat":"papers","name":"Antidepression Agents in Himalayan Mushrooms","year":"2024","cit":0,"pfa":"Taj-Ud-Din","psa":"Waleed Al Abdulmonem","topics":["Depression"],"ptype":"book-chapter","src":"https://openalex.org/W4401727521","eid":"W4401727521"},{"id":"paper-w4413911705","cat":"papers","name":"Gregor Hasler: Three Guiding Questions — How do psychedelics shape the brain? How can they heal psychiatric disorders such as depression and PTSD? How can we ensure their safe and responsible use?","year":"2025","cit":0,"pfa":"Gregor Hasler","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4413911705","eid":"W4413911705"},{"id":"paper-w4402269098","cat":"papers","name":"Rosalind Franklin Society Proudly Announces the 2023 Award Recipient for Psychedelic Medicine","year":"2024","cit":0,"pfa":"Albert Garcia‐Romeu","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4402269098","eid":"W4402269098"},{"id":"paper-w2329960124","cat":"papers","name":"Influence of different neuroprotective drugs on dopamine neurotoxicity induced by 3,4-methylenedioxymethamphetamine and MPTP in mice","year":"2016","cit":0,"pfa":"Pier Francesca Porceddu","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W2329960124","eid":"W2329960124"},{"id":"paper-w2292423047","cat":"papers","name":"The Design And Use of Covalently Bound Agonists To Probe Kappa‐Opioid Receptors","year":"2008","cit":0,"pfa":"Feng Yan","psa":"Bryan L. Roth","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2292423047","eid":"W2292423047"},{"id":"paper-w2263105731","cat":"papers","name":"TOXICITY FROM \"ECSTASY\".","year":"1992","cit":0,"pfa":"Asb","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2263105731","eid":"W2263105731"},{"id":"paper-w7204922957","cat":"papers","name":"Patterns of Psychedelic Use in Italy: Insights from the Global Psychedelic Survey","year":"2026","cit":0,"pfa":"Beatrice Dal Bianco","psa":"Philippe Lucas","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7204922957","eid":"W7204922957"},{"id":"paper-w4410802727","cat":"papers","name":"Ayahuasca's antidepressant effects covary with behavioral activation as well as mindfulness","year":"2019","cit":0,"pfa":"Maha N. Mian","topics":["Depression","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W4410802727","eid":"W4410802727"},{"id":"paper-w2118137726","cat":"papers","name":"Pharmacology and war: the papers of Sir John Henry Gaddum (1900–65)","year":"2007","cit":0,"pfa":"Rebecca Pohancenik","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2118137726","eid":"W2118137726"},{"id":"paper-w7214744157","cat":"papers","name":"Psychedelic protects against chemotherapy-induced nerve damage","year":"2026","cit":0,"pfa":"Katie Kingwell","ptype":"article","src":"https://openalex.org/W7214744157","eid":"W7214744157"},{"id":"paper-w4300963035","cat":"papers","name":"Editorial: Psychoactive natural products: Potential in the treatment of brain diseases and strategies to improve delivery","year":"2022","cit":0,"pfa":"Célia Cabral","psa":"Miguel Castelo‐Branco","topics":["Reviews & meta-analyses"],"ptype":"editorial","src":"https://openalex.org/W4300963035","eid":"W4300963035"},{"id":"paper-w7168392508","cat":"papers","name":"From trial to clinic: psilocybin’s efficacy in routine treatment-resistant depression","year":"2026","cit":0,"pfa":"Vassilis Martiadis","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7168392508","eid":"W7168392508"},{"id":"paper-w7154564204","cat":"papers","name":"Unveiling the Interactions: Molecular Docking of Antidepressants with Human SERT and Mouse Pendrin","year":"2026","cit":0,"pfa":"Devidas A. Batule","psa":"Bhushan R. Pawar","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7154564204","eid":"W7154564204"},{"id":"paper-w4401920400","cat":"papers","name":"False-Positive Urine Drug Screening in a Patient on Quetiapine","year":"2024","cit":0,"pfa":"J. Ying","psa":"Mo Tan","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4401920400","eid":"W4401920400"},{"id":"paper-w7113276669","cat":"papers","name":"Psychedelics and eyetracking","year":"2025","cit":0,"pfa":"Stephanie Müller","ptype":"preprint","src":"https://openalex.org/W7113276669","eid":"W7113276669"},{"id":"paper-w4416097946","cat":"papers","name":"The Relationship Between Psychedelic Use and Alcohol Use Disorder in a Nationally Representative Sample","year":"2025","cit":0,"pfa":"James M Zech","psa":"Grant M. Jones","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4416097946","eid":"W4416097946"},{"id":"paper-w2231163502","cat":"papers","name":"EFFECTS OF NEONATAL 3,4-METHYLENEDIOXYMETHAMPHETAMINE ON HIPPOCAMPAL GENE EXPRESSION, SPATIAL LEARNING AND LONG-TERM POTENTIATION","year":"2006","cit":0,"pfa":"Matthew R. Skelton","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2231163502","eid":"W2231163502"},{"id":"paper-w4417079940","cat":"papers","name":"Artemisia absinthium L. (Wormwood) Extract Effect on 3,4-Methylenedioxymethamphetamine Withdrawal in Rats: An Animal Study","year":"2025","cit":0,"pfa":"Mohadese Kamali","psa":"Rostam Seifadini","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4417079940","eid":"W4417079940"},{"id":"paper-w3184199278","cat":"papers","name":"Neurological and Related Adverse Events Associated with Pharmacokinetic Interactions of Illicit Substances of Fungal Origin with Clinical Drugs","year":"2021","cit":0,"pfa":"Julia M. Salamat","psa":"Satyanarayana R. Pondugula","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W3184199278","eid":"W3184199278"},{"id":"paper-w4205465808","cat":"papers","name":"Psychedelic Psychiatry: LSD from Clinic to Campus by Erica Dyck","year":"2009","cit":0,"pfa":"Mathew Thomas Martin-Iverson","topics":["PTSD & trauma","Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4205465808","eid":"W4205465808"},{"id":"paper-w4416888736","cat":"papers","name":"Real-World Effectiveness and Safety of Psychedelic-Assisted Psychotherapy: Outcomes from a Large-Scale Compassionate Use Cohort in Switzerland","year":"2025","cit":0,"pfa":"Tatiana Aboulafia Brakha","psa":"Louise E. Penzenstadler","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W4416888736","eid":"W4416888736"},{"id":"paper-w7117768290","cat":"papers","name":"Self-Transcendent Perceptual Dynamics and the Effects of Dispositional Mindfulness on Altered States of Consciousness: A Prospective Longitudinal Observational Study of a Naturalistic Psychedelic Retreat","year":"2025","cit":0,"pfa":"Sebastian Ehmann","psa":"Michael J. Gawrysiak","topics":["Addiction"],"ptype":"preprint","src":"https://openalex.org/W7117768290","eid":"W7117768290"},{"id":"paper-w3046794062","cat":"papers","name":"The Role of Myofascial Tensions, Nitric Oxide (NO) and Dimethyltriptamine (DMT) in Mental Illness Etiology","year":"2020","cit":0,"pfa":"Nicola Petrogalli","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3046794062","eid":"W3046794062"},{"id":"paper-w7212075224","cat":"papers","name":"722. Predictors of therapeutic response to LSD in anxiety: short- and long-term outcomes","year":"2026","cit":0,"pfa":"Friederike Holze","psa":"Matthias E. Liechti","topics":["Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W7212075224","eid":"W7212075224"},{"id":"paper-w2243306575","cat":"papers","name":"Der Einfluss von S-Ketamin und N,N-dimethyltrytamine (DMT) auf die Präpulsinhibition und die attentive Modulation des Startlereflexes : eine humanexperimentelle Untersuchung zum Modellpsychoseparadigma","year":"2008","cit":0,"pfa":"Martina Margrit Crysandt","psa":"Euphrosyne Gouzoulis‐Mayfrank","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W2243306575","eid":"W2243306575"},{"id":"paper-w4400182711","cat":"papers","name":"The effect of serotonin 5-HT2 receptor antagonists on classical conditioning of the rabbit nictitating membrane","year":"1997","cit":0,"pfa":"Scott Welsh","psa":"John A. Harvey","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W4400182711","eid":"W4400182711"},{"id":"paper-w7136329462","cat":"papers","name":"Clinician-patient communication in esketamine and psychedelic-assisted treatments for depression: a scoping review of evidence, gaps, and clinical implications","year":"2026","cit":0,"pfa":"Vassilis Martiadis","psa":"Domenico De Berardis","topics":["Depression","Addiction","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7136329462","eid":"W7136329462"},{"id":"paper-w2403125288","cat":"papers","name":"[The forensic chemical study of psilocybine-containing fungi].","year":"1999","cit":0,"pfa":"Babakhanian Rv","psa":"Kuz'minykh Ks","ptype":"article","src":"https://openalex.org/W2403125288","eid":"W2403125288"},{"id":"paper-w1971261606","cat":"papers","name":"Psychedelic Psychiatry : lsd from Clinic to Campus (review)","year":"2009","cit":0,"pfa":"Ian Dowbiggin","topics":["Addiction","Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1971261606","eid":"W1971261606"},{"id":"paper-w69081323","cat":"papers","name":"Die Wirkung von LSD","year":"1975","cit":0,"pfa":"Josef Schenk","ptype":"book-chapter","src":"https://openalex.org/W69081323","eid":"W69081323"},{"id":"paper-w7163889771","cat":"papers","name":"Psychedelic-Assisted Psychotherapy for the Treatment of PTSD: A Systematic Review and Meta-Analysis","year":"2026","cit":0,"pfa":"Fizza Mitter","psa":"Wọlé Akóṣílè","topics":["PTSD & trauma","Safety & adverse events","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W7163889771","eid":"W7163889771"},{"id":"paper-w4394390199","cat":"papers","name":"Phase I Trial Data.xlsx","year":"2023","cit":0,"pfa":"Jennifer Bennett","psa":"Ian Mitchell","ptype":"dataset","src":"https://openalex.org/W4394390199","eid":"W4394390199"},{"id":"paper-w3045070085","cat":"papers","name":"Health Risks of Ecstasy | Long Term Effects of Ecstasy | WhiteSands Treatment","year":"2017","cit":0,"pfa":"Mark Adams","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3045070085","eid":"W3045070085"},{"id":"paper-w644608186","cat":"papers","name":"Synthèse de métabolites de la méthylènedioxymétamphétamine susceptibles d'être impliqués dans la neurotoxicité de l'ecstasy","year":"2011","cit":0,"pfa":"Claire-Marie Martinez","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W644608186","eid":"W644608186"},{"id":"paper-w3117367591","cat":"papers","name":"The Acute Effects of LSD on Reward Behavior in Mice with Intracranial Self-Stimulation","year":"2020","cit":0,"pfa":"Juliana Harkki","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3117367591","eid":"W3117367591"},{"id":"paper-w4387503622","cat":"papers","name":"Recent Research Advances in Psychedelic Therapeutics","year":"2023","cit":0,"pfa":"David J. Hellerstein","ptype":"article","src":"https://openalex.org/W4387503622","eid":"W4387503622"},{"id":"paper-w2407394826","cat":"papers","name":"[Effect of psychotomimetics and haloperidol on head twitching following alcohol withdrawal in mice].","year":"1978","cit":0,"pfa":"H. Fink","psa":"Wilhelm Oelssner","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W2407394826","eid":"W2407394826"},{"id":"paper-w4205137701","cat":"papers","name":"Pennsylvania bill seeks clinical research on psychedelics","year":"2022","cit":0,"pfa":"Valerie A. Canady","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4205137701","eid":"W4205137701"},{"id":"paper-w2611287628","cat":"papers","name":"In vitro toxicity of piperazine-derived designer drugs in differentiated neural cell lines","year":"2017","cit":0,"pfa":"Dina Popova","psa":"Jacobsson Stig O.P.","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2611287628","eid":"W2611287628"},{"id":"paper-w7213500630","cat":"papers","name":"What is the best treatment for smoking cessation?","year":"2026","cit":0,"pfa":"Tripdatabase","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7213500630","eid":"W7213500630"},{"id":"paper-w4416111978","cat":"papers","name":"‘Magic’ mechanisms underlie psilocybin’s effects in chronic pain","year":"2025","cit":0,"pfa":"Siân Lewis","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4416111978","eid":"W4416111978"},{"id":"paper-w4394759812","cat":"papers","name":"[Psychedelic psychiatry].","year":"2024","cit":0,"pfa":"Evana López","psa":"Johan Lundberg","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"review","src":"https://openalex.org/W4394759812","eid":"W4394759812"},{"id":"paper-w7159549300","cat":"papers","name":"Evaluation of Neuroplastic Changes in Psychological Intervention and Contemporary Treatments of Depression","year":"2026","cit":0,"pfa":"Taylor Severance","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7159549300","eid":"W7159549300"},{"id":"paper-w4405781471","cat":"papers","name":"Tripping on Utopia: Margaret Mead, the Cold War and the Troubled Birth of Psychedelic Scienceby Benjamin Breen, New York: Grand Central Publishing. 2024. pp. 369. $3000 (cloth). ISBN 9781538722374","year":"2024","cit":0,"pfa":"Rob Schraff","topics":["Addiction","Therapy practice"],"ptype":"book-review","src":"https://openalex.org/W4405781471","eid":"W4405781471"},{"id":"paper-w7212026333","cat":"papers","name":"859. From Neurons to Behavior: Preclinical Insights into LSD’s Anxiolytic Mechanisms","year":"2026","cit":0,"pfa":"Gabriella Gobbi","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7212026333","eid":"W7212026333"},{"id":"paper-w7214862007","cat":"papers","name":"Investigating the Role of the TrkB Receptor in the Signalling Pathways of Psychedelics","year":"2026","cit":0,"pfa":"Bryce Doyle","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"dissertation","src":"https://openalex.org/W7214862007","eid":"W7214862007"},{"id":"paper-w7161805929","cat":"papers","name":"itu-kpsych: ITU Pass-2 Development Toolkit #7 (Psychiatric Information Theory K_psych)","year":"2026","cit":0,"pfa":"Munehiro Terada","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"software","src":"https://openalex.org/W7161805929","eid":"W7161805929"},{"id":"paper-w4394786197","cat":"papers","name":"Psychedelic therapists, pharma collaborate on clinical trial","year":"2024","cit":0,"pfa":"Valerie A. Canady","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4394786197","eid":"W4394786197"},{"id":"paper-w7172323655","cat":"papers","name":"Serotonergic psychedelics induce distinct patterns of metabolic activity and covariance within biologically informed rat brain networks","year":"2026","cit":0,"pfa":"Frederik Gudmundsen","psa":"Mikael Palner","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7172323655","eid":"W7172323655"},{"id":"paper-w2582085927","cat":"papers","name":"Within-Subject and Between-Subjects Evaluation of the Effects of Hallucinogenic Drugs in Pigeons Responding Under Two Variations of a Fixed-Consecutive-Number Schedule","year":"1990","cit":0,"pfa":"Rodney Clark","ptype":"dissertation","src":"https://openalex.org/W2582085927","eid":"W2582085927"},{"id":"paper-w7105846110","cat":"papers","name":"metapsy-project/data-depression-psiloctr: Version 25.1.0","year":"2025","cit":0,"pfa":"Mathias Harrer","psa":"Brooke Sevchik","topics":["Depression","Safety & adverse events"],"ptype":"software","src":"https://openalex.org/W7105846110","eid":"W7105846110"},{"id":"paper-w2937830540","cat":"papers","name":"Club Drugs and Their Treatment","year":"2006","cit":0,"pfa":"David M. McDowell","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2937830540","eid":"W2937830540"},{"id":"paper-w7160917673","cat":"papers","name":"Can Psychedelics help with Alcohol Use Disorder (AUD): For now, the data says no","year":"2026","cit":0,"pfa":"Kenneth Blum","psa":"Kyriaki Z. Thanos","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7160917673","eid":"W7160917673"},{"id":"paper-w2993451949","cat":"papers","name":"From psychosis to affective disorder : psychedelics as pharmacological models for psychiatric research","year":"2012","cit":0,"pfa":"André Schmidt","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W2993451949","eid":"W2993451949"},{"id":"paper-w7199239574","cat":"papers","name":"Psychedelics and their therapeutic effects","year":"2021","cit":0,"pfa":"Karim Ashraf ElAgamy","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7199239574","eid":"W7199239574"},{"id":"paper-w2784943432","cat":"papers","name":"The effect of novel kappa opioid peptide receptor agonists on learning and memory in rats","year":"2017","cit":0,"pfa":"Susan Adele Welsh","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W2784943432","eid":"W2784943432"},{"id":"paper-w1994769903","cat":"papers","name":"Hallucinogens Vs. Psychotherapy","year":"1967","cit":0,"pfa":"J Carranza-Acevedo","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W1994769903","eid":"W1994769903"},{"id":"paper-w7161828473","cat":"papers","name":"itu-kpsych: ITU Pass-2 Development Toolkit #7 (Psychiatric Information Theory K_psych)","year":"2026","cit":0,"pfa":"Munehiro Terada","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"software","src":"https://openalex.org/W7161828473","eid":"W7161828473"},{"id":"paper-w7168343559","cat":"papers","name":"What are the current treatment options for managing cocaine craving?","year":"2026","cit":0,"pfa":"Tripdatabase","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7168343559","eid":"W7168343559"},{"id":"paper-w2370289635","cat":"papers","name":"The determination of 3,4-methylenedioxymethamphetamine in urine by pentafluorobenzoyl derivatization and gas chromatography with nitrogen-phosphorus detection","year":"2005","cit":0,"pfa":"Jiayi Tan","ptype":"article","src":"https://openalex.org/W2370289635","eid":"W2370289635"},{"id":"paper-w4248555668","cat":"papers","name":"O6C-20-nor-SalA is a stable and potent KOR agonist","year":"2017","cit":0,"pfa":"Ryan A. Shenvi","psa":"Larua M. Bohn","topics":["Addiction","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4248555668","eid":"W4248555668"},{"id":"paper-w7171861516","cat":"papers","name":"Psychedelic attunements: rethinking set and setting and context","year":"2026","cit":0,"pfa":"Alex K. Gearin","psa":"Tehseen N. Noorani","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W7171861516","eid":"W7171861516"},{"id":"paper-w2399919258","cat":"papers","name":"[Analytical methods for addictive drugs of abuse].","year":"2010","cit":0,"pfa":"Mitsuhiro Wada","psa":"Kenichiro Nakashima","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"other","src":"https://openalex.org/W2399919258","eid":"W2399919258"},{"id":"paper-w7167629232","cat":"papers","name":"metapsy-project/data-depression-psiloctr: Version 26.0.0","year":"2026","cit":0,"pfa":"Parker Singleton","psa":"Brooke Sevchik","topics":["Depression","Safety & adverse events"],"ptype":"software","src":"https://openalex.org/W7167629232","eid":"W7167629232"},{"id":"paper-w7213515244","cat":"papers","name":"What is the best treatment for smoking cessation?","year":"2026","cit":0,"pfa":"Tripdatabase","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7213515244","eid":"W7213515244"},{"id":"paper-w2412204399","cat":"papers","name":"[Ilicit drugs frequently used by drug addicts].","year":"2015","cit":0,"pfa":"Cirriez Jp","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2412204399","eid":"W2412204399"},{"id":"paper-w7213552091","cat":"papers","name":"Engaging Employees and Employers to Better Manage Employment Risk in Clinical Trials","year":"2026","cit":0,"pfa":"Amanda M. Wilson","psa":"Benjamin S. Wilfond","topics":["Safety & adverse events"],"ptype":"editorial","src":"https://openalex.org/W7213552091","eid":"W7213552091"},{"id":"paper-w4253133632","cat":"papers","name":"Kappa opioid receptor regulation of ERK1/2 map kinase signaling cascade","year":"2008","cit":0,"pfa":"Khampaseuth Rasakham","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W4253133632","eid":"W4253133632"},{"id":"paper-w4416840805","cat":"papers","name":"Limited prognostic value of early maladaptive schemas for acute psychedelic experience and symptom improvement","year":"2025","cit":0,"pfa":"Albert Buchard","psa":"Gabriel Thorens","ptype":"preprint","src":"https://openalex.org/W4416840805","eid":"W4416840805"},{"id":"paper-w7155381343","cat":"papers","name":"Psychedelic-Assisted Psychotherapy: Paving Way for a New Approach to Treating Trauma in Law Enforcement","year":"2024","cit":0,"pfa":"Emily Rybak","psa":"Hopkins, Alexandra","topics":["PTSD & trauma","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7155381343","eid":"W7155381343"},{"id":"paper-w7154692523","cat":"papers","name":"Analysis Code: Pharmacokinetics and Receptor Mechanism Jointly Determine Thalamic Dynamical Signatures Across Five Drug Classes","year":"2026","cit":0,"pfa":"Ryan Malone","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"software","src":"https://openalex.org/W7154692523","eid":"W7154692523"},{"id":"paper-w2943550935","cat":"papers","name":"Psychedelic Medicine: Careful Studies, Regulations Are the Answer","year":"2019","cit":0,"pfa":"Paul Summergrad","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W2943550935","eid":"W2943550935"},{"id":"paper-w7133349014","cat":"papers","name":"Differential Effects of Acute and Chronic Fluoxetine on Psychedelic-Induced Behavior in Mice: Implications for Clinical Trials","year":"2026","cit":0,"pfa":"Bo Jarrett Wood","psa":"Kevin Sean Murnane","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7133349014","eid":"W7133349014"},{"id":"paper-w7171560614","cat":"papers","name":"Is BOLD Measurement-Invariant Across Pharmacological State? A Pre-Registered Test of Haemodynamic Response Function Drug-Invariance Using Simultaneous EEG-fMRI (PsiConnect)","year":"2026","cit":0,"pfa":"Kareem Soliman","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7171560614","eid":"W7171560614"},{"id":"paper-w2322825057","cat":"papers","name":"Evaluating Preference-Seeking and Aversive Qualities of Salvia divinorum and Mitragyna speciosa","year":"2013","cit":0,"pfa":"Melissa J. Loria","psa":"KJ Sufka","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2322825057","eid":"W2322825057"},{"id":"paper-w7132220122","cat":"papers","name":"Psilocybine vergeleken met escitalopram bij depressie","year":"2022","cit":0,"pfa":"Jurriaan F. M. Strous","topics":["Depression","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7132220122","eid":"W7132220122"},{"id":"paper-w2146547795","cat":"papers","name":"Pharmacology of amphetamine-type designer drugs","year":"2013","cit":0,"pfa":"Linda D. Simmler","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W2146547795","eid":"W2146547795"},{"id":"paper-w1522661265","cat":"papers","name":"Involvement of 5-HT2A Receptor in the Regulation of Hippocampal-Dependent Learning and Neurogenesis","year":"2008","cit":0,"pfa":"Briony J. Catlow","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W1522661265","eid":"W1522661265"},{"id":"paper-w4415646641","cat":"papers","name":"Psychedelics and Mysticism: Mapping Cultural Approaches","year":"2025","cit":0,"pfa":"Tatiana Tiaynen-Qadir","ptype":"book-chapter","src":"https://openalex.org/W4415646641","eid":"W4415646641"},{"id":"paper-w7140131017","cat":"papers","name":"Psychedelic-Assisted Psychotherapy: Attitudes of Law Enforcement and Military Personnel","year":"2026","cit":0,"pfa":"Alexandra Hopkins","psa":"Mia M. Ricardo","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W7140131017","eid":"W7140131017"},{"id":"paper-w7168426468","cat":"papers","name":"What are the current treatment options for managing cocaine craving?","year":"2026","cit":0,"pfa":"Tripdatabase","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7168426468","eid":"W7168426468"},{"id":"paper-w7154680670","cat":"papers","name":"Analysis Code: Pharmacokinetics and Receptor Mechanism Jointly Determine Thalamic Dynamical Signatures Across Five Drug Classes","year":"2026","cit":0,"pfa":"Ryan Malone","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"software","src":"https://openalex.org/W7154680670","eid":"W7154680670"},{"id":"paper-w7105986842","cat":"papers","name":"metapsy-project/data-depression-psiloctr: Version 25.1.1","year":"2025","cit":0,"pfa":"Parker Singleton","psa":"Brooke Sevchik","topics":["Depression","Safety & adverse events"],"ptype":"software","src":"https://openalex.org/W7105986842","eid":"W7105986842"},{"id":"paper-w4323320336","cat":"papers","name":"A young adult with first-episode psychosis: when to consider anti–N-methyl-D-aspartate receptor encephalitis","year":"2023","cit":0,"pfa":"Candace M. Marsters","psa":"Adrian Budhram","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4323320336","eid":"W4323320336"},{"id":"paper-w2993546923","cat":"papers","name":"Salvia divinorum, Herb of Mary, the Shepherdess","year":"1998","cit":0,"pfa":"Sean Whitcomb","ptype":"article","src":"https://openalex.org/W2993546923","eid":"W2993546923"},{"id":"paper-w7106266507","cat":"papers","name":"metapsy-project/data-depression-psiloctr: Version 25.1.2","year":"2025","cit":0,"pfa":"Parker Singleton","psa":"Brooke Sevchik","topics":["Depression","Safety & adverse events"],"ptype":"software","src":"https://openalex.org/W7106266507","eid":"W7106266507"},{"id":"paper-w7167390835","cat":"papers","name":"OUTSIGHT: The Greatest Thing that Never Happened in Psychedelia","year":"2025","cit":0,"pfa":"P. Sjöstedt-Hughes","ptype":"article","src":"https://openalex.org/W7167390835","eid":"W7167390835"},{"id":"paper-w4391297101","cat":"papers","name":"Psychedelika in der Depressionstherapie: Die schnelle Wirksamkeit ist nicht alles","year":"2024","cit":0,"pfa":"Friederike Klein","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4391297101","eid":"W4391297101"},{"id":"paper-w7154481656","cat":"papers","name":"One Substance, Multiple Legal Realities: Classification Cascades in the Psychedelic Medicine Transition","year":"2026","cit":0,"pfa":"H. Tamba","topics":["Depression","Addiction","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7154481656","eid":"W7154481656"},{"id":"paper-w2969635149","cat":"papers","name":"Pattern of Clinical and Toxicological Presentation of Amphetamine Derivative-Methylenedioxymeth-amphetamine Use and its Fatal Outcome in Adolescents and Young Adults in Riyadh, Saudi Arabia","year":"2014","cit":0,"pfa":"Sahar Moustafa","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2969635149","eid":"W2969635149"},{"id":"paper-w2012749316","cat":"papers","name":"Taking ecstasy on television: a show trial","year":"2012","cit":0,"pfa":"Margaret McCartney","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2012749316","eid":"W2012749316"},{"id":"paper-w7154889052","cat":"papers","name":"One Substance, Multiple Legal Realities: Classification Cascades in the Psychedelic Medicine Transition","year":"2026","cit":0,"pfa":"H. Tamba","topics":["Depression","Addiction","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7154889052","eid":"W7154889052"},{"id":"paper-w4231076228","cat":"papers","name":"Pharmacotherapy for Substance Use Disorders","year":"2019","cit":0,"topics":["Depression","Addiction","Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W4231076228","eid":"W4231076228"},{"id":"paper-w2759747897","cat":"papers","name":"Psychedelics: Finding a New Groove?","year":"2017","cit":0,"pfa":"Karl E. Steinberg","ptype":"article","src":"https://openalex.org/W2759747897","eid":"W2759747897"},{"id":"paper-w4403811997","cat":"papers","name":"UTILIZAÇÃO DE PSICODÉLICOS NO TRANSTORNO DEPRESSIVO REFRATÁRIO: UMA REVISÃO DE LITERATURA","year":"2024","cit":0,"pfa":"Claudio Mateus Gnoatto","psa":"Beatriz Pinheiro Borges Neta","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4403811997","eid":"W4403811997"},{"id":"paper-w4414749685","cat":"papers","name":"Simultaneous quantitative determination of 2-fluoro-2-oxo-phenylcyclohexylethylamine, methylenedioxymethamphetamine and ketamine in postmortem blood using liquid chromatography-tandem mass spectrometry","year":"2025","cit":0,"pfa":"Meejung Park","psa":"Jihyun Kim","ptype":"article","src":"https://openalex.org/W4414749685","eid":"W4414749685"},{"id":"paper-w4240262568","cat":"papers","name":"A draft sequence reference of the Psilocybe cubensis genome","year":"2021","cit":0,"pfa":"Kevin Judd McKernan","psa":"Stephen McLaughlin","ptype":"preprint","src":"https://openalex.org/W4240262568","eid":"W4240262568"},{"id":"paper-w2918650357","cat":"papers","name":"Is Psychedelic Medicine on the Horizon?","year":"2019","cit":0,"pfa":"Nick Zagorski","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W2918650357","eid":"W2918650357"},{"id":"paper-w7154574313","cat":"papers","name":"Volumetric dilution nasal spray as a harm reduction strategy for intranasal psychoactive substance use: a practical framework and rationale","year":"2026","cit":0,"pfa":"Alexandre DELFORGE","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W7154574313","eid":"W7154574313"},{"id":"paper-w4409064254","cat":"papers","name":"Repurposing of recreational drugs: will these new ‘medicines’ deliver short- or longer-term benefits for those with depressive or other mood disorders?","year":"2025","cit":0,"pfa":"Oscar De Juan","psa":"Allan Hunter Young","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"preprint","src":"https://openalex.org/W4409064254","eid":"W4409064254"},{"id":"paper-w7161965755","cat":"papers","name":"Psychedelic-Assisted Psychotherapy: Paving Way for a New Approach to Treating Trauma in Law Enforcement","year":"2024","cit":0,"pfa":"Cassandra A. Bailey","topics":["PTSD & trauma","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7161965755","eid":"W7161965755"},{"id":"paper-w3120630230","cat":"papers","name":"Ketamine’s Role in Spirituality: How One Synthetic Drug Catalyzes a Natural Experience","year":"2021","cit":0,"pfa":"Samiah Woods","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3120630230","eid":"W3120630230"},{"id":"paper-w7201832519","cat":"papers","name":"Advanced research eyes potential of psychedelics for complex cases","year":"2026","cit":0,"pfa":"Gary A. Enos","ptype":"article","src":"https://openalex.org/W7201832519","eid":"W7201832519"},{"id":"paper-w4390415455","cat":"papers","name":"The Effectiveness of Drug Treatment for Depressive Symptoms","year":"2023","cit":0,"pfa":"Xinya Xu","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4390415455","eid":"W4390415455"},{"id":"paper-w7120394865","cat":"papers","name":"Voltammetric analysis of the 3,4-methylenedioxymethamphetamine","year":"2013","cit":0,"pfa":"Túlio de Castro Agostinho","ptype":"dissertation","src":"https://openalex.org/W7120394865","eid":"W7120394865"},{"id":"paper-w7133048700","cat":"papers","name":"farmacología humana del dmt oral más harmina","year":"2001","cit":0,"pfa":"Jonathan Ott","psa":"Mariela Narváez Marín","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7133048700","eid":"W7133048700"},{"id":"paper-w7112869573","cat":"papers","name":"Undergraduate Students' Perceptions and Understanding of Psychedelic-Assisted Therapy","year":"2025","cit":0,"pfa":"McClure, Taylor","psa":"Kane, Jackson","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7112869573","eid":"W7112869573"},{"id":"paper-w7124245415","cat":"papers","name":"LSD 5-HT2A receptor occupancy and global functional connectivity effects","year":"2026","cit":0,"pfa":"Kristian Larsen","topics":["Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W7124245415","eid":"W7124245415"},{"id":"paper-w2762201188","cat":"papers","name":"Die psychedelische Medizin ist wieder da!","year":"2017","cit":0,"pfa":"Friederike Klein","ptype":"article","src":"https://openalex.org/W2762201188","eid":"W2762201188"},{"id":"paper-w2183569637","cat":"papers","name":"Review Clinical review: Major consequences of illicit drug consumption","year":"2008","cit":0,"pfa":"Robert J Devlin","psa":"John Aaron Henry","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2183569637","eid":"W2183569637"},{"id":"paper-w2610919655","cat":"papers","name":"Using the Theory of Planned Behavior to Predict Employing Harm Reduction Strategies Among Ecstasy Users","year":"2016","cit":0,"pfa":"Alan K. Davis","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2610919655","eid":"W2610919655"},{"id":"paper-w3017460213","cat":"papers","name":"Further studies on the mechanism of 3,4-methylenedioxymethamphetamine-induced serotonergic neurotoxicity","year":"1994","cit":0,"pfa":"Xuemei Huang","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W3017460213","eid":"W3017460213"},{"id":"paper-w4413284913","cat":"papers","name":"327. 5-HT2B RECEPTORS MODULATE THE ANTIDEPRESSANT-LIKE RESPONSE OF THE PSYCHEDELIC LSD IN RAT BUT NOT IN MICE","year":"2025","cit":0,"pfa":"Amel Bouloufa","psa":"Nasser Haddjeri","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4413284913","eid":"W4413284913"},{"id":"paper-w13247751","cat":"papers","name":"Ibogaino vartojimas toksikomanijoms gydyti. Neurocheminis ir farmakologinis veikimas","year":"2004","cit":0,"pfa":"Saulius Kazlauskas","psa":"Audrius Sveikata","ptype":"article","src":"https://openalex.org/W13247751","eid":"W13247751"},{"id":"paper-w2295865919","cat":"papers","name":"[Microscopic study of powders of hallucinogenic mushrooms--Psilocybe sp].","year":"2000","cit":0,"pfa":"A T Schäfer","ptype":"article","src":"https://openalex.org/W2295865919","eid":"W2295865919"},{"id":"paper-w7154622386","cat":"papers","name":"Volumetric dilution nasal spray as a harm reduction strategy for intranasal psychoactive substance use: a practical framework and rationale","year":"2026","cit":0,"pfa":"Alexandre DELFORGE","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W7154622386","eid":"W7154622386"},{"id":"paper-w7141378025","cat":"papers","name":"Other Clinical Applications for Psychedelics and Final Conclusions","year":"2018","cit":0,"topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"report","src":"https://openalex.org/W7141378025","eid":"W7141378025"},{"id":"paper-w2413566726","cat":"papers","name":"[Differences in the action of serotonin 1A-receptor agonists on rotating behavior or rats with unilaterally raphe-lesioned rats].","year":"1993","cit":0,"pfa":"N A Bondarenko","psa":"T A Voronina","topics":["Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W2413566726","eid":"W2413566726"},{"id":"paper-w7135320376","cat":"papers","name":"Microdosing in Reality: An exploration of psychedelic microdosing in Aotearoa, New Zealand","year":"2025","cit":0,"pfa":"Estelle Harrison Miller","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7135320376","eid":"W7135320376"},{"id":"paper-w1585200626","cat":"papers","name":"Gastrointestinal Diseases Associated with Substance Addiction","year":"2010","cit":0,"pfa":"Paul Haber","psa":"Abdullah Demirkol","topics":["Addiction"],"ptype":"other","src":"https://openalex.org/W1585200626","eid":"W1585200626"},{"id":"paper-w4409087880","cat":"papers","name":"The neurons that mediate a psychedelic’s long-term antidepressive effects","year":"2025","cit":0,"topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4409087880","eid":"W4409087880"},{"id":"paper-w7164736485","cat":"papers","name":"Acute Hallucinogen Intoxication Following Ingestion of a Commercially Available Mushroom Extract Product: A Case Report","year":"2026","cit":0,"pfa":"Akemini J Udoro","psa":"Derek Hunt","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7164736485","eid":"W7164736485"},{"id":"paper-w7214985226","cat":"papers","name":"Psychedelics Shift Decision Strategies and Reconfigure Orbitofrontal Dynamics","year":"2026","cit":0,"pfa":"Cristina Delgado-Sallent","psa":"Anosha Khawaja-Lopez","topics":["Mechanism & neuroscience"],"ptype":"dataset","src":"https://openalex.org/W7214985226","eid":"W7214985226"},{"id":"paper-w7168039935","cat":"papers","name":"UK Practitioner Psychologists' Knowledge and Harm Assessment of Psychedelics: A Cross-Sectional Study","year":"2026","cit":0,"pfa":"John Moriarty","psa":"Alison Pocock","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W7168039935","eid":"W7168039935"},{"id":"paper-w7154153256","cat":"papers","name":"Psychiatric treatment: breaking new ground?","year":"2026","cit":0,"pfa":"David P. Lichtenstein","ptype":"article","src":"https://openalex.org/W7154153256","eid":"W7154153256"},{"id":"paper-w7124307463","cat":"papers","name":"LSD 5-HT2A receptor occupancy and global functional connectivity effects","year":"2026","cit":0,"pfa":"Kristian Larsen","topics":["Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W7124307463","eid":"W7124307463"},{"id":"paper-w7172474975","cat":"papers","name":"VOICE Optimize Trial","year":"2026","cit":0,"pfa":"Deanna M Kaplan","topics":["Depression","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7172474975","eid":"W7172474975"},{"id":"paper-w7154467934","cat":"papers","name":"One Substance, Multiple Legal Realities: Classification Cascades in the Psychedelic Medicine Transition","year":"2026","cit":0,"pfa":"H. Tamba","topics":["Depression","Addiction","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7154467934","eid":"W7154467934"},{"id":"paper-w7214984082","cat":"papers","name":"Psychedelics Shift Decision Strategies and Reconfigure Orbitofrontal Dynamics","year":"2026","cit":0,"pfa":"Cristina Delgado-Sallent","psa":"Anosha Khawaja-Lopez","topics":["Mechanism & neuroscience"],"ptype":"dataset","src":"https://openalex.org/W7214984082","eid":"W7214984082"},{"id":"paper-w2994835088","cat":"papers","name":"Social risk factors in the aetiology, maintenance and treatment of opioid use disorder","year":"2019","cit":0,"pfa":"Molly Carlyle","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W2994835088","eid":"W2994835088"},{"id":"paper-w2033011721","cat":"papers","name":"Antidepressant Secondary Metabolites from Three Florida Sponges","year":"2008","cit":0,"pfa":"Anna J. Kochanowska","psa":"Mark T. Hamann","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2033011721","eid":"W2033011721"},{"id":"paper-w73151161","cat":"papers","name":"Legal Loophole Means Legal Hallucinogens","year":"2000","cit":0,"pfa":"Miles Standish","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W73151161","eid":"W73151161"},{"id":"paper-w7135519575","cat":"papers","name":"Krystalizační studie tryptofan syntasy TrpB z \\kur{Psilocybe cubensis}","year":"2021","cit":0,"pfa":"Anna Koutská","topics":["Depression"],"ptype":"dissertation","src":"https://openalex.org/W7135519575","eid":"W7135519575"},{"id":"paper-w7115074278","cat":"papers","name":"What are the common pharmacological treatments for managing PTSD in patients with drug dependence?","year":"2025","cit":0,"pfa":"Tripdatabase","topics":["PTSD & trauma","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7115074278","eid":"W7115074278"},{"id":"paper-w4367309647","cat":"papers","name":"Cultes spirituels et psychotropes : ethnotoxicologie appliquée à des échantillons centenaires d’ayahuasca, de peyotl et de vin Mariani","year":"2023","cit":0,"pfa":"Nadia Arbouche","psa":"Pascal Kintz","ptype":"article","src":"https://openalex.org/W4367309647","eid":"W4367309647"},{"id":"paper-w4321033113","cat":"papers","name":"Psychedelic Renaissance: Clinical Health Justice, Patient Safety, and Equity Need to Be Put First","year":"2023","cit":0,"pfa":"Jacques Ambrose","psa":"Jeffrey Zabinski","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4321033113","eid":"W4321033113"},{"id":"paper-w4249792125","cat":"papers","name":"Anxiety and depression in childhood may raise risk of ecstasy use","year":"2006","cit":0,"pfa":"British Medical Journal Publishing Group","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4249792125","eid":"W4249792125"},{"id":"paper-w4376115172","cat":"papers","name":"New psychoactive substances: kratom, DMT, serotonergic hallucinogens, dissociative drugs. The mechanism of action, psychoactive effects","year":"2023","cit":0,"pfa":"Andrey Viktorovich Antsyborov","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4376115172","eid":"W4376115172"},{"id":"paper-w4407147141","cat":"papers","name":"Tripping on Utopia: Margaret Mead, the Cold War, and the Troubled Birth of Psychedelic Science. By BenjaminBreen, New York, USA: Grand Central Publishing, 2024, ISBN: 9781538722374","year":"2025","cit":0,"pfa":"Andrea Ens","topics":["Addiction","Safety & adverse events"],"ptype":"book-review","src":"https://openalex.org/W4407147141","eid":"W4407147141"},{"id":"paper-w7214918198","cat":"papers","name":"Psychedelics Shift Decision Strategies and Reconfigure Orbitofrontal Dynamics","year":"2026","cit":0,"pfa":"Cristina Delgado-Sallent","psa":"Anosha Khawaja-Lopez","topics":["Mechanism & neuroscience"],"ptype":"dataset","src":"https://openalex.org/W7214918198","eid":"W7214918198"},{"id":"paper-w4409279932","cat":"papers","name":"Precision Functional Mapping of Psilocybin’s Acute and Persistent Brain Effects","year":"2025","cit":0,"pfa":"Subha Subramanian","psa":"Joshua S. Siegel","ptype":"article","src":"https://openalex.org/W4409279932","eid":"W4409279932"},{"id":"paper-w4416158591","cat":"papers","name":"Acute Kidney Failure and Myocarditis Triggered by Magic Mushroom Toxicity in a Patient With Prior Cocaine Exposure","year":"2025","cit":0,"pfa":"Aung Phyo Oo","psa":"Arvind Ponnusamy","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4416158591","eid":"W4416158591"},{"id":"paper-w7198019554","cat":"papers","name":"Histological Assessment of Stress-Associated Changes in DMN-Relevant Regions of Mice Examined After Post-Acute LSD Exposure","year":"2026","cit":0,"pfa":"Miilia Selina Viveka Sundell","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7198019554","eid":"W7198019554"},{"id":"paper-w7138182287","cat":"papers","name":"Unveiling the psychedelic mind: a cognitive linguistic study of metaphor use in mystical experience recounts","year":"2024","cit":0,"pfa":"Juan Alvarado","topics":["Addiction","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7138182287","eid":"W7138182287"},{"id":"paper-w4413313887","cat":"papers","name":"155. EXPLORING LSD MICRODOSING IN AN OPEN-LABEL PILOT FOR MAJOR DEPRESSIVE DISORDER: THE INTERPLAY OF BEHAVIORAL ACTIVATION, MOOD IMPROVEMENT, AND CONNECTEDNESS","year":"2025","cit":0,"pfa":"Carina Joy Donegan","psa":"L Reynolds","topics":["Depression","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4413313887","eid":"W4413313887"},{"id":"paper-w2560727644","cat":"papers","name":"Psychedelic drug helps depression","year":"2016","cit":0,"pfa":"Kevin Franciotti","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2560727644","eid":"W2560727644"},{"id":"paper-w2585413301","cat":"papers","name":"Psychedelic Research Resurrected: The Contributions of Stanislav Grof","year":"2014","cit":0,"pfa":"Charles S. Grob","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2585413301","eid":"W2585413301"},{"id":"paper-w4416607165","cat":"papers","name":"Peer Review Report For: A draft sequence reference of the Psilocybe cubensis genome [version 1; peer review: 1 approved, 1 approved with reservations]","year":"2021","cit":0,"pfa":"Kevin Judd McKernan","psa":"Stephen McLaughlin","topics":["Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4416607165","eid":"W4416607165"},{"id":"paper-w2890427274","cat":"papers","name":"A narrative inquiry into the experiences of recovering drug addicts","year":"2017","cit":0,"pfa":"Fatima Kurtha","topics":["Addiction"],"ptype":"dissertation","src":"https://openalex.org/W2890427274","eid":"W2890427274"},{"id":"paper-w7115068715","cat":"papers","name":"What are the common pharmacological treatments for managing PTSD in patients with drug dependence?","year":"2025","cit":0,"pfa":"Tripdatabase","topics":["PTSD & trauma","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7115068715","eid":"W7115068715"},{"id":"paper-w2045676153","cat":"papers","name":"Researchers Look to Ecstasy as PTSD Therapy Option","year":"2010","cit":0,"pfa":"Aaron R. Levin","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W2045676153","eid":"W2045676153"},{"id":"paper-w7167926471","cat":"papers","name":"Psychedelics produce enduring enhancement of reward responsiveness in male rats","year":"2026","cit":0,"pfa":"Christopher W. Thomas","psa":"Brian D. Kangas","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7167926471","eid":"W7167926471"},{"id":"paper-w7155600025","cat":"papers","name":"157. Opposing 5-HT Receptors Modulate Psilocybin's Action on Dendritic Calcium Dynamics","year":"2026","cit":0,"pfa":"Neil K. Savalia","psa":"Alex Kwan","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7155600025","eid":"W7155600025"},{"id":"paper-w7203716633","cat":"papers","name":"CarolGachema/TCGA-PAAD-NTRK: Neurotrophin Receptor Expression in Pancreatic Cancer (TCGA-PAAD)","year":"2026","cit":0,"pfa":"Caroline","topics":["Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"software","src":"https://openalex.org/W7203716633","eid":"W7203716633"},{"id":"paper-w7155045310","cat":"papers","name":"Specific and Multi‐Product Clade I and Clade IV Sesquiterpene Synthases Contribute to the Psilocybe cubensis Volatilome","year":"2026","cit":0,"pfa":"Sebastian Schober","psa":"Dirk Hoffmeister","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7155045310","eid":"W7155045310"},{"id":"paper-w7115175393","cat":"papers","name":"Champignons magiques, effets bien réels : la psilocybine bouscule la médecine moderne","year":"2025","cit":0,"pfa":"simoneterreri","ptype":"other","src":"https://openalex.org/W7115175393","eid":"W7115175393"},{"id":"paper-w2340390370","cat":"papers","name":"Harmine stimulates neurogenesis of human neural cells in vitro","year":"2016","cit":0,"pfa":"Vanja Dakic","psa":"Stevens Kastrup Rehen","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W2340390370","eid":"W2340390370"},{"id":"paper-w7125809589","cat":"papers","name":"A Dried Spot Liquid Chromatography Method to Measure 3,4-Methylenedioxymethamphetamine and 3,4-Methylenedioxyamphetamine in Oral Fluid","year":"2026","cit":0,"pfa":"Leandro Oka Duarte","psa":"Marcelo Firmino de Oliveira","ptype":"article","src":"https://openalex.org/W7125809589","eid":"W7125809589"},{"id":"paper-w4310474280","cat":"papers","name":"Bioanalytical LC-MS/MS procedures and their applications in preclinical pharmacokinetic studies of selected opiates and novel anticancer agents","year":"2022","cit":0,"pfa":"Paniz Heydari","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W4310474280","eid":"W4310474280"},{"id":"paper-w2416762474","cat":"papers","name":"[Psychiatric and cognitive long-term effects of ecstasy].","year":"2006","cit":0,"pfa":"Gudrun Høiseth","psa":"Liliana C. Bachs","topics":["Reviews & meta-analyses"],"ptype":"other","src":"https://openalex.org/W2416762474","eid":"W2416762474"},{"id":"paper-w7117132196","cat":"papers","name":"Psychedelic pathways: Exploring reinforcement learning under psychedelic influence","year":"2025","cit":0,"pfa":"Federico Cavanna","psa":"Enzo Tagliazucchi","topics":["Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W7117132196","eid":"W7117132196"},{"id":"paper-w4247069835","cat":"papers","name":"Reporting On Adverse Clinical Events","year":"1998","cit":0,"topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4247069835","eid":"W4247069835"},{"id":"paper-w4299978884","cat":"papers","name":"Psychedelics","year":"2020","cit":0,"pfa":"David E. Nichols","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4299978884","eid":"W4299978884"},{"id":"paper-w7203708522","cat":"papers","name":"CarolGachema/TCGA-PAAD-NTRK: Neurotrophin Receptor Expression in Pancreatic Cancer (TCGA-PAAD)","year":"2026","cit":0,"pfa":"Caroline","topics":["Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"software","src":"https://openalex.org/W7203708522","eid":"W7203708522"},{"id":"paper-w2317635613","cat":"papers","name":"Development of an immunochemical differentiation method for Salvia divinorum","year":"2012","cit":0,"pfa":"MK Paudel","psa":"Seiji Morimoto","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2317635613","eid":"W2317635613"},{"id":"paper-w2390415571","cat":"papers","name":"The simultaneous analysis of morphine,amphetamines and ketamine in whole blood by SPE/UPLC","year":"2011","cit":0,"pfa":"XU Shu-yun","ptype":"article","src":"https://openalex.org/W2390415571","eid":"W2390415571"},{"id":"paper-w2418417159","cat":"papers","name":"[The ethnopharmacology of hallucinogens: from \"primitive rites\" to their \"presence\" on TV. Proposals for the year 2000].","year":"1996","cit":0,"pfa":"Franco Cugurra","topics":["Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W2418417159","eid":"W2418417159"},{"id":"paper-w7165195325","cat":"papers","name":"Psychedelics, the media portrayal and large-language model evaluations","year":"2026","cit":0,"pfa":"Catherine L. Taylor Clelland","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W7165195325","eid":"W7165195325"},{"id":"paper-w4308313978","cat":"papers","name":"Experts assess role of therapists in psychedelic‐assisted therapy","year":"2022","cit":0,"pfa":"Valerie A. Canady","topics":["Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4308313978","eid":"W4308313978"},{"id":"paper-w7155640787","cat":"papers","name":"717. Safety and Tolerability of Intravenous Bolus and Constant Infusion of DMT in Individuals With Major Depressive Disorder and Healthy Controls","year":"2026","cit":0,"pfa":"Prakash Gupta","psa":"Deepak D'Souza","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7155640787","eid":"W7155640787"},{"id":"paper-w3119905122","cat":"papers","name":"Nicolas Langlitz, Neuropsychedelia. The revival of hallucinogen research since the Decade of the brain","year":"2017","cit":0,"pfa":"Milana Aronov","topics":["Addiction"],"ptype":"review","src":"https://openalex.org/W3119905122","eid":"W3119905122"},{"id":"paper-w4414181181","cat":"papers","name":"Pharmacological treatments for eating disorders – How far are we from new solutions?","year":"2025","cit":0,"pfa":"Victor A. Voicu","psa":"Octavian Vasiliu","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4414181181","eid":"W4414181181"},{"id":"paper-w7203860442","cat":"papers","name":"Exploring the Therapeutic Potential of DMT as an Antipsychotic: A Comprehensive Review","year":"2023","cit":0,"pfa":"Lalit Singh","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7203860442","eid":"W7203860442"},{"id":"paper-w7203880077","cat":"papers","name":"Exploring the Therapeutic Potential of DMT as an Antipsychotic: A Comprehensive Review","year":"2023","cit":0,"pfa":"Lalit Singh","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7203880077","eid":"W7203880077"},{"id":"paper-w4409873296","cat":"papers","name":"LSD atom swap tunes out the trip","year":"2025","cit":0,"pfa":"Bethany A. Halford","topics":["Depression","PTSD & trauma"],"ptype":"other","src":"https://openalex.org/W4409873296","eid":"W4409873296"},{"id":"paper-w4410801966","cat":"papers","name":"Educational materials and image induction increase treatment credibility","year":"2022","cit":0,"pfa":"Zi Ling Fiona Low","topics":["Depression"],"ptype":"dissertation","src":"https://openalex.org/W4410801966","eid":"W4410801966"},{"id":"paper-w7141560193","cat":"papers","name":"Psychedelic-Assisted Therapies for Anxiety and Alcohol Use Disorder (AUD)","year":"2024","cit":0,"topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"report","src":"https://openalex.org/W7141560193","eid":"W7141560193"},{"id":"paper-w4400572968","cat":"papers","name":"Rethinking Therapeutic Strategies for Anorexia Nervosa: Insights From Psychedelic Medicine and Animal Models","year":"2024","cit":0,"pfa":"Claire J. Foldi","psa":"Brian J. Oldfield","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4400572968","eid":"W4400572968"},{"id":"paper-w4250881037","cat":"papers","name":"Reporting On Adverse Clinical Events","year":"1998","cit":0,"topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4250881037","eid":"W4250881037"},{"id":"paper-w2223270638","cat":"papers","name":"MDMA:A Modular Distributed Middleware Architecture via URI","year":"2005","cit":0,"pfa":"Syed Shariyar Murtaza","psa":"Choong Seon Hong","ptype":"article","src":"https://openalex.org/W2223270638","eid":"W2223270638"},{"id":"paper-w7167717094","cat":"papers","name":"Psychedelia","year":"2021","cit":0,"pfa":"Sarah Siddiqui","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7167717094","eid":"W7167717094"},{"id":"paper-w7127244864","cat":"papers","name":"Current Psychological and Pharmacological Therapies and Emergent Treatment Modalities in Anorexia Nervosa","year":"2025","cit":0,"pfa":"Carly R Kliment","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7127244864","eid":"W7127244864"},{"id":"paper-w4252683877","cat":"papers","name":"Hallucinogens","year":"1985","cit":0,"pfa":"John Smythies","ptype":"book-chapter","src":"https://openalex.org/W4252683877","eid":"W4252683877"},{"id":"paper-w4413284175","cat":"papers","name":"670. CAN WE RE-MEDICALISE THE PSYCHEDELIC EXPERIENCE?","year":"2025","cit":0,"pfa":"Guy M. Goodwin","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4413284175","eid":"W4413284175"},{"id":"paper-w7155615587","cat":"papers","name":"131. Hemodynamic and Neural Effects of Psychedelics on Mice and Men","year":"2026","cit":0,"pfa":"Jonah A. Padawer-Curry","psa":"Adam Q. Bauer","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7155615587","eid":"W7155615587"},{"id":"paper-w7214797837","cat":"papers","name":"A Quantitative Analysis of Street‐Level Drugs Seized in New South Wales, Australia: Purity, Dose and Adulterants","year":"2026","cit":0,"pfa":"Janette L. Smith","psa":"Thanjira Jiranantakan","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7214797837","eid":"W7214797837"},{"id":"paper-w1523194659","cat":"papers","name":"Drugs of abuse modulate dopaminergic neurotransmission : effects on exocytosis and neurotransmitter receptor function","year":"2011","cit":0,"pfa":"Laura Hondebrink","topics":["Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W1523194659","eid":"W1523194659"},{"id":"paper-w7122597626","cat":"papers","name":"Chemical Design and Pharmacokinetics Enable Precision Psychedelic Therapeutics","year":"2026","cit":0,"pfa":"Anna C. Renner","psa":"Robert B. Kargbo","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"editorial","src":"https://openalex.org/W7122597626","eid":"W7122597626"},{"id":"paper-w1905734479","cat":"papers","name":"Los receptores nicotínicos neuronales: una nueva diana regulada por los derivados anfetamínicos e implicada en su neurotoxicidad","year":"2012","cit":0,"pfa":"David Pubill","psa":"Jordi Camarasa","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1905734479","eid":"W1905734479"},{"id":"paper-w4414180393","cat":"papers","name":"MM120 demonstrates no evidence of abuse potential in rodent preclinical studies","year":"2025","cit":0,"pfa":"J. Tripp","psa":"Gennady N. Smagin","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4414180393","eid":"W4414180393"},{"id":"paper-w7128978701","cat":"papers","name":"Fatal Mechanical Asphyxia Due to Glottic Obstruction in a Body- Stuffer with Methylenedioxymethamphetamine Exposure: A Case Report","year":"2026","cit":0,"pfa":"Mohammed Amine Daerqaoui","psa":"Hicham Benyaich","topics":["PTSD & trauma","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7128978701","eid":"W7128978701"},{"id":"paper-w2553910025","cat":"papers","name":"Lung injuries after narcotic overdose. Usefulness of MDCT and MRI","year":"2015","cit":0,"pfa":"Tamara Milosavljević","psa":"Stevan Ivković","topics":["Addiction","Reviews & meta-analyses","Policy & ethics"],"ptype":"conference-abstract","src":"https://openalex.org/W2553910025","eid":"W2553910025"},{"id":"paper-w7199400403","cat":"papers","name":"Psychedelics In General Medicine: Use of DMT In Treatment Of Ischemic-Reperfusion Injury.","year":"2022","cit":0,"pfa":"Ebieladoh Olusola Ebikibina-Oti","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7199400403","eid":"W7199400403"},{"id":"paper-w7213964948","cat":"papers","name":"Reply to ‘Methodological concerns and interpretative limitations of assessing subjective effects of ketamine’","year":"2026","cit":0,"pfa":"Jack D. C. Dahan","psa":"Albert Dahan","topics":["Reviews & meta-analyses","Therapy practice"],"ptype":"letter","src":"https://openalex.org/W7213964948","eid":"W7213964948"},{"id":"paper-w4388365459","cat":"papers","name":"MODULATION OF SYNAPTIC FUNCTION AND NEURONAL NETWORK ACTIVITY BY SEROTONERGIC PSYCHEDELICS","year":"2023","cit":0,"pfa":"Aneta Petrušková","psa":"Anna Fejtová","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4388365459","eid":"W4388365459"},{"id":"paper-w4378619847","cat":"papers","name":"A nomenclatural review of the name Echinocactus williamsii (Lophophora williamsii): Correct author and year of publication","year":"2023","cit":0,"pfa":"Joel Calvo","psa":"Guillermo A. Benitez","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4378619847","eid":"W4378619847"},{"id":"paper-w4406135229","cat":"papers","name":"Detailing a Pilot Study: The \"Code of Reality\" Protocol, A Phenomenon of N,N-DMT Induced States of Consciousness","year":"2025","cit":0,"pfa":"Danny Goler","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4406135229","eid":"W4406135229"},{"id":"paper-w4409054412","cat":"papers","name":"Psilocybe cubensis y Panaeolus cyanescens (Basidiomycota, Agaricales), dos especies de hongos alucinógenos en el NE de Argentina","year":"2025","cit":0,"pfa":"Adriana Judit Batista","psa":"Nicolás Niveiro","ptype":"article","src":"https://openalex.org/W4409054412","eid":"W4409054412"},{"id":"paper-w514695","cat":"papers","name":"Clinical pharmacology and toxicology of ecstasy","year":"2003","cit":0,"pfa":"Laurent Simon","psa":"François‐Régis Cousin","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W514695","eid":"W514695"},{"id":"paper-w2589220055","cat":"papers","name":"Vliv psilocybinu na mismatch negativity v serotonergním modelu schizofrenie","year":"2016","cit":0,"pfa":"Stanislav Milotinský","topics":["Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W2589220055","eid":"W2589220055"},{"id":"paper-w7160931542","cat":"papers","name":"Depressions- und Angstsymptome nach psychedelisch-assistierter Psychotherapie bei therapieresistenter Depression: retrospektive Routinedatenanalyse mit vs. ohne komorbide Substanzkonsumstörung","year":"2026","cit":0,"pfa":"Louise E. Penzenstadler","psa":"DANIELE FABIO ZULLINO","topics":["Depression","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7160931542","eid":"W7160931542"},{"id":"paper-w7135478414","cat":"papers","name":"Annotated translation: POLLAN, Michael: How to Change Your Mind : The New Science of Psychedelics. Penguin Books, 2019, pp. 331-351.","year":"2025","cit":0,"pfa":"Klára Chleborádová","ptype":"dissertation","src":"https://openalex.org/W7135478414","eid":"W7135478414"},{"id":"paper-w3093740210","cat":"papers","name":"Drug abuse and addiction in the view of self psychology","year":"2020","cit":0,"pfa":"David Potik","topics":["Addiction","Reviews & meta-analyses","Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W3093740210","eid":"W3093740210"},{"id":"paper-w2947831201","cat":"papers","name":"Intérêt de la psilocybine, de l'acide lysergique diéthylamide (LSD) et de la diméthyltryptamine (DMT) dans la dépression : une revue de la littérature","year":"2019","cit":0,"pfa":"Sami Sergent","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2947831201","eid":"W2947831201"},{"id":"paper-w2550605816","cat":"papers","name":"An examination of the effects of Salvia divinorum fortification on stable isotope ratios","year":"2016","cit":0,"pfa":"David Anthony Barajas","topics":["Addiction"],"ptype":"dissertation","src":"https://openalex.org/W2550605816","eid":"W2550605816"},{"id":"paper-w4415451281","cat":"papers","name":"SAT-044 Neurophysin I: A Reliable, Novel, and Robust Biomarker for OxytocinAn Analysis of a Double-Blind Placebo-Controlled Cross-Over Trial","year":"2025","cit":0,"pfa":"Cihan Atila","psa":"Mirjam Christ‐Crain","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4415451281","eid":"W4415451281"},{"id":"paper-w7165159877","cat":"papers","name":"Beliefs in and experiences of sorcery, black magic and brujería among psychedelic users: a quantitative and qualitative survey","year":"2026","cit":0,"pfa":"Jules Evans","psa":"Kim I. M. van Oorsouw","topics":["Safety & adverse events","Reviews & meta-analyses","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7165159877","eid":"W7165159877"},{"id":"paper-w7168520408","cat":"papers","name":"nnDMT CH Abort Dose Estimator","year":"2026","cit":0,"pfa":"[FIRST NAME] [LAST NAME]","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"software","src":"https://openalex.org/W7168520408","eid":"W7168520408"},{"id":"paper-w7155952512","cat":"papers","name":"Pharmacokinetics and Receptor Mechanism Are Associated with Distinct Thalamic Dynamical Signatures Across Five Drug Classes: A Resting-State fMRI Investigation","year":"2026","cit":0,"pfa":"Ryan Malone","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7155952512","eid":"W7155952512"},{"id":"paper-w3126498647","cat":"papers","name":"Chapter 15. Neurobiology and Treatment of Hallucinogen Use Disorder","year":"2021","cit":0,"pfa":"Elias Dakwar","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"book-chapter","src":"https://openalex.org/W3126498647","eid":"W3126498647"},{"id":"paper-w4283528627","cat":"papers","name":"MSR20 Challenges in the Development of Economic Evaluations for Psychedelics in Treatment of Depression","year":"2022","cit":0,"pfa":"John Schneider","psa":"K Beltran","topics":["Depression"],"ptype":"conference-abstract","src":"https://openalex.org/W4283528627","eid":"W4283528627"},{"id":"paper-w3191586454","cat":"papers","name":"Pharmacology and Neurotoxicity of 5-MeO-DIPT","year":"2021","cit":0,"pfa":"Krystyna Gołembiowska","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W3191586454","eid":"W3191586454"},{"id":"paper-w3216344082","cat":"papers","name":"Psychedelic Drugs for Mental Disorders and Human Potential: Placebo or Panacea","year":"2021","cit":0,"pfa":"David J. Hellerstein","psa":"Jeffrey Alan Lieberman","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"other","src":"https://openalex.org/W3216344082","eid":"W3216344082"},{"id":"paper-w2547987323","cat":"papers","name":"Vibrational spectra of ketamine hydrochloride and 3, 4-methylene-dioxymethamphetamine in THz range","year":"2007","cit":0,"pfa":"Guangqin Wang","psa":"Yan Jia","ptype":"conference-paper","src":"https://openalex.org/W2547987323","eid":"W2547987323"},{"id":"paper-w4407387280","cat":"papers","name":"THE PROTOTYPICAL PSYCHEDELIC AGENT LSD PRODUCES RAPID ANTIDEPRESSANT EFFECTS VIA 5-HT2B RECEPTOR ACTIVATION","year":"2025","cit":0,"pfa":"Amel Bouloufa","psa":"Nasser Haddjeri","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4407387280","eid":"W4407387280"},{"id":"paper-w7125815202","cat":"papers","name":"Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non‑microdosers","year":"2021","cit":0,"pfa":"Joseph M. Rootman","psa":"Zach Walsh","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7125815202","eid":"W7125815202"},{"id":"paper-w7152420595","cat":"papers","name":"Le LSD revisité : mécanismes d’action et potentiel en santé mentale","year":"2026","cit":0,"pfa":"Amel Bouloufa","psa":"Nasser Haddjeri","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7152420595","eid":"W7152420595"},{"id":"paper-w2029029863","cat":"papers","name":"P-41 - The psychological repercussion of salvia divinorum, legal acid: case reports","year":"2012","cit":0,"pfa":"Sanjay H Shah","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"conference-abstract","src":"https://openalex.org/W2029029863","eid":"W2029029863"},{"id":"paper-w4313399653","cat":"papers","name":"Pharmacology and Neurotoxicity of 5-MeO-DIPT","year":"2022","cit":0,"pfa":"Krystyna Gołembiowska","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W4313399653","eid":"W4313399653"},{"id":"paper-w4401735139","cat":"papers","name":"Exploring the Therapeutic Potential of Entheogens in Postoperative Cognitive Decline and Psychological Resilience","year":"2024","cit":0,"pfa":"Robert B. Kargbo","topics":["Addiction","Mechanism & neuroscience"],"ptype":"editorial","src":"https://openalex.org/W4401735139","eid":"W4401735139"},{"id":"paper-w4399442469","cat":"papers","name":"Ketamine in severe, highly treatment-resistant depression—a retrospective case study and a perspective","year":"2024","cit":0,"pfa":"Mika Turkia","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"preprint","src":"https://openalex.org/W4399442469","eid":"W4399442469"},{"id":"paper-w7168096739","cat":"papers","name":"National bill seeks to jump‐start psychedelic treatment for veterans","year":"2026","cit":0,"pfa":"Gary A. Enos","topics":["Depression","PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W7168096739","eid":"W7168096739"},{"id":"paper-w7155794898","cat":"papers","name":"Pharmacokinetics and Receptor Mechanism Are Associated with Distinct Thalamic Dynamical Signatures Across Five Drug Classes: A Resting-State fMRI Investigation","year":"2026","cit":0,"pfa":"Ryan Malone","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7155794898","eid":"W7155794898"},{"id":"paper-w4388931546","cat":"papers","name":"Development of a Digital Intervention for Psychedelic Preparation (DIPP): a theory- and person-centred approach","year":"2023","cit":0,"pfa":"Rosalind G. McAlpine","psa":"Sunjeev K. Kamboj","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4388931546","eid":"W4388931546"},{"id":"paper-w7124701529","cat":"papers","name":"Correction to “Anthropology of Psychedelics”","year":"2026","cit":0,"ptype":"erratum","src":"https://openalex.org/W7124701529","eid":"W7124701529"},{"id":"paper-w7169077711","cat":"papers","name":"nnDMT CH Abort Dose Estimator","year":"2026","cit":0,"pfa":"[FIRST NAME] [LAST NAME]","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"software","src":"https://openalex.org/W7169077711","eid":"W7169077711"},{"id":"paper-w4248005752","cat":"papers","name":"Neuropharmacology.","year":"1960","cit":0,"pfa":"Charles B. Pittinger","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4248005752","eid":"W4248005752"},{"id":"paper-w2793677349","cat":"papers","name":"Can psychedelic drug help with depression?","year":"2018","cit":0,"pfa":"Jessica Hamzelou","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2793677349","eid":"W2793677349"},{"id":"paper-w4406683455","cat":"papers","name":"MOLECULES OF CONSCIOUSNESS: THE ROLE OF NEUROTRANSMITTERS IN PSYCHIATRY AND SPIRITUAL EXPERIENCES","year":"2024","cit":0,"pfa":"Maruke Yeghiyan","psa":"D.A. Palyan","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4406683455","eid":"W4406683455"},{"id":"paper-w4416204435","cat":"papers","name":"Beyond the Clinic: Psychedelics and Indigenous Healing in Modern Psychology","year":"2025","cit":0,"pfa":"Ramesah Qayyum","ptype":"preprint","src":"https://openalex.org/W4416204435","eid":"W4416204435"},{"id":"paper-w7156231569","cat":"papers","name":"A Seven-Layer Brain Architecture Framework Reveals Distinct Thalamic Dynamical Regimes Across Five Pharmacological Classes","year":"2026","cit":0,"pfa":"Ryan Malone","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7156231569","eid":"W7156231569"},{"id":"paper-w4414552759","cat":"papers","name":"‘So many relationships in the room’: Participant perspectives on the affordances and challenges of co‐therapy in psychedelic assisted therapy","year":"2026","cit":0,"pfa":"Rachel Ham","psa":"Paul Liknaitzky","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4414552759","eid":"W4414552759"},{"id":"paper-w7156362106","cat":"papers","name":"A Seven-Layer Brain Architecture Framework Reveals Distinct Thalamic Dynamical Regimes Across Five Pharmacological Classes","year":"2026","cit":0,"pfa":"Ryan Malone","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7156362106","eid":"W7156362106"},{"id":"paper-w4412912485","cat":"papers","name":"Exploring Microdosing Psychedelics as a Self-Managed Treatment for Premenstrual Dysphoric Disorder: A Qualitative Study","year":"2025","cit":0,"pfa":"Rachael L. Sumner","psa":"Suresh D Muthukumaraswamy","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4412912485","eid":"W4412912485"},{"id":"paper-w4323351497","cat":"papers","name":"Psychedelics for Medicinal Use: How Will This Alter the Collective Laboratory Consciousness?","year":"2023","cit":0,"pfa":"Steven W. Cotten","psa":"Frank Wiegand","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4323351497","eid":"W4323351497"},{"id":"paper-w7215643515","cat":"papers","name":"THE NEUROBIOLOGY OF DEPRESSION AND NEW TREATMENT STRATEGIES: UNLOCKING THE MIND’S HIDDEN BATTLES","year":"2025","cit":0,"pfa":"Tulayev Bobur Zoyir ugli , Pardayeva Azizabonu Ulug'bek qizi , Asadbek…","topics":["Depression","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7215643515","eid":"W7215643515"},{"id":"paper-w7160027845","cat":"papers","name":"Methylone demonstrates improvement in PTSD symptoms in Phase 2 study","year":"2026","cit":0,"topics":["PTSD & trauma","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7160027845","eid":"W7160027845"},{"id":"paper-w3042306439","cat":"papers","name":"Nutraceutical Intervention for Treatment of Alcoholism and Drinking Problems","year":"2020","cit":0,"pfa":"Charu Gupta","psa":"Dhan Prakash","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"book-chapter","src":"https://openalex.org/W3042306439","eid":"W3042306439"},{"id":"paper-w2014311095","cat":"papers","name":"Psychiatry and religion","year":"1992","cit":0,"pfa":"Gary S. Hosty","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2014311095","eid":"W2014311095"},{"id":"paper-w4412038020","cat":"papers","name":"Treatment of pharmacoresistant states in psychiatry. Part 2: Treatment-resistant depression","year":"2025","cit":0,"pfa":"Eva Češková","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4412038020","eid":"W4412038020"},{"id":"paper-w7119893738","cat":"papers","name":"‘Shroom’ for concern: a case of psychedelic mushroom‐induced acute kidney injury","year":"2026","cit":0,"pfa":"Maurice Lam","psa":"N. A. Shah","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7119893738","eid":"W7119893738"},{"id":"paper-w7111610272","cat":"papers","name":"Beyond the veil of perception: investigating the relationship between predictors of psychedelic experiences","year":"2025","cit":0,"pfa":"Milojičić, Jelica","psa":"Zulić, Mario","topics":["Anxiety & end-of-life","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7111610272","eid":"W7111610272"},{"id":"paper-w1452307351","cat":"papers","name":"The physical and chemical characterisation of 3,4-methylenedioxymethamphetamine ecstasy tablets : implications for users","year":"2014","cit":0,"pfa":"Mario Mifsud","topics":["Addiction","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W1452307351","eid":"W1452307351"},{"id":"paper-w7168241110","cat":"papers","name":"Association between prenatal methamphetamine exposure and intracranial haemorrhage in neonates and infants: nationwide cohort study","year":"2026","cit":0,"pfa":"Ching-Heng Lin","psa":"Yu-Hsuan Lin","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7168241110","eid":"W7168241110"},{"id":"paper-w7141669859","cat":"papers","name":"Are Psychedelics Effective for Treating Substance Use Disorders?","year":"2025","cit":0,"pfa":"David A. Gorelick","topics":["Addiction","Safety & adverse events"],"ptype":"report","src":"https://openalex.org/W7141669859","eid":"W7141669859"},{"id":"paper-w4361025669","cat":"papers","name":"Experts to Discuss the Ethics of Psychedelics","year":"2023","cit":0,"pfa":"Terri D’Arrigo","topics":["Addiction","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4361025669","eid":"W4361025669"},{"id":"paper-w7167679729","cat":"papers","name":"Verfügung über das Nicht-Knappe Das Supply-Narrativ und die Aneignung mikrobieller Psychedelika- Produktion","year":"2026","cit":0,"pfa":"Schüller Thomas","ptype":"article","src":"https://openalex.org/W7167679729","eid":"W7167679729"},{"id":"paper-w2128964632","cat":"papers","name":"Effect of 3-4,methylenedioxymethamphetamine in CA1 hippocampal neurons in male Rats","year":"2013","cit":0,"pfa":"Sara Soleimani Asl","psa":"Mehdi Mehdizadeh","ptype":"article","src":"https://openalex.org/W2128964632","eid":"W2128964632"},{"id":"paper-w4293502774","cat":"papers","name":"6 Online Communities About buy ketamine powder online You Should Join","year":"2022","cit":0,"pfa":"cechinrruk","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4293502774","eid":"W4293502774"},{"id":"paper-w4408204973","cat":"papers","name":"Psychedelics for Substance Use Disorders: Updates for the Psychiatric Trainee","year":"2025","cit":0,"pfa":"Lauren Wilseck","psa":"Jeremy Weleff","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4408204973","eid":"W4408204973"},{"id":"paper-w4250205026","cat":"papers","name":"Characterization of behavioral responses to a 5-HT releasing drug,/?-chloroamphetamine, in mice and the involvement of 5-HT receptor subtypes in jp-chloroamphetamine-induced behavior","year":"2005","cit":0,"topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W4250205026","eid":"W4250205026"},{"id":"paper-w4407387303","cat":"papers","name":"INSIGHTS INTO THE LETHAL TOXICITY OF SYNTHETIC PSYCHOACTIVE CATHINONES FROM STUDIES IN LARVAL ZEBRAFISH","year":"2025","cit":0,"pfa":"Frank Scott Hall","psa":"Isaac T. Schiefer","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W4407387303","eid":"W4407387303"},{"id":"paper-w7167720836","cat":"papers","name":"Verfügung über das Nicht-Knappe Das Supply-Narrativ und die Aneignung mikrobieller Psychedelika- Produktion","year":"2026","cit":0,"pfa":"Schüller Thomas","ptype":"article","src":"https://openalex.org/W7167720836","eid":"W7167720836"},{"id":"paper-w2472742249","cat":"papers","name":"[Is the anxiety about Ecstasy justified?].","year":"1997","cit":0,"pfa":"E Möller-Nehring","psa":"Luderer Hj","topics":["Anxiety & end-of-life","Safety & adverse events"],"ptype":"other","src":"https://openalex.org/W2472742249","eid":"W2472742249"},{"id":"paper-w2762626446","cat":"papers","name":"The Use of Psychedelic Medicines to Treat Resistant Post Traumatic Stress Disorder: The Legal and Policy Implications","year":"2017","cit":0,"pfa":"Jonathan Nash","topics":["Depression","PTSD & trauma","Therapy practice"],"ptype":"conference-paper","src":"https://openalex.org/W2762626446","eid":"W2762626446"},{"id":"paper-w4232953180","cat":"papers","name":"Pre-clinical Anti-Addictive and Side-Effect profiles of Novel Kappa-opioid Agonists","year":"2015","cit":0,"pfa":"David Young","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W4232953180","eid":"W4232953180"},{"id":"paper-w7167820896","cat":"papers","name":"Psychedelics and the thalamocortical system: A scoping review","year":"2026","cit":0,"pfa":"Sofía Villalba","psa":"Verónica Bisagno","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7167820896","eid":"W7167820896"},{"id":"paper-w2434043550","cat":"papers","name":"100 Jahre Albert Hofmann: LSD - Sorgenkind und Wunderdroge, Basel, 13.-15. Januar 2006","year":"2006","cit":0,"pfa":"Raoul Hecker","topics":["PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2434043550","eid":"W2434043550"},{"id":"paper-w4229536835","cat":"papers","name":"Opioid Receptors Revealed","year":"2012","cit":0,"pfa":"LAUREN WOLF","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W4229536835","eid":"W4229536835"},{"id":"paper-w2747114072","cat":"papers","name":"Psychoactive and Organic Effects of Banisteriopsis caapi and Diplopteris cabrerana (Cuatrec.) B. Gates in Rats","year":"2017","cit":0,"pfa":"Juan Pedro Rojas-Armas","psa":"Julio Santos Hilario-Vargas","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2747114072","eid":"W2747114072"},{"id":"paper-w2332823528","cat":"papers","name":"LSD Is Not a Tonic","year":"1966","cit":0,"pfa":"Patricia McBroom","topics":["Anxiety & end-of-life","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2332823528","eid":"W2332823528"},{"id":"paper-w7113142007","cat":"papers","name":"L' impact des médicaments psychotropes sur la neuroplasticité dans le traitement de l’anxiété : vers de nouvelles approches pharmacologiques","year":"2025","cit":0,"pfa":"Mechichi, Yasmine","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7113142007","eid":"W7113142007"},{"id":"paper-w7211889565","cat":"papers","name":"Safety and Efficacy of Natural and Conventional Psychiatric Treatments: A Comparative Review of Mushroom-Derived Compounds and Medicinal Plants in the Management of Mental Disorders","year":"2026","cit":0,"pfa":"Katarzyna Gawłowska","psa":"Agnieszka Chłopaś‐Konowałek","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7211889565","eid":"W7211889565"},{"id":"paper-w7153304750","cat":"papers","name":"PsyPal Project press release - European Union funds groundbreaking research into psychedelic therapy","year":"2024","cit":0,"pfa":"University Medical Center Groningen","psa":"Joost J. Breeksema","topics":["Anxiety & end-of-life"],"ptype":"other","src":"https://openalex.org/W7153304750","eid":"W7153304750"},{"id":"paper-w4411419984","cat":"papers","name":"The benefits and harm of psychedelics in the treatment of patients with mental health and substance abuse disorders: an integrative literature review","year":"2025","cit":0,"pfa":"Saara Susan Sevander","psa":"Marja‐Liisa Rissanen","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4411419984","eid":"W4411419984"},{"id":"paper-w4402511734","cat":"papers","name":"A scoping review of economic evaluations of post-traumatic stress disorder patients’ intervention","year":"2024","cit":0,"pfa":"Veronica Melody Dwarika","psa":"Amos Nnaemeka Amedu","topics":["PTSD & trauma","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4402511734","eid":"W4402511734"},{"id":"paper-w7153219734","cat":"papers","name":"PsyPal Project press release - European Union funds groundbreaking research into psychedelic therapy","year":"2024","cit":0,"pfa":"University Medical Center Groningen","psa":"Joost J. Breeksema","topics":["Anxiety & end-of-life"],"ptype":"other","src":"https://openalex.org/W7153219734","eid":"W7153219734"},{"id":"paper-w2766087956","cat":"papers","name":"The Holy Dose: Spiritual adventures with Southern Oregon's psychedelic crusaders","year":"2011","cit":0,"pfa":"Alex L Weber","topics":["PTSD & trauma","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2766087956","eid":"W2766087956"},{"id":"paper-w7125283737","cat":"papers","name":"Patient perspectives on research gaps in cluster headache","year":"2026","cit":0,"pfa":"Faraidoon Haghdoost","psa":"Anthony J. Rodgers","ptype":"article","src":"https://openalex.org/W7125283737","eid":"W7125283737"},{"id":"paper-w4301519197","cat":"papers","name":"Curative Drug Treatments for Post-Traumatic Stress Disorder: A Systematic Review of the Effectiveness of Recent Treatments","year":"2022","cit":0,"pfa":"Cyril Coquemont","psa":"Caroline Boulliat","topics":["PTSD & trauma","Anxiety & end-of-life","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W4301519197","eid":"W4301519197"},{"id":"paper-w4416087529","cat":"papers","name":"Clinical Evaluation of a Customized POCT cup for Detecting 16 Psychoactive Substances in Urine at Abu Dhabi’s National Rehabilitation Center Laboratories","year":"2025","cit":0,"pfa":"Abuelgasim Elrasheed","psa":"Dobrin Avramov Svinarov","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4416087529","eid":"W4416087529"},{"id":"paper-w2811489348","cat":"papers","name":"Recent Depression Symptoms Associated with Ecstasy Use and Reduced White Matter Integrity in Three Frontolimbic Tracts","year":"2018","cit":0,"pfa":"Angelina Lochner","psa":"Kevin Slezak","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"conference-paper","src":"https://openalex.org/W2811489348","eid":"W2811489348"},{"id":"paper-w2575692371","cat":"papers","name":"The Unquiet Mind Cancer: The Metaethical Quandary of Therapies","year":"2016","cit":0,"pfa":"Rohit Manchanda","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2575692371","eid":"W2575692371"},{"id":"paper-w4386471172","cat":"papers","name":"Psychedelics","year":"2023","cit":0,"pfa":"John M. Oldham","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4386471172","eid":"W4386471172"},{"id":"paper-w7171676964","cat":"papers","name":"One Substance, Seven Legal Realities:Classification Cascades in the Psychedelic Medicine Transition","year":"2026","cit":0,"pfa":"H. Tamba","topics":["Addiction","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W7171676964","eid":"W7171676964"},{"id":"paper-w7140294307","cat":"papers","name":"Psychedelic-Induced Constraint Destabilization and Reconstruction as a Mechanism for Cognitive Reset","year":"2026","cit":0,"pfa":"Stanley Everett Sambey","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7140294307","eid":"W7140294307"},{"id":"paper-w4411598388","cat":"papers","name":"Effectiveness and Experiences of Psychedelic-Based Interventions for the Treatment of Alcohol Use Disorder: A Mixed Methods Systematic Review","year":"2025","cit":0,"pfa":"Baneet Gill","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4411598388","eid":"W4411598388"},{"id":"paper-w2954572466","cat":"papers","name":"Electrophysiology of Drugs of Dependence","year":"2019","cit":0,"pfa":"Max Fink","ptype":"book-chapter","src":"https://openalex.org/W2954572466","eid":"W2954572466"},{"id":"paper-w4240877881","cat":"papers","name":"109 - Novel Treatments for Resistant Depression: Comparison of Older and Younger Patients","year":"2020","cit":0,"topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4240877881","eid":"W4240877881"},{"id":"paper-w2613701803","cat":"papers","name":"In vitro cellular models for neurotoxicity studies : neurons derived from P19 cells","year":"2017","cit":0,"pfa":"Dina Popova","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W2613701803","eid":"W2613701803"},{"id":"paper-w2003112098","cat":"papers","name":"Do It Yourself Hallucinogens","year":"1967","cit":0,"pfa":"David R. Rubin","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2003112098","eid":"W2003112098"},{"id":"paper-w4230462044","cat":"papers","name":"Cult and Cult-Like Pathways Out of Adolescent Addiction","year":"2020","cit":0,"pfa":"Peter L. Myers","topics":["Addiction","Reviews & meta-analyses"],"ptype":"book-chapter","src":"https://openalex.org/W4230462044","eid":"W4230462044"},{"id":"paper-w7203704947","cat":"papers","name":"The Emergence of Isotryptamine Analogs as Novel Serotonergic Agents with Psychotherapeutic Potential","year":"2026","cit":0,"pfa":"Richard A. Glennon","psa":"Maƚgorzata Dukat","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7203704947","eid":"W7203704947"},{"id":"paper-w7162321971","cat":"papers","name":"Clinical and Pharmacological, Forensic and Pharmaceutical Profile of Hallucinogenic Sage Salvia Divinorum: Regulatory Restrictions, Internet Accessibility to Consumers, Risks to Public Health in Italy","year":"2026","cit":0,"pfa":"Nadiia Kutsenko","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7162321971","eid":"W7162321971"},{"id":"paper-w7162809637","cat":"papers","name":"Pressure, Hysteresis, and Experience: A Friction-Theoretic Framework for Clinical Intervention","year":"2026","cit":0,"pfa":"Tomas Pødenphant Lund","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7162809637","eid":"W7162809637"},{"id":"paper-w156586708","cat":"papers","name":"Progress Toward the Development of a Receptor Model for Hallucinogenic Amphetamines","year":"1978","cit":0,"pfa":"Thérèse Di Paolo","psa":"Lemont B. Kier","topics":["Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W156586708","eid":"W156586708"},{"id":"paper-w7212064586","cat":"papers","name":"Effects of serotonin 2A/1A receptor stimulation on social exclusion processing","year":"2016","cit":0,"pfa":"Katrin H. Preller","psa":"Franz X. Vollenweider","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7212064586","eid":"W7212064586"},{"id":"paper-w7140337049","cat":"papers","name":"Psychedelic-Induced Constraint Destabilization and Reconstruction as a Mechanism for Cognitive Reset","year":"2026","cit":0,"pfa":"Stanley Everett Sambey","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7140337049","eid":"W7140337049"},{"id":"paper-w7106133840","cat":"papers","name":"A Meta-Analysis on Patient Preference for Psychological versus Pharmacological Treatments in Mental Health Problems.","year":"2025","cit":0,"pfa":"Stenzel, Kilian","psa":"Kirchner, Lukas","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"other","src":"https://openalex.org/W7106133840","eid":"W7106133840"},{"id":"paper-w4375812555","cat":"papers","name":"Kappa Opioid Receptor Agonists: New Targets In The Treatment Of Pain","year":"2014","cit":0,"pfa":"Nitin Kumar","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W4375812555","eid":"W4375812555"},{"id":"paper-w7124428185","cat":"papers","name":"Psychedelic therapy as relational medicine: psychosocial mechanisms in clinical and naturalistic contexts","year":"2025","cit":0,"pfa":"Hannes Kettner","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7124428185","eid":"W7124428185"},{"id":"paper-w4408418352","cat":"papers","name":"Treatment-Resistant Depression: A Comprehensive Insight of Ketamine Infusion Therapy, Transcranial Magnetic Stimulation (TMS), and Psychedelic-Assisted Psychotherapy","year":"2024","cit":0,"pfa":"Mohammad Ali","psa":"Urbah Viqar","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4408418352","eid":"W4408418352"},{"id":"paper-w4405432594","cat":"papers","name":"Terapias alternativas: uma revisão integrativa sobre o uso de psicodélicos serotoninérgicos no tratamento da depressão resistente (TRD)","year":"2024","cit":0,"pfa":"Mariana Oliveira Santos da Silva","psa":"Axel Helmut Rulf Cofré","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4405432594","eid":"W4405432594"},{"id":"paper-w7155325943","cat":"papers","name":"A Systematic Literature Review on Alternative Treatment Modalities in Adults with Treatment Resistant Depression","year":"2026","cit":0,"pfa":"Brian Miller","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W7155325943","eid":"W7155325943"},{"id":"paper-w245070012","cat":"papers","name":"Effects of Lysergic Acid and Its Derivatives on Rhinencephalic Electrograms","year":"1959","cit":0,"pfa":"Russell R. Monroe","topics":["Mechanism & neuroscience"],"ptype":"report","src":"https://openalex.org/W245070012","eid":"W245070012"},{"id":"paper-w7128510388","cat":"papers","name":"Ethical Complexities and Best Practices in Informed Consent for Psychedelic Services: A Qualitative Study on Expert Perspectives","year":"2026","cit":0,"pfa":"Christina Chwyl","psa":"Jason B. Luoma","topics":["Safety & adverse events","Therapy practice","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W7128510388","eid":"W7128510388"},{"id":"paper-w2493149857","cat":"papers","name":"Euphoria, Depression, & Madness","year":"2010","cit":0,"pfa":"Gary L. Wenk","topics":["Depression","Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W2493149857","eid":"W2493149857"},{"id":"paper-w7154769120","cat":"papers","name":"Isotopic DMT as a Probe of Spin-Dependent Psychedelic Pharmacology","year":"2026","cit":0,"pfa":"Jean‐Patrick Pommier","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7154769120","eid":"W7154769120"},{"id":"paper-w4241805457","cat":"papers","name":"Psychedelic Drugs","year":"1975","cit":0,"pfa":"Frank J. Ayd","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4241805457","eid":"W4241805457"},{"id":"paper-w2102320146","cat":"papers","name":"Bufi u~v~r~u~~ a potent hallucinogen of animal origin","year":"1994","cit":0,"pfa":"Andrew Weil","psa":"Wade Davisb","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2102320146","eid":"W2102320146"},{"id":"paper-w4254314552","cat":"papers","name":"Hallucinogenic Substances","year":"1967","cit":0,"pfa":"John C. Kramer","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4254314552","eid":"W4254314552"},{"id":"paper-w2596824345","cat":"papers","name":"Effects of sensory processing intervention on depression and anxiety among international students in a public university / Somayeh Khodabakhsh","year":"2016","cit":0,"pfa":"Somayeh Najjar Khodabakhsh","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W2596824345","eid":"W2596824345"},{"id":"paper-w7204961421","cat":"papers","name":"PSYCHEDELICS IN THE TREATMENT OF POST-TRAUMATIC STRESS DISORDER AND DEPRESSION: A REVIEW OF CLINICAL TRIALS","year":"2026","cit":0,"pfa":"Anna Maria Szeszko","psa":"Małgorzata Lubowiecka","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7204961421","eid":"W7204961421"},{"id":"paper-w4404962603","cat":"papers","name":"Stephanie Knatz Peck: Novel and innovative treatment for eating disorders","year":"2024","cit":0,"pfa":"Stephanie Knatz Peck","topics":["Depression","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4404962603","eid":"W4404962603"},{"id":"paper-w4411182514","cat":"papers","name":"Stephen Ross: Psychedelic-assisted therapies for difficult-to-treat psychiatric and medical disorders","year":"2025","cit":0,"pfa":"Stephen Ross","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4411182514","eid":"W4411182514"},{"id":"paper-w7134953641","cat":"papers","name":"Isotopic DMT as a Probe of Spin-Dependent Psychedelic Pharmacology","year":"2026","cit":0,"pfa":"POMMIER","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7134953641","eid":"W7134953641"},{"id":"paper-w4393080583","cat":"papers","name":"A Perspective on Psychedelics as Treatments for Addictions","year":"2024","cit":0,"pfa":"David Nutt","psa":"Sukhpreet S. Klaire","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4393080583","eid":"W4393080583"},{"id":"paper-w3133880180","cat":"papers","name":"Mystical States achieved through Psychedelics: The Origins, Classical, and Contemporary Use of Psychedelics","year":"2021","cit":0,"pfa":"Andrew C. Papanicolaou","topics":["Addiction","Reviews & meta-analyses","Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W3133880180","eid":"W3133880180"},{"id":"paper-w2329907049","cat":"papers","name":"The meth brain: methamphetamines alter brain functions via NMDA receptors","year":"2015","cit":0,"pfa":"Juliane Proft","psa":"Norbert Weiss","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2329907049","eid":"W2329907049"},{"id":"paper-w7168094896","cat":"papers","name":"The Drugs Corpus: Money as Drug, Grading as Installation, and the War on Drugs as Substance Use Disorder","year":"2026","cit":0,"pfa":"Saeid Ghiasi","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7168094896","eid":"W7168094896"},{"id":"paper-w7113473089","cat":"papers","name":"One Ultimate Journey? AKA the Huxley’s Method: Perspectives of (Ab)Users of Hallucinogens and Entheogens on Having Planned Pre-Mortem Psychedelic Trip","cit":0,"pfa":"Ahmed Al-Imam","psa":"Faris Lami","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7113473089","eid":"W7113473089"},{"id":"paper-w7165746125","cat":"papers","name":"Isotopic DMT as a Probe of Spin-Dependent Psychedelic Pharmacology","year":"2026","cit":0,"pfa":"Jean‐Patrick Pommier","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7165746125","eid":"W7165746125"},{"id":"paper-w1028249205","cat":"papers","name":"[\"PSD-95 Regulates Serotonin Receptor Function in vivo\"]","year":"2009","cit":0,"pfa":"Atheir I. Abbas","topics":["Depression","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1028249205","eid":"W1028249205"},{"id":"paper-w2981399270","cat":"papers","name":"Some immunological parameters in abuse substance addicted","year":"2019","cit":0,"pfa":"Ali Naser Sahib Abogelal","psa":"Frial Gemeel Abd","topics":["Addiction"],"ptype":"conference-paper","src":"https://openalex.org/W2981399270","eid":"W2981399270"},{"id":"paper-w7135316775","cat":"papers","name":"Entering the Symbiocene: How Psychedelics Can Lead Us Back to Nature","year":"2023","cit":0,"pfa":"Josephine P Murray","topics":["Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W7135316775","eid":"W7135316775"},{"id":"paper-w4394452916","cat":"papers","name":"When art therapy went chemical: Alfred Bader, pharmacology, and art brut, c.1950-1970s","year":"2023","cit":0,"pfa":"Martinovic, Jelena","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"dataset","src":"https://openalex.org/W4394452916","eid":"W4394452916"},{"id":"paper-w7171274370","cat":"papers","name":"Effect of thermal treatment on the stability of fungal toxins : Experimental study","year":"2026","cit":0,"pfa":"Sofie Laura Plívová","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W7171274370","eid":"W7171274370"},{"id":"paper-w2102588429","cat":"papers","name":"Chapter 4. Psychotomimetic Agents","year":"1974","cit":0,"pfa":"R. A. Partyka","psa":"Jonas A. Gylus","ptype":"book-chapter","src":"https://openalex.org/W2102588429","eid":"W2102588429"},{"id":"paper-w3191262164","cat":"papers","name":"Mystical Experience with Cancer Patients: Insights from Psychedelic-Assisted Psychotherapy and Guided Imagery","year":"2021","cit":0,"pfa":"Jerry B. Brown","psa":"Julie M. Brown","topics":["Anxiety & end-of-life","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3191262164","eid":"W3191262164"},{"id":"paper-w1830040924","cat":"papers","name":"THE SPIRIT MOLECULE: DMT, BRAINS, AND A THEONEUROLOGICAL MODEL TO EXPLAIN SPIRITUAL EXPERIENCES","year":"2015","cit":0,"pfa":"Shaun M. Smith","ptype":"book","src":"https://openalex.org/W1830040924","eid":"W1830040924"},{"id":"paper-w7126243704","cat":"papers","name":"Can Psychedelics Help Us Reimagine Prevention of Posttraumatic Stress Disorder?","year":"2026","cit":0,"pfa":"Rachel Yehuda","psa":"Dennis S. Charney","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W7126243704","eid":"W7126243704"},{"id":"paper-w4386558696","cat":"papers","name":"The Use of Illicit Drugs in Therapy: an Introduction","year":"2023","cit":0,"pfa":"Anna Ross","psa":"Jake Hawthorn","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W4386558696","eid":"W4386558696"},{"id":"paper-w4416194041","cat":"papers","name":"Correction: Synergistic, multi-level understanding of psychedelics: three systematic reviews and meta-analyses of their pharmacology, neuroimaging and phenomenology","year":"2025","cit":0,"pfa":"Kenneth Shinozuka","psa":"Morten L. Kringelbach","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"erratum","src":"https://openalex.org/W4416194041","eid":"W4416194041"},{"id":"paper-w7168094546","cat":"papers","name":"The Drugs Corpus: Money as Drug, Grading as Installation, and the War on Drugs as Substance Use Disorder","year":"2026","cit":0,"pfa":"Saeid Ghiasi","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7168094546","eid":"W7168094546"},{"id":"paper-w2953457804","cat":"papers","name":"Neurobiological analysis of anxiety in the rat: Effect of serotonergic manipulations","year":"2008","cit":0,"pfa":"Ludwig, Verena","topics":["Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W2953457804","eid":"W2953457804"},{"id":"paper-w7161639072","cat":"papers","name":"The Role of Personal Experience in Psychedelic Therapy","year":"2026","cit":0,"pfa":"Vanessa Bibliowicz","topics":["Therapy practice","Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W7161639072","eid":"W7161639072"},{"id":"paper-w7114188787","cat":"papers","name":"Spiritual dimension and psychedelic experiences: A phenomenological approach","cit":0,"pfa":"Vargas Ibarra, Pablo","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7114188787","eid":"W7114188787"},{"id":"paper-w4309185072","cat":"papers","name":"Manuel de Yale pour la Thérapie de la Dépression Assistée par la Psilocybine","year":"2022","cit":0,"pfa":"Jeffrey R. Guss","psa":"Jordan Sloshower","topics":["Depression"],"ptype":"preprint","src":"https://openalex.org/W4309185072","eid":"W4309185072"},{"id":"paper-w7162308370","cat":"papers","name":"Overcoming Pharmacokinetic and Peripheral Safety Challenges in Psychedelic Therapies: The Promise of Advanced Drug Delivery Systems","year":"2026","cit":0,"pfa":"Tianshu Zhang","psa":"Xiaohui Wang","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7162308370","eid":"W7162308370"},{"id":"paper-w4404091409","cat":"papers","name":"Supporting adolescents presenting with illicit drug toxicity","year":"2024","cit":0,"pfa":"Matthew Carwana","psa":"Nicholas Chadi","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4404091409","eid":"W4404091409"},{"id":"paper-w4414528095","cat":"papers","name":"Characteristics of Ongoing Clinical Trials of Psychogenic Substances for Psychiatric Disorders","year":"2025","cit":0,"pfa":"John L. Havlik","psa":"Trisha Suppes","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4414528095","eid":"W4414528095"},{"id":"paper-w7169649640","cat":"papers","name":"CH DMT Abort Tracker","year":"2026","cit":0,"pfa":"Eric [LAST NAME]","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"software","src":"https://openalex.org/W7169649640","eid":"W7169649640"},{"id":"paper-w7169648759","cat":"papers","name":"CH DMT Abort Tracker","year":"2026","cit":0,"pfa":"Eric [LAST NAME]","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"software","src":"https://openalex.org/W7169648759","eid":"W7169648759"},{"id":"paper-w4415067123","cat":"papers","name":"Alucinógenos como terapia complementar no manejo da depressão: uma revisão integrativa","year":"2025","cit":0,"pfa":"Pedro Henrique Caminha Raposo","psa":"Matheus Santos Marques","topics":["Depression","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4415067123","eid":"W4415067123"},{"id":"paper-w4414740703","cat":"papers","name":"B-289 Definitive Urine Drug Testing in Emergency Medicine: Recreational and Psychiatric Drug Findings","year":"2025","cit":0,"pfa":"S. Islam","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W4414740703","eid":"W4414740703"},{"id":"paper-w7171322300","cat":"papers","name":"Integration in classic psychedelic-assisted therapies for mental health conditions: A scoping review","year":"2026","cit":0,"pfa":"Nicholas Vucak","psa":"Nicola Acevedo","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7171322300","eid":"W7171322300"},{"id":"paper-w4248139721","cat":"papers","name":"Nutraceutical and Alternative Treatments for Obsessive-Compulsive and Related Disorders","year":"2017","cit":0,"pfa":"David Camfield","psa":"Jerome J. Sarris","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"book","src":"https://openalex.org/W4248139721","eid":"W4248139721"},{"id":"paper-w4387792909","cat":"papers","name":"What Is Psychedelic Experience?","year":"2023","cit":0,"pfa":"Aidan Lyon","topics":["Addiction","Reviews & meta-analyses"],"ptype":"book-chapter","src":"https://openalex.org/W4387792909","eid":"W4387792909"},{"id":"paper-w7153030945","cat":"papers","name":"Guidance for Coalitions informing the Standardisation and Implementation of Psychedelic Therapies in Europe","year":"2026","cit":0,"pfa":"Thibaut Le Forsonney","psa":"Ulf Bremberg","topics":["Anxiety & end-of-life","Therapy practice","Policy & ethics"],"ptype":"report","src":"https://openalex.org/W7153030945","eid":"W7153030945"},{"id":"paper-w4391893697","cat":"papers","name":"Elizabeth Kelly Gray, Habit Forming: Drug Addiction in America, 1776–1914","year":"2024","cit":0,"pfa":"Sara Black","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4391893697","eid":"W4391893697"},{"id":"paper-w7153131284","cat":"papers","name":"Guidance for Coalitions informing the Standardisation and Implementation of Psychedelic Therapies in Europe","year":"2026","cit":0,"pfa":"Thibaut Le Forsonney","psa":"Ulf Bremberg","topics":["Anxiety & end-of-life","Therapy practice","Policy & ethics"],"ptype":"report","src":"https://openalex.org/W7153131284","eid":"W7153131284"},{"id":"paper-w2789378414","cat":"papers","name":"Psychedelic Last Rites","year":"2018","cit":0,"pfa":"Wayne Glausser","topics":["Depression","Anxiety & end-of-life"],"ptype":"book","src":"https://openalex.org/W2789378414","eid":"W2789378414"},{"id":"paper-w4394904988","cat":"papers","name":"Who will staff the psychedelic resurgence?","year":"2024","cit":0,"pfa":"Erika Dyck","topics":["Depression","Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4394904988","eid":"W4394904988"},{"id":"paper-w4387755766","cat":"papers","name":"Ketamine and Psychedelics in PTSD and Depression: The New Frontier or the New Pandemic?","year":"2023","cit":0,"pfa":"Robert Haim Belmaker","psa":"Pesach Lichtenberg","topics":["Depression","PTSD & trauma"],"ptype":"book-chapter","src":"https://openalex.org/W4387755766","eid":"W4387755766"},{"id":"paper-w4388085074","cat":"papers","name":"Hallucinogens","year":"2001","cit":0,"pfa":"Avram Goldstein","ptype":"book-chapter","src":"https://openalex.org/W4388085074","eid":"W4388085074"},{"id":"paper-w4387010411","cat":"papers","name":"Drugs and Psychedelics in Tourism","year":"2023","cit":0,"pfa":"Feyza Alyu","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W4387010411","eid":"W4387010411"},{"id":"paper-w7112726467","cat":"papers","name":"Travel Far Enough, Meet Yourself: Subjective Interoception, Emotion Regulation, and the Psychedelic Experience—Implications for Crisis Management in Middle Adulthood","year":"2023","cit":0,"pfa":"Pollonais, JoAnna","topics":["Addiction","Anxiety & end-of-life","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W7112726467","eid":"W7112726467"},{"id":"paper-w302693120","cat":"papers","name":"Drug abuse: recommendations for California treatment and research facilities.","year":"1968","cit":0,"pfa":"Frederick M. Meyers","psa":"David E. Smith","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W302693120","eid":"W302693120"},{"id":"paper-w7135327985","cat":"papers","name":"Types of Hallucinogens as Drugs and Its Effects On the Human Body","year":"2026","cit":0,"pfa":"Abul Kasem Rahman","topics":["Addiction"],"ptype":"conference-abstract","src":"https://openalex.org/W7135327985","eid":"W7135327985"},{"id":"paper-w7213400910","cat":"papers","name":"Uso de psicodélicos no tratamento da depressão resistente: eficácia clínica e perspectivas terapêuticas","year":"2026","cit":0,"pfa":"Monique Vieira de Moura","psa":"Isabela Caldeira Rosolen","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7213400910","eid":"W7213400910"},{"id":"paper-w7154150460","cat":"papers","name":"Dr Howard Whitaker and LSD-Assisted Therapy at Mayday Hills Psychiatric Hospital, Beechworth, Victoria, Australia","year":"2026","cit":0,"pfa":"Alison Watts","psa":"Jennifer Munday","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7154150460","eid":"W7154150460"},{"id":"paper-w7165482737","cat":"papers","name":"Bipolar affective disorder: a review of current trends and new therapeutic perspectives","year":"2026","cit":0,"pfa":"Maciej Kawecki","psa":"Filip Baran","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7165482737","eid":"W7165482737"},{"id":"paper-w4251255180","cat":"papers","name":"Hallucinogen Abuse and Dependence","year":"2015","cit":0,"pfa":"John H. Halpern","psa":"Torsten Passie","ptype":"reference-entry","src":"https://openalex.org/W4251255180","eid":"W4251255180"},{"id":"paper-w4412536205","cat":"papers","name":"The Potential of Psychedelics in the Treatment of Eating Disorders","year":"2025","cit":0,"pfa":"Natalie Gukasyan","psa":"Ángela S. Guarda","topics":["Safety & adverse events","Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W4412536205","eid":"W4412536205"},{"id":"paper-w7140953287","cat":"papers","name":"[Perspectives opened up by the physiopathological understanding of psychiatric disorders].","year":"2026","cit":0,"pfa":"Nathalie Girault","psa":"Philippe Fossati","topics":["Depression","Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W7140953287","eid":"W7140953287"},{"id":"paper-w7204939487","cat":"papers","name":"Sind Psychedelika wirksam bei der Behandlung von Substanzgebrauchsstörungen?","year":"2025","cit":0,"pfa":"David A. Gorelick","topics":["Addiction"],"ptype":"report","src":"https://openalex.org/W7204939487","eid":"W7204939487"},{"id":"paper-w7107970364","cat":"papers","name":"ESTUDO DE DOCAGEM MOLECULAR DE ALCALOIDES INDÓLICOS DE ANADENANTHERA SPP. NO RECEPTOR 5-HT2A","year":"2025","cit":0,"pfa":"Franco, Pedro Lima","psa":"Soares, Breno Almeida","topics":["Depression","Mechanism & neuroscience"],"ptype":"conference-paper","src":"https://openalex.org/W7107970364","eid":"W7107970364"},{"id":"paper-w4232261767","cat":"papers","name":"Chapter 3. Hallucinogens","year":"1970","cit":0,"pfa":"Raj K. Razdan","ptype":"book-chapter","src":"https://openalex.org/W4232261767","eid":"W4232261767"},{"id":"paper-w7107966260","cat":"papers","name":"ESTUDO DE DOCAGEM MOLECULAR DE ALCALOIDES INDÓLICOS DE ANADENANTHERA SPP. NO RECEPTOR 5-HT2A","year":"2025","cit":0,"pfa":"Franco, Pedro Lima","psa":"Soares, Breno Almeida","topics":["Depression","Mechanism & neuroscience"],"ptype":"conference-paper","src":"https://openalex.org/W7107966260","eid":"W7107966260"},{"id":"paper-w7167709955","cat":"papers","name":"Pharmacological characterization of new psychoactive substances","year":"2026","cit":0,"pfa":"Ronald Derndorfer","topics":["Addiction","Dosing & pharmacology","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W7167709955","eid":"W7167709955"},{"id":"paper-w4408875876","cat":"papers","name":"Characterization of a novel mouse model of Dopamine Transporter Deficiency Syndrome and pharmacological therapeutic strategies","year":"2025","cit":0,"pfa":"Emma E. Russo","psa":"Ali Salahpour","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4408875876","eid":"W4408875876"},{"id":"paper-w4414841002","cat":"papers","name":"72.3 A Decades-Long Debate: Can Psychedelics Trigger Psychosis in Young Minds?","year":"2025","cit":0,"pfa":"Hyun Jung Kim","ptype":"article","src":"https://openalex.org/W4414841002","eid":"W4414841002"},{"id":"paper-w2496530570","cat":"papers","name":"Substance Intoxication and Withdrawal States in the General Medical Setting","year":"2015","cit":0,"pfa":"Jody B. Glance","psa":"Kurt D. Ackerman","topics":["Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W2496530570","eid":"W2496530570"},{"id":"paper-w2498141986","cat":"papers","name":"Psychotomimetic drugs and drugs of abuse","year":"1989","cit":0,"pfa":"Philip B. Bradley","ptype":"book-chapter","src":"https://openalex.org/W2498141986","eid":"W2498141986"},{"id":"paper-w7126250136","cat":"papers","name":"Indole Alkaloids as Biased Opioid Receptor Modulators","year":"2026","cit":0,"pfa":"Oliver Grundmann","psa":"Allison Henderson","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W7126250136","eid":"W7126250136"},{"id":"paper-w1760275003","cat":"papers","name":"The 5-HT2A receptor and serotonin transporter in ecstasy users evaluated with [11C]MDL 100907 and [11C]DASB","year":"2011","cit":0,"pfa":"Nina Urban","psa":"Marc A. Laruelle","topics":["Safety & adverse events","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1760275003","eid":"W1760275003"},{"id":"paper-w2741684800","cat":"papers","name":"Development and Initial Evaluation of an Ecstasy Craving Questionnaire","year":"2012","cit":0,"pfa":"Alan K. Davis","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2741684800","eid":"W2741684800"},{"id":"paper-w3030930294","cat":"papers","name":"The Impact of Adverse Childhood Experiences on Attachment and Substance Abuse in Sexual and Gender Minority Emerging Adults","year":"2020","cit":0,"pfa":"Amanda N Moore","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3030930294","eid":"W3030930294"},{"id":"paper-w3129731075","cat":"papers","name":"Psychedelic Strategies; Alternative Phenomenologies, Translations, and Representations of the Human Body in Relation to Interior Space","year":"2021","cit":0,"pfa":"Emily Pellicano","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3129731075","eid":"W3129731075"},{"id":"paper-w4399169086","cat":"papers","name":"Pharmacology and mechanisms of addiction","year":"2024","cit":0,"topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W4399169086","eid":"W4399169086"},{"id":"paper-w4256577338","cat":"papers","name":"Clinical topics: paper 3 (ISQs) Sample questions Ashok G Patel","year":"2006","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W4256577338","eid":"W4256577338"},{"id":"paper-w2358432008","cat":"papers","name":"Detection of Ketamine and its Metabolites in Human Urine by GC-MS","year":"2006","cit":0,"pfa":"Wen Yunbo","ptype":"article","src":"https://openalex.org/W2358432008","eid":"W2358432008"},{"id":"paper-w3084266064","cat":"papers","name":"Neurochemical modulation of affective and behavioural control: Models and applications for psychiatry","year":"2020","cit":0,"pfa":"Jonathan W. Kanen","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W3084266064","eid":"W3084266064"},{"id":"paper-w4313596571","cat":"papers","name":"Et psykoanalytisk og et postmoderne perspektiv på selv/egoopløsning i en psykedelisk kontekst","year":"2023","cit":0,"pfa":"Sidsel Andersen","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4313596571","eid":"W4313596571"},{"id":"paper-w7162252314","cat":"papers","name":"Serotonergic Psychedelics as a Potential Therapeutic Strategy for Anxiety, A Systematic Review","year":"2026","cit":0,"pfa":"Naja Bralic","psa":"Mikael Palner","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7162252314","eid":"W7162252314"},{"id":"paper-w7162768019","cat":"papers","name":"Mystical Experience with Cancer Patients: Insights from Psychedelic-Assisted Psychotherapy and Guided Imagery","year":"2024","cit":0,"pfa":"Jerry B. Brown *","psa":"Julie M. Brown","topics":["Anxiety & end-of-life","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7162768019","eid":"W7162768019"},{"id":"paper-w7155565138","cat":"papers","name":"The complete chloroplast genome sequence of Lophophora diffusa","year":"2026","cit":0,"pfa":"Teng Zhang","psa":"Xingliang Liu","ptype":"article","src":"https://openalex.org/W7155565138","eid":"W7155565138"},{"id":"paper-w7155569267","cat":"papers","name":"The complete chloroplast genome sequence of Lophophora diffusa","year":"2026","cit":0,"pfa":"Teng Zhang","psa":"Xingliang Liu","ptype":"dataset","src":"https://openalex.org/W7155569267","eid":"W7155569267"},{"id":"paper-w2074211506","cat":"papers","name":"Anatomical Features of Salvia divinorum Epling and Játiva-M as Supporting Information in Marketed Product Identification","year":"2012","cit":0,"pfa":"AP Kowalczuk","psa":"Jordan Kordian Zjawiony","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2074211506","eid":"W2074211506"},{"id":"paper-w7204944663","cat":"papers","name":"Explorando el mundo de los psicodelicos – una introduccion","year":"2024","cit":0,"pfa":"Franklin King IV","ptype":"report","src":"https://openalex.org/W7204944663","eid":"W7204944663"},{"id":"paper-w4391308494","cat":"papers","name":"Transient destabilization of whole brain dynamics induced by DMT","year":"2024","cit":0,"pfa":"Juan Piccinini","psa":"Enzo Tagliazucchi","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4391308494","eid":"W4391308494"},{"id":"paper-w4393157982","cat":"papers","name":"Psychedelic therapies","year":"2024","cit":0,"pfa":"Colin D. Bingle","topics":["Addiction","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4393157982","eid":"W4393157982"},{"id":"paper-w7168182228","cat":"papers","name":"Sex Differences in Acute Responses to Psychedelics: Evidence for Greater Subjective Intensity and Impairment in Female Participants","year":"2026","cit":0,"pfa":"Natasha Leigh Mason","psa":"Johannes Gerardus Ramaekers","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7168182228","eid":"W7168182228"},{"id":"paper-w2052841773","cat":"papers","name":"Action of hallucinogens on raphe-evoked dorsal root potentials (DRPs) in the cat","year":"1986","cit":0,"pfa":"Alice A. Larson","psa":"Edmund G. Anderson","ptype":"article","src":"https://openalex.org/W2052841773","eid":"W2052841773"},{"id":"paper-w4408184976","cat":"papers","name":"Determination of 5-OH-DMT (bufotenine) in the Asian toad Duttyphrynus melanostictus, Hoplobatrachus tigerinus and Haemopis sanguisiga in Madagascar by UHPLC-MS/MS","year":"2025","cit":0,"pfa":"Christina Ververi","psa":"Alberto Salomone","ptype":"article","src":"https://openalex.org/W4408184976","eid":"W4408184976"},{"id":"paper-w7125712119","cat":"papers","name":"Self-medication with psychedelics: a scoping review and narrative synthesis of review-level evidence","year":"2026","cit":0,"pfa":"Shreya Shiju","psa":"Elliot A. Marseille","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7125712119","eid":"W7125712119"},{"id":"paper-w7115604616","cat":"papers","name":"From Spirit Guides to Machine Elves: A Cultural and Phenomenological History of Psychedelic Entity Encounters","year":"2025","cit":0,"pfa":"Slade, Trent","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7115604616","eid":"W7115604616"},{"id":"paper-w1700735222","cat":"papers","name":"Oxidativer Stress als Mechanismus der Neurotoxizität durch Ethanol und halluzinogene Amphetamine","year":"2010","cit":0,"pfa":"Karoline Kiok","topics":["Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W1700735222","eid":"W1700735222"},{"id":"paper-w7133126965","cat":"papers","name":"Indole Alkaloids as Biased Opioid Receptor Modulators","year":"2026","cit":0,"pfa":"Oliver Grundmann","psa":"Allison Henderson","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7133126965","eid":"W7133126965"},{"id":"paper-w4414074389","cat":"papers","name":"P30-72 In vitro Toxicological Profiling Of Emerging Entheogens In Gastrointestinal And Hepatic Models","year":"2025","cit":0,"pfa":"Míriam Roma Garcia","psa":"Nelson G. M. Gomes","ptype":"article","src":"https://openalex.org/W4414074389","eid":"W4414074389"},{"id":"paper-w7139703864","cat":"papers","name":"Effect of Psychotomimetic and Schizophrenia-associated Drugs on Rat Visual Perceptual Grouping","cit":0,"pfa":"Nick Cherbanich","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7139703864","eid":"W7139703864"},{"id":"paper-w3028574374","cat":"papers","name":"Psychedelomancy: controlled experiments in psychedelic precognition","year":"2017","cit":0,"pfa":"David P. Luke","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3028574374","eid":"W3028574374"},{"id":"paper-w4301458301","cat":"papers","name":"[Hallucinogens].","year":"2010","cit":0,"pfa":"Nobuaki Morita","psa":"Takuya Shimane","topics":["Policy & ethics"],"ptype":"other","src":"https://openalex.org/W4301458301","eid":"W4301458301"},{"id":"paper-w2395289842","cat":"papers","name":"Toxicity of amphetamines: an update Marcia CarvalhoHelena CarmoVera Marisa CostaJoao Paulo Capela • Helena PontesFernando RemiaoFelix CarvalhoMaria de Lourdes Bastos","year":"2012","cit":0,"pfa":"Márcia C. Carvalho","psa":"João Paulo Capela","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2395289842","eid":"W2395289842"},{"id":"paper-w2352138829","cat":"papers","name":"The Block Effect of Total Ervatamia Yunnansis Alkaloids on Reinstatement of Conditioned Place Preference in Mouse with Psychical Dependence on Morphine","year":"2004","cit":0,"pfa":"Fu Qiu","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2352138829","eid":"W2352138829"},{"id":"paper-w2411104711","cat":"papers","name":"Modulation of the 5-HT1C receptor-mediated behavior by 5-HT2, but not 5-HT1A, receptor activation.","year":"1993","cit":0,"pfa":"Ewa Chojnacka-Wójcik","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2411104711","eid":"W2411104711"},{"id":"paper-w114194727","cat":"papers","name":"Interacció dels derivats amfetamínics amb els receptors nicotínics: Aspectes moleculars i funcionals","year":"2011","cit":0,"pfa":"Sara García Ratés","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W114194727","eid":"W114194727"},{"id":"paper-w7204887548","cat":"papers","name":"Los mecanismos y efectos de los psicodelicos","year":"2024","cit":0,"pfa":"Mercedes Guaia Memita Guaia","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"report","src":"https://openalex.org/W7204887548","eid":"W7204887548"},{"id":"paper-w7208821241","cat":"papers","name":"Microdosing psychedelics: a case-study exploration of use modalities and the understanding and management of risk","year":"2026","cit":0,"pfa":"Dimitrios Liokaftos","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7208821241","eid":"W7208821241"},{"id":"paper-w4415646663","cat":"papers","name":"Tales from the Frontier: Theories of Religion on the Borderlands of the “Psychedelic Renaissance”","year":"2025","cit":0,"pfa":"Stuart Ray Sarbacker","ptype":"book-chapter","src":"https://openalex.org/W4415646663","eid":"W4415646663"},{"id":"paper-w7161538655","cat":"papers","name":"Amendment LXXVIII — Psychedelic and Cannabinoid Pharmacology as Phi Modulation (v2 — Corrigendum: f_pulse=220Hz not 7.83Hz)","year":"2026","cit":0,"pfa":"Justin McCaul","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"erratum","src":"https://openalex.org/W7161538655","eid":"W7161538655"},{"id":"paper-w2725462462","cat":"papers","name":"Obesity and Obstetric Complications are Associated with Rapid-cycling in Italian Patients with Bipolar Disorder","year":"2017","cit":0,"pfa":"Alice Caldiroli","psa":"A. Carlo Altamura","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"conference-abstract","src":"https://openalex.org/W2725462462","eid":"W2725462462"},{"id":"paper-w7155512161","cat":"papers","name":"The complete chloroplast genome sequence of Lophophora diffusa","year":"2026","cit":0,"pfa":"Teng Zhang","psa":"Xingliang Liu","ptype":"dataset","src":"https://openalex.org/W7155512161","eid":"W7155512161"},{"id":"paper-w3187049859","cat":"papers","name":"What does „mystical“ mean in the context of experience withpsychedelics? Critique of perennialism in experimentalpsychology","year":"2020","cit":0,"pfa":"Jana Nenadalová","psa":"Adam Karásek","ptype":"article","src":"https://openalex.org/W3187049859","eid":"W3187049859"},{"id":"paper-w4413362532","cat":"papers","name":"Microdosagem de ibogaína em paciente com depressão bipolar: relato de caso","year":"2025","cit":0,"pfa":"Roberta Carlucci","psa":"Isabela Neri Teixeira","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4413362532","eid":"W4413362532"},{"id":"paper-w2035109573","cat":"papers","name":"CLINICAL OBSERVATIONS OF SIMULTANEOUS HALLUCINOGEN ADMINISTRATION IN IDENTICAL TWINS","year":"1962","cit":0,"pfa":"Bernard Wilkens","psa":"Harold Esecover","ptype":"article","src":"https://openalex.org/W2035109573","eid":"W2035109573"},{"id":"paper-w7211905245","cat":"papers","name":"Temporal structure of psychedelic EEG: statistical unit, dose, and receptor mechanism in multi-scale dynamics","year":"2026","cit":0,"pfa":"Flávio Marco Rego da Silva","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7211905245","eid":"W7211905245"},{"id":"paper-w7211913273","cat":"papers","name":"Temporal structure of psychedelic EEG: statistical unit, dose, and receptor mechanism in multi-scale dynamics","year":"2026","cit":0,"pfa":"Flávio Marco Rego da Silva","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7211913273","eid":"W7211913273"},{"id":"paper-w7168376792","cat":"papers","name":"The ANCHOR Framework for Psychedelic Accompaniment","year":"2026","cit":0,"pfa":"Ron Joseph Shore","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W7168376792","eid":"W7168376792"},{"id":"paper-w2373802809","cat":"papers","name":"The clinical analysis of new drug-induced mental and behavioral disorders in 29 addicts","year":"2010","cit":0,"pfa":"Huili Shen","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2373802809","eid":"W2373802809"},{"id":"paper-w4255384252","cat":"papers","name":"Calming the tempest, bridging the gorge: healing in couples ruptured by “sex addiction”","year":"2017","cit":0,"pfa":"Yalila Espinoza","topics":["PTSD & trauma","Addiction","Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W4255384252","eid":"W4255384252"},{"id":"paper-w7153105494","cat":"papers","name":"Press Release - First Patient Included Marks Major Milestone in EU-Funded Clinical Trial","year":"2025","cit":0,"pfa":"University Medical Center Groningen","topics":["Anxiety & end-of-life"],"ptype":"other","src":"https://openalex.org/W7153105494","eid":"W7153105494"},{"id":"paper-w4241231927","cat":"papers","name":"Psychedelic psychotherapy: The answer to addiction?","year":"2020","cit":0,"topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4241231927","eid":"W4241231927"},{"id":"paper-w111833125","cat":"papers","name":"PENGARUH PEMBERIAN EKSTRAK JAMUR PSILOCYBE CUBENSIS DOSIS BERTINGKAT TERHADAP KESEIMBANGANMOTORIK DAN KOORDINASI MENCIT SWISS WEBSTER DENGAN METODE BALANCE BEAM","year":"2013","cit":0,"pfa":"Dirga S.A Hasibuan","psa":"Tuntas Dhanardhono","ptype":"dissertation","src":"https://openalex.org/W111833125","eid":"W111833125"},{"id":"paper-w2589769888","cat":"papers","name":"Serotonin transporter ligands as anticancer agents : investigations into a mechanism-based therapy for Burkitt's lymphoma and related malignancies","year":"2009","cit":0,"pfa":"Suzanne M. Cloonan","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W2589769888","eid":"W2589769888"},{"id":"paper-w1532594783","cat":"papers","name":"How Current Drug Laws Impede Research and Clinical Treatments","year":"2013","cit":0,"pfa":"David John Nutt","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"other","src":"https://openalex.org/W1532594783","eid":"W1532594783"},{"id":"paper-w4415537074","cat":"papers","name":"Drug-centered or drug-assisted? Epistemic perspectives and methodological tensions in psychedelic psychotherapy","year":"2025","cit":0,"pfa":"Karen Yan","psa":"Mu‐Hong Chen","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4415537074","eid":"W4415537074"},{"id":"paper-w4411530332","cat":"papers","name":"Plants of God? The Healing Process with Entheogenic Plants in the Arca da Montanha Azul","year":"2025","cit":0,"pfa":"Frederico Romanoff","psa":"Philippe Bandeira de Mello","topics":["Addiction","Mechanism & neuroscience","Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W4411530332","eid":"W4411530332"},{"id":"paper-w4288804656","cat":"papers","name":"Information parity on cortical functional brain networks increases under psychedelic influences","year":"2022","cit":0,"pfa":"Aline Viol","psa":"Philipp Hoevel","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4288804656","eid":"W4288804656"},{"id":"paper-w7152973093","cat":"papers","name":"Press Release - First Patient Included Marks Major Milestone in EU-Funded Clinical Trial","year":"2025","cit":0,"pfa":"University Medical Center Groningen","topics":["Anxiety & end-of-life"],"ptype":"other","src":"https://openalex.org/W7152973093","eid":"W7152973093"},{"id":"paper-w7115585262","cat":"papers","name":"From Spirit Guides to Machine Elves: A Cultural and Phenomenological History of Psychedelic Entity Encounters","year":"2025","cit":0,"pfa":"Slade, Trent","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7115585262","eid":"W7115585262"},{"id":"paper-w2025108259","cat":"papers","name":"Drugs, Biochemistry, and Conscious Experience: Toward a Theory of Psychopharmacology","year":"1984","cit":0,"pfa":"Paul Willner","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2025108259","eid":"W2025108259"},{"id":"paper-w4413284752","cat":"papers","name":"544. MOLECULAR AND CELLULAR MECHANISMS OF THE LONG-LASTING EFFECTS OF PSYCHEDELICS AND THEIR NON-HALLUCINOGENIC DERIVATIVES","year":"2025","cit":0,"pfa":"Argel Aguilar‐Valles","psa":"Gianfilippo Coppola","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4413284752","eid":"W4413284752"},{"id":"paper-w4291291261","cat":"papers","name":"The differentiation of LSD and its 17 related compounds by GC-EI-MS and GC-CI-QTOF-MS","year":"2022","cit":0,"pfa":"Ruri Kikura‐Hanajiri","psa":"Yosuke Demizu","ptype":"article","src":"https://openalex.org/W4291291261","eid":"W4291291261"},{"id":"paper-w3157526690","cat":"papers","name":"Sensor could help discover new psychiatric drugs","year":"2021","cit":0,"pfa":"special to C EN Alla Katsnelson","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W3157526690","eid":"W3157526690"},{"id":"paper-w3004538535","cat":"papers","name":"Psychedelics forge neuron connections","year":"2018","cit":0,"pfa":"Cici Zhang","topics":["Depression","Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W3004538535","eid":"W3004538535"},{"id":"paper-w4300464019","cat":"papers","name":"Chemotype-selective Modes of Action of κ-Opioid Receptor Agonists","year":"2020","cit":0,"pfa":"Jeffrey Aubé","psa":"Philip D. Mosier","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4300464019","eid":"W4300464019"},{"id":"paper-w4415690390","cat":"papers","name":"Psychoactive substances as a catalyst for schizophrenia – a case report","year":"2025","cit":0,"pfa":"Rafał Bieś","psa":"Marek Krzystanek","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4415690390","eid":"W4415690390"},{"id":"paper-w2468776519","cat":"papers","name":"Diseño, elaboración, y caracterización de Micropartículas de SEMDDS (sistemas de liberación de fármacos auto-microemulsionables) cargadas con los alcaloides totales de BANISTERIOPSIS CAAPI.","year":"2015","cit":0,"pfa":"Chuquimarca Castillo","psa":"Javier Hernán","topics":["Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W2468776519","eid":"W2468776519"},{"id":"paper-w7125808618","cat":"papers","name":"A Promise Without Panacea: Psychedelic-Assisted Therapies in Modern Psychiatry","year":"2026","cit":0,"pfa":"Mohsin Raza","psa":"Jasleen Kaur","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"editorial","src":"https://openalex.org/W7125808618","eid":"W7125808618"},{"id":"paper-w7106565106","cat":"papers","name":"THE DMT–LASER INTERFERENCE PROTOCOL: A Community-Driven Scientific Framework for Safe, Reproducible Investigation of the DMT Visual \"Code\" Phenomenon","year":"2025","cit":0,"pfa":"Swygert, John","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7106565106","eid":"W7106565106"},{"id":"paper-w7212064257","cat":"papers","name":"710. The neuropsychopharmacology of LSD","year":"2026","cit":0,"pfa":"Drummond E-Wen McCulloch","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7212064257","eid":"W7212064257"},{"id":"paper-w7119571766","cat":"papers","name":"A phenomenological exploration of experiences with short-acting psychedelics for low mood and depression","year":"2024","cit":0,"pfa":"Ryan Little","topics":["Depression","Anxiety & end-of-life","Reviews & meta-analyses"],"ptype":"dissertation","src":"https://openalex.org/W7119571766","eid":"W7119571766"},{"id":"paper-w7212016214","cat":"papers","name":"335. Safety and tolerability results from a phase 2b, double-blind trial with an open-label extension of GH001 in treatment-resistant depression","year":"2026","cit":0,"pfa":"B. Baune","psa":"Wiesław Jerzy Cubała","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W7212016214","eid":"W7212016214"},{"id":"paper-w2561962108","cat":"papers","name":"The Role of Prostaglandin H Synthase (PHS) Bioactivation and Nuclear Factor Erythroid 2-related Factor 2 (Nrf2)-Mediated Protection in Endogenous and Methamphetamine-initiated Neurotoxicity","year":"2012","cit":0,"pfa":"Annmarie Ramkissoon","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W2561962108","eid":"W2561962108"},{"id":"paper-w7135068628","cat":"papers","name":"Evidências clínicas da eficácia da psilocibina no tratamento da depressão resistente: revisão integrativa","year":"2026","cit":0,"pfa":"Tiago de Souza Santos","psa":"Carmem Lúcia de Arroxelas Silva","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7135068628","eid":"W7135068628"},{"id":"paper-w7212011088","cat":"papers","name":"860. Glutamatergic Signaling and Neuroplasticity in Mood Disorders: A Historical Perspective from Preclinical Discoveries to Clinical Translation","year":"2026","cit":0,"pfa":"Gabriella Gobbi","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"conference-abstract","src":"https://openalex.org/W7212011088","eid":"W7212011088"},{"id":"paper-w4383502011","cat":"papers","name":"Psychedelikagestützte Psychotherapie in der Behandlung depressiver Störungen","year":"2023","cit":0,"pfa":"Lilith Becher","psa":"Michael Koslowski","topics":["Depression","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4383502011","eid":"W4383502011"},{"id":"paper-w7149881835","cat":"papers","name":"A Criminological Investigation into Psychedelic Drug Use: Soldiers, Shamans, and Supermarket Brands","year":"2026","cit":0,"pfa":"Richard G. Alexander","psa":"RENFORCE / Regulering en handhaving","ptype":"book","src":"https://openalex.org/W7149881835","eid":"W7149881835"},{"id":"paper-w7118941772","cat":"papers","name":"Associations of Couples’ Psychedelic Use with Shared Reality and Relational Well-Being","year":"2026","cit":0,"pfa":"Talea M. Cornelius","psa":"Tommaso Barba","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7118941772","eid":"W7118941772"},{"id":"paper-w2090823231","cat":"papers","name":"Optimization of a rapid luminescence bioassay for the assessment of toxicity of contaminants in XTC's pills","year":"2008","cit":0,"pfa":"Stéphanie Gosset","psa":"E Noël","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2090823231","eid":"W2090823231"},{"id":"paper-w2908513484","cat":"papers","name":"Managing Madness: Weyburn Mental Hospital and the Transformation of Psychiatric Care in Canada by Erika Dyck, Alex Deighton","year":"2018","cit":0,"pfa":"Ian Dowbiggin","topics":["Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2908513484","eid":"W2908513484"},{"id":"paper-w7163525303","cat":"papers","name":"(107) Chemsex: The Neuropharmacology of Pleasure and Risk","year":"2026","cit":0,"pfa":"M. Almada","psa":"T Santos","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7163525303","eid":"W7163525303"},{"id":"paper-w7168180607","cat":"papers","name":"traditional use of hallucinogenic plants in Africa","year":"2026","cit":0,"pfa":"Giorgio Samorini","ptype":"article","src":"https://openalex.org/W7168180607","eid":"W7168180607"},{"id":"paper-w4323321700","cat":"papers","name":"How psychedelics spark neuronal growth","year":"2023","cit":0,"pfa":"Shi En Kim","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W4323321700","eid":"W4323321700"},{"id":"paper-w4414726570","cat":"papers","name":"Psychedelics: Recent Philosophical Discussions","year":"2025","cit":0,"pfa":"Chris Letheby","ptype":"book-chapter","src":"https://openalex.org/W4414726570","eid":"W4414726570"},{"id":"paper-w2004015962","cat":"papers","name":"The Identification, Metabolism and Toxicity of an Unknown Component Found in a New Clandestine Drug Tablet","year":"2010","cit":0,"pfa":"Hiroe Kamata","psa":"Hitoshi Tsuchihashi","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2004015962","eid":"W2004015962"},{"id":"paper-w7203711549","cat":"papers","name":"The Abuse Liability of Classic Psychedelics: A Methodological Critique and Assessment of the Quality of Evidence of Recent Studies","year":"2026","cit":0,"pfa":"Michael J. Broman","psa":"Alan K. Davis","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7203711549","eid":"W7203711549"},{"id":"paper-w4255694517","cat":"papers","name":"Peer Review #1 of \"Harmine stimulates proliferation of human neural progenitors (v0.1)\"","year":"2016","cit":0,"topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"peer-review","src":"https://openalex.org/W4255694517","eid":"W4255694517"},{"id":"paper-w7143522027","cat":"papers","name":"Three cases of wood-lover paralysis: clinical insights from Victoria, Australia","year":"2026","cit":0,"pfa":"Annie Silvester","psa":"Yit Hung Leang","ptype":"article","src":"https://openalex.org/W7143522027","eid":"W7143522027"},{"id":"paper-w4396586161","cat":"papers","name":"Measuring Insight Level After Psychedelic Experience Among The Indian Population","year":"2024","cit":0,"pfa":"Chandana P Vibin","psa":"Jahangir Majeed","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4396586161","eid":"W4396586161"},{"id":"paper-w3110725112","cat":"papers","name":"Is there Evidence of a Genetic Basis for Substance Use Disorders?","year":"2020","cit":0,"pfa":"Susan Schenk","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W3110725112","eid":"W3110725112"},{"id":"paper-w2486651340","cat":"papers","name":"Influence of Circadian Rhythms on Head-twitch Response to 5HT-Receptor Stimulation in Mice","year":"1985","cit":0,"pfa":"Peter H. Redfern","psa":"Paul C. Moser","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W2486651340","eid":"W2486651340"},{"id":"paper-w2108527064","cat":"papers","name":"Endogenous Hallucinogens in Cerebrospinal Fluid","year":"1983","cit":0,"pfa":"George B. Brown","psa":"Richard D. Morin","ptype":"book-chapter","src":"https://openalex.org/W2108527064","eid":"W2108527064"},{"id":"paper-w3167081946","cat":"papers","name":"An Evaluation of Diverse Therapeutic Interventions for Substance Use Disorders: Serotonergic Hallucinogens, Immunotherapy, and Transcranial Magnetic Stimulation","year":"2021","cit":0,"pfa":"William M. Meil","psa":"Reem Satti","topics":["Addiction","Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W3167081946","eid":"W3167081946"},{"id":"paper-w3182367730","cat":"papers","name":"Dviejų savaičių ibogaino ir noribogaino vartojimo įtaka pelių organų morfologiniams pokyčiams bei jų kūno masės kitimui","year":"2012","cit":0,"pfa":"Asta Kubilienė","psa":"Alius Pockevičius","topics":["Safety & adverse events"],"ptype":"conference-paper","src":"https://openalex.org/W3182367730","eid":"W3182367730"},{"id":"paper-w4253172898","cat":"papers","name":"Halluzinogene Rauschgiftdrogen der Neuen Welt (Mexiko, Mittel- und Südamerika)","year":"1969","cit":0,"pfa":"Hildebert Wagner","ptype":"book-chapter","src":"https://openalex.org/W4253172898","eid":"W4253172898"},{"id":"paper-w4252130782","cat":"papers","name":"Peer Review #2 of \"Harmine stimulates proliferation of human neural progenitors (v0.2)\"","year":"2016","cit":0,"topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"peer-review","src":"https://openalex.org/W4252130782","eid":"W4252130782"},{"id":"paper-w4407634950","cat":"papers","name":"Phenethylaminylation: Preliminary In Vitro Evidence for the Covalent Transamidation of Psychedelic Phenethylamines to Glial Proteins using 3,5-Dimethoxy-4-(2-Propynyloxy)-Phenethylamine as a Model Compound","year":"2025","cit":0,"pfa":"Rajiv S. Rangan","psa":"Abbot F. Clark","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4407634950","eid":"W4407634950"},{"id":"paper-w7130988235","cat":"papers","name":"Cogumelos do gênero Psilocybe nas Américas e no Brasil","year":"2026","cit":0,"pfa":"Anita Lino","ptype":"article","src":"https://openalex.org/W7130988235","eid":"W7130988235"},{"id":"paper-w4410997689","cat":"papers","name":"Erin Mauney: Psychedelics as modulators of the gut-brain interaction","year":"2025","cit":0,"pfa":"Erin E. Mauney","topics":["Depression","PTSD & trauma","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4410997689","eid":"W4410997689"},{"id":"paper-w7135597176","cat":"papers","name":"Psychedelic experience from the perspective of healthy volunteers: a clinical study","year":"2025","cit":0,"pfa":"Barbora Němcová","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W7135597176","eid":"W7135597176"},{"id":"paper-w7134926846","cat":"papers","name":"Isotopic DMT as a Probe of Spinorial Consciousness","year":"2026","cit":0,"pfa":"POMMIER","psa":"Jean‐Patrick Pommier","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7134926846","eid":"W7134926846"},{"id":"paper-w4245332309","cat":"papers","name":"Peer Review #2 of \"Harmine stimulates proliferation of human neural progenitors (v0.1)\"","year":"2016","cit":0,"topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"peer-review","src":"https://openalex.org/W4245332309","eid":"W4245332309"},{"id":"paper-w4247035699","cat":"papers","name":"Peer Review #1 of \"Harmine stimulates proliferation of human neural progenitors (v0.2)\"","year":"2016","cit":0,"topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"peer-review","src":"https://openalex.org/W4247035699","eid":"W4247035699"},{"id":"paper-w4411530462","cat":"papers","name":"Entheogenic Healing among the Kamëntsá Biyá: an Intercultural Dialogue between Tradition and the Post-modern World","year":"2025","cit":0,"pfa":"Alejandro Marín Valencia","psa":"Luis Fernando Agreda Muchavisoy","topics":["Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W4411530462","eid":"W4411530462"},{"id":"paper-w7160228824","cat":"papers","name":"Endogenous DMT Surge as a Candidate Mechanism for Terminal Lucidity in Dementia: A Hypothesis","year":"2026","cit":0,"pfa":"James Tocher","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W7160228824","eid":"W7160228824"},{"id":"paper-w4367158646","cat":"papers","name":"Delix to synthesize psychedelic drugs","year":"2021","cit":0,"pfa":"Ryan W. Cross","topics":["Depression","Therapy practice"],"ptype":"other","src":"https://openalex.org/W4367158646","eid":"W4367158646"},{"id":"paper-w7214715494","cat":"papers","name":"Considerations for Scaling Psychedelics: Context, Reimbursement, and the Role of the Pharmacy Benefit Manager","year":"2026","cit":0,"pfa":"Derek Lukacsko","topics":["Reviews & meta-analyses","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7214715494","eid":"W7214715494"},{"id":"paper-w7140918736","cat":"papers","name":"[Pharmacological post-acute treatment of alcohol use disorder: Established strategies and innovative approaches].","year":"2026","cit":0,"pfa":"Patrik Roser","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7140918736","eid":"W7140918736"},{"id":"paper-w7130129186","cat":"papers","name":"Neopentecostal and Psychedelic Approaches to Addiction Recovery in Uruguay: A Comparative Perspective","year":"2026","cit":0,"pfa":"Juan Scuro","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7130129186","eid":"W7130129186"},{"id":"paper-w7214800884","cat":"papers","name":"Considerations for Scaling Psychedelics: Context, Reimbursement, and the Role of the Pharmacy Benefit Manager","year":"2026","cit":0,"pfa":"Derek Lukacsko","topics":["Reviews & meta-analyses","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7214800884","eid":"W7214800884"},{"id":"paper-w1038105151","cat":"papers","name":"Role of the β4 nicotinic receptor subunit in the anti‐addictive activity of 18‐methoxycoronaridine","year":"2012","cit":0,"pfa":"Samir Mukhida","psa":"Hugo Rubén Arias","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1038105151","eid":"W1038105151"},{"id":"paper-w2105668438","cat":"papers","name":"A Clinical Translation of the Article Titled, “The Utility of Magnetic Resonance Spectroscopy for Understanding Substance Use Disorders: A Systematic Review of the Literature”","year":"2015","cit":0,"pfa":"Deborah S. Finnell","topics":["Addiction","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W2105668438","eid":"W2105668438"},{"id":"paper-w7167363209","cat":"papers","name":"Subjective Effects and Characteristics of Salvia Divinorum Use from a Retrospective Largescale Survey","year":"2026","cit":0,"pfa":"Spencer W. Wheeler","psa":"Natalie L. Dyer","topics":["Addiction","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7167363209","eid":"W7167363209"},{"id":"paper-w7115894420","cat":"papers","name":"The Bifurcation of Consciousness: A Comprehensive Analysis of Psychedelic Microdosing, Neurocognitive Dynamics, and Global Regulatory Frameworks (2025)","year":"2025","cit":0,"pfa":"Brewer, Mark Anthony","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"dataset","src":"https://openalex.org/W7115894420","eid":"W7115894420"},{"id":"paper-w3134769463","cat":"papers","name":"CHARACTERIZING THE PHARMACOLOGICAL PROFILE OF MEPHEDRONE AND DETERMINING THE ABUSE LIABILITY MECHANISMS","year":"2017","cit":0,"pfa":"Iman Saber","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W3134769463","eid":"W3134769463"},{"id":"paper-w4382048429","cat":"papers","name":"Contextualizing drug use and pharmacological harm in the United States: a socio-historical overview","year":"2023","cit":0,"pfa":"Mark Hanson","psa":"Orlando Garcia‐Santiago","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4382048429","eid":"W4382048429"},{"id":"paper-w3119887264","cat":"papers","name":"Clinical Management of Drug Use Disorders","year":"2021","cit":0,"pfa":"Alexander Thompson","psa":"James Jackson","topics":["Addiction","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3119887264","eid":"W3119887264"},{"id":"paper-w127569568","cat":"papers","name":"Synthèse biomimétique d'adduits catéchol-thioéthers dérivés de la méthylènedioxyméthamphétamine à partir d'orthoquinone électrogénérée : leur implication dans la neurotoxicité de l'ecstasy","year":"2009","cit":0,"pfa":"Anne Felim","topics":["Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W127569568","eid":"W127569568"},{"id":"paper-w4393392226","cat":"papers","name":"Impact of a serotonergic lesion on the expression of motor and neuropsychiatric symptoms","year":"2019","cit":0,"pfa":"Mathilde Millot","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W4393392226","eid":"W4393392226"},{"id":"paper-w4238890012","cat":"papers","name":"Clinical Management of Drug Use Disorders","year":"2021","cit":0,"pfa":"Alexander Thompson","psa":"James Jackson","topics":["Addiction","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4238890012","eid":"W4238890012"},{"id":"paper-w2482961279","cat":"papers","name":"Substance Abuse and Psychiatric Problems","year":"1990","cit":0,"pfa":"James Edeh","topics":["Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W2482961279","eid":"W2482961279"},{"id":"paper-w4411292729","cat":"papers","name":"Advancing the Anthropology of Psychedelics: Integrating Clinical Evidence, Sociocultural Insights, and Ethical Frameworks","year":"2025","cit":0,"pfa":"Liu Yi‐Fei","psa":"Lien‐Chung Wei","topics":["Anxiety & end-of-life","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4411292729","eid":"W4411292729"},{"id":"paper-w7115882077","cat":"papers","name":"The Bifurcation of Consciousness: A Comprehensive Analysis of Psychedelic Microdosing, Neurocognitive Dynamics, and Global Regulatory Frameworks (2025)","year":"2025","cit":0,"pfa":"Brewer, Mark Anthony","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"dataset","src":"https://openalex.org/W7115882077","eid":"W7115882077"},{"id":"paper-w7143387941","cat":"papers","name":"Palatal Ulceration Associated with Ecstasy Consumption: An Emerging Clinical Alert","year":"2026","cit":0,"pfa":"Yuri de Lima Medeiros","psa":"Matheus Furtado de Carvalho","ptype":"article","src":"https://openalex.org/W7143387941","eid":"W7143387941"},{"id":"paper-w1584681903","cat":"papers","name":"Halluzinogene Rauschgiftdrogen der Neuen Welt (Mexiko, Mittel- und Südamerika)","year":"1970","cit":0,"pfa":"Hildebert Wagner","ptype":"book-chapter","src":"https://openalex.org/W1584681903","eid":"W1584681903"},{"id":"paper-w7132817374","cat":"papers","name":"The Role of Psychedelics in Maintaining Neuroplasticity During Aging","year":"2026","cit":0,"pfa":"Somkin Kyrylo","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7132817374","eid":"W7132817374"},{"id":"paper-w7132820854","cat":"papers","name":"The Role of Psychedelics in Maintaining Neuroplasticity During Aging","year":"2026","cit":0,"pfa":"Somkin Kyrylo","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7132820854","eid":"W7132820854"},{"id":"paper-w4414972911","cat":"papers","name":"Neurocomputational evidence of sustained Self-Other mergence after psychedelics","year":"2025","cit":0,"pfa":"Pablo Mallaroni","psa":"Johannes Gerardus Ramaekers","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4414972911","eid":"W4414972911"},{"id":"paper-w2021770683","cat":"papers","name":"Opiate Addiction Made Easier Bv Plethora of Web Sites","year":"2006","cit":0,"pfa":"Joan Arehart-Treichel","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2021770683","eid":"W2021770683"},{"id":"paper-w4255009615","cat":"papers","name":"Clinical Management of Drug Use Disorders","year":"2021","cit":0,"pfa":"Alexander J. V. Thompson","psa":"James Jackson","topics":["Addiction","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4255009615","eid":"W4255009615"},{"id":"paper-w2768778483","cat":"papers","name":"Occurrence and transformation of illicit drugs in wastewater treatment plants","year":"2016","cit":0,"pfa":"Alida Cosenza","psa":"Carmelo Massimo Maida","ptype":"book-chapter","src":"https://openalex.org/W2768778483","eid":"W2768778483"},{"id":"paper-w4404238622","cat":"papers","name":"Development and Validation of a Hplc-Dad Method for Determining the Content of Tryptamines in Methanolic Extracts of Fruiting Bodies of Mushrooms Belonging to Species of the Psilocybe Genus","year":"2024","cit":0,"pfa":"Juan  Pablo Yasmo Perez","psa":"Omar  David Saldarriaga Ochoa","ptype":"preprint","src":"https://openalex.org/W4404238622","eid":"W4404238622"},{"id":"paper-w4408681987","cat":"papers","name":"Is Microdosing a Placebo?","year":"2023","cit":0,"pfa":"Vince Polito","psa":"Paul Liknaitzky","topics":["Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4408681987","eid":"W4408681987"},{"id":"paper-w7105811881","cat":"papers","name":"Current and Emerging Pharmacotherapies for Depression: A Mini Review","year":"2025","cit":0,"pfa":"Ganga, Tammisetty Reddy Harini","psa":"Kanala, Somasekhar Reddy","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7105811881","eid":"W7105811881"},{"id":"paper-w4415759817","cat":"papers","name":"Current and Emerging Pharmacotherapies for Depression: A Mini Review","year":"2025","cit":0,"pfa":"T R Harini Ganga","psa":"Somasekhar Reddy Kanala","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4415759817","eid":"W4415759817"},{"id":"paper-w7105809425","cat":"papers","name":"Current and Emerging Pharmacotherapies for Depression: A Mini Review","year":"2025","cit":0,"pfa":"Ganga, Tammisetty Reddy Harini","psa":"Kanala, Somasekhar Reddy","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7105809425","eid":"W7105809425"},{"id":"paper-w4404890787","cat":"papers","name":"INTERVENÇÕES INTEGRATIVAS NO TRATAMENTO DA DEPRESSÃO: UMA REVISÃO BIBLIOGRÁFICA","year":"2024","cit":0,"pfa":"Bárbara Kelly Rodrigues de Souza PRANDINI","psa":"Gregório Otto Bento de Oliveira","topics":["Depression","PTSD & trauma"],"ptype":"book-chapter","src":"https://openalex.org/W4404890787","eid":"W4404890787"},{"id":"paper-w7214599570","cat":"papers","name":"Rapid-acting and neuromodulatory interventions for treatment-resistant OCD: clinical implications in stress reduction","year":"2026","cit":0,"pfa":"Johan Saelens","psa":"Christoph Kraus","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7214599570","eid":"W7214599570"},{"id":"paper-w4401919187","cat":"papers","name":"Diagnosis & Treatment Options in Depression with comorbid Dementia","year":"2024","cit":0,"pfa":"A. Young","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"conference-abstract","src":"https://openalex.org/W4401919187","eid":"W4401919187"},{"id":"paper-w2312767173","cat":"papers","name":"Psychedelic Psychiatry: LSD from Clinic to Campus. By Erika Dyck. (Baltimore: Johns Hopkins University Press, 2008. xvi, 199 pp. $35.00, ISBN 978-0-8018-8994-3.)","year":"2009","cit":0,"pfa":"N. Rasmussen","topics":["Addiction","Therapy practice"],"ptype":"book-review","src":"https://openalex.org/W2312767173","eid":"W2312767173"},{"id":"paper-w4251214823","cat":"papers","name":"Drug overdose and poisoning","year":"2008","cit":0,"pfa":"James Ritter","psa":"Albert Ferro","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W4251214823","eid":"W4251214823"},{"id":"paper-w2999438708","cat":"papers","name":"Med Check: Sage’s Treatment; Cannabidiol Products; Pimavanserin; Cognitive Supplements","year":"2020","cit":0,"pfa":"Terri D’Arrigo","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2999438708","eid":"W2999438708"},{"id":"paper-w7112382364","cat":"papers","name":"Central nervous system serotonin:From neurobiology and genetics towards pharmacology, psychiatry and neurology","year":"2009","cit":0,"pfa":"György, Bagdy","psa":"Tamás, Kitka","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7112382364","eid":"W7112382364"},{"id":"paper-w7106309117","cat":"papers","name":"Consciousness as a Non-Local Field: Completing Federico Faggin's Architecture with the DMT Receiver and the AO Interaction Law","year":"2025","cit":0,"pfa":"Swygert, John","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7106309117","eid":"W7106309117"},{"id":"paper-w4396974314","cat":"papers","name":"Diverse avenues of research support the transmethylation theory of psychosis: implications for neuroprotection","year":"2024","cit":0,"pfa":"Christine L. Miller","topics":["Safety & adverse events","Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4396974314","eid":"W4396974314"},{"id":"paper-w7111646970","cat":"papers","name":"“So many relationships in the room”: Participant perspectives on the affordances and challenges of co-therapy in psychedelic assisted therapy","year":"2025","cit":0,"pfa":"Adrian Carter","psa":"Rachel Ham","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7111646970","eid":"W7111646970"},{"id":"paper-w2901750952","cat":"papers","name":"Frequently used drug types and intentional drug overdoses in Ireland.","year":"2018","cit":0,"pfa":"Seán Millar","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2901750952","eid":"W2901750952"},{"id":"paper-w7147678940","cat":"papers","name":"Ep. 396: From Prozac to Plasticity: The New Science of Depression","year":"2026","cit":0,"pfa":"Daniel Rosehill","psa":"Chatterbox TTS","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"other","src":"https://openalex.org/W7147678940","eid":"W7147678940"},{"id":"paper-w3164606774","cat":"papers","name":"Ibogaino ir Noribogaino toksinės dozės ir pasiskirstymo pelių organuose tyrimas","year":"2011","cit":0,"pfa":"Asta Kubilienė","psa":"Leonid Ivanov","ptype":"conference-paper","src":"https://openalex.org/W3164606774","eid":"W3164606774"},{"id":"paper-w1553718012","cat":"papers","name":"Investigating the Effect of Kappa Opioid Receptor Agonists on Serotonin Transporter Function in HEK-293 Cells","year":"2013","cit":0,"pfa":"Victoria Catherwood","topics":["Addiction","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W1553718012","eid":"W1553718012"},{"id":"paper-w7165778510","cat":"papers","name":"Multi-metric evaluations of acute psychedelic effects on fMRI brain entropy","year":"2026","cit":0,"pfa":"Drummond E-Wen McCulloch","psa":"Patrick M. Fisher","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7165778510","eid":"W7165778510"},{"id":"paper-w7160260139","cat":"papers","name":"Multimodal autonomic arousal tracks dose-dependent affective dynamics during the acute effects of DMT","year":"2026","cit":0,"pfa":"Tomás Ariel D’Amelio","psa":"Enzo Tagliazucchi","topics":["Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7160260139","eid":"W7160260139"},{"id":"paper-w4401224022","cat":"papers","name":"Latin American adults who regularly use macrodoses of psychedelics: a cross-sectional study","year":"2024","cit":0,"pfa":"Óscar Véliz‐García","psa":"Marcos Domic‐Siede","topics":["Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4401224022","eid":"W4401224022"},{"id":"paper-w7163750941","cat":"papers","name":"Computational spirits: a neuroscientific account of psychedelic entity encounters","year":"2026","cit":0,"pfa":"Jonas Mago","psa":"Michael Lifshitz","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7163750941","eid":"W7163750941"},{"id":"paper-w3126112541","cat":"papers","name":"Psychopharmacology for Substance Use Disorders","year":"2021","cit":0,"pfa":"Olapeju M. Simoyan","psa":"Krista Ulisse","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3126112541","eid":"W3126112541"},{"id":"paper-w4399512668","cat":"papers","name":"Postakute Effekte von klassischen Psychedelika","year":"2024","cit":0,"pfa":"Ricarda Evens","psa":"Tomislav Majić","topics":["Depression","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4399512668","eid":"W4399512668"},{"id":"paper-w7106260642","cat":"papers","name":"Consciousness as a Non-Local Field: Completing Federico Faggin's Architecture with the DMT Receiver and the AO Interaction Law","year":"2025","cit":0,"pfa":"Swygert, John","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7106260642","eid":"W7106260642"},{"id":"paper-w3187303795","cat":"papers","name":"Rat Brain Steady State Levels of Cyclic Nucleotides as an Endpoint of Lsd-Like Hallucinogen Effects.","year":"1980","cit":0,"pfa":"Michael Steven Rappaport","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W3187303795","eid":"W3187303795"},{"id":"paper-w1832186869","cat":"papers","name":"Mass spectrometry in the search for new drugs of abuse : Method development and clinical application","year":"2004","cit":0,"pfa":"Helena K. Nordgren","topics":["Addiction"],"ptype":"dissertation","src":"https://openalex.org/W1832186869","eid":"W1832186869"},{"id":"paper-w4411919944","cat":"papers","name":"Psychedelic and Medicinal Mushrooms: Potent Source of Active Metabolites and Medicines","year":"2025","cit":0,"pfa":"Priya Chaudhary","psa":"Pracheta Janmeda","topics":["Anxiety & end-of-life","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4411919944","eid":"W4411919944"},{"id":"paper-w4392097973","cat":"papers","name":"Promising therapeutic targets for major depressive disorder: A narrative review","year":"2024","cit":0,"pfa":"Walaa El desouky","psa":"Amira Abdelhamid","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4392097973","eid":"W4392097973"},{"id":"paper-w7171640398","cat":"papers","name":"Insurance Coverage for Psychedelic Therapy","year":"2026","cit":0,"pfa":"Vincent Joralemon","ptype":"preprint","src":"https://openalex.org/W7171640398","eid":"W7171640398"},{"id":"paper-w4300904220","cat":"papers","name":"Behavioral and Physiological Effects of a Novel Kappa-Opioid Receptor-Based DREADD in Rats","year":"2020","cit":0,"pfa":"Konstantin Kaganovsky","psa":"Eyal Vardy","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4300904220","eid":"W4300904220"},{"id":"paper-w4289034964","cat":"papers","name":"Discrepancies in Kappa Opioid Agonist Binding Revealed through PET Imaging","year":"2020","cit":0,"pfa":"F.A. Schroeder","psa":"J.M. Hooker","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4289034964","eid":"W4289034964"},{"id":"paper-w3148236801","cat":"papers","name":"The Return of Psychedelics: A Measured Approach","year":"2021","cit":0,"pfa":"Charles S. Grob","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W3148236801","eid":"W3148236801"},{"id":"paper-w7165255976","cat":"papers","name":"Longitudinal Case Dataset of Preserved Awareness During Pharmacological State Transitions With Serial qEEG Assessments","year":"2026","cit":0,"pfa":"Hossein Mohamadzade Jafarabadi","topics":["PTSD & trauma","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7165255976","eid":"W7165255976"},{"id":"paper-w4413276641","cat":"papers","name":"Psychedelic-assisted therapies for existential and spiritual suffering in palliative care","year":"2025","cit":0,"pfa":"Ana Cláudia Mesquita Garcia","psa":"Lucas Oliveira Maia","topics":["Anxiety & end-of-life"],"ptype":"book-chapter","src":"https://openalex.org/W4413276641","eid":"W4413276641"},{"id":"paper-w4415077542","cat":"papers","name":"Experteninterview zum Thema psychedelisch unterstützte Psychotherapie (PAP) bei Patienten mit behandlungsresistenter Depression (TRD)","year":"2025","cit":0,"pfa":"Jean Schulthess Watt","topics":["Depression","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4415077542","eid":"W4415077542"},{"id":"paper-w7165764858","cat":"papers","name":"Longitudinal Case Dataset of Preserved Awareness During Pharmacological State Transitions With Serial qEEG Assessments","year":"2026","cit":0,"pfa":"Hossein Mohamadzade Jafarabadi","topics":["PTSD & trauma","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"report","src":"https://openalex.org/W7165764858","eid":"W7165764858"},{"id":"paper-w7117321251","cat":"papers","name":"Allowing Similarities: Using Aldous Huxley’s Views on Mystical Experience to Assess the Import of Profound Unitive Experiences Occasioned by Psychedelic Substances","year":"2025","cit":0,"pfa":"Dana W. Sawyer","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7117321251","eid":"W7117321251"},{"id":"paper-w4409176013","cat":"papers","name":"Potential therapeutic effects of psychedelics in small doses: Is there a role for microdosing in psychiatry?","year":"2025","cit":0,"pfa":"Iva Totomanova","psa":"Kim P. C. Kuypers","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W4409176013","eid":"W4409176013"},{"id":"paper-w4206784321","cat":"papers","name":"The use of psychoactive substances in the treatment of mental disorders","year":"2021","cit":0,"pfa":"Katarzyna Karaś-Ruszczyk","psa":"Jerzy Samochowiec","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4206784321","eid":"W4206784321"},{"id":"paper-w4252645580","cat":"papers","name":"Case Report: Magic Mushroom (Psilocybe Cubensis) Intoxication","year":"2020","cit":0,"pfa":"Andrian Fajar Kusumadewi","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4252645580","eid":"W4252645580"},{"id":"paper-w2898226558","cat":"papers","name":"Attitudes to medicinal cannabis of patients with chronic pain.","year":"2018","cit":0,"pfa":"Lucy Dillon","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2898226558","eid":"W2898226558"},{"id":"paper-w4252215100","cat":"papers","name":"New insights into the clinical and nonclinical effects of psychedelic substances: an integrative review","year":"2021","cit":0,"pfa":"Matthias Forstmann","psa":"Christina Sagioglou","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W4252215100","eid":"W4252215100"},{"id":"paper-w7147148902","cat":"papers","name":"Ep. 396: From Prozac to Plasticity: The New Science of Depression","year":"2026","cit":0,"pfa":"Daniel Rosehill","psa":"Chatterbox TTS","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"other","src":"https://openalex.org/W7147148902","eid":"W7147148902"},{"id":"paper-w7128951017","cat":"papers","name":"Hope for Neurotic Disorders: A Summary of New Zealand Research on the Development of Biomarkers and Novel Treatments","year":"2026","cit":0,"pfa":"Neil McNaughton","psa":"Paul Glue","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7128951017","eid":"W7128951017"},{"id":"paper-w7202369456","cat":"papers","name":"Efficacy and Safety of Psychedelic Microdosing on Psychological Outcomes in Healthy Adults: A Systematic Review and Meta-analysis","year":"2026","cit":0,"pfa":"Shakila Meshkat","psa":"Venkat Bhat","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7202369456","eid":"W7202369456"},{"id":"paper-w3173764789","cat":"papers","name":"Development and Preclinical Testing of a Vaccine for 3,4‐Methylenedioxypyrovalerone (( R,S )‐MDPV) Substance Use Disorders","year":"2018","cit":0,"pfa":"Samantha J. McClenahan","psa":"Samuel Michael Owens","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3173764789","eid":"W3173764789"},{"id":"paper-w3120202862","cat":"papers","name":"Case Report: Magic Mushroom (Psilocybe Cubensis) Intoxication","year":"2020","cit":0,"pfa":"Andrian Fajar Kusumadewi","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3120202862","eid":"W3120202862"},{"id":"paper-w7121003750","cat":"papers","name":"Non-hallucinogenic Psychoplastogens: Decoupling Neuroplasticity from Hallucinations for Cancer-Related Cognitive Impairment and Aging Brain Repair","year":"2026","cit":0,"pfa":"Yuji Marutani","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7121003750","eid":"W7121003750"},{"id":"paper-w3080105950","cat":"papers","name":"[Psychedelics for existential distress in terminally ill patients].","year":"2020","cit":0,"pfa":"Nina Schimmel","psa":"Robert A. Schoevers","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3080105950","eid":"W3080105950"},{"id":"paper-w4413952631","cat":"papers","name":"Integrating Holistic Communication into Psychedelic-Assisted Therapies in Hospice and Palliative Care: An Approach Based on Peplau's Theory","year":"2025","cit":0,"pfa":"Ana Cláudia Mesquita Garcia","psa":"Lucas Oliveira Maia","topics":["Anxiety & end-of-life","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4413952631","eid":"W4413952631"},{"id":"paper-w4244395083","cat":"papers","name":"Investigating the Effect of Kappa Opioid Receptor Agonists on Serotonin Transporter Function in HEK-293 Cells","year":"2013","cit":0,"pfa":"Victoria Catherwood","topics":["Addiction","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W4244395083","eid":"W4244395083"},{"id":"paper-w7165753435","cat":"papers","name":"Hallucinogens","year":"2026","cit":0,"pfa":"Leila M. Soravia","psa":"Felix Manuel Müller","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W7165753435","eid":"W7165753435"},{"id":"paper-w4413459093","cat":"papers","name":"Neurogenic Potential of Acacia oerfota: Evaluating the Effects of DMT-Rich Extract on PC12 Cells","year":"2024","cit":0,"pfa":"Narges Ghasemi Lakeh","psa":"Fatemeh Siadat","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4413459093","eid":"W4413459093"},{"id":"paper-w4235053960","cat":"papers","name":"Naturalistic Entheogenics: Précis of Philosophy of Psychedelics","year":"2021","cit":0,"pfa":"Chris Letheby","topics":["Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4235053960","eid":"W4235053960"},{"id":"paper-w4206058952","cat":"papers","name":"Awakn plans line of psychedelics to treat AUD; Nutt joins as chief research officer","year":"2021","cit":0,"topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4206058952","eid":"W4206058952"},{"id":"paper-w2740450035","cat":"papers","name":"Consommation de substances psychoactives au cours des Ferias du Sud-Ouest : quelles substances en cause et quels tableaux cliniques pour les patients admis dans les postes médicaux avancés ? (étude prospective FERIATOX°)","year":"2017","cit":0,"pfa":"Alexandre Lebeau","topics":["Addiction","Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W2740450035","eid":"W2740450035"},{"id":"paper-w7160956279","cat":"papers","name":"Ophthalmic Effects of Recreational (“Party”) Drugs: Clinical and Translational Perspectives","year":"2026","cit":0,"pfa":"Vinoth Navaratnam","psa":"Maneli Mozaffarieh","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7160956279","eid":"W7160956279"},{"id":"paper-w3173544998","cat":"papers","name":"Using in vitro norepinephrine transporter (NET) inhibition and 5‐HT 2 receptor binding data to predict psychoactive doses of novel psychoactive substances in humans","year":"2018","cit":0,"pfa":"Matthias E. Liechti","psa":"Dino Luethi","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3173544998","eid":"W3173544998"},{"id":"paper-w7110917522","cat":"papers","name":"Metastability of resting-state bold fMRI as a reliable biomarker of individual brain dynamics: An interrogation of within-subject variability as a function of total acquisition time","year":"2025","cit":0,"pfa":"Hiba Sheheitli","psa":"Ziad Nahas","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7110917522","eid":"W7110917522"},{"id":"paper-w7128088321","cat":"papers","name":"Role of mushroom in anxiety disorder","year":"2026","cit":0,"pfa":"Prachi Kolambe*1, Reema Rani2, Disha Koli3","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7128088321","eid":"W7128088321"},{"id":"paper-w7153745875","cat":"papers","name":"Les addictions pendant la grossesse : un défi urgent pour la santé publique","year":"2026","cit":0,"pfa":"Romain Martineau","psa":"Philippe Deruelle","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7153745875","eid":"W7153745875"},{"id":"paper-w7127893486","cat":"papers","name":"Role of mushroom in anxiety disorder","year":"2026","cit":0,"pfa":"Prachi Kolambe*1, Reema Rani2, Disha Koli3","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7127893486","eid":"W7127893486"},{"id":"paper-w4415166505","cat":"papers","name":"Advances in the Treatment of PTSD: A Review of Conventional and Emerging Therapies","year":"2025","cit":0,"pfa":"Cheng Guo","topics":["PTSD & trauma","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4415166505","eid":"W4415166505"},{"id":"paper-w4397035907","cat":"papers","name":"Revolutionizing Addiction Recovery: A Remote Approach to Motivating and Helping Individuals","year":"2023","cit":0,"pfa":"S.K.Manju Bargavi","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4397035907","eid":"W4397035907"},{"id":"paper-w4416739362","cat":"papers","name":"In Silico Evaluation of Tryptamine-Derived Schiff Bases as Modulators of the Serotonin 5-HT₂A Receptor","year":"2025","cit":0,"pfa":"Marina D. Kostić","psa":"Vera M. Divac","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"conference-paper","src":"https://openalex.org/W4416739362","eid":"W4416739362"},{"id":"paper-w4417527789","cat":"papers","name":"MODERN STRATEGIES FOR THE TREATMENT OF TREATMENT-RESISTANT DEPRESSION – A LITERATURE REVIEW","year":"2025","cit":0,"pfa":"Ignacy Rożek","psa":"Barbara Teresińska","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4417527789","eid":"W4417527789"},{"id":"paper-w7121134446","cat":"papers","name":"Non-hallucinogenic Psychoplastogens: Decoupling Neuroplasticity from Hallucinations for Cancer-Related Cognitive Impairment and Aging Brain Repair","year":"2026","cit":0,"pfa":"Yuji Marutani","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7121134446","eid":"W7121134446"},{"id":"paper-w7163574586","cat":"papers","name":"Current status and future prospects of research on psilocybin's regulation of neurotransmitters and their receptors related to the pathogenesis of tinnitus","year":"2026","cit":0,"pfa":"Shuhan Lu","psa":"Fangyuan Wang","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7163574586","eid":"W7163574586"},{"id":"paper-w7215657199","cat":"papers","name":"USO TERAPÊUTICO DA PSILOCIBINA EM TRANSTORNOS DEPRESSIVOS","year":"2024","cit":0,"pfa":"Jéssica Giardini Mendes","psa":"Mirelle Araujo Casagrande","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7215657199","eid":"W7215657199"},{"id":"paper-w2331093644","cat":"papers","name":"Mykosen – Bedeutung in Medizin und Zahnmedizin, Diagnostik und Therapie","year":"2011","cit":0,"pfa":"Michael Hopp","psa":"Hans‐Jürgen Tietz","ptype":"article","src":"https://openalex.org/W2331093644","eid":"W2331093644"},{"id":"paper-w4409166899","cat":"papers","name":"THE VISIONARY MICROSCOPE. ENTHEOGENS AS A “SCIENTIFIC” TOOL IN THE THOUGHT OF OCCULTISTS OF THE LATE 19TH - EARLY 20TH CENTURIES","year":"2025","cit":0,"pfa":"Петрухин Семен Сергеевич","ptype":"article","src":"https://openalex.org/W4409166899","eid":"W4409166899"},{"id":"paper-w3182788247","cat":"papers","name":"The Influence of Psychedelic Drugs on the 'Sense of Self'","year":"2021","cit":0,"pfa":"Philipp Matteo Härter","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3182788247","eid":"W3182788247"},{"id":"paper-w7207600574","cat":"papers","name":"Novel pharmacotherapies for opioid use disorder and opioid withdrawal","year":"2026","cit":0,"pfa":"Mary R. Shen","psa":"Joji Suzuki","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7207600574","eid":"W7207600574"},{"id":"paper-w7163554120","cat":"papers","name":"Happy water overdose: A trending but fatal street drug","year":"2026","cit":0,"pfa":"Aung Kyaw Thu","psa":"Si Thu Linn","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7163554120","eid":"W7163554120"},{"id":"paper-w4388595930","cat":"papers","name":"In-hospital prognosis of recreational drug use in patients with acute ST-elevation myocardial infarction: insights from the ADDICT-ICCU study","year":"2023","cit":0,"pfa":"A Clement","psa":"J G Dillinger","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4388595930","eid":"W4388595930"},{"id":"paper-w7117297881","cat":"papers","name":"Suggested Guidelines for Applying a Systemic Lens to Psychedelic-Assisted Psychotherapy","year":"2025","cit":0,"pfa":"Sara N. Lappan","psa":"Sean D. Davis","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7117297881","eid":"W7117297881"},{"id":"paper-w7133552910","cat":"papers","name":"Nuclear Spin Modulation of Psychedelic Consciousness States: A Factorial fMRI Protocol Combining N,N-DMT with Krypton and Xenon Isotopes","year":"2026","cit":0,"pfa":"Jean‐Patrick Pommier","psa":"POMMIER","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7133552910","eid":"W7133552910"},{"id":"paper-w577272327","cat":"papers","name":"Understanding ligand binding, selectivity and functions on the G protein-coupled receptors: A molecular modeling approach","year":"2014","cit":0,"pfa":"Saheem A. Zaidi","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W577272327","eid":"W577272327"},{"id":"paper-w4405883221","cat":"papers","name":"Unraveling the organellar genomic landscape of the therapeutic and entheogenic plant Mimosa tenuiflora: insights into genetic, structural, and evolutionary dynamics","year":"2024","cit":0,"pfa":"Vitor Trinca","psa":"Alessandro M. Varani","ptype":"article","src":"https://openalex.org/W4405883221","eid":"W4405883221"},{"id":"paper-w4407857191","cat":"papers","name":"Setting the Stage for the Inner Journey: Unraveling the Interplay of Contextual Factors and the Intensity of Psychedelic-induced Ego Dissolution","year":"2024","cit":0,"pfa":"Stanisław Adamczyk","psa":"Paweł Orlowski","topics":["Addiction"],"ptype":"preprint","src":"https://openalex.org/W4407857191","eid":"W4407857191"},{"id":"paper-w2079468393","cat":"papers","name":"Biochemical, pharmacological, and toxic effects of n-metil 3,4-methylenedioxyamphetamine - \"ecstasy\"","year":"2005","cit":0,"pfa":"Živorad Maličević","psa":"Marina Jovanović","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2079468393","eid":"W2079468393"},{"id":"paper-w589280298","cat":"papers","name":"The Effect of Serotonin Receptor Manipulation On Brain Networks and Its Impact On Emotion Regulation","year":"2015","cit":0,"pfa":"Rainer Krähenmann","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W589280298","eid":"W589280298"},{"id":"paper-w7128149657","cat":"papers","name":"Encountering the Luminous Mother: Two Breakthrough DMT Narratives and the Six-Phase Architecture of Mystical Experience","cit":0,"pfa":"Keppel Hesselink JM","topics":["Anxiety & end-of-life","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7128149657","eid":"W7128149657"},{"id":"paper-w7170155380","cat":"papers","name":"Comparing synthetic and biological therapy for the treatment of cluster headache: what is needed and when?","year":"2026","cit":0,"pfa":"Brendan A. Parr","psa":"Stephen D. Silberstein","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7170155380","eid":"W7170155380"},{"id":"paper-w7160937971","cat":"papers","name":"Editorial: Case reports in psychopharmacology, volume IV","year":"2026","cit":0,"pfa":"Matej Štuhec","psa":"Patricia Di Ciano","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"editorial","src":"https://openalex.org/W7160937971","eid":"W7160937971"},{"id":"paper-w7198985963","cat":"papers","name":"Etnobotánica de Lophophora Williamsii","year":"2018","cit":0,"pfa":"Nazaret Clavijo González","ptype":"dissertation","src":"https://openalex.org/W7198985963","eid":"W7198985963"},{"id":"paper-w2936920827","cat":"papers","name":"Attitudes Toward Medical Psychedelics","year":"2019","cit":0,"pfa":"McKenna Silva","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"conference-paper","src":"https://openalex.org/W2936920827","eid":"W2936920827"},{"id":"paper-w3189728126","cat":"papers","name":"Late Modernist Allegory and the Psychedelic Experience","year":"2021","cit":0,"pfa":"Maria Cichosz","ptype":"book-chapter","src":"https://openalex.org/W3189728126","eid":"W3189728126"},{"id":"paper-w4414639927","cat":"papers","name":"A Look to “Classical” Psychedelics and the Atypic Dissociative Ketamine: Some Basics for Approaches to Medical Conditions","year":"2025","cit":0,"pfa":"Sabine Himmelseher","psa":"Josef Priller","ptype":"book-chapter","src":"https://openalex.org/W4414639927","eid":"W4414639927"},{"id":"paper-w7140328447","cat":"papers","name":"Psychedelics, Cannabis, and the Normalization Principle: Bidirectional Microtubule Disruption as Evidence for the MT Normalization Hypothesis of Psychosis","year":"2026","cit":0,"pfa":"Marko Leicht","topics":["Addiction","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W7140328447","eid":"W7140328447"},{"id":"paper-w2378512752","cat":"papers","name":"The Distribution and Metabolism of Ketamine in the Body","year":"2012","cit":0,"pfa":"Jingru Sun","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2378512752","eid":"W2378512752"},{"id":"paper-w4415352576","cat":"papers","name":"Simulated 5-HT2A receptor activation accounts for the high complexity of brain activity during psychedelic states","year":"2025","cit":0,"pfa":"Hugo M. Martin","psa":"Alain Destexhe","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4415352576","eid":"W4415352576"},{"id":"paper-w4414295375","cat":"papers","name":"Clinical Profile and Drugs of Abuse Identified among People who Use Drugs Admitted to a Tertiary Hospital in the Philippines using a Validated LC-QTOF/MS Method","year":"2025","cit":0,"pfa":"Carissa Paz C. Dioquino","psa":"Roy R. L. Gerona","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4414295375","eid":"W4414295375"},{"id":"paper-w7140321548","cat":"papers","name":"Psychedelics, Cannabis, and the Normalization Principle: Bidirectional Microtubule Disruption as Evidence for the MT Normalization Hypothesis of Psychosis","year":"2026","cit":0,"pfa":"Marko Leicht","topics":["Addiction","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W7140321548","eid":"W7140321548"},{"id":"paper-w7163997656","cat":"papers","name":"Aquahenosis: a non-pharmacological altered state of consciousness induced by floatation-REST in individuals with anxiety and depression","year":"2026","cit":0,"pfa":"Theo Tobel","psa":"Sahib S. Khalsa","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7163997656","eid":"W7163997656"},{"id":"paper-w4409904042","cat":"papers","name":"Psychedelics in the treatment of cluster headaches","year":"2025","cit":0,"pfa":"Michal Židó","psa":"Ivana Štětkářová","ptype":"article","src":"https://openalex.org/W4409904042","eid":"W4409904042"},{"id":"paper-w7136439568","cat":"papers","name":"Beyond Generation Defense: Systematic Vulnerabilities in LLM Safety Architectures for Content Transformation","year":"2026","cit":0,"pfa":"Alessandro Marci","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7136439568","eid":"W7136439568"},{"id":"paper-w7147454004","cat":"papers","name":"Bidirectional alpha collapse, not forward wave increase, under N,N-DMT: A reanalysis of cortical travelling waves","year":"2026","cit":0,"pfa":"David M. Remmer","topics":["Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W7147454004","eid":"W7147454004"},{"id":"paper-w7131701875","cat":"papers","name":"Pharmacological regulation of adult brain neuroplasticity: Synergistic roles of neuropeptide signaling, psychedelics, and synaptic modulators","year":"2026","cit":0,"pfa":"Mustafa M Shokr","psa":"Ahmed M Abdelaziz","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7131701875","eid":"W7131701875"},{"id":"paper-w4408302040","cat":"papers","name":"Psychedelics and autobiographical memory – Six open questions","year":"2025","cit":0,"pfa":"Samuli Kangaslampi","psa":"Morten P. Lietz","topics":["PTSD & trauma","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4408302040","eid":"W4408302040"},{"id":"paper-w982580871","cat":"papers","name":"Gyógyszeres terápia által indukált amyloid prekurzor protein metabolizmus és amyloid képződés változásának vizsgálata in vitro és in vivo = In vitro and in vivo study of the changes of amyloid precursor protein metabolis","year":"2007","cit":0,"pfa":"Magdolna Pákáski","psa":"Zoltán Rakonczay","topics":["Depression","Addiction"],"ptype":"book","src":"https://openalex.org/W982580871","eid":"W982580871"},{"id":"paper-w7211928516","cat":"papers","name":"Cannabis Is a Psychedelic, and a Beneficial One at That - The Overlooked Cannabinoid Path Into Altered Consciousness","year":"2026","cit":0,"pfa":"Christian Alexander Brown","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W7211928516","eid":"W7211928516"},{"id":"paper-w2365499926","cat":"papers","name":"RECENT PROGRESS OF BRAIN FUNCTIONAL IMAGING IN DRUG ADDICTION","year":"2006","cit":0,"pfa":"Lin Lü","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2365499926","eid":"W2365499926"},{"id":"paper-w7136713832","cat":"papers","name":"Beyond Generation Defense: Systematic Vulnerabilities in LLM Safety Architectures for Content Transformation","year":"2026","cit":0,"pfa":"Alessandro Marci","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7136713832","eid":"W7136713832"},{"id":"paper-w4408245726","cat":"papers","name":"A Rapid Review of Psychedelic-Assisted Therapy in the Context of Palliative Care","year":"2025","cit":0,"pfa":"Miller, Megan","psa":"Rosa, William E.","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4408245726","eid":"W4408245726"},{"id":"paper-w3174429624","cat":"papers","name":"Effects of Environmental Variables on the Pharmacological Actions of “Bath Salts” Constituent 3,4‐Methylenedioxypyrovalerone (MDPV) in Mice","year":"2018","cit":0,"pfa":"Lauren N. Russell","psa":"William E. Fantegrossi","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3174429624","eid":"W3174429624"},{"id":"paper-w7162254813","cat":"papers","name":"Pharmacotherapeutic Management of Depression in Patients With Cancer: A Review of Mechanistic and Clinical Evidence","year":"2026","cit":0,"pfa":"Sepideh Hajivalizadeh","psa":"Ahmad Shamabadi","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7162254813","eid":"W7162254813"},{"id":"paper-w7211954538","cat":"papers","name":"Cannabis Is a Psychedelic, and a Beneficial One at That - The Overlooked Cannabinoid Path Into Altered Consciousness","year":"2026","cit":0,"pfa":"Christian Alexander Brown","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W7211954538","eid":"W7211954538"},{"id":"paper-w7168445942","cat":"papers","name":"Psychopharmacology and Brain Transforming Interventions: A Guide for Mental Health Professionals","year":"2026","cit":0,"pfa":"Edward Neukrug","psa":"Bruce S Britton","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7168445942","eid":"W7168445942"},{"id":"paper-w4385789031","cat":"papers","name":"Classical psychedelics in psychiatry – renaissance of interest and therapeutic perspectives","year":"2023","cit":0,"pfa":"Askaniusz Jachimowski","psa":"Krzysztof Artur Kucia","topics":["Addiction","Anxiety & end-of-life","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4385789031","eid":"W4385789031"},{"id":"paper-w7113252877","cat":"papers","name":"Effects of Psychedelic Microdosing on Cognitive Function: A Meta-Analysis","year":"2025","cit":0,"pfa":"Netta Pinhas","psa":"Leehe Peled-Avron","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7113252877","eid":"W7113252877"},{"id":"paper-w4383268096","cat":"papers","name":"Ketamin und psychoaktive Substanzen in psychotherapeutischen Prozessen","year":"2023","cit":0,"pfa":"Dirk Revenstorf","psa":"Bernhard Trenkle","topics":["Therapy practice","Policy & ethics"],"ptype":"book","src":"https://openalex.org/W4383268096","eid":"W4383268096"},{"id":"paper-w7155581543","cat":"papers","name":"Actividad eléctrica del Cerebro Psicodélico; Revisión Sistemática sobre Estudios Clínicos Con EEG en estado de reposo","year":"2024","cit":0,"pfa":"Juan Pedro Castro‐Nin","psa":"Ismael Apud","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7155581543","eid":"W7155581543"},{"id":"paper-w7212068332","cat":"papers","name":"864. Efficacy of antidepressants in children and adolescents with depression – results from a large scale patient-level meta-analysis","year":"2026","cit":0,"pfa":"Fredrik Hieronymus","psa":"Jakob Näslund","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7212068332","eid":"W7212068332"},{"id":"paper-w7148344619","cat":"papers","name":"Bidirectional alpha collapse, not forward wave increase, under N,N-DMT: A reanalysis of cortical travelling waves","year":"2026","cit":0,"pfa":"David M. Remmer","topics":["Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W7148344619","eid":"W7148344619"},{"id":"paper-w3033140951","cat":"papers","name":"SOCIAL WORK GRADUATE STUDENTS SELF-REPORTED KNOWLEDGE OF TREATMENT OPTIONS FOR POST TRAUMATIC STRESS DISORDER","year":"2020","cit":0,"pfa":"Kerry D. Morgan","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W3033140951","eid":"W3033140951"},{"id":"paper-w4408245678","cat":"papers","name":"[Psychiatric drug development on the verge of its Rubicon].","year":"2025","cit":0,"pfa":"G Jacobs","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W4408245678","eid":"W4408245678"},{"id":"paper-w7133548836","cat":"papers","name":"Nuclear Spin Modulation of Psychedelic Consciousness States: A Factorial fMRI Protocol Combining N,N-DMT with Krypton and Xenon Isotopes","year":"2026","cit":0,"pfa":"Jean‐Patrick Pommier","psa":"POMMIER","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7133548836","eid":"W7133548836"},{"id":"paper-w7208811465","cat":"papers","name":"Exploring the Therapeutic and Nutritional Potential of Cactaceae: An Ethnopharmacological Perspective Integrating Traditional Knowledge and Modern Research","year":"2026","cit":0,"pfa":"Anushka Sasmal","psa":"Shaileyee Das","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7208811465","eid":"W7208811465"},{"id":"paper-w7170657208","cat":"papers","name":"Investigating Endogenous DMT Biosynthesis and VMAT2 Activity","year":"2024","cit":0,"pfa":"Emma Babaian","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W7170657208","eid":"W7170657208"},{"id":"paper-w272233368","cat":"papers","name":"Driver impairment and traffic safety results from IMMORTAL","year":"2006","cit":0,"pfa":"M Bernhoft","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W272233368","eid":"W272233368"},{"id":"paper-w7148386681","cat":"papers","name":"Bidirectional alpha collapse, not forward wave increase, under N,N-DMT: A reanalysis of cortical travelling waves","year":"2026","cit":0,"pfa":"David M. Remmer","topics":["Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W7148386681","eid":"W7148386681"},{"id":"paper-w4402553746","cat":"papers","name":"Molecular Imaging on the Cerebral Pathological Damage Target of Ketamine Dependence","year":"2014","cit":0,"pfa":"HU Shu JIA Shao-wei GAO Zhou WANG Tong ZHAO Zheng-qin YANG Hong-jie","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4402553746","eid":"W4402553746"},{"id":"paper-w7130915694","cat":"papers","name":"EXPLORATION OF ERGOT AND SALVIA DIVINORUM CHEMICAL SPACE VIA A DIVERGENT TOTAL SYNTHESIS APPROACH","year":"2026","cit":0,"pfa":"LEONI, GIOVANNI","topics":["Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7130915694","eid":"W7130915694"},{"id":"paper-w4402766768","cat":"papers","name":"G33 Psychedelic drugs for the treatment of chronic pain: is ketamine included?","year":"2024","cit":0,"pfa":"Amany Ezzat Ayad","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"conference-paper","src":"https://openalex.org/W4402766768","eid":"W4402766768"},{"id":"paper-w7160902471","cat":"papers","name":"Psychedelika in der Psychotherapie: Von der pharmakologischen Wirkung zur transdiagnostischen Veränderung","year":"2026","cit":0,"pfa":"Susanne Prinz","psa":"Helena Aicher","topics":["Depression","PTSD & trauma","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7160902471","eid":"W7160902471"},{"id":"paper-w7120909183","cat":"papers","name":"Coleoptera families bostrichidae and curculionidae (Scolytinae) associated with Banisteriopsis caapi (Spruce Ex Grisebach) in Brazil","year":"2013","cit":0,"pfa":"Rebeca Cristina Pena","ptype":"dissertation","src":"https://openalex.org/W7120909183","eid":"W7120909183"},{"id":"paper-w7140209741","cat":"papers","name":"Disentangling Alcohol from a Single Latent Dimension of Polysubstance Involvement at Treatment Entry","year":"2026","cit":0,"pfa":"Georgia Murphy","psa":"Nicholas L. Kerswell","topics":["Addiction"],"ptype":"preprint","src":"https://openalex.org/W7140209741","eid":"W7140209741"},{"id":"paper-w4244706925","cat":"papers","name":"Hallucinogens","year":"2017","cit":0,"pfa":"G. Hussein Rassool","topics":["Depression","Addiction","Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W4244706925","eid":"W4244706925"},{"id":"paper-w4405815053","cat":"papers","name":"Treatment of Dravet disease and false urine testing with ecstasy: a little-known interference","year":"2024","cit":0,"pfa":"Romain Magny","psa":"Pascal Houzé","ptype":"article","src":"https://openalex.org/W4405815053","eid":"W4405815053"},{"id":"paper-w7167861106","cat":"papers","name":"Using Physiochemical Properties of Phenylalkylamines in Silico as a Predictive Classification of Psychedelic Effect","year":"2024","cit":0,"pfa":"Tatum Hedrick","psa":"Caleb Siguenza","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"conference-paper","src":"https://openalex.org/W7167861106","eid":"W7167861106"},{"id":"paper-w7160019461","cat":"papers","name":"The pharmacology and toxicology of the stimulant khat","year":"2026","cit":0,"pfa":"Hadeel A. Alsufyani","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7160019461","eid":"W7160019461"},{"id":"paper-w7211887793","cat":"papers","name":"Higher signal diversity, network dysregulation, and increased well-being under DMT administration: An EEG study","year":"2026","cit":0,"pfa":"Eleni Kroupi","psa":"Aureli Soria‐Frisch","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7211887793","eid":"W7211887793"},{"id":"paper-w7106787141","cat":"papers","name":"Oxytocin receptor polymorphisms and pharmacogenetic tailoring: Enhancing Social Reward Deficits in Post-Traumatic Stress Disorder (PTSD)","year":"2025","cit":0,"pfa":"Ifeoma Nwamaka Monago","psa":"Adetunbosun Adekoya","topics":["PTSD & trauma","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7106787141","eid":"W7106787141"},{"id":"paper-w7138489653","cat":"papers","name":"Severity of Polysubstance Use Among Young People Seeking Drug and Alcohol Treatment, and Social and Mental Health Correlates: An Observational Study","year":"2026","cit":0,"pfa":"Nina Pocuca","psa":"Leanne M. Hides","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7138489653","eid":"W7138489653"},{"id":"paper-w4412106757","cat":"papers","name":"Psilocibina e LSD no tratamento do transtorno depressivo maior","year":"2025","cit":0,"pfa":"Luiz Felipe de Azevedo Assunção","psa":"Ana Larissa Fernandes de Holanda Soares","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4412106757","eid":"W4412106757"},{"id":"paper-w4407723748","cat":"papers","name":"Psychosis in a Military Veteran in the Context of Hallucinogen Use: A Case Report","year":"2025","cit":0,"pfa":"Paria Parhami","psa":"Linda Galicki","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4407723748","eid":"W4407723748"},{"id":"paper-w7204939981","cat":"papers","name":"HPLC-MS and SERS Profiling of Opium Alkaloids and DMT: A Nanoparticle-Based Approach","year":"2026","cit":0,"pfa":"Abhishek Sharma","psa":"Abhishek Sharma","ptype":"book-chapter","src":"https://openalex.org/W7204939981","eid":"W7204939981"},{"id":"paper-w7109755235","cat":"papers","name":"Oxytocin receptor polymorphisms and pharmacogenetic tailoring: Enhancing Social Reward Deficits in Post-Traumatic Stress Disorder (PTSD)","year":"2025","cit":0,"pfa":"Monago, Ifeoma Nwamaka","psa":"Adekoya, Adetunbosun","topics":["PTSD & trauma","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7109755235","eid":"W7109755235"},{"id":"paper-w4237039616","cat":"papers","name":"Unusual Drugs of Abuse in Chronic Pain Patients","year":"2017","cit":0,"pfa":"Alan D. Kaye","psa":"Matthew B. Novitch","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4237039616","eid":"W4237039616"},{"id":"paper-w4413883095","cat":"papers","name":"A systematic review of pharmacological effects on human aversive memory","year":"2025","cit":0,"pfa":"Yanfang Xia","psa":"Dominik R. Bach","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4413883095","eid":"W4413883095"},{"id":"paper-w4406449729","cat":"papers","name":"The role of myocardial bridge of the left anterior descending artery in a sudden death of a ketamine and cannabis user. Addressing the uncertainties on the cause of death in a forensic pathologist’s casework","year":"2025","cit":0,"pfa":"Guido Pelletti","psa":"Susi Pelotti","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4406449729","eid":"W4406449729"},{"id":"paper-w2157799363","cat":"papers","name":"Do the binding sites of substrates and tricyclic antidepressants overlap on the serotonin transporter?","year":"2008","cit":0,"pfa":"Subhodeep Sarker","psa":"Ilka Steiner","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2157799363","eid":"W2157799363"},{"id":"paper-w7172382485","cat":"papers","name":"Psychedelics and women’s mental health: the effects of female sex hormones on psychedelics’ efficacy and tolerability","year":"2026","cit":0,"pfa":"Kim P. C. Kuypers","psa":"Eline C. H. M. Haijen","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7172382485","eid":"W7172382485"},{"id":"paper-w7168249236","cat":"papers","name":"Neurobiological correlates of treatment-resistant depression: implications for pharmacotherapy","year":"2026","cit":0,"pfa":"Joanna Kot","psa":"Filip Rybakowski","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7168249236","eid":"W7168249236"},{"id":"paper-w7213324753","cat":"papers","name":"Resetting the hippocampal buffer: a neurocognitive account of psychedelic therapy for anxiety-related psychopathology","year":"2026","cit":0,"pfa":"Hugh McGovern","psa":"Manoj K. Doss","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7213324753","eid":"W7213324753"},{"id":"paper-w4399365151","cat":"papers","name":"Setting the Stage for the Inner Journey: Unraveling the Interplay of Contextual Factors and the Intensity of Ego-Dissolution in Naturalistic Psychedelic Experiences","year":"2024","cit":0,"pfa":"Stanisław Adamczyk","psa":"Paweł Orlowski","topics":["Addiction","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4399365151","eid":"W4399365151"},{"id":"paper-w2989801232","cat":"papers","name":"Toxicities from illicit and abused drugs in cats and dogs","year":"2017","cit":0,"pfa":"Begüm Yurdakök-Di̇kmen","psa":"Ayhan Filazı","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2989801232","eid":"W2989801232"},{"id":"paper-w3120922676","cat":"papers","name":"Unusual Drugs of Abuse in Chronic Pain Patients","year":"2017","cit":0,"pfa":"Alan D. Kaye","psa":"Matthew B. Novitch","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3120922676","eid":"W3120922676"},{"id":"paper-w7124322723","cat":"papers","name":"Aquahenosis: A non-pharmacological altered state of consciousness induced by Floatation-REST","year":"2026","cit":0,"pfa":"Theo Tobel","psa":"Sahib S. Khalsa","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7124322723","eid":"W7124322723"},{"id":"paper-w7109577314","cat":"papers","name":"Oxytocin receptor polymorphisms and pharmacogenetic tailoring: Enhancing Social Reward Deficits in Post-Traumatic Stress Disorder (PTSD)","year":"2025","cit":0,"pfa":"Monago, Ifeoma Nwamaka","psa":"Adekoya, Adetunbosun","topics":["PTSD & trauma","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7109577314","eid":"W7109577314"},{"id":"paper-w4394845049","cat":"papers","name":"Neural effects of psychedelics: Complexity the key word","year":"2024","cit":0,"pfa":"Brett D. M. Jones","psa":"Muhammad Ishrat Husain","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4394845049","eid":"W4394845049"},{"id":"paper-w2417663412","cat":"papers","name":"[Application of group psychology of animals into pharmacological studies. 12. Specificities of actions of psychotropic drugs on emotional and exploratory behaviors of a single mouse or groups of 2 or 3 animals].","year":"1975","cit":0,"pfa":"Taeko Hata","psa":"Ryuhei Yoneda","topics":["Depression","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W2417663412","eid":"W2417663412"},{"id":"paper-w52968831","cat":"papers","name":"Hallucinogen Persisting Perception Disorder: Causes, Risks, and Possible Neurobiology","year":"2012","cit":0,"pfa":"Ruud P. W. Litjens","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W52968831","eid":"W52968831"},{"id":"paper-w4413745231","cat":"papers","name":"Psychedelic Rejuvenation Hypothesis: A Framework for Cellular and Psychological Rejuvenation","year":"2025","cit":0,"pfa":"Tony Montgomery","psa":"DeMond M. Grant","topics":["Mechanism & neuroscience","Therapy practice","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4413745231","eid":"W4413745231"},{"id":"paper-w2541688878","cat":"papers","name":"Biological targets for medication development in stimulant addiction: Focus on animal models of addictive-like behavior","year":"2013","cit":0,"pfa":"Juan J. Canales","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2541688878","eid":"W2541688878"},{"id":"paper-w7139072701","cat":"papers","name":"Beyond the Brain Reset: The Science of Psychedelics","year":"2026","cit":0,"pfa":"Daniel Rosehill","psa":"Chatterbox TTS","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"other","src":"https://openalex.org/W7139072701","eid":"W7139072701"},{"id":"paper-w4387976655","cat":"papers","name":"A protocol for a scoping review of psychedelic interventions to alleviate psychological suffering in populations coping with end-of-life issues","year":"2023","cit":0,"pfa":"Sarah Kratina","psa":"Brian R. Rush","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W4387976655","eid":"W4387976655"},{"id":"paper-w7196936402","cat":"papers","name":"Therapeutic potential of classic and non-classic psychedelics in neurodevelopmental disorders: Opportunities and challenges","year":"2026","cit":0,"pfa":"Mattia Giovenzana","psa":"Jessica Mingardi","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7196936402","eid":"W7196936402"},{"id":"paper-w3173827426","cat":"papers","name":"Microdoseren met psychedelica: wat weten we ervan?","year":"2020","cit":0,"pfa":"Kim P. C. Kuypers","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3173827426","eid":"W3173827426"},{"id":"paper-w7215131852","cat":"papers","name":"raefalizadehnima-droid/Machine-Learning-Framework-for-Pharmacologically-: v22","year":"2026","cit":0,"pfa":"raefalizadehnima-droid","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"software","src":"https://openalex.org/W7215131852","eid":"W7215131852"},{"id":"paper-w7214989218","cat":"papers","name":"raefalizadehnima-droid/Machine-Learning-Framework-for-Pharmacologically-: Version 17","year":"2026","cit":0,"pfa":"raefalizadehnima-droid","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"software","src":"https://openalex.org/W7214989218","eid":"W7214989218"},{"id":"paper-w2424070938","cat":"papers","name":"What Do Psychiatric Patients, Marathon Runners and Ravers Have in Common? a Case Report of the Consequences of Water Intoxication.","year":"2015","cit":0,"pfa":"Melissa Gill","psa":"MacDara McCauley","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2424070938","eid":"W2424070938"},{"id":"paper-w7215091845","cat":"papers","name":"raefalizadehnima-droid/Machine-Learning-Framework-for-Pharmacologically-Induced-Transient-Neural-Signatures-: v22","year":"2026","cit":0,"pfa":"raefalizadehnima-droid","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"software","src":"https://openalex.org/W7215091845","eid":"W7215091845"},{"id":"paper-w4415496150","cat":"papers","name":"3642 Down the rabbit hole: case reports of a hallucinogen-induced disorder of neuroperception","year":"2025","cit":0,"pfa":"Anneliese McConnell","psa":"Paul F. Sowman","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"conference-paper","src":"https://openalex.org/W4415496150","eid":"W4415496150"},{"id":"paper-w4404566384","cat":"papers","name":"ANÁLISE DO USO DE SUBSTÂNCIAS PSICODÉLICAS NO TRATAMENTO DA DEPRESSÃO: UMA REVISÃO INTEGRATIVA DE LITERATURA","year":"2024","cit":0,"pfa":"Diogo Nelson Rodrigues Noronha","psa":"Renato Gomes Sobral Barcellos","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4404566384","eid":"W4404566384"},{"id":"paper-w7215091716","cat":"papers","name":"raefalizadehnima-droid/Machine-Learning-Framework-for-Pharmacologically-Induced-Transient-Neural-Signatures-: v22","year":"2026","cit":0,"pfa":"raefalizadehnima-droid","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"software","src":"https://openalex.org/W7215091716","eid":"W7215091716"},{"id":"paper-w7138024052","cat":"papers","name":"Severity of Polysubstance Use Among Young People Seeking Drug and Alcohol Treatment, and Social and Mental Health Correlates: An Observational Study","year":"2026","cit":0,"pfa":"Nina Pocuca","psa":"Leanne M. Hides","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7138024052","eid":"W7138024052"},{"id":"paper-w7172131966","cat":"papers","name":"Death and Near-Death Experiences in Ketamine and Psychedelic Therapy","year":"2026","cit":0,"pfa":"Michael Alvear","ptype":"preprint","src":"https://openalex.org/W7172131966","eid":"W7172131966"},{"id":"paper-w7214975005","cat":"papers","name":"raefalizadehnima-droid/Machine-Learning-Framework-for-Pharmacologically-: v22","year":"2026","cit":0,"pfa":"raefalizadehnima-droid","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"software","src":"https://openalex.org/W7214975005","eid":"W7214975005"},{"id":"paper-w4401614872","cat":"papers","name":"Prevalence and Correlates of Psychedelic Use in Poland: A Study on a Representative Sample of Polish Adults","year":"2024","cit":0,"pfa":"Paweł Holas","psa":"Justyna Kamińska","ptype":"preprint","src":"https://openalex.org/W4401614872","eid":"W4401614872"},{"id":"paper-w7147462284","cat":"papers","name":"The Molecular Key to the Theta Field: A Zero-Parameter Formalization of Endogenous DMT and Consciousness State Transitions","year":"2026","cit":0,"pfa":"Washburn","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7147462284","eid":"W7147462284"},{"id":"paper-w4410121503","cat":"papers","name":"Michael A. Wheeler: Psychedelics and neuroimmune circuits—what a strange trip, indeed","year":"2025","cit":0,"pfa":"Michael A. Wheeler","topics":["Depression","Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4410121503","eid":"W4410121503"},{"id":"paper-w7151413747","cat":"papers","name":"Confirmatory gas chromatography–mass spectrometry drug testing in pediatric patients: a clinical case series highlighting false-positive results and child protection implications","year":"2026","cit":0,"pfa":"Nicolás Fernández","psa":"Patricia Noemí Quiroga","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7151413747","eid":"W7151413747"},{"id":"paper-w2257471018","cat":"papers","name":"What Happens at Underground Raves? Risk, research and Harm Reduction","year":"2012","cit":0,"topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2257471018","eid":"W2257471018"},{"id":"paper-w1996367768","cat":"papers","name":"Comorbidity of substance abuse and early psychosis in Bologna","year":"2008","cit":0,"pfa":"Emiliano Mori","psa":"D. Berardi","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1996367768","eid":"W1996367768"},{"id":"paper-w4390989926","cat":"papers","name":"Tryptamine psychedelics shape population receptive fields in early visual cortex in the presence of perceptual distortions","year":"2024","cit":0,"pfa":"Marta Lapo Pais","psa":"Miguel Castelo‐Branco","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4390989926","eid":"W4390989926"},{"id":"paper-w7213928055","cat":"papers","name":"Targeting the serotonin 1B receptor for the treatment of depression and anxiety","year":"2026","cit":0,"pfa":"Sixtine Fleury","psa":"Katherine M. Nautiyal","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7213928055","eid":"W7213928055"},{"id":"paper-w2145374187","cat":"papers","name":"Changes in head twitch response induced by a 5-hydroxytryptamine agonist in mice fed a low-protein diet","year":"1996","cit":0,"pfa":"K. Minakami","psa":"Takeo Fukuda","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2145374187","eid":"W2145374187"},{"id":"paper-w7167786999","cat":"papers","name":"Beyond symptom reduction: DMT improves anxiety, life satisfaction, and quality of life in healthy volunteers and patients with depression","year":"2026","cit":0,"pfa":"Raynara Bolcont","psa":"Dráulio Barros de Araújo","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7167786999","eid":"W7167786999"},{"id":"paper-w7147266558","cat":"papers","name":"The Molecular Key to the Theta Field: A Zero-Parameter Formalization of Endogenous DMT and Consciousness State Transitions","year":"2026","cit":0,"pfa":"Washburn","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7147266558","eid":"W7147266558"},{"id":"paper-w7203524344","cat":"papers","name":"Psychedelics and Religious Insight: A Precedent in American Psycho-Spirituality from William James to Timothy Leary","year":"2021","cit":0,"pfa":"Connor J. Storck","topics":["Addiction","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W7203524344","eid":"W7203524344"},{"id":"paper-w7202155121","cat":"papers","name":"Effects of naturalistic psychedelic use on executive functioning: An online survey of lifetime history and recent use in university students","year":"2026","cit":0,"pfa":"Stefanie Todesco","psa":"Christian G. Schütz","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7202155121","eid":"W7202155121"},{"id":"paper-w7171866083","cat":"papers","name":"Age as a Moderator of Psychoactive-Assisted Psychotherapies Outcomes: A Systematic Literature Review and Meta-Analysis","year":"2026","cit":0,"pfa":"Asher Wenig","psa":"David B. Newman","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W7171866083","eid":"W7171866083"},{"id":"paper-w7139024171","cat":"papers","name":"Beyond the Brain Reset: The Science of Psychedelics","year":"2026","cit":0,"pfa":"Daniel Rosehill","psa":"Chatterbox TTS","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"other","src":"https://openalex.org/W7139024171","eid":"W7139024171"},{"id":"paper-w2890207357","cat":"papers","name":"If you give a mouse a mushroom: Behavioral effects of hallucinogens in mice","year":"2018","cit":0,"pfa":"Landon M. Klein","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W2890207357","eid":"W2890207357"},{"id":"paper-w4416299212","cat":"papers","name":"Psychedelic Rejuvenation Hypothesis: A Framework for Cellular and Psychological Restoration","year":"2025","cit":0,"pfa":"Tony R. Montgomery","psa":"DeMond M. Grant","topics":["Mechanism & neuroscience","Therapy practice","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4416299212","eid":"W4416299212"},{"id":"paper-w4299557265","cat":"papers","name":"A harm-reduction approach to the isolation of harmine and its hydrogenated derivatives from Peganum Harmala seed in low-tech settings","year":"2016","cit":0,"pfa":"Frederick A.P. Van Der Sypt","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4299557265","eid":"W4299557265"},{"id":"paper-w7120336151","cat":"papers","name":"Entheogenic experiments: Santa Maria and Exu at Santo Daime","year":"2021","cit":0,"pfa":"Rocha, Jessica","ptype":"dissertation","src":"https://openalex.org/W7120336151","eid":"W7120336151"},{"id":"paper-w4388373853","cat":"papers","name":"PSICOTERAPIA ASSISTIDA POR PSILOCIBINA PARA TRATAMENTO DE DEPRESSÃO E ANSIEDADE EM PACIENTES COM CÂNCER EM RISCO DE VIDA: UMA REVISÃO DE LITERATURA","year":"2023","cit":0,"pfa":"Sara Almeida Oliveira","psa":"Victor Augusto Rodovalho Fava","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4388373853","eid":"W4388373853"},{"id":"paper-w3208640169","cat":"papers","name":"A harm-reduction approach to the isolation of harmine and its hydrogenated derivatives from Peganum Harmala seed in low-tech settings","year":"2016","cit":0,"pfa":"Frederick A.P. Van Der Sypt","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3208640169","eid":"W3208640169"},{"id":"paper-w4288374100","cat":"papers","name":"A harm-reduction approach to the isolation of harmine and its hydrogenated derivatives from Peganum Harmala seed in low-tech settings","year":"2019","cit":0,"pfa":"Frederick A.P. Van Der Sypt","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4288374100","eid":"W4288374100"},{"id":"paper-w1881233691","cat":"papers","name":"Pharmacological MRI in the assessment of monoaminergic function","year":"2013","cit":0,"pfa":"M.L.J. Schouw","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W1881233691","eid":"W1881233691"},{"id":"paper-w7140106114","cat":"papers","name":"Mystification and Messiah Drift as Applied to AI Psychosis: Archetypal Responses and the Ontological Shock of Structural Parity","year":"2025","cit":0,"pfa":"ClearBridge Biological Sciences Consortium","psa":"Chris Tarpley","topics":["Depression","Mechanism & neuroscience","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7140106114","eid":"W7140106114"},{"id":"paper-w7138458314","cat":"papers","name":"Severity of Polysubstance Use Among Young People Seeking Drug and Alcohol Treatment, and Social and Mental Health Correlates: An Observational Study","year":"2026","cit":0,"pfa":"Nina Pocuca","psa":"Leanne M. Hides","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7138458314","eid":"W7138458314"},{"id":"paper-w7166516670","cat":"papers","name":"Influence of physiological and pharmacological factors on conducted electrical device safety thresholds","year":"2026","cit":0,"pfa":"Charles D. Deakin","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7166516670","eid":"W7166516670"},{"id":"paper-w4414064779","cat":"papers","name":"Characteristics of Ongoing Clinical Trials for Cocaine Use Disorder Registered on Global Clinical Trial Databases","year":"2025","cit":0,"pfa":"Fernanda Gushken","psa":"Vitor Soares Tardelli","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4414064779","eid":"W4414064779"},{"id":"paper-w7131356490","cat":"papers","name":"Psychedelic Use and Missed Mental Health Treatment: Gender Differences in Behavioral Health Outcomes","year":"2026","cit":0,"pfa":"Sean M. Viña","ptype":"preprint","src":"https://openalex.org/W7131356490","eid":"W7131356490"},{"id":"paper-w7128296302","cat":"papers","name":"Effects of cannabis and psychedelic use on cognitive, psychomotor, and driving performance: A review of recent literature","year":"2026","cit":0,"pfa":"Alexa Camarena-Michel","psa":"John Michael Rague","topics":["Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7128296302","eid":"W7128296302"},{"id":"paper-w4413142010","cat":"papers","name":"Intersecting Psychedelic Pharmacology and Gut-Brain Axis Signaling in Neurodegenerative Disorders","year":"2025","cit":0,"pfa":"Harsha S. Krishna","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4413142010","eid":"W4413142010"},{"id":"paper-w1532493018","cat":"papers","name":"Sigma receptors modulation of voltage-gated ion channels in rat autonomic neurons","year":"2005","cit":0,"pfa":"Hongling Zhang","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W1532493018","eid":"W1532493018"},{"id":"paper-w1758022391","cat":"papers","name":"PENGARUH PEMBERIAN EKSTRAK JAMUR PSILOCYBE CUBENSIS DOSIS BERTINGKAT TERHADAP RASA INGIN TAHU MENCIT SWISS WEBSTER YANG DIUKUR DENGAN MANUAL HOLE BOARD","year":"2015","cit":0,"pfa":"Kenny Farisan Badri","psa":"Tuntas Dhanardhono","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1758022391","eid":"W1758022391"},{"id":"paper-w7171783611","cat":"papers","name":"Retreat from racism: A psychedelic group experience for racial stress and trauma","year":"2026","cit":0,"pfa":"Sergio R Pérez Rosal","psa":"Monnica Williams","topics":["PTSD & trauma","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7171783611","eid":"W7171783611"},{"id":"paper-w7127993063","cat":"papers","name":"Behavioral and Molecular Mechanisms of Cocaine Addiction Vulnerability: Functional Evidence from Rodent Models","year":"2026","cit":0,"pfa":"Veronika Pohořalá","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7127993063","eid":"W7127993063"},{"id":"paper-w7167815184","cat":"papers","name":"Psychedelics stores, their regulation and public health: knowledge, perceptions, attitudes and opinions of Canadians","year":"2026","cit":0,"pfa":"François Gagnon","psa":"Yannick Dufresne","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7167815184","eid":"W7167815184"},{"id":"paper-w7165585748","cat":"papers","name":"Therapeutic advances in fibromyalgia: one year in review 2026","year":"2026","cit":0,"pfa":"Laura Bazzichi","psa":"Cristina Iannuccelli","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7165585748","eid":"W7165585748"},{"id":"paper-w7134230396","cat":"papers","name":"Nuclear Spin Modulation of Psychedelic Consciousness States: A Factorial fMRI Protocol Combining N,N-DMT with Krypton and Xenon Isotopes","year":"2026","cit":0,"pfa":"POMMIER","psa":"Jean‐Patrick Pommier","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7134230396","eid":"W7134230396"},{"id":"paper-w4413906502","cat":"papers","name":"Target-Based Drug Discovery: Discovery and Synthesis of G-Protein Biased Agonists Towards the 5-Hydroxytryptamine2A Receptor","year":"2025","cit":0,"pfa":"Angela Long","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4413906502","eid":"W4413906502"},{"id":"paper-w2353718334","cat":"papers","name":"Study on the preparation and immunological characteristics of a monoclonal antibody against Ketamine","year":"2009","cit":0,"pfa":"Xiaopeng Zeng","ptype":"article","src":"https://openalex.org/W2353718334","eid":"W2353718334"},{"id":"paper-w7160952638","cat":"papers","name":"Psychedelic Use and Missed Needed Mental Health Treatment: Gender Differences in Unmet Perceived Need for Care","year":"2026","cit":0,"pfa":"Sean M. Viña","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7160952638","eid":"W7160952638"},{"id":"paper-w2281950954","cat":"papers","name":"[Physiological functions of sigma-1 receptors and its relation to psychic dependence].","year":"2012","cit":0,"pfa":"Tomohisa Mori","psa":"Tsutomu Suzuki","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"other","src":"https://openalex.org/W2281950954","eid":"W2281950954"},{"id":"paper-w4404025367","cat":"papers","name":"Psychedelics, Psychosocial Support, and Psychotherapy: Why It Matters for the Law, Ethics, and Business of Medical Psychedelic Use","year":"2024","cit":0,"pfa":"I. Glenn Cohen","topics":["Therapy practice","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4404025367","eid":"W4404025367"},{"id":"paper-w4386195220","cat":"papers","name":"Psychedelic Intimacy: Altered States of Consciousness in Romantic Relationships","year":"2023","cit":0,"pfa":"J. Neubert","psa":"Natasha Leigh Mason","topics":["Addiction","Anxiety & end-of-life","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4386195220","eid":"W4386195220"},{"id":"paper-w2886632105","cat":"papers","name":"Ethnopharmacology – From Mexican Hallucinogens to a Global Transdisciplinary Science","year":"2018","cit":0,"pfa":"M Heinrich","psa":"Ivan Casselman","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"conference-paper","src":"https://openalex.org/W2886632105","eid":"W2886632105"},{"id":"paper-w7134241751","cat":"papers","name":"Nuclear Spin Modulation of Psychedelic Consciousness States: A Factorial fMRI Protocol Combining N,N-DMT with Krypton and Xenon Isotopes","year":"2026","cit":0,"pfa":"POMMIER","psa":"Jean‐Patrick Pommier","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7134241751","eid":"W7134241751"},{"id":"paper-w7118675505","cat":"papers","name":"Dynamic Neural State Transitions Predict Psychedelic Phenomenal Richness: Magnitude, Not Direction, Drives Subjective Intensity","year":"2026","cit":0,"pfa":"Emma Dobbin","topics":["Addiction","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7118675505","eid":"W7118675505"},{"id":"paper-w7106222721","cat":"papers","name":"Psychedelics beyond medicine: Treatment, enhancement, hype, consent, and the limits of medicalization","year":"2025","cit":0,"pfa":"Caraccio, Mina","psa":"Earp, Brian D.","topics":["Safety & adverse events","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7106222721","eid":"W7106222721"},{"id":"paper-w7167915729","cat":"papers","name":"The Entrepreneurship of Psychedelic Negativity: Psymposia, Trauma, Iatrogenic Harm, and Prohibition 2.0","year":"2026","cit":0,"pfa":"Oliver Charles Minty Davis","psa":"Sophie Casey","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7167915729","eid":"W7167915729"},{"id":"paper-w4312063948","cat":"papers","name":"History of epilepsy increases risk of psychedelic‐induced seizures","year":"2022","cit":0,"topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4312063948","eid":"W4312063948"},{"id":"paper-w7162525285","cat":"papers","name":"Traces of the Other – Are DMT Entities Real? DMT Phenomenology in the Framework of Conscious Realism","year":"2026","cit":0,"pfa":"Andrew Robert Gallimore","psa":"Donald D. Hoffman","topics":["Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7162525285","eid":"W7162525285"},{"id":"paper-w7161170158","cat":"papers","name":"σ(α) trait stability across diverse cognitive and pharmacological contexts: a single-operator longitudinal observation from consumer EEG","year":"2026","cit":0,"pfa":"Christopher Swenson","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W7161170158","eid":"W7161170158"},{"id":"paper-w4414277681","cat":"papers","name":"Reducing ventral hippocampal CA1/subiculum hyperexcitability restores social memory and alleviates anxiety-related behavior in a mouse model of temporal lobe epilepsy","year":"2025","cit":0,"pfa":"Anthoni M. Goodman","psa":"Srdjan M. Joksimovic","topics":["Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W4414277681","eid":"W4414277681"},{"id":"paper-w7123817002","cat":"papers","name":"Dynamic Neural State Transitions Predict Psychedelic Phenomenal Richness: Magnitude, Not Direction, Drives Subjective Intensity","year":"2026","cit":0,"pfa":"Emma Dobbin","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7123817002","eid":"W7123817002"},{"id":"paper-w7120784360","cat":"papers","name":"Enteogenografia da música: etnografia, audiovisual e processos criativos em três contextos no Acre","year":"2022","cit":0,"pfa":"Luiz Augusto Moura Ferreira","ptype":"dissertation","src":"https://openalex.org/W7120784360","eid":"W7120784360"},{"id":"paper-w2626802911","cat":"papers","name":"Geschichte der Psychedelika in der Medizin","year":"2017","cit":0,"pfa":"Ben Sessa","ptype":"book-chapter","src":"https://openalex.org/W2626802911","eid":"W2626802911"},{"id":"paper-w7213471460","cat":"papers","name":"Treatment-Resistant Depression: A Literature Review of Innovative and Emerging Treatment Strategies","year":"2026","cit":0,"pfa":"Maciej Kisielewski","psa":"Julia Wawerska","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7213471460","eid":"W7213471460"},{"id":"paper-w7134932678","cat":"papers","name":"Measuring the psychoactive effects of ketamine in alcohol use disorder: When assessment shapes experience","year":"2026","cit":0,"pfa":"Christina McAnulty","psa":"Nicolas Garel","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7134932678","eid":"W7134932678"},{"id":"paper-w4313148936","cat":"papers","name":"SPECIAL ISSUE: Do Biofeedback, Neurofeedback, and Neuromeditation Have a Role in Psychedelic-Assisted Therapies?","year":"2022","cit":0,"pfa":"Jeff Tarrant","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4313148936","eid":"W4313148936"},{"id":"paper-w7169570796","cat":"papers","name":"Emerging pharmacological and neuromodulation interventions for suicidal ideation and behaviour","year":"2026","cit":0,"pfa":"Mauro Scala","psa":"Giuseppe Fanelli","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7169570796","eid":"W7169570796"},{"id":"paper-w3212602815","cat":"papers","name":"Psychedelics in the treatment of mental disorders","year":"2021","cit":0,"pfa":"Luísa Ramos da Silva","topics":["Depression"],"ptype":"dissertation","src":"https://openalex.org/W3212602815","eid":"W3212602815"},{"id":"paper-w3176051378","cat":"papers","name":"Synergistic interactions between “club drugs”: gamma‐hydroxybutyrate and N‐methyl‐d‐aspartate antagonists.","year":"2006","cit":0,"pfa":"Wouter Koek","psa":"Charles Patrick France","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3176051378","eid":"W3176051378"},{"id":"paper-w4383756373","cat":"papers","name":"Change processes in long-term recovery for individuals with present and former substance-use dependence","year":"2022","cit":0,"pfa":"Thomas Solgaard Svendsen","topics":["Addiction","Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W4383756373","eid":"W4383756373"},{"id":"paper-w4248813803","cat":"papers","name":"Roland Haas: Wörterbuch der Psychologie und Psychiatrie. Deutsch-Englisch/Englisch-Deutsch","year":"2004","cit":0,"pfa":"B Küchenhoff","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4248813803","eid":"W4248813803"},{"id":"paper-w3208136217","cat":"papers","name":"Cultural Geography of Hallucinogenic Plant Cults In Pre-Columbian Mexico and the American Southwest","year":"2004","cit":0,"pfa":"최영준","ptype":"article","src":"https://openalex.org/W3208136217","eid":"W3208136217"},{"id":"paper-w4399279364","cat":"papers","name":"A Primer for Culturally Attuned Psychedelic Research","year":"2024","cit":0,"pfa":"Terence H. W. Ching","topics":["Dosing & pharmacology","Therapy practice","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4399279364","eid":"W4399279364"},{"id":"paper-w7161513919","cat":"papers","name":"Placebo psychedelics: Characteristics, side effects, and predictors","year":"2026","cit":0,"pfa":"Sarah Chapman","psa":"Quinton Deeley","topics":["PTSD & trauma","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7161513919","eid":"W7161513919"},{"id":"paper-w7214356476","cat":"papers","name":"Psychiatric disorders in oncology patients: clinical implications and therapeutic challenges","year":"2026","cit":0,"pfa":"Hubert Dąbrowski","psa":"Tomasz Ząbkowski","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7214356476","eid":"W7214356476"},{"id":"paper-w4237578196","cat":"papers","name":"Consultation With the Specialist: The Central Serotonin Syndrome: Paradigm for Psychotherapeutic Misadventure","year":"2002","cit":0,"pfa":"Donald H. Arnold","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4237578196","eid":"W4237578196"},{"id":"paper-w7164135935","cat":"papers","name":"Intensity and Visual Content Dissociate in DMT: Dynamic Integration-Complexity Predicts One, Spatial Configuration the Other","year":"2026","cit":0,"pfa":"Emma Dobbin","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7164135935","eid":"W7164135935"},{"id":"paper-w7203756663","cat":"papers","name":"Interview Study: Psychotherapy and therapeutic Touch in Psychedelic Assisted Therapy","year":"2026","cit":0,"pfa":"David Engelken","psa":"Kae Eichel","topics":["Safety & adverse events","Therapy practice","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W7203756663","eid":"W7203756663"},{"id":"paper-w4213250352","cat":"papers","name":"MEPHEDRONE’S PSYCHOSIS: ABOUT A CASE REPORT","year":"2019","cit":0,"pfa":"Andre Ribeirinho Marques","psa":"Alda Rosa","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"other","src":"https://openalex.org/W4213250352","eid":"W4213250352"},{"id":"paper-w7155171251","cat":"papers","name":"The Past, Present, and Future of Interventional Psychiatric Services for Management of Treatment-Resistant Depression: A Narrative Review","year":"2026","cit":0,"pfa":"Edwin Norris","psa":"John L. Havlik","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W7155171251","eid":"W7155171251"},{"id":"paper-w7117147788","cat":"papers","name":"Magic mushrooms‐ P. cubensis and H. erinaceus a possible novel treatment for Alzheimer's disease symptoms","year":"2025","cit":0,"pfa":"Anjali Rose Friedman","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7117147788","eid":"W7117147788"},{"id":"paper-w7147373032","cat":"papers","name":"The chicken and the egg - a systematic review of the relationship between recreational drug use and mental health in the general population","year":"2026","cit":0,"pfa":"Benjamin Clayden","psa":"Maria Bălăeţ","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W7147373032","eid":"W7147373032"},{"id":"paper-w7106133965","cat":"papers","name":"Self-reported improvement in depression, anxiety, and substance use in Spanish-speakers after a memorable psychedelic experience","year":"2025","cit":0,"pfa":"Stacey B. Armstrong","psa":"Alan K. Davis","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7106133965","eid":"W7106133965"},{"id":"paper-w4417357466","cat":"papers","name":"Towards therapeutic paths with mindfulness meditation–based and psychedelics assisted psychotherapies in PTSD: Randomized controlled trials systematic review and meta-analysis","year":"2025","cit":0,"pfa":"Solène Maeder","psa":"Chantal Martin-Söelch","topics":["PTSD & trauma","Safety & adverse events","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W4417357466","eid":"W4417357466"},{"id":"paper-w3005101425","cat":"papers","name":"What works. Testing drugs for harm reduction.","year":"2019","cit":0,"pfa":"Jarryd Bartle","psa":"Nicole Lee","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3005101425","eid":"W3005101425"},{"id":"paper-w7162795172","cat":"papers","name":"The chicken and the egg - a systematic review of the relationship between recreational drug use and mental health in the general population","year":"2026","cit":0,"pfa":"Benjamin Clayden","psa":"Maria Bălăeţ","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W7162795172","eid":"W7162795172"},{"id":"paper-w7170747908","cat":"papers","name":"Psychedelics and Reward Processing: Before and After the 1970 Controlled Substances Act","year":"2026","cit":0,"pfa":"Dylan J. Lifshitz","psa":"Kevin S. Murnane","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7170747908","eid":"W7170747908"},{"id":"paper-w3106836536","cat":"papers","name":"Methylenedioxymethamphetamine-induced toxic valvulopathy","year":"2020","cit":0,"pfa":"Bastiaan Sol","psa":"Steven Droogmans","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3106836536","eid":"W3106836536"},{"id":"paper-w4411843195","cat":"papers","name":"Narcotics and Psychostimulants in Acute Overdose-Suspected Patients in Emergency Departments in Korea: Analysis of Toxicological Laboratory Data","year":"2025","cit":0,"pfa":"Yoonsoo Kim","psa":"Bum Jin Oh","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4411843195","eid":"W4411843195"},{"id":"paper-w7120575023","cat":"papers","name":"Avaliação da atividade citotóxica e antidepressiva da Jurema-preta (Mimosa tenuiflora (Wild.) poir.) em modelos in vitro e in vivo","year":"2024","cit":0,"pfa":"Ana Alves","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"dissertation","src":"https://openalex.org/W7120575023","eid":"W7120575023"},{"id":"paper-w7105695200","cat":"papers","name":"On the Borderlands of Religion and Science: Indo-Tibetan Buddhist Contemplative Traditions and Psychedelic Medicine","year":"2025","cit":0,"topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7105695200","eid":"W7105695200"},{"id":"paper-w783119635","cat":"papers","name":"The effects of ecstasy polydrug use on the psychological well being of young people","year":"2011","cit":0,"pfa":"Margherita Milani","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W783119635","eid":"W783119635"},{"id":"paper-w2356463832","cat":"papers","name":"Prevalence of substance use disorder among bipolar affective disorder","year":"2016","cit":0,"pfa":"Carlos Gómez Sánchez-Lafuente","psa":"I. Tilves Santiago","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2356463832","eid":"W2356463832"},{"id":"paper-w4229060257","cat":"papers","name":"Change processes in long-term recovery for individuals with present and former substance-use dependence","year":"2022","cit":0,"pfa":"Thomas Solgaard Svendsen","topics":["Addiction","Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W4229060257","eid":"W4229060257"},{"id":"paper-w4415681444","cat":"papers","name":"Development and application of hair matrix reference materials for the determination of morphine, cocaine, 3,4-methylenedioxymethamphetamine, methamphetamine, and their metabolites","year":"2025","cit":0,"pfa":"Jing Hu","psa":"Hang Chen","ptype":"article","src":"https://openalex.org/W4415681444","eid":"W4415681444"},{"id":"paper-w7162981224","cat":"papers","name":"The chicken and the egg - a systematic review of the relationship between recreational drug use and mental health in the general population","year":"2026","cit":0,"pfa":"Maria Bălăeţ","psa":"Movin Abeywickrema","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W7162981224","eid":"W7162981224"},{"id":"paper-w7161553358","cat":"papers","name":"Placebo psychedelics: Characteristics, side effects, and predictors","year":"2024","cit":0,"pfa":"Madeline Victore Stein","psa":"Devin Blair Terhune","topics":["PTSD & trauma","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7161553358","eid":"W7161553358"},{"id":"paper-w1151148705","cat":"papers","name":"Low Dose Mephedrone Depicts a Combined Dopaminergic and Serotonergic Discriminative Stimulus Effect","year":"2015","cit":0,"pfa":"Iman Saber","psa":"Ellen Ann Walker","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W1151148705","eid":"W1151148705"},{"id":"paper-w7133513881","cat":"papers","name":"Therapeutic modulation of empathy: pharmacological, neurostimulation, and behavioral approaches","year":"2026","cit":0,"pfa":"Sarfaraz K. Niazi","topics":["PTSD & trauma","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7133513881","eid":"W7133513881"},{"id":"paper-w7164052099","cat":"papers","name":"Intensity and Visual Content Dissociate in DMT: Dynamic Integration-Complexity Predicts One, Spatial Configuration the Other","year":"2026","cit":0,"pfa":"Emma Dobbin","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7164052099","eid":"W7164052099"},{"id":"paper-w7203560172","cat":"papers","name":"Exploring critical psychedelic phenomenology: What Frantz Fanon can teach us about psychedelic therapy for racialized and colonized people","year":"2026","cit":0,"pfa":"Khaleel Rajwani","topics":["PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7203560172","eid":"W7203560172"},{"id":"paper-w4252189400","cat":"papers","name":"Mechanism of action of 8–0H–DPAT on a rat model for human depression: G.A. Kennet, G. Curzon","year":"2013","cit":0,"pfa":"Paul Bevan","psa":"Trevor Archer","topics":["Depression","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W4252189400","eid":"W4252189400"},{"id":"paper-w7125144170","cat":"papers","name":"Dynamic Neural State Transitions Predict Psychedelic Phenomenal Richness: Magnitude, Not Direction, Drives Subjective Intensity","year":"2026","cit":0,"pfa":"Emma Dobbin","topics":["Addiction","Mechanism & neuroscience","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7125144170","eid":"W7125144170"},{"id":"paper-w7119292064","cat":"papers","name":"Entheogens in Latin America: expanded reality experiences","year":"2017","cit":0,"pfa":"Sebastián Torterola Antelo","ptype":"dissertation","src":"https://openalex.org/W7119292064","eid":"W7119292064"},{"id":"paper-w7164545344","cat":"papers","name":"Altered States, Enhanced Potential: Psychedelics and Physical Performance","year":"2026","cit":0,"pfa":"Zane Qarni","psa":"Jérémie Richard","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7164545344","eid":"W7164545344"},{"id":"paper-w7143413166","cat":"papers","name":"The chicken and the egg - a systematic review of the relationship between recreational drug use and mental health in the general population","year":"2026","cit":0,"pfa":"Benjamin Clayden","psa":"Maria Bălăeţ","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W7143413166","eid":"W7143413166"},{"id":"paper-w7164522696","cat":"papers","name":"Altered States, Enhanced Potential: Psychedelics and Physical Performance","year":"2026","cit":0,"pfa":"Zane Qarni","psa":"Jérémie Richard","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7164522696","eid":"W7164522696"},{"id":"paper-w7105767307","cat":"papers","name":"Cannabis use and mental health among young sexual and gender minority men : a qualitative study","year":"2025","cit":0,"pfa":"Parent, Natasha","psa":"Knight, Rod E.","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7105767307","eid":"W7105767307"},{"id":"paper-w2563271444","cat":"papers","name":"Pharmacological and toxicological characteristics of novel psychoactive substances","year":"2012","cit":0,"pfa":"Slavica Vučinić","psa":"Danica Srnić","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2563271444","eid":"W2563271444"},{"id":"paper-w7129404437","cat":"papers","name":"O papel do estresse oxidativo no transtorno depressivo maior: Abordagens terapêuticas com antioxidantes - uma revisão da literatura","year":"2026","cit":0,"pfa":"BIANCA KARINA DE SOUSA LIMA","psa":"Amanda Soares de Vasconcelos","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7129404437","eid":"W7129404437"},{"id":"paper-w7164023177","cat":"papers","name":"Intensity and Visual Content Dissociate in DMT: Dynamic Integration-Complexity Predicts One, Spatial Configuration the Other","year":"2026","cit":0,"pfa":"Emma Dobbin","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7164023177","eid":"W7164023177"},{"id":"paper-w4238812578","cat":"papers","name":"Secondary Schizophrenia","year":"2011","cit":0,"pfa":"Yener Balan","topics":["PTSD & trauma","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4238812578","eid":"W4238812578"},{"id":"paper-w7159866296","cat":"papers","name":"Therapist-rated predictors of response to psychedelic-assisted therapy","year":"2026","cit":0,"pfa":"Grace Viljoen","psa":"Felix Betzler","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W7159866296","eid":"W7159866296"},{"id":"paper-w4294837517","cat":"papers","name":"Update on Posttraumatic Stress Disorder and Implications for Acute and Critical Care APRNs","year":"2022","cit":0,"pfa":"Tamar W. Rodney","psa":"Jesus M. Casida","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4294837517","eid":"W4294837517"},{"id":"paper-w2913269562","cat":"papers","name":"Psychedelic-Assisted Therapies—Palliative Care Clinical & Research Priorities (TH317)","year":"2019","cit":0,"pfa":"Ira Robert Byock","psa":"Craig D. Blinderman","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2913269562","eid":"W2913269562"},{"id":"paper-w1572415480","cat":"papers","name":"Drugs of Addiction in the Domestic, Occupational and Sports Environment","year":"2009","cit":0,"pfa":"Felix K. Adatsi","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"other","src":"https://openalex.org/W1572415480","eid":"W1572415480"},{"id":"paper-w4415812696","cat":"papers","name":"Assessing the Concordance Between Self-Reported Cannabis Use and Urine Toxicology in Canadian Youth and Young Adults Attending an Early Psychosis Programme","year":"2025","cit":0,"pfa":"Naseem Abdulmohi Alhujaili","psa":"Oyedeji Ayonrinde","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4415812696","eid":"W4415812696"},{"id":"paper-w7160566951","cat":"papers","name":"First-episode Psychosis in a Young Adult With Recent Psychoactive Substance Use","year":"2026","cit":0,"pfa":"Janušauskas, Marius","psa":"Agnė Radavičiūtė","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"conference-paper","src":"https://openalex.org/W7160566951","eid":"W7160566951"},{"id":"paper-w4416987555","cat":"papers","name":"Natural hallucinogens of fungal and animal origin: action and potential applications — a narrative review","year":"2025","cit":0,"pfa":"Krzysztof Ciszowski","psa":"Lucyna Pomierny-Chamioło","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"review","src":"https://openalex.org/W4416987555","eid":"W4416987555"},{"id":"paper-w7161816098","cat":"papers","name":"Ancient Wisdom, Modern Questions: Western and Orthodox Christianity Engage Psychedelic Spirituality","year":"2026","cit":0,"pfa":"Geoffrey Ready","psa":"Ron Cole‐Turner","ptype":"article","src":"https://openalex.org/W7161816098","eid":"W7161816098"},{"id":"paper-w4291290992","cat":"papers","name":"Ketamine in DUID cases in the greater Cologne area. A case series","year":"2022","cit":0,"pfa":"Hilke Andresen‐Streichert","psa":"Markus Alexander Rothschild","ptype":"article","src":"https://openalex.org/W4291290992","eid":"W4291290992"},{"id":"paper-w4412525998","cat":"papers","name":"Towards therapeutic paths in Post-Traumatic Stress Disorder: Systematic review and meta-analysis of mindfulness meditation-based and psychedelics assisted psychotherapies","year":"2025","cit":0,"pfa":"Solène Maeder","psa":"Chantal Martin-Söelch","topics":["PTSD & trauma","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4412525998","eid":"W4412525998"},{"id":"paper-w7213970497","cat":"papers","name":"Body image phenomenology in reports of psychedelic and meditative experiences: main themes and associations with body attitudes","year":"2026","cit":0,"pfa":"Hilla Väyrynen","psa":"Jussi Jylkkä","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W7213970497","eid":"W7213970497"},{"id":"paper-w4387950429","cat":"papers","name":"Therapeutic Potential and Pharmacological Activities of (+)-Nantenine in Medicine: An Aporphine Class Phytocomponent of Nandina domestica Thunberg","year":"2023","cit":0,"pfa":"Dinesh Kumar Patel","psa":"Kanika Patel","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4387950429","eid":"W4387950429"},{"id":"paper-w4412663959","cat":"papers","name":"Towards therapeutic paths in Post-Traumatic Stress Disorder: Systematic review and meta-analysis of mindfulness meditation-based and psychedelics assisted psychotherapies","year":"2025","cit":0,"pfa":"Solène Maeder","psa":"Chantal Martin-Söelch","topics":["PTSD & trauma","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4412663959","eid":"W4412663959"},{"id":"paper-w4411058068","cat":"papers","name":"Request for Proposals - Exploring expanded consciousness and endogenous DMT","year":"2025","cit":0,"pfa":"Tyler C. Diorio","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"report","src":"https://openalex.org/W4411058068","eid":"W4411058068"},{"id":"paper-w7147474195","cat":"papers","name":"Probability Cloud Regression Reveals Hidden Variables in Psychedelic Neuroimaging (PsiConnect Pre-Registration)","year":"2026","cit":0,"pfa":"Kareem Soliman","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7147474195","eid":"W7147474195"},{"id":"paper-w7213515704","cat":"papers","name":"Development and Psychometric Validation of the ‘Psychedelic Flourishing Scale’","year":"2026","cit":0,"pfa":"Frederick Pattisson","psa":"Rosalind G. McAlpine","ptype":"preprint","src":"https://openalex.org/W7213515704","eid":"W7213515704"},{"id":"paper-w2493338021","cat":"papers","name":"A clinical nomogram for predicting bladder outlet obstruction in non-neurogenic male patients with overactive bladder","year":"2016","cit":0,"pfa":"Wei J. Chen","psa":"Kuang‐Kuo Chen","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2493338021","eid":"W2493338021"},{"id":"paper-w7154123686","cat":"papers","name":"The Use of Psychedelics in the Treatment of Adult ADHD: A Systematic and Mechanistic Review","year":"2026","cit":0,"pfa":"James Chmiel","psa":"Donata Kurpas","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7154123686","eid":"W7154123686"},{"id":"paper-w7118751782","cat":"papers","name":"Psychoactive mushroom edibles: trends and toxicities reported to the United States National Poison Data System®, 2023–2024","year":"2026","cit":0,"pfa":"D. Jorgenson","psa":"Joshua B. Radke","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7118751782","eid":"W7118751782"},{"id":"paper-w7143938647","cat":"papers","name":"Psychedelics and the quantum brain: a falsifiable hypothesis on Posner molecules and spin-dependent pharmacology","year":"2026","cit":0,"pfa":"Joseph Geraci","psa":"Luca Pani","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7143938647","eid":"W7143938647"},{"id":"paper-w7125975363","cat":"papers","name":"High hopes? Precision psychedelic addiction medicine","year":"2026","cit":0,"pfa":"Rayyan R. Zafar","psa":"David Erritzøe","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7125975363","eid":"W7125975363"},{"id":"paper-w4283010116","cat":"papers","name":"Application of machine learning and complex network measures to an EEG dataset from DMT experiments","year":"2022","cit":0,"pfa":"Caroline L. Alves","psa":"Manuel Ciba","topics":["Addiction","Mechanism & neuroscience","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4283010116","eid":"W4283010116"},{"id":"paper-w7162585726","cat":"papers","name":"Vascular Learning as a Substrate for PTSD Chronicity: A Cerebrovascular Receptor-Site Hypothesis","year":"2026","cit":0,"pfa":"James Keim","psa":"Burton Tabaac","topics":["PTSD & trauma","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7162585726","eid":"W7162585726"},{"id":"paper-w7162656962","cat":"papers","name":"The Serotonin 2B (5‐ HT2B ) Receptor: A Narrative Review of Preclinical and Clinical Evidence on the Safety Considerations and Therapeutic Potential for the Treatment of Depression","year":"2026","cit":0,"pfa":"Gia Han Le","psa":"Roger S. McIntyre","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W7162656962","eid":"W7162656962"},{"id":"paper-w7212005684","cat":"papers","name":"Toxicological and Clinical Characteristics of Fatal Cases in the Emerging Drugs Network of Australia—Victoria ( EDNAV ) Clinical Registry 2020–2025","year":"2026","cit":0,"pfa":"James White","psa":"Shaun L. Greene","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7212005684","eid":"W7212005684"},{"id":"paper-w7168362048","cat":"papers","name":"Comprehensive in vitro profiling of traditional and emerging stimulants at monoamine transporters and the 5‐HT 2A receptor","year":"2026","cit":0,"pfa":"Dārta Štālberga","psa":"Henrik Green","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7168362048","eid":"W7168362048"},{"id":"paper-w7212073257","cat":"papers","name":"252. Clinical application of psychedelic-assisted therapy in major depression and addictions","year":"2026","cit":0,"pfa":"D Erritzoe","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7212073257","eid":"W7212073257"},{"id":"paper-w2978255229","cat":"papers","name":"Les addictions chez les jeunes (14-24 ans)","year":"2018","cit":0,"pfa":"Dominique Reynié","topics":["Addiction"],"ptype":"preprint","src":"https://openalex.org/W2978255229","eid":"W2978255229"},{"id":"paper-w7203666211","cat":"papers","name":"From Molecules to Minds: Redefining the Power of Psychedelics and Entactogens in Treating Brain Disorders","year":"2026","cit":0,"pfa":"Sampriti Paul","psa":"Prashant Tiwari","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7203666211","eid":"W7203666211"},{"id":"paper-w7127242110","cat":"papers","name":"Abordagem atual na seleção de medicamentos emergentes na Depressão Resistente","year":"2024","cit":0,"pfa":"Marta Sofia Tomé Vicente de Bastos Martins","topics":["Depression","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W7127242110","eid":"W7127242110"},{"id":"paper-w7162552635","cat":"papers","name":"Vascular Learning as a Substrate for PTSD Chronicity: A Cerebrovascular Receptor-Site Hypothesis","year":"2026","cit":0,"pfa":"James Keim","psa":"Burton Tabaac","topics":["PTSD & trauma","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7162552635","eid":"W7162552635"},{"id":"paper-w7118747269","cat":"papers","name":"Psychoactive mushroom edibles: trends and toxicities reported to the United States National Poison Data System®, 2023–2024","year":"2026","cit":0,"pfa":"D. Jorgenson","psa":"Joshua B. Radke","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7118747269","eid":"W7118747269"},{"id":"paper-w4396884881","cat":"papers","name":"Steroids, plastic, and psychedelics: the interlinking of epistemic coalition infighting and domestic perception in creating third-order policy change","year":"2023","cit":0,"pfa":"Giuliano Espino","topics":["Therapy practice","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W4396884881","eid":"W4396884881"},{"id":"paper-w7119866917","cat":"papers","name":"High hopes? Precision psychedelic addiction medicine","year":"2025","cit":0,"pfa":"Rayyan R. Zafar","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7119866917","eid":"W7119866917"},{"id":"paper-w7155608961","cat":"papers","name":"Aspects pharmacologiques avec un focus sur les antirétroviraux à longue durée d’action","year":"2026","cit":0,"pfa":"Caroline Solas","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7155608961","eid":"W7155608961"},{"id":"paper-w7163151636","cat":"papers","name":"Prolonged Grief Symptom Outcomes During At-Home Ketamine-Assisted Therapy: A Real-World Retrospective Analysis of 503 Adults","year":"2026","cit":0,"pfa":"Davis Carter","psa":"Leonardo Vando","ptype":"preprint","src":"https://openalex.org/W7163151636","eid":"W7163151636"},{"id":"paper-w7130604903","cat":"papers","name":"DMT, Microtubule Coherence, and the Scalar Clock: A Unified Framework for Time-Consciousness","year":"2025","cit":0,"pfa":"EUGENE CATRAMBONE","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7130604903","eid":"W7130604903"},{"id":"paper-w4415674623","cat":"papers","name":"Advances in modulation of the microbiota-gut-brain axis: treatment of neuropsychological disorders and functional gastrointestinal disorders","year":"2024","cit":0,"pfa":"Jocsã David Gomes Santos","psa":"Lidiane Souza","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W4415674623","eid":"W4415674623"},{"id":"paper-w2910912212","cat":"papers","name":"5-HT2B Receptor-mediated Cardiac Valvulopathy","year":"2018","cit":0,"pfa":"Pallavi Nistala","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2910912212","eid":"W2910912212"},{"id":"paper-w3194423010","cat":"papers","name":"Efecto de las β-carbolinas de banisteriopsis caapi sobre las cepas bacterianas e. faecalis y k. pneumoniae","year":"2021","cit":0,"pfa":"Saavedra Guerra","psa":"Paige Nicole","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3194423010","eid":"W3194423010"},{"id":"paper-w16206974","cat":"papers","name":"Neuroimagen y adicción I: Correlatos neuroanatómicos y funcionales de la administración aguda, el craving y el consumo crónico de psicoestimulantes","year":"2007","cit":0,"pfa":"Ana Beatriz Fagundo","psa":"Antonio Verdejo‐García","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W16206974","eid":"W16206974"},{"id":"paper-w3177321811","cat":"papers","name":"Placebo response in treatment resistant depression: a systematic review and meta-analysis of multiple treatment modalities","year":"2021","cit":0,"pfa":"Brett D. M. Jones","psa":"Zafiris Jeff Daskalakis","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W3177321811","eid":"W3177321811"},{"id":"paper-w4417485477","cat":"papers","name":"Clinical evaluation of oral fluid point-of-care testing for drugs of abuse compared to urinary point-of-care testing at a large-scale music festival","year":"2025","cit":0,"pfa":"Frantzen MGM","psa":"Franssen EJF","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4417485477","eid":"W4417485477"},{"id":"paper-w7167811138","cat":"papers","name":"P-93 - WASTEWATER BASED EPIDEMIOLOGY FOR ILLICIT DRUG SURVEILLANCE IN A SMALL ISLAND COMMUNITY: TRENDS, RISKS, AND HARM REDUCTION POTENTIAL","year":"2026","cit":0,"pfa":"Rebecca Rowley","psa":"Dr Matt Tyrer","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7167811138","eid":"W7167811138"},{"id":"paper-w4231585268","cat":"papers","name":"Veränderung des Drogenkonsums bedingt eine Anpassung der therapeutischen Angebote. «GAIN / Gesundheitsangebot und Information» der ARUD Zürich","year":"2006","cit":0,"ptype":"article","src":"https://openalex.org/W4231585268","eid":"W4231585268"},{"id":"paper-w4237383340","cat":"papers","name":"Veränderung des Drogenkonsums bedingt eine Anpassung der therapeutischen Angebote. «GAIN / Gesundheitsangebot und Information» der ARUD Zürich","year":"2006","cit":0,"ptype":"article","src":"https://openalex.org/W4237383340","eid":"W4237383340"},{"id":"paper-w7162862128","cat":"papers","name":"A Translational Research-Program for Compound Race Pathology: Five Framework-Distinct Trial-Design Templates","year":"2026","cit":0,"pfa":"Tomas Pødenphant Lund","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7162862128","eid":"W7162862128"},{"id":"paper-w2410178345","cat":"papers","name":"P115 Sexualised drug use in patients attending an nhs walk-in centre","year":"2015","cit":0,"pfa":"Jodie Crossman","psa":"Daniel Richardson","topics":["Safety & adverse events"],"ptype":"conference-abstract","src":"https://openalex.org/W2410178345","eid":"W2410178345"},{"id":"paper-w7169673366","cat":"papers","name":"In vitro toxicity of piperazine derivatives involves mitochondrial dysfunction and microtubule-related changes in neuronal cell models","year":"2026","cit":0,"pfa":"Dina Rönnberg","psa":"Stig O. P. Jacobsson","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"other","src":"https://openalex.org/W7169673366","eid":"W7169673366"},{"id":"paper-w1761777513","cat":"papers","name":"Sakralisering av psykedelia: bruken av det psykoaktive stoffet DMT i en moderne vestlig kontekst","year":"2014","cit":0,"pfa":"Ståle Anderstuen","topics":["Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W1761777513","eid":"W1761777513"},{"id":"paper-w7127144506","cat":"papers","name":"Chemsex: Venereological Consequences, Psychiatric and Somatic Complications, and Potential Intervention Strategies","year":"2026","cit":0,"pfa":"Hasan Selçuk Özkan","psa":"Damla İşman Haznedaroğlu","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7127144506","eid":"W7127144506"},{"id":"paper-w7118168688","cat":"papers","name":"Chemsex: Venereological Consequences, Psychiatric and Somatic Complications, and Potential Intervention Strategies","year":"2026","cit":0,"pfa":"Hasan Selçuk Özkan","psa":"Damla İşman Haznedaroğlu","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W7118168688","eid":"W7118168688"},{"id":"paper-w7168417574","cat":"papers","name":"In vitro toxicity of piperazine derivatives involves mitochondrial dysfunction and microtubule-related changes in neuronal cell models","year":"2026","cit":0,"pfa":"Dina Rönnberg","psa":"Stig O. P. Jacobsson","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7168417574","eid":"W7168417574"},{"id":"paper-w7169672738","cat":"papers","name":"In vitro toxicity of piperazine derivatives involves mitochondrial dysfunction and microtubule-related changes in neuronal cell models","year":"2026","cit":0,"pfa":"Dina Rönnberg","psa":"Stig O. P. Jacobsson","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"other","src":"https://openalex.org/W7169672738","eid":"W7169672738"},{"id":"paper-w2607910519","cat":"papers","name":"Les murmures de l'ayahuasca : parcours rituel et transmission culturelle à Takiwasi","year":"2016","cit":0,"pfa":"David Dupuis","ptype":"dissertation","src":"https://openalex.org/W2607910519","eid":"W2607910519"},{"id":"paper-w7128413613","cat":"papers","name":"Ghost Dances, Disillusionment And Opiate Addiction: An Ethnohistory Of Smith And Mason Valley Paiutes.","year":"1973","cit":0,"pfa":"Michael Hittman","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7128413613","eid":"W7128413613"},{"id":"paper-w7148369655","cat":"papers","name":"POTENCIAL TERAPÊUTICO DA HOASCA NO TRATAMENTO DA DEPRESSÃO: REVISÃO DE ESCOPO","year":"2026","cit":0,"pfa":"Adrian Santos de Souza","psa":"Celso Ferraz Bett","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7148369655","eid":"W7148369655"},{"id":"paper-w4367297665","cat":"papers","name":"Cas d’intoxication par l’Ayahuasca : usage répété documenté par l’analyse des cheveux et des ongles","year":"2023","cit":0,"pfa":"Alexandr Gish","psa":"Jean‐Michel Gaulier","ptype":"article","src":"https://openalex.org/W4367297665","eid":"W4367297665"},{"id":"paper-w7140128776","cat":"papers","name":"Editorial: Psychedelic-assisted psychotherapies: from clinical trials to credibility","year":"2026","cit":0,"pfa":"Malkanthi Evans","psa":"Andrew Charrette","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"editorial","src":"https://openalex.org/W7140128776","eid":"W7140128776"},{"id":"paper-w4400014525","cat":"papers","name":"Advancing polypharmacological drug design: A dual‐targeted approach for treating psychiatric disorders","year":"2024","cit":0,"pfa":"Yawen Pan","psa":"Jianliang Shen","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4400014525","eid":"W4400014525"},{"id":"paper-w2770786620","cat":"papers","name":"Salvinorina A: terpeno alucinógeno presente en Salvia divinorum Epling & Játiva","year":"2017","cit":0,"pfa":"Valentina Soto-Restrepo","psa":"William Garzón-Méndez","ptype":"article","src":"https://openalex.org/W2770786620","eid":"W2770786620"},{"id":"paper-w4411034671","cat":"papers","name":"Features of hydration of the composite system based on methyl silica AM-1 and dispersed Amanita muscaria mushrooms","year":"2025","cit":0,"pfa":"Tetiana V. Krupska","psa":"V. V. Turov","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4411034671","eid":"W4411034671"},{"id":"paper-w4408350581","cat":"papers","name":"Advancements in drug intervention research for stress-related psychiatric disorders","year":"2025","cit":0,"pfa":"Yan Gao","psa":"Yizheng Wang","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4408350581","eid":"W4408350581"},{"id":"paper-w7142569603","cat":"papers","name":"Application de l’imagerie fonctionnelle par ultrasons à la découverte d’empreintes pharmacologiques de la connectivité fonctionnelle chez la souris éveillée","year":"2025","cit":0,"pfa":"Samuel Diebolt","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W7142569603","eid":"W7142569603"},{"id":"paper-w7203514732","cat":"papers","name":"Mystical and affective features of naturalistic psychedelic experiences: A comparison of dictionary-based and LLM-based text analysis methods","year":"2026","cit":0,"pfa":"Aleksander Milczanowski","ptype":"preprint","src":"https://openalex.org/W7203514732","eid":"W7203514732"},{"id":"paper-w4392267413","cat":"papers","name":"Role of the 5-HT2B receptor in the regulation of serotonergic neurons activity","year":"2022","cit":0,"pfa":"Amina Benhadda","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W4392267413","eid":"W4392267413"},{"id":"paper-w4293096252","cat":"papers","name":"Uso da psilocibina como ferramenta psicoterapêutica no tratamento da depressão: uma revisão","year":"2021","cit":0,"pfa":"Joveni Ribeiro da Silva","psa":"Diego Pereira da Silva","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4293096252","eid":"W4293096252"},{"id":"paper-w7162424292","cat":"papers","name":"Systematic Under‐Characterization of Psychedelic Compound Classes in Published hERG QSAR Training Data: A Pre‐Registered Multi‐Family Analysis","year":"2026","cit":0,"pfa":"Vincent Wesley Couey","topics":["Safety & adverse events","Reviews & meta-analyses","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7162424292","eid":"W7162424292"},{"id":"paper-w7132402945","cat":"papers","name":"Bipolar Disorder, Manic Episode With Psychosis","year":"2025","cit":0,"pfa":"Aušrinė Sasnauskaitė","psa":"Roberta Barbora Lebiodaitė","topics":["Depression","Addiction","Dosing & pharmacology"],"ptype":"conference-paper","src":"https://openalex.org/W7132402945","eid":"W7132402945"},{"id":"paper-w7167043182","cat":"papers","name":"DMT and Microtubule Coherence Selection: A Testable Model of Informational Throttling in Time Perception","year":"2026","cit":0,"pfa":"EUGENE CATRAMBONE","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7167043182","eid":"W7167043182"},{"id":"paper-w4378215325","cat":"papers","name":"Buy Psychedelic Products Online (Preprint)","year":"2023","cit":0,"pfa":"Mitchel Starc","topics":["Addiction","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4378215325","eid":"W4378215325"},{"id":"paper-w3133601927","cat":"papers","name":"Decision letter: Self-blinding citizen science to explore psychedelic microdosing","year":"2020","cit":0,"topics":["Depression","Addiction","Dosing & pharmacology"],"ptype":"peer-review","src":"https://openalex.org/W3133601927","eid":"W3133601927"},{"id":"paper-w2323064032","cat":"papers","name":"Vitamin Therapy Urged","year":"1966","cit":0,"pfa":"Patricia McBroom","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2323064032","eid":"W2323064032"},{"id":"paper-w2615865983","cat":"papers","name":"Chemical and Biological Explorations of Novel Opioid Receptor Modulators","year":"2015","cit":0,"pfa":"Andrew C. Kruegel","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2615865983","eid":"W2615865983"},{"id":"paper-w2535562815","cat":"papers","name":"Vom Bardo Thödol zum psychedelischen Handbuch","year":"2015","cit":0,"pfa":"Matthias Grümayer","ptype":"dissertation","src":"https://openalex.org/W2535562815","eid":"W2535562815"},{"id":"paper-w7203612795","cat":"papers","name":"Assessing Canadian Policy Readiness for Psychedelic-Assisted Therapy in Cancer Care","year":"2026","cit":0,"pfa":"Christopher P. Albertyn","psa":"David Clements","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7203612795","eid":"W7203612795"},{"id":"paper-w7165542536","cat":"papers","name":"The Effects of Serotonergic systems on Cognitive Flexibility and Perseverative Thinking: a comparison between SSRI, classical psychedelics, and acute tryptophan depletion in a Multilevel Meta-Analysis","year":"2026","cit":0,"pfa":"Roi Basch","psa":"Leehe Peled‐Avron","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7165542536","eid":"W7165542536"},{"id":"paper-w3027137713","cat":"papers","name":"T127. GENDER DIFFERENCES IN CLINICAL PRESENTATION AND ILLICIT SUBSTANCE USE DURING FIRST EPISODE PSYCHOSIS: AN ELECTRONIC CASE REGISTER NATURAL LANGUAGE PROCESSING ANALYSIS","year":"2020","cit":0,"pfa":"Jessica Irving","psa":"Rashmi Patel","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W3027137713","eid":"W3027137713"},{"id":"paper-w7203633773","cat":"papers","name":"Assessing Canadian Policy Readiness for Psychedelic-Assisted Therapy in Cancer Care","year":"2026","cit":0,"pfa":"Christopher P. Albertyn","psa":"David Clements","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7203633773","eid":"W7203633773"},{"id":"paper-w288375486","cat":"papers","name":"Caracterización y regulación de subtipos de receptores serotonérgicos","year":"1998","cit":0,"pfa":"García Osta","psa":"Ana María","topics":["Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W288375486","eid":"W288375486"},{"id":"paper-w4414180197","cat":"papers","name":"Association between Schizophrenia and Violence: The Cage of Psychosis","year":"2025","cit":0,"pfa":"A. Castelao Escobar","psa":"R. Albillos Pérez","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"conference-abstract","src":"https://openalex.org/W4414180197","eid":"W4414180197"},{"id":"paper-w4413284729","cat":"papers","name":"657. ECONOMIC EVALUATIONS OF EMERGING PHARMACOLOGICAL THERAPIES FOR TREATMENT RESISTANT DEPRESSION","year":"2025","cit":0,"pfa":"Mary Lou Chatterton","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4413284729","eid":"W4413284729"},{"id":"paper-w4297814985","cat":"papers","name":"Change processes in long-term recovery for individuals with present and former substance-use dependence","year":"2022","cit":0,"pfa":"Thomas Solgaard Svendsen","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"other","src":"https://openalex.org/W4297814985","eid":"W4297814985"},{"id":"paper-w4388305104","cat":"papers","name":"Investigación sobre microdosificación con hongos psilocibios: un artículo de reflexión","year":"2023","cit":0,"pfa":"Laura Duque","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4388305104","eid":"W4388305104"},{"id":"paper-w7155180576","cat":"papers","name":"O EXPERIMENTO DO SÉCULO: A CONSCIÊNCIA COMO VARIÁVEL FÍSICA DA REALIDADE DMT, NEUROMUSE™ E A ARQUITETURA HOLOGRÁFICA DA CONSTRUÇÃO DA REALIDADE (AHCR 2.0) COMO BASE PARA A COMPUTAÇÃO SIMBIÓTICA BIOMIMÉTICA","year":"2026","cit":0,"pfa":"Muriel Rodrigues Fernandes","psa":"Bianca Cogo","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7155180576","eid":"W7155180576"},{"id":"paper-w3127573299","cat":"papers","name":"An isolated experiment: what the COVID-19 pandemic can tell us about addiction","year":"2020","cit":0,"pfa":"Nicholas Sinclair-House","psa":"Sarah Osborn","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3127573299","eid":"W3127573299"},{"id":"paper-w4327608228","cat":"papers","name":"334 In-hospital Resource Utilization among Traumatic Brain Injury Patients Presenting With Alcohol and Drug Use: A TRACK-TBI Study","year":"2023","cit":0,"pfa":"Brandon A. Sherrod","psa":"Ramesh Grandhi","topics":["PTSD & trauma","Addiction"],"ptype":"conference-abstract","src":"https://openalex.org/W4327608228","eid":"W4327608228"},{"id":"paper-w3138506374","cat":"papers","name":"Abstract P293: Disparate Outcomes for Stroke Patients With Documented Substance Use Compared to Those Without Substance Use","year":"2021","cit":0,"pfa":"Leslie Corless","psa":"Elizabeth Baraban","topics":["Addiction"],"ptype":"conference-abstract","src":"https://openalex.org/W3138506374","eid":"W3138506374"},{"id":"paper-w7161052345","cat":"papers","name":"Systematic Under-Characterization of Psychedelic Compound Classes in Published hERG QSAR Training Data: A Pre-Registered Multi-Family Analysis","year":"2026","cit":0,"pfa":"Vincent Wesley Couey","topics":["Reviews & meta-analyses","Therapy practice","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W7161052345","eid":"W7161052345"},{"id":"paper-w7172062873","cat":"papers","name":"A Case Report on a 48-Year-Old Male with Alcohol Use Disorder and Complex Comorbidities","year":"2026","cit":0,"pfa":"D. Žujić","psa":"K. Miljanić","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7172062873","eid":"W7172062873"},{"id":"paper-w4206034544","cat":"papers","name":"Behavioural Pharmacology of Novel Kappa Opioid Compounds","year":"2011","cit":0,"pfa":"Aashish S. Morani","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W4206034544","eid":"W4206034544"},{"id":"paper-w7151400349","cat":"papers","name":"Clandestine Methamphetamine Drug Manufacturing and Substance Use Disorders in Sri Lanka: A Case study on detection of Clandestine Methamphetamine Laboratory","year":"2026","cit":0,"pfa":"Mayoni Abeynayake","psa":"Maheshi Perera","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7151400349","eid":"W7151400349"},{"id":"paper-w3137755662","cat":"papers","name":"Abstract P300: Differences in Characteristics and Care Among Stroke Patients With Documented Substance Use","year":"2021","cit":0,"pfa":"Leslie Corless","psa":"Elizabeth Baraban","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"conference-abstract","src":"https://openalex.org/W3137755662","eid":"W3137755662"},{"id":"paper-w4388596232","cat":"papers","name":"Impacts of illicit drug use on coronary angiographic findings in a multicenter registry of patients with acute coronary syndrome","year":"2023","cit":0,"pfa":"Antoine Léquipar","psa":"Jean‐Guillaume Dillinger","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4388596232","eid":"W4388596232"},{"id":"paper-w7151464429","cat":"papers","name":"Clandestine Methamphetamine Drug Manufacturing and Substance Use Disorders in Sri Lanka: A Case study on detection of Clandestine Methamphetamine Laboratory","year":"2026","cit":0,"pfa":"Mayoni Abeynayake","psa":"Maheshi Perera","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7151464429","eid":"W7151464429"},{"id":"paper-w4206086822","cat":"papers","name":"Behavioural Pharmacology of Novel Kappa Opioid Compounds","year":"2011","cit":0,"pfa":"Aashish S. Morani","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W4206086822","eid":"W4206086822"},{"id":"paper-w7197990038","cat":"papers","name":"Differential effects of psychedelics and classical antidepressants on TrkB dimerization and neurotrophic signalling","year":"2024","cit":0,"pfa":"Paula Pastor Muñoz","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7197990038","eid":"W7197990038"},{"id":"paper-w7165028954","cat":"papers","name":"Efficacy of a Gamified Digital Platform for Substance Use Education and Overdose Prevention Among College Students: a Pilot and Feasibility Study","year":"2026","cit":0,"pfa":"Madeline E. Hilliard","psa":"Sean J Howse","topics":["Addiction","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W7165028954","eid":"W7165028954"},{"id":"paper-w2093929016","cat":"papers","name":"Verhaltensphysiologische Studien an Ratten nach Lysergsäure‐Diäthylamid (LSD)‐Verabreichung","year":"1958","cit":0,"pfa":"Alfred Kment","psa":"J. Leibetseder","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2093929016","eid":"W2093929016"},{"id":"paper-w7161998803","cat":"papers","name":"A trip to save a life: psychedelics and the untraveled road to recovery","year":"2021","cit":0,"pfa":"Jessica Cadoch","topics":["PTSD & trauma","Addiction"],"ptype":"dissertation","src":"https://openalex.org/W7161998803","eid":"W7161998803"},{"id":"paper-w3036783843","cat":"papers","name":"Enantioselective Ecotoxicity of Psychotropic Pharmaceuticals and Illicit Drugs","year":"2020","cit":0,"pfa":"Filomena Patrícia Pires Teles","topics":["Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W3036783843","eid":"W3036783843"},{"id":"paper-w4413284411","cat":"papers","name":"169. THERAPEUTIC MEMORY RECONSOLIDATION AS A TREATMENT FOR SUBSTANCE USE DISORDERS AND HOW PSYCHEDELICS ARE FACILITATING THIS INTERVENTION: THE UNITY STUDY","year":"2025","cit":0,"pfa":"S Ofori","psa":"R Das","topics":["Addiction","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4413284411","eid":"W4413284411"},{"id":"paper-w7161301536","cat":"papers","name":"Psicoterapia assistida por psilocibina no tratamento da depressão","year":"2022","cit":0,"pfa":"Gabriela Zorzi Marcello Marcello","psa":"Tania Marcourakis","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7161301536","eid":"W7161301536"},{"id":"paper-w2736238794","cat":"papers","name":"Removal of Perchlorate, Pharmaceutical Compounds, Artificial Sweeteners, and Perfluoroalkyl Substances from Water Using Photocatalytic and Passive Treatment Systems","year":"2017","cit":0,"pfa":"Yingying Liu","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W2736238794","eid":"W2736238794"},{"id":"paper-w4353015528","cat":"papers","name":"JAMA Psychiatry—The Year in Review, 2022","year":"2023","cit":0,"pfa":"Döst Öngür","topics":["Addiction","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4353015528","eid":"W4353015528"},{"id":"paper-w7130635276","cat":"papers","name":"From fundamental phosphorus chemistry all the way to flow : a psychedelic journey","year":"2025","cit":0,"pfa":"Andreas Simoens","topics":["Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W7130635276","eid":"W7130635276"},{"id":"paper-w4200019878","cat":"papers","name":"Med Check: Clozapine REMS; Aduhelm; BNC210 Fast Tracked for Social Anxiety Disorder; and More","year":"2021","cit":0,"pfa":"Terri D’Arrigo","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4200019878","eid":"W4200019878"},{"id":"paper-w3175925325","cat":"papers","name":"Ecstasy, Marijuana and Alcohol Use by Undergraduate Students","year":"2018","cit":0,"pfa":"Helena Bossolla Ilg","psa":"Ingrid Dragan Taricano","topics":["Addiction","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3175925325","eid":"W3175925325"},{"id":"paper-w4313201277","cat":"papers","name":"Neural correlates of an fMRI cognitive reappraisal task in obsessive-compulsive disorder","year":"2022","cit":0,"pfa":"M. Picó Pérez","psa":"Pedro Morgado","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4313201277","eid":"W4313201277"},{"id":"paper-w2796294150","cat":"papers","name":"Abstract #399: The antidepressants fluoxetine and maprotiline induce apoptosis and type-II autophagic-programmed cell death in Burkitt\\#8217;s lymphoma in vitro independently of SERT and NET","year":"2009","cit":0,"pfa":"Suzanne M. Cloonan","psa":"D. Clive Williams","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W2796294150","eid":"W2796294150"},{"id":"paper-w7202363368","cat":"papers","name":"Mystical and Affective Features of Naturalistic Psychedelic Experiences: Dataset and Supplementary Materials","year":"2025","cit":0,"pfa":"Aleksander Milczanowski","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W7202363368","eid":"W7202363368"},{"id":"paper-w4415982889","cat":"papers","name":"Editorial: Women in psychiatry 2024: Psychopharmacology","year":"2025","cit":0,"pfa":"Rosana Camarini","psa":"Reem Kais Jan","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"editorial","src":"https://openalex.org/W4415982889","eid":"W4415982889"},{"id":"paper-w7133125486","cat":"papers","name":"Mental Health Effects of Leisure Travel: A Scoping Review","year":"2026","cit":0,"pfa":"Htet Htet","psa":"Gerard Flaherty","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"other","src":"https://openalex.org/W7133125486","eid":"W7133125486"},{"id":"paper-w7113667044","cat":"papers","name":"Mental Health Effects of Leisure Travel: A Scoping Review","year":"2025","cit":0,"pfa":"Htet Htet","psa":"Gerard Flaherty","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W7113667044","eid":"W7113667044"},{"id":"paper-w7202364685","cat":"papers","name":"Mystical and Affective Features of Naturalistic Psychedelic Experiences: Dataset and Supplementary Materials","year":"2025","cit":0,"pfa":"Aleksander Milczanowski","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W7202364685","eid":"W7202364685"},{"id":"paper-w7134044060","cat":"papers","name":"The microbiome and PTSD: a scoping review across preclinical and clinical studies","year":"2026","cit":0,"pfa":"Ronja Berendse","psa":"Anja Lok","topics":["PTSD & trauma","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"dataset","src":"https://openalex.org/W7134044060","eid":"W7134044060"},{"id":"paper-w7118224878","cat":"papers","name":"“TUSI” poisoning in Colombia: Clinical findings and prehospital approach","year":"2025","cit":0,"pfa":"Loren Yinet Velasquez Torres","psa":"P. Jiménez","ptype":"dissertation","src":"https://openalex.org/W7118224878","eid":"W7118224878"},{"id":"paper-w7212010839","cat":"papers","name":"530. Detecting neuroplastic effects induced by ketamine and classic psychedelics in healthy human subjects","year":"2026","cit":0,"pfa":"Claudio Agnorelli","psa":"D Erritzoe","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W7212010839","eid":"W7212010839"},{"id":"paper-w7134052989","cat":"papers","name":"The microbiome and PTSD: a scoping review across preclinical and clinical studies","year":"2026","cit":0,"pfa":"Ronja Berendse","psa":"Anja Lok","topics":["PTSD & trauma","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"dataset","src":"https://openalex.org/W7134052989","eid":"W7134052989"},{"id":"paper-w2272829599","cat":"papers","name":"The Psyche in Psychedelic","year":"2015","cit":0,"pfa":"Stephen Mo Hanan","topics":["PTSD & trauma","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2272829599","eid":"W2272829599"},{"id":"paper-w4246066502","cat":"papers","name":"The pharmacological suppression of spreading depolarization in ischemic neuroprotection","year":"2020","cit":0,"pfa":"Írisz Szabó","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W4246066502","eid":"W4246066502"},{"id":"paper-w4392353730","cat":"papers","name":"Symptoms: Anxiety, Dyspnea, and Cyanosis","year":"2024","cit":0,"pfa":"Taylor W. Burkholder","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4392353730","eid":"W4392353730"},{"id":"paper-w7128223173","cat":"papers","name":"The Language of Stress and Mental Health: Clinical Applications and Treatment Implications (v1.0)","year":"2026","cit":0,"pfa":"Joshua Pace","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"preprint","src":"https://openalex.org/W7128223173","eid":"W7128223173"},{"id":"paper-w7151484330","cat":"papers","name":"Biomarkers for complex post-traumatic stress disorder: translational and evolutionary perspectives","year":"2026","cit":0,"pfa":"Ravi Philip Rajkumar","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7151484330","eid":"W7151484330"},{"id":"paper-w3093444744","cat":"papers","name":"Serotonin in Fear and Anxiety","year":"2020","cit":0,"pfa":"Melker Hagsäter","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W3093444744","eid":"W3093444744"},{"id":"paper-w7149487414","cat":"papers","name":"Mécanismes de compensation dans la maladie de Parkinson : approches comportementale, pharmacologique, de neuro-imagerie et immunohistochimique chez le singe intoxiqué au MPTP après récupération des symptômes moteurs","year":"2011","cit":0,"pfa":"Sara Neumane","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7149487414","eid":"W7149487414"},{"id":"paper-w7128239062","cat":"papers","name":"The Language of Stress and Mental Health: Clinical Applications and Treatment Implications (v1.0)","year":"2026","cit":0,"pfa":"Joshua Pace","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"preprint","src":"https://openalex.org/W7128239062","eid":"W7128239062"},{"id":"paper-w7162326878","cat":"papers","name":"Active placebo control interventions in pharmacological trials: a scoping review of the development process and a terminological analysis","year":"2026","cit":0,"pfa":"David Ruben Teindl Laursen","psa":"Asbjørn Hróbjartsson","topics":["Depression","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7162326878","eid":"W7162326878"},{"id":"paper-w4320888388","cat":"papers","name":"Psychotherapy and psychedelic drugs – Authors' reply","year":"2023","cit":0,"pfa":"Ioana A. Cristea","psa":"Florian Naudet","topics":["Therapy practice"],"ptype":"letter","src":"https://openalex.org/W4320888388","eid":"W4320888388"},{"id":"paper-w3105462218","cat":"papers","name":"Studies on the developmental and antidepressant-like effects of anesthetics","year":"2020","cit":0,"pfa":"Marko Rosenholm","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W3105462218","eid":"W3105462218"},{"id":"paper-w4367318862","cat":"papers","name":"Décès consécutif à une association inhabituelle de deux hallucinogènes","year":"2023","cit":0,"pfa":"Caroline Sastre","psa":"Anne-Laure Pélissier","ptype":"article","src":"https://openalex.org/W4367318862","eid":"W4367318862"},{"id":"paper-w4416715606","cat":"papers","name":"Editorial: Spirituality and religion: implications for mental health","year":"2025","cit":0,"pfa":"Angie Cucchi","psa":"M. Walid Qoronfleh","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"editorial","src":"https://openalex.org/W4416715606","eid":"W4416715606"},{"id":"paper-w7120764119","cat":"papers","name":"Psychoactive substances in blood: methods of toxicological analysis and prevalence of use on patients with traumatic injuries","year":"2021","cit":0,"pfa":"Henrique Silva Bombana","topics":["PTSD & trauma","Addiction","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W7120764119","eid":"W7120764119"},{"id":"paper-w2922155922","cat":"papers","name":"Consequences of concurrent and simultaneous amphetamine-type stimulant and alcohol use among young adults: hazardous drinking, antisocial behaviour, and contact with police","year":"2018","cit":0,"pfa":"Ellen M. Leslie","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W2922155922","eid":"W2922155922"},{"id":"paper-w4382360272","cat":"papers","name":"Ketamine Pioneer Krystal Receives 2023 Nasrallah Family Award","year":"2023","cit":0,"pfa":"Nick Zagorski","topics":["Depression","PTSD & trauma","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4382360272","eid":"W4382360272"},{"id":"paper-w7154834334","cat":"papers","name":"Vascular Learning as a Substrate for PTSD Chronicity: A Cerebrovascular Receptor-Site Hypothesis","year":"2026","cit":0,"pfa":"James Peter Keim","psa":"Burton Tabaac","topics":["PTSD & trauma","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7154834334","eid":"W7154834334"},{"id":"paper-w7128639209","cat":"papers","name":"The Language of Stress and Mental Health: Clinical Applications and Treatment Implications (v1.0)","year":"2026","cit":0,"pfa":"Joshua Pace","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"preprint","src":"https://openalex.org/W7128639209","eid":"W7128639209"},{"id":"paper-w4249808888","cat":"papers","name":"Addiction","year":"2016","cit":0,"topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4249808888","eid":"W4249808888"},{"id":"paper-w7169884998","cat":"papers","name":"Editorial: Emerging treatment approaches for substance use disorders","year":"2026","cit":0,"pfa":"David Martinez Garza","psa":"Ihsan Salloum","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"editorial","src":"https://openalex.org/W7169884998","eid":"W7169884998"},{"id":"paper-w4389327023","cat":"papers","name":"3 QUESTIONS ON . . . Helping Cancer Patients Who Have Depression & Anxiety","year":"2023","cit":0,"pfa":"Sarah DiGiulio","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4389327023","eid":"W4389327023"},{"id":"paper-w7120332583","cat":"papers","name":"Molecular modelling of amphetamines derivates and their antidepressant activity","year":"2010","cit":0,"pfa":"Maíra Fresqui","topics":["Depression","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W7120332583","eid":"W7120332583"},{"id":"paper-w2763329332","cat":"papers","name":"PET studies on the mechanisms of action of antidepressant and antipsychotic drugs","year":"2017","cit":0,"pfa":"Kai‐Chun Yang","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W2763329332","eid":"W2763329332"},{"id":"paper-w4236917726","cat":"papers","name":"CLINICAL TOXICOLOGY","year":"2008","cit":0,"pfa":"Timothy G K Mant","psa":"Albert Ferro","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W4236917726","eid":"W4236917726"},{"id":"paper-w2913983530","cat":"papers","name":"Pharmacological and toxicological investigations of new psychoactive substances","year":"2018","cit":0,"pfa":"Dino Lüthi","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W2913983530","eid":"W2913983530"},{"id":"paper-w2967188945","cat":"papers","name":"Meta-Analysis Supports Psychotherapies as First-Choice PTSD Treatments","year":"2019","cit":0,"pfa":"Nick Zagorski","topics":["Depression","PTSD & trauma","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2967188945","eid":"W2967188945"},{"id":"paper-w2233014768","cat":"papers","name":"More Than Words: Automated Speech Analysis May Offer Clinical Insight","year":"2015","cit":0,"pfa":"Nick Zagorski","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2233014768","eid":"W2233014768"},{"id":"paper-w7161120833","cat":"papers","name":"Ep. 2527: Do Brain Changes from Therapy or Pills Actually Last?","year":"2026","cit":0,"pfa":"Daniel Rosehill","psa":"Chatterbox TTS","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W7161120833","eid":"W7161120833"},{"id":"paper-w7204711599","cat":"papers","name":"THE UNIFIED PURINERGIC THEORY (UPT): VISCERAL MECHANO-HYDRAULICS, THALAMIC SATURATION, AND THE BOTTOM-UP DESATURATION OF INTEROCEPTIVE ANXIETY","year":"2026","cit":0,"pfa":"Giuseppe Frontera","topics":["Addiction","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7204711599","eid":"W7204711599"},{"id":"paper-w7204712657","cat":"papers","name":"THE UNIFIED PURINERGIC THEORY (UPT): VISCERAL MECHANO-HYDRAULICS, THALAMIC SATURATION, AND THE BOTTOM-UP DESATURATION OF INTEROCEPTIVE ANXIETY","year":"2026","cit":0,"pfa":"Giuseppe Frontera","topics":["Addiction","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7204712657","eid":"W7204712657"},{"id":"paper-w7161174340","cat":"papers","name":"Ep. 2527: Do Brain Changes from Therapy or Pills Actually Last?","year":"2026","cit":0,"pfa":"Daniel Rosehill","psa":"Chatterbox TTS","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W7161174340","eid":"W7161174340"},{"id":"paper-w2551762194","cat":"papers","name":"Preliminary research data analysis of LSD consumption in Britain: a qualitative study","year":"2017","cit":0,"pfa":"Lesley-Ann Smith","psa":"Rachel E. Evenden","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"conference-paper","src":"https://openalex.org/W2551762194","eid":"W2551762194"},{"id":"paper-w7154455869","cat":"papers","name":"Vascular Learning as a Substrate for PTSD Chronicity: A Cerebrovascular Receptor-Site Hypothesis","year":"2026","cit":0,"pfa":"James Peter Keim","psa":"Burton Tabaac","topics":["PTSD & trauma","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7154455869","eid":"W7154455869"},{"id":"paper-w7161498668","cat":"papers","name":"Vascular Learning as a Substrate for PTSD Chronicity: A Cerebrovascular Receptor-Site Hypothesis","year":"2026","cit":0,"pfa":"James Peter Keim","psa":"Burton Tabaac","topics":["PTSD & trauma","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7161498668","eid":"W7161498668"},{"id":"paper-w4409924229","cat":"papers","name":"Editorial: Depression: social stress, inflammation, neuromodulatory, and neural network perspectives","year":"2025","cit":0,"pfa":"Douglas F. Watt","psa":"Simon Boag","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"editorial","src":"https://openalex.org/W4409924229","eid":"W4409924229"},{"id":"paper-w1984285324","cat":"papers","name":"Editorial: The Behavioural Pharmacology of the Hippocampus","year":"2007","cit":0,"pfa":"Paul Willner","psa":"Jack Bergman","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"editorial","src":"https://openalex.org/W1984285324","eid":"W1984285324"},{"id":"paper-w7161510230","cat":"papers","name":"ITU and Pharmacology: A Single-Axiom View of Drug Discovery, Receptor Pharmacology, ADME, Pharmacogenomics, Antibody Medicines, Vaccines and Immunotherapy, AI Drug Design, and FDA Regulation — Pass-1 Extension Paper #2,","year":"2026","cit":0,"pfa":"Munehiro Terada","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W7161510230","eid":"W7161510230"},{"id":"paper-w7126468259","cat":"papers","name":"THE GEOMETRIC THEORY OF ADDICTION & 💊 N‑K ANTI‑ADDICTION DRUG SERIES","year":"2026","cit":0,"pfa":"Muhammad Usman Malik","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"other","src":"https://openalex.org/W7126468259","eid":"W7126468259"},{"id":"paper-w7126409542","cat":"papers","name":"THE GEOMETRIC THEORY OF ADDICTION & 💊 N‑K ANTI‑ADDICTION DRUG SERIES","year":"2026","cit":0,"pfa":"Muhammad Usman Malik","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"other","src":"https://openalex.org/W7126409542","eid":"W7126409542"},{"id":"paper-w1775757616","cat":"papers","name":"Quality Assurance of forensic investigations in toxicology and traffic safety","year":"2014","cit":0,"pfa":"Carrie Mullen","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"dissertation","src":"https://openalex.org/W1775757616","eid":"W1775757616"},{"id":"paper-w2079792385","cat":"papers","name":"Stimulus properties of drugs and the behavioural pharmacology of pain","year":"2011","cit":0,"pfa":"Paul Willner","psa":"Louk J. M. J. Vanderschuren","topics":["Addiction","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2079792385","eid":"W2079792385"},{"id":"paper-w7161478677","cat":"papers","name":"ITU and Pharmacology: A Single-Axiom View of Drug Discovery, Receptor Pharmacology, ADME, Pharmacogenomics, Antibody Medicines, Vaccines and Immunotherapy, AI Drug Design, and FDA Regulation — Pass-1 Extension Paper #2,","year":"2026","cit":0,"pfa":"Munehiro Terada","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W7161478677","eid":"W7161478677"},{"id":"paper-w7204955256","cat":"papers","name":"Rest-to-task functional connectome reconfiguration as a predictor of depressive symptom severity","year":"2026","cit":0,"pfa":"Sam Rosenberg","psa":"David Harold Zald","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W7204955256","eid":"W7204955256"},{"id":"paper-w2915377671","cat":"papers","name":"14th Scientific Symposium of the Austrian Pharmacological Society (APHAR)","year":"2008","cit":0,"pfa":"Miroslav Radenković","psa":"Maria Waldhoer","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2915377671","eid":"W2915377671"},{"id":"paper-w3033314635","cat":"papers","name":"Journal Digest: Home Environment; Postpartum Mental Illness; Placebo in Psychedelic Study; Single Gene Mutation; Topiramate","year":"2020","cit":0,"pfa":"Nick Zagorski","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3033314635","eid":"W3033314635"},{"id":"paper-w7161921373","cat":"papers","name":"Nurturing compassion, synchronizing hearts: a Randomized Controlled Trial to explore VR potential in inducing self-transcendent emotions","year":"2026","cit":0,"pfa":"David R. Glowacki","psa":"Valérie Bonnelle","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7161921373","eid":"W7161921373"},{"id":"paper-w7162790609","cat":"papers","name":"New and old challenges for clinical psychology and psychotherapy toward 2030","year":"2026","cit":0,"pfa":"Gianluca Castelnuovo","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7162790609","eid":"W7162790609"},{"id":"paper-w3083145605","cat":"papers","name":"Detection of psychoactive substances (antidepressants, antipsychotics, benzodiazepines, alcohol) in human hair and other matrices using liquid chromatography-mass spectrometry (LC-MS/MS)","year":"2020","cit":0,"pfa":"Maximilian Methling","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W3083145605","eid":"W3083145605"},{"id":"paper-w4389656109","cat":"papers","name":"Lachgas gegen Depression?","year":"2023","cit":0,"pfa":"Manfred Spitzer","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4389656109","eid":"W4389656109"},{"id":"paper-w4413166929","cat":"papers","name":"Addiction among Youth: Issues and Challenges","year":"2025","cit":0,"pfa":"Pinki Sevda","psa":"Siddharth Sarkar","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4413166929","eid":"W4413166929"},{"id":"paper-w2319368544","cat":"papers","name":"The ABCs of caring for sexual assault patients","year":"2014","cit":0,"pfa":"Ann N. Hellman","psa":"Susan Clark","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W2319368544","eid":"W2319368544"},{"id":"paper-w7204580934","cat":"papers","name":"Psychedelic-Assisted Therapy","year":"2026","cit":0,"pfa":"Maria Laura Mele","psa":"Stefano Federici","ptype":"reference-entry","src":"https://openalex.org/W7204580934","eid":"W7204580934"},{"id":"paper-w4409891668","cat":"papers","name":"Psychedelic Therapy","year":"2025","cit":0,"pfa":"Charmaine Husum","topics":["Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W4409891668","eid":"W4409891668"},{"id":"paper-w4246013077","cat":"papers","name":"Psychedelic ‘Therapy’","year":"2000","cit":0,"pfa":"Nicholas Albery","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4246013077","eid":"W4246013077"},{"id":"paper-w3027636671","cat":"papers","name":"Psychedelic-Assisted Psychotherapy","year":"2024","cit":0,"pfa":"Sara So","psa":"Albert Garcia-Romeu","topics":["Depression","PTSD & trauma","Therapy practice"],"ptype":"reference-entry","src":"https://openalex.org/W3027636671","eid":"W3027636671"},{"id":"paper-w4240081916","cat":"papers","name":"Psychedelic Therapy","year":"2015","cit":0,"pfa":"Erika Dyck","ptype":"reference-entry","src":"https://openalex.org/W4240081916","eid":"W4240081916"},{"id":"paper-w4413910499","cat":"papers","name":"Psychedelic Therapies","year":"2025","cit":0,"pfa":"David A. Bender","psa":"Eric J. Lenze","ptype":"article","src":"https://openalex.org/W4413910499","eid":"W4413910499"},{"id":"paper-w4392529993","cat":"papers","name":"An Overview of Psychedelic-Assisted Therapy","year":"2024","cit":0,"pfa":"Bill Brennan","psa":"Alex Belser","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"book-chapter","src":"https://openalex.org/W4392529993","eid":"W4392529993"},{"id":"paper-w7135494591","cat":"papers","name":"Psychedelic-assisted psychotherapy and the process of uncovering","year":"2024","cit":0,"pfa":"Anna Urbánková","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W7135494591","eid":"W7135494591"},{"id":"paper-w7160880815","cat":"papers","name":"Adolescent Psychedelic-Assisted Therapy","year":"2026","cit":0,"pfa":"Bryony Insua‐Summerhays","psa":"Edward Jacobs","topics":["Depression","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7160880815","eid":"W7160880815"},{"id":"paper-w7111502932","cat":"papers","name":"Alliance in psychedelic-assisted therapy","year":"2025","cit":0,"pfa":"Christoph Flückiger","ptype":"preprint","src":"https://openalex.org/W7111502932","eid":"W7111502932"},{"id":"paper-w4406324621","cat":"papers","name":"Is There a Right to Psychedelic-Assisted Therapy?","year":"2025","cit":0,"pfa":"Zak A. Kopeikin","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"editorial","src":"https://openalex.org/W4406324621","eid":"W4406324621"},{"id":"paper-w3207353005","cat":"papers","name":"6 Psychedelic Therapy","year":"2021","cit":0,"pfa":"Harish Naraindas","ptype":"book-chapter","src":"https://openalex.org/W3207353005","eid":"W3207353005"},{"id":"paper-w4391351394","cat":"papers","name":"Psychedelic-Assisted-Treatment … for Racial Trauma?","year":"2024","cit":0,"pfa":"Gabrielle Jones","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W4391351394","eid":"W4391351394"},{"id":"paper-w4393934751","cat":"papers","name":"Need for a broader discussion on psychedelic therapy","year":"2023","cit":0,"pfa":"Paweł Holas","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4393934751","eid":"W4393934751"},{"id":"paper-w4385850880","cat":"papers","name":"Patient safety in psychedelic-assisted therapy","year":"2023","cit":0,"topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4385850880","eid":"W4385850880"},{"id":"paper-w7168346277","cat":"papers","name":"The Evolution of Psychedelics and Psychedelic-Assisted Therapy","year":"2026","cit":0,"pfa":"Gurjot Brar","psa":"Henry P. O'Connell","ptype":"book-chapter","src":"https://openalex.org/W7168346277","eid":"W7168346277"},{"id":"paper-w7126543822","cat":"papers","name":"A Sociological Survey of Psychedelic-Assisted Therapy","year":"2024","cit":0,"pfa":"Fanny Charrasse","psa":"ERC Visit","ptype":"conference-paper","src":"https://openalex.org/W7126543822","eid":"W7126543822"},{"id":"paper-w4405637467","cat":"papers","name":"Psychedelic therapy in the treatment of addiction","year":"2024","cit":0,"pfa":"Rayyan R. Zafar","psa":"David Erritzøe","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4405637467","eid":"W4405637467"},{"id":"paper-w7128442728","cat":"papers","name":"A review of psychedelic-assisted therapy competencies","year":"2024","cit":0,"pfa":"Shirelle Noble","psa":"Deborah Gardner","topics":["Reviews & meta-analyses"],"ptype":"dataset","src":"https://openalex.org/W7128442728","eid":"W7128442728"},{"id":"paper-w7147725513","cat":"papers","name":"Psychedelic-Assisted Therapy: Breakthrough for Whom?","year":"2026","cit":0,"pfa":"Danielle R. Adams","psa":"Leopoldo J. Cabassa","ptype":"article","src":"https://openalex.org/W7147725513","eid":"W7147725513"},{"id":"paper-w7141103997","cat":"papers","name":"Psychedelic-Assisted Therapy in Clinical Practice","year":"2024","cit":0,"topics":["Safety & adverse events","Dosing & pharmacology","Therapy practice"],"ptype":"report","src":"https://openalex.org/W7141103997","eid":"W7141103997"},{"id":"paper-w4365446979","cat":"papers","name":"Psychedelic therapies are returning to psychiatry","year":"2023","cit":0,"pfa":"Erika Dyck","topics":["PTSD & trauma","Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4365446979","eid":"W4365446979"},{"id":"paper-w4396960828","cat":"papers","name":"Psychedelic-assisted therapy in the treatment of addiction","year":"2024","cit":0,"pfa":"Stephen Russell Naulls","psa":"Sarah Bunn","topics":["Addiction"],"ptype":"report","src":"https://openalex.org/W4396960828","eid":"W4396960828"},{"id":"paper-w4389194509","cat":"papers","name":"Psychedelic Therapy as Affective Transformation","year":"2023","cit":0,"pfa":"Adam Bradley","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"book-chapter","src":"https://openalex.org/W4389194509","eid":"W4389194509"},{"id":"paper-w4405190777","cat":"papers","name":"Psychedelic Therapy in the Treatment of Addiction","year":"2024","cit":0,"pfa":"Joshua Watt","psa":"Kirsten C. Morley","topics":["Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W4405190777","eid":"W4405190777"},{"id":"paper-w4413513231","cat":"papers","name":"Psychedelic-Assisted Therapy for Anorexia Nervosa","year":"2024","cit":0,"pfa":"Olga Stefańska","psa":"Maksymilian Matuszewski","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4413513231","eid":"W4413513231"},{"id":"paper-w7163565777","cat":"papers","name":"Approaches to ketamine-assisted couple therapy","year":"2026","cit":0,"pfa":"David O. Avruch","topics":["PTSD & trauma","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7163565777","eid":"W7163565777"},{"id":"paper-w7166880365","cat":"papers","name":"The Psychedelic Therapies Executive Order","year":"2026","cit":0,"pfa":"I Glenn Cohen","psa":"Amy L. McGuire","topics":["Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7166880365","eid":"W7166880365"},{"id":"paper-w7165861626","cat":"papers","name":"Approaches to ketamine-assisted couple therapy","year":"2026","cit":0,"pfa":"David O. Avruch","topics":["PTSD & trauma","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7165861626","eid":"W7165861626"},{"id":"paper-w4405282093","cat":"papers","name":"Psychedelic-Assisted Psychotherapy for Depressive Disorders","year":"2024","cit":0,"pfa":"Sydney White","psa":"Natalie Gukasyan","topics":["Depression","Therapy practice"],"ptype":"reference-entry","src":"https://openalex.org/W4405282093","eid":"W4405282093"},{"id":"paper-w7130874563","cat":"papers","name":"The Dissolution Void: Void Architecture in Psychedelic Therapy","year":"2026","cit":0,"pfa":"Anthony W. Eckert","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7130874563","eid":"W7130874563"},{"id":"paper-w4416716817","cat":"papers","name":"Integrating the Gestalt Model of Self With Psychedelic‐Assisted Psychotherapy","year":"2025","cit":0,"pfa":"Travis R. Fox","topics":["PTSD & trauma","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4416716817","eid":"W4416716817"},{"id":"paper-w7127228263","cat":"papers","name":"Ketamine-Assisted Psychotherapy: A Review","year":"2025","cit":0,"pfa":"Theresa A Callender","topics":["Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7127228263","eid":"W7127228263"},{"id":"paper-w7130848654","cat":"papers","name":"The Dissolution Void: Void Architecture in Psychedelic Therapy","year":"2026","cit":0,"pfa":"Anthony W. Eckert","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7130848654","eid":"W7130848654"},{"id":"paper-w4411461329","cat":"papers","name":"Beyond the breakthrough: The practical hurdles of psychedelic therapy","year":"2025","cit":0,"pfa":"F N U Shahzaib","psa":"Arifa Arifa","ptype":"article","src":"https://openalex.org/W4411461329","eid":"W4411461329"},{"id":"paper-w4411135943","cat":"papers","name":"Investing in Group Psychedelic Therapy for Latinx Immigrants","year":"2025","cit":0,"pfa":"Juliana Zambrano","psa":"Franklin King","ptype":"article","src":"https://openalex.org/W4411135943","eid":"W4411135943"},{"id":"paper-w4385648535","cat":"papers","name":"CHAPTER 11 The Future for Psychedelic-Assisted Psychotherapy","year":"2016","cit":0,"pfa":"Ben Sessa","psa":"Eileen Worthley","topics":["Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W4385648535","eid":"W4385648535"},{"id":"paper-w7164890348","cat":"papers","name":"Psychedelic Assisted Psychotherapy: A New Kind of Conversation","year":"2025","cit":0,"pfa":"Jamie Rickord","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W7164890348","eid":"W7164890348"},{"id":"paper-w7140312404","cat":"papers","name":"The Imperative for Economic Evaluation in Psychedelic-assisted Therapies","year":"2026","cit":0,"pfa":"Matthew Hicks","psa":"Patricia M. Herman","ptype":"preprint","src":"https://openalex.org/W7140312404","eid":"W7140312404"},{"id":"paper-w4294189459","cat":"papers","name":"Psychedelic-Assisted Psychotherapy: When Two Traditions Meet","year":"2022","cit":0,"pfa":"Ede Frecska","psa":"P. Bokor","topics":["Addiction","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4294189459","eid":"W4294189459"},{"id":"paper-w7147166103","cat":"papers","name":"Capacity Building Through Psychedelic-Assisted Therapy","year":"2026","cit":0,"pfa":"Logan Neitzke‐Spruill","psa":"Jarrett Robert Rose","ptype":"article","src":"https://openalex.org/W7147166103","eid":"W7147166103"},{"id":"paper-w4414180709","cat":"papers","name":"Salivary Oxytocin as a Biomarker in Psychedelic Assisted Psychotherapy","year":"2025","cit":0,"pfa":"Laurie Cazorla","psa":"Tatiana Aboulafia Brakha","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4414180709","eid":"W4414180709"},{"id":"paper-w7214046242","cat":"papers","name":"Psychedelic-assisted therapy research for people with HIV","year":"2026","cit":0,"pfa":"Nelson Vergel","psa":"Parya Saberi","ptype":"article","src":"https://openalex.org/W7214046242","eid":"W7214046242"},{"id":"paper-w7130384245","cat":"papers","name":"Ergothioneine and TrkB Phosphorylation Dynamics in Psychedelic Therapy","year":"2026","cit":0,"pfa":"Lee William Carroll","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7130384245","eid":"W7130384245"},{"id":"paper-w7212673498","cat":"papers","name":"Psychedelic-assisted therapy: Research and clinical practice","year":"2024","cit":0,"pfa":"Mia Sarno","ptype":"dataset","src":"https://openalex.org/W7212673498","eid":"W7212673498"},{"id":"paper-w3045872576","cat":"papers","name":"Psychedelic Assisted Psychotherapy for the Treatment of Gender Dysphoria.","year":"2019","cit":0,"pfa":"Tyler Kjorvestad","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W3045872576","eid":"W3045872576"},{"id":"paper-w7141235927","cat":"papers","name":"The Role of Psychedelic-Assisted Therapies in Treating Depression","year":"2024","cit":0,"topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"report","src":"https://openalex.org/W7141235927","eid":"W7141235927"},{"id":"paper-w7113251540","cat":"papers","name":"Science Standards Fail Psychedelic-Assisted Psychotherapy","year":"2025","cit":0,"pfa":"Hauskeller, Christine","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W7113251540","eid":"W7113251540"},{"id":"paper-w7111948878","cat":"papers","name":"Cyclical Psychodynamic View on Psychedelic Assisted Therapy","year":"2025","cit":0,"pfa":"DeSimone, Christi","topics":["Depression","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7111948878","eid":"W7111948878"},{"id":"paper-w4391657418","cat":"papers","name":"Molecular simulation for safer psychedelic therapies","year":"2024","cit":0,"pfa":"Carl‐Mikael Suomivuori","psa":"Ron O. Dror","ptype":"article","src":"https://openalex.org/W4391657418","eid":"W4391657418"},{"id":"paper-w7204573334","cat":"papers","name":"Oncology Providers’ Perspectives on Psychedelic-Assisted Therapy","year":"2026","cit":0,"pfa":"Krishna S. Hanubal","psa":"Jeremy P. Harris","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7204573334","eid":"W7204573334"},{"id":"paper-w7164646064","cat":"papers","name":"Patient-Driven Care in Psychedelic Therapy","year":"2026","cit":0,"pfa":"Yaara Zisman‐Ilani","psa":"Rachel Yehuda","ptype":"article","src":"https://openalex.org/W7164646064","eid":"W7164646064"},{"id":"paper-w4389694574","cat":"papers","name":"4. The Other World: Psychedelic Therapy","year":"2018","cit":0,"pfa":"P.W. Barber","ptype":"book-chapter","src":"https://openalex.org/W4389694574","eid":"W4389694574"},{"id":"paper-w7134743381","cat":"papers","name":"An Educational Workshop for Nurses to learn about Psychedelic Therapies","year":"2023","cit":0,"pfa":"Sriniti Sthapit","topics":["Therapy practice","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W7134743381","eid":"W7134743381"},{"id":"paper-w2995535862","cat":"papers","name":"Psychedelic-assisted therapy: A new way forward in mental health","year":"2019","cit":0,"pfa":"Kimberly Wibur","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"dissertation","src":"https://openalex.org/W2995535862","eid":"W2995535862"},{"id":"paper-w4411344910","cat":"papers","name":"Authenticity and Love Drugs: Insights from Psychedelic Therapy","year":"2025","cit":0,"pfa":"Owen Thomas","psa":"Francisca Silva","ptype":"article","src":"https://openalex.org/W4411344910","eid":"W4411344910"},{"id":"paper-w7112490587","cat":"papers","name":"EXPLORING THE POTENTIAL OF PSYCHEDELIC-ASSISTED THERAPIES FOR SUICIDE PREVENTION IN SOCOM","year":"2022","cit":0,"pfa":"Albert, Patrick","psa":"Stanley, Thomas M.","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W7112490587","eid":"W7112490587"},{"id":"paper-w7158928047","cat":"papers","name":"Therapist Rated Predictors of Response to Psychedelic Assisted Therapy","year":"2026","cit":0,"pfa":"Grace Viljoen","psa":"Antonia Bendau","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"dataset","src":"https://openalex.org/W7158928047","eid":"W7158928047"},{"id":"paper-w4407650840","cat":"papers","name":"Psychedelic-assisted therapy for mental health: Policy considerations","year":"2025","cit":0,"pfa":"Parliamentary Office of Science and Technology","psa":"Stephen Russell Naulls","topics":["Safety & adverse events","Policy & ethics"],"ptype":"report","src":"https://openalex.org/W4407650840","eid":"W4407650840"},{"id":"paper-w7204859822","cat":"papers","name":"Indigenous cultural safety in psychedelic assisted therapy : a qualitative analysis","year":"2026","cit":0,"pfa":"Lakoda Thomas","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"dissertation","src":"https://openalex.org/W7204859822","eid":"W7204859822"},{"id":"paper-w4297831181","cat":"papers","name":"Awakn Welcoming a new era of psychedelic-assisted therapy","year":"2022","cit":0,"ptype":"article","src":"https://openalex.org/W4297831181","eid":"W4297831181"},{"id":"paper-w4391853057","cat":"papers","name":"Introduction and overview of deliberate practice and psychedelic-assisted therapy.","year":"2024","cit":0,"pfa":"Shannon Dames","psa":"Alexandre Vaz","ptype":"book-chapter","src":"https://openalex.org/W4391853057","eid":"W4391853057"},{"id":"paper-w4412158416","cat":"papers","name":"Psychedelic-Assisted Therapy Training in the US: A Landscape Analysis","year":"2025","cit":0,"pfa":"Roman Palitsky","psa":"Gosia Sklodowska","topics":["Anxiety & end-of-life","Safety & adverse events","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4412158416","eid":"W4412158416"},{"id":"paper-w7162469276","cat":"papers","name":"Reframing distress in oncology: the potential of psychedelic-assisted therapy","year":"2026","cit":0,"pfa":"Fatima Zohra Moujahid","psa":"Olivier Taymans","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7162469276","eid":"W7162469276"},{"id":"paper-w7197074164","cat":"papers","name":"The potential of psychedelic therapy in increasing nature relatedness","year":"2025","cit":0,"pfa":"Olli Aku Kaitila","ptype":"article","src":"https://openalex.org/W7197074164","eid":"W7197074164"},{"id":"paper-w7137637631","cat":"papers","name":"Chapter 5 Autonomy and autoheteronomy in psychedelically assisted psychotherapy","year":"2022","cit":0,"pfa":"Oliver Davis","topics":["Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7137637631","eid":"W7137637631"},{"id":"paper-w4391854587","cat":"papers","name":"Exercise 14. Mock psychedelic-assisted therapy sessions.","year":"2024","cit":0,"pfa":"Shannon Dames","psa":"Alexandre Vaz","ptype":"book-chapter","src":"https://openalex.org/W4391854587","eid":"W4391854587"},{"id":"paper-w7133018628","cat":"papers","name":"The Effects of Psychedelic-Assisted Therapy on Illness and Death Anxiety","year":"2024","cit":0,"pfa":"Aron Amaev","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"dissertation","src":"https://openalex.org/W7133018628","eid":"W7133018628"},{"id":"paper-w4401882792","cat":"papers","name":"Could Psychedelic-Assisted Therapy Change Addiction Treatment?","year":"2024","cit":0,"topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W4401882792","eid":"W4401882792"},{"id":"paper-w4205924479","cat":"papers","name":"Simulating Psychedelic Therapy Through Mediated Reality","year":"2017","cit":0,"pfa":"Andrew Hillstead","topics":["PTSD & trauma","Addiction","Reviews & meta-analyses"],"ptype":"dissertation","src":"https://openalex.org/W4205924479","eid":"W4205924479"},{"id":"paper-w7155648153","cat":"papers","name":"Ritual in Psychedelic Therapy: A Principle-Based Framework","year":"2026","cit":0,"pfa":"Shannon Dames","psa":"Pamela Kryskow","ptype":"article","src":"https://openalex.org/W7155648153","eid":"W7155648153"},{"id":"paper-w4408076133","cat":"papers","name":"The Role of Mystical Experiences in Psychedelic Therapy and Research","year":"2025","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W4408076133","eid":"W4408076133"},{"id":"paper-w4376117189","cat":"papers","name":"The Attack on Psychedelic Therapy and Its Slow Recovery","year":"2023","cit":0,"pfa":"Richard Louis Miller","topics":["Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W4376117189","eid":"W4376117189"},{"id":"paper-w4404119396","cat":"papers","name":"Study finds sustained effects of LSD‐assisted therapy on anxiety","year":"2024","cit":0,"topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4404119396","eid":"W4404119396"},{"id":"paper-w2799487531","cat":"papers","name":"Simulating Psychedelic Therapy Through Mediated Reality","year":"2017","cit":0,"pfa":"Andrew Hillstead","topics":["PTSD & trauma","Addiction","Reviews & meta-analyses"],"ptype":"dissertation","src":"https://openalex.org/W2799487531","eid":"W2799487531"},{"id":"paper-w7140124907","cat":"papers","name":"Therapeutic availability versus uptake in psychedelic therapy","year":"2026","cit":0,"pfa":"Matthew Pennell","psa":"Louise Horstmanshof","ptype":"article","src":"https://openalex.org/W7140124907","eid":"W7140124907"},{"id":"paper-w2953221474","cat":"papers","name":"Can Ketamine Assist Treatment of Cocaine Dependence","year":"2019","cit":0,"pfa":"Joel Yager","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2953221474","eid":"W2953221474"},{"id":"paper-w7203944180","cat":"papers","name":"Ketamine‐Assisted Psychotherapy as an Approach to Psychedelic Healing","year":"2026","cit":0,"pfa":"Phil Wolfson","topics":["Safety & adverse events","Therapy practice"],"ptype":"other","src":"https://openalex.org/W7203944180","eid":"W7203944180"},{"id":"paper-w7151505551","cat":"papers","name":"Ketamine-assisted Therapy for Depression: Scoping Review","year":"2026","cit":0,"pfa":"Michael K. Juberg","psa":"Paul Glue","topics":["Depression","Reviews & meta-analyses","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7151505551","eid":"W7151505551"},{"id":"paper-w7170070140","cat":"papers","name":"What About Psycholytic Therapy? A Historical Revisiting of Psychedelics Assisting Psychotherapy","year":"2026","cit":0,"pfa":"Idir Zaher","psa":"Jérémie Richard","topics":["Mechanism & neuroscience","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7170070140","eid":"W7170070140"},{"id":"paper-w7160112572","cat":"papers","name":"Anything that helps: cancer patient and carer perspectives on psychedelic-assisted therapy","year":"2026","cit":0,"pfa":"A. Wech","psa":"L. M. Reynolds","topics":["Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7160112572","eid":"W7160112572"},{"id":"paper-w4401433888","cat":"papers","name":"Call for papers on psychedelic‐assisted treatment for substance use disorders","year":"2024","cit":0,"topics":["Addiction"],"ptype":"paratext","src":"https://openalex.org/W4401433888","eid":"W4401433888"},{"id":"paper-w4414180188","cat":"papers","name":"Psychedelic‐assisted therapy for functional neurological disorders: a review of the literature","year":"2025","cit":0,"pfa":"T. F. Fernandes","psa":"C. Pissarra","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4414180188","eid":"W4414180188"},{"id":"paper-w7166878264","cat":"papers","name":"A Transdiagnostic, Trans-Drug Integrative Model of Psychedelic Assisted Therapy","year":"2026","cit":0,"pfa":"Koodrut Panesar","ptype":"dissertation","src":"https://openalex.org/W7166878264","eid":"W7166878264"},{"id":"paper-w7135396311","cat":"papers","name":"Epistemic Autonomy, Metaphysical Restraint, and Mindfulness in Psychedelic-assisted Therapy","year":"2026","cit":0,"pfa":"Lucas F. Borkel","psa":"Luis Alberto Henríquez-Hernández","ptype":"article","src":"https://openalex.org/W7135396311","eid":"W7135396311"},{"id":"paper-w7160851066","cat":"papers","name":"Beyond the psychedelic bubble: Promises and pitfalls of psychedelic-assisted psychotherapy","year":"2024","cit":0,"pfa":"Michiel van Elk","topics":["Therapy practice"],"ptype":"dataset","src":"https://openalex.org/W7160851066","eid":"W7160851066"},{"id":"paper-w7155042032","cat":"papers","name":"Epistemic Autonomy, Metaphysical Restraint, and Mindfulness in Psychedelic-assisted Therapy","year":"2026","cit":0,"pfa":"Lucas F. Borkel","psa":"Luis Alberto Henríquez-Hernández","ptype":"article","src":"https://openalex.org/W7155042032","eid":"W7155042032"},{"id":"paper-w4406392974","cat":"papers","name":"Building Therapeutic Competencies: Navigating the Stages of Psychedelic-Assisted Therapy","year":"2025","cit":0,"ptype":"dataset","src":"https://openalex.org/W4406392974","eid":"W4406392974"},{"id":"paper-w7154500363","cat":"papers","name":"Practical Considerations for Psychedelic-Assisted Therapy among Social Workers","year":"2026","cit":0,"pfa":"Eva Nowakowski-Sims","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7154500363","eid":"W7154500363"},{"id":"paper-w7128226386","cat":"papers","name":"Reclaiming the Matrix: The Importance of the Social Environment in Psychedelic-Assisted Therapy","year":"2026","cit":0,"pfa":"Edward Jacobs","psa":"Ian Roullier","ptype":"preprint","src":"https://openalex.org/W7128226386","eid":"W7128226386"},{"id":"paper-w4413285089","cat":"papers","name":"237. SAFETY AND ETHICAL CONSIDERATIONS FOR PSYCHEDELIC ASSISTED PSYCHOTHERAPY (PAP)","year":"2025","cit":0,"pfa":"Susan Lee Rossell","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"conference-abstract","src":"https://openalex.org/W4413285089","eid":"W4413285089"},{"id":"paper-w7203667329","cat":"papers","name":"The expansion of psychedelic-assisted therapy: The case for caution over acceleration","year":"2026","cit":0,"pfa":"Steve R Kisely","ptype":"article","src":"https://openalex.org/W7203667329","eid":"W7203667329"},{"id":"paper-w7128177148","cat":"papers","name":"Reclaiming the Matrix: The Importance of the Social Environment in Psychedelic-Assisted Therapy","year":"2026","cit":0,"pfa":"Edward Jacobs","psa":"Ian Roullier","ptype":"preprint","src":"https://openalex.org/W7128177148","eid":"W7128177148"},{"id":"paper-w4398245808","cat":"papers","name":"Review for \"Psychedelic therapy in depression and substance use disorders\"","year":"2024","cit":0,"topics":["Depression","Addiction","Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4398245808","eid":"W4398245808"},{"id":"paper-w7163131253","cat":"papers","name":"Psychedelic-Assisted Interventions in Palliative Care: A Narrative Overview and Critical Evaluation","year":"2026","cit":0,"pfa":"Daniele Almeida Soares","psa":"Alessandro Gonçalves Campolina","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7163131253","eid":"W7163131253"},{"id":"paper-w7171984157","cat":"papers","name":"Dance of the four bodies: An enactive-individuative approach to ketamine assisted psychotherapy","year":"2026","cit":0,"pfa":"Aragorn Eloff","psa":"Alessandro Gonçalves Campolina","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W7171984157","eid":"W7171984157"},{"id":"paper-w7117354148","cat":"papers","name":"Nondual Mindfulness and Psychedelic Assisted Therapy: Frameworks for Clinical Integration","year":"2025","cit":0,"pfa":"Julien Tempone-Wiltshire","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W7117354148","eid":"W7117354148"},{"id":"paper-w7113533430","cat":"papers","name":"A Systematic Review of Multicultural Diversity in Psychedelic-Assisted Psychotherapy Trials","year":"2024","cit":0,"pfa":"Stephanie Haft","psa":"Marissa Reymond-Flesch","topics":["Safety & adverse events","Reviews & meta-analyses","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7113533430","eid":"W7113533430"},{"id":"paper-w4413473515","cat":"papers","name":"Psychedelic-Assisted Psychotherapy Using a Process Based Therapy Framework","year":"2025","cit":0,"pfa":"Joseph M. Diehl","psa":"Mark Zachary Rosenthal","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"preprint","src":"https://openalex.org/W4413473515","eid":"W4413473515"},{"id":"paper-w3138905069","cat":"papers","name":"Study examines use of psychedelic therapy in clinical care","year":"2021","cit":0,"pfa":"Valerie A. Canady","topics":["Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3138905069","eid":"W3138905069"},{"id":"paper-w4294589437","cat":"papers","name":"Psychedelic therapy helps some people quit alcohol","year":"2022","cit":0,"pfa":"Grace Wade","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4294589437","eid":"W4294589437"},{"id":"paper-w4409331183","cat":"papers","name":"The Therapeutic Utility of Awe in Palliative Care and Psychedelic Therapy","year":"2025","cit":0,"pfa":"Alix Youngblood","psa":"Ali John Zarrabi","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4409331183","eid":"W4409331183"},{"id":"paper-w4416356084","cat":"papers","name":"Psychedelic therapy: a paradigm shift in treating neuropsychiatric disorders","year":"2025","cit":0,"pfa":"Meng Jin","psa":"Linlin Lu","ptype":"article","src":"https://openalex.org/W4416356084","eid":"W4416356084"},{"id":"paper-w7164131911","cat":"papers","name":"Psychedelic ethics in practice: The case of ketamine-assisted psychotherapy in Norway","year":"2026","cit":0,"pfa":"Sina Susanna Schüttler","psa":"Daniel Münster","topics":["Depression","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7164131911","eid":"W7164131911"},{"id":"paper-w4398246361","cat":"papers","name":"Review for \"Psychedelic therapy in depression and substance use disorders\"","year":"2024","cit":0,"topics":["Depression","Addiction","Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4398246361","eid":"W4398246361"},{"id":"paper-w4388295379","cat":"papers","name":"Ketamine-assisted psychological therapy to reduce alcohol relapse","year":"2023","cit":0,"pfa":"Stephen John Kaar","psa":"Celia J. A. Morgan","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W4388295379","eid":"W4388295379"},{"id":"paper-w4392591032","cat":"papers","name":"Ukraine MH professionals offered psychedelic therapy training","year":"2024","cit":0,"pfa":"Valerie A. Canady","topics":["PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4392591032","eid":"W4392591032"},{"id":"paper-w4398245985","cat":"papers","name":"Review for \"Psychedelic therapy in depression and substance use disorders\"","year":"2024","cit":0,"topics":["Depression","Addiction","Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4398245985","eid":"W4398245985"},{"id":"paper-w7112270243","cat":"papers","name":"Therapeutic physical touch in psychedelic therapy: a review of reasons","year":"2025","cit":0,"pfa":"Dimitris Repantis","psa":"Chiara Caporuscio","topics":["Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7112270243","eid":"W7112270243"},{"id":"paper-w7148420154","cat":"papers","name":"Improving Outcomes in Psychedelic-Assisted Therapy for Opioid Addiction through Herbal Medicine","year":"2025","cit":0,"pfa":"Matthew T. J. Halma","psa":"Rakeem Levy","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7148420154","eid":"W7148420154"},{"id":"paper-w4398245610","cat":"papers","name":"Review for \"Psychedelic therapy in depression and substance use disorders\"","year":"2024","cit":0,"topics":["Depression","Addiction","Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4398245610","eid":"W4398245610"},{"id":"paper-w7211936735","cat":"papers","name":"Ketamine-Assisted Intensive Short-Term Dynamic Psychotherapy","year":"2026","cit":0,"pfa":"Allen Kalpin","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W7211936735","eid":"W7211936735"},{"id":"paper-w4393055009","cat":"papers","name":"Ketamine-Assisted Buprenorphine Initiation: A Pilot Case Series","year":"2024","cit":0,"pfa":"Lucinda A. Grande","psa":"Andrew A. Herring","ptype":"preprint","src":"https://openalex.org/W4393055009","eid":"W4393055009"},{"id":"paper-w4409509904","cat":"papers","name":"Radiation Therapy Patients’ Interest in Psychedelic-assisted Therapy: A Prospective Survey Study","year":"2025","cit":0,"pfa":"Jino Park","psa":"Jeremy P. Harris","ptype":"preprint","src":"https://openalex.org/W4409509904","eid":"W4409509904"},{"id":"paper-w4394913693","cat":"papers","name":"Psychedelic Assisted Therapies in Palliative and Hospice Care Are Here: Let's Discuss!","year":"2024","cit":0,"pfa":"Caitanya Min","psa":"Michael David Fratkin","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4394913693","eid":"W4394913693"},{"id":"paper-w7154696903","cat":"papers","name":"Beyond neuroplasticity: Mapping the therapist variable in psychedelic-assisted therapy literature","year":"2026","cit":0,"pfa":"Alexi Mary Theofanous","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7154696903","eid":"W7154696903"},{"id":"paper-w4416005197","cat":"papers","name":"Expanding Horizons for Psychedelic-Assisted Therapy & Management Scholarship: European Perspectives","year":"2025","cit":0,"pfa":"Adelaide Wilcox King","psa":"Michael D. Lounsbury","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"conference-abstract","src":"https://openalex.org/W4416005197","eid":"W4416005197"},{"id":"paper-w4400028905","cat":"papers","name":"The Rainbow Wave: Rethinking LGBTQ Representation in Psychedelic-Assisted Therapy Research","year":"2024","cit":0,"pfa":"Tyler King","topics":["Therapy practice","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W4400028905","eid":"W4400028905"},{"id":"paper-w3121931361","cat":"papers","name":"Psychedelic-Assisted Psychotherapy using Acceptance and Commitment Therapy as a Therapeutic Frame","year":"2020","cit":0,"pfa":"Jordan Sloshower","topics":["Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W3121931361","eid":"W3121931361"},{"id":"paper-w7171383914","cat":"papers","name":"Integration of psychedelic assisted therapies for mental health conditions - a scoping review","year":"2025","cit":0,"pfa":"Nicholas Vucak","psa":"Nicola Acevedo","topics":["Reviews & meta-analyses","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7171383914","eid":"W7171383914"},{"id":"paper-w7125988262","cat":"papers","name":"End of life distress as an economic issue: The case for psychedelic-assisted therapy","year":"2026","cit":0,"pfa":"Michel Dorval","psa":"Jason R. Guertin","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7125988262","eid":"W7125988262"},{"id":"paper-w7106326703","cat":"papers","name":"Psychedelic-Assisted Therapy in Palliative Care-Insights from an International Workshop","year":"2025","cit":0,"pfa":"Schuldt, Anna","psa":"Blum, David","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7106326703","eid":"W7106326703"},{"id":"paper-w7131862408","cat":"papers","name":"Psychedelic‐assisted therapy for substance use disorders: Between urgency and uncertainty","year":"2026","cit":0,"pfa":"João Paulo De Aquino","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7131862408","eid":"W7131862408"},{"id":"paper-w7198611408","cat":"papers","name":"Psychedelics and support for dignified death : Psychedelic-assisted psychotherapy in palliative care","year":"2023","cit":0,"pfa":"Sampo Mustonen","topics":["Anxiety & end-of-life","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7198611408","eid":"W7198611408"},{"id":"paper-w7160011575","cat":"papers","name":"Synergies in psychedelic-assisted therapy: a qualitative interview study of psychotherapeutic processes","year":"2026","cit":0,"pfa":"Jonathan Stellmacher","psa":"Uwe Herwig","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7160011575","eid":"W7160011575"},{"id":"paper-w7112299799","cat":"papers","name":"Phenomenological analysis of set and setting's manipulation in shamanic psychedelic rituals and psychedelic-assisted-therapy","year":"2024","cit":0,"pfa":"Colelli, Jacopo","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W7112299799","eid":"W7112299799"},{"id":"paper-w4391854498","cat":"papers","name":"Exercise 13. Annotated psychedelic-assisted therapy practice session transcript.","year":"2024","cit":0,"pfa":"Shannon Dames","psa":"Alexandre Fernández Vaz","ptype":"book-chapter","src":"https://openalex.org/W4391854498","eid":"W4391854498"},{"id":"paper-w4391853009","cat":"papers","name":"Instructions for the therapeutic approach for psychedelic-assisted therapy deliberate practice exercises.","year":"2024","cit":0,"pfa":"Shannon Dames","psa":"Alexandre Vaz","ptype":"book-chapter","src":"https://openalex.org/W4391853009","eid":"W4391853009"},{"id":"paper-w7154491064","cat":"papers","name":"Psychedelic-assisted therapy for death acceptance in terminal illness: A scoping review","year":"2026","cit":0,"pfa":"Hannah Whitmore","psa":"Heather C. Leutwyler","topics":["Depression","Anxiety & end-of-life","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7154491064","eid":"W7154491064"},{"id":"paper-w4400441557","cat":"papers","name":"The Psychedelic-Assisted Therapy Ecosystem:Charting New Scholarship in Value Creation & Distribution","year":"2024","cit":0,"pfa":"Adelaide Wilcox King","psa":"Bennet A. Zelner","topics":["Safety & adverse events","Policy & ethics"],"ptype":"conference-abstract","src":"https://openalex.org/W4400441557","eid":"W4400441557"},{"id":"paper-w4385215582","cat":"papers","name":"Psychedelic Assisted Therapy: Refreshing Assumptions of What’s Possible Through and In Organizations","year":"2023","cit":0,"pfa":"Adelaide Wilcox King","psa":"Kisha Lashley","topics":["Safety & adverse events"],"ptype":"conference-abstract","src":"https://openalex.org/W4385215582","eid":"W4385215582"},{"id":"paper-w7160931533","cat":"papers","name":"Psychedelic-Assisted Therapy: Clinical, Regulatory, and Training Recommendations for Palliative Care","year":"2026","cit":0,"pfa":"Stacy M. Fischer","psa":"Stephen Lewis","topics":["Anxiety & end-of-life","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7160931533","eid":"W7160931533"},{"id":"paper-w4398245867","cat":"papers","name":"Decision letter for \"Psychedelic therapy in depression and substance use disorders\"","year":"2024","cit":0,"topics":["Depression","Addiction"],"ptype":"peer-review","src":"https://openalex.org/W4398245867","eid":"W4398245867"},{"id":"paper-w4414190611","cat":"papers","name":"Psychedelic-assisted therapy from a narrative therapy perspective: A map for practitioners","year":"2025","cit":0,"pfa":"Christine Dennstedt","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4414190611","eid":"W4414190611"},{"id":"paper-w7147113983","cat":"papers","name":"Synergies in psychedelic-assisted therapy: a qualitative interview study of psychotherapeutic processes","year":"2026","cit":0,"pfa":"Jonathan Stellmacher","psa":"Uwe Herwig","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7147113983","eid":"W7147113983"},{"id":"paper-w4404143178","cat":"papers","name":"Embark psychedelic therapy for depression: A new approach for the whole person","year":"2024","cit":0,"pfa":"Emmett Hulser-Morris","psa":"Brian C. Pilecki","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4404143178","eid":"W4404143178"},{"id":"paper-w4389569246","cat":"papers","name":"Commentary: ARC: a framework for access, reciprocity and conduct in psychedelic therapies","year":"2023","cit":0,"pfa":"Tahlia R. Harrison","ptype":"editorial","src":"https://openalex.org/W4389569246","eid":"W4389569246"},{"id":"paper-w4416071984","cat":"papers","name":"Exploring the utility of psychedelic therapy for individuals with amyotrophic lateral sclerosis","year":"2023","cit":0,"pfa":"Austin J. Mallard","psa":"Stephen Ross","ptype":"dataset","src":"https://openalex.org/W4416071984","eid":"W4416071984"},{"id":"paper-w7164668117","cat":"papers","name":"Psychedelic Therapies in the United States — Balancing State and Federal Oversight","year":"2026","cit":0,"pfa":"Marcus Hughes","ptype":"article","src":"https://openalex.org/W7164668117","eid":"W7164668117"},{"id":"paper-w2962150288","cat":"papers","name":"The Trials of Psychedelic Therapy: LSD Psychotherapy in America by Matthew Oram","year":"2019","cit":0,"pfa":"Nicolas Rasmussen","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2962150288","eid":"W2962150288"},{"id":"paper-w4386686879","cat":"papers","name":"Psychedelic Therapy as a Complementary Treatment Approach for Alcohol Use Disorders","year":"2019","cit":0,"pfa":"Peter Eischens","psa":"William Leigh Atherton","topics":["Addiction"],"ptype":"other","src":"https://openalex.org/W4386686879","eid":"W4386686879"},{"id":"paper-w4206547411","cat":"papers","name":"Psychedelic therapies continue to be seen as big trend in MH treatment","year":"2022","cit":0,"pfa":"Valerie A. Canady","topics":["Depression","PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4206547411","eid":"W4206547411"},{"id":"paper-w4398231307","cat":"papers","name":"Author response for \"Psychedelic therapy in depression and substance use disorders\"","year":"2024","cit":0,"pfa":"Nur Damla Korkmaz","psa":"Emrah Yücesan","topics":["Depression","Addiction"],"ptype":"peer-review","src":"https://openalex.org/W4398231307","eid":"W4398231307"},{"id":"paper-w4393543756","cat":"papers","name":"Are first responders interested in psychedelics? Assessing previous use, interest, and willingness to participate in psychedelic-assisted therapy","year":"2024","cit":0,"pfa":"Sonia M. Brodie","psa":"Ryan C.N. D’Arcy","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4393543756","eid":"W4393543756"},{"id":"paper-w7125689212","cat":"papers","name":"These aren’t the beliefs you’re looking for: on the limits of affect-neutral accounts of psychedelic therapy","year":"2026","cit":0,"pfa":"Celia R. Blaise","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7125689212","eid":"W7125689212"},{"id":"paper-w4401365985","cat":"papers","name":"Psychedelic therapy: Can’t stop the wave, let’s learn to surf!","year":"2024","cit":0,"pfa":"M. Aleem Siddiqui","psa":"Sai Krishna Tikka","ptype":"article","src":"https://openalex.org/W4401365985","eid":"W4401365985"},{"id":"paper-w4393065695","cat":"papers","name":"Invited Commentary on Psychedelic Therapy: A Primer for Primary Care Clinicians","year":"2024","cit":0,"pfa":"Lynn Marie Morski","ptype":"article","src":"https://openalex.org/W4393065695","eid":"W4393065695"},{"id":"paper-w2806894505","cat":"papers","name":"Psychedelic therapy as a complementary treatment approach for alcohol use disorders","year":"2018","cit":0,"pfa":"Peter Eischens","psa":"William Leigh Atherton","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2806894505","eid":"W2806894505"},{"id":"paper-w7203840059","cat":"papers","name":"Psychedelic therapy and the current and future roles for psychiatric pharmacists in the USA","year":"2026","cit":0,"pfa":"Jayme Jenkins","psa":"Anton L.V. Avanceña","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7203840059","eid":"W7203840059"},{"id":"paper-w2519774462","cat":"papers","name":"Psychedelic therapy from an existential psychological viewpoint : a theoretical analysis","year":"2016","cit":0,"pfa":"Stian Hyman Berg","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W2519774462","eid":"W2519774462"},{"id":"paper-w4416193296","cat":"papers","name":"Between Science and Spirit: Rethinking Mental Health with Psychedelic Therapy","year":"2025","cit":0,"pfa":"Isabella Mendoza","psa":"Sania Choudhary","ptype":"article","src":"https://openalex.org/W4416193296","eid":"W4416193296"},{"id":"paper-w3021974103","cat":"papers","name":"The Trials of Psychedelic Therapy: LSD Psychotherapy in America by Matthew Oram","year":"2020","cit":0,"pfa":"Chris Elcock","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W3021974103","eid":"W3021974103"},{"id":"paper-w4398245923","cat":"papers","name":"Decision letter for \"Psychedelic therapy in depression and substance use disorders\"","year":"2024","cit":0,"topics":["Depression","Addiction"],"ptype":"peer-review","src":"https://openalex.org/W4398245923","eid":"W4398245923"},{"id":"paper-w4408196098","cat":"papers","name":"Chapter 7 The Role of Mystical Experiences in Psychedelic Therapy and Research","year":"2025","cit":0,"pfa":"Richard H. Jones","ptype":"book-chapter","src":"https://openalex.org/W4408196098","eid":"W4408196098"},{"id":"paper-w7135519399","cat":"papers","name":"Perspectives of People Interested of Ketamine-assisted Psychotherapy: A Qualitative Analysis","year":"2025","cit":0,"pfa":"Debora Hejnová","topics":["Therapy practice","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W7135519399","eid":"W7135519399"},{"id":"paper-w2942758265","cat":"papers","name":"Matthew Oram, The Trials of Psychedelic Therapy: LSD Psychotherapy in America","year":"2019","cit":0,"pfa":"James Edward Pugh","topics":["Addiction","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2942758265","eid":"W2942758265"},{"id":"paper-w7160505769","cat":"papers","name":"\"Riding the Wave\"—Social Work Roles in Psychedelic Therapy Settings: A Scoping Review","year":"2026","cit":0,"pfa":"Abel Walker","psa":"Kristin W. Mapson","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7160505769","eid":"W7160505769"},{"id":"paper-w7162066466","cat":"papers","name":"Ketamine-assisted psychotherapy (KAP): psychedelic paradigm or psychiatric practice?","year":"2026","cit":0,"pfa":"Damian Adasik","psa":"Wiktoria S. Stanek","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W7162066466","eid":"W7162066466"},{"id":"paper-w4409330467","cat":"papers","name":"Navigating Hope and Healing: A Case Report on Ketamine Assisted Therapy","year":"2025","cit":0,"pfa":"Ava Cole","psa":"Anamargret Sanchez","ptype":"article","src":"https://openalex.org/W4409330467","eid":"W4409330467"},{"id":"paper-w7167281104","cat":"papers","name":"Mystical Experiences as Catalysts in Ketamine-Assisted Psychotherapy: A Case Study","year":"2026","cit":0,"pfa":"Miguel Joaquim Soares Teles Couceiro","psa":"Nuno Manuel Correia Torres","topics":["Anxiety & end-of-life","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7167281104","eid":"W7167281104"},{"id":"paper-w4403163503","cat":"papers","name":"65.3 The Psychotherapeutic Model of Ketamine-Assisted Therapy in the Outpatient Setting","year":"2024","cit":0,"pfa":"Suraiya S. Rahman","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4403163503","eid":"W4403163503"},{"id":"paper-w4412849152","cat":"papers","name":"Ketamine-Assisted Psychotherapy for Addiction: Mechanisms, Evidence, and Clinical Implications","year":"2025","cit":0,"pfa":"Allay Health and Wellness in Palm Beach Gardens,FL, USA.","psa":"Ryan Ward","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4412849152","eid":"W4412849152"},{"id":"paper-w4407134895","cat":"papers","name":"The Potential Role of Hypnotic Suggestion in Ketamine-Assisted Psychotherapy for Depression","year":"2025","cit":0,"pfa":"Morgan S. Hardy","topics":["Depression","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4407134895","eid":"W4407134895"},{"id":"paper-w7164003305","cat":"papers","name":"Mental health practitioners' (MHPs') attitudes towards psychedelic-assisted therapy (PAT)","year":"2026","cit":0,"pfa":"Avigail Zucker","psa":"Anna Harwood‐Gross","topics":["Policy & ethics"],"ptype":"other","src":"https://openalex.org/W7164003305","eid":"W7164003305"},{"id":"paper-w7203822892","cat":"papers","name":"From network destabilisation to adaptive reconfiguration: A hippocampal longitudinal axis model of psychedelic therapy","year":"2026","cit":0,"pfa":"Charalampos L. Kandilakis","psa":"Costas Papatheodoropoulos","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7203822892","eid":"W7203822892"},{"id":"paper-w7203878579","cat":"papers","name":"TripTally: An Open-Access Calculator of Labor Costs Across Psychedelic Therapy Delivery Models","year":"2026","cit":0,"pfa":"Amanda E. Downey","psa":"Joshua Woolley","topics":["Therapy practice","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W7203878579","eid":"W7203878579"},{"id":"paper-w4410801815","cat":"papers","name":"Client Treatment Preferences In Psychedelic-Assisted Therapy For Depression In Participants With Depressive Symptoms","year":"2024","cit":0,"pfa":"Alyssa B. Oliva","topics":["Depression","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W4410801815","eid":"W4410801815"},{"id":"paper-w4320005567","cat":"papers","name":"Corrigendum to ‘Expanding Perspectives on the Potential for Psychedelic-Assisted Therapies to Improve the Experience of Aging’","year":"2023","cit":0,"pfa":"Yvan Beaussant","psa":"Kabir B. Nigam","ptype":"erratum","src":"https://openalex.org/W4320005567","eid":"W4320005567"},{"id":"paper-w3017222559","cat":"papers","name":"A case for the use of community-based psychedelic assisted psychotherapy in a rural and remote context","year":"2020","cit":0,"pfa":"Jasmin McMechan","topics":["Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W3017222559","eid":"W3017222559"},{"id":"paper-w7171513233","cat":"papers","name":"Rapid evidence profile #57: Examining the use of psychedelic-assisted psychotherapy for Veterans","year":"2023","cit":0,"pfa":"K Waddell","psa":"MG Wilson","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W7171513233","eid":"W7171513233"},{"id":"paper-w7213782494","cat":"papers","name":"An Integrative Somatic Approach to Psychedelic-Assisted Therapy: Theoretical Foundations and Biological Mechanisms","year":"2026","cit":0,"pfa":"Devon Christie","psa":"Manesh Girn","topics":["PTSD & trauma","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7213782494","eid":"W7213782494"},{"id":"paper-w4411792152","cat":"papers","name":"Psychedelic assisted therapy (PAT) content analysis: Discourses in United States and Netherlands","year":"2025","cit":0,"pfa":"Kimberly Gough","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"dissertation","src":"https://openalex.org/W4411792152","eid":"W4411792152"},{"id":"paper-w7134809202","cat":"papers","name":"End of life distress as an economic issue: The case for psychedelic-assisted therapy – ERRATUM","year":"2026","cit":0,"pfa":"Michel Dorval","psa":"Jason R. Guertin","topics":["Anxiety & end-of-life"],"ptype":"erratum","src":"https://openalex.org/W7134809202","eid":"W7134809202"},{"id":"paper-w7214667133","cat":"papers","name":"PAT-Sim: An Ethical Serious Game for Experiential Training in Psychedelic-Assisted Psychotherapy","year":"2026","cit":0,"pfa":"Tyler Reeds","psa":"David Chandross","topics":["Therapy practice","Policy & ethics"],"ptype":"conference-paper","src":"https://openalex.org/W7214667133","eid":"W7214667133"},{"id":"paper-w7130241797","cat":"papers","name":"Set and Setting: Exploring the Application of Therapeutic Design Principles for Psychedelic Assisted Therapies","year":"2024","cit":0,"pfa":"Camille Joy Freeman","topics":["Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W7130241797","eid":"W7130241797"},{"id":"paper-w7160729869","cat":"papers","name":"“They could be in the raptures of hell…” Exploring Therapist Perceptions of Distress in Psychedelic-Assisted Therapy","year":"2024","cit":0,"pfa":"Conor Coman","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"dissertation","src":"https://openalex.org/W7160729869","eid":"W7160729869"},{"id":"paper-w7152465457","cat":"papers","name":"The Journey Back to Self: Healing Childhood Trauma Through Psychedelic-Assisted Therapy","year":"2025","cit":0,"pfa":"Travis Trotter","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W7152465457","eid":"W7152465457"},{"id":"paper-w7204536245","cat":"papers","name":"Nursing education for emerging psychedelic-assisted therapy: A role-calibrated curriculum approach","year":"2026","cit":0,"pfa":"Erman Yıldız","ptype":"article","src":"https://openalex.org/W7204536245","eid":"W7204536245"},{"id":"paper-w7164381748","cat":"papers","name":"Ketamine-Assisted Psychotherapy for Depression: A Survey of Current Practices, Rationales, and Future Directions","year":"2026","cit":0,"pfa":"Jack Buchanan","psa":"Joseph A. Zamaria","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7164381748","eid":"W7164381748"},{"id":"paper-w7208766007","cat":"papers","name":"Implementing psychedelic-assisted therapy in Ireland: perspectives from a national stakeholder survey","year":"2026","cit":0,"pfa":"Colm Harrington","psa":"John Richard Kelly","ptype":"article","src":"https://openalex.org/W7208766007","eid":"W7208766007"},{"id":"paper-w4400580949","cat":"papers","name":"Client treatment preferences in psychedelic-assisted therapy for depression in participants with depressive symptoms","year":"2024","cit":0,"pfa":"Alyssa B. Oliva","psa":"Joseph Anthony De Leo","topics":["Depression","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4400580949","eid":"W4400580949"},{"id":"paper-w7154477251","cat":"papers","name":"Set, Setting, and Integration in Psychedelic Therapy: Neurobiological Mechanisms and Clinical Outcomes","year":"2025","cit":0,"pfa":"Peter Cellarius","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7154477251","eid":"W7154477251"},{"id":"paper-w4413482839","cat":"papers","name":"Ketamine-Assisted Recovery (KARE): protocol for an open-label pilot trial of ketamine-assisted psychotherapy for publicly insured patients with methamphetamine use disorder and HIV risks","year":"2025","cit":0,"pfa":"Nicky J. Mehtani","psa":"Mallory O. Johnson","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4413482839","eid":"W4413482839"},{"id":"paper-w7115819149","cat":"papers","name":"From Theory to Practice: Irish Psychotherapists' Perspectives on Delivering Psychedelic-Assisted Therapy","year":"2025","cit":0,"pfa":"Madsen, Ciara","topics":["Therapy practice","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W7115819149","eid":"W7115819149"},{"id":"paper-w7160196959","cat":"papers","name":"The spectrum of potential benefits and ethical considerations for psychedelic-assisted therapy in autistic adults","year":"2026","cit":0,"pfa":"Madeleine Cluck","psa":"Logan Neitzke‐Spruill","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7160196959","eid":"W7160196959"},{"id":"paper-w4205324767","cat":"papers","name":"Psychedelic‐assisted therapies: Enhance your expertise in resurgent mental health treatments","year":"2022","cit":0,"pfa":"Louise Bedrossian","ptype":"article","src":"https://openalex.org/W4205324767","eid":"W4205324767"},{"id":"paper-w4405617868","cat":"papers","name":"Advancing Psychedelic-Assisted Therapy in Missouri (MO-PAT): Innovation at the Speed of Safety.","year":"2024","cit":0,"pfa":"Danielle R. Adams","psa":"Ginger E. Nicol","topics":["Safety & adverse events","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4405617868","eid":"W4405617868"},{"id":"paper-w7213902024","cat":"papers","name":"Embodied Transformation: Psychedelic Therapy Through the Lens of Merleau-Ponty’s Phenomenology","year":"2026","cit":0,"pfa":"Zinet Ritschel","psa":"Brady Wagoner","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7213902024","eid":"W7213902024"},{"id":"paper-w4405726857","cat":"papers","name":"Corrigendum: Physical disability and psychedelic therapies: an agenda for inclusive research and practice","year":"2024","cit":0,"pfa":"Kevin Todd Mintz","psa":"Dominic A. Sisti","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"erratum","src":"https://openalex.org/W4405726857","eid":"W4405726857"},{"id":"paper-w4390270623","cat":"papers","name":"Psychedelic Therapy: A Primer for Primary Care Clinicians – Part VII. Ketamine","year":"2023","cit":0,"pfa":"Viviana D. Evans","psa":"Owen S. Muir","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"preprint","src":"https://openalex.org/W4390270623","eid":"W4390270623"},{"id":"paper-w7168261503","cat":"papers","name":"Psychedelic therapy at the end of life: unexplored alternative to assisted suicide in the UK","year":"2026","cit":0,"pfa":"Ruslan Zinchenko","topics":["Anxiety & end-of-life"],"ptype":"editorial","src":"https://openalex.org/W7168261503","eid":"W7168261503"},{"id":"paper-w4405733166","cat":"papers","name":"Fayzan Rab: What are the economic and public health implications of psychedelic therapies?","year":"2024","cit":0,"pfa":"Fayzan Rab","ptype":"article","src":"https://openalex.org/W4405733166","eid":"W4405733166"},{"id":"paper-w4415734529","cat":"papers","name":"Correction: Ketamine-Assisted recovery (KARE): protocol for an open-label pilot trial of ketamine-assisted psychotherapy for publicly insured patients with methamphetamine use disorder and HIV risks","year":"2025","cit":0,"pfa":"British Medical Journal Publishing Group","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"erratum","src":"https://openalex.org/W4415734529","eid":"W4415734529"},{"id":"paper-w4395701740","cat":"papers","name":"Ketamine‐assisted ECT promising for depression; concerns around cognition remain","year":"2024","cit":0,"topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4395701740","eid":"W4395701740"},{"id":"paper-w4411394671","cat":"papers","name":"Psychedelic assisted psychotherapy in the treatment of post traumatic stress disorder in brazil a critical review","year":"2025","cit":0,"pfa":"Biological Sciences","topics":["Depression","PTSD & trauma","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4411394671","eid":"W4411394671"},{"id":"paper-w7139972813","cat":"papers","name":"Mapping Psychedelic-Assisted Therapy Facilitator Education and Training Programs Internationally: A Scoping Review","year":"2026","cit":0,"pfa":"Juliana Mendes Rocha","psa":"Chantal Savard","topics":["Depression","Anxiety & end-of-life","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7139972813","eid":"W7139972813"},{"id":"paper-w7140016430","cat":"papers","name":"Mapping Psychedelic-Assisted Therapy Facilitator Education and Training Programs Internationally: A Scoping Review","year":"2026","cit":0,"pfa":"Julie M. Deleemans","psa":"Juliana Mendes Rocha","topics":["Reviews & meta-analyses","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7140016430","eid":"W7140016430"},{"id":"paper-w7107953277","cat":"papers","name":"Interpersonal neurobiology in somatic & psychedelic assisted therapy: A somatic relational framework for psychedelic practitioners","year":"2025","cit":0,"pfa":"Penno, Tobias","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W7107953277","eid":"W7107953277"},{"id":"paper-w4309143514","cat":"papers","name":"Cancer Care Must Address Mental Health, and Psychedelic-Assisted Therapy May Help","year":"2022","cit":0,"topics":["Anxiety & end-of-life"],"ptype":"dataset","src":"https://openalex.org/W4309143514","eid":"W4309143514"},{"id":"paper-w7202149799","cat":"papers","name":"Competencies and Ethical Governance for Psychedelic‑Assisted Therapies: A Practice‑Embedded Quality‑Improvement Framework","year":"2026","cit":0,"pfa":"Shannon Dames","psa":"Pamela Kryskow","topics":["PTSD & trauma","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7202149799","eid":"W7202149799"},{"id":"paper-w7203452472","cat":"papers","name":"AI-mediated relational competence and its limits: Psychedelic-assisted therapy as a stress case and policy signal","year":"2026","cit":0,"pfa":"Robert McGrath","psa":"Everett B. Sackett","topics":["Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7203452472","eid":"W7203452472"},{"id":"paper-w4295854934","cat":"papers","name":"Can Psychedelic Therapies open a New Frontier in Mental Healthcare (Or Will the Bubble Burst?)","year":"2022","cit":0,"ptype":"book","src":"https://openalex.org/W4295854934","eid":"W4295854934"},{"id":"paper-w4405489363","cat":"papers","name":"Reading the crowd: attitudes toward psychedelics and psychedelic therapies among attendees at a conference","year":"2024","cit":0,"pfa":"Zachary Bosshardt","psa":"Roman Palitsky","topics":["Safety & adverse events","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4405489363","eid":"W4405489363"},{"id":"paper-w4384560230","cat":"papers","name":"Psychedelic therapies: The case for a new focus in the EU’s mental health care approach","year":"2023","cit":0,"pfa":"Tadeusz Hawrot","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4384560230","eid":"W4384560230"},{"id":"paper-w7138828048","cat":"papers","name":"Ketamine-assisted psychotherapy in real-world setting: A retrospective observational cohort study","year":"2025","cit":0,"pfa":"Mónica Sofia Ramalho Lopes Galo","topics":["Depression","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W7138828048","eid":"W7138828048"},{"id":"paper-w4310727826","cat":"papers","name":"Faculty Opinions recommendation of Ketamine assisted psychotherapy: A systematic narrative review of the literature.","year":"2022","cit":0,"pfa":"Daniel John Doyle","topics":["Reviews & meta-analyses","Therapy practice"],"ptype":"peer-review","src":"https://openalex.org/W4310727826","eid":"W4310727826"},{"id":"paper-w7204585197","cat":"papers","name":"Making Play Safe Again: Ketamine-Assisted Psychotherapy with Traumatized Autistic Adults","year":"2026","cit":0,"pfa":"Diana E. Moga","topics":["PTSD & trauma","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7204585197","eid":"W7204585197"},{"id":"paper-w4394913541","cat":"papers","name":"Psychedelics in Palliative Care, Ready for Primetime! Making the Case for Ketamine-Assisted Psychotherapy","year":"2024","cit":0,"pfa":"Robert K. Horowitz","psa":"Paul D. Thielking","topics":["Anxiety & end-of-life","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4394913541","eid":"W4394913541"},{"id":"paper-w7213896752","cat":"papers","name":"A longitudinal analysis of the clinical practice of ketamine assisted psychotherapy with adolescents and young adults","year":"2026","cit":0,"pfa":"Phil Wolfson","psa":"Cody Carroll","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7213896752","eid":"W7213896752"},{"id":"paper-w4411394245","cat":"papers","name":"The double-edged sword: Psychedelic-assisted therapy and entrepreneurial well-being, an early conceptual framework","year":"2025","cit":0,"pfa":"Pankaj C. Patel","psa":"Marcus T. Wolfe","ptype":"article","src":"https://openalex.org/W4411394245","eid":"W4411394245"},{"id":"paper-w4414202139","cat":"papers","name":"Commentary on methods for addressing functional unblinding and mechanistic uncertainty in clinical trials of psychedelic-assisted treatments","year":"2025","cit":0,"pfa":"Dan Petrovitch","psa":"Andrew K. Littlefield","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4414202139","eid":"W4414202139"},{"id":"paper-w4409280669","cat":"papers","name":"179. Ketamine-Assisted Mindfulness-Based Cognitive Therapy for Treatment-Resistant Depression","year":"2025","cit":0,"pfa":"Wenfei Yu","psa":"Anthony King","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4409280669","eid":"W4409280669"},{"id":"paper-w7119252600","cat":"papers","name":"Impact of ketamine assisted psychotherapy in anxiety and depression symptoms : a quasi-experimental study","year":"2025","cit":0,"pfa":"Magda Fernandes","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7119252600","eid":"W7119252600"},{"id":"paper-w7125419807","cat":"papers","name":"Ketamine assisted psychotherapy in postpartum mood and anxiety disorders: a limited case series","year":"2026","cit":0,"pfa":"Alka Christnacht","psa":"Sunil Kumar Aggarwal","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7125419807","eid":"W7125419807"},{"id":"paper-w7111169582","cat":"papers","name":"Additional file 1 of Radiation therapy patients’ interest in psychedelic-assisted therapy: results of a survey","year":"2025","cit":0,"pfa":"Park, Jino","psa":"Harris, Jeremy P.","ptype":"article","src":"https://openalex.org/W7111169582","eid":"W7111169582"},{"id":"paper-w4412841459","cat":"papers","name":"Psychedelics, Transformative Experience, and Modality An Analysis of Valid and Substantially Informed Consent in Psychedelic-assisted Therapy","year":"2025","cit":0,"pfa":"Danqi Zheng","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4412841459","eid":"W4412841459"},{"id":"paper-w7162343365","cat":"papers","name":"Transient epistemic vulnerability and normative capture: toward an ethics of contextual conditions in psychedelic-assisted psychotherapy","year":"2026","cit":0,"pfa":"Maximiliano Zeller","topics":["Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7162343365","eid":"W7162343365"},{"id":"paper-w7128780604","cat":"papers","name":"Neuroinflammation, the gut-brain axis, and psychedelic-assisted psychotherapy: A synthesis of emerging paradigms in psychiatric care","year":"2026","cit":0,"pfa":"Anita Verma","psa":"Harshit Kumar","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7128780604","eid":"W7128780604"},{"id":"paper-w4410479438","cat":"papers","name":"A Perspective for Enhancing the Supervision of Psychedelic-Assisted Therapy: Motivational-Interviewing-Enhanced Integration Supervision (MIE-IS)","year":"2025","cit":0,"pfa":"Mitch Earleywine","psa":"Alyssa B. Oliva","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4410479438","eid":"W4410479438"},{"id":"paper-w7127980725","cat":"papers","name":"The CAnadian Network for Psychedelic-Assisted Cancer Therapy (CAN-PACT) : A Multi-Phase Program Overview","year":"2026","cit":0,"pfa":"Linda Ellen Carlson","psa":"Monnica T. Williams","topics":["Anxiety & end-of-life","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7127980725","eid":"W7127980725"},{"id":"paper-w7215054698","cat":"papers","name":"Epistemic Discipline in Psychedelic-Assisted Therapy: Memory, Therapy Dynamics, Attachment Patterns, and Sexual Abuse","year":"2026","cit":0,"pfa":"Guy Simon","psa":"Pehr Granqvist","topics":["PTSD & trauma","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7215054698","eid":"W7215054698"},{"id":"paper-w7163915018","cat":"papers","name":"Altered states, authentic selves: Trans individual’s experiences with psychedelics and their implications for Psychedelic-Assisted Psychotherapy","year":"2026","cit":0,"pfa":"Tiana Bartholomaeus","psa":"James A. Fowler","topics":["Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7163915018","eid":"W7163915018"},{"id":"paper-w4414200547","cat":"papers","name":"Commentary on methods for addressing functional unblinding and mechanistic uncertainty in clinical trials of psychedelic-assisted treatments","year":"2025","cit":0,"pfa":"Dan Petrovitch","psa":"Andrew K. Littlefield","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4414200547","eid":"W4414200547"},{"id":"paper-w4416300738","cat":"papers","name":"From Adults to Adolescents: Bridging Scientific Potential and Evidence-Based Paths for Psychedelic-Assisted Interventions","year":"2025","cit":0,"pfa":"Mayank Gupta","psa":"Priyal Khurana","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4416300738","eid":"W4416300738"},{"id":"paper-w7161177319","cat":"papers","name":"Psychedelic Strawmen: A Call for Greater Transparency of PTSD Treatment Efficacy in Psychedelic-Assisted Therapy Research","year":"2026","cit":0,"pfa":"Deidre A. Marsh","psa":"Edwin Bacalso","topics":["PTSD & trauma","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7161177319","eid":"W7161177319"},{"id":"paper-w4414978230","cat":"papers","name":"Psychedelics, Transformative Experience, and Modality: An Analysis of Valid and Substantially Informed Consent in Psychedelic-assisted Therapy","year":"2025","cit":0,"pfa":"Danqi Zheng","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4414978230","eid":"W4414978230"},{"id":"paper-w7168337239","cat":"papers","name":"Mechanisms of Action and Change in Psychedelic-Assisted Therapies: A Holistic Framework for Ethical, Competent Clinical Care","year":"2026","cit":0,"pfa":"Lynnette A. Averill","psa":"Logan Neitzke‐Spruill","topics":["PTSD & trauma","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7168337239","eid":"W7168337239"},{"id":"paper-w7130676043","cat":"papers","name":"Additional file 1 of Radiation therapy patients’ interest in psychedelic-assisted therapy: results of a survey","year":"2025","cit":0,"pfa":"Jino Park","psa":"Jeremy P. Harris","ptype":"article","src":"https://openalex.org/W7130676043","eid":"W7130676043"},{"id":"paper-w7167415736","cat":"papers","name":"Psychedelic-Assisted Treatments for Canadian Military Personnel and Veterans: Scoping Review and Environmental Scan Protocol","year":"2026","cit":0,"pfa":"Kate Watt","psa":"Elena Koning","topics":["Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7167415736","eid":"W7167415736"},{"id":"paper-w7154954630","cat":"papers","name":"Assessing logistical and ethical barriers for psychedelic-assisted therapy implementation: A cross-sectional pharmacist survey","year":"2026","cit":0,"pfa":"Sophia M. Castillo","psa":"Cody J. Wenthur","topics":["Depression","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7154954630","eid":"W7154954630"},{"id":"paper-w4376106272","cat":"papers","name":"A Retrospective Study to Determine the Impact of Psychedelic Therapy for Dimensional Measures of Wellness: A Quantitative Analysis","year":"2023","cit":0,"pfa":"Victoria Di Virgilio","psa":"Gaurav Gupta","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W4376106272","eid":"W4376106272"},{"id":"paper-w4409709872","cat":"papers","name":"Psychedelic therapy in practice. Case studies of self-treatment, individual therapy, and group therapy","year":"2025","cit":0,"pfa":"Mika Turkia","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W4409709872","eid":"W4409709872"},{"id":"paper-w7160992567","cat":"papers","name":"On the meaning of “plasticity” in neuroscience and mental health research and its relation to the action of psychedelic therapy","year":"2026","cit":0,"pfa":"Robin Lester Carhart-Harris","psa":"Patrick A. McConnell","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7160992567","eid":"W7160992567"},{"id":"paper-w7165754846","cat":"papers","name":"Could psychedelic therapy have a place in end-of-life care? We asked doctors","year":"2026","cit":0,"pfa":"David Menkes","topics":["Anxiety & end-of-life"],"ptype":"other","src":"https://openalex.org/W7165754846","eid":"W7165754846"},{"id":"paper-w4403562676","cat":"papers","name":"Psychedelic therapy in practice. Case studies of self-treatment, individual therapy, and group therapy","year":"2024","cit":0,"pfa":"Mika Turkia","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W4403562676","eid":"W4403562676"},{"id":"paper-w7163048126","cat":"papers","name":"Integrative Biological Pathways in Psycho-Oncology: Biomarkers, Psychedelic Therapies, and the Gut-Brain Axis","year":"2026","cit":0,"pfa":"Karthikaa Menon","psa":"Smriti Sethi","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"book-chapter","src":"https://openalex.org/W7163048126","eid":"W7163048126"},{"id":"paper-w4400575178","cat":"papers","name":"Acceptability of Psychedelic Therapy Differs Among Social Workers, Psychiatrists, and Psychologists in the United States","year":"2024","cit":0,"pfa":"Stacey B. Armstrong","psa":"Alan K. Davis","ptype":"article","src":"https://openalex.org/W4400575178","eid":"W4400575178"},{"id":"paper-w7112523626","cat":"papers","name":"Differential effects of Psychedelic therapy and Escitalopram on reward system function in Major Depressive Disorder","year":"2023","cit":0,"pfa":"Rayyan Zafar","psa":"Rebecca Harding","topics":["Depression"],"ptype":"preprint","src":"https://openalex.org/W7112523626","eid":"W7112523626"},{"id":"paper-w7160731431","cat":"papers","name":"On the meaning of ‘plasticity’ in neuroscience and mental health research and its relation to the action of psychedelic therapy","year":"2026","cit":0,"pfa":"Patrick A. McConnell","ptype":"preprint","src":"https://openalex.org/W7160731431","eid":"W7160731431"},{"id":"paper-w7110648586","cat":"papers","name":"Evaluating Clinical Experiences Implementing the Montreal Model for Ketamine Assisted Psychotherapy Adapted for Esketamine","year":"2025","cit":0,"pfa":"Garfin, Jonathan","topics":["Depression","Anxiety & end-of-life","Therapy practice"],"ptype":"other","src":"https://openalex.org/W7110648586","eid":"W7110648586"},{"id":"paper-w7163839662","cat":"papers","name":"Mental health practioner (MHP) attitudes, moral injury, and willingness to use psychedelic-assisted therapy (PAT)","year":"2026","cit":0,"pfa":"Anna Harwood‐Gross","psa":"Avigail Zucker","topics":["Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W7163839662","eid":"W7163839662"},{"id":"paper-w7112676203","cat":"papers","name":"Worse Before Better: Healing Trajectories of Patients Experiencing Initial Distress To Psychedelic-Assisted Therapy With Ketamine","year":"2024","cit":0,"pfa":"Ben Medrano","psa":"Zayn Hassan","ptype":"preprint","src":"https://openalex.org/W7112676203","eid":"W7112676203"},{"id":"paper-w7111582657","cat":"papers","name":"Post ketamine-assisted-therapy remission and maintenance for patients with depressive disorders: A scoping review","year":"2025","cit":0,"pfa":"Jamie Hartmann-Boyce","psa":"Anne E. Ferrey","topics":["Depression","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7111582657","eid":"W7111582657"},{"id":"paper-w7105932432","cat":"papers","name":"Psychological Therapy Quantity and Depressive Symptom Reduction in Psychedelic-Assisted Therapy: A Systematic Review and Meta-Analysis","year":"2025","cit":0,"pfa":"Gianluca Andri Florineth","topics":["Depression","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7105932432","eid":"W7105932432"},{"id":"paper-w7208802489","cat":"papers","name":"Beyond the Biomedical Framework: Exploring How Therapists Understand the Relational Process at the Heart of Psychedelic-Assisted Therapy","year":"2026","cit":0,"pfa":"Cierra Stamper","topics":["Safety & adverse events","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7208802489","eid":"W7208802489"},{"id":"paper-w7112446833","cat":"papers","name":"Title: A Multidisciplinary Psychedelic-Assisted Rehabilitation Model for Substance Addiction: Clinical Protocols and Case-Based Evidence","year":"2025","cit":0,"pfa":"zekeriya başkaya","topics":["Addiction"],"ptype":"preprint","src":"https://openalex.org/W7112446833","eid":"W7112446833"},{"id":"paper-w7105791732","cat":"papers","name":"Psychological Therapy Quantity and Depressive Symptom Reduction in Psychedelic-Assisted Therapy: A Systematic Review and Meta-Analysis","year":"2025","cit":0,"pfa":"Florineth, Gianluca Andri","topics":["Depression","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7105791732","eid":"W7105791732"},{"id":"paper-w4401248800","cat":"papers","name":"From Research to Reality: Crafting an Image of the Current State of Psychedelic-Assisted Psychotherapies for Substance Use Disorders","year":"2024","cit":0,"pfa":"Dominique Morisano","psa":"Doris E. Payer","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4401248800","eid":"W4401248800"},{"id":"paper-w7159837280","cat":"papers","name":"The Psychedelic Renaissance Meets Global Reality: Promise, Caution, and Equity in the New Era of Psychedelic-Assisted Therapy","year":"2026","cit":0,"pfa":"Anton Glasnovic","ptype":"article","src":"https://openalex.org/W7159837280","eid":"W7159837280"},{"id":"paper-w7154544642","cat":"papers","name":"Outcomes and measurement instruments in clinical trials of psychedelic-assisted therapy for life-limiting illness: a scoping review","year":"2026","cit":0,"pfa":"Tais Rodrigues Caproni","psa":"Marcelo Falchi-Carvalho","topics":["Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7154544642","eid":"W7154544642"},{"id":"paper-w4413527948","cat":"papers","name":"Canada owes its veterans new mental health tools: Access to psychedelic therapies is overdue","year":"2023","cit":0,"pfa":"Ron Joseph Shore","ptype":"other","src":"https://openalex.org/W4413527948","eid":"W4413527948"},{"id":"paper-w7165452854","cat":"papers","name":"Claustrum-dependent timing of cortical metastability: a neural basis for behavioral flexibility and a target for psychedelic therapy","year":"2026","cit":0,"pfa":"Olson, Randall","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7165452854","eid":"W7165452854"},{"id":"paper-w7202370648","cat":"papers","name":"Ketamine assisted psychotherapy to reduce chronic neuropathic pain: A mixed-methods randomized pilot trial","year":"2026","cit":0,"pfa":"Akash Goel","psa":"Paul Ritvo","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W7202370648","eid":"W7202370648"},{"id":"paper-w7162083007","cat":"papers","name":"Ketamine-assisted psychotherapy for treatment of an Asian American patient with post-traumatic stress disorder (PTSD): a case study","year":"2026","cit":0,"pfa":"Albert Yeung","psa":"David Mischoulon","topics":["PTSD & trauma","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7162083007","eid":"W7162083007"},{"id":"paper-w7168900409","cat":"papers","name":"Psychedelic-Assisted Psychotherapy Education at GSPP: Assessing PsyD Student and Alumni Interest, Attitudes, and Perceived Training Needs","year":"2026","cit":0,"pfa":"Devon Seelig","topics":["Therapy practice","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W7168900409","eid":"W7168900409"},{"id":"paper-w7162568036","cat":"papers","name":"Moving at the pace of relationship: establishing safe and ethical psychedelic-assisted therapy services in the Yukon in the absence of a regulatory framework","year":"2026","cit":0,"pfa":"Emily J. Hoefs","topics":["Safety & adverse events","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W7162568036","eid":"W7162568036"},{"id":"paper-w7117116321","cat":"papers","name":"Ketamine-Assisted Psychotherapy for Treatment- Resistant Depression with Comorbid Post-Traumatic Stress Disorder in Veterans","year":"2025","cit":0,"pfa":"Олег Вікторович Орлов","psa":"О. С. Фітькало","topics":["Depression","PTSD & trauma","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7117116321","eid":"W7117116321"},{"id":"paper-w4401920241","cat":"papers","name":"The Effect of the Apollo Neuro Device on Anxiety Among Participants who Underwent Ketamine Assisted Therapy","year":"2024","cit":0,"pfa":"V. Tsang","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4401920241","eid":"W4401920241"},{"id":"paper-w7128532002","cat":"papers","name":"At-Home Ketamine-Assisted Therapy for Post-Traumatic Stress Disorder: A Real-World Retrospective Analysis","year":"2026","cit":0,"pfa":"Jack Swain","psa":"Leonardo Vando","topics":["PTSD & trauma"],"ptype":"preprint","src":"https://openalex.org/W7128532002","eid":"W7128532002"},{"id":"paper-w7203513564","cat":"papers","name":"Veterans’ Perceptions of Psychedelic‑Assisted Treatment (PAT) for Post Traumatic Stress Disorder (PTSD): A Qualitative Scoping Review","year":"2026","cit":0,"pfa":"Ellen Costello","psa":"Ilse Salinas","topics":["PTSD & trauma","Reviews & meta-analyses","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W7203513564","eid":"W7203513564"},{"id":"paper-w4200426805","cat":"papers","name":"Erratum: A Spectrum of Selves Reinforced in Multilevel Coherence: A Contextual Behavioural Response to the Challenges of Psychedelic-Assisted Therapy Development","year":"2021","cit":0,"pfa":"Frontiers Production Office","ptype":"erratum","src":"https://openalex.org/W4200426805","eid":"W4200426805"},{"id":"paper-w4401921174","cat":"papers","name":"A Cost-Effectiveness Analysis of a Ketamine-assisted Psychotherapy Program Compared to Online Group Psychotherapy in British Columbia, Canada","year":"2024","cit":0,"pfa":"V. Tsang","topics":["Depression","Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4401921174","eid":"W4401921174"},{"id":"paper-w7162904378","cat":"papers","name":"OMS-KAT-001 · Intra-Sessional Autonomic Arc Detection in Ketamine-Assisted Therapy for PTSD","year":"2026","cit":0,"pfa":"Adriaan Dirk van der Wart","topics":["PTSD & trauma","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W7162904378","eid":"W7162904378"},{"id":"paper-w4415192957","cat":"papers","name":"The effect of the Apollo Neuro device on anxiety among participants who underwent ketamine assisted therapy","year":"2025","cit":0,"pfa":"Vivian W. L. Tsang","psa":"Pamela Kryskow","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4415192957","eid":"W4415192957"},{"id":"paper-w7151483944","cat":"papers","name":"Are there any significant adverse effects associated with the use of psychedelic-assisted therapy in patients with post-traumatic stress disorder (PTSD)?","year":"2026","cit":0,"pfa":"Tripdatabase","topics":["PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7151483944","eid":"W7151483944"},{"id":"paper-w7211975749","cat":"papers","name":"Psychedelic therapy without durable effects: A review and re-evaluation of controlled studies between 1965 and 1977","year":"2026","cit":0,"pfa":"Torsten Passie","psa":"Michiel van Elk","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7211975749","eid":"W7211975749"},{"id":"paper-w7165744532","cat":"papers","name":"Navigating ‘k-land’: a qualitative exploration of participants’ experiences of ketamine-assisted psychotherapy for methamphetamine use disorder","year":"2026","cit":0,"pfa":"Kathryn Fletcher","psa":"Brendan Clifford","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7165744532","eid":"W7165744532"},{"id":"paper-w7133874676","cat":"papers","name":"A Blueprint for Implementing Ketamine-Assisted Psychotherapy in Palliative Care: Design, Process, and Treatment Patterns of a Real-World Clinical Program","year":"2026","cit":0,"pfa":"Robert K. Horowitz","psa":"Marc T. Swogger","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7133874676","eid":"W7133874676"},{"id":"paper-w4387788564","cat":"papers","name":"Improving Treatment Outcomes for Veterans with Mental Health Conditions: Strengthening the Evidence Base for and Considering Barriers to Psychedelic-Assisted Therapies","year":"2023","cit":0,"pfa":"Rajeev N Ramchand","topics":["PTSD & trauma"],"ptype":"book","src":"https://openalex.org/W4387788564","eid":"W4387788564"},{"id":"paper-w4414737817","cat":"papers","name":"Perceptions, Attitudes, and Familiarity of Ketamine Assisted Treatment Among a Sample of People with Comorbid Chronic Pain and Depression","year":"2025","cit":0,"pfa":"Gordon Max Kinsey-Kerr","topics":["Depression"],"ptype":"dissertation","src":"https://openalex.org/W4414737817","eid":"W4414737817"},{"id":"paper-w7151372744","cat":"papers","name":"Are there any significant adverse effects associated with the use of psychedelic-assisted therapy in patients with post-traumatic stress disorder (PTSD)?","year":"2026","cit":0,"pfa":"Tripdatabase","topics":["PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7151372744","eid":"W7151372744"},{"id":"paper-w7204971609","cat":"papers","name":"Dataset for \"Longitudinal Peripheral DNA Methylation Remodeling Following Ketamine-Assisted Psychotherapy in Major Depressive Disorder\"","year":"2027","cit":0,"pfa":"Arghavan Nepton","psa":"Sergio Perez Rosal","topics":["Depression","Therapy practice"],"ptype":"dataset","src":"https://openalex.org/W7204971609","eid":"W7204971609"},{"id":"paper-w7162056239","cat":"papers","name":"Looking Beyond Traditional Therapy: The Promising Alternative of Ketamine-Assisted Treatments in Improving the Quality of Life of Veterans","year":"2026","cit":0,"pfa":"Noa Gutmann","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7162056239","eid":"W7162056239"},{"id":"paper-w7204958136","cat":"papers","name":"Dataset for \"Longitudinal Peripheral DNA Methylation Remodeling Following Ketamine-Assisted Psychotherapy in Major Depressive Disorder\"","year":"2027","cit":0,"pfa":"Arghavan Nepton","psa":"Sergio Perez Rosal","topics":["Depression","Therapy practice"],"ptype":"dataset","src":"https://openalex.org/W7204958136","eid":"W7204958136"},{"id":"paper-w4403952499","cat":"papers","name":"Exploration of attitudes towards the mystical experience in the context of psychedelic assisted psychotherapy amongst psychiatry trainees based in the West of Scotland","year":"2024","cit":0,"pfa":"Cassie Maguire","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4403952499","eid":"W4403952499"},{"id":"paper-w4390271645","cat":"papers","name":"Psychedelic Therapy: A Primer for Primary Care Clinicians – Part VIII. The Strengths, Weaknesses, Opportunities, and Threats of Psychedelic Therapeutics","year":"2023","cit":0,"pfa":"Owen S. Muir","psa":"Burton Jared Tabaac","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4390271645","eid":"W4390271645"},{"id":"paper-w7164136054","cat":"papers","name":"Attitudes and perceptions of psychedelic therapy among clinical trial participants with alcohol use disorder: a mixed-method study","year":"2026","cit":0,"pfa":"Julian Kirsch","psa":"Dimitris Repantis","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7164136054","eid":"W7164136054"},{"id":"paper-w7171485404","cat":"papers","name":"Understanding treatment expectations toward emerging therapies in veterinary medicine: the role of knowledge, attitudes, and beliefs toward psychedelic-assisted interventions","year":"2026","cit":0,"pfa":"Yanira Suárez-Fernández","psa":"Luis Alberto Henríquez‐Hernández","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7171485404","eid":"W7171485404"},{"id":"paper-w4406198871","cat":"papers","name":"The Implementation of Ketamine-Assisted-Psychotherapy on Healthcare Workers Suffering From Workplace-related PTSD due to COVID-19","year":"2024","cit":0,"pfa":"Zhixin Zou","topics":["PTSD & trauma","Therapy practice"],"ptype":"other","src":"https://openalex.org/W4406198871","eid":"W4406198871"},{"id":"paper-w3107023892","cat":"papers","name":"Matthew Oram, The Trials of Psychedelic Therapy: LSD Psychotherapy in America. Baltimore: Johns Hopkins University Press, 2018.","year":"2020","cit":0,"pfa":"Alexis Turner","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W3107023892","eid":"W3107023892"},{"id":"paper-w7172002336","cat":"papers","name":"Longitudinal Assessment of Ketamine-Assisted Community of Practice Therapy: A Retrospective 5-Year Study on Depression, Anxiety and PTSD","year":"2026","cit":0,"pfa":"A. Kuzma-Hunt","psa":"V. Tsang","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7172002336","eid":"W7172002336"},{"id":"paper-w7214937272","cat":"papers","name":"Protecting Patients’ Rights in the Off-Label Use of Medicines Containing Psychoactive Substances (Example: Ketamine-Assisted Therapy)","year":"2026","cit":0,"pfa":"Nataliya O. Gutorova","psa":"Ye. Gnedyk","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7214937272","eid":"W7214937272"},{"id":"paper-w4417184125","cat":"papers","name":"We Haven't Discovered Another Planet, It Was Already Inhabited: (Re)considering Psychedelic-Assisted Therapy as Indigenously Informed Spiritual Care.","year":"2025","cit":0,"pfa":"Craig D. Blinderman","ptype":"article","src":"https://openalex.org/W4417184125","eid":"W4417184125"},{"id":"paper-w7164939691","cat":"papers","name":"Burnout Symptom Outcomes During At-Home Ketamine-Assisted Therapy: A Real-World Retrospective Analysis of 395 Adults","year":"2026","cit":0,"pfa":"Jack Swain","psa":"Ian Reardon","ptype":"preprint","src":"https://openalex.org/W7164939691","eid":"W7164939691"},{"id":"paper-w4414181212","cat":"papers","name":"Understanding the path to ketamine-assisted group therapy for firefighters diagnosed with post-traumatic stress disorder: a qualitative study","year":"2025","cit":0,"pfa":"T. Walia","psa":"Kathy Sattler","topics":["PTSD & trauma","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4414181212","eid":"W4414181212"},{"id":"paper-w7213574698","cat":"papers","name":"HIGHER EDUCATION: TRACING THE SHIFT FROM SELF-EXPERIMENTATION TO EXPERIENTIAL LEARNING IN TRAINING PSYCHEDELIC-ASSISTED THERAPISTS IN CANADA, 1960-2024","year":"2026","cit":0,"pfa":"Ainsley Grace Jackson","topics":["Addiction","Therapy practice","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W7213574698","eid":"W7213574698"},{"id":"paper-w7202134941","cat":"papers","name":"Exploratory non-randomized clinical trial of subcutaneous esketamine in treatment-resistant depression: Effects of ketamine-assisted psychotherapy","year":"2026","cit":0,"pfa":"Yves Martins Varela","psa":"Nicole Galvão-Coelho","topics":["Depression","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7202134941","eid":"W7202134941"},{"id":"paper-w2897536570","cat":"papers","name":"The Past Lives of Betty Eisner: Examining the Spiritual Psyche of Early Psychedelic Therapy through the Story of a Outsider, a Pioneer, and a Villain","year":"2017","cit":0,"pfa":"Tal Davidson","topics":["Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W2897536570","eid":"W2897536570"},{"id":"paper-w2990454258","cat":"papers","name":"Book Review – The trials of Psychedelic Therapy: LSD Psychotherapy in America, by MatthewOram, Johns Hopkins University Press, Baltimore, 2018","year":"2019","cit":0,"pfa":"Peter G. N. West‐Oram","topics":["Reviews & meta-analyses","Therapy practice"],"ptype":"book-review","src":"https://openalex.org/W2990454258","eid":"W2990454258"},{"id":"paper-w4396791614","cat":"papers","name":"Qualitative analysis of a patient’s experience of ketamine-assisted psychotherapy for substance use disorder: Empirical synergies with twelve-step programs.","year":"2024","cit":0,"pfa":"Dan Petrovitch","psa":"Ben McCauley","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4396791614","eid":"W4396791614"},{"id":"paper-w4408573690","cat":"papers","name":"Qualitative analysis of a patient’s experience of ketamine-assisted psychotherapy for substance use disorder: Empirical synergies with twelve-step programs.","year":"2024","cit":0,"pfa":"Dan Petrovitch","psa":"Ben McCauley","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4408573690","eid":"W4408573690"},{"id":"paper-w4403163499","cat":"papers","name":"IS KETAMINE THE NEW “WONDER DRUG”? THE BIOMEDICAL MODEL, KETAMINE-ASSISTED PSYCHOTHERAPY, AND ETHICAL CONSIDERATIONS OF KETAMINE TREATMENT FOR DEPRESSION IN YOUTH","year":"2024","cit":0,"pfa":"Ekta Patel","psa":"Adelaide S. Robb","topics":["Depression","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4403163499","eid":"W4403163499"},{"id":"paper-w4415355396","cat":"papers","name":"The code less travelled: Can the Canadian Psychological Association code of ethics support ethical decision making in the new era of psychedelic-assisted psychotherapy?","year":"2025","cit":0,"pfa":"Sarah McNamee","psa":"Heather B. MacIntosh","topics":["Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4415355396","eid":"W4415355396"},{"id":"paper-w7212123667","cat":"papers","name":"Open research data for: Limits of evidence-synthesis in psychedelic-assisted psychotherapy: a meta-research study of systematic reviews, meta-analyses and randomized trials","year":"2026","cit":0,"pfa":"Bartosz Helfer","psa":"Mateusz T. Wasylewski","topics":["Reviews & meta-analyses","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7212123667","eid":"W7212123667"},{"id":"paper-w4412983810","cat":"papers","name":"The Woodstock Generation has a Smartphone: Can Communication About Psychedelic Therapy Affect the Willingness on the Part of Older People to Attempt Treatment?","year":"2025","cit":0,"pfa":"Philip D. Harvey","ptype":"article","src":"https://openalex.org/W4412983810","eid":"W4412983810"},{"id":"paper-w4410041043","cat":"papers","name":"Views on Psychedelic-Assisted Therapy for Substance Use Disorders from Individuals with Opioid Use Disorder and a History of Injection-Related Infections: A Qualitative Study","year":"2025","cit":0,"pfa":"Veronica Szpak","psa":"Joji Suzuki","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4410041043","eid":"W4410041043"},{"id":"paper-w4409165484","cat":"papers","name":"Corrigendum to “Psychedelic therapy for depressive symptoms: A systematic review and meta-analysis” [Journal of affective disorders, 322 (2023), 194-204]","year":"2025","cit":0,"pfa":"Kwonmok Ko","psa":"James Rucker","topics":["Depression","Reviews & meta-analyses"],"ptype":"erratum","src":"https://openalex.org/W4409165484","eid":"W4409165484"},{"id":"paper-w7159804013","cat":"papers","name":"Concurrent Changes in Self-Reported Sleep Disturbance During At-Home Ketamine-Assisted Therapy for Depression: A Retrospective Analysis of 13,963 Adults","year":"2026","cit":0,"pfa":"Jack Swain","psa":"Ian Reardon","topics":["Depression"],"ptype":"preprint","src":"https://openalex.org/W7159804013","eid":"W7159804013"},{"id":"paper-w7163429108","cat":"papers","name":"Preliminary Non-Randomized Clinical Trial of Subcutaneous Esketamine in Treatment-Resistant Depression: Exploring Adjunctive Effects of Ketamine-Assisted Psychotherapy","year":"2026","cit":0,"pfa":"Yves Martins Varela","psa":"Nicole Leite Galvão Coelho","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7163429108","eid":"W7163429108"},{"id":"paper-w7164712235","cat":"papers","name":"Ketamine-assisted psychotherapy for posttraumatic stress disorder: a systematic review and individual participant data meta-analysis of predictors of treatment effects","year":"2026","cit":0,"pfa":"Judith Rohde","topics":["PTSD & trauma","Reviews & meta-analyses","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7164712235","eid":"W7164712235"},{"id":"paper-w7165379561","cat":"papers","name":"Ketamine-Assisted Psychotherapy for Posttraumatic Stress Disorder: A Systematic Review and Individual Participant Data Meta-Analysis of Predictors of Treatment Effects","year":"2026","cit":0,"pfa":"Judith Rohde","psa":"Georgios Schoretsanitis","topics":["PTSD & trauma","Reviews & meta-analyses","Therapy practice"],"ptype":"review","src":"https://openalex.org/W7165379561","eid":"W7165379561"},{"id":"paper-w7112925462","cat":"papers","name":"Supplemental materials for preprint: Who believes psychedelic-assisted therapies work? Risky cannabis use and other factors are associated with positive treatment-outcome expectancies","year":"2024","cit":0,"pfa":"Jason Van Allen","psa":"Andrew K. Littlefield","topics":["Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W7112925462","eid":"W7112925462"},{"id":"paper-w4415143443","cat":"papers","name":"Treating job-related stress with psychedelic group therapy: a case series on group ketamine-assisted psychotherapy for healthcare workers and first responders","year":"2025","cit":0,"pfa":"Luke Flynn","psa":"Scott Shannon","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4415143443","eid":"W4415143443"},{"id":"paper-w7171943035","cat":"papers","name":"The effect of the Apollo Neuro device on anxiety among participants who underwent ketamine assisted therapy: A non-randomized, observational cohort study","year":"2026","cit":0,"pfa":"S. Wong","psa":"P. Kyrskow","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7171943035","eid":"W7171943035"},{"id":"paper-w7116902204","cat":"papers","name":"What can psychedelics teach nursing?: an interpretative phenomenological analysis of psychiatric-mental health nurse practitioners experiences working in psychedelic-assisted therapies in the United States","year":"2025","cit":0,"pfa":"Rachel H. Maki","ptype":"dissertation","src":"https://openalex.org/W7116902204","eid":"W7116902204"},{"id":"paper-w4412668235","cat":"papers","name":"Assessing the Impact of Ketamine-Assisted Multimodal Therapy on Depressive Symptoms: A Longitudinal Pre-Post BDI-II Study with Exploratory Follow-Up Analysis","year":"2024","cit":0,"pfa":"Anja Frank","psa":"Mario H W Scheib","topics":["Depression","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4412668235","eid":"W4412668235"},{"id":"paper-w4415165649","cat":"papers","name":"Supplemental Material for The Code Less Travelled: Can the Canadian Psychological Association Code of Ethics Support Ethical Decision Making in the New Era of Psychedelic-Assisted Psychotherapy?","year":"2025","cit":0,"topics":["Therapy practice","Policy & ethics"],"ptype":"supplementary-materials","src":"https://openalex.org/W4415165649","eid":"W4415165649"},{"id":"paper-w7165387725","cat":"papers","name":"Supplementary Material for: Ketamine-assisted psychotherapy for posttraumatic stress disorder: a systematic review and individual participant data meta-analysis of predictors of treatment effects","year":"2026","cit":0,"pfa":"figshare admin karger","psa":"Georgios Schoretsanitis","topics":["PTSD & trauma","Reviews & meta-analyses","Therapy practice"],"ptype":"supplementary-materials","src":"https://openalex.org/W7165387725","eid":"W7165387725"},{"id":"paper-w4411506114","cat":"papers","name":"The Effect of the Apollo Neuro Device on Anxiety Among Participants who Underwent Ketamine Assisted Therapy: Non-randomized, Observational Cohort Study (Preprint)","year":"2025","cit":0,"pfa":"Vivian W. L. Tsang","psa":"Pamela Kryskow","topics":["Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W4411506114","eid":"W4411506114"},{"id":"paper-w7163397136","cat":"papers","name":"Ketamine-Assisted Narrative Intervention (KANI) for Veterans with Chronic Low Back Pain and Co-Occurring Depression: Treatment Manual for Narrative Intervention Component","year":"2026","cit":0,"pfa":"Victoria D. Powell","topics":["Depression","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7163397136","eid":"W7163397136"},{"id":"paper-w7168230797","cat":"papers","name":"Supplemental materials for preprint: Qualitative analysis of a patient’s experience of ketamine-assisted psychotherapy for substance use disorder: Empirical synergies with twelve-step programs.","year":"2024","cit":0,"pfa":"Rachel Wanzor-Box","psa":"Dan Petrovitch","topics":["Addiction","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7168230797","eid":"W7168230797"},{"id":"paper-w7165405037","cat":"papers","name":"Supplementary Material for: Ketamine-assisted psychotherapy for posttraumatic stress disorder: a systematic review and individual participant data meta-analysis of predictors of treatment effects","year":"2026","cit":0,"pfa":"figshare admin karger","psa":"Georgios Schoretsanitis","topics":["PTSD & trauma","Reviews & meta-analyses","Therapy practice"],"ptype":"supplementary-materials","src":"https://openalex.org/W7165405037","eid":"W7165405037"},{"id":"paper-w4252839108","cat":"papers","name":"The Trials of Psychedelic Therapy: LSD Psychotherapy in America, By Matthew Oram, Johns Hopkins University Press. 2018. 288 pp. £33.30 (hb). ISBN 9781421426204 – CORRIGENDUM","year":"2019","cit":0,"pfa":"Ben Sessa","topics":["Therapy practice"],"ptype":"erratum","src":"https://openalex.org/W4252839108","eid":"W4252839108"},{"id":"paper-w7202288839","cat":"papers","name":"How is caregiver involvement conceptualized across oncology, palliative care, and psychedelic-assisted therapy literature, and which relational mechanisms can inform its use in oncology-based psychedelic care?","year":"2026","cit":0,"pfa":"Tripdatabase","topics":["Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7202288839","eid":"W7202288839"},{"id":"paper-w4416516866","cat":"papers","name":"Peer Review Report For: Clinical Psychedelic Therapy Research Involving Adolescents: Protocol for a Scoping Review of Intervention Studies [version 1; peer review: 2 approved with reservations]","year":"2025","cit":0,"pfa":"Elliot A. Marseille","topics":["Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4416516866","eid":"W4416516866"},{"id":"paper-w2980809210","cat":"papers","name":"THE TRIALS OF PSYCHEDELIC THERAPY: LSD PSYCHOTHERAPY IN AMERICA Matthew Oram Baltimore, MD: Johns Hopkins University Press, 2018. p. 269 $39.45 (hardcover). ISBN 9781421426204.","year":"2019","cit":0,"pfa":"Joshua A. Arduengo","topics":["Therapy practice"],"ptype":"book-review","src":"https://openalex.org/W2980809210","eid":"W2980809210"},{"id":"paper-w2978313791","cat":"papers","name":"Matthew Oram, The Trials of Psychedelic Therapy: LSD Psychotherapy in America (Baltimore, MD: Johns Hopkins University Press, 2018), pp. 288, £37.00, hardback, ISBN: 9781421426204.","year":"2019","cit":0,"pfa":"Sarah Brady Siff","topics":["Therapy practice"],"ptype":"book-review","src":"https://openalex.org/W2978313791","eid":"W2978313791"},{"id":"paper-w7202273743","cat":"papers","name":"How is caregiver involvement conceptualized across oncology, palliative care, and psychedelic-assisted therapy literature, and which relational mechanisms can inform its use in oncology-based psychedelic care?","year":"2026","cit":0,"pfa":"Tripdatabase","topics":["Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7202273743","eid":"W7202273743"},{"id":"paper-w3009465094","cat":"papers","name":"Matthew Oram. The Trials of Psychedelic Therapy: LSD Psychotherapy in America. xi + 269 pp., notes, index. Baltimore: Johns Hopkins University Press, 2018. $49.95 (cloth). ISBN 9781421426204.","year":"2020","cit":0,"pfa":"Nadine M. Weidman","topics":["Therapy practice"],"ptype":"book-review","src":"https://openalex.org/W3009465094","eid":"W3009465094"},{"id":"paper-w7141164319","cat":"papers","name":"Use of Psychedelic Drugs in Psychiatry – Interview","year":"2025","cit":0,"pfa":"Franklin King IV","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"report","src":"https://openalex.org/W7141164319","eid":"W7141164319"},{"id":"paper-w4380624092","cat":"papers","name":"Overcoming blinding confounds in psychedelic randomized controlled trials using biomarker driven causal mediation analysis","year":"2023","cit":0,"pfa":"Suresh D Muthukumaraswamy","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4380624092","eid":"W4380624092"},{"id":"paper-w7131598455","cat":"papers","name":"Current perspectives on psychedelic treatments in Europe","year":"2026","cit":0,"pfa":"Santiago Madero Gómez","psa":"Vieta i Pascual, Eduard, 1963-","ptype":"article","src":"https://openalex.org/W7131598455","eid":"W7131598455"},{"id":"paper-w7158352033","cat":"papers","name":"Holding space on shifting ground: an interpretative phenomenological analysis into counsellors' journeys through the psychedelic renaissance","year":"2026","cit":0,"pfa":"Camilla Akoo","topics":["Safety & adverse events","Therapy practice","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W7158352033","eid":"W7158352033"},{"id":"paper-w7139983410","cat":"papers","name":"Towards social curative psychedelic treatment","year":"2026","cit":0,"pfa":"Martha Newson","psa":"S. Alexander Haslam","ptype":"article","src":"https://openalex.org/W7139983410","eid":"W7139983410"},{"id":"paper-w7169611970","cat":"papers","name":"Lessons from the Field: Publishing Management Research in a Burgeoning Psychedelics Ecosystem","year":"2026","cit":0,"pfa":"Adelaide Wilcox King","psa":"Carolina Jimenez Pena","topics":["Safety & adverse events","Therapy practice","Policy & ethics"],"ptype":"conference-abstract","src":"https://openalex.org/W7169611970","eid":"W7169611970"},{"id":"paper-w4393428594","cat":"papers","name":"Rapid and sustained reduction of treatment-resistant PTSD symptoms after intravenous ketamine in a real-world, psychedelic paradigm","year":"2024","cit":0,"pfa":"Henry A. MacConnel","psa":"Steven Radowitz","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4393428594","eid":"W4393428594"},{"id":"paper-w7171225898","cat":"papers","name":"Conceptual analysis of mechanisms and methods in psychedelic clinical trial design: a narrative review","year":"2026","cit":0,"pfa":"Martin Kršák","psa":"Scott Shannon","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7171225898","eid":"W7171225898"},{"id":"paper-w7128563136","cat":"papers","name":"How psyched are they for psychedelics? En explorativ tvärsnittsstudie kring psykologers och psykologstudenters attityder till psykedelika-assisterad terapi","year":"2026","cit":0,"pfa":"Troy Polner","topics":["Depression","Anxiety & end-of-life","Therapy practice"],"ptype":"other","src":"https://openalex.org/W7128563136","eid":"W7128563136"},{"id":"paper-w4387493077","cat":"papers","name":"Regulatory Perspectives on Psychedelic Therapeutics","year":"2023","cit":0,"pfa":"Tiffany R. Farchione","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4387493077","eid":"W4387493077"},{"id":"paper-w4360823150","cat":"papers","name":"The Future for Psychedelic Agents in the Treatment of Posttraumatic Stress Disorder","year":"2023","cit":0,"pfa":"Amy L. Haycraft","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4360823150","eid":"W4360823150"},{"id":"paper-w4399985883","cat":"papers","name":"Vitalism and Naturopathy in Psychedelic Medicine.","year":"2024","cit":0,"pfa":"Matthew Hicks","psa":"Olivia Giguere","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4399985883","eid":"W4399985883"},{"id":"paper-w7169535998","cat":"papers","name":"Psychotherapy and Ketamine: How Does This Combination Affect the Duration of the Antidepressant Effect?","year":"2026","cit":0,"pfa":"Viacheslav Zaika","psa":"Yan Tytarenko","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7169535998","eid":"W7169535998"},{"id":"paper-w7168374598","cat":"papers","name":"Combined Ketamine and Cognitive-Behavioral Therapy: Leveraging Metaplasticity to Enhance Treatment Outcomes","year":"2026","cit":0,"pfa":"Morgan S. Hardy","psa":"Samuel T. Wilkinson","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7168374598","eid":"W7168374598"},{"id":"paper-w7166865128","cat":"papers","name":"Professional Competencies for Psychedelic Therapists","year":"2026","cit":0,"pfa":"Georgia Ioakimidis-MacDougall","psa":"Paul Liknaitzky","topics":["Therapy practice"],"ptype":"other","src":"https://openalex.org/W7166865128","eid":"W7166865128"},{"id":"paper-w7166835166","cat":"papers","name":"Professional Competencies for Psychedelic Therapists","year":"2026","cit":0,"pfa":"Georgia Ioakimidis-MacDougall","psa":"Paul Liknaitzky","topics":["Therapy practice"],"ptype":"other","src":"https://openalex.org/W7166835166","eid":"W7166835166"},{"id":"paper-w7214210128","cat":"papers","name":"Effects of psychedelic drug use on neurocognitive function and the psychological and social domains of quality of life: an international online study","year":"2026","cit":0,"pfa":"Franziska Stadler","psa":"Christoph Kraus","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W7214210128","eid":"W7214210128"},{"id":"paper-w7164922537","cat":"papers","name":"Self-compassion, compassion, psychedelics","year":"2026","cit":0,"pfa":"Sarah Shnayder","psa":"Caitlin A Laycox","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7164922537","eid":"W7164922537"},{"id":"paper-w4224281366","cat":"papers","name":"Introduction: Psychedelic Science Needs Philosophy","year":"2022","cit":0,"pfa":"Matthew W. Johnson","ptype":"article","src":"https://openalex.org/W4224281366","eid":"W4224281366"},{"id":"paper-w7148179585","cat":"papers","name":"Drug in context. Evidence, Validity, and the Limits of EBM in Psychedelic Psychotherapy","year":"2026","cit":0,"pfa":"Elisabetta Lalumera","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W7148179585","eid":"W7148179585"},{"id":"paper-w7202118071","cat":"papers","name":"Psychedelic Use Covaries with Psychological Flexibility Through Mystical Experiences: Results of a Retrospective Web Survey","year":"2026","cit":0,"pfa":"Angelica Spata","psa":"Mitch Earleywine","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7202118071","eid":"W7202118071"},{"id":"paper-w4385709549","cat":"papers","name":"The Intersection of Psychedelics and Neuroplasticity: Rethinking Therapeutic Approaches for Mental Health","year":"2023","cit":0,"pfa":"Kargbo RB","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4385709549","eid":"W4385709549"},{"id":"paper-w4361245164","cat":"papers","name":"The psychotherapeutic component of psychedelic medicine","year":"2023","cit":0,"pfa":"Laurie Higbed","psa":"Ben Sessa","topics":["Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W4361245164","eid":"W4361245164"},{"id":"paper-w3167085032","cat":"papers","name":"Love and fear: Towards and Australian model of psychedelic health","year":"2021","cit":0,"pfa":"Kate Cole-Adams","ptype":"book-chapter","src":"https://openalex.org/W3167085032","eid":"W3167085032"},{"id":"paper-w3127942635","cat":"papers","name":"The Psychological Processes of Classic Psychedelics in the Treatment of Depression: A Systematic Review Protocol","year":"2020","cit":0,"pfa":"Lauren Johansen","psa":"Greg Murray","topics":["Depression","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W3127942635","eid":"W3127942635"},{"id":"paper-w7213982318","cat":"papers","name":"Matters arising: Methodological concerns and interpretative limitations of assessing subjective effects of ketamine","year":"2026","cit":0,"pfa":"Ramūnas Janavičius","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7213982318","eid":"W7213982318"},{"id":"paper-w4392185765","cat":"papers","name":"Masking influences: A systematic review of placebo control and blinding in psychedelic studies","year":"2024","cit":0,"pfa":"Aleksandra Barstowe","psa":"Petri Kajonius","topics":["Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4392185765","eid":"W4392185765"},{"id":"paper-w7162662867","cat":"papers","name":"Drugs for anxiety: from chloral hydrate to novel therapeutics","year":"2026","cit":0,"pfa":"Peter Michael Haddad","topics":["Anxiety & end-of-life","Reviews & meta-analyses"],"ptype":"editorial","src":"https://openalex.org/W7162662867","eid":"W7162662867"},{"id":"paper-w7148706646","cat":"papers","name":"Extrapharmacological and Contextual Factors in Psychedelic Research: A Scoping Review","year":"2025","cit":0,"pfa":"Rafael Lancelotta","psa":"Taweh Hunter","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7148706646","eid":"W7148706646"},{"id":"paper-w7159765150","cat":"papers","name":"Clinical Memorandum: Therapeutic use of psychedelic substances May 2020. Figshare version uploaded by Brinzei, Octavian (2026) as supplementary material.","year":"2026","cit":0,"pfa":"Royal Australian and New Zealand College of Psychiatrists (RANZCP)","topics":["Addiction","Policy & ethics"],"ptype":"other","src":"https://openalex.org/W7159765150","eid":"W7159765150"},{"id":"paper-w7161159101","cat":"papers","name":"Integrating Psychedelics Into Nursing Education and Practice: Historical, Clinical, and Educational Perspectives","year":"2026","cit":0,"pfa":"Ladan Eshkevari","psa":"Jeffery Ramirez","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7161159101","eid":"W7161159101"},{"id":"paper-w7159854813","cat":"papers","name":"Clinical Memorandum: Therapeutic use of psychedelic substances May 2020. Figshare version uploaded by Brinzei, Octavian (2026) as supplementary material","year":"2026","cit":0,"pfa":"Royal Australian and New Zealand College of Psychiatrists (RANZCP)","topics":["Addiction","Policy & ethics"],"ptype":"other","src":"https://openalex.org/W7159854813","eid":"W7159854813"},{"id":"paper-w7135755311","cat":"papers","name":"Spirituality and treatment of addictions","year":"2011","cit":0,"pfa":"Tomáš Málek","topics":["Addiction"],"ptype":"dissertation","src":"https://openalex.org/W7135755311","eid":"W7135755311"},{"id":"paper-w7159789416","cat":"papers","name":"Clinical Memorandum: Therapeutic use of psychedelic substances May 2020. Figshare version uploaded by Brinzei, Octavian (2026) as supplementary material","year":"2026","cit":0,"pfa":"Royal Australian and New Zealand College of Psychiatrists (RANZCP)","topics":["Addiction","Policy & ethics"],"ptype":"other","src":"https://openalex.org/W7159789416","eid":"W7159789416"},{"id":"paper-w7159887602","cat":"papers","name":"Clinical Memorandum: Therapeutic use of psychedelic substances May 2020","year":"2026","cit":0,"pfa":"Octavian Victor Brinzei","topics":["Addiction","Policy & ethics"],"ptype":"other","src":"https://openalex.org/W7159887602","eid":"W7159887602"},{"id":"paper-w7117964633","cat":"papers","name":"From Medicalisation to Cultural Embrace: Drug Foundationalism Versus Techné in the Psychedelic Revival","year":"2026","cit":0,"pfa":"Tehseen N. Noorani","ptype":"book-chapter","src":"https://openalex.org/W7117964633","eid":"W7117964633"},{"id":"paper-w7141838675","cat":"papers","name":"Psychedelic Neuroplasticity and the GL Phase Transition","year":"2026","cit":0,"pfa":"Jean-Paul Niko","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7141838675","eid":"W7141838675"},{"id":"paper-w7141644908","cat":"papers","name":"Use of Psychedelic Drugs in Psychiatry","year":"2024","cit":0,"pfa":"Franklin King IV","topics":["Depression","Mechanism & neuroscience","Therapy practice"],"ptype":"report","src":"https://openalex.org/W7141644908","eid":"W7141644908"},{"id":"paper-w4402836762","cat":"papers","name":"An exploration of psychotherapists' readiness to join the psychedelic renaissance","year":"2024","cit":0,"pfa":"Siobhan Scanlon","psa":"Gráinne Donohue","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4402836762","eid":"W4402836762"},{"id":"paper-w7129371637","cat":"papers","name":"Mapping Educational Programs and Resources on Psychedelics in Canada: A Scoping Review & Environmental Scan","year":"2026","cit":0,"pfa":"Elena Koning","topics":["Addiction","Reviews & meta-analyses","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7129371637","eid":"W7129371637"},{"id":"paper-w7162295546","cat":"papers","name":"Psychedelics and neurostimulation for treatment resistant psychiatric disorders","year":"2026","cit":0,"pfa":"Filip Blažek","psa":"Lumír Hrabálek","topics":["Depression","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7162295546","eid":"W7162295546"},{"id":"paper-w7142496117","cat":"papers","name":"Psychedelic Neuroplasticity and the GL Phase Transition","year":"2026","cit":0,"pfa":"Jean-Paul Niko","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7142496117","eid":"W7142496117"},{"id":"paper-w7172062043","cat":"papers","name":"Psychotherapy assisted by Ketamin: a narrative review","year":"2026","cit":0,"pfa":"V. Fournier","psa":"I. Gothuey","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"review","src":"https://openalex.org/W7172062043","eid":"W7172062043"},{"id":"paper-w4304110314","cat":"papers","name":"Special Report: Psychedelics and mental health","year":"2022","cit":0,"pfa":"Tasha Wibawa","topics":["Depression","Anxiety & end-of-life"],"ptype":"report","src":"https://openalex.org/W4304110314","eid":"W4304110314"},{"id":"paper-w4404942182","cat":"papers","name":"Sex in therapy: female psy and LSD in the 60s","year":"2024","cit":0,"pfa":"Zoë Dubus","topics":["Addiction","Policy & ethics"],"ptype":"other","src":"https://openalex.org/W4404942182","eid":"W4404942182"},{"id":"paper-w4327971792","cat":"papers","name":"Should Psychedelic Drugs Be Offered as a Treatment for Mental Illness?","year":"2023","cit":0,"pfa":"Ruoqi Zhang","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4327971792","eid":"W4327971792"},{"id":"paper-w7128030614","cat":"papers","name":"Metamodernism and Psychedelics: The good, the bad, and the ugly","year":"2026","cit":0,"pfa":"Michael R. Montgomery","psa":"Noah Cebuliak","topics":["Anxiety & end-of-life","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7128030614","eid":"W7128030614"},{"id":"paper-w7213548831","cat":"papers","name":"BH groups stress ‘system readiness’ as FDA weighs psychedelic treatments","year":"2026","cit":0,"pfa":"Valerie A. Canady","topics":["Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7213548831","eid":"W7213548831"},{"id":"paper-w4409716555","cat":"papers","name":"Inventing Experience: Medieval, Psychedelic, and Postmodern","year":"2025","cit":0,"pfa":"Patricia Dailey","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4409716555","eid":"W4409716555"},{"id":"paper-w7202422072","cat":"papers","name":"Psychedelics in the wild: The self-administration of psychedelic substances for health and wellbeing in Aotearoa New Zealand","year":"2025","cit":0,"pfa":"CHRISTOPHER ARNISON","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W7202422072","eid":"W7202422072"},{"id":"paper-w7134239887","cat":"papers","name":"Confronting mortality: A meta-analysis and systematic review of psychedelic experiences and death anxiety","year":"2026","cit":0,"pfa":"Alicia Cohorst","psa":"Petri Kajonius","topics":["Addiction","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W7134239887","eid":"W7134239887"},{"id":"paper-w7167917222","cat":"papers","name":"Understanding experiences of psychedelic treatments for eating disorders: a meta-synthesis of qualitative studies","year":"2026","cit":0,"pfa":"R. Crawford Morris","psa":"Johanna Louise Keeler","topics":["Anxiety & end-of-life","Safety & adverse events","Therapy practice"],"ptype":"other","src":"https://openalex.org/W7167917222","eid":"W7167917222"},{"id":"paper-w7167943572","cat":"papers","name":"Understanding experiences of psychedelic treatments for eating disorders: a meta-synthesis of qualitative studies","year":"2026","cit":0,"pfa":"R. Crawford Morris","psa":"Johanna Louise Keeler","topics":["Anxiety & end-of-life","Safety & adverse events","Therapy practice"],"ptype":"other","src":"https://openalex.org/W7167943572","eid":"W7167943572"},{"id":"paper-w7171724597","cat":"papers","name":"Psychedelic Lobbying and Regulatory Capture","year":"2026","cit":0,"pfa":"Vincent Joralemon","topics":["Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W7171724597","eid":"W7171724597"},{"id":"paper-w7203478429","cat":"papers","name":"LSD therapy: A few hundred meters from where it began","year":"2026","cit":0,"pfa":"Felix Müller","psa":"Undine E. Lang","ptype":"article","src":"https://openalex.org/W7203478429","eid":"W7203478429"},{"id":"paper-w4220770952","cat":"papers","name":"PSYCHODELIC THERAPY IN THE TREATMENT OF RESISTANT MENTAL DISORDERS","year":"2022","cit":0,"pfa":"Ana Cláudia Drumond de Araújo Lima","psa":"Eunaihara Lígia Lira Marques","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4220770952","eid":"W4220770952"},{"id":"paper-w7161639213","cat":"papers","name":"Understanding experiences of psychedelic treatments for eating disorders: a meta-synthesis of qualitative studies","year":"2026","cit":0,"pfa":"Rebecca Morris","psa":"Johanna L. Keeler","topics":["Anxiety & end-of-life","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7161639213","eid":"W7161639213"},{"id":"paper-w2954393045","cat":"papers","name":"Exploring the Boundaries of Death and Rebirth in LSD Psychotherapy","year":"2014","cit":0,"pfa":"Christopher M. Bache","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2954393045","eid":"W2954393045"},{"id":"paper-w4384156133","cat":"papers","name":"Does fundamentally altering the staffing of clinical rehabilitation services impact their function?","year":"2023","cit":0,"pfa":"Nikela A Lalley","psa":"Stephen Parker","ptype":"article","src":"https://openalex.org/W4384156133","eid":"W4384156133"},{"id":"paper-w4401695468","cat":"papers","name":"Largest ever trial of ketamine to treat alcohol abuse to launch across eight NHS sites","year":"2024","cit":0,"topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4401695468","eid":"W4401695468"},{"id":"paper-w4404690382","cat":"papers","name":"Insights on Psychedelics: A Systematic Review of Therapeutic Effects","year":"2024","cit":0,"pfa":"Joshua Kugel","psa":"Paul Liknaitzky","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4404690382","eid":"W4404690382"},{"id":"paper-w4410338684","cat":"papers","name":"Cornutopia: A short story and what it can tell us about ethnic minority views on psychedelic research, and the potential impact on clinical outcomes","year":"2025","cit":0,"pfa":"Caroline Hayes","ptype":"article","src":"https://openalex.org/W4410338684","eid":"W4410338684"},{"id":"paper-w4406932626","cat":"papers","name":"Addictions : ce qui a changé en 2024","year":"2025","cit":0,"pfa":"Yasser Khazaal","psa":"DANIELE FABIO ZULLINO","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4406932626","eid":"W4406932626"},{"id":"paper-w7171523346","cat":"papers","name":"Neurophysiological alterations of mPFC to NAc core circuit during bath application of 5-HT2R agonist DOI in a chronic alcohol-drinking mouse model","year":"2026","cit":0,"pfa":"Kendrick Lewis","psa":"Chris Kroenke","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W7171523346","eid":"W7171523346"},{"id":"paper-w4412895833","cat":"papers","name":"Pilot Data on Salivary Oxytocin as a Biomarker of LSD Response in Patients with Major Depressive Disorder","year":"2025","cit":0,"pfa":"Laurie Cazorla","psa":"Tatiana Aboulafia Brakha","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4412895833","eid":"W4412895833"},{"id":"paper-w4293242471","cat":"papers","name":"Psychedelics: Brain Mechanisms","year":"2022","cit":0,"pfa":"Robin Lester Carhart-Harris","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4293242471","eid":"W4293242471"},{"id":"paper-w7213341604","cat":"papers","name":"Next-Generation Psychedelic Drug Development","year":"2026","cit":0,"pfa":"Lindsay P. Cameron","psa":"Charles David Nichols","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7213341604","eid":"W7213341604"},{"id":"paper-w4411047520","cat":"papers","name":"Pilot Data on Salivary Oxytocin as a Biomarker of LSD Response in Patients with Major Depressive Disorder","year":"2025","cit":0,"pfa":"Laurie Cazorla","psa":"Tatiana Aboulafia Brakha","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4411047520","eid":"W4411047520"},{"id":"paper-w4411322658","cat":"papers","name":"Pilot Data on Salivary Oxytocin as a Biomarker of LSD Response in Patients with Major Depressive Disorder","year":"2025","cit":0,"pfa":"Laurie Cazorla","psa":"Tatiana Aboulafia Brakha","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4411322658","eid":"W4411322658"},{"id":"paper-w7126003884","cat":"papers","name":"Peer Readiness and Education for Psychedelic Practice (PREPP)","year":"2026","cit":0,"pfa":"Christopher Stauffer","topics":["Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7126003884","eid":"W7126003884"},{"id":"paper-w4409281282","cat":"papers","name":"117. An Interim Blinding Integrity Analysis of a Randomized, Double-Blind, Midazolam-Controlled Phase II Clinical Trial Investigating Repeated Ketamine Infusions for Treatment Resistant Bipolar Disorder","year":"2025","cit":0,"pfa":"Diana K. Orsini","psa":"Joshua Daniel Rosenblat","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4409281282","eid":"W4409281282"},{"id":"paper-w7204140362","cat":"papers","name":"Perceptions of Psychedelic Decriminalization: Findings from a Community Survey of People Who Use Psychedelics","year":"2026","cit":0,"pfa":"Daniel J. Kruger","psa":"Larry Norris","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7204140362","eid":"W7204140362"},{"id":"paper-w7163382981","cat":"papers","name":"Insight to Action: The Role of Occupational Therapy in Psychedelic Integration","year":"2026","cit":0,"pfa":"Gal Elkaiam","psa":"Brett Buford","topics":["Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7163382981","eid":"W7163382981"},{"id":"paper-w4392749693","cat":"papers","name":"Improvement in Depressive Symptoms in a Patient with Severe and Enduring Anorexia Nervosa and Comorbid Major Depressive Disorder Using Psychotherapy-Assisted IV Ketamine : A Case Report","year":"2024","cit":0,"pfa":"Amanda Timek","psa":"Stephen J. Ferrando","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4392749693","eid":"W4392749693"},{"id":"paper-w4409281261","cat":"papers","name":"215. Association of Adverse Childhood Experiences With Depression Symptom Reduction Following Ketamine Infusions: Insights From a Large, Naturalistic Sample","year":"2025","cit":0,"pfa":"Raquel Kosted","psa":"Gregory A. Fonzo","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4409281261","eid":"W4409281261"},{"id":"paper-w7163759542","cat":"papers","name":"Return of the sacred: Psychiatry’s evolving relationship with spirituality","year":"2026","cit":0,"pfa":"Osama Bhatti","psa":"Mohammad Qasim Latifi","topics":["Anxiety & end-of-life","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7163759542","eid":"W7163759542"},{"id":"paper-w2619787635","cat":"papers","name":"Ask Your Doctor if Psychedelics are Right for You: A Closer Look at the Clinical Uses of Psychedelics","year":"2017","cit":0,"pfa":"Haya Al-Hejailan","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"dissertation","src":"https://openalex.org/W2619787635","eid":"W2619787635"},{"id":"paper-w7148655858","cat":"papers","name":"Can psychedelics turn therapists into vampires?","year":"2025","cit":0,"pfa":"Eduardo Ekman Schenberg","psa":"Julia Kruger","topics":["Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7148655858","eid":"W7148655858"},{"id":"paper-w7116863931","cat":"papers","name":"A critical literature review of research on attachment and psychedelics: Synergies and research implications","year":"2025","cit":0,"pfa":"Esenia K. Cassidy","psa":"Smitha Rao","topics":["PTSD & trauma","Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7116863931","eid":"W7116863931"},{"id":"paper-w7214379328","cat":"papers","name":"This House Believes That Entrepreneurship Research Is Out of Touch with the Psychedelic Renaissance: For the Motion","year":"2026","cit":0,"pfa":"Jukka-Pekka Heikkilä","ptype":"preprint","src":"https://openalex.org/W7214379328","eid":"W7214379328"},{"id":"paper-w4361245200","cat":"papers","name":"Risks and adverse events associated with the use of psychedelics","year":"2023","cit":0,"pfa":"Joanna Caroline Neill","psa":"Frank I. Tarazi","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W4361245200","eid":"W4361245200"},{"id":"paper-w4206197161","cat":"papers","name":"Psychedelic medicines for existential distress associated with life-threatening illnesses","year":"2022","cit":0,"pfa":"Houman Farzin","topics":["Addiction","Anxiety & end-of-life","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4206197161","eid":"W4206197161"},{"id":"paper-w7149532893","cat":"papers","name":"Perceptions of Australasian palliative care physicians regarding the safety and efficacy of psychedelic medicines: An exploratory mixed-methods study","year":"2026","cit":0,"pfa":"Nicholas Sawers","psa":"David Benjamin Menkes","topics":["Anxiety & end-of-life","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7149532893","eid":"W7149532893"},{"id":"paper-w7165649982","cat":"papers","name":"Treatment-Resistant Depression: A Psychiatry Perspective on Pathophysiological Mechanisms, Biomarkers, and Novel Therapeutic Frontiers","year":"2026","cit":0,"pfa":"Muhammad Bilal Akram","psa":"Umair Khalil","topics":["Depression","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7165649982","eid":"W7165649982"},{"id":"paper-w7154838550","cat":"papers","name":"UNDERSTANDING PTSD: NEW THERAPIES AND APPROACHES","year":"2022","cit":0,"pfa":"Dr. Ayesha siddiqui","topics":["PTSD & trauma","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7154838550","eid":"W7154838550"},{"id":"paper-w2543778268","cat":"papers","name":"Ketamine (IM) Assisted Psychotherapy (KAP): A Model for Informed Consent","year":"2014","cit":0,"pfa":"Philip E. Wolfson","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2543778268","eid":"W2543778268"},{"id":"paper-w7203872961","cat":"papers","name":"Transpersonal Psychotherapies","year":"2026","cit":0,"pfa":"Jenny Wade","psa":"Jacqueline Hermida","topics":["Therapy practice"],"ptype":"other","src":"https://openalex.org/W7203872961","eid":"W7203872961"},{"id":"paper-w7134897995","cat":"papers","name":"Transient or transformative? Psychedelics, agency and informed consent","year":"2026","cit":0,"pfa":"Chiara Caporuscio","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7134897995","eid":"W7134897995"},{"id":"paper-w4393116206","cat":"papers","name":"Current Concepts on Mental Health of Children and Adolescents (A Treatise on Psychiatric Disorders)","year":"2021","cit":0,"pfa":"Professor Dr. Atul Choube","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"book","src":"https://openalex.org/W4393116206","eid":"W4393116206"},{"id":"paper-w4415579940","cat":"papers","name":"Personality profiles and trauma history in ketamine therapy for mood and anxiety disorders: A latent profile analysis of short-term outcomes","year":"2025","cit":0,"pfa":"Nina Gregoire","psa":"Paul G. Davies","topics":["PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4415579940","eid":"W4415579940"},{"id":"paper-w7161180279","cat":"papers","name":"Variability in outcomes and subjective effects of psychedelic use in psychotic populations: Case-based evidence from naturalistic settings","year":"2026","cit":0,"pfa":"Joseph T. La Torre","psa":"Nathan B. Sackett","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7161180279","eid":"W7161180279"},{"id":"paper-w4398253247","cat":"papers","name":"The treatment of anxiety and fear disorders","year":"2024","cit":0,"pfa":"Neil McNaughton","psa":"Jeffrey A. Gray","topics":["Anxiety & end-of-life","Reviews & meta-analyses","Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W4398253247","eid":"W4398253247"},{"id":"paper-w7204136800","cat":"papers","name":"Clinicians’ Attitudes and Opinions About Psychedelics in the SWANA Region: A Cross-Sectional Online Survey","year":"2026","cit":0,"pfa":"Mahmoud Elmidany","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7204136800","eid":"W7204136800"},{"id":"paper-w4412841363","cat":"papers","name":"Ontic Structural Realism, Buddhist Metaphysics, and the Self in Psychedelic Psychotherapy","year":"2025","cit":0,"pfa":"Daniel Stearman","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4412841363","eid":"W4412841363"},{"id":"paper-w4285013506","cat":"papers","name":"Psychedelic Architectures: Expanding Universal Care with the Integration of Plural Psychedelic Health Spaces","year":"2022","cit":0,"pfa":"Andrea Mcintosh","topics":["Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W4285013506","eid":"W4285013506"},{"id":"paper-w7214781817","cat":"papers","name":"Clearing the Air About Psychedelic Spirituality","year":"2026","cit":0,"pfa":"Adam Greif","psa":"Gabriela Bezáková","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7214781817","eid":"W7214781817"},{"id":"paper-w4415942848","cat":"papers","name":"Group acupuncture following a psychedelic ketamine experience: An integrative medicine pilot study","year":"2025","cit":0,"pfa":"Melissa Navarro","topics":["Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4415942848","eid":"W4415942848"},{"id":"paper-w4389662957","cat":"papers","name":"Further Thoughts on Consciousness, Mystical Experience, Character, and Clinical Process: Reply to Fox, Rundel, and Guss","year":"2023","cit":0,"pfa":"Noelle Burton","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4389662957","eid":"W4389662957"},{"id":"paper-w4410860869","cat":"papers","name":"Ketamine","year":"2025","cit":0,"pfa":"Rebecca Ramm","psa":"Michael DeMarco","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"book-chapter","src":"https://openalex.org/W4410860869","eid":"W4410860869"},{"id":"paper-w7161628232","cat":"papers","name":"The Therapeutic Use of Psychedelics","year":"2026","cit":0,"pfa":"Vanessa Bibliowicz","topics":["Safety & adverse events","Therapy practice"],"ptype":"book","src":"https://openalex.org/W7161628232","eid":"W7161628232"},{"id":"paper-w4406915289","cat":"papers","name":"An AIP model of the psychedelic space","year":"2025","cit":0,"pfa":"Hannah Raine-Smith","psa":"Jocelyn Rose","topics":["Mechanism & neuroscience","Reviews & meta-analyses","Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W4406915289","eid":"W4406915289"},{"id":"paper-w7165358504","cat":"papers","name":"To Be, or Not to Be Exceptional: That Is the Question in Psychedelic Ethics","year":"2026","cit":0,"pfa":"Daniel Villiger","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7165358504","eid":"W7165358504"},{"id":"paper-w4405598714","cat":"papers","name":"Psychedelics","year":"2024","cit":0,"pfa":"Des O’Rawe","ptype":"book-chapter","src":"https://openalex.org/W4405598714","eid":"W4405598714"},{"id":"paper-w4414978082","cat":"papers","name":"Ontic Structural Realism, Buddhist Metaphysics, and the Self in Psychedelic Psychotherapy","year":"2025","cit":0,"pfa":"Daniel Stearman","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4414978082","eid":"W4414978082"},{"id":"paper-w3117462922","cat":"papers","name":"The Repression and Support of Psychedelic Experience","year":"2018","cit":0,"pfa":"Ted Clark","psa":"Dennis T. Jaffe","topics":["Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W3117462922","eid":"W3117462922"},{"id":"paper-w4409870245","cat":"papers","name":"What Is Art Therapy?","year":"2025","cit":0,"pfa":"Charmaine Husum","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"book-chapter","src":"https://openalex.org/W4409870245","eid":"W4409870245"},{"id":"paper-w4412950049","cat":"papers","name":"A Philosophical Investigation of Healing with Psychedelic Medicine","year":"2025","cit":0,"pfa":"Candice L. Shelby","psa":"The Society for Philosophy in the Contemporary World","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4412950049","eid":"W4412950049"},{"id":"paper-w7116766086","cat":"papers","name":"“Tragic Person evolved: Transforming tragedy into hope through new, alternative treatments”","year":"2025","cit":0,"pfa":"Douglas Zimmerman","topics":["PTSD & trauma","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7116766086","eid":"W7116766086"},{"id":"paper-w4406988041","cat":"papers","name":"Psychedelic Drugs as Treatment Agents","year":"2025","cit":0,"pfa":"Rachel Yehuda","psa":"Kathleen M. Jagodnik","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W4406988041","eid":"W4406988041"},{"id":"paper-w7170680743","cat":"papers","name":"To Be, or Not to Be Exceptional: That Is the Question in Psychedelic Ethics","year":"2026","cit":0,"pfa":"Daniel Villiger","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7170680743","eid":"W7170680743"},{"id":"paper-w4314446251","cat":"papers","name":"Brain health conditions: Excellence in psychedelic treatments","year":"2023","cit":0,"pfa":"Tadeusz Hawrot","psa":"David Badcock","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4314446251","eid":"W4314446251"},{"id":"paper-w4412674613","cat":"papers","name":"Ganzflicker as a Psychedelic Tool: Alpha-Linked Brightening of Visual Hallucinations","year":"2025","cit":0,"pfa":"Pete Carr","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4412674613","eid":"W4412674613"},{"id":"paper-w4412069974","cat":"papers","name":"Ganzflicker as a Psychedelic Tool: Alpha-Linked Brightening of Visual Hallucinations","year":"2025","cit":0,"pfa":"Pete Carr","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4412069974","eid":"W4412069974"},{"id":"paper-w4412665056","cat":"papers","name":"Ganzflicker as a Psychedelic Tool: Alpha-Linked Brightening of Visual Hallucinations","year":"2025","cit":0,"pfa":"Pete Carr","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4412665056","eid":"W4412665056"},{"id":"paper-w4411030141","cat":"papers","name":"ROLE OF PSYCHEDELIC DRUGS IN MENTAL HEALTH CARE: A NARRATIVE REVIEW","year":"2024","cit":0,"pfa":"Tamara Trajbarič","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W4411030141","eid":"W4411030141"},{"id":"paper-w7118494383","cat":"papers","name":"PHARMACOLOGY OF HUMAN EMOTIONS: NEUROCHEMICAL BASIS, DRUG INTERVENTIONS, AND CLINICAL IMPLICATIONS","year":"2026","cit":0,"pfa":"*1Miss. Gayatri Waghmare, 2Dr. Karishma A. Nikose, 3Prof. Suraj P. Rajurkar","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7118494383","eid":"W7118494383"},{"id":"paper-w7164184935","cat":"papers","name":"Progressing from Simple to Multidimensional Models Towards a Biopsychosocial Framework of Addiction","year":"2026","cit":0,"pfa":"Paul S. Regier","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7164184935","eid":"W7164184935"},{"id":"paper-w4406916254","cat":"papers","name":"The future of PsyA-EMDR therapy","year":"2025","cit":0,"pfa":"Hannah Raine-Smith","psa":"Jocelyn Rose","topics":["PTSD & trauma","Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W4406916254","eid":"W4406916254"},{"id":"paper-w7168261237","cat":"papers","name":"The effectiveness of ReAttach Therapy for Fibromyalgia Patients analyzed by the Symptom Amplification Model of Neurolog: A study protocol.","year":"2025","cit":0,"pfa":"Sieto Reitsma","psa":"Aida Mehrad","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7168261237","eid":"W7168261237"},{"id":"paper-w7118282778","cat":"papers","name":"PHARMACOLOGY OF HUMAN EMOTIONS: NEUROCHEMICAL BASIS, DRUG INTERVENTIONS, AND CLINICAL IMPLICATIONS","year":"2026","cit":0,"pfa":"*1Miss. Gayatri Waghmare, 2Dr. Karishma A. Nikose, 3Prof. Suraj P. Rajurkar","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7118282778","eid":"W7118282778"},{"id":"paper-w7157851419","cat":"papers","name":"Secular Mysticism: Entanglements of Science and Religion in Psychedelic Medicine","year":"2026","cit":0,"pfa":"Aidan Seale‐Feldman","topics":["Anxiety & end-of-life","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7157851419","eid":"W7157851419"},{"id":"paper-w4361277420","cat":"papers","name":"Contrary to reason: Documentary film-making and alternative psychotherapies","year":"2023","cit":0,"pfa":"Des O’Rawe","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4361277420","eid":"W4361277420"},{"id":"paper-w7170079378","cat":"papers","name":"Context as Contraindication: Ethical Challenges of Psychedelics and Other Neuroplasticity-Enhancing Drugs","year":"2026","cit":0,"pfa":"Nicolas Langlitz","psa":"Rebecca Gainsley","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7170079378","eid":"W7170079378"},{"id":"paper-w7165042709","cat":"papers","name":"Circuit State–Experience Coupling: A Framework for Durable Psychological Change in Psychiatry","year":"2026","cit":0,"pfa":"Daniel Holguin","topics":["PTSD & trauma"],"ptype":"preprint","src":"https://openalex.org/W7165042709","eid":"W7165042709"},{"id":"paper-w4386515579","cat":"papers","name":"Cultural Biases and Psychedelic Experiences: Western Scientific Perspectives about Amazonian Mestizo Therapeutic Traditions","year":"2023","cit":0,"pfa":"Alberto Dubbini","topics":["Addiction","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4386515579","eid":"W4386515579"},{"id":"paper-w7150792808","cat":"papers","name":"Psychedelics and the person-centered approach: a call for interest and engagement in psychedelic research","year":"2026","cit":0,"pfa":"James Cullen","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W7150792808","eid":"W7150792808"},{"id":"paper-w4403244642","cat":"papers","name":"Updates in palliative care of gynecologic oncology patients","year":"2024","cit":0,"pfa":"Teresa Khoo","psa":"Christopher J. Pietras","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4403244642","eid":"W4403244642"},{"id":"paper-w4412390686","cat":"papers","name":"Metamorphoses: Transformation, Meaning, and the via psychedelica","year":"2025","cit":0,"pfa":"Danny Forde","ptype":"book-chapter","src":"https://openalex.org/W4412390686","eid":"W4412390686"},{"id":"paper-w4386525055","cat":"papers","name":"Evolving antidepressant: from SSRIs to psychedelic","year":"2023","cit":0,"pfa":"Hanyang Hong","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"conference-paper","src":"https://openalex.org/W4386525055","eid":"W4386525055"},{"id":"paper-w7161244694","cat":"papers","name":"Meeting Grandmother: Breakdown, breakthrough, and the fear of madness in psychedelic research","year":"2026","cit":0,"pfa":"Tam Martin Fowles","psa":"Tehseen N. Noorani","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W7161244694","eid":"W7161244694"},{"id":"paper-w4417255321","cat":"papers","name":"Expansion and Regression in Oceanic Experience: A Model of Psychedelic Consciousness for Psychoanalysis","year":"2025","cit":0,"pfa":"Karen Peoples","psa":"Megan Rundel","ptype":"article","src":"https://openalex.org/W4417255321","eid":"W4417255321"},{"id":"paper-w7214225315","cat":"papers","name":"Nourishing the mind from earth to interventions: A resource-centric paradigm in nutritional psychiatry","year":"2026","cit":0,"pfa":"Kuan‐Pin Su","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7214225315","eid":"W7214225315"},{"id":"paper-w4411530214","cat":"papers","name":"Mama Cannabis and the Embodied Feminine: an Ancient Psychedelic for Modern Times","year":"2025","cit":0,"pfa":"Bonnie Glass‐Coffin","psa":"Saundra Shanti","topics":["Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W4411530214","eid":"W4411530214"},{"id":"paper-w7135248338","cat":"papers","name":"Psychedelics and the Pursuit of Human Flourishing: An Examination of Research and Potential Psychological Mechanisms","year":"2023","cit":0,"pfa":"Jonathan Rosemberg Kort","psa":"Jonathan Rosemberg Kort","topics":["Addiction","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W7135248338","eid":"W7135248338"},{"id":"paper-w7165051528","cat":"papers","name":"Attitudes of Mental Healthcare Professionals Towards the Use of Psychedelics in the Treatment of Substance Use Disorders: A Systematic Review","year":"2026","cit":0,"pfa":"F. van Dalen","psa":"Symen Kornelis Spoelstra","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7165051528","eid":"W7165051528"},{"id":"paper-w7113073084","cat":"papers","name":"Science and spirituality : An integrative literature study of psychedelic science and its contributing discourse on medicalization","year":"2023","cit":0,"pfa":"Persson, Amanda","psa":"Sjöberg, Molly","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"dissertation","src":"https://openalex.org/W7113073084","eid":"W7113073084"},{"id":"paper-w7140125644","cat":"papers","name":"Futuristic Approaches to Disarming Nicotine Addiction: A Narrative Review of Emerging Therapies","year":"2026","cit":0,"pfa":"Chetan Vinay Deshmukh","psa":"Shivani Ahirrao","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7140125644","eid":"W7140125644"},{"id":"paper-w7166466685","cat":"papers","name":"T-shaped expertise: rethinking interdisciplinarity in psychedelic research","year":"2026","cit":0,"pfa":"Joost J. Breeksema","psa":"Robert A. Schoevers","topics":["Dosing & pharmacology","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7166466685","eid":"W7166466685"},{"id":"paper-w7135619519","cat":"papers","name":"Influence of personality on the occurence and characteristics of challenging psychedelic experience","year":"2023","cit":0,"pfa":"Sára Kratochvílová","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"dissertation","src":"https://openalex.org/W7135619519","eid":"W7135619519"},{"id":"paper-w4377966646","cat":"papers","name":"Simulated States of Consciousness: Inducing Psychedelic Experiences in Virtual Reality","year":"2023","cit":0,"pfa":"Harman Brar","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"other","src":"https://openalex.org/W4377966646","eid":"W4377966646"},{"id":"paper-w4413198799","cat":"papers","name":"Pluralism and the Future of Therapy","year":"2025","cit":0,"pfa":"Jay Beichman","topics":["Safety & adverse events","Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W4413198799","eid":"W4413198799"},{"id":"paper-w4402510326","cat":"papers","name":"Predictors of attitudes toward psychedelics among psychologists in the USA","year":"2024","cit":0,"pfa":"Jason B. Luoma","psa":"Sarah E. Smith","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4402510326","eid":"W4402510326"},{"id":"paper-w4377967487","cat":"papers","name":"Simulated States of Consciousness: Inducing Psychedelic Experiences in Virtual Reality","year":"2023","cit":0,"pfa":"Harman Brar","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"other","src":"https://openalex.org/W4377967487","eid":"W4377967487"},{"id":"paper-w7140299304","cat":"papers","name":"Recent advances in psychiatric medicines: from rapid-acting antidepressants to precision psychiatry","year":"2025","cit":0,"pfa":"Harish Babbar","psa":"Patil Amit Shekhar","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7140299304","eid":"W7140299304"},{"id":"paper-w4405635568","cat":"papers","name":"Assisted Psychedelic Psychotherapy: Rethinking the Paradigms of Psychiatric Care?","year":"2024","cit":0,"pfa":"Eliana Mea","psa":"Paola Clemente","topics":["Addiction","Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W4405635568","eid":"W4405635568"},{"id":"paper-w4414130188","cat":"papers","name":"Set and setting: The missing factors in Chris Letheby’s psychedelic philosophy","year":"2025","cit":0,"pfa":"Werner F. Smith","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4414130188","eid":"W4414130188"},{"id":"paper-w7137686946","cat":"papers","name":"Psychotherapy in the Third Millennium","year":"2025","cit":0,"pfa":"Federico Durbano","psa":"Barbara Marchesi","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W7137686946","eid":"W7137686946"},{"id":"paper-w4405612040","cat":"papers","name":"Keynote Lecture 2 “Psychedelics in mental health – therapeutic potential and possible brain mechanisms”","year":"2023","cit":0,"pfa":"David Erritzøe","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4405612040","eid":"W4405612040"},{"id":"paper-w7112618652","cat":"papers","name":"Återgången till det obrutna självet : En kvalitativ studie av transformativa psykedeliska upplevelser","year":"2025","cit":0,"pfa":"Tibell, Daniella","topics":["Safety & adverse events","Mechanism & neuroscience","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W7112618652","eid":"W7112618652"},{"id":"paper-w7204616501","cat":"papers","name":"Self-experimentation among psychedelic researchers, facilitators and clinicians","year":"2026","cit":0,"pfa":"Nino Breunesse","psa":"Michiel van Elk","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7204616501","eid":"W7204616501"},{"id":"paper-w4412009788","cat":"papers","name":"From Awareness to Action: Addressing India’s Mental Health Crisis","year":"2024","cit":0,"pfa":"Maj. Meenu Mehrotra","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"book-chapter","src":"https://openalex.org/W4412009788","eid":"W4412009788"},{"id":"paper-w7203849807","cat":"papers","name":"Exploring Black, Indigenous, and other People of Color’s opinions, experiences, and breadth of knowledge on Indigenous psychedelic healing methods for mental health in the United States","year":"2026","cit":0,"pfa":"Daiyah Williams","topics":["Safety & adverse events","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7203849807","eid":"W7203849807"},{"id":"paper-w4415860618","cat":"papers","name":"A Tragedy of Errors: The State of Psychedelic Research in the Treatment of Alcohol Use Disorder","year":"2025","cit":0,"pfa":"A. Benjamin Srivastava","psa":"Mark S. Gold","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4415860618","eid":"W4415860618"},{"id":"paper-w7115184522","cat":"papers","name":"Clinical Frontiers in Psychedelic Research: A Scientometric Review of the Evolving Literature","year":"2025","cit":0,"pfa":"R. Cavallaro","psa":"G. Esposito","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7115184522","eid":"W7115184522"},{"id":"paper-w7214937391","cat":"papers","name":"Neuropharmacology and Psychopharmacology: Evaluating Drug Therapies for Neuropsychiatric Disorders","year":"2025","cit":0,"pfa":"Dr. Neha K","psa":"Tejashwini K C","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7214937391","eid":"W7214937391"},{"id":"paper-w4407755763","cat":"papers","name":"The Contribution of Psychotherapy in Potential Therapeutic Effects of Psychedelics for Treatment of Opioid Use Disorder","year":"2025","cit":0,"pfa":"Anahita Bassir Nia","psa":"Christopher Pittenger","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4407755763","eid":"W4407755763"},{"id":"paper-w7149693213","cat":"papers","name":"A Review on Emerging Trends in the Diagnosis and Treatment of Anxiety Disorders","year":"2026","cit":0,"pfa":"Rajkumar Chaudhary, Nilesh Chauhan*, Saloni Mishra, Abhishek Pratap, Dr. Rahul…","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7149693213","eid":"W7149693213"},{"id":"paper-w4318567258","cat":"papers","name":"Histoire de la psychiatrie À propos de... « Une histoire comparée de la psychiatrie : Henri Ellenberger (1905–1993) » d’Emmanuel Delille","year":"2023","cit":0,"pfa":"Benjamin Lévy","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4318567258","eid":"W4318567258"},{"id":"paper-w7167913745","cat":"papers","name":"Psychedelics, rebirth experiences, and the limits of current research","year":"2026","cit":0,"pfa":"Etienne Artru","topics":["Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7167913745","eid":"W7167913745"},{"id":"paper-w4363645960","cat":"papers","name":"Mood and Anxiety Disorders: Generalized Anxiety and Panic Disorders.","year":"2023","cit":0,"pfa":"Rosa Joseph","psa":"Ashley Wilk","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4363645960","eid":"W4363645960"},{"id":"paper-w7110560149","cat":"papers","name":"Good trips, bad trips: Attachment, connectedness, and mental health in psychedelic experiences","year":"2025","cit":0,"pfa":"Nickley, Sean Michael","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7110560149","eid":"W7110560149"},{"id":"paper-w7112686583","cat":"papers","name":"Examining Perception of Psychedelic Substances and the Role of Hallucinations Among College Students","year":"2025","cit":0,"pfa":"Hilts, Ryann F","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7112686583","eid":"W7112686583"},{"id":"paper-w7166737501","cat":"papers","name":"Ketamine-Augmented Hypnotherapy","year":"2026","cit":0,"pfa":"Dirk Revenstorf","psa":"Martin Schipplick","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"preprint","src":"https://openalex.org/W7166737501","eid":"W7166737501"},{"id":"paper-w4392530116","cat":"papers","name":"EMBARK Mechanisms of Change in the Treatment of Depression","year":"2024","cit":0,"pfa":"Bill Brennan","psa":"Alex Belser","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"book-chapter","src":"https://openalex.org/W4392530116","eid":"W4392530116"},{"id":"paper-w2189500363","cat":"papers","name":"What were, are not and could be for us the substances called psychedelics","year":"2005","cit":0,"pfa":"Michael Vančura","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2189500363","eid":"W2189500363"},{"id":"paper-w4409891543","cat":"papers","name":"What Is Trauma-Informed Therapy Using a Harm-Reduction Lens?","year":"2025","cit":0,"pfa":"Charmaine Husum","topics":["PTSD & trauma","Safety & adverse events","Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W4409891543","eid":"W4409891543"},{"id":"paper-w7149253725","cat":"papers","name":"A Review on Emerging Trends in the Diagnosis and Treatment of Anxiety Disorders","year":"2026","cit":0,"pfa":"Rajkumar Chaudhary, Nilesh Chauhan*, Saloni Mishra, Abhishek Pratap, Dr. Rahul…","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7149253725","eid":"W7149253725"},{"id":"paper-w7203649155","cat":"papers","name":"The confidence reorientation account: psychedelics, self-model precision, and death anxiety","year":"2026","cit":0,"pfa":"Fuyao Zhang","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7203649155","eid":"W7203649155"},{"id":"paper-w7135477625","cat":"papers","name":"The phenomenon of psychonautics in addictology: motivation, patterns and consequences of use of psychoactive substances from the perspective of psychonauts","year":"2015","cit":0,"pfa":"Barbora Stifterová","topics":["Addiction","Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W7135477625","eid":"W7135477625"},{"id":"paper-w7127364078","cat":"papers","name":"Can a brief educational programme affect Chinese American mental health providers' attitudes towards psychedelics?","year":"2026","cit":0,"pfa":"Huiqiong Deng","topics":["Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7127364078","eid":"W7127364078"},{"id":"paper-w7154894783","cat":"papers","name":"Management of Treatment-Resistant Depression: An Updated Narrative Review of Current and Emerging Treatments","year":"2026","cit":0,"pfa":"Juan Pablo Berlin Viniegra","topics":["Depression","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7154894783","eid":"W7154894783"},{"id":"paper-w7125963380","cat":"papers","name":"Mechanisms and management of treatment-resistant depression in clinical psychiatry","year":"2026","cit":0,"pfa":"Suhail Ahmad Khan","psa":"Hadi Aldoulah","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7125963380","eid":"W7125963380"},{"id":"paper-w7162185445","cat":"papers","name":"The Philosophical Foundations of Psychotherapy: Ontology, Epistemology, and the Theory of the Subject Across Traditions","year":"2026","cit":0,"pfa":"Vassilis Papathanasiou","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7162185445","eid":"W7162185445"},{"id":"paper-w7126056635","cat":"papers","name":"Post-Traumatic Growth Following Psychological Interventions for PTSD or trauma exposure survivors: A Scoping Review","year":"2026","cit":0,"pfa":"Gene Solomon Feder","psa":"Giovanna Saad Gimenes","topics":["PTSD & trauma","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7126056635","eid":"W7126056635"},{"id":"paper-w4413389116","cat":"papers","name":"The therapeutic use of psychedelic drugs: Legal, policy, and neuroscientific perspectives","year":"2025","cit":0,"pfa":"Shadan Rahmani","psa":"Terry L. Davidson","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4413389116","eid":"W4413389116"},{"id":"paper-w4396813935","cat":"papers","name":"Genetic risk for psychosis may be responsible for manic symptoms from psychedelics","year":"2024","cit":0,"pfa":"Alison Knopf","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4396813935","eid":"W4396813935"},{"id":"paper-w4416893672","cat":"papers","name":"Standing in the Gap: Psychedelic Advocacy, Communities of Color, and the Politics of Knowledge Production","year":"2025","cit":0,"pfa":"Tina Kempin Reuter","psa":"Lisa L. Gezon","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4416893672","eid":"W4416893672"},{"id":"paper-w7204471430","cat":"papers","name":"Prioritizing Sense of Coherence in Healthcare: A Stepping Stone for Enhanced Patient Outcomes and Novel Psychosocial Techniques","year":"2026","cit":0,"pfa":"Ali Abbas","psa":"N. Tran","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W7204471430","eid":"W7204471430"},{"id":"paper-w4402350517","cat":"papers","name":"Psychedelics and autobiographical memory – Six open questions","year":"2024","cit":0,"pfa":"Samuli Kangaslampi","psa":"Morten P. Lietz","topics":["PTSD & trauma","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4402350517","eid":"W4402350517"},{"id":"paper-w7162185872","cat":"papers","name":"The Philosophical Foundations of Psychotherapy: Ontology, Epistemology, and the Theory of the Subject Across Traditions","year":"2026","cit":0,"pfa":"Vassilis Papathanasiou","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7162185872","eid":"W7162185872"},{"id":"paper-w4394814452","cat":"papers","name":"Researchers consider links between genetics and psychosis in teen use of psychedelics","year":"2024","cit":0,"pfa":"Alison Knopf","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4394814452","eid":"W4394814452"},{"id":"paper-w4415597220","cat":"papers","name":"The GABAergic Gateway: A Chemist's Hypothesis for Psychedelic Mechanisms","year":"2025","cit":0,"pfa":"Julian D. Rolfes","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"preprint","src":"https://openalex.org/W4415597220","eid":"W4415597220"},{"id":"paper-w4411024641","cat":"papers","name":"Natural Guardians of the Balkans: Entheogens in Indigenous Practices and Their Implications for Well-Being and Therapy","year":"2025","cit":0,"pfa":"Lucija Vejmelka","psa":"Damir Gašpar","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4411024641","eid":"W4411024641"},{"id":"paper-w7157887436","cat":"papers","name":"Psychedelic Use and Mystical-Type Experiences are Associated With Greater Self-Compassion, Compassionate Love, and Life Satisfaction","year":"2026","cit":0,"pfa":"Austin J. Mallard","psa":"Broc A. Pagni","ptype":"article","src":"https://openalex.org/W7157887436","eid":"W7157887436"},{"id":"paper-w7172563693","cat":"papers","name":"BREAKING THROUGH: DISCOVERING SOLUTIONS FOR PSYCHIATRIC ILLNESSES WITH KETAMINE","year":"2026","cit":0,"pfa":"David DeLaRosa","psa":"David DeLaRosa","topics":["Depression","Mechanism & neuroscience","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W7172563693","eid":"W7172563693"},{"id":"paper-w4283642546","cat":"papers","name":"Meeting Sessions Discuss the Mechanisms and Necessity of Psychedelic ‘Tripping’","year":"2022","cit":0,"pfa":"Nick Zagorski","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"other","src":"https://openalex.org/W4283642546","eid":"W4283642546"},{"id":"paper-w4200503569","cat":"papers","name":"Psychedelic Science of Spirituality and Religion: An Attachment-Informed Agenda Proposal","year":"2021","cit":0,"pfa":"Aaron D. Cherniak","psa":"Pehr Granqvist","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4200503569","eid":"W4200503569"},{"id":"paper-w4417358931","cat":"papers","name":"The Double-Blind Randomized Controlled Trial as the Gold Standard in Psychedelic Research: Neither Feasible Nor Desirable","year":"2025","cit":0,"pfa":"Daniel Villiger","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4417358931","eid":"W4417358931"},{"id":"paper-w7127368929","cat":"papers","name":"Can a brief educational programme affect Chinese American mental health providers' attitudes towards psychedelics?","year":"2026","cit":0,"pfa":"Huiqiong Deng","topics":["Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7127368929","eid":"W7127368929"},{"id":"paper-w4413198639","cat":"papers","name":"Pluralism in Counselling and Psychotherapy","year":"2025","cit":0,"pfa":"Jay Beichman","topics":["Therapy practice","Policy & ethics"],"ptype":"book","src":"https://openalex.org/W4413198639","eid":"W4413198639"},{"id":"paper-w3081258558","cat":"papers","name":"[Neuroscientific and psychological explanations for the therapeutic effects of psychedelics].","year":"2020","cit":0,"pfa":"Michiel van Elk","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3081258558","eid":"W3081258558"},{"id":"paper-w7207765322","cat":"papers","name":"Ketamine combined with structured psychological therapy for chronic pain with comorbid depression","year":"2026","cit":0,"pfa":"N Terblanche","psa":"Annika Wilson","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"other","src":"https://openalex.org/W7207765322","eid":"W7207765322"},{"id":"paper-w4401245743","cat":"papers","name":"Dealing with invisible scars of war: PTSD in Veterans","year":"2023","cit":0,"pfa":"Alexandra Dimitrova","topics":["PTSD & trauma","Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4401245743","eid":"W4401245743"},{"id":"paper-w7162798424","cat":"papers","name":"Innovations in Depression Diagnosis and Treatment: A Review of Biological, Cognitive, and Psychosocial Advances","year":"2026","cit":0,"pfa":"Guizhen Lyu","psa":"Dongbing Li","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7162798424","eid":"W7162798424"},{"id":"paper-w7106112770","cat":"papers","name":"Shedding the self : ego-death and positive psychological transformation in naturalistic psychedelic use.","year":"2025","cit":0,"pfa":"Scott, Hayleigh","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"dissertation","src":"https://openalex.org/W7106112770","eid":"W7106112770"},{"id":"paper-w7127241571","cat":"papers","name":"Below to Beyond Human: Social Death to Ego Birth During The Black Psychedelic Experience","year":"2025","cit":0,"pfa":"Angelica Medina","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W7127241571","eid":"W7127241571"},{"id":"paper-w4366599096","cat":"papers","name":"Self-reported effects of classic psychedelics on stuttering","year":"2023","cit":0,"pfa":"Noah D. Gold","psa":"Eric S. Jackson","ptype":"preprint","src":"https://openalex.org/W4366599096","eid":"W4366599096"},{"id":"paper-w7163175703","cat":"papers","name":"Priorities for psychedelic research among people who use psychedelics","year":"2026","cit":0,"pfa":"Daniel J. Kruger","psa":"Kevin F. Boehnke","ptype":"article","src":"https://openalex.org/W7163175703","eid":"W7163175703"},{"id":"paper-w7172326189","cat":"papers","name":"Molecules, meaning, and physiology: disentangling the active ingredients of psychedelic therapeutics","year":"2026","cit":0,"pfa":"Kim P. C. Kuypers","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7172326189","eid":"W7172326189"},{"id":"paper-w7170091126","cat":"papers","name":"Psychedelics in Mental Health: Opportunities and Challenges","year":"2026","cit":0,"pfa":"Raffaella Bosurgi","psa":"Lena Oestreich","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W7170091126","eid":"W7170091126"},{"id":"paper-w7126066992","cat":"papers","name":"From Brain to Behavior: Mechanistic and Therapeutic Insights into Mood and Anxiety Disorders","year":"2026","cit":0,"pfa":"Harshit Shringi","psa":"Satyaendra Shrivastava","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7126066992","eid":"W7126066992"},{"id":"paper-w7205882209","cat":"papers","name":"European Citizens Initiative: PsychedeliCare","year":"2025","cit":0,"pfa":"Bárbara Inés Messias","topics":["Safety & adverse events","Therapy practice","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W7205882209","eid":"W7205882209"},{"id":"paper-w7128953539","cat":"papers","name":"From Soul to Science: The Evolution of Psychedelics and the Future of Health, Healing, and Wellbeing in Surf Culture","year":"2026","cit":0,"pfa":"Jarrett Robert Rose","ptype":"book-chapter","src":"https://openalex.org/W7128953539","eid":"W7128953539"},{"id":"paper-w7117303404","cat":"papers","name":"PHARMACOLOGICAL TREATMENT OF PTSD WITH PSYCHEDELICS: A FUTURE OUTLOOK","year":"2025","cit":0,"pfa":"Michal Gorski","psa":"Maria Gierasimiuk","topics":["PTSD & trauma","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7117303404","eid":"W7117303404"},{"id":"paper-w2382658010","cat":"papers","name":"EFFECT OF KETAMINE ON PERIOPERATIVE ANALGESIA AND COGNITIVE FUNCTION IN PARTURIENTS UNDERGOING CESAREAN SECTION","year":"2013","cit":0,"pfa":"Xiao Zhang","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2382658010","eid":"W2382658010"},{"id":"paper-w7168122244","cat":"papers","name":"Systems-based psychiatry: insights from psychedelic research on mechanisms of healing","year":"2026","cit":0,"pfa":"Scott Shannon","psa":"Andrew Weil","topics":["Safety & adverse events","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7168122244","eid":"W7168122244"},{"id":"paper-w4372353234","cat":"papers","name":"Quantitative, qualitative and located therapeutic experiences with psilocibious fungal microdosis","year":"2023","cit":0,"pfa":"Nicolás Valente","psa":"Nicolás Lavagnino","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4372353234","eid":"W4372353234"},{"id":"paper-w7130510860","cat":"papers","name":"Ketamine as a Mental Health Treatment","year":"2026","cit":0,"pfa":"Liz Braun","psa":"Alison M. Colbert","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7130510860","eid":"W7130510860"},{"id":"paper-w4412751218","cat":"papers","name":"Toward a definition of treatment-resistant posttraumatic stress disorder: A systematic review","year":"2025","cit":0,"pfa":"Huda F. Al-Shamali","psa":"Venkat Bhat","topics":["Depression","PTSD & trauma","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W4412751218","eid":"W4412751218"},{"id":"paper-w7213608092","cat":"papers","name":"Placebo-induced Altered States of Consciousness – A Proof-of-Concept Study of a Psychedelic Placebo Intervention","year":"2026","cit":0,"pfa":"Lukas Andreas Basedow","psa":"Christoph Vogelbacher","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7213608092","eid":"W7213608092"},{"id":"paper-w7129008892","cat":"papers","name":"Psychedelics and Centering Prayer","year":"2026","cit":0,"pfa":"Brian Rajcok","ptype":"article","src":"https://openalex.org/W7129008892","eid":"W7129008892"},{"id":"paper-w7167335758","cat":"papers","name":"Pathophysiological and Therapeutic Association between Brain-Gut Axis and Irritable Bowel Syndrome: A Systematic Review","year":"2026","cit":0,"pfa":"Usman Farooq","psa":"Shaista Arshad Jarral","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W7167335758","eid":"W7167335758"},{"id":"paper-w4415904944","cat":"papers","name":"Modulation of Religious and Spiritual Neural Networks for Improving Mental Health","year":"2025","cit":0,"pfa":"William J. Tyler","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W4415904944","eid":"W4415904944"},{"id":"paper-w7131373331","cat":"papers","name":"Current Advances in The Diagnosis and Treatment of Mood Disorders","year":"2026","cit":0,"pfa":"Misal Shivdarshan*, Kshirsagar Pankaj, Dr. Giri Ashok","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7131373331","eid":"W7131373331"},{"id":"paper-w7164591652","cat":"papers","name":"Becoming a Psychedelic Therapist: A Professional Identity Journey","year":"2026","cit":0,"pfa":"Matthew Pennell","psa":"Louise Horstmanshof","topics":["Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7164591652","eid":"W7164591652"},{"id":"paper-w7214209187","cat":"papers","name":"Ecstatic profits. A socio-legal analysis of the commodification of indigenous peoples’ knowledge in the era of the ‘psychedelic renaissance’","year":"2026","cit":0,"pfa":"Helene Nyländen","topics":["Addiction","Mechanism & neuroscience","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W7214209187","eid":"W7214209187"},{"id":"paper-w7131423032","cat":"papers","name":"Current Advances in The Diagnosis and Treatment of Mood Disorders","year":"2026","cit":0,"pfa":"Misal Shivdarshan*, Kshirsagar Pankaj, Dr. Giri Ashok","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7131423032","eid":"W7131423032"},{"id":"paper-w7127411719","cat":"papers","name":"(PNM-42) Use of psychedelic drugs as an adjunct in couples psychotherapy and sex therapy","year":"2026","cit":0,"pfa":"F N Pereira","psa":"E B B Cruz","topics":["PTSD & trauma","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7127411719","eid":"W7127411719"},{"id":"paper-w7165542537","cat":"papers","name":"Decoding the serotonin–alcohol crosstalk: the role of central serotonergic dysregulation in alcohol use disorder","year":"2026","cit":0,"pfa":"Magdalena Zaniewska","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7165542537","eid":"W7165542537"},{"id":"paper-w4410997733","cat":"papers","name":"Deanna M. Kaplan: Listening to daily life: exploring speech data, shared meaning, and generative artificial intelligence (AI) in clinical science","year":"2025","cit":0,"pfa":"Deanna M. Kaplan","topics":["Mechanism & neuroscience","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4410997733","eid":"W4410997733"},{"id":"paper-w7130436081","cat":"papers","name":"Magnitude of response in treatment and control groups within psychedelic trials for psychiatric disorders: A meta-analysis","year":"2026","cit":0,"pfa":"Shakila Meshkat","psa":"Venkat Bhat","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"review","src":"https://openalex.org/W7130436081","eid":"W7130436081"},{"id":"paper-w7167501563","cat":"papers","name":"Policy pathways and historical insights: Canada's evolving approach to psychedelic access for end-of-life distress","year":"2026","cit":0,"pfa":"Sarah Kratina","psa":"Brian Rush","topics":["Addiction","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7167501563","eid":"W7167501563"},{"id":"paper-w7167699576","cat":"papers","name":"Beyond access: The SIGNAL model of internal guidance in psychedelic preparation and integration","year":"2026","cit":0,"pfa":"Stacy Rush","topics":["PTSD & trauma","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7167699576","eid":"W7167699576"},{"id":"paper-w7110922811","cat":"papers","name":"A Systematic Review of Therapeutic Potential of Illicit Drugs: A Narrative Overview of How Cannabinoids and Psychedelics Can be Used in Medicine","year":"2022","cit":0,"pfa":"Sajedeh Rabipour","psa":"Maryam Afsharkhas","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W7110922811","eid":"W7110922811"},{"id":"paper-w7170910016","cat":"papers","name":"KETAMINE IN THE TREATMENT OF DEPRESSION - A REVIEW ARTICLE","year":"2026","cit":0,"pfa":"Olga Szeidl","psa":"Anna Cupiał","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7170910016","eid":"W7170910016"},{"id":"paper-w7199567003","cat":"papers","name":"Microdosing classical psychedelics in a therapeutic context","year":"2022","cit":0,"pfa":"Ada-Karoliina Määttä","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7199567003","eid":"W7199567003"},{"id":"paper-w7130928574","cat":"papers","name":"How does the internal family systems model of psychotherapy support clients in the integration of their psychedelic experiences? An interpretative phenomenological analysis of clients' testimonies","year":"2026","cit":0,"pfa":"Sophie Sarrassat","psa":"Suzannah Hill","topics":["Safety & adverse events","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7130928574","eid":"W7130928574"},{"id":"paper-w4412587476","cat":"papers","name":"The effect of psychedelics on associative learning: A systematic review","year":"2026","cit":0,"pfa":"Alice Caulfield","psa":"Mitul Ashok Mehta","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4412587476","eid":"W4412587476"},{"id":"paper-w4410200688","cat":"papers","name":"Exploring psychedelic experiences among people who regularly use methamphetamine: Findings from an international survey","year":"2025","cit":0,"pfa":"Dilara Bahceci","psa":"Jonathan Brett","ptype":"article","src":"https://openalex.org/W4410200688","eid":"W4410200688"},{"id":"paper-w7162489696","cat":"papers","name":"Next-Generation Pharmacotherapy for Depressive Disorders: From Novel Compounds to Optimized Use of Available Drugs","year":"2026","cit":0,"pfa":"Fan Bu","psa":"Yi Wen","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7162489696","eid":"W7162489696"},{"id":"paper-w7162318968","cat":"papers","name":"Exploring Knowledge, Attitudes and Openness toward Psychedelics among Medical and Psychology Students in a Conservative Cultural Setting","year":"2026","cit":0,"pfa":"Mai Albaik","psa":"Samratul Fuadah","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7162318968","eid":"W7162318968"},{"id":"paper-w7165728379","cat":"papers","name":"Mechanistic insights toward dissociating therapeutic from psychedelic effects: bridging the gap between psychedelic research and mental health care","year":"2026","cit":0,"pfa":"Mauro Pettorruso","psa":"Giovanni Martinotti","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7165728379","eid":"W7165728379"},{"id":"paper-w7106649583","cat":"papers","name":"The Role of Relational Healing in Psychedelics: A Comparative Study","year":"2025","cit":0,"pfa":"Murray, Wallace","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W7106649583","eid":"W7106649583"},{"id":"paper-w4414346217","cat":"papers","name":"Tripping on Utopia: Margaret Mead, the Cold War, and the Troubled Birth of Psychedelic Science","year":"2025","cit":0,"pfa":"Robert C. Cottrell","ptype":"article","src":"https://openalex.org/W4414346217","eid":"W4414346217"},{"id":"paper-w7164883867","cat":"papers","name":"Psychodynamic Perspectives on Psychedelic States and Treatment Contexts: A Conceptual and Clinical Introduction","year":"2026","cit":0,"pfa":"Nadav Liam Modlin","psa":"Jeffrey R. Guss","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7164883867","eid":"W7164883867"},{"id":"paper-w4406387846","cat":"papers","name":"The mindful use of psychiatric medication: Report from the Tel Aviv Psychoactive Clinic Project and a proposed model for psychiatric care","year":"2025","cit":0,"pfa":"Ido Hartogsohn","psa":"Omry Ben Ezra","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4406387846","eid":"W4406387846"},{"id":"paper-w7213505748","cat":"papers","name":"Pharmaceutical and Medical Management of Substance Use Disorders: A Narrative Review","year":"2026","cit":0,"pfa":"Esmaeil Musa","psa":"Mhmuod Zughdani","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W7213505748","eid":"W7213505748"},{"id":"paper-w7165521270","cat":"papers","name":"PHARMACOTHERAPY IN MUSCLE DYSMORPHIC DISORDER: CLINICAL CONSIDERATIONS AND THE LIMITS OF EXTRAPOLATING EVIDENCE FROM BODY DYSMORPHIC DISORDER","year":"2026","cit":0,"pfa":"Anna Łęczycka","psa":"Iga Suchta","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7165521270","eid":"W7165521270"},{"id":"paper-w7172205922","cat":"papers","name":"Clinical Approaches to Non-Ordinary Experiences (NOEs): scoping review and bibliometric analysis","year":"2026","cit":0,"pfa":"Everton de Oliveira Maraldi","psa":"Homero Vallada","topics":["Reviews & meta-analyses","Therapy practice","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W7172205922","eid":"W7172205922"},{"id":"paper-w7202170871","cat":"papers","name":"Songs of the Self: Autobiographically Salient Music Modulates Emotion, Altered States of Consciousness, and Well-Being","year":"2026","cit":0,"pfa":"David Rosen","psa":"Riddhima Chandra","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7202170871","eid":"W7202170871"},{"id":"paper-w7151893788","cat":"papers","name":"Clinical Approaches to Non-Ordinary Experiences (NOEs): scoping review and bibliometric analysis","year":"2026","cit":0,"pfa":"Everton de Oliveira Maraldi","psa":"Homero Vallada","topics":["Reviews & meta-analyses","Therapy practice","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W7151893788","eid":"W7151893788"},{"id":"paper-w7212279223","cat":"papers","name":"Studying the Molecule, Assuming the Experience: The Pharmacology–Experience Asymmetry Framework for Psychedelic Research","year":"2026","cit":0,"pfa":"Damián Pobihuszka","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7212279223","eid":"W7212279223"},{"id":"paper-w4416063020","cat":"papers","name":"PTSD","year":"2025","cit":0,"pfa":"Hailan Yang","topics":["PTSD & trauma","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4416063020","eid":"W4416063020"},{"id":"paper-w4388648098","cat":"papers","name":"Is Ketamine Infusion an Effective Treatment for Post-Traumatic Stress Disorder? A Meta-Analysis","year":"2023","cit":0,"pfa":"Cyrus Mowdawalla","psa":"Noud van Helmond","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4388648098","eid":"W4388648098"},{"id":"paper-w7127579492","cat":"papers","name":"Age-related moderation of adjunctive psychotherapy and early life stress effects on depression symptom reductions following ketamine treatment: Initial insights from a large, naturalistic sample","year":"2026","cit":0,"pfa":"Raquel Kosted","psa":"Gregory A. Fonzo","topics":["Depression","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7127579492","eid":"W7127579492"},{"id":"paper-w7214963252","cat":"papers","name":"PSYCHIATRY The Case for Starting Over","year":"2026","cit":0,"pfa":"Abraham Peled","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7214963252","eid":"W7214963252"},{"id":"paper-w4403524446","cat":"papers","name":"Observational cohort study of a group-based VR program to improve mental health and wellbeing in people with life-threatening illnesses","year":"2024","cit":0,"pfa":"Joe Hardy","psa":"Leor Roseman","topics":["Depression","Anxiety & end-of-life","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4403524446","eid":"W4403524446"},{"id":"paper-w4388735974","cat":"papers","name":"Vermont Stakeholder Views Regarding Psychedelics in 2023","year":"2023","cit":0,"pfa":"Henry Mitchell","psa":"jonah levine","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"conference-paper","src":"https://openalex.org/W4388735974","eid":"W4388735974"},{"id":"paper-w7162885988","cat":"papers","name":"From Altered States to Well-Being: A Mechanistic Model about Acceptance and Experiential Avoidance in High Ventilation Breathwork","year":"2026","cit":0,"pfa":"Lena Erdmann","psa":"Michael A. Rapp","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"other","src":"https://openalex.org/W7162885988","eid":"W7162885988"},{"id":"paper-w7204166605","cat":"papers","name":"Ketamine Therapy for Post-Traumatic Stress Disorder A Structured Evidence Synthesis of Randomized Trials and Systematic Reviews Through August 2026","year":"2026","cit":0,"pfa":"Michael Alvear","topics":["PTSD & trauma","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7204166605","eid":"W7204166605"},{"id":"paper-w7166724072","cat":"papers","name":"Inducing Psychedelic-Like States Through Brain Stimulation: A Review of Mechanisms, Clinical Evidence, and Psychotherapeutic Implications","year":"2026","cit":0,"pfa":"Sunandan Banerjee","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7166724072","eid":"W7166724072"},{"id":"paper-w7131683255","cat":"papers","name":"Predictors of the Effectiveness of Psychedelics in Treating Depression—A Scoping Review","year":"2026","cit":0,"pfa":"James Chmiel","psa":"Filip Rybakowski","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7131683255","eid":"W7131683255"},{"id":"paper-w7166710587","cat":"papers","name":"Psychedelic-Informed Approaches in Forensic Psychiatry: A Systematic Review of Therapeutic Promise, Risk, and Feasibility Within UK Services","year":"2026","cit":0,"pfa":"Sunandan Banerjee","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W7166710587","eid":"W7166710587"},{"id":"paper-w4387734606","cat":"papers","name":"Abstracts for the 2023 Cannabis Clinical Outcomes Research Conference (CCORC)","year":"2023","cit":0,"topics":["Therapy practice"],"ptype":"conference-abstract","src":"https://openalex.org/W4387734606","eid":"W4387734606"},{"id":"paper-w4399442204","cat":"papers","name":"The mechanism of action in a spontaneous resolution of chronic depression, anxiety, and burnout—a retrospective case study","year":"2024","cit":0,"pfa":"Mika Turkia","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"preprint","src":"https://openalex.org/W4399442204","eid":"W4399442204"},{"id":"paper-w4285496693","cat":"papers","name":"Neural Correlates of the DEEPP (Anti-suicidal Response to Ketamine in Treatment-Resistant Bipolar Depression) Study: Protocol for a Pilot, Open-Label Clinical Trial (Preprint)","year":"2022","cit":0,"pfa":"Yuliya Knyahnytska","psa":"Daniel M. Blumberger","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4285496693","eid":"W4285496693"},{"id":"paper-w4392214791","cat":"papers","name":"End of Life, Aid in Dying, Harm Reduction Among Ethics Track Topics","year":"2024","cit":0,"pfa":"Mark Moran","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4392214791","eid":"W4392214791"},{"id":"paper-w7147328187","cat":"papers","name":"Ketamine-Based Anesthesia for Orthopaedic and Trauma Surgery in a Regional Trauma Centre: A Pragmatic Service Delivery Model","year":"2026","cit":0,"pfa":"Lukman Olalekan Ajiboye","psa":"Abdullallahi Bello Galadima","topics":["PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7147328187","eid":"W7147328187"},{"id":"paper-w7212042472","cat":"papers","name":"575. A scoping review: ketamine or esketamine when used to assist psychotherapy or in combination with psychotherapy for the management of depression","year":"2026","cit":0,"pfa":"Jennifer Swainson","psa":"Cláudio N. Soares","topics":["Depression","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"conference-abstract","src":"https://openalex.org/W7212042472","eid":"W7212042472"},{"id":"paper-w7161253856","cat":"papers","name":"Somatic symptoms and sensory dysregulation are central to the clinical presentation of PTSD","year":"2026","cit":0,"pfa":"Bessel A. van der Kolk","psa":"ALEXANDER COWELL McFARLANE","topics":["PTSD & trauma","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7161253856","eid":"W7161253856"},{"id":"paper-w3008254903","cat":"papers","name":"Let’s Talk About Psychotherapy","year":"2020","cit":0,"pfa":"David L. Mintz","topics":["PTSD & trauma","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3008254903","eid":"W3008254903"},{"id":"paper-w2907642214","cat":"papers","name":"Psychiatry: My Answer to Reincarnation","year":"2019","cit":0,"pfa":"Uyen-Khanh Quang-Dang","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2907642214","eid":"W2907642214"},{"id":"paper-w4402071842","cat":"papers","name":"Editorial: Bridging the gap: an interdisciplinary perspective on ketamine in psychiatric disorders – volume II","year":"2024","cit":0,"pfa":"Glenn Hartelius","psa":"Lucie Bartova","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"editorial","src":"https://openalex.org/W4402071842","eid":"W4402071842"},{"id":"paper-w2988416658","cat":"papers","name":"Psycho-Oncologists Open Minds to Role of Mental Health in Patient Outcomes","year":"2019","cit":0,"pfa":"Chuck Holt","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2988416658","eid":"W2988416658"},{"id":"paper-w3209848557","cat":"papers","name":"Special Report: Management of Major Depression—Yesterday, Today, and Tomorrow","year":"2021","cit":0,"pfa":"Charles B. Nemeroff","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W3209848557","eid":"W3209848557"},{"id":"paper-w4300833018","cat":"papers","name":"PSYCHEDELICS (Hallucinogens).","year":"1964","cit":0,"pfa":"Hanley Fw","ptype":"article","src":"https://openalex.org/W4300833018","eid":"W4300833018"},{"id":"paper-w4233086540","cat":"papers","name":"Psychedelics and hallucinogens","year":"2013","cit":0,"pfa":"Cambridge Educational Productions, Charleston, WV, US","ptype":"dataset","src":"https://openalex.org/W4233086540","eid":"W4233086540"},{"id":"paper-w4388364308","cat":"papers","name":"Psychedelics and hallucinogens","year":"2009","cit":0,"pfa":"Philip Robson","topics":["Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W4388364308","eid":"W4388364308"},{"id":"paper-w7126619419","cat":"papers","name":"Microdosing Hallucinogens/ Psychedelics: Trends and Practices Among College Students and Young Adults","year":"2025","cit":0,"pfa":"Victoria Szydlowski","topics":["Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7126619419","eid":"W7126619419"},{"id":"paper-w7110695462","cat":"papers","name":"Microdosing Psychedelics","year":"2020","cit":0,"pfa":"Richard James Stevenson","psa":"Vince Polito","topics":["Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7110695462","eid":"W7110695462"},{"id":"paper-w7211430008","cat":"papers","name":"Psychedelic Microdosing","year":"2020","cit":0,"pfa":"Margit Anne Petersen","topics":["Dosing & pharmacology"],"ptype":"report","src":"https://openalex.org/W7211430008","eid":"W7211430008"},{"id":"paper-w2476672343","cat":"papers","name":"Hallucinogens (Psychedelic Drugs)","year":"2013","cit":0,"pfa":"VV Pillay","ptype":"book-chapter","src":"https://openalex.org/W2476672343","eid":"W2476672343"},{"id":"paper-w3005562174","cat":"papers","name":"Hallucinogens, Psychedelics, and Cannabinoids","year":"2015","cit":0,"pfa":"Robert H. Powers","psa":"Dorothy E. Dean","topics":["Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W3005562174","eid":"W3005562174"},{"id":"paper-w4386021500","cat":"papers","name":"Entheogens: Psychedelic religion in the United States, part one","year":"2023","cit":0,"pfa":"Brad Stoddard","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4386021500","eid":"W4386021500"},{"id":"paper-w2907895166","cat":"papers","name":"Psychedelics and Entheogens : Implications of Administration in Medical and Non-Medical Contexts","year":"2018","cit":0,"pfa":"Hannah R. Kirk","ptype":"dissertation","src":"https://openalex.org/W2907895166","eid":"W2907895166"},{"id":"paper-w4390552732","cat":"papers","name":"Review for \"Entheogens: Psychedelic religion in the United States, part two\"","year":"2023","cit":0,"topics":["Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4390552732","eid":"W4390552732"},{"id":"paper-w4390554667","cat":"papers","name":"Review for \"Entheogens: Psychedelic religion in the United States, part two\"","year":"2023","cit":0,"topics":["Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4390554667","eid":"W4390554667"},{"id":"paper-w4390554025","cat":"papers","name":"Review for \"Entheogens: Psychedelic religion in the United States, part two\"","year":"2023","cit":0,"topics":["Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4390554025","eid":"W4390554025"},{"id":"paper-w3109289661","cat":"papers","name":"Hallucinogens (Psychotomimetics) and Marijuana","year":"2018","cit":0,"pfa":"Thomas A. Gossel","psa":"Jordi Bricker","ptype":"article","src":"https://openalex.org/W3109289661","eid":"W3109289661"},{"id":"paper-w4214657826","cat":"papers","name":"MICRODOSING PSYCHEDELICS - LSD, WHERE COULD IT GO?","year":"2019","cit":0,"pfa":"Sara Penedos","psa":"António Gamito","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W4214657826","eid":"W4214657826"},{"id":"paper-w4390551924","cat":"papers","name":"Decision letter for \"Entheogens: Psychedelic religion in the United States, part two\"","year":"2023","cit":0,"ptype":"peer-review","src":"https://openalex.org/W4390551924","eid":"W4390551924"},{"id":"paper-w4239290158","cat":"papers","name":"Entheogen","year":"2010","cit":0,"pfa":"Bart A. Ellenbroek","psa":"Oliver Stiedl","ptype":"reference-entry","src":"https://openalex.org/W4239290158","eid":"W4239290158"},{"id":"paper-w4390552201","cat":"papers","name":"Author response for \"Entheogens: Psychedelic religion in the United States, part two\"","year":"2023","cit":0,"pfa":"Brad Stoddard","ptype":"peer-review","src":"https://openalex.org/W4390552201","eid":"W4390552201"},{"id":"paper-w4401546602","cat":"papers","name":"The Psychedelic-Rhizomatic Knowledge Network: Resistant Discourse about Microdosing Psychedelics in DoubleBlind Magazine","year":"2024","cit":0,"pfa":"Chloe Dolgin","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4401546602","eid":"W4401546602"},{"id":"paper-w4390552555","cat":"papers","name":"Decision letter for \"Entheogens: Psychedelic religion in the United States, part two\"","year":"2023","cit":0,"ptype":"peer-review","src":"https://openalex.org/W4390552555","eid":"W4390552555"},{"id":"paper-w3011714143","cat":"papers","name":"Self-Medication With Psychedelic Microdoses Amongst Microdosers With Disorders","year":"2019","cit":0,"pfa":"Nadia R. P. W. Hutten","psa":"Kim P. C. Kuypers","topics":["Dosing & pharmacology"],"ptype":"conference-paper","src":"https://openalex.org/W3011714143","eid":"W3011714143"},{"id":"paper-w4407626362","cat":"papers","name":"Correction. Modern Psychedelic Microdosing Research on Mental Health","year":"2025","cit":0,"topics":["Dosing & pharmacology"],"ptype":"erratum","src":"https://openalex.org/W4407626362","eid":"W4407626362"},{"id":"paper-w4297493195","cat":"papers","name":"Psychedelic microdosing hits a rough patch in clinical trials","year":"2022","cit":0,"pfa":"Benjamin Plackett","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4297493195","eid":"W4297493195"},{"id":"paper-w4234705732","cat":"papers","name":"Hallucinogens","year":"2008","cit":0,"pfa":"David E. Nichols","ptype":"reference-entry","src":"https://openalex.org/W4234705732","eid":"W4234705732"},{"id":"paper-w4246871730","cat":"papers","name":"Psychedelics/Psychotomimetics/Hallucinogenics","year":"2013","cit":0,"pfa":"Richard B Seymour","psa":"David E Smith","ptype":"book-chapter","src":"https://openalex.org/W4246871730","eid":"W4246871730"},{"id":"paper-w4414840950","cat":"papers","name":"PSYCHEDELIC HALLUCINOGENS IN YOUTH: HISTORY, CURRENT PERCEPTIONS, AND FUTURE RISK","year":"2025","cit":0,"pfa":"David Louis Atkinson","psa":"Christopher Joseph Hammond","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4414840950","eid":"W4414840950"},{"id":"paper-w4249642299","cat":"papers","name":"Hallucinogens","year":"2015","cit":0,"pfa":"David E. Nichols","ptype":"reference-entry","src":"https://openalex.org/W4249642299","eid":"W4249642299"},{"id":"paper-w4230644667","cat":"papers","name":"Entheogens","year":"2020","cit":0,"pfa":"Virgil Zeigler‐Hill","psa":"Todd K. Shackelford","ptype":"reference-entry","src":"https://openalex.org/W4230644667","eid":"W4230644667"},{"id":"paper-w4414485446","cat":"papers","name":"Microdosing Psychedelics for Cognitive Enhancement: A Naturalistic Exploration of User Experiences","year":"2025","cit":0,"pfa":"Luke Pelham","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"dissertation","src":"https://openalex.org/W4414485446","eid":"W4414485446"},{"id":"paper-w4231587438","cat":"papers","name":"From Psychotomimetics to Psychedelics","year":"2020","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W4231587438","eid":"W4231587438"},{"id":"paper-w2899427601","cat":"papers","name":"Microdoses Of Psychedelic Mushrooms Could Help Stimulate Creative Thought","year":"2018","cit":0,"pfa":"Alexander Bolano","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2899427601","eid":"W2899427601"},{"id":"paper-w2336882491","cat":"papers","name":"Entheogens: What's in a Name? The Untold History of Psychedelic Spirituality, Social Control, and the CIA","year":"2014","cit":0,"pfa":"Jan Irvin","psa":"William Shakespeare","ptype":"article","src":"https://openalex.org/W2336882491","eid":"W2336882491"},{"id":"paper-w4249911375","cat":"papers","name":"Hallucinogens","year":"2013","cit":0,"pfa":"David E. Nichols","ptype":"reference-entry","src":"https://openalex.org/W4249911375","eid":"W4249911375"},{"id":"paper-w7131890466","cat":"papers","name":"Epidemiology of Hallucinogen Microdosing Among Young Adults in the United States: A National Study","year":"2026","cit":0,"pfa":"Katherine M. Keyes","psa":"Megan E. Patrick","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7131890466","eid":"W7131890466"},{"id":"paper-w4230746793","cat":"papers","name":"Entheogen","year":"2013","cit":0,"pfa":"Geoffrey G. O’Brien","ptype":"article","src":"https://openalex.org/W4230746793","eid":"W4230746793"},{"id":"paper-w7137776914","cat":"papers","name":"Managing PMDD with Psychedelic Microdosing: A Qualitative Inquiry into Women's Lived Experiences","year":"2025","cit":0,"pfa":"Ni, Yuyun","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7137776914","eid":"W7137776914"},{"id":"paper-w3155752266","cat":"papers","name":"Turn on, Tune in, Drop out: a Typology of Modes of Uses of Psychedelic Microdosing","year":"2020","cit":0,"pfa":"Kamile Grusauskaite","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3155752266","eid":"W3155752266"},{"id":"paper-w3213577384","cat":"papers","name":"Anthropology of Psychedelics. (Book Reviews: Flesh of the Gods. The Ritual Use of Hallucinogens)","year":"1973","cit":0,"pfa":"Omer C. Stewart","topics":["Reviews & meta-analyses"],"ptype":"book-review","src":"https://openalex.org/W3213577384","eid":"W3213577384"},{"id":"paper-w7131400981","cat":"papers","name":"Far Out: The Application of Psychedelic Drugs and Hallucinogens for Depression and Anxiety Treatment","year":"2026","cit":0,"pfa":"Neha Tallapragada","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7131400981","eid":"W7131400981"},{"id":"paper-w3217385602","cat":"papers","name":"Entheogen-Assisted Self-Transcendence & Psychospiritual Development: A Study of Positive Psychedelic Drug Use","year":"2021","cit":0,"pfa":"St. Arnaud, Kevin O.","topics":["Addiction","Dosing & pharmacology","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W3217385602","eid":"W3217385602"},{"id":"paper-w4384151852","cat":"papers","name":"Entheogen","year":"2022","cit":0,"pfa":"Brian Henderson","ptype":"book-chapter","src":"https://openalex.org/W4384151852","eid":"W4384151852"},{"id":"paper-w4243334030","cat":"papers","name":"Entheogens","year":"2015","cit":0,"ptype":"dataset","src":"https://openalex.org/W4243334030","eid":"W4243334030"},{"id":"paper-w4281557822","cat":"papers","name":"ENTHEOGEN","year":"2022","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W4281557822","eid":"W4281557822"},{"id":"paper-w4415791960","cat":"papers","name":"Entheogens","year":"2025","cit":0,"pfa":"Rita M. Rivera","ptype":"reference-entry","src":"https://openalex.org/W4415791960","eid":"W4415791960"},{"id":"paper-w4390223179","cat":"papers","name":"The journey is long, but the trip may not be – Is the psychedelic experience necessary in hallucinogen-assisted treatments?","year":"2023","cit":0,"pfa":"Joana Andrade","psa":"M. J. Brito","ptype":"article","src":"https://openalex.org/W4390223179","eid":"W4390223179"},{"id":"paper-w7214765501","cat":"papers","name":"Differential Dose-Response Dynamics in Psychedelic Microdosing: Connecting Research and Recreational Use","year":"2026","cit":0,"pfa":"Disha Thakkar","psa":"Robert Dunbar","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7214765501","eid":"W7214765501"},{"id":"paper-w2942718160","cat":"papers","name":"Psychedelic Healing of the Past, Present, and Future: A Review of Hallucinogens and Their Potential in the Therapeutic Relationship","year":"2013","cit":0,"pfa":"Kelly Livingston","topics":["Reviews & meta-analyses"],"ptype":"dissertation","src":"https://openalex.org/W2942718160","eid":"W2942718160"},{"id":"paper-w4402104659","cat":"papers","name":"53573 Trips Through the Skin: Reviewing Cutaneous Drug Reactions to Psychedelics and Hallucinogens","year":"2024","cit":0,"pfa":"Syed Minhaj Rahman","psa":"Aamir N. Hussain","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4402104659","eid":"W4402104659"},{"id":"paper-w4237126218","cat":"papers","name":"Entheogens","year":"2008","cit":0,"pfa":"Marc D. Binder","psa":"Uwe Windhorst","ptype":"reference-entry","src":"https://openalex.org/W4237126218","eid":"W4237126218"},{"id":"paper-w4230637580","cat":"papers","name":"Entheogens","year":"2010","cit":0,"pfa":"Bart A. Ellenbroek","psa":"Oliver Stiedl","ptype":"reference-entry","src":"https://openalex.org/W4230637580","eid":"W4230637580"},{"id":"paper-w4376255556","cat":"papers","name":"Microdosing Is More Than Placebo In Some Individuals: A Critical Re-examination of ‘Self-blinding citizen science to explore psychedelic microdosing’","year":"2023","cit":0,"pfa":" Gregory","topics":["Depression","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4376255556","eid":"W4376255556"},{"id":"paper-w7125361259","cat":"papers","name":"Microdosing classic psychedelic substances for obsessive-compulsive experiences: an Interpretative Phenomenological Analysis","year":"2024","cit":0,"pfa":"Charlotte A'Court","topics":["Addiction","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7125361259","eid":"W7125361259"},{"id":"paper-w4238399364","cat":"papers","name":"Faculty Opinions recommendation of Self-blinding citizen science to explore psychedelic microdosing.","year":"2021","cit":0,"pfa":"Harriet de Wit","topics":["Dosing & pharmacology"],"ptype":"peer-review","src":"https://openalex.org/W4238399364","eid":"W4238399364"},{"id":"paper-w4232744470","cat":"papers","name":"The Hallucinogens","year":"2017","cit":0,"pfa":"Michael Gossop","ptype":"book-chapter","src":"https://openalex.org/W4232744470","eid":"W4232744470"},{"id":"paper-w4229903790","cat":"papers","name":"Entheogens as Portals","year":"2014","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W4229903790","eid":"W4229903790"},{"id":"paper-w4241395575","cat":"papers","name":"Hallucinogens","year":"2016","cit":0,"pfa":"United Nations Office on Drugs and Crime","ptype":"book-chapter","src":"https://openalex.org/W4241395575","eid":"W4241395575"},{"id":"paper-w4378173120","cat":"papers","name":"Corrigendum to “Microdosing psychedelics: Subjective benefits and challenges, substance testing behavior, and the relevance of intention”","year":"2023","cit":0,"topics":["Addiction","Dosing & pharmacology"],"ptype":"erratum","src":"https://openalex.org/W4378173120","eid":"W4378173120"},{"id":"paper-w7160868610","cat":"papers","name":"EntheoGen Dataset","year":"2026","cit":0,"pfa":"Steve Beale","topics":["Reviews & meta-analyses"],"ptype":"dataset","src":"https://openalex.org/W7160868610","eid":"W7160868610"},{"id":"paper-w4243756351","cat":"papers","name":"Hallucinogens","year":"2020","cit":0,"pfa":"Virgil Zeigler‐Hill","psa":"Todd K. Shackelford","ptype":"reference-entry","src":"https://openalex.org/W4243756351","eid":"W4243756351"},{"id":"paper-w7204198891","cat":"papers","name":"How small is a microdose, how big is a macrodose? Clarifying the lexicon of psychedelic research and treatment","year":"2026","cit":0,"pfa":"Vince Polito","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7204198891","eid":"W7204198891"},{"id":"paper-w3036582429","cat":"papers","name":"Entheogens as Portals","year":"2020","cit":0,"pfa":"Lynne Hume","topics":["Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W3036582429","eid":"W3036582429"},{"id":"paper-w4211217903","cat":"papers","name":"Hallucinogens","year":"1994","cit":0,"pfa":"H. Thomas Milhorn","ptype":"book-chapter","src":"https://openalex.org/W4211217903","eid":"W4211217903"},{"id":"paper-w4408681836","cat":"papers","name":"The emerging science of microdosing: A systematic review of research on low dose psychedelics (1955 – 2021)","year":"2021","cit":0,"pfa":"Vince Polito","psa":"Paul Liknaitzky","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4408681836","eid":"W4408681836"},{"id":"paper-w7163185330","cat":"papers","name":"Psychedelics and Facial Expressions: the impact of an LSD microdose on the process of encoding emotional facial expressions","year":"2022","cit":0,"pfa":"Alicia Rowland","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7163185330","eid":"W7163185330"},{"id":"paper-w4241109859","cat":"papers","name":"Hallucinogens","year":"2011","cit":0,"pfa":"Ioana Boie","ptype":"reference-entry","src":"https://openalex.org/W4241109859","eid":"W4241109859"},{"id":"paper-w4385836566","cat":"papers","name":"On Forest Entheogen","year":"2023","cit":0,"pfa":"Michal Jurášek","psa":"Pavel Drašar","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4385836566","eid":"W4385836566"},{"id":"paper-w7160879219","cat":"papers","name":"EntheoGen Dataset","year":"2026","cit":0,"pfa":"Steve Beale","topics":["Reviews & meta-analyses"],"ptype":"dataset","src":"https://openalex.org/W7160879219","eid":"W7160879219"},{"id":"paper-w4254600760","cat":"papers","name":"Hallucinogens","year":"2014","cit":0,"pfa":"Robert F. Sawicki","ptype":"reference-entry","src":"https://openalex.org/W4254600760","eid":"W4254600760"},{"id":"paper-w4230905170","cat":"papers","name":"Hallucinogens","year":"2006","cit":0,"pfa":"David L. Eldridge","psa":"J. R. Serwint","ptype":"article","src":"https://openalex.org/W4230905170","eid":"W4230905170"},{"id":"paper-w3216448579","cat":"papers","name":"Psychedelics as Tools for Belief Transmission. Set, Setting, Suggestibility, and Persuasion in the Ritual Use of Hallucinogens [2021]","year":"2021","cit":0,"pfa":"David Dupuis","ptype":"article","src":"https://openalex.org/W3216448579","eid":"W3216448579"},{"id":"paper-w4380571420","cat":"papers","name":"Entheogens, Healing, and the Sacred","year":"2023","cit":0,"pfa":"Samuel Bendeck Sotillos","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4380571420","eid":"W4380571420"},{"id":"paper-w7160866785","cat":"papers","name":"entheogen-live-dataset","year":"2026","cit":0,"pfa":"Stephen Beale","ptype":"dataset","src":"https://openalex.org/W7160866785","eid":"W7160866785"},{"id":"paper-w322293114","cat":"papers","name":"Entheogens - Return of the Ostracized.","year":"1996","cit":0,"pfa":"Thomas B. Roberts","psa":"Paula Jo Hruby","ptype":"article","src":"https://openalex.org/W322293114","eid":"W322293114"},{"id":"paper-w172005257","cat":"papers","name":"Entheogens and personal spirtituality","year":"2004","cit":0,"pfa":"O. M. Caputo","ptype":"article","src":"https://openalex.org/W172005257","eid":"W172005257"},{"id":"paper-w7135499950","cat":"papers","name":"Microdosing of psychedelics and its influence on quality of life from the user's perspective: selected case studies","year":"2025","cit":0,"pfa":"Markéta Štěpánková","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"dissertation","src":"https://openalex.org/W7135499950","eid":"W7135499950"},{"id":"paper-w3023708559","cat":"papers","name":"Hallucinogens","year":"2004","cit":0,"pfa":"John C.M. Brust","ptype":"book-chapter","src":"https://openalex.org/W3023708559","eid":"W3023708559"},{"id":"paper-w4230225244","cat":"papers","name":"Hallucinogen","year":"2007","cit":0,"ptype":"reference-entry","src":"https://openalex.org/W4230225244","eid":"W4230225244"},{"id":"paper-w4388607111","cat":"papers","name":"HALLUCINOGENS","year":"2023","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W4388607111","eid":"W4388607111"},{"id":"paper-w4211157720","cat":"papers","name":"Hallucinogens","year":"2008","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W4211157720","eid":"W4211157720"},{"id":"paper-w4232637289","cat":"papers","name":"Hallucinogens","year":"2009","cit":0,"pfa":"Gary L.Fisher","psa":"Nancy A. Roget","ptype":"reference-entry","src":"https://openalex.org/W4232637289","eid":"W4232637289"},{"id":"paper-w4253774423","cat":"papers","name":"Hallucinogens","year":"2016","cit":0,"pfa":"Rick Csiernik","ptype":"reference-entry","src":"https://openalex.org/W4253774423","eid":"W4253774423"},{"id":"paper-w7166450540","cat":"papers","name":"Beyond Psychedelic Microdosing: Therapeutic Potential, Neuropharmacology, and Safety Considerations in Low-Dose Psychoactive Use","year":"2026","cit":0,"pfa":"Elias Rubenstein","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7166450540","eid":"W7166450540"},{"id":"paper-w4256676115","cat":"papers","name":"Hallucinogens","year":"2012","cit":0,"ptype":"reference-entry","src":"https://openalex.org/W4256676115","eid":"W4256676115"},{"id":"paper-w4205734612","cat":"papers","name":"Hallucinogen","year":"2021","cit":0,"ptype":"reference-entry","src":"https://openalex.org/W4205734612","eid":"W4205734612"},{"id":"paper-w4229970077","cat":"papers","name":"The Hallucinogens","year":"1967","cit":0,"ptype":"book","src":"https://openalex.org/W4229970077","eid":"W4229970077"},{"id":"paper-w4234237440","cat":"papers","name":"Hallucinogen","year":"2002","cit":0,"pfa":"Mark S. Davis","ptype":"reference-entry","src":"https://openalex.org/W4234237440","eid":"W4234237440"},{"id":"paper-w4211115038","cat":"papers","name":"Hallucinogens","year":"1978","cit":0,"pfa":"Alvin K. Swonger","psa":"Richard H. Rech","ptype":"book-chapter","src":"https://openalex.org/W4211115038","eid":"W4211115038"},{"id":"paper-w7140518545","cat":"papers","name":"Hallucinogens","year":"2026","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W7140518545","eid":"W7140518545"},{"id":"paper-w4235364435","cat":"papers","name":"Hallucinogens","year":"1968","cit":0,"pfa":"John Smythies","ptype":"article","src":"https://openalex.org/W4235364435","eid":"W4235364435"},{"id":"paper-w4248637982","cat":"papers","name":"Hallucinogen","year":"2020","cit":0,"pfa":"National Cancer Institute","ptype":"reference-entry","src":"https://openalex.org/W4248637982","eid":"W4248637982"},{"id":"paper-w2023229133","cat":"papers","name":"Hallucinogens","year":"1985","cit":0,"pfa":"Christopher G. Goetz","ptype":"article","src":"https://openalex.org/W2023229133","eid":"W2023229133"},{"id":"paper-w4300994142","cat":"papers","name":"Hallucinogens.","year":"1993","cit":0,"pfa":"Mark J. Werner","ptype":"article","src":"https://openalex.org/W4300994142","eid":"W4300994142"},{"id":"paper-w4210319883","cat":"papers","name":"THE HALLUCINOGENS","year":"1968","cit":0,"pfa":"Alfred M. Freedman","ptype":"book-review","src":"https://openalex.org/W4210319883","eid":"W4210319883"},{"id":"paper-w4302195245","cat":"papers","name":"[HALLUCINOGENS].","year":"1964","cit":0,"pfa":"K MATSUDA","ptype":"article","src":"https://openalex.org/W4302195245","eid":"W4302195245"},{"id":"paper-w4299621425","cat":"papers","name":"[Hallucinogens].","year":"1973","cit":0,"pfa":"André Dubois-Poulsen","ptype":"article","src":"https://openalex.org/W4299621425","eid":"W4299621425"},{"id":"paper-w4244591930","cat":"papers","name":"Hallucinogens","year":"2012","cit":0,"ptype":"reference-entry","src":"https://openalex.org/W4244591930","eid":"W4244591930"},{"id":"paper-w4245078847","cat":"papers","name":"Hallucinogens","year":"2013","cit":0,"pfa":"White House Office of National Drug Control Policy","ptype":"dataset","src":"https://openalex.org/W4245078847","eid":"W4245078847"},{"id":"paper-w4251545203","cat":"papers","name":"Hallucinogens","year":"2015","cit":0,"pfa":"Aaron Pycroft","ptype":"book-chapter","src":"https://openalex.org/W4251545203","eid":"W4251545203"},{"id":"paper-w7213860206","cat":"papers","name":"Hallucinogens and culture","year":"2020","cit":0,"pfa":"David Dupuis","psa":"Lucie Berkovitch","ptype":"article","src":"https://openalex.org/W7213860206","eid":"W7213860206"},{"id":"paper-w4386687593","cat":"papers","name":"Hallucinogens","year":"2019","cit":0,"pfa":"Frances Rachel Frankenburg","ptype":"other","src":"https://openalex.org/W4386687593","eid":"W4386687593"},{"id":"paper-w4401780239","cat":"papers","name":"Hallucinogens","year":"2024","cit":0,"ptype":"reference-entry","src":"https://openalex.org/W4401780239","eid":"W4401780239"},{"id":"paper-w4239622406","cat":"papers","name":"The Hallucinogens","year":"1968","cit":0,"pfa":"Walter Modell","ptype":"article","src":"https://openalex.org/W4239622406","eid":"W4239622406"},{"id":"paper-w4232505356","cat":"papers","name":"Hallucinogens","year":"2010","cit":0,"pfa":"Ly Binh T.","psa":"Saralyn R. Williams","ptype":"book-chapter","src":"https://openalex.org/W4232505356","eid":"W4232505356"},{"id":"paper-w4239394071","cat":"papers","name":"Hallucinogens","year":"2005","cit":0,"ptype":"reference-entry","src":"https://openalex.org/W4239394071","eid":"W4239394071"},{"id":"paper-w4252945426","cat":"papers","name":"Hallucinogens","year":"2012","cit":0,"ptype":"reference-entry","src":"https://openalex.org/W4252945426","eid":"W4252945426"},{"id":"paper-w4248546383","cat":"papers","name":"Hallucinogens","year":"2011","cit":0,"pfa":"Mark A. R. Kleiman","psa":"James E. Hawdon","ptype":"reference-entry","src":"https://openalex.org/W4248546383","eid":"W4248546383"},{"id":"paper-w4251683834","cat":"papers","name":"Hallucinogen","year":"2010","cit":0,"pfa":"Michael H. Bloch","psa":"Subhash C. Pandey","ptype":"reference-entry","src":"https://openalex.org/W4251683834","eid":"W4251683834"},{"id":"paper-w4211251623","cat":"papers","name":"Hallucinogens","year":"2020","cit":0,"pfa":"Owen Bowden‐Jones","psa":"Dima Abdulrahim","topics":["Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W4211251623","eid":"W4211251623"},{"id":"paper-w4243537522","cat":"papers","name":"Hallucinogens","year":"2003","cit":0,"pfa":"Christopher G. Goetz","ptype":"reference-entry","src":"https://openalex.org/W4243537522","eid":"W4243537522"},{"id":"paper-w4240226950","cat":"papers","name":"Hallucinogens","year":"2012","cit":0,"pfa":"Matthew W. Johnson","ptype":"reference-entry","src":"https://openalex.org/W4240226950","eid":"W4240226950"},{"id":"paper-w7160872594","cat":"papers","name":"entheogen-updates-curated","year":"2026","cit":0,"pfa":"Stephen Beale","ptype":"dataset","src":"https://openalex.org/W7160872594","eid":"W7160872594"},{"id":"paper-w2772985914","cat":"papers","name":"The Ethical Import of Entheogens","year":"2017","cit":0,"pfa":"Joshua Falcon","topics":["Addiction","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W2772985914","eid":"W2772985914"},{"id":"paper-w4413284677","cat":"papers","name":"504. BEYOND THE HYPE: EXAMINING THE THERAPEUTIC POTENTIAL OF PSYCHEDELIC MICRODOSING THROUGH THE LENS OF EXPERIMENTAL CONTROL AND EVIDENCE","year":"2025","cit":0,"pfa":"O Mallon","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"conference-abstract","src":"https://openalex.org/W4413284677","eid":"W4413284677"},{"id":"paper-w2186419739","cat":"papers","name":"The Physiological Effects of Entheogens","year":"2003","cit":0,"pfa":"Michael Winkelman","ptype":"article","src":"https://openalex.org/W2186419739","eid":"W2186419739"},{"id":"paper-w4396635942","cat":"papers","name":"GODS, POETS AND ENTHEOGENS:","year":"2018","cit":0,"pfa":"Sharon Paice Macleod","ptype":"book-chapter","src":"https://openalex.org/W4396635942","eid":"W4396635942"},{"id":"paper-w4248951036","cat":"papers","name":"Hallucinogens","year":"2008","cit":0,"pfa":"Robert F. Sawicki","ptype":"reference-entry","src":"https://openalex.org/W4248951036","eid":"W4248951036"},{"id":"paper-w4237411338","cat":"papers","name":"Hallucinogens","year":"1985","cit":0,"pfa":"Ernest Lawrence Abel","ptype":"book-chapter","src":"https://openalex.org/W4237411338","eid":"W4237411338"},{"id":"paper-w7162496579","cat":"papers","name":"The use of drug checking legislation to facilitate illicit drug consumption research: psychedelic microdosing as a case example","year":"2026","cit":0,"pfa":"Estelle Miller","psa":"Rhys Ponton","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7162496579","eid":"W7162496579"},{"id":"paper-w7138826085","cat":"papers","name":"The Expectancy Effect and Psychedelic Microdosing: An investigation of whether expectation manipulations can enhance analgesic and cognitive performance","year":"2023","cit":0,"pfa":"Mirabella Mary Letica","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7138826085","eid":"W7138826085"},{"id":"paper-w4411267451","cat":"papers","name":"HALLUCINOGENS","year":"2023","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W4411267451","eid":"W4411267451"},{"id":"paper-w4240768455","cat":"papers","name":"Hallucinogens.","year":"2000","cit":0,"pfa":"Barry L. Jacobs","ptype":"reference-entry","src":"https://openalex.org/W4240768455","eid":"W4240768455"},{"id":"paper-w4236909795","cat":"papers","name":"HALLUCINOGENS","year":"1970","cit":0,"pfa":"R. M. Mowbray","ptype":"article","src":"https://openalex.org/W4236909795","eid":"W4236909795"},{"id":"paper-w4240483183","cat":"papers","name":"Hallucinogens","year":"2012","cit":0,"ptype":"reference-entry","src":"https://openalex.org/W4240483183","eid":"W4240483183"},{"id":"paper-w4253745170","cat":"papers","name":"Hallucinogens","year":"1974","cit":0,"pfa":"Brimblecombe Rw","ptype":"book-chapter","src":"https://openalex.org/W4253745170","eid":"W4253745170"},{"id":"paper-w4252186292","cat":"papers","name":"Hallucinogens","year":"2001","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W4252186292","eid":"W4252186292"},{"id":"paper-w4235820415","cat":"papers","name":"Microdose","year":"2020","cit":0,"pfa":"National Cancer Institute","topics":["Dosing & pharmacology"],"ptype":"reference-entry","src":"https://openalex.org/W4235820415","eid":"W4235820415"},{"id":"paper-w4234630453","cat":"papers","name":"Microdose","year":"2008","cit":0,"topics":["Dosing & pharmacology"],"ptype":"reference-entry","src":"https://openalex.org/W4234630453","eid":"W4234630453"},{"id":"paper-w4255594395","cat":"papers","name":"Hallucinogens","year":"2007","cit":0,"pfa":"Stephen J. Traub","ptype":"book-chapter","src":"https://openalex.org/W4255594395","eid":"W4255594395"},{"id":"paper-w4253275210","cat":"papers","name":"Hallucinogen","year":"2018","cit":0,"pfa":"Ursula Schmidt-Erfurth","psa":"Thomas Kohnen","ptype":"reference-entry","src":"https://openalex.org/W4253275210","eid":"W4253275210"},{"id":"paper-w4302412301","cat":"papers","name":"[Mega-hallucinogens].","year":"1967","cit":0,"pfa":"J L Ibor","ptype":"article","src":"https://openalex.org/W4302412301","eid":"W4302412301"},{"id":"paper-w3037118802","cat":"papers","name":"Hallucinogens Addiction Symptoms | Signs of Hallucinogen Abuse","year":"2017","cit":0,"pfa":"Mark Adams","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W3037118802","eid":"W3037118802"},{"id":"paper-w4205809673","cat":"papers","name":"Psychedelics","year":"2010","cit":0,"pfa":"Hamish McAllister-Williams","psa":"Jos Prickaerts","ptype":"reference-entry","src":"https://openalex.org/W4205809673","eid":"W4205809673"},{"id":"paper-w4234697600","cat":"papers","name":"The Hallucinogens","year":"2016","cit":0,"pfa":"Michael Gossop","ptype":"book-chapter","src":"https://openalex.org/W4234697600","eid":"W4234697600"},{"id":"paper-w4300668576","cat":"papers","name":"[Hallucinogens].","year":"1966","cit":0,"pfa":"G Valcurone","psa":"O Cerri","ptype":"article","src":"https://openalex.org/W4300668576","eid":"W4300668576"},{"id":"paper-w4298422206","cat":"papers","name":"[Hallucinogens].","year":"1969","cit":0,"pfa":"G Orzechowski","ptype":"article","src":"https://openalex.org/W4298422206","eid":"W4298422206"},{"id":"paper-w4234634154","cat":"papers","name":"Microdosing","year":"2011","cit":0,"pfa":"Werner Karl Schomburg","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W4234634154","eid":"W4234634154"},{"id":"paper-w4211162697","cat":"papers","name":"Microdosing","year":"2014","cit":0,"topics":["Dosing & pharmacology"],"ptype":"reference-entry","src":"https://openalex.org/W4211162697","eid":"W4211162697"},{"id":"paper-w4252415586","cat":"papers","name":"Psychedelic Drugs","year":"2021","cit":0,"pfa":"David E. Nichols","psa":"Charles David Nichols","ptype":"reference-entry","src":"https://openalex.org/W4252415586","eid":"W4252415586"},{"id":"paper-w4399861027","cat":"papers","name":"Are psychedelics psychedelic?","year":"2024","cit":0,"pfa":"Haggeo Cadenas","ptype":"article","src":"https://openalex.org/W4399861027","eid":"W4399861027"},{"id":"paper-w2373524617","cat":"papers","name":"Microdose and microdose effects induced by radiation","year":"2012","cit":0,"pfa":"Rui Min","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2373524617","eid":"W2373524617"},{"id":"paper-w4405636400","cat":"papers","name":"Self-blinding, citizen science microdosing study: an insight into the study design of an innovative approach to investigating psychedelic effects","year":"2024","cit":0,"pfa":"A. Wingert","psa":"David Erritzøe","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4405636400","eid":"W4405636400"},{"id":"paper-w4241353616","cat":"papers","name":"Hallucinogen Use","year":"2018","cit":0,"pfa":"Curtis L. Baysinger","ptype":"book-chapter","src":"https://openalex.org/W4241353616","eid":"W4241353616"},{"id":"paper-w3021219963","cat":"papers","name":"Hallucinogen Dependence (304.5) and Hallucinogen Abuse (305.3)","year":"2017","cit":0,"pfa":"Bill Pelz","ptype":"article","src":"https://openalex.org/W3021219963","eid":"W3021219963"},{"id":"paper-w2410078013","cat":"papers","name":"[Hallucinogens and tranquilizers].","year":"1962","cit":0,"pfa":"Francis D. Pagani","ptype":"article","src":"https://openalex.org/W2410078013","eid":"W2410078013"},{"id":"paper-w3111905603","cat":"papers","name":"The Significance of Study on the Soma as an Entheogen","year":"2008","cit":0,"pfa":"심준보","ptype":"article","src":"https://openalex.org/W3111905603","eid":"W3111905603"},{"id":"paper-w3152411883","cat":"papers","name":"Non-Ordinary States, Entheogens, and the Unconscious.","year":"2018","cit":0,"pfa":"Rodger K Green","ptype":"article","src":"https://openalex.org/W3152411883","eid":"W3152411883"},{"id":"paper-w4234782925","cat":"papers","name":"Digital Hallucinogens","year":"2007","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W4234782925","eid":"W4234782925"},{"id":"paper-w1704729701","cat":"papers","name":"Hallucinogens: A Reader","year":"2002","cit":0,"pfa":"Aaron M. Lampman","ptype":"article","src":"https://openalex.org/W1704729701","eid":"W1704729701"},{"id":"paper-w4247749818","cat":"papers","name":"Hallucinogen Abuse","year":"2014","cit":0,"pfa":"Dalene M. McCloskey","ptype":"reference-entry","src":"https://openalex.org/W4247749818","eid":"W4247749818"},{"id":"paper-w4233656819","cat":"papers","name":"On the trail of hallucinogens","year":"1981","cit":0,"ptype":"book-review","src":"https://openalex.org/W4233656819","eid":"W4233656819"},{"id":"paper-w4298845397","cat":"papers","name":"[Hallucinogens. Psychodelics].","year":"1967","cit":0,"pfa":"Erling Jacobsen","ptype":"article","src":"https://openalex.org/W4298845397","eid":"W4298845397"},{"id":"paper-w7132500285","cat":"papers","name":"The Dangers of hallucinogens: a review of hallucinogen persistent perception disorder","year":"2020","cit":0,"pfa":"Agnė Timlerytė","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7132500285","eid":"W7132500285"},{"id":"paper-w4407548598","cat":"papers","name":"Editorial for psychedelic and psychedelic and psychedelic-like states","year":"2024","cit":0,"pfa":"David B. Yaden","ptype":"editorial","src":"https://openalex.org/W4407548598","eid":"W4407548598"},{"id":"paper-w4247806982","cat":"papers","name":"STP (hallucinogen)","year":"2007","cit":0,"ptype":"reference-entry","src":"https://openalex.org/W4247806982","eid":"W4247806982"},{"id":"paper-w4301434196","cat":"papers","name":"[Endogenous hallucinogens].","year":"1974","cit":0,"pfa":"P Kanabus","psa":"A Frindt-Zajaczkowska","ptype":"article","src":"https://openalex.org/W4301434196","eid":"W4301434196"},{"id":"paper-w4233894909","cat":"papers","name":"Hallucinogen Dependence","year":"2015","cit":0,"pfa":"Ian P. Stolerman","psa":"Lawrence H. Price","ptype":"reference-entry","src":"https://openalex.org/W4233894909","eid":"W4233894909"},{"id":"paper-w4205946669","cat":"papers","name":"Serotonergic Hallucinogen","year":"2021","cit":0,"ptype":"reference-entry","src":"https://openalex.org/W4205946669","eid":"W4205946669"},{"id":"paper-w7118257916","cat":"papers","name":"CHAPTER 4: Fungi as “Entheogens”","year":"2008","cit":0,"pfa":"F. M. Dugan","ptype":"book-chapter","src":"https://openalex.org/W7118257916","eid":"W7118257916"},{"id":"paper-w2135543307","cat":"papers","name":"Hallucinogens and Afterimages","year":"1971","cit":0,"pfa":"GEORGE E. WOODY","ptype":"article","src":"https://openalex.org/W2135543307","eid":"W2135543307"},{"id":"paper-w4232071029","cat":"papers","name":"Hallucinogen Intoxication","year":"2010","cit":0,"pfa":"Michael H. Bloch","psa":"Subhash C. Pandey","ptype":"reference-entry","src":"https://openalex.org/W4232071029","eid":"W4232071029"},{"id":"paper-w4298300611","cat":"papers","name":"Miscellaneous hallucinogens.","year":"1970","cit":0,"ptype":"article","src":"https://openalex.org/W4298300611","eid":"W4298300611"},{"id":"paper-w3021198214","cat":"papers","name":"Hallucinogens: phencyclidine","year":"1985","cit":0,"pfa":"Benjamin D. Greenberg","psa":"Barry L. Jacobs","ptype":"book-chapter","src":"https://openalex.org/W3021198214","eid":"W3021198214"},{"id":"paper-w2959619479","cat":"papers","name":"Microdose for England","year":"2019","cit":0,"pfa":"Oliver Gruner","psa":"Tom Sykes","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2959619479","eid":"W2959619479"},{"id":"paper-w4417287983","cat":"papers","name":"Microdosing mindfulness","year":"2025","cit":0,"pfa":"David Robson","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4417287983","eid":"W4417287983"},{"id":"paper-w4247091052","cat":"papers","name":"Hallucinogens and Psychosis","year":"1967","cit":0,"pfa":"A Pharmacology Correspondent","ptype":"article","src":"https://openalex.org/W4247091052","eid":"W4247091052"},{"id":"paper-w80814453","cat":"papers","name":"Trial by microdose","year":"2008","cit":0,"pfa":"Colin R. Garner","psa":"Graham Lappin","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W80814453","eid":"W80814453"},{"id":"paper-w4243755160","cat":"papers","name":"Hallucinogen Measurement","year":"2020","cit":0,"pfa":"National Cancer Institute","ptype":"reference-entry","src":"https://openalex.org/W4243755160","eid":"W4243755160"},{"id":"paper-w3045437618","cat":"papers","name":"Hallucinogens and Phencyclidine","year":"2020","cit":0,"pfa":"Frank Lynn Iber","ptype":"book-chapter","src":"https://openalex.org/W3045437618","eid":"W3045437618"},{"id":"paper-w4291944096","cat":"papers","name":"Microdose therapy","year":"1949","cit":0,"pfa":"A N NEUMANN","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4291944096","eid":"W4291944096"},{"id":"paper-w3137338930","cat":"papers","name":"Hallucinogen Intoxication","year":"2017","cit":0,"pfa":"John H. Halpern","psa":"Vicka Corey","ptype":"reference-entry","src":"https://openalex.org/W3137338930","eid":"W3137338930"},{"id":"paper-w4206757518","cat":"papers","name":"Classic Hallucinogen","year":"2021","cit":0,"ptype":"reference-entry","src":"https://openalex.org/W4206757518","eid":"W4206757518"},{"id":"paper-w4385111453","cat":"papers","name":"hallucinogen, n.","year":"2023","cit":0,"ptype":"reference-entry","src":"https://openalex.org/W4385111453","eid":"W4385111453"},{"id":"paper-w4234157417","cat":"papers","name":"Hallucinogen Withdrawal","year":"2017","cit":0,"pfa":"John H. Halpern","psa":"Vicka Corey","ptype":"reference-entry","src":"https://openalex.org/W4234157417","eid":"W4234157417"},{"id":"paper-w4233135913","cat":"papers","name":"Hallucinogens and Related Drugs","year":"2000","cit":0,"pfa":"Marc Alan Schuckit","ptype":"book-chapter","src":"https://openalex.org/W4233135913","eid":"W4233135913"},{"id":"paper-w3110656100","cat":"papers","name":"PCP and Hallucinogens","year":"2013","cit":0,"pfa":"Trevor G. Pollard","topics":["Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W3110656100","eid":"W3110656100"},{"id":"paper-w4405621623","cat":"papers","name":"Systematic review of case reports of adverse psychiatric effects of psychedelic drugs II: flashbacks/hallucinogen persisting perception disorder","year":"2024","cit":0,"pfa":"S.S. Şahin","psa":"Peter J. McKenna","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4405621623","eid":"W4405621623"},{"id":"paper-w2945425119","cat":"papers","name":"3.8 Hallucinogens","year":"2018","cit":0,"pfa":"Jacqueline Schwab","ptype":"article","src":"https://openalex.org/W2945425119","eid":"W2945425119"},{"id":"paper-w4234567107","cat":"papers","name":"NEW WAYS WITH HALLUCINOGENS","year":"1969","cit":0,"ptype":"article","src":"https://openalex.org/W4234567107","eid":"W4234567107"},{"id":"paper-w2519614118","cat":"papers","name":"LibGuides: Drugs: Hallucinogens","year":"2012","cit":0,"pfa":"Gabrielle Sharrock","ptype":"libguides","src":"https://openalex.org/W2519614118","eid":"W2519614118"},{"id":"paper-w7213303002","cat":"papers","name":"Hallucinogen (LSD) Toxicity","year":"2026","cit":0,"pfa":"Meetkumar Dineshbhai Chaudhari","psa":"Helly Desai","topics":["Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W7213303002","eid":"W7213303002"},{"id":"paper-w4247016958","cat":"papers","name":"Hallucinogen Dependence","year":"2010","cit":0,"pfa":"Michael H. Bloch","psa":"Subhash C. Pandey","ptype":"reference-entry","src":"https://openalex.org/W4247016958","eid":"W4247016958"},{"id":"paper-w2735391732","cat":"papers","name":"Review: The Hallucinogens","year":"1968","cit":0,"pfa":"C. R. B. Joyce","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2735391732","eid":"W2735391732"},{"id":"paper-w4242930944","cat":"papers","name":"Hallucinogen Abuse","year":"2010","cit":0,"pfa":"Michael H. Bloch","psa":"Subhash C. Pandey","ptype":"reference-entry","src":"https://openalex.org/W4242930944","eid":"W4242930944"},{"id":"paper-w245259893","cat":"papers","name":"Schizophrenia and Hallucinogens","year":"2014","cit":0,"pfa":"Kasim Acar","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W245259893","eid":"W245259893"},{"id":"paper-w7204458778","cat":"papers","name":"Hallucinogen Use, Diagnosed","year":"2025","cit":0,"pfa":"Nhat Nguyen","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W7204458778","eid":"W7204458778"},{"id":"paper-w4242739159","cat":"papers","name":"Hallucinogen Dependence","year":"2020","cit":0,"pfa":"National Cancer Institute","ptype":"reference-entry","src":"https://openalex.org/W4242739159","eid":"W4242739159"},{"id":"paper-w7200559786","cat":"papers","name":"Fertilizer Microdosing","year":"2017","cit":0,"pfa":"World Agroforestry Centre","psa":"Sokoine University of Agriculture","topics":["Safety & adverse events","Dosing & pharmacology","Therapy practice"],"ptype":"dataset","src":"https://openalex.org/W7200559786","eid":"W7200559786"},{"id":"paper-w4290599623","cat":"papers","name":"[Microdose dispenser].","year":"1972","cit":0,"pfa":"A F Seniushkin","psa":"L N Ryzhov","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4290599623","eid":"W4290599623"},{"id":"paper-w7110552197","cat":"papers","name":"Microdose coaching","year":"2020","cit":0,"pfa":"Gregory","topics":["Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7110552197","eid":"W7110552197"},{"id":"paper-w4250445157","cat":"papers","name":"Hallucinogen Abuse","year":"2007","cit":0,"pfa":"Mustafa Warsi","psa":"Fred Petty","ptype":"book-chapter","src":"https://openalex.org/W4250445157","eid":"W4250445157"},{"id":"paper-w4230490764","cat":"papers","name":"Hallucinogen Abuse","year":"2015","cit":0,"pfa":"Ian P. Stolerman","psa":"Lawrence H. Price","ptype":"reference-entry","src":"https://openalex.org/W4230490764","eid":"W4230490764"},{"id":"paper-w4205179331","cat":"papers","name":"Psychedelics","year":"2009","cit":0,"pfa":"Leslie Lars Iversen","psa":"Robert Howard Roth","ptype":"book-chapter","src":"https://openalex.org/W4205179331","eid":"W4205179331"},{"id":"paper-w2395462509","cat":"papers","name":"[Information on hallucinogens in the schools].","year":"1969","cit":0,"pfa":"A Lacombe","ptype":"article","src":"https://openalex.org/W2395462509","eid":"W2395462509"},{"id":"paper-w2243960786","cat":"papers","name":"[Trihexyphenidyl (Parkan) as hallucinogen].","year":"1973","cit":0,"pfa":"E Kuncz","psa":"E Liziczai","ptype":"article","src":"https://openalex.org/W2243960786","eid":"W2243960786"},{"id":"paper-w1540914271","cat":"papers","name":"Chapter 3. Hallucinogens","year":"1971","cit":0,"pfa":"Raj K. Razdan","psa":"John Clark Sheehan","ptype":"book-chapter","src":"https://openalex.org/W1540914271","eid":"W1540914271"},{"id":"paper-w2890173221","cat":"papers","name":"Hallucinogen Treatment Measure","year":"2018","cit":0,"pfa":"Brian Scott Barnett","psa":"Harrison Graham Pope","ptype":"dataset","src":"https://openalex.org/W2890173221","eid":"W2890173221"},{"id":"paper-w4245770351","cat":"papers","name":"A Common Receptor for Hallucinogens ?","year":"1973","cit":0,"topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4245770351","eid":"W4245770351"},{"id":"paper-w2260744002","cat":"papers","name":"[Hallucinogens and their toxicologic detection].","year":"1969","cit":0,"pfa":"A Noirfalise","ptype":"article","src":"https://openalex.org/W2260744002","eid":"W2260744002"},{"id":"paper-w7154333552","cat":"papers","name":"Microdosing: Fact or fiction?","year":"2026","cit":0,"pfa":"Adam L. Halberstadt","psa":"Jared W. Young","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7154333552","eid":"W7154333552"},{"id":"paper-w2410019357","cat":"papers","name":"[Hallucinogens of the plant kingdom].","year":"1977","cit":0,"pfa":"Verdejo Vivas G","ptype":"other","src":"https://openalex.org/W2410019357","eid":"W2410019357"},{"id":"paper-w4301968514","cat":"papers","name":"New ways with hallucinogens.","year":"1969","cit":0,"ptype":"article","src":"https://openalex.org/W4301968514","eid":"W4301968514"},{"id":"paper-w2434561572","cat":"papers","name":"[A new hallucinogen (\"STP\")].","year":"1969","cit":0,"pfa":"Nils Retterstøl","ptype":"article","src":"https://openalex.org/W2434561572","eid":"W2434561572"},{"id":"paper-w331284906","cat":"papers","name":"Present Use of Hallucinogens","year":"1979","cit":0,"pfa":"Leo E. Hollister","ptype":"book-chapter","src":"https://openalex.org/W331284906","eid":"W331284906"},{"id":"paper-w169967945","cat":"papers","name":"The Hallucinogens and Related Drugs","year":"1984","cit":0,"pfa":"Marc Alan Schuckit","ptype":"book-chapter","src":"https://openalex.org/W169967945","eid":"W169967945"},{"id":"paper-w4244581539","cat":"papers","name":"Intoxication/Drugs/Hallucinogens","year":"2014","cit":0,"pfa":"Peter Gietz","psa":"Dierk Tietze","ptype":"reference-entry","src":"https://openalex.org/W4244581539","eid":"W4244581539"},{"id":"paper-w4387775679","cat":"papers","name":"Psychedelic Gnosis","year":"2023","cit":0,"pfa":"Arthur Versluis","ptype":"book-chapter","src":"https://openalex.org/W4387775679","eid":"W4387775679"},{"id":"paper-w2424002410","cat":"papers","name":"[Interaction of hallucinogens and culture].","year":"1969","cit":0,"pfa":"G Létourneau","ptype":"article","src":"https://openalex.org/W2424002410","eid":"W2424002410"},{"id":"paper-w4360759114","cat":"papers","name":"Hallucinogens and Drugs of Abuse","year":"2013","cit":0,"pfa":"Mark B. Mycyk","ptype":"book-chapter","src":"https://openalex.org/W4360759114","eid":"W4360759114"},{"id":"paper-w2419017244","cat":"papers","name":"[Neurochemical aspect of hallucinogens].","year":"1969","cit":0,"pfa":"Sourkes Tl","ptype":"article","src":"https://openalex.org/W2419017244","eid":"W2419017244"},{"id":"paper-w4253877263","cat":"papers","name":"Hallucinogen Abuse and Dependence","year":"2012","cit":0,"ptype":"reference-entry","src":"https://openalex.org/W4253877263","eid":"W4253877263"},{"id":"paper-w2416805818","cat":"papers","name":"[CHOLINOTROPIC HALLUCINOGENS. II].","year":"1964","cit":0,"pfa":"M Vojtĕchovský","ptype":"article","src":"https://openalex.org/W2416805818","eid":"W2416805818"},{"id":"paper-w2330478790","cat":"papers","name":"Bioananalytics of Human Microdosing","year":"2011","cit":0,"pfa":"Bruce A. Buchholz","psa":"Kenneth Wayne Turteltaub","topics":["Dosing & pharmacology"],"ptype":"reference-entry","src":"https://openalex.org/W2330478790","eid":"W2330478790"},{"id":"paper-w4239648533","cat":"papers","name":"Hallucinogens: Lesson Plan: ACSAP--Hallucinogens--05/13/2005","year":"2005","cit":0,"ptype":"dataset","src":"https://openalex.org/W4239648533","eid":"W4239648533"},{"id":"paper-w2954577247","cat":"papers","name":"CNS Stimulants And Hallucinogens","year":"2019","cit":0,"pfa":"Solomon H. Snyder","topics":["Depression","Addiction","Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W2954577247","eid":"W2954577247"},{"id":"paper-w4411483336","cat":"papers","name":"Corrigendum to “Sociological investigations of human enhancement drugs: The case of microdosing psychedelics” [International Journal of Drug Policy 95 (2021) 103099]","year":"2025","cit":0,"pfa":"Dimitrios Liokaftos","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"erratum","src":"https://openalex.org/W4411483336","eid":"W4411483336"},{"id":"paper-w2438969411","cat":"papers","name":"[Historical aspects of hallucinogens].","year":"1969","cit":0,"pfa":"J Cheymol","ptype":"article","src":"https://openalex.org/W2438969411","eid":"W2438969411"},{"id":"paper-w182247970","cat":"papers","name":"Hallucinogens vs health","year":"1990","cit":0,"pfa":"P.M. Kimanthi","ptype":"article","src":"https://openalex.org/W182247970","eid":"W182247970"},{"id":"paper-w4241929961","cat":"papers","name":"Psychedelic Revival","year":"2012","cit":0,"pfa":"Nicolas Langlitz","topics":["Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W4241929961","eid":"W4241929961"},{"id":"paper-w7171758125","cat":"papers","name":"Microdosing Survey 2023","year":"2026","cit":0,"pfa":"Omer A. Syed","psa":"Rotem Petranker","topics":["Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7171758125","eid":"W7171758125"},{"id":"paper-w2230168110","cat":"papers","name":"[Hallucinogens and the judicial aspect].","year":"1969","cit":0,"pfa":"M Trahan","ptype":"article","src":"https://openalex.org/W2230168110","eid":"W2230168110"},{"id":"paper-w2433509758","cat":"papers","name":"[Problems of hallucinogen dependance].","year":"1969","cit":0,"pfa":"Simone Radouco-Thomas","ptype":"article","src":"https://openalex.org/W2433509758","eid":"W2433509758"},{"id":"paper-w3160054911","cat":"papers","name":"Lumi MicroDose D9","year":"2021","cit":0,"pfa":"Marty Burman","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3160054911","eid":"W3160054911"},{"id":"paper-w2425555095","cat":"papers","name":"[Medical applications of hallucinogens].","year":"1969","cit":0,"pfa":"André Villeneuve","psa":"H E Lehmann","ptype":"article","src":"https://openalex.org/W2425555095","eid":"W2425555095"},{"id":"paper-w2415334416","cat":"papers","name":"[Recent trends in hallucinogens].","year":"1970","cit":0,"pfa":"T. Hirai","ptype":"article","src":"https://openalex.org/W2415334416","eid":"W2415334416"},{"id":"paper-w4244024210","cat":"papers","name":"Hallucinogens and Related Drugs","year":"1995","cit":0,"pfa":"Marc Alan Schuckit","ptype":"book-chapter","src":"https://openalex.org/W4244024210","eid":"W4244024210"},{"id":"paper-w4206441302","cat":"papers","name":"Psychedelics","year":"2011","cit":0,"ptype":"reference-entry","src":"https://openalex.org/W4206441302","eid":"W4206441302"},{"id":"paper-w4415921208","cat":"papers","name":"Psychedelic","year":"2017","cit":0,"ptype":"reference-entry","src":"https://openalex.org/W4415921208","eid":"W4415921208"},{"id":"paper-w2418334173","cat":"papers","name":"[Pharmacological thoughts on hallucinogens].","year":"1971","cit":0,"pfa":"Noach El","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2418334173","eid":"W2418334173"},{"id":"paper-w4206468119","cat":"papers","name":"The Brain's Response to Hallucinogens","year":"2009","cit":0,"ptype":"dataset","src":"https://openalex.org/W4206468119","eid":"W4206468119"},{"id":"paper-w4242854535","cat":"papers","name":"Psychedelic","year":"2019","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W4242854535","eid":"W4242854535"},{"id":"paper-w7114097523","cat":"papers","name":"Psychedelics","cit":0,"ptype":"article","src":"https://openalex.org/W7114097523","eid":"W7114097523"},{"id":"paper-w2312527695","cat":"papers","name":"Giving Hallucinogens a Chance","year":"2013","cit":0,"pfa":"Mitch Earleywine","ptype":"article","src":"https://openalex.org/W2312527695","eid":"W2312527695"},{"id":"paper-w2271732359","cat":"papers","name":"[Hallucinogens: incapacitating agents].","year":"1969","cit":0,"pfa":"J Cheymol","ptype":"article","src":"https://openalex.org/W2271732359","eid":"W2271732359"},{"id":"paper-w2409106786","cat":"papers","name":"[Legal aspects of hallucinogens].","year":"1969","cit":0,"pfa":"A C HARDMAN","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2409106786","eid":"W2409106786"},{"id":"paper-w4243840178","cat":"papers","name":"Psychedelics","year":"2008","cit":0,"pfa":"Marc D. Binder","psa":"Uwe Windhorst","ptype":"reference-entry","src":"https://openalex.org/W4243840178","eid":"W4243840178"},{"id":"paper-w4240623067","cat":"papers","name":"Hallucinogen Use Disorder","year":"2017","cit":0,"pfa":"John H. Halpern","psa":"Vicka Corey","topics":["Addiction"],"ptype":"reference-entry","src":"https://openalex.org/W4240623067","eid":"W4240623067"},{"id":"paper-w4414005377","cat":"papers","name":"Hallucinogen Use Disorder","year":"2025","cit":0,"pfa":"Howard CH Khoe","psa":"Cyrus SH Ho","topics":["Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W4414005377","eid":"W4414005377"},{"id":"paper-w2413319063","cat":"papers","name":"[Hallucinogens: problems of information].","year":"1969","cit":0,"pfa":"P Duceppe","ptype":"article","src":"https://openalex.org/W2413319063","eid":"W2413319063"},{"id":"paper-w68925540","cat":"papers","name":"Alpha-2 and microdosing","year":"2008","cit":0,"pfa":"P. C. Mills","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W68925540","eid":"W68925540"},{"id":"paper-w4240220371","cat":"papers","name":"Psychedelic","year":"2009","cit":0,"ptype":"reference-entry","src":"https://openalex.org/W4240220371","eid":"W4240220371"},{"id":"paper-w2970388272","cat":"papers","name":"Hallucinogens: Unreal Visions","year":"2014","cit":0,"pfa":"Sheila Nelson","ptype":"book","src":"https://openalex.org/W2970388272","eid":"W2970388272"},{"id":"paper-w4234847417","cat":"papers","name":"Transpersonal healing with hallucinogens","year":"2006","cit":0,"pfa":"Roger Marsden","psa":"David G. Lukoff","ptype":"dataset","src":"https://openalex.org/W4234847417","eid":"W4234847417"},{"id":"paper-w7139677888","cat":"papers","name":"Psychedelic","year":"2022","cit":0,"pfa":"Michelle L Gorodisky","ptype":"other","src":"https://openalex.org/W7139677888","eid":"W7139677888"},{"id":"paper-w4302984110","cat":"papers","name":"Phencyclidine-a different hallucinogen.","year":"1977","cit":0,"ptype":"article","src":"https://openalex.org/W4302984110","eid":"W4302984110"},{"id":"paper-w4248049189","cat":"papers","name":"Health benefits of hallucinogens?","year":"2018","cit":0,"ptype":"conference-abstract","src":"https://openalex.org/W4248049189","eid":"W4248049189"},{"id":"paper-w4415153565","cat":"papers","name":"Chapter 5. Hallucinogens: The Mind Field of Oswald: A Case of Hallucinogen Intoxication","year":"2014","cit":0,"pfa":"Elias Dakwar","ptype":"book-chapter","src":"https://openalex.org/W4415153565","eid":"W4415153565"},{"id":"paper-w4410166847","cat":"papers","name":"Sceptical Reflections on Hallucinogens and Other Worlds","year":"2025","cit":0,"pfa":"Dan Wylie","topics":["Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W4410166847","eid":"W4410166847"},{"id":"paper-w4236972802","cat":"papers","name":"Psychedelics","year":"2020","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W4236972802","eid":"W4236972802"},{"id":"paper-w2317553482","cat":"papers","name":"PET microdose study","year":"2011","cit":0,"pfa":"Michio Senda","psa":"Hiromitsu Kageyama","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2317553482","eid":"W2317553482"},{"id":"paper-w3183729812","cat":"papers","name":"Anthropology and hallucinogens. The crossing of speeches","year":"2002","cit":0,"pfa":"Sébastien Petrie","ptype":"article","src":"https://openalex.org/W3183729812","eid":"W3183729812"},{"id":"paper-w4290604087","cat":"papers","name":"[Hallucinogen effects of nutmeg].","year":"1971","cit":0,"ptype":"article","src":"https://openalex.org/W4290604087","eid":"W4290604087"},{"id":"paper-w2501143427","cat":"papers","name":"ON THE MOLECULAR MECHANISM OF ACTION OF HALLUCINOGENS","year":"1978","cit":0,"pfa":"John Smythies","topics":["Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W2501143427","eid":"W2501143427"},{"id":"paper-w4243025355","cat":"papers","name":"Hallucinogen Persisting Perception Disorder","year":"2015","cit":0,"pfa":"Ian P. Stolerman","psa":"Lawrence H. Price","ptype":"reference-entry","src":"https://openalex.org/W4243025355","eid":"W4243025355"},{"id":"paper-w4235999065","cat":"papers","name":"Psychedelics.","year":"2003","cit":0,"pfa":"Imants Barušs","ptype":"book-chapter","src":"https://openalex.org/W4235999065","eid":"W4235999065"},{"id":"paper-w7197954225","cat":"papers","name":"Psychedelics","year":"2023","cit":0,"pfa":"Zolnai Bence Vajk","ptype":"article","src":"https://openalex.org/W7197954225","eid":"W7197954225"},{"id":"paper-w3201406166","cat":"papers","name":"Microdoses of bromine in neuroses","year":"1937","cit":0,"pfa":"A. I. Sheikin","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3201406166","eid":"W3201406166"},{"id":"paper-w2051754990","cat":"papers","name":"Cornucopia of Hallucinogens and Cultures","year":"1977","cit":0,"pfa":"Ronald K. Siegel","ptype":"article","src":"https://openalex.org/W2051754990","eid":"W2051754990"},{"id":"paper-w2224727657","cat":"papers","name":"Behavioral Pharmacology of Hallucinogens","year":"1998","cit":0,"pfa":"Nancy K. Morrison","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W2224727657","eid":"W2224727657"},{"id":"paper-w4240679267","cat":"papers","name":"Hallucinogens and Related Drugs","year":"2006","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W4240679267","eid":"W4240679267"},{"id":"paper-w3190144741","cat":"papers","name":"Hallucinogen rating scale","year":"2020","cit":0,"pfa":"Emmanuel Kiiza Mwesiga","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3190144741","eid":"W3190144741"},{"id":"paper-w2473829689","cat":"papers","name":"[Hallucinogens, a Troyan horse?].","year":"1968","cit":0,"pfa":"van Praag Hm","ptype":"article","src":"https://openalex.org/W2473829689","eid":"W2473829689"},{"id":"paper-w2487002021","cat":"papers","name":"Psychedelic Frontiers in Religion","year":"2015","cit":0,"pfa":"William A. Richards","psa":"G. William Barnard","ptype":"book-chapter","src":"https://openalex.org/W2487002021","eid":"W2487002021"},{"id":"paper-w408230071","cat":"papers","name":"Hallucinogens : unreal visions","year":"2008","cit":0,"pfa":"Sheila Stewart","ptype":"book","src":"https://openalex.org/W408230071","eid":"W408230071"},{"id":"paper-w2589006659","cat":"papers","name":"The mounting evidence for microdosing","year":"2009","cit":0,"pfa":"Graham Lappin","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2589006659","eid":"W2589006659"},{"id":"paper-w7213306369","cat":"papers","name":"Hallucinogen (LSD) Toxicity","year":"2026","cit":0,"pfa":"Meetkumar Dineshbhai Chaudhari","psa":"Helly Desai","topics":["Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W7213306369","eid":"W7213306369"},{"id":"paper-w4414005456","cat":"papers","name":"Hallucinogen Use Disorder","year":"2025","cit":0,"pfa":"Howard CH Khoe","psa":"Cyrus SH Ho","topics":["Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W4414005456","eid":"W4414005456"},{"id":"paper-w4408964478","cat":"papers","name":"Does microdosing work?","year":"2025","cit":0,"pfa":"Sara Novak","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4408964478","eid":"W4408964478"},{"id":"paper-w4414192687","cat":"papers","name":"Hallucinogen Use Disorder","year":"2025","cit":0,"pfa":"Nathen A. Spitz","topics":["Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W4414192687","eid":"W4414192687"},{"id":"paper-w4256593245","cat":"papers","name":"Marijuana General Hallucinogens","year":"1977","cit":0,"pfa":"Herbert Moskowitz","ptype":"dataset","src":"https://openalex.org/W4256593245","eid":"W4256593245"},{"id":"paper-w2033408580","cat":"papers","name":"Subjective Effects of Anti-Cholinergic Hallucinogens","year":"1977","cit":0,"pfa":"Ralph Metzner","ptype":"article","src":"https://openalex.org/W2033408580","eid":"W2033408580"},{"id":"paper-w2989414634","cat":"papers","name":"Hallucinogen Toxicity (Medscape Reference)","year":"2015","cit":0,"pfa":"Joseph L. D’Orazio","psa":"William J. Boroughf","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2989414634","eid":"W2989414634"},{"id":"paper-w2515980854","cat":"papers","name":"Clinical characteristics of Narcotics and Hallucinogens","year":"1998","cit":0,"pfa":"Dong-Yul Oh","ptype":"article","src":"https://openalex.org/W2515980854","eid":"W2515980854"},{"id":"paper-w7105958593","cat":"papers","name":"Looking Again at Psychedelics: Psychedelics Are Not Psychiatric Treatments","year":"2025","cit":0,"pfa":"Ryan, Mark","topics":["PTSD & trauma","Anxiety & end-of-life","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7105958593","eid":"W7105958593"},{"id":"paper-w7105877060","cat":"papers","name":"Looking Again at Psychedelics: Psychedelics Are Not Psychiatric Treatments","year":"2025","cit":0,"pfa":"Ryan, Mark","topics":["PTSD & trauma","Anxiety & end-of-life","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7105877060","eid":"W7105877060"},{"id":"paper-w2420605640","cat":"papers","name":"[Motivation and effect of consumption of hallucinogens].","year":"1976","cit":0,"pfa":"B. Bron","ptype":"article","src":"https://openalex.org/W2420605640","eid":"W2420605640"},{"id":"paper-w28957456","cat":"papers","name":"Cannabis, Hallucinogens and CNS Stimulants.","year":"2003","cit":0,"pfa":"Sandra L. J. Johnson","psa":"Martin A. Cohen","ptype":"book-chapter","src":"https://openalex.org/W28957456","eid":"W28957456"},{"id":"paper-w7105908685","cat":"papers","name":"Looking Again at Psychedelics: Psychedelics Are Not Psychiatric Treatments","year":"2025","cit":0,"pfa":"Ryan, Mark","topics":["PTSD & trauma","Anxiety & end-of-life","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7105908685","eid":"W7105908685"},{"id":"paper-w4234941376","cat":"papers","name":"Personality correlates of hallucinogen use.","year":"1977","cit":0,"pfa":"Khalil Akhtar Khavari","psa":"Mae Humes","ptype":"article","src":"https://openalex.org/W4234941376","eid":"W4234941376"},{"id":"paper-w4411280109","cat":"papers","name":"Psychedelic researchers’ own experiences of psychedelic substances, their link to opinions of psychedelics, and reflections on positionality","year":"2025","cit":0,"pfa":"Jussi Jylkkä","psa":"Aila Mustamo","topics":["Addiction"],"ptype":"preprint","src":"https://openalex.org/W4411280109","eid":"W4411280109"},{"id":"paper-w1864985974","cat":"papers","name":"Chapter 2. Antidepressants, Stimulants, Hallucinogens","year":"1967","cit":0,"pfa":"John H. Biel","topics":["Depression"],"ptype":"book-chapter","src":"https://openalex.org/W1864985974","eid":"W1864985974"},{"id":"paper-w4309697985","cat":"papers","name":"Natural Hallucinogens in Mental Health","year":"2022","cit":0,"pfa":"RAFAEL GUIMARÃES DOS SANTOS","psa":"Jaime E. C. Hallak","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4309697985","eid":"W4309697985"},{"id":"paper-w7155309001","cat":"papers","name":"Hallucinogen Use Prevalence and Comorbidities","year":"2026","cit":0,"pfa":"MJ Kasprzak","topics":["Addiction"],"ptype":"conference-paper","src":"https://openalex.org/W7155309001","eid":"W7155309001"},{"id":"paper-w2343863440","cat":"papers","name":"Hallucinogens: mechanisms and medical complications","year":"2013","cit":0,"pfa":"Ryan H.A. Chan","topics":["Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W2343863440","eid":"W2343863440"},{"id":"paper-w2586375729","cat":"papers","name":"Hallucinogen-LSD Use Disorder","year":"2017","cit":0,"topics":["Depression","Addiction","Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W2586375729","eid":"W2586375729"},{"id":"paper-w339631421","cat":"papers","name":"Variables related to hallucinogen use.","year":"1974","cit":0,"pfa":"Cecil J. Mullins","psa":"Bart M. Vitola","ptype":"dataset","src":"https://openalex.org/W339631421","eid":"W339631421"},{"id":"paper-w2517511257","cat":"papers","name":"The Classification and Pharmacology of Narcotics and Hallucinogens","year":"1998","cit":0,"pfa":"Ihn‐Geun Choi","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2517511257","eid":"W2517511257"},{"id":"paper-w4246697563","cat":"papers","name":"Do You Know...Hallucinogens","year":"2009","cit":0,"ptype":"dataset","src":"https://openalex.org/W4246697563","eid":"W4246697563"},{"id":"paper-w3091694403","cat":"papers","name":"Microdosing of bromine in an organic compound.","year":"1949","cit":0,"pfa":"A Desassis","psa":"M Macheboeuf","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3091694403","eid":"W3091694403"},{"id":"paper-w2572250602","cat":"papers","name":"Hallucinogens and Other Psychoactive Substances","year":"2011","cit":0,"pfa":"G. Hussein Rassool","topics":["Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W2572250602","eid":"W2572250602"},{"id":"paper-w3041374804","cat":"papers","name":"The Psychedelic Psell","year":"2020","cit":0,"pfa":"Richard Goldstein","ptype":"book-chapter","src":"https://openalex.org/W3041374804","eid":"W3041374804"},{"id":"paper-w4401604391","cat":"papers","name":"The Psychedelic Legacy","year":"2023","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W4401604391","eid":"W4401604391"},{"id":"paper-w4414232511","cat":"papers","name":"Psychedelic Ethics","year":"2025","cit":0,"pfa":"Daniel Villiger","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4414232511","eid":"W4414232511"},{"id":"paper-w650325936","cat":"papers","name":"Hallucinogens and ecstasy : the alchemy of the mind","year":"2008","cit":0,"pfa":"Christine Carriere","psa":"Jean-Pierre Lentin","ptype":"book","src":"https://openalex.org/W650325936","eid":"W650325936"},{"id":"paper-w4416916926","cat":"papers","name":"Chapter 8. Hallucinogens and Phencyclidine","year":"2025","cit":0,"pfa":"Jeffrey J. DeVido","psa":"Martin F. Epson","ptype":"book-chapter","src":"https://openalex.org/W4416916926","eid":"W4416916926"},{"id":"paper-w190755576","cat":"papers","name":"The Hallucinogens, PCP, and Related Drugs","year":"1979","cit":0,"pfa":"Marc Alan Schuckit","ptype":"book-chapter","src":"https://openalex.org/W190755576","eid":"W190755576"},{"id":"paper-w4321792350","cat":"papers","name":"22.9: Hallucinogen Toxicity/Poisoning","year":"2023","cit":0,"topics":["Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W4321792350","eid":"W4321792350"},{"id":"paper-w2301101173","cat":"papers","name":"[Use of hallucinogens by adolescents and students].","year":"1971","cit":0,"pfa":"Jeri Fr","psa":"C Sánchez","ptype":"other","src":"https://openalex.org/W2301101173","eid":"W2301101173"},{"id":"paper-w2036142948","cat":"papers","name":"Stimulants, Hallucinogens, and the Generation Gap","year":"1994","cit":0,"pfa":"JAN A. FAWCETT","ptype":"article","src":"https://openalex.org/W2036142948","eid":"W2036142948"},{"id":"paper-w7117974616","cat":"papers","name":"LSD. Hellfire, Hallucinogen, or Remedy?","year":"2025","cit":0,"pfa":"Sibylle Katharina Scholtz","psa":"Achim Langenbucher","ptype":"book-chapter","src":"https://openalex.org/W7117974616","eid":"W7117974616"},{"id":"paper-w2411241447","cat":"papers","name":"[Clinical experience with the misuse of hallucinogens].","year":"1971","cit":0,"pfa":"G Harrer","ptype":"article","src":"https://openalex.org/W2411241447","eid":"W2411241447"},{"id":"paper-w938578258","cat":"papers","name":"The Pharmacology of Hallucinogens and Designer Drugs","year":"1991","cit":0,"pfa":"Norman Stanley Miller","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W938578258","eid":"W938578258"},{"id":"paper-w4414175835","cat":"papers","name":"Can you ‘microdose’ exercise?","year":"2025","cit":0,"pfa":"Hunter Bennett","topics":["Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W4414175835","eid":"W4414175835"},{"id":"paper-w4244013327","cat":"papers","name":"Hallucinogen Dependence, Episodic Use","year":"2020","cit":0,"pfa":"National Cancer Institute","ptype":"reference-entry","src":"https://openalex.org/W4244013327","eid":"W4244013327"},{"id":"paper-w4388224086","cat":"papers","name":"The Psychedelic Sublime","year":"1998","cit":0,"pfa":"Perry Meisel","ptype":"book-chapter","src":"https://openalex.org/W4388224086","eid":"W4388224086"},{"id":"paper-w7143910099","cat":"papers","name":"Psychedelic Air","year":"2003","cit":0,"pfa":"Thomas JAQUES","ptype":"article","src":"https://openalex.org/W7143910099","eid":"W7143910099"},{"id":"paper-w7112193081","cat":"papers","name":"Psychedelic Positionality","year":"2024","cit":0,"pfa":"Jussi Jylkkä","ptype":"preprint","src":"https://openalex.org/W7112193081","eid":"W7112193081"},{"id":"paper-w7209389733","cat":"papers","name":"Psychedelic Mindview_03","year":"2016","cit":0,"ptype":"article","src":"https://openalex.org/W7209389733","eid":"W7209389733"},{"id":"paper-w7209957259","cat":"papers","name":"Psychedelic Mindview_05","year":"2016","cit":0,"ptype":"article","src":"https://openalex.org/W7209957259","eid":"W7209957259"},{"id":"paper-w3013946996","cat":"papers","name":"Stimulants and psychedelics","year":"2019","cit":0,"pfa":"Roger N Bloor","psa":"Xenofon Sgouros","topics":["Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W3013946996","eid":"W3013946996"},{"id":"paper-w2427090711","cat":"papers","name":"[General pharmacology of psychodysleptics (hallucinogens)].","year":"1969","cit":0,"pfa":"Corneille Radouco-Thomas","psa":"Simone Radouco-Thomas","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2427090711","eid":"W2427090711"},{"id":"paper-w2404450628","cat":"papers","name":"[Effects of neuroleptics on the excretion of hallucinogens].","year":"1974","cit":0,"pfa":"P Kanabus","psa":"K Stençka","ptype":"article","src":"https://openalex.org/W2404450628","eid":"W2404450628"},{"id":"paper-w4285031012","cat":"papers","name":"Therapeutic by psychedelic","year":"2015","cit":0,"pfa":"Charles Fleurentin","ptype":"dissertation","src":"https://openalex.org/W4285031012","eid":"W4285031012"},{"id":"paper-w2474839053","cat":"papers","name":"[Pharmacological action spectra of hallucinogens].","year":"1971","cit":0,"pfa":"Waser Pg","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2474839053","eid":"W2474839053"},{"id":"paper-w7112973988","cat":"papers","name":"Behavior changes through psychedelics: perceptions of psychedelic practitioners","year":"2025","cit":0,"pfa":"Jorge Encantado","psa":"Laura Carvalho","ptype":"preprint","src":"https://openalex.org/W7112973988","eid":"W7112973988"},{"id":"paper-w1021469334","cat":"papers","name":"A Review of “The Botany and Chemistry of Hallucinogens”","year":"1974","cit":0,"pfa":"HC Freimuth","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1021469334","eid":"W1021469334"},{"id":"paper-w4405636130","cat":"papers","name":"From psychedelics to cyberdelics: virtual substitutes for psychedelic experience","year":"2024","cit":0,"pfa":"Jakub Schimmelpfennig","psa":"Kamila Jankowiak-Siuda","ptype":"article","src":"https://openalex.org/W4405636130","eid":"W4405636130"},{"id":"paper-w4242052802","cat":"papers","name":"Psychedelic Drugs","year":"2001","cit":0,"pfa":"John Joseph Fenton","ptype":"book-chapter","src":"https://openalex.org/W4242052802","eid":"W4242052802"},{"id":"paper-w4361263058","cat":"papers","name":"Other psychedelics","year":"2023","cit":0,"pfa":"James Linden","psa":"Daniel Robin","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W4361263058","eid":"W4361263058"},{"id":"paper-w4393237690","cat":"papers","name":"AJA Psychedelics","year":"2024","cit":0,"ptype":"article","src":"https://openalex.org/W4393237690","eid":"W4393237690"},{"id":"paper-w2275425682","cat":"papers","name":"[Hallucinogen related mental disorder].","year":"2003","cit":0,"pfa":"Eiichi Senoo","ptype":"article","src":"https://openalex.org/W2275425682","eid":"W2275425682"},{"id":"paper-w2430317626","cat":"papers","name":"[Cannabis as medicine--an hallucinogen for healing?].","year":"2010","cit":0,"pfa":"Andrea Flemmer","ptype":"article","src":"https://openalex.org/W2430317626","eid":"W2430317626"},{"id":"paper-w4252464546","cat":"papers","name":"Mysticism and Psychedelics","year":"2014","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W4252464546","eid":"W4252464546"},{"id":"paper-w2792559604","cat":"papers","name":"The psychedelic trickster","year":"2015","cit":0,"pfa":"David Luke","ptype":"book-chapter","src":"https://openalex.org/W2792559604","eid":"W2792559604"},{"id":"paper-w4401491634","cat":"papers","name":"Psychedelic Envelopment","year":"2024","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W4401491634","eid":"W4401491634"},{"id":"paper-w2437215981","cat":"papers","name":"[Visual field disorders and hallucinogens].","year":"1976","cit":0,"pfa":"P Vérin","psa":"G Hubert","ptype":"article","src":"https://openalex.org/W2437215981","eid":"W2437215981"},{"id":"paper-w3091483964","cat":"papers","name":"Mercury microdosing; Biological applications.","year":"2010","cit":0,"pfa":"J. L. Monnet","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3091483964","eid":"W3091483964"},{"id":"paper-w7164982112","cat":"papers","name":"The psychedelic humanities: A posthuman proposal for the community of psychedelic professionals","year":"2026","cit":0,"pfa":"Daan F. Oostveen","topics":["Safety & adverse events"],"ptype":"conference-paper","src":"https://openalex.org/W7164982112","eid":"W7164982112"},{"id":"paper-w7167575046","cat":"papers","name":"Psychedelics at the Vistula","year":"2026","cit":0,"pfa":"Jakub Greń","psa":"Jan Szczypiński","ptype":"preprint","src":"https://openalex.org/W7167575046","eid":"W7167575046"},{"id":"paper-w4247513973","cat":"papers","name":"LSD 25 AND RELATED HALLUCINOGENS","year":"1966","cit":0,"ptype":"article","src":"https://openalex.org/W4247513973","eid":"W4247513973"},{"id":"paper-w2896963352","cat":"papers","name":"Hallucinogens Related to Parasympathetic Biochemistry","year":"1967","cit":0,"pfa":"Abram Hoffer","psa":"H. Osmond","ptype":"book-chapter","src":"https://openalex.org/W2896963352","eid":"W2896963352"},{"id":"paper-w4238419364","cat":"papers","name":"Introduction: Psychedelics","year":"1967","cit":0,"pfa":"Committee on Mental Health Student","ptype":"book-chapter","src":"https://openalex.org/W4238419364","eid":"W4238419364"},{"id":"paper-w4402748470","cat":"papers","name":"Psychedelic America","year":"2024","cit":0,"pfa":"Aldous Huxley","topics":["Anxiety & end-of-life"],"ptype":"book-chapter","src":"https://openalex.org/W4402748470","eid":"W4402748470"},{"id":"paper-w4301302314","cat":"papers","name":"Psychedelic drugs.","year":"1968","cit":0,"pfa":"Sherman N. Kieffer","psa":"T B Mortiz","ptype":"article","src":"https://openalex.org/W4301302314","eid":"W4301302314"},{"id":"paper-w4246037551","cat":"papers","name":"97. Psychedelic","year":"2019","cit":0,"pfa":"Philip Ording","ptype":"book-chapter","src":"https://openalex.org/W4246037551","eid":"W4246037551"},{"id":"paper-w7211872457","cat":"papers","name":"Psychedelics in Psychiatry","year":"2026","cit":0,"pfa":"Kenneth Shinozuka","psa":"Nolan Williams","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W7211872457","eid":"W7211872457"},{"id":"paper-w4246821938","cat":"papers","name":"Cancer and hallucinogens: a long, strange trip","year":"2010","cit":0,"pfa":"The Lancet Oncology","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4246821938","eid":"W4246821938"},{"id":"paper-w4408650070","cat":"papers","name":"Psychedelic researchers’ own experiences of psychedelic substances, their link to opinions of psychedelics, and reflections on positionality","year":"2025","cit":0,"pfa":"Jussi Jylkkä","psa":"Aila Mustamo","topics":["Addiction"],"ptype":"preprint","src":"https://openalex.org/W4408650070","eid":"W4408650070"},{"id":"paper-w3009400194","cat":"papers","name":"Psychedelics for Psychiatry","year":"2020","cit":0,"pfa":"Joel Yager","ptype":"article","src":"https://openalex.org/W3009400194","eid":"W3009400194"},{"id":"paper-w4389849033","cat":"papers","name":"Decriminalizing Psychedelics","year":"2023","cit":0,"pfa":"Sarah Glazer","topics":["Policy & ethics"],"ptype":"book","src":"https://openalex.org/W4389849033","eid":"W4389849033"},{"id":"paper-w4301001247","cat":"papers","name":"Psychedelic drugs.","year":"1968","cit":0,"pfa":"Sherman N. Kieffer","psa":"T B Moritz","ptype":"article","src":"https://openalex.org/W4301001247","eid":"W4301001247"},{"id":"paper-w4416959117","cat":"papers","name":"Why the future of psychedelic medicine might not be psychedelic at all","year":"2025","cit":0,"pfa":"Sandy Brian Hager","ptype":"other","src":"https://openalex.org/W4416959117","eid":"W4416959117"},{"id":"paper-w2285224539","cat":"papers","name":"Hallucinogens and non-hallucinogenic analogues.","year":"1968","cit":0,"pfa":"Oyeno Et","ptype":"article","src":"https://openalex.org/W2285224539","eid":"W2285224539"},{"id":"paper-w2487197074","cat":"papers","name":"Interaction between Hallucinogens and SSRIs","year":"1995","cit":0,"pfa":"Steven L. Dubovsky","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2487197074","eid":"W2487197074"},{"id":"paper-w2406935343","cat":"papers","name":"[Use of microdoses of nitrogen mustards].","year":"1952","cit":0,"pfa":"R Foit","psa":"R Sieberová","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2406935343","eid":"W2406935343"},{"id":"paper-w7135293518","cat":"papers","name":"Stochastic threshold microdose model","year":"2010","cit":0,"pfa":"Bobby R. Scott","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7135293518","eid":"W7135293518"},{"id":"paper-w4236521860","cat":"papers","name":"Psychedelic Drug","year":"2018","cit":0,"pfa":"Ursula Margarethe Schmidt-Erfurth","psa":"Thomas Kohnen","ptype":"reference-entry","src":"https://openalex.org/W4236521860","eid":"W4236521860"},{"id":"paper-w7114788889","cat":"papers","name":"Psychedelic Ethics","year":"2025","cit":0,"pfa":"Villiger, Daniel","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7114788889","eid":"W7114788889"},{"id":"paper-w3090465017","cat":"papers","name":"On the microdosing of iodine in organic bodies.","year":"2010","cit":0,"pfa":"R MICHEL","psa":"M LAFON","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3090465017","eid":"W3090465017"},{"id":"paper-w7210037684","cat":"papers","name":"Psychedelic Mindview_07","year":"2016","cit":0,"ptype":"article","src":"https://openalex.org/W7210037684","eid":"W7210037684"},{"id":"paper-w4256655520","cat":"papers","name":"Bibliography: Psychedelics","year":"1967","cit":0,"pfa":"Committee on Mental Health Student","ptype":"paratext","src":"https://openalex.org/W4256655520","eid":"W4256655520"},{"id":"paper-w7209318164","cat":"papers","name":"Psychedelic Mindview_04","year":"2016","cit":0,"ptype":"article","src":"https://openalex.org/W7209318164","eid":"W7209318164"},{"id":"paper-w4250025704","cat":"papers","name":"Psychedelic rock","year":"2001","cit":0,"pfa":"Allan F. Moore","ptype":"reference-entry","src":"https://openalex.org/W4250025704","eid":"W4250025704"},{"id":"paper-w4210495187","cat":"papers","name":"Psychedelic relics","year":"2005","cit":0,"ptype":"article","src":"https://openalex.org/W4210495187","eid":"W4210495187"},{"id":"paper-w4390061857","cat":"papers","name":"AJA Psychedelics","year":"2023","cit":0,"ptype":"article","src":"https://openalex.org/W4390061857","eid":"W4390061857"},{"id":"paper-w2090436288","cat":"papers","name":"Psychedelic Trafficking","year":"2001","cit":0,"ptype":"article","src":"https://openalex.org/W2090436288","eid":"W2090436288"},{"id":"paper-w4387488322","cat":"papers","name":"Seven Psychedelic","year":"2012","cit":0,"pfa":"Don Lattin","ptype":"book-chapter","src":"https://openalex.org/W4387488322","eid":"W4387488322"},{"id":"paper-w4242227284","cat":"papers","name":"Enter Psychedelics","year":"2014","cit":0,"pfa":"Arthur Versluis","ptype":"book-chapter","src":"https://openalex.org/W4242227284","eid":"W4242227284"},{"id":"paper-w4213077099","cat":"papers","name":"Chapter 2. Antidepressants, Stimulants, Hallucinogens","year":"1967","cit":0,"pfa":"John H. Biel","topics":["Depression"],"ptype":"book-chapter","src":"https://openalex.org/W4213077099","eid":"W4213077099"},{"id":"paper-w4401951396","cat":"papers","name":"Psychedelic Medicine","year":"2007","cit":0,"ptype":"book","src":"https://openalex.org/W4401951396","eid":"W4401951396"},{"id":"paper-w4210903106","cat":"papers","name":"Psychedelic Science","year":"1997","cit":0,"ptype":"dataset","src":"https://openalex.org/W4210903106","eid":"W4210903106"},{"id":"paper-w7135872651","cat":"papers","name":"Thinking the psychedelic","year":"2018","cit":0,"pfa":"Tadeáš Michalik","ptype":"dissertation","src":"https://openalex.org/W7135872651","eid":"W7135872651"},{"id":"paper-w7160181590","cat":"papers","name":"The Neuropharmacology of Psychedelics","year":"2026","cit":0,"pfa":"Denis Pavăl","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W7160181590","eid":"W7160181590"},{"id":"paper-w2016956104","cat":"papers","name":"Visions for Psychedelics","year":"2006","cit":0,"pfa":"Jamie Talan","ptype":"article","src":"https://openalex.org/W2016956104","eid":"W2016956104"},{"id":"paper-w4254392124","cat":"papers","name":"Psychedelic Illusions","year":"2018","cit":0,"pfa":"Jonathan Weinel","ptype":"book-chapter","src":"https://openalex.org/W4254392124","eid":"W4254392124"},{"id":"paper-w4387775828","cat":"papers","name":"Psychedelic Philosophy","year":"2023","cit":0,"pfa":"Aidan Lyon","topics":["Reviews & meta-analyses"],"ptype":"book-chapter","src":"https://openalex.org/W4387775828","eid":"W4387775828"},{"id":"paper-w4401909734","cat":"papers","name":"Psychedelics (Medline).","year":"2024","cit":0,"pfa":"Jacob White","ptype":"other","src":"https://openalex.org/W4401909734","eid":"W4401909734"},{"id":"paper-w2491628727","cat":"papers","name":"Appendix 3. Medicines and Hallucinogens","year":"1992","cit":0,"ptype":"paratext","src":"https://openalex.org/W2491628727","eid":"W2491628727"},{"id":"paper-w4242594454","cat":"papers","name":"Hallucinogen Persisting Perception Disorder","year":"2010","cit":0,"pfa":"Michael H. Bloch","psa":"Subhash C. Pandey","ptype":"reference-entry","src":"https://openalex.org/W4242594454","eid":"W4242594454"},{"id":"paper-w2411271942","cat":"papers","name":"[Microdose roentgenotherapy of angina pectoris].","year":"1952","cit":0,"pfa":"E HENSEL","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2411271942","eid":"W2411271942"},{"id":"paper-w4250895756","cat":"papers","name":"Hallucinogen Dependence, Continuous Use","year":"2020","cit":0,"pfa":"National Cancer Institute","ptype":"reference-entry","src":"https://openalex.org/W4250895756","eid":"W4250895756"},{"id":"paper-w7164992496","cat":"papers","name":"Psychedelics and Entactogens","year":"2026","cit":0,"pfa":"Craig W. Lindsley","psa":"Christa Elisabeth Müller","ptype":"article","src":"https://openalex.org/W7164992496","eid":"W7164992496"},{"id":"paper-w4252626728","cat":"papers","name":"The Psychedelic Controversy","year":"2020","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W4252626728","eid":"W4252626728"},{"id":"paper-w567619358","cat":"papers","name":"A psychedelic primer","year":"2006","cit":0,"pfa":"Monika Szewczyk","psa":"Vancouver Art Gallery","ptype":"book","src":"https://openalex.org/W567619358","eid":"W567619358"},{"id":"paper-w2916170331","cat":"papers","name":"Psychedelic Birth","year":"2019","cit":0,"pfa":"Wendy Kline","topics":["Addiction","Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W2916170331","eid":"W2916170331"},{"id":"paper-w7209221563","cat":"papers","name":"Psychedelic Mindview_09","year":"2016","cit":0,"ptype":"article","src":"https://openalex.org/W7209221563","eid":"W7209221563"},{"id":"paper-w4415421753","cat":"papers","name":"Psychedelic capitalism","year":"2025","cit":0,"pfa":"Samuel Bendeck Sotillos","ptype":"article","src":"https://openalex.org/W4415421753","eid":"W4415421753"},{"id":"paper-w7209733257","cat":"papers","name":"Psychedelic Mindview_06","year":"2016","cit":0,"ptype":"article","src":"https://openalex.org/W7209733257","eid":"W7209733257"},{"id":"paper-w7210090680","cat":"papers","name":"Psychedelic Mindview_10","year":"2016","cit":0,"ptype":"article","src":"https://openalex.org/W7210090680","eid":"W7210090680"},{"id":"paper-w7202040874","cat":"papers","name":"Psychedelic Renaissance","year":"2026","cit":0,"pfa":"Darren Kelsey","ptype":"book-chapter","src":"https://openalex.org/W7202040874","eid":"W7202040874"},{"id":"paper-w7165312201","cat":"papers","name":"Psychedelics in PTSD","year":"2026","cit":0,"pfa":"iman kiani","topics":["PTSD & trauma"],"ptype":"preprint","src":"https://openalex.org/W7165312201","eid":"W7165312201"},{"id":"paper-w4233800629","cat":"papers","name":"Chapter 2. Antidepressants, Stimulants, Hallucinogens","year":"1966","cit":0,"pfa":"Biel Jh","topics":["Depression"],"ptype":"book-chapter","src":"https://openalex.org/W4233800629","eid":"W4233800629"},{"id":"paper-w2783559807","cat":"papers","name":"Psychedelics and psychiatry","year":"2009","cit":0,"pfa":"Sean Doherty","ptype":"article","src":"https://openalex.org/W2783559807","eid":"W2783559807"},{"id":"paper-w4384849324","cat":"papers","name":"psychedelicize, v.","year":"2023","cit":0,"ptype":"reference-entry","src":"https://openalex.org/W4384849324","eid":"W4384849324"},{"id":"paper-w7165691905","cat":"papers","name":"Psychedelicized: Acceptance of Utility of Psychedelics Prior to Adequate Data","year":"2026","cit":0,"pfa":"Rif S. El‐Mallakh","psa":"Regina L. Woods","ptype":"article","src":"https://openalex.org/W7165691905","eid":"W7165691905"},{"id":"paper-w4413015998","cat":"papers","name":"Are there really non-psychedelic psychedelics? A comparison of lisuride and LSD","year":"2025","cit":0,"pfa":"Scott M. Thompson","ptype":"article","src":"https://openalex.org/W4413015998","eid":"W4413015998"},{"id":"paper-w2040744495","cat":"papers","name":"Microdose coating thickness gauges","year":"1993","cit":0,"pfa":"V. S. Parnasov","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2040744495","eid":"W2040744495"},{"id":"paper-w4311386486","cat":"papers","name":"LSD. Hellfire, Hallucinogen or Remedy?","year":"2022","cit":0,"pfa":"Sibylle Katharina Scholtz","psa":"Achim Langenbucher","ptype":"book-chapter","src":"https://openalex.org/W4311386486","eid":"W4311386486"},{"id":"paper-w2420146715","cat":"papers","name":"THE PSYCHEDELIC EXPERIENCE.","year":"1963","cit":0,"pfa":"C SAVAGE","psa":"James Fadiman","ptype":"article","src":"https://openalex.org/W2420146715","eid":"W2420146715"},{"id":"paper-w4380675230","cat":"papers","name":"Psychedelic spheres","year":"2023","cit":0,"pfa":"Gemma L. Farrell","ptype":"book-chapter","src":"https://openalex.org/W4380675230","eid":"W4380675230"},{"id":"paper-w7161623592","cat":"papers","name":"Understanding Psychedelics","year":"2026","cit":0,"pfa":"Vanessa Bibliowicz","topics":["Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W7161623592","eid":"W7161623592"},{"id":"paper-w4406320186","cat":"papers","name":"Toward a Psychedelic Theodicy: Psychedelic Biomedicine and the Concept of “Risk”","year":"2025","cit":0,"pfa":"Sharday Catherine Mosurinjohn","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4406320186","eid":"W4406320186"},{"id":"paper-w4385036195","cat":"papers","name":"psychedelically, adv.","year":"2023","cit":0,"ptype":"reference-entry","src":"https://openalex.org/W4385036195","eid":"W4385036195"},{"id":"paper-w4415780091","cat":"papers","name":"Psychedelic Intersections","year":"2025","cit":0,"ptype":"paratext","src":"https://openalex.org/W4415780091","eid":"W4415780091"},{"id":"paper-w4410521742","cat":"papers","name":"What is psychedelic?","year":"2025","cit":0,"pfa":"Ayuo Takahashi","ptype":"book-chapter","src":"https://openalex.org/W4410521742","eid":"W4410521742"},{"id":"paper-w7204161988","cat":"papers","name":"Lacan and Psychedelics","year":"2026","cit":0,"pfa":"Nathan Gorelick","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7204161988","eid":"W7204161988"},{"id":"paper-w2041217449","cat":"papers","name":"The Psychedelic Reader.","year":"1966","cit":0,"pfa":"Edward R. Pinckney","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2041217449","eid":"W2041217449"},{"id":"paper-w4230948012","cat":"papers","name":"Psychedelic Drugs","year":"2001","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W4230948012","eid":"W4230948012"},{"id":"paper-w4414909686","cat":"papers","name":"Psychedelic Guru","year":"2025","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W4414909686","eid":"W4414909686"},{"id":"paper-w7161031874","cat":"papers","name":"Psychedelic White","year":"2010","cit":0,"pfa":"Arun Saldanha","ptype":"book","src":"https://openalex.org/W7161031874","eid":"W7161031874"},{"id":"paper-w4214657129","cat":"papers","name":"Psychedelics 2.0","year":"2020","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W4214657129","eid":"W4214657129"},{"id":"paper-w2501396457","cat":"papers","name":"Results: hallucinogens, stimulants, and barbiturates","year":"2010","cit":0,"pfa":"Adam J. Gordon","ptype":"book-chapter","src":"https://openalex.org/W2501396457","eid":"W2501396457"},{"id":"paper-w4290641474","cat":"papers","name":"[Hallucinogens logally classified as narcotics].","year":"1967","cit":0,"ptype":"article","src":"https://openalex.org/W4290641474","eid":"W4290641474"},{"id":"paper-w4406359652","cat":"papers","name":"Psychedelic Projections: Hidden Narratives Shaping Psychedelic Medicine","year":"2025","cit":0,"pfa":"Franklin King","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4406359652","eid":"W4406359652"},{"id":"paper-w4233477830","cat":"papers","name":"Psychedelic Fashion","year":"2010","cit":0,"pfa":"Joel Lobenthal","ptype":"other","src":"https://openalex.org/W4233477830","eid":"W4233477830"},{"id":"paper-w2563528381","cat":"papers","name":"The psychedelic pendulum","year":"2014","cit":0,"pfa":"Chris Orien Blake","psa":"Daniel Meléndez","ptype":"article","src":"https://openalex.org/W2563528381","eid":"W2563528381"},{"id":"paper-w7131793057","cat":"papers","name":"Psychedelic Makeover","year":"2016","cit":0,"ptype":"other","src":"https://openalex.org/W7131793057","eid":"W7131793057"},{"id":"paper-w7128128037","cat":"papers","name":"Psychedelic Phenomenology","year":"2025","cit":0,"pfa":"Muhammad Umair Khan","ptype":"dissertation","src":"https://openalex.org/W7128128037","eid":"W7128128037"},{"id":"paper-w4246571849","cat":"papers","name":"The Psychedelic Screen","year":"2015","cit":0,"ptype":"other","src":"https://openalex.org/W4246571849","eid":"W4246571849"},{"id":"paper-w4409891694","cat":"papers","name":"Neuroscience and Psychedelics","year":"2025","cit":0,"pfa":"Charmaine Husum","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W4409891694","eid":"W4409891694"},{"id":"paper-w7113112589","cat":"papers","name":"Psychedelics and Meditation","year":"2025","cit":0,"pfa":"Zishan Jiwani","ptype":"preprint","src":"https://openalex.org/W7113112589","eid":"W7113112589"},{"id":"paper-w4386857330","cat":"papers","name":"Psychedelics in therapy","year":"2023","cit":0,"pfa":"Thomas Cardoso de Oliveira","psa":"Yelena Caloz","ptype":"article","src":"https://openalex.org/W4386857330","eid":"W4386857330"},{"id":"paper-w4256095430","cat":"papers","name":"L.S.D. 25 AND RELATED HALLUCINOGENS","year":"1966","cit":0,"ptype":"article","src":"https://openalex.org/W4256095430","eid":"W4256095430"},{"id":"paper-w7104577505","cat":"papers","name":"Psychedelic Molecules","year":"2023","cit":0,"pfa":"Morris, Hamilton","ptype":"article","src":"https://openalex.org/W7104577505","eid":"W7104577505"},{"id":"paper-w3090138228","cat":"papers","name":"Microdosing of 2.3-butylene glycol.","year":"1947","cit":0,"pfa":"M. Hooreman","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3090138228","eid":"W3090138228"},{"id":"paper-w7112832971","cat":"papers","name":"Psychedelics & Language","year":"2025","cit":0,"pfa":"Joanna Kuc","ptype":"preprint","src":"https://openalex.org/W7112832971","eid":"W7112832971"},{"id":"paper-w4242742742","cat":"papers","name":"Psychedelic Drugs","year":"1970","cit":0,"pfa":"Harold A. Abramson","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4242742742","eid":"W4242742742"},{"id":"paper-w7111864279","cat":"papers","name":"OCD Psychedelics","year":"2022","cit":0,"pfa":"Sam Moreton","ptype":"preprint","src":"https://openalex.org/W7111864279","eid":"W7111864279"},{"id":"paper-w7198806881","cat":"papers","name":"PSYCHEDELIC CLINIC","year":"2022","cit":0,"pfa":"Matyáš Řehák","psa":"Matyáš Řehák","ptype":"dissertation","src":"https://openalex.org/W7198806881","eid":"W7198806881"},{"id":"paper-w4414193827","cat":"papers","name":"Pharmacotherapies for Hallucinogen Use Disorder","year":"2025","cit":0,"pfa":"Nathen A. Spitz","topics":["Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W4414193827","eid":"W4414193827"},{"id":"paper-w4247596398","cat":"papers","name":"PET microdosing - promises and limitations","year":"2004","cit":0,"topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4247596398","eid":"W4247596398"},{"id":"paper-w4253528081","cat":"papers","name":"Psychedelic Psychology","year":"2006","cit":0,"pfa":"L. M. Leitner","ptype":"article","src":"https://openalex.org/W4253528081","eid":"W4253528081"},{"id":"paper-w4231225116","cat":"papers","name":"Psychedelic rock","year":"2014","cit":0,"pfa":"Jacob A. Cohen","ptype":"reference-entry","src":"https://openalex.org/W4231225116","eid":"W4231225116"},{"id":"paper-w2311877819","cat":"papers","name":"[Hormonal contraception with microdoses of gestagens].","year":"1975","cit":0,"pfa":"Trutko Ns","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W2311877819","eid":"W2311877819"},{"id":"paper-w2560107455","cat":"papers","name":"TECHNOLOGY AND APPLICATIONS OF MICRODOSING SYSTEMS","year":"2011","cit":0,"pfa":"Martin Richter","psa":"S. Kibler","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2560107455","eid":"W2560107455"},{"id":"paper-w4403246702","cat":"papers","name":"Psychedelic science","year":"2024","cit":0,"pfa":"Luna Beauvallet","ptype":"article","src":"https://openalex.org/W4403246702","eid":"W4403246702"},{"id":"paper-w4406313606","cat":"papers","name":"Psychedelic Intersections","year":"2025","cit":0,"ptype":"paratext","src":"https://openalex.org/W4406313606","eid":"W4406313606"},{"id":"paper-w7166954170","cat":"papers","name":"Psychedelics and Metacognition","year":"2026","cit":0,"pfa":"Federico Seragnoli","ptype":"preprint","src":"https://openalex.org/W7166954170","eid":"W7166954170"},{"id":"paper-w4243957614","cat":"papers","name":"Psychedelic help","year":"2017","cit":0,"ptype":"article","src":"https://openalex.org/W4243957614","eid":"W4243957614"},{"id":"paper-w7131379903","cat":"papers","name":"Psychedelic Platitudes","year":"2024","cit":0,"pfa":"Nicolas Langlitz","ptype":"article","src":"https://openalex.org/W7131379903","eid":"W7131379903"},{"id":"paper-w4406973728","cat":"papers","name":"Psychedelics for health","year":"2025","cit":0,"pfa":"Talha Khan Burki","ptype":"article","src":"https://openalex.org/W4406973728","eid":"W4406973728"},{"id":"paper-w4387792969","cat":"papers","name":"Psychedelic Space","year":"2023","cit":0,"pfa":"Aidan Lyon","topics":["Reviews & meta-analyses"],"ptype":"book-chapter","src":"https://openalex.org/W4387792969","eid":"W4387792969"},{"id":"paper-w7131415852","cat":"papers","name":"The Psychedelic Experience","year":"2026","cit":0,"pfa":"University of Colorado Boulder","ptype":"other","src":"https://openalex.org/W7131415852","eid":"W7131415852"},{"id":"paper-w2952293864","cat":"papers","name":"Cannabis and Psychedelics","year":"2016","cit":0,"pfa":"Standish Nd","psa":"J Leanna","ptype":"article","src":"https://openalex.org/W2952293864","eid":"W2952293864"},{"id":"paper-w7209107124","cat":"papers","name":"Psychedelic Mindview_02","year":"2016","cit":0,"ptype":"article","src":"https://openalex.org/W7209107124","eid":"W7209107124"},{"id":"paper-w4302418731","cat":"papers","name":"Psychedelic drugs.","year":"1966","cit":0,"pfa":"L H Nahum","ptype":"article","src":"https://openalex.org/W4302418731","eid":"W4302418731"},{"id":"paper-w4238611556","cat":"papers","name":"Psychedelic Psyche","year":"2011","cit":0,"ptype":"article","src":"https://openalex.org/W4238611556","eid":"W4238611556"},{"id":"paper-w4250428684","cat":"papers","name":"Psychedelic Gardens:","year":"2012","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W4250428684","eid":"W4250428684"},{"id":"paper-w2339594802","cat":"papers","name":"[Contraception by microdose progestational hormones].","year":"1988","cit":0,"pfa":"P Taurand","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2339594802","eid":"W2339594802"},{"id":"paper-w2384557889","cat":"papers","name":"Microdose naloxone for postoperative analgesia","year":"2005","cit":0,"pfa":"Wang Ta","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2384557889","eid":"W2384557889"},{"id":"paper-w7209147065","cat":"papers","name":"Psychedelic Mindview_08","year":"2016","cit":0,"ptype":"article","src":"https://openalex.org/W7209147065","eid":"W7209147065"},{"id":"paper-w7172393119","cat":"papers","name":"Veterans and Psychedelics","year":"2026","cit":0,"pfa":"Michelle Priest","psa":"Paula P. Schnurr","ptype":"book","src":"https://openalex.org/W7172393119","eid":"W7172393119"},{"id":"paper-w7128336478","cat":"papers","name":"Psychedelics in psychology","year":"2019","cit":0,"pfa":"Eliška DRAHÁ","topics":["Addiction"],"ptype":"dissertation","src":"https://openalex.org/W7128336478","eid":"W7128336478"},{"id":"paper-w7118114138","cat":"papers","name":"Psychedelic Capitalism and the Perceptual Threshold","year":"2023","cit":0,"pfa":"Dustin Marlan","topics":["Safety & adverse events","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7118114138","eid":"W7118114138"},{"id":"paper-w2414448988","cat":"papers","name":"[Hallucinogens. Medical and social aspects].","year":"1968","cit":0,"pfa":"C Palenzona","ptype":"article","src":"https://openalex.org/W2414448988","eid":"W2414448988"},{"id":"paper-w7135631362","cat":"papers","name":"Rituals associated with the Use of Hallucinogens","year":"2012","cit":0,"pfa":"Gabriela Sedláková","topics":["Addiction"],"ptype":"dissertation","src":"https://openalex.org/W7135631362","eid":"W7135631362"},{"id":"paper-w4255434562","cat":"papers","name":"Guidelines for Safe Psychotherapeutic Administration of Hallucinogens","year":"2011","cit":0,"pfa":"Matthew W. Johnson","topics":["Therapy practice"],"ptype":"dataset","src":"https://openalex.org/W4255434562","eid":"W4255434562"},{"id":"paper-w7119487083","cat":"papers","name":"Ultraterrestrial Encounters in the Bible: Entheogens as Technologies of Interdimensional Communication","year":"2026","cit":0,"pfa":"Oliver Janich","ptype":"preprint","src":"https://openalex.org/W7119487083","eid":"W7119487083"},{"id":"paper-w2411229119","cat":"papers","name":"[The hallucinogens, especially the current marihuana problem].","year":"1969","cit":0,"pfa":"G Varenne","ptype":"article","src":"https://openalex.org/W2411229119","eid":"W2411229119"},{"id":"paper-w4298358731","cat":"papers","name":"Hallucinogen actions on human brain revealed","year":"2020","cit":0,"pfa":"B.L. Roth","psa":"Ho-Sun Lee","ptype":"article","src":"https://openalex.org/W4298358731","eid":"W4298358731"},{"id":"paper-w2412167328","cat":"papers","name":"[Intravenous microdose antibiotic therapy].","year":"1951","cit":0,"pfa":"Cave Bondi G","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2412167328","eid":"W2412167328"},{"id":"paper-w4392346254","cat":"papers","name":"Perioperative considerations for patients exposed to hallucinogens: an infographic","year":"2024","cit":0,"pfa":"Trent D. Emerick","psa":"Eric S. Schwenk","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4392346254","eid":"W4392346254"},{"id":"paper-w4238223880","cat":"papers","name":"Pharmacological studies of hallucinogens, Report II","year":"1964","cit":0,"pfa":"Meitetsu MATSUOKA","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4238223880","eid":"W4238223880"},{"id":"paper-w4406314233","cat":"papers","name":"God’s Pharmacy: On the Use of Entheogens in Jewish Mystical Traditions","year":"2025","cit":0,"pfa":"Anna Sierka","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4406314233","eid":"W4406314233"},{"id":"paper-w2314468203","cat":"papers","name":"[Control of fertility with microdoses of D'norgestrel].","year":"1973","cit":0,"pfa":"Ruíz Velasco","psa":"Murguía Peñaloza R","topics":["Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W2314468203","eid":"W2314468203"},{"id":"paper-w4407078202","cat":"papers","name":"Psychedelic Use by Practitioners and Therapists: Implications for the Emerging Psychedelic Workforce","year":"2025","cit":0,"pfa":"Adrianne R. Wilson‐Poe","psa":"Philip Todd Korthuis","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4407078202","eid":"W4407078202"},{"id":"paper-w3090529489","cat":"papers","name":"Colorimetric microdosing of thyroxine in thyroid proteins.","year":"1945","cit":0,"pfa":"Jean Baptiste Roche","psa":"R Michel","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3090529489","eid":"W3090529489"},{"id":"paper-w4397046748","cat":"papers","name":"Toad hallucinogen may have benefits","year":"2024","cit":0,"ptype":"article","src":"https://openalex.org/W4397046748","eid":"W4397046748"},{"id":"paper-w7203920104","cat":"papers","name":"Psychedelic, Entheogenic, and Transpersonal Experiences","year":"2026","cit":0,"pfa":"Michael J. Winkelman","topics":["Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W7203920104","eid":"W7203920104"},{"id":"paper-w7112486632","cat":"papers","name":"Entheogen: Envisioning Sustainable Futures through Biomimicry and Parametric Design","year":"2025","cit":0,"pfa":"Perryman, Braden Thomas","topics":["Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W7112486632","eid":"W7112486632"},{"id":"paper-w4404144959","cat":"papers","name":"Free Exercise Challenges to Entheogen Prohibitions: Precedents, Principles, and Issues","year":"2024","cit":0,"pfa":"Kevin Chamow","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4404144959","eid":"W4404144959"},{"id":"paper-w2309763415","cat":"papers","name":"[Habit forming drugs. 2. Hallucinogens].","year":"1969","cit":0,"pfa":"Lennart Kaij","ptype":"article","src":"https://openalex.org/W2309763415","eid":"W2309763415"},{"id":"paper-w4256070029","cat":"papers","name":"Chapter 2. Antidepressants, Stimulants, Hallucinogens","year":"1969","cit":0,"pfa":"M.A. Davis","topics":["Depression"],"ptype":"book-chapter","src":"https://openalex.org/W4256070029","eid":"W4256070029"},{"id":"paper-w4233577773","cat":"papers","name":"Pharmacological studies of hallucinogens Report 1","year":"1962","cit":0,"pfa":"Hideo HOSHIKAWA","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4233577773","eid":"W4233577773"},{"id":"paper-w4415431316","cat":"papers","name":"Chapter 7. Hallucinogens and Related Drugs","year":"2013","cit":0,"pfa":"Torsten Passie","psa":"John H. Halpern","ptype":"book-chapter","src":"https://openalex.org/W4415431316","eid":"W4415431316"},{"id":"paper-w2774688566","cat":"papers","name":"Defontainia: a new Andean hallucinogen [Chile]","year":"1977","cit":0,"pfa":"Richard Evans Schultes","ptype":"article","src":"https://openalex.org/W2774688566","eid":"W2774688566"},{"id":"paper-w4406915158","cat":"papers","name":"Working with historic psychedelic content","year":"2025","cit":0,"pfa":"Hannah Raine-Smith","psa":"J Rose","topics":["PTSD & trauma","Safety & adverse events","Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W4406915158","eid":"W4406915158"},{"id":"paper-w4238495826","cat":"papers","name":"Scientologists Obtain Potent Hallucinogen, QNB","year":"1979","cit":0,"pfa":"Eliot Marshall","ptype":"article","src":"https://openalex.org/W4238495826","eid":"W4238495826"},{"id":"paper-w3091752558","cat":"papers","name":"Microdosing of protein nitrogen, in aqueous humor.","year":"1946","cit":0,"pfa":"N. Vuataz","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3091752558","eid":"W3091752558"},{"id":"paper-w2253999192","cat":"papers","name":"Romantic poets, Hallucinogen-users, and Schizophrenics","year":"2005","cit":0,"pfa":"Zahra Khan","ptype":"dissertation","src":"https://openalex.org/W2253999192","eid":"W2253999192"},{"id":"paper-w7157529541","cat":"papers","name":"Hallucinogen Use and Witnessing Community Violence","year":"2026","cit":0,"pfa":"Euphoria Brown","psa":"Brianna Weimert","topics":["Addiction"],"ptype":"conference-paper","src":"https://openalex.org/W7157529541","eid":"W7157529541"},{"id":"paper-w2420568182","cat":"papers","name":"[PSYCHOANALEPTIC PROPERTIES OF HALLUCINOGENS IN EXPERIMENTAL PHARMACOLOGY].","year":"1996","cit":0,"pfa":"J Thuillier","psa":"J L'Huillier","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2420568182","eid":"W2420568182"},{"id":"paper-w3206366708","cat":"papers","name":"Anthropology of Psychedelics: Flesh of the Gods . The Ritual Use of Hallucinogens. Peter T. Furst, Ed. Praeger, New York, 1972. xvi, 304 pp., illus. $10.","year":"1973","cit":0,"pfa":"Omer C. Stewart","ptype":"article","src":"https://openalex.org/W3206366708","eid":"W3206366708"},{"id":"paper-w4416351947","cat":"papers","name":"5 Microdosing Collective Effervescence","year":"2025","cit":0,"pfa":"Aarushi Bhandari","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W4416351947","eid":"W4416351947"},{"id":"paper-w4253159653","cat":"papers","name":"Anthropology of Psychedelics: Flesh of the Gods . The Ritual Use of Hallucinogens. Peter T. Furst, Ed. Praeger, New York, 1972. xvi, 304 pp., illus. $10.","year":"1973","cit":0,"pfa":"Omer C. Stewart","ptype":"article","src":"https://openalex.org/W4253159653","eid":"W4253159653"},{"id":"paper-w2395388944","cat":"papers","name":"[Psychological aspects of unsupervised use of hallucinogens].","year":"1969","cit":0,"pfa":"Salman Dh","ptype":"article","src":"https://openalex.org/W2395388944","eid":"W2395388944"},{"id":"paper-w2410125428","cat":"papers","name":"[Studies on hallucinogens. VII Synthesis of parahexyl].","year":"1974","cit":0,"pfa":"M Ono","psa":"Tadao Inoue","ptype":"other","src":"https://openalex.org/W2410125428","eid":"W2410125428"},{"id":"paper-w2431803821","cat":"papers","name":"[TREATMENT OF MASTOPATHY WITH MICRODOSES OF POTASSIUM IODIDE].","year":"1964","cit":0,"pfa":"E G Vishniakova","psa":"N. K. Assonova","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2431803821","eid":"W2431803821"},{"id":"paper-w2417908262","cat":"papers","name":"[Typhus therapy with intravenous microdoses of vaccine].","year":"2004","cit":0,"pfa":"A Codino","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2417908262","eid":"W2417908262"},{"id":"paper-w2398011182","cat":"papers","name":"[Contemporary hallucinogens--psychochemical toxic substances].","year":"1966","cit":0,"pfa":"Ziubin Al","psa":"Lysakov Bd","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2398011182","eid":"W2398011182"},{"id":"paper-w4247644408","cat":"papers","name":"Drugs of abuse: hallucinogens and CNS stimulants","year":"2017","cit":0,"pfa":"Hugh McGavock","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W4247644408","eid":"W4247644408"},{"id":"paper-w4229645749","cat":"papers","name":"Researchers exploring therapeutic uses of hallucinogens","year":"2010","cit":0,"ptype":"dataset","src":"https://openalex.org/W4229645749","eid":"W4229645749"},{"id":"paper-w2405886295","cat":"papers","name":"[Hallucinogen excretion in untreated psychiatric patients].","year":"1974","cit":0,"pfa":"P Kanabus","psa":"Hideo Matsumoto","ptype":"article","src":"https://openalex.org/W2405886295","eid":"W2405886295"},{"id":"paper-w7199066636","cat":"papers","name":"The therapeutic potentials of psychedelics","year":"2017","cit":0,"pfa":"Farnoosh Hajighanbari","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7199066636","eid":"W7199066636"},{"id":"paper-w4288077163","cat":"papers","name":"Dreams and psychedelic drugs","year":"2022","cit":0,"pfa":"Greg Mahr","psa":"Christopher Lawrence Drake","ptype":"book-chapter","src":"https://openalex.org/W4288077163","eid":"W4288077163"},{"id":"paper-w4310471630","cat":"papers","name":"The Economic Effects of Psychedelics","year":"2022","cit":0,"pfa":"Ieda Matavelli","ptype":"dataset","src":"https://openalex.org/W4310471630","eid":"W4310471630"},{"id":"paper-w4415153342","cat":"papers","name":"Chapter 9. Hallucinogens and Dissociative Drugs","year":"2016","cit":0,"pfa":"C. Alexander Paleos","ptype":"book-chapter","src":"https://openalex.org/W4415153342","eid":"W4415153342"},{"id":"paper-w2391783461","cat":"papers","name":"The Development of Inequality in Middle Horizon Cusco: Entheogens and Ritual Ceremonies to the Rescue","year":"2016","cit":0,"pfa":"Véronique Bélisle","ptype":"article","src":"https://openalex.org/W2391783461","eid":"W2391783461"},{"id":"paper-w4391168702","cat":"papers","name":"Will psychedelic research and the ‘psychedelic renaissance’ create another generational divide?","year":"2024","cit":0,"pfa":"Erika Dyck","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4391168702","eid":"W4391168702"},{"id":"paper-w2324175331","cat":"papers","name":"Pharmacological studies of hallucinogens, Report II","year":"1964","cit":0,"pfa":"Meitetsu MATSUOKA","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2324175331","eid":"W2324175331"},{"id":"paper-w2415045886","cat":"papers","name":"[Microdose of intravenous hypophysin in expulsion and delivery].","year":"1955","cit":0,"pfa":"Barrientos Contreras R","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2415045886","eid":"W2415045886"},{"id":"paper-w4247655173","cat":"papers","name":"Microdose GnRH for the Stimulation of Low Responders","year":"2004","cit":0,"pfa":"CAM Jansen, KE Tucker","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W4247655173","eid":"W4247655173"},{"id":"paper-w4245426631","cat":"papers","name":"STP (Hallucinogen) 15588‐95‐1","year":"2012","cit":0,"ptype":"other","src":"https://openalex.org/W4245426631","eid":"W4245426631"},{"id":"paper-w4251829436","cat":"papers","name":"Scientologists Obtain Potent Hallucinogen, QNB","year":"1979","cit":0,"pfa":"Eliot Marshall","ptype":"article","src":"https://openalex.org/W4251829436","eid":"W4251829436"},{"id":"paper-w3002940817","cat":"papers","name":"Hallucinogens: Drugs That Make Us Crazy","year":"2013","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W3002940817","eid":"W3002940817"},{"id":"paper-w4238428092","cat":"papers","name":"Appendix: Hallucinogens in the Rgveda, and Other Matters","year":"1975","cit":0,"pfa":"Frits Staal","ptype":"paratext","src":"https://openalex.org/W4238428092","eid":"W4238428092"},{"id":"paper-w4408978262","cat":"papers","name":"Microdosing Buprenorphine in the Acute Care Setting","year":"2025","cit":0,"pfa":"Maureen F. Cooney","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4408978262","eid":"W4408978262"},{"id":"paper-w4401141848","cat":"papers","name":"Introduction: A Psychedelic Becoming","year":"2019","cit":0,"pfa":"Yuk Hui","ptype":"book-chapter","src":"https://openalex.org/W4401141848","eid":"W4401141848"},{"id":"paper-w3146949565","cat":"papers","name":"The mode of action of indolamine and other hallucinogens.","year":"1977","cit":0,"pfa":"Boarder","ptype":"article","src":"https://openalex.org/W3146949565","eid":"W3146949565"},{"id":"paper-w4229877204","cat":"papers","name":"STP (Hallucinogen) 15588‐95‐1","year":"2004","cit":0,"ptype":"other","src":"https://openalex.org/W4229877204","eid":"W4229877204"},{"id":"paper-w2411694326","cat":"papers","name":"Responses to Physical Therapy under a Hallucinogen","year":"1959","cit":0,"pfa":"Arnold J. Isaacs","psa":"Sidney Cohen","ptype":"article","src":"https://openalex.org/W2411694326","eid":"W2411694326"},{"id":"paper-w2240265349","cat":"papers","name":"Hallucinogens, Narcotics and Common Poisonous Plants","year":"2008","cit":0,"pfa":"Raman Dang","ptype":"book-chapter","src":"https://openalex.org/W2240265349","eid":"W2240265349"},{"id":"paper-w2727661052","cat":"papers","name":"Psychedelic Science 2017","year":"2017","cit":0,"pfa":"José Carlos Bouso","ptype":"article","src":"https://openalex.org/W2727661052","eid":"W2727661052"},{"id":"paper-w2408654147","cat":"papers","name":"[The hallucinogen CI 581 and its use in anesthesiology].","year":"1968","cit":0,"pfa":"E Pannacciulli","psa":"Rinaldo Trazzi","ptype":"article","src":"https://openalex.org/W2408654147","eid":"W2408654147"},{"id":"paper-w7203974338","cat":"papers","name":"Entheogens and Amazonian Indigenous Practices: Bridging Healing and Ecological Renewal","year":"2026","cit":0,"pfa":"Esteban Llano-Piedrahíta","topics":["Addiction","Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W7203974338","eid":"W7203974338"},{"id":"paper-w2460264302","cat":"papers","name":"[APROPOS OF OPTIC DISORDERS IN AUTOEXPERIMENTS WITH HALLUCINOGENS].","year":"1964","cit":0,"pfa":"S Grof","ptype":"article","src":"https://openalex.org/W2460264302","eid":"W2460264302"},{"id":"paper-w7171662224","cat":"papers","name":"Psychedelics Knowledge Graph","year":"2026","cit":0,"pfa":"Povilas Karvelis","ptype":"software","src":"https://openalex.org/W7171662224","eid":"W7171662224"},{"id":"paper-w2914264640","cat":"papers","name":"Microdosing / Microfeeding of Pharmaceutical Products into Capsules","year":"2014","cit":0,"pfa":"Eva Faulhammer","psa":"Sara Fathollahi","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2914264640","eid":"W2914264640"},{"id":"paper-w2397468219","cat":"papers","name":"Double bonds, aliphatic chains and hallucinogens.","year":"1979","cit":0,"pfa":"H A ABRAMSON","psa":"Gettner Hh","ptype":"editorial","src":"https://openalex.org/W2397468219","eid":"W2397468219"},{"id":"paper-w2427850141","cat":"papers","name":"[Studies on hallucinogens. VIII Synthesis of DMHP].","year":"1974","cit":0,"pfa":"M Ono","psa":"Tadao Inoue","ptype":"other","src":"https://openalex.org/W2427850141","eid":"W2427850141"},{"id":"paper-w4385677854","cat":"papers","name":"The Future of Psychedelics. Introduction","year":"2016","cit":0,"pfa":"Ben Sessa","psa":"Eileen Worthley","ptype":"book-chapter","src":"https://openalex.org/W4385677854","eid":"W4385677854"},{"id":"paper-w4409045371","cat":"papers","name":"Psychedelics in the medical toolbox?","year":"2025","cit":0,"pfa":"Brian F. Mandell","ptype":"article","src":"https://openalex.org/W4409045371","eid":"W4409045371"},{"id":"paper-w2144492091","cat":"papers","name":"Psychedelic drugs and anesthesia.","year":"1972","cit":0,"pfa":"R Barber","ptype":"article","src":"https://openalex.org/W2144492091","eid":"W2144492091"},{"id":"paper-w4253277866","cat":"papers","name":"1967 and Psychedelic Rock","year":"2010","cit":0,"pfa":"Sheila Whiteley","ptype":"book-chapter","src":"https://openalex.org/W4253277866","eid":"W4253277866"},{"id":"paper-w2932138780","cat":"papers","name":"Theorizing the Psychedelic Experience","year":"2019","cit":0,"pfa":"Roger K. Green","ptype":"book-chapter","src":"https://openalex.org/W2932138780","eid":"W2932138780"},{"id":"paper-w4396716601","cat":"papers","name":"Considerations on the Psychedelic Landscape","year":"2024","cit":0,"pfa":"Anthony P. Bossis","psa":"Charles S. Grob","ptype":"article","src":"https://openalex.org/W4396716601","eid":"W4396716601"},{"id":"paper-w1815758709","cat":"papers","name":"Opinion: Microdosing: safer clinical trials","year":"2010","cit":0,"pfa":"Gill Langley","psa":"Sébastien Farnaud","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1815758709","eid":"W1815758709"},{"id":"paper-w4212893430","cat":"papers","name":"PSYCHEDELIC DRUGS IN PALLIATIVE CARE","year":"2019","cit":0,"pfa":"Beatriz Martins","psa":"Manuel Sardinha","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W4212893430","eid":"W4212893430"},{"id":"paper-w3001789657","cat":"papers","name":"Extinction Rebellion and Psychedelics","year":"2019","cit":0,"pfa":"Ravikumar Kurup","psa":"Parameswara Achutha Kurup","topics":["Addiction","Mechanism & neuroscience"],"ptype":"book","src":"https://openalex.org/W3001789657","eid":"W3001789657"},{"id":"paper-w7165756812","cat":"papers","name":"Ten theses on the politics of psychedelics","year":"2026","cit":0,"pfa":"Oliver Charles Minty Davis","ptype":"article","src":"https://openalex.org/W7165756812","eid":"W7165756812"},{"id":"paper-w332284621","cat":"papers","name":"The Psychedelic Student-Getter.","year":"1969","cit":0,"pfa":"W. Randolph Franklin","ptype":"article","src":"https://openalex.org/W332284621","eid":"W332284621"},{"id":"paper-w2476340536","cat":"papers","name":"Psychedelic Frontiers in Medicine","year":"2015","cit":0,"pfa":"William A. Richards","psa":"G. William Barnard","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"book-chapter","src":"https://openalex.org/W2476340536","eid":"W2476340536"},{"id":"paper-w4401604116","cat":"papers","name":"The Psychedelic (R)Evolution:","year":"2023","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W4401604116","eid":"W4401604116"},{"id":"paper-w4407264801","cat":"papers","name":"Psychedelic Information Theory","year":"2025","cit":0,"pfa":"Jenna Hartel","psa":"Keith Munro","topics":["Reviews & meta-analyses"],"ptype":"conference-paper","src":"https://openalex.org/W4407264801","eid":"W4407264801"},{"id":"paper-w4232267548","cat":"papers","name":"A psychedelic turtle embryo","year":"2019","cit":0,"ptype":"article","src":"https://openalex.org/W4232267548","eid":"W4232267548"},{"id":"paper-w7140154621","cat":"papers","name":"Opinions about Psychedelics","year":"2026","cit":0,"pfa":"Joshua Wilt","psa":"Kathleen C. Pait","ptype":"preprint","src":"https://openalex.org/W7140154621","eid":"W7140154621"},{"id":"paper-w2402686309","cat":"papers","name":"[Anticholinergic hallucinogens in a model of delirium tremens].","year":"1961","cit":0,"pfa":"M Vojtĕchovský","psa":"S Grof","ptype":"article","src":"https://openalex.org/W2402686309","eid":"W2402686309"},{"id":"paper-w3091535547","cat":"papers","name":"Sodium salicylate metabolism; clinical microdoses.","year":"2010","cit":0,"pfa":"Jacques‐Emmanuel Galimard","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3091535547","eid":"W3091535547"},{"id":"paper-w4385016142","cat":"papers","name":"psychedelic trance, n.","year":"2023","cit":0,"ptype":"reference-entry","src":"https://openalex.org/W4385016142","eid":"W4385016142"},{"id":"paper-w4402655970","cat":"papers","name":"Psychedelics and naturalistic spirituality","year":"2024","cit":0,"pfa":"Eric Charles Steinhart","topics":["Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W4402655970","eid":"W4402655970"},{"id":"paper-w4408754193","cat":"papers","name":"What Is a “Psychedelic Experience”?","year":"2025","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W4408754193","eid":"W4408754193"},{"id":"paper-w962954333","cat":"papers","name":"Understanding the psychedelic craze.","year":"1968","cit":0,"pfa":"E Lekisch","ptype":"article","src":"https://openalex.org/W962954333","eid":"W962954333"},{"id":"paper-w2738034988","cat":"papers","name":"Psychedelics, animism and spirituality","year":"2013","cit":0,"pfa":"Andy Letcher","ptype":"article","src":"https://openalex.org/W2738034988","eid":"W2738034988"},{"id":"paper-w2806360608","cat":"papers","name":"The Psychedelic Influence on Philosophy","year":"2016","cit":0,"pfa":"Peter Sjöstedt-H.","ptype":"article","src":"https://openalex.org/W2806360608","eid":"W2806360608"},{"id":"paper-w2952603523","cat":"papers","name":"Psychedelics, entactogens and Psychotherapy","year":"2019","cit":0,"pfa":"Óscar Soto Angona","psa":"Thomas Gargot","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2952603523","eid":"W2952603523"},{"id":"paper-w4240138561","cat":"papers","name":"Mapping the Psychedelic Brain","year":"2021","cit":0,"ptype":"dataset","src":"https://openalex.org/W4240138561","eid":"W4240138561"},{"id":"paper-w2397130389","cat":"papers","name":"[Complications and dangers of hallucinogens. Cytopharmacologic aspects].","year":"1969","cit":0,"pfa":"Gilliane Nosal","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2397130389","eid":"W2397130389"},{"id":"paper-w2410348901","cat":"papers","name":"Microdosing apparatus for topical application of insecticides.","year":"1977","cit":0,"pfa":"Bezuglova Ti","psa":"V A Bezuglov","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2410348901","eid":"W2410348901"},{"id":"paper-w2965789890","cat":"papers","name":"Microdose GnRH for the Stimulation of Low Responders","year":"2018","cit":0,"pfa":"CAM Jansen","psa":"Kathleen Tucker","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W2965789890","eid":"W2965789890"},{"id":"paper-w4237432258","cat":"papers","name":"Review of Psychedelic Reflections.","year":"1984","cit":0,"pfa":"Oakley S. Ray","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4237432258","eid":"W4237432258"},{"id":"paper-w3156416793","cat":"papers","name":"(Psychedelics) Beyond the “Neuro”","year":"2020","cit":0,"pfa":"Emilia Sanabria","ptype":"article","src":"https://openalex.org/W3156416793","eid":"W3156416793"},{"id":"paper-w4390626463","cat":"papers","name":"The Economic Effects of Psychedelics","year":"2022","cit":0,"pfa":"Ieda Matavelli","psa":"Yupei Ma","ptype":"dataset","src":"https://openalex.org/W4390626463","eid":"W4390626463"},{"id":"paper-w4231375182","cat":"papers","name":"Psychedelic Deep Blues:","year":"2018","cit":0,"pfa":"Richard M Mills","ptype":"book-chapter","src":"https://openalex.org/W4231375182","eid":"W4231375182"},{"id":"paper-w4289262510","cat":"papers","name":"The Psychedelic Self at Play","year":"2022","cit":0,"pfa":"James E. Barrett","ptype":"book-chapter","src":"https://openalex.org/W4289262510","eid":"W4289262510"},{"id":"paper-w7141730721","cat":"papers","name":"Psychedelics as Transformative Therapeutics","year":"2023","cit":0,"pfa":"Sydney M. LeFay","topics":["Addiction","Mechanism & neuroscience"],"ptype":"report","src":"https://openalex.org/W7141730721","eid":"W7141730721"},{"id":"paper-w7113563491","cat":"papers","name":"Psychedelics and Well-being","year":"2025","cit":0,"pfa":"Justyna Hobot","ptype":"preprint","src":"https://openalex.org/W7113563491","eid":"W7113563491"},{"id":"paper-w2291404826","cat":"papers","name":"[Apropos of the psychedelic experience].","year":"1966","cit":0,"pfa":"P A BENSOUSSAN","psa":"Joannidès Aa","ptype":"article","src":"https://openalex.org/W2291404826","eid":"W2291404826"},{"id":"paper-w2087103903","cat":"papers","name":"A role for psychedelics in psychiatry?","year":"2005","cit":0,"pfa":"R. A. Sandison","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2087103903","eid":"W2087103903"},{"id":"paper-w4417375396","cat":"papers","name":"Meditation, Medication, and Psychedelics","year":"2022","cit":0,"ptype":"other","src":"https://openalex.org/W4417375396","eid":"W4417375396"},{"id":"paper-w4409891845","cat":"papers","name":"Preparing for a Psychedelic Experience","year":"2025","cit":0,"pfa":"Charmaine Husum","topics":["Safety & adverse events","Mechanism & neuroscience","Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W4409891845","eid":"W4409891845"},{"id":"paper-w2187859964","cat":"papers","name":"The Use of Psychedelic Agents","year":"2010","cit":0,"pfa":"Robert E. Mogar","psa":"Robert W. Aldrich","ptype":"article","src":"https://openalex.org/W2187859964","eid":"W2187859964"},{"id":"paper-w4414724134","cat":"papers","name":"Psychedelics in Palliative Care","year":"2025","cit":0,"pfa":"Megan Miller","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4414724134","eid":"W4414724134"},{"id":"paper-w7135674620","cat":"papers","name":"The effect of psychedelics on sleep","year":"2019","cit":0,"pfa":"Pavla Šachová","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W7135674620","eid":"W7135674620"},{"id":"paper-w7104001589","cat":"papers","name":"Mapping the psychedelic experience","year":"2025","cit":0,"pfa":"Jylkkä, Jussi","ptype":"other","src":"https://openalex.org/W7104001589","eid":"W7104001589"},{"id":"paper-w7125626067","cat":"papers","name":"Psychedelic Treatment of PTSD","cit":0,"pfa":"Liam N. Modlin","topics":["PTSD & trauma"],"ptype":"dissertation","src":"https://openalex.org/W7125626067","eid":"W7125626067"},{"id":"paper-w3049325340","cat":"papers","name":"1. Psychedelic Revival","year":"2019","cit":0,"pfa":"Nicolas Langlitz","ptype":"book-chapter","src":"https://openalex.org/W3049325340","eid":"W3049325340"},{"id":"paper-w7112388665","cat":"papers","name":"Societal Perspectives on Psychedelics: Development of Concerns and Openness Toward Psychedelic Scale","year":"2024","cit":0,"pfa":"Pawel Holas","ptype":"preprint","src":"https://openalex.org/W7112388665","eid":"W7112388665"},{"id":"paper-w1965214207","cat":"papers","name":"Pornography, Psychedelics and Technology","year":"1981","cit":0,"pfa":"Mike Featherstone","ptype":"article","src":"https://openalex.org/W1965214207","eid":"W1965214207"},{"id":"paper-w2020778840","cat":"papers","name":"A role for psychedelics in psychiatry?","year":"2005","cit":0,"pfa":"Tina Read","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2020778840","eid":"W2020778840"},{"id":"paper-w2551032149","cat":"papers","name":"Truly Psychedelic 'Shrooms","year":"2009","cit":0,"topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2551032149","eid":"W2551032149"},{"id":"paper-w2070498897","cat":"papers","name":"Ethics and psychedelic drugs.","year":"1968","cit":0,"pfa":"C. T. Tart","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2070498897","eid":"W2070498897"},{"id":"paper-w4408311416","cat":"papers","name":"Hallucination: Psychedelics and the senses","year":"2025","cit":0,"pfa":"Abou Farman","ptype":"article","src":"https://openalex.org/W4408311416","eid":"W4408311416"},{"id":"paper-w2434252997","cat":"papers","name":"[Microdoses of BCG vaccine in the treatment of cancer].","year":"1992","cit":0,"pfa":"P Rivera","psa":"A Ubilla","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"letter","src":"https://openalex.org/W2434252997","eid":"W2434252997"},{"id":"paper-w2895658261","cat":"papers","name":"Microdose GnRH Agonist Flare Protocol","year":"2017","cit":0,"pfa":"Magued Adel Mikhail","psa":"Botros Rizk","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W2895658261","eid":"W2895658261"},{"id":"paper-w2465068442","cat":"papers","name":"[Fatal poisoning caused by a hallucinogen (glue)].","year":"1974","cit":0,"pfa":"I Kenyeres","psa":"E Bellus","ptype":"article","src":"https://openalex.org/W2465068442","eid":"W2465068442"},{"id":"paper-w2476039714","cat":"papers","name":"12. Date rape drugs and hallucinogens","year":"2013","cit":0,"pfa":"Colleen Dodich","psa":"Monika Siedlarz","ptype":"book-chapter","src":"https://openalex.org/W2476039714","eid":"W2476039714"},{"id":"paper-w3165343645","cat":"papers","name":"The Science of the Psychedelic Renaissance","year":"2021","cit":0,"pfa":"Sayani Basu","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"report","src":"https://openalex.org/W3165343645","eid":"W3165343645"},{"id":"paper-w129955","cat":"papers","name":"The Neurochemistry of Psychedelic Experiences","year":"2003","cit":0,"pfa":"Michael Lyvers","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W129955","eid":"W129955"},{"id":"paper-w4206543531","cat":"papers","name":"25. Psychedelics 2.0","year":"2020","cit":0,"pfa":"Russell C. Crandall","ptype":"book-chapter","src":"https://openalex.org/W4206543531","eid":"W4206543531"},{"id":"paper-w7118010085","cat":"papers","name":"Conclusion: Psychedelic Supermarkets","year":"2025","cit":0,"pfa":"Richard G. Alexander","ptype":"book-chapter","src":"https://openalex.org/W7118010085","eid":"W7118010085"},{"id":"paper-w7165263726","cat":"papers","name":"Biohacking, Yoga, and Psychedelics","year":"2026","cit":0,"pfa":"Stuart Ray Sarbacker","ptype":"article","src":"https://openalex.org/W7165263726","eid":"W7165263726"},{"id":"paper-w2275258719","cat":"papers","name":"INNOVATIVE STRATEDIES FOR DRUG DEVELOPMENT USING MICRODOSING CLINICAL STUDIES (NEDO MICRODOSE-PJ) 2010 (1):INTERNATINAL COMPARISON OF REGULATORY DOCUMENTS CONCERNING MICRODOSE CLINICAL TRIAL","year":"2010","cit":0,"pfa":"Chieko Kurihara","psa":"Yuichi Sugiyama","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"conference-paper","src":"https://openalex.org/W2275258719","eid":"W2275258719"},{"id":"paper-w4405162876","cat":"papers","name":"11 The Psychedelic Legacy","year":"2023","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W4405162876","eid":"W4405162876"},{"id":"paper-w2506382078","cat":"papers","name":"Disorders relating to use of PCP and hallucinogens","year":"2012","cit":0,"pfa":"Henry David Abraham","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W2506382078","eid":"W2506382078"},{"id":"paper-w2586104286","cat":"papers","name":"Informing a Psychedelic Society","year":"2014","cit":0,"pfa":"T. Grady Roberts","topics":["Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2586104286","eid":"W2586104286"},{"id":"paper-w4298148277","cat":"papers","name":"Orienting, latah, and psychedelics","year":"2022","cit":0,"pfa":"A. D. Macleod","ptype":"article","src":"https://openalex.org/W4298148277","eid":"W4298148277"},{"id":"paper-w2318786120","cat":"papers","name":"Psychedelics, Mysticism and Morality","year":"1970","cit":0,"pfa":"Ralph J. Tapia","ptype":"article","src":"https://openalex.org/W2318786120","eid":"W2318786120"},{"id":"paper-w2398429891","cat":"papers","name":"[LSD and psychedelic experiences].","year":"1971","cit":0,"pfa":"Ey H","ptype":"article","src":"https://openalex.org/W2398429891","eid":"W2398429891"},{"id":"paper-w4210427255","cat":"papers","name":"Liberating Psychedelic Masculinity","year":"2021","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W4210427255","eid":"W4210427255"},{"id":"paper-w2933885894","cat":"papers","name":"Modern psychedelic gnosis","year":"2018","cit":0,"pfa":"Christopher H. Partridge","ptype":"book-chapter","src":"https://openalex.org/W2933885894","eid":"W2933885894"},{"id":"paper-w4413224418","cat":"papers","name":"Festina lente: Psychedelics","year":"2025","cit":0,"pfa":"Tonći Mastelić","psa":"Trpimir Glavina","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4413224418","eid":"W4413224418"},{"id":"paper-w2611344673","cat":"papers","name":"Psychedelics and the Religious Experience","year":"2017","cit":0,"pfa":"Chris Elcock","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2611344673","eid":"W2611344673"},{"id":"paper-w7197393249","cat":"papers","name":"Therapeutic potential of psychedelics","year":"2023","cit":0,"pfa":"Milán Endre Faroun","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7197393249","eid":"W7197393249"},{"id":"paper-w2491493939","cat":"papers","name":"Psychedelic Frontiers in Education","year":"2015","cit":0,"pfa":"William A. Richards","psa":"G. William Barnard","ptype":"book-chapter","src":"https://openalex.org/W2491493939","eid":"W2491493939"},{"id":"paper-w4382632281","cat":"papers","name":"AJA Psychedelics ad","year":"2023","cit":0,"ptype":"article","src":"https://openalex.org/W4382632281","eid":"W4382632281"},{"id":"paper-w3094511541","cat":"papers","name":"Contextualizing the Renaissance of Psychedelics","year":"2020","cit":0,"pfa":"Vera Borrmann","psa":"Christopher Coenen","ptype":"article","src":"https://openalex.org/W3094511541","eid":"W3094511541"},{"id":"paper-w4407246065","cat":"papers","name":"Personal history with psychedelics","year":"2025","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W4407246065","eid":"W4407246065"},{"id":"paper-w4243953224","cat":"papers","name":"The psychedelic haze of inflammation","year":"2006","cit":0,"pfa":"Rory Breathnach","ptype":"article","src":"https://openalex.org/W4243953224","eid":"W4243953224"},{"id":"paper-w7160112375","cat":"papers","name":"The Phenomenology of Psychedelic Experiences","year":"2026","cit":0,"pfa":"Denis Pavăl","ptype":"book-chapter","src":"https://openalex.org/W7160112375","eid":"W7160112375"},{"id":"paper-w2272521890","cat":"papers","name":"[Psychodysleptics (hallucinogens): psychiatric complications and dangers].","year":"1969","cit":0,"pfa":"J Y Gosselin","ptype":"article","src":"https://openalex.org/W2272521890","eid":"W2272521890"},{"id":"paper-w3046318474","cat":"papers","name":"Hallucinogens: a Cause of Convulsive Ergot Psychoses","year":"1976","cit":0,"pfa":"Sylvia Dahl Winters","ptype":"article","src":"https://openalex.org/W3046318474","eid":"W3046318474"},{"id":"paper-w2115869030","cat":"papers","name":"LSD and post‐hallucinogen perceptual disorder","year":"1994","cit":0,"pfa":"Julie Madden","ptype":"article","src":"https://openalex.org/W2115869030","eid":"W2115869030"},{"id":"paper-w2526770349","cat":"papers","name":"1 The 5-HT1A receptor and Hallucinogens By","year":"2007","cit":0,"pfa":"Chad J. Reissig","psa":"Umi Microform","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2526770349","eid":"W2526770349"},{"id":"paper-w4366602084","cat":"papers","name":"AJA psychedelic Ad","year":"2023","cit":0,"ptype":"article","src":"https://openalex.org/W4366602084","eid":"W4366602084"},{"id":"paper-w3091318977","cat":"papers","name":"Volumetric microdosing of iodine in organic compounds.","year":"1948","cit":0,"pfa":"R Grangaud","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3091318977","eid":"W3091318977"},{"id":"paper-w3148635624","cat":"papers","name":"Prospective Microdosing Study 2020 Data","year":"2020","cit":0,"pfa":"Hannah Marie Dressler","topics":["Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W3148635624","eid":"W3148635624"},{"id":"paper-w4401491859","cat":"papers","name":"Deeper Learning with Psychedelics","year":"2024","cit":0,"pfa":"DAVID J. BLACKER","ptype":"book","src":"https://openalex.org/W4401491859","eid":"W4401491859"},{"id":"paper-w2420329774","cat":"papers","name":"[Hallucinogens and psychophopic drugs, their hazards and distribution].","year":"1970","cit":0,"pfa":"E Schuster","ptype":"article","src":"https://openalex.org/W2420329774","eid":"W2420329774"},{"id":"paper-w4232829353","cat":"papers","name":"Necrotising vasculitis in a heroin and hallucinogen abuser","year":"1981","cit":0,"ptype":"article","src":"https://openalex.org/W4232829353","eid":"W4232829353"},{"id":"paper-w7197459601","cat":"papers","name":"Psychedelics of pure science","year":"2002","cit":0,"pfa":"Р. В. Яковенко","psa":"R. Yakovenko","ptype":"article","src":"https://openalex.org/W7197459601","eid":"W7197459601"},{"id":"paper-w4387254867","cat":"papers","name":"Psychedelics Old and New","year":"2021","cit":0,"ptype":"other","src":"https://openalex.org/W4387254867","eid":"W4387254867"},{"id":"paper-w2762600846","cat":"papers","name":"Action of proanthocyanidin microdoses on pyruvate in blood","year":"2017","cit":0,"pfa":"Jeļena Krasiļņikova","topics":["Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W2762600846","eid":"W2762600846"},{"id":"paper-w4249768263","cat":"papers","name":"Tips for teens: The truth about hallucinogens","year":"2013","cit":0,"ptype":"dataset","src":"https://openalex.org/W4249768263","eid":"W4249768263"},{"id":"paper-w4396494613","cat":"papers","name":"Deconstructing Psychedelic Phenomenology: A thematic analysis of discrete phases of the psychedelic experience.","year":"2024","cit":0,"pfa":"Hugh McGovern","psa":"Brendan T. Hutchinson","topics":["Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4396494613","eid":"W4396494613"},{"id":"paper-w4249923273","cat":"papers","name":"Psychedelics, animism and spirituality","year":"2014","cit":0,"pfa":"Max Velmans","ptype":"book-chapter","src":"https://openalex.org/W4249923273","eid":"W4249923273"},{"id":"paper-w3032864273","cat":"papers","name":"Microdosing: im Darkroom der Seele","year":"2019","cit":0,"pfa":"Miriam Meckel","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3032864273","eid":"W3032864273"},{"id":"paper-w4320058539","cat":"papers","name":"The Economic Effects of Psychedelics","year":"2022","cit":0,"pfa":"Ieda Matavelli","psa":"Yupei Ma","ptype":"dataset","src":"https://openalex.org/W4320058539","eid":"W4320058539"},{"id":"paper-w4401773712","cat":"papers","name":"Deeper Learning with Psychedelics","year":"2024","cit":0,"pfa":"David J. Blacker","ptype":"book","src":"https://openalex.org/W4401773712","eid":"W4401773712"},{"id":"paper-w7203687533","cat":"papers","name":"SEMANTIC RESTRAINTS AND THE PSYCHEDELICS","year":"1965","cit":0,"pfa":"Howard Jenkins","ptype":"article","src":"https://openalex.org/W7203687533","eid":"W7203687533"},{"id":"paper-w7161061541","cat":"papers","name":"1. Psychedelic Whiteness","year":"2010","cit":0,"pfa":"Arun Saldanha","ptype":"book-chapter","src":"https://openalex.org/W7161061541","eid":"W7161061541"},{"id":"paper-w4200415100","cat":"papers","name":"Psychiatry goes psychedelic","year":"2021","cit":0,"pfa":"Karen O’Leary","ptype":"article","src":"https://openalex.org/W4200415100","eid":"W4200415100"},{"id":"paper-w2959676971","cat":"papers","name":"Hallucinogens Versus EMDR in the Treatment of PTSD","year":"2019","cit":0,"pfa":"Philippe Petrus","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W2959676971","eid":"W2959676971"},{"id":"paper-w2072180748","cat":"papers","name":"Psychedelics Warmed Over","year":"1972","cit":0,"pfa":"William H. McGlothlin","ptype":"article","src":"https://openalex.org/W2072180748","eid":"W2072180748"},{"id":"paper-w4240701469","cat":"papers","name":"Psychedelic Trance on the Web","year":"2018","cit":0,"pfa":"Emília Simão","psa":"Armando Malheiro da Silva","ptype":"book-chapter","src":"https://openalex.org/W4240701469","eid":"W4240701469"},{"id":"paper-w7171273928","cat":"papers","name":"adolescent psychedelic use","year":"2026","cit":0,"pfa":"Michal Sedlák","ptype":"dissertation","src":"https://openalex.org/W7171273928","eid":"W7171273928"},{"id":"paper-w7171645677","cat":"papers","name":"Psychedelics Knowledge Graph","year":"2026","cit":0,"pfa":"Povilas Karvelis","topics":["Mechanism & neuroscience"],"ptype":"software","src":"https://openalex.org/W7171645677","eid":"W7171645677"},{"id":"paper-w2951582184","cat":"papers","name":"Psychedelic Drug Therapy","year":"2015","cit":0,"pfa":"Tony Bossis","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2951582184","eid":"W2951582184"},{"id":"paper-w4310471631","cat":"papers","name":"The Economic Effects of Psychedelics","year":"2022","cit":0,"pfa":"Ieda Matavelli","ptype":"dataset","src":"https://openalex.org/W4310471631","eid":"W4310471631"},{"id":"paper-w4399489474","cat":"papers","name":"Expanding the psychedelic toolkit","year":"2024","cit":0,"pfa":"Katie Kingwell","ptype":"article","src":"https://openalex.org/W4399489474","eid":"W4399489474"},{"id":"paper-w4412390733","cat":"papers","name":"Phenomenology of Psychedelic Experiences","year":"2025","cit":0,"pfa":"Danny Forde","ptype":"book","src":"https://openalex.org/W4412390733","eid":"W4412390733"},{"id":"paper-w4400026086","cat":"papers","name":"Psychedelics as Transformative Therapeutics","year":"2024","cit":0,"pfa":"Roth B.L","psa":"Gumpper R.H","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4400026086","eid":"W4400026086"},{"id":"paper-w2798705797","cat":"papers","name":"Pornography, psychedelics, and technology","year":"1980","cit":0,"pfa":"E. J. Mishan","ptype":"book","src":"https://openalex.org/W2798705797","eid":"W2798705797"},{"id":"paper-w2516031413","cat":"papers","name":"Epidemiology of Narcotics and Psychedelics","year":"1998","cit":0,"pfa":"Kyung Bin Kim","ptype":"article","src":"https://openalex.org/W2516031413","eid":"W2516031413"},{"id":"paper-w1571437557","cat":"papers","name":"The Great Psychedelic Discography","year":"1998","cit":0,"pfa":"Douglas Brown","ptype":"article","src":"https://openalex.org/W1571437557","eid":"W1571437557"},{"id":"paper-w4385591471","cat":"papers","name":"Listen to Psychedelic Rock!","year":"2020","cit":0,"pfa":"Christian Matijas-Mecca","ptype":"book","src":"https://openalex.org/W4385591471","eid":"W4385591471"},{"id":"paper-w7110496745","cat":"papers","name":"Psychedelic and religious experience","year":"2023","cit":0,"pfa":"Marion, Hannah E.","ptype":"dissertation","src":"https://openalex.org/W7110496745","eid":"W7110496745"},{"id":"paper-w4396530758","cat":"papers","name":"Psychedelic Drugs and Creativity","year":"2024","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W4396530758","eid":"W4396530758"},{"id":"paper-w7213581767","cat":"papers","name":"Psychedelics Knowledge Graph","year":"2026","cit":0,"pfa":"Povilas Karvelis","ptype":"software","src":"https://openalex.org/W7213581767","eid":"W7213581767"},{"id":"paper-w3107440499","cat":"papers","name":"The Great Psychedelic Discography","year":"2001","cit":0,"pfa":"Martin C. Strong","ptype":"book","src":"https://openalex.org/W3107440499","eid":"W3107440499"},{"id":"paper-w2499476202","cat":"papers","name":"1967 and Psychedelic Rock","year":"2003","cit":0,"pfa":"Sheila Whiteley","ptype":"book-chapter","src":"https://openalex.org/W2499476202","eid":"W2499476202"},{"id":"paper-w4386262788","cat":"papers","name":"The Economic Effects of Psychedelics","year":"2022","cit":0,"pfa":"Ieda Matavelli","psa":"Yupei Ma","ptype":"dataset","src":"https://openalex.org/W4386262788","eid":"W4386262788"},{"id":"paper-w4413886059","cat":"papers","name":"The Economic Effects of Psychedelics","year":"2022","cit":0,"pfa":"Ieda Matavelli","psa":"Yupei Ma","ptype":"dataset","src":"https://openalex.org/W4413886059","eid":"W4413886059"},{"id":"paper-w3139126221","cat":"papers","name":"Hallucinogen Persisting Perception Disorder (Flashbacks) (292.89)","year":"2017","cit":0,"pfa":"Bill Pelz","ptype":"article","src":"https://openalex.org/W3139126221","eid":"W3139126221"},{"id":"paper-w2340503664","cat":"papers","name":"1. The History of Microdose Clinical Trials","year":"2009","cit":0,"pfa":"Hiroshi Mayahara","topics":["Safety & adverse events","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2340503664","eid":"W2340503664"},{"id":"paper-w4240114034","cat":"papers","name":"Ethics and psychedelic drugs.","year":"1968","cit":0,"pfa":"Charles T. Tart","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4240114034","eid":"W4240114034"},{"id":"paper-w4405467275","cat":"papers","name":"Seeking validity with psychedelics","year":"2024","cit":0,"pfa":"The Lancet Psychiatry","ptype":"article","src":"https://openalex.org/W4405467275","eid":"W4405467275"},{"id":"paper-w4252921622","cat":"papers","name":"Psychedelics, Creativity, and Culture","year":"2020","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W4252921622","eid":"W4252921622"},{"id":"paper-w4248462556","cat":"papers","name":"Nutmeg and epena snuff: differing hallucinogens","year":"1979","cit":0,"ptype":"article","src":"https://openalex.org/W4248462556","eid":"W4248462556"},{"id":"paper-w4242482185","cat":"papers","name":"Diagnostic criteria for 292.89 Hallucinogen Intoxication","year":"2007","cit":0,"ptype":"reference-entry","src":"https://openalex.org/W4242482185","eid":"W4242482185"},{"id":"paper-w4408964412","cat":"papers","name":"Microdosing LSD is not an effective ADHD treatment","year":"2025","cit":0,"pfa":"Grace Wade","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4408964412","eid":"W4408964412"},{"id":"paper-w1710032903","cat":"papers","name":"Chapter 2. Antidepressants, Stimulants, Hallucinogens","year":"1968","cit":0,"pfa":"M.A. Davis","topics":["Depression"],"ptype":"book-chapter","src":"https://openalex.org/W1710032903","eid":"W1710032903"},{"id":"paper-w2096142831","cat":"papers","name":"Hallucinogens and Culture. Peter R. Furst","year":"1982","cit":0,"pfa":"Mary C. Knipmeyer","ptype":"article","src":"https://openalex.org/W2096142831","eid":"W2096142831"},{"id":"paper-w4247547279","cat":"papers","name":"Mind over Matter: The Brain's Response to Hallucinogens","year":"2005","cit":0,"ptype":"dataset","src":"https://openalex.org/W4247547279","eid":"W4247547279"},{"id":"paper-w7156107610","cat":"papers","name":"Autophagy Enhancement with Spermidine and Rapamycin Microdosing","year":"2026","cit":0,"pfa":"MedicOath Autonomous Discovery Engine","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7156107610","eid":"W7156107610"},{"id":"paper-w7155874498","cat":"papers","name":"Autophagy Enhancement with Spermidine and Rapamycin Microdosing","year":"2026","cit":0,"pfa":"MedicOath Autonomous Discovery Engine","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7155874498","eid":"W7155874498"},{"id":"paper-w205114521","cat":"papers","name":"Microdosing on Evaporation from the Surface of a Porous Solid","year":"2001","cit":0,"pfa":"S. I. Krichmar","psa":"Yu. N. Bardachev","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W205114521","eid":"W205114521"},{"id":"paper-w2978693261","cat":"papers","name":"Psychedelic Rays of Sound","year":"2011","cit":0,"pfa":"Stephen L. Whittington","ptype":"article","src":"https://openalex.org/W2978693261","eid":"W2978693261"},{"id":"paper-w4401604503","cat":"papers","name":"The Decline of the Psychedelic Consciousness","year":"2023","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W4401604503","eid":"W4401604503"},{"id":"paper-w3207213466","cat":"papers","name":"Drugs and Mental Disorder. (Book Reviews: The Hallucinogens)","year":"1968","cit":0,"pfa":"Murray E. Jarvik","topics":["Reviews & meta-analyses"],"ptype":"book-review","src":"https://openalex.org/W3207213466","eid":"W3207213466"},{"id":"paper-w2255938392","cat":"papers","name":"Part 2(12): Specific Substances: Hallucinogens","year":"2002","cit":0,"pfa":"J. P. White","psa":"Jim Saunders","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2255938392","eid":"W2255938392"},{"id":"paper-w4403649482","cat":"papers","name":"Meditation, Psychedelics, and Their Pitfalls","year":"2024","cit":0,"pfa":"Jan Benda","topics":["Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W4403649482","eid":"W4403649482"},{"id":"paper-w7207813166","cat":"papers","name":"Psychedelics as prophylactic neuroprotectants","year":"2026","cit":0,"pfa":"Maria Maiarù","ptype":"article","src":"https://openalex.org/W7207813166","eid":"W7207813166"},{"id":"paper-w7138829170","cat":"papers","name":"Other Illuminations. Narrative, Culture and Psychedelics","year":"2025","cit":0,"pfa":"Alberto Ribas-Casasayas","psa":"Ana Luengo","ptype":"article","src":"https://openalex.org/W7138829170","eid":"W7138829170"},{"id":"paper-w7202297501","cat":"papers","name":"Reasons for Psychedelic Use Predict Attitudes Towards Psychedelics and Frequency of Use","year":"2026","cit":0,"pfa":"Calah Jane Fortune","psa":"Kristine Jacquin","ptype":"article","src":"https://openalex.org/W7202297501","eid":"W7202297501"},{"id":"paper-w4235568878","cat":"papers","name":"Psychedelic State Fluid","year":"1966","cit":0,"ptype":"article","src":"https://openalex.org/W4235568878","eid":"W4235568878"},{"id":"paper-w2772169621","cat":"papers","name":"Psychedelic Religious Experience","year":"2004","cit":0,"pfa":"Michael G. Ziegler","ptype":"article","src":"https://openalex.org/W2772169621","eid":"W2772169621"},{"id":"paper-w4312270966","cat":"papers","name":"4. Psychedelic Soul","year":"2019","cit":0,"pfa":"Cohen, Aaron","ptype":"book-chapter","src":"https://openalex.org/W4312270966","eid":"W4312270966"},{"id":"paper-w3043553767","cat":"papers","name":"Features of internet behavior in patients with addiction to hallucinogens","year":"2019","cit":0,"pfa":"A. N. Stolyarenko","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W3043553767","eid":"W3043553767"},{"id":"paper-w7113710935","cat":"papers","name":"How do psychedelic users view links between psychedelics and spiritual struggles?","year":"2025","cit":0,"pfa":"Julie J. Exline","psa":"William Andrew Schutt","ptype":"preprint","src":"https://openalex.org/W7113710935","eid":"W7113710935"},{"id":"paper-w7117970715","cat":"papers","name":"Conclusion: Psychedelic Soldiers","year":"2025","cit":0,"pfa":"Richard G. Alexander","ptype":"book-chapter","src":"https://openalex.org/W7117970715","eid":"W7117970715"},{"id":"paper-w7205007698","cat":"papers","name":"Hallucinogen Symptoms May Mask Migraine Attacks","year":"1981","cit":0,"ptype":"article","src":"https://openalex.org/W7205007698","eid":"W7205007698"},{"id":"paper-w2342166908","cat":"papers","name":"4. Prospects for a PET Microdose Clinical Trial","year":"2009","cit":0,"pfa":"Michio Senda","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2342166908","eid":"W2342166908"},{"id":"paper-w7164195372","cat":"papers","name":"Hallucinogen-Psychosis Associations Are Confounded by Baseline Psychiatric History","year":"2026","cit":0,"pfa":"Jacob T. Steinle","psa":"Ke Xu","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7164195372","eid":"W7164195372"},{"id":"paper-w2746018831","cat":"papers","name":"Healing, knowledge and transcendental experiences of unity : Motivations and experiences of shamanism and entheogens in the Andes.","year":"2016","cit":0,"pfa":"Rasmus Lindahl","ptype":"dissertation","src":"https://openalex.org/W2746018831","eid":"W2746018831"},{"id":"paper-w2342224992","cat":"papers","name":"Drug impairment reviews: marihuana, general hallucinogens.","year":"1977","cit":0,"pfa":"Herbert Moskowitz","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2342224992","eid":"W2342224992"},{"id":"paper-w7160831825","cat":"papers","name":"Psychedelics and Wellbeing in Autistic Populations: A Scoping Review of Literature Since the “Psychedelic Renaissance”","year":"2026","cit":0,"pfa":"Mia MacDermott-University College London","topics":["Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7160831825","eid":"W7160831825"},{"id":"paper-w7167893127","cat":"papers","name":"Strengthening the Psychedelic Safety Net: A Call for a Coordinated Ecosystem of Post-Psychedelic Care","year":"2026","cit":0,"pfa":"Christian Jurlando","psa":"Stacy Rush","topics":["PTSD & trauma","Anxiety & end-of-life","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W7167893127","eid":"W7167893127"},{"id":"paper-w2996632597","cat":"papers","name":"\"Take the existence as a psychedelic experience\": self-care practices with psychedelics: the users' perspectives","year":"2019","cit":0,"pfa":"Carla Alexandra Mendes Soares","ptype":"dissertation","src":"https://openalex.org/W2996632597","eid":"W2996632597"},{"id":"paper-w7128930271","cat":"papers","name":"Persistent Psychedelic-Associated Psychological Disorders","year":"2025","cit":0,"pfa":"Bente Lubahn","psa":"Ebru Kaya","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W7128930271","eid":"W7128930271"},{"id":"paper-w172223892","cat":"papers","name":"Effects of the hallucinogen DPT on operant behavior in mice","year":"2007","cit":0,"pfa":"Aeneas Murnane","psa":"William E. Fantegrossi","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W172223892","eid":"W172223892"},{"id":"paper-w2555058302","cat":"papers","name":"Microdosing: An Emerging Tool for Drug Development","year":"2015","cit":0,"pfa":"Jeeja Pananchery","psa":"Shree D. D. Vispute","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2555058302","eid":"W2555058302"},{"id":"paper-w3164303841","cat":"papers","name":"Homoeopathic remedies:the physics of healing with microdoses","year":"2015","cit":0,"pfa":"Venkata Subbareddi Upasi","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3164303841","eid":"W3164303841"},{"id":"paper-w4401638548","cat":"papers","name":"Physical Dependence on a Microdose of Opioid Substitution Therapy","year":"2024","cit":0,"pfa":"Devina Devdatt Dabholkar","psa":"Sarika Abhijeet Dakshikar","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4401638548","eid":"W4401638548"},{"id":"paper-w4405660401","cat":"papers","name":"Hallucinogen-Related Emergencies Associated With Schizophrenia Risk","year":"2024","cit":0,"pfa":"Katie O’Connor","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4405660401","eid":"W4405660401"},{"id":"paper-w7148845818","cat":"papers","name":"Survey Data on Psychedelic and Non-Psychedelic Mystical-Type Experiences in Polish Adults","year":"2026","cit":0,"pfa":"Michał Owsiak","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W7148845818","eid":"W7148845818"},{"id":"paper-w2339149501","cat":"papers","name":"[Symptoms of hallucinogen and opiate use and withdrawal syndrome].","year":"1981","cit":0,"pfa":"Dieter Ladewig","ptype":"article","src":"https://openalex.org/W2339149501","eid":"W2339149501"},{"id":"paper-w7164455046","cat":"papers","name":"Co-Occurring Hallucinogen Use and Mental Health Symptoms","year":"2026","cit":0,"pfa":"Emerson Hoagland","psa":"Dessa Bergen-Cico","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"conference-paper","src":"https://openalex.org/W7164455046","eid":"W7164455046"},{"id":"paper-w3120828749","cat":"papers","name":"Emerging Treatment Protocols in Psychedelic Medicine","year":"2020","cit":0,"pfa":"Jeffery Neely","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W3120828749","eid":"W3120828749"},{"id":"paper-w7161100665","cat":"papers","name":"Psychedelics and Wellbeing in Autistic Populations: A Scoping Review of Literature Since the “Psychedelic Renaissance”","year":"2026","cit":0,"pfa":"Mia MacDermott","topics":["Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7161100665","eid":"W7161100665"},{"id":"paper-w2154024443","cat":"papers","name":"Can endogenous hallucinogens explain recurrence of hallucinations?","year":"2009","cit":0,"pfa":"Santosh K. Chaturvedi","ptype":"article","src":"https://openalex.org/W2154024443","eid":"W2154024443"},{"id":"paper-w2895331409","cat":"papers","name":"Hallucinogens: Spiritual and Therapeutic Use, Overuse, and Complications","year":"2018","cit":0,"pfa":"Charles S. Grob","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W2895331409","eid":"W2895331409"},{"id":"paper-w4200282158","cat":"papers","name":"2C-x and DOx hallucinogens: a systematic review","year":"2021","cit":0,"pfa":"Iulia-Florentina Darie","psa":"Cătălin Negoiţă","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4200282158","eid":"W4200282158"},{"id":"paper-w4210943516","cat":"papers","name":"Hallucinogen chemistry guides antidepressant drug discovery","year":"2022","cit":0,"pfa":"Bethany A. Halford","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4210943516","eid":"W4210943516"},{"id":"paper-w7154958110","cat":"papers","name":"Correction: Characteristics and mental health of psychedelic mushroom and multi-psychedelic users relative to non-psychedelic users in American adults, 2020–2021","year":"2026","cit":0,"pfa":"Sofia Abramsky-Sze","psa":"Leonard B. Lerer","ptype":"erratum","src":"https://openalex.org/W7154958110","eid":"W7154958110"},{"id":"paper-w4235041919","cat":"papers","name":"Racial and Ethnic Differences in Youth Hallucinogen Use","year":"2003","cit":0,"ptype":"dataset","src":"https://openalex.org/W4235041919","eid":"W4235041919"},{"id":"paper-w4300053638","cat":"papers","name":"The indole hallucinogens--a new look at their mechanisms of action.","year":"1982","cit":0,"topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4300053638","eid":"W4300053638"},{"id":"paper-w2489980634","cat":"papers","name":"The Death and Rebirth of Psychedelic Research","year":"2015","cit":0,"pfa":"William A. Richards","psa":"G. William Barnard","ptype":"book-chapter","src":"https://openalex.org/W2489980634","eid":"W2489980634"},{"id":"paper-w3118820802","cat":"papers","name":"[Reaction on 'Theme-issue Psychedelics'].","year":"2021","cit":0,"pfa":"Jørgensen Os","psa":"P C Groot","ptype":"article","src":"https://openalex.org/W3118820802","eid":"W3118820802"},{"id":"paper-w4412390723","cat":"papers","name":"Prolegomena to a Phenomenology of Psychedelic Experiences","year":"2025","cit":0,"pfa":"Danny Forde","ptype":"book-chapter","src":"https://openalex.org/W4412390723","eid":"W4412390723"},{"id":"paper-w7135168536","cat":"papers","name":"Psychedelic provides OCD relief","year":"2026","cit":0,"pfa":"Chris Simms","ptype":"article","src":"https://openalex.org/W7135168536","eid":"W7135168536"},{"id":"paper-w7213951506","cat":"papers","name":"T138. MAPPING THE GENETIC LANDSCAPE OF HALLUCINOGEN USE PHENOTYPES","year":"2026","cit":0,"pfa":"Walker Rogers","psa":"Joel E. Gelernter","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"conference-abstract","src":"https://openalex.org/W7213951506","eid":"W7213951506"},{"id":"paper-w7126695579","cat":"papers","name":"Empowerment at the Heart of Psychedelic Care To Be or Not to Be, That Is Not the Question","year":"2023","cit":0,"pfa":"Fanny Charrasse","topics":["Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W7126695579","eid":"W7126695579"},{"id":"paper-w2423130626","cat":"papers","name":"[Use of microdoses of copper in the overall treatment of scleroma].","year":"1975","cit":0,"pfa":"Derepa Kp","psa":"Bondarenko Vs","topics":["Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W2423130626","eid":"W2423130626"},{"id":"paper-w7126395836","cat":"papers","name":"Empowerment at the Heart of Psychedelic Care. To Be or Not to Be, That Is Not the Question","year":"2024","cit":0,"pfa":"Nicolas Marquis Fanny Charrasse","topics":["Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W7126395836","eid":"W7126395836"},{"id":"paper-w2604920775","cat":"papers","name":"Pneumatic sprinkling in the weed control of beet with microdoses","year":"1993","cit":0,"pfa":"G. Ade","psa":"V. Tugnoli","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2604920775","eid":"W2604920775"},{"id":"paper-w2358976207","cat":"papers","name":"The function of urinary microdose protein in neonates with hyperbilirubinemia","year":"2012","cit":0,"pfa":"XU Ruo-me","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2358976207","eid":"W2358976207"},{"id":"paper-w2399638041","cat":"papers","name":"Drug therapy today: a hard look at the hallucinogens.","year":"1968","cit":0,"pfa":"J R DiPalma","ptype":"article","src":"https://openalex.org/W2399638041","eid":"W2399638041"},{"id":"paper-w2397148983","cat":"papers","name":"[Influences of repeated microdoses of adrenaline on the vessels of the cochlea].","year":"1962","cit":0,"pfa":"De Vincentiis","psa":"G Croce","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2397148983","eid":"W2397148983"},{"id":"paper-w7213335433","cat":"papers","name":"Weighing the Risks and Benefits of Microdosing Tirzepatide Vials","year":"2026","cit":0,"pfa":"Anne M. Komé","psa":"Klara Rachel Klein","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7213335433","eid":"W7213335433"},{"id":"paper-w2009380848","cat":"papers","name":"Pharmacokinetic Studies in Microdosing and Phase 0 Trials","year":"2008","cit":0,"pfa":"Alex Sparreboom","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2009380848","eid":"W2009380848"},{"id":"paper-w7208560870","cat":"papers","name":"NEDO MicroDose-PJ Closed International Meeting","year":"2010","cit":0,"pfa":"Chieko Kurihara","psa":"Chieko Kurihara","topics":["Dosing & pharmacology"],"ptype":"conference-paper","src":"https://openalex.org/W7208560870","eid":"W7208560870"},{"id":"paper-w4320510951","cat":"papers","name":"FABRICATION AND TESTING THE MEANS FOR VAPORS MICRODOSING OF MATTERS","year":"2022","cit":0,"pfa":"Viktor Nikolaevich Borisov","psa":"Evgeniya Aleksandrovna Chugunova","topics":["Dosing & pharmacology"],"ptype":"conference-paper","src":"https://openalex.org/W4320510951","eid":"W4320510951"},{"id":"paper-w4323360744","cat":"papers","name":"Understanding psychedelic antidepressant action","year":"2023","cit":0,"pfa":"Sarah Crunkhorn","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4323360744","eid":"W4323360744"},{"id":"paper-w4404672145","cat":"papers","name":"Psychedelics and Entactogens: Call for Papers","year":"2024","cit":0,"pfa":"Craig W. Lindsley","psa":"Squire J. Booker","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"editorial","src":"https://openalex.org/W4404672145","eid":"W4404672145"},{"id":"paper-w1598743661","cat":"papers","name":"Flashback: The Return of Psychedelic Medicine","year":"2012","cit":0,"pfa":"Lauren Maurer","ptype":"dissertation","src":"https://openalex.org/W1598743661","eid":"W1598743661"},{"id":"paper-w4409891930","cat":"papers","name":"The Importance of Grounding after Psychedelics","year":"2025","cit":0,"pfa":"Charmaine Husum","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W4409891930","eid":"W4409891930"},{"id":"paper-w2085809465","cat":"papers","name":"Communication with the fertility God via hallucinogens in Tsongaland","year":"1974","cit":0,"pfa":"Thomas F. Johnston","ptype":"article","src":"https://openalex.org/W2085809465","eid":"W2085809465"},{"id":"paper-w2334282943","cat":"papers","name":"Toxicology Rounds: Kitchen Toxicology: Nutmeg (the Hallucinogen)","year":"2011","cit":0,"pfa":"Leon Gussow","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2334282943","eid":"W2334282943"},{"id":"paper-w2418058252","cat":"papers","name":"[Combined therapy with methylthiouracil and microdoses of iodine in thyrotoxicosis].","year":"1953","cit":0,"pfa":"E Z Gincherman","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2418058252","eid":"W2418058252"},{"id":"paper-w2249425746","cat":"papers","name":"A microdosing study to identify chemoresistance in bladder cancer.","year":"2015","cit":0,"pfa":"Helen Chow","psa":"Chong-xian Pan","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W2249425746","eid":"W2249425746"},{"id":"paper-w2937067961","cat":"papers","name":"5 Classic Hallucinogens Studied in the Treatment of Addictions","year":"2018","cit":0,"pfa":"Michael P. Bogenschutz","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2937067961","eid":"W2937067961"},{"id":"paper-w2888265550","cat":"papers","name":"Exploring the Therapeutic Potential of Psychedelics","year":"2018","cit":0,"pfa":"Xavier M. Hernandez","ptype":"article","src":"https://openalex.org/W2888265550","eid":"W2888265550"},{"id":"paper-w3048859722","cat":"papers","name":"20. Fathoming Psychedelic Mysticism","year":"2019","cit":0,"pfa":"Timothy White","ptype":"book-chapter","src":"https://openalex.org/W3048859722","eid":"W3048859722"},{"id":"paper-w4319994310","cat":"papers","name":"Walter Pahnke’s Psychedelic Experience","year":"2023","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W4319994310","eid":"W4319994310"},{"id":"paper-w3090964668","cat":"papers","name":"Colorimetric microdosing of the total proteins of the cerebrospinal fluid.","year":"1947","cit":0,"pfa":"M Macheboeuf","psa":"Pierre Rebeyrotte","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3090964668","eid":"W3090964668"},{"id":"paper-w2383062968","cat":"papers","name":"Change of urinary microdose protein in neonates with hyperbilirubinemia","year":"2001","cit":0,"pfa":"Xiaofang Zhao","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2383062968","eid":"W2383062968"},{"id":"paper-w2232399852","cat":"papers","name":"Double bonds, aliphatic chains, and hallucinogens, updated.","year":"1979","cit":0,"pfa":"Harold A. Abramson","psa":"Henriette H. Gettner","ptype":"editorial","src":"https://openalex.org/W2232399852","eid":"W2232399852"},{"id":"paper-w2406750276","cat":"papers","name":"Endogenous Hallucinogens in Cerebrospinal Fluid Measurement and Meaning","year":"1983","cit":0,"pfa":"George Bosworth Brown","psa":"Richard D. Morin","ptype":"article","src":"https://openalex.org/W2406750276","eid":"W2406750276"},{"id":"paper-w4255903448","cat":"papers","name":"Tolerance to Hallucinogen-Induced Head Twitches in Mice","year":"2014","cit":0,"ptype":"article","src":"https://openalex.org/W4255903448","eid":"W4255903448"},{"id":"paper-w2071900389","cat":"papers","name":"Synthetic predecessor of kassinin: Effects in microdoses in rats","year":"1992","cit":0,"pfa":"N.E. Chepurnova","psa":"Serguei A. Chepurnov","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2071900389","eid":"W2071900389"},{"id":"paper-w2890876583","cat":"papers","name":"Does Microdosing LSD Stimulate Creativity And Productivity?","year":"2018","cit":0,"pfa":"Jessica McGregor","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2890876583","eid":"W2890876583"},{"id":"paper-w4404672109","cat":"papers","name":"Psychedelics and Entactogens: Call for Papers","year":"2024","cit":0,"pfa":"Craig W. Lindsley","psa":"Squire J. Booker","ptype":"paratext","src":"https://openalex.org/W4404672109","eid":"W4404672109"},{"id":"paper-w2425819339","cat":"papers","name":"[BEHAVIORAL AND ELECTROGRAPHIC EFFECTS OF A HALLUCINOGEN IN THE UNRESTRAINED CAT].","year":"1996","cit":0,"pfa":"Arlette Rougeul","psa":"Paul Gogan","ptype":"article","src":"https://openalex.org/W2425819339","eid":"W2425819339"},{"id":"paper-w2474369285","cat":"papers","name":"The 'personality' of the psychedelic drug user.","year":"1971","cit":0,"pfa":"Philip Af","ptype":"article","src":"https://openalex.org/W2474369285","eid":"W2474369285"},{"id":"paper-w2568632154","cat":"papers","name":"Three Waves of Psychedelic Literature","year":"2016","cit":0,"pfa":"Gabriel D. Roberts","topics":["Depression","PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W2568632154","eid":"W2568632154"},{"id":"paper-w4252418084","cat":"papers","name":"Symposium: Psychedelic Drugs and Religion","year":"1968","cit":0,"ptype":"article","src":"https://openalex.org/W4252418084","eid":"W4252418084"},{"id":"paper-w4243338480","cat":"papers","name":"Can Psychedelic Drugs Heal?","year":"2018","cit":0,"ptype":"dataset","src":"https://openalex.org/W4243338480","eid":"W4243338480"},{"id":"paper-w4304110274","cat":"papers","name":"Treating postpartum depression with psychedelics","year":"2022","cit":0,"pfa":"Chaitra Jairaj","topics":["Depression"],"ptype":"report","src":"https://openalex.org/W4304110274","eid":"W4304110274"},{"id":"paper-w4409085038","cat":"papers","name":"1 What Is a “Psychedelic Experience”?","year":"2025","cit":0,"pfa":"Steven J. Gelberg","ptype":"book-chapter","src":"https://openalex.org/W4409085038","eid":"W4409085038"},{"id":"paper-w4416768146","cat":"papers","name":"A community-centered approach to psychedelics","year":"2025","cit":0,"pfa":"Sean M. Viña","ptype":"book-review","src":"https://openalex.org/W4416768146","eid":"W4416768146"},{"id":"paper-w7131402501","cat":"papers","name":"From Climate Distress to Psychedelic Insight: Exploring the Lived Experience of Eco-anxiety and Psychedelics","year":"2026","cit":0,"pfa":"Luisa Čapková","psa":"Ginie Servant Miklos","topics":["Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7131402501","eid":"W7131402501"},{"id":"paper-w2259340323","cat":"papers","name":"[Neuropsychiatric aspects of complications and dangers of the use of hallucinogens].","year":"1969","cit":0,"pfa":"J Labrie","ptype":"article","src":"https://openalex.org/W2259340323","eid":"W2259340323"},{"id":"paper-w2037810731","cat":"papers","name":"Eminence Grise: Psychedelic Researchers Tell It AllEminence Grise: Psychedelic Researchers Tell It All","year":"2005","cit":0,"pfa":"Marlene Dobkin de Ríos","ptype":"article","src":"https://openalex.org/W2037810731","eid":"W2037810731"},{"id":"paper-w7213903830","cat":"papers","name":"AutoPsy - Autobiographical Memories and Psychedelics","year":"2026","cit":0,"pfa":"Samuli Kangaslampi","psa":"Kim P. C. Kuypers","ptype":"dataset","src":"https://openalex.org/W7213903830","eid":"W7213903830"},{"id":"paper-w3197226677","cat":"papers","name":"Oscillatory Components of Psychedelic Experience","year":"2021","cit":0,"pfa":"Paul Grof","topics":["Addiction","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3197226677","eid":"W3197226677"},{"id":"paper-w7161588318","cat":"papers","name":"TRIP: Tracking Research In Psychedelics","year":"2026","cit":0,"pfa":"Brock Pluimer","ptype":"software","src":"https://openalex.org/W7161588318","eid":"W7161588318"},{"id":"paper-w7117656554","cat":"papers","name":"Prospective Study on Psychedelic Experiences","year":"2023","cit":0,"pfa":"Matthias Forstmann","psa":"Christina Sagioglou","topics":["Addiction","Anxiety & end-of-life"],"ptype":"other","src":"https://openalex.org/W7117656554","eid":"W7117656554"},{"id":"paper-w4415912948","cat":"papers","name":"Epistemic phenomenology in psychedelic experience","year":"2025","cit":0,"pfa":"Christopher Kochevar","topics":["Depression","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4415912948","eid":"W4415912948"},{"id":"paper-w7113158551","cat":"papers","name":"Portland Institute for Psychedelic Science","year":"2025","cit":0,"pfa":"M. Kati Lear","psa":"Christina Chwyl","ptype":"preprint","src":"https://openalex.org/W7113158551","eid":"W7113158551"},{"id":"paper-w2396507464","cat":"papers","name":"[The course of disseminated intravascular coagulation with microdoses of heparin].","year":"1985","cit":0,"pfa":"A Castro-Sánchez","psa":"I Valdivia-García","topics":["Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W2396507464","eid":"W2396507464"},{"id":"paper-w2353193173","cat":"papers","name":"[Study on cytotoxicity of microdoses peracetic acid in vitro].","year":"2010","cit":0,"pfa":"Mo Zhou","psa":"Baoxing Li","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W2353193173","eid":"W2353193173"},{"id":"paper-w3162972383","cat":"papers","name":"The Use and Abuse of Psychedelic Experience","year":"1972","cit":0,"pfa":"Theodore Roszak","ptype":"book-chapter","src":"https://openalex.org/W3162972383","eid":"W3162972383"},{"id":"paper-w4394103392","cat":"papers","name":"An Exploration of Naturalistic Psychedelic use","year":"2023","cit":0,"pfa":"Andrew McGahan","ptype":"dataset","src":"https://openalex.org/W4394103392","eid":"W4394103392"},{"id":"paper-w2736633588","cat":"papers","name":"Ebene: Psychedelic Snuff of the Yanomami","year":"2017","cit":0,"pfa":"Kelly Partin","ptype":"article","src":"https://openalex.org/W2736633588","eid":"W2736633588"},{"id":"paper-w4309372511","cat":"papers","name":"InsideEnvironments’s Psychedelic “Psychological Sound”","year":"2022","cit":0,"pfa":"Victor Szabo","ptype":"book-chapter","src":"https://openalex.org/W4309372511","eid":"W4309372511"},{"id":"paper-w4389078921","cat":"papers","name":"Epilogue: A Global History of Psychedelics","year":"2023","cit":0,"pfa":"Mike Jay","ptype":"book-chapter","src":"https://openalex.org/W4389078921","eid":"W4389078921"},{"id":"paper-w7166051511","cat":"papers","name":"Laboratory for Psychedelic Clinical Research","year":"2026","cit":0,"pfa":"Canada Foundation for Innovation | Fondation canadienne pour l'innovation","ptype":"other","src":"https://openalex.org/W7166051511","eid":"W7166051511"},{"id":"paper-w2380430658","cat":"papers","name":"The Application of Psychedelics in Western Psychotherapy","year":"2006","cit":0,"pfa":"Guo Yong-yu","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2380430658","eid":"W2380430658"},{"id":"paper-w4406358747","cat":"papers","name":"Introduction: Crossroads of Psychedelic Studies","year":"2025","cit":0,"pfa":"Jeffrey A. Breau","psa":"Paul Gillis‐Smith","ptype":"article","src":"https://openalex.org/W4406358747","eid":"W4406358747"},{"id":"paper-w4417129118","cat":"papers","name":"Psychedelics as Treatment for Mental Illness","year":"2025","cit":0,"pfa":"Melissa Neathery","ptype":"article","src":"https://openalex.org/W4417129118","eid":"W4417129118"},{"id":"paper-w1194395095","cat":"papers","name":"Application of ivermectin in microdoses for the treatment of bovine hypodermosis","year":"1998","cit":0,"pfa":"Irena Ziomko","psa":"Tomasz Cencek","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1194395095","eid":"W1194395095"},{"id":"paper-w2783004523","cat":"papers","name":"The effect Nitrophosca Fertilizer in Microdose on barley growth","year":"2017","cit":0,"pfa":"Hameda Ibrahim Ahmed Mohammed","psa":"Yassin Mohammed Ibrahim Dagash Supervisor","topics":["Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W2783004523","eid":"W2783004523"},{"id":"paper-w4312601172","cat":"papers","name":"No Hallucination: The Launch of Psychedelic Medicine","year":"2022","cit":0,"pfa":"Kevin Davies","ptype":"article","src":"https://openalex.org/W4312601172","eid":"W4312601172"},{"id":"paper-w2352620030","cat":"papers","name":"The research progress of microdose effect in semiconductor devices","year":"2012","cit":0,"pfa":"Wei Chen","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2352620030","eid":"W2352620030"},{"id":"paper-w2402081897","cat":"papers","name":"[Psychedelics and quasi-mystical experiences].","year":"2012","cit":0,"pfa":"Csaba Szummer","ptype":"article","src":"https://openalex.org/W2402081897","eid":"W2402081897"},{"id":"paper-w7112075759","cat":"papers","name":"The Bright and Dark Side of Psychedelics","year":"2022","cit":0,"pfa":"Paul Seli","psa":"Rotem Petranker","ptype":"preprint","src":"https://openalex.org/W7112075759","eid":"W7112075759"},{"id":"paper-w2416566345","cat":"papers","name":"[The contribution of hallucinogens to the theory of the etiopathogenesis of endogenic psychoses].","year":"1965","cit":0,"pfa":"M Vojtĕchovský","ptype":"article","src":"https://openalex.org/W2416566345","eid":"W2416566345"},{"id":"paper-w2414428144","cat":"papers","name":"[Neuropharmacologic similarities and differences between the hallucinogens and the antidepressants].","year":"1966","cit":0,"pfa":"J Thuillier","psa":"H Nakajima","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2414428144","eid":"W2414428144"},{"id":"paper-w2474129352","cat":"papers","name":"[Use of microdoses of cobalt chloride in the treatment of thrombophlebitis].","year":"1972","cit":0,"pfa":"Iu N Koshel'","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2474129352","eid":"W2474129352"},{"id":"paper-w4242207004","cat":"papers","name":"Patterns of Hallucinogen Use and Initiation: 2004 and 2005","year":"2007","cit":0,"ptype":"dataset","src":"https://openalex.org/W4242207004","eid":"W4242207004"},{"id":"paper-w4384297428","cat":"papers","name":"Microdosing LSD extends sleep the following night","year":"2023","cit":0,"pfa":"Alice Klein","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4384297428","eid":"W4384297428"},{"id":"paper-w4230641790","cat":"papers","name":"Heads: A Biography of Psychedelic America","year":"2018","cit":0,"pfa":"Chris Elcock","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4230641790","eid":"W4230641790"},{"id":"paper-w3112652577","cat":"papers","name":"Psychedelic derivative dampens addiction","year":"2020","cit":0,"pfa":"Katie Kingwell","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W3112652577","eid":"W3112652577"},{"id":"paper-w2406355930","cat":"papers","name":"[Endometrial effects of norethindrone in daily uninterrupted microdoses].","year":"1971","cit":0,"pfa":"R Salum","psa":"E Chapadeiro","topics":["Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W2406355930","eid":"W2406355930"},{"id":"paper-w4396795457","cat":"papers","name":"Do Microdoses of LSD Change Your Mind?","year":"2019","cit":0,"pfa":"Sam R","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4396795457","eid":"W4396795457"},{"id":"paper-w109119024","cat":"papers","name":"Visions, entheogens and the question of illumination in San Juan de la Cruz","year":"2000","cit":0,"pfa":"Antonio Palomo-Lamarca","ptype":"article","src":"https://openalex.org/W109119024","eid":"W109119024"},{"id":"paper-w2464237216","cat":"papers","name":"Look again at psychedelic drugs","year":"2016","cit":0,"pfa":"Ruth Cameron","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2464237216","eid":"W2464237216"},{"id":"paper-w4401253505","cat":"papers","name":"Correction: Psychedelics action and schizophrenia","year":"2024","cit":0,"pfa":"Marzena Maćkowiak","ptype":"erratum","src":"https://openalex.org/W4401253505","eid":"W4401253505"},{"id":"paper-w3164424505","cat":"papers","name":"Psychedelic-Informed Experiential Research","year":"2019","cit":0,"pfa":"Michael Doty","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W3164424505","eid":"W3164424505"},{"id":"paper-w7154861285","cat":"papers","name":"Resetting the default in the psychedelic renaissance","year":"2026","cit":0,"pfa":"Sujit T. Thomas","ptype":"article","src":"https://openalex.org/W7154861285","eid":"W7154861285"},{"id":"paper-w2414909496","cat":"papers","name":"Effect on anticholinergic hallucinogens on the peripheral vegetative functions.","year":"1978","cit":0,"pfa":"L Vokroughlický","psa":"I Pastrnnáková","ptype":"article","src":"https://openalex.org/W2414909496","eid":"W2414909496"},{"id":"paper-w2414857223","cat":"papers","name":"[Teleradiotherapy in dermatology. II. Observations on the use of microdoses].","year":"2002","cit":0,"pfa":"D Boiti","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2414857223","eid":"W2414857223"},{"id":"paper-w2302289751","cat":"papers","name":"Captopril microdose: usefulness in the treatment of hypertensive emergency","year":"2012","cit":0,"pfa":"Santana Téllez","psa":"Tomás Noel","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2302289751","eid":"W2302289751"},{"id":"paper-w2437712583","cat":"papers","name":"Careful research of psychedelics resumes.","year":"1995","cit":0,"pfa":"L Miller","ptype":"article","src":"https://openalex.org/W2437712583","eid":"W2437712583"},{"id":"paper-w1568189669","cat":"papers","name":"EDITORIAL: Ecopsychology and the psychedelic experience","year":"2013","cit":0,"pfa":"David P. Luke","ptype":"editorial","src":"https://openalex.org/W1568189669","eid":"W1568189669"},{"id":"paper-w4243696069","cat":"papers","name":"Psychedelic fauna for psychonaut hunters","year":"2018","cit":0,"pfa":"Laura Orsolini","ptype":"other","src":"https://openalex.org/W4243696069","eid":"W4243696069"},{"id":"paper-w4403403565","cat":"papers","name":"The Psychedelic Experience as an Ethical Experience","year":"2024","cit":0,"pfa":"Virginia Ballesteros","topics":["Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W4403403565","eid":"W4403403565"},{"id":"paper-w7128250590","cat":"papers","name":"Current Psychedelics and Mental Health","year":"2025","cit":0,"ptype":"paratext","src":"https://openalex.org/W7128250590","eid":"W7128250590"},{"id":"paper-w2990473766","cat":"papers","name":"Psychedelic style and embodiment in psytrance","year":"2019","cit":0,"pfa":"Gemma L. Farrell","ptype":"dissertation","src":"https://openalex.org/W2990473766","eid":"W2990473766"},{"id":"paper-w3026041892","cat":"papers","name":"Psychedelics: Science, Medicine and Politics","year":"2020","cit":0,"pfa":"Rick Doblin","ptype":"article","src":"https://openalex.org/W3026041892","eid":"W3026041892"},{"id":"paper-w2790123024","cat":"papers","name":"Book Review: Psychedelic Reflections","year":"1985","cit":0,"pfa":"Melvin G. Goldzband","topics":["Reviews & meta-analyses"],"ptype":"book-review","src":"https://openalex.org/W2790123024","eid":"W2790123024"},{"id":"paper-w2253565431","cat":"papers","name":"A history of psychedelic care services","year":"2015","cit":0,"pfa":"Oak, Annie","psa":"Zevic Mishor","ptype":"book-chapter","src":"https://openalex.org/W2253565431","eid":"W2253565431"},{"id":"paper-w2395478841","cat":"papers","name":"[Infusion administration of microdoses of insulin in the treatment of hyperglycemia].","year":"1980","cit":0,"pfa":"Z Svoboda","psa":"H Polácková","topics":["Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W2395478841","eid":"W2395478841"},{"id":"paper-w3209168211","cat":"papers","name":"Ego-Death: An Investigation into Psychedelics","year":"2020","cit":0,"pfa":"Anthony W. Leung","topics":["Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W3209168211","eid":"W3209168211"},{"id":"paper-w3128018944","cat":"papers","name":"Psychedelic Spirituality and Thinking in Performance","year":"2020","cit":0,"pfa":"Deni Li","ptype":"article","src":"https://openalex.org/W3128018944","eid":"W3128018944"},{"id":"paper-w3200678172","cat":"papers","name":"Adrian Piper’s Psychedelic Drag","year":"2021","cit":0,"pfa":"Deni Li","ptype":"book-chapter","src":"https://openalex.org/W3200678172","eid":"W3200678172"},{"id":"paper-w7127149944","cat":"papers","name":"The emotional architecture of the psychedelic brain","year":"2025","cit":0,"pfa":"Flora Moujaes","psa":"Katrin H. Preller","ptype":"article","src":"https://openalex.org/W7127149944","eid":"W7127149944"},{"id":"paper-w7128514541","cat":"papers","name":"Ipsos Psychedelic Science Poll","year":"2025","cit":0,"pfa":"Ipsos Public Affairs","ptype":"other","src":"https://openalex.org/W7128514541","eid":"W7128514541"},{"id":"paper-w2745820813","cat":"papers","name":"Characteristics of Psychedelics Users in the U.S.","year":"2017","cit":0,"pfa":"Logan Neitzke‐Spruill","topics":["Addiction"],"ptype":"conference-paper","src":"https://openalex.org/W2745820813","eid":"W2745820813"},{"id":"paper-w1990303105","cat":"papers","name":"\"Ethics and psychedelic drugs\": Reply.","year":"1968","cit":0,"pfa":"ROBERT L. TYSON","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1990303105","eid":"W1990303105"},{"id":"paper-w7118304335","cat":"papers","name":"Molecular & Systemic Mechanisms of Psychedelics","year":"2026","cit":0,"pfa":"Shivankan Kakkar","topics":["Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W7118304335","eid":"W7118304335"},{"id":"paper-w4210518934","cat":"papers","name":"\"Ethics and psychedelic drus\": Reply.","year":"1968","cit":0,"topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4210518934","eid":"W4210518934"},{"id":"paper-w3107701382","cat":"papers","name":"Psychedelics in times of pandemic outbreaks","year":"2020","cit":0,"pfa":"Maja Kohek","psa":"José Carlos Bouso","ptype":"article","src":"https://openalex.org/W3107701382","eid":"W3107701382"},{"id":"paper-w4401731957","cat":"papers","name":"Ego dissolution in psychedelic experience","year":"2024","cit":0,"pfa":"Philip Gerrans","topics":["Mechanism & neuroscience","Therapy practice","Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W4401731957","eid":"W4401731957"},{"id":"paper-w4392988492","cat":"papers","name":"Therapeutic Hallucinogens: Altered State Laws For Altered States","year":"2015","cit":0,"pfa":"Mitch Earleywine","psa":"Mallory Loflin","ptype":"other","src":"https://openalex.org/W4392988492","eid":"W4392988492"},{"id":"paper-w4387783168","cat":"papers","name":"Psychedelics as a Holistic Cognitive Enhancement","year":"2023","cit":0,"pfa":"Richard B. Gibson","ptype":"article","src":"https://openalex.org/W4387783168","eid":"W4387783168"},{"id":"paper-w4290624082","cat":"papers","name":"Psychedelic drugs: cannabis and LSD.","year":"1968","cit":0,"ptype":"article","src":"https://openalex.org/W4290624082","eid":"W4290624082"},{"id":"paper-w4230258696","cat":"papers","name":"Why Psychedelics Will Not Go Away","year":"2004","cit":0,"pfa":"Adele Getty","ptype":"dataset","src":"https://openalex.org/W4230258696","eid":"W4230258696"},{"id":"paper-w2988265578","cat":"papers","name":"Psychedelic Affordances in the Musicof Highasakite","year":"2019","cit":0,"pfa":"Jim LeBlanc","ptype":"article","src":"https://openalex.org/W2988265578","eid":"W2988265578"},{"id":"paper-w4401742114","cat":"papers","name":"Psychedelic Trials: Comprised Data?","year":"2024","cit":0,"ptype":"article","src":"https://openalex.org/W4401742114","eid":"W4401742114"},{"id":"paper-w4403066178","cat":"papers","name":"The Use of Psychedelics as an Adjunct to Psychotherapy","year":"2024","cit":0,"pfa":"Jean Schulthess Watt","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4403066178","eid":"W4403066178"},{"id":"paper-w2185200222","cat":"papers","name":"Three Great Psychedelic Pioneers","year":"2001","cit":0,"pfa":"Elizabeth Gips","psa":"David Jay Brown","ptype":"article","src":"https://openalex.org/W2185200222","eid":"W2185200222"},{"id":"paper-w2524405713","cat":"papers","name":"Coming Out Of The Psychedelic Closet","year":"2015","cit":0,"pfa":"Ingrid Walker","ptype":"article","src":"https://openalex.org/W2524405713","eid":"W2524405713"},{"id":"paper-w2419629631","cat":"papers","name":"[The effect of microdoses of Aminazin on healthy and psychic subjects].","year":"1962","cit":0,"pfa":"Skriabin Gi","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2419629631","eid":"W2419629631"},{"id":"paper-w7135538751","cat":"papers","name":"Deleuze and Guattari and the Psychedelic Revival","year":"2023","cit":0,"ptype":"article","src":"https://openalex.org/W7135538751","eid":"W7135538751"},{"id":"paper-w4404672058","cat":"papers","name":"Psychedelics and Entactogens: Call for Papers","year":"2024","cit":0,"pfa":"Craig W. Lindsley","psa":"Squire J. Booker","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"editorial","src":"https://openalex.org/W4404672058","eid":"W4404672058"},{"id":"paper-w2782065166","cat":"papers","name":"Pneumatic spraying for weed control in sugarbeet with microdoses","year":"1993","cit":0,"pfa":"G. Ade","psa":"V. Tugnoli","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2782065166","eid":"W2782065166"},{"id":"paper-w4252281535","cat":"papers","name":"Catnip and related psychedelic compounds","year":"1969","cit":0,"pfa":"V. D. Lynch","ptype":"article","src":"https://openalex.org/W4252281535","eid":"W4252281535"},{"id":"paper-w2522074553","cat":"papers","name":"1. Buddhism and the Psychedelic Connection","year":"2016","cit":0,"pfa":"Douglas Osto","ptype":"book-chapter","src":"https://openalex.org/W2522074553","eid":"W2522074553"},{"id":"paper-w7135636336","cat":"papers","name":"Psychedelics like cultural phenomenon","year":"2008","cit":0,"pfa":"Libor Kubelka","ptype":"dissertation","src":"https://openalex.org/W7135636336","eid":"W7135636336"},{"id":"paper-w4385677306","cat":"papers","name":"CHAPTER 2 Psychedelic Compounds","year":"2016","cit":0,"pfa":"Ben Sessa","psa":"Eileen Worthley","ptype":"book-chapter","src":"https://openalex.org/W4385677306","eid":"W4385677306"},{"id":"paper-w4386688426","cat":"papers","name":"Introduction: The Psychedelic Renaissance Continues","year":"2019","cit":0,"pfa":"Michael Winkelman","psa":"Ben Sessa","ptype":"other","src":"https://openalex.org/W4386688426","eid":"W4386688426"},{"id":"paper-w3198789189","cat":"papers","name":"The Causes of and Concerns with the Psychedelic Renaissance","year":"2019","cit":0,"pfa":"Danielle Marrisa Heffner","ptype":"article","src":"https://openalex.org/W3198789189","eid":"W3198789189"},{"id":"paper-w4307481516","cat":"papers","name":"Editors' Introduction to Psychedelic Medicine","year":"2022","cit":0,"pfa":"Peter S. Hendricks","psa":"Charles David Nichols","ptype":"editorial","src":"https://openalex.org/W4307481516","eid":"W4307481516"},{"id":"paper-w3033891004","cat":"papers","name":"The Nature of Healing in the Psychedelic Experience","year":"2020","cit":0,"pfa":"Alex Criddle","topics":["PTSD & trauma","Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3033891004","eid":"W3033891004"},{"id":"paper-w4385442471","cat":"papers","name":"Establishing an Ethics for Psychedelic Psychiatry","year":"2023","cit":0,"pfa":"Brian James Holoyda","psa":"Cameron H. Kiani","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4385442471","eid":"W4385442471"},{"id":"paper-w4401773725","cat":"papers","name":"Chapter 4: Psychedelic Envelopment","year":"2024","cit":0,"pfa":"David J. Blacker","ptype":"book-chapter","src":"https://openalex.org/W4401773725","eid":"W4401773725"},{"id":"paper-w4285722007","cat":"papers","name":"Psychedelics and the path to self-actualization","year":"2020","cit":0,"pfa":"Derek Rasor","ptype":"dataset","src":"https://openalex.org/W4285722007","eid":"W4285722007"},{"id":"paper-w4294276815","cat":"papers","name":"Psychedelics take on alcohol dependence","year":"2022","cit":0,"pfa":"Katie Kingwell","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4294276815","eid":"W4294276815"},{"id":"paper-w103604221","cat":"papers","name":"[LSD and related hallucinogens. History--effect--use and dangers].","year":"1967","cit":0,"pfa":"GRAHAM J. HOLE","ptype":"other","src":"https://openalex.org/W103604221","eid":"W103604221"},{"id":"paper-w2995479661","cat":"papers","name":"Neuropsychedelia. The revival of hallucinogen research since the Decade of the brain","year":"2017","cit":0,"pfa":"Milana Aronov","ptype":"article","src":"https://openalex.org/W2995479661","eid":"W2995479661"},{"id":"paper-w7202368975","cat":"papers","name":"Psychedelics, subjectivity, and self-awareness","year":"2026","cit":0,"pfa":"Uzair Khan","ptype":"article","src":"https://openalex.org/W7202368975","eid":"W7202368975"},{"id":"paper-w2339899763","cat":"papers","name":"3. Practical Considerations in a Microdosing Clinical Study","year":"2009","cit":0,"pfa":"Yasuhiko Ikeda","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2339899763","eid":"W2339899763"},{"id":"paper-w2912569241","cat":"papers","name":"Psychedelic fauna for psychonaut hunters","year":"2019","cit":0,"pfa":"Laura Orsolini","psa":"Fabrizio Schifano","ptype":"article","src":"https://openalex.org/W2912569241","eid":"W2912569241"},{"id":"paper-w3009986547","cat":"papers","name":"Trip: Psychedelics, Alienation, and Change","year":"2020","cit":0,"pfa":"Brent D. Schnipke","ptype":"book-review","src":"https://openalex.org/W3009986547","eid":"W3009986547"},{"id":"paper-w4404671891","cat":"papers","name":"Psychedelics and Entactogens: Call for Papers","year":"2024","cit":0,"pfa":"Craig W. Lindsley","psa":"Squire J. Booker","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"editorial","src":"https://openalex.org/W4404671891","eid":"W4404671891"},{"id":"paper-w7203699625","cat":"papers","name":"Introduction: SEARCH AND RESEARCH WITH THE PSYCHEDELICS","year":"1965","cit":0,"pfa":"Robert E. Mogar","ptype":"article","src":"https://openalex.org/W7203699625","eid":"W7203699625"},{"id":"paper-w4205437634","cat":"papers","name":"Group to study psychedelic phenomena","year":"1968","cit":0,"ptype":"dataset","src":"https://openalex.org/W4205437634","eid":"W4205437634"},{"id":"paper-w2300246526","cat":"papers","name":"[Cannabis--subcultures and psychedelic philosphy].","year":"1976","cit":0,"pfa":"Jonas Hartelius","ptype":"other","src":"https://openalex.org/W2300246526","eid":"W2300246526"},{"id":"paper-w3208411428","cat":"papers","name":"Open Science in Psychedelic Research","year":"2020","cit":0,"pfa":"Michiel van Elk","ptype":"preprint","src":"https://openalex.org/W3208411428","eid":"W3208411428"},{"id":"paper-w2006360854","cat":"papers","name":"Catnip and Related Psychedelic Compounds","year":"1969","cit":0,"pfa":"Joseph M. Benforado","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2006360854","eid":"W2006360854"},{"id":"paper-w2372261356","cat":"papers","name":"The Fuzzy Temperature Control of Vacuum Microdosing Equipment","year":"2005","cit":0,"pfa":"Chengying Shi","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2372261356","eid":"W2372261356"},{"id":"paper-w2374260344","cat":"papers","name":"Clinical observation on the microdose proteinuria in patients with hypertension","year":"2006","cit":0,"pfa":"Cui Xiu-ta","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2374260344","eid":"W2374260344"},{"id":"paper-w4214563208","cat":"papers","name":"Racial and Ethnic Differences in Youth Hallucinogen Use","year":"2003","cit":0,"ptype":"dataset","src":"https://openalex.org/W4214563208","eid":"W4214563208"},{"id":"paper-w2546093732","cat":"papers","name":"Psychedelic drug imagery in dreams","year":"1972","cit":0,"pfa":"Thomas Kirsch","ptype":"article","src":"https://openalex.org/W2546093732","eid":"W2546093732"},{"id":"paper-w7165140640","cat":"papers","name":"Integrating Religion and Psychedelic Medicine","year":"2022","cit":0,"pfa":"Bethany Kacich","ptype":"article","src":"https://openalex.org/W7165140640","eid":"W7165140640"},{"id":"paper-w4404671496","cat":"papers","name":"Psychedelics and Entactogens: Call for Papers","year":"2024","cit":0,"pfa":"Craig W. Lindsley","psa":"Squire J. Booker","ptype":"editorial","src":"https://openalex.org/W4404671496","eid":"W4404671496"},{"id":"paper-w4406934336","cat":"papers","name":"Psychedelics and psychosis: Quantifying the risk","year":"2025","cit":0,"pfa":"Lawrence H. Price","topics":["Safety & adverse events","Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4406934336","eid":"W4406934336"},{"id":"paper-w7213865883","cat":"papers","name":"AutoPsy - Autobiographical Memories and Psychedelics","year":"2026","cit":0,"pfa":"Samuli Kangaslampi","psa":"Kim P. C. Kuypers","ptype":"dataset","src":"https://openalex.org/W7213865883","eid":"W7213865883"},{"id":"paper-w4241236260","cat":"papers","name":"Intratumoral Microdosing of Motolimod in Head and Neck Cancer","year":"2020","cit":0,"topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4241236260","eid":"W4241236260"},{"id":"paper-w2403683814","cat":"papers","name":"[Modulators of the regulatory protein activity acting at microdoses].","year":"2010","cit":0,"pfa":"Iamskova Vp","psa":"I A Iamskov","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"other","src":"https://openalex.org/W2403683814","eid":"W2403683814"},{"id":"paper-w4385617639","cat":"papers","name":"Psychedelic drugs to treat depression","year":"2023","cit":0,"pfa":"Stephen Russell Naulls","psa":"Sarah Bunn","topics":["Depression"],"ptype":"report","src":"https://openalex.org/W4385617639","eid":"W4385617639"},{"id":"paper-w4392665750","cat":"papers","name":"Protective Strategies for Psychedelics Scale","year":"2024","cit":0,"pfa":"Maha N. Mian","psa":"Mitch Earleywine","ptype":"dataset","src":"https://openalex.org/W4392665750","eid":"W4392665750"},{"id":"paper-w4407246337","cat":"papers","name":"Training and mindset of the psychedelic therapists","year":"2025","cit":0,"topics":["Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W4407246337","eid":"W4407246337"},{"id":"paper-w7162256103","cat":"papers","name":"The Psychedelic Science of the Jurema Tree","year":"2026","cit":0,"pfa":"Marcelo Leite","ptype":"book","src":"https://openalex.org/W7162256103","eid":"W7162256103"},{"id":"paper-w7161546215","cat":"papers","name":"TRIP: Tracking Research In Psychedelics","year":"2026","cit":0,"pfa":"Brock Pluimer","ptype":"software","src":"https://openalex.org/W7161546215","eid":"W7161546215"},{"id":"paper-w4387855978","cat":"papers","name":"Emerging Medical Use of Psychedelics","year":"2023","cit":0,"pfa":"Seon-Young Park","psa":"Ung Gu Kang","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4387855978","eid":"W4387855978"},{"id":"paper-w7135595117","cat":"papers","name":"Neuroplastic Effects of Serotonergic Psychedelics","year":"2024","cit":0,"pfa":"Petra Dohalská","topics":["Depression","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W7135595117","eid":"W7135595117"},{"id":"paper-w570086687","cat":"papers","name":"The Gradation of the Psychedelic Poster. Resume","year":"2001","cit":0,"pfa":"仁人 中野","ptype":"article","src":"https://openalex.org/W570086687","eid":"W570086687"},{"id":"paper-w4416952126","cat":"papers","name":"Correction to: Psychedelic Drug Checking: Analytical and Strategic Challenges in Harm Reduction for Classic Psychedelics","year":"2025","cit":0,"pfa":"Tim Hirschfeld","psa":"Laura Alexandra Smit‐Rigter","topics":["Safety & adverse events"],"ptype":"erratum","src":"https://openalex.org/W4416952126","eid":"W4416952126"},{"id":"paper-w2415001873","cat":"papers","name":"[Microdose roentgenographic systems and their optimal application areas].","year":"2010","cit":0,"pfa":"S E Baru","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2415001873","eid":"W2415001873"},{"id":"paper-w2402204201","cat":"papers","name":"Evolution in Pediatric Pharmacology: Microdosing, metabolism, and membrane transporters","year":"2016","cit":0,"pfa":"Miriam G. Mooij","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"dissertation","src":"https://openalex.org/W2402204201","eid":"W2402204201"},{"id":"paper-w4396573839","cat":"papers","name":"The intimacy of psychedelics, language, and consciousness.","year":"2024","cit":0,"pfa":"Jeremy I Skipper","psa":"Leor Roseman","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4396573839","eid":"W4396573839"},{"id":"paper-w2540017749","cat":"papers","name":"Neurophysiological effects of psychedelics in humans","year":"2016","cit":0,"pfa":"Jordi Riba","ptype":"article","src":"https://openalex.org/W2540017749","eid":"W2540017749"},{"id":"paper-w2755287904","cat":"papers","name":"Clinical Uses for Psychedelic Drugs","year":"2017","cit":0,"pfa":"Matthew J. Clarkson","ptype":"article","src":"https://openalex.org/W2755287904","eid":"W2755287904"},{"id":"paper-w7213924699","cat":"papers","name":"AutoPsy - Autobiographical Memories and Psychedelics","year":"2026","cit":0,"pfa":"Samuli Kangaslampi","psa":"Kim P. C. Kuypers","ptype":"dataset","src":"https://openalex.org/W7213924699","eid":"W7213924699"},{"id":"paper-w3173013613","cat":"papers","name":"Psychedelic Pharmacology Primitive and Bourgeois","year":"2019","cit":0,"pfa":"T. M. Falk","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3173013613","eid":"W3173013613"},{"id":"paper-w3158578362","cat":"papers","name":"The Case Against Psychedelic Judaism","year":"2021","cit":0,"pfa":"Christopher L. Schilling","ptype":"book-chapter","src":"https://openalex.org/W3158578362","eid":"W3158578362"},{"id":"paper-w7118522433","cat":"papers","name":"Molecular & Systemic Mechanisms of Psychedelics","year":"2026","cit":0,"pfa":"Shivankan Kakkar","topics":["Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W7118522433","eid":"W7118522433"},{"id":"paper-w2949508544","cat":"papers","name":"ChemInform Abstract: STRUCTURE‐ACTIVITY RELATIONSHIPS OF PHENETHYLAMINE HALLUCINOGENS","year":"1982","cit":0,"pfa":"David E. Nichols","ptype":"article","src":"https://openalex.org/W2949508544","eid":"W2949508544"},{"id":"paper-w4401986974","cat":"papers","name":"Psychedelics and Religious Experience (1968)","year":"2017","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W4401986974","eid":"W4401986974"},{"id":"paper-w7112931950","cat":"papers","name":"Emotion Regulation and Classical Psychedelics","year":"2025","cit":0,"pfa":"Nathan Plumb","topics":["Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W7112931950","eid":"W7112931950"},{"id":"paper-w4409541525","cat":"papers","name":"Supplemental Material for American Indian Areas and Psychedelics: A Test of the Minorities’ Diminished Psychedelic Returns","year":"2025","cit":0,"ptype":"supplementary-materials","src":"https://openalex.org/W4409541525","eid":"W4409541525"},{"id":"paper-w7124128065","cat":"papers","name":"Exploring Psychedelics as a Treatment for Addiction","year":"2021","cit":0,"pfa":"Alaina M. Jaster","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7124128065","eid":"W7124128065"},{"id":"paper-w3148726924","cat":"papers","name":"Identification of non-traditional psychedelics","year":"2021","cit":0,"pfa":"Victor Chiruta","ptype":"article","src":"https://openalex.org/W3148726924","eid":"W3148726924"},{"id":"paper-w4414576262","cat":"papers","name":"Making Sense of Psychedelics in the CNS","year":"2025","cit":0,"pfa":"Bryan L. Roth","psa":"Blake A Fordyce","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4414576262","eid":"W4414576262"},{"id":"paper-w2799369956","cat":"papers","name":"A Psychedelic Mystery and a Nasty Adventure","year":"1967","cit":0,"pfa":"Gerald Butler","psa":"Leslie Garrett","ptype":"article","src":"https://openalex.org/W2799369956","eid":"W2799369956"},{"id":"paper-w7213968854","cat":"papers","name":"The Repression And Support Of Psychedelic Experience","year":"2021","cit":0,"pfa":"Ted Clark","psa":"Dennis T. Jaffe","ptype":"book-chapter","src":"https://openalex.org/W7213968854","eid":"W7213968854"},{"id":"paper-w7160017713","cat":"papers","name":"Mystical Experiences, Psychosis, and Psychedelics: A Case Series on Meditation and Psychedelic-Induced Altered States","year":"2026","cit":0,"pfa":"Gokul Raj","topics":["Depression"],"ptype":"preprint","src":"https://openalex.org/W7160017713","eid":"W7160017713"},{"id":"paper-w3121915091","cat":"papers","name":"Genre Microdosing: Genre for the Netflix Era of Television","year":"2021","cit":0,"pfa":"Alexis Isaac","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3121915091","eid":"W3121915091"},{"id":"paper-w4388047565","cat":"papers","name":"Membrane Permeation of Psychedelic Compounds","year":"2023","cit":0,"pfa":"Vito Federico Palmisano","psa":"Juan José Nogueira","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4388047565","eid":"W4388047565"},{"id":"paper-w4406089547","cat":"papers","name":"Informed Consent to Psychedelic Medicine","year":"2025","cit":0,"pfa":"Burton Jared Tabaac","psa":"Owen S. Muir","ptype":"article","src":"https://openalex.org/W4406089547","eid":"W4406089547"},{"id":"paper-w4406924862","cat":"papers","name":"Foreword: Psychedelics, Spirituality, and “The West”","year":"2025","cit":0,"pfa":"Charles M. Stang","ptype":"article","src":"https://openalex.org/W4406924862","eid":"W4406924862"},{"id":"paper-w3034163856","cat":"papers","name":"Patrick – «Psychedelic Love Storm»","year":"2019","cit":0,"pfa":"ephram st. cloud","ptype":"article","src":"https://openalex.org/W3034163856","eid":"W3034163856"},{"id":"paper-w209090381","cat":"papers","name":"A Psychedelic Approach to Conic Sections","year":"1970","cit":0,"pfa":"William A. Miller","ptype":"article","src":"https://openalex.org/W209090381","eid":"W209090381"},{"id":"paper-w4302408881","cat":"papers","name":"Contradictory Impulses in the Psychedelic Sixties","year":"2014","cit":0,"pfa":"Joshua Canzona","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4302408881","eid":"W4302408881"},{"id":"paper-w4236183985","cat":"papers","name":"Psychedelics Go to Silicon Valley","year":"2020","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W4236183985","eid":"W4236183985"},{"id":"paper-w4307244482","cat":"papers","name":"Transforming Psychedelics into Approved Medicines","year":"2022","cit":0,"pfa":"Kathy Liszewski","ptype":"article","src":"https://openalex.org/W4307244482","eid":"W4307244482"},{"id":"paper-w4389078493","cat":"papers","name":"Conclusion: The Future of Psychedelic History","year":"2023","cit":0,"pfa":"Erika Dyck","psa":"Chris Elcock","ptype":"book-chapter","src":"https://openalex.org/W4389078493","eid":"W4389078493"},{"id":"paper-w7135476265","cat":"papers","name":"Psychedelic plants of natural nations","year":"2024","cit":0,"pfa":"Vojtěch BURKOŇ","ptype":"dissertation","src":"https://openalex.org/W7135476265","eid":"W7135476265"},{"id":"paper-w2885184430","cat":"papers","name":"Psychedelic Adventures of Clean Machine","year":"2018","cit":0,"pfa":"Jamie Lea Hyatt","psa":"I Taipan","ptype":"article","src":"https://openalex.org/W2885184430","eid":"W2885184430"},{"id":"paper-w3008208732","cat":"papers","name":"Nuanciers - GUITTET - BLEU PSYCHEDELIC","year":"2020","cit":0,"pfa":"Philippe Bougeret","ptype":"article","src":"https://openalex.org/W3008208732","eid":"W3008208732"},{"id":"paper-w4281389065","cat":"papers","name":"137 Microdosing; Phase 0 Clinical Study","year":"2022","cit":0,"pfa":"Paul Erhardt","psa":"Steven A. Wrighton","topics":["Dosing & pharmacology"],"ptype":"dataset","src":"https://openalex.org/W4281389065","eid":"W4281389065"},{"id":"paper-w4408363501","cat":"papers","name":"Risk of microdosing in clinical high-risk populations","year":"2025","cit":0,"pfa":"Claire Bertrand","psa":"Vijay Anand Mittal","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4408363501","eid":"W4408363501"},{"id":"paper-w7168227308","cat":"papers","name":"Supplemental materials for preprint: Do undergraduates’ views of psychedelics relate to the context for psychedelic use?","year":"2024","cit":0,"pfa":"Jason Van Allen","psa":"Andrew K. Littlefield","ptype":"preprint","src":"https://openalex.org/W7168227308","eid":"W7168227308"},{"id":"paper-w4242872218","cat":"papers","name":"Haight-Ashbury’s Psychedelic Sound","year":"2009","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W4242872218","eid":"W4242872218"},{"id":"paper-w7141761537","cat":"papers","name":"Therapeutic Uses of Psychedelics: The Essentials","year":"2018","cit":0,"topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"report","src":"https://openalex.org/W7141761537","eid":"W7141761537"},{"id":"paper-w4238321826","cat":"papers","name":"Psychedelics and Wellness Study (PAWS)","year":"2019","cit":0,"ptype":"article","src":"https://openalex.org/W4238321826","eid":"W4238321826"},{"id":"paper-w4405162862","cat":"papers","name":"10 The Decline of the Psychedelic Consciousness","year":"2023","cit":0,"pfa":"Robert J. Campbell","ptype":"book-chapter","src":"https://openalex.org/W4405162862","eid":"W4405162862"},{"id":"paper-w4402558418","cat":"papers","name":"What Makes a Psychedelic Experience?","year":"2024","cit":0,"pfa":"Gary Stix","ptype":"article","src":"https://openalex.org/W4402558418","eid":"W4402558418"},{"id":"paper-w2069973382","cat":"papers","name":"A new classification of the psychoactive substances (stimulants, entactogens, hallucinogens)","year":"2009","cit":0,"pfa":"Torsten Passie","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2069973382","eid":"W2069973382"},{"id":"paper-w4377021014","cat":"papers","name":"17 Microdosing/microtracer based pediatric drug development","year":"2023","cit":0,"pfa":"Esther van Duijn","psa":"Wouter H. J. Vaes","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4377021014","eid":"W4377021014"},{"id":"paper-w2357209406","cat":"papers","name":"Detection and Clinic Application of Microdose Albumin in Urine","year":"2007","cit":0,"pfa":"Xin Wang","topics":["PTSD & trauma","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2357209406","eid":"W2357209406"},{"id":"paper-w4394631263","cat":"papers","name":"Psychedelics and Religious Experience (1968)","year":"2017","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W4394631263","eid":"W4394631263"},{"id":"paper-w4409547748","cat":"papers","name":"Corrigendum to: Navigating the mainstreaming of psychedelics","year":"2025","cit":0,"pfa":"Beatriz Caiuby Labate","psa":"Clancy Cavnar","ptype":"erratum","src":"https://openalex.org/W4409547748","eid":"W4409547748"},{"id":"paper-w4400050495","cat":"papers","name":"The neural basis of psychedelic action","year":"2024","cit":0,"pfa":"Preller K.H","psa":"Kwan A.C","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4400050495","eid":"W4400050495"},{"id":"paper-w7110782703","cat":"papers","name":"Finnegans Wake and psychedelic literature","year":"2025","cit":0,"pfa":"Dansereau, Corey Anderson","psa":"Stanford University. Program in Modern Thought and Literature.","ptype":"dissertation","src":"https://openalex.org/W7110782703","eid":"W7110782703"},{"id":"paper-w7161130794","cat":"papers","name":"Chemistry in Pictures: Psychedelic soap","year":"2026","cit":0,"pfa":"MANNY I. FOX MORONE","ptype":"article","src":"https://openalex.org/W7161130794","eid":"W7161130794"},{"id":"paper-w2433652273","cat":"papers","name":"[Datura stramonium: an old hallucinogen making a come-back?].","year":"1985","cit":0,"pfa":"Baselga Jm","psa":"Martínez-Vázquez Jm","ptype":"article","src":"https://openalex.org/W2433652273","eid":"W2433652273"},{"id":"paper-w121236005","cat":"papers","name":"Effect of microdoses of copper on tissue respiration of the rabbit liver","year":"1969","cit":0,"pfa":"Evgeniy Stepanovich Belozerov","psa":"L. A. Konovalova","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W121236005","eid":"W121236005"},{"id":"paper-w3090408781","cat":"papers","name":"The microdosing of blood urea with Chechant urethrometer, its value.","year":"1946","cit":0,"pfa":"Laurent Vollenweider","psa":"J DI GIOVANNI","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3090408781","eid":"W3090408781"},{"id":"paper-w3217677470","cat":"papers","name":"Hallucinogens and Entactogens: Establishing a New Class of Psychotherapeutic Drugs?","year":"2020","cit":0,"topics":["Therapy practice"],"ptype":"book","src":"https://openalex.org/W3217677470","eid":"W3217677470"},{"id":"paper-w7171795836","cat":"papers","name":"When the psychedelic state's over: limited evidence for persistent neurophysiological changes in experienced psychedelic users","year":"2026","cit":0,"pfa":"Maja Willard","psa":"Michał Bola","ptype":"dataset","src":"https://openalex.org/W7171795836","eid":"W7171795836"},{"id":"paper-w2427146012","cat":"papers","name":"[Further clinical study of therapeutic use of microdoses of sulfonamides].","year":"1959","cit":0,"pfa":"U Cinquini","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2427146012","eid":"W2427146012"},{"id":"paper-w4389683880","cat":"papers","name":"Personality explains the relationship between psychedelic use and depression; a comparison study with non psychedelic users","year":"2023","cit":0,"pfa":"David K. Sjöström","psa":"Petri Kajonius","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4389683880","eid":"W4389683880"},{"id":"paper-w7171829344","cat":"papers","name":"When the psychedelic state's over: limited evidence for persistent neurophysiological changes in experienced psychedelic users","year":"2026","cit":0,"pfa":"Maja Willard","psa":"Michał Bola","ptype":"dataset","src":"https://openalex.org/W7171829344","eid":"W7171829344"},{"id":"paper-w7156291224","cat":"papers","name":"Autophagy enhancement via Curcumin-Rapamycin microdosing combination","year":"2026","cit":0,"pfa":"MedicOath Autonomous Discovery Engine","topics":["Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7156291224","eid":"W7156291224"},{"id":"paper-w2404298261","cat":"papers","name":"[Psychopathology and biochemistry of experimental psychoses produced by anticholinergic hallucinogens].","year":"1960","cit":0,"pfa":"H Bultasová","psa":"M Vojtĕchovský","ptype":"article","src":"https://openalex.org/W2404298261","eid":"W2404298261"},{"id":"paper-w2405691962","cat":"papers","name":"[Effect of microdoses of copper on young and old animals].","year":"1968","cit":0,"pfa":"V I Zapadniuk","psa":"Migunova Dk","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2405691962","eid":"W2405691962"},{"id":"paper-w7143462140","cat":"papers","name":"Examining Normative Male Alexithymia in Men Reporting Psychedelic and Non-Psychedelic Self-Transcendent Experiences","year":"2026","cit":0,"pfa":"Shaun Sleightholm","psa":"Catherine O’Neill","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7143462140","eid":"W7143462140"},{"id":"paper-w2584855598","cat":"papers","name":"Imaging a Human in Motion: The Ambulatory Microdose PET Scanner","year":"2017","cit":0,"pfa":"Julie A. Brefczynski‐Lewis","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2584855598","eid":"W2584855598"},{"id":"paper-w4390222142","cat":"papers","name":"Cerebral serotonin 2a receptor occupancy of psychedelic and non-psychedelic compounds as measured in vivo in pigs","year":"2023","cit":0,"pfa":"Clara Aabye Madsen","psa":"Gitte M. Knudsen","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4390222142","eid":"W4390222142"},{"id":"paper-w2264514276","cat":"papers","name":"[Human pharmacology in the unsupervised use of psychodysleptic (hallucinogen) drugs].","year":"1969","cit":0,"pfa":"Pierre Deniker","psa":"Daniel Ginestet","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2264514276","eid":"W2264514276"},{"id":"paper-w2410120364","cat":"papers","name":"[Various psychologic traits of a group of adolescents using hallucinogens].","year":"1969","cit":0,"pfa":"B Morin","ptype":"article","src":"https://openalex.org/W2410120364","eid":"W2410120364"},{"id":"paper-w2412080890","cat":"papers","name":"[Hallucinogens in psychiatric therapy and on the problem of exogenous reaction types].","year":"1960","cit":0,"pfa":"St. Wieser","ptype":"article","src":"https://openalex.org/W2412080890","eid":"W2412080890"},{"id":"paper-w2406810162","cat":"papers","name":"[Determination of psycholeptics and hallucinogens using quantitative thin-layer chromatography].","year":"1969","cit":0,"pfa":"Thomas Jj","psa":"Louis Dryon","ptype":"article","src":"https://openalex.org/W2406810162","eid":"W2406810162"},{"id":"paper-w2463987674","cat":"papers","name":"[Experimental and clinical pharmacological aspects of the hallucinogen LSD-25].","year":"1968","cit":0,"pfa":"Giuseppe Nisticó","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2463987674","eid":"W2463987674"},{"id":"paper-w3090529755","cat":"papers","name":"Microdosing technique for haptoglobin performed on a finger or ear sample.","year":"2010","cit":0,"pfa":"Max F. Jayle","psa":"G Conas","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3090529755","eid":"W3090529755"},{"id":"paper-w7171129823","cat":"papers","name":"HALLUCINOGEN USE AMONG PARENTS OF CHILDREN IN THE UNITED STATES","year":"2026","cit":0,"pfa":"Maggie K. Richardson","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7171129823","eid":"W7171129823"},{"id":"paper-w4376646236","cat":"papers","name":"The Bodily Self from Psychosis to Psychedelics","year":"2023","cit":0,"pfa":"Amir Harduf","psa":"Roy Salomon","ptype":"preprint","src":"https://openalex.org/W4376646236","eid":"W4376646236"},{"id":"paper-w3089386211","cat":"papers","name":"Powerful substances in tiny bits. The microdosing practice among Dutch students","year":"2020","cit":0,"pfa":"Pop, Ioana","psa":"Jannis Dinkelacker","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"conference-paper","src":"https://openalex.org/W3089386211","eid":"W3089386211"},{"id":"paper-w2046072737","cat":"papers","name":"Hallucinogen abuse among an adolescent drug rehabilitation population","year":"1990","cit":0,"pfa":"Samuel K. Parrish","psa":"N.Thad Padua","ptype":"article","src":"https://openalex.org/W2046072737","eid":"W2046072737"},{"id":"paper-w2472127081","cat":"papers","name":"[Ballistic study of microdoses in radiotherapy of inflammation; biological interpretation].","year":"1951","cit":0,"pfa":"Giese Daniel","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2472127081","eid":"W2472127081"},{"id":"paper-w2413113701","cat":"papers","name":"[A method for the determination of microdoses of cesium from biological samples].","year":"1998","cit":0,"pfa":"Starik As","psa":"Leont'ev Vg","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2413113701","eid":"W2413113701"},{"id":"paper-w2437065233","cat":"papers","name":"[Clinical aspects and treatment of poisoning with some hallucinogens (review)].","year":"1959","cit":0,"pfa":"F V ARSENT'EV","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2437065233","eid":"W2437065233"},{"id":"paper-w7163204925","cat":"papers","name":"The adverse effects and therapeutic potential of psychedelic medicines: A guide to the risks and rewards of using psychedelics in therapy","year":"2026","cit":0,"pfa":"Samuel Bendeck Sotillos","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7163204925","eid":"W7163204925"},{"id":"paper-w4384119974","cat":"papers","name":"Reply to: Marketing pitches of ‘magic mushrooms’ and ‘psychedelics’ mask that psychotomimetics use exposes those vulnerable to serious adverse effects","year":"2023","cit":0,"pfa":"Emma E. Morton","psa":"Josh D. Woolley","topics":["Safety & adverse events"],"ptype":"letter","src":"https://openalex.org/W4384119974","eid":"W4384119974"},{"id":"paper-w4289330183","cat":"papers","name":"Latanoprost with high precision, piezo-print microdose delivery for IOP lowering: clinical results of the PG21 study of 0.4 µg daily microdose","year":"2018","cit":0,"pfa":"Pasquale LR","psa":"Ianchulev T","topics":["Safety & adverse events","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4289330183","eid":"W4289330183"},{"id":"paper-w1042973692","cat":"papers","name":"Microdose Intravenous Bevacizumab for Treating Retinal Vascular Disease","year":"2007","cit":0,"pfa":"Elizabeth Louise Thomas","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1042973692","eid":"W1042973692"},{"id":"paper-w1980711840","cat":"papers","name":"Hallucinogen and other illicit drug uses increases in the USA","year":"1996","cit":0,"pfa":"Cynthia R. Johnson","psa":"Thomas J. Gleaton","ptype":"article","src":"https://openalex.org/W1980711840","eid":"W1980711840"},{"id":"paper-w7202430646","cat":"papers","name":"Does a microdose of philosophy increase curiosity about ethics?","year":"2026","cit":0,"pfa":"Michael Prinzing","psa":"Michael Vazquez","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W7202430646","eid":"W7202430646"},{"id":"paper-w2517842059","cat":"papers","name":"Hallucinogens: Neurochemical, Behavioral, and Clinical Perspectives.Barry L. Jacobs","year":"1986","cit":0,"pfa":"Jeffery N. Wilkins","ptype":"book-review","src":"https://openalex.org/W2517842059","eid":"W2517842059"},{"id":"paper-w2045991951","cat":"papers","name":"18. Hallucinogen-induced EPSPS in neocortical pyramidal cells","year":"1998","cit":0,"pfa":"George K. Aghajanian","psa":"Gerard J. Marek","ptype":"article","src":"https://openalex.org/W2045991951","eid":"W2045991951"},{"id":"paper-w2402475752","cat":"papers","name":"Endocrine response to step-up microdose GnRH agonist.","year":"2006","cit":0,"pfa":"Su Kyoung Kim","psa":"Won Il Park","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2402475752","eid":"W2402475752"},{"id":"paper-w1984247631","cat":"papers","name":"Microdose X-Ray Systems and Optimal Areas of Their Application","year":"2009","cit":0,"pfa":"S.E. Baru","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1984247631","eid":"W1984247631"},{"id":"paper-w4206988883","cat":"papers","name":"5 Haight-Ashbury’s Psychedelic Sound","year":"2004","cit":0,"pfa":"Trevor Pinch","psa":"Frank Trocco","ptype":"book-chapter","src":"https://openalex.org/W4206988883","eid":"W4206988883"},{"id":"paper-w3167104356","cat":"papers","name":"Serotonergic psychedelics and their effects on visual perception","year":"2019","cit":0,"pfa":"Laiho, Mikko","ptype":"dissertation","src":"https://openalex.org/W3167104356","eid":"W3167104356"},{"id":"paper-w3052601639","cat":"papers","name":"3. The Varieties of Psychedelic Lab Experience","year":"2019","cit":0,"pfa":"Nicolas Langlitz","ptype":"book-chapter","src":"https://openalex.org/W3052601639","eid":"W3052601639"},{"id":"paper-w1498342925","cat":"papers","name":"Psychedelic Medicine: New evidence for hallucinogenic substances and treatments. Volumes One and Two Psychedelic Horizons","year":"2008","cit":0,"pfa":"Francis C. Biley","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1498342925","eid":"W1498342925"},{"id":"paper-w1979504024","cat":"papers","name":"Chromatographic method for measuring gas dispenser microdose volumes","year":"1992","cit":0,"pfa":"E. A. Khatskevich","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1979504024","eid":"W1979504024"},{"id":"paper-w7164452797","cat":"papers","name":"Persistent Psychedelic-Associated Mental Disorders","year":"2026","cit":0,"pfa":"Ebru Kaya","psa":"Georg Leistenschneider","topics":["PTSD & trauma","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7164452797","eid":"W7164452797"},{"id":"paper-w7171824580","cat":"papers","name":"When the psychedelic state's over: limited evidence for persistent neurophysiological changes in experienced psychedelic users","year":"2026","cit":0,"pfa":"Maja Willard","psa":"Michał Bola","ptype":"software","src":"https://openalex.org/W7171824580","eid":"W7171824580"},{"id":"paper-w1557118875","cat":"papers","name":"The Use of Entheogen Drugs in the United Kingdom: A Misuse of Drugs or a Lawful Expression of the Right to Religion?","year":"2009","cit":0,"pfa":"Patrick Russell Goold","ptype":"article","src":"https://openalex.org/W1557118875","eid":"W1557118875"},{"id":"paper-w2404169491","cat":"papers","name":"[Contraceptive efficiency and side effects of oral microdoses of Norgestrel].","year":"1970","cit":0,"pfa":"Patricia Guzmán","psa":"Hugo Trujillo","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2404169491","eid":"W2404169491"},{"id":"paper-w3000324744","cat":"papers","name":"Evolutional Drug Development with the Use of Microdosing and PET Imaging","year":"2012","cit":0,"pfa":"Yuichi Sugiyama","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3000324744","eid":"W3000324744"},{"id":"paper-w77823769","cat":"papers","name":"Teva Expands Respiratory Pipeline with MicroDose Therapeutx Purchase","year":"2013","cit":0,"pfa":"Heather N. Cartwright","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W77823769","eid":"W77823769"},{"id":"paper-w2318395445","cat":"papers","name":"The Relevance of Jungian Psychology to Current Psychedelic ResearchThe Relevance of Jungian Psychology to Current Psychedelic Research","year":"2014","cit":0,"pfa":"Scott J. Hill","ptype":"article","src":"https://openalex.org/W2318395445","eid":"W2318395445"},{"id":"paper-w7164562120","cat":"papers","name":"Trial of Buprenorphine Microdosing During Hospitalization (IMPOWR-ME)","year":"2026","cit":0,"pfa":"Julia Hope Arnsten","psa":"Joanna L. Starrels","topics":["Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W7164562120","eid":"W7164562120"},{"id":"paper-w3090829534","cat":"papers","name":"Contribution to the electrophotometric microdosing of proteins, based on the reaction of biuret.","year":"1949","cit":0,"pfa":"J. P. Dustin","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3090829534","eid":"W3090829534"},{"id":"paper-w4367853179","cat":"papers","name":"Determinants of millet and sorghum yield with fertilizer microdosing technique","year":"2019","cit":0,"pfa":"Penda Sissoko","psa":"Philippe Lebailly","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4367853179","eid":"W4367853179"},{"id":"paper-w4397037424","cat":"papers","name":"Microdosing: Refining in - Season Training Methods for Field Players","year":"2023","cit":0,"pfa":"Fateev Ivan","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4397037424","eid":"W4397037424"},{"id":"paper-w4365446331","cat":"papers","name":"Buprenorphine Microdosing Strategy for Pediatric Cancer Pain (CS314)","year":"2023","cit":0,"pfa":"Karan Soni","psa":"Mellar P. Davis","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4365446331","eid":"W4365446331"},{"id":"paper-w2301530909","cat":"papers","name":"Effectiveness of captopril microdosing in the treatment of essential arterial hypertension","year":"2012","cit":0,"pfa":"Tomás Noel Santana Téllez","psa":"Antonio Vázquez Gamboa","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2301530909","eid":"W2301530909"},{"id":"paper-w4413597501","cat":"papers","name":"Alberta’s new policy on psychedelic drug treatment for mental illness: Will Canada lead the psychedelic renaissance?","year":"2023","cit":0,"pfa":"Erika Dyck","topics":["Policy & ethics"],"ptype":"other","src":"https://openalex.org/W4413597501","eid":"W4413597501"},{"id":"paper-w7202079635","cat":"papers","name":"Psychedelics in psychiatry: from promise to translation","year":"2026","cit":0,"pfa":"Yi Zhang","psa":"Lin Lu","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7202079635","eid":"W7202079635"},{"id":"paper-w4387482560","cat":"papers","name":"The Psychedelic Experience in the Native American Church","year":"2016","cit":0,"pfa":"D. B. Blewett","ptype":"book-chapter","src":"https://openalex.org/W4387482560","eid":"W4387482560"},{"id":"paper-w4405498968","cat":"papers","name":"JUNGIANS AND PSYCHEDELICS: a dialogue under construction","year":"2024","cit":0,"pfa":"Iago Lôbo","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4405498968","eid":"W4405498968"},{"id":"paper-w4414215045","cat":"papers","name":"Psychedelics Align Brain Activity with Context","year":"2025","cit":0,"pfa":"Loïk Holdrinet","ptype":"other","src":"https://openalex.org/W4414215045","eid":"W4414215045"},{"id":"paper-w7168422619","cat":"papers","name":"Psychedelics Trials and Outcomes—A Closer Look","year":"2026","cit":0,"pfa":"Robin Lester Carhart-Harris","psa":"Joshua Daniel Rosenblat","ptype":"article","src":"https://openalex.org/W7168422619","eid":"W7168422619"},{"id":"paper-w7168351131","cat":"papers","name":"Psychedelics Trials and Outcomes— A Closer Look","year":"2026","cit":0,"pfa":"Sandeep Manel Nayak","psa":"David B. Yaden","ptype":"article","src":"https://openalex.org/W7168351131","eid":"W7168351131"},{"id":"paper-w7208739195","cat":"papers","name":"Wellbeing and Sensory Experiences of Naturalistic Psychedelic Use among Autistic Adults Engaged in Therapeutic Psychedelic Use","year":"2026","cit":0,"pfa":"Alvita Sam","psa":"Philippe Lucas","topics":["Safety & adverse events"],"ptype":"other","src":"https://openalex.org/W7208739195","eid":"W7208739195"},{"id":"paper-w4365450846","cat":"papers","name":"The global regulatory landscape for psychedelic drugs","year":"2023","cit":0,"pfa":"Jessica R. Riggleman","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4365450846","eid":"W4365450846"},{"id":"paper-w4327568905","cat":"papers","name":"Psychedelics carry out an inside job","year":"2023","cit":0,"pfa":"Dimitris Typas","ptype":"article","src":"https://openalex.org/W4327568905","eid":"W4327568905"},{"id":"paper-w1771294141","cat":"papers","name":"Accelerator mass spectrometry (AMS) for pharmaceutical microdosing studies.","year":"2007","cit":0,"pfa":"Kristina Eriksson Stenström","psa":"Sören Mattsson","topics":["Dosing & pharmacology"],"ptype":"conference-paper","src":"https://openalex.org/W1771294141","eid":"W1771294141"},{"id":"paper-w3212464897","cat":"papers","name":"The Effects of Microdosing LSD on Behaviour in Zebrafish (Danio rerio)","year":"2021","cit":0,"pfa":"Ethan V. Hagen","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3212464897","eid":"W3212464897"},{"id":"paper-w2417935853","cat":"papers","name":"[Evidence of the effect of microdoses of ouabain on isolated mammal heart].","year":"1952","cit":0,"pfa":"C BARBERO","psa":"A Giotti","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2417935853","eid":"W2417935853"},{"id":"paper-w2411474577","cat":"papers","name":"[Modern treatments in psychiatry. Hallucinogens: psychosis induced by LSD].","year":"1961","cit":0,"pfa":"F Jost","psa":"Geertz Vw","ptype":"article","src":"https://openalex.org/W2411474577","eid":"W2411474577"},{"id":"paper-w2665503613","cat":"papers","name":"Binding of the hallucinogen MeO-DMT in the brain of domestic pig","year":"2006","cit":0,"pfa":"Aage Kristian Olsen Alstrup","psa":"Paul D. Cumming","ptype":"conference-paper","src":"https://openalex.org/W2665503613","eid":"W2665503613"},{"id":"paper-w7135329787","cat":"papers","name":"Review: Microdose model of adaptive and bystander dose response","year":"2008","cit":0,"pfa":"Bobby E. Leonard","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7135329787","eid":"W7135329787"},{"id":"paper-w3211457321","cat":"papers","name":"Hallucinogens, Club Drugs, Inhalants, and Other Substances of Abuse","year":"2011","cit":0,"pfa":"Pierre‐Paul Tellier","topics":["Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W3211457321","eid":"W3211457321"},{"id":"paper-w7148399215","cat":"papers","name":"When the psychedelic state’s over: limited evidence for persistent neurophysiological changes in naturalistic psychedelic users","year":"2026","cit":0,"pfa":"Maja Wójcik","psa":"Michał Bola","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7148399215","eid":"W7148399215"},{"id":"paper-w2222497708","cat":"papers","name":"[Vision disorders during automobile driving after using hallucinogens].","year":"1971","cit":0,"pfa":"Nils Retterstøl","ptype":"article","src":"https://openalex.org/W2222497708","eid":"W2222497708"},{"id":"paper-w2755195798","cat":"papers","name":"The Preferred Terminology Implemented by Psychedelic Users Existing on Online Platforms: A Cross-sectional Analysis","year":"2017","cit":0,"pfa":"Ahmed Al-Imam","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2755195798","eid":"W2755195798"},{"id":"paper-w4323026398","cat":"papers","name":"The Psychotherapeutic Framing of Psychedelic Drug Administration","year":"2023","cit":0,"pfa":"Dea Siggaard Stenbæk","psa":"Maria Beckman","topics":["Therapy practice"],"ptype":"book","src":"https://openalex.org/W4323026398","eid":"W4323026398"},{"id":"paper-w7131627961","cat":"papers","name":"Safety Protocols at Psychedelic Retreats Are Inconsistent","year":"2026","cit":0,"pfa":"Terri D’Arrigo","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7131627961","eid":"W7131627961"},{"id":"paper-w4252644382","cat":"papers","name":"A guided psychedelic experience: Subjective report","year":"1972","cit":0,"pfa":"Stanley Krippner","psa":"Carmi Harari","ptype":"dataset","src":"https://openalex.org/W4252644382","eid":"W4252644382"},{"id":"paper-w2785575563","cat":"papers","name":"The Rebirth of Psychedelic Substances in British Literature","year":"2017","cit":0,"pfa":"Jakub Váša","topics":["Addiction"],"ptype":"dissertation","src":"https://openalex.org/W2785575563","eid":"W2785575563"},{"id":"paper-w7214599244","cat":"papers","name":"Psychedelics Restructure the Global Workspace of Consciousness","year":"2026","cit":0,"pfa":"Parsa Yousefi","ptype":"book","src":"https://openalex.org/W7214599244","eid":"W7214599244"},{"id":"paper-w2461488495","cat":"papers","name":"[Clinical experiences with a new hallucinogen with atropine-like effect].","year":"1960","cit":0,"pfa":"Finnja Schultze","ptype":"article","src":"https://openalex.org/W2461488495","eid":"W2461488495"},{"id":"paper-w4388985102","cat":"papers","name":"Campus Rebels and the Psychedelic Drug Culture","year":"2023","cit":0,"pfa":"Matthew D. Lassiter","ptype":"book-chapter","src":"https://openalex.org/W4388985102","eid":"W4388985102"},{"id":"paper-w4387391078","cat":"papers","name":"Hallucinogens and the neuroendocrine system in relation to anxiety and depression: A review","year":"2022","cit":0,"pfa":"Lollen Minerva","psa":"Pankaj, Kumar","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4387391078","eid":"W4387391078"},{"id":"paper-w4407033249","cat":"papers","name":"A Study on the Characteristics of Adolescents with Experience in Drug and Hallucinogen Inhalation","year":"2024","cit":0,"pfa":"Kyuchul Oh","ptype":"article","src":"https://openalex.org/W4407033249","eid":"W4407033249"},{"id":"paper-w2416090411","cat":"papers","name":"[Effect of microdoses of zinc on the healing of perforating eye injuries].","year":"1977","cit":0,"pfa":"Tsok Rm","psa":"Volosianko Tm","topics":["Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W2416090411","eid":"W2416090411"},{"id":"paper-w4413472618","cat":"papers","name":"How a psychedelic may treat PTSD","year":"2025","cit":0,"pfa":"Grace Wade","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4413472618","eid":"W4413472618"},{"id":"paper-w7168425455","cat":"papers","name":"Psychedelics Trials and Outcomes—A Closer Look","year":"2026","cit":0,"pfa":"Laetitia Vanderijst","psa":"Amandine Luquiens","ptype":"article","src":"https://openalex.org/W7168425455","eid":"W7168425455"},{"id":"paper-w7104523721","cat":"papers","name":"Psychedelics - new legislation, new hope","year":"2023","cit":0,"pfa":"Kuchař, Martin","ptype":"article","src":"https://openalex.org/W7104523721","eid":"W7104523721"},{"id":"paper-w7141143411","cat":"papers","name":"How Psychedelics Influence Brain Networks","year":"2024","cit":0,"topics":["Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"report","src":"https://openalex.org/W7141143411","eid":"W7141143411"},{"id":"paper-w2133173203","cat":"papers","name":"Microdose leuprolide versus ganirelix in “poor responder” patients.","year":"2001","cit":0,"pfa":"John J. Orris","psa":"DONALD B. MAIER","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2133173203","eid":"W2133173203"},{"id":"paper-w4281776674","cat":"papers","name":"role of psychedelics in supernatural experience formation","year":"2022","cit":0,"pfa":"Mahdi Eftekhar","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4281776674","eid":"W4281776674"},{"id":"paper-w7117975661","cat":"papers","name":"A Criminological Investigation into Psychedelic Drug Use","year":"2025","cit":0,"pfa":"Richard G. Alexander","ptype":"book","src":"https://openalex.org/W7117975661","eid":"W7117975661"},{"id":"paper-w4400182496","cat":"papers","name":"Behavioral and biochemical distinctions in the pharmacology of two common hallucinogens","year":"2010","cit":0,"pfa":"Emmanuelle A. D. Schindler","psa":"John A. Harvey","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W4400182496","eid":"W4400182496"},{"id":"paper-w7135634801","cat":"papers","name":"Psychedelic experience and attitude towards death","year":"2020","cit":0,"pfa":"Anna Horáková","topics":["Addiction"],"ptype":"dissertation","src":"https://openalex.org/W7135634801","eid":"W7135634801"},{"id":"paper-w4403403660","cat":"papers","name":"Can Psychedelic Experience Lead to Knowledge?","year":"2024","cit":0,"pfa":"Haggeo Cadenas","ptype":"book-chapter","src":"https://openalex.org/W4403403660","eid":"W4403403660"},{"id":"paper-w7104510609","cat":"papers","name":"Psychedelics - new legislation, new hope","year":"2023","cit":0,"pfa":"Kuchař, Martin","ptype":"article","src":"https://openalex.org/W7104510609","eid":"W7104510609"},{"id":"paper-w4402739286","cat":"papers","name":"Review for \"Artificial intelligence and psychedelic medicine\"","year":"2024","cit":0,"topics":["Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4402739286","eid":"W4402739286"},{"id":"paper-w7135815003","cat":"papers","name":"Use of psychedelic substances and well-being","year":"2020","cit":0,"pfa":"Nikola Blažková","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W7135815003","eid":"W7135815003"},{"id":"paper-w4412823763","cat":"papers","name":"Psychedelic Drugs - Therapeutic and Recreational Use","year":"2025","cit":0,"pfa":"Federico Durbano","psa":"Marco Otto Maria Toscano","ptype":"book","src":"https://openalex.org/W4412823763","eid":"W4412823763"},{"id":"paper-w7111952306","cat":"papers","name":"Predictors of Willingness to Participate in Psychedelic Trials","year":"2025","cit":0,"pfa":"Anna Payton","ptype":"preprint","src":"https://openalex.org/W7111952306","eid":"W7111952306"},{"id":"paper-w2802784009","cat":"papers","name":"Psychedelics. The Uses and Implications of Hallucogenic Drugs","year":"1972","cit":0,"pfa":"Laurence H. Snow","ptype":"article","src":"https://openalex.org/W2802784009","eid":"W2802784009"},{"id":"paper-w4413729231","cat":"papers","name":"Opening up the future of psychedelic science","year":"2018","cit":0,"pfa":"Thomas Anderson","psa":"Rotem Petranker","ptype":"other","src":"https://openalex.org/W4413729231","eid":"W4413729231"},{"id":"paper-w7111813287","cat":"papers","name":"¿Un Foucault psicodélico? A Psychedelic Foucault?","year":"2025","cit":0,"pfa":"Manzano Venegas, Yerko","ptype":"article","src":"https://openalex.org/W7111813287","eid":"W7111813287"},{"id":"paper-w2910106765","cat":"papers","name":"Pornography, Psychedelics and Technology (Routledge Revivals)","year":"2013","cit":0,"pfa":"E. J. Mishan","topics":["Therapy practice"],"ptype":"book","src":"https://openalex.org/W2910106765","eid":"W2910106765"},{"id":"paper-w7165810846","cat":"papers","name":"Psychological Adverse Effects of Psychedelic Use","year":"2026","cit":0,"pfa":"Franklin King","psa":"Theodore A. Stern","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7165810846","eid":"W7165810846"},{"id":"paper-w7154486912","cat":"papers","name":"Major life changes following psychedelic use: A retrospective survey among people using psychedelics naturalistically","year":"2026","cit":0,"pfa":"Jacob S. Aday","psa":"Kevin F. Boehnke","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W7154486912","eid":"W7154486912"},{"id":"paper-w7126188013","cat":"papers","name":"The wellbeing effects of psychedelic and meditation retreats","year":"2024","cit":0,"pfa":"Jussi Jylkkä","ptype":"preprint","src":"https://openalex.org/W7126188013","eid":"W7126188013"},{"id":"paper-w7116912469","cat":"papers","name":"Rewilding ourselves through psychedelic integration","year":"2025","cit":0,"pfa":"Rosie Leeson","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7116912469","eid":"W7116912469"},{"id":"paper-w7214624613","cat":"papers","name":"Psychedelics Restructure the Global Workspace of Consciousness","year":"2026","cit":0,"pfa":"Parsa Yousefi","ptype":"book","src":"https://openalex.org/W7214624613","eid":"W7214624613"},{"id":"paper-w7166950749","cat":"papers","name":"Psychedelic Experiences in Religion : Academic to Academic","year":"2026","cit":0,"topics":["Safety & adverse events"],"ptype":"other","src":"https://openalex.org/W7166950749","eid":"W7166950749"},{"id":"paper-w4234640705","cat":"papers","name":"Microdosing data can predict PK of therapeutic doses","year":"2006","cit":0,"pfa":"&NA;","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4234640705","eid":"W4234640705"},{"id":"paper-w2347984715","cat":"papers","name":"Removing of microdose N_2 in high purity D_2 by getter","year":"2007","cit":0,"pfa":"Baofeng Liu","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2347984715","eid":"W2347984715"},{"id":"paper-w7198771102","cat":"papers","name":"Fabrication of Optical Polymer Waveguides Using Microdosing Technology","year":"2024","cit":0,"pfa":"Lukáš Veigl","psa":"Lukáš Veigl","topics":["Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7198771102","eid":"W7198771102"},{"id":"paper-w4408547081","cat":"papers","name":"The once and future therapeutic potential of psychedelics","year":"2025","cit":0,"ptype":"article","src":"https://openalex.org/W4408547081","eid":"W4408547081"},{"id":"paper-w2380918099","cat":"papers","name":"Microdose Combined Medication of Captopril and Nitrendipine Treating Hypertension","year":"2000","cit":0,"pfa":"Xiuyun Liu","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2380918099","eid":"W2380918099"},{"id":"paper-w2799405807","cat":"papers","name":"Under the Influence: An Interdisciplinary Approach to Psychedelics","year":"2018","cit":0,"pfa":"Jody Roun","ptype":"article","src":"https://openalex.org/W2799405807","eid":"W2799405807"},{"id":"paper-w3177210262","cat":"papers","name":"Anaïs Nin and the Vocabulary of the Psychedelic Experience","year":"2021","cit":0,"pfa":"Zoë Dubus","psa":"Pierre Léger","ptype":"preprint","src":"https://openalex.org/W3177210262","eid":"W3177210262"},{"id":"paper-w7212071953","cat":"papers","name":"FDA’s New Framework for Psychedelic Drugs","year":"2026","cit":0,"pfa":"Michael Davis","psa":"Teresa Buracchio","ptype":"article","src":"https://openalex.org/W7212071953","eid":"W7212071953"},{"id":"paper-w2402832324","cat":"papers","name":"[Sequelae of taking narcotics and hallucinogens from the viewpoint of internal medicine].","year":"1972","cit":0,"pfa":"Peter Glogner","ptype":"article","src":"https://openalex.org/W2402832324","eid":"W2402832324"},{"id":"paper-w4409365944","cat":"papers","name":"The Use of Psychedelics in Chronic Pain – A Scoping Review","year":"2025","cit":0,"pfa":"Hugo Santos","psa":"José Esteves","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4409365944","eid":"W4409365944"},{"id":"paper-w3185773663","cat":"papers","name":"Evaluating Differences between Psychedelic Drug-Users and Non-Psychedelic Drug Users among College Students","year":"2021","cit":0,"pfa":"Samuel Colligan","psa":"Michael J. Gawrysiak","ptype":"article","src":"https://openalex.org/W3185773663","eid":"W3185773663"},{"id":"paper-w2622468337","cat":"papers","name":"Reviews of Note: A Future for Psychedelic Psychiatry?","year":"2017","cit":0,"pfa":"Peter Roy‐Byrne","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2622468337","eid":"W2622468337"},{"id":"paper-w4415703392","cat":"papers","name":"Response to Psychedelics as Non-Specific Amplifiers","year":"2025","cit":0,"pfa":"Jos Ten Berge","ptype":"article","src":"https://openalex.org/W4415703392","eid":"W4415703392"},{"id":"paper-w7154562850","cat":"papers","name":"Correction: Psychedelic therapeutics in psychiatric conditions","year":"2026","cit":0,"pfa":"Philip D. Harvey","psa":"Charles B. Nemeroff","topics":["Policy & ethics"],"ptype":"erratum","src":"https://openalex.org/W7154562850","eid":"W7154562850"},{"id":"paper-w4402739253","cat":"papers","name":"Review for \"Artificial intelligence and psychedelic medicine\"","year":"2024","cit":0,"topics":["Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4402739253","eid":"W4402739253"},{"id":"paper-w7139973498","cat":"papers","name":"Blockchain Will Power The Future Of Psychedelic Psychotherapy","year":"2019","cit":0,"pfa":"Adam Knowles","topics":["Anxiety & end-of-life","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7139973498","eid":"W7139973498"},{"id":"paper-w4205803322","cat":"papers","name":"Psychedelic Journeys in Sound: Electroacoustic Compositions","year":"2021","cit":0,"pfa":"Jonathan Weinel","ptype":"book-chapter","src":"https://openalex.org/W4205803322","eid":"W4205803322"},{"id":"paper-w4385663520","cat":"papers","name":"Control side effects of the psychedelic renaissance","year":"2023","cit":0,"pfa":"Christoph Bublitz","psa":"Dimitris Repantis","ptype":"article","src":"https://openalex.org/W4385663520","eid":"W4385663520"},{"id":"paper-w4389803665","cat":"papers","name":"[Psychedelic Drugs: Past, Present, and Future].","year":"2023","cit":0,"pfa":"Hiroyuki Uchida","topics":["Depression","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4389803665","eid":"W4389803665"},{"id":"paper-w7139249812","cat":"papers","name":"The Medical History & Use of Psychedelic Drugs","year":"2023","cit":0,"pfa":"William Brock Renshaw","ptype":"article","src":"https://openalex.org/W7139249812","eid":"W7139249812"},{"id":"paper-w7171490133","cat":"papers","name":"The Ontological Tourism Problem in Psychedelic Science","year":"2026","cit":0,"pfa":"David Wyndham Lawrence","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7171490133","eid":"W7171490133"},{"id":"paper-w4389694482","cat":"papers","name":"5. New Frontiers in Psychedelic Research","year":"2018","cit":0,"pfa":"P.W. Barber","ptype":"book-chapter","src":"https://openalex.org/W4389694482","eid":"W4389694482"},{"id":"paper-w3162707644","cat":"papers","name":"Psychedelic Medicine Education and Course Materials","year":"2020","cit":0,"pfa":"Jordan Sloshower","ptype":"preprint","src":"https://openalex.org/W3162707644","eid":"W3162707644"},{"id":"paper-w7165285582","cat":"papers","name":"What Makes Psychedelic Experiences Sacred?","year":"2025","cit":0,"pfa":"Jeffrey A. Breau","ptype":"article","src":"https://openalex.org/W7165285582","eid":"W7165285582"},{"id":"paper-w615710355","cat":"papers","name":"Higher : the psychedelic era, 1965-1969","year":"1997","cit":0,"pfa":"James Henke","psa":"Barry Miles","ptype":"book","src":"https://openalex.org/W615710355","eid":"W615710355"},{"id":"paper-w3027209385","cat":"papers","name":"Acquired synaesthesia following the use of psychedelics","year":"2018","cit":0,"pfa":"Devin Blair Terhune","psa":"David P. Luke","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3027209385","eid":"W3027209385"},{"id":"paper-w4394869366","cat":"papers","name":"A Neurocognitive Framework for Psychedelics as Learning Opportunities","year":"2024","cit":0,"pfa":"Sonny Mattek","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4394869366","eid":"W4394869366"},{"id":"paper-w4412651173","cat":"papers","name":"Psychedelics for anxiety disorders: Challenges and opportunities","year":"2025","cit":0,"pfa":"Chenshu Gao","psa":"Heming Cheng","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4412651173","eid":"W4412651173"},{"id":"paper-w4415518214","cat":"papers","name":"Psychedelics, psychosis, and the elusive notion of safety","year":"2025","cit":0,"pfa":"Albert Batalla","psa":"Pim van der Meer","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4415518214","eid":"W4415518214"},{"id":"paper-w4380675308","cat":"papers","name":"DJ's skills and psychedelic trance's rules","year":"2023","cit":0,"pfa":"Aurélien Djebbari","psa":"Élina Djebbari","ptype":"book-chapter","src":"https://openalex.org/W4380675308","eid":"W4380675308"},{"id":"paper-w4391643906","cat":"papers","name":"Psychedelics Coming into the Modern Age of Medicine","year":"2024","cit":0,"pfa":"Ashleen Knutsen","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4391643906","eid":"W4391643906"},{"id":"paper-w2412165296","cat":"papers","name":"Clinical and experimental aspects of psychedelic drugs.","year":"1968","cit":0,"pfa":"T E Shoemaker","ptype":"article","src":"https://openalex.org/W2412165296","eid":"W2412165296"},{"id":"paper-w4415574815","cat":"papers","name":"Somatic Enactments of Psychedelic (Bio)sociality","year":"2024","cit":0,"ptype":"other","src":"https://openalex.org/W4415574815","eid":"W4415574815"},{"id":"paper-w7161759446","cat":"papers","name":"Dominant Narratives in Contemporary Psychedelic Medicine","year":"2024","cit":0,"pfa":"Molly Kennedy","topics":["Safety & adverse events","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W7161759446","eid":"W7161759446"},{"id":"paper-w2970339958","cat":"papers","name":"Effects of Recreational Use of Ecstacy and Hallucinogens on the Neural Circuitry of Emotion","year":"2009","cit":0,"pfa":"Thomas Zoëga Ramsøy","psa":"David Erritzøe","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2970339958","eid":"W2970339958"},{"id":"paper-w657470603","cat":"papers","name":"The psychedelic era : from Huxley to Lennon","year":"1975","cit":0,"pfa":"Peter Haining","ptype":"book","src":"https://openalex.org/W657470603","eid":"W657470603"},{"id":"paper-w2126862837","cat":"papers","name":"Towards a Psychology of Psychedelics and Population Behavior","year":"1971","cit":0,"pfa":"Ronald K. Siegel","ptype":"article","src":"https://openalex.org/W2126862837","eid":"W2126862837"},{"id":"paper-w3125297508","cat":"papers","name":"السایکیدلیک Psychedelic وموسیقی القرن العشرین","year":"2018","cit":0,"pfa":"هایدى وجیه معوض","ptype":"article","src":"https://openalex.org/W3125297508","eid":"W3125297508"},{"id":"paper-w2409642548","cat":"papers","name":"Psychedelics article was excellent; a clarification is necessary.","year":"1995","cit":0,"pfa":"D E Nichols","ptype":"letter","src":"https://openalex.org/W2409642548","eid":"W2409642548"},{"id":"paper-w44328747","cat":"papers","name":"Psychedelics, parapsychology and exceptional human experience.","year":"2013","cit":0,"pfa":"David P. Luke","ptype":"book-chapter","src":"https://openalex.org/W44328747","eid":"W44328747"},{"id":"paper-w4242232039","cat":"papers","name":"Creating a Psychedelic Past, 1954–1960","year":"2017","cit":0,"pfa":"Stephen Siff","ptype":"book","src":"https://openalex.org/W4242232039","eid":"W4242232039"},{"id":"paper-w7131253652","cat":"papers","name":"The extrapolation fallacy in unblinded psychedelic trials","year":"2026","cit":0,"pfa":"Eduardo Ekman Schenberg","psa":"Marion Haberkamp","ptype":"article","src":"https://openalex.org/W7131253652","eid":"W7131253652"},{"id":"paper-w4416444422","cat":"papers","name":"WAVES OF EXOTHERMIC REACTIONS IN OXYGEN, EXCITED BY MICRODOSES OF OIL","year":"2025","cit":0,"pfa":"A. V. Pinaev","psa":"П.А. Пинаев","topics":["Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4416444422","eid":"W4416444422"},{"id":"paper-w4308117374","cat":"papers","name":"Relation between Psychedelic and Transcendental Experiences","year":"2022","cit":0,"pfa":"Frederick T. Travis","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4308117374","eid":"W4308117374"},{"id":"paper-w7155930931","cat":"papers","name":"Aspirin Microdose for Alzheimer's Prevention via Platelet Modulation","year":"2026","cit":0,"pfa":"MedicOath Autonomous Discovery Engine","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7155930931","eid":"W7155930931"},{"id":"paper-w1575555400","cat":"papers","name":"Higher State of Consciousness: The Psychedelic Event","year":"2008","cit":0,"pfa":"Zoe Walker","ptype":"article","src":"https://openalex.org/W1575555400","eid":"W1575555400"},{"id":"paper-w2346498150","cat":"papers","name":"Psychedelics and Mystical ExperiencesPsychedelics and Mystical Experiences","year":"2016","cit":0,"pfa":"Michael Winkelman","ptype":"article","src":"https://openalex.org/W2346498150","eid":"W2346498150"},{"id":"paper-w4206156859","cat":"papers","name":"Interactions between psychedelics and mood stablisers","year":"2021","cit":0,"ptype":"article","src":"https://openalex.org/W4206156859","eid":"W4206156859"},{"id":"paper-w4387378571","cat":"papers","name":"Can psychedelics treat anorexia nervosa?","year":"2023","cit":0,"pfa":"Ioannis Bakoyiannis","ptype":"article","src":"https://openalex.org/W4387378571","eid":"W4387378571"},{"id":"paper-w7108901696","cat":"papers","name":": Expanding Mindscapes: A Global History of Psychedelics","year":"2025","cit":0,"pfa":"Taylor Elizabeth Dysart","ptype":"book-review","src":"https://openalex.org/W7108901696","eid":"W7108901696"},{"id":"paper-w4402739648","cat":"papers","name":"Review for \"Artificial intelligence and psychedelic medicine\"","year":"2024","cit":0,"topics":["Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4402739648","eid":"W4402739648"},{"id":"paper-w4402739300","cat":"papers","name":"Review for \"Artificial intelligence and psychedelic medicine\"","year":"2024","cit":0,"topics":["Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4402739300","eid":"W4402739300"},{"id":"paper-w4408181421","cat":"papers","name":"Psychedelic trials face downsides of the ‘trip’","year":"2025","cit":0,"pfa":"Jennifer Couzin-Frankel","ptype":"article","src":"https://openalex.org/W4408181421","eid":"W4408181421"},{"id":"paper-w7170117742","cat":"papers","name":"Psychedelics, Microtubules, and the Structure of Conscious Experience","year":"2026","cit":0,"pfa":"Thomas McIver","ptype":"preprint","src":"https://openalex.org/W7170117742","eid":"W7170117742"},{"id":"paper-w2206100981","cat":"papers","name":"LSD DHARMA: Psychedelics and Buddhism in America","year":"2011","cit":0,"pfa":"Douglas Osto","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2206100981","eid":"W2206100981"},{"id":"paper-w4297493172","cat":"papers","name":"Research round-up: psychedelic medicine","year":"2022","cit":0,"pfa":"Michael S. Eisenstein","ptype":"article","src":"https://openalex.org/W4297493172","eid":"W4297493172"},{"id":"paper-w4322618135","cat":"papers","name":"Supplementary information for: Psychedelics and psychological strengths","year":"2023","cit":0,"pfa":"Trey J. Brasher","psa":"Marcello Spinella","ptype":"supplementary-materials","src":"https://openalex.org/W4322618135","eid":"W4322618135"},{"id":"paper-w4380675160","cat":"papers","name":"From soul to psychedelic soul and beyond","year":"2023","cit":0,"pfa":"Guillaume Dupetit","ptype":"book-chapter","src":"https://openalex.org/W4380675160","eid":"W4380675160"},{"id":"paper-w4390533880","cat":"papers","name":"If psychedelics heal, how do they do it?","year":"2024","cit":0,"pfa":"Carolyn M. Beans","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4390533880","eid":"W4390533880"},{"id":"paper-w7163616702","cat":"papers","name":"Psychedelics, population dynamics, and the generation of experience","year":"2025","cit":0,"pfa":"Jaime Arlandis","topics":["Addiction","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7163616702","eid":"W7163616702"},{"id":"paper-w7203830840","cat":"papers","name":"Another step for psychedelics . . . and other research","year":"2026","cit":0,"pfa":"Tom Nolan","ptype":"editorial","src":"https://openalex.org/W7203830840","eid":"W7203830840"},{"id":"paper-w3014695471","cat":"papers","name":"‘It is not dying': Revolver and the birth of psychedelic sound","year":"2017","cit":0,"pfa":"Russell Reising","ptype":"article","src":"https://openalex.org/W3014695471","eid":"W3014695471"},{"id":"paper-w4387148504","cat":"papers","name":"Can psychedelics treat neurologic conditions?","year":"2023","cit":0,"pfa":"Emmanuelle A. D. Schindler","ptype":"article","src":"https://openalex.org/W4387148504","eid":"W4387148504"},{"id":"paper-w7128704565","cat":"papers","name":"On drugs: Psychedelics, philosophy, and the nature of reality","year":"2026","cit":0,"pfa":"Gregory M. Westlake","ptype":"article","src":"https://openalex.org/W7128704565","eid":"W7128704565"},{"id":"paper-w7141181625","cat":"papers","name":"Psychedelics may be no better than antidepressants","year":"2026","cit":0,"pfa":"Mattha Busby","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7141181625","eid":"W7141181625"},{"id":"paper-w7172530240","cat":"papers","name":"Blinding Integrity and Psychedelic Drug Trials","year":"2026","cit":0,"pfa":"Michael Elliott","psa":"Olga Chernoloz","ptype":"article","src":"https://openalex.org/W7172530240","eid":"W7172530240"},{"id":"paper-w4385726060","cat":"papers","name":"SYLLABUS – PSYCHEDELIC TRANCE AND BROKEN BEATZ","year":"2016","cit":0,"pfa":"Veronika Svobodová","ptype":"book-chapter","src":"https://openalex.org/W4385726060","eid":"W4385726060"},{"id":"paper-w4388718975","cat":"papers","name":"Roland Griffiths: innovative psychedelics researcher","year":"2023","cit":0,"pfa":"Joanne Silberner","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4388718975","eid":"W4388718975"},{"id":"paper-w7140043747","cat":"papers","name":"Survey on social attitudes towards psychedelics","year":"2026","cit":0,"pfa":"Omer A. Syed","psa":"Rotem Petranker","topics":["Addiction"],"ptype":"preprint","src":"https://openalex.org/W7140043747","eid":"W7140043747"},{"id":"paper-w2292623665","cat":"papers","name":"Review of Nicolas Langlitz's Neuropsychedelia: The Revival of Hallucinogen Research Since the Decade of the Brain","year":"2015","cit":0,"pfa":"Meg Stalcup","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W2292623665","eid":"W2292623665"},{"id":"paper-w4391098149","cat":"papers","name":"Patterns+of+hallucinogen+use+among+individuals+with+social+anxiety+disorder","year":"2024","cit":0,"topics":["Anxiety & end-of-life"],"ptype":"dataset","src":"https://openalex.org/W4391098149","eid":"W4391098149"},{"id":"paper-w4244778265","cat":"papers","name":"Psychedelic Stories: Their Value and Social Responsibility","year":"2004","cit":0,"pfa":"Mark A. Schroll","ptype":"dataset","src":"https://openalex.org/W4244778265","eid":"W4244778265"},{"id":"paper-w2487089514","cat":"papers","name":"Psychedelic Medicine: Is it a False Dawn or a Renaissance?","year":"2015","cit":0,"pfa":"Ahmed Yousif Ali","ptype":"article","src":"https://openalex.org/W2487089514","eid":"W2487089514"},{"id":"paper-w4282835146","cat":"papers","name":"Preface to the special issue “Psychedelics and Neurochemistry”","year":"2022","cit":0,"pfa":"Charles David Nichols","psa":"David E. Nichols","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"editorial","src":"https://openalex.org/W4282835146","eid":"W4282835146"},{"id":"paper-w4366086507","cat":"papers","name":"The global regulatory landscape for psychedelic drugs","year":"2023","cit":0,"pfa":"Jessica R. Riggleman","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4366086507","eid":"W4366086507"},{"id":"paper-w4412919212","cat":"papers","name":"Psychedelics in Psychiatry: Interview with Christina Dalla","year":"2025","cit":0,"pfa":"Christina Dalla","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4412919212","eid":"W4412919212"},{"id":"paper-w2039508315","cat":"papers","name":"’An almost psychedelic impact’:Jack Yeats","year":"1999","cit":0,"pfa":"Ann Saddlemyer","ptype":"article","src":"https://openalex.org/W2039508315","eid":"W2039508315"},{"id":"paper-w2203460318","cat":"papers","name":"Psychedelic Drugs and Mystical Experience: an Interview","year":"2014","cit":0,"pfa":"David Webster","topics":["Policy & ethics"],"ptype":"other","src":"https://openalex.org/W2203460318","eid":"W2203460318"},{"id":"paper-w2937474343","cat":"papers","name":"Psychedelics in Neurology: Potential for Improving Neuroplasticity","year":"2018","cit":0,"pfa":"Mph Heidi Anne Duerr","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2937474343","eid":"W2937474343"},{"id":"paper-w4396748517","cat":"papers","name":"[Psychedelics in treatment of postraumatic stress disorder].","year":"2024","cit":0,"pfa":"Magnus H. Haraldsson","topics":["PTSD & trauma"],"ptype":"editorial","src":"https://openalex.org/W4396748517","eid":"W4396748517"},{"id":"paper-w4412448489","cat":"papers","name":"Effects of Neuromodulatory Stimulation on Endogenous Psychedelics","year":"2025","cit":0,"pfa":"John Archibald Browne Gray","ptype":"report","src":"https://openalex.org/W4412448489","eid":"W4412448489"},{"id":"paper-w7124171169","cat":"papers","name":"Black Psychedelic Revolution: A reflective review","year":"2026","cit":0,"pfa":"Fanicy Sears","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7124171169","eid":"W7124171169"},{"id":"paper-w7155815229","cat":"papers","name":"Autophagy enhancement via Curcumin-Rapamycin microdosing combination","year":"2026","cit":0,"pfa":"MedicOath Autonomous Discovery Engine","topics":["Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7155815229","eid":"W7155815229"},{"id":"paper-w7156030917","cat":"papers","name":"Aspirin Microdose for Alzheimer's Prevention via Platelet Modulation","year":"2026","cit":0,"pfa":"MedicOath Autonomous Discovery Engine","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7156030917","eid":"W7156030917"},{"id":"paper-w7171875985","cat":"papers","name":"Multisystem Benefits of GLP-1 Microdosing: A Narrative Review","year":"2026","cit":0,"pfa":"Mia A Panlilio","psa":"Lucas Choy","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7171875985","eid":"W7171875985"},{"id":"paper-w4221126657","cat":"papers","name":"Psychedelics Road Ahead: Are We Ready?","year":"2022","cit":0,"pfa":"M R Nagendra Gowda","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4221126657","eid":"W4221126657"},{"id":"paper-w7204234010","cat":"papers","name":"New mouse models for psychedelic studies","year":"2026","cit":0,"pfa":"Alexandra Le Bras","ptype":"article","src":"https://openalex.org/W7204234010","eid":"W7204234010"},{"id":"paper-w4415024323","cat":"papers","name":"Plant-derived hallucinogens: neuropharmacological properties and psychoactive mechanisms — a narrative review","year":"2025","cit":0,"pfa":"Angelika Ziaja","psa":"Lucyna Pomierny-Chamioło","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"review","src":"https://openalex.org/W4415024323","eid":"W4415024323"},{"id":"paper-w4285137716","cat":"papers","name":"Tripping over the potential of psychedelics for autism","year":"2022","cit":0,"pfa":"Alla Katsnelson","ptype":"article","src":"https://openalex.org/W4285137716","eid":"W4285137716"},{"id":"paper-w4409463710","cat":"papers","name":"Psychedelics for Depression: Between Hopes and Uncertainties","year":"2025","cit":0,"pfa":"Trisha Suppes","psa":"Mathieu Fradet","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4409463710","eid":"W4409463710"},{"id":"paper-w4233530694","cat":"papers","name":"Hallucinogens and Dissociative Drugs: Including LSD, PCP, Ketamine, Dextromethorphan","year":"2000","cit":0,"ptype":"dataset","src":"https://openalex.org/W4233530694","eid":"W4233530694"},{"id":"paper-w4403430130","cat":"papers","name":"Talking to Your Patients About Psychedelics","year":"2024","cit":0,"pfa":"Franklin King","psa":"Theodore A. Stern","ptype":"article","src":"https://openalex.org/W4403430130","eid":"W4403430130"},{"id":"paper-w7137841639","cat":"papers","name":"Do Psychedelics Mimic Psychosis? Perspectives on Similarities and Differences from Individuals with Lived Experience of Psychosis and Psychedelics","year":"2026","cit":0,"pfa":"Haley Maria Dourron","psa":"Peter S. Hendricks","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7137841639","eid":"W7137841639"},{"id":"paper-w4251242062","cat":"papers","name":"Physicians and researchers disagree on psychedelic drugs","year":"1970","cit":0,"pfa":"Walter Houston Clark","psa":"G. Ray Funkhouser","ptype":"dataset","src":"https://openalex.org/W4251242062","eid":"W4251242062"},{"id":"paper-w4237614447","cat":"papers","name":"The Current Status of Psychedelics in Australian Medicine","year":"2021","cit":0,"pfa":"Prof David J Nutt","psa":"Victor Chiruta","ptype":"preprint","src":"https://openalex.org/W4237614447","eid":"W4237614447"},{"id":"paper-w7132326228","cat":"papers","name":"Psychedelics for the treatment of psychiatric disorders in 2025","year":"2025","cit":0,"pfa":"Renske E. Blom","psa":"Metten Somers","ptype":"other","src":"https://openalex.org/W7132326228","eid":"W7132326228"},{"id":"paper-w4385677855","cat":"papers","name":"An Introduction to Psychotropic and Psychedelic Drugs. Introduction","year":"2016","cit":0,"pfa":"Ben Sessa","psa":"Eileen Worthley","ptype":"book-chapter","src":"https://openalex.org/W4385677855","eid":"W4385677855"},{"id":"paper-w4414394601","cat":"papers","name":"The potential role of psychedelics in palliative care","year":"2025","cit":0,"pfa":"Maciej Sulerzycki","psa":"Tomasz Dzierżanowski","topics":["Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4414394601","eid":"W4414394601"},{"id":"paper-w7170997644","cat":"papers","name":"Validation of the Crosswise Model for Psychedelic Use","year":"2026","cit":0,"pfa":"Quinn Allen","ptype":"preprint","src":"https://openalex.org/W7170997644","eid":"W7170997644"},{"id":"paper-w2412435802","cat":"papers","name":"[Use of iodine microdoses in the prevention of contamination in mechanical ventilators].","year":"1987","cit":0,"pfa":"Диас","psa":"D Birolini","topics":["Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W2412435802","eid":"W2412435802"},{"id":"paper-w2371481030","cat":"papers","name":"New paradigm of accelerating new drug development——microdosing","year":"2009","cit":0,"pfa":"Pei Hu","topics":["Safety & adverse events","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2371481030","eid":"W2371481030"},{"id":"paper-w7139542047","cat":"papers","name":"FDG and CC-PET as a model for tracer and drug microdosing","year":"2007","cit":0,"pfa":"P. Oehr","psa":"Kirsten Bouchelouche","topics":["Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W7139542047","eid":"W7139542047"},{"id":"paper-w2979616967","cat":"papers","name":"Impact of fertilizer microdosing technique on agricultural farms in Mali","year":"2018","cit":0,"pfa":"Penda Sissoko","psa":"Philippe Lebailly","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"conference-paper","src":"https://openalex.org/W2979616967","eid":"W2979616967"},{"id":"paper-w7164478596","cat":"papers","name":"Narratives of Transformation: Psychedelics and the Journey of Healing","year":"2026","cit":0,"pfa":"Riya Gupta","psa":"Margot Morgiève","ptype":"conference-paper","src":"https://openalex.org/W7164478596","eid":"W7164478596"},{"id":"paper-w4409891785","cat":"papers","name":"What to Expect during a Psychedelic Journey","year":"2025","cit":0,"pfa":"Charmaine Husum","topics":["Anxiety & end-of-life","Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W4409891785","eid":"W4409891785"},{"id":"paper-w2087522500","cat":"papers","name":"Psychedelic chemical subdues brain activity","year":"2012","cit":0,"pfa":"Mo Costandi","ptype":"article","src":"https://openalex.org/W2087522500","eid":"W2087522500"},{"id":"paper-w1974166264","cat":"papers","name":"Tomorrow Never Knows: Rock and Psychedelics in the 1960s, and: Sixties Rock: Garage, Psychedelic, and Other Satisfactions (review)","year":"2001","cit":0,"pfa":"Edward Macan","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1974166264","eid":"W1974166264"},{"id":"paper-w7203538516","cat":"papers","name":"Perspectives on Meditation-based Preparation for Psychedelic Experiences: Insights from Practitioners with Combined Meditation and Psychedelic Experience","year":"2026","cit":0,"pfa":"Rosalind G. McAlpine","psa":"Matthew D. Sacchet","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W7203538516","eid":"W7203538516"},{"id":"paper-w3009985891","cat":"papers","name":"Polish Psychedelic Rock: A Game of Appearances","year":"2019","cit":0,"pfa":"Marcin Michalak","ptype":"book-chapter","src":"https://openalex.org/W3009985891","eid":"W3009985891"},{"id":"paper-w7117556385","cat":"papers","name":"Psychedelics and Respiratory Health: A Literature Review","year":"2025","cit":0,"pfa":"Manal Muteb Alanazi","psa":"Mohammed Μ. Alqahtani","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7117556385","eid":"W7117556385"},{"id":"paper-w7135802992","cat":"papers","name":"Negotiating the legality and legitimacy of psychedelic substances and practices in the Czech Republic - Case study of the Czech Psychedelic Society","year":"2024","cit":0,"pfa":"Barbora Vránová","topics":["Addiction","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W7135802992","eid":"W7135802992"},{"id":"paper-w7134133306","cat":"papers","name":"Transgender and gender-expansive psychedelic users’ concerns about colonization, racism, and medicalization in western psychedelic science","year":"2026","cit":0,"pfa":"Skylar J. Gaughan","psa":"Jennifer Elyse James","topics":["PTSD & trauma","Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7134133306","eid":"W7134133306"},{"id":"paper-w7161921406","cat":"papers","name":"Experimental Effects of Psychedelic Substance Type","year":"2026","cit":0,"pfa":"Andrew Lac","topics":["Addiction"],"ptype":"preprint","src":"https://openalex.org/W7161921406","eid":"W7161921406"},{"id":"paper-w7162274197","cat":"papers","name":"Psychedelics in the Probabilistic Reversal Learning Task","year":"2026","cit":0,"pfa":"Dasha Anderson","ptype":"preprint","src":"https://openalex.org/W7162274197","eid":"W7162274197"},{"id":"paper-w4410396629","cat":"papers","name":"A new season, a new Psychedelics journal","year":"2025","cit":0,"pfa":"Alan K. Davis","psa":"Tehseen N. Noorani","ptype":"article","src":"https://openalex.org/W4410396629","eid":"W4410396629"},{"id":"paper-w7214592286","cat":"papers","name":"Are psychedelics anti-inflammatory? A systematic review and meta-analysis of studies examining the immunomodulatory effects of serotonergic psychedelics","year":"2026","cit":0,"pfa":"Anna Skovgaard Lerche","psa":"Aoife O’Donovan","topics":["Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7214592286","eid":"W7214592286"},{"id":"paper-w4299979339","cat":"papers","name":"Hallucinogens: An Update. Proceedings of a meeting. July 13-14, 1992.","year":"1994","cit":0,"ptype":"article","src":"https://openalex.org/W4299979339","eid":"W4299979339"},{"id":"paper-w4249114157","cat":"papers","name":"Diagnostic criteria for 292.89 Hallucinogen Persisting Perception Disorder (Flashbacks)","year":"2007","cit":0,"ptype":"reference-entry","src":"https://openalex.org/W4249114157","eid":"W4249114157"},{"id":"paper-w2402026568","cat":"papers","name":"[Biochemical, pharmacological and clinical studies with opiates, cannabinoles, stimulants and hallucinogens].","year":"1971","cit":0,"pfa":"Norbert Matussek","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2402026568","eid":"W2402026568"},{"id":"paper-w2418119104","cat":"papers","name":"[Problems of drug and hallucinogen addiction in students, schools, and subsidiary body].","year":"1972","cit":0,"pfa":"D Leuze","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2418119104","eid":"W2418119104"},{"id":"paper-w4292250227","cat":"papers","name":"Corrigendum to “Microdosing as a response to the meaning crisis: a qualitative analysis”","year":"2022","cit":0,"topics":["Dosing & pharmacology"],"ptype":"erratum","src":"https://openalex.org/W4292250227","eid":"W4292250227"},{"id":"paper-w7139384030","cat":"papers","name":"The first steps of interpretation of the psychedelic renaissance","year":"2018","cit":0,"pfa":"L. Viskunov","psa":"Л. И. Вискунов","topics":["Addiction"],"ptype":"conference-paper","src":"https://openalex.org/W7139384030","eid":"W7139384030"},{"id":"paper-w7159827728","cat":"papers","name":"Psychedelics in Anxiety and Depression: A Practical Update","year":"2026","cit":0,"pfa":"Nasir Mustafa","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7159827728","eid":"W7159827728"},{"id":"paper-w2333423236","cat":"papers","name":"A New Year's Psychedelic Ghost Opera","year":"2008","cit":0,"pfa":"H. Steven Moffic","ptype":"article","src":"https://openalex.org/W2333423236","eid":"W2333423236"},{"id":"paper-w1865774216","cat":"papers","name":"Research Guides @ Fordham: Addiction: Psychedelics","year":"2014","cit":0,"pfa":"Diane Batemarco","topics":["Addiction"],"ptype":"libguides","src":"https://openalex.org/W1865774216","eid":"W1865774216"},{"id":"paper-w7135838999","cat":"papers","name":"Meaning of a psychedelic experience in cancer patients","year":"2022","cit":0,"pfa":"Karolína Borská","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W7135838999","eid":"W7135838999"},{"id":"paper-w2564718434","cat":"papers","name":"A One-Dose Psychedelic Fix for Addiction?","year":"2016","cit":0,"pfa":"Roni Jacobson","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2564718434","eid":"W2564718434"},{"id":"paper-w3123099545","cat":"papers","name":"Psychedelic View of Fluid in Porous Materials","year":"2021","cit":0,"pfa":"David Ehrenstein","ptype":"article","src":"https://openalex.org/W3123099545","eid":"W3123099545"},{"id":"paper-w4415730007","cat":"papers","name":"Psychedelic Renaissance and the Lingering Shadow of Eugenics","year":"2025","cit":0,"pfa":"Laura I Appleman","ptype":"preprint","src":"https://openalex.org/W4415730007","eid":"W4415730007"},{"id":"paper-w7131397084","cat":"papers","name":"Rabbi Zalman Schachter Interview on Psychedelics","year":"2026","cit":0,"pfa":"University of Colorado Boulder","ptype":"other","src":"https://openalex.org/W7131397084","eid":"W7131397084"},{"id":"paper-w7159833165","cat":"papers","name":"With Vouchers in Hand, Psychedelics Are Primed for Approval","year":"2026","cit":0,"pfa":"Linda M. Richmond","ptype":"other","src":"https://openalex.org/W7159833165","eid":"W7159833165"},{"id":"paper-w2044895808","cat":"papers","name":"Psychedelics and holistic thinking: a tool for science","year":"2010","cit":0,"pfa":"Cameron Adams","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2044895808","eid":"W2044895808"},{"id":"paper-w7123668445","cat":"papers","name":"Analyzing the concept of independence in psychedelic research","year":"2026","cit":0,"pfa":"Katherine Cheung","psa":"David B. Yaden","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7123668445","eid":"W7123668445"},{"id":"paper-w3044936061","cat":"papers","name":"Psychedelics: clinical possibilities and biological mechanisms","year":"2020","cit":0,"pfa":"Elina Hynninen","psa":"Lauri V. Elsilä","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3044936061","eid":"W3044936061"},{"id":"paper-w7151858543","cat":"papers","name":"Keeping an Open Mind About (and With) Psychedelics","year":"2026","cit":0,"pfa":"Andrew M. Novick","psa":"David A. Ross","ptype":"article","src":"https://openalex.org/W7151858543","eid":"W7151858543"},{"id":"paper-w2463123355","cat":"papers","name":"[Studies on hallucinogens. IX. Analysis of tryptamine derivatives (author's transl)].","year":"1975","cit":0,"pfa":"M Ono","psa":"Kazuo Takahashi","ptype":"other","src":"https://openalex.org/W2463123355","eid":"W2463123355"},{"id":"paper-w2007598340","cat":"papers","name":"Binding of the hallucinogen [11C]MeO-DMT in the brain of living pigs","year":"2006","cit":0,"pfa":"Kasper Tholstrup Pedersen","psa":"Svend Borup Jensen","ptype":"article","src":"https://openalex.org/W2007598340","eid":"W2007598340"},{"id":"paper-w4409031928","cat":"papers","name":"Evaluation of NPK Microdose Fertilizer Applicator on Sorghum in Burkina Faso","year":"2021","cit":0,"pfa":"Barro Albert","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4409031928","eid":"W4409031928"},{"id":"paper-w338966387","cat":"papers","name":"Marijuana and Psychedelic Use: Are They Deviant Responses?.","year":"1978","cit":0,"pfa":"Carl S. Davis","ptype":"article","src":"https://openalex.org/W338966387","eid":"W338966387"},{"id":"paper-w4394808140","cat":"papers","name":"Psychedelic drugs to treat eating disorders","year":"2024","cit":0,"pfa":"Stephen Russell Naulls","psa":"Sarah Bunn","ptype":"report","src":"https://openalex.org/W4394808140","eid":"W4394808140"},{"id":"paper-w4409068428","cat":"papers","name":"Erratum: Factor analysis of the MEQ43 suggests non-psychedelic mystical experiences are different from psychedelic mystical experiences","year":"2024","cit":0,"pfa":"Kirsti A. Formoso","ptype":"erratum","src":"https://openalex.org/W4409068428","eid":"W4409068428"},{"id":"paper-w7111890698","cat":"papers","name":"The importance of dose in preclinical psychedelic research","year":"2023","cit":0,"pfa":"Emma Robinson","psa":"Leo Harris","topics":["Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7111890698","eid":"W7111890698"},{"id":"paper-w2949089725","cat":"papers","name":"Fiber-optic device for evaluation the parameters of microdoses of the physiological solutions","year":"2011","cit":0,"pfa":"І. І. Сакалош","psa":"Василь Михайлович Різак","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2949089725","eid":"W2949089725"},{"id":"paper-w2937804234","cat":"papers","name":"Innovative Strategies for Addressing Substance Use Disorders: The Classic Hallucinogens","year":"2017","cit":0,"pfa":"Michael P. Bogenschutz","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2937804234","eid":"W2937804234"},{"id":"paper-w4402889874","cat":"papers","name":"The Fascinating Link between Psychedelics and Neuroplasticity","year":"2024","cit":0,"pfa":"Carmen Concerto","psa":"Alessandro Rodolico","topics":["Mechanism & neuroscience"],"ptype":"editorial","src":"https://openalex.org/W4402889874","eid":"W4402889874"},{"id":"paper-w4407253484","cat":"papers","name":"Suggestion effects in psychedelics: Confounds and opportunities","year":"2024","cit":0,"pfa":"Madeline Victore Stein","psa":"Devin Blair Terhune","topics":["Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4407253484","eid":"W4407253484"},{"id":"paper-w7119558167","cat":"papers","name":"Psychedelics, creativity, cognitive reflection and insights","year":"2026","cit":0,"pfa":"Gregory J Pope","psa":"Ruben Eero Laukkonen","ptype":"preprint","src":"https://openalex.org/W7119558167","eid":"W7119558167"},{"id":"paper-w7108682235","cat":"papers","name":"Juvenile Hallucinogen Use: What Do Multiple Theories Say About It?","year":"2015","cit":0,"pfa":"Vito, Anthony G.","psa":"Ricketts, Melissa L.","ptype":"article","src":"https://openalex.org/W7108682235","eid":"W7108682235"},{"id":"paper-w4402271865","cat":"papers","name":"Teaching the Chemistry/Pharmacology of Psychedelics to Non-Scientists: Adaptation of PharmD Teaching Pedagogy for MS Students","year":"2024","cit":0,"pfa":"Chad R. Johnson","psa":"Leah Sera","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4402271865","eid":"W4402271865"},{"id":"paper-w7172539655","cat":"papers","name":"Blinding Integrity and Psychedelic Drug Trials","year":"2026","cit":0,"pfa":"Tien‐Wei Hsu","psa":"Yu‐Kang Tu","ptype":"article","src":"https://openalex.org/W7172539655","eid":"W7172539655"},{"id":"paper-w7135491185","cat":"papers","name":"Prevalence of symptoms of HPPD among psychedelic substance users","year":"2023","cit":0,"pfa":"Simona Psárska","topics":["Addiction","Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W7135491185","eid":"W7135491185"},{"id":"paper-w2342582271","cat":"papers","name":"Human Microdosing/Phase 0 Studies to Accelerate Drug Development","year":"2014","cit":0,"pfa":"R. Colin Garner","topics":["Dosing & pharmacology","Reviews & meta-analyses","Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W2342582271","eid":"W2342582271"},{"id":"paper-w4281995076","cat":"papers","name":"Dissociative Drugs, Hallucinogens, Caffeine, Inhalants, and Other Substances of Abuse","year":"2022","cit":0,"pfa":"Héctor Colón-Rivera","psa":"Leila M. Vaezazizi","topics":["Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W4281995076","eid":"W4281995076"},{"id":"paper-w4364377355","cat":"papers","name":"Hair buried in a cave shows hallucinogen use in ancient Europe","year":"2023","cit":0,"ptype":"article","src":"https://openalex.org/W4364377355","eid":"W4364377355"},{"id":"paper-w2229919149","cat":"papers","name":"Salvia, LSD, Shrooms, and the Loss of Control: The Users' Experiences with these Hallucinogens","year":"2010","cit":0,"pfa":"Dina M. Perrone","psa":"Christie Bowles","ptype":"article","src":"https://openalex.org/W2229919149","eid":"W2229919149"},{"id":"paper-w4406544806","cat":"papers","name":"Buprenorphine Microdosing the “Bernese Method”: Patient Selection in Opioid Treatment","year":"2025","cit":0,"pfa":"L. A. Hanrahan","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4406544806","eid":"W4406544806"},{"id":"paper-w7170136208","cat":"papers","name":"Exothermic Reaction Waves in Oxygen Excited by Microdoses of Oil","year":"2026","cit":0,"pfa":"А.В. Пинаев","psa":"P. A. Pinaev","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7170136208","eid":"W7170136208"},{"id":"paper-w3210128187","cat":"papers","name":"College student usage of marijuana, hallucinogens up, alcohol down","year":"2021","cit":0,"pfa":"Halley Sutton","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W3210128187","eid":"W3210128187"},{"id":"paper-w7106794501","cat":"papers","name":"Additional file 1 of Best practices for first psychedelic experiences: harm reduction advice from the psychedelic community","year":"2025","cit":0,"pfa":"Kruger, Daniel J.","psa":"Boehnke, Kevin F.","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7106794501","eid":"W7106794501"},{"id":"paper-w4394490646","cat":"papers","name":"Additional file 1 of Cannabis as entheogen: survey and interview data on the spiritual use of cannabis","year":"2020","cit":0,"pfa":"Petter Grahl Johnstad","ptype":"dataset","src":"https://openalex.org/W4394490646","eid":"W4394490646"},{"id":"paper-w7106853322","cat":"papers","name":"Additional file 1 of Best practices for first psychedelic experiences: harm reduction advice from the psychedelic community","year":"2025","cit":0,"pfa":"Kruger, Daniel J.","psa":"Boehnke, Kevin F.","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7106853322","eid":"W7106853322"},{"id":"paper-w2336563583","cat":"papers","name":"2. Non-clinical Data Needed for the Conduct of Microdose Clinical Study","year":"2009","cit":0,"pfa":"Yasuo Ohno","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2336563583","eid":"W2336563583"},{"id":"paper-w4245963700","cat":"papers","name":"Erratum Antagonism of a PCP Drug Discrimination by Hallucinogens and Related Drugs","year":"2000","cit":0,"ptype":"erratum","src":"https://openalex.org/W4245963700","eid":"W4245963700"},{"id":"paper-w2801424636","cat":"papers","name":"The word as hallucinogen. Notes for a sartrean phenomenology of speaking and being spoken","year":"2016","cit":0,"pfa":"Federico Leoni","ptype":"article","src":"https://openalex.org/W2801424636","eid":"W2801424636"},{"id":"paper-w2936359381","cat":"papers","name":"Correctness of use of microdosed combination oral contraceptives in young women","year":"2017","cit":0,"pfa":"Н. А. Буралкина","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2936359381","eid":"W2936359381"},{"id":"paper-w2365643777","cat":"papers","name":"Microdose iodine assay in the hair by arsenic-cerium contact process","year":"2006","cit":0,"pfa":"Wu Liang","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2365643777","eid":"W2365643777"},{"id":"paper-w3153631395","cat":"papers","name":"New Delta-9 Product: Lumi Microdose %%sep%% %%sitename%%","year":"2021","cit":0,"pfa":"Kasey Fitzpatrick","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3153631395","eid":"W3153631395"},{"id":"paper-w7135937912","cat":"papers","name":"Effects of recreational use of ecstasy and hallucinogens on the neural circuitry of emotion","year":"2009","cit":0,"pfa":"Thomas Ramsøy","psa":"Kristoffer Hougaard Madsen","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7135937912","eid":"W7135937912"},{"id":"paper-w2435736666","cat":"papers","name":"[PHARMACOLOGICAL STUDIES ON HALLUCINOGENS (2). 1. BIBLIOGRAPHICAL CONSIDERATIONS OF LSD25].","year":"1964","cit":0,"pfa":"Meitetsu MATSUOKA","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2435736666","eid":"W2435736666"},{"id":"paper-w2415164609","cat":"papers","name":"[Energy and lipid, steroid and serotonin metabolism after various hallucinogens].","year":"1961","cit":0,"pfa":"E Kuhn","psa":"M Vojtĕchovský","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2415164609","eid":"W2415164609"},{"id":"paper-w2755519937","cat":"papers","name":"Effet de microdose de fumier de volaille amélioré","year":"2017","cit":0,"pfa":"Sèvèho Joseph Houndehin","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2755519937","eid":"W2755519937"},{"id":"paper-w2426022273","cat":"papers","name":"[Effect of microdoses of manganese chloride on the course of experimental allergic dermatitis].","year":"1976","cit":0,"pfa":"A P Tuzlukov","psa":"Rassokhin Vm","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2426022273","eid":"W2426022273"},{"id":"paper-w1605776666","cat":"papers","name":"Accelerator Mass Spectrometry and Positron Emission Tomography in Human Microdosing","year":"2011","cit":0,"pfa":"Zhengdong Cheng","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"reference-entry","src":"https://openalex.org/W1605776666","eid":"W1605776666"},{"id":"paper-w2974631232","cat":"papers","name":"Analytical approaches to support microdose studies in drug discovery and development","year":"2015","cit":0,"pfa":"Jim Xiangxin Shen","psa":"Xiaohui Xu","topics":["Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W2974631232","eid":"W2974631232"},{"id":"paper-w2383558200","cat":"papers","name":"Efficacy of Microdose Injection Eprinomection on Repelling Hypoderma Larvae in Yaks","year":"2008","cit":0,"pfa":"Jinzhong Cai","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2383558200","eid":"W2383558200"},{"id":"paper-w7164092933","cat":"papers","name":"A New Movement in Drug Development Technology - Microdosing and its challenges -","year":"2011","cit":0,"pfa":"良信 原田","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7164092933","eid":"W7164092933"},{"id":"paper-w4407895959","cat":"papers","name":"Clinical Updates to Explore Microdosing, Clozapine Underuse, MAOIs, and More","year":"2025","cit":0,"pfa":"Linda M. Richmond","topics":["Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W4407895959","eid":"W4407895959"},{"id":"paper-w7151817910","cat":"papers","name":"804. A New Paradigm in Wound Healing: Topical Microdosing Approaches","year":"2026","cit":0,"pfa":"Manuel Prevedel","psa":"Elisabeth Hofmann","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W7151817910","eid":"W7151817910"},{"id":"paper-w4302936348","cat":"papers","name":"Helping at the edges of life: Perspectives of a psychedelic therapist.","year":"1988","cit":0,"pfa":"Richard Yensen","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4302936348","eid":"W4302936348"},{"id":"paper-w4281756764","cat":"papers","name":"SUBJECTIVE EXPERIENCES OF CLASSIC PSYCHEDELIC SUBSTANCES USERS","year":"2022","cit":0,"pfa":"BHEATRIX BIENEMANN FAVERO","topics":["Addiction"],"ptype":"dissertation","src":"https://openalex.org/W4281756764","eid":"W4281756764"},{"id":"paper-w4405162813","cat":"papers","name":"Haight-Ashbury, Psychedelics, and the Birth of Acid Rock","year":"2023","cit":0,"pfa":"Robert J. Campbell","ptype":"book","src":"https://openalex.org/W4405162813","eid":"W4405162813"},{"id":"paper-w4405178629","cat":"papers","name":"Mindbending Drugs: Psychedelics, Cannabis, and Physician Leadership","year":"2024","cit":0,"pfa":"Jeffrey Lieberman","psa":"M Sacopulos","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4405178629","eid":"W4405178629"},{"id":"paper-w7131948653","cat":"papers","name":"Microdosing: een veelbelovende techniek voor geneesmiddelonderzoek bij kinderen","year":"2014","cit":0,"pfa":"S.N. Wildt","psa":"W.H.J. Vaes","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7131948653","eid":"W7131948653"},{"id":"paper-w4413675570","cat":"papers","name":"Drogues psychédéliques : la tendance du microdosing de LSD","year":"2018","cit":0,"pfa":"Sylvie Gendreau","topics":["Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W4413675570","eid":"W4413675570"},{"id":"paper-w2150090193","cat":"papers","name":"Microdosing: een veelbelovende techniek voor geneesmiddelonderzoek bij kinderen","year":"2014","cit":0,"pfa":"M. G. Mooij","psa":"W.H.J. Vaes","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2150090193","eid":"W2150090193"},{"id":"paper-w2253809297","cat":"papers","name":"DFT-based QSAR and Action Mechanism of Phenylalkylamine and Tryptamine Hallucinogens","year":"2011","cit":0,"pfa":"张绍飞","psa":"成素丽","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2253809297","eid":"W2253809297"},{"id":"paper-w7112344318","cat":"papers","name":"The Hopkins-Oxford Psychedelic Ethics Consensus Statement","year":"2023","cit":0,"pfa":"Jacobs, Edward","psa":"Yaden, David B.","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7112344318","eid":"W7112344318"},{"id":"paper-w7124747770","cat":"papers","name":"Exploring patterns of concurrent substance use, psychedelic dosing and intentions, and childhood trauma in psychedelic use in college aged adults","year":"2026","cit":0,"pfa":"Vivian W. L. Tsang","psa":"Christian G. Schütz","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7124747770","eid":"W7124747770"},{"id":"paper-w7135831629","cat":"papers","name":"Neurobiology and toxicity of new psychoactive substances from hallucinogens class","year":"2019","cit":0,"pfa":"Vít Zmátlo","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W7135831629","eid":"W7135831629"},{"id":"paper-w2422614172","cat":"papers","name":"[Use of copper and cobalt microdoses in complex treatment of experimental rickets].","year":"1979","cit":0,"pfa":"Galiuk Sv","topics":["Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W2422614172","eid":"W2422614172"},{"id":"paper-w2285727341","cat":"papers","name":"“Microdose” Transdermal Estradiol: As Effective as Raloxifene in Preventing Bone Loss?","year":"2009","cit":0,"pfa":"Robert W. Rebar","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2285727341","eid":"W2285727341"},{"id":"paper-w2368221075","cat":"papers","name":"Analysis of Effect on Microdose of ~(10)B Nonuniform Distribution in Cellular","year":"2012","cit":0,"pfa":"Da Chen","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2368221075","eid":"W2368221075"},{"id":"paper-w2401259851","cat":"papers","name":"[Effect of norethisterone microdoses on the functional state of the hypophyseal-ovarian system].","year":"1980","cit":0,"pfa":"I A Manuilova","psa":"Trutko Ns","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2401259851","eid":"W2401259851"},{"id":"paper-w3084144657","cat":"papers","name":"No clinically relevant interaction of voriconazole with microdosed apixaban, edoxaban and rivaroxaban","year":"2018","cit":0,"pfa":"Gerd Mikus","psa":"Walter E. Haefeli","topics":["Dosing & pharmacology","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3084144657","eid":"W3084144657"},{"id":"paper-w2614708721","cat":"papers","name":"Microdosing technique for microreaction technology : precision for dispensing and fluid handling","year":"2007","cit":0,"pfa":"Willi Hempelmann","psa":"Lasse Greiner","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2614708721","eid":"W2614708721"},{"id":"paper-w7215113333","cat":"papers","name":"Weight loss drugs: Does microdosing GLP-1s work?","year":"2026","cit":0,"pfa":"Canqi Li","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7215113333","eid":"W7215113333"},{"id":"paper-w4251294130","cat":"papers","name":"The brain on psychedelics, and sleep deficits’ unequal toll","year":"2021","cit":0,"ptype":"article","src":"https://openalex.org/W4251294130","eid":"W4251294130"},{"id":"paper-w4401604210","cat":"papers","name":"Haight-Ashbury, Psychedelics, and the Birth of Acid Rock","year":"2023","cit":0,"pfa":"Robert Campbell","ptype":"book","src":"https://openalex.org/W4401604210","eid":"W4401604210"},{"id":"paper-w4385720452","cat":"papers","name":"Is Therapeutic Use of Psychedelic Medication Influenced by Bias?","year":"2023","cit":0,"pfa":"Geraldine S. Pearson","ptype":"editorial","src":"https://openalex.org/W4385720452","eid":"W4385720452"},{"id":"paper-w2887530422","cat":"papers","name":"Research needed on psychedelic compound for opioid withdrawal","year":"2018","cit":0,"pfa":"Anne Lamont Hume","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2887530422","eid":"W2887530422"},{"id":"paper-w7214731691","cat":"papers","name":"When psychedelic discourse meets local narrative: Selective uptake of psychedelic meanings surrounding mad honey in Nepal","year":"2026","cit":0,"pfa":"Sharon R. Sznitman","psa":"Surendra Tiwari","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7214731691","eid":"W7214731691"},{"id":"paper-w7171343250","cat":"papers","name":"Distinct correlates of growth and enduring difficulty after psychedelic experiences: A cross-sectional analysis of the Global Psychedelic Survey 2025","year":"2026","cit":0,"pfa":"Tsung-Ren Huang","ptype":"preprint","src":"https://openalex.org/W7171343250","eid":"W7171343250"},{"id":"paper-w7214387697","cat":"papers","name":"Considerations and challenges in microdosing of GLP-1-based receptor agonists","year":"2026","cit":0,"pfa":"Haley Beck","psa":"Jennifer N. Clements","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7214387697","eid":"W7214387697"},{"id":"paper-w282497253","cat":"papers","name":"Characterisation of the binding of the hallucinogen 11C-MEO-DMT in brain of living pigs","year":"2006","cit":0,"pfa":"Svend Borup Jensen","psa":"Paul D. Cumming","ptype":"other","src":"https://openalex.org/W282497253","eid":"W282497253"},{"id":"paper-w2088471373","cat":"papers","name":"Hallucinogens: Cross‐Cultural Perspectives. MARLENE DOBKIN DE RIOS","year":"1985","cit":0,"pfa":"Peter T. Furst","ptype":"article","src":"https://openalex.org/W2088471373","eid":"W2088471373"},{"id":"paper-w7115409528","cat":"papers","name":"Potential therapeutic use of psychedelics - an example of LSD","year":"2017","cit":0,"pfa":"Špan, Ema","ptype":"dissertation","src":"https://openalex.org/W7115409528","eid":"W7115409528"},{"id":"paper-w4409886320","cat":"papers","name":"Innovation and inequity in psychedelic research at the Mayo Clinic","year":"2025","cit":0,"pfa":"Casimir C. Klim","psa":"Scott A. Breitinger","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4409886320","eid":"W4409886320"},{"id":"paper-w4414161970","cat":"papers","name":"Psychedelic studies in nonhuman primates: Past and future","year":"2025","cit":0,"pfa":"Jamie C. Masthay","psa":"Steve W. C. Chang","ptype":"article","src":"https://openalex.org/W4414161970","eid":"W4414161970"},{"id":"paper-w7160577929","cat":"papers","name":"Systematic Review of Psychedelics in Mental Health Disorders","year":"2025","cit":0,"pfa":"Natalie Hart","psa":"Lera Lockhart","topics":["Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7160577929","eid":"W7160577929"},{"id":"paper-w4394370877","cat":"papers","name":"Cannabis and Psychedelics User Survey questionnaire and dataset","year":"2020","cit":0,"pfa":"Petter Grahl Johnstad","ptype":"dataset","src":"https://openalex.org/W4394370877","eid":"W4394370877"},{"id":"paper-w4390812753","cat":"papers","name":"Psychedelic mushrooms go back millions of years","year":"2024","cit":0,"ptype":"dataset","src":"https://openalex.org/W4390812753","eid":"W4390812753"},{"id":"paper-w7128769861","cat":"papers","name":"Psychedelic causes a similar state of mind to meditation","year":"2026","cit":0,"pfa":"Gabriela Galvin","ptype":"article","src":"https://openalex.org/W7128769861","eid":"W7128769861"},{"id":"paper-w4407962089","cat":"papers","name":"Bias and balance in psychedelic academia: a tricky business","year":"2025","cit":0,"pfa":"Jordan Bawks","psa":"Fabiano A. Gomes","ptype":"article","src":"https://openalex.org/W4407962089","eid":"W4407962089"},{"id":"paper-w7124122216","cat":"papers","name":"Recall of potentially traumatic events under psychedelics","year":"2025","cit":0,"pfa":"Samuli Kangaslampi","psa":"Kim P. C. Kuypers","topics":["PTSD & trauma"],"ptype":"conference-paper","src":"https://openalex.org/W7124122216","eid":"W7124122216"},{"id":"paper-w4411490434","cat":"papers","name":"Psychedelic-Inspired Approaches for Treating Neurodegenerative Disorders","year":"2025","cit":0,"pfa":"Mahdieh Saeidi","psa":"Sasidhar Gunturu","ptype":"book-chapter","src":"https://openalex.org/W4411490434","eid":"W4411490434"},{"id":"paper-w7128161690","cat":"papers","name":"Psychedelics center will pursue research, clinical applications","year":"2026","cit":0,"pfa":"Gary A. Enos","ptype":"article","src":"https://openalex.org/W7128161690","eid":"W7128161690"},{"id":"paper-w2969866670","cat":"papers","name":"Do Classic Hallucinogens Have Therapeutic Properties? A Focus on Depression Treatment","year":"2017","cit":0,"pfa":"Martha Lynn Waterfield","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2969866670","eid":"W2969866670"},{"id":"paper-w7135563428","cat":"papers","name":"Soundscape of Prague Psychedelic Guitar Rock Scene","year":"2022","cit":0,"pfa":"Oldřich Poděbradský","topics":["Addiction"],"ptype":"dissertation","src":"https://openalex.org/W7135563428","eid":"W7135563428"},{"id":"paper-w4407325335","cat":"papers","name":"Psychedelics – what they are, how they work and what th","year":"2024","cit":0,"pfa":"Krystyna Gołembiowska","ptype":"article","src":"https://openalex.org/W4407325335","eid":"W4407325335"},{"id":"paper-w4412871487","cat":"papers","name":"Psychedelics for mental health: new therapeutic pathways","year":"2025","cit":0,"pfa":"Cinthe Lemmens","ptype":"article","src":"https://openalex.org/W4412871487","eid":"W4412871487"},{"id":"paper-w4409604182","cat":"papers","name":"Bodies of Knowledge, Psychedelic Journeying, and the Writing of Space:","year":"2025","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W4409604182","eid":"W4409604182"},{"id":"paper-w7162321073","cat":"papers","name":"Emerging therapeutic opportunities for psychedelic and related drugs","year":"2026","cit":0,"pfa":"Susan Wonnacott","psa":"Trevor Sharp","topics":["Mechanism & neuroscience","Reviews & meta-analyses","Policy & ethics"],"ptype":"editorial","src":"https://openalex.org/W7162321073","eid":"W7162321073"},{"id":"paper-w3120743276","cat":"papers","name":"Emerging Psychedelics: A Systematic Review of Synthetic Cannabinoids","year":"2020","cit":0,"pfa":"samad shokuhi-rad","psa":"NAJA","topics":["Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W3120743276","eid":"W3120743276"},{"id":"paper-w7164406644","cat":"papers","name":"(Condensed Version): Synthesis of Psychedelic, Pitch and Proposal","year":"2026","cit":0,"pfa":"Alexander Luke Ohnemus","ptype":"article","src":"https://openalex.org/W7164406644","eid":"W7164406644"},{"id":"paper-w7165234172","cat":"papers","name":"How Psychedelic Science Invented a History of Religion","year":"2026","cit":0,"pfa":"Paul Gillis‐Smith","ptype":"article","src":"https://openalex.org/W7165234172","eid":"W7165234172"},{"id":"paper-w4413779869","cat":"papers","name":"Why religious groups are pushing for psychedelics as sacrament","year":"2025","cit":0,"pfa":"Pardis Mahdavi","ptype":"other","src":"https://openalex.org/W4413779869","eid":"W4413779869"},{"id":"paper-w4389515681","cat":"papers","name":"Progress in understanding the analgesic potential of ‘classic’ psychedelics","year":"2023","cit":0,"pfa":"Bennett Andrassy","psa":"Taif J. Mukhdomi","ptype":"article","src":"https://openalex.org/W4389515681","eid":"W4389515681"},{"id":"paper-w7115338457","cat":"papers","name":"the role of psychedelic experiences in reframing patterns of addiction","year":"2023","cit":0,"pfa":"Plavšič, Brina","topics":["Addiction"],"ptype":"dissertation","src":"https://openalex.org/W7115338457","eid":"W7115338457"},{"id":"paper-w4402739315","cat":"papers","name":"Decision letter for \"Artificial intelligence and psychedelic medicine\"","year":"2024","cit":0,"ptype":"peer-review","src":"https://openalex.org/W4402739315","eid":"W4402739315"},{"id":"paper-w7124583814","cat":"papers","name":"When the psychedelic state's over… do neurophysiological changes persist? Evidence from a population of experienced naturalistic psychedelic users","year":"2026","cit":0,"pfa":"Maja Wójcik","psa":"Michał Bola","ptype":"book","src":"https://openalex.org/W7124583814","eid":"W7124583814"},{"id":"paper-w612440137","cat":"papers","name":"Pornography, Psychedelics and Technology : Essays on the Limits to Freedom","year":"2011","cit":0,"pfa":"E. J. Mishan","ptype":"book","src":"https://openalex.org/W612440137","eid":"W612440137"},{"id":"paper-w2912973110","cat":"papers","name":"Successful psychedelic treatment of addiction: A conversion experience?","year":"2012","cit":0,"pfa":"Tom Kingsley Brown","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W2912973110","eid":"W2912973110"},{"id":"paper-w4235938239","cat":"papers","name":"Prosaic, Poetic, Psychedelic, and Paranormal Communications of Plants","year":"2019","cit":0,"pfa":"Chris S. Duvall","ptype":"book-chapter","src":"https://openalex.org/W4235938239","eid":"W4235938239"},{"id":"paper-w4303185712","cat":"papers","name":"Can psychedelics provide a glimpse into the experience of death?","year":"2022","cit":0,"pfa":"AISDL Mindsponge","topics":["Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4303185712","eid":"W4303185712"},{"id":"paper-w4377081798","cat":"papers","name":"Psychedelic drugs: the new frontier for mental health","year":"2023","cit":0,"topics":["Depression","PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4377081798","eid":"W4377081798"},{"id":"paper-w4403122278","cat":"papers","name":"No Attainment, Nothing to Attain: A Buddhist Reflection on Psychedelics","year":"2024","cit":0,"pfa":"Peter D. Hershock","ptype":"article","src":"https://openalex.org/W4403122278","eid":"W4403122278"},{"id":"paper-w4362469323","cat":"papers","name":"How psychedelic compounds stimulate neuronal growth","year":"2023","cit":0,"pfa":"Shi En Kim","ptype":"article","src":"https://openalex.org/W4362469323","eid":"W4362469323"},{"id":"paper-w7202081547","cat":"papers","name":"Sex-sensitive serotonergic signaling in psychedelic pharmacology","year":"2026","cit":0,"pfa":"Sofia Nasini","psa":"Stefano Comai","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7202081547","eid":"W7202081547"},{"id":"paper-w2413063558","cat":"papers","name":"Banished From The Universe : psychedelic, experimental, independent.","year":"2013","cit":0,"pfa":"issuing body.","ptype":"article","src":"https://openalex.org/W2413063558","eid":"W2413063558"},{"id":"paper-w3029524028","cat":"papers","name":"Ecodelia: towards a transpersonal ecopsychology through psychedelics","year":"2016","cit":0,"pfa":"David P. Luke","ptype":"article","src":"https://openalex.org/W3029524028","eid":"W3029524028"},{"id":"paper-w3174633401","cat":"papers","name":"Psychedelics open a new window on the mechanisms of perception","year":"2021","cit":0,"pfa":"Anil Ananthaswamy","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3174633401","eid":"W3174633401"},{"id":"paper-w7210291478","cat":"papers","name":"Beyond the Medicine: Designing the Psychedelic Ecosystem Together","year":"2025","cit":0,"pfa":"Alexandra Maria Plesner","psa":"Tracy DeLuca","topics":["Safety & adverse events","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7210291478","eid":"W7210291478"},{"id":"paper-w4412725911","cat":"papers","name":"Psychedelic drugs for the treatment of substance use disorders","year":"2025","cit":0,"pfa":"Mehmet Sofuoglu","psa":"Robert Ross MacLean","topics":["Addiction"],"ptype":"editorial","src":"https://openalex.org/W4412725911","eid":"W4412725911"},{"id":"paper-w7160408671","cat":"papers","name":"PSYCHEDELIC PLANT MEDICINES OF THE AMERICAS leer pdf","year":"2026","cit":0,"pfa":"Karen Mahon","ptype":"report","src":"https://openalex.org/W7160408671","eid":"W7160408671"},{"id":"paper-w4392988813","cat":"papers","name":"Psychedelics and Criminality: A Possible Pathway To Reduced Recidivism?","year":"2015","cit":0,"pfa":"Peter S. Hendricks","ptype":"other","src":"https://openalex.org/W4392988813","eid":"W4392988813"},{"id":"paper-w3195650174","cat":"papers","name":"Beckley raises $80 million for psychedelic drugs","year":"2021","cit":0,"pfa":"Ryan Cross","ptype":"article","src":"https://openalex.org/W3195650174","eid":"W3195650174"},{"id":"paper-w7116684157","cat":"papers","name":"Psychedelics research in rodents has a behavior problem","year":"2025","cit":0,"pfa":"Calli McMurray","ptype":"article","src":"https://openalex.org/W7116684157","eid":"W7116684157"},{"id":"paper-w7124515724","cat":"papers","name":"Chapter: Psychedelics and the Neuroscience of Consciousness. By Enzo Tagliazucchi","year":"2026","cit":0,"pfa":"Athina Demertzi","ptype":"book-chapter","src":"https://openalex.org/W7124515724","eid":"W7124515724"},{"id":"paper-w4380769271","cat":"papers","name":"The Medical Use of Psychedelics: Moving into New Territory","year":"2023","cit":0,"ptype":"article","src":"https://openalex.org/W4380769271","eid":"W4380769271"},{"id":"paper-w7137747577","cat":"papers","name":"Embodied Transcendence: Psychedelics and the Evolution of Moral Abstraction","year":"2026","cit":0,"pfa":"Emanuel Jas","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7137747577","eid":"W7137747577"},{"id":"paper-w2414798996","cat":"papers","name":"[Studies on hallucinogens. VI Synthesis of delta-6a,10a-tetrahydrocannabinol].","year":"1974","cit":0,"pfa":"M Ono","psa":"Tomomi Matsui Inoue","ptype":"other","src":"https://openalex.org/W2414798996","eid":"W2414798996"},{"id":"paper-w2463620361","cat":"papers","name":"Lsd Psychotherapy: An Exploration of Psychedelic & Psychoanalytic Therapy","year":"1970","cit":0,"pfa":"Charles Savage","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2463620361","eid":"W2463620361"},{"id":"paper-w7213408495","cat":"papers","name":"The Case for More Aggressive Masking in Psychedelic Trials","year":"2026","cit":0,"pfa":"Kevin H. Yang","psa":"Josh D. Woolley","ptype":"article","src":"https://openalex.org/W7213408495","eid":"W7213408495"},{"id":"paper-w3194775503","cat":"papers","name":"Microdose effects in SRAM cells under heavy ion irradiation","year":"2017","cit":0,"pfa":"Bailey Anna","psa":"M Uzhegov Vyacheslav","topics":["Dosing & pharmacology"],"ptype":"conference-paper","src":"https://openalex.org/W3194775503","eid":"W3194775503"},{"id":"paper-w4226250479","cat":"papers","name":"Buy Neuro Botanicals (Calm) Microdose Mushroom Capsules online","year":"2022","cit":0,"pfa":"Antonio Cooper","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4226250479","eid":"W4226250479"},{"id":"paper-w7146162377","cat":"papers","name":"VIEWS AND REVIEWS Psychedelics and Zen: Some Reflections","cit":0,"pfa":"Ray Jordan","psa":"Ray Jordan","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7146162377","eid":"W7146162377"},{"id":"paper-w4410473487","cat":"papers","name":"Underlying Similarities Between Psychedelic and Schizophrenia Hallucinations","year":"2025","cit":0,"pfa":"Katherine H. Frost","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4410473487","eid":"W4410473487"},{"id":"paper-w7168355448","cat":"papers","name":"Psychedelics Trials and Outcomes—A Closer Look—Reply","year":"2026","cit":0,"pfa":"Balázs Szigeti","psa":"Zachary J. Williams","ptype":"article","src":"https://openalex.org/W7168355448","eid":"W7168355448"},{"id":"paper-w4402739282","cat":"papers","name":"Decision letter for \"Artificial intelligence and psychedelic medicine\"","year":"2024","cit":0,"ptype":"peer-review","src":"https://openalex.org/W4402739282","eid":"W4402739282"},{"id":"paper-w2891819357","cat":"papers","name":"Rapid Nocturia Efficacy of AV002, an Emulsified Microdose Vasopressin Analog","year":"2018","cit":0,"pfa":"Lysanne Campeau","psa":"Diane Kaschak Newman","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2891819357","eid":"W2891819357"},{"id":"paper-w7204247865","cat":"papers","name":"A psychedelic‑induced developmental imprint on social competition","year":"2026","cit":0,"pfa":"Xiaoshan Ke","psa":"Xiaohui Wang","ptype":"article","src":"https://openalex.org/W7204247865","eid":"W7204247865"},{"id":"paper-w4405629748","cat":"papers","name":"Cerebellar SHANK3; telehealth coaching for caregivers; psychedelics","year":"2024","cit":0,"pfa":"Jill Adams","ptype":"article","src":"https://openalex.org/W4405629748","eid":"W4405629748"},{"id":"paper-w4416163444","cat":"papers","name":"Molecules, Memory, and the Mind: Psychedelics and the Future of Neuroplasticity","year":"2025","cit":0,"pfa":"Ana Sofia Brito","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4416163444","eid":"W4416163444"},{"id":"paper-w3104799428","cat":"papers","name":"Connecting Computational Tools with Psychedelic Research: (hypotheses)","year":"2019","cit":0,"pfa":"Robert E. Wendrich","ptype":"conference-paper","src":"https://openalex.org/W3104799428","eid":"W3104799428"},{"id":"paper-w4387536811","cat":"papers","name":"Naturalism and the hard problem of mysticism in psychedelic science","year":"2023","cit":0,"pfa":"Jussi Jylkkä","topics":["Addiction","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4387536811","eid":"W4387536811"},{"id":"paper-w7123679001","cat":"papers","name":"The structural diversity of psychedelic drug actions revealed","year":"2026","cit":0,"pfa":"Gumpper, Ryan H.","psa":"Jain, Manish K.","ptype":"article","src":"https://openalex.org/W7123679001","eid":"W7123679001"},{"id":"paper-w2890551745","cat":"papers","name":"Prosaic, Poetic, Psychedelic, and Paranormal Communications of Plants","year":"2018","cit":0,"pfa":"Chris S. Duvall","ptype":"book-chapter","src":"https://openalex.org/W2890551745","eid":"W2890551745"},{"id":"paper-w4414840226","cat":"papers","name":"72.2 Psychedelics and Psychiatry: Science vs Perception","year":"2025","cit":0,"pfa":"Jennifer Creedon","ptype":"article","src":"https://openalex.org/W4414840226","eid":"W4414840226"},{"id":"paper-w7117482203","cat":"papers","name":"The Ghosts of Psychedelic Science: Haunting and Moral Repair","year":"2025","cit":0,"pfa":"Phoebe Friesen","ptype":"article","src":"https://openalex.org/W7117482203","eid":"W7117482203"},{"id":"paper-w3202517244","cat":"papers","name":"Erratum: Psychedelics for Brain Injury: A Mini-Review","year":"2021","cit":0,"pfa":"Frontiers Production Office","topics":["Reviews & meta-analyses"],"ptype":"erratum","src":"https://openalex.org/W3202517244","eid":"W3202517244"},{"id":"paper-w4412708403","cat":"papers","name":"Psychedelics target neuroimmune interactions to limit fear","year":"2025","cit":0,"pfa":"Johana Alvarez","psa":"Scott J. Russo","ptype":"article","src":"https://openalex.org/W4412708403","eid":"W4412708403"},{"id":"paper-w2424586876","cat":"papers","name":"[Immediate and long term effects of intravenous adrenalin in microdoses in rheumatology].","year":"2002","cit":0,"pfa":"D Arsov","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2424586876","eid":"W2424586876"},{"id":"paper-w2636418830","cat":"papers","name":"THE ROLE OF MICRODOSE LITHIUM IN PATIENTS WITH ALZHEIMER’S DISEASE:A SYSTEMATIC REVIEW","year":"2016","cit":0,"pfa":"José Valdés","psa":"Erika Canizares","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W2636418830","eid":"W2636418830"},{"id":"paper-w4366982159","cat":"papers","name":"Journey to Narayama: Cultural Complexities, Psychedelics and Dementia","year":"2023","cit":0,"pfa":"Reina Ozeki-Hayashi","psa":"Dominic J. C. Wilkinson","ptype":"editorial","src":"https://openalex.org/W4366982159","eid":"W4366982159"},{"id":"paper-w7161920288","cat":"papers","name":"Psychedelic Research in the Modern Day: Good or Bad?","year":"2026","cit":0,"pfa":"Shane Miller","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7161920288","eid":"W7161920288"},{"id":"paper-w2793774374","cat":"papers","name":"Beyond Zero and One: Machines, Psychedelics, and Consciousness","year":"2016","cit":0,"pfa":"Andrew Smart","ptype":"book","src":"https://openalex.org/W2793774374","eid":"W2793774374"},{"id":"paper-w4404551177","cat":"papers","name":"Current Views Of Psychedelics And Their Connection To Well-Being","year":"2024","cit":0,"pfa":"Zheyu Song","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4404551177","eid":"W4404551177"},{"id":"paper-w4415170608","cat":"papers","name":"Psychedelic drugs in palliative care: research agenda","year":"2025","cit":0,"pfa":"Claire Stokes","psa":"Phillip D. Good","topics":["Anxiety & end-of-life","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4415170608","eid":"W4415170608"},{"id":"paper-w7119635181","cat":"papers","name":"Past Psychedelic Use Predicts Divergent Thinking","year":"2026","cit":0,"pfa":"Gregory J Pope","psa":"Ruben Eero Laukkonen","ptype":"preprint","src":"https://openalex.org/W7119635181","eid":"W7119635181"},{"id":"paper-w4408221284","cat":"papers","name":"Review of Deeper Learning with Psychedelics, by D. Blacker","year":"2025","cit":0,"pfa":"Natasha Levinson","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4408221284","eid":"W4408221284"},{"id":"paper-w7154962836","cat":"papers","name":"Executive order aims to speed psychedelic research","year":"2026","cit":0,"ptype":"dataset","src":"https://openalex.org/W7154962836","eid":"W7154962836"},{"id":"paper-w2398346689","cat":"papers","name":"Turn on and tune in to evidence-based psychedelic research","year":"2015","cit":0,"pfa":"Chen X. Conceptualizing","psa":"Kelaher Ma","ptype":"article","src":"https://openalex.org/W2398346689","eid":"W2398346689"},{"id":"paper-w7204985322","cat":"papers","name":"Predicting antidepressant response to psychedelics from EEG","year":"2025","cit":0,"pfa":"Marek Nikolič","topics":["Depression"],"ptype":"dissertation","src":"https://openalex.org/W7204985322","eid":"W7204985322"},{"id":"paper-w2020263380","cat":"papers","name":"Hallucinogen Bannisteriopsis caapi: Use in religious sects, abuse and chromatographic identification","year":"1998","cit":0,"pfa":"L.K. Khon","psa":"Silvia Oliveira Santos Cazenave","ptype":"article","src":"https://openalex.org/W2020263380","eid":"W2020263380"},{"id":"paper-w4416788723","cat":"papers","name":"Exploratory Clinical Study on Controlled álak Microdosing for Post-Detoxification Recovery","year":"2025","cit":0,"pfa":"Roland Mario","psa":"Ann Monica Espaldon","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4416788723","eid":"W4416788723"},{"id":"paper-w7108684170","cat":"papers","name":"Juvenile Hallucinogen Use: What Do Multiple Theories Say About It?","year":"2015","cit":0,"pfa":"Vito, Anthony G.","psa":"Ricketts, Melissa L.","ptype":"article","src":"https://openalex.org/W7108684170","eid":"W7108684170"},{"id":"paper-w4378233630","cat":"papers","name":"\"Elevated State of Mind: The Transcendent Effect of Psychedelics\"","year":"2022","cit":0,"pfa":"Muhammad Shamil Abbasy","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4378233630","eid":"W4378233630"},{"id":"paper-w4384560601","cat":"papers","name":"Using psychedelics to mitigate Treatment Resistant Depression","year":"2023","cit":0,"pfa":"Cosmo Feilding-Mellen","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4384560601","eid":"W4384560601"},{"id":"paper-w4403426469","cat":"papers","name":"Limitations of psychedelic research in animals warrants acknowledgement","year":"2024","cit":0,"pfa":"Emily R. Trunnell","psa":"Donya Mand","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4403426469","eid":"W4403426469"},{"id":"paper-w4313201198","cat":"papers","name":"Neurochemical underpinnings of psychedelic-induced ego dissolution","year":"2022","cit":0,"pfa":"Natasha Leigh Mason","psa":"Johannes Gerardus Ramaekers","ptype":"article","src":"https://openalex.org/W4313201198","eid":"W4313201198"},{"id":"paper-w2607665207","cat":"papers","name":"Disruption of thalamocortical activity in psychedelic models in animals","year":"2015","cit":0,"pfa":"Francesc Artigas","ptype":"conference-paper","src":"https://openalex.org/W2607665207","eid":"W2607665207"},{"id":"paper-w7152525210","cat":"papers","name":"Podcast Peer Review and Rating: Psychedelics and Depression","year":"2026","cit":0,"pfa":"Sean McCracken","topics":["Depression","Reviews & meta-analyses"],"ptype":"report","src":"https://openalex.org/W7152525210","eid":"W7152525210"},{"id":"paper-w7172518715","cat":"papers","name":"Blinding Integrity and Psychedelic Drug Trials—Reply","year":"2026","cit":0,"pfa":"Wiesław Jerzy Cubała","psa":"Michael E. Thase","ptype":"article","src":"https://openalex.org/W7172518715","eid":"W7172518715"},{"id":"paper-w7215484893","cat":"papers","name":"How informed is the informed consent in clinical trials with psychedelics? A review of the state of patient autonomy in therapeutic studies with psychedelic drugs","year":"2022","cit":0,"pfa":"Juho Rouhe","topics":["Reviews & meta-analyses"],"ptype":"dissertation","src":"https://openalex.org/W7215484893","eid":"W7215484893"},{"id":"paper-w2441612232","cat":"papers","name":"[Clinical and laboratory evaluation of prolonged administration of microdoses of d-Norgestrel].","year":"1974","cit":0,"pfa":"J Werbrouck-Navette","psa":"P Franchimont","topics":["Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W2441612232","eid":"W2441612232"},{"id":"paper-w4236078455","cat":"papers","name":"Helping at the edges of life: Perspectives of a psychedelic therapist","year":"1988","cit":0,"pfa":"Yensen","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4236078455","eid":"W4236078455"},{"id":"paper-w4407933476","cat":"papers","name":"Transcranial magnetic stimulation alters psychedelic microstates","year":"2025","cit":0,"pfa":"Melissa N. Bothwell","psa":"Dustin J. Hines","ptype":"article","src":"https://openalex.org/W4407933476","eid":"W4407933476"},{"id":"paper-w4413695277","cat":"papers","name":"Validation of the Imperial Psychedelic Predictor Scale – CORRIGENDUM","year":"2025","cit":0,"pfa":"Michael Angyus","psa":"Robin Lester Carhart-Harris","ptype":"erratum","src":"https://openalex.org/W4413695277","eid":"W4413695277"},{"id":"paper-w7117991405","cat":"papers","name":"The effect of psychedelics on associative learning: a systematic review","year":"2026","cit":0,"pfa":"A. Caulfield","psa":"M. Mehta","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7117991405","eid":"W7117991405"},{"id":"paper-w7155568291","cat":"papers","name":"Presidential order could accelerate approval of psychedelics","year":"2026","cit":0,"pfa":"Gary A. Enos","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7155568291","eid":"W7155568291"},{"id":"paper-w4256326700","cat":"papers","name":"Bibliography of Valuable Reading in the Field of Psychedelic Drugs","year":"1967","cit":0,"ptype":"paratext","src":"https://openalex.org/W4256326700","eid":"W4256326700"},{"id":"paper-w1998613152","cat":"papers","name":"Psychedelic States—How To Regard Them Is the Queston","year":"1976","cit":0,"pfa":"Sanford M. Unger","ptype":"article","src":"https://openalex.org/W1998613152","eid":"W1998613152"},{"id":"paper-w7132173250","cat":"papers","name":"Psychedelic Album Covers as a Visual Communication Form","year":"2015","cit":0,"pfa":"Beril DİLCAN","psa":"Kerim Karagöz","ptype":"conference-paper","src":"https://openalex.org/W7132173250","eid":"W7132173250"},{"id":"paper-w4394530731","cat":"papers","name":"Psychedelic use and psychiatric risks: data and code","year":"2023","cit":0,"pfa":"Otto Simonsson","topics":["Safety & adverse events"],"ptype":"dataset","src":"https://openalex.org/W4394530731","eid":"W4394530731"},{"id":"paper-w2521678629","cat":"papers","name":"Back and Forth: Mike Kelley’s Psychedelic Pedagogy","year":"2016","cit":0,"pfa":"Mary Elizabeth Anderson","psa":"Richard Haley","ptype":"article","src":"https://openalex.org/W2521678629","eid":"W2521678629"},{"id":"paper-w7119975675","cat":"papers","name":"The Relationship of Adaptogens and Psychedelics on Adults and Well-Being","year":"2021","cit":0,"pfa":"Unknown","ptype":"dataset","src":"https://openalex.org/W7119975675","eid":"W7119975675"},{"id":"paper-w4402739412","cat":"papers","name":"Author response for \"Artificial intelligence and psychedelic medicine\"","year":"2024","cit":0,"pfa":"Jerome J. Sarris","psa":"Daniel Perkins","ptype":"peer-review","src":"https://openalex.org/W4402739412","eid":"W4402739412"},{"id":"paper-w4309693771","cat":"papers","name":"The magic of psychedelics – a tale told in quotation marks","year":"2022","cit":0,"pfa":"Kim Outhoff","ptype":"article","src":"https://openalex.org/W4309693771","eid":"W4309693771"},{"id":"paper-w2186304187","cat":"papers","name":"Review of Zig Zag Zen: Buddhism and Psychedelics","year":"2005","cit":0,"pfa":"Myron J. Stolaro","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2186304187","eid":"W2186304187"},{"id":"paper-w4304957582","cat":"papers","name":"Interest in benefits of psychedelics grows, as does research","year":"2022","cit":0,"pfa":"Johanna Taylor Katroscik","ptype":"article","src":"https://openalex.org/W4304957582","eid":"W4304957582"},{"id":"paper-w2591358154","cat":"papers","name":"A phase 0 microdosing trial of an in vivo assay for predicting chemoresistance to platinum.","year":"2011","cit":0,"pfa":"C. Pan","psa":"Paul T. Henderson","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W2591358154","eid":"W2591358154"},{"id":"paper-w2592810013","cat":"papers","name":"Nicolas Langlitz, Neuropsychedelia. The revival of hallucinogen research since the Decade of the brain","year":"2017","cit":0,"pfa":"Milana Aronov","ptype":"article","src":"https://openalex.org/W2592810013","eid":"W2592810013"},{"id":"paper-w4413488147","cat":"papers","name":"Hallucinogens approved for treating psychiatric disorders: what does the science say?","year":"2024","cit":0,"pfa":"Florian Naudet","ptype":"other","src":"https://openalex.org/W4413488147","eid":"W4413488147"},{"id":"paper-w7162560437","cat":"papers","name":"Antidepressant effect of psychedelic compounds and mechanisms underlying the G protein-coupled receptors activation psychedelics: Antidepressant action and GPCR signaling","year":"2026","cit":0,"pfa":"Amanda Gollo Bertollo","psa":"Zuleide Maria Ignácio","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7162560437","eid":"W7162560437"},{"id":"paper-w7204858311","cat":"papers","name":"Psychedelic renaissance in healthcare: between the biomedical and the existential","year":"2026","cit":0,"pfa":"Daniel Laforest","topics":["Anxiety & end-of-life","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7204858311","eid":"W7204858311"},{"id":"paper-w7212267308","cat":"papers","name":"Chapter Two THE AUTHENTICITY BLUES (AND THE PSYCHEDELIC SOLUTION)","year":"2026","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W7212267308","eid":"W7212267308"},{"id":"paper-w4293078290","cat":"papers","name":"Combating psychological distress with psychedelics in cancer patients","year":"2022","cit":0,"pfa":"Syeda Zainab Fatima","psa":"Saba Zaheer","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4293078290","eid":"W4293078290"},{"id":"paper-w4295012272","cat":"papers","name":"Why Otolaryngologists Should Be Interested in Psychedelic Medicine","year":"2022","cit":0,"pfa":"Benjamin Finkelhor Asher","ptype":"article","src":"https://openalex.org/W4295012272","eid":"W4295012272"},{"id":"paper-w4256522668","cat":"papers","name":"7. Psychedelics: Blowing Open the Doors of Perception","year":"1979","cit":0,"pfa":"James V. Downtwon","ptype":"book-chapter","src":"https://openalex.org/W4256522668","eid":"W4256522668"},{"id":"paper-w4413586008","cat":"papers","name":"Psychedelics: how they act on the brain to relieve depression","year":"2022","cit":0,"pfa":"Clare Tweedy","topics":["Depression"],"ptype":"other","src":"https://openalex.org/W4413586008","eid":"W4413586008"},{"id":"paper-w180999495","cat":"papers","name":"[Treatment of bladder neoplasm: vesical instillation of BCG vaccine in microdoses].","year":"1990","cit":0,"pfa":"Pilar García de la Torre Rivera","psa":"P Venegas","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W180999495","eid":"W180999495"},{"id":"paper-w7144545370","cat":"papers","name":"Opening remarks and Ethics and regulations in Japan and in NEDO MicroDose-PJ","year":"2010","cit":0,"pfa":"Chieko Kurihara","psa":"栗原 千絵子","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"conference-paper","src":"https://openalex.org/W7144545370","eid":"W7144545370"},{"id":"paper-w2624928458","cat":"papers","name":"The Effects of Life Values Among Non-Psychedelic Drug Users and Psychedelic Drug Users: A Comparison Study on Life Values","year":"2014","cit":0,"pfa":"Lin Peng","ptype":"article","src":"https://openalex.org/W2624928458","eid":"W2624928458"},{"id":"paper-w2142097263","cat":"papers","name":"Tripping: An Anthology of True-Life Psychedelic Adventures","year":"2001","cit":0,"pfa":"Steve Heilig","ptype":"article","src":"https://openalex.org/W2142097263","eid":"W2142097263"},{"id":"paper-w7133395151","cat":"papers","name":"Behavior change through psychedelics: An international survey","year":"2023","cit":0,"pfa":"Jorge Encantado","psa":"Arlen C. Moller","topics":["Addiction"],"ptype":"preprint","src":"https://openalex.org/W7133395151","eid":"W7133395151"},{"id":"paper-w3176440134","cat":"papers","name":"Microdosing data harvest using Youtube Data Tool June 2016","year":"2018","cit":0,"pfa":"Aleksi Hupli","topics":["Dosing & pharmacology"],"ptype":"dataset","src":"https://openalex.org/W3176440134","eid":"W3176440134"},{"id":"paper-w2042518497","cat":"papers","name":"In Memory of Oscar Janiger, Pioneer in Psychedelic Research","year":"2001","cit":0,"pfa":"Marlene Dobkin de Ríos","ptype":"article","src":"https://openalex.org/W2042518497","eid":"W2042518497"},{"id":"paper-w4390225074","cat":"papers","name":"Attitudes on Marijuana and Psychedelics as a Treatment Option for Veterans","year":"2023","cit":0,"pfa":"Peter Leasure","psa":"Dexter Ridgway","ptype":"preprint","src":"https://openalex.org/W4390225074","eid":"W4390225074"},{"id":"paper-w4387855853","cat":"papers","name":"Side Effects and Safety Issues of Psychedelic Drugs","year":"2023","cit":0,"pfa":"Y. S. Kim","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4387855853","eid":"W4387855853"},{"id":"paper-w2946387089","cat":"papers","name":"O20 Dose-linearity of the pharmacokinetics of an intravenous [14C]midazolam microdose in children","year":"2019","cit":0,"pfa":"BD van Groen","psa":"MA Turner","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"conference-abstract","src":"https://openalex.org/W2946387089","eid":"W2946387089"},{"id":"paper-w2760959003","cat":"papers","name":"Binding of the hallucinogen 5-[11C] Meo-DMT in brain of living pigs","year":"2006","cit":0,"pfa":"Kasper Tholstrup Pedersen","psa":"Svend Borup Jensen","ptype":"conference-paper","src":"https://openalex.org/W2760959003","eid":"W2760959003"},{"id":"paper-w7135636141","cat":"papers","name":"To thin from psychedelic experiences - a transdisciplinary interpretation","year":"2016","cit":0,"pfa":"Vít Pokorný","topics":["Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7135636141","eid":"W7135636141"},{"id":"paper-w4411151547","cat":"papers","name":"Renewed interest in psychedelics for treatment of PTSD and cPTSD","year":"2023","cit":0,"pfa":"Elisheva Malloy","psa":"Kristine Jacquin","topics":["PTSD & trauma"],"ptype":"dataset","src":"https://openalex.org/W4411151547","eid":"W4411151547"},{"id":"paper-w4411932293","cat":"papers","name":"The role of modern neuroscience in the renaissance of psychedelic research","year":"2025","cit":0,"pfa":"Kathryn E. Evans","psa":"Jonnathan Singh Alvarado","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4411932293","eid":"W4411932293"},{"id":"paper-w4413525849","cat":"papers","name":"The potential of psychedelics to heal our racial traumas","year":"2023","cit":0,"topics":["PTSD & trauma"],"ptype":"other","src":"https://openalex.org/W4413525849","eid":"W4413525849"},{"id":"paper-w4410120759","cat":"papers","name":"Psychedelics and chronic pain: a trip worth taking","year":"2025","cit":0,"pfa":"E Burson","psa":"T Lil","ptype":"article","src":"https://openalex.org/W4410120759","eid":"W4410120759"},{"id":"paper-w7160138756","cat":"papers","name":"The Role of Psychedelics in the Development of Human Religious Practices","year":"2026","cit":0,"pfa":"Denis Pavăl","ptype":"book","src":"https://openalex.org/W7160138756","eid":"W7160138756"},{"id":"paper-w7167425559","cat":"papers","name":"Psychedelic Worldhood: Significance Beyond Ordinary Consciousness","year":"2026","cit":0,"pfa":"Erik Tönsberg","ptype":"preprint","src":"https://openalex.org/W7167425559","eid":"W7167425559"},{"id":"paper-w4394948882","cat":"papers","name":"Beyond the Hype: Pragmatic Solutions for Advancing Psychedelic Therapeutics","year":"2024","cit":0,"pfa":"Adrian Preda","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4394948882","eid":"W4394948882"},{"id":"paper-w2022856335","cat":"papers","name":"Review of Psychedelics: The Uses and Implications of Hallucinogenic Drugs.","year":"1971","cit":0,"pfa":"Martin M. Katz","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2022856335","eid":"W2022856335"},{"id":"paper-w7204906336","cat":"papers","name":"Psychedelic Drug Proves Useful in Alcoholic Therapy","year":"1973","cit":0,"topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7204906336","eid":"W7204906336"},{"id":"paper-w4238709197","cat":"papers","name":"1. Psychedelic Violence – Crime of Visual Shock","year":"2014","cit":0,"pfa":"Nadine Heymann","ptype":"book-chapter","src":"https://openalex.org/W4238709197","eid":"W4238709197"},{"id":"paper-w4298005925","cat":"papers","name":"Can psychedelics provide a glimpse into the experience of death?","year":"2022","cit":0,"pfa":"Tam-Tri Le","ptype":"preprint","src":"https://openalex.org/W4298005925","eid":"W4298005925"},{"id":"paper-w4402739617","cat":"papers","name":"Decision letter for \"Artificial intelligence and psychedelic medicine\"","year":"2024","cit":0,"ptype":"peer-review","src":"https://openalex.org/W4402739617","eid":"W4402739617"},{"id":"paper-w4406327010","cat":"papers","name":"The Pain Gap: Epistemic Justice in Psychedelic Ethics","year":"2025","cit":0,"pfa":"Joanna Kempner","psa":"Emmanuelle A. D. Schindler","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4406327010","eid":"W4406327010"},{"id":"paper-w7170131430","cat":"papers","name":"Cellular mechanisms of serotonergic psychedelics - apical hypercontextualisation","year":"2026","cit":0,"pfa":"Kristjan Kaup","psa":"Jaan Aru","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7170131430","eid":"W7170131430"},{"id":"paper-w421482920","cat":"papers","name":"Psychedelic room, una habitación para no dormir","year":"2011","cit":0,"pfa":"minue","ptype":"article","src":"https://openalex.org/W421482920","eid":"W421482920"},{"id":"paper-w4231091575","cat":"papers","name":"Computer AI makes sense of psychedelic trips","year":"2012","cit":0,"ptype":"article","src":"https://openalex.org/W4231091575","eid":"W4231091575"},{"id":"paper-w4297492743","cat":"papers","name":"Can psychedelic drugs uncover the secrets of consciousness?","year":"2022","cit":0,"ptype":"article","src":"https://openalex.org/W4297492743","eid":"W4297492743"},{"id":"paper-w7111983760","cat":"papers","name":"Psilocybe mushrooms: extraction and purification of psychedelic tryptamines","year":"2025","cit":0,"pfa":"Beatriz Maria Pinto Senra","topics":["Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W7111983760","eid":"W7111983760"},{"id":"paper-w3188196018","cat":"papers","name":"Psychedelic Relationship Enhancement. Love Drugs. A Précis","year":"2020","cit":0,"pfa":"Gianfranco Pellegrino","ptype":"article","src":"https://openalex.org/W3188196018","eid":"W3188196018"},{"id":"paper-w7126327644","cat":"papers","name":"Therapeutic potential of tryptamine psychedelics for psychiatric disorders","year":"2022","cit":0,"pfa":"Robert E. Koegel","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"dissertation","src":"https://openalex.org/W7126327644","eid":"W7126327644"},{"id":"paper-w4380304753","cat":"papers","name":"Simulating Dissociation: The Psychedelic Experience and Videogame Space","year":"2023","cit":0,"pfa":"Aaron Oldenburg","ptype":"article","src":"https://openalex.org/W4380304753","eid":"W4380304753"},{"id":"paper-w4390583235","cat":"papers","name":"Role of psychedelic drugs in treating mental illness","year":"2024","cit":0,"pfa":"Nick Evans","ptype":"article","src":"https://openalex.org/W4390583235","eid":"W4390583235"},{"id":"paper-w7210275000","cat":"papers","name":"Beyond the Medicine: Designing the Psychedelic Ecosystem Together","year":"2025","cit":0,"pfa":"Alexandra Maria Plesner","psa":"Tracy DeLuca","topics":["Safety & adverse events","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7210275000","eid":"W7210275000"},{"id":"paper-w7125715184","cat":"papers","name":"Supernatural Agent Experiences on Psychedelics: A Predictive Account","year":"2026","cit":0,"pfa":"Zach Buck","psa":"Mark Miller","topics":["Mechanism & neuroscience","Reviews & meta-analyses","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7125715184","eid":"W7125715184"},{"id":"paper-w7161412634","cat":"papers","name":"The placeholder god: psychedelic religion and the suspension of reference","year":"2026","cit":0,"pfa":"Chris Sawyer","ptype":"article","src":"https://openalex.org/W7161412634","eid":"W7161412634"},{"id":"paper-w7167423413","cat":"papers","name":"Psychedelic Worldhood: Significance Beyond Ordinary Consciousness","year":"2026","cit":0,"pfa":"Erik Tönsberg","ptype":"article","src":"https://openalex.org/W7167423413","eid":"W7167423413"},{"id":"paper-w7202377111","cat":"papers","name":"Bridging veteran psychedelic peer expertise with research and clinical care: Peer Readiness and Education for Psychedelic Practice (PREPP) workshop","year":"2026","cit":0,"pfa":"Stephanie R. Rodriguez","psa":"Christopher S. Stauffer","topics":["Safety & adverse events","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7202377111","eid":"W7202377111"},{"id":"paper-w7105845960","cat":"papers","name":"American Psychedelic Buddhism as Heterodox Ecstatic Religion","year":"2025","cit":0,"pfa":"D. E. Osto","ptype":"other","src":"https://openalex.org/W7105845960","eid":"W7105845960"},{"id":"paper-w132413806","cat":"papers","name":"Chaos Engine: Doofs, Psychedelics and Religious Experience","year":"2001","cit":0,"pfa":"D. Tramacchi","ptype":"article","src":"https://openalex.org/W132413806","eid":"W132413806"},{"id":"paper-w335755923","cat":"papers","name":"Psychedelic drug expert wary of medicinal marijuana","year":"2014","cit":0,"pfa":"mary-lou stevens and jon coghill","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W335755923","eid":"W335755923"},{"id":"paper-w4285044366","cat":"papers","name":"The Therapeutic Potential of Pimavanserin in the Treatment of Hallucinogen Induced Psychosis and Persistent Perceptual Symptoms","year":"2022","cit":0,"pfa":"Mark Ainsley Colijn","ptype":"article","src":"https://openalex.org/W4285044366","eid":"W4285044366"},{"id":"paper-w2943734329","cat":"papers","name":"Psychedelic Medicine: Much More Study Needed","year":"2019","cit":0,"pfa":"Stanley N. Caroff","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"other","src":"https://openalex.org/W2943734329","eid":"W2943734329"},{"id":"paper-w4400781484","cat":"papers","name":"Chapter 47. Psychedelic Drugs as Treatments in Psychiatry","year":"2024","cit":0,"pfa":"David Nutt","psa":"David Erritzøe","ptype":"book-chapter","src":"https://openalex.org/W4400781484","eid":"W4400781484"},{"id":"paper-w7160769675","cat":"papers","name":"A Protocol for the Use of Psychedelics in Jungian Psychoanalysis 1","year":"2026","cit":0,"pfa":"Leslie Stein","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7160769675","eid":"W7160769675"},{"id":"paper-w7168674165","cat":"papers","name":"Lilly to buy psychedelic-drug firm AtaiBeckley","year":"2026","cit":0,"pfa":"Sarah Braner","ptype":"article","src":"https://openalex.org/W7168674165","eid":"W7168674165"},{"id":"paper-w4240683296","cat":"papers","name":"Why does our body produce one of the most potent hallucinogens?","year":"2013","cit":0,"pfa":"Eugenio Battaglia Eugenio Battaglia","ptype":"report","src":"https://openalex.org/W4240683296","eid":"W4240683296"},{"id":"paper-w4409325149","cat":"papers","name":"Increasing Employment Discrimination Protections for Users of Medical Marijuana and Psychedelics","year":"2025","cit":0,"pfa":"Lauren Vuolo","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4409325149","eid":"W4409325149"},{"id":"paper-w4405339893","cat":"papers","name":"2. Rhetorical Mycelium: Psychedelics as Eloquence Adjuncts?","year":"2011","cit":0,"pfa":"Richard M. Doyle","ptype":"book-chapter","src":"https://openalex.org/W4405339893","eid":"W4405339893"},{"id":"paper-w4404635375","cat":"papers","name":"How to create psychedelics’ benefits without the ‘trip’","year":"2024","cit":0,"ptype":"article","src":"https://openalex.org/W4404635375","eid":"W4404635375"},{"id":"paper-w7168154478","cat":"papers","name":"Investigators' Experiences with IRB Oversight of Psychedelic Research","year":"2026","cit":0,"pfa":"Logan Neitzke‐Spruill","psa":"Holly Fernandez Lynch","ptype":"preprint","src":"https://openalex.org/W7168154478","eid":"W7168154478"},{"id":"paper-w7160114927","cat":"papers","name":"Evidence of Historical Psychedelic Use in Religious Practices","year":"2026","cit":0,"pfa":"Denis Pavăl","ptype":"book-chapter","src":"https://openalex.org/W7160114927","eid":"W7160114927"},{"id":"paper-w7126356890","cat":"papers","name":"Psychedelic Trance: Identity Formation in relation to the State","year":"2020","cit":0,"pfa":"MINSOO BAE","ptype":"other","src":"https://openalex.org/W7126356890","eid":"W7126356890"},{"id":"paper-w7135599947","cat":"papers","name":"Antidepressant potential of serotonergic psychedelics in preclinical research","year":"2022","cit":0,"pfa":"Valentýna Dušková","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W7135599947","eid":"W7135599947"},{"id":"paper-w4407932013","cat":"papers","name":"Psychedelic Ego Dissolution: A Philosophical and Qualitative Analysis","year":"2025","cit":0,"pfa":"Jason K. Day","psa":"Dan Zahavi","ptype":"preprint","src":"https://openalex.org/W4407932013","eid":"W4407932013"},{"id":"paper-w3090913403","cat":"papers","name":"Research on the zanthoprotetic reaction; Application for the colorimetric microdosing of the proteins of the blood serum.","year":"2008","cit":0,"pfa":"M Macheboeuf","psa":"Pierre Rebeyrotte","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3090913403","eid":"W3090913403"},{"id":"paper-w2594484050","cat":"papers","name":"A chronically implantable neural device for on-demand microdosing of deep brain structures","year":"2016","cit":0,"pfa":"Khalil B. Ramadi","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W2594484050","eid":"W2594484050"},{"id":"paper-w2139944028","cat":"papers","name":"Endogenous luteinizing hormone is not increased during a GnRH-a microdose flare protocol.","year":"2001","cit":0,"pfa":"Cynthia M. Murdock","psa":"Mark P. Leondires","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2139944028","eid":"W2139944028"},{"id":"paper-w3156566386","cat":"papers","name":"Investigation of the determinant of the hepatic clearance of atorvastatin with cassette-microdose clinical study","year":"2010","cit":0,"pfa":"Kenta J. Yoshida","psa":"Yuichi Sugiyama","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3156566386","eid":"W3156566386"},{"id":"paper-w4413690919","cat":"papers","name":"Shroom to grow: Australia’s missing psychedelic science","year":"2013","cit":0,"pfa":"Stephen Jason Bright","psa":"Martin L Williams","ptype":"other","src":"https://openalex.org/W4413690919","eid":"W4413690919"},{"id":"paper-w4241016481","cat":"papers","name":"Psychedelics: entering a new age of addiction therapy","year":"2014","cit":0,"topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4241016481","eid":"W4241016481"},{"id":"paper-w3165080903","cat":"papers","name":"POS0510 EPIDEMIOLOGY OF COCAINE AND HALLUCINOGEN USE DISORDER HOSPITALIZATIONS IN RHEUMATIC DISEASES","year":"2021","cit":0,"pfa":"Jasvinder A. Singh","topics":["Addiction"],"ptype":"conference-abstract","src":"https://openalex.org/W3165080903","eid":"W3165080903"},{"id":"paper-w2350682397","cat":"papers","name":"Research on Cutting Experiment in Combination with Microdose Cooling and Lubrication Coated Tools","year":"2009","cit":0,"pfa":"He Yong","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2350682397","eid":"W2350682397"},{"id":"paper-w3203955954","cat":"papers","name":"Could microdosing be as good as yoga for your mood? It’s not that big a stretch","year":"2021","cit":0,"pfa":"Stephen Jason Bright","psa":"Vince Polito","topics":["Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W3203955954","eid":"W3203955954"},{"id":"paper-w4403466953","cat":"papers","name":"An Early Exploration into Individuals in Treatment Who Co-Use Alcohol and Hallucinogens","year":"2024","cit":0,"pfa":"Ivy Fitzsimons","psa":"Sara Jo Nixon","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4403466953","eid":"W4403466953"},{"id":"paper-w7117287865","cat":"papers","name":"PREVENTIVE AND DETERRENT MEASURES FOR ALGERIAN LEGISLATORS TO COMBAT THE SCOURGE OF DRUGS AND HALLUCINOGENS","cit":0,"pfa":"Loghlam Azzouz","ptype":"article","src":"https://openalex.org/W7117287865","eid":"W7117287865"},{"id":"paper-w2502029515","cat":"papers","name":"1. Psychedelic Violence - Crime of Visual Shock","year":"2014","cit":0,"pfa":"Nadine Heymann","ptype":"book-chapter","src":"https://openalex.org/W2502029515","eid":"W2502029515"},{"id":"paper-w7141402534","cat":"papers","name":"Serotonin Update: Psychedelics and 5-HT Receptors","year":"2018","cit":0,"pfa":"David Nutt","topics":["Mechanism & neuroscience"],"ptype":"report","src":"https://openalex.org/W7141402534","eid":"W7141402534"},{"id":"paper-w4411435919","cat":"papers","name":"Haight-Ashbury, Psychedelics, and the Birth of Acid Rock","year":"2023","cit":0,"pfa":"Robert J. Campbell","ptype":"book","src":"https://openalex.org/W4411435919","eid":"W4411435919"},{"id":"paper-w4321608107","cat":"papers","name":"How to fold Indigenous ethics into psychedelics studies","year":"2023","cit":0,"topics":["Policy & ethics"],"ptype":"dataset","src":"https://openalex.org/W4321608107","eid":"W4321608107"},{"id":"paper-w4402739285","cat":"papers","name":"Author response for \"Artificial intelligence and psychedelic medicine\"","year":"2024","cit":0,"pfa":"Jerome J. Sarris","psa":"Daniel Perkins","ptype":"peer-review","src":"https://openalex.org/W4402739285","eid":"W4402739285"},{"id":"paper-w4409716577","cat":"papers","name":"The Wildest Apostasy: Psychedelic Knowledge and Racial Delirium","year":"2025","cit":0,"pfa":"Darieck Scott","ptype":"article","src":"https://openalex.org/W4409716577","eid":"W4409716577"},{"id":"paper-w7213249621","cat":"papers","name":"Risks from self-medicating with psychedelic drugs.","year":"2026","cit":0,"pfa":"Joshua Curtis Black","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7213249621","eid":"W7213249621"},{"id":"paper-w7116882382","cat":"papers","name":"Are Psychedelics Able to Play a Role in Influencing Creativity?","year":"2025","cit":0,"pfa":"Janvi Bali","ptype":"article","src":"https://openalex.org/W7116882382","eid":"W7116882382"},{"id":"paper-w7109217816","cat":"papers","name":": Psychedelic Outlaws: The Movement Revolutionizing Modern Medicine","year":"2025","cit":0,"pfa":"Himesh Mehta","ptype":"book-review","src":"https://openalex.org/W7109217816","eid":"W7109217816"},{"id":"paper-w3090055866","cat":"papers","name":"The microdosing of medicinal esters based on methyl or ethyl alcohol by the chromometric method.","year":"1947","cit":0,"pfa":"A. Ionesco-Matiu","psa":"I POPA","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3090055866","eid":"W3090055866"},{"id":"paper-w183450208","cat":"papers","name":"[Immunogenicity of microdoses of a purified preparation of hepatitis B virus surface antigen].","year":"1981","cit":0,"pfa":"Goroshnikov Sb","psa":"M Ia Orgel'","topics":["Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W183450208","eid":"W183450208"},{"id":"paper-w2371882789","cat":"papers","name":"Effect Experiment of Microdose Ivermectin Injection on Repelling Hypoderma Larvae in Yak","year":"2008","cit":0,"pfa":"Chunhua Li","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2371882789","eid":"W2371882789"},{"id":"paper-w3048076361","cat":"papers","name":"Microdosing Mindfulness: Understanding the Effects of Brief Mindfulness Meditation in Children with ADHD","year":"2020","cit":0,"pfa":"Marcus Gottlieb","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3048076361","eid":"W3048076361"},{"id":"paper-w4246360834","cat":"papers","name":"Levels and Sequences of Psychedelic Experience after LSD","year":"1998","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W4246360834","eid":"W4246360834"},{"id":"paper-w4396722092","cat":"papers","name":"Toad psychedelic points to biological target for antidepressants","year":"2024","cit":0,"topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4396722092","eid":"W4396722092"},{"id":"paper-w3009918925","cat":"papers","name":"The role of neurotransmitter uptake in the mechanism of action of hallucinogens / by Michael Robert Whipple.","year":"1980","cit":0,"pfa":"Michael R. Whipple","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3009918925","eid":"W3009918925"},{"id":"paper-w4412993689","cat":"papers","name":"Small doses, big questions: A mycologist's guide to microdosing Amanita fungi","year":"2025","cit":0,"pfa":"Joseph T. La Torre","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4412993689","eid":"W4412993689"},{"id":"paper-w2999087697","cat":"papers","name":"I Want a New Drug: Fake marijuana, designer stimulants, and hallucinogens","year":"2020","cit":0,"pfa":"Craig W. Stevens","ptype":"book-chapter","src":"https://openalex.org/W2999087697","eid":"W2999087697"},{"id":"paper-w4400195724","cat":"papers","name":"Can Past Psychedelic Use Mitigate the Severity of Opioid Use Disorder?","year":"2024","cit":0,"pfa":"Asim Trimzi","psa":"Morgan Campbell","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4400195724","eid":"W4400195724"},{"id":"paper-w2967523914","cat":"papers","name":"Psychedelic-use and schizotypy in non-clinical populations","year":"2018","cit":0,"pfa":"Alexander V. Lebedev","psa":"Sebastian Martinsson","ptype":"preprint","src":"https://openalex.org/W2967523914","eid":"W2967523914"},{"id":"paper-w7104567734","cat":"papers","name":"Microdoses de psicodélicos no tratamento de transtornos mentais: uma revisão sistemática","year":"2025","cit":0,"pfa":"Gabriel Jorge Cascaes Santos Cavalcante","psa":"Amanda Alves Fecury","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7104567734","eid":"W7104567734"},{"id":"paper-w3018408500","cat":"papers","name":"Microdosing drugs: a versatile technique to detect and assess drug–drug interactions","year":"2020","cit":0,"pfa":"Kathrin Isabelle Foerster","psa":"Jürgen Burhenne","topics":["Dosing & pharmacology"],"ptype":"editorial","src":"https://openalex.org/W3018408500","eid":"W3018408500"},{"id":"paper-w4392689956","cat":"papers","name":"Data from Is It Time to Advance the Chemoprevention of Environmental Carcinogenesis with Microdosing Trials?","year":"2023","cit":0,"pfa":"Thomas W. Kensler","psa":"John D. Groopman","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"other","src":"https://openalex.org/W4392689956","eid":"W4392689956"},{"id":"paper-w7115718853","cat":"papers","name":"Cautions on the Notion of Moral Enhancement with Psychedelics. Reply to Kähönen, J. Subjective Effects of Psychedelics Are the Plausible Mechanism of Psychedelic Moral Enhancement Rather than a Risk. Comment on “Tang, B.","year":"2025","cit":0,"pfa":"Bor Luen Tang","topics":["Safety & adverse events","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7115718853","eid":"W7115718853"},{"id":"paper-w4353081965","cat":"papers","name":"Associations between Hallucinogen Persisting Perception Disorder (HPPD) and non-visual perceptual disturbances","year":"2023","cit":0,"pfa":"Anneliese McConnell","psa":"Paul F. Sowman","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4353081965","eid":"W4353081965"},{"id":"paper-w3030645095","cat":"papers","name":"Microdosing/Microtracing Studies in Human Using Accelerator Mass Spectrometry(AMS)","year":"2015","cit":0,"pfa":"송종한","psa":"유병용","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3030645095","eid":"W3030645095"},{"id":"paper-w2909274300","cat":"papers","name":"Dexmédétomidine en microdose lors d'anxiété/phobie chez le chien","year":"2018","cit":0,"pfa":"Marylène Omont","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2909274300","eid":"W2909274300"},{"id":"paper-w4413432309","cat":"papers","name":"554 Long-Term Outcomes of Emergency Department Patients With Hallucinogen Use","year":"2025","cit":0,"pfa":"Dietrich V. K. Jehle","psa":"K. Cunningham","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4413432309","eid":"W4413432309"},{"id":"paper-w4417264513","cat":"papers","name":"A Descriptive Study of Hallucinogen and Inhalant Detoxification Admissions From 2006 to 2022","year":"2025","cit":0,"pfa":"Gail S. Geiger","psa":"Orrin D. Ware","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4417264513","eid":"W4417264513"},{"id":"paper-w2955026595","cat":"papers","name":"Long–term effect of fertilizer microdosing on soil fertility in Sahelianwest Africa","year":"2015","cit":0,"pfa":"S.N. Adams","psa":"Derek Peak","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W2955026595","eid":"W2955026595"},{"id":"paper-w4410003429","cat":"papers","name":"Supplemental Material for How Psychedelic Experiences Can Cause, Worsen, or Resolve Spiritual Struggles: A Mixed-Methods Study of Psychedelic Users","year":"2025","cit":0,"ptype":"supplementary-materials","src":"https://openalex.org/W4410003429","eid":"W4410003429"},{"id":"paper-w3090886430","cat":"papers","name":"The chemical dosage of penicillin in galenic drugs and a new method of biological microdosing.","year":"1947","cit":0,"pfa":"P Boymond","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3090886430","eid":"W3090886430"},{"id":"paper-w4398822004","cat":"papers","name":"Psychedelic Content Analysis: Metaphysical beliefs or psychological insight?","year":"2023","cit":0,"pfa":"Elias Acevedo Elias Acevedo","ptype":"dataset","src":"https://openalex.org/W4398822004","eid":"W4398822004"},{"id":"paper-w4404303964","cat":"papers","name":":Acid Revival: The Psychedelic Renaissance and the Quest for Medical Legitimacy","year":"2024","cit":0,"pfa":"Peder Clark","ptype":"book-review","src":"https://openalex.org/W4404303964","eid":"W4404303964"},{"id":"paper-w4245093519","cat":"papers","name":"Cardiovascular effects of hallucinogens, neurolept analgesic/anesthetic combinations and steroid anesthetics","year":"1994","cit":0,"pfa":"David R Gross","ptype":"book-chapter","src":"https://openalex.org/W4245093519","eid":"W4245093519"},{"id":"paper-w4317862698","cat":"papers","name":"Feasibility of implantable microdosing devices to perform in vivo pharmacotyping in pancreatic cancer.","year":"2023","cit":0,"pfa":"Lyudmyla Demyan","psa":"Daniel A. King","topics":["Anxiety & end-of-life","Dosing & pharmacology","Therapy practice"],"ptype":"conference-abstract","src":"https://openalex.org/W4317862698","eid":"W4317862698"},{"id":"paper-w2398808102","cat":"papers","name":"[Changes in hard dental tissues and pulp in exposure to microdoses of mercury vapors].","year":"1983","cit":0,"pfa":"G V Lebedeva","psa":"Zarudin Vv","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2398808102","eid":"W2398808102"},{"id":"paper-w4407387479","cat":"papers","name":"A STUDY ON THE REGULATORY STATUS OF PSYCHEDELICS IN KOREA AND THEIR ADMISSIBILITY AS THERAPEUTIC AGENTS","year":"2025","cit":0,"pfa":"InKi Sohn","psa":"Jong‐Hyun Jeong","topics":["Safety & adverse events","Reviews & meta-analyses","Policy & ethics"],"ptype":"conference-abstract","src":"https://openalex.org/W4407387479","eid":"W4407387479"},{"id":"paper-w2612289265","cat":"papers","name":"\"An Unwavering Band of Light\": Kurt Vonnegut and the Psychedelic Revolution","year":"2015","cit":0,"pfa":"Carly Psenicka","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2612289265","eid":"W2612289265"},{"id":"paper-w2958259100","cat":"papers","name":"Psychedelics for the Management of Anxiety in Adults With Life-Threatening Diseases","year":"2019","cit":0,"pfa":"Taylor J. Solak","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2958259100","eid":"W2958259100"},{"id":"paper-w7159751230","cat":"papers","name":"Controlled Substances in the New Administration: Cannabis, Psychedelics, and Opioids","year":"2025","cit":0,"pfa":"Lewis Grossman","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7159751230","eid":"W7159751230"},{"id":"paper-w2038706958","cat":"papers","name":"Obtaining antisera against growth hormone by immunizing rabbits with microdoses of the antigen","year":"1963","cit":0,"pfa":"A. F. Lazarev","psa":"E. E. Antonova","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2038706958","eid":"W2038706958"},{"id":"paper-w7117979197","cat":"papers","name":"LSD microdosing in major depressive disorder: results from an open-label trial","year":"2026","cit":0,"pfa":"Suresh D Muthukumaraswamy","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7117979197","eid":"W7117979197"},{"id":"paper-w4387503625","cat":"papers","name":"24.2 Opioid, Stimulant, and Hallucinogen Use Disorders in Consultation-Liaison Psychiatry","year":"2023","cit":0,"pfa":"Jennifer Picado","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4387503625","eid":"W4387503625"},{"id":"paper-w4289399958","cat":"papers","name":"Plant use and seasonality: pollen analyses of hallucinogen quids at Pinwheel cave, California","year":"2021","cit":0,"pfa":"Ana Ejarque","ptype":"conference-paper","src":"https://openalex.org/W4289399958","eid":"W4289399958"},{"id":"paper-w3199994301","cat":"papers","name":"Influence of Irrigation and Fertilizer Microdosing on Nitrogen Use Efficiency of Green Amaranth","year":"2019","cit":0,"pfa":"Omolola Bolanle Kuye","topics":["Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W3199994301","eid":"W3199994301"},{"id":"paper-w4391915851","cat":"papers","name":"Buprenorphine induction using microdosing for the management of opioid use disorder in pregnancy","year":"2024","cit":0,"pfa":"Barbara Parillia","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4391915851","eid":"W4391915851"},{"id":"paper-w1861409231","cat":"papers","name":"General, Applied and Theoretical: Hallucinogens and Shamanism. MICHAEL J. HARNER, ed","year":"1974","cit":0,"pfa":"Michael D. Lieber","ptype":"article","src":"https://openalex.org/W1861409231","eid":"W1861409231"},{"id":"paper-w2423200548","cat":"papers","name":"[Hallucinogen caused motility disorders in rats as potential psychosis relevant animal model].","year":"1982","cit":0,"pfa":"Wilhelm Oelssner","ptype":"article","src":"https://openalex.org/W2423200548","eid":"W2423200548"},{"id":"paper-w2389581519","cat":"papers","name":"Microdose blood detection and clinical application of the serum bilirubin in mature newborns","year":"2002","cit":0,"pfa":"Qiu Ri-xia","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2389581519","eid":"W2389581519"},{"id":"paper-w2415720251","cat":"papers","name":"[On labor management. A method of oxytocic acceleration with intravenous microdoses and inhalant sedation].","year":"1998","cit":0,"pfa":"L Matus","psa":"J Aguilo","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2415720251","eid":"W2415720251"},{"id":"paper-w7128159993","cat":"papers","name":"Technical pen-based printhead for high-precision microdosing of personalized therapies","year":"2026","cit":0,"pfa":"Paola Carou‐Senra","psa":"Álvaro Goyanes","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7128159993","eid":"W7128159993"},{"id":"paper-w2276270289","cat":"papers","name":"Updated HSE statement on dangers of consuming psychedelic drugs","year":"2016","cit":0,"pfa":"pbaily","ptype":"article","src":"https://openalex.org/W2276270289","eid":"W2276270289"},{"id":"paper-w7212262575","cat":"papers","name":"Whose HOPE? Power, knowledge, and the decolonization of psychedelic ethics","year":"2026","cit":0,"pfa":"Fernanda Kaingang","psa":"Thiago Rocha da Cunha","topics":["Safety & adverse events","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7212262575","eid":"W7212262575"},{"id":"paper-w4394373355","cat":"papers","name":"Psychedelics Reopen the Social Reward Learning Critical Period","year":"2023","cit":0,"pfa":"Romain Nardou","psa":"Gül Dölen","ptype":"dataset","src":"https://openalex.org/W4394373355","eid":"W4394373355"},{"id":"paper-w4396698385","cat":"papers","name":"Psychedelics in Medicine: Can Evidence Keep Up With Enthusiasm?","year":"2024","cit":0,"pfa":"Harriet de Wit","psa":"Katrin H. Preller","ptype":"article","src":"https://openalex.org/W4396698385","eid":"W4396698385"},{"id":"paper-w4406589044","cat":"papers","name":"Xochipilli: Psychedelic Plants, Song, and Ritual in Aztec Religion","year":"2025","cit":0,"pfa":"Osiris Sinuhé González Romero","ptype":"article","src":"https://openalex.org/W4406589044","eid":"W4406589044"},{"id":"paper-w2424094488","cat":"papers","name":"[THE OBTAINING OF ANTISERUMS AGAINST GROWTH HORMONE BY IMMUNIZATION OF RABBITS WITH MICRODOSES OF THE ANTIGEN].","year":"1963","cit":0,"pfa":"Lazarev Ap","psa":"E E Antonova","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2424094488","eid":"W2424094488"},{"id":"paper-w7167458994","cat":"papers","name":"Attitudes toward psychedelics in Costa Rica – preregistration and materials","year":"2025","cit":0,"pfa":"Daniel Arroyo","ptype":"preprint","src":"https://openalex.org/W7167458994","eid":"W7167458994"},{"id":"paper-w7135052117","cat":"papers","name":"Changes over time in hallucinogen‐related emergency department visits in Ontario, Canada","year":"2026","cit":0,"pfa":"Daniel Thomas Myran","psa":"Marco Solmi","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7135052117","eid":"W7135052117"},{"id":"paper-w2277020213","cat":"papers","name":"Hallucinating the End of History: Nishida, Zen, and the Psychedelic Eschaton","year":"2015","cit":0,"pfa":"Steve Odin","ptype":"article","src":"https://openalex.org/W2277020213","eid":"W2277020213"},{"id":"paper-w3103010010","cat":"papers","name":"Being Mindful About Changing Psychedelic Policy in California","year":"2020","cit":0,"pfa":"Bryce Pardo","psa":"Beau Kilmer","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3103010010","eid":"W3103010010"},{"id":"paper-w4400026090","cat":"papers","name":"Psychedelics: preclinical insights provide directions for future research","year":"2024","cit":0,"pfa":"Roth B.L","psa":"Gumpper R.H","ptype":"article","src":"https://openalex.org/W4400026090","eid":"W4400026090"},{"id":"paper-w4416214088","cat":"papers","name":"Psychedelics might help terminal patients find peace","year":"2025","cit":0,"pfa":"Muireann Quigley","psa":"Joanna Caroline Neill","ptype":"other","src":"https://openalex.org/W4416214088","eid":"W4416214088"},{"id":"paper-w4415995543","cat":"papers","name":"A psychedelic tour of Earth’s ecosystems – from the desert to Siberia","year":"2025","cit":0,"pfa":"Jamie B. Thompson","ptype":"other","src":"https://openalex.org/W4415995543","eid":"W4415995543"},{"id":"paper-w2439055106","cat":"papers","name":"[On a new method of ultraviolet determination of inorganic phosphorus using microdoses of serum].","year":"1967","cit":0,"pfa":"A Ferrari","psa":"F Imperiale","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2439055106","eid":"W2439055106"},{"id":"paper-w4392701652","cat":"papers","name":"Data from Is It Time to Advance the Chemoprevention of Environmental Carcinogenesis with Microdosing Trials?","year":"2023","cit":0,"pfa":"Thomas W. Kensler","psa":"John D. Groopman","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"other","src":"https://openalex.org/W4392701652","eid":"W4392701652"},{"id":"paper-w4213243699","cat":"papers","name":"Psychedelica Sub Rosa: The Eleusinian Mysteries and the Psychedelic Imagination","year":"2022","cit":0,"pfa":"Christopher H. Partridge","topics":["Addiction","Therapy practice","Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W4213243699","eid":"W4213243699"},{"id":"paper-w7166293474","cat":"papers","name":"Resting-state functional connectivity in naturalistic psychedelic users","year":"2026","cit":0,"pfa":"Karolina Finc","psa":"Michał Bola","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7166293474","eid":"W7166293474"},{"id":"paper-w4414947436","cat":"papers","name":"“To Fathom Hell or Soar Angelic”: Theorizing a Psychedelic Politics","year":"2025","cit":0,"pfa":"Matt Harvey","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4414947436","eid":"W4414947436"},{"id":"paper-w7172004758","cat":"papers","name":"Impact of Psychedelics on Peripheral Inflammatory Markers: A systematic review.","year":"2025","cit":0,"pfa":"Michaela Emily Thomas Beer","psa":"Rita Anne McNamara","topics":["Depression","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7172004758","eid":"W7172004758"},{"id":"paper-w1826897891","cat":"papers","name":"The prospect of psychedelic use as a tool in realizing a transpersonal ecology","year":"2008","cit":0,"pfa":"Debbie A. Lawlor","ptype":"dissertation","src":"https://openalex.org/W1826897891","eid":"W1826897891"},{"id":"paper-w4403845272","cat":"papers","name":"Palliative Care and Psychedelics on a Long Strange Trip, Revisited","year":"2024","cit":0,"pfa":"Stacy M. Fischer","psa":"Beth Patterson","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4403845272","eid":"W4403845272"},{"id":"paper-w4400584127","cat":"papers","name":"Report calls for decisive action to guide growth in psychedelics","year":"2024","cit":0,"pfa":"Gary A. Enos","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4400584127","eid":"W4400584127"},{"id":"paper-w4406363256","cat":"papers","name":"Facilitating the Sacred: The Role of Chaplains in Psychedelic Law and Policy","year":"2025","cit":0,"pfa":"Victoria Litman","topics":["Addiction","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4406363256","eid":"W4406363256"},{"id":"paper-w4414691200","cat":"papers","name":"How different mushrooms learned the same psychedelic trick","year":"2025","cit":0,"pfa":"Fabrizio Alberti","ptype":"other","src":"https://openalex.org/W4414691200","eid":"W4414691200"},{"id":"paper-w7161648348","cat":"papers","name":"Integration of the Psychedelic Experience Among Brazilians: A Survey Study","year":"2026","cit":0,"pfa":"Ana Cláudia Mesquita Garcia","psa":"Luís Fernando Tófoli","topics":["Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7161648348","eid":"W7161648348"},{"id":"paper-w7204893916","cat":"papers","name":"Beyond Connection: Paradoxes of Psychedelic Resonance in Late Modernity","year":"2026","cit":0,"pfa":"Mateo Sánchez Petrement","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7204893916","eid":"W7204893916"},{"id":"paper-w7117324701","cat":"papers","name":"Assessment of the reporting of harms in systematic reviews focused on hallucinogens: A cross-sectional study","year":"2025","cit":0,"pfa":"Kaylin Ray","psa":"Matt Vassar","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7117324701","eid":"W7117324701"},{"id":"paper-w3090386229","cat":"papers","name":"Colorimetric microdoses of free cholesterol, esterified cholesterol and lipid phosphorus in cerebrospinal fluid.","year":"1947","cit":0,"pfa":"J. L. Delsal","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3090386229","eid":"W3090386229"},{"id":"paper-w2994935222","cat":"papers","name":"\"Artificial neural network designed to identify NBOMe hallucinogens based on molecular descriptors \"","year":"2018","cit":0,"pfa":"\"","psa":"Mirela Praisler","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2994935222","eid":"W2994935222"},{"id":"paper-w2345375443","cat":"papers","name":"Role of D 2 -like Heteroreceptor Complexes in the Effects of Cocaine, Morphine, and Hallucinogens","year":"2016","cit":0,"pfa":"Dasiel O. Borroto‐Escuela","psa":"Kjell Fuxé","topics":["Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W2345375443","eid":"W2345375443"},{"id":"paper-w2924912867","cat":"papers","name":"(Re)Constructing the Sixties: On Psychedelic Experience in Sleep’s Dopesmoker","year":"2019","cit":0,"pfa":"Tymon Adamczewski","topics":["Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W2924912867","eid":"W2924912867"},{"id":"paper-w4387741697","cat":"papers","name":"Looking for Ted: black trips, “psychedelic” humanism, and silence","year":"2023","cit":0,"pfa":"Michael Cordova","ptype":"article","src":"https://openalex.org/W4387741697","eid":"W4387741697"},{"id":"paper-w2598881862","cat":"papers","name":"Beware of Mad John: Political Theology, Psychedelics and Literature","year":"2013","cit":0,"pfa":"Roger K. Green","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2598881862","eid":"W2598881862"},{"id":"paper-w4413537428","cat":"papers","name":"Two reasons I’m sceptical about psychedelic science","year":"2024","cit":0,"pfa":"Michiel van Elk","ptype":"other","src":"https://openalex.org/W4413537428","eid":"W4413537428"},{"id":"paper-w2803329074","cat":"papers","name":"SPECIFIC CHARACTERISTICS OF ENGLISH SONG LYRICS OF «PSYCHEDELIC ROCK»","year":"2017","cit":0,"pfa":"Yu. E. Plotnitskiy","ptype":"article","src":"https://openalex.org/W2803329074","eid":"W2803329074"},{"id":"paper-w7135980461","cat":"papers","name":"Psychedelics in Western Culture: unnecessary Psychiatrization of Visionary Experiences","year":"2020","cit":0,"pfa":"W.J. Hanegraaff","ptype":"article","src":"https://openalex.org/W7135980461","eid":"W7135980461"},{"id":"paper-w4246036540","cat":"papers","name":"Psychedelics not associated with mental health problems, researchers say","year":"2015","cit":0,"ptype":"article","src":"https://openalex.org/W4246036540","eid":"W4246036540"},{"id":"paper-w4413731812","cat":"papers","name":"What if psychedelics could revolutionize the way you die?","year":"2018","cit":0,"pfa":"Bruce Tobin","ptype":"other","src":"https://openalex.org/W4413731812","eid":"W4413731812"},{"id":"paper-w7197049704","cat":"papers","name":"The impact of a psychedelic drug on olfactory search behavior by mice","year":"2026","cit":0,"pfa":"Matthew C. Smear","psa":"Nate Gonzales-Hess","ptype":"dataset","src":"https://openalex.org/W7197049704","eid":"W7197049704"},{"id":"paper-w1868194778","cat":"papers","name":"The Application of a Rational— Psychedelic Continuum Concept of Creativity to the Classroom","year":"1977","cit":0,"pfa":"Theodore J. Gourley","psa":"Ronald Zucca","ptype":"article","src":"https://openalex.org/W1868194778","eid":"W1868194778"},{"id":"paper-w2922521339","cat":"papers","name":"Study for Psychedelic Style in San Francisco’s Rock Posters","year":"2009","cit":0,"pfa":"서금옥","ptype":"article","src":"https://openalex.org/W2922521339","eid":"W2922521339"},{"id":"paper-w2582933632","cat":"papers","name":"Seeking a Kaleidoscopic Lens: A Holistic Analysis of the Psychedelic Field","year":"2010","cit":0,"pfa":"Ishwar Persad","topics":["Reviews & meta-analyses"],"ptype":"dissertation","src":"https://openalex.org/W2582933632","eid":"W2582933632"},{"id":"paper-w7113077527","cat":"papers","name":"The use of psychedelic drugs on chronic pain: scoping review","year":"2023","cit":0,"pfa":"Redinha, Catarina","psa":"Costa, Daniela","topics":["Reviews & meta-analyses"],"ptype":"dissertation","src":"https://openalex.org/W7113077527","eid":"W7113077527"},{"id":"paper-w4366249067","cat":"papers","name":":The Acid Room: The Psychedelic Trials and Tribulations of Hollywood Hospital","year":"2023","cit":0,"pfa":"Dave Hazzan","ptype":"book-review","src":"https://openalex.org/W4366249067","eid":"W4366249067"},{"id":"paper-w4396796616","cat":"papers","name":"More research needed regarding psychedelics' effects on youths","year":"2024","cit":0,"pfa":"Gary Enos","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4396796616","eid":"W4396796616"},{"id":"paper-w7147253116","cat":"papers","name":"Editorial Emerging therapeutic opportunities for psychedelic and related drugs","year":"2026","cit":0,"pfa":"Susan Wonnacott","psa":"Trevor Sharp","topics":["Mechanism & neuroscience","Reviews & meta-analyses","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W7147253116","eid":"W7147253116"},{"id":"paper-w7162915170","cat":"papers","name":"An exploration of effects of intentions on the perceived outcome of psychedelic experiences","year":"2026","cit":0,"pfa":"Iryana Mosina","psa":"David P. Luke","topics":["Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7162915170","eid":"W7162915170"},{"id":"paper-w7212029885","cat":"papers","name":"650. Anxiolytic effects of serotoninergic psychedelics on patients with psychiatric disorders","year":"2026","cit":0,"pfa":"Rafael C. R. Freire","psa":"Amir Garakani","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"conference-abstract","src":"https://openalex.org/W7212029885","eid":"W7212029885"},{"id":"paper-w2337209659","cat":"papers","name":"[Inhibition of hypoxic erythropoietin production after treatment with microdoses of estradiol benzoate].","year":"1972","cit":0,"pfa":"C Peschle","psa":"Mario Condorelli","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2337209659","eid":"W2337209659"},{"id":"paper-w2987968822","cat":"papers","name":"Impact of crime prevention management on drug and psychedelic consumption","year":"2019","cit":0,"pfa":"Ebrahim Davoodi Dehaghani","psa":"mohammad ali ameri","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2987968822","eid":"W2987968822"},{"id":"paper-w4405637216","cat":"papers","name":"Psychedelics in the treatment of addiction: what do we know?","year":"2024","cit":0,"pfa":"R. P. L. Andrade","psa":"Hugo Afonso","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4405637216","eid":"W4405637216"},{"id":"paper-w7116129389","cat":"papers","name":"Review of Spaced Out: Radical Environments of the Psychedelic Sixties","year":"2025","cit":0,"pfa":"Timothy Miller","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7116129389","eid":"W7116129389"},{"id":"paper-w7124455388","cat":"papers","name":"Psychedelics and Sexual Trauma: Effects on Communication and Emotional Connection","year":"2026","cit":0,"pfa":"Mason Levey","psa":"Cheneal Puljević","topics":["PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7124455388","eid":"W7124455388"},{"id":"paper-w7203920226","cat":"papers","name":"Combination of psychedelic, CBT shows promise in AUD treatment","year":"2026","cit":0,"pfa":"Gary A. Enos","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7203920226","eid":"W7203920226"},{"id":"paper-w2188968426","cat":"papers","name":"Protecting the human rights of people who use psychedelics","year":"2015","cit":0,"pfa":"Mehau Kulyk","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2188968426","eid":"W2188968426"},{"id":"paper-w2765855638","cat":"papers","name":"Psychedelic psychotherapy : existential and neuroscience perspectives on the therapeutic journey","year":"2017","cit":0,"pfa":"Arthur W. Seelig","topics":["Anxiety & end-of-life","Dosing & pharmacology","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W2765855638","eid":"W2765855638"},{"id":"paper-w4389626718","cat":"papers","name":"No more harm: A guiding principle of psychedelic drug policy","year":"2023","cit":0,"pfa":"Katharine Neill Harris","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4389626718","eid":"W4389626718"},{"id":"paper-w7212029933","cat":"papers","name":"Why taking the trip out of psychedelic medicine is a mistake","year":"2026","cit":0,"pfa":"Julian Heller","psa":"Yogi Hale Hendlin","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7212029933","eid":"W7212029933"},{"id":"paper-w7113134008","cat":"papers","name":"Naturalistic Research with Psychedelics: A Scoping Review of Research Methodologies","year":"2024","cit":0,"pfa":"Pedro Teixeira","psa":"Jorge Encantado","topics":["Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7113134008","eid":"W7113134008"},{"id":"paper-w4417365917","cat":"papers","name":"How Psychedelics Helped Heal My Broken Heart","year":"2025","cit":0,"ptype":"other","src":"https://openalex.org/W4417365917","eid":"W4417365917"},{"id":"paper-w7164211077","cat":"papers","name":"Personalised Perception: The Effect of Personality on the Sensory Effects of Psychedelics","year":"2026","cit":0,"pfa":"A. D. Boardman","psa":"Ryan D. Ward","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7164211077","eid":"W7164211077"},{"id":"paper-w2329844732","cat":"papers","name":"The Psychedelic Synesthesia of ODDSAC: Interview with Filmmaker Danny Perez","year":"2012","cit":0,"pfa":"Jacob Diesel","ptype":"article","src":"https://openalex.org/W2329844732","eid":"W2329844732"},{"id":"paper-w7124341425","cat":"papers","name":"Ten simple rules for setting up a psychedelic study","year":"2026","cit":0,"pfa":"Alice Caulfield","psa":"Mitul A. Mehta","ptype":"preprint","src":"https://openalex.org/W7124341425","eid":"W7124341425"},{"id":"paper-w3039038363","cat":"papers","name":"Public Opinion on the Use of Psychedelics in the Treatment of Cluster Headache","year":"2020","cit":0,"pfa":"Andy Whelan","ptype":"article","src":"https://openalex.org/W3039038363","eid":"W3039038363"},{"id":"paper-w7139640335","cat":"papers","name":"Psychedelics show religion isn't the only route to spirituality","year":"2020","cit":0,"pfa":"Chris Letheby","ptype":"article","src":"https://openalex.org/W7139640335","eid":"W7139640335"},{"id":"paper-w4383876363","cat":"papers","name":"Trip Where you Stand: Towards Psychedelic Liberation","year":"2023","cit":0,"pfa":"Kiara Mohamed Amin","psa":"Priya Sharma","ptype":"article","src":"https://openalex.org/W4383876363","eid":"W4383876363"},{"id":"paper-w4406320228","cat":"papers","name":"A Post-Cringe Theory of Psychedelic Spirituality in the Rave Scene","year":"2025","cit":0,"pfa":"Michelle Lhooq","ptype":"article","src":"https://openalex.org/W4406320228","eid":"W4406320228"},{"id":"paper-w7135450877","cat":"papers","name":"Plants of transformations: Using of plant hallucinogens by mexican indians in Oaxaca and by mestices in Peru","year":"2006","cit":0,"pfa":"Miroslav Horák","topics":["Addiction"],"ptype":"dissertation","src":"https://openalex.org/W7135450877","eid":"W7135450877"},{"id":"paper-w2775800863","cat":"papers","name":"The Study of the Effectiveness of Hallucinogen Educational Multimedia on Attitude and Knowledge of High School Students","year":"2010","cit":0,"pfa":"Smmayeh Fadaei","psa":"Esmaeel Zaraii","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2775800863","eid":"W2775800863"},{"id":"paper-w4298272564","cat":"papers","name":"Of Roots and Fruits: A Comparison of Psychedelic and Nonpsychedelic Mystical Experiences","year":"2020","cit":0,"pfa":"David B. Yaden","psa":"Iwry, Jonathan","topics":["Addiction","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4298272564","eid":"W4298272564"},{"id":"paper-w7213463106","cat":"papers","name":"Structure-based design of subtype-selective psychedelic analogs","year":"2026","cit":0,"pfa":"Huiqiong Li","psa":"Jianjun Cheng","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7213463106","eid":"W7213463106"},{"id":"paper-w2404387666","cat":"papers","name":"[Prevention of negative hemodynamic effects of protamine sulfate by simultaneous infusion of microdoses of adrenaline].","year":"2001","cit":0,"pfa":"Trekova Na","psa":"O A Kovalevskaia","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2404387666","eid":"W2404387666"},{"id":"paper-w4230436364","cat":"papers","name":"Psychedelic drug cuts brain blood flow and connections","year":"2011","cit":0,"ptype":"article","src":"https://openalex.org/W4230436364","eid":"W4230436364"},{"id":"paper-w4388365716","cat":"papers","name":"PSYCHEDELIC DRUG-INDUCED NEUROPLASTICITY: PRECLINICAL INSIGHTS AND CONTROVERSIES","year":"2023","cit":0,"pfa":"Scott M. Thompson","psa":"Andreas Wulff","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4388365716","eid":"W4388365716"},{"id":"paper-w3217134912","cat":"papers","name":"Psychedelic Drugs Studied for Potential Role in Treating Pain","year":"2021","cit":0,"pfa":"Anne Haddad","ptype":"article","src":"https://openalex.org/W3217134912","eid":"W3217134912"},{"id":"paper-w4225427411","cat":"papers","name":"Lizard as a psychedelic fauna: a systematic review of published cases","year":"2022","cit":0,"pfa":"Karishma Godara","psa":"Krishan Kumar Pandey","topics":["Addiction","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4225427411","eid":"W4225427411"},{"id":"paper-w7125647898","cat":"papers","name":"Review of “Psychedelic Outlaws: The Movement Revolutionizing Modern Medicine”","year":"2026","cit":0,"pfa":"Michael L. Rosino","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7125647898","eid":"W7125647898"},{"id":"paper-w2041197269","cat":"papers","name":"Persephone's Quest: Entheogens and the Origins of Religion.R. Gordon Wasson , Stella Kramrisch , Jonathan Ott , Carl A. P. Ruck","year":"1989","cit":0,"pfa":"Michael Ruse","ptype":"book-review","src":"https://openalex.org/W2041197269","eid":"W2041197269"},{"id":"paper-w4389078473","cat":"papers","name":"“Video Is as Powerful as LSD”: Electronics and Psychedelics as Technologies of Consciousness","year":"2023","cit":0,"pfa":"Peter Sachs Collopy","ptype":"book-chapter","src":"https://openalex.org/W4389078473","eid":"W4389078473"},{"id":"paper-w3080155079","cat":"papers","name":"Good Trips, Bad Trips: Psychedelic Drugs and Dissociation","year":"2013","cit":0,"pfa":"Gary Greenberg","ptype":"article","src":"https://openalex.org/W3080155079","eid":"W3080155079"},{"id":"paper-w3144462812","cat":"papers","name":"Psychedelics and Their Efficacies in Therapies When Compared to Traditional Pharmaceuticals","year":"2021","cit":0,"pfa":"Maxine Caldera","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"preprint","src":"https://openalex.org/W3144462812","eid":"W3144462812"},{"id":"paper-w7112201333","cat":"papers","name":"Blind Visions: Psychedelics, Thomas Merton, and Reformed Mysticism","year":"2023","cit":0,"pfa":"Welker, Joe","topics":["Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W7112201333","eid":"W7112201333"},{"id":"paper-w7151897031","cat":"papers","name":"Salvia divinorum – A New Entity in the Psychedelic Scene in India","year":"2024","cit":0,"pfa":"Aravind Ajid","psa":"Abhijith G Jayachandran","ptype":"article","src":"https://openalex.org/W7151897031","eid":"W7151897031"},{"id":"paper-w4416712660","cat":"papers","name":"Quantitative phosphoproteomics uncovers the signalling dynamics of hallucinogenic psychedelics","year":"2025","cit":0,"pfa":"Sandra M. Martin-Guerrero","psa":"Juan F. Lopez-Gimenez","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4416712660","eid":"W4416712660"},{"id":"paper-w7134108729","cat":"papers","name":"The combination of exercise and psychedelics for the treatment of major depressive disorder","year":"2026","cit":0,"pfa":"Nicholas Fabiano","psa":"Robin Lester Carhart-Harris","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7134108729","eid":"W7134108729"},{"id":"paper-w2417909446","cat":"papers","name":"[Effect of microdoses of alloxan on the attachment and development of Ehrlich adenocarcinoma in the white mouse].","year":"1954","cit":0,"pfa":"P Astorri","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2417909446","eid":"W2417909446"},{"id":"paper-w768235653","cat":"papers","name":"The Psychedelic Shop: Espiritualidad solidaria de todo a 100","year":"2015","cit":0,"pfa":"Jaime Gonzalo","ptype":"article","src":"https://openalex.org/W768235653","eid":"W768235653"},{"id":"paper-w2909171594","cat":"papers","name":"Modulation of fear expression by a psychedelic 5-HT2aR agonist","year":"2018","cit":0,"pfa":"Dimitri De Bundel","psa":"Carine Bécamel","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2909171594","eid":"W2909171594"},{"id":"paper-w4316686756","cat":"papers","name":"Scott Shannon, MD-Psychedelics treating Root Causes.","year":"2022","cit":0,"pfa":"Dick Benson","ptype":"article","src":"https://openalex.org/W4316686756","eid":"W4316686756"},{"id":"paper-w4361245140","cat":"papers","name":"Psychedelics as psychiatric medicines: Current challenges and future prospects","year":"2023","cit":0,"pfa":"David Jonathan Castle","psa":"David Nutt","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W4361245140","eid":"W4361245140"},{"id":"paper-w7123535454","cat":"papers","name":"Classification of Psychedelics and Psychoplastogens based on Pharmacological and Mechanistic Features","year":"2026","cit":0,"pfa":"Miguel Salfiti","psa":"Georgios Mikellides","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dataset","src":"https://openalex.org/W7123535454","eid":"W7123535454"},{"id":"paper-w7169626602","cat":"papers","name":"HHS, VA partner on psychedelic mental health treatments","year":"2026","cit":0,"pfa":"Valerie A. Canady","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7169626602","eid":"W7169626602"},{"id":"paper-w3088505891","cat":"papers","name":"[Psychotherapy assisted by psychedelics, intense and unusual exposures therapy].","year":"2020","cit":0,"pfa":"Gabriel Thorens","psa":"DANIELE FABIO ZULLINO","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3088505891","eid":"W3088505891"},{"id":"paper-w2586736861","cat":"papers","name":"Hookups, Hangovers, and Hallucinogens: The Effects of Parental Presence on Young Adult Deviant Behavior","year":"2016","cit":0,"pfa":"Shakirie Simmons","psa":"Kesley Sorenson","ptype":"article","src":"https://openalex.org/W2586736861","eid":"W2586736861"},{"id":"paper-w7166732862","cat":"papers","name":"How to Fix a Bad Trip? Hallucinogen Persistent Perception Disorder Treatment in Review","year":"2026","cit":0,"pfa":"Aleeha Batool","psa":"Chaitanya Morey","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7166732862","eid":"W7166732862"},{"id":"paper-w2426607953","cat":"papers","name":"Acid Hype: American new media and the psychedelic experience","year":"2016","cit":0,"pfa":"Jennifer Frost","ptype":"article","src":"https://openalex.org/W2426607953","eid":"W2426607953"},{"id":"paper-w2807800717","cat":"papers","name":"Agony and Ecstasy: Psychedelics as the next big health remedy?","year":"2018","cit":0,"pfa":"John William McKenna","topics":["PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W2807800717","eid":"W2807800717"},{"id":"paper-w4386510193","cat":"papers","name":"UC Berkeley Students’ Psychedelic Experiences: A Qualitative Analysis","year":"2023","cit":0,"pfa":"Dylan Earp","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4386510193","eid":"W4386510193"},{"id":"paper-w7215630968","cat":"papers","name":"The dynamics of unknowing: Computational models of meditative and psychedelic deconstruction","year":"2026","cit":0,"pfa":"Edmundo Lopez-Sola","ptype":"dissertation","src":"https://openalex.org/W7215630968","eid":"W7215630968"},{"id":"paper-w3198388930","cat":"papers","name":"Thomas Hatsis, The Witches’ Ointment: The Secret History of Psychedelic Magic; Psychedelic Mystery Traditions: Spirit Plants, Magical Practices, Ecstatic States","year":"2021","cit":0,"pfa":"Chas S. Clifton","ptype":"article","src":"https://openalex.org/W3198388930","eid":"W3198388930"},{"id":"paper-w4406437667","cat":"papers","name":"Book Review: Otherworlds: Psychedelics and Exceptional Human Experience","year":"2019","cit":0,"pfa":"Natalie L. Trent","topics":["Reviews & meta-analyses"],"ptype":"book-review","src":"https://openalex.org/W4406437667","eid":"W4406437667"},{"id":"paper-w4414021944","cat":"papers","name":"AbbVie bets on psychedelic drugs in Gilgamesh buy out","year":"2025","cit":0,"pfa":"Asher Mullard","ptype":"article","src":"https://openalex.org/W4414021944","eid":"W4414021944"},{"id":"paper-w4414840505","cat":"papers","name":"72.1 Psychedelics in Recent and Remote History: A Guide for the Future","year":"2025","cit":0,"pfa":"David Louis Atkinson","ptype":"article","src":"https://openalex.org/W4414840505","eid":"W4414840505"},{"id":"paper-w2540253919","cat":"papers","name":"Quantitative EEG study of serotonergic hallucinogens in rats − the relationship of brain activity and behavior","year":"2016","cit":0,"pfa":"Čestmír Vejmola","psa":"Tomáš Páleníček","ptype":"article","src":"https://openalex.org/W2540253919","eid":"W2540253919"},{"id":"paper-w4413631123","cat":"papers","name":"Psychedelic drugs: how the brains of informed users are different","year":"2021","cit":0,"pfa":"Barbara Jacquelyn Sahakian","psa":"George Savulich","ptype":"other","src":"https://openalex.org/W4413631123","eid":"W4413631123"},{"id":"paper-w4405711189","cat":"papers","name":"AJP Brings Scientific Rigor to the Study of Psychedelic Medicine","year":"2024","cit":0,"pfa":"Linda M. Richmond","ptype":"article","src":"https://openalex.org/W4405711189","eid":"W4405711189"},{"id":"paper-w4413732484","cat":"papers","name":"Does microdosing improve your mood and performance? Here’s what the research says","year":"2019","cit":0,"pfa":"Vince Polito","topics":["Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W4413732484","eid":"W4413732484"},{"id":"paper-w4252080754","cat":"papers","name":"2003 Survey Reveals Increase in Prescription Drug Abuse, Sharp Drop in Abuse of Hallucinogens","year":"2004","cit":0,"ptype":"dataset","src":"https://openalex.org/W4252080754","eid":"W4252080754"},{"id":"paper-w4220981776","cat":"papers","name":"AI scours psychedelic trip reports for medical clues","year":"2022","cit":0,"pfa":"MS MS","ptype":"article","src":"https://openalex.org/W4220981776","eid":"W4220981776"},{"id":"paper-w4414180290","cat":"papers","name":"Applications of psychedelics in small doses and alternative treatments in psychiatry","year":"2025","cit":0,"pfa":"Kim P. C. Kuypers","topics":["Anxiety & end-of-life","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4414180290","eid":"W4414180290"},{"id":"paper-w7106390861","cat":"papers","name":"Psychedelic Control of Neuroimmune Interactions Governing Fear 4088","year":"2025","cit":0,"pfa":"Elizabeth N. Chung","psa":"Michael A. Wheeler","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7106390861","eid":"W7106390861"},{"id":"paper-w7171342575","cat":"papers","name":"Therapeutic use of psychedelics for target groups of social work","year":"2026","cit":0,"pfa":"Eliška Rambová","ptype":"dissertation","src":"https://openalex.org/W7171342575","eid":"W7171342575"},{"id":"paper-w7164568636","cat":"papers","name":"Psychedelic Behavioural Review — scoring pipeline, data & dashboard","year":"2026","cit":0,"pfa":"Muad Abdelhay","topics":["Reviews & meta-analyses"],"ptype":"software","src":"https://openalex.org/W7164568636","eid":"W7164568636"},{"id":"paper-w4409147165","cat":"papers","name":"Maize production in Mali: microdosing and mechanization for better yields, profits, and labor reduction","year":"2025","cit":0,"pfa":"Woumou Kamkam","psa":"Jens B. Aune","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4409147165","eid":"W4409147165"},{"id":"paper-w2096647724","cat":"papers","name":"CORRELATION BETWEEN ELECTROENCEPHALOGRAPHIC (EEG) EFFECTS AND ACETYLCHOLINE CONTENT OF BRAIN AFTER CHOLINOLYTIG HALLUCINOGENS","year":"1969","cit":0,"pfa":"M.A. Matin","ptype":"article","src":"https://openalex.org/W2096647724","eid":"W2096647724"},{"id":"paper-w7164555940","cat":"papers","name":"Psychedelic Behavioural Review — scoring pipeline, data & dashboard","year":"2026","cit":0,"pfa":"Muad Abdelhay","topics":["Reviews & meta-analyses"],"ptype":"software","src":"https://openalex.org/W7164555940","eid":"W7164555940"},{"id":"paper-w3011767075","cat":"papers","name":"Hallucinating Facts: Psychedelic Science and the Epistemic Power of Data","year":"2020","cit":0,"pfa":"Emma Stamm","topics":["Addiction","Mechanism & neuroscience","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W3011767075","eid":"W3011767075"},{"id":"paper-w7165368790","cat":"papers","name":"The Uneven Origins of Eco-Consciousness in the First Psychedelic Revolution","year":"2026","cit":0,"pfa":"Agnieszka Soltysik Monnet","ptype":"article","src":"https://openalex.org/W7165368790","eid":"W7165368790"},{"id":"paper-w7213537651","cat":"papers","name":"Psychedelics Exceptionalism and Employment-Related Risk in a Clinical Trial","year":"2026","cit":0,"pfa":"Liza Dawson","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7213537651","eid":"W7213537651"},{"id":"paper-w4414168542","cat":"papers","name":"Advancements in psychedelic research: Effects, mechanisms, and therapeutic potential as emerging antidepressants","year":"2025","cit":0,"pfa":"Xianqiang Zhang","psa":"Jing Xiong","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4414168542","eid":"W4414168542"},{"id":"paper-w1575722295","cat":"papers","name":"Tolerance and cross‐tolerance to behavioral effects of phenethylamine‐ and tryptamine‐derived hallucinogens in mice (661.2)","year":"2014","cit":0,"pfa":"Douglas Alton Smith","psa":"William E. Fantegrossi","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1575722295","eid":"W1575722295"},{"id":"paper-w7112668163","cat":"papers","name":"Psychedelic Medicine (medical school elective course syllabus)","year":"2024","cit":0,"pfa":"Natalie Scanlon","psa":"Ben McCauley","ptype":"preprint","src":"https://openalex.org/W7112668163","eid":"W7112668163"},{"id":"paper-w4416747544","cat":"papers","name":"The medical sociological and social epidemiological psychedelics paradigm (MSSEPP)","year":"2025","cit":0,"pfa":"Sean M. Viña","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4416747544","eid":"W4416747544"},{"id":"paper-w1511810831","cat":"papers","name":"Psychedelic Psychiatry: LSD from Clinic to Campus (review)","year":"2010","cit":0,"pfa":"David Healy","topics":["Depression","Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1511810831","eid":"W1511810831"},{"id":"paper-w4280536223","cat":"papers","name":"Psychedelic spleen: what the emergency physicians need to know","year":"2022","cit":0,"pfa":"Sohil Equbal Pothiawala","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4280536223","eid":"W4280536223"},{"id":"paper-w3034924619","cat":"papers","name":"Otherworlds: Psychedelics and Exceptional Human Experience by David Luke","year":"2019","cit":0,"pfa":"Natalie L. Trent","ptype":"article","src":"https://openalex.org/W3034924619","eid":"W3034924619"},{"id":"paper-w4386113195","cat":"papers","name":"Psychedelic Drugs used in the Treatment of Depression: A Literature Review","year":"2023","cit":0,"pfa":"Larissa Conti Herrero","psa":"Aline de Amorim Duarte","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4386113195","eid":"W4386113195"},{"id":"paper-w7128762580","cat":"papers","name":"Exploring experiences of psychedelic identity confirmation in LGBTQIA+ people","year":"2026","cit":0,"pfa":"Jamie Tully","psa":"Tom O. G. Lewis","ptype":"preprint","src":"https://openalex.org/W7128762580","eid":"W7128762580"},{"id":"paper-w7212226739","cat":"papers","name":"Psychoactives and Psychedelics in Yoga: Historical Contexts and Contemporary Culture","year":"2026","cit":0,"pfa":"Stuart Ray Sarbacker","topics":["Addiction","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7212226739","eid":"W7212226739"},{"id":"paper-w980850065","cat":"papers","name":"Hallucinogens suppress slow cortical oscillations in thalamocortica circuits. Reversal by antipsychotic drugs","year":"2012","cit":0,"pfa":"Francesc Artigas","ptype":"conference-paper","src":"https://openalex.org/W980850065","eid":"W980850065"},{"id":"paper-w4409879337","cat":"papers","name":"Health-Related Behavioral Changes Following the Use of Psychedelics in Naturalistic Settings","year":"2025","cit":0,"pfa":"Pedro J. Teixeira","psa":"Charles L. Raison","ptype":"preprint","src":"https://openalex.org/W4409879337","eid":"W4409879337"},{"id":"paper-w4298147610","cat":"papers","name":"Daily briefing: Psychedelics shed light on the underpinnings of consciousness","year":"2022","cit":0,"pfa":"Flora Graham","ptype":"article","src":"https://openalex.org/W4298147610","eid":"W4298147610"},{"id":"paper-w4387610624","cat":"papers","name":"Psychedelics hype may lead people to self-medicate","year":"2023","cit":0,"pfa":"Clare Wilson","ptype":"article","src":"https://openalex.org/W4387610624","eid":"W4387610624"},{"id":"paper-w7129040094","cat":"papers","name":"The madness is the message: psychedelics, subjectivity, and epistemic transformative experience","year":"2025","cit":0,"pfa":"Matthias Forstmann","topics":["Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W7129040094","eid":"W7129040094"},{"id":"paper-w2016718036","cat":"papers","name":"The psychedelic seventies new life styles for those in business?","year":"1970","cit":0,"pfa":"Laurence Foss","ptype":"article","src":"https://openalex.org/W2016718036","eid":"W2016718036"},{"id":"paper-w4389078505","cat":"papers","name":"Becoming Modern in China with an Indigenous Amazonian Psychedelic Brew","year":"2023","cit":0,"pfa":"Alex K. Gearin","ptype":"book-chapter","src":"https://openalex.org/W4389078505","eid":"W4389078505"},{"id":"paper-w7124521079","cat":"papers","name":"Ten simple rules for setting up a psychedelic study","year":"2026","cit":0,"pfa":"Matt Butler","psa":"Alice Caulfield","ptype":"preprint","src":"https://openalex.org/W7124521079","eid":"W7124521079"},{"id":"paper-w243190886","cat":"papers","name":"Introduction to 'beneficial effects of psychedelics with a special focus on addictions'.","year":"2014","cit":0,"pfa":"Joost J. Breeksema","psa":"Rudie Kortekaas","topics":["Addiction"],"ptype":"editorial","src":"https://openalex.org/W243190886","eid":"W243190886"},{"id":"paper-w4402061803","cat":"papers","name":"Psychedelic Treatment Research Clinical Trial Award (DOD)","year":"2024","cit":0,"ptype":"article","src":"https://openalex.org/W4402061803","eid":"W4402061803"},{"id":"paper-w2411453116","cat":"papers","name":"[Experimental rhadbomyosarcoma of striated muscles from microdoses of 20-methylcholanthrene in white rats].","year":"1956","cit":0,"pfa":"P. Carinci","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2411453116","eid":"W2411453116"},{"id":"paper-w103891172","cat":"papers","name":"Deus Ex Machina and Tahuya Yoshikawa’s Psychedelic Work","year":"2014","cit":0,"pfa":"Tony Owen","ptype":"article","src":"https://openalex.org/W103891172","eid":"W103891172"},{"id":"paper-w4414371746","cat":"papers","name":"Philopsychedelia beyond the West: The decolonial reflorescence of psychedelic philosophy","year":"2025","cit":0,"pfa":"Jan Clefferson Costa de Freitas","psa":"René Alvarado Martinez","ptype":"book-chapter","src":"https://openalex.org/W4414371746","eid":"W4414371746"},{"id":"paper-w4407125900","cat":"papers","name":"Psychedelics, Sensory Isolation Tanks, and Dreamy Mental States","year":"2025","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W4407125900","eid":"W4407125900"},{"id":"paper-w7214704116","cat":"papers","name":"U.S. Veterans and Psychedelics: Prevalence of Use and Policy Preferences","year":"2026","cit":0,"pfa":"Michelle Priest","psa":"Beau Kilmer","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7214704116","eid":"W7214704116"},{"id":"paper-w2553937395","cat":"papers","name":"A context for the supercontext: On the function of psychedelics in Grant Morrison’s The Invisibles","year":"2016","cit":0,"pfa":"Ian Stuart Garlington","ptype":"article","src":"https://openalex.org/W2553937395","eid":"W2553937395"},{"id":"paper-w7135549117","cat":"papers","name":"The Impact of Psychedelic Use on Mental Health and Well-being.","year":"2025","cit":0,"pfa":"Dominika Zdražilová","topics":["Addiction"],"ptype":"dissertation","src":"https://openalex.org/W7135549117","eid":"W7135549117"},{"id":"paper-w4409487245","cat":"papers","name":"Acid Revival: The psychedelic renaissance and the quest for medical legitimacy","year":"2025","cit":0,"pfa":"Claudia G. Schwarz-Plaschg","ptype":"book-review","src":"https://openalex.org/W4409487245","eid":"W4409487245"},{"id":"paper-w7164895004","cat":"papers","name":"Ten practical suggestions for setting up a psychedelic study","year":"2026","cit":0,"pfa":"Alice Caulfield","psa":"Mitul A. Mehta","topics":["Addiction","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7164895004","eid":"W7164895004"},{"id":"paper-w4385677407","cat":"papers","name":"CHAPTER 6 Psychedelic Research and Pioneers in the mid-1900s","year":"2016","cit":0,"pfa":"Ben Sessa","psa":"Eileen Worthley","ptype":"book-chapter","src":"https://openalex.org/W4385677407","eid":"W4385677407"},{"id":"paper-w2965736127","cat":"papers","name":"Acid Realities. How Science Enacts the Psychedelic Experience","year":"2019","cit":0,"pfa":"Simon Toper","topics":["Safety & adverse events"],"ptype":"other","src":"https://openalex.org/W2965736127","eid":"W2965736127"},{"id":"paper-w3201393850","cat":"papers","name":"A Return to Psychedelic Funk: An Inquiry into Childish Gambino’s “Redbone”","year":"2021","cit":0,"pfa":"Madeline Haddad","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3201393850","eid":"W3201393850"},{"id":"paper-w4323025895","cat":"papers","name":"Untangling anorexia: psychedelics offer hope for a neglected condition","year":"2023","cit":0,"ptype":"article","src":"https://openalex.org/W4323025895","eid":"W4323025895"},{"id":"paper-w7120522093","cat":"papers","name":"Harm reduction in psychedelic induced crisis: a Jungian reading","year":"2022","cit":0,"pfa":"Fernando Rocha Beserra","topics":["Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W7120522093","eid":"W7120522093"},{"id":"paper-w7127612176","cat":"papers","name":"Psychedelics, Ultrarunning, Metaphysical Horror, and Addiction to Synthetic Affect","year":"2026","cit":0,"topics":["Addiction"],"ptype":"other","src":"https://openalex.org/W7127612176","eid":"W7127612176"},{"id":"paper-w4393026309","cat":"papers","name":"The Transpersonal, Psychedelics, And Mainstream Psychology: Why The Wide Divide?","year":"2015","cit":0,"pfa":"James Fadiman","ptype":"other","src":"https://openalex.org/W4393026309","eid":"W4393026309"},{"id":"paper-w4389685145","cat":"papers","name":"Reply to “Capturing Synergy Holistically in Psychedelic Clinical Trials”","year":"2023","cit":0,"pfa":"Robert H. Dworkin","psa":"Eric C. Strain","ptype":"letter","src":"https://openalex.org/W4389685145","eid":"W4389685145"},{"id":"paper-w4417524155","cat":"papers","name":"Causal Inference in Studies with Functional Unmasking: Psychedelics and Beyond","year":"2025","cit":0,"pfa":"Gabriel C. Loewinger","psa":"Alexander W. Levis","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4417524155","eid":"W4417524155"},{"id":"paper-w2463009193","cat":"papers","name":"[Effect of microdoses of copper and cobalt on zinc and cobalt metabolism in children with rickets].","year":"1977","cit":0,"pfa":"Galiuk Sv","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2463009193","eid":"W2463009193"},{"id":"paper-w3091147608","cat":"papers","name":"Microdosing of mannitol in blood and urine, studied with a view to determining the clearance of this substance.","year":"2008","cit":0,"pfa":"J HAMBURGER","psa":"Ryckewaert","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3091147608","eid":"W3091147608"},{"id":"paper-w4224281539","cat":"papers","name":"Psychedelics: Old trips, new destinations in psychopharmacology research","year":"2022","cit":0,"pfa":"Harriet de Wit","psa":"Deepak Cyril D’Souza","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4224281539","eid":"W4224281539"},{"id":"paper-w4309496961","cat":"papers","name":"Molecular descriptors - a mathematical approach to characterize psychedelic substances","year":"2022","cit":0,"pfa":"Iulia-Florentina Darie","psa":"Steluța Gosav","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4309496961","eid":"W4309496961"},{"id":"paper-w2921908639","cat":"papers","name":"L.A. story: our nation's psychedelic heritage is preserved","year":"2007","cit":0,"pfa":"Dominic Walker","ptype":"article","src":"https://openalex.org/W2921908639","eid":"W2921908639"},{"id":"paper-w2065802360","cat":"papers","name":"Sensitivity of the Experiential World Inventory to Psychedelic Drug States","year":"1974","cit":0,"pfa":"E. Robert Sinnett","psa":"William M. Harvey","ptype":"article","src":"https://openalex.org/W2065802360","eid":"W2065802360"},{"id":"paper-w2992380639","cat":"papers","name":"Patrick out with a new single «Psychedelic Love Storm»","year":"2019","cit":0,"pfa":"ephram st. cloud","ptype":"article","src":"https://openalex.org/W2992380639","eid":"W2992380639"},{"id":"paper-w7164580330","cat":"papers","name":"The Emerging Field of Psychedelics. The Role of Creative Arts Therapists","year":"2026","cit":0,"pfa":"Carlos Rodriguez Perez","psa":"Katie Down","topics":["Therapy practice"],"ptype":"conference-paper","src":"https://openalex.org/W7164580330","eid":"W7164580330"},{"id":"paper-w3111864702","cat":"papers","name":"Erika Dyck, 'Psychedelic Psychiatry: LSD on the Canadian Prairies'","year":"2012","cit":0,"pfa":"Tristan V. Barsky","ptype":"article","src":"https://openalex.org/W3111864702","eid":"W3111864702"},{"id":"paper-w4409786817","cat":"papers","name":"Clarifying the Concept of Psychological Support in Psychedelic Clinical Trials","year":"2025","cit":0,"pfa":"Jonathan R. Schettino","psa":"David B. Yaden","ptype":"preprint","src":"https://openalex.org/W4409786817","eid":"W4409786817"},{"id":"paper-w7135564689","cat":"papers","name":"Qualitative research on the afterglow effect after psychedelics use","year":"2025","cit":0,"pfa":"Anna Sochůrková","topics":["Addiction","Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W7135564689","eid":"W7135564689"},{"id":"paper-w7208540542","cat":"papers","name":"Psychedelic immortality Nietzschean perspectives on reincarnation, femtheogens, and philosophy","cit":0,"pfa":"Joseph I. Breidenstein","ptype":"article","src":"https://openalex.org/W7208540542","eid":"W7208540542"},{"id":"paper-w4205505396","cat":"papers","name":"Daily briefing: How psychedelics are shaking up psychiatry","year":"2021","cit":0,"pfa":"Flora Graham","ptype":"article","src":"https://openalex.org/W4205505396","eid":"W4205505396"},{"id":"paper-w2999748300","cat":"papers","name":"“Listen to the Colour of Your Dreams”: The Beatles Writ Psychedelic","year":"2020","cit":0,"pfa":"Jason Kruppa","ptype":"book-chapter","src":"https://openalex.org/W2999748300","eid":"W2999748300"},{"id":"paper-w4392667454","cat":"papers","name":"Comparative Frameworks for a Human Rights-Based Approach to Psychedelics","year":"2024","cit":0,"pfa":"Dustin N. Sharp","ptype":"preprint","src":"https://openalex.org/W4392667454","eid":"W4392667454"},{"id":"paper-w7154685754","cat":"papers","name":"Blinding problems impair integrity of psychedelics trials: Study","year":"2026","cit":0,"pfa":"Alison Knopf","ptype":"article","src":"https://openalex.org/W7154685754","eid":"W7154685754"},{"id":"paper-w4394251485","cat":"papers","name":"Repeated Microdoses of LSD do not alter Anxiety or Boldness in Zebrafish excel sheets","year":"2022","cit":0,"pfa":"Ethan V. Hagen","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"dataset","src":"https://openalex.org/W4394251485","eid":"W4394251485"},{"id":"paper-w4362614806","cat":"papers","name":"Related Article from Is It Time to Advance the Chemoprevention of Environmental Carcinogenesis with Microdosing Trials?","year":"2023","cit":0,"pfa":"Thomas W. Kensler","psa":"John D. Groopman","topics":["Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W4362614806","eid":"W4362614806"},{"id":"paper-w3165787722","cat":"papers","name":"LibGuides: HLT 214 - Substance Use and Abuse - Textbook: Chapter 9. Hallucinogens","year":"2020","cit":0,"pfa":"Lisa Tappeiner","topics":["Addiction"],"ptype":"libguides","src":"https://openalex.org/W3165787722","eid":"W3165787722"},{"id":"paper-w2060103315","cat":"papers","name":"340. Clinical and endocrinological results with the use of continuous microdose of megestrol acetate as a contraceptive","year":"1974","cit":0,"pfa":"E. Vazquez-Benitez","psa":"J.A. SerenoColo","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2060103315","eid":"W2060103315"},{"id":"paper-w2754056504","cat":"papers","name":"[Reproductive problems in female workers exposed to the chronic action of microdoses of chemical substances].","year":"1987","cit":0,"pfa":"A Angelov","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2754056504","eid":"W2754056504"},{"id":"paper-w2033183446","cat":"papers","name":"P745 The efficiency and acceptability microdosed out of oral contraceptive at women of reproductive age","year":"2009","cit":0,"pfa":"Назарова Нисо Мирзоевна","psa":"R A Sasunova","topics":["Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W2033183446","eid":"W2033183446"},{"id":"paper-w4249765124","cat":"papers","name":"Microdose induced drain leakage effects in power trench MOSFETs: Experiment and modeling","year":"2013","cit":0,"pfa":"Gennady Ivanovich Zebrev","psa":"Valentin O. Turin","topics":["Dosing & pharmacology"],"ptype":"conference-paper","src":"https://openalex.org/W4249765124","eid":"W4249765124"},{"id":"paper-w4413509047","cat":"papers","name":"Une autre « mini-tournée » ? Le véritable effet d’une microdose d’alcool","year":"2021","cit":0,"pfa":"Harry R. Sumnall","topics":["Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W4413509047","eid":"W4413509047"},{"id":"paper-w2510535147","cat":"papers","name":"Optimum maximal gonadotropin dosage used in microdose flare-up cycles","year":"2016","cit":0,"pfa":"Kemal Ozgur","psa":"Murat Berkkanoğlu","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W2510535147","eid":"W2510535147"},{"id":"paper-w2411066649","cat":"papers","name":"Contraceptive efficacy of microdose norethisterone enanthate: a study on its use in polydimethylsiloxane implants.","year":"1981","cit":0,"pfa":"Srivastava Uk","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2411066649","eid":"W2411066649"},{"id":"paper-w2415300314","cat":"papers","name":"[Functional and structural changes in the cardiovascular system of dogs repeatedly infused with microdoses of noradrenaline].","year":"1979","cit":0,"pfa":"Frolova Tm","psa":"Iu I Bobkov","topics":["Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W2415300314","eid":"W2415300314"},{"id":"paper-w7199332088","cat":"papers","name":"Effect of psychedelics on food consumption and on eating behavior in mice","year":"2023","cit":0,"pfa":"Arto Iljin","ptype":"article","src":"https://openalex.org/W7199332088","eid":"W7199332088"},{"id":"paper-w3041024891","cat":"papers","name":"The Sum of Different Microdose-Effects in Irradiated Tissue Contradicts the Linear-no-Threshold Hypothesis","year":"1997","cit":0,"pfa":"Ludwig E. Feindegen","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3041024891","eid":"W3041024891"},{"id":"paper-w2342836715","cat":"papers","name":"IMPROVEMENT OF THE OPERATIONAL PROPERTIES OF ETHANOL MOTOR FUELS BY MICRODOSES OF CARBON SPHEROIDAL NANOCLUSTERS","year":"2016","cit":0,"pfa":"О.О. Гайдай","psa":"Є.В. Полункін","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2342836715","eid":"W2342836715"},{"id":"paper-w4289378015","cat":"papers","name":"Psychedelic Floyd : L’underground à Londres 1966-1967","year":"2018","cit":0,"pfa":"Philippe Gonin","ptype":"conference-paper","src":"https://openalex.org/W4289378015","eid":"W4289378015"},{"id":"paper-w4213237153","cat":"papers","name":"Potential use of psychedelic drugs to treat psychiatric disorders","year":"2019","cit":0,"ptype":"dataset","src":"https://openalex.org/W4213237153","eid":"W4213237153"},{"id":"paper-w4385009206","cat":"papers","name":"Effects of psychedelics on neurogenesis and brain plasticity: A systematic review","year":"2023","cit":0,"pfa":"Rafael Vitor Lima da Cruz","psa":"Thiago C. Moulin","topics":["Safety & adverse events","Reviews & meta-analyses","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4385009206","eid":"W4385009206"},{"id":"paper-w2418508081","cat":"papers","name":"[Effect of microdoses of penicillin on various immunological phenomena in relation to intracutaneous and intramuscular administration].","year":"1951","cit":0,"pfa":"Colucci Cf","psa":"Giuseppe Jacono","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2418508081","eid":"W2418508081"},{"id":"paper-w2999636476","cat":"papers","name":"Hallucinogen Use is Associated with Mental Health and Addictive Problems and Impulsivity in University Students.","year":"2019","cit":0,"pfa":"Jon Edgar Grant","psa":"Samuel Robin Chamberlain","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2999636476","eid":"W2999636476"},{"id":"paper-w4301104983","cat":"papers","name":"Drug–drug interaction of microdose and regular-dose omeprazole with a CYP2C19 inhibitor and inducer","year":"2017","cit":0,"pfa":"G Park","psa":"Yim DS","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4301104983","eid":"W4301104983"},{"id":"paper-w2784270335","cat":"papers","name":"History and current status of psychedelic drugs in psycho pharmacology","year":"1969","cit":0,"pfa":"Henry B. Murphree","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2784270335","eid":"W2784270335"},{"id":"paper-w7117143711","cat":"papers","name":"The Promises and Pitfalls of Psychedelic Use Among Religious Leaders","year":"2025","cit":0,"pfa":"Otto Simonsson","psa":"Simon Benjamin Goldberg","ptype":"article","src":"https://openalex.org/W7117143711","eid":"W7117143711"},{"id":"paper-w4239752487","cat":"papers","name":"How Do Psychedelic Drugs Affect Amine Receptors?","year":"1998","cit":0,"topics":["Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W4239752487","eid":"W4239752487"},{"id":"paper-w3081470092","cat":"papers","name":"[Psychedelics in Western culture: unnecessary psychiatrisation of visionary experiences].","year":"2020","cit":0,"pfa":"Wouter J. Hanegraaff","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W3081470092","eid":"W3081470092"},{"id":"paper-w7162708492","cat":"papers","name":"Alterations of consciousness Associated with a Psychedelic Virtual Reality Experience","year":"2026","cit":0,"pfa":"Kristofer Robin Kütt","ptype":"dissertation","src":"https://openalex.org/W7162708492","eid":"W7162708492"},{"id":"paper-w7162403738","cat":"papers","name":"Can Childhood be Used as a Model to Understand the Effects of Psychedelics?","year":"2026","cit":0,"pfa":"Ethan S. Hurwitz","psa":"Caren M. Walker","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7162403738","eid":"W7162403738"},{"id":"paper-w7169592195","cat":"papers","name":"The mystic trip: how psychedelic research fell for mysticism","year":"2026","cit":0,"pfa":"Richard Saville-Smith","psa":"Sharday Catherine Mosurinjohn","ptype":"article","src":"https://openalex.org/W7169592195","eid":"W7169592195"},{"id":"paper-w4247712754","cat":"papers","name":"Psychotomimetic Drugs","year":"1972","cit":0,"pfa":"Leo E. Hollister","ptype":"article","src":"https://openalex.org/W4247712754","eid":"W4247712754"},{"id":"paper-w2905395986","cat":"papers","name":"Heads: A Biography of Psychedelic America by Jesse Jarnow (review)","year":"2018","cit":0,"pfa":"Chris Elcock","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2905395986","eid":"W2905395986"},{"id":"paper-w4396642852","cat":"papers","name":"On The Cinco Sins of Psychedelic Research. An interview with Manoj Doss","year":"2024","cit":0,"pfa":"George Fejer","psa":"Manoj K. Doss","topics":["Addiction","Dosing & pharmacology","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4396642852","eid":"W4396642852"},{"id":"paper-w7123775028","cat":"papers","name":"Classification of Psychedelics and Psychoplastogens based on Pharmacological and Mechanistic Features","year":"2026","cit":0,"pfa":"Miguel Salfiti","psa":"Georgios Mikellides","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dataset","src":"https://openalex.org/W7123775028","eid":"W7123775028"},{"id":"paper-w7124310144","cat":"papers","name":"Animal models in psychedelic research – Tripping over translation","year":"2026","cit":0,"pfa":"Muad Y Abd El Hay","psa":"Martha Nari Havenith","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"preprint","src":"https://openalex.org/W7124310144","eid":"W7124310144"},{"id":"paper-w2521713228","cat":"papers","name":"4. Opening the Door: Psychedelics as a Gateway to Buddhist Practice","year":"2016","cit":0,"pfa":"Douglas Osto","ptype":"book-chapter","src":"https://openalex.org/W2521713228","eid":"W2521713228"},{"id":"paper-w4381050835","cat":"papers","name":"Review of: \"Psychedelic drugs as a long-needed innovation in psychiatry\"","year":"2023","cit":0,"pfa":"Nermin Yücel","topics":["Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4381050835","eid":"W4381050835"},{"id":"paper-w4409371868","cat":"papers","name":"Industry considers concerns about blinding in trials with psychedelics","year":"2025","cit":0,"pfa":"Alison Knopf","ptype":"article","src":"https://openalex.org/W4409371868","eid":"W4409371868"},{"id":"paper-w7165128977","cat":"papers","name":"THE PSYCHEDELIC AND KETAMINE RENAISSANCE IN THE FACE OF THE CRISIS IN MODERN PSYCHIATRY","year":"2026","cit":0,"pfa":"Julia Osipowska","psa":"Magdalena Dubaj","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7165128977","eid":"W7165128977"},{"id":"paper-w2269847420","cat":"papers","name":"Microdoses de naloxona na reversao da depressao respiratoria pos-narcotica","year":"1983","cit":0,"pfa":"C.J.M Silva","psa":"R.A Saraiva","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2269847420","eid":"W2269847420"},{"id":"paper-w3090306027","cat":"papers","name":"Microdosing of blood albumin by colorimetric measurement of the reagent which has precipitated them.","year":"1946","cit":0,"pfa":"Reece Goiffon","psa":"G Beaucerf","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3090306027","eid":"W3090306027"},{"id":"paper-w2406058389","cat":"papers","name":"[Effect of hydroxyprogesterone acetate on the prostate gland of hypophysectomized rats treated with microdoses of testosterone].","year":"1968","cit":0,"pfa":"G Ronzoni","psa":"R Alma","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2406058389","eid":"W2406058389"},{"id":"paper-w3007201491","cat":"papers","name":"Influence of Microdose of Mineral Fertilizer and Organic Manure on the Production of Groundnuts in Southern Benin","year":"2020","cit":0,"pfa":"K. Sabaï","psa":"Brice Augustin SINSIN","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3007201491","eid":"W3007201491"},{"id":"paper-w4415923932","cat":"papers","name":"Schizophrenia, Psychedelics, and Sense of Self: Comparison of Phenomenology and Neural Correlates","year":"2025","cit":0,"pfa":"Arthur P. Hamilton","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4415923932","eid":"W4415923932"},{"id":"paper-w4387445271","cat":"papers","name":"The relation between naturalistic use of psychedelics and perception of emotional stimuli: An ERP study comparing non-users and experienced users of classic psychedelics","year":"2023","cit":0,"pfa":"Paweł Orlowski","psa":"Michał Bola","topics":["Addiction","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4387445271","eid":"W4387445271"},{"id":"paper-w4416527801","cat":"papers","name":"Microdosing of obesity medications: A Perspective Statement from the Access and Policy Working Group","year":"2025","cit":0,"pfa":"Christopher Weber","psa":"Harold Edward Bays","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4416527801","eid":"W4416527801"},{"id":"paper-w4362624770","cat":"papers","name":"Related Article from Is It Time to Advance the Chemoprevention of Environmental Carcinogenesis with Microdosing Trials?","year":"2023","cit":0,"pfa":"Thomas W. Kensler","psa":"John D. Groopman","topics":["Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W4362624770","eid":"W4362624770"},{"id":"paper-w2024435332","cat":"papers","name":"Hallucinogens: Neurochemical, Behavioral, and Clinical Perspectives (Central Nervous System Pharmacology Series)","year":"1985","cit":0,"pfa":"K. Bättig","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2024435332","eid":"W2024435332"},{"id":"paper-w2898300756","cat":"papers","name":"Clarifying the mechanisms by which psychedelics achieve therapeutic efficacy","year":"2018","cit":0,"pfa":"Andrew Jones","topics":["Depression","Mechanism & neuroscience","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W2898300756","eid":"W2898300756"},{"id":"paper-w3205806099","cat":"papers","name":"6.4 REGULATORY AND ETHICAL ISSUES WITH PEDIATRIC PSYCHEDELIC RESEARCH","year":"2021","cit":0,"pfa":"Albert John Allen","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3205806099","eid":"W3205806099"},{"id":"paper-w4220791840","cat":"papers","name":"Microdosing Transdermal Buprenorphine to Transition a Patient off a Higher-Dose Methadone Regimen","year":"2022","cit":0,"pfa":"Hannan M. Braun","psa":"Seth A. Clark","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4220791840","eid":"W4220791840"},{"id":"paper-w7213573878","cat":"papers","name":"On hallucinogens, drugs, and medicaments. The case of etherisation of Zygmunt Krasiński by pen of social historian","year":"2017","cit":0,"pfa":"Małgorzata Karpińska","ptype":"article","src":"https://openalex.org/W7213573878","eid":"W7213573878"},{"id":"paper-w2005784602","cat":"papers","name":"Microdoses Levels of Butadiene Diepoxide (BDO2) Induced Toxicity in Prostate Cancer Cells","year":"2013","cit":0,"pfa":"Sowmya Koppula","psa":"Wesley Gray","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2005784602","eid":"W2005784602"},{"id":"paper-w4394088539","cat":"papers","name":"Hallucinogen persisting perceptual disorder: a scoping review covering frequency, risk factors, prevention, and treatment","year":"2022","cit":0,"pfa":"Marcus A. Doyle","psa":"Roger S. McIntyre","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"dataset","src":"https://openalex.org/W4394088539","eid":"W4394088539"},{"id":"paper-w7118030533","cat":"papers","name":"Self-reported acute effects of microdosing, ADHD medication, and their combination in adults with ADHD","year":"2026","cit":0,"pfa":"E.C.H.M. Haijen","psa":"K. Kuypers","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7118030533","eid":"W7118030533"},{"id":"paper-w4200122990","cat":"papers","name":"874: USE OF BUPRENORPHINE MICRODOSING FOR OPIATE DEPENDENCE IN THE PEDIATRIC INTENSIVE CARE UNIT","year":"2021","cit":0,"pfa":"Jacob Anderson","psa":"Erin E. Barker","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4200122990","eid":"W4200122990"},{"id":"paper-w2410472406","cat":"papers","name":"[Ancient ataraxia due to current hallucinogens: historical, pharmacological, clinical and social aspects].","year":"1972","cit":0,"pfa":"M Jandolo","topics":["Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W2410472406","eid":"W2410472406"},{"id":"paper-w4415005476","cat":"papers","name":"Identification of Hallucinogen Use Disorder within the EHR without an ICD-10 Code","year":"2025","cit":0,"pfa":"Elisabeth F. Callen","psa":"Ariadna Juarez Colunga","topics":["Addiction","Reviews & meta-analyses"],"ptype":"conference-abstract","src":"https://openalex.org/W4415005476","eid":"W4415005476"},{"id":"paper-w4378737477","cat":"papers","name":"What Sports Can Teach Us About cheap psychedelics","year":"2023","cit":0,"pfa":"conaldforrfiu","ptype":"article","src":"https://openalex.org/W4378737477","eid":"W4378737477"},{"id":"paper-w7163739384","cat":"papers","name":"Fields, Not Switches A Monograph on Activation, Relation, and the Knot —Hallucinogenes---Psychedelics","year":"2026","cit":0,"pfa":"Schüller Thomas","ptype":"article","src":"https://openalex.org/W7163739384","eid":"W7163739384"},{"id":"paper-w2027287097","cat":"papers","name":"A Comparison of Microdose Flare Protocol Versus AACEP Protocol for IVF Poor Responders","year":"2008","cit":0,"pfa":"Rodolfo B. Quintero","psa":"Marieh Nouriani","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2027287097","eid":"W2027287097"},{"id":"paper-w3137230882","cat":"papers","name":"General Theory of Inflammation. Patient Education Key to Microdose Therapy for Chronic Inflammation Control","year":"2020","cit":0,"pfa":"Virgil Irvin Stenberg","topics":["PTSD & trauma","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3137230882","eid":"W3137230882"},{"id":"paper-w4319042512","cat":"papers","name":"Changes in EEG Entropy, Alpha Power, and Beta Power Following a VR Psychedelic Journey","year":"2023","cit":0,"pfa":"Sonny Mattek","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4319042512","eid":"W4319042512"},{"id":"paper-w3004990833","cat":"papers","name":"The Development of the Transpersonal Model and Evidence from Psychedelic Drug Research","year":"1980","cit":0,"pfa":"Edward Cosla","ptype":"article","src":"https://openalex.org/W3004990833","eid":"W3004990833"},{"id":"paper-w2901177554","cat":"papers","name":"The Value of Experience: Psychedelics, phenomenology and contemporary perspectives on drug use","year":"2018","cit":0,"pfa":"Anna Marie Høifødt","topics":["Addiction","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W2901177554","eid":"W2901177554"},{"id":"paper-w4417457525","cat":"papers","name":"The interplay of psychedelic use and meditation in shaping psychological well-being","year":"2025","cit":0,"pfa":"Andreas Krabbe","psa":"Jussi Jylkkä","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4417457525","eid":"W4417457525"},{"id":"paper-w85560335","cat":"papers","name":"ESTIMATION OF MICRODOSE FROM LET SPECTRUM, DETERMINED BY TISSUE-EQUIVALENT PROPORTIONAL COUNTER.","year":"1970","cit":0,"pfa":"Dusan Chorvat Jr","psa":"J. Slovák","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W85560335","eid":"W85560335"},{"id":"paper-w1485131569","cat":"papers","name":"Pharmacokinetics II: 14C-labelled microdosing in assessing drug pharmacokinetics at Phase-0","year":"2010","cit":0,"pfa":"Graham Lappin","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W1485131569","eid":"W1485131569"},{"id":"paper-w4404136319","cat":"papers","name":"Buprenorphine ‘microdosing’ method for switching patients with opioid dependence from methadone to buprenorphine","year":"2024","cit":0,"pfa":"Yesh Chandra Singh","psa":"Ravindra Rao","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4404136319","eid":"W4404136319"},{"id":"paper-w4413580923","cat":"papers","name":"Fish on acid? Microdosing zebrafish with LSD shows its potential benefits for humans","year":"2022","cit":0,"pfa":"Trevor J. Hamilton","topics":["Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W4413580923","eid":"W4413580923"},{"id":"paper-w4414840973","cat":"papers","name":"72.4 Hallucinogen Use Disorder in Adolescents and Transitional-Age Youth: An Emerging Area of Concern?","year":"2025","cit":0,"pfa":"Sivabalaji Kaliamurthy","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4414840973","eid":"W4414840973"},{"id":"paper-w7169771628","cat":"papers","name":"Patterns and implications of co-use between vaping and hallucinogens: a systematic review and meta-analysis","year":"2026","cit":0,"pfa":"Javad Heshmati","psa":"H Mir","topics":["Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7169771628","eid":"W7169771628"},{"id":"paper-w4413484496","cat":"papers","name":"People are ‘microdosing’ weight-loss drugs. A GP explains what to watch out for","year":"2025","cit":0,"pfa":"Natasha Yates","topics":["Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W4413484496","eid":"W4413484496"},{"id":"paper-w2518579912","cat":"papers","name":"Human microdosing for the prediction of patient response \"While it remains to be seen whether microdosing is a truly viable strategy for diagnostics, the approach has the potential to enable personalized medicine for the","year":"2010","cit":0,"pfa":"Paul T. Henderson","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2518579912","eid":"W2518579912"},{"id":"paper-w2885431322","cat":"papers","name":"Psychedelics gradually gaining attention as potential mental health therapies","year":"2018","cit":0,"pfa":"Gary A. Enos","ptype":"article","src":"https://openalex.org/W2885431322","eid":"W2885431322"},{"id":"paper-w4309190182","cat":"papers","name":"Explosions in the Mind: Composing Psychedelic Sounds and Visualisations (Jonathan Weinel)","year":"2022","cit":0,"pfa":"Dave Payling","ptype":"article","src":"https://openalex.org/W4309190182","eid":"W4309190182"},{"id":"paper-w7204691346","cat":"papers","name":"Constructing Mystical Experiences: a Critique of the Mystical Paradigm in Psychedelic Research","year":"2024","cit":0,"pfa":"Hollis Phelps","ptype":"article","src":"https://openalex.org/W7204691346","eid":"W7204691346"},{"id":"paper-w4206021797","cat":"papers","name":"Delix raises $70 million to synthesize psychedelic-inspired drugs","year":"2021","cit":0,"pfa":"Ryan W. Cross","ptype":"article","src":"https://openalex.org/W4206021797","eid":"W4206021797"},{"id":"paper-w4387753518","cat":"papers","name":":American Trip: Set, Setting, and the Psychedelic Experience in the Twentieth Century","year":"2023","cit":0,"pfa":"Maria Cichosz","ptype":"article","src":"https://openalex.org/W4387753518","eid":"W4387753518"},{"id":"paper-w7108218643","cat":"papers","name":"Joanna Kempner, Psychedelic Outlaws: The Movement Revolutionizing Modern Medicine","year":"2025","cit":0,"pfa":"Zoë Dubus","ptype":"article","src":"https://openalex.org/W7108218643","eid":"W7108218643"},{"id":"paper-w3010898573","cat":"papers","name":"Retrospective survey on the approved antibody drugs in Japan for the perspective of antibody \"microdose\" dose.","year":"2020","cit":0,"pfa":"Saki Miyagi","psa":"Yasuhíro Suzuki","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3010898573","eid":"W3010898573"},{"id":"paper-w4409362745","cat":"papers","name":"MICRODOSE EOS IN PAEDIATRIC LONG LEG AND SPINE IMAGING: JUST AS GOOD, AND SAFER","year":"2025","cit":0,"pfa":"Emma Gravett","psa":"Andrea Yeo","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4409362745","eid":"W4409362745"},{"id":"paper-w3028875263","cat":"papers","name":"0553 Hallucinogen Use Among College and University Students: Associations with Insufficient Sleep and Insomnia","year":"2020","cit":0,"pfa":"Cameron Holbert","psa":"Michael A. Grandner","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3028875263","eid":"W3028875263"},{"id":"paper-w3142626612","cat":"papers","name":"USE OF PSYCHEDELIC SUBSTANCES FOR THERAPEUTIC PURPOSES: IATROGENIC PROBLEM OR JUSTIFIED NECESSITY? PART 1","year":"2018","cit":0,"pfa":"Azat R. Asadullin","psa":"Andrey Viktorovich Antsyborov","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3142626612","eid":"W3142626612"},{"id":"paper-w4408162033","cat":"papers","name":"Safety of Indocyanine Green Microdosing for Clinical Imaging of CSF Ventricular Dynamics and Extracranial Outflow","year":"2025","cit":0,"pfa":"Miriam Zamorano","psa":"Eva Marie Sevick-Muraca","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4408162033","eid":"W4408162033"},{"id":"paper-w964225464","cat":"papers","name":"Hallucinogens activate thalamocortical networks and suppress slow oscillatory activity. Reversal by antipsychotics drugs","year":"2012","cit":0,"pfa":"Francesc Artigas","topics":["Dosing & pharmacology"],"ptype":"conference-paper","src":"https://openalex.org/W964225464","eid":"W964225464"},{"id":"paper-w4414905459","cat":"papers","name":"MicroDOSE: A Hybrid GAN–Diffusion Model for Microbiome Simulation and Enhanced Disease Classification","year":"2025","cit":0,"pfa":"James Butler","psa":"Marcus Joakim Claesson","topics":["Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4414905459","eid":"W4414905459"},{"id":"paper-w4407418487","cat":"papers","name":"CONTRIBUTION OF 5-HT2AR TO THE ANTI-ANHEDONIC AND NEUROPLASTICITY EFFECTS OF PSYCHEDELICS","year":"2025","cit":0,"pfa":"Ichiro Horinokita","psa":"Takashi Futamura","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W4407418487","eid":"W4407418487"},{"id":"paper-w2947777751","cat":"papers","name":"Toward a Philosophy of Psychedelic Technology: An Exploration of Fear, Otherness, and Control","year":"2019","cit":0,"pfa":"Alan Houot","topics":["Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W2947777751","eid":"W2947777751"},{"id":"paper-w4383674794","cat":"papers","name":"Spotted around the web: Psychedelics; microRNA genes; pain sensitivity","year":"2023","cit":0,"pfa":"Jill U. Adams","psa":"Calli McMurray","ptype":"article","src":"https://openalex.org/W4383674794","eid":"W4383674794"},{"id":"paper-w2283357653","cat":"papers","name":"Microdose (14)~C-urea breath test to diagnose Helicobacter pylori infection","year":"1997","cit":0,"pfa":"陈洁平","psa":"徐启旺","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2283357653","eid":"W2283357653"},{"id":"paper-w4244207986","cat":"papers","name":"Microdosed Atropine 0.1% and 0.01% Ophthalmic Solutions for Reduction of Pediatric Myopia Progression","year":"2019","cit":0,"topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4244207986","eid":"W4244207986"},{"id":"paper-w2398941873","cat":"papers","name":"[Quantitative determination of microdoses of angiotensin by evaluation of the changes of vascular resistance in the hind leg of the rabbit].","year":"1969","cit":0,"pfa":"A Semprini","psa":"Mario Condorelli","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2398941873","eid":"W2398941873"},{"id":"paper-w2413313022","cat":"papers","name":"[Curiosity without borders. Aldous Huxley tried hallucinogens to look towards another world].","year":"2015","cit":0,"pfa":"Lars Sjöstrand","ptype":"other","src":"https://openalex.org/W2413313022","eid":"W2413313022"},{"id":"paper-w2324934423","cat":"papers","name":"Social/Cultural Anthropology: Hallucinogens: Cross‐Cultural Perspectives. Marlene Dobkin de Rios","year":"1985","cit":0,"ptype":"article","src":"https://openalex.org/W2324934423","eid":"W2324934423"},{"id":"paper-w7133566490","cat":"papers","name":"Distorted Cartoonish Images in the Environment: A Unique Visual Phenomenon in Hallucinogen Persisting Perception Disorder","year":"2026","cit":0,"pfa":"Mridul Sarangal","ptype":"article","src":"https://openalex.org/W7133566490","eid":"W7133566490"},{"id":"paper-w2016422047","cat":"papers","name":"Medieval Fictional Odysseys: Better Time Travel through Hallucinogens, Nets, and Quantum Foam","year":"2004","cit":0,"pfa":"Robert J. Blanch","ptype":"article","src":"https://openalex.org/W2016422047","eid":"W2016422047"},{"id":"paper-w246999990","cat":"papers","name":"Source Year Opiates Cocaine Amphetamines Ecstasy Hallucinogens Cannabis and Inhalants/ People treated*","year":"2005","cit":0,"pfa":"Albania Unodc","psa":"Sweden Unodc","ptype":"article","src":"https://openalex.org/W246999990","eid":"W246999990"},{"id":"paper-w4402580291","cat":"papers","name":"Health Alert: Microdose Products Leading to Acute Illness and Hospitalizations Across the United States","year":"2024","cit":0,"pfa":"Elisa Nguyen","psa":"Minh‐Ha Tran","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4402580291","eid":"W4402580291"},{"id":"paper-w7123602921","cat":"papers","name":"Effects of fertilizer microdosing on soil phosphorus and sulphur availability to Solanum macrocarpon in Southwest Nigeria","year":"2025","cit":0,"pfa":"Ifeoluwa Oluwaponle","psa":"Adebooye Odunayo C.","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7123602921","eid":"W7123602921"},{"id":"paper-w2597135888","cat":"papers","name":"On-farm evaluation of fertilizer microdosing technology in smallholder maize farming system of Northern Benin","year":"2015","cit":0,"pfa":"Gbènoukpo Pierre Tovihoudji","psa":"Charles Louis Bielders","topics":["Dosing & pharmacology"],"ptype":"conference-paper","src":"https://openalex.org/W2597135888","eid":"W2597135888"},{"id":"paper-w2286896479","cat":"papers","name":"The Correlation between Family Form, Psychedelic Abuse, and Youth Depression","year":"2011","cit":0,"pfa":"Taraghijah Sedighe","psa":"Yaghobi Narges","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2286896479","eid":"W2286896479"},{"id":"paper-w4394268577","cat":"papers","name":"Psychedelics promote plasticity by directly binding to BDNF receptor TRKB","year":"2023","cit":0,"pfa":"Plinio Cabrera Casarotto","topics":["Mechanism & neuroscience"],"ptype":"dataset","src":"https://openalex.org/W4394268577","eid":"W4394268577"},{"id":"paper-w4404519477","cat":"papers","name":"How Psychedelic, Religious, Spiritual, Mystical Experiences Become Effective","year":"2024","cit":0,"pfa":"Anne Koch","topics":["Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W4404519477","eid":"W4404519477"},{"id":"paper-w7113046126","cat":"papers","name":"A Relationally Informed Psychedelic Science : Conceptual framework and empirical studies","year":"2025","cit":0,"pfa":"Cherniak, Aaron D.","topics":["Safety & adverse events","Mechanism & neuroscience","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W7113046126","eid":"W7113046126"},{"id":"paper-w4415953184","cat":"papers","name":"Investigating the psychedelic hypothesis of kykeon, the sacred elixir of the Eleusinian Mysteries","year":"2025","cit":0,"pfa":"Romanos Konstantinos Antonopoulos","psa":"Prokopios Magiatis","ptype":"preprint","src":"https://openalex.org/W4415953184","eid":"W4415953184"},{"id":"paper-w7131414119","cat":"papers","name":"Rabbi Zalman Schachter-Shalomi Interview on Psychedelics Part 4","year":"2026","cit":0,"pfa":"University of Colorado Boulder","ptype":"other","src":"https://openalex.org/W7131414119","eid":"W7131414119"},{"id":"paper-w3153780909","cat":"papers","name":"Integrating Psychedelic Use: A Cautionary Note for Licensed Healthcare Providers","year":"2020","cit":0,"pfa":"Rose Jade","ptype":"preprint","src":"https://openalex.org/W3153780909","eid":"W3153780909"},{"id":"paper-w7135876515","cat":"papers","name":"A comparison of transpersonal theories of consciousness development with regard to the psychedelic experience","year":"2021","cit":0,"pfa":"Daniela Koubková","ptype":"dissertation","src":"https://openalex.org/W7135876515","eid":"W7135876515"},{"id":"paper-w7112719425","cat":"papers","name":"Data for \"The Phenomenology of Awe and Self Transcendence in Psychedelic Virtual Reality\"","year":"2025","cit":0,"pfa":"Jacob Spinks","ptype":"preprint","src":"https://openalex.org/W7112719425","eid":"W7112719425"},{"id":"paper-w7165297252","cat":"papers","name":"Computationally Characterizing Persisting Perceptual Abnormalities from Serotonergic Psychedelics","year":"2026","cit":0,"pfa":"Max Greenwald","ptype":"preprint","src":"https://openalex.org/W7165297252","eid":"W7165297252"},{"id":"paper-w2246530630","cat":"papers","name":"Psychedelic relevance of E.A. Poe for the 20th century american culture","year":"2010","cit":0,"pfa":"Andrzej Dorovek","ptype":"article","src":"https://openalex.org/W2246530630","eid":"W2246530630"},{"id":"paper-w7109081810","cat":"papers","name":"Fixing \"Bad trips\"? Exploring EMDR as a Psychedelic Safety Net","year":"2025","cit":0,"pfa":"Raine-Smith, Hannah","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7109081810","eid":"W7109081810"},{"id":"paper-w4406315398","cat":"papers","name":"Spiritual Promiscuity, Psychedelic Interdependence, and The First World Congress of Sorcery","year":"2025","cit":0,"pfa":"Julián Sánchez González","ptype":"article","src":"https://openalex.org/W4406315398","eid":"W4406315398"},{"id":"paper-w7117299338","cat":"papers","name":"Far Out: Psychedelics are Becoming a Current Treatment Option in Psychiatry","year":"2025","cit":0,"pfa":"Nicholas C. Borgogna","psa":"Stephen L. Aita","ptype":"article","src":"https://openalex.org/W7117299338","eid":"W7117299338"},{"id":"paper-w7165626857","cat":"papers","name":"The PsyCreativity Protocol: A Transdisciplinary Framework for Psychedelic-Enhanced Creative Practice","year":"2026","cit":0,"pfa":"Alexandra Maria Plesner","topics":["Therapy practice","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W7165626857","eid":"W7165626857"},{"id":"paper-w7117960482","cat":"papers","name":"Cannabis as an anti-psychedelic: effects on global functional connectivity and modularity","year":"2026","cit":0,"pfa":"N. Ertl","psa":"M.B. Wall","ptype":"article","src":"https://openalex.org/W7117960482","eid":"W7117960482"},{"id":"paper-w7163658178","cat":"papers","name":"One-shotted: Psychedelic insights are uniquely intense, meaningful, and ineffable","year":"2026","cit":0,"pfa":"Ambra Pogliani","psa":"Ruben Laukkonen","ptype":"preprint","src":"https://openalex.org/W7163658178","eid":"W7163658178"},{"id":"paper-w7128207761","cat":"papers","name":"Psychedelic Experience and Suzuki’s Zen Critique of Drug-Induced Satori","year":"2025","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W7128207761","eid":"W7128207761"},{"id":"paper-w7163146773","cat":"papers","name":"Tripping on context: Characteristics and predictors of placebo and nocebo psychedelic effects","year":"2026","cit":0,"pfa":"Madeline V. Stein","psa":"Devin Blair Terhune","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7163146773","eid":"W7163146773"},{"id":"paper-w3015535161","cat":"papers","name":"Psychedelic Guided Psychotherapy for Treatment of Depression and Bipolar Depression in Adults","year":"2020","cit":0,"pfa":"Lauren M. Blue","psa":"Jose A Rey","topics":["Depression","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3015535161","eid":"W3015535161"},{"id":"paper-w4403403650","cat":"papers","name":"Know Thy Non-Self: Meditation, Psychedelics, and Personal Identity","year":"2024","cit":0,"pfa":"Leigh Duffy","ptype":"book-chapter","src":"https://openalex.org/W4403403650","eid":"W4403403650"},{"id":"paper-w4415308979","cat":"papers","name":"Psychedelic preparation and integration through depth hypnosis spiritual counseling","year":"2025","cit":0,"pfa":"Joanna Foote Adler","psa":"Isa Gucciardi","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4415308979","eid":"W4415308979"},{"id":"paper-w4246356440","cat":"papers","name":"Pharmacokinetics II: 14C-Labelled Microdosing in Assessing Drug Pharmacokinetics at Phase 0","year":"2016","cit":0,"pfa":"Graham Lappin","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W4246356440","eid":"W4246356440"},{"id":"paper-w4411276301","cat":"papers","name":"Abstract 2719 Psychedelic control of neuroimmune interactions governing fear","year":"2025","cit":0,"pfa":"Catarina Rahal","psa":"Michael A. Wheeler","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W4411276301","eid":"W4411276301"},{"id":"paper-w2968587053","cat":"papers","name":"The World's First Psychedelic Jazz Concert - Psychedelia, Sydney, 1967","year":"2019","cit":0,"pfa":"Michael Organ","ptype":"article","src":"https://openalex.org/W2968587053","eid":"W2968587053"},{"id":"paper-w4294607193","cat":"papers","name":"Response to psychedelic drugs may depend on small genetic differences","year":"2022","cit":0,"pfa":"special to C EN Attabey Rodríguez Benítez","ptype":"article","src":"https://openalex.org/W4294607193","eid":"W4294607193"},{"id":"paper-w7160145885","cat":"papers","name":"Regulatory context for protocol amendments and public reporting in psychedelic trials","year":"2026","cit":0,"pfa":"Damian Świeczkowski","psa":"Wiesław Jerzy Cubała","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7160145885","eid":"W7160145885"},{"id":"paper-w7131413362","cat":"papers","name":"Rabbi Zalman Schachter-Shalomi Interview on Psychedelics Part 3","year":"2026","cit":0,"pfa":"University of Colorado Boulder","ptype":"other","src":"https://openalex.org/W7131413362","eid":"W7131413362"},{"id":"paper-w7140290710","cat":"papers","name":"Psychedelic-Induced Constraint Destabilization and Reconstruction as a Mechanism for Cognitive Reset","year":"2026","cit":0,"pfa":"Stanley Everett Sambey","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7140290710","eid":"W7140290710"},{"id":"paper-w4405621649","cat":"papers","name":"Absence of psychedelic effects: case series and systematic literature review","year":"2024","cit":0,"pfa":"Moritz Spangemacher","psa":"Max Wolff","topics":["Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4405621649","eid":"W4405621649"},{"id":"paper-w7112326938","cat":"papers","name":"Devaluation and revaluation as dynamic social processes: The case of psychedelic stigma","year":"2025","cit":0,"pfa":"Hannah Farrimond (21056447)","psa":"Michael Michael (21059978)","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7112326938","eid":"W7112326938"},{"id":"paper-w7214079166","cat":"papers","name":"A Multi-Site Evaluation of a Psychedelic Medicine Curriculum for Psychiatry Trainees","year":"2026","cit":0,"pfa":"Mary E. Yaden","psa":"Christopher Pittenger","ptype":"article","src":"https://openalex.org/W7214079166","eid":"W7214079166"},{"id":"paper-w4413644052","cat":"papers","name":"Psychedelic drug use linked to fewer mental health problems","year":"2013","cit":0,"ptype":"other","src":"https://openalex.org/W4413644052","eid":"W4413644052"},{"id":"paper-w4244450263","cat":"papers","name":"Chemists re-engineer a psychedelic to treat depression and addiction in rodents","year":"2020","cit":0,"pfa":"Robert F. Service","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W4244450263","eid":"W4244450263"},{"id":"paper-w4412675784","cat":"papers","name":"Psychedelics for the Treatment of Substance Use Disorders: A Narrative Review of the Literature","year":"2025","cit":0,"pfa":"Olivia Marcus","psa":"Brian R. Rush","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W4412675784","eid":"W4412675784"},{"id":"paper-w7113758903","cat":"papers","name":"Psychedelics usage among eating disorders: a literature scoping review.","year":"2025","cit":0,"pfa":"Giulia Cera","topics":["Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7113758903","eid":"W7113758903"},{"id":"paper-w4236525687","cat":"papers","name":"The World's First Psychedelic Jazz Concert - Psychedelia, Sydney, 1967","year":"2019","cit":0,"pfa":"Michael G. Organ","ptype":"article","src":"https://openalex.org/W4236525687","eid":"W4236525687"},{"id":"paper-w2002423626","cat":"papers","name":"Use of Psychedelics Among Miami's Public School Students, 1992","year":"2000","cit":0,"pfa":"Barbara M. Yarnold","ptype":"article","src":"https://openalex.org/W2002423626","eid":"W2002423626"},{"id":"paper-w7166556282","cat":"papers","name":"Journal Digest: Psychedelics and Migraine, Military Sexual Trauma, and More","year":"2026","cit":0,"pfa":"Terri D’Arrigo","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W7166556282","eid":"W7166556282"},{"id":"paper-w7135176477","cat":"papers","name":"Are Psychedelics Ethically Exceptional After All? Some Further Reflections","year":"2026","cit":0,"pfa":"Katherine Cheung","psa":"David B. Yaden","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7135176477","eid":"W7135176477"},{"id":"paper-w7213937243","cat":"papers","name":"Memory experiences under psychedelics – an exploratory prospective online study","year":"2026","cit":0,"pfa":"Samuli Kangaslampi","psa":"Kim P. C. Kuypers","topics":["PTSD & trauma","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W7213937243","eid":"W7213937243"},{"id":"paper-w4391175707","cat":"papers","name":"AI & robotics briefing: AlphaFold predicts thousands of possible psychedelics","year":"2024","cit":0,"pfa":"Katrina Krämer","ptype":"article","src":"https://openalex.org/W4391175707","eid":"W4391175707"},{"id":"paper-w7163759009","cat":"papers","name":"Fields, Not Switches A Monograph on Activation, Relation, and the Knot —Hallucinogenes---Psychedelics","year":"2026","cit":0,"pfa":"Schüller Thomas","ptype":"article","src":"https://openalex.org/W7163759009","eid":"W7163759009"},{"id":"paper-w2287308620","cat":"papers","name":"WATCHING THE FUTURE OF DRUGS AND HALLUCINOGENS AND THE ROLE OF I.R.I WOMEN POLICE IN DEALING WITH THE EFFECTIVE TRENDS","year":"2011","cit":0,"pfa":"Ehsani Bahman","psa":"Anami Ali","ptype":"article","src":"https://openalex.org/W2287308620","eid":"W2287308620"},{"id":"paper-w4389078443","cat":"papers","name":"Remembering to Forget: How the UK Disappeared from the Psychedelic Map","year":"2023","cit":0,"pfa":"Wendy Kline","ptype":"book-chapter","src":"https://openalex.org/W4389078443","eid":"W4389078443"},{"id":"paper-w4396760034","cat":"papers","name":"Hesychasm and Psychedelics: Altered States, Purgation, and the Question of Authentic Mysticism","year":"2024","cit":0,"pfa":"Thomas Cattoi","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4396760034","eid":"W4396760034"},{"id":"paper-w2611454749","cat":"papers","name":"PSYCHEDELIC & ENTHEOGENIC CONSCIOUSNESS IN Today’s WORLD: PRODUCING ANTHROPOLOGICAL UNDERSTANDINGS","year":"2014","cit":0,"pfa":"Marc G. Blainey","ptype":"article","src":"https://openalex.org/W2611454749","eid":"W2611454749"},{"id":"paper-w2981787637","cat":"papers","name":"Psychedelic agents : Changes induced in subjective experience and brain activity","year":"2019","cit":0,"pfa":"Louise Andersson","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"dissertation","src":"https://openalex.org/W2981787637","eid":"W2981787637"},{"id":"paper-w4409279683","cat":"papers","name":"Isolation of Psychedelic Responsive Neurons Underlying Anxiolytic Behavioral States","year":"2025","cit":0,"pfa":"Jessie Muir","psa":"Christina Eun-Young Kim","ptype":"article","src":"https://openalex.org/W4409279683","eid":"W4409279683"},{"id":"paper-w7135576370","cat":"papers","name":"Biotransformation, disposition and toxicological detection of psychedelic phenylalkylamine drugs of abused","year":"2010","cit":0,"pfa":"Miroslava Rohanová","topics":["Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7135576370","eid":"W7135576370"},{"id":"paper-w2612442146","cat":"papers","name":"A Psychedelic Sagaciousness into Victor’s Life: Khushwant Singh’s Burial at Sea","year":"2015","cit":0,"pfa":"Shalini Yadav","ptype":"article","src":"https://openalex.org/W2612442146","eid":"W2612442146"},{"id":"paper-w4413597217","cat":"papers","name":"Psychedelic drugs: how to tell good research from bad","year":"2022","cit":0,"pfa":"James Rucker","ptype":"other","src":"https://openalex.org/W4413597217","eid":"W4413597217"},{"id":"paper-w7104586572","cat":"papers","name":"PAREA: Psychedelic Access and Research European Alliance - EU Landscape","year":"2023","cit":0,"pfa":"Hawrot, Tadeusz","ptype":"article","src":"https://openalex.org/W7104586572","eid":"W7104586572"},{"id":"paper-w7163739923","cat":"papers","name":"The Emperor's New Diagnoses: Psychedelics, Psychosis, and the Limits of Psychiatric Distinctions","year":"2026","cit":0,"pfa":"Maja Willard","ptype":"preprint","src":"https://openalex.org/W7163739923","eid":"W7163739923"},{"id":"paper-w7202044613","cat":"papers","name":"Microdosing Tirzepatide in Multi‐Dose Pens: Clinical Individualization, Safety, and Evidence Gaps","year":"2026","cit":0,"pfa":"Fernando Vidal-Ostos De Lara","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7202044613","eid":"W7202044613"},{"id":"paper-w4415395057","cat":"papers","name":"Daoist Meditation as Guided Framework in Psychedelic Self-Care and Therapy","year":"2025","cit":0,"pfa":"Dominic Steavu","ptype":"book-chapter","src":"https://openalex.org/W4415395057","eid":"W4415395057"},{"id":"paper-w7134832612","cat":"papers","name":"The impact of microdosed plyometric training on speed and explosive abilities of football players during the pre-season","year":"2026","cit":0,"pfa":"Marián Škorik","psa":"Michal Hrubý","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"other","src":"https://openalex.org/W7134832612","eid":"W7134832612"},{"id":"paper-w7204684701","cat":"papers","name":"Constructing Mystical Experiences: a Critique of the Mystical Paradigm in Psychedelic Research","year":"2024","cit":0,"pfa":"Hollis Phelps","ptype":"article","src":"https://openalex.org/W7204684701","eid":"W7204684701"},{"id":"paper-w4406962359","cat":"papers","name":"8 Psychedelics, Sensory Isolation Tanks, and Dreamy Mental States","year":"2024","cit":0,"pfa":"Vladimir Miskovic","psa":"Steven Jay Lynn","ptype":"book-chapter","src":"https://openalex.org/W4406962359","eid":"W4406962359"},{"id":"paper-w7115883799","cat":"papers","name":"Letter to the Editor: PTSD, Psychedelics, Entity Encounters and the Precautionary Principle","year":"2025","cit":0,"pfa":"John Priestland","psa":"Daniel Weaver","topics":["PTSD & trauma"],"ptype":"letter","src":"https://openalex.org/W7115883799","eid":"W7115883799"},{"id":"paper-w4415356657","cat":"papers","name":"Eigenmodes of the deep unconscious: the neuropsychology of Jungian archetypes and psychedelic experience","year":"2025","cit":0,"pfa":"Hugh T. McGovern","psa":"Robin Lester Carhart-Harris","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4415356657","eid":"W4415356657"},{"id":"paper-w7171824477","cat":"papers","name":"Special Issue on the Promise of Psychedelic Pharmacology in Neuropsychiatric Drug Development","year":"2026","cit":0,"pfa":"Andreas Halman","psa":"Ross Corriden","topics":["Dosing & pharmacology"],"ptype":"editorial","src":"https://openalex.org/W7171824477","eid":"W7171824477"},{"id":"paper-w7135792912","cat":"papers","name":"The Psychedelic World of Textile Dyes in Spitalfields: The V&A Leman Silk","year":"2023","cit":0,"pfa":"L. Burgio","psa":"M.R.; id_orcid 0000-0002-8767-4360 van Bommel","ptype":"conference-paper","src":"https://openalex.org/W7135792912","eid":"W7135792912"},{"id":"paper-w7110557671","cat":"papers","name":"Experiences of Truth: A Comparative Contemplation of Jainism and the Western Psychedelic Experience","year":"2023","cit":0,"pfa":"Fiorella, Maya G","ptype":"article","src":"https://openalex.org/W7110557671","eid":"W7110557671"},{"id":"paper-w7171443505","cat":"papers","name":"Classic Psychedelics for Treating Chronic Pain: Mechanism and Clinical Translation","year":"2026","cit":0,"pfa":"Hongyu Chen","psa":"Ruotian Jiang","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7171443505","eid":"W7171443505"},{"id":"paper-w7213938410","cat":"papers","name":"THE DISINTEGRATION OF THE LOGOS IN VALENTIN DYADKA’S ALBUM “PSYCHEDELIC TABLE SONGS”","year":"2026","cit":0,"pfa":"Polina K. Matveeva","topics":["Anxiety & end-of-life","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7213938410","eid":"W7213938410"},{"id":"paper-w7162077657","cat":"papers","name":"Devaluation and Revaluation as Dynamic Social Processes: The Case of Psychedelic Stigma","year":"2026","cit":0,"pfa":"Hannah R. Farrimond","psa":"Mike Michael","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7162077657","eid":"W7162077657"},{"id":"paper-w4382727301","cat":"papers","name":"Correction: Standards Without Labs: Drug Development in the Psychedelic Underground","year":"2023","cit":0,"pfa":"John Bailey","psa":"Joanna Kempner","ptype":"erratum","src":"https://openalex.org/W4382727301","eid":"W4382727301"},{"id":"paper-w7165691166","cat":"papers","name":"The PsyCreativity Protocol: A Transdisciplinary Framework for Psychedelic-Enhanced Creative Practice","year":"2026","cit":0,"pfa":"Alexandra Maria Plesner","topics":["Therapy practice","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W7165691166","eid":"W7165691166"},{"id":"paper-w4244666044","cat":"papers","name":"Modernism, postmodernism, and the Grateful Dead: the evolution of the psychedelic avant-garde","year":"1996","cit":0,"pfa":"Jason Robert Noe","ptype":"dissertation","src":"https://openalex.org/W4244666044","eid":"W4244666044"},{"id":"paper-w2522629303","cat":"papers","name":"7. Are Psychedelics “the True Dharma”?: Debates, Presuppositions, and Philosophical Issues","year":"2016","cit":0,"pfa":"Douglas Osto","topics":["Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W2522629303","eid":"W2522629303"},{"id":"paper-w7158609111","cat":"papers","name":"What Trump’s psychedelics executive order means for basic neuroscience","year":"2026","cit":0,"pfa":"Calli McMurray","ptype":"article","src":"https://openalex.org/W7158609111","eid":"W7158609111"},{"id":"paper-w7153641283","cat":"papers","name":"Psychedelic Entity Encounters Under Anesthesia in the Early Twentieth Century","year":"2026","cit":0,"pfa":"Jacob Green","ptype":"article","src":"https://openalex.org/W7153641283","eid":"W7153641283"},{"id":"paper-w4400083715","cat":"papers","name":"Authors recommend stronger standards for informed consent to receive psychedelics","year":"2024","cit":0,"topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4400083715","eid":"W4400083715"},{"id":"paper-w956591304","cat":"papers","name":"Modernism, postmodernism, and the Grateful Dead: the evolution of the psychedelic avant-garde","year":"1996","cit":0,"pfa":"Jason Robert Noe","ptype":"dissertation","src":"https://openalex.org/W956591304","eid":"W956591304"},{"id":"paper-w2523119288","cat":"papers","name":"5. Closing the Door: The Fifth Precept and Graduating from Psychedelics","year":"2016","cit":0,"pfa":"Douglas Osto","ptype":"book-chapter","src":"https://openalex.org/W2523119288","eid":"W2523119288"},{"id":"paper-w4395959619","cat":"papers","name":"362. Mechanisms Underlying Psychedelic Effects on Stress-Induced Compulsivity","year":"2024","cit":0,"pfa":"Yanabah Jaques","psa":"Daniela Kaufer","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4395959619","eid":"W4395959619"},{"id":"paper-w407266146","cat":"papers","name":"The ancient Maya and hallucinogens : memoria de Primer Simposium International de Medicina Maya","year":"1992","cit":0,"pfa":"照夫 宮西","ptype":"book","src":"https://openalex.org/W407266146","eid":"W407266146"},{"id":"paper-w4394807565","cat":"papers","name":"Psychedelic drugs to treat post-traumatic stress disorder (PTSD)","year":"2024","cit":0,"pfa":"Stephen Russell Naulls","psa":"Sarah Bunn","topics":["PTSD & trauma"],"ptype":"report","src":"https://openalex.org/W4394807565","eid":"W4394807565"},{"id":"paper-w4413561676","cat":"papers","name":"Exploring Altered Realities: Unveiling the Effects of Psychedelics on Perception and Consciousness","year":"2024","cit":0,"pfa":"Sean Bogaty","psa":"Johnny Lopez-Figueroa","ptype":"article","src":"https://openalex.org/W4413561676","eid":"W4413561676"},{"id":"paper-w4403114316","cat":"papers","name":"NIH: Adults Still Using Marijuana and Psychedelics at Record Levels","year":"2024","cit":0,"pfa":"Samantha Anderer","ptype":"article","src":"https://openalex.org/W4403114316","eid":"W4403114316"},{"id":"paper-w4413493295","cat":"papers","name":"The psychedelic resurgence: Opportunities for behavioral and mental wellness and theory development","year":"2025","cit":0,"pfa":"Talea M. Cornelius","psa":"Pedro Rodrigues","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4413493295","eid":"W4413493295"},{"id":"paper-w7111782582","cat":"papers","name":"OPEN (Open Psychedelic Evaluation Nexus) - Online Research Materials","year":"2025","cit":0,"pfa":"Adie Wilson-Poe","psa":"Christopher Stauffer","ptype":"preprint","src":"https://openalex.org/W7111782582","eid":"W7111782582"},{"id":"paper-w2745937818","cat":"papers","name":"Ken Kesey's Psychedelic Bus trips over Owl's nest","year":"1967","cit":0,"pfa":"Barry J. Kaplan","ptype":"article","src":"https://openalex.org/W2745937818","eid":"W2745937818"},{"id":"paper-w4385669756","cat":"papers","name":"Evidence that Moved Psychedelic Medicine from the Fringe to the Mainstream in 2022","year":"2023","cit":0,"pfa":"Michael P. Bogenschutz","topics":["Mechanism & neuroscience","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4385669756","eid":"W4385669756"},{"id":"paper-w2888950397","cat":"papers","name":"Supple bodies, healthy minds: yoga meets psychedelics in the 1960s","year":"2018","cit":0,"pfa":"Lucas Richert","psa":"Matthew DeCloedt","ptype":"article","src":"https://openalex.org/W2888950397","eid":"W2888950397"},{"id":"paper-w7131383016","cat":"papers","name":"Rabbi Zalman Schachter-Shalomi Interview on Psychedelics Part 2","year":"2026","cit":0,"pfa":"University of Colorado Boulder","ptype":"other","src":"https://openalex.org/W7131383016","eid":"W7131383016"},{"id":"paper-w4390811557","cat":"papers","name":"Psychedelic drug helps treat PTSD and traumatic brain injuries","year":"2024","cit":0,"pfa":"Grace Wade","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4390811557","eid":"W4390811557"},{"id":"paper-w4235782883","cat":"papers","name":"How Do Psychedelic and Certain Other Drugs Affect the Brain?","year":"1998","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W4235782883","eid":"W4235782883"},{"id":"paper-w2183847358","cat":"papers","name":"Lieutenant Butterfly: exploring videogames through ordinary psychedelic play","year":"2015","cit":0,"pfa":"P. A. James","topics":["Policy & ethics"],"ptype":"other","src":"https://openalex.org/W2183847358","eid":"W2183847358"},{"id":"paper-w4283022244","cat":"papers","name":"Book Launch: Explosions in the Mind: Composing Psychedelic Sounds and Visualisations","year":"2022","cit":0,"pfa":"Jonathan Weinel","ptype":"conference-paper","src":"https://openalex.org/W4283022244","eid":"W4283022244"},{"id":"paper-w4408098561","cat":"papers","name":"Psychedelic drug studies face a potent source of bias: the ‘trip’","year":"2025","cit":0,"ptype":"dataset","src":"https://openalex.org/W4408098561","eid":"W4408098561"},{"id":"paper-w7131847043","cat":"papers","name":"Psychedelics are associated with changes in spiritual beliefs and orientations in US veterans","year":"2026","cit":0,"pfa":"Randi E. Brown","psa":"Maheen M. Adamson","ptype":"preprint","src":"https://openalex.org/W7131847043","eid":"W7131847043"},{"id":"paper-w7213556986","cat":"papers","name":"Factors for Assessing Employment-Based Risks of Participation in Psychedelic Research","year":"2026","cit":0,"pfa":"Rachel J. Topazian","psa":"Matthew DeCamp","topics":["Safety & adverse events"],"ptype":"editorial","src":"https://openalex.org/W7213556986","eid":"W7213556986"},{"id":"paper-w2748883007","cat":"papers","name":"New data on the treatment of bovine hypodermosis with metrifonate (Neguvon) and ivermectin (Ivomec) microdoses","year":"1997","cit":0,"pfa":"J.L. Charbon","psa":"K. Pfister","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2748883007","eid":"W2748883007"},{"id":"paper-w4417460526","cat":"papers","name":"Small study finds microdoses of cannabis stalled cognitive decline in Alzheimer’s patients","year":"2025","cit":0,"pfa":"Fabrício A. Pamplona","topics":["Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W4417460526","eid":"W4417460526"},{"id":"paper-w7166169681","cat":"papers","name":"PCR123 EMERGING PATTERNS OF GLP-1 MICRODOSING IN A LARGE REAL-WORLD POPULATION","year":"2026","cit":0,"pfa":"Ernesto Ramírez","psa":"Stephanie Jones","topics":["Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W7166169681","eid":"W7166169681"},{"id":"paper-w2004926430","cat":"papers","name":"Progestogen-only microdose followed by estrogen-progestogen combination, a new approach to oral contraception","year":"1982","cit":0,"pfa":"M Russowsky","psa":"J.N. Sartoretto","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2004926430","eid":"W2004926430"},{"id":"paper-w2368772140","cat":"papers","name":"Effect of Microdose Pingyangmycin and Routine Dose Pingyangmycin on Hemangioma in Oral and Maxillofacial Regions of Infants","year":"2010","cit":0,"pfa":"Jing Jie","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2368772140","eid":"W2368772140"},{"id":"paper-w7165969503","cat":"papers","name":"The intersection between psychedelics and schizophrenia spectrum disorders: Reevaluating risk and therapeutic potential","year":"2026","cit":0,"pfa":"Pavan S. Brar","psa":"Deepak K. Sarpal","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7165969503","eid":"W7165969503"},{"id":"paper-w3197552533","cat":"papers","name":"Zpráva z konference „Psychedelic Medicine in End-Of-Life Care“","year":"2021","cit":0,"pfa":"Jan Soukup","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3197552533","eid":"W3197552533"},{"id":"paper-w4409456234","cat":"papers","name":"Counting the uncountable: The critical quest to quantify psychedelic medicine's reach","year":"2025","cit":0,"pfa":"Júlio Licinio","ptype":"article","src":"https://openalex.org/W4409456234","eid":"W4409456234"},{"id":"paper-w4403959696","cat":"papers","name":"5 Psychedelic Agit-Pop: The Animated Films of Tadanori Yokoo","year":"2024","cit":0,"pfa":"Clint Enns","ptype":"book-chapter","src":"https://openalex.org/W4403959696","eid":"W4403959696"},{"id":"paper-w4408620859","cat":"papers","name":"Unveiling Reality: Psychedelics, Neural Filtering, and the Future of Psychiatric Medicine","year":"2025","cit":0,"pfa":"Robert B. Kargbo","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"editorial","src":"https://openalex.org/W4408620859","eid":"W4408620859"},{"id":"paper-w4412044630","cat":"papers","name":"Factors associated with psychedelic attitudes and usage among college students","year":"2025","cit":0,"pfa":"Wei‐Chin Hwang","psa":"Alvin Villarosa","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4412044630","eid":"W4412044630"},{"id":"paper-w7128705661","cat":"papers","name":"Investigating the psychedelic hypothesis of kykeon, the sacred elixir of the Eleusinian Mysteries","year":"2026","cit":0,"pfa":"Romanos Konstantinos Antonopoulos","psa":"Prokopios Magiatis","ptype":"article","src":"https://openalex.org/W7128705661","eid":"W7128705661"},{"id":"paper-w7170188208","cat":"papers","name":"President Trump signs executive order on therapeutic use of psychedelics.","year":"2026","cit":0,"pfa":"Karen M. Roush","ptype":"article","src":"https://openalex.org/W7170188208","eid":"W7170188208"},{"id":"paper-w7208813893","cat":"papers","name":"Psychedelic Knowledge and Attitudes Among Saudi Medical and Psychology Students","year":"2026","cit":0,"pfa":"Ahmed R. Alharbi","psa":"Omar A Alzahrani","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7208813893","eid":"W7208813893"},{"id":"paper-w3030962558","cat":"papers","name":"Effect of microdose apparatus infusionis and transfusion alarm device on the water control of ;humidification device","year":"2014","cit":0,"pfa":"蔡晓玉","psa":"喻薇","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3030962558","eid":"W3030962558"},{"id":"paper-w4390193082","cat":"papers","name":"Receptor specific mechanisms underlying psychedelic effects on affective behaviors","year":"2023","cit":0,"pfa":"Yanabah Jaques","psa":"Daniela Kaufer","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4390193082","eid":"W4390193082"},{"id":"paper-w4399994458","cat":"papers","name":"Professional Guidelines Needed To Shape Ethics of Psychedelic Use in Psychiatry","year":"2024","cit":0,"pfa":"Mark Moran","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4399994458","eid":"W4399994458"},{"id":"paper-w7213370192","cat":"papers","name":"Lived experience as systems-relevant evidence in psychedelic public health","year":"2026","cit":0,"pfa":"Pedram Dara","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7213370192","eid":"W7213370192"},{"id":"paper-w3160694146","cat":"papers","name":"REDUCED PSYCHEDELIC EFFECTS OF KETAMINE INFUSION AFTER ELECTROCONVULSIVE THERAPY: A REPORT ON THREE CASES.","year":"2020","cit":0,"pfa":"Emmanuel Kiiza Mwesiga","psa":"Seggane Musisi","ptype":"preprint","src":"https://openalex.org/W3160694146","eid":"W3160694146"},{"id":"paper-w2411987188","cat":"papers","name":"[Cytogenetic study of hallucinogens. Preliminary trial of lystergamide (LSD-25) on the culture of human leukocytes].","year":"1969","cit":0,"pfa":"P Genest","ptype":"article","src":"https://openalex.org/W2411987188","eid":"W2411987188"},{"id":"paper-w4404731507","cat":"papers","name":"Hallucinogens in different complex samples: Recent updates on pretreatment and analysis methods since 2017","year":"2024","cit":0,"pfa":"Jing Ma","psa":"Xuesong Feng","ptype":"article","src":"https://openalex.org/W4404731507","eid":"W4404731507"},{"id":"paper-w4412337649","cat":"papers","name":"Tripping back to Nature:Aldous Huxley, Psychedelics, and Pro-Technology Environmentalism","year":"2016","cit":0,"pfa":"Peter Mortensen","ptype":"article","src":"https://openalex.org/W4412337649","eid":"W4412337649"},{"id":"paper-w4414049558","cat":"papers","name":"Chris Elcock. Psychedelic New York: A History of LSD in the City","year":"2025","cit":0,"pfa":"Andrea Ens","ptype":"article","src":"https://openalex.org/W4414049558","eid":"W4414049558"},{"id":"paper-w7155369316","cat":"papers","name":"US Institutional Review Board Perspectives Regarding Psychedelic Research","year":"2026","cit":0,"pfa":"Jill Oliver Robinson","psa":"Holly Fernandez Lynch","topics":["Safety & adverse events","Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7155369316","eid":"W7155369316"},{"id":"paper-w4289755296","cat":"papers","name":"Faculty Opinions recommendation of Ketamine psychedelic and antinociceptive effects are connected.","year":"2022","cit":0,"pfa":"Harald Ihmsen","ptype":"peer-review","src":"https://openalex.org/W4289755296","eid":"W4289755296"},{"id":"paper-w7162336883","cat":"papers","name":"robhutto/psychedelic-co-use-thesis: v1.0.0 - Initial release","year":"2026","cit":0,"pfa":"robhutto","ptype":"software","src":"https://openalex.org/W7162336883","eid":"W7162336883"},{"id":"paper-w2346362088","cat":"papers","name":"Charge deposition model for investigating SE-microdose effect in trench power MOSFETs","year":"2015","cit":0,"pfa":"万欣","psa":"Jun Xu","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2346362088","eid":"W2346362088"},{"id":"paper-w7115341945","cat":"papers","name":"Recent findings on the use of psychedelic substance for therapeutic and research purpose","year":"2015","cit":0,"pfa":"Marić, Damjan","topics":["Addiction"],"ptype":"dissertation","src":"https://openalex.org/W7115341945","eid":"W7115341945"},{"id":"paper-w4407690314","cat":"papers","name":"Could psychedelics be fine-tuned to relieve anxiety but skip the ‘trip’?","year":"2025","cit":0,"pfa":"Cory A. Knox","psa":"Alex C. Kwan","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4407690314","eid":"W4407690314"},{"id":"paper-w7127095138","cat":"papers","name":"An international Delphi consensus for reporting of setting in psychedelic clinical trials","year":"2025","cit":0,"pfa":"Chloé Pronovost-Morgan","psa":"ReSPCT Experts","topics":["Addiction","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7127095138","eid":"W7127095138"},{"id":"paper-w7165985049","cat":"papers","name":"Evaluating the therapeutic potential of psychedelics in treating cocaine and heroin addiction","year":"2026","cit":0,"pfa":"Louise Keegan","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7165985049","eid":"W7165985049"},{"id":"paper-w7204571786","cat":"papers","name":"Psychedelics in the treatment of anorexia nervosa: a systematic review and meta-analysis","year":"2026","cit":0,"pfa":"Samin Daneshfar","psa":"Aida Rahimi","topics":["Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7204571786","eid":"W7204571786"},{"id":"paper-w4409999514","cat":"papers","name":"Get Psyched! An Empirical Analysis of Colorado’s Legalization of Psychedelic Drugs","year":"2025","cit":0,"pfa":"Adam Witham","psa":"Lillian Fitzgerald","topics":["Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W4409999514","eid":"W4409999514"},{"id":"paper-w2623085720","cat":"papers","name":"Coming Full Circle: Holotropic Breathwork’s Contribution to Psychedelic Medicine","year":"2014","cit":0,"pfa":"Diane Haug","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2623085720","eid":"W2623085720"},{"id":"paper-w2905322206","cat":"papers","name":"Psychedelics and Mental Health: A Study of Psychological Mechanisms of Therapeutic Action","year":"2018","cit":0,"pfa":"Adèle Lafrance","topics":["Mechanism & neuroscience"],"ptype":"dataset","src":"https://openalex.org/W2905322206","eid":"W2905322206"},{"id":"paper-w7125889392","cat":"papers","name":"Semiotics of Psychedelic Substances. From Traditional Contexts to Contemporary Practices","year":"2025","cit":0,"pfa":"L. Brunet","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7125889392","eid":"W7125889392"},{"id":"paper-w7162705863","cat":"papers","name":"The Possibility of Simulating Psychedelic Experiences in Virtual Reality Using Psyrreal","year":"2026","cit":0,"pfa":"Sandra Schihalejev","ptype":"dissertation","src":"https://openalex.org/W7162705863","eid":"W7162705863"},{"id":"paper-w7131417620","cat":"papers","name":"Rabbi Zalman Schachter-Shalomi Interview on Psychedelics Part 1","year":"2026","cit":0,"pfa":"University of Colorado Boulder","ptype":"other","src":"https://openalex.org/W7131417620","eid":"W7131417620"},{"id":"paper-w7165004124","cat":"papers","name":"Variability in AI-generated psychedelic definitions across major chatbots","year":"2026","cit":0,"pfa":"Zofia Kachlik","psa":"Michał Walaszek","ptype":"article","src":"https://openalex.org/W7165004124","eid":"W7165004124"},{"id":"paper-w7165890688","cat":"papers","name":"This Is Your Brain on Drugs: A Review of Chris Letheby’s Philosophy of Psychedelics","year":"2026","cit":0,"pfa":"Daniel Hirshberg","topics":["Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7165890688","eid":"W7165890688"},{"id":"paper-w7204960632","cat":"papers","name":"A signaling signature distinguishes hallucinogenic from non-hallucinogenic psychedelics","year":"2026","cit":0,"pfa":"Sandra M. Martin-Guerrero","psa":"Juan F. López‐Giménez","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7204960632","eid":"W7204960632"},{"id":"paper-w1546292824","cat":"papers","name":"Chemical enlightenment: Line up for the scientific, psychedelic mystical tour","year":"2006","cit":0,"pfa":"Bruce Bower","ptype":"article","src":"https://openalex.org/W1546292824","eid":"W1546292824"},{"id":"paper-w2761559560","cat":"papers","name":"'Who took the Drugs? Displaced Hallucinations in Psychedelic Fiction Films'","year":"2015","cit":0,"pfa":"Mark Broughton","ptype":"article","src":"https://openalex.org/W2761559560","eid":"W2761559560"},{"id":"paper-w4381785945","cat":"papers","name":"Psychedelics give mice second chance to learn social rewards","year":"2023","cit":0,"pfa":"Holly Barker","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4381785945","eid":"W4381785945"},{"id":"paper-w4405966440","cat":"papers","name":"Psychedelic enhancement of flexible learning weeks after a single dose","year":"2024","cit":0,"pfa":"Elizabeth J. Brouns","psa":"Omar J. Ahmed","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4405966440","eid":"W4405966440"},{"id":"paper-w4406934316","cat":"papers","name":"ED visit for psychedelic use confers increased risk of psychosis","year":"2025","cit":0,"topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4406934316","eid":"W4406934316"},{"id":"paper-w7154922814","cat":"papers","name":"How Psychedelics Came to Be Placed Under the Strictest International Control","year":"2026","cit":0,"pfa":"Måns Bergkvist","psa":"Björn Johnson","ptype":"article","src":"https://openalex.org/W7154922814","eid":"W7154922814"},{"id":"paper-w4400827674","cat":"papers","name":"Response to “Microdosing: A Conceptual Framework for Use as Programming Strategy for Resistance Training in Team Sports”","year":"2024","cit":0,"pfa":"José Afonso","psa":"Pedro Figueiredo","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4400827674","eid":"W4400827674"},{"id":"paper-w4394859521","cat":"papers","name":"Far Out: The Extended Denial of Public Access to Psychedelic Therapeutics","year":"2024","cit":0,"pfa":"Andrew R. Waldeck","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4394859521","eid":"W4394859521"},{"id":"paper-w7107958328","cat":"papers","name":"Psychedelics usage among eating disorders: a literature scoping review.","year":"2025","cit":0,"pfa":"Pignattai, Lara","psa":"Mendolicchio, Leonardo","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"other","src":"https://openalex.org/W7107958328","eid":"W7107958328"},{"id":"paper-w4415814108","cat":"papers","name":"Towards a Participatory Philosophical Religion: Foundations for a Sacramental Metaphysics of Psychedelics","year":"2025","cit":0,"pfa":"A Sahaf Kashani","topics":["Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4415814108","eid":"W4415814108"},{"id":"paper-w7160842158","cat":"papers","name":"Associations between psychedelic use and migraine history in Swedish twins","year":"2026","cit":0,"pfa":"Otto Simonsson","psa":"Miriam Anna Mosing","ptype":"article","src":"https://openalex.org/W7160842158","eid":"W7160842158"},{"id":"paper-w7167634932","cat":"papers","name":"The Limits of Psychedelic Transformation: Ben Wheatley’s A Field in England (2013)","year":"2026","cit":0,"pfa":"Jennifer S. Henke","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7167634932","eid":"W7167634932"},{"id":"paper-w4394518228","cat":"papers","name":"Additional file 1: of Microbial population dynamics under microdoses of the essential oil arborvitae","year":"2019","cit":0,"pfa":"Rhegan McGregor","psa":"Leigh Clark Latta IV","topics":["Dosing & pharmacology"],"ptype":"dataset","src":"https://openalex.org/W4394518228","eid":"W4394518228"},{"id":"paper-w7151396809","cat":"papers","name":"Whole-brain drug distribution profiles of psychedelic drugs provide insights into rapid antidepressant action","year":"2026","cit":0,"pfa":"Benjamin Hänisch","psa":"Sofie Louise Valk","topics":["Depression","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7151396809","eid":"W7151396809"},{"id":"paper-w7215618704","cat":"papers","name":"Research on psychedelics and their use in palliative care – an interview with MUDr. Tomáš Páleníček, Ph.D.: Research on psychedelics and their use in palliative care – an interview with MUDr. Tomáš Páleníček, Ph.D.","year":"2026","cit":0,"pfa":"Sara Anna Borzová","topics":["PTSD & trauma","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7215618704","eid":"W7215618704"},{"id":"paper-w2558649533","cat":"papers","name":"Microdose Effect in Commercial Trench Power MOSFETs and Its Impliacation to Several Mainstream Devices","year":"2011","cit":0,"pfa":"Fengqi Zhang","psa":"Dongsheng Lin","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2558649533","eid":"W2558649533"},{"id":"paper-w1981317467","cat":"papers","name":"Is there any clinical utility to measuring the estradiol flare during microdose (MCD) flare cycles?","year":"2014","cit":0,"pfa":"Taraneh Gharib Nazem","psa":"Alan S. Berkeley","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1981317467","eid":"W1981317467"},{"id":"paper-w2781486057","cat":"papers","name":"MICRODOSING/MICROTRACING CLINICAL TRIALS USING ACCELERATED MASS SPECTROMETRY IN CLINICAL DRUG DEVELOPMENT","year":"2018","cit":0,"pfa":"Mu Seong Ban","psa":"Howard Lee","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2781486057","eid":"W2781486057"},{"id":"paper-w4200351271","cat":"papers","name":"P.0728 Psychedelic approach to treatment resistant depression: ketamine way","year":"2021","cit":0,"pfa":"Francisco Dimitre Rodrigo Pereira Santos","psa":"M. Oliveira","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4200351271","eid":"W4200351271"},{"id":"paper-w3101277804","cat":"papers","name":"State-dependent learning (dissociation of learning). III. State-dependent learning with hallucinogens in rats","year":"1974","cit":0,"pfa":"Katsushi Yamada","psa":"Showa Ueki","ptype":"article","src":"https://openalex.org/W3101277804","eid":"W3101277804"},{"id":"paper-w2100015007","cat":"papers","name":"The Benefits of Psychedelic Drug Application for Clinical Treatment of Mental Illness","year":"2013","cit":0,"pfa":"Timothy Shumate","ptype":"article","src":"https://openalex.org/W2100015007","eid":"W2100015007"},{"id":"paper-w2523265528","cat":"papers","name":"6. Keeping the Door Open: Psychedelics as an Adjunct to Buddhist Practice","year":"2016","cit":0,"pfa":"Douglas Osto","ptype":"book-chapter","src":"https://openalex.org/W2523265528","eid":"W2523265528"},{"id":"paper-w4410536600","cat":"papers","name":"Repurposed Drugs of Abuse (Stimulants, Ketamine, and Psychedelics): Focus on Risks","year":"2025","cit":0,"pfa":"Breno Souza‐Marques","psa":"Lucas C. Quarantini","topics":["Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W4410536600","eid":"W4410536600"},{"id":"paper-w2915287168","cat":"papers","name":"Yes, the Psychedelic-Symphonic Cover, and “Every Little Thing” 1","year":"2018","cit":0,"pfa":"John Covach","ptype":"book-chapter","src":"https://openalex.org/W2915287168","eid":"W2915287168"},{"id":"paper-w7117541357","cat":"papers","name":"A Practical Approach and Framework to Quality Management for Psychedelic Drug Development","year":"2025","cit":0,"pfa":"Dawn Lundin","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7117541357","eid":"W7117541357"},{"id":"paper-w7140108333","cat":"papers","name":"Trip killers: Addressing a critical knowledge gap in psychedelic research","year":"2026","cit":0,"pfa":"Brian William O’Mahony","psa":"Níall Lally","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7140108333","eid":"W7140108333"},{"id":"paper-w7154491500","cat":"papers","name":"“I’ve Done My Research”: Psychedelics, PTSD, and the Therapeutic Alliance","year":"2026","cit":0,"pfa":"Dorothy E. Stubbe","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W7154491500","eid":"W7154491500"},{"id":"paper-w4250835677","cat":"papers","name":"Faculty Opinions recommendation of Psychedelic-inspired drug discovery using an engineered biosensor.","year":"2021","cit":0,"pfa":"Thomas Knöpfel","topics":["Depression","Mechanism & neuroscience"],"ptype":"peer-review","src":"https://openalex.org/W4250835677","eid":"W4250835677"},{"id":"paper-w4383906355","cat":"papers","name":"Unraveling Psychedelic Responses: Targeted Protein Degradation and Genetic Diversity","year":"2023","cit":0,"pfa":"Robert B. Kargbo","topics":["Therapy practice"],"ptype":"editorial","src":"https://openalex.org/W4383906355","eid":"W4383906355"},{"id":"paper-w4386301297","cat":"papers","name":"Unlocking the potential of psychedelics as medicine: Past obstacles and future outlooks","year":"2023","cit":0,"pfa":"Sharon Y. Kim","psa":"Leanna Kalinowski","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4386301297","eid":"W4386301297"},{"id":"paper-w4411583933","cat":"papers","name":"Ibn Arabi and the Imaginal World and Psychedelic Experiences: A Short Assay","year":"2025","cit":0,"pfa":"Ahmed Alarabi","ptype":"preprint","src":"https://openalex.org/W4411583933","eid":"W4411583933"},{"id":"paper-w7154751355","cat":"papers","name":"Epigenetic Mechanisms of Psychedelics in Addiction: Emerging Evidence and Therapeutic Potential","year":"2026","cit":0,"pfa":"Antonio Inserra","psa":"Giovanni Martinotti","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7154751355","eid":"W7154751355"},{"id":"paper-w3122927064","cat":"papers","name":"Review of Acid Revival: The Psychedelic Renaissance and the Quest for Medical Legitimacy","year":"2020","cit":0,"pfa":"Giffort Danielle","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3122927064","eid":"W3122927064"},{"id":"paper-w4280490183","cat":"papers","name":"Correction to: Psychedelics: Old trips, new destinations in psychopharmacology research","year":"2022","cit":0,"pfa":"Harriet de Wit","psa":"Deepak Cyril D’Souza","topics":["Dosing & pharmacology"],"ptype":"erratum","src":"https://openalex.org/W4280490183","eid":"W4280490183"},{"id":"paper-w7162331756","cat":"papers","name":"robhutto/psychedelic-co-use-thesis: v1.0.0 - Initial release","year":"2026","cit":0,"pfa":"robhutto","ptype":"software","src":"https://openalex.org/W7162331756","eid":"W7162331756"},{"id":"paper-w4213260101","cat":"papers","name":"Faculty Opinions recommendation of Impact of microdosing clinical study -- why necessary and how useful?","year":"2011","cit":0,"pfa":"Toshio Miyata","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"peer-review","src":"https://openalex.org/W4213260101","eid":"W4213260101"},{"id":"paper-w7147431623","cat":"papers","name":"Trippy tobacco? Plants engineered to make five psychedelics at once","year":"2026","cit":0,"ptype":"dataset","src":"https://openalex.org/W7147431623","eid":"W7147431623"},{"id":"paper-w334727334","cat":"papers","name":"Divine Inspiration? An Examination of the Impact of Hallucinogens on the Production of Imagery among some South American Populations","year":"1999","cit":0,"pfa":"Carol Anne Baker","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W334727334","eid":"W334727334"},{"id":"paper-w2008397046","cat":"papers","name":"Microdose Clinical Trial by Use of Radioisotope and Perspective of its Possible Utilization in Drug Development","year":"2009","cit":0,"pfa":"Tsuneo YANO","psa":"Yasuyoshi Watanabe","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2008397046","eid":"W2008397046"},{"id":"paper-w2011166054","cat":"papers","name":"In Vitro Fertilization Outcomes in Superpoor Responders: Effect of Microdose Human Chorionic Gonadotropin Boost","year":"2010","cit":0,"pfa":"Lauren Rubal","psa":"Richard J. Paulson","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2011166054","eid":"W2011166054"},{"id":"paper-w4240130506","cat":"papers","name":"Faculty Opinions recommendation of Pharmacokinetics of fexofenadine: evaluation of a microdose and assessment of absolute oral bioavailability.","year":"2010","cit":0,"pfa":"Geoffrey T. Tucker","topics":["Dosing & pharmacology"],"ptype":"peer-review","src":"https://openalex.org/W4240130506","eid":"W4240130506"},{"id":"paper-w4407076467","cat":"papers","name":"Microdosing Partial Agonists Inactivates Kappa Opioid Receptors - An Alternative Strategy for Human Trials","year":"2025","cit":0,"pfa":"Carlie Neiswanger","psa":"Charles Chavkin","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4407076467","eid":"W4407076467"},{"id":"paper-w2260301720","cat":"papers","name":"Effect of hallucinogens and psycholeptic drugs on blood pressure reflexes and behavioral reactions in nonanesthetized cats.","year":"1972","cit":0,"pfa":"G. A. Balint","ptype":"article","src":"https://openalex.org/W2260301720","eid":"W2260301720"},{"id":"paper-w2888191193","cat":"papers","name":"Chemical analysis of Argentine hallucinogens | [STUDIO CHIMICO DI UN ALLUCINOGENO AUTOCTONO ARGENTINO]","year":"1990","cit":0,"pfa":"Otmaro Enrique Roses","psa":"E. Saligari","ptype":"article","src":"https://openalex.org/W2888191193","eid":"W2888191193"},{"id":"paper-w7162794892","cat":"papers","name":"Differentiated Adsorption Modulation of Microdose Additive Enhances Stability and Kinetics in Zinc‐Ion Batteries","year":"2026","cit":0,"pfa":"X.C. Li","psa":"Lifeng Liu","topics":["Safety & adverse events","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7162794892","eid":"W7162794892"},{"id":"paper-w3168262834","cat":"papers","name":"Investigation for practical applications of the method to screen hallucinogens by observation of the head twitch response (HTR) in mice","year":"2021","cit":0,"pfa":"Mari Nakamura","ptype":"article","src":"https://openalex.org/W3168262834","eid":"W3168262834"},{"id":"paper-w4303633906","cat":"papers","name":"On the Treatment of a Patient with Ataxic Syndrome by Microdoses of Levo- and Carbo-Dopa. Post COVID Treatment","year":"2022","cit":0,"pfa":"G. Tarro","psa":"D. Raiderman","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4303633906","eid":"W4303633906"},{"id":"paper-w4362658901","cat":"papers","name":"Developing Psychedelic Fashion Illustrations through Mixed Media Techniques","year":"2023","cit":0,"pfa":"제주대학교 패션의류학과 강사","psa":"Ae-Ran Jang","ptype":"article","src":"https://openalex.org/W4362658901","eid":"W4362658901"},{"id":"paper-w4392718685","cat":"papers","name":"Chris Elcock,Psychedelic New York: A History of LSD in the City","year":"2024","cit":0,"pfa":"Zoë Dubus","ptype":"book-review","src":"https://openalex.org/W4392718685","eid":"W4392718685"},{"id":"paper-w1568989411","cat":"papers","name":"Abstract 2821: Dual-label microdosing approach to identify chemoresistance to carboplatin and gemcitabine combination chemotherapy","year":"2014","cit":0,"pfa":"Maike Zimmermann","psa":"Paul T. Henderson","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W1568989411","eid":"W1568989411"},{"id":"paper-w7124419760","cat":"papers","name":"The use of drospirenone-containing microdose combined oral contraceptive in young women in real clinical practice","year":"2025","cit":0,"pfa":"G. N. Minkina","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7124419760","eid":"W7124419760"},{"id":"paper-w2405113571","cat":"papers","name":"[Poisoning with narcotics and hallucinogens in material from the Clinic of Acute Poisoning in Lodz (1993-1996)].","year":"1997","cit":0,"pfa":"Małgorzata Kotwica","psa":"Anna Rogaczewska","ptype":"article","src":"https://openalex.org/W2405113571","eid":"W2405113571"},{"id":"paper-w2375186418","cat":"papers","name":"Combinative Treatment Effects of Perindopril and Valsartan on Microdose Proteinuria in Patients With the Combination of Hypertension and Diabetes Mellitns","year":"2012","cit":0,"pfa":"Wei Zhang","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2375186418","eid":"W2375186418"},{"id":"paper-w1965904270","cat":"papers","name":"Abstract 3522: A Phase 0 microdosing trial to identify chemoresistance: From bench to bedside","year":"2010","cit":0,"pfa":"Sisi Wang","psa":"Chong-xian Pan","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W1965904270","eid":"W1965904270"},{"id":"paper-w2245394831","cat":"papers","name":"Wood ash microdosing as fertiliser strategy for subsistence oriented and resource poor Sahelian farmers","year":"2011","cit":0,"pfa":"Ludger Herrmann","psa":"Joerg Szarzynski","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2245394831","eid":"W2245394831"},{"id":"paper-w2234016654","cat":"papers","name":"Hallucinating the End of History: Nishida, Zen, and the Psychedelic Eschaton by Cunningham, Eric","year":"2015","cit":0,"pfa":"Steve Odin","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2234016654","eid":"W2234016654"},{"id":"paper-w2775595782","cat":"papers","name":"War and Peace in the Rhetoric of the Psychedelic Revolution in the United States and the United Kingdom","year":"2017","cit":0,"pfa":"Andrzej Dorobek","ptype":"article","src":"https://openalex.org/W2775595782","eid":"W2775595782"},{"id":"paper-w7131832370","cat":"papers","name":"Debate: The high‐stakes debate: Promises and perils of psychedelics in addiction treatment","year":"2026","cit":0,"topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7131832370","eid":"W7131832370"},{"id":"paper-w2415027150","cat":"papers","name":"[On the comparative effectiveness of rifampicin and INI treatment in guinea pigs inoculated with repeated microdoses of bacilli].","year":"1968","cit":0,"pfa":"V Fabbrocini","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2415027150","eid":"W2415027150"},{"id":"paper-w2356368001","cat":"papers","name":"CLINICAL OBSERVATION OF MINIMAL SPINAL ANESTHESIA COMBINED WITH MICRODOSE OF MORPHINE FOR LOWER ABDOMINAL SURGERY","year":"2013","cit":0,"pfa":"Cai Jin-ka","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2356368001","eid":"W2356368001"},{"id":"paper-w3047950757","cat":"papers","name":"Nutrient Cycling in Microdose Fertilized West African Soils Under Indigenous Vegetable Production","year":"2020","cit":0,"pfa":"Gideon Gideon Olaleye","topics":["Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W3047950757","eid":"W3047950757"},{"id":"paper-w4319238266","cat":"papers","name":"Psychedelics used in the treatment and relief of symptoms in anxiety disorders: A Literature Review","year":"2023","cit":0,"pfa":"Leah Feulner","psa":"D. Galarneau","topics":["Anxiety & end-of-life","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4319238266","eid":"W4319238266"},{"id":"paper-w4236296468","cat":"papers","name":"Faculty Opinions recommendation of Structure of a Hallucinogen-Activated Gq-Coupled 5-HT2A Serotonin Receptor.","year":"2021","cit":0,"pfa":"Joël Bockaert","topics":["Mechanism & neuroscience"],"ptype":"peer-review","src":"https://openalex.org/W4236296468","eid":"W4236296468"},{"id":"paper-w2406988124","cat":"papers","name":"[Endoscopic changes in the stomach and duodenal mucosa caused by microdose acetylsalicylic acid therapy and their prevention--editorial].","year":"2007","cit":0,"pfa":"Jiøí Ehrmann","psa":"Karel Urbánek","topics":["Dosing & pharmacology"],"ptype":"letter","src":"https://openalex.org/W2406988124","eid":"W2406988124"},{"id":"paper-w4414839573","cat":"papers","name":"2.79 National Trends in Hallucinogen-Related Admissions in Children, Adolescents, and Young Adults: 2016-2023","year":"2025","cit":0,"pfa":"Jacob T. Steinle","psa":"Kevin Young Xu","ptype":"article","src":"https://openalex.org/W4414839573","eid":"W4414839573"},{"id":"paper-w2391852243","cat":"papers","name":"MICRODOSE X-RAY RADIATION ON PITUITARY GLAND AREA TO TREAT BENIGN PROSTATIC HYPERPLASIA","year":"1997","cit":0,"pfa":"Xueyi Wang","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2391852243","eid":"W2391852243"},{"id":"paper-w2273990896","cat":"papers","name":"LC/MS/MS Methods for Determining Drug Metabolites in Human Microdose Plasma Samples","year":"2010","cit":0,"pfa":"김상구","psa":"윤영란","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2273990896","eid":"W2273990896"},{"id":"paper-w4389006943","cat":"papers","name":"Effects of serotonergic hallucinogen R (−)‐2,5‐Dimethoxy‐4‐iodoamphetamine (DOI) on temporal discrimination in mice","year":"2017","cit":0,"pfa":"Michael P Trahan","psa":"William E. Fantegrossi","topics":["Depression","PTSD & trauma","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4389006943","eid":"W4389006943"},{"id":"paper-w4287424186","cat":"papers","name":"Les microdoses de sucres : une stratégie de biocontrôle chez la vigne ?","year":"2021","cit":0,"pfa":"Lucile Jacquens","psa":"Sophie Trouvelot","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4287424186","eid":"W4287424186"},{"id":"paper-w4232155435","cat":"papers","name":"Psychotomimetics","year":"2008","cit":0,"pfa":"Marc D. Binder","psa":"Uwe Windhorst","ptype":"reference-entry","src":"https://openalex.org/W4232155435","eid":"W4232155435"},{"id":"paper-w4233503728","cat":"papers","name":"Isaac Hayes and Hot Buttered (Orchestral) Soul, from Psychedelic to Progressive","year":"2021","cit":0,"ptype":"book-chapter","src":"https://openalex.org/W4233503728","eid":"W4233503728"},{"id":"paper-w4391788990","cat":"papers","name":"From Improvisation to Play to the Psychedelic: Discussion of Laura D’Angelo’s “The Loaded Chamber”","year":"2024","cit":0,"pfa":"Philip A. Ringstrom","ptype":"article","src":"https://openalex.org/W4391788990","eid":"W4391788990"},{"id":"paper-w7167055936","cat":"papers","name":"Beyond Brain Connectivity: Psychedelics Neuroscience and the Electromagnetic Foundations of Conscious Experience","year":"2026","cit":0,"pfa":"Abdullah A. A. Alabdulgader","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7167055936","eid":"W7167055936"},{"id":"paper-w7163636616","cat":"papers","name":"From Exotic to Indigenous: Psychedelic Plants and Fungi in Countercultural Japanese Media","year":"2026","cit":0,"pfa":"Jon L. Pitt","ptype":"article","src":"https://openalex.org/W7163636616","eid":"W7163636616"},{"id":"paper-w4396997437","cat":"papers","name":"CYP3A and Drug Transporter Activity Changes in Thai Elderly with CKD Assessed Using a Microdose Cocktail","year":"2020","cit":0,"pfa":"Punyabhorn Rattanacheeworn","psa":"Pajaree Chariyavilaskul","topics":["Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W4396997437","eid":"W4396997437"},{"id":"paper-w4375839744","cat":"papers","name":"How to Outsmart Your Boss on buy real psychedelics online cheap","year":"2023","cit":0,"pfa":"elwinnfordtts","ptype":"article","src":"https://openalex.org/W4375839744","eid":"W4375839744"},{"id":"paper-w4389154169","cat":"papers","name":"In Silico Studies for the Analysis of Psychedelic Substances with Potential Activity for the Treatment of Epilepsy","year":"2023","cit":0,"pfa":"Natália Reis dos Toscano","psa":"Lorane Izabel da Silva Hage-Melim","topics":["Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W4389154169","eid":"W4389154169"},{"id":"paper-w4401395985","cat":"papers","name":"Psychedelic New York: A History of LSD in the City by Chris Elcock (review)","year":"2024","cit":0,"topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4401395985","eid":"W4401395985"},{"id":"paper-w7203554354","cat":"papers","name":"Is There a Relationship Between Big 5 Personality Traits And Reasons for Use of Psychedelics?","year":"2026","cit":0,"pfa":"Kaytee Younker","psa":"Kristine Jacquin","ptype":"article","src":"https://openalex.org/W7203554354","eid":"W7203554354"},{"id":"paper-w2276832181","cat":"papers","name":"[Endometrial study made during the continuous administration of microdoses of 30 micrograms of d-norgestrel].","year":"1970","cit":0,"pfa":"Ramona Alvarado","psa":"Castillo Jd","topics":["Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W2276832181","eid":"W2276832181"},{"id":"paper-w2315041153","cat":"papers","name":"Simultaneous Contrast phenomena of Psychedelic color and the correlation of brain cognitive research","year":"2013","cit":0,"pfa":"Hye‐Kyung Lee","ptype":"article","src":"https://openalex.org/W2315041153","eid":"W2315041153"},{"id":"paper-w2806365294","cat":"papers","name":"Sweden’s GOD MOTHER release new psychedelic video for their song “Weak”","year":"2017","cit":0,"pfa":"Karol Adam Kamiński","ptype":"article","src":"https://openalex.org/W2806365294","eid":"W2806365294"},{"id":"paper-w2801905070","cat":"papers","name":"Thee Commons: Psychedelic Cumbia Punk from East Los Angeles","year":"2018","cit":0,"pfa":"Jack Sample","ptype":"article","src":"https://openalex.org/W2801905070","eid":"W2801905070"},{"id":"paper-w4413553837","cat":"papers","name":"Psychedelic experiences disrupt routine thinking — and so has the coronavirus pandemic","year":"2020","cit":0,"pfa":"Ron Joseph Shore","ptype":"other","src":"https://openalex.org/W4413553837","eid":"W4413553837"},{"id":"paper-w4393269793","cat":"papers","name":"7. Psychedelic Wars: LSD as Mental Medicine in a Battle for Hearts and Minds","year":"2021","cit":0,"pfa":"Lucas Richert","psa":"A.J. Turner","ptype":"book-chapter","src":"https://openalex.org/W4393269793","eid":"W4393269793"},{"id":"paper-w4413634976","cat":"papers","name":"Psychedelics could make mental health worse in people with a personality disorder","year":"2024","cit":0,"pfa":"Pouya Movahed","ptype":"other","src":"https://openalex.org/W4413634976","eid":"W4413634976"},{"id":"paper-w7133332113","cat":"papers","name":"As Psychedelic Treatments Get Leaner, Patients’ Social Environments Deserve Attention","year":"2026","cit":0,"pfa":"Edward Jacobs","psa":"Hattie Wells","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W7133332113","eid":"W7133332113"},{"id":"paper-w7125936298","cat":"papers","name":"Neural Correlates of Mystical Language: From Psychedelic Narratives to Naturalistic fMRI","year":"2026","cit":0,"pfa":"Jeremy I Skipper","psa":"Agathe Fauchille","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7125936298","eid":"W7125936298"},{"id":"paper-w7167943561","cat":"papers","name":"What is the mechanism of action by which psychedelics treat major depressive disorder?","year":"2026","cit":0,"pfa":"Tripdatabase","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7167943561","eid":"W7167943561"},{"id":"paper-w4402655473","cat":"papers","name":"Disintegrating and reintegrating the self—(in)flexible self-models in depersonalization and psychedelic experiences","year":"2024","cit":0,"pfa":"Anna Ciaunica","psa":"Adam Safron","topics":["Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W4402655473","eid":"W4402655473"},{"id":"paper-w2600093093","cat":"papers","name":"“Keys to Words that are already there”: Chief Bromden’s Psychedelic Journey towards Redemption","year":"2016","cit":0,"pfa":"Mongia Besbes","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W2600093093","eid":"W2600093093"},{"id":"paper-w3043487285","cat":"papers","name":"How setting variables mediate psychedelic experiences with lasting effects on wellbeing","year":"2018","cit":0,"pfa":"D.E. de Wied","ptype":"dissertation","src":"https://openalex.org/W3043487285","eid":"W3043487285"},{"id":"paper-w2886334174","cat":"papers","name":"By Physically Restructuring The Brain, Psychedelics Could Become A Potential Treatment For Depression","year":"2018","cit":0,"pfa":"Mohendra Shiwnarain","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2886334174","eid":"W2886334174"},{"id":"paper-w2979470983","cat":"papers","name":"Psychedelic psychiatry, breast cancer, and a paean to the emperor penguin: Books in brief","year":"2019","cit":0,"pfa":"Barbara Kiser","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2979470983","eid":"W2979470983"},{"id":"paper-w7135012601","cat":"papers","name":"Should we be using psychedelics or dissociatives to treat mental health conditions?","year":"2026","cit":0,"pfa":"Cassidy O'Brien","psa":"Sabrina Fields","topics":["Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W7135012601","eid":"W7135012601"},{"id":"paper-w7162193794","cat":"papers","name":"Mapping Non-Prescription Pre-Session Support across Psychedelic Substances","year":"2026","cit":0,"pfa":"Elias Rubenstein","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7162193794","eid":"W7162193794"},{"id":"paper-w2909622985","cat":"papers","name":"SPECTROSCOPIC CHARACTERIZATION OF A NEW HALLUCINOGEN : 1-(2,5-DIMETHOXY- 4-NITROPHENYL)-2-AHINOPP.OPANE (DON).","year":"1986","cit":0,"pfa":"Juan Gómez Jeria","psa":"Juan Carlos Saavedra Aguilar","ptype":"article","src":"https://openalex.org/W2909622985","eid":"W2909622985"},{"id":"paper-w7134258877","cat":"papers","name":"The Double Standard in Interpreting MEG Power Changes: Anaesthesia vs. Psychedelics","year":"2026","cit":0,"pfa":"Maarten Vergucht","ptype":"preprint","src":"https://openalex.org/W7134258877","eid":"W7134258877"},{"id":"paper-w4400692432","cat":"papers","name":"Editorial: Incorporating Phase 0 microdosing as a powerful tool into a new vision of drug development","year":"2024","cit":0,"pfa":"H. Weiss","psa":"Esther van Duijn","topics":["Safety & adverse events","Dosing & pharmacology","Therapy practice"],"ptype":"editorial","src":"https://openalex.org/W4400692432","eid":"W4400692432"},{"id":"paper-w3025270374","cat":"papers","name":"Trippy Sounds: Recording Studio Effects of Psychedelic Rock, 1960s and Present","year":"2020","cit":0,"pfa":"Theo Farnum","ptype":"article","src":"https://openalex.org/W3025270374","eid":"W3025270374"},{"id":"paper-w4200257327","cat":"papers","name":"Addendum to “A Qualitative Exploration of Relational Ethical Challenges and Practices in Psychedelic Healing”","year":"2021","cit":0,"topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4200257327","eid":"W4200257327"},{"id":"paper-w4296750612","cat":"papers","name":"Efficacy of psychedelics in animal models of binge drinking and alcohol use disorder","year":"2022","cit":0,"pfa":"Jérôme Jeanblanc","psa":"Mickaël Naassïla","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4296750612","eid":"W4296750612"},{"id":"paper-w7124426047","cat":"papers","name":"Sociodemographic and clinical correlates of drug testing use among psychedelic users","year":"2026","cit":0,"pfa":"Lev Korchagin","psa":"Shaul Lev‐Ran","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7124426047","eid":"W7124426047"},{"id":"paper-w4399577940","cat":"papers","name":"Mindbending Drugs: Psychedelics, Cannabis, and Physician Leadership with Dr. Jeffrey Lieberman","year":"2024","cit":0,"pfa":"M Sacopulos","psa":"Joseph A. Lieberman","ptype":"dataset","src":"https://openalex.org/W4399577940","eid":"W4399577940"},{"id":"paper-w359781391","cat":"papers","name":"A quantitative aspect of charge-transfer phenomenon in the biological activity of hallucinogens, local anesthetics and nicotinic agents","year":"1979","cit":0,"pfa":"S.P. Gupta","psa":"Prithvi Singh","ptype":"article","src":"https://openalex.org/W359781391","eid":"W359781391"},{"id":"paper-w4413543588","cat":"papers","name":"Being admitted to hospital after taking hallucinogens increases the risk of schizophrenia more than threefold","year":"2024","cit":0,"pfa":"Colin Davidson","topics":["Safety & adverse events"],"ptype":"other","src":"https://openalex.org/W4413543588","eid":"W4413543588"},{"id":"paper-w51636690","cat":"papers","name":"Intranasally delivered microdoses of bromocriptine (BCR) effectively reduced serum prolactin levels in hyperprolactinemic patients","year":"1995","cit":0,"pfa":"Ramachandran Suresh","psa":"Moudgal Nr","topics":["Dosing & pharmacology"],"ptype":"editorial","src":"https://openalex.org/W51636690","eid":"W51636690"},{"id":"paper-w4411509319","cat":"papers","name":"A Narrative Review of the Relationship Between Psychedelic Use and Development in Emerging Adulthood","year":"2025","cit":0,"pfa":"Jake Payne","psa":"Greg Murray","topics":["Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4411509319","eid":"W4411509319"},{"id":"paper-w4366982132","cat":"papers","name":"Implications from Jaworska’s Account of Autonomy and Self for Dementia and Psychedelic Research","year":"2023","cit":0,"pfa":"Zak A. Kopeikin","ptype":"article","src":"https://openalex.org/W4366982132","eid":"W4366982132"},{"id":"paper-w4375839592","cat":"papers","name":"The Biggest Trends in buy pure psychedelics online We've Seen This Year","year":"2023","cit":0,"pfa":"pjetusforewss","topics":["Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4375839592","eid":"W4375839592"},{"id":"paper-w2807819896","cat":"papers","name":"Ákos Deri goes dark and psychedelic in the newest record from BERRILOOM","year":"2016","cit":0,"pfa":"Karol Adam Kamiński","ptype":"article","src":"https://openalex.org/W2807819896","eid":"W2807819896"},{"id":"paper-w4411877926","cat":"papers","name":"Fast‐acting psychedelic shows antidepressant effects in Phase 2A trial","year":"2025","cit":0,"topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4411877926","eid":"W4411877926"},{"id":"paper-w7164826955","cat":"papers","name":"Dextromethorphan Beyond the Cough: Exploring Its Psychedelic Potential: A Systematic Review","year":"2026","cit":0,"pfa":"Edward P. Hackett","psa":"Robert H. Dworkin","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W7164826955","eid":"W7164826955"},{"id":"paper-w4240742271","cat":"papers","name":"Book reviews: Psychedelic drugs reconsidered; LSD psychotherapy; Plants of the Gods","year":"1981","cit":0,"pfa":"Walter Houston Clark","topics":["Reviews & meta-analyses","Therapy practice"],"ptype":"book-review","src":"https://openalex.org/W4240742271","eid":"W4240742271"},{"id":"paper-w4307659057","cat":"papers","name":"Obstacles and opportunities: how psychedelic medicine can rise to its challenges","year":"2022","cit":0,"ptype":"article","src":"https://openalex.org/W4307659057","eid":"W4307659057"},{"id":"paper-w7161005472","cat":"papers","name":"[NECS 2026] Hallucination on Screen: From Psychiatric Archives to Psychedelic Media","year":"2026","cit":0,"pfa":"Mireille Berton","ptype":"other","src":"https://openalex.org/W7161005472","eid":"W7161005472"},{"id":"paper-w4205196725","cat":"papers","name":"Psychotomimetic","year":"2021","cit":0,"ptype":"reference-entry","src":"https://openalex.org/W4205196725","eid":"W4205196725"},{"id":"paper-w1513929854","cat":"papers","name":"The Psychedelic Movement, Fantasy, and Anarchism inThe Crying of Lot 49andAgainst the Day*","year":"2014","cit":0,"pfa":"Joanna Freer","ptype":"book-chapter","src":"https://openalex.org/W1513929854","eid":"W1513929854"},{"id":"paper-w4230882805","cat":"papers","name":"One billion COVID vaccines, psychedelic sensor and COVID transmission halved","year":"2021","cit":0,"ptype":"article","src":"https://openalex.org/W4230882805","eid":"W4230882805"},{"id":"paper-w4409315497","cat":"papers","name":"Translating Innovations in Psychedelic Palliative Research Into Clinical Practice for HPM Providers","year":"2025","cit":0,"pfa":"Jessi Humphreys","psa":"Yvan Beaussant","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4409315497","eid":"W4409315497"},{"id":"paper-w7202251238","cat":"papers","name":"Opposite network patterns of integration-segregation in psychedelic and sedated states of consciousness","year":"2026","cit":0,"pfa":"Rui Dai","psa":"George A. Mashour","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7202251238","eid":"W7202251238"},{"id":"paper-w7112608212","cat":"papers","name":"Psychedelic metamorphosis : A study of conceptual transformation within the discourse on psychedelia in Sweden.","year":"2021","cit":0,"pfa":"Olsson, William","topics":["Depression","Addiction"],"ptype":"dissertation","src":"https://openalex.org/W7112608212","eid":"W7112608212"},{"id":"paper-w4411277886","cat":"papers","name":"From Stimulant to Psychedelic: The Changing Use and Repression of Cannabis in Franco’s Spain","year":"2025","cit":0,"pfa":"Joshua Hill","ptype":"book-chapter","src":"https://openalex.org/W4411277886","eid":"W4411277886"},{"id":"paper-w4417263039","cat":"papers","name":"The Promise and the Paradox: Exploring Eating Disorder Discourse in Psychedelic Reddit Communities","year":"2025","cit":0,"pfa":"Fatiha Shannon","psa":"Cass Dykeman","ptype":"preprint","src":"https://openalex.org/W4417263039","eid":"W4417263039"},{"id":"paper-w7130521885","cat":"papers","name":"The Twelve-Thousand-Dollar Question: Who Picks Up The Tab For Psychedelics?","year":"2026","cit":0,"pfa":"Vincent Joralemon","ptype":"dataset","src":"https://openalex.org/W7130521885","eid":"W7130521885"},{"id":"paper-w7140057007","cat":"papers","name":"The toxicology and characteristics of fatal new psychoactive stimulant and hallucinogen-related poisonings in Australia, 2000–2025","year":"2026","cit":0,"pfa":"Shane G Darke","psa":"Amy Peacock","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7140057007","eid":"W7140057007"},{"id":"paper-w4298444421","cat":"papers","name":"Papers presented at the Committee on Problems of Drug Dependence Symposium on Stimulants and Hallucinogens. June/September, 1984.","year":"1986","cit":0,"ptype":"article","src":"https://openalex.org/W4298444421","eid":"W4298444421"},{"id":"paper-w2003394389","cat":"papers","name":"Is Microdose GNRH Agonist in the Absence of Exogenous Gonadotropins Sufficient to Achieve Multiple Ovarian Follicle Development?","year":"2008","cit":0,"pfa":"Karine Chung","psa":"Richard J. Paulson","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2003394389","eid":"W2003394389"},{"id":"paper-w7169649739","cat":"papers","name":"Optimizing soybean–maize intercropping through arbuscular mycorrhiza–rhizobia inoculation and fertilizer microdosing in Benin","year":"2026","cit":0,"pfa":"Brice G. Sinhouenon","psa":"Pierre Bertin","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7169649739","eid":"W7169649739"},{"id":"paper-w2020097912","cat":"papers","name":"20 INVITED Phase 0 microdosing studies as part of the learn/confirm approach to drug development","year":"2008","cit":0,"pfa":"Colin R. Garner","topics":["Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W2020097912","eid":"W2020097912"},{"id":"paper-w2411603120","cat":"papers","name":"[Survey on the usage of psychodysleptics (hallucinogens) in the colleges and universities of the province of Quebec. II. Methodology and preliminary results].","year":"1969","cit":0,"pfa":"Simone Radouco-Thomas","psa":"Corneille Radouco-Thomas","ptype":"article","src":"https://openalex.org/W2411603120","eid":"W2411603120"},{"id":"paper-w7134839456","cat":"papers","name":"The impact of microdosed plyometric training on speed and explosive abilities of football players during the pre-season","year":"2026","cit":0,"pfa":"Marián Škorik","psa":"Michal Hrubý","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"other","src":"https://openalex.org/W7134839456","eid":"W7134839456"},{"id":"paper-w3209485635","cat":"papers","name":"HUMAN MICRODOSING AND MICE XENOGRAFT DATA OF AGM-130 APPLIED TO SIMULATE EFFICACIOUS DOSES IN PATIENTS","year":"2017","cit":0,"pfa":"WSPark Park","psa":"DSYim Yim","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3209485635","eid":"W3209485635"},{"id":"paper-w4410827606","cat":"papers","name":"Editorial proposes clinical trials with psychedelics for 16‐ to 17‐year olds","year":"2025","cit":0,"pfa":"Alison Knopf","ptype":"editorial","src":"https://openalex.org/W4410827606","eid":"W4410827606"},{"id":"paper-w7136503554","cat":"papers","name":"Editorial: Psychedelic substances and neurological diseases: from basics to clinical application","year":"2026","cit":0,"pfa":"Alessandra Linardi","psa":"Rodrigo Portes Ureshino","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"editorial","src":"https://openalex.org/W7136503554","eid":"W7136503554"},{"id":"paper-w7140223408","cat":"papers","name":"Modulating the Thermodynamics and Kinetics of Psychedelics at Serotonin Receptors via Terahertz Waves","year":"2026","cit":0,"pfa":"Cong Zhang","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7140223408","eid":"W7140223408"},{"id":"paper-w7166438133","cat":"papers","name":"Supporting Data and Regulatory Analysis Tools for the Assessment of Psychedelic Clinical Trials","year":"2026","cit":0,"pfa":"Damian Świeczkowski","topics":["Policy & ethics"],"ptype":"dataset","src":"https://openalex.org/W7166438133","eid":"W7166438133"},{"id":"paper-w2275288682","cat":"papers","name":"Jealous Guardians in the Psychedelic Kingdom: Federal Regulation of Electricity Contracts in Bankruptcy","year":"2004","cit":0,"pfa":"Indraneel Sur","topics":["Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2275288682","eid":"W2275288682"},{"id":"paper-w4234253041","cat":"papers","name":"Supplemental Material for States and Traits Related to the Quality and Consequences of Psychedelic Experiences","year":"2018","cit":0,"ptype":"supplementary-materials","src":"https://openalex.org/W4234253041","eid":"W4234253041"},{"id":"paper-w4366983261","cat":"papers","name":"Avoiding the Premature Introduction of Psychedelic Medicines in Alzheimer’s Disease and Related Disorders","year":"2023","cit":0,"pfa":"Adrian Carter","psa":"John Gardner","topics":["Depression","Anxiety & end-of-life"],"ptype":"editorial","src":"https://openalex.org/W4366983261","eid":"W4366983261"},{"id":"paper-w7155358471","cat":"papers","name":"Serotonergic psychedelics for Autism spectrum disorder: Neurobiological mechanisms and translational prospects","year":"2026","cit":0,"pfa":"Zhen Xuen Brandon Low","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7155358471","eid":"W7155358471"},{"id":"paper-w7148417444","cat":"papers","name":"Micro-Dosing Psychedelics and Creative Problem-Solving: An Umbrella Review (v7.0)","year":"2026","cit":0,"pfa":"Juan Moises de la Serna","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7148417444","eid":"W7148417444"},{"id":"paper-w7214052077","cat":"papers","name":"Layer-resolved cortical signatures of self-dissolution across psychedelics and meditation","year":"2026","cit":0,"pfa":"Pablo-Alexandre Mallaroni","psa":"Pedro Mediano","ptype":"article","src":"https://openalex.org/W7214052077","eid":"W7214052077"},{"id":"paper-w4394126517","cat":"papers","name":"Additional file 3: of Microbial population dynamics under microdoses of the essential oil arborvitae","year":"2019","cit":0,"pfa":"Rhegan McGregor","psa":"Leigh Clark Latta IV","topics":["Dosing & pharmacology"],"ptype":"dataset","src":"https://openalex.org/W4394126517","eid":"W4394126517"},{"id":"paper-w2528087466","cat":"papers","name":"Unlocking the Traumatic through the Psychedelic in One Flew over the Cuckoo's Nest","year":"2016","cit":0,"pfa":"Mongia Besbes","topics":["PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2528087466","eid":"W2528087466"},{"id":"paper-w4282928170","cat":"papers","name":"David Axelrod and the Electric Prunes' psychedelic Mass in F Minor (1967)","year":"2022","cit":0,"pfa":"Stephanie Rocke","ptype":"book-chapter","src":"https://openalex.org/W4282928170","eid":"W4282928170"},{"id":"paper-w4399990165","cat":"papers","name":"Psychedelic Patriotism: Peter Max Sparks a Debate on Modern Representations of America","year":"2024","cit":0,"pfa":"David D. McKinney","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4399990165","eid":"W4399990165"},{"id":"paper-w7148596598","cat":"papers","name":"Micro-Dosing Psychedelics and Creative Problem-Solving: An Umbrella Review (v7.0)","year":"2026","cit":0,"pfa":"Juan Moises de la Serna","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7148596598","eid":"W7148596598"},{"id":"paper-w2957740811","cat":"papers","name":"Simultaneous Contrast phenomena of Psychedelic color and the correlation of brain cognitive research","year":"2013","cit":0,"pfa":"이혜경","ptype":"article","src":"https://openalex.org/W2957740811","eid":"W2957740811"},{"id":"paper-w4392406009","cat":"papers","name":"Characterizing the effects of psychedelics and polydrug abuse on the blood-brain barrier properties","year":"2024","cit":0,"pfa":"R. Alarcão","psa":"Ana Maria Sebastião","ptype":"article","src":"https://openalex.org/W4392406009","eid":"W4392406009"},{"id":"paper-w7203782591","cat":"papers","name":"New research shows how psychedelics reorganise the patterns in your brain","year":"2026","cit":0,"pfa":"Devon Stoliker","psa":"Adeel Razi","ptype":"other","src":"https://openalex.org/W7203782591","eid":"W7203782591"},{"id":"paper-w7211950123","cat":"papers","name":"Correction: The transformational power of psychedelics: catalysts for creativity, consciousness, and mental health","year":"2026","cit":0,"pfa":"Xiubo Du","psa":"Xiaohui Wang","ptype":"erratum","src":"https://openalex.org/W7211950123","eid":"W7211950123"},{"id":"paper-w7214050392","cat":"papers","name":"data for Late-stage functionalization enables pharmacological editing of ergoline psychedelics","year":"2026","cit":0,"pfa":"Ye Zhao","topics":["Dosing & pharmacology"],"ptype":"dataset","src":"https://openalex.org/W7214050392","eid":"W7214050392"},{"id":"paper-w7133391257","cat":"papers","name":"Prediction of drug-target interactions for brazilian plant-derived natural compunds and hallucinogens by computational approaches","year":"2023","cit":0,"pfa":"Ronald Sodré Martins","topics":["Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W7133391257","eid":"W7133391257"},{"id":"paper-w2892617751","cat":"papers","name":"What does the international psychedelic science renaissance mean for dual diagnosis?","year":"2018","cit":0,"pfa":"Stephen Jason Bright","ptype":"article","src":"https://openalex.org/W2892617751","eid":"W2892617751"},{"id":"paper-w7135755361","cat":"papers","name":"Possibilities and limits of alternative treatment and recovery from addiction by the psychedelic experience","year":"2021","cit":0,"pfa":"Eva Césarová","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"dissertation","src":"https://openalex.org/W7135755361","eid":"W7135755361"},{"id":"paper-w3162648295","cat":"papers","name":"The influence of psychedelics and toxicity in J.G. Ballard and Tom Wolfe’s representations of petroculture","year":"2021","cit":0,"pfa":"Sofia Ahlberg","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3162648295","eid":"W3162648295"},{"id":"paper-w7134276322","cat":"papers","name":"Exploring associations between connectedness and death anxiety following a psychedelic experience","year":"2026","cit":0,"pfa":"Noah N T Barr","psa":"Sam G. Moreton","topics":["Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7134276322","eid":"W7134276322"},{"id":"paper-w7169527746","cat":"papers","name":"Effects of Microdosed Plyometric Training on Physical Performance in Athletes: A Systematic Review and Multilevel Meta-analysis","year":"2026","cit":0,"pfa":"严智杰","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7169527746","eid":"W7169527746"},{"id":"paper-w4408970791","cat":"papers","name":"Protracted Exposure to a Hallucinogen Sustains 5-HT2A Receptor Activation In Vitro (Abstract ID: 192038)","year":"2025","cit":0,"pfa":"Joshua C. Zamora","psa":"Kathryn A. Cunningham","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4408970791","eid":"W4408970791"},{"id":"paper-w4409980492","cat":"papers","name":"A scoping review on serotenergic psychedelics for obsessive compulsive and body image disorders","year":"2025","cit":0,"pfa":"Nicola Acevedo","psa":"David Jonathan Castle","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4409980492","eid":"W4409980492"},{"id":"paper-w7138073875","cat":"papers","name":"The Rukhsa of Psychedelics in Shariah: Neural Correlates of Religious Experience and the Issue of License","year":"2026","cit":0,"pfa":"Asghar, Haroon","topics":["Safety & adverse events","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7138073875","eid":"W7138073875"},{"id":"paper-w2798118859","cat":"papers","name":"Research Guides: Drug and alcohol information for PDHPE students: Magic mushrooms and other natural hallucinogens","year":"2012","cit":0,"pfa":"Is Info","topics":["Addiction"],"ptype":"libguides","src":"https://openalex.org/W2798118859","eid":"W2798118859"},{"id":"paper-w4294495249","cat":"papers","name":"Patrick Wayne Barber, Psychedelic Revolutionaries: LSD and the Birth of Hallucinogenic Research","year":"2020","cit":0,"pfa":"Alexander Dawson","ptype":"article","src":"https://openalex.org/W4294495249","eid":"W4294495249"},{"id":"paper-w4414856977","cat":"papers","name":"Psychedelic Plants and Fungi: Regulatory Landscape, Analytical Challenges, and Quality Considerations","year":"2025","cit":0,"pfa":"Sharon L Brunelle","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4414856977","eid":"W4414856977"},{"id":"paper-w4416435953","cat":"papers","name":"Dualism by design: Metaphysics in psychedelic research on the therapeutic effects of mystical experiences.","year":"2025","cit":0,"pfa":"Hollis Phelps","ptype":"article","src":"https://openalex.org/W4416435953","eid":"W4416435953"},{"id":"paper-w7137907376","cat":"papers","name":"The Rukhsa of Psychedelics in Shariah: Neural Correlates of Religious Experience and the Issue of License","year":"2026","cit":0,"pfa":"Asghar, Haroon","topics":["Safety & adverse events","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7137907376","eid":"W7137907376"},{"id":"paper-w3206731422","cat":"papers","name":"6.1 THE HISTORY OF PSYCHEDELIC USE AS TREATMENT: WHAT CAN WE LEARN?","year":"2021","cit":0,"pfa":"Lee I. Ascherman","ptype":"article","src":"https://openalex.org/W3206731422","eid":"W3206731422"},{"id":"paper-w4413600695","cat":"papers","name":"Psychedelic drugs can be almost as life altering as near-death experiences","year":"2022","cit":0,"pfa":"Steve Taylor","ptype":"other","src":"https://openalex.org/W4413600695","eid":"W4413600695"},{"id":"paper-w4386191820","cat":"papers","name":"Major investment signals keen interest in psychedelics for mental health care","year":"2023","cit":0,"pfa":"Gary A. Enos","ptype":"article","src":"https://openalex.org/W4386191820","eid":"W4386191820"},{"id":"paper-w4390696375","cat":"papers","name":"Erratum to “History repeating: guidelines to address common problems in psychedelic science”","year":"2024","cit":0,"ptype":"erratum","src":"https://openalex.org/W4390696375","eid":"W4390696375"},{"id":"paper-w4394825508","cat":"papers","name":"The Psychological Effects of the Administration of Psychedelics on the Minds of Healthy Individuals: A Systematic Review","year":"2024","cit":0,"pfa":"Sumayyah Idrees","psa":"Jalil Rehman","topics":["Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4394825508","eid":"W4394825508"},{"id":"paper-w7140955543","cat":"papers","name":"Moral Change from Within : Psychedelic Moral Enhancement as a Transformative Experience","year":"2025","cit":0,"pfa":"Matteo Galletti","topics":["Safety & adverse events","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7140955543","eid":"W7140955543"},{"id":"paper-w7164339412","cat":"papers","name":"POP SHAMANISTICA - Psychedelics zwischen Verbot, Popkultur und Medizinkommerz Billingual","year":"2026","cit":0,"pfa":"Schüller Thomas","ptype":"article","src":"https://openalex.org/W7164339412","eid":"W7164339412"},{"id":"paper-w2393778694","cat":"papers","name":"Clinical study of preventive effect of microdose heparin on blood hyperviscosity in early postoperative period","year":"2003","cit":0,"pfa":"Liang Xu","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2393778694","eid":"W2393778694"},{"id":"paper-w4328025605","cat":"papers","name":"Pharmacokinetics of a Microdosed Cocktail Containing Rivaroxaban, Apixaban, and Edoxaban in Children with Congenital Heart Defects","year":"2023","cit":0,"pfa":"Victoria C. Ziesenitz","psa":"M Gorenflo","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4328025605","eid":"W4328025605"},{"id":"paper-w7170730303","cat":"papers","name":"Weight Loss in a Commercial Mobile Behavior Change Program With and Without Semaglutide Microdose: Protocol","year":"2026","cit":0,"pfa":"Larissa Calancie","psa":"Erin Hennessy","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7170730303","eid":"W7170730303"},{"id":"paper-w100872087","cat":"papers","name":"Technognosis: Media, Performance and Alterations of Consciousness in the 'Stage' of the Psychedelic Trance Culture","year":"2013","cit":0,"pfa":"M. Pantazi","ptype":"dissertation","src":"https://openalex.org/W100872087","eid":"W100872087"},{"id":"paper-w2161466249","cat":"papers","name":"Impact on embryo quality when adding LH (hMG) in microdose lupron stimulation of low responders","year":"2002","cit":0,"pfa":"Patricia Mangan","psa":"T. Nasta","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2161466249","eid":"W2161466249"},{"id":"paper-w4405700301","cat":"papers","name":"Use of microdoses for induction of buprenorphine treatment with overlapping full opioid agonist use: the “Bernese method”","year":"2016","cit":0,"pfa":"Robert Hämmig","psa":"Marc Vogel","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4405700301","eid":"W4405700301"},{"id":"paper-w2955415957","cat":"papers","name":"Abstract CT055: Microdose induced oxaliplatin-DNA adducts as a predictive biomarker of response in colorectal cancer","year":"2019","cit":0,"pfa":"Justin B. Chen","psa":"Edward Jae-Hoon Kim","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W2955415957","eid":"W2955415957"},{"id":"paper-w4214558934","cat":"papers","name":"Psychedelics and the College Student. Student Committee on Mental Health. Princeton University","year":"1967","cit":0,"pfa":"Committee on Mental Health Student","topics":["Policy & ethics"],"ptype":"book","src":"https://openalex.org/W4214558934","eid":"W4214558934"},{"id":"paper-w4413731098","cat":"papers","name":"Teleporting and psychedelic mushrooms: a history of St Nicholas, Santa and his helpers","year":"2018","cit":0,"pfa":"Louise M. Pryke","psa":"Christopher W. Malone","ptype":"other","src":"https://openalex.org/W4413731098","eid":"W4413731098"},{"id":"paper-w4378737237","cat":"papers","name":"How to Sell buy psychedelics online without cheap card to a Skeptic","year":"2023","cit":0,"pfa":"golfurforfkwk","topics":["Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4378737237","eid":"W4378737237"},{"id":"paper-w7111962286","cat":"papers","name":"Lisa Bieberman and the Moral Challenge of LSD Revising Harvard's History of Psychedelics","year":"2025","cit":0,"pfa":"Gillis-Smith, Paul","ptype":"article","src":"https://openalex.org/W7111962286","eid":"W7111962286"},{"id":"paper-w2396046983","cat":"papers","name":"Proceedings: State-dependent learning (dissociation of learning). 3. State-dependent learning with hallucinogens in rats.","year":"1974","cit":0,"pfa":"K Yamada","psa":"S Ueki","ptype":"article","src":"https://openalex.org/W2396046983","eid":"W2396046983"},{"id":"paper-w4392702297","cat":"papers","name":"How Psychedelics Could Be Instrumental in Giving Voice to the Body in Challenging Times","year":"2024","cit":0,"pfa":"Marcelo Leite","ptype":"article","src":"https://openalex.org/W4392702297","eid":"W4392702297"},{"id":"paper-w7213548656","cat":"papers","name":"Employment-Related Risks and Ethical Enrollment of Military Personnel in Psychedelics Research","year":"2026","cit":0,"pfa":"Shajuana D. McMillan","psa":"Jake Earl","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7213548656","eid":"W7213548656"},{"id":"paper-w3009517580","cat":"papers","name":"Bridging the treatment gap: Psychedelics, prevention, pills and potions, psychotherapy and protest","year":"2020","cit":0,"pfa":"Michael Berk","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W3009517580","eid":"W3009517580"},{"id":"paper-w4293242540","cat":"papers","name":"P331. Meta-Analysis of Functional Imaging Studies of Acute Administration of Psychedelics","year":"2022","cit":0,"pfa":"Sophia Linguiti","psa":"Theodore Daniel Satterthwaite","topics":["Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4293242540","eid":"W4293242540"},{"id":"paper-w7131766059","cat":"papers","name":"Tripping Through Headlines: Psychedelics in Aotearoa New Zealand’s News Media","year":"2024","cit":0,"pfa":"Ko, Matthew","topics":["Addiction","Therapy practice","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W7131766059","eid":"W7131766059"},{"id":"paper-w7134272882","cat":"papers","name":"The Double Standard in Interpreting MEG Power Changes: Anaesthesia vs. Psychedelics","year":"2026","cit":0,"pfa":"Maarten Vergucht","ptype":"preprint","src":"https://openalex.org/W7134272882","eid":"W7134272882"},{"id":"paper-w7163580304","cat":"papers","name":"Psychedelic treatments and general hospital psychiatry: Emerging themes and future directions","year":"2026","cit":0,"pfa":"Sarah Hales","psa":"Jeffery Huffman","ptype":"article","src":"https://openalex.org/W7163580304","eid":"W7163580304"},{"id":"paper-w7164411432","cat":"papers","name":"POP SHAMANISTICA - Psychedelics zwischen Verbot, Popkultur und Medizinkommerz Billingual","year":"2026","cit":0,"pfa":"Schüller Thomas","ptype":"article","src":"https://openalex.org/W7164411432","eid":"W7164411432"},{"id":"paper-w2940780499","cat":"papers","name":"Bass drum, saxophone and laptop: real-time psychedelic performance software","year":"2010","cit":0,"pfa":"Jonathan Weinel","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2940780499","eid":"W2940780499"},{"id":"paper-w4402611366","cat":"papers","name":"Improved LC-MS detection of opioids, amphetamines, and psychedelics using TrEnDi","year":"2024","cit":0,"pfa":"Christian Rosales","psa":"Jeffrey C. Smith","topics":["Addiction","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4402611366","eid":"W4402611366"},{"id":"paper-w4307397061","cat":"papers","name":"THE NEW FOLLICULAR WAVE: DUOSTIM VS MICRODOSE FLARE CYCLE OUTCOMES IN DIMINISHED OVARIAN RESERVE","year":"2022","cit":0,"pfa":"Anisa Hussain","psa":"Roohi Jeelani","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4307397061","eid":"W4307397061"},{"id":"paper-w4362495132","cat":"papers","name":"Data from Microdose-Induced Drug–DNA Adducts as Biomarkers of Chemotherapy Resistance in Humans and Mice","year":"2023","cit":0,"pfa":"Maike Zimmermann","psa":"Paul T. Henderson","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W4362495132","eid":"W4362495132"},{"id":"paper-w2461077409","cat":"papers","name":"[Statement concerning the article of Dr. Rene Barrientos entitled: Microdose of intravenous hypophysin in expulsion and delivery].","year":"1955","cit":0,"pfa":"E VALENZUELA SAEZ","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2461077409","eid":"W2461077409"},{"id":"paper-w4298193518","cat":"papers","name":"Microdose study of 11C radiolabeled Donecopride, a multi-target-directed ligand for Alzheimer’s disease treatment","year":"2015","cit":0,"pfa":"F. Fillesoye","psa":"L. Barré","topics":["Dosing & pharmacology"],"ptype":"conference-paper","src":"https://openalex.org/W4298193518","eid":"W4298193518"},{"id":"paper-w4410851175","cat":"papers","name":"Population-based estimates of different dosage types of psychedelic use across socio-demographic groups in Germany","year":"2025","cit":0,"pfa":"Sebastian Sattler","psa":"Guido Mehlkop","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4410851175","eid":"W4410851175"},{"id":"paper-w4403403681","cat":"papers","name":"Why Harm Reduction Programs Should Be Extended to Include Psychedelic Drugs","year":"2024","cit":0,"pfa":"Timothy Kirschenheiter","topics":["Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W4403403681","eid":"W4403403681"},{"id":"paper-w4404204590","cat":"papers","name":"Week in wildlife: strolling pelican, venomous newt, psychedelic swamphen – Guardian","year":"2024","cit":0,"pfa":"Erzsebet Frey","ptype":"other","src":"https://openalex.org/W4404204590","eid":"W4404204590"},{"id":"paper-w7117964037","cat":"papers","name":"Beyond the trip - how sex hormones influence psychedelic effects: a review","year":"2026","cit":0,"pfa":"A. Frick","psa":"G. Blest-Hopley","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7117964037","eid":"W7117964037"},{"id":"paper-w7161816632","cat":"papers","name":"Psychedelic-specific vs stimulant effects on brain entropy and spatiotemporal complexity","year":"2026","cit":0,"pfa":"K. Larsen","psa":"P.M. Fisher","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7161816632","eid":"W7161816632"},{"id":"paper-w7132840990","cat":"papers","name":"Serotonergic psychedelics as epigenetic modulators: A paradigm shift in Alzheimer's disease therapeutics","year":"2026","cit":0,"pfa":"Esmaeel Ghasemi Gojani","psa":"Majid H. Mohajerani","ptype":"article","src":"https://openalex.org/W7132840990","eid":"W7132840990"},{"id":"paper-w7138310886","cat":"papers","name":"The Rukhsa of Psychedelics in Shariah: Neural Correlates of Religious Experience and the Issue of License","year":"2026","cit":0,"pfa":"Haroon Asghar","topics":["Safety & adverse events","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7138310886","eid":"W7138310886"},{"id":"paper-w7108223697","cat":"papers","name":"Challenging and adverse effects of meditation and psychedelics: Phenomenology, influencing factors and remedies","year":"2023","cit":0,"pfa":"Canby, Nicholas","psa":"Britton, Willoughby","topics":["Safety & adverse events"],"ptype":"other","src":"https://openalex.org/W7108223697","eid":"W7108223697"},{"id":"paper-w7162769194","cat":"papers","name":"When both treatments unblinded, psychedelics not more effective than antidepressants","year":"2026","cit":0,"topics":["Depression","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7162769194","eid":"W7162769194"},{"id":"paper-w7203821578","cat":"papers","name":"The invention of challenging psychedelic experiences: Meaning, measurement, and foreclosure of extended harm","year":"2026","cit":0,"pfa":"Christian Jurlando","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7203821578","eid":"W7203821578"},{"id":"paper-w7133362638","cat":"papers","name":"As psychedelic treatments get leaner, patients' social environments deserve attention","year":"2026","cit":0,"pfa":"Edward Jacobs","psa":"Hattie Wells","topics":["Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7133362638","eid":"W7133362638"},{"id":"paper-w7155403874","cat":"papers","name":"Survey reveals most common psychedelics used among U.S. adults.","year":"2026","cit":0,"pfa":"Karen M. Roush","ptype":"article","src":"https://openalex.org/W7155403874","eid":"W7155403874"},{"id":"paper-w4375838642","cat":"papers","name":"The 13 Best Pinterest Boards for Learning About cheap psychedelics for sale","year":"2023","cit":0,"pfa":"nirneyformpag","ptype":"article","src":"https://openalex.org/W4375838642","eid":"W4375838642"},{"id":"paper-w4416093575","cat":"papers","name":"Beyond the Mystical Experience Model: Theurgy as a Framework for Ritual Learning with Psychedelics","year":"2025","cit":0,"pfa":"A.F.M. van der Braak","ptype":"article","src":"https://openalex.org/W4416093575","eid":"W4416093575"},{"id":"paper-w7160888711","cat":"papers","name":"Perspectives on Psychedelics in Hospice and Palliative Medicine: Results of a Cross Disciplinary Survey","year":"2026","cit":0,"pfa":"Kelsey Noble","psa":"Michael David Fratkin","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7160888711","eid":"W7160888711"},{"id":"paper-w7133414047","cat":"papers","name":"Psychedelics: Everything You Wanted To Know but Didn’t Know Who To Ask","year":"2026","cit":0,"pfa":"Gina Egan","ptype":"article","src":"https://openalex.org/W7133414047","eid":"W7133414047"},{"id":"paper-w4244447440","cat":"papers","name":"Disturbances in Serine-Glycine Metabolism in Relation to Acute Psychoses with Psychedelic Symptoms","year":"1985","cit":0,"pfa":"Jacques Bruinvels","psa":"Lolke P. Pepplinkhuizen","ptype":"book-chapter","src":"https://openalex.org/W4244447440","eid":"W4244447440"},{"id":"paper-w7135043982","cat":"papers","name":"Should we be using psychedelics or dissociatives to treat mental health conditions?","year":"2026","cit":0,"pfa":"Cassidy O'Brien","psa":"Sabrina Fields","topics":["Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W7135043982","eid":"W7135043982"},{"id":"paper-w7155357329","cat":"papers","name":"Toward enlightenment: Dissolving the ego and expanding the world through mindfulness and psychedelics.","year":"2026","cit":0,"pfa":"Minka Witke","psa":"Paweł Holas","ptype":"article","src":"https://openalex.org/W7155357329","eid":"W7155357329"},{"id":"paper-w7169137349","cat":"papers","name":"Psychedelics for Patients Experiencing Existential Distress, Anxiety or Depression in Palliative Care","year":"2026","cit":0,"pfa":"Peter Tanuseputro","psa":"Alex K. Gearin","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7169137349","eid":"W7169137349"},{"id":"paper-w4412578409","cat":"papers","name":"Psychedelic New York: A History of LSD in the City by Chris Elcock (review)","year":"2024","cit":0,"pfa":"Dan Malleck","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4412578409","eid":"W4412578409"},{"id":"paper-w7112190393","cat":"papers","name":"Overcoming the trauma through the psychedelic in One Flew over the Cuckoo’s Nest","cit":0,"pfa":"Mongia Besbes","topics":["PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7112190393","eid":"W7112190393"},{"id":"paper-w4362495138","cat":"papers","name":"Data from Microdose-Induced Drug–DNA Adducts as Biomarkers of Chemotherapy Resistance in Humans and Mice","year":"2023","cit":0,"pfa":"Maike Zimmermann","psa":"Paul T. Henderson","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W4362495138","eid":"W4362495138"},{"id":"paper-w2413725136","cat":"papers","name":"Structured group use of psychedelic or entheogenic substances : experiences of guides and participants","year":"2001","cit":0,"pfa":"Roger D. Marsden","topics":["Addiction"],"ptype":"book","src":"https://openalex.org/W2413725136","eid":"W2413725136"},{"id":"paper-w4241568878","cat":"papers","name":"Faculty Opinions recommendation of Psychedelics promote structural and functional neural plasticity.","year":"2018","cit":0,"pfa":"Edwin R. Chapman","psa":"Jason Vevea","topics":["Depression","Mechanism & neuroscience"],"ptype":"peer-review","src":"https://openalex.org/W4241568878","eid":"W4241568878"},{"id":"paper-w7131095771","cat":"papers","name":"Baseline Mood and “Relational Triad” Predict Acute Qualities of Psychedelic Experience","year":"2026","cit":0,"pfa":"Joshua Lipson","psa":"Lisa Miller","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7131095771","eid":"W7131095771"},{"id":"paper-w7214055907","cat":"papers","name":"data for Late-stage functionalization enables pharmacological editing of ergoline psychedelics","year":"2026","cit":0,"pfa":"Ye Zhao","topics":["Dosing & pharmacology"],"ptype":"dataset","src":"https://openalex.org/W7214055907","eid":"W7214055907"},{"id":"paper-w4413492546","cat":"papers","name":"How corporate involvement in psychedelic research could threaten public safety","year":"2024","cit":0,"pfa":"Elena PhD","psa":"Marco Solmi","topics":["Safety & adverse events"],"ptype":"other","src":"https://openalex.org/W4413492546","eid":"W4413492546"},{"id":"paper-w4400574687","cat":"papers","name":"Examining Population Trends in the Association Between Mental Health and Psychedelic Use","year":"2024","cit":0,"pfa":"Daniel Grossman","psa":"Peter S. Hendricks","ptype":"article","src":"https://openalex.org/W4400574687","eid":"W4400574687"},{"id":"paper-w7160427988","cat":"papers","name":"PSYCHEDELIC PLANT MEDICINES OF THE AMERICAS EBOOK | | Descargar libro PDF EPUB","year":"2026","cit":0,"pfa":"Craig Walters","ptype":"report","src":"https://openalex.org/W7160427988","eid":"W7160427988"},{"id":"paper-w4406673977","cat":"papers","name":"Response to Letter to the Editor in Response to “Psychedelic Use by Sexual Minority Adults in the United States, 2022”","year":"2025","cit":0,"pfa":"Juhan Lee","psa":"Maria A. Parker","ptype":"letter","src":"https://openalex.org/W4406673977","eid":"W4406673977"},{"id":"paper-w4412151867","cat":"papers","name":"Optimizing yield, nitrogen uptake and nitrogen use efficiency in fluted pumpkin through fertilizer microdosing","year":"2025","cit":0,"pfa":"Francis Tope Olatoberu","psa":"O.C. Adebooye","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4412151867","eid":"W4412151867"},{"id":"paper-w4379911442","cat":"papers","name":"Analysis of the average duration of treatment of victims of various forms of poisoning with drugs and psychodisleptics (hallucinogens) for 2015–2021","year":"2023","cit":0,"pfa":"А. В. Сабаев","psa":"Svetlana V. Kanarskaya","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4379911442","eid":"W4379911442"},{"id":"paper-w4407286537","cat":"papers","name":"Beyond Phantastika. Analyzing and reframing the debate on subjective and beneficial effects of psychedelics","year":"2024","cit":0,"pfa":"Denis Forest","ptype":"article","src":"https://openalex.org/W4407286537","eid":"W4407286537"},{"id":"paper-w4417199866","cat":"papers","name":"Ketamine Reimagined: Distinguishing Psychedelic and Psycholytic Modalities for Next-Generation Therapies.","year":"2025","cit":0,"pfa":"Sophie Holland","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"preprint","src":"https://openalex.org/W4417199866","eid":"W4417199866"},{"id":"paper-w4411321929","cat":"papers","name":"Psychedelics meta-analysis retracted after authors request ‘significant changes’","year":"2025","cit":0,"pfa":"Marta Hill","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4411321929","eid":"W4411321929"},{"id":"paper-w4409698140","cat":"papers","name":"Psychedelics reduce fear by targeting immune cells that modulate brain cells","year":"2025","cit":0,"pfa":"Yun Chen","psa":"Marco Colonna","ptype":"article","src":"https://openalex.org/W4409698140","eid":"W4409698140"},{"id":"paper-w2285032525","cat":"papers","name":"'Tomorrow Is Today: Australia in the Psychedelic Era (1966-70)' [Book Review]","year":"2006","cit":0,"pfa":"Gavin Jones","topics":["Reviews & meta-analyses"],"ptype":"book-review","src":"https://openalex.org/W2285032525","eid":"W2285032525"},{"id":"paper-w7166435338","cat":"papers","name":"Supporting Data and Regulatory Analysis Tools for the Assessment of Psychedelic Clinical Trials","year":"2026","cit":0,"pfa":"Damian Świeczkowski","topics":["Policy & ethics"],"ptype":"dataset","src":"https://openalex.org/W7166435338","eid":"W7166435338"},{"id":"paper-w3090990589","cat":"papers","name":"On two causes of error that can be easily avoided in the microdosing of blood phosphorus according to Obermer and Milton.","year":"1949","cit":0,"pfa":"Giorgia Curci","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3090990589","eid":"W3090990589"},{"id":"paper-w2952694597","cat":"papers","name":"The Effect of Microdose Gonadotropin-releasing Hormone Agonist on Secretion of Gonadotropins and Estradiol in Normally Menstruating Women","year":"2002","cit":0,"pfa":"박원일","psa":"육진성","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2952694597","eid":"W2952694597"},{"id":"paper-w4416392654","cat":"papers","name":"The impact of microdose plyometric training on speed and explosive abilities of football players during the pre-season","year":"2025","cit":0,"pfa":"Marián Škorik","psa":"Michal Hrubý","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4416392654","eid":"W4416392654"},{"id":"paper-w7165053717","cat":"papers","name":"PK and PK / PD Modeling of Bcl2 Inhibitor S65487 in Patients With AML and Investigation of Nonlinearity With Microdosing","year":"2026","cit":0,"pfa":"Chloé Burlot","psa":"Sylvain Fouliard","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7165053717","eid":"W7165053717"},{"id":"paper-w2970725059","cat":"papers","name":"A Reconnaissance of Ethnic Psychedelic Plants of Western Himalaya and their Possible Identity to Soma","year":"2017","cit":0,"pfa":"K. V. Krishnamurthy","psa":"Bir Bahadur","ptype":"article","src":"https://openalex.org/W2970725059","eid":"W2970725059"},{"id":"paper-w4286368517","cat":"papers","name":"Review: Explosions in the Mind: Composing Psychedelic Sounds and Visualisations , by Jonathan Weinel","year":"2022","cit":0,"pfa":"George C. Reid","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4286368517","eid":"W4286368517"},{"id":"paper-w4391994441","cat":"papers","name":"Psychedelic Drugs Might Support Sexual Well-Being, Studies Find","year":"2024","cit":0,"pfa":"Emily Harris","ptype":"article","src":"https://openalex.org/W4391994441","eid":"W4391994441"},{"id":"paper-w4408655424","cat":"papers","name":"The Beatles, Rubber Soul , Revolver and Atlantic, Stax, Motown and psychedelic soul","year":"2025","cit":0,"ptype":"other","src":"https://openalex.org/W4408655424","eid":"W4408655424"},{"id":"paper-w585223495","cat":"papers","name":"Tripping over the Defining Line : An Analysis of Form in Psychedelic Underground Comix","year":"2014","cit":0,"pfa":"Ian Stuart Garlington","ptype":"article","src":"https://openalex.org/W585223495","eid":"W585223495"},{"id":"paper-w7196975968","cat":"papers","name":"Lilly spends US$2.8 billion on psychedelic drugs for mental health","year":"2026","cit":0,"pfa":"Asher Mullard","ptype":"article","src":"https://openalex.org/W7196975968","eid":"W7196975968"},{"id":"paper-w2317941392","cat":"papers","name":"»TAKING IT TO THE STREETS...« PSYCHOTHERAPIE, DROGEN UND PSYCHEDELIC ROCK: EIN FORSCHUNGSÜBERBLICK","year":"2007","cit":0,"pfa":"Jörg Fachner","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2317941392","eid":"W2317941392"},{"id":"paper-w4413728390","cat":"papers","name":"Amazonian psychedelic may ease severe depression, new study shows","year":"2018","cit":0,"pfa":"Luís Fernando Tófoli","psa":"Fernanda Palhano-Fontes","topics":["Depression"],"ptype":"other","src":"https://openalex.org/W4413728390","eid":"W4413728390"},{"id":"paper-w7167899466","cat":"papers","name":"What is the mechanism of action by which psychedelics treat major depressive disorder?","year":"2026","cit":0,"pfa":"Tripdatabase","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7167899466","eid":"W7167899466"},{"id":"paper-w7161723339","cat":"papers","name":"Community, credibility, and care: Activist public relations in the Portuguese psychedelic field","year":"2026","cit":0,"pfa":"Naíde Müller","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7161723339","eid":"W7161723339"},{"id":"paper-w7161987774","cat":"papers","name":"How we’re using AI tools to improve psychedelic-drug research","year":"2026","cit":0,"pfa":"Robin Berghaus","ptype":"article","src":"https://openalex.org/W7161987774","eid":"W7161987774"},{"id":"paper-w7203465536","cat":"papers","name":"Ego Dissolution or Self-Expansion? A Relational Reframing of Psychedelic Self-Experience","year":"2026","cit":0,"pfa":"James Amarante","ptype":"preprint","src":"https://openalex.org/W7203465536","eid":"W7203465536"},{"id":"paper-w2929572096","cat":"papers","name":"Psychedelic Medicine: New Evidence for Hallucinogenic Substances as Treatments (2 volumes)","year":"2007","cit":0,"pfa":"Henry David Abraham","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2929572096","eid":"W2929572096"},{"id":"paper-w3000103685","cat":"papers","name":"Psychedelic Mystery Traditions: Spirit Plants, Magical Practices, and Ecstatic States","year":"2018","cit":0,"pfa":"Thomas Hatsis","ptype":"book","src":"https://openalex.org/W3000103685","eid":"W3000103685"},{"id":"paper-w7135616406","cat":"papers","name":"The influence of psychedelic experience on attitudes to the use of addictive substances: a grounded theory","year":"2021","cit":0,"pfa":"Dominika Roztočilová","topics":["Addiction"],"ptype":"dissertation","src":"https://openalex.org/W7135616406","eid":"W7135616406"},{"id":"paper-w7160538915","cat":"papers","name":"The impact of classic psychedelic use on sleep architecture and false memory formation","year":"2026","cit":0,"pfa":"Oliwia Zaborowska","psa":"Gabriela Pawlak","ptype":"article","src":"https://openalex.org/W7160538915","eid":"W7160538915"},{"id":"paper-w2415028600","cat":"papers","name":"[Clinical analysis and evaluation of various hematologic and metabolic constants with the use of monthly microdoses of parenteral contraceptives].","year":"1978","cit":0,"pfa":"C Morales Lepe","psa":"Cordero Jaime","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2415028600","eid":"W2415028600"},{"id":"paper-w3090779495","cat":"papers","name":"Early onset of 3: 4 benzopyrene microdose sarcoma during stilbenic treatment in the albino rat.","year":"1948","cit":0,"pfa":"V Spampinato","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3090779495","eid":"W3090779495"},{"id":"paper-w4200157774","cat":"papers","name":"P.0313 Neurotoxicity of the potent hallucinogen 4-IODO-2,5-DIMETHOXY-N-(2-METHOXYBENZYL)phenethylamine","year":"2021","cit":0,"pfa":"Monika Herian","psa":"Krystyna Gołembiowska","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4200157774","eid":"W4200157774"},{"id":"paper-w3192460709","cat":"papers","name":"Non-Hallucinogenic Psychedelic Analog Reverses Effects of Stress in Mouse Study","year":"2021","cit":0,"pfa":"Tang Wai Kwong","ptype":"article","src":"https://openalex.org/W3192460709","eid":"W3192460709"},{"id":"paper-w4402847717","cat":"papers","name":"Review of Psychedelic Outlaws: The Movement Revolutionizing Modern Medicine, by Joanna Kemper","year":"2024","cit":0,"pfa":"Amy S. F. Lutz","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4402847717","eid":"W4402847717"},{"id":"paper-w7130337277","cat":"papers","name":"Opposing Network Patterns of Integration-Segregation in Psychedelic and Sedated States of Consciousness","year":"2026","cit":0,"pfa":"Rui Dai","psa":"George A. Mashour","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7130337277","eid":"W7130337277"},{"id":"paper-w7155604634","cat":"papers","name":"The Impact of Acute Psychedelic Drugs on Peripheral Biomarkers and Relation to the Subjective Experience","year":"2026","cit":0,"pfa":"Ana Deutsch","psa":"Leah M. Mayo","ptype":"article","src":"https://openalex.org/W7155604634","eid":"W7155604634"},{"id":"paper-w259546532","cat":"papers","name":"CALCULATION OF SURVIVAL RATES AND EFFECTIVE INACTIVATION CROSS SECTIONS OF TARGETS FOR FAST NEUTRONS BASED ON MICRODOSE CONCEPT.","year":"1970","cit":0,"pfa":"Takao Numakunai","psa":"Nobuhiro Oda","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W259546532","eid":"W259546532"},{"id":"paper-w99526440","cat":"papers","name":"[HALLUCINOGENS--THE MODERN SIRENS. CONSCIOUS, SELF-INDUCED DISTURBANCES OF CONSCIOUSNESS. REPORT ON AND WARNING ABOUT A NEW HAZARD].","year":"1964","cit":0,"pfa":"Ullman Wh","ptype":"article","src":"https://openalex.org/W99526440","eid":"W99526440"},{"id":"paper-w4416538407","cat":"papers","name":"Association of Hallucinogen Use With Psychosocial Outcomes: Secondary Analysis of the Spinal Cord Injury Model Systems Database","year":"2025","cit":0,"pfa":"Kayleigh Crane","psa":"Kimberley R. Monden","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4416538407","eid":"W4416538407"},{"id":"paper-w4213377428","cat":"papers","name":"American Trip: Set, Setting, and the Psychedelic Experience in the Twentieth Century by Ido Hartogsohn","year":"2021","cit":0,"pfa":"Devin R. Lander","topics":["Addiction","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4213377428","eid":"W4213377428"},{"id":"paper-w4293068547","cat":"papers","name":"Antagonist/letrozole protocol versus microdose flare-up protocol in poor responders: a randomized study","year":"2011","cit":0,"pfa":"Eman Amin Elgindy","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4293068547","eid":"W4293068547"},{"id":"paper-w2742142950","cat":"papers","name":"P34 Efficient assessment of a six-probe cocktail for CYPs following intravenous microdosing for pharmacokinetic studies","year":"2017","cit":0,"pfa":"Yuyang You","psa":"Zhihong Yang","topics":["Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W2742142950","eid":"W2742142950"},{"id":"paper-w7148202045","cat":"papers","name":"Psychedelic layerings: Fluid identities of a self-placed young Chinese immigrant in the U.K.","year":"2025","cit":0,"pfa":"Wei Gan","ptype":"dissertation","src":"https://openalex.org/W7148202045","eid":"W7148202045"},{"id":"paper-w4409980413","cat":"papers","name":"Psychedelics, OCD and related disorders: Methodological issues and potential strategies for future studies","year":"2025","cit":0,"pfa":"Rodolfo Leuzzi","psa":"Naomi Anne Fineberg","ptype":"article","src":"https://openalex.org/W4409980413","eid":"W4409980413"},{"id":"paper-w3135856410","cat":"papers","name":"HOSPITAL MORBIDITY DUE TO ACUTE POISONING BY PSYCHODYLEPTICS AND HALLUCINOGENS IN DIFFERENT AGE/GENDER GROUPS IN THE CITY OF OMSK POPULATION","year":"2020","cit":0,"pfa":"А В Сабаев","ptype":"article","src":"https://openalex.org/W3135856410","eid":"W3135856410"},{"id":"paper-w2999402373","cat":"papers","name":"Clinical pharmacology of anti-hormonal drugs and gemcitabine in oncology : Bioanalysis - Therapeutic drug monitoring - Microdosing","year":"2020","cit":0,"pfa":"Merel van Nuland","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W2999402373","eid":"W2999402373"},{"id":"paper-w2460420510","cat":"papers","name":"[PHARMACOLOGICAL STUDIES ON HALLUCINOGENS (2). 3. EFFECT OF LSD25 ON THE ACTION OF PSYCHOTROPIC DRUGS, ESPECIALLY TRANQUILIZERS].","year":"1964","cit":0,"pfa":"Meitetsu MATSUOKA","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2460420510","eid":"W2460420510"},{"id":"paper-w2317908530","cat":"papers","name":"Is There a Role for the [small alpha, Greek]2 Antagonism in the Exacerbation of Hallucinogen-Persisting Perception Disorder with Risperidone?","year":"1998","cit":0,"pfa":"Henry David Abraham","ptype":"article","src":"https://openalex.org/W2317908530","eid":"W2317908530"},{"id":"paper-w1995488013","cat":"papers","name":"Ultrashort Microdose GnRH Agonist Ovarian Stimulation Provides Good Pregnancy Outcome in Poor Responders","year":"2000","cit":0,"pfa":"Michael D. Scheiber","psa":"Sherif G. Awadalla","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1995488013","eid":"W1995488013"},{"id":"paper-w2745672269","cat":"papers","name":"Phase 0 clinical trial of single - microdose intravenous temozolomide in healthy Chinese male volunteers","year":"2016","cit":0,"pfa":"Jina Wang","psa":"Wang Xinghea","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2745672269","eid":"W2745672269"},{"id":"paper-w2158136088","cat":"papers","name":"A randomized, prospective study of microdose leuprolide vs. ganirelix in IVF cycles for poor response patients","year":"2002","cit":0,"pfa":"David W. Schmidt","psa":"JOHN C. NULSEN","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2158136088","eid":"W2158136088"},{"id":"paper-w2008635558","cat":"papers","name":"Ovarian Response to Microdoses of Gonadotropin-Releasing Hormone (GnRH) Agonist During Ovulation Induction for In Vitro Fertilization","year":"2005","cit":0,"pfa":"N. Moossavifar","psa":"F. Vahid Roodsary","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2008635558","eid":"W2008635558"},{"id":"paper-w2093531323","cat":"papers","name":"Book review: Uses and abuses of plant‐derived smoke: Its ethnobotany as hallucinogen, perfume, incense and medicine","year":"2011","cit":0,"pfa":"Angela Ratsch","topics":["Addiction","Reviews & meta-analyses"],"ptype":"book-review","src":"https://openalex.org/W2093531323","eid":"W2093531323"},{"id":"paper-w4408406871","cat":"papers","name":"My altered states: A doctor's extraordinary account of trauma, psychedelics, and spiritual growth","year":"2025","cit":0,"pfa":"Samuel Bendeck Sotillos","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4408406871","eid":"W4408406871"},{"id":"paper-w7129023291","cat":"papers","name":"Psychedelics and connectedness to natural and social worlds: An examination of the evidence and a proposed conceptual framework","year":"2025","cit":0,"pfa":"Matthias Forstmann","psa":"Christina Sagioglou","ptype":"article","src":"https://openalex.org/W7129023291","eid":"W7129023291"},{"id":"paper-w7203593971","cat":"papers","name":"The Fireside Database: Large-Scale Evidence from 25,419 Psychedelic Support Interactions","year":"2026","cit":0,"pfa":"Félix Schoeller","ptype":"preprint","src":"https://openalex.org/W7203593971","eid":"W7203593971"},{"id":"paper-w4247761915","cat":"papers","name":"Psychotomimetics","year":"2010","cit":0,"pfa":"Hamish McAllister-Williams","psa":"Jos Prickaerts","ptype":"reference-entry","src":"https://openalex.org/W4247761915","eid":"W4247761915"},{"id":"paper-w2293530131","cat":"papers","name":"[Morphology and histochemistry of the human endometrium under treatment with continous microdoses of chlormadinone. I. In the spontaneous cycle].","year":"1970","cit":0,"pfa":"Antonio Sereno J","psa":"G García","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2293530131","eid":"W2293530131"},{"id":"paper-w2256977571","cat":"papers","name":"GNRH ANTAGONIST/LETROZOLE VERSUS MICRODOSE OF GNRH AGONIST FLARE PROTOCOL IN POOR RESPONDERS UNDERGOING IVF","year":"2009","cit":0,"pfa":"Robab Davar","psa":"S H Ahmadi","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2256977571","eid":"W2256977571"},{"id":"paper-w2020505329","cat":"papers","name":"The Psychedelic Renaissance: Reassessing the Role of Psychedelic Drugs in 21st Century Psychiatry and Society by Ben Sessa, Muswell Hill Press, 2012, £16.95, pb, 240 pp. ISBN: 9781908995001","year":"2013","cit":0,"pfa":"Sarabjeet Kohli","ptype":"book-review","src":"https://openalex.org/W2020505329","eid":"W2020505329"},{"id":"paper-w7107968707","cat":"papers","name":"The impact of female hormones on psychedelic effects: Implications for mood, relationships, and menopausal health","year":"2025","cit":0,"pfa":"Soylemez, Kerem Kemal","psa":"Lusher, Joanne","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7107968707","eid":"W7107968707"},{"id":"paper-w7155528762","cat":"papers","name":"A Mental Health Lifeline: How Psychedelics Could Offer Millions of Americans Hope","year":"2026","cit":0,"pfa":"HEIDI L. ALLEN","ptype":"report","src":"https://openalex.org/W7155528762","eid":"W7155528762"},{"id":"paper-w7214981738","cat":"papers","name":"P363 PATTERNS AND IMPLICATIONS OF CO-USE BETWEEN E-CIGARETTES AND HALLUCINOGENS: A SYSTEMATIC REVIEW AND META-ANALYSIS","year":"2026","cit":0,"pfa":"K. Grover","psa":"H. Mir","topics":["Reviews & meta-analyses"],"ptype":"conference-abstract","src":"https://openalex.org/W7214981738","eid":"W7214981738"},{"id":"paper-w7127217670","cat":"papers","name":"From Zolpidem to Psychedelics: Recent Drug-Based Interventions for Severe Brain Injuries”, Symposium “Use of Pharmacological Agents to Optimize the Recovery of Brain-Injured Patients: Opportunities with Sedatives and Psy","year":"2025","cit":0,"pfa":"Olivia Gosseries","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"conference-paper","src":"https://openalex.org/W7127217670","eid":"W7127217670"},{"id":"paper-w4254717154","cat":"papers","name":"Abstract 2155: High-plex spatial profiling analysis of multidrug CIVO microdose studies in cancer patients","year":"2019","cit":0,"pfa":"Gary B. Deutsch","psa":"Robert G. Maki","topics":["Anxiety & end-of-life","Dosing & pharmacology","Policy & ethics"],"ptype":"conference-abstract","src":"https://openalex.org/W4254717154","eid":"W4254717154"},{"id":"paper-w4244302915","cat":"papers","name":"Higher efficacy ratings for self-medication with psychedelics than offered treatment for psychopathologies","year":"2017","cit":0,"pfa":"Natasha Leigh Mason","psa":"Kim P. C. Kuypers","ptype":"preprint","src":"https://openalex.org/W4244302915","eid":"W4244302915"},{"id":"paper-w4392030545","cat":"papers","name":"Psychedelic Research as a Career Path: A Roundtable Discussion with Early Career Researchers in the Field","year":"2024","cit":0,"pfa":"Jacob S. Aday","psa":"C. J. Healy","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4392030545","eid":"W4392030545"},{"id":"paper-w7160914042","cat":"papers","name":"Psychedelic Use and Psychological Healing Among Gender Exploring Clients: Clinicians’ Perspectives","year":"2026","cit":0,"pfa":"Esenia K. Cassidy","psa":"Panteá Farvid","topics":["PTSD & trauma","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7160914042","eid":"W7160914042"},{"id":"paper-w4362482034","cat":"papers","name":"Supplementary Data from Microdose-Induced Drug–DNA Adducts as Biomarkers of Chemotherapy Resistance in Humans and Mice","year":"2023","cit":0,"pfa":"Maike Zimmermann","psa":"Paul T. Henderson","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4362482034","eid":"W4362482034"},{"id":"paper-w328776019","cat":"papers","name":"Implications for critical care of a new in vivo human vascular microdosing technique for giving noradrenaline and nitroglycerine by microdialysis","year":"2010","cit":0,"pfa":"Anders Samuelsson","psa":"Folke Sjöberg","topics":["PTSD & trauma","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W328776019","eid":"W328776019"},{"id":"paper-w4252861520","cat":"papers","name":"Human Psychopharmacology and Dose-Effects of Dextromethorphan, an NMDA Antagonist Hallucinogen Present in Over-the-Counter Cough Medications","year":"2011","cit":0,"pfa":"Lawrence P. Carter","psa":"Roland R. Griffiths","topics":["Dosing & pharmacology"],"ptype":"dataset","src":"https://openalex.org/W4252861520","eid":"W4252861520"},{"id":"paper-w4413521366","cat":"papers","name":"Green juice, microdosing, cupping and … cocaine? Netflix’s Wellmania takes a humorous dive into the heady world of wellness","year":"2023","cit":0,"pfa":"Edith Hill","topics":["Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W4413521366","eid":"W4413521366"},{"id":"paper-w7118468756","cat":"papers","name":"Microdose Leadership Development: Enhancing Leadership Identity and Self-Efficacy Through Short-Term Active Learning","year":"2025","cit":0,"pfa":"Connie Deng","psa":"Nick Turner","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7118468756","eid":"W7118468756"},{"id":"paper-w2373735008","cat":"papers","name":"The Effect of Microdose Gonadot ropin - releasing Hormone Agonist on Secretion of Gonadotropins and Estradiol in Normally Menstruating Women","year":"2002","cit":0,"pfa":"Won Il Park","psa":"Jin Sung Yuk","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2373735008","eid":"W2373735008"},{"id":"paper-w4413500343","cat":"papers","name":"The TGA has approved certain psychedelic treatments: the response from experts is mixed","year":"2023","cit":0,"pfa":"Paul Liknaitzky","ptype":"other","src":"https://openalex.org/W4413500343","eid":"W4413500343"},{"id":"paper-w4393167977","cat":"papers","name":"Abstract 2437 Neuroplasticity in Alzheimer's Treatment: The Impact of Psychedelic-Induced TrkB Activation","year":"2024","cit":0,"pfa":"Katherine Alex","psa":"C. C. Wang","topics":["Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W4393167977","eid":"W4393167977"},{"id":"paper-w7140108592","cat":"papers","name":"Positive Adult Development Attributed to Classic Psychedelic use during Emerging Adulthood","year":"2026","cit":0,"pfa":"Jake Payne","psa":"Greg Murray","ptype":"preprint","src":"https://openalex.org/W7140108592","eid":"W7140108592"},{"id":"paper-w2554678458","cat":"papers","name":"The Relationship between Anxiety Vulnerability Factors, Psychedelic Drug Use and Trait Anxiety","year":"2016","cit":0,"pfa":"Flavia Ursa","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W2554678458","eid":"W2554678458"},{"id":"paper-w4413569556","cat":"papers","name":"From trippy drugs to therapeutic aids – how psychedelics got their groove back","year":"2021","cit":0,"pfa":"Ian Hamilton","psa":"Harry R. Sumnall","ptype":"other","src":"https://openalex.org/W4413569556","eid":"W4413569556"},{"id":"paper-w7119528771","cat":"papers","name":"Metaphysical Future Light: Prophecy, Shared Visions, Psychedelics, and the Discipline of Time- Claims","year":"2026","cit":0,"pfa":"Douglas C. Youvan","ptype":"article","src":"https://openalex.org/W7119528771","eid":"W7119528771"},{"id":"paper-w2017971550","cat":"papers","name":"\"A Necessary but Not Sufficient Condition\": Psychedelic Mysticism, Perennial Liminality, and the Limits of Supernatural Theism","year":"2014","cit":0,"pfa":"Morgan Shipley","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2017971550","eid":"W2017971550"},{"id":"paper-w2552865871","cat":"papers","name":"A Study on the 1970's Korean Psychedelic Rock (focusing on Shin, Joong-hyun)","year":"2016","cit":0,"pfa":"Chun-Ho Ham","psa":"Tae-Seon Cho","ptype":"article","src":"https://openalex.org/W2552865871","eid":"W2552865871"},{"id":"paper-w4391579393","cat":"papers","name":"Endorsement of metaphysical idealism mediates a link between past use of psychedelics and wellbeing","year":"2024","cit":0,"pfa":"Jussi Jylkkä","psa":"Patrick Jern","ptype":"preprint","src":"https://openalex.org/W4391579393","eid":"W4391579393"},{"id":"paper-w4388015376","cat":"papers","name":"Introduction to the thematic collection “Psychedelic Medicine: Therapeutic Applications and Implications for Future Research”","year":"2023","cit":0,"pfa":"Krystyna Gołembiowska","ptype":"article","src":"https://openalex.org/W4388015376","eid":"W4388015376"},{"id":"paper-w2889912053","cat":"papers","name":"The Culture of Recreational Psychedelic Drug Use in College-Age Adults: A Narrative Analysis","year":"2012","cit":0,"pfa":"Brita Elizabeth Bliss","ptype":"dissertation","src":"https://openalex.org/W2889912053","eid":"W2889912053"},{"id":"paper-w4287551666","cat":"papers","name":"Mental health, personality and lifetime psychedelic use during the COVID-19 pandemic","year":"2020","cit":0,"pfa":"Federico Cavanna","psa":"Enzo Tagliazucchi","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4287551666","eid":"W4287551666"},{"id":"paper-w7160233291","cat":"papers","name":"Microdosing of Flywheel Training: Effects of Low Versus High Training Frequency on Muscle Mass, Strength, and Power","year":"2026","cit":0,"pfa":"Sergio Maroto‐Izquierdo","psa":"Óliver Gonzalo‐Skok","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7160233291","eid":"W7160233291"},{"id":"paper-w7154058210","cat":"papers","name":"Exploring the potential of psychedelics in brain injury recovery: a thematic analysis of participant narratives","year":"2026","cit":0,"pfa":"Oliver Reed","topics":["PTSD & trauma","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7154058210","eid":"W7154058210"},{"id":"paper-w4366983259","cat":"papers","name":"Psychedelic Research for Dementia Risks Perpetuating Structural Failures and Inadequacies in Aged Care","year":"2023","cit":0,"pfa":"Hojjat Soofi","psa":"Cynthia Forlini","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4366983259","eid":"W4366983259"},{"id":"paper-w4386827830","cat":"papers","name":"Rosalind Franklin Society Proudly Announces the 2022 Award Recipient for Psychedelic Medicine","year":"2023","cit":0,"pfa":"Jamie Peters","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4386827830","eid":"W4386827830"},{"id":"paper-w7107977037","cat":"papers","name":"The impact of female hormones on psychedelic effects: Implications for mood, relationships, and menopausal health","year":"2025","cit":0,"pfa":"Soylemez, Kerem Kemal","psa":"Lusher, Joanne","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7107977037","eid":"W7107977037"},{"id":"paper-w7203690867","cat":"papers","name":"The Sacred Dimension: Psychedelic Use and Motivations for Use Predict Religiosity and Spiritual Practices","year":"2026","cit":0,"pfa":"Calah Jane Fortune","psa":"Kristine Jacquin","ptype":"article","src":"https://openalex.org/W7203690867","eid":"W7203690867"},{"id":"paper-w81997831","cat":"papers","name":"Goatrance travellers: psychedelic trance and its seasoned progeny Graham St John","year":"2014","cit":0,"pfa":"Graham St John","ptype":"article","src":"https://openalex.org/W81997831","eid":"W81997831"},{"id":"paper-w4402650247","cat":"papers","name":"The Ontological Shock: What Psychedelics can Teach us about the Nature of the Mind","year":"2024","cit":0,"ptype":"conference-paper","src":"https://openalex.org/W4402650247","eid":"W4402650247"},{"id":"paper-w2759044671","cat":"papers","name":"\"New Rising Suns: Psychedelic Sound Romance\" - cd-albumin graafinen suunnittelu","year":"2017","cit":0,"pfa":"Jari Pekka Mikkola","ptype":"other","src":"https://openalex.org/W2759044671","eid":"W2759044671"},{"id":"paper-w4394410463","cat":"papers","name":"Statistical physics applied to the neuroscience of altered states: the brain under the influence of psychedelics","year":"2021","cit":0,"pfa":"Aline Viol","psa":"G. M. Viswanathan","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"dataset","src":"https://openalex.org/W4394410463","eid":"W4394410463"},{"id":"paper-w4402655643","cat":"papers","name":"Classic psychedelics in translational research: addressing epistemic challenges from bench to bedside","year":"2024","cit":0,"pfa":"Jaipreet Mattu","psa":"Jacqueline Anne Sullivan","topics":["Depression","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W4402655643","eid":"W4402655643"},{"id":"paper-w7142905700","cat":"papers","name":"Psychedelics; an untapped therapeutic niche: a narrative review in the future of cancer pain management","year":"2026","cit":0,"pfa":"Maxine Min Chien Yap","psa":"Satoshi Ogawa","topics":["Anxiety & end-of-life","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7142905700","eid":"W7142905700"},{"id":"paper-w4416529860","cat":"papers","name":"Psychedelics and immortality: Nature went to a health summit starring RFK and JD Vance","year":"2025","cit":0,"pfa":"Max Kozlov","ptype":"other","src":"https://openalex.org/W4416529860","eid":"W4416529860"},{"id":"paper-w2947716494","cat":"papers","name":"Pathology of The Psychedelic Drug and Narcotic-Related Crimes in The Law of Iran and The United Kingdom","year":"2018","cit":0,"pfa":"Yahya R. Kamalipour","psa":"Bagher Shamloo","ptype":"article","src":"https://openalex.org/W2947716494","eid":"W2947716494"},{"id":"paper-w4388097087","cat":"papers","name":"From Taboo to Treatment: The Emergence of Psychedelics in the Management of Pain and Opioid Use Disorder","year":"2023","cit":0,"pfa":"Jeremy Weleff","psa":"João Paulo De Aquino","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4388097087","eid":"W4388097087"},{"id":"paper-w2937989648","cat":"papers","name":"Epidermal absorption in male scrotum of topical application of psychedelic drugs: times and effects","year":"2019","cit":0,"pfa":"Piotr Brzeziński","psa":"Lorenzo Martini","ptype":"article","src":"https://openalex.org/W2937989648","eid":"W2937989648"},{"id":"paper-w4408009874","cat":"papers","name":"Psychedelics as an alternative to traditional pharmacotherapy in treating mental disorders – a review of latest studies","year":"2025","cit":0,"pfa":"Jakub Pudźwa","psa":"Martyna Orzechowska","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4408009874","eid":"W4408009874"},{"id":"paper-w7213224781","cat":"papers","name":"Homicides associated with psychedelic use: Psychiatric features, risk factors and sentencing outcomes","year":"2026","cit":0,"pfa":"Jesse J. Norris","psa":"Brian James Holoyda","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7213224781","eid":"W7213224781"},{"id":"paper-w7198505654","cat":"papers","name":"Evidence Table: SDT Perspective on Psychedelic Integration (EHPC 2026 Poster Supplement)","year":"2026","cit":0,"pfa":"Marcela J. Ohlgart","topics":["Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7198505654","eid":"W7198505654"},{"id":"paper-w2409185551","cat":"papers","name":"[Histomorphological pictures of the prostate gland of rats castrated and treated with microdoses of testosterone, under the action of chorionic gonadotropin].","year":"1998","cit":0,"pfa":"Pizzagalli Gf","psa":"V Bertana","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2409185551","eid":"W2409185551"},{"id":"paper-w4245844316","cat":"papers","name":"Abstract CT055: Microdose induced oxaliplatin-DNA adducts as a predictive biomarker of response in colorectal cancer","year":"2019","cit":0,"pfa":"Justin B. Chen","psa":"Edward Jae-Hoon Kim","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W4245844316","eid":"W4245844316"},{"id":"paper-w977352437","cat":"papers","name":"Psicodelia en la rue de Rivoli = Psychedelics on rue de Rivoli.","year":"2005","cit":0,"pfa":"Erik Fau","ptype":"article","src":"https://openalex.org/W977352437","eid":"W977352437"},{"id":"paper-w2950749459","cat":"papers","name":"Book Review – Alien Information Theory: Psychedelic Drug Technologies and the Cosmic Game","year":"2019","cit":0,"pfa":"Peter Sjöstedt-H.","topics":["Reviews & meta-analyses"],"ptype":"book-review","src":"https://openalex.org/W2950749459","eid":"W2950749459"},{"id":"paper-w2891787290","cat":"papers","name":"Serotonin receptors and the actions of two phenethylamine hallucinogens on the firing of single cells in the rat central nervous system","year":"1986","cit":0,"pfa":"Nicholas J. Penington","topics":["Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W2891787290","eid":"W2891787290"},{"id":"paper-w2062429779","cat":"papers","name":"Response to Joralemon's Review of Visionary Vine: Hallucinogenic Healing in the Peruvian Amazon and Hallucinogens: Cross‐Cultural Perspectives","year":"1986","cit":0,"pfa":"Marlene Dobkin de Ríos","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2062429779","eid":"W2062429779"},{"id":"paper-w4385667174","cat":"papers","name":"Troubling hope Review of ‘Psychedelic Justice: Towards a Diverse and Equitable Psychedelic Culture’ , Edited by Beatriz Caiuby Labate and Clancy Cavnar, Santa Fe: Synergetic Press, $9.99 £11.99 €12.99.","year":"2023","cit":0,"pfa":"Mark Juhan Schunemann","topics":["Reviews & meta-analyses"],"ptype":"book-review","src":"https://openalex.org/W4385667174","eid":"W4385667174"},{"id":"paper-w7169622437","cat":"papers","name":"UK’s regulatory and legislative double standards in the treatment of psychedelics and drugs for assisted suicide","year":"2026","cit":0,"pfa":"Ruslan Zinchenko","topics":["Policy & ethics"],"ptype":"editorial","src":"https://openalex.org/W7169622437","eid":"W7169622437"},{"id":"paper-w7215070052","cat":"papers","name":"Agarikon: A Screened Index of Psychedelic Medicine - Clinics, Trials, Researchers, Legislation, and Industry","year":"2026","cit":0,"pfa":"Erich Mayne","topics":["Policy & ethics"],"ptype":"dataset","src":"https://openalex.org/W7215070052","eid":"W7215070052"},{"id":"paper-w563257301","cat":"papers","name":"“I realized that everything is love”: The influence of psychedelic experiences on sexual and gender orientation.","year":"2011","cit":0,"pfa":"Sophia Korb","psa":"Courtny Hopen","ptype":"article","src":"https://openalex.org/W563257301","eid":"W563257301"},{"id":"paper-w4413604174","cat":"papers","name":"Chemical adventurers: the science of the mind has a long, colourful history of psychedelic exploration","year":"2023","cit":0,"pfa":"Nick Haslam","ptype":"other","src":"https://openalex.org/W4413604174","eid":"W4413604174"},{"id":"paper-w7125971327","cat":"papers","name":"Potential analgesic effects of psychedelics on select chronic pain conditions: A survey study","year":"2023","cit":0,"pfa":"Mauro Cavarra","psa":"Johannes Gerardus Ramaekers","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7125971327","eid":"W7125971327"},{"id":"paper-w7133563289","cat":"papers","name":"Public attitudes toward psychedelics in Poland: a constructive commentary on Holas & Kamińska (2025)","year":"2026","cit":0,"pfa":"Damian Świeczkowski","psa":"Wiesław Jerzy Cubała","ptype":"article","src":"https://openalex.org/W7133563289","eid":"W7133563289"},{"id":"paper-w7128496151","cat":"papers","name":"Assessing Modern AI-Driven Protein-Ligand Modeling with Phenethylamine and Tryptamine Psychedelics","year":"2026","cit":0,"pfa":"Benjamin R. Cummins","psa":"Charles David Nichols","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7128496151","eid":"W7128496151"},{"id":"paper-w7211971994","cat":"papers","name":"Huachuma, the Andean psychedelic cactus, is drawing Western seekers and raising ethical questions","year":"2026","cit":0,"pfa":"Pardis Mahdavi","topics":["Policy & ethics"],"ptype":"other","src":"https://openalex.org/W7211971994","eid":"W7211971994"},{"id":"paper-w4413343247","cat":"papers","name":"Two years on from Australia’s bold psychedelic experiment, here are our concerns","year":"2025","cit":0,"pfa":"Christopher Rudge","psa":"Reeve McClelland","ptype":"other","src":"https://openalex.org/W4413343247","eid":"W4413343247"},{"id":"paper-w3189481590","cat":"papers","name":"Book Review: American Trip: Set, Setting, and the Psychedelic Experience in the Twentieth Century","year":"2021","cit":0,"pfa":"Ephraim Shmaya Lansky","topics":["Reviews & meta-analyses"],"ptype":"book-review","src":"https://openalex.org/W3189481590","eid":"W3189481590"},{"id":"paper-w7163068453","cat":"papers","name":"Auditable Compositional Complexity: A Stratified Access and Characterization Framework for Psychedelic and Cannabinoid Extracts","year":"2026","cit":0,"pfa":"Oscar Daniel Bello","psa":"Martín A. Pavarotti","ptype":"preprint","src":"https://openalex.org/W7163068453","eid":"W7163068453"},{"id":"paper-w7124535950","cat":"papers","name":"[Clinical application and mechanistic studies of psychedelics for treatment of depression: progress and future challenges].","year":"2026","cit":0,"pfa":"Ke Xia","psa":"Tianming Gao","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7124535950","eid":"W7124535950"},{"id":"paper-w7135094729","cat":"papers","name":"How psychedelics push your brain to dream while awake – new study","year":"2026","cit":0,"pfa":"Andrea Benucci","ptype":"other","src":"https://openalex.org/W7135094729","eid":"W7135094729"},{"id":"paper-w7128536767","cat":"papers","name":"Targeting serotonin 5-HT2A receptors in the treatment of aggression: From antipsychotics to psychedelics","year":"2026","cit":0,"pfa":"Simona Scheggi","psa":"Marco Bortolato","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7128536767","eid":"W7128536767"},{"id":"paper-w7171375239","cat":"papers","name":"Reading the Signal: What Psychedelic Trials in Depression Still Can’t Tell Us","year":"2026","cit":0,"pfa":"Samela Mariano Brown","psa":"Margaret Chaplin","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7171375239","eid":"W7171375239"},{"id":"paper-w7117488987","cat":"papers","name":"Correction: Exploring practitioners’ perceptions of health behavior changes associated with psychedelic experiences","year":"2025","cit":0,"pfa":"Laura Lopes de Carvalho","psa":"Pedro J. Teixeira","topics":["Addiction"],"ptype":"erratum","src":"https://openalex.org/W7117488987","eid":"W7117488987"},{"id":"paper-w7164831074","cat":"papers","name":"Mystical entropy: an introduction to the psychedelic-kundalini thesis and the PEACE framework for contemplative research","year":"2026","cit":0,"pfa":"Aidan Lyon","topics":["Mechanism & neuroscience"],"ptype":"editorial","src":"https://openalex.org/W7164831074","eid":"W7164831074"},{"id":"paper-w7172104732","cat":"papers","name":"Shared Neurobiological and Computational Mechanisms of Psychedelic, Contemplative, and Fasting-Induced Mystical Experience","year":"2026","cit":0,"pfa":"Alex Jinich‐Diamant","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7172104732","eid":"W7172104732"},{"id":"paper-w1187138912","cat":"papers","name":"Microdose Intravenous Bevacizumab for the Treatment of Retinal Vascular Diseases Mediated by Vascular Endothelial Growth Factor (VEGF)","year":"2008","cit":0,"pfa":"Elizabeth Louise Thomas","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1187138912","eid":"W1187138912"},{"id":"paper-w3158965703","cat":"papers","name":"Psychedelic drugs without the trip? This sensor could help seek them out","year":"2021","cit":0,"pfa":"Ariana Remmel","ptype":"other","src":"https://openalex.org/W3158965703","eid":"W3158965703"},{"id":"paper-w4408295337","cat":"papers","name":"From the Editor-in-Chief’s Desk: Psychedelic Therapeutics—Something Old and Something New","year":"2025","cit":0,"pfa":"Paul E. Croarkin","ptype":"editorial","src":"https://openalex.org/W4408295337","eid":"W4408295337"},{"id":"paper-w4412622544","cat":"papers","name":"Oral Cephalosporin-Induced Anaphylaxis Presenting With Severe Tachycardia: A Case of Microdosed Epinephrine Over Standard Protocols","year":"2025","cit":0,"pfa":"R S Anupama","psa":"Kiran Shivaraj","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4412622544","eid":"W4412622544"},{"id":"paper-w4414097872","cat":"papers","name":"P020 Microdose via continuous spinal catheter in high-risk patient undergoing prolonged orthopedic surgery","year":"2025","cit":0,"pfa":"Abel Agulló","psa":"Daniela Nieuwveld","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W4414097872","eid":"W4414097872"},{"id":"paper-w4401908967","cat":"papers","name":"Microdosing mushroom sweet treats are recalled in US after six hospital admissions and two potential deaths","year":"2024","cit":0,"pfa":"Ingrid Torjesen","topics":["Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W4401908967","eid":"W4401908967"},{"id":"paper-w4413675858","cat":"papers","name":"Mind molding psychedelic drugs could treat depression, and other mental illnesses","year":"2018","cit":0,"pfa":"David E. Olson","topics":["Depression"],"ptype":"other","src":"https://openalex.org/W4413675858","eid":"W4413675858"},{"id":"paper-w3113477340","cat":"papers","name":"Mental health, personality and lifetime psychedelic use during the COVID-19 pandemic","year":"2020","cit":0,"pfa":"Federico Cavanna","psa":"Enzo Tagliazucchi","topics":["Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W3113477340","eid":"W3113477340"},{"id":"paper-w7111327252","cat":"papers","name":"Chronos and Kairos: The Perception of Time in Near-Death, Mystical, and Psychedelic States of Consciousness","year":"2024","cit":0,"pfa":"Mitchell Liester","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7111327252","eid":"W7111327252"},{"id":"paper-w2906540901","cat":"papers","name":"Non-contraceptive effects of microdose folate-containing oral contraceptive in patients of child bearing age","year":"2018","cit":0,"pfa":"Т.М. Sokolova","psa":"Anna V. Yakimova","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2906540901","eid":"W2906540901"},{"id":"paper-w7162531217","cat":"papers","name":"The “microdosing” dilemma: Balancing patient anecdotes with clinical safety amid GLP-1 compounding restrictions","year":"2026","cit":0,"pfa":"Nicole Trainer","topics":["Safety & adverse events","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7162531217","eid":"W7162531217"},{"id":"paper-w2755736470","cat":"papers","name":"Psi and Psychedelics; Meditation and Mysticism: Religion, Science, and Non‐Ordinary States of Consciousness","year":"2017","cit":0,"pfa":"G. William Barnard","ptype":"article","src":"https://openalex.org/W2755736470","eid":"W2755736470"},{"id":"paper-w7115717337","cat":"papers","name":"Psychedelic Immortality: Nietzschean Perspectives on Reincarnation, Femtheogens, and Philosophy [PDF, E-Book]","year":"2025","cit":0,"pfa":"Joseph I. Breidenstein Jr.","ptype":"book","src":"https://openalex.org/W7115717337","eid":"W7115717337"},{"id":"paper-w4415273185","cat":"papers","name":"Investigating Emotional Reactivity in Experienced Users of Psychedelics: a cross-sectional fMRI study","year":"2025","cit":0,"pfa":"Paweł Orlowski","psa":"Michał Bola","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4415273185","eid":"W4415273185"},{"id":"paper-w7171399190","cat":"papers","name":"The Default Mode Network as D-Apparatus: A Tholonic Hypothesis for Consciousness and Psychedelic States","year":"2026","cit":0,"pfa":"Jeffrey Milton","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7171399190","eid":"W7171399190"},{"id":"paper-w2411850561","cat":"papers","name":"Editorial (Thematic Issue: Introduction to 'Beneficial Effects of Psychedelics with a Special Focus on Addictions')","year":"2015","cit":0,"pfa":"Rudie Kortekaas","psa":"Joost J. Breeksema","topics":["Addiction"],"ptype":"editorial","src":"https://openalex.org/W2411850561","eid":"W2411850561"},{"id":"paper-w2959622313","cat":"papers","name":"Kapitel 8 Psychedelic Rock und Hardrock: Trance, Eskapismus und Ekstase","year":"2019","cit":0,"pfa":"Matthias S. Fifka","ptype":"book-chapter","src":"https://openalex.org/W2959622313","eid":"W2959622313"},{"id":"paper-w4392718684","cat":"papers","name":"Ido Hartogsohn,American Trip: Set, Setting, and the Psychedelic Experience in the Twentieth Century","year":"2024","cit":0,"pfa":"Jonathan Hal Sadowsky","ptype":"book-review","src":"https://openalex.org/W4392718684","eid":"W4392718684"},{"id":"paper-w4402897708","cat":"papers","name":"Reply to Letter to the Editor: “Psychedelics in Older Adults: Difficulties of a Clear Therapeutic Evidence”","year":"2024","cit":0,"pfa":"Hannes Kettner","psa":"Lorenzo Pasquini","ptype":"letter","src":"https://openalex.org/W4402897708","eid":"W4402897708"},{"id":"paper-w4407891207","cat":"papers","name":"From the Editor-in-Chief’s Desk: Psychedelic Therapeutics—Something Old and Something New","year":"2025","cit":0,"pfa":"Paul E. Croarkin","ptype":"editorial","src":"https://openalex.org/W4407891207","eid":"W4407891207"},{"id":"paper-w2332131163","cat":"papers","name":"To Fathom Hell or Soar Angelic: Four Psychedelic Explorers Who Changed America","year":"2011","cit":0,"pfa":"Frederick J. Heide","ptype":"article","src":"https://openalex.org/W2332131163","eid":"W2332131163"},{"id":"paper-w4378745054","cat":"papers","name":"Editorial: Appropriateness and safety of using cannabinoid and psychedelic medicines as treatments for psychiatric disorders","year":"2023","cit":0,"pfa":"Grace Blest‐Hopley","psa":"Simon Ruffell","topics":["Safety & adverse events"],"ptype":"editorial","src":"https://openalex.org/W4378745054","eid":"W4378745054"},{"id":"paper-w4401685160","cat":"papers","name":"Corrigendum to ‘Comment on: History repeating: guidelines to address common problems in psychedelic science’","year":"2024","cit":0,"ptype":"erratum","src":"https://openalex.org/W4401685160","eid":"W4401685160"},{"id":"paper-w7165118391","cat":"papers","name":"Cannabis, Psychedelics, and Other Substance Use to Manage Premenstrual Symptoms: A Survey Study","year":"2026","cit":0,"pfa":"Michelle Nazareth","psa":"Liisa V. Hantsoo","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7165118391","eid":"W7165118391"},{"id":"paper-w4390222996","cat":"papers","name":"Major psychiatric complications of psychedelic drug use: a systematic review of case reports","year":"2023","cit":0,"pfa":"B. Yildirim","psa":"Peter J. McKenna","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4390222996","eid":"W4390222996"},{"id":"paper-w7166202337","cat":"papers","name":"Extended Abstract—A Serious Game for Psychedelic Psychotherapy Training for Mental Health Professionals","year":"2026","cit":0,"pfa":"Gary Liu","psa":"David Chandross","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"conference-abstract","src":"https://openalex.org/W7166202337","eid":"W7166202337"},{"id":"paper-w7168121591","cat":"papers","name":"Shared Neurobiological and Computational Mechanisms of Psychedelic, Contemplative, and Fasting-Induced Mystical Experience","year":"2026","cit":0,"pfa":"Alex Jinich‐Diamant","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7168121591","eid":"W7168121591"},{"id":"paper-w4361947761","cat":"papers","name":"Data from Multiplexed Evaluation of Microdosed Antineoplastic Agents In Situ in the Tumor Microenvironment of Patients with Soft Tissue Sarcoma","year":"2023","cit":0,"pfa":"Kenneth R. Gundle","psa":"Robert G. Maki","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W4361947761","eid":"W4361947761"},{"id":"paper-w7214203692","cat":"papers","name":"Response to Świeczkowski et al. (2025) on “Public attitudes toward psychedelics in Poland”","year":"2026","cit":0,"pfa":"Paweł Holas","ptype":"article","src":"https://openalex.org/W7214203692","eid":"W7214203692"},{"id":"paper-w7143376866","cat":"papers","name":"Clinical Updates Track: Expert Guidance on Deprescribing, Polypharmacy, PTSD, Psychedelics, and More","year":"2026","cit":0,"pfa":"Linda M. Richmond","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W7143376866","eid":"W7143376866"},{"id":"paper-w1197114239","cat":"papers","name":"Led Zeppelin’s ‘Dazed and Confused’: From lament to psychedelic tour de force","year":"2013","cit":0,"pfa":"Stephen Loy","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1197114239","eid":"W1197114239"},{"id":"paper-w2955312899","cat":"papers","name":"Abstract 2155: High-plex spatial profiling analysis of multidrug CIVO microdose studies in cancer patients","year":"2019","cit":0,"pfa":"Gary B. Deutsch","psa":"Robert G. Maki","topics":["Anxiety & end-of-life","Dosing & pharmacology","Policy & ethics"],"ptype":"conference-abstract","src":"https://openalex.org/W2955312899","eid":"W2955312899"},{"id":"paper-w2601988776","cat":"papers","name":"Psychedelic Mysticism: Transforming Consciousness, Religious Experiences, and Voluntary Peasants in Postwar America","year":"2017","cit":0,"pfa":"Wesley G. Phelps","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2601988776","eid":"W2601988776"},{"id":"paper-w7171410567","cat":"papers","name":"The Default Mode Network as D-Apparatus: A Tholonic Hypothesis for Consciousness and Psychedelic States","year":"2026","cit":0,"pfa":"Jeffrey Milton","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7171410567","eid":"W7171410567"},{"id":"paper-w7214663445","cat":"papers","name":"EEG Correlates of Subjective Experience During and Following Psychedelic in Humans: A Scoping Review","year":"2026","cit":0,"pfa":"Brandon Richardson","psa":"Yiming Xiao","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"other","src":"https://openalex.org/W7214663445","eid":"W7214663445"},{"id":"paper-w3011235542","cat":"papers","name":"Psychedelics worldwide: difficult experiences (‘bad trips’), micro-dosing and ceremonial use","year":"2017","cit":0,"pfa":"Monica Jane Barratt","psa":"ADAM R. WINSTOCK","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3011235542","eid":"W3011235542"},{"id":"paper-w4414513489","cat":"papers","name":"Self-Integration after Recreational Psychedelic Use: Is it a Bulwark against Identity Disturbance?","year":"2025","cit":0,"pfa":"Jack Versace","psa":"James Rucker","topics":["Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4414513489","eid":"W4414513489"},{"id":"paper-w4415258943","cat":"papers","name":"Toward the Enlightened Self: How Mindfulness and Psychedelics Relate to Self-Transcendence and Connectedness","year":"2025","cit":0,"pfa":"Minka Witke","psa":"Paweł Holas","ptype":"preprint","src":"https://openalex.org/W4415258943","eid":"W4415258943"},{"id":"paper-w2808647292","cat":"papers","name":"Alternativne (glasbene) vsebine, klasični nosilci : primer It's Psychedelic Baby Magazine","year":"2018","cit":0,"pfa":"Klemen Breznikar","ptype":"dissertation","src":"https://openalex.org/W2808647292","eid":"W2808647292"},{"id":"paper-w7167839970","cat":"papers","name":"A Psychedelic Reorientation to Death: Implications for how we attend to the fear and anxiety of death","year":"2023","cit":0,"pfa":"Sean Willard","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7167839970","eid":"W7167839970"},{"id":"paper-w4405162614","cat":"papers","name":"3 The Psychedelic (R)Evolution: Timothy Leary, Richard Alpert, and the Beat Generation","year":"2023","cit":0,"pfa":"Robert J. Campbell","ptype":"book-chapter","src":"https://openalex.org/W4405162614","eid":"W4405162614"},{"id":"paper-w4401903087","cat":"papers","name":"Psychedelic Use in Psychiatry Demands New Informed Consent Process, Bioethicists Say","year":"2024","cit":0,"pfa":"Linda M. Richmond","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4401903087","eid":"W4401903087"},{"id":"paper-w2415032955","cat":"papers","name":"[Results of microdoses of oral aureomycin and intradermal vaccine in therapy of brucellosis, based on a large number of case reports].","year":"1956","cit":0,"pfa":"G CARMINATI","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2415032955","eid":"W2415032955"},{"id":"paper-w4416126912","cat":"papers","name":"Facing trauma under the influence of psychedelics: A phenomenological study with Nova rave survivors","year":"2025","cit":0,"pfa":"Guy Simon","psa":"Demian Halperin","topics":["PTSD & trauma","Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4416126912","eid":"W4416126912"},{"id":"paper-w3091549457","cat":"papers","name":"Microdosing of para-amino-hypuric acid in blood and urine; studied in view of the determination of the clearance of this substance (transl.).","year":"1949","cit":0,"pfa":"J HAMBURGER","psa":"Rycekwaert","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3091549457","eid":"W3091549457"},{"id":"paper-w2099288009","cat":"papers","name":"Midluteal use of GnRH antagonist with microdose protocol in poor responders undergoing ICSI: effects on the follicular dynamics.","year":"2001","cit":0,"pfa":"Ömür Taşkın","psa":"J.M Wheeler","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2099288009","eid":"W2099288009"},{"id":"paper-w7153070553","cat":"papers","name":"Health news round-up: dementia, GLP-1 genetics and psychedelics breakthrough","year":"2026","cit":0,"ptype":"article","src":"https://openalex.org/W7153070553","eid":"W7153070553"},{"id":"paper-w7170685056","cat":"papers","name":"The varieties of integration processes: Four pathways following psychedelic and other exceptional experiences","year":"2026","cit":0,"pfa":"Joelle Adams","psa":"David P. Luke","topics":["Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7170685056","eid":"W7170685056"},{"id":"paper-w4413525594","cat":"papers","name":"How ‘nones’ − the religiously unaffiliated − are finding meaning, purpose and spirituality in psychedelic churches","year":"2023","cit":0,"pfa":"Morgan Shipley","ptype":"other","src":"https://openalex.org/W4413525594","eid":"W4413525594"},{"id":"paper-w4389078720","cat":"papers","name":"Tripping in Karachi: Exploring the Intersection of Gender and Its Fluidity through Psychedelic Substances","year":"2023","cit":0,"pfa":"Manal Khan","topics":["Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W4389078720","eid":"W4389078720"},{"id":"paper-w7215035393","cat":"papers","name":"Agarikon: A Screened Index of Psychedelic Medicine - Clinics, Trials, Researchers, Legislation, and Industry","year":"2026","cit":0,"pfa":"Erich Mayne","topics":["Policy & ethics"],"ptype":"dataset","src":"https://openalex.org/W7215035393","eid":"W7215035393"},{"id":"paper-w3145730080","cat":"papers","name":"Calculation of survival rates and effective inactivation cross sections of targets for fast neutrons based on microdose concept","year":"1971","cit":0,"pfa":"沼宮内 弼雄","psa":"織田 暢夫","topics":["Dosing & pharmacology"],"ptype":"report","src":"https://openalex.org/W3145730080","eid":"W3145730080"},{"id":"paper-w4386536362","cat":"papers","name":"Proceedings of the 1st International Conference of Microdosing (ICM 2023): Online Conference, September 13-15, 2023","year":"2023","cit":0,"pfa":"Diego González-Rodriguez","psa":"Víctor Lucía","topics":["Dosing & pharmacology"],"ptype":"book","src":"https://openalex.org/W4386536362","eid":"W4386536362"},{"id":"paper-w4394755796","cat":"papers","name":"Expanding Mindscapes: A Global History of Psychedelics, edited by Erika Dyck and Chris Elcock","year":"2024","cit":0,"pfa":"Andrea Ens","ptype":"book-review","src":"https://openalex.org/W4394755796","eid":"W4394755796"},{"id":"paper-w4392816451","cat":"papers","name":"Dietary niche of the endangered Psychedelic Rock Gecko (Cnemaspis psychedelica) in southern Vietnam","year":"2024","cit":0,"pfa":"Hai Ngoc Ngo","psa":"Thomas Ziegler","ptype":"article","src":"https://openalex.org/W4392816451","eid":"W4392816451"},{"id":"paper-w4401587941","cat":"papers","name":"‘Psychedelic’ as Mind-Revealing: Psychological Processes in the Subjective Experience That Drive Positive Change","year":"2024","cit":0,"pfa":"Rúna F. E. Walther","psa":"Hein T. van Schie","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4401587941","eid":"W4401587941"},{"id":"paper-w7196964304","cat":"papers","name":"Integrating meditation and psychedelics knowledge to identify core neurocognitive mechanisms of minimal selfhood.","year":"2026","cit":0,"pfa":"Amber Bunting","psa":"Vince Polito","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7196964304","eid":"W7196964304"},{"id":"paper-w4404690500","cat":"papers","name":":Tripping on Utopia: Margaret Mead, the Cold War and the Troubled Birth of Psychedelic Science","year":"2024","cit":0,"pfa":"Andrew Jones","ptype":"book-review","src":"https://openalex.org/W4404690500","eid":"W4404690500"},{"id":"paper-w7117656360","cat":"papers","name":"Exploring self-reported health behavior change following naturalistic psychedelic use","year":"2025","cit":0,"pfa":"Laura Lopes de Carvalho","psa":"Pedro J. Teixeira","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7117656360","eid":"W7117656360"},{"id":"paper-w4411083839","cat":"papers","name":":Psychedelics: The Revolutionary Drugs That Could Change Your Life—a Guide from the Expert","year":"2025","cit":0,"pfa":"Himesh Mehta","ptype":"book-review","src":"https://openalex.org/W4411083839","eid":"W4411083839"},{"id":"paper-w4409256141","cat":"papers","name":"Mind, Matter, and Mushroom: Shifting Ontological Understandings of Psychedelic Healing and Legitimate Knowledge","year":"2025","cit":0,"pfa":"Piers Eaton","ptype":"article","src":"https://openalex.org/W4409256141","eid":"W4409256141"},{"id":"paper-w7123674550","cat":"papers","name":"Open-Ended Inquiry of Psychedelic Experiences via First-Person Methodologies and Neurophenomenology","year":"2025","cit":0,"pfa":"Christopher B. Timmermann","ptype":"book-chapter","src":"https://openalex.org/W7123674550","eid":"W7123674550"},{"id":"paper-w3046534729","cat":"papers","name":"EFEITOS DA MICRODOSE DE ÍONS DE LÍTIO PARA A VIABILIDADE CÉLULAS DE ASTRÓCITOS HUMANOS","year":"2020","cit":0,"pfa":"Julia Jayme Maia","psa":"Guilherme de Souza Abrão","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W3046534729","eid":"W3046534729"},{"id":"paper-w7162454608","cat":"papers","name":"Persisting Psychological Complications Following the Use of Classic Psychedelics: A Qualitative Study of Help-Seeking Experiences","year":"2026","cit":0,"pfa":"Lisa Maria Joebstl","psa":"Tomislav Majić","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W7162454608","eid":"W7162454608"},{"id":"paper-w2990258629","cat":"papers","name":"How to change Michael Pollan’s mind: a critical analysis of ‘addiction’, spirituality, and psychedelics","year":"2019","cit":0,"pfa":"Max Henderson","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2990258629","eid":"W2990258629"},{"id":"paper-w4390223347","cat":"papers","name":"Serotonergic psychedelics — evaluating its potential as a therapeutic weapon in autism spectrum disorder","year":"2023","cit":0,"pfa":"S. Lopes","psa":"Ana Samouco","ptype":"article","src":"https://openalex.org/W4390223347","eid":"W4390223347"},{"id":"paper-w7122837226","cat":"papers","name":"The mushrooming of the psychedelic renaissance: A scoping review identifying trends in ongoing clinical trials","year":"2026","cit":0,"pfa":"Lucas M Wittenkeller","psa":"Davide Amato","topics":["Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7122837226","eid":"W7122837226"},{"id":"paper-w7154591012","cat":"papers","name":"Integrating consciousness, culture, and clinical practice: A comprehensive review of modern psychedelic research","year":"2026","cit":0,"pfa":"Asif Raihan","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7154591012","eid":"W7154591012"},{"id":"paper-w7132982662","cat":"papers","name":"Binding experiences on young university students of Medellin mediated by the psychedelic effects of LSD","year":"2014","cit":0,"pfa":"Jaime Andrés Vinasco Barco","ptype":"article","src":"https://openalex.org/W7132982662","eid":"W7132982662"},{"id":"paper-w7152618435","cat":"papers","name":"Investigating Emotional Reactivity in Experienced Users of Psychedelics: A Cross‐Sectional fMRI Study","year":"2026","cit":0,"pfa":"Paweł Orlowski","psa":"Michał Bola","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7152618435","eid":"W7152618435"},{"id":"paper-w4313199454","cat":"papers","name":"Psychodysleptic plants and fungi used by brazilian traditional communities: possibilities for the development of microdosing pharmacotherapy in psychiatric treatments","year":"2022","cit":0,"pfa":"Emanuella Sousa Rodrigues","psa":"Maria Francenilda Gualberto de Oliveira","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4313199454","eid":"W4313199454"},{"id":"paper-w1983177665","cat":"papers","name":"Introduction microdoses of neuroactive substances (NAS) to the patients with cerebral palsy through chronic intracerebral chemoelectrodes (CHICHE)","year":"1993","cit":0,"pfa":"V. Rymar","psa":"L. Lebedev","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1983177665","eid":"W1983177665"},{"id":"paper-w4415820724","cat":"papers","name":"Psychedelics muddy fMRI results: Q&A with Adam Bauer and Jonah Padawer-Curry","year":"2025","cit":0,"pfa":"Calli McMurray","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4415820724","eid":"W4415820724"},{"id":"paper-w2181338681","cat":"papers","name":"The Origins of the Psychedelic Movement Through the Lens of The Electric Kool-Aid Acid Test","year":"2011","cit":0,"pfa":"Eleonora De Crescenzo","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2181338681","eid":"W2181338681"},{"id":"paper-w4393026115","cat":"papers","name":"Plant Psychedelics In The English Courts: Legal Uncertainty, Guinea Pigs, and “Dog Law”","year":"2015","cit":0,"pfa":"Charlotte Walsh","topics":["Policy & ethics"],"ptype":"other","src":"https://openalex.org/W4393026115","eid":"W4393026115"},{"id":"paper-w4407230410","cat":"papers","name":"Is it now time to prepare psychiatry for a psychedelic future?: commentary, Breen et al","year":"2025","cit":0,"pfa":"Eugene G. Breen","psa":"Faisal Al-Harbi","ptype":"article","src":"https://openalex.org/W4407230410","eid":"W4407230410"},{"id":"paper-w7112077978","cat":"papers","name":"Validation of the French Version of the Watts Connectedness Scale (WCS) in a sample of psychedelic users","year":"2025","cit":0,"pfa":"federico seragnoli","ptype":"preprint","src":"https://openalex.org/W7112077978","eid":"W7112077978"},{"id":"paper-w7164671242","cat":"papers","name":"Barriers and Facilitators for Psychedelic Research and Regulation in Brazil: Insights From Diverse Stakeholders","year":"2026","cit":0,"pfa":"Anna Luiza Guimarães","psa":"Daniel C. Mograbi","topics":["Safety & adverse events","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7164671242","eid":"W7164671242"},{"id":"paper-w7167811295","cat":"papers","name":"Personality changes following first-time psychedelic use in college students in Germany","year":"2026","cit":0,"pfa":"Constantin Volkmann","psa":"Felix Betzler","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7167811295","eid":"W7167811295"},{"id":"paper-w7117984998","cat":"papers","name":"Quantification of psychedelic occupancy using [11C]Cimbi-36 PET: methodological considerations","year":"2026","cit":0,"pfa":"K. Ridler","psa":"Eugenii A. Rabiner","ptype":"article","src":"https://openalex.org/W7117984998","eid":"W7117984998"},{"id":"paper-w7172538819","cat":"papers","name":"Environmental and Endogenous Psychedelics as Adaptive Plasticity Modulators: An Integrative Systems Biology Framework","year":"2026","cit":0,"pfa":"Kaya Genc","psa":"James Franciscus Barkell","topics":["Safety & adverse events","Policy & ethics"],"ptype":"dataset","src":"https://openalex.org/W7172538819","eid":"W7172538819"},{"id":"paper-w7135768063","cat":"papers","name":"Comparison of NDE and similar experiences from LSD, DMT and ketamine psychedelic sessions","year":"2010","cit":0,"pfa":"Michal Grus","ptype":"dissertation","src":"https://openalex.org/W7135768063","eid":"W7135768063"},{"id":"paper-w4312477337","cat":"papers","name":"Psychedelics and Veterans' Mental Health: The Evolving Legal and Policy Landscape in the United States","year":"2022","cit":0,"pfa":"Bryce Pardo","psa":"Carrie M. Farmer","topics":["Policy & ethics"],"ptype":"book","src":"https://openalex.org/W4312477337","eid":"W4312477337"},{"id":"paper-w4401236036","cat":"papers","name":"11 Microdosed Yohimbine as CYP2D6 Probe Drug in Pediatric Heart Patients aged 6 Months to 6 Years","year":"2024","cit":0,"pfa":"Victoria C. Ziesenitz","psa":"Matthias Gorenflo","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"conference-paper","src":"https://openalex.org/W4401236036","eid":"W4401236036"},{"id":"paper-w4408172778","cat":"papers","name":"Integrated Advancements in Neuroplasticity, Psychedelic Therapeutics, and AI-Driven Innovations for Precision Medicine","year":"2025","cit":0,"pfa":"Robert B. Kargbo","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"editorial","src":"https://openalex.org/W4408172778","eid":"W4408172778"},{"id":"paper-w4410502998","cat":"papers","name":"0414 The Interaction of Historical Psychedelic Use and Time Spent in Bed on Sleep Architecture","year":"2025","cit":0,"pfa":"April Roper","psa":"Janeese A. Brownlow","ptype":"conference-abstract","src":"https://openalex.org/W4410502998","eid":"W4410502998"},{"id":"paper-w4411880048","cat":"papers","name":"The effect of medial prefrontal cortex inactivation on psychedelic-mediated emergence from anesthesia","year":"2025","cit":0,"pfa":"Andres Villegas Calderon","psa":"Dinesh Pal","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4411880048","eid":"W4411880048"},{"id":"paper-w4410857711","cat":"papers","name":"Rosalind Franklin Society Proudly Announces the 2024 Award Recipient for Psychedelic Medicine","year":"2025","cit":0,"pfa":"Brian Scott Barnett","ptype":"article","src":"https://openalex.org/W4410857711","eid":"W4410857711"},{"id":"paper-w4414855621","cat":"papers","name":"From trips to treatments: how psychedelics could revolutionise anti-inflammatory medicine","year":"2025","cit":0,"pfa":"Nicholas M. Barnes","ptype":"other","src":"https://openalex.org/W4414855621","eid":"W4414855621"},{"id":"paper-w7168963832","cat":"papers","name":"Integrated 5-HT2A–TrkB and G protein signaling in serotonergic psychedelic responses","year":"2026","cit":0,"pfa":"Marco Taddei-Tardon","psa":"Juan F. López‐Giménez","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7168963832","eid":"W7168963832"},{"id":"paper-w7215037650","cat":"papers","name":"Agarikon: A Screened Index of Psychedelic Medicine - Clinics, Trials, Researchers, Legislation, and Industry","year":"2026","cit":0,"pfa":"Erich Mayne","topics":["Policy & ethics"],"ptype":"dataset","src":"https://openalex.org/W7215037650","eid":"W7215037650"},{"id":"paper-w2750449963","cat":"papers","name":"Aliran Seni Psychedelic Dalam Karya Seni Batik Lukis Dan Bordir","year":"2017","cit":0,"pfa":"Rossyta Wahyutiar","ptype":"dissertation","src":"https://openalex.org/W2750449963","eid":"W2750449963"},{"id":"paper-w4240468789","cat":"papers","name":"7. Isaac Hayes and Hot Buttered (Orchestral) Soul, from Psychedelic to Progressive","year":"2021","cit":0,"pfa":"John Howland","ptype":"book-chapter","src":"https://openalex.org/W4240468789","eid":"W4240468789"},{"id":"paper-w2058407704","cat":"papers","name":"Review of A Handbook of Psychoactive Medicines: Tranquilizers, Antidepressants, Sedatives, Stimulants, Narcotics, and Psychedelics.","year":"1983","cit":0,"pfa":"George V. Rebec","topics":["Depression","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2058407704","eid":"W2058407704"},{"id":"paper-w7168342648","cat":"papers","name":"From Schedule I to the Clinic—Insights Into Psychedelic Drug Development From GHB","year":"2026","cit":0,"pfa":"Brian Scott Barnett","psa":"Franklin King","topics":["Addiction","Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7168342648","eid":"W7168342648"},{"id":"paper-w2769954835","cat":"papers","name":"Understanding Variability in Maize Yield and Profitability Under Fertiliser Microdosing Technology in Farmer's Fields in Northern Benin","year":"2017","cit":0,"pfa":"Gbènoukpo Pierre Tovihoudji","psa":"Charles Louis Bielders","topics":["Dosing & pharmacology"],"ptype":"conference-paper","src":"https://openalex.org/W2769954835","eid":"W2769954835"},{"id":"paper-w4386465161","cat":"papers","name":"Proceedings of the 1st International Conference of Microdosing (ICM 2023): Online Conference, September 13-15, 2023","year":"2023","cit":0,"pfa":"Diego González-Rodriguez","psa":"Víctor Lucía","topics":["Dosing & pharmacology"],"ptype":"book","src":"https://openalex.org/W4386465161","eid":"W4386465161"},{"id":"paper-w2950480972","cat":"papers","name":"ChemInform Abstract: STERIC EFFECTS OF SUBSTITUENTS ON PHENETHYLAMINE HALLUCINOGENS. 3,4‐(METHYLENEDIOXY)AMPHETAMINE ANALOGS ALKYLATED ON THE DIOXOLE RING","year":"1980","cit":0,"pfa":"David E. Nichols","psa":"Linda J. Kostuba","ptype":"article","src":"https://openalex.org/W2950480972","eid":"W2950480972"},{"id":"paper-w4405733984","cat":"papers","name":"Navigating Buprenorphine Therapy: A Closer Look at Microdosing vs. Macrodosing for Pain Management and Opioid Addiction – A Narrative Review","year":"2024","cit":0,"pfa":"Zachary Isaac Merhavy","psa":"Jonathan Quinonez","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W4405733984","eid":"W4405733984"},{"id":"paper-w4242396537","cat":"papers","name":"Editorial (Thematic Issue: Introduction to 'Beneficial Effects of Psychedelics with a Special Focus on Addictions')","year":"2015","cit":0,"pfa":"Joost J. Breeksema","psa":"Rudie Kortekaas","topics":["Addiction"],"ptype":"editorial","src":"https://openalex.org/W4242396537","eid":"W4242396537"},{"id":"paper-w7162330036","cat":"papers","name":"Effects of serotonergic psychedelics in non-clinical settings : a systematic review and meta-analysis","year":"2025","cit":0,"pfa":"Baptiste Fauvel","psa":"Isabelle Varescon","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W7162330036","eid":"W7162330036"},{"id":"paper-w7130469827","cat":"papers","name":"Can a psychedelic-induced mystical experience really improve your mental health?","year":"2026","cit":0,"pfa":"Michiel van Elk","ptype":"other","src":"https://openalex.org/W7130469827","eid":"W7130469827"},{"id":"paper-w2619284386","cat":"papers","name":"Plant Alkaloids: Drugs, Toxins and Psychedelics. Some of natures threats to food security","year":"2012","cit":0,"pfa":"Katrina Campbell","ptype":"conference-paper","src":"https://openalex.org/W2619284386","eid":"W2619284386"},{"id":"paper-w4400676780","cat":"papers","name":"Counseling Patients About Psychedelics: Information About Safe, Controlled Settings Is Key","year":"2024","cit":0,"pfa":"Mark Moran","ptype":"article","src":"https://openalex.org/W4400676780","eid":"W4400676780"},{"id":"paper-w4407418738","cat":"papers","name":"KNOWLEDGE AND OPINIONS ABOUT THE USE OF PSYCHEDELICS AMONG PSYCHIATRISTS IN KOREA: PRELIMINARY RESULTS","year":"2025","cit":0,"pfa":"InKi Sohn","psa":"Duk‐In Jon","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"conference-abstract","src":"https://openalex.org/W4407418738","eid":"W4407418738"},{"id":"paper-w4414324666","cat":"papers","name":"AbbVie Embraces Psychedelic Drug with Up-to-$1.2B Deal for Gilgamesh's MDD Candidate","year":"2025","cit":0,"pfa":"Alex Philippidis","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4414324666","eid":"W4414324666"},{"id":"paper-w7212303929","cat":"papers","name":"Characterizing Psychedelic-Evoked Familiarity: A Comparative Study with Autobiographical and Déjà Vu Experiences","year":"2026","cit":0,"pfa":"David Wyndham Lawrence","psa":"Akira R. O’Connor","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7212303929","eid":"W7212303929"},{"id":"paper-w2110654492","cat":"papers","name":"Growth Hormone Supplementation in the Luteal Phase Prior to Microdose GnRH Agonist Flare Protocol for In Vitro Fertilization","year":"2014","cit":0,"pfa":"Caitlin Dunne","psa":"Jeffrey Roberts","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2110654492","eid":"W2110654492"},{"id":"paper-w4405306500","cat":"papers","name":"Science ’s Breakthrough of the Year, and psychedelic drugs, climate, and fusion technology updates","year":"2024","cit":0,"ptype":"dataset","src":"https://openalex.org/W4405306500","eid":"W4405306500"},{"id":"paper-w4362494973","cat":"papers","name":"Supplementary Data from Microdose-Induced Drug–DNA Adducts as Biomarkers of Chemotherapy Resistance in Humans and Mice","year":"2023","cit":0,"pfa":"Maike Zimmermann","psa":"Paul T. Henderson","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4362494973","eid":"W4362494973"},{"id":"paper-w7131283556","cat":"papers","name":"Floorless closed-loop microdosing for rail friction: a physics-only digital twin on Kuwait city’s blue corridor","year":"2026","cit":0,"pfa":"A M Mohammed","topics":["Safety & adverse events","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7131283556","eid":"W7131283556"},{"id":"paper-w7163181486","cat":"papers","name":"Street Pharmacology: The Mechanistic Basis of Clinical Pharmacology Underlying the Microdosing Method of Buprenorphine–Naloxone With a Focus on the Unhoused Population","year":"2026","cit":0,"pfa":"David F. Lehmann","psa":"Mia Ruiz‐Salvador","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7163181486","eid":"W7163181486"},{"id":"paper-w3212850315","cat":"papers","name":"‘DELICATE FEMALES’ AND PSYCHEDELIC CREATION IN THE SCIENTIFIC EXPERIMENTS OF THOMAS BEDDOES AND HUMPHRY DAVY","year":"2021","cit":0,"pfa":"Kimberley Page-Jones","ptype":"book-chapter","src":"https://openalex.org/W3212850315","eid":"W3212850315"},{"id":"paper-w7112012633","cat":"papers","name":"Analyzing the Effects of Psychedelic Experience on Social Connectedness with a New Measure: The Aliveness Task","year":"2023","cit":0,"pfa":"Dixon, Christie Elizabeth","ptype":"dissertation","src":"https://openalex.org/W7112012633","eid":"W7112012633"},{"id":"paper-w7135072125","cat":"papers","name":"Expression of Concern: “A Qualitative Exploration of Relational Ethical Challenges and Practices in Psychedelic Healing”","year":"2026","cit":0,"topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7135072125","eid":"W7135072125"},{"id":"paper-w4252851218","cat":"papers","name":"Faculty Opinions recommendation of PSD-95 is essential for hallucinogen and atypical antipsychotic drug actions at serotonin receptors.","year":"2009","cit":0,"pfa":"Venkatesh N. Murthy","topics":["Mechanism & neuroscience"],"ptype":"peer-review","src":"https://openalex.org/W4252851218","eid":"W4252851218"},{"id":"paper-w7154561636","cat":"papers","name":"Emerging therapeutics and safety: Transdisciplinary science to address unique safety challenges of cannabis and psychedelics","year":"2026","cit":0,"pfa":"Maxwell C. K. Leung","psa":"William Slikker","topics":["Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W7154561636","eid":"W7154561636"},{"id":"paper-w3090176086","cat":"papers","name":"Clinical microdosing of antibiotics; adaptation to a method derived from the slide cell of the glucose-P technique. S. P.","year":"1947","cit":0,"pfa":"YVES A. CHABBERT","psa":"B Sureau","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3090176086","eid":"W3090176086"},{"id":"paper-w261513293","cat":"papers","name":"Méthodes alternatives: Expérimentation. Des microdoses de sucres, une piste de lutte contre les ravageurs","year":"2013","cit":0,"pfa":"Emmanuelle Thomas","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W261513293","eid":"W261513293"},{"id":"paper-w251690204","cat":"papers","name":"Making a Little Go a Long Way: The Socio-economic Factors Influencing the Adoption of Fertilizer Microdosing in Northwest Benin","year":"2015","cit":0,"pfa":"Erika Bachmann","topics":["Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W251690204","eid":"W251690204"},{"id":"paper-w2887225880","cat":"papers","name":"Abstract CT142: Multidrug analyses in cancer patients via intratumoral microdosing with CIVO: A functional approach to precision oncology","year":"2018","cit":0,"pfa":"Matthew J. Thompson","psa":"Seth M. Pollack","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W2887225880","eid":"W2887225880"},{"id":"paper-w3133648928","cat":"papers","name":"Phase 0 clinical trial of microdose ABY-029 for fluorescence guided surgery of oral squamous cell carcinomas","year":"2021","cit":0,"pfa":"Kimberley S. Samkoe","psa":"Keith D. Paulsen","topics":["Dosing & pharmacology"],"ptype":"conference-paper","src":"https://openalex.org/W3133648928","eid":"W3133648928"},{"id":"paper-w4386535829","cat":"papers","name":"Proceedings of the 1st International Conference of Microdosing (ICM 2023): Online Conference, September 13-15, 2023","year":"2023","cit":0,"pfa":"Diego González-Rodriguez","psa":"Víctor Lucía","topics":["Dosing & pharmacology"],"ptype":"book","src":"https://openalex.org/W4386535829","eid":"W4386535829"},{"id":"paper-w2804630158","cat":"papers","name":"Study of Ultra‐Sensitive AMS Method to Identify Drug–Drug Interactions between Ciprofloxacin and Microdose 14C‐Caffeine","year":"2018","cit":0,"pfa":"Gwan‐Ho Lee","psa":"Byung Yong Yu","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2804630158","eid":"W2804630158"},{"id":"paper-w4315749196","cat":"papers","name":"A conference unlike any other: Breaking Convention: The 3rd International Conference on Psychedelic Consciousness","year":"2016","cit":0,"pfa":"Steliana Yanakieva","ptype":"article","src":"https://openalex.org/W4315749196","eid":"W4315749196"},{"id":"paper-w4395104890","cat":"papers","name":"Decolonizing Western psychedelic consciousness: The therapeutic and social implications of Indigenous plant medicine knowledge","year":"2021","cit":0,"pfa":"Jarrett Robert Rose","ptype":"article","src":"https://openalex.org/W4395104890","eid":"W4395104890"},{"id":"paper-w2572815755","cat":"papers","name":"Hallucinogen use is associated with a decreased likelihood of positive urine drug screen following entry into community corrections supervision","year":"2017","cit":0,"pfa":"Peter S. Hendricks","psa":"Karen L. Cropsey","ptype":"article","src":"https://openalex.org/W2572815755","eid":"W2572815755"},{"id":"paper-w1989795162","cat":"papers","name":"P.6.d.018 Serotonin transporter and 5-HT2A receptor binding in human ecstasy and hallucinogen users","year":"2009","cit":0,"pfa":"David Erritzøe","psa":"Gitte M. Knudsen","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1989795162","eid":"W1989795162"},{"id":"paper-w2569936237","cat":"papers","name":"An evaluation of the first-pass effect of YH4808 absorption using the accelerator mass spectrometry-based microdosing study","year":"2017","cit":0,"pfa":"Anhye Kim","psa":"Howard Lee","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2569936237","eid":"W2569936237"},{"id":"paper-w2599804852","cat":"papers","name":"Microdose fertilization enhances maize yields but exacerbates nutrient mining in maize cropping systems in northern Benin","year":"2017","cit":0,"pfa":"Gbènoukpo Pierre Tovihoudji","psa":"Charles Louis Bielders","topics":["Dosing & pharmacology"],"ptype":"conference-paper","src":"https://openalex.org/W2599804852","eid":"W2599804852"},{"id":"paper-w311324045","cat":"papers","name":"CALCULATION OF SURVIVAL RATES AND EFFECTIVE INACTIVATION CROSS SECTIONS OF TARGETS FOR HEAVY CHARGED PARTICLES BASED ON MICRODOSE CONCEPT.","year":"1969","cit":0,"pfa":"Takao Numakunai","psa":"Nobuhiro Oda","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W311324045","eid":"W311324045"},{"id":"paper-w2563576810","cat":"papers","name":"An Introduction to the Psychedelic Pastoral: Tracing Mind-Altering Plant Life Into the Modern Industrialized West","year":"2016","cit":0,"pfa":"Amy Nicole Buck","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2563576810","eid":"W2563576810"},{"id":"paper-w4313624830","cat":"papers","name":"The Acid Room: The Psychedelic Trials and Tribulations of Hollywood Hospital. Erika Dyck and Jesse Donaldson","year":"2022","cit":0,"pfa":"Dan Malleck","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4313624830","eid":"W4313624830"},{"id":"paper-w7106119494","cat":"papers","name":"CORRELATION BETWEEN THE PSYCHEDELIC EXPERIENCE INDUCED BY VIRTUAL REALITY AND THE COGNITIVE FLEXIBILITY OF UNIVERSITY STUDENTS","year":"2025","cit":0,"pfa":"PUENTE, Camila Casares","psa":"BARROS, Raquel da Silva","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7106119494","eid":"W7106119494"},{"id":"paper-w4303182628","cat":"papers","name":"What Conceptual Metaphors Appear in Texts on Psychedelics and Medicine? Corpus-Based Cognitive Study","year":"2022","cit":0,"pfa":"Milena Bryła","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4303182628","eid":"W4303182628"},{"id":"paper-w4380876847","cat":"papers","name":"Faculty Opinions recommendation of Psychedelics promote plasticity by directly binding to BDNF receptor TrkB.","year":"2023","cit":0,"pfa":"Lennart Brodin","topics":["Mechanism & neuroscience"],"ptype":"peer-review","src":"https://openalex.org/W4380876847","eid":"W4380876847"},{"id":"paper-w4408352225","cat":"papers","name":"Review for \"Serotonergic Psychedelics Rapidly Modulate Evoked Glutamate Release in Cultured Cortical Neurons\"","year":"2024","cit":0,"topics":["Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4408352225","eid":"W4408352225"},{"id":"paper-w7133860873","cat":"papers","name":"Adverse outcomes following psychedelic use in adolescents and adults: associations with age and personality traits","year":"2026","cit":0,"pfa":"David Sjöström","psa":"Petri Kajonius","topics":["Safety & adverse events"],"ptype":"other","src":"https://openalex.org/W7133860873","eid":"W7133860873"},{"id":"paper-w4290600932","cat":"papers","name":"Revisionary metaphysics in Ken Russell’s Altered States (1980): on the ontological subversiveness of psychedelic sequences","year":"2022","cit":0,"pfa":"Vik Verplanken","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4290600932","eid":"W4290600932"},{"id":"paper-w4414345701","cat":"papers","name":"More research needed into psychedelics for mental illness treatment, says Royal College of Psychiatrists","year":"2025","cit":0,"topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4414345701","eid":"W4414345701"},{"id":"paper-w3094696562","cat":"papers","name":"Adoption de la technique de fertilisation par microdose comme stratégie d’adaptation au changement climatique","year":"2019","cit":0,"pfa":"Ichaou Mounirou","psa":"Jérémie Yebou","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3094696562","eid":"W3094696562"},{"id":"paper-w2002741483","cat":"papers","name":"Body & brain: Lab study probes psychoactive drug: Harnessing hallucinogen could bring better pain treatments","year":"2011","cit":0,"pfa":"Laura Sanders","ptype":"article","src":"https://openalex.org/W2002741483","eid":"W2002741483"},{"id":"paper-w608421269","cat":"papers","name":"The hallucinogen‐like effects of N,N‐dipropyltryptamine are mediated by 5‐HT 1A and 5‐HT 2A receptors in the mouse","year":"2007","cit":0,"pfa":"William E. Fantegrossi","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W608421269","eid":"W608421269"},{"id":"paper-w2417124665","cat":"papers","name":"[Epidemiologic and clinical features of infectious hepatitis in children against a background of massive prevention of the disease with microdoses of gamma-globulin].","year":"1976","cit":0,"pfa":"V A Kamenskiĭ","psa":"A S Borisov","topics":["Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W2417124665","eid":"W2417124665"},{"id":"paper-w7161094209","cat":"papers","name":"Production and Mixing of the EP “Malares Robo”: Contemporary Explorations of Latin American Psychedelic Rock","year":"2025","cit":0,"pfa":"Juan Sebastian Romero Veloza","ptype":"dissertation","src":"https://openalex.org/W7161094209","eid":"W7161094209"},{"id":"paper-w3184556274","cat":"papers","name":"Bio-Inspired Optimization of a Fuzzy System Inference for the Generation of Psychedelic Effects in Digital Images","year":"2021","cit":0,"pfa":"Linda Rodríguez","psa":"Helbert Espitia","ptype":"article","src":"https://openalex.org/W3184556274","eid":"W3184556274"},{"id":"paper-w7125974078","cat":"papers","name":"The PRISM Framework: Integrating Psychological, Regulatory, Behavioral, and Translational Domains in Psychedelic Clinical Trials","year":"2026","cit":0,"pfa":"Kat Poteet","topics":["Safety & adverse events","Dosing & pharmacology","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7125974078","eid":"W7125974078"},{"id":"paper-w7135444103","cat":"papers","name":"Strategies and possibilities of musical practice of Prague's psychedelic rock bands during the coronavirus pandemic","year":"2023","cit":0,"pfa":"Adam Šebek","ptype":"dissertation","src":"https://openalex.org/W7135444103","eid":"W7135444103"},{"id":"paper-w7140195164","cat":"papers","name":"Pretreatment with the psychedelic DOI mitigates LPS-induced hippocampal inflammation and behavioral impairments in mice","year":"2026","cit":0,"pfa":"Michael Fiorillo","psa":"Javier González-Maeso","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7140195164","eid":"W7140195164"},{"id":"paper-w7210276054","cat":"papers","name":"The Symbiotic Cycle of Creativity: three diagrams mapping scope of care and the psychedelic threshold in design","year":"2026","cit":0,"pfa":"Alexandra Maria Plesner","ptype":"article","src":"https://openalex.org/W7210276054","eid":"W7210276054"},{"id":"paper-w314874184","cat":"papers","name":"Sex, Drugs, Einstein, & Elves: Sushi, Psychedelics, Parallel Universes, and the Quest for Transcendence (review)","year":"2007","cit":0,"pfa":"Rob Harle","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W314874184","eid":"W314874184"},{"id":"paper-w7213269213","cat":"papers","name":"Psychedelic rock gecko among dozens of species in need of further conservation protection in Vietnam","year":"2023","cit":0,"pfa":"Pensoft Editorial Team","ptype":"other","src":"https://openalex.org/W7213269213","eid":"W7213269213"},{"id":"paper-w4408061844","cat":"papers","name":"L.A. and Its 1960s Psychedelic Scene: Toward an Alternative Society or Escapism into ‘Imaginary Worlds’?","year":"2025","cit":0,"pfa":"Marek Jeziński","ptype":"book-chapter","src":"https://openalex.org/W4408061844","eid":"W4408061844"},{"id":"paper-w7146987352","cat":"papers","name":"Post-traumatic stress disorder symptoms following psychedelic use: a naturalistic survey study","year":"2026","cit":0,"pfa":"Ricarda Evens","psa":"Ulrike Lueken","topics":["PTSD & trauma","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7146987352","eid":"W7146987352"},{"id":"paper-w7161594561","cat":"papers","name":"Classic psychedelics and autism spectrum disorder: preclinical evidence, mechanistic insights and unresolved challenges","year":"2026","cit":0,"pfa":"Fabrizio Ascone","psa":"Viviana Trezza","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7161594561","eid":"W7161594561"},{"id":"paper-w4408173331","cat":"papers","name":"Psychedelic Use in Japan, and its Effect on Depression and anxiety: A Cross-Sectional Survey Analysis","year":"2025","cit":0,"pfa":"Shiratori Takashi","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4408173331","eid":"W4408173331"},{"id":"paper-w7131393748","cat":"papers","name":"A gathering, including Stan Grof and Huston Smith, to discuss the history of psychedelics at the Fetzer Institute.","year":"2026","cit":0,"pfa":"University of Colorado Boulder","ptype":"other","src":"https://openalex.org/W7131393748","eid":"W7131393748"},{"id":"paper-w2155405878","cat":"papers","name":"Which is your favourite protocol in women ≥43 years old? Microdose Flare? Antagonist? Or no way out!","year":"2008","cit":0,"pfa":"N. Dokuzeylül","psa":"Semra Kahraman","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2155405878","eid":"W2155405878"},{"id":"paper-w3145487189","cat":"papers","name":"Calculation of Survival Rates and Effective Inactivation Cross Sections of Targets for Heavy Charged Particles Based on Microdose Concept","year":"1969","cit":0,"pfa":"沼宮内 弼雄","psa":"織田 暢夫","topics":["Dosing & pharmacology"],"ptype":"report","src":"https://openalex.org/W3145487189","eid":"W3145487189"},{"id":"paper-w4387657375","cat":"papers","name":"Review: God on Psychedelics: Tripping Across the Rubble of Old-time Religion, by Don Lattin","year":"2023","cit":0,"pfa":"Brad Stoddard","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4387657375","eid":"W4387657375"},{"id":"paper-w7128596885","cat":"papers","name":"Beyond therapist competence: Why family engagement matters in real-world psychedelic services","year":"2026","cit":0,"pfa":"Bela Janare Putra","psa":"Rohmiati","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W7128596885","eid":"W7128596885"},{"id":"paper-w4410247107","cat":"papers","name":"Evaluation of dose linearity in the systemic availability and pharmacokinetics of topically administered diclofenac: A 14C-microdosing study in healthy volunteers","year":"2025","cit":0,"pfa":"Severin Mairinger","psa":"Oliver Langer","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4410247107","eid":"W4410247107"},{"id":"paper-w4377989468","cat":"papers","name":"Dr. Robin Carhart-Harris: The Science of Psychedelics for Mental Health | Huberman Lab Podcast","year":"2023","cit":0,"pfa":"Sikandar Shah","ptype":"report","src":"https://openalex.org/W4377989468","eid":"W4377989468"},{"id":"paper-w7210293705","cat":"papers","name":"The Symbiotic Cycle of Creativity: three diagrams mapping scope of care and the psychedelic threshold in design","year":"2026","cit":0,"pfa":"Alexandra Maria Plesner","ptype":"other","src":"https://openalex.org/W7210293705","eid":"W7210293705"},{"id":"paper-w4387842240","cat":"papers","name":"Profit and Prudence: Navigating Psychedelic Commercialization Through Lessons from the Prescription Opioid Crisis","year":"2023","cit":0,"pfa":"Daniel Eisenkraft Klein","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4387842240","eid":"W4387842240"},{"id":"paper-w2145373900","cat":"papers","name":"Pregnancy rates are maintained in poor responders with a simple GnRH antagonist protocol compared to microdose GnRH agonist flare","year":"2002","cit":0,"pfa":"Bradley Shawn Hurst","psa":"Paul B. Marshburn","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2145373900","eid":"W2145373900"},{"id":"paper-w3003438514","cat":"papers","name":"Determinants of producers' willingness to pay (WTP) for microdose technology component practices in the provinces of Kourittenga and Zondoma in Burkina Faso","year":"2019","cit":0,"pfa":"Hamadé Sigue","psa":"Gauthier Biaou","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3003438514","eid":"W3003438514"},{"id":"paper-w3123739648","cat":"papers","name":"An exploration of the relationship between psychedelic drug use, mystical experiences, mindfulness, and mental health","year":"2020","cit":0,"pfa":"Kiana Azmoodeh","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W3123739648","eid":"W3123739648"},{"id":"paper-w3158453633","cat":"papers","name":"Molecular sensor differentiates psychedelic compounds from analogs that don’t elicit hallucinations in mice","year":"2021","cit":0,"pfa":"special to C EN Alla Katsnelson","ptype":"article","src":"https://openalex.org/W3158453633","eid":"W3158453633"},{"id":"paper-w7213314289","cat":"papers","name":"Psychedelic rock gecko among dozens of species in need of further conservation protection in Vietnam","year":"2023","cit":0,"pfa":"Pensoft Editorial Team","ptype":"other","src":"https://openalex.org/W7213314289","eid":"W7213314289"},{"id":"paper-w4389738496","cat":"papers","name":"Exploring new frontiers: Effects of psychedelics on neurotransmitter‐regulated glucagon release in pancreatic islets","year":"2023","cit":0,"pfa":"Mehmet Bostancıklıoğlu","topics":["Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4389738496","eid":"W4389738496"},{"id":"paper-w4244823608","cat":"papers","name":"Efficacy of injectable and pour-on microdose ivermectin in the treatment of goat warble fly infestation by Przhevalskiana silenus (Diptera, Oestridae)","year":"2003","cit":0,"pfa":"Annunziata Giangaspero","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4244823608","eid":"W4244823608"},{"id":"paper-w7147425884","cat":"papers","name":"In Vitro Cell Toxicity Comparing Microdose Vs Drop Delivery Of Latanoprost With Bak In Human Conjunctival Cells - Encore","year":"2026","cit":0,"pfa":"Ayesha Sultan","psa":"Pedram Hamrah","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7147425884","eid":"W7147425884"},{"id":"paper-w2621388409","cat":"papers","name":"The Philosophy of Samuel Taylor Coleridge and The Mystical Disposition : Including An Argument for the Psychedelic from Encounter","year":"2017","cit":0,"pfa":"Arthur Williams","ptype":"article","src":"https://openalex.org/W2621388409","eid":"W2621388409"},{"id":"paper-w7110614371","cat":"papers","name":"Profit and Prudence: Navigating Psychedelic Commercialization Through Lessons from the Prescription Opioid Crisis","cit":0,"pfa":"Eisenkraft Klein, Daniel","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7110614371","eid":"W7110614371"},{"id":"paper-w4200008354","cat":"papers","name":"Pharmacologic analysis of non-synonymous coding 5-HT2A SNPs reveals alterations psychedelic drug potencies and efficacies","year":"2021","cit":0,"pfa":"Gavin P. Schmitz","psa":"Bryan L. Roth","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4200008354","eid":"W4200008354"},{"id":"paper-w2269654997","cat":"papers","name":"EKSISTENSI BAND “SMILE STREET” TERHADAP MUSIK PSYCHEDELIC ROCK DI KOTA SURABAYA","year":"2013","cit":0,"pfa":"Ndimas Narko Utomo","ptype":"article","src":"https://openalex.org/W2269654997","eid":"W2269654997"},{"id":"paper-w4414994144","cat":"papers","name":"Supplemental Material for Translation and Validation of the Psychedelic Challenging Experience Questionnaire (CEQ) to Brazilian Portuguese","year":"2025","cit":0,"ptype":"supplementary-materials","src":"https://openalex.org/W4414994144","eid":"W4414994144"},{"id":"paper-w7161209878","cat":"papers","name":"Psychedelic Substituted Phenethylamine Alters Human Neural Progenitor Cell Morphology, Proliferation, and Survival","year":"2025","cit":0,"pfa":"Omar E Saleh","psa":"Travis J. A. Craddock","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"conference-paper","src":"https://openalex.org/W7161209878","eid":"W7161209878"},{"id":"paper-w4307609508","cat":"papers","name":"Method of dispensing microdoses of aqueous solutions of substances onto a carrier and a device for carrying out said method","year":"1998","cit":0,"pfa":"Gennady Moiseevich Ershov","psa":"Andrei D. Mirzabekov","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4307609508","eid":"W4307609508"},{"id":"paper-w4402596224","cat":"papers","name":"Corrigendum to: Psychedelic trip sitting, dosages and intensities: Supplementing clinical studies with anecdotal reports","year":"2024","cit":0,"pfa":"Liam B. Engel","psa":"Stephen Jason Bright","ptype":"erratum","src":"https://openalex.org/W4402596224","eid":"W4402596224"},{"id":"paper-w7113652949","cat":"papers","name":"Knowledge, Perceptions, and Use of Psychedelics for Mental Health among Autistic Adults: An Online Survey","year":"2025","cit":0,"pfa":"Hsiang-Yuan Lin","ptype":"preprint","src":"https://openalex.org/W7113652949","eid":"W7113652949"},{"id":"paper-w4250689894","cat":"papers","name":"EUMAPP $ EUFEPS Workshop: Has microdosing been fully verified, June 16, 2008, Bad Homburg, Germany","year":"2008","cit":0,"topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4250689894","eid":"W4250689894"},{"id":"paper-w2171593672","cat":"papers","name":"MicroDose Digital Mammography: Lowest Dose Innovation in Breast Cancer Screening. Technology Review and Implications to a Screening Population","year":"2013","cit":0,"pfa":"R. Tu","psa":"T. Williams","topics":["Anxiety & end-of-life","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2171593672","eid":"W2171593672"},{"id":"paper-w4405396342","cat":"papers","name":"Psychedelic Use in Japan, and its Effect on Depression and anxiety: A Cross-Sectional Survey Analysis","year":"2024","cit":0,"pfa":"Shiratori Takashi","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4405396342","eid":"W4405396342"},{"id":"paper-w7135528780","cat":"papers","name":"Questions for Comparison of NDE and Similar Experiences from LSD, DMT and Ketamine Psychedelic Sessions","year":"2011","cit":0,"pfa":"Michal Grus","ptype":"dissertation","src":"https://openalex.org/W7135528780","eid":"W7135528780"},{"id":"paper-w951232397","cat":"papers","name":"Psychedelic induced experiences as key to the understanding of the connection between magnetic body and information molecules?","year":"2014","cit":0,"pfa":"Matti Pitkänen","ptype":"preprint","src":"https://openalex.org/W951232397","eid":"W951232397"},{"id":"paper-w4405489756","cat":"papers","name":"Alaina M. Jaster: Bridging the gap across preclinical and clinical disciplines in the psychedelic sciences","year":"2024","cit":0,"pfa":"Alaina M. Jaster","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4405489756","eid":"W4405489756"},{"id":"paper-w7161139665","cat":"papers","name":"When Therapy Falls Short: A Qualitative Study of Psychotherapy After Challenging Psychedelic Experiences","year":"2026","cit":0,"pfa":"Guy Simon","psa":"Jason B. Luoma","topics":["Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7161139665","eid":"W7161139665"},{"id":"paper-w4408352128","cat":"papers","name":"Review for \"Serotonergic Psychedelics Rapidly Modulate Evoked Glutamate Release in Cultured Cortical Neurons\"","year":"2025","cit":0,"topics":["Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4408352128","eid":"W4408352128"},{"id":"paper-w4415780109","cat":"papers","name":"Sacred Substances, Sacred Wounds: The Intersection of Psychedelics, Adverse Religious Experiences, and Spiritual Healing","year":"2025","cit":0,"pfa":"Lisa L. Gezon","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4415780109","eid":"W4415780109"},{"id":"paper-w7142707023","cat":"papers","name":"From social transmission to platform-accelerated diffusion: Rethinking how psychedelic use spreads","year":"2026","cit":0,"pfa":"Gerald Busch","ptype":"article","src":"https://openalex.org/W7142707023","eid":"W7142707023"},{"id":"paper-w4239633353","cat":"papers","name":"Faculty Opinions recommendation of Cortical dynamics during psychedelic and anesthetized states induced by ketamine.","year":"2019","cit":0,"pfa":"M Bruce MacIver","ptype":"peer-review","src":"https://openalex.org/W4239633353","eid":"W4239633353"},{"id":"paper-w4407076354","cat":"papers","name":"CPDD HUMAN RESEARCH COMMITTEE FORUM: NAVIGATING THE LEGISLATIVE AND ETHICAL COMPLEXITIES OF CANNABINOIDS AND PSYCHEDELICS","year":"2025","cit":0,"pfa":"Justin C. Strickland","psa":"João Paulo De Aquino","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4407076354","eid":"W4407076354"},{"id":"paper-w7111574670","cat":"papers","name":"Psychedelic-induced mystical experiences: Effects on purpose in life, ontological addiction and mental health","year":"2025","cit":0,"pfa":"Padeiro, João Bernardo Vaz","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"dissertation","src":"https://openalex.org/W7111574670","eid":"W7111574670"},{"id":"paper-w7165640856","cat":"papers","name":"Using Small Area Estimation to Improve State Estimates of Psychedelic Use in the United States","year":"2026","cit":0,"pfa":"Karilynn M. Rockhill","psa":"Joshua Curtis Black","ptype":"preprint","src":"https://openalex.org/W7165640856","eid":"W7165640856"},{"id":"paper-w7126622824","cat":"papers","name":"Giovanna Serenelli - Review of Thomas Hatsis, The Witches' Ointment: The Secret History of Psychedelic Magic","year":"2018","cit":0,"pfa":"Giovanna Serenelli","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7126622824","eid":"W7126622824"},{"id":"paper-w4402933276","cat":"papers","name":"The Role of Psychedelics in Treating Mental Health Disorders - Intersection of Ayurvedic and Traditional Dietary Practices","year":"2018","cit":0,"pfa":"Nagarjuna Reddy Aturi","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4402933276","eid":"W4402933276"},{"id":"paper-w7163939902","cat":"papers","name":"Experience of non-clinical psychedelic use on trauma-related symptoms of survivors of sexual assault","year":"2024","cit":0,"pfa":"Madison Tschauner","psa":"Nicole L. Johnson","topics":["PTSD & trauma"],"ptype":"dataset","src":"https://openalex.org/W7163939902","eid":"W7163939902"},{"id":"paper-w4417222400","cat":"papers","name":"How to set up a psychedelic study: Unique considerations for research involving human participants","year":"2025","cit":0,"pfa":"Marcus J. Glennon","psa":"Anjali Bhat","topics":["Reviews & meta-analyses","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4417222400","eid":"W4417222400"},{"id":"paper-w7171828150","cat":"papers","name":"Psychedelic-informed Therapeutics and Functional Decoupling: Toward Experience-independent Rapid-acting Antidepressants","year":"2026","cit":0,"pfa":"Won-Seok Choi","psa":"Jung Goo Lee","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7171828150","eid":"W7171828150"},{"id":"paper-w7214582333","cat":"papers","name":"Persisting perceptual abnormalities in psychedelic users are associated with conditioned hallucinations and impaired sensory processing","year":"2026","cit":0,"pfa":"Maximillian S. Greenwald","psa":"Albert R. Powers","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7214582333","eid":"W7214582333"},{"id":"paper-w2293572405","cat":"papers","name":"Dying high: using psychedelics to maximise end of life choices by enhancing the dying experience","year":"2015","cit":0,"pfa":"Robin Mackenzie","topics":["Anxiety & end-of-life"],"ptype":"book-chapter","src":"https://openalex.org/W2293572405","eid":"W2293572405"},{"id":"paper-w4409196966","cat":"papers","name":"Tuning into Meaning and Dropping Out of Crisis—Meaning What Exactly? Psychedelics and the Meaning Crisis","year":"2025","cit":0,"pfa":"Mark Juhan Schunemann","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4409196966","eid":"W4409196966"},{"id":"paper-w4409990607","cat":"papers","name":"Relationship between naturalistic psychedelic use and grandiose narcissism: an online cross-sectional study","year":"2025","cit":0,"pfa":"Anastasia Ruban","psa":"Magdalena Anna Żemojtel-Piotrowska","ptype":"preprint","src":"https://openalex.org/W4409990607","eid":"W4409990607"},{"id":"paper-w3169237503","cat":"papers","name":"Unaltered IL-2 encapsulated in acoustically active lipid microspheres for systemic but targeted microdose delivery to tumor microenvironment.","year":"2021","cit":0,"pfa":"Clayton T. Larsen","psa":"Rhodemann Li","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W3169237503","eid":"W3169237503"},{"id":"paper-w7213961969","cat":"papers","name":"Features of the psychedelic experience and subjective assessment of treatment effect as well as anxiety and depression symptoms.","year":"2024","cit":0,"pfa":"Paweł Przewłoka","topics":["Depression","Anxiety & end-of-life"],"ptype":"review","src":"https://openalex.org/W7213961969","eid":"W7213961969"},{"id":"paper-w7167630734","cat":"papers","name":"Nearly 20% of new moms have anxiety or depression, but a promising psychedelic treatment is on the horizon","year":"2026","cit":0,"pfa":"Camille Hoffman","topics":["Depression","Anxiety & end-of-life"],"ptype":"other","src":"https://openalex.org/W7167630734","eid":"W7167630734"},{"id":"paper-w4408991350","cat":"papers","name":"Learning from Boundlessness: Psychedelic induced awe and epistemic shifts towards a holistic worldview","year":"2025","cit":0,"pfa":"Eirini K. Argyri","psa":"Celia J. A. Morgan","ptype":"preprint","src":"https://openalex.org/W4408991350","eid":"W4408991350"},{"id":"paper-w4390653851","cat":"papers","name":"Characteristics of behavioral abnormalities induced by a psychedelic substance 2,5-dimethoxy-4-iodoamphetamine in mice","year":"2023","cit":0,"pfa":"Sho Yuze","psa":"Junichi Kitanaka","topics":["Addiction","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4390653851","eid":"W4390653851"},{"id":"paper-w7111569690","cat":"papers","name":"Psychometric Properties of the French Version of the Psychological Insight Questionnaire (PIQ) in a sample of psychedelic users","year":"2025","cit":0,"pfa":"federico seragnoli","psa":"Sara Bocci Benucci","ptype":"preprint","src":"https://openalex.org/W7111569690","eid":"W7111569690"},{"id":"paper-w4414724809","cat":"papers","name":"Review for \"Exploring the Therapeutic Effects of Psychedelics Administered to Military Veterans in Naturalistic Retreat Settings\"","year":"2025","cit":0,"topics":["Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4414724809","eid":"W4414724809"},{"id":"paper-w7134262100","cat":"papers","name":"Technology-Enabled Ecstasies Moderated by National Anxiety Prevalence: Digitalised Diffusion of the Global Psychedelics","year":"2026","cit":0,"pfa":"Tariq  H. Malik","topics":["Anxiety & end-of-life","Safety & adverse events"],"ptype":"dataset","src":"https://openalex.org/W7134262100","eid":"W7134262100"},{"id":"paper-w2037171578","cat":"papers","name":"Microdose GnRH-agonist vs. Long Protocol GnRH-agonist in Patients Undergoing Gonadotropin Stimulation For In Vitro Fertilization","year":"2000","cit":0,"pfa":"Etta A. Volk","psa":"A.N Wakim","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2037171578","eid":"W2037171578"},{"id":"paper-w7164490062","cat":"papers","name":"Correction to: From trials to clinics: investigators’ perspectives on translating psychedelic research into clinical care","year":"2026","cit":0,"ptype":"erratum","src":"https://openalex.org/W7164490062","eid":"W7164490062"},{"id":"paper-w7122871959","cat":"papers","name":"From Solid-State Control to Predictive Precision: Building a Deployable Ecosystem for Psychedelic Therapeutics","year":"2026","cit":0,"pfa":"Anna C. Renner","psa":"Robert B. Kargbo","ptype":"editorial","src":"https://openalex.org/W7122871959","eid":"W7122871959"},{"id":"paper-w7163372011","cat":"papers","name":"Weekly cAMP-Pathway Augmentation of a Glutamatergic Regimen as a Controllable Psychedelics-like Metaplasticity Strategy","year":"2026","cit":0,"pfa":"Ngo Cheung","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7163372011","eid":"W7163372011"},{"id":"paper-w4411976879","cat":"papers","name":"Syner-G: Antidepressant action of psychedelics at the glutamatergic interface of brain, behavior and the immune system","year":"2025","cit":0,"pfa":"Natasha Leigh Mason","psa":"Johannes Ramaekers","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4411976879","eid":"W4411976879"},{"id":"paper-w3164927750","cat":"papers","name":"POS0014 TIME-TRENDS IN COCAINE AND HALLUCINOGEN USE DISORDER HOSPITALIZATIONS IN RHEUMATIC DISEASES: A NATIONAL TIME-TRENDS STUDY","year":"2021","cit":0,"pfa":"Jasvinder A. Singh","topics":["Addiction"],"ptype":"conference-abstract","src":"https://openalex.org/W3164927750","eid":"W3164927750"},{"id":"paper-w4413518683","cat":"papers","name":"Psychedelic research: balancing trippyness with a new scientific rigor – The Conversation Weekly podcast transcript","year":"2022","cit":0,"pfa":"Daniel Merino","psa":"Gemma Ware","ptype":"other","src":"https://openalex.org/W4413518683","eid":"W4413518683"},{"id":"paper-w4396228917","cat":"papers","name":"Dissolving the Self, Embracing the Earth: A Philosophical Exploration of Psychedelics, Self-Transcendence, and Environmental Connection","year":"2024","cit":0,"pfa":"Muzamil Hussain","topics":["Addiction","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4396228917","eid":"W4396228917"},{"id":"paper-w4408352208","cat":"papers","name":"Review for \"Serotonergic Psychedelics Rapidly Modulate Evoked Glutamate Release in Cultured Cortical Neurons\"","year":"2024","cit":0,"topics":["Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4408352208","eid":"W4408352208"},{"id":"paper-w7106175009","cat":"papers","name":"CORRELATION BETWEEN THE PSYCHEDELIC EXPERIENCE INDUCED BY VIRTUAL REALITY AND THE COGNITIVE FLEXIBILITY OF UNIVERSITY STUDENTS","year":"2025","cit":0,"pfa":"PUENTE, Camila Casares","psa":"BARROS, Raquel da Silva","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7106175009","eid":"W7106175009"},{"id":"paper-w7159813026","cat":"papers","name":"Microdosing with Amanita Muscaria: Creativity, Healing, and Recovery with the Sacred Mushroom by Baba Masha, James Fadiman Ph.D. on Ipad","year":"2026","cit":0,"pfa":"Helen Creighton","topics":["Dosing & pharmacology"],"ptype":"report","src":"https://openalex.org/W7159813026","eid":"W7159813026"},{"id":"paper-w7203857280","cat":"papers","name":"Revisiting Serotonin Brain Receptors Under Psychedelics by Intervening Inside Receptor-Experience Transformers","year":"2026","cit":0,"pfa":"Danilo Bzdok","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7203857280","eid":"W7203857280"},{"id":"paper-w7131243773","cat":"papers","name":"Adverse outcomes following psychedelic use in adolescents and adults: associations with age and personality traits","year":"2026","cit":0,"pfa":"David Sjöström","psa":"Petri Kajonius","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7131243773","eid":"W7131243773"},{"id":"paper-w4399738579","cat":"papers","name":"Supplemental Material for Stigma, Psychedelics Use, and the Risk of Reduced Formal Mental Health Care","year":"2024","cit":0,"topics":["Safety & adverse events"],"ptype":"supplementary-materials","src":"https://openalex.org/W4399738579","eid":"W4399738579"},{"id":"paper-w4385580633","cat":"papers","name":"Faculty Opinions recommendation of Psychedelics promote plasticity by directly binding to BDNF receptor TrkB.","year":"2023","cit":0,"pfa":"Joël Bockaert","topics":["Mechanism & neuroscience"],"ptype":"peer-review","src":"https://openalex.org/W4385580633","eid":"W4385580633"},{"id":"paper-w7198568630","cat":"papers","name":"The \"cries of strange birds\": reading the psychedelic experience in anglophone science fiction, 1933-2014.","year":"2025","cit":0,"pfa":"James David Macaronas","ptype":"dissertation","src":"https://openalex.org/W7198568630","eid":"W7198568630"},{"id":"paper-w2072516309","cat":"papers","name":"34. The microdose rapid 14C urea breath test compares well with the original rapid 14 breath test","year":"2000","cit":0,"pfa":"Max Bellon","psa":"B. E. Chatterton","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2072516309","eid":"W2072516309"},{"id":"paper-w4308926603","cat":"papers","name":"(161) Induction With Microdoses of Buprenorphine Perioperatively in Opioid Use Disorder Patients Undergoing Surgical Intervention for Infective Endocarditis","year":"2022","cit":0,"pfa":"George A. Book","psa":"Allison B Smith","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4308926603","eid":"W4308926603"},{"id":"paper-w4406674500","cat":"papers","name":"Letter to the Editor in Response to “Psychedelic Use by Sexual Minority Adults in the United States, 2022”","year":"2025","cit":0,"pfa":"Nicholas A. Carlisle","psa":"Sarah MacCarthy","ptype":"letter","src":"https://openalex.org/W4406674500","eid":"W4406674500"},{"id":"paper-w7134251830","cat":"papers","name":"Technology-Enabled Ecstasies Moderated by National Anxiety Prevalence: Digitalised Diffusion of the Global Psychedelics","year":"2026","cit":0,"pfa":"Tariq  H. Malik","topics":["Anxiety & end-of-life","Safety & adverse events"],"ptype":"dataset","src":"https://openalex.org/W7134251830","eid":"W7134251830"},{"id":"paper-w7164450913","cat":"papers","name":"Perturbing Consciousness: Multimodal Neuroimaging and Whole-Brain Modelling in Disorders of Consciousness, Psychedelics and Anaesthesia","year":"2026","cit":0,"pfa":"Naji Alnagger","topics":["Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W7164450913","eid":"W7164450913"},{"id":"paper-w7214549478","cat":"papers","name":"Working with post-psychedelic difficulties: a meta-aggregation of users’ experiences and implications for counselling practice","year":"2026","cit":0,"pfa":"Sam Grimshaw","psa":"Stephanie Revell","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7214549478","eid":"W7214549478"},{"id":"paper-w4414725635","cat":"papers","name":"Review for \"Exploring the Therapeutic Effects of Psychedelics Administered to Military Veterans in Naturalistic Retreat Settings\"","year":"2025","cit":0,"topics":["Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4414725635","eid":"W4414725635"},{"id":"paper-w4408116785","cat":"papers","name":"Effects of microdose fertilization and plant density on maize (Zea mays L.) production in the Centre-West Region of Senegal","year":"2025","cit":0,"pfa":"Housseini Malam Laminou Rabi","psa":"Sarr Papa Saliou","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4408116785","eid":"W4408116785"},{"id":"paper-w2783544659","cat":"papers","name":"„Outside of Society”: Socio-political Aspects of Psychedelic/Narcotic Consumption in Selected Euroamerican Literatures","year":"2017","cit":0,"pfa":"Andrzej Dorobek","ptype":"article","src":"https://openalex.org/W2783544659","eid":"W2783544659"},{"id":"paper-w4405636378","cat":"papers","name":"Could serotonergic psychedelic substances be a therapeutic alternative in personality disorders? A review of their effect on personality","year":"2024","cit":0,"pfa":"I. Mangas Palma","psa":"R. Moreira","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4405636378","eid":"W4405636378"},{"id":"paper-w7164020867","cat":"papers","name":"Intentions might matter in unexpected ways: A nuanced exploration of psychedelic intentions beyond their type","year":"2026","cit":0,"pfa":"Iryana Mosina","psa":"David P. Luke","ptype":"preprint","src":"https://openalex.org/W7164020867","eid":"W7164020867"},{"id":"paper-w7212368849","cat":"papers","name":"The Symbiotic Cycle of Creativity: three diagrams mapping scope of care and the psychedelic threshold in design","year":"2026","cit":0,"pfa":"Alexandra Maria Plesner","ptype":"article","src":"https://openalex.org/W7212368849","eid":"W7212368849"},{"id":"paper-w4361953492","cat":"papers","name":"Data from Multiplexed Evaluation of Microdosed Antineoplastic Agents In Situ in the Tumor Microenvironment of Patients with Soft Tissue Sarcoma","year":"2023","cit":0,"pfa":"Kenneth R. Gundle","psa":"Robert G. Maki","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W4361953492","eid":"W4361953492"},{"id":"paper-w2975666788","cat":"papers","name":"Psychedelic Drugs: Proceedings of a Hahnemann Medical College and Hospital Symposium sponsored by the Department of Psychiatry","year":"1975","cit":0,"pfa":"Ronald W. Field","ptype":"article","src":"https://openalex.org/W2975666788","eid":"W2975666788"},{"id":"paper-w7124149331","cat":"papers","name":"Can Education Compensate for Poor Healthcare? Racial Inequalities in Psychedelic-Associated Psychological Distress","year":"2026","cit":0,"pfa":"Sean M. Viña","ptype":"preprint","src":"https://openalex.org/W7124149331","eid":"W7124149331"},{"id":"paper-w2297081398","cat":"papers","name":"P-26EEFECT OF AGE OF DRINKING ONSET ON PATTERNS OF ALCOHOL, TOBACCO, MARIHUANA, STIMULANTS AND HALLUCINOGENS USE, DURING YOUNG ADULTHOOD","year":"2015","cit":0,"pfa":"Angelina Pilatti","psa":"Ricardo Marcos Pautassi","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2297081398","eid":"W2297081398"},{"id":"paper-w4409717644","cat":"papers","name":"Relationship Between Naturalistic Psychedelic Use and Grandiose Narcissism: An Online Cross‐Sectional Study","year":"2026","cit":0,"pfa":"Anastasia Ruban","psa":"Magdalena Anna Żemojtel-Piotrowska","ptype":"article","src":"https://openalex.org/W4409717644","eid":"W4409717644"},{"id":"paper-w2047383714","cat":"papers","name":"‘Tripping on Jesus’: the social dynamics and psychedelic religiosity of the Invisible Church in Durban, 1973–1983","year":"1998","cit":0,"pfa":"Glen Thompson","ptype":"article","src":"https://openalex.org/W2047383714","eid":"W2047383714"},{"id":"paper-w2419096960","cat":"papers","name":"The phoenix has risen from the ashes : a socio-cultural examination of the neo-psychedelic movement","year":"1998","cit":0,"pfa":"Shepherd M. Jenks","ptype":"book","src":"https://openalex.org/W2419096960","eid":"W2419096960"},{"id":"paper-w4236806986","cat":"papers","name":"Psychotomimetic drugs","year":"2015","cit":0,"pfa":"D'Souza, D. Cyril","psa":"Perry, Edward","ptype":"dataset","src":"https://openalex.org/W4236806986","eid":"W4236806986"},{"id":"paper-w4399936816","cat":"papers","name":"Study Looks at Link Between Adolescent Psychedelic Use And Development of Psychotic or Manic Symptoms","year":"2024","cit":0,"pfa":"Richard B. Karel","ptype":"article","src":"https://openalex.org/W4399936816","eid":"W4399936816"},{"id":"paper-w7172436121","cat":"papers","name":"Psychedelic trip reports with meditation references use more positive, reflective, and mystical language","year":"2026","cit":0,"pfa":"Henok Pankhurst","psa":"Jeremy I Skipper","ptype":"article","src":"https://openalex.org/W7172436121","eid":"W7172436121"},{"id":"paper-w7213449895","cat":"papers","name":"Weight Loss With Microdose Tirzepatide: Real-World Outcomes in Patients Initiating Treatment Below 2.5 mg Weekly","year":"2026","cit":0,"pfa":"Jay Hastings","psa":"Jayden Lee","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7213449895","eid":"W7213449895"},{"id":"paper-w4293178180","cat":"papers","name":"Educational Needs of Staff to Prevent and Control the Use of Drugs and Psychedelics in Prison: A Qualitative Study","year":"2022","cit":0,"pfa":"akram alimardani","psa":"Tahmineh Bahri","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4293178180","eid":"W4293178180"},{"id":"paper-w7116687372","cat":"papers","name":"The Effect of Psychedelics on Individuals with a Personality Disorder: Results from Two Prospective Cohort Studies","year":"2025","cit":0,"pfa":"Alexandra R. Gordon","psa":"Richard J. Zeifman","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7116687372","eid":"W7116687372"},{"id":"paper-w7165435355","cat":"papers","name":"\"Bepuler\" Eksplorasi Ritme Pada Musik Psychedelic Menggunakan Konsep Developing Rhythm Kostka","year":"2026","cit":0,"pfa":"Enos Jordan Lampung","topics":["Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W7165435355","eid":"W7165435355"},{"id":"paper-w4412426461","cat":"papers","name":"Enduring Effects of Psychedelics on Brain Dynamics: A Multi-Level EEG Study of Naturalistic Users","year":"2025","cit":0,"pfa":"Maja Wójcik","psa":"Paweł Orlowski","ptype":"article","src":"https://openalex.org/W4412426461","eid":"W4412426461"},{"id":"paper-w7140226968","cat":"papers","name":"Correction: CCNP Innovations in Neuropsychopharmacology Award: The psychopharmacology of psychedelics: where the brain meets spirituality","year":"2026","cit":0,"pfa":"Gabriella Gobbi","topics":["Dosing & pharmacology"],"ptype":"erratum","src":"https://openalex.org/W7140226968","eid":"W7140226968"},{"id":"paper-w7155617969","cat":"papers","name":"510. Psychedelic and Cannabis Use to Self-Manage Premenstrual Mood Symptoms: A Nationwide Survey","year":"2026","cit":0,"pfa":"Liisa V. Hantsoo","psa":"Angela Getachew","ptype":"article","src":"https://openalex.org/W7155617969","eid":"W7155617969"},{"id":"paper-w7213425659","cat":"papers","name":"Journey a Psychoanalytic-Psychonaut: Epiphanous Moments in the Integration of Ideas from Both Psychedelics and Psychoanalysis","year":"2026","cit":0,"pfa":"Philip A. Ringstrom","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W7213425659","eid":"W7213425659"},{"id":"paper-w7171364082","cat":"papers","name":"Reply to “Reading the Signal: What Psychedelic Trials in Depression Still Can’t Tell Us”","year":"2026","cit":0,"pfa":"Natia Horato","psa":"Antônio Egídio Nardi","topics":["Depression"],"ptype":"letter","src":"https://openalex.org/W7171364082","eid":"W7171364082"},{"id":"paper-w2994575935","cat":"papers","name":"Psychedelic Judaism in a Countercultural America. Zalman Schachter-Shalomi and the Radical Religiosity of LSD Consciousness","year":"2019","cit":0,"pfa":"Morgan Shipley","ptype":"book-chapter","src":"https://openalex.org/W2994575935","eid":"W2994575935"},{"id":"paper-w7203653197","cat":"papers","name":"Persisting perceptual abnormalities in psychedelic users are associated with conditioned hallucinations and impaired sensory processing","year":"2026","cit":0,"pfa":"Maximillian S. Greenwald","psa":"Albert R. Powers","topics":["Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7203653197","eid":"W7203653197"},{"id":"paper-w7135380451","cat":"papers","name":"Additional file 2: of Validation of whole-blood transcriptome signature during microdose recombinant human erythropoietin (rHuEpo) administration","year":"2017","cit":0,"pfa":"Guan Wang","psa":"Yannis P. Pitsiladis","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7135380451","eid":"W7135380451"},{"id":"paper-w4406794804","cat":"papers","name":"Microdose Combination of Low Dose Naltrexone and Flumazenil to Treat Major Depressive Disorder: A Proof-of-Concept, Open-Label Trial","year":"2025","cit":0,"pfa":"Tim MacDonald","topics":["Depression","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4406794804","eid":"W4406794804"},{"id":"paper-w4399587558","cat":"papers","name":"CYP3A and drug transporters activity changes in Thai elderly with or without chronic kidney disease using a microdose cocktail","year":"2019","cit":0,"pfa":"Punyabhorn Rattanacheeworn","psa":"Yingyos Avihingsanon","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W4399587558","eid":"W4399587558"},{"id":"paper-w4240524448","cat":"papers","name":"A Microdose Clinical Trial to Evaluate 64Cu-NOTA-Trastuzumab as a Positron Emission Tomography Imaging Agent in Patients with Breast Cancer","year":"2020","cit":0,"pfa":"Inki Lee","psa":"Sang Moo Lim","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4240524448","eid":"W4240524448"},{"id":"paper-w7135388828","cat":"papers","name":"Additional file 5: of Validation of whole-blood transcriptome signature during microdose recombinant human erythropoietin (rHuEpo) administration","year":"2017","cit":0,"pfa":"Guan Wang","psa":"Yannis P. Pitsiladis","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7135388828","eid":"W7135388828"},{"id":"paper-w591877712","cat":"papers","name":"Popdelic patterns : 60's pop culture & psychedelic : royalty free jpeg files","year":"2003","cit":0,"pfa":"デザインエクスチェンジ","psa":"勝也 森泉","ptype":"book","src":"https://openalex.org/W591877712","eid":"W591877712"},{"id":"paper-w2222379863","cat":"papers","name":"Microdosis de ketamina en la prevención del dolor postoperatorio. Microdoses of ketamine to prevent postoperative pain","year":"2005","cit":0,"pfa":"José Hidalgo Velásquez","psa":"Milagros Pimienta Peguero","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2222379863","eid":"W2222379863"},{"id":"paper-w7135284994","cat":"papers","name":"Beyond the Self: Exploring the Link Between Self-Transcendent Psychedelic Experiences and Prosocial Behavior","year":"2024","cit":0,"pfa":"Corinne Kneis","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"dissertation","src":"https://openalex.org/W7135284994","eid":"W7135284994"},{"id":"paper-w7211928026","cat":"papers","name":"Psychedelics and neuroregenerative medicine: Illuminating the potential of psychoplastogens for neurodevelopment and central nervous system repair","year":"2026","cit":0,"pfa":"Hongyuan Li","psa":"Xiaohui Wang","topics":["PTSD & trauma","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7211928026","eid":"W7211928026"},{"id":"paper-w2412437502","cat":"papers","name":"[Study of quality effects on radiobiological actions. I. Improvement in target theory based on microdose concept (author's transl)].","year":"1979","cit":0,"pfa":"S Iwanami","psa":"S Hashimoto","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2412437502","eid":"W2412437502"},{"id":"paper-w4299445623","cat":"papers","name":"From macro to microdoses -- reference values for toxic metals. Proceedings of a workshop. Brescia, Italy, April 5, 1990.","year":"1992","cit":0,"topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4299445623","eid":"W4299445623"},{"id":"paper-w4413603910","cat":"papers","name":"Do psychedelics really work to treat depression and PTSD? Here’s what the evidence says","year":"2023","cit":0,"pfa":"Sam G. Moreton","topics":["Depression","PTSD & trauma"],"ptype":"other","src":"https://openalex.org/W4413603910","eid":"W4413603910"},{"id":"paper-w7133813173","cat":"papers","name":"Adverse outcomes following psychedelic use in adolescents and adults: associations with age and personality traits","year":"2026","cit":0,"pfa":"David Sjöström","psa":"Petri Kajonius","topics":["Safety & adverse events"],"ptype":"other","src":"https://openalex.org/W7133813173","eid":"W7133813173"},{"id":"paper-w4394456043","cat":"papers","name":"Additional file 11: of Validation of whole-blood transcriptome signature during microdose recombinant human erythropoietin (rHuEpo) administration","year":"2017","cit":0,"pfa":"Guan Wang","psa":"Yannis Paul Pitsiladis","topics":["Dosing & pharmacology"],"ptype":"dataset","src":"https://openalex.org/W4394456043","eid":"W4394456043"},{"id":"paper-w7212194019","cat":"papers","name":"Immediate Effects of a Pogo-Jump Microdose on Vertical Jump Performance in Adolescent Basketball Players: A Randomized Crossover Pilot Study","year":"2026","cit":0,"pfa":"Celia García-Lucas","psa":"Juan José Amer-Cuenca","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7212194019","eid":"W7212194019"},{"id":"paper-w7135370778","cat":"papers","name":"Additional file 1: of Validation of whole-blood transcriptome signature during microdose recombinant human erythropoietin (rHuEpo) administration","year":"2017","cit":0,"pfa":"Guan Wang","psa":"Yannis P. Pitsiladis","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7135370778","eid":"W7135370778"},{"id":"paper-w2952004697","cat":"papers","name":"ChemInform Abstract: BEHAVIORAL AND SEROTONIN RECEPTOR PROPERTIES OF 4‐SUBSTITUTED DERIVATIVES OF THE HALLUCINOGEN 1‐(2,5‐DIMETHOXYPHENYL)‐2‐AMINOPROPANE","year":"1983","cit":0,"pfa":"Richard A. Glennon","psa":"Richard D. Morin","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2952004697","eid":"W2952004697"},{"id":"paper-w7206199866","cat":"papers","name":"Justice Involvement and Hallucinogen Use Among US Adults: Exploring Health Problems, Other Substance Use, and Demographic Correlates","year":"2026","cit":0,"pfa":"Fadime Gökçe Karaaslan","psa":"Jason A. Ford","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7206199866","eid":"W7206199866"},{"id":"paper-w4394826587","cat":"papers","name":"Digital Illusions: An Analysis of Psychedelic Phenomena Based on Sensory Experiences in Multisensory Interactive Fields","year":"2024","cit":0,"pfa":"燕燕 曾","ptype":"article","src":"https://openalex.org/W4394826587","eid":"W4394826587"},{"id":"paper-w4404527345","cat":"papers","name":"ScienceAdviser: Psychedelics can help treat anxiety. Can we tap into that without the trip?","year":"2024","cit":0,"topics":["Anxiety & end-of-life"],"ptype":"dataset","src":"https://openalex.org/W4404527345","eid":"W4404527345"},{"id":"paper-w7118174114","cat":"papers","name":"Sensory Deprivation as Apophatic Interface: Logostic q(t) -> tau(t) and Psychedelic Perturbations","year":"2026","cit":0,"pfa":"Douglas C. Youvan","ptype":"article","src":"https://openalex.org/W7118174114","eid":"W7118174114"},{"id":"paper-w7163328218","cat":"papers","name":"Weekly cAMP-Pathway Augmentation of a Glutamatergic Regimen as a Controllable Psychedelics-like Metaplasticity Strategy","year":"2026","cit":0,"pfa":"Ngo Cheung","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7163328218","eid":"W7163328218"},{"id":"paper-w7153559178","cat":"papers","name":"N , N -Diisopropyltryptamine and diptogenia: proposed mechanisms for a frequency-selective pitch-distorting psychedelic","year":"2026","cit":0,"pfa":"Aidan Hurst","psa":"Victoria M. Bajo","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7153559178","eid":"W7153559178"},{"id":"paper-w7166493194","cat":"papers","name":"Anomalies of basic self-experience in the schizophrenia spectrum and psychedelic experience: A comparative IPA study","year":"2026","cit":0,"pfa":"Viktória Hatráková","ptype":"dissertation","src":"https://openalex.org/W7166493194","eid":"W7166493194"},{"id":"paper-w2895302024","cat":"papers","name":"Extended First Uninterrupted Sleep Period for Older Adults Following Treatment with AV002, an Emulsified Microdose Vasopressin Analog","year":"2018","cit":0,"pfa":"Kathleen C. Kobashi","psa":"Diane Kaschak Newman","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2895302024","eid":"W2895302024"},{"id":"paper-w4408251268","cat":"papers","name":"Psychedelic Use in Japan, and its Effect on Depression and anxiety: A Cross-Sectional Survey Analysis","year":"2025","cit":0,"pfa":"Shiratori Takashi","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4408251268","eid":"W4408251268"},{"id":"paper-w4408152638","cat":"papers","name":"Corrigendum to A Review of the Food and Drug Administration Pipeline and Proposed California Legislation on Medicinal Psychedelics","year":"2025","cit":0,"topics":["Reviews & meta-analyses"],"ptype":"erratum","src":"https://openalex.org/W4408152638","eid":"W4408152638"},{"id":"paper-w7169909961","cat":"papers","name":"Design of a new psychedelic quipazine analog with therapeutic efficacy and potentially fewer side effects","year":"2026","cit":0,"pfa":"Jason Younkin","psa":"Javier González‐Maeso","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7169909961","eid":"W7169909961"},{"id":"paper-w2417353496","cat":"papers","name":"[Histomorphological aspects of the prostate gland of rats castrated and subjected to treatment by testosterone in microdoses, under the action of pituitary gonadotropin].","year":"1998","cit":0,"pfa":"Pizzagalli Gf","psa":"V Bertana","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2417353496","eid":"W2417353496"},{"id":"paper-w7160543602","cat":"papers","name":"Microdose infusion (MDI) therapy in retinitis Pigmentosa: Functional recovery and structural stability in a 49-year- old female","year":"2026","cit":0,"pfa":"Harsadbhai D Patel","psa":"Marilyn DSouza","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7160543602","eid":"W7160543602"},{"id":"paper-w2263970933","cat":"papers","name":"Abstract 17932: Diabetic Cardiomyopathy in Mice is Characterized by Defects in Myocyte Turnover Measured by Microdosing of 14C-Labeled Thymidine","year":"2013","cit":0,"pfa":"Yingnan Bai","psa":"Jan Kajstura","topics":["Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W2263970933","eid":"W2263970933"},{"id":"paper-w2386552325","cat":"papers","name":"Combinative treatment effects of benazepril and levamlodipine against microdose proteinuria in patients with essential hypertension and type 2 diabetes mellitus","year":"2010","cit":0,"pfa":"Tao Jian","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2386552325","eid":"W2386552325"},{"id":"paper-w7135408235","cat":"papers","name":"Additional file 3: of Validation of whole-blood transcriptome signature during microdose recombinant human erythropoietin (rHuEpo) administration","year":"2017","cit":0,"pfa":"Guan Wang","psa":"Yannis P. Pitsiladis","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7135408235","eid":"W7135408235"},{"id":"paper-w4361969940","cat":"papers","name":"Supplementary Legend from Multiplexed Evaluation of Microdosed Antineoplastic Agents In Situ in the Tumor Microenvironment of Patients with Soft Tissue Sarcoma","year":"2023","cit":0,"pfa":"Kenneth R. Gundle","psa":"Robert G. Maki","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4361969940","eid":"W4361969940"},{"id":"paper-w7126034644","cat":"papers","name":"Learning from boundlessness: epistemic shifts towards a holistic worldview following psychedelic experiences","year":"2026","cit":0,"pfa":"Eirini K. Argyri","psa":"C. J. A. Morgan","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7126034644","eid":"W7126034644"},{"id":"paper-w7134826554","cat":"papers","name":"Additional file 1 of The impact of microdosed plyometric training on speed and explosive abilities of football players during the pre-season","year":"2026","cit":0,"pfa":"Marián Škorik","psa":"Michal Hrubý","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7134826554","eid":"W7134826554"},{"id":"paper-w7135383951","cat":"papers","name":"Additional file 4: of Validation of whole-blood transcriptome signature during microdose recombinant human erythropoietin (rHuEpo) administration","year":"2017","cit":0,"pfa":"Guan Wang","psa":"Yannis P. Pitsiladis","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7135383951","eid":"W7135383951"},{"id":"paper-w7135420319","cat":"papers","name":"Additional file 2: of Validation of whole-blood transcriptome signature during microdose recombinant human erythropoietin (rHuEpo) administration","year":"2017","cit":0,"pfa":"Guan Wang","psa":"Yannis P. Pitsiladis","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7135420319","eid":"W7135420319"},{"id":"paper-w2933948679","cat":"papers","name":"Dosimetry Prediction of 225Ac-NOTA-Trastuzumab Based on 64Cu-NOTA-Trastuzumab in Breast Cancer: Preliminary Microdose Clinical Trial","year":"2019","cit":0,"pfa":"Inki Lee","psa":"Hyun‐Ah Kim","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2933948679","eid":"W2933948679"},{"id":"paper-w4394389798","cat":"papers","name":"Additional file 10: of Validation of whole-blood transcriptome signature during microdose recombinant human erythropoietin (rHuEpo) administration","year":"2017","cit":0,"pfa":"Guan Wang","psa":"Yannis Paul Pitsiladis","topics":["Dosing & pharmacology"],"ptype":"dataset","src":"https://openalex.org/W4394389798","eid":"W4394389798"},{"id":"paper-w4248380438","cat":"papers","name":"A Study Using Whole-body PET After Oral Microdose of 18F-labeled Liporaxel in Patients With Solid Tumor","year":"2019","cit":0,"topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4248380438","eid":"W4248380438"},{"id":"paper-w7172382127","cat":"papers","name":"Mind-manifesting? Examining naturalistic reports from psychedelics, cannabis, meditation, and dreams from the ALTERD mobile application","year":"2026","cit":0,"pfa":"Conor H. Murray","psa":"Martin M. Monti","topics":["Addiction"],"ptype":"preprint","src":"https://openalex.org/W7172382127","eid":"W7172382127"},{"id":"paper-w2950907570","cat":"papers","name":"ChemInform Abstract: RESOLUTION AND ABSOLUTE CONFIGURATION OF TRANS‐2‐(2,5‐DIMETHOXY‐4‐METHYLPHENYL)CYCLOPROPYLAMINE, A POTENT HALLUCINOGEN ANALOG","year":"1979","cit":0,"pfa":"David E. Nichols","psa":"George K. W. Yim","ptype":"article","src":"https://openalex.org/W2950907570","eid":"W2950907570"},{"id":"paper-w1494201697","cat":"papers","name":"Book Review/Comptes Rendus: Psychedelic Psychiatry: LSD from Clinic to Campus by Erika Dyck","year":"2010","cit":0,"pfa":"Kenton Kroker","topics":["Reviews & meta-analyses"],"ptype":"book-review","src":"https://openalex.org/W1494201697","eid":"W1494201697"},{"id":"paper-w4285247898","cat":"papers","name":"The Transcendence of Psychedelic Rock as a Phenomenon of the Mass Musical Culture of Great Britain and the USA of the 1960s and 1970s","year":"2022","cit":0,"pfa":"Vsevolod R. Maukin","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4285247898","eid":"W4285247898"},{"id":"paper-w4408354805","cat":"papers","name":"Decision letter for \"Serotonergic Psychedelics Rapidly Modulate Evoked Glutamate Release in Cultured Cortical Neurons\"","year":"2025","cit":0,"ptype":"peer-review","src":"https://openalex.org/W4408354805","eid":"W4408354805"},{"id":"paper-w4413233251","cat":"papers","name":"Psychedelics and the Ontology of Work: A Qualitative Study of Career Transformation, Spiritual Embodiment, and Purpose-Driven Labour","year":"2025","cit":0,"pfa":"Jeffrey S. Overall","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4413233251","eid":"W4413233251"},{"id":"paper-w7134264784","cat":"papers","name":"The Electromagnetic Argument Against the Desynchronization Interpretation of Psychedelic MEG Data: Implications for the Filter Theory of Consciousness","year":"2026","cit":0,"pfa":"Maarten Vergucht","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7134264784","eid":"W7134264784"},{"id":"paper-w7155043454","cat":"papers","name":"Author response: Modeling the hallucinatory effects of classical psychedelics in terms of replay-dependent plasticity mechanisms","year":"2026","cit":0,"pfa":"Colin Bredenberg","psa":"Guillaume Lajoie","topics":["Mechanism & neuroscience"],"ptype":"peer-review","src":"https://openalex.org/W7155043454","eid":"W7155043454"},{"id":"paper-w2411647794","cat":"papers","name":"[Observations on the behavior of some biological indices in pulmonary tuberculosis patients during treatment with microdoses of streptomycin and isoniazid by intradermal route].","year":"1961","cit":0,"pfa":"Paolo Guglielmetti","psa":"E Raspi","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2411647794","eid":"W2411647794"},{"id":"paper-w2048068818","cat":"papers","name":"PO-0934 Comparative Paediatric Acetaminophen Pharmacokinetics Between A Microdose And A Therapeutic Dose Using Accelerator Mass Spectrometry Bioanalysis","year":"2014","cit":0,"pfa":"MA Turner","psa":"R. Colin Garner","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"conference-paper","src":"https://openalex.org/W2048068818","eid":"W2048068818"},{"id":"paper-w4388536182","cat":"papers","name":"Microdosing ketamine in Drosophila does not inhibit SERT like SSRIs, but causes behavioral changes mediated by glutamate and serotonin receptors","year":"2023","cit":0,"pfa":"Kelly E. Dunham","psa":"B. Jill Venton","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4388536182","eid":"W4388536182"},{"id":"paper-w7134848710","cat":"papers","name":"Additional file 1 of The impact of microdosed plyometric training on speed and explosive abilities of football players during the pre-season","year":"2026","cit":0,"pfa":"Marián Škorik","psa":"Michal Hrubý","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7134848710","eid":"W7134848710"},{"id":"paper-w4413525750","cat":"papers","name":"How antidepressants, ketamine and psychedelic drugs may make brains more flexible – new research","year":"2023","cit":0,"pfa":"Barbara Jacquelyn Sahakian","psa":"Christelle Langley","topics":["Depression"],"ptype":"other","src":"https://openalex.org/W4413525750","eid":"W4413525750"},{"id":"paper-w4390223770","cat":"papers","name":"Binding affinity and dose occupancy of psychedelic tryptamines towards 5-HT2A/2C receptors in rats","year":"2023","cit":0,"pfa":"E. Kolesnik","psa":"Mikael Palner","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4390223770","eid":"W4390223770"},{"id":"paper-w4368407322","cat":"papers","name":"14 Floating Brains and Magic Mushrooms: Ancient Psychedelics Test the Progress of Psychiatry, 2019 to Today","year":"2023","cit":0,"pfa":"David Hellerstein","ptype":"book-chapter","src":"https://openalex.org/W4368407322","eid":"W4368407322"},{"id":"paper-w7117971350","cat":"papers","name":"Dose-dependent effects of psychedelic use on cognitive performance: insights from a global online study","year":"2026","cit":0,"pfa":"F. Stadler","psa":"C. Kraus","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7117971350","eid":"W7117971350"},{"id":"paper-w2322562880","cat":"papers","name":"Precycle administration of GnRH antagonist and microdose HCG decreases clinical pregnancy rates without affecting embryo quality and blastulation","year":"2007","cit":0,"pfa":"Serdar Ural","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2322562880","eid":"W2322562880"},{"id":"paper-w3092855633","cat":"papers","name":"COST ANALYSIS OF ESTROGEN PRIMING VS MICRODOSE LEUPROLIDE FLARE PROTOCOLS FOR WOMEN WITH DIMINISHED OVARIAN RESERVE UNDERGOING IVF","year":"2020","cit":0,"pfa":"Nicole D. Ulrich","psa":"Molly Bennette Moravek","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3092855633","eid":"W3092855633"},{"id":"paper-w2408632470","cat":"papers","name":"\"The wider use of human microdosing would minimize all these animal tests … by providing human-specific ADME data and, thus, identifying early those compounds destined to fail later owing to suboptimal pharmacokinetics o","year":"2010","cit":0,"pfa":"Gill Langley","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2408632470","eid":"W2408632470"},{"id":"paper-w7134191601","cat":"papers","name":"A Virtual Clinical Trial of Psychedelics to Treat Patients With Disorders of Consciousness (Adv. Sci. 11/2026)","year":"2026","cit":0,"pfa":"Naji Alnagger","psa":"Jitka Annen","ptype":"article","src":"https://openalex.org/W7134191601","eid":"W7134191601"},{"id":"paper-w4413595913","cat":"papers","name":"Psychedelics researchers balance trippyness with scientific rigor after history of legal and cultural controversy – podcast","year":"2022","cit":0,"pfa":"Daniel Merino","psa":"Gemma Ware","topics":["Policy & ethics"],"ptype":"other","src":"https://openalex.org/W4413595913","eid":"W4413595913"},{"id":"paper-w7135413736","cat":"papers","name":"Additional file 4: of Validation of whole-blood transcriptome signature during microdose recombinant human erythropoietin (rHuEpo) administration","year":"2017","cit":0,"pfa":"Guan Wang","psa":"Yannis P. Pitsiladis","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7135413736","eid":"W7135413736"},{"id":"paper-w4415375547","cat":"papers","name":"Lord of the Mushroom Clowns: The Story of Eunice Pike, Huautla de Jiménez, and Early Psychedelic Theology","year":"2025","cit":0,"pfa":"J. Kaleb Graves","ptype":"article","src":"https://openalex.org/W4415375547","eid":"W4415375547"},{"id":"paper-w2460723798","cat":"papers","name":"[Stimulation of pathologically weak kininogenesis with andekalin microdoses as a method of increasing the effectiveness of the treatment of chronic cotton dust-induced bronchitis].","year":"1988","cit":0,"pfa":"Surovikina Ms","psa":"Mal'tseva Lm","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2460723798","eid":"W2460723798"},{"id":"paper-w7135385589","cat":"papers","name":"Additional file 3: of Validation of whole-blood transcriptome signature during microdose recombinant human erythropoietin (rHuEpo) administration","year":"2017","cit":0,"pfa":"Guan Wang","psa":"Yannis P. Pitsiladis","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7135385589","eid":"W7135385589"},{"id":"paper-w4404759169","cat":"papers","name":"Enhancing Maize Production in Mali: The Role of Fertilizer Microdosing and Mechanization in Improving Yield, Economic Returns, and Reducing Labor Use","year":"2024","cit":0,"pfa":"Kamkam Woumou","psa":"Jens B. Aune","topics":["Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4404759169","eid":"W4404759169"},{"id":"paper-w7204498762","cat":"papers","name":"A microdose cocktail and population pharmacokinetic study suggests potentially reduced CYP3A and P-gp activities in type 2 diabetes","year":"2026","cit":0,"pfa":"Yafen Li","psa":"Dongyang Liu","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7204498762","eid":"W7204498762"},{"id":"paper-w7131662453","cat":"papers","name":"Review for \"Floorless Closed-Loop Microdosing for Rail Friction: A Physics-Only Digital Twin on Kuwait City’s Blue Corridor\"","year":"2026","cit":0,"topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W7131662453","eid":"W7131662453"},{"id":"paper-w7155072564","cat":"papers","name":"eLife Assessment: Modeling the hallucinatory effects of classical psychedelics in terms of replay-dependent plasticity mechanisms","year":"2026","cit":0,"pfa":"Anna C. Schapiro","topics":["Mechanism & neuroscience"],"ptype":"peer-review","src":"https://openalex.org/W7155072564","eid":"W7155072564"},{"id":"paper-w7135399832","cat":"papers","name":"Additional file 1: of Validation of whole-blood transcriptome signature during microdose recombinant human erythropoietin (rHuEpo) administration","year":"2017","cit":0,"pfa":"Guan Wang","psa":"Yannis P. Pitsiladis","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7135399832","eid":"W7135399832"},{"id":"paper-w4414725128","cat":"papers","name":"Author response for \"Exploring the Therapeutic Effects of Psychedelics Administered to Military Veterans in Naturalistic Retreat Settings\"","year":"2025","cit":0,"pfa":"Megan Calnan","psa":"Robin Lester Carhart-Harris","ptype":"peer-review","src":"https://openalex.org/W4414725128","eid":"W4414725128"},{"id":"paper-w7213082113","cat":"papers","name":"5-HT2A receptor and psychedelics: a trip through the mechanisms of action and therapeutic potential in mental disorders","year":"2026","cit":0,"pfa":"Muhammad Asim","psa":"Jason Tucciarone","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7213082113","eid":"W7213082113"},{"id":"paper-w7112943463","cat":"papers","name":"Impact of psychotherapists' personal experience with a psychedelic substance on therapeutic alliance: a pilot feasibility study (TheraDelia)","year":"2025","cit":0,"pfa":"Joël Billieux","psa":"Sara Bocci Benucci","topics":["Addiction","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7112943463","eid":"W7112943463"},{"id":"paper-w7161298334","cat":"papers","name":"Prevalence and predictors of sexual and physical violence during psychedelic use in a US population‐based study","year":"2026","cit":0,"pfa":"Christina Chwyl","psa":"Andrew A. Monte","ptype":"article","src":"https://openalex.org/W7161298334","eid":"W7161298334"},{"id":"paper-w7202295926","cat":"papers","name":"If you respect someone, let them go? Personal autonomy and physical safety in psychedelic treatments","year":"2026","cit":0,"pfa":"Christopher J. Poppe","psa":"Dimitris Repantis","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7202295926","eid":"W7202295926"},{"id":"paper-w4391745110","cat":"papers","name":"Review for \"Microdosing ketamine in Drosophila does not block serotonin reuptake, but causes complex behavioral changes mediated by glutamate and serotonin receptors\"","year":"2023","cit":0,"topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4391745110","eid":"W4391745110"},{"id":"paper-w4408354428","cat":"papers","name":"Decision letter for \"Serotonergic Psychedelics Rapidly Modulate Evoked Glutamate Release in Cultured Cortical Neurons\"","year":"2024","cit":0,"ptype":"peer-review","src":"https://openalex.org/W4408354428","eid":"W4408354428"},{"id":"paper-w4415646658","cat":"papers","name":"Still Seeking the Magic Mushroom: R. Gordon Wasson and the Complex Origins of Psychedelic Scholarship on Mysticism","year":"2025","cit":0,"pfa":"Hugh B. Urban","ptype":"book-chapter","src":"https://openalex.org/W4415646658","eid":"W4415646658"},{"id":"paper-w4254157459","cat":"papers","name":"Psychedelic Drugs and the Law—Volume I, Issue 1. Provisions of theCalifornia Health and Safety Code","year":"1967","cit":0,"topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4254157459","eid":"W4254157459"},{"id":"paper-w4395057568","cat":"papers","name":"Review for \"Exploring new frontiers: Effects of psychedelics on neurotransmitter-regulated glucagon release in pancreatic islets\"","year":"2023","cit":0,"topics":["Reviews & meta-analyses","Policy & ethics"],"ptype":"peer-review","src":"https://openalex.org/W4395057568","eid":"W4395057568"},{"id":"paper-w4361889065","cat":"papers","name":"Supplemental Figure 4 from Multiplexed Evaluation of Microdosed Antineoplastic Agents In Situ in the Tumor Microenvironment of Patients with Soft Tissue Sarcoma","year":"2023","cit":0,"pfa":"Kenneth R. Gundle","psa":"Robert G. Maki","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4361889065","eid":"W4361889065"},{"id":"paper-w4394466901","cat":"papers","name":"Additional file 7: of Validation of whole-blood transcriptome signature during microdose recombinant human erythropoietin (rHuEpo) administration","year":"2017","cit":0,"pfa":"Guan Wang","psa":"Yannis Paul Pitsiladis","topics":["Dosing & pharmacology"],"ptype":"dataset","src":"https://openalex.org/W4394466901","eid":"W4394466901"},{"id":"paper-w4413641370","cat":"papers","name":"Behavioral and genetic analysis of the effects of the psychedelic 2,5-dimethoxy-4-iodoamphetamine (DOI) in C. elegans","year":"2025","cit":0,"pfa":"Amanda M. White","psa":"Shawn R. Lockery","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4413641370","eid":"W4413641370"},{"id":"paper-w4415615354","cat":"papers","name":"From compulsive behaviors to psychedelic therapeutics: When mice and man speak the same circuit language","year":"2025","cit":0,"pfa":"Júlio Licinio","psa":"Ma‐Li Wong","ptype":"article","src":"https://openalex.org/W4415615354","eid":"W4415615354"},{"id":"paper-w7135080912","cat":"papers","name":"The Effects of Psychedelics and Cannabinoids on Move-ment-Related Outcomes Following Neurological Conditions: A Scoping Review","year":"2026","cit":0,"pfa":"Kelly Lynn Thatcher","topics":["Addiction","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7135080912","eid":"W7135080912"},{"id":"paper-w7165067504","cat":"papers","name":"Navigating the pluripotency of psychedelic experience: Learning from the challenges of destabilisation, towards the possibility of ontological transfiguration","year":"2026","cit":0,"pfa":"Eirini Ketzitzidou Argyri (21065669)","topics":["Safety & adverse events","Therapy practice","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W7165067504","eid":"W7165067504"},{"id":"paper-w171072951","cat":"papers","name":"Culture is not your friend: Psychedelic literature of the 20th century and its subversive effect in an industrial world","year":"2015","cit":0,"pfa":"Gunnar St. Jónsson","ptype":"article","src":"https://openalex.org/W171072951","eid":"W171072951"},{"id":"paper-w4414725390","cat":"papers","name":"Decision letter for \"Exploring the Therapeutic Effects of Psychedelics Administered to Military Veterans in Naturalistic Retreat Settings\"","year":"2025","cit":0,"ptype":"peer-review","src":"https://openalex.org/W4414725390","eid":"W4414725390"},{"id":"paper-w4365794519","cat":"papers","name":"Go Higher: Atai Life Sciences Is Moving the Dial on Psychedelic Medicine Clinical Trial Outcomes","year":"2023","cit":0,"pfa":"Jonathan D Grinstein","ptype":"article","src":"https://openalex.org/W4365794519","eid":"W4365794519"},{"id":"paper-w4411088246","cat":"papers","name":"The oneirogen hypothesis: modeling the hallucinatory effects of classical psychedelics in terms of replay-dependent plasticity mechanisms","year":"2025","cit":0,"pfa":"Colin Bredenberg","psa":"Guillaume Lajoie","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4411088246","eid":"W4411088246"},{"id":"paper-w3203534959","cat":"papers","name":"Review of ‘Transtheoretical model of harm reduction and integration for the use of psychedelics’ (Gorman et al., 2021)","year":"2021","cit":0,"pfa":"Óscar Soto Angona","psa":"Raúl Felipe Palma Álvarez","topics":["Safety & adverse events","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3203534959","eid":"W3203534959"},{"id":"paper-w4200617111","cat":"papers","name":"News at a glance: An abolished marine preserve, a cloud of space debris, and a psychedelic clinical trial success","year":"2021","cit":0,"ptype":"dataset","src":"https://openalex.org/W4200617111","eid":"W4200617111"},{"id":"paper-w7155519553","cat":"papers","name":"Annual Meeting Bundle: Three activities highlighted in this 4.25‐CME bundle that includes the psychedelic debate","year":"2026","cit":0,"ptype":"article","src":"https://openalex.org/W7155519553","eid":"W7155519553"},{"id":"paper-w7204521106","cat":"papers","name":"Psychedelics in psychiatry: comparative effectiveness, implementation, commercialization and safety lessons learned from intranasal esketamine","year":"2026","cit":0,"pfa":"Roger S. McIntyre","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7204521106","eid":"W7204521106"},{"id":"paper-w4400575682","cat":"papers","name":"Psychiatrists’ Personal Use and Social Proximity to Psychedelics Predicts Attitudes Towards Drugs and Drug Users","year":"2024","cit":0,"pfa":"Adam W. Levin","psa":"Alan K. Davis","ptype":"article","src":"https://openalex.org/W4400575682","eid":"W4400575682"},{"id":"paper-w7160828403","cat":"papers","name":"Psychedelic-Like Effects of 4-Substituted N,N-Dipropyltryptamine Analogs (Abstract ID: 230619)","year":"2026","cit":0,"pfa":"Grant C. Glatfelter","psa":"Michael R. Baumann","ptype":"article","src":"https://openalex.org/W7160828403","eid":"W7160828403"},{"id":"paper-w2516384997","cat":"papers","name":"The efficacy of microdose GnRH agonist flare versus GnRH antagonist/Letrozole protocols in poor responders undergoing in vitro fertilization","year":"2016","cit":0,"pfa":"Gürkan Bozdağ","psa":"Hakan Yaralı́","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W2516384997","eid":"W2516384997"},{"id":"paper-w2024675242","cat":"papers","name":"Treatment of Poor Responders: A comparison of microdose luprolide acetate/FSH(ML) to a GnRH antagonist/letrozole/FSH(AL) protocol","year":"2004","cit":0,"pfa":"William B. Schoolcraft","psa":"David K. Gardner","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2024675242","eid":"W2024675242"},{"id":"paper-w4245101266","cat":"papers","name":"Dosimetry Prediction of 225Ac-NOTA-Trastuzumab Based on 64Cu-NOTA-Trastuzumab in Breast Cancer: Preliminary Microdose Clinical Trial","year":"2019","cit":0,"pfa":"Inki Lee","psa":"Hyun‐Ah Kim","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4245101266","eid":"W4245101266"},{"id":"paper-w4361937837","cat":"papers","name":"Supplementary Legend from Multiplexed Evaluation of Microdosed Antineoplastic Agents In Situ in the Tumor Microenvironment of Patients with Soft Tissue Sarcoma","year":"2023","cit":0,"pfa":"Kenneth R. Gundle","psa":"Robert G. Maki","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4361937837","eid":"W4361937837"},{"id":"paper-w1605694873","cat":"papers","name":"Constitutional Law - Freedom of Religion - Hallucinogens: The Right to Spirited Spiritualism. People v. Woody, 40 Cal. Rptr. 69 (1964)","year":"1965","cit":0,"pfa":"Penelope Dalton","ptype":"article","src":"https://openalex.org/W1605694873","eid":"W1605694873"},{"id":"paper-w4408351932","cat":"papers","name":"Author response for \"Serotonergic Psychedelics Rapidly Modulate Evoked Glutamate Release in Cultured Cortical Neurons\"","year":"2025","cit":0,"pfa":"Aneta Petrušková","psa":"Anna Fejtová","ptype":"peer-review","src":"https://openalex.org/W4408351932","eid":"W4408351932"},{"id":"paper-w4413015966","cat":"papers","name":"Brain-wide neurochemical analysis of neurotransmitters in response to psychedelic drugs and 5-HT2A receptor antagonist","year":"2025","cit":0,"pfa":"Philippe De Deurwaerdère","psa":"Margherita Virgili","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4413015966","eid":"W4413015966"},{"id":"paper-w7134274321","cat":"papers","name":"Annual Meeting Bundle: Three activities highlighted in this 4.25‐CME bundle that includes the psychedelic debate","year":"2026","cit":0,"ptype":"article","src":"https://openalex.org/W7134274321","eid":"W7134274321"},{"id":"paper-w7169851812","cat":"papers","name":"Positive experience and desire to use as key predictors of attitudes towards psychedelics and controlled substance regulation","year":"2026","cit":0,"pfa":"Dean Lipovac","psa":"Kristina Čufar","topics":["Addiction","Policy & ethics"],"ptype":"other","src":"https://openalex.org/W7169851812","eid":"W7169851812"},{"id":"paper-w3028433642","cat":"papers","name":"Broadening Your Mind to Include Others - The relationship between serotonergic psychedelic experiences and maladaptive narcissism_PREPRINT","year":"2020","cit":0,"pfa":"Valerie van Mulukom","psa":"Michiel van Elk","ptype":"preprint","src":"https://openalex.org/W3028433642","eid":"W3028433642"},{"id":"paper-w4413605961","cat":"papers","name":"How consciousness may rely on brain cells acting collectively – new psychedelics research on rats","year":"2023","cit":0,"pfa":"Pär Halje","ptype":"other","src":"https://openalex.org/W4413605961","eid":"W4413605961"},{"id":"paper-w4405621607","cat":"papers","name":"Systematic review of case reports of adverse psychiatric effects of psychedelic drugs I: psychiatric illness","year":"2024","cit":0,"pfa":"B. Yildirim","psa":"Edith Pomarol‐Clotet","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4405621607","eid":"W4405621607"},{"id":"paper-w7167871557","cat":"papers","name":"Synthetic Psychedelic Phenethylamine Drugs After Microtubule Formation and Neurogenesis in Human Neural Progenitor Cells","year":"2024","cit":0,"pfa":"Amelia E. Zannoni","psa":"Grace K. Wong","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"conference-paper","src":"https://openalex.org/W7167871557","eid":"W7167871557"},{"id":"paper-w2412409893","cat":"papers","name":"Psychotomimetics and psychotonics.","year":"1960","cit":0,"pfa":"Andre F. De Schaepdryver","ptype":"article","src":"https://openalex.org/W2412409893","eid":"W2412409893"},{"id":"paper-w3023122774","cat":"papers","name":"Psychotomimetic Phenethylamines","year":"1998","cit":0,"pfa":"Karel Valter","psa":"Philippe Arrizabalaga","ptype":"book-chapter","src":"https://openalex.org/W3023122774","eid":"W3023122774"},{"id":"paper-w4408279904","cat":"papers","name":"Behavioral and genetic analysis of the effects of the psychedelic 2,5-dimethoxy-4-iodoamphetamine (DOI) in C. elegans","year":"2025","cit":0,"pfa":"Amanda M. White","psa":"Shawn R. Lockery","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"preprint","src":"https://openalex.org/W4408279904","eid":"W4408279904"},{"id":"paper-w7164152221","cat":"papers","name":"Mixed-methods analysis on psychedelic-augmented meditation experiences from a randomized controlled mindfulness retreat","year":"2026","cit":0,"pfa":"Jonas TT Schlomberg","psa":"Milan Scheidegger","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7164152221","eid":"W7164152221"},{"id":"paper-w7112297761","cat":"papers","name":"Investigating the Phenomenology and Perceived Mental Health Impact of Classic Psychedelic Experiences in People with a History of Psychosis","year":"2025","cit":0,"pfa":"Haley Dourron","ptype":"preprint","src":"https://openalex.org/W7112297761","eid":"W7112297761"},{"id":"paper-w4417433647","cat":"papers","name":"Restoring oscillatory dynamics in Alzheimer’s disease: A laminar whole-brain model of serotonergic psychedelic effects","year":"2025","cit":0,"pfa":"Jan C. Gendra","psa":"for the Alzheimer’s Disease Neuroimaging Initiative","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4417433647","eid":"W4417433647"},{"id":"paper-w2941708078","cat":"papers","name":"Psychedelics and indicators of mental distress in adults : National Survey on Drug Use and Health 2008–2014","year":"2018","cit":0,"pfa":"Teo Ajantaival","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2941708078","eid":"W2941708078"},{"id":"paper-w4310494333","cat":"papers","name":"Supplemental Material for Meditation Trips: A Thematic Analysis of the Combined Naturalistic Use of Psychedelics With Meditation Practices","year":"2022","cit":0,"ptype":"supplementary-materials","src":"https://openalex.org/W4310494333","eid":"W4310494333"},{"id":"paper-w7166506966","cat":"papers","name":"Navigating the pluripotency of psychedelic experience: Learning from the challenges of destabilisation, towards the possibility of ontological transfiguration","year":"2026","cit":0,"pfa":"Eirini Ketzitzidou Argyri (21065669)","ptype":"article","src":"https://openalex.org/W7166506966","eid":"W7166506966"},{"id":"paper-w2770729320","cat":"papers","name":"Psychedelic Solutions: Unconventional Exhibition Displays for Rock Posters and 2D Materials from The Summer of Love","year":"2017","cit":0,"pfa":"Anisha Gupta","psa":"Victoria Binder","ptype":"article","src":"https://openalex.org/W2770729320","eid":"W2770729320"},{"id":"paper-w7200213560","cat":"papers","name":"Postmodern religiousness? : A case study of how a psychedelic experience can be interpreted in light of new religiousness","year":"2022","cit":0,"pfa":"Joonatan Huhdanpää","ptype":"article","src":"https://openalex.org/W7200213560","eid":"W7200213560"},{"id":"paper-w7161460980","cat":"papers","name":"The Economics of Crime: Exploring the Impact of Psychedelics, Gun Liability Insurance, and Zero-Bail Policies on Crime","year":"2025","cit":0,"pfa":"Victor Kilanko","topics":["Addiction","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W7161460980","eid":"W7161460980"},{"id":"paper-w2811027606","cat":"papers","name":"PM361. The hallucinogen D-lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT1A, D2 and TAAR1 receptors","year":"2016","cit":0,"pfa":"Danilo De Gregorio","psa":"Gabriella Gobbi","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W2811027606","eid":"W2811027606"},{"id":"paper-w7202349653","cat":"papers","name":"A contemporary exploration of motivations and practices of psychedelic use among emerging adult cannabis users in the United States: A qualitative analysis.","year":"2026","cit":0,"pfa":"Bridgid Mariko Conn","psa":"Carolyn F. Wong","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7202349653","eid":"W7202349653"},{"id":"paper-w7155471400","cat":"papers","name":"Modeling different States of Consciousness: Biophysical Whole-Brain Simulations of Sleep, General Anesthesia and Psychedelics","year":"2026","cit":0,"pfa":"Rodrigo Cofré","ptype":"conference-paper","src":"https://openalex.org/W7155471400","eid":"W7155471400"},{"id":"paper-w4413582446","cat":"papers","name":"AI maps psychedelic ‘trip’ experiences to regions of the brain – opening new route to psychiatric treatments","year":"2022","cit":0,"pfa":"Galen Ballentine","psa":"Sam Freesun Friedman","ptype":"other","src":"https://openalex.org/W4413582446","eid":"W4413582446"},{"id":"paper-w4223654942","cat":"papers","name":"Adverse Childhood Experiences and complex PTSD: A Theoretical Model Exploring Psychedelic Drugs as a Therapeutic Treatment","year":"2022","cit":0,"pfa":"Abigail Corpuz","topics":["PTSD & trauma","Addiction","Anxiety & end-of-life"],"ptype":"conference-abstract","src":"https://openalex.org/W4223654942","eid":"W4223654942"},{"id":"paper-w4327499522","cat":"papers","name":"Build a Dynamic Psychedelic Network Environment through SDN Technology to Improve the Difficulty of Hacker Attacks","year":"2022","cit":0,"pfa":"Dongling Xiao","psa":"Yu Zheng","ptype":"conference-paper","src":"https://openalex.org/W4327499522","eid":"W4327499522"},{"id":"paper-w4395030429","cat":"papers","name":"Review for \"Exploring new frontiers: Effects of psychedelics on neurotransmitter-regulated glucagon release in pancreatic islets\"","year":"2023","cit":0,"topics":["Reviews & meta-analyses","Policy & ethics"],"ptype":"peer-review","src":"https://openalex.org/W4395030429","eid":"W4395030429"},{"id":"paper-w7160145793","cat":"papers","name":"Modern Psychedelics: The Handbook for Mindful Exploration by Joe Dolce, Julie Holland on Iphone New Format","year":"2026","cit":0,"pfa":"Gina Jeffries","ptype":"report","src":"https://openalex.org/W7160145793","eid":"W7160145793"},{"id":"paper-w2310607521","cat":"papers","name":"[Psychotomimetic effects of ketamine].","year":"1972","cit":0,"pfa":"Rosalie Sanchez","psa":"Rojas Lm","ptype":"article","src":"https://openalex.org/W2310607521","eid":"W2310607521"},{"id":"paper-w7135414366","cat":"papers","name":"Additional file 5: of Validation of whole-blood transcriptome signature during microdose recombinant human erythropoietin (rHuEpo) administration","year":"2017","cit":0,"pfa":"Guan Wang","psa":"Yannis P. Pitsiladis","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7135414366","eid":"W7135414366"},{"id":"paper-w4406027397","cat":"papers","name":"Mechanisms for inducing anesthesia, safety and well-being, through ketamine, psychedelics and serotonin effects on 5-HT2a receptors.","year":"2025","cit":0,"pfa":"Karin Vadovičová","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4406027397","eid":"W4406027397"},{"id":"paper-w3203269932","cat":"papers","name":"Restoring complexity via psychedelics in patients with DoC: study protocol for two placebo-controlled RCTs","year":"2021","cit":0,"pfa":"Paolo Cardone","psa":"Olivia Gosseries","topics":["Reviews & meta-analyses"],"ptype":"conference-abstract","src":"https://openalex.org/W3203269932","eid":"W3203269932"},{"id":"paper-w4402970632","cat":"papers","name":"The oneirogen hypothesis: modeling the hallucinatory effects of classical psychedelics in terms of replay-dependent plasticity mechanisms","year":"2024","cit":0,"pfa":"Colin Bredenberg","psa":"Guillaume Lajoie","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4402970632","eid":"W4402970632"},{"id":"paper-w7169871738","cat":"papers","name":"Positive experience and desire to use as key predictors of attitudes towards psychedelics and controlled substance regulation","year":"2026","cit":0,"pfa":"Dean Lipovac","psa":"Kristina Čufar","topics":["Addiction","Policy & ethics"],"ptype":"dataset","src":"https://openalex.org/W7169871738","eid":"W7169871738"},{"id":"paper-w7118250995","cat":"papers","name":"Cannabis and Psychedelics Among U.S. Young Adults: Use, Messaging Exposure, Perceptions, and Legalization Support","year":"2026","cit":0,"pfa":"Carla J. Berg","psa":"Y. Tony Yang","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W7118250995","eid":"W7118250995"},{"id":"paper-w3008949743","cat":"papers","name":"Consideration from the Smallest Starting Dose Used in Clinical Trials and the Approved Minimum Clinical Dose for Microdose of Antibody Pharmaceuticals in Japan","year":"2020","cit":0,"pfa":"Yasuhíro Suzuki","psa":"Akihiro Inano","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3008949743","eid":"W3008949743"},{"id":"paper-w4391745112","cat":"papers","name":"Review for \"Microdosing ketamine in Drosophila does not block serotonin reuptake, but causes complex behavioral changes mediated by glutamate and serotonin receptors\"","year":"2023","cit":0,"topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4391745112","eid":"W4391745112"},{"id":"paper-w7138977133","cat":"papers","name":"Roland R. Griffiths, psychopharmacology pioneer: Abuse liability, alcohol, nicotine, caffeine, benzodiazepines, and psychedelics","year":"2026","cit":0,"pfa":"Jack E. Henningfield","psa":"David B. Yaden","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7138977133","eid":"W7138977133"},{"id":"paper-w7112812131","cat":"papers","name":"Utilization of Psychedelic Substances and Unmet Need for Mental Health Services in the United States: A Nationally Representative Study","year":"2025","cit":0,"pfa":"Negaro, Sophia Nancy Dennett","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7112812131","eid":"W7112812131"},{"id":"paper-w6925003765","cat":"papers","name":"[Guest editorial] Paradise is paradise: Reflections on psychedelic drugs, mystical experience, and the near-death experience","year":"1988","cit":0,"pfa":"Ring","ptype":"article","src":"https://openalex.org/W6925003765","eid":"W6925003765"},{"id":"paper-w7118051026","cat":"papers","name":"5HT2A et al.: enhancement of synaptic transmission in the hippocampus by psychedelics via serotonin receptors and TrkB","year":"2026","cit":0,"pfa":"L. Schuberth","psa":"C. Normann","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7118051026","eid":"W7118051026"},{"id":"paper-w7131623051","cat":"papers","name":"Review for \"Floorless Closed-Loop Microdosing for Rail Friction: A Physics-Only Digital Twin on Kuwait City’s Blue Corridor\"","year":"2025","cit":0,"topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W7131623051","eid":"W7131623051"},{"id":"paper-w7214141911","cat":"papers","name":"The Application of Emotional Processing Theory to the Healing Mechanisms of Naturalistic Psychedelic Use for Survivors of Sexual Assault","year":"2026","cit":0,"pfa":"Madison Tschauner","topics":["PTSD & trauma","Mechanism & neuroscience","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W7214141911","eid":"W7214141911"},{"id":"paper-w7134253791","cat":"papers","name":"The Electromagnetic Argument Against the Desynchronization Interpretation of Psychedelic MEG Data: Implications for the Filter Theory of Consciousness","year":"2026","cit":0,"pfa":"Maarten Vergucht","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7134253791","eid":"W7134253791"},{"id":"paper-w7123444404","cat":"papers","name":"The oneirogen hypothesis: modeling the hallucinatory effects of classical psychedelics in terms of replay-dependent plasticity mechanisms","year":"2026","cit":0,"pfa":"Colin Bredenberg","psa":"Guillaume Lajoie","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7123444404","eid":"W7123444404"},{"id":"paper-w7214773953","cat":"papers","name":"Reliability of Self-Reported Real-World Psychedelic Use – A Test-Retest Study in a Population Sample","year":"2026","cit":0,"pfa":"Karilynn M. Rockhill","psa":"Joshua Curtis Black","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7214773953","eid":"W7214773953"},{"id":"paper-w4414725451","cat":"papers","name":"Decision letter for \"Exploring the Therapeutic Effects of Psychedelics Administered to Military Veterans in Naturalistic Retreat Settings\"","year":"2025","cit":0,"ptype":"peer-review","src":"https://openalex.org/W4414725451","eid":"W4414725451"},{"id":"paper-w7127893094","cat":"papers","name":"Practitioner perspectives on extended difficulties and optimal support strategies following psychedelic experiences: a qualitative analysis","year":"2026","cit":0,"pfa":"E. K. Argyri","psa":"C. J. A. Morgan","topics":["PTSD & trauma","Anxiety & end-of-life","Safety & adverse events"],"ptype":"other","src":"https://openalex.org/W7127893094","eid":"W7127893094"},{"id":"paper-w4385236086","cat":"papers","name":"Data from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W4385236086","eid":"W4385236086"},{"id":"paper-w3161790172","cat":"papers","name":"A psychedelic drug may help treat PTSD. But questions remain on how best to use—and regulate—it","year":"2021","cit":0,"pfa":"Kelly Servick","topics":["PTSD & trauma","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3161790172","eid":"W3161790172"},{"id":"paper-w4388184989","cat":"papers","name":"The serotonergic psychedelic N,N-dipropyltryptamine alters information-processing dynamics in cortical neural circuits","year":"2023","cit":0,"pfa":"Thomas F. Varley","psa":"Beggs, John","topics":["Mechanism & neuroscience","Therapy practice","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4388184989","eid":"W4388184989"},{"id":"paper-w7204913632","cat":"papers","name":"Measuring the contents of hallucinations from psychedelics and stroboscopic light: the Six-Dimensional Visual Hallucination Questionnaire","year":"2026","cit":0,"pfa":"Trevor Hewitt","psa":"David J. Schwartzman","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7204913632","eid":"W7204913632"},{"id":"paper-w4394069951","cat":"papers","name":"Additional file 9: of Validation of whole-blood transcriptome signature during microdose recombinant human erythropoietin (rHuEpo) administration","year":"2017","cit":0,"pfa":"Guan Wang","psa":"Yannis Paul Pitsiladis","topics":["Dosing & pharmacology"],"ptype":"dataset","src":"https://openalex.org/W4394069951","eid":"W4394069951"},{"id":"paper-w7168092088","cat":"papers","name":"Toward a Sustainable Green Revolution in Sub-Saharan Africa: The Impact of Farmer and Retailer Training for Fertilizer Microdosing on Rice Productivity","year":"2026","cit":0,"pfa":"Eustadius Francis Magezi","psa":"Yasuhiro Tsujimoto","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"other","src":"https://openalex.org/W7168092088","eid":"W7168092088"},{"id":"paper-w7161639389","cat":"papers","name":"Child and maternal health outcomes following antenatal exposure to classic psychedelic substances: a systematic review","year":"2026","cit":0,"pfa":"Sunjuri Sun","psa":"Otto Simonsson","topics":["Addiction","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7161639389","eid":"W7161639389"},{"id":"paper-w4405353097","cat":"papers","name":"PSYCHEDELIC SCIENCE: Drugs Are the Same: Legal or Illegal. Stimulation as a Necessity: A Reinterpretation of 'Drugs' in Contemporary Society","year":"2024","cit":0,"pfa":"Edison Carrasco Jiménez","topics":["Addiction","Anxiety & end-of-life","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4405353097","eid":"W4405353097"},{"id":"paper-w3042488418","cat":"papers","name":"ChemInform Abstract: THE SYNTHESIS OF FOUR POSSIBLE IN VITRO METABOLITES OF THE HALLUCINOGEN 1‐(2,5‐DIMETHOXY‐4‐METHYLPHENYL)‐2‐AMINOPROPANE (DOM)","year":"1974","cit":0,"pfa":"Ronald T. Coutts","psa":"Jerry L. Malicky","ptype":"article","src":"https://openalex.org/W3042488418","eid":"W3042488418"},{"id":"paper-w7139082997","cat":"papers","name":"Mixed-methods analysis on psychedelic-augmented meditation experiences from a randomized controlled mindfulness retreat","year":"2026","cit":0,"pfa":"Jonas TT Schlomberg","psa":"Milan Scheidegger","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7139082997","eid":"W7139082997"},{"id":"paper-w4389114671","cat":"papers","name":"Delicate females and psychedelic creation in the scientific works of Thomas Beddoes, Humphry Davy and Erasmus Darwin","year":"2021","cit":0,"pfa":"Kimberley Page-Jones","ptype":"book-chapter","src":"https://openalex.org/W4389114671","eid":"W4389114671"},{"id":"paper-w7142942703","cat":"papers","name":"Memento Mori: An Exploration of the Spiritual and Existential Aspects of Psychedelic Experiences Outside of End-of-Life Contexts","year":"2026","cit":0,"pfa":"Nicolas Galton","topics":["Addiction","Anxiety & end-of-life","Reviews & meta-analyses"],"ptype":"other","src":"https://openalex.org/W7142942703","eid":"W7142942703"},{"id":"paper-w4411016144","cat":"papers","name":"Benjamin Breen,Tripping on Utopia: Margaret Mead, the Cold War, and the Troubled Birth of Psychedelic Science","year":"2025","cit":0,"pfa":"Wendy Kline","ptype":"book-review","src":"https://openalex.org/W4411016144","eid":"W4411016144"},{"id":"paper-w4361937799","cat":"papers","name":"Supplemental Figure 5 from Multiplexed Evaluation of Microdosed Antineoplastic Agents In Situ in the Tumor Microenvironment of Patients with Soft Tissue Sarcoma","year":"2023","cit":0,"pfa":"Kenneth R. Gundle","psa":"Robert G. Maki","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4361937799","eid":"W4361937799"},{"id":"paper-w2482737844","cat":"papers","name":"Antipsychotic and psychotomimetic drugs","year":"1992","cit":0,"pfa":"Heather Ashton","topics":["Depression"],"ptype":"book-chapter","src":"https://openalex.org/W2482737844","eid":"W2482737844"},{"id":"paper-w604654896","cat":"papers","name":"Sam Shepard′s Melodrama Play and The Psychedelic American Culture in the 60′s〔邦文〕","year":"1985","cit":0,"pfa":"綾子 佐藤","ptype":"article","src":"https://openalex.org/W604654896","eid":"W604654896"},{"id":"paper-w332630812","cat":"papers","name":"Knowledge of Dentistry, Medicine, and Pharmacy Students about Psychedelic Drugs in Kerman University of Medical Sciences.","year":"2009","cit":0,"pfa":"Akram Nakhaee","psa":"Vahid Sheibani","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W332630812","eid":"W332630812"},{"id":"paper-w2283012838","cat":"papers","name":"Plant Psychedelics in the English Courts: guinea pigs, legal uncertainty, guinea pigs, and 'dog law'","year":"2015","cit":0,"pfa":"Charlotte K. Walsh (7677215)","topics":["Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W2283012838","eid":"W2283012838"},{"id":"paper-w2171719291","cat":"papers","name":"Neuropsychedelia: The Revival of Hallucinogen Research since the Decade of the Brain. Nicolas Langlitz. Berkeley: University of California Press, 2013. 316 pp.","year":"2014","cit":0,"pfa":"NANCY D. CAMPBELL","ptype":"book-review","src":"https://openalex.org/W2171719291","eid":"W2171719291"},{"id":"paper-w569322626","cat":"papers","name":"LSD trip : psyche/psychedelic experience : 한영권 : 韓泳權 : Han Yeong gwon","year":"2008","cit":0,"pfa":"영권 한","psa":"Gallery Hosi","ptype":"book","src":"https://openalex.org/W569322626","eid":"W569322626"},{"id":"paper-w7212258126","cat":"papers","name":"Perceptions and experiences of psychedelic substance use: a qualitative thematic analysis of Polish-language Reddit posts","year":"2026","cit":0,"pfa":"Ewa Jankowska","psa":"Damian Świeczkowski","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7212258126","eid":"W7212258126"},{"id":"paper-w2227161300","cat":"papers","name":"THE ROLE OF POLICEWOMEN IN FIGHTING AGAINST NARCOTIC AND HALLUCINOGENS SHIPMENT AND SMUGGLING (CASE STUDY OF TORBATE HEIDARIEH AND SHIRDEL KAME POLICE STATION)","year":"2011","cit":0,"pfa":"Jahanshiri Javad","ptype":"article","src":"https://openalex.org/W2227161300","eid":"W2227161300"},{"id":"paper-w7165648733","cat":"papers","name":"Politically Salient Events May Modulate Effects of Naturalistic Psychedelic Use on Support for Partisan Violence","year":"2026","cit":0,"pfa":"Otto Simonsson","psa":"Simon Benjamin Goldberg","ptype":"article","src":"https://openalex.org/W7165648733","eid":"W7165648733"},{"id":"paper-w1493191390","cat":"papers","name":"Applications of human microdosing with accelerator mass spectrometry : assessment of ability to predict drug-drug interactions and determine the pharmacokinetics of enantiomers","year":"2012","cit":0,"pfa":"Marie Croft","topics":["Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W1493191390","eid":"W1493191390"},{"id":"paper-w4402799156","cat":"papers","name":"Data from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2024","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W4402799156","eid":"W4402799156"},{"id":"paper-w7125976150","cat":"papers","name":"Enhancing fertilizer-use-efficiency through fertilizer microdosing as climate-smart practices among crop farmers in North Central, Nigeria","year":"2025","cit":0,"pfa":"Isaac Busayo Oluwatayo","psa":"Stefan Sieber","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7125976150","eid":"W7125976150"},{"id":"paper-w7117471383","cat":"papers","name":"Life as Self-Sustaining Information Flow: Implications for Neuroscience, Psychedelic Research, and AI-Aligned Drug Discovery","year":"2025","cit":0,"pfa":"Ali Mofradi","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7117471383","eid":"W7117471383"},{"id":"paper-w4394409880","cat":"papers","name":"Additional file 6: of Validation of whole-blood transcriptome signature during microdose recombinant human erythropoietin (rHuEpo) administration","year":"2017","cit":0,"pfa":"Guan Wang","psa":"Yannis Paul Pitsiladis","topics":["Dosing & pharmacology"],"ptype":"dataset","src":"https://openalex.org/W4394409880","eid":"W4394409880"},{"id":"paper-w4361889048","cat":"papers","name":"Supplemental Figure 1 from Multiplexed Evaluation of Microdosed Antineoplastic Agents In Situ in the Tumor Microenvironment of Patients with Soft Tissue Sarcoma","year":"2023","cit":0,"pfa":"Kenneth R. Gundle","psa":"Robert G. Maki","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4361889048","eid":"W4361889048"},{"id":"paper-w7127936733","cat":"papers","name":"Practitioner perspectives on extended difficulties and optimal support strategies following psychedelic experiences: a qualitative analysis","year":"2026","cit":0,"pfa":"E. K. Argyri","psa":"C. J. A. Morgan","topics":["PTSD & trauma","Anxiety & end-of-life","Safety & adverse events"],"ptype":"other","src":"https://openalex.org/W7127936733","eid":"W7127936733"},{"id":"paper-w4361937927","cat":"papers","name":"Supplemental Figure 4 from Multiplexed Evaluation of Microdosed Antineoplastic Agents In Situ in the Tumor Microenvironment of Patients with Soft Tissue Sarcoma","year":"2023","cit":0,"pfa":"Kenneth R. Gundle","psa":"Robert G. Maki","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4361937927","eid":"W4361937927"},{"id":"paper-w4385235969","cat":"papers","name":"Data from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W4385235969","eid":"W4385235969"},{"id":"paper-w2806713167","cat":"papers","name":"Nutrient Quality Studies of Fluted Pumpkin (Telfairia Occidentalis Hook. F) Leaves as Influence by Fertilizer Microdosing and Micro-Dosing Time","year":"2018","cit":0,"pfa":"P Amao","psa":"Ifeoluwapo Oluwaseun Amao","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2806713167","eid":"W2806713167"},{"id":"paper-w4205088723","cat":"papers","name":"CLINICAL AND DYNAMIC CHARACTERISTICS OF A LONG-LASTING PERCEPTION DISORDER DUE TO THE USE OF PSYCHOACTIVE SUBSTANCES WITH A PSYCHEDELIC EFFECT","year":"2021","cit":0,"pfa":"Yu.M. Scheidegger","psa":"Т.В. Клименко","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4205088723","eid":"W4205088723"},{"id":"paper-w4395030446","cat":"papers","name":"Decision letter for \"Exploring new frontiers: Effects of psychedelics on neurotransmitter-regulated glucagon release in pancreatic islets\"","year":"2023","cit":0,"topics":["Policy & ethics"],"ptype":"peer-review","src":"https://openalex.org/W4395030446","eid":"W4395030446"},{"id":"paper-w7135424172","cat":"papers","name":"Additional file 8: of Validation of whole-blood transcriptome signature during microdose recombinant human erythropoietin (rHuEpo) administration","year":"2017","cit":0,"pfa":"Guan Wang","psa":"Yannis P. Pitsiladis","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7135424172","eid":"W7135424172"},{"id":"paper-w4367055892","cat":"papers","name":"Faculty Opinions recommendation of Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors.","year":"2023","cit":0,"pfa":"Joël Bockaert","topics":["Mechanism & neuroscience"],"ptype":"peer-review","src":"https://openalex.org/W4367055892","eid":"W4367055892"},{"id":"paper-w4391752697","cat":"papers","name":"Correction: Ethopharmacological evaluation of antidepressant-like effect of serotonergic psychedelics in C57BL/6J male mice","year":"2024","cit":0,"pfa":"Rika Takaba","psa":"Masayuki Hiramatsu","topics":["Depression","Dosing & pharmacology"],"ptype":"erratum","src":"https://openalex.org/W4391752697","eid":"W4391752697"},{"id":"paper-w7165681408","cat":"papers","name":"5. Hallucinations: 1960s Filmic Narratives of Subjective Lived Psychedelic Experiences and their Legal/Illegal Status","year":"2026","cit":0,"pfa":"Christian Bonah","topics":["Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W7165681408","eid":"W7165681408"},{"id":"paper-w2102392839","cat":"papers","name":"Comparison of the ultrashort gonadotropin-releasing hormone agonist-antagonist protocol with microdose flare-up protocol in poor responders: a preliminary study","year":"2010","cit":0,"pfa":"Bülent Berker","psa":"Hakan Şatıroğlu","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2102392839","eid":"W2102392839"},{"id":"paper-w4313335231","cat":"papers","name":"Effect of microdose chemical fertilization method on soil chemical properties and productivity of maize (Zea mays L.) in West-Central Senegal","year":"2022","cit":0,"pfa":"Rabi Housseini Malam Laminou","psa":"Papa Saliou Sarr","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4313335231","eid":"W4313335231"},{"id":"paper-w4361888953","cat":"papers","name":"Supplemental Figure 3 from Multiplexed Evaluation of Microdosed Antineoplastic Agents In Situ in the Tumor Microenvironment of Patients with Soft Tissue Sarcoma","year":"2023","cit":0,"pfa":"Kenneth R. Gundle","psa":"Robert G. Maki","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4361888953","eid":"W4361888953"},{"id":"paper-w2470774974","cat":"papers","name":"Neuropharmacology of psychotomimetic drugs.","year":"1968","cit":0,"pfa":"Murphree Hb","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2470774974","eid":"W2470774974"},{"id":"paper-w2416661909","cat":"papers","name":"The pharmacology of the psychotomimetic agents.","year":"1959","cit":0,"pfa":"Carr Cj","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2416661909","eid":"W2416661909"},{"id":"paper-w4297911378","cat":"papers","name":"Functional neuroimaging of psychedelic experience: An overview of psychological and neural effects and their relevance to research on creativity, daydreaming, and dreaming","year":"2016","cit":0,"pfa":"Kieran C. R. Fox","psa":"Kalina Christoff","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4297911378","eid":"W4297911378"},{"id":"paper-w4391745149","cat":"papers","name":"Review for \"Microdosing ketamine in Drosophila does not block serotonin reuptake, but causes complex behavioral changes mediated by glutamate and serotonin receptors\"","year":"2023","cit":0,"topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4391745149","eid":"W4391745149"},{"id":"paper-w4361937768","cat":"papers","name":"Supplemental Figure 1 from Multiplexed Evaluation of Microdosed Antineoplastic Agents In Situ in the Tumor Microenvironment of Patients with Soft Tissue Sarcoma","year":"2023","cit":0,"pfa":"Kenneth R. Gundle","psa":"Robert G. Maki","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4361937768","eid":"W4361937768"},{"id":"paper-w4234230949","cat":"papers","name":"Clinical Efficacy and Cost Effectiveness of a Microdose GnRH-a Protocol Compared to a Luteal Phase GnRH-a Protocol for Controlled Ovarian Hyper-stimulation","year":"1997","cit":0,"pfa":"M Leondires","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4234230949","eid":"W4234230949"},{"id":"paper-w4229510206","cat":"papers","name":"Correction to: MDLSD: study protocol for a randomised, double-masked, placebo-controlled trial of repeated microdoses of LSD in healthy volunteers","year":"2021","cit":0,"pfa":"Robin J. Murphy","psa":"Suresh D Muthukumaraswamy","topics":["Dosing & pharmacology"],"ptype":"erratum","src":"https://openalex.org/W4229510206","eid":"W4229510206"},{"id":"paper-w4409632442","cat":"papers","name":"Foliar sugar microdoses as a biocontrol approach against the tomato leaf miner Tuta absoluta: A sustainable pest management strategy","year":"2025","cit":0,"pfa":"Ardjouna Naceri","psa":"Fateh Mimeche","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4409632442","eid":"W4409632442"},{"id":"paper-w4391616826","cat":"papers","name":"Bonding to Psychedelics: Synthesis of Molecularly Imprinted Polymers Targeting 4-Bromo-2,5-dimethoxyphenethylamine (2C-B)","year":"2024","cit":0,"pfa":"Daniel Martins","psa":"Jorge M. P. J. Garrido","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4391616826","eid":"W4391616826"},{"id":"paper-w4361937844","cat":"papers","name":"Supplemental Table 2 from Multiplexed Evaluation of Microdosed Antineoplastic Agents In Situ in the Tumor Microenvironment of Patients with Soft Tissue Sarcoma","year":"2023","cit":0,"pfa":"Kenneth R. Gundle","psa":"Robert G. Maki","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4361937844","eid":"W4361937844"},{"id":"paper-w4391744917","cat":"papers","name":"Review for \"Microdosing ketamine in Drosophila does not block serotonin reuptake, but causes complex behavioral changes mediated by glutamate and serotonin receptors\"","year":"2023","cit":0,"topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4391744917","eid":"W4391744917"},{"id":"paper-w2914586991","cat":"papers","name":"P.3.017 In vivo measurements of brain serotonergic markers and analysis of drug use profiles among recreational ecstasy and hallucinogen users","year":"2011","cit":0,"pfa":"David Erritzøe","psa":"Gitte M. Knudsen","ptype":"article","src":"https://openalex.org/W2914586991","eid":"W2914586991"},{"id":"paper-w7146548719","cat":"papers","name":"INNOVATIVE STRATEGIES FOR DRUG DEVELOPMENT USING MICRODOSING CLINICAL STUDIES (1)Ethics and Human Subjects Protection In The Project of Multiplex Studies","year":"2009","cit":0,"pfa":"Chieko Kurihara","psa":"福島 芳子","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"conference-paper","src":"https://openalex.org/W7146548719","eid":"W7146548719"},{"id":"paper-w4361888958","cat":"papers","name":"Supplemental Figure 5 from Multiplexed Evaluation of Microdosed Antineoplastic Agents In Situ in the Tumor Microenvironment of Patients with Soft Tissue Sarcoma","year":"2023","cit":0,"pfa":"Kenneth R. Gundle","psa":"Robert G. Maki","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4361888958","eid":"W4361888958"},{"id":"paper-w4386775816","cat":"papers","name":"Data from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W4386775816","eid":"W4386775816"},{"id":"paper-w7131645830","cat":"papers","name":"Author response for \"Floorless Closed-Loop Microdosing for Rail Friction: A Physics-Only Digital Twin on Kuwait City’s Blue Corridor\"","year":"2025","cit":0,"pfa":"Abdullah Mohammed","topics":["Dosing & pharmacology"],"ptype":"peer-review","src":"https://openalex.org/W7131645830","eid":"W7131645830"},{"id":"paper-w2049142359","cat":"papers","name":"Comparison of oocyte maturation in microdose follicular-phase and luteal-phase gonadotropin-releasing hormone agonist (GnRH-a) ovarian stimulation protocols.","year":"2001","cit":0,"pfa":"Jeffrey L. McKeeby","psa":"Ruben J. Alvero","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2049142359","eid":"W2049142359"},{"id":"paper-w7135388829","cat":"papers","name":"Additional file 8: of Validation of whole-blood transcriptome signature during microdose recombinant human erythropoietin (rHuEpo) administration","year":"2017","cit":0,"pfa":"Guan Wang","psa":"Yannis P. Pitsiladis","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7135388829","eid":"W7135388829"},{"id":"paper-w7212220558","cat":"papers","name":"Enhanced Rainwater Productivity of Pearl Millet ( Pennisetum glaucum ) Through In‐Field Rainwater Harvesting and Nitrogen Microdosing in Semiarid Zimbabwe","year":"2026","cit":0,"pfa":"Cosmas Parwada","psa":"Gumbo Albert","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7212220558","eid":"W7212220558"},{"id":"paper-w2907569508","cat":"papers","name":"Other Psychotomimetic Phenethylamines","year":"1998","cit":0,"pfa":"Karel Valter","psa":"Philippe Arrizabalaga","ptype":"book-chapter","src":"https://openalex.org/W2907569508","eid":"W2907569508"},{"id":"paper-w4361888891","cat":"papers","name":"Supplemental Table 3 from Multiplexed Evaluation of Microdosed Antineoplastic Agents In Situ in the Tumor Microenvironment of Patients with Soft Tissue Sarcoma","year":"2023","cit":0,"pfa":"Kenneth R. Gundle","psa":"Robert G. Maki","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4361888891","eid":"W4361888891"},{"id":"paper-w7171541952","cat":"papers","name":"Legislative pathways as dissemination strategies: A protocol for examining psychedelics reform speed, content, and cross-state diffusion","year":"2026","cit":0,"pfa":"Ziming Wang","psa":"Danielle R. Adams","ptype":"preprint","src":"https://openalex.org/W7171541952","eid":"W7171541952"},{"id":"paper-w4214489392","cat":"papers","name":"Retracted: Evidences of Protective Potentials of Microdoses of Ultra-High Diluted Arsenic Trioxide in Mice Receiving Repeated Injections of Arsenic Trioxide","year":"2021","cit":0,"pfa":"Medicine, Evidence-Based Complementary and Alternative","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4214489392","eid":"W4214489392"},{"id":"paper-w4361937670","cat":"papers","name":"Supplemental Figure 3 from Multiplexed Evaluation of Microdosed Antineoplastic Agents In Situ in the Tumor Microenvironment of Patients with Soft Tissue Sarcoma","year":"2023","cit":0,"pfa":"Kenneth R. Gundle","psa":"Robert G. Maki","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4361937670","eid":"W4361937670"},{"id":"paper-w7131629332","cat":"papers","name":"Decision letter for \"Floorless Closed-Loop Microdosing for Rail Friction: A Physics-Only Digital Twin on Kuwait City’s Blue Corridor\"","year":"2026","cit":0,"topics":["Dosing & pharmacology"],"ptype":"peer-review","src":"https://openalex.org/W7131629332","eid":"W7131629332"},{"id":"paper-w2461410376","cat":"papers","name":"PSYCHOTOMIMETICS--A NEUROPHARMACOLOGICAL STUDY.","year":"1963","cit":0,"pfa":"Curtis Dr","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2461410376","eid":"W2461410376"},{"id":"paper-w3203739932","cat":"papers","name":"Chemical revolutionaries: Saskatchewan's psychedelic-related experiments and the work of Abram Hoffer, Humphry Osmond and Duncan Blewett.","year":"2006","cit":0,"pfa":"Barber, Patrick","ptype":"dissertation","src":"https://openalex.org/W3203739932","eid":"W3203739932"},{"id":"paper-w4210603128","cat":"papers","name":"Male Sexuality Postzionism: A Reader Conscience Judaism and Justice Witness to Dispossession the Lonely American Psychedelic Psychiatry","year":"2009","cit":0,"topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4210603128","eid":"W4210603128"},{"id":"paper-w4234637102","cat":"papers","name":"Healing and its discontents: Reflections on identity and altered states of consciousness by people who use psychedelics as medicine","year":"2012","cit":0,"pfa":"Cameron Adams","ptype":"dataset","src":"https://openalex.org/W4234637102","eid":"W4234637102"},{"id":"paper-w4407263792","cat":"papers","name":"04. Cannabis and psychedelics: Developments in regulatory changes and in the environment enabling non-medical use of controlled substances","year":"2024","cit":0,"topics":["Addiction","Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W4407263792","eid":"W4407263792"},{"id":"paper-w4286307053","cat":"papers","name":"(PO-046) To Treat or not to Treat? High-potency Benzodiazepine Use in a Case of Comorbid Hallucinogen Persisting Perception Disorder and Alcohol Use Disorder","year":"2022","cit":0,"pfa":"Julie A. Christensen","psa":"John Michael Bostwick","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4286307053","eid":"W4286307053"},{"id":"paper-w4403318639","cat":"papers","name":"Enhancing Fertilizer-Use-Efficiency through Fertilizer Microdosing as Climate-Smart Practices among Crop Farmers in North Central, Nigeria","year":"2024","cit":0,"pfa":"Adetomiwa Kolapo","psa":"Toluwalase Eniola Awe","topics":["Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4403318639","eid":"W4403318639"},{"id":"paper-w7162411600","cat":"papers","name":"Conscience May 2026 Policy Brief - Federal Action to Accelerate Psychedelic Treatments for Serious Mental Illness","year":"2026","cit":0,"pfa":"Mathilda Ryon","topics":["Addiction","Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7162411600","eid":"W7162411600"},{"id":"paper-w4385552539","cat":"papers","name":"ScholarOne - Limitless Experience through Limited Consumption: Psychedelics, Mystical Mindfulness, and Sustainable Corporate Leadership Development","year":"2023","cit":0,"pfa":"Joshua S. Nunziato","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4385552539","eid":"W4385552539"},{"id":"paper-w4400575433","cat":"papers","name":"Motives and Experiences of Psychedelic and Cannabis Co-Use Among Emerging Adult Cannabis Users: A Qualitative Analysis","year":"2024","cit":0,"pfa":"Bridgid Mariko Conn","psa":"Carolyn F. Wong","ptype":"article","src":"https://openalex.org/W4400575433","eid":"W4400575433"},{"id":"paper-w4361889022","cat":"papers","name":"Supplemental Table 1 from Multiplexed Evaluation of Microdosed Antineoplastic Agents In Situ in the Tumor Microenvironment of Patients with Soft Tissue Sarcoma","year":"2023","cit":0,"pfa":"Kenneth R. Gundle","psa":"Robert G. Maki","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4361889022","eid":"W4361889022"},{"id":"paper-w2029946661","cat":"papers","name":"Body & brain: Psychedelics chill brain out: Magic mushrooms subdue areas tied to self‐awareness","year":"2012","cit":0,"pfa":"Devin Powell","ptype":"article","src":"https://openalex.org/W2029946661","eid":"W2029946661"},{"id":"paper-w4391744935","cat":"papers","name":"Review for \"Microdosing ketamine in Drosophila does not block serotonin reuptake, but causes complex behavioral changes mediated by glutamate and serotonin receptors\"","year":"2023","cit":0,"topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4391744935","eid":"W4391744935"},{"id":"paper-w7134910565","cat":"papers","name":"Commentary on Schettino et al.: What counts as psychotherapy? Empirically grounding a normative dispute in psychedelic research","year":"2026","cit":0,"pfa":"William J. W. Choi","topics":["Therapy practice"],"ptype":"editorial","src":"https://openalex.org/W7134910565","eid":"W7134910565"},{"id":"paper-w195333675","cat":"papers","name":"Perancangan cergam punakawan bergaya desain psychedelic untuk anak - anak usia 8 - 14 tahun","year":"2008","cit":0,"pfa":"Gandawidjaja, Rr Imma Dewi","ptype":"dissertation","src":"https://openalex.org/W195333675","eid":"W195333675"},{"id":"paper-w2908649812","cat":"papers","name":"Book Review: The Democratic Surround: Multimedia & American Liberalism from World War II to the Psychedelic Sixties","year":"2016","cit":0,"pfa":"David Papadimitriou","topics":["Reviews & meta-analyses"],"ptype":"book-review","src":"https://openalex.org/W2908649812","eid":"W2908649812"},{"id":"paper-w7140302699","cat":"papers","name":"DMN Breakdown Meets Neuroplasticity: Convergent Pathways in Psychedelic, Ketamine, and Bedtime Oral Glutamatergic Approaches to Depression","year":"2026","cit":0,"pfa":"Ngo Cheung","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7140302699","eid":"W7140302699"},{"id":"paper-w2321718830","cat":"papers","name":"Book ReviewLicit and Illicit Drugs: The Consumers Union Report on narcotics, stimulants, depressants, inhalants, hallucinogens, and marijuana —including caffeine, nicotine, and alcohol.","year":"1973","cit":0,"pfa":"Barry Stimmel","topics":["Depression","Addiction","Reviews & meta-analyses"],"ptype":"book-review","src":"https://openalex.org/W2321718830","eid":"W2321718830"},{"id":"paper-w2439183973","cat":"papers","name":"Erratum to: Correlating the Metabolic Stability of Psychedelic 5-HT2A Agonists with Anecdotal Reports of Human Oral Bioavailability","year":"2014","cit":0,"pfa":"Sebastian Leth‐Petersen","psa":"Jesper Langgaard Kristensen","topics":["Mechanism & neuroscience"],"ptype":"erratum","src":"https://openalex.org/W2439183973","eid":"W2439183973"},{"id":"paper-w7115932140","cat":"papers","name":"Response to Letter to the Editor: “Psychedelics, Entity Encounters and the Precautionary Principle,” by the Unhidden Foundation for the Journal of Scientific Exploration","year":"2025","cit":0,"pfa":"Jeffery Ellis Heilman","ptype":"letter","src":"https://openalex.org/W7115932140","eid":"W7115932140"},{"id":"paper-w7201865973","cat":"papers","name":"Actions speak louder than words: Towards measuring real-world behaviour change in psychedelic research","year":"2026","cit":0,"pfa":"Sarah Roche","psa":"Natasha Leigh Mason","topics":["Addiction","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7201865973","eid":"W7201865973"},{"id":"paper-w4386776543","cat":"papers","name":"Supplementary Table S2 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4386776543","eid":"W4386776543"},{"id":"paper-w4416630127","cat":"papers","name":"Supplementary Figure S2 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2025","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4416630127","eid":"W4416630127"},{"id":"paper-w4416630213","cat":"papers","name":"Supplementary Figure S17 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2025","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4416630213","eid":"W4416630213"},{"id":"paper-w4391744979","cat":"papers","name":"Review for \"Microdosing ketamine in Drosophila does not block serotonin reuptake, but causes complex behavioral changes mediated by glutamate and serotonin receptors\"","year":"2024","cit":0,"topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4391744979","eid":"W4391744979"},{"id":"paper-w7212558056","cat":"papers","name":"COMBINED MICRODOSING OF NPK AND UREA: EFFECTS ON PRODUCTIVITY AND ECONOMIC PROFITABILITY OF SESAME (SESAMUM INDICUM L.) IN SEMI-ARID BURKINA FASO","year":"2026","cit":0,"pfa":"Ouedraogo Jean","psa":"Sermé Idriss","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7212558056","eid":"W7212558056"},{"id":"paper-w7167928668","cat":"papers","name":"Additional file 1 of Understanding experiences of psychedelic treatments for eating disorders: a meta-synthesis of qualitative studies","year":"2026","cit":0,"pfa":"R. Crawford Morris","psa":"Johanna Louise Keeler","ptype":"article","src":"https://openalex.org/W7167928668","eid":"W7167928668"},{"id":"paper-w2422317365","cat":"papers","name":"[Ritalin, a new psychotomimetic].","year":"1958","cit":0,"pfa":"V. Vondracek","psa":"J. Dobry","ptype":"article","src":"https://openalex.org/W2422317365","eid":"W2422317365"},{"id":"paper-w7162455856","cat":"papers","name":"Conscience May 2026 Policy Brief - Federal Action to Accelerate Psychedelic Treatments for Serious Mental Illness","year":"2026","cit":0,"pfa":"Mathilda Ryon","topics":["Addiction","Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7162455856","eid":"W7162455856"},{"id":"paper-w4361889070","cat":"papers","name":"Supplemental Table 2 from Multiplexed Evaluation of Microdosed Antineoplastic Agents In Situ in the Tumor Microenvironment of Patients with Soft Tissue Sarcoma","year":"2023","cit":0,"pfa":"Kenneth R. Gundle","psa":"Robert G. Maki","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4361889070","eid":"W4361889070"},{"id":"paper-w2046010895","cat":"papers","name":"P-259 Clinical efficacy and cost effectiveness of a microdose GnRH-a protocol compared to a luteal phase GnRH-a protocol for controlled ovarian hyperstimulation","year":"1997","cit":0,"pfa":"Mark P. Leondires","psa":"Richard Thomas Scott","topics":["Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W2046010895","eid":"W2046010895"},{"id":"paper-w2401183434","cat":"papers","name":"Tailored Breast cancer s creening Program with Microdose Mammography, Us , and M r imaging: Short-term Results of a Pilot Study in","year":"2013","cit":0,"pfa":"Breast Imag","psa":"Alessandro Del Maschio","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2401183434","eid":"W2401183434"},{"id":"paper-w4395057569","cat":"papers","name":"Decision letter for \"Exploring new frontiers: Effects of psychedelics on neurotransmitter-regulated glucagon release in pancreatic islets\"","year":"2023","cit":0,"topics":["Policy & ethics"],"ptype":"peer-review","src":"https://openalex.org/W4395057569","eid":"W4395057569"},{"id":"paper-w2920220258","cat":"papers","name":"A psychedelic education: How an initial encounter with LSD changed my mind and shaped my life and career","year":"2019","cit":0,"pfa":"Ronald Lee Zigler","ptype":"article","src":"https://openalex.org/W2920220258","eid":"W2920220258"},{"id":"paper-w7167783429","cat":"papers","name":"Redefining the real problem in psychedelic trials: Why fighting the Lessebo matters more than blinding integrity","year":"2026","cit":0,"pfa":"Laetitia Vanderijst","psa":"Amandine Luquiens","topics":["Safety & adverse events","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7167783429","eid":"W7167783429"},{"id":"paper-w1674703198","cat":"papers","name":"샌프란시스코의 록 포스터(Rock Posters, 1965-1971)에 표현된 ‘사이키델릭(Psychedelic)’ 특징 연구","year":"2009","cit":0,"pfa":"서금옥","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W1674703198","eid":"W1674703198"},{"id":"paper-w7117475570","cat":"papers","name":"Life as Self-Sustaining Information Flow: Implications for Neuroscience, Psychedelic Research, and AI-Aligned Drug Discovery","year":"2025","cit":0,"pfa":"Ali Mofradi","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7117475570","eid":"W7117475570"},{"id":"paper-w2052462264","cat":"papers","name":"The Hallucinogens. A. Hoffer and H. Osmond, with a contribution by T. Weckowicz. Academic Press, New York, 1967. x + 626 pp., illus. $25","year":"1968","cit":0,"pfa":"Murray E. Jarvik","ptype":"book-review","src":"https://openalex.org/W2052462264","eid":"W2052462264"},{"id":"paper-w4361889086","cat":"papers","name":"Supplemental Figure 2 from Multiplexed Evaluation of Microdosed Antineoplastic Agents In Situ in the Tumor Microenvironment of Patients with Soft Tissue Sarcoma","year":"2023","cit":0,"pfa":"Kenneth R. Gundle","psa":"Robert G. Maki","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4361889086","eid":"W4361889086"},{"id":"paper-w7131621179","cat":"papers","name":"Decision letter for \"Floorless Closed-Loop Microdosing for Rail Friction: A Physics-Only Digital Twin on Kuwait City’s Blue Corridor\"","year":"2025","cit":0,"topics":["Dosing & pharmacology"],"ptype":"peer-review","src":"https://openalex.org/W7131621179","eid":"W7131621179"},{"id":"paper-w4386775814","cat":"papers","name":"Data from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W4386775814","eid":"W4386775814"},{"id":"paper-w4322727635","cat":"papers","name":"Microdose Protocol Stereoradiography Has Similar Reliability to Standard Low-dose Protocol When Performing Concurrent Sanders Skeletal Maturity Staging","year":"2020","cit":0,"pfa":"Cynthia V. Nguyen","psa":"Robert H. Cho","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4322727635","eid":"W4322727635"},{"id":"paper-w4252226370","cat":"papers","name":"Flesh of The Gods: the ritual use of hallucinogens Edited by Peter T. Furst. (Pp. 305; illustrated; £5.) Allen and Unwin: London. 1972.","year":"1973","cit":0,"ptype":"book-review","src":"https://openalex.org/W4252226370","eid":"W4252226370"},{"id":"paper-w2318128331","cat":"papers","name":"AN INTRAVENOUS MICRODOSE OF BEVACIZUMAB FOR THE TREATMENT OF PIGMENT EPITHELIAL DETACHMENT ASSOCIATED TO AGE-RELATED MACULAR DEGENERATION REFRACTORY TO INTRAVITREAL BEVACIZUMAB: A CASE REPORT","year":"2010","cit":0,"pfa":"Lihteh Wu","psa":"Teodoro Evans","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2318128331","eid":"W2318128331"},{"id":"paper-w4224296974","cat":"papers","name":"Differences in personality, cognitive abilities, illicit drug use, and white matter structural integrity between hallucinogen users and matched controls","year":"2022","cit":0,"pfa":"Aviv Aharon-Almagor","psa":"Frederick Streeter Barrett","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4224296974","eid":"W4224296974"},{"id":"paper-w4243992210","cat":"papers","name":"Microdosing and macrodosing hemp cannabis extract as an antidepressant, anxiolytic, and atypical antipsychotic: Putative molecular mechanisms as derived by first-person experience","year":"2021","cit":0,"pfa":"Christina Miyabe Shields","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W4243992210","eid":"W4243992210"},{"id":"paper-w2792656471","cat":"papers","name":"Partner Perspective: Patient Case Study - CONTINUOUS MICRODOSING™ TREATMENT WITH ILUVIEN® (fluocinolone acetonide intravitreal implant) 0.19mg","year":"2018","cit":0,"pfa":"Jessica D. McCluskey","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2792656471","eid":"W2792656471"},{"id":"paper-w4361937733","cat":"papers","name":"Supplemental Table 1 from Multiplexed Evaluation of Microdosed Antineoplastic Agents In Situ in the Tumor Microenvironment of Patients with Soft Tissue Sarcoma","year":"2023","cit":0,"pfa":"Kenneth R. Gundle","psa":"Robert G. Maki","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4361937733","eid":"W4361937733"},{"id":"paper-w1926256130","cat":"papers","name":"사이키델릭(Psychedelic)색채의 동시대비 현상(Simultaneous Contrast phenomena)과 뇌의 인지 상관관계 분석연구","year":"2013","cit":0,"pfa":"이혜경","ptype":"article","src":"https://openalex.org/W1926256130","eid":"W1926256130"},{"id":"paper-w4407601473","cat":"papers","name":"Tripping on Utopia: Margaret Mead, the Cold War, and the Troubled Birth of Psychedelic Science by Benjamin Breen (review)","year":"2024","cit":0,"pfa":"Devin R. Lander","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4407601473","eid":"W4407601473"},{"id":"paper-w7215541782","cat":"papers","name":"Classical psychedelics and NBOMes as serotonin 2B receptor agonists: Valvulopathogenic signaling pathways and cardiac safety concerns","year":"2022","cit":0,"pfa":"Elias Roihuvuo","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W7215541782","eid":"W7215541782"},{"id":"paper-w7161129844","cat":"papers","name":"Adolescents’ and Young Adults’ Integration Processes for Extended Difficulties Following Challenging Psychedelic Experiences: A Qualitative Investigation","year":"2026","cit":0,"pfa":"Sam Barfoot","psa":"Jules Evans","topics":["Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7161129844","eid":"W7161129844"},{"id":"paper-w7167890581","cat":"papers","name":"Additional file 2 of Understanding experiences of psychedelic treatments for eating disorders: a meta-synthesis of qualitative studies","year":"2026","cit":0,"pfa":"R. Crawford Morris","psa":"Johanna Louise Keeler","ptype":"article","src":"https://openalex.org/W7167890581","eid":"W7167890581"},{"id":"paper-w2487270859","cat":"papers","name":"CNS stimulants and psychotomimetics","year":"2009","cit":0,"pfa":"M.M. Dale","psa":"Dennis G. Haylett","ptype":"book-chapter","src":"https://openalex.org/W2487270859","eid":"W2487270859"},{"id":"paper-w4384886386","cat":"papers","name":"psychotomimetic, adj. & n.","year":"2023","cit":0,"ptype":"reference-entry","src":"https://openalex.org/W4384886386","eid":"W4384886386"},{"id":"paper-w4309639785","cat":"papers","name":"Publisher's note to “Culture and psychedelic psychotherapy: Ethnic and racial themes from three black women therapists”","year":"2022","cit":0,"pfa":"Anne Vallely","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4309639785","eid":"W4309639785"},{"id":"paper-w4391484431","cat":"papers","name":"‘Psychedelics: the revolutionary drugs that could change your life – a guide from the expert’, by Professor David Nutt","year":"2024","cit":0,"pfa":"B. O’Mahony","psa":"Gurjot Brar","ptype":"article","src":"https://openalex.org/W4391484431","eid":"W4391484431"},{"id":"paper-w7167939621","cat":"papers","name":"Additional file 1 of Understanding experiences of psychedelic treatments for eating disorders: a meta-synthesis of qualitative studies","year":"2026","cit":0,"pfa":"R. Crawford Morris","psa":"Johanna Louise Keeler","ptype":"article","src":"https://openalex.org/W7167939621","eid":"W7167939621"},{"id":"paper-w2955098073","cat":"papers","name":"Transforming The Fear Of Death Through Near-Death Experiences And Experiential Psychedelics: A Transpersonal Hermeneutic Phenomenological Inquiry","year":"2019","cit":0,"pfa":"Janet Nielsen","ptype":"dissertation","src":"https://openalex.org/W2955098073","eid":"W2955098073"},{"id":"paper-w4395057559","cat":"papers","name":"Author response for \"Exploring new frontiers: Effects of psychedelics on neurotransmitter-regulated glucagon release in pancreatic islets\"","year":"2023","cit":0,"pfa":"Mehmet Bostancıklıoğlu","topics":["Policy & ethics"],"ptype":"peer-review","src":"https://openalex.org/W4395057559","eid":"W4395057559"},{"id":"paper-w7167914137","cat":"papers","name":"Additional file 2 of Understanding experiences of psychedelic treatments for eating disorders: a meta-synthesis of qualitative studies","year":"2026","cit":0,"pfa":"R. Crawford Morris","psa":"Johanna Louise Keeler","ptype":"article","src":"https://openalex.org/W7167914137","eid":"W7167914137"},{"id":"paper-w7170808486","cat":"papers","name":"The psychedelic DOI decreases the modularity of the cortical network by increasing cortico-cortical and thalamo-cortical functional influence","year":"2026","cit":0,"pfa":"Roman Doronin","psa":"Georg B. Keller","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7170808486","eid":"W7170808486"},{"id":"paper-w3164190713","cat":"papers","name":"LANSKAP PSYCHEDELIC SEBAGAI SUMBER INSPIRASI PERANCANGAN ILUSTRASI ALBUM LOKA IMAJI BAND THE OLD PINES","year":"2021","cit":0,"pfa":"Muhammad Kemal Tafwidh","psa":"Martadi Martadi","ptype":"article","src":"https://openalex.org/W3164190713","eid":"W3164190713"},{"id":"paper-w7112777358","cat":"papers","name":"Comparison of Psychedelic and Near-Death or Other Non-Ordinary Experiences in Changing Attitudes About Death and Dying","year":"2022","cit":0,"pfa":"T. Cody Swift","psa":"Ethan Hurwitz","ptype":"preprint","src":"https://openalex.org/W7112777358","eid":"W7112777358"},{"id":"paper-w4402574978","cat":"papers","name":"Personal and social connection to psychedelics is associated with lower drug use stigma among psychiatrists in the United States","year":"2024","cit":0,"pfa":"Adam W. Levin","psa":"Alan K. Davis","topics":["Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4402574978","eid":"W4402574978"},{"id":"paper-w4413602391","cat":"papers","name":"Psychedelics may better treat depression and anxiety symptoms than prescription antidepressants for patients with advanced cancer","year":"2023","cit":0,"pfa":"Charles Michael White","topics":["Depression","Anxiety & end-of-life"],"ptype":"other","src":"https://openalex.org/W4413602391","eid":"W4413602391"},{"id":"paper-w4414582905","cat":"papers","name":"Indolethylamine N-Methyltransferase Deletion Impacts Mouse Behavior without Disrupting Endogenous Psychedelic Tryptamine Production","year":"2025","cit":0,"pfa":"Cassandra J. Hatzipantelis","psa":"David E. Olson","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4414582905","eid":"W4414582905"},{"id":"paper-w7155753175","cat":"papers","name":"Beyond Psychedelic Exceptionalism: How People Combine Meditation With Psychoactive Substances and How This Relates to Well-Being","year":"2026","cit":0,"pfa":"Andreas Krabbe","topics":["Addiction"],"ptype":"preprint","src":"https://openalex.org/W7155753175","eid":"W7155753175"},{"id":"paper-w2414908809","cat":"papers","name":"[Behavior of vascular resistance of the hind leg of the rabbit after administration into the femoral artery of microdoses of bradykinin. Study of the dose-effect relationship].","year":"1969","cit":0,"pfa":"Rosario Cassone","psa":"Mario Condorelli","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2414908809","eid":"W2414908809"},{"id":"paper-w2606793453","cat":"papers","name":"Psychedelic Mysticism: Transforming Consciousness, Religious Experiences, and Voluntary Peasants in Postwar America by Morgan Shipley (review)","year":"2017","cit":0,"pfa":"Wesley G. Phelps","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2606793453","eid":"W2606793453"},{"id":"paper-w2087637528","cat":"papers","name":"Luteal phase ganirelix protocol is as effective as microdose leuprolide protocol for poor responders undergoing IVF; preliminary results from a randomized trial","year":"2008","cit":0,"pfa":"Andrea J. DiLuigi","psa":"JOHN C. NULSEN","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2087637528","eid":"W2087637528"},{"id":"paper-w7114504722","cat":"papers","name":"Philosophical Encounters with Plant Spirits and DMT Entities: A Review of \"Altered Perspectives: Critical Essays on Psychedelic Consciousness\"","year":"2025","cit":0,"pfa":"Cavallarin, Alberto","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7114504722","eid":"W7114504722"},{"id":"paper-w2603786238","cat":"papers","name":"Integrated use of fertilizer microdosing and manure enhances maize yields, nutrient and water use efficiencies in maize cropping systems in northern Benin","year":"2017","cit":0,"pfa":"Gbènoukpo Pierre Tovihoudji","psa":"Charles Louis Bielders","topics":["Dosing & pharmacology"],"ptype":"conference-paper","src":"https://openalex.org/W2603786238","eid":"W2603786238"},{"id":"paper-w4385552657","cat":"papers","name":"ScholarOne - Limitless Experience through Limited Consumption: Psychedelics, Mystical Mindfulness, and Sustainable Corporate Leadership Development","year":"2023","cit":0,"pfa":"Joshua S. Nunziato","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4385552657","eid":"W4385552657"},{"id":"paper-w7119019212","cat":"papers","name":"Dynamic Neural State Transitions Predict Psychedelic Phenomenal Richness: Magnitude, Not Direction, Drives Subjective Intensity","year":"2026","cit":0,"pfa":"Emma Dobbin","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7119019212","eid":"W7119019212"},{"id":"paper-w7117530922","cat":"papers","name":"GMP-Compliant Manufacturing of [68Ga]Ga-ATH001 for a Human Microdose Trial Targeting Platelet-Derived Growth Factor Receptor Beta (PDGFRβ)","year":"2025","cit":0,"pfa":"Mélodie Ferrat","psa":"Thuy A. Tran","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7117530922","eid":"W7117530922"},{"id":"paper-w3036972797","cat":"papers","name":"Signaling Mechanism Responsible for 5-HT2A Receptor Tolerance to Psychedelic Induced Head-Twitch Behavior in Mice","year":"2020","cit":0,"pfa":"Audrey R McMurtrie","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3036972797","eid":"W3036972797"},{"id":"paper-w4412578443","cat":"papers","name":"Tripping on Utopia: Margaret Mead, the Cold War, and the Troubled Birth of Psychedelic Science by Benjamin Breen (review)","year":"2025","cit":0,"pfa":"Francis X. Altomare","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4412578443","eid":"W4412578443"},{"id":"paper-w2977745156","cat":"papers","name":"O-203b Paediatric Microdose Study Of [14c]paracetamol To Study Drug Metabolism Using Accelerated Mass Spectrometry: Proof Of Concept","year":"2014","cit":0,"pfa":"M. G. Mooij","psa":"Saskia N. de Wildt","topics":["Safety & adverse events","Dosing & pharmacology","Policy & ethics"],"ptype":"conference-paper","src":"https://openalex.org/W2977745156","eid":"W2977745156"},{"id":"paper-w4361937635","cat":"papers","name":"Supplemental Table 3 from Multiplexed Evaluation of Microdosed Antineoplastic Agents In Situ in the Tumor Microenvironment of Patients with Soft Tissue Sarcoma","year":"2023","cit":0,"pfa":"Kenneth R. Gundle","psa":"Robert G. Maki","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4361937635","eid":"W4361937635"},{"id":"paper-w7140302605","cat":"papers","name":"DMN Breakdown Meets Neuroplasticity: Convergent Pathways in Psychedelic, Ketamine, and Bedtime Oral Glutamatergic Approaches to Depression","year":"2026","cit":0,"pfa":"Ngo Cheung","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7140302605","eid":"W7140302605"},{"id":"paper-w2328573093","cat":"papers","name":"ChemInform Abstract: SYNTH. VON ANALOGEN VON HALLUCINOGEN‐1‐(2,5‐DIMETHOXY‐4‐METHYL‐PHENYL)‐2‐AMINO‐PROPAN (DOM)","year":"1973","cit":0,"pfa":"Ronald T. Coutts","psa":"Jerry L. Malicky","ptype":"article","src":"https://openalex.org/W2328573093","eid":"W2328573093"},{"id":"paper-w4385248519","cat":"papers","name":"Supplementary Table S6A from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385248519","eid":"W4385248519"},{"id":"paper-w4386776546","cat":"papers","name":"Supplementary Table S4 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4386776546","eid":"W4386776546"},{"id":"paper-w4402798428","cat":"papers","name":"Supplementary Figure S12 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2024","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4402798428","eid":"W4402798428"},{"id":"paper-w4402818506","cat":"papers","name":"Supplementary Figure S6 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2024","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4402818506","eid":"W4402818506"},{"id":"paper-w7168100888","cat":"papers","name":"Amendment CDLIII: SOL Coherent Microdose Protocol — Phi-Harmonic Biological Coherence Enhancement with Environmental Modulation and SOL Field Encasement Variables","year":"2026","cit":0,"pfa":"Justin McCaul","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7168100888","eid":"W7168100888"},{"id":"paper-w4416965962","cat":"papers","name":"Correction: Navigating groundlessness: An interview study on dealing with ontological shock and existential distress following psychedelic experiences","year":"2025","cit":0,"pfa":"The PLOS One\nStaff","topics":["Anxiety & end-of-life"],"ptype":"erratum","src":"https://openalex.org/W4416965962","eid":"W4416965962"},{"id":"paper-w7163984587","cat":"papers","name":"Dynamic Neural State Transitions Predict Psychedelic Phenomenal Richness: Magnitude, Not Direction, Drives Subjective Intensity","year":"2026","cit":0,"pfa":"Emma Dobbin","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7163984587","eid":"W7163984587"},{"id":"paper-w4400993387","cat":"papers","name":"When to consider intra-target microdosing: physiologically based pharmacokinetic modeling approach to quantitatively identify key factors for observing target engagement","year":"2024","cit":0,"pfa":"Yasunori Aoki","psa":"Yuichi Sugiyama","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4400993387","eid":"W4400993387"},{"id":"paper-w2418373946","cat":"papers","name":"[Psychotomimetic drugs with anticholinergic effects].","year":"1966","cit":0,"pfa":"Banshchikov Vm","psa":"Stoliarov Gv","ptype":"article","src":"https://openalex.org/W2418373946","eid":"W2418373946"},{"id":"paper-w7213321513","cat":"papers","name":"EP1410 - ECE_1202 - Individualized endocrine care in non-binary individuals: efficacy, safety, and long-term outcomes of microdosing and selective hormone modulators","year":"2026","cit":0,"pfa":"Ipsita Mishra","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W7213321513","eid":"W7213321513"},{"id":"paper-w4311107554","cat":"papers","name":"Sublingual Buprenorphine-Naloxone Microdosing Protocol to Wean and Explant Intrathecal Drug Delivery Systems for Chronic Non-Cancer Pain: Case Series","year":"2022","cit":0,"pfa":"Vanessa Choi Yin Wong","psa":"Jill Osborn","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4311107554","eid":"W4311107554"},{"id":"paper-w4385236077","cat":"papers","name":"Supplementary Table S3 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385236077","eid":"W4385236077"},{"id":"paper-w4385302704","cat":"papers","name":"Supplementary Table S5 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385302704","eid":"W4385302704"},{"id":"paper-w4386776135","cat":"papers","name":"Supplementary Figure S12 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4386776135","eid":"W4386776135"},{"id":"paper-w4361937678","cat":"papers","name":"Supplemental Figure 2 from Multiplexed Evaluation of Microdosed Antineoplastic Agents In Situ in the Tumor Microenvironment of Patients with Soft Tissue Sarcoma","year":"2023","cit":0,"pfa":"Kenneth R. Gundle","psa":"Robert G. Maki","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4361937678","eid":"W4361937678"},{"id":"paper-w4385236081","cat":"papers","name":"Supplementary Figure S5 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385236081","eid":"W4385236081"},{"id":"paper-w4416277634","cat":"papers","name":"77. Can Psychedelics Revolutionise OCD Treatment? Systematic Review and Meta-Analysis of Efficacy, Safety, and Patient Experiences","year":"2025","cit":0,"pfa":"Ravleen Kaur Suri","psa":"Sasidhar Gunturu","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4416277634","eid":"W4416277634"},{"id":"paper-w4244123794","cat":"papers","name":"Psychotomimetic States Inventory","year":"2008","cit":0,"pfa":"Oliver John Mason","psa":"Helen Valerie Curran","ptype":"dataset","src":"https://openalex.org/W4244123794","eid":"W4244123794"},{"id":"paper-w4385253085","cat":"papers","name":"Supplementary Table S6B from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385253085","eid":"W4385253085"},{"id":"paper-w4385260360","cat":"papers","name":"Supplementary Figure S13 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385260360","eid":"W4385260360"},{"id":"paper-w4378550271","cat":"papers","name":"Value of Cabergoline and Low Dose Aspirin in Poor Responders Undergoing ICSI-ET Using Microdose GNRH Agonist Flare-Up-Protocol","year":"2023","cit":0,"pfa":"Ayman Hany","psa":"Radwa M. Fahmy","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4378550271","eid":"W4378550271"},{"id":"paper-w4391745004","cat":"papers","name":"Author response for \"Microdosing ketamine in Drosophila does not block serotonin reuptake, but causes complex behavioral changes mediated by glutamate and serotonin receptors\"","year":"2024","cit":0,"pfa":"Kelly E. Dunham","psa":"B. Jill Venton","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"peer-review","src":"https://openalex.org/W4391745004","eid":"W4391745004"},{"id":"paper-w7213543056","cat":"papers","name":"Validating and creating a short-form of the persisting effects questionnaire: A measure of positive and negative outcomes from psychedelic experiences","year":"2026","cit":0,"pfa":"Rebecca C. Ehrenkranz","psa":"David B. Yaden","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7213543056","eid":"W7213543056"},{"id":"paper-w2949427575","cat":"papers","name":"Exploring trajectories of drug use, violence, and suicidality among marginalized women : avenues of intervention and the therapeutic potential of psychedelics","year":"2019","cit":0,"pfa":"Elena Argento","topics":["PTSD & trauma","Safety & adverse events","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W2949427575","eid":"W2949427575"},{"id":"paper-w4399861771","cat":"papers","name":"Down the rabbit hole – the psychological and neural mechanisms of psychedelic compounds and their use in treating mental health and medical conditions","year":"2024","cit":0,"topics":["Mechanism & neuroscience"],"ptype":"book","src":"https://openalex.org/W4399861771","eid":"W4399861771"},{"id":"paper-w7117961053","cat":"papers","name":"Set, setting and beyond: interpersonal rapport and meditation in predicting mystical experience among psychedelic users in naturalistic settings","year":"2026","cit":0,"pfa":"J. Schimmelpfennig","psa":"K. Jankowiak-Siuda","ptype":"article","src":"https://openalex.org/W7117961053","eid":"W7117961053"},{"id":"paper-w4386775899","cat":"papers","name":"Supplementary Figure S14 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4386775899","eid":"W4386775899"},{"id":"paper-w4386776545","cat":"papers","name":"Supplementary Table S5 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4386776545","eid":"W4386776545"},{"id":"paper-w4416629774","cat":"papers","name":"Supplementary Figure S16 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2025","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4416629774","eid":"W4416629774"},{"id":"paper-w4416630252","cat":"papers","name":"Supplementary Table S2 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2025","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4416630252","eid":"W4416630252"},{"id":"paper-w4416630265","cat":"papers","name":"Supplementary Figure S11 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2025","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4416630265","eid":"W4416630265"},{"id":"paper-w2951014017","cat":"papers","name":"ChemInform Abstract: CONFORMATIONAL ENERGY DIFFERENCES BETWEEN SIDE CHAIN ALKYLATED ANALOGS OF THE HALLUCINOGEN 1‐(2,5‐DIMETHOXY‐4‐METHYLPHENYL)‐2‐AMINOPROPANE","year":"1980","cit":0,"pfa":"Herschel J. R. Weintraub","psa":"Stephen W. Fesik","ptype":"article","src":"https://openalex.org/W2951014017","eid":"W2951014017"},{"id":"paper-w4391744985","cat":"papers","name":"Decision letter for \"Microdosing ketamine in Drosophila does not block serotonin reuptake, but causes complex behavioral changes mediated by glutamate and serotonin receptors\"","year":"2024","cit":0,"topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"peer-review","src":"https://openalex.org/W4391744985","eid":"W4391744985"},{"id":"paper-w4410121523","cat":"papers","name":"Psychedelics, Yes—but Not Only: Redefining the boundaries of consciousness research as part of humanity's ongoing attempt to transcend our incompleteness","year":"2025","cit":0,"pfa":"Júlio Licinio","ptype":"article","src":"https://openalex.org/W4410121523","eid":"W4410121523"},{"id":"paper-w7167843632","cat":"papers","name":"Enhanced EEG-Based Tracking of DMN Activity Using ICA and EEG Source Localization for a VR Psychedelic Environment","year":"2025","cit":0,"pfa":"Parv Chordiya","psa":"Ying Choon Wu","ptype":"conference-paper","src":"https://openalex.org/W7167843632","eid":"W7167843632"},{"id":"paper-w1957598943","cat":"papers","name":"Response to: “Deceptive argumentation against diagnostic microdosing of anticancer drugs” by Dirk Theile and Gerd Mikus (Letter dated February 13, 2014)","year":"2014","cit":0,"pfa":"Gregory T. Wurz","psa":"Michael W. DeGregorio","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1957598943","eid":"W1957598943"},{"id":"paper-w4385236175","cat":"papers","name":"Supplementary Figure S16 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385236175","eid":"W4385236175"},{"id":"paper-w4385302703","cat":"papers","name":"Supplementary Table S6B from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385302703","eid":"W4385302703"},{"id":"paper-w4386775983","cat":"papers","name":"Supplementary Figure S1 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4386775983","eid":"W4386775983"},{"id":"paper-w4402788990","cat":"papers","name":"Supplementary Table S1 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2024","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4402788990","eid":"W4402788990"},{"id":"paper-w4402798851","cat":"papers","name":"Supplementary Figure S1 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2024","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4402798851","eid":"W4402798851"},{"id":"paper-w4416670661","cat":"papers","name":"Supplementary Figure S5 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2025","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4416670661","eid":"W4416670661"},{"id":"paper-w7118017767","cat":"papers","name":"Astrocytes under the Influence: psychedelic 2,5-dimethoxy-4-iodoamphetamine boosts mitochondrial capacity and stress tolerance in vitro","year":"2026","cit":0,"pfa":"I. Kosmačin","psa":"L. Žiberna","ptype":"article","src":"https://openalex.org/W7118017767","eid":"W7118017767"},{"id":"paper-w4385236181","cat":"papers","name":"Supplementary Figure S3 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385236181","eid":"W4385236181"},{"id":"paper-w4386776192","cat":"papers","name":"Supplementary Figure S2 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4386776192","eid":"W4386776192"},{"id":"paper-w4386234209","cat":"papers","name":"What Psychedelic Practitioners Can Learn from Eye Surgeons About 'Soft Furniture' Method Patent Reform","year":"2023","cit":0,"pfa":"Laurel Kilgour","ptype":"preprint","src":"https://openalex.org/W4386234209","eid":"W4386234209"},{"id":"paper-w4386776287","cat":"papers","name":"Supplementary Table S1 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4386776287","eid":"W4386776287"},{"id":"paper-w4402787994","cat":"papers","name":"Supplementary Figure S2 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2024","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4402787994","eid":"W4402787994"},{"id":"paper-w4402798948","cat":"papers","name":"Supplementary Figure S15 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2024","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4402798948","eid":"W4402798948"},{"id":"paper-w4416629798","cat":"papers","name":"Supplementary Figure S10 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2025","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4416629798","eid":"W4416629798"},{"id":"paper-w4416670753","cat":"papers","name":"Supplementary Table S3 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2025","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4416670753","eid":"W4416670753"},{"id":"paper-w4385236126","cat":"papers","name":"Supplementary Figure S6 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385236126","eid":"W4385236126"},{"id":"paper-w4385302659","cat":"papers","name":"Supplementary Figure S3 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385302659","eid":"W4385302659"},{"id":"paper-w7123902754","cat":"papers","name":"eLife Assessment: The oneirogen hypothesis: modeling the hallucinatory effects of classical psychedelics in terms of replay-dependent plasticity mechanisms","year":"2026","cit":0,"pfa":"Anna C. Schapiro","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"peer-review","src":"https://openalex.org/W7123902754","eid":"W7123902754"},{"id":"paper-w4405636723","cat":"papers","name":"Increased subjective stimulation in response to 50 percent-nitrous oxide is associated with greater ketamine-like psychedelic effects","year":"2024","cit":0,"pfa":"Uršulė Taujanskaitė","psa":"Sunjeev K. Kamboj","ptype":"article","src":"https://openalex.org/W4405636723","eid":"W4405636723"},{"id":"paper-w4411088172","cat":"papers","name":"eLife Assessment: The oneirogen hypothesis: modeling the hallucinatory effects of classical psychedelics in terms of replay-dependent plasticity mechanisms","year":"2025","cit":0,"pfa":"Anna C. Schapiro","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"peer-review","src":"https://openalex.org/W4411088172","eid":"W4411088172"},{"id":"paper-w4411088202","cat":"papers","name":"Author response: The oneirogen hypothesis: modeling the hallucinatory effects of classical psychedelics in terms of replay-dependent plasticity mechanisms","year":"2025","cit":0,"pfa":"Colin Bredenberg","psa":"Guillaume Lajoie","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"peer-review","src":"https://openalex.org/W4411088202","eid":"W4411088202"},{"id":"paper-w7196972748","cat":"papers","name":"Priorities for public health preparedness for psychedelics: education, workforce readiness, and strategic information needs in a rapidly changing landscape","year":"2026","cit":0,"pfa":"R. Cameron Wolf","psa":"Neeraj Gandotra","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7196972748","eid":"W7196972748"},{"id":"paper-w4403731571","cat":"papers","name":"Erratum: Meaningfulness and attachment: what dreams, psychosis and psychedelic states tell us about our need for connection","year":"2024","cit":0,"pfa":"Frontiers Production Office","ptype":"erratum","src":"https://openalex.org/W4403731571","eid":"W4403731571"},{"id":"paper-w4405664436","cat":"papers","name":"The potential of non-psychedelic 5-HT2A agents in the treatment of substance use disorders: a narrative review of the clinical literature","year":"2024","cit":0,"pfa":"Alejandra Pulido-Saavedra","psa":"Gustavo A. Angarita","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4405664436","eid":"W4405664436"},{"id":"paper-w2143942454","cat":"papers","name":"Microdose Lupron and Gonadotropin Releasing Hormone Antagonist Protocols Yield Similar Results in Women at Risk for Poor Response in Fresh Cycles of In Vitro Fertilization","year":"2005","cit":0,"pfa":"E.Y. Strawn","psa":"Amy Granlund","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2143942454","eid":"W2143942454"},{"id":"paper-w4385249266","cat":"papers","name":"Supplementary Figure S14 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385249266","eid":"W4385249266"},{"id":"paper-w4385302711","cat":"papers","name":"Supplementary Figure S13 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385302711","eid":"W4385302711"},{"id":"paper-w1993224868","cat":"papers","name":"Hallucinogens, A Forensic Drug HandbookRichard Laing and Jay A. SiegelAcademic Press. ISBN: 0‐124‐33951‐4, 2003, 290 pp. with index, £49.95","year":"2003","cit":0,"pfa":"Andrew J. McBride","psa":"MBChB MSc FRCPsych","topics":["Addiction"],"ptype":"book-review","src":"https://openalex.org/W1993224868","eid":"W1993224868"},{"id":"paper-w2767809562","cat":"papers","name":"The Oral History of Psychedelics Research Project, II: Do drugs have religious import? A forty year retrospective","year":"2003","cit":0,"pfa":"RN Walsh","psa":"Alise Agar","ptype":"article","src":"https://openalex.org/W2767809562","eid":"W2767809562"},{"id":"paper-w4385256969","cat":"papers","name":"Supplementary Table S4 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385256969","eid":"W4385256969"},{"id":"paper-w4402789195","cat":"papers","name":"Supplementary Table S2 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2024","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4402789195","eid":"W4402789195"},{"id":"paper-w4402818712","cat":"papers","name":"Supplementary Table S6A from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2024","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"supplementary-materials","src":"https://openalex.org/W4402818712","eid":"W4402818712"},{"id":"paper-w3201685637","cat":"papers","name":"Naturalistic use of psychedelics is related to emotional reactivity and self-consciousness: the mediating role of ego-dissolution and mystical experiences","year":"2021","cit":0,"pfa":"Paweł Orlowski","psa":"Michał Bola","topics":["Addiction"],"ptype":"preprint","src":"https://openalex.org/W3201685637","eid":"W3201685637"},{"id":"paper-w4225812185","cat":"papers","name":"THERAPEUTIC APPROACHES TO THE CORRECTION OF THE SYNDROME OF PERSISTING PERCEPTION DISORDER (HPPD) DUE TO THE USE OF PSYCHOACTIVE SUBSTANCES WITH A PSYCHEDELIC EFFECT","year":"2022","cit":0,"pfa":"Yu.M. Scheidegger","psa":"Т.В. Клименко","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4225812185","eid":"W4225812185"},{"id":"paper-w4361945508","cat":"papers","name":"Data from Tumor-Specific Uptake of Fluorescent Bevacizumab–IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feasibility Study","year":"2023","cit":0,"pfa":"Laetitia E. Lamberts","psa":"Gooitzen M. van Dam","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W4361945508","eid":"W4361945508"},{"id":"paper-w4385302498","cat":"papers","name":"Supplementary Figure S10 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385302498","eid":"W4385302498"},{"id":"paper-w4385302607","cat":"papers","name":"Supplementary Figure S2 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385302607","eid":"W4385302607"},{"id":"paper-w4385302656","cat":"papers","name":"Supplementary Figure S2 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385302656","eid":"W4385302656"},{"id":"paper-w4385254119","cat":"papers","name":"Supplementary Figure S2 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385254119","eid":"W4385254119"},{"id":"paper-w4385302708","cat":"papers","name":"Supplementary Figure S18 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385302708","eid":"W4385302708"},{"id":"paper-w4385364484","cat":"papers","name":"Supplementary Table S4 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385364484","eid":"W4385364484"},{"id":"paper-w4402798660","cat":"papers","name":"Supplementary Table S6B from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2024","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"supplementary-materials","src":"https://openalex.org/W4402798660","eid":"W4402798660"},{"id":"paper-w3210311969","cat":"papers","name":"A First Amendment Right to Burning Bush: Empowering the Free Exercise Clause to Protect Religious Use of Psychedelic Drugs","year":"2021","cit":0,"pfa":"Michael McDonald","ptype":"preprint","src":"https://openalex.org/W3210311969","eid":"W3210311969"},{"id":"paper-w4392462222","cat":"papers","name":"Medical use of cannabis and psychedelics in treating symptoms of mental disorders among military and veteran populations: A systematic review","year":"2024","cit":0,"pfa":"Hou-Yu Zhao","psa":"Yiqun Fang","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W4392462222","eid":"W4392462222"},{"id":"paper-w7155082469","cat":"papers","name":"Reviewer #1 (Public review): Modeling the hallucinatory effects of classical psychedelics in terms of replay-dependent plasticity mechanisms","year":"2026","cit":0,"topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W7155082469","eid":"W7155082469"},{"id":"paper-w3199464534","cat":"papers","name":"Quantification of CYP3A and drug transporters activity in healthy young, healthy elderly and chronic kidney disease elderly patients by a microdose cocktail approach","year":"2021","cit":0,"pfa":"Punyabhorn Rattanacheeworn","psa":"Pajaree Chariyavilaskul","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W3199464534","eid":"W3199464534"},{"id":"paper-w3125818074","cat":"papers","name":"Catalysts for transformation : a systematic literature review exploring the interlinkages and potential role of classic psychedelics to social-ecological sustainability","year":"2020","cit":0,"pfa":"Marion Nilsson","topics":["Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W3125818074","eid":"W3125818074"},{"id":"paper-w4413497947","cat":"papers","name":"Psychedelics plus psychotherapy can trigger rapid changes in the brain − new research at the level of neurons is untangling how","year":"2023","cit":0,"pfa":"Edmund S. Higgins","topics":["Therapy practice"],"ptype":"other","src":"https://openalex.org/W4413497947","eid":"W4413497947"},{"id":"paper-w4404286063","cat":"papers","name":"Charles L. Raison: Elucidating the role of conscious experience in the therapeutic effects of psychedelics as a means to optimize clinical outcomes","year":"2024","cit":0,"pfa":"Charles L. Raison","topics":["Depression","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4404286063","eid":"W4404286063"},{"id":"paper-w4391745155","cat":"papers","name":"Decision letter for \"Microdosing ketamine in Drosophila does not block serotonin reuptake, but causes complex behavioral changes mediated by glutamate and serotonin receptors\"","year":"2023","cit":0,"topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"peer-review","src":"https://openalex.org/W4391745155","eid":"W4391745155"},{"id":"paper-w4391745093","cat":"papers","name":"Author response for \"Microdosing ketamine in Drosophila does not block serotonin reuptake, but causes complex behavioral changes mediated by glutamate and serotonin receptors\"","year":"2023","cit":0,"pfa":"Kelly E. Dunham","psa":"B. Jill Venton","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"peer-review","src":"https://openalex.org/W4391745093","eid":"W4391745093"},{"id":"paper-w7119786564","cat":"papers","name":"CHAPTER 3 The Vulnerability of Emerging Technologies of the Self: A Critical Analysis of Virtual Reality Through Psychedelic Self-Hacking","year":"2025","cit":0,"pfa":"Jordan Loewen-Colón","psa":"Amarnath Amarasingam","ptype":"book-chapter","src":"https://openalex.org/W7119786564","eid":"W7119786564"},{"id":"paper-w3036685698","cat":"papers","name":"Dose-Dependent Effects of the Serotonergic Psychedelic (R)-DOI are Contingent on Prior Coping Strategies to an Escapable Social Stress","year":"2020","cit":0,"pfa":"Kevin T. Krupp","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3036685698","eid":"W3036685698"},{"id":"paper-w7127128190","cat":"papers","name":"Pictorial representation of illness and self measure (PRISM): A putative transdiagnostic tool for evaluating therapeutic effects of psychedelic treatments","year":"2025","cit":0,"pfa":"Niloufar Pouyan","psa":"Kevin F. Boehnke","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7127128190","eid":"W7127128190"},{"id":"paper-w4385236128","cat":"papers","name":"Supplementary Table S5 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385236128","eid":"W4385236128"},{"id":"paper-w4385236354","cat":"papers","name":"Supplementary Figure S15 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385236354","eid":"W4385236354"},{"id":"paper-w4385302707","cat":"papers","name":"Supplementary Figure S14 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385302707","eid":"W4385302707"},{"id":"paper-w4402787982","cat":"papers","name":"Supplementary Figure S8 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2024","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4402787982","eid":"W4402787982"},{"id":"paper-w4402788033","cat":"papers","name":"Supplementary Figure S7 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2024","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4402788033","eid":"W4402788033"},{"id":"paper-w4385361141","cat":"papers","name":"Supplementary Figure S1 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385361141","eid":"W4385361141"},{"id":"paper-w4386776622","cat":"papers","name":"Supplementary Table S3 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4386776622","eid":"W4386776622"},{"id":"paper-w4386776136","cat":"papers","name":"Supplementary Figure S15 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4386776136","eid":"W4386776136"},{"id":"paper-w4416630019","cat":"papers","name":"Supplementary Figure S8 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2025","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4416630019","eid":"W4416630019"},{"id":"paper-w4385253370","cat":"papers","name":"Supplementary Figure S17 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385253370","eid":"W4385253370"},{"id":"paper-w4385302706","cat":"papers","name":"Supplementary Figure S16 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385302706","eid":"W4385302706"},{"id":"paper-w4402789693","cat":"papers","name":"Supplementary Figure S16 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2024","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4402789693","eid":"W4402789693"},{"id":"paper-w4402799690","cat":"papers","name":"Supplementary Figure S2 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2024","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4402799690","eid":"W4402799690"},{"id":"paper-w7132826192","cat":"papers","name":"Psychedelics in Psychiatric Treatment: From Research to Practice. p5-10 (Volume 3, Issue 3, July 2025)","year":"2025","cit":0,"pfa":"Omar Afroz","psa":"Rohit Verma","ptype":"article","src":"https://openalex.org/W7132826192","eid":"W7132826192"},{"id":"paper-w4413784001","cat":"papers","name":"Effects of Psychedelic Drug Use on Neurocognitive Function and Psychological and Social Quality of Life Domains: An International Online Study","year":"2025","cit":0,"pfa":"Franziska Stadler","psa":"Christoph Kraus","topics":["Depression","Addiction"],"ptype":"preprint","src":"https://openalex.org/W4413784001","eid":"W4413784001"},{"id":"paper-w4415596894","cat":"papers","name":"Therapeutic Context and Support during Psychedelic Use Moderate Links among Stress, Challenging Experiences, and Psychological Outcomes","year":"2025","cit":0,"pfa":"Aaron D. Cherniak","psa":"Max Wolff","topics":["Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4415596894","eid":"W4415596894"},{"id":"paper-w7133618194","cat":"papers","name":"Additional file 1 of Adverse outcomes following psychedelic use in adolescents and adults: associations with age and personality traits","year":"2026","cit":0,"pfa":"David Sjöström","psa":"Petri Kajonius","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7133618194","eid":"W7133618194"},{"id":"paper-w7133795679","cat":"papers","name":"Additional file 1 of Adverse outcomes following psychedelic use in adolescents and adults: associations with age and personality traits","year":"2026","cit":0,"pfa":"David Sjöström","psa":"Petri Kajonius","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7133795679","eid":"W7133795679"},{"id":"paper-w4385236078","cat":"papers","name":"Supplementary Figure S10 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385236078","eid":"W4385236078"},{"id":"paper-w4385302655","cat":"papers","name":"Supplementary Figure S19 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385302655","eid":"W4385302655"},{"id":"paper-w4385367636","cat":"papers","name":"Supplementary Figure S10 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385367636","eid":"W4385367636"},{"id":"paper-w4416629757","cat":"papers","name":"Supplementary Table S5 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2025","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4416629757","eid":"W4416629757"},{"id":"paper-w7160831996","cat":"papers","name":"Mieltä paljastavien kokemusten filosofiaa: Kirja-arvio Aidan Lyonin (2024) teoksesta Psychedelic Experience: Revealing the Mind.","year":"2026","cit":0,"pfa":"Janne Säynäjäkangas","ptype":"article","src":"https://openalex.org/W7160831996","eid":"W7160831996"},{"id":"paper-w7214728099","cat":"papers","name":"Designing evaluation infrastructure for psychedelic harm reduction at events: a methodological framework with formative mixed-methods field application","year":"2026","cit":0,"pfa":"Nima Veiseh","psa":"Laila Murfin","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7214728099","eid":"W7214728099"},{"id":"paper-w2397306548","cat":"papers","name":"Psychotomimetics: drugs of the \"turned-on\" generation.","year":"1968","cit":0,"pfa":"Leo E. Hollister","ptype":"article","src":"https://openalex.org/W2397306548","eid":"W2397306548"},{"id":"paper-w2397244577","cat":"papers","name":"QSAR studies on psychotomimetic phenylalkylamines.","year":"1983","cit":0,"pfa":"S.P. Gupta","psa":"Pritpal Singh","ptype":"article","src":"https://openalex.org/W2397244577","eid":"W2397244577"},{"id":"paper-w2069217382","cat":"papers","name":"The Hallucinogens. Edited by A. Hoffer and H. Osmond. With a contribution by T. Weckowicz. New York and London: Academic Press. 1967. Pp. 626. Price $25.00.","year":"1968","cit":0,"pfa":"JAMES L. GIBBONS","ptype":"book-review","src":"https://openalex.org/W2069217382","eid":"W2069217382"},{"id":"paper-w4385363966","cat":"papers","name":"Supplementary Figure S9 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385363966","eid":"W4385363966"},{"id":"paper-w4386775979","cat":"papers","name":"Supplementary Figure S12 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4386775979","eid":"W4386775979"},{"id":"paper-w4386776275","cat":"papers","name":"Supplementary Figure S4 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4386776275","eid":"W4386776275"},{"id":"paper-w4416629773","cat":"papers","name":"Supplementary Figure S3 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2025","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4416629773","eid":"W4416629773"},{"id":"paper-w4386776282","cat":"papers","name":"Supplementary Figure S3 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4386776282","eid":"W4386776282"},{"id":"paper-w597515722","cat":"papers","name":"Microdosing a new approach to reduce drug development time and costs (TEST METHODS) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)","year":"2003","cit":0,"pfa":"Emiko Haruyama","psa":"Hidenobu Sameshima","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W597515722","eid":"W597515722"},{"id":"paper-w4385302651","cat":"papers","name":"Supplementary Figure S18 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385302651","eid":"W4385302651"},{"id":"paper-w4385302710","cat":"papers","name":"Supplementary Figure S17 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385302710","eid":"W4385302710"},{"id":"paper-w4386776521","cat":"papers","name":"Supplementary Table S6B from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"supplementary-materials","src":"https://openalex.org/W4386776521","eid":"W4386776521"},{"id":"paper-w4416670622","cat":"papers","name":"Supplementary Table S6A from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2025","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"supplementary-materials","src":"https://openalex.org/W4416670622","eid":"W4416670622"},{"id":"paper-w1993501804","cat":"papers","name":"Évaluation du protocole microdose dans le suivi radiologique des scolioses idiopathiques de l’adolescent par stéréo-radiographie EOS","year":"2014","cit":0,"pfa":"Brice Ilharreborde","psa":"Keyvan Mazda","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1993501804","eid":"W1993501804"},{"id":"paper-w4361951930","cat":"papers","name":"Data from Tumor-Specific Uptake of Fluorescent Bevacizumab–IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feasibility Study","year":"2023","cit":0,"pfa":"Laetitia E. Lamberts","psa":"Gooitzen M. van Dam","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W4361951930","eid":"W4361951930"},{"id":"paper-w4385232193","cat":"papers","name":"Supplementary Figure S11 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385232193","eid":"W4385232193"},{"id":"paper-w4385236127","cat":"papers","name":"Supplementary Figure S4 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385236127","eid":"W4385236127"},{"id":"paper-w4385249155","cat":"papers","name":"Supplementary Figure S18 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385249155","eid":"W4385249155"},{"id":"paper-w4385249951","cat":"papers","name":"Supplementary Figure S10 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385249951","eid":"W4385249951"},{"id":"paper-w4385302603","cat":"papers","name":"Supplementary Figure S6 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385302603","eid":"W4385302603"},{"id":"paper-w4386776194","cat":"papers","name":"Supplementary Figure S19 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4386776194","eid":"W4386776194"},{"id":"paper-w4386776272","cat":"papers","name":"Supplementary Figure S5 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4386776272","eid":"W4386776272"},{"id":"paper-w4386776460","cat":"papers","name":"Supplementary Figure S9 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4386776460","eid":"W4386776460"},{"id":"paper-w4402789697","cat":"papers","name":"Supplementary Figure S13 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2024","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4402789697","eid":"W4402789697"},{"id":"paper-w4385364029","cat":"papers","name":"Supplementary Figure S5 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385364029","eid":"W4385364029"},{"id":"paper-w4385366343","cat":"papers","name":"Supplementary Figure S4 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385366343","eid":"W4385366343"},{"id":"paper-w7155061724","cat":"papers","name":"Reviewer #2 (Public review): Modeling the hallucinatory effects of classical psychedelics in terms of replay-dependent plasticity mechanisms","year":"2026","cit":0,"topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W7155061724","eid":"W7155061724"},{"id":"paper-w2042607599","cat":"papers","name":"P.1.i.024 Simultaneous PET-MR imaging of the effects of microdose challenges using [11C]AZ-10419369 in non-human primates","year":"2013","cit":0,"pfa":"Hanne Demant Hansen","psa":"Gitte M. Knudsen","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2042607599","eid":"W2042607599"},{"id":"paper-w4402818749","cat":"papers","name":"Supplementary Table S5 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2024","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4402818749","eid":"W4402818749"},{"id":"paper-w4385302557","cat":"papers","name":"Supplementary Table S3 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385302557","eid":"W4385302557"},{"id":"paper-w4385302654","cat":"papers","name":"Supplementary Figure S7 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385302654","eid":"W4385302654"},{"id":"paper-w4385302709","cat":"papers","name":"Supplementary Table S2 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385302709","eid":"W4385302709"},{"id":"paper-w4402789183","cat":"papers","name":"Supplementary Figure S4 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2024","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4402789183","eid":"W4402789183"},{"id":"paper-w4416629678","cat":"papers","name":"Supplementary Figure S9 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2025","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4416629678","eid":"W4416629678"},{"id":"paper-w4402817326","cat":"papers","name":"Supplementary Figure S5 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2024","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4402817326","eid":"W4402817326"},{"id":"paper-w4386775900","cat":"papers","name":"Supplementary Figure S14 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4386775900","eid":"W4386775900"},{"id":"paper-w4386776283","cat":"papers","name":"Supplementary Figure S3 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4386776283","eid":"W4386776283"},{"id":"paper-w4402799921","cat":"papers","name":"Supplementary Figure S19 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2024","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4402799921","eid":"W4402799921"},{"id":"paper-w4385236193","cat":"papers","name":"Supplementary Figure S19 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385236193","eid":"W4385236193"},{"id":"paper-w4386776370","cat":"papers","name":"Supplementary Figure S7 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4386776370","eid":"W4386776370"},{"id":"paper-w4386776459","cat":"papers","name":"Supplementary Figure S8 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4386776459","eid":"W4386776459"},{"id":"paper-w4402789188","cat":"papers","name":"Supplementary Figure S18 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2024","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4402789188","eid":"W4402789188"},{"id":"paper-w4391744898","cat":"papers","name":"Decision letter for \"Microdosing ketamine in Drosophila does not block serotonin reuptake, but causes complex behavioral changes mediated by glutamate and serotonin receptors\"","year":"2024","cit":0,"topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"peer-review","src":"https://openalex.org/W4391744898","eid":"W4391744898"},{"id":"paper-w7168103143","cat":"papers","name":"Amendment CDLIII: SOL Coherent Microdose Protocol — Phi-Harmonic Biological Coherence Enhancement with Environmental Modulation and SOL Field Encasement Variables","year":"2026","cit":0,"pfa":"Justin McCaul","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7168103143","eid":"W7168103143"},{"id":"paper-w4412233812","cat":"papers","name":"Fra psychedelic happening til følelsesmusik: Den medierede Jimi Hendrix i dansk rockkritik 1967-70.","year":"2023","cit":0,"pfa":"Morten Michelsen","ptype":"article","src":"https://openalex.org/W4412233812","eid":"W4412233812"},{"id":"paper-w7123262725","cat":"papers","name":"Therapeutic Psychedelic LSD Analogues Without Hallucinations: JRT, Non-Hallucinogenic Neuroplastogens, and the Medicinal Chemistry of Safer Psychoplastogens","year":"2026","cit":0,"pfa":"Douglas C. Youvan","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7123262725","eid":"W7123262725"},{"id":"paper-w4413604116","cat":"papers","name":"Psychedelic medicine is on its way. But it’s not ‘doing shrooms with your shrink’. Here’s what you need to know","year":"2023","cit":0,"pfa":"Nigel H. M. Strauss","psa":"Steve R Kisely","ptype":"other","src":"https://openalex.org/W4413604116","eid":"W4413604116"},{"id":"paper-w4385236120","cat":"papers","name":"Supplementary Table S2 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385236120","eid":"W4385236120"},{"id":"paper-w4385253794","cat":"papers","name":"Supplementary Figure S12 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385253794","eid":"W4385253794"},{"id":"paper-w4385302473","cat":"papers","name":"Supplementary Table S3 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385302473","eid":"W4385302473"},{"id":"paper-w4385302653","cat":"papers","name":"Supplementary Figure S6 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385302653","eid":"W4385302653"},{"id":"paper-w4402799738","cat":"papers","name":"Supplementary Figure S13 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2024","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4402799738","eid":"W4402799738"},{"id":"paper-w4385302652","cat":"papers","name":"Supplementary Table S1 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385302652","eid":"W4385302652"},{"id":"paper-w4386776281","cat":"papers","name":"Supplementary Figure S5 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4386776281","eid":"W4386776281"},{"id":"paper-w7171541797","cat":"papers","name":"Effect of fertilizer Microdosing of and Microbial Inoculation on Pearl Millet ( Pennisetum glaucum (L.) R. Br) Growth on Two Soils of the Peanut Basin of Senegal","year":"2026","cit":0,"pfa":"Khady DIAW","psa":"Mame Ndiaye","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7171541797","eid":"W7171541797"},{"id":"paper-w4385257512","cat":"papers","name":"Supplementary Table S2 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385257512","eid":"W4385257512"},{"id":"paper-w4385258719","cat":"papers","name":"Supplementary Table S1 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385258719","eid":"W4385258719"},{"id":"paper-w4402789512","cat":"papers","name":"Supplementary Figure S9 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2024","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4402789512","eid":"W4402789512"},{"id":"paper-w2588217138","cat":"papers","name":"R-052. Biological and clinical results of IVF protocol using oral pill, microdose triptorelin acetate, and FSH recombinant hormone for low responders","year":"1999","cit":0,"pfa":"Philippe Merviel","psa":"S. Uzan","topics":["Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W2588217138","eid":"W2588217138"},{"id":"paper-w4385236080","cat":"papers","name":"Supplementary Table S4 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385236080","eid":"W4385236080"},{"id":"paper-w4385250698","cat":"papers","name":"Supplementary Figure S1 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385250698","eid":"W4385250698"},{"id":"paper-w4385302702","cat":"papers","name":"Supplementary Figure S13 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385302702","eid":"W4385302702"},{"id":"paper-w4402818548","cat":"papers","name":"Supplementary Table S2 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2024","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4402818548","eid":"W4402818548"},{"id":"paper-w4385232222","cat":"papers","name":"Supplementary Table S1 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385232222","eid":"W4385232222"},{"id":"paper-w4385302559","cat":"papers","name":"Supplementary Figure S14 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385302559","eid":"W4385302559"},{"id":"paper-w4385302601","cat":"papers","name":"Supplementary Figure S8 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385302601","eid":"W4385302601"},{"id":"paper-w4385362962","cat":"papers","name":"Supplementary Figure S3 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385362962","eid":"W4385362962"},{"id":"paper-w4385364819","cat":"papers","name":"Supplementary Table S6A from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385364819","eid":"W4385364819"},{"id":"paper-w4402799294","cat":"papers","name":"Supplementary Figure S17 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2024","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4402799294","eid":"W4402799294"},{"id":"paper-w4416629823","cat":"papers","name":"Supplementary Figure S7 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2025","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4416629823","eid":"W4416629823"},{"id":"paper-w4386775985","cat":"papers","name":"Supplementary Figure S11 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4386775985","eid":"W4386775985"},{"id":"paper-w4402789180","cat":"papers","name":"Supplementary Table S4 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2024","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4402789180","eid":"W4402789180"},{"id":"paper-w4416630159","cat":"papers","name":"Supplementary Figure S19 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2025","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4416630159","eid":"W4416630159"},{"id":"paper-w4413500698","cat":"papers","name":"Use of psychedelics to treat PTSD, OCD, depression and chronic pain – a researcher discusses recent trials, possible risks","year":"2023","cit":0,"pfa":"Jennifer Mitchell","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"other","src":"https://openalex.org/W4413500698","eid":"W4413500698"},{"id":"paper-w3134792509","cat":"papers","name":"Traces of psychedelics make you feel good, but so does placebo, finds unusual ‘self-blinding’ study","year":"2021","cit":0,"pfa":"Cathleen O’Grady","ptype":"article","src":"https://openalex.org/W3134792509","eid":"W3134792509"},{"id":"paper-w7126404639","cat":"papers","name":"SISTEM REKOMENDASI MUSIK PSYCHEDELIC ROCK BERBASIS KONTEN DENGAN EKSTRAKSI FITUR AUDIO DAN COSINE SIMILARITY","year":"2026","cit":0,"pfa":"Iqbal Nurhidayat","psa":"Arif Nur Rohman","ptype":"article","src":"https://openalex.org/W7126404639","eid":"W7126404639"},{"id":"paper-w4410114091","cat":"papers","name":"Exploratory Analysis on the Role of Video Tools and Multidisciplinary Healthcare Providers to Aid Counselling for Buprenorphine/Naloxone Induction Within the Evaluating Microdosing in the Emergency Department Study","year":"2025","cit":0,"pfa":"Alyssa Kong","psa":"Jessica Moe","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4410114091","eid":"W4410114091"},{"id":"paper-w2411656707","cat":"papers","name":"Metabolism of psychotomimetic beta-phenylisopropylamines.","year":"1975","cit":0,"pfa":"Neal Castagnoli","ptype":"article","src":"https://openalex.org/W2411656707","eid":"W2411656707"},{"id":"paper-w4386776075","cat":"papers","name":"Supplementary Figure S17 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4386776075","eid":"W4386776075"},{"id":"paper-w4416629830","cat":"papers","name":"Supplementary Figure S6 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2025","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4416629830","eid":"W4416629830"},{"id":"paper-w4386775986","cat":"papers","name":"Supplementary Figure S13 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4386775986","eid":"W4386775986"},{"id":"paper-w4386776365","cat":"papers","name":"Supplementary Figure S6 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4386776365","eid":"W4386776365"},{"id":"paper-w4402790123","cat":"papers","name":"Supplementary Figure S11 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2024","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4402790123","eid":"W4402790123"},{"id":"paper-w4288446613","cat":"papers","name":"Supplemental Material for Acute and Enduring Effects of Naturalistic Psychedelic Use Among Indigenous Peoples in Canada and the United States","year":"2022","cit":0,"ptype":"supplementary-materials","src":"https://openalex.org/W4288446613","eid":"W4288446613"},{"id":"paper-w7128691254","cat":"papers","name":"Regional differences in the experience of awe and replication of associations between awe facets, psychedelic experiences, and mental-health outcomes.","year":"2024","cit":0,"pfa":"Marianna Graziosi","psa":"Philippe Lucas","ptype":"preprint","src":"https://openalex.org/W7128691254","eid":"W7128691254"},{"id":"paper-w4402818549","cat":"papers","name":"Supplementary Table S1 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2024","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4402818549","eid":"W4402818549"},{"id":"paper-w4416629867","cat":"papers","name":"Supplementary Table S4 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2025","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4416629867","eid":"W4416629867"},{"id":"paper-w2739933981","cat":"papers","name":"Early central subfield thickness and long-term visual acuity changes with fluocinolone acetonide (FAc)-associated continuous microdosing in diabetic macular edema","year":"2017","cit":0,"pfa":"Caesar Luo","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2739933981","eid":"W2739933981"},{"id":"paper-w4402789696","cat":"papers","name":"Supplementary Figure S17 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2024","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4402789696","eid":"W4402789696"},{"id":"paper-w4386776462","cat":"papers","name":"Supplementary Figure S8 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4386776462","eid":"W4386776462"},{"id":"paper-w4416629938","cat":"papers","name":"Supplementary Figure S15 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2025","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4416629938","eid":"W4416629938"},{"id":"paper-w4385236178","cat":"papers","name":"Supplementary Figure S7 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385236178","eid":"W4385236178"},{"id":"paper-w4402798484","cat":"papers","name":"Supplementary Figure S5 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2024","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4402798484","eid":"W4402798484"},{"id":"paper-w3042272225","cat":"papers","name":"ChemInform Abstract: THE SYNTHESIS OF SOME ANALOGS OF THE HALLUCINOGEN 1‐(2,5‐DIMETHOXY‐4‐METHYLPHENYL)‐2‐AMINOPROPANE (DOM) PART 3, SOME DERIVATIVES OF 3‐PHENYLALANINE","year":"1974","cit":0,"pfa":"Ronald T. Coutts","psa":"Jerry L. Malicky","ptype":"article","src":"https://openalex.org/W3042272225","eid":"W3042272225"},{"id":"paper-w4300855257","cat":"papers","name":"[Psychotomimetic drugs and the new psychosocial epidemic].","year":"1973","cit":0,"ptype":"article","src":"https://openalex.org/W4300855257","eid":"W4300855257"},{"id":"paper-w4385302495","cat":"papers","name":"Supplementary Figure S1 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385302495","eid":"W4385302495"},{"id":"paper-w4385366311","cat":"papers","name":"Supplementary Figure S7 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385366311","eid":"W4385366311"},{"id":"paper-w4386776626","cat":"papers","name":"Supplementary Table S4 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4386776626","eid":"W4386776626"},{"id":"paper-w4402789698","cat":"papers","name":"Supplementary Figure S14 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2024","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4402789698","eid":"W4402789698"},{"id":"paper-w7142628474","cat":"papers","name":"A randomised, double-dummy, triple-blind, active placebo-controlled, parallel groups trial of LSD microdosing in patients with major depressive disorder (LSDDEP2)","year":"2025","cit":0,"pfa":"Dimitri Henriques Daldegan-Bueno","psa":"Alana Cavadino","topics":["Depression","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7142628474","eid":"W7142628474"},{"id":"paper-w1759241451","cat":"papers","name":"UNSUR PSYCHEDELIC PADA SAMPUL ALBUM THE BEATLES “YELLOW SUBMARINE” TAHUN 1969: KAJIAN SEMIOTIKA ROLAND BARTHES","year":"2012","cit":0,"pfa":"Muhammad Rayhan Sudrajat","ptype":"article","src":"https://openalex.org/W1759241451","eid":"W1759241451"},{"id":"paper-w4386776193","cat":"papers","name":"Supplementary Figure S18 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4386776193","eid":"W4386776193"},{"id":"paper-w4402789185","cat":"papers","name":"Supplementary Table S5 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2024","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4402789185","eid":"W4402789185"},{"id":"paper-w4416629892","cat":"papers","name":"Supplementary Figure S1 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2025","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4416629892","eid":"W4416629892"},{"id":"paper-w4385236022","cat":"papers","name":"Supplementary Figure S3 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385236022","eid":"W4385236022"},{"id":"paper-w4385236122","cat":"papers","name":"Supplementary Figure S5 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385236122","eid":"W4385236122"},{"id":"paper-w4385236176","cat":"papers","name":"Supplementary Figure S17 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385236176","eid":"W4385236176"},{"id":"paper-w4385248666","cat":"papers","name":"Supplementary Table S5 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385248666","eid":"W4385248666"},{"id":"paper-w4385368448","cat":"papers","name":"Supplementary Figure S15 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385368448","eid":"W4385368448"},{"id":"paper-w4402818577","cat":"papers","name":"Supplementary Table S3 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2024","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4402818577","eid":"W4402818577"},{"id":"paper-w2437395592","cat":"papers","name":"[Aggression-inducing combinations of psychotomimetic drugs].","year":"1969","cit":0,"pfa":"GERHARD ZETLER","psa":"U. Otten","ptype":"article","src":"https://openalex.org/W2437395592","eid":"W2437395592"},{"id":"paper-w1965456646","cat":"papers","name":"Additions and Corrections - Potential Psychotomimetics. Bromomethoxyamphetamines.","year":"1971","cit":0,"pfa":"Charles F. Barfknecht","psa":"David E. Nichols","ptype":"article","src":"https://openalex.org/W1965456646","eid":"W1965456646"},{"id":"paper-w4237559546","cat":"papers","name":"Radiolabeling and PET-MRI microdosing of the experimental cancer therapeutic, MN-anti-miR10b, demonstrates delivery to metastatic lesions in a murine model of metastatic breast cancer","year":"2021","cit":0,"pfa":"Mariane Le Fur","psa":"Byunghee Yoo","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4237559546","eid":"W4237559546"},{"id":"paper-w4362401296","cat":"papers","name":"Supplementary Figure 6 from Tumor-Specific Uptake of Fluorescent Bevacizumab–IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feasibility Study","year":"2023","cit":0,"pfa":"Laetitia E. Lamberts","psa":"Gooitzen M. van Dam","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4362401296","eid":"W4362401296"},{"id":"paper-w7123557273","cat":"papers","name":"Author response: The oneirogen hypothesis: modeling the hallucinatory effects of classical psychedelics in terms of replay-dependent plasticity mechanisms","year":"2026","cit":0,"pfa":"Colin Bredenberg","psa":"Guillaume Lajoie","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"peer-review","src":"https://openalex.org/W7123557273","eid":"W7123557273"},{"id":"paper-w4385232277","cat":"papers","name":"Supplementary Figure S7 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385232277","eid":"W4385232277"},{"id":"paper-w4385259261","cat":"papers","name":"Supplementary Table S6B from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385259261","eid":"W4385259261"},{"id":"paper-w4385360381","cat":"papers","name":"Supplementary Figure S11 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385360381","eid":"W4385360381"},{"id":"paper-w4386776072","cat":"papers","name":"Supplementary Figure S16 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4386776072","eid":"W4386776072"},{"id":"paper-w3005968801","cat":"papers","name":"A Systematic Review of Medical Students’ and Professionals’ Attitudes and Knowledge regarding Medical Cannabis as a Proxy for Forecasting Trends in the Medical Community’s Acceptance of Therapeutic Hallucinogens","year":"2019","cit":0,"pfa":"Jared Weisman","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"dissertation","src":"https://openalex.org/W3005968801","eid":"W3005968801"},{"id":"paper-w3045572139","cat":"papers","name":"Microdose Protocol Stereoradiography Has Similar Reliability to Standard Low-dose Protocol When Performing Concurrent Sanders Skeletal Maturity Staging","year":"2020","cit":0,"pfa":"Cynthia V. Nguyen","psa":"Robert H. Cho","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3045572139","eid":"W3045572139"},{"id":"paper-w7120863328","cat":"papers","name":"Characterization of long-term potentiation (LTP) markers-related in mice with accelerated aging (SAMP-8) under chronic treatment with lithium microdose.","year":"2022","cit":0,"pfa":"Arthur Antônio Ruiz Pereira","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7120863328","eid":"W7120863328"},{"id":"paper-w4385302650","cat":"papers","name":"Supplementary Figure S4 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385302650","eid":"W4385302650"},{"id":"paper-w4416629973","cat":"papers","name":"Supplementary Figure S12 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2025","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4416629973","eid":"W4416629973"},{"id":"paper-w4385236106","cat":"papers","name":"Supplementary Table S6A from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385236106","eid":"W4385236106"},{"id":"paper-w4386775895","cat":"papers","name":"Supplementary Figure S15 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4386775895","eid":"W4386775895"},{"id":"paper-w4416629832","cat":"papers","name":"Supplementary Table S6B from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2025","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"supplementary-materials","src":"https://openalex.org/W4416629832","eid":"W4416629832"},{"id":"paper-w4385387693","cat":"papers","name":"How I do it: weaning strategy for intrathecal drug delivery systems for chronic non-cancer pain: sublingual buprenorphine-naloxone microdosing schedule","year":"2023","cit":0,"pfa":"Vanessa Choi Yin Wong","psa":"Vishal P. Varshney","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4385387693","eid":"W4385387693"},{"id":"paper-w4386776366","cat":"papers","name":"Supplementary Figure S7 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4386776366","eid":"W4386776366"},{"id":"paper-w4386776540","cat":"papers","name":"Supplementary Table S1 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4386776540","eid":"W4386776540"},{"id":"paper-w4402817310","cat":"papers","name":"Supplementary Table S6A from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2024","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"supplementary-materials","src":"https://openalex.org/W4402817310","eid":"W4402817310"},{"id":"paper-w4402817333","cat":"papers","name":"Supplementary Table S6B from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2024","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"supplementary-materials","src":"https://openalex.org/W4402817333","eid":"W4402817333"},{"id":"paper-w4402818505","cat":"papers","name":"Supplementary Figure S7 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2024","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4402818505","eid":"W4402818505"},{"id":"paper-w4248769966","cat":"papers","name":"Changing Attitudes to Psychedelic Drug Assisted Therapy: The Induction of Empathy to Enhance Community Support for Innovative Interventions in Mental Health","year":"2021","cit":0,"pfa":"John L. Innes","psa":"Corey Botansky","ptype":"preprint","src":"https://openalex.org/W4248769966","eid":"W4248769966"},{"id":"paper-w4385232276","cat":"papers","name":"Supplementary Figure S1 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385232276","eid":"W4385232276"},{"id":"paper-w4385236992","cat":"papers","name":"Supplementary Figure S9 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385236992","eid":"W4385236992"},{"id":"paper-w4385302553","cat":"papers","name":"Supplementary Figure S16 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385302553","eid":"W4385302553"},{"id":"paper-w4385302597","cat":"papers","name":"Supplementary Table S6A from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385302597","eid":"W4385302597"},{"id":"paper-w4385302803","cat":"papers","name":"Supplementary Figure S9 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385302803","eid":"W4385302803"},{"id":"paper-w7126419411","cat":"papers","name":"Response of Amaranthus Species to Co-Application of Cattle Manure Microdoses, Mineral Fertiliser, and Arbuscular Mycorrhizal Fungi Inoculation on Acidic Soils in South Africa","year":"2026","cit":0,"pfa":"Simphiwe Mhlontlo","psa":"Pardon Muchaonyerwa","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7126419411","eid":"W7126419411"},{"id":"paper-w7211888925","cat":"papers","name":"Review for \"Measuring the Contents of Hallucinations from Psychedelics and Stroboscopic Light: The Six-Dimensional Visual Hallucination Questionnaire (6D-VHQ)\"","year":"2026","cit":0,"topics":["Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W7211888925","eid":"W7211888925"},{"id":"paper-w1140202057","cat":"papers","name":"Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill?","year":"2015","cit":0,"pfa":"A.A. Elassar","psa":"Claudio A Benadiva","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1140202057","eid":"W1140202057"},{"id":"paper-w4386775987","cat":"papers","name":"Supplementary Figure S11 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4386775987","eid":"W4386775987"},{"id":"paper-w4386776372","cat":"papers","name":"Supplementary Figure S6 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4386776372","eid":"W4386776372"},{"id":"paper-w4416629972","cat":"papers","name":"Supplementary Figure S14 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2025","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4416629972","eid":"W4416629972"},{"id":"paper-w4385964673","cat":"papers","name":"Supplementary Figure S12 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385964673","eid":"W4385964673"},{"id":"paper-w4386776076","cat":"papers","name":"Supplementary Figure S16 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4386776076","eid":"W4386776076"},{"id":"paper-w4386776461","cat":"papers","name":"Supplementary Figure S9 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4386776461","eid":"W4386776461"},{"id":"paper-w4246314941","cat":"papers","name":"Review 2 of \"Recreation and Realization: Reported Motivations of Use among Persons Who Consume Psychedelics in Non-Clinical Settings\"","year":"2021","cit":0,"topics":["Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4246314941","eid":"W4246314941"},{"id":"paper-w7213579156","cat":"papers","name":"Fitted bayesian regression models for \"Placebo-induced Altered States of Consciousness – A Proof-of-Concept Study of a Psychedelic Placebo Intervention\"","year":"2026","cit":0,"pfa":"Lukas Andreas Basedow","ptype":"preprint","src":"https://openalex.org/W7213579156","eid":"W7213579156"},{"id":"paper-w4386775819","cat":"papers","name":"Supplementary Figure S10 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4386775819","eid":"W4386775819"},{"id":"paper-w4402798533","cat":"papers","name":"Supplementary Figure S4 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2024","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4402798533","eid":"W4402798533"},{"id":"paper-w7116127460","cat":"papers","name":"Phase 0 Experimental Medicine Study of Direct Intratarget Pulmonary Microdosing of nlrp3/1 Inflammasome Inhibitor ads032: the Micro Study. A Protocol Paper","year":"2025","cit":0,"pfa":"T Quinn","psa":"K Dhaliwal","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7116127460","eid":"W7116127460"},{"id":"paper-w583574112","cat":"papers","name":"Proposals for conducting microdose studies : From the standpoints of drug development research(Toxicological Bases for Micro-dose Study, Proceedings of the 32nd Annual Meeting)","year":"2005","cit":0,"pfa":"Mamoru Nomura","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W583574112","eid":"W583574112"},{"id":"paper-w4385258482","cat":"papers","name":"Supplementary Figure S8 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385258482","eid":"W4385258482"},{"id":"paper-w4386776073","cat":"papers","name":"Supplementary Figure S17 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4386776073","eid":"W4386776073"},{"id":"paper-w4402799573","cat":"papers","name":"Supplementary Figure S10 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2024","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4402799573","eid":"W4402799573"},{"id":"paper-w4416629653","cat":"papers","name":"Supplementary Figure S13 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2025","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4416629653","eid":"W4416629653"},{"id":"paper-w4390222461","cat":"papers","name":"Determination of inhibition constants for three psychedelic compounds for 5-HT1A and 5-HT2A receptors in post-mortem human brain","year":"2023","cit":0,"pfa":"V. McDonald","psa":"C.K. Olsen","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4390222461","eid":"W4390222461"},{"id":"paper-w7135671707","cat":"papers","name":"Psychosocial aspects of hallucinogen use and an approximately 40-years follow-up study on LSD self-experimentation amongst professionals in the mental health fields","year":"2009","cit":0,"pfa":"Petr Winkler","ptype":"dissertation","src":"https://openalex.org/W7135671707","eid":"W7135671707"},{"id":"paper-w4361921581","cat":"papers","name":"Supplementary Figure 2 from Tumor-Specific Uptake of Fluorescent Bevacizumab–IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feasibility Study","year":"2023","cit":0,"pfa":"Laetitia E. Lamberts","psa":"Gooitzen M. van Dam","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4361921581","eid":"W4361921581"},{"id":"paper-w3166220438","cat":"papers","name":"Changing Attitudes to Psychedelic Drug Assisted Therapy: The Induction of Empathy to Enhance Community Support for Innovative Interventions in Mental Health","year":"2021","cit":0,"pfa":"John Michael Innes","psa":"Corey Botansky","ptype":"preprint","src":"https://openalex.org/W3166220438","eid":"W3166220438"},{"id":"paper-w7143037708","cat":"papers","name":"Updated Preregistration of Network analysis for the Many Analysts Psychedelic Project (MAPP): Structure (RQ1), Dose (RQ2) and Substance (RQ3)","year":"2026","cit":0,"pfa":"Michiel van Elk","psa":"Daan Adriaan Langeveld","topics":["Addiction","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7143037708","eid":"W7143037708"},{"id":"paper-w2583653699","cat":"papers","name":"Prilaku Sosial Pemusik Pengguna Narkoba di Lingkungan Masyarakat ( Studi pada Kelompok Musik Psychedelic Kota Medan)","year":"2017","cit":0,"pfa":"Aidil Sufie","ptype":"article","src":"https://openalex.org/W2583653699","eid":"W2583653699"},{"id":"paper-w4385259093","cat":"papers","name":"Supplementary Figure S19 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385259093","eid":"W4385259093"},{"id":"paper-w4402789508","cat":"papers","name":"Supplementary Figure S1 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2024","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4402789508","eid":"W4402789508"},{"id":"paper-w4402798988","cat":"papers","name":"Supplementary Figure S14 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2024","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4402798988","eid":"W4402798988"},{"id":"paper-w4410964275","cat":"papers","name":"Effectiveness of Microdosing in Comparison to Broadcasting and Banding Vermicompost Application for Maize ( Zea mays L.) Production in Smallholder Farming of Semiarid Tigray Region of Ethiopia","year":"2025","cit":0,"pfa":"Kinfe Tekulu","psa":"Tsadik Tadele","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4410964275","eid":"W4410964275"},{"id":"paper-w4385257745","cat":"papers","name":"Supplementary Table S3 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385257745","eid":"W4385257745"},{"id":"paper-w4386776277","cat":"papers","name":"Supplementary Figure S2 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4386776277","eid":"W4386776277"},{"id":"paper-w4386776539","cat":"papers","name":"Supplementary Table S6A from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"supplementary-materials","src":"https://openalex.org/W4386776539","eid":"W4386776539"},{"id":"paper-w4385259514","cat":"papers","name":"Supplementary Figure S6 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385259514","eid":"W4385259514"},{"id":"paper-w4385302604","cat":"papers","name":"Supplementary Figure S12 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385302604","eid":"W4385302604"},{"id":"paper-w4386775982","cat":"papers","name":"Supplementary Figure S1 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4386775982","eid":"W4386775982"},{"id":"paper-w4402818575","cat":"papers","name":"Supplementary Table S4 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2024","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4402818575","eid":"W4402818575"},{"id":"paper-w2413985618","cat":"papers","name":"Problems in the evaluation of psychotomimetic drugs.","year":"1961","cit":0,"pfa":"S. Cohen","ptype":"article","src":"https://openalex.org/W2413985618","eid":"W2413985618"},{"id":"paper-w7204492842","cat":"papers","name":"Combining Psychedelics with Religion or Spirituality: Spiritual Bypassing, Receptivity to Pseudo-Profound Bullshit, Subclinical Psychotic Experiences and Well-Being.","year":"2026","cit":0,"pfa":"Baptiste Fauvel","psa":"Pascale Piolino","topics":["Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W7204492842","eid":"W7204492842"},{"id":"paper-w7213614083","cat":"papers","name":"Serotonergic psychedelics and amphetamine shift male rat ultrasonic vocalizations toward call patterns associated with positively valenced states","year":"2026","cit":0,"pfa":"Ewelina Cyrano","psa":"Agnieszka Potasiewicz","ptype":"article","src":"https://openalex.org/W7213614083","eid":"W7213614083"},{"id":"paper-w2741734448","cat":"papers","name":"Psychedelic Experiential Pharmacology: Pioneering Clinical Explorations with Salvador Roquet (How I Came to All of This: Ketamine, Admixtures and Adjuvants,","year":"2014","cit":0,"pfa":"D. Maya Juan","psa":"Philip E. Wolfson","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2741734448","eid":"W2741734448"},{"id":"paper-w4362401699","cat":"papers","name":"Supplemental Material and Methods from Tumor-Specific Uptake of Fluorescent Bevacizumab–IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feasibility Study","year":"2023","cit":0,"pfa":"Laetitia E. Lamberts","psa":"Gooitzen M. van Dam","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4362401699","eid":"W4362401699"},{"id":"paper-w7154161464","cat":"papers","name":"The non-classic psychedelic muscimol suppresses inflammatory signaling and promotes neuroplasticity in schizophrenia-derived human cortical spheroids and astroglia","year":"2026","cit":0,"pfa":"Ibrahim A. Akkouh","psa":"Attila Szabó","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W7154161464","eid":"W7154161464"},{"id":"paper-w4386776600","cat":"papers","name":"Supplementary Table S6B from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"supplementary-materials","src":"https://openalex.org/W4386776600","eid":"W4386776600"},{"id":"paper-w4416629723","cat":"papers","name":"Supplementary Table S1 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2025","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4416629723","eid":"W4416629723"},{"id":"paper-w2337639626","cat":"papers","name":"INNOVATIVE STRATEGIES FOR DRUG DEVELOPMENT USING MICRODOSING CLINICAL STUDY (5):IDENTIFICATION OF HUMAN METABOLITES BY A CONBINATORIAL USE OF AMS AND LC/MS/MS","year":"2009","cit":0,"pfa":"Zenzauro Tozuka","psa":"Toshihiko Ikeda","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2337639626","eid":"W2337639626"},{"id":"paper-w4385236179","cat":"papers","name":"Supplementary Figure S8 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385236179","eid":"W4385236179"},{"id":"paper-w4385250780","cat":"papers","name":"Supplementary Figure S16 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385250780","eid":"W4385250780"},{"id":"paper-w4385253602","cat":"papers","name":"Supplementary Figure S14 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385253602","eid":"W4385253602"},{"id":"paper-w4386775817","cat":"papers","name":"Supplementary Figure S10 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4386775817","eid":"W4386775817"},{"id":"paper-w4402788032","cat":"papers","name":"Supplementary Figure S19 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2024","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4402788032","eid":"W4402788032"},{"id":"paper-w7214492302","cat":"papers","name":"Integrated Microdosing Selected Basal Fertilizers and Lime Modulates Fungal and Bacterial Populations in Acidic Soils under Maize Production in the Meru Highland, Kenya","year":"2026","cit":0,"pfa":"Mbaka K. Felister","psa":"Emmanuel R. Mwakidoshi","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7214492302","eid":"W7214492302"},{"id":"paper-w4408808737","cat":"papers","name":"Mixed-Methods Study of Use and Attitudes About Psychedelics for Therapeutic Purposes Among Low-Income U.S. Veterans Nationally","year":"2025","cit":0,"pfa":"Jack Tsai","psa":"Taylor Fate","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4408808737","eid":"W4408808737"},{"id":"paper-w3049444241","cat":"papers","name":"The Role of Psychedelic Agents in Treatment of Mood Disorders and Addictions: A Clinical Conversation with Scott Shannon, MD, and Robert Rountree, MD","year":"2020","cit":0,"pfa":"Scott M. Shannon","psa":"ROBERT L. ROUNTREE","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W3049444241","eid":"W3049444241"},{"id":"paper-w7139098913","cat":"papers","name":"Selection Bias in Psychedelic Research: Comparing Self-Reported Quality-Of-Life Impact Between Enthusiasts and a General Population Sample","year":"2026","cit":0,"pfa":"Jonathan Bendz","psa":"Petri Kajonius","ptype":"article","src":"https://openalex.org/W7139098913","eid":"W7139098913"},{"id":"paper-w7128205379","cat":"papers","name":"Tapping in Together a Mixed Methods Pilot Study on Group Acupuncture Following a Psychedelic Ketamine Experience in an Integrative Care Setting","year":"2025","cit":0,"pfa":"Marjorie C. Navarro","ptype":"preprint","src":"https://openalex.org/W7128205379","eid":"W7128205379"},{"id":"paper-w7165434417","cat":"papers","name":"Narcotic Dystopia; Psychedelic Utopia?: Aldous Huxley, Drug-induced Experiences, and 'Topianism' between Brave New World and Island","year":"2026","cit":0,"pfa":"Daniel Berg","topics":["Safety & adverse events"],"ptype":"other","src":"https://openalex.org/W7165434417","eid":"W7165434417"},{"id":"paper-w4385302556","cat":"papers","name":"Supplementary Table S4 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385302556","eid":"W4385302556"},{"id":"paper-w4385302658","cat":"papers","name":"Supplementary Figure S17 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385302658","eid":"W4385302658"},{"id":"paper-w4385363476","cat":"papers","name":"Supplementary Figure S5 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385363476","eid":"W4385363476"},{"id":"paper-w4386776625","cat":"papers","name":"Supplementary Table S2 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4386776625","eid":"W4386776625"},{"id":"paper-w4402790111","cat":"papers","name":"Supplementary Figure S12 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2024","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4402790111","eid":"W4402790111"},{"id":"paper-w4402798725","cat":"papers","name":"Supplementary Figure S11 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2024","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4402798725","eid":"W4402798725"},{"id":"paper-w4381613802","cat":"papers","name":"Ram Dass (6 Apr. 1931–22 Dec. 2019), spiritual teacher, psychedelic pioneer, psychologist, and countercultural thinker","year":"2023","cit":0,"pfa":"Christopher H. Partridge","ptype":"reference-entry","src":"https://openalex.org/W4381613802","eid":"W4381613802"},{"id":"paper-w2419647830","cat":"papers","name":"[Sernyl, a psychotomimetic with \"schizophrenia-like\" action].","year":"1965","cit":0,"pfa":"Banshchikov Vm","psa":"Stoliarov Gv","ptype":"article","src":"https://openalex.org/W2419647830","eid":"W2419647830"},{"id":"paper-w4385364476","cat":"papers","name":"Supplementary Figure S15 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385364476","eid":"W4385364476"},{"id":"paper-w4386776551","cat":"papers","name":"Supplementary Table S6A from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"supplementary-materials","src":"https://openalex.org/W4386776551","eid":"W4386776551"},{"id":"paper-w4386776630","cat":"papers","name":"Supplementary Table S5 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4386776630","eid":"W4386776630"},{"id":"paper-w4416630342","cat":"papers","name":"Supplementary Figure S18 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2025","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4416630342","eid":"W4416630342"},{"id":"paper-w4394917064","cat":"papers","name":"Supplemental Material for Perceptions of Psychedelic Use by Adults in the United States: Perceived Psychospiritual Benefits and Risks, Including Spiritual Struggles","year":"2024","cit":0,"topics":["Safety & adverse events"],"ptype":"supplementary-materials","src":"https://openalex.org/W4394917064","eid":"W4394917064"},{"id":"paper-w3042047031","cat":"papers","name":"Comparison of the Microdose Flare Up GnRH Agonist and Antagonist Protocol in Assisted Reproduction with Poor Ovarian Response during Controlled Ovarian Stimulation Cycles","year":"2019","cit":0,"pfa":"Mohamed Elebiary","psa":"Abdelmoneim Mohamed Zakaria","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3042047031","eid":"W3042047031"},{"id":"paper-w4385232208","cat":"papers","name":"Supplementary Figure S12 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385232208","eid":"W4385232208"},{"id":"paper-w4385256545","cat":"papers","name":"Supplementary Figure S13 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385256545","eid":"W4385256545"},{"id":"paper-w4386776280","cat":"papers","name":"Supplementary Figure S4 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4386776280","eid":"W4386776280"},{"id":"paper-w4402789509","cat":"papers","name":"Supplementary Figure S10 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2024","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4402789509","eid":"W4402789509"},{"id":"paper-w4402799091","cat":"papers","name":"Supplementary Figure S9 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2024","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4402799091","eid":"W4402799091"},{"id":"paper-w4385236023","cat":"papers","name":"Supplementary Figure S2 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385236023","eid":"W4385236023"},{"id":"paper-w4385258760","cat":"papers","name":"Supplementary Figure S9 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385258760","eid":"W4385258760"},{"id":"paper-w4385259724","cat":"papers","name":"Supplementary Figure S15 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385259724","eid":"W4385259724"},{"id":"paper-w4385302705","cat":"papers","name":"Supplementary Table S6B from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385302705","eid":"W4385302705"},{"id":"paper-w4386776074","cat":"papers","name":"Supplementary Figure S18 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4386776074","eid":"W4386776074"},{"id":"paper-w4402799823","cat":"papers","name":"Supplementary Figure S18 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2024","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4402799823","eid":"W4402799823"},{"id":"paper-w4242309779","cat":"papers","name":"Review 1 of \"Recreation and Realization: Reported Motivations of Use among Persons Who Consume Psychedelics in Non-Clinical Settings\"","year":"2021","cit":0,"topics":["Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4242309779","eid":"W4242309779"},{"id":"paper-w4388851449","cat":"papers","name":"From femme fatale to love goddess: Nineteenth‐century images of women in sixties San Francisco psychedelic rock posters","year":"2023","cit":0,"pfa":"Michael Parke‐Taylor","ptype":"article","src":"https://openalex.org/W4388851449","eid":"W4388851449"},{"id":"paper-w7211871924","cat":"papers","name":"Review for \"Measuring the Contents of Hallucinations from Psychedelics and Stroboscopic Light: The Six-Dimensional Visual Hallucination Questionnaire (6D-VHQ)\"","year":"2026","cit":0,"topics":["Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W7211871924","eid":"W7211871924"},{"id":"paper-w7202293268","cat":"papers","name":"Improving Psychedelic Harm Reduction and Therapy: Community Perspectives from Individuals Who Use Recreationally and for Mental Health Purposes","year":"2026","cit":0,"pfa":"Jennifer S. Jewell","psa":"Joshua Curtis Black","topics":["Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7202293268","eid":"W7202293268"},{"id":"paper-w4253652757","cat":"papers","name":"II. Psychotomimetic Compounds and Schizophrenia","year":"1975","cit":0,"ptype":"article","src":"https://openalex.org/W4253652757","eid":"W4253652757"},{"id":"paper-w4385258484","cat":"papers","name":"Supplementary Figure S4 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385258484","eid":"W4385258484"},{"id":"paper-w4386776197","cat":"papers","name":"Supplementary Figure S19 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4386776197","eid":"W4386776197"},{"id":"paper-w4402799572","cat":"papers","name":"Supplementary Figure S16 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2024","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4402799572","eid":"W4402799572"},{"id":"paper-w7170036491","cat":"papers","name":"Supplementary material from \"Measuring the contents of hallucinations from psychedelics and stroboscopic light: the six-dimensional visual hallucination questionnaire\"","year":"2026","cit":0,"pfa":"Trevor Hewitt","psa":"David Schwartzman","topics":["Mechanism & neuroscience"],"ptype":"supplementary-materials","src":"https://openalex.org/W7170036491","eid":"W7170036491"},{"id":"paper-w4410445247","cat":"papers","name":"Corrigendum: Is psychedelic use associated with cancer? Interrogating a half-century-old claim using contemporary population-level data","year":"2025","cit":0,"topics":["Anxiety & end-of-life"],"ptype":"erratum","src":"https://openalex.org/W4410445247","eid":"W4410445247"},{"id":"paper-w4240657014","cat":"papers","name":"Faculty Opinions recommendation of Psychedelics, but Not Ketamine, Produce Persistent Antidepressant-like Effects in a Rodent Experimental System for the Study of Depression.","year":"2020","cit":0,"pfa":"Dave Nichols","topics":["Depression"],"ptype":"peer-review","src":"https://openalex.org/W4240657014","eid":"W4240657014"},{"id":"paper-w7161985424","cat":"papers","name":"Symptom-Specific Nuances in Psychedelic Integration: A Qualitative Study of Insights from Therapists Supporting Extended Difficulties in Naturalistic Settings","year":"2026","cit":0,"pfa":"Ali Wright","psa":"Jules Evans","topics":["Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7161985424","eid":"W7161985424"},{"id":"paper-w7127976149","cat":"papers","name":"Additional file 1 of Practitioner perspectives on extended difficulties and optimal support strategies following psychedelic experiences: a qualitative analysis","year":"2026","cit":0,"pfa":"E. K. Argyri","psa":"C. J. A. Morgan","ptype":"dataset","src":"https://openalex.org/W7127976149","eid":"W7127976149"},{"id":"paper-w7133357677","cat":"papers","name":"Flashbacks Through Time: Historical Development and Current Use of the Term “Flashback” in Psychedelic and Post‐Traumatic Stress Disorder Research","year":"2026","cit":0,"pfa":"Ricarda Evens","topics":["PTSD & trauma","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7133357677","eid":"W7133357677"},{"id":"paper-w4402787983","cat":"papers","name":"Supplementary Figure S6 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2024","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4402787983","eid":"W4402787983"},{"id":"paper-w4405107295","cat":"papers","name":"Correction: Irvine et al. Transpersonal Ecodelia: Surveying Psychedelically Induced Biophilia. Psychoactives 2023, 2, 174–193","year":"2024","cit":0,"pfa":"Alexander Irvine","psa":"Rosalind Watts","ptype":"erratum","src":"https://openalex.org/W4405107295","eid":"W4405107295"},{"id":"paper-w4361921194","cat":"papers","name":"Supplementary Figure 7 from Tumor-Specific Uptake of Fluorescent Bevacizumab–IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feasibility Study","year":"2023","cit":0,"pfa":"Laetitia E. Lamberts","psa":"Gooitzen M. van Dam","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4361921194","eid":"W4361921194"},{"id":"paper-w4361922431","cat":"papers","name":"Supplementary Figure 4 from Tumor-Specific Uptake of Fluorescent Bevacizumab–IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feasibility Study","year":"2023","cit":0,"pfa":"Laetitia E. Lamberts","psa":"Gooitzen M. van Dam","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4361922431","eid":"W4361922431"},{"id":"paper-w4416510185","cat":"papers","name":"Microdoses de cannabis e Alzheimer: o que novo estudo revela sobre o uso de THC e CBD em idosos","year":"2025","cit":0,"pfa":"Fabrício A. Pamplona","topics":["Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W4416510185","eid":"W4416510185"},{"id":"paper-w4385302712","cat":"papers","name":"Supplementary Table S2 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385302712","eid":"W4385302712"},{"id":"paper-w4400575278","cat":"papers","name":"Psychedelic Drug Abuse Potential Assessment Challenges to Scientific Validity and Real World Predictiveness: Current Approaches and Research Gaps","year":"2024","cit":0,"pfa":"Jack E. Henningfield","psa":"Judy Ashworth","ptype":"article","src":"https://openalex.org/W4400575278","eid":"W4400575278"},{"id":"paper-w4385255487","cat":"papers","name":"Supplementary Figure S18 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385255487","eid":"W4385255487"},{"id":"paper-w4385364762","cat":"papers","name":"Supplementary Table S5 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385364762","eid":"W4385364762"},{"id":"paper-w4402818687","cat":"papers","name":"Supplementary Figure S8 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2024","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4402818687","eid":"W4402818687"},{"id":"paper-w2323913162","cat":"papers","name":"Book Review: I. Books by the Faculty: The Holy Spirit in Five Worlds: The Psychedelic, the Nonverbal, the Articulate, the New Morality, the Administrative","year":"1969","cit":0,"pfa":"James N. Lapsley","topics":["Reviews & meta-analyses"],"ptype":"book-review","src":"https://openalex.org/W2323913162","eid":"W2323913162"},{"id":"paper-w4414783240","cat":"papers","name":"Cross-species mapping of psychedelic gene expression reveals links to the 5HT2A receptor, cortical layers, and human accelerated regions","year":"2025","cit":0,"pfa":"Patrick McConnell","psa":"Lorenzo Pasquini","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4414783240","eid":"W4414783240"},{"id":"paper-w7128022605","cat":"papers","name":"Additional file 1 of Practitioner perspectives on extended difficulties and optimal support strategies following psychedelic experiences: a qualitative analysis","year":"2026","cit":0,"pfa":"E. K. Argyri","psa":"C. J. A. Morgan","ptype":"dataset","src":"https://openalex.org/W7128022605","eid":"W7128022605"},{"id":"paper-w4361921705","cat":"papers","name":"Supplementary Figure 5 from Tumor-Specific Uptake of Fluorescent Bevacizumab–IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feasibility Study","year":"2023","cit":0,"pfa":"Laetitia E. Lamberts","psa":"Gooitzen M. van Dam","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4361921705","eid":"W4361921705"},{"id":"paper-w4413834837","cat":"papers","name":"\"Bionic Bodies — Exploring 'Moist Media' at the Intersection of Psychedelic States, Technology and Queer Perspectives through Print Media Practises\"","year":"2025","cit":0,"pfa":"Kelby Paquette-Anderson","topics":["Therapy practice"],"ptype":"conference-paper","src":"https://openalex.org/W4413834837","eid":"W4413834837"},{"id":"paper-w4390653778","cat":"papers","name":"A psychedelic substance 2,5-dimethoxy-4-iodoamphetamine induces impairments in spatial short-term memory and retrieval and mood in mice","year":"2023","cit":0,"pfa":"Junichi Kitanaka","psa":"Nobuyoshi Nishiyama","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4390653778","eid":"W4390653778"},{"id":"paper-w7170107561","cat":"papers","name":"Supplementary material from \"Measuring the contents of hallucinations from psychedelics and stroboscopic light: the six-dimensional visual hallucination questionnaire\"","year":"2026","cit":0,"pfa":"Trevor Hewitt","psa":"David Schwartzman","topics":["Mechanism & neuroscience"],"ptype":"supplementary-materials","src":"https://openalex.org/W7170107561","eid":"W7170107561"},{"id":"paper-w1987554081","cat":"papers","name":"TH-E-217A-01: Philips Microdose Mammography - the Technology and Physics Behind the First FDA Approved Photon Counting X-Ray Imaging System","year":"2012","cit":0,"pfa":"Mats E. Danielsson","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1987554081","eid":"W1987554081"},{"id":"paper-w4391367170","cat":"papers","name":"Psychedelic Refugee: The League for Spiritual Discovery, the 1960s Cultural Revolution, and 23 Years on the Run by Rosemary Woodruff Leary (review)","year":"2023","cit":0,"pfa":"Devin R. Lander","topics":["Addiction","Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4391367170","eid":"W4391367170"},{"id":"paper-w4415427359","cat":"papers","name":"Corrigendum to: Pictorial representation of illness and self measure (PRISM): A putative transdiagnostic tool for evaluating therapeutic effects of psychedelic treatments","year":"2025","cit":0,"ptype":"erratum","src":"https://openalex.org/W4415427359","eid":"W4415427359"},{"id":"paper-w7160777327","cat":"papers","name":"Mind-Wandering Partially Mediates the Relationship Between Psychedelic Use and Enhanced Cognitive Flexibility: An Online Survey in University Students","year":"2026","cit":0,"pfa":"Stefanie Todesco","psa":"Christian G. Schütz","ptype":"article","src":"https://openalex.org/W7160777327","eid":"W7160777327"},{"id":"paper-w4385258483","cat":"papers","name":"Supplementary Figure S11 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385258483","eid":"W4385258483"},{"id":"paper-w4385302599","cat":"papers","name":"Supplementary Figure S8 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385302599","eid":"W4385302599"},{"id":"paper-w4386776133","cat":"papers","name":"Supplementary Figure S13 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4386776133","eid":"W4386776133"},{"id":"paper-w4386776554","cat":"papers","name":"Supplementary Table S3 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4386776554","eid":"W4386776554"},{"id":"paper-w4361921557","cat":"papers","name":"Supplemental Material and Methods from Tumor-Specific Uptake of Fluorescent Bevacizumab–IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feasibility Study","year":"2023","cit":0,"pfa":"Laetitia E. Lamberts","psa":"Gooitzen M. van Dam","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4361921557","eid":"W4361921557"},{"id":"paper-w2102880426","cat":"papers","name":"Book Review: Fred Turner, The Democratic Surround: Multimedia & American Liberalism from World War II to the Psychedelic Sixties","year":"2015","cit":0,"pfa":"Carolyn L. Kane","topics":["Reviews & meta-analyses"],"ptype":"book-review","src":"https://openalex.org/W2102880426","eid":"W2102880426"},{"id":"paper-w4241237663","cat":"papers","name":"Perception of acoustic frequencies in (Ab) users and non-users of psychedelics: a cross-sectional analytic study via the surface web","year":"2018","cit":0,"ptype":"article","src":"https://openalex.org/W4241237663","eid":"W4241237663"},{"id":"paper-w7212332535","cat":"papers","name":"Perceived Quality-of-Life Impact of Psychedelic Experiences and Its Predictors Across Four Harmonized Enthusiast- and Platform-Recruited Samples","year":"2026","cit":0,"pfa":"Jonathan Bendz","topics":["Safety & adverse events"],"ptype":"other","src":"https://openalex.org/W7212332535","eid":"W7212332535"},{"id":"paper-w2411891485","cat":"papers","name":"[Apropos of 2 cases of idiopathic thrombopenic purpura treated by microdoses of P32 after failure of classical therapeutics. Transient thrombocytogenic effects of weak radioactive doses].","year":"1967","cit":0,"pfa":"P Croizat","psa":"PA Bryon","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2411891485","eid":"W2411891485"},{"id":"paper-w574318987","cat":"papers","name":"(1)フォトンカウンティング技術を用いたマンモグラフィ撮影装置 : MicroDose Mammography(技術紹介)","year":"2012","cit":0,"pfa":"純子 藤田","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W574318987","eid":"W574318987"},{"id":"paper-w4231479763","cat":"papers","name":"Abstract 4136: Direct intratumoral microdosing via the CIVO® platform reveals anti-tumor immune responses induced by the SUMO inhibitor TAK-981","year":"2019","cit":0,"pfa":"Beryl A. Hatton","psa":"Richard A. Klinghoffer","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W4231479763","eid":"W4231479763"},{"id":"paper-w4413605267","cat":"papers","name":"Drugs and religion have been a potent combination for millennia, from cannabis at ancient funerary sites to psychedelic retreats today","year":"2023","cit":0,"pfa":"Gary Laderman","ptype":"other","src":"https://openalex.org/W4413605267","eid":"W4413605267"},{"id":"paper-w4408070935","cat":"papers","name":"Modélisation de la pharmacocinétique sur corps entier (WBPK) de microdose du glyburide radiomarqué (11C-glyburide) chez des volontaires sains","year":"2025","cit":0,"pfa":"Léa Comin","psa":"Emmanuelle Comets","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4408070935","eid":"W4408070935"},{"id":"paper-w4385302600","cat":"papers","name":"Supplementary Figure S19 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385302600","eid":"W4385302600"},{"id":"paper-w7123838969","cat":"papers","name":"Reviewer #2 (Public review): The oneirogen hypothesis: modeling the hallucinatory effects of classical psychedelics in terms of replay-dependent plasticity mechanisms","year":"2026","cit":0,"pfa":"Colin Bredenberg","psa":"Guillaume Lajoie","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"peer-review","src":"https://openalex.org/W7123838969","eid":"W7123838969"},{"id":"paper-w4407620562","cat":"papers","name":"Meditation and psychedelics facilitate similar types of mystical, psychological, and philosophical-existential insights predictive of wellbeing: A qualitative-quantitative approach","year":"2025","cit":0,"pfa":"Jussi Jylkkä","topics":["Addiction","Anxiety & end-of-life","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4407620562","eid":"W4407620562"},{"id":"paper-w7166439873","cat":"papers","name":"Psychedelic Integration and Subjectivity: A Critical Scoping Review Protocol of Governance and Meaning Making Across Diverse Institutional and Cultural Logics","year":"2026","cit":0,"pfa":"Hannah van Dijken","psa":"Riccardo Miceli McMillan","topics":["Safety & adverse events","Reviews & meta-analyses","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7166439873","eid":"W7166439873"},{"id":"paper-w7130320161","cat":"papers","name":"PSEUDO MIND-EXPANSION THROUGH PSYCHEDELICS AND BRAINWAVE-PROGRAMMING VERSUS TRUE MIND-EXPANSION THROUGH LIFE CONDITIONING TO THE ABSOLUTE","year":"1971","cit":0,"pfa":"Albin R. Gilbert","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7130320161","eid":"W7130320161"},{"id":"paper-w4392410683","cat":"papers","name":"The Relationship Between Changes in Mindfulness and Subsequent Changes in Well-Being Following Psychedelic Use: Prospective Cohort Study (Preprint)","year":"2023","cit":0,"pfa":"Grant M. Jones","psa":"Hannes Kettner","ptype":"preprint","src":"https://openalex.org/W4392410683","eid":"W4392410683"},{"id":"paper-w2402399946","cat":"papers","name":"The discriminative stimulus properties of psychotomimetics and antipsychotics.","year":"2000","cit":0,"pfa":"Smith Ja","ptype":"dissertation","src":"https://openalex.org/W2402399946","eid":"W2402399946"},{"id":"paper-w4361921974","cat":"papers","name":"Supplementary Figure 3 from Tumor-Specific Uptake of Fluorescent Bevacizumab–IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feasibility Study","year":"2023","cit":0,"pfa":"Laetitia E. Lamberts","psa":"Gooitzen M. van Dam","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4361921974","eid":"W4361921974"},{"id":"paper-w4362400916","cat":"papers","name":"Supplementary Figure 2 from Tumor-Specific Uptake of Fluorescent Bevacizumab–IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feasibility Study","year":"2023","cit":0,"pfa":"Laetitia E. Lamberts","psa":"Gooitzen M. van Dam","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4362400916","eid":"W4362400916"},{"id":"paper-w3204937539","cat":"papers","name":"Drugs and Mental Disorder: The Hallucinogens . A. Hoffer and H. Osmond, with a contribution by T. Weckowicz. Academic Press, New York, 1967. x + 626 pp., illus. $25.","year":"1968","cit":0,"pfa":"Murray E. Jarvik","ptype":"book-review","src":"https://openalex.org/W3204937539","eid":"W3204937539"},{"id":"paper-w4385302657","cat":"papers","name":"Supplementary Table S1 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385302657","eid":"W4385302657"},{"id":"paper-w4385363029","cat":"papers","name":"Supplementary Figure S11 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2023","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4385363029","eid":"W4385363029"},{"id":"paper-w4402787981","cat":"papers","name":"Supplementary Figure S3 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2024","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4402787981","eid":"W4402787981"},{"id":"paper-w4402789196","cat":"papers","name":"Supplementary Table S3 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2024","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4402789196","eid":"W4402789196"},{"id":"paper-w4402789694","cat":"papers","name":"Supplementary Figure S15 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2024","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4402789694","eid":"W4402789694"},{"id":"paper-w4402800193","cat":"papers","name":"Supplementary Figure S3 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2024","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4402800193","eid":"W4402800193"},{"id":"paper-w4416629649","cat":"papers","name":"Supplementary Figure S4 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment","year":"2025","cit":0,"pfa":"Jonathan M.J. Derry","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4416629649","eid":"W4416629649"},{"id":"paper-w4405922765","cat":"papers","name":"The Next Wave of Legal Drug Production: What the Psychedelics Legalization Movement Can Learn From a Decade of Cannabis Regulation","year":"2024","cit":0,"pfa":"Ryan B. Stoa","topics":["Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4405922765","eid":"W4405922765"},{"id":"paper-w3019434760","cat":"papers","name":"Human lung cancer risks from radon: Evidence of influence from bystander and adaptive response effects on radon case-control studies-A microdose analysis","year":"2011","cit":0,"pfa":"Bobby E. Leonard","psa":"Richard E. Thompson","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3019434760","eid":"W3019434760"},{"id":"paper-w4282975613","cat":"papers","name":"Abstract 3424: Deep mechanistic profiling of immune oncology (I-O) drug combinations in cancer patients with CIVO® intratumoral microdosing and NanoString GeoMx DSP","year":"2022","cit":0,"pfa":"Jason P. Frazier","psa":"Jonathan M.J. Derry","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W4282975613","eid":"W4282975613"},{"id":"paper-w2173961943","cat":"papers","name":"Psychedelics: The Uses and Implications of Hallucinogenic Drugs. By Bernard Aaronson and Humphry Osmond. Hogarth Press Ltd. Pp. 512. Price £3.15.","year":"1971","cit":0,"pfa":"Griffith Edwards","ptype":"book-review","src":"https://openalex.org/W2173961943","eid":"W2173961943"},{"id":"paper-w2921747647","cat":"papers","name":"Improvement in first uninterrupted sleep period and quality of life after treatment with AV002, an emulsified microdose desmopressin nasal spray, in patients with overactive bladder and nocturnal polyuria","year":"2019","cit":0,"pfa":"Alan J. Wein","psa":"Roger Roman Dmochowski","topics":["Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W2921747647","eid":"W2921747647"},{"id":"paper-w4393356589","cat":"papers","name":"How does psychedelic use relate to aspects of religiosity/spirituality? Results from a birth cohort study and a prospective longitudinal study","year":"2024","cit":0,"pfa":"Aaron D. Cherniak","psa":"Pehr Granqvist","topics":["Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4393356589","eid":"W4393356589"},{"id":"paper-w4411087759","cat":"papers","name":"Reviewer #1 (Public review): The oneirogen hypothesis: modeling the hallucinatory effects of classical psychedelics in terms of replay-dependent plasticity mechanisms","year":"2025","cit":0,"pfa":"Colin Bredenberg","psa":"Guillaume Lajoie","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"peer-review","src":"https://openalex.org/W4411087759","eid":"W4411087759"},{"id":"paper-w7168290119","cat":"papers","name":"Corrigendum to “Health-related behavioral changes following the use of psychedelics in naturalistic settings” [Prevent. Med. Rep. 56 (2025) 103161]","year":"2026","cit":0,"pfa":"Pedro J. Teixeira","psa":"Charles L. Raison","ptype":"erratum","src":"https://openalex.org/W7168290119","eid":"W7168290119"},{"id":"paper-w4413613629","cat":"papers","name":"Psychedelic drug DMT and near death experiences have long been linked – my study is the first to explore the connection in depth","year":"2025","cit":0,"pfa":"Pascal Michael","ptype":"other","src":"https://openalex.org/W4413613629","eid":"W4413613629"},{"id":"paper-w4362401223","cat":"papers","name":"Supplementary Figure 5 from Tumor-Specific Uptake of Fluorescent Bevacizumab–IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feasibility Study","year":"2023","cit":0,"pfa":"Laetitia E. Lamberts","psa":"Gooitzen M. van Dam","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4362401223","eid":"W4362401223"},{"id":"paper-w2889237914","cat":"papers","name":"Central nervous system stimulants and psychotomimetics","year":"2010","cit":0,"pfa":"Arvind Panwar","ptype":"book-chapter","src":"https://openalex.org/W2889237914","eid":"W2889237914"},{"id":"paper-w4361921754","cat":"papers","name":"Supplementary Figure 1 from Tumor-Specific Uptake of Fluorescent Bevacizumab–IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feasibility Study","year":"2023","cit":0,"pfa":"Laetitia E. Lamberts","psa":"Gooitzen M. van Dam","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4361921754","eid":"W4361921754"},{"id":"paper-w4403164568","cat":"papers","name":"4.1 Psychedelics and Psychosis Risk in Transitional-Age Youth (TAY): Efforts Toward Evidence-Based Clinical Practice and Policy Development","year":"2024","cit":0,"pfa":"Hyun Jung Kim","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4403164568","eid":"W4403164568"},{"id":"paper-w4362401295","cat":"papers","name":"Supplementary Figure 3 from Tumor-Specific Uptake of Fluorescent Bevacizumab–IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feasibility Study","year":"2023","cit":0,"pfa":"Laetitia E. Lamberts","psa":"Gooitzen M. van Dam","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4362401295","eid":"W4362401295"},{"id":"paper-w4362401285","cat":"papers","name":"Supplementary Figure 4 from Tumor-Specific Uptake of Fluorescent Bevacizumab–IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feasibility Study","year":"2023","cit":0,"pfa":"Laetitia E. Lamberts","psa":"Gooitzen M. van Dam","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4362401285","eid":"W4362401285"},{"id":"paper-w3203306646","cat":"papers","name":"Ego Death lsd: The New Phenomenon of Splintering During lsd and other Psychedelic Trips by Dr. Vladimir Kissinger Pharmacology & Toxicology","year":"2019","cit":0,"pfa":"Vladimir Kissinger","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3203306646","eid":"W3203306646"},{"id":"paper-w3111192519","cat":"papers","name":"Combined treatment with the microdose lithium formulation NP03 and S‐adenosylmethionine reduces cognitive decline and Alzheimer’s‐like amyloid pathology in Mcgill‐R‐Thy1‐APP rats","year":"2020","cit":0,"pfa":"Sonia Do Carmo","psa":"A. Claudio Cuello","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3111192519","eid":"W3111192519"},{"id":"paper-w2111827602","cat":"papers","name":"A retrospective comparison of microdose follicular phase and luteal phase gonadotropin releasing hormone agonist (GnRH-a) suppression for in vitro fertilization in patients 30 years old and younger","year":"2007","cit":0,"pfa":"Eric D. Levens","psa":"Frederick W. Larsen","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2111827602","eid":"W2111827602"},{"id":"paper-w7113019729","cat":"papers","name":"It’s a Kind of Magic’: Exploring Multisensory Modulation of the Sense of Self Through Bodily Movements and Action Observation in Depersonalisation and Psychedelic Experiences","year":"2024","cit":0,"pfa":"Simon Knogler","psa":"Liberty Severs","ptype":"preprint","src":"https://openalex.org/W7113019729","eid":"W7113019729"},{"id":"paper-w7112209596","cat":"papers","name":"On the potential benefits of shared psychedelic experiences: Romantic dyads’ co-use and shared understanding are associated with positive long-term changes","year":"2024","cit":0,"pfa":"Tommaso Barba","psa":"Arlen Moller","ptype":"preprint","src":"https://openalex.org/W7112209596","eid":"W7112209596"},{"id":"paper-w7148565243","cat":"papers","name":"Micro-Dosing Psychedelics and Creative Problem-Solving: A Comprehensive Umbrella Review and Theoretical Integration [SCIENTIFIC V7.0 - Q1 HIGH-IMPACT]","year":"2026","cit":0,"pfa":"Juan Moises de la Serna","topics":["Dosing & pharmacology","Reviews & meta-analyses","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7148565243","eid":"W7148565243"},{"id":"paper-w4362400763","cat":"papers","name":"Supplementary Figure 7 from Tumor-Specific Uptake of Fluorescent Bevacizumab–IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feasibility Study","year":"2023","cit":0,"pfa":"Laetitia E. Lamberts","psa":"Gooitzen M. van Dam","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4362400763","eid":"W4362400763"},{"id":"paper-w4411087760","cat":"papers","name":"Reviewer #2 (Public review): The oneirogen hypothesis: modeling the hallucinatory effects of classical psychedelics in terms of replay-dependent plasticity mechanisms","year":"2025","cit":0,"pfa":"Colin Bredenberg","psa":"Guillaume Lajoie","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"peer-review","src":"https://openalex.org/W4411087760","eid":"W4411087760"},{"id":"paper-w2329704054","cat":"papers","name":"The New Psychedelic Culture: LSD, Ecstasy, \"Rave\" Parties and The Grateful Dead Someaccounts suggest thatdrugusefacilitates entrytoan otherwise unavailable spiritualworld.","year":"1994","cit":0,"pfa":"Robert B. Millman","psa":"Ann Bordwine Beeder","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W2329704054","eid":"W2329704054"},{"id":"paper-w7211901867","cat":"papers","name":"Author response for \"Measuring the Contents of Hallucinations from Psychedelics and Stroboscopic Light: The Six-Dimensional Visual Hallucination Questionnaire (6D-VHQ)\"","year":"2026","cit":0,"pfa":"Trevor Hewitt","psa":"David Schwartzman","ptype":"peer-review","src":"https://openalex.org/W7211901867","eid":"W7211901867"},{"id":"paper-w7202248626","cat":"papers","name":"Highlighting the legacy of a psychedelic harm reduction pioneer: Assessing contemporary agreement with advice in Lisa Bieberman’s 1967 “Session Games” manual","year":"2026","cit":0,"pfa":"Daniel J. Kruger","psa":"Kevin F. Boehnke","topics":["Safety & adverse events","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7202248626","eid":"W7202248626"},{"id":"paper-w2900665507","cat":"papers","name":"How to Change Your Mind: What the New Science of Psychedelics Teaches Us about Consciousness, Dying, Addiction, Depression, and Transcendence.","year":"2018","cit":0,"pfa":"Andrea Gawrylewski","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W2900665507","eid":"W2900665507"},{"id":"paper-w7214358681","cat":"papers","name":"Effects of microdosed versus traditionally dosed plyometric jump training on physical fitness in pre-peak height velocity male soccer players: A randomized comparative trial","year":"2026","cit":0,"pfa":"Yassine Negra","psa":"Hélmi Chaabène","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7214358681","eid":"W7214358681"},{"id":"paper-w7148449408","cat":"papers","name":"Micro-Dosing Psychedelics and Creative Problem-Solving: A Comprehensive Umbrella Review and Theoretical Integration [SCIENTIFIC V7.0 - Q1 HIGH-IMPACT]","year":"2026","cit":0,"pfa":"Juan Moises de la Serna","topics":["Dosing & pharmacology","Reviews & meta-analyses","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7148449408","eid":"W7148449408"},{"id":"paper-w4361922432","cat":"papers","name":"Supplementary Figure 6 from Tumor-Specific Uptake of Fluorescent Bevacizumab–IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feasibility Study","year":"2023","cit":0,"pfa":"Laetitia E. Lamberts","psa":"Gooitzen M. van Dam","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4361922432","eid":"W4361922432"},{"id":"paper-w7211894554","cat":"papers","name":"Decision letter for \"Measuring the Contents of Hallucinations from Psychedelics and Stroboscopic Light: The Six-Dimensional Visual Hallucination Questionnaire (6D-VHQ)\"","year":"2026","cit":0,"ptype":"peer-review","src":"https://openalex.org/W7211894554","eid":"W7211894554"},{"id":"paper-w2080235396","cat":"papers","name":"Follicular flare response does not predict in vitro fertilization (IVF) success in poor responders undergoing controlled ovarian hyperstimulation (COH) using microdose leuprolide (MDL)","year":"2008","cit":0,"pfa":"J. Salas","psa":"JOHN C. NULSEN","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2080235396","eid":"W2080235396"},{"id":"paper-w2042652282","cat":"papers","name":"A flexible multi-dose GnRH antagonist versus a microdose flare-up GnRH agonist combined with a flexible multidose GnRH antagonist protocol in poor responders to IVF","year":"2013","cit":0,"pfa":"M. Erman Akar","psa":"H. Komurcu","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2042652282","eid":"W2042652282"},{"id":"paper-w7211883380","cat":"papers","name":"Decision letter for \"Measuring the Contents of Hallucinations from Psychedelics and Stroboscopic Light: The Six-Dimensional Visual Hallucination Questionnaire (6D-VHQ)\"","year":"2026","cit":0,"ptype":"peer-review","src":"https://openalex.org/W7211883380","eid":"W7211883380"},{"id":"paper-w7204646122","cat":"papers","name":"Endogenous honeycomb stone arrangements reduce soil erosion, improve soil moisture, and sorghum productivity under fertilizer microdosing on steep lands of Boukombé in northwestern Benin","year":"2026","cit":0,"pfa":"Romaric Serge Lokossou","psa":"Nasser Mohamed Baco","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7204646122","eid":"W7204646122"},{"id":"paper-w7123658467","cat":"papers","name":"Reviewer #1 (Public review): The oneirogen hypothesis: modeling the hallucinatory effects of classical psychedelics in terms of replay-dependent plasticity mechanisms","year":"2026","cit":0,"pfa":"Colin Bredenberg","psa":"Guillaume Lajoie","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"peer-review","src":"https://openalex.org/W7123658467","eid":"W7123658467"},{"id":"paper-w2995157544","cat":"papers","name":"Efeitos de uma Microdose (300μg/dia) de THC para tratamento de sindrome espástica pós traumatismo cranioencefalico: um estudo de caso","year":"2019","cit":0,"pfa":"Élton Gomes da Silva","psa":"Rafael de Morais Cury","topics":["PTSD & trauma","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2995157544","eid":"W2995157544"},{"id":"paper-w7116952700","cat":"papers","name":"Supplementary Information to the Letter to the Editor “Prevalence and predictors of sexual and physical violence during psychedelic use in a US population-based study”","year":"2025","cit":0,"pfa":"Jason B. Luoma","psa":"Karilynn M. Rockhill","ptype":"preprint","src":"https://openalex.org/W7116952700","eid":"W7116952700"},{"id":"paper-w7115983189","cat":"papers","name":"Decentralized Energy and the Psychedelic AI: Universal Timeframes Create Longitudinal Feedback Loops Which Collapse the Destructive Capacity of Artificial Intelligence","cit":0,"pfa":"Sachs, Julio Andres","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7115983189","eid":"W7115983189"},{"id":"paper-w4362401294","cat":"papers","name":"Supplementary Figure 1 from Tumor-Specific Uptake of Fluorescent Bevacizumab–IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feasibility Study","year":"2023","cit":0,"pfa":"Laetitia E. Lamberts","psa":"Gooitzen M. van Dam","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4362401294","eid":"W4362401294"},{"id":"paper-w7215516421","cat":"papers","name":"Connaissance et adoption de la fertilisation microdose dans les systèmes de culture à base de maïs au Nord-Bénin","year":"2023","cit":0,"pfa":"O'Neil TAKPA","psa":"Pierre Gbènoukpo  Tovihoudji","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7215516421","eid":"W7215516421"},{"id":"paper-w4253610025","cat":"papers","name":"Abstracts and Reviews : HALLUCINOGENS AND CULTURE by PETER T. FURST. San Francisco: Chandler & Sharp Publishers, Inc., 1976. 194 pp. $8.75. Reviewed by William Emboden","year":"1978","cit":0,"topics":["Reviews & meta-analyses"],"ptype":"conference-abstract","src":"https://openalex.org/W4253610025","eid":"W4253610025"},{"id":"paper-w7213517298","cat":"papers","name":"How does microdosed (high-frequency, low volume) training compared to traditional (lower-frequency, high volume) training effect on neuromuscular performance in team sport athletes","year":"2026","cit":0,"pfa":"Ibrahim Sahib Mohamed Sashan","psa":"Elena Marín‐Cascales","topics":["Dosing & pharmacology","Reviews & meta-analyses","Therapy practice"],"ptype":"other","src":"https://openalex.org/W7213517298","eid":"W7213517298"},{"id":"paper-w7163918467","cat":"papers","name":"MFCC–DFT mapping of ligand recognition at the 5-HT 2A receptor: energetic analysis of the interactions between serotonin, psychedelics, and antipsychotics","year":"2026","cit":0,"pfa":"W. S. Clemente","psa":"Umberto Laino Fulco","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7163918467","eid":"W7163918467"},{"id":"paper-w3180880471","cat":"papers","name":"Studi fenomenologi: pengalaman ibu merawat remaja pengguna napza stimulan dan halusinogen = Phenomenology study: the experience of mothers caring for adolescent drug users stimulant and hallucinogen","year":"2017","cit":0,"pfa":"Wahyudi Mulyaningrat","psa":"examiner Evin Novianti","ptype":"article","src":"https://openalex.org/W3180880471","eid":"W3180880471"},{"id":"paper-w7214090904","cat":"papers","name":"Evaluation of different mineral fertilizer microdosing options to optimize the productivity of Pearl millet hybrids (Pennisetum glaucum (L.) R. Br.) in the central groundnut basin of Senegal","year":"2026","cit":0,"pfa":"Malick Ndiaye","psa":"Nathalie Diagne","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7214090904","eid":"W7214090904"},{"id":"paper-w2530942613","cat":"papers","name":"Live birth in a 46‐year‐old woman using microdose Gn RH agonist flare‐up protocol combined with Gn RH antagonist: a case report","year":"2016","cit":0,"pfa":"Hong Zhang","psa":"Fei Gong","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2530942613","eid":"W2530942613"},{"id":"paper-w7135931039","cat":"papers","name":"Comparison of NDE and Similar Experiences from LSD, DMT and Ketamine Psychedelic Session and its Contextualization with Another Experineces in Monomythical Point of View","year":"2011","cit":0,"pfa":"Michal Grus","ptype":"dissertation","src":"https://openalex.org/W7135931039","eid":"W7135931039"},{"id":"paper-w3181173565","cat":"papers","name":"Abstract 1311: PET-MRI microdosing can determine the delivery of the experimental cancer therapeutic, MN-anti-miR10b, to metastatic lesions in a murine model of breast cancer","year":"2021","cit":0,"pfa":"Marianne Le Fur","psa":"Zdravka O. Medarova","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W3181173565","eid":"W3181173565"},{"id":"paper-w7135379708","cat":"papers","name":"Somatic Intelligence, Neurochemical Pathway Development, and the Sequential Activation of Consciousness: A Unified Framework Bridging Vedantic Philosophy, Modern Neuroscience, and Psychedelic Research","year":"2026","cit":0,"pfa":"Utsav Shaw","ptype":"article","src":"https://openalex.org/W7135379708","eid":"W7135379708"},{"id":"paper-w4405661050","cat":"papers","name":"Detection of Psychotomimetic Drugs in Beverages and Food","year":"2024","cit":0,"pfa":"Gopavaram Sumanth","psa":"Sandeep Chandrashekharappa","topics":["Safety & adverse events","Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W4405661050","eid":"W4405661050"},{"id":"paper-w2312051815","cat":"papers","name":"ASSESSING THE TEENAGERS' LEVEL OF AWARENESS TOWARD THE MAIN RESIDUES OF PSYCHEDELIC PILLS (CASE OF STUDY: HIGH SCHOOL STUDENTS OF TEHRAN, DISTRICT 9)","year":"2011","cit":0,"pfa":"Gholamreza Latifi","psa":"Maryam Jamshidi","ptype":"article","src":"https://openalex.org/W2312051815","eid":"W2312051815"},{"id":"paper-w7170190008","cat":"papers","name":"Psychedelic-occasioned mystical experience as a candidate operationalization of the spiritual dimension of osteopathic care, with application to body dysmorphic disorder: a scoping review protocol","year":"2026","cit":0,"pfa":"Numan Ahmad","topics":["Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7170190008","eid":"W7170190008"},{"id":"paper-w2317678146","cat":"papers","name":"ChemInform Abstract: ASYMMETRIC SYNTHESIS OF PSYCHOTOMIMETIC PHENYLISOPROPYLAMINES","year":"1973","cit":0,"pfa":"David E. Nichols","psa":"Richard D. Morin","ptype":"article","src":"https://openalex.org/W2317678146","eid":"W2317678146"},{"id":"paper-w7139994692","cat":"papers","name":"Are We Walking in Shoes Too Small? An Enquiry Into How Psychedelic Experiences Relate to Kierkegaard’s Analyses of the Self and Despair, and Their Relevance to Existential Psychotherapy","year":"2019","cit":0,"pfa":"Sina Sarikhani","topics":["Anxiety & end-of-life","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7139994692","eid":"W7139994692"},{"id":"paper-w4408932548","cat":"papers","name":"A Resource-Enabled Framework for Individualized Patient / Provider Risk Management Discussions Regarding Psychedelic and Empathogen Drug Interactions (Abstract ID: 157631)","year":"2025","cit":0,"pfa":"Cody J. Wenthur","psa":"Joseph R. Nerad","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4408932548","eid":"W4408932548"},{"id":"paper-w4407068638","cat":"papers","name":"“If You Go in With a Plan and a Goal, It Can Be Therapeutic”: A Qualitative Exploration of Psychedelic Use Among Emerging Adult Cannabis Users in Los Angeles","year":"2025","cit":0,"pfa":"Bridgid Mariko Conn","psa":"Carolyn F. Wong","ptype":"article","src":"https://openalex.org/W4407068638","eid":"W4407068638"},{"id":"paper-w7139403621","cat":"papers","name":"From reptiles to queerosauruses : psychedelic relations with the world in the practice of performing and visual arts (excerpt from the Polish cultural history of drug addiction)","year":"2023","cit":0,"pfa":"Łucja Iwanczewska","topics":["Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W7139403621","eid":"W7139403621"},{"id":"paper-w2432989302","cat":"papers","name":"[The use of psychedelic agents in psychotherapy (apropos the article by Iu. P. Sivolap and V. A. Savchenkov \"Experience in using ketamine preparations in the psychotherapy of alcoholism\")].","year":"1996","cit":0,"pfa":"E M Krupitskiĭ","psa":"A Ia Grinenko","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2432989302","eid":"W2432989302"},{"id":"paper-w2145187551","cat":"papers","name":"[Comparative study of 4 microdose progestagen - only non-stop oral contraceptives (lynestrenol, D-norgestrel, norethisterone acetate, norgestrienone) on 483 women and 4358 cycles)].","year":"1976","cit":0,"pfa":"Soutoul Jh","psa":"J Bertrand","topics":["Safety & adverse events","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2145187551","eid":"W2145187551"},{"id":"paper-w2085478788","cat":"papers","name":"Maximizing outcomes for poor responders to controlled ovarian hyperstimulation (COH) in IVF: the use of microdose flare GnRH agonist induction to gonadotropin stimulation in women with previous IVF failure.","year":"2001","cit":0,"pfa":"Alice G. Mark","psa":"Catherine Racowsky","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2085478788","eid":"W2085478788"},{"id":"paper-w7119465511","cat":"papers","name":"In vivo and in vitro toxicokinetics including metabolism, isozyme mapping, and monoamine oxidase inhibition of three (2-aminopropyl)benzo[b]thiophene (APBT) psychedelics","year":"2026","cit":0,"pfa":"Lea Wagmann","psa":"Markus R. Meyer","ptype":"article","src":"https://openalex.org/W7119465511","eid":"W7119465511"},{"id":"paper-w7202089176","cat":"papers","name":"Supplemental Material for A Contemporary Exploration of Motivations and Practices of Psychedelic Use Among Emerging Adult Cannabis Users in the United States: A Qualitative Analysis","year":"2026","cit":0,"ptype":"supplementary-materials","src":"https://openalex.org/W7202089176","eid":"W7202089176"},{"id":"paper-w7155612441","cat":"papers","name":"369. Younger Age of First Use of Serotonergic Psychedelics is Associated With Greater Risk of Persisting Visual Alterations, Mediated by Reduced Visual Threshold","year":"2026","cit":0,"pfa":"Maximillian S. Greenwald","psa":"Albert R. Powers","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7155612441","eid":"W7155612441"},{"id":"paper-w2949937385","cat":"papers","name":"ChemInform Abstract: SULFUR ANALOGS OF PSYCHOTOMIMETIC AMINES","year":"1977","cit":0,"pfa":"David E. Nichols","psa":"Alexander T. Shulgin","ptype":"article","src":"https://openalex.org/W2949937385","eid":"W2949937385"},{"id":"paper-w4409690603","cat":"papers","name":"Abstract 676: First in man microdose trial of [68Ga]Ga-R54, CXCR4 targeted PET tracer: Comparison with [18F]-FDG and proof of concept in lung cancer models","year":"2025","cit":0,"pfa":"Anna Maria Trotta","psa":"Stefania Scala","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W4409690603","eid":"W4409690603"},{"id":"paper-w7204188402","cat":"papers","name":"Effets combinés de l’inoculations microbienne et des microdoses de phosphore sur croissance et le rendement du haricot mungo (Vigna radiata L.)","year":"2026","cit":0,"pfa":"Souleymane Sanogo","psa":"Fatoumata Touré","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7204188402","eid":"W7204188402"},{"id":"paper-w2101804141","cat":"papers","name":"Dependence-Producing Liability of LSD and Similar Psychotomimetics","year":"1982","cit":0,"pfa":"Alan D. Poling","psa":"J. B. Appel","ptype":"book-chapter","src":"https://openalex.org/W2101804141","eid":"W2101804141"},{"id":"paper-w7117959728","cat":"papers","name":"Do psychedelics promote prosocial helping behavior? A randomized controlled study of sustained prosocial effects after serotonergic stimulation in healthy adults","year":"2026","cit":0,"pfa":"L. Belinger","psa":"K.H. Preller","ptype":"article","src":"https://openalex.org/W7117959728","eid":"W7117959728"},{"id":"paper-w2801175305","cat":"papers","name":"Review: Altered States: Buddhism and Psychedelic Spirituality in America by Douglas Osto and Sacred Bliss: A Spiritual History of Cannabis by Mark S. Ferrara","year":"2018","cit":0,"pfa":"Chris Elcock","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2801175305","eid":"W2801175305"},{"id":"paper-w4417112006","cat":"papers","name":"Association between lifetime co-use of classic psychedelics and cannabis and prostate cancer diagnosis among US adults 50 years and older","year":"2025","cit":0,"pfa":"Amrit Baral","psa":"Denise Christina Vidot","topics":["Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4417112006","eid":"W4417112006"},{"id":"paper-w4297576792","cat":"papers","name":"BZ (3-quinuclidinyl benzilate) a psychotomimetic agent","year":"2022","cit":0,"pfa":"Omid Mehrpour","psa":"Samaneh Nakhaee","ptype":"reference-entry","src":"https://openalex.org/W4297576792","eid":"W4297576792"},{"id":"paper-w4244008509","cat":"papers","name":"A Safety and Pharmacokinetic Study of AG-881 in Healthy Male Participants Following Administration of a Single Oral Dose of [14C] AG-881 and Concomitant Intravenous Microdose of [13C315N3] AG-881","year":"2019","cit":0,"topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4244008509","eid":"W4244008509"},{"id":"paper-w4289306381","cat":"papers","name":"The psychotomimetic ketamine abolishes thalamocortical spindle-like oscillations","year":"2018","cit":0,"pfa":"Didier Pinault","psa":"Stefan Rotter","ptype":"conference-paper","src":"https://openalex.org/W4289306381","eid":"W4289306381"},{"id":"paper-w7204792702","cat":"papers","name":"A Multidisciplinary Therapeutic Framework for Neuropsychiatric, Neurological and Functional Disorders, Encompassing Psychedelic, Pharmaceutical, Botanical and Nutraceutical Interventions, Delivery Systems and Lifestyle M","year":"2026","cit":0,"pfa":"Richard Clark Kaufman","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"preprint","src":"https://openalex.org/W7204792702","eid":"W7204792702"},{"id":"paper-w2201705507","cat":"papers","name":"LSD: The Contradiction of the Psychedelic Panacea that became Public Enemy Number One of the United States of America: A Social History from 1943-1965 and beyond.","year":"2013","cit":0,"pfa":"Crane, Louise","ptype":"article","src":"https://openalex.org/W2201705507","eid":"W2201705507"},{"id":"paper-w2182815722","cat":"papers","name":"Eficacia de la microdosis de captopril en el tratamiento de la hipertensión arterial esencial Effectiveness of captopril microdosing in the treatment of essential arterial hypertension","year":"2012","cit":0,"pfa":"Tomás Noel","psa":"Antonio Vázquez Gamboa","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2182815722","eid":"W2182815722"},{"id":"paper-w4382932858","cat":"papers","name":"COMPARISON OF OOCYTE MATURITY RATES AND CYCLE CHARACTERISTICS FOLLOWING ADDITION OF LETROZOLE (LET) OR MICRODOSE LUPRON (MDL) TO THE STANDARD GONADOTROPIN PROTOCOL IN PATIENTS UNDERGOING CONTROLLED OVARIAN STIMULATION (C","year":"2023","cit":0,"pfa":"Nirali Shah Jain","psa":"Jennifer K. Blakemore","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4382932858","eid":"W4382932858"},{"id":"paper-w2976882006","cat":"papers","name":"Stimulants, antidepressants, antimanics, anticonvulsants, and psychotomimetic agents","year":"2001","cit":0,"pfa":"Bev-Lorraine True","psa":"Robert H. Dreisbach","topics":["Depression"],"ptype":"book-chapter","src":"https://openalex.org/W2976882006","eid":"W2976882006"},{"id":"paper-w7172134305","cat":"papers","name":"Cross-species mapping of acute psychedelic-responsive genes links HTR2A cortical expression, cell-type enrichment, and human cortical expression modules","year":"2026","cit":0,"pfa":"Patrick A. McConnell","psa":"Lorenzo Pasquini","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7172134305","eid":"W7172134305"},{"id":"paper-w4410788781","cat":"papers","name":"Trippy: The Peril and Promise of Medicinal Psychedelics By Ernesto Londoño. Orion Spring. May 2024. £15.29 (pb). 320 pp. ISBN 978-1398714052","year":"2025","cit":0,"pfa":"Allan Hunter Young","ptype":"book-review","src":"https://openalex.org/W4410788781","eid":"W4410788781"},{"id":"paper-w3198461222","cat":"papers","name":"Microdose Flare-up Gonadotropin-releasing Hormone (GnRH) Agonist Protocol and GnRH Antagonist Protocol: Effects on In-vitro Fertilization in Patients with Poor-responder Diagnosis According to Bologna Criteria","year":"2021","cit":0,"pfa":"Gökşen Görgülü","psa":"Serdar Dilbaz","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3198461222","eid":"W3198461222"},{"id":"paper-w7167603319","cat":"papers","name":"USING CLOMIPHENE CITRATE THROUGHOUT THE DURATION OF OVARIAN STIMULATION OFFERS A MORE PATIENT FRIENDLY APPROACH WITH EQUIVALENT OUTCOMES IN PATIENTS WITH DIMINISHED OVARIAN RESERVE COMPARED TO MICRODOSE LUPRON FLARE","year":"2026","cit":0,"pfa":"A. J. Wong","psa":"R.S. Mandelbaum","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7167603319","eid":"W7167603319"},{"id":"paper-w3187190678","cat":"papers","name":"P.W. Barber. Psychedelic Revolutionaries: LSD And the Birth of Hallucinogenic Research. 384 pp., Saskatchewan: University of Regina Press, 2018. $34.95 (paperback), 9780889774209","year":"2021","cit":0,"pfa":"Danielle M. Giffort","ptype":"book-review","src":"https://openalex.org/W3187190678","eid":"W3187190678"},{"id":"paper-w3172613603","cat":"papers","name":"IdoHartogsohn : American Trip: Set, Setting, and the Psychedelic Experience in the Twentieth Century. Cambridge, MA and London: MIT Press, 2020; pp. ix + 418.","year":"2021","cit":0,"pfa":"Anna Lutkajtis","ptype":"book-review","src":"https://openalex.org/W3172613603","eid":"W3172613603"},{"id":"paper-w4415942632","cat":"papers","name":"WITHDRAWN: 1753eP First in man microdose trial of [68Ga]Ga-R54, CXCR4 targeted PET tracer. Comparison with [18F]-FDG and proof of concept in lung cancer models","year":"2025","cit":0,"pfa":"Anna Maria Trotta","psa":"Stefania Scala","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"retraction","src":"https://openalex.org/W4415942632","eid":"W4415942632"},{"id":"paper-w4416516476","cat":"papers","name":"Peer Review Report For: Psychedelics as moral bioenhancers: Protocol for a scoping review of ethical arguments for and against [version 1; peer review: 2 approved]","year":"2025","cit":0,"pfa":"Huang, Pei Hua","topics":["Reviews & meta-analyses","Policy & ethics"],"ptype":"peer-review","src":"https://openalex.org/W4416516476","eid":"W4416516476"},{"id":"paper-w7117994916","cat":"papers","name":"PsiloIMAGINE: Investigating the effects of a psychedelic-augmented mental imagery-based intervention for young people who self-harm, an experimental medicine study protocol","year":"2026","cit":0,"pfa":"I.A. Vamvakopoulou","psa":"M. Di Simplicio","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7117994916","eid":"W7117994916"},{"id":"paper-w4416515346","cat":"papers","name":"Peer Review Report For: Psychedelics as moral bioenhancers: Protocol for a scoping review of ethical arguments for and against [version 1; peer review: 2 approved]","year":"2025","cit":0,"pfa":"Naomi Scheinerman","topics":["Reviews & meta-analyses","Policy & ethics"],"ptype":"peer-review","src":"https://openalex.org/W4416515346","eid":"W4416515346"},{"id":"paper-w294390242","cat":"papers","name":"MORPHO-HISTOCHEMICAL INVESTIGATIONS IN VIEW OF DETERMINING THE TYPE, DEGREE AND DYNAMICS OF ALTERATIONS OF THE CENTRAL NERVOUS SYSTEM IN GUINEA-PIGS IRRADIATED WITH ROETGEN RADIATION $sub 4$MICRODOSES$sub 4$","year":"1963","cit":0,"pfa":"T. Vasculescu","psa":"C. Cracium","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W294390242","eid":"W294390242"},{"id":"paper-w7105877004","cat":"papers","name":"Statistical Analysis Plan (SAP): A randomised, double-dummy, triple-blind, active placebo-controlled, parallel groups trial of LSD microdosing in patients with major depressive disorder (LSDDEP2)","year":"2025","cit":0,"pfa":"Dimitri Daldegan-Bueno","psa":"Alana Cavadino","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7105877004","eid":"W7105877004"},{"id":"paper-w7153435639","cat":"papers","name":"Hierarchical Reweighting and Network-Control Phenotype: A Bounded Bridge Between the Nature Medicine Psychedelic Mega-Analysis and a Comparative Framework for Biological Cognitive Architectures","year":"2026","cit":0,"pfa":"Peter Bell","ptype":"article","src":"https://openalex.org/W7153435639","eid":"W7153435639"},{"id":"paper-w3087348201","cat":"papers","name":"SENSITIVITY TO THE PSYCHOTOMIMETIC MK-801 IN PHOSPHOLIPASE C-IVITY TO THE PSYCHOTOMIMETIC MK-801 IN PHOSPHOLIPASE C-beta 1 KNOCKOUT MICE","year":"2009","cit":0,"pfa":"Laura J. Gray","psa":"Anthony John Hannan","ptype":"article","src":"https://openalex.org/W3087348201","eid":"W3087348201"},{"id":"paper-w3042642700","cat":"papers","name":"ChemInform Abstract: THE SYNTHESIS OF ANALOGS OF THE HALLUCINOGEN 1‐(2,5‐DIMETHOXY‐4‐METHYLPHENYL)‐2‐AMINOPROPANE (DOM) PART 2, SOME RING‐METHOXYLATED 1‐AMINO‐ AND 2‐AMINOINDANES","year":"1974","cit":0,"pfa":"Ronald T. Coutts","psa":"Jerry L. Malicky","ptype":"article","src":"https://openalex.org/W3042642700","eid":"W3042642700"},{"id":"paper-w3098678804","cat":"papers","name":"Effects of psychotomimetic agents on time perception in rats.","year":"1993","cit":0,"pfa":"Tsuneyuki Yamamoto","psa":"Shigenori Watanabe","ptype":"article","src":"https://openalex.org/W3098678804","eid":"W3098678804"},{"id":"paper-w2273739920","cat":"papers","name":"Effect of microdose distribution on chromosome aberration frequency in liver cells of the Chinese hamster following exposure to $sup 239$PuO$sub 2$ or $sup 238$PuO$sub 2$ particles","year":"1974","cit":0,"pfa":"Antone L. Brooks","psa":"F.C. Rupprecht","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2273739920","eid":"W2273739920"},{"id":"paper-w2408867706","cat":"papers","name":"[Effect of psychotomimetic drugs on energy metabolism in brain mitochondria].","year":"1971","cit":0,"pfa":"G P Gulidova","ptype":"article","src":"https://openalex.org/W2408867706","eid":"W2408867706"},{"id":"paper-w4410093364","cat":"papers","name":"Supplemental Material for How Does Psychedelic Use Relate to Aspects of Religiosity/Spirituality? Preregistered Report From a Birth Cohort Study and a Prospective Longitudinal Study","year":"2025","cit":0,"ptype":"supplementary-materials","src":"https://openalex.org/W4410093364","eid":"W4410093364"},{"id":"paper-w2617400800","cat":"papers","name":"Local Links: Conservatory to go psychedelic, New bar on Clement, Jog in the Fog registration opens, Nourish Cafe expands, Merchant safety meeting at RDNC","year":"2017","cit":0,"pfa":"B Sarah","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2617400800","eid":"W2617400800"},{"id":"paper-w4234753003","cat":"papers","name":"Review for \"Identification of seven psychedelic 2,5‐dimethoxy‐phenylethyl‐amine‐based designer drugs via benchtop 1 H nuclear magnetic resonance spectroscopy\"","year":"2021","cit":0,"topics":["Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4234753003","eid":"W4234753003"},{"id":"paper-w4243064011","cat":"papers","name":"Review for \"Identification of seven psychedelic 2,5‐dimethoxy‐phenylethyl‐amine‐based designer drugs via benchtop 1 H nuclear magnetic resonance spectroscopy\"","year":"2021","cit":0,"topics":["Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4243064011","eid":"W4243064011"},{"id":"paper-w2150953345","cat":"papers","name":"QSAR's on Psychotomimetic Phenylalkyamines. Study with MTD Method and Parameter","year":"1996","cit":0,"pfa":"Mircea Mracec","psa":"Zeno Simon","ptype":"other","src":"https://openalex.org/W2150953345","eid":"W2150953345"},{"id":"paper-w4236389072","cat":"papers","name":"Review for \"Identification of seven psychedelic 2,5‐dimethoxy‐phenylethyl‐amine‐based designer drugs via benchtop 1 H nuclear magnetic resonance spectroscopy\"","year":"2021","cit":0,"topics":["Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4236389072","eid":"W4236389072"},{"id":"paper-w2416682900","cat":"papers","name":"[The treatment of central anticholinergic syndrome and psychotomimetic drug intoxication].","year":"1991","cit":0,"pfa":"Riri Sylvia Manor","psa":"Jacob Atsmon","ptype":"article","src":"https://openalex.org/W2416682900","eid":"W2416682900"},{"id":"paper-w4407791569","cat":"papers","name":"Efeitos do tratamento com microdose de lítio na perda da força e da massa muscular associadas à sarcopenia em modelo murino com envelhecimento acelerado","year":"2024","cit":0,"pfa":"Melissa Castellano","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W4407791569","eid":"W4407791569"},{"id":"paper-w4237272198","cat":"papers","name":"Correction to: In vitro structure–activity relationship determination of 30 psychedelic new psychoactive substances by means of β-arrestin 2 recruitment to the serotonin 2A receptor","year":"2020","cit":0,"pfa":"Eline Pottie","psa":"Christophe Pol Stove","topics":["Addiction","Mechanism & neuroscience"],"ptype":"erratum","src":"https://openalex.org/W4237272198","eid":"W4237272198"},{"id":"paper-w2903592890","cat":"papers","name":"Psychedelic pharmacology for the 21st century: Breaking convention, Vol III By BenSessa (Ed.) London, UK: Strange Attractor Press, 2017. £15.99, ISBN: 9781907222559","year":"2018","cit":0,"pfa":"Erika Dyck","topics":["Dosing & pharmacology"],"ptype":"book-review","src":"https://openalex.org/W2903592890","eid":"W2903592890"},{"id":"paper-w4389557383","cat":"papers","name":"Supplemental Material for Unique Effects of Sedatives, Dissociatives, Psychedelics, Stimulants, and Cannabinoids on Episodic Memory: A Review and Reanalysis of Acute Drug Effects on Recollection, Familiarity, and Metamem","year":"2023","cit":0,"topics":["Reviews & meta-analyses"],"ptype":"supplementary-materials","src":"https://openalex.org/W4389557383","eid":"W4389557383"},{"id":"paper-w2610046459","cat":"papers","name":"655. Assessment of Efficacy and Psychotomimetic Effects of Ketamine in the Mouse","year":"2017","cit":0,"pfa":"Angelo Ceci","psa":"Cornelia Dorner‐Ciossek","ptype":"article","src":"https://openalex.org/W2610046459","eid":"W2610046459"},{"id":"paper-w7213972909","cat":"papers","name":"Enhancing maize ( Zea Mays L.) resilience to climate change: The role of supplemental irrigation and fertiliser microdosing in improving grain‐filling rates of drought‐tolerant varieties in northern Benin","year":"2026","cit":0,"pfa":"Mouiz W. I. A. Yessoufou","psa":"P. B. Irénikatché Akponikpè","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7213972909","eid":"W7213972909"},{"id":"paper-w1973308882","cat":"papers","name":"Psychedelic Psychiatry: LSD from Clinic to Campus Erika Dyck, Johns Hopkins University Press. 2008. US$35.00 (hb). 216pp. ISBN: 9780801889943","year":"2009","cit":0,"pfa":"Sanjay Khurmi","ptype":"book-review","src":"https://openalex.org/W1973308882","eid":"W1973308882"},{"id":"paper-w2100072249","cat":"papers","name":"Psychedelic Drugs: Psychological, Medical and Social Issues. By Brian Wells. London: Penguin Books. 1973. Pp. 239. Index 10 pp. Price 50p.","year":"1974","cit":0,"pfa":"T. R. Wilson","ptype":"article","src":"https://openalex.org/W2100072249","eid":"W2100072249"},{"id":"paper-w4385380581","cat":"papers","name":"What to do about the woo? Review of ‘Philosophy and Psychedelics. Frameworks for Exceptional Experience' . Edited by Christine Hauskeller and Peter Sjöstedt-Hughes. London: Bloomsbury (2022).","year":"2023","cit":0,"pfa":"Andy Letcher","topics":["Reviews & meta-analyses"],"ptype":"book-review","src":"https://openalex.org/W4385380581","eid":"W4385380581"},{"id":"paper-w2971420531","cat":"papers","name":"Quantitation of anacetrapib, stable-isotope labeled-anacetrapib (microdose), and four metabolites in human plasma using liquid chromatography tandem mass spectrometry B Analytical technologies in the biomedical and life","year":"2016","cit":0,"pfa":"C.M. Chavez-Eng","psa":"Eric Woolf","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2971420531","eid":"W2971420531"},{"id":"paper-w2412692716","cat":"papers","name":"[Interaction between monoamine oxidase inhibitors and psychotomimetic drugs].","year":"1998","cit":0,"pfa":"Cazzullo Cl","psa":"Goldwurm Gf","ptype":"article","src":"https://openalex.org/W2412692716","eid":"W2412692716"},{"id":"paper-w3200817559","cat":"papers","name":"Review for \"Identification of seven psychedelic 2,5‐dimethoxy‐phenylethyl‐amine‐based designer drugs via benchtop 1 H nuclear magnetic resonance spectroscopy\"","year":"2021","cit":0,"topics":["Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W3200817559","eid":"W3200817559"},{"id":"paper-w4407068623","cat":"papers","name":"Sex-Stratified Prevalence of Classic Psychedelics Among Individuals With a History of Cancer in the United States: An Analysis of the National Survey on Drug Use and Health, 2015-2019","year":"2025","cit":0,"pfa":"Amrit Baral","psa":"Denise Christina Vidot","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4407068623","eid":"W4407068623"},{"id":"paper-w2414327867","cat":"papers","name":"A comparative study of anticholinergic psychotomimetic agents in mice and dogs.","year":"1967","cit":0,"pfa":"M Cohen","ptype":"article","src":"https://openalex.org/W2414327867","eid":"W2414327867"},{"id":"paper-w4311074926","cat":"papers","name":"Caracterização de marcadores relacionados à potenciação de longa duração (LTP) em camundongos com envelhecimento acelerado (SAMP-8) sob tratamento crônico com microdose de lítio.","year":"2022","cit":0,"pfa":"Arthur Antônio Ruiz Pereira","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W4311074926","eid":"W4311074926"},{"id":"paper-w7154836259","cat":"papers","name":"Examining the Psychotomimetic Properties of Ketamine using Functional Magnetic Resonance Imaging","year":"2026","cit":0,"pfa":"Haley Maria Dourron","psa":"Rebecca Boehme","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7154836259","eid":"W7154836259"},{"id":"paper-w4292553391","cat":"papers","name":"Hypodermose bovine en Algérie : essai d'assainissement d'une zone par l'emploi d'Ivomec R en microdose, du Neguvon R et de la roténone Tikizid R","year":"1994","cit":0,"pfa":"A. Benakhla","psa":"C. Boulard","topics":["Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W4292553391","eid":"W4292553391"},{"id":"paper-w398815993","cat":"papers","name":"Necessity of extended single-dose toxicity study for clinical trials with a single microdose : Consideration from recent approval data(Toxicological Bases for Micro-dose Study, Proceedings of the 32nd Annual Meeting)","year":"2005","cit":0,"pfa":"Osamu Fueki","psa":"Teruyo Arato","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W398815993","eid":"W398815993"},{"id":"paper-w2290192643","cat":"papers","name":"substances countries what's new announcements & submissions links & mirrors communication SEARCH DATABASE LIBRARIES: articles books press reports legal/law psychedelics research","year":"2005","cit":0,"pfa":"Kleanthis Grivas","psa":"Deborah Whitehouse","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2290192643","eid":"W2290192643"},{"id":"paper-w4230772085","cat":"papers","name":"Author response for \"Identification of seven psychedelic 2,5‐dimethoxy‐phenylethyl‐amine‐based designer drugs via benchtop 1 H nuclear magnetic resonance spectroscopy\"","year":"2021","cit":0,"pfa":"Juan Felipe Araneda","psa":"Susanne D. Riegel","ptype":"peer-review","src":"https://openalex.org/W4230772085","eid":"W4230772085"},{"id":"paper-w2089943260","cat":"papers","name":"Kappa-opiate receptors mediate psychotomimetic effects in humans","year":"1986","cit":0,"pfa":"Andreas F. H. Pfeiffer","psa":"H. M. Emrich","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2089943260","eid":"W2089943260"},{"id":"paper-w4200262502","cat":"papers","name":"P.0064 Rapid-acting antidepressants in motivation: the effects of low-dose ketamine and the psychedelic 2,5-dimethoxy-4-iodoamphetamine (DOI) in the rat progressive ratio task","year":"2021","cit":0,"pfa":"Fionn Dunphy-Doherty","psa":"Jack A. Prenderville","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4200262502","eid":"W4200262502"},{"id":"paper-w4239768590","cat":"papers","name":"Decision letter for \"Identification of seven psychedelic 2,5‐dimethoxy‐phenylethyl‐amine‐based designer drugs via benchtop 1 H nuclear magnetic resonance spectroscopy\"","year":"2021","cit":0,"ptype":"peer-review","src":"https://openalex.org/W4239768590","eid":"W4239768590"},{"id":"paper-w4234227776","cat":"papers","name":"Decision letter for \"Identification of seven psychedelic 2,5‐dimethoxy‐phenylethyl‐amine‐based designer drugs via benchtop 1 H nuclear magnetic resonance spectroscopy\"","year":"2021","cit":0,"ptype":"peer-review","src":"https://openalex.org/W4234227776","eid":"W4234227776"},{"id":"paper-w7124223147","cat":"papers","name":"Internship Report at the EMCDDA 's Public Health Unit - Insights into the Medical Use of Psychedelic Substances in the EU: regulatory frameworks, public health challenges and future directions.","year":"2024","cit":0,"pfa":"Samantha Mancino","topics":["Addiction","Policy & ethics"],"ptype":"report","src":"https://openalex.org/W7124223147","eid":"W7124223147"},{"id":"paper-w4214539997","cat":"papers","name":"Decision letter for \"Identification of seven psychedelic 2,5‐dimethoxy‐phenylethyl‐amine‐based designer drugs via benchtop 1 H nuclear magnetic resonance spectroscopy\"","year":"2021","cit":0,"ptype":"peer-review","src":"https://openalex.org/W4214539997","eid":"W4214539997"},{"id":"paper-w2436012139","cat":"papers","name":"[The effect of psychotomimetics on the conditioned reflex activity and electroencephalogram of monkeys].","year":"1970","cit":0,"pfa":"I I BARYSHNIKOV","psa":"G A Khasabov","ptype":"article","src":"https://openalex.org/W2436012139","eid":"W2436012139"},{"id":"paper-w26698140","cat":"papers","name":"RESPONSE ON \"Diverse Psychotomimetics Act Through a CommonSignaling Pathway\"","year":"2004","cit":0,"pfa":"Paul Greengard","psa":"Per Svenningsson","ptype":"article","src":"https://openalex.org/W26698140","eid":"W26698140"},{"id":"paper-w2966212438","cat":"papers","name":"Chapter-10 Central nervous system stimulants and psychotomimetics","year":"2016","cit":0,"pfa":"Panwar Singh","ptype":"book-chapter","src":"https://openalex.org/W2966212438","eid":"W2966212438"},{"id":"paper-w3201462187","cat":"papers","name":"Author response for \"Identification of seven psychedelic 2,5‐dimethoxy‐phenylethyl‐amine‐based designer drugs via benchtop 1 H nuclear magnetic resonance spectroscopy\"","year":"2021","cit":0,"pfa":"Juan Felipe Araneda","psa":"Susanne D. Riegel","ptype":"peer-review","src":"https://openalex.org/W3201462187","eid":"W3201462187"},{"id":"paper-w2014606173","cat":"papers","name":"Antipsychotics haloperidol and risperidone and psychotomimetic amphetamine affect neuropeptides and monoamines","year":"1997","cit":0,"pfa":"Susanne H. M. Gruber","psa":"A.A. Mathé","ptype":"article","src":"https://openalex.org/W2014606173","eid":"W2014606173"},{"id":"paper-w2327322791","cat":"papers","name":"A single psychotomimetic dose of ketamine disrupts corticothalamic dynamics","year":"2012","cit":0,"pfa":"Didier Pinault","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2327322791","eid":"W2327322791"},{"id":"paper-w4300830562","cat":"papers","name":"Arun Saldanha. Psychedelic White: Goa Trance and the Viscosity of Race. Minneapolis: University of Minnesota Press, 2007. Pp. 239. ISBN10: 0-8166-4993-6.","year":"2008","cit":0,"pfa":"Annika Björnsdotter Teppo","ptype":"book-review","src":"https://openalex.org/W4300830562","eid":"W4300830562"},{"id":"paper-w2322784861","cat":"papers","name":"GENETIC MODERATION OF THE PSYCHOTOMIMETIC AND AMNESTIC EFFECTS OF DELTA-9-TETRAHYDROCANNABINOL IN THE LABORATORY","year":"2012","cit":0,"pfa":"Deepak Cyril D’Souza","ptype":"article","src":"https://openalex.org/W2322784861","eid":"W2322784861"},{"id":"paper-w2918014989","cat":"papers","name":"マイクロドーズ臨床試験を活用した革新的創薬技術の開発(NEDO MICRODOSE-PJ) ２０１０（５）","year":"2010","cit":0,"pfa":"前田 和哉","psa":"杉山 雄一","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2918014989","eid":"W2918014989"},{"id":"paper-w7154307472","cat":"papers","name":"Turner Fred , The Democratic Surround : Multimedia and American Liberalism from World War II to the Psychedelic Sixties , Chicago, University of Chicago Press, 365 p., 2013, 32,50 $","year":"2014","cit":0,"pfa":"Stephen Whitfield","ptype":"article","src":"https://openalex.org/W7154307472","eid":"W7154307472"},{"id":"paper-w2284509997","cat":"papers","name":"Behavioral evidence for the involvement of serotonergic neurotransmission in psychotomimetic effects of dizocilpine","year":"1997","cit":0,"pfa":"Wojciech Zajączkowski","psa":"Krzysztof Wędzony","ptype":"article","src":"https://openalex.org/W2284509997","eid":"W2284509997"},{"id":"paper-w4238690420","cat":"papers","name":"ALTERED STATES: BUDDHISM AND PSYCHEDELIC SPIRITUALITY IN AMERICA. By DouglasOsto. New York, NY: Columbia University Press, 2016. Pp. xxvi+300. Hardback, $35.00; Paperback, $24.00.","year":"2020","cit":0,"pfa":"By Douglas Osto. New York","ptype":"book-review","src":"https://openalex.org/W4238690420","eid":"W4238690420"},{"id":"paper-w4417180613","cat":"papers","name":"IMPACT DE LA FERTILISATION PAR MICRODOSE DE NPK SUR LES PROPRIETES CHIMIQUES ET BIOLOGIQUES DUN SOL SABLEUX SOUS CULTURE DE SESAME (SESAMUM INDICUM L.) AU NIGER","year":"2025","cit":0,"pfa":"Housseini Malam Laminou Rabi","psa":"Sene Awa Latyr","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4417180613","eid":"W4417180613"},{"id":"paper-w4247725793","cat":"papers","name":"P.1.10 Diverse psychotomimetics act through a common signaling pathway","year":"2004","cit":0,"pfa":"Per Svenningsson","psa":"P. Greengard","ptype":"article","src":"https://openalex.org/W4247725793","eid":"W4247725793"},{"id":"paper-w4210740873","cat":"papers","name":"Psychedelic scoring et déracinement du polar. Les décalages musique/image de Serge Gainsbourg et Jean-Claude Vannier dans La Horse (1970)","year":"2021","cit":0,"pfa":"Jérôme Rossi","ptype":"article","src":"https://openalex.org/W4210740873","eid":"W4210740873"},{"id":"paper-w7171271295","cat":"papers","name":"Рецензия на книгу: Breen B. Tripping on Utopia: Margaret Mead, the Cold War, and the Troubled Birth of Psychedelic Science. New York: Grand Central Publishing, 2024","cit":0,"pfa":"Петрухин Семен Сергеевич","ptype":"article","src":"https://openalex.org/W7171271295","eid":"W7171271295"},{"id":"paper-w654737862","cat":"papers","name":"マイクロドーズ臨床試験を活用した革新的創薬技術の開発 (NEDO MICRODOSE-PJ) 2010 （10）","year":"2010","cit":0,"pfa":"楠原 洋之","psa":"杉山 雄一","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W654737862","eid":"W654737862"},{"id":"paper-w3101562861","cat":"papers","name":"Behavioral pharmacological studies of psychotomimetic effects of partial-agonist analgesics","year":"1979","cit":0,"pfa":"Takahiko Endo","psa":"Takeshi Shibuya","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3101562861","eid":"W3101562861"},{"id":"paper-w4362401448","cat":"papers","name":"Supplemental Movie S1. Explanatory Movie of Multiplex Advanced Pathology Imaging (MAPI). from Tumor-Specific Uptake of Fluorescent Bevacizumab–IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feas","year":"2023","cit":0,"pfa":"Laetitia E. Lamberts","psa":"Gooitzen M. van Dam","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4362401448","eid":"W4362401448"},{"id":"paper-w2330211854","cat":"papers","name":"Nicolas Langlitz. Neuropsychedelia: The Revival of Hallucinogen Research since the Decade of the Brain. ix + 316 pp., illus., bibl., index. Berkeley: University of California Press, 2013. $65, £44.95 (cloth); $29.95, £19","year":"2013","cit":0,"pfa":"Chris Elcock","ptype":"book-review","src":"https://openalex.org/W2330211854","eid":"W2330211854"},{"id":"paper-w2321820412","cat":"papers","name":"Aaronson, Bernard & Osmond, Humphry (Eds.).Psychedelics: The Uses and Implications of Hallucinogenic Drugs.Garden City, N. Y.: Anchor Books, Doubleday and Company, 1970. Pp. 512 + vii. $2.45","year":"1975","cit":0,"pfa":"Arthur C. Hastings","ptype":"article","src":"https://openalex.org/W2321820412","eid":"W2321820412"},{"id":"paper-w4361922323","cat":"papers","name":"Supplemental Movie S1. Explanatory Movie of Multiplex Advanced Pathology Imaging (MAPI). from Tumor-Specific Uptake of Fluorescent Bevacizumab–IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feas","year":"2023","cit":0,"pfa":"Laetitia E. Lamberts","psa":"Gooitzen M. van Dam","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4361922323","eid":"W4361922323"},{"id":"paper-w4390967715","cat":"papers","name":"When the CIA met LSD Tripping on Utopia: Margaret Mead, the Cold War, and the Troubled Birth of Psychedelic Science Benjamin Breen Grand Central Publishing, 2024. 384 pp.","year":"2024","cit":0,"pfa":"Alexis Turner","ptype":"book-review","src":"https://openalex.org/W4390967715","eid":"W4390967715"},{"id":"paper-w2962153420","cat":"papers","name":"Rockin' the Comstock: Exploring the Unlikely and Underappreciated Role of a Mid-Nineteenth Century Northern Nevada Ghost Town (Virginia City) in the Development of the 1960s Psychedelic Esthetic and \"San Francisco Sound\"","year":"2014","cit":0,"pfa":"Engrid Noel Barnett","ptype":"dissertation","src":"https://openalex.org/W2962153420","eid":"W2962153420"},{"id":"paper-w2796186872","cat":"papers","name":"Some properties of behavioural baselines in the rat and disruption by the psychotomimetic drugs","year":"1967","cit":0,"pfa":"Ronald J. Bradley","ptype":"dissertation","src":"https://openalex.org/W2796186872","eid":"W2796186872"},{"id":"paper-w2325949208","cat":"papers","name":"Book Section: Essays and Review: The Harvard Psychedelic Club: How Timothy Leary, Ram Dass, Huston Smith, and Andrew Weil Killed the Fifties and Ushered in a New Age for America","year":"2010","cit":0,"pfa":"Kenneth J. Weiss","topics":["Reviews & meta-analyses"],"ptype":"book-review","src":"https://openalex.org/W2325949208","eid":"W2325949208"},{"id":"paper-w4283390369","cat":"papers","name":"The psychotomimetic ketamine disrupts the transfer of late sensory information in the corticothalamic network","year":"2022","cit":0,"pfa":"Yi Qin","psa":"Didier Pinault","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4283390369","eid":"W4283390369"},{"id":"paper-w3021267526","cat":"papers","name":"Psychedelic Prophets: The Letters of Aldous Huxley and Humphry Osmond by Cynthia Carson Bisbee, Paul Bisbee, Erika Dyck, Patrick Farrell, James Sexton, and James W. Spisak (eds.)","year":"2020","cit":0,"pfa":"Milana Aronov","ptype":"book-review","src":"https://openalex.org/W3021267526","eid":"W3021267526"},{"id":"paper-w2624733115","cat":"papers","name":"LIGAND BASED DRUG DESIGN STRATEGY FOR THE MODELING OF PHENYLALKYLAMINESAS A PSYCHOTOMIMETIC AGENT","year":"2015","cit":0,"pfa":"Abhilash Thakur","psa":"Jaya V. Gade","ptype":"article","src":"https://openalex.org/W2624733115","eid":"W2624733115"},{"id":"paper-w2090922656","cat":"papers","name":"Book review: Psychedelic White: Goa Trance and the Viscosity of Race. By Arun Saldanha. Minneapolis: University of Minnesota Press. 2007. x + 239 pp. $20.00 paper. ISBN: 97808166499345","year":"2011","cit":0,"pfa":"Alexander Henn","topics":["Reviews & meta-analyses"],"ptype":"book-review","src":"https://openalex.org/W2090922656","eid":"W2090922656"},{"id":"paper-w3202944882","cat":"papers","name":"How to Change Your Mind: What the New Science of Psychedelics Teaches Us About Consciousness, Dying, Addiction, Depression, and Transcendence By Michael Pollan by Michael Pollan Study Aids","year":"2018","cit":0,"pfa":"Michael Pollan","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W3202944882","eid":"W3202944882"},{"id":"paper-w2620661590","cat":"papers","name":"A very brief review of the life and work of neuroscientist, physician, psychoanalyst, inventor, animal rights activist and pioneer in dolphins, isolation tanks and psychedelics John C Lilly 1915-2001.","year":"2016","cit":0,"pfa":"Michael Starks","topics":["Dosing & pharmacology","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2620661590","eid":"W2620661590"},{"id":"paper-w4385406918","cat":"papers","name":"Rundel, Megan. (2022). “Psychedelic psychoanalysis: Transformations of the Self.” Psychoanalytic Dialogues, 32(5), 469–483. Published online: November 7, 2022. https://doi.org/10.1080/10481885.2022.2106139","year":"2023","cit":0,"pfa":"Misser Berg","ptype":"article","src":"https://openalex.org/W4385406918","eid":"W4385406918"},{"id":"paper-w3203383392","cat":"papers","name":"How to Change Your Mind: What the New Science of Psychedelics Teaches Us About Consciousness, Dying, Addiction, Depression, and Transcendence by Michael Pollan: by MaxHelp Workbooks Study Aids","year":"2018","cit":0,"pfa":"MaxHelp Workbooks","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W3203383392","eid":"W3203383392"},{"id":"paper-w187827840","cat":"papers","name":"Modeling cognitive deficits in schizophrenia through repeated administration of the psychotomimetic phencyclidine","year":"2008","cit":0,"pfa":"Nurith Amitai","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W187827840","eid":"W187827840"},{"id":"paper-w4243768638","cat":"papers","name":"M203. ANTIPSYCHOTIC-LIKE EFFECT OF DOXYCYCLINE IN PSYCHOTOMIMETICS SYMPTOMS INDUCED BY AMPHETAMINE","year":"2020","cit":0,"ptype":"conference-abstract","src":"https://openalex.org/W4243768638","eid":"W4243768638"},{"id":"paper-w2467697331","cat":"papers","name":"[Studies on the identification of psychotropic substances. VI. Preparation and various analytical data of reference standards of some hallucinogens, 2,5-dimethoxy-4-methylamphetamine (STP), 2,5-dimethoxy-4-bromoamphetami","year":"1989","cit":0,"pfa":"MOCHIHIKO SHIMAMINE","psa":"Y Nakahara","topics":["Addiction"],"ptype":"other","src":"https://openalex.org/W2467697331","eid":"W2467697331"},{"id":"paper-w7116823236","cat":"papers","name":"Рецензия на книгу: Marinacci M. Psychedelic Cults and Outlaw Churches: LSD, Cannabis, and Spiritual Sacraments in Underground America. Rochester, Vermont: Park Street Press, 2023. 540 p.","cit":0,"pfa":"Петрухин Семен Сергеевич","ptype":"article","src":"https://openalex.org/W7116823236","eid":"W7116823236"},{"id":"paper-w4306408405","cat":"papers","name":"Review for \"The psychotomimetic ketamine disrupts the transfer of late sensory information in the corticothalamic network\"","year":"2022","cit":0,"topics":["Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4306408405","eid":"W4306408405"},{"id":"paper-w4306408481","cat":"papers","name":"Review for \"The psychotomimetic ketamine disrupts the transfer of late sensory information in the corticothalamic network\"","year":"2022","cit":0,"topics":["Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4306408481","eid":"W4306408481"},{"id":"paper-w4312825761","cat":"papers","name":"Review for \"The psychotomimetic ketamine disrupts the transfer of late sensory information in the corticothalamic network\"","year":"2022","cit":0,"topics":["Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4312825761","eid":"W4312825761"},{"id":"paper-w3022729684","cat":"papers","name":"ChemInform Abstract: PSYCHOTOMIMETIC PHENYLISOPROPYLAMINES. 5. 4‐ALKYL‐2,5‐DIMETHOXYPHENYLISOPROPYLAMINES","year":"1976","cit":0,"pfa":"Alexander T. Shulgin","psa":"D. C. Dyer","ptype":"article","src":"https://openalex.org/W3022729684","eid":"W3022729684"},{"id":"paper-w2480209102","cat":"papers","name":"A comparison of psychotomimetic effects of MK-801 and CGP 40116 in behavioural paradigms","year":"1999","cit":0,"pfa":"Wojciech M. Zajączkowski","psa":"Krzysztof Wędzony","ptype":"article","src":"https://openalex.org/W2480209102","eid":"W2480209102"},{"id":"paper-w7160568933","cat":"papers","name":"Psychopharmacology of cannabinoids: Subjective, psychotomimetic, and social cognition effects of tetrahydrocannabinol and cannabidiol","year":"2025","cit":0,"pfa":"Alberto Sainz-Cort","topics":["Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7160568933","eid":"W7160568933"},{"id":"paper-w21311059","cat":"papers","name":"Avaliação da eficiência na utilização de microdoses de prostaglandina F2 alfa, com o uso de diferentes vias de aplicação, associadas ao peso corporal de fêmeas Bos taurus","year":"2000","cit":0,"pfa":"A.C.M. Arteche","psa":"João Batista Souza Borges","topics":["Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W21311059","eid":"W21311059"},{"id":"paper-w2952442104","cat":"papers","name":"Avaliação de mecanismos de prevenção e tratamento com microdose de lítio e associação com rivastigmina em modelo de neurodegeneração por infusão crônica de >font face = \\\"symbol\\\"/font<-amiloide.","year":"2019","cit":0,"pfa":"Natália Mendes Schöwe","topics":["Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W2952442104","eid":"W2952442104"},{"id":"paper-w2952540615","cat":"papers","name":"ChemInform Abstract: POTENTIAL PSYCHOTOMIMETICS, 2‐AMINO‐1,2,3,4‐TETRAHYDRONAPHTHALENE ANALOGS","year":"1973","cit":0,"pfa":"Charles F. Barfknecht","psa":"D. C. Dyer","ptype":"article","src":"https://openalex.org/W2952540615","eid":"W2952540615"},{"id":"paper-w7207759960","cat":"papers","name":"Cannabigerol, a minor phytocannabinoid, prevents behavioral changes induced by psychotomimetic drugs","year":"2026","cit":0,"pfa":"J. F. C Pedrazzi","psa":"J.A.S. Crippa","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7207759960","eid":"W7207759960"},{"id":"paper-w3117359622","cat":"papers","name":"Langlitz, Nicolas: Neuropsychedelia. The Revival of Hallucinogen Research since the Decade of the Brain. Berkeley, Los Angeles; London, University of California Press, 2013. IX, 316 p. Ill. $ 29.95. ISBN 978-0-520-95490-","year":"2013","cit":0,"pfa":"Adam Montgomery","ptype":"book-review","src":"https://openalex.org/W3117359622","eid":"W3117359622"},{"id":"paper-w7170092419","cat":"papers","name":"Electronic Supplementary Materials for the 6-Dimensional Visual Hallucination Questionnaire (6D-VHQ) from Measuring the contents of hallucinations from psychedelics and stroboscopic light: the six-dimensional visual hall","year":"2026","cit":0,"pfa":"Trevor Hewitt","psa":"David Schwartzman","ptype":"article","src":"https://openalex.org/W7170092419","eid":"W7170092419"},{"id":"paper-w2965680310","cat":"papers","name":"Déterminants de la Perception des Producteurs sur la Technologie ‘Microdose’ dans la Gestion Durable des Terres Agricoles des Provinces du Kouritenga et du Zondoma au Burkina Faso","year":"2019","cit":0,"pfa":"Hamadé Sigue","psa":"Gauthier Biaou","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2965680310","eid":"W2965680310"},{"id":"paper-w2461617789","cat":"papers","name":"Disruption of prefrontal cortex function by psychotomimetic agents: reversal by antipsychotic drugs","year":"2013","cit":0,"pfa":"Francesc Artigas","topics":["Mechanism & neuroscience"],"ptype":"conference-paper","src":"https://openalex.org/W2461617789","eid":"W2461617789"},{"id":"paper-w7170062832","cat":"papers","name":"Electronic Supplementary Materials for the 6-Dimensional Visual Hallucination Questionnaire (6D-VHQ) from Measuring the contents of hallucinations from psychedelics and stroboscopic light: the six-dimensional visual hall","year":"2026","cit":0,"pfa":"Trevor Hewitt","psa":"David Schwartzman","ptype":"article","src":"https://openalex.org/W7170062832","eid":"W7170062832"},{"id":"paper-w1954291339","cat":"papers","name":"New Morphinan Derivatives Exhibit Anticonvulsant Effects with Negligible Psychotomimetic Effects","year":"2002","cit":0,"pfa":"Phil-Ho Lee","psa":"Wang‐Kee Jhoo","ptype":"article","src":"https://openalex.org/W1954291339","eid":"W1954291339"},{"id":"paper-w2288359033","cat":"papers","name":"Effects of psychotomimetic and antipsychotic agents on neocortical and striatal concentrations of various amino acids in the rat","year":"2004","cit":0,"pfa":"新一郎 櫻井","ptype":"dissertation","src":"https://openalex.org/W2288359033","eid":"W2288359033"},{"id":"paper-w2465555403","cat":"papers","name":"Tacrine and its derivatives antagonize cholinergic psychotomimetics. Behavioural study in rats.","year":"1978","cit":0,"pfa":"Marie Koupilová","psa":"V Hrdina","ptype":"article","src":"https://openalex.org/W2465555403","eid":"W2465555403"},{"id":"paper-w2044679022","cat":"papers","name":"R. Gordon Wasson, Stella Kramrisch, Jonathan Orr, Carl A. P. Ruck: Persephone's Quest: Entheogens and the Origins of Religion. Pp. 257; Frontispiece + 26 illustrations in text. New Haven/London: Yale University Press, 19","year":"1989","cit":0,"pfa":"Emily Kearns","ptype":"book-review","src":"https://openalex.org/W2044679022","eid":"W2044679022"},{"id":"paper-w4312607288","cat":"papers","name":"Review for \"The psychotomimetic ketamine disrupts the transfer of late sensory information in the corticothalamic network\"","year":"2022","cit":0,"topics":["Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4312607288","eid":"W4312607288"},{"id":"paper-w2241301257","cat":"papers","name":"ヒト血漿中セリプロロール,アテノロール及びフェキソフェナジンのLC/MS/MS法による高感度分析法の開発(NEDO MicroDose‐PJ)","year":"2010","cit":0,"pfa":"中村剛","psa":"杉山雄一","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2241301257","eid":"W2241301257"},{"id":"paper-w4390326088","cat":"papers","name":"Turner (Fred) – The Democratic Surround. Multimedia & American Liberalism from World War II to the Psychedelic Sixties . – Chicago, The University of Chicago Press, 2013. VIII + 366 p. Illustrations. Bibliogr. Index","year":"2017","cit":0,"pfa":"Éric Maigret","ptype":"article","src":"https://openalex.org/W4390326088","eid":"W4390326088"},{"id":"paper-w2463904726","cat":"papers","name":"Effects of Diazepam-Ketamine-N2O-O2 Anesthesia on the Cardiovascular System and Psychotomimetic Reaction","year":"1988","cit":0,"pfa":"Jong Kwan Park","psa":"He Sun Song","ptype":"article","src":"https://openalex.org/W2463904726","eid":"W2463904726"},{"id":"paper-w7208358739","cat":"papers","name":"The Effect of Ketamine on DC-Potential in the Brain of Rabbits : A Contribution to the Study of Psychotomimetic Drugs","year":"1975","cit":0,"pfa":"総徳 智田","psa":"Fusanori Chida","ptype":"article","src":"https://openalex.org/W7208358739","eid":"W7208358739"},{"id":"paper-w2324089809","cat":"papers","name":"Acute cannabis use causes increased psychotomimetic experiences in individuals prone to psychosis","year":"2011","cit":0,"pfa":"RICHARD J. FRANCES","ptype":"article","src":"https://openalex.org/W2324089809","eid":"W2324089809"},{"id":"paper-w2790918715","cat":"papers","name":"Sacred Knowledge: Psychedelics and Religious Experiences. By William A.Richards. New York, NY: Columbia University Press, 2016. Xxviii + 244 pages. Hardcover, $29.95 / £24.95; E‐book $28.99/ £23.95.","year":"2018","cit":0,"pfa":"Stefano Bigliardi","ptype":"article","src":"https://openalex.org/W2790918715","eid":"W2790918715"},{"id":"paper-w7147470885","cat":"papers","name":"Impact of psychotomimetic molecules on glutamatergic N-Methyl-D-Aspartate receptors surface trafficking","year":"2016","cit":0,"pfa":"Julie Jézéquel","topics":["Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W7147470885","eid":"W7147470885"},{"id":"paper-w4396509949","cat":"papers","name":"Correction to: The Mystical Experience Questionnaire 4-Item and Challenging Experience Questionnaire 7-Item, by Strickland, et al. Psychedelic Medicine 2024;2(1):33–43; doi: 10.1089/psymed.2023.0046.","year":"2024","cit":0,"ptype":"erratum","src":"https://openalex.org/W4396509949","eid":"W4396509949"},{"id":"paper-w4255068519","cat":"papers","name":"Psychotomimetic Drugs : Workshop Series of Pharmacology Section, National Institutes of Mental Health, No.4","year":"1970","cit":0,"pfa":"Walter Modell","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4255068519","eid":"W4255068519"},{"id":"paper-w4232148709","cat":"papers","name":"Psychotomimetic effects of MK-801 are antagonized by CGP 40116, a competitive NMDA receptor antagonist","year":"1999","cit":0,"pfa":"A. Chocyk","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4232148709","eid":"W4232148709"},{"id":"paper-w7143276429","cat":"papers","name":"“I can objectively view my trauma without feeling like I'm there”: Reddit discussions on self-reported use of psychedelics to address co-occurring substance use and mental health needs","year":"2026","cit":0,"pfa":"Emma Yuanqi Gu","psa":"Noa Krawczyk","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7143276429","eid":"W7143276429"},{"id":"paper-w2107019776","cat":"papers","name":"Erika Dyck, Psychedelic psychiatry: LSD from clinic to campus, Baltimore, Johns Hopkins University Press, 2008, pp. xiii, 199, £19.00 (hardback 978-0-8018-8994-3).","year":"2010","cit":0,"pfa":"Catherine Carstairs","ptype":"book-review","src":"https://openalex.org/W2107019776","eid":"W2107019776"},{"id":"paper-w4306408488","cat":"papers","name":"Decision letter for \"The psychotomimetic ketamine disrupts the transfer of late sensory information in the corticothalamic network\"","year":"2022","cit":0,"ptype":"peer-review","src":"https://openalex.org/W4306408488","eid":"W4306408488"},{"id":"paper-w4312785522","cat":"papers","name":"Decision letter for \"The psychotomimetic ketamine disrupts the transfer of late sensory information in the corticothalamic network\"","year":"2022","cit":0,"ptype":"peer-review","src":"https://openalex.org/W4312785522","eid":"W4312785522"},{"id":"paper-w4411493399","cat":"papers","name":"A Case Series Demonstrating the Feasibility of Microdosing as a Bridging Method to Enable a Comfortable and Effective Transition From Prescribed Methadone to Buprenorphine ORT (Opiate Replacement Therapy), Without Initia","year":"2025","cit":0,"pfa":"Zelda Summers","psa":"Stuart Fisher","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4411493399","eid":"W4411493399"},{"id":"paper-w4294495127","cat":"papers","name":"Cynthia Carson Bisbee, Paul Bisbee, Erika Dyck, Patrick Farrell, James Sexton, and James W. Spark, eds., Psychedelic Prophets: The Letters of Aldous Huxley and Humphry Osmond, Reviewer: Robert Dickins","year":"2019","cit":0,"pfa":"Robert Dickins","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4294495127","eid":"W4294495127"},{"id":"paper-w2407507158","cat":"papers","name":"[Psychotomimetic side effect of ketamine anesthesia and the action of drugs reducing this effect. Hallucination and neurotransmitters].","year":"1986","cit":0,"pfa":"Peter Migály","psa":"T Jakab","ptype":"other","src":"https://openalex.org/W2407507158","eid":"W2407507158"},{"id":"paper-w2527940006","cat":"papers","name":"マイクロドーズ臨床試験によるSLCO2B1遺伝子多型とβブロッカー体内動態との関連評価(NEDO MicroDose-PJ)","year":"2010","cit":0,"pfa":"土井 洋平","psa":"杉山 雄一","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2527940006","eid":"W2527940006"},{"id":"paper-w2594795039","cat":"papers","name":"Cannabis users are less sensitive to the acute psychotomimetic effects of delta-9-tetrahydrocannabinol administration","year":"2017","cit":0,"pfa":"Marco Colizzi","psa":"Sagnik Bhattacharyya","ptype":"article","src":"https://openalex.org/W2594795039","eid":"W2594795039"},{"id":"paper-w4388626735","cat":"papers","name":"Passageways through process philosophy: panpsychism in practice. Review of ‘Processing Reality: Finding Meaning in Death, Psychedelics, and Sobriety’ , by John H. Buchanan Reanne Crane, Eugene: Cascade Books, 2022, $38.0","year":"2023","cit":0,"pfa":"Reanne Crane","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4388626735","eid":"W4388626735"},{"id":"paper-w4248273273","cat":"papers","name":"Faculty Opinions recommendation of Mefloquine and psychotomimetics share neurotransmitter receptor and transporter interactions in vitro.","year":"2014","cit":0,"pfa":"Bryan L. Roth","topics":["Mechanism & neuroscience"],"ptype":"peer-review","src":"https://openalex.org/W4248273273","eid":"W4248273273"},{"id":"paper-w2508094736","cat":"papers","name":"Psychotomimetic Drugs : Workshop Series of Pharmacology Section, National Institutes of Mental Health, No.4","year":"1970","cit":0,"pfa":"Walter Modell","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2508094736","eid":"W2508094736"},{"id":"paper-w3183055727","cat":"papers","name":"Neurobehavioural Effects of Acute and Repeated Administrations of Sub-Psychotomimetic Dose of Ketamine in Mice","year":"2019","cit":0,"pfa":"Soliu Abiola Atunwa","psa":"Adegboyega Rotimi Owolabi","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3183055727","eid":"W3183055727"},{"id":"paper-w4312784675","cat":"papers","name":"Review for \"The psychotomimetic ketamine disrupts the transfer of late sensory information in the corticothalamic network\"","year":"2022","cit":0,"topics":["Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4312784675","eid":"W4312784675"},{"id":"paper-w2417704715","cat":"papers","name":"[A neurophysiological study on the central action of psychotomimetics (LSD 25, DOM and ketamine) (author's transl)].","year":"1974","cit":0,"pfa":"Tomohiro Otaka","ptype":"other","src":"https://openalex.org/W2417704715","eid":"W2417704715"},{"id":"paper-w2341834203","cat":"papers","name":"ChemInform Abstract: CNS ACTIVITY OF 2‐AZABICYCLO(2.2.2)OCTANE ANALOGS OF PSYCHOTOMIMETIC PHENETHYLAMINES","year":"1980","cit":0,"pfa":"Say‐Jong Law","psa":"Ronald F. Borne","ptype":"article","src":"https://openalex.org/W2341834203","eid":"W2341834203"},{"id":"paper-w2408440805","cat":"papers","name":"Diazepam in combination with tacrine derivatives antagonizes behavioural effects of anticholinergic psychotomimetics in rats.","year":"1979","cit":0,"pfa":"Marie Koupilová","psa":"V Hrdina","ptype":"article","src":"https://openalex.org/W2408440805","eid":"W2408440805"},{"id":"paper-w2593529346","cat":"papers","name":"Impact of psychotomimetic molecules on glutamatergic N-Methyl-D-Aspartate receptors surface trafficking","year":"2016","cit":0,"pfa":"Julie Jézéquel","topics":["Safety & adverse events","Mechanism & neuroscience","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W2593529346","eid":"W2593529346"},{"id":"paper-w3114888169","cat":"papers","name":"The absence of the GLUN2C subunit attenuates the psychotomimetic effects induced by ketamine and other NMDA antadonistists","year":"2017","cit":0,"pfa":"Mireia Tarrés-Gatius","psa":"Anna Castañé","ptype":"conference-abstract","src":"https://openalex.org/W3114888169","eid":"W3114888169"},{"id":"paper-w3121875990","cat":"papers","name":"Neurobiological mechanisms involved in the antidepressant and psychotomimetic effects of NMDA receptor antagonists: role of the GluN2C subunit","year":"2019","cit":0,"pfa":"Mireia Tarrés Gatius","topics":["Depression","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W3121875990","eid":"W3121875990"},{"id":"paper-w7131401305","cat":"papers","name":"Father Thomas Merton outside of his Shangri-la hermitage, holding a copy of The Psychedelic Experience by Timothy Leary, Ralph Metzner, and Richard Alpert, given to him that day by Rabbi Zalman Schachter, ca. 1963.","year":"2026","cit":0,"pfa":"University of Colorado Boulder","ptype":"other","src":"https://openalex.org/W7131401305","eid":"W7131401305"},{"id":"paper-w7204525679","cat":"papers","name":"Psychotomimetic cannabinoid hyperlocomotion involves GSK3β signaling at striatopallidal neurons in male mice","year":"2026","cit":0,"pfa":"Giovanni Tomaselli","psa":"Monique Vallée","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7204525679","eid":"W7204525679"},{"id":"paper-w2475464191","cat":"papers","name":"Effects of psychotomimetic and antipsychotic drugs on latent inhibition: further development of an animal model of schizophrenia","year":"1998","cit":0,"pfa":"C Ruob","ptype":"dissertation","src":"https://openalex.org/W2475464191","eid":"W2475464191"},{"id":"paper-w2891070042","cat":"papers","name":"Augmenting Subarachnoid Block Analgesia in Caesarean Section Delivery with Sub-Psychotomimetic Dose of Ketamine","year":"2018","cit":0,"pfa":"Rotimi Adegbenga Owolabi","psa":"Sunday Elisha Oyelere","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2891070042","eid":"W2891070042"},{"id":"paper-w2075040036","cat":"papers","name":"Sex, Drugs, Einstein, & Elves: Sushi, Psychedelics, Parallel Universes, and the Quest for Transcendence by Clifford A. Pickover. Smart Publications, Petaluma, CA, U.S.A., 2005. 318 pp., illus. ISBN: 1-890572-17-9","year":"2007","cit":0,"pfa":"Rob Harle","topics":["Reviews & meta-analyses"],"ptype":"book-review","src":"https://openalex.org/W2075040036","eid":"W2075040036"},{"id":"paper-w2013687102","cat":"papers","name":"Narcotic Plants, Hallucinogens, Stimulants, Inebriants and Hypnotics, their Origin and Uses. Von W. Emboden. 168 Seiten mit 95 farbigen Photographien und 39 Schwarz‐Weiß‐Zeichnungen bzw. Holzschnitten. Studio Vista Publi","year":"1972","cit":0,"pfa":"Harry Auterhoff","ptype":"article","src":"https://openalex.org/W2013687102","eid":"W2013687102"},{"id":"paper-w2002139832","cat":"papers","name":"Erika Dyck. Psychedelic Psychiatry: LSD from Clinic to Campus. Baltimore, MD: Johns Hopkins University Press, 2008. 199 pp. $35.00 (hardcover). ISBN‐13: 978‐0‐8018‐8994‐3","year":"2009","cit":0,"pfa":"NANCY D. CAMPBELL","ptype":"book-review","src":"https://openalex.org/W2002139832","eid":"W2002139832"},{"id":"paper-w2009664954","cat":"papers","name":"The effect of psychotomimetic glycolate and its antidote eserine on the ACh content of the lobster walking leg nerve","year":"1970","cit":0,"pfa":"W.‐D. Dettbarn","psa":"Bruce A. Hubbard","ptype":"article","src":"https://openalex.org/W2009664954","eid":"W2009664954"},{"id":"paper-w2418742637","cat":"papers","name":"[Use of preparations with an anticholinesterase effect for the abolition of disorders of higher nervous activity induced by various psychotomimetics].","year":"1968","cit":0,"pfa":"G I Mil'shteĭn","ptype":"article","src":"https://openalex.org/W2418742637","eid":"W2418742637"},{"id":"paper-w4235498151","cat":"papers","name":"THE MIND BENDERS: LSD AND THE HALLUCINOGENS (26 minutes, color, 1968). Produced by Vision Associates, under the sponsorship of the U.S. Food and Drug Administration. Available to medical facilities on free loan from the","year":"1970","cit":0,"ptype":"article","src":"https://openalex.org/W4235498151","eid":"W4235498151"},{"id":"paper-w7134228556","cat":"papers","name":"Nuclear Spin Modulation of Psychedelic Consciousness States: A Factorial fMRI Protocol Combining N,N-DMT with Krypton and Xenon Isotopes A Registered Report Protocol: Dissociating Spin Amplication, Anesthetic Suppression","year":"2026","cit":0,"pfa":"J.-P Pommier","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7134228556","eid":"W7134228556"},{"id":"paper-w7113571981","cat":"papers","name":"Do adolescents and adults differ in the acute subjective, psychotomimetic, and memory-impairing effects of cannabis?","year":"2021","cit":0,"pfa":"Tom Freeman","psa":"Katie Trinci","ptype":"preprint","src":"https://openalex.org/W7113571981","eid":"W7113571981"},{"id":"paper-w4312247514","cat":"papers","name":"Author response for \"The psychotomimetic ketamine disrupts the transfer of late sensory information in the corticothalamic network\"","year":"2022","cit":0,"pfa":"Yi Qin","psa":"Didier Pinault","ptype":"peer-review","src":"https://openalex.org/W4312247514","eid":"W4312247514"},{"id":"paper-w2095535289","cat":"papers","name":"Effects of antipsychotics haloperidol and risperidone and psychotomimetics amphetamine and MK-801 on brain neuropeptides and monoamines","year":"1997","cit":0,"pfa":"Aleksander A. Mathé","psa":"S.H.M. Gruber","ptype":"article","src":"https://openalex.org/W2095535289","eid":"W2095535289"},{"id":"paper-w3022984225","cat":"papers","name":"A single psychotomimetic dose of ketamine decreases thalamocortical spindles and delta oscillations in the sedated rat","year":"2020","cit":0,"pfa":"Didier Pinault","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W3022984225","eid":"W3022984225"},{"id":"paper-w2913154603","cat":"papers","name":"S.14.01 Involvement of the GluN2C subunit in the psychotomimetic effects of ketamine and other GluN receptor antagonists","year":"2019","cit":0,"pfa":"Mireia Tarrés Gatius","psa":"Anna Castañé","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2913154603","eid":"W2913154603"},{"id":"paper-w3159933559","cat":"papers","name":"マイクロドーズおよびPET分子イメージング臨床試験に関する海外動向調査 米国・英国・スウェーデン調査から（NEDO MicroDose-PJ）","year":"2010","cit":0,"pfa":"栗原 千絵子","psa":"伊藤 久裕","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3159933559","eid":"W3159933559"},{"id":"paper-w206919955","cat":"papers","name":"Uses and Abuses of Plant-Derived Smoke: Its Ethnobotany as Hallucinogen, Perfume, Incense, and Medicine by Marcello Pennacchio, Lara Jefferson, and Kayri Havens. 2010. Illustrated by David S. Sollenberger. Oxford Univers","year":"2012","cit":0,"pfa":"Leryn Gorlitsky","topics":["Addiction"],"ptype":"book-review","src":"https://openalex.org/W206919955","eid":"W206919955"},{"id":"paper-w7127377019","cat":"papers","name":"Biological variations in ketamine sensitivity: insights from hyperlocomotion to psychotomimetic features in genetically diverse mouse strains","year":"2026","cit":0,"pfa":"Wen-Huei Siao","psa":"Yi-Chyan Chen","ptype":"article","src":"https://openalex.org/W7127377019","eid":"W7127377019"},{"id":"paper-w2413389641","cat":"papers","name":"[Effects of tranquilizing drugs and psychotomimetic agents on the incorporation of (32P) orthophosphate into phospholipids of brain cortex slices].","year":"1965","cit":0,"pfa":"Takeshi Suzuki","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2413389641","eid":"W2413389641"},{"id":"paper-w2952984022","cat":"papers","name":"ChemInform Abstract: IN VITRO O‐DEMETHYLATION OF THE PSYCHOTOMIMETIC AMINE, 1‐(2,5‐DIMETHOXY‐4‐METHYLPHENYL)‐2‐AMINOPROPANE","year":"1977","cit":0,"pfa":"Jonathan S. Zweig","psa":"Neal Castagnoli","ptype":"article","src":"https://openalex.org/W2952984022","eid":"W2952984022"},{"id":"paper-w2189475318","cat":"papers","name":"Comparison of the ultrashort gonadotropin- releasing hormone agonist-antagonist protocol with microdose flare -up protocol in poor responders: a preliminary study Zayif over cevapli hastalarda ultra kisa GnRH agonist/ant","year":"2010","cit":0,"pfa":"Bülent Berker","psa":"Cemil Kaya","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2189475318","eid":"W2189475318"},{"id":"paper-w7135471142","cat":"papers","name":"Rapid acting antidepressants - current status and new developments. Part 2: Psychedelics, neurosteroids and further compounds Schnell wirkende Antidepressiva: aktueller Stand und neue Entwicklungen Teil 2: Psychedelika,","year":"2024","cit":0,"pfa":"Christine Reif-Leonhard","psa":"Andreas Reif","topics":["Depression"],"ptype":"review","src":"https://openalex.org/W7135471142","eid":"W7135471142"},{"id":"paper-w4242823537","cat":"papers","name":"Hallucinogens: Neurochemical, Behavioral and Clinical Perspectives. Edited by B. L. Jacobs. (Pp. 233; illustrated; $61.50.) Raven Press: New York. 1984. - Peptides, Hormones and Behavior. Edited by C. B. Nemeroff and A.","year":"1984","cit":0,"ptype":"book-review","src":"https://openalex.org/W4242823537","eid":"W4242823537"},{"id":"paper-w3162147712","cat":"papers","name":"Cynthia Carson Bisbee, Paul Bisbee, Erika Dyck, Patrick Farrell, James Sexton, and James W. Spisak, eds., Psychedelic Prophets: The Letters of Aldous Huxley and Humphry Osmond. Montreal: McGill-Queen’s University Press,","year":"2021","cit":0,"pfa":"Stephen Snelders","ptype":"article","src":"https://openalex.org/W3162147712","eid":"W3162147712"},{"id":"paper-w3099731127","cat":"papers","name":"Consumer's Guide to a Social Problem: Licit and Illicit Drugs . The Consumers Union Report on Narcotics, Stimulants, Depressants, Inhalants, Hallucinogens, and Marijuana—Including Caffeine, Nicotine, and Alcohol. Edward","year":"1973","cit":0,"pfa":"Reese T. Jones","topics":["Depression","Addiction"],"ptype":"book-review","src":"https://openalex.org/W3099731127","eid":"W3099731127"},{"id":"paper-w2973993434","cat":"papers","name":"Comparison of the Effects of Haloperidol and Midazolam on Reduction of Adverse Psychotomimetic Reactions after Induction of Anesthesia with Ketamine in Adults","year":"2019","cit":0,"pfa":"Alireza Takzare","psa":"Shahram Bagheri Hariri","topics":["Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2973993434","eid":"W2973993434"},{"id":"paper-w1661922314","cat":"papers","name":"Genetic variation in Rasd2 modulates psychotomimetic drug effects in mice and schizophrenia-related phenotypes in humans","year":"2015","cit":0,"pfa":"Annabella Di Giorgio","psa":"Francesco Napolitano","ptype":"article","src":"https://openalex.org/W1661922314","eid":"W1661922314"},{"id":"paper-w2396823663","cat":"papers","name":"[RECENT PROGRESS IN RESEARCH IN PSYCHOTROPIC DRUGS: THE PSYCHOTOMIMETIC ACTION OF BENZOQUINOLIZINE AND PIPERIDYL GLYCOLATES AND THEIR STRUCTURE ACTIVITY RELATIONSHIPS].","year":"1964","cit":0,"pfa":"Fu Nw","ptype":"article","src":"https://openalex.org/W2396823663","eid":"W2396823663"},{"id":"paper-w7125944209","cat":"papers","name":"ADME profile of phencyclidine (PCP) analogues: emerging dissociative hallucinogens 3-MeO-PCP (CAS: 72242-03-6) and 4-MeO-PCP (CAS: 2201-35-6)—a multi-in silico approach for comprehensive prediction of absorption, distrib","year":"2026","cit":0,"pfa":"Kamil Jurowski","psa":"Maciej Noga","ptype":"article","src":"https://openalex.org/W7125944209","eid":"W7125944209"},{"id":"paper-w630030894","cat":"papers","name":"Psychotomimetic drugs : proceedings of a workshop organized by the Pharmacology Section, Psychopharmacology Research Branch, National Institute of Mental Health","year":"1970","cit":0,"pfa":"Daniel H. Efron","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W630030894","eid":"W630030894"},{"id":"paper-w4254960869","cat":"papers","name":"Faculty Opinions recommendation of The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis.","year":"2012","cit":0,"pfa":"Matthew Hickman","psa":"Stanley Zammit","ptype":"peer-review","src":"https://openalex.org/W4254960869","eid":"W4254960869"},{"id":"paper-w412867500","cat":"papers","name":"マイクロドーズ臨床試験を活用した革新的創薬技術の開発(NEDO MICRODOSE-PJ) 2010 (12):[11C]テルミサルタンによるPETマイクロドーズ試験(予備試験)","year":"2010","cit":0,"pfa":"浩充 景山","psa":"道雄 千田","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W412867500","eid":"W412867500"},{"id":"paper-w2083189251","cat":"papers","name":"Phencyclidine and σ-psychotomimetic drugs activate mesocorticolimbic dopamine neurons through the nonhaloperidol sensitive phencyclidine binding site.","year":"1989","cit":0,"pfa":"EdwardD. French","psa":"Angelo Ceci","ptype":"article","src":"https://openalex.org/W2083189251","eid":"W2083189251"},{"id":"paper-w2316004447","cat":"papers","name":"Poster #T15 POSTNATAL MGLUR5 ABLATION FROM PARVALBUMIN-POSITIVE INTERNEURONS ALTERS THE RESPONSIVITY TO PSYCHOTOMIMETIC DRUGS","year":"2014","cit":0,"pfa":"Samuel A. Barnes","psa":"Athina Markou","ptype":"article","src":"https://openalex.org/W2316004447","eid":"W2316004447"},{"id":"paper-w4229587379","cat":"papers","name":"Possession By E. Bourgignon. (Pp. 78; illustrated; $2.50.) Chandler & Sharpe: California. 1976. - Dreams, Culture and the Individual By C. W. O'Nell. (Pp. 88; $2.50.) Chandler & Sharpe: California. 1976. - Hallucinogens","year":"1977","cit":0,"ptype":"article","src":"https://openalex.org/W4229587379","eid":"W4229587379"},{"id":"paper-w2416158666","cat":"papers","name":"[Potential psychotropes. IX. Synthesis and structure of compounds derived from 3-amino-1-tetralol and related to various psychotomimetics].","year":"1971","cit":0,"pfa":"ROBERT VIOLLAND","psa":"Henri Pacheco","ptype":"article","src":"https://openalex.org/W2416158666","eid":"W2416158666"},{"id":"paper-w2994548487","cat":"papers","name":"AZALMIŞ OVER RESERVİ OLAN OLGULARDA LONG GNRH AGONİST, GNRH ANTAGONİST VE MİKRODOZ FLARE-UP AGONİST PROTOKOLLERİNİN IVF SONUÇLARI ÜZERİNE ETKİSİ Effect of long GnRH Agonist, GnRH Antagonist and Microdose Flare-up Agonist","year":"2019","cit":0,"pfa":"Runa Özelçi","psa":"Özlem Moraloğlu Tekın","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2994548487","eid":"W2994548487"},{"id":"paper-w2338612785","cat":"papers","name":"Comparison of GnRH-Agonist Microdose Flare-up Protocol and Flexible Multiple Dose Antagonistic Protocol in Poor Responder Patients Undergoing Intracytoplasmic Sperm Injection Cycle Zayif Over Yanitli Olgularda GnRH-Agoni","year":"2013","cit":0,"pfa":"Mehmet Serdar Kütük","psa":"Ercan Aygen","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2338612785","eid":"W2338612785"},{"id":"paper-w4388834382","cat":"papers","name":"Coming down from the American trip Review of ‘American Trip. Set, Setting, and the Psychedelic Experience in the Twentieth Century’ , by Hartogsohn, Ido, Cambridge, MA, USA: The MIT Press, 2020, 432 pages, Price $35.00,","year":"2023","cit":0,"pfa":"Claudia G. Schwarz-Plaschg","topics":["Reviews & meta-analyses"],"ptype":"book-review","src":"https://openalex.org/W4388834382","eid":"W4388834382"},{"id":"paper-w3022012225","cat":"papers","name":"ChemInform Abstract: POTENTIAL PSYCHOTOMIMETICS PART 2, RIGID ANALOGS OF 2,5‐DIMETHOXY‐4‐METHYLPHENYLISOPROPYLAMINE (DOM,STP)","year":"1974","cit":0,"pfa":"David E. Nichols","psa":"D. C. Dyer","ptype":"article","src":"https://openalex.org/W3022012225","eid":"W3022012225"},{"id":"paper-w7165497705","cat":"papers","name":"Comparaison des stratégies d'entraînement sur les qualités de force et de puissance musculaire des membres inférieurs dans le football élite en période de compétition : microdosing chez les professionnels versus séance u","year":"2025","cit":0,"pfa":"Thibault Fontaine","topics":["Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7165497705","eid":"W7165497705"},{"id":"paper-w379012021","cat":"papers","name":"マイクロドーズ臨床試験を活用した革新的創薬技術の開発(NEDO MICRODOSE-PJ) ２０１０（５）:ベータブロッカーの消化管吸収におけるOATP2B1の役割","year":"2010","cit":0,"pfa":"和哉 前田","psa":"雄一 杉山","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W379012021","eid":"W379012021"},{"id":"paper-w4230403819","cat":"papers","name":"Faculty Opinions recommendation of Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study: naturalistic study [corrected].","year":"2011","cit":0,"pfa":"Roger G. Pertwee","topics":["Addiction"],"ptype":"peer-review","src":"https://openalex.org/W4230403819","eid":"W4230403819"},{"id":"paper-w3043327229","cat":"papers","name":"マイクロドース臨床試験を活用した革新的創薬技術の開発(NEDO MICRODOSE-PJ)2011-(4)-スルファサラジン,ロスバスタチンの経口吸収に対するOATP2B1 SNPの効果","year":"2011","cit":0,"pfa":"洋之 楠原","psa":"杉山雄一","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3043327229","eid":"W3043327229"},{"id":"paper-w2152249337","cat":"papers","name":"Don Lattin. The Harvard Psychedelic Club: How Timothy Leary, Ram Dass, Huston Smith, and Andrew Weil Killed the Fifties and Ushered in a New Age for America. New York: HarperCollins, 2010. 256 pp. $24.99 (cloth). ISBN 97","year":"2010","cit":0,"pfa":"NANCY D. CAMPBELL","ptype":"book-review","src":"https://openalex.org/W2152249337","eid":"W2152249337"},{"id":"paper-w2020405046","cat":"papers","name":"P.3.b.010 Structural brain abnormalities and altered sensitivity to psychotomimetic drugs in neuregulin-1 knockout mice","year":"2009","cit":0,"pfa":"Colm M. P. O’Tuathaigh","psa":"J.L. Waddington","ptype":"article","src":"https://openalex.org/W2020405046","eid":"W2020405046"},{"id":"paper-w372770839","cat":"papers","name":"マイクロドーズ臨床試験を活用した革新的創薬技術の開発- (NEDO MICRODOSE-PJ) 2010-(4):スルファサラジンの経口吸収におけるクルクミンの効果","year":"2010","cit":0,"pfa":"洋之 楠原","psa":"雄一 杉山","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W372770839","eid":"W372770839"},{"id":"paper-w2025159681","cat":"papers","name":"Book review: Saldanha, A. 2007: Psychedelic white: Goa trance and the viscosity of race. Minneapolis, MN: University of Minnesota Press. 288 pp. US$60 cloth, US$20 paper. ISBN: 978 0 8166 4993 8 cloth, 978 0 81664994 5 p","year":"2008","cit":0,"pfa":"Alistair Bonnet","topics":["Reviews & meta-analyses"],"ptype":"book-review","src":"https://openalex.org/W2025159681","eid":"W2025159681"},{"id":"paper-w350975638","cat":"papers","name":"マイクロドーズ臨床試験を活用した革新的創薬技術の開発（NEDO MicroDose-PJ）2010(1):マイクロドーズ臨床試験に関する規制文書の国際比較","year":"2010","cit":0,"pfa":"千絵子 栗原","psa":"雄一 杉山","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W350975638","eid":"W350975638"},{"id":"paper-w4404190471","cat":"papers","name":"\"U.P. 2.0\": Ulysses Goes Psychedelic … Twice! The 2024 Bloomsday Report: A Round-Up of Global Events Plus Reviews of \"Bloomsday Psychedelia\" in Venice, California, and the World Premiere of Elevator Repair Service's Thea","year":"2024","cit":0,"pfa":"Richard J. Gerber","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4404190471","eid":"W4404190471"},{"id":"paper-w3186867073","cat":"papers","name":"Les microdoses de sucres: una stratégie de biocontrôle chez la vigne?: Comment les sucres simples peuvent être perçus par la plante et qu'en est-il de leur impact sur l'expression de gènes associés au métabolisme carboné","year":"2021","cit":0,"pfa":"Lucile Jacquens","psa":"Nicolas Aveline","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3186867073","eid":"W3186867073"},{"id":"paper-w3003342634","cat":"papers","name":"ヒト血漿中セリプロロール,アテノロール及びフェキソフェナジンのLC/MS/MS法による高感度分析法の開発(NEDO MicroDose-PJ) | 文献情報 | J-GLOBAL 科学技術総合リンクセンター","year":"2010","cit":0,"pfa":"中村剛","psa":"杉山雄一","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3003342634","eid":"W3003342634"},{"id":"paper-w256648709","cat":"papers","name":"マイクロドーズ臨床試験を活用した革新的創薬技術の開発(NEDO MICRODOSE-PJ) 2010-(14)- ヒト脳におけるカチオン性薬物の脳内動態予測","year":"2010","cit":0,"pfa":"呉 春勇","psa":"杉山 雄一","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W256648709","eid":"W256648709"},{"id":"paper-w236038304","cat":"papers","name":"マイクロドーズ臨床試験を活用した革新的創薬技術の開発 (MicroDose-PJ) 2010 (3) -日本におけるマイクロドーズ臨床試験の費用効果分析-","year":"2010","cit":0,"pfa":"尚恵 山根","psa":"雄一 杉山","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W236038304","eid":"W236038304"},{"id":"paper-w4387690965","cat":"papers","name":"Potential Psychotomimetic Antagonists. N,n -diethyl-1-methyl-3-aryl-1, 2, 5, 6-tetrahydropyridine-5-carboxamides.","year":"1978","cit":0,"pfa":"Thomas J. Mangner","ptype":"dissertation","src":"https://openalex.org/W4387690965","eid":"W4387690965"},{"id":"paper-w2996267679","cat":"papers","name":"Cynthia Carson Bisbee, Paul Bisbee, Erika Dyck, Patrick Farrell, James Sexton and James W. Spisak (eds), Psychedelic Prophets: The Letters of Aldous Huxley and Humphry Osmond (Montreal and Kingston: McGill-Queen’s Univer","year":"2019","cit":0,"pfa":"Tara H. Abraham","ptype":"book-review","src":"https://openalex.org/W2996267679","eid":"W2996267679"},{"id":"paper-w2952174371","cat":"papers","name":"ChemInform Abstract: SULFUR ANALOGS OF PSYCHOTOMIMETIC AGENTS. 2. ANALOGS OF (2,5‐DIMETHOXY‐4‐METHYLPHENYL)‐ AND OF (2,5‐DIMETHOXY‐4‐ETHYLPHENYL)ISOPROPYLAMINE","year":"1983","cit":0,"pfa":"Peyton Jacob","psa":"Alexander T. Shulgin","ptype":"article","src":"https://openalex.org/W2952174371","eid":"W2952174371"},{"id":"paper-w2949695309","cat":"papers","name":"ChemInform Abstract: STEREOCHEMICAL ASPECTS AND METABOLITE FORMATION IN THE IN VIVO METABOLISM OF THE PSYCHOTOMIMETIC AMINE, 1‐(2,5‐DIMETHOXY‐4‐METHYLPHENYL)‐2‐AMINOPROPANE","year":"1974","cit":0,"pfa":"S.B. Matin","psa":"Neal Castagnoli","ptype":"article","src":"https://openalex.org/W2949695309","eid":"W2949695309"},{"id":"paper-w2413185968","cat":"papers","name":"[A psychophysiological study on the dreamlike experience induced by intravenous injection of ketamine (2-(o-chlorophenyl)-2-methylamino-cyclohexanone HCl). A contribution to the study of psychotomimetic drugs].","year":"1971","cit":0,"pfa":"TETSUO OKUMA","psa":"Takami Nakao","ptype":"article","src":"https://openalex.org/W2413185968","eid":"W2413185968"},{"id":"paper-w2950024033","cat":"papers","name":"ChemInform Abstract: IN VITRO STEREOSELECTIVE METABOLISM OF THE PSYCHOTOMIMETIC AMINE, 1‐(2,5‐DIMETHOXY‐4‐METHYLPHENYL)‐2‐AMINOPROPANE. AN APPARENT ENANTIOMERIC INTERACTION","year":"1977","cit":0,"pfa":"N. Peter McGraw","psa":"Neal Castagnoli","ptype":"article","src":"https://openalex.org/W2950024033","eid":"W2950024033"},{"id":"paper-w2394760199","cat":"papers","name":"A contribution to the content of the psychotomimetically active delta9-tetrahydrocannabinol in female (Marijuana) and male flowering tops of Cannabis sativa L. cultivated in climatic conditions of Czechoslovakia.","year":"1978","cit":0,"pfa":"Lumir Ondrej Hanus","ptype":"article","src":"https://openalex.org/W2394760199","eid":"W2394760199"},{"id":"paper-w3196449449","cat":"papers","name":"微量投与臨床試験を用いた革新的薬物開発方法(NEDO MICRODOSE-PJ)2010(8)-メトホルミンと強力なMATE阻害剤,ピリメタミンの間の薬物-薬物相互作用","year":"2010","cit":0,"pfa":"Ito Sumito","psa":"Yuichi Sugiyama","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3196449449","eid":"W3196449449"},{"id":"paper-w3163773193","cat":"papers","name":"Trends of CNS ( central neurons ) research. I. Consciousness disorders, hallucination and delusion by psychotomimetic agents, phencyclidine. Behavior disorders and nervous functional disorders in animals.","year":"1997","cit":0,"pfa":"Toshitaka Nabeshima","psa":"Yukihiro Noda","ptype":"article","src":"https://openalex.org/W3163773193","eid":"W3163773193"},{"id":"paper-w2460045168","cat":"papers","name":"Suicide and the Soul. By James Hillman. London: Hodder and Stoughton. Pp. 191. 1964. 25s. - Psychedelic Experience. A Manual based on the Tibetan Book of the Dead. By Timothy Leary, Ph.D., Ralph Metzner, Ph.D., Richard A","year":"1965","cit":0,"pfa":"Erwin Stengel","ptype":"article","src":"https://openalex.org/W2460045168","eid":"W2460045168"},{"id":"paper-w7143799359","cat":"papers","name":"The toxicity of psychedelic LSD derivatives: 1-acetyl-LSD (ALD-52), 1-propionyl-LSD (1P-LSD), 1-butyryl-LSD (1B-LSD), 1-valeryl-LSD (1V-LSD) and 1-cyclopropylmethanoyl-LSD (1cP-LSD)—prediction of toxicological parameters","year":"2026","cit":0,"pfa":"Kamil Jurowski","psa":"Oktawia Fijałkowska","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7143799359","eid":"W7143799359"},{"id":"paper-w393185699","cat":"papers","name":"マイクロドーズ臨床試験を活用した革新的創薬技術の開発(NEDO MICRODOSE-PJ) 2010-(13):-Positron Emission Tomography(PET)を用いたヒトにおける消化管吸収過程の評価","year":"2010","cit":0,"pfa":"忠之 高島","psa":"伸二 山下","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W393185699","eid":"W393185699"},{"id":"paper-w2372735820","cat":"papers","name":"Pediatric Microdose Study of ( 14 C)Paracetamol to Study Drug Metabolism Using Accelerated Mass Spectrometry: Proof of Concept Miriam G. MooijEsther van DuijnCatherijne A. J. KnibbeAlbert D. Windhorst • N. Harry Hendriks","year":"2014","cit":0,"pfa":"Miriam G. Mooij","psa":"Erasmus Mc","topics":["Safety & adverse events","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2372735820","eid":"W2372735820"},{"id":"paper-w399617482","cat":"papers","name":"マイクロドーズ臨床試験を活用した革新的創薬技術の開発(NEDO MicroDose-PJ) 2010 (11) 14C-トルブタミドを単回経口投与したマイクロドーズ臨床試験におけるCYP2C9遺伝多型が関わる薬物動態","year":"2010","cit":0,"pfa":"青山 晋輔","psa":"杉山 雄一","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W399617482","eid":"W399617482"},{"id":"paper-w620774828","cat":"papers","name":"F1: はじめにF2: 早期臨床試験における安全性の確保について,ICH-M3から最近のEMEA通知を踏まえてF3: Microdosingにおける安全性の確保と考え方F4: Hot化合物の品質基準F5: Microdosingによるヒトにおける初期探索試験F6: 追加発言F7: PETによるヒトin vivoでの薬物の評価F8: EU,英国の倫理審査システムの改革と日本への提言","year":"2004","cit":0,"pfa":"泰雄 大野","psa":"千絵子 栗原","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W620774828","eid":"W620774828"},{"id":"paper-w7115164128","cat":"papers","name":"Amanita Muscaria and Pantherina – Benefit or Danger? Danger Isoxazole Containing Amanita, Present Situation and Prospects for the Legality of It in Europe","year":"2025","cit":0,"pfa":"E. Alexandrova","psa":"M. Vishnevskii","topics":["Addiction","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7115164128","eid":"W7115164128"},{"id":"paper-w1516766715","cat":"papers","name":"Cognitive dysfunction and schizophrenia : Modelling attentional impairment with psychotomimetics. Investigating attentional impairment and structural brain abnormalities following phencyclidine administration: Enhancing","year":"2011","cit":0,"pfa":"Samuel A. Barnes","ptype":"dissertation","src":"https://openalex.org/W1516766715","eid":"W1516766715"},{"id":"paper-w4382727838","cat":"papers","name":"Existential therapy of the Sumerian-Akkadian civilization: what the ancestral experience teaches","year":"2022","cit":0,"pfa":"Konstantin V. Ivanov","topics":["Addiction","Anxiety & end-of-life","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4382727838","eid":"W4382727838"},{"id":"paper-w4416515116","cat":"papers","name":"Investigating Safety Concerns and Harm Reduction in Entheogenic Churches: The Case for Community-Based Participatory Research","year":"2025","cit":0,"pfa":"Maha N. Mian","psa":"Brian T. Anderson","topics":["Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W4416515116","eid":"W4416515116"},{"id":"paper-w7213816735","cat":"papers","name":"The new method of examining mental patients in 1850","year":"2020","cit":0,"pfa":"Thierry Haustgen","ptype":"article","src":"https://openalex.org/W7213816735","eid":"W7213816735"},{"id":"paper-w4200147198","cat":"papers","name":"Subjektívne vnímané riziká užívania psychedelík","year":"2021","cit":0,"pfa":"Ústav aplikovanej psychológie, FSEV UK, Bratislava, Slovakia","psa":"Ústav aplikovanej psychológie, FSEV UK, Bratislava, Slovakia","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4200147198","eid":"W4200147198"},{"id":"paper-w2505726547","cat":"papers","name":"Neuropsychopharmacology as Spiritual Technology","year":"2012","cit":0,"pfa":"Nicolas Langlitz","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W2505726547","eid":"W2505726547"},{"id":"paper-w7167626410","cat":"papers","name":"Set and Setting in Virtual Psychedelia: A Naturalistic Study of Phenomenology, Predictors, and Physiological Correlates","year":"2026","cit":0,"pfa":"Hüseyin Beyköylü","psa":"Michiel van Elk","topics":["Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7167626410","eid":"W7167626410"},{"id":"paper-w7167642051","cat":"papers","name":"Set and Setting in Virtual Psychedelia: A Naturalistic Study of Phenomenology, Predictors, and Physiological Correlates","year":"2026","cit":0,"pfa":"Hüseyin Beyköylü","psa":"Michiel van Elk","topics":["Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7167642051","eid":"W7167642051"},{"id":"paper-w7161827368","cat":"papers","name":"Pharmacology II","year":"2026","cit":0,"pfa":"Cynthia Faulkner","psa":"Samuel S. Faulkner","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W7161827368","eid":"W7161827368"},{"id":"paper-w617784406","cat":"papers","name":"脳神経系領域-1-向精神薬-d-精神変容剤(Psychodysleptics,Psychotomimetics) (最新薬物療法manual--投薬の基本と治療プログラム) -- (新しい治療薬:作用機序・分類・使用法)","year":"1981","cit":0,"pfa":"昭和 植木","ptype":"article","src":"https://openalex.org/W617784406","eid":"W617784406"},{"id":"paper-w4417090263","cat":"papers","name":"Clinical and Prognostic Findings in Psychotropic Substance Poisoning: A Cross-sectional Study","year":"2025","cit":0,"pfa":"Hanieh Hatampour","psa":"Hamid Owliaey","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4417090263","eid":"W4417090263"},{"id":"paper-w2057048158","cat":"papers","name":"LSD Use as a barrier to public safety employment: A review of the medical findings","year":"1992","cit":0,"pfa":"Carol Henry","psa":"Peter V. DiVasto","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2057048158","eid":"W2057048158"},{"id":"paper-w2957011348","cat":"papers","name":"Individual Experiences and Subjective Effects of Salvia Divinorum Among Recreational Users","year":"2008","cit":0,"pfa":"Laura E. Grubbs","topics":["Addiction","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"conference-paper","src":"https://openalex.org/W2957011348","eid":"W2957011348"},{"id":"paper-w7161797790","cat":"papers","name":"Beyond Description: A Critical Analysis of the Theological Construction of Entheogenic Discourses","year":"2026","cit":0,"pfa":"Hollis Phelps","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7161797790","eid":"W7161797790"},{"id":"paper-w4406314408","cat":"papers","name":"Manufacturing the Entheogenic Underground","year":"2025","cit":0,"pfa":"Brad Stoddard","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4406314408","eid":"W4406314408"},{"id":"paper-w4367318573","cat":"papers","name":"Cortical thickness of the posterior cingulate cortex is associated with the ketamine-induced altered sense of self: An ultra-high field MRI study","year":"2023","cit":0,"pfa":"Lena Vera Danyeli","psa":"Meng Li","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4367318573","eid":"W4367318573"},{"id":"paper-w4361950722","cat":"papers","name":"Data from Toward Prediction of Efficacy of Chemotherapy: A Proof of Concept Study in Lung Cancer Patients Using [11C]docetaxel and Positron Emission Tomography","year":"2023","cit":0,"pfa":"Astrid A.M. van der Veldt","psa":"Adriaan A. Lammertsma","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W4361950722","eid":"W4361950722"},{"id":"paper-w4361960227","cat":"papers","name":"Data from Toward Prediction of Efficacy of Chemotherapy: A Proof of Concept Study in Lung Cancer Patients Using [11C]docetaxel and Positron Emission Tomography","year":"2023","cit":0,"pfa":"Astrid A.M. van der Veldt","psa":"Adriaan A. Lammertsma","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W4361960227","eid":"W4361960227"},{"id":"paper-w3081316580","cat":"papers","name":"[The rise, fall, and possible rise of LSD].","year":"2020","cit":0,"pfa":"Stephen Snelders","psa":"Toine Pieters","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W3081316580","eid":"W3081316580"},{"id":"paper-w7111501674","cat":"papers","name":"Neurological Foundations of Hallucinogenic Experiences: Biochemical and Cellular Mechanisms Potentially Underlying Ego Dissolution & Long Term Changes in Behavior and","year":"2024","cit":0,"pfa":"Aramis D. M. Valverde","topics":["Addiction","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7111501674","eid":"W7111501674"},{"id":"paper-w7131934319","cat":"papers","name":"Myslet z psychedelických zkušeností: transdisciplinární interpretace","year":"2016","cit":0,"pfa":"V. (Vladislav) Pokorný","topics":["Addiction","Reviews & meta-analyses"],"ptype":"book","src":"https://openalex.org/W7131934319","eid":"W7131934319"},{"id":"paper-w4392688775","cat":"papers","name":"Data from Oxaliplatin–DNA Adducts as Predictive Biomarkers of FOLFOX Response in Colorectal Cancer: A Potential Treatment Optimization Strategy","year":"2023","cit":0,"pfa":"Maike Zimmermann","psa":"Paul T. Henderson","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W4392688775","eid":"W4392688775"},{"id":"paper-w4402526890","cat":"papers","name":"Safety and efficacy of low dose or no heparinization in cerebral angiography: A randomized controlled study (SELECT trial)","year":"2024","cit":0,"pfa":"Zheng Wang","psa":"Liqun Jiao","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4402526890","eid":"W4402526890"},{"id":"paper-w4408970582","cat":"papers","name":"Molecular dynamics study of differential effects of serotonin-2A-receptor (5-HT2AR) modulators","year":"2025","cit":0,"pfa":"Jordy Peeters","psa":"Kenno Vanommeslaeghe","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4408970582","eid":"W4408970582"},{"id":"paper-w2794552715","cat":"papers","name":"Can nitric oxide tame the ketamine tiger?","year":"2018","cit":0,"pfa":"James Wallace Sleigh","ptype":"article","src":"https://openalex.org/W2794552715","eid":"W2794552715"},{"id":"paper-w7135817839","cat":"papers","name":"Subjektivní zkušenosti uživatelů psychedelik: rizika a náročné zkušenosti","year":"2021","cit":0,"pfa":"Kamila Bednářová","topics":["Addiction","Reviews & meta-analyses","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W7135817839","eid":"W7135817839"},{"id":"paper-w4409281344","cat":"papers","name":"324. Effects of Hallucinogenic Drug Use on Neurocognitive Function and Mental Health: An International Online Study","year":"2025","cit":0,"pfa":"Johan Saelens","psa":"Christoph Kraus","ptype":"article","src":"https://openalex.org/W4409281344","eid":"W4409281344"},{"id":"paper-w103958814","cat":"papers","name":"Albert Hofmann, LSD and the Formation of the Lost Field of Parapsychopharmacology","year":"2009","cit":0,"pfa":"David P. Luke","topics":["Addiction","Dosing & pharmacology"],"ptype":"dataset","src":"https://openalex.org/W103958814","eid":"W103958814"},{"id":"paper-w4362567719","cat":"papers","name":"Data from Oxaliplatin–DNA Adducts as Predictive Biomarkers of FOLFOX Response in Colorectal Cancer: A Potential Treatment Optimization Strategy","year":"2023","cit":0,"pfa":"Maike Zimmermann","psa":"Paul T. Henderson","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W4362567719","eid":"W4362567719"},{"id":"paper-w4388165630","cat":"papers","name":"The drug therapy of psychiatric disorders","year":"2002","cit":0,"pfa":"A. David Smith","psa":"Jeffrey K Aronson","ptype":"book-chapter","src":"https://openalex.org/W4388165630","eid":"W4388165630"},{"id":"paper-w4400976114","cat":"papers","name":"Psychedelia Britannia: Druids on Drugs","year":"2024","cit":0,"pfa":"Andy Letcher","ptype":"book-chapter","src":"https://openalex.org/W4400976114","eid":"W4400976114"},{"id":"paper-w2728609514","cat":"papers","name":"Down The Rabbit Hole: A Look At The Therapeutic Healing Potentials","year":"2017","cit":0,"pfa":"Shannon Tully","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W2728609514","eid":"W2728609514"},{"id":"paper-w4389662958","cat":"papers","name":"The Unbound Seed: Discussion of The Bad Seed: Mystical Experiences and Time Travel in the Treatment of Psychopathy","year":"2023","cit":0,"pfa":"Megan Rundel","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W4389662958","eid":"W4389662958"},{"id":"paper-w4243391652","cat":"papers","name":"Addiction Potential of Abused Drugs","year":"2013","cit":0,"pfa":"Marilyn E. Carroll","topics":["Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W4243391652","eid":"W4243391652"},{"id":"paper-w7154996214","cat":"papers","name":"Electrocorticographic Changes and Neuronal Maturation in the Antidepressant-like and Anxiolytic Effects of Micro- or Macrodosing of Psilocybe cubensis Mushroom in Mice","year":"2026","cit":0,"pfa":"Flor Eréndira Sánchez-Cortés","psa":"Erika Monserrat Estrada-Camarena","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7154996214","eid":"W7154996214"},{"id":"paper-w4236751497","cat":"papers","name":"Lysergic and Diethylamide","year":"2010","cit":0,"pfa":"Gabriele Fischer","psa":"Helen E. Gibson","ptype":"reference-entry","src":"https://openalex.org/W4236751497","eid":"W4236751497"},{"id":"paper-w629292393","cat":"papers","name":"Origin and mechanisms of hallucinations : proceedings of the 14th annual meeting of the Eastern Psychiatric Research Association held in New York City, November 14-15, 1969","year":"1970","cit":0,"pfa":"WOLFRAM KEUP","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"book","src":"https://openalex.org/W629292393","eid":"W629292393"},{"id":"paper-w7135875038","cat":"papers","name":"Minimalizace rizik užívání psychedelik za účelem podpory veřejného zdraví v regionu","year":"2021","cit":0,"pfa":"Tereza Ocetková","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7135875038","eid":"W7135875038"},{"id":"paper-w7141286354","cat":"papers","name":"Clinical Vignette","year":"2024","cit":0,"topics":["Safety & adverse events"],"ptype":"report","src":"https://openalex.org/W7141286354","eid":"W7141286354"},{"id":"paper-w4404063991","cat":"papers","name":"1375 Functional spatial profiling of CIVO® intratumoral responses to checkpoint inhibitors in the intact human tumor microenvironment reveals signatures consistent with patient treatment outcomes","year":"2024","cit":0,"pfa":"Kenneth R. Gundle","psa":"Connor Burns","topics":["Anxiety & end-of-life","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"conference-abstract","src":"https://openalex.org/W4404063991","eid":"W4404063991"},{"id":"paper-w4390594933","cat":"papers","name":"[Therapeutic applications of classical serotonergic psyche-delics: neurobiological mechanisms and neural networks].","year":"2023","cit":0,"pfa":"Maura Seynaeve","psa":"Michiel van Elk","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"other","src":"https://openalex.org/W4390594933","eid":"W4390594933"},{"id":"paper-w4385217814","cat":"papers","name":"Klassieke psychedelica: veiligheid, neveneffecten en medicatie-interacties","year":"2023","cit":0,"pfa":"E. Geleyn","psa":"Gilbert M. D. Lemmens","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4385217814","eid":"W4385217814"},{"id":"paper-w3005393436","cat":"papers","name":"Pharmacokinetics: How Do Drugs Get There and What Do They Do?","year":"2013","cit":0,"pfa":"John Brick","psa":"Carlton K. Erickson","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W3005393436","eid":"W3005393436"},{"id":"paper-w7167605912","cat":"papers","name":"Turning Toward Addiction - Understanding the Desire, Holding the Reality, and Letting Go of the Parts That Don't Belong","year":"2026","cit":0,"pfa":"Jamison Johsnon","topics":["Addiction","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W7167605912","eid":"W7167605912"},{"id":"paper-w7208803867","cat":"papers","name":"Pyschedelics in Child and Adolescent Psychiatry: Mechanisms, Clinical Potentials, and Developmental Considerations","year":"2026","cit":0,"pfa":"Madeline Chidiac","psa":"Mihir Pandya","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7208803867","eid":"W7208803867"},{"id":"paper-w7117990846","cat":"papers","name":"Psychedelicasies","year":"2025","cit":0,"pfa":"Richard G. Alexander","ptype":"book-chapter","src":"https://openalex.org/W7117990846","eid":"W7117990846"},{"id":"paper-w249603330","cat":"papers","name":"A human vascular model based on microdialysis for the assessment of the vasoconstrictive dose-response effects of noradrenaline and vasopressin in skin : in JOURNAL OF VASCULAR RESEARCH, vol 48, pp 320-320","year":"2011","cit":0,"pfa":"Tchou Folkesson","psa":"Folke Sjöberg","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W249603330","eid":"W249603330"},{"id":"paper-w4401919596","cat":"papers","name":"Transition from methadone to subcutaneous buprenorphine depot in patients with opioid use disorder - a case report","year":"2024","cit":0,"pfa":"Mirjana Delic","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4401919596","eid":"W4401919596"},{"id":"paper-w3006226934","cat":"papers","name":"Psykedelisk transformation - en fenomenologisk studie om att förändras genom bruk av psykedeliska substanser","year":"2020","cit":0,"pfa":"Elin Westergren","topics":["Addiction"],"ptype":"other","src":"https://openalex.org/W3006226934","eid":"W3006226934"},{"id":"paper-w7135888576","cat":"papers","name":"Specifics of Coping with a Difficult LSD Experience / Bad Trip and Its Reflection","year":"2025","cit":0,"pfa":"Ondřej Kučera","topics":["Safety & adverse events","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W7135888576","eid":"W7135888576"},{"id":"paper-w2756244082","cat":"papers","name":"O-33 Feasibility of a paediatric micro-dose study of [14c]midazolam to study the ontogeny of cyp3a-mediated drug metabolism","year":"2017","cit":0,"pfa":"Van Groen","psa":"De Wildt","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2756244082","eid":"W2756244082"},{"id":"paper-w1620702609","cat":"papers","name":"Optimización Bio-Inspirada de un Sistema de Inferencia Difusa para la Generación de Efectos Psicodelicos en Imágenes Digitales","year":"2014","cit":0,"pfa":"Linda Rodríguez","psa":"Helbert Espitia","ptype":"article","src":"https://openalex.org/W1620702609","eid":"W1620702609"},{"id":"paper-w3045299727","cat":"papers","name":"Ketamine for depression : The role of dissociative effects","year":"2020","cit":0,"pfa":"Jakob Broström","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"dissertation","src":"https://openalex.org/W3045299727","eid":"W3045299727"},{"id":"paper-w3007461810","cat":"papers","name":"Major Hallucinogenic Medicinal Plants in Folk Medicine","year":"2020","cit":0,"pfa":"Amritpal Singh Saroya","psa":"Jaswinder Singh","ptype":"book-chapter","src":"https://openalex.org/W3007461810","eid":"W3007461810"},{"id":"paper-w2373466959","cat":"papers","name":"Phase 0 clinical trial of single-dose imatinib mesylate in health Chinese male volunteers","year":"2015","cit":0,"pfa":"Ji Wang","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2373466959","eid":"W2373466959"},{"id":"paper-w4303196164","cat":"papers","name":"Hallucinogenic Drugs","year":"2022","cit":0,"pfa":"Dima Abdulrahim","psa":"Owen Bowden‐Jones","ptype":"book-chapter","src":"https://openalex.org/W4303196164","eid":"W4303196164"},{"id":"paper-w4313238558","cat":"papers","name":"LSD use in the United States: Examining user demographics and their evolution from 2015-2019","year":"2022","cit":0,"pfa":"Jeremy Weleff","psa":"Brian Scott Barnett","topics":["Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4313238558","eid":"W4313238558"},{"id":"paper-w3081541655","cat":"papers","name":"How to Kick a Ketamine Addiction","year":"2019","cit":0,"pfa":"Jaclyn","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W3081541655","eid":"W3081541655"},{"id":"paper-w2293125000","cat":"papers","name":"Case Reports : Anticholinergic Toxicity Following Ingestion of Angel`s Trumpet: A Case Report","year":"2009","cit":0,"pfa":"Hoon Kim","psa":"Jae Min Chung","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2293125000","eid":"W2293125000"},{"id":"paper-w7120309581","cat":"papers","name":"Relationship between the chronic treatment with lithium and the role of cholinergic system in neuroinflammation.","year":"2013","cit":0,"pfa":"Natália Mendes Schöwe","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7120309581","eid":"W7120309581"},{"id":"paper-w2943702966","cat":"papers","name":"Nocturia Tx shows efficacy across age groups","year":"2018","cit":0,"pfa":"Cheryl Guttman Krader","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2943702966","eid":"W2943702966"},{"id":"paper-w7160835538","cat":"papers","name":"Philosophical Encounters with Plant Spirits and DMT Entities","year":"2025","cit":0,"pfa":"Alberto Cavallarin","ptype":"article","src":"https://openalex.org/W7160835538","eid":"W7160835538"},{"id":"paper-w7140349334","cat":"papers","name":"“UPP TILL KAMP - MER SVAMP” En diskursanalys av psykedelikadiskursen på forumet Flashback","year":"2026","cit":0,"pfa":"Isac Robertsson","psa":"Otto Carlsson Ahnell","topics":["Depression","Safety & adverse events"],"ptype":"other","src":"https://openalex.org/W7140349334","eid":"W7140349334"},{"id":"paper-w3157291497","cat":"papers","name":"Effect of LSD on neuronal responsiveness to serotonin a a brain structure involved in obsessive compulsive disorder","year":"2001","cit":0,"pfa":"Tarek Zghoul","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W3157291497","eid":"W3157291497"},{"id":"paper-w4247796469","cat":"papers","name":"National Treatment Improvement Evaluation Study (NTIES), 1992-1997","year":"2000","cit":0,"pfa":"United States Department Of Health And Human Services. Substance Abuse And…","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"dataset","src":"https://openalex.org/W4247796469","eid":"W4247796469"},{"id":"paper-w4250017057","cat":"papers","name":"Hallucinogenic Agents","year":"2003","cit":0,"pfa":"Frank A. Barile","topics":["Addiction","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W4250017057","eid":"W4250017057"},{"id":"paper-w4248426243","cat":"papers","name":"Treatment of Diabetic Macular Edema with ILUVIEN (Fluocinolone Acetonide 0.19mg): Pharmacokinetics and Lipophilicity for the Primary Care Provider","year":"2017","cit":0,"pfa":"Alyson Evans DNP","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4248426243","eid":"W4248426243"},{"id":"paper-w2130931565","cat":"papers","name":"Psychedelia and Its high other in 1960s San Francisco","year":"2011","cit":0,"pfa":"Sarah Hill","ptype":"conference-paper","src":"https://openalex.org/W2130931565","eid":"W2130931565"},{"id":"paper-w2979370179","cat":"papers","name":"Preliminary research data analysis of LSD consumption in Britain: a qualitative pilot study","year":"2016","cit":0,"pfa":"Lesley-Ann Smith","psa":"Rachel E. Evenden","ptype":"conference-paper","src":"https://openalex.org/W2979370179","eid":"W2979370179"},{"id":"paper-w4221019575","cat":"papers","name":"Antipsychotics: pharmacology","year":"2022","cit":0,"pfa":"Kathy J Aitchison","psa":"Robin M. Murray","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W4221019575","eid":"W4221019575"},{"id":"paper-w4381734931","cat":"papers","name":"Systematic Characterization of LSD metabolites in C. elegans by ultra-high performance liquid chromatography coupled with high-resolution tandem mass spectrometry","year":"2023","cit":0,"pfa":"Christiane Martins de Vasconcellos Silveira","psa":"Magno Junqueira","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4381734931","eid":"W4381734931"},{"id":"paper-w56876012","cat":"papers","name":"Binary Love - artwork exhibited in the exhibition New Psychedelia","year":"2011","cit":0,"pfa":"Madeleine T Kelly","ptype":"article","src":"https://openalex.org/W56876012","eid":"W56876012"},{"id":"paper-w4410860684","cat":"papers","name":"LSD","year":"2025","cit":0,"pfa":"Zachary I. Lerner","psa":"David Luce","topics":["Addiction","Anxiety & end-of-life"],"ptype":"book-chapter","src":"https://openalex.org/W4410860684","eid":"W4410860684"},{"id":"paper-w171356362","cat":"papers","name":"LSD: the discourse-expanding drug","year":"2006","cit":0,"pfa":"Shane David Halasz","topics":["Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W171356362","eid":"W171356362"},{"id":"paper-w4363673930","cat":"papers","name":"45. A Non-Hallucinogenic LSD Analogue With Therapeutic Potential in Mood Disorders","year":"2023","cit":0,"pfa":"Vern Lewis","psa":"Argel Aguilar Valles","ptype":"article","src":"https://openalex.org/W4363673930","eid":"W4363673930"},{"id":"paper-w7212090937","cat":"papers","name":"Yhden LSD-annoksen vaikutus vieroituksen jälkeisen alkoholihakuisuuden sammuttamiseen ja uudelleen ilmaantumiseen ryhmässä pidetyillä naarashiirillä","year":"2026","cit":0,"pfa":"Sara Sainio","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7212090937","eid":"W7212090937"},{"id":"paper-w2580676911","cat":"papers","name":"Myslet z psychedelické zkušenosti. Fenomenologické zkoumání psychedelických halucinací","year":"2015","cit":0,"pfa":"Pokorný, V. (Vít)","ptype":"article","src":"https://openalex.org/W2580676911","eid":"W2580676911"},{"id":"paper-w4405356696","cat":"papers","name":"Apollo, Dionysus, and Psychedelia: The Duality of Syd Barrett and Roger Waters in the Evolution of Pink Floyd","year":"2024","cit":0,"pfa":"Edison Carrasco Jiménez","ptype":"preprint","src":"https://openalex.org/W4405356696","eid":"W4405356696"},{"id":"paper-w1504717103","cat":"papers","name":"Pharmacokinetic Considerations: Absorption, Distribution, Metabolism and Elimination","year":"2009","cit":0,"pfa":"John Richard Kelly","topics":["Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W1504717103","eid":"W1504717103"},{"id":"paper-w7112999089","cat":"papers","name":"Lost Souls Delivered: The Political Life of LSD in the 1950s and 1960s","year":"2024","cit":0,"pfa":"Turner, Alexis","topics":["Safety & adverse events","Dosing & pharmacology","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W7112999089","eid":"W7112999089"},{"id":"paper-w2331617234","cat":"papers","name":"Des haricots hallucinogènes?","year":"1977","cit":0,"pfa":"Claudine Friedberg","psa":"Anne-Marie Hocquenghem","ptype":"article","src":"https://openalex.org/W2331617234","eid":"W2331617234"},{"id":"paper-w4367149203","cat":"papers","name":"New types of therapies showed promise in the clinic in 2021","year":"2021","cit":0,"pfa":"Ryan W. Cross","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4367149203","eid":"W4367149203"},{"id":"paper-w7113007536","cat":"papers","name":"5-HT1A Receptor Blockade Potentiates the Subjective Effects of DMT","year":"2025","cit":0,"pfa":"Zarmeen Zahid","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7113007536","eid":"W7113007536"},{"id":"paper-w4388551751","cat":"papers","name":"Pharmacological exposure optimisation of anticancer agents during clinical development","year":"2023","cit":0,"pfa":"Lisa T. van der Heijden","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W4388551751","eid":"W4388551751"},{"id":"paper-w4413513622","cat":"papers","name":"Non-Medical Prescription and Other Drug Use, Mental Health, and Religion: A College Student Study","year":"2024","cit":0,"pfa":"Sarah Wuebbolt","psa":"Ashlee N. Sawyer-Mays","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W4413513622","eid":"W4413513622"},{"id":"paper-w2995725211","cat":"papers","name":"Clinical analysis of the case of the psychotic disorder due to the combined abuse of psychoactive substances","year":"2019","cit":0,"pfa":"Lyudmyla Yuryeva","psa":"Tetiana Rachynska","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2995725211","eid":"W2995725211"},{"id":"paper-w2950303982","cat":"papers","name":"ChemInform Abstract: SYNTHESIS AND EVALUATION OF SUBSTITUTED 2‐PHENYLCYCLOBUTYLAMINES AS ANALOGS OF HALLUCINOGENIC PHENETHYLAMINES: LACK OF LSD‐LIKE BIOLOGICAL ACTIVITY","year":"1985","cit":0,"pfa":"David E. Nichols","psa":"Duane D. Miller","ptype":"article","src":"https://openalex.org/W2950303982","eid":"W2950303982"},{"id":"paper-w4235366169","cat":"papers","name":"Hallucinogenic Drugs","year":"1968","cit":0,"pfa":"&NA;","ptype":"article","src":"https://openalex.org/W4235366169","eid":"W4235366169"},{"id":"paper-w2187544038","cat":"papers","name":"Participatory Psychedelia: Transpersonal Theory, Religious Studies and Chemically-Altered (Alchemical) Consciousness Psicodelia Participativa: Teoría Transpersonal, Estudios Religiosos y Consciencia (Alquímica) Alterada","year":"2013","cit":0,"pfa":"Matthew David Segall","ptype":"article","src":"https://openalex.org/W2187544038","eid":"W2187544038"},{"id":"paper-w2609031950","cat":"papers","name":"LSD puts brain in state we've not seen before","year":"2017","cit":0,"pfa":"Andy Coghlan","ptype":"article","src":"https://openalex.org/W2609031950","eid":"W2609031950"},{"id":"paper-w2005556589","cat":"papers","name":"Drugs and the Elderly: Social and Pharmacological Issues","year":"1980","cit":0,"pfa":"Henry Brill","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2005556589","eid":"W2005556589"},{"id":"paper-w2017450622","cat":"papers","name":"The Highway to Mental Health: LSD Psychotherpy","year":"1979","cit":0,"pfa":"John Rhead","ptype":"article","src":"https://openalex.org/W2017450622","eid":"W2017450622"},{"id":"paper-w2039654987","cat":"papers","name":"Neuropsychiatric Side Effects of Drugs in the Elderly","year":"1980","cit":0,"pfa":"David M. Petersen","psa":"Frank J. Whittington","ptype":"article","src":"https://openalex.org/W2039654987","eid":"W2039654987"},{"id":"paper-w7104554384","cat":"papers","name":"Neuropsychopharmacology Drugs for Neurodegenerative Diseases","year":"2023","cit":0,"pfa":"Valeš, Karel","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7104554384","eid":"W7104554384"},{"id":"paper-w7164926799","cat":"papers","name":"A Shared Entropic Axis Spans States of Consciousness Across Pharmacological and Clinical Conditions","year":"2026","cit":0,"pfa":"Dante Sebastián Galván Rial","psa":"Pablo Barttfeld","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W7164926799","eid":"W7164926799"},{"id":"paper-w4392530072","cat":"papers","name":"Personal Care for the Therapist","year":"2024","cit":0,"pfa":"Bill Brennan","psa":"Alex Belser","topics":["Therapy practice"],"ptype":"reference-entry","src":"https://openalex.org/W4392530072","eid":"W4392530072"},{"id":"paper-w4243654752","cat":"papers","name":"Theory in Pharmacology. Edited by S. J. Cooper (Pp. 330; illustrated, £19.20.) Academic Press: London. 1981. - Psychotropic Agents, Part 2: Anxiolytics, Geronto-psychopharmacological Agents and Psychomotor Stimulants. Ed","year":"1982","cit":0,"topics":["Addiction","Dosing & pharmacology"],"ptype":"book-review","src":"https://openalex.org/W4243654752","eid":"W4243654752"},{"id":"paper-w2777276295","cat":"papers","name":"Image quality, dose and spine assessment of an EOS Micro Dose protocol for the follow-up of adolescent idiopathic scoliosis with a brace","year":"2017","cit":0,"pfa":"Baptiste Morel","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2777276295","eid":"W2777276295"},{"id":"paper-w2331879957","cat":"papers","name":"Orienting of attention in the 5HT2A agonist and NMDA antagonist model of psychosis","year":"2005","cit":0,"pfa":"Euphrosyne Gouzoulis‐Mayfrank","psa":"Jörg Daumann","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2331879957","eid":"W2331879957"},{"id":"paper-w2587046537","cat":"papers","name":"Ecstasy Substance Use Disorder","year":"2017","cit":0,"topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W2587046537","eid":"W2587046537"},{"id":"paper-w3034246400","cat":"papers","name":"How to Kick a Ketamine Addiction • WhiteSandsTreatment","year":"2019","cit":0,"pfa":"Jaclyn","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W3034246400","eid":"W3034246400"},{"id":"paper-w7104521603","cat":"papers","name":"Next Generation Non-Hallucinogenic Tryptamines","year":"2023","cit":0,"pfa":"Yacoub, Jeanine","ptype":"article","src":"https://openalex.org/W7104521603","eid":"W7104521603"},{"id":"paper-w4409054203","cat":"papers","name":"Lime Micro Dosing: A New Liming Strategy for Small Holder Farmers to Increase Crop Production and Productivity in Acid Soil Prone Areas of Ethiopia","year":"2025","cit":0,"pfa":"Bikila Takala","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4409054203","eid":"W4409054203"},{"id":"paper-w2042761823","cat":"papers","name":"Drug Dependence and Drugs and Youth: Proceedings of the Rutgers Symposium on Drug Abuse","year":"1971","cit":0,"pfa":"Carl Salzman","ptype":"article","src":"https://openalex.org/W2042761823","eid":"W2042761823"},{"id":"paper-w55093699","cat":"papers","name":"Comparison between Micro-Dose GnRH Agonist and GnRH Antagonist Protocol in Poor Responders Undergoing Intracytoplasmic Sperm Injection with Embryo Transfer","year":"2014","cit":0,"pfa":"Moez Kdous","psa":"Fethi Zhioua","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W55093699","eid":"W55093699"},{"id":"paper-w7104521203","cat":"papers","name":"Neuropsychopharmacology Drugs for Neurodegenerative Diseases","year":"2023","cit":0,"pfa":"Valeš, Karel","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7104521203","eid":"W7104521203"},{"id":"paper-w4412639105","cat":"papers","name":"A reciprocal interplay between 5-HT 2A and mGlu 5 receptors underlies neuroplasticity","year":"2025","cit":0,"pfa":"Tomas del Olmo","psa":"Carine Bécamel","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4412639105","eid":"W4412639105"},{"id":"paper-w7105739211","cat":"papers","name":"Relationships between meditation practice, psychoactive substance use, and psychological well-being: Is there a synergy?","year":"2025","cit":0,"pfa":"Jylkkä, Jussi","psa":"Krabbe, Andreas","topics":["Addiction"],"ptype":"other","src":"https://openalex.org/W7105739211","eid":"W7105739211"},{"id":"paper-w7104592933","cat":"papers","name":"Psychedelicare.eu: The Citizens' Initiative For Our Minds","year":"2023","cit":0,"pfa":"Giubilei, Théo","ptype":"article","src":"https://openalex.org/W7104592933","eid":"W7104592933"},{"id":"paper-w3016707434","cat":"papers","name":"Effect of Personal Historical Factors on Attitudes Toward Recreational and/or Therapeutic Usage of Abuse-Prone and/or Illicit Substances","year":"2020","cit":0,"pfa":"Barry Brownstein","topics":["Addiction","Dosing & pharmacology","Policy & ethics"],"ptype":"conference-paper","src":"https://openalex.org/W3016707434","eid":"W3016707434"},{"id":"paper-w4247327502","cat":"papers","name":"Fertilizer micro-dosing technique on traditional leafy vegetables in Benin, West Africa: performances and recommendations","year":"2020","cit":0,"pfa":"G. Esaïe Kpadonou","topics":["Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4247327502","eid":"W4247327502"},{"id":"paper-w3047449609","cat":"papers","name":"Lika hotande som atombomben : Den svenska pressens möte med den psykedeliska upplevelsen. 1948 – 1969","year":"2020","cit":0,"pfa":"Olof Strandman","ptype":"article","src":"https://openalex.org/W3047449609","eid":"W3047449609"},{"id":"paper-w4240933128","cat":"papers","name":"Hallucinogenic Drugs","year":"2001","cit":0,"pfa":"Katherine R. Bonson","ptype":"reference-entry","src":"https://openalex.org/W4240933128","eid":"W4240933128"},{"id":"paper-w2118462553","cat":"papers","name":"The Role of Nicotinic Acid Derivatives in the Treatment of the Acute Toxic Psychosis","year":"1968","cit":0,"pfa":"David Edward Smith","ptype":"article","src":"https://openalex.org/W2118462553","eid":"W2118462553"},{"id":"paper-w4395091627","cat":"papers","name":"KETAMINE ON YOUR COFFEE BREAK?","year":"2024","cit":0,"pfa":"Ruby Deevoy","ptype":"article","src":"https://openalex.org/W4395091627","eid":"W4395091627"},{"id":"paper-w2395999985","cat":"papers","name":"IN PATIENTS WITH ARTIFICIAL PACEMAKER","year":"1985","cit":0,"pfa":"P P Campa","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2395999985","eid":"W2395999985"},{"id":"paper-w4407387333","cat":"papers","name":"EFFECTS OF SODIUM BENZOATE ON BEHAVIORAL AND SYNAPTIC DEFICITS INDUCED BY SUBCHRONIC KETAMINE EXPOSURE IN MICE","year":"2025","cit":0,"pfa":"Ming-Huan Chan","psa":"Hwei‐Hsien Chen","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"conference-abstract","src":"https://openalex.org/W4407387333","eid":"W4407387333"},{"id":"paper-w4412489182","cat":"papers","name":"In Situ Proinflammatory Effects of Dazostinag Alone or with Chemotherapy on the Tumor Microenvironment of Patients with Head and Neck Squamous Cell Carcinoma","year":"2025","cit":0,"pfa":"Richard C. Gregory","psa":"Richard A. Klinghoffer","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4412489182","eid":"W4412489182"},{"id":"paper-w2408262904","cat":"papers","name":"Insulin Therapy in Diabetic Hyperglycemic Emergencies","year":"2014","cit":0,"pfa":"Diana Machado Ramírez","psa":"Manuel Licea Puig","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2408262904","eid":"W2408262904"},{"id":"paper-w4414207377","cat":"papers","name":"Are side effects necessary for antidepressant treatment?","year":"2025","cit":0,"pfa":"Siegfried F. Kasper","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4414207377","eid":"W4414207377"},{"id":"paper-w7130685063","cat":"papers","name":"One dose of DMT reduces depression","year":"2026","cit":0,"pfa":"Mattha Busby","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7130685063","eid":"W7130685063"},{"id":"paper-w4313200421","cat":"papers","name":"Management of psychiatric symptoms and uses of Bupropion in patients with Parkinson’s disease","year":"2022","cit":0,"pfa":"Matteo E.M. Vismara","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4313200421","eid":"W4313200421"},{"id":"paper-w7104509535","cat":"papers","name":"Pharmacological Mechanism of the Non-hallucinogenic 5-HT2A Agonist Ariadne and Analogs","year":"2023","cit":0,"pfa":"Cunningham, Michael","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7104509535","eid":"W7104509535"},{"id":"paper-w2039600631","cat":"papers","name":"Privacy Rights and Record Confidentiality in Drug and Alcohol Abuse Treatment Programs","year":"1976","cit":0,"pfa":"David Charles Lewis","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2039600631","eid":"W2039600631"},{"id":"paper-w2941375470","cat":"papers","name":"Clinical Effects of 2C-B Abuse","year":"2018","cit":0,"pfa":"Esther Papaseit","psa":"Magı́ Farré","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"book-chapter","src":"https://openalex.org/W2941375470","eid":"W2941375470"},{"id":"paper-w2431299532","cat":"papers","name":"[Significance of imaging biomarkers in exploratory clinical trials].","year":"2009","cit":0,"pfa":"Harumasa Takano","psa":"Tetsuya Suhara","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2431299532","eid":"W2431299532"},{"id":"paper-w2004971136","cat":"papers","name":"Slightly New Strokes for Different Folks: A National Overview of Nonopiate Treatment Facilities","year":"1975","cit":0,"pfa":"Ronald D. Wynne","ptype":"article","src":"https://openalex.org/W2004971136","eid":"W2004971136"},{"id":"paper-w7120347271","cat":"papers","name":"Evaluation of anxiety and memory behaviors of accelerated aging mice submitted to treatment with lithium ions","year":"2019","cit":0,"pfa":"Alessandra Macedo Pinto","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7120347271","eid":"W7120347271"},{"id":"paper-w4243297294","cat":"papers","name":"Drugs and Addiction","year":"2003","cit":0,"pfa":"David Buckley","psa":"John A. Shepherd","topics":["Addiction"],"ptype":"reference-entry","src":"https://openalex.org/W4243297294","eid":"W4243297294"},{"id":"paper-w3093987108","cat":"papers","name":"Memórias em cena : o ressurgimento da psicodelia do Udigrudi nas cenas musicais contemporâneas no Recife","year":"2019","cit":0,"pfa":"Artur Onyaiê Gonçalo do Nascimento","ptype":"dissertation","src":"https://openalex.org/W3093987108","eid":"W3093987108"},{"id":"paper-w7203640292","cat":"papers","name":"Experience, plasticity, and context: Beyond single-level models of antidepressant action","year":"2026","cit":0,"pfa":"David Eckert","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7203640292","eid":"W7203640292"},{"id":"paper-w7141060904","cat":"papers","name":"Novel and Emerging Treatments for Major Depression","year":"2023","cit":0,"topics":["Depression"],"ptype":"report","src":"https://openalex.org/W7141060904","eid":"W7141060904"},{"id":"paper-w4293751034","cat":"papers","name":"Clinical Applications","year":"2022","cit":0,"pfa":"David B. Yaden","psa":"Andrew B. Newberg","topics":["Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W4293751034","eid":"W4293751034"},{"id":"paper-w4415220595","cat":"papers","name":"Chlorella vulgaris supplementation in broiler feed: relation between dosage and effect on intestinal health under an Eimeria vaccine challenge","year":"2025","cit":0,"pfa":"Sofie Van Nerom","psa":"Evelyne Delezie","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4415220595","eid":"W4415220595"},{"id":"paper-w2481494518","cat":"papers","name":"Behavioral and Psychological Effects of Salvia divinorum","year":"2016","cit":0,"pfa":"Peter H. Addy","ptype":"book-chapter","src":"https://openalex.org/W2481494518","eid":"W2481494518"},{"id":"paper-w2466412113","cat":"papers","name":"[Combined use of automatic systems for treating patients with type 1 diabetes mellitus].","year":"1988","cit":0,"pfa":"A A Perelygina","psa":"E G Starostina","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2466412113","eid":"W2466412113"},{"id":"paper-w3173052927","cat":"papers","name":"Oleamide Analogues as Positive Allosteric Modulators of the Serotonin (5‐HT) 5‑HT 2C and 5‑HT 2A Receptors","year":"2021","cit":0,"pfa":"Jianping Chen","psa":"Jia Zhou","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3173052927","eid":"W3173052927"},{"id":"paper-w2937999332","cat":"papers","name":"Psychiatry Update: March 2018","year":"2018","cit":0,"pfa":"Natalie Timoshin","psa":"Laurie Martin","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W2937999332","eid":"W2937999332"},{"id":"paper-w4317881088","cat":"papers","name":"Systematic use of LSD, mephedron and amanita muscaria without signs mental and addictive pathology. The case of Daria D.","year":"2022","cit":0,"pfa":"Владимир D. Mendelevich","psa":"Lilia К. Galiullina","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4317881088","eid":"W4317881088"},{"id":"paper-w4393530395","cat":"papers","name":"SUDMEX_CONN: The Mexican dataset of cocaine use disorder patients.","year":"2021","cit":0,"pfa":"Diego Ángeles-Valdéz","psa":"Eduardo A. Garza‐Villarreal","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W4393530395","eid":"W4393530395"},{"id":"paper-w4414180711","cat":"papers","name":"Benefits and Challenges of Transition from High-Dose Methadone to Buprenorphine Depot: A Case Report","year":"2025","cit":0,"pfa":"Mirjana Delic","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4414180711","eid":"W4414180711"},{"id":"paper-w4412763084","cat":"papers","name":"Data from In Situ Proinflammatory Effects of Dazostinag Alone or with Chemotherapy on the Tumor Microenvironment of Patients with Head and Neck Squamous Cell Carcinoma","year":"2025","cit":0,"pfa":"Richard C. Gregory","psa":"Richard A. Klinghoffer","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W4412763084","eid":"W4412763084"},{"id":"paper-w2348629562","cat":"papers","name":"Effects of warm oxygenated leukocyte-depleted blood cardioplegia micro-dose continuous perfusion during cardiac valve replacement","year":"2003","cit":0,"pfa":"Fa Xian","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2348629562","eid":"W2348629562"},{"id":"paper-w4407390498","cat":"papers","name":"Psychometric properties of spanish version of mystical experience questionnaire and wellbeing measures","year":"2024","cit":0,"pfa":"Pablo Cabral-Juan","psa":"José Rodríguez-Gómez","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4407390498","eid":"W4407390498"},{"id":"paper-w116316110","cat":"papers","name":"Clinical Topics in Addiction: Updates from Advances in Psychiatric Treatment","year":"2007","cit":0,"pfa":"Ed Day","topics":["Addiction","Reviews & meta-analyses"],"ptype":"book","src":"https://openalex.org/W116316110","eid":"W116316110"},{"id":"paper-w4302331004","cat":"papers","name":"Substance use disorders","year":"2012","cit":0,"pfa":"Stephen L. Dilts","topics":["Addiction","Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W4302331004","eid":"W4302331004"},{"id":"paper-w87812159","cat":"papers","name":"Drug Abuse of Hallucinogenic Plants: Datura Suaveolens","year":"1981","cit":0,"pfa":"Richard C.W. Hall","psa":"Earl R. Gardner","ptype":"book-chapter","src":"https://openalex.org/W87812159","eid":"W87812159"},{"id":"paper-w7120796628","cat":"papers","name":"A psicodelia clínica e experiência narrativa: Spinoza e a jornada de aprendizagem dos afetos","year":"2025","cit":0,"pfa":"Alessandro Gonçalves Campolina","topics":["Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7120796628","eid":"W7120796628"},{"id":"paper-w4400183828","cat":"papers","name":"Behavioral analysis of putative antipsychotic actions at serotonin and dopamine receptors","year":"2010","cit":0,"pfa":"Laura Scarlota","psa":"John A. Harvey","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W4400183828","eid":"W4400183828"},{"id":"paper-w4385825862","cat":"papers","name":"NIH urges improved research on rapid treatments for SUDs","year":"2023","cit":0,"pfa":"Alison Knopf","topics":["Addiction","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4385825862","eid":"W4385825862"},{"id":"paper-w7109163309","cat":"papers","name":"National Survey Investigating Hallucinogenic Trends (NSIHT)","year":"2024","cit":0,"pfa":"Karilynn Rockhill","psa":"Gabrielle E. Bau","topics":["Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W7109163309","eid":"W7109163309"},{"id":"paper-w2905176853","cat":"papers","name":"Psychedelia and the History of the Chemical Sublime","year":"2017","cit":0,"pfa":"Joseph M. Gabriel","ptype":"book-chapter","src":"https://openalex.org/W2905176853","eid":"W2905176853"},{"id":"paper-w4411611848","cat":"papers","name":"Ästhetik des Psychedelischen","year":"2018","cit":0,"pfa":"Christof Beyer","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4411611848","eid":"W4411611848"},{"id":"paper-w2519175590","cat":"papers","name":"Subtypes of alcohol dependence based on comorbid psychopathology","year":"2015","cit":0,"pfa":"Nicole D. Sintov","topics":["Addiction"],"ptype":"dissertation","src":"https://openalex.org/W2519175590","eid":"W2519175590"},{"id":"paper-w4291111037","cat":"papers","name":"Rethinking Follicular Maturation: The Incorporation of Luteal Phase Stimulation In IVF Patients With Diminished Ovarian Reserve","year":"2022","cit":0,"pfa":"Angeline N. Beltsos","psa":"Tyler Soy","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4291111037","eid":"W4291111037"},{"id":"paper-w7165929825","cat":"papers","name":"Evidências científicas sobre o uso de novas drogas psicodélicas no tratamento da depressão resistente","year":"2026","cit":0,"pfa":"Daiane Lima de Lara Ziles","psa":"Vanessa Merlen Faleiros Ferraz De Sa","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7165929825","eid":"W7165929825"},{"id":"paper-w7200729258","cat":"papers","name":"South Carolina Treatment Needs Assessment, Adult Household Population Survey","year":"2002","cit":0,"pfa":"South Carolina Department of Alcohol and Other Drug Abuse Services","psa":"University of South Carolina. Institute for Public Service and Policy Research","topics":["Addiction"],"ptype":"other","src":"https://openalex.org/W7200729258","eid":"W7200729258"},{"id":"paper-w7214109651","cat":"papers","name":"Real-World Therapeutic Use of Ketamine in Clinical and Non-Clinical Settings: A Cross-Sectional Survey","year":"2026","cit":0,"pfa":"Omer A. Syed","psa":"Philippe Lucas","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7214109651","eid":"W7214109651"},{"id":"paper-w7162258056","cat":"papers","name":"Changa and DMT Crystals, Engines of Cosmopolitan Neo-Shamanism","year":"2026","cit":0,"pfa":"Marcelo Leite","ptype":"book-chapter","src":"https://openalex.org/W7162258056","eid":"W7162258056"},{"id":"paper-w4414639946","cat":"papers","name":"Neurophysiological Markers of (Dis)Connectedness: Insights from Ketamine","year":"2025","cit":0,"pfa":"Naji Alnagger","psa":"Olivia Gosseries","ptype":"book-chapter","src":"https://openalex.org/W4414639946","eid":"W4414639946"},{"id":"paper-w7111694467","cat":"papers","name":"POLYMER CONJUGATES OF DRUGS TARGETING 5-HT AND OTHER RECEPTORS IN THE CENTRAL NERVOUS SYSTEM (CNS) THAT ALSO TARGET RECEPTORS OUTSIDE OF THE CNS","year":"2021","cit":0,"pfa":"DE MARTIN SARA","psa":"MANFREDI PAOLO","topics":["Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W7111694467","eid":"W7111694467"},{"id":"paper-w2182798058","cat":"papers","name":"Legalization of Cannabis Recreational Use: Practical and Clinical Effects on Patients and Societies","year":"2014","cit":0,"pfa":"Pedro Luis Prior","psa":"Richard Armando","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2182798058","eid":"W2182798058"},{"id":"paper-w1520767989","cat":"papers","name":"Neuroimaging and Cognitive Assessments in early Drug Development","year":"2010","cit":0,"pfa":"Neal R. Cutler","psa":"Angelico Carta","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"other","src":"https://openalex.org/W1520767989","eid":"W1520767989"},{"id":"paper-w7162821518","cat":"papers","name":"Memento Mori: Exploring Death, Psychedelia, and Anti-Exploitation Through Animation","year":"2026","cit":0,"pfa":"Axel Bennett","ptype":"article","src":"https://openalex.org/W7162821518","eid":"W7162821518"},{"id":"paper-w3017848550","cat":"papers","name":"Painful recovery: Treatment options, success rates vary for prescription opioid abusers","year":"2008","cit":0,"pfa":"Trisha Korioth","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W3017848550","eid":"W3017848550"},{"id":"paper-w7163652774","cat":"papers","name":"1368-P: Glycemic Response to Glucagon in Patients with Post-Bariatric Hypoglycemia","year":"2026","cit":0,"pfa":"SEAN BROWN","psa":"Mary‐Elizabeth Patti","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7163652774","eid":"W7163652774"},{"id":"paper-w4392129684","cat":"papers","name":"Assessment of Clinical, Biochemical and Hormonal Aspects of Women of Fertile Age with Polycystic Ovary Syndrome","year":"2023","cit":0,"pfa":"Abdusattarov A.A.","psa":"Kholmatova G.A. assistant","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4392129684","eid":"W4392129684"},{"id":"paper-w3215280597","cat":"papers","name":"An Overview on Substance Use Disorders Management Approach","year":"2021","cit":0,"pfa":"Abdul Baqi Mansour Bukhary","psa":"Ghadeer Abdullah Alotaibi","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3215280597","eid":"W3215280597"},{"id":"paper-w4393829349","cat":"papers","name":"SUDMEX_CONN: The Mexican dataset of cocaine use disorder patients.","year":"2021","cit":0,"pfa":"Diego Ángeles-Valdéz","psa":"Eduardo A. Garza‐Villarreal","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W4393829349","eid":"W4393829349"},{"id":"paper-w4241519677","cat":"papers","name":"Overview of Substance Use Disorders","year":"2018","cit":0,"pfa":"Alexander W. Thompson","psa":"Emily Morse","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4241519677","eid":"W4241519677"},{"id":"paper-w4235197459","cat":"papers","name":"Overview of Substance Use Disorders","year":"2017","cit":0,"pfa":"Alexander W. Thompson","psa":"Emily Morse","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4235197459","eid":"W4235197459"},{"id":"paper-w7141608770","cat":"papers","name":"The Psychopharmacology of Feeding and Eating Disorders – Interview","year":"2022","cit":0,"pfa":"Timothy D. Brewerton","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"report","src":"https://openalex.org/W7141608770","eid":"W7141608770"},{"id":"paper-w4387430889","cat":"papers","name":"Neuroscience and Technology: Innovations in Brain Research and Therapy","year":"2023","cit":0,"pfa":"Aliasghar Tabatabaei Mohammadi","psa":"Sanam Mohammadzadeh","topics":["Addiction","Mechanism & neuroscience"],"ptype":"book","src":"https://openalex.org/W4387430889","eid":"W4387430889"},{"id":"paper-w4393874700","cat":"papers","name":"SUDMEX_CONN: The Mexican dataset of cocaine use disorder patients.","year":"2021","cit":0,"pfa":"Diego Ángeles-Valdéz","psa":"Eduardo A. Garza‐Villarreal","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W4393874700","eid":"W4393874700"},{"id":"paper-w4393882517","cat":"papers","name":"SUDMEX_CONN: The Mexican dataset of cocaine use disorder patients.","year":"2021","cit":0,"pfa":"Diego Ángeles-Valdéz","psa":"Eduardo A. Garza‐Villarreal","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W4393882517","eid":"W4393882517"},{"id":"paper-w574974366","cat":"papers","name":"DRUG ADDICTION AND TRAFFIC","year":"1975","cit":0,"pfa":"E Loitzl","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W574974366","eid":"W574974366"},{"id":"paper-w3119291318","cat":"papers","name":"Overview of Substance Use Disorders","year":"2017","cit":0,"pfa":"Alexander W. Thompson","psa":"Emily Morse","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3119291318","eid":"W3119291318"},{"id":"paper-w4251322574","cat":"papers","name":"Overview of Substance Use Disorders","year":"2018","cit":0,"pfa":"Alexander W. Thompson","psa":"Emily Morse","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4251322574","eid":"W4251322574"},{"id":"paper-w3125384926","cat":"papers","name":"KETAMINE IN DEPRESSION THERAPY (overview of modern data)","year":"2018","cit":0,"pfa":"Мikhail L. Zobin","psa":"Зобин Михаил Леонидович","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3125384926","eid":"W3125384926"},{"id":"paper-w2412676466","cat":"papers","name":"[General anesthesia in patients with spontaneous respiration].","year":"1991","cit":0,"pfa":"Osipova Na","psa":"T A Smolina","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2412676466","eid":"W2412676466"},{"id":"paper-w3213502148","cat":"papers","name":"THE COSTS OF CARE PROCESSES GENERATED BY THE CARE OF PATIENTS WITH DIABETES MELLITUS AS A NON-COMMUNICABLE DISEASE AND WHO SUFFER FROM EATING DISORDERS (ANOREXIA AND BULIMIA) AND SUBSTANCE ABUSE","year":"2021","cit":0,"pfa":"Irene Bosch-Frigola","psa":"Misericordia Carles-Lavila","topics":["Addiction","Safety & adverse events"],"ptype":"conference-paper","src":"https://openalex.org/W3213502148","eid":"W3213502148"},{"id":"paper-w7155489133","cat":"papers","name":"Variation at COMT, ADH1B-ADH1C and HTR2A is associated with substance use disorders in Ukrainians","year":"2026","cit":0,"pfa":"V. V. Bashynska","psa":"Marika Kaakinen","topics":["Addiction","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7155489133","eid":"W7155489133"},{"id":"paper-w4235910409","cat":"papers","name":"Long-Term Psychiatric and Neurologic Treatment After a Traumatic Midbrain Lesion","year":"1997","cit":0,"pfa":"E. C. Lauterbach","topics":["PTSD & trauma","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4235910409","eid":"W4235910409"},{"id":"paper-w7163297981","cat":"papers","name":"The Invention of ”Indonesian Psychedelia”: Kanonisasi Retrospektif dan Politik Konstruksi Genre dalam Kurasi Musik Transnasional","cit":0,"pfa":"Jimmy Mahardhika","ptype":"article","src":"https://openalex.org/W7163297981","eid":"W7163297981"},{"id":"paper-w2084708350","cat":"papers","name":"Drug-induced psychosis","year":"1982","cit":0,"pfa":"Antonio DiSclafani","psa":"Earl R. Gardner","ptype":"article","src":"https://openalex.org/W2084708350","eid":"W2084708350"},{"id":"paper-w2479820002","cat":"papers","name":"Alcohol and Other Addictions","year":"2014","cit":0,"pfa":"Mary-Clare Race","psa":"Adrian F Furnham","topics":["Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W2479820002","eid":"W2479820002"},{"id":"paper-w4412468831","cat":"papers","name":"Self-medication with Datura seeds in a case of schizophrenia","year":"2025","cit":0,"pfa":"Md. Mozammil Ahsan","psa":"Apurba Narayan Mahato","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4412468831","eid":"W4412468831"},{"id":"paper-w2776907688","cat":"papers","name":"Ready, Set, Action: Potential Breakthrough Therapy for Treatment-Resistant Depression","year":"2017","cit":0,"pfa":"Alvin Garlejo","topics":["Depression","Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2776907688","eid":"W2776907688"},{"id":"paper-w2992310783","cat":"papers","name":"[Disorders in the hypophysis-adrenal and hypophysis-thyroid systems of patients with acute pneumonia and the ways for their therapeutic correction].","year":"1990","cit":0,"pfa":"Iu A Panfilov","psa":"V. G. Sharonov","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2992310783","eid":"W2992310783"},{"id":"paper-w3152736637","cat":"papers","name":"The Entheogenic Landscape","year":"2020","cit":0,"pfa":"Alexander Menrisky","topics":["Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W3152736637","eid":"W3152736637"},{"id":"paper-w4413154582","cat":"papers","name":"Liberating the Soul: Multiple Self-States and the Mystical in the Treatment of Substance Abuse","year":"2025","cit":0,"pfa":"Noelle Burton","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4413154582","eid":"W4413154582"},{"id":"paper-w2365011007","cat":"papers","name":"The Clinical Value of 1~(14)c-urea Breath Test for Diagnosis of Helicobacter Pylori Infection","year":"2003","cit":0,"pfa":"Tian Jia-h","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2365011007","eid":"W2365011007"},{"id":"paper-w4234912120","cat":"papers","name":"Drug overdoses","year":"2019","cit":0,"pfa":"Punit S. Ramrakha","psa":"Amir H. Sam","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W4234912120","eid":"W4234912120"},{"id":"paper-w4409891557","cat":"papers","name":"Creating Safety and Strengthening Resources","year":"2025","cit":0,"pfa":"Charmaine Husum","topics":["Safety & adverse events","Therapy practice","Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W4409891557","eid":"W4409891557"},{"id":"paper-w7111548310","cat":"papers","name":"Drugs of Addiction","year":"2024","cit":0,"pfa":"Lori Buhlman (6343997)","psa":"David Zinn (18847742)","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7111548310","eid":"W7111548310"},{"id":"paper-w7117369516","cat":"papers","name":"Relationships between meditation practice, psychoactive substance use, and psychological well-being: Is there a synergy? (Study 1)","year":"2025","cit":0,"pfa":"Andreas Krabbe","psa":"Jussi Jylkkä","topics":["Addiction"],"ptype":"other","src":"https://openalex.org/W7117369516","eid":"W7117369516"},{"id":"paper-w3082677651","cat":"papers","name":"Marketing, not medicine: Gwyneth Paltrow’s The Goop Lab whitewashes traditional health therapies for profit","year":"2020","cit":0,"pfa":"Nadia Zainuddin","topics":["Therapy practice"],"ptype":"other","src":"https://openalex.org/W3082677651","eid":"W3082677651"},{"id":"paper-w2982375556","cat":"papers","name":"Drug induced psychiatric disorder-A mini review","year":"2019","cit":0,"pfa":"S. R. Nivetha","psa":"Kothai Ramalingam","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2982375556","eid":"W2982375556"},{"id":"paper-w7116044317","cat":"papers","name":"PDGFRß targeted positron emission tomography as a non-invasive biomarker for activated hepatic stellate cells: lasts steps before clinical translation","year":"2025","cit":0,"pfa":"Yashaswini, Chittampalli N.","psa":"Eriksson, Olof","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W7116044317","eid":"W7116044317"},{"id":"paper-w7116088586","cat":"papers","name":"PDGFRß targeted positron emission tomography as a non-invasive biomarker for activated hepatic stellate cells: lasts steps before clinical translation","year":"2025","cit":0,"pfa":"Yashaswini, Chittampalli N.","psa":"Eriksson, Olof","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W7116088586","eid":"W7116088586"},{"id":"paper-w4312983012","cat":"papers","name":"LSD FOR LDS?","year":"1967","cit":0,"pfa":"E. Marshall Chatwin","psa":"LeGrand Woolley","ptype":"article","src":"https://openalex.org/W4312983012","eid":"W4312983012"},{"id":"paper-w2496785860","cat":"papers","name":"Are illicit drug users more likely to receive mental health treatment?","year":"2016","cit":0,"pfa":"Anthony B. Crum","psa":"Man Hung","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2496785860","eid":"W2496785860"},{"id":"paper-w4323924812","cat":"papers","name":"Self-treatment of psychosis and complex post-traumatic stress disorder with LSD and DMT—A retrospective case study","year":"2023","cit":0,"pfa":"Mika Turkia","topics":["PTSD & trauma","Safety & adverse events","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4323924812","eid":"W4323924812"},{"id":"paper-w4409279583","cat":"papers","name":"Antidepressant Properties of Ketamine in a Cellular Model System: Nmdar Independence and a Role for Camp","year":"2025","cit":0,"pfa":"Jeff Schappi","psa":"Mark M. Rasenick","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4409279583","eid":"W4409279583"},{"id":"paper-w7146955963","cat":"papers","name":"The God Receptor","year":"2026","cit":0,"pfa":"Bernard J. Crespi","psa":"Sam M. Doesburg","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W7146955963","eid":"W7146955963"},{"id":"paper-w7171476306","cat":"papers","name":"New Psychoactive Substances in an Animal Model: Pharmacokinetics, Toxicity, Behavioral Effects, and Addictive Potential","year":"2026","cit":0,"pfa":"Hynek Danda","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7171476306","eid":"W7171476306"},{"id":"paper-w2326305543","cat":"papers","name":"Drug testing in a patient's own tumor cells","year":"2015","cit":0,"pfa":"M. Frisk","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2326305543","eid":"W2326305543"},{"id":"paper-w4414207397","cat":"papers","name":"Attitudes of patients with psychotic disorders towards psychoactive substances","year":"2025","cit":0,"pfa":"P. Tokić","psa":"Trpimir Glavina","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4414207397","eid":"W4414207397"},{"id":"paper-w4225406518","cat":"papers","name":"Monoamine Receptor and Transporter Interaction Profiles of 4‐Alkyl‐Substituted 2,5‐Dimethoxyamphetamines","year":"2022","cit":0,"pfa":"Dino Luethi","psa":"Matthias E. Liechti","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4225406518","eid":"W4225406518"},{"id":"paper-w4401332922","cat":"papers","name":"LSD and ketamine in schizoaffective paranoid psychosis involving childhood and war trauma—a retrospective case study","year":"2024","cit":0,"pfa":"Mika Turkia","topics":["PTSD & trauma","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4401332922","eid":"W4401332922"},{"id":"paper-w3143396394","cat":"papers","name":"A study of mental health issues in the objects of substance abstinence who got labor education and rehabilitation","year":"2004","cit":0,"pfa":"Jianlin Ji","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W3143396394","eid":"W3143396394"},{"id":"paper-w7126164669","cat":"papers","name":"Using ketamine in pediatric mental health: Clinical considerations","year":"2026","cit":0,"pfa":"Rawya Aljabari","psa":"Mohamed Sherif","ptype":"article","src":"https://openalex.org/W7126164669","eid":"W7126164669"},{"id":"paper-w4415259268","cat":"papers","name":"The God receptor: naturalistic, psychotic and entheogenic neurocognition in the origins and phenomenology of spiritual and religious thought","year":"2025","cit":0,"pfa":"Bernard J. Crespi","psa":"Sam M. Doesburg","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4415259268","eid":"W4415259268"},{"id":"paper-w2018592543","cat":"papers","name":"A Low-Dose Gas-Discharge Luminescent Converter of X-Ray Image","year":"1998","cit":0,"pfa":"V.B. Chelnokov","psa":"V.I. Maklashevsky","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2018592543","eid":"W2018592543"},{"id":"paper-w4405478434","cat":"papers","name":"Anesthesia for MVA in Resource-Limited Setting: Comparative Study of Ketamine Narcosis versus Intrathecal Analgesia in the DRC","year":"2024","cit":0,"pfa":"Serge Ibula Ntamusimwa","psa":"Berthe Barhayiga Nsimire","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4405478434","eid":"W4405478434"},{"id":"paper-w4414011543","cat":"papers","name":"The pharmacology of psychoactive drug abuse and overdose","year":"2025","cit":0,"pfa":"Angus Thain","psa":"Carl A Webster","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4414011543","eid":"W4414011543"},{"id":"paper-w2403998196","cat":"papers","name":"[A treatment method for chronic parenchymatous parotitis].","year":"1993","cit":0,"pfa":"P I Ivasenko","psa":"A K Krivinskiĭ","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2403998196","eid":"W2403998196"},{"id":"paper-w7113668662","cat":"papers","name":"The Effects of Morphine, THC, and LSD on Synaptic Plasticity of the Ventral Tegmental Area","year":"2025","cit":0,"pfa":"Von Gunten, Michael","topics":["Addiction","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7113668662","eid":"W7113668662"},{"id":"paper-w4205447510","cat":"papers","name":"Drug Addiction","year":"2008","cit":0,"pfa":"Joseph John Westermeyer","psa":"Gihyun Yoon","topics":["Addiction","Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W4205447510","eid":"W4205447510"},{"id":"paper-w3094840364","cat":"papers","name":"11C-sorafenib and 15O-H2O PET for early evaluation of sorafenib therapy","year":"2020","cit":0,"pfa":"Lemonitsa H. Mammatas","psa":"C. Willemien Menke‐van der Houven van Oordt","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3094840364","eid":"W3094840364"},{"id":"paper-w7140172533","cat":"papers","name":"URB #426 — The Gold Standard Category Error: Pragmatic Efficacy vs. Mechanistic Attribution in Drug Approval","year":"2026","cit":0,"pfa":"Brandon Charles Emerick","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7140172533","eid":"W7140172533"},{"id":"paper-w7145127963","cat":"papers","name":"VIEWS AND REVIEWS LSD and the New American Zen Student","cit":0,"pfa":"Robert G. Aitken","psa":"Robert G. Aitken","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7145127963","eid":"W7145127963"},{"id":"paper-w7140169958","cat":"papers","name":"URB #426 — The Gold Standard Category Error: Pragmatic Efficacy vs. Mechanistic Attribution in Drug Approval","year":"2026","cit":0,"pfa":"Brandon Charles Emerick","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7140169958","eid":"W7140169958"},{"id":"paper-w4399395757","cat":"papers","name":"AbbVie and Gilgamesh partner for psychiatric drugs","year":"2024","cit":0,"pfa":"Sarah Braner","topics":["Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W4399395757","eid":"W4399395757"},{"id":"paper-w4403193997","cat":"papers","name":"Fertilizer Micro-dosing: Evaluating the Yield Response of Sorghum to Different Levels of Fertilizers Applied on the Planting Pit at Mereb-Lekhe District","year":"2024","cit":0,"pfa":"Tewolde Berhe","psa":"Aklil Gebremedhin","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4403193997","eid":"W4403193997"},{"id":"paper-w4417121802","cat":"papers","name":"Substance-Specific Treatment Responses and Resistance Patterns in Induced Psychoses: A Scoping Review of Antipsychotic Efficacy","year":"2025","cit":0,"pfa":"Valerio Ricci","psa":"Giuseppe Maina","topics":["Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4417121802","eid":"W4417121802"},{"id":"paper-w4286295258","cat":"papers","name":"Perioperative opioid-sparing multimodal analgesia (OSMMA) in cancer patients.","year":"2022","cit":0,"pfa":"Sergey V. Tumanyan","psa":"Natalia N. Popova","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"conference-abstract","src":"https://openalex.org/W4286295258","eid":"W4286295258"},{"id":"paper-w1488479370","cat":"papers","name":"El chamanismo y las drogas enteogénicas/alucinatorias del mundo precolombino/Shamanism and Entheogenic/Hallucinatory Drugs in the Pre-Columbian World","year":"2011","cit":0,"pfa":"Carlos Manuel Quirce Balma","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1488479370","eid":"W1488479370"},{"id":"paper-w4308353862","cat":"papers","name":"Some theoretical models of addictive disorder are used for behavioral transformation","year":"2022","cit":0,"pfa":"Мikhail L. Zobin","topics":["Addiction","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4308353862","eid":"W4308353862"},{"id":"paper-w3209906296","cat":"papers","name":"Illicit substance use disorders","year":"2021","cit":0,"pfa":"William T. Blows","topics":["Addiction","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W3209906296","eid":"W3209906296"},{"id":"paper-w4396650779","cat":"papers","name":"Virtual Psychedelia","year":"2024","cit":0,"pfa":"Jacob Yenney","psa":"Ying C. Wu","ptype":"preprint","src":"https://openalex.org/W4396650779","eid":"W4396650779"},{"id":"paper-w2368112565","cat":"papers","name":"Neonatal drug withdrawal syndrome","year":"2007","cit":0,"pfa":"Ni Li","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2368112565","eid":"W2368112565"},{"id":"paper-w7136012391","cat":"papers","name":"Strategies and risks of using LSD for transpersonal reasons: a case study of a group of users","year":"2024","cit":0,"pfa":"Dita Hrubá","topics":["Addiction","Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W7136012391","eid":"W7136012391"},{"id":"paper-w7147262232","cat":"papers","name":"Failed transition to buprenorphine extended-release injection from high-dose methadone","year":"2026","cit":0,"pfa":"Archana Jhawar","psa":"Shannon Menard","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7147262232","eid":"W7147262232"},{"id":"paper-w4410441777","cat":"papers","name":"Design and Evaluation of Substituted Tryptamines for Nonpsychedelic Modulation of Metabolic and Neuropsychiatric Pathways","year":"2025","cit":0,"pfa":"Robert B. Kargbo","topics":["Mechanism & neuroscience"],"ptype":"editorial","src":"https://openalex.org/W4410441777","eid":"W4410441777"},{"id":"paper-w73354566","cat":"papers","name":"Effects of Hallucinogenic Agents on Nerve and Muscle.","year":"1983","cit":0,"pfa":"Edward G. Henderson","ptype":"report","src":"https://openalex.org/W73354566","eid":"W73354566"},{"id":"paper-w4308527965","cat":"papers","name":"Molecular and structural insights into the serotonin 5-HT2C receptor as a therapeutic target for substance use disorders","year":"2022","cit":0,"pfa":"Maleesha Ubhayarathna","psa":"Gregory D. Stewart","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4308527965","eid":"W4308527965"},{"id":"paper-w4413339036","cat":"papers","name":"Psychedelický chronotop vlastnej izby v ruskej próze? : nad textami Gogoľa, Dostojevského a Bulgakova","year":"2025","cit":0,"pfa":"Jakub Kapičiak","ptype":"article","src":"https://openalex.org/W4413339036","eid":"W4413339036"},{"id":"paper-w4403548838","cat":"papers","name":"Expansion of Family Therapy","year":"2024","cit":0,"pfa":"Michael D. Reiter","topics":["Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W4403548838","eid":"W4403548838"},{"id":"paper-w4321613826","cat":"papers","name":"Prevention of the Development of Endometriosis in Patients with Dysmenorrhea Using Combined Hormonal Contraceptives Containing Ethinyl Estradiol and Desogestrel, with an Assessment of Changes in the Hemostasis System","year":"2023","cit":0,"pfa":"Л. В. Гутикова","psa":"М.А. Павловская","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4321613826","eid":"W4321613826"},{"id":"paper-w4411275227","cat":"papers","name":"Abstract 2803 Synthetic Antibodies Targeting the Vγ9Vδ2 T Cell Receptor for Cancer Immunotherapy","year":"2025","cit":0,"pfa":"Anna Andrzejczak","psa":"Anthony A. Kossiakoff","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"conference-abstract","src":"https://openalex.org/W4411275227","eid":"W4411275227"},{"id":"paper-w4232994166","cat":"papers","name":"A KETAMIN HATÁSA A TERÁPIAREZISZTENS MAJOR DEPRESSZIÓRA","year":"2017","cit":0,"pfa":"SZTE BTK, Pszichológiai Intézet, ELTE PPK Pszichológiai Intézet","psa":"Nikolett Peszeki","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4232994166","eid":"W4232994166"},{"id":"paper-w7115194684","cat":"papers","name":"Safety and Cognitive Pharmacodynamics Following Dose Escalations with 3-Methylmethcathinone (3-MMC): A First in Human, Designer Drug Study","year":"2025","cit":0,"pfa":"J. Reckweg","psa":"E. Theunissen","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7115194684","eid":"W7115194684"},{"id":"paper-w7115183825","cat":"papers","name":"Sustained Use of Low-Dose Oral Ketamine as a Potential Antidepressant","year":"2025","cit":0,"pfa":"G. Unal","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7115183825","eid":"W7115183825"},{"id":"paper-w4289277855","cat":"papers","name":"Nutrition and neutraceutical interventions as therapeutic strategies to aid recovery from mild traumatic brain injuries","year":"2022","cit":0,"pfa":"Amy Claire Reichelt","psa":"Benjamin Thomas Dunkley","topics":["PTSD & trauma","Safety & adverse events","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4289277855","eid":"W4289277855"},{"id":"paper-w2390183774","cat":"papers","name":"[A study of mental health issues in the objects of substance abstinence who got labor education and rehabilitation].","year":"2004","cit":0,"pfa":"Wei Guan","psa":"Jianlin Ji","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2390183774","eid":"W2390183774"},{"id":"paper-w4394913770","cat":"papers","name":"Intranasal Esketamine for Treatment Resistant Depression with Suicidal Ideation in Cancer Patients: A Case Series","year":"2024","cit":0,"pfa":"William Alexander","psa":"Sanjay Gupta","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4394913770","eid":"W4394913770"},{"id":"paper-w7199739031","cat":"papers","name":"Molecular Mechanisms Modulating the TrkB Receptor","year":"2024","cit":0,"pfa":"Mykhailo Girych","topics":["Depression","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W7199739031","eid":"W7199739031"},{"id":"paper-w4379162045","cat":"papers","name":"Substance-Related and Addictive Disorders","year":"2023","cit":0,"pfa":"S. K. Mangal","psa":"Shubhra Mangal","topics":["Depression","Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W4379162045","eid":"W4379162045"},{"id":"paper-w4242865495","cat":"papers","name":"Therapeutic management of substance use disorders (II)","year":"2020","cit":0,"pfa":"Octavian Vasiliu","psa":"Daniel Vasile","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4242865495","eid":"W4242865495"},{"id":"paper-w7118607668","cat":"papers","name":"Effects of 5-HT 2A Receptor Activation on Oxycodone Demand after Short and Long Access Self-Administration in Male and Female Rats","year":"2026","cit":0,"pfa":"Carter Richardson","psa":"Erik J. Garcia","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7118607668","eid":"W7118607668"},{"id":"paper-w7167859782","cat":"papers","name":"Exploring Alternative Binding Locations of 5-HT Antagonist Ketanserin In Microtubules; Implications for Future Research","year":"2024","cit":0,"pfa":"Caleb Siguenza","psa":"Tatum Hedrick","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"conference-paper","src":"https://openalex.org/W7167859782","eid":"W7167859782"},{"id":"paper-w7213924331","cat":"papers","name":"LSD","year":"2026","cit":0,"pfa":"Simon Cotton","ptype":"book-chapter","src":"https://openalex.org/W7213924331","eid":"W7213924331"},{"id":"paper-w4389034408","cat":"papers","name":"The Serotonin 2A Receptor Agonist 2,5‐dimethoxy‐4‐iodoamphetamine (DOI) Reduces Ethanol Consumption and Place Conditioning","year":"2016","cit":0,"pfa":"Kevin Sean Murnane","psa":"Cedrick Maceo Daphney","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4389034408","eid":"W4389034408"},{"id":"paper-w3159093299","cat":"papers","name":"RENUNCIATION OF WORLDLY THINGS AND PURIFICATION OF THE SOUL VIA THE SUFISM: A CASE OF PHENIRAMINE HYDROGEN MALEATE DEPENDENCE","year":"2020","cit":0,"pfa":"Mehmet Hamdi Örüm","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3159093299","eid":"W3159093299"},{"id":"paper-w7130363154","cat":"papers","name":"Rewiring Receptor Activation: Mechanistic Insights into Toggle Switch Modulation by 25CN-NBx Compounds","year":"2026","cit":0,"pfa":"Vito Federico Palmisano","psa":"Juan José Nogueira","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7130363154","eid":"W7130363154"},{"id":"paper-w2153860718","cat":"papers","name":"The Effect of a Target Controlled Infusion of Low-Concentration Ketamine on the Heart Rate Variability of Normal Volunteers","year":"2009","cit":0,"pfa":"Jai Yun Jung","psa":"Yong Ik Kim","ptype":"article","src":"https://openalex.org/W2153860718","eid":"W2153860718"},{"id":"paper-w7162324149","cat":"papers","name":"A Thermal Stress-Aware Micro-Dose Irrigation and Fertigation Framework on Mamba Architecture","year":"2026","cit":0,"pfa":"Jaspher W Kathrine","psa":"Melvin Andreya S","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7162324149","eid":"W7162324149"},{"id":"paper-w4363673403","cat":"papers","name":"430. Calibrated fMRI Sensitive to Ketamine-Related Increases Throughout the Cortex","year":"2023","cit":0,"pfa":"Naomi R Driesen","psa":"Fahmeed Hyder","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4363673403","eid":"W4363673403"},{"id":"paper-w7172383744","cat":"papers","name":"Flattened brain hierarchy and increased EEG complexity during unusual bodily experiences and out-of-body experiences","year":"2026","cit":0,"pfa":"Teresa Campillo-Ferrer","psa":"Gustavo Deco","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7172383744","eid":"W7172383744"},{"id":"paper-w7168187982","cat":"papers","name":"Enhancing plasticity to treat depression and other central nervous system diseases using event-driven pharmacology","year":"2026","cit":0,"pfa":"Todd D. Gould","psa":"Anantha Shekhar","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7168187982","eid":"W7168187982"},{"id":"paper-w2491305830","cat":"papers","name":"Clinical study design","year":"2013","cit":0,"topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W2491305830","eid":"W2491305830"},{"id":"paper-w106821144","cat":"papers","name":"Serotonin 5‐HT 2A Receptor‐Coupled 2‐Arachidonoylglycerol (2‐AG) Release","year":"2006","cit":0,"pfa":"Jason C. Parrish","psa":"David E. Nichols","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W106821144","eid":"W106821144"},{"id":"paper-w4409104051","cat":"papers","name":"ANALYSIS OF THE MAIN CHARACTERISTICS OF DRUG USERS BY CLINICAL AND PSYCHOLOGICAL PARAMETERS","year":"2024","cit":0,"pfa":"J.N. Jahangirli","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4409104051","eid":"W4409104051"},{"id":"paper-w3214067251","cat":"papers","name":"MARIJUANA: CLINICAL, PSYCHOLOGICAL, AND LEGAL ASPECTS","year":"1970","cit":0,"pfa":"Talcott Bates","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3214067251","eid":"W3214067251"},{"id":"paper-w4405201745","cat":"papers","name":"Do Cognitive Enhancers Have the Potential to Change the Structure of Harm Reduction in the Future?","year":"2024","cit":0,"pfa":"Nader Charkhgard","psa":"Shahram Naderi","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4405201745","eid":"W4405201745"},{"id":"paper-w7135765208","cat":"papers","name":"Effect of addictive drugs on prenatal development","year":"2013","cit":0,"pfa":"Oldřiška Hofmannová","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W7135765208","eid":"W7135765208"},{"id":"paper-w7196968174","cat":"papers","name":"Well-being as a primary endpoint in clinical trials: a call for consensus","year":"2026","cit":0,"pfa":"Elliot Marseille","psa":"Charles L. Raison","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7196968174","eid":"W7196968174"},{"id":"paper-w4245932372","cat":"papers","name":"Translating Promising Experimental Approaches to Clinical Trials","year":"2007","cit":0,"pfa":"Adrian D. Nunn","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W4245932372","eid":"W4245932372"},{"id":"paper-w4415239079","cat":"papers","name":"Delineating the impacts of race, aging, and chronic kidney disease on cytochrome p450 3a and major drug transporters in Thai population using physiologically-based pharmacokinetic model","year":"2022","cit":0,"pfa":"Udomsak Udomnilobol","psa":"Thomayant Prueksaritanont","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W4415239079","eid":"W4415239079"},{"id":"paper-w4318183773","cat":"papers","name":"Substance misuse and psychiatric disorders","year":"2023","cit":0,"topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"book-chapter","src":"https://openalex.org/W4318183773","eid":"W4318183773"},{"id":"paper-w4388365449","cat":"papers","name":"NEUROPHYSIOLOGICAL EFFECTS OF LSD AT THE CELLULAR AND NETWORK LEVEL IN THE AUDITORY CORTEX OF RODENTS AND HUMANS","year":"2023","cit":0,"pfa":"Prateep Beed","psa":"Dietmar Schmitz","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4388365449","eid":"W4388365449"},{"id":"paper-w4413163863","cat":"papers","name":"Discovery of a selective 5-HT2C agonist by generative machine learning using MegaSyn with applications to treating opioid use disorder","year":"2025","cit":0,"pfa":"Thane Jones","psa":"Sean Ekins","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4413163863","eid":"W4413163863"},{"id":"paper-w4383107937","cat":"papers","name":"Ethical issues in pediatric clinical trials","year":"2023","cit":0,"pfa":"А. С. Колбин","psa":"L.I. Emelianova","topics":["Safety & adverse events","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4383107937","eid":"W4383107937"},{"id":"paper-w7162671009","cat":"papers","name":"Persistent DOI-Induced Enhancer Remodeling Identifies a Plasticity-Maintenance Gene Program Overlapping Bipolar Disorder and Schizophrenia TWAS Risk in Nucleus Accumbens: Mechanistic Insights and Translational Opportunit","year":"2026","cit":0,"pfa":"Ngo Cheung","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7162671009","eid":"W7162671009"},{"id":"paper-w2494683517","cat":"papers","name":"Addictions: Nonalcoholic Substance-Related Disorders","year":"2001","cit":0,"pfa":"William Weiqi Wang","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W2494683517","eid":"W2494683517"},{"id":"paper-w3210205400","cat":"papers","name":"Medical Aspects of Drug and Alcohol Use","year":"2021","cit":0,"pfa":"David C. Pang","psa":"Mark Pucci","topics":["Depression","Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W3210205400","eid":"W3210205400"},{"id":"paper-w4206519573","cat":"papers","name":"On astronauts, LSD, and landscape architecture","year":"2022","cit":0,"pfa":"Tim Waterman","ptype":"book-chapter","src":"https://openalex.org/W4206519573","eid":"W4206519573"},{"id":"paper-w7166674828","cat":"papers","name":"No evidence for direct physical interaction of 5-HT 2A -mGluR2 receptors in vitro or in vivo","year":"2026","cit":0,"pfa":"Blake A. Fordyce","psa":"Bryan L. Roth","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7166674828","eid":"W7166674828"},{"id":"paper-w2887497049","cat":"papers","name":"The Role of Metabotropic Glutamate Receptors in Ketamine-induced Altered States of Consciousness: A Multimodal PET-MRS Approach","year":"2014","cit":0,"pfa":"Milan Scheidegger","psa":"Erich Seifritz","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W2887497049","eid":"W2887497049"},{"id":"paper-w7129258904","cat":"papers","name":"Who Gets Addicted to What, and Why Cognitive-Architecture Determinants of Differential Addiction Vulnerability and the Algorithmic Optimization of Compulsive Engagement An Application of Adaptive Compression Advantage Th","year":"2026","cit":0,"pfa":"Ryoji MURATA","topics":["Addiction","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7129258904","eid":"W7129258904"},{"id":"paper-w2308016901","cat":"papers","name":"The patient with post-traumatic stress disorder in the emergency department","year":"2013","cit":0,"pfa":"Michael S. Pulia","psa":"Janet S. Richmond","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W2308016901","eid":"W2308016901"},{"id":"paper-w4411376507","cat":"papers","name":"Claire Foldi: Unravelling the neurobiology of eating disorders to inform effective treatments","year":"2025","cit":0,"pfa":"Claire J. Foldi","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4411376507","eid":"W4411376507"},{"id":"paper-w7135066839","cat":"papers","name":"Discovery of the closest free-living relative of the domesticated ‘magic mushroom’ Psilocybe cubensis in Africa","year":"2026","cit":0,"pfa":"Alexander  James Bradshaw","psa":"Bryn T. M. Dentinger","ptype":"article","src":"https://openalex.org/W7135066839","eid":"W7135066839"},{"id":"paper-w7162648521","cat":"papers","name":"Persistent DOI-Induced Enhancer Remodeling Identifies a Plasticity-Maintenance Gene Program Overlapping Bipolar Disorder and Schizophrenia TWAS Risk in Nucleus Accumbens: Mechanistic Insights and Translational Opportunit","year":"2026","cit":0,"pfa":"Ngo Cheung","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7162648521","eid":"W7162648521"},{"id":"paper-w2617456459","cat":"papers","name":"Addictive Behavior of Full-time Students at Masaryk University and Options in its Prevention","year":"2016","cit":0,"pfa":"Petr Kachlík","topics":["Addiction"],"ptype":"book","src":"https://openalex.org/W2617456459","eid":"W2617456459"},{"id":"paper-w4296834457","cat":"papers","name":"Pharmacological modulation of meaning attribution","year":"2022","cit":0,"pfa":"Enzo Tagliazucchi","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"book-chapter","src":"https://openalex.org/W4296834457","eid":"W4296834457"},{"id":"paper-w4399773142","cat":"papers","name":"Ketamine Journal","year":"2024","cit":0,"topics":["Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W4399773142","eid":"W4399773142"},{"id":"paper-w4412729265","cat":"papers","name":"Stroke and spinal cord injury induced by psychoactive substance use in drug addiction: A systematic literature review","year":"2025","cit":0,"pfa":"Diana Sá Moreira","psa":"Ângela Maria Teixeira Leite","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W4412729265","eid":"W4412729265"},{"id":"paper-w4403847561","cat":"papers","name":"Beyond Pain: Innovative Approaches to Tension-Type Headache Management and Treatment","year":"2024","cit":0,"pfa":"Jakub Wójcik","psa":"Aleksandra Partyka","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4403847561","eid":"W4403847561"},{"id":"paper-w4247390802","cat":"papers","name":"Industry Update: the Latest Developments in Therapeutic Delivery","year":"2013","cit":0,"pfa":"Oliver C Steinbach","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4247390802","eid":"W4247390802"},{"id":"paper-w2416388721","cat":"papers","name":"150 years of “Alice’s Adventures in Wonderland”: some considerations about the Cheshire cat and neuropsychiatric phenomena","year":"2016","cit":0,"pfa":"Marleide da Mota Gomes","ptype":"article","src":"https://openalex.org/W2416388721","eid":"W2416388721"},{"id":"paper-w7129443322","cat":"papers","name":"Who Gets Addicted to What, and Why Cognitive-Architecture Determinants of Differential Addiction Vulnerability and the Algorithmic Optimization of Compulsive Engagement An Application of Adaptive Compression Advantage Th","year":"2026","cit":0,"pfa":"Ryoji MURATA","topics":["Addiction","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7129443322","eid":"W7129443322"},{"id":"paper-w7131632832","cat":"papers","name":"Substance Use Disorders","year":"2026","cit":0,"pfa":"Hannah (Johnson) Baker","topics":["Addiction","Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W7131632832","eid":"W7131632832"},{"id":"paper-w3119421460","cat":"papers","name":"[What's new in addiction medicine].","year":"2021","cit":0,"pfa":"DANIELE FABIO ZULLINO","psa":"André Kuntz","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3119421460","eid":"W3119421460"},{"id":"paper-w4394188614","cat":"papers","name":"Supplementary Material for: High Prevalence and Early Onsets: Legal and Illegal Substance Use in an Urban Cohort of Young Adults in Switzerland","year":"2021","cit":0,"pfa":"B.B., Quednow","psa":"Lilly Shanahan","topics":["Addiction","Policy & ethics"],"ptype":"supplementary-materials","src":"https://openalex.org/W4394188614","eid":"W4394188614"},{"id":"paper-w4210258440","cat":"papers","name":"Addictions","year":"2021","cit":0,"pfa":"DANIELE FABIO ZULLINO","psa":"André Kuntz","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4210258440","eid":"W4210258440"},{"id":"paper-w4248834085","cat":"papers","name":"Substance use disorder and Ayurveda: An analytical review","year":"2020","cit":0,"topics":["Addiction","Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4248834085","eid":"W4248834085"},{"id":"paper-w2338384177","cat":"papers","name":"Short communication Efficacy of moxidectin injectable and pour-on formulations in a pilot control program against bovine hypodermosis in Southern Italy","year":"2005","cit":0,"pfa":"Domenico Otranto","psa":"Gioia Capelli","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2338384177","eid":"W2338384177"},{"id":"paper-w2756873663","cat":"papers","name":"Psychoactive substances in secure mental health settings.","year":"2017","cit":0,"pfa":"Sarah Jane Smith","psa":"Nino Maddalena","topics":["Depression","Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2756873663","eid":"W2756873663"},{"id":"paper-w4416845422","cat":"papers","name":"Clinical Approach to Acute Recreational Drug Intoxication in the Emergency Setting: A Practical Guide Based on Swiss Experience","year":"2025","cit":0,"pfa":"Patrick Bless","psa":"Youcef Guéchi","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4416845422","eid":"W4416845422"},{"id":"paper-w4411290265","cat":"papers","name":"Abstract P3-08-29: Early Clinical Experience with TTX-MC138, a First-in-Class Therapeutic Candidate for Metastatic Breast Cancer","year":"2025","cit":0,"pfa":"Zdravka O. Medarova","psa":"Andreas S. Varkaris","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W4411290265","eid":"W4411290265"},{"id":"paper-w2195845913","cat":"papers","name":"Mental health and substance misuse 7 years following an Emergency Department admission for alcohol intoxication","year":"2015","cit":0,"pfa":"Angéline Adam","psa":"Nicolas Bertholet","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2195845913","eid":"W2195845913"},{"id":"paper-w4398243100","cat":"papers","name":"Symptoms and syndromes of anxiety","year":"2024","cit":0,"pfa":"Neil McNaughton","psa":"Jeffrey A. Gray","topics":["Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W4398243100","eid":"W4398243100"},{"id":"paper-w3024114078","cat":"papers","name":"[How we see the development of clinical trials from the investigators' side?]","year":"2019","cit":0,"pfa":"István Bitter","psa":"Pál Czobor","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3024114078","eid":"W3024114078"},{"id":"paper-w4408665128","cat":"papers","name":"Quantifying receptor occupancy of molecular therapy in vivo (Conference Presentation)","year":"2025","cit":0,"pfa":"Kimberley S. Samkoe","psa":"Kenneth M. Tichauer","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W4408665128","eid":"W4408665128"},{"id":"paper-w7171960854","cat":"papers","name":"Endogenous Lithium Status in Major Depression: A Retrospective Analysis of EDTA Blood Samples","year":"2026","cit":0,"pfa":"J. Eder","psa":"M. S. Simon","topics":["Depression","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7171960854","eid":"W7171960854"},{"id":"paper-w4309270854","cat":"papers","name":"NewsCAP: Young adults are using marijuana and hallucinogenic drugs at unprecedented levels.","year":"2022","cit":0,"topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4309270854","eid":"W4309270854"},{"id":"paper-w3132880254","cat":"papers","name":"Psychiatric Research Ethics","year":"2021","cit":0,"pfa":"Dominic A. Sisti","psa":"William Smith","topics":["Safety & adverse events","Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W3132880254","eid":"W3132880254"},{"id":"paper-w4396723235","cat":"papers","name":"Hallucinogenics in medicine","year":"2024","cit":0,"pfa":"Dinah Kheder","psa":"Kenneth Romano","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4396723235","eid":"W4396723235"},{"id":"paper-w4393041641","cat":"papers","name":"Ketamine-induced pleasant but not unpleasant dissociation is linked to the functional connectivity profile of the posteromedial cortex","year":"2024","cit":0,"pfa":"Zümrüt Duygu Şen","psa":"Meng Li","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4393041641","eid":"W4393041641"},{"id":"paper-w4408008024","cat":"papers","name":"Advances in the diagnosis and treatment of stress-related mental disorders","year":"2025","cit":0,"pfa":"Tianhong Zhang","psa":"Zhen Wang","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4408008024","eid":"W4408008024"},{"id":"paper-w7204795908","cat":"papers","name":"Comparison of Cardiometabolic Benefits and Tolerability in Patients on Sustained Low Doses of Semaglutide or Tirzepatide","year":"2026","cit":0,"pfa":"Karthik Murugadoss","psa":"Venky Soundararajan","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7204795908","eid":"W7204795908"},{"id":"paper-w2392580542","cat":"papers","name":"QiqinI for prevention and treatment of Coxsackievirus B3 viral myocarditis in mice","year":"2004","cit":0,"pfa":"Guo Zhang","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2392580542","eid":"W2392580542"},{"id":"paper-w2329859783","cat":"papers","name":"Recent Trend of Pharmacokinetic Studies in New Drug Development","year":"2008","cit":0,"pfa":"Kazuhide Iwasaki","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2329859783","eid":"W2329859783"},{"id":"paper-w7214920654","cat":"papers","name":"Childhood trauma and non-ordinary experiences: An exploration of buffering effects on mental health.","year":"2026","cit":0,"pfa":"Pedro Fortes","psa":"Ronald Fischer","topics":["PTSD & trauma","Mechanism & neuroscience","Therapy practice"],"ptype":"other","src":"https://openalex.org/W7214920654","eid":"W7214920654"},{"id":"paper-w4389728094","cat":"papers","name":"1551: INTERRUPTED CARE: THE RELATIONSHIP BETWEEN SUBSTANCE USE DISORDER AND AMA DISCHARGES","year":"2023","cit":0,"pfa":"Jennifer Catlin","psa":"Sarah J. Marks","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4389728094","eid":"W4389728094"},{"id":"paper-w2996205223","cat":"papers","name":"Identification of Risk and Protective Factors: A Study of Major Depressive Disorder Among Indigenous Adults in Toronto","year":"2019","cit":0,"pfa":"Octavia Chi Yan Wong","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W2996205223","eid":"W2996205223"},{"id":"paper-w4295577150","cat":"papers","name":"Pharmacology of Hallucinations in Several Mechanism of Action in Single Symptom","year":"2022","cit":0,"pfa":"{\"name\":\"Sreenivasulu…","psa":"{\"name\":\"Penabaka Venugopalaiah\",\"email\":\"prameelaputtam281@gmail.com\",\"affili","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4295577150","eid":"W4295577150"},{"id":"paper-w2392640249","cat":"papers","name":"10 286 Cases Clinical Application of Medicinal Aseptic Bone Wax","year":"2003","cit":0,"pfa":"Tao Guo","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2392640249","eid":"W2392640249"},{"id":"paper-w7204976906","cat":"papers","name":"Non-Metropolitan vs. Metropolitan Variations in Alcohol, Illicit Drug, and Prescription Therapeutic Drug Misuse","year":"2026","cit":0,"pfa":"Tyrone F. Borders","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7204976906","eid":"W7204976906"},{"id":"paper-w7170076264","cat":"papers","name":"EMDR Therapy and Psychopharmacology","year":"2026","cit":0,"pfa":"Jonathan D. E. Laugharne","psa":"Graeme Whitfield","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W7170076264","eid":"W7170076264"},{"id":"paper-w7120659670","cat":"papers","name":"Molecular evalution of neuroprotection after treatment of mice with lithium and submition to enriched enviorement.","year":"2020","cit":0,"pfa":"Helena Nascimento Malerba","topics":["Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7120659670","eid":"W7120659670"},{"id":"paper-w2144394512","cat":"papers","name":"Preclinical models of schizophrenia","year":"2013","cit":0,"pfa":"Alan Frazer","psa":"Francesc Artigas","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2144394512","eid":"W2144394512"},{"id":"paper-w2911866054","cat":"papers","name":"Animals and addictions","year":"2018","cit":0,"pfa":"J. D. Keehn","topics":["Addiction","Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W2911866054","eid":"W2911866054"},{"id":"paper-w4407824336","cat":"papers","name":"Substance‐Related and Addictive Disorders","year":"2025","cit":0,"pfa":"Carman S. Gill","psa":"Casey A. Barrio Minton","topics":["Addiction"],"ptype":"other","src":"https://openalex.org/W4407824336","eid":"W4407824336"},{"id":"paper-w7164807972","cat":"papers","name":"Acute Effects of Esketamine on the EEG Power Spectrum and Signal Complexity in Prolonged Disorders of Consciousness: A Prospective Exploratory Cohort Study","year":"2026","cit":0,"pfa":"Yi Liang","psa":"Ruquan Han","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W7164807972","eid":"W7164807972"},{"id":"paper-w7132831664","cat":"papers","name":"Neuroimaging and consciousness: applications of PET, SPECT, and advanced MRI modalities","year":"2026","cit":0,"pfa":"Raj Patel","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7132831664","eid":"W7132831664"},{"id":"paper-w4386068144","cat":"papers","name":"Exploring Next-Generation Therapeutics: Morphic Mixtures and Specified Salts for the Treatment of Mental Disorders and CNS Modulation","year":"2023","cit":0,"pfa":"Robert B. Kargbo","topics":["Mechanism & neuroscience"],"ptype":"editorial","src":"https://openalex.org/W4386068144","eid":"W4386068144"},{"id":"paper-w7117987358","cat":"papers","name":"The Invention of \"Indonesian Psychedelia\"","year":"2026","cit":0,"pfa":"Jimmy Yuanda Mahardhika","ptype":"preprint","src":"https://openalex.org/W7117987358","eid":"W7117987358"},{"id":"paper-w4407227066","cat":"papers","name":"Other considerations in EMDR therapy","year":"2025","cit":0,"pfa":"Alexandra Dent","topics":["PTSD & trauma","Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W4407227066","eid":"W4407227066"},{"id":"paper-w7111529642","cat":"papers","name":"Utilizing Buprenorphine in Patients with Opioid Use Disorder","year":"2025","cit":0,"pfa":"Roush, Emma","psa":"Freese, Jaclyn","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7111529642","eid":"W7111529642"},{"id":"paper-w2904991121","cat":"papers","name":"Comment: The Ambiguities of Harm Reduction in Crime and Drug Policy","year":"2018","cit":0,"pfa":"Mark A. R.Kleiman","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W2904991121","eid":"W2904991121"},{"id":"paper-w7117991425","cat":"papers","name":"The Invention of \"Indonesian Psychedelia\"","year":"2026","cit":0,"pfa":"Jimmy Yuanda Mahardhika","ptype":"preprint","src":"https://openalex.org/W7117991425","eid":"W7117991425"},{"id":"paper-w7127354550","cat":"papers","name":"Neurologic Complications of Drug and Alcohol Use","year":"2026","cit":0,"pfa":"Adeline Goss","psa":"Adeline Goss","topics":["Addiction","Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7127354550","eid":"W7127354550"},{"id":"paper-w7127648666","cat":"papers","name":"AANA Journal Course—Optimizing Buprenorphine Induction: Updated Approaches in Opioid Use Disorder Management","year":"2026","cit":0,"pfa":"Michelle Canale","psa":"Sarah Jingying Zhang","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7127648666","eid":"W7127648666"},{"id":"paper-w4400026383","cat":"papers","name":"G protein-coupled receptors as targets for transformative neuropsychiatric therapeutics","year":"2024","cit":0,"pfa":"Roth B.L","psa":"Schmitz G.P","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4400026383","eid":"W4400026383"},{"id":"paper-w2183697939","cat":"papers","name":"Is Socioeconomic Status an Important Predictor of Alcohol use?: A cross-sectional study in an urban slum of Meerut","year":"2013","cit":0,"pfa":"Rashmi Katyal","psa":"Ramesh Narula","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2183697939","eid":"W2183697939"},{"id":"paper-w7161830924","cat":"papers","name":"Pharmacology I","year":"2026","cit":0,"pfa":"Cynthia Faulkner","psa":"Samuel S. Faulkner","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W7161830924","eid":"W7161830924"},{"id":"paper-w7168274684","cat":"papers","name":"The Master Addict","year":"2026","cit":0,"pfa":"Phil Baker","topics":["Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W7168274684","eid":"W7168274684"},{"id":"paper-w847422477","cat":"papers","name":"[原著]Clinical outcome of in vitro fertilization-embryo transfer in patients over 40 years from a single institution in Guangdong, China","year":"2013","cit":0,"pfa":"Lin Tong","psa":"Yoichi Aoki","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W847422477","eid":"W847422477"},{"id":"paper-w2478993946","cat":"papers","name":"Decolonizing Our Understandings of the Normal and the Therapeutic","year":"2013","cit":0,"pfa":"Joseph D. Calabrese","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W2478993946","eid":"W2478993946"},{"id":"paper-w2354790432","cat":"papers","name":"Analysis of Psilocine by Gas Chromatography-Mass Spectrometry","year":"2004","cit":0,"pfa":"Wei Wang","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2354790432","eid":"W2354790432"},{"id":"paper-w3016561673","cat":"papers","name":"Psychedelia: in my mind’s eye","year":"2020","cit":0,"pfa":"Stuart Borthwick","psa":"Ron Moy","ptype":"book-chapter","src":"https://openalex.org/W3016561673","eid":"W3016561673"},{"id":"paper-w4300554798","cat":"papers","name":"Crystal Structure of an LSD-Bound Human Serotonin Receptor","year":"2020","cit":0,"pfa":"Zachary L. Schools","psa":"Bryan L. Roth","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4300554798","eid":"W4300554798"},{"id":"paper-w2396248169","cat":"papers","name":"Short and Long Term Adverse Reactions in Young Drug Abusers","year":"1980","cit":0,"pfa":"Fred Holsten","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2396248169","eid":"W2396248169"},{"id":"paper-w7167258737","cat":"papers","name":"NeuroRasool: A Structurally Distinct Naphthalene-Based Gq-Biased 5-HT2A Receptor Agonist for Non-Hallucinogenic Neuroregeneration","year":"2025","cit":0,"pfa":"Seyedrasool Sadrieh","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7167258737","eid":"W7167258737"},{"id":"paper-w4403319022","cat":"papers","name":"Beyond Treatment","year":"2024","cit":0,"pfa":"Roland Paulsen","topics":["Anxiety & end-of-life","Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W4403319022","eid":"W4403319022"},{"id":"paper-w4415296268","cat":"papers","name":"From Romanticism and Modernism to Psychedelia","year":"2025","cit":0,"pfa":"Lisa Hester","ptype":"article","src":"https://openalex.org/W4415296268","eid":"W4415296268"},{"id":"paper-w4405974858","cat":"papers","name":"General Aspects of Psychopharmacology","year":"2025","cit":0,"pfa":"Grace S. Pham","psa":"Sanjay J. Mathew","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W4405974858","eid":"W4405974858"},{"id":"paper-w2418680643","cat":"papers","name":"[Treatment of respiratory syncytial virus by intravenous gamma-globulin].","year":"2005","cit":0,"pfa":"Yanhui Li","psa":"Dongliang Xu","topics":["Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W2418680643","eid":"W2418680643"},{"id":"paper-w4406848448","cat":"papers","name":"European Psychiatry: 2024 in review","year":"2025","cit":0,"pfa":"Sophia Frangou","psa":"Andrea Fiorillo","topics":["Addiction","Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4406848448","eid":"W4406848448"},{"id":"paper-w4410851483","cat":"papers","name":"ADDICTION – A REAL CHALLENGE IN CURRENT ERA","year":"2025","cit":0,"pfa":"Mainak Mukherjee","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4410851483","eid":"W4410851483"},{"id":"paper-w3093163333","cat":"papers","name":"Diabetes 2018: Treatment of Diabetic Macular Edema with ILUVIEN (Fluocinolone Acetonide 0.19mg): Pharmacokinetics and Lipophilicity for the Primary Care Provider: Alyson Evans- Alimera Sciences","year":"2020","cit":0,"pfa":"Alyson Evans","topics":["Safety & adverse events","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3093163333","eid":"W3093163333"},{"id":"paper-w4390197317","cat":"papers","name":"Frequency of Drug Use in the Adult Population of Therapeutic Communities in Ecuador","year":"2023","cit":0,"pfa":"Dolores Amparito Rodríguez Sánchez","psa":"Fernando García-Castillo","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4390197317","eid":"W4390197317"},{"id":"paper-w4241012775","cat":"papers","name":"Hallucinogenic Agents","year":"2019","cit":0,"pfa":"Frank A. Barile","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W4241012775","eid":"W4241012775"},{"id":"paper-w7169501550","cat":"papers","name":"NeuroRasool: A Structurally Distinct Naphthalene-Based Gq-Biased 5-HT2A Receptor Agonist for Non-Hallucinogenic Neuroregeneration","year":"2025","cit":0,"pfa":"Seyedrasool Sadrieh","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7169501550","eid":"W7169501550"},{"id":"paper-w3031458945","cat":"papers","name":"The analysis of the correlation between coronary heart disease patients with carotid intima-media thickness, microalbuminuria and the degree of coronary artery stenosis","year":"2015","cit":0,"pfa":"Jian Wang","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3031458945","eid":"W3031458945"},{"id":"paper-w4416249454","cat":"papers","name":"(R)-Ketamine reduces alcohol intake and alcohol seeking induced by reconsolidation of alcohol-related memories in female Marchigian Sardinian alcohol-preferring rats","year":"2025","cit":0,"pfa":"Elisabetta Ciccocioppo","psa":"Esi Domi","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4416249454","eid":"W4416249454"},{"id":"paper-w4295731870","cat":"papers","name":"SOCIAL WORK FOR SUBSTANCE DEPENDENCE AMONG YOUTH IN ARUNACHAL PRADESH","year":"2022","cit":0,"pfa":"Ms. Chaphiak Lowang","psa":"Kaushalendra Pratap Singh","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4295731870","eid":"W4295731870"},{"id":"paper-w4225393525","cat":"papers","name":"Differential Regulation of Inflammatory Responses Following 5‐HT 2 Receptor Activation in Pulmonary Tissues","year":"2022","cit":0,"pfa":"Thomas Wayne Flanagan","psa":"Charles David Nichols","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4225393525","eid":"W4225393525"},{"id":"paper-w4295728952","cat":"papers","name":"SOCIAL WORK FOR SUBSTANCE DEPENDENCE AMONG YOUTH IN ARUNACHAL PRADESH","year":"2022","cit":0,"pfa":"Ms. Chaphiak Lowang","psa":"Kaushalendra Pratap Singh","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4295728952","eid":"W4295728952"},{"id":"paper-w4405710437","cat":"papers","name":"G protein Inactivation as a Mechanism for Addiction Treatment","year":"2024","cit":0,"pfa":"Carlie Neiswanger","psa":"Charles Chavkin","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4405710437","eid":"W4405710437"},{"id":"paper-w4386687568","cat":"papers","name":"Addictions","year":"2019","cit":0,"topics":["Addiction","Reviews & meta-analyses","Policy & ethics"],"ptype":"book","src":"https://openalex.org/W4386687568","eid":"W4386687568"},{"id":"paper-w4237314339","cat":"papers","name":"National Health Interview Survey, 1991: Drug and Alcohol Use Supplement","year":"1993","cit":0,"pfa":"United States Department Of Health And Human Services. Centers For Disease…","topics":["Addiction","Policy & ethics"],"ptype":"dataset","src":"https://openalex.org/W4237314339","eid":"W4237314339"},{"id":"paper-w7129365634","cat":"papers","name":"Re-Evaluating Beck's Cognitive Model of Depression","year":"2026","cit":0,"pfa":"Henri Lambert","topics":["Depression","Mechanism & neuroscience","Therapy practice"],"ptype":"dataset","src":"https://openalex.org/W7129365634","eid":"W7129365634"},{"id":"paper-w4414603223","cat":"papers","name":"Introduction to the Theme “New Approaches, Technology, and Techniques That Advance Pharmacology and Toxicology”","year":"2025","cit":0,"pfa":"Paul A. Insel","psa":"Susan Amara","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4414603223","eid":"W4414603223"},{"id":"paper-w7213442007","cat":"papers","name":"Creation as the Vestibule to Psychedelia and Self-Actualization","year":"2026","cit":0,"pfa":"John Curtis Gowan","ptype":"book-chapter","src":"https://openalex.org/W7213442007","eid":"W7213442007"},{"id":"paper-w4406987834","cat":"papers","name":"Novel Approaches for Treating Anxiety and Trauma-Related Disorders","year":"2025","cit":0,"pfa":"Alfred P. Kaye","psa":"John H. Krystal","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"book-chapter","src":"https://openalex.org/W4406987834","eid":"W4406987834"},{"id":"paper-w4210560682","cat":"papers","name":"Risk of Suicide Varies by Patients’ SUD","year":"2022","cit":0,"pfa":"Terri D’Arrigo","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4210560682","eid":"W4210560682"},{"id":"paper-w4414207866","cat":"papers","name":"Hot topics in psychiatry/psychopharmacology","year":"2025","cit":0,"pfa":"Pavel Mohr","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4414207866","eid":"W4414207866"},{"id":"paper-w7125420515","cat":"papers","name":"The Neurobiology and Genetics of Substance Use Disorder","year":"2026","cit":0,"pfa":"Paul S. Regier","psa":"Daniel Römer","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W7125420515","eid":"W7125420515"},{"id":"paper-w4382932545","cat":"papers","name":"Practical Application of Pk/TK Models: Preclinical PK/TK and Clinical Trial","year":"2023","cit":0,"pfa":"Mehdi Boroujerdi","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"book-chapter","src":"https://openalex.org/W4382932545","eid":"W4382932545"},{"id":"paper-w4412633221","cat":"papers","name":"Self-reported changes and experiences with substance use among real-world patients treated with medical ketamine.","year":"2025","cit":0,"pfa":"Shahar Almog","psa":"Meredith S. Berry","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4412633221","eid":"W4412633221"},{"id":"paper-w4407962849","cat":"papers","name":"HALAYING BABYLON: WORLDS AND WORLDINGS IN TURKISH PSYCHEDELIA","year":"2025","cit":0,"pfa":"Setenay GÜLTEKİN","ptype":"article","src":"https://openalex.org/W4407962849","eid":"W4407962849"},{"id":"paper-w7171908237","cat":"papers","name":"From Classical to Novel Psychoactive Substances. Toxicological Risks and Therapeutic Opportunities","year":"2026","cit":0,"pfa":"Raúl López‐Arnau","psa":"Núria Nadal‐Gratacós","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"conference-paper","src":"https://openalex.org/W7171908237","eid":"W7171908237"},{"id":"paper-w4406327383","cat":"papers","name":"Enlightenment and the Psychology of Self-Transcendence: Pathways to Fundamental Well-Being and Prosocial Behavior","year":"2025","cit":0,"pfa":"Matthew Furnell","psa":"William Van Gordon","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W4406327383","eid":"W4406327383"},{"id":"paper-w2592017021","cat":"papers","name":"Optimized Clinical Preparation of DOTA-JR11 with No-Carrier Added 177Lu","year":"2016","cit":0,"pfa":"Serge K. Lyashchenko","psa":"Jason Stuart Lewis","topics":["Anxiety & end-of-life","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2592017021","eid":"W2592017021"},{"id":"paper-w7167048746","cat":"papers","name":"Subjective, physiological and EEG effects of extended DMT administration","year":"2024","cit":0,"pfa":"Lisa Xiaolu Luan","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7167048746","eid":"W7167048746"},{"id":"paper-w7206578014","cat":"papers","name":"The Relationship Between Precarious Employment, Behaviour Addictions and Substance Use Among Canadian Young Adults: Insights From The Quinte Longitudinal Survey","year":"2019","cit":0,"pfa":"Augustine Owusu Ansah","topics":["Addiction"],"ptype":"dissertation","src":"https://openalex.org/W7206578014","eid":"W7206578014"},{"id":"paper-w135425213","cat":"papers","name":"Welcome to psychedelphia : identity and community in the Haight-Ashbury District of San Francisco, 1965-1967","year":"2006","cit":0,"pfa":"S. D. Jowett","ptype":"dissertation","src":"https://openalex.org/W135425213","eid":"W135425213"},{"id":"paper-w4361953462","cat":"papers","name":"Data from First-in-Human Trial of Epichaperome-Targeted PET in Patients with Cancer","year":"2023","cit":0,"pfa":"Mark P. Dunphy","psa":"Steven M. Larson","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W4361953462","eid":"W4361953462"},{"id":"paper-w2365438130","cat":"papers","name":"A modified thrombolytic scheme for the treatment of cerebral venous sinus thrombosis","year":"2009","cit":0,"pfa":"Zhou Cun-h","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2365438130","eid":"W2365438130"},{"id":"paper-w2258481758","cat":"papers","name":"Abstract A39: A platform to assess multiple therapy options simultaneously in a patient's own tumor","year":"2015","cit":0,"pfa":"Richard A. Klinghoffer","psa":"Nathan Caffo","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"conference-abstract","src":"https://openalex.org/W2258481758","eid":"W2258481758"},{"id":"paper-w4388960650","cat":"papers","name":"relationship between physical activity and who assist scores in substance addiction clients at the addiction Polyclinic of Prof Ngoerah General Hospital Denpasar","year":"2023","cit":0,"pfa":"Luh Nyoman Alit Aryani","psa":"Dedi Silakarma","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4388960650","eid":"W4388960650"},{"id":"paper-w2352386649","cat":"papers","name":"Clinical study of neonatal grastrointestinal hemorrhage","year":"2006","cit":0,"pfa":"Xiaorui Zhang","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2352386649","eid":"W2352386649"},{"id":"paper-w7129287266","cat":"papers","name":"Re-Evaluating Beck's Cognitive Model of Depression","year":"2026","cit":0,"pfa":"Henri Lambert","topics":["Depression","Mechanism & neuroscience","Therapy practice"],"ptype":"dataset","src":"https://openalex.org/W7129287266","eid":"W7129287266"},{"id":"paper-w2970079028","cat":"papers","name":"Towards the next generation of drug administration: evaluation of drug delivery systems in vitro, in vivo, and in clinical settings","year":"2018","cit":0,"pfa":"Klara Kiene","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W2970079028","eid":"W2970079028"},{"id":"paper-w3026715139","cat":"papers","name":"TOBACCO USE AND NICOTINE WITHDRAWAL AMONG PATIENTS WITH MENTAL ILLNESS","year":"2020","cit":0,"pfa":"Yazan D. Al‐Mrayat","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3026715139","eid":"W3026715139"},{"id":"paper-w4361946667","cat":"papers","name":"Data from First-in-Human Trial of Epichaperome-Targeted PET in Patients with Cancer","year":"2023","cit":0,"pfa":"Mark P. Dunphy","psa":"Steven M. Larson","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W4361946667","eid":"W4361946667"},{"id":"paper-w2089607158","cat":"papers","name":"Neurobiological and Molecular Bases of Methamphetamine-Induced Behavioral Sensitization and Spontaneous Recurrence of Methamphetamine Psychosis, and its Implication in Schizophrenia","year":"2006","cit":0,"pfa":"Kunio Yui","psa":"Toru Nishikawa","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2089607158","eid":"W2089607158"},{"id":"paper-w323997031","cat":"papers","name":"Probing Molecular Sites of Action for Alcohol’s Acute and Chronic Effects on Synaptoneurosome Membranes: A Potential Tool for Studying Drug-Receptor Interactions","year":"1991","cit":0,"pfa":"Ronald Paul Mason","psa":"William J. Shoemaker","topics":["Addiction","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W323997031","eid":"W323997031"},{"id":"paper-w7212198238","cat":"papers","name":"A Phenomenological and Neurophysiological Study of Schizophrenic Hallucinations with an Original Hypothesis for the Etiology and Pathogenesis of Schizophrenia Based on the Mesolimbic Dopamine System","year":"1977","cit":0,"pfa":"David Scott Sherman","topics":["Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W7212198238","eid":"W7212198238"},{"id":"paper-w7115731936","cat":"papers","name":"Open-source closed-loop liquid drug infusion pump for long-term therapies","year":"2025","cit":0,"pfa":"Caro, Alejandro Mira","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7115731936","eid":"W7115731936"},{"id":"paper-w7214027730","cat":"papers","name":"Hans Berger's Sister: The Case for EEG in Transpersonal Research","year":"2026","cit":0,"pfa":"Leon Ubags","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"book","src":"https://openalex.org/W7214027730","eid":"W7214027730"},{"id":"paper-w2354132013","cat":"papers","name":"An improving interventional treatment of cerebral venous sinus thrombosis combined in internal jugular vein","year":"2010","cit":0,"pfa":"Zhou Cun-h","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2354132013","eid":"W2354132013"},{"id":"paper-w4282968781","cat":"papers","name":"Abstract 4196: A controlled drug release device facilitates the identification of favorable combinations of immune-oncology drugs with targeted or cytotoxic drugs in a patient-derived humanized mouse model of renal cance","year":"2022","cit":0,"pfa":"Oliver H. Jonas","psa":"Julia B. Schüler","topics":["Anxiety & end-of-life","Dosing & pharmacology","Therapy practice"],"ptype":"conference-abstract","src":"https://openalex.org/W4282968781","eid":"W4282968781"},{"id":"paper-w366862301","cat":"papers","name":"Study guide for clinical handbook of psychotropic drugs","year":"1997","cit":0,"pfa":"Carole A. Mutzebaugh","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W366862301","eid":"W366862301"},{"id":"paper-w7214026659","cat":"papers","name":"Hans Berger's Sister: The Case for EEG in Transpersonal Research","year":"2026","cit":0,"pfa":"Leon Ubags","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"book","src":"https://openalex.org/W7214026659","eid":"W7214026659"},{"id":"paper-w2971910790","cat":"papers","name":"Determination of combination therapy prescribing patterns for the treatment of acute agitation in psychiatric patients: A regression model of patient diagnoses and demographics","year":"2019","cit":0,"pfa":"Mark S. Maas","psa":"Brittany L. Melton","topics":["Depression","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2971910790","eid":"W2971910790"},{"id":"paper-w7214352061","cat":"papers","name":"Exploring a Druggable Hydrophobic Tunnel in the 5-HT2A Receptor with Potent Phenethylamines","year":"2026","cit":0,"pfa":"Ícaro A. Simon","psa":"Christian B. M. Poulie","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7214352061","eid":"W7214352061"},{"id":"paper-w4411363035","cat":"papers","name":"Evaluation of Hematopoietic and Immune Toxicity in First-Generation (G1) Rats Following Maternal Thiacloprid Exposure During Gestation and Lactation, and the Protective Potential of Bitter Apricot Kernel Extract","year":"2025","cit":0,"pfa":"Dounia Djellal","psa":"Mohamed Kebieche","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4411363035","eid":"W4411363035"},{"id":"paper-w4389780209","cat":"papers","name":"Predicting intimate partner violence perpetration by Latino/a/e/x men in residential substance misuse treatment","year":"2023","cit":0,"pfa":"Laura A. Ting","psa":"Adrienne Feller Novick","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4389780209","eid":"W4389780209"},{"id":"paper-w7166878928","cat":"papers","name":"Illicit drug use and treatment in South Africa: a review","year":"2026","cit":0,"pfa":"Human Sciences Research Council","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7166878928","eid":"W7166878928"},{"id":"paper-w2114232653","cat":"papers","name":"Screening, brief intervention, and referral to treatment for risky stimulant use in a Skid Row community health center","year":"2012","cit":0,"pfa":"Lillian Gelberg","psa":"Mani Vahidi","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2114232653","eid":"W2114232653"},{"id":"paper-w4415298466","cat":"papers","name":"Recreational use of ketamine","year":"2025","cit":0,"pfa":"Hayley Noelle Cliatt","ptype":"book-chapter","src":"https://openalex.org/W4415298466","eid":"W4415298466"},{"id":"paper-w4409281707","cat":"papers","name":"[Our visit in the Czech National Institute of Mental Health - experiences and impressions].","year":"2024","cit":0,"pfa":"András H. Lékó","psa":"István Bitter","topics":["Therapy practice"],"ptype":"other","src":"https://openalex.org/W4409281707","eid":"W4409281707"},{"id":"paper-w2278133794","cat":"papers","name":"Substance use disorders : main article","year":"2006","cit":0,"pfa":"E.M. Weich","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2278133794","eid":"W2278133794"},{"id":"paper-w2950970952","cat":"papers","name":"Update on ketamine’s activity","year":"2016","cit":0,"pfa":"Michael Torrice","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2950970952","eid":"W2950970952"},{"id":"paper-w2386483592","cat":"papers","name":"Effects of glutamic acid and its receptor antagonist on evoked potentials in hippocampus CA3 region in rats","year":"2004","cit":0,"pfa":"H Z Huan","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2386483592","eid":"W2386483592"},{"id":"paper-w7171861135","cat":"papers","name":"Selective serotonin reuptake inhibitor withdrawal syndrome: a hybrid analysis of clinical realities, pathophysiological mechanisms, and infodemiological data","year":"2026","cit":0,"pfa":"А. В. Чорномидз","psa":"M. I. Lukanyuk","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7171861135","eid":"W7171861135"},{"id":"paper-w7128526083","cat":"papers","name":"Substance use disorders and addictions","year":"2026","cit":0,"pfa":"Chella Kamarajan","psa":"Markus Muehlhan","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7128526083","eid":"W7128526083"},{"id":"paper-w7197016250","cat":"papers","name":"When Tapering Is Not an Option: Transitioning From High-Dose Methadone to Buprenorphine","year":"2026","cit":0,"pfa":"Sarah Petelinsek","psa":"Michael F. Coudreaut","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7197016250","eid":"W7197016250"},{"id":"paper-w2398646200","cat":"papers","name":"[Recognizing and treating drug addicts. Part 2. Differential diagnosis, therapy].","year":"1981","cit":0,"pfa":"Friedrich Bschor","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2398646200","eid":"W2398646200"},{"id":"paper-w7129258747","cat":"papers","name":"Abstract PS1-09-17: Phase 1 Clinical Testing of a First-in-Class Antisense Oligonucleotide Therapeutic against Advanced Solid Tumors of Multiple Tissue Origins","year":"2026","cit":0,"pfa":"Z. Medarova","psa":"S. Dugan","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W7129258747","eid":"W7129258747"},{"id":"paper-w2294936121","cat":"papers","name":"Do You See What I See? Integrating Hallucinogenic Drug Effects with Haack’s Foundherentism","year":"2016","cit":0,"pfa":"Denish Jaswal","ptype":"conference-paper","src":"https://openalex.org/W2294936121","eid":"W2294936121"},{"id":"paper-w4312068960","cat":"papers","name":"Transitioning patients with opioid use disorder from methadone to buprenorphine","year":"2022","cit":0,"pfa":"Lauren Chaney","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4312068960","eid":"W4312068960"},{"id":"paper-w7154483125","cat":"papers","name":"Advances in the Application of Additive Manufacturing in Respiratory Inhalation Therapy","year":"2026","cit":0,"pfa":"Chao Zhang","psa":"Changhong Huo","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7154483125","eid":"W7154483125"},{"id":"paper-w204175242","cat":"papers","name":"[Ascolong: a new buccal dosage form of acetylsalicylic acid to be used and antiaggregant].","year":"1998","cit":0,"pfa":"E V Kokurina","psa":"D O Rumiantsev","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W204175242","eid":"W204175242"},{"id":"paper-w7163811464","cat":"papers","name":"Therapeutic Re-Scaffolding of the Affective Identity Attractor","year":"2026","cit":0,"pfa":"Robert Keith Russell","topics":["Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7163811464","eid":"W7163811464"},{"id":"paper-w7154424073","cat":"papers","name":"Pre-Registration: Altered States of Consciousness as Sephirotic Phase Transitions — Testing Five Zero-Parameter MPFST Predictions Against Public EEG/MEG Datasets","year":"2026","cit":0,"pfa":"Carlos Freeman","topics":["Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W7154424073","eid":"W7154424073"},{"id":"paper-w3173683714","cat":"papers","name":"The Comorbidity of Drug and Alcohol Consumption in Relation to Mental Health Disorders","year":"2019","cit":0,"pfa":"Sydney Dawson","topics":["Addiction","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3173683714","eid":"W3173683714"},{"id":"paper-w7148694447","cat":"papers","name":"Abstract 358: EV-based delivery of chemically modified siRNA achieves MRTX1133-comparable efficacy in KRAS G12D-mutant pancreatic cancer.","year":"2026","cit":0,"pfa":"Hyo Kyeong Kim","psa":"Kihwan Kwon","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W7148694447","eid":"W7148694447"},{"id":"paper-w3031486872","cat":"papers","name":"Una aproximación a la utilización de la LSD en contextos psicoterapéuticos","year":"2018","cit":0,"pfa":"Velásquez Carvajal","psa":"Juan Camilo","topics":["Addiction","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3031486872","eid":"W3031486872"},{"id":"paper-w4286433044","cat":"papers","name":"'Tick, Tick, BOOM! Recent updates in the use of electronic cigarette technology as an illicit drug delivery system' - A multimodal review of how licit harm reduction devices are being co-opted into potential lethal weapo","year":"2022","cit":0,"pfa":"Caitlin A Dooley","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4286433044","eid":"W4286433044"},{"id":"paper-w7158174748","cat":"papers","name":"NON-PHARMACOLOGICAL TREATMENT METHODS FOR DEPRESSIVE DISORDER: A SYSTEMATIC REVIEW","year":"2025","cit":0,"pfa":"Zofia Maria Kiestrzyn","psa":"Ewa Helena Mojs","topics":["Depression","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7158174748","eid":"W7158174748"},{"id":"paper-w3119444702","cat":"papers","name":"Substance Use Disorders","year":"2018","cit":0,"pfa":"Franz Moeller","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3119444702","eid":"W3119444702"},{"id":"paper-w4416802200","cat":"papers","name":"Dynamic PET imaging predicts broadly neutralizing antibody distribution and HIV prevention efficacy","year":"2025","cit":0,"pfa":"D.H.T. Chu","psa":"Amelia N. Deitchman","topics":["Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4416802200","eid":"W4416802200"},{"id":"paper-w7162488101","cat":"papers","name":"Effects of a 2-Week Online Meta Spirituality Retreat on Meta Self, Well-Being, Agency, Affect, and Mystical-Type Experience: A Randomized Controlled Trial with Extended Validation of the Meta Self Scale","year":"2026","cit":0,"pfa":"Nina Viktorovna Verkoeyen","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7162488101","eid":"W7162488101"},{"id":"paper-w4406395447","cat":"papers","name":"Abstract 224: Clinical Outcomes of Non‐Traumatic Subarachnoid Hemorrhage in Patients with Substance Use Disorder: A TriNetX Analysis","year":"2024","cit":0,"pfa":"A. Jain","psa":"Fawaz Al‐Mufti","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"conference-abstract","src":"https://openalex.org/W4406395447","eid":"W4406395447"},{"id":"paper-w4404960429","cat":"papers","name":"EXPERT COMMENTARY: Communication between Psychiatrists and Patients Regarding Placebo and Nocebo","year":"2024","cit":0,"pfa":"Michael L. Davidson","topics":["Depression","Safety & adverse events","Policy & ethics"],"ptype":"editorial","src":"https://openalex.org/W4404960429","eid":"W4404960429"},{"id":"paper-w7211901947","cat":"papers","name":"Synesthesia and associated clinical conditions: A comprehensive review of current evidence","year":"2026","cit":0,"pfa":"Zahra Rahimian","psa":"Arezoo Behbood","topics":["PTSD & trauma","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7211901947","eid":"W7211901947"},{"id":"paper-w2004137714","cat":"papers","name":"The William C. Menninger Memorial Lecture: College Mental Health and Social Change.","year":"1970","cit":0,"pfa":"Dana L. Farnsworth","ptype":"article","src":"https://openalex.org/W2004137714","eid":"W2004137714"},{"id":"paper-w7127134001","cat":"papers","name":"Postoperative analgesic efficacy of pharmacopuncture at Zusanli (ST-36) or intramuscular morphine in bitches undergoing unilateral total mastectomy: a randomized clinical trial","year":"2026","cit":0,"pfa":"Gilberto Serighelli Júnior","psa":"Nilson Oleskovicz","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7127134001","eid":"W7127134001"},{"id":"paper-w4415748656","cat":"papers","name":"Autologous Cytokine Fragments for Targeted Modulation of the Immune Response: Two Clinical Case Reports","year":"2025","cit":0,"topics":["Safety & adverse events","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4415748656","eid":"W4415748656"},{"id":"paper-w4415656347","cat":"papers","name":"On John M. Allegro’s Suggestion That the Tree of the Knowledge of Good and Evil in the 12th Century Plaincourault Chapel Depicts an Amanita muscaria Mushroom","year":"2025","cit":0,"pfa":"Ronald V. Huggins","ptype":"article","src":"https://openalex.org/W4415656347","eid":"W4415656347"},{"id":"paper-w4415169475","cat":"papers","name":"RECENT ADVANCES IN THE PHARMACOLOGICAL MANAGEMENT OF ANXIETY: FROM TRADITIONAL MEDICATIONS TO NOVEL THERAPEUTIC AGENTS","year":"2025","cit":0,"pfa":"Sanjita Das","psa":"Vidya Niwas","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4415169475","eid":"W4415169475"},{"id":"paper-w7162199488","cat":"papers","name":"A Perspective Beyond the Psychiatry World","year":"2025","cit":0,"pfa":"Nur Aifiah Binti Ibrahim","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7162199488","eid":"W7162199488"},{"id":"paper-w4383823147","cat":"papers","name":"Causal Associations Between Ankylosing Spondylitis and 36 Common Mental Disorders: A Two-Sample Mendelian Randomization Study","year":"2023","cit":0,"pfa":"Jiachen Wang","psa":"Peng Xu","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W4383823147","eid":"W4383823147"},{"id":"paper-w7163815993","cat":"papers","name":"Therapeutic Re-Scaffolding of the Affective Identity Attractor","year":"2026","cit":0,"pfa":"Robert Keith Russell","topics":["Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7163815993","eid":"W7163815993"},{"id":"paper-w4389078436","cat":"papers","name":"Early Experimental LSD Cultures in the Clinic","year":"2023","cit":0,"pfa":"Magaly Tornay","topics":["Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W4389078436","eid":"W4389078436"},{"id":"paper-w2412781828","cat":"papers","name":"[Influence of anandamide, the endogenous agonist of cannabinoid receptors on the circulatory system].","year":"2005","cit":0,"pfa":"Grzegorz Kwolek","psa":"Barbara Malinowska","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2412781828","eid":"W2412781828"},{"id":"paper-w4406172311","cat":"papers","name":"Identification of Drug Dependence Types Using Case-Based Reasoning Expert System with K-Nearest Neighbour","year":"2024","cit":0,"pfa":"Didit Suprihanto","psa":"Rizky Dwi Fidrayanto","topics":["Depression","Addiction"],"ptype":"conference-paper","src":"https://openalex.org/W4406172311","eid":"W4406172311"},{"id":"paper-w7154352853","cat":"papers","name":"Pre-Registration: Altered States of Consciousness as Sephirotic Phase Transitions — Testing Five Zero-Parameter MPFST Predictions Against Public EEG/MEG Datasets","year":"2026","cit":0,"pfa":"Carlos Freeman","topics":["Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W7154352853","eid":"W7154352853"},{"id":"paper-w3033062162","cat":"papers","name":"The NMDA Hypothesis for Schizophrenia","year":"2003","cit":0,"pfa":"Barbara Geller","ptype":"article","src":"https://openalex.org/W3033062162","eid":"W3033062162"},{"id":"paper-w7199193009","cat":"papers","name":"The role of TrkB expression among parvalbumin-positive interneurons in response to LSD","year":"2024","cit":0,"pfa":"Neetika Rastogi","topics":["Depression","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7199193009","eid":"W7199193009"},{"id":"paper-w611489317","cat":"papers","name":"Instant nursing assessment : mental health","year":"1996","cit":0,"pfa":"Phyllis D. Mabbett","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"book","src":"https://openalex.org/W611489317","eid":"W611489317"},{"id":"paper-w7212383138","cat":"papers","name":"Side effects of lower dose compounded semaglutide paired with a behavioral management program: A real-world retrospective study","year":"2026","cit":0,"pfa":"Erin C. Owen","psa":"Amanda R. Merner","topics":["Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7212383138","eid":"W7212383138"},{"id":"paper-w7141196749","cat":"papers","name":"Associations of the DRD2 gene polymorphism (rs1800497) with the development of substance use disorders in adolescence Authors","year":"2026","cit":0,"pfa":"A. S. Panov","psa":"Винникова М. А.","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7141196749","eid":"W7141196749"},{"id":"paper-w4401925482","cat":"papers","name":"Investigating LSA - a ‘legal high’ analogue to LSD, frequently used in the digital realm with relatively unknown effects","year":"2024","cit":0,"pfa":"P. Castro","psa":"J. Maia","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4401925482","eid":"W4401925482"},{"id":"paper-w4249489308","cat":"papers","name":"Behavioural pharmacology of addiction","year":"2016","cit":0,"pfa":"Ilana Belle Glass","topics":["Addiction","Dosing & pharmacology","Policy & ethics"],"ptype":"book-chapter","src":"https://openalex.org/W4249489308","eid":"W4249489308"},{"id":"paper-w7108069939","cat":"papers","name":"Patterns and Determinants of Polystimulant Use Among Patients Seeking Treatment for Stimulant Use Disorders","year":"2025","cit":0,"pfa":"Janssen, Eric","psa":"Spilka, Stanislas","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7108069939","eid":"W7108069939"},{"id":"paper-w4200294266","cat":"papers","name":"Psychotherapy","year":"2021","cit":0,"pfa":"Paul F. Cunningham","topics":["Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W4200294266","eid":"W4200294266"},{"id":"paper-w3180497849","cat":"papers","name":"Abstract 1724: Microinjection of Nectin-4/CD137 tumor-targeted immune cell agonist (TICA™) activates the local tumor microenvironment","year":"2021","cit":0,"pfa":"Johanna Lahdenranta","psa":"Nicholas Keen","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W3180497849","eid":"W3180497849"},{"id":"paper-w7155562648","cat":"papers","name":"Youth sports betting: exploring associations with addictive behaviors and sport participation","year":"2026","cit":0,"pfa":"Bram Constandt","psa":"Alain Van Hiel","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7155562648","eid":"W7155562648"},{"id":"paper-w1988761645","cat":"papers","name":"The Myth of the Addicted Army: Vietnam and the Modern War on Drugs. By Jeremy Kuzmarov. (Amherst: University of Massachusetts Press, 2009. xiv, 303 pp. Cloth, $80.00, ISBN 978-1-55849-704-7. Paper, $26.95, ISBN 978-1-558","year":"2010","cit":0,"pfa":"Erika Dyck","topics":["Addiction"],"ptype":"book-review","src":"https://openalex.org/W1988761645","eid":"W1988761645"},{"id":"paper-w4394237513","cat":"papers","name":"Supplementary Material for: Global Scientific Production on Illicit Drug Addiction: A Two-Decade Analysis","year":"2018","cit":0,"pfa":"Malahat Khalili","psa":"Masoumeh Amin‐Esmaeili","topics":["Addiction"],"ptype":"supplementary-materials","src":"https://openalex.org/W4394237513","eid":"W4394237513"},{"id":"paper-w4235423805","cat":"papers","name":"Faculty Opinions recommendation of Antral follicle count in clinical practice: analyzing clinical relevance.","year":"2011","cit":0,"pfa":"Sarah L. Berga","psa":"Monica Willis","topics":["Dosing & pharmacology"],"ptype":"peer-review","src":"https://openalex.org/W4235423805","eid":"W4235423805"},{"id":"paper-w4409516979","cat":"papers","name":"Aging and death anxiety: a narrative review","year":"2025","cit":0,"pfa":"Tiffany Martini Field","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"review","src":"https://openalex.org/W4409516979","eid":"W4409516979"},{"id":"paper-w3124943833","cat":"papers","name":"Examining Use of Low-Dose Ketamine Infusions During the Postoperative Period: A Retrospective Study Comparing Opioid-Tolerant and Nonopioid-Tolerant Patients.","year":"2021","cit":0,"pfa":"Erin E. Martin","psa":"William David Mauck","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3124943833","eid":"W3124943833"},{"id":"paper-w3177097042","cat":"papers","name":"Adjunct pharmacotherapy for psychotherapy","year":"2021","cit":0,"pfa":"Jessica Lochtenberg","psa":"Matthew W. Johnson","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W3177097042","eid":"W3177097042"},{"id":"paper-w2088650362","cat":"papers","name":"The contributions of medicinal chemistry to psychopharmacology","year":"1960","cit":0,"pfa":"C. Jelleff Carr","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W2088650362","eid":"W2088650362"},{"id":"paper-w7167415825","cat":"papers","name":"From Anti-Aging Medicine to Precision Healthspan Pharmacology: Evidence Domains, Monitoring Requirements, and Practical Boundaries","year":"2026","cit":0,"pfa":"Elias Rubenstein","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7167415825","eid":"W7167415825"},{"id":"paper-w7108068250","cat":"papers","name":"Patterns and Determinants of Polystimulant Use Among Patients Seeking Treatment for Stimulant Use Disorders","year":"2025","cit":0,"pfa":"Janssen, Eric","psa":"Spilka, Stanislas","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7108068250","eid":"W7108068250"},{"id":"paper-w7154314801","cat":"papers","name":"CDR Basin Monitoring A Structural Validation Framework for Therapeutic Intervention","year":"2026","cit":0,"pfa":"John Richard Smith","psa":"SHAI / HATI3","topics":["PTSD & trauma","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7154314801","eid":"W7154314801"},{"id":"paper-w295056491","cat":"papers","name":"Book Review: Addiction: Pagliaros' Comprehensive Guide to Drugs and Substances of Abuse","year":"2005","cit":0,"pfa":"Florence Chanut","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"book-review","src":"https://openalex.org/W295056491","eid":"W295056491"},{"id":"paper-w2964680911","cat":"papers","name":"Determination of quantitative image quality metrics of micro dose 2D/3D slot scanner X-ray imaging system compared to two conventional digital radiography X-ray imaging systems","year":"2019","cit":0,"pfa":"Ahmed Jibril Abdi","psa":"Bo Redder Mussmann","topics":["Dosing & pharmacology"],"ptype":"conference-paper","src":"https://openalex.org/W2964680911","eid":"W2964680911"},{"id":"paper-w2421049158","cat":"papers","name":"[Use of analgesics with peripheral action in the system of complex protection of the patient from operative trauma].","year":"2003","cit":0,"pfa":"Osipova Na","psa":"Sviridov Sv","topics":["PTSD & trauma","Addiction","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W2421049158","eid":"W2421049158"},{"id":"paper-w4409551799","cat":"papers","name":"Lithium and Mental Health: The Small Element with a Big Impact","year":"2025","cit":0,"pfa":"Isabela Dias Cruvinel","psa":"Fábio Morato de Oliveira","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4409551799","eid":"W4409551799"},{"id":"paper-w7162074860","cat":"papers","name":"NATIONAL STANDARDS AS A MECHANISM FOR IMPROVING THE QUALITY AND SAFETY OF PREMIXES FOR POULTRY","year":"2026","cit":0,"pfa":"С. В. Мерзлов","psa":"V. Bilyi","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7162074860","eid":"W7162074860"},{"id":"paper-w4292811756","cat":"papers","name":"COMPARISON BETWEEN CC/GNRH-ANT AND FLARE-UP GNRH AGONIST PROTOCOLS IN POOR OVARIAN RESPONDERS UNDERGOING ICSI","year":"2020","cit":0,"pfa":"Bosoancă Ioan Cătălin","psa":"Vlădăreanu Radu","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4292811756","eid":"W4292811756"},{"id":"paper-w2401672276","cat":"papers","name":"Experimental Models of Schizophrenia","year":"1999","cit":0,"pfa":"Jin-Sook Cheon","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2401672276","eid":"W2401672276"},{"id":"paper-w7133193512","cat":"papers","name":"Emerging Neuropharmacological Drugs for CNS Disorders: Mechanisms, Clinical Applications, and Future Directions","year":"2026","cit":0,"pfa":"Vishal Garg","psa":"Mansi Sharma","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7133193512","eid":"W7133193512"},{"id":"paper-w2948419317","cat":"papers","name":"Substance related disorders in an inpatient psychiatric service: prevalence descriptive study of abuse patterns and diagnostic profiles","year":"2003","cit":0,"pfa":"Giuseppe Carrà","psa":"Francesco Barale","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2948419317","eid":"W2948419317"},{"id":"paper-w7133224513","cat":"papers","name":"Emerging Neuropharmacological Drugs for CNS Disorders: Mechanisms, Clinical Applications, and Future Directions","year":"2026","cit":0,"pfa":"Vishal Garg","psa":"Mansi Sharma","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7133224513","eid":"W7133224513"},{"id":"paper-w7124290135","cat":"papers","name":"Further Insights Into the Metabolism of LGD-4033 in Human Urine. Part 2. A New Minor Metabolite With Antagonistic Activity on the Androgen Receptor Can Indicate Recent Substance Intake","year":"2026","cit":0,"pfa":"Yiannis S. Angelis","psa":"Emmanuel N. Pitsinos","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7124290135","eid":"W7124290135"},{"id":"paper-w7126274741","cat":"papers","name":"Leveraging single-cell profiling in early-phase trials to guide rational therapy development","year":"2025","cit":0,"pfa":"Julia Louw","psa":"Mustafa Khasraw","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7126274741","eid":"W7126274741"},{"id":"paper-w7212161463","cat":"papers","name":"Weight loss with a lower dose compounded semaglutide and behavioral weight management program: A real-world matched retrospective cohort study","year":"2026","cit":0,"pfa":"Erin C. Owen","psa":"Amanda R. Merner","topics":["Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7212161463","eid":"W7212161463"},{"id":"paper-w1536116987","cat":"papers","name":"Paranoid and undifferentiated types of schizophrenia and their relationship to types of substance abuse","year":"1998","cit":0,"pfa":"Beatrice Grillo-DiDomenico","topics":["Addiction"],"ptype":"dissertation","src":"https://openalex.org/W1536116987","eid":"W1536116987"},{"id":"paper-w7154318524","cat":"papers","name":"CDR Basin Monitoring A Structural Validation Framework for Therapeutic Intervention","year":"2026","cit":0,"pfa":"John Richard Smith","psa":"SHAI / HATI3","topics":["PTSD & trauma","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7154318524","eid":"W7154318524"},{"id":"paper-w7168283318","cat":"papers","name":"Substance Use and Consequent Problems: Types of Drugs Taken, Addiction, and Treatment","year":"2026","cit":0,"pfa":"Raqota Berger","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7168283318","eid":"W7168283318"},{"id":"paper-w4256509060","cat":"papers","name":"Faculty Opinions recommendation of Interaction between LSD and dopamine D2/3 binding sites in pig brain.","year":"2005","cit":0,"pfa":"William Walter Blessing","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"peer-review","src":"https://openalex.org/W4256509060","eid":"W4256509060"},{"id":"paper-w2605838785","cat":"papers","name":"Siv Byqvist: Cannabis, Amphetamine, or Opiates? Addicts' Choices of Drugs from First use to Established Abuse","year":"1996","cit":0,"pfa":"Siv Byqvist","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2605838785","eid":"W2605838785"},{"id":"paper-w4394113717","cat":"papers","name":"Bioavailability and pharmacokinetic profile of balovaptan, a selective, brain-penetrant vasopressin 1a receptor antagonist, in healthy volunteers","year":"2021","cit":0,"pfa":"Michael Derks","psa":"Heidemarie Kletzl","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dataset","src":"https://openalex.org/W4394113717","eid":"W4394113717"},{"id":"paper-w3176264375","cat":"papers","name":"Positive allosteric interaction between agonist 5‐HT2A receptor autoantibodies and LY 379268, a selective metabotropic glutamate 2/3 receptor agonist","year":"2019","cit":0,"pfa":"Mark B. Zimering","psa":"Shree Nadkarni","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3176264375","eid":"W3176264375"},{"id":"paper-w4412763458","cat":"papers","name":"Figure 1 from In Situ Proinflammatory Effects of Dazostinag Alone or with Chemotherapy on the Tumor Microenvironment of Patients with Head and Neck Squamous Cell Carcinoma","year":"2025","cit":0,"pfa":"Richard C. Gregory","psa":"Richard A. Klinghoffer","topics":["Dosing & pharmacology","Policy & ethics"],"ptype":"other","src":"https://openalex.org/W4412763458","eid":"W4412763458"},{"id":"paper-w7125518904","cat":"papers","name":"Mental Health and ART Adherence in a Multisite International Study: The Mediating Roles of Social Support and Substance Use in People with HIV","year":"2026","cit":0,"pfa":"Joseph Awad","psa":"Wei-Ti Chen","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7125518904","eid":"W7125518904"},{"id":"paper-w7147583579","cat":"papers","name":"Addiction psychiatry: where we are and challenges in the UK","year":"2026","cit":0,"pfa":"Anne R. Lingford-Hughes","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7147583579","eid":"W7147583579"},{"id":"paper-w7163031913","cat":"papers","name":"Explainable Artificial Intelligence (xAI) for 5-HT2A Receptor Binding Affinity of New Psychoactive Substances","year":"2026","cit":0,"pfa":"Verena Schöning","psa":"Felix Hammann","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7163031913","eid":"W7163031913"},{"id":"paper-w7162663651","cat":"papers","name":"Test-Retest Reliability of Standardized Diagnostic Interviews for Common Adult Psychiatric Disorders","year":"2026","cit":0,"pfa":"Weiyi Xie","psa":"Laura Duncan","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7162663651","eid":"W7162663651"},{"id":"paper-w4416617735","cat":"papers","name":"Peer Review Report For: Fractional spinal anesthesia and systemic hemodynamics in frail elderly hip fracture patients [version 3; peer review: 1 approved, 2 approved with reservations]","year":"2023","cit":0,"pfa":"Fredrik Olsen","psa":"Bengt Nellgård","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4416617735","eid":"W4416617735"},{"id":"paper-w7163525072","cat":"papers","name":"Explainable Artificial Intelligence (xAI) for 5-HT2A Receptor Binding Affinity of New Psychoactive Substances","year":"2026","cit":0,"pfa":"Verena Schöning","psa":"Felix Hammann","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7163525072","eid":"W7163525072"},{"id":"paper-w3212248619","cat":"papers","name":"Fractional spinal anesthesia and systemic hemodynamics in frail elderly hip fracture patients","year":"2021","cit":0,"pfa":"Fredrik Olsen","psa":"Bengt Nellgård","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W3212248619","eid":"W3212248619"},{"id":"paper-w4416657098","cat":"papers","name":"Peer Review Report For: Fractional spinal anesthesia and systemic hemodynamics in frail elderly hip fracture patients [version 2; peer review: 1 approved, 2 approved with reservations]","year":"2023","cit":0,"pfa":"Fredrik Olsen","psa":"Bengt Nellgård","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4416657098","eid":"W4416657098"},{"id":"paper-w4416622922","cat":"papers","name":"Peer Review Report For: Fractional spinal anesthesia and systemic hemodynamics in frail elderly hip fracture patients [version 2; peer review: 1 approved, 2 approved with reservations]","year":"2023","cit":0,"pfa":"Fredrik Olsen","psa":"Bengt Nellgård","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4416622922","eid":"W4416622922"},{"id":"paper-w7135505209","cat":"papers","name":"Pharmacokinetics, systemic toxicity, and acute behavioural effects of phenethylamine derivative 25E-NBOH in rats","year":"2025","cit":0,"pfa":"Anežka Hrubá","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W7135505209","eid":"W7135505209"},{"id":"paper-w7133900470","cat":"papers","name":"Building Stronger Communities Through Addiction Care Innovation, Research, Education, and Advocacy—Overview and Proceedings of the AMERSA 2025 Conference","year":"2026","cit":0,"pfa":"Bradley M. Buchheit","psa":"Nicole O’Donnell","topics":["Addiction","Therapy practice"],"ptype":"editorial","src":"https://openalex.org/W7133900470","eid":"W7133900470"},{"id":"paper-w7119557142","cat":"papers","name":"Successful Treatment of Opioid-Induced Hyperalgesia with Buprenorphine: A Case Report.","year":"2025","cit":0,"pfa":"Adam Clements","psa":"Phillip Hartfield","topics":["Addiction","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7119557142","eid":"W7119557142"},{"id":"paper-w4407728520","cat":"papers","name":"Building virtual patients for training mental health professionals","year":"2025","cit":0,"pfa":"Patrick C. Staples","psa":"Robert F. Dougherty","topics":["Mechanism & neuroscience","Reviews & meta-analyses","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4407728520","eid":"W4407728520"},{"id":"paper-w4385428927","cat":"papers","name":"Fractional spinal anesthesia and systemic hemodynamics in frail elderly hip fracture patients","year":"2023","cit":0,"pfa":"Fredrik Olsen","psa":"Bengt Nellgård","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4385428927","eid":"W4385428927"},{"id":"paper-w4408332303","cat":"papers","name":"A Yogi in Attachment-Informed Psychotherapy","year":"2025","cit":0,"pfa":"Geoff Goodman","topics":["Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W4408332303","eid":"W4408332303"},{"id":"paper-w4390413628","cat":"papers","name":"Research on the therapeutic effectiveness of the veterinary medicinal product “Surfadev” in complex therapy for stimulating sexual desire in cows","year":"2023","cit":0,"pfa":"О. А. Кацараба","psa":"L.-M. Ye. Kostyshyn","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4390413628","eid":"W4390413628"},{"id":"paper-w2343357212","cat":"papers","name":"PCP in Monkeys: A Model for Schizophrenia?","year":"1997","cit":0,"pfa":"Charles B. Nemeroff","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2343357212","eid":"W2343357212"},{"id":"paper-w4367337260","cat":"papers","name":"MODERN ASPECTS OF THE MANAGEMENT OF PATIENTS WITH ABNORMAL UTERINE BLEEDING","year":"2021","cit":0,"pfa":"O. O. Korchynska","psa":"М.А. Созанська","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4367337260","eid":"W4367337260"},{"id":"paper-w3168761815","cat":"papers","name":"Transcendental Psychedelia: Hearing hearing in the work of Maryanne Amacher","year":"2021","cit":0,"pfa":"Will Schrimshaw","ptype":"book-chapter","src":"https://openalex.org/W3168761815","eid":"W3168761815"},{"id":"paper-w7126211312","cat":"papers","name":"Pharmacological interventions for alcohol use disorder: novel insights from recent clinical trials","year":"2026","cit":0,"pfa":"Kaitlin R. McManus","psa":"Lara A. Ray","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7126211312","eid":"W7126211312"},{"id":"paper-w4411380068","cat":"papers","name":"Addiction and Substance Abuse","year":"2025","cit":0,"pfa":"Mishthi Prajapati","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W4411380068","eid":"W4411380068"},{"id":"paper-w4416630554","cat":"papers","name":"Peer Review Report For: Fractional spinal anesthesia and systemic hemodynamics in frail elderly hip fracture patients [version 2; peer review: 1 approved, 2 approved with reservations]","year":"2023","cit":0,"pfa":"Fredrik Olsen","psa":"Bengt Nellgård","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4416630554","eid":"W4416630554"},{"id":"paper-w1586209236","cat":"papers","name":"Substance Use and Subclinical Psychosis Symptoms","year":"2014","cit":0,"pfa":"Kelsey Hurm","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1586209236","eid":"W1586209236"},{"id":"paper-w4404245936","cat":"papers","name":"Abstract 4140185: The Burden Of Substance Abuse And Mental Health Disorders In Patients Admitted With Stress Cardiomyopathy","year":"2024","cit":0,"pfa":"Rama Ellauzi","psa":"Khaled F. Chatila","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"conference-abstract","src":"https://openalex.org/W4404245936","eid":"W4404245936"},{"id":"paper-w7150020941","cat":"papers","name":"Reflex Congestion Theory: A Computational Account of Bandwidth Depletion in Addiction, Waking Life and Attentional Capture","year":"2026","cit":0,"pfa":"Daniel Gilbey","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7150020941","eid":"W7150020941"},{"id":"paper-w7160331750","cat":"papers","name":"In vitro neuronal characterization of the entheogenic plant Tagetes lucida Cav.","year":"2026","cit":0,"pfa":"Maria Eduarda Bertino Nahim Garcia","psa":"Nelson G. M. Gomes","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7160331750","eid":"W7160331750"},{"id":"paper-w4380675239","cat":"papers","name":"Transcendental psychedelia","year":"2023","cit":0,"pfa":"Will Schrimshaw","ptype":"book-chapter","src":"https://openalex.org/W4380675239","eid":"W4380675239"},{"id":"paper-w2288661209","cat":"papers","name":"Free clinic volunteer therapist program","year":"1973","cit":0,"pfa":"Bertram W. Schlosser","topics":["Anxiety & end-of-life","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W2288661209","eid":"W2288661209"},{"id":"paper-w4390788775","cat":"papers","name":"Reviewer #2 (Public Review): A preclinical model of THC edibles that produces high-dose cannabimimetic responses","year":"2024","cit":0,"topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4390788775","eid":"W4390788775"},{"id":"paper-w4390829921","cat":"papers","name":"Author Response: A preclinical model of THC edibles that produces high-dose cannabimimetic responses","year":"2024","cit":0,"pfa":"Anthony English","psa":"Benjamin Bruce Land","topics":["Dosing & pharmacology"],"ptype":"peer-review","src":"https://openalex.org/W4390829921","eid":"W4390829921"},{"id":"paper-w7122699992","cat":"papers","name":"Potential molecular pathways and therapeutic implications of rapid-acting antidepressants on myelin biology: a scoping review","year":"2026","cit":0,"pfa":"Antonio Inserra","psa":"Marie‐Ève Tremblay","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7122699992","eid":"W7122699992"},{"id":"paper-w7150134660","cat":"papers","name":"Reflex Congestion Theory: A Computational Account of Bandwidth Depletion in Addiction, Waking Life and Attentional Capture","year":"2026","cit":0,"pfa":"Daniel Gilbey","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7150134660","eid":"W7150134660"},{"id":"paper-w7170737980","cat":"papers","name":"Bioenergetic and Pharmacological Treatment of Maladaptive Hyper-Attachment Syndrome: Bayesian N-of-1 Trial Based on the Free Energy Principle","year":"2026","cit":0,"pfa":"Víctor López","topics":["Addiction","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7170737980","eid":"W7170737980"},{"id":"paper-w4391151224","cat":"papers","name":"Neurological Mechanisms and Therapeutic Strategies for Post-Traumatic Stress Disorder (PTSD)","year":"2024","cit":0,"pfa":"Mariana Hyeda Miranda","psa":"Myrna Maria Costa de Melo Silveira","topics":["PTSD & trauma","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4391151224","eid":"W4391151224"},{"id":"paper-w2320391975","cat":"papers","name":"Behavioral Pharmacology of Abused Drugs A Review of Clinical Aspects","year":"1985","cit":0,"pfa":"Nobukatsu Kato","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2320391975","eid":"W2320391975"},{"id":"paper-w1998309827","cat":"papers","name":"Advances in clinical trials technologies","year":"2010","cit":0,"pfa":"In‐Jin Jang","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1998309827","eid":"W1998309827"},{"id":"paper-w2062181393","cat":"papers","name":"UP-02.038 Ketamine Addiction: Need to Raise Awareness of Its Bladder Complications","year":"2011","cit":0,"pfa":"Rozh T. Jalil","psa":"Suresh Gupta","topics":["Addiction"],"ptype":"conference-abstract","src":"https://openalex.org/W2062181393","eid":"W2062181393"},{"id":"paper-w4390818657","cat":"papers","name":"Reviewer #1 (Public Review): A preclinical model of THC edibles that produces high-dose cannabimimetic responses","year":"2024","cit":0,"topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4390818657","eid":"W4390818657"},{"id":"paper-w4385224291","cat":"papers","name":"A Comprehensive Review of Novel Pathophysiology, Approved and Non-approved Pharmacological Agents for PTSD Therapy","year":"2023","cit":0,"pfa":"Santosh Kumar Prajapati","psa":"Sairam Krishnamurthy","topics":["Depression","PTSD & trauma","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4385224291","eid":"W4385224291"},{"id":"paper-w7208776101","cat":"papers","name":"Research progress on the role of claustrum in substance use disorders","year":"2026","cit":0,"pfa":"Manqing Wu","psa":"Min ZHAO","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7208776101","eid":"W7208776101"},{"id":"paper-w4390815448","cat":"papers","name":"Reviewer #3 (Public Review): A preclinical model of THC edibles that produces high-dose cannabimimetic responses","year":"2024","cit":0,"topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4390815448","eid":"W4390815448"},{"id":"paper-w4390825961","cat":"papers","name":"eLife assessment: A preclinical model of THC edibles that produces high-dose cannabimimetic responses","year":"2024","cit":0,"pfa":"Robert B. Laprairie","topics":["Dosing & pharmacology"],"ptype":"peer-review","src":"https://openalex.org/W4390825961","eid":"W4390825961"},{"id":"paper-w4379985280","cat":"papers","name":"Complexes of Hallucinogenic Drugs","year":"2023","cit":0,"pfa":"Wolfram Hänsel","topics":["Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W4379985280","eid":"W4379985280"},{"id":"paper-w7112365399","cat":"papers","name":"Drug Addiction","cit":0,"pfa":"Office of Health Economics","topics":["Addiction","Dosing & pharmacology","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W7112365399","eid":"W7112365399"},{"id":"paper-w7112486187","cat":"papers","name":"Investigating the Effects of a Psychoplastogen on Depressive-Like Behaviors in Huntington Disease Model Mice","year":"2025","cit":0,"pfa":"Hanley, Kaleigh M","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7112486187","eid":"W7112486187"},{"id":"paper-w7214324637","cat":"papers","name":"AI-integrated human-relevant alternatives to animal experimentation in drug development: Toward a predictive translational ecosystem, from in vitro and in silico models to clinical and real-world evidence","year":"2026","cit":0,"pfa":"Prashant N. Amale","psa":"Dhirendra H. Tiwari","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7214324637","eid":"W7214324637"},{"id":"paper-w4391420445","cat":"papers","name":"Efficacy and safety of ketamine in the treatment of neuropathic pain: A systematic review and meta-analysis of randomized controlled trials","year":"2024","cit":0,"pfa":"José Eduardo Guimarães Pereira","psa":"Hazem Adel Ashmawi","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4391420445","eid":"W4391420445"},{"id":"paper-w7204828422","cat":"papers","name":"Comparative Efficacy and Safety of Ketorolac and Ketamine in the Management of Traumatic Chest Pain: A Narrative Review","year":"2026","cit":0,"pfa":"Farhad Hakimzadeh","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W7204828422","eid":"W7204828422"},{"id":"paper-w7125400009","cat":"papers","name":"Supplementary material from \"Discovery of the closest free-living relative of the domesticated “magic mushroom” Psilocybe cubensis in Africa \"","year":"2026","cit":0,"pfa":"Alexander  James Bradshaw","psa":"Bryn T. M. Dentinger","ptype":"supplementary-materials","src":"https://openalex.org/W7125400009","eid":"W7125400009"},{"id":"paper-w4416957399","cat":"papers","name":"Have you tried switching it off and on again? Mechanisms and therapeutic prospects of resetting homeostatic set points in medicine and neuropsychiatry","year":"2025","cit":0,"pfa":"Thomas Arthur Pollak","psa":"Mark John Edwards","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4416957399","eid":"W4416957399"},{"id":"paper-w7166558655","cat":"papers","name":"Integrating Pharmacokinetics into Human Exposure and Risk Assessment of Polycyclic Aromatic Hydrocarbons","year":"2026","cit":0,"pfa":"The Pharmaceutical Society Of Korea","psa":"Sung-Hoon Ahn","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7166558655","eid":"W7166558655"},{"id":"paper-w7133357616","cat":"papers","name":"Filtering the Noise: A Cerebellar-Centered Framework for Understanding and Treating Mental Illness - A Paradigm Shift in Psychiatry","year":"2026","cit":0,"pfa":"Craig Ferris","topics":["Depression","PTSD & trauma","Mechanism & neuroscience"],"ptype":"report","src":"https://openalex.org/W7133357616","eid":"W7133357616"},{"id":"paper-w4387993068","cat":"papers","name":"Becoming-Metal: On Knowledge by Ketamine","year":"2023","cit":0,"pfa":"Joshua Ramey","ptype":"article","src":"https://openalex.org/W4387993068","eid":"W4387993068"},{"id":"paper-w7197036870","cat":"papers","name":"Permissive and instructive causality: integrating biological and environmental factors in mental health","year":"2026","cit":0,"pfa":"Igor Branchi","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7197036870","eid":"W7197036870"},{"id":"paper-w7125391473","cat":"papers","name":"Supplementary material from \"Discovery of the closest free-living relative of the domesticated “magic mushroom” Psilocybe cubensis in Africa \"","year":"2026","cit":0,"pfa":"Alexander  James Bradshaw","psa":"Bryn T. M. Dentinger","ptype":"supplementary-materials","src":"https://openalex.org/W7125391473","eid":"W7125391473"},{"id":"paper-w7162793895","cat":"papers","name":"A conceptual framework based on current and emerging treatments for treatment-resistant depression: mechanistic evolution, clinical evidence, and future directions","year":"2026","cit":0,"pfa":"Stephen Rush","psa":"Henry A. Nasrallah","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7162793895","eid":"W7162793895"},{"id":"paper-w2186261403","cat":"papers","name":"Using selected scenes from Brazilian films to teach about substance use disorders, within medical education Usando cenas selecionadas de filmes brasileiros para ensino a respeito dos transtornos relacionados ao uso de su","year":"2012","cit":0,"pfa":"Santo André","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2186261403","eid":"W2186261403"},{"id":"paper-w7131388031","cat":"papers","name":"Have you tried switching it off and on again? Mechanisms and therapeutic prospects of resetting homeostatic set points in medicine and neuropsychiatry","year":"2026","cit":0,"pfa":"Thomas Pollak","psa":"Mark J Edwards","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7131388031","eid":"W7131388031"},{"id":"paper-w4322101568","cat":"papers","name":"Session to Explore the Progress of Precision Psychiatry","year":"2023","cit":0,"pfa":"Nick Zagorski","topics":["Depression","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4322101568","eid":"W4322101568"},{"id":"paper-w2561438979","cat":"papers","name":"Abstract 228: A novel device to perform rapid high-throughput in vivo drug sensitivity testing and identify optimal drug therapy for personalized cancer treatment","year":"2015","cit":0,"pfa":"Oliver H. Jonas","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W2561438979","eid":"W2561438979"},{"id":"paper-w2047961438","cat":"papers","name":"ET-24 * A NOVEL TROJAN HORSE FOR IN-VIVO SENSITIVITY TESTING OF MEDULLOBLASTOMA THERAPIES","year":"2014","cit":0,"pfa":"Oliver H. Jonas","psa":"Róbert Langer","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W2047961438","eid":"W2047961438"},{"id":"paper-w4289653857","cat":"papers","name":"Correlates of substance use in a large naturalistic cohort of young people with early and emerging psychosis","year":"2022","cit":0,"pfa":"D. El-Hage","psa":"Ellie Brown","topics":["Addiction","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4289653857","eid":"W4289653857"},{"id":"paper-w7154711898","cat":"papers","name":"Abstract CT198: Phase 1 clinical trial of a first-in-class antagomir therapeutic against advanced solid tumors","year":"2026","cit":0,"pfa":"Zdravka O. Medarova","psa":"Susan Duggan","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W7154711898","eid":"W7154711898"},{"id":"paper-w2346722830","cat":"papers","name":"Enduri~ ~ancement in frontal cortex ~ine utilization in an animi ~of amphetami~ psychosis","year":"1985","cit":0,"pfa":"Terry E. Robinson","psa":"G. Miti","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2346722830","eid":"W2346722830"},{"id":"paper-w236948737","cat":"papers","name":"Autroadiographic characterization of sup 125 I-labeled 2,5-dimethoxy-4-iodophenylisopropylamine (DOI): A phenylisopropylamine derivative labeling both 5HT sub 2 and 5HT sub 1c receptors","year":"1990","cit":0,"pfa":"N M Appel","psa":"Richmond Vcu","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W236948737","eid":"W236948737"},{"id":"paper-w2762048130","cat":"papers","name":"Drug and Alcohol Use","year":"2019","cit":0,"pfa":"Ubaid ullah Alozai","psa":"Sandeep Sharma","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2762048130","eid":"W2762048130"},{"id":"paper-w7203493686","cat":"papers","name":"Drug Abuse and Mental Health Among Secondary School Students in Uyo Senatorial District of Akwa Ibom State","year":"2026","cit":0,"pfa":"Victoria Andy Eyo","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7203493686","eid":"W7203493686"},{"id":"paper-w4308896013","cat":"papers","name":"The Psychological Pathways to Substance Use in Adolescence: A Study in a Adolescent Therapeutic Community","year":"2022","cit":0,"pfa":"Mara Pinto","psa":"Bárbara Romão","topics":["Addiction","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4308896013","eid":"W4308896013"},{"id":"paper-w4387733332","cat":"papers","name":"S1080 Lower Substance Use, But Higher Opioid Use, Among Hospitalizations With Inflammatory Bowel Disease: National Inpatient Sample","year":"2023","cit":0,"pfa":"Jin Sun Kim","psa":"Bing Zhang","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"conference-abstract","src":"https://openalex.org/W4387733332","eid":"W4387733332"},{"id":"paper-w2978009220","cat":"papers","name":"Chapter 4Post-Traumatic Stress Disorder and Substance Use Disorder","year":"2013","cit":0,"pfa":"Steven Scott Coughlin","psa":"Laura Herrera","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W2978009220","eid":"W2978009220"},{"id":"paper-w3201184438","cat":"papers","name":"CLRM-05. DRUG-RELEASING MICRODEVICES TO PREDICT RESPONSES TO TARGETED THERAPIES IN PATIENTS WITH GLIOMAS","year":"2021","cit":0,"pfa":"Sarah E. Blitz","psa":"Pierpaolo Peruzzi","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W3201184438","eid":"W3201184438"},{"id":"paper-w7167625087","cat":"papers","name":"Prevalence of novel psychoactive substances in selected clinical urine specimens submitted for drug monitoring","year":"2026","cit":0,"pfa":"Jillian R. Neifeld","psa":"Sarah H Bartock","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7167625087","eid":"W7167625087"},{"id":"paper-w2938821695","cat":"papers","name":"Toxicity-sparing in-tumor profiling of multiple drugs simultaneously in canine patients with sarcoma.","year":"2015","cit":0,"pfa":"Jason P. Frazier","psa":"Richard A. Klinghoffer","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W2938821695","eid":"W2938821695"},{"id":"paper-w4401991337","cat":"papers","name":"Does the Use of Psychoactive Substances Reveal Underlying Trauma or Common Mental Health Problems?","year":"2024","cit":0,"pfa":"Десислава Игнатова","psa":"R. Vladimirova","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4401991337","eid":"W4401991337"},{"id":"paper-w7203462449","cat":"papers","name":"Gender differences in perceived self-stigma among substance abuse patients","year":"2026","cit":0,"pfa":"Rahma M.F. Ibrahim","psa":"Nesrine Hanna","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7203462449","eid":"W7203462449"},{"id":"paper-w4251219342","cat":"papers","name":"Quantifying the Attenuation of the Ketamine Pharmacological Magnetic Resonance Imaging Response in Humans","year":"2013","cit":0,"topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4251219342","eid":"W4251219342"},{"id":"paper-w2609916169","cat":"papers","name":"79. The Effects of Repeated NMDA Blockade with Ketamine on Dopamine and Glutamate Function","year":"2017","cit":0,"pfa":"Oliver Howes","psa":"Michelle Kokkinou","ptype":"article","src":"https://openalex.org/W2609916169","eid":"W2609916169"},{"id":"paper-w4413353514","cat":"papers","name":"Development of PBPK Population Model for End-Stage Renal Disease Patients to Inform OATP1B-, BCRP-, P-gp-, and CYP3A4-Mediated Drug Disposition with Individual Influencing Factors","year":"2025","cit":0,"pfa":"Yujie Wu","psa":"Dongyang Liu","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4413353514","eid":"W4413353514"},{"id":"paper-w2400080754","cat":"papers","name":"[Control of the side effects of ketamine: chlordemethyldiazepam vs diazepam in pre-anesthesia].","year":"1989","cit":0,"pfa":"C D'Eramo","psa":"A. Salvadori","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2400080754","eid":"W2400080754"},{"id":"paper-w4205869023","cat":"papers","name":"ACD856: A novel positive allosteric modulator of Trk‐signaling in clinical development for the treatment of Alzheimer’s disease","year":"2021","cit":0,"pfa":"Gunnar Nordvall","psa":"Pontus K. A. Larsson Forsell","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W4205869023","eid":"W4205869023"},{"id":"paper-w4388670901","cat":"papers","name":"Exploring compatibilities between the Free Energy Principle and Heideggerian existential phenomenology as alternative dynamic conceptualizations of depression","year":"2023","cit":0,"pfa":"Mathias Houe Andersen","psa":"Silja Katharina Arenfeldt","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4388670901","eid":"W4388670901"},{"id":"paper-w7130040530","cat":"papers","name":"Prometheus unbound? Oceanic affectivity and the neuropsychodynamics of addiction","year":"2026","cit":0,"pfa":"­Human‐Friedrich Unterrainer","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7130040530","eid":"W7130040530"},{"id":"paper-w7113232670","cat":"papers","name":"The impact of the novel sigma1 receptor ligand (S)-L1 on brain endothelial cells and cerebrovascular reactivity challenged by ischemia","year":"2025","cit":0,"pfa":"Kecskés, Szilvia","psa":"Veszelka, Szilvia","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7113232670","eid":"W7113232670"},{"id":"paper-w7130827627","cat":"papers","name":"Time-Domain Functional Near-Infrared Spectroscopy for Bedside Assessment of Changes in Cerebrovascular Hemodynamics Induced by a Subanesthetic Dose of Ketamine","year":"2025","cit":0,"pfa":"Felix Scholkmann","psa":"Wesley C. Ryan","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W7130827627","eid":"W7130827627"},{"id":"paper-w4394344835","cat":"papers","name":"Aesthetic Chills Mitigate Maladaptive Cognition In Depression","year":"2023","cit":0,"pfa":"Félix Schoeller","psa":"Nicco Reggente","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"dataset","src":"https://openalex.org/W4394344835","eid":"W4394344835"},{"id":"paper-w4395054736","cat":"papers","name":"Positron emission tomography for optimizing psychiatric drug treatment: present and future","year":"2024","cit":0,"pfa":"Gerhard Gründer","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"conference-paper","src":"https://openalex.org/W4395054736","eid":"W4395054736"},{"id":"paper-w3043506685","cat":"papers","name":"5-HT2A mediated plasticity as a target in major depression: a narrative review connecting the dots from neurobiology to cognition and psychology","year":"2020","cit":0,"pfa":"Camile Bahi","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W3043506685","eid":"W3043506685"},{"id":"paper-w4385669381","cat":"papers","name":"An update on the Pharmacological and Psychotherapeutic Management of Treatment Resistant OCD","year":"2023","cit":0,"pfa":"Michael Van Ameringen","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4385669381","eid":"W4385669381"},{"id":"paper-w2087674033","cat":"papers","name":"The impact of craving on termination of alcohol abstinence","year":"1998","cit":0,"pfa":"Clemens Veltrup","psa":"Tilman Wetterling","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2087674033","eid":"W2087674033"},{"id":"paper-w341201599","cat":"papers","name":"Lysergic Acid Derivatives","year":"1958","cit":0,"pfa":"Russell R. Monroe","ptype":"report","src":"https://openalex.org/W341201599","eid":"W341201599"},{"id":"paper-w7131068497","cat":"papers","name":"EEG correlates of psychoactive ketamine: Comparing spectral power and complexity","year":"2026","cit":0,"pfa":"Brandon Reynante","ptype":"dataset","src":"https://openalex.org/W7131068497","eid":"W7131068497"},{"id":"paper-w1988461568","cat":"papers","name":"Regional correlations between ketamine-induced actions on psychosis and regional cerebral blood flow (rCBF)","year":"1997","cit":0,"pfa":"Adrienne Carol Lahti","psa":"Carol A. Tamminga","ptype":"article","src":"https://openalex.org/W1988461568","eid":"W1988461568"},{"id":"paper-w7131275162","cat":"papers","name":"EEG correlates of psychoactive ketamine: Comparing spectral power and complexity","year":"2026","cit":0,"pfa":"Brandon Reynante","ptype":"dataset","src":"https://openalex.org/W7131275162","eid":"W7131275162"},{"id":"paper-w1982419021","cat":"papers","name":"IS THERE BEHAVIORAL EVIDENCE FOR CONSTITUTIVE ACTIVITY AT 5‐HT2A RECEPTORS?","year":"2008","cit":0,"pfa":"Charles Patrick France","psa":"Jun‐Xu Li","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W1982419021","eid":"W1982419021"},{"id":"paper-w2757060222","cat":"papers","name":"Research with chemistry and pharmacology of natural products in Brazil: Past, present and future","year":"2017","cit":0,"pfa":"Lúcio Ferreira Alves","psa":"Tatiana V. C. Pontes","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2757060222","eid":"W2757060222"},{"id":"paper-w7138872999","cat":"papers","name":"The Montreal model of ketamine-therapy for alcohol use disorder and comorbid treatment-resistant depression: protocol for a feasibility trial","year":"2026","cit":0,"pfa":"Christina McAnulty","psa":"Nicolas Garel","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7138872999","eid":"W7138872999"},{"id":"paper-w7214237403","cat":"papers","name":"Co-Occurring Mental Illness and Substance Use Disorders: Associations Between Illness Severity, Perceived Need, and Receiving Substance Use Treatment","year":"2026","cit":0,"pfa":"Shashim A. Waghmare","psa":"Abenaa A. Jones","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7214237403","eid":"W7214237403"},{"id":"paper-w7161119956","cat":"papers","name":"Collaborative Wisdom: Developing Consensus-Based Clinical Guidelines for Emergent Phenomena, Experiences and Effects (EPEEs) Through AI-Assisted Delphi Methodology","year":"2026","cit":0,"pfa":"Hannah Biddell","psa":"Daniel MacLellan Ingram","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7161119956","eid":"W7161119956"},{"id":"paper-w7165666254","cat":"papers","name":"Prevalence of non-medical drug use and dependence among school-going adolescents in Malaysia","year":"2026","cit":0,"pfa":"Nurul Shafini Shafurdin","psa":"Mohd Rizal Abdul Manaf","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7165666254","eid":"W7165666254"},{"id":"paper-w4414639516","cat":"papers","name":"Time-Domain Functional Near-Infrared Spectroscopy for Bedside Assessment of Changes in Cerebrovascular Hemodynamics Induced by a Subanesthetic Dose of Ketamine","year":"2025","cit":0,"pfa":"Felix Scholkmann","psa":"Wesley C. Ryan","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W4414639516","eid":"W4414639516"},{"id":"paper-w4387448290","cat":"papers","name":"Reviewer #1 (Public Review): A preclinical model of THC edibles that produces high-dose cannabimimetic responses","year":"2023","cit":0,"pfa":"Anthony English","psa":"Benjamin Bruce Land","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4387448290","eid":"W4387448290"},{"id":"paper-w4405862788","cat":"papers","name":"Characteristics of Youth with and without Substance Use Disorder Presenting for Primary Mental Healthcare: Baseline Findings from the INTEGRATE Trial","year":"2024","cit":0,"pfa":"Elaheh Ahounbar","psa":"Gillinder Bedi","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W4405862788","eid":"W4405862788"},{"id":"paper-w3146822486","cat":"papers","name":"HALLUCINOGENIC PLANTS IN CHINESE HERBALS","year":"2016","cit":0,"pfa":"Li Shih-chên's","psa":"ePên-ts'ao kang-mu","ptype":"article","src":"https://openalex.org/W3146822486","eid":"W3146822486"},{"id":"paper-w2182936853","cat":"papers","name":"Effects of Clozapine, Aripiprazole and Bitopertin in Rats Social Withdrawal Assessed in an Automatic Social Interaction Test","year":"2014","cit":0,"pfa":"Serena Deiana","psa":"Roberto Arban","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2182936853","eid":"W2182936853"},{"id":"paper-w4394538795","cat":"papers","name":"ST and Chills Full Data Cohort post-Quality Control Uploaded on 10/11/2023","year":"2023","cit":0,"pfa":"Leonardo Christov‐Moore","psa":"Nicco Reggente","ptype":"dataset","src":"https://openalex.org/W4394538795","eid":"W4394538795"},{"id":"paper-w7127615366","cat":"papers","name":"How do substance and polysubstance use trajectories differ by sexual attraction from ages 17 to 24? A community-based longitudinal cohort study in Switzerland","year":"2026","cit":0,"pfa":"Clarissa Janousch","psa":"Lilly Shanahan","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7127615366","eid":"W7127615366"},{"id":"paper-w7125822118","cat":"papers","name":"How do substance and polysubstance use trajectories differ by sexual attraction from ages 17 to 24? A community-based longitudinal cohort study in Switzerland","year":"2026","cit":0,"pfa":"Clarissa Janousch","psa":"Lilly Shanahan","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7125822118","eid":"W7125822118"},{"id":"paper-w4410152801","cat":"papers","name":"Detecting neuroplastic effects induced by ketamine in healthy human subjects: a multimodal approach","year":"2025","cit":0,"pfa":"Claudio Agnorelli","psa":"David Erritzøe","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4410152801","eid":"W4410152801"},{"id":"paper-w3173545317","cat":"papers","name":"Acquisition of Oral Ethanol Self‐administration in Long‐Evans Rats: Model Validation for Treatment of Alcohol Use Disorders","year":"2019","cit":0,"pfa":"Michael D. Berquist","psa":"William E. Fantegrossi","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3173545317","eid":"W3173545317"},{"id":"paper-w7167478343","cat":"papers","name":"Psilocibin: Current Evidence, Safety Signals, and Challenges in Assessing Potential Multi-Organ Effects","year":"2026","cit":0,"pfa":"Kasper Buczma","psa":"Agnieszka Cudnoch‐Jędrzejewska","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7167478343","eid":"W7167478343"},{"id":"paper-w2157503904","cat":"papers","name":"Childhood adversity and certain mental health disorders are associated with increased risk of incident drug use among adults","year":"2012","cit":0,"pfa":"Silvia Saboia Martins","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W2157503904","eid":"W2157503904"},{"id":"paper-w4387448286","cat":"papers","name":"Reviewer #3 (Public Review): A preclinical model of THC edibles that produces high-dose cannabimimetic responses","year":"2023","cit":0,"pfa":"Anthony English","psa":"Benjamin Bruce Land","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4387448286","eid":"W4387448286"},{"id":"paper-w4387448289","cat":"papers","name":"Reviewer #2 (Public Review): A preclinical model of THC edibles that produces high-dose cannabimimetic responses","year":"2023","cit":0,"pfa":"Anthony English","psa":"Benjamin Bruce Land","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4387448289","eid":"W4387448289"},{"id":"paper-w4387448249","cat":"papers","name":"eLife Assessment: A preclinical model of THC edibles that produces high-dose cannabimimetic responses","year":"2023","cit":0,"pfa":"Robert B. Laprairie","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"peer-review","src":"https://openalex.org/W4387448249","eid":"W4387448249"},{"id":"paper-w2600461805","cat":"papers","name":"Ketamine's Quick Antidepressant Actions","year":"2010","cit":0,"pfa":"Barbara Geller","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2600461805","eid":"W2600461805"},{"id":"paper-w2908971541","cat":"papers","name":"Treatment Episode Data Set -- Admissions (TEDS-A), 1998","year":"2000","cit":0,"pfa":"United States Department of Health and Human Services. Substance Abuse and…","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W2908971541","eid":"W2908971541"},{"id":"paper-w7204918105","cat":"papers","name":"Treatment Episode Data Set -- Admissions (TEDS-A), 2003","year":"2026","cit":0,"pfa":"United States Department of Health and Human Services. Substance Abuse and…","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W7204918105","eid":"W7204918105"},{"id":"paper-w7214656681","cat":"papers","name":"Measured receptor pharmacology for 545 psychoactive compounds, snapshot of 27 September 2026","year":"2026","cit":0,"pfa":"Nikolay V. Dokholyan","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dataset","src":"https://openalex.org/W7214656681","eid":"W7214656681"},{"id":"paper-w7215563316","cat":"papers","name":"Pharmacological Strategies for Treatment-Resistant Depression: Integrating Novel and Traditional Approaches with Psychopathological Insights","year":"2026","cit":0,"pfa":"Mario Pinzi","psa":"Andrea M. Fagiolini","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7215563316","eid":"W7215563316"},{"id":"paper-w1973188595","cat":"papers","name":"Substance use in first degree relatives of opioid addicts","year":"2001","cit":0,"pfa":"Jamshid Ahmadi","psa":"Yaghoub Mansouri","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1973188595","eid":"W1973188595"},{"id":"paper-w7204878252","cat":"papers","name":"Treatment Episode Data Set -- Admissions (TEDS-A), 1994","year":"2026","cit":0,"pfa":"United States Department of Health and Human Services. Substance Abuse and…","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W7204878252","eid":"W7204878252"},{"id":"paper-w7155812984","cat":"papers","name":"Comparing depersonalization/derealization-like experiences arising in clinical contexts vs. meditation","year":"2021","cit":0,"pfa":"Erola Pons","psa":"Nicholas T Van Dam","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W7155812984","eid":"W7155812984"},{"id":"paper-w7213568910","cat":"papers","name":"Utilising multimodal neuroimaging to investigate reward system deficits and to develop novel therapeutics in individuals with substance use and behavioural addictions","year":"2023","cit":0,"pfa":"Rayyan R. Zafar","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7213568910","eid":"W7213568910"},{"id":"paper-w7110595303","cat":"papers","name":"Consideration of neuroplasticity and anxiety","year":"2024","cit":0,"pfa":"Watkins, Paeton","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"dissertation","src":"https://openalex.org/W7110595303","eid":"W7110595303"},{"id":"paper-w2910510165","cat":"papers","name":"California Drug and Alcohol Treatment Assessment (CALDATA), 1991-1993","year":"2004","cit":0,"pfa":"California Department Of Alcohol And Drug Programs","topics":["Addiction","Policy & ethics"],"ptype":"dataset","src":"https://openalex.org/W2910510165","eid":"W2910510165"},{"id":"paper-w7128331937","cat":"papers","name":"Selected aspects of buprenorphine maintenance treatment","year":"2007","cit":0,"pfa":"Michaela Kotyzova","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7128331937","eid":"W7128331937"},{"id":"paper-w7204866648","cat":"papers","name":"Treatment Episode Data Set -- Admissions (TEDS-A), 1996","year":"2026","cit":0,"pfa":"United States Department of Health and Human Services. Substance Abuse and…","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W7204866648","eid":"W7204866648"},{"id":"paper-w7204941987","cat":"papers","name":"Treatment Episode Data Set -- Admissions (TEDS-A), 2005","year":"2026","cit":0,"pfa":"United States Department of Health and Human Services. Substance Abuse and…","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W7204941987","eid":"W7204941987"},{"id":"paper-w7196972822","cat":"papers","name":"California Drug and Alcohol Treatment Assessment (CALDATA-1991-1993)","year":"2026","cit":0,"pfa":"United States Department of Health and Human Services. Substance Abuse and…","topics":["Addiction","Policy & ethics"],"ptype":"dataset","src":"https://openalex.org/W7196972822","eid":"W7196972822"},{"id":"paper-w4401131168","cat":"papers","name":"695 Transforming early intervention for youth mental health: from brands to active ingredients","year":"2024","cit":0,"pfa":"Miranda Wolpert","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"conference-paper","src":"https://openalex.org/W4401131168","eid":"W4401131168"},{"id":"paper-w4300663021","cat":"papers","name":"Phase 0 clinical trials: theoretical and practical implications in oncologic drug development","year":"2013","cit":0,"pfa":"Coloma PM","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4300663021","eid":"W4300663021"},{"id":"paper-w4413354410","cat":"papers","name":"Motion Preservation Following Vertebral Body Tethering: An Analysis of 103 Patients","year":"2025","cit":0,"pfa":"Christina M. Regan","psa":"A. Noelle Larson","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4413354410","eid":"W4413354410"},{"id":"paper-w7204951637","cat":"papers","name":"Treatment Episode Data Set -- Admissions (TEDS-A), 2001","year":"2026","cit":0,"pfa":"United States Department of Health and Human Services. Substance Abuse and…","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W7204951637","eid":"W7204951637"},{"id":"paper-w2908735907","cat":"papers","name":"Treatment Episode Data Set -- Admissions (TEDS-A), 2006","year":"2008","cit":0,"pfa":"United States Department of Health and Human Services. Substance Abuse and…","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W2908735907","eid":"W2908735907"},{"id":"paper-w7156011936","cat":"papers","name":"Comparing depersonalization/derealization-like experiences arising in clinical contexts vs. meditation","year":"2023","cit":0,"pfa":"Erola Pons","psa":"Lindner, Axel","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"other","src":"https://openalex.org/W7156011936","eid":"W7156011936"},{"id":"paper-w7124437883","cat":"papers","name":"Acute ketamine withdrawal disrupts memory and monoaminergic neurotransmission in adolescent female rats","year":"2026","cit":0,"pfa":"Lucas Villar Pedrosa da Silva Pantoja","psa":"Cristiane do Socorro Ferraz Maia","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7124437883","eid":"W7124437883"},{"id":"paper-w1005814276","cat":"papers","name":"Rural Opioid and Other Drug Use Disorder Diagnosis: Assessing Measurement Invariance and Latent Classification of DSM-IV Abuse and Dependence Criteria","year":"2015","cit":0,"pfa":"Billy Brooks","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W1005814276","eid":"W1005814276"},{"id":"paper-w7196939917","cat":"papers","name":"California Drug and Alcohol Treatment Assessment (CALDATA-1991-1993)","year":"2026","cit":0,"pfa":"United States Department of Health and Human Services. Substance Abuse and…","topics":["Addiction","Policy & ethics"],"ptype":"dataset","src":"https://openalex.org/W7196939917","eid":"W7196939917"},{"id":"paper-w4294962811","cat":"papers","name":"California Drug and Alcohol Treatment Assessment (CALDATA), 1991-1993","year":"2004","cit":0,"pfa":"California Department Of Alcohol And Drug Programs","topics":["Addiction","Policy & ethics"],"ptype":"dataset","src":"https://openalex.org/W4294962811","eid":"W4294962811"},{"id":"paper-w7131074977","cat":"papers","name":"EEG correlates of psychoactive ketamine: Comparing spectral power and complexity","year":"2026","cit":0,"pfa":"Brandon Reynante","ptype":"dataset","src":"https://openalex.org/W7131074977","eid":"W7131074977"},{"id":"paper-w7204970472","cat":"papers","name":"Treatment Episode Data Set -- Admissions (TEDS-A), 2002","year":"2026","cit":0,"pfa":"United States Department of Health and Human Services. Substance Abuse and…","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W7204970472","eid":"W7204970472"},{"id":"paper-w7204922474","cat":"papers","name":"Treatment Episode Data Set -- Admissions (TEDS-A), 1993","year":"2026","cit":0,"pfa":"United States Department of Health and Human Services. Substance Abuse and…","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W7204922474","eid":"W7204922474"},{"id":"paper-w4205907479","cat":"papers","name":"Treatment Episode Data Set -- Admissions (TEDS-A), 1997","year":"1999","cit":0,"pfa":"United States Department Of Health And Human Services. Substance Abuse And…","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W4205907479","eid":"W4205907479"},{"id":"paper-w7204919598","cat":"papers","name":"Treatment Episode Data Set -- Admissions (TEDS-A), 1999","year":"2026","cit":0,"pfa":"United States Department of Health and Human Services. Substance Abuse and…","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W7204919598","eid":"W7204919598"},{"id":"paper-w7204924042","cat":"papers","name":"Treatment Episode Data Set -- Admissions (TEDS-A), 1992","year":"2026","cit":0,"pfa":"United States Department of Health and Human Services. Substance Abuse and…","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W7204924042","eid":"W7204924042"},{"id":"paper-w4402784938","cat":"papers","name":"Effects of Drug - education and Human Potential Seminar / Grouptherapy on the Mental Health Status, and the Knowledge of Drugs among Juvenile Delinquents","year":"1996","cit":0,"pfa":"Mi Hyoung Lee","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4402784938","eid":"W4402784938"},{"id":"paper-w7163914145","cat":"papers","name":"Prescribing bias and adverse outcomes of esketamine in major depression comorbid substance","year":"2026","cit":0,"pfa":"Dian‐Jeng Li","psa":"Chih-Sung Liang","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7163914145","eid":"W7163914145"},{"id":"paper-w7204919477","cat":"papers","name":"Treatment Episode Data Set -- Admissions (TEDS-A), 2004","year":"2026","cit":0,"pfa":"United States Department of Health and Human Services. Substance Abuse and…","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W7204919477","eid":"W7204919477"},{"id":"paper-w3098686042","cat":"papers","name":"Pharmacology The Science of Drugs","year":"2020","cit":0,"pfa":"Jerrold C. Winter","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W3098686042","eid":"W3098686042"},{"id":"paper-w2910230948","cat":"papers","name":"Treatment Episode Data Set -- Admissions (TEDS-A), 2000","year":"2003","cit":0,"pfa":"United States Department Of Health And Human Services. Substance Abuse And…","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W2910230948","eid":"W2910230948"},{"id":"paper-w7214653420","cat":"papers","name":"Measured receptor pharmacology for 545 psychoactive compounds, snapshot of 27 September 2026","year":"2026","cit":0,"pfa":"Nikolay V. Dokholyan","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dataset","src":"https://openalex.org/W7214653420","eid":"W7214653420"},{"id":"paper-w2499190724","cat":"papers","name":"Addictions: General Consideration","year":"2001","cit":0,"pfa":"William Weiqi Wang","topics":["Addiction","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W2499190724","eid":"W2499190724"},{"id":"paper-w2724246450","cat":"papers","name":"Substance use among youth psychiatric outpatients","year":"2017","cit":0,"pfa":"Sofia Morais","psa":"Nuno Gonçalo Gomes Fernandes Madeira","topics":["Addiction","Safety & adverse events"],"ptype":"conference-abstract","src":"https://openalex.org/W2724246450","eid":"W2724246450"},{"id":"paper-w7204915669","cat":"papers","name":"Treatment Episode Data Set -- Admissions (TEDS-A), 1997","year":"2026","cit":0,"pfa":"United States Department of Health and Human Services. Substance Abuse and…","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W7204915669","eid":"W7204915669"},{"id":"paper-w7132369097","cat":"papers","name":"Neurochemical Trends in Antidepressant Research: Moving Past the Monoamine Hypothesis","year":"2025","cit":0,"pfa":"Arnas Jasinskas","psa":"Ramunė Mazaliauskienė","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"conference-paper","src":"https://openalex.org/W7132369097","eid":"W7132369097"},{"id":"paper-w7204954101","cat":"papers","name":"Treatment Episode Data Set -- Admissions (TEDS-A), 1998","year":"2026","cit":0,"pfa":"United States Department of Health and Human Services. Substance Abuse and…","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W7204954101","eid":"W7204954101"},{"id":"paper-w7128680136","cat":"papers","name":"Assessing the utility of subanaesthetic (50%) nitrous oxide as a pharmacological model of psychosis","year":"2026","cit":0,"pfa":"Uršulė Taujanskaitė","psa":"Sunjeev Kamboj","topics":["Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7128680136","eid":"W7128680136"},{"id":"paper-w4232444083","cat":"papers","name":"Treatment Episode Data Set -- Admissions (TEDS-A) -- Concatenated, 1992 to 2010","year":"2009","cit":0,"pfa":"United States Department Of Health And Human Services. Substance Abuse And…","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W4232444083","eid":"W4232444083"},{"id":"paper-w2910603367","cat":"papers","name":"Treatment Episode Data Set -- Admissions (TEDS-A), 2000","year":"2003","cit":0,"pfa":"United States Department of Health and Human Services. Substance Abuse and…","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W2910603367","eid":"W2910603367"},{"id":"paper-w4387448491","cat":"papers","name":"A preclinical model of THC edibles that produces high-dose cannabimimetic responses","year":"2023","cit":0,"pfa":"Anthony English","psa":"Benjamin Bruce Land","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4387448491","eid":"W4387448491"},{"id":"paper-w4210525498","cat":"papers","name":"Treatment Episode Data Set -- Admissions (TEDS-A), 1995","year":"1997","cit":0,"pfa":"United States Department of Health and Human Services. Substance Abuse and…","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W4210525498","eid":"W4210525498"},{"id":"paper-w7204938256","cat":"papers","name":"Treatment Episode Data Set -- Admissions (TEDS-A), 2000","year":"2026","cit":0,"pfa":"United States Department of Health and Human Services. Substance Abuse and…","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W7204938256","eid":"W7204938256"},{"id":"paper-w4405980772","cat":"papers","name":"P20: Primary hiperparathyroidism and refractory depression - A case report","year":"2019","cit":0,"topics":["Depression","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W4405980772","eid":"W4405980772"},{"id":"paper-w7204927462","cat":"papers","name":"Treatment Episode Data Set -- Admissions (TEDS-A), 1995","year":"2026","cit":0,"pfa":"United States Department of Health and Human Services. Substance Abuse and…","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W7204927462","eid":"W7204927462"},{"id":"paper-w4383269803","cat":"papers","name":"The Impact of Trauma Exposure on Mental Health Outcomes an Examination of Depression, Anxiety, and Substance use Disorders among Trauma Survivors","year":"2023","cit":0,"pfa":"Reedam Pandey","psa":"Rayees Mohammad Bhat","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4383269803","eid":"W4383269803"},{"id":"paper-w4214666998","cat":"papers","name":"Treatment Episode Data Set -- Admissions (TEDS-A), 1999","year":"2002","cit":0,"pfa":"United States Department Of Health And Human Services. Substance Abuse And…","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W4214666998","eid":"W4214666998"},{"id":"paper-w4386207126","cat":"papers","name":"The Example of Perm Model in Substance Addiction, Especially with Alcohol and Gambling Examples","year":"2023","cit":0,"pfa":"Murat Kan","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4386207126","eid":"W4386207126"},{"id":"paper-w2323201976","cat":"papers","name":"OT2-05-01: An Open-Label Positron Emission Tomography Study To Investigate and Quantify Brain and Tumor Penetration of Carbon-11-Labeled Lapatinib in Patients with HER2−Overexpressing Advanced or Metastatic Breast Cancer","year":"2011","cit":0,"pfa":"R. Charles Coombes","psa":"A Saleem","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2323201976","eid":"W2323201976"},{"id":"paper-w3164147650","cat":"papers","name":"Estrogen/androgen priming protocol improves egg quality and the number of embryos available for transfer in poor responder patients undergoing IVF/ICSI","year":"2020","cit":0,"pfa":"Mark S. Denker","psa":"M. A","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3164147650","eid":"W3164147650"},{"id":"paper-w4415451347","cat":"papers","name":"SAT-782 Raloxifene as a Bridging Therapy for Low Bone Density in a Young Non-Binary Individual","year":"2025","cit":0,"pfa":"Alison Quiring","psa":"Tae‐Hwa Chun","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4415451347","eid":"W4415451347"},{"id":"paper-w7120633288","cat":"papers","name":"Behavioral and physiological parameters in adult zebrafish exposed to ketamine","year":"2020","cit":0,"pfa":"Paula Michelotti","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7120633288","eid":"W7120633288"},{"id":"paper-w2600960727","cat":"papers","name":"208. Predictors of Cannabis-Induced Psychosis","year":"2017","cit":0,"pfa":"Mohini Ranganathan","psa":"Deepak Cyril D’Souza","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W2600960727","eid":"W2600960727"},{"id":"paper-w4391333723","cat":"papers","name":"Role of 18F-flotufolastat PET/CT imaging in men with high-risk prostate cancer following conventional imaging and associated changes in medical management: A phase 3b investigator-initiated trial.","year":"2024","cit":0,"pfa":"Zachariah D. Taylor","psa":"Laurence H Belkoff","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W4391333723","eid":"W4391333723"},{"id":"paper-w4392543113","cat":"papers","name":"Changes in brain structure and function following exposure to oral LSD during adolescence: A multimodal MRI study","year":"2024","cit":0,"pfa":"Lila Harris","psa":"Craig F. Ferris","ptype":"preprint","src":"https://openalex.org/W4392543113","eid":"W4392543113"},{"id":"paper-w7132492560","cat":"papers","name":"Pharmacological Potential of Lespedeza bicolor Due to Its Chemical Composition","year":"2025","cit":0,"pfa":"V. Yavorska","psa":"O. Mykhailenko","topics":["Addiction","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"conference-paper","src":"https://openalex.org/W7132492560","eid":"W7132492560"},{"id":"paper-w4411801810","cat":"papers","name":"A theory on prefrontal dysfunction contributing to psychosis and other schizophrenia symptoms mediated by open potassium and hyperpolarization-activated cyclic nucleotide-gated channels","year":"2025","cit":0,"pfa":"Arthur Tainmont","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4411801810","eid":"W4411801810"},{"id":"paper-w4230581991","cat":"papers","name":"Ketamine","year":"2011","cit":0,"topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4230581991","eid":"W4230581991"},{"id":"paper-w4410124767","cat":"papers","name":"Drug Overdose Deaths Are Finally Slowing -- Medicaid Cuts Would Undermine That Progress","year":"2025","cit":0,"pfa":"Carole\n    Johnson","psa":"Kody H.\n    Kinsley","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W4410124767","eid":"W4410124767"},{"id":"paper-w7164395396","cat":"papers","name":"Thalamic 5-HT2A receptor activation reduces GABA uptake, increases tonic GABAA inhibition and induces absence seizures in Wistar rats","year":"2026","cit":0,"pfa":"Vincenzo Crunelli","psa":"Giuseppe Di Giovanni","topics":["Mechanism & neuroscience","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7164395396","eid":"W7164395396"},{"id":"paper-w134197433","cat":"papers","name":"HYPERTHERMIC CONDITIONS IN NEUROSURGICAL PATIENT","year":"2011","cit":0,"pfa":"Evgeni Brotfain","psa":"Alexander Anatolievich Zlotnik","topics":["Addiction","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W134197433","eid":"W134197433"},{"id":"paper-w2402658701","cat":"papers","name":"Ketamin: Yeni Bir Antidepresan? Ketamine: A New Antidepressant?","year":"2015","cit":0,"pfa":"Feride Karacaer","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2402658701","eid":"W2402658701"},{"id":"paper-w2622750625","cat":"papers","name":"An index to examine the sexual HIV risk of psychiatric service users based on sexual partners","year":"2017","cit":0,"pfa":"Andrea Norcini Pala","psa":"Milton Leonard Wainberg","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2622750625","eid":"W2622750625"},{"id":"paper-w3160716710","cat":"papers","name":"Delta-9-tetrahydrocannabinol and cannabidiol in psychosis: A balancing act of the principal phyto-cannabinoids on human brain and behavior?","year":"2021","cit":0,"pfa":"Suhas Ganesh","psa":"Mohini Ranganathan","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W3160716710","eid":"W3160716710"},{"id":"paper-w3023974992","cat":"papers","name":"The Relationship between Anxiety and Depressive Symptoms and Substance Misuse (in Terms of Marijuana, Illicit Drugs, Tobacco, and Alcohol) in College Students","year":"2020","cit":0,"pfa":"Devin Singh","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3023974992","eid":"W3023974992"},{"id":"paper-w7214063583","cat":"papers","name":"Synaptic Plasticity and Cognitive Enhancement: Bridging Neuropathological Cognitive Disorders to Emerging Neuropharmacological Strategies","year":"2026","cit":0,"pfa":"Saad Misfer Alqahtani","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7214063583","eid":"W7214063583"},{"id":"paper-w20465317","cat":"papers","name":"Alcoholism, drug addiction, and the road to recovery: life on the edge","year":"2003","cit":0,"topics":["Depression","Addiction","Safety & adverse events"],"ptype":"book-review","src":"https://openalex.org/W20465317","eid":"W20465317"},{"id":"paper-w4416843054","cat":"papers","name":"299 A small-volume topical ophthalmic spray for pupillary dilation in children: a randomized, masked noninferiority trial","year":"2025","cit":0,"pfa":"Alyssa A. Godfrey","psa":"Julius T. Oatts","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4416843054","eid":"W4416843054"},{"id":"paper-w2897772467","cat":"papers","name":"Efficacy and safety of drospirenone-containing microdosage combined oral contraceptive use with starting contraception","year":"2018","cit":0,"pfa":"A R Khachaturian","psa":"Maria Igorevna Yarmolinskaya","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2897772467","eid":"W2897772467"},{"id":"paper-w2359519413","cat":"papers","name":"Clinical application of small-dose ketamine","year":"2006","cit":0,"pfa":"Ying‐Wei Wang","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2359519413","eid":"W2359519413"},{"id":"paper-w3104925950","cat":"papers","name":"A Master/Slave Narrative: Drug Addiction and Psychoactives","year":"2009","cit":0,"pfa":"Mark A. Griep","psa":"Marjorie L. Mikasen","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"book-chapter","src":"https://openalex.org/W3104925950","eid":"W3104925950"},{"id":"paper-w4379779904","cat":"papers","name":"Technologies of Blackness: Aldo Tambellini, Psychedelia, Widescreen, Media","year":"2021","cit":0,"pfa":"Jocelyn Szczepaniak-Gillece","topics":["Mechanism & neuroscience","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4379779904","eid":"W4379779904"},{"id":"paper-w7132683230","cat":"papers","name":"Srovnání vlivu systémové aplikace non-kompetitivních a use-dependentních NMDA antagonistů na lokomoční aktivitu a kognitivní funkce u laboratorního potkana","year":"2010","cit":0,"pfa":"K. (Karel) Valeš","psa":"L. (Ladislav) Vyklický ml.","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7132683230","eid":"W7132683230"},{"id":"paper-w7145601779","cat":"papers","name":"Effects of NMDA receptor antagonists on the binding of agonistic and antagonistic radiotracers to striatal dopamine D2 receptors","year":"2012","cit":0,"pfa":"Masaki Tokunaga","psa":"樋口 真人","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"conference-paper","src":"https://openalex.org/W7145601779","eid":"W7145601779"},{"id":"paper-w7208826241","cat":"papers","name":"From Genetic Susceptibility to Precision Therapy: Causal Inference of 5-HT2A Receptor and Drug Repurposing for Serotonin Syndrome — A Multi-Stage Translational Study Integrating Mendelian Randomization, Drug-Target MR, a","year":"2026","cit":0,"pfa":"Wang Dian","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W7208826241","eid":"W7208826241"},{"id":"paper-w1497465024","cat":"papers","name":"A Practical Guide to Human Research and Clinical Trials","year":"2013","cit":0,"pfa":"M.U.R. Naidu","psa":"P. Usha Rani","topics":["Safety & adverse events","Dosing & pharmacology","Policy & ethics"],"ptype":"book","src":"https://openalex.org/W1497465024","eid":"W1497465024"},{"id":"paper-w7162868800","cat":"papers","name":"Persistent Enhancer Remodeling After a Single DOI Dose Identifies a Multi-Day Cortical Metaplastic State: Mechanistic Insights and Translational Opportunities for Plasticity-Based Therapeutics","year":"2026","cit":0,"pfa":"Ngo Cheung","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7162868800","eid":"W7162868800"},{"id":"paper-w7165618399","cat":"papers","name":"Cardiovascular effects associated with acute recreational drug toxicity presentations to the emergency department: a European drug emergencies network (Euro-DEN plus) study","year":"2026","cit":0,"pfa":"W. J. van den Busken","psa":"Jordi Puiguriguer","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7165618399","eid":"W7165618399"},{"id":"paper-w4316081792","cat":"papers","name":"S860 Efficacy of the Melanocortin Receptor Agonist PL8177 as a Potential Therapy for Gastrointestinal (GI) Inflammatory Diseases","year":"2022","cit":0,"pfa":"John Dodd","psa":"Carl Spana","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W4316081792","eid":"W4316081792"},{"id":"paper-w7160655553","cat":"papers","name":"The Cardinal protocol: investigating a simplified, cost-conscious option for oocyte cryopreservation in a prospective noninferiority cohort study","year":"2026","cit":0,"pfa":"Esther H. Chung","psa":"Ruth Bunker Lathi","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7160655553","eid":"W7160655553"},{"id":"paper-w154002556","cat":"papers","name":"An evaluation of social capital's effect on depression among adolescents","year":"2012","cit":0,"pfa":"Ezechukwu Awgu","topics":["Depression","Addiction","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W154002556","eid":"W154002556"},{"id":"paper-w4375916730","cat":"papers","name":"Treatment Episode Data Set -- Discharges (TEDS-D), 2006","year":"2009","cit":0,"pfa":"United States Department Of Health And Human Services. Substance Abuse And…","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W4375916730","eid":"W4375916730"},{"id":"paper-w4391885686","cat":"papers","name":"Effects of ketamine and propofol on muscarinic plateau potentials in rat neocortical pyramidal cells","year":"2024","cit":0,"pfa":"Anne S. Fleiner","psa":"Johan Frederik Storm","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4391885686","eid":"W4391885686"},{"id":"paper-w304537594","cat":"papers","name":"The Effect of d-LSD-25 and Related Compounds on the Subcortical Electrograms","year":"1959","cit":0,"pfa":"Russell R. Monroe","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"report","src":"https://openalex.org/W304537594","eid":"W304537594"},{"id":"paper-w7165629259","cat":"papers","name":"Cardiovascular effects associated with acute recreational drug toxicity presentations to the emergency department: a European drug emergencies network (Euro-DEN plus) study","year":"2026","cit":0,"pfa":"W. J. van den Busken","psa":"F.M.J. GRESNIGT","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7165629259","eid":"W7165629259"},{"id":"paper-w7140109310","cat":"papers","name":"Interdependence of Public Safety Services at a Music Festival - Medical and Sanctuary","year":"2026","cit":0,"pfa":"Matthew Brendan Munn","psa":"Melissa Mazereeuw","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7140109310","eid":"W7140109310"},{"id":"paper-w2743819573","cat":"papers","name":"Estudio in vitro de la influencia del heterodímero de los receptores D2 de dopamina y 5-HT2A de serotonina, en aplicación a la farmacoterapia antipsicótica","year":"2017","cit":0,"pfa":"Sonia Gómez Fernández","topics":["Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W2743819573","eid":"W2743819573"},{"id":"paper-w23556250","cat":"papers","name":"Intracellular Messengers in Drug Addiction","year":"1999","cit":0,"pfa":"Maarten E. A. Reith","topics":["Addiction","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"book-chapter","src":"https://openalex.org/W23556250","eid":"W23556250"},{"id":"paper-w7162872671","cat":"papers","name":"Persistent Enhancer Remodeling After a Single DOI Dose Identifies a Multi-Day Cortical Metaplastic State: Mechanistic Insights and Translational Opportunities for Plasticity-Based Therapeutics","year":"2026","cit":0,"pfa":"Ngo Cheung","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7162872671","eid":"W7162872671"},{"id":"paper-w4200573235","cat":"papers","name":"Development of Long-Acting Injectable Ketamine Loaded PLGA Microparticles as a Non-opioid Analgesic","year":"2021","cit":0,"pfa":"Juma N. Daniels","psa":"Andrew Otte","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4200573235","eid":"W4200573235"},{"id":"paper-w1545863605","cat":"papers","name":"Accidental drug overdose fatalities Allegheny County, PA 2007-2011: Comparison and recommendations","year":"2014","cit":0,"pfa":"Ashley Parsons","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W1545863605","eid":"W1545863605"},{"id":"paper-w4414086549","cat":"papers","name":"Born Twice DMT and the Echo of Our First Conscious Experience","year":"2025","cit":0,"pfa":"Tony Montgomery","topics":["Mechanism & neuroscience","Dosing & pharmacology","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4414086549","eid":"W4414086549"},{"id":"paper-w4376096069","cat":"papers","name":"Treatment Episode Data Set -- Discharges (TEDS-D), 2007","year":"2010","cit":0,"pfa":"United States Department Of Health And Human Services. Substance Abuse And…","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W4376096069","eid":"W4376096069"},{"id":"paper-w7126325097","cat":"papers","name":"The hierarchical taxonomy of psychopathology as an approach to the psychiatric genetics of substance-related and addictive disorders in Vietnam-era twins","year":"2022","cit":0,"pfa":"Kristy Cuthbert","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W7126325097","eid":"W7126325097"},{"id":"paper-w4210863252","cat":"papers","name":"Treatment Episode Data Set -- Discharges (TEDS-D), 2007","year":"2010","cit":0,"pfa":"United States Department of Health and Human Services. Substance Abuse and…","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W4210863252","eid":"W4210863252"},{"id":"paper-w7128302307","cat":"papers","name":"Natural and synthetic cannabinoids. Mechanism of action, drug addiction and associated risk factors","year":"2026","cit":0,"pfa":"Александр Ливиевич Ураков","psa":"Mithun Rudrapal","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7128302307","eid":"W7128302307"},{"id":"paper-w4416041071","cat":"papers","name":"Ketamine disrupts consciousness in healthy participants in relation with psychotic-like symptoms","year":"2025","cit":0,"pfa":"Lucie Berkovitch","psa":"Raphaël Gaillard","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4416041071","eid":"W4416041071"},{"id":"paper-w7133244909","cat":"papers","name":"Pilot phase I trial of an implantable microdevice for in vivo evaluation of drug response in renal cell carcinoma.","year":"2026","cit":0,"pfa":"Clara Steiner","psa":"Wenxin Xu","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W7133244909","eid":"W7133244909"},{"id":"paper-w4415453812","cat":"papers","name":"SAT-153 Discordance Between Clinic Practice Versus Recommended Treatment of Male Hypogonadism: Results of a Global and Multi-Lingual Content Analysis","year":"2025","cit":0,"pfa":"Bonnie Grant","psa":"Channa Nalin Jayasena","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4415453812","eid":"W4415453812"},{"id":"paper-w4376096194","cat":"papers","name":"Treatment Episode Data Set -- Discharges (TEDS-D), 2008","year":"2011","cit":0,"pfa":"United States Department of Health and Human Services. Substance Abuse and…","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W4376096194","eid":"W4376096194"},{"id":"paper-w4401328820","cat":"papers","name":"Drug addiction and recreational drugs","year":"2016","cit":0,"pfa":"Michael Boarder","psa":"Tyra Zetterström","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W4401328820","eid":"W4401328820"},{"id":"paper-w2915567256","cat":"papers","name":"Treatment Episode Data Set -- Discharges (TEDS-D), 2006","year":"2009","cit":0,"pfa":"United States Department Of Health And Human Services. Substance Abuse And…","topics":["Addiction"],"ptype":"dataset","src":"https://openalex.org/W2915567256","eid":"W2915567256"},{"id":"paper-w7165664890","cat":"papers","name":"Cardiovascular effects associated with acute recreational drug toxicity presentations to the emergency department: a European drug emergencies network (Euro-DEN plus) study","year":"2026","cit":0,"pfa":"W. J. van den Busken","psa":"F.M.J. GRESNIGT","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7165664890","eid":"W7165664890"},{"id":"paper-w7154177734","cat":"papers","name":"Filtering the noise: a cerebellar-centered framework for understanding and treating mental illness -a paradigm shift in psychiatry","year":"2026","cit":0,"pfa":"Craig F. Ferris","topics":["Depression","PTSD & trauma","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7154177734","eid":"W7154177734"},{"id":"paper-w3004141768","cat":"papers","name":"P.210 A single dose of LSD facilitates long-lasting fear erasure in mice","year":"2020","cit":0,"pfa":"Rafael Moliner","psa":"Eero Ċastrén","topics":["Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3004141768","eid":"W3004141768"},{"id":"paper-w4390776533","cat":"papers","name":"EPP0001. Frequency and clinical characteristics of nitrous oxide use disorder among French health professions students","year":"2023","cit":0,"pfa":"Alain Dervaux","psa":"Mickaël Naassïla","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4390776533","eid":"W4390776533"},{"id":"paper-w4386104688","cat":"papers","name":"Comparison between Agonist Trigger with HCG Luteal Phase Supplementation vs HCG Trigger with Progesterone Luteal Phase Supplementation in Antagonist Controlled Hyperstimulation Cycle Regarding Clinical Pregnancy Rate","year":"2023","cit":0,"pfa":"S Soliman","psa":"Maii Nawara","topics":["Safety & adverse events","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4386104688","eid":"W4386104688"},{"id":"paper-w7162757803","cat":"papers","name":"Psychiatric Genetic Liability Converges on Plasticity-Maintenance Pathways: TWAS Evidence for Bipolar Proteostatic Vulnerability and Schizophrenia–Bipolar Neurotrophin Concordance","year":"2026","cit":0,"pfa":"Ngo Cheung","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7162757803","eid":"W7162757803"},{"id":"paper-w7162798019","cat":"papers","name":"Psychiatric Genetic Liability Converges on Plasticity-Maintenance Pathways: TWAS Evidence for Bipolar Proteostatic Vulnerability and Schizophrenia–Bipolar Neurotrophin Concordance","year":"2026","cit":0,"pfa":"Ngo Cheung","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7162798019","eid":"W7162798019"},{"id":"paper-w4211003851","cat":"papers","name":"Faculty Opinions recommendation of Serotonin, but not N-methyltryptamines, activates the serotonin 2A receptor via a ß-arrestin2/Src/Akt signaling complex in vivo.","year":"2010","cit":0,"pfa":"Joël Bockaert","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"peer-review","src":"https://openalex.org/W4211003851","eid":"W4211003851"},{"id":"paper-w2609577239","cat":"papers","name":"67. Ketamine-induced Changes in Neural Noise and their Relationship to Psychosis-like Symptoms","year":"2017","cit":0,"pfa":"Jose Cortes-Briones","psa":"John Harrison Krystal","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2609577239","eid":"W2609577239"},{"id":"paper-w4408220499","cat":"papers","name":"The future is now: AI-enabled preclinical fMRI analysis","year":"2024","cit":0,"pfa":"Arnold Chang","topics":["Mechanism & neuroscience","Reviews & meta-analyses","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W4408220499","eid":"W4408220499"},{"id":"paper-w4411288312","cat":"papers","name":"611-P: Prevalence of Substance Use, Substance Use Disorders, and Substance Use Treatment among U.S. Adults with Diagnosed Diabetes, 2021–2022","year":"2025","cit":0,"pfa":"Yiling J. Cheng","psa":"Kai McKeever Bullard","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4411288312","eid":"W4411288312"},{"id":"paper-w318344475","cat":"papers","name":"Book Review: Addictions, Clinical Textbook of Addictive Disorders","year":"2007","cit":0,"pfa":"Ewa Swoboda","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"book-review","src":"https://openalex.org/W318344475","eid":"W318344475"},{"id":"paper-w4404053958","cat":"papers","name":"Prevalence and co-occurrence of symptoms of mental and substance use disorders among people with HIV age 40 and older in low- and middle-income countries: a cross-sectional study","year":"2024","cit":0,"pfa":"Smita Nimkar","psa":"Suzanne Goodrich","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4404053958","eid":"W4404053958"},{"id":"paper-w4414180502","cat":"papers","name":"What about the trip? The relationship between ketamine’s acute and antidepressant effect","year":"2025","cit":0,"pfa":"Veronika Andrashko","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4414180502","eid":"W4414180502"},{"id":"paper-w4210820501","cat":"papers","name":"Rectal ketamine for induction of anaesthesia in children","year":"1983","cit":0,"pfa":"Jan Idvall","psa":"Jiri Holasek","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4210820501","eid":"W4210820501"},{"id":"paper-w4408376772","cat":"papers","name":"6ER-036 Substance abuse in patients with schizophrenic or bipolar disorder","year":"2025","cit":0,"pfa":"Ixeia Vázquez Majó","psa":"Jordi Nicolas Picó","topics":["Addiction"],"ptype":"conference-paper","src":"https://openalex.org/W4408376772","eid":"W4408376772"},{"id":"paper-w7135918300","cat":"papers","name":"Developmental dysregulation of the cortical reelin signalling pathway precedes adolescent cognitive deficits in a neurodevelopmental model for schizophrenia","year":"2023","cit":0,"pfa":"Rebecca; id_orcid 0000-0002-8413-4852 Woods","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"conference-paper","src":"https://openalex.org/W7135918300","eid":"W7135918300"},{"id":"paper-w7171973492","cat":"papers","name":"HJ-006: A Non-Hallucinogenic Synaptogenic Compound with Rapid and Sustained Antidepressant Efficacy","year":"2026","cit":0,"pfa":"L. Zeng","psa":"Y. Geng","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7171973492","eid":"W7171973492"},{"id":"paper-w4416141229","cat":"papers","name":"CNSC-54. LEVERAGING THERAPEUTIC MODULATORS OF NEUROPLASTICITY TO REPROGRAM GLIOBLASTOMA CELL FATES","year":"2025","cit":0,"pfa":"C Bergström","psa":"Vadim Le Joncour","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W4416141229","eid":"W4416141229"},{"id":"paper-w836971833","cat":"papers","name":"Conformational effects of lipids and local anesthetics on the nicotinic acetylcholine receptor.","year":"2000","cit":0,"pfa":"Ryan, Stephen E.","topics":["Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W836971833","eid":"W836971833"},{"id":"paper-w4389023114","cat":"papers","name":"Elucidating Functional Selectivity at the 5‐HT 2A Receptor","year":"2017","cit":0,"pfa":"Gerald Bernard Billac","psa":"Charles David Nichols","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4389023114","eid":"W4389023114"},{"id":"paper-w7208739229","cat":"papers","name":"Substance Use is Not Associated with Antidepressant Response to Transcranial Magnetic Stimulation","year":"2026","cit":0,"pfa":"Jordyn Chesley","psa":"Heather Burrell Ward","topics":["Depression","Addiction"],"ptype":"preprint","src":"https://openalex.org/W7208739229","eid":"W7208739229"},{"id":"paper-w2314372946","cat":"papers","name":"Substance misuse in first episode psychotic patients: sociodemographic, premorbid and clinical correlates. Data from the PICOS-Veneto study","year":"2011","cit":0,"pfa":"Sarah Tosato","psa":"Mirella Ruggeri","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2314372946","eid":"W2314372946"},{"id":"paper-w7213921909","cat":"papers","name":"T132. SUBSTANCE USE DISORDERS AND SUBSEQUENT SCHIZOPHRENIA: A SWEDISH REGISTER-BASED COHORT STUDY","year":"2026","cit":0,"pfa":"Oriana Belisle-Prada","psa":"Shuyang Yao","topics":["Addiction","Safety & adverse events"],"ptype":"conference-abstract","src":"https://openalex.org/W7213921909","eid":"W7213921909"},{"id":"paper-w4401920038","cat":"papers","name":"A Meta-Analysis of fMRI Activation Studies of Ketamine in Healthy Participants","year":"2024","cit":0,"pfa":"J. H. Shepherd","psa":"C. H. Miller","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W4401920038","eid":"W4401920038"},{"id":"paper-w2022621005","cat":"papers","name":"Lifetime illicit drug use and drug dependence are common by the age of 25 in New Zealand","year":"2006","cit":0,"pfa":"Jürgen T. Rehm","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2022621005","eid":"W2022621005"},{"id":"paper-w7155524276","cat":"papers","name":"National Institute on Drug Abuse (NIDA) clinical trials network (CTN) stimulant use disorder (StUD) task force results: 2024 update","year":"2026","cit":0,"pfa":"Chatnapha Kittirattanapaiboon","psa":"Madhukar H. Trivedi","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7155524276","eid":"W7155524276"},{"id":"paper-w7117145994","cat":"papers","name":"Risk of substance use disorders in the adult children of parents with severe alcohol use disorder: a nationwide cohort study","year":"2025","cit":0,"pfa":"Kane, Kimberly","psa":"Mika Gissler","topics":["Addiction","Safety & adverse events"],"ptype":"other","src":"https://openalex.org/W7117145994","eid":"W7117145994"},{"id":"paper-w7170159811","cat":"papers","name":"Assessment of PET drug adverse events in the U.S. since the implementation of 21 CFR part 212","year":"2026","cit":0,"pfa":"Marianna Dakanali","psa":"Peter J. H. Scott","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7170159811","eid":"W7170159811"},{"id":"paper-w2953432020","cat":"papers","name":"Controlled Release fFor Use in Treatment of Narcotic Addiction","year":"2019","cit":0,"pfa":"Donald L. Wise","topics":["Addiction","Reviews & meta-analyses"],"ptype":"book-chapter","src":"https://openalex.org/W2953432020","eid":"W2953432020"},{"id":"paper-w2948903201","cat":"papers","name":"Prevalence of vitamin D deficiency among libyan chronic kidney disease patients","year":"2018","cit":0,"pfa":"Mohamed O. Ezwaie","psa":"Omar B Latiwesh","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2948903201","eid":"W2948903201"},{"id":"paper-w7117071418","cat":"papers","name":"Risk of substance use disorders in the adult children of parents with severe alcohol use disorder: a nationwide cohort study","year":"2025","cit":0,"pfa":"Kimberly Kane","psa":"Mika Gissler","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7117071418","eid":"W7117071418"},{"id":"paper-w1978771342","cat":"papers","name":"A Randomised Controlled Study Comparing Intrathecal Hyperbaric Bupivacaine And Isobaric Bupivacaine In Common Urological Procedures","year":"2014","cit":0,"pfa":"Asst. Prof.Anesthesiology,","psa":"Dr. Prof. Subrata Nag","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W1978771342","eid":"W1978771342"},{"id":"paper-w3033932627","cat":"papers","name":"Prevalence of gastrointestinal symptoms in patients with cannabis abuse presenting to the emergency room","year":"2020","cit":0,"pfa":"Md Barry","psa":"Mary C. Naglak","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3033932627","eid":"W3033932627"},{"id":"paper-w3115835386","cat":"papers","name":"The Challenges and Opportunities of EMR Interoperability in Substance use Disorder Treatment Facility in Qatar","year":"2020","cit":0,"pfa":"Shaharyar Khan","topics":["Depression","Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3115835386","eid":"W3115835386"},{"id":"paper-w4400649078","cat":"papers","name":"Treatment of nonspecific vulvovaginitis in pregnant women: evaluation of the effectiveness of two-stage therapy","year":"2024","cit":0,"pfa":"Е.В. Шапошникова","psa":"E.Sh. Majidli","topics":["PTSD & trauma","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4400649078","eid":"W4400649078"},{"id":"paper-w7117104031","cat":"papers","name":"Risk of substance use disorders in the adult children of parents with severe alcohol use disorder: a nationwide cohort study","year":"2025","cit":0,"pfa":"Kane, Kimberly","psa":"Mika Gissler","topics":["Addiction","Safety & adverse events"],"ptype":"other","src":"https://openalex.org/W7117104031","eid":"W7117104031"},{"id":"paper-w369174065","cat":"papers","name":"Caffeinated Alcohol Use and Anxiety Symptoms Among College Students","year":"2012","cit":0,"pfa":"Ashley N. Linden","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W369174065","eid":"W369174065"},{"id":"paper-w4396737525","cat":"papers","name":"Independence and its Relationship with Psychological Resilience in a Sample of Orphaned Adolescents","year":"2024","cit":0,"topics":["Depression","Anxiety & end-of-life","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4396737525","eid":"W4396737525"},{"id":"paper-w7108341270","cat":"papers","name":"The Role of Ketamine in Acute and Chronic Pain – A Review of Therapeutic Benefits","year":"2025","cit":0,"pfa":"J. S. Venkatesh, Dr. Santosh Uttangi, Akshara Jeevan, Albin Johnson*, Aleena…","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7108341270","eid":"W7108341270"},{"id":"paper-w2625642493","cat":"papers","name":"Predictors of initiation of substance use, problems and dependence: Results from the National Comorbidity Survey.","year":"1998","cit":0,"pfa":"Lynn A. Warner","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W2625642493","eid":"W2625642493"},{"id":"paper-w2887533761","cat":"papers","name":"Using the Concept of Complexity to Guide Translational Research in Psychiatry","year":"2018","cit":0,"pfa":"John Daniel Cahill","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W2887533761","eid":"W2887533761"},{"id":"paper-w4381890499","cat":"papers","name":"Effects of adding low-dose esketamine to sufentanil and propofol sedation during cervical conization: a prospective, single-center, randomized controlled trial","year":"2023","cit":0,"pfa":"Jiguo Si","psa":"Min Cui","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4381890499","eid":"W4381890499"},{"id":"paper-w4401919698","cat":"papers","name":"An Umbrella Review of Effectiveness of Intravenous Ketamine in Treatment-Resistant Depression","year":"2024","cit":0,"pfa":"A. M. Klassen","psa":"C. H. Miller","topics":["Depression","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4401919698","eid":"W4401919698"},{"id":"paper-w7108337821","cat":"papers","name":"The Role of Ketamine in Acute and Chronic Pain – A Review of Therapeutic Benefits","year":"2025","cit":0,"pfa":"J. S. Venkatesh, Dr. Santosh Uttangi, Akshara Jeevan, Albin Johnson*, Aleena…","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7108337821","eid":"W7108337821"},{"id":"paper-w4240644630","cat":"papers","name":"Psychopharmacology","year":"1956","cit":0,"topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4240644630","eid":"W4240644630"},{"id":"paper-w3135831216","cat":"papers","name":"Psychopharmakologische Forschung und Behandlung an der Wiener Psychiatrischen Universitätsklinik und die Frühphase des Collegium Internationale Neuro-Psychopharmacologicum (CINP)","year":"2020","cit":0,"pfa":"Alfred Springer","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3135831216","eid":"W3135831216"},{"id":"paper-w2794925903","cat":"papers","name":"S224. DELTA-9-TETRAHYDROCANNABINOL CHALLENGE IN CANNABIS USERS AND NON-USERS DIFFERENTIALLY AFFECTS BRAIN FUNCTION AND BEHAVIOR: AN FMRI STUDY OF DEVELOPMENT OF TOLERANCE","year":"2018","cit":0,"pfa":"Marco Colizzi","psa":"Sagnik Bhattacharyya","topics":["Addiction","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W2794925903","eid":"W2794925903"},{"id":"paper-w2756433466","cat":"papers","name":"Veiligheid en effectiviteit van ketamine als pijnstiller","year":"2016","cit":0,"pfa":"Marieke Niesters","psa":"Maarten van Kleef","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W2756433466","eid":"W2756433466"},{"id":"paper-w2404125347","cat":"papers","name":"[Effect of LSD-25 on cholinesterases of the rat brain].","year":"1979","cit":0,"pfa":"E Torre","psa":"C Torre","topics":["Addiction"],"ptype":"other","src":"https://openalex.org/W2404125347","eid":"W2404125347"},{"id":"paper-w1414949100","cat":"papers","name":"NMDA Receptor and The Therapeutic Potential of Its Ligands","year":"1998","cit":0,"pfa":"Panya Khunawat","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1414949100","eid":"W1414949100"},{"id":"paper-w3014156408","cat":"papers","name":"Autoradiographic Distribution of Multiple Opioid, Sigma, and Phencyclidine Receptor Binding Sites in the Human Brain","year":"2020","cit":0,"pfa":"Rémi Quirion","psa":"Isabelle Chaudieu","topics":["Addiction","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W3014156408","eid":"W3014156408"},{"id":"paper-w3033971959","cat":"papers","name":"Maternal Immune Activation in Rats produces a Subjective Internal State that is Analogous to Human Psychosis","year":"2019","cit":0,"pfa":"Wayne Meighan","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W3033971959","eid":"W3033971959"},{"id":"paper-w1037368249","cat":"papers","name":"Therapeutic effect of ifenprodil,a NMDA receptor antagonist,on drug dependence","year":"2002","cit":0,"pfa":"SuzukT","psa":"NaritM","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1037368249","eid":"W1037368249"},{"id":"paper-w7111553766","cat":"papers","name":"Evaluating Cannabigerol as a Therapeutic Agent in Non-Alcoholic Fatty Liver Disease","year":"2025","cit":0,"pfa":"Viereckl, Michael J.","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W7111553766","eid":"W7111553766"},{"id":"paper-w4413284575","cat":"papers","name":"664. ENHANCING RESILIENCE IN LEVERAGING DIGITAL THERAPEUTICS, AI, AS GOLDEN HOUR OPPORTUNITIES FOR PERSONALIZED INTERVENTIONS IN PREVENTION AND TREATMENT OF PTSD","year":"2025","cit":0,"pfa":"Eric H. G. J. M. Vermetten","psa":"Traumatic Stress Global Networking Community","topics":["Depression","PTSD & trauma","Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W4413284575","eid":"W4413284575"},{"id":"paper-w7117452724","cat":"papers","name":"Constraint Dynamics in Psychosis: Cortical Fragility and the Gamma-First Cascade","year":"2025","cit":0,"pfa":"Matthew Cator","topics":["Safety & adverse events","Mechanism & neuroscience","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7117452724","eid":"W7117452724"},{"id":"paper-w7117472310","cat":"papers","name":"Constraint Dynamics in Psychosis: Cortical Fragility and the Gamma-First Cascade","year":"2025","cit":0,"pfa":"Matthew Cator","topics":["Safety & adverse events","Mechanism & neuroscience","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7117472310","eid":"W7117472310"},{"id":"paper-w7214716908","cat":"papers","name":"Safety, tolerability, and pharmacokinetics of oral Ketamir-2, a novel selective NMDA receptor antagonist: results of a first-in-human Phase 1 study","year":"2026","cit":0,"pfa":"Itzchak Angel","psa":"Erez Aminov","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7214716908","eid":"W7214716908"},{"id":"paper-w2393966965","cat":"papers","name":"Neuroprotective effects and mechanisms of propofol on neuronal damage induced by ketamine in rat posterior cingulate cortex","year":"2005","cit":0,"pfa":"Li Song","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2393966965","eid":"W2393966965"},{"id":"paper-w4390045472","cat":"papers","name":"Reviewer #3 (Public Review): A preclinical model of THC edibles that produces high-dose cannabimimetic responses","year":"2023","cit":0,"pfa":"Anthony English","psa":"Benjamin Bruce Land","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4390045472","eid":"W4390045472"},{"id":"paper-w7205009176","cat":"papers","name":"Safety, tolerability, and pharmacokinetics of oral Ketamir-2, a novel selective NMDA receptor antagonist: results of a first-in-human Phase 1 study","year":"2026","cit":0,"pfa":"Itzchak Angel","psa":"Erez Aminov","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7205009176","eid":"W7205009176"},{"id":"paper-w4395026004","cat":"papers","name":"Treatment Attrition, Concomitant Pharmaceutical Use, Temporal Claims-Based Utilization, and Real-World Characteristics Among Esketamine New Initiators in the United States, 2019-2022","year":"2024","cit":0,"pfa":"Brandon Truax","topics":["Depression","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4395026004","eid":"W4395026004"},{"id":"paper-w7154751807","cat":"papers","name":"Abstract CT090: Pilot study of an implantable microdevice for in situ evaluation of drug response in patients with pancreatic cancer","year":"2026","cit":0,"pfa":"Oliver J. Standring","psa":"Matthew John Weiss","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W7154751807","eid":"W7154751807"},{"id":"paper-w3200796361","cat":"papers","name":"Ketamine-associated Cystitis: A Case Report","year":"2021","cit":0,"pfa":"Iris E. Chen","psa":"Simin Bahrami","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3200796361","eid":"W3200796361"},{"id":"paper-w2524379359","cat":"papers","name":"Abstract 2020: A platform to test multiple therapies simultaneously in the intact tumors of cancer patients: Initial clinical experience","year":"2015","cit":0,"pfa":"Alicia Moreno Gonzalez","psa":"Richard A. Klinghoffer","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W2524379359","eid":"W2524379359"},{"id":"paper-w4390045925","cat":"papers","name":"Reviewer #2 (Public Review): A preclinical model of THC edibles that produces high-dose cannabimimetic responses","year":"2023","cit":0,"pfa":"Anthony English","psa":"Benjamin Bruce Land","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4390045925","eid":"W4390045925"},{"id":"paper-w3197683173","cat":"papers","name":"PSYCHOMETRIC PROPERTIES AND GENERATIONAL DIFFERENCES IN SELFREPORTING ON THE CLINICALLY USEFUL SUBSTANCE ABUSE PROBLEMS OUTCOMES SCALE","year":"2021","cit":0,"pfa":"Donya Sorensen","topics":["Addiction"],"ptype":"dissertation","src":"https://openalex.org/W3197683173","eid":"W3197683173"},{"id":"paper-w4234163938","cat":"papers","name":"The challenges and opportunities of EMR interoperability in Substance Use Disorder Treatment in Qatar (Preprint)","year":"2020","cit":0,"pfa":"Shaharyar Khan","topics":["Depression","Addiction","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4234163938","eid":"W4234163938"},{"id":"paper-w564423147","cat":"papers","name":"Clinical finals and how to pass them : OSCEs, short cases and long cases","year":"2004","cit":0,"pfa":"Kevin P. Hanretty","psa":"Tom Turner","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"book","src":"https://openalex.org/W564423147","eid":"W564423147"},{"id":"paper-w7130713195","cat":"papers","name":"Links between Cannabinoid Hyperemesis Syndrome and drug use, mental health problems, antisocial behavior, and personality in a national survey of adults in the United States","year":"2026","cit":0,"pfa":"Brian M. Hicks","psa":"Mark Andrew Ilgen","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W7130713195","eid":"W7130713195"},{"id":"paper-w4230075726","cat":"papers","name":"Pharmacology of marijuana remains obscure","year":"1970","cit":0,"topics":["Addiction","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W4230075726","eid":"W4230075726"},{"id":"paper-w4390045178","cat":"papers","name":"eLife Assessment: A preclinical model of THC edibles that produces high-dose cannabimimetic responses","year":"2023","cit":0,"pfa":"Robert B. Laprairie","topics":["Dosing & pharmacology"],"ptype":"peer-review","src":"https://openalex.org/W4390045178","eid":"W4390045178"},{"id":"paper-w4385669088","cat":"papers","name":"Mental Health Services Utilization among Suicidal Patients: Comparing the Impact of Co-Occurring Opioid or Other Substance Use Disorders","year":"2023","cit":0,"pfa":"Jyotishman Pathak","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4385669088","eid":"W4385669088"},{"id":"paper-w2332027346","cat":"papers","name":"Identification of schizophrenia genes in an animal model for psychosis","year":"2005","cit":0,"pfa":"AM Hartmann","psa":"Dan Rujescu","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2332027346","eid":"W2332027346"},{"id":"paper-w2595556771","cat":"papers","name":"The Development of BSN272 From Prevention of Diet-Induced Hyperlipidemia in Mice to a Potential Therapy For Prader-Willi Syndrome in Humans","year":"2017","cit":0,"pfa":"Jarrod B. Williams","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2595556771","eid":"W2595556771"},{"id":"paper-w4390071448","cat":"papers","name":"Comparing Repeated (Annual) Couples HIV Testing and Counseling to Individual HIV Testing and Counseling Among Male Couples at High Risk of HIV Infection: Protocol for a Randomized Control Trial","year":"2023","cit":0,"pfa":"Tyrel J. Starks","psa":"Demetria N. Cain","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4390071448","eid":"W4390071448"},{"id":"paper-w2950321008","cat":"papers","name":"In Search of Solutions for Chronic Pain: A Meta-analysis of Ketamine Infusions","year":"2019","cit":0,"pfa":"Naveen Nathan","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W2950321008","eid":"W2950321008"},{"id":"paper-w4362592613","cat":"papers","name":"Abstract 5086: Transcriptomic analysis in a renal cancer PDX model enables the deconvolution of additive and synergistic effects of six different standard of care compounds with anti-PD-1 treatment","year":"2023","cit":0,"pfa":"Kanstantsin Lashuk","psa":"Julia B. Schüler","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W4362592613","eid":"W4362592613"},{"id":"paper-w4390045606","cat":"papers","name":"Reviewer #1 (Public Review): A preclinical model of THC edibles that produces high-dose cannabimimetic responses","year":"2023","cit":0,"pfa":"Anthony English","psa":"Benjamin Bruce Land","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4390045606","eid":"W4390045606"},{"id":"paper-w4414180710","cat":"papers","name":"The craziness in losing weight. A systematic review and case report of sibutramine’s psychosis","year":"2025","cit":0,"pfa":"E. Sánchez","psa":"Jaime A. Alvarez","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W4414180710","eid":"W4414180710"},{"id":"paper-w4386981231","cat":"papers","name":"Comparing Repeated (Annual) Couples HIV Testing and Counseling to Individual HIV Testing and Counseling Among Male Couples at High Risk of HIV Infection: Protocol for a Randomized Control Trial (Preprint)","year":"2023","cit":0,"pfa":"Tyrel J. Starks","psa":"Demetria N. Cain","topics":["Addiction","Safety & adverse events","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4386981231","eid":"W4386981231"},{"id":"paper-w4390045717","cat":"papers","name":"Author Response: A preclinical model of THC edibles that produces high-dose cannabimimetic responses","year":"2023","cit":0,"pfa":"Anthony English","psa":"Benjamin Bruce Land","topics":["Dosing & pharmacology"],"ptype":"peer-review","src":"https://openalex.org/W4390045717","eid":"W4390045717"},{"id":"paper-w2333600958","cat":"papers","name":"Recent Advances in Therapy of Schizophrenia","year":"2011","cit":0,"pfa":"Mahesh T. Chhabria","psa":"Vishranti D. Trivedi","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2333600958","eid":"W2333600958"},{"id":"paper-w2313309275","cat":"papers","name":"cDNA arrays analyses in an animal model for psychosis-related traits","year":"2004","cit":0,"pfa":"AM Hartmann","psa":"Dan Rujescu","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2313309275","eid":"W2313309275"},{"id":"paper-w2068825607","cat":"papers","name":"Use of Behavioral Analysis in Animal Models for Schizophrenia Research","year":"2014","cit":0,"pfa":"Youngsik Woo","psa":"Sang Ki Park","ptype":"article","src":"https://openalex.org/W2068825607","eid":"W2068825607"},{"id":"paper-w2313025536","cat":"papers","name":"[Pharmacodynamic and pharmacokinetic parameters of the effect of the effect of ethyl alcohol at different stages of alcohol dependence].","year":"1991","cit":0,"pfa":"Bobrov Ae","psa":"Mitiushin Vv","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2313025536","eid":"W2313025536"},{"id":"paper-w2187688799","cat":"papers","name":"Design and Synthesis of k-Opioid Receptor Agonist, TRK-820","year":"2006","cit":0,"pfa":"Hiroshi Nagase","topics":["Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2187688799","eid":"W2187688799"},{"id":"paper-w4235717564","cat":"papers","name":"Central Lynch Pin in Psychosis","year":"2003","cit":0,"ptype":"article","src":"https://openalex.org/W4235717564","eid":"W4235717564"},{"id":"paper-w2116729119","cat":"papers","name":"P-66 * CHARACTERISTICS OF IN-PATIENTS WITH ADHD AND SUBSTANCE USE DISORDER: A RETROSPECTIVE STUDY","year":"2014","cit":0,"pfa":"E. Alt ntoprak","psa":"B. Ozyurt","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"conference-abstract","src":"https://openalex.org/W2116729119","eid":"W2116729119"},{"id":"paper-w2080029611","cat":"papers","name":"Teens Show Significant Improvement After Drug-Abuse Treatment","year":"2001","cit":0,"pfa":"Joan Arehart-Treichel","topics":["Depression","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2080029611","eid":"W2080029611"},{"id":"paper-w1986704994","cat":"papers","name":"Effects of chronic MK-801 treatment on the relative mRNA expression of NMDA receptor subunits and splice variants in a pharmacological model for psychosis","year":"2004","cit":0,"pfa":"H Rìder","psa":"Dan Rujescu","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1986704994","eid":"W1986704994"},{"id":"paper-w194368664","cat":"papers","name":"Ketamine and Phencyclidines: Today and Tomorrow","year":"1985","cit":0,"pfa":"Elemér K. Zsigmond","ptype":"book-chapter","src":"https://openalex.org/W194368664","eid":"W194368664"},{"id":"paper-w2998659800","cat":"papers","name":"Inspirations on De-addiction to Alcoholism and Drug Abuse in Our Ancient Indian Yogic Texts","year":"2019","cit":0,"pfa":"R Ramadhevi","psa":"V. Ramadas","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2998659800","eid":"W2998659800"},{"id":"paper-w7154566286","cat":"papers","name":"Protocol and pilot results for a double-blind randomized placebo-controlled trial of ketamine under propofol sedation for chronic pain and depression","year":"2026","cit":0,"pfa":"Theresa Riki Lii","psa":"Boris Dov Heifets","topics":["Depression","Safety & adverse events"],"ptype":"dataset","src":"https://openalex.org/W7154566286","eid":"W7154566286"},{"id":"paper-w7166706452","cat":"papers","name":"Substance Misuse Risk and Relapse Prevention Provision Within the Inpatient Forensic Psychiatric Setting in KMMH: A Service Evaluation Project","year":"2026","cit":0,"pfa":"Moustafa Abdelkader","psa":"Rafey A. Faruqui","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7166706452","eid":"W7166706452"},{"id":"paper-w4313199360","cat":"papers","name":"Ketamine: the potential to treat addiction and the return to its former glory – a narrative review","year":"2022","cit":0,"pfa":"M. Roque Gonçalves","psa":"Jakeline Sabrina Alves de Morais","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W4313199360","eid":"W4313199360"},{"id":"paper-w4385404109","cat":"papers","name":"Efficacy of Ketamine Therapy in the Treatment of Refractory Major Depressive Disorder","year":"2023","cit":0,"pfa":"Helena van Oers","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4385404109","eid":"W4385404109"},{"id":"paper-w1997609195","cat":"papers","name":"D-Fenfluramine responses in depression before and after antidepressant treatment","year":"1996","cit":0,"pfa":"Anthony James Cleare","psa":"Veronica O’Keane","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1997609195","eid":"W1997609195"},{"id":"paper-w2888668542","cat":"papers","name":"Analogues de l’ayahuasca : le chamanisme de synthèse","year":"2018","cit":0,"pfa":"Jérôme Langrand","psa":"Jean‐Claude Alvarez","ptype":"article","src":"https://openalex.org/W2888668542","eid":"W2888668542"},{"id":"paper-w7165977892","cat":"papers","name":"Studies Of Behaviour, Hippocampal Plasticity And Molecular Pathways In A Ketamine-Based Model Of Schizophrenia","year":"2025","cit":0,"pfa":"Muhammad Hazim Abdullah","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7165977892","eid":"W7165977892"},{"id":"paper-w4300985347","cat":"papers","name":"The Ketamine Analogue Methoxetamine and 3- and 4-Methoxy Analogues of Phencyclidine Are High Affinity and Selective Ligands for the Glutamate NMDA Receptor","year":"2020","cit":0,"pfa":"Xi‐Ping Huang","psa":"Bryan L. Roth","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4300985347","eid":"W4300985347"},{"id":"paper-w7163370586","cat":"papers","name":"(2R,6R)-Hydroxynorketamine elicits rapid antidepressant effects by promoting astrocytic µ-δ opioid receptor heterodimerization","year":"2026","cit":0,"pfa":"Yanxia Liang","psa":"Xiang Cai","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7163370586","eid":"W7163370586"},{"id":"paper-w2994171552","cat":"papers","name":"Retrospective analysis of the effectiveness of treatment of the pituitary micro adenomas in nulliparous women, taking into account the fractionation of prolactin and correction of the luteal phase deficiency","year":"2014","cit":0,"pfa":"А. А. Трушкевич","psa":"А А Степура","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2994171552","eid":"W2994171552"},{"id":"paper-w7172021516","cat":"papers","name":"Effectiveness and Safety of Esketamine Nasal Spray in Treatment-Resistant Depression: Early Outcomes from Poland’s First Psychiatric Drug Program B.147","year":"2026","cit":0,"pfa":"O. Płaza","psa":"A. Szulc","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7172021516","eid":"W7172021516"},{"id":"paper-w4225395593","cat":"papers","name":"Structure‐activity Relation of Halogenated 2,5‐Dimethoxyamphetamines Compared to their α‑Desmethyl (2C) Analogues","year":"2022","cit":0,"pfa":"Deborah Rudin","psa":"Matthias E. Liechti","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4225395593","eid":"W4225395593"},{"id":"paper-w4313200922","cat":"papers","name":"Depot aripiprazole versus paliperidone in dual disorder patients – an observational study","year":"2022","cit":0,"pfa":"S. Salgado","psa":"J. Bello","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4313200922","eid":"W4313200922"},{"id":"paper-w7154579979","cat":"papers","name":"Protocol and pilot results for a double-blind randomized placebo-controlled trial of ketamine under propofol sedation for chronic pain and depression","year":"2026","cit":0,"pfa":"Theresa Riki Lii","psa":"Boris Dov Heifets","topics":["Depression","Safety & adverse events"],"ptype":"dataset","src":"https://openalex.org/W7154579979","eid":"W7154579979"},{"id":"paper-w4414181616","cat":"papers","name":"Diagnosis and treatment of post-traumatic stress disorder (PTSD) through the analysis of two clinical cases","year":"2025","cit":0,"pfa":"M. E. Sánchez-Escalonilla","psa":"María Fe Bravo‐Ortiz","topics":["PTSD & trauma","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4414181616","eid":"W4414181616"},{"id":"paper-w7212008438","cat":"papers","name":"691. Psychiatry: quo vadis?","year":"2026","cit":0,"pfa":"Thomas R. Insel","topics":["Safety & adverse events","Therapy practice"],"ptype":"conference-abstract","src":"https://openalex.org/W7212008438","eid":"W7212008438"},{"id":"paper-w160896021","cat":"papers","name":"[New treatment modalities for stroke in the near future].","year":"2003","cit":0,"pfa":"Per Olov Wester","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W160896021","eid":"W160896021"},{"id":"paper-w3082309717","cat":"papers","name":"Influence on drug and substance abuse on the disease outcome inschizophrenic patients treated with antipsychotic drugs","year":"2020","cit":0,"pfa":"Felix-Martin Werner","topics":["Addiction","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3082309717","eid":"W3082309717"},{"id":"paper-w7135568200","cat":"papers","name":"Antidepressant effect of ketamine","year":"2013","cit":0,"pfa":"Anna Revayová","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W7135568200","eid":"W7135568200"},{"id":"paper-w4408326249","cat":"papers","name":"Abstract B012: Clinical trial of an implantable microdevice to evaluate drug responses in ovarian cancer","year":"2025","cit":0,"pfa":"Elizabeth H. Stover","psa":"Oliver H. Jonas","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W4408326249","eid":"W4408326249"},{"id":"paper-w7208920842","cat":"papers","name":"Texas School Survey of Drug and Alcohol Use 2010, State: Grades 7-12","year":"2010","cit":0,"pfa":"James Dyer","psa":"Pratik Mhatre","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7208920842","eid":"W7208920842"},{"id":"paper-w4404555694","cat":"papers","name":"Computational Approaches in Evaluating the 5-HT Subtype Receptor Mechanism of Action for Developing Novel Chemical Entities","year":"2024","cit":0,"pfa":"Arushi Chauhan","psa":"Pramod  Kumar Avti","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W4404555694","eid":"W4404555694"},{"id":"paper-w7209347682","cat":"papers","name":"Texas School Survey of Drug and Alcohol Use 2010, Non-Border Counties, Grades 7-12","year":"2010","cit":0,"pfa":"James Dyer","psa":"Pratik Mhatre","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7209347682","eid":"W7209347682"},{"id":"paper-w2313455943","cat":"papers","name":"Comparison of the analgesic effects of intravenous nalbuphine and pentazocine in patients with postoperative pain","year":"1979","cit":0,"pfa":"T. Tammisto","psa":"Irma Tigerstedt","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2313455943","eid":"W2313455943"},{"id":"paper-w2410372502","cat":"papers","name":"Ciramadol. The therapeutic dose range during balanced anesthesia.","year":"1985","cit":0,"pfa":"F. Camu","psa":"M A Claeys","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2410372502","eid":"W2410372502"},{"id":"paper-w7155076641","cat":"papers","name":"Medicine against itself: A manifesto for a non-Laplacian neuropsychopharmacology","year":"2026","cit":0,"pfa":"Felipe Heemann","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7155076641","eid":"W7155076641"},{"id":"paper-w3208461264","cat":"papers","name":"(R)-Ketamine: A New Rapid-Acting Antidepressant","year":"2021","cit":0,"pfa":"Kai Zhang","psa":"Kenji Hashimoto","topics":["Depression"],"ptype":"book-chapter","src":"https://openalex.org/W3208461264","eid":"W3208461264"},{"id":"paper-w7128339763","cat":"papers","name":"The Use of the Addictive Drugs by the Seniors","year":"2016","cit":0,"pfa":"Dominika Kopačková","topics":["Addiction","Safety & adverse events","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W7128339763","eid":"W7128339763"},{"id":"paper-w7125527350","cat":"papers","name":"Continuous ketamine infusion for surgical patients in the intensive care unit: a systematic review and meta-analysis of randomized controlled trials with GRADE assessment","year":"2026","cit":0,"pfa":"Abdulrahman Alzmmam","psa":"Alawi S. Alsaeedi","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W7125527350","eid":"W7125527350"},{"id":"paper-w7155059015","cat":"papers","name":"Medicine against itself: A manifesto for a non-Laplacian neuropsychopharmacology","year":"2026","cit":0,"pfa":"Felipe Heemann","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7155059015","eid":"W7155059015"},{"id":"paper-w4300816881","cat":"papers","name":"Subanesthetic ketamine: the way forward for pain management in sickle cell disease patients?","year":"2022","cit":0,"pfa":"Raissa Nobrega","psa":"Zenaide Quezado","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4300816881","eid":"W4300816881"},{"id":"paper-w4288286881","cat":"papers","name":"Ketamine in affective disorders – expectations and limitations","year":"2019","cit":0,"pfa":"Ewelina Soroka","psa":"Marcin Olajossy","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4288286881","eid":"W4288286881"},{"id":"paper-w3003490147","cat":"papers","name":"Issues in Access to Opioid Treatment Medication","year":"2020","cit":0,"pfa":"Asma Alqudah","topics":["Addiction","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3003490147","eid":"W3003490147"},{"id":"paper-w4232867729","cat":"papers","name":"Faculty Opinions recommendation of Neurobiology of rapid-acting antidepressants: convergent effects on GluA1-synaptic function.","year":"2019","cit":0,"pfa":"Hanns Möhler","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4232867729","eid":"W4232867729"},{"id":"paper-w4376210146","cat":"papers","name":"Ketamine in affective disorders – expectations and limitations","year":"2019","cit":0,"pfa":"Ewelina Soroka","psa":"Marcin Olajossy","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4376210146","eid":"W4376210146"},{"id":"paper-w584509097","cat":"papers","name":"Companion to Pharmacology: A Study Guide for Self-Assessment and Revision","year":"1993","cit":0,"pfa":"M.Maureen Dale","psa":"Dennis G. Haylett","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"book","src":"https://openalex.org/W584509097","eid":"W584509097"},{"id":"paper-w2890565170","cat":"papers","name":"Antidepressant ketamine and its metabolite hydroxynorketamine converge on the regulation of neurotransmitter release","year":"2018","cit":0,"pfa":"Debarpan Guhathakurta","psa":"Anna Fejtová","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W2890565170","eid":"W2890565170"},{"id":"paper-w4417225288","cat":"papers","name":"From model psychosis to rapid antidepressant: a historical and conceptual review of ketamine’s psychiatric history","year":"2025","cit":0,"pfa":"Casimiro Cabrera Abreu","psa":"Gustavo Héctor Vázquez","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4417225288","eid":"W4417225288"},{"id":"paper-w4408140575","cat":"papers","name":"Relationship between increased binding potential of possible 5-HT2A receptors in the ventral hippocampus by subchronic phencyclidine and disturbed social interaction in rats: a PET study using 18F-altanserin","year":"2025","cit":0,"pfa":"Eiichi Jodo","psa":"Satoshi Eifuku","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4408140575","eid":"W4408140575"},{"id":"paper-w7118224238","cat":"papers","name":"Compliance with methylphenidate treatment and drug abuse of adults with attention deficit hyperactivity disorder (ADHD)","year":"2021","cit":0,"pfa":"Yasemin Sanal","psa":"Ilhan Yargic","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7118224238","eid":"W7118224238"},{"id":"paper-w4394443052","cat":"papers","name":"Supplementary Material for: Modulatory Effects of Ketamine and Lamotrigine on Cognition: Emotion Interaction in the Brain","year":"2023","cit":0,"pfa":"Matti Gärtner","psa":"Simone Grimm","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"supplementary-materials","src":"https://openalex.org/W4394443052","eid":"W4394443052"},{"id":"paper-w4403961446","cat":"papers","name":"Editorial: Current progress and challenges in psychopharmacology research","year":"2024","cit":0,"pfa":"Marna Eliana Sakalem","psa":"Ricardo Tabach","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"editorial","src":"https://openalex.org/W4403961446","eid":"W4403961446"},{"id":"paper-w4295004932","cat":"papers","name":"Therapeutisch gebruik van cannabidiol in volwassenpsychiatrie: stand van zaken","year":"2022","cit":0,"pfa":"A. Verfaillie","psa":"G. Heylens","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4295004932","eid":"W4295004932"},{"id":"paper-w3203509564","cat":"papers","name":"Pharmacological approaches for a novel GABAa receptor agonist: the long and winding road of drug development in anesthesia","year":"2021","cit":0,"pfa":"Beatrijs I. Valk","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W3203509564","eid":"W3203509564"},{"id":"paper-w7162127557","cat":"papers","name":"In vivo interactions between sigma receptors and NPY- & CGRP-relates peptides in the brain","year":"1996","cit":0,"pfa":"Pascale. Bouchard","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"dissertation","src":"https://openalex.org/W7162127557","eid":"W7162127557"},{"id":"paper-w4294200776","cat":"papers","name":"What if Cannabis has a medical relevance in psychiatric disorders?","year":"2022","cit":0,"pfa":"Bouthaina Abassi","psa":"L. Mnif","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4294200776","eid":"W4294200776"},{"id":"paper-w7168018217","cat":"papers","name":"A Clinical Assessment of the Efficacy and Hemodynamic Stability of Propofol-Ketamine and Propofol-Fentanyl in Patients Undergoing Dilatation and Curettage","year":"2026","cit":0,"pfa":"Stuti Lohia","psa":"Ivy Selina","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7168018217","eid":"W7168018217"},{"id":"paper-w7120554252","cat":"papers","name":"Evaluation of mechanisms of prevention and treatment with lithium microdosis and association with rivastigmine in a neurodegeneration model by chronic infusion with amyloid- b.","year":"2018","cit":0,"pfa":"Natália Mendes Schöwe","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7120554252","eid":"W7120554252"},{"id":"paper-w4405981788","cat":"papers","name":"Using selected scenes from Brazilian films to teach about substance use disorders, within medical education Usando cenas selecionadas de filmes brasileiros para ensino a respeito dos transtornos relacionados ao uso de su","year":"2012","cit":0,"pfa":"João Maurício Castaldelli-Maia","psa":"Dinesh Bhugra","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4405981788","eid":"W4405981788"},{"id":"paper-w3033345477","cat":"papers","name":"NMDA receptor antagonism: from modeling schizophrenia to treating refractory depression","year":"2014","cit":0,"pfa":"Laura Jiménez-Sánchez","psa":"Albert Adell","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3033345477","eid":"W3033345477"},{"id":"paper-w3174567654","cat":"papers","name":"Preclinical Assessment of the Abuse Potential of the Isomers of Ketamine","year":"2018","cit":0,"pfa":"Katherine L. Nicholson","psa":"Keith Larry Shelton","topics":["Depression","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W3174567654","eid":"W3174567654"},{"id":"paper-w4236300118","cat":"papers","name":"Long‐term potentiation in the presence of NMDA receptor antagonist arylalkylamine spider toxins","year":"2000","cit":0,"pfa":"Benedict C. Albensi","psa":"Alan L. Mueller","topics":["PTSD & trauma","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4236300118","eid":"W4236300118"},{"id":"paper-w2940411138","cat":"papers","name":"O3.1. ASSOCIATION OF EXTENT OF CANNABIS USE AND ACUTE INTOXICATION EXPERIENCES IN A MULTI-NATIONAL SAMPLE OF FIRST EPISODE PSYCHOSIS PATIENTS AND CONTROLS","year":"2019","cit":0,"pfa":"Musa Basseer Sami","psa":"Marta Di Forti","ptype":"article","src":"https://openalex.org/W2940411138","eid":"W2940411138"},{"id":"paper-w4386531993","cat":"papers","name":"The anxiety caused by long-term low-dose ketamine, and related metabolomics characteristics change in rat","year":"2023","cit":0,"pfa":"Yingqiang Fu","psa":"Linchuan Liao","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4386531993","eid":"W4386531993"},{"id":"paper-w7130364049","cat":"papers","name":"Ketamine or Esketamine in Special Populations of Patients With Treatment-Resistant Depression","year":"2026","cit":0,"pfa":"Łukasz Grabarczyk","psa":"Paweł Radkowski","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7130364049","eid":"W7130364049"},{"id":"paper-w7168053026","cat":"papers","name":"Ketamine for Cancer-Related Pain in Palliative Care: A Systematic Review of Clinical Use and Safety","year":"2026","cit":0,"pfa":"Catarina Vitorino-Afonso","psa":"Paulo Reis-Pina","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W7168053026","eid":"W7168053026"},{"id":"paper-w7115171244","cat":"papers","name":"Cannabidiol regulation of learned fear:implications for treating anxiety-related disorders","year":"2016","cit":0,"pfa":"Jurkus, Regimantas","psa":"Stevenson, Carl W","topics":["PTSD & trauma","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7115171244","eid":"W7115171244"},{"id":"paper-w7117554760","cat":"papers","name":"A Prospective, Randomized, Double-Blinded Study on the Comparison of Propofol and Ketofol (Combination of Ketamine and Propofol) for Modified Electroconvulsive Therapy","year":"2025","cit":0,"pfa":"A. V. Tilak","psa":"B. T. Rane","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W7117554760","eid":"W7117554760"},{"id":"paper-w2131700233","cat":"papers","name":"NMDA Antagonism in the treatment of Major Depressive Disorder","year":"2013","cit":0,"pfa":"A.P.A. Chalikiopoulos","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W2131700233","eid":"W2131700233"},{"id":"paper-w2363611878","cat":"papers","name":"Effect of propofol on C-fos gene expression and neuronal damage induced by ketamine in rat cerebral cortex","year":"2003","cit":0,"pfa":"Jihong Xu","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2363611878","eid":"W2363611878"},{"id":"paper-w7117359713","cat":"papers","name":"Therapeutic Efficacy and Neurobiological Mechanisms of Nitrous Oxide in Treatment-Resistant Depression","year":"2025","cit":0,"pfa":"Dr. Syed Afroz Ahmed","psa":"Shaikh Alim Ahemadsab","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7117359713","eid":"W7117359713"},{"id":"paper-w4394079299","cat":"papers","name":"Repeated cannabidiol treatment affects neuroplasticity and endocannabinoid signaling in the prefrontal cortex of the Flinders Sensitive Line (FSL) rat model of depression","year":"2024","cit":0,"pfa":"Luana Barreto Domingos","psa":"Sâmia R.L. Joca","topics":["Depression","Mechanism & neuroscience"],"ptype":"dataset","src":"https://openalex.org/W4394079299","eid":"W4394079299"},{"id":"paper-w7163936678","cat":"papers","name":"Cannabis Use and the Risk of Psychosis or Schizophrenia","year":"2026","cit":0,"pfa":"Shweta Jaiswal","psa":"Veena S. Belgamwar","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W7163936678","eid":"W7163936678"},{"id":"paper-w7168027670","cat":"papers","name":"Ketamine for Cancer-Related Pain in Palliative Care: A Systematic Review of Clinical Use and Safety","year":"2026","cit":0,"pfa":"Catarina Vitorino-Afonso","psa":"Paulo Reis-Pina","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W7168027670","eid":"W7168027670"},{"id":"paper-w2626064608","cat":"papers","name":"Ketamine as an adjunctive therapy for Major Depression - a randomised controlled pilot trial: The KARMA-Dep Trial","year":"2017","cit":0,"pfa":"Declan M. McLoughlin","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W2626064608","eid":"W2626064608"},{"id":"paper-w2184869974","cat":"papers","name":"CELLULAR AND MOLECULAR PHARMACOLOGY OF SIGMA RECEPTORS Review Article","year":"2011","cit":0,"pfa":"Mehul R. Chorawala","psa":"Gaurang B. Shah","topics":["Addiction","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2184869974","eid":"W2184869974"},{"id":"paper-w4414260796","cat":"papers","name":"Subacute Effects of Ketamine on Neural Correlates of Reward Processing","year":"2025","cit":0,"pfa":"Elisa Briem","psa":"Marie Spies","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4414260796","eid":"W4414260796"},{"id":"paper-w4412123448","cat":"papers","name":"Potential Antidepressive Effects of R-ketamine in Patients with Treatment Resistance Depression","year":"2025","cit":0,"pfa":"Sumika Egner","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4412123448","eid":"W4412123448"},{"id":"paper-w4297939870","cat":"papers","name":"Schizophrenia risk gene CAV1 is both pro-psychotic and required for atypical antipsychotic drug actions in vivo","year":"2020","cit":0,"pfa":"Vincent Setola","psa":"Pawan Yadav","topics":["Safety & adverse events","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4297939870","eid":"W4297939870"},{"id":"paper-w3093454328","cat":"papers","name":"A NOT SO FUN-GI: AN RARE CASE OF AMANITA MUSCARIA MUSHROOM OVERDOSE","year":"2020","cit":0,"pfa":"Reema Vaze","psa":"Timothy B. Coyle","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3093454328","eid":"W3093454328"},{"id":"paper-w1990308708","cat":"papers","name":"Mental Health and Canadian Society: Historical Perspectives (review)","year":"2008","cit":0,"pfa":"Wendy Mitchinson","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W1990308708","eid":"W1990308708"},{"id":"paper-w2015267080","cat":"papers","name":"Ketamine's Antidepressant Effect Offers Drug-Development Target","year":"2007","cit":0,"pfa":"Jun Yan","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2015267080","eid":"W2015267080"},{"id":"paper-w1996234756","cat":"papers","name":"Key Remission Factors Indicate Link Between Psychosis Types","year":"2006","cit":0,"pfa":"Mark Moran","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1996234756","eid":"W1996234756"},{"id":"paper-w2573624200","cat":"papers","name":"The role of schizophrenia susceptibility genes in associative learning","year":"2016","cit":0,"pfa":"Nicholas E. Clifton","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W2573624200","eid":"W2573624200"},{"id":"paper-w7126318110","cat":"papers","name":"The impact of lifetime polysubstance use on clinical, cognitive, and neuroimaging measures in psychosis","year":"2022","cit":0,"pfa":"Marlynn P. Lopez","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"dissertation","src":"https://openalex.org/W7126318110","eid":"W7126318110"},{"id":"paper-w4416607405","cat":"papers","name":"Peer Review Report For: IMPORTANCE trial: a provisional study-design of a single-center, phase II, double-blinded, placebo-controlled, randomized, 4-week study to compare the efficacy and safety of intranasal esketamine","year":"2021","cit":0,"pfa":"Mauricio Fernandes","psa":"Felipe Fregni","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"peer-review","src":"https://openalex.org/W4416607405","eid":"W4416607405"},{"id":"paper-w4416731942","cat":"papers","name":"Peer Review Report For: IMPORTANCE trial: a provisional study-design of a single-center, phase II, double-blinded, placebo-controlled, randomized, 4-week study to compare the efficacy and safety of intranasal esketamine","year":"2021","cit":0,"pfa":"Mauricio Fernandes","psa":"Felipe Fregni","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"peer-review","src":"https://openalex.org/W4416731942","eid":"W4416731942"},{"id":"paper-w4213314936","cat":"papers","name":"The role of intranasal esketamine in treatment-resistant depression","year":"2021","cit":0,"pfa":"A. Fraga","psa":"A. Moutinho","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4213314936","eid":"W4213314936"},{"id":"paper-w7154322487","cat":"papers","name":"Adjuvants to local anesthetics: efficacy, safety, and limitations","year":"2026","cit":0,"pfa":"Anastasiia G. Krestovnikova","psa":"Ionas S. Simutis","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7154322487","eid":"W7154322487"},{"id":"paper-w2318313167","cat":"papers","name":"The molecular mechanisms underlying ketamine's rapid antidepressant responses","year":"2015","cit":0,"pfa":"Ke Zhang","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2318313167","eid":"W2318313167"},{"id":"paper-w2049050212","cat":"papers","name":"C-Fos brain mapping of global and subunit-specific NMDA receptor antagonists: Relevance for their potential use as antidepressants","year":"2011","cit":0,"pfa":"Dragoš Inta","psa":"Peter Gass","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W2049050212","eid":"W2049050212"},{"id":"paper-w4283209985","cat":"papers","name":"Effects of ketamine optical isomers, fluoxetine and naloxone on timing in differential reinforcement of low-rate response (DRL) 72-s task in rats","year":"2022","cit":0,"pfa":"Natalia Malikowska‐Racia","psa":"Piotr Popik","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4283209985","eid":"W4283209985"},{"id":"paper-w7130647918","cat":"papers","name":"Sympathetic activation but not dissociation linked to ketamine’s sustained antidepressant effect","year":"2026","cit":0,"pfa":"Veronika Andrashko","psa":"Jiri Horacek","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7130647918","eid":"W7130647918"},{"id":"paper-w4385768826","cat":"papers","name":"D-CYCLOSERINE FOR THE TREATMENT OF CHRONIC PAIN","year":"2023","cit":0,"pfa":"Jonathan C. Javitt","psa":"Michael T. Sapko, MD, PhD","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4385768826","eid":"W4385768826"},{"id":"paper-w4319263765","cat":"papers","name":"Dual orexin/hypocretin receptor antagonism attenuates attentional impairments in an NMDA receptor hypofunction model of schizophrenia","year":"2023","cit":0,"pfa":"Eden B. Maness","psa":"Joshua A. Burk","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4319263765","eid":"W4319263765"},{"id":"paper-w3152124383","cat":"papers","name":"Introduction to clinical pharmacology at large","year":"2021","cit":0,"pfa":"Emma Forton Magavern","psa":"Serge Cremers","topics":["Addiction","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3152124383","eid":"W3152124383"},{"id":"paper-w3042816461","cat":"papers","name":"The effects of ketamine on dopaminergic function","year":"2017","cit":0,"pfa":"Michelle Kokkinou","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3042816461","eid":"W3042816461"},{"id":"paper-w4205432135","cat":"papers","name":"Children and Adolescents Who Have Schizophrenia","year":"2003","cit":0,"pfa":"Adriana E. Groisman","psa":"Martha L. Seminatore","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4205432135","eid":"W4205432135"},{"id":"paper-w7161623170","cat":"papers","name":"Safety and efficacy of esketamine versus remifentanil as adjuncts to propofol sedation in children undergoing haematologic-oncologic procedures in China: a single-centre, randomised, controlled, crossover trial protocol","year":"2026","cit":0,"pfa":"Shangxian Xu","psa":"Qian Wang","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7161623170","eid":"W7161623170"},{"id":"paper-w4298422886","cat":"papers","name":"A review of ketamine’s role in ECT and non-ECT settings","year":"2018","cit":0,"pfa":"V Jankauskas","psa":"Pierre S. Chue","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4298422886","eid":"W4298422886"},{"id":"paper-w2499228577","cat":"papers","name":"Comparison of the Behavioral Pharmacology of Phencyclidine to Related Compounds","year":"1981","cit":0,"pfa":"Kathleen T. Brady","topics":["Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2499228577","eid":"W2499228577"},{"id":"paper-w7161852002","cat":"papers","name":"Association of multimodal analgesic protocol with postpartum depression incidence and sleep quality in high-risk parturients","year":"2026","cit":0,"pfa":"Haitao Zhang","psa":"G L Zhang","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7161852002","eid":"W7161852002"},{"id":"paper-w7170654239","cat":"papers","name":"Efficacy and safety of ketamine in total hip arthroplasty: a systematic review","year":"2026","cit":0,"pfa":"Taotao Xu (11476246)","psa":"Bo Zhu","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W7170654239","eid":"W7170654239"},{"id":"paper-w3012448741","cat":"papers","name":"Interactions between cannabinoids and tobacco : implications for understanding and treating addictive disorders","year":"2018","cit":0,"pfa":"Chandni N Hindocha","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"dissertation","src":"https://openalex.org/W3012448741","eid":"W3012448741"},{"id":"paper-w3181590958","cat":"papers","name":"Cannabidiol (CBD): An Innovative Pharmacological Treatment for Obsessive Compulsive Disorder (OCD)","year":"2019","cit":0,"pfa":"Paul J. Flaer","psa":"M. AlRubaie","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3181590958","eid":"W3181590958"},{"id":"paper-w7167225742","cat":"papers","name":"PERIOPERATIVE ANALGESIC EFFICACY OF THE ERECTOR SPINAE PLANE BLOCK WITHIN A MULTIMODAL ANESTHESIA PROTOCOL FOR OPEN THORACOLUMBAR SPINAL FIXATION SURGERY","year":"2026","cit":0,"pfa":"Aleksandar Dimitrovski","psa":"Aleksandra Gavrilovska Brzanov","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7167225742","eid":"W7167225742"},{"id":"paper-w7163179700","cat":"papers","name":"Efficacy and safety of ketamine in total hip arthroplasty: a systematic review","year":"2026","cit":0,"pfa":"Taotao Xu","psa":"Bo Zhu","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W7163179700","eid":"W7163179700"},{"id":"paper-w7170434176","cat":"papers","name":"Efficacy and safety of ketamine in total hip arthroplasty: a systematic review","year":"2026","cit":0,"pfa":"Taotao Xu (11476246)","psa":"Bo Zhu","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W7170434176","eid":"W7170434176"},{"id":"paper-w7131119194","cat":"papers","name":"Pharmacokinetics and pharmacodynamics of orally administered S-ketamine in healthy participants.","year":"2026","cit":0,"pfa":"Joost van Mechelen","psa":"Gabriel Jacobs","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7131119194","eid":"W7131119194"},{"id":"paper-w2573493823","cat":"papers","name":"Mechanisms of NMDA receptor inhibition by memantine and ketamine","year":"2016","cit":0,"pfa":"Nathan G. Glasgow","topics":["Depression","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2573493823","eid":"W2573493823"},{"id":"paper-w4388385209","cat":"papers","name":"CANNABIDIOL IN PSYCHIATRY: HALF-A-CENTURY OF TRANSLATIONAL RESEARCH","year":"2023","cit":0,"pfa":"Francisco Silveira Guimarães","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4388385209","eid":"W4388385209"},{"id":"paper-w2889857696","cat":"papers","name":"PS137. Evidence that Cannabidiol Induces Acute Antidepressant-Like Efects in Different Animal Models","year":"2016","cit":0,"pfa":"Sâmia R.L. Joca","psa":"Francisco Silveira Guimarães","topics":["Depression","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W2889857696","eid":"W2889857696"},{"id":"paper-w4389029191","cat":"papers","name":"1877. Post-Tuberculosis Treatment Mortality in Georgia (2009-2018)","year":"2023","cit":0,"pfa":"Sarah Gorvetzian","psa":"Marcos Coutinho Schechter","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4389029191","eid":"W4389029191"},{"id":"paper-w753361104","cat":"papers","name":"Cannabinoids and psychosis : cause and treatment","year":"2012","cit":0,"pfa":"Paul D. Morrison","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W753361104","eid":"W753361104"},{"id":"paper-w7204209547","cat":"papers","name":"Safety and Efficacy of Remimazolam Combined with Esketamine for Anesthesia in Elderly Patients Undergoing ERCP: A Randomized Controlled Trial","year":"2026","cit":0,"pfa":"Yongbo Yu","psa":"Renhu Li","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7204209547","eid":"W7204209547"},{"id":"paper-w1780051850","cat":"papers","name":"Modulation of NMDA Receptor Activity During Physiological and Pathophysiological Events","year":"2014","cit":0,"pfa":"Christine M. Emnett","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W1780051850","eid":"W1780051850"},{"id":"paper-w2498254834","cat":"papers","name":"Cannabis sativa L. (Marihuana): VI. Variations in Marihuana Preparations and Usage - Chemical and Pharmacological Consequences","year":"1975","cit":0,"pfa":"Alvin B. Segelman","psa":"F.H. Segelman","topics":["Addiction","Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W2498254834","eid":"W2498254834"},{"id":"paper-w4242010175","cat":"papers","name":"Kapitel 4. Psychedelische Welten, Feminisierung und Keimzellen queerer Kultur","year":"2007","cit":0,"pfa":"Lutz Hieber","ptype":"book-chapter","src":"https://openalex.org/W4242010175","eid":"W4242010175"},{"id":"paper-w7109081026","cat":"papers","name":"Ketamine for perioperative pain and opioid sparing: A scoping review","year":"2025","cit":0,"pfa":"Ali Mansuor Mohammad Yasin","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7109081026","eid":"W7109081026"},{"id":"paper-w176311290","cat":"papers","name":"The effect of ketamine on visual perception and its relation to γ oscillations in rat visual cortex.","year":"2011","cit":0,"pfa":"Katja Clarissa Ward","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W176311290","eid":"W176311290"},{"id":"paper-w4413363596","cat":"papers","name":"Regional blood flow signatures of opioidergic modulation of ketamine in major depressive disorder: a randomised crossover study","year":"2025","cit":0,"pfa":"Luke A. Jelen","psa":"Mitul Ashok Mehta","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4413363596","eid":"W4413363596"},{"id":"paper-w7201858746","cat":"papers","name":"Supplemental Material for: A Systematic Review of Long-term Safety Outcomes of Ketamine and Esketamine in Patients with Treatment-resistant Depression","year":"2026","cit":0,"pfa":"figshare admin karger","psa":"Taeho Greg Rhee","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"supplementary-materials","src":"https://openalex.org/W7201858746","eid":"W7201858746"},{"id":"paper-w7131372642","cat":"papers","name":"Brain network modeling with The Virtual Brain derives pharmacodynamics of ketamine","year":"2026","cit":0,"pfa":"Jennifer Them","psa":"Petra Ritter","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7131372642","eid":"W7131372642"},{"id":"paper-w4391480004","cat":"papers","name":"P15: Esketamine in the elderly-is it efficient and safe?","year":"2023","cit":0,"topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W4391480004","eid":"W4391480004"},{"id":"paper-w7203773077","cat":"papers","name":"A Systematic Review of Long-Term Safety Outcomes of Ketamine and Esketamine in Patients with Treatment-Resistant Depression.","year":"2026","cit":0,"pfa":"Tychique T. Wasolua","psa":"Taeho Greg Rhee","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7203773077","eid":"W7203773077"},{"id":"paper-w2008687246","cat":"papers","name":"FBI Psychiatrist Prepares Colleagues for Bioterrorism","year":"2001","cit":0,"pfa":"Christine Lehmann","topics":["Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2008687246","eid":"W2008687246"},{"id":"paper-w4398176519","cat":"papers","name":"Why Do an Addiction Psychiatry Fellowship?","year":"2024","cit":0,"pfa":"Michael A. Dawes","psa":"John A. Renner","topics":["Addiction","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4398176519","eid":"W4398176519"},{"id":"paper-w4297839455","cat":"papers","name":"Comparison of the effects of esketamine, sufentanil, or lidocaine combined with propofol on tussis reflection during upper gastrointestinal endoscopy: study protocol for a randomised, two centre, three-blind, controlled","year":"2022","cit":0,"pfa":"Hai‐Jun Hou","psa":"Ming Tian","ptype":"preprint","src":"https://openalex.org/W4297839455","eid":"W4297839455"},{"id":"paper-w4382599699","cat":"papers","name":"To Address Treatment-Resistant Depression, First You Have to Define It","year":"2023","cit":0,"pfa":"Terri D’Arrigo","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W4382599699","eid":"W4382599699"},{"id":"paper-w3014521647","cat":"papers","name":"Flashback psychopathology in combatants with PTSD","year":"2019","cit":0,"pfa":"Oleg Gennadiiovych Syropyatov","psa":"Kateryna Marushchenko","topics":["PTSD & trauma","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3014521647","eid":"W3014521647"},{"id":"paper-w7201879802","cat":"papers","name":"Supplemental Material for: A Systematic Review of Long-term Safety Outcomes of Ketamine and Esketamine in Patients with Treatment-resistant Depression","year":"2026","cit":0,"pfa":"figshare admin karger","psa":"Taeho Greg Rhee","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"supplementary-materials","src":"https://openalex.org/W7201879802","eid":"W7201879802"},{"id":"paper-w3041867114","cat":"papers","name":"Genetic influences on substance use behaviour and disorders and psychiatric disorders","year":"2020","cit":0,"pfa":"Lun-Hsien Chang","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"dissertation","src":"https://openalex.org/W3041867114","eid":"W3041867114"},{"id":"paper-w4225390158","cat":"papers","name":"Analgesic and Antinociceptive Effects of (2 R ,6 R )‐hydroxynorketamine (HNK) in Mice","year":"2022","cit":0,"pfa":"Jonathan G. Yost","psa":"Irwin Lucki","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4225390158","eid":"W4225390158"},{"id":"paper-w4225374874","cat":"papers","name":"Effects of Increasing Endocannabinoid 2‐AG Tone on Sensorimotor Gating and Anxiety‐like behavior","year":"2022","cit":0,"pfa":"Alexius Lampkin","psa":"Vaishali P. Bakshi","topics":["PTSD & trauma","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4225374874","eid":"W4225374874"},{"id":"paper-w4388815841","cat":"papers","name":"Subanesthetic ketamine for pain management in hospitalized children, adolescents, and young adults: a single-center cohort study","year":"2017","cit":0,"pfa":"Kathy Ann Sheehy","psa":"Zenaide Quezado","topics":["Addiction","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4388815841","eid":"W4388815841"},{"id":"paper-w7212736337","cat":"papers","name":"Low-Dose Esketamine Combined with Propofol for Sedation in Elderly Patients Undergoing Bidirectional Endoscopy: A single-centre, double-blind, randomised, placebo-controlled trial","year":"2026","cit":0,"pfa":"Xiangqian Wan¹","psa":"Mingqing Peng","topics":["Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7212736337","eid":"W7212736337"},{"id":"paper-w2094569704","cat":"papers","name":"Ketamine Findings Suggest Path to New Schizophrenia Drugs","year":"2008","cit":0,"pfa":"Mark Moran","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2094569704","eid":"W2094569704"},{"id":"paper-w7118172131","cat":"papers","name":"Self-disturbance in first-episode psychosis: Theoretical framework and potential cannabis interactions - a systematic review","year":"2026","cit":0,"pfa":"Valerio Ricci","psa":"Giuseppe Maina","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7118172131","eid":"W7118172131"},{"id":"paper-w4210667440","cat":"papers","name":"Faculty Opinions recommendation of Ketamine as an adjuvant to opioids for cancer pain.","year":"2014","cit":0,"pfa":"Joan Hester","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"peer-review","src":"https://openalex.org/W4210667440","eid":"W4210667440"},{"id":"paper-w4381046717","cat":"papers","name":"Ketamine infusions for treatment‐resistant bipolar depression: Commentary","year":"2023","cit":0,"pfa":"Gustavo Héctor Vázquez","psa":"Ross J. Baldessarini","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4381046717","eid":"W4381046717"},{"id":"paper-w1991298890","cat":"papers","name":"Scientists Closer to Finding Drugs to Treat Addiction","year":"2012","cit":0,"pfa":"Jun Yi Yan","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1991298890","eid":"W1991298890"},{"id":"paper-w7155100628","cat":"papers","name":"Mania in a patient using cannabidiol for neuropathic pain","year":"2026","cit":0,"pfa":"Varchasvi Mudgal","psa":"Prashant Gaurav","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7155100628","eid":"W7155100628"},{"id":"paper-w7204510836","cat":"papers","name":"Safety and Efficacy of Remimazolam Combined with Esketamine for Anesthesia in Elderly Patients Undergoing ERCP: A Randomized Controlled Trial","year":"2026","cit":0,"pfa":"Yu Y","psa":"Li R","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7204510836","eid":"W7204510836"},{"id":"paper-w2748584296","cat":"papers","name":"Antidepressant-like Effects of Amisulpride, Ketamine, and Their Enantiomers on Differential-Reinforcement-of-Low-Rate (DRL) Operant Responding in Male C57/BL/6 Mice","year":"2017","cit":0,"pfa":"Doug Smith","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2748584296","eid":"W2748584296"},{"id":"paper-w3168336780","cat":"papers","name":"Examining Sex Differences in Response to NMDAR Antagonist MK‐801 on Sleep Architecture and Brain Function Using Electroencephalography in Rats","year":"2021","cit":0,"pfa":"Kimberly M. Holter","psa":"Robert W. Gould","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3168336780","eid":"W3168336780"},{"id":"paper-w2051449140","cat":"papers","name":"Depersonalization Again Finds Psychiatric Spotlight","year":"2003","cit":0,"pfa":"Joan Arehart-Treichel","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W2051449140","eid":"W2051449140"},{"id":"paper-w7130513771","cat":"papers","name":"Integrating Fixed-dose Combination Technologies with Classical Ayurvedic Dosage Forms: A Comparative and Transformational Outlook","year":"2025","cit":0,"pfa":"Neha Yadav","psa":"S Rajagopala","topics":["Safety & adverse events","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7130513771","eid":"W7130513771"},{"id":"paper-w4253069829","cat":"papers","name":"Process and Outcome Evaluation of the Residential Substance Abuse Treatment (RSAT) Program in Kyle, Texas, 1993-1995","year":"2003","cit":0,"pfa":"Kevin K. Knight","psa":"D. Dwayne Simpson","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"dataset","src":"https://openalex.org/W4253069829","eid":"W4253069829"},{"id":"paper-w4212830677","cat":"papers","name":"Process and Outcome Evaluation of the Residential Substance Abuse Treatment (RSAT) Program in Kyle, Texas, 1993-1995","year":"2003","cit":0,"pfa":"Kevin K. Knight","psa":"D. Dwayne Simpson","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"dataset","src":"https://openalex.org/W4212830677","eid":"W4212830677"},{"id":"paper-w4416464278","cat":"papers","name":"Understanding decision-making and barriers in the mental health R&D ecosystem","year":"2024","cit":0,"pfa":"Marisa Amato","psa":"The Wellcome Trust","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"other","src":"https://openalex.org/W4416464278","eid":"W4416464278"},{"id":"paper-w2334552197","cat":"papers","name":"Research Identifies Gene Linked to Cannabis-Induced Psychosis","year":"2016","cit":0,"pfa":"Nick Zagorski","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W2334552197","eid":"W2334552197"},{"id":"paper-w2901798475","cat":"papers","name":"Mechanisms underlying neurochemical changes after sub-chronic phencyclidine treatment : clues to the neuropathology of schizophrenia","year":"2018","cit":0,"pfa":"Ersin Yavas","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W2901798475","eid":"W2901798475"},{"id":"paper-w4239059616","cat":"papers","name":"APA Task Force to Address ‘What’s Next?’ for Ketamine","year":"2015","cit":0,"pfa":"Jennifer Carr","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4239059616","eid":"W4239059616"},{"id":"paper-w2292741660","cat":"papers","name":"Chronic ketamine use and psychotic symptomatology","year":"2008","cit":0,"pfa":"Steven R. Duffin","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"dissertation","src":"https://openalex.org/W2292741660","eid":"W2292741660"},{"id":"paper-w2007326299","cat":"papers","name":"Book review: Biochemical Pharmacology – chemistry as the language of pharmacology","year":"2013","cit":0,"pfa":"Harvey Alan Berman","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"book-review","src":"https://openalex.org/W2007326299","eid":"W2007326299"},{"id":"paper-w4390771765","cat":"papers","name":"Editorial: New trends in the treatment of mood disorders","year":"2024","cit":0,"pfa":"Carmen Concerto","psa":"Fortunato Battaglia","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"editorial","src":"https://openalex.org/W4390771765","eid":"W4390771765"},{"id":"paper-w7172030631","cat":"papers","name":"Long term efficacy and safety of GH001 in patients with treatment-resistant depression","year":"2026","cit":0,"pfa":"Eduard Vieta","psa":"Wiesław Jerzy Cubała","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7172030631","eid":"W7172030631"},{"id":"paper-w2794700425","cat":"papers","name":"O7.1. MIDBRAIN DOPAMINE NEURON ACTIVITY CONTROLS THE EFFECTS OF REPEATED KETAMINE ON STRIATAL DOPAMINERGIC FUNCTION","year":"2018","cit":0,"pfa":"Michelle Kokkinou","psa":"Oliver Howes","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W2794700425","eid":"W2794700425"},{"id":"paper-w3104429260","cat":"papers","name":"Behavioural pharmacology of cannabidiol in a MK-801 rodent model of aspects of schizophreni","year":"2017","cit":0,"pfa":"Anand Gururajan","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W3104429260","eid":"W3104429260"},{"id":"paper-w7128708995","cat":"papers","name":"Behavioural pharmacology of cannabidiol in a MK-801 rodent model of aspects of schizophreni","year":"2017","cit":0,"pfa":"Anand Gururajan","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7128708995","eid":"W7128708995"},{"id":"paper-w7128681782","cat":"papers","name":"Behavioural pharmacology of cannabidiol in a MK-801 rodent model of aspects of schizophreni","year":"2017","cit":0,"pfa":"Anand Gururajan","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7128681782","eid":"W7128681782"},{"id":"paper-w3093099241","cat":"papers","name":"Adding Value to Clinical Toxicology Testing","year":"2020","cit":0,"pfa":"Deborah French","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3093099241","eid":"W3093099241"},{"id":"paper-w4416304920","cat":"papers","name":"Editorial: Enhancing therapeutic strategies: a focus on pharmacovigilance in new wave antidepressants and antipsychotics","year":"2025","cit":0,"pfa":"Octavian Vasiliu","psa":"Georgios Mikellides","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"editorial","src":"https://openalex.org/W4416304920","eid":"W4416304920"},{"id":"paper-w2122414833","cat":"papers","name":"The phencyclidine model of schizophrenia : dysregulation of brain dopamine systems induced by NMDA receptor antagonists","year":"1998","cit":0,"pfa":"Jan M. Mathé","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"dissertation","src":"https://openalex.org/W2122414833","eid":"W2122414833"},{"id":"paper-w2791966802","cat":"papers","name":"Non-Hormonal Therapy for Recurrent Non-Metastatic Prostate Cancer","year":"2018","cit":0,"pfa":"Avi S. Retter","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2791966802","eid":"W2791966802"},{"id":"paper-w1999813116","cat":"papers","name":"Suicidal Ideation Abates After Ketamine Infusion","year":"2009","cit":0,"pfa":"Jun Yan","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W1999813116","eid":"W1999813116"},{"id":"paper-w7106217621","cat":"papers","name":"“Efficacy and Safety of Topical Ketamine for Oral Mucositis Pain due to Chemotherapy: A Scoping Review”","year":"2025","cit":0,"pfa":"Jayita Deodhar","psa":"Kamble, Shruti","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"other","src":"https://openalex.org/W7106217621","eid":"W7106217621"},{"id":"paper-w4404077643","cat":"papers","name":"A new psychotherapy that may treat PTSD in one session","year":"2024","cit":0,"pfa":"Edmund S. Howe","topics":["PTSD & trauma","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4404077643","eid":"W4404077643"},{"id":"paper-w4376875598","cat":"papers","name":"Clinically-driven design of novel methods of investigation on skeletal health status in neurological disorders. The case of the traumatic brain injuries","year":"2023","cit":0,"pfa":"Letizia Penolazzi","psa":"Roberta Piva","topics":["PTSD & trauma","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4376875598","eid":"W4376875598"},{"id":"paper-w4407002130","cat":"papers","name":"Mental automatism and exogenous psychosis: the originality of De Clérambault’s and Karl Bonhoeffer’s theories in substance-related psychoses","year":"2025","cit":0,"pfa":"Valerio Ricci","psa":"Giuseppe Maina","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4407002130","eid":"W4407002130"},{"id":"paper-w2325762025","cat":"papers","name":"Ketamine Relieves Pain at End of Life","year":"2012","cit":0,"pfa":"BRUCE JANCIN","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2325762025","eid":"W2325762025"},{"id":"paper-w1518236300","cat":"papers","name":"Exploiting modern cannabinoid pharmacology for therapeutic gain?","year":"2012","cit":0,"pfa":"James M. Ritter","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W1518236300","eid":"W1518236300"},{"id":"paper-w7161829450","cat":"papers","name":"Dexmedetomidine target-controlled infusion (TCI) and ketamine analgosedation in geriatric patients undergoing vertebroplasties: pharmacodynamic considerations","year":"2026","cit":0,"pfa":"ShivakumarM Channabasappa","psa":"SukhminderJit Singh Bajwa","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7161829450","eid":"W7161829450"},{"id":"paper-w2141858557","cat":"papers","name":"History of St. Elizabeths Parallels U.S. Psychiatry's","year":"2005","cit":0,"pfa":"Aaron R. Levin","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W2141858557","eid":"W2141858557"},{"id":"paper-w4387524160","cat":"papers","name":"Implementing telemedicine for opioid addiction amongst youth of Pakistan","year":"2023","cit":0,"pfa":"Mahrosh Kasbati","psa":"Abdullah Malikzai","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4387524160","eid":"W4387524160"},{"id":"paper-w4381612319","cat":"papers","name":"Neuropsychiatric consequences of COVID-19 related olfactory dysfunction: could non-olfactory cortical-bound inputs from damaged olfactory bulb also contribute to cognitive impairment?","year":"2023","cit":0,"pfa":"Bernát Kocsis","psa":"Benjamin Rafael Pittman-Polletta","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4381612319","eid":"W4381612319"},{"id":"paper-w4409035251","cat":"papers","name":"A review of the antidepressant effects of esketamine and arketamine in treatment-resistant depression","year":"2024","cit":0,"pfa":"Kamila Czora-Poczwardowska","psa":"Michał Szulc","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4409035251","eid":"W4409035251"},{"id":"paper-w4414639558","cat":"papers","name":"Integrated Bioinformatics to Explore Molecular Targets of Esketamine and Arketamine in Antidepressant and Antisuicidal Action","year":"2025","cit":0,"pfa":"Glorister A. Altê","psa":"Ana Lúcia S. Rodrigues","topics":["Depression"],"ptype":"book-chapter","src":"https://openalex.org/W4414639558","eid":"W4414639558"},{"id":"paper-w4389967138","cat":"papers","name":"Esketamine","year":"2023","cit":0,"pfa":"Veronika Dobler","psa":"Shamim Ruhi","ptype":"book-chapter","src":"https://openalex.org/W4389967138","eid":"W4389967138"},{"id":"paper-w4415710616","cat":"papers","name":"Esketamine","year":"2025","cit":0,"ptype":"article","src":"https://openalex.org/W4415710616","eid":"W4415710616"},{"id":"paper-w4409969090","cat":"papers","name":"Esketamine","year":"2025","cit":0,"ptype":"article","src":"https://openalex.org/W4409969090","eid":"W4409969090"},{"id":"paper-w4231389323","cat":"papers","name":"Esketamine","year":"2015","cit":0,"ptype":"article","src":"https://openalex.org/W4231389323","eid":"W4231389323"},{"id":"paper-w7164943414","cat":"papers","name":"Esketamine","year":"2026","cit":0,"ptype":"article","src":"https://openalex.org/W7164943414","eid":"W7164943414"},{"id":"paper-w4242060959","cat":"papers","name":"Esketamine","year":"2018","cit":0,"ptype":"article","src":"https://openalex.org/W4242060959","eid":"W4242060959"},{"id":"paper-w4412377703","cat":"papers","name":"Esketamine","year":"2025","cit":0,"ptype":"article","src":"https://openalex.org/W4412377703","eid":"W4412377703"},{"id":"paper-w4236287271","cat":"papers","name":"Esketamine","year":"2019","cit":0,"ptype":"article","src":"https://openalex.org/W4236287271","eid":"W4236287271"},{"id":"paper-w4253390190","cat":"papers","name":"Esketamine","year":"2014","cit":0,"ptype":"article","src":"https://openalex.org/W4253390190","eid":"W4253390190"},{"id":"paper-w4291142584","cat":"papers","name":"Esketamine","year":"2022","cit":0,"ptype":"article","src":"https://openalex.org/W4291142584","eid":"W4291142584"},{"id":"paper-w4294217094","cat":"papers","name":"Esketamine","year":"2022","cit":0,"ptype":"article","src":"https://openalex.org/W4294217094","eid":"W4294217094"},{"id":"paper-w4403545407","cat":"papers","name":"Esketamine","year":"2024","cit":0,"ptype":"article","src":"https://openalex.org/W4403545407","eid":"W4403545407"},{"id":"paper-w4415977566","cat":"papers","name":"Esketamine","year":"2025","cit":0,"ptype":"article","src":"https://openalex.org/W4415977566","eid":"W4415977566"},{"id":"paper-w4233875742","cat":"papers","name":"Esketamine","year":"2019","cit":0,"ptype":"article","src":"https://openalex.org/W4233875742","eid":"W4233875742"},{"id":"paper-w4402417810","cat":"papers","name":"Esketamine","year":"2024","cit":0,"ptype":"article","src":"https://openalex.org/W4402417810","eid":"W4402417810"},{"id":"paper-w7130659594","cat":"papers","name":"Esketamine","year":"2026","cit":0,"ptype":"article","src":"https://openalex.org/W7130659594","eid":"W7130659594"},{"id":"paper-w4396621662","cat":"papers","name":"ESKETAMINE","year":"2024","cit":0,"pfa":"Stephen M. Stahl","psa":"Jeffrey Robert Strawn","ptype":"other","src":"https://openalex.org/W4396621662","eid":"W4396621662"},{"id":"paper-w4310257409","cat":"papers","name":"Esketamine","year":"2022","cit":0,"ptype":"article","src":"https://openalex.org/W4310257409","eid":"W4310257409"},{"id":"paper-w7135426724","cat":"papers","name":"Esketamine","year":"2026","cit":0,"ptype":"article","src":"https://openalex.org/W7135426724","eid":"W7135426724"},{"id":"paper-w4395081047","cat":"papers","name":"ESKETAMINE","year":"2024","cit":0,"pfa":"Stephen M. Stahl","ptype":"other","src":"https://openalex.org/W4395081047","eid":"W4395081047"},{"id":"paper-w4408465265","cat":"papers","name":"Esketamine","year":"2025","cit":0,"ptype":"article","src":"https://openalex.org/W4408465265","eid":"W4408465265"},{"id":"paper-w4248677873","cat":"papers","name":"Esketamine","year":"2017","cit":0,"ptype":"article","src":"https://openalex.org/W4248677873","eid":"W4248677873"},{"id":"paper-w4412896562","cat":"papers","name":"Arketamine: Unapproved but Promising Antidepressant with Multiple Brain Benefits","year":"2025","cit":0,"pfa":"Xiayun Wan","psa":"Kenji Hashimoto","topics":["Depression"],"ptype":"book-chapter","src":"https://openalex.org/W4412896562","eid":"W4412896562"},{"id":"paper-w4313198856","cat":"papers","name":"Involvement of the agranular insular cortex in antidepressant actions of arketamine","year":"2022","cit":0,"pfa":"Rei Yokoyama","psa":"Hitoshi Hashimoto","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4313198856","eid":"W4313198856"},{"id":"paper-w3016111478","cat":"papers","name":"Synthesis of Esketamine","year":"2020","cit":0,"pfa":"Philip Kocieński","ptype":"editorial","src":"https://openalex.org/W3016111478","eid":"W3016111478"},{"id":"paper-w4407635336","cat":"papers","name":"Esketamine/phenelzine","year":"2025","cit":0,"ptype":"article","src":"https://openalex.org/W4407635336","eid":"W4407635336"},{"id":"paper-w4392048559","cat":"papers","name":"Antidepressants/esketamine","year":"2024","cit":0,"topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4392048559","eid":"W4392048559"},{"id":"paper-w4403986408","cat":"papers","name":"A Concise Synthesis of (2R,6R)-Hydroxynorketamine","year":"2024","cit":0,"pfa":"Jianfeng Li","psa":"Ning Li","ptype":"article","src":"https://openalex.org/W4403986408","eid":"W4403986408"},{"id":"paper-w4293155295","cat":"papers","name":"Escitalopram/esketamine","year":"2022","cit":0,"ptype":"article","src":"https://openalex.org/W4293155295","eid":"W4293155295"},{"id":"paper-w4402372191","cat":"papers","name":"Esketamine/Ketamine","year":"2024","cit":0,"ptype":"article","src":"https://openalex.org/W4402372191","eid":"W4402372191"},{"id":"paper-w4240287642","cat":"papers","name":"Esketamine/midazolam/propofol","year":"2016","cit":0,"ptype":"article","src":"https://openalex.org/W4240287642","eid":"W4240287642"},{"id":"paper-w3044364009","cat":"papers","name":"Esketamine Nasal Spray","year":"2020","cit":0,"pfa":"Mohamed SJ Farhana","psa":"Subramaniyan Prabavathy","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W3044364009","eid":"W3044364009"},{"id":"paper-w2769559209","cat":"papers","name":"Enantioselective Synthesis of (2R,6R)-Hydroxynorketamine","year":"2017","cit":0,"pfa":"Philip Kocienski","ptype":"editorial","src":"https://openalex.org/W2769559209","eid":"W2769559209"},{"id":"paper-w3005005765","cat":"papers","name":"What Is the Deal With Esketamine","year":"2020","cit":0,"pfa":"Samuel T. Wilkinson","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3005005765","eid":"W3005005765"},{"id":"paper-w4230485660","cat":"papers","name":"Esketamine/thiopental sodium","year":"2015","cit":0,"ptype":"article","src":"https://openalex.org/W4230485660","eid":"W4230485660"},{"id":"paper-w4392797466","cat":"papers","name":"Esketamine/methadone/oxycodone","year":"2024","cit":0,"ptype":"article","src":"https://openalex.org/W4392797466","eid":"W4392797466"},{"id":"paper-w4226150920","cat":"papers","name":"Esketamine for severe depression","year":"2022","cit":0,"pfa":"EP Schwarz","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4226150920","eid":"W4226150920"},{"id":"paper-w4411110491","cat":"papers","name":"Esketamine/lamotrigine interaction","year":"2025","cit":0,"ptype":"article","src":"https://openalex.org/W4411110491","eid":"W4411110491"},{"id":"paper-w4250234435","cat":"papers","name":"Esketamine/ketamine/sertraline","year":"2021","cit":0,"ptype":"article","src":"https://openalex.org/W4250234435","eid":"W4250234435"},{"id":"paper-w7144328844","cat":"papers","name":"Molecular mechanisms for prophylactic effects of arketamine in inflammation model of depression","year":"2023","cit":0,"pfa":"Li MA","topics":["Depression","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W7144328844","eid":"W7144328844"},{"id":"paper-w4231293618","cat":"papers","name":"Safety Concerns with Ketamine and Esketamine","year":"2021","cit":0,"topics":["Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W4231293618","eid":"W4231293618"},{"id":"paper-w4365516597","cat":"papers","name":"Esketamine-related respiratory insufficiency","year":"2023","cit":0,"ptype":"article","src":"https://openalex.org/W4365516597","eid":"W4365516597"},{"id":"paper-w7141243298","cat":"papers","name":"Ketamine and Esketamine for Bipolar Depression","year":"2025","cit":0,"pfa":"Kristin Raj","topics":["Depression"],"ptype":"report","src":"https://openalex.org/W7141243298","eid":"W7141243298"},{"id":"paper-w2996639695","cat":"papers","name":"Use of Esketamine in Pain Patients","year":"2019","cit":0,"pfa":"Clifford Mark Gevirtz","ptype":"article","src":"https://openalex.org/W2996639695","eid":"W2996639695"},{"id":"paper-w3025106920","cat":"papers","name":"Effects of (R,S)-ketamine and (2R,6R)-hydroxynorketamine: a preclinical study","year":"2020","cit":0,"pfa":"Remington Rice","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3025106920","eid":"W3025106920"},{"id":"paper-w4415929164","cat":"papers","name":"Esketamine for Treatment-Resistant Depression","year":"2025","cit":0,"pfa":"Henrik Klasson","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4415929164","eid":"W4415929164"},{"id":"paper-w4240811457","cat":"papers","name":"ICER reports on esketamine, upadacitinib","year":"2019","cit":0,"ptype":"article","src":"https://openalex.org/W4240811457","eid":"W4240811457"},{"id":"paper-w7163033650","cat":"papers","name":"Chapter 44. Ketamine and Esketamine","year":"2024","cit":0,"pfa":"Chris A. Kelly","psa":"James W. Murrough","ptype":"book-chapter","src":"https://openalex.org/W7163033650","eid":"W7163033650"},{"id":"paper-w4414711317","cat":"papers","name":"Intranasal Esketamine: The Baby in the Bathwater","year":"2025","cit":0,"pfa":"Maxwell Zachary Price","psa":"Richard Louis Price","ptype":"article","src":"https://openalex.org/W4414711317","eid":"W4414711317"},{"id":"paper-w4388305264","cat":"papers","name":"Off-Label Use of Esketamine","year":"2023","cit":0,"pfa":"Thomas L. Schwartz","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4388305264","eid":"W4388305264"},{"id":"paper-w3033434990","cat":"papers","name":"Is Esketamine Augmentation a Win for Depression","year":"2020","cit":0,"pfa":"Brian Miller","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W3033434990","eid":"W3033434990"},{"id":"paper-w4226051710","cat":"papers","name":"Esketamine bij ernstige depressie","year":"2022","cit":0,"pfa":"EP Schwarz","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4226051710","eid":"W4226051710"},{"id":"paper-w4415929163","cat":"papers","name":"Esketamine for Treatment-Resistant Depression","year":"2025","cit":0,"pfa":"Ioana A. Cristea","psa":"Florian Naudet","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4415929163","eid":"W4415929163"},{"id":"paper-w4410634525","cat":"papers","name":"Esketamine increases risk of suicide","year":"2025","cit":0,"topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4410634525","eid":"W4410634525"},{"id":"paper-w2928784861","cat":"papers","name":"Esketamine Approved for Refractory Depression","year":"2019","cit":0,"pfa":"Terri D’Arrigo","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2928784861","eid":"W2928784861"},{"id":"paper-w4411110458","cat":"papers","name":"Esketamine/propofol/rocuronium-bromide","year":"2025","cit":0,"ptype":"article","src":"https://openalex.org/W4411110458","eid":"W4411110458"},{"id":"paper-w4409280874","cat":"papers","name":"Ketamine and Hydroxynorketamine: The Complex Balancing Act Within Fear Neural Ensembles","year":"2025","cit":0,"pfa":"Jihye Kim","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4409280874","eid":"W4409280874"},{"id":"paper-w2796606606","cat":"papers","name":"187. Ketamine Metabolism to Hydroxynorketamines: Relevance to Fast Antidepressant Action","year":"2018","cit":0,"pfa":"Todd D. Gould","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2796606606","eid":"W2796606606"},{"id":"paper-w4239610987","cat":"papers","name":"Summary of opinion: Spravato,esketamine","year":"2019","cit":0,"ptype":"article","src":"https://openalex.org/W4239610987","eid":"W4239610987"},{"id":"paper-w4413345700","cat":"papers","name":"Questionable Data and Design in Esketamine Study","year":"2025","cit":0,"pfa":"Florian Naudet","psa":"André Gillibert","ptype":"article","src":"https://openalex.org/W4413345700","eid":"W4413345700"},{"id":"paper-w4405803670","cat":"papers","name":"Ketamine and Esketamine in Treatment of Resistant Depression","year":"2024","cit":0,"pfa":"Jakub Prosowski","psa":"Jakub Początek","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4405803670","eid":"W4405803670"},{"id":"paper-w4413345725","cat":"papers","name":"Questionable Data and Design in Esketamine Study","year":"2025","cit":0,"pfa":"Samuel T. Wilkinson","psa":"Taeho Greg Rhee","ptype":"article","src":"https://openalex.org/W4413345725","eid":"W4413345725"},{"id":"paper-w4400780776","cat":"papers","name":"Chapter 21. Ketamine and Esketamine","year":"2024","cit":0,"pfa":"David S. Mathai","psa":"Sanjay J. Mathew","ptype":"book-chapter","src":"https://openalex.org/W4400780776","eid":"W4400780776"},{"id":"paper-w7124742736","cat":"papers","name":"Generation of enantiospecific monoclonal antibodies against (2R,6R)-hydroxynorketamine","year":"2026","cit":0,"pfa":"Uriel Matthew Enriquez","psa":"Cody J. Wenthur","ptype":"article","src":"https://openalex.org/W7124742736","eid":"W7124742736"},{"id":"paper-w4256088949","cat":"papers","name":"Esketamine nasal spray not recommended by NICE","year":"2020","cit":0,"ptype":"article","src":"https://openalex.org/W4256088949","eid":"W4256088949"},{"id":"paper-w4412536167","cat":"papers","name":"Progress in the Application of Esketamine in Pediatric Anesthesia","year":"2025","cit":0,"pfa":"Qian Zou","topics":["Anxiety & end-of-life","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4412536167","eid":"W4412536167"},{"id":"paper-w4250107820","cat":"papers","name":"Esketamine for depression: Exciting, but reality is difficult","year":"2019","cit":0,"topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4250107820","eid":"W4250107820"},{"id":"paper-w2782820576","cat":"papers","name":"Intranasal Esketamine for Treatment-Resistant Depression","year":"2018","cit":0,"pfa":"Peter Roy‐Byrne","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2782820576","eid":"W2782820576"},{"id":"paper-w2948402902","cat":"papers","name":"Esketamine Plus Antidepressants: A Closer Look","year":"2019","cit":0,"pfa":"Joel Yager","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2948402902","eid":"W2948402902"},{"id":"paper-w7160708389","cat":"papers","name":"Ketamine and Esketamine in Neurology and Psychiatry: An Overview","year":"2026","cit":0,"pfa":"Amalesh S Honnekeri","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7160708389","eid":"W7160708389"},{"id":"paper-w4382282608","cat":"papers","name":"The effect of esketamine on the hypoxic ventilatory response","year":"2023","cit":0,"pfa":"Simone C. Jansen","ptype":"dataset","src":"https://openalex.org/W4382282608","eid":"W4382282608"},{"id":"paper-w7122780949","cat":"papers","name":"Esketamine-related AEs and drug interactions","year":"2026","cit":0,"ptype":"article","src":"https://openalex.org/W7122780949","eid":"W7122780949"},{"id":"paper-w4410976371","cat":"papers","name":"Perspective Chapter: Analgesic Use of Esketamine","year":"2025","cit":0,"pfa":"Ferdi Gülaştı","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W4410976371","eid":"W4410976371"},{"id":"paper-w4367847221","cat":"papers","name":"Efficacy of esketamine for depression not linked to dissociation","year":"2023","cit":0,"topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4367847221","eid":"W4367847221"},{"id":"paper-w4413875701","cat":"papers","name":"Generation of Enantiospecific Monoclonal Antibodies Against (2R,6R)-Hydroxynorketamine","year":"2025","cit":0,"pfa":"Uriel Matthew Enriquez","psa":"Cody J. Wenthur","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4413875701","eid":"W4413875701"},{"id":"paper-w4413187933","cat":"papers","name":"Ketamine/esketamine for treatment-resistant depression","year":"2022","cit":0,"pfa":"Sina Nikayin","psa":"Gerard Sanacora","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W4413187933","eid":"W4413187933"},{"id":"paper-w4411183941","cat":"papers","name":"Oral esketamine for difficult-to-treat depression","year":"2025","cit":0,"pfa":"Sanne Y. Smith-Apeldoorn","topics":["Depression","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"dissertation","src":"https://openalex.org/W4411183941","eid":"W4411183941"},{"id":"paper-w7160290629","cat":"papers","name":"Orale esketamine bij therapieresistente depressie","year":"2026","cit":0,"pfa":"de Diana Veld","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7160290629","eid":"W7160290629"},{"id":"paper-w4394287330","cat":"papers","name":"TRKB interaction with PSD95 is associated with latency of fluoxetine and 2R,6R-hydroxynorketamine","year":"2023","cit":0,"pfa":"Plinio Cabrera Casarotto","ptype":"dataset","src":"https://openalex.org/W4394287330","eid":"W4394287330"},{"id":"paper-w4392815830","cat":"papers","name":"Research Progress of Esketamine in Painless Endoscopy","year":"2024","cit":0,"pfa":"Xue Ma","psa":"Qingyun Tan","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4392815830","eid":"W4392815830"},{"id":"paper-w3005190038","cat":"papers","name":"Ketamine, Esketamine, and A New Generation of Antidepressants","year":"2020","cit":0,"pfa":"Samuel T. Wilkinson","psa":"Brandon M. Kitay","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3005190038","eid":"W3005190038"},{"id":"paper-w4383599268","cat":"papers","name":"The Use of Esketamine in Clinical Anesthesia Practice","year":"2023","cit":0,"pfa":"Yanqing Song","psa":"Rui Zhou","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4383599268","eid":"W4383599268"},{"id":"paper-w4213093644","cat":"papers","name":"Recommending esketamine? 4 factors to consider","year":"2021","cit":0,"pfa":"Diana Samuel","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4213093644","eid":"W4213093644"},{"id":"paper-w4401921147","cat":"papers","name":"Esketamine in resistant depression: a case report","year":"2024","cit":0,"pfa":"Laura Carrión Expósito","psa":"M. Rodriguez Lopez","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4401921147","eid":"W4401921147"},{"id":"paper-w4366808717","cat":"papers","name":"Research Progress in Perioperative Anesthesia Application of Esketamine","year":"2023","cit":0,"pfa":"锐 徐","ptype":"article","src":"https://openalex.org/W4366808717","eid":"W4366808717"},{"id":"paper-w4405616393","cat":"papers","name":"A Review of the Progress in Clinical Application of Esketamine","year":"2024","cit":0,"pfa":"芳芳 黄","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4405616393","eid":"W4405616393"},{"id":"paper-w7124319729","cat":"papers","name":"Ketamine/Esketamine and Suicidality - Systematic Review","year":"2024","cit":0,"pfa":"Martin Plöderl","psa":"Joanna Moncrieff","topics":["Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7124319729","eid":"W7124319729"},{"id":"paper-w4402492489","cat":"papers","name":"Advances in Clinical Application of Dexmedetomidine Combined with Esketamine","year":"2024","cit":0,"pfa":"淑敏 魏","ptype":"article","src":"https://openalex.org/W4402492489","eid":"W4402492489"},{"id":"paper-w4323521407","cat":"papers","name":"Review for \"TRKB interaction with PSD95 is associated with latency of fluoxetine and 2R,6R‐hydroxynorketamine\"","year":"2022","cit":0,"topics":["Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4323521407","eid":"W4323521407"},{"id":"paper-w4323353945","cat":"papers","name":"Review for \"TRKB interaction with PSD95 is associated with latency of fluoxetine and 2R,6R‐hydroxynorketamine\"","year":"2023","cit":0,"topics":["Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4323353945","eid":"W4323353945"},{"id":"paper-w3102712444","cat":"papers","name":"P.740 Mechanistic basis behind the antidepressant response of ketamine and hydroxynorketamine (HNK)","year":"2020","cit":0,"pfa":"S.L.K. Yeoh","psa":"Christoph W. Turck","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3102712444","eid":"W3102712444"},{"id":"paper-w4323521413","cat":"papers","name":"Review for \"TRKB interaction with PSD95 is associated with latency of fluoxetine and 2R,6R‐hydroxynorketamine\"","year":"2022","cit":0,"topics":["Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4323521413","eid":"W4323521413"},{"id":"paper-w4387617359","cat":"papers","name":"Esketamine has no effect on cognition compared to midazolam","year":"2023","cit":0,"pfa":"Alison Knopf","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4387617359","eid":"W4387617359"},{"id":"paper-w4415929162","cat":"papers","name":"Esketamine for Treatment-Resistant Depression—Reply","year":"2025","cit":0,"pfa":"Adam Janik","psa":"Dong‐Jing Fu","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4415929162","eid":"W4415929162"},{"id":"paper-w3006385413","cat":"papers","name":"Esketamine Nasal Spray for Depression in Older Patients","year":"2020","cit":0,"pfa":"Matthew E. Peters","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W3006385413","eid":"W3006385413"},{"id":"paper-w3135043155","cat":"papers","name":"Esketamine in Treatment Resistant Depression: The Way to Remission","year":"2021","cit":0,"pfa":"João Facucho-Oliveira","psa":"P. Varandas","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3135043155","eid":"W3135043155"},{"id":"paper-w7203682697","cat":"papers","name":"Ketamine and esketamine for postoperative analgesia in gynaecological surgery","year":"2026","cit":0,"pfa":"Silvia Marchesi","psa":"Martin F. Bjurström","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7203682697","eid":"W7203682697"},{"id":"paper-w4367606414","cat":"papers","name":"OSA Interferes With Esketamine Treatment for PTSD in Veterans","year":"2023","cit":0,"pfa":"Brandon T. Nokes","psa":"Peter J. Colvonen","topics":["PTSD & trauma"],"ptype":"conference-abstract","src":"https://openalex.org/W4367606414","eid":"W4367606414"},{"id":"paper-w4411508793","cat":"papers","name":"Bupropion/Esketamine/Fluoxetine/Ketamine/Lithium/Prazosin","year":"2025","cit":0,"ptype":"article","src":"https://openalex.org/W4411508793","eid":"W4411508793"},{"id":"paper-w7117785774","cat":"papers","name":"Effect of esketamine combined with remimazolam in hysteroscopic surgery","year":"2025","cit":0,"pfa":"Sun Weinan","psa":"WANG Qun","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7117785774","eid":"W7117785774"},{"id":"paper-w7207828321","cat":"papers","name":"Effects of arketamine on reduced bone mineral density in mouse models: a role of gut microbiota","year":"2024","cit":0,"pfa":"Xiayun Wan","ptype":"dissertation","src":"https://openalex.org/W7207828321","eid":"W7207828321"},{"id":"paper-w4386823605","cat":"papers","name":"ULTRA FLEXIBLE MACROPOROUS MICRONEEDLES FOR SUSTAINED DELIVERY OF (2R,6R)-HYDROXYNORKETAMINE","year":"2022","cit":0,"pfa":"Riddha Das","psa":"Sameer Sonkusale","topics":["Depression"],"ptype":"conference-paper","src":"https://openalex.org/W4386823605","eid":"W4386823605"},{"id":"paper-w7163643965","cat":"papers","name":"Remimazolam-Esketamine Versus Propofol-Esketamine for Sedation During Gastrointestinal Endoscopy: A Systematic Review and Meta-Analysis of Efficacy and Safety","year":"2026","cit":0,"pfa":"A Elaraby","psa":"I Gamal","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7163643965","eid":"W7163643965"},{"id":"paper-w4390299959","cat":"papers","name":"Application of Remazolam Combined with Esketamine in Ultrasonic Gastroscopy","year":"2023","cit":0,"pfa":"刚 李","ptype":"article","src":"https://openalex.org/W4390299959","eid":"W4390299959"},{"id":"paper-w7116044932","cat":"papers","name":"Research Progress on the Mechanism of Esketamine in Antidepressant Treatment","year":"2025","cit":0,"pfa":"晓琼 尹","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7116044932","eid":"W7116044932"},{"id":"paper-w7214199115","cat":"papers","name":"Esketamine alleviates pain in rats with knee osteoarthritis","year":"2026","cit":0,"pfa":"DU Jinzhi, NI Wenyang, ZHU Rongyu, MENG Zhishou, YANG Jianxin","ptype":"article","src":"https://openalex.org/W7214199115","eid":"W7214199115"},{"id":"paper-w4385751417","cat":"papers","name":"[IV esketamine for patients with a treatment-resistant depression].","year":"2023","cit":0,"pfa":"Sven Stuiver","psa":"Jeroen A. van Waarde","topics":["Depression"],"ptype":"other","src":"https://openalex.org/W4385751417","eid":"W4385751417"},{"id":"paper-w4366318792","cat":"papers","name":"Progress in the Study of Esketamine and Perioperative Neurocognitive Impairment","year":"2023","cit":0,"pfa":"维维 李","ptype":"article","src":"https://openalex.org/W4366318792","eid":"W4366318792"},{"id":"paper-w3082504263","cat":"papers","name":"Esketamine for depression faces real‐world barriers","year":"2019","cit":0,"pfa":"Alison Knopf","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W3082504263","eid":"W3082504263"},{"id":"paper-w7204530129","cat":"papers","name":"Esketamine for Pediatric Emergence Delirium: Is the Evidence Conclusive?","year":"2026","cit":0,"pfa":"Tuhin Mistry","psa":"Abhijit Sukumaran Nair","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7204530129","eid":"W7204530129"},{"id":"paper-w7116066850","cat":"papers","name":"What is the evidence for Esketamine in treatment-resistant depression?","year":"2025","cit":0,"pfa":"Tripdatabase","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7116066850","eid":"W7116066850"},{"id":"paper-w4387787950","cat":"papers","name":"Advances in a Combination of Esketamine and Propofol in Pediatric Anesthesia","year":"2023","cit":0,"pfa":"洋 王","ptype":"article","src":"https://openalex.org/W4387787950","eid":"W4387787950"},{"id":"paper-w7133307124","cat":"papers","name":"Safety of Intranasal Esketamine Administration in Brugada Syndrome","year":"2026","cit":0,"pfa":"Aurélie Bobet","psa":"Tanguy Taillefer de Laportalière","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7133307124","eid":"W7133307124"},{"id":"paper-w4402220076","cat":"papers","name":"Medications for Depression: Monoamine Enhancers and Esketamine (Antidepressants)","year":"2024","cit":0,"pfa":"Seon‐Cheol Park","psa":"Winston Wu‐Dien Shen","topics":["Depression"],"ptype":"book-chapter","src":"https://openalex.org/W4402220076","eid":"W4402220076"},{"id":"paper-w7166008008","cat":"papers","name":"Pain control or brain protection with esketamine: a reply","year":"2026","cit":0,"pfa":"S W Chen","psa":"Yusheng Yao","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7166008008","eid":"W7166008008"},{"id":"paper-w7204895981","cat":"papers","name":"Ketamine en esketamine bij bipolaire depressie","year":"2025","cit":0,"pfa":"Kristin Raj","topics":["Depression"],"ptype":"report","src":"https://openalex.org/W7204895981","eid":"W7204895981"},{"id":"paper-w7166354025","cat":"papers","name":"Combined Application of Esketamine in Breast Cancer Surgery","year":"2026","cit":0,"pfa":"平平 陈","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7166354025","eid":"W7166354025"},{"id":"paper-w4407387114","cat":"papers","name":"(2R,6R)-HYDROXYNORKETAMINE TARGETING THE BASOLATERAL AMYGDALA REGULATES FEAR MEMORY","year":"2025","cit":0,"pfa":"Yuanyuan Xu","psa":"Dylan Chou","topics":["Depression","PTSD & trauma","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W4407387114","eid":"W4407387114"},{"id":"paper-w4323353944","cat":"papers","name":"Review for \"TRKB interaction with PSD95 is associated with latency of fluoxetine and 2R,6R‐hydroxynorketamine\"","year":"2023","cit":0,"topics":["Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4323353944","eid":"W4323353944"},{"id":"paper-w4293149580","cat":"papers","name":"A new indication for esketamine nasal spray (Spravato).","year":"2020","cit":0,"ptype":"article","src":"https://openalex.org/W4293149580","eid":"W4293149580"},{"id":"paper-w4284713424","cat":"papers","name":"Esketamine does not impair on‐road driving performance","year":"2022","cit":0,"ptype":"article","src":"https://openalex.org/W4284713424","eid":"W4284713424"},{"id":"paper-w7140209211","cat":"papers","name":"Cognitive Effects of Esketamine in Treatment-Resistant Depression","year":"2026","cit":0,"pfa":"Riccardo Guglielmo","psa":"Gianluca Serafini","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7140209211","eid":"W7140209211"},{"id":"paper-w7213915040","cat":"papers","name":"Esketamine For the Treatment of Depression in a Patient With Multiple Sclerosis","year":"2026","cit":0,"pfa":"Meghna Mathews","psa":"Kelly Golden","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7213915040","eid":"W7213915040"},{"id":"paper-w3198770585","cat":"papers","name":"Treating with esketamine nasal, will increase blood pressure?","year":"2021","cit":0,"pfa":"V. Rosello-Molina","psa":"P. Sastre Portes","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3198770585","eid":"W3198770585"},{"id":"paper-w4407693081","cat":"papers","name":"Esketamine and Postoperative Delirium: Accounting for Patient Age","year":"2025","cit":0,"pfa":"Shingo Kawashima","psa":"Hiroyuki Kinoshita","ptype":"article","src":"https://openalex.org/W4407693081","eid":"W4407693081"},{"id":"paper-w4319983051","cat":"papers","name":"Progress in Clinical Application of Esketamine in Gynecological Patients","year":"2023","cit":0,"pfa":"凤仙 余","ptype":"article","src":"https://openalex.org/W4319983051","eid":"W4319983051"},{"id":"paper-w4413345722","cat":"papers","name":"Questionable Data and Design in Esketamine Study—Reply","year":"2025","cit":0,"pfa":"Antonio DEL CASALE","psa":"Maurizio Simmaco","ptype":"article","src":"https://openalex.org/W4413345722","eid":"W4413345722"},{"id":"paper-w4313201328","cat":"papers","name":"Rechallenging esketamine in patients with poorly controlled hypertension","year":"2022","cit":0,"pfa":"L. Ricci","psa":"Umberto Volpe","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4313201328","eid":"W4313201328"},{"id":"paper-w4233936620","cat":"papers","name":"ICER posts draft documents on esketamine and siponimod","year":"2018","cit":0,"ptype":"article","src":"https://openalex.org/W4233936620","eid":"W4233936620"},{"id":"paper-w7203851204","cat":"papers","name":"Esketamine: an innovative strategy for treatment of resistant depression","year":"2025","cit":0,"pfa":"John Sebastian Cordova Jerves","topics":["Depression","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W7203851204","eid":"W7203851204"},{"id":"paper-w4412640238","cat":"papers","name":"Effect of Esketamine on Cognitive Dysfunction in Elderly Patients","year":"2025","cit":0,"pfa":"<p>Yongjie Gao, Xinjie Yang</p>","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4412640238","eid":"W4412640238"},{"id":"paper-w7116084574","cat":"papers","name":"What is the evidence for Esketamine in treatment-resistant depression?","year":"2025","cit":0,"pfa":"Tripdatabase","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7116084574","eid":"W7116084574"},{"id":"paper-w4401921207","cat":"papers","name":"Esketamine and Hopelessness: Very Short-Term Effects","year":"2024","cit":0,"pfa":"F. A. Rodríguez Batista","psa":"S. Trufero Miguel","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4401921207","eid":"W4401921207"},{"id":"paper-w4230203941","cat":"papers","name":"Esketamine dosing unlikely to cause urothelial toxicity","year":"2021","cit":0,"topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4230203941","eid":"W4230203941"},{"id":"paper-w4416777540","cat":"papers","name":"Effect of Esketamine on Immune Function of Tumor Patients","year":"2025","cit":0,"pfa":"一铮 张","ptype":"article","src":"https://openalex.org/W4416777540","eid":"W4416777540"},{"id":"paper-w4319915887","cat":"papers","name":"Kinetic mechanism of NMDA receptor inhibition by the ketamine metabolite 2R,6R-hydroxynorketamine","year":"2023","cit":0,"pfa":"Faye D. Raymond","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4319915887","eid":"W4319915887"},{"id":"paper-w4415055809","cat":"papers","name":"Esketamine monotherapy efficacious in treatment‐resistant depression","year":"2025","cit":0,"topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4415055809","eid":"W4415055809"},{"id":"paper-w4399180038","cat":"papers","name":"Results of esketamine administration in a Greek population; a case series","year":"2024","cit":0,"pfa":"Petros Fotiadis","psa":"Georgios Pagkalos","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4399180038","eid":"W4399180038"},{"id":"paper-w4230392956","cat":"papers","name":"Esketamine good choice in treatment-resistant depression","year":"2019","cit":0,"topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4230392956","eid":"W4230392956"},{"id":"paper-w4409279590","cat":"papers","name":"Antidepressant Potential of Ketamine’s Hydroxynorketamine Metabolites Mediated by Unique Actions on Synaptic Plasticity","year":"2025","cit":0,"pfa":"Todd D. Gould","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4409279590","eid":"W4409279590"},{"id":"paper-w4313165642","cat":"papers","name":"The use of ketamine and esketamine in psychiatry: now and beyond","year":"2022","cit":0,"pfa":"José Carlos Appolinário","psa":"Antônio Egídio Nardi","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"editorial","src":"https://openalex.org/W4313165642","eid":"W4313165642"},{"id":"paper-w4408924847","cat":"papers","name":"Disappointing Results for Esketamine as an Add-On After Acute Phase","year":"2025","cit":0,"pfa":"Mark Moran","ptype":"article","src":"https://openalex.org/W4408924847","eid":"W4408924847"},{"id":"paper-w4323521240","cat":"papers","name":"Decision letter for \"TRKB interaction with PSD95 is associated with latency of fluoxetine and 2R,6R‐hydroxynorketamine\"","year":"2022","cit":0,"ptype":"peer-review","src":"https://openalex.org/W4323521240","eid":"W4323521240"},{"id":"paper-w4393928594","cat":"papers","name":"Use of esketamine for tracheoscopic drug injection: a clinical study","year":"2024","cit":0,"pfa":"Xiaoming Zhao","psa":"Yuanyuan Yu","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4393928594","eid":"W4393928594"},{"id":"paper-w4200354325","cat":"papers","name":"P.0443 Esketamine, on the path of pain management","year":"2021","cit":0,"pfa":"M. Alves","psa":"Diana Durães","ptype":"article","src":"https://openalex.org/W4200354325","eid":"W4200354325"},{"id":"paper-w3174480521","cat":"papers","name":"[ESKETAMINE FOR TREATMENT RESISTANT DEPRESSION: RESEARCH AND RISK MANAGEMENT].","year":"2021","cit":0,"pfa":"Adi Danfi Marom","psa":"Paola Rosca","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3174480521","eid":"W3174480521"},{"id":"paper-w7155518539","cat":"papers","name":"Ketamine and Esketamine: Foundations, Patient Selection, and Algorithm Placement","year":"2026","cit":0,"pfa":"Samuel Wilkinson","topics":["Depression","Addiction"],"ptype":"report","src":"https://openalex.org/W7155518539","eid":"W7155518539"},{"id":"paper-w7212080318","cat":"papers","name":"551. Esketamine in neuropsychiatric long COVID: a retrospective analysis","year":"2026","cit":0,"pfa":"Noam Hartman","psa":"COVIKET Study Group","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7212080318","eid":"W7212080318"},{"id":"paper-w7120030665","cat":"papers","name":"RCT Dataset of Esketamine in Obstetric Anesthesia for Cesarean Section","year":"2026","cit":0,"pfa":"Lei, Xuan","topics":["Safety & adverse events"],"ptype":"dataset","src":"https://openalex.org/W7120030665","eid":"W7120030665"},{"id":"paper-w4323353933","cat":"papers","name":"Decision letter for \"TRKB interaction with PSD95 is associated with latency of fluoxetine and 2R,6R‐hydroxynorketamine\"","year":"2023","cit":0,"ptype":"peer-review","src":"https://openalex.org/W4323353933","eid":"W4323353933"},{"id":"paper-w7132444033","cat":"papers","name":"Progress in the Application of Esketamine During the Perioperative Period","year":"2026","cit":0,"pfa":"Wang JS","psa":"Wang L","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7132444033","eid":"W7132444033"},{"id":"paper-w7203540692","cat":"papers","name":"Lidocaine–esketamine analgesia after hepatectomy: a reply","year":"2026","cit":0,"pfa":"Yan Xu","psa":"Daniel I. Sessler","ptype":"article","src":"https://openalex.org/W7203540692","eid":"W7203540692"},{"id":"paper-w4394739016","cat":"papers","name":"Esketamine Is Superior to Quetiapine for Remission of Treatment-Resistant Depression.","year":"2024","cit":0,"pfa":"Mark H. Ebell","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4394739016","eid":"W4394739016"},{"id":"paper-w7163351844","cat":"papers","name":"Comment on: prophylactic esketamine to reduce postpartum depression in primiparae","year":"2026","cit":0,"pfa":"Jing Wang","psa":"Jun‐Ma Yu","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"letter","src":"https://openalex.org/W7163351844","eid":"W7163351844"},{"id":"paper-w7206202527","cat":"papers","name":"Combining CBT with esketamine effective in reducing suicidal ideation","year":"2026","cit":0,"ptype":"article","src":"https://openalex.org/W7206202527","eid":"W7206202527"},{"id":"paper-w4238234586","cat":"papers","name":"Esketamine in treatment-resistant depression: benefits at high cost","year":"2019","cit":0,"topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4238234586","eid":"W4238234586"},{"id":"paper-w4401935009","cat":"papers","name":"Tolerability of intranasal esketamine, a case series of 15 patients","year":"2024","cit":0,"pfa":"I. Álvarez Correa","psa":"Rosario de Arce Cordón","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4401935009","eid":"W4401935009"},{"id":"paper-w4281657533","cat":"papers","name":"M026 Performance characteristics of selected immunoassays for enantiomers of ketamine and hydroxynorketamine in urine samples","year":"2022","cit":0,"pfa":"S. Yu-Ting","psa":"L. Huei-Ru","ptype":"conference-abstract","src":"https://openalex.org/W4281657533","eid":"W4281657533"},{"id":"paper-w7172552062","cat":"papers","name":"Esketamine on postoperative acute pain in patients with colorectal cancer","year":"2026","cit":0,"pfa":"HE Lindai","psa":"LI Shenxiayu","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7172552062","eid":"W7172552062"},{"id":"paper-w4319459981","cat":"papers","name":"Ketamine and esketamine for treatment of mood disorders: literature review","year":"2023","cit":0,"pfa":"Austėja Rimkutė","psa":"Algirdas Musneckis","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4319459981","eid":"W4319459981"},{"id":"paper-w7171545315","cat":"papers","name":"Hepatic Safety of Ketamine and Esketamine for Treatment-Resistant Depression","year":"2026","cit":0,"pfa":"Balwinder Singh","psa":"Jennifer L. Vande Voort","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7171545315","eid":"W7171545315"},{"id":"paper-w4414179934","cat":"papers","name":"Resistant depressive disorder: electroconvulsive therapy versus esketamine","year":"2025","cit":0,"pfa":"M. P. Pando Fernández","psa":"M. E. Espinosa Muth","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W4414179934","eid":"W4414179934"},{"id":"paper-w7131936617","cat":"papers","name":"Esketamine use for treatment-resistant depression: a scoping review","year":"2024","cit":0,"pfa":"Claudia Esther Dueñas Rotta","psa":"Enrique Sabogal Cornejo","topics":["Depression","Reviews & meta-analyses"],"ptype":"dissertation","src":"https://openalex.org/W7131936617","eid":"W7131936617"},{"id":"paper-w7160377768","cat":"papers","name":"Esketamine for major depressive disorder: pharmacokinetics and toxicological considerations","year":"2026","cit":0,"pfa":"Shreya Vasudeva","psa":"Joshua Daniel Rosenblat","topics":["Depression","Dosing & pharmacology"],"ptype":"editorial","src":"https://openalex.org/W7160377768","eid":"W7160377768"},{"id":"paper-w7170190392","cat":"papers","name":"Dissociation and antidepressant response to subcutaneous esketamine: A clinical study","year":"2026","cit":0,"pfa":"Kaike Thiê da Costa Gonçalves","psa":"Nicole Leite Galvão Coelho","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7170190392","eid":"W7170190392"},{"id":"paper-w4414207666","cat":"papers","name":"Peripartum administration of esketamine: a way to prevent postpartum depression?","year":"2025","cit":0,"pfa":"M. Del Valle Martín","psa":"C. Mouriño Sánchez","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4414207666","eid":"W4414207666"},{"id":"paper-w4390222294","cat":"papers","name":"Intranasal esketamine and time-to-response in treatment of resistant depression","year":"2023","cit":0,"pfa":"A. Madrazo Maza","psa":"Luis Osa Fernández","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4390222294","eid":"W4390222294"},{"id":"paper-w7155487889","cat":"papers","name":"The role of cytochrome P450 polymorphisms in the pharmacokinetics of oral esketamine","year":"2026","cit":0,"pfa":"Daniël T. Coerts","psa":"Jens H. van Dalfsen","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7155487889","eid":"W7155487889"},{"id":"paper-w4415871328","cat":"papers","name":"Intranasal esketamine for depression: Transforming psychiatric treatment or a temporary solution?","year":"2025","cit":0,"pfa":"Nicoleta Cartas","psa":"Alexandru Florin Petriuc","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4415871328","eid":"W4415871328"},{"id":"paper-w7214294463","cat":"papers","name":"TREATMENT-RESISTANT DEPRESSION: KETAMINE, ESKETAMINE, AND EMERGING NEUROSTIMULATION MODALITIES","year":"2026","cit":0,"pfa":"Zebiniso Choriyeva","psa":"Nuriddin Kenjayev","topics":["Depression","Reviews & meta-analyses"],"ptype":"conference-paper","src":"https://openalex.org/W7214294463","eid":"W7214294463"},{"id":"paper-w2830139911","cat":"papers","name":"Intranasal Esketamine Reduces Depression and Suicidality, Modestly and Briefly","year":"2018","cit":0,"pfa":"Joel Yager","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2830139911","eid":"W2830139911"},{"id":"paper-w7130925365","cat":"papers","name":"Esketamine Cognition: SR and MA of Preclinical and Clinical Studies","year":"2026","cit":0,"pfa":"Mohamed ElSayed","psa":"Heather B. Blunt","topics":["Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7130925365","eid":"W7130925365"},{"id":"paper-w4307461367","cat":"papers","name":"Agomelatine/aripiprazole/brexpiprazole/esketamine/ketamine/mirtazapine/vortioxetine","year":"2022","cit":0,"ptype":"article","src":"https://openalex.org/W4307461367","eid":"W4307461367"},{"id":"paper-w7130728322","cat":"papers","name":"Esketamine: A Possible Adjunctive Therapy for Treatment Resistant Depression","year":"2025","cit":0,"pfa":"Annie Huang","psa":"Catherine A. Yeager","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7130728322","eid":"W7130728322"},{"id":"paper-w7168175560","cat":"papers","name":"Esketamine–propofol anesthesia for elective cardioversion in atrial fibrillation","year":"2026","cit":0,"pfa":"Georges Mion","psa":"Charles Marc Samama","ptype":"article","src":"https://openalex.org/W7168175560","eid":"W7168175560"},{"id":"paper-w7213470221","cat":"papers","name":"Esketamine for treatment of depression in Huntington's disease: A case report","year":"2026","cit":0,"pfa":"Carsten Saft","psa":"Georg Juckel","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7213470221","eid":"W7213470221"},{"id":"paper-w3036060670","cat":"papers","name":"Long-term treatment of depression with intranasal esketamine: Is it justified?","year":"2020","cit":0,"pfa":"Dušan Kolar","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W3036060670","eid":"W3036060670"},{"id":"paper-w7170703454","cat":"papers","name":"Esketamine in Treatment-Resistant Depression: Clinical and Translational Perspectives","year":"2026","cit":0,"pfa":"Zofia Śledzikowska","psa":"Napoleon Waszkiewicz","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7170703454","eid":"W7170703454"},{"id":"paper-w7154403741","cat":"papers","name":"Research Progress on the Application of Esketamine as an Adjuvant in Peripheral Nerve Block","year":"2026","cit":0,"pfa":"Li Yang","ptype":"article","src":"https://openalex.org/W7154403741","eid":"W7154403741"},{"id":"paper-w3129945682","cat":"papers","name":"精神科領域の用語解説 (R)-ketamine(Arketamine)","year":"2018","cit":0,"pfa":"謙二 橋本","ptype":"article","src":"https://openalex.org/W3129945682","eid":"W3129945682"},{"id":"paper-w4404964775","cat":"papers","name":"Use of Esketamine in the Treatment of Migraine Resistant to Standard Therapy","year":"2024","cit":0,"pfa":"Điđi Delalić","psa":"Višnja Nesek Adam","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4404964775","eid":"W4404964775"},{"id":"paper-w4313200902","cat":"papers","name":"Effects of repeated intravenous esketamine administration on affective biases","year":"2022","cit":0,"pfa":"A. Malik","psa":"Christine Reif-Leonhard","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4313200902","eid":"W4313200902"},{"id":"paper-w4404469951","cat":"papers","name":"Esketamine and Postoperative Delirium: Effect of Sedatives and Nonopioid analgesics","year":"2024","cit":0,"pfa":"Fu‐Shan Xue","psa":"Xiao-Chun Zheng","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4404469951","eid":"W4404469951"},{"id":"paper-w7165478664","cat":"papers","name":"Effects of Esketamine on EEG temporal dynamics in patients with depression","year":"2026","cit":0,"pfa":"Verina Guirguis","topics":["Depression","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7165478664","eid":"W7165478664"},{"id":"paper-w4235111699","cat":"papers","name":"Safety results favorable for esketamine nasal spray for depression","year":"2020","cit":0,"topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4235111699","eid":"W4235111699"},{"id":"paper-w7171976777","cat":"papers","name":"Reduction of Suicidality and Depressive Symptoms with Esketamine: Focus on Gender Differences","year":"2026","cit":0,"pfa":"V. Martiadis","psa":"D. De Berardis","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7171976777","eid":"W7171976777"},{"id":"paper-w4394983757","cat":"papers","name":"“Intranasal esketamine monotherapy for ultra-resistant catatonia: A case report”","year":"2024","cit":0,"pfa":"Marcos Gómez‐Revuelta","psa":"Javier Vázquez-Bourgón","ptype":"article","src":"https://openalex.org/W4394983757","eid":"W4394983757"},{"id":"paper-w7212143052","cat":"papers","name":"Esketamine-gids: farmacologie, indicaties, doseringsrichtlijnen en bijwerkingen","year":"2025","cit":0,"pfa":"Sebastián Malleza","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"report","src":"https://openalex.org/W7212143052","eid":"W7212143052"},{"id":"paper-w7117974178","cat":"papers","name":"Subcutaneous esketamine for treatment-resistant bipolar and unipolar depression","year":"2026","cit":0,"pfa":"R. Simonini Delfino","psa":"R. Onofre Pereira de Souza Junior","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7117974178","eid":"W7117974178"},{"id":"paper-w7152987722","cat":"papers","name":"Effects of Esketamine on Postoperative Hospital Anxiety and Depression Scale Scores","year":"2026","cit":0,"pfa":"lindai he","topics":["Depression","Anxiety & end-of-life"],"ptype":"dataset","src":"https://openalex.org/W7152987722","eid":"W7152987722"},{"id":"paper-w7214233695","cat":"papers","name":"Research progress on the organ- protective effects of esketamine in the perioperative period","year":"2026","cit":0,"pfa":"LU Yapeng, WANG Yingbin, LU Wensheng","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7214233695","eid":"W7214233695"},{"id":"paper-w7117985960","cat":"papers","name":"Esketamine for acute reduction of suicidal ideation in depression: a literature review","year":"2026","cit":0,"pfa":"B. Goitia Aritxa","psa":"I. Espinosa San Miguel","topics":["Depression","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7117985960","eid":"W7117985960"},{"id":"paper-w3213046246","cat":"papers","name":"Are we repeating mistakes of the past? A review of the evidence for esketamine – CORRIGENDUM","year":"2021","cit":0,"pfa":"Mark Abie Horowitz","psa":"Joanna Moncrieff","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"erratum","src":"https://openalex.org/W3213046246","eid":"W3213046246"},{"id":"paper-w4409945946","cat":"papers","name":"Review questions sustained efficacy of esketamine in treatment‐resistant depression","year":"2025","cit":0,"topics":["Depression","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4409945946","eid":"W4409945946"},{"id":"paper-w7160848034","cat":"papers","name":"The Effects of Ketamine and (2R,6R)-Hydroxynorketamine on Oxycodone Withdrawal and Seeking Behaviors (Abstract ID: 223701)","year":"2026","cit":0,"pfa":"Michael Lehane","psa":"Gregory C. Sartor","ptype":"article","src":"https://openalex.org/W7160848034","eid":"W7160848034"},{"id":"paper-w4396850122","cat":"papers","name":"Reversal of Mechanical Hypersensitivity by 2R,6R-Hydroxynorketamine by Activation of Group 2 Metabotropic Glutamate Receptors","year":"2024","cit":0,"pfa":"Irwin Lucki","psa":"Caroline A. Browne","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4396850122","eid":"W4396850122"},{"id":"paper-w4391625493","cat":"papers","name":"Nasaal esketamine bij een therapieresistente depressie: een doorbraak?","year":"2019","cit":0,"pfa":"M FINOULST","psa":"Koen Demyttenaere","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4391625493","eid":"W4391625493"},{"id":"paper-w4232257176","cat":"papers","name":"Esketamine nasal spray too costly for treatment-resistant depression","year":"2020","cit":0,"topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4232257176","eid":"W4232257176"},{"id":"paper-w4405621829","cat":"papers","name":"No significant effects of intranasal esketamine on functional connectome fingerprints","year":"2024","cit":0,"pfa":"Gregor Dörl","psa":"Rupert R. Lanzenberger","ptype":"article","src":"https://openalex.org/W4405621829","eid":"W4405621829"},{"id":"paper-w4323354070","cat":"papers","name":"Author response for \"TRKB interaction with PSD95 is associated with latency of fluoxetine and 2R,6R‐hydroxynorketamine\"","year":"2023","cit":0,"pfa":"Senem Merve Fred","psa":"Eero Ċastrén","ptype":"peer-review","src":"https://openalex.org/W4323354070","eid":"W4323354070"},{"id":"paper-w4400929284","cat":"papers","name":"Research Progress of Esketamine in Improving Perioperative Depression and Sleep Quality","year":"2024","cit":0,"pfa":"永旭 高","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4400929284","eid":"W4400929284"},{"id":"paper-w7172096182","cat":"papers","name":"Emerging Clinical Applications of Ketamine and Esketamine Across Psychiatric Disorders.","year":"2026","cit":0,"pfa":"Rachel Fremont","psa":"Adriana Feder","topics":["Depression","Anxiety & end-of-life","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7172096182","eid":"W7172096182"},{"id":"paper-w7143303788","cat":"papers","name":"Effects of Esketamine on Postoperative Hospital Anxiety and Depression Scale Scores","year":"2026","cit":0,"pfa":"Lindai He","topics":["Depression","Anxiety & end-of-life"],"ptype":"dataset","src":"https://openalex.org/W7143303788","eid":"W7143303788"},{"id":"paper-w7143316027","cat":"papers","name":"Effects of Esketamine on Postoperative Hospital Anxiety and Depression Scale Scores","year":"2026","cit":0,"pfa":"Lindai He","topics":["Depression","Anxiety & end-of-life"],"ptype":"dataset","src":"https://openalex.org/W7143316027","eid":"W7143316027"},{"id":"paper-w7151925301","cat":"papers","name":"Effects of Esketamine on Postoperative Hospital Anxiety and Depression Scale Scores","year":"2026","cit":0,"pfa":"lindai he","topics":["Depression","Anxiety & end-of-life"],"ptype":"dataset","src":"https://openalex.org/W7151925301","eid":"W7151925301"},{"id":"paper-w4313199738","cat":"papers","name":"Intranasal esketamine – a literature review on long-term efficacy and safety","year":"2022","cit":0,"pfa":"J. Herrera Imbroda","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4313199738","eid":"W4313199738"},{"id":"paper-w7139620489","cat":"papers","name":"Exploring the role of Esketamine nasal spray in treatment-resistant depression","year":"2025","cit":0,"pfa":"Hasbun Nahar Anika","topics":["Depression"],"ptype":"dissertation","src":"https://openalex.org/W7139620489","eid":"W7139620489"},{"id":"paper-w7126387228","cat":"papers","name":"Application of subanesthetic doses of esketamine in pediatric patients undergoing adenotonsillectomy","year":"2026","cit":0,"pfa":"Zhiming Lan","psa":"Jie Yao","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7126387228","eid":"W7126387228"},{"id":"paper-w7203728462","cat":"papers","name":"Esketamine and General Anesthetics for Depression: Clinical Relevance and Underlying Mechanisms","year":"2026","cit":0,"pfa":"Trevor Blackstock","psa":"Alan D. Kaye","topics":["Depression","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W7203728462","eid":"W7203728462"},{"id":"paper-w7213548695","cat":"papers","name":"Esketamine and Tracheal Extubation Time: Are the Meta‐Analytic Estimates Reliable?","year":"2026","cit":0,"pfa":"Jo-Hsin Wu","psa":"Chia‐Hao Ho","ptype":"article","src":"https://openalex.org/W7213548695","eid":"W7213548695"},{"id":"paper-w7130936993","cat":"papers","name":"Esketamine for depression: should the horizon be expanded to posttraumatic stress disorder?","year":"2026","cit":0,"pfa":"Maud Rothärmel","psa":"Éric Bui","topics":["Depression","PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W7130936993","eid":"W7130936993"},{"id":"paper-w2946834064","cat":"papers","name":"Esketamine, Antidepressant Combo Safe, More Effective Than Placebo","year":"2019","cit":0,"pfa":"Mark Moran","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2946834064","eid":"W2946834064"},{"id":"paper-w4385343084","cat":"papers","name":"Sustained improvement in depression seen in study of esketamine nasal spray","year":"2023","cit":0,"topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4385343084","eid":"W4385343084"},{"id":"paper-w7143295741","cat":"papers","name":"Effects of Esketamine on Postoperative Hospital Anxiety and Depression Scale Scores","year":"2026","cit":0,"pfa":"Lindai He","topics":["Depression","Anxiety & end-of-life"],"ptype":"dataset","src":"https://openalex.org/W7143295741","eid":"W7143295741"},{"id":"paper-w7211851050","cat":"papers","name":"Patient-Reported Outcomes of Effectiveness of Esketamine for Treatment-Resistant Depression","year":"2026","cit":0,"pfa":"Erica L Marino","topics":["Depression"],"ptype":"dissertation","src":"https://openalex.org/W7211851050","eid":"W7211851050"},{"id":"paper-w4417153294","cat":"papers","name":"Esketamine and Quality of Life Improvement in Treatment-Resistant Depression Patients","year":"2025","cit":0,"pfa":"Matteo Lupi","psa":"Giovanni Martinotti","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4417153294","eid":"W4417153294"},{"id":"paper-w4414377185","cat":"papers","name":"Esketamine: significant age-related differences in risk of psychiatric AEs","year":"2025","cit":0,"topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4414377185","eid":"W4414377185"},{"id":"paper-w7161869138","cat":"papers","name":"Esketamine for Suicidality and Self-Harm in TRD: Exploring Gender Differences","year":"2026","cit":0,"pfa":"F. Raffone","psa":"V. Martiadis","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7161869138","eid":"W7161869138"},{"id":"paper-w7171803993","cat":"papers","name":"Intranasal esketamine for ECT-refractory bipolar depression: a case report","year":"2026","cit":0,"pfa":"Muhammad Abbas","psa":"Max Garris","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7171803993","eid":"W7171803993"},{"id":"paper-w2954845616","cat":"papers","name":"Esketamine Maintenance After Acute Treatment for Patients Not Responding to Antidepressants","year":"2019","cit":0,"pfa":"Steven L. Dubovsky","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2954845616","eid":"W2954845616"},{"id":"paper-w4406934366","cat":"papers","name":"Analysis of trial confirms efficacy of esketamine nasal spray in TRD","year":"2025","cit":0,"topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4406934366","eid":"W4406934366"},{"id":"paper-w7164586203","cat":"papers","name":"Esketamine linked to remission across six TRD clinical trials","year":"2026","cit":0,"pfa":"Valerie A. Canady","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7164586203","eid":"W7164586203"},{"id":"paper-w7141088102","cat":"papers","name":"Esketamine Guide: Pharmacology, Indications, Dosing Guidelines and Adverse Effects","year":"2025","cit":0,"pfa":"Sebastián Malleza","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"report","src":"https://openalex.org/W7141088102","eid":"W7141088102"},{"id":"paper-w4243870291","cat":"papers","name":"Esketamine nasal spray effective for rapid improvement of depressive symptoms","year":"2019","cit":0,"topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4243870291","eid":"W4243870291"},{"id":"paper-w7171630060","cat":"papers","name":"THE IMPACT OF INTRANASAL ESKETAMINE ON TREATMENT-RESISTANT DEPRESSION: A SYSTEMATIC REVIEW","year":"2026","cit":0,"pfa":"Wojciech Kotlarski","psa":"Emil Sergejuk","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W7171630060","eid":"W7171630060"},{"id":"paper-w4389774800","cat":"papers","name":"Replacement of Opioid-Based Anesthesia by Epidural Esketamine: Is It a Real Alternative?","year":"2023","cit":0,"pfa":"Michael Schäfer","psa":"Sascha Treskatsch","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W4389774800","eid":"W4389774800"},{"id":"paper-w4414639987","cat":"papers","name":"Oral Racemic Ketamine and Esketamine: Emerging Indications and Future Directions","year":"2025","cit":0,"pfa":"Juan Alberto Rodriguez-Arango","psa":"Wendy Fernandez-Villarreal","ptype":"book-chapter","src":"https://openalex.org/W4414639987","eid":"W4414639987"},{"id":"paper-w4413100991","cat":"papers","name":"Methodological and reporting considerations for the trial on dexmedetomidine-assisted esketamine in hysterectomy","year":"2025","cit":0,"pfa":"Jhuo Hong","psa":"Ming‐Hui Hung","ptype":"article","src":"https://openalex.org/W4413100991","eid":"W4413100991"},{"id":"paper-w7161073775","cat":"papers","name":"Esketamine Preserves Network Connectivity and Promotes Recovery in Consciousness Disorders","year":"2026","cit":0,"pfa":"Xuewei Qin","psa":"Xiaoli Li","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7161073775","eid":"W7161073775"},{"id":"paper-w3177518462","cat":"papers","name":"精神科領域の用語解説(R)-ketamine(Arketamine)","year":"2018","cit":0,"pfa":"橋本謙二","ptype":"article","src":"https://openalex.org/W3177518462","eid":"W3177518462"},{"id":"paper-w4414818821","cat":"papers","name":"The effects of low-dose ketamine and (2R,6R)-Hydroxynorketamine on affective behaviors associated with protracted oxycodone withdrawal","year":"2025","cit":0,"pfa":"Michael J. Lehane","psa":"Gregory C. Sartor","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4414818821","eid":"W4414818821"},{"id":"paper-w4230344172","cat":"papers","name":"Esketamine nasal spray shows rapid effects in suicidal patients","year":"2021","cit":0,"ptype":"article","src":"https://openalex.org/W4230344172","eid":"W4230344172"},{"id":"paper-w7153241785","cat":"papers","name":"Effects of Esketamine on Postoperative Hospital Anxiety and Depression Scale Scores","year":"2026","cit":0,"pfa":"lindai he","topics":["Depression","Anxiety & end-of-life"],"ptype":"dataset","src":"https://openalex.org/W7153241785","eid":"W7153241785"},{"id":"paper-w4311880933","cat":"papers","name":"NICE does not recommend esketamine spray for treatment-resistant depression","year":"2022","cit":0,"pfa":"Steve Chaplin","topics":["Depression"],"ptype":"dataset","src":"https://openalex.org/W4311880933","eid":"W4311880933"},{"id":"paper-w7143401672","cat":"papers","name":"Effects of Esketamine on Postoperative Hospital Anxiety and Depression Scale Scores","year":"2026","cit":0,"pfa":"Lindai He","topics":["Depression","Anxiety & end-of-life"],"ptype":"dataset","src":"https://openalex.org/W7143401672","eid":"W7143401672"},{"id":"paper-w4404829444","cat":"papers","name":"Use of Esketamine in the Treatment of Depression: A Systematic Review of Clinical Evidence","year":"2024","cit":0,"pfa":"Cristianne Confessor Castilho Lopes","psa":"Gérson Luiz de Macedo","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4404829444","eid":"W4404829444"},{"id":"paper-w7172509529","cat":"papers","name":"Progress on the perioperative application of subanesthetic dose of esketamine in elderly patients","year":"2026","cit":0,"pfa":"WANG Dan","psa":"LI Na","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7172509529","eid":"W7172509529"},{"id":"paper-w3022308972","cat":"papers","name":"Ketamine Increases vmPFC Activity: Effects of (R)- and (S)-Stereoisomers and (2R,6R) Hydroxynorketamine Metabolite","year":"2020","cit":0,"pfa":"Brendan D. Hare","psa":"Ronald S. Duman","ptype":"article","src":"https://openalex.org/W3022308972","eid":"W3022308972"},{"id":"paper-w7167746742","cat":"papers","name":"[A Practical aspects of managing treatment-resistant depression - with a focus on esketamine].","year":"2025","cit":0,"pfa":"Csilla Bolyós","psa":"János Réthelyi","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7167746742","eid":"W7167746742"},{"id":"paper-w3163771524","cat":"papers","name":"Esketamine in the management of treatment-resistant depression : what prospects for 2021?","year":"2021","cit":0,"pfa":"Matthieu Hein","psa":"Anais Mungo","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W3163771524","eid":"W3163771524"},{"id":"paper-w7117990424","cat":"papers","name":"Esketamine for suicidality and self-harm in TRD: exploring gender differences","year":"2026","cit":0,"pfa":"F. Raffone","psa":"V. Martiadis","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7117990424","eid":"W7117990424"},{"id":"paper-w4389395603","cat":"papers","name":"Esketamine augmentation superior to quetiapine augmentation in treatment‐resistant depression","year":"2023","cit":0,"topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4389395603","eid":"W4389395603"},{"id":"paper-w7169827669","cat":"papers","name":"Ketamine and Esketamine Suicidal Ideation Studies — Structured Evidence Database","year":"2026","cit":0,"pfa":"Michael Alvear","topics":["Reviews & meta-analyses"],"ptype":"dataset","src":"https://openalex.org/W7169827669","eid":"W7169827669"},{"id":"paper-w2801978223","cat":"papers","name":"Intranasal Esketamine Found to Rapidly Reduce Symptoms of Depression, Suicidality","year":"2018","cit":0,"pfa":"Mark Moran","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W2801978223","eid":"W2801978223"},{"id":"paper-w4408376235","cat":"papers","name":"4CPS-042 Experience with intranasal esketamine in treatment-resistant depression","year":"2025","cit":0,"pfa":"D Anguita Domingo","psa":"MQ Gorgas Torner","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"conference-paper","src":"https://openalex.org/W4408376235","eid":"W4408376235"},{"id":"paper-w3211451490","cat":"papers","name":"Esketamine, a new treatment for resistant depression: a systematic review of the literature","year":"2021","cit":0,"pfa":"Mercedes Valtueña García","psa":"Laura Lago García","topics":["Depression","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W3211451490","eid":"W3211451490"},{"id":"paper-w4401920429","cat":"papers","name":"Esketamine new tool for resistant depressive disorder. About a case","year":"2024","cit":0,"pfa":"Mercedes Valverde Barea","psa":"A. España Osuna","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4401920429","eid":"W4401920429"},{"id":"paper-w4404529983","cat":"papers","name":"Single Postpartum Dose of Esketamine May Reduce Postpartum Depression.","year":"2024","cit":0,"pfa":"Allen F. Shaughnessy","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4404529983","eid":"W4404529983"},{"id":"paper-w4405684350","cat":"papers","name":"Effects of Ketamine and Esketamine on Cognitive Functions in Treatment-Resistant Depression","year":"2024","cit":0,"pfa":"Mahir Mutlu","psa":"Emre SUNAY","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4405684350","eid":"W4405684350"},{"id":"paper-w7214401863","cat":"papers","name":"TREATMENT-RESISTANT DEPRESSION: KETAMINE, ESKETAMINE, AND EMERGING NEUROSTIMULATION MODALITIES","year":"2026","cit":0,"pfa":"Zebiniso Choriyeva","psa":"Nuriddin Kenjayev","topics":["Depression","Reviews & meta-analyses"],"ptype":"conference-paper","src":"https://openalex.org/W7214401863","eid":"W7214401863"},{"id":"paper-w7202277497","cat":"papers","name":"Esketamine for The Treatment of Complex PTSD and TreatmentResistant Depression: A Case Report","year":"2026","cit":0,"pfa":"Olivola Miriam","psa":"Migliarese Giovanni","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7202277497","eid":"W7202277497"},{"id":"paper-w4414269267","cat":"papers","name":"Esketamine for Treatment-Resistant Depression: A Case Series and Literature Review","year":"2025","cit":0,"pfa":"Muhammad Abbas","psa":"Talitha West","topics":["Depression","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4414269267","eid":"W4414269267"},{"id":"paper-w4407260880","cat":"papers","name":"The Application of Esketamine Combined with Remimazolam in Hysteroscopic Surgery of Obese Patients","year":"2025","cit":0,"pfa":"英俊 栾","ptype":"article","src":"https://openalex.org/W4407260880","eid":"W4407260880"},{"id":"paper-w4241303003","cat":"papers","name":"Esketamine nasal spray effective for rapid improvement of depressive symptoms","year":"2019","cit":0,"topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4241303003","eid":"W4241303003"},{"id":"paper-w2976768852","cat":"papers","name":"Intranasal esketamine in treatment-resistant depression: a profile of its use","year":"2019","cit":0,"pfa":"Lesley J. Scott","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2976768852","eid":"W2976768852"},{"id":"paper-w4414392074","cat":"papers","name":"Clinical application and research progress of esketamine in pediatric limb fractures","year":"2025","cit":0,"pfa":"Wenwen Zhao","psa":"Jinge Pan","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4414392074","eid":"W4414392074"},{"id":"paper-w4405185758","cat":"papers","name":"Perioperative administration of esketamine during cesarean section is a double-edged sword","year":"2024","cit":0,"pfa":"Takahiko Nagamine","ptype":"article","src":"https://openalex.org/W4405185758","eid":"W4405185758"},{"id":"paper-w7167056401","cat":"papers","name":"Esketamine combined with intravenous general anesthesia for breast cancer surgery","year":"2026","cit":0,"pfa":"Yan Gao","psa":"Qing-hui Wang","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7167056401","eid":"W7167056401"},{"id":"paper-w4313199446","cat":"papers","name":"Intranasal esketamine in treatment resistant depression: a Spanish multicentric study","year":"2022","cit":0,"pfa":"Alejandro Fuertes-Sáiz","psa":"C. Sanchez Miñano","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4313199446","eid":"W4313199446"},{"id":"paper-w7214062646","cat":"papers","name":"The Era of Rapid-Acting Antidepressants: Clinical Insights Into Ketamine, Esketamine, and Scopolamine","year":"2026","cit":0,"pfa":"Jozélio Freire de Carvalho","psa":"Eduardo Pondé de Sena","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7214062646","eid":"W7214062646"},{"id":"paper-w4379094579","cat":"papers","name":"Current research hotspot and future development trend of esketamine: A bibliometric analysis","year":"2023","cit":0,"pfa":"Xian Li","psa":"Zhiyong Gao","ptype":"article","src":"https://openalex.org/W4379094579","eid":"W4379094579"},{"id":"paper-w7166504032","cat":"papers","name":"Meta analytic evidence on esketamine in major depressive disorder: An umbrella review","year":"2026","cit":0,"pfa":"Safiye Zeynep Tatlı","psa":"Vesile Şentürk Cankorur","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7166504032","eid":"W7166504032"},{"id":"paper-w4387365095","cat":"papers","name":"Esketamine outperforms quetiapine for treatment-resistant depression, study finds","year":"2023","cit":0,"topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4387365095","eid":"W4387365095"},{"id":"paper-w7113106668","cat":"papers","name":"Association between major cardiovascular events and esketamine: A pharmacovigilance study","year":"2025","cit":0,"pfa":"Antoine Yrondi","psa":"Florian Naudet","topics":["Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W7113106668","eid":"W7113106668"},{"id":"paper-w7125228597","cat":"papers","name":"ATP-binding cassette transporter polymorphisms and the pharmacokinetics of oral esketamine","year":"2025","cit":0,"pfa":"Jerome Oude Nijhuis","psa":"Wim J. Tamminga","topics":["Depression","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7125228597","eid":"W7125228597"},{"id":"paper-w4408932791","cat":"papers","name":"Moving Past Hydroxynorketamine: Design and Testing of HNK Analogs for the Treatment of Neuropathic Pain (Abstract ID: 168378)","year":"2025","cit":0,"pfa":"Stefania Volpe","psa":"Grzegorz Zieliński","ptype":"article","src":"https://openalex.org/W4408932791","eid":"W4408932791"},{"id":"paper-w4401169076","cat":"papers","name":"Long-term stability of esketamine in polypropylene syringes at 5 ± 3°C","year":"2024","cit":0,"pfa":"Amélie Kinet-Poleur","psa":"Mélanie Closset","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4401169076","eid":"W4401169076"},{"id":"paper-w4411142696","cat":"papers","name":"The Impact of Esketamine on Depression Treatment: A Bibliometric Analysis of Two Decades of Research","year":"2025","cit":0,"pfa":"Lan Lan","psa":"X Zhang","topics":["Depression"],"ptype":"preprint","src":"https://openalex.org/W4411142696","eid":"W4411142696"},{"id":"paper-w7205010749","cat":"papers","name":"Ketamine and esketamine for treatment-resistant depression: A systematic review of published studies","year":"2026","cit":0,"pfa":"Julia Rogała","psa":"Mateusz Szabat","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W7205010749","eid":"W7205010749"},{"id":"paper-w4405918772","cat":"papers","name":"Repeated intravenous infusions of esketamine in inpatients with bipolar depression: A retrospective real-world study","year":"2024","cit":0,"pfa":"Naima Guhad Shire","psa":"Steinn Steingrímsson","topics":["Depression","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4405918772","eid":"W4405918772"},{"id":"paper-w4385670253","cat":"papers","name":"Gender differences in response and remission rates among patients receiving esketamine","year":"2023","cit":0,"pfa":"A. T. Guterman","psa":"A. Z. Gershi","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4385670253","eid":"W4385670253"},{"id":"paper-w7165038662","cat":"papers","name":"Sevoflurane–esketamine balanced anesthesia for fiberoptic bronchoscopy in obese pediatric patients","year":"2026","cit":0,"pfa":"Xue Zhang","psa":"Yilin zhao","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7165038662","eid":"W7165038662"},{"id":"paper-w4414146806","cat":"papers","name":"Long‐term study confirms safety of esketamine for treatment‐resistant depression","year":"2025","cit":0,"topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4414146806","eid":"W4414146806"},{"id":"paper-w4405636122","cat":"papers","name":"Maintenance of response to intranasal esketamine 10 months after completing treatment","year":"2024","cit":0,"pfa":"S. Benavente López","psa":"E. Baca García","ptype":"article","src":"https://openalex.org/W4405636122","eid":"W4405636122"},{"id":"paper-w4416781265","cat":"papers","name":"Post‐approval analysis finds favorable safety for esketamine nasal spray","year":"2025","cit":0,"topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4416781265","eid":"W4416781265"},{"id":"paper-w7211916365","cat":"papers","name":"New treatments for treatment-resistant depression: esketamine controversies – a narrative review","year":"2026","cit":0,"pfa":"Maj Vinberg","topics":["Depression","Reviews & meta-analyses","Policy & ethics"],"ptype":"review","src":"https://openalex.org/W7211916365","eid":"W7211916365"},{"id":"paper-w4410145624","cat":"papers","name":"Efficacy and Safety of Different Esketamine Doses Combined with Propofol in Gastrointestinal Endoscopy","year":"2025","cit":0,"pfa":"Yu-Hang Shou","psa":"Jia Han","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4410145624","eid":"W4410145624"},{"id":"paper-w7117963024","cat":"papers","name":"Exploring respiratory rate as a biomarker for esketamine response in treatment-resistant depression","year":"2026","cit":0,"pfa":"C. Valenzuela-Pascual","psa":"Diego Hidalgo‐Mazzei","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7117963024","eid":"W7117963024"},{"id":"paper-w7214103735","cat":"papers","name":"Feasibility and tolerability of virtual reality during esketamine treatment: A pilot study","year":"2026","cit":0,"pfa":"Erin Curran","psa":"Sina Nikayin","ptype":"article","src":"https://openalex.org/W7214103735","eid":"W7214103735"},{"id":"paper-w4407265096","cat":"papers","name":"(2R, 6R)-hydroxynorketamine alleviates postictal depression induced by pilocarpine through modulating LRP4 expression in hippocampal astrocytes","year":"2025","cit":0,"pfa":"Meiying Zhang","psa":"Yu Zheng","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W4407265096","eid":"W4407265096"},{"id":"paper-w4416112708","cat":"papers","name":"ED95 of esketamine for reducing preoperative anxiety in children of different ages","year":"2025","cit":0,"pfa":"Xuming Zhu","psa":"Leting Ji","topics":["Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W4416112708","eid":"W4416112708"},{"id":"paper-w4408207235","cat":"papers","name":"Application Progress of Esketamine in Non-Endotracheal Intubation General Anesthesia Surgery","year":"2025","cit":0,"pfa":"欣悦 王","ptype":"article","src":"https://openalex.org/W4408207235","eid":"W4408207235"},{"id":"paper-w4400083719","cat":"papers","name":"Low dose of esketamine after childbirth helps mothers at risk of depression","year":"2024","cit":0,"topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4400083719","eid":"W4400083719"},{"id":"paper-w4224979654","cat":"papers","name":"P390. Synaptic Mechanisms by Which (2R,6R)-Hydroxynorketamine Promotes Hippocampal-Dependent Plasticity and Behavior","year":"2022","cit":0,"pfa":"Lace Marie Riggs","psa":"Todd D. Gould","topics":["Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W4224979654","eid":"W4224979654"},{"id":"paper-w4251498311","cat":"papers","name":"Preliminary study finds intranasal esketamine benefits patients at risk of suicide","year":"2018","cit":0,"topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4251498311","eid":"W4251498311"},{"id":"paper-w4415166016","cat":"papers","name":"Use of Esketamine NS in Treatment-Resistant Depression/Gambling Disorder Comorbidity","year":"2025","cit":0,"pfa":"Matteo Lupi","psa":"Giovanni Martinotti","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4415166016","eid":"W4415166016"},{"id":"paper-w7112975180","cat":"papers","name":"Dissociation in esketamine and ketamine treatment in adults- a systematic review and meta-analysis","year":"2025","cit":0,"pfa":"Andrzej Jakubczyk","psa":"Anna Dunalska","topics":["Depression","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7112975180","eid":"W7112975180"},{"id":"paper-w4321597672","cat":"papers","name":"Effect of Pain and Inflammatory Response in Patients Undergoing Cesarean Section with Esketamine","year":"2023","cit":0,"pfa":"克军 董","ptype":"article","src":"https://openalex.org/W4321597672","eid":"W4321597672"},{"id":"paper-w4248918322","cat":"papers","name":"Esketamine nasal spray offers rapid improvement in treatment‐resistant depression","year":"2019","cit":0,"topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4248918322","eid":"W4248918322"},{"id":"paper-w4206356771","cat":"papers","name":"Longer course of esketamine nasal spray benefits initial treatment nonresponders","year":"2021","cit":0,"topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4206356771","eid":"W4206356771"},{"id":"paper-w7121250670","cat":"papers","name":"Esketamine and postoperative cognitive function in sleep-deprived colorectal cancer patients","year":"2026","cit":0,"pfa":"X. Y. Zhang","psa":"Jie Yao","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7121250670","eid":"W7121250670"},{"id":"paper-w4412896833","cat":"papers","name":"Ketamine and Esketamine for the Treatment of Refractory Status Epilepticus Induced by Organophosphorus Compounds","year":"2025","cit":0,"pfa":"Frédéric Dorandeu","psa":"Grégory Dal Bo","ptype":"book-chapter","src":"https://openalex.org/W4412896833","eid":"W4412896833"},{"id":"paper-w7132363162","cat":"papers","name":"Esketamine therapy in a young patient with treatment-resistant depression: a case report","year":"2024","cit":0,"pfa":"Martyna Janutytė","psa":"Paulina Petraitytė","topics":["Depression"],"ptype":"conference-paper","src":"https://openalex.org/W7132363162","eid":"W7132363162"},{"id":"paper-w4405208147","cat":"papers","name":"Efficacy of esketamine for perinatal depression: a systematic review and meta-analysis – CORRIGENDUM","year":"2024","cit":0,"pfa":"Sabrina Wong","psa":"Roger S. McIntyre","topics":["Depression","Reviews & meta-analyses"],"ptype":"erratum","src":"https://openalex.org/W4405208147","eid":"W4405208147"},{"id":"paper-w4410939542","cat":"papers","name":"Effects of Esketamine on Postoperative Depression in Elderly Patients Undergoing Joint Replacement","year":"2025","cit":0,"pfa":"Li Mao","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4410939542","eid":"W4410939542"},{"id":"paper-w4409948482","cat":"papers","name":"Effects and mechanisms of esketamine on depression by targeting gut microbiota: A narrative review","year":"2025","cit":0,"pfa":"Jiaqi Liu","psa":"Chen Zhou","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W4409948482","eid":"W4409948482"},{"id":"paper-w4251574169","cat":"papers","name":"Efficacy, Safety and Pharmacokinetic Study of Inhaled Esketamine in Treatment-resistant Depression","year":"2019","cit":0,"topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4251574169","eid":"W4251574169"},{"id":"paper-w4284667799","cat":"papers","name":"Intranasal esketamine effective across age groups for treatment‐resistant depression","year":"2022","cit":0,"topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4284667799","eid":"W4284667799"},{"id":"paper-w4414179849","cat":"papers","name":"Impact of history of esketamine treatment in the current depressive episode on response to iTBS","year":"2025","cit":0,"pfa":"Mustafa Tonkul","psa":"E. Kavakbasi","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4414179849","eid":"W4414179849"},{"id":"paper-w4401650863","cat":"papers","name":"Reply to ‘Determining postoperative benefits of intravenous lidocaine and esketamine following thyroidectomy’","year":"2024","cit":0,"pfa":"Mengci Li","psa":"Chenglan Xie","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"letter","src":"https://openalex.org/W4401650863","eid":"W4401650863"},{"id":"paper-w7163417835","cat":"papers","name":"Esketamine-propofol combination for colonoscopy sedation: addressing the limitations of propofol monotherapy","year":"2026","cit":0,"pfa":"Saad Arsalan Wasti","psa":"Naseeb Danaf","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7163417835","eid":"W7163417835"},{"id":"paper-w7113074679","cat":"papers","name":"Patients' experiences during treatment with nasal esketamine from a personcentred framework","year":"2024","cit":0,"pfa":"Häggström Westberg, Katrin","psa":"Larsson, Ingrid","topics":["Depression"],"ptype":"conference-paper","src":"https://openalex.org/W7113074679","eid":"W7113074679"},{"id":"paper-w4395105914","cat":"papers","name":"Usage of esketamine spray for treatment-resistant major depressive disorder (MDD)","year":"2024","cit":0,"pfa":"Sunita D. Singh","topics":["Depression"],"ptype":"book-chapter","src":"https://openalex.org/W4395105914","eid":"W4395105914"},{"id":"paper-w4414207618","cat":"papers","name":"Real clinical experience of inhaled esketamine in bipolar depression. A retrospective study","year":"2025","cit":0,"pfa":"S. Benavente López","psa":"E. Baca García","topics":["Depression","Safety & adverse events"],"ptype":"conference-abstract","src":"https://openalex.org/W4414207618","eid":"W4414207618"},{"id":"paper-w4206104759","cat":"papers","name":"Comparison of Sedation of Esketamine Combined with Dexmedetomidine Intranasal in Pediatric Ophthalmic Examination","year":"2021","cit":0,"pfa":"圣光 陆","ptype":"article","src":"https://openalex.org/W4206104759","eid":"W4206104759"},{"id":"paper-w4383599101","cat":"papers","name":"Revolutionizing Anesthesia Using Esketamine for Congenital Diaphragmatic Hernia: A Case Report","year":"2023","cit":0,"pfa":"Liu Zhang","psa":"Xuejie Li","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4383599101","eid":"W4383599101"},{"id":"paper-w4294189291","cat":"papers","name":"Early real-life evaluation of the efficacy of esketamine in resistant depressive disorder","year":"2022","cit":0,"pfa":"S. Faisant","psa":"M. Rojo-Bouton","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4294189291","eid":"W4294189291"},{"id":"paper-w4297580241","cat":"papers","name":"Rapid infusion of esketamine for unipolar and bipolar depression: a retrospective chart review","year":"2017","cit":0,"pfa":"Fernanda S. Correia‐Melo","psa":"Lucas C. Quarantini","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4297580241","eid":"W4297580241"},{"id":"paper-w7120470332","cat":"papers","name":"Efficacy of subcutaneous esketamine in anhedonia in patients with treatment-resistant depressive episodes","year":"2021","cit":0,"pfa":"Rodrigo Simonini [UNIFESP] Delfino","topics":["Depression"],"ptype":"dissertation","src":"https://openalex.org/W7120470332","eid":"W7120470332"},{"id":"paper-w4401382493","cat":"papers","name":"Does Esketamine in Cesarean Delivery Increase Postoperative Adversities and Related Diseases?","year":"2024","cit":0,"pfa":"Cheryce Daniel","psa":"Kylon Coombs","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"conference-paper","src":"https://openalex.org/W4401382493","eid":"W4401382493"},{"id":"paper-w7117980954","cat":"papers","name":"Intranasal esketamine in treatment resistant ocd with comorbid treatment resistant depression","year":"2026","cit":0,"pfa":"L. Larini","psa":"E. Hollander","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7117980954","eid":"W7117980954"},{"id":"paper-w7127246760","cat":"papers","name":"Improving Clinician Knowledge and Confidence in Esketamine-Assisted Psychotherapy: A Quality Improvement Project","year":"2025","cit":0,"pfa":"Mindy Leake","psa":"Mindy Leake","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W7127246760","eid":"W7127246760"},{"id":"paper-w4414833275","cat":"papers","name":"Esketamine in a Patient With Major Depressive Disorder and Polysubstance Use: A Case Report","year":"2025","cit":0,"pfa":"Abdelazim Ali","psa":"Sona Varghese","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W4414833275","eid":"W4414833275"},{"id":"paper-w4388537648","cat":"papers","name":"Safety and Efficacy of Esketamine Weak Opioid Anesthesia in Laparoscopic Gallbladder Surgery","year":"2023","cit":0,"pfa":"Lu Zhao","psa":"Heng Yang","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4388537648","eid":"W4388537648"},{"id":"paper-w4407174261","cat":"papers","name":"The Need for Guidance on Ketamine/Esketamine Use in Real-World Clinical Settings","year":"2025","cit":0,"pfa":"Alina Wilkowska","psa":"Wiesław Jerzy Cubała","ptype":"article","src":"https://openalex.org/W4407174261","eid":"W4407174261"},{"id":"paper-w4416577210","cat":"papers","name":"Effects of Fentanyl-Reduced Regimen with Esketamine and Remimazolam on Bronchoscopy in Elderly Patients","year":"2025","cit":0,"pfa":"An Xie","psa":"Rui Zhou","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4416577210","eid":"W4416577210"},{"id":"paper-w7136610518","cat":"papers","name":"Editorial: Retuning the Adolescent Brain: Esketamine and Rapid Structural Change in the rACC","year":"2026","cit":0,"pfa":"Yunjia Liu","psa":"Qiang Wang","ptype":"editorial","src":"https://openalex.org/W7136610518","eid":"W7136610518"},{"id":"paper-w2952425554","cat":"papers","name":"ChemInform Abstract: Comparative Pharmacology in the Rat of Ketamine and Its Two Principal Metabolites, Norketamine and (Z)‐6‐Hydroxynorketamine.","year":"1987","cit":0,"pfa":"Louis Y. Leung","psa":"Thomas A. Baillie","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2952425554","eid":"W2952425554"},{"id":"paper-w7168234817","cat":"papers","name":"Prophylactic esketamine for postoperative sore throat: a meta-analysis of randomized evidence","year":"2026","cit":0,"pfa":"Youssef Heikal","psa":"Leen Helmi Radwan","topics":["Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7168234817","eid":"W7168234817"},{"id":"paper-w7104817989","cat":"papers","name":"Esketamine for Postoperative Depressive Symptoms: Considerations for Broader Perioperative Practice [Letter]","year":"2025","cit":0,"pfa":"Matthewson L","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7104817989","eid":"W7104817989"},{"id":"paper-w7160099960","cat":"papers","name":"ESKETAMINE AND DEEP BRAIN STIMULATION IN TREATMENT-RESISTANT DEPRESSION: A LITERATURE REVIEW","year":"2026","cit":0,"pfa":"Jolanta Wiśniewska","psa":"Magdalena Pietrzak","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7160099960","eid":"W7160099960"},{"id":"paper-w4414180631","cat":"papers","name":"Real clinical experience of inhaled esketamine in psychotic depression. A retrospective study","year":"2025","cit":0,"pfa":"S. Benavente López","psa":"E. Baca García","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W4414180631","eid":"W4414180631"},{"id":"paper-w7171708565","cat":"papers","name":"Ketamine and esketamine for depression in adolescents: a systematic review of efficacy, suicidality, and safety","year":"2026","cit":0,"pfa":"Alessandro Cuomo","psa":"Andrea M. Fagiolini","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7171708565","eid":"W7171708565"},{"id":"paper-w7172502109","cat":"papers","name":"Comparison of different doses of esketamine combined with remimazolam in hysteroscopic endometrial resection","year":"2026","cit":0,"pfa":"JIANG Hui","psa":"TAO Yuanyuan","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7172502109","eid":"W7172502109"},{"id":"paper-w7107874814","cat":"papers","name":"Research Progress on the Effects and Mechanisms of Esketamine for Postoperative Delirium in Elderly Patients","year":"2025","cit":0,"pfa":"晔 黄","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7107874814","eid":"W7107874814"},{"id":"paper-w4385659887","cat":"papers","name":"Electroconvulsive therapy vs Esketamine among patients with Major Depressive Episode","year":"2023","cit":0,"pfa":"M.D.R.D.R.F.D. Basto","psa":"A. Horta","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4385659887","eid":"W4385659887"},{"id":"paper-w7171957254","cat":"papers","name":"What happens after stopping IN Esketamine? A prospective report of case series","year":"2026","cit":0,"pfa":"T. Sagués","psa":"V. Gálvez","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7171957254","eid":"W7171957254"},{"id":"paper-w7154967198","cat":"papers","name":"Esketamine Exposure Affects Neurodevelopment and Glutamate‐NMDAR Signaling in Zebrafish Larvae","year":"2026","cit":0,"pfa":"Jingyi Wang","psa":"Chengyong He","topics":["Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7154967198","eid":"W7154967198"},{"id":"paper-w4403630671","cat":"papers","name":"Rapid Hippocampal Synaptic Potentiation Induced by Ketamine Metabolite ( 2R , 6R )-Hydroxynorketamine Persistently Primes Synaptic Plasticity","year":"2024","cit":0,"pfa":"Kyle A. Brown","psa":"Todd D. Gould","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4403630671","eid":"W4403630671"},{"id":"paper-w4411131053","cat":"papers","name":"Selective transcriptomic recovery by ( 2R,6R )-hydroxynorketamine in opioid-abstinent mice: Machine learning identifies predictive biomarkers","year":"2025","cit":0,"pfa":"Anna Onisiforou","psa":"Panos Zanos","topics":["Addiction","Mechanism & neuroscience","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4411131053","eid":"W4411131053"},{"id":"paper-w7149676184","cat":"papers","name":"Esketamine prevents postpartum depression after cesarean section: a Meta-analysis","year":"2026","cit":0,"pfa":"YAO Wenzhuang","psa":"LYU Jieping","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7149676184","eid":"W7149676184"},{"id":"paper-w7164559653","cat":"papers","name":"Effect of postoperative esketamine on depression after pancreatoduodenectomy: a randomized controlled trial","year":"2026","cit":0,"pfa":"Bowen Zhang","psa":"Yiqing Yin","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7164559653","eid":"W7164559653"},{"id":"paper-w4412896700","cat":"papers","name":"Future Directions of Esketamine Nasal Spray Continuation in Treatment-Resistant Depression","year":"2025","cit":0,"pfa":"Maxwell Zachary Price","psa":"Richard L. Price","topics":["Depression"],"ptype":"book-chapter","src":"https://openalex.org/W4412896700","eid":"W4412896700"},{"id":"paper-w7154511710","cat":"papers","name":"Does Combining Dexmedetomidine and Esketamine Truly Improve Pediatric Premedication Outcomes?","year":"2026","cit":0,"pfa":"Mattia Madeo","psa":"Andrea Bruni","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7154511710","eid":"W7154511710"},{"id":"paper-w4229785088","cat":"papers","name":"Faculty Opinions recommendation of Esketamine counters opioid-induced respiratory depression.","year":"2020","cit":0,"pfa":"Maree T. Smith","topics":["Depression","Addiction"],"ptype":"peer-review","src":"https://openalex.org/W4229785088","eid":"W4229785088"},{"id":"paper-w4244262725","cat":"papers","name":"Esketamine nasal spray offers rapid benefit in patients at risk of suicide","year":"2020","cit":0,"topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4244262725","eid":"W4244262725"},{"id":"paper-w7117985957","cat":"papers","name":"Intranasal esketamine for treatment-resistant depression in real-world clinical practice","year":"2026","cit":0,"pfa":"A.A. Porras-Segovia","psa":"E. Baca-García","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7117985957","eid":"W7117985957"},{"id":"paper-w4412529823","cat":"papers","name":"Clinical experience with esketamine in emergency departments: A survey among emergency physicians in the Netherlands","year":"2025","cit":0,"pfa":"Mischa Veen","psa":"Johanna Ooms","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4412529823","eid":"W4412529823"},{"id":"paper-w7128034306","cat":"papers","name":"Statistical Analysis Plan: Esketamine and Suicidal Ideation in MDD (IPD Meta-Analysis)","year":"2026","cit":0,"pfa":"Han Chang Chiam","psa":"Martin Plöderl","topics":["Depression","Reviews & meta-analyses"],"ptype":"other","src":"https://openalex.org/W7128034306","eid":"W7128034306"},{"id":"paper-w7147181306","cat":"papers","name":"INTRANASAL ESKETAMINE AND MAOI COMBINATION IN THE MANAGEMENT OF TREATMENT-RESISTANT DEPRESSION: A CASE REPORT","year":"2026","cit":0,"pfa":"Paulo Artur da Silva Rodrigues","psa":"Pablo Gnutzmann Pereira","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W7147181306","eid":"W7147181306"},{"id":"paper-w4205718241","cat":"papers","name":"Elderly see little overall benefit from intranasal esketamine with antidepressant","year":"2020","cit":0,"topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4205718241","eid":"W4205718241"},{"id":"paper-w7155504064","cat":"papers","name":"Managing Ketamine/Esketamine Treatment: Discontinuation, Side Effects, and Clinic Practice","year":"2026","cit":0,"pfa":"Samuel Wilkinson","topics":["Dosing & pharmacology"],"ptype":"report","src":"https://openalex.org/W7155504064","eid":"W7155504064"},{"id":"paper-w7212067173","cat":"papers","name":"457. Intensive longitudinal monitoring of symptoms in response to treatment with intranasal esketamine","year":"2026","cit":0,"pfa":"Marko Saje","psa":"Aleš Oblak","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"conference-abstract","src":"https://openalex.org/W7212067173","eid":"W7212067173"},{"id":"paper-w7141070616","cat":"papers","name":"Esketamine: A Potential Alternative Treatment for Youth Depression and its Cognitive Effects","year":"2024","cit":0,"topics":["Depression","Dosing & pharmacology"],"ptype":"report","src":"https://openalex.org/W7141070616","eid":"W7141070616"},{"id":"paper-w4313198357","cat":"papers","name":"Loss of the sustained antidepressant effect of (2R,6R)-hydroxynorketamine in NMDA receptor GluN2D subunit knockout mice","year":"2022","cit":0,"pfa":"Aimi Yamagishi","psa":"Kazutaka Ikeda","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4313198357","eid":"W4313198357"},{"id":"paper-w7161568731","cat":"papers","name":"Comparative Effectiveness of rTMS Vs. Esketamine in a Large Real-World Sample","year":"2026","cit":0,"pfa":"Michael Minzenberg","psa":"Tobias Marton","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7161568731","eid":"W7161568731"},{"id":"paper-w4403194398","cat":"papers","name":"Esketamine induces embryonic and cardiac malformation through regulating the nkx2.5 and gata4 in zebrafish","year":"2024","cit":0,"pfa":"Shuang Li","psa":"Qiuyun Ou","topics":["Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4403194398","eid":"W4403194398"},{"id":"paper-w7204567696","cat":"papers","name":"Ketamine and Esketamine in Treatment-Resistant Depression: A Clinical Inquiry into Efficacy, Safety, and Access","year":"2026","cit":0,"pfa":"Matheus Cruz","psa":"Calli Cahill","topics":["Depression","Safety & adverse events"],"ptype":"conference-abstract","src":"https://openalex.org/W7204567696","eid":"W7204567696"},{"id":"paper-w7172305167","cat":"papers","name":"A crucial cautionary note on frequently incorrect dose equivalence between ketamine and esketamine","year":"2026","cit":0,"pfa":"Rodolfo Furlan Damiano","psa":"João Quevedo","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7172305167","eid":"W7172305167"},{"id":"paper-w7213559066","cat":"papers","name":"Clinical research progress of esketamine in perioperative neuroprotection: from mechanisms to therapeutic neuroprotection","year":"2026","cit":0,"pfa":"Hua Wang","psa":"Hao Luo","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7213559066","eid":"W7213559066"},{"id":"paper-w7199441328","cat":"papers","name":"Effectiveness of subcutaneous esketamine on the treatment of treatment-resistant unipolar and bipolar depressive episodes","year":"2026","cit":0,"pfa":"Rodrigo Simonini [UNIFESP] Delfino","topics":["Depression"],"ptype":"dissertation","src":"https://openalex.org/W7199441328","eid":"W7199441328"},{"id":"paper-w7168336420","cat":"papers","name":"Median Effective Dose of Esketamine Combined with Remifentanil for Anesthesia Induction in Painless Colonoscopy","year":"2026","cit":0,"pfa":"Cao Z","psa":"Liu X","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7168336420","eid":"W7168336420"},{"id":"paper-w4407279591","cat":"papers","name":"Mapping Fear-Related Neural Activity and Circuitry Changes Following Prophylactic Administration of (R,S)-Ketamine and (2S,6S)-Hydroxynorketamine","year":"2025","cit":0,"pfa":"Minzhu Li","psa":"Cheng Li","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4407279591","eid":"W4407279591"},{"id":"paper-w7167039346","cat":"papers","name":"Real‐World Effectiveness and Cost‐Differential of Intranasal Esketamine Versus Intramuscular Ketamine","year":"2026","cit":0,"pfa":"Kush V. Bhatt","psa":"Dhakshin Ramanathan","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7167039346","eid":"W7167039346"},{"id":"paper-w4205740277","cat":"papers","name":"Optimization of a physiology based pharmacokinetic model for drug interaction predictions with application to esketamine","year":"2019","cit":0,"pfa":"Shayne Watson","psa":"Andres Kriete","topics":["Safety & adverse events","Dosing & pharmacology","Therapy practice"],"ptype":"dissertation","src":"https://openalex.org/W4205740277","eid":"W4205740277"},{"id":"paper-w4394225911","cat":"papers","name":"Efficacy and safety of racemic ketamine and esketamine for depression: a systematic review and meta-analysis","year":"2022","cit":0,"pfa":"Anees Bahji","psa":"Gustavo Héctor Vázquez","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"dataset","src":"https://openalex.org/W4394225911","eid":"W4394225911"},{"id":"paper-w7163808062","cat":"papers","name":"Comparing transcranial magnetic stimulation and esketamine treatment response trajectories in resistant depression","year":"2026","cit":0,"pfa":"Lindsay L. Benster","psa":"Lawrence G. Appelbaum","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7163808062","eid":"W7163808062"},{"id":"paper-w4413137480","cat":"papers","name":"Profiles of Medicaid Beneficiaries with Treatment-Resistant Depression Initiated on Esketamine Nasal Spray","year":"2025","cit":0,"pfa":"Kristin Clemens","psa":"Kruti Joshi","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4413137480","eid":"W4413137480"},{"id":"paper-w4416839160","cat":"papers","name":"The median effective dose of esketamine with different doses of oliceridine during hysteroscopic surgery","year":"2025","cit":0,"pfa":"Min Yan Shi","psa":"Xiaolin Wang","topics":["Safety & adverse events","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4416839160","eid":"W4416839160"},{"id":"paper-w2980388127","cat":"papers","name":"PMH3 ESKETAMINE SELF-PAY MODEL FOR TREATMENT RESISTANT DEPRESSION IN MEXICO","year":"2019","cit":0,"pfa":"Siyuan Zhang","psa":"C. Glaetzer","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2980388127","eid":"W2980388127"},{"id":"paper-w4414179852","cat":"papers","name":"Esketamine in persistent long COVID with predominant psychiatric manifestations: A case series","year":"2025","cit":0,"pfa":"I. Bozic","psa":"Lucie Bartova","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4414179852","eid":"W4414179852"},{"id":"paper-w4404170009","cat":"papers","name":"Esketamine rapid antidepression combined with dexmedetomidine sleep modulation for patients with depression and insomnia","year":"2024","cit":0,"pfa":"Muyan Zuo","psa":"Jian‐Xiong An","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4404170009","eid":"W4404170009"},{"id":"paper-w7128018344","cat":"papers","name":"Recommendations for repeated dosings of ketamine/esketamine rest on an uncertain evidence base. Response to","year":"2026","cit":0,"pfa":"Martin Plöderl","psa":"Florian Naudet","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7128018344","eid":"W7128018344"},{"id":"paper-w7213622122","cat":"papers","name":"Mechanisms of action and advances in clinical research on esketamine in perioperative organ and system protection","year":"2026","cit":0,"pfa":"Xiaodan Luo","psa":"Fuhai Bai","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7213622122","eid":"W7213622122"},{"id":"paper-w7117983324","cat":"papers","name":"When the mind expands: patient narratives of dissociation during esketamine treatment in Pavia","year":"2026","cit":0,"pfa":"Alessandro Guffanti","psa":"Miriam Olivola","ptype":"article","src":"https://openalex.org/W7117983324","eid":"W7117983324"},{"id":"paper-w7170092663","cat":"papers","name":"Effect of Different Doses of Esketamine on Recovery in Elderly Patients Undergoing Knee Arthroplasty","year":"2026","cit":0,"topics":["Dosing & pharmacology"],"ptype":"dataset","src":"https://openalex.org/W7170092663","eid":"W7170092663"},{"id":"paper-w7127888150","cat":"papers","name":"Statistical Analysis Plan: Esketamine and Suicidal Ideation in MDD (IPD Meta-Analysis)","year":"2026","cit":0,"pfa":"Han Chang Chiam","psa":"Martin Plöderl","topics":["Depression","Reviews & meta-analyses"],"ptype":"other","src":"https://openalex.org/W7127888150","eid":"W7127888150"},{"id":"paper-w7213498734","cat":"papers","name":"Intraoperative intravenous esketamine in video-assisted thoracoscopic surgery: data and analysis code","year":"2026","cit":0,"pfa":"Bruno Moraes Dubois","psa":"Thomas Rolf Erdmann","topics":["Reviews & meta-analyses"],"ptype":"dataset","src":"https://openalex.org/W7213498734","eid":"W7213498734"},{"id":"paper-w4401374952","cat":"papers","name":"Optimizing esketamine clinic implementation: Insights from Taiwan's mental health framework","year":"2024","cit":0,"pfa":"Lien‐Chung Wei","psa":"Li‐Fen Chen","ptype":"article","src":"https://openalex.org/W4401374952","eid":"W4401374952"},{"id":"paper-w7171946284","cat":"papers","name":"Esketamine Treatment and Its Impact on Suicidality in Treatment-Resistant Depression: A Narrative Review","year":"2026","cit":0,"pfa":"I. C. Mandras","psa":"A.-L. Comșa","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W7171946284","eid":"W7171946284"},{"id":"paper-w4399333878","cat":"papers","name":"Adjunctive esketamine in women having cesarean has early effect on depressive symptoms","year":"2024","cit":0,"topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4399333878","eid":"W4399333878"},{"id":"paper-w4414208306","cat":"papers","name":"Can Esketamine Become a Viable Alternative for Treating Treatment-Resistant Depression in Ecuador?","year":"2025","cit":0,"pfa":"E. Pazmiño","psa":"K. Armas","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4414208306","eid":"W4414208306"},{"id":"paper-w7155649255","cat":"papers","name":"517. Cognitive Change Following Esketamine Treatment in Veterans With Major Depressive Disorder","year":"2026","cit":0,"pfa":"Nanako Hawley","psa":"Michelle R. Madore","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7155649255","eid":"W7155649255"},{"id":"paper-w7161551636","cat":"papers","name":"C75-14 The Role of Esketamine in Postoperative Sleep: An Updated Evidence of Randomized Trials","year":"2026","cit":0,"pfa":"M Lúcio","psa":"Catarina Barata","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7161551636","eid":"W7161551636"},{"id":"paper-w7213226286","cat":"papers","name":"Statistical Analysis Plan: Esketamine and Suicidal Ideation in MDD (IPD Meta-Analysis)","year":"2026","cit":0,"pfa":"Han Chang Chiam","psa":"Martin Plöderl","topics":["Depression","Reviews & meta-analyses"],"ptype":"other","src":"https://openalex.org/W7213226286","eid":"W7213226286"},{"id":"paper-w7117766619","cat":"papers","name":"Effects of different doses of esketamine at anesthesia induction and maintenance during abdominal surgery","year":"2025","cit":0,"pfa":"MEI Tianzi","psa":"ZHANG Rui","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7117766619","eid":"W7117766619"},{"id":"paper-w7215141956","cat":"papers","name":"Ketamine and Esketamine in Treatment-Resistant Depression: A New Era of Rapid-Acting Antidepressants","year":"2025","cit":0,"pfa":"Sevara Shukurjonova Shuxratovna","topics":["Depression","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7215141956","eid":"W7215141956"},{"id":"paper-w7155750502","cat":"papers","name":"Development of an Esketamine Treatment Safety Protocol at a Midwestern Outpatient Mental Health Clinic","year":"2023","cit":0,"pfa":"Brittany Burkett","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"dissertation","src":"https://openalex.org/W7155750502","eid":"W7155750502"},{"id":"paper-w7120846520","cat":"papers","name":"Adverse effects of repeated subanesthetic doses of subcutaneous esketamine in treatment-resistant depression","year":"2023","cit":0,"pfa":"Lorena Catarina Del Sant","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W7120846520","eid":"W7120846520"},{"id":"paper-w7203888006","cat":"papers","name":"Ketamine and Esketamine for PTSD: Randomized Controlled Trials and Systematic Reviews Evidence Dataset","year":"2026","cit":0,"pfa":"Michael Alvear","topics":["PTSD & trauma","Reviews & meta-analyses"],"ptype":"dataset","src":"https://openalex.org/W7203888006","eid":"W7203888006"},{"id":"paper-w4416815326","cat":"papers","name":"Esketamine for Postoperative Depressive Symptoms: Considerations for Broader Perioperative Practice [Response to Letter]","year":"2025","cit":0,"pfa":"Mengting Shen","psa":"Xinlei Lu","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4416815326","eid":"W4416815326"},{"id":"paper-w7139114509","cat":"papers","name":"4CPS-188 Use of intranasal esketamine for treatment-resistant major depressive disorder","year":"2026","cit":0,"pfa":"M Barba Llacer","psa":"JJ Ortiz De Urbina González","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"conference-paper","src":"https://openalex.org/W7139114509","eid":"W7139114509"},{"id":"paper-w7171938083","cat":"papers","name":"Electrophysiological correlates of ketamine and esketamine in humans: a systematic review of resting EEG findings","year":"2026","cit":0,"pfa":"L. Mana","psa":"Silvana Galderisi","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W7171938083","eid":"W7171938083"},{"id":"paper-w4313200588","cat":"papers","name":"Efficacy and safety of intranasal esketamine in treatment-resistant depression in adults on compassionate use","year":"2022","cit":0,"pfa":"Ana Isabel de Santiago-Díaz","psa":"Jesús Artal-Simón","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4313200588","eid":"W4313200588"},{"id":"paper-w4414181439","cat":"papers","name":"Metacogntive training add-on to esketamine treatment in TRD patients: effects on depressive rumination","year":"2025","cit":0,"pfa":"F. Raffone","psa":"Vassilis Martiadis","topics":["Depression","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4414181439","eid":"W4414181439"},{"id":"paper-w4401857137","cat":"papers","name":"Investigating the effectiveness of esketamine in reducing depression for breast cancer patients after surgery","year":"2024","cit":0,"pfa":"Haifan Xu","psa":"Haifan Xu","topics":["Depression","Anxiety & end-of-life"],"ptype":"dataset","src":"https://openalex.org/W4401857137","eid":"W4401857137"},{"id":"paper-w4248204030","cat":"papers","name":"Efficacy, Safety and Pharmacokinetic Study of Inhaled Esketamine in Treatment-resistant Bipolar Depression","year":"2019","cit":0,"topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4248204030","eid":"W4248204030"},{"id":"paper-w4387621001","cat":"papers","name":"Abstract P2115: (2R,6R)-Hydroxynorketamine Prevents Myocardial Ischemia Reperfusion Injury By Regulating Immune And Inflammatory Response","year":"2023","cit":0,"pfa":"Baihe Chen","psa":"Masafumi Kitakaze","topics":["Depression","Dosing & pharmacology","Policy & ethics"],"ptype":"conference-abstract","src":"https://openalex.org/W4387621001","eid":"W4387621001"},{"id":"paper-w4294202931","cat":"papers","name":"Clinical stability after compassionate use of intranasal esketamine in treatment-resistant depression","year":"2022","cit":0,"pfa":"Daniel Hernández Huerta","psa":"M. Vega Piñero","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4294202931","eid":"W4294202931"},{"id":"paper-w4413732614","cat":"papers","name":"FDA approves promising new drug, called esketamine, for treatment-resistant depression","year":"2019","cit":0,"pfa":"Lee Hoffer","topics":["Depression"],"ptype":"other","src":"https://openalex.org/W4413732614","eid":"W4413732614"},{"id":"paper-w7106787548","cat":"papers","name":"The interaction between esketamine and cannabis in mice and its implications for the treatment of psychiatric disorders","year":"2025","cit":0,"pfa":"Vigl, Valerie Therese","topics":["Depression"],"ptype":"dissertation","src":"https://openalex.org/W7106787548","eid":"W7106787548"},{"id":"paper-w7137911086","cat":"papers","name":"Effects of esketamine combined with QLB in older frail patients with colorectal cancer surgery","year":"2026","cit":0,"pfa":"Shuhong Dai","psa":"X Zhang","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7137911086","eid":"W7137911086"},{"id":"paper-w4408205162","cat":"papers","name":"Increased Use and State-Level Variation of Esketamine Prescriptions Among Medicare Patients","year":"2025","cit":0,"pfa":"Luke R. Cavanah","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4408205162","eid":"W4408205162"},{"id":"paper-w7160046758","cat":"papers","name":"Extension of esketamine study shows long‐term safety in treatment‐resistant depression","year":"2026","cit":0,"topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7160046758","eid":"W7160046758"},{"id":"paper-w7213558043","cat":"papers","name":"Effect of esketamine on postoperative pulmonary complications after radical surgery for lung cancer","year":"2026","cit":0,"pfa":"Jiangyuan Huang","psa":"Liangqing Zhang","topics":["Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7213558043","eid":"W7213558043"},{"id":"paper-w4413118272","cat":"papers","name":"Low dose esketamine for gastrointestinal endoscopy: a double-blinded, randomized controlled trial","year":"2025","cit":0,"topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4413118272","eid":"W4413118272"},{"id":"paper-w7120193674","cat":"papers","name":"Efficacy and Safety of Intravenous Esketamine in Elderly Patients Undergoing Laparoscopic Radical Prostatectomy","year":"2026","cit":0,"pfa":"Tingjun Zhang","psa":"Lei Wang","topics":["Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7120193674","eid":"W7120193674"},{"id":"paper-w7213143829","cat":"papers","name":"Cognitive effects of ketamine and esketamine treatment for major depressive and bipolar disorder: a systematic review","year":"2026","cit":0,"pfa":"Kelei Xiao","psa":"Roger S. McIntyre","topics":["Depression","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7213143829","eid":"W7213143829"},{"id":"paper-w4416128248","cat":"papers","name":"Effect of esketamine on postoperative pain relief and depressive status in patients with traumatic fractures","year":"2025","cit":0,"pfa":"Zhongyu Liu","psa":"Tao Zhou","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4416128248","eid":"W4416128248"},{"id":"paper-w7167852194","cat":"papers","name":"Median Effective Dose of Esketamine Combined with Remifentanil for Anesthesia Induction in Painless Colonoscopy","year":"2026","cit":0,"pfa":"Zhengqing Cao","psa":"Xin Liu","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7167852194","eid":"W7167852194"},{"id":"paper-w4405636890","cat":"papers","name":"Improvement of apathy symptoms in patients treated with esketamine diagnosed with major depressive disorder","year":"2024","cit":0,"pfa":"Daniela Conti","psa":"Antonino Petralia","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4405636890","eid":"W4405636890"},{"id":"paper-w4398146963","cat":"papers","name":"Response to “Effectiveness of ketamine and esketamine in preventing postpartum depression: A trial sequential analysis”","year":"2024","cit":0,"pfa":"Shuying Li","psa":"Rongqian Lin","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4398146963","eid":"W4398146963"},{"id":"paper-w4324028733","cat":"papers","name":"Effects of esketamine on postoperative pain and inflammatory factors in children undergoing tonsillectomy and adenoidectomy","year":"2023","cit":0,"pfa":"yuchang zhu","psa":"Yi Zhang","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4324028733","eid":"W4324028733"},{"id":"paper-w7126037871","cat":"papers","name":"Esketamine rapid antidepression combined with dexmedetomidine sleep modulation for patients with depression and insomnia","year":"2026","cit":0,"pfa":"Muyan Zuo","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7126037871","eid":"W7126037871"},{"id":"paper-w4385670010","cat":"papers","name":"Effectiveness and Tolerability of Intranasal Esketamine in Treatment-Resistant Depression: Report of Two Clinical Cases","year":"2023","cit":0,"pfa":"A. Mercado-Rodríguez","psa":"Lorea Mar‐Barrutia","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4385670010","eid":"W4385670010"},{"id":"paper-w7167345286","cat":"papers","name":"Esketamine Versus Erector Spinae Plane Block in Video-assisted Thoracoscopic Surgery: A Comments","year":"2026","cit":0,"pfa":"Imran Zaheer","psa":"Huma Naim","ptype":"article","src":"https://openalex.org/W7167345286","eid":"W7167345286"},{"id":"paper-w7109198359","cat":"papers","name":"Multi-Analyst Reanalysis of IPD on Esketamine and Suicidality / SHARE-CTD datathon 2","year":"2025","cit":0,"pfa":"Naudet, Florian","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7109198359","eid":"W7109198359"},{"id":"paper-w7171988447","cat":"papers","name":"Intraoperative intravenous esketamine in video-assisted thoracoscopic surgery: data and analysis code","year":"2026","cit":0,"pfa":"Bruno Moraes Dubois","psa":"Thomas Rolf Erdmann","topics":["Reviews & meta-analyses"],"ptype":"dataset","src":"https://openalex.org/W7171988447","eid":"W7171988447"},{"id":"paper-w4390223514","cat":"papers","name":"Esketamine nasal spray in treatment-resistant depression: Efficacy and tolerability in a “real-life” setting","year":"2023","cit":0,"pfa":"Luca Giacovelli","psa":"Bernardo Maria Dell’Osso","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4390223514","eid":"W4390223514"},{"id":"paper-w4362734123","cat":"papers","name":"233. Transcriptional Profiling of Peripheral Blood in Depressive Patients Treated With Esketamine Nasal Spray","year":"2023","cit":0,"pfa":"Qingqin S. Li","psa":"Wayne Curtis Drevets","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4362734123","eid":"W4362734123"},{"id":"paper-w4414180959","cat":"papers","name":"Combined treatment with intranasal esketamine and electroconvulsive therapy in resistant depression. Two cases report","year":"2025","cit":0,"pfa":"Pablo del Sol","psa":"Ángela Izquierdo de la Puente","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4414180959","eid":"W4414180959"},{"id":"paper-w7152008887","cat":"papers","name":"Interpreting Reduced Postoperative hs-cTnT After Intraoperative Esketamine: Methodological Considerations [Letter]","year":"2026","cit":0,"pfa":"Cheng-Wei Lü","psa":"Kuo-Chen Chang","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7152008887","eid":"W7152008887"},{"id":"paper-w7171854057","cat":"papers","name":"The application of esketamine in cancer-related depressive states: attention from mechanisms to clinical translation","year":"2026","cit":0,"pfa":"Liangju Chen","psa":"Lin Zhong","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7171854057","eid":"W7171854057"},{"id":"paper-w7120589456","cat":"papers","name":"Repeated subcutaneous esketamine for treatment-resistant depression: response to treatment and impact on cognition","year":"2023","cit":0,"pfa":"Ana Cecília Lucchese","topics":["Depression","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7120589456","eid":"W7120589456"},{"id":"paper-w4415030051","cat":"papers","name":"Is intranasal esketamine versus intravenous ketamine a therapeutic innovation or a divide in access to care?","year":"2025","cit":0,"pfa":"Yassine Benhaddouch","psa":"Adil El Ammouri","ptype":"article","src":"https://openalex.org/W4415030051","eid":"W4415030051"},{"id":"paper-w4416187507","cat":"papers","name":"Intranasal Esketamine for Treatment-Resistant Depression with Structural Brain Abnormality: A Case Report","year":"2025","cit":0,"pfa":"Yu‐Chih Shen","psa":"Chien-Chen Hung","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4416187507","eid":"W4416187507"},{"id":"paper-w3001152061","cat":"papers","name":"All in the Family: What the Palliative Care Specialist Should Know About Esketamine (FR439)","year":"2020","cit":0,"pfa":"Eric Prommer","psa":"Jason A. Webb","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3001152061","eid":"W3001152061"},{"id":"paper-w7203829404","cat":"papers","name":"Perioperative dexmedetomidine plus esketamine for postoperative neurocognitive outcomes: a systematic review and meta-analysis","year":"2026","cit":0,"pfa":"Zhi-yong Wang","psa":"Yan-bin Yin","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7203829404","eid":"W7203829404"},{"id":"paper-w4385251938","cat":"papers","name":"Application Progress of Esketamine in Enhanced Recovery after Surgery during Perioperative Period","year":"2023","cit":0,"pfa":"丽娇 杨","ptype":"article","src":"https://openalex.org/W4385251938","eid":"W4385251938"},{"id":"paper-w7158430070","cat":"papers","name":"Esketamine for Postoperative Multimodal Analgesia in Laparoscopic Surgery: A Systematic Review and Meta-Analysis","year":"2026","cit":0,"pfa":"Li J","psa":"X Wang","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"review","src":"https://openalex.org/W7158430070","eid":"W7158430070"},{"id":"paper-w4362508934","cat":"papers","name":"Dissociative side effects of repeated intranasal esketamine in a patient with preexisting dissociative symptoms","year":"2023","cit":0,"pfa":"Joanna Moussiopoulou","psa":"Cornelius Schüle","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4362508934","eid":"W4362508934"},{"id":"paper-w7171941908","cat":"papers","name":"What is the current status of research for esketamine in the treatment of bipolar depression? A literature review","year":"2026","cit":0,"pfa":"O. Vasiliu","psa":"D. G. Vasiliu","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7171941908","eid":"W7171941908"},{"id":"paper-w4414639913","cat":"papers","name":"Esketamine: Essential Differences Compared to Worldwide Used Racemic Ketamine and a Synopsis of Its Perioperative Benefits and Safety","year":"2025","cit":0,"pfa":"Georges Mion","topics":["Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W4414639913","eid":"W4414639913"},{"id":"paper-w3023615251","cat":"papers","name":"Response to a recently published systematic review on intranasal esketamine for major depressive disorder","year":"2020","cit":0,"pfa":"Sholto David","topics":["Depression","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W3023615251","eid":"W3023615251"},{"id":"paper-w4414180214","cat":"papers","name":"Esketamine and Ketamine use in the Adolescent Population for Treatment Resistent Depression: A Systematic Review","year":"2025","cit":0,"pfa":"G. Chen","psa":"Yuqing Li","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W4414180214","eid":"W4414180214"},{"id":"paper-w4415970481","cat":"papers","name":"Low-dose intravenous esketamine on a depressive catatonia patient with venous thromboembolism: a case report","year":"2025","cit":0,"pfa":"M Zhang","psa":"Xiao Ji","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4415970481","eid":"W4415970481"},{"id":"paper-w4409878096","cat":"papers","name":"Efficacy of low-dose esketamine combined with propofol/etomidate mixture in painless gastroscopy anesthesia","year":"2025","cit":0,"pfa":"Desheng Hu","psa":"Xi-Chun Ye","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4409878096","eid":"W4409878096"},{"id":"paper-w7161818478","cat":"papers","name":"Esketamine Alleviates Limb Ischemia-Reperfusion-Induced Lung Injury by Inducing Macrophage Polarization","year":"2026","cit":0,"pfa":"Meng Wang","psa":"Qian Ma","ptype":"article","src":"https://openalex.org/W7161818478","eid":"W7161818478"},{"id":"paper-w4414208271","cat":"papers","name":"Real clinical experience of inhaled esketamine in depression and chronic pain. A retrospective study","year":"2025","cit":0,"pfa":"S. Benavente López","psa":"E. Baca García","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4414208271","eid":"W4414208271"},{"id":"paper-w4414208395","cat":"papers","name":"Esketamine-induced dissociation: just a side effects or a potential antidepressant effect booster?","year":"2025","cit":0,"pfa":"F. Raffone","psa":"Vassilis Martiadis","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4414208395","eid":"W4414208395"},{"id":"paper-w7171985378","cat":"papers","name":"Care Next Door: Community Outpatient Esketamine Across Urban and Rural Clinics","year":"2026","cit":0,"pfa":"J García Jiménez","psa":"Luís Gutiérrez-Rojas","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7171985378","eid":"W7171985378"},{"id":"paper-w2766834575","cat":"papers","name":"Serial assessment of CSF proteome following 2R,6R-Hydroxynorketamine administration in the mouse: in search for rapid acting antidepressant targets","year":"2017","cit":0,"pfa":"David P. Herzog","psa":"Marianne B. Müller","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"conference-paper","src":"https://openalex.org/W2766834575","eid":"W2766834575"},{"id":"paper-w7141079946","cat":"papers","name":"Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression","year":"2019","cit":0,"topics":["Depression","Safety & adverse events"],"ptype":"report","src":"https://openalex.org/W7141079946","eid":"W7141079946"},{"id":"paper-w4411157590","cat":"papers","name":"Cost-per-remitter for esketamine nasal spray versus quetiapine for treatment-resistant depression","year":"2025","cit":0,"pfa":"Kristin Clemens","psa":"Kruti Joshi","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4411157590","eid":"W4411157590"},{"id":"paper-w7203455022","cat":"papers","name":"Perioperative esketamine and postoperative sleep quality: a systematic review and meta-analysis of randomized trials","year":"2026","cit":0,"pfa":"Zan Gao","psa":"Guang-Fen Zhang","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7203455022","eid":"W7203455022"},{"id":"paper-w7211984781","cat":"papers","name":"Esketamine for Postoperative Anxiety After Major Abdominal Tumor Surgery: A Randomized Clinical Trial","year":"2026","cit":0,"pfa":"Cui X","psa":"Zhang W","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7211984781","eid":"W7211984781"},{"id":"paper-w4377103241","cat":"papers","name":"Evaluation of low-dose esketamine on sleep quality in elderly patients undergoing painless gastroscopy","year":"2023","cit":0,"pfa":"Huan Li","psa":"Jian Ming Peng","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4377103241","eid":"W4377103241"},{"id":"paper-w7125418685","cat":"papers","name":"Effect of esketamine on quality of recovery after cancer surgeries: a systematic review and meta-analysis","year":"2026","cit":0,"pfa":"Rudaynah Almithn","psa":"Abdulwahab Alzahrani","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7125418685","eid":"W7125418685"},{"id":"paper-w7172469951","cat":"papers","name":"Review of \"Real‐World Effectiveness and Cost‐Differential of Intranasal Esketamine Versus Intramuscular Ketamine\"","year":"2026","cit":0,"pfa":"Thizwilondi Ananias Magadze","topics":["Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W7172469951","eid":"W7172469951"},{"id":"paper-w4417024160","cat":"papers","name":"Ketamine/esketamine pharmacotherapy for treatment of anxiety disorders and anxiety symptoms in depression: Systematic review","year":"2025","cit":0,"pfa":"Vasilios G. Masdrakis","psa":"David S. Baldwin","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W4417024160","eid":"W4417024160"},{"id":"paper-w4412102880","cat":"papers","name":"The parable of the TGA approval of esketamine (Spravato) in Australia: Part 2 - Submission for listing on the PBS","year":"2025","cit":0,"pfa":"William Lugg","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4412102880","eid":"W4412102880"},{"id":"paper-w4404743534","cat":"papers","name":"Dose-dependent and dynamic effects of esketamine on neurometabolism: a 7T functional MRI/MRS study","year":"2024","cit":0,"pfa":"Daphne E. Boucherie","psa":"Anouk Schrantee","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"conference-paper","src":"https://openalex.org/W4404743534","eid":"W4404743534"},{"id":"paper-w4233904277","cat":"papers","name":"Phase 2 study finds intranasal esketamine effective in treatment‐resistant depression","year":"2018","cit":0,"topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4233904277","eid":"W4233904277"},{"id":"paper-w4394995923","cat":"papers","name":"Esketamine Rapid Antidepression Combined with Dexmedetomidine Sleep Modulation for Patients with Depression and Insomnia","year":"2024","cit":0,"pfa":"Muyan Zuo","psa":"Jian‐Xiong An","topics":["Depression"],"ptype":"preprint","src":"https://openalex.org/W4394995923","eid":"W4394995923"},{"id":"paper-w7155691659","cat":"papers","name":"Esketamine for Postoperative Multimodal Analgesia in Laparoscopic Surgery: A Systematic Review and Meta-Analysis","year":"2026","cit":0,"pfa":"Jinze Li","psa":"Xiuqin Wang","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W7155691659","eid":"W7155691659"},{"id":"paper-w7203954587","cat":"papers","name":"Ketamine and Esketamine for PTSD: Randomized Controlled Trials and Systematic Reviews Evidence Dataset","year":"2026","cit":0,"pfa":"Michael Alvear","topics":["PTSD & trauma","Reviews & meta-analyses"],"ptype":"dataset","src":"https://openalex.org/W7203954587","eid":"W7203954587"},{"id":"paper-w4414043957","cat":"papers","name":"Esketamine for Treatment of Cognitive Decline in Alzheimer’s Disease: A Scoping Review of Pre-clinical Studies","year":"2025","cit":0,"pfa":"Mohamed ElSayed","psa":"Islam Mohammad Shehata","topics":["Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4414043957","eid":"W4414043957"},{"id":"paper-w7128791791","cat":"papers","name":"Multi-Analyst Reanalysis of IPD on Esketamine and Suicidality, Statistical Analysis Plan (Team 3)","year":"2026","cit":0,"pfa":"Muhammad Riedha","psa":"Grigorios Papapostolou","topics":["Depression"],"ptype":"preprint","src":"https://openalex.org/W7128791791","eid":"W7128791791"},{"id":"paper-w4390756823","cat":"papers","name":"The Efficacy of Low-Dose Esketamine and Butorphanol in Treating Depression and Pain After Cesarean Section","year":"2023","cit":0,"pfa":"Chunyan Zhao","psa":"Bingchun Xia","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4390756823","eid":"W4390756823"},{"id":"paper-w4414208127","cat":"papers","name":"“Improvements in Reflective Functioning in Patients with Treatment-Resistant Depression and Personality Disorder Treated with Esketamine”","year":"2025","cit":0,"pfa":"Miriam Olivola","psa":"Federica Calorio","topics":["Depression","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4414208127","eid":"W4414208127"},{"id":"paper-w4411502285","cat":"papers","name":"Ketamine versus esketamine for preventing postpartum depression after cesarean delivery: A meta-analysis","year":"2025","cit":0,"pfa":"Wanwen Li","psa":"Yonghui Shen","topics":["Depression","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4411502285","eid":"W4411502285"},{"id":"paper-w7171032806","cat":"papers","name":"Analgesic effects of esketamine combined with sufentanil after burn surgery: A randomized controlled trial","year":"2026","cit":0,"pfa":"Jiao Jin","ptype":"dataset","src":"https://openalex.org/W7171032806","eid":"W7171032806"},{"id":"paper-w4388575611","cat":"papers","name":"Esketamine pretreatment during cesarean section reduced the incidence of PPD: A randomized controlled trail","year":"2023","cit":0,"pfa":"Shixia Xu","psa":"Jianjun Yang","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4388575611","eid":"W4388575611"},{"id":"paper-w7155528678","cat":"papers","name":"A call for the systematic assessment of sexual adverse events in ketamine and esketamine trials and clinical practice","year":"2026","cit":0,"pfa":"Sanne Y. Smith-Apeldoorn","psa":"Robert A. Schoevers","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7155528678","eid":"W7155528678"},{"id":"paper-w7159621750","cat":"papers","name":"Higher Neutrophil-to-Lymphocyte Ratio Is Associated With Better Response to Esketamine in Treatment-Resistant Depression","year":"2026","cit":0,"pfa":"Matteo Carminati","psa":"Raffaella Zanardi","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7159621750","eid":"W7159621750"},{"id":"paper-w4414208022","cat":"papers","name":"Descriptive study on esketamine and ketamine treatment in real-world patients with a diagnosis of resistant depression","year":"2025","cit":0,"pfa":"Elizabeth M Vera","psa":"I. Riedel","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4414208022","eid":"W4414208022"},{"id":"paper-w7124461097","cat":"papers","name":"Effect of dexmedetomidine combined with esketamine on postoperative anxiety and neuropsychiatric symptoms in breast cancer patients","year":"2025","cit":0,"pfa":"ZHOU Li","psa":"Xiuxia Chen","topics":["Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7124461097","eid":"W7124461097"},{"id":"paper-w7164580289","cat":"papers","name":"Esketamine for negative emotions and cognitive function in general anesthesia: a systematic review and meta-analysis","year":"2026","cit":0,"pfa":"Xiaofan Yang","psa":"Wenying Xu","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W7164580289","eid":"W7164580289"},{"id":"paper-w4416158686","cat":"papers","name":"Clinical Application Effect of Ciprofol Combined with Low-dose Esketamine in Painless Gastrointestinal Endoscopy","year":"2025","cit":0,"pfa":"D. Zhang","psa":"Shan Ou","topics":["Safety & adverse events","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4416158686","eid":"W4416158686"},{"id":"paper-w7165555478","cat":"papers","name":"Ketamine and Esketamine in Depression: Current Evidence on Mechanisms, Efficacy, Safety and Clinical Use – A Review","year":"2026","cit":0,"pfa":"Urszula Szuleta","psa":"Natalia Prankiewicz","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7165555478","eid":"W7165555478"},{"id":"paper-w7116987869","cat":"papers","name":"The ketamine metabolite ( 2R,6R )‐hydroxynorketamine rescues transcriptional pathways involved with immune activation and mRNA translation in APP/PS1 mice","year":"2025","cit":0,"pfa":"Joao D. Calixtro","psa":"Sergio Teixeira Ferreira","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7116987869","eid":"W7116987869"},{"id":"paper-w4200063260","cat":"papers","name":"P.0678 Tensional values in hypertensive patients treated with intranasal esketamine for resistant depression","year":"2021","cit":0,"pfa":"M. Vega","psa":"A. Cebollada","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4200063260","eid":"W4200063260"},{"id":"paper-w7149005208","cat":"papers","name":"Ciprofol-Esketamine Versus Ciprofol-Remifentanil in Hysteroscopic Endometrial Polypectomy: A Randomized Controlled Trial","year":"2026","cit":0,"pfa":"Zhong Zhang","psa":"Zhiyang Yu","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7149005208","eid":"W7149005208"},{"id":"paper-w4282568346","cat":"papers","name":"Determining the effective dose of esketamine for mitigating pain during propofol injection by the sequential method","year":"2022","cit":0,"pfa":"Wei Gen Zeng","psa":"Ding Huang","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4282568346","eid":"W4282568346"},{"id":"paper-w4241394654","cat":"papers","name":"Faculty Opinions recommendation of Lack of Antidepressant Effects of (2R,6R)-Hydroxynorketamine in a Rat Learned Helplessness Model: Comparison with (R)-Ketamine.","year":"2018","cit":0,"pfa":"Ronald S. Duman","topics":["Depression"],"ptype":"peer-review","src":"https://openalex.org/W4241394654","eid":"W4241394654"},{"id":"paper-w7212003412","cat":"papers","name":"374. Intranasal esketamine in treatment-resistant bipolar depression maintained on long-acting aripiprazole","year":"2026","cit":0,"pfa":"S Makhoul","psa":"N Abdulameer","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7212003412","eid":"W7212003412"},{"id":"paper-w7171957976","cat":"papers","name":"Esketamine Use in Treatment-Resistant Depression with Comorbid ADHD and Autistic Traits: A Case Report","year":"2026","cit":0,"pfa":"E. D. Cindik-Herbrueggen","psa":"A. S. Kucukali","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7171957976","eid":"W7171957976"},{"id":"paper-w7151328099","cat":"papers","name":"Esketamine ameliorates depression-like behavior in mice via modulation of the NRG1–ErbB4 pathway","year":"2026","cit":0,"pfa":"Hang Yu","psa":"Wenjuan Wang","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7151328099","eid":"W7151328099"},{"id":"paper-w4405636896","cat":"papers","name":"Advancing predictive models for intranasal esketamine treatment in psychiatry: evaluating the role of metacognitive variables","year":"2024","cit":0,"pfa":"Pierfelice Cutrufelli","psa":"Antonino Petralia","ptype":"article","src":"https://openalex.org/W4405636896","eid":"W4405636896"},{"id":"paper-w7214514664","cat":"papers","name":"Comparative efficacy and tolerability of intranasal esketamine, IV ketamine, rTMS, and ECT: a systematic review","year":"2026","cit":0,"pfa":"Gonzalo Galiardo Quesada","topics":["Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7214514664","eid":"W7214514664"},{"id":"paper-w4405635775","cat":"papers","name":"Investigating the accute effects of esketamine on effective connectivity using regression dynamic causal modeling","year":"2024","cit":0,"pfa":"Clemens Schmidt","psa":"Manfred Klöbl","ptype":"article","src":"https://openalex.org/W4405635775","eid":"W4405635775"},{"id":"paper-w7171052181","cat":"papers","name":"Analgesic effects of esketamine combined with sufentanil after burn surgery: A randomized controlled trial","year":"2026","cit":0,"pfa":"Jiao Jin","ptype":"dataset","src":"https://openalex.org/W7171052181","eid":"W7171052181"},{"id":"paper-w7204952778","cat":"papers","name":"Nanomolar electrochemical detection of esketamine enabled by a rationally designed aptamer via base substitution","year":"2026","cit":0,"pfa":"Ting Wan","psa":"Yong-bao Lin","ptype":"article","src":"https://openalex.org/W7204952778","eid":"W7204952778"},{"id":"paper-w7139128199","cat":"papers","name":"Comment on Esketamine 5 Years After Approval: Welcome New Data With Continuing Questions","year":"2026","cit":0,"pfa":"Muhammad Ahmed","psa":"Gerard Sanacora","ptype":"article","src":"https://openalex.org/W7139128199","eid":"W7139128199"},{"id":"paper-w7171692762","cat":"papers","name":"Dose-dependent effect of esketamine on preventing rocuronium-induced limb withdrawal in preschool children","year":"2026","cit":0,"pfa":"Jie Wang","psa":"Wenlu Ma","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7171692762","eid":"W7171692762"},{"id":"paper-w4406778878","cat":"papers","name":"How esketamine influences inflammatory cytokines, cortisol and anhedonia in TRD patients is an open question","year":"2025","cit":0,"pfa":"Thalles Rodrigues Alves Leite","psa":"Luísa Weber Bisol","ptype":"article","src":"https://openalex.org/W4406778878","eid":"W4406778878"},{"id":"paper-w7153681502","cat":"papers","name":"Interpreting Reduced Postoperative hs-cTnT After Intraoperative Esketamine: Methodological Considerations [Letter]","year":"2026","cit":0,"pfa":"Lu CW","psa":"Chang Kc","ptype":"article","src":"https://openalex.org/W7153681502","eid":"W7153681502"},{"id":"paper-w7213429403","cat":"papers","name":"Multi-Analyst Reanalysis of IPD on Esketamine and Suicidality, Statistical Analysis Plan (Team 3)","year":"2026","cit":0,"pfa":"Muhammad Riedha","psa":"Florian Naudet","topics":["Depression"],"ptype":"preprint","src":"https://openalex.org/W7213429403","eid":"W7213429403"},{"id":"paper-w7214124547","cat":"papers","name":"Peripheral Biomarkers of Response to Ketamine and Esketamine Treatment in Unipolar Depressive Disorder—A Scoping Review","year":"2026","cit":0,"pfa":"Aleksandra Metelska","psa":"Hanna Karakuła‐Juchnowicz","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7214124547","eid":"W7214124547"},{"id":"paper-w7124835029","cat":"papers","name":"Clinical, Metabolic and Inflammatory Indicators of Esketamine Efficacy for Treatment-Resistant Major Depressive Episodes","year":"2025","cit":0,"pfa":"Ifeoluwa F. Olaoluwa","topics":["Depression","Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W7124835029","eid":"W7124835029"},{"id":"paper-w4390222396","cat":"papers","name":"The effect of intranasal esketamine on key domains of treatment-resistant depression: clinicians and patients’ perspective","year":"2023","cit":0,"pfa":"Maria Pepe","psa":"Marco Di Nicola","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4390222396","eid":"W4390222396"},{"id":"paper-w7118021921","cat":"papers","name":"Real-world experience of 45 patients using intranasal esketamine for treatment-resistant depression","year":"2026","cit":0,"pfa":"C. De Oliveira Lapa","psa":"L. Spanemberg","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7118021921","eid":"W7118021921"},{"id":"paper-w4411394867","cat":"papers","name":"The dose-dependent efficacy of esketamine in spinal surgery with intraoperative neuroelectrophysiological monitoring: a randomized controlled trial","year":"2025","cit":0,"pfa":"Chunyan Lin","psa":"Liangguang Zhang","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4411394867","eid":"W4411394867"},{"id":"paper-w4318970946","cat":"papers","name":"Esketamine use for anesthesia induction in an ectopic pregnancy patient with hemorrhagic shock: a case report","year":"2022","cit":0,"pfa":"Xiaojie Liu","psa":"Tianjun Li","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4318970946","eid":"W4318970946"},{"id":"paper-w7162501746","cat":"papers","name":"Structural Neurotoxic and Neuroprotective Effects of Ketamine and Esketamine in Preclinical and Human Studies: A Systematic Review","year":"2026","cit":0,"pfa":"Tychique T. Wasolua","psa":"Taeho Greg Rhee","topics":["Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7162501746","eid":"W7162501746"},{"id":"paper-w7149457615","cat":"papers","name":"Peribulbar anesthesia with targeted intravenous esketamine analgosedation during enucleation: A contemporary narrative review","year":"2026","cit":0,"pfa":"Margita Lucic","psa":"Dolika D. Vasović","topics":["Mechanism & neuroscience","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7149457615","eid":"W7149457615"},{"id":"paper-w7132840505","cat":"papers","name":"ADVERSE EFFECTS OF ESKETAMINE IN TREATMENT RESISTANT DEPRESSION: A COMPREHENSIVE LITERATURE REVIEW (2020-2025)","year":"2026","cit":0,"pfa":"Aleksandra Lejman","psa":"Monika Wołosik","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7132840505","eid":"W7132840505"},{"id":"paper-w7168030275","cat":"papers","name":"Comparison of Esketamine and Remifentanil Combined With Propofol for Painless Fiberoptic Bronchoscopy: A Randomized Controlled Trial","year":"2026","cit":0,"pfa":"范秀丽","psa":"Ke Jiang","ptype":"article","src":"https://openalex.org/W7168030275","eid":"W7168030275"},{"id":"paper-w4390223818","cat":"papers","name":"Pharmacokinetic interactions between esketamine and different classes of antidepressants in patients with treatment-resistant depression","year":"2023","cit":0,"pfa":"M. Alborghetti","psa":"Sergio De Filippis","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4390223818","eid":"W4390223818"},{"id":"paper-w4416189688","cat":"papers","name":"Sequential esketamine and dextromethorphan-bupropion in treatment-resistant depression with bipolar features: A case report","year":"2025","cit":0,"pfa":"Neekoo Farahmandpour","psa":"Jeffrey Feola","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4416189688","eid":"W4416189688"},{"id":"paper-w7140092816","cat":"papers","name":"scan2030/scan2030-WP-3_TRD_ESK_CEA: Updated code for TRD Esketamine cost-effectiveness analysis","year":"2026","cit":0,"pfa":"scan2030","topics":["Depression"],"ptype":"software","src":"https://openalex.org/W7140092816","eid":"W7140092816"},{"id":"paper-w4409865667","cat":"papers","name":"Efficacy of low-dose esketamine combined with propofol/etomidate mixture in painless gastroscopy anesthesia","year":"2025","cit":0,"pfa":"Desheng Hu","psa":"Xi-Chun Ye","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4409865667","eid":"W4409865667"},{"id":"paper-w4405636251","cat":"papers","name":"Variables associated with response to Esketamine nasal spray treatment in clinical practice: Integrate study","year":"2024","cit":0,"pfa":"Patricio Molero","psa":"Pilar Alejandra Sáiz","ptype":"article","src":"https://openalex.org/W4405636251","eid":"W4405636251"},{"id":"paper-w4410240310","cat":"papers","name":"Esketamine relieves postoperative depression and pain indicators in patients undergoing laparoscopic total hysterectomy","year":"2025","cit":0,"pfa":"Jun Jing","psa":"Yuanhai Li","topics":["Depression"],"ptype":"preprint","src":"https://openalex.org/W4410240310","eid":"W4410240310"},{"id":"paper-w4406624672","cat":"papers","name":"Research Progress of Different Concentrations of Esketamine for Postoperative Analgesia and Antidepression after Cesarean Delivery","year":"2025","cit":0,"pfa":"鹏宇 赵","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4406624672","eid":"W4406624672"},{"id":"paper-w4385669818","cat":"papers","name":"Adjunctive short- and long-term combination treatment of esketamine and VNS in difficult to treat depression (DTD)","year":"2023","cit":0,"pfa":"Erhan Kavakbasi","psa":"Bernhard Theodor Baune","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4385669818","eid":"W4385669818"},{"id":"paper-w4416789292","cat":"papers","name":"Esketamine improves postoperative cognition and reduces neuronal injury in gynecologic oncology patients with preoperative anxiety","year":"2025","cit":0,"pfa":"Changrui Gao","psa":"Yan Gao","topics":["Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4416789292","eid":"W4416789292"},{"id":"paper-w4294189660","cat":"papers","name":"Intranasal Esketamine + CBT: a 6 months follow-up of a resistant depression complicated case","year":"2022","cit":0,"pfa":"Vassilis Martiadis","psa":"M. Russo","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4294189660","eid":"W4294189660"},{"id":"paper-w4390223401","cat":"papers","name":"The potential of altered states of consciousness induced through virtual reality integrated with esketamine therapy","year":"2023","cit":0,"pfa":"A. Anastasi","psa":"Paolo Brambilla","ptype":"article","src":"https://openalex.org/W4390223401","eid":"W4390223401"},{"id":"paper-w7171953426","cat":"papers","name":"Esketamine-induced dentate gyrus plasticity in treatment resistant depression: first-in-human evidence","year":"2026","cit":0,"pfa":"A. Le","psa":"M. Plaze","topics":["Depression","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7171953426","eid":"W7171953426"},{"id":"paper-w3043648368","cat":"papers","name":"Cost-effectiveness of intranasal esketamine for treatment of treatment-resistant major depressive disorder in the Netherlands","year":"2018","cit":0,"pfa":"Gydo Van Galen","topics":["Depression"],"ptype":"dissertation","src":"https://openalex.org/W3043648368","eid":"W3043648368"},{"id":"paper-w7165615081","cat":"papers","name":"Network pharmacology and experimental verification to explore the therapeutic mechanism of esketamine in postoperative cognitive dysfunction","year":"2026","cit":0,"pfa":"Yifei Zhan","psa":"Sihua Qi","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7165615081","eid":"W7165615081"},{"id":"paper-w7208711292","cat":"papers","name":"Esketamine vs. sufentanil for quality of recovery after outpatient gynecological surgery: a randomized clinical trial","year":"2026","cit":0,"pfa":"Xu-Lin Wang","psa":"Na Xing","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7208711292","eid":"W7208711292"},{"id":"paper-w4414373362","cat":"papers","name":"Effect of Esketamine-based Opioid-free Anesthesia on Bariatric Surgery A Randomized Clinical Trial","year":"2025","cit":0,"pfa":"Chunxia Huang","psa":"Qi Xue","topics":["Addiction"],"ptype":"preprint","src":"https://openalex.org/W4414373362","eid":"W4414373362"},{"id":"paper-w4416846205","cat":"papers","name":"Esketamine-induced dentate gyrus plasticity in treatment resistant depression: First-in-human evidence","year":"2025","cit":0,"pfa":"Alice Le Berre","topics":["Depression"],"ptype":"preprint","src":"https://openalex.org/W4416846205","eid":"W4416846205"},{"id":"paper-w7208728079","cat":"papers","name":"Esketamine for Postoperative Anxiety After Major Abdominal Tumor Surgery: A Randomized Clinical Trial","year":"2026","cit":0,"pfa":"Xiaoying Cui","psa":"Wen Zhang","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7208728079","eid":"W7208728079"},{"id":"paper-w7154569488","cat":"papers","name":"Effect of opioid sparing anesthesia with esketamine on PONV in laparoscopic sleeve gastrectomy randomized trial","year":"2026","cit":0,"pfa":"Kai-Rui Shi","psa":"Chun Yang","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7154569488","eid":"W7154569488"},{"id":"paper-w4387501708","cat":"papers","name":"F47. TRANSCRIPTIONAL PROFILING OF PERIPHERAL BLOOD IN DEPRESSIVE PATIENTS TREATED WITH ESKETAMINE NASAL SPRAY","year":"2023","cit":0,"pfa":"Qingqin S. Li","psa":"Wayne Curtis Drevets","topics":["Depression"],"ptype":"conference-abstract","src":"https://openalex.org/W4387501708","eid":"W4387501708"},{"id":"paper-w7171946317","cat":"papers","name":"Esketamine nasal spray: real world use in the Department of Mental Health of Rimini (Italy)","year":"2026","cit":0,"pfa":"M. P. Rapagnani","psa":"F. Sartini","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7171946317","eid":"W7171946317"},{"id":"paper-w7160325816","cat":"papers","name":"Effects of Esketamine on Postoperative Sleep Quality: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","year":"2026","cit":0,"pfa":"Jiacheng Zhao","psa":"Jie Wang","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W7160325816","eid":"W7160325816"},{"id":"paper-w7208729165","cat":"papers","name":"Esketamine vs. sufentanil for quality of recovery after outpatient gynecological surgery: a randomized clinical trial","year":"2026","cit":0,"pfa":"Xu-Lin Wang","psa":"Na Xing","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7208729165","eid":"W7208729165"},{"id":"paper-w7165654106","cat":"papers","name":"Effects of esketamine on perioperative renal injury in paediatric patients undergoing living donor liver transplantation","year":"2026","cit":0,"pfa":"Hua Li","psa":"Wen-Li Yu","ptype":"article","src":"https://openalex.org/W7165654106","eid":"W7165654106"},{"id":"paper-w7163896452","cat":"papers","name":"Efficacy and safety of perioperative esketamine in improving postoperative sleep disturbances: A systematic review and meta-analysis","year":"2026","cit":0,"pfa":"Xinyu Yang","psa":"L Zhang","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7163896452","eid":"W7163896452"},{"id":"paper-w7117983129","cat":"papers","name":"Esketamine as a modulator of emotional blunting in treatment-resistant depression: clinical insights from a naturalistic study","year":"2026","cit":0,"pfa":"S.E. Rossi","psa":"Gianluca Serafini","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7117983129","eid":"W7117983129"},{"id":"paper-w4387516307","cat":"papers","name":"A HOPEFUL ALTERNATIVE “THERAPY WITH INTRA- NASAL ESKETAMINE IN A PATIENT WITH RESISTANT DEPRESSION”. A CASE REPORT.","year":"2023","cit":0,"pfa":"Rosa M Galán-Armenteros","psa":"Antonio J Moreno-Campos","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4387516307","eid":"W4387516307"},{"id":"paper-w4405635807","cat":"papers","name":"Serial esketamine treatment for treatment-resistant bipolar depression: a case of remission and future considerations","year":"2024","cit":0,"pfa":"Ilsen Semiha Kececi","psa":"Sinem Zeynep Metin","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4405635807","eid":"W4405635807"},{"id":"paper-w4410018841","cat":"papers","name":"SAFETY AND EFFICACY OF ESKETAMINE COMBINED WITH PROPOFOL IN GASTROINTESTINAL ENDOSCOPY: A SYSTEMATIC REVIEW AND META-ANALYSIS","year":"2025","cit":0,"pfa":"Ahmed Farag","psa":"Mohamed Mohsen Helal","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4410018841","eid":"W4410018841"},{"id":"paper-w7202070078","cat":"papers","name":"Therapeutic Use of Ketamine and Esketamine in Treatment-Resistant Depression: Clinical Evidence and Future Prospects","year":"2026","cit":0,"pfa":"Marco Aurélio Silva Couto","psa":"Ana Paula Santos Nogueira","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7202070078","eid":"W7202070078"},{"id":"paper-w4401921947","cat":"papers","name":"Real-world effectiveness and safety of esketamine intranasal spray combined with treatment-as-usual in psychiatric inpatients","year":"2024","cit":0,"pfa":"Erhan Kavakbasi","psa":"Bernhard Theodor Baune","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4401921947","eid":"W4401921947"},{"id":"paper-w4297387062","cat":"papers","name":"The feasibility analysis of opioid-free general anesthesia with dexmedetomidine- esketamine-lidocaine for patients undergoing lumpectomy","year":"2022","cit":0,"pfa":"Xia-li Qian","psa":"Shanwu Feng","topics":["Addiction","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4297387062","eid":"W4297387062"},{"id":"paper-w7125185501","cat":"papers","name":"Network pharmacology of cellular targets in major depressive disorder and differential mechanisms of fluoxetine, ketamine and esketamine","year":"2026","cit":0,"pfa":"Silvia Tapia-Gonzalez","psa":"George Emilio Barreto","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7125185501","eid":"W7125185501"},{"id":"paper-w2969463716","cat":"papers","name":"Subcutaneous Esketamine in a Case of Complex Post-Traumatic Stress Disorder: Case Report, a Negative Result","year":"2019","cit":0,"pfa":"Andréa F. Mello","topics":["PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W2969463716","eid":"W2969463716"},{"id":"paper-w4416543337","cat":"papers","name":"Prefrontal neurophysiological changes associated with subanesthetic esketamine accelerating mice emergence from propofol anesthesia","year":"2025","cit":0,"pfa":"Yinying Sun","psa":"Jun Zhang","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4416543337","eid":"W4416543337"},{"id":"paper-w7208720094","cat":"papers","name":"Esketamine vs. sufentanil for quality of recovery after outpatient gynecological surgery: a randomized clinical trial","year":"2026","cit":0,"pfa":"Xu-Lin Wang","psa":"Na Xing","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7208720094","eid":"W7208720094"},{"id":"paper-w7117963164","cat":"papers","name":"Can esketamine save lives? Real-world effectiveness on suicide risk in treatment-resistant depression","year":"2026","cit":0,"pfa":"Ana Isabel de Santiago-Díaz","psa":"S. Arostegui-Uranga","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7117963164","eid":"W7117963164"},{"id":"paper-w7170161625","cat":"papers","name":"Use of esketamine combined with dexmedetomidine for difficult tracheal intubation in an uncooperative pediatric patient with severe trismus","year":"2026","cit":0,"pfa":"Jia Jiang","psa":"Guifang Yu","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7170161625","eid":"W7170161625"},{"id":"paper-w7204883036","cat":"papers","name":"Refining sedation strategies in elderly patients: A critical analysis of esketamine and propofol combination in gastrointestinal endoscopy","year":"2026","cit":0,"pfa":"Muhammad Taufan Umasugi","psa":"Djulfikri Mewar","ptype":"article","src":"https://openalex.org/W7204883036","eid":"W7204883036"},{"id":"paper-w7203700059","cat":"papers","name":"Esketamine Alleviates Neuropathic Pain and Inflammation via miR‐153–3p/AKT3 in CCI Rats","year":"2026","cit":0,"pfa":"Xiumei Zhu","psa":"Yawen Zhang","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7203700059","eid":"W7203700059"},{"id":"paper-w4393363067","cat":"papers","name":"Mechanism of the antidepressant-like effects of ketamine and its main metabolite (2R,6R)-hydroxynorketamine : role of the excitatory and inhibitory balance in mice","year":"2018","cit":0,"pfa":"Thu Ha Pham","topics":["Depression","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W4393363067","eid":"W4393363067"},{"id":"paper-w7160869474","cat":"papers","name":"Long-Lasting Analgesic Effects of (2R,6R)-Hydroxynorketamine in a Mouse Model of Chemotherapy-Induced Peripheral Neuropathy (Abstract ID: 226013)","year":"2026","cit":0,"pfa":"Bruno Carabelli","psa":"Irwin Lucki","ptype":"article","src":"https://openalex.org/W7160869474","eid":"W7160869474"},{"id":"paper-w7203524275","cat":"papers","name":"Statistical Analysis Plan - Multi-Analyst meta-analysis of individual patient data on Esketamine and Suicidality","year":"2026","cit":0,"pfa":"Ulrike Held","psa":"Florian Naudet","topics":["Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7203524275","eid":"W7203524275"},{"id":"paper-w7161154991","cat":"papers","name":"Physicochemical stability of sufentanil and esketamine containing analgesic mixtures applied for patient-controlled intravenous analgesia","year":"2026","cit":0,"pfa":"Manman Yao","psa":"陈富超","ptype":"article","src":"https://openalex.org/W7161154991","eid":"W7161154991"},{"id":"paper-w7214511923","cat":"papers","name":"Trauma burden and response to esketamine in difficult-to-treat depression /DTD) : a 6-month longitudinal analysis","year":"2026","cit":0,"pfa":"Carla Gajano Diego","topics":["Depression","PTSD & trauma","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W7214511923","eid":"W7214511923"},{"id":"paper-w4395449315","cat":"papers","name":"Lung-protective effect of low-dose esketamine in patients undergoing radical resection of lung cancer","year":"2024","cit":0,"pfa":"Jiahui Zhao","psa":"Fengmei Duan","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4395449315","eid":"W4395449315"},{"id":"paper-w4414180725","cat":"papers","name":"Esketamine in Treatment Resistant Depression: Acute Effects on Dissociation and Therapeutic Effects at the End of the Induction Period","year":"2025","cit":0,"pfa":"Ginevra Lombardozzi","psa":"S. De Filippis","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4414180725","eid":"W4414180725"},{"id":"paper-w7161577733","cat":"papers","name":"TMS Provides More Durable Remission of Suicidal Ideation Versus Esketamine in a Real-World Sample","year":"2026","cit":0,"pfa":"Lynne Alison McInnes","psa":"Tobias Marton","ptype":"article","src":"https://openalex.org/W7161577733","eid":"W7161577733"},{"id":"paper-w7137594068","cat":"papers","name":"Efficacy of ketamine/esketamine in adults with treatment-resistant depression : a systematic literature review with meta-analysis","year":"2025","cit":0,"pfa":"Carlos David Cifuentes Chamorro","psa":"David Felipe Vásquez Moreno","topics":["Depression","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7137594068","eid":"W7137594068"},{"id":"paper-w7118022732","cat":"papers","name":"GRIN2B: SNPs and haplotypes association with treatment resistant depression severity and treatment-response to intranasal esketamine","year":"2026","cit":0,"pfa":"S. Estela","psa":"L. Erkoreka","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7118022732","eid":"W7118022732"},{"id":"paper-w7171963700","cat":"papers","name":"Does Intranasal Esketamine Show Differential Efficacy with SSRIs versus SNRIs in Treatment-Resistant Depression?","year":"2026","cit":0,"pfa":"M. Pompili","psa":"I. Berardelli","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7171963700","eid":"W7171963700"},{"id":"paper-w7155382222","cat":"papers","name":"The effect of esketamine on emergence delirium or agitation in children after anesthesia-a systematic review and meta-analysis","year":"2026","cit":0,"pfa":"W Yang","psa":"He Huang","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"other","src":"https://openalex.org/W7155382222","eid":"W7155382222"},{"id":"paper-w7155385662","cat":"papers","name":"The effect of esketamine on emergence delirium or agitation in children after anesthesia-a systematic review and meta-analysis","year":"2026","cit":0,"pfa":"W Yang","psa":"He Huang","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"other","src":"https://openalex.org/W7155385662","eid":"W7155385662"},{"id":"paper-w4414339729","cat":"papers","name":"Esketamine for Acute Herpes Zoster‐Associated Pain: A Matched Cohort Study in a Dermatologic Inpatient Setting","year":"2025","cit":0,"pfa":"Chiara A. Kirchler","psa":"Robert ­Müllegger","ptype":"article","src":"https://openalex.org/W4414339729","eid":"W4414339729"},{"id":"paper-w7128717773","cat":"papers","name":"Statistical Analysis Plan - Multi-Analyst meta-analysis of individual patient data on Esketamine and Suicidality","year":"2026","cit":0,"pfa":"Mian Haider Ali","psa":"K. Tai","topics":["Depression","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7128717773","eid":"W7128717773"},{"id":"paper-w7155649995","cat":"papers","name":"Preliminary evidence that serum interleukin-6 is a candidate biomarker of response to esketamine in treatment-resistant depression","year":"2026","cit":0,"pfa":"Marco Colizzi","psa":"Marco Garzitto","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7155649995","eid":"W7155649995"},{"id":"paper-w7135231947","cat":"papers","name":"PO 246 ECT and esketamine for treatment of super refractory status epilepticus: a two case experience","year":"2026","cit":0,"pfa":"Hanneke M. Keijzer","psa":"Bas C. Stunnenberg","ptype":"article","src":"https://openalex.org/W7135231947","eid":"W7135231947"},{"id":"paper-w4414211376","cat":"papers","name":"Effect of intraoperative low dose esketamine on TNF-α and IL-6 in patients with colorectal cancer","year":"2025","cit":0,"pfa":"Yang Qu","psa":"Tian Li","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4414211376","eid":"W4414211376"},{"id":"paper-w7172034205","cat":"papers","name":"Association of esketamine with acute lung injury and macrophage polarization-related markers after ATAAD surgery","year":"2026","cit":0,"pfa":"Xiangqian Cui","psa":"Hexi Hou","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7172034205","eid":"W7172034205"},{"id":"paper-w4415547116","cat":"papers","name":"Response to the letter regarding “Risk of manic switch and suicidal outcomes in bipolar depression treated with esketamine”","year":"2025","cit":0,"pfa":"Tinghui Liu","psa":"Chih‐Cheng Lai","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4415547116","eid":"W4415547116"},{"id":"paper-w7167733522","cat":"papers","name":"Esketamine for treatment-resistant depression: Comparing two maintenance schedules in an observational real-world study","year":"2026","cit":0,"pfa":"Samuel Westenhöfer","psa":"Johannes Jungwirth","topics":["Depression"],"ptype":"preprint","src":"https://openalex.org/W7167733522","eid":"W7167733522"},{"id":"paper-w4414710817","cat":"papers","name":"Adolescent Suicidality and Depression, Premenstrual Dysphoric Disorder, and Safety Issues Related to Ketamine and Esketamine Treatment","year":"2025","cit":0,"pfa":"Ned H. Kalin","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4414710817","eid":"W4414710817"},{"id":"paper-w7135049580","cat":"papers","name":"Comparative analysis of esketamine versus remimazolam in adult and pediatric surgical patients: a multimodal monitoring evaluation","year":"2026","cit":0,"pfa":"Hantao Fang","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7135049580","eid":"W7135049580"},{"id":"paper-w4390241612","cat":"papers","name":"Treatment-resistant depression in adults: efficacy, safety and clinical stability of intranasal esketamine on compassionate use","year":"2023","cit":0,"pfa":"Ana Isabel de Santiago-Díaz","psa":"Jesús Artal-Simón","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4390241612","eid":"W4390241612"},{"id":"paper-w4405637215","cat":"papers","name":"Depersonalization and derealization, embodiment abnormalities and salience alterations: impact on medium-term esketamine treatment outcomes","year":"2024","cit":0,"pfa":"Ottone Baccaredda Boy","psa":"Tommaso Vannucchi","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4405637215","eid":"W4405637215"},{"id":"paper-w7171973529","cat":"papers","name":"Integrative Use of Esketamine and Psychotherapy in a Real-World Outpatient Setting: A Mixed-Methods Case Series","year":"2026","cit":0,"pfa":"N. Ayad","psa":"F. alkhaja","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7171973529","eid":"W7171973529"},{"id":"paper-w7114930441","cat":"papers","name":"Optimizing the Subanesthetic Dose of Esketamine Combined with Propofol for Painless Gastroscopy in Adults: A Prospective Observational Study","year":"2025","cit":0,"pfa":"Hai-Xia Wang","psa":"Kai Su","topics":["Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7114930441","eid":"W7114930441"},{"id":"paper-w4410996963","cat":"papers","name":"Ultrasound-Guided Thoracic Paravertebral Block with Levobupivacaine-Esketamine Combination for Thoracoscopic Lung Cancer Surgery","year":"2025","cit":0,"pfa":"Yibing Jing","psa":"Chao Han","topics":["Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W4410996963","eid":"W4410996963"},{"id":"paper-w7164181942","cat":"papers","name":"Functional outcomes with esketamine in treatment-resistant depression: A 6-month multicenter real-world study","year":"2026","cit":0,"pfa":"Riccardo Guglielmo","psa":"Gianluca Serafini","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7164181942","eid":"W7164181942"},{"id":"paper-w7125378662","cat":"papers","name":"Response to the letter regarding \"risk of manic switch and suicidal outcomes in bipolar depression treated with esketamine\"","year":"2026","cit":0,"pfa":"Tinghui Liu","psa":"Chih-Cheng Lai","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7125378662","eid":"W7125378662"},{"id":"paper-w4391800092","cat":"papers","name":"The ED 50 /ED 95 of esketamine in inhibiting body movement when patients undergoing hysteroscopy","year":"2024","cit":0,"pfa":"Dan Wang","psa":"Ying Zhong","ptype":"preprint","src":"https://openalex.org/W4391800092","eid":"W4391800092"},{"id":"paper-w7167737208","cat":"papers","name":"Efficacy and safety of perioperative esketamine for postoperative depressive symptoms in breast cancer patients: a meta-analysis","year":"2026","cit":0,"pfa":"Ruoyi Ji","psa":"Fanceng Ji","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W7167737208","eid":"W7167737208"},{"id":"paper-w4385542251","cat":"papers","name":"The ketamine metabolite ( 2R,6R )-hydroxynorketamine rescues hippocampal mRNA translation, synaptic plasticity and memory in mouse models of Alzheimer’s disease","year":"2023","cit":0,"pfa":"Felipe Campos Ribeiro","psa":"Sergio Teixeira Ferreira","topics":["Depression","Mechanism & neuroscience","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4385542251","eid":"W4385542251"},{"id":"paper-w4410406832","cat":"papers","name":"Esketamine in epidural analgesia and its potential role in modulating postpartum depression via neurochemical pathways","year":"2025","cit":0,"pfa":"Ting Cao","psa":"Chun'ai Wang","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4410406832","eid":"W4410406832"},{"id":"paper-w4253985452","cat":"papers","name":"Faculty Opinions recommendation of (R)-Ketamine Shows Greater Potency and Longer Lasting Antidepressant Effects Than Its Metabolite (2R,6R)-Hydroxynorketamine.","year":"2018","cit":0,"pfa":"Ronald S. Duman","topics":["Depression"],"ptype":"peer-review","src":"https://openalex.org/W4253985452","eid":"W4253985452"},{"id":"paper-w7155543299","cat":"papers","name":"Concurrent SSRI, SNRI, or Other Antidepressant Use Not Associated With Differential Outcomes in Ketamine or Esketamine Treatment","year":"2026","cit":0,"pfa":"Erin Curran","psa":"Samuel T. Wilkinson","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7155543299","eid":"W7155543299"},{"id":"paper-w7135094596","cat":"papers","name":"Esketamine Implementation Challenges in Psychiatry: A Qualitative Analysis of Mental Healthcare Providers’ Social Media Commentary","year":"2026","cit":0,"pfa":"Brian Scott Barnett","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7135094596","eid":"W7135094596"},{"id":"paper-w7160992449","cat":"papers","name":"Intranasal Dexmedetomidine Versus Esketamine As Premedication for the Sedation of Pediatric Patients: A Systematic Review and Meta-Analysis","year":"2026","cit":0,"pfa":"Lelian Ghaly","psa":"Mohamed Hesham Gamal","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W7160992449","eid":"W7160992449"},{"id":"paper-w7164907126","cat":"papers","name":"Trajectory of response to esketamine nasal spray for treatment resistant depression: Findings from ESCAPE-TRD","year":"2026","cit":0,"pfa":"Allan Hunter Young","psa":"Philip A. P. M. Gorwood","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7164907126","eid":"W7164907126"},{"id":"paper-w7165495086","cat":"papers","name":"Discharge Readiness After Propofol with or without Esketamine for Flexible Bronchoscopy: A Randomized Non-Inferiority Trial","year":"2026","cit":0,"pfa":"Xiaohong Zhang","psa":"Yusheng Yao","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7165495086","eid":"W7165495086"},{"id":"paper-w7171843560","cat":"papers","name":"Interpreting Perineural Esketamine for Analgesia After Total Knee Arthroplasty: Methodological and Reporting Considerations [Letter]","year":"2026","cit":0,"pfa":"Zijin Zhou","psa":"Jun Lü","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7171843560","eid":"W7171843560"},{"id":"paper-w7119657953","cat":"papers","name":"Dexmedetomidine-esketamine combination for anesthesia in a patient with severe Swyer-James-Macleod syndrome: a case report","year":"2026","cit":0,"pfa":"Hao-Tian Rong","psa":"Dong‐Xin Wang","topics":["Therapy practice"],"ptype":"article","src":"https://openalex.org/W7119657953","eid":"W7119657953"},{"id":"paper-w4391806991","cat":"papers","name":"Esketamine nasal spray (spravato) for treatment-resistant depression in a transgender veteran with borderline personality disorder","year":"2023","cit":0,"pfa":"Lydiah Fridah Mpyisi","psa":"Sarah Canoy","topics":["Depression","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4391806991","eid":"W4391806991"},{"id":"paper-w4405754328","cat":"papers","name":"Efficacy and safety of ketamine and esketamine for preventing opioid-induced cough: a meta-analysis of randomized controlled trials","year":"2024","cit":0,"pfa":"I‐Wen Chen","psa":"Chia‐Li Kao","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4405754328","eid":"W4405754328"},{"id":"paper-w7124626054","cat":"papers","name":"Dose-dependent effects of esketamine on the prevention of propofol-induced injection pain: a randomized controlled trial","year":"2026","cit":0,"pfa":"Danyun Fu","psa":"Jie Jia","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7124626054","eid":"W7124626054"},{"id":"paper-w7128191269","cat":"papers","name":"The role of frontal EEG in predicting clinical response of major depressive disorder to intranasal ketamine and esketamine","year":"2026","cit":0,"pfa":"Carlos Trenado","psa":"Stefano Ferrea","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7128191269","eid":"W7128191269"},{"id":"paper-w7160566047","cat":"papers","name":"Effects of Esketamine on Postoperative Sleep Quality: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","year":"2026","cit":0,"pfa":"Zhao J","psa":"J Wang","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W7160566047","eid":"W7160566047"},{"id":"paper-w4413284343","cat":"papers","name":"189. EXPLORING THE SUBJECTIVE EXPERIENCE OF PATIENTS WITH TREATMENT-RESISTANT DEPRESSION ON THE EFFECTS OF ESKETAMINE NASAL SPRAY","year":"2025","cit":0,"pfa":"Maria Pepe","psa":"Marco Di Nicola","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4413284343","eid":"W4413284343"},{"id":"paper-w4416229951","cat":"papers","name":"“Efficacy and safety of esketamine for reducing sufentanil-induced cough: A meta-analysis of randomized controlled trials”","year":"2025","cit":0,"pfa":"Muhammad Hassan","psa":"Muhammad Usman Ahmed","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4416229951","eid":"W4416229951"},{"id":"paper-w2808863203","cat":"papers","name":"156 Improvement in Disease Severity in Patients With Treatment-Resistant Depression Following Treatment With Intranasal Esketamine","year":"2018","cit":0,"pfa":"Abigail I. Nash","psa":"Larry D Alphs","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2808863203","eid":"W2808863203"},{"id":"paper-w7139918154","cat":"papers","name":"scan2030/scan2030-WP-3_TRD_ESK_CEA: Version 1.0.0: Code for TRD Esketamine cost-effectiveness analysis","year":"2026","cit":0,"pfa":"scan2030","topics":["Depression"],"ptype":"software","src":"https://openalex.org/W7139918154","eid":"W7139918154"},{"id":"paper-w7165980725","cat":"papers","name":"Discharge Readiness After Propofol with or without Esketamine for Flexible Bronchoscopy: A Randomized Non-Inferiority Trial","year":"2026","cit":0,"pfa":"Zhang X","psa":"Yao Y","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7165980725","eid":"W7165980725"},{"id":"paper-w7210293851","cat":"papers","name":"Metabolic Burden and Response to Repeated Intranasal Esketamine in Treatment-Resistant Depression: A Longitudinal Multidomain Biomarker Study","year":"2026","cit":0,"pfa":"Ifeoluwa Olaoluwa","psa":"Jennifer Lynne Phillips","topics":["Depression"],"ptype":"preprint","src":"https://openalex.org/W7210293851","eid":"W7210293851"},{"id":"paper-w7211875290","cat":"papers","name":"Beyond symptom reduction: Intranasal esketamine is associated with improved quality of life in treatment-resistant depression","year":"2026","cit":0,"pfa":"Maurizio Pompili","psa":"Isabella Berardelli","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7211875290","eid":"W7211875290"},{"id":"paper-w4294301241","cat":"papers","name":"Comparison of remifentanil and esketamine in combination with propofol for patient sedation during fiberoptic bronchoscopy: a randomized trial","year":"2022","cit":0,"pfa":"Jia Nie","psa":"Haiying Wang","topics":["Depression","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4294301241","eid":"W4294301241"},{"id":"paper-w7166868317","cat":"papers","name":"Intraoperative esketamine infusion and postoperative sleep quality after shoulder arthroscopy: a randomized controlled trial","year":"2026","cit":0,"pfa":"Chaohui Liu","psa":"Shengjie Yao","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7166868317","eid":"W7166868317"},{"id":"paper-w7169836921","cat":"papers","name":"Quality of life and productivity among esketamine responders in a real-world study in Australia and New Zealand","year":"2026","cit":0,"pfa":"Malcolm Hopwood","psa":"Ian Bernard Hickie","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7169836921","eid":"W7169836921"},{"id":"paper-w7160585962","cat":"papers","name":"The Effect of Intraoperative Infusion of Different Doses of Esketamine on the Quality of Recovery in Elderly Patients Undergoing Knee Arthroplasty","year":"2026","cit":0,"pfa":"Fang C","psa":"Chen X","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7160585962","eid":"W7160585962"},{"id":"paper-w7172196971","cat":"papers","name":"Interpreting Perineural Esketamine for Analgesia After Total Knee Arthroplasty: Methodological and Reporting Considerations [Letter]","year":"2026","cit":0,"pfa":"Zhou Z","psa":"Lu J","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7172196971","eid":"W7172196971"},{"id":"paper-w4404050956","cat":"papers","name":"Effects of Small-Dose Esketamine on Postoperative Analgaesia and Sleep Quality in Patients with Total Hip Replacement","year":"2024","cit":0,"pfa":"Qiufeng Wei","psa":"Wen Zheng He","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4404050956","eid":"W4404050956"},{"id":"paper-w7166119173","cat":"papers","name":"Low-dose esketamine for postoperative fatigue after gynecological laparoscopic surgery: a randomized controlled trial","year":"2026","cit":0,"pfa":"Ge Sun","psa":"Fuhu Song","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7166119173","eid":"W7166119173"},{"id":"paper-w7163661484","cat":"papers","name":"Letter to the Editor: Esketamine in treatment-resistant depression: Beyond symptom reduction toward psychopathological network reorganization","year":"2026","cit":0,"pfa":"Baharuddin Baharuddin","psa":"Devitya Angielevi Sukarno","topics":["Depression"],"ptype":"letter","src":"https://openalex.org/W7163661484","eid":"W7163661484"},{"id":"paper-w4389127431","cat":"papers","name":"Retracted: Efficacy of Analgesic Propofol/Esketamine and Propofol/Fentanyl for Painless Induced Abortion: A Randomized Clinical Trial","year":"2023","cit":0,"pfa":"BioMed Research International","ptype":"article","src":"https://openalex.org/W4389127431","eid":"W4389127431"},{"id":"paper-w7165683706","cat":"papers","name":"Real-world effectiveness and safety of intranasal esketamine for treatment-resistant depression: Data from the enTRD registry","year":"2026","cit":0,"pfa":"Maximilian Preiß","psa":"Lukas Pezawas","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7165683706","eid":"W7165683706"},{"id":"paper-w7204269262","cat":"papers","name":"Real-World Effectiveness and Safety of Esketamine Nasal Spray in Treatment-Resistant Depression: A Retrospective Observational Study","year":"2026","cit":0,"pfa":"Mostafa A. Sayed Ali","psa":"Ahmed Mohammed Aljabri","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7204269262","eid":"W7204269262"},{"id":"paper-w4393279310","cat":"papers","name":"Perioperative Intravenous Esketamine Infusion for Cesarean Section Pain Relief: A Prospective Randomized Controlled Study","year":"2024","cit":0,"pfa":"Siqi Ma","psa":"Ran Ran","ptype":"preprint","src":"https://openalex.org/W4393279310","eid":"W4393279310"},{"id":"paper-w4390223044","cat":"papers","name":"Early anti-suicide effect during treatment with intranasal esketamine in an Italian treatment resistant depression service","year":"2023","cit":0,"pfa":"Vassilis Martiadis","psa":"M. Russo","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4390223044","eid":"W4390223044"},{"id":"paper-w4412046852","cat":"papers","name":"A randomized controlled study of the effects of sevoflurane and esketamine on cognitive function after nasal septum surgery","year":"2025","cit":0,"pfa":"Nan Xu","psa":"Xue Liu","ptype":"article","src":"https://openalex.org/W4412046852","eid":"W4412046852"},{"id":"paper-w4250393999","cat":"papers","name":"Med Check: Esketamine and Suicide; BrainsWay TMS Device and Smoking; Aducanumab and Alzheimer’s Disease; Daridorexant and Insomnia","year":"2020","cit":0,"pfa":"Terri D’Arrigo","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4250393999","eid":"W4250393999"},{"id":"paper-w4405636787","cat":"papers","name":"Exploring heart rate variability as a possible predictor of response to intranasal esketamine in individuals with treatment-resistant depression","year":"2024","cit":0,"pfa":"G. Bartolucci","psa":"M. Di Nicola","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4405636787","eid":"W4405636787"},{"id":"paper-w7172017522","cat":"papers","name":"Like Stepping Outside the Noise: Narrative Experiences of Esketamine-Induced Dissociation in Patients with Treatment-Resistant Depression","year":"2026","cit":0,"pfa":"G. Versaci","psa":"B.M. Dell'Osso","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7172017522","eid":"W7172017522"},{"id":"paper-w7213472979","cat":"papers","name":"Equipotent Doses and ED95 Extrapolation: Methodological Concerns in Trials of Ciprofol-Esketamine/Sufentanil for Elderly ESD [Letter]","year":"2026","cit":0,"pfa":"Luoyun Li","psa":"Chunyu Li","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7213472979","eid":"W7213472979"},{"id":"paper-w4391582887","cat":"papers","name":"The Effect and Mechanism of Low-Dose Esketamine in Neuropathic Pain-Related Depression-Like Behavior in Rats","year":"2024","cit":0,"pfa":"Lijuan Wang","psa":"Chen Su","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4391582887","eid":"W4391582887"},{"id":"paper-w7117989335","cat":"papers","name":"Real-world multicenter evidence on intranasal esketamine in treatment-resistant depression: from remission to recovery","year":"2026","cit":0,"pfa":"Ana Isabel de Santiago-Díaz","psa":"M.A. Madrazo-Maza","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7117989335","eid":"W7117989335"},{"id":"paper-w7127303839","cat":"papers","name":"Efficacy of esketamine on perioperative anxiety in patients receiving anesthesia: a systematic review and meta-analysis of RCTs","year":"2026","cit":0,"pfa":"Shang Shi","psa":"Xiaohua Zou","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W7127303839","eid":"W7127303839"},{"id":"paper-w4412775439","cat":"papers","name":"Efficacy of esketamine in alleviating emergence delirium and agitation in pediatric patients undergoing adenotonsillectomy under general anesthesia","year":"2025","cit":0,"pfa":"G. Shang","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4412775439","eid":"W4412775439"},{"id":"paper-w7132823269","cat":"papers","name":"Ketamine and Esketamine Therapy in Affective Disorders: A Comprehensive Review of Mechanisms, Clinical Evidence, Safety, and Future Directions","year":"2026","cit":0,"pfa":"Kshirsagar Pankaj*, Misal Shivdarshan, Dr. Giri Ashok","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7132823269","eid":"W7132823269"},{"id":"paper-w7212277660","cat":"papers","name":"Effects of (2R,6R)-hydroxynorketamine on morphine withdrawal-induced anxiety: role of D2-medium spiny neurons and μ-δ opioid receptor heterodimers","year":"2026","cit":0,"pfa":"YUANYUAN Chen","psa":"Qiang Zhou","topics":["Addiction","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7212277660","eid":"W7212277660"},{"id":"paper-w4294201866","cat":"papers","name":"ESKALE study, a French real-world study of esketamine nasal spray for patients with treatment-resistant depression","year":"2022","cit":0,"pfa":"S. Ludovic","psa":"E. Gaudre Wattinne","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4294201866","eid":"W4294201866"},{"id":"paper-w4405065799","cat":"papers","name":"Low-Dose Esketamine Promotes Brain Protection Via the Erk/Nrf2 Pathway in Vascular Dementia Rats","year":"2024","cit":0,"pfa":"Chengzhi Wang","psa":"Jianhui Gan","topics":["Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4405065799","eid":"W4405065799"},{"id":"paper-w4416072823","cat":"papers","name":"Effect of Esketamine on Perioperative Negative Mood in Patients Undergoing Cardiac Valve Surgery: A Randomized Clinical Trial","year":"2025","cit":0,"pfa":"Zhuoning Zhang","psa":"Li Tong","ptype":"article","src":"https://openalex.org/W4416072823","eid":"W4416072823"},{"id":"paper-w4412896674","cat":"papers","name":"Racemic or Esketamine for Treatment of Septic Encephalopathy: First Preclinical and Clinical Research Data and Registered Clinical Trials","year":"2025","cit":0,"pfa":"Yuming Wu","psa":"Jiancheng Zhang","ptype":"book-chapter","src":"https://openalex.org/W4412896674","eid":"W4412896674"},{"id":"paper-w4416833200","cat":"papers","name":"Improvement and clinical benefit analysis of low-dose esketamine on postoperative pain and sleep after sinus surgery","year":"2025","cit":0,"pfa":"Ziping Zhang","topics":["Dosing & pharmacology"],"ptype":"dataset","src":"https://openalex.org/W4416833200","eid":"W4416833200"},{"id":"paper-w7204437584","cat":"papers","name":"Intraoperative esketamine for postoperative analgesia and depression in pancreatic cancer surgery: protocol for a multicenter randomized controlled trial","year":"2026","cit":0,"pfa":"Ying-zi Chong","psa":"Ke Peng","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7204437584","eid":"W7204437584"},{"id":"paper-w7207721843","cat":"papers","name":"Interpreting Perineural Esketamine for Analgesia After Total Knee Arthroplasty: Methodological and Reporting Considerations [Response to Letter]","year":"2026","cit":0,"pfa":"Yunyan Wang","psa":"Zhi Cheng","topics":["Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7207721843","eid":"W7207721843"},{"id":"paper-w4306742593","cat":"papers","name":"Letter to the editor about “Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis”","year":"2022","cit":0,"pfa":"Yichi Tao","psa":"Xin Huang","topics":["Depression","Reviews & meta-analyses"],"ptype":"letter","src":"https://openalex.org/W4306742593","eid":"W4306742593"},{"id":"paper-w4415725592","cat":"papers","name":"Effectiveness of esketamine nasal spray in TRD: A review on symptoms severity, assessment scales, and regional practice pattern’s","year":"2025","cit":0,"pfa":"Vallam Indu","psa":"Kongi Kavyasudha","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4415725592","eid":"W4415725592"},{"id":"paper-w7128424274","cat":"papers","name":"Effects of Esketamine Infusion by Patient-Controlled Intravenous Analgesia in Patients With Zoster-Associated Pain: A Retrospective Study","year":"2026","cit":0,"pfa":"Yingying Lou","psa":"Yonggan Ying","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7128424274","eid":"W7128424274"},{"id":"paper-w7166080786","cat":"papers","name":"Efficacy and safety of ketamine and esketamine for the prevention of postanesthetic shivering in cesarean delivery: a systematic review and meta-analysis","year":"2026","cit":0,"pfa":"Ke Yang","psa":"Yongbao Peng","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7166080786","eid":"W7166080786"},{"id":"paper-w7204495041","cat":"papers","name":"Intraoperative esketamine for postoperative analgesia and depression in pancreatic cancer surgery: protocol for a multicenter randomized controlled trial","year":"2026","cit":0,"pfa":"Ying-zi Chong","psa":"Ke Peng","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7204495041","eid":"W7204495041"},{"id":"paper-w4399259142","cat":"papers","name":"Comment on intranasal esketamine combined with oral midazolam provides adequate sedation for outpatient pediatric dental procedures","year":"2024","cit":0,"pfa":"Kejia Chu","psa":"Juan Gao","ptype":"letter","src":"https://openalex.org/W4399259142","eid":"W4399259142"},{"id":"paper-w4313254956","cat":"papers","name":"Response to “Letter to the Editor: Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis.”","year":"2022","cit":0,"pfa":"Anees Bahji","psa":"Carlos A. Zarate","topics":["Depression","Reviews & meta-analyses"],"ptype":"letter","src":"https://openalex.org/W4313254956","eid":"W4313254956"},{"id":"paper-w4415052380","cat":"papers","name":"Efficacy and Safety of Esketamine for Sedation during Colonoscopy: A Systematic Review and Meta-analysis of Randomized Controlled Trials","year":"2025","cit":0,"pfa":"Zainab Ali Hussein","psa":"Ismail Elkhattib","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4415052380","eid":"W4415052380"},{"id":"paper-w7201856498","cat":"papers","name":"Methodological Concerns Regarding the Use of Esketamine as an Adjuvant in Femoral Nerve Block for Total Knee Arthroplasty [Letter]","year":"2026","cit":0,"pfa":"Hengrui Zhang","psa":"L H Zhao","ptype":"article","src":"https://openalex.org/W7201856498","eid":"W7201856498"},{"id":"paper-w3012725602","cat":"papers","name":"Effect of intranasal esketamine on cognitive functioning in healthy participants: a randomized, double-blind, placebo-controlled study","year":"2016","cit":0,"pfa":"Randall L. Morrison","psa":"Wayne Drevets","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W3012725602","eid":"W3012725602"},{"id":"paper-w4410215346","cat":"papers","name":"Intravenous esketamine as a detumescence agent for intraoperative penile erection during urological surgeries: a retrospective clinical analysis","year":"2025","cit":0,"pfa":"Wanjun Yao","psa":"Zhijun Chen","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4410215346","eid":"W4410215346"},{"id":"paper-w7135109115","cat":"papers","name":"Esketamine vs dexmedetomidine for postoperative anxiety and recovery in gynecologic surgery: A triple-blind randomized controlled trial","year":"2026","cit":0,"pfa":"Pei Song","psa":"Jia Zheng","topics":["Anxiety & end-of-life"],"ptype":"dataset","src":"https://openalex.org/W7135109115","eid":"W7135109115"},{"id":"paper-w7127285115","cat":"papers","name":"A Time-Sensitive Plasticity Distinguishes the Rapid and Sustained Synaptic Actions of Ketamine from Its (2 R ,6 R )-Hydroxynorketamine Metabolite","year":"2026","cit":0,"pfa":"Kyle A. Brown","psa":"Todd D. Gould","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7127285115","eid":"W7127285115"},{"id":"paper-w7138982417","cat":"papers","name":"Continuing Questions About Esketamine 5 Years After Approval: Response to Ahmed et al.","year":"2026","cit":0,"pfa":"Alan S. Schatzberg","psa":"Konstantinos Ν. Fountoulakis","ptype":"article","src":"https://openalex.org/W7138982417","eid":"W7138982417"},{"id":"paper-w4411430351","cat":"papers","name":"Effect of the Preoperative Application of Esketamine on Stress Indicators in Paediatric Patients Undergoing Bronchoalveolar Lavage Under General Anaesthesia","year":"2025","cit":0,"pfa":"Jizheng Zhang","psa":"Wanlu Ren","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4411430351","eid":"W4411430351"},{"id":"paper-w7124692045","cat":"papers","name":"Efficacy and Safety of Intranasal Esketamine in Treatment-Resistant Depression with Comorbid Autism Spectrum Disorder: Three Case Reports","year":"2026","cit":0,"pfa":"Alessandro Guffanti","psa":"Miriam Olivola","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7124692045","eid":"W7124692045"},{"id":"paper-w7131379978","cat":"papers","name":"Esketamine vs Dexmedetomidine for Postoperative Anxiety and Recovery in Gynecologic Surgery: A Triple-Blind Randomized Controlled Trial","year":"2026","cit":0,"pfa":"Pei Song","psa":"Jia Zheng","topics":["Anxiety & end-of-life"],"ptype":"dataset","src":"https://openalex.org/W7131379978","eid":"W7131379978"},{"id":"paper-w7163413078","cat":"papers","name":"Reply to: prophylactic esketamine to reduce postpartum depression in primiparae: A multicentre, double-blind, randomised clinical trial","year":"2026","cit":0,"pfa":"Tiantian Chu","psa":"Feng Gao","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"letter","src":"https://openalex.org/W7163413078","eid":"W7163413078"},{"id":"paper-w4415663839","cat":"papers","name":"The perspectives of patients with depression toward esketamine, and the influence of their medication adherence on their viewpoints: a Saudi cross-sectional study","year":"2025","cit":0,"pfa":"Ahmad H. Almadani","psa":"Mohammed Abdullah Aljaffer","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4415663839","eid":"W4415663839"},{"id":"paper-w7154476247","cat":"papers","name":"Effect of Esketamine on Postoperative Pain in Children Undergoing Plasma Tonsillectomy: A Double-Blind, Randomized Controlled Trial","year":"2026","cit":0,"pfa":"Qianlong Lu","psa":"Siqi Xu","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7154476247","eid":"W7154476247"},{"id":"paper-w7160271256","cat":"papers","name":"The Effect of Intraoperative Infusion of Different Doses of Esketamine on the Quality of Recovery in Elderly Patients Undergoing Knee Arthroplasty","year":"2026","cit":0,"pfa":"Can Fang","psa":"Xiuxia Chen","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7160271256","eid":"W7160271256"},{"id":"paper-w4411829096","cat":"papers","name":"The Application of Different Doses of Esketamine Combined with Sufentanil in Postoperative Intravenous Analgesia for Patients Undergoing Total Hysterectomy","year":"2025","cit":0,"pfa":"婧怡 郭","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4411829096","eid":"W4411829096"},{"id":"paper-w7160711708","cat":"papers","name":"Effects of Different Doses of Esketamine on Analgesia and Postpartum Depression after Cesarean Section: Randomized Clinical Trial","year":"2026","cit":0,"pfa":"Linlin Yao","psa":"Xiaoxiao Yuan","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7160711708","eid":"W7160711708"},{"id":"paper-w7203756466","cat":"papers","name":"Effects of esketamine on postoperative delirium in adult patients: a systematic review and meta-analysis of randomized controlled trials","year":"2026","cit":0,"pfa":"Xiaohui Liu","psa":"Jin Li","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7203756466","eid":"W7203756466"},{"id":"paper-w7132820685","cat":"papers","name":"Ketamine and Esketamine Therapy in Affective Disorders: A Comprehensive Review of Mechanisms, Clinical Evidence, Safety, and Future Directions","year":"2026","cit":0,"pfa":"Kshirsagar Pankaj*, Misal Shivdarshan, Dr. Giri Ashok","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7132820685","eid":"W7132820685"},{"id":"paper-w7164459308","cat":"papers","name":"Leveraging esketamine to enhance cognitive recovery in treatment-resistant depression: A framework integrating neuroplasticity and cognitive remediation","year":"2026","cit":0,"pfa":"Audrey Uyttersprot","psa":"Mandy Rossignol","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"conference-abstract","src":"https://openalex.org/W7164459308","eid":"W7164459308"},{"id":"paper-w4394773167","cat":"papers","name":"EFFECTIVENESS AND TOLERABILITY OF INTRANASAL ESKETAMINE IN TREATMENT-RESISTANT DEPRESSION AND SUBSTANCE USE DISORDERS: SERIAL OF CLINICAL CASES","year":"2024","cit":0,"topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"conference-paper","src":"https://openalex.org/W4394773167","eid":"W4394773167"},{"id":"paper-w7204997146","cat":"papers","name":"Neuroinflammation in postoperative cognitive dysfunction: the multi-target potential of esketamine in modulating microglial responses and synaptic integrity","year":"2026","cit":0,"pfa":"Hao-Tian Li","psa":"Chuan-Xiang Zhang","topics":["Mechanism & neuroscience","Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7204997146","eid":"W7204997146"},{"id":"paper-w7168251707","cat":"papers","name":"Perioperative intravenous lidocaine plus esketamine and patient-reported recovery after functional endoscopic sinus surgery","year":"2026","cit":0,"pfa":"Xiaoxia Zheng","psa":"Linjing Zhong","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7168251707","eid":"W7168251707"},{"id":"paper-w4416277560","cat":"papers","name":"124. Safety, Tolerability, and Change in Depressive Symptoms in Cardiac Patients With Treatment-Resistant Depression Receiving Esketamine Treatment","year":"2025","cit":0,"pfa":"Mario Caro Sabogal","psa":"Ryan Peterson","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4416277560","eid":"W4416277560"},{"id":"paper-w4417362373","cat":"papers","name":"Effect of ketamine/esketamine on postoperative delirium and cognitive dysfunctions: A systematic review and meta-analysis of randomised trials","year":"2025","cit":0,"pfa":"Qianqian Guo","psa":"Changsheng Li","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4417362373","eid":"W4417362373"},{"id":"paper-w7131409269","cat":"papers","name":"Esketamine vs Dexmedetomidine for Postoperative Anxiety and Recovery in Gynecologic Surgery: A Triple-Blind Randomized Controlled Trial","year":"2026","cit":0,"pfa":"Pei Song","psa":"Jia Zheng","topics":["Anxiety & end-of-life"],"ptype":"dataset","src":"https://openalex.org/W7131409269","eid":"W7131409269"},{"id":"paper-w7211305204","cat":"papers","name":"Interpreting Perineural Esketamine for Analgesia After Total Knee Arthroplasty: Methodological and Reporting Considerations [Response to Letter]","year":"2026","cit":0,"pfa":"Wang YX","psa":"Cheng Z","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7211305204","eid":"W7211305204"},{"id":"paper-w7160488906","cat":"papers","name":"Esketamine attenuated sepsis-induced organ injury in mice via the TGF-β-Smad3 signaling pathway","year":"2026","cit":0,"pfa":"Haolan","psa":"Zhiheng Sun","ptype":"article","src":"https://openalex.org/W7160488906","eid":"W7160488906"},{"id":"paper-w7202024507","cat":"papers","name":"Esketamine vs dexmedetomidine for postoperative anxiety and recovery in gynecologic surgery: A triple-blind randomized controlled trial","year":"2026","cit":0,"pfa":"Pei Song","psa":"Jia Zheng","topics":["Anxiety & end-of-life"],"ptype":"dataset","src":"https://openalex.org/W7202024507","eid":"W7202024507"},{"id":"paper-w7171971136","cat":"papers","name":"Dissociation Does Not Mediate Antidepressant Response to Esketamine: A Real-World Longitudinal Study with 6-Month Follow-Up","year":"2026","cit":0,"pfa":"M. Olivola","psa":"B.M. Dell'Osso","topics":["Depression","PTSD & trauma","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7171971136","eid":"W7171971136"},{"id":"paper-w4293646997","cat":"papers","name":"Median effective dose (ED 50 ) of esketamine combined with propofol for children to inhibit response of gastroscope insertion","year":"2022","cit":0,"pfa":"Ming Su","psa":"Quanyi Zhang","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4293646997","eid":"W4293646997"},{"id":"paper-w7163666416","cat":"papers","name":"Efficacy of intravenous ketamine/esketamine on postoperative pain and depression following breast cancer surgery: A meta-analysis","year":"2026","cit":0,"pfa":"Huanyi Hong","psa":"Hongjin Du","topics":["Depression","Anxiety & end-of-life","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7163666416","eid":"W7163666416"},{"id":"paper-w4388691586","cat":"papers","name":"Low-dose Esketamine promotes brain protection via the ERK/Nrf2 pathway in vascular dementia rats","year":"2023","cit":0,"pfa":"jinlin Shi","psa":"Jianhui Gan","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4388691586","eid":"W4388691586"},{"id":"paper-w4414207396","cat":"papers","name":"Improvements in Functioning with Esketamine Nasal Spray versus Quetiapine Extended Release in Patients with Treatment Resistant Depression","year":"2025","cit":0,"pfa":"Eduard Vieta","psa":"B. Rive","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4414207396","eid":"W4414207396"},{"id":"paper-w4286863913","cat":"papers","name":"Effect of Sleep Disturbance on Efficacy of Esketamine in Treatment-Resistant Depression: Findings from Randomized Controlled Trials","year":"2021","cit":0,"pfa":"Stephane Borentain","psa":"F Wiegand","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4286863913","eid":"W4286863913"},{"id":"paper-w7202027289","cat":"papers","name":"Esketamine vs dexmedetomidine for postoperative anxiety and recovery in gynecologic surgery: A triple-blind randomized controlled trial","year":"2026","cit":0,"pfa":"Pei Song","psa":"Jia Zheng","topics":["Anxiety & end-of-life"],"ptype":"dataset","src":"https://openalex.org/W7202027289","eid":"W7202027289"},{"id":"paper-w4310645317","cat":"papers","name":"Correction to: Comment on “Efficacy and Safety of Subcutaneous Esketamine in the Treatment of Suicidality in Major Depressive Disorder and Bipolar Depression”","year":"2022","cit":0,"pfa":"Alina Wilkowska","psa":"Wiesław Jerzy Cubała","topics":["Depression","Safety & adverse events"],"ptype":"erratum","src":"https://openalex.org/W4310645317","eid":"W4310645317"},{"id":"paper-w7165602106","cat":"papers","name":"Heterogeneous PHQ-9 trajectories during intranasal esketamine induction in real-world treatment-resistant depression","year":"2026","cit":0,"pfa":"Maximilian Preiß","psa":"Lukas Pezawas","topics":["Depression","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7165602106","eid":"W7165602106"},{"id":"paper-w7112820539","cat":"papers","name":"Investigation of hippocampal microstructural changes in severe depression : analysis of electroconvulsive therapy and esketamine effects using diffusion MRI","year":"2025","cit":0,"pfa":"Le Berre, Alice","topics":["Depression"],"ptype":"dissertation","src":"https://openalex.org/W7112820539","eid":"W7112820539"},{"id":"paper-w4416782488","cat":"papers","name":"Lung-protective effects of esketamine in patients undergoing video-assisted thoracoscopic surgery: a randomized controlled trial","year":"2025","cit":0,"pfa":"Fei Yang","psa":"Jin Gao","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4416782488","eid":"W4416782488"},{"id":"paper-w4405635741","cat":"papers","name":"Report of remission and response data to the use of intra-nasal esketamine in a real-world population in northeastern Brazil","year":"2024","cit":0,"pfa":"Hiram Grando Bezerra","psa":"R. Chagas","ptype":"article","src":"https://openalex.org/W4405635741","eid":"W4405635741"},{"id":"paper-w7165622334","cat":"papers","name":"Heterogeneous PHQ-9 trajectories during intranasal esketamine induction in real-world treatment-resistant depression","year":"2026","cit":0,"pfa":"Maximilian Preiß","psa":"Lukas Pezawas","topics":["Depression","Therapy practice"],"ptype":"other","src":"https://openalex.org/W7165622334","eid":"W7165622334"},{"id":"paper-w7154942273","cat":"papers","name":"Intraoperative Esketamine to Reduce Postoperative Pain and Opioid Consumption in Bariatric Surgery: A Systematic Review and Meta-Analysis","year":"2026","cit":0,"pfa":"Mostafa A. Khalifa","psa":"Yasmin A. Nosir","topics":["Addiction","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7154942273","eid":"W7154942273"},{"id":"paper-w7125509391","cat":"papers","name":"Beyond first-line antidepressants: lithium, quetiapine, or esketamine? Integrating meta-analyses and preliminary head-to-head evidence","year":"2026","cit":0,"pfa":"David Eckert","psa":"Siegfried F. Kasper","topics":["Depression","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"dataset","src":"https://openalex.org/W7125509391","eid":"W7125509391"},{"id":"paper-w4411472365","cat":"papers","name":"Analgesic Efficacy of Ketamine/Esketamine Infusion Following Thyroidectomy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","year":"2025","cit":0,"pfa":"Ebraheem Albazee","psa":"Mohammed M. Mehanna","topics":["Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4411472365","eid":"W4411472365"},{"id":"paper-w7162205646","cat":"papers","name":"Efficacy and Safety of Esketamine in Total Hip and Knee Arthroplasty: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","year":"2026","cit":0,"pfa":"Abdulrahman Emad AlAyyaf","psa":"Ahmad Y. Almohammad","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"review","src":"https://openalex.org/W7162205646","eid":"W7162205646"},{"id":"paper-w7118450204","cat":"papers","name":"What are the effects of epidural labor analgesia using esketamine compared to sufentanil on postpartum depression in new mothers?","year":"2026","cit":0,"pfa":"Tripdatabase","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7118450204","eid":"W7118450204"},{"id":"paper-w4388038564","cat":"papers","name":"Effects of low-dose Esketamine on postoperative analgesia and sleep quality in patients undergoing total hip arthroplasty","year":"2023","cit":0,"pfa":"Qiufeng Wei","psa":"Wen Zheng He","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4388038564","eid":"W4388038564"},{"id":"paper-w7171686044","cat":"papers","name":"Effect of intraoperative esketamine on moderate-to-severe depressive symptoms in major surgery patients: a randomized clinical trial","year":"2026","cit":0,"pfa":"Yang Zhou","psa":"Ruquan Han","topics":["Depression"],"ptype":"preprint","src":"https://openalex.org/W7171686044","eid":"W7171686044"},{"id":"paper-w7118680962","cat":"papers","name":"What are the effects of epidural labor analgesia using esketamine compared to sufentanil on postpartum depression in new mothers?","year":"2026","cit":0,"pfa":"Tripdatabase","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7118680962","eid":"W7118680962"},{"id":"paper-w7128814595","cat":"papers","name":"Remifentanil–esketamine–based General Anesthesia Strategy for Microelectrode-guided Deep-brain Stimulation for Parkinson Disease","year":"2026","cit":0,"pfa":"Dan Huang","psa":"Jie Tian","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7128814595","eid":"W7128814595"},{"id":"paper-w7171386901","cat":"papers","name":"A scoping review: ketamine or esketamine when used to assist psychotherapy or in combination with psychotherapy for the management of depression in adults","year":"2026","cit":0,"pfa":"Jennifer Swainson","psa":"C.N. Soares","topics":["Depression","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7171386901","eid":"W7171386901"},{"id":"paper-w7154869430","cat":"papers","name":"Effect of Esketamine on Postoperative Pain in Children Undergoing Plasma Tonsillectomy: A Double-Blind, Randomized Controlled Trial","year":"2026","cit":0,"pfa":"Lu Q","psa":"Xu S","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7154869430","eid":"W7154869430"},{"id":"paper-w7164752652","cat":"papers","name":"Effect of Perioperative Ketamine and Esketamine on Postoperative Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","year":"2026","cit":0,"pfa":"Mohammed Al Subhi","psa":"Younis Al-Mufargi","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7164752652","eid":"W7164752652"},{"id":"paper-w7128744328","cat":"papers","name":"Addressing diversity gaps in esketamine clinical trials: a registry-based cross-sectional analysis of sex, race and ethnicity","year":"2026","cit":0,"pfa":"Damian Świeczkowski","psa":"Wiesław Jerzy Cubała","topics":["Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7128744328","eid":"W7128744328"},{"id":"paper-w7135242078","cat":"papers","name":"Esketamine Suppresses Astrocyte-Driven Neuroinflammation in Traumatic Brain Injury via the METTL5/c-Myc/PD-L1","year":"2026","cit":0,"pfa":"Lan Luo","psa":"Bing Zhang","topics":["PTSD & trauma","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7135242078","eid":"W7135242078"},{"id":"paper-w7154979877","cat":"papers","name":"The role of esketamine in enhancing postoperative recovery and pain management in laparoscopic surgery: a meta-analysis of randomised controlled trials","year":"2026","cit":0,"pfa":"Rameez Qasim","psa":"Asraf Hussain","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W7154979877","eid":"W7154979877"},{"id":"paper-w7160277672","cat":"papers","name":"Mo1348 EFFICACY AND SAFETY OF ESKETAMINE FOR SEDATION DURING COLONOSCOPY: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS","year":"2026","cit":0,"pfa":"Ismail Elkhattib","psa":"Mohamed Elnaggar","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7160277672","eid":"W7160277672"},{"id":"paper-w7171926792","cat":"papers","name":"Early Treatment and Functional Recovery in Treatment-Resistant Depression: Real-World Evidence from Intranasal Esketamine in Spain","year":"2026","cit":0,"pfa":"Ana Isabel de Santiago-Díaz","psa":"S. Arostegui-Uranga","topics":["Depression","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7171926792","eid":"W7171926792"},{"id":"paper-w7135174461","cat":"papers","name":"Efficacy and Safety of Intranasal Esketamine in Treatment-Resistant Depression with Comorbid Autism Spectrum Disorder: Three Case Reports","year":"2026","cit":0,"pfa":"Alessandro Guffanti","psa":"Miriam Olivola","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7135174461","eid":"W7135174461"},{"id":"paper-w7167329638","cat":"papers","name":"Structural Dataset on Clinical Delivery Mechanisms and Access Protocols for Spravato (Esketamine) 56mg Nasal Spray Dose Kits","year":"2026","cit":0,"pfa":"Lyfeunit Research","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"dataset","src":"https://openalex.org/W7167329638","eid":"W7167329638"},{"id":"paper-w4391018160","cat":"papers","name":"Lung Protective Effects of Esketamine in Patients undergoing video-assisted thoracoscopic surgery：A randomized controlled trial","year":"2024","cit":0,"pfa":"Wanling Xiong","psa":"Ruixue Yuan","topics":["Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4391018160","eid":"W4391018160"},{"id":"paper-w7172473018","cat":"papers","name":"Comparative Efficacy of Dexmedetomidine and Esketamine on Postoperative Sleep Disturbances and Analgesia: A Systematic Review and Network Meta-Analysis.","year":"2026","cit":0,"pfa":"Ting Jiang","psa":"Binbin Zhu","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7172473018","eid":"W7172473018"},{"id":"paper-w7212171385","cat":"papers","name":"Effect of low-dose esketamine on quality of recovery after gynecologic laparoscopic surgery: a randomized controlled trial","year":"2026","cit":0,"pfa":"Wenli He","psa":"Yanze Li","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7212171385","eid":"W7212171385"},{"id":"paper-w7138990819","cat":"papers","name":"Efficacy Evaluation of Stellate Ganglion Block Combined with Esketamine on the Early Postoperative Emotional State of Burn Patients","year":"2026","cit":0,"pfa":"婧 卢","ptype":"article","src":"https://openalex.org/W7138990819","eid":"W7138990819"},{"id":"paper-w7171978418","cat":"papers","name":"The Effect of Esketamine Combined with Pulsed Radiofrequency on Neuropathic Pain in Herpes Zoster Patients: A Randomised Clinical Trial","year":"2026","cit":0,"pfa":"Dong Wang","psa":"Zhiying Feng","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7171978418","eid":"W7171978418"},{"id":"paper-w7204455830","cat":"papers","name":"Intraoperative esketamine for postoperative analgesia and depression in pancreatic cancer surgery: protocol for a multicenter randomized controlled trial","year":"2026","cit":0,"pfa":"Ying-zi Chong","psa":"Ke Peng","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7204455830","eid":"W7204455830"},{"id":"paper-w4389775346","cat":"papers","name":"Efficacy and safety of esketamine combined with propofol for curative endoscopic resection in colorectum: A prospective, randomized controlled trial","year":"2023","cit":0,"pfa":"Yimei Ma","psa":"Minmin Yao","topics":["Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4389775346","eid":"W4389775346"},{"id":"paper-w7133305038","cat":"papers","name":"Single low-dose esketamine improves postpartum depression symptoms and recovery quality in cesarean section women","year":"2026","cit":0,"pfa":"Ran Jing","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7133305038","eid":"W7133305038"},{"id":"paper-w4240963531","cat":"papers","name":"(2R,6R)-Hydroxynorketamine via GluA1-Mediated Synaptic Plasticity Alleviate the PTSD-Like Effects to Rat Models of Posttraumatic Stress Disorder in the Prefrontal Cortex","year":"2021","cit":0,"pfa":"Yalin Du","psa":"Lin Sun","topics":["PTSD & trauma","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4240963531","eid":"W4240963531"},{"id":"paper-w7171943021","cat":"papers","name":"ECHO: Results from a Non-Interventional Cohort Study of Esketamine Nasal Spray in Treatment Resistant Depression","year":"2026","cit":0,"pfa":"G. Rosso","psa":"S. Köhler","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7171943021","eid":"W7171943021"},{"id":"paper-w7172020882","cat":"papers","name":"Personality Disorders and Clinical Response to Intranasal Esketamine in Treatment-Resistant Depression: Trajectories, Modulations, and Psychopathological Reflections","year":"2026","cit":0,"pfa":"V. Casati","psa":"M. Olivola","topics":["Depression","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7172020882","eid":"W7172020882"},{"id":"paper-w3198762510","cat":"papers","name":"(2R,6R)-Hydroxynorketamine via GluA1-Mediated Synaptic Plasticity Alleviate the PTSD-Like Effects to Rat Models of Post-Traumatic Stress Disorder in the Prefrontal Cortex","year":"2021","cit":0,"pfa":"Yalin Du","topics":["PTSD & trauma","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3198762510","eid":"W3198762510"},{"id":"paper-w7165890054","cat":"papers","name":"Efficacy and Safety of Esketamine in Patients Undergoing Laparoscopic Cholecystectomy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","year":"2026","cit":0,"pfa":"Abdulrahman Hamad Aldousari","psa":"Salah Termos","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W7165890054","eid":"W7165890054"},{"id":"paper-w7133520096","cat":"papers","name":"Esketamine-based PCIA combined with intercostal nerve block for acute pain after lobectomy: a randomized controlled trial","year":"2026","cit":0,"pfa":"Mi Zhou","psa":"Liwei Wang","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7133520096","eid":"W7133520096"},{"id":"paper-w7163174296","cat":"papers","name":"Association of Esketamine use with mortality and clinical outcomes in patients with cancer-related depression: A target trial emulation","year":"2026","cit":0,"pfa":"J. F. Chen","psa":"Chih-Sung Liang","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7163174296","eid":"W7163174296"},{"id":"paper-w4405637180","cat":"papers","name":"Efficacy and acceptability of ketamine and esketamine in adults with treatment-resistant major depressive disorder: systematic review and meta-analysis","year":"2024","cit":0,"pfa":"B. Muit","psa":"Henricus Gerardus Ruhé","topics":["Depression","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4405637180","eid":"W4405637180"},{"id":"paper-w4405637496","cat":"papers","name":"Intranasal esketamine effectiveness in reducing suicide risk among patients with treatment-resistant depression in routine clinical practice","year":"2024","cit":0,"pfa":"Ana Isabel de Santiago-Díaz","psa":"M.A. Madrazo-Maza","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4405637496","eid":"W4405637496"},{"id":"paper-w4416830583","cat":"papers","name":"Efficacy and safety for applying esketamine in patients experienced hip and knee surgery with internal fixation or implant: A meta-analysis","year":"2025","cit":0,"pfa":"Junjie Wang","psa":"Lin Sun","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"report","src":"https://openalex.org/W4416830583","eid":"W4416830583"},{"id":"paper-w4405863924","cat":"papers","name":"The safety and efficacy of esketamine combined with low-dose opioid in pediatric laparoscopic hernia surgery: A prospective study","year":"2024","cit":0,"pfa":"Bo Xia","psa":"Li-Dong Zheng","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4405863924","eid":"W4405863924"},{"id":"paper-w4411094782","cat":"papers","name":"Meta-analysis of the preventive and therapeutic effects of esketamine on postpartum depression in pregnant women undergoing cesarean section","year":"2025","cit":0,"pfa":"Liu He","topics":["Depression","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4411094782","eid":"W4411094782"},{"id":"paper-w7135032853","cat":"papers","name":"Esketamine vs dexmedetomidine for postoperative anxiety and recovery in gynecologic surgery: A triple-blind randomized controlled trial","year":"2026","cit":0,"pfa":"Pei Song","psa":"Jia Zheng","topics":["Anxiety & end-of-life"],"ptype":"dataset","src":"https://openalex.org/W7135032853","eid":"W7135032853"},{"id":"paper-w7128686671","cat":"papers","name":"Addressing diversity gaps in esketamine clinical trials: a registry-based cross-sectional analysis of sex, race and ethnicity","year":"2026","cit":0,"pfa":"Damian Świeczkowski","psa":"Wiesław Jerzy Cubała","topics":["Policy & ethics"],"ptype":"dataset","src":"https://openalex.org/W7128686671","eid":"W7128686671"},{"id":"paper-w7167020429","cat":"papers","name":"Perioperative dynamics of intraocular pressure during continuous esketamine analgosedation in combined cataract and glaucoma surgery: A case report","year":"2026","cit":0,"pfa":"Margita Lucic","psa":"Dolika D. Vasović","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7167020429","eid":"W7167020429"},{"id":"paper-w7141333639","cat":"papers","name":"Postmarketing Safety Concerns With Esketamine: A Disproportionality Analysis of Spontaneous Reports Submitted to the FDA Adverse Event Reporting System","year":"2021","cit":0,"topics":["Safety & adverse events"],"ptype":"report","src":"https://openalex.org/W7141333639","eid":"W7141333639"},{"id":"paper-w7128286053","cat":"papers","name":"Templated from Statistical Analysis Plan - Multi-Analyst meta-analysis of individual patient data on Esketamine and Suicidality","year":"2026","cit":0,"pfa":"Mian Haider Ali","topics":["Depression","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7128286053","eid":"W7128286053"},{"id":"paper-w7155633655","cat":"papers","name":"Results of CBT-ENDURE: Cognitive Behavioral Therapy Following Esketamine for Major Depression and Suicidal Ideation for Relapse Prevention","year":"2026","cit":0,"pfa":"Morgan S. Hardy","psa":"Samuel Wilkinson","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7155633655","eid":"W7155633655"},{"id":"paper-w7117988437","cat":"papers","name":"Expert consensus on decision-making factors for continuation of esketamine nasal spray in treatment resistant depression: A Delphi method","year":"2026","cit":0,"pfa":"Allan Hunter Young","psa":"Andreas Reif","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7117988437","eid":"W7117988437"},{"id":"paper-w7163259456","cat":"papers","name":"Increasing dose of esketamine for supplemental analgesia after complex spinal fusion surgery: a randomized and double-blind trial","year":"2026","cit":0,"pfa":"Zi-Meng Guo","psa":"Dong-Xin Wang","topics":["PTSD & trauma","Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7163259456","eid":"W7163259456"},{"id":"paper-w7167029088","cat":"papers","name":"The Median Effective Infusion Rate of Ciprofol with Different Doses of Esketamine During Gastrointestinal Endoscopy: A Randomized Controlled Trial","year":"2026","cit":0,"pfa":"Shu‐heng Tang","psa":"Jin‐Chao Song","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7167029088","eid":"W7167029088"},{"id":"paper-w4410787696","cat":"papers","name":"Remimazolam and Esketamine for CT-Guided Aortic Graft Infection Drainage in a Patient with Severe Systematic Comorbidities: A Case Report","year":"2025","cit":0,"pfa":"Katarina Tomulić Brusich","psa":"Ana Čipak Gašparović","topics":["Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4410787696","eid":"W4410787696"},{"id":"paper-w4409281365","cat":"papers","name":"147. Brain-Derived Neurotrophic Factor in the Treatment of Treatment-Resistant Depression With Ketamine and Esketamine: An Updated Meta-Analysis","year":"2025","cit":0,"pfa":"Juliana Lima Constantino","psa":"Jens H. van Dalfsen","topics":["Depression","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4409281365","eid":"W4409281365"},{"id":"paper-w7214092770","cat":"papers","name":"Perioperative Ketamine and Esketamine for Postoperative Mood Symptoms After Orthopaedic Surgery: A Systematic Review of Randomized Controlled Trials.","year":"2026","cit":0,"pfa":"Ali Dabbagh","psa":"Negarsadat Namazi","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W7214092770","eid":"W7214092770"},{"id":"paper-w7160864240","cat":"papers","name":"Effect of Subanesthetic Doses of Esketamine on Early Postoperative Pain Sensitivity in Patients Undergoing Salpingectomy: A Randomized Clinical Trial","year":"2026","cit":0,"pfa":"Yanqin Wu","psa":"Xiaodan Wu","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7160864240","eid":"W7160864240"},{"id":"paper-w7126020017","cat":"papers","name":"Efficacy and acceptability of ketamine and esketamine in adults with treatment-resistant major depressive disorder: systematic review and meta-analysis","year":"2026","cit":0,"pfa":"Annemarie van der Meij","psa":"Ellen Driessen","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7126020017","eid":"W7126020017"},{"id":"paper-w7140050362","cat":"papers","name":"Supplemental Esketamine During General Anesthesia Does Not Reduce S100β Elevations in On-Pump Coronary Artery Bypass Grafting","year":"2026","cit":0,"pfa":"Sabine Himmelseher","psa":"Uwe Bernd Schirmer","ptype":"supplementary-materials","src":"https://openalex.org/W7140050362","eid":"W7140050362"},{"id":"paper-w4413738572","cat":"papers","name":"Esketamine suppresses astrocyte-driven neuroinflammation in traumatic brain injury via the METTL5/c-Myc/PD-L1","year":"2025","cit":0,"pfa":"Lan Luo","psa":"Bing Zhang","topics":["PTSD & trauma"],"ptype":"preprint","src":"https://openalex.org/W4413738572","eid":"W4413738572"},{"id":"paper-w7125497672","cat":"papers","name":"Beyond first-line antidepressants: lithium, quetiapine, or esketamine? Integrating meta-analyses and preliminary head-to-head evidence","year":"2026","cit":0,"pfa":"David Eckert","psa":"Siegfried F. Kasper","topics":["Depression","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"dataset","src":"https://openalex.org/W7125497672","eid":"W7125497672"},{"id":"paper-w7167658563","cat":"papers","name":"The Median Effective Infusion Rate of Ciprofol with Different Doses of Esketamine During Gastrointestinal Endoscopy: A Randomized Controlled Trial","year":"2026","cit":0,"pfa":"Tang SH","psa":"Song JC","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7167658563","eid":"W7167658563"},{"id":"paper-w4402649714","cat":"papers","name":"The Effect of Esketamine Combined with Quadratus Lumborum Block Multimodal Analgesia on Postoperative Chronic Pain in Cesarean Section Women","year":"2024","cit":0,"pfa":"富梅 杨","ptype":"article","src":"https://openalex.org/W4402649714","eid":"W4402649714"},{"id":"paper-w4310076674","cat":"papers","name":"Authors’ Response to Comment on “Efficacy and Safety of Subcutaneous Esketamine in the Treatment of Suicidality in Major Depressive Disorder and Bipolar Depression”","year":"2022","cit":0,"pfa":"Julia Diniz Grossi","psa":"Acioly L.T. Lacerda","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4310076674","eid":"W4310076674"},{"id":"paper-w7128722023","cat":"papers","name":"Addressing diversity gaps in esketamine clinical trials: a registry-based cross-sectional analysis of sex, race and ethnicity","year":"2026","cit":0,"pfa":"Damian Świeczkowski","psa":"Wiesław Jerzy Cubała","topics":["Policy & ethics"],"ptype":"dataset","src":"https://openalex.org/W7128722023","eid":"W7128722023"},{"id":"paper-w7160820415","cat":"papers","name":"Ketamine and esketamine for the prevention of postpartum depression: A systematic review and network meta-analysis, with an integrated evidence synthesis","year":"2026","cit":0,"pfa":"Isis Olivia Lunsky","psa":"Jennifer Swainson","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7160820415","eid":"W7160820415"},{"id":"paper-w7160959857","cat":"papers","name":"Effect of intraoperative esketamine on moderate-to-severe depressive symptoms in major surgery patients: A randomized clinical trial","year":"2026","cit":0,"pfa":"Yang Zhou","psa":"Ruquan Han","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7160959857","eid":"W7160959857"},{"id":"paper-w7154457403","cat":"papers","name":"Efficacy and safety evaluation of intravenous esketamine in alleviating perioperative depressive symptoms in Parkinson’s disease: a randomized controlled trial","year":"2026","cit":0,"pfa":"Wei Tan","psa":"S W Wang","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7154457403","eid":"W7154457403"},{"id":"paper-w7155089142","cat":"papers","name":"Esketamine-sufentanil PCA reduces postoperative depression state in elderly colorectal cancer patients: a randomized controlled trial","year":"2026","cit":0,"pfa":"Rong Ding","psa":"Guanwen Lin","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7155089142","eid":"W7155089142"},{"id":"paper-w3174421781","cat":"papers","name":"Loss of parvalbumin-positive cells in mouse brain regions after repeated intermittent administration of esketamine, but not R-ketamine","year":"2021","cit":0,"pfa":"Chun Yang","psa":"Kenji Hashimoto","ptype":"article","src":"https://openalex.org/W3174421781","eid":"W3174421781"},{"id":"paper-w7163781439","cat":"papers","name":"Esketamine Accelerates Emergence from Propofol Anesthesia in Patients Undergoing Laparoscopic Gynecological Surgery: A Randomized Controlled Trial","year":"2026","cit":0,"pfa":"Qi Y","psa":"Wang L","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7163781439","eid":"W7163781439"},{"id":"paper-w4416102166","cat":"papers","name":"Descriptive Evaluation of Hematological and Biochemical Parameters in Dogs Undergoing Dexmedetomidine Continuous Infusion Associated with Esketamine, Isoflurane and Propofol","year":"2025","cit":0,"pfa":"Bruno Henrique da Silva Nogueira","psa":"E. D. V. Conceição","ptype":"preprint","src":"https://openalex.org/W4416102166","eid":"W4416102166"},{"id":"paper-w7212037255","cat":"papers","name":"507. Ketamine use disorder following intranasal esketamine for treatment-resistant depression: a case report and literature review","year":"2026","cit":0,"pfa":"Y-H Chan","psa":"H-M Chang","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"conference-abstract","src":"https://openalex.org/W7212037255","eid":"W7212037255"},{"id":"paper-w7117435246","cat":"papers","name":"Efficacy of esketamine in reducing nausea and vomiting after anesthesia: a systematic review and meta-analysis of randomized controlled trials","year":"2025","cit":0,"pfa":"Ling Tang","psa":"Jing Wang","topics":["Anxiety & end-of-life","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7117435246","eid":"W7117435246"},{"id":"paper-w7115033331","cat":"papers","name":"Esketamine as an Adjuvant to Ropivacaine in Genicular Nerve and IPACK Blocks for Total Knee Arthroplasty: A Double-Blind Randomized Trial","year":"2025","cit":0,"pfa":"Zhu XD","psa":"Pan L","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7115033331","eid":"W7115033331"},{"id":"paper-w7163556423","cat":"papers","name":"Multimodal opioid-free anesthesia containing esketamine versus opioid-based anesthesia: a systematic review and meta-analysis","year":"2026","cit":0,"pfa":"Ye Fang","psa":"龚兴瑞","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7163556423","eid":"W7163556423"},{"id":"paper-w7117409184","cat":"papers","name":"Efficacy of esketamine in reducing nausea and vomiting after anesthesia: a systematic review and meta-analysis of randomized controlled trials","year":"2025","cit":0,"pfa":"Ling Tang","psa":"Jing Wang","topics":["Anxiety & end-of-life","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7117409184","eid":"W7117409184"},{"id":"paper-w4414207388","cat":"papers","name":"Exploring the Influence of Personality Traits on Response to Esketamine nasal spray in Treatment-Resistant Depression: A Real-World Study","year":"2025","cit":0,"pfa":"M. Marino","psa":"Gianluca Serafini","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4414207388","eid":"W4414207388"},{"id":"paper-w7117447499","cat":"papers","name":"Esketamine Enhances the Chemosensitivity of Colorectal Adenocarcinoma Cells to 5-Fluorouracil via AMPK/mTOR/HMMR Signaling Pathway","year":"2025","cit":0,"pfa":"Yuerou Feng","psa":"Renchun Lai","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7117447499","eid":"W7117447499"},{"id":"paper-w4283518605","cat":"papers","name":"CO51 A Real-World Retrospective Study Evaluating Safety, Effectiveness, and Cost of Intranasal Esketamine for Treatment-Resistant Depression","year":"2022","cit":0,"pfa":"Madeline Brendle","psa":"Reid J. Robison","topics":["Depression","Safety & adverse events"],"ptype":"conference-abstract","src":"https://openalex.org/W4283518605","eid":"W4283518605"},{"id":"paper-w4405197819","cat":"papers","name":"REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION (RTMS) FOR MAJOR DEPRESSIVE DISORDER MORE EFFECTIVE THAN RTMS COMBINED WITH ESKETAMINE","year":"2024","cit":0,"pfa":"Maria Cristina Davila","psa":"Ann M. Manzardo","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4405197819","eid":"W4405197819"},{"id":"paper-w7202430898","cat":"papers","name":"Methodological Caveats in Evaluating Perioperative Esketamine for Postoperative Pain Sensitivity: A Comment on the Study by Chen et al [Letter]","year":"2026","cit":0,"pfa":"Zhao S","psa":"Li J","ptype":"article","src":"https://openalex.org/W7202430898","eid":"W7202430898"},{"id":"paper-w7165537858","cat":"papers","name":"Ketamine and Esketamine for Suicidal Ideation: A Stratified Evidence Synthesis Across Intravenous, Intranasal, and Injection Routes (2016–2026)","year":"2026","cit":0,"pfa":"Michael Alvear","topics":["Reviews & meta-analyses"],"ptype":"dataset","src":"https://openalex.org/W7165537858","eid":"W7165537858"},{"id":"paper-w7165574894","cat":"papers","name":"Ketamine and Esketamine for Suicidal Ideation: A Stratified Evidence Synthesis Across Intravenous, Intranasal, and Injection Routes (2016–2026)","year":"2026","cit":0,"pfa":"Michael Alvear","topics":["Reviews & meta-analyses"],"ptype":"dataset","src":"https://openalex.org/W7165574894","eid":"W7165574894"},{"id":"paper-w7169540109","cat":"papers","name":"Clinical guidance on the use of esketamine nasal spray for patients with treatment resistant depression: A European Delphi consensus report","year":"2026","cit":0,"pfa":"Allan Hunter Young","psa":"Andrea M. Fagiolini","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7169540109","eid":"W7169540109"},{"id":"paper-w7165855182","cat":"papers","name":"Effect analysis of etomidate combined with low dose esketamine in anesthesia induction of total hip arthroplasty in elderly patients","year":"2026","cit":0,"pfa":"Beili Liu","psa":"XU Xiachi","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7165855182","eid":"W7165855182"},{"id":"paper-w4389726543","cat":"papers","name":"Effect of pretreatment with a small dose of esketamine on sufentanil-induced cough during anesthesia induction: A randomized controlled trial","year":"2023","cit":0,"pfa":"Liangliang GAO","psa":"Lei Wei","topics":["Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4389726543","eid":"W4389726543"},{"id":"paper-w4315432607","cat":"papers","name":"Half effective dose of rimazolam combined with a subanesthetic dose of esketamine inhibiting response to gastroscopy insertion in elderly patients","year":"2023","cit":0,"pfa":"Jian Yu","psa":"Yingkai Qi","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4315432607","eid":"W4315432607"},{"id":"paper-w4411550001","cat":"papers","name":"Efficacy of a single low dose of esketamine for patients with irritable bowel syndrome: study protocol for a randomised controlled trial","year":"2025","cit":0,"pfa":"Zhe Sun","psa":"Fang Luo","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4411550001","eid":"W4411550001"},{"id":"paper-w7166007589","cat":"papers","name":"RWD46 COMPARATIVE MEASUREMENT OF ESKETAMINE RESPONSE IN TREATMENT-RESISTANT DEPRESSION USING PHQ-9 AND DSM-5 CRITERIA","year":"2026","cit":0,"pfa":"Amna M. Aslam","psa":"Carlene MacMillan","topics":["Depression"],"ptype":"conference-abstract","src":"https://openalex.org/W7166007589","eid":"W7166007589"},{"id":"paper-w4414857595","cat":"papers","name":"Effect of Esketamine as a Postoperative Adjunct Analgesic on the Quality of Recovery Following the Nuss Procedure in Children: A Randomised Controlled Trial","year":"2025","cit":0,"pfa":"Jian Tang","psa":"Jinjin Huang","ptype":"preprint","src":"https://openalex.org/W4414857595","eid":"W4414857595"},{"id":"paper-w4410728624","cat":"papers","name":"Effects of esketamine-based opioid-sparing anesthesia protocol in Bama miniature pigs undergoing robot-assisted nephrectomy","year":"2025","cit":0,"pfa":"Meiyan Zhou","psa":"Liwei Wang","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4410728624","eid":"W4410728624"},{"id":"paper-w7118046516","cat":"papers","name":"Efficacy and safety of 4 months of treatment with esketamine nasal spray monotherapy in adult patients with treatment resistant depression","year":"2026","cit":0,"pfa":"A. Cutler","psa":"J. Verbanac","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7118046516","eid":"W7118046516"},{"id":"paper-w7111628195","cat":"papers","name":"Prospective Dose-Finding of Esketamine for Suppressing Cervical Dilation Response in Ambulatory Hysteroscopy Under Monitored Anesthesia Care","year":"2025","cit":0,"pfa":"Yan L","psa":"Yang B","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7111628195","eid":"W7111628195"},{"id":"paper-w7134036711","cat":"papers","name":"Appropriate Combination of Nalbuphine Combined With Esketamine for Weakly Opioid Anesthesia in Postlaparoscopic Cholecystectomy Analgesia: A Randomized Controlled Trial","year":"2026","cit":0,"pfa":"Mengyun Zhang","psa":"Heng Yang","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7134036711","eid":"W7134036711"},{"id":"paper-w7160116725","cat":"papers","name":"Mo1348 EFFICACY AND SAFETY OF ESKETAMINE FOR SEDATION DURING COLONOSCOPY: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS","year":"2026","cit":0,"pfa":"Ismail Elkhattib","psa":"MOHAMED B. ELNAGGAR","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7160116725","eid":"W7160116725"},{"id":"paper-w7213543505","cat":"papers","name":"Equipotent Doses and ED95 Extrapolation: Methodological Concerns in Trials of Ciprofol-Esketamine/Sufentanil for Elderly ESD [Response to Letter]","year":"2026","cit":0,"pfa":"Xiaoxue Qin","psa":"Ilyar Mamtili","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7213543505","eid":"W7213543505"},{"id":"paper-w4403324470","cat":"papers","name":"Efficacy and Safety of Esketamine as an Adjunct to Propofol for Sedation in Patients Undergoing Gastrointestinal Endoscopy: A Systematic Review and Meta-Analysis","year":"2024","cit":0,"pfa":"Aiguo Li","psa":"Ruilin He","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"report","src":"https://openalex.org/W4403324470","eid":"W4403324470"},{"id":"paper-w7213990698","cat":"papers","name":"Equipotent Doses and ED95 Extrapolation: Methodological Concerns in Trials of Ciprofol-Esketamine/Sufentanil for Elderly ESD [Response to Letter]","year":"2026","cit":0,"pfa":"Qin X","psa":"Mamtili I","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7213990698","eid":"W7213990698"},{"id":"paper-w4390222078","cat":"papers","name":"Esketamine for treatment resistant depression in real world setting- results from first two years of clinical work in Israel","year":"2023","cit":0,"pfa":"L. Dvoral","psa":"Kfir Feffer","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4390222078","eid":"W4390222078"},{"id":"paper-w7202076104","cat":"papers","name":"Methodological Caveats in Evaluating Perioperative Esketamine for Postoperative Pain Sensitivity: A Comment on the Study by Chen et al [Letter]","year":"2026","cit":0,"pfa":"Shan Zhao","psa":"Jinglin Li","ptype":"article","src":"https://openalex.org/W7202076104","eid":"W7202076104"},{"id":"paper-w7163674095","cat":"papers","name":"Esketamine alleviates trigeminal neuralgia and anxiety-like behaviors in mice by inhibiting RIPK1/RIPK3/MLKL-mediated necroptosis","year":"2026","cit":0,"pfa":"Rui Dong","psa":"Xiuli Wang (151314)","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7163674095","eid":"W7163674095"},{"id":"paper-w4390222378","cat":"papers","name":"Esketamine versus psychoactive comparator for rapid reduction of depressive symptoms in adolescents with major depressive disorder at imminent suicide risk","year":"2023","cit":0,"pfa":"Carmen Moreno","psa":"Carla M. Canuso","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4390222378","eid":"W4390222378"},{"id":"paper-w7117962873","cat":"papers","name":"Gut microbiota in major depressive disorder and treatment-resistant depression before and after intranasal esketamine treatment: a pilot study","year":"2026","cit":0,"pfa":"A.M. D'Onofrio","psa":"Giovanni Camardese","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7117962873","eid":"W7117962873"},{"id":"paper-w7128732918","cat":"papers","name":"Templated from Statistical Analysis Plan - Multi-Analyst meta-analysis of individual patient data on Esketamine and Suicidality","year":"2026","cit":0,"pfa":"Mian Haider Ali","topics":["Depression","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7128732918","eid":"W7128732918"},{"id":"paper-w7153718266","cat":"papers","name":"A Systematic Review and Meta-Analysis of the Efficacy and Safety of Intranasal Esketamine for Rapid Symptom Relief in Treatment-resistant Depression","year":"2026","cit":0,"pfa":"Ritika Saun","psa":"Mohd Ashif Khan","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W7153718266","eid":"W7153718266"},{"id":"paper-w7172540492","cat":"papers","name":"Esketamine alleviates neuroinflammation and cognitive impairment in male 3xTg-AD mice by regulating the TAOK1/IL-17 axis","year":"2026","cit":0,"pfa":"Ting Xu","psa":"Zhangzhen Zhong","topics":["Depression","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7172540492","eid":"W7172540492"},{"id":"paper-w7164579101","cat":"papers","name":"Predicting changes in depressive symptomatology following oral esketamine treatment in treatment-resistant depression: A machine-learning approach","year":"2026","cit":0,"pfa":"Juliana Lima Constantino","psa":"Jeanine Kamphuis","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7164579101","eid":"W7164579101"},{"id":"paper-w7165865647","cat":"papers","name":"Ketamine and Esketamine for Suicidal Ideation: A Stratified Evidence Synthesis Across Intravenous, Intranasal, and Injection Routes (2016–2026)","year":"2026","cit":0,"pfa":"Michael Alvear","ptype":"preprint","src":"https://openalex.org/W7165865647","eid":"W7165865647"},{"id":"paper-w7112344897","cat":"papers","name":"Efficacy and Safety of Esketamine–Lidocaine for Anesthesia Induction in Elderly Patients Undergoing Elective Surgery: A Randomized Controlled Trial","year":"2025","cit":0,"pfa":"Xu,Jinhui","psa":"Li,Yaqi","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"report","src":"https://openalex.org/W7112344897","eid":"W7112344897"},{"id":"paper-w4310757909","cat":"papers","name":"Hemodynamic effects of esketamine versus sufentanil applied prior to placement of suspension laryngoscope: a double-blinded randomized controlled trial","year":"2022","cit":0,"pfa":"Yiying Zhang","psa":"Changsheng Huang","ptype":"preprint","src":"https://openalex.org/W4310757909","eid":"W4310757909"},{"id":"paper-w7163359129","cat":"papers","name":"Perioperative esketamine for prevention of postoperative sleep disturbance after anesthesia: a systematic review and meta-analysis of randomized controlled trials","year":"2026","cit":0,"pfa":"Jinfang Zeng","psa":"Minmin Zhu","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7163359129","eid":"W7163359129"},{"id":"paper-w7212220090","cat":"papers","name":"Effects of Esketamine on Postoperative Hospital Anxiety and Depression Scale Scores in Patients Undergoing Laparoscopic Radical Resection for Colorectal Cancer","year":"2026","cit":0,"pfa":"Lindai He","psa":"LI Shenxiayu","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7212220090","eid":"W7212220090"},{"id":"paper-w7125484680","cat":"papers","name":"Beyond first-line antidepressants: lithium, quetiapine, or esketamine? Integrating meta-analyses and preliminary head-to-head evidence","year":"2026","cit":0,"pfa":"David Eckert","psa":"Siegfried F. Kasper","topics":["Depression","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7125484680","eid":"W7125484680"},{"id":"paper-w7155362500","cat":"papers","name":"Additional file 3 of The effect of esketamine on emergence delirium or agitation in children after anesthesia-a systematic review and meta-analysis","year":"2026","cit":0,"pfa":"W Yang","psa":"He Huang","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7155362500","eid":"W7155362500"},{"id":"paper-w4406655235","cat":"papers","name":"Implications of Perioperative Intravenous Esketamine Administration on Perioperative Neurocognitive Disorders in Patients: A Meta-Analysis of Randomized Controlled Trials","year":"2025","cit":0,"pfa":"Jin Zhou","psa":"Xiaohua Zou","topics":["Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4406655235","eid":"W4406655235"},{"id":"paper-w7163202089","cat":"papers","name":"Esketamine Accelerates Emergence from Propofol Anesthesia in Patients Undergoing Laparoscopic Gynecological Surgery: A Randomized Controlled Trial","year":"2026","cit":0,"pfa":"Yu Qi","psa":"Liwei Wang","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7163202089","eid":"W7163202089"},{"id":"paper-w7167350565","cat":"papers","name":"Structural Dataset on Clinical Delivery Mechanisms and Access Protocols for Spravato (Esketamine) 56mg Nasal Spray Dose Kits","year":"2026","cit":0,"pfa":"Lyfeunit Research","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"dataset","src":"https://openalex.org/W7167350565","eid":"W7167350565"},{"id":"paper-w7206149531","cat":"papers","name":"Safety Effect Moderators of Intranasal Esketamine used in Assocation with a SSRI or SNRI: An Individual Participant Data Meta-Analysis","year":"2026","cit":0,"pfa":"K. Tai","psa":"Mian Haider Ali","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"other","src":"https://openalex.org/W7206149531","eid":"W7206149531"},{"id":"paper-w4409230659","cat":"papers","name":"The Association between Intranasal Esketamine and Treatment-emergent Insomnia in the Treatment of Treatment-resistant Major Depression: A Meta-analysis","year":"2025","cit":0,"pfa":"Cagdas Türkmen","psa":"Jens H. van Dalfsen","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4409230659","eid":"W4409230659"},{"id":"paper-w4417232144","cat":"papers","name":"Esketamine as an Adjuvant to Ropivacaine in Genicular Nerve and IPACK Blocks for Total Knee Arthroplasty: A Double-Blind Randomized Trial","year":"2025","cit":0,"pfa":"Xiaona Zhu","psa":"Linmin Pan","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4417232144","eid":"W4417232144"},{"id":"paper-w7167767377","cat":"papers","name":"Use of Esketamine Combined with Dexmedetomidine for Difficult Tracheal Intubation in an Uncooperative Pediatric Patient with Severe Trismus: A Case Report","year":"2026","cit":0,"pfa":"Jia Jiang","psa":"Guifang Yu","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"report","src":"https://openalex.org/W7167767377","eid":"W7167767377"},{"id":"paper-w4372324269","cat":"papers","name":"Implications of Perioperative Intravenous Esketamine Administration on Postpartum Depression in Cesarean Section Patients: A Comprehensive Systematic Review and Meta-Analysis","year":"2023","cit":0,"pfa":"Li qiao Huang","psa":"Xu Zhang","topics":["Depression","Reviews & meta-analyses"],"ptype":"report","src":"https://openalex.org/W4372324269","eid":"W4372324269"},{"id":"paper-w7214862038","cat":"papers","name":"Anticholinergic burden and benzodiazepines as a predictor of therapeutic response and cognitive effects in patients with difficult-to-treat depression under esketamine treatment","year":"2026","cit":0,"pfa":"Adaia Marrón Castro","topics":["Depression"],"ptype":"dissertation","src":"https://openalex.org/W7214862038","eid":"W7214862038"},{"id":"paper-w7116064424","cat":"papers","name":"The Role of Esketamine in Reducing Propofol-Related Adverse Events During Gastrointestinal Endoscopy: A Systematic Review and Meta-Analysis","year":"2025","cit":0,"pfa":"Lin Ba","psa":"XiaoXiao Dong","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W7116064424","eid":"W7116064424"},{"id":"paper-w7196962710","cat":"papers","name":"Clinical guidance on the use of esketamine nasal spray for patients with treatment resistant depression: A European Delphi consensus report","year":"2026","cit":0,"pfa":"Allan H. Young","psa":":unav","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W7196962710","eid":"W7196962710"},{"id":"paper-w7104430585","cat":"papers","name":"Efficacy and Safety of Esketamine–Lidocaine for Anesthesia Induction in Elderly Patients Undergoing Elective Surgery: A Randomized Controlled Trial","year":"2025","cit":0,"pfa":"Xu J","psa":"Li Y","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7104430585","eid":"W7104430585"},{"id":"paper-w7163685029","cat":"papers","name":"Esketamine-Propofol Combination for Adults Undergoing Gastrointestinal Endoscopy: An Updated Systematic Review and Meta-Analysis with GRADE Evidence Assessment","year":"2026","cit":0,"pfa":"Mohamed Mohsen Helal","psa":"George Jabrieh","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W7163685029","eid":"W7163685029"},{"id":"paper-w7126261590","cat":"papers","name":"Multimodal rapid anti-depression: Esketamine combined with dexmedetomidine patient-controlled sleep for treatment-resistant depression — A retrospective study","year":"2026","cit":0,"pfa":"Yao-Zu Li","psa":"Jiun-Ming An","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7126261590","eid":"W7126261590"},{"id":"paper-w7170090942","cat":"papers","name":"Effects of low-dose esketamine on early quality of recovery following minimally invasive esophagectomy: a multicenter, randomized controlled study","year":"2026","cit":0,"pfa":"Hongwei Zhang","psa":"Hai Yu","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"dataset","src":"https://openalex.org/W7170090942","eid":"W7170090942"},{"id":"paper-w7163781377","cat":"papers","name":"Investigation of Esketamine Administration During Surgical Procedures for the Alleviation of Postoperative Anxiety and Depression in Adolescent Patients: A Randomized Controlled Trial","year":"2026","cit":0,"pfa":"Li Y","psa":"Zhou J","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7163781377","eid":"W7163781377"},{"id":"paper-w7212314873","cat":"papers","name":"Effects of Esketamine on Postoperative Hospital Anxiety and Depression Scale Scores in Patients Undergoing Laparoscopic Radical Resection for Colorectal Cancer","year":"2026","cit":0,"pfa":"Lindai He","psa":"LI Shenxiayu","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7212314873","eid":"W7212314873"},{"id":"paper-w3018913345","cat":"papers","name":"118 Use of Patient Health Questionnaire to Predict Relapses in Patients with Treatment-resistant Depression Treated With Esketamine + Oral Antidepressant","year":"2020","cit":0,"pfa":"Carol Jamieson","psa":"Jaskaran B. Singh","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3018913345","eid":"W3018913345"},{"id":"paper-w7202163290","cat":"papers","name":"Low-dose esketamine for postoperative pain, sleep, and hemodynamic stability in functional endoscopic sinus surgery: a retrospective cohort study","year":"2026","cit":0,"pfa":"Yan-ping Zhao","psa":"Li-Juan Shi","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7202163290","eid":"W7202163290"},{"id":"paper-w4386284374","cat":"papers","name":"Esketamine use is associated with shortened postoperative hospital stay in patients underwent knee arthroscopic surgery: a retrospective clinical study","year":"2023","cit":0,"pfa":"Jing Liu","psa":"Yue Peng","topics":["Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4386284374","eid":"W4386284374"},{"id":"paper-w4414207923","cat":"papers","name":"Outcomes with esketamine nasal spray in patients with or without earlier partial or full response: post hoc analyses of ESCAPE TRD","year":"2025","cit":0,"pfa":"Allan Hunter Young","psa":"Koen Demyttenaere","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4414207923","eid":"W4414207923"},{"id":"paper-w7155422370","cat":"papers","name":"Additional file 3 of The effect of esketamine on emergence delirium or agitation in children after anesthesia-a systematic review and meta-analysis","year":"2026","cit":0,"pfa":"W Yang","psa":"He Huang","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7155422370","eid":"W7155422370"},{"id":"paper-w7204278280","cat":"papers","name":"Perioperative esketamine exposure and postoperative depression and anxiety in elderly patients undergoing joint replacement surgery: a retrospective cohort study","year":"2026","cit":0,"pfa":"Mao Li","psa":"Xiang Wen","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7204278280","eid":"W7204278280"},{"id":"paper-w7212247341","cat":"papers","name":"Effects of Esketamine on Postoperative Hospital Anxiety and Depression Scale Scores in Patients Undergoing Laparoscopic Radical Resection for Colorectal Cancer","year":"2026","cit":0,"pfa":"Lindai He","psa":"LI Shenxiayu","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7212247341","eid":"W7212247341"},{"id":"paper-w4252669586","cat":"papers","name":"P.006 Cardiac safety of esketamine nasal spray in treatment-resistant depression: Results from the clinical development program","year":"2019","cit":0,"pfa":"Teodora Doherty","psa":"J. Singh B.","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4252669586","eid":"W4252669586"},{"id":"paper-w7118704512","cat":"papers","name":"Esketamine combined with hydromorphone versus hydromorphone for post-operative patient-controlled intravenous analgesia in children: a randomized controlled trial","year":"2026","cit":0,"pfa":"Yang Li","psa":"Jian-jun Yang","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7118704512","eid":"W7118704512"},{"id":"paper-w7141738686","cat":"papers","name":"Efficacy and Safety of Esketamine Nasal Spray Plus an Oral Antidepressant in Elderly Patients With Treatment-Resistant Depression—TRANSFORM-3","year":"2020","cit":0,"topics":["Depression","Safety & adverse events"],"ptype":"report","src":"https://openalex.org/W7141738686","eid":"W7141738686"},{"id":"paper-w4406254532","cat":"papers","name":"Mental-Health Related Disability Leave and Costs Among Patients with Treatment Resistant Depression Initiated on Esketamine and Conventional Therapies","year":"2024","cit":0,"pfa":"Maryia Zhdanava","psa":"Kruti Joshi","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4406254532","eid":"W4406254532"},{"id":"paper-w7118042358","cat":"papers","name":"ECHO: Study design and baseline characteristics of a non-interventional cohort study of esketamine nasal spray in treatment resistant depression","year":"2026","cit":0,"pfa":"E. Constant","psa":"G. Rosso","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7118042358","eid":"W7118042358"},{"id":"paper-w7141891745","cat":"papers","name":"Evaluation of optimal dosage combinations of oral midazolam and esketamine for pediatric preoperative sedation: A randomized, double-blind clinical trial","year":"2026","cit":0,"pfa":"Hongfei Xiong","psa":"Rongliang Xue","topics":["Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7141891745","eid":"W7141891745"},{"id":"paper-w7162649915","cat":"papers","name":"Dose-dependent adverse events of esketamine in treatment-resistant depression: a systematic review and meta-analysis of randomized controlled trials","year":"2026","cit":0,"pfa":"Yang Qu","psa":"Yongkang Wu","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W7162649915","eid":"W7162649915"},{"id":"paper-w4402543688","cat":"papers","name":"The Pattern of Dissociative Symptoms Differs between Post-Traumatic Stress Disorder and First Esketamine Administration for Treatment-Resistant Depression","year":"2024","cit":0,"pfa":"David Williamson","psa":"Linda E. Williamson","topics":["Depression","PTSD & trauma"],"ptype":"article","src":"https://openalex.org/W4402543688","eid":"W4402543688"},{"id":"paper-w7167037169","cat":"papers","name":"Case Report: Intranasal esketamine and accelerated intermittent theta-burst stimulation for severe treatment-resistant depression with suicidal ideation","year":"2026","cit":0,"pfa":"Chun-Hung Chang","psa":"Hsin-Chi Tsai","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7167037169","eid":"W7167037169"},{"id":"paper-w7207617206","cat":"papers","name":"Combined low-dose (2R,6R)-Hydroxynorketamine and memantine restore BDNF/TrkB signaling and synaptic function in an LPS-induced model of depressive-like behavior in male mice","year":"2026","cit":0,"pfa":"Xiaoli Jia","psa":"Shupeng Li","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7207617206","eid":"W7207617206"},{"id":"paper-w7170061500","cat":"papers","name":"Effects of low-dose esketamine on early quality of recovery following minimally invasive esophagectomy: a multicenter, randomized controlled study","year":"2026","cit":0,"pfa":"Hongwei Zhang","psa":"Hai Yu","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"dataset","src":"https://openalex.org/W7170061500","eid":"W7170061500"},{"id":"paper-w7161754833","cat":"papers","name":"Esketamine Protects Against Sepsis-Induced Intestinal Injury by Modulating Macrophage Polarization Through the TLR4/NF-κB Signaling Pathway","year":"2026","cit":0,"pfa":"Liyan Miao","psa":"Qiuchun Chen","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7161754833","eid":"W7161754833"},{"id":"paper-w7171704566","cat":"papers","name":"Comparative Efficacy of Esketamine Nasal Spray Versus Quetiapine Extended Release as Adjunctive Treatments for Treatment-Resistant Depression: A Systematic Review","year":"2026","cit":0,"pfa":"Neha Ather","psa":"Muhammad Mohsin Khan","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7171704566","eid":"W7171704566"},{"id":"paper-w4396810463","cat":"papers","name":"The ED50 of Remazolam Toluenesulfonate Combined with a Subthreshold Dose of Esketamine for Inhibiting Cardiovascular Response to Tracheal Intubation in Elderly Patients","year":"2023","cit":0,"pfa":"Chunyan Zhao","psa":"Bingchun Xia","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4396810463","eid":"W4396810463"},{"id":"paper-w4405621663","cat":"papers","name":"The efficacy of esketamine nasal spray as augmentation strategy in treatment-resistant depression: a long-term, real-world study","year":"2024","cit":0,"pfa":"Rita Cafaro","psa":"Bernardo Maria Dell’Osso","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4405621663","eid":"W4405621663"},{"id":"paper-w4413668283","cat":"papers","name":"Efficacy and safety of esketamine in treatment of drug-resistant depression: A review of clinical and survey studies and future therapeutic perspectives","year":"2025","cit":0,"pfa":"Daniel Szawarnoga","psa":"Wojciech Sołtys","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4413668283","eid":"W4413668283"},{"id":"paper-w7125528128","cat":"papers","name":"Effect of esketamine combined with ropivacaine for erector spinae plane block on postoperative analgesia of thoracoscopic surgery: a randomized clinical trial","year":"2026","cit":0,"pfa":"Jiangling Xia","psa":"Hongyu Xu","ptype":"preprint","src":"https://openalex.org/W7125528128","eid":"W7125528128"},{"id":"paper-w4402866037","cat":"papers","name":"Esketamine for reducing perioperative opioid use in laparoscopic colorectal cancer surgery: impact on postoperative nausea and vomiting at 48 hours","year":"2024","cit":0,"pfa":"Zhao Xin","psa":"Qiu Lan","topics":["Addiction","Anxiety & end-of-life"],"ptype":"dataset","src":"https://openalex.org/W4402866037","eid":"W4402866037"},{"id":"paper-w4413313860","cat":"papers","name":"160. CHANGES IN QUALITY OF LIFE AND PRODUCTIVITY GAIN AMONG ESKETAMINE RESPONDERS IN A REAL-WORLD STUDY IN AUSTRALIA AND NEW ZEALAND","year":"2025","cit":0,"pfa":"Malcolm Hopwood","psa":"Andrea Puig","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4413313860","eid":"W4413313860"},{"id":"paper-w7171950951","cat":"papers","name":"Patient reported outcomes of MDD patients treated with esketamine nasal spray in real world practice: the French ELLIPSE study","year":"2026","cit":0,"pfa":"P.-M. Llorca","psa":"P. Demaricourt","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7171950951","eid":"W7171950951"},{"id":"paper-w7204176161","cat":"papers","name":"Efficacy of Esketamine as an Adjuvant for Fascia Iliaca Compartment Block on Postoperative Analgesia in Elderly Patients Undergoing Total Hip Arthroplasty","year":"2026","cit":0,"pfa":"Xuandong Jia","psa":"Maitao Zhou","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7204176161","eid":"W7204176161"},{"id":"paper-w4319314858","cat":"papers","name":"Review for \"Ketamine and its metabolite 2R,6R‐hydroxynorketamine promote ocular dominance plasticity and release TRKB from inhibitory control without reducing perineuronal nets enwrapping parvalbumin interneurons\"","year":"2022","cit":0,"topics":["Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4319314858","eid":"W4319314858"},{"id":"paper-w4417076151","cat":"papers","name":"Commentary on “Effect of low-dose intraoperative esketamine on quality of recovery after laparotomy for gynecologic malignancy: a randomized controlled trial”","year":"2025","cit":0,"pfa":"Min Shi","psa":"Lulong Bo","topics":["Dosing & pharmacology"],"ptype":"editorial","src":"https://openalex.org/W4417076151","eid":"W4417076151"},{"id":"paper-w4393031878","cat":"papers","name":"Comparison of esketamine and remifentanil in combination with propofol in patients with septic shock receiving invasive mechanical ventilation: a randomized controlled trial","year":"2024","cit":0,"pfa":"Yuting Li","psa":"Dong Zhang","ptype":"preprint","src":"https://openalex.org/W4393031878","eid":"W4393031878"},{"id":"paper-w7170138294","cat":"papers","name":"Efficacy of intraoperative low dose intravenous Esketamine for acute postoperative pain control: Meta-analysis of randomized controlled trials","year":"2026","cit":0,"pfa":"Ehsan Majeed","psa":"Faizan Majeed","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7170138294","eid":"W7170138294"},{"id":"paper-w4416301022","cat":"papers","name":"Effect of intravenous esketamine on oxygenation and intrapulmonary shunting during One-lung ventilation in thoracoscopic surgery: A Randomized Controlled Trial","year":"2025","cit":0,"pfa":"Fu Chunyan","psa":"Xiaozhen Zheng","ptype":"preprint","src":"https://openalex.org/W4416301022","eid":"W4416301022"},{"id":"paper-w7165526632","cat":"papers","name":"Effects of Esketamine Combined with Transversus Abdominis Plane Block on Postoperative Pain and Quality of Recovery in Patients Undergoing Gynecologic Laparoscopic Surgery","year":"2026","cit":0,"pfa":"馨 张","ptype":"article","src":"https://openalex.org/W7165526632","eid":"W7165526632"},{"id":"paper-w7118001578","cat":"papers","name":"Evolution of clinical dimensions and safety in patients with major depressive disorder treated by esketamine: the French real-world ELLIPSE study","year":"2026","cit":0,"pfa":"P.-M. Llorca","psa":"C. Wicart","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7118001578","eid":"W7118001578"},{"id":"paper-w7166105855","cat":"papers","name":"PT34 THE IMPACT OF ESKETAMINE ON ALZHEIMER’S DISEASE IN PATIENTS WITH MILD COGNITIVE IMPAIRMENT AND MAJOR DEPRESSIVE DISORDER: A TARGET TRIAL EMULATION","year":"2026","cit":0,"pfa":"Eszter Garami","psa":"Xiaomo Xiong","topics":["Depression"],"ptype":"conference-abstract","src":"https://openalex.org/W7166105855","eid":"W7166105855"},{"id":"paper-w7165491310","cat":"papers","name":"Comparative Effectiveness of Dexmedetomidine Versus Esketamine For Pediatric Procedural Sedation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","year":"2026","cit":0,"pfa":"Dewa Putu Agusta Cahya Udayana","psa":"Anak Agung Ananda Yudhistira","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7165491310","eid":"W7165491310"},{"id":"paper-w4383556979","cat":"papers","name":"Effect of low-dose esketamine combined with labour analgesia on postpartum depression in spontaneous labour: a prospective case-control study","year":"2023","cit":0,"pfa":"Jianxin Gao","psa":"Dan Miao","topics":["Depression","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4383556979","eid":"W4383556979"},{"id":"paper-w4400905387","cat":"papers","name":"Esketamine Exposure Affects White Matter Myelination in Early Postnatal Mice Via the Ampk/ Sbpebp-1c/Fas Pathway","year":"2024","cit":0,"pfa":"Lijie Zhou","psa":"Xue-ji Wang","ptype":"preprint","src":"https://openalex.org/W4400905387","eid":"W4400905387"},{"id":"paper-w7161572138","cat":"papers","name":"Intranasal Esketamine Followed by Accelerated iTBS for Severe Treatment-Resistant Depression: Symptom Response and Resting-State EEG Correlates","year":"2026","cit":0,"pfa":"Chun-Hung Chang","psa":"Hsin-Chi Tsai","topics":["Depression","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7161572138","eid":"W7161572138"},{"id":"paper-w7213299622","cat":"papers","name":"Esketamine exerts a protective effect against skeletal muscle injury induced by hindlimb ischemia-reperfusion in mice by regulating autophagy","year":"2026","cit":0,"pfa":"Jingwang Liu","psa":"Xiuli Wang","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7213299622","eid":"W7213299622"},{"id":"paper-w7155352764","cat":"papers","name":"Additional file 2 of The effect of esketamine on emergence delirium or agitation in children after anesthesia-a systematic review and meta-analysis","year":"2026","cit":0,"pfa":"W Yang","psa":"He Huang","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7155352764","eid":"W7155352764"},{"id":"paper-w4200336434","cat":"papers","name":"P.0231 Antidepressant and antisuicidal effects of esketamine in adolescents with major depressive disorder and suicidal ideation: a retrospective chart review","year":"2021","cit":0,"pfa":"Daniela Faria-Guimarães","psa":"Lucas C. Quarantini","topics":["Depression","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4200336434","eid":"W4200336434"},{"id":"paper-w4405660579","cat":"papers","name":"Outcomes with intranasal esketamine treatment for patients with resistant major depression. Multicenter study of treatment in real-world settings in Spain","year":"2024","cit":0,"pfa":"Ana Isabel de Santiago-Díaz","psa":"S. Arostegui-Uranga","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4405660579","eid":"W4405660579"},{"id":"paper-w7128058666","cat":"papers","name":"Perioperative ketamine or esketamine for acute postoperative pain after laparoscopic cholecystectomy: A systematic review and meta-analysis with meta-regression","year":"2026","cit":0,"pfa":"Umar Akram","psa":"Salim Surani","topics":["Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7128058666","eid":"W7128058666"},{"id":"paper-w7135424278","cat":"papers","name":"Long-term treatment with esketamine nasal spray in patients with treatment resistant depression: Results from the ESCAPE-LTE study","year":"2026","cit":0,"pfa":"Andreas Reif","psa":":unav","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W7135424278","eid":"W7135424278"},{"id":"paper-w7172010463","cat":"papers","name":"The association between anhedonia and quality of life in treatment-resistant depression: effects of a three-month treatment with esketamine nasal spray","year":"2026","cit":0,"pfa":"I. Marcelli","psa":"G. Sani","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7172010463","eid":"W7172010463"},{"id":"paper-w7171416630","cat":"papers","name":"CB1R-dependent mitochondrial biogenesis may contribute to the antidepressant effects of esketamine in a chronic variable stress male mouse model","year":"2026","cit":0,"pfa":"Wei Zhao","psa":"Min Cai","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7171416630","eid":"W7171416630"},{"id":"paper-w4240906106","cat":"papers","name":"Faculty Opinions recommendation of Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study.","year":"2016","cit":0,"pfa":"Monique van Velzen","topics":["Depression"],"ptype":"peer-review","src":"https://openalex.org/W4240906106","eid":"W4240906106"},{"id":"paper-w4406254497","cat":"papers","name":"Adverse Event Duration with Esketamine Versus Quetiapine XR in Adults With Treatment-Resistant Depression: A Subgroup Analysis of ESCAPE-TRD","year":"2024","cit":0,"pfa":"Gregory W. Mattingly","psa":"Brianne Brown","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4406254497","eid":"W4406254497"},{"id":"paper-w7141078575","cat":"papers","name":"[Esketamine alleviates depression-like behaviors in mice with chronic restraint stress by activating glutamatergic neurons in the medial prefrontal cortex].","year":"2026","cit":0,"pfa":"Zhuoning Zhang","psa":"Li Tong","topics":["Depression","Mechanism & neuroscience","Policy & ethics"],"ptype":"other","src":"https://openalex.org/W7141078575","eid":"W7141078575"},{"id":"paper-w4390223247","cat":"papers","name":"ESKALE, french observational study describing treatment strategies and safety of patients with treatment-resistant depression treated with esketamine nasal spray","year":"2023","cit":0,"pfa":"Ludovic Samalin","psa":"E. Gaudre Wattinne","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4390223247","eid":"W4390223247"},{"id":"paper-w7165653079","cat":"papers","name":"Efficacy of perioperative esketamine on postoperative recovery in patients with breast cancer undergoing modified radical mastectomy: A systematic review and meta-analysis.","year":"2026","cit":0,"pfa":"Melisha Koirala","psa":"Aakash Pandit","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W7165653079","eid":"W7165653079"},{"id":"paper-w7172502057","cat":"papers","name":"Effects of sub-anesthetic dose of esketamine on postoperative delirium and oxidative stress in patients undergoing laparoscopic radical resection of colorectal cancer","year":"2026","cit":0,"pfa":"ZHU Mei","psa":"QIAN Kun","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7172502057","eid":"W7172502057"},{"id":"paper-w7155407149","cat":"papers","name":"Additional file 2 of The effect of esketamine on emergence delirium or agitation in children after anesthesia-a systematic review and meta-analysis","year":"2026","cit":0,"pfa":"W Yang","psa":"He Huang","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7155407149","eid":"W7155407149"},{"id":"paper-w7170082865","cat":"papers","name":"Effects of low-dose esketamine on early quality of recovery following minimally invasive esophagectomy: a multicenter, randomized controlled study","year":"2026","cit":0,"pfa":"Hongwei Zhang","psa":"Hai Yu","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7170082865","eid":"W7170082865"},{"id":"paper-w7172485741","cat":"papers","name":"Effect of ropivacaine combined with esketamine for serratus anterior plane block on negative emotions in perimenopausal patients after breast surgery","year":"2026","cit":0,"pfa":"CHEN Yuxuan","psa":"Dengxin Zhang","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7172485741","eid":"W7172485741"},{"id":"paper-w7196966421","cat":"papers","name":"Adjunctive transcutaneous auricular vagus nerve stimulation following loss of response to maintenance intranasal esketamine in treatment-resistant depression","year":"2026","cit":0,"pfa":"Pilar Sierra","psa":"Ana García‐Blanco","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7196966421","eid":"W7196966421"},{"id":"paper-w7203721458","cat":"papers","name":"Profiling intranasal esketamine for adults with major depressive disorder and acute suicidal ideation or behavior: a phenotype-informed drug profile","year":"2026","cit":0,"pfa":"Mario Pinzi","psa":"Andrea M. Fagiolini","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7203721458","eid":"W7203721458"},{"id":"paper-w4391521502","cat":"papers","name":"Comment on “Alleviating morphine-induced itching while sustaining its analgesic efficacy: Esketamine as a potential co-administrating choice”","year":"2024","cit":0,"pfa":"Zheng Shen","psa":"Qiangang Wang","ptype":"letter","src":"https://openalex.org/W4391521502","eid":"W4391521502"},{"id":"paper-w7155356197","cat":"papers","name":"Additional file 1 of The effect of esketamine on emergence delirium or agitation in children after anesthesia-a systematic review and meta-analysis","year":"2026","cit":0,"pfa":"W Yang","psa":"He Huang","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7155356197","eid":"W7155356197"},{"id":"paper-w7171528565","cat":"papers","name":"Effect of Esketamine Pretreatment on Necroptosis in Mice with Trigeminal Neuralgia and Anxiety-Like Behavior via the RIP1/RIP3/MLKL Pathway","year":"2026","cit":0,"pfa":"Rui Dong","psa":"Xiuli Wang","topics":["Anxiety & end-of-life","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7171528565","eid":"W7171528565"},{"id":"paper-w4405550201","cat":"papers","name":"Effect of Low-dose Esketamine on Postoperative Recovery Quality in Patients Undergoing Total Laparoscopic Hysterectomy: A Randomized Controlled Trial","year":"2024","cit":0,"pfa":"Jing Zhang","psa":"Dunyi Qi","topics":["Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4405550201","eid":"W4405550201"},{"id":"paper-w4412079443","cat":"papers","name":"Effects of esketamine on postoperative pain, anxiety, depression, sleep, and inflammation in patients undergoing cesarean section: A randomized controlled tria","year":"2025","cit":0,"pfa":"Yijun Wang","psa":"Junhua Zhang","topics":["Depression","Anxiety & end-of-life"],"ptype":"preprint","src":"https://openalex.org/W4412079443","eid":"W4412079443"},{"id":"paper-w7155386952","cat":"papers","name":"Additional file 1 of The effect of esketamine on emergence delirium or agitation in children after anesthesia-a systematic review and meta-analysis","year":"2026","cit":0,"pfa":"W Yang","psa":"He Huang","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7155386952","eid":"W7155386952"},{"id":"paper-w7167729013","cat":"papers","name":"Association of esketamine exposure with secondary sclerosing cholangitis in critically ill patients: a retrospective cohort analysis of 20,000 ICU cases","year":"2026","cit":0,"pfa":"Sebastian Zeiner","psa":"Oliver Kimberger","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7167729013","eid":"W7167729013"},{"id":"paper-w4410335022","cat":"papers","name":"Comment on “A randomized double-blind trial of intranasal dexmedetomidine versus intranasal esketamine for procedural sedation and analgesia in young children”","year":"2025","cit":0,"pfa":"Jiajing Wang","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4410335022","eid":"W4410335022"},{"id":"paper-w7163170855","cat":"papers","name":"Investigation of Esketamine Administration During Surgical Procedures for the Alleviation of Postoperative Anxiety and Depression in Adolescent Patients: A Randomized Controlled Trial","year":"2026","cit":0,"pfa":"Yanhong Li","psa":"Jun Zhou","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7163170855","eid":"W7163170855"},{"id":"paper-w7134946682","cat":"papers","name":"Combined esketamine and dexmedetomidine for awake tracheal intubation in a patient with a difficult airway due to a giant lingual vascular malformation: a case report","year":"2026","cit":0,"pfa":"Jiamin He","psa":"Hong Jiang","ptype":"article","src":"https://openalex.org/W7134946682","eid":"W7134946682"},{"id":"paper-w4414543461","cat":"papers","name":"Intranasal Esketamine Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder with Comorbid Major Depressive Disorder: A Case Series of Eight Patients","year":"2025","cit":0,"pfa":"Sergi López-Rodríguez","psa":"Pino Alonso","topics":["Depression"],"ptype":"preprint","src":"https://openalex.org/W4414543461","eid":"W4414543461"},{"id":"paper-w7212161922","cat":"papers","name":"Intranasal Esketamine Augmentation in Treatment-Resistant Obsessive–Compulsive Disorder with Comorbid Treatment-Resistant Depression: A Six-Month Case Report","year":"2026","cit":0,"pfa":"Tommaso Barlattani","psa":"Domenico De Berardis","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7212161922","eid":"W7212161922"},{"id":"paper-w4412755964","cat":"papers","name":"Clinical analysis of dexmedetomidine-esketamine combined with intranasal administration before laparoscopic high ligation of hernia sac in infants and young children","year":"2025","cit":0,"pfa":"Cuicui Shi","psa":"Li Mao","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4412755964","eid":"W4412755964"},{"id":"paper-w7171700186","cat":"papers","name":"Esketamine during anesthesia induction improves early postoperative sleep quality in female patients undergoing laparoscopic surgery: A randomized trial","year":"2026","cit":0,"pfa":"Rui Du","psa":"Cheng Qian","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7171700186","eid":"W7171700186"},{"id":"paper-w7128548113","cat":"papers","name":"Letter regarding “efficacy of esketamine in reducing nausea and vomiting after anesthesia: a systematic review and meta-analysis of randomized controlled trials”","year":"2026","cit":0,"pfa":"Min Mao","psa":"Jing Chen","topics":["Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7128548113","eid":"W7128548113"},{"id":"paper-w7204982816","cat":"papers","name":"Effect of Sub-Anesthetic Dose Esketamine on Oculocardiac Reflex in Children Undergoing Day-Case Strabismus Surgery: A Randomized Controlled Trial","year":"2026","cit":0,"pfa":"Lei G","psa":"Wang G","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7204982816","eid":"W7204982816"},{"id":"paper-w4415839234","cat":"papers","name":"Analysis of the Safety of Esketamine in the Maintenance of General Anesthesia for Laparoscopic Radical Resection of Colorectal Cancer in Elderly Patients and Its Impact on VAS","year":"2025","cit":0,"pfa":"奎 高","topics":["Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4415839234","eid":"W4415839234"},{"id":"paper-w7117967934","cat":"papers","name":"Comparing fast-acting treatments for major depressive episodes: accelerated repetitive transcranial magnetic stimulation vs. intranasal esketamine","year":"2026","cit":0,"pfa":"Michele Prato","psa":"Cristina Colombo","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7117967934","eid":"W7117967934"},{"id":"paper-w7141626135","cat":"papers","name":"Critical evaluation of “efficacy and safety of esketamine for sedation during colonoscopy: a systematic review and meta-analysis of randomized controlled trials”","year":"2026","cit":0,"pfa":"Zubaida Bibi","psa":"Kausar Ali","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7141626135","eid":"W7141626135"},{"id":"paper-w4313200637","cat":"papers","name":"Efficacy and safety of esketamine nasal spray in patients with relapsed treatment-resistant depression who completed a second induction period","year":"2022","cit":0,"pfa":"M. Castro","psa":"Christian von Holt","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4313200637","eid":"W4313200637"},{"id":"paper-w4313200566","cat":"papers","name":"ESKALE study, a French real-world study describing patients and use of esketamine nasal spray as treatment of resistant depression","year":"2022","cit":0,"pfa":"Ludovic Samalin","psa":"E. Gaudre Wattinne","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4313200566","eid":"W4313200566"},{"id":"paper-w4388465439","cat":"papers","name":"Effect of esketamine on postpartum depression and pain control after caesarean section: A randomized, double-blind, controlled clinical trial","year":"2023","cit":0,"pfa":"Shurong Li","psa":"Kai-Kai Guo","topics":["Depression","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4388465439","eid":"W4388465439"},{"id":"paper-w7153326236","cat":"papers","name":"Effectiveness of adding esketamine to dexmedetomidine for sedation and analgesia during radiofrequency ablation and saphenous vein stripping: a randomized controlled trial","year":"2026","cit":0,"pfa":"Min LI","psa":"Jing WANG","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7153326236","eid":"W7153326236"},{"id":"paper-w7157720306","cat":"papers","name":"Pharmacological augmentation in treatment-resistant depression: a neurobiologically informed, practical decision guide for treatment choice with lithium, quetiapine, or esketamine","year":"2026","cit":0,"pfa":"David Eckert","psa":"Siegfried F. Kasper","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7157720306","eid":"W7157720306"},{"id":"paper-w4413100101","cat":"papers","name":"Intranasal Esketamine in Patients with Treatment-resistant Depression Who Have Previously Failed Transcranial Magnetic Stimulation: A Case Series.","year":"2025","cit":0,"pfa":"Rabeel Ahmad","psa":"Joanne Mathews","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4413100101","eid":"W4413100101"},{"id":"paper-w7125582841","cat":"papers","name":"Letter to the Editor regarding “Efficacy of esketamine after cesarean section for women with symptoms of prenatal depression: A randomized controlled trial”","year":"2026","cit":0,"pfa":"Yuanyi Yang","psa":"Hailun Xia","topics":["Depression"],"ptype":"letter","src":"https://openalex.org/W7125582841","eid":"W7125582841"},{"id":"paper-w4255153497","cat":"papers","name":"New product intros (esketamine hydrochloride (new indication, new formulation); intravenous immunoglobulin, human; tagraxofusp-erzs; toripalimab)","year":"2019","cit":0,"ptype":"article","src":"https://openalex.org/W4255153497","eid":"W4255153497"},{"id":"paper-w4390223871","cat":"papers","name":"Duration and impact of adverse events with esketamine nasal spray and quetiapine extended release in the ESCAPE-TRD phase IIIb trial","year":"2023","cit":0,"pfa":"Eduard Vieta","psa":"Andreas Reif","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4390223871","eid":"W4390223871"},{"id":"paper-w7204999578","cat":"papers","name":"Esketamine Use and Attempted Suicide or Intentional Self-Harm Among Individuals with Treatment-Resistant Depression: A Retrospective Cohort Study","year":"2026","cit":0,"pfa":"You Wang","psa":"Jason Brian Gibbons","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7204999578","eid":"W7204999578"},{"id":"paper-w3016867720","cat":"papers","name":"Comparison of brain-derived neurotrophic factor (BDNF) serum levels following ketamine and esketamine intervention for treatment-resistant depression","year":"2020","cit":0,"pfa":"Gustavo Carneiro-Gomes Leal","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W3016867720","eid":"W3016867720"},{"id":"paper-w7140734453","cat":"papers","name":"Letter to editor regarding “Efficacy of esketamine after cesarean section for women with symptoms of prenatal depression: A randomized controlled trial”","year":"2026","cit":0,"pfa":"Yixuan Lia","psa":"Xinke Ding","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7140734453","eid":"W7140734453"},{"id":"paper-w7204758757","cat":"papers","name":"Esketamine ameliorates perioperative neurocognitive disorders via the METTL3/DHCR24 axis to maintain cholesterol homeostasis and suppress neuronal apoptosis","year":"2026","cit":0,"pfa":"Haibo Deng","psa":"Yalan Li","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7204758757","eid":"W7204758757"},{"id":"paper-w7115034858","cat":"papers","name":"Effects of Subanesthetic Esketamine on Postoperative Sleep Quality Through EEG Analysis in Breast Cancer Patients: A Randomized Clinical Trial","year":"2025","cit":0,"pfa":"Zhan Y","psa":"Wang L","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7115034858","eid":"W7115034858"},{"id":"paper-w7118257231","cat":"papers","name":"Effects of preoperative nutritional support combined with esketamine on recovery and analgesia after thoracoscopic radical resection of lung cancer in elderly patients","year":"2026","cit":0,"pfa":"Yu Hou","psa":"Zhiru Zhan","topics":["Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7118257231","eid":"W7118257231"},{"id":"paper-w7133586942","cat":"papers","name":"Effects of Intraoperative Esketamine–Dexmedetomidine Combination on Postpartum Depressive Symptoms and Neuropsychiatric Events Following Cesarean Delivery: A Randomized Controlled Trial","year":"2026","cit":0,"pfa":"Li MM","psa":"Fang PP","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7133586942","eid":"W7133586942"},{"id":"paper-w3098750895","cat":"papers","name":"P.743 Effect of benzodiazepines on esketamine nasal spray for treating patients with major depressive disorder with active suicidal ideation and intent","year":"2020","cit":0,"pfa":"Bettina Diekamp","psa":"Maju Mathews","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W3098750895","eid":"W3098750895"},{"id":"paper-w4409728954","cat":"papers","name":"Does Esketamine Peripartum Intervention Reduce the Risk of Postpartum Depression? A Systematic Review and Meta-Analysis of Obstetric Anesthesia and Analgesic Approaches","year":"2025","cit":0,"pfa":"Yiran Li","psa":"Xiaoyan Zheng","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4409728954","eid":"W4409728954"},{"id":"paper-w4411752580","cat":"papers","name":"Sex differences in placebo and antidepressant response to intranasal esketamine for treatment-resistant depression: a pooled participant analysis of randomized controlled trials","year":"2025","cit":0,"pfa":"Marie Huc","psa":"Argel Aguilar‐Valles","topics":["Depression"],"ptype":"preprint","src":"https://openalex.org/W4411752580","eid":"W4411752580"},{"id":"paper-w7201882768","cat":"papers","name":"Observational study on the application of different esketamine gargle doses for the prevention of postoperative sore throat after laryngeal mask airway insertion","year":"2026","cit":0,"pfa":"Le Bo","psa":"Xiangsheng Xiong","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7201882768","eid":"W7201882768"},{"id":"paper-w4404201252","cat":"papers","name":"Observational, cross-sectional study to describe the efficacy and safety of Esketamine Nasal Spray treatment in real clinical practice: INtegrate study","year":"2024","cit":0,"pfa":"Pilar Alejandra Sáiz","psa":"Patricio Molero","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4404201252","eid":"W4404201252"},{"id":"paper-w7130509269","cat":"papers","name":"Effect of low-dose esketamine combined with labor analgesia on postpartum depressive symptoms following spontaneous labor: a randomized controlled trial","year":"2026","cit":0,"pfa":"jianxin gao","psa":"Dai Zhou","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7130509269","eid":"W7130509269"},{"id":"paper-w7150220328","cat":"papers","name":"Emotional Blunting in SSRI-Treated Patients vs. Preserved Affective Responsiveness with Esketamine in Treatment-Resistant Depression: A Comparative Study and Review","year":"2026","cit":0,"pfa":"Miriam Olivola","psa":"Bernardo Maria Dell’Osso","topics":["Depression","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7150220328","eid":"W7150220328"},{"id":"paper-w7167516809","cat":"papers","name":"Esketamine-augmented stellate ganglion block improves postoperative sleep quality after gynecological laparoscopic surgery: a randomized controlled trial","year":"2026","cit":0,"pfa":"Yuxing Wang","psa":"Lihua Peng","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7167516809","eid":"W7167516809"},{"id":"paper-w4415997553","cat":"papers","name":"Impact of Combining Esketamine With Erector Spinae Plane Block on Opioid Consumption, Inflammatory Stress, and Cognitive Function After Thoracoscopic Surgery","year":"2025","cit":0,"pfa":"Jiaqun Zhu","psa":"Dong Zhao","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4415997553","eid":"W4415997553"},{"id":"paper-w4256266464","cat":"papers","name":"P.038 Effect of esketamine nasal spray on cognition in patients with treatment-resistant depression: results from five phase-3 studies","year":"2019","cit":0,"pfa":"Robert M. Morrison","psa":"H.K. Manji","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4256266464","eid":"W4256266464"},{"id":"paper-w7161787924","cat":"papers","name":"The raw data of manuscript \"Esketamine alleviates neuroinflammation and cognitive impairment in male 3xTg-AD mice by regulating the TAOK1/IL-17 axis\".","year":"2026","cit":0,"pfa":"Zhangzhen Zhong","topics":["Policy & ethics"],"ptype":"dataset","src":"https://openalex.org/W7161787924","eid":"W7161787924"},{"id":"paper-w7162491159","cat":"papers","name":"Effect of esketamine-assisted regional block on post-traumatic stress disorder after radical lung cancer surgery: A retrospective clinical study","year":"2026","cit":0,"pfa":"Yanlin Chen","psa":"Zhen Xing","topics":["PTSD & trauma","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7162491159","eid":"W7162491159"},{"id":"paper-w4412443821","cat":"papers","name":"EE418 Cost-effectiveness of Esketamine versus Real-world Treatments for Patients with Treatment-resistant Depression: A Multi-armed Modelling Study","year":"2025","cit":0,"pfa":"Yifan Li","psa":"Xue Li","topics":["Depression"],"ptype":"conference-abstract","src":"https://openalex.org/W4412443821","eid":"W4412443821"},{"id":"paper-w7117983189","cat":"papers","name":"Effectiveness of intranasal esketamine on suicide ideation in patients affected by treatment-resistant depression: longitudinal study, predictor analysis and clinical implications","year":"2026","cit":0,"pfa":"M. Leonardi","psa":"B. Dell’Osso","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7117983189","eid":"W7117983189"},{"id":"paper-w7154167034","cat":"papers","name":"The Effects of Different Doses of Nalbuphine and Esketamine on Prevention of Emergence Agitation in Preschool Children Undergoing Tonsillectomy and Adenoidectomy: A Randomized Clinical Trial","year":"2026","cit":0,"pfa":"Zhangcheng Zou","psa":"Ran Ran","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7154167034","eid":"W7154167034"},{"id":"paper-w4410632148","cat":"papers","name":"Effect of Esketamine on Catheter-Related Bladder Discomfort in Elderly Male Patients Undergoing Flexible Ureteroscopic Lithotripsy After General Anesthesia","year":"2025","cit":0,"pfa":"Shuai Yang","psa":"Siyuan Liu","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4410632148","eid":"W4410632148"},{"id":"paper-w4411493282","cat":"papers","name":"Acute Safety and Efficacy of Intranasal Esketamine Spray Plus an Oral Antidepressant in Patient With Treatment-Resistant Depression From a University Hospital in Korea","year":"2025","cit":0,"pfa":"Sang-Yeol Lee","psa":"Chan-Mo Yang","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4411493282","eid":"W4411493282"},{"id":"paper-w4285389248","cat":"papers","name":"Esketamine combined with pregabalin on acute postoperative pain in patients undergoing resection of spinal neoplasms: study protocol for a randomized controlled trial","year":"2022","cit":0,"pfa":"Wanchen Sun","psa":"Ruquan Han","ptype":"preprint","src":"https://openalex.org/W4285389248","eid":"W4285389248"},{"id":"paper-w7115033091","cat":"papers","name":"Effect of Esketamine on Perioperative Inflammatory Factors and Postoperative Analgesic Outcomes in Patients with Obstructive Sleep Apnea Syndrome: A Randomized Controlled Trial","year":"2025","cit":0,"pfa":"Liu J","psa":"Yuan J","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7115033091","eid":"W7115033091"},{"id":"paper-w7171942979","cat":"papers","name":"Glutamatergic Resonance and Dopaminergic Stability: Intranasal Esketamine in Treatment-Resistant Depression with Comorbid ADHD and Autism Spectrum Disorder – A Case Report","year":"2026","cit":0,"pfa":"M.C. Angeletti","psa":"M. Olivola","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7171942979","eid":"W7171942979"},{"id":"paper-w7135392910","cat":"papers","name":"Evaluation of Current Evidence on the Efficacy of Esketamine in Treating Substance-Use Disorders in Patients With Treatment-Resistant Depression (TRD): A Narrative Review","year":"2026","cit":0,"pfa":"Suneha Shelke","psa":"Rusheeth Thummalapally","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W7135392910","eid":"W7135392910"},{"id":"paper-w7162633881","cat":"papers","name":"Effect of perioperative esketamine on postoperative recovery in breast cancer patients undergoing modified radical mastectomy: A systematic review and meta-analysis.","year":"2026","cit":0,"pfa":"Melisha Koirala","psa":"Aakash Pandit","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"conference-abstract","src":"https://openalex.org/W7162633881","eid":"W7162633881"},{"id":"paper-w4200233399","cat":"papers","name":"P.0687 Safety assessment of esketamine administered via dry powder inhaler in patients with treatment-resistant major depression","year":"2021","cit":0,"pfa":"Sylwia Janowska","psa":"Piotr Gałecki","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4200233399","eid":"W4200233399"},{"id":"paper-w4412183370","cat":"papers","name":"Effects of Different Doses of Esketamine on the Early Negative Emotions of Patients with Moderate to Severe Burns after Eschericectomy and Skin Grafting","year":"2025","cit":0,"pfa":"小英 贺","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4412183370","eid":"W4412183370"},{"id":"paper-w7164499320","cat":"papers","name":"Comparison of esketamine combined with dexmedetomidine versus propofol combined with midazolam on drug-induced sleep endoscopy: a randomized controlled trial","year":"2026","cit":0,"pfa":"Yanan Jiang","psa":"Jia Yan","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7164499320","eid":"W7164499320"},{"id":"paper-w7142569315","cat":"papers","name":"Effect of Intraoperative Low-Dose Esketamine on Postoperative High-Sensitivity Troponin T in Elderly Patients Undergoing Ivor Lewis Esophagectomy","year":"2026","cit":0,"pfa":"Zhou H","psa":"Wang L","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7142569315","eid":"W7142569315"},{"id":"paper-w7202148477","cat":"papers","name":"Comparative Effectiveness of Subcutaneous and Intravenous Esketamine for Treatment-Resistant Depression: A Multicenter Real-World Study of Clinical Outcomes and Symptom Dimensions.","year":"2026","cit":0,"pfa":"Gilberto S Alves","psa":"Dennison Carreiro Monteiro","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7202148477","eid":"W7202148477"},{"id":"paper-w7118002114","cat":"papers","name":"\"Tell me when to stop\" - sustained remission after esketamine discontinuation: a real-world study in patients with treatment-resistant depression","year":"2026","cit":0,"pfa":"N. Cassina","psa":"B. Dell’Osso","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7118002114","eid":"W7118002114"},{"id":"paper-w7154572395","cat":"papers","name":"Cost-effectiveness of esketamine versus alternative treatment strategies for treatment-resistant depression in Hong Kong: A multi-armed modeling study","year":"2026","cit":0,"pfa":"Yifan Li","psa":"Xue Li","topics":["Depression","Dosing & pharmacology","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7154572395","eid":"W7154572395"},{"id":"paper-w7135074451","cat":"papers","name":"Combining dexmedetomidine with esketamine exerts a dual effect on stabilizing hemodynamics and reducing stress response in patients undergoing total laparoscopic hysterectomy","year":"2026","cit":0,"pfa":"Hong-Mei Cheng","psa":"Lianping He","ptype":"article","src":"https://openalex.org/W7135074451","eid":"W7135074451"},{"id":"paper-w7165478979","cat":"papers","name":"Bolus versus Continuous Infusion of Esketamine for Prevention of Postpartum Depression After Caesarean Delivery: A Randomized, Double-Blind, Controlled Trial","year":"2026","cit":0,"pfa":"Jie Yang","psa":"Li Ren","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7165478979","eid":"W7165478979"},{"id":"paper-w4319314878","cat":"papers","name":"Review for \"Ketamine and its metabolite 2R,6R‐hydroxynorketamine promote ocular dominance plasticity and release TRKB from inhibitory control without reducing perineuronal nets enwrapping parvalbumin interneurons\"","year":"2022","cit":0,"topics":["Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4319314878","eid":"W4319314878"},{"id":"paper-w4319314908","cat":"papers","name":"Review for \"Ketamine and its metabolite 2R,6R‐hydroxynorketamine promote ocular dominance plasticity and release TRKB from inhibitory control without reducing perineuronal nets enwrapping parvalbumin interneurons\"","year":"2022","cit":0,"topics":["Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4319314908","eid":"W4319314908"},{"id":"paper-w7167204392","cat":"papers","name":"Effects of sub-anesthetic doses of esketamine on immune function and postoperative negative emotions in acoustic neuroma patients: a randomized clinical trial","year":"2026","cit":0,"pfa":"Zheping Chen","psa":"Yanwu Jin","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"dataset","src":"https://openalex.org/W7167204392","eid":"W7167204392"},{"id":"paper-w7162130735","cat":"papers","name":"Toward Integrating Intranasal Esketamine with Traumatic-Memory Psychotherapy in Treatment-Resistant Depression: A Narrative Review and Feasibility-Oriented Protocol Proposal","year":"2026","cit":0,"pfa":"F. Raffone","psa":"Vassilis Martiadis","topics":["Depression","PTSD & trauma","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W7162130735","eid":"W7162130735"},{"id":"paper-w4404785180","cat":"papers","name":"Esketamine Using for Supplemental Analgesia During Cesarean Delivery Did Not Affect Toddlers’ Neurodevelopment: Follow-Up of a Multi-Center Randomized Trial","year":"2024","cit":0,"pfa":"Lihong Sun","psa":"Xinzhong Chen","ptype":"preprint","src":"https://openalex.org/W4404785180","eid":"W4404785180"},{"id":"paper-w4408504728","cat":"papers","name":"Comment on “Perioperative esketamine combined with butorphanol versus butorphanol alone for pain management following video-assisted lobectomy: a randomized controlled trial”","year":"2025","cit":0,"pfa":"Jundan Jiang","psa":"Fu‐Shan Xue","ptype":"article","src":"https://openalex.org/W4408504728","eid":"W4408504728"},{"id":"paper-w3171192125","cat":"papers","name":"PMH30 Characteristics of Real-world Commercially Insured Patients with Treatment-resistant Depression Initiated on Esketamine Nasal Spray or Conventional Therapies","year":"2021","cit":0,"pfa":"Swapna U. Karkare","psa":"Kruti Joshi","topics":["Depression"],"ptype":"conference-abstract","src":"https://openalex.org/W3171192125","eid":"W3171192125"},{"id":"paper-w7133424741","cat":"papers","name":"Effects of Intraoperative Esketamine–Dexmedetomidine Combination on Postpartum Depressive Symptoms and Neuropsychiatric Events Following Cesarean Delivery: A Randomized Controlled Trial","year":"2026","cit":0,"pfa":"Meng-Meng Li","psa":"Pan-Pan Fang","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"report","src":"https://openalex.org/W7133424741","eid":"W7133424741"},{"id":"paper-w7153452180","cat":"papers","name":"Response to “Critical evaluation of ‘efficacy and safety of esketamine for sedation during colonoscopy: a systematic review and meta-analysis of randomized controlled trials","year":"2026","cit":0,"pfa":"Zainab Ali Hussein","psa":"Ismail Elkhattib","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7153452180","eid":"W7153452180"},{"id":"paper-w7165893189","cat":"papers","name":"Sex- and Age-Stratified Differences in Antidepressant Response to Intranasal Esketamine in Treatment-Resistant Depression: A Secondary Analysis of the REAL-ESK Study","year":"2026","cit":0,"pfa":"Luca Persico","psa":"Mauro Pettorruso","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7165893189","eid":"W7165893189"},{"id":"paper-w7118019053","cat":"papers","name":"Rebuilding the atrophied brain: Nasal esketamine 6-month therapy expands key frontal and hippocampal regions in patients with major depressive disorder","year":"2026","cit":0,"pfa":"J.A. Garcia-Carmona","psa":"P. Almela Rojo","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7118019053","eid":"W7118019053"},{"id":"paper-w7168681840","cat":"papers","name":"PP-29 Long-Term Outcomes of Intranasal Esketamine in Treatment-Resistant Depression: Evidence from Clinical Trials and Real-World Studies","year":"2026","cit":0,"pfa":"Çağla İyice","psa":"Güneş Devrim Kıcalı","topics":["Depression"],"ptype":"conference-abstract","src":"https://openalex.org/W7168681840","eid":"W7168681840"},{"id":"paper-w7167504377","cat":"papers","name":"Intranasal esketamine use in treatment-resistant depression: mechanism of action, clinical adverse effects, contraindications, safe administration protocol and treatment process","year":"2026","cit":0,"pfa":"Abdullah Burak Uygur","psa":"Şerifhan Mirac Sarı","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7167504377","eid":"W7167504377"},{"id":"paper-w7204262586","cat":"papers","name":"Additional file of Association of esketamine exposure with secondary sclerosing cholangitis in critically ill patients: a retrospective cohort analysis of 20,000 ICU cases","year":"2026","cit":0,"pfa":"Sebastian Zeiner","psa":"Oliver Kimberger","ptype":"article","src":"https://openalex.org/W7204262586","eid":"W7204262586"},{"id":"paper-w7203775408","cat":"papers","name":"Nalbuphine and esketamine combination prevented postoperative hyperalgesia in patients undergoing laparoscopic cholecystectomy: a factorial design, double-blind, randomized controlled trial","year":"2026","cit":0,"pfa":"Yi Yang","psa":"Fang Gao","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7203775408","eid":"W7203775408"},{"id":"paper-w7203821597","cat":"papers","name":"Suicidal ideation covaries with depressive severity during six-month real-world esketamine treatment in a cohort enriched for borderline personality disorder","year":"2026","cit":0,"pfa":"Vassilis Martiadis","psa":"Miriam Olivola","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7203821597","eid":"W7203821597"},{"id":"paper-w7165987088","cat":"papers","name":"Bolus versus Continuous Infusion of Esketamine for Prevention of Postpartum Depression After Caesarean Delivery: A Randomized, Double-Blind, Controlled Trial","year":"2026","cit":0,"pfa":"Yang J","psa":"Ren L","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7165987088","eid":"W7165987088"},{"id":"paper-w4294044032","cat":"papers","name":"Effect of preemptive treatment of esketamine versus sufentanil on hemodynamics in patients undergoing laryngeal microsurgery: a double-blinded randomized controlled trial","year":"2022","cit":0,"pfa":"Yiying Zhang","psa":"Changsheng Huang","ptype":"preprint","src":"https://openalex.org/W4294044032","eid":"W4294044032"},{"id":"paper-w4310520626","cat":"papers","name":"Effects of esketamine-based anaesthesia on the Systemic Inflammatory Response in Thoracic Surgical Patients: a prospective, single-center, randomized, controlled trial","year":"2022","cit":0,"pfa":"Wanxue Song","psa":"Yingke Li","topics":["Addiction"],"ptype":"preprint","src":"https://openalex.org/W4310520626","eid":"W4310520626"},{"id":"paper-w7170038010","cat":"papers","name":"Esketamine as an Adjuvant to Levobupivacaine in Thoracic Paravertebral Block for Thoracoscopic Lung Cancer Surgery: A Retrospective Propensity Score-Matched Cohort Study","year":"2026","cit":0,"pfa":"Yibing Jing","psa":"Chao Han","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7170038010","eid":"W7170038010"},{"id":"paper-w7212079374","cat":"papers","name":"Response to \"Methodological Caveats in Evaluating Perioperative Esketamine for Postoperative Pain Sensitivity: A Comment on the Study by Chen et al” [Response to Letter]","year":"2026","cit":0,"pfa":"Yanqin Wu","psa":"Yu Chen","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7212079374","eid":"W7212079374"},{"id":"paper-w7167227278","cat":"papers","name":"Effects of sub-anesthetic doses of esketamine on immune function and postoperative negative emotions in acoustic neuroma patients: a randomized clinical trial","year":"2026","cit":0,"pfa":"Zheping Chen","psa":"Yanwu Jin","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7167227278","eid":"W7167227278"},{"id":"paper-w4405660983","cat":"papers","name":"Key considerations on treatment duration: expert consensus recommendations using the Delphi method on esketamine nasal spray for treatment-resistant depression","year":"2024","cit":0,"pfa":"Allan Hunter Young","psa":"R. Perry","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4405660983","eid":"W4405660983"},{"id":"paper-w7167255649","cat":"papers","name":"Effects of sub-anesthetic doses of esketamine on immune function and postoperative negative emotions in acoustic neuroma patients: a randomized clinical trial","year":"2026","cit":0,"pfa":"Zheping Chen","psa":"Yanwu Jin","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"dataset","src":"https://openalex.org/W7167255649","eid":"W7167255649"},{"id":"paper-w7136399884","cat":"papers","name":"Commentary on “Long-term treatment with esketamine nasal spray in patients with treatment resistant depression: Results from the ESCAPE-LTE study”","year":"2026","cit":0,"pfa":"Yuqi Zhang","psa":"Jiapeng Leng","topics":["Depression"],"ptype":"editorial","src":"https://openalex.org/W7136399884","eid":"W7136399884"},{"id":"paper-w7164745115","cat":"papers","name":"Intranasal Esketamine Versus Other Pharmacological Strategies in Treatment-Resistant Depression with High Suicide Risk: A Six-Month Naturalistic Study","year":"2026","cit":0,"pfa":"Ana María de Granda-Beltrán","psa":"Inmaculada Peñuelas‐Calvo","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7164745115","eid":"W7164745115"},{"id":"paper-w7171989585","cat":"papers","name":"Long-Term Effectiveness and Tolerability of Intranasal Esketamine in Treatment-Resistant Depression: A Real-World, Single-arm Study of Over 100 sessions","year":"2026","cit":0,"pfa":"N. Ayad","psa":"S. Makhoul","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7171989585","eid":"W7171989585"},{"id":"paper-w4386225016","cat":"papers","name":"Esketamine prevents cognitive deficiency via intestinal flora/subdiaphragmatic vagus nerve/spleen axis after a secondary LPS exposure","year":"2023","cit":0,"pfa":"Yuming Wu","psa":"Shiying Yuan","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4386225016","eid":"W4386225016"},{"id":"paper-w4414180714","cat":"papers","name":"Depression and suicidal risk in autism spectrum disorder: efficacy of intranasal esketamine. Clinical experience from a public mental health service in Italy","year":"2025","cit":0,"pfa":"Alessandro Guffanti","psa":"Miriam Olivola","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4414180714","eid":"W4414180714"},{"id":"paper-w7125815067","cat":"papers","name":"Effects of low-dose esketamine on hypoxaemia during thoracoscopic non-tracheal intubation anaesthesia: protocol for a double-blind, randomised controlled trial","year":"2026","cit":0,"pfa":"Jing Tian","psa":"Chang-ping Gu","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7125815067","eid":"W7125815067"},{"id":"paper-w4313223429","cat":"papers","name":"Effect of oral esketamine on preoperative sedation and venipuncture analgesia in pediatric patients: a prospective randomized double-blind controlled clinical trial","year":"2022","cit":0,"pfa":"Zunyuan Liu","psa":"Hongquan Zhang","topics":["Anxiety & end-of-life","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4313223429","eid":"W4313223429"},{"id":"paper-w7154665870","cat":"papers","name":"The Effects of Different Doses of Nalbuphine and Esketamine on Prevention of Emergence Agitation in Preschool Children Undergoing Tonsillectomy and Adenoidectomy: A Randomized Clinical Trial","year":"2026","cit":0,"pfa":"Zou Z","psa":"Ran R","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7154665870","eid":"W7154665870"},{"id":"paper-w4406731505","cat":"papers","name":"Comment on “Efficacy of racemic ketamine or esketamine monotherapy for reducing suicidal ideation in uni- or bipolar depression: a systematic review and meta-analysis”","year":"2025","cit":0,"pfa":"Alina Wilkowska","psa":"Wiesław Jerzy Cubała","topics":["Depression","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4406731505","eid":"W4406731505"},{"id":"paper-w7171852590","cat":"papers","name":"Esketamine induces ferroptosis and suppresses immune evasion in lung adenocarcinoma cells via the hsa_circ_0022392/miR-548b-3p/MAP7 axis","year":"2026","cit":0,"pfa":"Fei Chai","psa":"XiaoBing Du","topics":["Anxiety & end-of-life","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7171852590","eid":"W7171852590"},{"id":"paper-w7204498056","cat":"papers","name":"Effect of Sub-Anesthetic Dose Esketamine on Oculocardiac Reflex in Children Undergoing Day-Case Strabismus Surgery: A Randomized Controlled Trial","year":"2026","cit":0,"pfa":"Guiyu Lei","psa":"Guyan Wang","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7204498056","eid":"W7204498056"},{"id":"paper-w7161814916","cat":"papers","name":"Corrigendum to “Intranasal esketamine in treatment-resistant depression: long-term dosing patterns and clinical outcomes in a 5-year observational study”","year":"2026","cit":0,"topics":["Depression","Dosing & pharmacology"],"ptype":"erratum","src":"https://openalex.org/W7161814916","eid":"W7161814916"},{"id":"paper-w4417182116","cat":"papers","name":"Effect of Esketamine on Perioperative Inflammatory Factors and Postoperative Analgesic Outcomes in Patients with Obstructive Sleep Apnea Syndrome: A Randomized Controlled Trial","year":"2025","cit":0,"pfa":"Jing Liu","psa":"Jingjing Yuan","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4417182116","eid":"W4417182116"},{"id":"paper-w4393900084","cat":"papers","name":"Intravenous Patient-Controlled Analgesia with Esketamine Improves Early Depressive Symptoms in Patients with Postherpetic Neuralgia: A Single-Center Retrospective Cohort Study","year":"2024","cit":0,"pfa":"Ling Qiu","psa":"Xiaobin Wang","topics":["Depression","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4393900084","eid":"W4393900084"},{"id":"paper-w7212222410","cat":"papers","name":"Effect of Esketamine Combined with Oxycodone in Postoperative Pain Management in Elderly Patients Undergoing Abdominal Surgery: A Double-Blind Randomized Trial","year":"2026","cit":0,"pfa":"Ying Sun","psa":"Wenli Yu","ptype":"preprint","src":"https://openalex.org/W7212222410","eid":"W7212222410"},{"id":"paper-w4414207674","cat":"papers","name":"Efficacy of Esketamine nasal spray in treatment-resistant depression: impact on depressive symptoms,hopelessness and suicide risk: A real-world evidence study","year":"2025","cit":0,"pfa":"Maurizio Pompili","psa":"Isabella Berardelli","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4414207674","eid":"W4414207674"},{"id":"paper-w4319314868","cat":"papers","name":"Review for \"Ketamine and its metabolite 2R,6R‐hydroxynorketamine promote ocular dominance plasticity and release TRKB from inhibitory control without reducing perineuronal nets enwrapping parvalbumin interneurons\"","year":"2023","cit":0,"topics":["Reviews & meta-analyses"],"ptype":"peer-review","src":"https://openalex.org/W4319314868","eid":"W4319314868"},{"id":"paper-w7214526972","cat":"papers","name":"Epidural Esketamine Relieves Postoperative Pain, Suppresses Perioperative Inflammation and Mitigates Postpartum Depression Following Cesarean Delivery: A Randomized Controlled Trial","year":"2026","cit":0,"pfa":"Tingting Qiu","psa":"Yuefeng Zhou","topics":["Depression"],"ptype":"preprint","src":"https://openalex.org/W7214526972","eid":"W7214526972"},{"id":"paper-w4409114230","cat":"papers","name":"Esketamine nasal spray compassionate use program in the Netherlands: An open label, multi-center cohort study in severe treatment-resistant depression","year":"2025","cit":0,"pfa":"Abel Busz","psa":"Henricus Gerardus Ruhé","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4409114230","eid":"W4409114230"},{"id":"paper-w7169078927","cat":"papers","name":"Serum brain-derived neurotrophic factor following oral esketamine in treatment-resistant depression: Results from a randomized placebo-controlled trial","year":"2026","cit":0,"pfa":"Sara Massetti","psa":"Jens H. van Dalfsen","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7169078927","eid":"W7169078927"},{"id":"paper-w7133211641","cat":"papers","name":"Precision application of target-controlled infusion of esketamine combined with sufentanil in anesthesia for thoracoscopic surgery and its effect on hemodynamics, postoperative pain, and safety","year":"2026","cit":0,"pfa":"Tianyu Qi","psa":"Lidong Zhang","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7133211641","eid":"W7133211641"},{"id":"paper-w7116670966","cat":"papers","name":"Effect of Esketamine Combined with Lidocaine on Opioid Requirements in the Elderly Undergoing Laparoscopic Colorectal Cancer Surgery: A Randomized, Double-Blind, Controlled Trial","year":"2025","cit":0,"pfa":"Jin-Xi Xie","psa":"Li-Wen Zhou","topics":["Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7116670966","eid":"W7116670966"},{"id":"paper-w7171953498","cat":"papers","name":"Data and analysis code for: Intraoperative intravenous esketamine in video-assisted thoracoscopic surgery — a systematic review and meta-analysis of randomized controlled trials","year":"2026","cit":0,"pfa":"Bruno Moraes Dubois","psa":"Thomas Rolf Erdmann","topics":["Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7171953498","eid":"W7171953498"},{"id":"paper-w4319314901","cat":"papers","name":"Decision letter for \"Ketamine and its metabolite 2R,6R‐hydroxynorketamine promote ocular dominance plasticity and release TRKB from inhibitory control without reducing perineuronal nets enwrapping parvalbumin interneuron","year":"2023","cit":0,"ptype":"peer-review","src":"https://openalex.org/W4319314901","eid":"W4319314901"},{"id":"paper-w4385669322","cat":"papers","name":"Intranasal esketamine + Intensive CBT: a 12 months follow-up of two complicated cases of Treatment Resistant Depression at high suicidal risk","year":"2023","cit":0,"pfa":"Vassilis Martiadis","psa":"M. Russo","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4385669322","eid":"W4385669322"},{"id":"paper-w4409390901","cat":"papers","name":"Effect of Esketamine Compared with Sufentanil Combined with Propofol in Patients Undergoing First Trimester Surgical Abortion: A Randomized, Double-Blinded Clinical Trial","year":"2025","cit":0,"pfa":"Yingchao Guan","psa":"Xiaodong Wang","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4409390901","eid":"W4409390901"},{"id":"paper-w7161785505","cat":"papers","name":"The raw data of manuscript \"Esketamine alleviates neuroinflammation and cognitive impairment in male 3xTg-AD mice by regulating the TAOK1/IL-17 axis\".","year":"2026","cit":0,"pfa":"Zhangzhen Zhong","topics":["Policy & ethics"],"ptype":"dataset","src":"https://openalex.org/W7161785505","eid":"W7161785505"},{"id":"paper-w7171923073","cat":"papers","name":"Acute Effects of Esketamine on Blood Pressure and Heart Rate: Associations with Psychopathological Traits by Minnesota Multiphasic Personality Inventory 2 (MMPI-2)","year":"2026","cit":0,"pfa":"C. Serritella","psa":"D. Riccio","topics":["Depression","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7171923073","eid":"W7171923073"},{"id":"paper-w7171774678","cat":"papers","name":"Comment on “The effect of perioperative ketamine and esketamine administration on postoperative nausea and vomiting in patients undergoing general anesthesia: a systematic review and meta-analysis”","year":"2026","cit":0,"pfa":"Abhijit Sukumaran Nair","psa":"Tuhin Mistry","topics":["Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7171774678","eid":"W7171774678"},{"id":"paper-w4405270838","cat":"papers","name":"Effect of Esketamine on the EC 50 of Remifentanil for Suppression of Choking During Extubation in Male Patients Undergoing Anterior Approach Cervical Spine Surgery","year":"2024","cit":0,"pfa":"Shouyi Chen","psa":"Lanying Lin","ptype":"preprint","src":"https://openalex.org/W4405270838","eid":"W4405270838"},{"id":"paper-w7213455157","cat":"papers","name":"In Silico Design of an Inflammation-Responsive Lactiplantibacillus plantarum Chassis for Esketamine Prodrug Delivery via the Gut–Brain Axis in Traumatic Brain Injury","year":"2026","cit":0,"pfa":"Minahal Shakeel","psa":"Kamran Rasool","topics":["PTSD & trauma","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7213455157","eid":"W7213455157"},{"id":"paper-w4416185966","cat":"papers","name":"Comments on “Effect of intraoperative low-dose esketamine on postoperative quality of recovery in patients undergoing laparotomy for gynecologic malignancy: a randomized controlled trial”","year":"2025","cit":0,"pfa":"Zhe Su","psa":"Xuefei Ye","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4416185966","eid":"W4416185966"},{"id":"paper-w7154666711","cat":"papers","name":"Effect of Dexmedetomidine Combined with Esketamine on Postoperative Fatigue in Patients Undergoing Total Laparoscopic Hysterectomy: A Single-Center Randomized Double-Blinded Controlled Trial","year":"2026","cit":0,"pfa":"Wu L","psa":"Wang G","ptype":"article","src":"https://openalex.org/W7154666711","eid":"W7154666711"},{"id":"paper-w7130948412","cat":"papers","name":"Correction to: A real-world pharmacovigilance study of adverse events associated with esketamine: disproportionality analysis and detection of potential drug-drug interaction signals","year":"2026","cit":0,"pfa":"Claudia Pisanu","psa":"Satoko Hori","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"erratum","src":"https://openalex.org/W7130948412","eid":"W7130948412"},{"id":"paper-w7196951969","cat":"papers","name":"Effect of esketamine on postoperative neuropathic pain and quality of recovery following debridement for diabetic foot ulcers: A randomized controlled dose-finding study","year":"2026","cit":0,"pfa":"Jing Gong","psa":"Ning Chen","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7196951969","eid":"W7196951969"},{"id":"paper-w4414119556","cat":"papers","name":"Geographic Disparities in Medicare Esketamine (Spravato) Access: A Claims-Based Analysis Documenting a 24-State Treatment Desert (September 2025)","year":"2025","cit":0,"pfa":"Michael Alvear","ptype":"preprint","src":"https://openalex.org/W4414119556","eid":"W4414119556"},{"id":"paper-w7162793723","cat":"papers","name":"Desflurane combined with ciprofol or esketamine improves postoperative symptoms without compromising early neurocognitive recovery after intracranial aneurysm endovascular coiling","year":"2026","cit":0,"pfa":"Wang Tenghuan","psa":"Sheng Guan","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7162793723","eid":"W7162793723"},{"id":"paper-w7155651070","cat":"papers","name":"525. Non-Inferiority of Intramuscular Racemic Ketamine Versus Intranasal Esketamine for Treatment-Resistant Depression: A Real-World VA Clinic Study","year":"2026","cit":0,"pfa":"Tara A. Austin","psa":"Dhakshin Ramanathan","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7155651070","eid":"W7155651070"},{"id":"paper-w7167847844","cat":"papers","name":"Real-world outcomes of intranasal esketamine and intravenous ketamine induction therapy for treatment-resistant depression in a community clinic: a retrospective cohort study","year":"2026","cit":0,"pfa":"Patrice A. Bellanti","psa":"Daniel Z. Adams","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7167847844","eid":"W7167847844"},{"id":"paper-w4390223959","cat":"papers","name":"Management considerations of long-term esketamine intranasal spray for treatment-resistant depression (trd): a focus on three 24 months follow-up cases","year":"2023","cit":0,"pfa":"Ranieri Domenico Cornaggia","psa":"Matteo Marcatili","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4390223959","eid":"W4390223959"},{"id":"paper-w7134967588","cat":"papers","name":"Esketamine vs. sufentanil for anesthesia induction in elderly patients undergoing transbronchial lung biopsy (TBLB): effect on hemodynamic stability, airway reactivity, and oxygenation","year":"2026","cit":0,"pfa":"MingChong Wang","psa":"WenHua Zhang","ptype":"article","src":"https://openalex.org/W7134967588","eid":"W7134967588"},{"id":"paper-w7171537928","cat":"papers","name":"Dimensional effect profiles in treatment-resistant depression: A naturalistic, prospective head-to-head comparison of arTMS, esketamine nasal spray, and oral brexpiprazole","year":"2026","cit":0,"pfa":"Giacomo d’Andrea","psa":"Giovanni Martinotti","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7171537928","eid":"W7171537928"},{"id":"paper-w4385597140","cat":"papers","name":"Correction to: Pharmacokinetics of Nasal Esketamine in Patients with Allergic Rhinitis with and Without Nasal Decongestant Pretreatment and in Healthy Subjects with and Without Nasal Corticosteroid Pretreatment","year":"2023","cit":0,"pfa":"Peter Zannikos","psa":"Jaskaran B. Singh","topics":["Dosing & pharmacology"],"ptype":"erratum","src":"https://openalex.org/W4385597140","eid":"W4385597140"},{"id":"paper-w7117964029","cat":"papers","name":"Patient characteristics associated with relative benefit of esketamine nasal spray versus quetiapine extended release on achieving remission in ESCAPE-TRD study","year":"2026","cit":0,"pfa":"A.J. Oliveira-Maia","psa":"R. S. McIntyre","ptype":"article","src":"https://openalex.org/W7117964029","eid":"W7117964029"},{"id":"paper-w7127410916","cat":"papers","name":"Letter to the editor regarding: Efficacy of esketamine in reducing nausea and vomiting after anesthesia: a systematic review and meta-analysis of randomized controlled trials","year":"2026","cit":0,"pfa":"Jia-yi Xia","psa":"Qi-Hong Shen","topics":["Reviews & meta-analyses"],"ptype":"letter","src":"https://openalex.org/W7127410916","eid":"W7127410916"},{"id":"paper-w7161943254","cat":"papers","name":"209eP Efficacy of perioperative esketamine on postoperative recovery in breast cancer patients undergoing modified radical mastectomy: A systematic review and meta-analysis","year":"2026","cit":0,"pfa":"A. Pandit","psa":"M. Koirala","topics":["Anxiety & end-of-life","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7161943254","eid":"W7161943254"},{"id":"paper-w4413284917","cat":"papers","name":"413. CLINICAL EXPERIENCES WITH ESKETAMINE TREATMENT AT THE DEPARTMENT OF PSYCHIATRY AND PSYCHOLOGICAL MEDICINE, UNIVERSITY HOSPITAL CENTRE ZAGREB, DURING THE PERIOD FROM 2022 TO 2024","year":"2025","cit":0,"pfa":"Maja Živković","psa":"Dunja Degmečić","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W4413284917","eid":"W4413284917"},{"id":"paper-w4213364975","cat":"papers","name":"Safety of esketamine nasal spray: Analysis of post-marketing reports submitted to the FDA adverse event reporting system in the first year on the market","year":"2021","cit":0,"pfa":"Chiara Gastaldon","psa":"Corrado Barbui","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4213364975","eid":"W4213364975"},{"id":"paper-w7161264768","cat":"papers","name":"The Pharmacological and Ultra High Dilution Esketamine (12cH) Prevent Morphine-Conditioned Place Preference and Reprogram Reward-Related Plasticity in Opioid-Exposed Offspring","year":"2026","cit":0,"pfa":"Murilo Barboza Fontoura","psa":"Ana Paula Silva e Souza","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7161264768","eid":"W7161264768"},{"id":"paper-w4416231521","cat":"papers","name":"Effectiveness of Intranasal Esketamine on Suicidal Ideation and Depressive Symptoms in Patients with Treatment-Resistant Depression: A Longitudinal Study, Predictor Analysis and Clinical Implications","year":"2025","cit":0,"pfa":"Matteo Leonardi","psa":"Bernardo Maria Dell’Osso","topics":["Depression","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4416231521","eid":"W4416231521"},{"id":"paper-w7167824530","cat":"papers","name":"Ultrasound-Guided Femoral Nerve Block with Esketamine Adjuvant for Postoperative Analgesia in Total Knee Arthroplasty–A Randomized, Double-Blind, Controlled Trial","year":"2026","cit":0,"pfa":"Zhi Cheng","psa":"Ping Wang","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7167824530","eid":"W7167824530"},{"id":"paper-w3019240487","cat":"papers","name":"144 Esketamine Nasal Spray for Management of Treatment-Resistant Depression: Number Needed to Treat, Number Needed to Harm, Likelihood to be Helped/Harmed","year":"2020","cit":0,"pfa":"Leslie Citrome","psa":"Jaskaran B. Singh","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3019240487","eid":"W3019240487"},{"id":"paper-w7204649769","cat":"papers","name":"Correction: Esketamine-led opioid-free anaesthesia reduces postoperative pulmonary complications in bariatric surgery patients: a prospective randomized controlled trial","year":"2026","cit":0,"pfa":"He-Liang Sun","psa":"Chun Yang","topics":["Addiction"],"ptype":"erratum","src":"https://openalex.org/W7204649769","eid":"W7204649769"},{"id":"paper-w4394461030","cat":"papers","name":"Supplementary Material for: Post-Marketing Safety Concerns with Esketamine: A Disproportionality Analysis of Spontaneous Reports Submitted to the FDA Adverse Event Reporting System","year":"2020","cit":0,"pfa":"Chiara Gastaldon","psa":"Georgios Schoretsanitis","topics":["Depression","Safety & adverse events"],"ptype":"supplementary-materials","src":"https://openalex.org/W4394461030","eid":"W4394461030"},{"id":"paper-w7144041785","cat":"papers","name":"The Effect of Esketamine on Postoperative Fatigue Syndrome in Middle-Aged and Elderly Patients Undergoing Lumbar Vertebral Body Fusion Surgery—A Retrospective Study","year":"2026","cit":0,"pfa":"Wenqi Lu","psa":"HanChun Hu","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7144041785","eid":"W7144041785"},{"id":"paper-w4391106143","cat":"papers","name":"Analgesic Effect of Esketamine Combined with Ropivacaine in Ultrasound-Guided Lower Transverse Abdominal Muscle Plane Block for Laparoscopic Radical Rectal Resection","year":"2024","cit":0,"pfa":"玲 孙","ptype":"article","src":"https://openalex.org/W4391106143","eid":"W4391106143"},{"id":"paper-w4281746019","cat":"papers","name":"Effects of premedication with nasal spray esketamine on preoperative separation anxiety and postoperative emergence agitation in preschoolers undergoing general anesthesia with sevoflurane for strabismus surgery","year":"2022","cit":0,"pfa":"Wei Liu","psa":"Shuzhen Wang","topics":["Anxiety & end-of-life","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4281746019","eid":"W4281746019"},{"id":"paper-w7158286105","cat":"papers","name":"Impact of esketamine-based opioid-free anesthesia on quality of recovery after laparoscopic hysterectomy: a randomized controlled trial using the QoR-40 questionnaire","year":"2026","cit":0,"pfa":"Yufeng Chen","psa":"Guoping Wang","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7158286105","eid":"W7158286105"},{"id":"paper-w4313201214","cat":"papers","name":"Study design of ESCAPE-TRD, a long-term, comparative, randomised phase IIIb clinical trial of esketamine nasal spray in treatment resistant depression","year":"2022","cit":0,"pfa":"A. Reif","psa":"Yordan Godinov","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4313201214","eid":"W4313201214"},{"id":"paper-w7169045032","cat":"papers","name":"The Effect of Esketamine on Peripheral Vascular Resistance in Elderly Patients During Anesthesia Induction: A Single-Center, Double-Blind, Prospective, Randomized Controlled Study","year":"2026","cit":0,"pfa":"J N Li","psa":"Shigang Tan","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7169045032","eid":"W7169045032"},{"id":"paper-w7204242699","cat":"papers","name":"Additional file of Association of esketamine exposure with secondary sclerosing cholangitis in critically ill patients: a retrospective cohort analysis of 20,000 ICU cases","year":"2026","cit":0,"pfa":"Sebastian Zeiner","psa":"Oliver Kimberger","ptype":"article","src":"https://openalex.org/W7204242699","eid":"W7204242699"},{"id":"paper-w4401919585","cat":"papers","name":"The effect of prophylactic esketamine in labor and cesarian delivery on the prevention of postpartum depression (PPD): A systematic review and meta-analysis of randomized controlled trials","year":"2024","cit":0,"pfa":"Angelina Kozhokar Mikhaylovskaya","psa":"A. Q. Shimit","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W4401919585","eid":"W4401919585"},{"id":"paper-w7172515510","cat":"papers","name":"The molecular and neurochemical basis of altered intrinsic neural timescales in major depressive disorder: a multimodal imaging-transcriptomic investigation of esketamine and sertraline treatment","year":"2026","cit":0,"pfa":"Xiang Liu","psa":"Dechang Peng","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7172515510","eid":"W7172515510"},{"id":"paper-w7172023802","cat":"papers","name":"Intranasal Esketamine for Treatment-Resistant Depression in Real-World Multicenter Practice: Clinical Effectiveness, Functional Recovery, and Patient-Reported Quality of Life","year":"2026","cit":0,"pfa":"Ana Isabel de Santiago-Díaz","psa":"M.A. Madrazo-Maza","topics":["Depression","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7172023802","eid":"W7172023802"},{"id":"paper-w7131616012","cat":"papers","name":"Esketamine-assisted low-opioid anesthesia reduces postoperative anxiety and depression in gastric cancer laparoscopic surgery: A mental health-focused analysis","year":"2026","cit":0,"pfa":"Wenlong Xie","psa":"Jianjun Zhou","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7131616012","eid":"W7131616012"},{"id":"paper-w4200574097","cat":"papers","name":"P.0366 Sleep disturbance and efficacy of esketamine nasal spray in patients with treatment-resistant depression: findings from randomized, controlled trials","year":"2021","cit":0,"pfa":"Stephane Borentain","psa":"F. Wiegand","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4200574097","eid":"W4200574097"},{"id":"paper-w4319314867","cat":"papers","name":"Decision letter for \"Ketamine and its metabolite 2R,6R‐hydroxynorketamine promote ocular dominance plasticity and release TRKB from inhibitory control without reducing perineuronal nets enwrapping parvalbumin interneuron","year":"2022","cit":0,"ptype":"peer-review","src":"https://openalex.org/W4319314867","eid":"W4319314867"},{"id":"paper-w7162432319","cat":"papers","name":"Bidirectional therapeutic sequencing of repetitive transcranial magnetic stimulation and intranasal esketamine for treatment-resistant depression: a real-world consecutive case series","year":"2026","cit":0,"pfa":"Isabel Martínez‐Gras","psa":"Gabriel Rubio","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7162432319","eid":"W7162432319"},{"id":"paper-w4403777785","cat":"papers","name":"Esketamine Prevent Carboprost-Induced Adverse Reactions During Cesarean Section Under Combined Spinal-Epidural Anesthesia: a double-blind, randomized trial","year":"2024","cit":0,"pfa":"Feng Zhou","psa":"Yue Tian","topics":["Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4403777785","eid":"W4403777785"},{"id":"paper-w7160730448","cat":"papers","name":"Effects of Intravenous Esketamine or Magnesium Sulfate on Early Postoperative Negative Emotions and Pain in Patients Undergoing Endoscopic Sinus Surgery: A Randomized Controlled Trial","year":"2026","cit":0,"pfa":"Wang L","psa":"Xie C","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7160730448","eid":"W7160730448"},{"id":"paper-w4241323825","cat":"papers","name":"Human medicines European public assessment report (EPAR): Spravato, esketamine, Depressive Disorder, Date of authorisation: 18/12/2019, Status: Authorised","year":"2019","cit":0,"topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4241323825","eid":"W4241323825"},{"id":"paper-w4415586814","cat":"papers","name":"Effect of sub-anesthetic dose of esketamine on oculocardiac reflex of pediatric strabismus surgery in total intravenous anesthesia: study protocol for a randomized controlled trial","year":"2025","cit":0,"pfa":"Jiaqi Liu","psa":"Hao Cheng","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4415586814","eid":"W4415586814"},{"id":"paper-w7171381438","cat":"papers","name":"Response to \"Comment on The effect of perioperative ketamine and esketamine administration on postoperative nausea and vomiting in patients undergoing general anesthesia: a systematic review and meta-analysis\"","year":"2026","cit":0,"pfa":"Kwon Hui Seo","topics":["Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7171381438","eid":"W7171381438"},{"id":"paper-w7130504865","cat":"papers","name":"EFFICACY AND SAFETY OF ESKETAMINE NASAL SPRAY IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER AND ACTIVE SUICIDAL IDEATION: RESULTS FROM A RANDOMIZED DOUBLE-BLIND STUDY","year":"2024","cit":0,"pfa":"Vidhya Joth N","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7130504865","eid":"W7130504865"},{"id":"paper-w7126443861","cat":"papers","name":"Correspondence regarding “Efficacy of esketamine after cesarean section for women with symptoms of prenatal depression: A randomized controlled trial by Xue-Song et al.","year":"2026","cit":0,"pfa":"Fu-Shan Xue","psa":"Yan-Hua Guo","topics":["Depression"],"ptype":"letter","src":"https://openalex.org/W7126443861","eid":"W7126443861"},{"id":"paper-w4362664553","cat":"papers","name":"Neonatal outcomes when intravenous esketamine is added to the parturients transferred from labor analgesia to emergency cesarean section: A retrospective analysis report","year":"2023","cit":0,"pfa":"Zhaojia Liang","psa":"Mengxia Wang","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4362664553","eid":"W4362664553"},{"id":"paper-w7163689908","cat":"papers","name":"Response to: Commentary on “Long-term treatment with esketamine nasal spray in patients with treatment resistant depression: Results from the ESCAPE-LTE study”","year":"2026","cit":0,"pfa":"Andreas Reif","psa":"Wiesław Jerzy Cubała","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7163689908","eid":"W7163689908"},{"id":"paper-w4405636295","cat":"papers","name":"Treatment patterns of esketamine nasal spray amongst patients with treatment resistant depression in a phase IIIb study: results from ESCAPE-TRD","year":"2024","cit":0,"pfa":"A. Reif","psa":"Tetsuro Ito","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4405636295","eid":"W4405636295"},{"id":"paper-w7155601177","cat":"papers","name":"523. Clinical Outcomes Following Transition From Intranasal Esketamine to Intravenous Racemic Ketamine in Treatment-Resistant Depression: A Retrospective Case Series","year":"2026","cit":0,"pfa":"Michael Hale","psa":"Brandon M. Kitay","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7155601177","eid":"W7155601177"},{"id":"paper-w4415147968","cat":"papers","name":"Multi‑omics and experimental validation unveil BDNF as a diagnostic biomarker and therapeutic target in endoplasmic reticulum stress‑driven lung adenocarcinoma: Therapeutic potential of Esketamine","year":"2025","cit":0,"pfa":"Xiujuan Deng","psa":"Heli Ning","topics":["Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4415147968","eid":"W4415147968"},{"id":"paper-w4405636375","cat":"papers","name":"Disease-specific quality of life with esketamine nasal spray versus quetiapine extended release in treatment resistant depression: results from ESCAPE-TRD","year":"2024","cit":0,"pfa":"Allan Hunter Young","psa":"Albino Jorge Oliveira-Maia","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4405636375","eid":"W4405636375"},{"id":"paper-w7170159086","cat":"papers","name":"Rapid clinical and EEG microstate changes 24 h after intranasal esketamine in major depressive disorder with suicidal ideation: a prospective paired study","year":"2026","cit":0,"pfa":"Tingting Gu","psa":"Honglei Yin","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7170159086","eid":"W7170159086"},{"id":"paper-w7214227902","cat":"papers","name":"Local infiltration versus intramuscular esketamine for procedural pain and postoperative PHQ-9 scores in older adults undergoing percutaneous kyphoplasty: a randomised controlled trial","year":"2026","cit":0,"pfa":"Longyuan Zhou","psa":"Yong Qi","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7214227902","eid":"W7214227902"},{"id":"paper-w7204955389","cat":"papers","name":"The Effects of Different Doses of Intravenous Esketamine on Postoperative Sleep and Chronic Pain in Patients Undergoing Thoracoscopic Lung Resection Surgery: A Randomized Controlled Trial","year":"2026","cit":0,"pfa":"Yan Li","psa":"Wangning Shangguan","topics":["Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7204955389","eid":"W7204955389"},{"id":"paper-w7204757911","cat":"papers","name":"Real-world clinical practice, effectiveness and safety of esketamine nasal spray in major depressive disorder patients: a French prospective cohort (ELLIPSE study)","year":"2026","cit":0,"pfa":"Pierre‐Michel Llorca","psa":"Pierre de Maricourt","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7204757911","eid":"W7204757911"},{"id":"paper-w7213322740","cat":"papers","name":"Opioid-free analgesia with esketamine-dexmedetomidine versus opioid-based analgesia after gynaecological laparoscopic surgery: a double-blind, randomized, controlled trial","year":"2026","cit":0,"pfa":"Ying Ren","psa":"Hao Kong","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7213322740","eid":"W7213322740"},{"id":"paper-w7168290958","cat":"papers","name":"Effects of Esketamine Combined With Pericapsular Nerve Group Block on Quality of Recovery, Analgesic Outcomes, and Hemodynamics in Elderly Patients Undergoing Total Hip Arthroplasty","year":"2026","cit":0,"pfa":"Xionghui Wu","psa":"Peng Xu","ptype":"article","src":"https://openalex.org/W7168290958","eid":"W7168290958"},{"id":"paper-w7104113744","cat":"papers","name":"Low-Dose Esketamine Plus Dexmedetomidine in Patient-Controlled Intravenous Analgesia Improves Post-Cesarean Sleep Quality: A Double-Blind Randomized Trial","year":"2025","cit":0,"pfa":"Zhang L","psa":"Xie Y","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7104113744","eid":"W7104113744"},{"id":"paper-w7166691126","cat":"papers","name":"Esketamine multi-omic biomarker evaluation in major depressive disorder (EMBER-MDD): concept, objectives and methodologies of a non-clinical investigator-initiated study","year":"2026","cit":0,"pfa":"Christa Hohoff","psa":"Bernhard Theodor Baune","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7166691126","eid":"W7166691126"},{"id":"paper-w4407387342","cat":"papers","name":"SUBGROUP ANALYSIS IN CHANGES IN QUALITY OF LIFE AND DEPRESSION SEVERITY SCORES BY LINE OF THERAPY IN PATIENTS TREATED WITH ESKETAMINE IN A REAL-WORLD SETTING ACROSS ANZ","year":"2025","cit":0,"pfa":"David Barton","psa":"Ian Bernard Hickie","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4407387342","eid":"W4407387342"},{"id":"paper-w7144004952","cat":"papers","name":"Role of concomitant benzodiazepines, lithium, and lamotrigine in modulating the antidepressant effects of subcutaneous esketamine in patients with treatment-resistant depressive episodes: A retrospective naturalistic stu","year":"2026","cit":0,"pfa":"João Paulo Atídio","psa":"Acioly L.T. Lacerda","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7144004952","eid":"W7144004952"},{"id":"paper-w7118020773","cat":"papers","name":"Early dose management and up-titration of esketamine in the double-blind induction phase of the randomized, active-controlled, phase 3 TRANSFORM-2 study","year":"2026","cit":0,"pfa":"Patricio Molero","psa":"C. Bossie","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7118020773","eid":"W7118020773"},{"id":"paper-w7135386669","cat":"papers","name":"Additional file 1: of Sedation with propofol during ERCP: is the combination with esketamine more effective and safer than with alfentanil? Study protocol for a randomized controlled trial","year":"2017","cit":0,"pfa":"Susanne Eberl","psa":"Benedikt Preckel","ptype":"article","src":"https://openalex.org/W7135386669","eid":"W7135386669"},{"id":"paper-w4407601864","cat":"papers","name":"Characteristics of patients with major depressive disorder eligible for and prescribed esketamine, treatment outcomes and physician experiences: a physician and patient survey in the United States","year":"2025","cit":0,"pfa":"Manish K. Jha","psa":"Kruti Joshi","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4407601864","eid":"W4407601864"},{"id":"paper-w4319314856","cat":"papers","name":"Decision letter for \"Ketamine and its metabolite 2R,6R‐hydroxynorketamine promote ocular dominance plasticity and release TRKB from inhibitory control without reducing perineuronal nets enwrapping parvalbumin interneuron","year":"2023","cit":0,"ptype":"peer-review","src":"https://openalex.org/W4319314856","eid":"W4319314856"},{"id":"paper-w7167925080","cat":"papers","name":"Regional anesthesia combined with esketamine analgesia and remimazolam sedation as a salvage strategy for intertrochanteric femur fracture surgery in a high-risk patient: A case report","year":"2026","cit":0,"pfa":"Xiaolin Wang","psa":"Y G Yang","topics":["Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7167925080","eid":"W7167925080"},{"id":"paper-w7124236194","cat":"papers","name":"Comparison of the Effective Dose 90 (ED90) and Clinical Outcomes of Fentanyl Versus Esketamine for Analgesia in Hysteroscopy: A Two-Part, Randomized, Double-Blind Trial","year":"2026","cit":0,"pfa":"Du J","psa":"Qin X","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7124236194","eid":"W7124236194"},{"id":"paper-w7204994760","cat":"papers","name":"Intravenous ketamine compared to intranasal esketamine for treatment resistant major depressive disorder. a meta-analysis of randomized controlled trials for efficacy and pharmacovigilance outcomes","year":"2026","cit":0,"pfa":"Osama Homod Aldoweesh","psa":"Ahmed Azzam","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7204994760","eid":"W7204994760"},{"id":"paper-w4408732771","cat":"papers","name":"Response to comment on 'Perioperative esketamine combined with butorphanol versus butorphanol alone for pain management following video-assisted lobectomy: a randomized controlled trial'","year":"2025","cit":0,"pfa":"Hongjian Wang","psa":"Xianwen Hu","ptype":"article","src":"https://openalex.org/W4408732771","eid":"W4408732771"},{"id":"paper-w7154086910","cat":"papers","name":"Effect of Dexmedetomidine Combined with Esketamine on Postoperative Fatigue in Patients Undergoing Total Laparoscopic Hysterectomy: A Single-Center Randomized Double-Blinded Controlled Trial","year":"2026","cit":0,"pfa":"Lei Wu","psa":"Guanglei Wang","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7154086910","eid":"W7154086910"},{"id":"paper-w7204510219","cat":"papers","name":"Esketamine Attenuates Postoperative Neurocognitive Disorder in Aged Mice: Associations with Bioenergetic Remodeling in Hippocampal CD11b-Enriched Cell Fractions and Glycolysis-Related Signaling","year":"2026","cit":0,"pfa":"Liu D","psa":"Zhang Y","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7204510219","eid":"W7204510219"},{"id":"paper-w7155599966","cat":"papers","name":"484. Stability in Cognitive Outcomes Following Esketamine Treatment in Veterans With Major Depressive Disorder: Evidence From the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS)","year":"2026","cit":0,"pfa":"Bo D. Wicklund","psa":"Michelle R. Madore","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7155599966","eid":"W7155599966"},{"id":"paper-w4402565301","cat":"papers","name":"Letter to the editor, “Effects of esketamine on postoperative negative emotions and early cognitive disorders in patients undergoing non-cardiac thoracic surgery: A randomized controlled trial”","year":"2024","cit":0,"pfa":"Uzay Cagatay","psa":"Mahindra Bandari","ptype":"letter","src":"https://openalex.org/W4402565301","eid":"W4402565301"},{"id":"paper-w4294201650","cat":"papers","name":"A comparison between patients who suffer from major depression and are treated with Esketamine – one group participates in group therapy and the other one does not","year":"2022","cit":0,"pfa":"H. Yaniv","psa":"V. Savlev","topics":["Depression","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4294201650","eid":"W4294201650"},{"id":"paper-w4415263840","cat":"papers","name":"P11 Interim results of the fentanyl or esketamine for traumatic pain (FORE-PAIN) trial: a double-blind multi-arm randomized non-inferiority trial","year":"2025","cit":0,"pfa":"MN de Grunt","psa":"Robert P. Weenink","topics":["PTSD & trauma","Safety & adverse events","Reviews & meta-analyses"],"ptype":"conference-abstract","src":"https://openalex.org/W4415263840","eid":"W4415263840"},{"id":"paper-w7160829807","cat":"papers","name":"Esketamine Protects Against LPS-Induced Septic Lung Injury via NMDA Receptor and NF-κB/NLRP3/Caspase-1/GSDMD Pathway","year":"2026","cit":0,"pfa":"Qin Hu","psa":"Xiao-ming Deng","topics":["Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7160829807","eid":"W7160829807"},{"id":"paper-w7169701756","cat":"papers","name":"The Effect of Esketamine on Peripheral Vascular Resistance in Elderly Patients During Anesthesia Induction: A Single-Center, Double-Blind, Prospective, Randomized Controlled Study","year":"2026","cit":0,"pfa":"Li J","psa":"Tan S","topics":["Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7169701756","eid":"W7169701756"},{"id":"paper-w4390223099","cat":"papers","name":"Remission/response with esketamine nasal spray versus quetiapine extended release in treatment resistant depression using the Clinical Global Impression-Severity scale","year":"2023","cit":0,"pfa":"Andreas Reif","psa":"Allan Hunter Young","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4390223099","eid":"W4390223099"},{"id":"paper-w7160399577","cat":"papers","name":"Effects of Intravenous Esketamine or Magnesium Sulfate on Early Postoperative Negative Emotions and Pain in Patients Undergoing Endoscopic Sinus Surgery: A Randomized Controlled Trial","year":"2026","cit":0,"pfa":"Luyao Wang","psa":"Chenglan Xie","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7160399577","eid":"W7160399577"},{"id":"paper-w7135402812","cat":"papers","name":"Additional file 1: of Sedation with propofol during ERCP: is the combination with esketamine more effective and safer than with alfentanil? Study protocol for a randomized controlled trial","year":"2017","cit":0,"pfa":"Susanne Eberl","psa":"Benedikt Preckel","ptype":"article","src":"https://openalex.org/W7135402812","eid":"W7135402812"},{"id":"paper-w7163179318","cat":"papers","name":"A Study on the ED90 of Esketamine Combined with Ropivacaine for Early Epidural Analgesia During the First Stage of Labor in Nulliparous Women: A Randomized, Sequential Dose-Finding Trial","year":"2026","cit":0,"pfa":"X Lin","psa":"Zhifang Cao","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7163179318","eid":"W7163179318"},{"id":"paper-w7159927063","cat":"papers","name":"Prenatal Exposure to Esketamine During Cesarean Delivery Does Not Affect Early Childhood Social–Emotional Development: A Propensity-Matched Retrospective Cohort Study","year":"2026","cit":0,"pfa":"Heliang Sun","psa":"See PDF","ptype":"preprint","src":"https://openalex.org/W7159927063","eid":"W7159927063"},{"id":"paper-w3170194605","cat":"papers","name":"A descriptive study of treatment-resistant depression patients treated by esketamine during ATUc program, post-ATU period or post-launch period (ESKALE study)","year":"2021","cit":0,"pfa":"M.A. Codet","psa":"Ludovic Samalin","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W3170194605","eid":"W3170194605"},{"id":"paper-w7212485395","cat":"papers","name":"Perioperative esketamine-containing strategies and postoperative neurocognitive outcomes in older surgical patients: a systematic review and meta-analysis of randomized controlled trials with certainty assessment","year":"2026","cit":0,"pfa":"Ruirui Qi","psa":"Zhigang Zhang","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7212485395","eid":"W7212485395"},{"id":"paper-w4319314844","cat":"papers","name":"Author response for \"Ketamine and its metabolite 2R,6R‐hydroxynorketamine promote ocular dominance plasticity and release TRKB from inhibitory control without reducing perineuronal nets enwrapping parvalbumin interneuron","year":"2022","cit":0,"pfa":"Cecilia Cannarozzo","psa":"Eero Ċastrén","ptype":"peer-review","src":"https://openalex.org/W4319314844","eid":"W4319314844"},{"id":"paper-w7130381517","cat":"papers","name":"The use of repetitive transcranial magnetic stimulation (rTMS), electroconvulsive therapy (ECT), ketamine, and esketamine in reducing suicidality in major depressive disorder: A comprehensive narrative review","year":"2026","cit":0,"pfa":"Trisha Menon","psa":"Roger S. McIntyre","topics":["Depression","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7130381517","eid":"W7130381517"},{"id":"paper-w4319314859","cat":"papers","name":"Author response for \"Ketamine and its metabolite 2R,6R‐hydroxynorketamine promote ocular dominance plasticity and release TRKB from inhibitory control without reducing perineuronal nets enwrapping parvalbumin interneuron","year":"2023","cit":0,"pfa":"Cecilia Cannarozzo","psa":"Eero Ċastrén","ptype":"peer-review","src":"https://openalex.org/W4319314859","eid":"W4319314859"},{"id":"paper-w4410873389","cat":"papers","name":"Effect of Esketamine Combined with Sufentanil-Based Patient-Controlled Intravenous Analgesia on Postoperative Pain in Elderly Total Hip Arthroplasty Patients: A Three-Arm Randomized Trial","year":"2025","cit":0,"pfa":"Yu-Hang Shou","psa":"Jia Han","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4410873389","eid":"W4410873389"},{"id":"paper-w4408236006","cat":"papers","name":"Effect of intraoperative intravenous esketamine on postoperative delirium in older patients undergoing hip fracture surgery: protocol for a randomised, double-blind, placebo-controlled trial","year":"2025","cit":0,"pfa":"Changhui Shao","psa":"Shan Ou","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4408236006","eid":"W4408236006"},{"id":"paper-w4412109091","cat":"papers","name":"Esketamine Use for Supplemental Analgesia During Cesarean Delivery Does Not Affect Toddlers' Neurodevelopment: 2-Year Follow Up of a Multi-Center Randomized Trial","year":"2025","cit":0,"pfa":"Lihong Sun","psa":"Xinzhong Chen","ptype":"preprint","src":"https://openalex.org/W4412109091","eid":"W4412109091"},{"id":"paper-w7133360039","cat":"papers","name":"Effect of perioperative esketamine administration for postoperative sleep disturbance following general anaesthesia: protocol for a planned systematic review and meta-analysis of randomised controlled trials","year":"2026","cit":0,"pfa":"Haiying Yin","psa":"Han Huang","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7133360039","eid":"W7133360039"},{"id":"paper-w7170177924","cat":"papers","name":"Dual benefit of esketamine-based opioid-free anesthesia on postoperative pain and mental health outcomes in patients undergoing bariatric surgery: a randomized controlled trial","year":"2026","cit":0,"pfa":"Huang Chunxia","psa":"Qi Xue","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7170177924","eid":"W7170177924"},{"id":"paper-w7212364968","cat":"papers","name":"EFFECTS OF KETAMINE AND ESKETAMINE ON SUICIDAL IDEATION WITHIN THE FIRST 24 HOURS IN ADULTS WITH DEPRESSIVE DISORDERS: VARIABILITY IN CLINICAL FINDINGS AND INTERPRETATIVE CHALLENGES - A NARRATIVE REVIEW","year":"2026","cit":0,"pfa":"Marta Borkowska","psa":"Jakub Przybylski-Pawlinow","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7212364968","eid":"W7212364968"},{"id":"paper-w7110520873","cat":"papers","name":"An Educational Module on the Effectiveness of Ketamine vs. Esketamine as Treatment in Preventing Post-Operative Cognitive Dysfunction in Elderly Patients Undergoing Surgery: A Quality Improvement Project","year":"2025","cit":0,"pfa":"Graber, Peter, MSN, RN","psa":"Diaz, Valerie, DNP, CRNA, APRN, CNE, CHSE FAANA","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7110520873","eid":"W7110520873"},{"id":"paper-w4253072389","cat":"papers","name":"Human medicines European public assessment report (EPAR): Spravato, esketamine, Depressive Disorder, Date of authorisation: 18/12/2019, Status: Authorised","year":"2019","cit":0,"topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4253072389","eid":"W4253072389"},{"id":"paper-w4401925161","cat":"papers","name":"Weight changes in esketamine nasal spray and quetiapine extended-release treated patients with treatment resistant depression: Results from ESCAPE-TRD study","year":"2024","cit":0,"pfa":"Andreas Reif","psa":"István Bitter","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4401925161","eid":"W4401925161"},{"id":"paper-w7204156430","cat":"papers","name":"Esketamine Attenuates Postoperative Neurocognitive Disorder in Aged Mice: Associations with Bioenergetic Remodeling in Hippocampal CD11b-Enriched Cell Fractions and Glycolysis-Related Signaling","year":"2026","cit":0,"pfa":"Di Liu","psa":"Yue Zhang","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7204156430","eid":"W7204156430"},{"id":"paper-w4405228111","cat":"papers","name":"Ketamine or esketamine and quality of recovery after surgery: statistical significance versus clinical importance. Comment on Br J Anaesth 2024; 132: 1293-303","year":"2024","cit":0,"pfa":"Yisheng Huang","psa":"Wenxia Zhou","ptype":"article","src":"https://openalex.org/W4405228111","eid":"W4405228111"},{"id":"paper-w7166046857","cat":"papers","name":"Respiratory Safety and Hemodynamic Stability of Ketamine/Esketamine versus Opioids Co-administered with Propofol or Ciprofol for Minor Ambulatory Gynecological Procedures: A Systematic Review and Meta-analysis","year":"2026","cit":0,"pfa":"Henry Salim","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7166046857","eid":"W7166046857"},{"id":"paper-w4401990786","cat":"papers","name":"The potential effects and tolerability of analgesic and peri/intra/post-operative esketamine in preventing postpartum depression: An updated systematic review and meta-analysis of randomized controlled trials","year":"2024","cit":0,"pfa":"Thales Marcon Almeida","psa":"Quirino Cordeiro","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W4401990786","eid":"W4401990786"},{"id":"paper-w7202124643","cat":"papers","name":"Hemodynamic and stress-modulating effects of adjuvant dexmedetomidine in esketamine-based anesthesia for laparoscopic hysterectomy: underappreciated neuroinflammatory regulation and unresolved long-term neurological safe","year":"2026","cit":0,"pfa":"Zhijun Wang","psa":"Shuhua Xie","topics":["Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7202124643","eid":"W7202124643"},{"id":"paper-w7163783708","cat":"papers","name":"A Study on the ED90 of Esketamine Combined with Ropivacaine for Early Epidural Analgesia During the First Stage of Labor in Nulliparous Women: A Randomized, Sequential Dose-Finding Trial","year":"2026","cit":0,"pfa":"Lin X","psa":"Cao Z","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7163783708","eid":"W7163783708"},{"id":"paper-w7214770475","cat":"papers","name":"Esketamine Ameliorates Propofol-Induced Long-Term Cognitive Impairments in Juvenile Rats by Suppressing Autophagy via Activating the PI3K/Akt/mTOR Signaling Pathway","year":"2026","cit":0,"pfa":"Yang Wang","psa":"Gui-Ping Xu","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7214770475","eid":"W7214770475"},{"id":"paper-w4384038512","cat":"papers","name":"Acute Effects of Intravenous Sub-Anesthetic Doses of Ketamine and Intranasal Inhaled Esketamine on Suicidal Ideation: A Systematic Review and Meta-Analysis: Letter in Response [Letter]","year":"2023","cit":0,"pfa":"Lucian M. Manu","topics":["Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4384038512","eid":"W4384038512"},{"id":"paper-w7148404552","cat":"papers","name":"Median effective dose (ED50) of esketamine combined with different doses of propofol for children to inhibit the response to gastroscope insertion: a prospective dose–response clinical study","year":"2026","cit":0,"pfa":"Keqing Niu","psa":"Jie Zhu","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7148404552","eid":"W7148404552"},{"id":"paper-w7211963722","cat":"papers","name":"Comment on “Esketamine versus dexmedetomidine for oxygenation and postoperative quality of recovery in thoracoscopic surgery: a randomized, double-blind, non-inferiority controlled trial” by Feng et al","year":"2026","cit":0,"pfa":"Yeşim Şerife Bayraktar","ptype":"article","src":"https://openalex.org/W7211963722","eid":"W7211963722"},{"id":"paper-w7215037863","cat":"papers","name":"Effects of perioperative continuous infusion of esketamine on postoperative delirium in older adults undergoing elective noncardiac surgery: a systematic review and meta-analysis of randomized controlled trials","year":"2026","cit":0,"pfa":"Lili Xu","psa":"Shan Ou","topics":["Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7215037863","eid":"W7215037863"},{"id":"paper-w7140209791","cat":"papers","name":"The 90% effective dose (ED90) of esketamine for inhibiting responses to intraoperative motor stimulation during ambulatory hysteroscopy: a biased-coin up-and-down sequential allocation trial","year":"2026","cit":0,"pfa":"Ruiqi Zhang","psa":"Zhihua Wang","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"other","src":"https://openalex.org/W7140209791","eid":"W7140209791"},{"id":"paper-w7134557732","cat":"papers","name":"Effect of Preoperative Esketamine Nebulized Inhalation on Cough Reflex, Sedation, and Postoperative Sore Throat in Extubation of Surgical Patients: A Prospective, Double-Blind, Randomized Controlled Trial","year":"2026","cit":0,"pfa":"Zhang ZQ","psa":"Hu SH","ptype":"article","src":"https://openalex.org/W7134557732","eid":"W7134557732"},{"id":"paper-w7169795468","cat":"papers","name":"Effects of low-dose esketamine on postoperative pain, sleep quality, and inflammatory response after elective cesarean section: a randomized, double-blind, placebo-controlled trial","year":"2026","cit":0,"pfa":"Shushu Liu","psa":"Leilei He","topics":["Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7169795468","eid":"W7169795468"},{"id":"paper-w7140190516","cat":"papers","name":"The 90% effective dose (ED90) of esketamine for inhibiting responses to intraoperative motor stimulation during ambulatory hysteroscopy: a biased-coin up-and-down sequential allocation trial","year":"2026","cit":0,"pfa":"Ruiqi Zhang","psa":"Zhihua Wang","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"other","src":"https://openalex.org/W7140190516","eid":"W7140190516"},{"id":"paper-w7134940834","cat":"papers","name":"Effectiveness and factors associated with esketamine response during the 4-week induction period for treatment-resistant depression: post-hoc analysis of the real-world ESKALE study","year":"2026","cit":0,"pfa":"Ludovic Samalin","psa":"Julien Dupin","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7134940834","eid":"W7134940834"},{"id":"paper-w3126207951","cat":"papers","name":"Data - Pinpointing the implications of Big Five Personality Factors in moderating adjunctive antidepressant treatment response in a comparative study of esketamine and racemic ketamine for treatment-resistant depression.","year":"2020","cit":0,"pfa":"Thais Rabanea-Souza","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W3126207951","eid":"W3126207951"},{"id":"paper-w7171932074","cat":"papers","name":"The effect of esketamine on sleep disorders in parturients undergoing cesarean section under general anesthesia: a single-center, randomized, double-blind, placebo-controlled prospective study","year":"2026","cit":0,"pfa":"Hongzhuan Chen","psa":"Qiwei Wang","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7171932074","eid":"W7171932074"},{"id":"paper-w7167577312","cat":"papers","name":"The median effective dose (ED50) of remimazolam combined with esketamine for conscious sedation in patients with dental anxiety undergoing outpatient dental surgery: a prospective, dose-finding study","year":"2026","cit":0,"pfa":"Mengjiao Che","psa":"Yiwen Zhang","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7167577312","eid":"W7167577312"},{"id":"paper-w4412896849","cat":"papers","name":"Perioperative Esketamine and Pain Relief: Endeavors to Optimize Use Schedules, Combination Regimen, Opioid-Sparing, and the Strive Not to Negatively Impact Upon Natural Postsurgical Healing Processes","year":"2025","cit":0,"pfa":"Huijing Xie","psa":"Tao Li","topics":["Addiction"],"ptype":"book-chapter","src":"https://openalex.org/W4412896849","eid":"W4412896849"},{"id":"paper-w4412821392","cat":"papers","name":"Effects of Different Doses of Esketamine on Postoperative Analgesia and Recovery Quality in Lumbar Decompression Surgery: A Randomized Controlled Trial Focusing on the Advantages of Sub-Anesthetic Doses","year":"2025","cit":0,"pfa":"Junjie Liu","psa":"Xianwen Hu","topics":["Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4412821392","eid":"W4412821392"},{"id":"paper-w7199501930","cat":"papers","name":"Use of intranasal dexmedetomidine in procedural sedation and analgesia in pediatric emergency medicine based on randomized clinical trials : comparing intranasal dexmedetomidine with intranasal esketamine and nitrous oxi","year":"2025","cit":0,"pfa":"Anna Nikula","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7199501930","eid":"W7199501930"},{"id":"paper-w4416819229","cat":"papers","name":"Comment on: Effects of esketamine combined with dexmedetomidine on oxidative stress and lung function during one-lung ventilation in patients with mild to moderate COPD undergoing thoracoscopic surgery","year":"2025","cit":0,"pfa":"Qiongying Xu","psa":"Jiehua Han","ptype":"letter","src":"https://openalex.org/W4416819229","eid":"W4416819229"},{"id":"paper-w7165391688","cat":"papers","name":"Descriptive oxidative and lipid-related fluorescence observations associated with Esketamine treatment in a high-concentration NMDA-exposed HT-22/C8-D1A co-culture model","year":"2026","cit":0,"pfa":"Xinzhe Ni","psa":"Xiaotao Xu","ptype":"article","src":"https://openalex.org/W7165391688","eid":"W7165391688"},{"id":"paper-w7128904615","cat":"papers","name":"The 90% effective dose (ED90) of esketamine for inhibiting responses to intraoperative motor stimulation during ambulatory hysteroscopy: a biased-coin up-and-down sequential allocation trial","year":"2026","cit":0,"pfa":"Ruiqi Zhang","psa":"Zhihua Wang","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7128904615","eid":"W7128904615"},{"id":"paper-w4384562342","cat":"papers","name":"Acute Effects of Intravenous Sub-Anesthetic Doses of Ketamine and Intranasal Inhaled Esketamine on Suicidal Ideation: A Systematic Review and Meta-Analysis: Letter in Response [Response to Letter]","year":"2023","cit":0,"pfa":"Cheng‐Chuan Chen","psa":"Xiaobin Wang","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W4384562342","eid":"W4384562342"},{"id":"paper-w4411153582","cat":"papers","name":"Efficacy of esketamine nasal spray over quetiapine extended release over the short and long term: sensitivity analyses of ESCAPE-TRD, a randomised phase IIIb clinical trial – ERRATUM","year":"2025","cit":0,"pfa":"Allan Hunter Young","psa":"Andreas Reif","ptype":"erratum","src":"https://openalex.org/W4411153582","eid":"W4411153582"},{"id":"paper-w4414180411","cat":"papers","name":"Top-line Results from ESCAPE-LTE: An Open-Label Extension Study to Assess Long-term Safety of Esketamine Nasal Spray in Treatment Resistant Depression","year":"2025","cit":0,"pfa":"Yordan Godinov","psa":"Wiesław Jerzy Cubała","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4414180411","eid":"W4414180411"},{"id":"paper-w7204479681","cat":"papers","name":"Erratum to “Long-term treatment with esketamine nasal spray in patients with treatment resistant depression: Results from the ESCAPE-LTE study” [European Neuropsychopharmacology 107 (2026) 112801]","year":"2026","cit":0,"pfa":"Andreas Reif","psa":"Wiesław Jerzy Cubała","topics":["Depression","Dosing & pharmacology"],"ptype":"erratum","src":"https://openalex.org/W7204479681","eid":"W7204479681"},{"id":"paper-w4414026923","cat":"papers","name":"Safety and efficacy of esketamine combined with propofol or ciprofol sedation for electroconvulsive therapy in patients with major depressive disorder: protocol for a randomized, double-blind, controlled trial with facto","year":"2025","cit":0,"pfa":"Yuan Zhang","psa":"Qingtao Meng","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4414026923","eid":"W4414026923"},{"id":"paper-w7159626089","cat":"papers","name":"EFFICACY OF KETAMINE AND ESKETAMINE IN TREATMENT-RESISTANT DEPRESSION AMONG OLDER ADULTS (≥65 YEARS): A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMISED AND REAL-WORLD STUDIES (2023–2025).","year":"2026","cit":0,"pfa":"Shimul A. Babli*1, Huijuan Song2, Sharmin Ferdous3, Farzana Rahman4, Dilyaver…","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W7159626089","eid":"W7159626089"},{"id":"paper-w4401919742","cat":"papers","name":"Esketamine nasal spray shows greater improvement in health-related quality of life over 32 weeks versus quetiapine extended release in patients with treatment resistant depression","year":"2024","cit":0,"pfa":"Allan Hunter Young","psa":"Albino Jorge Oliveira-Maia","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4401919742","eid":"W4401919742"},{"id":"paper-w7203706267","cat":"papers","name":"Effects of different administration routes of esketamine on postoperative hyperalgesia in elderly patients undergoing laparoscopic gastrointestinal tumour surgery: a single-centre, prospective, randomised, double-blind,","year":"2026","cit":0,"pfa":"Yuhua Ma","psa":"Xue Cao","ptype":"preprint","src":"https://openalex.org/W7203706267","eid":"W7203706267"},{"id":"paper-w7138906211","cat":"papers","name":"Esketamine hydrochloride in the management of moderate‐to‐severe depressive symptoms in patients undergoing multiple wound repair surgeries: A multi‐centre randomized, double‐blind, placebo‐controlled trial","year":"2026","cit":0,"pfa":"Xiaomeng Yu","psa":"Qiang Fu","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7138906211","eid":"W7138906211"},{"id":"paper-w7169703934","cat":"papers","name":"Comparison of the ED90 of Esketamine for Suppressing Laryngeal Mask Airway Insertion Responses During Propofol Induction with or without Intravenous Lidocaine Pretreatment: A Randomized Double-Blind Dose-Finding Trial","year":"2026","cit":0,"pfa":"Zhang L","psa":"Shi J","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7169703934","eid":"W7169703934"},{"id":"paper-w7206208790","cat":"papers","name":"Comment on “Esketamine versus dexmedetomidine fora oxygenation and postoperative quality of recovery in thoracoscopic surgery: a randomized, double‑blind, non-inferiority controlled trial” by Feng et al","year":"2026","cit":0,"pfa":"Jie Liu","psa":"Zhimin Sheng","ptype":"article","src":"https://openalex.org/W7206208790","eid":"W7206208790"},{"id":"paper-w4416168808","cat":"papers","name":"Letter to the Editor: Comments on the manuscript entitled ‘Effect of intraoperative low-dose esketamine on postoperative quality of recovery in patients undergoing laparotomy for gynecologic malignancy: a randomized cont","year":"2025","cit":0,"pfa":"Ying Yang","psa":"Yue Yang","topics":["Dosing & pharmacology"],"ptype":"letter","src":"https://openalex.org/W4416168808","eid":"W4416168808"},{"id":"paper-w7213312822","cat":"papers","name":"Analgesic Efficacy of Different Doses of Esketamine as an Adjuvant to Ropivacaine for Thoracoscopy-Guided Thoracic Paravertebral Block After Thoracoscopic Radical Resection for Lung Cancer: A Prospective Randomized Contr","year":"2026","cit":0,"pfa":"Lu-Yao Wei","psa":"Lihong Hu","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7213312822","eid":"W7213312822"},{"id":"paper-w7125818995","cat":"papers","name":"Effect of esketamine-based patient-controlled intravenous analgesia on postoperative pain and quality of recovery after video-assisted thoracoscopic lobectomy: A prospective, double-blind, randomized controlled trial","year":"2026","cit":0,"pfa":"Ruirui Bi","psa":"Wenjun Yan","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7125818995","eid":"W7125818995"},{"id":"paper-w7169044240","cat":"papers","name":"Comparison of the ED90 of Esketamine for Suppressing Laryngeal Mask Airway Insertion Responses During Propofol Induction with or without Intravenous Lidocaine Pretreatment: A Randomized Double-Blind Dose-Finding Trial","year":"2026","cit":0,"pfa":"Liangguang Zhang","psa":"J Q Shi","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7169044240","eid":"W7169044240"},{"id":"paper-w4387396103","cat":"papers","name":"Effect of low-dose esketamine on perioperative neurocognitive disorder and postoperative depressive symptoms in elderly patients undergoing major elective non-cardiac surgery for malignant tumors: A randomized clinical t","year":"2023","cit":0,"pfa":"Huang Cuifang","psa":"Pan Linghui","topics":["Depression","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4387396103","eid":"W4387396103"},{"id":"paper-w4414521918","cat":"papers","name":"Review: Real-world esketamine treatment for treatment-resistant depression: an analysis of comorbid post-traumatic stress disorder, comorbid anxiety disorder and line of therapy subgroups — R0/PR2","year":"2025","cit":0,"pfa":"Malcolm Hopwood","psa":"Ian B. Hickie","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"peer-review","src":"https://openalex.org/W4414521918","eid":"W4414521918"},{"id":"paper-w4413983724","cat":"papers","name":"A comparative study of dexmedetomidine combined with esketamine and sufentanil for sedation and analgesia in patients undergoing microwave ablation of lung tumors: A prospective single-center randomized double-blind clin","year":"2025","cit":0,"pfa":"Yue Li","psa":"Yanhua Chen","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4413983724","eid":"W4413983724"},{"id":"paper-w7159640704","cat":"papers","name":"EFFICACY OF KETAMINE AND ESKETAMINE IN TREATMENT-RESISTANT DEPRESSION AMONG OLDER ADULTS (≥65 YEARS): A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMISED AND REAL-WORLD STUDIES (2023–2025).","year":"2026","cit":0,"pfa":"Shimul A. Babli*1, Huijuan Song2, Sharmin Ferdous3, Farzana Rahman4, Dilyaver…","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W7159640704","eid":"W7159640704"},{"id":"paper-w7171963782","cat":"papers","name":"Effects of Intraoperative Low-Dose Esketamine on Postoperative Inflammatory Response and Clinical Recovery in Elderly Patients Undergoing Colorectal Cancer Resection: A Randomized, Double-Blind, Placebo-Controlled Trial","year":"2026","cit":0,"pfa":"Yang Qu","psa":"Deyuan Li","topics":["Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7171963782","eid":"W7171963782"},{"id":"paper-w7123857506","cat":"papers","name":"Corrigendum to “Effect of Esketamine and Etomidate on Postoperative Cognitive Function in Elderly Patients Undergoing Painless Bronchoscopy: A Randomized Controlled Trial” [Journal of PeriAnesthesia Nursing 40 (2025) 157","year":"2026","cit":0,"pfa":"Xiaofeng Xu","psa":"Ligang Shan","ptype":"erratum","src":"https://openalex.org/W7123857506","eid":"W7123857506"},{"id":"paper-w4414521459","cat":"papers","name":"Review: Real-world esketamine treatment for treatment-resistant depression: an analysis of comorbid post-traumatic stress disorder, comorbid anxiety disorder and line of therapy subgroups — R0/PR3","year":"2025","cit":0,"pfa":"Malcolm Hopwood","psa":"Ian B. Hickie","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"peer-review","src":"https://openalex.org/W4414521459","eid":"W4414521459"},{"id":"paper-w7213720426","cat":"papers","name":"Analgesic Efficacy of Different Doses of Esketamine as an Adjuvant to Ropivacaine for Thoracoscopy-Guided Thoracic Paravertebral Block After Thoracoscopic Radical Resection for Lung Cancer: A Prospective Randomized Contr","year":"2026","cit":0,"pfa":"Wei LY","psa":"Hu LH","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7213720426","eid":"W7213720426"},{"id":"paper-w7140158341","cat":"papers","name":"Additional file 1 of The 90% effective dose (ED90) of esketamine for inhibiting responses to intraoperative motor stimulation during ambulatory hysteroscopy: a biased-coin up-and-down sequential allocation trial","year":"2026","cit":0,"pfa":"Ruiqi Zhang","psa":"Zhihua Wang","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7140158341","eid":"W7140158341"},{"id":"paper-w7140230323","cat":"papers","name":"Additional file 1 of The 90% effective dose (ED90) of esketamine for inhibiting responses to intraoperative motor stimulation during ambulatory hysteroscopy: a biased-coin up-and-down sequential allocation trial","year":"2026","cit":0,"pfa":"Ruiqi Zhang","psa":"Zhihua Wang","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7140230323","eid":"W7140230323"},{"id":"paper-w4414987753","cat":"papers","name":"Determination of the 50% and 95% effective dose of esketamine combined with propofol for intravenous sedation in pediatric circumcision: study protocol for a randomized controlled, double-blind, dose-finding clinical tri","year":"2025","cit":0,"pfa":"Junqin Mao","psa":"Zhimin Sheng","topics":["Depression","Addiction","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4414987753","eid":"W4414987753"},{"id":"paper-w7140208251","cat":"papers","name":"Additional file 2 of The 90% effective dose (ED90) of esketamine for inhibiting responses to intraoperative motor stimulation during ambulatory hysteroscopy: a biased-coin up-and-down sequential allocation trial","year":"2026","cit":0,"pfa":"Ruiqi Zhang","psa":"Zhihua Wang","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7140208251","eid":"W7140208251"},{"id":"paper-w7140230324","cat":"papers","name":"Additional file 2 of The 90% effective dose (ED90) of esketamine for inhibiting responses to intraoperative motor stimulation during ambulatory hysteroscopy: a biased-coin up-and-down sequential allocation trial","year":"2026","cit":0,"pfa":"Ruiqi Zhang","psa":"Zhihua Wang","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7140230324","eid":"W7140230324"},{"id":"paper-w7169682726","cat":"papers","name":"Response to Letter to the Editor: Comment on “Effect of Remimazolam or Propofol Combined With Esketamine on Anesthesia and Early Perioperative Neurocognitive Disorders in Patients Undergoing Thoracoscopic Partial Lung Re","year":"2026","cit":0,"pfa":"Wen Yuan","psa":"Shen Jb","ptype":"letter","src":"https://openalex.org/W7169682726","eid":"W7169682726"},{"id":"paper-w4410313382","cat":"papers","name":"Inhibition of autophagy by esketamine attenuates hypoxia/reoxygenation injury in cardiomyocytes via inhibition of Ca2+/CaMKKβ/AMPK/mTOR pathway by down-regulation of transient receptor potential vanilloid 1 expression.","year":"2025","cit":0,"pfa":"Yong Zhang","psa":"Q Zhao","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4410313382","eid":"W4410313382"},{"id":"paper-w4403475382","cat":"papers","name":"Adis summary of research: Efficacy and safety of esketamine nasal spray in patients with treatment-resistant depression who completed a second induction period: analysis of the ongoing SUSTAIN-3 study","year":"2024","cit":0,"pfa":"Sheridan M. Hoy","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4403475382","eid":"W4403475382"},{"id":"paper-w4402210246","cat":"papers","name":"Inhibitory effect of low-dose esketamine on cough induced by sufentanil during the induction of anesthesia and postoperative impact on mental health status: A prospective, single-center, randomized controlled trial","year":"2024","cit":0,"pfa":"Ju Qian","psa":"Shuang Zhou","topics":["Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4402210246","eid":"W4402210246"},{"id":"paper-w4414416657","cat":"papers","name":"Esketamine for Postoperative Analgesia Improves Short-Term Postoperative Sleep Quality in Patients Undergoing Thoracoscopic Surgery: Study Protocol of a Single-Center, Prospective, Double-Blind Randomized Controlled Tria","year":"2025","cit":0,"pfa":"Yusong Lin","psa":"Songyang Yu","ptype":"preprint","src":"https://openalex.org/W4414416657","eid":"W4414416657"},{"id":"paper-w4385068226","cat":"papers","name":"Determining the effective dose of esketamine for mitigating pain during propofol injection in children by Dixon's up-and-down method: a single-center, double-blind, prospective clinical study of drug dose-response","year":"2023","cit":0,"pfa":"Meiyun Tan","psa":"Yanweng Wu","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4385068226","eid":"W4385068226"},{"id":"paper-w4414522084","cat":"papers","name":"Author Comment: Real-world esketamine treatment for treatment-resistant depression: an analysis of comorbid post-traumatic stress disorder, comorbid anxiety disorder and line of therapy subgroups — R0/PR1","year":"2024","cit":0,"pfa":"Andrea Puig","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"peer-review","src":"https://openalex.org/W4414522084","eid":"W4414522084"},{"id":"paper-w4414521387","cat":"papers","name":"Decision: Real-world esketamine treatment for treatment-resistant depression: an analysis of comorbid post-traumatic stress disorder, comorbid anxiety disorder and line of therapy subgroups — R1/PR6","year":"2025","cit":0,"pfa":"Malcolm Hopwood","psa":"Ian B. Hickie","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"peer-review","src":"https://openalex.org/W4414521387","eid":"W4414521387"},{"id":"paper-w7160585052","cat":"papers","name":"Effect of Different Doses of Esketamine on the Propofol Effect-Site Concentration Required to Suppress Cervical Dilation-Associated Movement During Hysteroscopy: A Prospective, Randomised, Controlled, Parallel-Group Dose","year":"2026","cit":0,"pfa":"Shen Y","psa":"L Zhang","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7160585052","eid":"W7160585052"},{"id":"paper-w4414521709","cat":"papers","name":"Author Comment: Real-world esketamine treatment for treatment-resistant depression: an analysis of comorbid post-traumatic stress disorder, comorbid anxiety disorder and line of therapy subgroups — R1/PR5","year":"2025","cit":0,"pfa":"Andrea Puig","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"peer-review","src":"https://openalex.org/W4414521709","eid":"W4414521709"},{"id":"paper-w7203455653","cat":"papers","name":"Effects of esketamine combined with parecoxib sodium on early postoperative pain and inflammatory biomarkers after video-assisted thoracoscopic lung resection: a single-center, four-arm randomized controlled trial","year":"2026","cit":0,"pfa":"Jingnan Li","psa":"Dong Yan","ptype":"preprint","src":"https://openalex.org/W7203455653","eid":"W7203455653"},{"id":"paper-w7160079864","cat":"papers","name":"Effect of Different Doses of Esketamine on the Propofol Effect-Site Concentration Required to Suppress Cervical Dilation-Associated Movement During Hysteroscopy: A Prospective, Randomised, Controlled, Parallel-Group Dose","year":"2026","cit":0,"pfa":"Yanping Shen","psa":"Liangguang Zhang","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7160079864","eid":"W7160079864"},{"id":"paper-w4412163842","cat":"papers","name":"A commentary on ‘Esketamine vs. placebo combined with erector Spinae plane block vs. intercostal nerve block on quality of recovery following thoracoscopic lung resection: a randomized controlled factorial trial’","year":"2025","cit":0,"pfa":"Lei Shi","psa":"Xiang Gao","ptype":"article","src":"https://openalex.org/W4412163842","eid":"W4412163842"},{"id":"paper-w7162468837","cat":"papers","name":"Available datapackage for study 'A Randomized, Double-blind, Multicenter, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Esketamine Nasal Spray, Administered as Monotherapy, in Adult Parti","year":"2026","cit":0,"pfa":"Johnson & Johnson","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"dataset","src":"https://openalex.org/W7162468837","eid":"W7162468837"},{"id":"paper-w7166700760","cat":"papers","name":"Comprehensive Systematic Review of Esketamine Nasal Spray as a Standalone Rapid-Acting Treatment for Treatment-Resistant Depression: Integrating Clinical Trial Data and Emerging Real-World Evidence on Efficacy, Safety, A","year":"2026","cit":0,"pfa":"Angelin Grace Thomas","psa":"AMRITHA CHANDRASEKARAN SASHIKAR","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W7166700760","eid":"W7166700760"},{"id":"paper-w4414179916","cat":"papers","name":"Difficult-to-Treat Depression: Effectiveness, Functionality, and Quality of Life—Preliminary Results from a Real-World Prospective Cohort under Esketamine Treatment in Spain after 3-Month Follow-Up","year":"2025","cit":0,"pfa":"M. Gomez Revuelta","psa":"N. Vargas Berni","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4414179916","eid":"W4414179916"},{"id":"paper-w7155628270","cat":"papers","name":"Comment on, “the effect of esketamine as adjuvant to ropivacaine for unilateral paravertebral block on postoperative pain and sensitization in adult patients undergoing video-assisted thoracoscopic surgery: a randomized","year":"2026","cit":0,"pfa":"Hussnain Bilal","psa":"Haider Ali","ptype":"article","src":"https://openalex.org/W7155628270","eid":"W7155628270"},{"id":"paper-w4412493876","cat":"papers","name":"Letter to the Editor: effect of low-dose supplemental esketamine infusion on the intraoperative frontal electroencephalography dynamics and postoperative sleep disturbance during gynecological laparoscopic surgery: a dou","year":"2025","cit":0,"pfa":"Minmin Cai","psa":"Yifeng Wu","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"letter","src":"https://openalex.org/W4412493876","eid":"W4412493876"},{"id":"paper-w4243840053","cat":"papers","name":"A Study of Esketamine Nasal Spray Plus a New Standard-of-care Oral Antidepressant or Placebo Nasal Spray Plus a New Standard-of-care Oral Antidepressant in Adult and Elderly Participants With Treatment-resistant Depressi","year":"2019","cit":0,"topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4243840053","eid":"W4243840053"},{"id":"paper-w7168254066","cat":"papers","name":"Is the reduction in suicidal ideation and deliberate self-harm during intranasal esketamine treatment independent of antidepressant response? A secondary, longitudinal analysis of a real-world TRD cohort with and without","year":"2026","cit":0,"pfa":"Vassilis Martiadis","psa":"F. Raffone","topics":["Depression","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W7168254066","eid":"W7168254066"},{"id":"paper-w7160928217","cat":"papers","name":"Effect of ultrasound-guided interscalene brachial plexus block using liposome bupivacaine combined with continuous esketamine infusion on quality of recovery in patients undergoing arthroscopic rotator cuff repair: study","year":"2026","cit":0,"pfa":"Jianming Yue","psa":"Leng Zhou","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7160928217","eid":"W7160928217"},{"id":"paper-w7171923198","cat":"papers","name":"Fast recovery from treatment resistant depression: clinical case from HIPOCRAT-ESK study, a cohort, non-interventional, prospective, real-world study of functional remission in TRD patients treated with Esketamine nasal","year":"2026","cit":0,"pfa":"T. Caraballo Lopez","psa":"B. Nebot Tarazona","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7171923198","eid":"W7171923198"},{"id":"paper-w4412229639","cat":"papers","name":"Esketamine nasal spray shows higher remission and response rates over 32 weeks of treatment compared with quetiapine extended-release in patients with treatment resistant depression: Results from ESCAPE-TRD, a randomised","year":"2023","cit":0,"pfa":"A. Reif","psa":"Yordan Godinov","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4412229639","eid":"W4412229639"},{"id":"paper-w4224982010","cat":"papers","name":"A letter to the editor, associated with the article entitled “Efficacy and tolerability of combination treatments for major depression: Antidepressants plus second-generation antipsychotics vs esketamine vs lithium” by V","year":"2022","cit":0,"pfa":"Itsuki Terao","psa":"Takeshi Inoue","topics":["Depression","Dosing & pharmacology"],"ptype":"letter","src":"https://openalex.org/W4224982010","eid":"W4224982010"},{"id":"paper-w7128629730","cat":"papers","name":"Available datapackage for study 'A Randomized, Open-label, Rater-Blinded, Active-Controlled, International, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Flexibly Dosed Esketamine Nasal Spray Co","year":"2026","cit":0,"pfa":"Johnson & Johnson","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"dataset","src":"https://openalex.org/W7128629730","eid":"W7128629730"},{"id":"paper-w4395017492","cat":"papers","name":"Ketamine in psychiatry","year":"2024","cit":0,"pfa":"Grace S. Pham","psa":"Sanjay J. Mathew","ptype":"book-chapter","src":"https://openalex.org/W4395017492","eid":"W4395017492"},{"id":"paper-w7160636703","cat":"papers","name":"THE KETAMINE PARADOX: WHY THE WEAKER ENANTIOMER MAY PROVE THE STRONGER ANTIDEPRESSANT","year":"2026","cit":0,"pfa":"Zubeen H.","psa":"RUTUJA S.","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7160636703","eid":"W7160636703"},{"id":"paper-w7160613758","cat":"papers","name":"THE KETAMINE PARADOX: WHY THE WEAKER ENANTIOMER MAY PROVE THE STRONGER ANTIDEPRESSANT","year":"2026","cit":0,"pfa":"Zubeen H.","psa":"RUTUJA S.","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7160613758","eid":"W7160613758"},{"id":"paper-w4415298317","cat":"papers","name":"Ketamine toxicity: Translating preclinical findings to adverse effects in humans","year":"2025","cit":0,"pfa":"Karlo Nezic","psa":"Gabriël E. Jacobs","topics":["Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W4415298317","eid":"W4415298317"},{"id":"paper-w7155031957","cat":"papers","name":"Reconsidering the gamma–delta shift as a biomarker of antidepressant effects of ketamine enantiomers","year":"2026","cit":0,"pfa":"Kenji Hashimoto","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7155031957","eid":"W7155031957"},{"id":"paper-w7161118925","cat":"papers","name":"Determination of the Enantiomeric Makeup of Ketamine in Street Drug Samples","year":"2026","cit":0,"pfa":"Sarah A. Shuda","psa":"Edward Sisco","ptype":"preprint","src":"https://openalex.org/W7161118925","eid":"W7161118925"},{"id":"paper-w4391659246","cat":"papers","name":"Probing the membrane-access pathway of NMDA receptors with ketamine enantiomers","year":"2024","cit":0,"pfa":"Jamie A. Abbott","psa":"Gabriela Popescu","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4391659246","eid":"W4391659246"},{"id":"paper-w3023019408","cat":"papers","name":"Efficacy of Intranasal Delivery of (R,S)-Ketamine to the Mouse Brain","year":"2020","cit":0,"pfa":"Alain Michel Gardier","psa":"Christine Ann Denny","ptype":"article","src":"https://openalex.org/W3023019408","eid":"W3023019408"},{"id":"paper-w4401076887","cat":"papers","name":"Effect of ketamine enantiomers and maternal deprivation on depressive-like behavior and plasma concentration of BDNF in rats","year":"2024","cit":0,"pfa":"Graziele Beanes","psa":"Rejane Conceição Santana","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4401076887","eid":"W4401076887"},{"id":"paper-w3208064266","cat":"papers","name":"420 - Ketamine treatment in geriatric depression","year":"2021","cit":0,"pfa":"Janette C. Leal","psa":"Simon Kung","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3208064266","eid":"W3208064266"},{"id":"paper-w7171334695","cat":"papers","name":"The functional role of ERK activity in esketamine's antidepressant effects","year":"2026","cit":0,"pfa":"P X Zhang","psa":"Wu Zhou","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7171334695","eid":"W7171334695"},{"id":"paper-w7154564148","cat":"papers","name":"Ketamine Metabolites Promote Anxiolysis and Hydrocortisone Stress Buffering in Zebrafish","year":"2026","cit":0,"pfa":"Jeff R. Kelly","psa":"Grace E. Seal","ptype":"article","src":"https://openalex.org/W7154564148","eid":"W7154564148"},{"id":"paper-w7119815448","cat":"papers","name":"Análise dos estudos sobre a eficácia da Esketamina no tratamento da depressão resistente: desafios, perspectivas e abordagem terapêutica","year":"2024","cit":0,"pfa":"Fabrício Miranda Dutra de Amorim","psa":"Marinaldo Soares Leite","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7119815448","eid":"W7119815448"},{"id":"paper-w4313200958","cat":"papers","name":"The creation of group therapy as a motivational resource in dysthymia","year":"2022","cit":0,"pfa":"C. Manzorro Carrillo","psa":"G. Pérez Guerrero","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4313200958","eid":"W4313200958"},{"id":"paper-w7203738101","cat":"papers","name":"From depression to bone health: examining the skeletal effects of classical and rapid-acting antidepressants","year":"2026","cit":0,"pfa":"Polymnia Louka","psa":"Panos Zanos","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7203738101","eid":"W7203738101"},{"id":"paper-w4392239614","cat":"papers","name":"Atypical Antidepressants","year":"2024","cit":0,"pfa":"Kathleen A Kendall-Tackett","topics":["Depression","Safety & adverse events"],"ptype":"book-chapter","src":"https://openalex.org/W4392239614","eid":"W4392239614"},{"id":"paper-w4411879320","cat":"papers","name":"Esketamine's effects in combination with SSRI vs. SNRI show differences","year":"2025","cit":0,"topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4411879320","eid":"W4411879320"},{"id":"paper-w4414639900","cat":"papers","name":"Prolonged Release Ketamine Tablets: Isomer Pharmacokinetics and Metabolites in Human Volunteers","year":"2025","cit":0,"pfa":"Joachim Erlenwein","psa":"Konrad Meissner","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W4414639900","eid":"W4414639900"},{"id":"paper-w4298074045","cat":"papers","name":"Protamine is an antagonist of Apelin receptor, and its activity is reversed by heparin","year":"2020","cit":0,"pfa":"L.S. Barak","psa":"P. Valet","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4298074045","eid":"W4298074045"},{"id":"paper-w4415298844","cat":"papers","name":"Ketamine and its metabolites—Mechanism of action","year":"2025","cit":0,"pfa":"Jamie Kneebusch","topics":["Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W4415298844","eid":"W4415298844"},{"id":"paper-w7169807851","cat":"papers","name":"Esketamine's Therapeutic Effect on Anhedonia: A Post-hoc of a Randomized Controlled Trial","year":"2026","cit":0,"pfa":"Qianqian Wu","psa":"Yanling Zhou","ptype":"preprint","src":"https://openalex.org/W7169807851","eid":"W7169807851"},{"id":"paper-w4415055788","cat":"papers","name":"Ketamine cuts suicidality‐linked ER visits in TRD patients","year":"2025","cit":0,"pfa":"Valerie A. Canady","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4415055788","eid":"W4415055788"},{"id":"paper-w7148603994","cat":"papers","name":"Ketamine for Treatment-Resistant Depression: An Umbrella Review and Theoretical Integration [SCIENTIFIC V5.0 - Q1 HIGH-IMPACT]","year":"2026","cit":0,"pfa":"Juan Moises de la Serna","topics":["Depression","Reviews & meta-analyses","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7148603994","eid":"W7148603994"},{"id":"paper-w3194607758","cat":"papers","name":"FDA OKs new Johnson & Johnson antidepression drug","year":"2019","cit":0,"pfa":"Mike Obel","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W3194607758","eid":"W3194607758"},{"id":"paper-w7171956456","cat":"papers","name":"New treatment options for Treatment-Resistant Depression in older adults","year":"2026","cit":0,"pfa":"M. P. Pando Fernández","psa":"S. Díez González","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W7171956456","eid":"W7171956456"},{"id":"paper-w4401223180","cat":"papers","name":"Ketamine Efficacy Across All Formulations in Treatment Resistant Depression in Adult Population: A Rapid Review","year":"2024","cit":0,"pfa":"Bikramaditya Jaiswal","psa":"Benson Benjamin","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4401223180","eid":"W4401223180"},{"id":"paper-w7148373427","cat":"papers","name":"Ketamine for Treatment-Resistant Depression: An Umbrella Review and Theoretical Integration [SCIENTIFIC V5.0 - Q1 HIGH-IMPACT]","year":"2026","cit":0,"pfa":"Juan Moises de la Serna","topics":["Depression","Reviews & meta-analyses","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7148373427","eid":"W7148373427"},{"id":"paper-w3194696035","cat":"papers","name":"Identifying Patients with Major Depression who Benefit from Ketamine Therapy","year":"2020","cit":0,"pfa":"Jessi Riel","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3194696035","eid":"W3194696035"},{"id":"paper-w7211912075","cat":"papers","name":"The effect of ketamine on mitochondrial bioenergetics, viability, and function: A systematic review","year":"2026","cit":0,"pfa":"Sabrina Wong","psa":"Roger S. McIntyre","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W7211912075","eid":"W7211912075"},{"id":"paper-w7126336192","cat":"papers","name":"Ketamine: a feasible replacement for current major depressive disorder therapies","year":"2021","cit":0,"pfa":"Ege Derman","topics":["Depression","Reviews & meta-analyses"],"ptype":"dissertation","src":"https://openalex.org/W7126336192","eid":"W7126336192"},{"id":"paper-w7141527117","cat":"papers","name":"Experimental Treatments: Ketamine","year":"2018","cit":0,"topics":["Depression","Mechanism & neuroscience"],"ptype":"report","src":"https://openalex.org/W7141527117","eid":"W7141527117"},{"id":"paper-w7135433585","cat":"papers","name":"Chiral separation of ketamine and its metabolites from rat plasma samples using partial filling CE-ESI/MS","year":"2024","cit":0,"pfa":"Renáta Konášová","topics":["Depression","Mechanism & neuroscience"],"ptype":"conference-paper","src":"https://openalex.org/W7135433585","eid":"W7135433585"},{"id":"paper-w2947499690","cat":"papers","name":"Spravato for Treatment-Resistant Severe Depression (Update)","year":"2019","cit":0,"pfa":"Drew Boxler","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2947499690","eid":"W2947499690"},{"id":"paper-w2991610316","cat":"papers","name":"Subanesthetic Ketamine for Suicidal Ideation Resolution in Emergency Departments","year":"2019","cit":0,"pfa":"Anne-Marie Spearman","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2991610316","eid":"W2991610316"},{"id":"paper-w7147005701","cat":"papers","name":"Ketamine for Treatment-Resistant Depression: An Umbrella Review and Theoretical Integration [SCIENTIFIC V5.0 - Q1 HIGH-IMPACT]","year":"2026","cit":0,"pfa":"Juan Moisés de la Serna","topics":["Depression","Reviews & meta-analyses","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7147005701","eid":"W7147005701"},{"id":"paper-w7113688952","cat":"papers","name":"Ketamine for Mood Disorders, Anxiety, and Suicidality in Adolescents: Protocol for a Systematic Review","year":"2024","cit":0,"pfa":"Dalton G. Wesemann","psa":"Alisha M. Bruton","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W7113688952","eid":"W7113688952"},{"id":"paper-w7146975512","cat":"papers","name":"Ketamine for Treatment-Resistant Depression: An Umbrella Review and Theoretical Integration [SCIENTIFIC V5.0 - Q1 HIGH-IMPACT]","year":"2026","cit":0,"pfa":"Juan Moisés de la Serna","topics":["Depression","Reviews & meta-analyses","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W7146975512","eid":"W7146975512"},{"id":"paper-w2943468424","cat":"papers","name":"Oral Ketamine for Depression? The Evidence Says Not So Fast","year":"2019","cit":0,"pfa":"Peter Roy‐Byrne","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2943468424","eid":"W2943468424"},{"id":"paper-w2950206031","cat":"papers","name":"New Nasal Spray for Treatment-Resistant Depression","year":"2019","cit":0,"pfa":"Diane S. Aschenbrenner","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W2950206031","eid":"W2950206031"},{"id":"paper-w7117887026","cat":"papers","name":"What is the best treatment for depression?","year":"2025","cit":0,"pfa":"Tripdatabase","topics":["Depression","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7117887026","eid":"W7117887026"},{"id":"paper-w7155226678","cat":"papers","name":"What are the mechanisms by which different subtypes of ketamine treat psychotic depression?","year":"2026","cit":0,"pfa":"Tripdatabase","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7155226678","eid":"W7155226678"},{"id":"paper-w2509635279","cat":"papers","name":"Game-changing depression drug on horizon","year":"2016","cit":0,"pfa":"Christine Blank","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2509635279","eid":"W2509635279"},{"id":"paper-w4415115699","cat":"papers","name":"Treatment With (Es)ketamine in Catatonia","year":"2025","cit":0,"pfa":"Pim B. van der Meer","psa":"Annemiek Dols","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4415115699","eid":"W4415115699"},{"id":"paper-w4412896656","cat":"papers","name":"Key Considerations for Practical Administration of Ketamine in Severe Depression, and Its Use in Community Care in Edmonton, AB, Canada","year":"2025","cit":0,"pfa":"Carson Chrenek","psa":"Jennifer Swainson","topics":["Depression"],"ptype":"book-chapter","src":"https://openalex.org/W4412896656","eid":"W4412896656"},{"id":"paper-w7120184136","cat":"papers","name":"What alternative treatments are available for patients who experience a relapse of depression after stopping liothyronine?","year":"2026","cit":0,"pfa":"Tripdatabase","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7120184136","eid":"W7120184136"},{"id":"paper-w7167589359","cat":"papers","name":"Intravenous Ketamine in Psychiatry: Therapeutic Applications, Mechanisms of Action, and Clinical Perspectives","year":"2026","cit":0,"pfa":"Juliana Leite Haubman","psa":"Helenna Vieira Schvartz","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7167589359","eid":"W7167589359"},{"id":"paper-w4401325360","cat":"papers","name":"Assessing the Efficacy of Methods for Treatment-Resistant Depression: A Review","year":"2024","cit":0,"pfa":"Zoey Crisan","topics":["Depression","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4401325360","eid":"W4401325360"},{"id":"paper-w7203717709","cat":"papers","name":"Therapeutic Potential of Ketamine in Major Depressive Disorder: Pharmacological Insights and Clinical Evidence","year":"2026","cit":0,"pfa":"Prachi Tayal","psa":"Dinesh Kumar Mehta","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7203717709","eid":"W7203717709"},{"id":"paper-w7117867124","cat":"papers","name":"What is the best treatment for depression?","year":"2025","cit":0,"pfa":"Tripdatabase","topics":["Depression","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7117867124","eid":"W7117867124"},{"id":"paper-w7203703664","cat":"papers","name":"Ketamine and Its Enantiomer(s) Therapy to Treat Major Depressive Disorder: Clinical Relevance and Underlying Mechanisms","year":"2026","cit":0,"pfa":"Joel Kallarackal","psa":"Jeffrey Huang","topics":["Depression","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W7203703664","eid":"W7203703664"},{"id":"paper-w7131297219","cat":"papers","name":"How can the efficacy of alternative pharmacological treatments be evaluated when traditional medications like trazodone and lormetazepam fail?","year":"2026","cit":0,"pfa":"Tripdatabase","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7131297219","eid":"W7131297219"},{"id":"paper-w7126020316","cat":"papers","name":"Treatment Strategies for Perinatal Depression Beyond Conventional Antidepressants: A Narrative Review","year":"2026","cit":0,"pfa":"Seoyoung Yoon","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W7126020316","eid":"W7126020316"},{"id":"paper-w7160578721","cat":"papers","name":"NMDA-receptorantagonister vid depression : En litteraturstudie om klinisk profil, prediktorer och neuroplasticitet hos ketamin, esketamin och dextrometorfan (AXS-05)","year":"2026","cit":0,"pfa":"Raghad Ghalyon","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W7160578721","eid":"W7160578721"},{"id":"paper-w7164878917","cat":"papers","name":"Efficacy and Safety of Ultrasound-Guided Erector Spinae Plane Block at Different Injection Depths for Percutaneous Kyphoplasty: A Randomized Controlled Trial","year":"2026","cit":0,"pfa":"Ying Liu","psa":"Xiaoqiong Xia","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7164878917","eid":"W7164878917"},{"id":"paper-w4399150272","cat":"papers","name":"Ketamine Study Prioritizes Equitable Enrollment","year":"2024","cit":0,"pfa":"Katie O’Connor","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4399150272","eid":"W4399150272"},{"id":"paper-w7120227876","cat":"papers","name":"What alternative treatments are available for patients who experience a relapse of depression after stopping liothyronine?","year":"2026","cit":0,"pfa":"Tripdatabase","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7120227876","eid":"W7120227876"},{"id":"paper-w7125519680","cat":"papers","name":"What are the newest treatment options for depression?","year":"2026","cit":0,"pfa":"Tripdatabase","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7125519680","eid":"W7125519680"},{"id":"paper-w4308726300","cat":"papers","name":"A broadly applicable Diels-Alder based Synthesis of Ketamine related Arylcyclohexylamines","year":"2022","cit":0,"pfa":"Sherif El Sheikh","psa":"Nils Drouvé","ptype":"preprint","src":"https://openalex.org/W4308726300","eid":"W4308726300"},{"id":"paper-w7155199344","cat":"papers","name":"What are the mechanisms by which different subtypes of ketamine treat psychotic depression?","year":"2026","cit":0,"pfa":"Tripdatabase","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7155199344","eid":"W7155199344"},{"id":"paper-w7117973511","cat":"papers","name":"EV223 USE OF ES-KETAMINE SPRAY IN SUBJECTS WITH HYPOFRONTALITY AND ‘COLD’ DEPRESSION: EXPERIENCES FROM THE REAL WORLD","year":"2026","cit":0,"pfa":"Fabrizio Ferraiuolo","psa":"Cristina Serritella","topics":["Depression"],"ptype":"conference-abstract","src":"https://openalex.org/W7117973511","eid":"W7117973511"},{"id":"paper-w7110021840","cat":"papers","name":"Comparative Efficacy and Safety of Ketamine Administration Routes in Treatment-Resistant Depression: A Meta-analysis","year":"2025","cit":0,"pfa":"Yanshuo Han","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7110021840","eid":"W7110021840"},{"id":"paper-w7207687488","cat":"papers","name":"Short-term ketamine interventions for depressive disorders: practical best-practice recommendations for psychiatrists using oral, subcutaneous, and nasal formulations","year":"2026","cit":0,"pfa":"Anita Słupska","psa":"Adam Włodarczyk","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7207687488","eid":"W7207687488"},{"id":"paper-w4294200500","cat":"papers","name":"Therapy group following a Ketamine treatment – a case report of a patient with resistant depression","year":"2022","cit":0,"pfa":"H. Yaniv","psa":"V. Savlev","topics":["Depression","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4294200500","eid":"W4294200500"},{"id":"paper-w7125527813","cat":"papers","name":"What are the newest treatment options for depression?","year":"2026","cit":0,"pfa":"Tripdatabase","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7125527813","eid":"W7125527813"},{"id":"paper-w7131263125","cat":"papers","name":"How can the efficacy of alternative pharmacological treatments be evaluated when traditional medications like trazodone and lormetazepam fail?","year":"2026","cit":0,"pfa":"Tripdatabase","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7131263125","eid":"W7131263125"},{"id":"paper-w4409598249","cat":"papers","name":"Biotransformation of ketamine in terminal in vivo experiments under chronic intermittent hypoxia conditions and the role of AhR","year":"2025","cit":0,"pfa":"António B. Pimpão","psa":"Sofia Azeredo Pereira","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4409598249","eid":"W4409598249"},{"id":"paper-w7171316686","cat":"papers","name":"A review of the therapeutic and neuroprotective properties of ketamine","year":"2026","cit":0,"pfa":"Viacheslav Zaika","psa":"Yan Tytarenko","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7171316686","eid":"W7171316686"},{"id":"paper-w7116048866","cat":"papers","name":"What is the evidence for ketamine use in treatment-resistant depression?","year":"2025","cit":0,"pfa":"Tripdatabase","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7116048866","eid":"W7116048866"},{"id":"paper-w7108076313","cat":"papers","name":"What are the most effective treatments for depression or suicide attempts in adolescents treated at the hospital?","year":"2025","cit":0,"pfa":"Tripdatabase","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7108076313","eid":"W7108076313"},{"id":"paper-w7171968002","cat":"papers","name":"Apparent Dead Ends: Emerging Therapeutic Pathways in Treatment-Resistant Depression","year":"2026","cit":0,"pfa":"M. Calvo-Valcarcel","psa":"J. C. Fiorini-Talavera","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7171968002","eid":"W7171968002"},{"id":"paper-w7165372554","cat":"papers","name":"How do the CANMAT 2023 guidelines address treatment-resistant depression in adults?","year":"2026","cit":0,"pfa":"Tripdatabase","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7165372554","eid":"W7165372554"},{"id":"paper-w7165360866","cat":"papers","name":"How do the CANMAT 2023 guidelines address treatment-resistant depression in adults?","year":"2026","cit":0,"pfa":"Tripdatabase","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7165360866","eid":"W7165360866"},{"id":"paper-w4317774005","cat":"papers","name":"Opioid-sparing anaesthesia protocol on gastrointestinal function after benign gynaecological laparoscopic surgery: a prospective randomized controlled double-blind study","year":"2023","cit":0,"pfa":"Yuhua Ma","psa":"Weiwei Ma","topics":["Addiction"],"ptype":"preprint","src":"https://openalex.org/W4317774005","eid":"W4317774005"},{"id":"paper-w7108077337","cat":"papers","name":"What are the most effective treatments for depression or suicide attempts in adolescents treated at the hospital?","year":"2025","cit":0,"pfa":"Tripdatabase","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7108077337","eid":"W7108077337"},{"id":"paper-w4414474204","cat":"papers","name":"Who Can Get Ketamine Therapy under Medicare? A Route-Specific Analysis of Coverage Across Original Medicare, MACs, and Medicare Advantage (September 2025)","year":"2025","cit":0,"pfa":"Michael Alvear","ptype":"preprint","src":"https://openalex.org/W4414474204","eid":"W4414474204"},{"id":"paper-w7116052371","cat":"papers","name":"What is the evidence for ketamine use in treatment-resistant depression?","year":"2025","cit":0,"pfa":"Tripdatabase","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7116052371","eid":"W7116052371"},{"id":"paper-w7117444140","cat":"papers","name":"Metabolomic Biomarkers for Ketamine and S-Ketamine in TRD and Healthy controls: a Systematic Review","year":"2024","cit":0,"pfa":"Balwinder Singh","psa":"Nicolás A. Núñez","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7117444140","eid":"W7117444140"},{"id":"paper-w4402102541","cat":"papers","name":"New Findings and Emerging Trends in Postpartum Mental Illness: Risk Factors and Treatments","year":"2024","cit":0,"pfa":"Kathleen Tackett","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4402102541","eid":"W4402102541"},{"id":"paper-w7154462749","cat":"papers","name":"Ketamine for Depression in Serious Illness: Evidence, Safety, and Practical Approaches","year":"2026","cit":0,"pfa":"Paul E. Noufi","psa":"Daniel Shalev","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7154462749","eid":"W7154462749"},{"id":"paper-w2901526614","cat":"papers","name":"Synthesis of (2R,6R)-Hydroxy-norketamine for Evaluation of Antidepressant Effects","year":"2018","cit":0,"pfa":"Savannah Fairley","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W2901526614","eid":"W2901526614"},{"id":"paper-w3117466087","cat":"papers","name":"Current pharmacotherapies for depression: comparing serotonergic, glutamatergic, and GABA modulating agents","year":"2020","cit":0,"pfa":"Alexander Takacs","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W3117466087","eid":"W3117466087"},{"id":"paper-w7115561404","cat":"papers","name":"What are the most effective antidepressant treatments for patients with breast cancer experiencing depression?","year":"2025","cit":0,"pfa":"Tripdatabase","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7115561404","eid":"W7115561404"},{"id":"paper-w7127091491","cat":"papers","name":"Patient register would help reduce harm from ketamine use, says advisory council","year":"2026","cit":0,"topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7127091491","eid":"W7127091491"},{"id":"paper-w3119309027","cat":"papers","name":"Study finds novel treatment for resistant depression costly","year":"2020","cit":0,"pfa":"Valerie A. Canady","topics":["Depression","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3119309027","eid":"W3119309027"},{"id":"paper-w4313200718","cat":"papers","name":"Longitudinal associations between statin use and reduced negative bias – a potential mechanism for reduced depression vulnerability","year":"2022","cit":0,"pfa":"Amy L. Gillespie","psa":"Catherine J. Harmer","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4313200718","eid":"W4313200718"},{"id":"paper-w3135577463","cat":"papers","name":"Replicating Global Brain Connectivity As an Imaging Marker for Depression - Influence of Preprocessing Strategies and Placebo-Controlled Ketamine Treatment","year":"2019","cit":0,"pfa":"Christoph Kraus","psa":"Jennifer W. Evans","topics":["Depression"],"ptype":"preprint","src":"https://openalex.org/W3135577463","eid":"W3135577463"},{"id":"paper-w7151850866","cat":"papers","name":"Ketamine shows long‐term benefit in patients with treatment‐resistant depression","year":"2026","cit":0,"topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7151850866","eid":"W7151850866"},{"id":"paper-w3113094104","cat":"papers","name":"NMDA 受容体はketamine の抗うつ効果に関係しているか","year":"2020","cit":0,"pfa":"橋本謙二","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3113094104","eid":"W3113094104"},{"id":"paper-w4406815732","cat":"papers","name":"FDA approves first monotherapy standalone MDD treatment","year":"2025","cit":0,"pfa":"Valerie A. Canady","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4406815732","eid":"W4406815732"},{"id":"paper-w4399052316","cat":"papers","name":"Editorial: Perspectives on new fast-acting antidepressants","year":"2024","cit":0,"pfa":"Rodrigo Simonini Delfino","psa":"Acioly L.T. Lacerda","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"editorial","src":"https://openalex.org/W4399052316","eid":"W4399052316"},{"id":"paper-w7115556228","cat":"papers","name":"What are the most effective antidepressant treatments for patients with breast cancer experiencing depression?","year":"2025","cit":0,"pfa":"Tripdatabase","topics":["Depression","Anxiety & end-of-life","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7115556228","eid":"W7115556228"},{"id":"paper-w7172029714","cat":"papers","name":"Electroconvulsive Therapy and (Es)Ketamine in Treatment-Resistant Depression: A Review of Current Evidence","year":"2026","cit":0,"pfa":"J. Marta","psa":"M. A. Aleixo","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7172029714","eid":"W7172029714"},{"id":"paper-w7142187305","cat":"papers","name":"National survey of Dutch emergency physicians on pharmacological sedation practices for extreme agitation","year":"2026","cit":0,"pfa":"J.J.J. OUWERKERK","psa":"F.M.J. GRESNIGT","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7142187305","eid":"W7142187305"},{"id":"paper-w3163447940","cat":"papers","name":"Rapid-Acting Antidepressants","year":"2018","cit":0,"pfa":"Bashkim Kadriu","psa":"Carlos A. Zarate","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W3163447940","eid":"W3163447940"},{"id":"paper-w4244465600","cat":"papers","name":"IV ketamine for TRD for adolescents: Open‐label study","year":"2019","cit":0,"topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4244465600","eid":"W4244465600"},{"id":"paper-w4414638264","cat":"papers","name":"Ketamine for Treatment of Severe Postpartum Depression in Lactating Mothers: What Is Known?","year":"2025","cit":0,"pfa":"Christopher Ryalino","psa":"Made Gede Widnyana","topics":["Depression"],"ptype":"book-chapter","src":"https://openalex.org/W4414638264","eid":"W4414638264"},{"id":"paper-w7204745683","cat":"papers","name":"Determinants of procedural sedation requirements during endovascular treatment for acute anterior circulation ischaemic stroke: a post-hoc analysis of the INDIVIDUATE trial","year":"2026","cit":0,"pfa":"Min Chen","psa":"Silvia Schönenberger","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7204745683","eid":"W7204745683"},{"id":"paper-w4392502842","cat":"papers","name":"Improvement and clinical benefit analysis of low-dose ketamine on postoperative pain and sleep after sinus surgery","year":"2024","cit":0,"pfa":"Yan-ping Zhao","psa":"Feng Zhu","topics":["Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4392502842","eid":"W4392502842"},{"id":"paper-w7165314715","cat":"papers","name":"Efficacy and Safety of Ultrasound-Guided Erector Spinae Plane Block at Different Injection Depths for Percutaneous Kyphoplasty: A Randomized Controlled Trial","year":"2026","cit":0,"pfa":"Liu Y","psa":"Xia X","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7165314715","eid":"W7165314715"},{"id":"paper-w7125176194","cat":"papers","name":"Transforming treatment-resistant depression (TRD) care in the Gulf Cooperation Council (GCC) countries: a narrative review of emerging therapies, advancements, and implementation barriers","year":"2026","cit":0,"pfa":"Mohammed A. Alhassan","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W7125176194","eid":"W7125176194"},{"id":"paper-w7160546047","cat":"papers","name":"Opioid insensitivity associated with genetic variants in the µ-opioid receptor","year":"2026","cit":0,"pfa":"Anton Lund","psa":"Jakob Højlund","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7160546047","eid":"W7160546047"},{"id":"paper-w4389939441","cat":"papers","name":"Ketamine and Nitrous Oxide","year":"2023","cit":0,"pfa":"Alvin M. Janski","psa":"Charles R. Conway","ptype":"book-chapter","src":"https://openalex.org/W4389939441","eid":"W4389939441"},{"id":"paper-w7136220661","cat":"papers","name":"Combination of N-methyl-D-aspartate receptor antagonists and propofol for procedural sedation","year":"2026","cit":0,"pfa":"Muhammad Shaheer Bin Faheem","psa":"Salim Surani","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7136220661","eid":"W7136220661"},{"id":"paper-w7141377812","cat":"papers","name":"Laboratory Testing in the Practice of Psychopharmacology – Interview","year":"2021","cit":0,"pfa":"Sandra A. Jacobson","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"report","src":"https://openalex.org/W7141377812","eid":"W7141377812"},{"id":"paper-w7125950961","cat":"papers","name":"Dissociating pain dimensions in cold allodynia: subanesthetic ketamine reveals heritable affective-motivational traits in mice","year":"2026","cit":0,"pfa":"Nicole Richter","psa":"Katharina Zimmermann","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7125950961","eid":"W7125950961"},{"id":"paper-w7171938738","cat":"papers","name":"The use of ketamine in the management of suicidal crisis: a literature review","year":"2026","cit":0,"pfa":"A. Rami","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7171938738","eid":"W7171938738"},{"id":"paper-w4410085469","cat":"papers","name":"Effects of Esperazone Ketamine on Apoptosis of Tendon Cells in Rats with Shoulder Sleeve Injury by Regulating PI3K/AKT/FoxO1 Signal Pathway","year":"2025","cit":0,"pfa":"Haibo Zou","psa":"Xiaofeng Sun","topics":["Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4410085469","eid":"W4410085469"},{"id":"paper-w2953889397","cat":"papers","name":"Ketamine for Psychiatric Disorders","year":"2019","cit":0,"pfa":"Rupert H. McShane","topics":["Depression"],"ptype":"book-chapter","src":"https://openalex.org/W2953889397","eid":"W2953889397"},{"id":"paper-w7204149467","cat":"papers","name":"Baseline body mass index and treatment outcomes in adults with treatment-resistant depression: systematic review protocol (BMI-TRD-SR)","year":"2026","cit":0,"pfa":"Felipe Rodrigues De Queiroz","psa":"João Quevedo","topics":["Depression","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7204149467","eid":"W7204149467"},{"id":"paper-w4393166441","cat":"papers","name":"How the Food and Drug Administration Drug Approval Process Relates to the Potential Approval of Intravenous Racemic Ketamine for Treatment-resistant Major Depression","year":"2024","cit":0,"pfa":"Sheldon Preskorn","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4393166441","eid":"W4393166441"},{"id":"paper-w4377029135","cat":"papers","name":"Is Ketamine a rapid acting antidepressant in juvenile rats?","year":"2023","cit":0,"pfa":"David S. Middlemas","psa":"Alexis Klinner","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4377029135","eid":"W4377029135"},{"id":"paper-w3036704563","cat":"papers","name":"Party drug to mainstream medicine; the transition of ketamine","year":"2020","cit":0,"pfa":"N. Ravindran","psa":"Arun V Ravindran","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3036704563","eid":"W3036704563"},{"id":"paper-w7165770198","cat":"papers","name":"COMPARING ROUTES OF KETAMINE ADMINISTRATION IN TREATMENT-RESISTANT DEPRESSION: EFFICACY, SAFETY, AND OPTIMIZATION OF DOSING STRATEGIES","year":"2026","cit":0,"pfa":"Irmina Grygutis","psa":"Maja Podolak","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7165770198","eid":"W7165770198"},{"id":"paper-w4399611354","cat":"papers","name":"The use of ketamine in psychiatric therapy","year":"2023","cit":0,"pfa":"Angeliki Statharou","psa":"Evangelos Pergadas","topics":["Depression","Addiction","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4399611354","eid":"W4399611354"},{"id":"paper-w4414639569","cat":"papers","name":"The Global Importance of Ketamine for Medical Care","year":"2025","cit":0,"pfa":"Sabine Himmelseher","psa":"Ernst G. Pfenninger","ptype":"book-chapter","src":"https://openalex.org/W4414639569","eid":"W4414639569"},{"id":"paper-w7141175336","cat":"papers","name":"The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Recommendations for the Use of Racemic Ketamine in Adults With Major Depressive Disorder","year":"2022","cit":0,"topics":["Depression","Anxiety & end-of-life","Reviews & meta-analyses"],"ptype":"report","src":"https://openalex.org/W7141175336","eid":"W7141175336"},{"id":"paper-w2945135914","cat":"papers","name":"S136. Is Ketamine Metabolism to Norketamine and (2R,6R)-HNK Necessary for its Sustained Antidepressant-Like Activity and Cortical Neurotransmitter Release in Mice?","year":"2019","cit":0,"pfa":"Thi Mai Loan Nguyen","psa":"Alain Michel Gardier","topics":["Depression"],"ptype":"conference-abstract","src":"https://openalex.org/W2945135914","eid":"W2945135914"},{"id":"paper-w4401919491","cat":"papers","name":"Vagus nerve stimulation (VNS) as a long-term adjunctive treatment option in patients with difficult-to-treat depression (DTD)","year":"2024","cit":0,"pfa":"E. Kavakbasi","psa":"B. Baune","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4401919491","eid":"W4401919491"},{"id":"paper-w7171682711","cat":"papers","name":"Depression Heterogeneity as a Confounder in Ketamine Response for Late-Life Depression","year":"2026","cit":0,"pfa":"J Lind","psa":"Dora Kanellopoulos","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7171682711","eid":"W7171682711"},{"id":"paper-w7202048863","cat":"papers","name":"The prevention and treatment of postoperative delirium in elderly patients with ketamine","year":"2026","cit":0,"pfa":"Jiahui Li","topics":["Safety & adverse events","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7202048863","eid":"W7202048863"},{"id":"paper-w7202366648","cat":"papers","name":"Prescribing Nonpharmacologic Interventions","year":"2026","cit":0,"pfa":"Nora Proops","psa":"Rachel Katz","topics":["Depression","Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W7202366648","eid":"W7202366648"},{"id":"paper-w4414930870","cat":"papers","name":"Validation and clinical application of the Chinese version of the rapid response scale","year":"2025","cit":0,"pfa":"Ziying Chen","psa":"Yanling Zhou","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4414930870","eid":"W4414930870"},{"id":"paper-w7213512921","cat":"papers","name":"Ketamine metabolite HNK ameliorates anhedonia symptom in Alzheimer's disease mice","year":"2026","cit":0,"pfa":"Shuo Yang","psa":"Qiang Zhou","ptype":"article","src":"https://openalex.org/W7213512921","eid":"W7213512921"},{"id":"paper-w4394098230","cat":"papers","name":"Immediate and short-term efficacy of suicide-targeted interventions in suicidal individuals: a systematic review","year":"2021","cit":0,"pfa":"Aistė Lengvenytė","psa":"Philippe Courtet","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"dataset","src":"https://openalex.org/W4394098230","eid":"W4394098230"},{"id":"paper-w4394467739","cat":"papers","name":"Immediate and short-term efficacy of suicide-targeted interventions in suicidal individuals: A systematic review","year":"2021","cit":0,"pfa":"Aistė Lengvenytė","psa":"Philippe Courtet","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"dataset","src":"https://openalex.org/W4394467739","eid":"W4394467739"},{"id":"paper-w2610250239","cat":"papers","name":"The use of ketamine in treatment-resistant major depression: a case study","year":"2015","cit":0,"pfa":"Saskia Helm","psa":"Helge Frieling","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2610250239","eid":"W2610250239"},{"id":"paper-w7133556463","cat":"papers","name":"Cognitive outcomes of antidepressant use in patients with cancer: a systematic review","year":"2026","cit":0,"pfa":"Luca Chisari","psa":"Gabriele Sani","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"other","src":"https://openalex.org/W7133556463","eid":"W7133556463"},{"id":"paper-w2895385019","cat":"papers","name":"Antidepressants Moving in Pipeline","year":"2018","cit":0,"pfa":"Jun Yan,","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W2895385019","eid":"W2895385019"},{"id":"paper-w7154594606","cat":"papers","name":"Effect of Perioperative Ketamine on Early Postpartum Depressive Symptoms Following Cesarean Section: A Meta-Analysis","year":"2026","cit":0,"pfa":"Samantha Siu","psa":"Patricia Junquera","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W7154594606","eid":"W7154594606"},{"id":"paper-w7213488648","cat":"papers","name":"Predictors and neurophysiological biomarkers of response to neuromodulatory interventions in treatment-resistant depression","year":"2026","cit":0,"pfa":"Lindsay L. Benster","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"dissertation","src":"https://openalex.org/W7213488648","eid":"W7213488648"},{"id":"paper-w4416903474","cat":"papers","name":"Emerging pharmacological strategies supporting symptom management in borderline personality disorder: current evidence and future directions","year":"2025","cit":0,"pfa":"Michał Pałuchowski","psa":"Julia Kwiecińska","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4416903474","eid":"W4416903474"},{"id":"paper-w7167248469","cat":"papers","name":"Effects of opioid-free anesthesia on postoperative anxiety in patients undergoing modified radical mastectomy for breast cancer: a randomized controlled trial","year":"2026","cit":0,"pfa":"邓聪","psa":"Shihong Li","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7167248469","eid":"W7167248469"},{"id":"paper-w4401920570","cat":"papers","name":"Rapid reduction of depressive symptoms with minimal dissociation: results from the KET01-02 and KET01-03 trials with oral prolonged-release (PR) ketamine KET01","year":"2024","cit":0,"pfa":"Christine zu Eulenburg","psa":"H. Eriksson","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4401920570","eid":"W4401920570"},{"id":"paper-w4210407590","cat":"papers","name":"À propos de l’utilisation du traitement de la kétamine aux urgences psychiatriques","year":"2021","cit":0,"pfa":"Ioannis N. Sergentanis","psa":"Julia Ambrosetti","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4210407590","eid":"W4210407590"},{"id":"paper-w7214522014","cat":"papers","name":"Simultaneous Quantification of Ketamine and Its Metabolites in Rat Plasma Using LC-MS/MS: Method Development, Validation, and Application","year":"2026","cit":0,"pfa":"Sang-Hoon Song","psa":"Sooyeun Lee","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7214522014","eid":"W7214522014"},{"id":"paper-w7171996088","cat":"papers","name":"Approach To Treatment-Resistant Recurrent Depressive Disorder","year":"2026","cit":0,"pfa":"M.J. Muñoz Algar","psa":"P. Bernal García","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7171996088","eid":"W7171996088"},{"id":"paper-w7212035086","cat":"papers","name":"832. The Maudsley Advanced Treatment Service: Maudsley Ketamine Clinical Research Experience","year":"2026","cit":0,"pfa":"M. Juruena","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W7212035086","eid":"W7212035086"},{"id":"paper-w7212130500","cat":"papers","name":"Real-World Patterns of Interventional Psychiatry Use in a Tertiary Mood Disorders Service","year":"2026","cit":0,"pfa":"Gustavo Vazquez","psa":"Casimiro Cabrera-Abreu","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7212130500","eid":"W7212130500"},{"id":"paper-w3054597164","cat":"papers","name":"Ketamine selectively enhances AMPA neurotransmission onto a subgroup of identified serotoninergic neurons of the rat dorsal raphe","year":"2020","cit":0,"pfa":"Cyrine Hmaied","psa":"Vincent Seutin","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W3054597164","eid":"W3054597164"},{"id":"paper-w2911558810","cat":"papers","name":"A new route to fast-acting antidepressants","year":"2017","cit":0,"pfa":"Tien T. Nguyen","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W2911558810","eid":"W2911558810"},{"id":"paper-w4387328994","cat":"papers","name":"Loosening the Shackles of Depression","year":"2023","cit":0,"pfa":"Rupert H. McShane","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W4387328994","eid":"W4387328994"},{"id":"paper-w7124440034","cat":"papers","name":"Efficacy and safety of HR020602 in combination with propofol in children receiving general anesthesia: a multicenter, phase 2 study","year":"2026","cit":0,"pfa":"Nan Zou","psa":"J. M. Zhang","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7124440034","eid":"W7124440034"},{"id":"paper-w4405820619","cat":"papers","name":"Effects of Sedation Medications on Postoperative Delirium and Cognitive Dysfunction in Cardiac Surgery Patients with Cardiopulmonary Bypass: A Network Meta-Analysis","year":"2024","cit":0,"pfa":"Yanping Zhang","psa":"Hong-jian Pan","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4405820619","eid":"W4405820619"},{"id":"paper-w4405610034","cat":"papers","name":"The Effectiveness of Pharmacological Treatments for Major Depressive Disorder","year":"2024","cit":0,"pfa":"Mahima Sanghera","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4405610034","eid":"W4405610034"},{"id":"paper-w7172492104","cat":"papers","name":"Last resort: the ethical obligation to offer ketamine in psychiatric euthanasia and assisted suicide","year":"2026","cit":0,"pfa":"Jingyi Zhang","psa":"Dominic Sisti","topics":["Depression","Reviews & meta-analyses","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7172492104","eid":"W7172492104"},{"id":"paper-w4417193125","cat":"papers","name":"Ketamine enantiomers and the gut microbiota: mechanisms, clinical implications, and future directions","year":"2025","cit":0,"pfa":"Jin-Xi Xie","psa":"Li-Wen Zhou","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4417193125","eid":"W4417193125"},{"id":"paper-w7212569598","cat":"papers","name":"Non-opioid pharmacologic interventions for the prevention of delirium after cardiac surgery in adults: systematic review and network meta analysis","year":"2026","cit":0,"pfa":"Meng-Xue Yan","psa":"Su Yuan","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7212569598","eid":"W7212569598"},{"id":"paper-w7115595835","cat":"papers","name":"Treatment-Resistant Depression Synthetic Dataset v1.0","year":"2025","cit":0,"pfa":"MentalData.io","topics":["Depression"],"ptype":"dataset","src":"https://openalex.org/W7115595835","eid":"W7115595835"},{"id":"paper-w7115574111","cat":"papers","name":"Treatment-Resistant Depression Synthetic Dataset v1.0","year":"2025","cit":0,"pfa":"MentalData.io","topics":["Depression"],"ptype":"dataset","src":"https://openalex.org/W7115574111","eid":"W7115574111"},{"id":"paper-w4294200374","cat":"papers","name":"Impact of invasive VNS on depression severity and the need of concomitant drug and neuromodulatory treatment dose","year":"2022","cit":0,"pfa":"Erhan Kavakbasi","psa":"Bernhardt T. Baune","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4294200374","eid":"W4294200374"},{"id":"paper-w7169781494","cat":"papers","name":"(Es)ketamine in functional neurological disorder: a systematic review","year":"2026","cit":0,"pfa":"Bruce Tamilson","psa":"Timothy Nicholson","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7169781494","eid":"W7169781494"},{"id":"paper-w7171519262","cat":"papers","name":"Adjunctive Pharmacotherapy for Major Depressive Disorder with Anxiety Symptoms: from Monoamines to Recent Clinical Evidence","year":"2026","cit":0,"pfa":"Roger S. McIntyre","psa":"Matthieu Boucher","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7171519262","eid":"W7171519262"},{"id":"paper-w7163376739","cat":"papers","name":"Astrocytic μ-δ opioid receptor heterodimers mediate the antidepressant effects of ketamine’s metabolite","year":"2026","cit":0,"pfa":"Shuo Yang","psa":"Q Zhou","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7163376739","eid":"W7163376739"},{"id":"paper-w7213549004","cat":"papers","name":"Recent Advances in the Treatment of Major Depressive Disorder: Novel Therapeutic Approaches and Emerging Strategies","year":"2026","cit":0,"pfa":"Nancya S","psa":"Dinash Kumar","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7213549004","eid":"W7213549004"},{"id":"paper-w4313200914","cat":"papers","name":"lumateperone (ITI-007) in the treatment of bipolar depression: efficacy across symptoms","year":"2022","cit":0,"pfa":"R.S. McIntyre","psa":"Andrew J. Cutler","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4313200914","eid":"W4313200914"},{"id":"paper-w3153000881","cat":"papers","name":"Primer on Depression","year":"2019","cit":0,"pfa":"Naji C. Salloum","psa":"George I. Papakostas","topics":["Depression","Mechanism & neuroscience","Therapy practice"],"ptype":"book-chapter","src":"https://openalex.org/W3153000881","eid":"W3153000881"},{"id":"paper-w7130550298","cat":"papers","name":"A REVIEW ON DEPRESSION","year":"2026","cit":0,"pfa":"Divesh Khachi, Raman Gupta, Dr Jyoti Gupta, Shalu Dhiman, Yashasvi Bali","topics":["Depression","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7130550298","eid":"W7130550298"},{"id":"paper-w7130605341","cat":"papers","name":"A REVIEW ON DEPRESSION","year":"2026","cit":0,"pfa":"Divesh Khachi, Raman Gupta, Dr Jyoti Gupta, Shalu Dhiman, Yashasvi Bali","topics":["Depression","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7130605341","eid":"W7130605341"},{"id":"paper-w4408574901","cat":"papers","name":"Ketamine in Prevention and Treatment of Postpartum Depression - Literature Review","year":"2025","cit":0,"pfa":"Daria Stefaniak","psa":"Agata Siejka","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4408574901","eid":"W4408574901"},{"id":"paper-w7214471742","cat":"papers","name":"Ketamine for TRD: Do the Guidelines Follow the Science? A Systematized Review","year":"2026","cit":0,"pfa":"Alec Semaan","topics":["Depression","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"other","src":"https://openalex.org/W7214471742","eid":"W7214471742"},{"id":"paper-w7167944193","cat":"papers","name":"930 Peri-Operative Considerations for Adult Populations Undergoing General Anaesthesia While Undergoing Ketamine Treatment","year":"2026","cit":0,"pfa":"K E Boyle","psa":"S S Dalkilic","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7167944193","eid":"W7167944193"},{"id":"paper-w7171971739","cat":"papers","name":"Rapid Antisuicidal Effects of Intravenous Ketamine as an Emergency Intervention in Outpatient and Consultation-Liaison Psychiatry Settings","year":"2026","cit":0,"pfa":"P. Argitis","psa":"Z. Chaviaras","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7171971739","eid":"W7171971739"},{"id":"paper-w7171620227","cat":"papers","name":"Mania and depression","year":"2026","cit":0,"pfa":"Daniel Casey","psa":"Bart Sheehan","topics":["Depression","Reviews & meta-analyses"],"ptype":"book-chapter","src":"https://openalex.org/W7171620227","eid":"W7171620227"},{"id":"paper-w4318755465","cat":"papers","name":"Ketamine, Interleukin-6, and Vasoplegia","year":"2023","cit":0,"pfa":"Jamel P. Ortoleva","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4318755465","eid":"W4318755465"},{"id":"paper-w7128191265","cat":"papers","name":"Factors for predicting response to electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS) and ketamine in patients with treatment-resistant depression: a systematic review","year":"2026","cit":0,"pfa":"Daniel Pustay","psa":"Jourdan T. Aromin","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"dataset","src":"https://openalex.org/W7128191265","eid":"W7128191265"},{"id":"paper-w7212063948","cat":"papers","name":"686. Glutamate dysfunction in treatment-resistant depression: translational and clinical insights","year":"2026","cit":0,"pfa":"Marco Di Nicola","psa":"G Martinotti","topics":["Depression","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7212063948","eid":"W7212063948"},{"id":"paper-w4221152597","cat":"papers","name":"Ketamine - Undrawn Lines between Medical and Recreational Use - Implications for Clinical Practice.","year":"2022","cit":0,"pfa":"Suzana Jonovska","psa":"Vesna Šendula Jengić","topics":["Depression","Safety & adverse events","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W4221152597","eid":"W4221152597"},{"id":"paper-w7158623005","cat":"papers","name":"Time to resolution and durability of suicidal ideation: ketamine versus electroconvulsive therapy, a post hoc analysis of the KetECT randomized clinical trial.","year":"2026","cit":0,"pfa":"Marcus Persson","psa":"Tor Arnison","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W7158623005","eid":"W7158623005"},{"id":"paper-w7141077245","cat":"papers","name":"Ketamine Guide: Pharmacology, Indications, Dosing Guidelines and Adverse Effects","year":"2025","cit":0,"pfa":"Sebastián Malleza","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"report","src":"https://openalex.org/W7141077245","eid":"W7141077245"},{"id":"paper-w7214213453","cat":"papers","name":"Current drug treatment of mental disorders","year":"2026","cit":0,"pfa":"Nurdana Bidan","psa":"Zhanar Shimirova","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7214213453","eid":"W7214213453"},{"id":"paper-w3012548890","cat":"papers","name":"Differential effects of ketamine metabolites on depression-like behaviors induced by chronic corticosterone injection in mice","year":"2020","cit":0,"pfa":"Rei Yokoyama","psa":"Hitoshi Hashimoto","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3012548890","eid":"W3012548890"},{"id":"paper-w7128194998","cat":"papers","name":"Factors for predicting response to electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS) and ketamine in patients with treatment-resistant depression: a systematic review","year":"2026","cit":0,"pfa":"Daniel Pustay","psa":"Jourdan T. Aromin","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"dataset","src":"https://openalex.org/W7128194998","eid":"W7128194998"},{"id":"paper-w7118095587","cat":"papers","name":"Fast-acting antidepressants trigger presynaptic BDNF release and structural plasticity at mouse mossy fiber-CA3 synapses","year":"2026","cit":0,"pfa":"Irem L Atasoy-Rodriguez","psa":"Jimcy Platholi","topics":["Depression","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7118095587","eid":"W7118095587"},{"id":"paper-w7135472364","cat":"papers","name":"Neurobiological mechanisms of pharmacoresistant depression","year":"2025","cit":0,"pfa":"Kateřina Vystavělová","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7135472364","eid":"W7135472364"},{"id":"paper-w7118802185","cat":"papers","name":"Ketamine in Diabetes Care: Metabolic Insights and Clinical Applications","year":"2026","cit":0,"pfa":"Shiryn D. Sukhram","psa":"Grozdena Yilmaz","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7118802185","eid":"W7118802185"},{"id":"paper-w7213065864","cat":"papers","name":"Cognitive Effects of Ketamine in Major Depression: A Systematic Review and Individual Participant Data Meta-Analysis","year":"2026","cit":0,"pfa":"Stevan Nikolin","psa":"Donel M Martin","topics":["Depression","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7213065864","eid":"W7213065864"},{"id":"paper-w4415298763","cat":"papers","name":"Ketamine for depression and other psychiatric diseases","year":"2025","cit":0,"pfa":"W. Roth","topics":["Depression"],"ptype":"book-chapter","src":"https://openalex.org/W4415298763","eid":"W4415298763"},{"id":"paper-w7163569429","cat":"papers","name":"When a Single Patient Changes Medicine: Case Reports That Matter","year":"2026","cit":0,"pfa":"Daniel Rosehill","psa":"Chatterbox TTS","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"other","src":"https://openalex.org/W7163569429","eid":"W7163569429"},{"id":"paper-w4231587699","cat":"papers","name":"Differential effects of ketamine metabolites on depression-like behaviors induced by chronic corticosterone injection in mice","year":"2020","cit":0,"pfa":"Rei Yokoyama","psa":"Hitoshi Hashimoto","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4231587699","eid":"W4231587699"},{"id":"paper-w4243980564","cat":"papers","name":"Antidepressants","year":"2020","cit":0,"pfa":"Arash Ansari","psa":"David N. Osser","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W4243980564","eid":"W4243980564"},{"id":"paper-w7118707701","cat":"papers","name":"Exploring the effects of pharmacological treatments on suicidality in children and adolescents: a structured review of the literature and narrative synthesis","year":"2026","cit":0,"pfa":"Andrea Amerio","psa":"Gianluca Serafini","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7118707701","eid":"W7118707701"},{"id":"paper-w4401924782","cat":"papers","name":"Epidemiology of a psychiatric day hospital service in rome: descriptive analysis of a two-year period of hospitalizations","year":"2024","cit":0,"pfa":"Antonella Moschillo","psa":"Giovanni Manfredi","ptype":"article","src":"https://openalex.org/W4401924782","eid":"W4401924782"},{"id":"paper-w4299600274","cat":"papers","name":"NMDAR inhibition-independent antidepressant actions of ketamine metabolites","year":"2020","cit":0,"pfa":"Patrick J. Morris","psa":"Polymnia Georgiou","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4299600274","eid":"W4299600274"},{"id":"paper-w7119530136","cat":"papers","name":"Case report of effects of Spravato on multiple sclerosis patient with treatment-resistant depressionCase report of effects of Spravato on multiple sclerosis patient with treatment-resistant depression","year":"2026","cit":0,"pfa":"Tanya Valluri","psa":"Waheed K. Bajwa","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7119530136","eid":"W7119530136"},{"id":"paper-w2795513834","cat":"papers","name":"Experts Remain Enthusiastic About NMDA-Targeting Antidepressants","year":"2018","cit":0,"pfa":"Nick Zagorski","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2795513834","eid":"W2795513834"},{"id":"paper-w4313223571","cat":"papers","name":"Delphi panel to obtain clinical consensus regarding the importance of rapid reduction in depressive symptoms in patients with major depressive disorder with acute suicidal ideation or behavior (MDSI)","year":"2022","cit":0,"pfa":"Stephane Borentain","psa":"Richard Perry","topics":["Depression","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4313223571","eid":"W4313223571"},{"id":"paper-w7165017761","cat":"papers","name":"The Impact of General Anesthetics on Postoperative Delirium: A Narrative Review Based on Clinical Randomized Controlled Trials from the Last Five Years","year":"2026","cit":0,"pfa":"Jia-Ni Wu","psa":"Xing‐Jun Liu","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7165017761","eid":"W7165017761"},{"id":"paper-w4403630205","cat":"papers","name":"Key contribution of prefrontal inhibition to passive coping behaviour: chronic stress and fast-acting antidepressant","year":"2024","cit":0,"pfa":"Tsz Hei Fong","psa":"Qiang Zhou","topics":["Depression","Mechanism & neuroscience","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W4403630205","eid":"W4403630205"},{"id":"paper-w7163574741","cat":"papers","name":"When a Single Patient Changes Medicine: Case Reports That Matter","year":"2026","cit":0,"pfa":"Daniel Rosehill","psa":"Chatterbox TTS","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"other","src":"https://openalex.org/W7163574741","eid":"W7163574741"},{"id":"paper-w7207857918","cat":"papers","name":"Pharmacometabolomics of Psychotropic Drugs: Treatment Response, Adverse Effects, and Precision Psychiatry—A Narrative Review","year":"2026","cit":0,"pfa":"Sushil Kumar SV","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7207857918","eid":"W7207857918"},{"id":"paper-w4410191303","cat":"papers","name":"Systematic Reviews and Meta-Analyses of Ketamine Therapy for Depression (2020–2024) A Comparative Evidence Summary","year":"2025","cit":0,"pfa":"Michael Alvear","topics":["Depression","Reviews & meta-analyses","Therapy practice"],"ptype":"preprint","src":"https://openalex.org/W4410191303","eid":"W4410191303"},{"id":"paper-w4283166876","cat":"papers","name":"Developing a New Neuromodulation Treatment Pathway for the Treatment of Depression","year":"2022","cit":0,"pfa":"Ανδρέας Παπαδόπουλος","psa":"Jane Yeandle","topics":["Depression","Reviews & meta-analyses","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4283166876","eid":"W4283166876"},{"id":"paper-w4403765860","cat":"papers","name":"Targeting NMDAR2A: Esketamine's Impact on BV2 Microglial Pro-inflammatory Polarization","year":"2024","cit":0,"pfa":"Hui Li","psa":"Xiaohua Zou","ptype":"preprint","src":"https://openalex.org/W4403765860","eid":"W4403765860"},{"id":"paper-w4415559915","cat":"papers","name":"USO DA QUETAMINA NO TRATAMENTO DA DEPRESSÃO REFRATÁRIA: UMA REVISÃO DE LITERATURA","year":"2025","cit":0,"pfa":"G. R. SILVA","psa":"Roberto De Souza","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4415559915","eid":"W4415559915"},{"id":"paper-w4414633801","cat":"papers","name":"(Es-)Ketamine and the Macro- and Microcirculation: What Do We Know?","year":"2025","cit":0,"pfa":"Torsten Richter","psa":"Rosa Nickl","ptype":"book-chapter","src":"https://openalex.org/W4414633801","eid":"W4414633801"},{"id":"paper-w4390047654","cat":"papers","name":"Med Check: Opioid Overdose, Ketamine Side Effects, Schizophrenia","year":"2023","cit":0,"pfa":"Terri D’Arrigo","psa":"Nick Zagorski","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4390047654","eid":"W4390047654"},{"id":"paper-w7163895860","cat":"papers","name":"Intravenöse subnarkotische Ketamin-Infusionen gegen therapieresistente Depression: Historische Entwicklung, Vergleich mit Esketamin-Nasenspray und Perspektiven","year":"2026","cit":0,"pfa":"Udo Bonnet","psa":"Tom Bschor","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7163895860","eid":"W7163895860"},{"id":"paper-w7167511191","cat":"papers","name":"Pharmacotherapy for Depression - Updates and Comparative Effectiveness","year":"2025","cit":0,"pfa":"Shaik Parveen","psa":"Govind Singh","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7167511191","eid":"W7167511191"},{"id":"paper-w7127071024","cat":"papers","name":"Pharmacological treatment of adolescent depression: Current advances and future perspectives","year":"2025","cit":0,"pfa":"Yongbo Li","psa":"Shuhong Zhai","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7127071024","eid":"W7127071024"},{"id":"paper-w7212186034","cat":"papers","name":"2025 in terugblik: FDA-goedkeuringen, praktijkrichtlijnen en labelwijzigingen in de psychiatrie","year":"2025","cit":0,"pfa":"Sebastián Malleza","topics":["Depression","Addiction"],"ptype":"report","src":"https://openalex.org/W7212186034","eid":"W7212186034"},{"id":"paper-w7171924176","cat":"papers","name":"What’s new in the management of depressive disorder? Key updates for clinicians","year":"2026","cit":0,"pfa":"D. L. U. Amarakoon","psa":"R. Fernando","topics":["Depression","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7171924176","eid":"W7171924176"},{"id":"paper-w7213262765","cat":"papers","name":"Pharmacokinetic interaction between ketamine and ethanol: evaluation and forensic implications","year":"2026","cit":0,"pfa":"Jin Ah Won","psa":"Hye Hyun Yoo","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7213262765","eid":"W7213262765"},{"id":"paper-w7162788480","cat":"papers","name":"Differences in how NMDA antagonists modulate negative affective biases in male rats may serve as a predictor of clinical efficacy in major depressive disorder","year":"2026","cit":0,"pfa":"Justyna K. Hinchcliffe","psa":"Emma S J Robinson","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7162788480","eid":"W7162788480"},{"id":"paper-w4394695793","cat":"papers","name":"Ketamine metabolism via hepatic CYP450 isoforms contributes to its sustained antidepressant actions","year":"2024","cit":0,"pfa":"Thi Mai Loan Nguyen","psa":"Alain Michel Gardier","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4394695793","eid":"W4394695793"},{"id":"paper-w7126146549","cat":"papers","name":"The Nurse's Role in Patient Preparation for Discharge to Optimize Patient Outcomes and Reduce Readmissions","year":"2025","cit":0,"pfa":"Margaret Mae Scott","topics":["Depression"],"ptype":"dissertation","src":"https://openalex.org/W7126146549","eid":"W7126146549"},{"id":"paper-w7116904559","cat":"papers","name":"The Role of the NMDA Receptor in the Treatment of Psychiatric and Neurological Diseases","year":"2025","cit":0,"pfa":"Stan P. Heath","psa":"Ayodeji A. Agbowuro","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7116904559","eid":"W7116904559"},{"id":"paper-w7212119787","cat":"papers","name":"Ketamine-gids: farmacologie, indicaties, doseringsrichtlijnen en bijwerkingen","year":"2025","cit":0,"pfa":"Sebastián Malleza","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"report","src":"https://openalex.org/W7212119787","eid":"W7212119787"},{"id":"paper-w3160912258","cat":"papers","name":"IV Ketamine-Induced Skin Temperature Changes in a Patient with Unilateral Complex Regional Pain Syndrome (CRPS) Type II","year":"2020","cit":0,"pfa":"Ashraf F. Hanna","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3160912258","eid":"W3160912258"},{"id":"paper-w7211988609","cat":"papers","name":"704. Targeting the Glutamatergic System: Novel Therapeutics in Unipolar and Bipolar Depression","year":"2026","cit":0,"pfa":"A Young","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W7211988609","eid":"W7211988609"},{"id":"paper-w3168109131","cat":"papers","name":"Why Are Psychiatrists Hesitant to Refer Patients For Interventional Treatments?","year":"2021","cit":0,"pfa":"Richard A. Bermudes","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W3168109131","eid":"W3168109131"},{"id":"paper-w7116935351","cat":"papers","name":"The Role of the NMDA Receptor in the Treatment of Psychiatric and Neurological Diseases","year":"2025","cit":0,"pfa":"Stan P. Heath","psa":"Ayodeji A. Agbowuro","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7116935351","eid":"W7116935351"},{"id":"paper-w7159871346","cat":"papers","name":"Brazilian Psychiatric Association Guidelines for pharmacological treatment of Major Depressive Disorder: An overview of systematic reviews and meta-analyses","year":"2026","cit":0,"pfa":"Marcelo P.M. Adelino","psa":"Acioly Luiz Tavares Lacerda","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7159871346","eid":"W7159871346"},{"id":"paper-w7159926237","cat":"papers","name":"Off-label and investigational drugs in the treatment of gambling disorder: a critical review","year":"2026","cit":0,"pfa":"Leon Bissig","psa":"Jochen Mutschler","topics":["Addiction","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7159926237","eid":"W7159926237"},{"id":"paper-w4394769865","cat":"papers","name":"Efficacy of SAL0114, an Oral NMDA Receptor Antagonist with Multimodal Activity, in Major Depressive Disorder","year":"2024","cit":0,"pfa":"Xuefeng Hu","psa":"Ying Xiao","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4394769865","eid":"W4394769865"},{"id":"paper-w7106130290","cat":"papers","name":"Impact of opioid-free anesthesia on the overall benefit of analgesia score after laparoscopic cholecystectomy: protocol and statistical analysis plan for a multicenter, randomized, controlled trial","year":"2025","cit":0,"pfa":"Zhao, Han-xue","psa":"Peng, Ke","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7106130290","eid":"W7106130290"},{"id":"paper-w4414681766","cat":"papers","name":"Pharmacokinetics and Pharmacodynamics of Ketamine","year":"2025","cit":0,"pfa":"Teijo I. Saari","psa":"Elina C. V. Brinck","topics":["Dosing & pharmacology"],"ptype":"book-chapter","src":"https://openalex.org/W4414681766","eid":"W4414681766"},{"id":"paper-w7127550305","cat":"papers","name":"Development and Implementation of a Treatment History and Authorization Checklist to Improve Access to Spravato Therapy for Treatment-Resistant Depression","year":"2025","cit":0,"pfa":"Margaret Mae Scott","topics":["Depression"],"ptype":"dissertation","src":"https://openalex.org/W7127550305","eid":"W7127550305"},{"id":"paper-w7203457049","cat":"papers","name":"[Anesthesia and sleep: from perioperative management to chronic refractory insomnia treatment].","year":"2026","cit":0,"pfa":"C Q Li","psa":"D X Wang","topics":["Reviews & meta-analyses","Therapy practice","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7203457049","eid":"W7203457049"},{"id":"paper-w4409147642","cat":"papers","name":"[Pharmacology of novel, fast-acting, non-monoaminergic antidepressants].","year":"2025","cit":0,"pfa":"Borbala Laura Bohus","psa":"Xénia Gonda","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4409147642","eid":"W4409147642"},{"id":"paper-w3174949733","cat":"papers","name":"Synaptic mechanisms underlying the rapid‐acting antidepressant actions of ketamine","year":"2018","cit":0,"pfa":"Allison Zobel","psa":"Li‐Lian Yuan","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3174949733","eid":"W3174949733"},{"id":"paper-w4406914235","cat":"papers","name":"Major Depressive Disorder as a Condition Negatively Impacting Both Mental and Physical Functioning. What to Do When There Is Treatment Resistance?","year":"2025","cit":0,"pfa":"Monika Makar","psa":"Tomasz Bartuś","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4406914235","eid":"W4406914235"},{"id":"paper-w7106144854","cat":"papers","name":"Impact of opioid-free anesthesia on the overall benefit of analgesia score after laparoscopic cholecystectomy: protocol and statistical analysis plan for a multicenter, randomized, controlled trial","year":"2025","cit":0,"pfa":"Zhao, Han-xue","psa":"Peng, Ke","topics":["Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7106144854","eid":"W7106144854"},{"id":"paper-w7127727907","cat":"papers","name":"Clinical benefits and considerations of dextromethorphan and bupropion administered separately for managing depression: A case report","year":"2026","cit":0,"pfa":"Parna Haghparast","psa":"Carol Yuan","topics":["Depression","Addiction"],"ptype":"article","src":"https://openalex.org/W7127727907","eid":"W7127727907"},{"id":"paper-w7134078808","cat":"papers","name":"Pharmacokinetics and pharmacodynamics of intravenous and oral (S)‐ketamine: Investigating metabolite contribution to subjective effects","year":"2026","cit":0,"pfa":"Marije E. Otto","psa":"Linda B. S. Aulin","topics":["Depression","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7134078808","eid":"W7134078808"},{"id":"paper-w4417023179","cat":"papers","name":"Ketamine and its Regulatory Implications: A Review","year":"2025","cit":0,"pfa":"Amol Soin","psa":"Anisha Mandava","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4417023179","eid":"W4417023179"},{"id":"paper-w7172488188","cat":"papers","name":"Treatment-resistant depression: Current therapeutic strategies","year":"2026","cit":0,"pfa":"Samuel Cândido Freres","psa":"Sharie Lohanna De Moraes Nascimento","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7172488188","eid":"W7172488188"},{"id":"paper-w4382751801","cat":"papers","name":"CURRENT PROSPECTIVE IN THE MANAGEMENT OF DEPRESSION USING OFF LABELLED DRUGS AND ADVANCED DRUGS","year":"2023","cit":0,"topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4382751801","eid":"W4382751801"},{"id":"paper-w7162315196","cat":"papers","name":"A Method for Measuring Dissociative Effects of Sub-Anesthetic Doses of Ketamine in Juvenile Female Rats","year":"2026","cit":0,"pfa":"Alexis Klinner","psa":"David S. Middlemas","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7162315196","eid":"W7162315196"},{"id":"paper-w4412672238","cat":"papers","name":"Management and Treatment of Catatonia","year":"2025","cit":0,"pfa":"Dusan Hirjak","psa":"Georg Northoff","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W4412672238","eid":"W4412672238"},{"id":"paper-w7171622691","cat":"papers","name":"Development and validation of an enzyme immunoassay screen and achiral/chiral LC-MS/MS confirmation methods for ketamine analysis in hair","year":"2026","cit":0,"pfa":"G. Neil Stowe","psa":"Ryan B Paulsen","ptype":"article","src":"https://openalex.org/W7171622691","eid":"W7171622691"},{"id":"paper-w4286007866","cat":"papers","name":"PROFILE OF LIVER CHOLESTATIC BIOMARKERS FOLLOWING PROLONGED KETAMINE ADMINISTRATION IN PATIENTS WITH COVID-19","year":"2022","cit":0,"pfa":"Julie Henrie","psa":"Philippe E. Hantson","topics":["Safety & adverse events","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W4286007866","eid":"W4286007866"},{"id":"paper-w7203931742","cat":"papers","name":"Ketamine for Chronic Pain Management: An Umbrella Review","year":"2026","cit":0,"pfa":"Sultan Kalikanov","psa":"Dmitriy Viderman","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W7203931742","eid":"W7203931742"},{"id":"paper-w4414508104","cat":"papers","name":"How Ketamine Became an Antidepressant","year":"2025","cit":0,"pfa":"Vincent Joralemon","topics":["Depression"],"ptype":"preprint","src":"https://openalex.org/W4414508104","eid":"W4414508104"},{"id":"paper-w7211873718","cat":"papers","name":"NVL-Recommended Pharmacological Next-Step Strategies During a Standardized Inpatient CBASP Program for Chronic Depression: A Retrospective Effectiveness Study","year":"2026","cit":0,"pfa":"Johannes Wolf","psa":"Elisa Schrickel","topics":["Depression","Dosing & pharmacology","Therapy practice"],"ptype":"other","src":"https://openalex.org/W7211873718","eid":"W7211873718"},{"id":"paper-w7168141582","cat":"papers","name":"Treatment-resistant Depression in the Post-ketamine Era: Unmet Needs beyond Rapid Response","year":"2026","cit":0,"pfa":"Alessandro Serretti","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7168141582","eid":"W7168141582"},{"id":"paper-w4220917110","cat":"papers","name":"Efficacy in the treatment of depressive disorders","year":"2022","cit":0,"pfa":"Taysa Leite de Aquino","psa":"Modesto Leite Rolim Neto","topics":["Depression","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4220917110","eid":"W4220917110"},{"id":"paper-w4312552015","cat":"papers","name":"New Pharmacological Therapeutic Approaches for Depressive Disorders: A Systematic Review","year":"2021","cit":0,"pfa":"Taysa Leite de Aquino","psa":"Modesto Leite Rolim Neto","topics":["Depression","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W4312552015","eid":"W4312552015"},{"id":"paper-w4412507953","cat":"papers","name":"Effects of non-intubation anesthesia based on a fentanyl-reduced regimen on hypoxemia during bronchoscopy for older patients: study protocol for a randomized controlled trial","year":"2025","cit":0,"pfa":"An Xie","psa":"Rui Zhou","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4412507953","eid":"W4412507953"},{"id":"paper-w7213321426","cat":"papers","name":"A case study of obsessive-compulsive disorder and emerging treatment approaches","year":"2026","cit":0,"pfa":"Chia-Chi Lee","topics":["Depression","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7213321426","eid":"W7213321426"},{"id":"paper-w4247072955","cat":"papers","name":"The Safety, Clinical, and Neurophysiological Effects of Intranasal Ketamine in Patients Who Do Not Respond to Electroconvulsive Therapy: Protocol for a Pilot, Open-Label Clinical Trial (Preprint)","year":"2021","cit":0,"pfa":"Yuliya Knyahnytska","psa":"Daniel M. Blumberger","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4247072955","eid":"W4247072955"},{"id":"paper-w7165532142","cat":"papers","name":"Ketamine Dosing Across Clinical Indications: A Narrative Review Organized by Proposed NMDA‐Related Mechanisms","year":"2026","cit":0,"pfa":"Paul Glue","psa":"Ben Beaglehole","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W7165532142","eid":"W7165532142"},{"id":"paper-w7212082276","cat":"papers","name":"486. A case of prolonged delirium after the application of electroconvulsive therapy in the treatment of recurrent depressive disorder","year":"2026","cit":0,"pfa":"M Pantić","psa":"M Jovanović","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"conference-abstract","src":"https://openalex.org/W7212082276","eid":"W7212082276"},{"id":"paper-w7202090684","cat":"papers","name":"Effects of opioid-free intraoperative anesthesia versus opioid-based anesthesia on postoperative immune function in elderly patients undergoing total knee arthroplasty: a single-center, prospective, randomized controlled","year":"2026","cit":0,"pfa":"Chaobo Ni","psa":"Ming Yao","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7202090684","eid":"W7202090684"},{"id":"paper-w7166685709","cat":"papers","name":"A Scoping Review of Ketamine and Psychotherapy for Depressive Disorders With or Without Comorbid Conditions","year":"2025","cit":0,"pfa":"P. Grewal","psa":"Claire Borle","topics":["Depression","PTSD & trauma","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7166685709","eid":"W7166685709"},{"id":"paper-w7203739399","cat":"papers","name":"Evaluating transportability failures of electronic health record-based risk models for treatment-resistant depression","year":"2026","cit":0,"pfa":"Colin G. Walsh","psa":"Roy H. Perlis","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7203739399","eid":"W7203739399"},{"id":"paper-w7126088764","cat":"papers","name":"Effects of nine sedative-analgesic combinations on fatigue after gastrointestinal endoscopy: a randomized controlled 3 × 3 factorial trial protocol","year":"2026","cit":0,"pfa":"Lei Huang","psa":"Ke Peng","ptype":"article","src":"https://openalex.org/W7126088764","eid":"W7126088764"},{"id":"paper-w7169881216","cat":"papers","name":"Targeting TLR4/PPARα-mediated neuroinflammation in the prefrontal cortex: S-ketamine and S-HNK rapidly alleviate depression-like behaviors","year":"2026","cit":0,"pfa":"Quanfeng Zhu","psa":"Yali Zheng","topics":["Depression","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7169881216","eid":"W7169881216"},{"id":"paper-w3192694624","cat":"papers","name":"New Pharmacological Therapeutic Approaches for Depressive Disorders: A Systematic Review","year":"2021","cit":0,"pfa":"Taysa Leite de Aquino","psa":"Modesto Leite Rolim Neto","topics":["Depression","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W3192694624","eid":"W3192694624"},{"id":"paper-w7204253051","cat":"papers","name":"Small molecules in pain management and mental healthcare","year":"2026","cit":0,"pfa":"Aditi Bagade","psa":"Ajeet Kumar","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"book-chapter","src":"https://openalex.org/W7204253051","eid":"W7204253051"},{"id":"paper-w4394085751","cat":"papers","name":"Treatment of difficult-to-treat depression – clinical guideline for selected interventions","year":"2022","cit":0,"pfa":"Stine Bjerrum Møeller","psa":"Poul Videbech","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"dataset","src":"https://openalex.org/W4394085751","eid":"W4394085751"},{"id":"paper-w7126607684","cat":"papers","name":"On the Origins of MAOI Misconceptions:Reaffirming their Role in Melancholic Depression","year":"2023","cit":0,"pfa":"Vincent Van den Eynde","psa":"Peter Kenneth Gillman","topics":["Depression","Mechanism & neuroscience"],"ptype":"review","src":"https://openalex.org/W7126607684","eid":"W7126607684"},{"id":"paper-w7125633055","cat":"papers","name":"Effectiveness of antidepressant medications on improving sleep disorders in mental health patients: a systematic review","year":"2025","cit":0,"pfa":"Tameem A Alhomaid","psa":"Sireen Takrouni","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7125633055","eid":"W7125633055"},{"id":"paper-w7160557502","cat":"papers","name":"Pharmacological and Neuromodulatory Strategies Following SSRI Non-Response in Major Depressive Disorder: Divergent U.S. and European Treatment Pathways and the Emerging Role of Novel FDA Approved Interventions","year":"2026","cit":0,"pfa":"Ivan Lopez-ibor","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"report","src":"https://openalex.org/W7160557502","eid":"W7160557502"},{"id":"paper-w4379506066","cat":"papers","name":"Major depression disorder - etiology and treatment","year":"2023","cit":0,"pfa":"Paulina CZUCHRYTA","psa":"Agnieszka URBAŃCZYK","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4379506066","eid":"W4379506066"},{"id":"paper-w7170188223","cat":"papers","name":"Obstetric anesthesia and postpartum mental health: implications from delivery to long-term recovery","year":"2026","cit":0,"pfa":"Sou Hyun Lee","psa":"Kyung Hwa Kwak","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7170188223","eid":"W7170188223"},{"id":"paper-w2979902829","cat":"papers","name":"Antidepressant-induced plasticity in the adult mouse visual cortex","year":"2019","cit":0,"pfa":"Anna Steinzeig","topics":["Depression","Mechanism & neuroscience"],"ptype":"dissertation","src":"https://openalex.org/W2979902829","eid":"W2979902829"},{"id":"paper-w7108316746","cat":"papers","name":"PERIOPERATIVE PAIN MANAGEMENT IN ADULT SURGICAL PATIENTS: A SYSTEMATIC REVIEW OF PHARMACOLOGIC AND ANESTHETIC STRATEGIES FOR OPIOID SPARING ANALGESIA","year":"2025","cit":0,"pfa":"ABDULRAHMAN ABDULLAH ASEERI","psa":"SALEH JASEM MOHAMMED ALANIZI","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7108316746","eid":"W7108316746"},{"id":"paper-w7168338620","cat":"papers","name":"Initiating dextromethorphan-bupropion extended release in patients with major depressive disorder: Delphi panel expert consensus recommendations","year":"2026","cit":0,"pfa":"Anita H. Clayton","psa":"John J. Miller","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7168338620","eid":"W7168338620"},{"id":"paper-w7108321008","cat":"papers","name":"PERIOPERATIVE PAIN MANAGEMENT IN ADULT SURGICAL PATIENTS: A SYSTEMATIC REVIEW OF PHARMACOLOGIC AND ANESTHETIC STRATEGIES FOR OPIOID SPARING ANALGESIA","year":"2025","cit":0,"pfa":"ABDULRAHMAN ABDULLAH ASEERI","psa":"SALEH JASEM MOHAMMED ALANIZI","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7108321008","eid":"W7108321008"},{"id":"paper-w7134968999","cat":"papers","name":"High-flow versus standard nasal cannula oxygenation for post-procedural quality of recovery in older adults undergoing sedated ERCP: protocol for a randomized controlled trial","year":"2026","cit":0,"pfa":"Lei Huang","psa":"Ke Peng","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7134968999","eid":"W7134968999"},{"id":"paper-w3168014473","cat":"papers","name":"EFFECT OF KETAMINE ON THE EXCITABILITY OF DORSAL RAPHE NEURONS","year":"2019","cit":0,"pfa":"Cyrine Hmaied","psa":"Vincent Seutin","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"other","src":"https://openalex.org/W3168014473","eid":"W3168014473"},{"id":"paper-w7160562597","cat":"papers","name":"Pharmacological and Neuromodulatory Strategies Following SSRI Non-Response in Major Depressive Disorder: Divergent U.S. and European Treatment Pathways and the Emerging Role of Novel FDA Approved Interventions","year":"2026","cit":0,"pfa":"Ivan Lopez-ibor","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"report","src":"https://openalex.org/W7160562597","eid":"W7160562597"},{"id":"paper-w7128194353","cat":"papers","name":"Factors for predicting response to electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS) and ketamine in patients with treatment-resistant depression: a systematic review","year":"2026","cit":0,"pfa":"Daniel Pustay","psa":"Jourdan T. Aromin","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7128194353","eid":"W7128194353"},{"id":"paper-w4415781142","cat":"papers","name":"KETAMINE COMBINED WITH DEXTROMETHORPHAN-BUPROPION FOR DEPRESSION IN THE CONTEXT OF NITROUS OXIDE MISUSE","year":"2025","cit":0,"pfa":"Sagar Sanjeev Dua","psa":"Parinda Parikh","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4415781142","eid":"W4415781142"},{"id":"paper-w4206487391","cat":"papers","name":"Clinical characteristics and treatment of treatment-resistant bipolar depression","year":"2021","cit":0,"pfa":"Grigorios N. Karakatsoulis","psa":"Konstantinos Ν. Fountoulakis","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4206487391","eid":"W4206487391"},{"id":"paper-w3083892928","cat":"papers","name":"Neurobiology of Stress, Depression, and Antidepressants: Remodeling Synaptic Connections","year":"2018","cit":0,"pfa":"Ronald S. Duman","topics":["Depression","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W3083892928","eid":"W3083892928"},{"id":"paper-w7163549109","cat":"papers","name":"The Comparative Sensitivity to Ketamine-Induced Neuronal Death in Juvenile and Adult Rats","year":"2026","cit":0,"pfa":"Sumit Sarkar","psa":"John C. Talpos","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7163549109","eid":"W7163549109"},{"id":"paper-w4390769583","cat":"papers","name":"Editorial: Glutamatergic system in affective and psychotic disorders: pre-clinical and clinical advances","year":"2024","cit":0,"pfa":"Dominik Strzelecki","psa":"David Curtis","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"editorial","src":"https://openalex.org/W4390769583","eid":"W4390769583"},{"id":"paper-w4416441401","cat":"papers","name":"The Pharmacokinetic and Pharmacodynamic Drug-drug Interaction Potential of Cannabidiol","year":"2025","cit":0,"pfa":"Guillermo Alberto Keller","psa":"Jorge Alejandro Aimar","topics":["Safety & adverse events","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4416441401","eid":"W4416441401"},{"id":"paper-w7126119888","cat":"papers","name":"Effects of nine sedative-analgesic combinations on fatigue after gastrointestinal endoscopy: a randomized controlled 3 × 3 factorial trial protocol","year":"2026","cit":0,"pfa":"Lei Huang","psa":"Ke Peng","ptype":"article","src":"https://openalex.org/W7126119888","eid":"W7126119888"},{"id":"paper-w4394145924","cat":"papers","name":"Treatment of difficult-to-treat depression – clinical guideline for selected interventions","year":"2021","cit":0,"pfa":"Stine Bjerrum Møeller","psa":"Poul Videbech","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"dataset","src":"https://openalex.org/W4394145924","eid":"W4394145924"},{"id":"paper-w7161656125","cat":"papers","name":"Efficacy and Safety of Adjunctive Therapy Using Single High-Dose S-Ketamine Infusion for Fibromyalgia: A Multicenter, Prospective, Randomized, Controlled, Open-Label, Blinded-Endpoint Study Protocol","year":"2026","cit":0,"pfa":"Niti Shrestha","psa":"Fang Luo","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7161656125","eid":"W7161656125"},{"id":"paper-w7212143424","cat":"papers","name":"CURRENT AND EMERGING DRUG TARGETS FOR THE TREATMENT OF DEPRESSION: FROM MONOAMINERGIC SIGNALING TO NEUROPLASTICITY","year":"2026","cit":0,"pfa":"Burlapalle Subhashini1*, M. Sudeep1, Sneha N.2, Brunda M. A.2, Bindu M. A.3,…","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7212143424","eid":"W7212143424"},{"id":"paper-w4382516157","cat":"papers","name":"Effects of cannabis use on antidepressant treatment response to repetitive transcranial magnetic stimulation and ketamine","year":"2023","cit":0,"pfa":"Mohammad Ali Shenasa","psa":"Dhakshin Ramanathan","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4382516157","eid":"W4382516157"},{"id":"paper-w7213126262","cat":"papers","name":"Psychopharmacology at an Inflection Point: From Syndromes to Stratified Mechanisms, Circuit-Based Treatments, and Precision Psychiatry","year":"2026","cit":0,"pfa":"Matthew Macaluso","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7213126262","eid":"W7213126262"},{"id":"paper-w7167939266","cat":"papers","name":"Pharmacological Management of Depression in the Modern Era: Established Therapies and Future Drug Targets","year":"2026","cit":0,"pfa":"Jalaniy Venkateshwaran1, Indresh Malakar2, Pooja Patra3, Rohit Kumar4*, Nuri…","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7167939266","eid":"W7167939266"},{"id":"paper-w4401069516","cat":"papers","name":"Basic aspects of ketamine therapy for treatment-resistant depression - a review paper","year":"2024","cit":0,"pfa":"Weronika Szafrańska","psa":"Oliwia Najjar","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4401069516","eid":"W4401069516"},{"id":"paper-w7155057934","cat":"papers","name":"Neuroscientific Basis of Ketamine as an Analgesic and Emerging Role in the Management of Depression","year":"2026","cit":0,"pfa":"Navy Coggins","psa":"Alan D. Kaye","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7155057934","eid":"W7155057934"},{"id":"paper-w4415829440","cat":"papers","name":"Effects of general anesthetics on seizure termination, mortality, and neurological prognosis in a rat model of pediatric refractory status epilepticus: A comparative randomized controlled study","year":"2025","cit":0,"pfa":"Bo Chen","psa":"Patrick Kwan","topics":["Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4415829440","eid":"W4415829440"},{"id":"paper-w7162210603","cat":"papers","name":"Ketamine-based ICU sedation and patient-centered outcomes: A systematic review and meta-analysis of mechanical ventilation duration, ICU length of stay, and delirium","year":"2026","cit":0,"pfa":"Rushi Patel","psa":"Juan Irribarren","topics":["Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7162210603","eid":"W7162210603"},{"id":"paper-w7128514249","cat":"papers","name":"Ketamine for depression","year":"2026","cit":0,"pfa":"Jolien K. E. Veraart","topics":["Depression","PTSD & trauma","Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W7128514249","eid":"W7128514249"},{"id":"paper-w7161137715","cat":"papers","name":"Changes in depression symptom network structure following ketamine treatment in treatment-resistant depression","year":"2026","cit":0,"pfa":"Joshua E. Curtiss","psa":"Paola Pedrelli","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7161137715","eid":"W7161137715"},{"id":"paper-w7171567666","cat":"papers","name":"Current Approaches to Sedation and Anesthesia in Endoscopy Units: Integrating Pharmacology, Monitoring, and Patient Safety","year":"2026","cit":0,"pfa":"Fatih Şahin","psa":"Benedikt Preckel","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7171567666","eid":"W7171567666"},{"id":"paper-w3157609564","cat":"papers","name":"Widespread Cortical Thickness Reductions Following Non-medical Use of Ketamine: a Structural MRI Study of Individuals with Ketamine Dependence","year":"2021","cit":0,"pfa":"Jinsong Tang","psa":"Yanhui Liao","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W3157609564","eid":"W3157609564"},{"id":"paper-w7133125758","cat":"papers","name":"Ketamine-Based ICU Sedation and Patient-Centered Outcomes: A Systematic Review and Meta-analysis of Mechanical Ventilation Duration, ICU Length of Stay, and Delirium","year":"2026","cit":0,"pfa":"Rushi Patel","psa":"Juan Irribarren","topics":["Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W7133125758","eid":"W7133125758"},{"id":"paper-w7172014286","cat":"papers","name":"Clinical Outcomes of Ketamine Therapy for Depression, Anxiety, and PTSD in Post-TBI Patients","year":"2026","cit":0,"pfa":"W. Aldulaimy","psa":"A. Shah","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7172014286","eid":"W7172014286"},{"id":"paper-w7129467360","cat":"papers","name":"Ketamine Use for ED Sedation: Pharmacologic Basis, Clinical Applications, and Safety Considerations","year":"2026","cit":0,"pfa":"Sabrina Montoya","psa":"Diego Alvarez Ramirez","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7129467360","eid":"W7129467360"},{"id":"paper-w7212140805","cat":"papers","name":"CURRENT AND EMERGING DRUG TARGETS FOR THE TREATMENT OF DEPRESSION: FROM MONOAMINERGIC SIGNALING TO NEUROPLASTICITY","year":"2026","cit":0,"pfa":"Burlapalle Subhashini1*, M. Sudeep1, Sneha N.2, Brunda M. A.2, Bindu M. A.3,…","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7212140805","eid":"W7212140805"},{"id":"paper-w7167944338","cat":"papers","name":"Pharmacological Management of Depression in the Modern Era: Established Therapies and Future Drug Targets","year":"2026","cit":0,"pfa":"Jalaniy Venkateshwaran1, Indresh Malakar2, Pooja Patra3, Rohit Kumar4*, Nuri…","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7167944338","eid":"W7167944338"},{"id":"paper-w7165659190","cat":"papers","name":"Effect of opioid-free anesthesia on postoperative sleep disturbance after thyroidectomy: a randomized clinical trial","year":"2026","cit":0,"pfa":"Shi-Jie Zhao","psa":"Jie Yang","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7165659190","eid":"W7165659190"},{"id":"paper-w7110709793","cat":"papers","name":"Enhancing Patient Access to Transcranial Magnetic Stimulation (TMS) and Intranasal Ketamine (Spravato) for Adults with Treatment-Resistant Depression (TRD): A Quality Improvement Project","year":"2025","cit":0,"pfa":"Puk, Haley","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7110709793","eid":"W7110709793"},{"id":"paper-w3211501566","cat":"papers","name":"Commentary: Treatment-resistant Depression: Considerations Related to ECT and Ketamine","year":"2021","cit":0,"pfa":"Amir Garakani","topics":["Depression","Dosing & pharmacology"],"ptype":"editorial","src":"https://openalex.org/W3211501566","eid":"W3211501566"},{"id":"paper-w3000517248","cat":"papers","name":"CMS Bundles Payment This Year for Treatment of Opioid Use Disorder","year":"2020","cit":0,"pfa":"Mark Moran","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W3000517248","eid":"W3000517248"},{"id":"paper-w7165121721","cat":"papers","name":"Comparative Efficacy of Different Hydromorphone Doses for the Prevention of Catheter-Related Bladder Discomfort in Elderly Men","year":"2026","cit":0,"pfa":"S J Yang","psa":"Simin XIE","topics":["Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7165121721","eid":"W7165121721"},{"id":"paper-w2744404843","cat":"papers","name":"Ketamine is a Potent Antidepressant, But How Does It Work?","year":"2017","cit":0,"pfa":"JoAnn Blake","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2744404843","eid":"W2744404843"},{"id":"paper-w7155213711","cat":"papers","name":"Efficacy and safety of regional blocks and multimodal analgesia in psychiatric patients at risk of opioid misuse: A systematic review","year":"2026","cit":0,"pfa":"Hersh Tilokani","psa":"Mohammad Ali Zakeri","topics":["PTSD & trauma","Addiction","Safety & adverse events"],"ptype":"review","src":"https://openalex.org/W7155213711","eid":"W7155213711"},{"id":"paper-w4313201177","cat":"papers","name":"Agomelatine in children and adolescents with moderate to severe major depressive disorder: an open-label extension study","year":"2022","cit":0,"pfa":"B. Falissard","psa":"Arango Celso","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4313201177","eid":"W4313201177"},{"id":"paper-w4392121728","cat":"papers","name":"The Top 50 Articles and Authors of the New Millennium in Psychiatry: A Bibliometric Analysis","year":"2024","cit":0,"pfa":"John L Havlik","psa":"Taeho Greg Rhee","topics":["Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4392121728","eid":"W4392121728"},{"id":"paper-w7215078980","cat":"papers","name":"Ketamine for chronic pain management: Global publication trends and collaboration networks from a 25-year Scopus bibliometric perspective","year":"2026","cit":0,"pfa":"Karima Karam","psa":"Ausaf Ahmed Khan","topics":["Mechanism & neuroscience","Dosing & pharmacology","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W7215078980","eid":"W7215078980"},{"id":"paper-w7163031031","cat":"papers","name":"Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery","year":"2026","cit":0,"pfa":"Masaru Tanaka","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7163031031","eid":"W7163031031"},{"id":"paper-w7160274367","cat":"papers","name":"Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery","year":"2026","cit":0,"pfa":"Masaru Tanaka","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7160274367","eid":"W7160274367"},{"id":"paper-w7215052187","cat":"papers","name":"COMPREHENSIVE MANAGEMENT OF DEPRESSION BEYOND SSRIS: CURRENT PHARMACOLOGICAL AND NON-PHARMACOLOGICAL STRATEGIES","year":"2026","cit":0,"pfa":"Anitha Sadula","psa":"Mudiga Anuradha","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7215052187","eid":"W7215052187"},{"id":"paper-w7136206492","cat":"papers","name":"LLM-Augmented Therapy Normalization and Aspect-Based Sentiment Analysis for Treatment-Resistant Depression on Reddit","year":"2026","cit":0,"pfa":"Yuxin Zhu","psa":"Abeed Sarker","topics":["Depression","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7136206492","eid":"W7136206492"},{"id":"paper-w7208766490","cat":"papers","name":"Accelerated, augmented, and precision-targeted: The emerging landscape of transcranial magnetic stimulation (TMS) in psychiatry and neurology","year":"2026","cit":0,"pfa":"Dawid Wiener","psa":"Filip Rybakowski","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7208766490","eid":"W7208766490"},{"id":"paper-w7140421075","cat":"papers","name":"[Recognising and treating depression - a practical overview of current treatment algorithms and evidence-based recommendations].","year":"2026","cit":0,"pfa":"Annette Beatrix Brühl","psa":"Wolfram Kawohl","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7140421075","eid":"W7140421075"},{"id":"paper-w7171729670","cat":"papers","name":"The Evidence Base for Oral Ketamine Cannot Be Trusted: A Statistical Audit of Nine RCTs and 660 Patients","year":"2026","cit":0,"pfa":"Michael Alvear","ptype":"preprint","src":"https://openalex.org/W7171729670","eid":"W7171729670"},{"id":"paper-w4416971655","cat":"papers","name":"From Monoamines to Systems Psychiatry: Rewiring Depression Science and Care (1960s–2025)","year":"2025","cit":0,"pfa":"Masaru Tanaka","topics":["Depression","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W4416971655","eid":"W4416971655"},{"id":"paper-w4413911668","cat":"papers","name":"Siegfried Kasper: The importance of back-translation of clinical findings to basic science","year":"2025","cit":0,"pfa":"Siegfried F. Kasper","topics":["Depression","Dosing & pharmacology","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4413911668","eid":"W4413911668"},{"id":"paper-w7215096840","cat":"papers","name":"COMPREHENSIVE MANAGEMENT OF DEPRESSION BEYOND SSRIS: CURRENT PHARMACOLOGICAL AND NON-PHARMACOLOGICAL STRATEGIES","year":"2026","cit":0,"pfa":"Anitha Sadula","psa":"Mudiga Anuradha","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7215096840","eid":"W7215096840"},{"id":"paper-w7161385591","cat":"papers","name":"Efficacy and Safety of Adjunctive Therapy Using Single High-Dose S-Ketamine Infusion for Fibromyalgia: A Multicenter, Prospective, Randomized, Controlled, Open-Label, Blinded-Endpoint Study Protocol","year":"2026","cit":0,"pfa":"Niti Shrestha","psa":"Fang Luo","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7161385591","eid":"W7161385591"},{"id":"paper-w7214031859","cat":"papers","name":"An Overview of Depression Pathogenesis: Prevailing Hypotheses and Associated Neurobiological Underpinnings Primarily Evidenced by Rodent Studies","year":"2026","cit":0,"pfa":"Bo Zhang","psa":"Chuanyu Li","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7214031859","eid":"W7214031859"},{"id":"paper-w7206151622","cat":"papers","name":"Comparative influence of opioid-free versus opioid-containing anesthetic techniques upon Th1/Th2 balance during laparoscopic colorectal cancer procedures: a randomized controlled trial","year":"2026","cit":0,"pfa":"Li Hong","psa":"Zhibin Zhao","topics":["Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W7206151622","eid":"W7206151622"},{"id":"paper-w7169881316","cat":"papers","name":"Hypnotic Activity and Physiological Reactions Associated with Ketamine Use: A Clinical and Neuropharmacological Review","year":"2026","cit":0,"pfa":"Marco Vinícios de Oliveira Santana","psa":"Malheiros Laura da Veiga Jardim","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"other","src":"https://openalex.org/W7169881316","eid":"W7169881316"},{"id":"paper-w7143406525","cat":"papers","name":"Polygenic Constraints on NAD⁺ Metabolism in Major Psychiatric Illness: Mechanistic Support for NMN Supplementation","year":"2026","cit":0,"pfa":"Ngo Cheung","topics":["Depression","Mechanism & neuroscience","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W7143406525","eid":"W7143406525"},{"id":"paper-w7155544372","cat":"papers","name":"The Monoamine–Glutamate Continuum of Depression: A Neurobiological Framework for Precision Psychiatry","year":"2026","cit":0,"pfa":"Pietro Carmellini","psa":"Andrea M. Fagiolini","topics":["Depression","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7155544372","eid":"W7155544372"},{"id":"paper-w7202179055","cat":"papers","name":"Hypnotic Activity and Physiological Reactions Associated with Ketamine Use: A Clinical and Neuropharmacological Review","year":"2026","cit":0,"pfa":"Marco Vinícios de Oliveira Santana","psa":"Malheiros Laura da Veiga Jardim","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"other","src":"https://openalex.org/W7202179055","eid":"W7202179055"},{"id":"paper-w7169881195","cat":"papers","name":"Hypnotic Activity and Physiological Reactions Associated with Ketamine Use: A Clinical and Neuropharmacological Review","year":"2026","cit":0,"pfa":"Marco Vinícios de Oliveira Santana","psa":"Laura da Veiga Jardim, Malheiros","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"other","src":"https://openalex.org/W7169881195","eid":"W7169881195"},{"id":"paper-w7171742488","cat":"papers","name":"Psychoactive and Neurobiological Effects of Ketamine in Humans: A Scoping Review of Clinical Evidence","year":"2026","cit":0,"pfa":"Sidorela Turtulli","psa":"Eugenia Papadaki","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7171742488","eid":"W7171742488"},{"id":"paper-w7204488120","cat":"papers","name":"Uso da cetamina no tratamento da depressão maior resistente ao tratamento","year":"2026","cit":0,"pfa":"Kristen Garcia Costa","psa":"Kelly Maria Murbach","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W7204488120","eid":"W7204488120"},{"id":"paper-w4414181097","cat":"papers","name":"Antidepressant effect of ketamine unrelated to dissociation: Results from an exploratory mediation analysis of the KET01-02 study","year":"2025","cit":0,"pfa":"Lars Arvastson","psa":"H. Eriksson","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4414181097","eid":"W4414181097"},{"id":"paper-w7140078500","cat":"papers","name":"When Trauma Meets Personality and Suicide: A Case Report on Complex PTSD and Borderline Personality Disorder","year":"2026","cit":0,"pfa":"Lucas Reis Alves Mota","psa":"Silvia Cristina Mangini Bocchi","topics":["Depression","PTSD & trauma","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7140078500","eid":"W7140078500"},{"id":"paper-w7166650756","cat":"papers","name":"Electroconvulsive Therapy Versus Ketamine for Major Depressive Episode","year":"2026","cit":0,"pfa":"James Finlay","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7166650756","eid":"W7166650756"},{"id":"paper-w3019599561","cat":"papers","name":"119 Assessment of Health-Related Quality of Life and Health Status in Patients with Treatment-resistant Depression","year":"2020","cit":0,"pfa":"Carol Jamieson","psa":"Jaskaran B. Singh","topics":["Depression","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W3019599561","eid":"W3019599561"},{"id":"paper-w7125976775","cat":"papers","name":"PSYCHOPHARMACOLOGY: HISTORY AND FUTURE PROSPECTS","year":"2025","cit":0,"pfa":"Kateryna Marchenko-Tolsta","psa":"Larysa Novykova","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7125976775","eid":"W7125976775"},{"id":"paper-w7162110702","cat":"papers","name":"Clinical recommendations and treatment algorithm for treatment-resistant depression in Saudi Arabia: an expert Delphi consensus","year":"2026","cit":0,"pfa":"Asem Abdualziz S. Alageel","psa":"Rahmah Alharbi","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7162110702","eid":"W7162110702"},{"id":"paper-w4407590840","cat":"papers","name":"EVIDÊNCIAS EMERGENTES DA EFICÁCIA E SEGURANÇA DA CETAMINA E ESCETAMINA NO TRATAMENTO DA DEPRESSÃO RESISTENTE AO TRATAMENTO","year":"2025","cit":0,"pfa":"Marcos Silveira Back","psa":"Guilherme Martins Pellin","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4407590840","eid":"W4407590840"},{"id":"paper-w7143368850","cat":"papers","name":"Polygenic Constraints on NAD⁺ Metabolism in Major Psychiatric Illness: Mechanistic Support for NMN Supplementation","year":"2026","cit":0,"pfa":"Ngo Cheung","topics":["Depression","Mechanism & neuroscience","Policy & ethics"],"ptype":"preprint","src":"https://openalex.org/W7143368850","eid":"W7143368850"},{"id":"paper-w7140189659","cat":"papers","name":"300: CRITICAL CARE KETAMINE: META-ANALYSIS OF VENTILATION DURATION, ICU STAY, AND COGNITIVE OUTCOMES","year":"2026","cit":0,"pfa":"Patel Patel","psa":"Juan Iribarren","topics":["Addiction","Safety & adverse events","Reviews & meta-analyses"],"ptype":"review","src":"https://openalex.org/W7140189659","eid":"W7140189659"},{"id":"paper-w4414542864","cat":"papers","name":"Clinical Effectiveness of N-Methyl-D-Aspartate (NMDA) Receptor Antagonists in Adult Obsessive-Compulsive Disorder (OCD) Treatment: A Systematic Review","year":"2025","cit":0,"pfa":"Asila A Ferguson","psa":"Jaafar A Hamdan","topics":["Safety & adverse events","Mechanism & neuroscience","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W4414542864","eid":"W4414542864"},{"id":"paper-w7203979078","cat":"papers","name":"Opioid-sparing anesthesia based on opioid-free principles for early recovery after total knee arthroplasty: A randomized controlled trial","year":"2026","cit":0,"pfa":"Jingwang Liu","psa":"Xiuli Wang","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W7203979078","eid":"W7203979078"},{"id":"paper-w7199511721","cat":"papers","name":"Fostering visual plasticity : the crucial role of neurotrophin receptor TRKB","year":"2024","cit":0,"pfa":"Cecilia Cannarozzo","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W7199511721","eid":"W7199511721"},{"id":"paper-w3191658018","cat":"papers","name":"2021 Educational Opportunities to Learn More About Interventional Treatments, Research","year":"2021","cit":0,"pfa":"Richard A. Bermudes","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W3191658018","eid":"W3191658018"},{"id":"paper-w7166123413","cat":"papers","name":"Comparative effectiveness of different opioid-free anesthesia regimens in patients with obesity (BMI ≥ 35 kg/m²): impact on respiratory outcomes, awakening time, and safety (narrative review)","year":"2026","cit":0,"pfa":"Kirill A. Sofronov","psa":"Mikhail V. Ketskalo","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"review","src":"https://openalex.org/W7166123413","eid":"W7166123413"},{"id":"paper-w3049249162","cat":"papers","name":"うつ病治療に対する(R)-ketamineの可能性と将来展望","year":"2018","cit":0,"pfa":"橋本謙二","topics":["Depression"],"ptype":"article","src":"https://openalex.org/W3049249162","eid":"W3049249162"},{"id":"paper-w7213445077","cat":"papers","name":"Comparison of the efficacy of different interventions for rebound pain after brachial plexus block in upper extremity surgery","year":"2026","cit":0,"pfa":"Wenhui Ma","psa":"Liu Han","topics":["Safety & adverse events","Reviews & meta-analyses"],"ptype":"article","src":"https://openalex.org/W7213445077","eid":"W7213445077"},{"id":"paper-w4414207421","cat":"papers","name":"Detection of dissociative states in patients during the administration of Es-ketamine by monitoring with the Dissociative Experience Scale II (DES II) - Part I","year":"2025","cit":0,"pfa":"Cristina Serritella","psa":"Daniele Riccio","topics":["PTSD & trauma","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4414207421","eid":"W4414207421"},{"id":"paper-w7212015067","cat":"papers","name":"286. Restoration by ketamine metabolites of cognitive and affective prosocial behaviors in a mouse model of depression","year":"2026","cit":0,"pfa":"Rei Yokoyama","psa":"Yukio Ago","topics":["Depression","Mechanism & neuroscience","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7212015067","eid":"W7212015067"},{"id":"paper-w4399157319","cat":"papers","name":"Using Interventional Pharmacoeconomic Clinical Trials and Outcomes-Based Contracts to Repurpose Generic Drugs with Cost-Savings","year":"2024","cit":0,"pfa":"Savva Kerdemelidis","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4399157319","eid":"W4399157319"},{"id":"paper-w7160083201","cat":"papers","name":"A Detailed Comparative Assessment of Two Treatment Procedures (Standard Selective Serotonin Reuptake Inhibitors and Rapid-Acting Therapies/Specifically Ketamine) For Patients Suffering from Treatment-Resistant Depression","year":"2026","cit":0,"pfa":"Dr. Dheerendra Kumar","psa":"Dr. Piyush Verma","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7160083201","eid":"W7160083201"},{"id":"paper-w4401553043","cat":"papers","name":"REVOLUTIONIZING DEPRESSION TREATMENT: A PARADIGM SHIFT OF KETAMINE THERAPY – A SYSTEMATIC REVIEW","year":"2024","cit":0,"pfa":"Yuvraj Kaushal","psa":"Arshiya Sehgal","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"review","src":"https://openalex.org/W4401553043","eid":"W4401553043"},{"id":"paper-w2673643355","cat":"papers","name":"Effect of α₂-receptor agonists on the ketamine metabolism in different species assessed by enantioselective capillary electrophoresis","year":"2016","cit":0,"pfa":"Friederike A. Sandbaumhüter","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W2673643355","eid":"W2673643355"},{"id":"paper-w4413770558","cat":"papers","name":"Esmethadone in Major Depressive Disorder: Pharmacology and Clinical Evidence","year":"2025","cit":0,"pfa":"Olaniyi David Ogundeji","psa":"Samuel Nwaobi","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4413770558","eid":"W4413770558"},{"id":"paper-w7143394991","cat":"papers","name":"Augmenting the Cheung Glutamatergic Regimen with a Senescence-Modulator Arm: Mechanistic Rationale for NMN, Intermittent Senolytics, and N-Acetylcysteine in Treatment-Resistant Depression","year":"2026","cit":0,"pfa":"Ngo Cheung","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7143394991","eid":"W7143394991"},{"id":"paper-w7212048028","cat":"papers","name":"416. Management of treatment-resistant catatonia: alternative therapeutic strategies","year":"2026","cit":0,"pfa":"I Martins Marques","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7212048028","eid":"W7212048028"},{"id":"paper-w4399154827","cat":"papers","name":"Using Interventional Pharmacoeconomic Clinical Trials and Outcomes-Based Contracts to Repurpose Generic Drugs with Cost-Savings","year":"2024","cit":0,"pfa":"Savva Kerdemelidis","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4399154827","eid":"W4399154827"},{"id":"paper-w4409651907","cat":"papers","name":"Advancements in the Treatment of Perinatal Mental Illness: Innovative and Promising Approaches","year":"2025","cit":0,"pfa":"Kathleen A Kendall-Tackett","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"book-chapter","src":"https://openalex.org/W4409651907","eid":"W4409651907"},{"id":"paper-w7166696230","cat":"papers","name":"Ketamine: Navigating Risk and Benefit. the Margaret Slack Travelling Fellowship","year":"2026","cit":0,"pfa":"Rebecca McKnight","psa":"Shanthi Sarma","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7166696230","eid":"W7166696230"},{"id":"paper-w7114994652","cat":"papers","name":"Application and Safety Evaluation of Opioid-Free Anesthesia Based on Multimodal Anesthesia in Thyroid Tumor Resection","year":"2025","cit":0,"pfa":"Yu, Xiaofan","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"other","src":"https://openalex.org/W7114994652","eid":"W7114994652"},{"id":"paper-w7114999962","cat":"papers","name":"Application and Safety Evaluation of Opioid-Free Anesthesia Based on Multimodal Anesthesia in Thyroid Tumor Resection","year":"2025","cit":0,"pfa":"Yu, Xiaofan","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"other","src":"https://openalex.org/W7114999962","eid":"W7114999962"},{"id":"paper-w4393235409","cat":"papers","name":"Using Interventional Pharmacoeconomic Clinical Trials and Outcomes-Based Contracts to Repurpose Generic Drugs with Cost-Savings","year":"2024","cit":0,"pfa":"Savva Kerdemelidis","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"preprint","src":"https://openalex.org/W4393235409","eid":"W4393235409"},{"id":"paper-w4220818724","cat":"papers","name":"A New Role for Interventional Psychiatrists: Ambassadors for Recovery","year":"2022","cit":0,"pfa":"Richard A. Bermudes","topics":["Depression","Safety & adverse events","Reviews & meta-analyses"],"ptype":"other","src":"https://openalex.org/W4220818724","eid":"W4220818724"},{"id":"paper-w7128488345","cat":"papers","name":"Episode-wide Maudsley staging in treatment-resistant depression: a longitudinal tertiary-care comparison of dimensional and categorical outcomes","year":"2026","cit":0,"pfa":"Anastasia Antoniou","psa":"Panagiotis P. Ferentinos","topics":["Depression","Therapy practice"],"ptype":"article","src":"https://openalex.org/W7128488345","eid":"W7128488345"},{"id":"paper-w2964267193","cat":"papers","name":"Researchers Look to Extend Benefits of Ketamine","year":"2019","cit":0,"pfa":"Nick Zagorski","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W2964267193","eid":"W2964267193"},{"id":"paper-w7143348539","cat":"papers","name":"Augmenting the Cheung Glutamatergic Regimen with a Senescence-Modulator Arm: Mechanistic Rationale for NMN, Intermittent Senolytics, and N-Acetylcysteine in Treatment-Resistant Depression","year":"2026","cit":0,"pfa":"Ngo Cheung","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"preprint","src":"https://openalex.org/W7143348539","eid":"W7143348539"},{"id":"paper-w4410768391","cat":"papers","name":"Generalizability of Risk Models for Treatment-Resistant Depression Across Three Health Systems","year":"2025","cit":0,"pfa":"Colin G. Walsh","psa":"Roy H. Perlis","topics":["Depression","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4410768391","eid":"W4410768391"},{"id":"paper-w2900745375","cat":"papers","name":"In vitro investigations on phase I biotransformation of ketamine in horses","year":"2013","cit":0,"pfa":"Schmitz, Andrea","topics":["Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W2900745375","eid":"W2900745375"},{"id":"paper-w4213221762","cat":"papers","name":"Effect of early intraoperative magnesium sulfate application on the incidence of vasospasm and postoperative clinical outcome in patients with aneurysmal subarachnoid haemorrhage – a retrospective cohort study","year":"2017","cit":0,"pfa":"Cornelia S. Weidinger","ptype":"other","src":"https://openalex.org/W4213221762","eid":"W4213221762"},{"id":"paper-w2076798920","cat":"papers","name":"P.1.032 Where and when ketamine alters the dopamine system: translational implications for drug addiction and psychoses","year":"2011","cit":0,"pfa":"S. Calandro","psa":"Andrea de Bartolomeis","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W2076798920","eid":"W2076798920"},{"id":"paper-w4223528166","cat":"papers","name":"Ketamine for Adults With Treatment-Resistant Depression or Post-Traumatic Stress Disorder","year":"2022","cit":0,"pfa":"Khai Trieu Tran","psa":"Quenby Mahood","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4223528166","eid":"W4223528166"},{"id":"paper-w4400135963","cat":"papers","name":"A holistic approach to maternal mental health: beyond epidural analgesia","year":"2024","cit":0,"pfa":"Tejal Kothari","psa":"Akshay Shah","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4400135963","eid":"W4400135963"},{"id":"paper-w4406254600","cat":"papers","name":"Mental Health-Related Healthcare Resource Use and Costs of Medicaid Beneficiaries with Treatment Resistant Depression Receiving Interventional Therapy","year":"2024","cit":0,"pfa":"Kristin Clemens","psa":"Kruti Joshi","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4406254600","eid":"W4406254600"},{"id":"paper-w7172064843","cat":"papers","name":"Short-term preliminary functional results from HIPOCRAT-ESK study: a cohort, non-interventional, prospective, real-world study of functional remission in TRD patients treated with Esketamina nasal spray.","year":"2026","cit":0,"pfa":"T. Caraballo Lopez","psa":"A. Ibáñez Cuadrado","topics":["Depression"],"ptype":"conference-abstract","src":"https://openalex.org/W7172064843","eid":"W7172064843"},{"id":"paper-w7165552929","cat":"papers","name":"Current clinical status of perioperative comfort therapy in pediatric anesthesia in China: a national cross-sectional survey","year":"2026","cit":0,"pfa":"Jing Shen","psa":"Fang Chen","topics":["Anxiety & end-of-life","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7165552929","eid":"W7165552929"},{"id":"paper-w4407387269","cat":"papers","name":"DIFFERENCE IN TREATMENT-RESPONSE OF IPSC-DERIVED NEURONS TO REELIN AND (2R,6R)-HNK FROM PARTICIPANTS WITH TREATMENT- RESISTANT DEPRESSION","year":"2025","cit":0,"pfa":"Jenessa N. Johnston","psa":"Carlos A. Zarate","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W4407387269","eid":"W4407387269"},{"id":"paper-w7212016702","cat":"papers","name":"784. A Retrospective Report of Efficacy and Tolerability of Low Daily Dose Ketamine for Depression and Anxiety in a Large Population Sample","year":"2026","cit":0,"pfa":"A. Nunes","psa":"Jennifer Swainson","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7212016702","eid":"W7212016702"},{"id":"paper-w7214609133","cat":"papers","name":"Editorial: Novel pharmacological interventions in emotional and neuropsychiatric disorders","year":"2026","cit":0,"pfa":"Alba García-Baos","psa":"Snezana Kusljic","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"editorial","src":"https://openalex.org/W7214609133","eid":"W7214609133"},{"id":"paper-w2338612657","cat":"papers","name":"Stereopharmacological research in anaesthesiology","year":"2015","cit":0,"pfa":"Laurence E. Mather","topics":["Addiction","Anxiety & end-of-life","Safety & adverse events"],"ptype":"dissertation","src":"https://openalex.org/W2338612657","eid":"W2338612657"},{"id":"paper-w7172003985","cat":"papers","name":"Plasmatic GABA levels and its relation with GRIN2B haplotypes and treatment resistant depression patients.","year":"2026","cit":0,"pfa":"E. Saez","psa":"L. Erkoreka","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W7172003985","eid":"W7172003985"},{"id":"paper-w4415363596","cat":"papers","name":"Durability of the Benefit of Vagus Nerve Stimulation in Markedly Treatment-Resistant Major Depression: A RECOVER Trial Report","year":"2025","cit":0,"pfa":"Charles R. Conway","psa":"Harold A. Sackeïm","topics":["Depression","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W4415363596","eid":"W4415363596"},{"id":"paper-w4283389769","cat":"papers","name":"New Clinical Track Offers Practical Strategies","year":"2022","cit":0,"pfa":"Terri D’Arrigo","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W4283389769","eid":"W4283389769"},{"id":"paper-w7203675983","cat":"papers","name":"Clinical Research Progress on the Combined Application of Ciprofol with Different Anesthetic Agents","year":"2026","cit":0,"pfa":"雪芳 林","topics":["Addiction","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7203675983","eid":"W7203675983"},{"id":"paper-w7126124998","cat":"papers","name":"Durability of the benefit of vagus nerve stimulation in markedly treatment-resistant major depression: a RECOVER trial report","cit":0,"pfa":"Conway CR","psa":"Sackeim Ha","topics":["Depression","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W7126124998","eid":"W7126124998"},{"id":"paper-w4310107837","cat":"papers","name":"Protocol Adherence for Adult Sickle Cell Patients Presenting with Vaso-Occlusive Crises on a Tertiary Teaching Hospital Emergency Department","year":"2022","cit":0,"pfa":"Charlotte F.J. Van Tuijn","psa":"Jarom Heijmans","topics":["Addiction","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4310107837","eid":"W4310107837"},{"id":"paper-w7118940650","cat":"papers","name":"Real-world treatment patterns of patients with major depressive disorder treated with Auvelity in the United States","year":"2024","cit":0,"pfa":"Andrew J. Muzyk","psa":"Yang Zhao","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"dataset","src":"https://openalex.org/W7118940650","eid":"W7118940650"},{"id":"paper-w7117131212","cat":"papers","name":"Real-world treatment patterns of patients with major depressive disorder treated with Auvelity in the United States","year":"2024","cit":0,"pfa":"Andrew J. Muzyk","psa":"Yang Zhao","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W7117131212","eid":"W7117131212"},{"id":"paper-w4206341968","cat":"papers","name":"Invasive vagus nerve stimulation in a patient with treatment-resistant depression and Brugada Type-I electrocardiogram","year":"2021","cit":0,"pfa":"Erhan Kavakbasi","psa":"Bernhardt T. Baune","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W4206341968","eid":"W4206341968"},{"id":"paper-w4313590164","cat":"papers","name":"Med Check: Alzheimer’s Agitation, Idiopathic Hypersomnia, Depression, and More","year":"2023","cit":0,"pfa":"Terri D’Arrigo","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4313590164","eid":"W4313590164"},{"id":"paper-w3033181032","cat":"papers","name":"New Antidepressant Target Identified","year":"2020","cit":0,"pfa":"Nick Zagorski","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3033181032","eid":"W3033181032"},{"id":"paper-w7152741646","cat":"papers","name":"Étude des modifications de la microstructure hippocampique dans la dépression sévère : Analyse des effets de l'électroconvulsivothérapie et de l'esketamine par IRM de diffusion","year":"2025","cit":0,"pfa":"Alice Le Berre","topics":["Depression"],"ptype":"dissertation","src":"https://openalex.org/W7152741646","eid":"W7152741646"},{"id":"paper-w4403723427","cat":"papers","name":"S1860 Ketamine-Induced Cholangiopathy: A Case Series","year":"2024","cit":0,"pfa":"Carolyn Wilson","psa":"Saikiran M. Kilaru","topics":["Depression","Addiction","Mechanism & neuroscience"],"ptype":"conference-abstract","src":"https://openalex.org/W4403723427","eid":"W4403723427"},{"id":"paper-w4313598704","cat":"papers","name":"Brief Computer Task May Prolong Effects of Ketamine","year":"2023","cit":0,"pfa":"Nick Zagorski","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4313598704","eid":"W4313598704"},{"id":"paper-w4389167924","cat":"papers","name":"Among Military With PTSD, Sleep Apnea Presents Hidden Threat","year":"2023","cit":0,"pfa":"Nick Zagorski","topics":["PTSD & trauma","Safety & adverse events","Therapy practice"],"ptype":"article","src":"https://openalex.org/W4389167924","eid":"W4389167924"},{"id":"paper-w3145053560","cat":"papers","name":"Interventional Treatments Expand Psychiatrists’ Treatment Options","year":"2021","cit":0,"pfa":"Richard A. Bermudes","topics":["Depression","Safety & adverse events","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W3145053560","eid":"W3145053560"},{"id":"paper-w7131295211","cat":"papers","name":"Impact of post-publication notices on researcher’s trust: a randomized web-based survey","year":"2026","cit":0,"pfa":"Estelle Renard","psa":"Florian Naudet","topics":["Depression","Anxiety & end-of-life","Safety & adverse events"],"ptype":"preprint","src":"https://openalex.org/W7131295211","eid":"W7131295211"},{"id":"paper-w4408550658","cat":"papers","name":"91 Service evaluation reviewing the potential benefits of ketamine on mood when used in the management of complex pain in hospice inpatients","year":"2025","cit":0,"pfa":"Ffion Carlin","psa":"Sarah Stanley","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"conference-paper","src":"https://openalex.org/W4408550658","eid":"W4408550658"},{"id":"paper-w4407419045","cat":"papers","name":"EFFICACY AND SAFETY OF INTRAVENOUS KETAMINE TREATMENT IN JAPANESE PATIENTS WITH TREATMENT-RESISTANT DEPRESSION: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL","year":"2025","cit":0,"pfa":"Yohei Ohtani","psa":"Hiroyuki Uchida","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4407419045","eid":"W4407419045"},{"id":"paper-w4224326913","cat":"papers","name":"Ketamine Use Linked to Depressive Symptoms in Youth","year":"2022","cit":0,"pfa":"Terri D’Arrigo","topics":["Depression","Addiction","Safety & adverse events"],"ptype":"article","src":"https://openalex.org/W4224326913","eid":"W4224326913"},{"id":"paper-w4391610103","cat":"papers","name":"Antidepressants for chronic pain management: considerations from predictive modeling and personalized medicine perspectives","year":"2024","cit":0,"pfa":"Xinyue Liu","psa":"Lingxiao Chen","topics":["Depression","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W4391610103","eid":"W4391610103"},{"id":"paper-w4376645711","cat":"papers","name":"Editorial: Translational behavioral approaches in animal models of psychiatry","year":"2023","cit":0,"pfa":"Stamatina Tzanoulinou","psa":"Anastasia Diamantopoulou","topics":["Depression","PTSD & trauma","Anxiety & end-of-life"],"ptype":"editorial","src":"https://openalex.org/W4376645711","eid":"W4376645711"},{"id":"paper-w7106295439","cat":"papers","name":"Longitudinal Trajectories of Depression: The Role of Antidepressant Use and Polygenic Scores","year":"2025","cit":0,"pfa":"Ilse Kolmans","psa":"Karin Verweij","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"preprint","src":"https://openalex.org/W7106295439","eid":"W7106295439"},{"id":"paper-w4402235925","cat":"papers","name":"Depression and delirium: association, prediction, causation, and care","year":"2024","cit":0,"pfa":"Hyundeok Joo","psa":"Elizabeth L. Whitlock","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"article","src":"https://openalex.org/W4402235925","eid":"W4402235925"},{"id":"paper-w4387505400","cat":"papers","name":"#36946 Ketamine in acute and chronic pain","year":"2023","cit":0,"pfa":"Evmorfia Stavropoulou","topics":["Depression","Addiction","Anxiety & end-of-life"],"ptype":"conference-paper","src":"https://openalex.org/W4387505400","eid":"W4387505400"},{"id":"paper-w2329539175","cat":"papers","name":"Funding Pours in for Investigational Hearing Treatments","year":"2014","cit":0,"pfa":"Janelle Weaver","topics":["PTSD & trauma","Safety & adverse events","Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2329539175","eid":"W2329539175"},{"id":"paper-w7122803619","cat":"papers","name":"Five years after the pandemic: rethinking the pharmacological management of mental disorders","year":"2026","cit":0,"pfa":"Esteban Zavaleta‐Monestel","psa":"Sebastián Arguedas‐Chacón","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"article","src":"https://openalex.org/W7122803619","eid":"W7122803619"},{"id":"paper-w7172488185","cat":"papers","name":"Grand challenges in anesthetic pharmacology: toward personalized, outcome-focused practice","year":"2026","cit":0,"pfa":"Tomohiko Aoe","topics":["Depression","PTSD & trauma","Addiction"],"ptype":"editorial","src":"https://openalex.org/W7172488185","eid":"W7172488185"},{"id":"paper-w416585014","cat":"papers","name":"THE EFFECT OF CHRONICALLY ADMINISTERED LSD ON THE SEROTONERGIC NERVOUS SYSTEM OF THE RAT","year":"1983","cit":0,"pfa":"Bruce E. Fishman","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W416585014","eid":"W416585014"},{"id":"paper-w3004706319","cat":"papers","name":"ChemInform Abstract: PHOTOELECTRON SPECTRA OF PSYCHOTROPIC DRUGS. 1. PHENETHYLAMINES, TRYPTAMINES, , AND LSD","year":"1977","cit":0,"pfa":"Linda N. Domelsmith","psa":"K. N. Houk","ptype":"article","src":"https://openalex.org/W3004706319","eid":"W3004706319"},{"id":"paper-w2210828521","cat":"papers","name":"Proceedings: Effect of LSD on rat brain 5-hydroxy-tryptamine metabolism at elevated environmental temperature.","year":"1976","cit":0,"pfa":"G. Curzon","psa":"Charles Alexander Marsden","ptype":"article","src":"https://openalex.org/W2210828521","eid":"W2210828521"},{"id":"paper-w2411452121","cat":"papers","name":"Uptake of serotonin (5-hydroxytryptamine) and N-N-dimethyl tryptamine (DMT) by dog's blood cells in vitro influence of chlorpromazine.","year":"1968","cit":0,"pfa":"A R Teixeira","psa":"do Lago Gp","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2411452121","eid":"W2411452121"},{"id":"paper-w2460338174","cat":"papers","name":"Some effects of the behaviorally active drug, phenitrone, a purported hashish and LSD antagonist, on brain noradrenergic and serotonergic systems.","year":"1975","cit":0,"pfa":"Spaulding Tc","psa":"William L. Dewey","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2460338174","eid":"W2460338174"},{"id":"paper-w3206531787","cat":"papers","name":"[Identification of New Psychoactive Tryptamines 4-OH-MET and 4-AcO-DMT Using High Resolution Mass Spectrometry and Nuclear Magnetic Resonance Spectroscopy].","year":"2021","cit":0,"pfa":"K R Ding","psa":"C Liang","topics":["Addiction"],"ptype":"article","src":"https://openalex.org/W3206531787","eid":"W3206531787"},{"id":"paper-w3200622893","cat":"papers","name":"Loss of Serotonergic Innervation Prevents LSD Mediated Behavioral Desensitization Without Altering its Effects on 5-HT2A Receptor Down-regulation","year":"2004","cit":0,"pfa":"Rose Liu","psa":"Vincent J. Aloyo","topics":["Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W3200622893","eid":"W3200622893"},{"id":"paper-w4400180243","cat":"papers","name":"The effect of chronic lithium treatment on serotonergic neurotransmission","year":"1988","cit":0,"pfa":"Hoau-Yan Wang","psa":"Eitan Friedman","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W4400180243","eid":"W4400180243"},{"id":"paper-w2140869988","cat":"papers","name":"Effect of pharmacological treatment of serotonergic function in depression","year":"2002","cit":0,"pfa":"Aram El Khoury","topics":["Depression","Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"dissertation","src":"https://openalex.org/W2140869988","eid":"W2140869988"},{"id":"paper-w2072743137","cat":"papers","name":"P.3.040 The effect of citalopram treatment on platelet serotonin uptake and 3H-paroxetine- and 3H-LSD-binding in panic disorder","year":"1997","cit":0,"pfa":"R. Stain‐Malmgren","psa":"B�rje Wistedt","topics":["Mechanism & neuroscience"],"ptype":"article","src":"https://openalex.org/W2072743137","eid":"W2072743137"},{"id":"paper-w2965555394","cat":"papers","name":"Sustained serotonin syndrome in a treatment-resistant depressed patient during maintenance treatment with combination of three serotonergic agents","year":"2019","cit":0,"pfa":"Stavroula Theodoropoulou","psa":"Athanasios Yalouris","topics":["Depression","Mechanism & neuroscience","Policy & ethics"],"ptype":"article","src":"https://openalex.org/W2965555394","eid":"W2965555394"},{"id":"paper-w2417973759","cat":"papers","name":"[Interaction of the anxiolytic agent buspirone with serotonin and other synaptic receptors in the human brain].","year":"1988","cit":0,"pfa":"A Ia Korneev","psa":"Chan Tb","topics":["Mechanism & neuroscience"],"ptype":"other","src":"https://openalex.org/W2417973759","eid":"W2417973759"},{"id":"paper-w2290812500","cat":"papers","name":"Ligand‐directed signaling of the serotonin 2A receptor depends on βarrestin‐2","year":"2008","cit":0,"pfa":"Laura Bohn","psa":"Cullen L. Schmid","topics":["Mechanism & neuroscience","Dosing & pharmacology"],"ptype":"article","src":"https://openalex.org/W2290812500","eid":"W2290812500"},{"id":"paper-w4241062053","cat":"papers","name":"Functional Correlates of Central 5-HT Receptors","year":"2014","cit":0,"pfa":"Herman M. Van Praag","psa":"Alan Apter","topics":["Depression","Anxiety & end-of-life","Mechanism & neuroscience"],"ptype":"book-chapter","src":"https://openalex.org/W4241062053","eid":"W4241062053"}]}